Immunohistochemical JJ O
staining NN O
was VBD O
positive JJ O
for IN O
S NNP B-Gene
- : I-Gene
100 CD I-Gene
in IN O
all DT O
9 CD O
cases NNS O
stained VBD O
, , O
positive JJ O
for IN O
HMB NNP B-Gene
- : I-Gene
45 CD I-Gene
in IN O
9 CD O
( ( O
90 CD O
% NN O
) ) O
of IN O
10 CD O
, , O
and CC O
negative JJ O
for IN O
cytokeratin NN B-Gene
in IN O
all DT O
9 CD O
cases NNS O
in IN O
which WDT O
myxoid JJ O
melanoma NN O
remained VBD O
in IN O
the DT O
block NN O
after IN O
previous JJ O
sections NNS O
. . O

Chloramphenicol NNP B-Gene
acetyltransferase NN I-Gene
assays VBZ O
examining VBG O
the DT O
ability NN O
of IN O
IE86 NNP B-Gene
to TO O
repress VB O
activity NN O
from IN O
the DT O
HCMV NNP O
major JJ O
IE NNP B-Gene
promoter NN I-Gene
or CC O
activate VB O
the DT O
HCMV NNP B-Gene
early JJ I-Gene
promoter NN I-Gene
for IN O
the DT O
2 CD O
. . O
2 CD O
- : O
kb NN O
class NN O
of IN O
RNAs NNP O
demonstrated VBD O
the DT O
functional JJ O
integrity NN O
of IN O
the DT O
IE86 NNP B-Gene
protein NN I-Gene
. . O

A DT O
new JJ O
DNA NNP B-Gene
repair NN I-Gene
gene NN I-Gene
from IN O
Schizosaccharomyces NNS O
pombe VBP O
with IN O
homology NN O
to TO O
RecA NNP B-Gene
was VBD O
identified VBN O
and CC O
characterized VBN O
. . O

Our PRP$ O
study NN O
also RB O
demonstrated VBD O
significant JJ O
increases NNS O
in IN O
the DT O
number NN O
of IN O
larger JJR O
myelinated JJ O
fibers NNS O
crossing VBG O
the DT O
repair NN O
site NN O
in IN O
comparison NN O
with IN O
the DT O
neonatal JJ O
and CC O
adult NN O
groups NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
4 CD O
) ) O
. . O

Cloning VBG O
and CC O
sequencing NN O
of IN O
the DT O
upstream JJ O
region NN O
of IN O
pepX NN B-Gene
revealed VBD O
the DT O
presence NN O
of IN O
two CD O
ORFs NNP O
of IN O
360 CD O
and CC O
1 CD O
, , O
338 CD O
bp NN O
that WDT O
were VBD O
shown VBN O
to TO O
be VB O
able JJ O
to TO O
encode VB O
proteins NNS O
with IN O
high JJ O
homology NN O
to TO O
GlnR NNP B-Gene
and CC O
GlnA NNP B-Gene
proteins NNS I-Gene
, , O
respectively RB O
. . O

Both DT O
mutant JJ O
receptors NNS O
were VBD O
expressed VBN O
on IN O
the DT O
cell NN O
surface NN O
and CC O
bound NN O
insulin NN B-Gene
normally RB O
, , O
but CC O
showed VBD O
markedly RB O
impaired JJ O
autophosphorylation NN O
in IN O
response NN O
to TO O
insulin NN B-Gene
. . O

Furthermore RB O
, , O
analysis NN O
of IN O
the DT O
E2 NNP B-Gene
proteins VBZ I-Gene
present JJ O
in IN O
various JJ O
cell NN O
lines NNS O
harboring VBG O
specific JJ O
BPV NNP O
- : O
1 CD O
mutants NNS O
, , O
including VBG O
the DT O
2558 CD O
acceptor NN O
mutant NN O
, , O
proves VBZ O
that IN O
alternate NN O
modes NNS O
of IN O
E2 NNP B-Gene
expression NN O
exist NN O
. . O

Molecular JJ O
modelling NN O
suggested VBD O
that IN O
the DT O
tetramerization NN O
domain NN O
was VBD O
a DT O
four CD O
- : O
helix NN O
bundle NN O
, , O
stabilized VBN O
by IN O
interactions NNS O
of IN O
seven CD O
conserved VBD O
aromatic JJ O
amino NN O
acids NNS O
. . O

Hematology NNP O
problem NN O
of IN O
the DT O
month NN O
: : O
band NN O
or CC O
seg NN O
? . O

PKA NNP B-Gene
phosphorylated VBD O
WT1 NNP B-Gene
at IN O
Ser NNP O
- : O
365 CD O
and CC O
Ser NNP O
- : O
393 CD O
in IN O
vitro NN O
, , O
as RB O
well RB O
as IN O
at IN O
additional JJ O
sites NNS O
, , O
and CC O
this DT O
phosphorylation NN O
abolished VBD O
the DT O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
WT1 NNP B-Gene
in IN O
vitro NN O
. . O

ROCK NNP B-Gene
- : I-Gene
I PRP I-Gene
, , O
Kinectin NNP B-Gene
, , O
and CC O
mDia2 NN B-Gene
can MD O
bind VB O
the DT O
wild JJ O
type NN O
forms NNS O
of IN O
both DT O
RhoA NNP B-Gene
and CC O
Cdc42 NNP B-Gene
in IN O
a DT O
GTP NNP O
- : O
dependent JJ O
manner NN O
in IN O
vitro NN O
. . O

These DT O
results NNS O
support VBD O
the DT O
hypothesis NN O
that WDT O
in IN O
the DT O
presence NN O
of IN O
tryptophan NN O
the DT O
ribosome NN O
translating VBG O
tnaC NN B-Gene
blocks NNS O
Rho NNP B-Gene
' POS O
s JJ O
access NN O
to TO O
the DT O
boxA NN B-Gene
and CC O
rut NN B-Gene
sites NNS I-Gene
, , O
thereby RB O
preventing VBG O
transcription NN O
termination NN O
. . O

Suppressors NNS O
of IN O
defective JJ O
silencing NN O
in IN O
yeast NN O
: : O
effects NNS O
on IN O
transcriptional JJ O
repression NN O
at IN O
the DT O
HMR NNP B-Gene
locus NN I-Gene
, , O
cell NN O
growth NN O
and CC O
telomere JJ O
structure NN O
. . O

The DT O
pJR NN O
vectors NNS O
differ VBP O
among IN O
them PRP O
in IN O
: : O
( ( O
a DT O
) ) O
the DT O
selectable JJ O
marker NN O
( ( O
Saccharomyces NNPS O
cerevisiae VBP O
LEU NNP B-Gene
2 CD I-Gene
gene NN I-Gene
, , O
which WDT O
complements VBZ O
S NNP B-Gene
. . I-Gene
pombe NN I-Gene
leu1 SYM I-Gene
- : I-Gene
gene NN I-Gene
and CC O
S NNP O
. . O
pombe NN O
ura4 JJ B-Gene
+ NN I-Gene
and CC O
his3 NN B-Gene
+ NNP I-Gene
genes NNS I-Gene
) ) O
; : O
( ( O
b NN O
) ) O
the DT O
thiamine NN O
- : O
repressible JJ O
nmt1 JJ B-Gene
promoter NN I-Gene
( ( O
3X CD O
, , O
41X CD O
and CC O
81X CD O
with IN O
extremely RB O
high JJ O
, , O
moderate JJ O
or CC O
low JJ O
transcription NN O
efficiency NN O
, , O
respectively RB O
) ) O
; : O
and CC O
( ( O
c NN O
) ) O
the DT O
multiple JJ O
cloning NN O
site NN O
( ( O
two CD O
multiple NN O
cloning VBG O
sites NNS O
, , O
with IN O
12 CD O
restriction NN O
sites NNS O
each DT O
) ) O
. . O

The DT O
transcription NN O
of IN O
most JJS O
RP NNP B-Gene
genes NNS I-Gene
is VBZ O
activated VBN O
by IN O
two CD O
Rap1p NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
, , O
250 CD O
to TO O
400 CD O
bp NNS O
upstream RB O
from IN O
the DT O
initiation NN O
of IN O
transcription NN O
. . O

Cardiac JJ O
markers NNS O
troponin VBP B-Gene
T NNP I-Gene
, , O
CK NNP B-Gene
- : O
MB NNP B-Gene
mass NN O
and CC O
myoglobin NN B-Gene
were VBD O
helpful JJ O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
chest NN O
pain NN O
, , O
even RB O
when WRB O
the DT O
ECG NNP O
was VBD O
unremarkable JJ O
or CC O
nonspecific JJ O
. . O

Finally RB O
, , O
in IN O
situ JJ O
RNA NNP O
hybridization NN O
studies NNS O
revealed VBD O
a DT O
very RB O
specific JJ O
pattern NN O
of IN O
EphA8 NNP B-Gene
gene NN I-Gene
expression NN O
restricted VBN O
to TO O
the DT O
rostral JJ O
region NN O
of IN O
midbrain NN O
tectum NN O
during IN O
embryonic JJ O
development NN O
. . O

None NN O
were VBD O
restricted VBN O
from IN O
clinical JJ O
duties NNS O
, , O
were VBD O
given VBN O
varicella SYM B-Gene
- : I-Gene
zoster NN I-Gene
immune JJ I-Gene
globulin NN I-Gene
, , O
or CC O
developed VBD O
disease NN O
. . O

Positional NNP O
cloning NN O
has VBZ O
already RB O
produced VBN O
the DT O
sequences NNS O
of IN O
more JJR O
than IN O
70 CD O
human JJ O
genes NNS O
associated VBN O
with IN O
specific JJ O
diseases NNS O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
demonstrate VBP O
that IN O
binding NN O
of IN O
the DT O
GA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
GABP NNP B-Gene
) ) O
to TO O
ets VB B-Gene
sequence NN I-Gene
motifs NNS I-Gene
within IN O
each DT O
repeated VBN O
unit NN O
is VBZ O
required VBN O
for IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
COXIV NNP B-Gene
promoter NN I-Gene
. . O

These DT O
activities NNS O
are VBP O
all DT O
required VBN O
for IN O
stimulation NN O
of IN O
cell NN O
growth NN O
by IN O
middle JJ B-Gene
- : I-Gene
T NN I-Gene
and CC O
activate JJ O
members NNS O
of IN O
the DT O
MAP NNP B-Gene
kinase NNP I-Gene
family NN I-Gene
. . O

HPLC NNP O
phosphopeptide NN O
mapping NN O
, , O
amino JJ O
acid NN O
sequencing NN O
, , O
and CC O
site NN O
- : O
directed VBN O
mutagenesis NN O
determined VBD O
that IN O
NCLK NNP B-Gene
phosphorylates VBZ O
Ser NNP O
( ( O
67 CD O
) ) O
of IN O
I PRP B-Gene
- : I-Gene
1 CD I-Gene
. . O

A DT O
chaotropic NN O
detergent NN O
, , O
0 CD O
. . O
1 CD O
% NN O
Nonidet NNP O
P NNP O
- : O
40 CD O
, , O
also RB O
abolished VBD O
the DT O
interaction NN O
, , O
further RB O
supporting VBG O
the DT O
hydrophobic JJ O
nature NN O
of IN O
the DT O
interaction NN O
. . O

Genomic NNP O
and CC O
cDNA NN O
clones NNS O
homologous JJ O
to TO O
the DT O
yeast NN O
GCN2 NNP B-Gene
eIF VBZ B-Gene
- : I-Gene
2alpha CD I-Gene
kinase NN O
( ( O
yGCN2 NN O
) ) O
were VBD O
isolated VBN O
from IN O
Drosophila NNP O
melanogaster NN O
. . O

Overexpression NN O
of IN O
RORgamma NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
inhibit VB O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
- : O
mediated VBN O
apoptosis NN O
in IN O
T NNP O
cell NN O
hybridomas NN O
and CC O
to TO O
repress VB O
the DT O
induction NN O
of IN O
Fas NNP B-Gene
- : I-Gene
ligand NN I-Gene
and CC O
interleukin JJ B-Gene
2 CD I-Gene
. . O

The DT O
final JJ O
sigma54 NN B-Gene
- : I-Gene
dependent JJ I-Gene
DmpR NNP I-Gene
activator NN I-Gene
regulates VBZ O
transcription NN O
of IN O
the DT O
dmp NN B-Gene
operon NN I-Gene
that WDT O
encodes VBZ O
the DT O
enzymes NNS O
for IN O
catabolism NN O
of IN O
( ( O
methyl NN O
) ) O
phenols NNS O
. . O

When WRB O
tethered VBN O
to TO O
a DT O
heterologous JJ O
DNA NNP O
- : O
binding NN O
domain NN O
, , O
PSU1 NNP B-Gene
can MD O
activate VB O
transcription NN O
on IN O
its PRP$ O
own JJ O
. . O

The DT O
sorption NN O
mechanisms NNS O
changed VBD O
from IN O
adsorption NN O
to TO O
partition NN O
in IN O
the DT O
process NN O
of IN O
repetitious JJ O
sorption NN O
. . O

Tyrosine NNP O
112 CD O
of IN O
latent JJ B-Gene
membrane NN I-Gene
protein NN I-Gene
2A CD I-Gene
is VBZ O
essential JJ O
for IN O
protein JJ B-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
loading NN O
and CC O
regulation NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
latency NN O
. . O

Prognosis NN O
of IN O
asymptomatic JJ O
multiple JJ O
myeloma NN O
. . O

In IN O
contrast NN O
to TO O
behavioral JJ O
deviation NN O
( ( O
the DT O
avoidance NN O
conditioning NN O
lost VBN O
) ) O
, , O
the DT O
haloperidol NN O
intrastriatal JJ O
microinjections NNS O
did VBD O
not RB O
affect VB O
the DT O
DA NNP O
synaptic JJ O
level NN O
in IN O
rostral JJ O
neostriatum NN O
. . O

From IN O
250 CD O
g NN O
of IN O
cells NNS O
, , O
we PRP O
isolated VBD O
1 CD O
mg NN O
of IN O
PDH NNP B-Gene
complex NN I-Gene
with IN O
a DT O
specific JJ O
activity NN O
of IN O
12 CD O
. . O
6 CD O
U NNP O
/ NNP O
mg NN O
of IN O
protein NN O
. . O

Deletion NN O
of IN O
the DT O
proximal JJ O
octanucleotide NN O
motif NN O
from IN O
the DT O
plasmid NN O
containing VBG O
the DT O
- : O
461 CD O
fragment NN O
of IN O
the DT O
LPL NNP B-Gene
promoter NN I-Gene
, , O
resulted VBD O
in IN O
a DT O
79 CD O
and CC O
76 CD O
% NN O
decrease NN O
in IN O
the DT O
level NN O
of IN O
expression NN O
in IN O
transfected JJ O
3T3 CD O
- : O
L1 NN O
adipocytes NNS O
and CC O
HepG2 NNP O
hepatocytes NNS O
, , O
respectively RB O
. . O

The DT O
fragments NNS O
of IN O
each DT O
region NN O
were VBD O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
and CC O
analyzed VBN O
by IN O
gel JJ O
electrophoresis NN O
to TO O
detect VB O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
. . O

A DT O
third JJ O
prominent JJ O
component NN O
of IN O
apparent JJ O
molecular JJ O
mass NN O
16 CD O
kDa NN O
displayed VBD O
several JJ O
properties NNS O
, , O
including VBG O
ability NN O
to TO O
bind VB O
45Ca2 CD O
+ NNP O
, , O
that WDT O
are VBP O
characteristic JJ O
of IN O
the DT O
regulatory JJ O
( ( O
B NNP O
) ) O
subunit NN O
of IN O
mammalian JJ B-Gene
calcineurin NN I-Gene
and CC O
was VBD O
recognized VBN O
by IN O
an DT O
antiserum NN O
raised VBN O
against IN O
bovine NN B-Gene
calcineurin NN I-Gene
. . O

Elimination NN O
of IN O
ETH1 NNP B-Gene
in IN O
apn1 NN B-Gene
strains NNS O
also RB O
increased VBD O
spontaneous JJ O
mutation NN O
rates NNS O
9 CD O
- : O
or CC O
31 CD O
- : O
fold NN O
compared VBN O
to TO O
the DT O
wild JJ O
type NN O
as IN O
determined VBN O
by IN O
reversion NN O
to TO O
adenine VB O
or CC O
lysine VB O
prototrophy NN O
, , O
respectively RB O
. . O

With IN O
the DT O
help NN O
of IN O
a DT O
nomogram JJ O
one CD O
can MD O
read VB O
off RP O
the DT O
refraction NN O
, , O
when WRB O
axis NN O
length NN O
and CC O
corneal JJ O
curvature NN O
are VBP O
known VBN O
. . O

A DT O
direct JJ O
role NN O
for IN O
sterol NN B-Gene
regulatory JJ I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
in IN O
activation NN O
of IN O
3 CD B-Gene
- : I-Gene
hydroxy NN I-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
methylglutaryl NN I-Gene
coenzyme VBZ I-Gene
A DT I-Gene
reductase NN I-Gene
gene NN I-Gene
. . O

We PRP O
have VBP O
identified VBN O
three CD O
binding VBG O
sites NNS O
for IN O
protein NN O
complexes NNS O
: : O
a DT O
palindrome NN O
, , O
a DT O
direct JJ O
repeat NN O
, , O
and CC O
a DT O
C NNP O
+ NNP O
T NNP O
sequence NN O
that WDT O
corresponds VBZ O
to TO O
seven CD O
GAGA NNP O
motifs NNS O
on IN O
the DT O
transcribed JJ O
strand NN O
. . O

Modification NN O
of IN O
dopamine NN B-Gene
D2 NNP I-Gene
receptor NN I-Gene
activity NN O
by IN O
pergolide NN O
in IN O
Parkinson NNP O
' POS O
s JJ O
disease NN O
: : O
an DT O
in IN O
vivo NN O
study NN O
by IN O
PET NNP O
. . O

In IN O
the DT O
p51 NN B-Gene
subunit NN I-Gene
, , O
the DT O
Cys181 NNP O
side NN O
- : O
chain NN O
is VBZ O
oriented VBN O
in IN O
a DT O
similar JJ O
direction NN O
to TO O
the DT O
Tyr181 NNP O
side NN O
- : O
chain NN O
in IN O
the DT O
wild JJ O
- : O
type NN O
complex NN O
. . O

Expense NN O
limits VBZ O
the DT O
use NN O
of IN O
hepatitis NN O
B NNP O
vaccines NNS O
, , O
but CC O
low JJ O
- : O
dose NN O
intradermal JJ O
immunization NN O
has VBZ O
been VBN O
evaluated VBN O
as IN O
a DT O
cost NN O
- : O
saving VBG O
strategy NN O
in IN O
numerous JJ O
studies NNS O
. . O

Blood NNP O
flow NN O
velocity NN O
waveforms NNS O
were VBD O
recorded VBN O
by IN O
pulsed JJ O
Doppler NNP O
examination NN O
of IN O
the DT O
fetal JJ O
internal JJ O
carotid NN O
and CC O
middle JJ O
cerebral JJ O
arteries NNS O
using VBG O
the DT O
established VBN O
transabdominal JJ O
route NN O
as RB O
well RB O
as IN O
a DT O
new JJ O
transvaginal JJ O
approach NN O
. . O

Expansins NNS B-Gene
are VBP O
a DT O
family NN O
of IN O
proteins NNS O
that WDT O
catalyse VBP O
long JJ O
- : O
term NN O
extension NN O
of IN O
isolated JJ O
plant NN O
cell NN O
walls NNS O
due JJ O
to TO O
an DT O
as IN O
yet RB O
unknown JJ O
biochemical JJ O
mechanism NN O
. . O

The DT O
cglIM NN B-Gene
gene NN I-Gene
is VBZ O
organized VBN O
in IN O
an DT O
unusual JJ O
operon NN O
which WDT O
contains VBZ O
, , O
in IN O
addition NN O
, , O
two CD O
genes NNS O
encoding VBG O
stress NN O
- : O
sensitive JJ O
restriction NN O
enzymes NNS O
. . O

A DT O
soap NN O
and CC O
water NN O
( ( O
1 CD O
: : O
1 CD O
, , O
v FW O
/ NNP O
v NN O
) ) O
solution NN O
effectively RB O
decontaminated VBD O
powdered JJ O
stratum NN O
corneum NN O
. . O

Srb10 NNP B-Gene
is VBZ O
a DT O
physiological JJ O
regulator NN O
of IN O
Gcn4 NNP B-Gene
stability NN O
because IN O
both DT O
phosphorylation NN O
and CC O
turnover NN O
of IN O
Gcn4 NNP B-Gene
are VBP O
diminished VBN O
in IN O
srb10 JJ B-Gene
mutants NNS I-Gene
. . O

Ongoing VBG O
and CC O
future JJ O
investigations NNS O
may MD O
better VB O
define VB O
the DT O
optimal JJ O
approach NN O
for IN O
local JJ O
control NN O
, , O
the DT O
optimal JJ O
duration NN O
of IN O
maintenance NN O
chemotherapy NN O
, , O
and CC O
the DT O
possible JJ O
role NN O
of IN O
biologic JJ O
response NN O
modifiers NNS O
and CC O
growth NN O
factors NNS O
in IN O
further JJ O
improving VBG O
the DT O
outcome NN O
for IN O
patients NNS O
with IN O
this DT O
disease NN O
. . O

Sulphur NNP O
amino NN O
acids NNS O
( ( O
g JJ O
/ $ O
16 CD O
g NN O
N NNP O
) ) O
were VBD O
higher JJR O
in IN O
the DT O
isolates NNS O
than IN O
in IN O
the DT O
flours NN O
. . O

These DT O
characteristic JJ O
structural NN O
features NNS O
were VBD O
used VBN O
to TO O
create VB O
the DT O
abbreviation NN O
AZF1 NNP B-Gene
( ( O
Asparagine NNP B-Gene
- : I-Gene
rich JJ I-Gene
Zinc NNP I-Gene
Finger NNP I-Gene
protein NN I-Gene
) ) O
. . O

A DT O
prostaglandin NN O
analogue NN O
given VBN O
in IN O
early JJ O
pregnancy NN O
and CC O
human JJ B-Gene
chorionic NN I-Gene
gonadotropin NN I-Gene
given VBN O
near IN O
the DT O
end NN O
of IN O
the DT O
ensuing VBG O
follicular JJ O
phase NN O
were VBD O
used VBN O
for IN O
controlling VBG O
the DT O
reproductive JJ O
cycle NN O
, , O
timing VBG O
oocyte JJ O
collection NN O
, , O
and CC O
synchronizing VBG O
the DT O
cycles NNS O
of IN O
oocyte JJ O
donors NNS O
and CC O
embryo NN O
recipients NNS O
. . O

High JJ O
levels NNS O
of IN O
serum NN O
calcitonin NN B-Gene
were VBD O
found VBN O
in IN O
patients NNS O
with IN O
chronic JJ O
renal JJ O
failure NN O
. . O

By IN O
using VBG O
space NN O
- : O
discrete JJ O
/ NNP O
continuous JJ O
metapopulation NN O
dynamic JJ O
models NNS O
and CC O
computer NN O
simulations NNS O
, , O
we PRP O
show VBP O
that IN O
there EX O
can MD O
be VB O
two CD O
principally RB O
different JJ O
regimes NNS O
of IN O
metapopulation NN O
dynamics NNS O
. . O

Proliferative NNP O
vasculopathy NN O
and CC O
cutaneous JJ O
hemorrhages NNS O
in IN O
porcine NN O
neonates NNS O
infected VBN O
with IN O
the DT O
porcine NN O
reproductive NN O
and CC O
respiratory JJ O
syndrome JJ O
virus NN O
. . O

No DT O
patient NN O
with IN O
bradyarrhythmia NN O
- : O
related JJ O
SCD NNP O
had VBD O
manifest JJS O
atrioventricular JJ O
block NN O
or CC O
bundle NN O
branch NN O
block NN O
. . O

While IN O
no DT O
significant JJ O
differences NNS O
in IN O
the DT O
tensile JJ O
responses NNS O
or CC O
failure NN O
characteristics NNS O
were VBD O
noted VBN O
for IN O
irradiated JJ O
and CC O
nonirradiated JJ O
grafts NNS O
in IN O
the DT O
drip NN O
, , O
in IN O
the DT O
bath NN O
environment NN O
the DT O
nonirradiated JJ O
tissues NNS O
had VBD O
greater JJR O
strength NN O
and CC O
modulus NN O
. . O

The DT O
proposed VBN O
mechanism NN O
of IN O
effect NN O
states NNS O
that IN O
mono NN O
( ( O
2 CD O
- : O
ethylhexyl NN O
) ) O
phthalate NN O
( ( O
MEHP NNP O
) ) O
, , O
the DT O
primary JJ O
hydrolysis NN O
product NN O
of IN O
DEHP NNP O
, , O
mimics VBZ O
the DT O
inducing NN O
prostaglandins NNS O
( ( O
PG NNP O
) ) O
PGD NNP O
( ( O
2 CD O
) ) O
, , O
9alpha CD O
, , O
11betaPGF2 CD O
, , O
and CC O
PGF2alpha NNP O
, , O
and CC O
thromboxanes NNS O
in IN O
the DT O
lungs NNS O
, , O
thereby RB O
increasing VBG O
the DT O
risk NN O
of IN O
inducing VBG O
inflammation NN O
in IN O
the DT O
airways NNS O
, , O
which WDT O
is VBZ O
a DT O
characteristic JJ O
of IN O
asthma NN O
. . O

Processing NN O
of IN O
the DT O
NS3 NNP B-Gene
' POS I-Gene
- : O
5B CD B-Gene
polyprotein NN O
was VBD O
complex JJ O
and CC O
occurred VBD O
rapidly RB O
. . O

Application NN O
of IN O
the DT O
method NN O
to TO O
a DT O
representative JJ O
set NN O
of IN O
50 CD O
known VBN O
genes NNS O
from IN O
Arabidopsis NNP O
thaliana NN O
showed VBD O
significant JJ O
improvement NN O
in IN O
prediction NN O
accuracy NN O
compared VBN O
to TO O
previous JJ O
spliced JJ O
alignment NN O
methods NNS O
. . O

Vocal JJ O
cord NN O
abduction NN O
rehabilitation NN O
by IN O
nervous JJ O
selective JJ O
anastomosis NN O
. . O

Plethysmographic NNP O
technique NN O
and CC O
indirect JJ O
blood NN O
pressure NN O
recordings NNS O
were VBD O
used VBN O
. . O

Bone NNP O
marrow NN O
abnormalities NNS O
in IN O
Hodgkin NNP O
' POS O
s NN O
disease NN O
are VBP O
reviewed VBN O
and CC O
the DT O
current JJ O
understanding NN O
of IN O
the DT O
pathological JJ O
mechanisms NNS O
leading VBG O
to TO O
aplastic JJ O
anemia NN O
is VBZ O
discussed VBN O
. . O

Detection NN O
of IN O
anti JJ O
- : O
lymphocyte NN O
antibodies NNS O
using VBG O
the DT O
immunoperoxidase NN B-Gene
antiglobulin NN B-Gene
technic NN O
. . O

The DT O
mean JJ O
values NNS O
of IN O
the DT O
concentrations NNS O
of IN O
the DT O
components NNS O
due JJ O
to TO O
tobacco VB O
smoke NN O
are VBP O
: : O
CO NNP O
= VBZ O
1 CD O
. . O
1 CD O
ppm NN O
, , O
NO NNP O
= NNP O
32 CD O
ppb NN O
, , O
NO2 NNP O
= VBZ O
24 CD O
ppb NN O
, , O
nicotine JJ O
= NN O
0 CD O
. . O
9 CD O
micrograms NNS O
/ JJ O
m3 NN O
, , O
particulate VBP O
matter NN O
= $ O
133 CD O
micrograms NNS O
/ JJ O
m3 NN O
. . O

Infection NN O
with IN O
Neisseria NNP O
meningitidis NNP O
group NN O
B NNP O
has VBZ O
been VBN O
difficult JJ O
to TO O
detect VB O
, , O
partly RB O
because IN O
this DT O
bacterial JJ O
group NN O
' POS O
s NN O
polysaccharide NN O
is VBZ O
a DT O
weak JJ O
immunogen NN O
. . O

Laser NNP O
ablation NN O
has VBZ O
been VBN O
employed VBN O
as IN O
a DT O
therapeutic JJ O
measure NN O
for IN O
chronic JJ O
pulmonary JJ O
emphysema NN O
. . O

The DT O
drug NN O
sensitivity NN O
was VBD O
100 CD O
% NN O
for IN O
vancomycin NN O
( ( O
VCM NNP O
) ) O
, , O
30 CD O
% NN O
for IN O
imipenam NN O
( ( O
IMP NNP O
) ) O
, , O
31 CD O
% NN O
for IN O
minomycin NN O
( ( O
MINO NNP O
) ) O
, , O
31 CD O
% NN O
for IN O
amikacin NN O
( ( O
AMK NNP O
) ) O
, , O
and CC O
7 CD O
% NN O
for IN O
fosfomycin NN O
( ( O
FOM NNP O
) ) O
. . O

Glomerular JJ O
hemodynamics NNS O
during IN O
abortion NN O
induced VBN O
by IN O
RU NNP O
486 CD O
and CC O
sepsis NN O
in IN O
rats NNS O
. . O

Intravenous JJ O
glucose JJ O
tolerance NN O
tests NNS O
were VBD O
performed VBN O
before IN O
operation NN O
, , O
before IN O
starting VBG O
CyA NNP O
and CC O
after IN O
3 CD O
weeks NNS O
. . O

Pharmacologic NNP O
aspects NNS O
of IN O
neonatal JJ O
hyperbilirubinemia NN O
. . O

DNA NNP B-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
DNA NNP B-Gene
- : I-Gene
PK NN I-Gene
) ) O
consists VBZ O
of IN O
a DT O
heterodimeric JJ O
protein NN O
( ( O
Ku NNP B-Gene
) ) O
and CC O
a DT O
large JJ O
catalytic JJ O
subunit NN O
( ( O
DNA NNP B-Gene
- : I-Gene
PKcs NN I-Gene
) ) O
. . O

Serodiagnosis NN O
of IN O
ectromelia NN O
in IN O
laboratory NN O
mice NN O

No DT O
mutation NN O
of IN O
the DT O
NRL NNP B-Gene
gene NN I-Gene
was VBD O
found VBN O
in IN O
any DT O
of IN O
the DT O
two CD O
families NNS O
. . O

Ten CD O
out RP O
- : O
patients NNS O
with IN O
pustulosis NN O
palmaris NN O
et FW O
plantaris NN O
were VBD O
examined VBN O
with IN O
direct JJ O
immunofluorescence NN O
( ( O
IF NNP O
) ) O
technique NN O
for IN O
deposition NN O
of IN O
fibrinogen NN B-Gene
, , O
fibrin NN B-Gene
or CC O
its PRP$ O
degradation NN O
products NNS O
( ( O
FR NNP B-Gene
- : I-Gene
antigen NN I-Gene
) ) O
in IN O
affected JJ O
and CC O
unaffected JJ O
skin NN O
, , O
together RB O
with IN O
heparin JJ O
- : O
precipitable JJ O
fraction NN O
( ( O
HPF NNP O
) ) O
, , O
cryoglobulin NN B-Gene
and CC O
total JJ O
plasma NN O
fibrinogen NN B-Gene
in IN O
the DT O
blood NN O
. . O

In IN O
addition NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
expression NN O
of IN O
individual JJ O
members NNS O
of IN O
one CD O
subfamily NN O
of IN O
KRAB NNP B-Gene
zinc NNP I-Gene
finger NN I-Gene
genes NNS I-Gene
is VBZ O
restricted VBN O
to TO O
specific JJ O
hematopoietic JJ O
cell NN O
lineages NNS O
. . O

We PRP O
recently RB O
reported VBD O
a DT O
placenta NN O
- : O
specific JJ O
enhancer NN O
in IN O
the DT O
human JJ B-Gene
leukemia NN I-Gene
inhibitory NN I-Gene
factor NN I-Gene
receptor NN I-Gene
( ( O
LIFR NNP B-Gene
) ) O
gene NN O
and CC O
now RB O
show VBP O
detailed JJ O
characterization NN O
of IN O
the DT O
226 CD O
- : O
base NN O
pair NN O
enhancer NN O
( ( O
- : O
4625 CD O
/ SYM O
- : O
4400 CD O
nucleotides NNS O
) ) O
. . O

Despite IN O
continuous JJ O
compliance NN O
, , O
unexplained JJ O
resurgence NN O
of IN O
serum NN O
ferritin NN B-Gene
levels NNS O
occurred VBD O
in IN O
4 CD O
/ JJ O
7 CD O
patients NNS O
of IN O
the DT O
' POS O
veteran NN O
' '' O
group NN O
after IN O
4 CD O
- : O
5 CD O
years NNS O
on IN O
L1 NNP O
. . O

Initial JJ O
screening NN O
of IN O
a DT O
rat NN O
liver NN O
cDNA NN O
library NN O
with IN O
an DT O
oligonucleotide JJ O
probe NN O
derived VBN O
from IN O
the DT O
rat NN O
SCP2 NNP B-Gene
protein NN O
sequence NN O
revealed VBD O
an DT O
825 CD O
- : O
base NN O
pair NN O
cDNA NN O
clone NN O
coding VBG O
for IN O
the DT O
complete JJ O
SCP2 NNP B-Gene
protein NN O
sequence NN O
. . O

The DT O
UAS NNP O
of IN O
the DT O
AAC2 NNP B-Gene
gene NN I-Gene
contains NNS O
at IN O
least JJS O
two CD O
distinct JJ O
motifs NNS O
for IN O
DNA NNP O
- : O
binding VBG O
transcriptional JJ O
activators NNS O
, , O
including VBG O
one CD O
which WDT O
is VBZ O
identical JJ O
with IN O
the DT O
core NN O
HAP2 NNP B-Gene
/ VBZ I-Gene
3 CD I-Gene
/ NN I-Gene
4 CD I-Gene
binding NN I-Gene
motif NN I-Gene
, , O
and CC O
a DT O
second JJ O
one NN O
with IN O
the DT O
ABF1 NNP B-Gene
consensus NN I-Gene
binding VBG I-Gene
sequence NN I-Gene
. . O

Causes NNS O
of IN O
death NN O
found VBN O
in IN O
an DT O
epidemiological JJ O
study NN O
of IN O
native JJ O
chickens NNS O
in IN O
Thai NNP O
villages NNS O
. . O

Simultaneously RB O
a DT O
greater JJR O
null NNP O
was VBD O
found VBN O
with IN O
no DT O
change NN O
in IN O
plasma JJ O
epinephrine JJ O
response NN O
. . O

A DT O
genomic JJ O
DNA NNP O
clone NN O
encoding VBG O
oryzacystatin NN B-Gene
( ( O
Oc NNP B-Gene
) ) O
, , O
a DT O
cysteine JJ B-Gene
proteinase NN I-Gene
inhibitor NN O
( ( O
cystatin NN B-Gene
) ) O
of IN O
rice NN O
, , O
was VBD O
isolated VBN O
from IN O
a DT O
lambda JJ O
EMBL3 NNP O
phage NN O
library NN O
constructed VBD O
with IN O
Sau3AI NNP B-Gene
partial JJ O
digests NNS O
of IN O
rice NN O
chromosomal NN O
DNA NNP O
, , O
by IN O
screening VBG O
with IN O
an DT O
oc JJ B-Gene
cDNA NN I-Gene
as IN O
a DT O
probe NN O
. . O

The DT O
effect NN O
of IN O
the DT O
opiate JJ O
antagonist NN O
naloxone NN O
was VBD O
evaluated VBN O
in IN O
11 CD O
unselected JJ O
patients NNS O
with IN O
cerebral JJ O
ischemia NN O
. . O

Neither DT O
side NN O
effect NN O
nor CC O
abnormal JJ O
laboratory NN O
findings NNS O
due JJ O
to TO O
this DT O
drug NN O
were VBD O
observed VBN O
. . O

The DT O
effects NNS O
of IN O
a DT O
1 CD O
- : O
or CC O
24 CD O
- : O
hour NN O
pretreatment JJ O
regimen NNS O
with IN O
monophosphoryl NN O
lipid VBP O
A NNP O
( ( O
MLA NNP O
, , O
35 CD O
micrograms NNS O
/ VBP O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
on IN O
myocardial JJ O
stunning NN O
produced VBN O
by IN O
repetitive JJ O
coronary JJ O
occlusions NNS O
were VBD O
studied VBN O
in IN O
barbital JJ O
- : O
anesthetized JJ O
dogs NNS O
. . O

Transient JJ O
cotransfection NN O
of IN O
tat NN B-Gene
cDNA NN I-Gene
in IN O
sense NN O
orientation NN O
( ( O
tat JJ B-Gene
/ NNP I-Gene
S NNP I-Gene
) ) O
, , O
together RB O
with IN O
a DT O
plasmid NN O
containing VBG O
the DT O
c NN B-Gene
- : I-Gene
fos NN I-Gene
promoter NN I-Gene
( ( O
FC3 NNP B-Gene
, , O
from IN O
- : O
711 CD O
to TO O
+ VB O
42 CD O
) ) O
in IN O
front NN O
of IN O
the DT O
bacterial JJ B-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
gene NN O
significantly RB O
enhanced VBD O
CAT NNP B-Gene
activity NN O
in IN O
Jurkat NNP O
cells NNS O
activated VBN O
by IN O
the DT O
addition NN O
of IN O
15 CD O
% NN O
fetal JJ O
calf NN O
serum NN O
( ( O
FCS NNP O
) ) O
or CC O
5 CD O
micrograms NNS O
/ VBP O
mL JJ O
phytohemagglutinin NN B-Gene
plus CC O
10 CD O
( ( O
- : O
7 CD O
) ) O
mol NN O
/ NNP O
L NNP O
phorbol NN O
myristate NN O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
U937 NNP O
cells NNS O
activated VBN O
by IN O
15 CD O
% NN O
FCS NNP O
or CC O
10 CD O
( ( O
- : O
7 CD O
) ) O
mol NN O
/ NNP O
L NNP O
PMA NNP O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
hoped VBN O
that IN O
by IN O
defining VBG O
the DT O
transcriptional JJ O
control NN O
of IN O
the DT O
L7 NNP B-Gene
gene NN I-Gene
insights NNS O
into IN O
the DT O
mechanisms NNS O
that WDT O
control VBP O
functional JJ O
fate NN O
and CC O
organization NN O
in IN O
the DT O
nervous JJ O
system NN O
can MD O
be VB O
gained VBN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
dietary JJ O
safflower JJR O
phospholipids NNS O
may MD O
be VB O
a DT O
valuable JJ O
ingredient NN O
to TO O
layers NNS O
for IN O
reducing VBG O
liver NN O
triglycerides NNS O
and CC O
serum VB O
cholesterol NN O
without IN O
any DT O
adverse JJ O
effects NNS O
. . O

However RB O
, , O
a DT O
similar JJ O
mutation NN O
of IN O
a DT O
leucine NN O
residue NN O
to TO O
arginine VB O
at IN O
position NN O
422 CD O
showed VBD O
no DT O
alteration NN O
of IN O
heterodimerization NN O
, , O
DNA NNP O
binding NN O
, , O
or CC O
transcriptional JJ O
activation NN O
. . O

The DT O
cleavage NN O
dipeptides NNS O
of IN O
C1YVV NNP B-Gene
NIa NNP I-Gene
protease NN I-Gene
are VBP O
Q NNP O
( ( O
E NNP O
) ) O
/ VBP O
S NNP O
( ( O
A NNP O
, , O
G NNP O
) ) O
. . O

In IN O
contrast NN O
, , O
similar JJ O
rates NNS O
of IN O
B NNP O
. . O
sphaericus NN O
products NNS O
, , O
ABG NNP O
- : O
6184 CD O
technical JJ O
powder NN O
and CC O
BSP NNP O
- : O
2 CD O
flowable JJ O
concentrate NN O
, , O
produced VBD O
no DT O
significant JJ O
reduction NN O
. . O

It PRP O
was VBD O
concluded VBN O
that IN O
Scotchbond NNP O
2 CD O
and CC O
Prisma NNP O
Universal NNP O
Bond NNP O
2 CD O
are VBP O
effective JJ O
and CC O
are VBP O
the DT O
dentine JJ O
bonding NN O
agents NNS O
of IN O
choice NN O
. . O

The DT O
major JJ O
findings NNS O
of IN O
our PRP$ O
studies NNS O
are VBP O
as IN O
follows VBZ O
: : O
1 CD O
) ) O
There EX O
are VBP O
no DT O
detectable JJ O
signals NNS O
around IN O
GDF NNP B-Gene
- : I-Gene
9 CD I-Gene
- : O
deficient NN O
follicles NNS O
for IN O
several JJ O
theca NNS O
cell VBP O
layer JJ O
markers NNS O
[ VBP O
i NN O
. . O
e NN O
. . O

Here RB O
we PRP O
report VBP O
that DT O
Dbp5p NNP B-Gene
and CC O
Rat7p NNP B-Gene
interact VBP O
through IN O
their PRP$ O
Nterminal JJ O
domains NNS O
. . O

Regulation NN O
of IN O
the DT O
alpha NN B-Gene
inhibin NN I-Gene
gene NN I-Gene
by IN O
cyclic JJ O
adenosine NN O
3 CD O
' '' O
, , O
5 CD O
' POS O
- : O
monophosphate NN O
after IN O
transfection NN O
into IN O
rat NN O
granulosa NN O
cells NNS O
. . O

Thus RB O
, , O
phosphodiesterase NN O
inhibitors NNS O
that WDT O
produce VBP O
an DT O
opiate NN O
quasi SYM O
- : O
withdrawal NN O
syndrome JJ O
potentiate NN O
interoceptive JJ O
stimuli NNS O
and CC O
weight JJ O
loss NN O
associated VBN O
with IN O
the DT O
withdrawal NN O
syndrome NN O
precipitated VBN O
by IN O
naltrexone NN O
in IN O
morphine JJ O
- : O
dependent JJ O
rats NNS O
. . O

A DT O
limited JJ O
study NN O
in IN O
a DT O
glassware NN O
factory NN O
( ( O
As2O3 NNP O
exposure NN O
) ) O
involving VBG O
the DT O
measurement NN O
of IN O
total JJ O
airborne JJ O
arsenic NN O
, , O
the DT O
determination NN O
of IN O
urinary JJ O
arsenic NN O
, , O
and CC O
the DT O
evaluation NN O
of IN O
hand NN O
and CC O
mouth NN O
contamination NN O
by IN O
arsenic JJ O
before IN O
and CC O
after IN O
the DT O
workshift NN O
suggests VBZ O
that IN O
the DT O
high JJ O
urinary JJ O
arsenic NN O
levels NNS O
( ( O
300 CD O
microgram NN O
/ NN O
g FW O
creatinine NN O
) ) O
are VBP O
likely JJ O
to TO O
be VB O
more RBR O
related JJ O
to TO O
an DT O
increased VBN O
oral JJ O
intake NN O
from IN O
contaminated VBN O
hands NNS O
than IN O
to TO O
an DT O
increased VBN O
absorption NN O
from IN O
the DT O
lungs NNS O
. . O

Both DT O
of IN O
these DT O
domains NNS O
have VBP O
striking VBG O
sequence NN O
homology NN O
with IN O
human JJ O
SIM NNP B-Gene
and CC O
Drosophila NNP O
SIM NNP B-Gene
proteins VBZ O
. . O

The DT O
60A CD B-Gene
transcripts NNS I-Gene
and CC O
protein NNS O
are VBP O
first RB O
detected VBN O
at IN O
the DT O
onset NN O
of IN O
gastrulation NN O
, , O
primarily RB O
in IN O
the DT O
mesoderm NN O
of IN O
the DT O
extending VBG O
germ JJ O
band NN O
. . O

OBJECTIVES NN O
: : O
To TO O
measure VB O
coagulation NN B-Gene
factor NN I-Gene
VIII NNP I-Gene
: : I-Gene
coagulant NN I-Gene
( ( O
F NNP B-Gene
. . I-Gene
VIII NN I-Gene
: : I-Gene
C NNP I-Gene
) ) O
and CC O
C1 NNP B-Gene
- : I-Gene
esterase NN I-Gene
inhibitor NN I-Gene
( ( O
C1 NNP B-Gene
- : I-Gene
INH NN I-Gene
) ) O
, , O
hemostasis SYM O
- : O
associated VBN O
acute JJ O
- : O
phase NN O
reactant JJ O
proteins NNS O
and CC O
coagulation NN B-Gene
factors NNS I-Gene
VII NNP I-Gene
( ( O
F NNP B-Gene
. . I-Gene
VII NNP I-Gene
) ) O
, , O
IX NNP O
( ( O
F NNP B-Gene
. . I-Gene
IX NNP I-Gene
) ) O
, , O
and CC O
X NNP O
( ( O
F NNP B-Gene
. . I-Gene
X NN I-Gene
) ) O
, , O
hemostasis NN O
proteins NNS O
not RB O
associated VBN O
with IN O
an DT O
acute JJ O
- : O
phase NN O
response NN O
, , O
in IN O
a DT O
select JJ O
population NN O
of IN O
horses NNS O
with IN O
colic JJ O
and CC O
hemostasis NN O
abnormalities NNS O
, , O
and CC O
presumed VBN O
to TO O
have VB O
acute JJ O
- : O
phase NN O
changes NNS O
. . O

Peroxydase NNP B-Gene
reaction NN O
stains NNS O
were VBD O
negative JJ O
, , O
chloroacetate JJ B-Gene
esterase NN I-Gene
were VBD O
strongly RB O
positive JJ O
. . O

This DT O
difference NN O
may MD O
result VB O
from IN O
the DT O
lower JJR O
match NN O
to TO O
the DT O
ARG NNP O
box NN O
consensus NN O
of IN O
the DT O
O NNP B-Gene
( ( I-Gene
rocD NN I-Gene
) ) I-Gene
site NN I-Gene
. . O

Intrastriatal JJ O
grafts NNS O
of IN O
nigral JJ O
and CC O
adrenal JJ O
tissues NNS O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
effective JJ O
in IN O
alleviating VBG O
many JJ O
of IN O
the DT O
simple JJ O
motor NN O
and CC O
sensorimotor NN O
deficits NNS O
associated VBN O
with IN O
lesions NNS O
of IN O
the DT O
nigrostriatal JJ O
dopamine NN O
system NN O
. . O

Copyright JJ O
2000 CD O
Academic NNP O
Press NNP O
. . O

We PRP O
report VBP O
a DT O
case NN O
of IN O
pheochromocytoma NN O
manifesting VBG O
during IN O
the DT O
third JJ O
trimester NN O
of IN O
pregnancy NN O
. . O

Although IN O
the DT O
E NNP O
- : O
box NN O
consensus NN O
is VBZ O
minimally RB O
defined VBN O
as IN O
CANNTG NNP O
, , O
the DT O
adjacent JJ O
nucleotides NNS O
of IN O
functional JJ O
E NNP O
- : O
boxes NNS O
are VBP O
variable JJ O
for IN O
genes NNS O
regulated VBN O
by IN O
the DT O
bHLH NN B-Gene
proteins NNS I-Gene
. . O

Here RB O
is VBZ O
presented VBN O
the DT O
monitoring NN O
of IN O
the DT O
accidental JJ O
spill NN O
on IN O
vertical JJ O
distribution NN O
of IN O
heavy JJ O
metals NNS O
in IN O
the DT O
estuarine NN O
sediments NNS O
. . O

Among IN O
the DT O
mixed JJ O
race NN O
persons NNS O
one CD O
Chukcha NNP O
- : O
Eskimo NN O
had VBD O
AS NNP O
, , O
one CD O
Eskimo NNP O
- : O
Russian JJ O
had VBD O
psoriatic JJ O
arthritis NN O
( ( O
PsA NNP O
) ) O
. . O

VE NNP O
- : O
DEF NN O
animals NNS O
had VBD O
significantly RB O
higher JJR O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
levels NNS O
of IN O
myocardial JJ O
lipid JJ O
peroxidation NN O
and CC O
lower JJR O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
protein NN O
thiols IN O
following VBG O
I PRP O
- : O
R NN O
compared VBN O
to TO O
the DT O
CON NNP O
animals NNS O
. . O

Only RB O
seven CD O
patients NNS O
, , O
five CD O
of IN O
whom WP O
have VBP O
metastatic JJ O
disease NN O
, , O
survive VBP O
more JJR O
than IN O
10 CD O
years NNS O
after IN O
first JJ O
presentation NN O
; : O
nine CD O
patients NNS O
, , O
one CD O
of IN O
whom WP O
has VBZ O
secondaries NNS O
, , O
survive VBP O
for IN O
5 CD O
years NNS O
or CC O
less JJR O
. . O

The DT O
ORs NNP O
of IN O
GC NNP O
, , O
adjusted VBN O
for IN O
age NN O
and CC O
sex NN O
, , O
varied VBD O
from IN O
17 CD O
. . O
1 CD O
, , O
for IN O
those DT O
with IN O
baseline JJ O
diagnoses NNS O
of IN O
superficial JJ O
intestinal JJ O
metaplasia NN O
( ( O
IM NNP O
) ) O
, , O
to TO O
29 CD O
. . O
3 CD O
, , O
for IN O
those DT O
with IN O
deep JJ O
IM NNP O
or CC O
mild JJ O
dysplasia NN O
( ( O
DYS NNP O
) ) O
or CC O
IM NNP O
with IN O
glandular JJ O
atrophy NN O
and CC O
neck NN O
hyperplasia NN O
, , O
to TO O
104 CD O
. . O
2 CD O
, , O
for IN O
those DT O
with IN O
moderate JJ O
or CC O
severe JJ O
DYS NNP O
, , O
as IN O
compared VBN O
with IN O
subjects NNS O
with IN O
superficial JJ O
gastritis NN O
( ( O
SG NNP O
) ) O
or CC O
chronic JJ O
atrophic JJ O
gastritis NN O
( ( O
CAG NNP O
) ) O
at IN O
baseline NN O
. . O

We PRP O
consider VBP O
that DT O
DIL NNP O
- : O
CP NNP O
is VBZ O
a DT O
safe JJ O
and CC O
excellent JJ O
CP NNP O
in IN O
CABG NNP O
surgery NN O
and CC O
we PRP O
are VBP O
now RB O
utilizing VBG O
this DT O
CP NNP O
in IN O
all DT O
patients NNS O
requiring VBG O
CABG NNP O
surgery NN O
. . O

During IN O
1985 CD O
, , O
1990 CD O
, , O
and CC O
1995 CD O
, , O
respectively RB O
, , O
11 CD O
. . O
7 CD O
, , O
11 CD O
. . O
3 CD O
, , O
and CC O
11 CD O
. . O
4 CD O
infants NNS O
per IN O
100 CD O
, , O
0 CD O
live JJ O
births NNS O
had VBD O
a DT O
diagnosis NN O
of IN O
HSV NNP O
( ( O
P NNP O
= NNP O
. . O
98 CD O
) ) O
. . O

Cerebral125 NNP B-Gene
albumin NN I-Gene
was VBD O
increased VBN O
to TO O
similar JJ O
proportions NNS O
in IN O
those DT O
groups NNS O
submitted VBD O
to TO O
hyperosmolality NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
function NN O
of IN O
the DT O
DS2 NNP B-Gene
may MD O
be VB O
the DT O
protection NN O
of IN O
the DT O
nuclear JJ O
DNA NN O
from IN O
desiccation NN O
. . O

In IN O
situ JJ O
hybridization NN O
with IN O
the DT O
antisense NN O
RNA NNP O
probes VBZ O
further RB O
supported VBN O
the DT O
expression NN O
changes NNS O
of IN O
these DT O
six CD O
clones NNS O
and CC O
localized VBD O
the DT O
changes NNS O
in IN O
multiple JJ O
germ NN O
cell NN O
stages NNS O
as RB O
well RB O
as IN O
other JJ O
cell NN O
types NNS O
( ( O
Sertoli NNP O
, , O
interstitial JJ O
and CC O
peritubular JJ O
cells NNS O
) ) O
. . O

R NNP O
- : O
wave NN O
voltage NN O
in IN O
the DT O
right JJ O
precordial JJ O
leads NNS O
in IN O
anthracycline NN O
cardiomyopathy NN O
: : O
a DT O
clinical JJ O
study NN O
. . O

Limb NNP O
allografts NNS O
in IN O
rats NNS O
immunosuppressed VBN O
with IN O
cyclosporin NN O
A NNP O
. . O

Mutations NNS O
at IN O
three CD O
sites NNS O
have VBP O
larger JJR O
effects NNS O
in IN O
muscle NN O
than IN O
nonmuscle NN O
cells NNS O
; : O
an DT O
A NNP O
/ NN O
T NNP O
- : O
rich JJ O
site NN O
mutation NN O
has VBZ O
a DT O
pronounced JJ O
effect NN O
in IN O
both DT O
striated JJ O
muscle NN O
types NNS O
, , O
mutations NNS O
at IN O
the DT O
MEF1 NNP B-Gene
( ( I-Gene
Right NNP I-Gene
E NNP I-Gene
- : I-Gene
box NN I-Gene
) ) I-Gene
site NN I-Gene
are VBP O
relatively RB O
specific JJ O
to TO O
expression NN O
in IN O
skeletal JJ O
muscle NN O
, , O
and CC O
mutations NNS O
at IN O
the DT O
CArG NNP O
site NN O
are VBP O
relatively RB O
specific JJ O
to TO O
expression NN O
in IN O
cardiac JJ O
muscle NN O
. . O

The DT O
monkey NN B-Gene
LHR NNP I-Gene
cDNA NN I-Gene
displayed VBD O
83 CD O
- : O
94 CD O
% NN O
overall JJ O
sequence NN O
homology NN O
with IN O
the DT O
other JJ O
mammalian JJ B-Gene
LHR NNP I-Gene
cDNAs NN I-Gene
. . O

Alanine NNP O
substitution NN O
mutations NNS O
in IN O
the DT O
Zta NNP B-Gene
activation NN I-Gene
domain NN I-Gene
which WDT O
eliminate VBP O
the DT O
ability NN O
of IN O
Zta NNP B-Gene
to TO O
stimulate VB O
the DT O
D NNP B-Gene
- : I-Gene
A DT I-Gene
complex JJ I-Gene
were VBD O
examined VBN O
. . O

In IN O
contrast NN O
with IN O
previous JJ O
two CD O
- : O
pool NN O
models NNS O
, , O
provisions NNS O
were VBD O
made VBN O
for IN O
folate JJ O
turnover NN O
by IN O
urinary JJ O
folate NN O
excretion NN O
( ( O
as IN O
measured VBN O
here RB O
) ) O
and CC O
by IN O
fecal JJ O
excretion NN O
and CC O
catabolic JJ O
processes NNS O
. . O

In IN O
female JJ O
Sl NNP B-Gene
( ( I-Gene
pan NN I-Gene
) ) I-Gene
/ NN I-Gene
Sl NNP I-Gene
( ( I-Gene
pan NN I-Gene
) ) I-Gene
mice NN O
, , O
ovarian JJ O
follicle NN O
development NN O
is VBZ O
arrested VBN O
at IN O
the DT O
one CD O
layered VBD O
cuboidal JJ O
stage NN O
as IN O
a DT O
result NN O
of IN O
reduced JJ O
KL NNP B-Gene
expression NN O
in IN O
follicle NN O
cells NNS O
, , O
indicating VBG O
a DT O
role NN O
for IN O
c SYM B-Gene
- : I-Gene
kit NN I-Gene
in IN O
oocyte JJ O
growth NN O
. . O

Among IN O
genes NNS O
induced VBN O
by IN O
added JJ O
pMesogenin1 NN B-Gene
is VBZ O
Xwnt NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
a DT O
signaling VBG O
factor NN O
that WDT O
induces VBZ O
a DT O
similar JJ O
repertoire NN O
of IN O
marker NN O
genes NNS O
and CC O
a DT O
similar JJ O
cellular JJ O
phenotype NN O
. . O

The DT O
hemodynamics NNS O
of IN O
isoproterenol JJ O
- : O
induced JJ O
cardiac JJ O
failure NN O
in IN O
the DT O
rat NN O
. . O

BACKGROUND NN O
: : O
Fluoroquinolones NNS O
( ( O
FQ NNP O
) ) O
are VBP O
contraindicated VBN O
in IN O
children NNS O
because IN O
of IN O
the DT O
risk NN O
of IN O
cartilage NN O
damage NN O
. . O

In IN O
patients NNS O
in IN O
group NN O
A NNP O
( ( O
"""" NNP O
normal JJ O
"""" NNP O
CI NNP O
) ) O
, , O
the DT O
CI NNP O
, , O
heart NN O
rate NN O
and CC O
the DT O
mean JJ O
circumferential JJ O
fiber NN O
shortening VBG O
velocity NN O
( ( O
mVCF NN O
) ) O
were VBD O
normal JJ O
, , O
but CC O
the DT O
TPR NNP O
was VBD O
increased VBN O
significantly RB O
. . O

Clinical JJ O
use NN O
of IN O
absorbable JJ O
polyglycolic JJ O
acid NN O
suture NN O
in IN O
Blalock NNP O
- : O
Taussig NNP O
' POS O
s NN O
operation NN O

A DT O
novel JJ O
approach NN O
was VBD O
developed VBN O
for IN O
identifying VBG O
transcription NN O
factor NN O
activities NNS O
associated VBN O
with IN O
NGF NNP B-Gene
- : O
activated VBN O
, , O
but CC O
not RB O
EGF NNP B-Gene
- : O
activated VBD O
, , O
signaling VBG O
, , O
using VBG O
random JJ O
oligonucleotide JJ O
clones NNS O
from IN O
a DT O
DNA NN O
recognition NN O
library NN O
to TO O
isolate VB O
specific JJ O
DNA NNP O
binding NN O
proteins NNS O
from IN O
PC12 NNP O
nuclear JJ O
extracts NNS O
. . O

D NNP O
. . O

Disciplinary JJ O
action NN O
for IN O
DNA NNP O
violation NN O
. . O

Since IN O
1970 CD O
the DT O
frequency NN O
of IN O
potassium NN O
- : O
induced JJ O
ulceration NN O
has VBZ O
been VBN O
low JJ O
- : O
- : O
3 CD O
cases NNS O
per IN O
100 CD O
0 CD O
patient JJ O
- : O
years NNS O
of IN O
slow JJ O
- : O
release NN O
tablet NN O
use NN O
. . O

Tl NNP O
- : O
201 CD O
uptake JJ O
ratio NN O
of IN O
the DT O
right JJ O
ventricle NN O
, , O
which WDT O
represents VBZ O
the DT O
ratio NN O
of IN O
total JJ O
counts NNS O
of IN O
the DT O
right JJ O
ventricle NN O
to TO O
counts NNS O
of IN O
the DT O
administered VBN O
dose NN O
of IN O
Tl NNP O
- : O
201 CD O
, , O
was VBD O
higher RBR O
in IN O
COPD NNP O
, , O
especially RB O
in IN O
pulmonary JJ O
emphysema NN O
and CC O
B NNP O
type NN O
COPD NNP O
by IN O
Burrows NNP O
classification NN O
than IN O
in IN O
controls NNS O
. . O

The DT O
deubiquitinating VBG O
enzyme NN O
DUB NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
induced VBN O
in IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
but CC O
as RB O
yet RB O
its PRP$ O
function NN O
has VBZ O
not RB O
been VBN O
determined VBN O
. . O

The DT O
bovine NN B-Gene
papillomavirus NN I-Gene
E2 NNP I-Gene
protein NN I-Gene
can MD O
inhibit VB O
the DT O
proliferation NN O
of IN O
HT NNP O
- : O
3 CD O
cells NNS O
, , O
a DT O
p53 NN B-Gene
- : O
negative JJ O
cervical JJ O
carcinoma NN O
cell NN O
line NN O
containing VBG O
integrated JJ O
human JJ O
papillomavirus NN O
type NN O
30 CD O
DNA NN O
. . O

A DT O
much RB O
less RBR O
expensive JJ O
solution NN O
than IN O
UW NNP O
, , O
containing VBG O
only RB O
K NNP O
( ( O
+ NNP O
) ) O
- : O
lactobionate NN O
, , O
KH2PO4 NNP O
, , O
MgSO4 NNP O
and CC O
raffinose VB O
, , O
can MD O
be VB O
used VBN O
successfully RB O
for IN O
preservation NN O
of IN O
rat NN O
hepatocytes NNS O
for IN O
24 CD O
hr NN O
for IN O
drug NN O
transport NN O
studies NNS O
. . O

Hydroxypropyl NNP O
methacrylate NN O
, , O
a DT O
new JJ O
water NN O
- : O
miscible JJ O
embedding VBG O
medium NN O
for IN O
electron NN O
microscopy NN O
. . O

The DT O
homologous JJ O
active JJ O
- : O
site NN O
framework NN O
of IN O
these DT O
enzymes NNS O
with IN O
distinct JJ O
structures NNS O
suggests VBZ O
convergent JJ O
evolution NN O
of IN O
a DT O
common JJ O
catalytic JJ O
mechanism NN O
. . O

Large JJ O
strain NN O
differences NNS O
were VBD O
found VBN O
for IN O
all DT O
variables NNS O
recorded VBN O
, , O
i NN O
. . O
e NN O
. . O
, , O
the DT O
proportion NN O
of IN O
attacking VBG O
males NNS O
, , O
the DT O
time NN O
spent VBN O
in IN O
the DT O
brightly RB O
lit JJ O
box NN O
, , O
and CC O
the DT O
number NN O
of IN O
transitions NNS O
between IN O
the DT O
lit NN O
and CC O
the DT O
dark NN O
boxes NNS O
. . O

In IN O
gel JJ O
mobility NN O
shift NN O
assays NNS O
, , O
factors NNS O
present VBP O
in IN O
nuclear JJ O
extracts NNS O
derived VBN O
from IN O
differentiated VBN O
osteoblast NN O
bound NN O
to TO O
oligonucleotide VB O
probes NNS O
containing VBG O
the DT O
E NNP O
- : O
box NN O
1 CD O
and CC O
E NNP O
- : O
box NN O
2 CD O
elements NNS O
. . O

Here RB O
we PRP O
describe VBP O
and CC O
map VBP O
two CD O
more JJR O
new JJ O
genes NNS O
identified VBN O
as IN O
allele JJ O
- : O
specific JJ O
suppressors NNS O
that WDT O
compensate VBP O
for IN O
carboxy JJ O
- : O
terminal JJ O
truncation NN O
of IN O
PET122 NNP B-Gene
. . O

One CD O
of IN O
these DT O
fragments NNS O
shows VBZ O
the DT O
highest JJS O
amino NN O
acid NN O
sequence NN O
homology NN O
to TO O
the DT O
insect JJ O
ecdysone NN O
inducible JJ O
gene NN B-Gene
E75 NNP I-Gene
. . O

Secretory JJ O
function NN O
of IN O
the DT O
prostate NN O
gland NN O
. . O

Changes NNS O
of IN O
plasma NN O
cortisol NN O
level NN O
in IN O
late JJ O
asthmatic JJ O
responses NNS O

We PRP O
find VBP O
that IN O
the DT O
measured VBN O
Nusselt NNP O
number NN O
decreased VBD O
about RB O
20 CD O
% NN O
over IN O
the DT O
range NN O
of IN O
Pr NNP O
spanned VBD O
in IN O
the DT O
experiment NN O
. . O

An DT O
NF1 NNP B-Gene
- : I-Gene
related JJ I-Gene
vitellogenin NN I-Gene
activator NN I-Gene
element NN I-Gene
mediates NNS O
transcription NN O
from IN O
the DT O
estrogen NN O
- : O
regulated VBN O
Xenopus NNP B-Gene
laevis FW I-Gene
vitellogenin NN I-Gene
promoter NN I-Gene
. . O

Perhaps RB O
in IN O
addition NN O
to TO O
, , O
or CC O
as IN O
part NN O
of IN O
, , O
its PRP$ O
essential JJ O
function NN O
in IN O
late JJ O
mitosis NN O
, , O
MOB1 NNP B-Gene
is VBZ O
required VBN O
for IN O
a DT O
cell NN O
cycle NN O
reset NN O
function NN O
necessary JJ O
for IN O
the DT O
initiation NN O
of IN O
the DT O
spindle JJ O
pole NN O
body NN O
duplication NN O
. . O

DR1 NNP B-Gene
molecules NNS I-Gene
purified VBD O
from IN O
human JJ O
lymphoblastoid NN O
cell NN O
lines NNS O
could MD O
specifically RB O
bind VB O
to TO O
these DT O
peptide JJ O
sequences NNS O
expressed VBN O
on IN O
the DT O
phage NN O
surface NN O
. . O

Sixty NNP O
- : O
five CD O
patients NNS O
( ( O
aged VBN O
between IN O
3 CD O
years NNS O
5 CD O
months NNS O
and CC O
60 CD O
years NNS O
) ) O
suffering VBG O
from IN O
medically RB O
resistant JJ O
temporal JJ O
lobe NN O
epilepsy NN O
( ( O
TLE NNP O
) ) O
were VBD O
operated VBN O
on IN O
over IN O
a DT O
period NN O
of IN O
33 CD O
months NNS O
in IN O
Bethel NNP O
Epilepsy NNP O
Center NNP O
. . O

Diagnosis NN O
and CC O
treatment NN O
planning NN O
in IN O
Class NNP O
II NNP O
, , O
division NN O
2 CD O

The DT O
3 CD O
' POS O
UTR NNP O
has VBZ O
several JJ O
stable JJ O
hairpins NNS O
that WDT O
are VBP O
flanked VBN O
by IN O
single JJ O
- : O
stranded VBN O
( ( O
A DT O
/ NNP O
U NNP O
) ) O
UGC NNP O
sequences NNS O
. . O

AIMS NNS O
: : O
To TO O
evaluate VB O
the DT O
role NN O
of IN O
environmental JJ O
intra JJ O
- : O
uterine JJ O
factors NNS O
in IN O
determining VBG O
the DT O
birthweights NNS O
of IN O
twins NNS O
with IN O
increased JJ O
susceptibility NN O
to TO O
diabetes NNS O
and CC O
discordant NN O
for IN O
abnormal JJ O
responses NNS O
to TO O
the DT O
oral JJ O
glucose JJ O
tolerance NN O
test NN O
( ( O
OGTT NNP O
) ) O
and CC O
verify VB O
the DT O
possible JJ O
association NN O
of IN O
within IN O
- : O
pair NN O
birthweight JJ O
differences NNS O
and CC O
metabolic JJ O
abnormalities NNS O
in IN O
adult JJ O
life NN O
. . O

Restriction NNP O
enzyme VBZ O
mapping NN O
and CC O
Southern JJ O
analysis NN O
indicated VBD O
further RBR O
that IN O
the DT O
human JJ B-Gene
MZF NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
is VBZ O
a DT O
single JJ O
- : O
copy NN O
gene NN O
. . O

Responses NNS O
of IN O
single JJ O
- : O
unit NN O
carotid NN O
body NN O
chemoreceptors NNS O
in IN O
adult NN O
rats NNS O
. . O

Tec NNP B-Gene
kinase NN I-Gene
signaling VBG O
in IN O
T NNP O
cells NNS O
is VBZ O
regulated VBN O
by IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
and CC O
the DT O
Tec NNP B-Gene
pleckstrin NN B-Gene
homology NN I-Gene
domain NN I-Gene
. . O

An DT O
analytic JJ O
method NN O
for IN O
comparative JJ O
parameter NN O
weighting VBG O
in IN O
magnetic JJ O
resonance NN O
( ( O
MR NNP O
) ) O
imaging NN O
has VBZ O
been VBN O
developed VBN O
using VBG O
the DT O
concept NN O
of IN O
"""" NNP O
fractional JJ O
sensitivity NN O
. . O
"""" VB O
This DT O
new JJ O
approach NN O
results NNS O
in IN O
easily RB O
calculated VBN O
indexes NNS O
for IN O
T1 NNP O
, , O
T2 NNP O
, , O
and CC O
hydrogen NN O
weighting NN O
. . O

Spatial JJ O
accuracy NN O
of IN O
primary JJ O
and CC O
secondary JJ O
memory NN O
- : O
guided VBD O
saccades NNS O
in IN O
schizophrenic JJ O
patients NNS O
. . O

In IN O
the DT O
context NN O
of IN O
liver NN O
allograft NN O
shortage NN O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
an DT O
ELT NNP O
should MD O
not RB O
be VB O
performed VBN O
in IN O
patients NNS O
with IN O
cardiac JJ O
failure NN O
, , O
more JJR O
than IN O
two CD O
OSF NNP O
, , O
or CC O
an DT O
APACHE NNP O
II NNP O
score VBD O
higher JJR O
than IN O
30 CD O
. . O

In IN O
one CD O
, , O
exploratory NN O
behavior NN O
( ( O
assessed VBN O
by IN O
hole NN O
pokes NNS O
) ) O
and CC O
locomotion NN O
were VBD O
assessed VBN O
during IN O
a DT O
10 CD O
- : O
min NN O
test NN O
session NN O
. . O

Analysis NN O
of IN O
the DT O
inferred JJ O
1 CD B-Gene
, , I-Gene
859 CD I-Gene
- : I-Gene
residue JJ I-Gene
ama SYM I-Gene
- : I-Gene
1 CD I-Gene
product NN I-Gene
showed VBD O
considerable JJ O
identity NN O
with IN O
the DT O
largest JJS O
subunit NN O
of IN O
RNAP NNP B-Gene
II NNP I-Gene
from IN O
other JJ O
organisms NNS O
, , O
including VBG O
the DT O
presence NN O
of IN O
a DT O
zinc NN O
finger NN O
motif NN O
near IN O
the DT O
amino NN O
terminus NN O
, , O
and CC O
a DT O
carboxyl JJ O
- : O
terminal JJ O
domain NN O
of IN O
42 CD O
tandemly NNS O
reiterated VBD O
heptamers NNS O
with IN O
the DT O
consensus NN O
Tyr NNP O
Ser NNP O
Pro NNP O
Thr NNP O
Ser NNP O
Pro NNP O
Ser NNP O
. . O

In IN O
these DT O
cases NNS O
, , O
greatly RB O
increased VBD O
human JJ B-Gene
chorionic JJ I-Gene
gonadotropin NN I-Gene
( ( O
hCG NN B-Gene
) ) O
levels NNS O
and CC O
suppressed VBD O
TSH NNP B-Gene
levels NNS O
suggest VBP O
that IN O
hCG NN B-Gene
has VBZ O
thyrotropic VBN O
activity NN O
. . O

Bipolarity NNP O
in IN O
Jungian NNP O
type NN O
theory NN O
and CC O
the DT O
Myers NNP O
- : O
Briggs NNP O
Type NNP O
Indicator NNP O
. . O

The DT O
present JJ O
results NNS O
demonstrate VBP O
that IN O
rats NNS O
with IN O
relatively RB O
small JJ O
remnants NNS O
of IN O
one CD O
olfactory NN O
bulb NN O
can MD O
perform VB O
a DT O
variety NN O
of IN O
odor JJ O
detection NN O
and CC O
discrimination NN O
tasks NNS O
as RB O
well RB O
or CC O
nearly RB O
as RB O
well RB O
as IN O
controls NNS O
. . O

The DT O
SR NNP B-Gene
protein NN I-Gene
family NN I-Gene
is VBZ O
involved VBN O
in IN O
constitutive JJ O
and CC O
regulated VBD O
pre SYM O
- : O
mRNA NN O
splicing NN O
and CC O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
evolutionarily RB O
conserved VBN O
in IN O
metazoan NN O
organisms NNS O
. . O

Another DT O
tentative JJ O
hotspot NN O
mutation NN O
in IN O
the DT O
third JJ O
patient NN O
, , O
a DT O
frame NN O
shift NN O
caused VBN O
by IN O
a DT O
G NNP O
nucleotide JJ O
insertion NN O
in IN O
a DT O
monotonous JJ O
repeat NN O
of IN O
six CD O
Gs NNP O
in IN O
HPRT NNP B-Gene
exon FW I-Gene
3 CD I-Gene
, , O
has VBZ O
been VBN O
reported VBN O
previously RB O
in IN O
three CD O
other JJ O
LN NNP O
patients NNS O
. . O

Each DT O
half NN O
molecule NN O
contains VBZ O
four CD O
disulfide NN O
linkages NNS O
and CC O
four CD O
cis NN O
peptides NNS O
. . O

METHODS NN O
: : O
One CD O
hundred VBD O
fourteen JJ O
consecutive JJ O
patients NNS O
( ( O
mean JJ O
age NN O
61 CD O
years NNS O
) ) O
with IN O
focal JJ O
pancreatic JJ O
masses NNS O
, , O
detected VBN O
on IN O
CT NNP O
, , O
underwent JJ O
EUS NNP O
- : O
FNA NN O
by IN O
using VBG O
a DT O
linear JJ O
- : O
array NN O
echoendoscope NN O
and CC O
22 CD O
- : O
gauge NN O
needles NNS O
. . O

Consistent JJ O
with IN O
effects NNS O
on IN O
STAT NNP B-Gene
activation NN O
, , O
altered VBD O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
also RB O
affected VBD O
EGF NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathway NN O
; : O
expression NN O
of IN O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
( ( I-Gene
Cys NNP I-Gene
- : I-Gene
- : I-Gene
> FW I-Gene
Ser NNP I-Gene
) ) I-Gene
inhibited VBD O
activity NN O
of IN O
MEK NNP B-Gene
by IN O
approximately RB O
25 CD O
% NN O
, , O
whereas JJ O
expression NN O
of IN O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
resulted VBD O
in IN O
a DT O
approximately RB O
25 CD O
% NN O
increase NN O
. . O

We PRP O
have VBP O
cloned VBN O
a DT O
novel JJ O
100 CD O
- : O
kDa NN O
mammalian JJ O
protein NN O
, , O
which WDT O
was VBD O
recognized VBN O
by IN O
an DT O
anti JJ O
- : O
peptide NN O
antibody NN O
against IN O
an DT O
epitope NN O
- : O
containing VBG O
nuclear JJ O
localization NN O
signal NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
p65 NN B-Gene
subunit NN I-Gene
. . O

Normal JJ O
values NNS O
for IN O
the DT O
peripheral JJ O
blood NN O
and CC O
bone NN O
marrow NN O
of IN O
the DT O
grey NN O
( ( O
Armenian JJ O
) ) O
hamster NN O

The DT O
mean NN O
extracted VBD O
concentration NN O
of IN O
flucloxacillin NN O
obtained VBN O
at IN O
operation NN O
was VBD O
12 CD O
. . O
9 CD O
micrograms NNS O
/ JJ O
ml NN O
( ( O
SD NNP O
5 CD O
. . O
25 CD O
) ) O
in IN O
synovial JJ O
fluid NN O
; : O
2 CD O
. . O
9 CD O
micrograms NNS O
/ JJ O
g NN O
( ( O
SD NNP O
3 CD O
. . O
59 CD O
) ) O
in IN O
synovium NN O
; : O
2 CD O
. . O
0 CD O
micrograms NNS O
/ JJ O
g NN O
( ( O
SD NNP O
1 CD O
. . O
48 CD O
) ) O
in IN O
cancellous JJ O
bone NN O
and CC O
1 CD O
. . O
3 CD O
micrograms NNS O
/ JJ O
g NN O
( ( O
SD NNP O
1 CD O
. . O
25 CD O
) ) O
in IN O
cortical JJ O
bone NN O
. . O

When WRB O
nifA JJ B-Gene
mRNA NN I-Gene
5 CD O
' '' O
start NN O
points NNS O
were VBD O
mapped VBN O
by IN O
primer NN O
extension NN O
, , O
both CC O
a DT O
minor JJ O
upstream NN O
transcript NN O
( ( O
s PRP O
) ) O
starting VBG O
45 CD O
bp JJ O
distal NN O
to TO O
the DT O
anaerobox NN O
and CC O
a DT O
major JJ O
downstream NN O
transcript NN O
starting VBG O
10 CD O
bp JJ O
distal NN O
to TO O
the DT O
sigma NN B-Gene
54 CD I-Gene
box NN O
were VBD O
observed VBN O
. . O

In IN O
this DT O
study NN O
, , O
evidence NN O
is VBZ O
presented VBN O
that IN O
temporally RB O
and CC O
spatially RB O
specific JJ O
mef2 NN B-Gene
expression NN O
is VBZ O
controlled VBN O
by IN O
a DT O
complex JJ O
array NN O
of IN O
cis NN O
- : O
acting VBG O
regulatory JJ O
modules NNS O
that WDT O
are VBP O
responsive JJ O
to TO O
different JJ O
genetic JJ O
signals NNS O
. . O

5 CD O
( ( O
Sunset NNP O
Yellow NNP O
FCF NNP O
) ) O
were VBD O
determined VBN O
using VBG O
liquid JJ O
chromatography NN O
/ NNP O
mass NN O
spectrometry NN O
( ( O
LC NNP O
/ NNP O
MS NNP O
) ) O
with IN O
electrospray JJ O
ionization NN O
. . O

The DT O
rCBF NN O
and CC O
vasomotion NN O
were VBD O
recorded VBN O
by IN O
laser NN O
- : O
doppler NN O
fluxmetry NN O
. . O

Internal NNP O
amino NN O
acid NN O
sequence NN O
has VBZ O
now RB O
been VBN O
obtained VBN O
from IN O
this DT O
protein NN O
which WDT O
shares NNS O
50 CD O
- : O
100 CD O
% NN O
sequence NN O
identity NN O
with IN O
sequences NNS O
encoded VBN O
by IN O
mammalian JJ B-Gene
G NNP I-Gene
alpha NN I-Gene
11 CD I-Gene
and CC O
G NNP B-Gene
alpha VBP I-Gene
q JJ I-Gene
cDNAs NN I-Gene
. . O

She PRP O
improved VBD O
with IN O
a DT O
combination NN O
of IN O
benzodiazepines NNS O
and CC O
the DT O
acetylcholinesterase NN B-Gene
inhibitor NN O
physostigmine NN O
. . O

Molecular JJ O
identification NN O
of IN O
smg JJ B-Gene
- : I-Gene
4 CD I-Gene
, , O
required VBN O
for IN O
mRNA JJ O
surveillance NN O
in IN O
C NNP O
. . O
elegans NNS O
. . O

PAS1 NNP B-Gene
, , O
a DT O
yeast JJ O
gene NN O
required VBN O
for IN O
peroxisome JJ O
biogenesis NN O
, , O
encodes VBZ O
a DT O
member NN O
of IN O
a DT O
novel JJ O
family NN O
of IN O
putative JJ O
ATPases NNS B-Gene
. . O

The DT O
1 CD O
, , O
2 CD O
, , O
3 CD O
and CC O
4 CD O
year NN O
survival NN O
rates NNS O
were VBD O
94 CD O
% NN O
, , O
84 CD O
% NN O
, , O
76 CD O
% NN O
and CC O
63 CD O
% NN O
, , O
respectively RB O
. . O

Up RB O
to TO O
95 CD O
% NN O
of IN O
the DT O
total JJ O
UV NNP O
exposure NN O
received VBD O
is VBZ O
in IN O
the DT O
UV NNP O
- : O
A DT O
waveband NN O
( ( O
320 CD O
- : O
400 CD O
nm NN O
) ) O
. . O

Thirty NNP O
minutes NNS O
of IN O
supine JJ O
restraint NN O
decreased VBD O
DOPAC NNP O
concentrations NNS O
in IN O
the DT O
median JJ O
eminence NN O
of IN O
female JJ O
rats NNS O
that WDT O
were VBD O
not RB O
exposed VBN O
to TO O
ether VB O
, , O
and CC O
brief JJ O
exposure NN O
to TO O
ether VB O
enhanced VB O
this DT O
effect NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
that IN O
an DT O
in IN O
vitro NN O
- : O
synthesized VBN O
alphavirus NN O
RNA NNP O
lacking VBG O
a DT O
poly NN O
( ( O
A DT O
) ) O
tail NN O
can MD O
initiate VB O
infection NN O
and CC O
produce VB O
3 CD O
' '' O
polyadenylated VBN O
viral JJ O
genome NN O
in IN O
vivo NN O
. . O

17 CD O
. . O
5 CD O
% NN O
of IN O
cycles NNS O
) ) O
. . O

On IN O
cessation NN O
of IN O
steroid JJ O
therapy NN O
the DT O
patient NN O
was VBD O
noted VBN O
to TO O
have VB O
radiologic JJ O
manifestations NNS O
of IN O
hypertrophic JJ O
osteoarthropathy NN O
( ( O
HOA NNP O
) ) O
as RB O
well RB O
as IN O
clinical JJ O
and CC O
laboratory JJ O
features NNS O
of IN O
rheumatoid JJ O
arthritis NN O
( ( O
RA NNP O
) ) O
. . O

Paradoxically RB O
, , O
coexpression NN O
of IN O
the DT O
transcriptionally RB O
inactive JJ O
, , O
amino JJ O
- : O
terminally RB O
deleted VBN O
IDX NNP B-Gene
- : I-Gene
1 CD I-Gene
mutant JJ I-Gene
proteins NNS I-Gene
, , O
either RB O
with IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
IDX NNP I-Gene
- : I-Gene
1 CD I-Gene
or CC O
with IN O
themselves PRP O
, , O
results NNS O
in IN O
a DT O
marked JJ O
enhancement NN O
of IN O
transactivation NN O
of IN O
the DT O
transcriptional JJ O
TAAT NNP B-Gene
- : I-Gene
1 CD I-Gene
element NN I-Gene
reporter NN I-Gene
. . O

Hematopoietic JJ B-Gene
growth NN I-Gene
factors NNS I-Gene
have VBP O
already RB O
had VBN O
an DT O
enormous JJ O
impact NN O
on IN O
transfusion NN O
practice NN O
by IN O
eliminating VBG O
or CC O
reducing VBG O
the DT O
need NN O
for IN O
red JJ O
blood NN O
cell NN O
transfusions NNS O
in IN O
a DT O
variety NN O
of IN O
anemic JJ O
states NNS O
characterized VBN O
by IN O
an DT O
absolute NN O
or CC O
relative JJ O
decrease NN O
in IN O
erythropoietin NN B-Gene
. . O

This DT O
night NN O
- : O
day NN O
oscillation NN O
is VBZ O
driven VBN O
by IN O
the DT O
endogenous JJ O
clock NN O
( ( O
located VBN O
in IN O
the DT O
suprachiasmatic JJ O
nucleus NN O
, , O
SCN NNP O
) ) O
. . O

Src NNP B-Gene
homology NN I-Gene
( ( O
SH NNP B-Gene
) ) O
domain VBP O
dependent JJ O
protein NN O
- : O
protein NN O
interactions NNS O
are VBP O
important JJ O
to TO O
tyrosine VB B-Gene
kinase NN I-Gene
receptor NN I-Gene
signal JJ O
transduction NN O
. . O

CONCLUSION NN O
: : O
The DT O
authors NNS O
emphasize VBP O
that IN O
the DT O
initial JJ O
management NN O
of IN O
primary JJ O
STS NNP O
should MD O
be VB O
adequate JJ O
and CC O
suggest VBP O
that IN O
safty JJ O
margin NN O
of IN O
> NN O
or CC O
= $ O
2 CD O
cm NN O
should MD O
be VB O
adhered VBN O
to TO O
. . O

The DT O
DNA NNP O
sequence NN O
encodes VBZ O
a DT O
protein NN O
of IN O
1520 CD O
amino NN O
acids NNS O
with IN O
sequence NN O
homology NN O
to TO O
the DT O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
abl NN I-Gene
proto NN I-Gene
- : I-Gene
oncogene JJ I-Gene
product NN I-Gene
, , O
beginning VBG O
at IN O
the DT O
amino NN O
terminus NN O
and CC O
extending VBG O
656 CD O
amino JJ O
acids NNS O
through IN O
the DT O
region NN O
essential JJ O
for IN O
tyrosine JJ B-Gene
kinase NN I-Gene
activity NN O
. . O

CRS NNP B-Gene
function NN O
in IN O
a DT O
5 CD O
' POS O
LTR NNP O
- : O
linked VBN O
gene NN O
expression NN O
assay VBP O
correlates NNS O
with IN O
the DT O
ability NN O
of IN O
both DT O
p60CRS NNS B-Gene
and CC O
p40CRS NN B-Gene
to TO O
interact VB O
with IN O
5 CD O
' POS O
LTR NNP O
RNA NNP O
in IN O
vitro NN O
. . O

In IN O
mitogen NN O
- : O
stimulated VBN O
splenocytes NNS O
, , O
Gfi NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
begins VBZ O
to TO O
rise VB O
at IN O
12 CD O
h NN O
after IN O
stimulation NN O
and CC O
reaches VBZ O
very RB O
high JJ O
levels NNS O
after IN O
50 CD O
h NN O
, , O
suggesting VBG O
that IN O
it PRP O
may MD O
be VB O
functionally RB O
involved VBN O
in IN O
events NNS O
occurring VBG O
after IN O
the DT O
interaction NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
with IN O
its PRP$ O
receptor NN O
, , O
perhaps RB O
during IN O
the DT O
transition NN O
from IN O
the DT O
G1 NNP O
to TO O
the DT O
S NNP O
phase NN O
of IN O
the DT O
cell NN O
cycle NN O
. . O

The DT O
authors NNS O
did VBD O
not RB O
detect VB O
any DT O
significant JJ O
correlations NNS O
between IN O
parameters NNS O
of IN O
the DT O
lipids NNS O
of IN O
bone NN O
marrow NN O
and CC O
leptin NN B-Gene
levels NNS O
in IN O
serum NN O
and CC O
bone NN O
marrow NN O
. . O

In IN O
vivo NN O
, , O
MyoD NNP B-Gene
requires VBZ O
this DT O
tryptophan JJ O
motif NN O
to TO O
evoke VB O
chromatin NN O
remodeling VBG O
in IN O
the DT O
Myogenin NNP B-Gene
promoter NN I-Gene
and CC O
to TO O
activate VB O
Myogenin NNP B-Gene
transcription NN O
. . O

In IN O
accordance NN O
with IN O
clinical JJ O
improvement NN O
we PRP O
found VBD O
a DT O
decrease NN O
of IN O
laboratory JJ O
indicators NNS O
of IN O
inflammation NN O
( ( O
C NNP B-Gene
- : I-Gene
reactive JJ I-Gene
protein NN I-Gene
, , O
alpha RB B-Gene
2 CD I-Gene
- : I-Gene
globuline NN I-Gene
, , O
prostaglandin VB O
E2 NNP O
) ) O
. . O

Each DT O
type NN O
was VBD O
divided VBN O
into IN O
two CD O
subgroups NNS O
on IN O
the DT O
basis NN O
of IN O
whether IN O
the DT O
body NN O
and CC O
tail NN O
of IN O
the DT O
pancreas NN O
showed VBD O
intense JJ O
fatty JJ O
replacement NN O
( ( O
type VB O
a DT O
= JJ O
negative JJ O
for IN O
intense JJ O
fatty JJ O
replacement NN O
, , O
type NN O
b NN O
= NNP O
positive JJ O
for IN O
intense JJ O
fatty JJ O
replacement NN O
) ) O
. . O

This DT O
mechanism NN O
is VBZ O
in IN O
contrast NN O
to TO O
other JJ O
cases NNS O
of IN O
splicing VBG O
regulation NN O
by IN O
PTB NNP B-Gene
, , O
in IN O
which WDT O
the DT O
protein NN O
represses VBZ O
the DT O
splice NN O
site NN O
to TO O
which WDT O
it PRP O
binds VBZ O
. . O

This DT O
growth NN O
arrest NN O
is VBZ O
partly RB O
suppressed VBN O
on IN O
minimal JJ O
medium NN O
or CC O
under IN O
conditions NNS O
in IN O
which WDT O
the DT O
cells NNS O
are VBP O
less RBR O
dependent JJ O
on IN O
mitochondrial JJ O
metabolism NN O
. . O

Human NNP B-Gene
acid VBZ I-Gene
ceramidase NN I-Gene
( ( O
( ( B-Gene
AC NNP I-Gene
) ) I-Gene
N NNP I-Gene
- : I-Gene
acylsphingosine NN I-Gene
amidohydrolase NN I-Gene
, , O
EC NNP B-Gene
3 CD I-Gene
. . I-Gene
5 CD I-Gene
. . O

Respiratory JJ O
parameters NNS O
suggested VBD O
that IN O
M6G NNP O
produced VBD O
less JJR O
respiratory JJ O
depression NN O
than IN O
morphine NN O
. . O

The DT O
healing VBG O
rate NN O
in IN O
HIV NNP O
- : O
positive JJ O
patients NNS O
was VBD O
66 CD O
percent NN O
after IN O
14 CD O
weeks NNS O
and CC O
100 CD O
percent NN O
after IN O
32 CD O
weeks NNS O
; : O
the DT O
corresponding JJ O
figures NNS O
for IN O
patients NNS O
with IN O
acquired JJ O
immunodeficiency NN O
syndrome NN O
were VBD O
0 CD O
and CC O
50 CD O
percent NN O
. . O

This DT O
study NN O
proposes VBZ O
an DT O
estimator NN O
for IN O
such JJ O
global JJ O
synchronizing NN O
effects NNS O
upon IN O
unit NN O
- : O
pair NN O
correlations NNS O
based VBN O
on IN O
local JJ O
field NN O
potentials NNS O
( ( O
LFPs NNP O
) ) O
. . O

The DT O
aim NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
correlate VB O
the DT O
responsiveness NN O
to TO O
bronchoprovocation NN O
with IN O
methacholine NN O
in IN O
subjects NNS O
a DT O
with IN O
allergic JJ O
rhinitis NN O
during IN O
and CC O
out IN O
of IN O
the DT O
pollen NN O
season NN O
with IN O
total JJ O
serum NN O
IgE NNP B-Gene
and CC O
blood NN O
eosinophils NNS O
. . O

A DT O
comparison NN O
of IN O
physical JJ O
and CC O
cytogenetic JJ O
estimates NNS O
of IN O
radiation NN O
dose NN O
in IN O
patients NNS O
treated VBN O
with IN O
iodine JJ O
- : O
131 CD O
for IN O
thyroid JJ O
carcinoma NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
in IN O
patients NNS O
with IN O
first JJ O
- : O
attack NN O
genital JJ O
herpes NNS O
, , O
the DT O
type NN O
of IN O
HSV NNP O
is VBZ O
the DT O
most RBS O
important JJ O
determinant NN O
of IN O
subsequent JJ O
recurrences NNS O
and CC O
that DT O
intravenous JJ O
acyclovir NN O
has VBZ O
little JJ O
effect NN O
on IN O
subsequent JJ O
recurrences NNS O
. . O

Overall JJ O
, , O
lesions NNS O
infiltrating VBG O
the DT O
deep JJ O
lamina NN O
propria NNS O
do VBP O
not RB O
exhibit VB O
a DT O
reduced JJ O
frequency NN O
of IN O
occurrence NN O
compared VBN O
to TO O
lesions NNS O
infiltrating VBG O
the DT O
skeletal JJ O
muscle NN O
; : O
however RB O
, , O
carcinomas VBP O
affecting VBG O
other JJ O
oral JJ O
sites NNS O
showed VBD O
a DT O
reduced JJ O
frequency NN O
of IN O
deeply NN O
infiltrating VBG O
lesions NNS O
in IN O
comparison NN O
to TO O
more RBR O
superficial JJ O
lesions NNS O
. . O

Determined VBN O
as IN O
migration NN O
differentials NNS O
, , O
chemotactic JJ O
and CC O
chemokinetic JJ O
responsiveness NN O
tended VBD O
to TO O
be VB O
higher JJR O
in IN O
the DT O
neutropenic JJ O
group NN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
under IN O
the DT O
selected VBN O
conditions NNS O
a DT O
linear JJ O
dependence NN O
exists NNS O
between IN O
the DT O
betaI NN O
% NN O
value NN O
and CC O
lgC NN O
within IN O
the DT O
range NN O
of IN O
0 CD O
. . O
5 CD O
- : O
- : O
10 CD O
mug NN O
ruscogenin NN O
. . O

CAL NNP O
gain NN O
amounted VBD O
to TO O
4 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
3 CD O
mm NN O
, , O
60 CD O
% NN O
of IN O
the DT O
defects NNS O
showing VBG O
CAL NNP O
gain NN O
> NN O
or CC O
= $ O
4 CD O
mm NN O
. . O

By IN O
using VBG O
total JJ O
- : O
protein NN O
extracts VBZ O
from IN O
mycelia JJ O
grown VBN O
under IN O
penicillin NN O
producing VBG O
conditions NNS O
we PRP O
have VBP O
detected VBN O
a DT O
DNA NNP O
- : O
binding NN O
activity NN O
that WDT O
specifically RB O
shifts VBZ O
a DT O
promoter NN O
fragment NN O
located VBN O
between IN O
- : O
654 CD O
and CC O
- : O
455 CD O
( ( O
relative JJ O
to TO O
IPNS NNP B-Gene
tsp NN I-Gene
) ) O
. . O

Plasma NNP O
and CC O
bladder VB O
platinum NN O
concentration NN O
were VBD O
measured VBN O
following VBG O
intravesical JJ O
DDP NNP O
, , O
and CC O
also RB O
histopathological JJ O
examination NN O
, , O
urinalysis NN O
, , O
complete JJ O
blood NN O
count NN O
and CC O
blood NN O
chemistry NN O
were VBD O
performed VBN O
in IN O
order NN O
to TO O
know VB O
the DT O
toxicity NN O
of IN O
intravesical JJ O
DDP NNP O
. . O

SUP46 NNP B-Gene
is VBZ O
implicated VBN O
in IN O
translation NN O
fidelity NN O
and CC O
encodes VBZ O
the DT O
ribosomal JJ B-Gene
protein NN I-Gene
S13 NNP I-Gene
. . O

DMI NNP O
and CC O
2 CD O
- : O
OH NNP O
- : O
DMI NN O
concentrations NNS O
were VBD O
determined VBN O
in IN O
a DT O
similar JJ O
group NN O
of IN O
61 CD O
DMI NNP O
- : O
treated VBD O
patients NNS O
. . O

Because IN O
endogenous JJ O
HSF NNP B-Gene
DNA NNP O
- : O
binding NN O
activity NN O
is VBZ O
low JJ O
and CC O
anti JJ B-Gene
- : I-Gene
hHSF1 NN I-Gene
antibody NN I-Gene
does VBZ O
not RB O
recognize VB O
Xenopus NNP B-Gene
HSF NNP I-Gene
, , O
we PRP O
employed VBP O
this DT O
system NN O
for IN O
mapping VBG O
regions NNS O
in IN O
hHSF1 NN B-Gene
that WDT O
are VBP O
required VBN O
for IN O
the DT O
maintenance NN O
of IN O
the DT O
monomeric JJ O
state NN O
. . O

Pneumothorax NN O
following VBG O
lung NN O
abscess NN O
in IN O
the DT O
renal JJ O
transplant NN O
patient NN O
. . O

Protein NNP O
phosphorylation NN O
appears VBZ O
to TO O
play VB O
a DT O
critical JJ O
role NN O
in IN O
uPA JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
these DT O
cells NNS O
; : O
protein CC B-Gene
kinase VB I-Gene
C NNP I-Gene
- : O
activating VBG O
phorbol NN O
esters NNS O
cooperate VBP O
with IN O
pp60v JJ B-Gene
- : I-Gene
src NN I-Gene
to TO O
synergistically RB O
increase VB O
uPA JJ B-Gene
mRNA NN I-Gene
, , O
whereas WP O
cyclic JJ B-Gene
AMP NNP I-Gene
( ( I-Gene
cAMP NN I-Gene
) ) I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase VBD I-Gene
- : O
activating VBG O
agents NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
8 CD O
- : O
bromo NN O
cAMP NN O
) ) O
repress NN O
uPA JJ B-Gene
mRNA NN I-Gene
levels NNS O
. . O

The DT O
third JJ O
ORF NNP O
generates VBZ O
a DT O
transcript NN O
of IN O
1 CD O
. . O
6 CD O
kb NN O
and CC O
encodes VBZ O
a DT O
protein NN O
of IN O
382 CD O
residues NNS O
including VBG O
a DT O
perfect JJ O
match NN O
to TO O
the DT O
consensus NN O
sequence NN O
of IN O
a DT O
C2H2 NNP O
zinc NN O
finger NN O
domain NN O
; : O
it PRP O
shares NNS O
a DT O
strong JJ O
homology NN O
with IN O
yeast JJ B-Gene
Mig1p NNP I-Gene
and CC O
Cre NNP B-Gene
- : I-Gene
A NN I-Gene
from IN I-Gene
Aspergillus NNP I-Gene
, , I-Gene
Emericella NNP I-Gene
and CC I-Gene
E NNP I-Gene
. . I-Gene
coli NN I-Gene
. . O

The DT O
effect NN O
of IN O
the DT O
thromboxane NN B-Gene
A2 NNP I-Gene
( ( I-Gene
TXA2 NNP I-Gene
) ) I-Gene
/ VBP I-Gene
prostaglandin JJ I-Gene
endoperoxide JJ I-Gene
receptor NN I-Gene
antagonist NN O
, , O
SQ NNP O
29 CD O
, , O
548 CD O
on IN O
pacing VBG O
- : O
induced JJ O
ischemia NN O
was VBD O
determined VBN O
in IN O
anesthetized JJ O
open JJ O
- : O
chest JJS O
dogs NNS O
. . O

When WRB O
the DT O
LCx NNP O
was VBD O
partially RB O
occluded VBN O
, , O
mild JJ O
PM NNP O
- : O
induced JJ O
tachycardia NN O
resulted VBD O
in IN O
decreased JJ O
AoP NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
45 CD O
) ) O
as RB O
well RB O
as IN O
in IN O
decreased JJ O
SV NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
48 CD O
) ) O
; : O
the DT O
LVEDP NNP O
remained VBD O
high JJ O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
2 CD O
) ) O
. . O

Furthermore RB O
, , O
the DT O
wide JJ O
distribution NN O
of IN O
the DT O
GFP NNP B-Gene
- : O
POLO NNP B-Gene
protein NN O
to TO O
all DT O
compartments NNS O
of IN O
the DT O
mitotic JJ O
apparatus NN O
provides VBZ O
a DT O
valuable JJ O
tool NN O
for IN O
future JJ O
studies NNS O
on IN O
cell NN O
cycle NN O
during IN O
development NN O
. . O

( ( O
Cactaceae NNP O
) ) O
waste NN O
matter NN O
. . O

Gene NNP O
silencing VBG O
associated VBN O
with IN O
repeated VBN O
DNA NN O
sequences NNS O
has VBZ O
been VBN O
reported VBN O
for IN O
many JJ O
eukaryotes NNS O
, , O
including VBG O
plants NNS O
. . O

It PRP O
also RB O
contains VBZ O
a DT O
picornaviral JJ B-Gene
3C CD I-Gene
- : I-Gene
like IN I-Gene
protease NN I-Gene
domain NN I-Gene
and CC O
two CD O
papain VBP B-Gene
- : I-Gene
like IN I-Gene
protease NN I-Gene
domains NNS I-Gene
. . O

Vacuolar NNP O
membrane NN O
vesicles NNS O
from IN O
hum1 NN B-Gene
mutants NNS I-Gene
lack VBP O
all DT O
Ca2 NNP O
+ NNP O
/ NNP O
H NNP O
+ NNP O
antiport NN O
activity NN O
, , O
demonstrating VBG O
that IN O
Hum1p NNP B-Gene
catalyzes VBZ O
the DT O
exchange NN O
of IN O
Ca2 NNP O
+ NNP O
for IN O
H NNP O
+ NNP O
across IN O
the DT O
yeast NN O
vacuolar JJ O
membrane NN O
. . O

Prevalence NN O
of IN O
sleep JJ O
- : O
disordered VBN O
breathing NN O
( ( O
SDB NNP O
) ) O
is VBZ O
reported VBN O
to TO O
increase VB O
in IN O
menopausal JJ O
women NNS O
. . O

Droperidol NNP O
- : O
induced VBD O
extrapyramidal JJ O
symptoms NNS O
in IN O
an DT O
adolescent NN O
following VBG O
strabismus NN O
surgery NN O
. . O

Improvement NN O
of IN O
the DT O
polypyrimidine NN O
tract NN O
also RB O
increased VBD O
the DT O
splicing NN O
efficiency NN O
, , O
but CC O
to TO O
a DT O
degree NN O
slightly RB O
less JJR O
than IN O
that DT O
obtained VBN O
with IN O
the DT O
branchpoint NN O
mutation NN O
. . O

These DT O
data NNS O
provide VBP O
strong JJ O
evidence NN O
that IN O
E2F NNP B-Gene
or CC O
an DT O
E2F NNP B-Gene
- : I-Gene
related JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
nonmuscle NN B-Gene
myosin NN I-Gene
expression NN O
. . O

During IN O
coronary JJ O
stenosis NN O
, , O
on IN O
the DT O
contrary JJ O
, , O
intracoronary JJ O
procaterol NN O
at IN O
the DT O
same JJ O
dose NN O
significantly RB O
deteriorated VBD O
regional JJ O
myocardial JJ O
dysfunction NN O
without IN O
changing VBG O
LCX NNP O
flow NN O
, , O
global JJ O
hemodynamics NNS O
and CC O
cardiac JJ O
lactate NN O
metabolism NN O
. . O

( ( O
total JJ O
soluble JJ O
solids NNS O
) ) O
and CC O
organoleptic JJ O
characteristics NNS O
under IN O
the DT O
influence NN O
of IN O
different JJ O
treatments NNS O
. . O

The DT O
iron NN O
dependence NN O
of IN O
transcription NN O
and CC O
expression NN O
of IN O
cvaA NN B-Gene
, , O
which WDT O
encodes VBZ O
a DT O
transporter NN O
accessory NN O
protein NN O
, , O
and CC O
cvi NN B-Gene
, , O
encoding VBG O
the DT O
colicin NN B-Gene
V NNP I-Gene
immunity NN I-Gene
protein NN I-Gene
, , O
was VBD O
assessed VBN O
under IN O
conditions NNS O
of IN O
iron NN O
excess NN O
or CC O
depletion NN O
. . O

Obstruction NN O
of IN O
the DT O
ERF NNP B-Gene
repressor NN I-Gene
function NN O
by IN O
the DT O
transactivating VBG O
members NNS O
of IN O
the DT O
ets NNS B-Gene
family NN I-Gene
of IN O
genes NNS O
( ( O
i NN O
. . O
e NN O
. . O
gag SYM B-Gene
- : O
myb NN B-Gene
- : O
ets NNS B-Gene
) ) O
may MD O
be VB O
essential JJ O
for IN O
the DT O
control NN O
of IN O
genes NNS O
involved VBN O
in IN O
cell NN O
proliferation NN O
and CC O
may MD O
also RB O
underlie VB O
their PRP$ O
tumorigenic JJ O
effects NNS O
. . O

Neither DT O
Ha NNP B-Gene
- : I-Gene
Ras NNP I-Gene
( ( O
G12V NNP O
, , O
T35S NNP O
) ) O
( ( O
Ha NNP B-Gene
- : I-Gene
RasV12S35 NN I-Gene
) ) O
, , O
which WDT O
activates VBZ O
the DT O
Rafl NNP B-Gene
signaling VBG O
pathway RB O
, , O
nor CC O
Ha NNP B-Gene
- : I-Gene
Ras NNP I-Gene
( ( I-Gene
G12V NNP I-Gene
, , I-Gene
E37G NNP I-Gene
) ) I-Gene
( ( O
Ha NNP B-Gene
- : I-Gene
RasV12G37 NN I-Gene
) ) O
, , O
which WDT O
stimulates VBZ O
the DT O
RalGDS NNP B-Gene
pathway NN O
, , O
did VBD O
not RB O
have VB O
significant JJ O
effects NNS O
on IN O
factor NN O
- : O
withdrawal NN O
apoptosis NN O
of IN O
myeloid JJ O
cells NNS O
. . O

Diver NNP O
respiratory NN O
responses NNS O
to TO O
a DT O
tunable NN O
closed VBD O
- : O
circuit NN O
breathing NN O
apparatus NN O
. . O

The DT O
CPK NNP B-Gene
- : I-Gene
MB NNP I-Gene
isoenzyme NN O
showed VBD O
no DT O
percentage NN O
increase NN O
of IN O
total JJ O
CPK NNP B-Gene
higher JJR O
than IN O
5 CD O
% NN O
, , O
measured VBN O
at IN O
6 CD O
, , O
12 CD O
, , O
and CC O
24 CD O
h NN O
after IN O
the DT O
shock NN O
, , O
independent JJ O
of IN O
the DT O
number NN O
of IN O
attempts NNS O
of IN O
cardioversion NN O
. . O

Dipetalonema NNP O
( ( O
Alafilaria NNP O
) ) O
hydrochoerus NN O
subgen NN O
. . O

et DT O
sp NN O
. . O

n NN O
. . O

The DT O
PRB NNP B-Gene
- : I-Gene
1b CD I-Gene
gene NN I-Gene
encodes NNS O
for IN O
a DT O
basic JJ O
- : O
type JJ O
component NN O
of IN O
the DT O
pathogenesis NN O
- : O
related VBN O
PR NNP B-Gene
- : I-Gene
1 CD I-Gene
protein JJ I-Gene
family NN I-Gene
. . O

These DT O
changes NNS O
were VBD O
the DT O
result NN O
of IN O
a DT O
decrease NN O
in IN O
afterload NN O
: : O
mean JJ O
aortic JJ O
pressure NN O
fell VBD O
from IN O
85 CD O
+ NNS O
/ SYM O
- : O
11 CD O
. . O
8 CD O
to TO O
68 CD O
+ NNS O
/ SYM O
- : O
19 CD O
. . O
6 CD O
mmHg NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
systemic JJ O
arterial JJ O
resistance NN O
fell VBD O
from IN O
2 CD O
886 CD O
+ NN O
/ NNP O
- : O
745 CD O
to TO O
2 CD O
10 CD O
+ NN O
/ NNP O
- : O
610 CD O
dynes NNS O
/ NNP O
cm VBD O
- : O
5 CD O
/ NN O
sec NN O
/ NNP O
m VBD O
- : O
2 CD O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Pharmacological NNP O
and CC O
pharmacokinetic JJ O
characteristics NNS O
of IN O
the DT O
non JJ O
- : O
ionic JJ O
monomeric NN O
X NNP O
- : O
ray NN O
contrast NN O
agent NN O
iopromide NN O
( ( O
Ultravist NNP O
, , O
CAS NNP O
73334 CD O
- : O
7 CD O
- : O
3 CD O
) ) O
were VBD O
evaluated VBN O
in IN O
preclinical JJ O
studies NNS O
. . O

This DT O
domain NN O
without IN O
the DT O
canonical JJ O
anticodon NN O
loop NN O
or CC O
the DT O
tyrosine JJ O
anticodon NN O
acts NNS O
as IN O
an DT O
anchor NN O
for IN O
TyrRS NNP B-Gene
interaction NN O
leading VBG O
to TO O
a DT O
better JJR O
efficiency NN O
of IN O
tyrosylation NN O
. . O

Children NNS O
who WP O
developed VBD O
lower JJR O
respiratory NN O
tract JJ O
infections NNS O
or CC O
PCP NNP O
had VBD O
increased VBN O
rates NNS O
of IN O
decline NN O
of IN O
CD4 NNP B-Gene
cell NN O
counts NNS O
during IN O
the DT O
first JJ O
6 CD O
months NNS O
of IN O
life NN O
. . O

Acute JJ O
experiments NNS O
on IN O
nembutal JJ O
- : O
anesthetized VBN O
cats NNS O
( ( O
50 CD O
mg NN O
/ NNP O
kg NN O
) ) O
were VBD O
employed VBN O
to TO O
investigate VB O
the DT O
effect NN O
of IN O
1 CD O
T NNP O
pulsating VBG O
magnetic JJ O
field NN O
( ( O
PMF NNP O
) ) O
on IN O
neuromuscular JJ O
system NN O
of IN O
the DT O
leg NN O
. . O

The DT O
GTPase NNP B-Gene
activity NN O
of IN O
CDC42Ce NNP B-Gene
is VBZ O
moderately RB O
stimulated VBN O
by IN O
human JJ B-Gene
n SYM I-Gene
- : I-Gene
chimaerin NN I-Gene
, , O
a DT O
GTPase NNP B-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
for IN O
the DT O
related JJ O
p21 NN B-Gene
rac1 NN B-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
both DT O
transcription NN O
activators NNS O
depend VBP O
on IN O
or CC O
interact VB O
with IN O
different JJ O
subunits NNS O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
, , O
although IN O
their PRP$ O
role NN O
in IN O
formation NN O
of IN O
proper JJ O
DNA NNP O
geometry NN O
may MD O
also RB O
be VB O
crucial JJ O
. . O

A DT O
sequence NN O
homology NN O
analysis NN O
between IN O
human JJ B-Gene
nm23 SYM I-Gene
- : I-Gene
H1 NN I-Gene
and CC O
the DT O
homolog NN O
gene NN O
of IN O
the DT O
rat NN O
( ( O
NDP NNP B-Gene
- : I-Gene
K NNP I-Gene
beta NN I-Gene
) ) O
shows VBZ O
that IN O
exon SYM O
- : O
intron NN O
boundaries NNS O
are VBP O
well RB O
conserved VBN O
between IN O
these DT O
two CD O
species NNS O
. . O

BACKGROUND NN O
: : O
Previous JJ O
studies NNS O
have VBP O
indicated VBN O
that IN O
the DT O
60 CD O
- : O
, , O
30 CD O
- : O
, , O
28 CD O
- : O
and CC O
12 CD O
- : O
item NN O
versions NNS O
of IN O
the DT O
General NNP O
Health NNP O
Questionnaire NNP O
( ( O
GHQ NNP O
) ) O
are VBP O
liable JJ O
to TO O
retest VB O
effects NNS O
, , O
especially RB O
when WRB O
administered VBN O
multiple JJ O
times NNS O
with IN O
short JJ O
intervals NNS O
. . O

Although IN O
it PRP O
has VBZ O
two CD O
potential JJ O
binding NN O
sites NNS O
, , O
the DT O
purified JJ O
MerR NNP B-Gene
homodimer NN I-Gene
binds VBZ O
only RB O
one CD O
Hg NNP O
( ( O
II NNP O
) ) O
ion NN O
, , O
employing VBG O
Cys82 NNP O
from IN O
one CD O
monomer NN O
and CC O
Cys117 NNP O
and CC O
Cys126 NNP O
from IN O
the DT O
other JJ O
. . O

Bacterial JJ O
metabolism NN O
of IN O
4 CD O
- : O
chlorophenoxyacetate NN O
. . O

However RB O
, , O
in IN O
the DT O
subgroup NN O
with IN O
normal JJ O
Ht NNP O
( ( O
< JJ O
0 CD O
. . O
45 CD O
l JJ O
/ NNP O
l NN O
; : O
n CC O
= VB O
201 CD O
) ) O
there EX O
was VBD O
a DT O
significant JJ O
reduction NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
of IN O
the DT O
mortality NN O
after IN O
3 CD O
months NNS O
( ( O
27 CD O
% NN O
and CC O
16 CD O
% NN O
, , O
respectively RB O
) ) O
and CC O
an DT O
increase NN O
of IN O
independence NN O
at IN O
home NN O
( ( O
35 CD O
% NN O
and CC O
48 CD O
% NN O
, , O
respectively RB O
) ) O
due JJ O
to TO O
a DT O
reduction NN O
of IN O
the DT O
viscosity NN O
by IN O
means NNS O
of IN O
haemodilution NN O
with IN O
albumin NN B-Gene
( ( O
a DT O
specific NN O
viscosity NN O
effect NN O
in IN O
the DT O
normovolaemic JJ O
group NN O
) ) O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
, , O
although IN O
both DT O
the DT O
N NNP O
- : O
and CC O
C NNP O
- : O
terminal JJ O
regions NNS O
of IN O
talin NN B-Gene
bind NN O
actin NN B-Gene
, , O
the DT O
properties NNS O
of IN O
these DT O
two CD O
regions NNS O
of IN O
the DT O
protein NN O
are VBP O
distinct JJ O
. . O

In IN O
addition NN O
, , O
the DT O
- : O
119 CD O
to TO O
- : O
81 CD O
fragment NN O
of IN O
the DT O
CCK NNP B-Gene
promoter NN I-Gene
contains VBZ O
a DT O
transcriptional JJ O
enhancer NN O
that WDT O
potentiates VBZ O
the DT O
transcription NN O
from IN O
the DT O
herpes NNS O
simplex JJ O
virus NN O
thymidine NN B-Gene
kinase NN I-Gene
promoter NN I-Gene
in IN O
a DT O
position NN O
- : O
and CC O
orientation MD O
- : O
independent JJ O
manner NN O
. . O

The DT O
carcinogen NN O
bioassay NN O
therefore NN O
is VBZ O
a DT O
very RB O
important JJ O
component NN O
of IN O
the DT O
battery NN O
of IN O
toxicological JJ O
tests NNS O
used VBN O
in IN O
hazard JJ O
evaluation NN O
. . O

Accordingly RB O
, , O
we PRP O
designated VBD O
this DT O
gene NN B-Gene
CTL1 NNP I-Gene
( ( O
capping VBG B-Gene
enzyme NN I-Gene
RNAtriphosphatase NNP I-Gene
- : I-Gene
like IN I-Gene
1 CD I-Gene
) ) O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
open JJ O
- : O
section NN O
effect NN O
decreases VBZ O
the DT O
torsional JJ O
stiffness NN O
and CC O
stress JJ O
concentration NN O
effects NNS O
decrease VBP O
the DT O
torsional JJ O
strength NN O
of IN O
a DT O
long JJ O
bone NN O
with IN O
a DT O
longitudinal JJ O
defect NN O
. . O

Recent JJ O
advances NNS O
have VBP O
shown VBN O
that IN O
volatile JJ O
sulfur NN O
is VBZ O
a DT O
result NN O
of IN O
ecological JJ O
interactions NNS O
and CC O
transformation NN O
processes NNS O
through IN O
planktonic JJ O
food NN O
webs NN O
. . O

Serum NNP O
Fibrin NNP B-Gene
Degradation NNP I-Gene
Products NNP I-Gene
( ( O
FDP NNP B-Gene
) ) O
were VBD O
determined VBN O
in IN O
50 CD O
oral JJ O
cancer NN O
patients NNS O
and CC O
50 CD O
normal JJ O
individuals NNS O
prior RB O
to TO O
any DT O
kind NN O
of IN O
treatment NN O
. . O

It PRP O
has VBZ O
been VBN O
demonstrated VBN O
previously RB O
that IN O
Pax NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
a DT O
paired JJ B-Gene
domain NN I-Gene
( ( O
PD NNP B-Gene
) ) O
/ NN O
homeodomain NN B-Gene
( ( O
HD NNP B-Gene
) ) O
transcription NN O
factor NN O
critical JJ O
for IN O
eye NN O
development NN O
, , O
contributes NNS O
to TO O
the DT O
activation NN O
of IN O
the DT O
alphaB NN B-Gene
- : I-Gene
, , I-Gene
alphaA SYM I-Gene
- : I-Gene
, , I-Gene
delta1 SYM I-Gene
- : I-Gene
, , I-Gene
and CC I-Gene
zeta SYM I-Gene
- : I-Gene
crystallin NN I-Gene
genes NNS O
in IN O
the DT O
lens NNS O
. . O

Therefore RB O
, , O
the DT O
impaired JJ O
floor NN O
plate NN O
development NN O
in IN O
oep JJ B-Gene
mutants NNS I-Gene
is VBZ O
not RB O
caused VBN O
by IN O
the DT O
absence NN O
of IN O
the DT O
floor NN B-Gene
plate NN I-Gene
inducer NN I-Gene
shh NN I-Gene
. . O

San NNP O
Martin NNP O
' POS O
s JJ O
psychological JJ O
traits NNS O
coupled VBN O
to TO O
his PRP$ O
work NN O
with IN O
masonic JJ O
lodges NNS O
that WDT O
allowed VBD O
him PRP O
to TO O
display VB O
his PRP$ O
abilities NNS O
as IN O
strategist NN O
and CC O
political JJ O
ruler NN O
. . O

Our PRP$ O
laboratory NN O
has VBZ O
recently RB O
identified VBN O
two CD O
phosducin JJ B-Gene
- : I-Gene
like IN I-Gene
orphan JJ I-Gene
proteins NNS I-Gene
( ( O
PhLOP1 NNP B-Gene
and CC O
PhLOP2 NNP B-Gene
) ) O
that WDT O
lack VBP O
the DT O
ability NN O
to TO O
interact VB O
with IN O
Gbetagamma NNP B-Gene
. . O

Fatal JJ O
encephalitis NN O
in IN O
a DT O
patient NN O
with IN O
chronic JJ O
graft NN O
- : O
versus NN O
- : O
host NN O
disease NN O
. . O

Of IN O
the DT O
serum NN B-Gene
neutralizing NN I-Gene
( ( I-Gene
SN NNP I-Gene
) ) I-Gene
antibody NN I-Gene
negative JJ O
calves NNS O
89 CD O
. . O
7 CD O
% NN O
( ( O
26 CD O
/ RB O
29 CD O
) ) O
and CC O
92 CD O
. . O
8 CD O
% NN O
( ( O
90 CD O
/ RB O
97 CD O
) ) O
developed VBD O
SN NNP B-Gene
antibody NN I-Gene
1 CD O
month NN O
after IN O
intranasal NN O
and CC O
intramuscular JJ O
vaccination NN O
, , O
respectively RB O
. . O

Finally RB O
, , O
using VBG O
in IN O
vitro NN O
binding NN O
studies NNS O
, , O
we PRP O
showed VBD O
that IN O
SREBP2 NNP B-Gene
was VBD O
able JJ O
to TO O
displace VB O
ADD1 NNP B-Gene
/ NNP O
SREBP1 NNP B-Gene
binding VBG O
from IN O
the DT O
sterol NN O
regulatory JJ O
element NN O
( ( O
SRE NNP O
) ) O
site NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
G NNP B-Gene
- : I-Gene
protein NN I-Gene
gene NN I-Gene
family NN I-Gene
may MD O
be VB O
distributed VBN O
over IN O
at IN O
least JJS O
two CD O
human JJ O
chromosomes NNS O
. . O

When WRB O
cysteine NN O
is VBZ O
scanned VBN O
through IN O
the DT O
helices NNS O
, , O
characteristic JJ O
repeating VBG O
patterns NNS O
of IN O
solvent JJ O
exposure NN O
and CC O
burial NN O
are VBP O
observed VBN O
. . O

To TO O
characterize VB O
this DT O
effect NN O
, , O
we PRP O
looked VBD O
for IN O
targets NNS O
of IN O
NS1 NNP B-Gene
influenza NN I-Gene
virus NN I-Gene
protein NN I-Gene
among IN O
cellular JJ O
translation NN O
factors NNS O
. . O

We PRP O
present VBP O
this DT O
case NN O
because IN O
of IN O
the DT O
rarity NN O
of IN O
left JJ O
ventricular JJ O
involvement NN O
associated VBN O
with IN O
ARVD NNP O
. . O

A DT O
two CD O
phase NN O
slug NN O
flow NN O
tubular NN O
heat NN O
exchanger NN O
was VBD O
used VBN O
for IN O
the DT O
thermal JJ O
inactivation NN O
of IN O
Listeria NNP O
monocytogenes NNS O
in IN O
natural JJ O
infected JJ O
milk NN O
from IN O
seven CD O
cows NNS O
. . O

The DT O
equilibrium NN O
phosphorus NN O
content NN O
( ( O
EPC0 NNP O
) ) O
of IN O
surface NN O
soil NN O
was VBD O
generally RB O
higher JJR O
than IN O
the DT O
SRP NNP O
content NN O
of IN O
drainage NN O
water NN O
, , O
at IN O
one CD O
farm NN O
by IN O
1 CD O
order NN O
of IN O
magnitude NN O
. . O

The DT O
central JJ O
visual JJ O
fields NNS O
of IN O
2165 CD O
normal JJ O
and CC O
106 CD O
glaucoma NNS O
eyes NNS O
were VBD O
measured VBN O
using VBG O
a DT O
threshold NN O
related VBN O
suprathreshold JJ O
strategy NN O
. . O

After IN O
all DT O
doses NNS O
of IN O
d JJ O
- : O
amphetamine NN O
, , O
responding VBG O
occurred VBD O
largely RB O
on IN O
the DT O
saline NN O
key NN O
under IN O
both DT O
schedules NNS O
. . O

Evolutionary JJ O
conservation NN O
of IN O
homeodomain NN B-Gene
- : O
binding NN O
sites NNS O
and CC O
other JJ O
sequences NNS O
upstream RB O
and CC O
within IN O
the DT O
major JJ O
transcription NN O
unit NN O
of IN O
the DT O
Drosophila NNP B-Gene
segmentation NN I-Gene
gene NN I-Gene
engrailed VBD I-Gene
. . O

A DT O
polypeptide NN O
chain NN O
of IN O
34 CD O
residues NNS O
of IN O
the DT O
deduced JJ O
yeast NN O
amino NN O
acid NN O
sequence NN O
closely RB O
resembles VBZ O
a DT O
peptide JJ O
sequence NN O
at IN O
the DT O
ADP NNP O
binding VBG O
site NN O
of IN O
bovine JJ B-Gene
muscle NN I-Gene
pyruvate NN I-Gene
kinase NN I-Gene
. . O

In IN O
this DT O
study NN O
, , O
rabbits NNS O
were VBD O
used VBN O
to TO O
evaluate VB O
the DT O
sutured VBN O
wound IN O
reaction NN O
with IN O
Dexon NNP O
or CC O
nylon NN O
in IN O
the DT O
conjunctival NN O
flap NN O
1 CD O
, , O
4 CD O
, , O
7 CD O
, , O
14 CD O
and CC O
28 CD O
days NNS O
after IN O
trabeculectomy JJ O
surgery NN O
with IN O
or CC O
without IN O
the DT O
use NN O
of IN O
mitomycin NN O
- : O
C NNP O
. . O

CONCLUSIONS NN O
: : O
Physiologic JJ O
pacing VBG O
provides VBZ O
little JJ O
benefit NN O
over IN O
ventricular JJ O
pacing NN O
for IN O
the DT O
prevention NN O
of IN O
stroke NN O
or CC O
death NN O
due JJ O
to TO O
cardiovascular JJ O
causes NNS O
. . O

MCh NNP O
infusion NN O
caused VBD O
a DT O
concentration NN O
- : O
dependent JJ O
increase NN O
in IN O
airway JJ O
resistance NN O
at IN O
constant JJ O
QBA NNP O
. . O

"""" NN O
In IN O
vitro NN O
"""" NNP O
study NN O
of IN O
dentin JJ O
adhesion NN O
to TO O
adhesives NNS O
made VBN O
from IN O
urethane JJ O
molecules NNS O
with IN O
free JJ O
groups NNS O
of IN O
isocyanate NN O

An DT O
examination NN O
of IN O
the DT O
properties NNS O
of IN O
sequences NNS O
surrounding VBG O
ARS1 NNP O
left VBD O
open RP O
the DT O
possibility NN O
that WDT O
ABFI NNP B-Gene
enhances VBZ O
the DT O
initiation NN O
of IN O
DNA NNP O
replication NN O
at IN O
ARS1 NNP O
by IN O
transcriptional JJ O
activation NN O
. . O

The DT O
GafChromic NNP O
method NN O
has VBZ O
proven VBN O
to TO O
be VB O
an DT O
accurate NN O
and CC O
rapid JJ O
method NN O
of IN O
analysis NN O
and CC O
could MD O
be VB O
easily RB O
incorporated VBN O
into IN O
a DT O
quality JJ O
assurance NN O
program NN O
. . O

In IN O
contrast NN O
, , O
the DT O
contractile JJ O
action NN O
of IN O
arachidonic JJ O
acid NN O
, , O
via IN O
a DT O
presumed JJ O
cyclooxygenase NN B-Gene
product NN O
that WDT O
mediated VBD O
the DT O
contractions NNS O
caused VBN O
by IN O
both DT O
TF NNP B-Gene
and CC O
EGF NNP B-Gene
, , O
was VBD O
not RB O
blocked VBN O
by IN O
any DT O
of IN O
the DT O
signal JJ O
pathway NN O
probe NN O
inhibitors NNS O
. . O

The DT O
efficacy NN O
and CC O
safety NN O
of IN O
a DT O
novel JJ O
percutaneous JJ O
anaesthetic JJ O
preparation NN O
based VBN O
on IN O
amethocaine NN O
has VBZ O
been VBN O
investigated VBN O
in IN O
the DT O
paediatric JJ O
clinical JJ O
environment NN O
. . O

The DT O
neuroprotective JJ O
efficacy NN O
of IN O
the DT O
selective JJ O
N NNP O
- : O
type NN O
voltage NN O
- : O
sensitive JJ O
calcium NN O
channel NN O
blocker NN O
, , O
SNX NNP O
- : O
111 CD O
, , O
was VBD O
evaluated VBN O
in IN O
spontaneously RB O
hypertensive JJ O
rats NNS O
subjected VBD O
to TO O
60 CD O
min NN O
of IN O
focal JJ O
cerebral JJ O
ischemia NN O
by IN O
permanent JJ O
ligation NN O
of IN O
the DT O
right JJ O
common JJ O
carotid NN O
artery NN O
and CC O
temporary JJ O
occlusion NN O
of IN O
the DT O
right JJ O
middle JJ O
cerebral JJ O
artery NN O
. . O

Following VBG O
20 CD O
min NN O
of IN O
steady JJ O
state NN O
anaesthesia NN O
during IN O
which WDT O
measurements NNS O
of IN O
IOP NNP O
, , O
arterial JJ O
pressure NN O
, , O
heart NN O
rate NN O
, , O
FIO2 NNP O
, , O
FE NNP O
' POS O
CO2 NNP O
and CC O
CVP NNP O
were VBD O
recorded VBN O
, , O
one CD O
group NN O
of IN O
patients NNS O
received VBD O
atracurium JJ O
0 CD O
. . O
45 CD O
mg NN O
kg SYM O
- : O
1 CD O
and CC O
the DT O
other JJ O
pancuronium NN O
0 CD O
. . O
1 CD O
mg NN O
kg SYM O
- : O
1 CD O
. . O

1 CD O
) ) O
CFDN NNP O
, , O
AMPC NNP O
and CC O
MNZ NNP O
showed VBD O
a DT O
potent JJ O
antimicrobial JJ O
activity NN O
against IN O
H NNP O
. . O
pylori NN O
, , O
and CC O
especially RB O
, , O
AMPC NNP O
showed VBD O
a DT O
marked JJ O
bactericidal NN O
activity NN O
in IN O
a DT O
short JJ O
time NN O
. . O

Cell NNP O
factor NN O
- : O
mediated VBN O
regulatory JJ O
interactions NNS O
are VBP O
involved VBN O
in IN O
regulating VBG O
the DT O
restricted JJ O
expression NN O
of IN O
the DT O
HCMV NNP B-Gene
major JJ I-Gene
immediate JJ I-Gene
- : I-Gene
early JJ I-Gene
( ( I-Gene
IE NNP I-Gene
) ) I-Gene
gene NN I-Gene
( ( O
J NNP O
. . O

The DT O
ratio NN O
of IN O
radioactivity NN O
in IN O
tumour NNS O
compared VBN O
with IN O
normal JJ O
tissue NN O
( ( O
T NNP O
: : O
N NNP O
ratio NN O
) ) O
was VBD O
determined VBN O
after IN O
simultaneously RB O
injecting VBG O
microspheres NNS O
into IN O
the DT O
portal NN O
and CC O
arterial JJ O
circulation NN O
of IN O
each DT O
animal NN O
. . O

67 CD O
393 CD O
bp NN O
of IN O
contiguous JJ O
DNA NNP O
located VBD O
between IN O
markers NNS O
cdc18 NNS B-Gene
and CC O
cdc14 NN B-Gene
on IN O
the DT O
right JJ O
arm NN O
of IN O
fission NN O
yeast FW O
chromosome NN O
II NNP O
has VBZ O
been VBN O
sequenced VBN O
as IN O
part NN O
of IN O
the DT O
European NNP O
Union NNP O
Schizosaccharomyces NNP O
pombe VBD O
genome JJ O
sequencing NN O
project NN O
. . O

Deletion NN O
of IN O
the DT O
apeA JJ B-Gene
gene NN I-Gene
, , O
either CC O
with IN O
or CC O
without IN O
deletion NN O
of IN O
other JJ O
proteinases NNS O
( ( O
protease NN B-Gene
IV NNP I-Gene
and CC O
aminopeptidase VB B-Gene
N NNP I-Gene
) ) O
, , O
did VBD O
not RB O
have VB O
any DT O
effect NN O
on IN O
cell NN O
growth NN O
in IN O
the DT O
various JJ O
media NNS O
tested VBN O
. . O

A DT O
new JJ O
technique NN O
to TO O
create VB O
an DT O
artificial JJ O
stenosis NN O
in IN O
the DT O
native JJ O
LAD NNP O
using VBG O
a DT O
hemoclip NN O
. . O

Our PRP$ O
evidence NN O
derives NNS O
from IN O
three CD O
principal JJ O
observations NNS O
: : O
1 CD O
) ) O
a DT O
transfection NN O
construct NN O
containing VBG O
only RB O
122 CD O
nucleotides NNS O
( ( O
nt JJ O
) ) O
of IN O
promoter NN O
1 CD O
and CC O
328 CD O
nt NN O
of IN O
the DT O
5 CD O
' POS O
- : O
UTR NN O
retained VBD O
full JJ O
PGE2 NNP O
- : O
stimulated VBD O
reporter JJ O
expression NN O
; : O
2 CD O
) ) O
maximal NN O
PGE2 NNP O
- : O
driven NN O
reporter NN O
expression NN O
required VBD O
the DT O
presence NN O
of IN O
nt $ O
196 CD O
to TO O
328 CD O
of IN O
exon NNS O
1 CD O
when WRB O
tested VBN O
within IN O
the DT O
context NN O
of IN O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
promoter VBP I-Gene
1 CD I-Gene
; : O
3 CD O
) ) O
cotransfection NN O
of IN O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
promoter VBP I-Gene
- : O
luciferase NN B-Gene
- : O
reporter NN O
constructs NNS O
with IN O
a DT O
plasmid NN O
encoding VBG O
the DT O
alpha NN O
- : O
isoform NN O
of IN O
the DT O
catalytic JJ O
subunit NN O
of IN O
murine NN B-Gene
cAMP NN I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
PKA NNP B-Gene
) ) O
produced VBD O
results NNS O
comparable JJ O
to TO O
those DT O
seen VBN O
with IN O
PGE2 NNP O
treatment NN O
, , O
whereas JJ O
cotransfection NN O
with IN O
a DT O
plasmid NN O
encoding VBG O
a DT O
mutant JJ O
regulatory JJ O
subunit NN O
of IN O
PKA NNP B-Gene
that IN O
cannot NN O
bind NN O
cAMP NN O
blocked VBD O
PGE2 NNP O
- : O
induced JJ O
reporter NN O
expression NN O
. . O

The DT O
motor NN O
unit NN O
viewed VBD O
from IN O
above IN O
. . O

We PRP O
describe VBP O
here RB O
a DT O
Drosophila NNP B-Gene
melanogaster NN I-Gene
FAK NNP I-Gene
homologue NN I-Gene
, , O
DFak56 NNP B-Gene
, , O
which WDT O
maps VBZ O
to TO O
band VB O
56D CD O
on IN O
the DT O
right JJ O
arm NN O
of IN O
the DT O
second JJ O
chromosome NN O
. . O

The DT O
Dox NNP B-Gene
- : I-Gene
A2 NNP I-Gene
ORF NNP I-Gene
driven VBN O
by IN O
the DT O
TDH3 NNP B-Gene
promoter NN I-Gene
complemented VBD O
the DT O
phenotype NN O
of IN O
a DT O
strain NN O
deleted VBN O
for IN O
sun2 NN B-Gene
. . O

Cloning VBG O
and CC O
expression NN O
of IN O
two CD O
genes NNS O
encoding VBG O
auxin NN B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
from IN O
tobacco NN O
. . O

However RB O
, , O
when WRB O
a DT O
second JJ O
, , O
upstream JJ B-Gene
IRE NNP I-Gene
- : I-Gene
like IN I-Gene
sequence NN I-Gene
was VBD O
evaluated VBN O
by IN O
EMSA NNP O
, , O
a DT O
DNA NN O
binding VBG O
pattern JJ O
distinct NN O
from IN O
that DT O
seen VBN O
following VBG O
exposure NN O
to TO O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
alone RB O
was VBD O
observed VBN O
after IN O
prolonged JJ O
stimulation NN O
with IN O
both DT O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

Angiographic NNP O
work NN O
- : O
up RB O
in IN O
a DT O
patient NN O
with IN O
late JJ O
vaginal JJ O
metastasis NN O
from IN O
a DT O
renal JJ O
carcinoma NN O
. . O

The DT O
aim NN O
of IN O
this DT O
retrospective JJ O
study NN O
was VBD O
to TO O
demonstrate VB O
that IN O
in IN O
certain JJ O
cases NNS O
of IN O
expulsive JJ O
choroidal NN O
hemorrhage NN O
( ( O
ECH NNP O
) ) O
anatomical JJ O
success NN O
and CC O
useful JJ O
vision NN O
can MD O
be VB O
obtained VBN O
with IN O
repeated JJ O
vitreoretinal JJ O
surgery NN O
. . O

METHODS NNS O
: : O
We PRP O
studied VBD O
20 CD O
symptomatic JJ O
patients NNS O
with IN O
HOCM NNP O
( ( O
12 CD O
men NNS O
) ) O
, , O
mean JJ O
age NN O
52 CD O
+ NN O
/ NNP O
- : O
17 CD O
years NNS O
, , O
before IN O
and CC O
after IN O
septal JJ O
reduction NN O
using VBG O
echocardiography NN O
and CC O
electrocardiogram NN O
( ( O
ECG NNP O
) ) O
. . O

Nodal NNP O
domains NNS O
are VBP O
regions NNS O
where WRB O
a DT O
function NN O
has VBZ O
definite VBN O
sign NN O
. . O

Serum NNP O
E2 NNP O
concentrations NNS O
increased VBD O
numerically RB O
two CD O
- : O
to TO O
threefold VB O
from IN O
d JJ O
56 CD O
to TO O
140 CD O
in IN O
controls NNS O
fed VBN O
MGA NNP O
, , O
compared VBN O
with IN O
controls NNS O
not RB O
fed VBN O
MGA NNP O
. . O

The DT O
ADP NNP B-Gene
- : I-Gene
ribosylation NN I-Gene
factor NN I-Gene
( ( O
ARF NNP B-Gene
) ) O
family NN O
is VBZ O
one CD O
of IN O
four CD O
subfamilies NNS O
of IN O
the DT O
RAS NNP B-Gene
superfamily RB I-Gene
of IN O
low JJ B-Gene
molecular JJ I-Gene
weight NN I-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
( ( O
G NNP B-Gene
proteins VBZ I-Gene
) ) O
. . O

INTERPRETATION NN O
: : O
It PRP O
is VBZ O
probable JJ O
that IN O
the DT O
cognitive JJ O
dissonance NN O
created VBN O
by IN O
more JJR O
health NN O
information NN O
on IN O
smoking NN O
after IN O
1964 CD O
, , O
i NN O
. . O
e NN O
. . O
the DT O
necessary JJ O
motivation NN O
to TO O
quit VB O
, , O
was VBD O
reduced VBN O
as IN O
a DT O
result NN O
of IN O
strategic JJ O
changes NNS O
in IN O
the DT O
amount NN O
and CC O
content NN O
of IN O
advertising NN O
. . O

Once RB O
ICP NNP O
reaches VBZ O
critical JJ O
values NNS O
( ( O
> $ O
30 CD O
mm NN O
Hg NNP O
) ) O
herniation NN O
occurs NNS O
, , O
usually RB O
within IN O
2 CD O
to TO O
5 CD O
days NNS O
. . O

Characterization NN O
of IN O
the DT O
3 CD O
' POS O
ends NNS O
of IN O
the DT O
plus JJ O
- : O
strand NN O
DNA NN O
fragments NNS O
reveals NNS O
( ( O
1 CD O
) ) O
that IN O
the DT O
upstream JJ O
fragment NN O
is VBZ O
elongated VBN O
beyond IN O
PPT2 NNP B-Gene
creating VBG O
a DT O
plus JJ O
- : O
strand NN O
overlap NN O
and CC O
( ( O
2 CD O
) ) O
that IN O
the DT O
majority NN O
of IN O
plus CC O
- : O
strand NN O
strong JJ O
- : O
stop NN O
DNA NN O
fragments NNS O
bear VBP O
a DT O
copy NN O
of IN O
the DT O
minus NN O
- : O
strand NN O
primer NN O
binding VBG O
site NN O
in IN O
agreement NN O
with IN O
the DT O
accepted JJ O
model NN O
of IN O
retroviral JJ O
genomic JJ O
RNA NNP O
reverse NN O
transcription NN O
. . O

Abundant JJ O
infiltration NN O
of IN O
lymphocytes NNS O
and CC O
plasma NN O
cells NNS O
was VBD O
also RB O
wide JJ O
- : O
spread NN O
beneath IN O
the DT O
carcinoma NN O
in IN O
situ NN O
, , O
together RB O
with IN O
the DT O
lymphoid JJ O
follicles NNS O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
THOV NNP B-Gene
NP NNP I-Gene
contains VBZ O
a DT O
motif NN O
( ( O
KRxxxxxxxxxKTKK NNP O
) ) O
at IN O
amino NN O
acid VBP O
positions NNS O
179 CD O
- : O
193 CD O
that IN O
represents VBZ O
a DT O
classical JJ O
bipartite NN O
nuclear JJ O
localization NN O
signal NN O
( ( O
NLS NNP O
) ) O
. . O

The DT O
authors NNS O
made VBD O
an DT O
analysis NN O
of IN O
social JJ O
- : O
economical JJ O
conditions NNS O
limiting VBG O
the DT O
possibilities NNS O
of IN O
rendering VBG O
cardiosurgical JJ O
care NN O
to TO O
children NNS O
. . O

One CD O
hundred VBD O
units NNS O
/ NNP O
kg NN O
of IN O
recombinant JJ B-Gene
human JJ I-Gene
erythropoietin NN I-Gene
( ( O
rhEPO NN B-Gene
) ) O
was VBD O
given VBN O
subcutaneously RB O
3 CD O
times NNS O
a DT O
week NN O
for IN O
3 CD O
weeks NNS O
. . O

Using VBG O
the DT O
rap1t NN B-Gene
alleles VBZ I-Gene
to TO O
generate VB O
wild JJ O
- : O
type NN O
cells NNS O
differing VBG O
only RB O
in IN O
telomere JJ O
tract JJ O
lengths NNS O
, , O
we PRP O
also RB O
show VBP O
that IN O
telomere JJ O
position NN O
effects NNS O
are VBP O
highly RB O
sensitive JJ O
to TO O
changes NNS O
in IN O
the DT O
size NN O
( ( O
or CC O
structure NN O
) ) O
of IN O
the DT O
telomeric JJ O
tract NN O
. . O

CONCLUSIONS NN O
: : O
Ketamine NNP O
- : O
induced VBD O
dissociative JJ O
anesthesia NN O
produces VBZ O
persistently RB O
elevated VBN O
BIS NNP O
index NN O
which WDT O
is VBZ O
different JJ O
from IN O
thiamylal NN O
and CC O
those DT O
reported VBN O
with IN O
other JJ O
conventional JJ O
anesthetic JJ O
agents NNS O
. . O

Pharmacokinetics NNS O
of IN O
Carbamazepine NNP O
in IN O
man NN O
: : O
a DT O
review NN O
. . O

Supershift NNP O
EMSAs NNP O
identified VBD O
that IN O
upstream JJ B-Gene
stimulatory NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
- : I-Gene
2 CD I-Gene
( ( O
USF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
- : I-Gene
2 CD I-Gene
) ) O
were VBD O
part NN O
of IN O
these DT O
complexes NNS O
. . O

Glucagon NNP B-Gene
also RB O
induced VBD O
LUC NNP B-Gene
activity NN O
very RB O
strongly RB O
when WRB O
the DT O
CRE1 NNP O
and CC O
CRE2 NNP O
sites NNS O
were VBD O
combined VBN O
; : O
induction NN O
of IN O
the DT O
( ( O
CRE1 NNP O
) ) O
3 CD O
( ( O
CRE2 NNP O
) ) O
2SV40 CD O
- : O
LUC NN B-Gene
constructs NNS O
was VBD O
positively RB O
modulated VBN O
by IN O
the DT O
pO2 NN O
. . O

Ectopic NNP O
expression NN O
of IN O
d JJ B-Gene
- : I-Gene
axin NN I-Gene
inhibited JJ O
Wingless NNP B-Gene
signaling NN O
. . O

In IN O
contrast NN O
, , O
the DT O
failure NN O
of IN O
the DT O
QKTT NNP O
motif NN O
and CC O
TGN46 NNP O
cytoplasmic JJ O
tail NN O
to TO O
induce VB O
steady JJ O
- : O
state NN O
ER NNP O
localization NN O
of IN O
vesicular JJ B-Gene
stomatitis NN I-Gene
virus NN I-Gene
glycoprotein NN I-Gene
( ( O
VSVG NNP B-Gene
) ) O
chimeras NN O
in IN O
HeLa NNP O
and CC O
NRK NNP O
cells NNS O
indicates VBZ O
that IN O
significant JJ O
differences NNS O
in IN O
early JJ O
secretory NN O
trafficking NN O
also RB O
exist VBP O
. . O

Here RB O
the DT O
cloning NN O
and CC O
molecular JJ O
analysis NN O
of IN O
the DT O
Zm NNP B-Gene
- : I-Gene
ERabp1 NN I-Gene
, , O
Zm NNP B-Gene
- : I-Gene
ERabp4 NN I-Gene
, , O
and CC O
Zm NNP B-Gene
- : I-Gene
ERabp5 NNP I-Gene
genes NNS I-Gene
is VBZ O
presented VBN O
. . O

The DT O
glucose JJ O
areas NNS O
following VBG O
the DT O
ingestion NN O
of IN O
the DT O
foods NNS O
were VBD O
: : O
Study NN O
1 CD O
: : O
glucose JJ O
11 CD O
. . O
7 CD O
, , O
orange NN O
juice NN O
7 CD O
. . O
3 CD O
, , O
sucrose VBD O
5 CD O
. . O
2 CD O
, , O
glucose JJ O
+ NNP O
fructose VBD O
6 CD O
. . O
3 CD O
, , O
and CC O
fructose RB O
0 CD O
. . O
7 CD O
mmol JJ O
X NNP O
h NN O
/ NNP O
l NN O
; : O
Study NNP O
2 CD O
: : O
glucose JJ O
14 CD O
. . O
6 CD O
, , O
orange NN O
juice NN O
7 CD O
. . O
3 CD O
, , O
apples NNS O
5 CD O
. . O
5 CD O
, , O
and CC O
apple NN O
juice NN O
4 CD O
. . O
7 CD O
mmol JJ O
X NNP O
h NN O
/ NNP O
l NN O
; : O
Study NNP O
3 CD O
: : O
glucose JJ O
12 CD O
. . O
6 CD O
, , O
ice NN O
cream NN O
8 CD O
. . O
1 CD O
, , O
milk NN O
3 CD O
. . O
7 CD O
, , O
and CC O
lactose RB O
4 CD O
. . O
1 CD O
mmol JJ O
X NNP O
h NN O
/ NNP O
l NN O
. . O

Stromelysin NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
matrix NN B-Gene
metalloproteinase NN I-Gene
- : I-Gene
3 CD I-Gene
( ( O
MMP NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
, , O
is VBZ O
an DT O
important JJ O
endopeptidase NN O
selectively RB O
expressed VBN O
by IN O
somatic JJ O
cells NNS O
in IN O
organ JJ O
tissues NNS O
. . O

CONCLUSION NN O
: : O
Intravenous JJ O
diazepam NNS O
administration NN O
before IN O
EGD NNP O
produces VBZ O
a DT O
significant JJ O
fall NN O
in IN O
SpO2 NNP O
during IN O
the DT O
procedure NN O
, , O
and CC O
so RB O
should MD O
be VB O
avoided VBN O
; : O
continuous JJ O
monitoring NN O
of IN O
SpO2 NNP O
should MD O
be VB O
done VBN O
during IN O
EGD NNP O
. . O

The DT O
time NN O
course NN O
of IN O
RNA1 NNP B-Gene
replication NN O
and CC O
RNA3 NNP B-Gene
synthesis NN O
in IN O
induced JJ O
yeast NN O
paralleled VBD O
that IN O
in IN O
yeast NN O
transfected VBN O
with IN O
natural JJ O
FHV NNP O
virion NN O
RNA NNP O
. . O

The DT O
pia NN O
mater NN O
at IN O
the DT O
site NN O
of IN O
the DT O
entry NN O
of IN O
blood NN O
vessels NNS O
into IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

A DT O
single JJ O
MEF NNP B-Gene
- : I-Gene
2 CD I-Gene
site NN I-Gene
is VBZ O
a DT O
major JJ O
positive JJ O
regulatory JJ O
element NN O
required VBN O
for IN O
transcription NN O
of IN O
the DT O
muscle NN O
- : O
specific JJ O
subunit NN O
of IN O
the DT O
human JJ B-Gene
phosphoglycerate NN I-Gene
mutase NN I-Gene
gene NN I-Gene
in IN O
skeletal JJ O
and CC O
cardiac JJ O
muscle NN O
cells NNS O
. . O

Comparison NNP O
of IN O
genomic JJ O
sequence NN O
shows NNS O
that IN O
the DT O
ph NN B-Gene
locus NN I-Gene
has VBZ O
been VBN O
duplicated VBN O
, , O
and CC O
that IN O
it PRP O
contains VBZ O
proximal JJ O
and CC O
distal JJ O
transcription NN O
units NNS O
. . O

Architecture NN O
and CC O
anatomy NN O
of IN O
the DT O
genomic JJ O
locus NN O
encoding VBG O
the DT O
human JJ O
leukemia NN O
- : O
associated VBN O
transcription NN O
factor NN O
RUNX1 NNP B-Gene
/ NNP O
AML1 NNP B-Gene
. . O

We PRP O
have VBP O
examined VBN O
reporter NN O
gene NN O
( ( O
beta SYM B-Gene
- : I-Gene
gal NN I-Gene
) ) O
expression NN O
directed VBN O
by IN O
human JJ B-Gene
heat NN I-Gene
shock NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
1 CD I-Gene
and CC I-Gene
2 CD I-Gene
( ( O
HSF1 NNP B-Gene
and CC O
HSF2 NNP B-Gene
) ) O
in IN O
HeLa NNP O
cells NNS O
and CC O
in IN O
yeast NN O
( ( O
Saccharomyces NNP O
cerevisiae NN O
) ) O
. . O

The DT O
physicians NNS O
in IN O
charge NN O
of IN O
all DT O
patients NNS O
with IN O
evidence NN O
of IN O
acute JJ O
Q NNP O
fever NN O
( ( O
seroconversion NN O
and CC O
/ NN O
or CC O
presence NN O
of IN O
IgM NNP B-Gene
) ) O
or CC O
chronic JJ O
Q NNP O
fever NN O
( ( O
prolonged JJ O
disease NN O
and CC O
/ NN O
or CC O
IgG NNP B-Gene
antibody NN I-Gene
titer NN O
to TO O
phase VB O
I PRP O
of IN O
Coxiella NNP O
burnetii NN O
> NN O
or CC O
= VB O
800 CD O
) ) O
were VBD O
asked VBN O
to TO O
complete VB O
a DT O
questionnaire NN O
, , O
which WDT O
was VBD O
computerized VBN O
. . O

In IN O
particular JJ O
, , O
changes NNS O
in IN O
intracellular JJ O
Ca2 NNP O
+ NN O
have VBP O
the DT O
potential NN O
to TO O
either DT O
inhibit NN O
or CC O
augment VB O
the DT O
ability NN O
of IN O
cAMP NN O
to TO O
stimulate VB O
transcription NN O
, , O
depending VBG O
on IN O
the DT O
presence NN O
of IN O
specific JJ O
forms NNS O
of IN O
Ca2 NNP B-Gene
+ NNP I-Gene
/ NNP I-Gene
calmodulin SYM I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinases NNS I-Gene
. . O

This DT O
enzyme NN O
is VBZ O
designated VBN O
( ( B-Gene
1 CD I-Gene
- : I-Gene
- : I-Gene
> $ I-Gene
4 CD I-Gene
) ) I-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
xylan NN I-Gene
endohydrolase NN I-Gene
isoenzyme NN I-Gene
X NNP I-Gene
- : I-Gene
I PRP I-Gene
. . O

These DT O
results NNS O
were VBD O
superior JJ O
to TO O
those DT O
in IN O
24 CD O
patients NNS O
with IN O
conventional JJ O
end NN O
- : O
to TO O
- : O
end NN O
sutures VBZ O
on IN O
clinical JJ O
testing NN O
. . O

Tilmicosin NNP O
is VBZ O
a DT O
novel JJ O
macrolide NN O
antibiotic JJ O
developed VBD O
for IN O
exclusive JJ O
use NN O
in IN O
veterinary JJ O
medicine NN O
. . O

Regulation NN O
of IN O
urokinase JJ B-Gene
plasminogen NN I-Gene
activator NN I-Gene
gene NN I-Gene
transcription NN O
in IN O
the DT O
RAW264 NNP O
murine NN O
macrophage NN O
cell NN O
line NN O
by IN O
macrophage NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
dependent JJ O
upon IN O
the DT O
level NN O
of IN O
cell NN O
- : O
surface NN O
receptor NN O
. . O

The DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
Tat NNP I-Gene
protein NN I-Gene
regulates VBZ O
transcription NN O
by IN O
stimulating VBG O
RNA NNP B-Gene
polymerase NN I-Gene
processivity NN O
. . O

UbiA NNP B-Gene
is VBZ O
also RB O
unique JJ O
among IN O
known JJ O
polyubiquitin NN B-Gene
genes NNS I-Gene
in IN O
containing VBG O
four CD O
cis NN O
- : O
spliced JJ O
introns NNS O
within IN O
its PRP$ O
coding VBG O
sequence NN O
. . O

Epithelial JJ O
nerve NN O
fiber NN O
defects NNS O
included VBD O
absence NN O
or CC O
distorted JJ O
architecture NN O
of IN O
the DT O
basal NN O
epithelial JJ O
plexus NN O
and CC O
intra JJ O
- : O
epithelial JJ O
terminals NNS O
. . O

RACK1 NNP B-Gene
, , O
a DT O
receptor NN O
for IN O
activated JJ B-Gene
C NNP I-Gene
kinase NN I-Gene
and CC O
a DT O
homolog NN O
of IN O
the DT O
beta NN O
subunit NN O
of IN O
G NNP B-Gene
proteins NNS I-Gene
, , O
inhibits NNS O
activity NN O
of IN O
src JJ B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
and CC O
growth NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

Female JJ O
subjects NNS O
, , O
including VBG O
both DT O
normal JJ O
subjects NNS O
and CC O
idiopathic JJ O
calcium NN O
stone NN O
- : O
formers NNS O
, , O
have VBP O
higher JJR O
urinary JJ O
cyclic NN O
AMP NNP O
levels NNS O
than IN O
their PRP$ O
male NN O
counterparts NNS O
, , O
and CC O
this DT O
difference NN O
is VBZ O
significant JJ O
when WRB O
urinary JJ O
cyclic NN O
AMP NNP O
is VBZ O
expressed VBN O
in IN O
the DT O
units NNS O
mumol VBP O
/ JJ O
g NN O
of IN O
creatinine NN O
. . O

Only RB O
the DT O
3 CD O
. . O
0 CD O
- : O
kb NN O
transcript NN O
was VBD O
detected VBN O
in IN O
adult NN O
tissues NNS O
, , O
where WRB O
its PRP$ O
expression NN O
was VBD O
restricted VBN O
almost RB O
exclusively RB O
to TO O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

The DT O
effects NNS O
of IN O
systemic JJ O
glucose JJ O
concentration NN O
on IN O
brain NN O
metabolism NN O
following VBG O
repeated VBD O
brain NN O
ischemia NN O
. . O

The DT O
target NN O
contained VBD O
between IN O
positions NNS O
- : O
403 CD O
and CC O
- : O
125 CD O
acts NNS O
independently RB O
of IN O
orientation NN O
, , O
in IN O
different JJ O
cell NN O
types NNS O
and CC O
species NNS O
, , O
and CC O
in IN O
the DT O
context NN O
of IN O
a DT O
heterologous JJ O
promoter NN O
. . O

We PRP O
propose VBP O
that IN O
refeeding NN O
may MD O
be VB O
an DT O
important JJ O
mechanism NN O
for IN O
activation NN O
of IN O
certain JJ O
viral JJ O
infections NNS O
previously RB O
suppressed VBN O
by IN O
famine NN O
. . O

Heat NNP O
- : O
inducible JJ O
CAT NNP B-Gene
activity NN O
was VBD O
detectable JJ O
when WRB O
additional JJ O
sequences NNS O
from IN O
the DT O
native JJ O
promoter NN O
containing VBG O
three CD O
CCAAT NNP O
boxes NNS O
and CC O
a DT O
single JJ O
HSE NNP O
were VBD O
present JJ O
in IN O
the DT O
constructions NNS O
. . O

This DT O
partial JJ O
transection NN O
could MD O
permit VB O
vasopressin NN B-Gene
to TO O
be VB O
secreted VBN O
in IN O
response NN O
to TO O
a DT O
larger JJR O
rise NN O
in IN O
plasma JJ O
sodium NN O
concentration NN O
. . O

Here RB O
we PRP O
have VBP O
investigated VBN O
the DT O
structural JJ O
requirements NNS O
and CC O
consequences NNS O
of IN O
regulatory JJ O
phosphorylation NN O
for IN O
the DT O
interaction NN O
between IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
JNK NNP B-Gene
in IN O
vivo NN O
. . O

MZF NNP B-Gene
- : I-Gene
1 CD I-Gene
represses NNS O
CAT NNP B-Gene
reporter NN I-Gene
gene NN I-Gene
expression NN O
via IN O
GAL4 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
nonhematopoietic JJ O
cell NN O
lines NNS O
NIH NNP O
3T3 CD O
and CC O
293 CD O
. . O

Regulation NN O
of IN O
the DT O
human JJ O
p21 NN B-Gene
/ NNP O
WAF1 NNP B-Gene
/ NNP O
Cip1 NNP B-Gene
promoter NN O
in IN O
hepatic JJ O
cells NNS O
by IN O
functional JJ O
interactions NNS O
between IN O
Sp1 NNP B-Gene
and CC O
Smad NNP B-Gene
family NN I-Gene
members NNS I-Gene
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
a DT O
sequence NN O
match NN O
between IN O
enhancers NNS O
and CC O
certain JJ O
promoter NN O
elements NNS O
is VBZ O
critical JJ O
. . O

The DT O
results NNS O
strongly RB O
support VBP O
the DT O
notion NN O
that IN O
the DT O
OBF1 NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
and CC O
the DT O
OBF1 NNP B-Gene
protein NN I-Gene
are VBP O
important JJ O
for IN O
normal JJ O
ARS NNP O
function NN O
as IN O
an DT O
origin NN O
of IN O
replication NN O
. . O

Shape NNP O
factor NN O
correlated VBD O
well RB O
with IN O
hemodynamic JJ O
data NNS O
for IN O
RV NNP O
/ NNP O
LV NNP O
systolic JJ O
pressure NN O
ratios NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
93 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
for IN O
normalized JJ O
interventricular JJ O
pressure NN O
differences NNS O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
95 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
sequence NN O
of IN O
monkey JJ B-Gene
opsin NN I-Gene
closely RB O
resembles VBZ O
the DT O
human JJ O
sequence NN O
at IN O
the DT O
nucleotide NN O
and CC O
the DT O
amino NN O
acid NN O
levels NNS O
, , O
with IN O
the DT O
latter NN O
having VBG O
only RB O
7 CD O
differences NNS O
out IN O
of IN O
348 CD O
residues NNS O
. . O

The DT O
method NN O
has VBZ O
been VBN O
satisfactorily RB O
applied VBN O
to TO O
the DT O
determination NN O
of IN O
paracetamol NN O
in IN O
pharmaceutical JJ O
formulations NNS O
and CC O
biological JJ O
fluids NNS O
. . O

Intron NNP O
- : O
exon NN O
structure NN O
of IN O
the DT O
porcine NN B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha SYM I-Gene
- : I-Gene
encoding VBG I-Gene
gene NN I-Gene
. . O

We PRP O
report VBP O
here RB O
the DT O
isolation NN O
of IN O
a DT O
full JJ O
- : O
length NN O
cDNA NN O
clone NN O
coding VBG O
for IN O
a DT O
hitherto NN O
undiscovered JJ O
isoform NN O
of IN O
the DT O
bovine NN B-Gene
C NNP I-Gene
- : I-Gene
subunit NN I-Gene
. . O

The DT O
clinical JJ O
efficacy NN O
rates NNS O
evaluated VBD O
in IN O
151 CD O
cases NNS O
( ( O
KS NNP O
- : O
R1 NNP O
group NN O
in IN O
77 CD O
cases NNS O
, , O
oral JJ O
group NN O
in IN O
74 CD O
cases NNS O
) ) O
on IN O
standard JJ O
criteria NNS O
of IN O
committee NN O
members NNS O
were VBD O
88 CD O
. . O
3 CD O
% NN O
for IN O
the DT O
KS NNP O
- : O
R1 NNP O
group NN O
and CC O
86 CD O
. . O
5 CD O
% NN O
for IN O
the DT O
oral JJ O
group NN O
, , O
respectively RB O
. . O

The DT O
assembly NN O
of IN O
sequence NN O
ready JJ O
, , O
high JJ O
- : O
resolution NN O
physical JJ O
maps NNS O
and CC O
construction NN O
of IN O
minimally RB O
overlapping VBG O
contigs NNS O
for IN O
the DT O
human JJ O
as RB O
well RB O
as IN O
model NN O
genomes NNS O
requires VBZ O
accurate JJ O
determination NN O
of IN O
the DT O
extent NN O
of IN O
overlap NN O
between IN O
adjacent JJ O
clones NNS O
as RB O
well RB O
as IN O
their PRP$ O
relative JJ O
orientation NN O
. . O

Yeast NNP B-Gene
Gal11 NNP I-Gene
protein NN I-Gene
mediates VBZ O
the DT O
transcriptional JJ O
activation NN O
signal NN O
of IN O
two CD O
different JJ O
transacting VBG O
factors NNS O
, , O
Gal4 NNP B-Gene
and CC O
general JJ B-Gene
regulatory JJ I-Gene
factor NN I-Gene
I PRP I-Gene
/ VBP O
repressor JJ B-Gene
/ NNP I-Gene
activator NN I-Gene
site NN I-Gene
binding VBG I-Gene
protein JJ I-Gene
1 CD I-Gene
/ JJ O
translation NN B-Gene
upstream JJ I-Gene
factor NN I-Gene
. . O

Hemolytic JJ O
disease NN O
of IN O
African JJ O
newborn NNS O
. . O

The DT O
sequence NN O
contains VBZ O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
1744 CD O
nt NN O
in IN O
the DT O
virus NN O
- : O
sense NN O
strand NN O
, , O
a DT O
3 CD O
' POS O
untranslated JJ O
region NN O
of IN O
1360 CD O
nt NN O
and CC O
a DT O
3 CD O
' POS O
poly NN O
( ( O
A DT O
) ) O
tail NN O
. . O

There EX O
was VBD O
no DT O
further JJ O
increase NN O
in IN O
oxygen NN O
consumption NN O
when WRB O
these DT O
subjects NNS O
breathed VBD O
with IN O
inspiratory JJ O
pressures NNS O
above IN O
SIP NNP O
. . O

A DT O
protein NN O
lacking VBG O
the DT O
SH2 NNP B-Gene
and CC O
RING NNP O
finger NN O
domains VBZ O
has VBZ O
no DT O
activity NN O
, , O
but CC O
a DT O
chimeric JJ O
protein NN O
with IN O
the DT O
SH2 NNP B-Gene
and CC O
RING NNP O
finger NN O
domains NNS O
of IN O
SLI NNP B-Gene
- : I-Gene
1 CD I-Gene
replaced VBN O
by IN O
the DT O
equivalent JJ O
domains NNS O
of IN O
c SYM B-Gene
- : I-Gene
Cbl NNP I-Gene
has VBZ O
activity NN O
. . O

Both DT O
alleles NNS O
are VBP O
functionally RB O
expressed VBN O
and CC O
are VBP O
distributed VBN O
within IN O
CD4 NNP B-Gene
+ NNP O
/ NNP O
CD8 NNP B-Gene
+ NNP O
T NNP O
cell NN O
subsets NNS O
. . O

Termination NN O
of IN O
induced JJ O
VT NNP O
on IN O
the DT O
first JJ O
attempt NN O
was VBD O
comparable JJ O
with IN O
BV NNP O
pacing VBG O
( ( O
87 CD O
. . O
4 CD O
% NN O
) ) O
versus NN O
RV NNP O
pacing NN O
( ( O
89 CD O
. . O
6 CD O
% NN O
) ) O
. . O

The DT O
NAUSICAA NNP O
system NN O
gives VBZ O
a DT O
good JJ O
knowledge NN O
of IN O
LET NNP O
spectra NNP O
for IN O
the DT O
first JJ O
time NN O
in IN O
space NN O
dosimetry NN O
. . O

The DT O
report NN O
highlights VBZ O
the DT O
possible JJ O
contribution NN O
of IN O
stress JJ O
factors NNS O
in IN O
the DT O
context NN O
of IN O
therapy NN O
resistant JJ O
periodontal JJ O
disease NN O
, , O
and CC O
the DT O
results NNS O
seem VBP O
to TO O
be VB O
understandable JJ O
within IN O
the DT O
context NN O
of IN O
a DT O
stress NN O
system NN O
disorder RBR O
perspective NN O
. . O

We PRP O
linked VBD O
hypersensitivity NN O
site NN O
2 CD O
( ( O
HS2 NNP O
) ) O
from IN O
the DT O
locus NN O
control NN O
region NN O
( ( O
LCR NNP O
) ) O
to TO O
a DT O
A NNP B-Gene
gamma NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN O
( ( O
A DT B-Gene
gamma NN I-Gene
* NN I-Gene
) ) O
mutationally RB O
marked VBN O
to TO O
allow VB O
its PRP$ O
transcript NN O
to TO O
be VB O
distinguished VBN O
from IN O
endogenous JJ O
gamma NN B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN O
. . O

The DT O
Trx NNP B-Gene
- : O
CT NNP B-Gene
fusion NN O
protein NN O
was VBD O
produced VBN O
less RBR O
efficiently RB O
( ( O
20 CD O
% NN O
of IN O
total JJ O
soluble JJ O
cellular JJ O
protein NN O
) ) O
. . O

In IN O
Saccharomyces NNP O
cerevisiae VBP O
the DT O
cAMP NN B-Gene
- : I-Gene
dependent NN I-Gene
kinases NNS I-Gene
( ( O
PKAs NNP B-Gene
) ) O
promote VBP O
cytoplasmic JJ O
growth NN O
and CC O
modulate VB O
the DT O
growth NN O
- : O
regulated VBN O
mechanism NN O
triggering VBG O
the DT O
begin NN O
of IN O
DNA NNP O
synthesis NN O
. . O

Technetium NNP O
- : O
99m CD O
methylene NN O
diphosphonate NN O
scintimammography NN O
for IN O
evaluation NN O
of IN O
palpable JJ O
breast NN O
masses NNS O
. . O

In IN O
study NN O
2 CD O
, , O
the DT O
correlation NN O
coefficients NNS O
between IN O
the DT O
ISO2 NNP O
measurements NNS O
obtained VBN O
at IN O
the DT O
ulcer JJ O
margin NN O
and CC O
at IN O
the DT O
adjacent JJ O
normal JJ O
mucosa NN O
, , O
and CC O
delta JJ O
ISO2 NNP O
obtained VBN O
by IN O
the DT O
experienced JJ O
observer NN O
and CC O
one CD O
of IN O
the DT O
three CD O
learners NNS O
were VBD O
0 CD O
. . O
94 CD O
, , O
0 CD O
. . O
97 CD O
, , O
and CC O
0 CD O
. . O
94 CD O
, , O
respectively RB O
. . O

The DT O
human JJ B-Gene
insulin NN I-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
II NNP I-Gene
( ( O
IGF NNP B-Gene
- : I-Gene
II NNP I-Gene
) ) O
gene NN O
contains VBZ O
four CD O
promoters NNS O
( ( O
P1 NNP O
, , O
P2 NNP O
, , O
P3 NNP O
and CC O
P4 NNP O
) ) O
. . O

The DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
, , O
from IN O
nucleotide JJ O
- : O
837 CD O
to TO O
- : O
336 CD O
, , O
contains NNS O
TATA NNP O
and CC O
inverted VBN O
CAAT NNP O
boxes NNS O
as RB O
well RB O
as IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ O
SP1 NNP B-Gene
erythroid NN O
- : O
specific JJ O
cis NN O
- : O
acting VBG O
regulatory JJ O
elements NNS O
. . O

At IN O
the DT O
carboxyl NN O
terminus NN O
, , O
deletion NN O
as RB O
far RB O
as IN O
residue JJ O
388 CD O
did VBD O
not RB O
affect VB O
in IN O
vitro JJ O
TRF NNP B-Gene
. . I-Gene
C NNP I-Gene
assembly RB O
, , O
although IN O
trans NNS O
- : O
activating VBG O
activity NN O
was VBD O
abolished VBN O
. . O

CONCLUSIONS NN O
: : O
Translocation NN O
of IN O
bacteria NNS O
or CC O
endotoxin NN O
from IN O
the DT O
gastrointestinal JJ O
tract NN O
into IN O
the DT O
bloodstream NN O
has VBZ O
been VBN O
noted VBN O
in IN O
animal JJ O
experiments NNS O
; : O
however RB O
, , O
translocation NN O
was VBD O
not RB O
detected VBN O
in IN O
our PRP$ O
patients NNS O
with IN O
hemorrhagic JJ O
shock NN O
. . O

Acad NNP O
. . O

She PRP O
had VBD O
been VBN O
receiving VBG O
MTX NNP O
7 CD O
. . O
5 CD O
mg NN O
/ NN O
week NN O
for IN O
2 CD O
. . O
5 CD O
months NNS O
because IN O
of IN O
her PRP$ O
vasculitis NN O
symptoms NNS O
. . O

One CD O
of IN O
these DT O
SEBPs NNP B-Gene
, , O
SEBP2 NNP B-Gene
, , O
was VBD O
shown VBN O
to TO O
be VB O
the DT O
product NN O
of IN O
the DT O
homeotic JJ B-Gene
gene NN I-Gene
fork NN B-Gene
head NN I-Gene
. . O

Curing VBG O
shrinkage NN O
and CC O
volumetric JJ O
changes NNS O
of IN O
resin NN O
- : O
modified JJ O
glass NN O
ionomer NN O
restorative JJ O
materials NNS O
. . O

Changes NNS O
in IN O
dopamine NN B-Gene
receptor NN I-Gene
sensitivity NN O
in IN O
humans NNS O
after IN O
heavy JJ O
alcohol NN O
intake NN O
. . O

In IN O
a DT O
PC12 NNP O
cell NN O
mutant NN O
that WDT O
is VBZ O
deficient JJ O
in IN O
protein JJ B-Gene
kinase VB I-Gene
A DT I-Gene
activity NN O
( ( O
AB NNP O
. . O
11 CD O
) ) O
, , O
all DT O
three CD O
differentiating VBG O
agents NNS O
were VBD O
unable JJ O
to TO O
down VB O
- : O
regulate NN O
nrg SYM B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

Constructs NNS O
were VBD O
made VBN O
in IN O
which WDT O
an DT O
AATAAA NNP O
and CC O
the DT O
GT NNP O
- : O
rich JJ O
region NN O
were VBD O
separated VBN O
by IN O
various JJ O
distances NNS O
ranging VBG O
from IN O
7 CD O
to TO O
43 CD O
bp NN O
. . O

To TO O
analyze VB O
the DT O
mechanism NN O
of IN O
fos JJ B-Gene
/ NNP O
jun NN B-Gene
activation NN O
by IN O
TCDD NNP O
we PRP O
have VBP O
used VBN O
electrophoretic JJ O
mobility NN O
shift NN O
and CC O
transient JJ O
expression NN O
assays NNS O
of IN O
reporter NN O
gene NN O
constructs NNS O
containing VBG O
response NN O
elements NNS O
for IN O
12 CD O
- : O
O NNP O
- : O
tetradecanoyl NN O
- : O
phorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TRE NNP O
) ) O
, , O
serum FW O
( ( O
SRE NNP O
) ) O
, , O
cAMP NN O
( ( O
CRE NNP O
) ) O
, , O
and CC O
aromatic JJ O
hydrocarbons NNS O
( ( O
AhRE NNP O
) ) O
from IN O
the DT O
fos NN B-Gene
and CC O
jun NN B-Gene
genes NNS I-Gene
fused VBD O
to TO O
the DT O
firefly NN B-Gene
luciferase NN I-Gene
gene NN I-Gene
under IN O
the DT O
control NN O
of IN O
the DT O
SV40 NNP B-Gene
minimal JJ I-Gene
promoter NN I-Gene
. . O

Comparison NNP O
of IN O
the DT O
amino NN O
acid JJ O
sequences NNS O
of IN O
the DT O
RPO1 NNP B-Gene
polypeptides NNS I-Gene
of IN I-Gene
IIV6 NNP I-Gene
, , I-Gene
LCDV NNP I-Gene
, , I-Gene
and CC I-Gene
MCV NNP I-Gene
- : I-Gene
1 CD I-Gene
with IN O
the DT O
corresponding JJ O
prokaryotic JJ O
, , O
eukaryotic JJ O
, , O
and CC O
viral JJ O
proteins NNS O
revealed VBD O
differences NNS O
in IN O
amino NN O
acid NN O
similarity NN O
and CC O
phylogenetic JJ O
relationships NNS O
. . O

However RB O
, , O
C4B NNP B-Gene
proteins VBZ I-Gene
encoded VBN O
by IN O
monomodular JJ O
short JJ O
genes NNS O
may MD O
have VB O
relatively RB O
higher JJR O
concentrations NNS O
than IN O
those DT O
from IN O
long JJ B-Gene
C4A NNP I-Gene
genes NNS I-Gene
. . O

The DT O
crystal JJ O
structure NN O
of IN O
the DT O
VP16 NNP B-Gene
core NN I-Gene
has VBZ O
been VBN O
determined VBN O
at IN O
2 CD O
. . O
1 CD O
A DT O
resolution NN O
. . O

Cyclic NNP O
loading NN O
of IN O
bone NN O
during IN O
normal JJ O
daily JJ O
activity NN O
leads VBZ O
to TO O
the DT O
formation NN O
of IN O
microcracks NNS O
within IN O
the DT O
tissue NN O
matrix NN O
of IN O
compact JJ O
bone NN O
. . O

Additionally RB O
, , O
the DT O
mouse NN O
promoter NN O
contains VBZ O
22 CD O
copies NNS O
of IN O
a DT O
CT NNP O
dinucleotide NN O
repeat NN O
sequence NN O
located VBD O
approximately RB O
155 CD O
bp VBD O
5 CD O
' '' O
to TO O
exon VB O
1 CD O
. . O

Sera NN O
from IN O
euthyroid JJ O
post NN O
- : O
menopausal NN O
or CC O
pregnant JJ O
women NNS O
yielded VBD O
TSH NNP B-Gene
levels NNS O
within IN O
the DT O
normal JJ O
range NN O
. . O

FK506 NNP O
is VBZ O
10 CD O
- : O
to TO O
100 CD O
- : O
fold NN O
more RBR O
potent JJ O
than IN O
cyclosporin VBP O
A DT O
in IN O
preventing VBG O
organ JJ O
rejection NN O
and CC O
in IN O
toxicity NN O
. . O

The DT O
histamine NN B-Gene
H1 NNP I-Gene
receptor NN I-Gene
antagonists NNS O
( ( O
antihistamines NNS O
) ) O
are VBP O
an DT O
important JJ O
class NN O
of IN O
medications NNS O
used VBN O
for IN O
the DT O
relief NN O
of IN O
common JJ O
symptoms NNS O
associated VBN O
with IN O
hyperhistaminic JJ O
conditions NNS O
occurring VBG O
in IN O
children NNS O
and CC O
adults NNS O
. . O

One CD O
such JJ O
element NN O
, , O
1P CD O
, , O
was VBD O
employed VBN O
to TO O
clone VB O
from IN O
a DT O
rat NN O
pituitary JJ O
cDNA NN O
expression NN O
library VBZ O
a DT O
novel JJ O
417 CD B-Gene
- : I-Gene
amino NN I-Gene
acid JJ I-Gene
WD NNP I-Gene
protein NN I-Gene
, , O
designated VBN O
PREB NNP B-Gene
( ( I-Gene
PRL NNP I-Gene
regulatory JJ I-Gene
element NN I-Gene
binding NN I-Gene
) ) I-Gene
protein NN I-Gene
. . O

Pyrrolidine NNP O
dithiocarbamate NN O
, , O
a DT O
potent JJ O
transcriptional JJ O
inhibitor NN O
of IN O
the DT O
viral JJ B-Gene
LTR NNP I-Gene
, , O
abrogated VBD O
the DT O
cytokine NN O
responses NNS O
in IN O
both DT O
U1 NNP O
and CC O
ACH NNP O
- : O
2 CD O
cells NNS O
, , O
suggesting VBG O
a DT O
common JJ O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
mediated VBN O
transcriptional JJ O
mechanism NN O
in IN O
these DT O
cell NN O
types NNS O
despite IN O
their PRP$ O
different JJ O
modes NNS O
of IN O
provirus NN O
latency NN O
. . O

French JJ O
bean NN O
contains VBZ O
a DT O
small JJ O
family NN O
of IN O
genes NNS B-Gene
encoding VBG I-Gene
PAL NNP I-Gene
and CC O
two CD O
of IN O
these DT O
genes NNS O
, , O
PAL2 NNP B-Gene
and CC O
PAL3 NNP B-Gene
, , O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
differentially RB O
expressed VBN O
at IN O
the DT O
mRNA NN O
level NN O
in IN O
bean JJ O
tissues NNS O
. . O

We PRP O
report VBP O
a DT O
patient JJ O
developing VBG O
factor NN B-Gene
VII NNP I-Gene
inhibitor NN I-Gene
possibly RB O
as IN O
a DT O
reaction NN O
to TO O
penicillin VB O
administration NN O
; : O
it PRP O
gave VBD O
rise NN O
to TO O
fatal JJ O
haemorrhage NN O
. . O

A DT O
sequence NN O
comparison NN O
reveals NNS O
two CD O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) O
consensus NN O
sequences NNS O
, , O
basic JJ O
DNA NNP O
binding NN O
region NN O
and CC O
leucine NN O
zippers NNS O
1 CD O
and CC O
2 CD O
( ( O
bZIP1 NN O
and CC O
bZIP2 NN O
) ) O
, , O
within IN O
this DT O
region NN O
. . O

The DT O
product NN O
of IN O
rat JJ B-Gene
gene NN I-Gene
33 CD I-Gene
was VBD O
identified VBN O
as IN O
an DT O
ErbB NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
interacting NN I-Gene
protein NN I-Gene
in IN O
a DT O
two CD O
- : O
hybrid JJ O
screen NN O
employing VBG O
the DT O
ErbB NNP B-Gene
- : I-Gene
2 CD I-Gene
juxtamembrane NN I-Gene
and CC I-Gene
kinase NN I-Gene
domains NNS I-Gene
as IN O
bait NN O
. . O

A DT O
canonical JJ O
TATA NNP O
box NN O
was VBD O
not RB O
detected VBN O
. . O

The DT O
correlation NN O
between IN O
PaCO2 NNP O
and CC O
PtcO2 NNP O
in IN O
RDS NNP O
was VBD O
insufficient JJ O
to TO O
make VB O
clinical JJ O
judgement NN O
. . O

We PRP O
recently RB O
found VBD O
that IN O
the DT O
p72syk NN B-Gene
protein NN I-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
is VBZ O
physically RB O
associated VBN O
with IN O
the DT O
TCR NNP B-Gene
/ NNP O
CD3 NNP B-Gene
complex NN O
and CC O
is VBZ O
rapidly RB O
tyrosine JJ O
phosphorylated VBN O
and CC O
activated VBN O
by IN O
receptor NN O
triggering VBG O
also RB O
in IN O
T NNP O
cells NNS O
lacking VBG O
p56lck NN B-Gene
. . O

The DT O
behavior NN O
of IN O
different JJ O
types NNS O
of IN O
polytetrafluoroethylene NN O
( ( O
PTFE NNP O
) ) O
prostheses VBZ O
in IN O
the DT O
reparative JJ O
scarring NN O
process NN O
of IN O
abdominal JJ O
wall NN O
defects NNS O
. . O

Simple JJ O
reaction NN O
time NN O
( ( O
RT NNP O
) ) O
to TO O
a DT O
peripheral JJ O
visual JJ O
target NN O
( ( O
S2 NNP O
) ) O
is VBZ O
shortened VBN O
when WRB O
a DT O
non JJ O
- : O
informative JJ O
cue NN O
( ( O
S1 NNP O
) ) O
is VBZ O
flashed VBN O
at IN O
the DT O
S2 NNP O
location NN O
100 CD O
- : O
150 CD O
ms NN O
before IN O
target NN O
onset NN O
( ( O
early JJ O
facilitation NN O
) ) O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
late JJ O
MYO NNP O
/ NNP O
M NNP O
is VBZ O
more RBR O
useful JJ O
than IN O
washout NN O
rate NN O
to TO O
assess VB O
the DT O
effect NN O
of IN O
treatment NN O
on IN O
heart NN O
failure NN O
due JJ O
to TO O
DCM NNP O
. . O

Risk NN O
of IN O
HTLV NNP O
infection NN O
in IN O
patients NNS O
on IN O
haemodialysis NN O
. . O

The DT O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
can MD O
potentially RB O
encode VB O
26 CD O
- : O
and CC O
22 CD O
- : O
kDa NN O
proteins VBZ O
that IN O
differ NN O
only RB O
in IN O
their PRP$ O
carboxyl NN O
tails NNS O
because IN O
of IN O
an DT O
alternative JJ O
splicing NN O
mechanism NN O
. . O

( ( O
1992 CD O
) ) O
Biochemistry NNP O
31 CD O
, , O
3351 CD O
- : O
3358 CD O
] NN O
. . O

Anesthesia NNP O
was VBD O
maintained VBN O
with IN O
isoflurane NN O
( ( O
ISO NNP O
) ) O
/ VBP O
N2O NNP O
/ NNP O
O2 NNP O
inhalation NN O
. . O

The DT O
nucleosomal JJ O
response NN O
associated VBN O
with IN O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
induction NN O
is VBZ O
mediated VBN O
via IN O
alternative JJ O
MAP NNP B-Gene
kinase NN I-Gene
cascades NNS I-Gene
: : O
MSK1 NNP B-Gene
as IN O
a DT O
potential JJ O
histone NN B-Gene
H3 NNP I-Gene
/ NNP O
HMG NNP B-Gene
- : I-Gene
14 CD I-Gene
kinase NN O
. . O

A DT O
consensus NN O
binding VBG O
site NN O
for IN O
the DT O
transcription NN O
factor NN O
SP1 NNP B-Gene
was VBD O
identified VBN O
in IN O
intron NN O
As IN O
downstream NN O
of IN O
the DT O
proenkephalin JJ B-Gene
germ NN I-Gene
cell NN I-Gene
cap NN I-Gene
site NN I-Gene
region NN I-Gene
. . O

Interestingly RB O
, , O
a DT O
decreased JJ O
transcription NN O
from IN O
the DT O
endogenous JJ O
c SYM B-Gene
- : I-Gene
Myb NNP I-Gene
promoter NN I-Gene
was VBD O
observed VBN O
in IN O
several JJ O
HTLV NNP O
- : O
I PRP O
transformed VBD O
T NNP O
- : O
cell NN O
lines NNS O
. . O

Sample NNP O
treatment NN O
was VBD O
optimized VBN O
in IN O
order NN O
to TO O
achieve VB O
a DT O
complete JJ O
extraction NN O
of IN O
labetalol JJ O
diastereoisomers NNS O
and CC O
to TO O
avoid VB O
racemization NN O
during IN O
extraction NN O
. . O

It PRP O
has VBZ O
been VBN O
calculated VBN O
that IN O
600 CD O
, , O
0 CD O
new JJ O
cases NNS O
of IN O
lung NN O
cancer NN O
occur VBP O
worldwide IN O
every DT O
year NN O
, , O
most JJS O
of IN O
them PRP O
due JJ O
to TO O
smoking VBG O
. . O

Restriction NNP O
enzyme NN O
and CC O
heteroduplex JJ O
analyses NNS O
confirmed VBD O
that IN O
sequences NNS O
unique JJ O
to TO O
FeSV NNP O
( ( O
src JJ B-Gene
sequences NNS I-Gene
) ) O
are VBP O
located VBN O
at IN O
the DT O
center NN O
of IN O
the DT O
FeSV NNP O
genome NN O
and CC O
are VBP O
approximately RB O
1 CD O
. . O
5 CD O
kilobase NN O
pairs NNS O
in IN O
length NN O
. . O

Indium NNP O
- : O
111 CD O
leukocyte NN O
imaging NN O
in IN O
patients NNS O
with IN O
rheumatoid JJ O
arthritis NN O
. . O

Thus RB O
, , O
methylation NN O
of IN O
Pph21p NNP B-Gene
is VBZ O
important JJ O
for IN O
formation NN O
of IN O
PP2A NNP B-Gene
trimeric NN I-Gene
and CC I-Gene
dimeric NN I-Gene
complexes NNS I-Gene
, , O
and CC O
consequently RB O
, , O
for IN O
PP2A NNP B-Gene
function NN O
. . O

The DT O
in IN O
vitro JJ O
activity NN O
of IN O
mecillinam NN O
and CC O
amoxicillin NN O
/ NNP O
clavulanic JJ O
acid NN O
against IN O
Escherichia NNP O
coli VBP O
strains NNS O
producing VBG O
beta NN B-Gene
- : I-Gene
lactamases NNS I-Gene
of IN O
the DT O
TEM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
Oxa NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
chromosomal JJ O
type NN O
were VBD O
studied VBN O
using VBG O
the DT O
broth NN O
and CC O
agar JJ O
dilution NN O
technique NN O
. . O

Lithium NNP O
- : O
carbonate NN O
action NN O
during IN O
radiation NN O
therapy NN O
has VBZ O
been VBN O
studied VBN O
, , O
valuing VBG O
the DT O
positive JJ O
effect NN O
on IN O
leukopoiesis NN O
and CC O
the DT O
consequent NN O
better RBR O
clinical JJ O
conditions NNS O
of IN O
the DT O
patients NNS O
in IN O
course NN O
of IN O
treatment NN O
. . O

The DT O
in IN O
vivo NN O
profile NN O
of IN O
ZFH NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
the DT O
larval NN O
CNS NNP O
shows VBZ O
intriguing VBG O
overlap RP O
with IN O
DDC NNP B-Gene
in IN O
specific JJ O
serotonin NN O
and CC O
dopamine JJ O
neurons NNS O
. . O

The DT O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
gene NN I-Gene
is VBZ O
overexpressed VBN O
in IN O
a DT O
variety NN O
of IN O
tumor NN O
types NNS O
and CC O
appears VBZ O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
abnormal JJ O
growth NN O
of IN O
a DT O
number NN O
of IN O
cell NN O
types NNS O
. . O

This DT O
study NN O
was VBD O
carried VBN O
out IN O
to TO O
analyze VB O
PRL NNP B-Gene
secretion NN O
in IN O
metastatic JJ O
prostate NN O
cancer NN O
patients NNS O
both DT O
at IN O
basal NN O
conditions NNS O
and CC O
in IN O
response NN O
to TO O
L NNP O
- : O
Dopa NN O
and CC O
metoclopramide NN O
, , O
which WDT O
represents VBZ O
the DT O
most RBS O
classical JJ O
inhibitory NN O
and CC O
stimulatory NN O
tests NNS O
for IN O
PRL NNP B-Gene
secretion NN O
, , O
respectively RB O
. . O

Pneumonia NNP O
in IN O
children NNS O

When WRB O
excluding VBG O
children NNS O
with IN O
ocular JJ O
and CC O
cerebral JJ O
pathology NN O
, , O
32 CD O
matched VBD O
pairs NNS O
of IN O
premature NN O
and CC O
control NN O
children NNS O
remained VBD O
. . O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
isolation NN O
of IN O
bovine NN B-Gene
and CC I-Gene
rat NN I-Gene
GHF NNP I-Gene
- : I-Gene
1 CD I-Gene
cDNA NN I-Gene
clones NNS O
. . O

We PRP O
also RB O
compared VBN O
the DT O
sequence NN O
with IN O
the DT O
partly RB O
homologous JJ O
products NNS O
of IN O
the DT O
S NNP O
. . O
cerevisiae NN O
genes NNS O
TPS2 NNP B-Gene
and CC O
TSL1 NNP B-Gene
which WDT O
code NN O
for IN O
the DT O
larger JJR O
subunits NNS O
of IN O
the DT O
trehalose JJ B-Gene
synthase NN I-Gene
complex NN I-Gene
and CC O
with IN O
a DT O
TSL1 NNP B-Gene
homologue NN I-Gene
, , O
TPS3 NNP B-Gene
, , O
of IN O
unknown JJ O
function NN O
. . O

The DT O
JTc NNP O
delta NN O
among IN O
the DT O
three CD O
groups NNS O
did VBD O
not RB O
differ VB O
as RB O
well RB O
: : O
JTc NNP O
delta NN O
of IN O
the DT O
VT NNP O
group NN O
was VBD O
70 CD O
ms NN O
+ NNP O
/ NNP O
- : O
30 CD O
ms NN O
, , O
the DT O
JTc NNP O
delta NN O
of IN O
the DT O
PVC NNP O
group NN O
was VBD O
60 CD O
msec NN O
+ NN O
/ NNP O
- : O
25 CD O
msec NN O
, , O
and CC O
the DT O
JTc NNP O
delta NN O
of IN O
the DT O
control NN O
group NN O
was VBD O
70 CD O
ms NN O
+ NNP O
/ NNP O
- : O
30 CD O
ms NN O
. . O

We PRP O
previously RB O
described VBD O
two CD O
alanine JJ O
cluster NN O
mutations NNS O
, , O
R77 NNP O
to TO O
A NNP O
( ( O
R77A NNP O
) ) O
- : O
K79A NNP O
and CC O
E192A NNP O
- : O
E194A NNP O
, , O
which WDT O
selectively RB O
inactivated VBD O
the DT O
triphosphatase NN O
component NN O
. . O

Intracellular JJ O
recordings NNS O
were VBD O
performed VBN O
on IN O
the DT O
optic JJ O
tectum NN O
of IN O
the DT O
carp NN O
in IN O
vitro NN O
. . O

We PRP O
present VBP O
a DT O
case NN O
of IN O
type NN O
II NNP O
hyperbetalipoproteinemia NN O
in IN O
a DT O
patient NN O
whose WP$ O
diagnosis NN O
had VBD O
been VBN O
previously RB O
unrecognized VBN O
, , O
and CC O
who WP O
had VBD O
previously RB O
been VBN O
misdiagnosed VBN O
with IN O
rheumatoid JJ O
arthritis NN O
and CC O
later RB O
gout NN O
. . O

In IN O
a DT O
third JJ O
experiment NN O
, , O
a DT O
Chessmaster NNP O
gradually RB O
increases VBZ O
the DT O
number NN O
of IN O
boards NNS O
he PRP O
can MD O
reproduce VB O
with IN O
higher JJR O
than IN O
70 CD O
% NN O
average JJ O
accuracy NN O
to TO O
nine CD O
, , O
replacing VBG O
as RB O
many JJ O
as IN O
160 CD O
pieces NNS O
correctly RB O
. . O

The DT O
structural JJ O
analysis NN O
also RB O
demonstrated VBD O
that IN O
the DT O
heterogeneity NN O
of IN O
the DT O
HDC NNP B-Gene
mRNA NN I-Gene
is VBZ O
caused VBN O
by IN O
an DT O
insertion NN O
of IN O
the DT O
seventh JJ O
intron NN O
sequence NN O
and CC O
alternative JJ O
use NN O
of IN O
the DT O
splicing VBG O
acceptor NN O
site NN O
at IN O
the DT O
12th CD O
exon NN O
. . O

Significantly RB O
, , O
the DT O
polymerase NN O
chain NN O
reaction NN O
results NNS O
demonstrated VBD O
that IN O
gene NN B-Gene
IV NNP I-Gene
transcripts NNS I-Gene
were VBD O
associated VBN O
with IN O
hepatic JJ O
polysome NN O
fractions NNS O
, , O
indicating VBG O
their PRP$ O
active JJ O
utilization NN O
in IN O
this DT O
tissue NN O
. . O

Repression NN O
of IN O
glucocorticoid NN B-Gene
receptor NN I-Gene
- : O
mediated VBN O
transcriptional JJ O
activation NN O
by IN O
unliganded JJ O
thyroid NN B-Gene
hormone NN I-Gene
receptor NN I-Gene
( ( O
TR NNP B-Gene
) ) O
is VBZ O
TR JJ B-Gene
isoform NN O
- : O
specific NN O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
members NNS O
of IN O
this DT O
protein JJ O
family NN O
exhibit NN O
both DT O
prolyl JJ B-Gene
isomerase NN I-Gene
and CC O
chaperone NN O
activity NN O
. . O

Avian JJ O
reproductive JJ O
system NN O
: : O
daily JJ O
variations NNS O
in IN O
responses NNS O
to TO O
hormones NNS O
. . O

The DT O
process NN O
has VBZ O
been VBN O
applied VBN O
to TO O
the DT O
river NN O
reclamation NN O
in IN O
Yangpu NNP O
District NNP O
of IN O
Shanghai NNP O
City NNP O
, , O
China NNP O
. . O

Contacts NNS O
between IN O
Bacillus NNP O
subtilis NNS O
catabolite VBP O
regulatory JJ O
protein NN O
CcpA NNP B-Gene
and CC O
amyO VB B-Gene
target NN O
site NN O
. . O

Thus RB O
, , O
the DT O
consensus NN O
sequences VBZ O
for IN O
phosphatase NN O
regulation NN O
are VBP O
5 CD O
' '' O
- : O
GCACGTGGG NNP O
- : O
3 CD O
' POS O
and CC O
5 CD O
' '' O
- : O
GCACGTTTT NNP O
- : O
3 CD O
' '' O
which WDT O
differ VBP O
from IN O
the DT O
binding NN O
sequences NNS O
for IN O
the DT O
Cpflp NNP B-Gene
protein NN O
required VBN O
for IN O
transcription NN O
of IN O
the DT O
genes NNS O
in IN O
methionine JJ O
biosynthesis NN O
and CC O
for IN O
centromere JJ O
function NN O
. . O

Similar JJ O
observations NNS O
have VBP O
been VBN O
made VBN O
previously RB O
for IN O
other JJ O
genes NNS O
. . O

Conversely RB O
, , O
the DT O
central JJ O
regions NNS O
are VBP O
highly RB O
variable JJ O
. . O

We PRP O
previously RB O
showed VBD O
that IN O
the DT O
upstream JJ O
promoter NN O
element NN O
of IN O
the DT O
yeast NN B-Gene
RP39A NNP I-Gene
gene NN I-Gene
consists VBZ O
of IN O
these DT O
identical JJ O
sequence NN O
motifs NNS O
. . O

An DT O
anatomical JJ O
and CC O
histochemical JJ O
study NN O
has VBZ O
been VBN O
undertaken JJ O
and CC O
as IN O
a DT O
result NN O
emphasis NN O
is VBZ O
given VBN O
to TO O
recent JJ O
hypotheses NNS O
that IN O
suggest VBP O
there EX O
are VBP O
similarities NNS O
with IN O
Type NNP O
IV NNP O
glycogen NN O
storage NN O
disease NN O
( ( O
Andersen NNP O
' POS O
s JJ O
disease NN O
) ) O
which WDT O
, , O
although IN O
clinically RB O
distinct JJ O
, , O
has VBZ O
the DT O
same JJ O
enzyme NN O
defect NN O
. . O

Deadenylation NN O
and CC O
decay NN O
of IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN I-Gene
in IN O
K562 NNP O
cells NNS O
is VBZ O
extraordinarily RB O
slow JJ O
compared VBN O
with IN O
NIH NNP O
3T3 CD O
cells NNS O
, , O
suggesting VBG O
that IN O
the DT O
increased VBN O
stability NN O
gained VBN O
by IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN I-Gene
in IN O
K562 NNP O
cells NNS O
is VBZ O
mainly RB O
controlled VBN O
at IN O
the DT O
deadenylation NN O
step NN O
. . O

The DT O
effects NNS O
of IN O
social JJ O
isolation NN O
on IN O
morphine NN O
- : O
induced JJ O
locomotor NN O
activity NN O
were VBD O
compared VBN O
in IN O
: : O
( ( O
i NN O
) ) O
animals NNS O
with IN O
an DT O
intact JJ O
hypothalamo NN O
- : O
pituitary JJ O
- : O
adrenal NN O
( ( O
HPA NNP O
) ) O
axis NN O
; : O
( ( O
ii NN O
) ) O
animals NNS O
in IN O
which WDT O
stress NN O
- : O
induced JJ O
corticosterone NN O
secretion NN O
was VBD O
blocked VBN O
by IN O
adrenalectomy NN O
. . O

The DT O
mechanism NN O
by IN O
which WDT O
large JJ O
molecules NNS O
, , O
such JJ O
as IN O
the DT O
diphosphonate NN O
99mTc CD O
- : O
labeled VBN O
EHDP NNP O
or CC O
99mTc CD O
- : O
labeled VBN O
pyrophosphate NN O
, , O
pass NN O
through IN O
capillaries NNS O
in IN O
bone NN O
is VBZ O
by IN O
passive JJ O
diffusion NN O
. . O

Since IN O
the DT O
- : O
172 CD O
/ SYM O
- : O
148 CD O
element NN O
also RB O
conferred VBD O
estrogen NN O
and CC O
thyroid VB O
hormone NN O
responsiveness NN O
, , O
it PRP O
can MD O
be VB O
considered VBN O
a DT O
composite JJ O
hormone NN O
response NN O
element NN O
. . O

Moreover RB O
, , O
we PRP O
observed VBD O
that IN O
the DT O
function NN O
of IN O
T3R NNP B-Gene
- : O
RXR NNP B-Gene
heterodimers NNS O
on IN O
response NN O
elements NNS O
composed VBN O
of IN O
two CD O
half NN O
- : O
sites NNS O
in IN O
a DT O
directly RB O
repeated VBN O
orientation NN O
spaced VBN O
by IN O
4 CD O
nucleotides NNS O
is VBZ O
determined VBN O
in IN O
major JJ O
parts NNS O
by IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
sequence NN O
of IN O
the DT O
upstream JJ O
half NN O
- : O
site NN O
. . O

PLUS NNP O
- : O
3 CD O
is VBZ O
a DT O
new JJ O
Swedish JJ O
protocol NN O
of IN O
natural JJ O
speech NN O
in IN O
3 CD O
- : O
year NN O
- : O
old JJ O
children NNS O
. . O

TbRAB31 NNP B-Gene
behaviour NN O
was VBD O
also RB O
studied VBN O
during IN O
the DT O
cell NN O
cycle NN O
; : O
TbRAB31 NNP B-Gene
always RB O
localised VBD O
to TO O
a DT O
discrete JJ O
structure NN O
that WDT O
duplicated VBD O
very RB O
early RB O
in IN O
mitosis NN O
and CC O
relocated VBD O
to TO O
daughter VB O
cells NNS O
in IN O
a DT O
coordinate NN O
manner NN O
with IN O
the DT O
basal NN O
body NN O
and CC O
kinetoplast NN O
, , O
suggesting VBG O
the DT O
involvement NN O
of IN O
microtubules NNS O
. . O

The DT O
histidine NN O
- : O
tagged VBN O
gene NN O
, , O
rpoCHIS NN B-Gene
, , O
was VBD O
used VBN O
to TO O
replace VB O
the DT O
wild JJ O
- : O
type NN O
allele NN O
in IN O
the DT O
chromosome NN O
of IN O
S NNP O
. . O
coelicolor NN O
and CC O
S NNP O
. . O
lividans NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
total JJ O
pinealectomy NN O
in IN O
these DT O
already RB O
sympathectomized VBN O
blinded VBN O
rabbits NNS O
always RB O
resulted VBD O
in IN O
a DT O
substantial JJ O
deceleration NN O
of IN O
the DT O
rhythms NN O
( ( O
mean JJ O
delta NN O
tau NN O
= NNP O
+ VBZ O
0 CD O
. . O
23 CD O
h NN O
) ) O
. . O

A DT O
malignant JJ O
true JJ O
teratoma NN O
of IN O
liver NN O
in IN O
childhood NN O
. . O

The DT O
enzyme NN O
activities NNS O
studied VBN O
are VBP O
important JJ O
elements NNS O
in IN O
the DT O
pathophysiology NN O
of IN O
dental JJ O
caries NNS O
and CC O
may MD O
even RB O
be VB O
addressed VBN O
as IN O
virulence NN O
factors NNS O
. . O

Alternatively RB O
processed JJ O
isoforms NNS O
of IN O
cellular JJ B-Gene
nucleic NN I-Gene
acid SYM I-Gene
- : I-Gene
binding VBG I-Gene
protein JJ I-Gene
interact NN O
with IN O
a DT O
suppressor NN O
region NN O
of IN O
the DT O
human JJ B-Gene
beta NN I-Gene
- : I-Gene
myosin NN I-Gene
heavy NN I-Gene
chain NN I-Gene
gene NN I-Gene
. . O

The DT O
inhibition NN O
by IN O
the DT O
RIalpha NNP B-Gene
subunit NN I-Gene
is VBZ O
reversed VBN O
by IN O
addition NN O
of IN O
nanomolar JJ O
concentrations NNS O
of IN O
cAMP NN O
( ( O
Ka NNP O
= VBZ O
40 CD O
nM NN O
) ) O
, , O
thus RB O
demonstrating VBG O
that IN O
PrKX NNP B-Gene
is VBZ O
a DT O
novel NN O
, , O
type NN B-Gene
I PRP I-Gene
cAMP VBP I-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinase NN I-Gene
that WDT O
is VBZ O
activated VBN O
at IN O
lower JJR O
cAMP NN O
concentrations NNS O
than IN O
the DT O
holoenzyme NN O
with IN O
the DT O
Calpha NNP B-Gene
subunit NN I-Gene
of IN O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
. . O

These DT O
IgG NNP B-Gene
antibodies NNS I-Gene
in IN O
the DT O
babies NNS O
diminished VBD O
rapidly RB O
after IN O
delivery NN O
, , O
and CC O
were VBD O
detectable JJ O
only RB O
in IN O
3 CD O
cases NNS O
at IN O
2 CD O
, , O
3 CD O
, , O
and CC O
5 CD O
months NNS O
of IN O
ages NNS O
out IN O
of IN O
38 CD O
babies NNS O
up RB O
to TO O
21 CD O
months NNS O
. . O

Dopamine NNP O
neurons NNS O
in IN O
subjects NNS O
that WDT O
received VBD O
6 CD O
- : O
OHDA NN O
were VBD O
protected VBN O
by IN O
pre JJ O
- : O
treatment NN O
with IN O
GBR NNP O
- : O
12909 CD O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
used VBD O
footprinting VBG O
and CC O
gel JJ O
mobility NN O
retardation NN O
assays VBZ O
to TO O
reveal VB O
that IN O
bacterially RB O
synthesized VBN O
Zta NNP B-Gene
fusion NN I-Gene
proteins VBZ I-Gene
bound VBN O
directly RB O
to TO O
six CD O
TGTGCAA NNP O
- : O
like IN O
motifs NNS O
within IN O
DSL NNP B-Gene
. . O

After IN O
giving VBG O
a DT O
survey NN O
on IN O
the DT O
situation NN O
of IN O
antibiotic JJ O
resistance NN O
in IN O
the DT O
region NN O
of IN O
Northern NNP O
Bavaria NNP O
during IN O
1973 CD O
/ $ O
74 CD O
and CC O
comparing VBG O
the DT O
activity NN O
of IN O
a DT O
sulfamethoxazole NN O
( ( O
SMZ NNP O
) ) O
trimethoprim NN O
( ( O
TMP NNP O
) ) O
combination NN O
to TO O
other JJ O
commonly RB O
used VBN O
antibiotics NNS O
and CC O
chemotherapeutic JJ O
agents NNS O
, , O
the DT O
results NNS O
of IN O
tests NNS O
with IN O
the DT O
new JJ O
combination NN O
of IN O
N1 NNP O
- : O
( ( O
4 CD O
, , O
5 CD O
- : O
dimethyl NN O
- : O
2 CD O
- : O
oxazolyl NN O
) ) O
- : O
sulfanilamide NN O
) ) O
( ( O
sulfamoxole JJ O
) ) O
and CC O
2 CD O
, , O
4 CD O
- : O
diamino NN O
- : O
5 CD O
- : O
( ( O
3 CD O
, , O
4 CD O
, , O
5 CD O
- : O
trimethoxy NN O
- : O
benzyl NN O
) ) O
- : O
pyrimidine NN O
( ( O
trimethoprim JJ O
) ) O
at IN O
a DT O
ratio NN O
of IN O
5 CD O
: : O
1 CD O
( ( O
CN NNP O
3123 CD O
; : O
Nevin NNP O
, , O
Supristol NNP O
) ) O
are VBP O
compared VBN O
to TO O
those DT O
of IN O
tests NNS O
with IN O
TMP NNP O
/ NNP O
SMZ NNP O
. . O

Nuclear JJ O
localization NN O
and CC O
protein NN O
sequence NN O
similarities NNS O
suggested VBD O
that IN O
the DT O
SPT2 NNP B-Gene
/ NNP O
SIN1 NNP B-Gene
protein NN O
may MD O
be VB O
related VBN O
to TO O
the DT O
nonhistone NN B-Gene
chromosomal JJ I-Gene
protein NN I-Gene
HMG1 NNP I-Gene
. . O

Three CD O
cysteine NN O
and CC O
four CD O
tryptophan NN O
residues NNS O
, , O
previously RB O
identified VBN O
as IN O
conserved JJ O
amongst VBP O
nitrous JJ B-Gene
- : I-Gene
oxide NN I-Gene
reductases NNS I-Gene
, , O
are VBP O
found VBN O
in IN O
the DT O
Paracoccus NNP O
enzyme NN O
. . O

Aberrant NNP O
protein NN O
phosphorylation NN O
at IN O
tyrosine NN O
is VBZ O
responsible JJ O
for IN O
the DT O
growth NN O
- : O
inhibitory JJ O
action NN O
of IN O
pp60v NN B-Gene
- : I-Gene
src NN I-Gene
expressed VBN O
in IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
diagnosis NN O
of IN O
HCV NNP O
arthritis NN O
in IN O
patients NNS O
with IN O
positive JJ O
rheumatoid NN B-Gene
factor NN I-Gene
and CC O
chronic JJ O
inflammatory NN O
polyarthritis NN O
may MD O
be VB O
difficult JJ O
. . O

Furthermore RB O
, , O
the DT O
over IN O
- : O
replication NN O
phenotype NN O
produced VBN O
by IN O
this DT O
mutant JJ B-Gene
p65cdc18 NN I-Gene
is VBZ O
resistant JJ O
to TO O
increased VBN O
mitotic JJ O
cyclin NN B-Gene
/ NNP O
CDK NNP B-Gene
activity NN O
, , O
a DT O
known JJ O
inhibitor NN O
of IN O
over IN O
- : O
replication NN O
. . O

The DT O
lacS JJ B-Gene
gene NN I-Gene
was VBD O
cloned VBN O
in IN O
an DT O
E NNP O
. . O
coli SYM O
- : O
Streptococcus NNP O
shuttle JJ O
vector NN O
and CC O
was VBD O
expressed VBN O
both DT O
in IN O
a DT O
lacS JJ B-Gene
deletion NN O
derivative NN O
of IN O
S NNP O
. . O
thermophilus NN O
and CC O
in IN O
a DT O
pNZ63 NN O
- : O
cured VBN O
strain NN O
, , O
L NNP O
. . O
lactis NN O
NZ6091 NNP O
. . O

The DT O
combination NN O
of IN O
MISO NNP O
and CC O
WR NNP O
- : O
2721 CD O
gave VBD O
an DT O
intermediate JJ O
response NN O
compared VBN O
with IN O
either DT O
drug NN O
used VBN O
alone RB O
, , O
resulting VBG O
in IN O
some DT O
sensitization NN O
with IN O
single JJ O
doses NNS O
and CC O
an DT O
overall JJ O
protection NN O
with IN O
repeated VBN O
small JJ O
doses NNS O
. . O

The DT O
insulin NN B-Gene
- : O
induced JJ O
DNA NNP O
- : O
binding NN O
complex NN O
was VBD O
identified VBN O
as IN O
the DT O
p50 NN B-Gene
/ NNP O
p65 NN B-Gene
heterodimer NN O
. . O

Longitudinal NNP O
force NN O
- : O
length JJ O
relationships NNS O
of IN O
guinea NN O
pig NNS O
ureter NN O
were VBD O
studied VBN O
in IN O
vitro NN O
in IN O
animals NNS O
3 CD O
weeks NNS O
, , O
3 CD O
months NNS O
, , O
and CC O
3 CD O
years NNS O
of IN O
age NN O
. . O

A DT O
novel JJ O
cDNA NN O
clone NN O
termed VBD O
R2 NNP O
was VBD O
isolated VBN O
by IN O
subtractive JJ O
hybridization NN O
of IN O
a DT O
cDNA JJ O
library NN O
of IN O
phytohemagglutinin NN B-Gene
( ( O
PHA NNP B-Gene
) ) O
/ VBP O
phorbol JJ O
myristate NN O
acetate NN O
- : O
stimulated VBN O
Jurkat NNP O
cells NNS O
and CC O
by IN O
rescreening VBG O
a DT O
cDNA NN O
library NN O
of IN O
PHA NNP O
- : O
stimulated VBD O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

These DT O
observed VBN O
drug NN O
interactions NNS O
, , O
plus CC O
the DT O
known JJ O
effect NN O
of IN O
probenecid NN O
to TO O
block VB O
secretion NN O
of IN O
PZA NNP O
, , O
have VBP O
to TO O
be VB O
considered VBN O
in IN O
evaluating VBG O
the DT O
effect NN O
of IN O
the DT O
two CD O
drugs NNS O
given VBN O
together RB O
, , O
compared VBN O
to TO O
the DT O
effect NN O
of IN O
each DT O
drug NN O
given VBN O
separately RB O
. . O

Analyses NNS O
of IN O
tyrosine NN O
residue JJ O
- : O
mutated VBN O
PDGF NNP B-Gene
receptors NNS I-Gene
show VBP O
that IN O
Src NNP B-Gene
homology VBD I-Gene
2 CD I-Gene
domain NN I-Gene
- : I-Gene
containing NN I-Gene
proteins NNS I-Gene
including VBG O
Src NNP B-Gene
family NN I-Gene
kinases NNS I-Gene
, , O
phosphatidylinositol VBP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
, , O
the DT O
GTPase NNP B-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
of IN O
Ras NNP B-Gene
, , O
the DT O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
phosphatase NN I-Gene
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
phospholipase NN B-Gene
C NNP I-Gene
- : I-Gene
gamma NN I-Gene
, , O
and CC O
Crk NNP B-Gene
do VBP O
not RB O
play VB O
a DT O
major JJ O
role NN O
in IN O
mediating VBG O
the DT O
PDGF NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
p38 NN B-Gene
. . O

FTF NNP B-Gene
is VBZ O
also RB O
abundantly RB O
expressed VBN O
in IN O
the DT O
pancreas NNS O
and CC O
may MD O
exert VB O
differentiation NN O
functions NNS O
in IN O
endodermal JJ O
sublineages NNS O
, , O
similar JJ O
to TO O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
steroidogenic JJ O
tissues NNS O
. . O

We PRP O
suggest VBP O
that IN O
FlgN NNP B-Gene
and CC O
FliT NNP B-Gene
are VBP O
substrate JJ O
- : O
specific JJ O
flagellar JJ O
chaperones NNS O
that WDT O
prevent VBP O
oligomerization NN O
of IN O
the DT O
HAPs NNP B-Gene
by IN O
binding VBG O
to TO O
their PRP$ O
helical JJ O
domains NNS O
before IN O
export NN O
. . O

Sequencing VBG O
revealed VBD O
one CD O
large JJ O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
39 CD O
- : O
kDa NN O
protein NN O
. . O

The DT O
SCH9 NNP B-Gene
protein NN I-Gene
kinase NN I-Gene
mRNA NN I-Gene
contains VBZ O
a DT O
long JJ O
5 CD O
' POS O
leader NN O
with IN O
a DT O
small JJ O
open JJ O
reading NN O
frame NN O
. . O

Large JJ O
interpatient JJ O
variation NN O
in IN O
peak NN O
PCZ NNP O
plasma NN O
levels NNS O
( ( O
91 CD O
- : O
3215 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
was VBD O
seen VBN O
, , O
with IN O
the DT O
plasma NN O
half NN O
- : O
life NN O
( ( O
t1 JJ O
/ $ O
2 CD O
alpha NN O
) ) O
being VBG O
approximately RB O
57 CD O
min NNS O
in IN O
patients NNS O
given VBN O
135 CD O
- : O
180 CD O
mg NN O
/ NNP O
m2 NN O
PCZ NNP O
. . O

Forty NNP O
- : O
eight CD O
10 CD O
- : O
12 CD O
- : O
week NN O
- : O
old JJ O
male NN O
Sprague NNP O
- : O
Dawley NNP O
rats NNS O
were VBD O
randomized VBN O
to TO O
receive VB O
, , O
daily RB O
for IN O
28 CD O
days NNS O
: : O
( ( O
1 CD O
) ) O
CsA NNP O
vehicle NN O
p NN O
. . O
o NN O
. . O
plus CC O
FB NNP O
vehicle NN O
sc NN O
; : O
( ( O
2 CD O
) ) O
CsA NNP O
( ( O
15 CD O
mg NN O
/ NNP O
kg NN O
) ) O
p NN O
. . O
o NN O
. . O
plus CC O
FB NNP O
vehicle NN O
sc NN O
, , O
( ( O
3 CD O
) ) O
CsA NNP O
vehicle NN O
p NN O
. . O
o NN O
. . O
plus CC O
FB NNP O
( ( O
1 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
sc NN O
; : O
and CC O
( ( O
4 CD O
) ) O
CsA NNP O
( ( O
15 CD O
mg NN O
/ NNP O
kg NN O
) ) O
p NN O
. . O
o NN O
. . O
plus CC O
FB NNP O
( ( O
1 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
sc NN O
. . O

A DT O
false JJ O
positive JJ O
marker NN O
screen NN O
was VBD O
associated VBN O
with IN O
the DT O
occurrence NN O
of IN O
hand NN O
- : O
foot NN O
syndrome VBD O
even RB O
when WRB O
the DT O
effect NN O
of IN O
regimen NNS O
was VBD O
accounted VBN O
for IN O
by IN O
stratification NN O
( ( O
p JJ O
= NNP O
. . O
1 CD O
) ) O
. . O

Subcloning VBG O
of IN O
DNA NNP O
fragments NNS O
from IN O
the DT O
8 CD O
. . O
5 CD O
- : O
kilobase NN O
( ( O
kb NN O
) ) O
insert NN O
of IN O
pAVO4 NN O
defined VBD O
a DT O
4 CD O
- : O
kb NN O
DNA NNP O
fragment NN O
which WDT O
contained VBD O
the DT O
functional JJ B-Gene
FBP NNP I-Gene
+ NNP I-Gene
gene NN I-Gene
and CC O
its PRP$ O
regulatory JJ O
region NN O
. . O

General NNP O
formulae NN O
for IN O
estimating VBG O
heritability NN O
in IN O
a DT O
population NN O
with IN O
related JJ O
parents NNS O
. . O

One CD O
such JJ O
mutant NN O
also RB O
affects VBZ O
the DT O
overlapping VBG O
- : O
10 CD O
hexamer NN O
of IN O
PR NNP O
and CC O
results NNS O
in IN O
reduced JJ O
occupancy NN O
by IN O
both DT O
MerR NNP B-Gene
and CC O
RNA NNP B-Gene
polymerase NN I-Gene
, , O
likely RB O
as IN O
a DT O
result NN O
of IN O
inefficient JJ O
transcriptional JJ O
initiation NN O
of IN O
merR NN B-Gene
mRNA NN I-Gene
. . O

LDL NNP B-Gene
cholesterol NN I-Gene
decreased VBD O
from IN O
4 CD O
. . O
74 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
87 CD O
to TO O
3 CD O
. . O
78 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
78 CD O
mmol JJ O
/ NNP O
l NN O
after IN O
8 CD O
weeks NNS O
on IN O
simvastatin NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
apo NN B-Gene
B NNP I-Gene
fell VBD O
from IN O
142 CD O
+ NNS O
/ SYM O
- : O
31 CD O
to TO O
112 CD O
+ NNS O
/ SYM O
- : O
22 CD O
mg NN O
/ NN O
dl NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Egd1p NNP B-Gene
is VBZ O
homologous JJ O
to TO O
human JJ B-Gene
BTF3b NNP I-Gene
, , O
recently RB O
identified VBN O
as IN O
the DT O
beta NN O
subunit NN O
of IN O
the DT O
heterodimeric JJ B-Gene
nascent JJ I-Gene
- : I-Gene
polypeptide NN I-Gene
- : I-Gene
associated VBN I-Gene
complex JJ I-Gene
( ( O
NAC NNP B-Gene
) ) O
involved VBN O
in IN O
ensuring VBG O
signal JJ O
- : O
sequence NN O
- : O
specific JJ O
protein NN O
sorting NN O
and CC O
translocation NN O
[ NNP O
Wiedmann NNP O
et FW O
al NN O
. . O
, , O
Nature JJ O
370 CD O
( ( O
1994 CD O
) ) O
434 CD O
- : O
440 CD O
] NN O
. . O

LDL NNP B-Gene
cholesterol NN I-Gene
decreased VBD O
from IN O
4 CD O
. . O
74 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
87 CD O
to TO O
3 CD O
. . O
78 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
78 CD O
mmol JJ O
/ NNP O
l NN O
after IN O
8 CD O
weeks NNS O
on IN O
simvastatin NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
apo NN B-Gene
B NNP I-Gene
fell VBD O
from IN O
142 CD O
+ NNS O
/ SYM O
- : O
31 CD O
to TO O
112 CD O
+ NNS O
/ SYM O
- : O
22 CD O
mg NN O
/ NN O
dl NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Revascularization NN O
after IN O
anterior JJ O
maxillary JJ O
and CC O
mandibular JJ O
osteotomy NN O

Nuclear NNP B-Gene
- : I-Gene
encoded VBD I-Gene
chloroplast NN I-Gene
ribosomal JJ I-Gene
protein NN I-Gene
L12 NNP I-Gene
of IN I-Gene
Nicotiana NNP I-Gene
tabacum NN I-Gene
: : O
characterization NN O
of IN O
mature NN O
protein NN O
and CC O
isolation NN O
and CC O
sequence NN O
analysis NN O
of IN O
cDNA NN O
clones NNS O
encoding VBG O
its PRP$ O
cytoplasmic JJ O
precursor NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
autophosphorylation NN O
of IN O
Thr286 NNP O
( ( O
alpha JJ O
subunit NN O
) ) O
and CC O
Thr287 NNP O
( ( O
beta VB O
subunit NN O
) ) O
is VBZ O
responsible JJ O
for IN O
transition NN O
of IN O
CaM NNP B-Gene
- : I-Gene
kinase NN I-Gene
II NNP I-Gene
to TO O
the DT O
Ca2 NNP O
+ NNP O
- : O
independent JJ O
form NN O
. . O

We PRP O
did VBD O
not RB O
observe VB O
any DT O
changes NNS O
in IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
or CC O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
( ( O
Bcl NNP B-Gene
- : I-Gene
x NN I-Gene
, , O
Bax NNP B-Gene
, , O
and CC O
Bad NNP B-Gene
) ) O
in IN O
control NN O
or CC O
KCREB NNP B-Gene
- : O
transfected VBD O
cells NNS O
before IN O
or CC O
after IN O
treatment NN O
with IN O
Tg NNP O
. . O

Acute NNP O
stress NN O
in IN O
7 CD O
rats NNS O
also RB O
increased VBD O
the DT O
mean JJ O
amount NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
released VBN O
in IN O
the DT O
urine NN O
by IN O
31 CD O
. . O
5 CD O
% NN O
from IN O
775 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
69 CD O
. . O
2 CD O
to TO O
1 CD O
, , O
21 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
93 CD O
. . O
3 CD O
pg NN O
. . O
/ JJ O
ml NN O
. . O

9 CD O
. . O
7 CD O
( ( O
95 CD O
% NN O
CI NNP O
: : O
9 CD O
. . O
6 CD O
- : O
9 CD O
. . O
7 CD O
) ) O
micromol NN O
/ JJ O
L NNP O
among IN O
women NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
. . O

This DT O
study NN O
indicated VBD O
that IN O
the DT O
Japanese JJ O
quail NN O
was VBD O
less RBR O
sensitive JJ O
to TO O
particulate VB O
Mn3O4 NNP O
exposure NN O
than IN O
rodents NNS O
treated VBN O
comparably RB O
. . O

Analysis NN O
of IN O
human JJ O
genomic JJ O
DNA NN O
reveals NNS O
an DT O
intronless JJ O
sequence NN O
with IN O
strong JJ O
homology NN O
to TO O
human JJ B-Gene
G NNP I-Gene
alpha NN I-Gene
q NN I-Gene
cDNA NN I-Gene
. . O

Observation NN O
of IN O
dipolar JJ O
interactions NNS O
between IN O
Pb0 NNP O
defects NNS O
at IN O
the DT O
( ( O
111 CD O
) ) O
Si NNP O
/ NNP O
SiO2 NNP O
interface NN O
. . O

RESULTS NN O
: : O
Horses VBZ O
with IN O
colic NN O
had VBD O
significantly RB O
higher JJR O
fibrinogen NN B-Gene
concentration NN O
, , O
greater JJR O
alpha NN B-Gene
2AP CD I-Gene
and CC O
protein VB B-Gene
C NNP I-Gene
activities NNS O
, , O
and CC O
longer JJR O
PT NNP O
and CC O
APTT NNP O
than IN O
did VBD O
healthy JJ O
horses NNS O
. . O

The DT O
Prolactin NNP B-Gene
levels NNS O
were VBD O
within IN O
the DT O
physiological JJ O
norms NNS O
; : O
the DT O
responses NNS O
to TO O
TRH NNP B-Gene
were VBD O
normal JJ O
, , O
and CC O
elevated VBD O
only RB O
in IN O
a DT O
few JJ O
cases NNS O
. . O

Skeletal JJ O
muscle NN O
metaboreceptor NN O
exercise NN O
responses NNS O
are VBP O
attenuated VBN O
in IN O
heart NN O
failure NN O
. . O

Recently RB O
, , O
identical JJ O
RBE NNP B-Gene
sequences NNS I-Gene
have VBP O
been VBN O
identified VBN O
at IN O
other JJ O
locations NNS O
in IN O
the DT O
human JJ O
genome NN O
. . O

Using VBG O
Spurr NNP O
' POS O
s NN O
resin NN O
as IN O
a DT O
mounting NN O
medium NN O
, , O
we PRP O
could MD O
observe VB O
thick JJ O
specimens NNS O
with IN O
oil NN O
immersion NN O
objective NN O
lens VBZ O
without IN O
the DT O
use NN O
of IN O
coverslips NNS O
, , O
then RB O
avoid VBZ O
air NN O
bubbles NNS O
near IN O
the DT O
specimen NNS O
. . O

BACKGROUND NNS O
: : O
We PRP O
conducted VBD O
a DT O
phase NN O
I PRP O
study VBP O
with IN O
MDL NNP O
73 CD O
, , O
147EF CD O
, , O
a DT O
new JJ O
5 CD B-Gene
hydroxytryptamine NN I-Gene
3 CD I-Gene
( ( I-Gene
5 CD I-Gene
- : I-Gene
HT3 NN I-Gene
) ) I-Gene
receptor NN I-Gene
antagonist NN O
, , O
in IN O
25 CD O
patients NNS O
requiring VBG O
emetogenic JJ O
chemotherapy NN O
. . O

Modulation NN O
of IN O
AUUUA NNP O
response NN O
element NN O
binding NN O
by IN O
heterogeneous JJ B-Gene
nuclear JJ I-Gene
ribonucleoprotein NN I-Gene
A1 NNP I-Gene
in IN O
human JJ O
T NNP O
lymphocytes NNS O
. . O

The DT O
selective JJ O
alteration NN O
of IN O
the DT O
genome NN O
using VBG O
Cre NNP B-Gene
recombinase NN I-Gene
to TO O
target VB O
the DT O
rearrangement NN O
of IN O
genes NNS O
flanked VBN O
by IN O
LOX NNP B-Gene
recognition NN I-Gene
sequences NNS I-Gene
has VBZ O
required VBN O
the DT O
use NN O
of IN O
two CD O
separate JJ O
genetic JJ O
constructs NNS O
in IN O
trans NNS O
, , O
one CD O
containing NN O
cre NN O
and CC O
the DT O
other JJ O
containing VBG O
the DT O
gene NN O
of IN O
interest NN O
flanked VBN O
by IN O
LOX NNP B-Gene
sites NNS I-Gene
. . O

The DT O
gene NN O
is VBZ O
separated VBN O
into IN O
four CD O
exons NNS O
by IN O
three CD O
short JJ O
introns NNS O
, , O
and CC O
the DT O
open JJ O
reading NN O
frame NN O
consists VBZ O
of IN O
6660 CD O
base NN O
pairs NN O
( ( O
bp NN O
) ) O
capable NN O
of IN O
encoding VBG O
a DT O
polypeptide NN O
of IN O
2220 CD O
amino NN O
acid NN O
residues NNS O
. . O

Cardiac NNP O
taurine NN O
levels NNS O
and CC O
sarcolemmal JJ O
calcium NN O
binding NN O
activity NN O
in IN O
furazolidone NN O
- : O
induced VBN O
cardiomyopathy NN O
. . O

The DT O
effects NNS O
of IN O
diltiazem NN O
were VBD O
stereoselective JJ O
, , O
thus RB O
the DT O
potentiation NN O
induced VBN O
by IN O
d JJ O
- : O
cis NN O
diltiazem NN O
was VBD O
significantly RB O
greater JJR O
in IN O
all DT O
cases NNS O
than IN O
that DT O
induced VBN O
by IN O
l NN O
- : O
cis NN O
diltiazem NN O
, , O
which WDT O
suggests VBZ O
that IN O
calcium NN O
channel NN O
blockade NN O
plays VBZ O
a DT O
role NN O
in IN O
these DT O
interactions NNS O
. . O

Simple JJ O
models NNS O
of IN O
bimolecular JJ O
interaction NN O
did VBD O
not RB O
fully RB O
account VBP O
for IN O
the DT O
kinetic JJ O
profiles NNS O
obtained VBN O
with IN O
the DT O
parental JJ O
antibodies NNS O
and CC O
the DT O
hybrids NNS O
, , O
and CC O
this DT O
complexity NN O
suggested VBD O
the DT O
existence NN O
of IN O
a DT O
conformational JJ O
heterogeneity NN O
in IN O
these DT O
molecules NNS O
. . O

Electronic NNP O
data NNS O
processing NN O
( ( O
EDP NNP O
) ) O
latex VBP O
immunoassay VBP O
using VBG O
anti SYM B-Gene
- : I-Gene
human JJ I-Gene
seminal JJ I-Gene
acid NN I-Gene
phosphatase NN I-Gene
( ( O
anti JJ B-Gene
- : I-Gene
HSAP NN I-Gene
) ) O
immune NN O
serum NN O
was VBD O
applied VBN O
for IN O
the DT O
species NNS O
and CC O
organ JJ O
identification NN O
of IN O
human JJ O
seminal JJ O
stains NNS O
. . O

DNA NN O
blot NN O
hybridization NN O
suggests VBZ O
that IN O
the DT O
rat NN O
genome NN O
may MD O
contain VB O
more JJR O
than IN O
one CD O
gene NN O
encoding VBG O
PtdIns NNP B-Gene
transfer NN I-Gene
protein NN I-Gene
. . O

A DT O
randomized VBN O
, , O
prospective JJ O
study NN O
was VBD O
conducted VBN O
to TO O
compare VB O
ovarian JJ O
stimulation NN O
with IN O
human JJ B-Gene
menopausal NN I-Gene
gonadotropin NN I-Gene
( ( O
hMG NN B-Gene
) ) O
and CC O
human JJ B-Gene
follicle NN I-Gene
- : I-Gene
stimulating VBG I-Gene
hormone NN I-Gene
( ( O
hFSH NN B-Gene
) ) O
in IN O
an DT O
in IN O
vitro JJ O
fertilization NN O
and CC O
embryo NN O
transfer NN O
( ( O
IVF NNP O
- : O
ET NN O
) ) O
program NN O
. . O

The DT O
R2 NNP O
between IN O
MFI NNP O
of IN O
fresh JJ O
and CC O
frozen JJ O
muscle NN O
was VBD O
0 CD O
. . O
94 CD O
and CC O
0 CD O
. . O
92 CD O
for IN O
lamb NN O
and CC O
pork NN O
longissimus NN O
, , O
respectively RB O
. . O

Panlobular JJ O
emphysema NN O

M NNP B-Gene
- : I-Gene
Ras NNP I-Gene
interacted VBD O
poorly RB O
in IN O
a DT O
yeast NN O
two CD O
- : O
hybrid JJ O
assay NN O
with IN O
multiple JJ O
Ras NNP B-Gene
effectors NNS O
, , O
including VBG O
c SYM B-Gene
- : I-Gene
Raf NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
A NNP B-Gene
- : I-Gene
Raf NN I-Gene
, , O
B NNP B-Gene
- : I-Gene
Raf NN I-Gene
, , O
phosphoinositol SYM B-Gene
- : I-Gene
3 CD I-Gene
kinase NN I-Gene
delta NN I-Gene
, , O
RalGDS NNP B-Gene
, , O
and CC O
Rin1 NNP B-Gene
. . O

Hydrophobicity NNP O
analysis NN O
indicated VBD O
that IN O
the DT O
KlaA NNP B-Gene
and CC O
KlaB NNP B-Gene
polypeptides NNS I-Gene
are VBP O
likely JJ O
to TO O
be VB O
soluble JJ O
, , O
whereas IN O
the DT O
KlaC NNP B-Gene
polypeptide NN I-Gene
was VBD O
predicted VBN O
to TO O
have VB O
four CD O
potential JJ O
membrane NN O
- : O
spanning NN O
domains NNS O
. . O

Comparison NNP O
of IN O
the DT O
genomic JJ O
DNA NNP O
sequence NN O
with IN O
that DT O
of IN O
the DT O
four CD O
different JJ O
mRNAs NN O
indicates VBZ O
that IN O
these DT O
transcripts NNS O
are VBP O
produced VBN O
by IN O
alternative JJ O
splicing NN O
of IN O
the DT O
murine NN O
pre SYM O
- : O
mRNA NN O
according VBG O
to TO O
a DT O
cassette NN O
model NN O
. . O

Thyrotoxicosis NN O
due JJ O
to TO O
amiodarone VB O
is VBZ O
difficult JJ O
to TO O
treat VB O
and CC O
is VBZ O
further RBR O
complicated VBN O
by IN O
the DT O
pro JJ O
- : O
arrhythmic JJ O
potential NN O
of IN O
thyrotoxicosis NN O
and CC O
the DT O
fading JJ O
antiarrhythmic JJ O
effect NN O
after IN O
amiodarone NN O
withdrawal NN O
. . O

Separation NN O
of IN O
ninhydrin JJ O
- : O
positive JJ O
compounds NNS O
in IN O
urine NN O
by IN O
the DT O
combined JJ O
methods NNS O
of IN O
medium NN O
- : O
tension NN O
intophoresis NN O
and CC O
partition NN O
chromatography NN O

Recently RB O
, , O
we PRP O
discovered VBD O
that IN O
alanine JJ O
substitutions NNS O
of IN O
the DT O
active JJ O
center NN O
cleft NN O
residues VBZ O
significantly RB O
impair VB O
the DT O
depurinating NN O
and CC O
ribosome JJ O
inhibitory NN O
activity NN O
of IN O
PAP NNP B-Gene
. . O

Review NN O
: : O
deterioration NN O
of IN O
glucose JJ O
tolerance NN O
with IN O
age NN O
: : O
the DT O
role NN O
of IN O
insulin NN B-Gene
resistance NN O
. . O

The DT O
two CD O
mouse NN O
lines NNS O
carrying VBG O
the DT O
unfragmented JJ O
Hnf3g NNP B-Gene
- : O
lacZ NN B-Gene
YAC NN O
showed VBD O
tissue NN O
- : O
specific NN O
, , O
copy NN O
number NN O
- : O
dependent NN O
and CC O
position NN O
- : O
independent JJ O
expression NN O
, , O
proving VBG O
that IN O
170 CD O
kb NN O
of IN O
the DT O
Hnf3g NNP B-Gene
locus NN O
contain VBP O
all DT O
elements NNS O
important JJ O
in IN O
the DT O
regulation NN O
of IN O
Hnf3g NNP B-Gene
. . O

Further RB O
, , O
the DT O
ORFs NNP O
of IN O
components NNS O
3 CD O
and CC O
5 CD O
potentially RB O
encoded JJ O
proteins NNS O
of IN O
about IN O
20 CD O
kDa NNS O
, , O
the DT O
size NN O
of IN O
the DT O
BBTV NNP B-Gene
coat NN I-Gene
protein NN I-Gene
. . O

CONCLUSION NN O
: : O
Although IN O
quantitative JJ O
and CC O
qualitative JJ O
criteria NNS O
for IN O
diagnosing VBG O
fatty JJ O
liver NN O
on IN O
helical JJ O
CT NNP O
can MD O
be VB O
determined VBN O
, , O
they PRP O
are VBP O
protocol JJ O
- : O
specific NN O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
general JJ O
clinical JJ O
criteria NNS O
for IN O
inhalation NN O
injury NN O
- : O
- : O
presence NN O
of IN O
facial JJ O
or CC O
oropharyngeal JJ O
burns NNS O
, , O
carboxyhemoglobin NN B-Gene
levels NNS O
, , O
carbonaceous JJ O
sputum NN O
, , O
or CC O
closed VBD O
space NN O
injury NN O
- : O
- : O
did VBD O
not RB O
differentiate VB O
patients NNS O
with IN O
airway JJ O
injury NN O
only RB O
from IN O
those DT O
with IN O
parenchymal JJ O
injury NN O
. . O

In IN O
turn NN O
, , O
assembly NN O
of IN O
this DT O
complex JJ O
mediates VBZ O
the DT O
enzymatic JJ O
activation NN O
of IN O
the DT O
p21 NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
and CC O
facilitates NNS O
actin JJ B-Gene
polymerization NN O
. . O

These DT O
repressor NN O
sites NNS O
are VBP O
pyrimidine JJ O
rich JJ O
and CC O
bind VB O
avidly RB O
to TO O
the DT O
polypyrimidine NN B-Gene
tract NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
PTB NNP B-Gene
) ) O
in IN O
HeLa NNP O
nuclear JJ O
extracts NNS O
as IN O
determined VBN O
by IN O
UV NNP O
crosslinking VBG O
/ JJ O
competition NN O
assays NNS O
. . O

Cardiac JJ O
preservation NN O
. . O

Evaluation NN O
of IN O
thyroid JJ O
function NN O
. . O

Analysis NN O
of IN O
the DT O
DNA NN O
from IN O
15 CD O
cases NNS O
of IN O
sporadic JJ O
and CC O
familial JJ O
Wilms NNP O
' POS O
tumor NN O
did VBD O
not RB O
reveal VB O
any DT O
changes NNS O
, , O
indicating VBG O
that IN O
the DT O
translocation NN O
breakpoint NN O
does VBZ O
not RB O
reside VB O
in IN O
this DT O
gene NN O
. . O

These DT O
two CD O
mRNA NN O
species NNS O
are VBP O
produced VBN O
by IN O
differential JJ O
polyadenylation NN O
site NN O
usage NN O
. . O

During IN O
ISO NNP O
+ NNP O
AT NNP O
infusion NN O
, , O
abdominal JJ O
fat NN O
blood NN O
flow NN O
was VBD O
still RB O
significantly RB O
increased VBN O
as IN O
compared VBN O
with IN O
control NN O
values NNS O
in IN O
lean JJ O
and CC O
obese JJ O
subjects NNS O
. . O

Rats NNP O
underwent VBD O
either CC O
a DT O
90 CD O
- : O
95 CD O
% NN O
JIB NNP O
or CC O
a DT O
sham JJ O
operation NN O
. . O

The DT O
recovery NN O
of IN O
labelled JJ O
methoxydextrane NN O
is VBZ O
98 CD O
+ NN O
/ NNP O
- : O
7 CD O
% NN O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
the DT O
mtr JJ B-Gene
product NN I-Gene
causes VBZ O
both DT O
transcription NN O
attenuation NN O
and CC O
inhibition NN O
of IN O
translation NN O
of IN O
trpE NN B-Gene
mRNA NN I-Gene
. . O

In IN O
the DT O
ePTFE NN O
specimens NNS O
, , O
tissue NN O
coverage NN O
had VBD O
increased VBN O
. . O

No DT O
anisotropism NN O
was VBD O
recorded VBN O
in IN O
a DT O
tetrahydrofuran JJ O
solution NN O
. . O

A DT O
method NN O
is VBZ O
described VBN O
for IN O
detecting VBG O
targeted JJ O
events NNS O
at IN O
the DT O
mu NN B-Gene
heavy NN I-Gene
chain NN I-Gene
gene NN I-Gene
which WDT O
relies VBZ O
on IN O
co NN O
- : O
conversion NN O
( ( O
or CC O
co VB O
- : O
exchange NN O
) ) O
of IN O
a DT O
point NN O
mutation NN O
with IN O
a DT O
selectable JJ O
marker NN O
contained VBN O
on IN O
a DT O
replacement NN O
vector NN O
. . O

The DT O
ipiO NN B-Gene
genes NNS I-Gene
code NN O
for IN O
two CD O
almost RB O
identical JJ O
152 CD O
- : O
aa NN O
proteins NNS O
which WDT O
do VBP O
not RB O
have VB O
any DT O
homology NN O
with IN O
sequences NNS O
present JJ O
in IN O
data NN O
libraries NNS O
. . O

Human NNP O
expressed VBD O
sequence NN O
tag NN O
clones NNS O
were VBD O
identified VBN O
by IN O
sequence NN O
similarity NN O
to TO O
mammalian JJ B-Gene
and CC I-Gene
yeast JJ I-Gene
oligosaccharide IN I-Gene
- : I-Gene
processing NN I-Gene
mannosidases NNS I-Gene
, , O
and CC O
the DT O
full JJ O
- : O
length NN O
coding VBG O
region NN O
of IN O
the DT O
putative JJ O
mannosidase NN B-Gene
homolog NN I-Gene
was VBD O
isolated VBN O
by IN O
a DT O
combination NN O
of IN O
5 CD O
' POS O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
and CC O
direct JJ O
polymerase NN O
chain NN O
reaction NN O
from IN O
human JJ O
placental JJ O
cDNA NN O
. . O

Urease NNP B-Gene
activity NN O
of IN O
97 CD O
% NN O
of IN O
these DT O
organisms NNS O
became VBD O
evident JJ O
within IN O
30 CD O
min NNS O
. . O

Serum NNP O
levels NNS O
of IN O
IgG NNP B-Gene
and CC O
IgM NNP B-Gene
were VBD O
also RB O
raised VBN O
, , O
but CC O
contrary JJ O
to TO O
the DT O
findings NNS O
of IN O
other JJ O
observers NNS O
IgA NNP B-Gene
levels NNS O
were VBD O
normal JJ O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
pooling NN O
requirements NNS O
are VBP O
task JJ O
dependent NN O
. . O

SETTING NN O
: : O
A DT O
division NN O
of IN O
a DT O
large JJ O
tea NN O
plantation NN O
in IN O
Kandy NNP O
. . O

Twenty NNP O
- : O
eight CD O
( ( O
7 CD O
. . O
0 CD O
% NN O
) ) O
infants NNS O
without IN O
periventricular JJ O
hemorrhage NN O
were VBD O
revealed VBN O
as IN O
having VBG O
spastic JJ O
cerebral JJ O
palsy NN O
by IN O
neurodevelopmental JJ O
evaluation NN O
in IN O
later JJ O
infancy NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
an DT O
internal JJ O
short JJ O
element NN O
located VBN O
at IN O
the DT O
very RB O
5 CD O
' '' O
terminal NN O
of IN O
L1 NNP B-Gene
sequence NN I-Gene
and CC O
the DT O
nuclear JJ O
factor NN O
binding VBG O
to TO O
the DT O
element NN O
play VB O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
transcription NN O
of IN O
human JJ B-Gene
L1 NNP I-Gene
. . O

In IN O
the DT O
evening NN O
, , O
the DT O
amplitude NN O
of IN O
the DT O
responses NNS O
to TO O
both DT O
O2 NNP O
and CC O
CO2 NNP O
increased VBD O
but CC O
the DT O
increase NN O
in IN O
CO2 NNP O
sensitivity NN O
was VBD O
proportionally RB O
more RBR O
important JJ O
. . O

This DT O
study NN O
utilizes VBZ O
the DT O
mammalian JJ O
two CD O
- : O
hybrid NN O
system NN O
to TO O
examine VB O
the DT O
role NN O
of IN O
ligand NN O
in IN O
the DT O
dimerization NN O
of IN O
human JJ B-Gene
progesterone NN I-Gene
receptor NN I-Gene
( ( O
hPR NN B-Gene
) ) O
. . O

A DT O
more RBR O
complete JJ O
analysis NN O
of IN O
dose JJ O
response NN O
, , O
time NN O
and CC O
mode NN O
of IN O
Ga NNP O
administration NN O
( ( O
preinjury NN O
or CC O
postinjury NN O
) ) O
, , O
and CC O
availability NN O
of IN O
Ga NNP O
across IN O
the DT O
blood NN O
- : O
brain NN O
barrier NN O
is VBZ O
needed VBN O
to TO O
further RBR O
evaluate VB O
the DT O
efficacy NN O
of IN O
this DT O
compound NN O
. . O

The DT O
C NNP O
- : O
terminal JJ O
mature NN O
region NN O
is VBZ O
highly RB O
conserved VBN O
in IN O
other JJ O
serine JJ B-Gene
carboxypeptidases NNS I-Gene
. . O

Galphaq NNP B-Gene
, , O
Galpha12 NNP B-Gene
, , O
and CC O
Galpha13 NNP B-Gene
, , O
but CC O
not RB O
Galphai NNP B-Gene
, , O
activate NN O
SRF NNP B-Gene
through IN O
RhoA NNP B-Gene
. . O

The DT O
most RBS O
frequent JJ O
risk NN O
factor NN O
for IN O
ischaemic NN O
was VBD O
hypertension NN O
. . O

In IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
PHO85 NNP B-Gene
encodes VBZ O
a DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
Cdk NNP B-Gene
) ) O
catalytic JJ O
subunit NN O
with IN O
multiple JJ O
regulatory JJ O
roles NNS O
thought VBN O
to TO O
be VB O
specified VBN O
by IN O
association NN O
with IN O
different JJ O
cyclin NN B-Gene
partners NNS O
( ( O
Pcls NNP B-Gene
) ) O
. . O

In IN O
addition NN O
, , O
they PRP O
display VBP O
common JJ O
features NNS O
that WDT O
make VBP O
them PRP O
strikingly RB O
related VBN O
to TO O
snoRNA VB B-Gene
U14 NNP I-Gene
. . O

Several JJ O
different JJ O
oncogenes NNS O
and CC O
growth NN O
factors NNS O
promote VBP O
G1 NNP O
phase NN O
progression NN O
. . O

Chem NNP O
. . O

To TO O
do VB O
this DT O
, , O
segments NNS O
of IN O
DNA NN O
from IN O
the DT O
5 CD O
' POS O
flank NN O
of IN O
the DT O
initiation NN O
sites VBZ O
for IN O
germline NN O
epsilon NN O
RNA NNP O
were VBD O
ligated VBN O
to TO O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
and CC O
transfected VBN O
into IN O
two CD O
mouse NN O
B NNP O
cell NN O
lines NNS O
, , O
one CD O
of IN O
which WDT O
can MD O
be VB O
induced VBN O
to TO O
switch VB O
to TO O
IgE NNP B-Gene
. . O

Wegener NNP O
' POS O
s NN O
granulomatosis NN O

The DT O
ZnF20 NNP B-Gene
cDNA NN I-Gene
hybridized VBD O
to TO O
multiple VB O
transcripts NNS O
in IN O
a DT O
thyroid JJ O
cancer NN O
cell NN O
line NN O
( ( O
8 CD O
. . O
0 CD O
, , O
4 CD O
. . O
5 CD O
and CC O
2 CD O
kb NN O
) ) O
that WDT O
increased VBD O
after IN O
cycloheximide NN O
treatment NN O
and CC O
decayed VBD O
< $ O
2 CD O
h NN O
after IN O
addition NN O
of IN O
actinomycin JJ O
D NNP O
. . O

Effect NN O
of IN O
hyperglycemia NN O
on IN O
pain NN O
threshold NN O
in IN O
alloxan JJ O
- : O
diabetic JJ O
rats NNS O
. . O

Nine NNP O
new JJ O
naphthalene RB O
related JJ O
compounds NNS O
( ( O
I PRP O
, , O
IV NNP O
, , O
V NNP O
, , O
VII NNP O
- : O
XII NN O
) ) O
together RB O
with IN O
four CD O
known VBN O
compounds NNS O
( ( O
II NNP O
, , O
III NNP O
, , O
VI NNP O
, , O
XIII NNP O
) ) O
were VBD O
isolated VBN O
from IN O
the DT O
root NN O
bark NN O
of IN O
Oroxylum NNP O
indicum JJ O
Vent NNP O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
beta NN O
- : O
adrenergic JJ O
agonist NN O
, , O
isoproterenol NN O
, , O
has VBZ O
little JJ O
influence NN O
on IN O
vascular JJ O
capacitance NN O
or CC O
liver NN O
volume NN O
of IN O
dogs NNS O
, , O
unless IN O
the DT O
hepatic JJ O
outflow NN O
resistance NN O
is VBZ O
elevated VBN O
by IN O
agents NNS O
such JJ O
as IN O
histamine NN O
. . O

Nevertheless RB O
, , O
inactivation NN O
of IN O
the DT O
cyclin NN B-Gene
E NNP I-Gene
- : O
Cdk2 NN B-Gene
complex NN O
in IN O
response NN O
to TO O
mitogen VB O
starvation NN O
occurs NNS O
normally RB O
in IN O
MEFs NNP O
that WDT O
have VBP O
a DT O
homozygous JJ O
deletion NN O
of IN O
the DT O
p27 JJ B-Gene
gene NN I-Gene
. . O

One CD O
month NN O
after IN O
the DT O
DTaP NNP O
booster NN O
vaccination NN O
, , O
both DT O
groups NNS O
had VBD O
6 CD O
- : O
to TO O
40 CD O
- : O
fold NN O
increases NNS O
in IN O
serum NN O
antibody NN O
concentrations NNS O
to TO O
all DT O
antigens NNS O
tested VBN O
; : O
the DT O
concentrations NNS O
against IN O
the DT O
three CD O
pertussis NN B-Gene
antigens NNS I-Gene
were VBD O
higher JJR O
in IN O
the DT O
DTaP NNP O
- : O
primed VBD O
children NNS O
( ( O
p NN O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

On IN O
the DT O
constituents NNS O
of IN O
Dryopteris NNP O
polylepis NN O

The DT O
cases NNS O
included VBD O
35 CD O
de IN O
novo FW O
diffuse NN O
aggressive JJ O
lymphomas NN O
( ( O
DAL NNP O
; : O
19 CD O
large JJ O
- : O
cell NN O
, , O
4 CD O
mixed JJ O
- : O
cell NN O
, , O
and CC O
12 CD O
large JJ O
- : O
cell NN O
immunoblastic JJ O
) ) O
, , O
52 CD O
transformed VBD O
aggressive JJ O
lymphomas NN O
derived VBN O
from IN O
follicular JJ O
lymphomas NN O
( ( O
TFL NNP O
) ) O
, , O
42 CD O
indolent NN O
follicular JJ O
lymphomas NN O
( ( O
FL NNP O
) ) O
, , O
14 CD O
mantle NN O
cell NN O
lymphomas NN O
( ( O
MCL NNP O
) ) O
, , O
and CC O
27 CD O
small JJ O
noncleaved VBN O
cell NN O
lymphomas NN O
( ( O
SNCL NNP O
) ) O
. . O

Idiopathic JJ O
bilateral JJ O
recurrent NN O
branch NN O
retinal JJ O
arterial JJ O
occlusion NN O
( ( O
IBRBRAO NNP O
) ) O
is VBZ O
a DT O
rare JJ O
syndrome NN O
characterized VBN O
by IN O
migraine NN O
headaches NNS O
, , O
tinnitus NN O
, , O
vertigo NN O
, , O
hearing VBG O
loss NN O
, , O
and CC O
recurrent JJ O
branch NN O
retinal JJ O
artery NN O
occlusion NN O
of IN O
unknown JJ O
etiology NN O
. . O

Such JJ O
transgenic JJ O
plants NNS O
should MD O
enable VB O
not RB O
only RB O
the DT O
mutational JJ O
analysis NN O
of IN O
sequence NN O
elements NNS O
within IN O
the DT O
replication NN O
origin NN O
region NN O
, , O
but CC O
also RB O
the DT O
construction NN O
of IN O
a DT O
new JJ O
generation NN O
of IN O
vectors NNS O
for IN O
gene NN O
amplification NN O
in IN O
plants NNS O
, , O
based VBN O
on IN O
a DT O
minimal JJ O
virus NN O
replicon NN O
. . O

The DT O
mysteries NNS O
of IN O
geographic JJ O
variability NN O
in IN O
nonmelanoma JJ O
skin NN O
cancer NN O
incidence NN O
. . O

Only RB O
transcripts NNS O
specific VBP O
for IN O
TSGF NNP B-Gene
- : I-Gene
2 CD I-Gene
are VBP O
detected VBN O
in IN O
ovary JJ O
and CC O
testes VBZ O
tissues NNS O
of IN O
adults NNS O
as RB O
well RB O
as IN O
in IN O
puparia NN O
, , O
while IN O
neither DT O
gene NN O
is VBZ O
expressed VBN O
during IN O
the DT O
larval JJ O
developmental JJ O
stages NNS O
. . O

Expression NN O
of IN O
class NN B-Gene
IV NNP I-Gene
ADH NNP I-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
in IN O
human JJ O
stomach NN O
but CC O
not RB O
liver RB O
. . O

Leptinaemia NN O
does VBZ O
not RB O
correlate VB O
with IN O
the DT O
actual JJ O
or CC O
mean JJ O
blood NN O
pressure NN O
reading VBG O
nor CC O
with IN O
stage NN O
of IN O
hypertension NN O
according VBG O
to TO O
the DT O
WHO NNP O
classification NN O
. . O

Next JJ O
, , O
we PRP O
show VBP O
that IN O
two CD O
EMS NNP O
- : O
induced JJ O
mutations NNS O
, , O
previously RB O
shown VBN O
to TO O
interact VB O
genetically RB O
with IN O
zipper NN O
( ( O
Ebr NNP B-Gene
) ) O
, , O
disrupt VBZ O
the DT O
RhoA NNP B-Gene
locus NN I-Gene
. . O

The DT O
presence NN O
of IN O
local JJ O
abnormalities NNS O
in IN O
both DT O
patients NNS O
can MD O
support VB O
the DT O
hypothesis NN O
that IN O
the DT O
cortex NN O
, , O
especially RB O
of IN O
the DT O
temporal JJ O
anterior JJ O
lobe NN O
, , O
is VBZ O
involved VBN O
in IN O
the DT O
origin NN O
of IN O
the DT O
laughing NN O
seizures NNS O
. . O

A DT O
controlled JJ O
trial NN O
of IN O
recombinant JJ B-Gene
human JJ I-Gene
granulocyte NN I-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
after IN O
total JJ O
body NN O
irradiation NN O
, , O
high JJ O
- : O
dose NN O
chemotherapy NN O
, , O
and CC O
autologous JJ O
bone NN O
marrow NN O
transplantation NN O
for IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
or CC O
malignant JJ O
lymphoma NN O
. . O

T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
beta NN I-Gene
( ( O
TCR NNP B-Gene
beta NN I-Gene
) ) O
gene NN O
rearrangements NNS O
occur VBP O
in IN O
a DT O
third JJ O
of IN O
early JJ O
B NNP O
- : O
cell NN O
acute JJ O
lymphoblastic JJ O
leukemias NN O
( ( O
ALLs NNP O
) ) O
. . O

Lung NNP O
density NN O
increased VBD O
in IN O
quartz JJ O
- : O
exposed VBN O
, , O
but CC O
not RB O
in IN O
volcanic JJ O
- : O
ash NN O
- : O
exposed VBN O
animals NNS O
. . O

The DT O
morphological JJ O
effects NNS O
of IN O
two CD O
snake NN O
venoms NNS O
, , O
N NNP O
. . O
naja NN O
and CC O
A NNP O
. . O
piscivorus NN O
, , O
and CC O
of IN O
the DT O
Direct NNP B-Gene
Lytic NNP I-Gene
Factor NNP I-Gene
and CC O
Phospholipase NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
compounds NNS O
purified VBD O
from IN O
N NNP O
. . O
naja JJ O
crude NN O
venom NN O
, , O
were VBD O
investigated VBN O
on IN O
lung NN O
and CC O
cremaster NN O
vessels NNS O
of IN O
rats NNS O
. . O

The DT O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
receptor NN I-Gene
is VBZ O
a DT O
seven CD O
- : O
transmembrane NN O
spanning VBG O
receptor NN O
coupled VBD O
to TO O
specific JJ O
heterotrimeric JJ B-Gene
G NNP I-Gene
proteins VBZ I-Gene
including VBG O
Gi NNP B-Gene
and CC O
G16 NNP B-Gene
. . O

Atorvastatin NNP O
was VBD O
the DT O
most RBS O
cost JJ O
- : O
effective JJ O
HMG NNP B-Gene
- : I-Gene
CoA NNP I-Gene
reductase NN I-Gene
inhibitor NN O
. . O

Gel NNP O
retardation NN O
assays NNS O
combined VBN O
with IN O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
and CC O
diethyl JJ O
pyrocarbonate NN O
interference NN O
showed VBD O
that IN O
a DT O
nuclear JJ O
factor NN O
from IN O
differentiated VBN O
C2 NNP O
myotubes NNS O
and CC O
BC3H1 NNP O
myocytes VBZ O
recognized VBD O
a DT O
conserved VBN O
A NNP O
+ NNP O
T NNP O
- : O
rich JJ O
sequence NN O
within IN O
the DT O
peripheral JJ O
activating JJ O
region NN O
. . O

The DT O
size NN O
of IN O
the DT O
mutant JJ O
molecule NN O
corresponds NNS O
to TO O
the DT O
unprocessed JJ O
cytoplasmic NN O
precursor NN O
( ( O
pre JJ B-Gene
- : I-Gene
super JJ I-Gene
- : I-Gene
pro JJ I-Gene
- : I-Gene
PrB NN I-Gene
) ) O
, , O
as IN O
detected VBN O
in IN O
sec61 NN B-Gene
mutants NNS I-Gene
, , O
when WRB O
translocation NN O
into IN O
the DT O
endoplasmic JJ O
reticulum NN O
is VBZ O
blocked VBN O
. . O

OBJECTIVE NN O
: : O
To TO O
determine VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
amphotericin NN O
B NNP O
oral JJ O
suspension NN O
( ( O
ABOS NNP O
) ) O
for IN O
the DT O
treatment NN O
of IN O
fluconazole JJ O
refractory JJ O
oral JJ O
candidiasis NN O
in IN O
persons NNS O
with IN O
HIV NNP O
infection NN O
. . O

In IN O
simpler NN O
organisms NNS O
, , O
the DT O
ATP NNP B-Gene
sulfurylase NN I-Gene
and CC O
APS NNP B-Gene
kinase VB I-Gene
reactions NNS O
are VBP O
catalyzed VBN O
by IN O
separate JJ O
enzymes NNS O
encoded VBN O
by IN O
two CD O
or CC O
three CD O
genes NNS O
, , O
suggesting VBG O
that IN O
a DT O
fusion NN O
of IN O
separate JJ O
genes NNS O
during IN O
the DT O
course NN O
of IN O
evolution NN O
generated VBD O
the DT O
bifunctional JJ O
enzyme NN O
. . O

Investigations NNS O
using VBG O
hippocampal JJ O
slices NNS O
maintained VBD O
in IN O
vitro NNS O
have VBP O
demonstrated VBN O
that IN O
bursts NNS O
of IN O
oscillatory JJ O
field NN O
potentials NNS O
in IN O
the DT O
gamma NN O
frequency NN O
range NN O
( ( O
30 CD O
- : O
80 CD O
Hz NNP O
) ) O
are VBP O
followed VBN O
by IN O
a DT O
slower JJR O
oscillation NN O
in IN O
the DT O
beta NN O
1 CD O
range NN O
( ( O
12 CD O
- : O
20 CD O
Hz NNP O
) ) O
. . O

The DT O
actA JJ B-Gene
gene NN I-Gene
is VBZ O
present JJ O
as IN O
a DT O
single JJ O
copy NN O
in IN O
the DT O
genome NN O
of IN O
A NNP O
. . O
chrysogenum NN O
; : O
and CC O
its PRP$ O
expression NN O
level NN O
, , O
opposite RB O
to TO O
pcbC VB B-Gene
and CC O
cefEF VB B-Gene
cephalosporin JJ I-Gene
biosynthetic JJ I-Gene
genes NNS I-Gene
, , O
was VBD O
steady JJ O
during IN O
cephalosporin JJ O
fermentation NN O
, , O
showing VBG O
a DT O
single JJ O
1 CD O
. . O
4 CD O
- : O
kb NN O
transcript NN O
. . O

After IN O
nerve JJ O
injury NN O
, , O
the DT O
nociceptive JJ O
responses NNS O
through IN O
type NN O
I PRP O
neurons NNS O
, , O
which WDT O
are VBP O
polymodal JJ O
C NNP O
- : O
fibers NNS O
and CC O
drive NN O
NK1 NNP B-Gene
- : I-Gene
receptor NN I-Gene
mechanisms NNS O
in IN O
spinal JJ O
pain NN O
transmission NN O
, , O
were VBD O
completely RB O
lost VBN O
, , O
but CC O
without IN O
changes NNS O
in IN O
type NN O
II NNP O
ones NNS O
, , O
which WDT O
are VBP O
polymodal JJ O
C NNP O
- : O
fibers NNS O
and CC O
drive NN O
NMDA NNP B-Gene
receptor NN I-Gene
- : O
mechanisms NNS O
, , O
while IN O
type JJ O
III NNP O
ones NNS O
, , O
which WDT O
are VBP O
capsaicin JJ O
- : O
insensitive NN O
( ( O
possibly RB O
A NNP O
- : O
fibers NNS O
) ) O
and CC O
drive JJ O
NMDA NNP B-Gene
- : I-Gene
receptor NN I-Gene
mechanisms NNS O
, , O
were VBD O
markedly RB O
enhanced VBN O
. . O

The DT O
absorbed NN O
dose NN O
was VBD O
measured VBN O
by IN O
combination NN O
of IN O
two CD O
integrating VBG O
detectors NNS O
: : O
thermo NN O
- : O
luminescent NN O
dosemeter NN O
of IN O
Mg2SiO4 NNP O
: : O
Tb NNP O
( ( O
TDMS NNP O
) ) O
and CC O
plastic JJ O
nuclear JJ O
track NN O
detector NN O
( ( O
PNTD NNP O
) ) O
. . O

To TO O
compare VB O
the DT O
PAX3 NNP B-Gene
and CC O
putative JJ O
PAX3 NNP B-Gene
- : O
FKHR NNP B-Gene
transactivation NN O
domains NNS O
, , O
we PRP O
fused VBD O
C NNP O
- : O
terminal JJ O
test NN O
fragments NNS O
to TO O
the DT O
heterologous JJ O
GAL4 NNP B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
and CC O
tested JJ O
activation NN O
of IN O
a DT O
reporter NN O
gene NN O
co SYM O
- : O
transfected VBN O
into IN O
four CD O
cell NN O
types NNS O
. . O

Viscosity NNP O
experiments NNS O
on IN O
the DT O
catalytic JJ O
fragment NN O
kinase NN O
reaction NN O
demonstrated VBD O
that IN O
the DT O
chemical NN O
( ( O
phosphoryl JJ O
transfer NN O
) ) O
step NN O
had VBD O
a DT O
reduced VBN O
rate NN O
. . O

Excision NNP O
repair NN O
at IN O
the DT O
level NN O
of IN O
the DT O
nucleotide NN O
in IN O
the DT O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
MFA2 NNP I-Gene
gene NN I-Gene
: : O
mapping NN O
of IN O
where WRB O
enhanced JJ O
repair NN O
in IN O
the DT O
transcribed JJ O
strand NN O
begins VBZ O
or CC O
ends NNS O
and CC O
identification NN O
of IN O
only RB O
a DT O
partial JJ O
rad16 NN B-Gene
requisite NN O
for IN O
repairing VBG O
upstream JJ O
control NN O
sequences NNS O
. . O

It PRP O
was VBD O
shown VBN O
that IN O
estradiol JJ O
concentrations NNS O
obtained VBN O
after IN O
estradiol JJ O
valerate NN O
and CC O
micronized VBN O
estradiol JJ O
ingestion NN O
were VBD O
dependent JJ O
on IN O
the DT O
patient NN O
' POS O
s JJ O
age NN O
as RB O
well RB O
as IN O
on IN O
the DT O
constitutional JJ O
type NN O
. . O

This DT O
study NN O
compared VBN O
the DT O
gross JJ O
and CC O
fine JJ O
motor NN O
performance NN O
of IN O
14 CD O
traumatically RB O
brain NN O
- : O
injured JJ O
children NNS O
( ( O
five CD O
to TO O
15 CD O
years NNS O
old JJ O
, , O
with IN O
loss NN O
of IN O
consciousness NN O
for IN O
at IN O
least JJS O
24 CD O
hours NNS O
) ) O
to TO O
14 CD O
normal JJ O
children NNS O
group NN O
matched VBD O
for IN O
age NN O
and CC O
sex NN O
. . O

Serum NNP O
magnesium NN O
in IN O
79 CD O
patients NNS O
of IN O
gynecologic JJ O
neoplasms NNS O
treated VBN O
with IN O
cisplatin NN O
and CC O
their PRP$ O
controls NNS O
was VBD O
measured VBN O
. . O

PURPOSE NN O
: : O
The DT O
purposes NNS O
of IN O
the DT O
present JJ O
study NN O
were VBD O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
a DT O
12 CD O
- : O
wk NN O
laboratory NN O
based VBN O
aerobic JJ O
exercise NN O
program NN O
on IN O
cardiopulmonary JJ O
function NN O
, , O
CD4 NNP B-Gene
cell NN O
count NN O
, , O
and CC O
physician JJ O
- : O
assessed VBD O
health NN O
status NN O
among IN O
symptomatic JJ O
pre NN O
- : O
AIDS NNP O
HIV NNP O
- : O
infected JJ O
individuals NNS O
( ( O
N NNP O
= NNP O
28 CD O
) ) O
and CC O
to TO O
assess VB O
the DT O
degree NN O
to TO O
which WDT O
ill VB O
health NN O
was VBD O
associated VBN O
with IN O
exercise NN O
relapse NN O
. . O

Five CD O
women NNS O
( ( O
15 CD O
. . O
6 CD O
% NN O
) ) O
met VBD O
criteria NNS O
for IN O
PMS NNP O
. . O

Described NNP O
X NNP O
- : O
ray NN O
projection NN O
were VBD O
performed VBN O
in IN O
70 CD O
patients NNS O
. . O

Identification NN O
of IN O
dynein JJ B-Gene
heavy JJ I-Gene
chain NN I-Gene
genes NNS I-Gene
expressed VBN O
in IN O
human NN O
and CC O
mouse NN O
testis NN O
: : O
chromosomal JJ O
localization NN O
of IN O
an DT O
axonemal JJ B-Gene
dynein NN I-Gene
gene NN I-Gene
. . O

In IN O
contrast NN O
, , O
the DT O
Anabaena NNP O
strain NN O
7120 CD O
leuA NN B-Gene
gene NN O
did VBD O
not RB O
complement VB O
the DT O
nifV JJ B-Gene
mutation NN I-Gene
of IN O
R229I NNP O
efficiently RB O
. . O

Only RB O
17 CD O
% NN O
of IN O
all DT O
patients NNS O
admitted VBD O
it PRP O
at IN O
all DT O
times NNS O
. . O

There EX O
is VBZ O
no DT O
TATA NNP O
box NN O
appropriately RB O
spaced VBD O
upstream NN O
from IN O
the DT O
transcription NN O
initiation NN O
site NN O
. . O

Based VBN O
on IN O
the DT O
comparison NN O
of IN O
the DT O
predicted VBN O
amino NN O
acid JJ O
sequences NNS O
of IN O
1 CD B-Gene
- : I-Gene
sst NN I-Gene
and CC O
1 CD B-Gene
- : I-Gene
fft NN I-Gene
with IN O
those DT O
of IN O
other JJ O
plant NN O
fructosyl JJ B-Gene
transferase NN I-Gene
genes NNS I-Gene
, , O
we PRP O
postulate VBP O
that IN O
both DT O
plant NN O
fructan NN B-Gene
genes NNS I-Gene
have VBP O
evolved VBN O
from IN O
plant NN O
invertase NN B-Gene
genes NNS O
. . O

The DT O
present JJ O
findings NNS O
revealed VBD O
that IN O
the DT O
rib NN B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
was VBD O
a DT O
unique JJ O
alpha1 NN B-Gene
, , I-Gene
4 CD I-Gene
- : I-Gene
N NNP I-Gene
- : I-Gene
acetylglucosaminyltransferase NN I-Gene
involved VBN O
in IN O
the DT O
biosynthetic JJ O
initiation NN O
and CC O
elongation NN O
of IN O
heparan NN O
sulfate NN O
. . O

After IN O
transfection NN O
, , O
specific JJ O
TSH NNP B-Gene
beta NN I-Gene
promoter NN I-Gene
activity NN O
was VBD O
evident JJ O
in IN O
both DT O
TRH NNP B-Gene
- : O
responsive JJ O
pituitary JJ O
- : O
derived VBN O
GH3 NNP O
and CC O
primary JJ O
pituitary NN O
cell NN O
cultures NNS O
. . O

Additional JJ O
exonuclease NN B-Gene
III NNP I-Gene
protection NN O
was VBD O
observed VBN O
beyond IN O
the DT O
core NN O
region NN O
on IN O
both CC O
the DT O
5 CD O
' POS O
and CC O
3 CD O
' '' O
sides NNS O
, , O
suggesting VBG O
that IN O
E1 NNP B-Gene
interacted VBD O
with IN O
more RBR O
distal JJ O
sequences NNS O
as RB O
well RB O
. . O

The DT O
cDNA NN O
corresponding VBG O
to TO O
the DT O
FPS1 NNP B-Gene
gene NN I-Gene
was VBD O
isolated VBN O
by IN O
functional JJ O
complementation NN O
of IN O
a DT O
mutant JJ O
yeast NN O
strain NN O
defective JJ O
in IN O
FPS NNP B-Gene
activity NN O
( ( O
Delourme NNP O
, , O
D NNP O
. . O
, , O
Lacroute NNP O
, , O
F NNP O
. . O
, , O
and CC O
Karst NNP O
, , O
F NNP O
. . O

Ketanserin NNP O
, , O
a DT O
hypotensive JJ O
drug NN O
with IN O
5 CD B-Gene
- : I-Gene
HT2 NNP I-Gene
receptor NN I-Gene
antagonism NN O
, , O
when WRB O
administered VBN O
by IN O
topical JJ O
infusion NN O
of IN O
a DT O
0 CD O
. . O
25 CD O
% NN O
w NN O
/ NNP O
v NN O
solution NN O
by IN O
corneal NN O
and CC O
scleral JJ O
applications NNS O
, , O
was VBD O
found VBN O
to TO O
lower VB O
intraocular JJ O
pressure NN O
with IN O
four CD O
times NNS O
more RBR O
activity NN O
than IN O
its PRP$ O
metabolite NN O
, , O
ketanserinol NN O
. . O

The DT O
known VBN O
B1 NNP O
- : O
deficiency NN O
reaches VBZ O
excessive JJ O
high JJ O
values NNS O
with IN O
light JJ O
exercise NN O
. . O

We PRP O
have VBP O
examined VBN O
by IN O
in IN O
vitro NN O
footprinting VBG O
a DT O
region NN O
located VBN O
downstream NN O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
, , O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
promoter NN O
found VBD O
to TO O
be VB O
hypersensitive JJ O
to TO O
DNase NNP B-Gene
I PRP I-Gene
digestion VBP O
in IN O
vivo NN O
. . O

Furthermore RB O
, , O
in IN O
vivo NN O
and CC O
in IN O
vitro JJ O
protein NN O
- : O
protein NN O
interaction NN O
experiments NNS O
have VBP O
shown VBN O
that IN O
SR33 NNP B-Gene
protein NN I-Gene
interacts VBZ O
with IN O
itself PRP O
and CC O
with IN O
SR45 NNP B-Gene
protein NNS I-Gene
but CC O
not RB O
with IN O
two CD O
other JJ O
members NNS O
( ( O
SRZ21 NNP B-Gene
and CC O
SRZ22 NNP B-Gene
) ) O
of IN O
the DT O
SR NNP B-Gene
family NN I-Gene
that WDT O
are VBP O
known VBN O
to TO O
interact VB O
with IN O
the DT O
Arabidopsis NNP O
full JJ O
- : O
length NN O
U NNP B-Gene
- : I-Gene
70K CD I-Gene
only RB O
. . O

Furthermore RB O
, , O
heparin JJ B-Gene
lyase NN I-Gene
treatment NN O
of IN O
extracts NNS O
of IN O
cells NNS O
expressing VBG O
recombinant JJ B-Gene
YD NNP I-Gene
- : I-Gene
repeat NN I-Gene
protein NN I-Gene
releases VBZ O
this DT O
protein NN O
from IN O
high JJ O
molecular JJ O
mass NN O
aggregates NNS O
. . O

Phosphorylation NN O
and CC O
spindle JJ O
pole NN O
body NN O
localization NN O
of IN O
the DT O
Cdc15p NNP B-Gene
mitotic JJ I-Gene
regulatory JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
in IN I-Gene
budding VBG I-Gene
yeast NN I-Gene
. . O

The DT O
management NN O
of IN O
the DT O
"""" NNP O
chronic JJ O
"""" NNP O
patient NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
RPF NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
early JJ O
steps NNS O
in IN O
the DT O
differentiation NN O
of IN O
amacrine NN O
and CC O
ganglion NN O
cells NNS O
. . O

Since IN O
the DT O
integrated VBN O
13h00 CD O
- : O
16h00 CD O
plasma NN O
cortisol NN O
estimation NN O
is VBZ O
cheaper JJR O
and CC O
simpler JJR O
than IN O
the DT O
mean JJ O
13h00 CD O
- : O
16h00 CD O
plasma NN O
cortisol NN O
estimation NN O
, , O
we PRP O
recommend VBP O
it PRP O
as IN O
an DT O
adjunct NN O
in IN O
the DT O
diagnosis NN O
of IN O
Cushing VBG O
' '' O
s JJ O
syndrome NN O
. . O

The DT O
4 CD O
- : O
AP NNP O
( ( O
4 CD O
- : O
20 CD O
mM NN O
) ) O
effect NN O
resulted VBD O
in IN O
a DT O
decrease NN O
of IN O
the DT O
sensory JJ O
activity NN O
, , O
which WDT O
was VBD O
fully RB O
restored VBN O
by IN O
TEA NNP O
or CC O
Ba2 NNP O
+ NNP O
. . O

Disruption NN O
of IN O
microtubules NNS O
did VBD O
not RB O
affect VB O
the DT O
fidelity NN O
or CC O
kinetics NNS O
of IN O
vacuolar JJ O
protein NN O
sorting NN O
, , O
indicating VBG O
that IN O
Vps1p NNP B-Gene
function NN O
is VBZ O
not RB O
dependent JJ O
on IN O
microtubules NNS O
. . O

When WRB O
comparing VBG O
the DT O
barley NN B-Gene
PSI NNP I-Gene
- : I-Gene
K NNP I-Gene
and CC O
PSI NNP B-Gene
- : I-Gene
G NN I-Gene
with IN O
the DT O
reported VBN O
PSI NNP B-Gene
- : I-Gene
K NNP I-Gene
sequence NN I-Gene
from IN I-Gene
Synechococcus NNP I-Gene
vulcanus NN I-Gene
, , O
the DT O
degree NN O
of IN O
similarity NN O
is VBZ O
equal JJ O
, , O
suggesting VBG O
that IN O
an DT O
ancestral JJ O
gene NN O
has VBZ O
been VBN O
duplicated VBN O
in IN O
a DT O
chloroplast NN O
progenitor NN O
but CC O
not RB O
in IN O
a DT O
cyanobacterial NN O
. . O

The DT O
RS447 NNP B-Gene
human JJ B-Gene
megasatellite NN I-Gene
tandem NN I-Gene
repetitive JJ I-Gene
sequence NN I-Gene
encodes VBZ O
a DT O
novel JJ O
deubiquitinating NN O
enzyme NN O
with IN O
a DT O
functional JJ O
promoter NN O
. . O

Value NNP O
of IN O
Normotest NNP O
and CC O
antithrombin RB B-Gene
3 CD I-Gene
in IN O
the DT O
assessment NN O
of IN O
liver NN O
function NN O
. . O

RESULTS NN O
: : O
Of IN O
the DT O
29 CD O
patients NNS O
who WP O
received VBD O
concurrent JJ O
chemotherapy NN O
and CC O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
, , O
ten NN O
( ( O
34 CD O
% NN O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
[ NNP O
CI NNP O
] NNP O
, , O
17 CD O
. . O
9 CD O
to TO O
54 CD O
. . O
3 CD O
% NN O
) ) O
were VBD O
believed VBN O
to TO O
have VB O
clinically RB O
significant JJ O
bleomycin JJ O
toxicity NN O
. . O

Prevention NN O
by IN O
a DT O
heparin NN O
- : O
antithrombin NN B-Gene
III NNP I-Gene
combination NN O

However RB O
, , O
at IN O
18 CD O
months NNS O
of IN O
age NN O
, , O
significantly RB O
higher JJR O
levels NNS O
of IN O
IgG1 NNP B-Gene
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
and CC O
of IN O
IgG4 NNP B-Gene
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
were VBD O
found VBN O
in IN O
infants NNS O
with IN O
an DT O
elevated VBN O
IgE NNP B-Gene
( ( O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
8 CD O
. . O
0 CD O
kU JJ O
/ NNP O
l NN O
) ) O
than IN O
in IN O
those DT O
with IN O
a DT O
lower JJR O
level NN O
. . O

To TO O
study VB O
the DT O
role NN O
of IN O
heavy JJ O
chain NN O
motifs NNS O
in IN O
substrate JJ O
recognition NN O
, , O
secreted VBD O
variants NNS O
of IN O
recombinant JJ B-Gene
bovine NN I-Gene
proenteropeptidase NN I-Gene
were VBD O
constructed VBN O
by IN O
replacing VBG O
the DT O
transmembrane NN O
domain NN O
with IN O
a DT O
signal JJ O
peptide NN O
. . O

Chem NNP O
. . O

A DT O
third JJ O
one CD O
is VBZ O
homologous JJ O
in IN O
half NN O
of IN O
its PRP$ O
length NN O
to TO O
the DT O
prokaryotic JJ B-Gene
hydantoinase NN I-Gene
HyuA NNP B-Gene
and CC O
in IN O
the DT O
other JJ O
half NN O
to TO O
hydatoinase VB B-Gene
HyuB NNP B-Gene
. . O

Five CD O
additional JJ O
copies NNS O
of IN O
Lian JJ B-Gene
elements NNS I-Gene
were VBD O
isolated VBN O
, , O
mapped VBN O
by IN O
restriction NN O
digestion NN O
, , O
and CC O
partially RB O
sequenced VBN O
. . O

Hybridization NN O
of IN O
a DT O
probe NN O
from IN O
this DT O
region NN O
to TO O
electrophoretic JJ O
blots NNS O
of IN O
RNAs NNP O
from IN O
different JJ O
human JJ O
tissues NNS O
showed VBD O
a DT O
predominant JJ O
2 CD O
. . O
8 CD O
- : O
kilobase NN O
( ( O
kb NN O
) ) O
message NN O
accompanied VBN O
by IN O
weaker JJR O
bands NNS O
4 CD O
. . O
1 CD O
and CC O
2 CD O
. . O
1 CD O
kb NN O
in IN O
size NN O
. . O

Kinase NNP O
- : O
deficient NN O
erbB NN B-Gene
proteins NNS I-Gene
reduced VBD O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
EGF NNP B-Gene
) ) O
- : O
induced VBN O
tyrosine JJ O
phosphorylation NN O
of IN O
endogenous JJ O
Shc NNP B-Gene
proteins NNS I-Gene
and CC O
also RB O
reduced VBN O
immediate JJ O
and CC O
sustained VBD O
EGF NNP B-Gene
- : I-Gene
induced VBD I-Gene
ERK NNP I-Gene
MAPK NNP I-Gene
activities NNS O
in IN O
human JJ O
glioblastoma NN O
cells NNS O
, , O
although IN O
basal NN O
ERK NNP B-Gene
MAPK NNP I-Gene
activities NNS O
were VBD O
unaffected VBN O
. . O

Together RB O
, , O
the DT O
data NN O
suggest NN O
that IN O
cAMP VBZ O
- : O
dependent JJ O
control NN O
of IN O
the DT O
amounts NNS O
of IN O
the DT O
activator NN O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
vs NN O
. . O
the DT O
repressor NN O
COUP NNP B-Gene
- : I-Gene
TF NN I-Gene
could MD O
influence VB O
CRS2 NNP O
- : O
dependent JJ O
transcription NN O
. . O

In IN O
wild JJ O
- : O
type NN O
cells NNS O
, , O
SSM1b NNP B-Gene
transcripts VBZ I-Gene
accumulate NN O
to TO O
twice VB O
the DT O
level NN O
of IN O
SSM1a NNP B-Gene
transcripts NNS I-Gene
, , O
suggesting VBG O
that IN O
SSM1b NNP B-Gene
is VBZ O
responsible JJ O
for IN O
the DT O
majority NN O
of IN O
the DT O
Ssm1p NNP B-Gene
pool NN O
. . O

This DT O
paper NN O
describes VBZ O
the DT O
genomic JJ O
organization NN O
of IN O
mouse NN O
gC1qBP NN B-Gene
and CC O
the DT O
characterization NN O
of IN O
its PRP$ O
5 CD O
' '' O
flanking JJ O
region NN O
. . O

As IN O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
, , O
the DT O
BGP NNP B-Gene
gene NN I-Gene
is VBZ O
transcribed VBN O
into IN O
at IN O
least JJS O
seven CD O
distinct JJ O
mRNA NN O
species NNS O
. . O

Although IN O
large JJ O
epidemiologic JJ O
studies NNS O
are VBP O
best RB O
able JJ O
to TO O
identify VB O
the DT O
relative JJ O
contributions NNS O
of IN O
specific JJ O
risk NN O
factors NNS O
while IN O
controlling VBG O
for IN O
other JJ O
risk NN O
factors NNS O
, , O
new JJ O
studies NNS O
need VBP O
to TO O
focus VB O
on IN O
important JJ O
unresolved JJ O
questions NNS O
. . O

Patients NNS O
were VBD O
divided VBN O
into IN O
two CD O
group NN O
; : O
Control NNP O
group NN O
A NNP O
in IN O
which WDT O
a DT O
hot JJ O
- : O
water NN O
circulating VBG O
system NN O
was VBD O
used VBN O
and CC O
group NN O
B NNP O
in IN O
which WDT O
a DT O
transtracheal NN O
heating NN O
and CC O
humidification NN O
system NN O
by IN O
ANAMED NNP O
HUMITUBE NNP O
was VBD O
used VBN O
, , O
during IN O
gastric JJ O
cancer NN O
operation NN O
. . O

Apart RB O
from IN O
antimicrobial JJ O
properties NNS O
, , O
recent JJ O
data NNS O
indicate VBP O
that IN O
PMN NNP O
also RB O
exert VBP O
anti JJ O
- : O
inflammatory NN O
effects NNS O
by IN O
stimulation NN O
and CC O
release NN O
of IN O
cytokine JJ O
antagonists NNS O
such JJ O
as IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
antagonist NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1ra CD I-Gene
) ) O
. . O

Incubation NN O
of IN O
the DT O
purified JJ O
fusion NN O
proteins NNS O
with IN O
[ NNP O
gamma SYM O
- : O
32P CD O
] JJ O
ATP NNP O
in IN O
an DT O
in IN O
vitro NN O
assay NN O
showed VBD O
that IN O
both DT O
proteins NNS O
were VBD O
capable JJ O
of IN O
autophosphorylation NN O
. . O

Oxygen NN O
delivery NN O
and CC O
consumption NN O
and CC O
P50 NNP O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

Metal NNP O
coordination NN O
compounds NNS O
of IN O
thiabendazole NN O
. . O

Total JJ O
body NN O
water NN O
, , O
rhodanide JJ O
space NN O
and CC O
I PRP B-Gene
- : I-Gene
131 CD I-Gene
- : I-Gene
albumin NN I-Gene
space NN O
under IN O
the DT O
acute JJ O
effect NN O
of IN O
furosemide NN O

Thus RB O
it PRP O
appears VBZ O
that IN O
insertion NN O
of IN O
a DT O
transposable JJ O
element NN O
near IN O
the DT O
5 CD O
' POS O
terminus NN O
of IN O
the DT O
structural JJ O
gene NN O
can MD O
produce VB O
constitutive JJ O
expression NN O
of IN O
a DT O
normally RB O
glucose JJ O
- : O
repressed VBN O
enzyme NN O
. . O

Northern NNP O
and CC O
RT NNP O
- : O
PCR NNP O
analysis NN O
of IN O
Ube3a NNP B-Gene
expression NN O
in IN O
mouse NN O
tissues NNS O
from IN O
animals NNS O
with IN O
segmental JJ O
, , O
paternal JJ O
uniparental JJ O
disomy NN O
failed VBD O
to TO O
detect VB O
substantially RB O
reduced VBN O
or CC O
absent JJ O
expression NN O
compared VBN O
to TO O
control VB O
animals NNS O
, , O
failing VBG O
to TO O
provide VB O
any DT O
evidence NN O
for IN O
maternal JJ O
- : O
specific JJ O
expression NN O
from IN O
this DT O
locus NN O
. . O

Using VBG O
RACE NNP O
techniques NNS O
we PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBD O
one CD O
of IN O
the DT O
hamster NN O
liver RB O
3 CD B-Gene
- : I-Gene
hydroxy NN I-Gene
- : I-Gene
hexobarbital NN I-Gene
dehydrogenases NNS I-Gene
which WDT O
catalyze VBP O
not RB O
only RB O
cyclic JJ O
alcohols NNS O
but CC O
also RB O
17beta CD O
- : O
hydroxy NN O
- : O
steroids NNS O
and CC O
3alpha CD O
- : O
hydroxysteroids NNS O
. . O

In IN O
the DT O
second JJ O
case NN O
, , O
an DT O
epidermal JJ O
cyst NN O
was VBD O
diagnosed VBN O
. . O

Rats NNS O
treated VBD O
with IN O
8 CD O
- : O
OH NNP O
- : O
DPAT NNP O
were VBD O
not RB O
impaired VBN O
in IN O
their PRP$ O
ability NN O
to TO O
learn VB O
a DT O
visual JJ O
discrimination NN O
in IN O
a DT O
water NN O
maze NN O
. . O

Effects NNS O
of IN O
single JJ O
and CC O
combined VBN O
maltose JJ O
tetrapalmitate NN O
immunotherapy NN O
, , O
cyclophosphamide JJ O
chemotherapy NN O
and CC O
radiotherapy NN O
on IN O
ethyl JJ O
carbamate NN O
accelerated VBD O
primary JJ O
lung NN O
cancer NN O
in IN O
A NNP O
/ NNP O
J NNP O
mice NN O
. . O

GCN4 NNP B-Gene
encodes VBZ O
a DT O
transcriptional JJ O
activator NN O
of IN O
amino NN O
acid JJ O
biosynthetic JJ O
genes NNS O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
frequency NN O
of IN O
previous JJ O
transfusion NN O
in IN O
chronic JJ O
hepatitis NN O
, , O
cirrhosis NN O
and CC O
hepatocellular JJ O
carcinoma NN O
of IN O
type NN O
NANB NNP O
was VBD O
42 CD O
. . O
8 CD O
, , O
37 CD O
. . O
1 CD O
and CC O
15 CD O
. . O
1 CD O
% NN O
, , O
respectively RB O
, , O
whereas IN O
the DT O
incidence NN O
of IN O
early JJ O
posttransfusion NN O
hepatitis NN O
was VBD O
8 CD O
. . O
5 CD O
, , O
8 CD O
. . O
6 CD O
and CC O
7 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O
in IN O
chronic JJ O
liver NN O
diseases NNS O
with IN O
a DT O
history NN O
of IN O
jaundice NN O
and CC O
/ NN O
or CC O
hepatitis NN O
, , O
previous JJ O
transfusions NNS O
are VBP O
more RBR O
frequently RB O
associated VBN O
with IN O
type NN O
NANB NNP O
than IN O
with IN O
type NN O
B NNP O
disease NN O
. . O

ArgR NNP B-Gene
was VBD O
shown VBN O
to TO O
be VB O
a DT O
dimer NN O
of IN O
two CD O
equal JJ O
subunits NNS O
, , O
each DT O
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
37 CD O
, , O
0 CD O
Da NNP O
. . O

ATP NN O
by IN O
itself PRP O
also RB O
reduced VBD O
polypeptide JJ O
binding NN O
to TO O
Ssb1 NNP B-Gene
/ NNP I-Gene
2p CD I-Gene
to TO O
a DT O
level NN O
that WDT O
was VBD O
intermediate JJ O
between IN O
that DT O
observed VBD O
for IN O
the DT O
Ssa NNP B-Gene
Hsp70 NNP B-Gene
proteins VBZ I-Gene
tested VBN O
and CC O
BiP NNP B-Gene
and CC O
DnaK NNP B-Gene
. . O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
evaluate VB O
how WRB O
couplers NNS O
and CC O
their PRP$ O
placement NN O
affect IN O
the DT O
ALGO2 NNP O
click JJ O
spectral JJ O
properties NNS O
. . O

We PRP O
show VBP O
that IN O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
( ( O
the DT O
c NN B-Gene
- : I-Gene
fos JJ I-Gene
protooncogene JJ I-Gene
product NN I-Gene
) ) O
, , O
which WDT O
is VBZ O
an DT O
intrinsically RB O
unstable JJ O
nuclear JJ O
protein NN O
, , O
is VBZ O
metabolically RB O
highly RB O
stabilized VBN O
, , O
and CC O
greatly RB O
enhances VBZ O
the DT O
transforming VBG O
efficiency NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
, , O
by IN O
Mos NNP B-Gene
. . O

Potential JJ O
treatments NNS O
include VBP O
dobutamine NN O
, , O
KATP NNP O
channel NN O
activators NNS O
, , O
and CC O
21 CD O
- : O
aminosteroids NNS O
. . O

The DT O
effect NN O
of IN O
ICRF NNP O
- : O
187 CD O
on IN O
the DT O
antitumor NN O
response NN O
induced VBN O
by IN O
the DT O
combination NN O
of IN O
ADR NNP O
and CC O
WBH NNP O
was VBD O
also RB O
investigated VBN O
in IN O
order NN O
to TO O
assess VB O
alterations NNS O
in IN O
the DT O
therapeutic JJ O
index NN O
of IN O
this DT O
combined VBN O
therapeutic JJ O
modality NN O
treatment NN O
. . O

The DT O
negative JJ O
calcium NN O
balance NN O
with IN O
hyperparathyroidemia NN O
occurred VBD O
after IN O
continuous JJ O
oral JJ O
administration NN O
of IN O
Cd NNP O
and CC O
developed VBD O
via IN O
increased VBN O
urinary JJ O
excretion NN O
of IN O
calcium NN O
. . O

A DT O
. . O
, , O
Swift NNP O
, , O
A NNP O
. . O

The DT O
contrasting VBG O
effects NNS O
of IN O
dopaminergic JJ O
stimulation NN O
on IN O
the DT O
motor NN O
performance NN O
and CC O
on IN O
some DT O
aspects NNS O
of IN O
cognitive JJ O
processing NN O
suggest VBP O
the DT O
existence NN O
of IN O
complex JJ O
interactions NNS O
within IN O
pre JJ O
- : O
and CC O
postsynaptic JJ O
brain NN B-Gene
dopamine NN I-Gene
receptors NNS I-Gene
, , O
and CC O
an DT O
intervention NN O
of IN O
segregated JJ O
basal NN O
ganglia SYM O
- : O
prefrontal JJ O
cortex NN O
loops NNS O
in IN O
motor NN O
and CC O
cognitive JJ O
behaviour NN O
. . O

The DT O
histopathology NN O
and CC O
neovascularization NN O
did VBD O
not RB O
appreciably RB O
differ VBP O
between IN O
xenograft NN O
tumors NNS O
derived VBD O
from IN O
FGF4 NNP B-Gene
over IN O
- : O
expressing VBG O
versus NN O
control NN O
transfectants NNS O
. . O

Based VBN O
on IN O
restriction NN O
enzyme NN O
analysis NN O
, , O
Southern NNP O
blots NNS O
, , O
polymerase NN O
chain NN O
reaction NN O
analysis NN O
and CC O
DNA NNP O
sequencing NN O
, , O
it PRP O
was VBD O
confirmed VBN O
that IN O
the DT O
three CD O
overlapping VBG O
clones NNS O
isolated VBN O
cover VBP O
the DT O
entire JJ O
cHO NN B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
, , O
as RB O
well RB O
as IN O
approximately RB O
10 CD O
kb NNS O
of IN O
the DT O
flanking NN O
regions NNS O
on IN O
both DT O
ends NNS O
. . O

These DT O
mutant JJ O
proteins NNS O
retained VBD O
the DT O
ability NN O
to TO O
competitively RB O
inhibit VB O
kappa NN B-Gene
B NNP I-Gene
- : O
mediated VBD O
transcriptional JJ O
activation NN O
of IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
but CC O
failed VBD O
to TO O
efficiently RB O
transform VB O
chicken NN O
lymphoid NN O
cells NNS O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Effect NN O
of IN O
bromazepam NN O
on IN O
growth NN B-Gene
hormone NN I-Gene
and CC O
prolactin NN B-Gene
secretion NN O
in IN O
normal JJ O
subjects NNS O
. . O

In IN O
viral JJ O
infections NNS O
, , O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
was VBD O
correlated VBN O
with IN O
mononuclear JJ O
cells NNS O
( ( O
rs VB O
= RB O
0 CD O
. . O
41 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
, , O
white JJ O
blood NN O
cell NN O
counts NNS O
( ( O
rs VB O
= RB O
0 CD O
. . O
56 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
neutrophils FW O
( ( O
rs VB O
= RB O
0 CD O
. . O
41 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
and CC O
CRP NNP B-Gene
( ( O
rs VB O
= RB O
0 CD O
. . O
47 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
length NN O
scales NNS O
of IN O
the DT O
turbulence NN O
were VBD O
also RB O
estimated VBN O
: : O
at IN O
a DT O
Reynolds NNP O
number NN O
near IN O
4 CD O
, , O
0 CD O
the DT O
macroscale NN O
is VBZ O
about IN O
1 CD O
. . O
25 CD O
mm NN O
, , O
the DT O
Taylor NNP O
microscale NN O
is VBZ O
about IN O
0 CD O
. . O
85 CD O
mm NN O
, , O
and CC O
the DT O
Kolmogoroff NNP O
scale NN O
is VBZ O
near IN O
0 CD O
. . O
75 CD O
mm NN O
. . O

METHODS NN O
: : O
Fibrotic JJ O
changes NNS O
involving VBG O
bone NN O
marrow NN O
were VBD O
evaluated VBN O
histologically RB O
semiquantitatively RB O
using VBG O
reticulin JJ B-Gene
fiber JJ O
impregnation NN O
( ( O
method NN O
of IN O
Gomori NNP O
) ) O
. . O

VIII NNP O
in IN O
doses NNS O
2 CD O
- : O
3 CD O
times NNS O
higher JJR O
than IN O
usually RB O
used VBN O
in IN O
haemophiliacs NN O
without IN O
inhibitor NN O
were VBD O
successful JJ O
. . O

As IN O
pH NN O
and CC O
Hb NNP B-Gene
can MD O
also RB O
affect VB O
mixed JJ O
venous JJ O
CO2 NNP O
content NN O
, , O
the DT O
effect NN O
on IN O
Q NNP O
was VBD O
also RB O
assessed VBN O
. . O

A DT O
substantial JJ O
fraction NN O
of IN O
Cbl NNP B-Gene
was VBD O
constitutively RB O
associated VBN O
with IN O
Grb2 NNP B-Gene
and CC O
this DT O
interaction NN O
was VBD O
mediated VBN O
by IN O
Grb2 NNP B-Gene
SH3 NNP B-Gene
domains VBZ O
. . O

Activated VBN O
areas NNS O
have VBP O
been VBN O
identified VBN O
by IN O
means NNS O
of IN O
cross NN O
- : O
correlation NN O
analysis NN O
. . O

Furthermore RB O
, , O
the DT O
deletion NN O
of IN O
bcp NN B-Gene
from IN O
the DT O
chromosome NN O
had VBD O
no DT O
effect NN O
on IN O
gcv NN B-Gene
- : O
lacZ JJ B-Gene
expression NN O
. . O

JCAHO NNS O
revised VBN O
interpretation NN O

The DT O
mechanism NN O
underlying VBG O
such JJ O
analgesia NN O
has VBZ O
been VBN O
suggested VBN O
to TO O
involve VB O
the DT O
interaction NN O
between IN O
the DT O
two CD O
separate JJ O
but CC O
interconnected JJ O
motivational JJ O
systems NNS O
"""" VBP O
defense NN O
"""" NN O
and CC O
"""" NN O
pain NN O
. . O
"""" NN O
To TO O
determine VB O
the DT O
developmental JJ O
course NN O
of IN O
defense NN O
and CC O
nociception NN O
, , O
these DT O
processes NNS O
were VBD O
analyzed VBN O
during IN O
early JJ O
ontogeny NN O
in IN O
rats NNS O
. . O

Location NN O
and CC O
orientation NN O
of IN O
an DT O
activating VBG O
region NN O
in IN O
the DT O
Escherichia NNP O
coli NN O
transcription NN O
factor NN O
, , O
FNR NNP B-Gene
. . O

It PRP O
was VBD O
concluded VBN O
, , O
that IN O
on IN O
a DT O
given VBN O
section NN O
, , O
75 CD O
, , O
7 CD O
per IN O
cent NN O
of IN O
the DT O
trabeculae NN O
were VBD O
in IN O
contact NN O
with IN O
vascular JJ O
cavities NNS O
. . O

In IN O
electromobility NN O
shift NN O
assays NNS O
, , O
EWS NNP B-Gene
- : O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
to TO O
the DT O
SRE NNP O
is VBZ O
detectable JJ O
in IN O
the DT O
absence NN O
of IN O
SRF NNP B-Gene
whereas IN O
the DT O
binding NN O
of IN O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
not RB O
, , O
suggesting VBG O
that IN O
the DT O
interaction NN O
with IN O
DNA NNP O
is VBZ O
the DT O
step NN O
which WDT O
limits VBZ O
ternary JJ O
complex JJ O
formation NN O
by IN O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

A DT O
proportion NN O
of IN O
APC NNP B-Gene
wild JJ O
- : O
type NN O
colon NN O
carcinomas NN O
and CC O
melanomas NN O
also RB O
contains VBZ O
constitutive JJ O
nuclear JJ O
Tcf NNP B-Gene
- : I-Gene
4 CD I-Gene
/ NN O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
complexes NNS O
as IN O
a DT O
result NN O
of IN O
dominant JJ O
mutations NNS O
in IN O
the DT O
N NNP O
terminus NN O
of IN O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
that IN O
render VBZ O
it PRP O
insensitive JJ O
to TO O
downregulation NN O
by IN O
APC NNP B-Gene
, , O
GSK3 NNP B-Gene
beta NN I-Gene
, , O
and CC O
Axin NNP B-Gene
/ NNP O
Conductin NNP B-Gene
. . O

Plasma NNP O
ion NN O
changes NNS O
in IN O
venous JJ O
blood NN O
incubated VBN O
with IN O
beta NN B-Gene
receptor NN I-Gene
blockers NNS O
and CC O
subjected VBN O
to TO O
tonometry VB O
in IN O
vitro NN O
. . O

F NNP B-Gene
- : I-Gene
box NN I-Gene
proteins NNS I-Gene
are VBP O
receptors NNS O
that IN O
recruit NN O
phosphorylated VBN O
substrates NNS O
to TO O
the DT O
SCF NNP B-Gene
ubiquitin JJ B-Gene
- : O
ligase NN B-Gene
complex NN O
. . O

The DT O
former JJ O
group NN O
did VBD O
excrete RB O
less RBR O
dry JJ O
fecal JJ O
material NN O
compared VBN O
to TO O
both DT O
other JJ O
groups NNS O
. . O

The DT O
interaction NN O
of IN O
AF NNP O
- : O
1 CD O
with IN O
proteins NNS O
that WDT O
regulate VBP O
distinct JJ O
steps NNS O
of IN O
transcription NN O
may MD O
provide VB O
a DT O
mechanism NN O
for IN O
synergistic JJ O
activation NN O
of IN O
gene NN O
expression NN O
by IN O
AF NNP O
- : O
1 CD O
. . O

Fusion NN O
of IN O
ubiquitin NN B-Gene
to TO O
pADPRP VB B-Gene
increased VBN O
the DT O
yield NN O
of IN O
pADPRP NN B-Gene
approximately RB O
10 CD O
- : O
fold NN O
compared VBN O
to TO O
that DT O
of IN O
the DT O
unfused JJ O
enzyme NN O
. . O

Each DT O
individual NN O
shot VBD O
25 CD O
bullets NNS O
in IN O
about IN O
5 CD O
minutes NNS O
, , O
at IN O
an DT O
intensity NN O
level NN O
calculated VBD O
at IN O
163 CD O
dB NN O
. . O

Symptomatic JJ O
hyperventilators NNS O
had VBD O
a DT O
larger JJR O
number NN O
of IN O
sighs NNS O
and CC O
abnormally RB O
wide JJ O
fluctuations NNS O
in IN O
baseline NN O
for IN O
inspiratory JJ O
time NN O
, , O
expiratory JJ O
time NN O
, , O
and CC O
PETCO2 NNP O
. . O

We PRP O
determined VBD O
whether IN O
the DT O
human JJ B-Gene
StAR NNP I-Gene
promoter NN I-Gene
is VBZ O
responsive JJ O
to TO O
sterol VB B-Gene
regulatory JJ I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
( ( O
SREBPs NNP B-Gene
) ) O
. . O

We PRP O
derive VBP O
joint JJ O
probability NN O
density NN O
distributions NNS O
for IN O
three CD O
key NN O
uncertain JJ O
properties NNS O
of IN O
the DT O
climate NN O
system NN O
, , O
using VBG O
an DT O
optimal JJ O
fingerprinting NN O
approach NN O
to TO O
compare VB O
simulations NNS O
of IN O
an DT O
intermediate JJ O
complexity NN O
climate NN O
model NN O
with IN O
three CD O
distinct JJ O
diagnostics NNS O
of IN O
recent JJ O
climate NN O
observations NNS O
. . O

To TO O
gain VB O
insight NN O
into IN O
the DT O
expression NN O
of IN O
the DT O
AtCP1 NNP B-Gene
gene NN I-Gene
, , O
northern JJ O
blot NN O
analysis NN O
was VBD O
carried VBN O
out RP O
. . O

The DT O
model NN O
indicates VBZ O
that IN O
a DT O
0 CD O
. . O
76 CD O
% NN O
reduction NN O
in IN O
cigarette NN O
consumption NN O
is VBZ O
associated VBN O
with IN O
the DT O
availability NN O
of IN O
nicotine JJ O
patches NNS O
after IN O
1992 CD O
. . O

With IN O
the DT O
human JJ B-Gene
Rhotekin NNP I-Gene
cDNA NN I-Gene
as IN O
a DT O
probe NN O
, , O
Northern NNP O
hybridization NN O
revealed VBD O
that IN O
a DT O
4 CD O
. . O
0 CD O
- : O
kb NN O
transcript NN O
was VBD O
expressed VBN O
at IN O
a DT O
high JJ O
level NN O
in IN O
prostate NN O
and CC O
at IN O
a DT O
middle JJ O
level NN O
in IN O
13 CD O
of IN O
16 CD O
tissues NNS O
examined VBN O
, , O
but CC O
it PRP O
cannot VBZ O
be VB O
detected VBN O
in IN O
liver NN O
and CC O
lung NN O
tissues NNS O
. . O

There EX O
was VBD O
also RB O
a DT O
highly RB O
significant JJ O
correlation NN O
between IN O
total JJ O
selenium NN O
intake NN O
and CC O
liver NN O
selenium NN O
concentration NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
99 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
after IN O
1 CD O
mo NN O
of IN O
treatment NN O
, , O
but CC O
this DT O
time NN O
liver VBZ O
selenium NN O
did VBD O
not RB O
change VB O
with IN O
time NN O
, , O
and CC O
the DT O
correlation NN O
remained VBD O
highly RB O
significant JJ O
throughout IN O
the DT O
investigation NN O
. . O

Overlapping VBG O
clones NNS O
representing VBG O
full JJ O
- : O
length NN O
cDNAs NN O
for IN O
MMI NNP B-Gene
alpha NN I-Gene
were VBD O
obtained VBN O
from IN O
mouse NN O
brain NN O
. . O

Side JJ O
effect NN O
including VBG O
subjective JJ O
and CC O
objective JJ O
symptoms NNS O
were VBD O
strictly RB O
evaluated VBN O
in IN O
163 CD O
cases NNS O
( ( O
KS NNP O
- : O
R1 NNP O
group NN O
in IN O
83 CD O
cases NNS O
, , O
oral JJ O
group NN O
in IN O
80 CD O
cases NNS O
) ) O
, , O
but CC O
the DT O
incidence NN O
rate NN O
which WDT O
was VBD O
22 CD O
. . O
9 CD O
% NN O
for IN O
the DT O
KS NNP O
- : O
R1 NNP O
group NN O
and CC O
23 CD O
. . O
8 CD O
% NN O
for IN O
the DT O
oral JJ O
group NN O
showed VBD O
no DT O
significant JJ O
difference NN O
. . O

Spores NNS O
from IN O
Rhizopus NNP O
stolonifer NN O
were VBD O
suspended VBN O
in IN O
distilled JJ O
water NN O
( ( O
1 CD O
x RB O
10 CD O
( ( O
6 CD O
) ) O
spores NNS O
/ VBP O
mL NN O
) ) O
and CC O
used VBN O
as IN O
starter NN O
. . O

This DT O
open JJ O
reading NN O
frame NN O
was VBD O
confirmed VBN O
the DT O
correct NN O
one CD O
by IN O
direct JJ O
amino NN O
- : O
terminal JJ O
sequence NN O
analysis NN O
of IN O
the DT O
overproduced JJ O
msgB NN B-Gene
gene NN I-Gene
product NN I-Gene
. . O

The DT O
application NN O
of IN O
ultrafiltration NN O
to TO O
sample VB O
preparation NN O
in IN O
the DT O
detection NN O
and CC O
quantification NN O
of IN O
ethylene NN O
glycol NN O
in IN O
plasma NN O
by IN O
gas NN O
chromatography NN O
is VBZ O
described VBN O
. . O

A DT O
total NN O
of IN O
1060 CD O
clones NNS O
were VBD O
randomly RB O
selected VBN O
for IN O
sequencing VBG O
of IN O
one CD O
end NN O
. . O

Genetic JJ O
alterations NNS O
in IN O
elements NNS O
of IN O
normal JJ O
signal JJ O
transduction NN O
mechanisms NNS O
are VBP O
known VBN O
to TO O
be VB O
oncogenic JJ O
events NNS O
often RB O
resulting VBG O
in IN O
aberrant JJ O
activation NN O
of IN O
programs NNS O
of IN O
gene NN O
transcription NN O
. . O

This DT O
inhibitory NN O
domain NN O
has VBZ O
been VBN O
deleted VBN O
in IN O
all DT O
naturally RB O
occurring VBG O
AHC NNP B-Gene
deletion NN I-Gene
mutants NNS I-Gene
described VBD O
to TO O
date NN O
. . O

The DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
coding VBG O
region NN O
was VBD O
located VBN O
precisely RB O
by IN O
comparing VBG O
the DT O
deduced JJ O
amino NN O
acid NN O
sequence NN O
to TO O
the DT O
actual JJ O
N NNP O
- : O
terminal NN O
amino NN O
acid JJ O
sequence NN O
of IN O
IHF NNP B-Gene
. . O

Because IN O
the DT O
deletion NN O
included VBD O
the DT O
TK NNP B-Gene
gene NN I-Gene
, , O
selection NN O
with IN O
gancyclovir NN O
against IN O
cells NNS O
not RB O
having VBG O
undergone JJ O
recombination NN O
was VBD O
possible JJ O
. . O

The DT O
dopamine NN B-Gene
D4 NNP I-Gene
receptor NN I-Gene
as RB O
well RB O
as IN O
many JJ O
other JJ O
catecholaminergic JJ B-Gene
receptors NNS I-Gene
contain VBP O
several JJ O
putative JJ O
SH3 NNP B-Gene
binding NN I-Gene
domains NNS I-Gene
. . O

Cutaneous JJ O
necrosis NN O
associated VBN O
with IN O
protein NN B-Gene
S NNP I-Gene
deficiency NN O
. . O

Pentachlorophenol NNP O
accelerates VBZ O
the DT O
onset NN O
of IN O
HCB NNP O
porphyria NN O
, , O
in IN O
other JJ O
words NNS O
it PRP O
increases VBZ O
the DT O
total JJ O
urinary JJ O
porphyrin NN O
excretion NN O
and CC O
causes VBZ O
an DT O
earlier JJR O
disturbance NN O
of IN O
the DT O
porphyrin NN O
pattern NN O
. . O

The DT O
hydrophobicity NN O
plot NN O
of IN O
NHE NNP B-Gene
- : I-Gene
3 CD I-Gene
is VBZ O
very RB O
similar JJ O
to TO O
that DT O
of IN O
NHE NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NHE NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Until IN O
such JJ O
investigations NNS O
are VBP O
performed VBN O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
role NN O
for IN O
adjuvant JJ O
treatment NN O
is VBZ O
questionable JJ O
and CC O
that DT O
TME NNP O
surgery NN O
is VBZ O
preferred VBN O
as IN O
the DT O
treatment NN O
option NN O
for IN O
Stage NNP O
T1 NNP O
- : O
T3 NNP O
rectal JJ O
cancers NNS O
. . O

We PRP O
describe VBP O
here RB O
17 CD O
dominant JJ B-Gene
GCN2 NNP I-Gene
mutations NNS I-Gene
that WDT O
lead VBP O
to TO O
derepression NN O
of IN O
GCN4 NNP B-Gene
expression NN O
in IN O
the DT O
absence NN O
of IN O
amino NN O
acid JJ O
starvation NN O
. . O

In IN O
a DT O
maxicell NN O
system NN O
a DT O
protein NN O
with IN O
an DT O
approximate JJ O
molecular JJ O
weight NN O
of IN O
36 CD O
, , O
0 CD O
was VBD O
synthesized VBN O
. . O

An DT O
activation NN O
- : O
responsive JJ O
element NN O
in IN O
single JJ B-Gene
C NNP I-Gene
motif SYM I-Gene
- : I-Gene
1 CD I-Gene
/ NN O
lymphotactin NN B-Gene
promoter NN O
is VBZ O
a DT O
site NN O
of IN O
constitutive JJ O
and CC O
inducible JJ O
DNA NNP O
- : O
protein NN O
interactions NNS O
involving VBG O
nuclear JJ O
factor NN O
of IN O
activated JJ O
T NNP O
cell NN O
. . O

Bile NNP O
bilirubin NN O
did VBD O
not RB O
rise VB O
within IN O
12 CD O
h NN O
after IN O
haem JJ O
infusion NN O
a DT O
finding NN O
which WDT O
warrants NNS O
further JJ O
investigation NN O
. . O

Army NNP O
veterans NNS O
given VBN O
yellow JJ O
fever NN O
vaccine NN O
contaminated VBN O
with IN O
hepatitis NN O
B NNP O
virus NN O
in IN O
1942 CD O
and CC O
controls NNS O
and CC O
( ( O
b NN O
) ) O
a DT O
case NN O
- : O
control NN O
study NN O
comparing VBG O
veterans NNS O
with IN O
hepatocellular JJ O
carcinoma NN O
in IN O
Veterans NNP O
Affairs NNPS O
hospitals NNS O
with IN O
matched JJ O
controls NNS O
with IN O
respect NN O
to TO O
receipt VB O
of IN O
contaminated JJ O
vaccine NN O
in IN O
1942 CD O
. . O

Engagement NN O
of IN O
human JJ B-Gene
CD2 NNP I-Gene
by IN O
mitogenic JJ O
pairs NNS O
of IN O
anti JJ B-Gene
- : I-Gene
CD2 NNP I-Gene
mAb NN I-Gene
induces NNS O
tyrosine VBP O
phosphorylation NN O
of IN O
a DT O
number NN O
of IN O
intracellular JJ O
proteins NNS O
including VBG O
a DT O
120 CD O
kDa NN O
phosphoprotein NN O
that IN O
we PRP O
identify VBP O
as IN O
the DT O
proto NN B-Gene
- : I-Gene
oncogene NN I-Gene
c SYM I-Gene
- : I-Gene
Cbl NN I-Gene
. . O

The DT O
role NN O
of IN O
pharmacological JJ O
profiling NN O
in IN O
safety NN O
assessment NN O
. . O

The DT O
dying VBG O
tTG NN B-Gene
- : O
transfected JJ O
cells NNS O
exhibit VBP O
both DT O
cytoplasmic JJ O
and CC O
nuclear JJ O
changes NNS O
characteristic JJ O
of IN O
cells NNS O
undergoing JJ O
apoptosis NN O
. . O

Serum NNP B-Gene
PTH NNP I-Gene
tended VBD O
to TO O
increase VB O
in IN O
the DT O
WL NNP O
group NN O
but CC O
not RB O
in IN O
the DT O
WM NNP O
group NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
6 CD O
) ) O
. . O

The DT O
ether NN O
phospholipid VBD O
1 CD O
- : O
O NNP O
- : O
octadecyl NN O
- : O
2 CD O
- : O
O NNP O
- : O
methyl NN O
- : O
rac NN O
- : O
glycero NN O
- : O
3 CD O
- : O
phosphocholine NN O
( ( O
ET NNP O
- : O
18 CD O
- : O
OCH3 NN O
; : O
edelfosine NN O
) ) O
is VBZ O
a DT O
potent JJ O
inducer NN O
of IN O
apoptosis NN O
in IN O
human JJ O
tumor NN O
cells NNS O
. . O

Removal NN O
of IN O
thick NN O
, , O
permanently RB O
altered VBN O
mucoas NN O
is VBZ O
recommended VBN O
even RB O
in IN O
the DT O
absence NN O
of IN O
squamous JJ O
epithelium NN O
. . O

Analysis NN O
of IN O
the DT O
entire JJ O
16 CD O
. . O
7 CD O
- : O
kb NN O
mt VBZ O
genome NN O
determined VBD O
that IN O
a DT O
MDP1 NNP B-Gene
mediates VBZ O
cleavage NN O
of IN O
chick JJ O
mtDNA NN O
in IN O
vitro NN O
at IN O
three CD O
H NNP O
- : O
and CC O
two CD O
L NNP O
- : O
strand NN O
sequence NN O
- : O
specific JJ O
target NN O
sites NNS O
located VBN O
within IN O
a DT O
90 CD O
- : O
bp NN O
A DT O
+ NN O
T NNP O
- : O
rich JJ O
genomic JJ O
tract NN O
, , O
theoretically RB O
capable JJ O
of IN O
forming VBG O
stable JJ O
secondary JJ O
structures NNS O
, , O
approximately RB O
200 CD O
bases NNS O
upstream RB O
from IN O
the DT O
H NNP O
- : O
strand NN O
origin NN O
( ( O
OH NNP O
) ) O
of IN O
replication NN O
. . O

Aedes NNS O
aegypti VBP O
( ( O
L NNP O
. . O
) ) O
and CC O
Aedes NNP O
albopictus NN O
( ( O
Skuse NNP O
) ) O
in IN O
Singapore NNP O
City NNP O
. . O

We PRP O
have VBP O
improved VBN O
our PRP$ O
system NN O
for IN O
nuclear JJ O
contour JJ O
digitization NN O
and CC O
determined VBD O
its PRP$ O
theoretical JJ O
limitations NNS O
by IN O
digitizing VBG O
standardized JJ O
objects NNS O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
of IN O
the DT O
R2 NNP B-Gene
protein NN I-Gene
was VBD O
used VBN O
to TO O
provide VB O
evidence NN O
that IN O
this DT O
motif NN O
is VBZ O
also RB O
part NN O
of IN O
the DT O
active JJ O
site NN O
of IN O
the DT O
endonuclease NN O
encoded VBN O
by IN O
this DT O
element NN O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
molecular JJ O
lesions NNS O
of IN O
nine CD O
Scm NNP B-Gene
mutant JJ I-Gene
alleles NNS I-Gene
, , O
which WDT O
identify VBP O
functional JJ O
requirements NNS O
for IN O
specific JJ O
domains NNS O
. . O

The DT O
application NN O
of IN O
these DT O
microelectrodes NNS O
to TO O
the DT O
measurement NN O
of IN O
rapid JJ O
, , O
transient JJ O
changes NNS O
in IN O
retinal JJ O
[ NN O
K NNP O
+ NNP O
] NNP O
o NN O
is VBZ O
presented VBN O
. . O

Examination NN O
of IN O
the DT O
MMP NNP B-Gene
- : I-Gene
2 CD I-Gene
RE1 NNP I-Gene
sequence NN I-Gene
revealed VBD O
an DT O
incomplete JJ O
Y NNP O
- : O
box NN O
sequence NN O
( ( O
CTGCTGGGCAAG NNP O
) ) O
, , O
which WDT O
specifically RB O
interacted VBD O
with IN O
recombinant JJ B-Gene
YB NNP I-Gene
- : I-Gene
1 CD I-Gene
on IN O
DMS NNP O
protection NN O
footprinting VBG O
analysis NN O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURE NNP O
( ( O
S NNP O
) ) O
: : O
Serum NN O
levels NNS O
of IN O
FSH NNP B-Gene
, , O
LH NNP B-Gene
, , O
and CC O
inhibin VB B-Gene
A NNP I-Gene
and CC I-Gene
B NNP I-Gene
. . O

Baseline NNP O
measurements NNS O
of IN O
forced JJ O
expiratory NN O
volume NN O
in IN O
1 CD O
s NN O
( ( O
FEV1 NNP O
) ) O
, , O
specific JJ O
airway NN O
conductance NN O
( ( O
SGaw NNP O
) ) O
and CC O
the DT O
provocative JJ O
dose NN O
of IN O
carbachol NN O
causing VBG O
a DT O
35 CD O
% NN O
reduction NN O
in IN O
SGaw NNP O
( ( O
PD35 NNP O
) ) O
, , O
and CC O
a DT O
20 CD O
% NN O
reduction NN O
in IN O
FEV1 NNP O
( ( O
PD20 NNP O
) ) O
were VBD O
established VBN O
on IN O
entry NN O
while IN O
each DT O
subject NN O
was VBD O
still RB O
smoking VBG O
. . O

YAC NN O
and CC O
cosmid NN O
contigs NNS O
spanning VBG O
the DT O
Batten NNP B-Gene
disease NN I-Gene
( ( O
CLN3 NNP B-Gene
) ) O
region NN O
at IN O
16p12 CD O
. . O
1 CD O
- : O
p11 NN O
. . O
2 CD O
. . O

CyIIa NNP B-Gene
transcription NN O
follows VBZ O
, , O
and CC O
is VBZ O
therefore RB O
downstream NN O
of IN O
, , O
the DT O
initial JJ O
specification NN O
of IN O
these DT O
embryonic JJ O
domains NNS O
. . O

RESULTS NN O
: : O
Twenty CD O
- : O
two CD O
( ( O
26 CD O
% NN O
) ) O
patients NNS O
had VBD O
PHG NNP O
before IN O
( ( O
group NN O
A NNP O
) ) O
and CC O
64 CD O
( ( O
74 CD O
% NN O
) ) O
developed VBD O
PHG NNP O
after IN O
variceal JJ O
eradication NN O
( ( O
group NN O
B NNP O
) ) O
. . O

In IN O
contrast NN O
, , O
capsid NN B-Gene
proteins NNS I-Gene
derived VBN O
from IN O
the DT O
P1 NNP B-Gene
precursor NN I-Gene
with IN O
a DT O
valine JJ O
substitution NN O
at IN O
the DT O
amino NN O
terminus NN O
of IN O
VP1 NNP B-Gene
( ( O
VP1 NNP B-Gene
- : I-Gene
G001V NNP I-Gene
) ) O
assembled VBD O
empty JJ O
capsid NN O
particles NNS O
but CC O
were VBD O
deficient VBN O
in IN O
assembling VBG O
RNA NNP O
- : O
containing NN O
virions NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
levels NNS O
of IN O
oxygen NN O
free JJ O
radicals NNS O
were VBD O
increased VBN O
in IN O
hepatocytes NNS O
and CC O
mitochondria NNS O
. . O

Endurance NN O
training NN O
resulted VBD O
in IN O
an DT O
increase NN O
of IN O
stiffness NN O
associated VBN O
with IN O
a DT O
decrease NN O
of IN O
type NN O
II NNP O
fibers NNS O
. . O

The DT O
CEM NNP O
receives VBZ O
registration NN O
updates NNS O
via IN O
an DT O
HL7 NNP O
message NN O
and CC O
evaluates VBZ O
data NNS O
dependencies NNS O
in IN O
rules NNS O
via IN O
an DT O
interface NN O
to TO O
the DT O
relational JJ O
database NN O
. . O

Effects NNS O
of IN O
intramammary JJ O
endotoxin NN O
infusion NN O
on IN O
milking VBG O
- : O
induced VBN O
oxytocin IN B-Gene
release NN O
. . O

As IN O
was VBD O
observed VBN O
previously RB O
for IN O
MATa NNP B-Gene
cna1 NN B-Gene
cna2 NN B-Gene
double JJ O
mutants NNS O
, , O
MATa NNP B-Gene
cnb1 NN B-Gene
mutants NNS I-Gene
were VBD O
defective JJ O
in IN O
their PRP$ O
ability NN O
to TO O
recover VB O
from IN O
alpha JJ B-Gene
- : I-Gene
factor NN I-Gene
- : O
induced JJ O
growth NN O
arrest NN O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
[ NNP O
Hisanaga NNP O
, , O
S NNP O
. . O
, , O
Kusubata NNP O
, , O
M NNP O
. . O
, , O
Okumura NNP O
, , O
E NNP O
. . O

& CC O
Kishimoto NNP O
, , O
T NNP O
. . O

Apoptosis NN O
of IN O
small JJ O
cells NNS O
is VBZ O
still RB O
observed VBN O
after IN O
co JJ O
- : O
transfection NN O
of IN O
JBD NNP B-Gene
and CC O
LMP1 NNP B-Gene
but CC O
in IN O
addition NN O
a DT O
few JJ O
apoptotic JJ O
HD NNP O
- : O
MyZ NNP O
cells NNS O
with IN O
large JJ O
fused JJ O
nuclear JJ O
masses NNS O
are VBP O
identified VBN O
suggesting VBG O
that IN O
specific JJ O
inhibition NN O
of IN O
JNK NNP B-Gene
leads VBZ O
also RB O
to TO O
apoptosis NN O
of IN O
LMP1 NNP B-Gene
induced VBD O
RS NNP O
cells NNS O
. . O

The DT O
numerous JJ O
tests NNS O
demonstrate VBP O
that IN O
the DT O
HDL NNP O
- : O
2M CD O
can MD O
be VB O
extensively RB O
and CC O
successfully RB O
used VBN O
for IN O
therapy NN O
of IN O
insulin NN B-Gene
- : O
dependent NN O
diabetes VBZ O
mellitus NNS O
in IN O
clinical JJ O
practice NN O
. . O

Point NN O
mutations NNS O
in IN O
the DT O
third JJ O
SH3 NNP B-Gene
domain NN I-Gene
abolished VBD O
the DT O
vinexin NN B-Gene
- : O
Sos NNP B-Gene
interaction NN O
. . O

The DT O
Nmd3 NNP B-Gene
protein NN I-Gene
sequence NN I-Gene
does VBZ O
not RB O
contain VB O
readily RB O
recognizable JJ O
motifs NNS O
of IN O
known VBN O
function NN O
. . O

Depleted VBN O
and CC O
enriched VBN O
U3O8 NNP O
standard JJ O
reference NN O
materials NNS O
were VBD O
used VBN O
to TO O
calibrate VB O
the DT O
system NN O
. . O

After IN O
declamping VBG O
of IN O
the DT O
aorta NN O
, , O
there EX O
were VBD O
also RB O
severe JJ O
edema NN O
, , O
local JJ O
fibre NN O
necrosis NN O
, , O
and CC O
adhesion NN O
of IN O
leucocytes NNS O
, , O
whereas NNS O
muscle VBP O
fibre JJ O
areas NNS O
became VBD O
3 CD O
, , O
935 CD O
. . O
18 CD O
micro JJ O
531 CD O
microm NN O
( ( O
2 CD O
) ) O
for IN O
type NN O
I PRP O
and CC O
5 CD O
, , O
804 CD O
+ NN O
/ NNP O
- : O
1 CD O
, , O
75 CD O
microm NN O
( ( O
2 CD O
) ) O
for IN O
type NN O
II NNP O
. . O

In IN O
contrast NN O
, , O
recent JJ O
evidence NN O
suggests VBZ O
that IN O
children NNS O
with IN O
sickle JJ B-Gene
- : I-Gene
hemoglobin NN I-Gene
C NNP I-Gene
disease NN O
do VBP O
not RB O
develop VB O
functional JJ O
asplenia NN O
before IN O
3 CD O
to TO O
4 CD O
years NNS O
of IN O
age NN O
and CC O
thus RB O
may MD O
not RB O
benefit VB O
from IN O
penicillin NN O
prophylaxis NN O
. . O

Heterogeneous JJ B-Gene
nuclear JJ I-Gene
ribonucleoprotein NN I-Gene
( ( I-Gene
hnRNP NN I-Gene
) ) I-Gene
core NN I-Gene
protein NN I-Gene
A1 NNP I-Gene
is VBZ O
a DT O
major JJ O
component NN O
of IN O
mammalian JJ B-Gene
hnRNP NN I-Gene
40 CD I-Gene
S NNP I-Gene
particles NNS I-Gene
. . O

[ RB O
14C CD O
] SYM O
- : O
beta NN O
- : O
phenethylamine NN O
, , O
its PRP$ O
distribution NN O
after IN O
administration NN O
by IN O
various JJ O
routes NNS O
to TO O
cats NNS O
, , O
and CC O
the DT O
effects NNS O
of IN O
monoamine JJ B-Gene
oxidase NN I-Gene
inhibitors NNS O
. . O

MSSP NNP B-Gene
proteins NNS I-Gene
have VBP O
been VBN O
identified VBN O
by IN O
their PRP$ O
binding NN O
to TO O
an DT O
upstream JJ O
element NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
. . O

Diagnosis NN O
of IN O
unilateral JJ O
renal JJ O
artery NN O
lesions NNS O
after IN O
captopril JJ O
administration NN O
. . O

Biological JJ O
evaluation NN O
of IN O
mibolerone NN O
in IN O
the DT O
female JJ O
Beagle NNP O
. . O

Two CD O
disulphide NN O
bridges NNS O
, , O
which WDT O
are VBP O
conserved VBN O
in IN O
all DT O
spermadhesin NN O
molecules NNS O
and CC O
many JJ O
CUB NNP O
domains NNS O
, , O
crosslink VBP O
loop JJ O
LA NNP O
and CC O
strand VB O
beta NN O
4 CD O
and CC O
loops NNS O
LE NNP O
and CC O
LG NNP O
, , O
respectively RB O
, , O
at IN O
opposite JJ O
edges NNS O
of IN O
the DT O
same JJ O
face NN O
of IN O
the DT O
domain NN O
. . O

High JJ O
levels NNS O
of IN O
IC NNP O
coincided VBD O
with IN O
relative JJ O
hypocomplementemia NN O
. . O

However RB O
, , O
essential JJ O
contrast NN O
differences NNS O
existing VBG O
between IN O
the DT O
FSE NNP O
sequences NNS O
and CC O
their PRP$ O
routine JJ O
asymmetric JJ O
dual JJ O
SE NNP O
counterpart NN O
can MD O
be VB O
identified VBN O
. . O

Sex NN O
ratio NN O
at IN O
birth NN O
. . O

The DT O
effects NNS O
of IN O
coenzyme NN O
Q10 NNP O
( ( O
CoQ NNP O
) ) O
and CC O
captopril NN O
on IN O
functional JJ O
capacity NN O
, , O
hemodynamics NNS O
and CC O
survival NN O
were VBD O
studied VBN O
in IN O
154 CD O
rats NNS O
that WDT O
recovered VBD O
after IN O
experimental JJ O
myocardial JJ O
infarction NN O
. . O

This DT O
review NN O
seeks VBZ O
to TO O
summarize VB O
the DT O
disease NN O
, , O
to TO O
propose VB O
pathways NNS O
of IN O
carcinogenesis NN O
and CC O
to TO O
suggest VB O
ways NNS O
in IN O
which WDT O
the DT O
"""" NNP O
traditional JJ O
"""" NN O
risk NN O
factors NNS O
may MD O
be VB O
interpreted VBN O
on IN O
the DT O
basis NN O
of IN O
evolving VBG O
knowledge NN O
. . O

Dietetics NNS O
of IN O
childhood NN O
- : O
and CC O
juvenile NN O
diabetes NNS O

The DT O
highly RB O
conserved JJ O
ninth JJ O
heptad NN O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
heterodimerization NN O
, , O
appears VBZ O
to TO O
participate VB O
in IN O
the DT O
receptor NN O
- : O
inhibitor NN O
interaction NN O
, , O
suggesting VBG O
that IN O
the DT O
inhibitor NN O
is VBZ O
a DT O
related JJ O
member NN O
of IN O
the DT O
receptor NN O
gene NN O
family NN O
. . O

The DT O
negative JJ O
regulatory JJ O
activity NN O
of IN O
the DT O
N NNP O
- : O
terminal NN O
domain NN O
was VBD O
antagonized VBN O
by IN O
a DT O
C NNP O
- : O
terminal JJ O
segment NN O
of IN O
Pho81p NNP B-Gene
supplied VBD O
in IN O
trans NNS O
. . O

SUMMARY NNP O
BACKGROUND NNP O
DATA NNP O
: : O
Melanoma NNP O
care NN O
has VBZ O
not RB O
changed VBN O
significantly RB O
in IN O
the DT O
last JJ O
20 CD O
years NNS O
, , O
and CC O
the DT O
controversy NN O
of IN O
elective JJ O
lymph NN O
node NN O
dissections NNS O
in IN O
this DT O
disease NN O
continues VBZ O
to TO O
be VB O
discussed VBN O
. . O

The DT O
carboxyl NN O
- : O
terminal JJ O
portion NN O
of IN O
UKLF NNP B-Gene
contains NNS O
three CD O
zinc NN O
fingers NNS O
of IN O
the DT O
Cys2 NNP O
- : O
His2 NNP O
type NN O
and CC O
binds NNS O
in IN O
vitro NN O
to TO O
the DT O
CACCC NNP O
motif NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
and CC O
to TO O
the DT O
Sp1 NNP B-Gene
recognition NN I-Gene
sequence NN I-Gene
. . O

The DT O
protein NN O
was VBD O
associated VBN O
with IN O
purified JJ O
vaccinia NN O
virus NN O
particles NNS O
and CC O
with IN O
membranes NNS O
of IN O
immature NN O
and CC O
mature NN O
virions NNS O
that WDT O
were VBD O
visualized VBN O
by IN O
electron NN O
microscopy NN O
of IN O
infected JJ O
cells NNS O
. . O

At IN O
a DT O
PaCO2 NNP O
of IN O
40 CD O
mmHg NNS O
, , O
baseline NN O
brain NN O
pHi NN O
measured VBD O
7 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
, , O
while IN O
regional JJ O
cortical JJ O
blood NN O
flow NN O
was VBD O
47 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
3 CD O
ml NN O
. . O
100 CD O
g JJ O
- : O
1 CD O
. . O
min VB O
- : O
1 CD O
. . O

We PRP O
have VBP O
identified VBN O
two CD O
functional JJ O
elements NNS O
, , O
both DT O
located VBN O
downstream NN O
from IN O
the DT O
TATA NNP O
motif NN O
, , O
that WDT O
control VBP O
Id4 NNP B-Gene
promoter NN I-Gene
activity NN O
. . O

Spasmus JJ O
nutans NNS O
: : O
a DT O
syndrome NN O
of IN O
auto NN O
- : O
arousal NN O
. . O

Diagnosis NN O
of IN O
prostatic JJ O
carcinoma NN O
: : O
the DT O
yield NN O
of IN O
serum NN B-Gene
prostate NN I-Gene
specific JJ I-Gene
antigen NN I-Gene
, , O
digital JJ O
rectal JJ O
examination NN O
and CC O
transrectal JJ O
ultrasonography NN O
. . O

Model NN O
of IN O
spatiotemporal JJ O
dynamics NNS O
of IN O
stick JJ O
- : O
slip NN O
motion NN O
. . O

How WRB O
many JJ O
embryos VBP O
to TO O
transfer VB O
in IN O
patients NNS O
undergoing VBG O
IVF NNP O
? . O

Thrombosis NN O
of IN O
the DT O
renal JJ O
vein NN O
may MD O
be VB O
dramatic JJ O
and CC O
include VBP O
renal JJ O
failure NN O
. . O

Effects NNS O
of IN O
estrogen NN O
and CC O
glucocorticoids NNS O
on IN O
the DT O
adrenal JJ O
development NN O
of IN O
the DT O
fetus NN O
. . O

We PRP O
also RB O
identified VBD O
an DT O
alternative JJ O
spliced JJ O
form NN O
of IN O
Lyp NNP B-Gene
RNA NNP I-Gene
, , O
Lyp2 NNP B-Gene
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
influence NN O
of IN O
NaFe3 NNP O
+ NNP O
EDTA NNP O
, , O
and CC O
of IN O
increasing VBG O
dietary JJ O
levels NNS O
of IN O
Na2EDTA NNP O
, , O
on IN O
Zn NNP O
, , O
Cu NNP O
and CC O
Ca NNP O
metabolism NN O
in IN O
rats NNS O
fed VBP O
on IN O
Zn NNP O
- : O
sufficient NN O
and CC O
Zn NNP O
- : O
deficient NN O
soya SYM O
- : O
bean JJ O
- : O
isolate NN O
- : O
based VBN O
diets NNS O
. . O

The DT O
CT NNP O
characteristics NNS O
are VBP O
discussed VBN O
and CC O
the DT O
recent JJ O
literature NN O
is VBZ O
reviewed VBN O
. . O

A DT O
multi NN O
- : O
centre JJ O
evaluation NN O
of IN O
the DT O
card NN O
indirect JJ O
agglutination NN O
test NN O
for IN O
trypanosomiasis NN O
( ( O
TrypTect NNP O
CIATT NNP O
) ) O
. . O

Opposite JJ O
effects NNS O
of IN O
CYP1 NNP B-Gene
are VBP O
observed VBN O
in IN O
aerobic JJ O
, , O
heme JJ O
- : O
sufficient JJ O
cells NNS O
. . O

Of IN O
these DT O
patients NNS O
, , O
46 CD O
, , O
164 CD O
were VBD O
placed VBN O
on IN O
a DT O
waiting VBG O
list NN O
for IN O
transplantation NN O
, , O
23 CD O
, , O
275 CD O
of IN O
whom WP O
received VBD O
a DT O
first JJ O
cadaveric NN O
transplant NN O
between IN O
1991 CD O
and CC O
1997 CD O
. . O

This DT O
fragment NN O
contained VBD O
the DT O
C NNP O
- : O
terminal JJ O
47 CD O
nucleotides NNS O
of IN O
leuB NN B-Gene
, , O
encoding VBG O
3 CD B-Gene
- : I-Gene
isopropylmalate NN I-Gene
dehydrogenase NN I-Gene
; : O
asd CC B-Gene
, , O
encoding VBG O
aspartate JJ B-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
semialdehyde NN I-Gene
dehydrogenase NN I-Gene
( ( O
Asd NNP B-Gene
) ) O
; : O
and CC O
orfA VB O
, , O
whose WP$ O
product NN O
showed VBD O
similarity NN O
to TO O
the DT O
Asd NNP B-Gene
proteins NNS I-Gene
from IN I-Gene
Vibrio NNP I-Gene
spp NN I-Gene
. . O

Upon IN O
induction NN O
of IN O
SOS NNP O
, , O
viability NN O
increased VBD O
2 CD O
- : O
6 CD O
- : O
fold NN O
. . O

Distal NNP O
tubular JJ O
acidification NN O
and CC O
the DT O
threshold NN O
for IN O
proximal JJ O
tubular JJ O
bicarbonate NN O
reabsorption NN O
were VBD O
normal JJ O
, , O
as IN O
was VBD O
urine JJ O
concentrating NN O
capacity NN O
. . O

It PRP O
thus RB O
appears VBZ O
that IN O
MAPK NNP B-Gene
functions NNS O
in IN O
meiotic JJ O
maturation NN O
by IN O
preventing VBG O
unfertilized JJ O
eggs NNS O
from IN O
proceeding VBG O
into IN O
parthenogenetic JJ O
development NN O
. . O

Ultrasound NNP O
effect NN O
on IN O
the DT O
cytochrome JJ B-Gene
oxidase NN I-Gene
activity NN O

APOE NNP B-Gene
- : O
epsilon4 NN O
count NN O
predicts NNS O
age NN O
when WRB O
prevalence NN O
of IN O
AD NNP O
increases NNS O
, , O
then RB O
declines VBZ O
: : O
the DT O
Cache NNP O
County NNP O
Study NNP O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
cDNA NN O
encoding VBG O
human JJ B-Gene
MEKK3 NNP I-Gene
. . O

Oculus CC O
- : O
500 CD O
is VBZ O
a DT O
group NN O
of IN O
high JJ O
resolution NN O
imaging NN O
boards NNS O
for IN O
use NN O
with IN O
IBM NNP O
- : O
AT NN O
and CC O
compatible JJ O
computers NNS O
. . O

The DT O
diet NN O
of IN O
migrants NNS O
showed VBD O
both DT O
positive JJ O
( ( O
macronutrients NNS O
) ) O
and CC O
negative JJ O
( ( O
micronutrients NNS O
) ) O
differences NNS O
with IN O
the DT O
general JJ O
Dutch NNP O
diet NN O
. . O

We PRP O
have VBP O
cloned VBN O
the DT O
single JJ O
- : O
copy NN O
gene NN O
for IN O
the DT O
trans NNS B-Gene
- : I-Gene
spliceosomal JJ I-Gene
U5 NNP I-Gene
snRNA NN I-Gene
from IN O
the DT O
trypanosomatid NN O
species NNS O
Leptomonas NNP O
seymouri NN O
, , O
using VBG O
U5 NNP B-Gene
RNA NNP I-Gene
affinity NN O
selection NN O
and CC O
cDNA NN O
cloning NN O
. . O

In IN O
addition NN O
, , O
both CC O
the DT O
exon NN O
1 CD O
- : O
and CC O
exon VB O
2 CD O
- : O
initiated VBN O
forms NNS O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
Myc NNP I-Gene
protein NN I-Gene
stimulated VBD O
transcription NN O
of IN O
a DT O
Myc NNP B-Gene
/ NNP O
Max NNP B-Gene
- : O
responsive JJ O
reporter NN O
construct NN O
to TO O
a DT O
similar JJ O
level NN O
. . O

Proposals NNS O
on IN O
authorization NN O
; : O
by IN O
a DT O
group NN O
of IN O
nurses NNS O
from IN O
psychiatric JJ O
hospitals NNS O

To TO O
achieve VB O
complete JJ O
dissection NN O
of IN O
the DT O
anterior JJ O
vitreous JJ O
, , O
we PRP O
remove VBP O
even RB O
a DT O
clear JJ O
lens NN O
during IN O
the DT O
first JJ O
surgical JJ O
intervention NN O
in IN O
selected VBN O
cases NNS O
. . O

These DT O
genetic JJ O
alterations NNS O
do VBP O
not RB O
affect VB O
synthesis NN O
of IN O
the DT O
major JJ O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
protein NN I-Gene
, , O
p64 NN B-Gene
, , O
which WDT O
is VBZ O
initiated VBN O
from IN O
the DT O
first JJ O
AUG NNP O
codon NN O
in IN O
exon JJ O
2 CD O
. . O

IV NNP O
. . O
combined VBN O
sclerosis NN O
and CC O
resorption NN O
of IN O
the DT O
skull JJ O
base NN O
( ( O
6 CD O
cases NNS O
, , O
2 CD O
group NN O
I PRP O
lesions NNS O
and CC O
4 CD O
group NN O
II NNP O
lesions NNS O
) ) O
. . O

The DT O
Ogg1 NNP B-Gene
protein NN I-Gene
efficiently RB O
cleaves VBZ O
a DT O
DNA NN O
duplex NN O
where WRB O
a DT O
preformed JJ O
AP NNP B-Gene
site NN I-Gene
is VBZ O
placed VBN O
opposite IN O
a DT O
cytosine NN O
( ( O
AP NNP O
/ NNP O
C NNP O
) ) O
. . O

Lauciello NNP O
describes VBZ O
a DT O
technique NN O
for IN O
the DT O
placement NN O
of IN O
functionally RB O
generated VBN O
amalgam JJ O
stops NNS O
as IN O
restorations NNS O
within IN O
mandibular JJ O
acrylic JJ O
teeth NNS O
. . O

Fibrinogen NNP B-Gene
determination NN O
using VBG O
the DT O
KZM NNP O
- : O
1 CD O
meter NN O

Mutations NNS O
truncating VBG O
as RB O
many JJ O
as IN O
143 CD O
C NNP O
- : O
terminal JJ O
residues NNS O
from IN O
the DT O
transcriptional JJ O
activator NN O
encoded VBN O
by IN O
the DT O
areA JJ B-Gene
gene NN I-Gene
, , O
mediating VBG O
nitrogen NN O
metabolite JJ O
repression NN O
in IN O
Aspergillus NNP O
nidulans NNS O
, , O
do VBP O
not RB O
significantly RB O
reduce VB O
the DT O
ability NN O
of IN O
the DT O
areA JJ B-Gene
product NN I-Gene
to TO O
activate VB O
expression NN O
of IN O
most JJS O
genes NNS O
under IN O
areA DT B-Gene
control NN O
. . O

RESULTS NNS O
: : O
We PRP O
identified VBD O
a DT O
full JJ O
- : O
length NN O
cDNA NN O
with IN O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
2883 CD O
bp NN O
corresponding VBG O
to TO O
a DT O
predicted JJ O
protein NN O
of IN O
961 CD O
amino NN O
acids NNS O
that WDT O
shares NNS O
greater JJR O
than IN O
95 CD O
% NN O
homology NN O
with IN O
the DT O
rat NN B-Gene
gamma SYM I-Gene
- : I-Gene
aminobutyric JJ I-Gene
acid NN I-Gene
B NNP I-Gene
( ( I-Gene
GABAB NNP I-Gene
) ) I-Gene
receptor NN I-Gene
. . O

Because IN O
the DT O
hcf109 NN B-Gene
locus NN I-Gene
was VBD O
mapped VBN O
at IN O
a DT O
distance NN O
< NN O
0 CD O
. . O
1 CD O
centimorgans NNS O
from IN O
the DT O
phytochrome JJ B-Gene
C NNP I-Gene
gene NN I-Gene
, , O
its PRP$ O
molecular JJ O
characterization NN O
by IN O
positional JJ O
cloning NN O
is VBZ O
possible JJ O
. . O

As IN O
a DT O
result NN O
, , O
the DT O
subendocardial JJ O
/ NNP O
subepicardial JJ O
blood NN O
flow NN O
ratio NN O
( ( O
ENDO NNP O
/ NNP O
EPI NNP O
) ) O
increased VBD O
from IN O
0 CD O
. . O
44 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
during IN O
control NN O
stenosis NN O
to TO O
0 CD O
. . O
85 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
13 CD O
after IN O
ITF JJ O
1129 CD O
( ( O
10 CD O
micrograms NNS O
/ VBP O
kg JJ O
/ NNP O
min NN O
i NN O
. . O
v NN O
. . O
) ) O
and CC O
to TO O
0 CD O
. . O
81 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
12 CD O
after IN O
NTG NNP O
. . O

Analyses NNS O
of IN O
hGMR NN B-Gene
beta NN I-Gene
subunit NN I-Gene
mutants NNS I-Gene
revealed VBD O
two CD O
cytoplasmic JJ O
regions NNS O
involved VBN O
in IN O
activation NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
myc NN I-Gene
promoter NN I-Gene
, , O
one CD O
is VBZ O
essential JJ O
and CC O
the DT O
other JJ O
is VBZ O
dispensable JJ O
but CC O
enhances VBZ O
the DT O
activity NN O
. . O

In IN O
the DT O
former JJ O
instance NN O
, , O
in IN O
addition NN O
to TO O
serum VB O
calcium NN O
and CC O
phosphorous JJ O
ion NN O
concentrations NNS O
, , O
tissue NN O
pH NN O
, , O
blood NN O
supply NN O
, , O
hormones NNS O
, , O
i NN O
. . O
e NN O
. . O
, , O
vitamin JJ O
D NNP O
, , O
vitamin VBZ O
A NNP O
, , O
and CC O
various JJ O
enzymes NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
alkaline JJ B-Gene
phosphatase NN I-Gene
and CC O
pyrophosphatase NN B-Gene
) ) O
may MD O
all DT O
play VB O
significant JJ O
, , O
ancillary JJ O
, , O
time NN O
- : O
dependent NN O
, , O
but CC O
as IN O
yet RB O
undetermined JJ O
roles NNS O
. . O

Urinary JJ B-Gene
N NNP I-Gene
- : I-Gene
acetylglucosaminidase NN I-Gene
activity NN O
per IN O
mg FW O
creatinine NN O
did VBD O
not RB O
differ VB O
significantly RB O
between IN O
groups NNS O
. . O

The DT O
only JJ O
predictor NN O
of IN O
response NN O
to TO O
tacrolimus VB O
was VBD O
a DT O
previous JJ O
response NN O
to TO O
cyclosporin VB O
and CC O
prednisone VB O
, , O
either RB O
as IN O
a DT O
complete JJ O
or CC O
partial JJ O
remission NN O
( ( O
remission NN O
rate NN O
75 CD O
% NN O
vs NN O
15 CD O
. . O
3 CD O
; : O
P NNP O
= VBD O
0 CD O
. . O
36 CD O
) ) O
. . O

In IN O
similar JJ O
transient NN O
transfection NN O
experiments NNS O
in IN O
HeLa NNP O
cells NNS O
, , O
overexpression NN O
of IN O
the DT O
wt NN B-Gene
human JJ I-Gene
retinoblastoma NN I-Gene
susceptibility NN I-Gene
gene NN I-Gene
product NN I-Gene
, , O
RB NNP B-Gene
, , O
was VBD O
found VBN O
to TO O
repress VB O
the DT O
serum NN O
- : O
induced JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
- : O
225 CD O
to TO O
+ VB O
13 CD O
) ) O
, , O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
( ( O
- : O
711 CD O
to TO O
+ VB O
42 CD O
) ) O
, , O
and CC O
beta SYM B-Gene
- : I-Gene
actin NN I-Gene
( ( O
- : O
3400 CD O
to TO O
+ VB O
912 CD O
) ) O
promoters NNS O
but CC O
not RB O
the DT O
PRV NNP O
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
- : O
110 CD O
to TO O
+ VB O
13 CD O
) ) O
or CC O
the DT O
serum JJ O
- : O
induced JJ O
MHC NNP B-Gene
( ( O
- : O
528 CD O
to TO O
- : O
38 CD O
) ) O
promoters NNS O
. . O

Immunoglobulin NNP B-Gene
light NN I-Gene
chain NN I-Gene
( ( O
IgL NNP B-Gene
) ) O
diversity NN O
is VBZ O
generated VBN O
in IN O
the DT O
chicken NN O
by IN O
recombination NN O
between IN O
the DT O
single JJ O
functional JJ O
variable NN O
( ( O
VL NNP B-Gene
) ) O
and CC O
joining VBG O
( ( O
JL NNP B-Gene
) ) O
gene NN O
segments NNS O
and CC O
subsequent JJ O
somatic JJ O
diversification NN O
of IN O
the DT O
rearranged JJ O
VL NNP B-Gene
region NN O
. . O

Thus RB O
, , O
replication NN O
fork NN O
movement NN O
near IN O
HML NNP B-Gene
pauses VBZ O
at IN O
a DT O
silent JJ O
origin NN O
which WDT O
is VBZ O
competent NN O
for IN O
replication NN O
initiation NN O
but CC O
kept VBD O
silent JJ O
through IN O
Orc2p NNP B-Gene
, , O
a DT O
component NN O
of IN O
the DT O
replication NN O
initiator NN O
. . O

Hoeben NNP O
, , O
F NNP O
. . O
J NNP O
. . O

The DT O
major JJ O
PKC NNP B-Gene
beta NN I-Gene
transcription NN O
initiation NN O
site NN O
was VBD O
identified VBN O
by IN O
primer JJ O
extension NN O
and CC O
S1 NNP B-Gene
nuclease NN I-Gene
protection NN O
. . O

Taurine NNP O
deficiency NN O
significantly RB O
depressed VBD O
the DT O
amplitude NN O
of IN O
OP1 NNP O
and CC O
OP4 NNP O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridization NN O
of IN O
metaphase NN O
spreads NNS O
of IN O
chromosome NN O
8 CD O
, , O
containing VBG O
hybrid JJ O
cell NN O
line NN O
706 CD O
- : O
B6 NNP O
clone NN O
17 CD O
( ( O
CL NNP O
- : O
17 CD O
) ) O
with IN O
cosmid NN O
c101F1 NN O
, , O
placed VBD O
the DT O
9804 CD B-Gene
gene NN I-Gene
close RB O
to TO O
the DT O
telomere NN O
at IN O
8q24 CD O
. . O
3 CD O
. . O

Erythrocyte NNP O
AA NNP O
in IN O
FO NNP O
+ NNP O
EPO NNP B-Gene
- : O
supplemented VBD O
infants NNS O
remained VBD O
low JJ O
and CC O
below IN O
breast SYM O
- : O
and CC O
placebo VB O
formula NN O
- : O
fed NN O
levels NNS O
. . O

A DT O
preoperative JJ O
teaching NN O
booklet NN O
for IN O
pediatric JJ O
patients NNS O
. . O

Endorphins NNS B-Gene
and CC O
legal JJ O
issues NNS O
. . O

The DT O
mean JJ O
total JJ O
white JJ O
cell NN O
count NN O
increased VBD O
from IN O
a DT O
baseline NN O
of IN O
11 CD O
. . O
3 CD O
x JJ O
10 CD O
( ( O
9 CD O
) ) O
/ NN O
L NNP O
( ( O
SD NNP O
2 CD O
. . O
3 CD O
) ) O
to TO O
16 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
9 CD O
) ) O
/ NN O
L NNP O
( ( O
SD NNP O
4 CD O
. . O
6 CD O
) ) O
on IN O
day NN O
1 CD O
, , O
normalising VBG O
thereafter RB O
. . O

Conversely RB O
, , O
activation NN O
of IN O
this DT O
signaling VBG O
pathway NN O
by IN O
expression NN O
of IN O
a DT O
constitutively RB O
active JJ O
MKK1 NNP B-Gene
mutant NN I-Gene
dramatically RB O
increased VBD O
cyclin NN B-Gene
D1 NNP I-Gene
promoter NN O
activity NN O
and CC O
cyclin NN B-Gene
D1 NNP I-Gene
protein NN I-Gene
expression NN O
, , O
in IN O
a DT O
growth NN O
factor NN O
- : O
independent JJ O
manner NN O
. . O

Using VBG O
bovine NN B-Gene
and CC I-Gene
murine NN I-Gene
c SYM I-Gene
- : I-Gene
myb NN I-Gene
clones NNS O
, , O
no DT O
change NN O
in IN O
the DT O
rate NN O
of IN O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
gene NN I-Gene
transcription NN O
or CC O
mRNA NN O
stability NN O
was VBD O
detected VBN O
during IN O
the DT O
cell NN O
cycle NN O
. . O

Epigenetic JJ O
switching NN O
of IN O
transcriptional JJ O
states NNS O
: : O
cis NN O
- : O
and CC O
trans VBZ O
- : O
acting VBG O
factors NNS O
affecting VBG O
establishment NN O
of IN O
silencing VBG O
at IN O
the DT O
HMR NNP B-Gene
locus NN I-Gene
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Dissipation NN O
of IN O
claudication NN O
pain NN O
after IN O
walking NN O
: : O
implications NNS O
for IN O
endurance NN O
training NN O
. . O

Stability NN O
of IN O
pyrimethamine NN O
in IN O
a DT O
liquid JJ O
dosage NN O
formulation NN O
stored VBD O
for IN O
three CD O
months NNS O
. . O

A DT O
32P CD O
- : O
labeled VBN O
LAP NNP B-Gene
DNA NNP O
- : O
binding NN O
and CC O
dimerization NN O
domain NN O
"""" NNP O
zipper NNP O
probe NN O
"""" NN O
was VBD O
used VBN O
to TO O
isolate VB O
a DT O
clone NN O
that WDT O
encodes VBZ O
a DT O
new JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
homologous JJ I-Gene
protein NN I-Gene
: : O
CHOP NNP B-Gene
- : I-Gene
10 CD I-Gene
. . O

Introduction NN O
of IN O
v JJ B-Gene
- : I-Gene
fms NN I-Gene
into IN O
a DT O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
dependent JJ O
murine NN O
macrophage NN O
cell NN O
line NN O
induced VBN O
factor NN O
independence NN O
and CC O
tumorigenicity NN O
by IN O
a DT O
nonautocrine JJ O
mechanism NN O
. . O

MotA NNP B-Gene
also RB O
binds VBZ O
a DT O
DNA NN O
sequence NN O
( ( O
a DT O
MotA NNP B-Gene
box NN I-Gene
) ) O
, , O
centered VBN O
at IN O
position NN O
- : O
30 CD O
. . O

This DT O
machinery NN O
involves VBZ O
a DT O
secondary JJ O
structure NN O
, , O
SECIS NNP O
element NN O
, , O
in IN O
the DT O
selenoprotein NN B-Gene
- : O
encoding VBG O
mRNA NN O
, , O
directing VBG O
selenocysteine JJ O
insertion NN O
at IN O
the DT O
position NN O
of IN O
an DT O
opal JJ O
( ( O
UGA NNP O
) ) O
codon NN O
, , O
normally RB O
conferring VBG O
termination NN O
of IN O
translation NN O
. . O

The DT O
spectrum NN O
of IN O
histologically RB O
diagnosed VBN O
malignant JJ O
neoplasms NNS O
in IN O
Sabah NNP O
, , O
1983 CD O
- : O
1988 CD O
. . O

These DT O
studies NNS O
point VBP O
to TO O
the DT O
involvement NN O
of IN O
the DT O
MAP NNP B-Gene
kinase VB I-Gene
pathway NN O
in IN O
the DT O
activation NN O
of IN O
monocytic JJ O
cells NNS O
during IN O
transmigration NN O
to TO O
inflammatory VB O
sites NNS O
. . O

Using VBG O
a DT O
series NN O
of IN O
mutant JJ O
proteins NNS O
, , O
we PRP O
have VBP O
characterized VBN O
domains NNS O
responsible JJ O
for IN O
activation NN O
or CC O
repression NN O
. . O

The DT O
data NNS O
provide VBP O
strong JJ O
evidence NN O
that IN O
ThlA NNP B-Gene
is VBZ O
involved VBN O
in IN O
the DT O
metabolism NN O
of IN O
both DT O
acid NNS O
and CC O
solvent JJ O
formation NN O
, , O
whereas IN O
the DT O
physiological JJ O
function NN O
of IN O
ThlB NNP B-Gene
has VBZ O
yet RB O
to TO O
be VB O
elucidated VBN O
. . O

Coactivation NN O
of IN O
endogenous JJ O
or CC O
exogenous JJ O
G NNP B-Gene
( ( I-Gene
q NN I-Gene
) ) I-Gene
- : I-Gene
coupled VBN I-Gene
receptors NNS I-Gene
with IN O
the DT O
delta NN B-Gene
- : I-Gene
opioid JJ I-Gene
receptor NN I-Gene
produced VBD O
strong JJ O
stimulations NNS O
of IN O
PLCbeta NNP B-Gene
and CC O
such JJ O
responses NNS O
could MD O
be VB O
partially RB O
blocked VBN O
by IN O
pertussis NN B-Gene
toxin NN I-Gene
. . O

Biochemical JJ O
experiments NNS O
have VBP O
shown VBN O
that IN O
CopG NNP B-Gene
co VBD O
- : O
operatively RB O
associates VBZ O
to TO O
its PRP$ O
target NN O
DNA NN O
at IN O
low JJ O
protein NN O
: : O
DNA NN O
ratios NNS O
, , O
completely RB O
protecting VBG O
four CD O
helical JJ O
turns NNS O
on IN O
the DT O
same JJ O
face NN O
of IN O
the DT O
double JJ O
helix NN O
in IN O
both DT O
directions NNS O
from IN O
the DT O
inverted JJ O
repeat NN O
that WDT O
constitutes VBZ O
the DT O
CopG NNP B-Gene
primary JJ O
target NN O
. . O

CONCLUSIONS NN O
: : O
Use NN O
of IN O
the DT O
first JJ O
method NN O
was VBD O
associated VBN O
with IN O
a DT O
reduction NN O
in IN O
the DT O
time NN O
patients NNS O
remained VBN O
in IN O
the DT O
ICU NNP O
before IN O
transfer NN O
to TO O
another DT O
unit NN O
and CC O
savings NNS O
in IN O
nursing NN O
time NN O
, , O
but CC O
the DT O
two CD O
methods NNS O
did VBD O
not RB O
differ VB O
according VBG O
to TO O
clinical JJ O
outcomes NNS O
. . O

Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
nuclear JJ I-Gene
protein NN I-Gene
2 CD I-Gene
( ( O
EBNA2 NNP B-Gene
) ) O
binds VBZ O
to TO O
a DT O
component NN O
of IN O
the DT O
human JJ O
SNF NNP B-Gene
- : O
SWI NN B-Gene
complex NN O
, , O
hSNF5 NN B-Gene
/ NNP O
Ini1 NNP B-Gene
. . O

The DT O
factor NN O
structure NN O
of IN O
"""" JJ O
schizotypal NN O
' '' O
traits NNS O
: : O
a DT O
large JJ O
replication NN O
study NN O
. . O

The DT O
quantitative JJ O
determination NN O
of IN O
HBSAG NNP B-Gene
- : O
- : O
a DT O
valuable JJ O
aid NN O
in IN O
evaluating VBG O
the DT O
infectiousness NN O
of IN O
hepatitis NN O
B NNP O
virus NN O
carriers NNS O

Gene NNP O
constructs NNS O
possessing VBG O
the DT O
complete JJ B-Gene
tat NN I-Gene
, , O
rev NN B-Gene
( ( O
tat JJ B-Gene
+ NNP I-Gene
rev NN B-Gene
+ NN I-Gene
) ) O
and CC O
env JJ B-Gene
genes NNS I-Gene
were VBD O
transiently RB O
expressed VBN O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
as IN O
precursor NN B-Gene
SU NNP I-Gene
- : I-Gene
TM NNP I-Gene
( ( O
gp160 NN B-Gene
) ) O
, , O
SU NNP B-Gene
. . I-Gene
TM NNP I-Gene
( ( O
gp120 JJ B-Gene
x NNP I-Gene
41 CD I-Gene
) ) O
, , O
and CC O
nucleolar JJ B-Gene
rev NN I-Gene
protein NN I-Gene
. . O

Vascular JJ O
endothelial JJ O
cells NNS O
undergo JJ O
profound NN O
changes NNS O
upon IN O
cellular JJ O
activation NN O
including VBG O
expression NN O
of IN O
a DT O
spectrum NN O
of IN O
cell NN O
activation NN O
- : O
associated VBN O
genes NNS O
. . O

In IN O
a DT O
series NN O
of IN O
patients NNS O
with IN O
neuroinfection NN O
, , O
Lyme NNP O
disease NN O
, , O
Guillain NNP O
Barre NNP O
syndrome NN O
, , O
demyelinization NN O
, , O
partial JJ O
or CC O
generalized VBN O
, , O
epilepsy RB O
, , O
we PRP O
have VBP O
investigated VBN O
antiphospholipid JJ O
antibodies NNS O
of IN O
IgG NNP B-Gene
and CC O
IgM NNP B-Gene
subtypes NNS O
, , O
together RB O
with IN O
anticoagulant JJ O
factors NNS O
, , O
member NN O
of IN O
thrombocytes NNS O
, , O
sedimentation NN O
rate NN O
of IN O
erythrocytes NNS O
. . O

Sex NN O
selection NN O
via IN O
albumin JJ B-Gene
columns NNS O
: : O
20 CD O
years NNS O
of IN O
results NNS O
. . O

Extramedullary JJ O
relapse NN O
in IN O
childhood NN O
leukemia NN O
. . O

From IN O
S3 NNP O
( ( O
CBF NNP O
: : O
79 CD O
- : O
60 CD O
% NN O
) ) O
to TO O
S5 NNP O
( ( O
CBF NNP O
: : O
39 CD O
- : O
0 CD O
% NN O
) ) O
, , O
% NN O
WTh NNP O
, , O
1 CD O
/ NN O
TPC NNP O
and CC O
1 CD O
/ NNS O
T NNP O
were VBD O
significantly RB O
decreased VBN O
from IN O
those DT O
of IN O
the DT O
control NN O
levels NNS O
( ( O
all DT O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
authors NNS O
evaluated VBD O
the DT O
potential NN O
for IN O
thrombotic JJ O
complications NNS O
arising VBG O
from IN O
implantation NN O
of IN O
a DT O
ventricular JJ O
assist NN O
device NN O
( ( O
Sarns NNP O
/ NNP O
3M CD O
- : O
VAD NN O
) ) O
in IN O
four CD O
calves NNS O
. . O

Comparison NNP O
of IN O
Tc NNP O
- : O
99m CD O
sestamibi JJ O
perfusion NN O
imaging NN O
and CC O
echocardiography NN O
using VBG O
an DT O
arbutamine JJ O
infusion NN O
for IN O
the DT O
detection NN O
of IN O
coronary JJ O
artery NN O
disease NN O
. . O

The DT O
diagnosis NN O
of IN O
miliary JJ O
tuberculosis NN O
should MD O
be VB O
systematically RB O
considered VBN O
in IN O
ARDS NNP O
of IN O
unknown JJ O
origin NN O
. . O

We PRP O
present VBP O
here RB O
a DT O
detailed JJ O
genomic JJ O
sequencing VBG O
analysis NN O
of IN O
the DT O
cytosine NN O
methylation NN O
patterns NNS O
of IN O
the DT O
transposase NN B-Gene
binding NN O
sites NNS O
within IN O
both DT O
Ac NNP B-Gene
ends VBZ O
in IN O
the DT O
wx NN B-Gene
- : I-Gene
m9 NN I-Gene
: : O
: : O
Ac NNP B-Gene
allele NN I-Gene
, , O
where WRB O
Ac NNP B-Gene
is VBZ O
inserted VBN O
into IN O
the DT O
tenth JJ O
exon NN O
of IN O
the DT O
Waxy NNP B-Gene
gene NN I-Gene
. . O

Auto NNP O
- : O
and CC O
isotopy NN O
of IN O
the DT O
conjunctiva NN O

All DT O
62 CD O
isolates NNS O
were VBD O
resistant JJ O
to TO O
lincomycin VB O
, , O
colistin NN O
, , O
nystatin NN O
, , O
amphotericin NN O
B NNP O
, , O
trimethoprim JJ O
lactate NN O
, , O
polymyxin NN O
B NNP O
, , O
and CC O
anisomycin NN O
. . O

Takahashi NNP O
, , O
H NNP O
. . O

Carbohydrate NNP O
metabolism NN O
and CC O
the DT O
semen NNS O
profile NN O
: : O
glucose NN O
, , O
insulin NN B-Gene
, , O
and CC O
sperm JJ O
studies NNS O
. . O

Risk NN O
factors NNS O
associated VBN O
with IN O
a DT O
high JJ O
seroprevalence NN O
of IN O
hepatitis NN O
C NNP O
virus NN O
infection NN O
in IN O
Egyptian JJ O
blood NN O
donors NNS O
. . O

The DT O
data NN O
obtained VBD O
up RP O
to TO O
now RB O
only RB O
suggest VBP O
the DT O
future JJ O
potentiality NN O
of IN O
Bestatin NNP O
treatment NN O
for IN O
these DT O
types NNS O
of IN O
malignancy NN O
. . O

No DT O
difference NN O
in IN O
percentage NN O
of IN O
males NNS O
in IN O
semen JJ O
production NN O
was VBD O
noted VBN O
between IN O
strains NNS O
, , O
CP NNP O
levels NNS O
, , O
or CC O
feeding VBG O
regimens NNS O
. . O

The DT O
percentages NNS O
of IN O
recovery NN O
decreased VBN O
with IN O
storage NN O
time NN O
, , O
although IN O
the DT O
addition NN O
of IN O
dispersant NN O
( ( O
Tris NNP O
- : O
Tween NNP O
80 CD O
) ) O
before IN O
storage NN O
appeared VBD O
to TO O
partially RB O
prevent VB O
adhesion NN O
. . O

Interplane NNP O
coupling NN O
in IN O
the DT O
superconductor NN O
Y2Ba4Cu7O15 NNP O
as IN O
revealed VBN O
by IN O
NQR NNP O
spin SYM O
- : O
echo NN O
double JJ O
resonance NN O
. . O

OND $ O
8 CD O
mg NN O
tid NN O
days NNS O
2 CD O
- : O
3 CD O
, , O
and CC O
8 CD O
mg NN O
tid NN O
prn NN O
days NNS O
4 CD O
- : O
5 CD O
and CC O
prednisolone NN O
75 CD O
- : O
100 CD O
mg NN O
qds NN O
days NNS O
2 CD O
- : O
5 CD O
and CC O
2 CD O
) ) O
MCP NNP O
30 CD O
mg NN O
/ NNP O
metylprednisolone NN O
80 CD O
mg NN O
i NN O
. . O
v NN O
. . O
before IN O
CT NNP O
and CC O
MCP NNP O
20 CD O
mg NN O
p NN O
. . O
r NN O
. . O
after IN O
4 CD O
and CC O
8 CD O
h NN O
respectively RB O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
Ras NNP B-Gene
- : O
activated VBD O
Raf NNP B-Gene
- : O
MEK NNP B-Gene
- : O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated VBN I-Gene
kinase NN I-Gene
( ( O
ERK NNP B-Gene
) ) O
signaling VBG O
pathway NN O
can MD O
specifically RB O
control VB O
the DT O
expression NN O
of IN O
individual JJ O
integrin NN B-Gene
subunits NNS I-Gene
in IN O
a DT O
variety NN O
of IN O
human JJ O
and CC O
mouse NN O
cell NN O
lines NNS O
. . O

Plasma NNP O
renin NN B-Gene
activity NN O
did VBD O
not RB O
change VB O
in IN O
response NN O
to TO O
head VB O
- : O
up RP O
tilt NN O
or CC O
isoprenaline JJ O
infusion NN O
in IN O
the DT O
patients NNS O
. . O

The DT O
collection NN O
of IN O
mutants NNS O
displaying VBG O
TGN NNP O
sorting VBG O
defects NNS O
includes VBZ O
members NNS O
with IN O
mutations NNS O
in IN O
previously RB O
identified VBN O
vacuolar JJ B-Gene
protein NN I-Gene
sorting VBG I-Gene
genes NNS I-Gene
( ( O
VPS NNP B-Gene
) ) O
, , O
including VBG O
the DT O
dynamin JJ B-Gene
family NN O
member NN O
VPS1 NNP B-Gene
. . O

In IN O
whole JJ O
sardine NN O
, , O
domoic JJ O
acid NN O
was VBD O
detected VBN O
in IN O
levels NNS O
exceeding VBG O
sometimes RB O
the DT O
regulatory JJ O
limit NN O
. . O

Human NNP B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
IN NNP I-Gene
, , O
expressed VBN O
in IN O
Escherichia NNP O
coli NN O
, , O
was VBD O
purified VBN O
to TO O
near IN O
homogeneity NN O
. . O

Mouse NNP B-Gene
Impact NNP I-Gene
is VBZ O
a DT O
paternally RB O
expressed VBN O
gene NN O
encoding VBG O
an DT O
evolutionarily RB O
conserved VBN O
protein NN O
of IN O
unknown JJ O
function NN O
. . O

Effect NN O
of IN O
separate JJ O
and CC O
combined JJ O
effects NNS O
of IN O
plutonium NN O
- : O
239 CD O
, , O
hexachlorobutadiene NN O
and CC O
tributyl JJ O
phosphate NN O
on IN O
the DT O
thymus JJ O
gland NN O
of IN O
rats NNS O

Here RB O
we PRP O
report VBP O
on IN O
the DT O
isolation NN O
of IN O
ICK2 NNP B-Gene
, , O
and CC O
show VBP O
that IN O
it PRP O
interacts VBZ O
with IN O
Cdc2aAt NNP B-Gene
, , O
but CC O
not RB O
with IN O
a DT O
second JJ O
CDK NNP B-Gene
from IN I-Gene
Arabidopsis NNP I-Gene
, , O
Cdc2bAt NNP B-Gene
. . O

I PRP O
hypothesize VBP O
that IN O
white JJ B-Gene
gene NN I-Gene
expression NN O
from IN O
P NNP B-Gene
[ NNP I-Gene
en FW I-Gene
] NN I-Gene
is VBZ O
repressed VBN O
by IN O
the DT O
formation NN O
of IN O
a DT O
protein NN O
complex NN O
which WDT O
is VBZ O
initiated VBN O
at IN O
the DT O
engrailed JJ B-Gene
PS NNP I-Gene
sites NNS I-Gene
and CC O
also RB O
requires VBZ O
interactions NNS O
with IN O
flanking VBG O
genomic JJ O
DNA NN O
. . O

There EX O
was VBD O
either CC O
no DT O
change NN O
or CC O
an DT O
improvement NN O
in IN O
renographic JJ O
findings NNS O
( ( O
t1 JJ O
/ $ O
2 CD O
time NN O
and CC O
/ NN O
or CC O
split NN O
function NN O
) ) O
in IN O
40 CD O
patients NNS O
( ( O
93 CD O
% NN O
) ) O
. . O

nos SYM B-Gene
- : I-Gene
1 CD I-Gene
and CC O
nos JJ B-Gene
- : I-Gene
2 CD I-Gene
, , O
two CD O
genes NNS O
related VBN O
to TO O
Drosophila NNP B-Gene
nanos NNS I-Gene
, , O
regulate VB O
primordial JJ O
germ NN O
cell NN O
development NN O
and CC O
survival NN O
in IN O
Caenorhabditis NNP O
elegans NNS O
. . O

A DT O
potential JJ O
binding NN O
site NN O
for IN O
the DT O
dShc NN B-Gene
PTB NNP O
domain NN O
is VBZ O
located VBN O
at IN O
Tyr NNP O
- : O
1228 CD O
of IN O
DER NNP B-Gene
. . O

E47 NNP B-Gene
protein NN I-Gene
levels NNS O
remain VBP O
high JJ O
until IN O
the DT O
double JJ O
positive JJ O
developmental NN O
stage NN O
, , O
at IN O
which WDT O
point NN O
they PRP O
drop VBP O
to TO O
relatively RB O
moderate JJ O
levels NNS O
, , O
and CC O
are VBP O
further RB O
downregulated VBN O
upon IN O
transition NN O
to TO O
the DT O
single JJ O
positive JJ O
stage NN O
. . O

A DT O
p21 JJ B-Gene
peptide NN I-Gene
spanning VBG O
amino JJ O
acids NNS O
139 CD O
- : O
164 CD O
was VBD O
found VBN O
to TO O
bind VB O
PCNA NNP B-Gene
in IN O
a DT O
filter NN O
binding VBG O
assay NN O
and CC O
this DT O
peptide NN O
suppressed VBD O
recombinant JJ O
p21 NN B-Gene
- : O
PCNA NNP B-Gene
interaction NN O
. . O

The DT O
production NN O
of IN O
ceramide NN O
is VBZ O
emerging VBG O
as IN O
a DT O
fixture NN O
of IN O
programmed JJ O
cell NN O
death NN O
. . O

The DT O
first JJ O
involved JJ O
complementation NN O
of IN O
a DT O
nonphotosynthetic JJ O
mutant NN O
of IN O
Chlamydomonas NNP O
, , O
CC NNP O
- : O
2341 CD O
( ( O
ac SYM O
- : O
u JJ O
- : O
g NN O
- : O
2 CD O
. . O
3 CD O
) ) O
, , O
which WDT O
has VBZ O
a DT O
frameshift JJ O
mutation NN O
in IN O
the DT O
psaB NN B-Gene
gene NN I-Gene
, , O
and CC O
selection NN O
of IN O
photosynthetic JJ O
transformants NNS O
on IN O
minimal JJ O
medium NN O
. . O

It PRP O
acts VBZ O
on IN O
Cdks NNP B-Gene
in IN O
the DT O
G1 NNP O
and CC O
S NNP O
phases NNS O
of IN O
the DT O
cell NN O
cycle NN O
, , O
and CC O
also RB O
binds VBZ O
to TO O
proliferating VBG B-Gene
cell NN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
( ( O
PCNA NNP B-Gene
) ) O
, , O
blocking VBG O
DNA NNP O
replication NN O
in IN O
vitro NN O
. . O

Two CD O
patients NNS O
withdrew VBD O
from IN O
therapy NN O
, , O
one CD O
for IN O
personal JJ O
reasons NNS O
and CC O
one CD O
because IN O
a DT O
paraspinal JJ O
mass NN O
developed VBD O
. . O

This DT O
dimer NN O
interface NN O
is VBZ O
likely JJ O
important JJ O
for IN O
increasing VBG O
the DT O
DNA NNP O
- : O
binding NN O
specificity NN O
and CC O
affinity NN O
of IN O
the DT O
trimeric JJ O
form NN O
of IN O
HSF NNP B-Gene
, , O
as RB O
well RB O
as IN O
for IN O
increasing VBG O
cooperativity NN O
between IN O
adjacent JJ O
trimers NNS O
. . O

Characterisation NN O
of IN O
the DT O
chicken NN B-Gene
apolipoprotein VBZ I-Gene
A DT I-Gene
- : I-Gene
I PRP I-Gene
gene NN I-Gene
5 CD O
' '' O
- : O
flanking VBG O
region NN O
. . O

With IN O
histology NN O
and CC O
Evans NNP O
blue JJ O
injections NNS O
, , O
blood NN O
- : O
brain NN O
barrier NN O
alterations NNS O
were VBD O
seen VBN O
as RB O
early JJ O
as IN O
4 CD O
days NNS O
after IN O
a DT O
dose NN O
of IN O
50 CD O
Gy NNP O
. . O

From IN O
our PRP$ O
ultrastructural JJ O
and CC O
biochemical JJ O
studies NNS O
, , O
it PRP O
is VBZ O
evident JJ O
that IN O
Type NNP O
II NNP O
pneumocytes NNS O
are VBP O
an DT O
early JJ O
target NN O
of IN O
radiation NN O
and CC O
the DT O
release NN O
of IN O
surfactant NN O
into IN O
the DT O
alveolus NN O
shortly RB O
after IN O
exposure NN O
persists VBZ O
for IN O
days NNS O
and CC O
weeks NNS O
. . O

A DT O
. . O
, , O
Bowers NNPS O
, , O
K NNP O
. . O
E NNP O
, , O
and CC O
Matthews NNP O
, , O
C NNP O
. . O

Preferential NNP O
heterodimeric JJ O
parallel NN O
coiled VBD O
- : O
coil NN O
formation NN O
by IN O
synthetic JJ B-Gene
Max NNP I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Myc NNP I-Gene
leucine JJ I-Gene
zippers NNS I-Gene
: : O
a DT O
description NN O
of IN O
putative JJ O
electrostatic JJ O
interactions NNS O
responsible JJ O
for IN O
the DT O
specificity NN O
of IN O
heterodimerization NN O
. . O

The DT O
mutation NN O
within IN O
the DT O
asgB480 NN B-Gene
allele NN I-Gene
was VBD O
identified VBN O
as IN O
an DT O
A NNP O
- : O
to TO O
- : O
G NNP O
transition NN O
that WDT O
results NNS O
in IN O
a DT O
threonine NN O
- : O
to TO O
- : O
alanine NN O
substitution NN O
in IN O
the DT O
predicted JJ O
protein NN O
product NN O
. . O

No DT O
previous JJ O
studies NNS O
have VBP O
determined VBN O
the DT O
pharmaco NN O
- : O
dynamics NNS O
of IN O
intravenous JJ O
procainamide NN O
when WRB O
administered VBN O
in IN O
a DT O
dose NN O
of IN O
15 CD O
mg NNS O
/ JJ O
kg NN O
and CC O
at IN O
a DT O
rate NN O
of IN O
50 CD O
mg NNS O
/ JJ O
min NN O
, , O
as IN O
is VBZ O
common JJ O
practice NN O
during IN O
electropharmacologic JJ O
testing NN O
. . O

The DT O
main JJ O
causes NNS O
of IN O
liver JJ O
disease NN O
in IN O
the DT O
patients NNS O
with IN O
HCC NNP O
were VBD O
hepatitis VBN O
C NNP O
virus NN O
( ( O
HCV NNP O
) ) O
( ( O
77 CD O
% NN O
) ) O
, , O
alcohol NN O
abuse NN O
( ( O
73 CD O
% NN O
) ) O
, , O
and CC O
the DT O
combination NN O
of IN O
HCV NNP O
and CC O
alcohol NN O
abuse NN O
( ( O
50 CD O
% NN O
) ) O
. . O

GCR1 NNP B-Gene
gene NN I-Gene
function NN O
is VBZ O
required VBN O
for IN O
high JJ O
- : O
level NN O
glycolytic JJ O
gene NN O
expression NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
UV NNP O
induction NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
is VBZ O
mediated VBN O
by IN O
two CD O
UV NNP O
response NN O
elements NNS O
consisting VBG O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
like IN I-Gene
sequences NNS I-Gene
within IN O
its PRP$ O
5 CD O
' '' O
control NN O
region NN O
. . O

Induction NN O
of IN O
proto NN B-Gene
- : I-Gene
oncogene NN I-Gene
fos JJ I-Gene
transcription NN O
through IN O
the DT O
adenylate JJ B-Gene
cyclase NN I-Gene
pathway NN O
: : O
characterization NN O
of IN O
a DT O
cAMP NN O
- : O
responsive JJ O
element NN O
. . O

This DT O
result NN O
suggested VBD O
that IN O
mutant NN O
I299 NNP O
has VBZ O
diminished VBN O
cap SYM O
- : O
binding NN O
activity NN O
. . O

This DT O
gene NN O
encodes VBZ O
a DT O
putative JJ O
transcription NN O
factor NN O
with IN O
regions NNS O
of IN O
homology NN O
to TO O
several JJ O
other JJ O
proteins NNS O
including VBG O
the DT O
zinc NN O
fingers NNS O
and CC O
other JJ O
domains NNS O
of IN O
the DT O
Drosophila NNP B-Gene
trithorax NN I-Gene
gene NN I-Gene
product NN I-Gene
, , O
and CC O
the DT O
"""" NN O
AT NNP O
- : O
hook NN O
"""" NN O
DNA NNP O
- : O
binding VBG O
motif NN O
of IN O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
proteins VBZ I-Gene
. . O

Trial JJ O
treatment NN O
of IN O
schizophrenia NN O
with IN O
des NNS B-Gene
- : I-Gene
Tyr NNP I-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
endorphin NN I-Gene

Instead RB O
, , O
some DT O
small JJ O
negative JJ O
effects NNS O
are VBP O
observed JJ O
, , O
particularly RB O
involving VBG O
effects NNS O
of IN O
husbands NNS O
' POS O
retirement NN O
on IN O
the DT O
marital JJ O
satisfaction NN O
of IN O
employed JJ O
wives NNS O
. . O

Deletion NN O
or CC O
inactivation NN O
of IN O
CRY1 NNP B-Gene
leads VBZ O
to TO O
5 CD O
- : O
to TO O
10 CD O
- : O
fold JJ O
- : O
increased JJ O
levels NNS O
of IN O
CRY2 NNP B-Gene
mRNA NN I-Gene
. . O

To TO O
examine VB O
the DT O
possibility NN O
that WDT O
LNNB NNP O
performance NN O
of IN O
the DT O
schizophrenic JJ O
groups NNS O
may MD O
have VB O
been VBN O
related VBN O
to TO O
neuroleptic JJ O
medication NN O
, , O
analyses NNS O
were VBD O
completed VBN O
on IN O
the DT O
relationship NN O
between IN O
medication NN O
levels NNS O
and CC O
LNNB NNP O
scores NNS O
. . O

Guiding VBG O
patients NNS O
in IN O
the DT O
decision NN O
should MD O
involve VB O
a DT O
multidisciplinary JJ O
team NN O
composed VBD O
of IN O
a DT O
surgical JJ O
oncologist NN O
, , O
geneticist NN O
, , O
pathologist NN O
, , O
psychotherapist NN O
and CC O
plastic NN O
surgeon NN O
. . O

Each DT O
patient NN O
had VBD O
measurable JJ O
LH NNP B-Gene
and CC O
FSH NNP B-Gene
levels NNS O
, , O
with IN O
pulsed JJ O
nocturnal JJ O
secretion NN O
, , O
and CC O
pubertal JJ O
LH NNP B-Gene
and CC O
FSH NNP B-Gene
responses NNS O
to TO O
LRH NNP B-Gene
. . O

A DT O
bacteriological JJ O
relapse NN O
requiring VBG O
treatment NN O
occurred VBN O
by IN O
5 CD O
years NNS O
in IN O
16 CD O
. . O
8 CD O
% NN O
of IN O
113 CD O
R3 NNP O
, , O
5 CD O
. . O
2 CD O
% NN O
of IN O
97 CD O
R5 NNP O
, , O
and CC O
20 CD O
. . O
0 CD O
% NN O
of IN O
115 CD O
Z5 NNP O
patients NNS O
with IN O
organisms JJ O
sensitive JJ O
to TO O
streptomycin VB O
and CC O
isoniazid VB O
initially RB O
. . O

2 CD O
: : O
The DT O
dynamic JJ O
moduli NN O
of IN O
microcrystalline NN O
cellulose NN O
. . O

Sensory JJ O
evoked VBD O
field NN O
potentials NNS O
were VBD O
recorded VBN O
from IN O
the DT O
mesencephalic JJ O
reticular JJ O
formation NN O
( ( O
MRF NNP O
) ) O
, , O
central JJ O
gray NN O
( ( O
CG NNP O
) ) O
and CC O
somatosensory JJ O
cortex NN O
( ( O
SCX NNP O
) ) O
, , O
following VBG O
incremental JJ O
doses NNS O
of IN O
halothane NN O
in IN O
freely RB O
- : O
moving VBG O
rats NNS O
. . O

The DT O
results NNS O
of IN O
supershift JJ O
analysis NN O
using VBG O
specific JJ O
antibodies NNS O
against IN O
transcription NN O
factors NNS O
suggested VBD O
that IN O
both DT O
binding VBG O
complexes NNS O
contained VBD O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
components NNS O
p50 NN B-Gene
and CC O
p65 NN B-Gene
, , O
and CC O
did VBD O
not RB O
contain VB O
other JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
proteins NNS I-Gene
( ( O
p52 NN B-Gene
, , O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
Rel NNP B-Gene
B NNP I-Gene
) ) O
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
( ( O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
C NNP B-Gene
- : I-Gene
Jun NNP I-Gene
) ) O
, , O
CREB NNP B-Gene
or CC O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
) ) O
. . O

Angiotensin NNP B-Gene
effect NN O
in IN O
the DT O
human JJ O
kidney NN O
. . O

The DT O
Saccharomyces NNPS B-Gene
cerevisiae NN I-Gene
GAL1 NNP I-Gene
and CC O
GAL10 NNP B-Gene
genes NNS I-Gene
are VBP O
controlled VBN O
in IN O
response NN O
to TO O
the DT O
availability NN O
of IN O
galactose JJ O
and CC O
glucose JJ O
by IN O
multiple JJ O
activating NN O
and CC O
repressing VBG O
proteins NNS O
bound VBN O
at IN O
adjacent JJ O
or CC O
overlapping VBG O
sites NNS O
in IN O
UASG NNP O
. . O

Expression NN O
of IN O
GlcNAc NNP B-Gene
- : I-Gene
TI NNP I-Gene
mRNA NN I-Gene
in IN O
tobacco NN O
leaves NNS O
was VBD O
detected VBN O
using VBG O
RT NNP O
- : O
PCR NN O
. . O

These DT O
changes NNS O
correlate VBP O
directly RB O
with IN O
an DT O
increase NN O
in IN O
the DT O
acetylation NN O
levels NNS O
of IN O
all DT O
four CD O
core NN B-Gene
histones NNS I-Gene
in IN O
vivo NN O
. . O

Such JJ O
an DT O
interaction NN O
could MD O
be VB O
detected VBN O
using VBG O
a DT O
GST NNP B-Gene
- : O
POU NNP B-Gene
fusion NN O
protein NN O
bound NN O
to TO O
glutathione VB O
- : O
agarose JJ O
beads NNS O
. . O

Hypomagnesemia NNP O
was VBD O
due JJ O
to TO O
magnesium VB O
wasting NN O
by IN O
the DT O
kidney NN O
. . O

Regional JJ O
CBF NNP O
was VBD O
determined VBN O
by IN O
clearance NN O
of IN O
xenon $ O
133 CD O
in IN O
67 CD O
patients NNS O
undergoing JJ O
coronary JJ O
bypass NN O
grafting NN O
procedures NNS O
. . O

This DT O
multiple JJ O
- : O
electrode NN O
array NN O
for IN O
round NN O
window NN O
cochlear JJ O
implantation NN O
is VBZ O
a DT O
robust JJ O
, , O
reliable JJ O
system NN O
for IN O
inserting VBG O
20 CD O
mm NN O
along IN O
the DT O
scala NN O
tympani NN O
with IN O
a DT O
minimum NN O
of IN O
trauma NN O
and CC O
can MD O
provide VB O
for IN O
bipolar JJ O
stimulation NN O
. . O

These DT O
studies NNS O
suggest VBP O
an DT O
additional JJ O
component NN O
or CC O
cellular JJ O
environment NN O
is VBZ O
required VBN O
for IN O
SPRK NNP B-Gene
activation NN O
by IN O
Cdc42 NNP B-Gene
. . O

The DT O
corresponding JJ O
genotype NN O
was VBD O
determined VBN O
with IN O
a DT O
restriction NN O
enzyme SYM O
- : O
based VBN O
assay NN O
. . O

We PRP O
describe VBP O
a DT O
case NN O
of IN O
a DT O
perinephric JJ O
abscess NN O
treated VBN O
with IN O
amphotericin NN O
B NNP O
and CC O
nephrectomy NN O
. . O

Finally RB O
, , O
we PRP O
demonstrate VBP O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
can MD O
also RB O
active JJ O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
alpha NN I-Gene
promoter NN O
in IN O
nonmyeloid JJ O
cells NNS O
. . O

Similar JJ O
memory NN O
impairments NNS O
found VBN O
in IN O
medial JJ O
septal JJ O
- : O
vertical JJ O
diagonal JJ O
band NN O
of IN O
Broca NNP O
and CC O
nucleus JJ O
basalis NN O
lesioned VBD O
rats NNS O
: : O
are VBP O
memory JJ O
defects NNS O
induced VBN O
by IN O
nucleus JJ O
basalis NNS O
lesions NNS O
related VBN O
to TO O
the DT O
degree NN O
of IN O
non NN O
- : O
specific JJ O
subcortical JJ O
cell NN O
loss NN O
? . O

The DT O
function NN O
of IN O
nucleus JJ O
basalis NN O
( ( O
NB NNP O
) ) O
and CC O
medial JJ O
septal JJ O
- : O
vertical JJ O
diagonal JJ O
band NN O
of IN O
Broca NNP O
( ( O
MS NNP O
- : O
VDBB NN O
) ) O
in IN O
a DT O
place NN O
navigation NN O
task NN O
requiring VBG O
reference NN O
memory NN O
was VBD O
investigated VBN O
. . O

UV NNP O
cross SYM O
- : O
linking VBG O
experiments NNS O
demonstrated VBD O
that IN O
HSV NNP O
infection NN O
caused VBD O
enhanced JJ O
binding NN O
of IN O
protein NN O
factors NNS O
, , O
including VBG O
the DT O
64 CD B-Gene
- : I-Gene
kDa NN I-Gene
component NN I-Gene
of IN I-Gene
cleavage NN I-Gene
stimulation NN I-Gene
factor NN I-Gene
( ( O
CstF NNP B-Gene
) ) O
, , O
to TO O
poly VB O
( ( O
A DT O
) ) O
site NN O
RNAs NNP O
from IN O
virus NN O
genes NNS O
of IN O
all DT O
temporal JJ O
classes NNS O
and CC O
that IN O
this DT O
enhanced VBD O
binding NN O
required VBN O
expression NN O
of IN O
IE63 NNP B-Gene
. . O

As IN O
for IN O
31 CD O
stage NN O
I PRP O
- : O
II NNP O
lung NN O
cancer NN O
patients NNS O
, , O
CR NNP O
has VBZ O
been VBN O
observed VBN O
in IN O
82 CD O
. . O
8 CD O
% NN O
of IN O
them PRP O
and CC O
PR NNP O
in IN O
13 CD O
. . O
8 CD O
% NN O
; : O
the DT O
response NN O
was VBD O
always RB O
assessed VBN O
with IN O
chest NN O
radiography NN O
, , O
CT NNP O
, , O
FBS NNP O
, , O
cytology NN O
and CC O
/ NN O
or CC O
histology NN O
. . O

Our PRP$ O
purpose NN O
was VBD O
to TO O
determine VB O
if IN O
intact JJ O
perianal JJ O
( ( O
S4 NNP O
- : O
5 CD O
) ) O
pin NN O
sensation NN O
( ( O
PPS NNP O
) ) O
and CC O
bulbocavernosus NN O
( ( O
S2 NNP O
- : O
4 CD O
) ) O
reflex NN O
( ( O
BCR NNP O
) ) O
shortly RB O
after IN O
spinal JJ O
cord NN O
injury NN O
( ( O
SCI NNP O
) ) O
are VBP O
predictive JJ O
of IN O
bladder NN O
function NN O
recovery NN O
. . O

The DT O
transcription NN O
factor NN O
Sp1 NNP B-Gene
bound NN O
to TO O
eight CD O
sites NNS O
, , O
as IN O
demonstrated VBN O
by IN O
footprinting VBG O
assays NNS O
and CC O
gel JJ O
shift NN O
analysis NN O
with IN O
purified JJ O
Sp1 NNP B-Gene
. . O

The DT O
P69 NNP O
cell NN O
line NN O
was VBD O
derived VBN O
by IN O
immortalization NN O
of IN O
human JJ O
primary JJ O
prostate NN O
epithelial JJ O
cells NNS O
with IN O
simian JJ B-Gene
virus NN I-Gene
- : I-Gene
40 CD I-Gene
T NNP I-Gene
antigen NN I-Gene
and CC O
is VBZ O
rarely RB O
tumorigenic JJ O
. . O

The DT O
inhibitory JJ O
response NN O
to TO O
taps VB O
is VBZ O
essentially RB O
a DT O
protective NN O
reflex NN O
which WDT O
probably RB O
serves VBZ O
to TO O
reduce VB O
the DT O
activity NN O
of IN O
the DT O
jaw NN O
- : O
closing NN O
muscles NNS O
when WRB O
one CD O
bites VBZ O
unexpectedly RB O
on IN O
hard JJ O
objects NNS O
. . O

No DT O
effect NN O
of IN O
the DT O
intervention NN O
on IN O
depression NN O
scores NNS O
was VBD O
found VBN O
. . O

The DT O
defect NN O
in IN O
these DT O
proteins NNS O
was VBD O
also RB O
uniformly RB O
suppressed VBN O
by IN O
either DT O
Mn2 NNP O
+ NNP O
, , O
or CC O
the DT O
Mu NNP B-Gene
B NNP I-Gene
protein NN I-Gene
in IN O
the DT O
presence NN O
of IN O
ATP NNP O
and CC O
target NN O
DNA NNP O
. . O

The DT O
responses NNS O
of IN O
the DT O
"""" NNP O
stress NN O
hormones NNS O
"""" NNP O
cortisol NN O
, , O
11 CD O
- : O
deoxycortisol NN O
, , O
ACTH NNP B-Gene
, , O
vasopressin NN B-Gene
( ( O
AVP NNP B-Gene
) ) O
, , O
and CC O
corticotropin NN B-Gene
releasing VBG I-Gene
factor NN I-Gene
( ( O
CRF NNP B-Gene
) ) O
were VBD O
studied VBN O
in IN O
6 CD O
normal JJ O
males NNS O
in IN O
response NN O
to TO O
acute VB O
cortisol JJ O
deficiency NN O
induced VBN O
by IN O
the DT O
11 CD B-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
hydroxylase NN I-Gene
inhibitor NN O
, , O
metyrapone NN O
. . O

Further JJ O
research NN O
is VBZ O
recommended VBN O
to TO O
identify VB O
the DT O
coping NN O
styles NNS O
associated VBN O
with IN O
the DT O
high JJ O
EE NNP O
/ NNP O
low JJ O
EE NNP O
research NN O
classification NN O
. . O

Gentamicin NNP O
given VBN O
by IN O
DPI NNP O
and CC O
SVN NNP O
significantly RB O
decreased VBD O
the DT O
sputum NN O
Psa NNP O
density NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
, , O
by IN O
almost RB O
one CD O
order NN O
of IN O
magnitude NN O
. . O

Effect NN O
of IN O
2 CD O
- : O
( ( O
p JJ O
- : O
chlorophenyl NN O
) ) O
cyclopropylamine NN O
on IN O
5 CD O
- : O
hydroxyindole NN O
concentration NN O
and CC O
monoamine JJ B-Gene
oxidase NN I-Gene
activity NN O
in IN O
rat NN O
brain NN O
. . O

Owing VBG O
to TO O
parental JJ O
attitude NN O
, , O
a DT O
low JJ O
protein NN O
diet NN O
( ( O
1 CD O
- : O
5 CD O
g NN O
/ NNP O
kg NN O
) ) O
was VBD O
introduced VBN O
only RB O
late RB O
. . O

Of IN O
115 CD O
hepatitis NN O
B NNP O
patients NNS O
seen VBN O
at IN O
12 CD O
months NNS O
, , O
6 CD O
% NN O
had VBD O
chronic JJ O
hepatitis NN O
Bs NNP O
antigenaemia NN O
, , O
60 CD O
% NN O
had VBD O
developed VBN O
anti RB B-Gene
- : I-Gene
HBs NNP I-Gene
antibodies NNS I-Gene
, , O
and CC O
7 CD O
. . O
3 CD O
% NN O
still RB O
had VBD O
abnormal JJ O
liver NN O
function NN O
. . O

The DT O
regulatory JJ O
region NN O
also RB O
has VBZ O
a DT O
sequence NN O
similar JJ O
to TO O
the DT O
binding NN O
site NN O
for IN O
a DT O
liver NN O
- : O
specific JJ O
transcription NN O
factor NN O
, , O
hepatocyte JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
HNF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
at IN O
positions NNS O
- : O
120 CD O
to TO O
- : O
132 CD O
. . O

In IN O
addition NN O
, , O
the DT O
utility NN O
of IN O
beta NN B-Gene
2 CD I-Gene
transferrin NN I-Gene
assay NN O
in IN O
the DT O
diagnosis NN O
of IN O
cerebrospinal JJ O
fluid NN O
otorrhea NN O
is VBZ O
presented VBN O
. . O

Fourteen JJ O
patients NNS O
with IN O
New NNP O
York NNP O
Heart NNP O
Association NNP O
class NN O
II NNP O
congestive JJ O
heart NN O
failure NN O
were VBD O
enrolled VBN O
in IN O
a DT O
double JJ O
- : O
blind NN O
, , O
cross SYM O
- : O
over IN O
study NN O
. . O

The DT O
retinoid NN B-Gene
Z NNP I-Gene
receptor NN I-Gene
beta NN I-Gene
( ( O
RZR NNP B-Gene
beta NN I-Gene
) ) O
, , O
an DT O
orphan JJ O
receptor NN O
, , O
is VBZ O
a DT O
member NN O
of IN O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
( ( O
RAR NNP B-Gene
) ) O
/ VBP O
thyroid JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
( ( O
TR NNP B-Gene
) ) O
subfamily RB O
of IN O
nuclear JJ O
receptors NNS O
. . O

In IN O
the DT O
IA NNP O
task NN O
, , O
post NN O
- : O
training NN O
intraperitoneal JJ O
injections NNS O
of IN O
picrotoxin NN O
and CC O
bicuculline NN O
induced VBD O
a DT O
dose JJ O
- : O
dependent JJ O
enhancement NN O
of IN O
retention NN O
measured VBD O
24 CD O
h NN O
after IN O
the DT O
training NN O
, , O
while IN O
retention NN O
was VBD O
not RB O
affected VBN O
by IN O
bicuculline NN O
methiodide NN O
( ( O
a DT O
GABA NNP B-Gene
receptor NN I-Gene
antagonist NN O
that WDT O
does VBZ O
not RB O
readily RB O
cross VB O
the DT O
blood NN O
- : O
brain NN O
barrier NN O
) ) O
. . O

METHODS NN O
: : O
The DT O
passive NN O
and CC O
active JJ O
transport NN O
of IN O
fluorescein NN O
through IN O
the DT O
BRB NNP O
was VBD O
quantitated VBN O
by IN O
vitreous JJ O
fluorometry NN O
. . O

2000 CD O
update NN O
of IN O
recommendations NNS O
for IN O
the DT O
use NN O
of IN O
hematopoietic JJ B-Gene
colony NN I-Gene
- : I-Gene
stimulating JJ I-Gene
factors NNS I-Gene
: : O
evidence NN O
- : O
based VBN O
, , O
clinical JJ O
practice NN O
guidelines NNS O
. . O

Gamma NNP B-Gene
glutamyl JJ I-Gene
transpeptidase NN I-Gene
activity NN O
was VBD O
increased VBN O
up RB O
to TO O
15 CD O
times NNS O
above IN O
the DT O
upper JJ O
normal JJ O
limit NN O
in IN O
children NNS O
, , O
who WP O
received VBD O
aminopyrine NN O
for IN O
two CD O
weeks NNS O
or CC O
longer JJR O
. . O

Another DT O
sequence NN O
, , O
GGGXGGAG NNP O
, , O
which WDT O
is VBZ O
repeated VBN O
several JJ O
times NNS O
in IN O
many JJ O
polyomaviruses NNS O
and CC O
adenoviruses NNS O
, , O
and CC O
which WDT O
is VBZ O
thought VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
DNA NNP O
replication NN O
and CC O
/ NN O
or CC O
transcription NN O
, , O
is VBZ O
not RB O
found VBN O
in IN O
the DT O
JCV NNP O
sequence NN O
presented VBD O
. . O

A DT O
stable JJ O
heterologous JJ O
cell NN O
line NN O
containing VBG O
the DT O
mouse NN B-Gene
TRH NNP I-Gene
receptor NN I-Gene
was VBD O
constructed VBN O
by IN O
transfection NN O
of IN O
nonexcitable JJ O
293 CD O
cells NNS O
, , O
which WDT O
lack VBP O
L NNP O
channel NN O
activity NN O
. . O

Two CD O
classes NNS O
of IN O
Xanthomonas NNP O
pathogens NNS O
evading VBG O
Bs2 NNP O
host NN O
resistance NN O
and CC O
displaying VBG O
reduced JJ O
fitness NN O
were VBD O
found VBN O
to TO O
be VB O
specifically RB O
mutated VBN O
in IN O
avrBs2 NN B-Gene
. . O

Most JJS O
eukaryotic JJ O
mRNAs NN O
are VBP O
translated VBN O
by IN O
a DT O
"""" JJ O
scanning NN O
ribosome NN O
"""" NN O
mechanism NN O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
use NN O
of IN O
endogenous JJ O
creatinine JJ O
clearance NN O
to TO O
estimate VB O
the DT O
glomerular JJ O
filtration NN O
rate NN O
( ( O
GFR NNP O
) ) O
requires VBZ O
caution NN O
and CC O
the DT O
recognition NN O
of IN O
the DT O
limitations NNS O
of IN O
the DT O
method NN O
, , O
and CC O
that IN O
simpler JJR O
techniques NNS O
( ( O
serum JJ O
creatinine NN O
or CC O
estimated VBN O
endogenous JJ O
creatinine JJ O
clearance NN O
) ) O
are VBP O
preferable JJ O
in IN O
routine JJ O
practice NN O
. . O

All DT O
six CD O
ARF NNP B-Gene
cDNAs NN I-Gene
are VBP O
more JJR O
similar JJ O
to TO O
each DT O
other JJ O
than IN O
to TO O
other JJ O
approximately RB O
20 CD B-Gene
- : I-Gene
kDa NN I-Gene
guanine NN I-Gene
nucleotide IN I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

Overall JJ O
, , O
these DT O
findings NNS O
demonstrate VBP O
that IN O
mutations NNS O
E768D NNP O
and CC O
V804L NNP O
are VBP O
gain JJ O
- : O
of IN O
- : O
function NN O
mutations NNS O
that WDT O
confer VBP O
to TO O
the DT O
long JJ B-Gene
RET NNP I-Gene
isoform NN I-Gene
the DT O
capacity NN O
to TO O
exert VB O
a DT O
biological JJ O
effect NN O
, , O
although IN O
these DT O
mutations NNS O
are VBP O
more RBR O
weakly JJ O
activating NN O
than IN O
the DT O
MEN2A NNP B-Gene
and CC O
MEN2B NNP B-Gene
mutations NNS O
. . O

More RBR O
generally RB O
, , O
Ets1 NNP B-Gene
and CC O
Ets2 NNP B-Gene
could MD O
regulate VB O
transcription NN O
of IN O
cellular JJ O
genes NNS O
. . O

Sequencing VBG O
of IN O
a DT O
1 CD O
. . O
3 CD O
- : O
kilobase NN O
fragment NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
TSG6 NNP B-Gene
gene NN I-Gene
identified VBD O
TATA NNP O
- : O
like IN O
and CC O
CAAT NNP O
sequences NNS O
near IN O
the DT O
transcription NN O
start NN O
site NN O
. . O

Homozygous JJ O
mutation NN O
in IN O
two CD O
children NNS O
led VBD O
to TO O
amputation NN O
of IN O
legs NNS O
due JJ O
to TO O
purpura VB O
fulminans NNS O
. . O

Ecthyma NNP O
, , O
a DT O
known JJ O
disease NN O
, , O
of IN O
which WDT O
little JJ O
is VBZ O
known VBN O

In IN O
order NN O
to TO O
provide VB O
adequate JJ O
local JJ O
control NN O
without IN O
compromising VBG O
cosmetic JJ O
outcome NN O
, , O
the DT O
amount NN O
of IN O
breast NN O
tissue NN O
that WDT O
must MD O
be VB O
excised VBN O
in IN O
BCT NNP O
needs NNS O
to TO O
be VB O
individualized VBN O
. . O

Genetic JJ O
abnormalities NNS O
that WDT O
could MD O
lead VB O
to TO O
mutagenesis VB O
include VB O
chromosomal JJ O
abnormalities NNS O
and CC O
single JJ O
- : O
gene NN O
mutations NNS O
. . O

These DT O
intron NN O
chimeras NN O
show NN O
that IN O
peripheral JJ O
sequences NNS O
and CC O
the DT O
elements NNS O
that WDT O
define VBP O
the DT O
splice NN O
sites NNS O
are VBP O
adequate JJ O
for IN O
self JJ O
- : O
splicing NN O
activity NN O
but CC O
that IN O
the DT O
central JJ O
portions NNS O
containing VBG O
the DT O
catalytic JJ O
cores NNS O
of IN O
ai4 NN B-Gene
and CC O
bi4 NN B-Gene
are VBP O
deficient JJ O
; : O
these DT O
cores NNS O
are VBP O
the DT O
likely JJ O
targets NNS O
of IN O
the DT O
splicing NN O
proteins NNS O
. . O

Following VBG O
the DT O
observation NN O
that IN O
non JJ O
- : O
organ JJ O
- : O
specific JJ O
antibodies NNS O
are VBP O
related VBN O
with IN O
pregnancy NN O
loss NN O
and CC O
preeclampsia NN O
, , O
the DT O
role NN O
of IN O
organ JJ O
- : O
specific JJ O
antibodies NNS O
is VBZ O
currently RB O
being VBG O
extensively RB O
investigated VBN O
. . O

We PRP O
propose VBP O
that IN O
the DT O
reduced JJ O
responsiveness NN O
of IN O
CYP3A2 NNP B-Gene
is VBZ O
the DT O
result NN O
of IN O
preferential JJ O
binding NN O
of IN O
COUP NNP B-Gene
- : I-Gene
TF NN I-Gene
at IN O
the DT O
CYP3A2 NNP B-Gene
DexRE NNP I-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
. . O

In IN O
a DT O
stepwise NN O
logistic JJ O
regression NN O
analysis NN O
of IN O
SPT NNP O
and CC O
RAST NNP O
data NNS O
, , O
the DT O
occurrence NN O
of IN O
serum NN B-Gene
IgE NNP I-Gene
antibodies VBZ I-Gene
to TO I-Gene
P NNP I-Gene
. . I-Gene
orbiculare NN I-Gene
had VBD O
the DT O
highest JJS O
explanatory JJ O
value NN O
for IN O
current JJ O
eczema NN O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
is VBZ O
a DT O
redox JJ O
- : O
sensitive JJ O
transcription NN O
factor NN O
known VBN O
to TO O
be VB O
activated VBN O
by IN O
oxidative JJ O
stress NN O
as RB O
well RB O
as IN O
chemical NN O
and CC O
biological JJ O
reductants NNS O
. . O

The DT O
recombinant JJ O
enzymes NNS O
exist VBP O
as IN O
monomers NNS O
. . O

Renal NNP O
and CC O
extrarenal JJ O
arterial JJ O
fibromuscular JJ O
hyperplasia NN O
with IN O
hypertension NN O
. . O

Animal NNP O
studies NNS O
showed VBD O
that IN O
beam NN O
equalization NN O
significantly RB O
improved VBN O
fluoroscopic NN O
and CC O
angiographic JJ O
image NN O
quality NN O
. . O

Southwestern JJ O
blot NN O
analysis NN O
demonstrated VBD O
that IN O
this DT O
phosphoprotein NN O
can MD O
bind VB O
the DT O
kappa NN B-Gene
B NNP I-Gene
element NN I-Gene
directly RB O
and CC O
specifically RB O
. . O

A DT O
cohort NN O
of IN O
Swedish JJ O
children NNS O
was VBD O
monitored VBN O
from IN O
6 CD O
months NNS O
to TO O
11 CD O
years NNS O
of IN O
age NN O
. . O

The DT O
congenital NN O
forms NNS O
( ( O
7 CD O
cases NNS O
) ) O
all DT O
occurred VBD O
in IN O
female JJ O
infants NNS O
and CC O
involved VBD O
the DT O
mucosa NN O
overlying VBG O
either CC O
the DT O
anterior JJ O
ridge NN O
of IN O
the DT O
maxilla NN O
or CC O
the DT O
mandible JJ O
. . O

Although IN O
most JJS O
SH2 NNP B-Gene
- : O
pTyr NN B-Gene
interactions NNS O
occur VBP O
between IN O
two CD O
different JJ O
types NNS O
of IN O
molecules NNS O
, , O
some DT O
appear VBP O
to TO O
involve VB O
only RB O
a DT O
single JJ O
molecular JJ O
type NN O
. . O

Thus RB O
, , O
sgRNA2 NN B-Gene
has VBZ O
the DT O
3 CD O
' POS O
TE NNP O
in IN O
its PRP$ O
5 CD O
' POS O
UTR NNP O
. . O

Sequence NN O
conservation NN O
is VBZ O
greatest JJS O
for IN O
residues NNS O
located VBN O
near IN O
the DT O
active JJ O
centers NNS O
of IN O
the DT O
exo NN B-Gene
and CC O
pol NN B-Gene
domains NNS I-Gene
of IN O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
DNA NNP I-Gene
polymerase NN I-Gene
I PRP I-Gene
structure NN O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
the DT O
recently RB O
identified VBN O
isoforms NNS O
Vav2 NNP B-Gene
and CC O
Vav3 NNP B-Gene
, , O
which WDT O
are VBP O
broadly RB O
expressed VBN O
, , O
can MD O
couple VB O
with IN O
similar JJ O
classes NNS O
of IN O
receptors NNS O
, , O
nor CC O
is VBZ O
it PRP O
known IN O
whether IN O
all DT O
Vav NNP B-Gene
isoforms NNS I-Gene
possess JJ O
identical JJ O
functional JJ O
activities NNS O
. . O

On IN O
the DT O
diagnosis NN O
of IN O
bovine JJ O
leucosis NN O
and CC O
its PRP$ O
control NN O
in IN O
southern JJ O
Lower NNP O
Saxony NNP O

High JJ O
- : O
pressure NN O
effects NNS O
on IN O
ultrafast JJ O
- : O
relaxation NN O
kinetics NNS O
of IN O
excitons NNS O
in IN O
polydiacetylene NN O
4BCMU CD O
. . O

Effects NNS O
of IN O
verapamil NN O
and CC O
propranolol NN O
on IN O
early JJ O
afterdepolarizations NNS O
and CC O
ventricular JJ O
arrhythmias NNS O
induced VBN O
by IN O
epinephrine NN O
in IN O
congenital JJ O
long JJ O
QT NNP O
syndrome NN O
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
examine VB O
the DT O
antimicrobial JJ O
susceptibility NN O
to TO O
10 CD O
currently RB O
used VBN O
antimicrobial JJ O
agents NNS O
of IN O
50 CD O
strains NNS O
of IN O
P NNP O
. . O
acnes NNS O
isolated VBD O
from IN O
acne JJ O
lesions NNS O
and CC O
identified VBD O
using VBG O
a DT O
Rap NNP O
ID NNP O
ANA NNP O
II NNP O
panel NN O
. . O

Mental NNP O
development NN O
is VBZ O
generally RB O
normal JJ O
. . O

Sequences NNS O
needed VBN O
for IN O
iron NN O
- : O
regulated JJ O
expression NN O
of IN O
sid1 NN B-Gene
were VBD O
localized VBN O
to TO O
a DT O
306 CD O
bp JJ O
region NN O
mapping VBG O
2 CD O
. . O
3 CD O
and CC O
2 CD O
. . O
6 CD O
kb JJ O
upstream NN O
of IN O
the DT O
ATG NNP O
. . O

The DT O
average JJ O
coefficients NNS O
of IN O
correlation NN O
were VBD O
0 CD O
. . O
9998 CD O
and CC O
0 CD O
. . O
9993 CD O
for IN O
the DT O
QMF NNP O
and CC O
the DT O
QIT NNP O
system NN O
, , O
respectively RB O
. . O

This DT O
result NN O
supports VBZ O
the DT O
argument NN O
that IN O
the DT O
beta NN O
' POS O
subunit NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
determining VBG O
the DT O
progress NN O
of IN O
transcription NN O
elongation NN O
. . O

The DT O
E1 NNP B-Gene
gene NN I-Gene
is VBZ O
located VBN O
within IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
gene NN O
for IN O
RCC1 NNP B-Gene
, , O
a DT O
protein NN O
that WDT O
regulates VBZ O
onset IN O
of IN O
mitosis NN O
. . O

The DT O
other JJ O
element NN O
bound IN O
RBP NNP B-Gene
- : I-Gene
J NNP I-Gene
kappa VBZ I-Gene
with IN O
low JJ O
affinity NN O
. . O

The DT O
role NN O
of IN O
protein JJ B-Gene
kinase NNP I-Gene
C NNP I-Gene
signaling VBG O
in IN O
activated JJ O
DRA NNP B-Gene
transcription NN O
. . O

An DT O
open JJ O
reading NN O
frame NN O
of IN O
2862 CD O
bp NN O
encoding VBG O
a DT O
954 CD O
amino NN O
acid NN O
protein NN O
was VBD O
identified VBN O
. . O

Ten CD O
selenocysteine JJ O
residues NNS O
( ( O
deduced VBN O
) ) O
are VBP O
present JJ O
. . O

100 CD O
and CC O
14 CD O
p NN O
. . O

Pneumothorax NNP O
during IN O
laparoscopic JJ O
dissection NN O
of IN O
the DT O
diaphragmatic JJ O
hiatus NN O
. . O

The DT O
neuroleptic JJ O
- : O
induced JJ O
increase NN O
in IN O
central JJ O
DA NNP O
turnover NN O
( ( O
an DT O
indicator NN O
for IN O
the DT O
degree NN O
of IN O
DA NNP B-Gene
receptor NN I-Gene
blocking VBG O
) ) O
was VBD O
found VBN O
to TO O
be VB O
positively RB O
correlated VBN O
with IN O
the DT O
therapeutic JJ O
effect NN O
of IN O
neuroleptics NNS O
and CC O
the DT O
development NN O
of IN O
hypokinetic JJ O
- : O
rigid JJ O
symptoms NNS O
. . O

Selective JJ O
stimulation NN O
of IN O
central JJ O
alpha SYM B-Gene
- : I-Gene
autoreceptors NNS I-Gene
following VBG O
treatment NN O
with IN O
alpha JJ O
- : O
methyldopa NN O
and CC O
FLA NNP O
136 CD O
. . O

The DT O
effect NN O
of IN O
calcitonin NN B-Gene
, , O
a DT O
large JJ O
amount NN O
of IN O
calcium NN O
given VBN O
orally RB O
, , O
pentagastrin NN O
and CC O
glucagon NN B-Gene
on IN O
plasma NN O
47Ca CD O
radioactivity NN O
curves NNS O
in IN O
subjects NNS O
pretreated VBN O
with IN O
47Ca CD O
was VBD O
examined VBN O
. . O

Taken VBN O
together RB O
, , O
the DT O
results NNS O
suggest VBP O
that IN O
chlorphentermine NN O
may MD O
be VB O
capable JJ O
of IN O
producing VBG O
dual JJ O
stimulus NN O
effects NNS O
in IN O
animals NNS O
. . O

The DT O
malignity NN O
of IN O
nevoid JJ O
lentigo NN O
. . O

Tetrad NNP O
analysis NN O
and CC O
mitotic JJ O
recombination NN O
experiments NNS O
localized VBD O
the DT O
PEP4 NNP B-Gene
gene NN I-Gene
proximal NN O
to TO O
GAL4 NNP B-Gene
on IN O
chromosome NN O
XVI NN O
. . O

Two CD O
Lab NNP O
8 CD O
computer NN O
programmes NNS O
for IN O
use NN O
in IN O
the DT O
study NN O
of IN O
the DT O
isometric JJ O
and CC O
isotonic JJ O
contractile NN O
characteristics NNS O
of IN O
skeletal JJ O
muscle NN O
. . O

Pharmacokinetics NNS O
of IN O
FK NNP O
506 CD O
in IN O
transplant JJ O
patients NNS O
. . O

As IN O
the DT O
length NN O
of IN O
the DT O
fatty JJ O
acid NN O
decreased VBN O
, , O
the DT O
binding NN O
affinity NN O
was VBD O
reduced VBN O
; : O
myristic JJ O
acid NN O
( ( O
14 CD O
: : O
0 CD O
) ) O
bound NN O
with IN O
a DT O
K NNP O
( ( O
d NN O
) ) O
of IN O
1409 CD O
+ NNP O
/ NNP O
- : O
423 CD O
nM NN O
, , O
but CC O
medium SYM O
- : O
chain NN O
( ( O
decanoic JJ O
acid NN O
, , O
10 CD O
: : O
0 CD O
) ) O
and CC O
short JJ O
- : O
chain NN O
( ( O
octanoic JJ O
acid NN O
, , O
8 CD O
: : O
0 CD O
) ) O
lipids NNS O
were VBD O
not RB O
bound VBN O
at IN O
all DT O
. . O

Persistent NNP O
acantholytic JJ O
dermatosis NN O
with IN O
increased JJ O
light NN O
sensitivity NN O

Magnetic JJ O
resonance NN O
spectroscopy NN O
( ( O
MRS NNP O
) ) O
and CC O
imaging VBG O
( ( O
MRI NNP O
) ) O
are VBP O
now RB O
well RB O
established VBN O
techniques NNS O
for IN O
the DT O
study NN O
of IN O
cellular JJ O
metabolism NN O
and CC O
gross JJ O
structure NN O
of IN O
muscle NN O
. . O

However RB O
, , O
2 CD O
minimum JJ O
alveolar JJ O
concentration NN O
anesthesia NN O
did VBD O
significantly RB O
decrease VB O
the DT O
calculated JJ O
VE NNP O
at IN O
a DT O
PCO2 NNP O
of IN O
60 CD O
mmHg NNS O
( ( O
from IN O
7 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
2 CD O
to TO O
4 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
l NN O
. . O
min SYM O
- : O
1 CD O
) ) O
, , O
indicating VBG O
a DT O
rightward NN O
shift NN O
in IN O
the DT O
response NN O
relationship NN O
. . O

One CD O
maternal JJ O
death NN O
, , O
reduced VBD O
body NN O
weight NN O
, , O
and CC O
reduced VBD O
weight JJ O
gain NN O
were VBD O
noted VBN O
at IN O
the DT O
high JJ O
dose NN O
; : O
confirmed JJ O
pregnancy NN O
rates NNS O
were VBD O
84 CD O
to TO O
100 CD O
% NN O
for IN O
each DT O
group NN O
. . O

Pulmonary JJ O
arterial JJ O
pressure NN O
and CC O
structure NN O
in IN O
the DT O
patas NNS O
monkey NN O
after IN O
prolonged JJ O
administration NN O
of IN O
aminorex JJ O
fumarate NN O
. . O

Transient JJ O
overexpression NN O
of IN O
mutant JJ B-Gene
EphB1 NNP I-Gene
receptors NNS I-Gene
( ( O
Y594F NNP O
) ) O
blocked VBD O
Nck NNP B-Gene
recruitment NN O
to TO O
EphB1 NNP B-Gene
, , O
attenuated VBD O
downstream NN O
JNK NNP B-Gene
activation NN O
, , O
and CC O
blocked VBD O
cell NN O
attachment NN O
responses NNS O
. . O

Overexpression NN O
of IN O
the DT O
bZip NN O
interaction NN O
domain NN O
of IN O
CBP NNP B-Gene
specifically RB O
abolishes VBZ O
the DT O
positive JJ O
cross NN O
talk NN O
between IN O
TR NNP B-Gene
and CC O
p45 VB B-Gene
/ NNP O
NF NNP B-Gene
- : I-Gene
E2 NN I-Gene
. . O

High JJ O
- : O
frequency NN O
electrical JJ O
stimulation NN O
in IN O
the DT O
hippocampus NN O
leads VBZ O
to TO O
an DT O
increase NN O
in IN O
synaptic JJ O
efficacy NN O
that WDT O
lasts VBZ O
for IN O
many JJ O
hours NNS O
. . O

Drug NNP O
- : O
drug NN O
interactions NNS O
are VBP O
most RBS O
likely JJ O
to TO O
occur VB O
in IN O
patients NNS O
receiving VBG O
multiple JJ O
medications NNS O
and CC O
with IN O
drugs NNS O
that WDT O
have VBP O
a DT O
narrow JJ O
therapeutic JJ O
window NN O
. . O

In IN O
sixteen JJ O
patients NNS O
with IN O
moderate JJ O
essential JJ O
hypertension NN O
the DT O
effects NNS O
of IN O
10 CD O
- : O
day NN O
nifedipine JJ O
treatment NN O
on IN O
serum NN O
uric JJ O
acid NN O
and CC O
renal JJ O
excretion NN O
of IN O
uric JJ O
acid NNS O
were VBD O
evaluated VBN O
. . O

Ciprofloxacin NN O
: : O
an DT O
overview NN O
of IN O
adverse JJ O
experiences NNS O
. . O

In IN O
an DT O
ongoing JJ O
study NN O
the DT O
performance NN O
of IN O
the DT O
SMSP NNP O
is VBZ O
being VBG O
compared VBN O
with IN O
that DT O
of IN O
the DT O
Mini NNP O
Speech NNP O
Processor NNP O
( ( O
MSP NNP O
) ) O
. . O

The DT O
second JJ O
transcriptional JJ O
unit NN O
, , O
designated VBN O
UL26 NNP B-Gene
. . I-Gene
5 CD I-Gene
, , O
predicted VBD O
to TO O
specify VB O
a DT O
protein NN O
of IN O
329 CD O
amino NN O
acids NNS O
, , O
encodes VBZ O
the DT O
family NN B-Gene
35 CD I-Gene
proteins NNS I-Gene
; : O
it PRP O
is VBZ O
transcribed VBN O
by IN O
an DT O
mRNA NN O
which WDT O
initiates VBZ O
at IN O
approximately RB O
nucleotide JJ O
+ JJ O
1000 CD O
of IN O
the DT O
UL26 NNP B-Gene
transcription NN O
initiation NN O
site NN O
and CC O
is VBZ O
translated VBN O
from IN O
the DT O
methionine NN O
initiation NN O
codon NN O
located VBN O
at IN O
position NN O
+ NN O
1099 CD O
of IN O
the DT O
UL26 NNP B-Gene
transcriptional JJ I-Gene
unit NN I-Gene
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
the DT O
cooperation NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
essential JJ O
for IN O
transactivation NN O
of IN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
gene NN I-Gene
by IN O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
Tax VBP I-Gene
. . O

Using VBG O
this DT O
reporter NN O
gene NN O
system NN O
, , O
we PRP O
previously RB O
showed VBD O
that IN O
EPO NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
fos JJ I-Gene
promoter NN I-Gene
can MD O
be VB O
detected VBN O
rapidly RB O
and CC O
sensitively RB O
as IN O
an DT O
elevation NN O
of IN O
cellular JJ B-Gene
luciferase NN I-Gene
activity NN O
. . O

The DT O
findings NNS O
are VBP O
discussed VBN O
in IN O
the DT O
context NN O
of IN O
known JJ O
properties NNS O
of IN O
cortical JJ O
- : O
bar NN O
detectors NNS O
. . O

This DT O
observation NN O
calls VBZ O
for IN O
careful JJ O
monitoring NN O
of IN O
calcium NN O
and CC O
alkaline JJ B-Gene
phosphatase NN I-Gene
values NNS O
and CC O
possible JJ O
adjustments NNS O
of IN O
vitamin NN O
D NNP O
intake NN O
when WRB O
fortifiers NNS O
are VBP O
used VBN O
for IN O
extended JJ O
periods NNS O
. . O

Morphologic NNP O
variables NNS O
included VBD O
cancer NN O
volume NN O
, , O
histologic JJ O
grade NN O
, , O
capsular JJ O
penetration NN O
, , O
seminal JJ O
vesicle NN O
invasion NN O
, , O
and CC O
lymph JJ O
node JJ O
metastasis NN O
. . O

From IN O
Pap NNP O
to TO O
ApUp NNP O
. . O

The DT O
susceptibility NN O
of IN O
Aspergillus NNP O
fumigatus NN O
to TO O
mulundocandin VB O
, , O
an DT O
echinocandin JJ O
- : O
like IN O
compound NN O
, , O
and CC O
other JJ O
antifungal JJ O
agents NNS O
was VBD O
assessed VBN O
by IN O
the DT O
National NNP O
Committee NNP O
for IN O
Clinical NNP O
Laboratory NNP O
Standards NNP O
( ( O
NCCLS NNP O
) ) O
M38 NNP O
- : O
P NNP O
method NN O
, , O
a DT O
2 CD O
, , O
3 CD O
- : O
bis NN O
( ( O
2 CD O
- : O
methoxy NN O
- : O
4 CD O
- : O
nitro NN O
- : O
5 CD O
- : O
sulfophenyl NN O
) ) O
- : O
5 CD O
- : O
[ NN O
( ( O
phenyl JJ O
- : O
amino NN O
) ) O
carbonyl NN O
] SYM O
- : O
2H CD O
- : O
tetrazolium NN O
hydroxide NN O
( ( O
XTT NNP O
) ) O
- : O
based VBN O
colorimetric JJ O
assay NN O
, , O
and CC O
determination NN O
of IN O
morphologic JJ O
alterations NNS O
by IN O
microscopy NN O
. . O

Multiple JJ O
regression NN O
analyses NNS O
revealed VBD O
that IN O
WAIS NNP O
- : O
R NNP O
factor NN O
scores NNS O
Verbal NNP O
Comprehension NNP O
and CC O
Freedom NNP O
from IN O
Distractibility NNP O
accounted VBD O
for IN O
up IN O
to TO O
42 CD O
% NN O
of IN O
the DT O
variance NN O
in IN O
WMS NNP O
- : O
R NN O
and CC O
CVLT NNP O
indices NNS O
. . O

Determination NN O
of IN O
20 CD O
alpha JJ O
- : O
hydroxy NN O
- : O
9 CD O
beta NN O
, , O
10 CD O
alpha SYM O
- : O
pregna NN O
- : O
4 CD O
, , O
6 CD O
- : O
dien NN O
- : O
3 CD O
- : O
one NN O
in IN O
plasma NN O
by IN O
selected VBN O
ion NN O
monitoring NN O
. . O

Our PRP$ O
study NN O
reveals NNS O
that IN O
the DT O
modular JJ O
structure NN O
of IN O
the DT O
FSH NNP B-Gene
receptor NN I-Gene
gene NN O
generates NNS O
motifs VBP O
that IN O
allows VBZ O
coupling VBG O
to TO O
different JJ O
effectors NNS O
. . O

Homo NNP O
- : O
oligomerisation NN O
and CC O
nuclear JJ O
localisation NN O
of IN O
mouse NN B-Gene
histone NN I-Gene
deacetylase NN I-Gene
1 CD I-Gene
. . O

Ariga NNP O
, , O
Biochem NNP O
. . O

However RB O
, , O
mechanisms NNS O
underlying VBG O
HIV NNP O
- : O
1 CD O
gene NN O
expression NN O
in IN O
the DT O
CNS NNP O
are VBP O
poorly RB O
understood JJ O
. . O

Different JJ O
sequence NN O
elements NNS O
of IN O
both DT O
the DT O
retroviral JJ O
vectors NNS O
and CC O
the DT O
c JJ B-Gene
- : I-Gene
myc NN I-Gene
gene NN I-Gene
recombined VBD O
during IN O
genesis NN O
of IN O
highly RB O
oncogenic JJ O
retroviruses NNS O
CMII NNP O
, , O
MC29 NNP O
, , O
or CC O
MH2 NNP O
. . O

Ten CD O
weeks NNS O
after IN O
reconstruction NN O
, , O
the DT O
regenerating VBG O
nerves NNS O
already RB O
resembled VBN O
normal JJ O
nerves NNS O
. . O

Of IN O
these DT O
sites NNS O
, , O
PEA3 NNP B-Gene
and CC O
STAT NNP B-Gene
contributed VBD O
specifically RB O
to TO O
induction NN O
by IN O
v JJ B-Gene
- : I-Gene
src NN I-Gene
, , O
whereas IN O
the DT O
remaining VBG O
elements NNS O
were VBD O
also RB O
involved VBN O
in IN O
induction NN O
by IN O
the DT O
phorbol NN O
ester NN O
phorbol NN O
myristate NN O
acetate NN O
( ( O
PMA NNP O
) ) O
. . O

Results NNS O
from IN O
transient JJ O
assays NNS O
using VBG O
these DT O
mutants NNS O
showed VBD O
that IN O
the DT O
DE1 NNP O
received VBD O
signals NNS O
from IN O
phytochromes NNS B-Gene
A NNP I-Gene
and CC I-Gene
B NNP I-Gene
, , O
demonstrating VBG O
that IN O
this DT O
element NN O
is VBZ O
indeed RB O
a DT O
light JJ O
- : O
responsive JJ O
element NN O
. . O

Gel NNP O
retardation NN O
assays NNS O
detected VBD O
ZiaR NNP B-Gene
- : O
dependent NN O
complexes NNS O
forming VBG O
with IN O
the DT O
zia NN B-Gene
operator NN I-Gene
- : I-Gene
promoter NN I-Gene
and CC O
ZiaR NNP B-Gene
- : O
DNA NN O
binding NN O
was VBD O
enhanced VBN O
by IN O
treatment NN O
with IN O
a DT O
metal NN O
- : O
chelator NN O
in IN O
vitro NN O
. . O

Consistent JJ O
with IN O
a DT O
possible JJ O
role NN O
in IN O
transcription NN O
, , O
Paf1p NNP B-Gene
is VBZ O
localized VBN O
to TO O
the DT O
nucleus NN O
. . O

Serial JJ O
levels NNS O
of IN O
troponin NN B-Gene
T NNP I-Gene
and CC O
the DT O
activity NN O
of IN O
CK NNP B-Gene
- : I-Gene
MB NN I-Gene
were VBD O
measured VBN O
6 CD O
, , O
12 CD O
, , O
24 CD O
and CC O
48 CD O
h NN O
after IN O
aortic JJ O
unclamping NN O
. . O

The DT O
growth NN O
of IN O
Aer NNP O
. . O
hydrophila NN O
in IN O
filter NN O
- : O
sterilized VBN O
lettuce NN O
extract NN O
was VBD O
completely RB O
inhibited VBN O
by IN O
0 CD O
. . O
1 CD O
% NN O
( ( O
v JJ O
/ NNP O
v NN O
) ) O
BMC NNP O
whereas VBP O
that IN O
of IN O
Ps NNP O
. . O
fluorescens NNS O
was VBD O
not RB O
significantly RB O
affected VBN O
by IN O
1 CD O
% NN O
( ( O
v JJ O
/ NNP O
v NN O
) ) O
BMC NNP O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
the DT O
telomeres NNS O
of IN O
the DT O
two CD O
nuclei NNS O
have VBP O
different JJ O
functions NNS O
. . O

Ki NNP B-Gene
- : I-Gene
ras NN I-Gene
and CC O
p53 NN B-Gene
mutations NNS I-Gene
in IN O
pancreatic JJ O
ductal JJ O
adenocarcinoma NN O
. . O

Perceptions NNS O
of IN O
illness JJ O
intrusiveness NN O
were VBD O
significantly RB O
higher JJR O
when WRB O
both DT O
muscle NN O
cramp NN O
and CC O
headache NN O
symptoms NNS O
occurred VBD O
during IN O
one CD O
or CC O
more JJR O
assessment JJ O
intervals NNS O
as IN O
compared VBN O
to TO O
when WRB O
muscle NN O
cramps NNS O
or CC O
headaches NNS O
, , O
only RB O
, , O
occurred VBD O
. . O

The DT O
maximum JJ O
stress NN O
due JJ O
to TO O
the DT O
hygroscopic NN O
examination NN O
of IN O
the DT O
composite NN O
was VBD O
0 CD O
. . O
74 CD O
kg JJ O
/ NN O
mm2 NN O
at IN O
equilibrium NN O
of IN O
the DT O
water NN O
absorbed NN O
of IN O
the DT O
composite NN O
. . O

Transient JJ O
transfection NN O
assays NNS O
showed VBD O
that IN O
site NN O
A DT O
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
RXR NNP B-Gene
alpha SYM I-Gene
- : O
mediated VBN O
transactivation NN O
of IN O
the DT O
apoAI JJ B-Gene
gene NN I-Gene
basal NN I-Gene
promoter NN I-Gene
in IN O
human JJ O
hepatoma NN O
HepG2 NNP O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
RA NNP O
and CC O
that IN O
this DT O
transactivation NN O
is VBZ O
abolished VBN O
by IN O
increasing VBG O
amounts NNS O
of IN O
cotransfected VBN O
ARP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

OBJECTIVE NN O
: : O
To TO O
determine VB O
whether IN O
administration NN O
of IN O
misoprostol JJ O
prevents NNS O
gastric JJ O
hemorrhage NN O
in IN O
healthy JJ O
dogs NNS O
treated VBN O
with IN O
high JJ O
doses NNS O
of IN O
methylprednisolone NN O
sodium NN O
succinate NN O
( ( O
MPSS NNP O
) ) O
. . O

Tobramycin $ O
60 CD O
mg NN O
did VBD O
not RB O
show VB O
any DT O
remarkable JJ O
effect NN O
, , O
but CC O
dibecacin VBZ O
100 CD O
mg NN O
produced VBD O
a DT O
slight JJ O
potentiating VBG O
effect NN O
on IN O
the DT O
action NN O
of IN O
d NN O
- : O
tubocurarine NN O
. . O

AF NNP B-Gene
showed VBD O
a DT O
mixed JJ O
nuclear JJ O
/ JJ O
cytoplasmic JJ O
pattern NN O
of IN O
expression NN O
in IN O
the DT O
epithelial JJ O
, , O
endothelial JJ O
, , O
and CC O
stromal JJ O
component NN O
of IN O
the DT O
normal JJ O
breast NN O
and CC O
benign JJ O
lesions NNS O
, , O
whereas IN O
an DT O
impressive JJ O
loss NN O
of IN O
AF NNP B-Gene
expression NN O
was VBD O
noted VBN O
in IN O
in IN O
situ NN O
and CC O
invasive JJ O
breast NN O
cancer NN O
and CC O
tumoral JJ O
stroma NN O
. . O

For IN O
each DT O
night NN O
, , O
the DT O
diary NN O
allowed VBD O
the DT O
subjective JJ O
measurement NN O
of IN O
bedtime NN O
, , O
wake NN O
time NN O
, , O
time NN O
in IN O
bed NN O
( ( O
TIB NNP O
) ) O
, , O
sleep JJ O
efficiency NN O
, , O
number NN O
of IN O
minutes NNS O
of IN O
wake NN O
after IN O
sleep JJ O
onset NN O
( ( O
WASO NNP O
) ) O
, , O
alertness RB O
on IN O
awakening NN O
, , O
and CC O
percentage NN O
of IN O
morning NN O
needing VBG O
an DT O
alarm NN O
( ( O
or CC O
a DT O
person NN O
functioning VBG O
as IN O
one CD O
) ) O
. . O

The DT O
rat NN O
incisor NN O
is VBZ O
an DT O
excellent JJ O
model NN O
system NN O
in IN O
which WDT O
to TO O
study VB O
amelgenesis NN O
. . O

The DT O
measurement NN O
of IN O
the DT O
areas NNS O
of IN O
fibrin NN B-Gene
, , O
of IN O
tissue NN O
and CC O
fibrinolysis NN O
, , O
at IN O
the DT O
above NN O
mentioned VBD O
times NNS O
, , O
has VBZ O
been VBN O
effected VBN O
at IN O
standard JJ O
magnification NN O
( ( O
15 CD O
X NN O
) ) O
by IN O
an DT O
image NN O
analyser NN O
( ( O
Videoplan NNP O
) ) O
scale VBD O
1 CD O
: : O
8 CD O
. . O

Transcriptional JJ O
regulation NN O
of IN O
the DT O
yeast NN B-Gene
PHO8 NNP I-Gene
promoter NN I-Gene
in IN O
comparison NN O
to TO O
the DT O
coregulated VBN O
PHO5 NNP B-Gene
promoter NN I-Gene
. . O

Clinical JJ O
and CC O
angiographic JJ O
examinations NNS O
in IN O
occlusion NN O
disease NN O
of IN O
the DT O
great JJ O
intestinal JJ O
arteries NNS O

Transcription NN O
from IN O
adenovirus NN B-Gene
E2 NNP I-Gene
- : I-Gene
early JJ I-Gene
promoter NN I-Gene
is VBZ O
controlled VBN O
by IN O
a DT O
unique JJ O
array NN O
of IN O
four CD O
cis NN O
- : O
acting NN O
elements NNS O
which WDT O
include VBP O
an DT O
atypical JJ O
TBP NNP B-Gene
site NN I-Gene
, , O
two CD O
E2F NNP B-Gene
sites NNS I-Gene
present VBP O
in IN O
an DT O
inverted JJ O
orientation NN O
relative NN O
to TO O
each DT O
other JJ O
, , O
and CC O
an DT O
ATF NNP B-Gene
site NN I-Gene
. . O

Despite IN O
the DT O
absence NN O
of IN O
exercise NN O
- : O
induced VBN O
asthma NN O
( ( O
EIA NNP O
) ) O
while IN O
breathing VBG O
WH NNP O
air NN O
, , O
asthmatic JJ O
patients NNS O
still RB O
had VBD O
significantly RB O
higher JJR O
mean JJ O
GH NNP O
increments NNS O
than IN O
normal JJ O
subjects NNS O
( ( O
9 CD O
. . O
2 CD O
vs JJ O
2 CD O
. . O
3 CD O
ng JJ O
/ NNP O
ml NN O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Both DT O
EWS NNP B-Gene
- : O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
function NN O
as IN O
transcription NN O
factors NNS O
that WDT O
bind VBP O
specifically RB O
to TO O
ets NNS B-Gene
sequences NNS O
( ( O
the DT O
ets NNS B-Gene
boxes NNS O
) ) O
present VBP O
in IN O
promoter NN O
elements NNS O
. . O

Deletion NNP O
analyses NNS O
of IN O
the DT O
pCD41 NN B-Gene
ORF NNP I-Gene
- : I-Gene
A DT I-Gene
and CC O
the DT O
use NN O
of IN O
promoter NN O
constructs NNS O
further RBR O
mapped VBD O
an DT O
internal JJ O
functional JJ O
promoter NN O
within IN O
the DT O
pCD41 NN B-Gene
sequence NN I-Gene
that WDT O
can MD O
direct VB O
the DT O
synthesis NN O
of IN O
the DT O
trans NNS O
- : O
activating VBG O
protein NN O
. . O

Mean NNP O
+ NNP O
/ NNP O
- : O
SD NNP O
serum NN B-Gene
VEGF NNP I-Gene
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
in IN O
women NNS O
with IN O
PCO NNP O
and CC O
PCOS NNP O
( ( O
3 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
and CC O
3 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
66 CD O
ng JJ O
/ NNP O
ml NNP O
respectively RB O
) ) O
compared VBN O
with IN O
women NNS O
with IN O
normal JJ O
ovaries NNS O
( ( O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
. . O

CONCLUSION NN O
: : O
TNF NNP B-Gene
alpha NN I-Gene
, , O
TGF NNP B-Gene
beta NN I-Gene
, , O
PDGF NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
increased VBD O
LDLr NNP B-Gene
gene NN I-Gene
expression NN O
by IN O
increasing VBG O
sterol NN O
- : O
independent JJ O
and CC O
mitogenesis JJ O
- : O
independent JJ O
gene NN O
transcription NN O
. . O

SETTING NN O
: : O
University NNP O
of IN O
Paris NNP O
VII NNP O
hospital NN O
. . O
Patient NNP O
( ( O
s NN O
) ) O
: : O
Nine JJ O
women NNS O
had VBD O
embolization NN O
for IN O
symptomatic JJ O
myoma NN O
, , O
with IN O
12 CD O
pregnancies NNS O
observed VBN O
. . O

According VBG O
to TO O
Sugiura NNP O
' POS O
s NN O
classification NN O
, , O
they PRP O
consisted VBD O
of IN O
Type NNP O
Ia NNP O
in IN O
63 CD O
% NN O
, , O
Type NNP O
Ib NNP O
in IN O
11 CD O
% NN O
, , O
Type NNP O
II NNP O
in IN O
11 CD O
% NN O
, , O
and CC O
Type NNP O
III NNP O
in IN O
16 CD O
% NN O
. . O

The DT O
deduced JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
LvUSF2 NNP B-Gene
is VBZ O
nearly RB O
identical JJ O
to TO O
LvUSF1 NNP B-Gene
except IN O
at IN O
the DT O
amino JJ O
end NN O
, , O
where WRB O
they PRP O
are VBP O
sharply RB O
divergent JJ O
. . O

Sequencing VBG O
of IN O
the DT O
three CD O
pag SYM B-Gene
- : I-Gene
3 CD I-Gene
alleles NNS I-Gene
showed VBD O
that IN O
two CD O
apparent JJ O
null JJ O
alleles NNS O
encode VBP O
a DT O
nonsense JJ O
mutation NN O
before IN O
the DT O
zinc NN O
fingers NNS O
and CC O
a DT O
missense JJ O
mutation NN O
in IN O
the DT O
fourth JJ O
zinc NN O
finger NN O
that WDT O
changes VBZ O
a DT O
coordinating NN O
histidine NN O
to TO O
a DT O
tyrosine NN O
. . O

Both DT O
can MD O
be VB O
elevated VBN O
on IN O
a DT O
single JJ O
vascular NN O
pedicle NN O
based VBN O
on IN O
the DT O
superficial JJ O
temporal JJ O
artery NN O
, , O
the DT O
double JJ O
- : O
layered JJ O
temporal JJ O
fascia NN O
flap NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
RA NNP O
- : O
mediated VBD O
repression NN O
of IN O
the DT O
hMGP NN B-Gene
gene NN I-Gene
is VBZ O
due JJ O
to TO O
binding VBG O
of IN O
liganded JJ O
RAR NNP B-Gene
/ NNP O
RXR NNP B-Gene
to TO O
a DT O
novel JJ O
negative JJ O
RA NNP O
response NN O
element NN O
. . O

The DT O
conditions NNS O
for IN O
obtaining VBG O
titanium NN O
dioxide NN O
from IN O
the DT O
substrates NNS O
titanium VBP O
tetrachloride NN O
and CC O
oxygen NN O
and CC O
applying VBG O
this DT O
to TO O
a DT O
surgical JJ O
stainless NN O
steel NN O
of IN O
the DT O
type NN O
316L CD O
by IN O
the DT O
plasma NN O
assisted VBD O
chemical JJ O
vapour CD O
deposition NN O
method NN O
have VBP O
been VBN O
determined VBN O
. . O

Changes NNS O
in IN O
stimulation NN O
levels NNS O
over IN O
time NN O
in IN O
nucleus JJ O
22 CD O
cochlear JJ O
implant JJ O
users NNS O
. . O

The DT O
gonadotrope NN O
- : O
specific NN O
and CC O
regulated JJ O
expression NN O
of IN O
the DT O
GnRH NNP B-Gene
receptor NN I-Gene
( ( O
GnRH NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
gene NN O
is VBZ O
dependent JJ O
on IN O
multiple JJ O
transcription NN O
factors NNS O
that IN O
interact NN O
with IN O
the DT O
noncanonical JJ B-Gene
GnRH NNP I-Gene
- : I-Gene
R NN I-Gene
activating VBG I-Gene
sequence NN I-Gene
( ( O
GRAS NNP B-Gene
) ) O
, , O
the DT O
activator NN B-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
element NN O
, , O
and CC O
the DT O
steroidogenic JJ B-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
binding NN O
site NN O
. . O

Oscilloscope NNP O
triggering VBG O
circuit NN O
for IN O
recording VBG O
long JJ O
transients NNS O
at IN O
fast JJ O
sweep NN O
speeds NNS O
. . O

SFP NNP O
was VBD O
significantly RB O
elevated VBN O
in IN O
Hn NNP O
( ( O
s NN O
) ) O
. . O

We PRP O
exploit VBP O
the DT O
properties NNS O
of IN O
LexA NNP B-Gene
fusion NN I-Gene
proteins NNS I-Gene
to TO O
study VB O
the DT O
dimerization NN O
and CC O
DNA NNP O
- : O
contacting NN O
domains NNS O
of IN O
cRel NN B-Gene
. . O

The DT O
inferred JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
cyanobacterial JJ B-Gene
HemB NNP I-Gene
protein NN I-Gene
indicates VBZ O
a DT O
significant JJ O
difference NN O
in IN O
the DT O
metal NN O
cofactor NN O
requirement NN O
from IN O
the DT O
higher JJR O
- : O
plant NN O
enzymes NNS O
, , O
which WDT O
was VBD O
confirmed VBN O
by IN O
overexpression NN O
and CC O
biochemical JJ O
analysis NN O
. . O

Ea NNP O
value NN O
was VBD O
calculated VBN O
as IN O
the DT O
ratio NN O
of IN O
the DT O
steady JJ O
- : O
state NN O
end NN O
- : O
systolic JJ O
aortic JJ O
pressure NN O
( ( O
ESAP NNP O
) ) O
to TO O
stroke VB O
volume NN O
( ( O
thermodilution NN O
) ) O
. . O

We PRP O
cloned VBD O
and CC O
sequenced VBD O
the DT O
cDNAs NN O
against IN O
genomic JJ O
RNA NNP O
and CC O
mRNA NN O
for IN O
phosphoprotein NN B-Gene
( ( I-Gene
P NNP I-Gene
) ) I-Gene
of IN O
human JJ O
parainfluenza NN O
type NN O
2 CD O
virus NN O
( ( O
PIV NNP O
- : O
2 CD O
) ) O
. . O

cDNA NN O
clone NN O
from IN O
genomic JJ O
RNA NNP O
was VBD O
1439 CD O
nucleotides NNS O
in IN O
length NN O
excluding VBG O
poly NN O
( ( O
A DT O
) ) O
and CC O
was VBD O
found VBN O
to TO O
have VB O
two CD O
small JJ O
open JJ O
reading NN O
frames NNS O
encoding VBG O
proteins NNS O
of IN O
233 CD O
and CC O
249 CD O
amino NN O
acids NNS O
. . O

The DT O
predicted JJ O
molecular JJ O
weight NN O
of IN O
the DT O
polyprotein NN O
encoded VBN O
by IN O
ORF1 NNP O
is VBZ O
33 CD O
kilodaltons NNS O
( ( O
kDa NN O
) ) O
. . O

Osteocalcin NNP B-Gene
( ( O
OC NNP B-Gene
) ) O
is VBZ O
a DT O
matrix JJ B-Gene
calcium NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
expressed VBN O
in IN O
osteoblasts NNS O
and CC O
odontoblasts NNS O
undergoing VBG O
mineralization NN O
. . O

Transcriptional JJ O
activation NN O
of IN O
the DT O
chicken NN B-Gene
lysozyme NN I-Gene
gene NN I-Gene
by IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
Bp65 NNP I-Gene
( ( O
RelA NNP B-Gene
) ) O
and CC O
c SYM B-Gene
- : I-Gene
Rel NN I-Gene
, , O
but CC O
not RB O
by IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
Bp50 NNP I-Gene
. . O

Incidences NNS O
of IN O
nonfatal JJ O
stroke NN O
, , O
myocardial JJ O
infarction NN O
, , O
angina JJ O
pectoris NN O
und NN O
left VBD O
ventricular JJ O
hypertrophy NN O
could MD O
also RB O
be VB O
lowered VBN O
. . O

Both DT O
promoters NNS O
lack VBP O
a DT O
TATA NNP O
box NN O
, , O
and CC O
Pint NNP B-Gene
belongs NNS O
to TO O
the DT O
MED NNP B-Gene
- : I-Gene
1 CD I-Gene
class NN O
of IN O
promoters NNS O
, , O
which WDT O
initiate VBP O
transcription NN O
at IN O
multiple JJ O
sites NNS O
. . O

High JJ O
plasma NN B-Gene
AVP NNP I-Gene
levels NNS O
observed VBN O
in IN O
the DT O
two CD O
cases NNS O
suggest VBP O
that IN O
SSRIs NNP O
stimulate VBP O
AVP NNP B-Gene
secretion NN O
, , O
thereby RB O
causing VBG O
SIADH NNP O
. . O

C NNP O
- : O
SP NNP O
duration NN O
was VBD O
significantly RB O
reduced VBN O
in IN O
ALS NNP O
patients NNS O
compared VBN O
to TO O
controls NNS O
at IN O
low JJ O
stimulation NN O
intensity NN O
corresponding VBG O
to TO O
an DT O
MEP NNP O
threshold NN O
increased VBN O
by IN O
15 CD O
% NN O
. . O

Copyright JJ O
1999 CD O
Academic NNP O
Press NNP O
. . O

Overall JJ O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
resistant JJ O
genotypes NNS O
exist VBP O
among IN O
the DT O
WAD NNP O
goat NN O
population NN O
. . O

At IN O
60 CD O
days NNS O
the DT O
amount NN O
of IN O
gangliosides NNS O
was VBD O
on IN O
average JJ O
lower JJR O
in IN O
females NNS O
than IN O
in IN O
males NNS O
, , O
even RB O
if IN O
with IN O
some DT O
exception NN O
. . O

Purified NNP O
PLB NNP B-Gene
showed VBD O
optimal JJ O
lyase NN B-Gene
activity NN O
at IN O
pH NN O
10 CD O
. . O
0 CD O
. . O

Experimental JJ O
pancreatitis NN O
in IN O
pigs NNS O
. . O

A DT O
prerequisite NN O
for IN O
the DT O
synthesis NN O
of IN O
sialylated JJ O
glycoconjugates NNS O
is VBZ O
the DT O
activated JJ O
sugar NN O
- : O
nucleotide RB O
cytidine VBP O
5 CD O
' '' O
- : O
monophosphate NN O
N NNP O
- : O
acetylneuraminic JJ O
acid NN O
( ( O
CMP NNP O
- : O
Neu5Ac NN O
) ) O
, , O
which WDT O
provides VBZ O
a DT O
substrate NN O
for IN O
Golgi NNP B-Gene
sialyltransferases NNS I-Gene
. . O

Detailed JJ O
mutagenesis NN O
of IN O
the DT O
element NN O
' POS O
s NN O
rare JJ O
- : O
codon NN O
/ NN O
AU NNP O
- : O
rich JJ O
sequence NN O
boundary NN O
revealed VBD O
that IN O
the DT O
destabilizing JJ O
activity NN O
of IN O
the DT O
MATalpha1 NNP B-Gene
IE NNP I-Gene
is VBZ O
observed VBN O
when WRB O
the DT O
terminal JJ O
codon NN O
of IN O
the DT O
element NN O
' POS O
s NN O
rare JJ O
- : O
codon NN O
interval NN O
is VBZ O
translated VBN O
. . O

Children NNP O
born NN O
from IN O
chronic JJ O
alcoholic JJ O
mothers NNS O
have VBP O
shown VBN O
behavioral JJ O
teratogenic JJ O
effects NNS O
more RBR O
frequently RB O
than IN O
morphological JJ O
malformations NNS O
. . O

Functional JJ O
analysis NN O
of IN O
promoter NN O
activity NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
cyclin NN B-Gene
D2 NNP I-Gene
suggested VBD O
that IN O
the DT O
region NN O
- : O
1 CD O
, , O
100 CD O
to TO O
- : O
805 CD O
including VBG O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
, , O
PEA3 NNP B-Gene
, , O
AP2 NNP B-Gene
, , O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
, , O
c SYM B-Gene
- : I-Gene
Myc NNP I-Gene
, , O
and CC O
Sp1 NNP B-Gene
may MD O
have VB O
a DT O
major JJ O
positive JJ O
regulatory JJ O
activity NN O
for IN O
expression NN O
of IN O
cyclin NN B-Gene
D2 NNP I-Gene
. . O

Sensitive JJ O
fluorometric JJ O
method NN O
of IN O
determining VBG O
SH NNP O
- : O
and CC O
S NNP O
- : O
S NNP O
- : O
groups NNS O
when WRB O
jointly RB O
present JJ O

Therefore RB O
, , O
we PRP O
have VBP O
named VBN O
this DT O
gene NN O
UBP43 NNP B-Gene
. . O

The DT O
orbitofrontal NN O
, , O
cingulate NN O
, , O
and CC O
anteromedial JJ O
part NN O
of IN O
the DT O
dorsal NN O
premotor NN O
areas NNS O
were VBD O
preferentially RB O
activated VBN O
by IN O
the DT O
self NN O
- : O
initiated JJ O
hand NN O
movement NN O
task NN O
( ( O
SELF NNP O
) ) O
. . O

High JJ B-Gene
- : I-Gene
mobility NN I-Gene
- : I-Gene
group NN I-Gene
protein NN I-Gene
I PRP I-Gene
can MD O
modulate VB O
binding NN O
of IN O
transcription NN O
factors NNS O
to TO O
the DT O
U5 NNP B-Gene
region NN I-Gene
of IN O
the DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
proviral JJ I-Gene
promoter NN I-Gene
. . O

19F CD O
NMR NNP O
studies NNS O
in IN O
ABF4 NNP O
- : O
type NN O
layered VBD O
antiferromagnets NNS O
. . O

A DT O
Drosophila NNP B-Gene
shc NN I-Gene
gene NN I-Gene
product NN I-Gene
is VBZ O
implicated VBN O
in IN O
signaling VBG O
by IN O
the DT O
DER NNP B-Gene
receptor NN I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
. . O

Effect NN O
of IN O
intraventricular JJ O
administration NN O
of IN O
streptolysin JJ B-Gene
O NNP I-Gene
on IN O
the DT O
electroencephalogram NN O
of IN O
rabbits NNS O
. . O

In IN O
addition NN O
, , O
carp NN B-Gene
JAK1 NNP I-Gene
shows VBZ O
higher JJR O
sequence NN O
homology NN O
to TO O
mammalian JJ B-Gene
JAK1 NNP I-Gene
in IN O
both CC O
the DT O
kinase NN O
- : O
like IN O
( ( O
JH2 NNP B-Gene
) ) O
and CC O
kinase NN O
( ( O
JH1 NNP B-Gene
) ) O
domains VBZ O
( ( O
approximately RB O
70 CD O
% NN O
identity NN O
) ) O
. . O

CSF NNP O
adenosine JJ B-Gene
deaminase NN I-Gene
activity NN O
( ( O
ADA NNP O
) ) O
was VBD O
measured VBN O
at IN O
the DT O
same JJ O
time NN O
. . O

Symposium NN O
on IN O
presenile NN O
spongy NN O
encephalopathies NNS O
. . O

Conversely RB O
, , O
activated VBD O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
suppressed VBD O
the DT O
transactivation NN O
function NN O
of IN O
p53 NN B-Gene
, , O
while IN O
transrepression NN O
by IN O
p53 NN B-Gene
was VBD O
largely RB O
unaffected JJ O
. . O

To TO O
circumvent VB O
this DT O
problem NN O
, , O
a DT O
simple JJ O
two CD O
- : O
step NN O
strategy NN O
was VBD O
devised VBN O
by IN O
which WDT O
essential JJ O
cis NN O
- : O
acting VBG O
sites NNS O
like IN O
the DT O
a DT O
sequence NN O
can MD O
be VB O
readily RB O
deleted VBN O
from IN O
their PRP$ O
natural JJ O
loci NN O
in IN O
large JJ O
viral JJ O
DNA NNP O
genomes NNS O
. . O

Hex NNP B-Gene
is VBZ O
expressed VBN O
in IN O
the DT O
developing NN O
liver JJ O
coincident NN O
with IN O
the DT O
forkhead JJ B-Gene
/ NN O
winged VBD B-Gene
helix JJ I-Gene
transcription NN O
factor NN O
, , O
Hepatocyte NNP B-Gene
Nuclear NNP I-Gene
Factor NNP I-Gene
3beta CD I-Gene
( ( O
HNF3beta NNP B-Gene
) ) O
. . O

Plasma NNP O
levels NNS O
of IN O
protein NN B-Gene
C NNP I-Gene
, , O
protein NN B-Gene
S NNP I-Gene
, , O
and CC O
antithrombin JJ B-Gene
III NNP I-Gene
in IN O
patients NNS O
with IN O
subarachnoid JJ O
haemorrhage NN O
. . O

Chronic NNP O
graft NN O
- : O
versus NN O
- : O
host NN O
disease NN O
( ( O
cGVHD NN O
) ) O
is VBZ O
a DT O
major JJ O
complication NN O
of IN O
allogeneic JJ O
hematopoietic JJ O
cell NN O
transplantation NN O
. . O

Observations NNS O
on IN O
saccules NNS O
of IN O
rats NNS O
exposed VBN O
to TO O
long VB O
- : O
term NN O
hypergravity NN O
. . O

However RB O
, , O
inhibition NN O
of IN O
both CC O
the DT O
ERK NNP B-Gene
/ NNP O
RSK NNP B-Gene
and CC O
the DT O
p38 NN B-Gene
/ NNP O
MAPKAP NNP B-Gene
kinase VBD I-Gene
2 CD I-Gene
pathways NNS O
completely RB O
abolished VBD O
NGF NNP B-Gene
- : O
induced VBD O
CREB NNP B-Gene
Ser NNP O
- : O
133 CD O
phosphorylation NN O
. . O

The DT O
two CD O
methods NNS O
identify VBP O
the DT O
same JJ O
patients NNS O
only RB O
if IN O
micturitional JJ O
pressures NNS O
are VBP O
normal JJ O
( ( O
40 CD O
to TO O
60 CD O
cmH2O NN O
) ) O
to TO O
high JJ O
( ( O
over IN O
60 CD O
cmH2O NN O
) ) O
and CC O
the DT O
Sussett NNP O
formula NN O
is VBZ O
used VBN O
with IN O
a DT O
higher JJR O
( ( O
95th CD O
centile NN O
) ) O
cutoff NN O
. . O

This DT O
newly RB O
described VBN O
organism NN O
was VBD O
difficult JJ O
to TO O
identify VB O
due JJ O
to TO O
discrepancies NNS O
between IN O
the DT O
Vitek NNP O
and CC O
API NNP O
20E CD O
identification NN O
systems NNS O
. . O

Total JJ O
serum NN O
calcium NN O
was VBD O
7 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
mg JJ O
/ NNP O
dl NN O
, , O
whereas WP O
ionized VBD O
calcium NN O
was VBD O
5 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
mg JJ O
/ NNP O
dl NN O
, , O
phosphorus NN O
3 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
2 CD O
mg JJ O
/ NNP O
dl NN O
, , O
and CC O
alkaline JJ B-Gene
phosphatase NN I-Gene
149 CD O
+ NN O
/ NNP O
- : O
48 CD O
. . O
6 CD O
U NNP O
/ NNP O
liter NN O
. . O

Following VBG O
the DT O
injection NN O
of IN O
PGF2 NNP O
alpha NN O
, , O
heifers NNS O
were VBD O
observed VBN O
visually RB O
for IN O
signs NNS O
of IN O
estrus NN O
at IN O
730 CD O
and CC O
1630 CD O
( ( O
45 CD O
min RB O
each DT O
) ) O
. . O

Number NNP O
and CC O
size NN O
of IN O
the DT O
myelin NN O
structures VBZ O
in IN O
the DT O
pneumocytes NNS O
typ VBP O
II NNP O
increased VBD O
simultaneously RB O
. . O

In IN O
the DT O
first JJ O
series NN O
of IN O
experiments NNS O
, , O
Sprague NNP O
- : O
Dawley NNP O
male NN O
rats NNS O
were VBD O
implanted VBN O
unilaterally RB O
with IN O
guide JJ O
cannulas NNS O
aimed VBN O
at IN O
the DT O
lateral JJ O
ventricle NN O
. . O

Eight CD O
rabbits NNS O
were VBD O
exposed VBN O
to TO O
0 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
mg JJ O
/ NNP O
m3 NN O
Co2 NNP O
+ NNP O
as IN O
CoCl2 NNP O
and CC O
1 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
mg JJ O
/ NNP O
m3 NN O
Cr3 NNP O
+ NNP O
as IN O
Cr NNP O
( ( O
NO3 NNP O
) ) O
3 CD O
( ( O
group NN O
Co NNP O
+ NNP O
Cr NNP O
) ) O
, , O
eight CD O
to TO O
0 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
m3 NN O
Co2 NNP O
+ NNP O
( ( O
group NN O
Co NNP O
) ) O
, , O
and CC O
eight CD O
to TO O
filtered VBN O
air NN O
( ( O
control VB O
group NN O
) ) O
, , O
for IN O
4 CD O
months NNS O
, , O
5 CD O
days NNS O
/ JJ O
week NN O
, , O
and CC O
6 CD O
hr NNS O
/ JJ O
day NN O
. . O

Tyrosine NNP O
phosphorylated VBD O
STATs NNP B-Gene
dimerize NN O
and CC O
translocate NN O
into IN O
the DT O
nucleus NN O
to TO O
activate VB O
specific JJ O
genes NNS O
. . O

Significant JJ O
alterations NNS O
in IN O
the DT O
vasectomized JJ O
rats NNS O
from IN O
sham NN O
rats NNS O
included VBD O
: : O
testicular NN O
and CC O
epididymal JJ O
hypertrophy NN O
, , O
formation NN O
of IN O
pathologic JJ O
vas NN O
deferens VBZ O
granulomas NN O
, , O
decreased VBD O
total JJ O
serum NN O
protein NN O
, , O
lowered VBD O
alpha SYM B-Gene
- : I-Gene
globulin NN I-Gene
levels NNS O
as IN O
shown VBN O
by IN O
serum NN O
electrophoresis NN O
, , O
and CC O
increased VBD O
sperm NNS O
agglutinin IN B-Gene
antibody NN O
titers NNS O
. . O

SH2D1A NNP B-Gene
protein NN I-Gene
levels NNS O
are VBP O
up RB O
- : O
regulated VBN O
by IN O
CD40 NNP B-Gene
cross NN O
- : O
linking NN O
and CC O
down IN O
- : O
regulated VBN O
by IN O
B NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
ligation NN O
. . O

EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
the DT O
cis NN O
- : O
acting VBG O
CD23 NNP B-Gene
element NN I-Gene
increased VBD O
TK NNP B-Gene
- : O
promoted VBN O
mRNA NN O
and CC O
did VBD O
not RB O
alter VB O
the DT O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
TK NNP I-Gene
promoter NN I-Gene
transcription NN I-Gene
start NN I-Gene
site NN I-Gene
. . O

Furthermore RB O
, , O
our PRP$ O
novel JJ O
observation NN O
that IN O
expression NN O
of IN O
a DT O
highly RB O
activated VBN O
FGFR3 NNP B-Gene
kinase NN I-Gene
domain NN I-Gene
is VBZ O
able JJ O
to TO O
morphologically RB O
transform VB O
fibroblasts NNS O
suggests VBZ O
that IN O
dysregulation NN O
of IN O
FGFR3 NNP B-Gene
has VBZ O
the DT O
potential NN O
to TO O
play VB O
a DT O
role NN O
in IN O
human JJ O
neoplasia NN O
. . O

Clipping VBG O
resulted VBN O
in IN O
a DT O
serious JJ O
mislocalization NN O
of IN O
the DT O
position NN O
of IN O
the DT O
peak NN O
of IN O
the DT O
epicortical JJ O
potential JJ O
field NN O
. . O

Regional JJ O
insertional JJ O
mutagenesis NN O
of IN O
specific JJ O
genes NNS O
on IN O
the DT O
CIC5F11 NNP B-Gene
/ NNP O
CIC2B9 NNP B-Gene
locus NN O
of IN O
Arabidopsis NNP O
thaliana NNP O
chromosome NN O
5 CD O
using VBG O
the DT O
Ac NNP B-Gene
/ NNP O
Ds NNP B-Gene
transposon NN O
in IN O
combination NN O
with IN O
the DT O
cDNA NN O
scanning VBG O
method NN O
. . O

Intron NNP O
K1 NNP B-Gene
cox1 NN I-Gene
. . I-Gene
2 CD I-Gene
is VBZ O
not RB O
found VBN O
in IN O
S NNP O
. . O
cerevisiae NN O
and CC O
appears VBZ O
at IN O
an DT O
unique JJ O
location NN O
in IN O
K NNP O
. . O
lactis NN O
. . O

Another DT O
putative JJ O
HNF3 NNP B-Gene
site NN I-Gene
in IN O
close JJ O
apposition NN O
to TO O
a DT O
NF1 NNP B-Gene
/ NNP O
CTF NNP B-Gene
site NN O
was VBD O
localized VBN O
upstream NN O
of IN O
the DT O
silencer NN O
- : O
like IN O
element NN O
. . O

Monitoring VBG O
patients NNS O
with IN O
acute JJ O
leukemia NN O
for IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
TNF NNP B-Gene
levels NNS O
throughout IN O
the DT O
clinical JJ O
course NN O
of IN O
disease NN O
may MD O
help VB O
clarify VB O
the DT O
causes NNS O
of IN O
febrile JJ O
episodes NNS O
. . O

When WRB O
this DT O
DNA NNP O
fragment NN O
was VBD O
placed VBN O
upstream NN O
of IN O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
reporter NN O
gene NN O
and CC O
transfected VBN O
into IN O
a DT O
carp JJ O
CF NNP O
cell NN O
line NN O
, , O
it PRP O
could MD O
drive VB O
the DT O
synthesis NN O
of IN O
CAT NNP B-Gene
enzyme VBD I-Gene
16 CD O
times NNS O
more RBR O
efficiently RB O
than IN O
the DT O
promoterless NN O
pCAT SYM B-Gene
- : I-Gene
Basic NNP I-Gene
. . O

Handgrip NNP O
dynamometry NN O
was VBD O
also RB O
carried VBN O
out RP O
in IN O
249 CD O
of IN O
the DT O
patients NNS O
. . O

The DT O
product NN O
of IN O
the DT O
vpr NN B-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
of IN I-Gene
human JJ I-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
is VBZ O
a DT O
15 CD O
- : O
kDa NN O
, , O
arginine JJ O
- : O
rich JJ O
protein NN O
that WDT O
is VBZ O
present JJ O
in IN O
virions NNS O
in IN O
molar JJ O
quantities NNS O
equivalent VBP O
to TO O
that DT O
of IN O
Gag NNP B-Gene
. . O

Molecular JJ O
cloning NN O
of IN O
an DT O
amphibian JJ B-Gene
insulin NN I-Gene
receptor NN I-Gene
substrate VBP I-Gene
1 CD I-Gene
- : I-Gene
like IN I-Gene
cDNA NN I-Gene
and CC O
involvement NN O
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
in IN O
insulin NN B-Gene
- : O
induced JJ O
Xenopus NNP O
oocyte NN O
maturation NN O
. . O

A DT O
recombinant NN O
with IN O
a DT O
5 CD O
' POS O
end NN O
from IN O
src NN B-Gene
and CC O
a DT O
3 CD O
' POS O
end NN O
from IN O
ros NN B-Gene
, , O
called VBN O
SRC NNP B-Gene
x NNP O
ROS NNP B-Gene
, , O
transformed VBD O
chicken JJ O
embryo NN O
fibroblasts NNS O
( ( O
CEF NNP O
) ) O
to TO O
a DT O
spindle JJ O
shape NN O
morphology NN O
, , O
mimicking VBG O
that IN O
of IN O
UR2 NNP B-Gene
. . O

The DT O
deduced JJ O
protein NN O
sequence NN O
is VBZ O
characterized VBN O
by IN O
a DT O
putative JJ O
16 CD O
- : O
residue NN O
amino NN O
- : O
terminal JJ O
signal JJ O
peptide NN O
that WDT O
is VBZ O
cleaved VBN O
, , O
resulting VBG O
in IN O
a DT O
239 CD O
- : O
residue JJ O
polypeptide NN O
. . O

The DT O
authors NNS O
undertook VBP O
a DT O
retrospective JJ O
analysis NN O
of IN O
pathology NN O
with IN O
quantification NN O
of IN O
the DT O
percentage NN O
of IN O
papillary JJ O
serous JJ O
component NN O
( ( O
% NN O
PSC NNP O
) ) O
and CC O
p53 JJ B-Gene
expression NN O
. . O

IVOX NNP O
was VBD O
named VBN O
as IN O
an DT O
acronym NN O
for IN O
intravascular JJ O
oxygenator NN O
. . O

Conversely RB O
, , O
the DT O
inactive JJ O
dAK NN B-Gene
subunit NN I-Gene
is VBZ O
progressively RB O
activated VBN O
by IN O
1 CD O
) ) O
association NN O
with IN O
a DT O
dGK NN B-Gene
or CC O
dCK NN B-Gene
subunit NN I-Gene
and CC O
2 CD O
) ) O
the DT O
conformationally RB O
driven JJ O
heterotropic NNS O
affect NN O
of IN O
dGuo NN B-Gene
or CC O
dCyd NN B-Gene
bound NN O
to TO O
the DT O
opposing VBG O
subunit NN O
. . O

Plasma NNP O
fibrinogen NN B-Gene
was VBD O
measured VBN O
by IN O
the DT O
turbidimetric JJ O
method NN O
in IN O
timol JJ O
turbidimetric JJ O
units NNS O
. . O

Serum NNP O
levels NNS O
of IN O
testosterone NN O
also RB O
showed VBD O
no DT O
significant JJ O
changes NNS O
by IN O
exposure NN O
to TO O
p VB O
, , O
p NN O
' '' O
- : O
DDE NNP O
under IN O
the DT O
conditions NNS O
of IN O
this DT O
study NN O
. . O

Because IN O
of IN O
the DT O
functional JJ O
conservation NN O
of IN O
cell NN O
cycle NN O
control NN O
elements NNS O
, , O
the DT O
expression NN O
of IN O
a DT O
vertebrate NN B-Gene
wee1 NN I-Gene
or CC O
mik1 NN B-Gene
homolog NN I-Gene
would MD O
be VB O
expected VBN O
to TO O
rescue VB O
such JJ O
lethal JJ O
mutations NNS O
in IN O
yeast NN O
. . O

Our PRP$ O
results NNS O
concluded VBD O
that IN O
1 CD O
) ) O
the DT O
two CD O
inhibin NN B-Gene
/ NNP O
activin NN B-Gene
beta NN O
B NNP O
- : O
subunit NN O
mRNAs NN O
were VBD O
transcribed VBN O
from IN O
different JJ O
initiation NN O
sites NNS O
; : O
2 CD O
) ) O
both DT O
promoters NNS O
may MD O
be VB O
controlled VBN O
by IN O
up IN O
- : O
stream NN O
negative JJ O
regulatory JJ O
elements NNS O
; : O
and CC O
3 CD O
) ) O
neither NN O
of IN O
these DT O
promoters NNS O
is VBZ O
responsive JJ O
to TO O
cAMP VB O
and CC O
/ VB O
or CC O
phorbol VB O
esters NNS O
under IN O
the DT O
conditions NNS O
employed VBP O
. . O

Hisako NNP O
Minowa NNP O
who WP O
has VBZ O
worked VBN O
as IN O
a DT O
psychiatric JJ O
counsellor NN O
in IN O
industry NN O
for IN O
the DT O
past JJ O
20 CD O
years NNS O

The DT O
amino NN O
- : O
terminal JJ O
region NN O
of IN O
E1A NNP B-Gene
binds VBZ O
several JJ O
high JJ O
molecular JJ O
weight NN O
proteins NNS O
and CC O
inhibits VBZ O
the DT O
transcriptional JJ O
coactivator NN O
function NN O
of IN O
p300 NN B-Gene
and CC O
the DT O
homologous JJ O
cAMP NN B-Gene
response NN I-Gene
element NN I-Gene
( ( I-Gene
CRE NNP I-Gene
) ) I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
. . O

A DT O
total NN O
of IN O
26 CD O
BCG NNP O
strains NNS O
, , O
out IN O
of IN O
them PRP O
10 CD O
Czechoslovak JJ O
strains NNS O
( ( O
2 CD O
lyophilized VBN O
cultures NNS O
of IN O
BCG NNP O
of IN O
different JJ O
batch NN O
, , O
6 CD O
strains NNS O
isolated VBN O
from IN O
abscesses NNS O
of IN O
children NNS O
after IN O
BCG NNP O
- : O
vaccination NN O
and CC O
2 CD O
strains NNS O
from IN O
fatal JJ O
cases NNS O
after IN O
BCG NNP O
- : O
vaccination NN O
) ) O
and CC O
16 CD O
strains NNS O
obtained VBN O
from IN O
foreign JJ O
laboratories NNS O
, , O
were VBD O
used VBN O
. . O

All DT O
patients NNS O
in IN O
the DT O
control NN O
group NN O
showed VBD O
a DT O
significant JJ O
improvement NN O
in IN O
their PRP$ O
PEFR NNP O
while IN O
only RB O
3 CD O
patients NNS O
in IN O
the DT O
treated JJ O
group NN O
showed VBD O
an DT O
improvement NN O
. . O

Expression NN O
of IN O
the DT O
src NN B-Gene
homology NN I-Gene
3 CD I-Gene
( ( O
SH3 NNP B-Gene
) ) O
- : O
encoding NN O
, , O
expressed VBN O
in IN O
tumorigenic JJ O
astrocytes NNS O
( ( O
SETA NNP B-Gene
) ) O
gene NN O
is VBZ O
associated VBN O
with IN O
astrocyte JJ O
transformation NN O
in IN O
culture NN O
and CC O
tumors NNS O
in IN O
the DT O
adult NN O
brain NN O
. . O

CONCLUSION NN O
: : O
In IN O
our PRP$ O
animal JJ O
model NN O
, , O
blood NN O
- : O
brain NN O
barrier NN O
disruption NN O
was VBD O
a DT O
reproducible JJ O
, , O
integral JJ O
finding NN O
of IN O
single JJ O
- : O
fraction NN O
, , O
high JJ O
- : O
dose JJ O
irradiation NN O
injury NN O
. . O

The DT O
gene NN B-Gene
cat SYM I-Gene
- : I-Gene
86 CD I-Gene
, , O
specifying VBG O
chloramphenicol SYM B-Gene
- : I-Gene
inducible JJ I-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
, , O
is VBZ O
located VBN O
on IN O
the DT O
1 CD O
. . O
1 CD O
- : O
kilobase NN O
cloned VBD O
DNA NNP O
. . O

The DT O
Trk NNP B-Gene
/ NNP I-Gene
Nerve NNP I-Gene
Growth NNP I-Gene
Factor NNP I-Gene
receptor NN I-Gene
mediates VBZ O
the DT O
rapid JJ O
activation NN O
of IN O
a DT O
number NN O
of IN O
intracellular JJ O
signaling VBG O
proteins NNS O
, , O
including VBG O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
. . O

Treatment NN O
was VBD O
well RB O
- : O
tolerated VBN O
. . O

Research NN O
was VBD O
carried VBN O
out RP O
on IN O
the DT O
rheumatoid JJ B-Gene
factors NNS I-Gene
in IN O
the DT O
serum NN O
of IN O
917 CD O
patients NNS O
by IN O
means NNS O
of IN O
two CD O
tests NNS O
( ( O
one CD O
using VBG O
polystyrene NN O
and CC O
one CD O
with IN O
erythrocytes NNS O
) ) O
and CC O
the DT O
results NNS O
obtained VBD O
were VBD O
compared VBN O
using VBG O
a DT O
method NN O
of IN O
reference NN O
. . O

The DT O
discordant JJ O
behaviour NN O
in IN O
weakly JJ O
infected JJ O
mice NN O
was VBD O
due JJ O
to TO O
the DT O
occurrence NN O
in IN O
some DT O
animals NNS O
of IN O
a DT O
second JJ O
phase NN O
of IN O
more RBR O
rapid JJ O
increase NN O
of IN O
the DT O
parasitemia NN O
. . O

Wrist JJ O
measurement NN O
of IN O
blood NN O
pressure NN O
: : O
some DT O
critical JJ O
remarks NNS O
to TO O
oscillometry VB O
. . O

Positive JJ O
correlations NNS O
were VBD O
seen VBN O
between IN O
the DT O
measurements NNS O
for IN O
protein NNS O
intake VBP O
( ( O
r JJ O
= NNP O
. . O
58 CD O
, , O
P NNP O
= NNP O
. . O
26 CD O
) ) O
energy NN O
intake NN O
( ( O
r JJ O
= NNP O
. . O
78 CD O
, , O
P NNP O
< NNP O
. . O
1 CD O
) ) O
, , O
with IN O
mean JJ O
differences NNS O
of IN O
. . O
66 CD O
g JJ O
/ NNP O
kg NN O
/ NNP O
d NN O
( ( O
SD NNP O
. . O
38 CD O
) ) O
2 CD O
. . O
4 CD O
kcal JJ O
/ NN O
kg NN O
/ NNP O
day NN O
( ( O
SD NNP O
6 CD O
. . O
67 CD O
) ) O
, , O
respectively RB O
. . O

Increase NNP O
in IN O
blood NN O
NEFA NNP O
was VBD O
further RBR O
augmented VBN O
by IN O
fat JJ O
plus CC O
AA NNP O
supplementation NN O
, , O
but CC O
no DT O
changes NNS O
in IN O
concentrations NNS O
of IN O
Lys NNP O
or CC O
Met NNP O
in IN O
blood NN O
were VBD O
found VBN O
. . O

During IN O
the DT O
2h CD O
resuscitation NN O
period NN O
, , O
extracellular JJ O
aspartate NN O
and CC O
glutamate NN O
concentrations NNS O
in IN O
the DT O
cerebral JJ O
striatum NN O
were VBD O
higher JJR O
during IN O
hypoxaemic JJ O
resuscitation NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
44 CD O
and CC O
p VB O
= JJ O
0 CD O
. . O
55 CD O
, , O
respectively RB O
) ) O
than IN O
during IN O
resuscitation NN O
with IN O
21 CD O
% NN O
O2 NNP O
or CC O
100 CD O
% NN O
O2 NNP O
, , O
suggesting VBG O
an DT O
unfavourable JJ O
accumulation NN O
of IN O
potent JJ O
excitotoxins NNS O
during IN O
hypoxaemic JJ O
resuscitation NN O
. . O

The DT O
mean NN O
( ( O
+ JJ O
/ NNP O
- : O
sd NN O
) ) O
intra VBZ O
- : O
vesicular JJ O
pressure NN O
( ( O
IVP NNP O
) ) O
and CC O
maximal JJ O
urethral JJ O
closure NN O
pressures NNS O
( ( O
MUCP NNP O
) ) O
were VBD O
10 CD O
. . O
3 CD O
( ( O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
7 CD O
) ) O
and CC O
129 CD O
. . O
8 CD O
( ( O
+ JJ O
/ NNP O
- : O
19 CD O
. . O
6 CD O
) ) O
cmH2O NN O
, , O
respectively RB O
, , O
and CC O
the DT O
ratio NN O
between IN O
MUCP NNP O
and CC O
IVP NNP O
was VBD O
13 CD O
. . O
2 CD O
( ( O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
5 CD O
) ) O
. . O

The DT O
results NNS O
confirm VBP O
and CC O
extend VBP O
previous JJ O
work NN O
by IN O
other JJ O
researchers NNS O
. . O

In IN O
comparison NN O
of IN O
cDNA NN O
and CC O
genomic JJ O
sequences NNS O
four CD O
RNA NNP O
editing VBG O
events NNS O
were VBD O
found VBN O
in IN O
both DT O
atp9 JJ B-Gene
genes NNS I-Gene
. . O

PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
levels NNS O
increased VBN O
significantly RB O
in IN O
patients NNS O
who WP O
received VBD O
iohexol NNS O
but CC O
not RB O
in IN O
those DT O
who WP O
received VBD O
ioxaglate NN O
. . O

The DT O
resurgence NN O
of IN O
drug NN O
- : O
resistant JJ O
malaria NN O
makes VBZ O
urgent JJ O
the DT O
evaluation NN O
of IN O
new JJ O
antimalarial JJ O
agents NNS O
. . O

Comparison NNP O
of IN O
transmembrane NN O
and CC O
cytoplasmic JJ O
domains NNS O
to TO O
a DT O
third JJ O
cell NN O
- : O
surface NN O
proteoglycan JJ O
, , O
48K5 CD B-Gene
from IN O
human JJ O
lung NN O
fibroblasts NNS O
( ( O
Marynen NNP O
, , O
P NNP O
. . O
, , O
Zhang NNP O
, , O
J NNP O
. . O
, , O
Cassiman NNP O
, , O
J NNP O
. . O
, , O
Vanden NNP O
Berghe NNP O
, , O
H NNP O
. . O
, , O
and CC O
David NNP O
, , O
C NNP O
. . O

Staining VBG O
with IN O
IF NNP O
MoAB NNP O
alone RB O
of IN O
BAL NNP O
fluid NN O
only RB O
seemed VBD O
to TO O
be VB O
even RB O
more RBR O
sensitive JJ O
than IN O
silver RB O
methenamine JJ O
staining NN O
of IN O
BAL NNP O
, , O
TBB NNP O
and CC O
brushing VBG O
material NN O
. . O

Chlamydia NNP O
trachomatis NN O
and CC O
Chlamydia NNP O
psittaci NN O
were VBD O
not RB O
affected VBN O
by IN O
methanol JJ O
fixation NN O
. . O

To TO O
gain VB O
an DT O
understanding NN O
of IN O
the DT O
mGSTM2 NN B-Gene
regulation NN O
, , O
we PRP O
have VBP O
also RB O
cloned VBN O
and CC O
analyzed VBN O
its PRP$ O
promoter NN O
region NN O
. . O

Antisense NNP O
transcription NN O
of IN O
a DT O
murine NN B-Gene
FGFR NNP I-Gene
- : I-Gene
3 CD I-Gene
psuedogene NN I-Gene
during IN O
fetal JJ O
developement NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
the DT O
proline NN O
- : O
rich JJ O
region NN O
of IN O
CAP NNP B-Gene
is VBZ O
recognized VBN O
by IN O
the DT O
SH3 NNP B-Gene
domains NNS I-Gene
of IN O
several JJ O
proteins NNS O
, , O
including VBG O
the DT O
yeast NN B-Gene
actin SYM I-Gene
- : I-Gene
associated VBN I-Gene
protein NN I-Gene
Abp1p NNP I-Gene
. . O

An DT O
ASIC NNP O
- : O
chip NN O
for IN O
stereoscopic NN O
depth NN O
analysis NN O
in IN O
video NN O
- : O
real JJ O
- : O
time NN O
based VBN O
on IN O
visual JJ O
cortical JJ O
cell NN O
behavior NN O
. . O

Second JJ O
report NN O
of IN O
the DT O
Norwegian JJ O
Cancer NNP O
Society NNP O
. . O

Two CD O
nuclear JJ O
medicine NN O
physicians NNS O
blinded VBD O
to TO O
the DT O
surgical JJ O
findings NNS O
interpreted VBD O
all DT O
available JJ O
images NNS O
and CC O
various JJ O
Tc NNP O
- : O
99m CD O
MIBI NNP O
image NN O
combinations NNS O
at IN O
15 CD O
minutes NNS O
alone RB O
; : O
15 CD O
minutes NNS O
and CC O
2 CD O
hours NNS O
, , O
15 CD O
minutes NNS O
and CC O
4 CD O
hours NNS O
; : O
and CC O
15 CD O
minutes NNS O
and CC O
2 CD O
and CC O
4 CD O
hours NNS O
each DT O
with IN O
and CC O
without IN O
correlative JJ O
pertechnetate NN O
thyroid NN O
imaging NN O
. . O

In IN O
4 CD O
spinalized JJ O
cats NNS O
, , O
the DT O
effects NNS O
of IN O
afferent NN O
inputs NNS O
from IN O
hindlimb NN O
cutaneous JJ O
nerves NNS O
( ( O
sural JJ O
cutaneous JJ O
nerve NN O
: : O
Sur NNP O
) ) O
on IN O
mono NN O
- : O
and CC O
poly VB O
- : O
synaptic JJ O
reflex NN O
recorded VBN O
from IN O
tail NN O
muscle NN O
motoneurons NNS O
were VBD O
studied VBN O
before IN O
and CC O
after IN O
spinal JJ O
lesioning NN O
at IN O
S2 NNP O
- : O
3 CD O
level NN O
. . O

Sp1 NNP B-Gene
binds VBZ O
the DT O
CTC NNP O
repeat NN O
with IN O
an DT O
affinity NN O
, , O
KD NNP O
= VBZ O
0 CD O
. . O
37 CD O
nM NN O
, , O
at IN O
least JJS O
as RB O
high JJ O
as IN O
the DT O
consensus NN O
GC NNP O
box NN O
. . O

Measurements NNS O
of IN O
activity NN O
with IN O
the DT O
radioprotective JJ O
chamber NN O
VA NNP O
- : O
K NNP O
- : O
254 CD O
of IN O
the DT O
osimeter NN O
VA NNP O
- : O
J18 NN O

DNA NN O
sequence NN O
analysis NN O
of IN O
a DT O
3213 CD O
bp NN O
BamHI NNP B-Gene
- : O
ClaI NNP B-Gene
fragment NN O
revealed VBD O
that IN O
three CD O
open JJ O
reading VBG O
frames NNS O
( ( O
ORFs NNP O
) ) O
were VBD O
encoded VBN O
in IN O
the DT O
same JJ O
orientation NN O
. . O

In IN O
the DT O
VA NNP O
- : O
SMV NNP O
mode NN O
, , O
the DT O
connection NN O
was VBD O
made VBN O
with IN O
valved JJ O
conduits NNS O
from IN O
the DT O
LV NNP O
apex NN O
( ( O
inflow JJ O
) ) O
to TO O
the DT O
ascending VBG O
aorta NN O
( ( O
outflow JJ O
) ) O
( ( O
n JJ O
= NNP O
11 CD O
) ) O
or CC O
to TO O
the DT O
DAo NNP O
( ( O
n JJ O
= NNP O
12 CD O
) ) O
. . O

Concurrently RB O
, , O
we PRP O
monitored VBD O
weather CC O
conditions NNS O
and CC O
used JJ O
time NN O
- : O
activity NN O
budget NN O
data NNS O
of IN O
free JJ O
- : O
living NN O
birds NNS O
and CC O
laboratory NN O
data NNS O
on IN O
resting VBG O
metabolic JJ O
rate NN O
to TO O
construct VB O
time NN O
- : O
activity NN O
laboratory NN O
( ( O
TAL NNP O
) ) O
estimates NNS O
of IN O
daily JJ O
energy NN O
expenditure NN O
( ( O
DEE NNP O
) ) O
and CC O
to TO O
partition VB O
the DT O
verdins NNS O
' POS O
energy NN O
budget NN O
into IN O
thermoregulatory NN O
, , O
activity NN O
and CC O
basal NN O
components NNS O
. . O

Enhanced NNP O
hepatic JJ O
portal NN O
blood NN O
flow NN O
induced VBN O
by IN O
prostaglandin JJ O
E1 NNP O
following VBG O
liver JJ O
transplantation NN O
in IN O
pigs NNS O
. . O

Since IN O
September NNP O
1980 CD O
to TO O
June NNP O
1983 CD O
we PRP O
have VBP O
treated VBN O
32 CD O
patients NNS O
with IN O
ovarian JJ O
cancer NN O
. . O

Family RB O
environment NN O
was VBD O
an DT O
important JJ O
influence NN O
on IN O
interpersonal JJ O
relationships NNS O
, , O
substance NN O
use NN O
, , O
and CC O
social JJ O
support NN O
. . O

Although IN O
neither DT O
constitutively RB O
activated VBN O
MEK NNP B-Gene
( ( O
MEK NNP B-Gene
- : I-Gene
2E CD I-Gene
) ) O
nor CC O
v JJ B-Gene
- : I-Gene
Src NN I-Gene
was VBD O
sufficient JJ O
individually RB O
to TO O
differentiate VB O
the DT O
H19 NNP O
- : O
7 CD O
cells NNS O
, , O
coexpression NN O
of IN O
constitutively RB O
activated VBN O
MEK NNP B-Gene
and CC O
v SYM B-Gene
- : I-Gene
Src NN I-Gene
induced VBD O
neurite JJ O
outgrowth NN O
. . O

( ( O
3 CD O
) ) O
. . O

Hydropathy JJ O
analysis NN O
of IN O
KCC1 NNP B-Gene
indicates VBZ O
structural JJ O
homology NN O
to TO O
NKCC NNP B-Gene
, , O
including VBG O
12 CD O
transmembrane NN O
domains NNS O
, , O
a DT O
large JJ O
extracellular JJ O
loop NN O
with IN O
potential JJ O
N NNP O
- : O
linked VBN O
glycosylation NN O
sites NNS O
, , O
and CC O
cytoplasmic JJ O
N NNP O
- : O
and CC O
C NNP O
- : O
terminal JJ O
regions NNS O
. . O

Encapsidation NN O
of IN O
poliovirus NN O
replicons NNS O
encoding VBG O
the DT O
complete JJ O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
gag NN I-Gene
gene NN I-Gene
by IN O
using VBG O
a DT O
complementation NN O
system NN O
which WDT O
provides VBZ O
the DT O
P1 NNP B-Gene
capsid NN I-Gene
protein NN I-Gene
in IN O
trans NNS O
. . O

The DT O
rhaB NN B-Gene
transcription NN I-Gene
start NN I-Gene
site NN I-Gene
was VBD O
mapped VBN O
to TO O
- : O
24 CD O
relative NN O
to TO O
the DT O
start NN O
of IN O
translation NN O
. . O

We PRP O
showed VBD O
that IN O
Stat3 NNP B-Gene
and CC O
Stat3beta NNP B-Gene
were VBD O
affinity NN O
purified VBN O
using VBG O
phosphopeptides NNS O
containing VBG O
Y704 NNP O
and CC O
Y744 NNP O
but CC O
not RB O
by IN O
nonphosphorylated JJ O
peptide NN O
analogues NNS O
or CC O
by IN O
phosphopeptides NNS O
containing VBG O
Y729 NNP O
and CC O
Y764 NNP O
. . O

MK NNP O
- : O
927 CD O
: : O
a DT O
topically RB O
active JJ O
ocular JJ O
hypotensive NN O
carbonic JJ B-Gene
anhydrase NN I-Gene
inhibitor NN O
. . O

Neither CC O
the DT O
reaction NN O
of IN O
monosaccharides NNS O
nor CC O
the DT O
disaccharides NNS O
with IN O
beta NN O
- : O
alanine NN O
resulted VBD O
in IN O
the DT O
formation NN O
of IN O
maltol NN O
. . O

The DT O
treatments NNS O
were VBD O
60 CD O
mg JJ O
t NN O
. . O
i NN O
. . O
d NN O
. . O
and CC O
120 CD O
mg NN O
t NN O
. . O
i NN O
. . O
d NN O
. . O
during IN O
14 CD O
days NNS O
' POS O
treatment NN O
, , O
with IN O
the DT O
last JJ O
dose NN O
pulsed VBD O
with IN O
1 CD O
. . O
85 CD O
MBq NNP O
[ VBD O
14C CD O
] JJ O
diltiazem NN O
. . O

These DT O
genes NNS O
were VBD O
expressed VBN O
in IN O
a DT O
Saccharomyces NNP O
cerevisiae NN O
mutant NN O
in IN O
which WDT O
the DT O
endogenous JJ B-Gene
ferrochelatase NN I-Gene
gene NN I-Gene
( ( O
HEM15 NNP B-Gene
) ) O
had VBD O
been VBN O
deleted VBN O
, , O
and CC O
the DT O
phenotypes NNS O
of IN O
the DT O
transformants NNS O
were VBD O
characterized VBN O
. . O

Eleven JJ O
patients NNS O
tested VBD O
positive JJ O
for IN O
the DT O
hepatitis NN B-Gene
B NNP I-Gene
surface NN I-Gene
antigen NN I-Gene
( ( O
HBsAg NNP B-Gene
) ) O
. . O

There EX O
was VBD O
a DT O
weak JJ O
significant JJ O
correlation NN O
between IN O
TGF NNP B-Gene
beta VBD I-Gene
1 CD I-Gene
levels NNS O
and CC O
normal JJ O
cell NN O
radiosensitivity NN O
( ( O
lymphocyte JJ O
SF2 NNP O
) ) O
. . O

The DT O
membrane NN O
- : O
distal JJ O
cytoplasmic JJ O
region NN O
of IN O
human JJ B-Gene
granulocyte NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
receptor NN I-Gene
is VBZ O
required VBN O
for IN O
STAT3 NNP B-Gene
but CC O
not RB O
STAT1 NNP B-Gene
homodimer NN I-Gene
formation NN O
. . O

Further JJ O
studies NNS O
demonstrated VBD O
that IN O
the DT O
PPARalpha NNP B-Gene
ligand NN O
8 CD O
( ( O
S NNP O
) ) O
- : O
hydroxyeicosatetraenoic NN O
acid RB O
strongly RB O
promotes VBZ O
the DT O
interaction NN O
of IN O
PPARalpha NNP B-Gene
with IN O
the DT O
co NN O
- : O
activator NN O
RIP NNP B-Gene
- : I-Gene
140 CD I-Gene
but CC O
decreases VBZ O
the DT O
interaction NN O
of IN O
PPARalpha NNP B-Gene
with IN O
the DT O
co NN O
- : O
repressor NN O
SMRT NNP B-Gene
. . O

They PRP O
were VBD O
found VBN O
to TO O
be VB O
seropositive JJ O
for IN O
antibodies NNS O
to TO O
hepatitis VB O
C NNP O
virus NN O
by IN O
second JJ O
- : O
generation NN O
testing NN O
( ( O
RIBA NNP O
2 CD O
, , O
Ortho NNP O
Diagnostic NNP O
Systems NNPS O
Inc NNP O
, , O
Westwood NNP O
, , O
MA NNP O
) ) O
. . O

The DT O
level NN O
of IN O
the DT O
SUP4A53T61 NNP B-Gene
transcript NN I-Gene
was VBD O
threefold JJ O
higher JJR O
in IN O
the DT O
tap1 NN B-Gene
- : I-Gene
1 CD I-Gene
mutant NN I-Gene
than IN O
in IN O
the DT O
wild JJ O
type NN O
. . O

In IN O
Xenopus NNP O
, , O
BMPs NNP B-Gene
act NN O
as IN O
epidermal JJ O
inducers NNS O
and CC O
also RB O
as IN O
negative JJ O
regulators NNS O
of IN O
neurogenesis NN O
. . O

Mature NNP B-Gene
tobacco NN I-Gene
L12 NNP I-Gene
protein NN I-Gene
has VBZ O
44 CD O
% NN O
amino NN O
acid NN O
identity NN O
with IN O
ribosomal JJ O
protein NN O
L7 NNP B-Gene
/ NNP O
L12 NNP B-Gene
of IN O
Escherichia NNP O
coli NN O
. . O

Both DT O
P5CDh NNP B-Gene
cDNA NN I-Gene
clones NNS O
detect VBP O
a DT O
single JJ O
3 CD O
. . O
2 CD O
- : O
kb NN O
transcript NN O
on IN O
Northern NNP O
blots NNS O
of IN O
multiple JJ O
human JJ O
tissues NNS O
, , O
indicating VBG O
the DT O
long JJ O
cDNA NN O
containing VBG O
the DT O
3 CD O
' POS O
- : O
untranslated JJ O
intron NN O
represents VBZ O
the DT O
predominant JJ O
transcript NN O
. . O

Silicosis NN O
mortality NN O

Lung NNP O
mesenchyme NN O
serves VBZ O
as IN O
a DT O
' POS O
compleat NN O
' '' O
inducer NN O
of IN O
lung NN O
morphogenesis NN O
by IN O
secreting VBG O
soluble JJ O
peptide JJ O
growth NN O
factors NNS O
. . O

D NNP O
. . O

Therefore RB O
, , O
to TO O
understand VB O
how WRB O
ErbB1 NNP B-Gene
/ NNP O
ErbB2 NNP B-Gene
signaling VBG O
contributes NNS O
to TO O
this DT O
process NN O
, , O
we PRP O
used VBD O
the DT O
ErbB NNP B-Gene
kinase NNP I-Gene
inhibitor NN O
AG1478in NNP O
ErbB2 NNP B-Gene
- : O
dependent NN O
BT NNP O
- : O
474 CD O
and CC O
SKBR NNP O
- : O
3 CD O
human JJ O
breast NN O
cancer NN O
cells NNS O
. . O

Counter NNP O
- : O
current JJ O
heat NN O
exchange NN O
in IN O
the DT O
respiratory NN O
passages NNS O
: : O
effect NN O
on IN O
water NN O
and CC O
heat NN O
balance NN O
. . O

Non NNP O
- : O
complement NN O
- : O
dependent JJ O
sperm JJ O
- : O
immobilizing NN O
activity NN O
was VBD O
also RB O
detected VBN O
in IN O
the DT O
cervical JJ O
mucus NN O
of IN O
several JJ O
patients NNS O
. . O

Psychiatry NN O
and CC O
the DT O
skin NN O
. . O

Hence NNP O
, , O
scs32 VBZ B-Gene
only RB O
partially RB O
suppressed VBD O
the DT O
ts NN O
phenotype NN O
and CC O
was VBD O
unable JJ O
to TO O
suppress VB O
the DT O
Ino NNP O
- : O
phenotype NN O
of IN O
rpo26 NN B-Gene
- : I-Gene
31 CD I-Gene
. . O

The DT O
provisional JJ O
reports NNS O
are VBP O
based VBN O
mainly RB O
upon IN O
macroscopic NN O
findings NNS O
, , O
whereas IN O
the DT O
final JJ O
reports NNS O
include VBP O
the DT O
information NN O
provided VBN O
by IN O
supplementary JJ O
investigations NNS O
such JJ O
as IN O
microscopy NN O
, , O
histochemistry NN O
, , O
more RBR O
rarely RB O
electron JJ O
microscopy NN O
, , O
immunohistochemistry NN O
and CC O
/ NN O
or CC O
microbiology NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
third JJ O
intracellular JJ O
loop NN O
of IN O
the DT O
rat NN B-Gene
GnRH NNP I-Gene
- : I-Gene
R NN I-Gene
is VBZ O
involved VBN O
in IN O
receptor NN B-Gene
G NNP I-Gene
( ( I-Gene
q JJ I-Gene
/ NNP I-Gene
11 CD I-Gene
) ) I-Gene
protein NN I-Gene
coupling VBG O
and CC O
/ NNP O
or CC O
selectivity NN O
, , O
and CC O
in IN O
the DT O
GGH NNP O
( ( O
3 CD O
) ) O
1 CD O
' '' O
cell NN O
line NN O
, , O
this DT O
loop NN O
is VBZ O
also RB O
involved VBN O
in IN O
signal JJ O
transduction NN O
mediated VBD O
through IN O
the DT O
Gs NNP B-Gene
protein NN O
pathway NN O
. . O

The DT O
Nur77 NNP B-Gene
protein NN I-Gene
can MD O
act VB O
as IN O
a DT O
potent JJ O
transcription NN O
activator NN O
and CC O
may MD O
function VB O
to TO O
regulate VB O
the DT O
expression NN O
of IN O
downstream NN O
genes NNS O
in IN O
response NN O
to TO O
extracellular JJ O
stimuli NNS O
. . O

A DT O
beta2 NN B-Gene
RARE NNP I-Gene
reporter NN I-Gene
construct NN I-Gene
in IN O
which WDT O
the DT O
methylation NN O
- : O
susceptible JJ O
cytosines NNS O
in IN O
the DT O
sense NN O
strand NN O
were VBD O
replaced VBN O
by IN O
thymine JJ O
displayed VBN O
marked JJ O
loss NN O
of IN O
activity NN O
in IN O
a DT O
replicated JJ O
chromatin NN O
- : O
dependent JJ O
manner NN O
. . O

The DT O
homeobox NN B-Gene
gene NN I-Gene
ATK1 NNP I-Gene
of IN O
Arabidopsis NNP O
thaliana NN O
is VBZ O
expressed VBN O
in IN O
the DT O
shoot NN O
apex NN O
of IN O
the DT O
seedling NN O
and CC O
in IN O
flowers NNS O
and CC O
inflorescence NN O
stems NNS O
of IN O
mature NN O
plants NNS O
. . O

Mutational JJ O
analysis NN O
showed VBD O
that IN O
the DT O
U NNP O
- : O
box NN O
, , O
like IN O
the DT O
RING NNP O
finger NN O
in IN O
other JJ O
proteins NNS O
, , O
forms VBZ O
the DT O
physical JJ O
basis NN O
for IN O
the DT O
interaction NN O
with IN O
E2 NNP B-Gene
enzymes NNS I-Gene
. . O

Institution NN O
of IN O
both DT O
intravenous JJ O
and CC O
intracisternal JJ O
administration NN O
of IN O
amphotericin NN O
B NNP O
and CC O
possibly RB O
concomitant VB O
intravenous JJ O
administration NN O
of IN O
dexamethasone NN O
may MD O
be VB O
warranted VBN O
in IN O
situations NNS O
in IN O
which WDT O
the DT O
association NN O
of IN O
C NNP O
. . O
immitis NN O
with IN O
CNS NNP O
vasculitis NN O
or CC O
encephalitis NN O
appears VBZ O
likely JJ O
before IN O
serologic JJ O
or CC O
cultural JJ O
confirmation NN O
of IN O
C NNP O
. . O
immitis NN O
infection NN O
involving VBG O
the DT O
CNS NNP O
is VBZ O
available JJ O
. . O

One CD O
of IN O
these DT O
small JJ B-Gene
inteins NNS I-Gene
might MD O
be VB O
inactive JJ O
or CC O
a DT O
"""" JJ B-Gene
pseudo NN I-Gene
intein NN I-Gene
. . I-Gene
"""" VB I-Gene
The DT O
results NNS O
suggest VBP O
a DT O
modular JJ O
architecture NN O
for IN O
inteins NNS B-Gene
, , O
clarify VB O
their PRP$ O
origin NN O
and CC O
relationship NN O
to TO O
other JJ O
protein JJ O
families NNS O
, , O
and CC O
extend VB O
recent JJ O
experimental JJ O
findings NNS O
on IN O
the DT O
functional JJ O
roles NNS O
of IN O
intein NN B-Gene
N NNP I-Gene
, , I-Gene
C NNP I-Gene
, , I-Gene
and CC I-Gene
EN NNP I-Gene
motifs NNS I-Gene
. . O

Judicious JJ O
use NN O
of IN O
laboratory NN O
testing NN O
, , O
including VBG O
monitoring NN O
of IN O
CD4 NNP B-Gene
cell NN O
counts NNS O
, , O
is VBZ O
recommended VBN O
. . O

The DT O
effect NN O
of IN O
Rho NNP B-Gene
on IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
independent JJ O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathway RB O
, , O
as IN O
a DT O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
MEK NNP I-Gene
and CC O
a DT O
MEK NNP B-Gene
inhibitor NN O
( ( O
PD98059 NNP O
) ) O
did VBD O
not RB O
affect VB O
Rho NNP B-Gene
- : O
induced VBD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
. . O

A DT O
second JJ O
, , O
novel JJ O
C NNP O
subunit NN O
( ( O
CeCAT NNP B-Gene
alpha NN I-Gene
' '' I-Gene
, , O
374 CD O
residues NNS O
) ) O
has VBZ O
a DT O
unique JJ O
56 CD O
- : O
residue NN O
carboxyl SYM O
- : O
terminal JJ O
region NN O
that WDT O
is VBZ O
generated VBN O
by IN O
the DT O
alternative JJ O
splicing NN O
of IN O
the DT O
C NNP B-Gene
pre NN I-Gene
- : I-Gene
mRNA NN I-Gene
. . O

The DT O
results NNS O
demonstrate VBP O
that IN O
( ( O
i NN O
) ) O
no DT O
intact JJ O
capsids NNS O
were VBD O
assembled VBN O
when WRB O
the DT O
full JJ O
- : O
length NN O
or CC O
a DT O
truncated VBN O
( ( O
missing VBG O
the DT O
C NNP O
- : O
terminal JJ O
65 CD O
amino JJ O
acids NNS O
) ) O
UL80 NNP B-Gene
. . I-Gene
5 CD I-Gene
protein NN I-Gene
was VBD O
tested VBN O
; : O
( ( O
ii NN O
) ) O
when WRB O
the DT O
C NNP O
- : O
terminal JJ O
65 CD O
amino JJ O
acids NNS O
of IN O
the DT O
UL80 NNP B-Gene
. . I-Gene
5 CD I-Gene
protein NNS I-Gene
were VBD O
replaced VBN O
with IN O
the DT O
C NNP O
- : O
terminal JJ O
25 CD O
amino JJ O
acids NNS O
of IN O
the DT O
UL26 NNP B-Gene
. . I-Gene
5 CD I-Gene
protein NN I-Gene
, , O
intact JJ O
capsids NNS O
were VBD O
made VBN O
and CC O
direct JJ O
interaction NN O
of IN O
the DT O
UL80 NNP B-Gene
. . I-Gene
5 CD I-Gene
protein NN I-Gene
with IN O
VP5 NNP B-Gene
was VBD O
detected VBN O
; : O
( ( O
iii NN O
) ) O
assembly NN O
of IN O
intact JJ O
capsids NNS O
was VBD O
demonstrated VBN O
when WRB O
the DT O
sequence NN O
of IN O
the DT O
last JJ O
12 CD O
amino JJ O
acids NNS O
of IN O
the DT O
UL80 NNP B-Gene
. . I-Gene
5 CD I-Gene
protein NN I-Gene
was VBD O
changed VBN O
from IN O
RRIFVA NNP O
ALNKLE NNP O
to TO O
RRIFVAAMMKLE NNP O
; : O
( ( O
iv NN O
) ) O
self PRP O
- : O
interaction NN O
of IN O
the DT O
scaffold JJ O
proteins NNS O
is VBZ O
mediated VBN O
by IN O
sequences NNS O
N NNP O
terminal NN O
to TO O
the DT O
maturation NN O
cleavage NN O
site NN O
; : O
and CC O
( ( O
v NN O
) ) O
the DT O
UL26 NNP B-Gene
. . I-Gene
5 CD I-Gene
and CC O
UL80 NNP B-Gene
. . I-Gene
5 CD I-Gene
proteins NNS I-Gene
will MD O
not RB O
coassemble VB O
into IN O
scaffold JJ O
structures NNS O
. . O

The DT O
applicability NN O
of IN O
laparoscopic NN O
donor NN O
nephrectomy NN O
( ( O
LDN NNP O
) ) O
has VBZ O
not RB O
been VBN O
assessed VBN O
in IN O
the DT O
obese JJ O
donor NN O
. . O

Duch NNP O
, , O
and CC O
F NNP O
. . O

Gonadal NNP O
dysfunction NN O
in IN O
patients NNS O
with IN O
ataxia JJ O
telangiectasia NN O
. . O

We PRP O
propose VBP O
that IN O
two CD O
pathways NNS O
regulate VBP O
Stat5 NNP B-Gene
serine NN O
phosphorylation NN O
, , O
one CD O
that WDT O
is VBZ O
prolactin JJ B-Gene
- : O
activated VBN O
and CC O
PD98059 NNP O
- : O
resistant NN O
and CC O
one NN O
that WDT O
is VBZ O
constitutively RB O
active JJ O
and CC O
PD98059 NNP O
- : O
sensitive JJ O
and CC O
preferentially RB O
targets NNS O
Stat5a NNP B-Gene
. . O

Clb2 NNP B-Gene
/ NNP O
Cdc28 NNP B-Gene
kinase NN O
is VBZ O
not RB O
required VBN O
for IN O
the DT O
repression NN O
of IN O
MCB NNP B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
transcriptional JJ O
activity NN O
in IN O
G2 NNP O
and CC O
M NNP O
phase NN O
. . O

Parasitological JJ O
post NN O
- : O
mortem NN O
examination NN O
of IN O
all DT O
seropositive JJ O
animals NNS O
showed VBD O
five CD O
and CC O
seven CD O
false JJ O
- : O
positive JJ O
animals NNS O
when WRB O
E NNP B-Gene
/ NNP I-Gene
S NNP I-Gene
and CC I-Gene
CWE NNP I-Gene
antigens NNS I-Gene
were VBD O
used VBN O
, , O
respectively RB O
. . O

Our PRP$ O
study NN O
was VBD O
addressed VBN O
to TO O
the DT O
synthesis NN O
of IN O
some DT O
derivatives NNS O
of IN O
this DT O
sequence NN O
in IN O
order NN O
to TO O
obtain VB O
both DT O
peptide JJ O
substrates NNS O
suitable JJ O
for IN O
the DT O
detection NN O
of IN O
the DT O
Src NNP B-Gene
- : O
like IN O
tyrosine JJ B-Gene
kinase NN I-Gene
activity NN O
and CC O
active JJ O
site NN O
- : O
directed JJ O
inhibitors NNS O
specific VBP O
for IN O
this DT O
class NN O
of IN O
enzymes NNS O
. . O

In IN O
unc JJ B-Gene
- : I-Gene
4 CD I-Gene
mutants NNS I-Gene
, , O
VA NNP O
motor NN O
neurons NNS O
assume VBP O
the DT O
pattern NN O
of IN O
synaptic JJ O
input NN O
normally RB O
reserved VBN O
for IN O
their PRP$ O
lineal JJ O
sister NN O
cells NNS O
, , O
the DT O
VB NNP O
motor NN O
neurons NNS O
; : O
the DT O
loss NN O
of IN O
normal JJ O
input NN O
to TO O
the DT O
VAs NNP O
produces VBZ O
a DT O
distinctive JJ O
backward NN O
movement NN O
defect NN O
. . O

Lesions NNS O
were VBD O
made VBN O
by IN O
pressure NN O
injection NN O
of IN O
kainic JJ O
acid NN O
into IN O
the DT O
SOC NNP O
through IN O
a DT O
stereotaxically RB O
positioned VBN O
glass NN O
micropipette NN O
. . O

Furthermore RB O
, , O
no DT O
transcripts NNS O
of IN O
the DT O
same JJ O
size NN O
and CC O
having VBG O
the DT O
same JJ O
developmental JJ O
profile NN O
as IN O
those DT O
generated VBN O
by IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
E10 NNP I-Gene
fragment NN I-Gene
were VBD O
identified VBN O
by IN O
probes NNS O
covering VBG O
the DT O
remainder NN O
of IN O
the DT O
cloned JJ O
region NN O
. . O

To TO O
investigate VB O
the DT O
potential JJ O
role NN O
of IN O
SP1 NNP B-Gene
, , O
we PRP O
examined VBD O
nuclear JJ O
extracts NNS O
from IN O
HCMV NNP O
- : O
infected JJ O
cells NNS O
. . O

These DT O
results NNS O
were VBD O
robust JJ O
to TO O
changes NNS O
in IN O
the DT O
baseline NN O
assumptions NNS O
of IN O
the DT O
model NN O
. . O

Of IN O
the DT O
six CD O
cases NNS O
of IN O
malignant JJ O
polyposis NN O
, , O
none NN O
were VBD O
identified VBN O
using VBG O
CT NNP O
, , O
and CC O
only RB O
two CD O
were VBD O
diagnosed VBN O
by IN O
small JJ O
bowel NN O
follow JJ O
- : O
through IN O
. . O

Possibilities NNS O
and CC O
outlook NN O
for IN O
wrist JJ O
joint JJ O
endoprosthesis NN O

Thus RB O
, , O
in IN O
normal JJ O
intestinal JJ O
epithelial JJ O
goblet NN O
cells NNS O
, , O
TbetaRI NNP B-Gene
and CC O
TbetaRII NNP B-Gene
can MD O
respond VB O
to TO O
autocrine VB O
but CC O
not RB O
exogenous JJ O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
without IN O
the DT O
participation NN O
of IN O
TbetaRIII NNP B-Gene
. . O

We PRP O
characterized VBD O
three CD O
Arabidopsis NNP O
thaliana NN O
cDNA NN O
clones NNS O
that WDT O
could MD O
rescue VB O
the DT O
sterile JJ O
phenotype NN O
of IN O
the DT O
Schizosaccharomyces NNP B-Gene
pombe NN I-Gene
pde1 NN I-Gene
mutant NN I-Gene
, , O
which WDT O
is VBZ O
defective JJ O
in IN O
cAMP JJ B-Gene
phosphodiesterase NN I-Gene
. . O

Intravenous JJ O
versus NN O
oral JJ O
administration NN O
of IN O
amitriptyline NN O
in IN O
patients NNS O
with IN O
major JJ O
depression NN O
. . O

The DT O
antioxidant JJ O
agent NN O
pyrrolidine NN O
dithiocarbamate NN O
( ( O
PDTC NNP O
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
protect VB O
endothelial JJ O
cells NNS O
( ( O
EC NNP O
) ) O
from IN O
pro FW O
- : O
inflammatory NN O
- : O
induced JJ O
and CC O
pro JJ O
- : O
oxidant JJ O
- : O
induced JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

The DT O
differences NNS O
were VBD O
as IN O
follows VBZ O
: : O
for IN O
overall JJ O
response NN O
rate NN O
p NN O
= $ O
0 CD O
. . O
4 CD O
; : O
power NN O
( ( O
for IN O
p NN O
= CD O
0 CD O
. . O
5 CD O
) ) O
85 CD O
% NN O
; : O
for IN O
survival NN O
p NN O
= VBD O
0 CD O
. . O
9 CD O
; : O
for IN O
grade NN O
IV NNP O
granulocytopenia NN O
p NN O
= VBD O
0 CD O
. . O
3 CD O
; : O
and CC O
for IN O
febrile JJ O
neutropenia NN O
p NN O
= VBD O
0 CD O
. . O
61 CD O
. . O

We PRP O
now RB O
provide VBP O
evidence NN O
for IN O
physical JJ O
and CC O
functional JJ O
interaction NN O
between IN O
Doa4 NNP B-Gene
and CC O
the DT O
proteasome NN O
. . O

There EX O
is VBZ O
a DT O
national JJ O
effort NN O
to TO O
begin VB O
to TO O
ask VB O
all DT O
female JJ O
patients NNS O
about IN O
family NN O
violence NN O
. . O

By IN O
far RB O
- : O
Western JJ O
analysis NN O
and CC O
coimmunoprecipitation NN O
studies NNS O
, , O
we PRP O
demonstrate VBP O
that IN O
ZNF74 NNP B-Gene
interacts NNS O
, , O
via IN O
its PRP$ O
zinc NN O
finger NN O
domain NN O
, , O
with IN O
the DT O
hyperphosphorylated VBN O
largest JJS O
subunit NN O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
( ( O
pol JJ B-Gene
IIo NNP I-Gene
) ) O
but CC O
not RB O
with IN O
the DT O
hypophosphorylated JJ O
form NN O
. . O

Framingham NNP O
Type NNP O
A NNP O
behavior NN O
was VBD O
positively RB O
associated VBN O
with IN O
diastolic JJ O
blood NN O
pressure NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
17 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
among IN O
the DT O
women NNS O
. . O

The DT O
spontaneous JJ O
mutation NN O
blocking VBG O
pca JJ B-Gene
gene NN I-Gene
expression NN O
was VBD O
located VBN O
in IN O
the DT O
promoter NN O
for IN O
the DT O
pca NN B-Gene
operon NN I-Gene
. . O

Desmethylferrochloroquine NNP O
1a CD O
and CC O
didesmethylferrochloroquine JJ O
2 CD O
would MD O
be VB O
more RBR O
potent JJ O
against IN O
schizontocides NNS O
than IN O
CQ NNP O
in IN O
vitro NN O
against IN O
two CD O
strains NNS O
( ( O
HB3 NNP O
and CC O
Dd2 NNP O
) ) O
of IN O
Plasmodium NNP O
falciparum NN O
. . O

The DT O
starting NN O
point NN O
is VBZ O
the DT O
consideration NN O
that IN O
the DT O
conceptions NNS O
underlying VBG O
the DT O
ICIDH NNP O
are VBP O
not RB O
suitable JJ O
to TO O
serve VB O
as IN O
a DT O
mainstay NN O
of IN O
a DT O
model NN O
for IN O
diagnostics NNS O
in IN O
rehabilitation NN O
because IN O
they PRP O
do VBP O
not RB O
reflect VB O
essential JJ O
characteristics NNS O
of IN O
the DT O
diagnostic JJ O
process NN O
which WDT O
is VBZ O
the DT O
basis NN O
for IN O
intervention NN O
. . O

Responsiveness NN O
to TO O
beta VB O
- : O
2 CD O
agonist JJ O
therapy NN O
was VBD O
retained VBN O
with IN O
both DT O
agents NNS O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

In IN O
most JJS O
subjects NNS O
, , O
markers NNS O
of IN O
bone NN O
formation NN O
and CC O
resorption NN O
were VBD O
normal JJ O
. . O

However RB O
, , O
changing VBG O
the DT O
half JJ O
- : O
site NN O
to TO O
the DT O
consensus NN O
sequence NN O
AGGTCA NNP O
( ( O
IRper NNP O
- : O
1 CD O
) ) O
increased VBD O
binding NN O
of IN O
AaEcR NNP B-Gene
. . I-Gene
AaUSP NNP I-Gene
10 CD O
- : O
fold NN O
over IN O
IRhsp NNP O
- : O
1 CD O
and CC O
, , O
at IN O
the DT O
same JJ O
time NN O
, , O
reduced VBD O
the DT O
stringency NN O
of IN O
the DT O
spacer NN O
length NN O
requirement NN O
, , O
with IN O
IRper NNP O
- : O
0 CD O
to TO O
IRper NNP O
- : O
5 CD O
showing VBG O
detectable JJ O
binding NN O
. . O

The DT O
prevalence NN O
of IN O
hepatitis NN O
C NNP O
virus NN O
( ( O
HCV NNP O
) ) O
infection NN O
is VBZ O
relatively RB O
low JJ O
in IN O
childhood NN O
, , O
with IN O
anti JJ B-Gene
- : I-Gene
HCV JJ I-Gene
prevalence NN O
rates NNS O
of IN O
0 CD O
. . O
1 CD O
- : O
0 CD O
. . O
4 CD O
% NN O
in IN O
the DT O
Western JJ O
world NN O
. . O

Effect NN O
of IN O
alcohol NN O
on IN O
minimal JJ O
effective JJ O
nCPAP NN O
pressure NN O

In IN O
hypertensive JJ O
nephrosclerosis NN O
, , O
therapy NN O
containing VBG O
an DT O
ACEI NNP O
alone RB O
or CC O
in IN O
combination NN O
significantly RB O
reduces VBZ O
the DT O
incidence NN O
of IN O
renal JJ O
events NNS O
. . O

CCAAT NNP B-Gene
displacement NN I-Gene
protein NN I-Gene
binds VBZ O
to TO O
and CC O
negatively RB O
regulates VBZ O
human JJ O
papillomavirus NN O
type NN O
6 CD O
E6 NNP B-Gene
, , O
E7 NNP B-Gene
, , O
and CC O
E1 NNP B-Gene
promoters NNS O
. . O

The DT O
determination NN O
of IN O
physical JJ O
performance NN O
capacity NN O
was VBD O
based VBN O
on IN O
W170 NNP O
, , O
W85 NNP O
% NN O
and CC O
on IN O
predicted VBN O
VO2 NNP O
max NN O
measured VBD O
with IN O
continuously RB O
increasing VBG O
work NN O
load NN O
on IN O
a DT O
bicycle NN O
ergometer NN O
. . O

Nevertheless RB O
, , O
antibodies NNS O
directed VBD O
against IN O
an DT O
epitope NN O
- : O
tagged JJ O
version NN O
of IN O
Prp42p NNP B-Gene
specifically RB O
precipitate VBP O
U1 NNP B-Gene
snRNA NN I-Gene
from IN O
yeast JJ O
extracts NNS O
. . O

In IN O
the DT O
free JJ O
- : O
swimming VBG O
rotatory JJ O
test NN O
mice NN O
spend VBP O
most JJS O
of IN O
the DT O
time NN O
swimming VBG O
close RB O
to TO O
the DT O
wall NN O
of IN O
the DT O
container NN O
attempting VBG O
to TO O
escape VB O
from IN O
an DT O
aversive JJ O
test NN O
situation NN O
. . O

The DT O
major JJ O
myosin NN B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
of IN O
skeletal JJ B-Gene
muscle NN I-Gene
MyBP NNP I-Gene
- : I-Gene
C NNP I-Gene
( ( O
C NNP B-Gene
protein NN I-Gene
) ) O
resides VBZ O
in IN O
the DT O
COOH NNP O
- : O
terminal NN O
, , O
immunoglobulin JJ B-Gene
C2 NNP B-Gene
motif NN I-Gene
. . O

The DT O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
and CC O
skeletal JJ B-Gene
alpha NN I-Gene
- : I-Gene
actin NN I-Gene
gene NN I-Gene
promoters NNS I-Gene
contain VBP O
YY1 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
thought VBN O
to TO O
act VB O
either RB O
as IN O
positive JJ O
or CC O
negative JJ O
cis NN O
- : O
acting JJ O
elements NNS O
. . O

Functional JJ O
analysis NN O
of IN O
various JJ O
PTP NNP B-Gene
- : O
deficient NN O
DT40 NNP O
B NNP O
cell NN O
lines NNS O
stably RB O
expressing VBG O
wild JJ O
- : O
type NN O
chimeric JJ O
Fc NNP B-Gene
gamma NN I-Gene
RIIB1 NNP I-Gene
- : I-Gene
PECAM NNP I-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
indicated VBD O
that IN O
cytoplasmic JJ B-Gene
Src NNP I-Gene
homology NN I-Gene
2 CD I-Gene
- : I-Gene
domain NN I-Gene
- : I-Gene
containing NN I-Gene
phosphatases NNS I-Gene
, , O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
were VBD O
both DT O
necessary JJ O
and CC O
sufficient JJ O
to TO O
deliver VB O
inhibitory JJ O
negative JJ O
regulation NN O
upon IN O
coligation NN O
of IN O
BCR NNP B-Gene
complex JJ I-Gene
with IN O
inhibitory JJ O
receptor NN O
. . O

The DT O
alternative JJ O
exon NN O
introduces VBZ O
the DT O
novel JJ O
carboxyl NN O
terminus NN O
and CC O
a DT O
new JJ O
translation NN O
stop JJ O
signal NN O
, , O
while IN O
simultaneously RB O
converting VBG O
the DT O
coding NN O
sequence NN O
for IN O
40 CD O
carboxyl JJ O
- : O
terminal NN O
residues NNS O
in IN O
CeCAT NNP B-Gene
alpha VBP I-Gene
into IN O
3 CD O
' POS O
- : O
untranslated JJ O
nucleotides NNS O
. . O

We PRP O
have VBP O
isolated VBN O
and CC O
characterised VBN O
a DT O
differentially RB O
- : O
regulated VBN O
gene NN O
family NN O
in IN O
the DT O
protozoan NN O
parasite NN O
Leishmania NNP O
major JJ O
. . O

The DT O
authors NNS O
have VBP O
tested VBN O
the DT O
interference NN O
of IN O
the DT O
hemoglobin NN B-Gene
by IN O
two CD O
routine JJ O
methods NNS O
( ( O
Berthelot NNP O
classic JJ O
and CC O
Berthelot NNP O
modified VBD O
) ) O
for IN O
the DT O
determination NN O
of IN O
plasmatic JJ O
urea NN O
. . O

The DT O
appropriate JJ O
use NN O
and CC O
benefits NNS O
of IN O
bile JJ O
acid NN O
sequestrants NNS O
, , O
nicotinic JJ O
acid NN O
, , O
fibric JJ O
acids NNS O
, , O
3 CD B-Gene
- : I-Gene
hydroxy NN I-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
methylglutaryl NN I-Gene
coenzyme VBZ I-Gene
A NNP I-Gene
( ( I-Gene
HMG NNP I-Gene
- : I-Gene
CoA NN I-Gene
) ) I-Gene
reductase NN I-Gene
inhibitors NNS O
, , O
and CC O
probucol NN O
are VBP O
individually RB O
discussed VBN O
, , O
whereas JJ O
nonpharmacologic JJ O
approaches NNS O
used VBN O
in IN O
conjunction NN O
with IN O
the DT O
drugs NNS O
are VBP O
recommended VBN O
emphatically RB O
. . O

The DT O
single JJ O
site NN O
of IN O
glycosylation NN O
is VBZ O
located VBN O
near IN O
the DT O
C NNP O
- : O
terminus NN O
in IN O
the DT O
N NNP O
- : O
glycosylation NN O
sequon SYM O
- : O
Asn NNP O
- : O
Cys NNP O
- : O
Ser NNP O
- : O
in IN O
which WDT O
Cys NNP O
forms NNS O
part NN O
of IN O
a DT O
disulphide NN O
bridge NN O
. . O

Antileukoproteinase NNP B-Gene
( ( O
ALP NNP B-Gene
) ) O
is VBZ O
a DT O
low JJ O
mol NN O
wt NN O
mucosal NN O
secretory NN O
protein NN O
which WDT O
, , O
in IN O
human JJ O
tissues NNS O
, , O
inhibits VBZ O
the DT O
activities NNS O
of IN O
the DT O
neutral JJ O
serine NN B-Gene
lysosomal JJ I-Gene
proteinases NNS I-Gene
elastase NN B-Gene
and CC O
cathepsin NN B-Gene
- : I-Gene
G NNP I-Gene
. . O

The DT O
effects NNS O
of IN O
L655 NNP O
, , O
240 CD O
, , O
a DT O
selective JJ O
thromboxane NN O
and CC O
prostaglandin NN O
endoperoxide RB O
antagonist RB O
, , O
on IN O
ischemia NN O
- : O
and CC O
reperfusion NN O
- : O
induced JJ O
cardiac JJ O
arrhythmias NN O
. . O

Many JJ O
of IN O
these DT O
landfill JJ O
operations NNS O
were VBD O
undertaken VBN O
in IN O
the DT O
early JJ O
1950s CD O
and CC O
1960s CD O
, , O
when WRB O
knowledge NN O
regarding VBG O
the DT O
safe JJ O
and CC O
prolonged JJ O
containment NN O
of IN O
the DT O
waste NN O
buried VBN O
was VBD O
nonexistent JJ O
or CC O
minimal JJ O
at IN O
best JJS O
. . O

Redistribution NN O
of IN O
mannosidase NN B-Gene
I PRP I-Gene
was VBD O
also RB O
observed VBN O
in IN O
cells NNS O
incubated VBN O
at IN O
15 CD O
degrees NNS O
C NNP O
. . O

Organization NN O
of IN O
the DT O
human JJ B-Gene
LU NNP I-Gene
gene NN I-Gene
and CC O
molecular JJ O
basis NN O
of IN O
the DT O
Lu NNP B-Gene
( ( I-Gene
a DT I-Gene
) ) I-Gene
/ NN O
Lu NNP B-Gene
( ( I-Gene
b NN I-Gene
) ) I-Gene
blood NN O
group NN O
polymorphism NN O
. . O

Interestingly RB O
, , O
virions NNS O
also RB O
contained VBD O
smaller JJR O
proteins NNS O
that WDT O
reacted VBD O
with IN O
antibodies NNS O
specific VBP O
for IN O
the DT O
accessory JJ O
proteins NNS O
as RB O
well RB O
as IN O
SN NNP B-Gene
and CC O
CAT NNP B-Gene
fusion NN I-Gene
partners NNS O
. . O

MEASUREMENTS NNP O
AND CC O
MAIN NNP O
RESULTS NNP O
: : O
The DT O
two CD O
groups NNS O
were VBD O
similar JJ O
on IN O
entry NN O
into IN O
the DT O
study NN O
, , O
including VBG O
mean JJ O
FEV1 NNP O
measurements NNS O
( ( O
0 CD O
. . O
70 CD O
L NNP O
atropine NN O
/ NN O
0 CD O
. . O
60 CD O
L NNP O
metaproterenol NN O
, , O
P NNP O
greater JJR O
than IN O
. . O
5 CD O
) ) O
. . O

In IN O
Experiment NNP O
2 CD O
scopolamine NN O
hydrobromide NN O
, , O
0 CD O
. . O
5 CD O
and CC O
1 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
i NN O
. . O
p NN O
. . O
, , O
was VBD O
administered VBN O
1 CD O
h NN O
before IN O
each DT O
electrical JJ O
stimulation NN O
until IN O
each DT O
rat NN O
showed VBD O
the DT O
stage NN O
- : O
3 CD O
seizure NN O
. . O

So RB O
far RB O
no DT O
problems NNS O
with IN O
multiply NN O
resistant JJ O
strains NNS O
have VBP O
developed VBN O
. . O

Sources NNS O
of IN O
noise NN O
in IN O
these DT O
signals NNS O
were VBD O
evaluated VBN O
in IN O
preparations NNS O
stained VBN O
with IN O
the DT O
potentiometric JJ O
probe NN O
RH NNP O
- : O
414 CD O
. . O

Two CD O
studies NNS O
on IN O
the DT O
relationship NN O
between IN O
taking VBG O
a DT O
commercial JJ O
coaching NN O
course NN O
and CC O
performance NN O
on IN O
the DT O
Medical NNP O
College NNP O
Admission NNP O
Test NNP O
( ( O
MCAT NNP O
) ) O
are VBP O
reported VBN O
. . O

We PRP O
further VBP O
demonstrate VB O
that IN O
RU486 NNP O
- : O
PR NNP B-Gene
- : I-Gene
B NNP I-Gene
interacts VBZ O
physically RB O
with IN O
NCoR NNP B-Gene
in IN O
vitro NN O
. . O

After IN O
acclimation NN O
, , O
resting VBG O
supine NN O
and CC O
sitting VBG O
DPB NNP O
decreased VBD O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
by IN O
6 CD O
and CC O
9 CD O
mmHg NN O
, , O
respectively RB O
. . O

A DT O
system NN O
is VBZ O
described VBN O
in IN O
which WDT O
the DT O
volume NN O
flow NN O
rate NN O
of IN O
blood NN O
in IN O
a DT O
vessel NN O
is VBZ O
determined VBN O
using VBG O
transverse JJ O
colour NN O
Doppler NNP O
ultrasound IN O
imaging VBG O
. . O

Rabbit NNP O
eyes NNS O
were VBD O
removed VBN O
and CC O
held VBN O
in IN O
temperature NN O
- : O
regulated VBN O
chambers NNS O
and CC O
irrigated VBN O
with IN O
saline NN O
. . O

Significance NN O
of IN O
cytokine NN O
production NN O
and CC O
adhesion NN O
molecules NNS O
in IN O
malarial JJ O
immunopathology NN O
. . O

In IN O
addition NN O
, , O
double JJ O
mutants NNS O
with IN O
either DT O
dim1 JJ B-Gene
- : I-Gene
delta NN I-Gene
or CC O
dim2 VB B-Gene
- : I-Gene
1 CD I-Gene
and CC O
the DT O
endocytosis NN O
mutants NNS B-Gene
end4 VBP I-Gene
- : I-Gene
1 CD I-Gene
or CC O
act1 VB B-Gene
- : I-Gene
1 CD I-Gene
displayed JJ O
synthetic JJ O
growth NN O
defects NNS O
, , O
indicating VBG O
that IN O
the DT O
DIM NNP B-Gene
gene NN I-Gene
products NNS I-Gene
function VBP O
in IN O
a DT O
common JJ O
or CC O
parallel JJ O
endocytic JJ O
pathway NN O
. . O

Three CD O
of IN O
the DT O
proteins NNS O
involved VBN O
in IN O
checkpoint NN O
signaling NN O
, , O
Rad1 NNP B-Gene
, , O
Hus1 NNP B-Gene
, , O
and CC O
Rad9 NNP B-Gene
, , O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
by IN O
immunoprecipitation NN O
and CC O
yeast NN O
two CD O
- : O
hybrid JJ O
studies NNS O
. . O

During IN O
V NNP O
- : O
A DT O
bypass NN O
, , O
hemodynamics NNS O
were VBD O
stable JJ O
. . O

We PRP O
also RB O
show VBP O
that IN O
in IN O
fusions NNS O
with IN O
the DT O
DNA NN O
binding VBG O
domain NN O
of IN O
GAL4 NNP B-Gene
, , O
full JJ O
activity NN O
requires VBZ O
the DT O
entire JJ O
BHV NNP B-Gene
- : I-Gene
alpha NN I-Gene
TIF NNP I-Gene
, , O
although IN O
both DT O
amino NN O
and CC O
carboxyl NN O
termini NN O
display VB O
some DT O
activity NN O
on IN O
their PRP$ O
own JJ O
. . O

In IN O
a DT O
randomized JJ O
double JJ O
- : O
blind NN O
cross NN O
- : O
over IN O
study NN O
, , O
the DT O
subjects NNS O
received VBD O
theophylline JJ O
5 CD O
mg NN O
. . O
kg VB O
- : O
1 CD O
per IN O
day NN O
with IN O
omeprazole JJ O
20 CD O
mg JJ O
per IN O
day NN O
or CC O
identical JJ O
placebo NN O
during IN O
two CD O
periods NNS O
, , O
each DT O
of IN O
7 CD O
days NNS O
, , O
separated VBN O
by IN O
a DT O
washout JJ O
period NN O
of IN O
7 CD O
days NNS O
. . O

These DT O
results NNS O
suggested VBD O
that IN O
NfxB NNP B-Gene
negatively RB O
autoregulates VBZ O
the DT O
expression NN O
of IN O
nfxB JJ B-Gene
itself PRP O
. . O

The DT O
slower JJR O
- : O
electrophoretic JJ O
- : O
mobility NN O
form NN O
of IN O
p68 NN B-Gene
was VBD O
absent JJ O
in IN O
human JJ O
cells NNS O
in IN O
G1 NNP O
/ NNP O
S NNP O
and CC O
appeared VBD O
as IN O
the DT O
cells NNS O
entered VBD O
G2 NNP O
/ NNP O
M NNP O
. . O

The DT O
attainment NN O
of IN O
sexual JJ O
maturity NN O
in IN O
terms NNS O
of IN O
secondary JJ O
sexual JJ O
characteristics NNS O
, , O
the DT O
production NN O
of IN O
spermatozoa NN O
in IN O
the DT O
male NN O
, , O
and CC O
the DT O
cyclical JJ O
female NN O
pattern NN O
with IN O
release NN O
of IN O
ova NNS O
are VBP O
end JJ O
- : O
points NNS O
of IN O
the DT O
developmental JJ O
process NN O
. . O

The DT O
method NN O
involves VBZ O
preliminary JJ O
isolation NN O
of IN O
oxiracetam NN O
and CC O
internal JJ O
standard NN O
from IN O
plasma NN O
by IN O
solid JJ O
- : O
phase NN O
extraction NN O
prior RB O
to TO O
the DT O
formation NN O
of IN O
their PRP$ O
n JJ O
- : O
propyl NN O
carbamate NN O
derivatives NNS O
. . O

Tobacco NNP O
mosaic NN O
virus NN O
- : O
infected VBN O
tobacco NN O
( ( O
Nicotiana NNP O
tabacum RB O
var NN O
. . O

Neuronal JJ O
signaling NN O
properties NNS O
are VBP O
largely RB O
determined VBN O
by IN O
the DT O
quantity NN O
and CC O
combination NN O
of IN O
ion NN O
channels NNS O
expressed VBN O
. . O

During IN O
an DT O
8 CD O
- : O
wk NN O
follow SYM O
- : O
up RB O
, , O
parasites NNS O
reappeared VBD O
in IN O
10 CD O
patients NNS O
, , O
5 CD O
after IN O
each DT O
drug NN O
, , O
between IN O
1 CD O
and CC O
7 CD O
wk NN O
after IN O
treatment NN O
. . O

The DT O
experimental JJ O
end NN O
points NNS O
were VBD O
the DT O
time NN O
required VBN O
for IN O
treated JJ O
tumors NNS O
to TO O
reach VB O
3 CD O
times NNS O
their PRP$ O
treatment NN O
size NN O
, , O
the DT O
survival NN O
of IN O
stem NN O
cells NNS O
in IN O
the DT O
duodenal JJ O
crypts NNS O
, , O
and CC O
the DT O
breathing NN O
rate NN O
measured VBD O
early JJ O
( ( O
19 CD O
- : O
23 CD O
weeks NNS O
) ) O
and CC O
late JJ O
( ( O
41 CD O
- : O
46 CD O
weeks NNS O
) ) O
after IN O
treatment NN O
. . O

The DT O
real JJ O
challenge NN O
for IN O
the DT O
future NN O
will MD O
be VB O
the DT O
management NN O
of IN O
patients NNS O
who WP O
do VBP O
not RB O
respond VB O
to TO O
first VB O
- : O
line NN O
treatment NN O
. . O

Through IN O
deletion NN O
mutagenesis NN O
, , O
we PRP O
identify VBP O
amino JJ O
acids NNS O
2003 CD O
to TO O
2212 CD O
of IN O
CBP NNP B-Gene
, , O
which WDT O
we PRP O
call VBP O
carboxy JJ O
- : O
terminal JJ O
region NN O
2 CD O
( ( O
CR2 NNP O
) ) O
, , O
as IN O
the DT O
minimal JJ O
region NN O
for IN O
Tax NNP B-Gene
interaction NN O
. . O

Pulmonary JJ O
embolectomy NN O
and CC O
lung NN O
transplantation NN O
are VBP O
the DT O
main JJ O
indications NNS O
for IN O
the DT O
use NN O
of IN O
heart NN O
- : O
lung NN O
- : O
machine NN O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
binding NN O
partner NN O
for IN O
the DT O
Fanconi NNP B-Gene
anemia NN I-Gene
group NN I-Gene
C NNP I-Gene
protein NN I-Gene
( ( O
FANCC NNP B-Gene
) ) O
by IN O
yeast NN O
two CD O
- : O
hybrid JJ O
screening NN O
. . O

Anti NNP B-Gene
- : I-Gene
NPROSP NNP I-Gene
- : I-Gene
C NNP I-Gene
also RB O
exclusively RB O
detected JJ O
time NN O
- : O
dependent JJ O
appearances NNS O
of IN O
5 CD B-Gene
- : I-Gene
10 CD I-Gene
- : I-Gene
kDa NN I-Gene
proSP SYM I-Gene
- : I-Gene
C NN I-Gene
forms NNS O
in IN O
lamellar JJ O
bodies NNS O
and CC O
homogenates NNS O
. . O

The DT O
locus NN O
encoding VBG O
the DT O
XD NNP B-Gene
gene NN I-Gene
( ( O
designated VBN O
Xd NNP B-Gene
) ) O
was VBD O
mapped VBN O
to TO O
the DT O
distal JJ O
part NN O
of IN O
mouse NN O
chromosome NN O
17 CD O
by IN O
haplotype JJ O
analysis NN O
of IN O
114 CD O
interspecific JJ O
backcross NN O
mice NN O
. . O

The DT O
hepatitis NN B-Gene
A NNP I-Gene
virus NN I-Gene
antibody NN I-Gene
( ( O
anti JJ B-Gene
- : I-Gene
HAV NN I-Gene
) ) O
in IN O
chronic JJ O
diffuse NN O
liver NN O
diseases NNS O

Treatment NN O
with IN O
MK NNP O
- : O
801 CD O
induced VBD O
a DT O
burst JJ O
suppression NN O
in IN O
the DT O
EEG NNP O
and CC O
a DT O
transient JJ O
drop NN O
( ( O
11 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
5 CD O
mm JJ O
Hg NNP O
) ) O
in IN O
the DT O
mean JJ O
arterial JJ O
pressure NN O
. . O

Low NNP O
- : O
grade NN O
gastric JJ O
MALT NNP O
lymphoma NN O
and CC O
helicobacter NN O
heilmannii NN O
( ( O
Gastrospirillum NNP O
hominis NN O

1 CD O
. . O

Low NNP O
- : O
dose NN O
aspirin NN O
and CC O
recurrent JJ O
miscarriage NN O
. . O

The DT O
mean JJ O
waiting NN O
time NN O
to TO O
receive VB O
the DT O
pancreas NNS O
transplant NN O
was VBD O
244 CD O
days NNS O
for IN O
SPK NNP O
and CC O
167 CD O
days NNS O
for IN O
PAK NNP O
recipients NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

A DT O
follow NN O
- : O
up RB O
study NN O
of IN O
22 CD O
patients NNS O
with IN O
Ebstein NNP O
' POS O
s NN O
anomaly NN O
has VBZ O
been VBN O
performed VBN O
. . O

The DT O
enzymatic JJ O
response NN O
of IN O
neutrophils NNS O
and CC O
monocytes NNS O
was VBD O
similar JJ O
although IN O
the DT O
magnitude NN O
of IN O
the DT O
NADPH NNP B-Gene
oxidase NN I-Gene
activity NN O
was VBD O
significantly RB O
higher JJR O
in IN O
neutrophils NNS O
than IN O
in IN O
monocytes NNS O
. . O

The DT O
region NN O
between IN O
DXS52 NNP B-Gene
and CC O
Factor NNP B-Gene
VIII NNP I-Gene
gene NN I-Gene
in IN O
the DT O
human JJ O
Xq28 NNP O
chromosomal NN O
band NN O
contains VBZ O
a DT O
G NNP O
+ NNP O
C NNP O
- : O
rich JJ O
isochore NN O
to TO O
which WDT O
many JJ O
genes NNS O
have VBP O
been VBN O
mapped VBN O
. . O

Thigh NNP O
girth NN O
correlated VBD O
positively RB O
with IN O
HDL NNP B-Gene
and CC O
HDL2 NNP B-Gene
- : I-Gene
C NNP I-Gene
and CC O
mass NN O
, , O
and CC O
with IN O
LDL NNP B-Gene
particle NN O
size NN O
among IN O
women NNS O
. . O

Activation NN O
mediated VBN O
by IN O
Cat8p NNP B-Gene
was VBD O
no DT O
longer RBR O
detectable JJ O
in IN O
a DT O
cat1 NN B-Gene
mutant NN I-Gene
. . O

Common JJ O
foot NN O
pathologies NNS O
are VBP O
heel JJ O
pain NN O
, , O
metatarsalgia NN O
, , O
hammertoes NNS O
and CC O
clawtoes NNS O
, , O
bunions NNS O
, , O
hallux NN O
rigidus NN O
, , O
corns NNS O
and CC O
calluses NNS O
, , O
nail JJ O
pathologies NNS O
, , O
arthritis NN O
, , O
and CC O
neuropathies NNS O
. . O

A DT O
deproteinization NN O
procedure NN O
was VBD O
coupled VBN O
with IN O
a DT O
reversed JJ O
- : O
phase NN O
HPLC NNP O
separation NN O
using VBG O
a DT O
250x4 CD O
. . O
6 CD O
mm NN O
I PRP O
. . O
D NNP O
. . O

255 CD O
- : O
61 CD O
. . O

Studies NNS O
of IN O
biochemical JJ O
and CC O
morphological JJ O
changes NNS O
( ( O
between IN O
normal JJ O
and CC O
treated JJ O
animals NNS O
) ) O
show VBP O
that IN O
chrysotile NN O
induces NNS O
an DT O
increase NN O
in IN O
the DT O
lung NN O
free JJ O
cell NN O
population NN O
and CC O
pulmonary JJ O
surfactant NN O
levels NNS O
. . O

Characteristics NNS O
of IN O
lipase NN B-Gene
activity NN O
. . O

Interestingly RB O
, , O
PKA NNP B-Gene
activity NN O
is VBZ O
dispensable JJ O
in IN O
a DT O
strain NN O
lacking VBG O
Msn2p NNP B-Gene
and CC O
Msn4p NNP B-Gene
activity NN O
. . O

Immunoblotting NNP O
of IN O
expressed VBN O
recombinant JJ O
proteins NNS O
with IN O
the DT O
monoclonal JJ B-Gene
08L CD I-Gene
antibody NN I-Gene
localized VBD O
the DT O
08L CD B-Gene
epitope NN O
to TO O
the DT O
carboxyl JJ O
end NN O
of IN O
the DT O
protein NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
anthraquinone NN O
sennoside NN O
B NNP O
and CC O
rhein NN O
are VBP O
weakly JJ O
genotoxic NN O
. . O

The DT O
medium NN O
chains NNS O
of IN O
these DT O
complexes NNS O
, , O
mu1 NN B-Gene
and CC O
mu2 NN B-Gene
, , O
have VBP O
been VBN O
implicated VBN O
in IN O
two CD O
types NNS O
of IN O
interaction NN O
: : O
assembly NN O
with IN O
the DT O
beta1 NN B-Gene
and CC I-Gene
beta2 NN I-Gene
chains NNS I-Gene
of IN O
the DT O
corresponding NN O
complexes NNS O
and CC O
recognition NN O
of IN O
tyrosine NN O
- : O
based VBN O
sorting NN O
signals NNS O
. . O

We PRP O
conclude VBP O
from IN O
this DT O
study NN O
that WDT O
Arix NNP B-Gene
and CC O
NBPhox NNP B-Gene
exhibit NN O
indistinguishable JJ O
and CC O
independent JJ O
transcriptional JJ O
regulatory JJ O
properties NNS O
on IN O
the DT O
DBH NNP B-Gene
promoter NN I-Gene
. . O

Jkappa NNP B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
were VBD O
not RB O
required VBN O
for IN O
this DT O
activation NN O
, , O
and CC O
a DT O
mutant JJ B-Gene
EBNA NNP I-Gene
- : I-Gene
3C CD I-Gene
protein NN I-Gene
unable JJ O
to TO O
bind VB O
Jkappa NNP B-Gene
activated JJ O
transcription NN O
as RB O
efficiently RB O
as IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
EBNA NNP I-Gene
- : I-Gene
3C CD I-Gene
, , O
indicating VBG O
that IN O
EBNA NNP B-Gene
- : I-Gene
3C CD I-Gene
can MD O
regulate VB O
transcription NN O
through IN O
a DT O
mechanism NN O
that WDT O
is VBZ O
independent JJ O
of IN O
Jkappa NNP B-Gene
. . O

This DT O
family NN O
of IN O
proteins NNS O
binds NNS O
GC NNP O
- : O
rich JJ O
motifs NNS O
widely RB O
distributed VBN O
in IN O
gene NN O
promoters NNS O
, , O
resulting VBG O
in IN O
distinct JJ O
activation NN O
or CC O
repression NN O
of IN O
transcriptional JJ O
activities NNS O
. . O

Serum NNP B-Gene
IgM NNP I-Gene
and CC O
IgE NNP B-Gene
concentrations NNS O
, , O
allergen NN B-Gene
- : I-Gene
specific JJ I-Gene
IgE NNP I-Gene
scores NNS O
, , O
and CC O
the DT O
tumor NN O
E2R NNP B-Gene
status NN O
were VBD O
combined VBN O
to TO O
construct VB O
a DT O
three CD O
- : O
level NN O
risk NN O
classification NN O
that WDT O
was VBD O
more RBR O
prognostic JJ O
than IN O
any DT O
of IN O
the DT O
individual JJ O
components NNS O
. . O

Plasma NNP O
was VBD O
tested VBN O
before IN O
and CC O
after IN O
( ( O
14 CD O
+ NN O
/ NNP O
- : O
7 CD O
. . O
5 CD O
[ JJ O
SD NNP O
] NNP O
days NNS O
) ) O
surgery NN O
for IN O
IgG NNP B-Gene
antibodies NNS I-Gene
to TO O
the DT O
complex NN O
of IN O
heparin NN B-Gene
/ NNP I-Gene
platelet NN I-Gene
factor NN I-Gene
4 CD I-Gene
, , O
using VBG O
a DT O
standardized JJ O
, , O
validated VBD O
enzyme SYM O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
( ( O
ELISA NNP O
) ) O
. . O

A DT O
gene NN O
homologous JJ O
to TO O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
dnaA NN I-Gene
gene NN I-Gene
was VBD O
isolated VBN O
from IN O
Pseudomonas NNP O
putida NN O
and CC O
its PRP$ O
transcription NN O
was VBD O
investigated VBN O
in IN O
E NNP O
. . O
coli NN O
as RB O
well RB O
as IN O
in IN O
P NNP O
. . O
putida NN O
. . O

Because IN O
of IN O
the DT O
operon NN O
structure NN O
of IN O
this DT O
organism NN O
, , O
traditional JJ O
methods NNS O
such JJ O
as IN O
insertional JJ O
mutagenesis NN O
run VB O
the DT O
risk NN O
of IN O
introducing VBG O
polar JJ O
effects NNS O
on IN O
downstream NN O
genes NNS O
or CC O
creating VBG O
secondary JJ O
mutations NNS O
elsewhere RB O
in IN O
the DT O
genome NN O
. . O

Our PRP$ O
experiments NNS O
suggest VBP O
that IN O
the DT O
SCL NNP B-Gene
gene NN I-Gene
can MD O
be VB O
a DT O
target NN O
for IN O
the DT O
erythroid JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
GATA NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
that IN O
the DT O
SCL NNP B-Gene
gene NN I-Gene
product NN I-Gene
serves VBZ O
as IN O
a DT O
positive JJ O
regulator NN O
of IN O
erythroid JJ O
differentiation NN O
. . O

As IN O
high JJ O
- : O
speed NN O
, , O
volumetric JJ O
imaging NN O
, , O
computed VBD O
tomographic JJ O
scan JJ O
machines NNS O
such JJ O
as IN O
the DT O
Dynamic NNP O
Spatial NNP O
Reconstructor NNP O
become VBD O
available JJ O
with IN O
higher JJR O
density NN O
resolution NN O
, , O
perhaps RB O
a DT O
single JJ O
injection NN O
of IN O
contrast NN O
agent NN O
into IN O
the DT O
right JJ O
atrium NN O
or CC O
even RB O
a DT O
peripheral JJ O
vein NN O
may MD O
be VB O
adequate JJ O
to TO O
obtain VB O
all PDT O
these DT O
measurements NNS O
. . O

Endogenous JJ O
RMP NNP B-Gene
was VBD O
immunologically RB O
detected VBN O
interacting VBG O
with IN O
assembled JJ O
RPB5 NNP B-Gene
in IN O
RNA NNP B-Gene
polymerase NN I-Gene
in IN O
mammalian JJ O
cells NNS O
. . O

CONCLUSIONS NN O
: : O
AMVT NNP O
is VBZ O
rare JJ O
but CC O
a DT O
potentially RB O
lethal JJ O
emergency NN O
disease NN O
. . O

The DT O
protein NN O
coding VBG O
region NN O
, , O
1 CD O
, , O
696 CD O
bps NN O
long RB O
, , O
is VBZ O
divided VBN O
by IN O
an DT O
intron NN O
into IN O
two CD O
exons NNS O
. . O

In IN O
the DT O
mouse NN O
, , O
CtBP1 NNP B-Gene
is VBZ O
expressed VBN O
from IN O
embryo NN O
to TO O
adult VB O
, , O
but CC O
CtBP2 NNP B-Gene
is VBZ O
mainly RB O
expressed VBN O
during IN O
embryogenesis NN O
. . O

A DT O
thermal JJ O
Kubo NNP O
- : O
Martin NNP O
- : O
Schwinger NNP O
condition NN O
arises NNS O
due JJ O
to TO O
the DT O
coupling NN O
of IN O
a DT O
computer NN O
to TO O
a DT O
strong JJ O
periodic JJ O
source NN O
, , O
namely RB O
, , O
the DT O
daily JJ O
and CC O
weekly JJ O
usage NN O
patterns NNS O
of IN O
the DT O
system NN O
. . O

These DT O
characteristics NNS O
indicated VBD O
the DT O
pronounced JJ O
activity NN O
of IN O
collagenous JJ O
fiber JJ O
synthesis NN O
and CC O
the DT O
matrix NN O
of IN O
the DT O
osteoid JJ O
tissue NN O
. . O

Mitogen NNP B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinase NN I-Gene
phosphatase NN I-Gene
- : I-Gene
3 CD I-Gene
( ( O
MKP NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
is VBZ O
a DT O
dual JJ O
specificity NN O
phosphatase NN O
that WDT O
inactivates VBZ O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated VBN I-Gene
kinase NN I-Gene
( ( O
ERK NNP B-Gene
) ) O
MAP NNP B-Gene
kinases NNS I-Gene
. . O

Fifty NNP O
six CD O
young JJ O
patients NNS O
( ( O
age NN O
< VBZ O
45 CD O
yr NN O
) ) O
with IN O
doppler NN O
- : O
proven RB O
DVT NNP O
were VBD O
investigated VBN O
for IN O
the DT O
presence NN O
of IN O
resistance NN O
to TO O
activated VBN B-Gene
protein NN I-Gene
C NNP I-Gene
( ( O
APC NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
, , O
lupus JJ O
anticoagulant NN O
( ( O
LA NNP O
) ) O
, , O
anticardiolipin JJ B-Gene
antibodies NNS I-Gene
and CC O
deficiencies NNS O
of IN O
protein NN B-Gene
C NNP I-Gene
, , O
protein NN B-Gene
S NNP I-Gene
, , O
ATIII NNP B-Gene
activities NNS O
. . O

CONCLUSIONS NN O
: : O
Congenital JJ O
horizontal NN O
tarsal NN O
kink NN O
is VBZ O
rare JJ O
and CC O
its PRP$ O
cause NN O
is VBZ O
unknown JJ O
. . O

( ( O
5 CD O
) ) O
No DT O
changes NNS O
were VBD O
observed VBN O
in IN O
the DT O
gastric JJ O
venous JJ O
blood NN O
flow NN O
by IN O
continuous JJ O
intravenous JJ O
injection NN O
of IN O
cimetidine NN O
, , O
but CC O
by IN O
rapid JJ O
injection NN O
both DT O
the DT O
flow NN O
was VBD O
augmented VBN O
and CC O
the DT O
systemic JJ O
blood NN O
pressure NN O
decreased VBD O
transiently RB O
. . O

Two CD O
of IN O
these DT O
motifs NNS O
are VBP O
part NN O
of IN O
a DT O
highly RB O
conserved VBN O
and CC O
inducible JJ O
dyad NN O
symmetry NN O
element VBD O
shown VBN O
previously RB O
to TO O
control VB O
a DT O
remote JJ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
enhancer NN I-Gene
and CC O
the DT O
CD18 NNP B-Gene
promoter NN I-Gene
. . O

About RB O
20 CD O
% NN O
of IN O
single JJ O
- : O
stranded VBD O
DNA NNP O
binding NN O
was VBD O
observed VBN O
in IN O
the DT O
presence NN O
of IN O
MgdTDP NNP O
, , O
but CC O
none NN O
was VBD O
detectable JJ O
in IN O
the DT O
absence NN O
of IN O
nucleotides NNS O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
FCR1 NNP B-Gene
gene NN I-Gene
behaves NNS O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
drug NN O
resistance NN O
in IN O
C NNP O
. . O
albicans NNS O
and CC O
constitute VB O
the DT O
first JJ O
evidence NN O
that IN O
FCZ NNP O
resistance NN O
can MD O
result VB O
from IN O
the DT O
inactivation NN O
of IN O
a DT O
regulatory JJ O
factor NN O
such JJ O
as IN O
Fcr1p NNP B-Gene
. . O

Using VBG O
this DT O
method NN O
, , O
we PRP O
measured VBD O
absorption NN O
of IN O
low JJ O
doses NNS O
of IN O
vitamin NN O
A NNP O
, , O
which WDT O
may MD O
provide VB O
a DT O
more RBR O
physiological JJ O
approach NN O
to TO O
assessment NN O
of IN O
fat JJ O
malabsorption NN O
. . O

Magnetically RB O
induced JJ O
optical JJ O
self NN O
- : O
pulsing NN O
in IN O
a DT O
nonlinear JJ O
resonator NN O
. . O

In IN O
the DT O
PMR NNP O
target NN O
area NN O
but CC O
not RB O
in IN O
the DT O
nontreated JJ O
area NN O
an DT O
improvement NN O
in IN O
regional JJ O
myocardial JJ O
flow NN O
reserve NN O
occurs VBZ O
in IN O
wall NN O
segments NNS O
with IN O
initially RB O
severely RB O
or CC O
moderately RB O
reduced JJ O
stress NN O
perfusion NN O
. . O

Here RB O
we PRP O
show VBP O
that DT O
independent JJ O
of IN O
uncertainties NNS O
in IN O
the DT O
models NNS O
, , O
terrestrial JJ O
planets NNS O
with IN O
dense NN O
atmosphere NN O
like IN O
Venus NNP O
can MD O
evolve VB O
into IN O
one CD O
of IN O
only RB O
four CD O
possible JJ O
rotation NN O
states NNS O
. . O

Monotherapy NN O
with IN O
ceftazidime NN O
was VBD O
clinically RB O
and CC O
bacteriologically RB O
as RB O
effective JJ O
as IN O
a DT O
combination NN O
therapy NN O
with IN O
cefazolin NN O
and CC O
tobramycin NN O
. . O

Radionuclide NNP O
study NN O
and CC O
endomyocardial JJ O
biopsy NN O
revealed VBD O
remarkable JJ O
degeneration NN O
of IN O
myocardium NN O
. . O

The DT O
immunosuppressant JJ O
FK506 NNP O
inhibits NNS O
amino VBP O
acid JJ O
import NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Labial JJ O
bar NN O
. . O

Multivariate JJ O
predictors NNS O
were VBD O
concentric JJ O
remodeling NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
; : O
odds NNS O
ratio VBP O
, , O
13 CD O
. . O
5 CD O
) ) O
, , O
left VBD O
ventricular JJ O
ejection NN O
fraction NN O
> VBD O
2 CD O
SD NNP O
above IN O
normal JJ O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
single JJ O
- : O
vessel NN O
left VBD O
circumflex JJ O
disease NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
7 CD O
; : O
odds NNS O
ratio VBP O
, , O
7 CD O
. . O
6 CD O
) ) O
. . O

W NNP O
. . O

Low JJ O
molecular JJ O
weight NN O
heparins NNS O
have VBP O
stimulated VBN O
much JJ O
interest NN O
because IN O
of IN O
their PRP$ O
supposedly RB O
more RBR O
selective JJ O
action NN O
on IN O
Xa NNP B-Gene
factor NN I-Gene
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
CT NNP O
should MD O
be VB O
routinely RB O
employed VBN O
in IN O
patients NNS O
with IN O
N1 NNP O
- : O
N3 NNP O
neck NN O
disease NN O
to TO O
determine VB O
the DT O
proper JJ O
electron NN O
- : O
energy NN O
prescription NN O
. . O

Elevation NN O
of IN O
intracellular JJ O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
levels NNS O
are VBP O
also RB O
involved JJ O
because IN O
treatment NN O
with IN O
receptor NN O
- : O
associated VBN O
protein NN O
, , O
nifedipine NN O
, , O
MK801 NNP O
, , O
removal NN O
of IN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
from IN O
the DT O
medium NN O
and CC O
dantrolene NN O
all DT O
served VBD O
to TO O
inhibit VB O
calcium JJ O
elevation NN O
and CC O
attenuate VB O
the DT O
activation NN O
of IN O
CREB NNP B-Gene
. . O

Chronic NNP O
E NNP O
- : O
B NNP O
virus NN O
infection NN O
terminated VBN O
in IN O
malignant JJ O
lymphoma NN O
: : O
a DT O
case NN O
report NN O

The DT O
cdr1 NN B-Gene
sequence NN I-Gene
includes VBZ O
an DT O
additional JJ O
237 CD O
amino JJ O
acids NNS O
of IN O
the DT O
contiguous JJ O
fragment NN O
and CC O
encodes VBZ O
a DT O
product NN O
of IN O
predicted JJ O
Mr NNP O
67 CD O
, , O
0 CD O
. . O

In IN O
mice NN O
, , O
three CD O
major JJ O
families NNS O
of IN O
L1 NNP O
elements NNS O
, , O
termed VBN O
"""" IN O
A NNP O
, , O
"""" NNP O
"""" NNP O
F NNP O
, , O
"""" NNP O
and CC O
"""" NNP O
V NNP O
, , O
"""" NNP O
have VBP O
been VBN O
defined VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
sequence NN O
found VBD O
at IN O
the DT O
5 CD O
' POS O
terminus NN O
. . O

Cloning VBG O
and CC O
characterization NN O
of IN O
human JJ B-Gene
Lnk NNP I-Gene
, , O
an DT O
adaptor NN O
protein NN O
with IN O
pleckstrin JJ B-Gene
homology NN O
and CC O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
domains NNS I-Gene
that WDT O
can MD O
inhibit VB O
T NNP O
cell NN O
activation NN O
. . O

16 CD O
women NNS O
were VBD O
treated VBN O
with IN O
methadone NN O
to TO O
prevent VB O
withdrawal NN O
symptoms NNS O
. . O

In IN O
the DT O
final JJ O
model NN O
, , O
grade NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
2 CD O
) ) O
, , O
peritoneal JJ O
cytologic JJ O
results NNS O
( ( O
p JJ O
= NN O
0 CD O
. . O
2 CD O
) ) O
, , O
progesterone JJ B-Gene
receptor NN I-Gene
status NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
4 CD O
) ) O
, , O
and CC O
age NN O
as IN O
a DT O
continuous JJ O
variable NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
8 CD O
) ) O
were VBD O
most RBS O
closely RB O
associated VBN O
with IN O
disease NN O
- : O
free JJ O
survival NN O
. . O

The DT O
cardiac JJ B-Gene
myosin NN I-Gene
light NN I-Gene
chain NN I-Gene
- : I-Gene
2 CD I-Gene
( ( O
MLC NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
gene NN O
promoter NN O
contains VBZ O
several JJ O
positive JJ O
and CC O
negative JJ O
cis NN O
- : O
acting NN O
sequences NNS O
that WDT O
are VBP O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
its PRP$ O
expression NN O
. . O

FAK NNP B-Gene
localizes VBZ O
to TO O
sites NNS O
of IN O
transmembrane NN B-Gene
integrin NN I-Gene
receptor NN I-Gene
clustering NN O
and CC O
facilitates VBZ O
intracellular JJ O
signaling VBG O
events NNS O
. . O

The DT O
MCA NNP O
and CC O
UA NNP O
PI NNP O
values VBZ O
showed VBD O
the DT O
greatest JJS O
deviation NN O
for IN O
any DT O
single JJ O
- : O
vessel NN O
parameter NN O
. . O

Junctions NNS O
between IN O
cells NNS O
of IN O
the DT O
human JJ O
enamel NN O
organ NN O
. . O

An DT O
endometrial JJ O
luteal NN O
phase NN O
deficiency NN O
was VBD O
detected VBN O
in IN O
15 CD O
( ( O
30 CD O
% NN O
) ) O
of IN O
aborting VBG O
patients NNS O
. . O

Technique NN O
for IN O
obtaining VBG O
refined VBN O
ceramics NNS O
with IN O
dense JJ O
mass NN O

The DT O
distribution NN O
of IN O
cryptosporidia NN O
in IN O
the DT O
intestine NN O
and CC O
number NN O
of IN O
cryptosporidia JJ O
per IN O
ileal NN O
villus NN O
on IN O
different JJ O
DPI NNP O
were VBD O
also RB O
estimated VBN O
for IN O
detailed JJ O
characterization NN O
of IN O
the DT O
infection NN O
in IN O
kids NNS O
as IN O
a DT O
model NN O
for IN O
experimental JJ O
cryptosporidiosis NN O
. . O

Northern NNP O
blotting VBG O
analysis NN O
indicates VBZ O
that IN O
expression NN O
of IN O
the DT O
genes NNS O
corresponding VBG O
to TO O
these DT O
clones NNS O
is VBZ O
confined VBN O
to TO O
pollen VB O
tissue NN O
. . O

The DT O
first JJ O
contains VBZ O
ATF NNP B-Gene
/ NNP O
CRE NNP O
and CC O
TBP NNP B-Gene
/ NNP O
TATA NNP O
sequence NN O
motifs NNS O
within IN O
an DT O
87 CD O
- : O
bp NN O
region NN O
. . O

Both DT O
pancreatic JJ O
and CC O
intestinal JJ O
cell NN O
lines NNS O
were VBD O
found VBN O
to TO O
express VB O
a DT O
number NN O
of IN O
POU NNP B-Gene
( ( O
OCT NNP B-Gene
binding VBG O
) ) O
homeodomain NN O
proteins NNS O
examined VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
chloroplast NN O
( ( O
cp NN O
) ) O
DNA NN O
from IN O
maize NN O
( ( O
Zea NNP O
mays NNS O
) ) O
has VBZ O
been VBN O
completed VBN O
. . O

Despite IN O
the DT O
reported VBN O
detrimental JJ O
effects NNS O
on IN O
CNS NNP O
development NN O
, , O
a DT O
number NN O
of IN O
animal JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
pretreatment NN O
with IN O
corticosteroids NNS O
nevertheless RB O
protect VBP O
the DT O
brain NN O
from IN O
hypoxia JJ O
- : O
ischemic JJ O
injury NN O
; : O
however RB O
, , O
clinically RB O
such JJ O
treatment NN O
is VBZ O
no RB O
longer RB O
favored VBN O
. . O

Since IN O
CENP NNP B-Gene
- : I-Gene
B NNP I-Gene
gene NN I-Gene
is VBZ O
conserved VBN O
in IN O
mammalian JJ O
species NNS O
and CC O
CENP NNP B-Gene
- : I-Gene
B NN I-Gene
boxes NNS I-Gene
are VBP O
found VBN O
also RB O
in IN O
mouse NN O
centromere EX O
satellite JJ O
DNA NNP O
( ( O
minor JJ O
satellite NN O
) ) O
, , O
this DT O
sequence NN O
- : O
specific JJ O
DNA NNP O
- : O
protein NN O
interaction NN O
may MD O
be VB O
important JJ O
for IN O
some DT O
kind NN O
of IN O
common JJ O
centromere JJ O
function NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
and CC O
coimmunoprecipitation NN O
studies NNS O
suggest VBP O
that IN O
homo NN O
- : O
and CC O
heterodimerization NN O
occurs NNS O
between IN O
cKrox NNS B-Gene
family NN I-Gene
members NNS I-Gene
. . O

A DT O
genetic JJ O
and CC O
molecular JJ O
analysis NN O
of IN O
non JJ O
- : O
inducible JJ O
qutA NN B-Gene
mutants NNS I-Gene
showed VBD O
that IN O
all DT O
23 CD O
mutations NNS O
analysed VBD O
map NN O
within IN O
the DT O
N NNP O
- : O
terminal JJ O
half NN O
of IN O
the DT O
encoded JJ O
QUTA NNP B-Gene
protein NN I-Gene
. . O

There EX O
were VBD O
27 CD O
men NNS O
and CC O
156 CD O
women NNS O
. . O

The DT O
individual JJ O
subunits NNS O
of IN O
Ku NNP B-Gene
have VBP O
been VBN O
difficult JJ O
to TO O
isolate VB O
from IN O
human JJ O
cells NNS O
without IN O
denaturation NN O
and CC O
attempts NNS O
to TO O
produce VB O
functional JJ B-Gene
recombinant NN I-Gene
Ku NNP I-Gene
have VBP O
been VBN O
largely RB O
unsuccessful JJ O
. . O

Enhancers NNS O
containing VBG O
disrupted VBN O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
were VBD O
tested VBN O
in IN O
transient JJ O
expression NN O
assays NNS O
in IN O
the DT O
murine NN O
T NNP O
- : O
cell NN O
line NN O
EL4 NNP O
. . O
E1 NNP O
; : O
alterations NNS O
in IN O
the DT O
LVb NNP O
element NN O
affected VBD O
constitutive JJ O
enhancer NN O
activity NN O
, , O
while IN O
mutation NN O
of IN O
either CC O
the DT O
LVb NNP O
or CC O
LVc NNP O
element NN O
disrupted VBD O
phorbol NN O
ester NN O
- : O
induced JJ O
enhancer NN O
activity NN O
. . O

Most JJS O
kinases NNS O
are VBP O
not RB O
significantly RB O
inhibited VBN O
by IN O
roscovitine NN O
. . O

cdc2 NN B-Gene
/ NNP O
cyclin NN B-Gene
B NNP I-Gene
, , O
cdk2 NN B-Gene
/ NNP O
cyclin VBZ B-Gene
A NNP I-Gene
, , O
cdk2 NN B-Gene
/ NNP O
cyclin NN B-Gene
E NNP I-Gene
and CC O
cdk5 VB B-Gene
/ NNP O
p35 IN B-Gene
only RB O
are VBP O
substantially RB O
inhibited VBN O
( ( O
IC50 NNP O
values NNS O
of IN O
0 CD O
. . O
65 CD O
, , O
0 CD O
. . O
7 CD O
, , O
0 CD O
. . O
7 CD O
and CC O
0 CD O
. . O
2 CD O
microM NN O
, , O
respectively RB O
) ) O
. . O

cdk4 NN B-Gene
/ NNP O
cyclin NN B-Gene
D1 NNP I-Gene
and CC O
cdk6 VB B-Gene
/ NNP O
cyclin NN B-Gene
D2 NNP I-Gene
are VBP O
very RB O
poorly RB O
inhibited VBN O
by IN O
roscovitine NN O
( ( O
IC50 NNP O
> VBZ O
100 CD O
microM NN O
) ) O
. . O

Differential JJ O
drawing VBG O
size NN O
associated VBN O
with IN O
unilateral JJ O
brain NN O
damage NN O
. . O

Analyses NNS O
revealed VBD O
that IN O
scale NN O
matters NNS O
above IN O
and CC O
beyond IN O
the DT O
effect NN O
of IN O
quadrat JJ O
area NN O
. . O

Consistent JJ O
with IN O
this DT O
interpretation NN O
, , O
recombinant JJ B-Gene
CREB NNP I-Gene
and CC O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
proteins VBZ I-Gene
bound IN O
the DT O
junB NN B-Gene
CRE NNP O
- : O
like IN O
site NN O
, , O
but CC O
did VBD O
not RB O
interact VB O
with IN O
a DT O
mutant JJ O
CRE NNP O
- : O
like IN O
site NN O
. . O

Efforts NNS O
were VBD O
made VBN O
to TO O
determine VB O
the DT O
amount NN O
of IN O
time NN O
required VBN O
for IN O
kidney NN O
lesions NNS O
to TO O
develop VB O
and CC O
, , O
if IN O
possible JJ O
, , O
to TO O
delineate VB O
the DT O
potential JJ O
site NN O
of IN O
action NN O
of IN O
PBB NNP O
. . O

It PRP O
could MD O
also RB O
inhibit VB O
C1q NNP B-Gene
- : O
dependent JJ O
haemolysis NN O
of IN O
both DT O
IgG NNP B-Gene
- : O
and CC O
IgM NNP B-Gene
- : O
sensitized VBN O
erythrocytes NNS O
. . O

Similar JJ O
results NNS O
were VBD O
seen VBN O
on IN O
Western JJ O
blots NNS O
of IN O
Autographa NNP O
californica NN O
MNPV NNP O
( ( O
AcMNPV NNP O
) ) O
- : O
infected VBN O
Spodoptera NNP O
frugiperda NN O
cells NNS O
. . O

Effects NNS O
of IN O
early JJ O
monocular JJ O
deprivation NN O
on IN O
development NN O
of IN O
cortico NN O
- : O
geniculate NN O
projections NNS O
in IN O
the DT O
cat NN O
. . O

Cochlear NNP O
microphonic JJ O
potentials NNS O
in IN O
patients NNS O
with IN O
vestibular JJ O
schwannomas NN O
. . O

Snail NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
are VBP O
zinc JJ O
finger JJ O
transcriptional JJ O
regulators NNS O
first RB O
identified VBN O
in IN O
Drosophila NNP O
which WDT O
play VBP O
critical JJ O
roles NNS O
in IN O
cell NN O
fate NN O
determination NN O
. . O

In IN O
diethyl NN O
ether CC O
solution NN O
the DT O
main JJ O
peak NN O
is VBZ O
that IN O
of IN O
2 CD O
- : O
benzylidenamio NN O
- : O
1 CD O
- : O
phenylpropane NN O
, , O
which WDT O
has VBZ O
a DT O
retention NN O
time NN O
of IN O
23 CD O
, , O
2 CD O
minutes NNS O
under IN O
the DT O
condition NN O
delineated VBD O
. . O

Pol32Delta NNP B-Gene
strains NNS O
are VBP O
weak JJ O
antimutators NNS O
and CC O
are VBP O
defective JJ O
for IN O
damage NN O
- : O
induced JJ O
mutagenesis NN O
. . O

RESULTS NN O
: : O
Closure JJ O
time NN O
of IN O
fistulas NNS O
in IN O
patients NNS O
receiving VBG O
TPN NNP O
+ NNP O
somatostatin NN B-Gene
was VBD O
significantly RB O
shorter JJR O
( ( O
13 CD O
. . O
86 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
84 CD O
versus NN O
20 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
89 CD O
days NNS O
) ) O
than IN O
in IN O
those DT O
receiving VBG O
TPN NNP O
alone RB O
. . O

The DT O
effect NN O
of IN O
lithium NN O
on IN O
the DT O
osmoregulation NN O
of IN O
arginine JJ B-Gene
vasopressin NN I-Gene
secretion NN O
. . O

Paul NNP O
Monagle NNP O
addresses VBZ O
the DT O
epidemiology NN O
of IN O
neonatal JJ O
thrombosis NN O
outside IN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
in IN O
both DT O
arterial JJ O
and CC O
venous JJ O
locations NNS O
, , O
and CC O
those DT O
that WDT O
occur VBP O
in IN O
utero NN O
. . O

Again RB O
residue JJ O
Glu NNP O
- : O
381 CD O
of IN O
beta NN O
was VBD O
notably RB O
reduced VBN O
and CC O
no DT O
missing VBG O
residue NN O
from IN O
the DT O
epsilon NN O
peptide NN O
could MD O
be VB O
identified VBN O
, , O
but CC O
the DT O
peptide JJ O
sequence NN O
limited VBD O
the DT O
possible JJ O
choices NNS O
to TO O
Ser NNP O
- : O
106 CD O
, , O
Ser NNP O
- : O
107 CD O
, , O
or CC O
Ser NNP O
- : O
108 CD O
. . O

Ventral JJ O
rhinotomy NN O
is VBZ O
no DT O
more RBR O
difficult JJ O
than IN O
dorsal JJ O
rhinotomy NN O
, , O
has VBZ O
less JJR O
patient JJ O
morbidity NN O
and CC O
fewer JJR O
postoperative JJ O
complications NNS O
, , O
and CC O
is VBZ O
more RBR O
cosmetically RB O
acceptable JJ O
. . O

After IN O
resection NN O
of IN O
the DT O
proximal JJ O
fragment NN O
, , O
all DT O
scaphoid JJ O
contact NN O
area NN O
and CC O
pressure NN O
was VBD O
born VBN O
by IN O
the DT O
distal JJ O
scaphoid JJ O
fragment NN O
. . O

The DT O
results NNS O
presented VBD O
here RB O
show VBP O
that IN O
AR1 NNP B-Gene
of IN O
the DT O
promoter NN O
- : O
proximal JJ O
CAP NNP B-Gene
subunit NN I-Gene
was VBD O
required VBN O
for IN O
papBA JJ B-Gene
transcription NN O
even RB O
in IN O
the DT O
absence NN O
of IN O
the DT O
histone NN B-Gene
- : I-Gene
like IN I-Gene
protein NN I-Gene
H NNP B-Gene
- : I-Gene
NS NN I-Gene
. . O

Approximately RB O
50 CD O
% NN O
of IN O
the DT O
residues NNS O
are VBP O
conserved VBN O
among IN O
all DT O
three CD O
sequences NNS O
, , O
yet RB O
all DT O
three CD O
viruses NNS O
have VBP O
retained VBN O
response NN O
elements NNS O
for IN O
glucocorticoids NNS O
, , O
two CD O
positionally RB O
conserved VBN O
CCAAT NNP O
boxes NNS O
, , O
and CC O
positionally RB O
conserved VBN O
TATA NNP O
boxes NNS O
. . O

Electrophile NNP O
Response NNP O
Elements NNP O
( ( O
EpREs NNP O
) ) O
, , O
located VBN O
in IN O
5 CD O
' POS O
- : O
flanking NN O
sequences NNS O
of IN O
both DT O
the DT O
GCSh NNP B-Gene
and CC O
GCSl NNP B-Gene
subunit NN I-Gene
genes NNS I-Gene
, , O
are VBP O
hypothesized VBN O
to TO O
at IN O
least JJS O
partially RB O
mediate JJ O
gene NN O
induction NN O
following VBG O
xenobiotic JJ O
exposure NN O
. . O

As IN O
demonstrated VBN O
by IN O
gel JJ O
mobility NN O
shift NN O
analysis NN O
and CC O
supershift NN O
experiments NNS O
, , O
FIRE1 NNP B-Gene
, , O
located VBN O
between IN O
- : O
516 CD O
and CC O
- : O
498 CD O
, , O
is VBZ O
responsible JJ O
for IN O
binding VBG O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
. . O

Aviators NNS O
from IN O
the DT O
Light NNP O
Attack NNP O
Wing NNP O
, , O
Pacific NNP O
were VBD O
surveyed VBN O
and CC O
the DT O
results NNS O
were VBD O
categorized VBN O
by IN O
aircraft NN O
type NN O
. . O

Nonlocal JJ O
approach NN O
to TO O
scattering VBG O
in IN O
a DT O
one CD O
- : O
dimensional NN O
problem NN O
. . O

Although IN O
the DT O
risk NN O
of IN O
malformation NN O
in IN O
children NNS O
born VBN O
after IN O
ICSI NNP O
is VBZ O
not RB O
increased VBN O
there EX O
is VBZ O
an DT O
increased JJ O
risk NN O
to TO O
transmit VB O
genetic JJ O
abnormalities NNS O
in IN O
case NN O
of IN O
NOA NNP O
( ( O
such JJ O
as IN O
the DT O
rate NN O
of IN O
sex NN O
chromosome NN O
, , O
or CC O
microdeletions NNS O
of IN O
the DT O
Y NNP O
chromosome NN O
) ) O
and CC O
in IN O
case NN O
of IN O
congenital JJ O
OA NNP O
( ( O
mutations NNS O
of IN O
the DT O
cystic JJ B-Gene
fibrosis NN I-Gene
gene NN I-Gene
) ) O
. . O

Several JJ O
demographic JJ O
indices NNS O
of IN O
isolated JJ O
populations NNS O
in IN O
Uzbekistan NNP O

METHODS NN O
: : O
Between NNP O
August NNP O
1991 CD O
and CC O
June NNP O
1994 CD O
, , O
198 CD O
men NNS O
with IN O
clinical JJ O
T2 NNP O
or CC O
T3 NNP O
classified VBD O
( ( O
TNM NNP O
) ) O
prostate NN O
carcinoma NN O
( ( O
bone JJ O
scan JJ O
negative NN O
) ) O
who WP O
were VBD O
at IN O
high JJ O
risk NN O
of IN O
lymph JJ O
node JJ O
involvement NN O
underwent VBD O
a DT O
111In CD O
- : O
capromab NN O
pendetide JJ O
scan JJ O
prior NN O
to TO O
staging VBG O
lymphadenectomy NN O
. . O

The DT O
sera NN O
and CC O
nasal JJ O
secretions NNS O
of IN O
142 CD O
patients NNS O
, , O
who WP O
were VBD O
positive JJ O
in IN O
HD NNP O
or CC O
mites NNS O
skin JJ O
test NN O
, , O
were VBD O
subjected VBN O
to TO O
a DT O
radioallergosorbent JJ O
test NN O
( ( O
RAST NNP O
) ) O
for IN O
estimating VBG O
the DT O
specific JJ O
IgE NNP B-Gene
antibody NN I-Gene
activity NN O
to TO O
mites NNS O
. . O

Group NNP O
6 CD O
was VBD O
given VBN O
physostigmine NN O
, , O
0 CD O
. . O
1 CD O
mg JJ O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
, , O
known VBN O
to TO O
inhibit VB O
cholinesterase JJ B-Gene
degradation NN O
, , O
5 CD O
min NN O
before IN O
bupivacaine JJ O
administration NN O
, , O
and CC O
Group NNP O
7 CD O
received VBD O
a DT O
combination NN O
of IN O
physostigmine JJ O
pretreatment NN O
and CC O
electrical JJ O
vagal JJ O
stimulation NN O
. . O

IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
acts NNS O
as IN O
a DT O
transcriptional JJ O
activator NN O
, , O
while IN O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
acts NNS O
as IN O
a DT O
repressor NN O
. . O

A DT O
single JJ O
case NN O
of IN O
an DT O
adenocarcinoma NN O
, , O
arising VBG O
in IN O
a DT O
retroperitoneal NN O
enterogenous JJ O
cyst NN O
and CC O
which WDT O
presented VBD O
as IN O
a DT O
left JJ O
renal JJ O
cyst NN O
, , O
is VBZ O
reported VBN O
. . O

This DT O
5 CD O
' POS O
splice NN O
site NN O
sequence NN O
was VBD O
required VBN O
for IN O
enhanced JJ O
polyadenylation NN O
and CC O
was VBD O
recognized VBN O
by IN O
both DT O
U1 NNP B-Gene
small JJ I-Gene
nuclear JJ I-Gene
ribonucleoproteins NNS I-Gene
( ( O
snRNPs NN O
) ) O
and CC O
alternative JJ B-Gene
splicing NN I-Gene
factor NN I-Gene
/ IN O
splicing VBG B-Gene
factor NN I-Gene
2 CD I-Gene
( ( O
ASF NNP B-Gene
/ NNP O
SF2 NNP B-Gene
) ) O
. . O

Tests NNS O
of IN O
the DT O
method NN O
indicate NN O
( ( O
1 CD O
) ) O
the DT O
Mossbauer NNP O
source NN O
can MD O
be VB O
placed VBN O
on IN O
the DT O
basilar JJ O
membrane NN O
without IN O
altering VBG O
the DT O
signal JJ O
- : O
transmission NN O
properties NNS O
of IN O
the DT O
cochlea NN O
, , O
and CC O
( ( O
2 CD O
) ) O
the DT O
source NN O
adheres VBZ O
to TO O
the DT O
basilar JJ O
membrane NN O
. . O

Copyright JJ O
1998 CD O
Academic NNP O
Press NNP O
. . O

Marker NNP O
rescue NN O
analysis NN O
has VBZ O
localized VBN O
ts8 NN B-Gene
to TO O
a DT O
910 CD O
- : O
bp NN O
internal JJ O
segment NN O
of IN O
rpoB NN B-Gene
that WDT O
encodes VBZ O
the DT O
Rif NNP B-Gene
domain NN I-Gene
. . O

Children NNP O
with IN O
defective JJ O
vision NN O

Dementia NN O
is VBZ O
being VBG O
avoided VBN O
in IN O
NHS NNP O
and CC O
social JJ O
care NN O
. . O

Neither DT O
verapamil NN O
nor CC O
nifedipine JJ O
changed VBN O
collateral JJ O
myocardial JJ O
blood NN O
flow NN O
from IN O
0 CD O
. . O
10 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
2 CD O
in IN O
the DT O
subendocardium NN O
and CC O
0 CD O
. . O
17 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
ml JJ O
/ NNP O
min NN O
/ NNP O
g NN O
in IN O
the DT O
subepicardium NN O
. . O

In IN O
vitro JJ O
translation NN O
experiments NNS O
show VBP O
that IN O
human JJ O
cDNA NN O
derived VBD O
RNA NNP O
translates VBZ O
into IN O
a DT O
protein NN O
with IN O
a DT O
mobility NN O
of IN O
44 CD O
- : O
46 CD O
kD NN O
on IN O
SDS NNP O
polyacrylamide NN O
gels NNS O
. . O

One CD O
hundred CD O
replicate NN O
data NNS O
sets NNS O
of IN O
100 CD O
subjects NNS O
each DT O
were VBD O
simulated VBN O
for IN O
each DT O
missing VBG O
data NNS O
scenario NN O
. . O

Folate NNP O
metabolism NN O
in IN O
the DT O
human JJ O
malaria NN O
parasite NN O
Plasmodium NNP O
falciparum NN O
is VBZ O
an DT O
essential JJ O
activity NN O
for IN O
cell NN O
growth NN O
and CC O
replication NN O
, , O
and CC O
the DT O
target NN O
of IN O
an DT O
important JJ O
class NN O
of IN O
therapeutic JJ O
agents NNS O
in IN O
widespread JJ O
use NN O
. . O

For IN O
these DT O
patients NNS O
the DT O
introduction NN O
of IN O
a DT O
separate JJ O
category NN O
"""" NNP O
extended VBD O
oligoarthritis NN O
at IN O
onset JJ O
"""" NN O
should MD O
be VB O
considered VBN O
to TO O
establish VB O
comparable JJ O
patient JJ O
groups NNS O
. . O

Polysome NNP O
analysis NN O
further RB O
indicated VBD O
that IN O
these DT O
germ NNS B-Gene
cell VBP I-Gene
- : I-Gene
specific JJ I-Gene
Sp1 NNP I-Gene
mRNAs NN I-Gene
are VBP O
translated VBN O
, , O
albeit IN O
with IN O
a DT O
lower JJR O
efficiency NN O
than IN O
the DT O
somatic JJ O
transcript NN O
. . O

YAC NN O
and CC O
cosmid NN O
contigs NNS O
spanning VBG O
the DT O
BRCA1 NNP B-Gene
region NN I-Gene
were VBD O
used VBN O
to TO O
select VB O
cDNA NN O
clones NNS O
from IN O
pools NNS O
of IN O
cDNAs NN O
derived VBN O
from IN O
human JJ O
placenta NN O
, , O
HeLa NNP O
cells NNS O
, , O
activated VBD O
T NNP O
cells NNS O
, , O
and CC O
fetal JJ O
head NN O
. . O

A DT O
soluble JJ O
62 CD O
- : O
kDa NN O
protein NN O
was VBD O
produced VBN O
without IN O
the DT O
proteolytic JJ O
processing NN O
by IN O
inserting VBG O
the DT O
coding VBG O
sequence NN O
of IN O
amino JJ O
acids NNS O
112 CD O
to TO O
660 CD O
of IN O
ORF NNP O
- : O
2 CD O
in IN O
a DT O
baculovirus NN O
expression NN O
vector NN O
and CC O
using VBG O
the DT O
corresponding JJ O
virus NN O
to TO O
infect VB O
Sf9 NNP O
cells NNS O
. . O

In IN O
rats NNS O
anaesthetized VBN O
with IN O
+ NNP O
- : O
chloralose VBD O
the DT O
changes NNS O
in IN O
extracellular JJ O
pH NN O
and CC O
K NNP O
+ NNP O
in IN O
spinal JJ O
cord NN O
dorsal NN O
horn VBN O
were VBD O
studied VBN O
using VBG O
pH NN O
and CC O
K NNP O
+ NNP O
ion NN O
- : O
selective JJ O
electrodes NNS O
. . O

Human NNP B-Gene
AP NNP I-Gene
- : I-Gene
2rep CD I-Gene
repressed VBD O
both DT O
reporter JJ O
expression NN O
from IN O
a DT O
transiently RB O
transfected VBN O
AP NNP B-Gene
- : I-Gene
2alpha CD I-Gene
promoter NN I-Gene
and CC O
the DT O
endogenous JJ O
AP NNP B-Gene
- : I-Gene
2alpha CD I-Gene
gene NN I-Gene
and CC O
inversely RB O
was VBD O
negatively RB O
regulated VBN O
by IN O
AP NNP B-Gene
- : I-Gene
2alpha CD I-Gene
. . O

The DT O
presence NN O
of IN O
circulating VBG O
platelet NN O
aggregates NNS O
and CC O
elevated JJ O
levels NNS O
of IN O
fibrinopeptide NN B-Gene
A NNP I-Gene
( ( O
a DT O
cleavage NN O
product NN O
of IN O
fibrin NN B-Gene
) ) O
suggests VBZ O
that IN O
platelet NN O
activation NN O
and CC O
fibrin JJ B-Gene
deposition NN O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
this DT O
disorder NN O
. . O

Because IN O
the DT O
adrenergic NN O
nervous JJ O
system NN O
influences NNS O
cardiac JJ O
arrhythmias NN O
and CC O
myocardial JJ O
infarction NN O
can MD O
directly RB O
affect VB O
sympathetic JJ O
innervation NN O
in IN O
the DT O
heart NN O
, , O
we PRP O
investigated VBD O
the DT O
role NN O
of IN O
the DT O
sympathetic JJ O
nervous JJ O
system NN O
on IN O
reentry NN O
in IN O
the DT O
canine JJ O
heart NN O
4 CD O
days NNS O
after IN O
infarction NN O
. . O

They PRP O
have VBP O
not RB O
been VBN O
previously RB O
reported VBN O
as IN O
a DT O
reaction NN O
to TO O
i VB O
. . O
v NN O
. . O
contrast NN O
material NN O
. . O

A DT O
1 CD O
- : O
base NN O
pair NN O
mismatch NN O
within IN O
the DT O
corresponding JJ O
region NN O
of IN O
the DT O
CYP3A4 NNP B-Gene
gene NN I-Gene
was VBD O
sufficient JJ O
for IN O
a DT O
differential JJ O
enhancer NN O
activity NN O
. . O

In IN O
addition NN O
, , O
stonin VBD B-Gene
2 CD I-Gene
binds NNS O
to TO O
the DT O
C2B NNP O
domains NNS O
of IN O
synaptotagmins NNS B-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
. . O

On IN O
the DT O
role NN O
of IN O
transferrin NN B-Gene
in IN O
the DT O
uptake NN O
of IN O
gallium NN O
by IN O
tumor NN O
cells NNS O
. . O

Laboratory NN O
studies NNS O
using VBG O
Ca45 NNP O
labeled VBD O
teeth NNS O
and CC O
biologically RB O
stained VBD O
teeth NNS O
confirmed VBD O
that IN O
the DT O
dentifrice NN O
did VBD O
not RB O
decalcify VB O
enamel NN O
or CC O
bleach NN O
teeth NNS O
. . O

The DT O
yeast NN B-Gene
RER2 NNP I-Gene
gene NN I-Gene
, , O
identified VBN O
by IN O
endoplasmic JJ O
reticulum NN O
protein NN O
localization NN O
mutations NNS O
, , O
encodes NNS O
cis VBP B-Gene
- : I-Gene
prenyltransferase NN I-Gene
, , O
a DT O
key JJ O
enzyme NN O
in IN O
dolichol NN O
synthesis NN O
. . O

The DT O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
kinase NN I-Gene
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
functions NNS O
downstream NN O
of IN O
Rats NNP B-Gene
in IN O
a DT O
signal JJ O
transduction NN O
cascade NN O
which WDT O
transmits VBZ O
mitogenic JJ O
stimuli NNS O
from IN O
the DT O
plasma NN O
membrane NN O
to TO O
the DT O
nucleus NN O
. . O

The DT O
survival NN O
in IN O
the DT O
case NN O
of IN O
these DT O
patients NNS O
was VBD O
studied VBN O
five CD O
years NNS O
later RB O
. . O

In IN O
contrast NN O
, , O
the DT O
insulin NN B-Gene
response NN O
had VBD O
returned VBN O
to TO O
the DT O
non JJ O
- : O
pregnant JJ O
value NN O
by IN O
the DT O
second JJ O
day NN O
of IN O
the DT O
puerperium NN O
. . O

These DT O
data NNS O
strongly RB O
implicate VBP O
the DT O
normal JJ O
product NN O
of IN O
the DT O
int NN B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
, , O
which WDT O
is VBZ O
related VBN O
to TO O
the DT O
fibroblast NN B-Gene
growth NN I-Gene
factor NN I-Gene
family NN I-Gene
, , O
as IN O
a DT O
contributory NN O
factor NN O
in IN O
virally RB O
induced JJ O
mammary JJ O
tumors NNS O
. . O

The DT O
combination NN O
of IN O
Pitx2 NNP B-Gene
and CC O
another DT O
homeodomain NN B-Gene
protein NN I-Gene
, , O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
yielded VBD O
a DT O
synergistic JJ O
55 CD O
- : O
fold JJ O
activation NN O
of IN O
the DT O
prolactin NN B-Gene
promoter NN I-Gene
in IN O
transfection NN O
assays NNS O
. . O

Reaction NN O
of IN O
human JJ O
organism NN O
to TO O
exercise NN O
. . O

PhoP NNP B-Gene
- : O
PhoQ NN B-Gene
homologues NNS O
in IN O
Pseudomonas NNP O
aeruginosa NN O
regulate NN O
expression NN O
of IN O
the DT O
outer NN B-Gene
- : I-Gene
membrane NN I-Gene
protein NN I-Gene
OprH NNP I-Gene
and CC O
polymyxin NN O
B NNP O
resistance NN O
. . O

By IN O
using VBG O
a DT O
DNA NN O
sequence NN O
selected VBN O
for IN O
its PRP$ O
ability NN O
to TO O
bind VB O
recombinant JJ B-Gene
BCL NNP I-Gene
- : I-Gene
6 CD I-Gene
in IN O
vitro NN O
, , O
we PRP O
show VBP O
here RB O
that IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
is VBZ O
present JJ O
in IN O
DNA NNP O
- : O
binding NN O
complexes NNS O
in IN O
nuclear JJ O
extracts NNS O
from IN O
various JJ O
B NNP O
- : O
cell NN O
lines NNS O
. . O

These DT O
studies NNS O
have VBP O
shown VBN O
that IN O
the DT O
majority NN O
of IN O
tested VBN O
staphylococci NN O
were VBD O
resistant JJ O
to TO O
penicillin VB O
G NNP O
, , O
erythromycin NN O
, , O
and CC O
produced VBD O
beta SYM B-Gene
- : I-Gene
lactamase NN I-Gene
. . O

Analysis NN O
of IN O
Msy2 NNP B-Gene
mRNA FW I-Gene
expression NN O
in IN O
prepubertal JJ O
and CC O
adult NN O
mouse NN O
testes NNS O
, , O
and CC O
in IN O
isolated JJ O
populations NNS O
of IN O
germ NN O
cells NNS O
, , O
reveals NNS O
maximal JJ O
expression NN O
in IN O
postmeiotic JJ O
round NN O
spermatids NNS O
, , O
a DT O
cell NN O
type NN O
with IN O
abundant JJ O
amounts NNS O
of IN O
stored JJ O
messenger NN O
ribonucleoproteins NNS O
. . O

Radiolabeled VBN O
biantennary JJ O
N NNP O
- : O
glycans NNS O
synthesized VBN O
by IN O
Pro NNP O
( ( O
- : O
) ) O
5Lec20 CD O
were VBD O
proportionately RB O
less RBR O
ricin JJ O
- : O
bound NN O
than IN O
similar JJ O
species NNS O
from IN O
parental JJ O
CHO NNP O
cells NNS O
, , O
and CC O
Lec20 NNP O
cell NN O
extracts NNS O
had VBD O
a DT O
markedly RB O
reduced VBN O
ability NN O
to TO O
transfer VB O
Gal NNP O
to TO O
GlcNAc NNP O
- : O
terminating NN O
acceptors NNS O
. . O

The DT O
C NNP O
- : O
terminal JJ O
region NN O
contains VBZ O
the DT O
PTP NNP B-Gene
- : I-Gene
like IN I-Gene
domain NN I-Gene
, , O
whereas IN O
the DT O
N NNP O
- : O
terminal JJ O
region NN O
shows VBZ O
no DT O
homology NN O
to TO O
any DT O
known VBN O
mammalian JJ O
protein NN O
. . O

These DT O
equilibrium JJ O
solutions NNS O
are VBP O
then RB O
shown VBN O
to TO O
arise VB O
from IN O
the DT O
vertices NNS O
of IN O
a DT O
particular JJ O
convex NN O
polyhedron NN O
. . O

Co NNP O
- : O
transfection NN O
of IN O
the DT O
Sp1 NNP B-Gene
expression NN O
plasmid NN O
and CC O
the DT O
- : O
58 CD O
promoter NN O
construct NN O
into IN O
Drosophila NNP O
Schneider NNP O
cells NNS O
revealed VBD O
that IN O
Sp1 NNP B-Gene
contributed VBD O
to TO O
the DT O
kinase NN O
basal NN O
promoter NN O
activity NN O
by IN O
binding VBG O
to TO O
the DT O
non JJ O
- : O
consensus NN O
site NN O
in IN O
the DT O
- : O
58 CD O
region NN O
. . O

Several JJ O
agents NNS O
have VBP O
been VBN O
tried VBN O
for IN O
treatment NN O
, , O
often RB O
limited VBN O
by IN O
toxic JJ O
side NN O
effects NNS O
. . O

To TO O
study VB O
the DT O
origin NN O
of IN O
different JJ O
fMLF NN B-Gene
- : I-Gene
R NN I-Gene
transcripts NNS I-Gene
, , O
the DT O
genetic JJ O
linkage NN O
of IN O
chemotactic JJ O
receptor NN O
genes NNS O
, , O
and CC O
the DT O
regulation NN O
of IN O
fMLF JJ B-Gene
- : I-Gene
R NN I-Gene
gene NN I-Gene
expression NN O
, , O
we PRP O
determined VBD O
the DT O
copy NN O
number NN O
, , O
chromosomal JJ O
location NN O
, , O
structural JJ O
organization NN O
, , O
and CC O
5 CD O
' '' O
- : O
flanking VBG O
sequence NN O
of IN O
the DT O
human JJ B-Gene
fMLF NN I-Gene
- : I-Gene
R NNP I-Gene
gene NN I-Gene
. . O

In IN O
the DT O
next JJ O
week NN O
, , O
the DT O
beta NN O
- : O
adrenergic JJ O
antagonist NN O
atenolol NN O
was VBD O
added VBN O
at IN O
an DT O
initial JJ O
dose NN O
of IN O
25 CD O
mg NNS O
/ JJ O
day NN O
and CC O
titrated VBD O
to TO O
50 CD O
mg NNS O
/ JJ O
day NN O
within IN O
1 CD O
week NN O
. . O

Three CD O
group NN O
1 CD O
patients NNS O
developed VBD O
CMV NNP O
disease NN O
; : O
1 CD O
group NN O
2 CD O
patient NN O
developed VBD O
CMV NNP O
hepatitis NN O
. . O

Neomycin NNP O
is VBZ O
fairly RB O
effective JJ O
against IN O
staphylococci NN O
, , O
less RBR O
effective JJ O
against IN O
streptococci NN O
, , O
and CC O
fairly RB O
effective JJ O
against IN O
gram JJ O
- : O
negative JJ O
intestinal JJ O
organisms NNS O
. . O

49 CD O
, , O
XXXXY NNP O
chromosome NN O
anomaly NN O
: : O
an DT O
unusual JJ O
variant NN O
of IN O
Klinefelter NNP O
' POS O
s JJ O
syndrome NN O
. . O

Plate NNP O
luting NN O
, , O
a DT O
technique NN O
that WDT O
uses VBZ O
polymethylmethacrylate NN O
( ( O
PMMA NNP O
) ) O
interposed VBD O
between IN O
the DT O
plate NN O
and CC O
the DT O
bone NN O
, , O
as RB O
well RB O
as IN O
between IN O
the DT O
screw NN O
heads NNS O
and CC O
the DT O
plate NN O
, , O
to TO O
improve VB O
the DT O
stability NN O
of IN O
internal JJ O
fixation NN O
was VBD O
tested VBN O
in IN O
vitro NN O
using VBG O
20 CD O
paired JJ O
equine JJ O
third JJ O
metacarpal JJ O
bones NNS O
with IN O
mid JJ O
- : O
diaphyseal NN O
osteotomies NNS O
plated VBN O
with IN O
six CD O
- : O
hole NN O
broad JJ O
ASIF NNP O
compression NN O
plates NNS O
. . O

Epidemiological JJ O
data NNS O
are VBP O
quite JJ O
controversial JJ O
but CC O
sudden JJ O
death NN O
occurring VBG O
during IN O
sporting VBG O
activity NN O
is VBZ O
probably RB O
not RB O
a DT O
rare JJ O
occurrence NN O
. . O

Therapeutic JJ O
action NN O
of IN O
a DT O
new JJ O
antibiotic JJ O
- : O
corticoid NN O
association NN O
used VBN O
for IN O
instillations NNS O
in IN O
otology NN O

Temperature NN O
dependence NN O
of IN O
the DT O
sublattice NN O
spontaneous JJ O
magnetization NN O
of IN O
YBa2Cu3O6 NNP O
. . O

Hypoglycemic NNP O
action NN O
of IN O
"""" NN O
he PRP O
xiang VBD O
zhuang NNP O
qi NN O
gong NN O
"""" NN O
and CC O
its PRP$ O
mechanism NN O
on IN O
diabetes NNS O
mellitus NNS O

The DT O
five CD O
- : O
drug NN O
combination NN O
of IN O
fluorouracil JJ O
imidazole JJ O
carboxamide NN O
dimethyl NN O
triazeno NN O
, , O
vincristine NN O
, , O
bis SYM O
- : O
chloroethyl NN O
nitrosourea NN O
, , O
and CC O
prednisone NN O
( ( O
FIVB NNP O
+ NNP O
P NNP O
) ) O
was VBD O
given VBN O
to TO O
120 CD O
women NNS O
with IN O
metastatic JJ O
breast NN O
cancer NN O
. . O

A DT O
multivariate JJ O
analysis NN O
of IN O
risk NN O
factors NNS O
for IN O
relapse NN O
examined VBN O
age NN O
, , O
WBC NNP O
at IN O
diagnosis NN O
, , O
blast NN O
count NN O
at IN O
diagnosis NN O
, , O
percentage NN O
of IN O
marrow NN O
blasts NNS O
, , O
FAB NNP B-Gene
subtype NN O
, , O
the DT O
number NN O
of IN O
remission NN O
induction NN O
courses NNS O
to TO O
achieve VB O
a DT O
remission NN O
, , O
maintenance NN O
therapy NN O
, , O
consolidation NN O
therapy NN O
, , O
marrow NN O
cell NN O
dose NN O
, , O
donor JJ O
- : O
recipient NN O
sex NN O
, , O
GVHD NNP O
prophylaxis VBZ O
regimen NNS O
and CC O
isolation NN O
and CC O
decontamination NN O
in IN O
laminar JJ O
airflow NN O
rooms NNS O
. . O

Rolandic NNP O
spikes NNS O
and CC O
cognitive JJ O
function NN O
. . O

We PRP O
show VBP O
that IN O
a DT O
protein NN O
, , O
UBC9 NNP B-Gene
, , O
interacts VBZ O
specifically RB O
with IN O
TEL NNP B-Gene
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

4 CD O
. . O

With IN O
respect NN O
to TO O
effective JJ O
diffusivity NN O
of IN O
platelets NNS O
( ( O
De NNP O
) ) O
and CC O
the DT O
surface NN O
reactivity NN O
constant NN O
( ( O
K NNP O
) ) O
, , O
less RBR O
significant JJ O
differences NNS O
were VBD O
found VBN O
among IN O
artificial JJ O
materials NNS O
. . O

The DT O
GALT NNP O
- : O
primed VBD O
calves NNS O
had VBD O
increased VBN O
serum NN O
IgG NNP B-Gene
, , O
lavage NN O
IgG NNP B-Gene
and CC O
IgA NNP B-Gene
and CC O
increased VBD O
LNA NNP B-Gene
titers NNS O
in IN O
both DT O
lavage JJ O
fluids NNS O
and CC O
serum NN O
following VBG O
the DT O
SC NNP O
dose NN O
of IN O
killed VBN O
bacteria NNS O
. . O

For IN O
the DT O
present JJ O
work NN O
we PRP O
used VBD O
water NN O
saturated VBN O
with IN O
a DT O
50 CD O
/ NN O
50 CD O
mixture NN O
of IN O
H2 NNP O
and CC O
O2 NNP O
gases NNS O
, , O
for IN O
which WDT O
the DT O
heat NN O
defect NN O
is VBZ O
calculated VBN O
to TO O
be VB O
- : O
2 CD O
. . O
1 CD O
% NN O
. . O

Chaperones NNS O
/ NNP O
HSPs NNP B-Gene
thus RB O
play VB O
important JJ O
roles NNS O
within IN O
cell NN O
cycle NN O
processes VBZ O
. . O

No DT O
direct JJ O
repeats NNS O
flank VBD O
the DT O
pseudogene NN O
in IN O
the DT O
U2 NNP B-Gene
/ NNP I-Gene
4 CD I-Gene
locus NN I-Gene
. . O

CONCLUSION NNP O
( ( O
S NNP O
) ) O
: : O
Measuring VBG O
urinary JJ O
LH NNP B-Gene
levels NNS O
is VBZ O
an DT O
excellent JJ O
method NN O
for IN O
determining VBG O
ovulation NN O
. . O

The DT O
major JJ O
phenotypes NNS O
resulting VBG O
from IN O
Fab1p NNP B-Gene
kinase NNP I-Gene
inactivation NN O
include VBP O
temperature NN O
- : O
sensitive JJ O
growth NN O
, , O
vacuolar JJ O
acidification NN O
defects NNS O
, , O
and CC O
dramatic JJ O
increases NNS O
in IN O
vacuolar JJ O
size NN O
. . O

In IN O
flies NNS O
, , O
the DT O
dShc NN B-Gene
protein NN I-Gene
physically RB O
associates VBZ O
with IN O
the DT O
activated JJ O
Drosophila NNP B-Gene
epidermal JJ I-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
homolog NN I-Gene
( ( O
DER NNP B-Gene
) ) O
and CC O
is VBZ O
inducibly RB O
phosphorylated VBN O
on IN O
tyrosine NN O
by IN O
DER NNP B-Gene
. . O

Constitutive JJ O
activation NN O
of IN O
Rac1 NNP B-Gene
and CC O
RhoA NNP B-Gene
causes VBZ O
tumorigenic JJ O
transformation NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
, , O
and CC O
their PRP$ O
functions NNS O
may MD O
be VB O
required VBN O
for IN O
full JJ O
Ras NNP B-Gene
transformation NN O
. . O

The DT O
extraction NN O
measurements NNS O
were VBD O
used VBN O
to TO O
test VB O
for IN O
extracerebral JJ O
contamination NN O
of IN O
venous JJ O
outflow NN O
. . O

In IN O
addition NN O
, , O
the DT O
acetyltransferase NN O
activity NN O
of IN O
p300 NN B-Gene
was VBD O
observed VBN O
to TO O
be VB O
distinct JJ O
from IN O
the DT O
broadly RB O
essential JJ O
activation NN O
function NN O
of IN O
the DT O
CH3 NNP B-Gene
domain NN I-Gene
/ NNP O
E1A NNP B-Gene
- : O
binding NN O
region NN O
. . O

The DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
genomic JJ O
RNA NNP O
of IN O
rubella NN O
virus NN O
( ( O
RUB NNP O
) ) O
contains VBZ O
a DT O
14 CD O
- : O
nucleotide NN O
( ( O
nt JJ O
) ) O
single JJ O
- : O
stranded JJ O
leader NN O
( ( O
ss JJ O
- : O
leader NN O
) ) O
followed VBN O
by IN O
a DT O
stem NN O
- : O
and CC O
- : O
loop NN O
structure NN O
[ VBZ O
5 CD O
' '' O
( ( O
+ FW O
) ) O
SL NNP O
] NNP O
( ( O
nt RB O
15 CD O
to TO O
65 CD O
) ) O
, , O
the DT O
complement NN O
of IN O
which WDT O
at IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
minus NN O
- : O
strand NN O
RNA NNP O
[ VBZ O
3 CD O
' '' O
( ( O
- : O
) ) O
SL NNP O
] NNP O
has VBZ O
been VBN O
proposed VBN O
to TO O
function VB O
as IN O
a DT O
promoter NN O
for IN O
synthesis NN O
of IN O
genomic JJ O
plus CC O
strands NNS O
. . O

After IN O
profound JJ O
normovolemic JJ O
hemodilution NN O
( ( O
Hct NNP O
9 CD O
% NN O
) ) O
superiority NN O
of IN O
LV NNP O
MC NNP O
and CC O
LV NNP O
diastolic JJ O
properties NNS O
was VBD O
found VBN O
, , O
when WRB O
myocardial JJ O
oxygenation NN O
was VBD O
supported VBN O
by IN O
i NN O
. . O
v NN O
. . O
perflubron NN O
emulsion NN O
, , O
a DT O
temporary JJ O
O2 NNP O
carrier NN O
. . O

The DT O
entire JJ O
human NN B-Gene
teneurin NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TEN1 NNP B-Gene
) ) O
gene NN O
is VBZ O
contained VBN O
in IN O
eight CD O
PAC NNP O
clones NNS O
representing VBG O
part NN O
of IN O
the DT O
chromosomal JJ O
locus NN O
Xq25 NNP O
. . O

Marrow NNP O
cell NN O
necrosis NN O
in IN O
anorexia JJ O
nervosa NN O
and CC O
involuntary JJ O
starvation NN O
. . O

End NN O
points NNS O
measured VBN O
were VBD O
perioperative JJ O
( ( O
30 CD O
- : O
day NN O
) ) O
myocardial NN O
infarction NN O
( ( O
MI NNP O
) ) O
rate NN O
and CC O
death NN O
. . O

Elevated JJ O
expression NN O
of IN O
a DT O
previously RB O
uncharacterized JJ O
gene NN O
, , O
SPP381 NNP B-Gene
, , O
efficiently RB O
suppresses VBZ O
the DT O
growth NN O
and CC O
splicing VBG O
defects NNS O
of IN O
a DT O
temperature NN O
- : O
sensitive JJ O
( ( O
Ts NNP O
) ) O
mutant NN B-Gene
prp38 SYM I-Gene
- : I-Gene
1 CD I-Gene
. . O

One CD O
member NN O
of IN O
this DT O
family NN O
, , O
RFX1 NNP B-Gene
, , O
is VBZ O
a DT O
transcription NN O
factor NN O
for IN O
a DT O
variety NN O
of IN O
viral JJ O
and CC O
cellular JJ O
genes NNS O
. . O

On IN O
the DT O
other JJ O
side NN O
, , O
when WRB O
the DT O
aortic JJ O
ring NN O
was VBD O
perfused VBN O
with IN O
L NNP O
- : O
NNA NNP O
( ( O
NO NNP O
- : O
synthesis NN O
inhibitor NN O
) ) O
or CC O
methylene JJ O
blue NN O
( ( O
soluble JJ O
cGMPase NN B-Gene
inhibitor NN O
) ) O
, , O
the DT O
changes NNS O
could MD O
be VB O
attenuated VBN O
. . O

However RB O
, , O
the DT O
range NN O
of IN O
values NNS O
observed VBN O
is VBZ O
suggestive JJ O
of IN O
the DT O
need NN O
to TO O
investigate VB O
districts NNS O
with IN O
contrasting VBG O
values NNS O
of IN O
SYPLR NNP O
with IN O
respect NN O
to TO O
the DT O
inter NN O
- : O
relationships NNS O
between IN O
sociodemographic JJ O
characteristics NNS O
, , O
duration NN O
of IN O
symptoms NNS O
, , O
clinical JJ O
presentation NN O
and CC O
treatment NN O
efficacy NN O
. . O

Before IN O
birth NN O
, , O
there EX O
were VBD O
a DT O
few JJ O
perivascular JJ O
adrenergic JJ O
nerves NNS O
and CC O
correspondingly RB O
low JJ O
ovarian JJ O
NE NNP O
levels NNS O
. . O

The DT O
catalytic JJ O
site NN O
has VBZ O
an DT O
S1 NNP O
pocket NN O
lined VBD O
with IN O
conserved JJ O
hydrophobic NN O
residues NNS O
to TO O
accommodate VB O
the DT O
pyroglutamyl NN O
residue NN O
. . O

The DT O
C NNP O
- : O
terminal JJ O
mutants NNS O
were VBD O
strongly RB O
dominant JJ O
over IN O
TraR NNP B-Gene
, , O
suggesting VBG O
that IN O
they PRP O
can MD O
form VB O
heteromultimers NNS O
with IN O
the DT O
wild JJ O
- : O
type NN O
activator NN O
. . O

Group NNP O
I PRP O
comprised VBD O
5 CD O
adult NN O
Collies NNS O
that WDT O
received VBD O
at IN O
least JJS O
400 CD O
microg JJ O
/ NNP O
kg NN O
ivermectin NN O
p NN O
. . O
o NN O
. . O
and CC O
were VBD O
presented VBN O
to TO O
the DT O
VMTH NNP O
3 CD O
hours NNS O
after IN O
intoxication NN O
. . O

CONCLUSION NN O
: : O
This DT O
retrospective JJ O
analysis NN O
does VBZ O
not RB O
confirm VB O
the DT O
efficacy NN O
of IN O
one CD O
course NN O
of IN O
simultaneous JJ O
Mitomycin NNP O
- : O
C NNP O
and CC O
5 CD O
- : O
fluorouracil NN O
, , O
at IN O
least JJS O
in IN O
association NN O
with IN O
full JJ O
- : O
dose JJ O
radiotherapy NN O
incorporating VBG O
Iridium NNP O
- : O
192 CD O
boost NN O
. . O

Antithrombin NNP B-Gene
III NNP I-Gene
( ( O
AT NNP B-Gene
III NNP I-Gene
) ) O
is VBZ O
a DT O
plasma NN O
protein NN O
which WDT O
acts VBZ O
as IN O
the DT O
principal JJ O
inhibitor NN O
of IN O
thrombin NN B-Gene
and CC O
is VBZ O
a DT O
major JJ O
modulator NN O
of IN O
intravascular JJ O
coagulation NN O
. . O

Characterization NN O
of IN O
CR1 NNP B-Gene
repeat NN O
random NN O
PCR NNP O
markers NNS O
for IN O
mapping VBG O
the DT O
chicken NN O
genome NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
type NN O
of IN O
tyrosine JJ B-Gene
kinase NN I-Gene
receptor NN I-Gene
stimulated VBD O
also RB O
participates VBZ O
in IN O
the DT O
nature NN O
of IN O
the DT O
cAMP NN O
effect NN O
. . O

Thus RB O
, , O
although IN O
multiple JJ O
senescence NN O
pathways NNS O
are VBP O
activated VBN O
in IN O
response NN O
to TO O
a DT O
ras JJ B-Gene
oncogene NN I-Gene
, , O
inactivation NN O
of IN O
TGFbeta1 NNP B-Gene
secretion NN O
or CC O
response NN O
is VBZ O
sufficient JJ O
to TO O
block VB O
the DT O
senescence NN O
program NN O
. . O

We PRP O
have VBP O
found VBN O
that IN O
PEA2 NNP B-Gene
is VBZ O
also RB O
required VBN O
for IN O
the DT O
bipolar JJ O
budding NN O
pattern NN O
and CC O
that IN O
it PRP O
encodes VBZ O
a DT O
novel JJ O
protein NN O
with IN O
a DT O
predicted VBN O
coiled VBN O
- : O
coil NN O
domain NN O
. . O

The DT O
progression NN O
of IN O
non JJ O
- : O
A NN O
, , O
non SYM O
- : O
B NNP O
hepatitis NN O
to TO O
chronic JJ O
diseases NNS O
, , O
and CC O
the DT O
transformation NN O
to TO O
hepatocellular VB O
carcinoma NN O

Fas NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
require VB O
ICE NNP B-Gene
( ( O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
beta SYM I-Gene
- : I-Gene
converting VBG I-Gene
enzyme NN I-Gene
) ) O
family NN O
proteases VBZ O
to TO O
induce VB O
apoptosis NN O
from IN O
studies NNS O
utilizing VBG O
the DT O
cowpox NN O
ICE NNP B-Gene
inhibitor NN I-Gene
protein NN I-Gene
CrmA NNP B-Gene
, , O
the DT O
synthetic JJ O
tetrapeptide NN O
ICE NNP B-Gene
inhibitor NN O
YVAD NNP B-Gene
- : I-Gene
CMK NNP I-Gene
, , O
and CC O
the DT O
tripeptide NN O
pan SYM O
- : O
ICE NNP B-Gene
inhibitor NN O
Z NNP B-Gene
- : I-Gene
VAD NNP I-Gene
- : I-Gene
FMK NN I-Gene
. . O

Optima NNP O
) ) O
genomic VBP O
library JJ O
by IN O
hybridizing VBG O
with IN O
elicitor NN O
- : O
induced JJ O
stilbene JJ B-Gene
synthase NN I-Gene
cDNA NN I-Gene
as IN O
a DT O
probe NN O
. . O

In IN O
this DT O
study NN O
we PRP O
have VBP O
introduced VBN O
mutations NNS O
into IN O
the DT O
corresponding JJ O
elements NNS O
of IN O
two CD O
cox3 NN B-Gene
promoters NNS I-Gene
and CC O
show VBP O
that IN O
while IN O
the DT O
core NN O
element NN O
is VBZ O
essential JJ O
for IN O
cox3 JJ B-Gene
promoter NN I-Gene
activity NN O
, , O
upstream JJ O
element NN O
mutations NNS O
have VBP O
little JJ O
or CC O
no DT O
effect NN O
. . O

Nursing VBG O
education NN O
- : O
- : O
the DT O
computer NN O
obligation NN O
. . O

Mycotoxins NNS O
in IN O
feeds NNS O
and CC O
foods NNS O
. . O

The DT O
treatment NN O
group NN O
also RB O
showed VBD O
in IN O
vivo NN O
T NNP O
- : O
cell NN O
activation NN O
with IN O
an DT O
initial JJ O
lymphopenia NN O
followed VBN O
by IN O
a DT O
rebound NN O
lymphocytosis NN O
and CC O
upregulation NN O
of IN O
the DT O
subset NN O
markers NNS O
CD25 NNP B-Gene
( ( O
interleukin JJ B-Gene
2 CD I-Gene
receptor NN I-Gene
) ) O
and CC O
CD45RO NNP B-Gene
( ( O
T NNP O
- : O
memory NN O
cells NNS O
) ) O
. . O

The DT O
first JJ O
gene NN O
codes NNS O
for IN O
a DT O
protein NN O
containing VBG O
11 CD O
cystein NN O
residues NNS O
in IN O
an DT O
arrangement NN O
typical JJ O
for IN O
Fe NNP B-Gene
/ NNP I-Gene
S NNP I-Gene
proteins VBZ I-Gene
. . O

The DT O
rear NN O
silver NN O
liquid JJ O
chamber NN O
was VBD O
threefold JJ O
thick NN O
to TO O
17 CD O
MeV NNP O
protons NNS O
in IN O
water NN O
and CC O
it PRP O
efficiently RB O
produced VBD O
either CC O
13N CD O
by IN O
the DT O
16O CD O
( ( O
p NN O
, , O
alpha NN O
) ) O
13N CD O
reaction NN O
or CC O
[ $ O
18F CD O
] NNP O
fluoride JJ O
ion NN O
by IN O
the DT O
18O CD O
( ( O
p NN O
, , O
n RB O
) ) O
18F CD O
reaction NN O
. . O

Sleep NNP O
was VBD O
determined VBN O
again RB O
for IN O
an DT O
additional JJ O
3 CD O
days NNS O
and CC O
6 CD O
hours NNS O
. . O

Investigation NN O
of IN O
the DT O
control NN O
of IN O
coronavirus NN O
subgenomic JJ O
mRNA NN O
transcription NN O
by IN O
using VBG O
T7 NNP O
- : O
generated VBD O
negative JJ O
- : O
sense NN O
RNA NNP O
transcripts NNS O
. . O

Perilunar NNP O
luxation NN O
- : O
- : O
an DT O
unusual JJ O
injury NN O
demanding VBG O
immediate JJ O
and CC O
correct JJ O
treatment NN O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
identified VBD O
a DT O
strong JJ O
positive JJ O
cis NN O
- : O
regulatory JJ O
element NN O
at IN O
- : O
70 CD O
bp NN O
to TO O
- : O
75 CD O
bp NN O
in IN O
the DT O
LpS1 NNP B-Gene
beta NN I-Gene
promoter NN I-Gene
with IN O
the DT O
sequence NN O
( ( O
G NNP O
) ) O
6 CD O
and CC O
a DT O
similar JJ O
, , O
more RBR O
distal JJ O
cis NN O
- : O
element NN O
at IN O
- : O
721 CD O
bp NN O
to TO O
- : O
726 CD O
bp NN O
. . O

Relaxation NN O
of IN O
catch NN O
in IN O
a DT O
molluscan JJ O
smooth JJ O
muscle NN O
. . O

We PRP O
identified VBD O
a DT O
protein NN O
, , O
termed VBD O
NFIL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
A NNP I-Gene
( ( O
NF NNP B-Gene
beta VBZ I-Gene
A NNP I-Gene
) ) O
, , O
that WDT O
binds VBZ O
to TO O
a DT O
highly RB O
conserved VBN O
12 CD O
- : O
bp NN O
DNA NN O
sequence NN O
( ( O
- : O
49 CD O
to TO O
- : O
38 CD O
) ) O
located VBN O
upstream NN O
of IN O
the DT O
TATA NNP O
box NN O
motif NN O
in IN O
both CC O
the DT O
human NN B-Gene
and CC I-Gene
murine NN I-Gene
IL NNP I-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
genes NNS I-Gene
. . O

Saturable JJ O
spermidine NN O
transport NN O
in IN O
stk2 NN B-Gene
: : O
: : O
lacZ NN B-Gene
mutants NNS I-Gene
had VBD O
an DT O
approximately RB O
fivefold JJ O
- : O
lower JJR O
affinity NN O
and CC O
twofold JJ O
- : O
lower JJR O
Vmax NNP O
than IN O
in IN O
the DT O
parental JJ O
strain NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
v SYM B-Gene
- : I-Gene
Rel NNP I-Gene
specifically RB O
increased VBD O
expression NN O
from IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
multiple JJ O
Sp1 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
approximately RB O
sixfold VBP O
in IN O
chicken NN O
embryo NN O
fibroblasts NNS O
( ( O
CEFs NNP O
) ) O
, , O
even RB O
though IN O
v JJ B-Gene
- : I-Gene
Rel NN I-Gene
did VBD O
not RB O
bind VB O
directly RB O
to TO O
these DT O
sites NNS O
. . O

v SYM B-Gene
- : I-Gene
Rel NNP I-Gene
also RB O
increased VBD O
expression NN O
from IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
a DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP O
) ) O
in IN O
which WDT O
the DT O
kappa NN B-Gene
B NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
were VBD O
mutated VBN O
but CC O
which WDT O
still RB O
contained VBD O
intact JJ O
Sp1 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Sixteen JJ O
patients NNS O
were VBD O
studied VBN O
within IN O
24 CD O
hours NNS O
of IN O
resuscitation NN O
and CC O
all DT O
showed VBD O
depressed JJ O
right RB O
ventricular JJ O
ejection NN O
( ( O
RVEF NNP O
) ) O
and CC O
/ $ O
or CC O
an DT O
increased JJ O
end NN O
- : O
diastolic JJ O
volume NN O
( ( O
RVEDVI NNP O
) ) O
. . O

Here RB O
we PRP O
review VBP O
progress NN O
to TO O
date NN O
in IN O
this DT O
area NN O
. . O

DPA NNP O
attenuated VBD O
the DT O
increase NN O
of IN O
the DT O
intensity NN O
of IN O
the DT O
ischemic JJ O
and CC O
pressure NN O
pain NN O
components NNS O
with IN O
increasing VBG O
ischemia NN O
duration NN O
, , O
but CC O
only RB O
the DT O
effect NN O
on IN O
the DT O
pressure NN O
pain NN O
component NN O
was VBD O
significant JJ O
. . O

The DT O
S229A NNP O
variant NN O
can MD O
better VB O
flip VB O
modified JJ O
bases NNS O
but CC O
does VBZ O
not RB O
tightly RB O
lock VBZ O
the DT O
flipped JJ O
base NN O
into IN O
the DT O
adenine JJ O
- : O
binding NN O
pocket NN O
, , O
suggesting VBG O
that IN O
Ser229 NNP O
could MD O
form VB O
a DT O
contact NN O
to TO O
the DT O
flipped JJ O
adenine NN O
. . O

Therefore RB O
the DT O
prevalences NNS O
of IN O
total JJ O
diabetes NNS O
and CC O
GDM NNP O
were VBD O
1 CD O
. . O
19 CD O
% NN O
and CC O
0 CD O
. . O
56 CD O
% NN O
, , O
respectively RB O
. . O

Thus RB O
, , O
this DT O
study NN O
provides VBZ O
evidence NN O
that IN O
a DT O
novel NN O
, , O
ubiquitous JJ O
factor NN O
( ( O
HF NNP B-Gene
- : I-Gene
1a CD I-Gene
) ) O
and CC O
a DT O
muscle NN O
factor NN O
( ( O
HF NNP B-Gene
- : I-Gene
1b CD I-Gene
/ NN O
MEF NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
can MD O
form VB O
a DT O
novel NN O
, , O
E NNP O
- : O
box NN O
- : O
independent JJ O
pathway NN O
for IN O
muscle NN O
- : O
specific JJ O
expression NN O
in IN O
ventricular JJ O
cardiac JJ O
muscle NN O
cells NNS O
. . O

Magnetic JJ O
resonance NN O
imaging NN O
( ( O
MRI NNP O
) ) O
has VBZ O
enabled VBN O
us PRP O
to TO O
see VB O
the DT O
spinal JJ O
intramedullary JJ O
pathology NN O
as IN O
differences NNS O
in IN O
signal JJ O
intensity NN O
. . O

As IN O
with IN O
the DT O
heterologous JJ O
DNA NNP O
binding NN O
domain NN O
, , O
MZF NNP B-Gene
- : I-Gene
1 CD I-Gene
represses NNS O
reporter JJ O
gene NN O
expression NN O
in IN O
nonhematopoietic JJ O
cell NN O
lines NNS O
and CC O
activates VBZ O
expression NN O
in IN O
hematopoietic JJ O
cell NN O
lines NNS O
. . O

Chinese JJ O
Spring NN O
( ( O
CS NNP O
) ) O
carrying VBG O
the DT O
Q NNP B-Gene
gene NN I-Gene
to TO O
those DT O
of IN O
a DT O
chromosome NN O
deletion NN O
line NN O
of IN O
CS NNP O
, , O
namely RB O
, , O
q5 NN O
, , O
which WDT O
lacks VBZ O
15 CD O
% NN O
of IN O
5AL CD O
including VBG O
the DT O
Q NNP B-Gene
gene NN I-Gene
. . O

Histochemical JJ O
localization NN O
of IN O
GUS NNP B-Gene
revealed VBD O
promoter NN O
function NN O
in IN O
leaf NN O
epidermis NN O
, , O
mesophyll NN O
and CC O
vascular JJ O
bundles NNS O
, , O
in IN O
the DT O
cortex NN O
and CC O
vascular JJ O
cylinder NN O
of IN O
the DT O
root NN O
. . O

Yeast NNP B-Gene
U1 NNP I-Gene
snRNP NN I-Gene
is VBZ O
considerably RB O
more RBR O
complex JJ O
than IN O
its PRP$ O
metazoan NN O
counterpart NN O
, , O
which WDT O
suggests VBZ O
possible JJ O
differences NNS O
between IN O
yeast NN O
and CC O
metazoa NN O
in IN O
early JJ O
splicing NN O
events NNS O
. . O

Although IN O
a DT O
carboxyl JJ O
- : O
terminal JJ O
HSF NNP B-Gene
transcriptional JJ O
activation NN O
domain NN O
is VBZ O
critical JJ O
for IN O
the DT O
activation NN O
of IN O
CUP1 NNP B-Gene
transcription NN O
in IN O
response NN O
to TO O
both DT O
heat NN O
shock NN O
stress NN O
and CC O
glucose JJ O
starvation NN O
, , O
this DT O
region NN O
is VBZ O
dispensable JJ O
for IN O
transient NN O
heat NN O
shock NN O
activation NN O
of IN O
at IN O
least JJS O
two CD O
genes NNS O
encoding VBG O
members NNS O
of IN O
the DT O
S NNP O
. . O
cerevisiae NN O
hsp70 VBD B-Gene
family NN I-Gene
. . O

Developmental NNP O
toxicity NN O
of IN O
the DT O
class NN O
III NNP O
antiarrhythmic JJ O
agent NN O
almokalant NN O
in IN O
mice NN O
. . O

When WRB O
the DT O
CO2 NNP O
content NN O
reached VBD O
9 CD O
Vol NNP O
% NN O
the DT O
animals NNS O
became VBD O
apathic JJ O
and CC O
lost VBN O
body NN O
weight NN O
. . O

The DT O
tissue NN O
specificity NN O
of IN O
gene NN O
expression NN O
was VBD O
identical JJ O
to TO O
that DT O
described VBD O
previously RB O
for IN O
the DT O
CaMV NNP B-Gene
35S CD I-Gene
domain NN I-Gene
B NNP I-Gene
enhancer NN I-Gene
element NN I-Gene
. . O

Cardiac NNP B-Gene
endothelin NN I-Gene
release NN O
and CC O
infarct NN O
size NN O
, , O
myocardial JJ O
blood NN O
flow NN O
, , O
and CC O
ventricular JJ O
function NN O
in IN O
canine JJ O
infarction NN O
and CC O
reperfusion NN O
. . O

The DT O
relationship NN O
between IN O
primary JJ O
malignant JJ O
lymphoma NN O
of IN O
the DT O
thyroid NN O
and CC O
chronic JJ O
thyroiditis NN O
is VBZ O
discussed VBN O
. . O

In IN O
biopsies NNS O
CK NNP B-Gene
- : I-Gene
MB NNP I-Gene
fraction NN O
of IN O
total JJ O
myocardial JJ O
CPK NNP B-Gene
was VBD O
37 CD O
% NN O
, , O
the DT O
total JJ B-Gene
- : I-Gene
CPK NN I-Gene
activity NN O
of IN O
human JJ O
skeletal NN O
muscles NNS O
still RB O
shows VBZ O
a DT O
5 CD O
% NN O
fraction NN O
of IN O
CK NNP B-Gene
- : I-Gene
MB NN I-Gene
. . O

The DT O
primers NNS O
were VBD O
degenerate JJ O
sets NNS O
of IN O
oligonucleotides NNS O
derived VBN O
from IN O
known VBN O
amino NN O
acid NN O
sequences NNS O
of IN O
the DT O
PBAN NNP B-Gene
precursor NN I-Gene
. . O

Trypanosoma NNP O
cruzi NN O
. . O

These DT O
mutants NNS O
had VBD O
deletions NNS O
of IN O
the DT O
extreme NN O
amino NN O
- : O
terminal NN O
residues NNS O
as RB O
far RB O
as IN O
amino JJ O
acid NN O
residue JJ O
30 CD O
. . O

QBMDs NNP O
for IN O
a DT O
5 CD O
% NN O
change NN O
in IN O
response NN O
( ( O
QBMD05 NNP O
) ) O
were VBD O
6 CD O
- : O
fold NN O
lower JJR O
, , O
on IN O
average NN O
, , O
than IN O
the DT O
corresponding JJ O
NOAEL NNP O
. . O

BACKGROUND NN O
: : O
Gamma NNP O
knife VB O
radiosurgery NN O
( ( O
GKR NNP O
) ) O
is VBZ O
a DT O
safe JJ O
and CC O
effective JJ O
alternative NN O
to TO O
surgery NN O
for IN O
intracranial JJ O
lesions NNS O
. . O

Serum NNP O
leptin NN B-Gene
concentrations NNS O
in IN O
women NNS O
during IN O
gonadotropin JJ B-Gene
stimulation NN O
cycles NNS O
. . O

C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
V NNP I-Gene
> VBZ O
A NNP O
selectively RB O
binds VBZ O
only RB O
the DT O
subset NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
sites VBZ I-Gene
that WDT O
are VBP O
also RB O
DBP NNP B-Gene
sites NNS I-Gene
, , O
both CC O
as IN O
oligonucleotides NNS O
and CC O
within IN O
the DT O
natural JJ O
contexts NN O
of IN O
the DT O
albumin NN B-Gene
and CC O
cholesterol NN B-Gene
hydroxylase NN I-Gene
promoters NNS I-Gene
. . O

During IN O
the DT O
last JJ O
6 CD O
months NNS O
of IN O
the DT O
study NN O
a DT O
striking JJ O
change NN O
in IN O
epidemiology NN O
concerning VBG O
hepatitis NN O
A DT O
was VBD O
seen VBN O
, , O
apparently RB O
caused VBN O
by IN O
a DT O
steep JJ O
increase NN O
in IN O
the DT O
incidence NN O
of IN O
this DT O
type NN O
of IN O
hepatitis NN O
among IN O
drug NN O
addicts NNS O
. . O

In IN O
11 CD O
eyes NNS O
that WDT O
had VBD O
been VBN O
selected VBN O
at IN O
random JJ O
10 CD O
micrograms NNS O
of IN O
recombinant JJ B-Gene
tissue NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
were VBD O
injected VBN O
midvitreally RB O
24 CD O
hrs NN O
later RB O
. . O

Total JJ O
body NN O
irradiation NN O
was VBD O
delivered VBN O
according VBG O
to TO O
a DT O
hyperfractionated JJ O
scheme NN O
of IN O
12 CD O
fractions NNS O
given VBN O
three CD O
per IN O
day NN O
5 CD O
hr NN O
apart NN O
for IN O
4 CD O
days NNS O
. . O

Femoral NNP O
strain NN O
adaptation NN O
after IN O
total JJ O
hip JJ O
replacement NN O
: : O
a DT O
comparison NN O
of IN O
cemented JJ O
and CC O
porous JJ O
ingrowth NN O
components NNS O
in IN O
canines NNS O
. . O

In IN O
addition NN O
to TO O
the DT O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
domain NN I-Gene
, , O
p56lck NN B-Gene
possesses NNS O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
and CC I-Gene
3 CD I-Gene
( ( O
SH2 NNP B-Gene
and CC O
SH3 NNP B-Gene
) ) O
domains VBZ O
as RB O
well RB O
as IN O
a DT O
unique JJ O
N NNP O
- : O
terminal JJ O
region NN O
. . O

Relationships NNS O
with IN O
the DT O
acquired VBN O
immune JJ O
deficiency NN O
syndrome NN O
. . O

The DT O
determination NN O
of IN O
the DT O
double JJ O
bounds NNS O
in IN O
blood NN O
serum NN O
lipids NNS O
by IN O
titration NN O
with IN O
ozone NN O
: : O
the DT O
pathophysiology NN O
and CC O
diagnostic JJ O
significance NN O
] NN O
In IN O
this DT O
article NN O
the DT O
method NN O
of IN O
definition NN O
of IN O
double JJ O
binders NNS O
in IN O
lipids NNS O
of IN O
blood NN O
serum NN O
in IN O
patients NNS O
with IN O
different JJ O
diseases NNS O
basically RB O
atherosclerosis VBP O
and CC O
ischemic JJ O
heart NN O
disease NN O
, , O
with IN O
use NN O
titration NN O
by IN O
ozone NN O
is VBZ O
given VBN O
. . O

Most JJS O
smokers NNS O
would MD O
prefer VB O
to TO O
quit VB O
smoking VBG O
on IN O
their PRP$ O
own JJ O
. . O

Dosage NN O
in IN O
both DT O
cases NNS O
was VBD O
0 CD O
. . O
2 CD O
g JJ O
/ NNP O
m2 NN O
. . O

Thus RB O
our PRP$ O
observations NNS O
establish VB O
a DT O
functional JJ O
link NN O
between IN O
the DT O
PKC NNP B-Gene
and CC O
retinoid JJ O
pathways NNS O
, , O
which WDT O
are VBP O
generally RB O
considered VBN O
to TO O
have VB O
antagonistic JJ O
activities NNS O
on IN O
differentiation NN O
processes NNS O
. . O

A DT O
17 CD O
- : O
mer NN O
oligodeoxynucleotide NN O
, , O
corresponding VBG O
to TO O
a DT O
region NN O
of IN O
the DT O
VtHb NNP B-Gene
amino NN I-Gene
acid NN I-Gene
sequence NN I-Gene
was VBD O
used VBN O
as IN O
a DT O
hybridization NN O
probe NN O
to TO O
screen VB O
a DT O
Vitreoscilla NNP O
genomic JJ O
library NN O
constructed VBN O
in IN O
broad JJ O
- : O
host NN O
- : O
range NN O
cosmid NN O
vector NN O
pVK102 NN O
. . O

We PRP O
report VBP O
the DT O
successful JJ O
use NN O
of IN O
electroconvulsive JJ O
therapy NN O
for IN O
treatment NN O
of IN O
severe JJ O
depression NN O
in IN O
a DT O
young JJ O
man NN O
with IN O
adult JJ O
GM2 NNP O
gangliosidosis NN O
. . O

The DT O
sensitivity NN O
of IN O
the DT O
vas NN O
deferens VBZ O
to TO O
adrenaline VB O
was VBD O
also RB O
reduced VBN O
in IN O
scorbutic JJ O
guinea NN O
pigs NNS O
, , O
thus RB O
decreasing VBG O
their PRP$ O
fertility NN O
rate NN O
. . O

In IN O
case NN O
of IN O
a DT O
pathologically RB O
convoluted VBN O
internal JJ O
carotid NN O
the DT O
common JJ O
carotid NN O
artery NN O
was VBD O
resected VBN O
with IN O
an DT O
end NN O
- : O
to TO O
- : O
end NN O
anastomosis NN O
. . O

OODG NNP O
is VBZ O
a DT O
diagnostic JJ O
method NN O
permitting VBG O
assessment NN O
of IN O
ocular JJ O
pulse NN O
curves NNS O
and CC O
objective JJ O
determination NN O
of IN O
blood NN O
pressures NNS O
in IN O
the DT O
ophthalmic JJ O
circulatory NN O
system NN O
( ( O
retinal JJ O
and CC O
ciliary JJ O
arterial JJ O
blood NN O
pressures NNS O
) ) O
simultaneously RB O
for IN O
both DT O
eyes NNS O
, , O
without IN O
dilatation NN O
of IN O
the DT O
pupils NNS O
. . O

Two CD O
classes NNS O
of IN O
mutations NNS O
were VBD O
obtained VBN O
: : O
( ( O
i NN O
) ) O
those DT O
that WDT O
altered VBD O
the DT O
coding VBG O
region NN O
of IN O
HOL1 NNP B-Gene
, , O
conferring VBG O
the DT O
ability NN O
to TO O
take VB O
up RP O
histidinol NN O
; : O
and CC O
( ( O
ii NN O
) ) O
cis NN O
- : O
acting NN O
mutations NNS O
( ( O
selected VBN O
in IN O
a DT O
mutant JJ O
HOL1 NNP B-Gene
- : I-Gene
1 CD I-Gene
background NN O
) ) O
that WDT O
increased VBD O
expression NN O
of IN O
the DT O
Hol1 NNP B-Gene
protein NN I-Gene
. . O

Immunofluoresence NNP O
data NNS O
indicated VBD O
that IN O
once RB O
bound VBN O
to TO O
the DT O
mutant JJ O
receptor NN O
, , O
fluorescent JJ O
- : O
labeled VBN O
RAP NNP B-Gene
co SYM O
- : O
localized VBN O
with IN O
markers NNS O
of IN O
the DT O
endosomal JJ O
pathway NN O
, , O
whereas NNS O
, , O
in IN O
cells NNS O
expressing VBG O
the DT O
wild JJ O
- : O
type NN O
receptor NN O
, , O
RAP NNP B-Gene
fluorescence NN O
co NN O
- : O
localized VBN O
with IN O
lysosomal JJ O
markers NNS O
. . O

Therapy NN O
with IN O
dietary JJ O
modification NN O
and CC O
triglyceride VB O
lowering VBG O
drugs NNS O
resulted VBD O
in IN O
resolution NN O
of IN O
symptoms NNS O
and CC O
parotid NN O
swelling VBG O
in IN O
one CD O
patient NN O
. . O

Evaluation NN O
of IN O
1 CD O
, , O
10 CD O
- : O
phenanthroline NN O
as IN O
a DT O
reagent NN O
for IN O
sialic JJ O
acid JJ O
determinations NNS O
. . O

Recently RB O
we PRP O
have VBP O
performed VBN O
a DT O
detailed JJ O
analysis NN O
of IN O
specific JJ O
neuronal JJ O
populations NNS O
affected VBN O
by IN O
the DT O
mutation NN O
which WDT O
shed VBD O
new JJ O
light NN O
on IN O
the DT O
role NN O
of IN O
Krox NNP B-Gene
- : I-Gene
20 CD I-Gene
in IN O
the DT O
segmentation NN O
and CC O
on IN O
the DT O
physiological JJ O
consequences NNS O
of IN O
its PRP$ O
inactivation NN O
. . O

The DT O
cut NN O
- : O
off RB O
percentage NN O
positivity NN O
value NN O
was VBD O
established VBN O
using VBG O
500 CD O
brucellosis NN O
- : O
positive JJ O
and CC O
500 CD O
brucellosis NN O
- : O
negative JJ O
serum NN O
samples NNS O
, , O
confirmed VBN O
with IN O
reference NN O
to TO O
the DT O
sample NN O
data NNS O
using VBG O
the DT O
indirect JJ O
ELISA NNP O
kit NN O
. . O

The DT O
requirement NN O
of IN O
PilE NNP B-Gene
in IN O
pilus JJ O
biogenesis NN O
was VBD O
confirmed VBN O
by IN O
demonstrating VBG O
that IN O
chromosomal JJ B-Gene
pilE NN I-Gene
insertion NN I-Gene
mutants NNS I-Gene
were VBD O
pilus JJ O
- : O
and CC O
twitching VBG O
- : O
motility NN O
deficient NN O
. . O

CHAP NNP O
and CC O
the DT O
Department NNP O
of IN O
Veterans NNP O
Affairs NNPS O
. . O

Saccharomyces NNS O
cerevisiae VBP O
contains VBZ O
four CD O
known NN O
acyl SYM B-Gene
- : I-Gene
CoA NN I-Gene
synthetases NNS I-Gene
( ( O
fatty JJ B-Gene
acid NN I-Gene
activation NN I-Gene
proteins NNS I-Gene
, , O
Faaps NNP B-Gene
) ) O
. . O

The DT O
heart NN O
rate NN O
, , O
respiratory NN O
rate NN O
, , O
arterial JJ O
O2 NNP O
and CC O
systemic JJ O
vascular JJ O
resistance NN O
were VBD O
not RB O
significantly RB O
altered VBN O
. . O

PURPOSE NNP O
/ NNP O
OBJECTIVES NNP O
: : O
To TO O
examine VB O
the DT O
question NN O
of IN O
whether IN O
an DT O
early JJ O
first JJ O
full JJ O
- : O
term NN O
pregnancy NN O
( ( O
FFTP NNP O
) ) O
protects VBZ O
against IN O
breast NN O
cancer NN O
and CC O
whether IN O
interruption NN O
of IN O
the DT O
pregnancy NN O
with IN O
an DT O
induced JJ O
abortion NN O
increases NNS O
breast VBP O
cancer NN O
risk NN O
. . O

The DT O
products NNS O
of IN O
genes NNS O
ura10 NNS B-Gene
and CC O
ura3 NNS B-Gene
are VBP O
proposed VBN O
to TO O
participate VB O
in IN O
the DT O
channeling NN O
of IN O
orotidine JJ O
monophosphate NN O
. . O

The DT O
association NN O
of IN O
clopamide NN O
and CC O
hydergine NN O
( ( O
Brinedine NNP O
) ) O
in IN O
the DT O
treatment NN O
of IN O
the DT O
vasculo NN O
- : O
renal JJ O
syndromes NNS O
of IN O
pregnancy NN O

STUDY NNP O
DESIGN NNP O
AND NNP O
METHODS NNP O
: : O
A DT O
study NN O
was VBD O
initiated VBN O
to TO O
compare VB O
the DT O
collection NN O
of IN O
PBPCs NNP O
with IN O
the DT O
new JJ O
device NN O
, , O
the DT O
AutoPBSC NNP O
( ( O
version NN O
[ NNP O
V NNP O
] VBD O
6 CD O
. . O
0 CD O
with IN O
AutoPBSC NNP O
tubing VBG O
set NN O
) ) O
, , O
and CC O
that IN O
with IN O
the DT O
MNC NNP O
( ( O
mononuclear VBP O
cell NN O
) ) O
procedure NN O
( ( O
V4 NNP O
. . O
7 CD O
with IN O
white JJ O
cell NN O
tubing VBG O
set NN O
) ) O
, , O
for IN O
patients NNS O
and CC O
healthy JJ O
donors NNS O
. . O

Long NNP O
- : O
term NN O
effects NNS O
of IN O
clofibrate NN O
( ( O
Atromid NNP O
- : O
S NN O
) ) O
on IN O
serum NN O
lipids NNS O
in IN O
man NN O
. . O

Nuclear JJ B-Gene
protein NN I-Gene
phosphatase NN I-Gene
2A CD I-Gene
dephosphorylates NNS O
protein JJ B-Gene
kinase VBD I-Gene
A NNP I-Gene
- : O
phosphorylated VBN O
CREB NNP B-Gene
and CC O
regulates VBZ O
CREB NNP B-Gene
transcriptional JJ O
stimulation NN O
. . O

In IN O
Rat NNP O
- : O
1a CD O
cells NNS O
the DT O
expression NN O
of IN O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
jun NN I-Gene
mRNA NN I-Gene
was VBD O
associated VBN O
with IN O
the DT O
ability NN O
to TO O
clone VB O
in IN O
soft JJ O
agarose NN O
and CC O
form NN O
tumors NNS O
in IN O
nude JJ O
mice NN O
. . O

Finally RB O
, , O
three CD O
new JJ O
missense NN O
mutations NNS O
, , O
E138V NNP O
, , O
R254G NNP O
, , O
and CC O
P362R NNP O
, , O
were VBD O
identified VBN O
in IN O
the DT O
human JJ B-Gene
AC NNP I-Gene
gene NN I-Gene
from IN O
FD NNP O
patients NNS O
. . O

METHODS NNS O
: : O
Out NNP O
of IN O
171 CD O
patients NNS O
receiving VBG O
anticoagulation NN O
between IN O
July NNP O
1992 CD O
and CC O
December NNP O
1993 CD O
, , O
83 CD O
patients NNS O
with IN O
hemispheric JJ O
embolisms NNS O
received VBD O
heparin NN O
within IN O
72 CD O
hours NNS O
from IN O
onset NN O
( ( O
activated VBN O
partial JJ O
thromboplastin NN B-Gene
time NN O
[ NNP O
aPTT NN O
] VBD O
1 CD O
. . O
5 CD O
times NNS O
control JJ O
value NN O
) ) O
. . O

They PRP O
also RB O
interact VBP O
with IN O
GTPase NNP B-Gene
activating VBG I-Gene
proteins NNS I-Gene
encoded VBN O
by IN O
IRA1 NNP B-Gene
and CC O
IRA2 NNP B-Gene
. . O

R NNP O
. . O
, , O
Fleischmann NNP O
, , O
R NNP O
. . O
, , O
Venter NNP O
, , O
J NNP O
. . O

Construction NN O
of IN O
a DT O
RIP1 NNP B-Gene
deletion NN O
strain NN O
and CC O
isolation NN O
of IN O
temperature NN O
- : O
sensitive JJ O
mutants NNS O
. . O

Membrane NNP O
- : O
bound NN O
Steel NNP B-Gene
factor NN I-Gene
induces NNS O
more RBR O
persistent JJ O
tyrosine NN B-Gene
kinase NN I-Gene
activation NN O
and CC O
longer JJR O
life NN O
span NN O
of IN O
c SYM B-Gene
- : I-Gene
kit NN I-Gene
gene NN O
- : O
encoded VBD O
protein NN O
than IN O
its PRP$ O
soluble JJ O
form NN O
. . O

Activities NNS O
of IN O
hepatic JJ O
cytochrome NN B-Gene
P NNP I-Gene
- : I-Gene
450 CD I-Gene
- : O
dependent NN O
metabolizing VBG O
enzymes NNS O
such JJ O
as IN O
aminopyrine JJ B-Gene
- : I-Gene
and CC I-Gene
TMO NNP I-Gene
N NNP I-Gene
- : I-Gene
demethylase NN I-Gene
and CC O
aniline JJ B-Gene
hydroxylase NN I-Gene
activity NN O
were VBD O
decreased VBN O
by IN O
pretreatment NN O
of IN O
rats NNS O
with IN O
cimetidine NN O
, , O
whereas NNS O
in IN O
the DT O
rats NNS O
pretreated VBD O
with IN O
ranitidine NN O
, , O
these DT O
enzyme JJ O
activities NNS O
were VBD O
not RB O
changed VBN O
. . O

In IN O
a DT O
reconstituted JJ O
human JJ O
DNA NNP O
repair NN O
system NN O
containing VBG O
DNA NNP B-Gene
polymerase NN I-Gene
beta NN I-Gene
and CC O
DNA NNP B-Gene
ligase NN I-Gene
III NNP I-Gene
- : O
XRCC1 NN B-Gene
, , O
accurate JJ O
rejoining NN O
of IN O
a DT O
3 CD O
' POS O
mismatched JJ O
base NN O
residue NN O
at IN O
a DT O
single JJ O
- : O
strand NN O
break NN O
is VBZ O
dependent JJ O
on IN O
addition NN O
of IN O
the DT O
exonuclease NN O
. . O

The DT O
granules NNS O
grew VBD O
as IN O
the DT O
melted JJ O
material NN O
immersed VBN O
into IN O
the DT O
void JJ O
space NN O
among IN O
the DT O
adhered JJ O
particles NNS O
. . O

This DT O
was VBD O
most RBS O
pronounced JJ O
during IN O
the DT O
initial JJ O
phase NN O
of IN O
Erk NNP B-Gene
activation NN O
. . O

Syndromes NNS O
of IN O
abnormal JJ O
fat JJ O
redistribution NN O
and CC O
metabolic JJ O
complications NNS O
in IN O
HIV NNP O
- : O
infected JJ O
patients NNS O
. . O

Use NNP O
of IN O
the DT O
vena NN O
cava NN O
to TO O
extend VB O
the DT O
right JJ O
renal NN O
vein NN O
for IN O
cadaver NN O
transplantation NN O
is VBZ O
controversial JJ O
. . O

271 CD O
: : O
31290 CD O
- : O
31295 CD O
, , O
1996 CD O
) ) O
. . O

Despite IN O
the DT O
presence NN O
of IN O
one CD O
additional JJ O
ribonucleotide NN B-Gene
reductase NN I-Gene
, , O
the DT O
nrdAB JJ B-Gene
- : I-Gene
encoded JJ I-Gene
enzyme NN I-Gene
is VBZ O
essential JJ O
to TO O
the DT O
aerobic JJ O
growth NN O
of IN O
the DT O
cell NN O
because IN O
nrdAB JJ B-Gene
- : I-Gene
defective JJ I-Gene
mutants NNS I-Gene
of IN O
both DT O
species NNS O
are VBP O
not RB O
viable JJ O
in IN O
the DT O
presence NN O
of IN O
oxygen NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
and CC O
competition NN O
experiments NNS O
showed VBD O
that IN O
site NN O
A DT O
is VBZ O
recognized VBN O
by IN O
an DT O
NF1 NNP B-Gene
protein NN I-Gene
. . O

Under IN O
these DT O
schedules NNS O
, , O
a DT O
reinforced JJ O
response NN O
run NN O
consisted VBD O
of IN O
responding VBG O
between IN O
eight CD O
and CC O
12 CD O
times NNS O
on IN O
one CD O
response NN O
key NN O
( ( O
work VB O
key NN O
) ) O
and CC O
then RB O
responding VBG O
once RB O
on IN O
a DT O
second JJ O
response NN O
key NN O
( ( O
reinforced JJ O
key NN O
) ) O
. . O

Conformational JJ O
changes NNS O
of IN O
the DT O
ferric JJ B-Gene
uptake JJ I-Gene
regulation NN I-Gene
protein NN I-Gene
upon IN O
metal JJ O
activation NN O
and CC O
DNA NNP O
binding NN O
; : O
first JJ O
evidence NN O
of IN O
structural JJ O
homologies NNS O
with IN O
the DT O
diphtheria NN B-Gene
toxin NN I-Gene
repressor NN I-Gene
. . O

Various JJ O
companies NNS O
produce VBP O
this DT O
type NN O
of IN O
lens NNS O
. . O

As IN O
a DT O
reflection NN O
of IN O
uncertainties NNS O
in IN O
the DT O
estimates NNS O
for IN O
individual JJ O
sources NNS O
, , O
the DT O
90th CD O
percentiles NNS O
of IN O
PCDD NNP O
/ NNP O
F NNP O
releases VBZ O
for IN O
1999 CD O
ranged VBD O
up RB O
to TO O
4 CD O
. . O
1 CD O
g NN O
I PRP O
- : O
TEQ NN O
/ JJ O
y NN O
. . O

Human NNP O
antitetanus VBZ O
serum NN O
: : O
an DT O
unused JJ O
wealth NN O

CONCLUSIONS NN O
: : O
Lymphoscintigraphy NN O
of IN O
the DT O
cynomolgus NN O
monkey NN O
eyelids NNS O
reveals NNS O
discrete VBP O
lymphatic JJ O
drainage NN O
pathways NNS O
for IN O
the DT O
upper JJ O
and CC O
lower JJR O
eyelids NNS O
and CC O
a DT O
dual JJ O
pathway NN O
for IN O
the DT O
central JJ O
upper JJ O
eyelid NN O
. . O

Terminal NNP B-Gene
deoxynucleotidyl NN I-Gene
transferase NN I-Gene
- : O
mediated VBN O
nick JJ O
end NN O
labeling NN O
assays NNS O
revealed VBD O
that IN O
hormonal JJ O
activation NN O
of IN O
the DT O
PAX3 NNP B-Gene
repressors NNS I-Gene
induced VBD O
extensive JJ O
apoptosis NN O
that WDT O
correlated VBD O
with IN O
down RP O
- : O
regulation NN O
of IN O
BCL NNP B-Gene
- : I-Gene
X NN I-Gene
( ( I-Gene
L NNP I-Gene
) ) I-Gene
expression NN O
. . O

A DT O
given VBN O
standard NN O
input NN O
function NN O
and CC O
a DT O
given VBN O
value NN O
of IN O
distribution NN O
volume NN O
( ( O
Vd NNP O
) ) O
used VBD O
for IN O
the DT O
rCBF JJ O
measurement NN O
of IN O
this DT O
method NN O
were VBD O
calculated VBN O
from IN O
the DT O
dynamic JJ O
study NN O
by IN O
six CD O
normal JJ O
volunteers NNS O
. . O

The DT O
majority NN O
of IN O
MRF NNP O
units NNS O
were VBD O
behaviorally RB O
incongruent JJ O
; : O
in IN O
the DT O
most RBS O
frequently RB O
observed JJ O
case NN O
, , O
their PRP$ O
activity NN O
failed VBD O
to TO O
change VB O
reliably RB O
when WRB O
behavior NN O
habituated VBD O
. . O

Zarix NNP O
expected VBD O
patient JJ O
enrollment NN O
in IN O
Canadian JJ O
clinical JJ O
sites NNS O
to TO O
begin VB O
in IN O
Spring NN O
2001 CD O
[ NN O
397955 CD O
] NN O
, , O
[ VBZ O
405928 CD O
] NN O
. . O

Therefore RB O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
control VB O
hypertension NN O
and CC O
keep VB O
appropriate JJ O
renal JJ O
blood NN O
flow NN O
during IN O
living VBG O
renal JJ O
transplantation NN O
surgery NN O
. . O

PTP NNP B-Gene
- : I-Gene
S3 NN I-Gene
differs NNS O
from IN O
PTP NNP B-Gene
- : I-Gene
S4 NN I-Gene
in IN O
having VBG O
a DT O
deletion NN O
of IN O
19 CD O
amino JJ O
acids NNS O
corresponding VBG O
to TO O
exon VB O
E1 NNP O
. . O

EGF NNP B-Gene
acts NNS O
primarily RB O
by IN O
means NNS O
of IN O
transactivation NN O
domain NN O
AF NNP O
- : O
1 CD O
, , O
whereas NNS O
cAMP VBP O
acts NNS O
via IN O
transactivation NN O
domain NN O
AF NNP O
- : O
2 CD O
of IN O
the DT O
ER NNP B-Gene
. . O

Because IN O
PET NNP O
is VBZ O
also RB O
useful JJ O
for IN O
the DT O
pretreatment NN O
and CC O
follow VB O
- : O
up IN O
evaluation NN O
, , O
the DT O
use NN O
of IN O
stereotactic JJ O
PET NNP O
in IN O
these DT O
patients NNS O
can MD O
enable VB O
an DT O
accurate JJ O
comparison NN O
of IN O
PET NNP O
- : O
based VBN O
metabolic JJ O
data NNS O
with IN O
MR NNP O
- : O
based VBN O
anatomical JJ O
data NNS O
. . O

Each DT O
of IN O
these DT O
spliced VBN O
mRNAs NN O
has VBZ O
an DT O
untranslated JJ O
leader NN O
sequence NN O
of IN O
249 CD O
bases NNS O
and CC O
a DT O
single JJ O
intron NN O
of IN O
approximately RB O
540 CD O
bases NNS O
which WDT O
are VBP O
contained VBN O
entirely RB O
within IN O
TRs NNP O
/ NNP O
IRs NNP O
sequences NNS O
. . O

The DT O
highest JJS O
decrease NN O
in IN O
mutagenic JJ O
activity NN O
was VBD O
observed VBN O
when WRB O
enzymatic JJ O
bleaching NN O
was VBD O
used VBN O
together RB O
with IN O
chlorine NN O
. . O

Effects NNS O
of IN O
a DT O
booster NN O
dose NN O
of IN O
tetanus NN O
toxoid NN O
after IN O
different JJ O
primary JJ O
courses NNS O
of IN O
vaccination NN O
: : O
implications NNS O
on IN O
the DT O
use NN O
of IN O
immune JJ B-Gene
globulin NN I-Gene
. . O

If IN O
this DT O
is VBZ O
unavailable JJ O
, , O
then RB O
Supramid NNP O
has VBZ O
a DT O
proven NN O
record NN O
for IN O
good JJ O
tissue NN O
compatibility NN O
and CC O
resistance NN O
to TO O
infection NN O
. . O

The DT O
cop NN B-Gene
region NN I-Gene
also RB O
harbors VBZ O
a DT O
region NN O
of IN O
plasmid JJ O
incompatibility NN O
, , O
inc NN B-Gene
, , O
encompassing VBG O
a DT O
stem NN O
- : O
loop NN O
structure NN O
, , O
the DT O
repA NN B-Gene
promoter NN I-Gene
, , O
Prep NNP B-Gene
, , O
as RB O
well RB O
as IN O
two CD O
distinct JJ O
RepA NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
BD NNP O
- : O
1 CD O
and CC O
BD NNP O
- : O
2 CD O
. . O

PCNA NNP B-Gene
mRNA NN I-Gene
has VBZ O
a DT O
3 CD O
' POS O
UTR NNP O
antisense NN O
to TO O
yellow VB O
crescent NN O
RNA NNP O
and CC O
is VBZ O
localized VBN O
in IN O
ascidian JJ O
eggs NNS O
and CC O
embryos NN O
. . O

Judge NNP O
OKs NNP O
docs NN O
' '' O
bid NN O
for IN O
Chicago NNP O
hospital NN O
. . O

Other JJ O
uncertainties NNS O
in IN O
the DT O
dosimetry NN O
at IN O
Y NNP O
- : O
12 CD O
and CC O
Vinca NNP O
are VBP O
unaltered JJ O
. . O

Effects NNS O
of IN O
rhG NN B-Gene
- : I-Gene
CSF NN I-Gene
on IN O
neutrophil JJ O
functions NNS O
and CC O
survival NN O
in IN O
sepsis NN O
induced VBN O
diabetic JJ O
rats NNS O
. . O

Effects NNS O
of IN O
posteroventral JJ O
pallidotomy NN O
on IN O
Parkinson NNP O
' POS O
s JJ O
disease NN O
. . O

Furthermore RB O
, , O
Rac1 NNP B-Gene
activation NN O
of IN O
JNK NNP B-Gene
or CC O
SRF NNP B-Gene
, , O
or CC O
induction NN O
of IN O
lamellipodia NN O
, , O
was VBD O
neither DT O
necessary JJ O
nor CC O
sufficient JJ O
for IN O
Rac1 NNP B-Gene
transforming VBG O
activity NN O
. . O

A DT O
385 CD O
bp NN O
Glucocorticoid NNP O
Response NNP O
Unit NNP O
( ( O
GRU NNP O
) ) O
was VBD O
identified VBN O
whose WP$ O
glucocorticoid JJ O
induction NN O
was VBD O
enhanced VBN O
by IN O
dibutyryl NN O
- : O
cAMP NN O
and CC O
reduced VBN O
by IN O
phorbol NN O
esters NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
different JJ O
models NNS O
of IN O
intestinal JJ O
ischemia NN O
have VBP O
different JJ O
cytokine NN O
profiles NNS O
and CC O
that IN O
the DT O
early JJ O
TNF NNP B-Gene
response NN O
associated VBN O
with IN O
SMA NNP O
occlusion NN O
model NN O
is VBZ O
primarily RB O
due JJ O
to TO O
the DT O
laparotomy NN O
. . O

Studies NNS O
on IN O
swine NN O
enteroviruses NNS O
. . O

Natural NNP O
and CC O
induced VBD O
malarias NNS O
in IN O
western JJ O
hemisphere JJ O
monkeys NNS O
. . O

It PRP O
was VBD O
found VBN O
that IN O
increase NN O
in IN O
the DT O
RH NNP O
level NN O
boosts VBZ O
the DT O
current JJ O
values NNS O
by IN O
2 CD O
- : O
3 CD O
orders NNS O
of IN O
magnitude NN O
; : O
contrariwise NN O
, , O
the DT O
voltage NN O
values NNS O
rise VB O
by IN O
about RB O
three CD O
times NNS O
with IN O
drop NN O
in IN O
the DT O
RH NNP O
. . O

73 CD O
: : O
658 CD O
- : O
666 CD O
, , O
1999 CD O
) ) O
. . O

In IN O
these DT O
cells NNS O
, , O
ras FW B-Gene
- : O
induced JJ O
transition NN O
is VBZ O
accompanied VBN O
by IN O
a DT O
strong JJ O
induction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
binding NN O
activity NN O
along IN O
with IN O
increased JJ O
expression NN O
of IN O
CD44 NNP B-Gene
mRNA NN I-Gene
and CC O
protein NN O
. . O

Binding VBG O
site NN O
selection NN O
using VBG O
in IN O
vitro JJ O
- : O
synthesized JJ O
proteins NNS O
reveals NNS O
that IN O
the DT O
ROR NNP B-Gene
alpha VBZ I-Gene
1 CD I-Gene
and CC O
ROR NNP B-Gene
alpha VBP I-Gene
2 CD I-Gene
isoforms NNS I-Gene
bind VBP O
DNA NNP O
as IN O
monomers NNS O
to TO O
hormone VB O
response NN O
elements NNS O
composed VBN O
of IN O
a DT O
6 CD O
- : O
bp NN O
AT NNP O
- : O
rich JJ O
sequence NN O
preceding VBG O
a DT O
half JJ O
- : O
site NN O
core NN O
motif NN O
PuGGTCA NNP O
( ( O
RORE NNP B-Gene
) ) O
. . O

This DT O
study NN O
tested VBD O
the DT O
hypothesis NN O
that WDT O
sodium JJ O
channel NNS O
blocking VBG O
drugs NNS O
selectively RB O
prolong IN O
the DT O
late JJ O
potential NN O
, , O
or CC O
terminal JJ O
low JJ O
amplitude JJ O
signal NN O
, , O
portion NN O
of IN O
the DT O
signal JJ O
- : O
averaged VBD O
QRS NNP O
complex NN O
and CC O
that DT O
prolongation NN O
of IN O
the DT O
late JJ O
potential NN O
would MD O
correlate VB O
with IN O
slowing NN O
of IN O
ventricular JJ O
tachycardia NN O
. . O

Proteinuria NNP O
- : O
- : O
selected VBN O
physiopathological JJ O
and CC O
clinical JJ O
problems NNS O

IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
was VBD O
significantly RB O
higher JJR O
in IN O
endometrioma NN O
than IN O
in IN O
lesions NNS O
of IN O
other JJ O
localizations NNS O
. . O

Soft JJ O
- : O
x SYM O
- : O
ray NN O
lasing NN O
at IN O
32 CD O
. . O
6 CD O
nm NN O
in IN O
Ne NNP O
- : O
like IN O
Ti NNP O
ions NNS O
driven VBN O
by IN O
40 CD O
J NNP O
of IN O
energy NN O
from IN O
two CD O
650 CD O
- : O
ps NN O
laser NN O
pulses NNS O
. . O

All DT O
carcasses NNS O
resulted VBD O
in IN O
contamination NN O
with IN O
aerobic JJ O
mesophilic JJ O
bacteria NNS O
in IN O
the DT O
range NN O
from IN O
6 CD O
x NNS O
10 CD O
( ( O
3 CD O
) ) O
to TO O
1 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
6 CD O
) ) O
CFU NNP O
/ NNP O
ml NN O
liquid NN O
washed VBD O
, , O
and CC O
94 CD O
% NN O
them PRP O
with IN O
sporulate NN O
bacteria NNS O
, , O
the DT O
threshold NN O
being VBG O
under IN O
100 CD O
CFU NNP O
/ NNP O
ml NN O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Animal NNP O
age NN O
and CC O
sex NN O
had VBD O
no DT O
significant JJ O
effects NNS O
on IN O
CSF NNP O
composition NN O
, , O
but CC O
serum JJ O
IgG NNP B-Gene
concentration NN O
increased VBD O
with IN O
age NN O
. . O

The DT O
TYAC NNP O
/ NNP O
P1 NNP O
resource NN O
, , O
derivative JJ O
STSs NNP O
, , O
and CC O
polymorphisms NNS O
constitute VBP O
an DT O
enabling VBG O
resource NN O
to TO O
further JJ O
studies NNS O
of IN O
telomere JJ O
structure NN O
and CC O
function NN O
and CC O
a DT O
means NN O
for IN O
physical JJ O
and CC O
genetic JJ O
map NN O
integration NN O
and CC O
closure NN O
. . O

There EX O
were VBD O
significant JJ O
differences NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
between IN O
the DT O
fracture NN O
and CC O
nonfracture NN O
groups NNS O
in IN O
the DT O
total JJ O
femur NN O
BMD NNP O
( ( O
13 CD O
% NN O
) ) O
, , O
trabecular JJ O
BMD NNP O
in IN O
the DT O
distal JJ O
radius NN O
( ( O
4 CD O
% NN O
) ) O
, , O
and CC O
the DT O
fractal JJ O
dimension NN O
in IN O
the DT O
radiographs NN O
( ( O
FD2 NNP O
) ) O
( ( O
3 CD O
% NN O
) ) O
. . O

Transformed NNP O
cell NN O
lines NNS O
expressing VBG O
solely RB O
E1a NNP B-Gene
or CC O
E1a NNP B-Gene
and CC O
E1b NNP B-Gene
gene NN I-Gene
products NNS I-Gene
derived VBN O
from IN O
these DT O
viruses NNS O
display VBP O
enhanced VBN O
anchorage JJ O
- : O
independent JJ O
growth NN O
at IN O
37 CD O
degrees NNS O
C NNP O
versus NN O
32 CD O
degrees NNS O
C NNP O
and CC O
display VB O
a DT O
cytoskeletal JJ O
architecture NN O
resembling VBG O
untransformed JJ O
fibroblastic JJ O
CREF NNP O
cells NNS O
. . O

Utility NN O
of IN O
OAE NNP O
screener NN O
( ( O
GSI NNP O
70 CD O
) ) O
for IN O
the DT O
evaluation NN O
of IN O
distortion NN O
product NN O
otoacoustic JJ O
emissions NNS O
] VBP O
The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
ability NN O
of IN O
the DT O
OAE NNP O
screener NN O
GSI NNP O
70 CD O
to TO O
evaluate VB O
of IN O
cochlea NN O
function NN O
in IN O
neonates NNS O
, , O
infants NNS O
and CC O
adults NNS O
. . O

Evidence NN O
for IN O
such JJ O
peak JJ O
shifts NNS O
has VBZ O
been VBN O
found VBN O
in IN O
the DT O
responses NNS O
of IN O
auditory NN O
nerve NN O
fibers NNS O
, , O
cochlear JJ O
microphonics NNS O
, , O
and CC O
the DT O
responses NNS O
of IN O
outer JJ O
hair NN O
cells NNS O
and CC O
supporting VBG O
cells NNS O
in IN O
the DT O
cochlea NN O
, , O
as RB O
well RB O
as IN O
in IN O
basilar JJ O
membrane NN O
vibration NN O
measurements NNS O
, , O
and CC O
indirectly RB O
, , O
in IN O
psychophysical JJ O
data NNS O
. . O

Similar JJ O
to TO O
the DT O
mouse NN O
gene NN O
, , O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
human JJ B-Gene
CD79 NNP I-Gene
alpha NN I-Gene
lacks VBZ O
a DT O
TATA NNP O
box NN O
; : O
however RB O
, , O
unlike IN O
mouse NN B-Gene
CD79 NNP I-Gene
alpha NN I-Gene
, , O
a DT O
classical JJ O
octamer NN O
motif NNS O
could MD O
not RB O
be VB O
identified VBN O
in IN O
the DT O
human JJ O
gene NN O
. . O

Of IN O
202 CD O
initially RB O
seronegative JJ O
caretakers NNS O
( ( O
observed VBN O
for IN O
an DT O
average NN O
of IN O
305 CD O
days NNS O
per IN O
woman NN O
) ) O
, , O
19 CD O
seroconverted VBD O
, , O
for IN O
an DT O
annual JJ O
seroconversion NN O
rate NN O
of IN O
11 CD O
percent NN O
. . O

Activation NN O
of IN O
a DT O
CRE NNP O
- : O
dependent NN O
junB NN B-Gene
promoter NN I-Gene
/ NNP O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
reporter NN O
gene NN O
by IN O
the DT O
BCR NNP B-Gene
was VBD O
also RB O
blocked VBN O
by IN O
SB203580 NNP O
. . O

WA NNP O
constructs NNS O
afforded VBD O
relaxed NN O
and CC O
positive JJ O
topoisomers NNS O
, , O
and CC O
cyclization NN O
kinetics NNS O
indicated VBD O
slow JJ O
interconversion NN O
of IN O
precursors NNS O
to TO O
the DT O
two CD O
topoisomers NNS O
. . O

The DT O
mean JJ O
serum NN O
creatinine NN O
levels NNS O
were VBD O
similar JJ O
at IN O
one CD O
year NN O
( ( O
SPK NNP O
1 CD O
. . O
8 CD O
, , O
KTA NNP O
1 CD O
. . O
9 CD O
mg JJ O
/ NNP O
d NN O
) ) O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Molecular JJ O
characterization NN O
of IN O
the DT O
50 CD O
- : O
and CC O
57 CD O
- : O
kDa NN O
subunits NNS O
of IN O
the DT O
bovine NN B-Gene
vacuolar JJ I-Gene
proton NN I-Gene
pump NN I-Gene
. . O

Protein NNP O
electrophoresis NN O
showed VBD O
decreased JJ O
albumin NN B-Gene
levels NNS O
in IN O
both DT O
groups NNS O
, , O
with IN O
lower JJR O
values NNS O
in IN O
G2 NNP O
. . O

Induced NNP O
gamma SYM O
- : O
ray NN O
spectroscopy NN O

Lung NNP O
prostacyclin NN O
production NN O
may MD O
be VB O
related VBN O
to TO O
flow VB O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
using VBG O
crude JJ O
extracts NNS O
from IN O
FREJ4 NNP O
cells NNS O
revealed VBD O
the DT O
binding NN O
of IN O
a DT O
member NN O
( ( O
s JJ O
) ) O
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
to TO O
the DT O
P4 NNP B-Gene
EBS NNP I-Gene
, , O
as RB O
well RB O
as IN O
the DT O
interaction NN O
of IN O
two CD O
members NNS O
of IN O
the DT O
Sp1 NNP B-Gene
family NN I-Gene
, , O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
, , O
with IN O
the DT O
adjacent JJ O
GC NNP O
box NN O
. . O

The DT O
final JJ O
predicted NN O
structure NN O
has VBZ O
an DT O
overall JJ O
backbone NN O
deviation NN O
of IN O
0 CD O
. . O
7 CD O
A NN O
from IN O
that DT O
of IN O
ras NNS B-Gene
- : O
p21 NN B-Gene
. . O

Using VBG O
homology NN O
cloning VBG O
techniques NNS O
, , O
we PRP O
identified VBD O
a DT O
mouse NN O
homologue NN O
of IN O
E NNP B-Gene
( ( I-Gene
Pc NNP I-Gene
) ) I-Gene
, , O
termed VBD O
Epc1 NNP B-Gene
, , O
a DT O
yeast NN O
protein NN O
that IN O
we PRP O
name VBP O
EPL1 NNP B-Gene
, , O
and CC O
as RB O
well RB O
as IN O
additional JJ O
ESTs NNP O
from IN O
Caenorhabditis NNP O
elegans NNS O
, , O
mice NN O
and CC O
humans NNS O
. . O

Characterization NN O
of IN O
the DT O
regulon NN O
controlled VBN O
by IN O
the DT O
leucine JJ B-Gene
- : I-Gene
responsive JJ I-Gene
regulatory JJ I-Gene
protein NN I-Gene
in IN O
Escherichia NNP O
coli NN O
. . O

The DT O
3 CD O
' POS O
region NN O
, , O
GA2 NNP B-Gene
, , O
is VBZ O
necessary JJ O
for IN O
maximal JJ O
expression NN O
. . O

Some DT O
mutations NNS O
affected VBD O
Dhfr NNP B-Gene
in IN O
a DT O
qualitative JJ O
manner NN O
, , O
such JJ O
as IN O
by IN O
changing VBG O
the DT O
startpoint NN O
of IN O
one CD O
of IN O
the DT O
major JJ O
Dhfr NNP B-Gene
transcripts NNS I-Gene
or CC O
changing VBG O
the DT O
relative JJ O
abundance NN O
of IN O
the DT O
two CD O
major JJ O
Dhfr NNP B-Gene
transcripts NNS I-Gene
. . O

CONCLUSION NN O
: : O
A DT O
valve JJ O
- : O
like IN O
mechanism NN O
formed VBN O
by IN O
the DT O
capsulorhexis NN O
rim VBZ O
partially RB O
adhered VBN O
to TO O
the DT O
IOL NNP O
optic JJ O
can MD O
occur VB O
postoperatively RB O
. . O

To TO O
investigate VB O
the DT O
effects NNS O
of IN O
exogenous JJ O
hyaluronic JJ O
acid NN O
, , O
the DT O
development NN O
of IN O
port NN O
- : O
site NN O
metastasis NN O
was VBD O
examined VBN O
using VBG O
mouse NN O
adenocarcinoma NN O
cell NN O
- : O
line NN O
colon NN O
26 CD O
cells NNS O
. . O

The DT O
effect NN O
of IN O
CBZ NNP O
and CC O
DPH NNP O
can MD O
be VB O
explained VBN O
by IN O
interference NN O
with IN O
thyroid JJ O
hormone NN O
binding NN O
to TO O
TBG NNP B-Gene
combined VBN O
with IN O
enzyme JJ O
- : O
induced VBN O
increased JJ O
metabolic JJ O
clearance NN O
rate NN O
of IN O
thyroid NN O
hormones NNS O
without IN O
homeostatic JJ O
maintenance NN O
of IN O
premedication NN O
levels NNS O
of IN O
FT4 NNP O
and CC O
FT3 NNP O
. . O

The DT O
gene NN O
includes VBZ O
three CD O
exons NNS O
and CC O
two CD O
introns NNS O
within IN O
1 CD O
. . O
6 CD O
kilobases NNS O
of IN O
DNA NNP O
, , O
and CC O
the DT O
entire JJ O
open JJ O
reading NN O
frame NN O
for IN O
glycoprotein NN B-Gene
IX NNP I-Gene
is VBZ O
included VBN O
within IN O
the DT O
third JJ O
exon NN O
. . O

The DT O
full JJ O
- : O
length NN O
N NNP B-Gene
gene NN I-Gene
, , O
encoded VBN O
by IN O
open JJ O
reading NN O
frame NN O
7 CD O
, , O
was VBD O
cloned VBN O
from IN O
the DT O
Canadian NNP O
PRRS NNP O
virus NN O
, , O
PA NNP O
- : O
8 CD O
. . O

Transformations NNS O
in IN O
the DT O
morphine NN O
series NN O
. . O

Dissociable JJ O
effects NNS O
of IN O
lidocaine JJ O
inactivation NN O
of IN O
the DT O
rostral JJ O
and CC O
caudal JJ O
basolateral JJ O
amygdala NN O
on IN O
the DT O
maintenance NN O
and CC O
reinstatement NN O
of IN O
cocaine NN O
- : O
seeking VBG O
behavior NN O
in IN O
rats NNS O
. . O

Even RB O
if IN O
the DT O
electrocardiographic JJ O
signs NNS O
are VBP O
subdued VBN O
, , O
the DT O
underlying VBG O
blockade NN O
of IN O
I PRP O
( ( O
Kr NNP O
) ) O
current JJ O
may MD O
precipitate VB O
the DT O
occurrence NN O
of IN O
arrhythmia NN O
. . O

During IN O
the DT O
past JJ O
decade NN O
, , O
different JJ O
types NNS O
of IN O
endogenous JJ O
retroviral JJ O
sequences NNS O
have VBP O
been VBN O
defined VBN O
in IN O
the DT O
human JJ O
genome NN O
usually RB O
by IN O
low JJ O
stringency NN O
hybridization NN O
employing VBG O
DNA NNP O
probes NNS O
of IN O
evolutionary JJ O
conserved VBN O
animal JJ O
retrovirus NN O
genes NNS O
. . O

Menetrier NNP O
disease NN O
in IN O
a DT O
child NN O
. . O

A DT O
stable JJ O
interface NN O
depends VBZ O
on IN O
overall JJ O
stress NN O
and CC O
microstress NN O
distribution NN O
on IN O
the DT O
bone NN O
, , O
particularly RB O
trabecular JJ O
bone NN O
. . O

The DT O
5 CD O
- : O
year NN O
OS NNP O
for IN O
stage NN O
IIIB NNP O
was VBD O
30 CD O
. . O
9 CD O
% NN O
, , O
compared VBN O
to TO O
7 CD O
. . O
8 CD O
% NN O
for IN O
stage NN O
IV NNP O
. . O

Comparison NNP O
of IN O
the DT O
deduced JJ O
amino NN O
acid NN O
sequences NNS O
with IN O
protein JJ O
sequences NNS O
of IN O
T NNP O
. . O
pyriformis NN O
H2As NNP B-Gene
showed VBD O
only RB O
two CD O
and CC O
three CD O
differences NNS O
respectively RB O
, , O
in IN O
a DT O
total NN O
of IN O
137 CD O
amino JJ O
acids NNS O
for IN O
H2A1 NNP B-Gene
, , O
and CC O
132 CD O
amino NN O
acids NNS O
for IN O
H2A2 NNP B-Gene
, , O
indicating VBG O
the DT O
two CD O
genes NNS O
arose VBD O
before IN O
the DT O
divergence NN O
of IN O
these DT O
two CD O
species NNS O
. . O

Structural JJ O
changes NNS O
in IN O
the DT O
C NNP O
- : O
terminus NN O
of IN O
Ca2 NNP O
+ NNP O
- : O
bound NN O
rat NN B-Gene
S100B NNP I-Gene
( ( O
beta VB B-Gene
beta NN I-Gene
) ) O
upon IN O
binding VBG O
to TO O
a DT O
peptide NN O
derived VBN O
from IN O
the DT O
C NNP O
- : O
terminal JJ O
regulatory JJ O
domain NN O
of IN O
p53 NN B-Gene
. . O

Identification NN O
of IN O
RNase NNP B-Gene
T NNP I-Gene
as IN O
a DT O
high JJ O
- : O
copy NN O
suppressor NN O
of IN O
the DT O
UV NNP O
sensitivity NN O
associated VBN O
with IN O
single JJ B-Gene
- : I-Gene
strand NN I-Gene
DNA NNP I-Gene
exonuclease NN I-Gene
deficiency NN O
in IN O
Escherichia NNP O
coli NN O
. . O

Thrombolytic JJ O
therapy NN O
in IN O
spontaneous JJ O
coronary JJ O
artery NN O
dissection NN O
. . O

Thus RB O
, , O
through IN O
a DT O
change NN O
in IN O
conformation NN O
upon IN O
repair NN O
of IN O
the DT O
6RG CD O
lesion NN O
, , O
MGMT NNP B-Gene
switches VBZ O
from IN O
a DT O
DNA NNP O
repair NN O
factor NN O
to TO O
a DT O
transcription NN O
regulator NN O
( ( O
R NNP B-Gene
- : I-Gene
MGMT NN I-Gene
) ) O
, , O
enabling VBG O
the DT O
cell NN O
to TO O
sense NN O
as RB O
well RB O
as IN O
respond NN O
to TO O
mutagens NNS O
. . O

FK NNP O
33 CD O
- : O
824 CD O
, , O
a DT O
methionine NN O
- : O
enkephalin NN B-Gene
analogue NN O
, , O
suppressed VBD O
plasma NN O
ACTH NNP B-Gene
to TO O
85 CD O
% NN O
of IN O
basal NN O
level NN O
, , O
while IN O
bromocriptine NN O
( ( O
CB NNP O
- : O
154 CD O
) ) O
caused VBD O
no DT O
significant JJ O
change NN O
. . O

Precipitating VBG O
antibodies NNS O
for IN O
Thermophilic NNP O
actinomycetes NNS O
and CC O
M NNP O
. . O
f NN O
. . O
were VBD O
negative JJ O
. . O

In IN O
a DT O
group NN O
of IN O
13 CD O
patients NNS O
with IN O
obliterative JJ O
arteriopathies NNS O
of IN O
the DT O
lower JJR O
limbs VBZ O
the DT O
plasma NN O
levels NNS O
of IN O
thrombomodulin NN B-Gene
( ( O
TM NNP B-Gene
) ) O
, , O
betathromboglobulin NN B-Gene
( ( O
beta SYM B-Gene
- : I-Gene
TG NN I-Gene
) ) O
, , O
D NNP O
- : O
dimer NN O
( ( O
DD NNP O
) ) O
and CC O
plasminogen NN B-Gene
activator NN I-Gene
- : I-Gene
inhibitor NN I-Gene
( ( O
pAI JJ B-Gene
- : I-Gene
1 CD I-Gene
) ) O
were VBD O
measured VBN O
, , O
and CC O
compared VBN O
to TO O
the DT O
values NNS O
obtained VBN O
from IN O
10 CD O
healthy JJ O
volunteers NNS O
. . O

J NNP O
. . O

The DT O
3 CD O
' POS O
stem NN O
- : O
loop NN O
is VBZ O
highly RB O
divergent JJ O
in IN O
structure NN O
among IN O
species NNS O
and CC O
lies VBZ O
immediately RB O
upstream JJ O
of IN O
the DT O
binding NN O
site NN O
for IN O
Sm NNP B-Gene
proteins NNS I-Gene
. . O

Elimination NN O
of IN O
natural JJ O
antibodies NNS O
in IN O
discordant JJ O
xenografts NNS O

Thus RB O
, , O
Esigma54 NNP B-Gene
promoters NNS I-Gene
are VBP O
responsive JJ O
to TO O
CRP NNP B-Gene
, , O
a DT O
protein NN O
unrelated JJ O
to TO O
sigma54 VB B-Gene
activators NNS I-Gene
, , O
and CC O
the DT O
repression NN O
exerted VBD O
is VBZ O
the DT O
direct JJ O
result NN O
of IN O
an DT O
interaction NN O
between IN O
Esigma54 NNP B-Gene
and CC O
the DT O
CRP NNP B-Gene
- : I-Gene
cAMP NN I-Gene
complex NN I-Gene
. . O

The DT O
molecular JJ O
mechanism NN O
by IN O
which WDT O
Gle2p NNP B-Gene
and CC O
the DT O
Gle2p NNP B-Gene
- : O
Nup116p NNP B-Gene
interaction NN O
function NN O
in IN O
mRNA JJ O
export NN O
is VBZ O
unknown JJ O
. . O

The DT O
ARX2 NNP O
procedure NN O
models NNS O
the DT O
recorded JJ O
signal NN O
as IN O
the DT O
sum NN O
of IN O
three CD O
signals NNS O
: : O
( ( O
a DT O
) ) O
the DT O
background NN O
EEG NNP O
activity NN O
, , O
modelled VBD O
as IN O
an DT O
autoregressive JJ O
process NN O
driven VBN O
by IN O
a DT O
white JJ O
noise NN O
; : O
( ( O
b NN O
) ) O
a DT O
filtered JJ O
version NN O
of IN O
a DT O
reference NN O
signal NN O
carrying VBG O
the DT O
average JJ O
information NN O
contained VBN O
in IN O
each DT O
sweep NN O
; : O
( ( O
c NN O
) ) O
a DT O
signal JJ O
due JJ O
to TO O
the DT O
ocular JJ O
artefact NN O
propagation NN O
. . O

A DT O
novel JJ O
Drosophila NNP B-Gene
A NNP I-Gene
kinase NN I-Gene
anchor NN I-Gene
protein NN I-Gene
, , O
Drosophila NNP B-Gene
A NNP I-Gene
kinase NN I-Gene
anchor NN I-Gene
protein NN I-Gene
200 CD I-Gene
( ( O
DAKAP200 NNP B-Gene
) ) O
, , O
is VBZ O
predicted VBN O
to TO O
be VB O
involved VBN O
in IN O
routing VBG O
, , O
mediating NN O
, , O
and CC O
integrating VBG O
signals NNS O
carried VBN O
by IN O
cAMP NN O
, , O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
, , O
and CC O
diacylglycerol NN O
( ( O
Li NNP O
, , O
Z NNP O
. . O
, , O
Rossi NNP O
, , O
E NNP O
. . O

As IN O
the DT O
components NNS O
of IN O
these DT O
complexes NNS O
, , O
at IN O
least JJS O
five CD O
TRBPs NNP B-Gene
( ( O
p30 NN B-Gene
, , O
p37 NN B-Gene
, , O
p46 NN B-Gene
, , O
p50 NN B-Gene
, , O
and CC O
p56 NN B-Gene
) ) O
showing VBG O
specific JJ O
binding VBG O
to TO O
the DT O
TAR NNP O
RNA NNP O
were VBD O
detected VBN O
in IN O
the DT O
uv JJ O
cross NN O
- : O
linking VBG O
assay NN O
. . O

Aeromonas NNP O
salmonicida NN O
possesses VBZ O
two CD O
genes NNS O
encoding VBG O
homologs NNS O
of IN O
the DT O
major JJ B-Gene
outer NN I-Gene
membrane NN I-Gene
protein NN I-Gene
, , O
OmpA NNP B-Gene
. . O

In IN O
addition NN O
, , O
on IN O
the DT O
Cohler NNP O
' POS O
s JJ O
maternal JJ O
scale NN O
, , O
Korean JJ O
mothers NNS O
were VBD O
found VBN O
to TO O
view VB O
their PRP$ O
infants NNS O
as IN O
more RBR O
passive JJ O
and CC O
dependent JJ O
than IN O
American JJ O
mothers NNS O
did VBD O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
0 CD O
) ) O
. . O

Copyright NN O
2000 CD O
The DT O
Royal NNP O
College NNP O
of IN O
Radiologists NNP O
. . O

After IN O
24 CD O
hour NN O
incubation NN O
, , O
total JJ O
cell NN O
- : O
associated VBN O
IL NNP B-Gene
- : I-Gene
1Ra CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
were VBD O
measured VBN O
by IN O
specific JJ O
radioimmunoassay NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
pattern NN O
of IN O
blood NN O
supply NN O
is VBZ O
relevant JJ O
to TO O
the DT O
structural JJ O
organisation NN O
of IN O
mature NN O
lamellar JJ O
bone NN O
around IN O
the DT O
implant NN O
. . O

SEA NNP O
was VBD O
recorded VBN O
with IN O
bidirectional JJ O
filters NNS O
at IN O
25 CD O
- : O
250 CD O
HZ NNP O
and CC O
40 CD O
- : O
250 CD O
Hz NNP O
using VBG O
Simson NNP O
method NN O
. . O

On IN O
- : O
line NN O
angioscopic NN O
images NNS O
of IN O
tissue NN O
flaps NNS O
floating VBG O
in IN O
the DT O
lumen NNS O
, , O
recent JJ O
or CC O
structured JJ O
thrombi NN O
, , O
artery RB O
wall JJ O
dissections NNS O
, , O
plaque NN O
ruptures NNS O
, , O
deep JJ O
fissurations NNS O
and CC O
sub JJ O
- : O
intimal JJ O
haemorrhages NNS O
demonstrate VBP O
, , O
in IN O
live JJ O
colour NN O
, , O
the DT O
pathophysiological JJ O
mechanisms NN O
of IN O
coronary JJ O
artery NN O
stenosis NN O
. . O

Performance NN O
on IN O
two CD O
verbal JJ O
measures NNS O
- : O
the DT O
National NNP O
Adult NNP O
Reading NNP O
Test NNP O
- : O
Revised VBN O
( ( O
NART NNP O
- : O
R NN O
) ) O
and CC O
the DT O
Vocabulary NNP O
subtest NN O
from IN O
the DT O
Wechsler NNP O
Adult NNP O
Intelligence NNP O
Scale NNP O
- : O
Revised VBN O
( ( O
WAIS NNP O
- : O
R NN O
) ) O
- : O
showed VBN O
strong JJ O
correlations NNS O
with IN O
level NN O
of IN O
education NN O
. . O

Volunteers NNS O
were VBD O
irradiated VBN O
on IN O
their PRP$ O
backs NNS O
with IN O
suberythemal JJ O
UV NNP O
daily NN O
for IN O
5 CD O
d NN O
after IN O
application NN O
of IN O
the DT O
sunscreens NNS O
and CC O
their PRP$ O
base NN O
lotion NN O
to TO O
different JJ O
sites NNS O
. . O

The DT O
same JJ O
ligands VBZ O
also RB O
exhibit VB O
a DT O
similar JJ O
inhibitory NN O
effect NN O
on IN O
PDGF NNP B-Gene
- : I-Gene
BB NNP I-Gene
- : O
dependent NN O
[ VBZ O
3H CD O
] JJ O
thymidine NN O
incorporation NN O
in IN O
PAE NNP O
cells NNS O
expressing VBG O
the DT O
PDGF NNP B-Gene
beta SYM I-Gene
- : I-Gene
receptors NNS I-Gene
. . O

In IN O
macrophages NNS O
, , O
LPS NNP O
- : O
inducible JJ O
HIV NNP O
- : O
1 CD O
gene NN O
expression NN O
is VBZ O
mediated VBN O
in IN O
part NN O
by IN O
binding VBG O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
to TO O
identical JJ O
tandem NN O
binding VBG O
sites NNS O
located VBN O
within IN O
the DT O
long JJ O
terminal JJ O
repeat NN O
( ( O
LTR NNP O
) ) O
. . O

For IN O
this DT O
purpose NN O
, , O
the DT O
immediate JJ O
and CC O
the DT O
final JJ O
( ( O
after IN O
swelling VBG O
) ) O
fixation NN O
strengths NNS O
of IN O
two CD O
variations NNS O
of IN O
the DT O
swellable JJ O
bone NN O
anchor NN O
designs NNS O
( ( O
a DT O
smooth NN O
anchor NN O
and CC O
a DT O
screw JJ O
anchor NN O
) ) O
were VBD O
measured VBN O
in IN O
two CD O
different JJ O
foams NNS O
( ( O
used VBN O
to TO O
simulate VB O
bone NN O
) ) O
with IN O
different JJ O
densities NNS O
. . O

The DT O
domain NN O
structure NN O
of IN O
bovine NN B-Gene
LTBP NNP I-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
very RB O
similar JJ O
to TO O
that DT O
of IN O
the DT O
human JJ B-Gene
LTBP NNP I-Gene
- : I-Gene
2 CD I-Gene
, , O
containing VBG O
20 CD O
examples NNS O
of IN O
6 CD O
- : O
cysteine NN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
like IN I-Gene
repeats NNS I-Gene
, , O
16 CD O
of IN O
which WDT O
have VBP O
the DT O
consensus NN O
sequence NN O
for IN O
calcium NN O
binding NN O
, , O
together RB O
with IN O
4 CD O
examples NNS O
of IN O
8 CD O
- : O
cysteine NN O
motifs NNS O
characteristic JJ O
of IN O
fibrillins NNS B-Gene
and CC O
LTBP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

We PRP O
have VBP O
isolated VBN O
cDNAs NN O
for IN O
a DT O
gene NN O
coding VBG O
for IN O
a DT O
G NNP B-Gene
protein NN I-Gene
alpha VBD I-Gene
subunit NN I-Gene
from IN I-Gene
tomato NN I-Gene
( ( O
Lycopersicon NNP O
esculentum NN O
, , O
cv NN O
. . O

Natural NNP O
FL NNP B-Gene
protein NN I-Gene
has VBZ O
been VBN O
purified VBN O
from IN O
a DT O
stromal JJ O
cell NN O
line NN O
and CC O
shown VBN O
to TO O
be VB O
a DT O
65 CD O
kD NN O
nondisulfide SYM O
- : O
linked VBN O
homodimeric JJ O
glycoprotein NN O
comprised VBD O
of IN O
30 CD O
kD NN O
subunits NNS O
, , O
each DT O
containing VBG O
12 CD O
kD NN O
of IN O
N NNP O
- : O
and CC O
O NNP O
- : O
linked VBD O
sugars NNS O
. . O

To TO O
further VB O
our PRP$ O
knowledge NN O
about IN O
the DT O
systemic JJ O
humoral JJ O
immune NN O
system NN O
response NN O
to TO O
weak JJ O
hapten JJ O
- : O
syngeneic NN O
or CC O
allogeneic JJ O
protein NN O
conjugates NNS O
( ( O
corrosion NN O
and CC O
wear JJ O
products NNS O
of IN O
metallic JJ O
orthopedic JJ O
devices NNS O
) ) O
, , O
a DT O
sensitive JJ O
enzyme NN O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
( ( O
ELISA NNP O
) ) O
method NN O
for IN O
testing VBG O
for IN O
antibody NN O
( ( O
humoral JJ O
immunity NN O
) ) O
to TO O
metals NNS O
was VBD O
developed VBN O
. . O

The DT O
7 CD O
- : O
kb NN O
mRNA NN O
differs NNS O
by IN O
alternative JJ O
splicing NN O
such JJ O
that IN O
it PRP O
encodes VBZ O
a DT O
protein NN O
with IN O
a DT O
distinct JJ O
amino NN O
terminus NN O
. . O

The DT O
combination NN O
of IN O
F1 NNP O
and CC O
F2 NNP O
which WDT O
was VBD O
the DT O
best JJS O
predictor NN O
of IN O
CHD NNP O
in IN O
this DT O
population NN O
( ( O
G1 NNP O
) ) O
might MD O
be VB O
interpreted VBN O
as IN O
reflecting VBG O
trunk NN O
adiposity NN O
mainly RB O
abdominal JJ O
. . O

Between NNP O
acoR NN B-Gene
and CC O
acoXABC NN B-Gene
, , O
two CD O
different JJ O
types NNS O
of IN O
sequences NNS O
with IN O
dual JJ O
rotational JJ O
symmetry NN O
[ NNP O
CAC NNP O
- : O
( ( O
N11 NNP O
to TO O
N18 NNP O
) ) O
- : O
GTG NN O
and CC O
TGT NNP O
- : O
( ( O
N10 NNP O
to TO O
N14 NNP O
) ) O
- : O
ACA $ O
] NNS O
were VBD O
found VBN O
; : O
these DT O
sequences NNS O
are VBP O
similar JJ O
to TO O
NtrC NNP B-Gene
and CC O
NifA NNP B-Gene
upstream JJ I-Gene
activator NN I-Gene
sequences NNS I-Gene
, , O
respectively RB O
. . O

Analysis NN O
by IN O
cell NN O
surface NN O
immunofluorescence NN O
showed VBD O
that IN O
the DT O
UL28 NNP B-Gene
gene NN I-Gene
is VBZ O
not RB O
required VBN O
for IN O
expression NN O
of IN O
viral JJ O
glycoproteins NNS O
on IN O
the DT O
surface NN O
of IN O
infected JJ O
cells NNS O
. . O

By IN O
contrast NN O
, , O
kidneys NNS O
from IN O
rats NNS O
with IN O
chronic JJ O
metabolic JJ O
acidosis NN O
produced VBD O
significantly RB O
more RBR O
NH3 JJ O
than IN O
both DT O
these DT O
groups NNS O
( ( O
2 CD O
. . O
73 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
29 CD O
mumol JJ O
X NNP O
min NNP O
- : O
1 CD O
X NNP O
g VBD O
- : O
1 CD O
) ) O
. . O

Marinol NNP O
/ NNP O
marijuana NNP O
usage NN O
was VBD O
associated VBN O
with IN O
depressed JJ O
CD4 NNP B-Gene
+ NN I-Gene
counts NNS O
and CC O
elevated JJ O
amylase NN B-Gene
levels NNS O
within IN O
the DT O
DDI NNP O
subgroup NN O
. . O

Transcription NN O
of IN O
the DT O
gene NN O
for IN O
ivanolysin NN B-Gene
O NNP I-Gene
and CC O
expression NN O
of IN O
other JJ O
genes NNS O
of IN O
the DT O
virulence NN B-Gene
gene NN I-Gene
cluster NN I-Gene
in IN I-Gene
L NNP I-Gene
. . I-Gene
ivanovii NN I-Gene
were VBD O
dependent JJ O
on IN O
PrfA NNP B-Gene
. . O

Spectroscopy NN O
of IN O
negative JJ O
ions NNS O
utilizing VBG O
multiphoton NN O
detachment NN O
in IN O
a DT O
Raman NNP O
coupling NN O
regime NN O
. . O

On IN O
catabolism NN O
of IN O
aminoketones NNS O
in IN O
climacteric JJ O
age NN O

Ten CD O
- : O
year NN O
experience NN O
with IN O
one CD O
- : O
stage NN O
proctocolectomy NN O
and CC O
anal JJ O
ileostomy NN O
. . O

The DT O
minimum JJ O
inhibitory JJ O
concentrations NNS O
( ( O
MICs NNP O
) ) O
of IN O
ketoconazole NN O
, , O
miconazole NN O
, , O
itraconazole NN O
, , O
fluconazole NN O
, , O
and CC O
amphotericin NN O
B NNP O
were VBD O
significantly RB O
influenced VBN O
by IN O
the DT O
inoculum NN O
size NN O
, , O
regardless RB O
of IN O
the DT O
techniques NNS O
used VBN O
. . O

An DT O
experiment NN O
on IN O
the DT O
return NN O
- : O
of IN O
- : O
fear NN O
( ( O
ROF NNP O
) ) O
was VBD O
carried VBN O
out RP O
on IN O
40 CD O
snake JJ O
- : O
or CC O
spider VB O
- : O
phobic JJ O
subjects NNS O
in IN O
order NN O
to TO O
determine VB O
whether IN O
an DT O
arousing VBG O
event NN O
that WDT O
occurs VBZ O
shortly RB O
before IN O
retest JJ O
influences NNS O
the DT O
magnitude NN O
of IN O
the DT O
ROF NNP O
. . O

To TO O
begin VB O
to TO O
characterize VB O
the DT O
role NN O
of IN O
the DT O
RNA NNP O
subunits NNS O
in IN O
enzyme JJ O
function NN O
and CC O
substrate NN O
specificity NN O
, , O
we PRP O
swapped VBD O
two CD O
hairpin NN O
structures NNS O
( ( O
MRP3 NNP O
and CC O
P3 NNP O
) ) O
between IN O
RNase NNP B-Gene
MRP NNP I-Gene
RNA NNP I-Gene
and CC O
RNase NNP B-Gene
P NNP I-Gene
RNA NNP I-Gene
of IN I-Gene
S NNP I-Gene
. . I-Gene
cerevisiae NN I-Gene
. . O

OBJECTIVE NN O
: : O
To TO O
evaluate VB O
the DT O
overall JJ O
performance NN O
of IN O
a DT O
new JJ O
oscillometric JJ O
wrist NN O
blood NN O
pressure NN O
monitor NN O
( ( O
Braun NNP O
PrecisionSensor NNP O
, , O
Braun NNP O
GmbH NNP O
, , O
Kronberg NNP O
, , O
Germany NNP O
) ) O
as IN O
defined VBN O
by IN O
the DT O
ANSI NNP O
/ NNP O
AAMI NNP O
SP10 NNP O
- : O
1992 CD O
guidelines NNS O
, , O
and CC O
to TO O
analyze VB O
the DT O
data NN O
for IN O
the DT O
optimized JJ O
selection NN O
of IN O
the DT O
algorithm NN O
that WDT O
derives VBZ O
the DT O
blood NN O
pressure NN O
values NNS O
from IN O
the DT O
oscillometric JJ O
blood NN O
pressure NN O
curves NNS O
. . O

The DT O
basal NN O
promoter NN O
strength NN O
of IN O
constructs NNS O
that WDT O
contained VBD O
deletions NNS O
in IN O
the DT O
U5 NNP B-Gene
region NN I-Gene
of IN O
the DT O
LTR NNP O
was VBD O
analyzed VBN O
by IN O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
assays VBZ O
following VBG O
transfection NN O
of IN O
HeLa NNP O
cells NNS O
or CC O
Jurkat NNP O
T NNP O
- : O
cells NNS O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
viral JJ O
transactivator NN O
tax NN B-Gene
protein NN O
. . O

Growth NNP O
factor NN O
stimulation NN O
rapidly RB O
induces VBZ O
a DT O
reversible JJ O
change NN O
in IN O
the DT O
electrophoretic JJ O
mobility NN O
of IN O
the DT O
ternary JJ O
complex NN O
, , O
accompanied VBN O
by IN O
increased JJ O
phosphorylation NN O
of IN O
the DT O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
C NNP I-Gene
- : I-Gene
terminal JJ I-Gene
region NN I-Gene
and CC O
by IN O
the DT O
activation NN O
of IN O
a DT O
42 CD B-Gene
kd NN I-Gene
cellular JJ I-Gene
Elk NNP I-Gene
- : I-Gene
1 CD I-Gene
kinase NN I-Gene
. . O

Purified NNP O
spleen JJ O
GAP NNP B-Gene
accelerated VBD O
hydrolysis NN O
of IN O
GTP NNP O
bound NN O
to TO O
recombinant VB B-Gene
ARF1 NNP I-Gene
, , O
ARF3 NNP B-Gene
, , O
ARF5 NNP B-Gene
, , O
and CC O
ARF6 NNP B-Gene
; : O
no DT O
effect NN O
of IN O
NH2 NNP O
- : O
terminal JJ O
myristoylation NN O
was VBD O
observed VBN O
. . O

Hepatitis NNP O
C NNP O
virus NN O
infection NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
liver JJ O
failure NN O
from IN O
veno JJ O
- : O
occlusive JJ O
disease NN O
after IN O
bone NN O
marrow NN O
transplantation NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
low JJ O
concentrations NNS O
of IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
may MD O
be VB O
useful JJ O
for IN O
nonsurgical JJ O
treatment NN O
of IN O
human JJ O
vitreous JJ O
hemorrhage NN O
. . O

Among IN O
them PRP O
, , O
26 CD O
cases NNS O
were VBD O
benign JJ O
and CC O
34 CD O
malignant NN O
. . O

The DT O
regulation NN O
of IN O
Myf NNP B-Gene
- : I-Gene
5 CD I-Gene
and CC O
MyoD NNP B-Gene
function NN O
by IN O
a DT O
cAMP NN O
- : O
dependent JJ O
pathway NN O
may MD O
partly RB O
explain VB O
how WRB O
external JJ O
signals NNS O
generated VBN O
by IN O
serum NN O
and CC O
certain JJ O
peptide JJ O
growth NN O
factors NNS O
can MD O
be VB O
transduced VBN O
to TO O
the DT O
nucleus NN O
and CC O
inhibit NN O
dominant JJ O
- : O
acting VBG O
factors NNS O
that WDT O
are VBP O
responsible JJ O
for IN O
myoblast JJ O
differentiation NN O
. . O

Effects NNS O
of IN O
beta NN B-Gene
- : I-Gene
adrenergic JJ I-Gene
receptor NN I-Gene
blockade NN O
on IN O
airway NN O
conductance NN O
and CC O
lung NN O
volume NN O
in IN O
normal JJ O
and CC O
asthmatic JJ O
subjects NNS O
. . O

Several JJ O
Src NNP B-Gene
SH3 NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
were VBD O
phosphorylated VBN O
in IN O
Src NNP B-Gene
- : O
transformed VBD O
cells NNS O
. . O

This DT O
suggests VBZ O
that IN O
mechanisms VBZ O
other JJ O
than IN O
an DT O
excessive JJ O
increase NN O
in IN O
myocardial JJ O
oxygen NN O
demand NN O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
many JJ O
episodes NNS O
occurring VBG O
outside IN O
the DT O
hospital NN O
. . O

12 CD O
: : O
2684 CD O
- : O
2697 CD O
, , O
1998 CD O
) ) O
: : O
a DT O
key JJ O
step NN O
of IN O
this DT O
model NN O
is VBZ O
the DT O
activation NN O
of IN O
the DT O
MAPK NNP B-Gene
Fus3p NNP I-Gene
through IN O
the DT O
G NNP B-Gene
( ( I-Gene
betagamma NN I-Gene
) ) I-Gene
- : O
dependent JJ O
relocalization NN O
of IN O
the DT O
Ste5p NNP B-Gene
- : O
MAPK NNP B-Gene
cascade NN O
to TO O
the DT O
plasma NN O
membrane NN O
. . O

Hyperactivation NN O
of IN O
Cdc2 NNP B-Gene
in IN O
fission NN O
yeast NN O
causes VBZ O
cells NNS O
to TO O
undergo VB O
a DT O
lethal JJ O
premature NN O
mitosis NN O
called VBN O
mitotic JJ O
catastrophe NN O
. . O

METHODS NN O
: : O
P NNP B-Gene
- : I-Gene
selectin JJ I-Gene
expression NN O
of IN O
nonstimulated JJ O
and CC O
ADP NNP O
- : O
stimulated VBD O
platelets NNS O
was VBD O
flow JJ O
cytometrically RB O
measured VBN O
before IN O
the DT O
clopidogrel NN O
loading VBG O
dose JJ O
and CC O
on IN O
3 CD O
consecutive JJ O
days NNS O
in IN O
52 CD O
patients NNS O
with IN O
coronary JJ O
artery NN O
disease NN O
: : O
21 CD O
patients NNS O
in IN O
group NN O
1 CD O
received VBD O
300 CD O
mg NN O
of IN O
clopidogrel NN O
after IN O
stent JJ O
implantation NN O
and CC O
11 CD O
patients NNS O
in IN O
group NN O
2 CD O
received VBD O
the DT O
higher JJR O
450 CD O
- : O
mg NN O
clopidogrel NN O
loading VBG O
dose NN O
followed VBN O
by IN O
a DT O
daily JJ O
dose NN O
of IN O
75 CD O
mg NN O
of IN O
clopidogrel NN O
for IN O
both DT O
groups NNS O
. . O

In IN O
one CD O
glioblastoma NN O
cell NN O
line NN O
, , O
a DT O
Shc NNP B-Gene
- : O
associated VBD O
p190 NN B-Gene
was VBD O
identified VBN O
as IN O
the DT O
activated JJ O
PDGFR NNP B-Gene
. . O

We PRP O
screened VBD O
a DT O
K562 NNP O
cDNA NN O
library NN O
and CC O
identified VBD O
novel JJ O
transcripts NNS O
, , O
MZF1B NNP B-Gene
and CC O
MZF1C NNP B-Gene
. . O

Relapse NN O
of IN O
leukemia NN O
after IN O
prolonged JJ O
remission NN O
. . O

Anisotropic NNP O
heat NN O
transport NN O
in IN O
the DT O
octylcyanobiphenyl NN O
( ( O
8CB CD O
) ) O
liquid NN O
crystal NN O
. . O

The DT O
mean JJ O
marginal JJ O
discrepancy NN O
of IN O
provisional JJ O
restorations NNS O
was VBD O
compared VBN O
for IN O
restorations NNS O
fabricated VBN O
from IN O
stone NN O
, , O
low JJ O
- : O
viscosity NN O
poly NN O
( ( O
vinyl JJ O
siloxane NN O
) ) O
, , O
and CC O
medium SYM O
- : O
viscosity NN O
poly NN O
( ( O
vinyl JJ O
siloxane NN O
) ) O
. . O

Alignment NN O
of IN O
the DT O
cervical JJ O
spine NN O
, , O
vertebral JJ O
abnormalities NNS O
, , O
and CC O
disc NN O
changes NNS O
also RB O
were VBD O
evaluated VBN O
. . O

Cell NNP O
. . O

In IN O
the DT O
studies NNS O
described VBN O
in IN O
this DT O
report NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
signaling VBG O
pathway NN O
( ( O
s PRP O
) ) O
that WDT O
are VBP O
responsible JJ O
for IN O
CREB NNP B-Gene
activation NN O
in IN O
normal JJ O
T NNP O
cells NNS O
. . O

Schedule NN O
2 CD O
, , O
in IN O
which WDT O
2 CD O
. . O
4 CD O
mg JJ O
/ NNP O
kg NN O
c SYM O
- : O
DDP NN O
was VBD O
administered VBN O
immediately RB O
before IN O
X NNP O
- : O
ray NN O
on IN O
5 CD O
consecutive JJ O
days NNS O
produced VBD O
the DT O
highest JJS O
degree NN O
of IN O
enhancement NN O
of IN O
radiation NN O
effect NN O
( ( O
expressed VBN O
as IN O
dose JJ O
- : O
effect NN O
factor NN O
) ) O
; : O
and CC O
the DT O
next JJ O
greatest JJS O
enhancement NN O
was VBD O
produced VBN O
by IN O
12 CD O
mg NNS O
/ JJ O
kg FW O
c SYM O
- : O
DDP NN O
administered VBD O
24 CD O
h NN O
before IN O
the DT O
start NN O
of IN O
fractionated JJ O
daily JJ O
radiotherapy NN O
. . O

Interestingly RB O
, , O
an DT O
antibody NN O
against IN O
N NNP B-Gene
- : I-Gene
SMase NN I-Gene
can MD O
abrogate VB O
Ox NNP B-Gene
- : I-Gene
LDL NNP I-Gene
- : O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
apoptosis NN O
and CC O
therefore NN O
may MD O
be VB O
useful JJ O
for IN O
in IN O
vivo JJ O
studies NNS O
of IN O
apoptosis NN O
in IN O
experimental JJ O
animals NNS O
. . O

Influence NN O
of IN O
oil NN O
emulsions NNS O
and CC O
diphenyl NN O
on IN O
post NN O
- : O
harvest JJS O
physiconutritional JJ O
changes NNS O
in IN O
Kagzi NNP O
limes NNS O
( ( O
Citrus NNP O
aurantifolia RB O
) ) O
was VBD O
studied VBN O
. . O

Furthermore RB O
, , O
the DT O
use NN O
of IN O
zero CD O
- : O
loss NN O
filtering NN O
in IN O
combination NN O
with IN O
exit NN O
wavefront NN O
reconstruction NN O
is VBZ O
considerably RB O
more RBR O
effective JJ O
at IN O
removing VBG O
the DT O
effects NNS O
of IN O
multiple JJ O
elastic JJ O
and CC O
inelastic JJ O
scattering NN O
and CC O
microscope NN O
objective VBP O
lens NNS O
aberrations NNS O
than IN O
either DT O
technique NN O
by IN O
itself PRP O
. . O

However RB O
, , O
it PRP O
is VBZ O
only RB O
one CD O
- : O
half NN O
and CC O
one CD O
- : O
third VBZ O
the DT O
size NN O
of IN O
the DT O
proteolipids NNS O
from IN O
M NNP O
. . O
thermoautotrophicum NN O
and CC O
M NNP O
. . O
jannaschii NN O
, , O
respectively RB O
. . O

ahaK NN B-Gene
is VBZ O
expressed VBN O
in IN O
Escherichia NNP O
coli NN O
, , O
and CC O
it PRP O
is VBZ O
incorporated VBN O
into IN O
the DT O
cytoplasmic JJ O
membrane NN O
despite IN O
the DT O
different JJ O
chemical NN O
natures NNS O
of IN O
lipids NNS O
from IN O
archaea NN O
and CC O
bacteria NNS O
. . O

In IN O
agreement NN O
with IN O
this DT O
southern JJ O
blotting NN O
of IN O
mouse NN O
DNA NN O
with IN O
SmN NNP B-Gene
probes NNS O
reveals NNS O
bands NNS O
, , O
additional JJ O
to TO O
those DT O
derived VBN O
from IN O
the DT O
pseudogene NN O
, , O
which WDT O
are VBP O
characteristic JJ O
of IN O
an DT O
intron NN O
- : O
containing VBG O
SmN NNP B-Gene
gene NN I-Gene
. . O

If IN O
the DT O
haemoglobin NN B-Gene
concentration NN O
( ( O
Hb NNP B-Gene
) ) O
was VBD O
less JJR O
than IN O
12 CD O
g NN O
dL NN O
- : O
1 CD O
they PRP O
were VBD O
given VBN O
a DT O
four CD O
week NN O
course NN O
of IN O
ferrous JJ O
sulphate NN O
. . O

Sustained VBN O
activation NN O
of IN O
p21 JJ B-Gene
expression NN O
is VBZ O
proposed VBN O
to TO O
be VB O
a DT O
distinguishing JJ O
feature NN O
of IN O
the DT O
activity NN O
of IN O
NGF NNP B-Gene
that WDT O
contributes VBZ O
to TO O
PC12 VB O
growth NN O
arrest IN O
during IN O
differentiation NN O

Viable JJ O
flap NN O
areas NNS O
were VBD O
established VBN O
following VBG O
vascular JJ O
pedicle NN O
ligation NN O
( ( O
both DT O
vessels NNS O
or CC O
only RB O
artery NN O
or CC O
vein NN O
) ) O
, , O
on IN O
the DT O
third JJ O
day NN O
after IN O
flap JJ O
replantation NN O
in IN O
both DT O
island NN O
and CC O
free JJ O
flaps NNS O
. . O

This DT O
demonstrates VBZ O
that IN O
treatment NN O
of IN O
the DT O
graft NN O
recipient NN O
for IN O
a DT O
relatively RB O
short JJ O
period NN O
during IN O
and CC O
after IN O
surgery NN O
has VBZ O
a DT O
favorable JJ O
effect NN O
on IN O
the DT O
survival NN O
of IN O
grafted JJ O
dopaminergic JJ O
neurons NNS O
. . O

We PRP O
have VBP O
identified VBN O
two CD O
Marek NNP O
' POS O
s JJ O
Disease NNP O
Virus NNP O
( ( O
MDV NNP O
) ) O
genes NNS O
within IN O
the DT O
EcoRI NNP B-Gene
- : I-Gene
B NNP I-Gene
fragment NN I-Gene
of IN O
MDV NNP O
- : O
GA NNP O
genomic JJ O
DNA NNP O
. . O

This DT O
report NN O
focused VBD O
on IN O
the DT O
relationship NN O
between IN O
Type NNP O
A NNP O
behavior NN O
and CC O
eight CD O
basic JJ O
emotion NN O
dimensions NNS O
. . O

Implications NNS O
of IN O
this DT O
observation NN O
for IN O
pediatrics NNS O
are VBP O
discussed VBN O
. . O

[ RB O
82Br CD O
] JJ O
MISO NNP O
was VBD O
prepared VBN O
by IN O
irradiating VBG O
samples NNS O
of IN O
Br NNP O
- : O
MISO NN O
in IN O
a DT O
SLOWPOKE NNP O
reactor NN O
for IN O
2 CD O
h NN O
at IN O
a DT O
thermal JJ O
neutron NN O
flux NN O
of IN O
10 CD O
( ( O
12 CD O
) ) O
n NN O
cm SYM O
- : O
2 CD O
s JJ O
- : O
1 CD O
. . O

The DT O
size NN O
of IN O
the DT O
infarct NN O
was VBD O
determined VBN O
using VBG O
the DT O
creatine NN B-Gene
kinase NN I-Gene
integral JJ O
method NN O
. . O

Three CD O
new JJ O
aromatase NN B-Gene
inhibitors NNS O
have VBP O
recently RB O
completed VBN O
phase NN O
III NNP O
evaluation NN O
as IN O
treatment NN O
of IN O
metastatic JJ O
breast NN O
cancer NN O
in IN O
post NN O
- : O
menopausal NN O
women NNS O
whose WP$ O
disease NN O
has VBZ O
progressed VBN O
despite IN O
tamoxifen JJ O
therapy NN O
: : O
anastrozole NN O
( ( O
ARIMIDEX NNP O
, , O
Zeneca NNP O
) ) O
, , O
letrozole JJ O
( ( O
FEMARA NNP O
, , O
Novartis NNP O
) ) O
and CC O
vorozole JJ O
( ( O
RIVIZOR NNP O
, , O
Janssen NNP O
) ) O
. . O

The DT O
most RBS O
common JJ O
risk NN O
factor NN O
reported VBD O
for IN O
both DT O
recent JJ O
and CC O
all DT O
other JJ O
hepatitis NN O
C NNP O
cases NNS O
was VBD O
a DT O
history NN O
of IN O
injecting VBG O
drug NN O
use NN O
, , O
although IN O
the DT O
proportion NN O
of IN O
cases NNS O
with IN O
that DT O
history NN O
was VBD O
different JJ O
in IN O
NT NNP O
from IN O
ACT NNP O
and CC O
Queensland NNP O
. . O

Echocardiography NNP O
revealed VBD O
right JJ O
ventricular JJ O
diastolic NN O
collapse NN O
( ( O
RVDC NNP O
) ) O
without IN O
physical JJ O
signs NNS O
of IN O
cardiac JJ O
tamponade NN O
. . O

It PRP O
is VBZ O
reported VBN O
that IN O
, , O
at IN O
present JJ O
, , O
most JJS O
of IN O
the DT O
MRSAs NNP O
spreading NN O
in IN O
Japan NNP O
are VBP O
acceleratedly RB O
acquiring VBG O
resistance NN O
to TO O
many JJ O
drugs NNS O
, , O
and CC O
especially RB O
, , O
they PRP O
are VBP O
developing VBG O
high JJ O
resistance NN O
against IN O
beta SYM O
- : O
lactams NN O
. . O

CONCLUSIONS NN O
: : O
These DT O
findings NNS O
indicate VBP O
a DT O
physical JJ O
barrier NN O
of IN O
oesophageal NN O
surfactant NN O
which WDT O
could MD O
offer VB O
some DT O
degree NN O
of IN O
protection NN O
against IN O
gastro JJ O
- : O
oesophageal JJ O
reflux NN O
but CC O
one CD O
which WDT O
is VBZ O
particularly RB O
prone JJ O
to TO O
attack VB O
by IN O
bile NN O
. . O

Functional JJ O
disorders NNS O
of IN O
the DT O
ureter NN O
following VBG O
gynecologic NN O
surgery NN O

On IN O
the DT O
third JJ O
occasion NN O
water NN O
( ( O
W NNP O
) ) O
was VBD O
ingested VBN O
throughout IN O
the DT O
run NN O
. . O

HDL NNP B-Gene
- : I-Gene
cholesterol NN I-Gene
( ( O
+ JJ O
6 CD O
% NN O
, , O
P NNP O
less JJR O
than IN O
. . O
1 CD O
) ) O
and CC O
apolipoprotein VBZ B-Gene
A DT I-Gene
- : I-Gene
I PRP I-Gene
( ( O
+ VB O
6 CD O
% NN O
, , O
P NNP O
less JJR O
than IN O
. . O
1 CD O
) ) O
concentrations NNS O
increased VBD O
significantly RB O
only RB O
in IN O
the DT O
young JJ O
. . O

In IN O
14 CD O
cases NNS O
, , O
isolates NNS O
were VBD O
biotyped VBN O
yielding VBG O
eight CD O
with IN O
biotype NN O
II NNP O
, , O
four CD O
with IN O
biotype NN O
III NNP O
, , O
and CC O
one CD O
each DT O
with IN O
biotypes NNS O
IV NNP O
and CC O
V NNP O
. . O

PM NNP O
12 CD O
or CC O
18 CD O
mg NNS O
/ JJ O
kg JJ O
daily JJ O
plus CC O
a DT O
standard JJ O
dose NN O
of IN O
SB NNP O
for IN O
21 CD O
days NNS O
was VBD O
statistically RB O
more RBR O
effective JJ O
than IN O
SB NNP O
in IN O
producing VBG O
a DT O
final JJ O
cure NN O
for IN O
patients NNS O
with IN O
VL NNP O
in IN O
Bihar NNP O
, , O
India NNP O
. . O

CONCLUSIONS NN O
: : O
EBCT NNP O
technology NN O
allows VBZ O
minimally RB O
invasive JJ O
evaluation NN O
of IN O
intramyocardial JJ O
microcirculatory NN O
function NN O
and CC O
permits VBZ O
assessment NN O
of IN O
microvascular JJ O
BV NNP O
distribution NN O
in IN O
different JJ O
functional JJ O
components NNS O
. . O

An DT O
increase NN O
in IN O
hypothalamic JJ O
expression NN O
of IN O
at IN O
least JJS O
two CD O
of IN O
the DT O
erbB NN B-Gene
receptors NNS I-Gene
is VBZ O
initiated VBN O
before IN O
the DT O
pubertal JJ O
augmentation NN O
of IN O
gonadal JJ O
steroid JJ O
secretion NN O
and CC O
is VBZ O
completed VBN O
on IN O
the DT O
day NN O
of IN O
the DT O
first JJ O
preovulatory NN O
surge NN O
of IN O
gonadotropins NNS B-Gene
. . O

Promoter NN O
elements NNS O
include VBP O
an DT O
atypical JJ O
TATA NNP O
box NN O
( ( O
GTTA NNP O
) ) O
, , O
one CD O
CCAAT NNP O
box NN O
much RB O
further RBR O
from IN O
the DT O
initiation NN O
site NN O
, , O
three CD O
reverse NN O
compliments NNS O
of IN O
CCAAT NNP O
( ( O
ATTGG NNP O
) ) O
, , O
and CC O
two CD O
pyrimidine NN O
- : O
rich JJ O
nucleotide JJ O
stretches NNS O
. . O

Comparisons NNS O
of IN O
rrnB NN B-Gene
P1 NNP B-Gene
- : O
lacZ NN B-Gene
expression NN O
at IN O
different JJ O
ppGpp NN O
levels NNS O
is VBZ O
interpreted VBN O
for IN O
the DT O
rpoD NN B-Gene
( ( I-Gene
P504L NNP I-Gene
) ) I-Gene
mutant NN I-Gene
as IN O
resulting VBG O
from IN O
a DT O
hypersensitivity NN O
to TO O
ppGpp VB O
. . O

Measurement NN O
of IN O
SaO2 NNP O
at IN O
moderate JJ O
altitude NN O
can MD O
be VB O
helpful JJ O
in IN O
the DT O
care NN O
of IN O
both DT O
healthy JJ O
and CC O
ill JJ O
newborns NNS O
or CC O
infants NNS O
. . O

Accumulated VBN O
evidence NN O
indicates VBZ O
that IN O
, , O
upon IN O
stimulation NN O
with IN O
interferon NN B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
, , O
three CD O
beta SYM O
- : O
type NN O
subunits NNS O
, , O
designated VBN O
LMP2 NNP B-Gene
, , O
LMP7 NNP B-Gene
, , O
and CC O
PSMB10 NNP B-Gene
, , O
are VBP O
incorporated VBN O
into IN O
the DT O
20S CD B-Gene
proteasome NN I-Gene
by IN O
displacing VBG O
the DT O
housekeeping NN O
beta SYM O
- : O
type NN O
subunits NNS O
designated VBN O
PSMB6 NNP B-Gene
, , O
PSMB5 NNP B-Gene
, , O
and CC O
PSMB7 NNP B-Gene
, , O
respectively RB O
. . O

All DT O
other JJ O
ejaculate NN O
parameters NNS O
( ( O
density NN O
, , O
motility NN O
, , O
swelling VBG O
test NN O
, , O
penetration NN O
test NN O
) ) O
remained VBD O
unchanged JJ O
, , O
and CC O
there RB O
was VBD O
only RB O
one CD O
post NN O
- : O
therapeutic JJ O
pregnancy NN O
. . O

More RBR O
recently RB O
, , O
however RB O
, , O
a DT O
number NN O
of IN O
developments NNS O
such JJ O
as IN O
the DT O
successful JJ O
use NN O
of IN O
the DT O
inhaled JJ O
steroid NN O
budesonide NN O
and CC O
oral JJ O
dexamethasone NN O
have VBP O
reinforced VBN O
the DT O
argument NN O
for IN O
using VBG O
steroids NNS O
. . O

Pentane NNP O
and CC O
ethane NN O
, , O
which WDT O
arise VBP O
during IN O
lipid JJ O
peroxidation NN O
in IN O
vivo NN O
, , O
were VBD O
measured VBN O
by IN O
gas NN O
chromatography NN O
in IN O
breath NN O
samples NNS O
of IN O
rats NNS O
fed VBP O
for IN O
8 CD O
weeks NNS O
a DT O
vitamin NN O
E NNP O
- : O
deficient NN O
diet NN O
to TO O
which WDT O
had VBD O
been VBN O
added VBN O
0 CD O
, , O
11 CD O
, , O
or CC O
40 CD O
IU NNP O
vitamin NN O
E NNP O
acetate NN O
per IN O
kg NN O
. . O

Inhibition NN O
of IN O
Fusarium NNP O
moniliforme NN O
var NN O
. . O
subglutinans NNS O
, , O
the DT O
causal NN O
agent NN O
of IN O
pine JJ O
pitch NN O
canker NN O
, , O
by IN O
the DT O
soil NN O
bacterium NN O
Arthrobacter NNP O
sp NN O
. . O

With IN O
chemical JJ O
shift NN O
imaging NN O
, , O
the DT O
signal JJ O
intensity NN O
decreased VBN O
on IN O
the DT O
out RP O
- : O
of IN O
- : O
phase NN O
images NNS O
in IN O
six CD O
of IN O
seven CD O
( ( O
86 CD O
% NN O
) ) O
patients NNS O
with IN O
APA NNP O
and CC O
in IN O
eight CD O
of IN O
nine CD O
( ( O
89 CD O
% NN O
) ) O
patients NNS O
with IN O
BAH NNP O
. . O

Oncogenic NNP O
capacity NN O
of IN O
the DT O
E2F1 NNP B-Gene
gene NN I-Gene
. . O

Immobilization NN O
of IN O
the DT O
fracture NN O
in IN O
a DT O
collar NN O
and CC O
cuff NN O
sling NN O
was VBD O
as RB O
effective JJ O
as IN O
more RBR O
elaborate JJ O
methods NNS O
. . O

PCR NNP O
analysis NN O
indicates VBZ O
that IN O
this DT O
new JJ O
beta NN B-Gene
- : I-Gene
adducin NN I-Gene
isoform NN I-Gene
is VBZ O
expressed VBN O
in IN O
fetal JJ O
brain NN O
and CC O
liver NN O
, , O
bone NN O
marrow NN O
, , O
and CC O
NT NNP O
- : O
2 CD O
( ( O
neuroepithelial JJ O
) ) O
cells NNS O
, , O
but CC O
is VBZ O
not RB O
detected VBN O
in IN O
several JJ O
other JJ O
tissues NNS O
. . O

The DT O
small JJ B-Gene
GTPase NNP I-Gene
Rho NNP B-Gene
is VBZ O
implicated VBN O
in IN O
physiological JJ O
functions NNS O
associated VBN O
with IN O
actin JJ B-Gene
- : O
myosin NN B-Gene
filaments NNS O
such JJ O
as IN O
cytokinesis NN O
, , O
cell NN O
motility NN O
, , O
and CC O
smooth JJ O
muscle NN O
contraction NN O
. . O

Green JJ O
pepper NN O
significantly RB O
inhibited VBN O
N NNP O
- : O
nitrosothiazolidine NN O
- : O
carboxylic JJ O
acid JJ O
formation NN O
relative NN O
to TO O
ascorbic VB O
acid JJ O
alone RB O
. . O

We PRP O
report VBP O
the DT O
molecular JJ O
cloning NN O
and CC O
functional JJ O
characterization NN O
of IN O
USF2 NNP B-Gene
isoforms NNS I-Gene
, , O
corresponding VBG O
to TO O
a DT O
44 CD O
- : O
kDa NN O
subunit NN O
, , O
USF2a NNP B-Gene
, , O
and CC O
a DT O
new JJ O
38 CD O
- : O
kDa NN O
subunit NN O
, , O
USF2b NNP B-Gene
, , O
generated VBN O
by IN O
differential JJ O
splicing NN O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
tissue NN O
- : O
restricted VBN O
transcription NN O
factors NNS O
including VBG O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
and CC O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
interaction NN I-Gene
partner NN I-Gene
( ( O
PIP NNP B-Gene
) ) O
function NN O
synergistically RB O
with IN O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
plus CC O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
to TO O
stimulate VB O
the DT O
kappaE3 NN B-Gene
' POS I-Gene
- : I-Gene
enhancer NN I-Gene
in IN O
3T3 CD O
cells NNS O
. . O

Sulfuric JJ O
acid NN O
concentration NN O
in IN O
the DT O
catalyzed JJ O
breathalyzer NN O
ampules NNS O
. . O

OBJECTIVE NNP O
- : O
- : O
To TO O
assess VB O
the DT O
risk NN O
of IN O
hepatitis NN O
A NNP O
in IN O
international JJ O
travelers NNS O
and CC O
to TO O
recommend VB O
preventive JJ O
measures NNS O
. . O

In IN O
an DT O
earlier JJR O
study NN O
( ( O
Kimura NNP O
, , O
Y NNP O
. . O
, , O
Kurzydlowski NNP O
, , O
K NNP O
. . O
, , O
Tada NNP O
, , O
M NNP O
. . O
, , O
and CC O
MacLennan NNP O
, , O
D NNP O
. . O

We PRP O
report VBP O
an DT O
odd JJ O
case NN O
of IN O
marked JJ O
enlargement NN O
of IN O
suprapineal JJ O
recess NN O
in IN O
a DT O
patient NN O
with IN O
triventricular JJ O
hydrocephalus NN O
. . O

PCR NNP O
- : O
derived VBD O
fragments NNS O
were VBD O
used VBN O
as IN O
probes NNS O
for IN O
the DT O
isolation NN O
of IN O
the DT O
U3 NNP B-Gene
snRNA NN I-Gene
genes NNS I-Gene
from IN O
a DT O
genomic JJ O
library NN O
of IN O
Arabidopsis NNP O
. . O

We PRP O
emphasize VBP O
that IN O
ANCA NNP B-Gene
- : O
associated VBN O
vasculitis NN O
is VBZ O
another DT O
important JJ O
complication NN O
of IN O
RA NNP O
. . O

While IN O
these DT O
results NNS O
are VBP O
consistent JJ O
with IN O
previously RB O
reported VBN O
effects NNS O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
domain NN O
on IN O
nucleotide JJ O
binding NN O
, , O
they PRP O
also RB O
demonstrate VBP O
that IN O
interactions NNS O
with IN O
the DT O
N NNP O
- : O
terminal NN O
domains NNS O
are VBP O
necessary JJ O
to TO O
inhibit VB O
proton JJ O
transport NN O
. . O

They PRP O
consist VBP O
of IN O
at IN O
least JJS O
two CD O
separable JJ O
components NNS O
, , O
one CD O
heat NN O
stable JJ O
and CC O
the DT O
other JJ O
heat NN O
labile NN O
. . O

The DT O
( ( O
two CD O
- : O
motif NN O
) ) O
domain NN O
fold JJ O
contains VBZ O
a DT O
pair NN O
of IN O
calcium NN O
binding VBG O
sites NNS O
very RB O
similar JJ O
to TO O
those DT O
found VBN O
in IN O
a DT O
two CD B-Gene
- : I-Gene
domain NN I-Gene
prokaryotic JJ I-Gene
betagamma NN I-Gene
- : I-Gene
crystallin NN I-Gene
fold JJ I-Gene
family NN I-Gene
member NN I-Gene
, , O
Protein NNP B-Gene
S NNP I-Gene
. . O

Recombination NN O
between IN O
feline JJ O
leukemia NN O
virus NN O
subgroup NN O
B NNP O
or CC O
C NNP O
and CC O
endogenous JJ O
env NN B-Gene
elements NNS O
alters VBZ O
the DT O
in IN O
vitro JJ O
biological JJ O
activities NNS O
of IN O
the DT O
viruses NNS O
. . O

Antibodies NNS O
made VBN O
against IN O
fusion NN O
protein NN O
produced VBN O
by IN O
the DT O
DP1A NNP B-Gene
clone NN O
reacted VBD O
specifically RB O
with IN O
DP NNP B-Gene
- : I-Gene
I PRP I-Gene
and CC I-Gene
- : I-Gene
II NN I-Gene
on IN O
immunoblots NNS O
. . O

From IN O
these DT O
results NNS O
, , O
CBF NNP B-Gene
- : I-Gene
A DT I-Gene
is VBZ O
a DT O
novel JJ O
CArG NNP O
box NN O
- : O
, , O
ssDNA SYM B-Gene
- : I-Gene
and CC I-Gene
RNA NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
, , O
as RB O
well RB O
as IN O
a DT O
repressive JJ O
transcriptional JJ O
factor NN O
. . O

Thus RB O
, , O
Sir NNP B-Gene
proteins VBZ I-Gene
from IN O
K NNP O
. . O
lactis NN O
have VBP O
roles VBN O
in IN O
both DT O
silencing NN O
and CC O
telomere JJ O
length NN O
maintenance NN O
, , O
reflecting VBG O
conserved VBN O
functional JJ O
themes NNS O
. . O

Only RB O
one CD O
ADR NNP O
was VBD O
related VBN O
definitely RB O
to TO O
ciprofloxacin VB O
therapy NN O
. . O

This DT O
machine NN O
drift NN O
, , O
which WDT O
was VBD O
not RB O
associated VBN O
with IN O
a DT O
rise NN O
in IN O
water NN O
phantom NN O
temperature NN O
and CC O
did VBD O
not RB O
consistently RB O
correlate VB O
with IN O
estimated VBN O
x NNP O
- : O
ray NN O
tube NN O
heat NN O
, , O
could MD O
result VB O
in IN O
a DT O
significant JJ O
overestimation NN O
of IN O
regional JJ O
cerebral JJ O
blood NN O
flow NN O
( ( O
rCBF NN O
) ) O
for IN O
a DT O
xenon NNP O
/ NNP O
CT NNP O
rCBF NN O
protocol NN O
involving VBG O
5 CD O
- : O
7 CD O
sequential JJ O
scans NNS O
obtained VBN O
at IN O
1 CD O
- : O
min NN O
interscan JJ O
intervals NNS O
. . O

Upon IN O
analysis NN O
of IN O
various JJ O
deletion NN O
and CC O
point NN O
- : O
mutated JJ O
variants NNS O
of IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
coupled VBN O
to TO O
a DT O
reporter NN O
gene NN O
, , O
we PRP O
screened VBD O
for IN O
possible JJ O
cooperating VBG O
transcription NN O
factors NNS O
. . O

However RB O
, , O
each DT O
promoter NN O
activated VBN O
by IN O
IEP86 NNP B-Gene
was VBD O
synergistically RB O
affected VBN O
by IN O
the DT O
addition NN O
of IN O
IEP72 NNP B-Gene
. . O

Patients NNS O
had VBD O
to TO O
have VB O
adequate JJ O
liver NN O
, , O
renal JJ O
, , O
and CC O
marrow JJ O
functions NNS O
. . O

The DT O
high JJ O
selectivity NN O
of IN O
arrestins NNS B-Gene
for IN O
this DT O
particular JJ O
functional JJ O
form NN O
of IN O
receptor NN O
ensures NNS O
their PRP$ O
timely JJ O
binding NN O
and CC O
dissociation NN O
. . O

Regression NN O
analyses NNS O
showed VBD O
that IN O
SOREMP NNP O
dream NN O
occurrences NNS O
were VBD O
significantly RB O
related VBN O
to TO O
the DT O
amount NN O
of IN O
REM NNP O
sleep NN O
, , O
while IN O
NREMP NNP O
dream NN O
occurrences NNS O
were VBD O
related VBN O
to TO O
arousals NNS O
from IN O
NREM NNP O
sleep NN O
. . O

Three CD O
of IN O
these DT O
subunits NNS O
are VBP O
also RB O
homologous JJ O
to TO O
the DT O
dimeric JJ O
POR NNP B-Gene
from IN O
a DT O
mesophilic JJ O
archaeon NN O
, , O
Halobacterium NNP O
halobium NN O
( ( O
21 CD O
% NN O
identity NN O
) ) O
. . O

At IN O
a DT O
systolic JJ O
blood NN O
pressure NN O
( ( O
BP NNP O
) ) O
of IN O
60 CD O
mmHg NNS O
, , O
C02 NNP O
responsiveness NN O
was VBD O
abolished VBN O
, , O
but CC O
was VBD O
maintained VBN O
at IN O
higher JJR O
levels NNS O
of IN O
BP NNP O
. . O

Micro NNP O
high JJ O
- : O
performance NN O
liquid NN O
chromatographic JJ O
system NN O
with IN O
micro JJ O
precolumn NN O
and CC O
dual JJ O
electrochemical JJ O
detector NN O
for IN O
direct JJ O
injection NN O
analysis NN O
of IN O
catecholamines NNS O
in IN O
body NN O
fluids NNS O
. . O

Three CD O
groups NNS O
of IN O
patients NNS O
who WP O
had VBD O
undergone JJ O
subtotal JJ O
thyroidectomy NN O
for IN O
Graves NNP O
' POS O
s NN O
disease NN O
, , O
toxic JJ O
multinodular NN O
goitre NN O
, , O
or CC O
euthyroid VB O
multinodular JJ O
goitre NN O
12 CD O
to TO O
15 CD O
years NNS O
before RB O
and CC O
in IN O
whom WP O
a DT O
normal JJ O
serum NN O
thyroxine NN O
( ( O
T NNP O
- : O
4 CD O
) ) O
level NN O
was VBD O
found VBN O
were VBD O
each DT O
divided VBN O
into IN O
two CD O
subgroups NNS O
on IN O
the DT O
basis NN O
of IN O
a DT O
normal JJ O
or CC O
a DT O
raised VBN O
serum NN O
thyrotrophin JJ B-Gene
concentration NN O
. . O

This DT O
core NN O
sequence NN O
, , O
along IN O
with IN O
additional JJ O
nonspecific NN O
downstream NN O
nucleotides NNS O
, , O
is VBZ O
sufficient JJ O
for IN O
partial JJ O
suppression NN O
of IN O
spliceosome NN O
assembly NN O
and CC O
splicing NN O
of IN O
BPV NNP O
- : O
1 CD O
pre NN O
- : O
mRNAs NN O
. . O

Two CD O
cDNAs NN O
encoding VBG O
casein JJ B-Gene
kinase NN I-Gene
- : I-Gene
1 CD I-Gene
have VBP O
been VBN O
isolated VBN O
from IN O
a DT O
yeast NN O
cDNA NN O
library NN O
and CC O
termed VBD O
CKI1 NNP B-Gene
and CC O
CKI2 NNP B-Gene
. . O

A DT O
prospectively RB O
gated JJ O
2D CD O
axial JJ O
sequence NN O
with IN O
velocity NN O
encoding VBG O
in IN O
the DT O
craniocaudal JJ O
direction NN O
in IN O
the DT O
cervical JJ O
region NN O
was VBD O
set VBN O
at IN O
a DT O
velocity NN O
of IN O
+ NNP O
/ NNP O
- : O
10 CD O
cm NN O
/ NNP O
s NN O
. . O

Stable JJ O
association NN O
of IN O
U2 NNP B-Gene
snRNP NN I-Gene
with IN O
the DT O
branchpoint NN O
sequence NN O
of IN O
mammalian JJ O
pre NN O
- : O
mRNAs NN O
requires VBZ O
binding VBG O
of IN O
a DT O
non JJ O
- : O
snRNP NN O
protein NN O
to TO O
the DT O
polypyrimidine NN O
tract NN O
. . O

A DT O
concentration NN O
of IN O
12 CD O
. . O
5 CD O
ppm JJ O
SO2 NNP O
induced VBD O
a DT O
decrease NN O
from IN O
baseline NN O
values NNS O
of IN O
approximately RB O
80 CD O
% NN O
in IN O
mean JJ O
MCA NNP O
and CC O
of IN O
roughly RB O
70 CD O
% NN O
in IN O
mean JJ O
CBF NNP O
. . O

From IN O
life NN O
- : O
table JJ O
analyses NNS O
of IN O
these DT O
patients NNS O
, , O
we PRP O
estimated VBD O
that IN O
the DT O
incidence NN O
of IN O
secondary JJ O
chondrosarcoma NN O
in IN O
patients NNS O
who WP O
have VBP O
Ollier NNP O
disease NN O
is VBZ O
about IN O
25 CD O
per IN O
cent NN O
at IN O
the DT O
age NN O
of IN O
forty JJ O
years NNS O
, , O
and CC O
that IN O
malignant JJ O
degeneration NN O
is VBZ O
almost RB O
a DT O
certainty NN O
in IN O
patients NNS O
who WP O
have VBP O
Maffucci NNP O
syndrome NN O
. . O

The DT O
concentrations NNS O
of IN O
C4 NNP B-Gene
and CC O
C1 NNP B-Gene
- : I-Gene
INH NN I-Gene
increased VBD O
with IN O
advancing VBG O
stage NN O
of IN O
disease NN O
and CC O
were VBD O
above IN O
normal JJ O
mean JJ O
values NNS O
in IN O
all DT O
stages NNS O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
cosmid JJ O
containing NN O
DNA NN O
that WDT O
corresponds VBZ O
to TO O
the DT O
site NN O
of IN O
transposon JJ O
insertion NN O
in IN O
257DH4 CD O
and CC O
have VBP O
localized VBN O
Tn5 NNP B-Gene
on IN O
an DT O
8 CD B-Gene
. . I-Gene
0 CD I-Gene
kb JJ I-Gene
EcoRI NNP I-Gene
fragment NN I-Gene
. . O

Role NNP O
of IN O
the DT O
transcription NN O
start VB O
site NN O
core NN O
region NN O
and CC O
transcription NN B-Gene
factor NN I-Gene
YY1 NNP I-Gene
in IN O
Rous NNP B-Gene
sarcoma NN I-Gene
virus NN I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
promoter NN I-Gene
activity NN O
. . O

The DT O
specific JJ O
electrical JJ O
resistance NN O
of IN O
the DT O
cerebrospinal JJ O
fluid NN O
was VBD O
measured VBN O
by IN O
means NNS O
of IN O
conductometry NN O
in IN O
14 CD O
cases NNS O
of IN O
meningitis NN O
purulenta NN O
, , O
17 CD O
cases NNS O
of IN O
meningitis NN O
serosa NN O
, , O
10 CD O
cases NNS O
of IN O
encephalitis NN O
and CC O
in IN O
32 CD O
control NN O
subjects NNS O
. . O

PCR NNP O
/ NNP O
Southern NNP O
blot NN O
analysis NN O
of IN O
human JJ O
kidney NN O
cDNA NN O
using VBG O
primers NNS O
flanking VBG O
the DT O
hKID NN B-Gene
coding VBG I-Gene
sequence NN I-Gene
revealed VBD O
expression NN O
of IN O
a DT O
full JJ O
- : O
length NN O
mRNA NN O
and CC O
short JJ O
transcripts NNS O
with IN O
partial JJ O
exon NN O
1 CD O
and CC O
partial JJ O
exon NN O
4 CD O
deletions NNS O
. . O

Alterations NNS O
of IN O
the DT O
5q23 CD O
- : O
q31 NN O
interval NN O
are VBP O
frequently RB O
observed VBN O
in IN O
myelodysplasia NN O
and CC O
myeloid JJ O
leukemia NN O
. . O

Seventy NNP O
- : O
two CD O
of IN O
73 CD O
negative JJ O
controls NNS O
and CC O
all DT O
positive JJ O
blocks NNS O
as IN O
seen VBN O
on IN O
soft JJ O
tissue NN O
radiographs NN O
( ( O
STRs NNP O
) ) O
were VBD O
correctly RB O
coded VBN O
( ( O
specificity NN O
98 CD O
. . O
6 CD O
% NN O
, , O
sensitivity NN O
100 CD O
% NN O
) ) O
. . O

Two CD O
studies NNS O
assessed VBD O
two CD O
types NNS O
of IN O
reliability NN O
of IN O
the DT O
student NN O
Jenkins NNP O
Activity NNP O
Survey NNP O
( ( O
JAS NNP O
; : O
a DT O
questionnaire JJ O
measure NN O
of IN O
Type NNP O
A NNP O
behavior NN O
) ) O
. . O

Osteogenesis NN O
imperfecta NN O

Accordingly RB O
, , O
no DT O
Ha NNP B-Gene
- : I-Gene
ras NN I-Gene
codon VBZ I-Gene
12 CD I-Gene
mutations NNS O
are VBP O
found VBN O
in IN O
the DT O
EtNU NNP O
- : O
induced VBD O
mammary JJ O
tumors NNS O
. . O

We PRP O
show VBP O
that IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
activates NNS O
JRE NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
through IN O
an DT O
H7 NNP O
- : O
sensitive JJ O
pathway NN O
that WDT O
does VBZ O
not RB O
involve VB O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
, , O
cyclic JJ B-Gene
AMP NNP I-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
, , O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
or CC I-Gene
calmodulin VB I-Gene
- : I-Gene
dependent NN I-Gene
kinases NNS I-Gene
, , O
Ras NNP B-Gene
, , O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
or CC O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
) ) O
. . O

These DT O
observations NNS O
link VBP O
actin JJ B-Gene
plaque NN O
assembly NN O
to TO O
increased VBN O
cell NN O
substrate NN O
adhesion NN O
. . O

The DT O
infection NN O
rate NN O
was VBD O
five CD O
times NNS O
greater JJR O
in IN O
patients NNS O
with IN O
Hickman NNP O
catheters NNS O
than IN O
in IN O
those DT O
with IN O
Broviac NNP O
catheters NNS O
( ( O
p JJ O
= NN O
0 CD O
. . O
1 CD O
) ) O
. . O

Effect NN O
of IN O
aging VBG O
on IN O
respiratory NN O
skeletal JJ O
muscles NNS O
. . O

This DT O
binary JJ O
repeat NN O
contains NNS O
repetitive JJ O
DNA NNP O
elements NNS O
that WDT O
include VBP O
LINES NNP O
, , O
SINES NNP O
, , O
medium NN O
reiteration NN O
frequency NN O
repeats NNS O
, , O
and CC O
a DT O
transposon JJ O
- : O
like IN O
element NN O
. . O

Cross NNP O
- : O
reaction NN O
between IN O
a DT O
monoclonal JJ O
antibody NN O
and CC O
two CD O
alpha NN B-Gene
beta NN I-Gene
T NNP I-Gene
cell NN I-Gene
receptors NNS I-Gene
. . O

INO2 NNP B-Gene
, , O
a DT O
regulatory JJ O
gene NN O
in IN O
yeast JJ O
phospholipid JJ O
biosynthesis NN O
, , O
affects VBZ O
nuclear JJ O
segregation NN O
and CC O
bud NN O
pattern NN O
formation NN O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that DT O
depletion NN O
of IN O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
by IN O
long JJ O
- : O
term NN O
treatment NN O
of IN O
B16 NNP O
mouse NN O
melanoma NN O
cells NNS O
with IN O
phorbol NN O
dibutyrate NN O
( ( O
PDBu NNP O
) ) O
prevented VBD O
cell NN O
density NN O
- : O
dependent JJ O
melanogenesis NN O
. . O

The DT O
STE20 NNP B-Gene
gene NN I-Gene
, , O
encoding VBG O
a DT O
protein JJ O
kinase NN O
required VBN O
for IN O
pheromone JJ O
signal JJ O
transduction NN O
, , O
has VBZ O
recently RB O
been VBN O
identified VBN O
in IN O
a DT O
genetic JJ O
screen NN O
for IN O
high JJ O
- : O
gene NN O
- : O
dosage NN O
suppressors NNS O
of IN O
a DT O
partly RB O
defective JJ O
G NNP B-Gene
beta NN I-Gene
mutation NN O
. . O

Using VBG O
an DT O
opsonophagocytic JJ O
bacterial JJ O
assay NN O
and CC O
a DT O
suckling JJ O
rat NN O
model NN O
of IN O
GBS NNP O
sepsis NN O
, , O
we PRP O
analyzed VBD O
a DT O
modified JJ O
human JJ B-Gene
immunoglobulin NN I-Gene
for IN O
opsonic JJ O
and CC O
protective JJ O
antibody NN O
. . O

Endoscopic NNP O
transthoracic NN O
sympathectomy NN O
as IN O
adjuvant JJ O
treatment NN O
for IN O
critical JJ O
upper JJ O
- : O
limb NN O
ischaemia NN O
. . O

Allagille NNP O
' POS O
s JJ O
syndrome NN O
associated VBN O
with IN O
antenatal JJ O
ascites NNS O

The DT O
study NN O
goals NNS O
were VBD O
to TO O
isolate VB O
a DT O
full JJ O
- : O
length NN O
clone NN O
encoding VBG O
CO NNP B-Gene
- : I-Gene
Ag NN I-Gene
from IN O
a DT O
bovine NN O
corneal NN O
cDNA NN O
library NN O
and CC O
to TO O
express VB O
this DT O
clone NN O
in IN O
Escherichia NNP O
coli NN O
( ( O
E NNP O
. . O
coli NN O
) ) O
. . O

In IN O
all DT O
other JJ O
cases NNS O
, , O
vestibular JJ O
neurectomy NN O
or CC O
chemical NN O
vestibular JJ O
labyrinthectomy NN O
, , O
by IN O
means NNS O
of IN O
intratympanic JJ O
low JJ O
concentration NN O
gentamicin NN O
( ( O
20 CD O
mg NN O
/ NNP O
mL NN O
) ) O
, , O
are VBP O
indicated VBN O
. . O

To TO O
identify VB O
some DT O
of IN O
the DT O
genes NNS O
expressed VBN O
in IN O
LPS NNP O
- : O
activated VBN O
coelomocytes NNS O
, , O
we PRP O
sequenced VBD O
randomly RB O
chosen VBN O
clones NNS O
from IN O
a DT O
directionally RB O
constructed VBN O
cDNA NN O
library NN O
to TO O
produce VB O
a DT O
set NN O
of IN O
expressed JJ O
sequence NN O
tags NNS O
( ( O
ESTs NNP O
) ) O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
during IN O
pregnancy NN O
there EX O
are VBP O
increases NNS O
in IN O
bone NN O
formation NN O
rates NNS O
contributing VBG O
to TO O
the DT O
increases NNS O
in IN O
skeletal JJ O
mass NN O
. . O

Twenty NNP O
- : O
four CD O
hours NNS O
later RB O
, , O
the DT O
animals NNS O
were VBD O
randomized VBN O
to TO O
subretinal JJ O
treatment NN O
with IN O
2 CD O
. . O
5 CD O
micrograms NNS O
of IN O
tissue NN B-Gene
plasminogen NN I-Gene
activator NN I-Gene
or CC O
a DT O
similar JJ O
volume NN O
of IN O
physiologic JJ O
saline NN O
. . O

Vitrectomy NNP O
in IN O
ocular JJ O
traumatology NN O

The DT O
transit NN O
time NN O
was VBD O
significantly RB O
shortened VBN O
. . O

The DT O
concomitant JJ O
interaction NN O
of IN O
mSTI1 NN B-Gene
with IN O
hsp70 NN B-Gene
and CC O
hsp90 NN B-Gene
at IN O
its PRP$ O
N NNP O
- : O
and CC O
C NNP O
- : O
termini NN O
respectively RB O
is VBZ O
mediated VBN O
by IN O
the DT O
tetratricopeptide NN O
repeat NN O
( ( O
TPR NNP O
) ) O
motifs VBP O
in IN O
these DT O
regions NNS O
. . O

G NNP B-Gene
- : I-Gene
CSF NN I-Gene
was VBD O
started VBN O
on IN O
day NN O
3 CD O
of IN O
each DT O
cycle NN O
( ( O
5 CD O
microg NN O
/ NNP O
kg NN O
/ NNP O
day NN O
) ) O
and CC O
was VBD O
stopped VBN O
the DT O
day NN O
before IN O
the DT O
last JJ O
apheresis NN O
or CC O
when WRB O
absolute JJ O
neutrophil NN O
count NN O
was VBD O
above IN O
0 CD O
. . O
5 CD O
x JJ O
10 CD O
( ( O
9 CD O
) ) O
/ NN O
l NN O
. . O

Low NNP O
- : O
dose NN O
D NNP O
( ( O
0 CD O
. . O
4 CD O
- : O
0 CD O
. . O
8 CD O
mg NN O
) ) O
and CC O
DB NNP O
( ( O
1 CD O
. . O
0 CD O
- : O
5 CD O
. . O
0 CD O
mg NN O
) ) O
did VBD O
not RB O
significantly RB O
alter VB O
any DT O
parameter NN O
from IN O
control NN O
. . O

In IN O
order NN O
to TO O
screen VB O
for IN O
such JJ O
cofactors NNS O
, , O
we PRP O
have VBP O
used VBN O
a DT O
transcriptionally RB O
inactive JJ O
mutant NN O
of IN O
Xenopus NNP B-Gene
MEF2D NNP I-Gene
in IN O
a DT O
yeast NN O
two CD O
- : O
hybrid JJ O
screen NN O
. . O

The DT O
DNA NN O
helix NN O
at IN O
the DT O
tandemly NN O
repeated VBD O
, , O
13mer CD O
sequence NN O
is VBZ O
thermodynamically RB O
unstable JJ O
, , O
as IN O
evidenced VBN O
by IN O
hypersensitivity NN O
to TO O
single JJ B-Gene
- : I-Gene
strand NN I-Gene
- : I-Gene
specific JJ I-Gene
nuclease NN I-Gene
in IN O
a DT O
negatively RB O
supercoiled VBN O
plasmid NN O
, , O
and CC O
demonstrated VBN O
by IN O
stable JJ O
DNA NN O
unwinding VBG O
seen VBN O
after IN O
two CD O
- : O
dimensional JJ O
gel JJ O
electrophoresis NN O
of IN O
topoisomers NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
unique JJ O
properties NNS O
, , O
the DT O
newly RB O
characterized VBN O
hemagglutinin NN B-Gene
has VBZ O
been VBN O
termed VBN O
Limulus NNP B-Gene
18K CD I-Gene
agglutination NN I-Gene
- : I-Gene
aggregation NN I-Gene
factor NN I-Gene
( ( O
18K CD B-Gene
- : I-Gene
LAF NN I-Gene
) ) O
. . O

It PRP O
can MD O
be VB O
concluded VBN O
that IN O
in IN O
normotensive JJ O
subjects NNS O
, , O
uric JJ O
acid NN O
and CC O
xanthine JJ B-Gene
oxidase NN I-Gene
have VBP O
significant JJ O
association NN O
with IN O
blood NN O
pressure NN O
and CC O
thus RB O
are VBP O
one CD O
of IN O
the DT O
many JJ O
factors NNS O
which WDT O
are VBP O
involved VBN O
in IN O
the DT O
cause NN O
or CC O
effect NN O
of IN O
hypertension NN O
. . O

Ras NNP B-Gene
p21Val NN I-Gene
inhibits NNS O
myogenesis NN O
without IN O
altering VBG O
the DT O
DNA NN O
binding NN O
or CC O
transcriptional JJ O
activities NNS O
of IN O
the DT O
myogenic JJ B-Gene
basic JJ I-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
factors NNS I-Gene
. . O

However RB O
, , O
inclusion NN O
of IN O
the DT O
neighboring JJ O
CGGAAR NNP O
motifs NN O
from IN O
the DT O
ICP4 NNP B-Gene
promoter NN I-Gene
, , O
which WDT O
bind VBP O
factors NNS O
GABP NNP B-Gene
alpha NN I-Gene
and CC I-Gene
beta NN I-Gene
, , O
results NNS O
in IN O
a DT O
strong JJ O
synergistic JJ O
activation NN O
. . O

The DT O
toxicological JJ O
evaluation NN O
of IN O
chlorofluorocarbon NN O
22 CD O
( ( O
CFC NNP O
22 CD O
) ) O
. . O

The DT O
consensus NN O
highlights VBZ O
the DT O
importance NN O
of IN O
residues NNS O
other JJ O
than IN O
the DT O
eight CD O
motifs NNS O
that WDT O
are VBP O
often RB O
associated VBN O
with IN O
DEAD NNP B-Gene
- : I-Gene
box NN I-Gene
RNA NNP I-Gene
helicases VBZ I-Gene
, , O
as RB O
well RB O
as IN O
de FW O
- : O
emphasising VBG O
the DT O
importance NN O
of IN O
the DT O
"""" NN O
A NNP O
"""" NN O
residue NN O
within IN O
the DT O
"""" NNP O
DEAD NNP O
"""" NNP O
motif NN O
. . O

RNA NNP B-Gene
polymerase NN I-Gene
bound NN O
to TO O
the DT O
+ NN O
10A CD O
promoter NN O
partially RB O
protects VBZ O
a DT O
20 CD O
base NN O
- : O
pair NN O
sequence NN O
from IN O
DNase NNP B-Gene
I PRP I-Gene
digestion VBP O
upstream RB O
of IN O
the DT O
start NN O
site NN O
. . O

A DT O
single JJ O
nucleotide NN O
polymorphism NN O
( ( O
SNP NNP O
) ) O
in IN O
exon $ O
2 CD O
, , O
which WDT O
is VBZ O
tightly RB O
liked VBN O
to TO O
another DT O
SNP NNP O
( ( O
GTG83 NNP O
/ NNP O
ATG83 NNP O
) ) O
, , O
creates VBZ O
an DT O
additional JJ O
alternative NN O
in IN O
- : O
frame NN O
AUG NNP O
in IN O
B NNP B-Gene
- : I-Gene
type NN I-Gene
MTH1 NNP I-Gene
mRNAs NN I-Gene
yielding VBG O
the DT O
fourth JJ O
MTH1 NNP B-Gene
polypeptide NN I-Gene
, , O
p26 NN B-Gene
that WDT O
possesses VBZ O
an DT O
additional JJ O
mitochondrial NN O
targeting VBG O
signal NN O
. . O

One CD O
of IN O
these DT O
is VBZ O
located VBN O
in IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
, , O
and CC O
may MD O
encode VB O
regulatory JJ O
sequences NNS O
. . O

The DT O
euglobulin NN B-Gene
clot NN O
lysis NN O
time NN O
was VBD O
slightly RB O
longer RBR O
in IN O
the DT O
smokers NNS O
than IN O
in IN O
the DT O
non JJ O
- : O
smokers NNS O
in IN O
all DT O
three CD O
experimental JJ O
situations NNS O
, , O
but CC O
the DT O
differences NNS O
were VBD O
not RB O
significant JJ O
. . O

In IN O
both DT O
experiments NNS O
, , O
average JJ O
daily JJ O
gain NN O
and CC O
gain VB O
- : O
to TO O
- : O
feed NN O
ratio NN O
were VBD O
similar JJ O
for IN O
TR NNP O
and CC O
CR NNP O
. . O

A DT O
3 CD O
- : O
week NN O
regimen NNS O
of IN O
erythropoietin NN B-Gene
may MD O
help VB O
prevent VB O
the DT O
donor NN O
' POS O
s NNS O
need VBP O
to TO O
receive VB O
allogeneic JJ O
blood NN O
transfusion NN O
, , O
when WRB O
the DT O
initial JJ O
Hb NNP B-Gene
levels NNS O
were VBD O
below IN O
130 CD O
milligrams NNS O
. . O

Approximately RB O
60 CD O
% NN O
of IN O
cell NN O
bodies NNS O
of IN O
primary JJ O
neurons NNS O
innervating VBG O
the DT O
intra NN O
and CC O
perioral JJ O
structures NNS O
through IN O
the DT O
inferior JJ O
alveolar NN O
, , O
lingual JJ O
, , O
mental JJ O
, , O
and CC O
buccal JJ O
nerves NNS O
were VBD O
in IN O
the DT O
range NN O
between IN O
300 CD O
and CC O
600 CD O
micron NN O
2 CD O
in IN O
cross NN O
- : O
sectional JJ O
area NN O
: : O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
509 CD O
+ NN O
/ NNP O
- : O
243 CD O
micron NN O
2 CD O
, , O
420 CD O
+ NN O
/ NNP O
- : O
181 CD O
micron NN O
2 CD O
, , O
469 CD O
+ NN O
/ NNP O
- : O
200 CD O
micron NN O
2 CD O
, , O
and CC O
444 CD O
+ NN O
/ NNP O
- : O
186 CD O
micron NN O
2 CD O
, , O
respectively RB O
. . O

Effects NNS O
of IN O
diltiazem NN O
on IN O
netilmicin JJ O
- : O
induced JJ O
nephrotoxicity NN O
in IN O
rabbits NNS O
. . O

Molecular JJ O
and CC O
genetic JJ O
analysis NN O
of IN O
the DT O
yeast JJS B-Gene
early JJ I-Gene
meiotic JJ I-Gene
recombination NN I-Gene
genes NNS I-Gene
REC102 NNP I-Gene
and CC O
REC107 NNP B-Gene
/ NNP O
MER2 NNP B-Gene
. . O

Such JJ O
mutations NNS O
are VBP O
thought VBN O
to TO O
exert VB O
their PRP$ O
dominant JJ O
phenotype NN O
by IN O
sequestration NN O
of IN O
the DT O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factor NN I-Gene
( ( O
GNEF NNP B-Gene
) ) O
. . O

Like IN O
many JJ O
eukaryotic JJ O
transcription NN O
factors NNS O
, , O
these DT O
proteins NNS O
bind VBP O
to TO O
DNA NNP O
as IN O
dimers NNS O
. . O

One CD O
linker NN O
- : O
peptide NN O
insertion NN O
in IN O
the DT O
RsaA NNP B-Gene
C NNP I-Gene
terminus NN I-Gene
( ( I-Gene
amino JJ I-Gene
acid RB I-Gene
784 CD I-Gene
) ) I-Gene
had VBD O
no DT O
effect NN O
on IN O
S NNP O
- : O
layer NN O
biogenesis NN O
, , O
while IN O
another DT O
( ( O
amino NN O
acid RB O
907 CD O
) ) O
disrupted VBN O
secretion NN O
of IN O
the DT O
protein NN O
, , O
suggesting VBG O
that IN O
RsaA NNP B-Gene
possesses VBZ O
a DT O
secretion NN O
signal NN O
lying VBG O
C NNP O
terminal NN O
to TO O
amino VB O
acid JJ O
784 CD O
, , O
near IN O
or CC O
including VBG O
amino JJ O
acid JJ O
907 CD O
. . O

In IN O
regards NNS O
to TO O
the DT O
latter JJ O
activity NN O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
S3 NNP B-Gene
contains VBZ O
vigorous JJ O
N NNP B-Gene
- : I-Gene
glycosylase NN I-Gene
activity NN O
for IN O
the DT O
removal NN O
of IN O
8 CD O
- : O
oxoguanine NN O
residues NNS O
in IN O
DNA NN O
that WDT O
leaves VBZ O
baseless JJ O
sites NNS O
in IN O
their PRP$ O
places NNS O
. . O

Concentrations NNS O
of IN O
N NNP O
( ( O
O3 NNP O
- : O
) ) O
- : O
N NNP O
and CC O
N NNP O
( ( O
H3 NNP O
- : O
) ) O
- : O
N NN O
at IN O
Deoprayag NNP O
varied VBD O
from IN O
0 CD O
. . O
30 CD O
to TO O
0 CD O
. . O
50 CD O
and CC O
0 CD O
. . O
2 CD O
to TO O
0 CD O
. . O
12 CD O
mg JJ O
/ NNP O
L NNP O
, , O
respectively RB O
, , O
depending VBG O
on IN O
season NN O
. . O

No DT O
evidence NN O
for IN O
the DT O
presence NN O
of IN O
introns NNS O
within IN O
the DT O
acvA JJ B-Gene
gene NN I-Gene
has VBZ O
been VBN O
found VBN O
. . O

In IN O
all DT O
of IN O
these DT O
cases NNS O
, , O
expression NN O
of IN O
the DT O
implicated JJ O
genes NNS O
was VBD O
absent NN O
. . O

In IN O
SN NNP O
- : O
48 CD O
neuronal JJ O
cells NNS O
that IN O
express NN O
MR NNP B-Gene
, , O
GR NNP B-Gene
, , O
and CC O
5 CD B-Gene
- : I-Gene
HT1A NN I-Gene
receptors NNS I-Gene
, , O
deletion NN O
or CC O
inactivation NN O
of IN O
the DT O
nGRE NN O
( ( O
negative JJ O
GRE NNP O
) ) O
eliminated VBD O
negative JJ O
regulation NN O
of IN O
the DT O
rat NN B-Gene
5 CD I-Gene
- : I-Gene
HT1A NN I-Gene
or CC O
heterologous JJ O
promoters NNS O
by IN O
corticosteroids NNS O
, , O
whereas IN O
its PRP$ O
inclusion NN O
conferred VBN O
corticosteroid JJ O
- : O
induced JJ O
inhibition NN O
to TO O
a DT O
heterologous JJ O
promoter NN O
. . O

The DT O
weak JJ O
relationships NNS O
between IN O
F NNP O
and CC O
Zn NNP O
to TO O
Mg NNP O
clearly RB O
have VBP O
no DT O
significant JJ O
effect NN O
on IN O
the DT O
contents NNS O
of IN O
these DT O
elements NNS O
in IN O
bone NN O
. . O

Similarly RB O
, , O
supraventricular JJ O
tachycaydia NN O
following VBG O
resuscitative JJ O
efforts NNS O
appeared VBD O
to TO O
be VB O
associated VBN O
with IN O
a DT O
negative JJ O
outcome NN O
. . O

SAMPLE JJ O
POPULATION NNP O
: : O
MCB NN O
from IN O
7 CD O
racing VBG O
Greyhounds NNP O
euthanatized VBN O
for IN O
reasons NNS O
unrelated JJ O
to TO O
MCB NNP O
abnormalities NNS O
. . O

Nucleotide RB O
sequencing VBG O
indicates VBZ O
that IN O
this DT O
E1 NNP B-Gene
alpha NN I-Gene
cDNA NN I-Gene
clone NN O
is VBZ O
1821 CD O
base NN O
pairs NN O
( ( O
bp NN O
) ) O
in IN O
length NN O
with IN O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
1365 CD O
bp NN O
and CC O
a DT O
3 CD O
' POS O
- : O
untranslated JJ O
region NN O
of IN O
356 CD O
bp NN O
. . O

Confirming VBG O
measures NNS O
made VBN O
by IN O
nurses NNS O
and CC O
additionally RB O
, , O
ABPM NNP O
for IN O
women NNS O
, , O
seem VBP O
to TO O
lessen VB O
this DT O
effect NN O
. . O

Based VBN O
on IN O
previous JJ O
mapping NN O
of IN O
the DT O
G NNP B-Gene
beta NN I-Gene
gamma NN I-Gene
binding VBG I-Gene
region NN I-Gene
of IN O
beta NN B-Gene
ARK NNP I-Gene
, , O
and CC O
conserved VBD O
residues NNS O
within IN O
the DT O
PH NNP B-Gene
domain NN I-Gene
, , O
we PRP O
have VBP O
constructed VBN O
a DT O
series NN O
of IN O
mutants NNS O
in IN O
the DT O
carboxyl JJ O
terminus NN O
of IN O
beta NN B-Gene
ARK NNP I-Gene
in IN O
order NN O
to TO O
determine VB O
important JJ O
residues NNS O
involved VBN O
in IN O
G NNP B-Gene
beta NN I-Gene
gamma NN I-Gene
and CC O
PIP2 NNP O
binding NN O
. . O

After IN O
that DT O
report NN O
, , O
carboxypeptidase NN B-Gene
D NNP I-Gene
( ( O
CPD NNP B-Gene
) ) O
was VBD O
subsequently RB O
purified VBN O
from IN O
bovine NN O
pituitary JJ O
and CC O
characterized VBN O
as IN O
a DT O
novel JJ O
carboxypeptidase NN B-Gene
E NNP I-Gene
( ( O
CPE NNP B-Gene
) ) O
- : O
like IN O
enzyme NN O
, , O
with IN O
many JJ O
characteristics NNS O
in IN O
common JJ O
with IN O
duck NN O
gp180 NN B-Gene
( ( O
Song NNP O
, , O
L NNP O
. . O
, , O
Fricker NNP O
, , O
L NNP O
. . O
D NNP O
. . O
, , O
1995 CD O
. . O

An DT O
examination NN O
of IN O
the DT O
role NN O
of IN O
the DT O
carboxyl NN O
terminus NN O
in IN O
regulating VBG O
NGFI NNP B-Gene
- : I-Gene
B NNP I-Gene
transcriptional JJ O
activity NN O
revealed VBD O
that IN O
, , O
in IN O
accordance NN O
with IN O
other JJ O
nuclear JJ O
receptors NNS O
, , O
mutants NNS O
lacking VBG O
portions NNS O
of IN O
the DT O
carboxyl NN O
terminus NN O
had VBD O
greatly RB O
decreased VBN O
activity NN O
. . O

The DT O
IE13 NNP O
. . O
1 CD O
cell NN O
line NN O
was VBD O
able JJ O
to TO O
complement VB O
a DT O
recombinant JJ O
virus NN O
in IN O
which WDT O
both DT O
copies NNS O
of IN O
the DT O
IE NNP B-Gene
gene NN I-Gene
were VBD O
replaced VBN O
by IN O
insertion NN O
of IN O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
lacZ NN I-Gene
gene NN I-Gene
. . O

Effect NN O
of IN O
acute NN O
and CC O
chronic JJ O
psychogenic JJ O
stress NN O
on IN O
corticoadrenal NN O
and CC O
pituitary JJ B-Gene
- : I-Gene
thyroid NN I-Gene
hormones NNS I-Gene
in IN O
male JJ O
rats NNS O
. . O

CONCLUSION NN O
: : O
Some DT O
Gulf NNP O
War NNP O
veterans NNS O
may MD O
have VB O
delayed VBN O
, , O
chronic JJ O
neurotoxic NN O
syndromes NNS O
from IN O
wartime JJ O
exposure NN O
to TO O
combinations NNS O
of IN O
chemicals NNS O
that WDT O
inhibit VBP O
butyrylcholinesterase NN B-Gene
and CC O
neuropathy JJ B-Gene
target NN I-Gene
esterase NN I-Gene
. . O

The DT O
detection NN O
ratio NN O
peaked VBD O
at IN O
ages NNS O
30 CD O
to TO O
34 CD O
and CC O
decreased VBD O
heavily RB O
during IN O
the DT O
next JJ O
15 CD O
years NNS O
of IN O
age NN O
. . O

Constitutive JJ O
phosphorylation NN O
and CC O
nuclear JJ O
localization NN O
of IN O
Smad3 NNP B-Gene
are VBP O
correlated VBN O
with IN O
increased JJ O
collagen NN B-Gene
gene NN I-Gene
transcription NN O
in IN O
activated JJ O
hepatic JJ O
stellate NN O
cells NNS O
. . O

The DT O
unfolded JJ O
protein NN O
response NN O
regulates VBZ O
multiple JJ O
aspects NNS O
of IN O
secretory NN O
and CC O
membrane NN O
protein NN O
biogenesis NN O
and CC O
endoplasmic JJ O
reticulum NN O
quality NN O
control NN O
. . O

Spc42p NNP B-Gene
also RB O
was VBD O
identified VBN O
as IN O
a DT O
component NN O
of IN O
a DT O
cytoplasmic JJ O
SPB NNP O
subcomplex NN O
containing VBG O
Spc94p NNP B-Gene
/ NNP O
Nud1p NNP B-Gene
, , O
Cnm67p NNP B-Gene
, , O
and CC O
Spc42p NNP B-Gene
. . O

During IN O
conventional JJ O
hemofiltration NN O
using VBG O
substitution NN O
fluid NN O
with IN O
a DT O
Na NNP O
+ NNP O
concentration NN O
of IN O
140 CD O
mEq NNS O
/ JJ O
L NNP O
, , O
a DT O
decrease NN O
in IN O
extracellular JJ O
fluid NN O
volume NN O
was VBD O
noted VBN O
whereas IN O
the DT O
intracellular JJ O
fluid NN O
volume NN O
was VBD O
unaltered JJ O
. . O

High JJ O
values NNS O
of IN O
both DT O
retinol NN O
and CC O
beta NN O
- : O
carotene NN O
were VBD O
found VBN O
in IN O
full JJ O
fat NN O
cheeses NNS O
and CC O
whipping VBG O
cream NN O
: : O
from IN O
179 CD O
. . O
0 CD O
( ( O
cheese NN O
, , O
Edam NNP O
- : O
type NN O
) ) O
to TO O
318 CD O
. . O
7 CD O
micrograms NNS O
/ VBP O
100 CD O
g NN O
( ( O
whipping VBG O
cream NN O
) ) O
and CC O
from IN O
86 CD O
. . O
7 CD O
( ( O
cheese NN O
, , O
Edam NNP O
- : O
type NN O
) ) O
to TO O
186 CD O
. . O
5 CD O
micrograms NNS O
/ VBP O
100 CD O
g NN O
( ( O
whipping VBG O
cream NN O
) ) O
for IN O
all DT O
- : O
trans NNS O
retinol VBP O
and CC O
total JJ O
beta NN O
- : O
carotene NN O
, , O
respectively RB O
. . O

A DT O
further JJ O
study NN O
on IN O
plasminogen NN B-Gene
activator NN I-Gene
release NN O
by IN O
vasoactive JJ O
agents NNS O
in IN O
the DT O
isolated JJ O
perfused JJ O
dog NN O
leg NN O
. . O

Therefore RB O
, , O
we PRP O
suggested VBD O
that IN O
both DT O
proteins NNS O
might MD O
belong VB O
to TO O
the DT O
PLTP NNP B-Gene
family NN I-Gene
. . O

Pathology NN O
of IN O
neuritis NN O
caudae NN O
equinae NN O
in IN O
the DT O
horse NN O

We PRP O
present VBP O
the DT O
preliminary JJ O
results NNS O
obtained VBD O
on IN O
36 CD O
patients NNS O
which WDT O
were VBD O
followed VBN O
for IN O
a DT O
mean JJ O
period NN O
of IN O
12 CD O
months NNS O
. . O

CREB NNP B-Gene
was VBD O
identified VBN O
as IN O
one CD O
of IN O
the DT O
protein NN O
components NNS O
in IN O
several JJ O
of IN O
the DT O
gel NN O
shift NN O
complexes NNS O
formed VBN O
with IN O
the DT O
variant JJ O
CRE NNP O
. . O

Molecular JJ O
structure NN O
and CC O
evolutionary JJ O
origin NN O
of IN O
human JJ B-Gene
cardiac JJ I-Gene
muscle NN I-Gene
actin NN I-Gene
gene NN I-Gene
. . O

There EX O
was VBD O
no DT O
competition NN O
between IN O
activin NN B-Gene
A NNP I-Gene
and CC O
OP NNP B-Gene
- : I-Gene
1 CD I-Gene
for IN O
availability NN O
of IN O
Smad4 NNP B-Gene
, , O
indicating VBG O
that IN O
the DT O
concentration NN O
of IN O
this DT O
common JJ O
signal JJ O
transducer NN O
is VBZ O
not RB O
limiting VBG O
for IN O
generating VBG O
the DT O
observed JJ O
biological JJ O
responses NNS O
. . O

Molecular JJ O
cloning NN O
of IN O
mouse NN B-Gene
glycolate NN I-Gene
oxidase NN I-Gene
. . O

Cytomegalovirus NNP O
, , O
Chlamydia NNP O
pneumoniae NN O
, , O
and CC O
Helicobacter NNP O
pylori VBP O
IgG NNP B-Gene
antibodies NNS I-Gene
and CC O
restenosis NN O
after IN O
stent JJ O
implantation NN O
: : O
an DT O
angiographic JJ O
and CC O
intravascular JJ O
ultrasound NN O
study NN O
. . O

A DT O
platelet NN B-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
( ( O
PDGF NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
phosphopeptide IN O
containing VBG O
Tyr NNP O
- : O
857 CD O
does VBZ O
not RB O
bind VB O
appreciably RB O
to TO O
the DT O
Src NNP B-Gene
SH2 NNP I-Gene
domain NN I-Gene
, , O
suggesting VBG O
it PRP O
is VBZ O
not RB O
the DT O
PDGF NNP B-Gene
- : I-Gene
R NN I-Gene
binding NN O
site NN O
for IN O
Src NNP B-Gene
as IN O
previously RB O
reported VBN O
. . O

Losses NNS O
during IN O
the DT O
complete JJ O
procedure NN O
are VBP O
corrected VBN O
for IN O
using VBG O
radioactive JJ O
estrogen NN O
conjugates NNS O
during IN O
the DT O
first JJ O
steps NNS O
and CC O
later RB O
by IN O
adding VBG O
deuterated VBN O
internal JJ O
standards NNS O
of IN O
all DT O
compounds NNS O
measured VBN O
( ( O
matairesinol NN O
, , O
enterodiol NN O
, , O
enterolactone NN O
, , O
daidzein NN O
, , O
O NNP O
- : O
desmethylangolensin NN O
, , O
equol NN O
, , O
and CC O
genistein NN O
) ) O
. . O

The DT O
response NN O
properties NNS O
of IN O
cat NN O
horizontal JJ O
canal JJ O
afferents NNS O
( ( O
N NNP O
= NNP O
81 CD O
) ) O
were VBD O
characterized VBN O
by IN O
three CD O
parameters NNS O
: : O
their PRP$ O
long JJ O
time NN O
constants NNS O
( ( O
tau NN O
) ) O
, , O
low JJ O
frequency NN O
gain NN O
constants NNS O
( ( O
G1 NNP O
) ) O
, , O
and CC O
middle JJ O
frequency NN O
gain NN O
constants NNS O
( ( O
Gm NNP O
) ) O
. . O

We PRP O
propose VBP O
that IN O
noi JJ B-Gene
/ NNP O
pax2 NN B-Gene
. . I-Gene
1 CD I-Gene
participates NNS O
in IN O
sequential JJ O
signaling NN O
processes VBZ O
as IN O
a DT O
key JJ O
integrator NN O
of IN O
midbrain NN O
- : O
hindbrain NN O
boundary JJ O
development NN O
. . O

We PRP O
conclude VBP O
that IN O
grade NN O
III NNP O
BGCT NNP O
can MD O
be VB O
treated VBN O
by IN O
modified JJ O
intralesional JJ O
excision NN O
provided VBD O
the DT O
articular JJ O
surfaces NNS O
and CC O
part NN O
of IN O
the DT O
metaphysis NN O
are VBP O
intact JJ O
. . O

10 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
0 CD O
pmol JJ O
/ $ O
24 CD O
h NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
remained VBD O
elevated VBN O
. . O

A DT O
DNA NN O
fragment NN O
carrying VBG O
1 CD O
, , O
100 CD O
nucleotides NNS O
derived VBN O
from IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
UGT1A1 NNP B-Gene
gene NN I-Gene
was VBD O
enough RB O
for IN O
MC NNP O
induction NN O
. . O

The DT O
interferon NN B-Gene
- : O
inducible JJ O
protein NN B-Gene
kinase NN I-Gene
PKR NNP I-Gene
modulates VBZ O
the DT O
transcriptional JJ O
activation NN O
of IN O
immunoglobulin NN B-Gene
kappa NN I-Gene
gene NN I-Gene
. . O

Ultrasonic JJ O
evaluation NN O
of IN O
renal JJ O
calculi NN O
. . O

Despite IN O
an DT O
overall JJ O
survival NN O
rate NN O
of IN O
43 CD O
% NN O
, , O
survival NN O
to TO O
discharge VB O
varied JJ O
greatly RB O
( ( O
0 CD O
to TO O
100 CD O
% NN O
) ) O
among IN O
the DT O
24 CD O
diagnostic JJ O
groups NNS O
: : O
tumor NN O
lysis NN O
syndrome NN O
and CC O
systemic JJ O
lupus NN O
erythematosus NN O
( ( O
3 CD O
/ RB O
3 CD O
patients NNS O
each DT O
, , O
100 CD O
% NN O
) ) O
, , O
hemolytic JJ O
uremic JJ O
syndrome NN O
( ( O
8 CD O
/ RB O
9 CD O
patients NNS O
, , O
89 CD O
% NN O
) ) O
. . O

Our PRP$ O
study NN O
differs NNS O
from IN O
previous JJ O
studies NNS O
in IN O
that DT O
it PRP O
is VBZ O
limited VBN O
to TO O
one CD O
diagnostic JJ O
entity NN O
, , O
yet RB O
at IN O
the DT O
same JJ O
time NN O
evaluates VBZ O
a DT O
broad JJ O
range NN O
of IN O
social JJ O
and CC O
work NN O
- : O
related JJ O
factors NNS O
in IN O
disability NN O
. . O

The DT O
frameshift NN O
initiated VBN O
by IN O
ADEx2 NNP O
is VBZ O
believed VBN O
to TO O
alter VB O
the DT O
regular JJ O
coding NN O
sequence NN O
, , O
acting VBG O
as IN O
a DT O
loss NN O
- : O
of IN O
- : O
function NN O
ASIP NNP B-Gene
mutation NN I-Gene
. . O

This DT O
promoter NN O
could MD O
direct VB O
the DT O
constitutive JJ O
expression NN O
of IN O
the DT O
reporter NN O
beta SYM B-Gene
- : I-Gene
galactosidase NN I-Gene
at IN O
high JJ O
frequency NN O
in IN O
transfected JJ O
colonies NNS O
of IN O
transformed JJ O
cells NNS O
that IN O
express NN O
L NNP B-Gene
- : I-Gene
plastin NN I-Gene
constitutively RB O
; : O
by IN O
contrast NN O
, , O
this DT O
promoter NN O
was VBD O
virtually RB O
inactive JJ O
in IN O
transfected JJ O
colonies NNS O
of IN O
normal JJ O
fibroblasts NNS O
and CC O
it PRP O
exhibited VBD O
a DT O
low JJ O
frequency NN O
of IN O
constitutive JJ O
activation NN O
in IN O
transfected JJ O
colonies NNS O
of IN O
in IN O
vitro NN O
SV40 NNP O
- : O
transformed VBD O
fibroblasts NNS O
which WDT O
did VBD O
not RB O
exhibit VB O
L NNP B-Gene
- : I-Gene
plastin NN I-Gene
expression NN O
. . O

Mutation NN O
of IN O
the DT O
central JJ O
Tyr497 NNP O
to TO O
Phe VB O
blocks NNS O
the DT O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
insulin NN B-Gene
receptor NN I-Gene
substrate NN I-Gene
1 CD I-Gene
( ( O
IRS1 NNP B-Gene
) ) O
and CC O
diminishes VBZ O
proliferation NN O
in IN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

This DT O
study NN O
was VBD O
aimed VBN O
at IN O
assessing VBG O
whether IN O
c SYM O
- : O
DDP NNP O
administration NN O
immediately RB O
before IN O
radiotherapy NN O
could MD O
increase VB O
frequency NN O
and CC O
duration NN O
of IN O
objective JJ O
responses NNS O
, , O
as RB O
well RB O
as IN O
survival NN O
, , O
in IN O
patients NNS O
affected VBN O
with IN O
locally RB O
advanced JJ O
stages NNS O
of IN O
squamous JJ O
carcinomas NN O
of IN O
the DT O
head NN O
and CC O
neck NN O
. . O

A DT O
2 CD O
years NNS O
and CC O
9 CD O
months NNS O
old JJ O
female JJ O
patient NN O
, , O
with IN O
the DT O
diagnosis NN O
of IN O
Weaver NNP O
syndrome NN O
is VBZ O
reported VBN O
. . O

This DT O
indicates VBZ O
that IN O
recruitment NN O
of IN O
large JJ B-Gene
T NNP I-Gene
antigen NN I-Gene
to TO O
the DT O
rRNA NN O
promoter NN O
by IN O
SL1 NNP B-Gene
constitutes VBZ O
a DT O
crucial JJ O
step NN O
in IN O
the DT O
activation NN O
process NN O
. . O

The DT O
peptide NN O
sequences VBZ O
reveal NN O
that IN O
the DT O
factor NN O
consists VBZ O
of IN O
GABP NNP B-Gene
alpha NN I-Gene
and CC O
GABP NNP B-Gene
beta VBD I-Gene
1 CD I-Gene
with IN O
Ets NNP B-Gene
and CC O
Notch NNP B-Gene
motifs NNS I-Gene
, , O
respectively RB O
. . O

In IN O
an DT O
in IN O
vitro NN O
study NN O
, , O
10 CD O
/ NN O
0 CD O
nylon NN O
was VBD O
found VBN O
to TO O
require VB O
a DT O
significantly RB O
lower JJR O
laser NN O
energy NN O
density NN O
to TO O
produce VB O
suture JJ O
lysis NN O
following VBG O
a DT O
single JJ O
shot NN O
than IN O
either DT O
10 CD O
/ VBD O
0 CD O
Dacron NNP O
or CC O
10 CD O
/ JJ O
0 CD O
prolene NN O
. . O

In IN O
comparison NN O
with IN O
normal JJ O
pregnant JJ O
women NNS O
and CC O
normal JJ O
non JJ O
- : O
pregnant JJ O
women NNS O
, , O
women NNS O
with IN O
PIH NNP O
showed VBD O
an DT O
increase NN O
in IN O
heart NN O
rate NN O
, , O
suggesting VBG O
an DT O
increased VBN O
peripheral JJ O
sympathetic JJ O
tone NN O
, , O
and CC O
an DT O
initial JJ O
derangement NN O
in IN O
renal JJ O
function NN O
as IN O
shown VBN O
by IN O
the DT O
increase NN O
in IN O
serum JJ O
uric JJ O
acid NN O
and CC O
reduction NN O
in IN O
sodium NN O
excretion NN O
and CC O
total JJ O
and CC O
fractional JJ O
calcium NN O
excretion NN O
at IN O
any DT O
given VBN O
level NN O
of IN O
sodium JJ O
excretion NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Lrp NNP B-Gene
binds VBZ O
a DT O
central JJ O
palindromic JJ O
site NN O
, , O
interacting VBG O
predominantly RB O
with IN O
the DT O
major JJ O
groove NN O
of IN O
its PRP$ O
DNA NNP O
target NN O
, , O
and CC O
that IN O
additional JJ O
dimers NNS O
bind VBP O
to TO O
flanking VBG O
sites NNS O
to TO O
form VB O
a DT O
nucleoprotein JJ O
activation NN O
complex NN O
. . O

Platelet NNP O
aggregation NN O
and CC O
metabolic JJ O
control NN O
are VBP O
not RB O
affected VBN O
by IN O
calcium JJ O
antagonist NN O
treatment NN O
in IN O
type NN O
II NNP O
diabetes VBZ O
mellitus NN O
. . O

However RB O
, , O
the DT O
few JJ O
studies NNS O
that WDT O
address VBP O
antimicrobial JJ O
prophylaxis NN O
in IN O
bone NN O
marrow NN O
transplantation NN O
have VBP O
not RB O
always RB O
shown VBN O
a DT O
survival JJ O
benefit NN O
. . O

However RB O
, , O
the DT O
favored VBN O
, , O
parallel JJ O
beta NN O
helix NN O
model NN O
is VBZ O
a DT O
compact JJ O
coil NN O
of IN O
ten NNS O
helically RB O
arranged VBD O
beta NN O
strands NNS O
forming VBG O
two CD O
parallel JJ O
beta NN O
sheet NN O
faces VBZ O
. . O

Study NN O
on IN O
micromelias NNS O
in IN O
the DT O
mouse NN O
fetus NN O
caused VBN O
by IN O
x NNP O
- : O
radiation NN O
, , O
hypoxia NN O
, , O
trypan JJ O
blue JJ O
injection NN O
of IN O
hypervitaminosis NN O
- : O
A DT O
upon IN O
mother NN O
animals NNS O
during IN O
pregnancy NN O
. . O

In IN O
addition NN O
, , O
depletion NN O
of IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
from IN O
the DT O
nuclear JJ O
extract NN O
by IN O
using VBG O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
specific JJ O
antiserum NN O
or CC O
a DT O
sequence NN O
- : O
specific JJ O
DNA NNP O
affinity NN O
resin NN O
decreased VBN O
in IN O
vitro JJ O
transcription NN O
from IN O
the DT O
wild JJ O
- : O
type NN O
MMTV NNP O
promoter NN O
to TO O
a DT O
level JJ O
identical JJ O
to TO O
that DT O
obtained VBN O
from IN O
a DT O
promoter NN O
in IN O
which WDT O
all DT O
three CD O
octamer JJR O
- : O
related JJ O
sequences NNS O
were VBD O
mutated VBN O
. . O

Expression NN O
of IN O
activated JJ O
Cdc42 NNP B-Gene
results NNS O
in IN O
the DT O
translocation NN O
of IN O
PKClambda NNP B-Gene
from IN O
the DT O
nucleus NN O
into IN O
the DT O
cytosol NN O
, , O
and CC O
Cdc42 NNP B-Gene
and CC O
PKClambda NNP B-Gene
colocalize VBP O
at IN O
the DT O
plasma NN O
membrane NN O
and CC O
in IN O
the DT O
cytoplasm NN O
. . O

Within IN O
the DT O
human JJ O
enhancer NN O
, , O
these DT O
two CD O
sites NNS O
are VBP O
located VBN O
within IN O
the DT O
previously RB O
defined VBN O
DNase NNP B-Gene
I PRP I-Gene
footprints NNS I-Gene
, , O
NFAT NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NFIL NNP B-Gene
- : I-Gene
2B CD I-Gene
, , O
respectively RB O
. . O

In IN O
order NN O
to TO O
characterize VB O
the DT O
functional JJ O
elements NNS O
of IN O
the DT O
promoter NN O
that WDT O
in IN O
some DT O
way NN O
must MD O
respond VB O
to TO O
these DT O
regulatory JJ O
signals NNS O
, , O
a DT O
number NN O
of IN O
promoter NN O
mutations NNS O
were VBD O
constructed VBN O
, , O
including VBG O
a DT O
set NN O
of IN O
linker NN O
- : O
scanning NN O
mutations NNS O
across IN O
the DT O
entire JJ O
promoter NN O
region NN O
. . O

ECM NNP O
disruption NN O
in IN O
Lytechinus NNP O
embryos NN O
caused VBD O
a DT O
relative JJ O
drop NN O
in IN O
USF NNP B-Gene
RNA NNP I-Gene
accumulation NN O
levels NNS O
to TO O
approximately RB O
60 CD O
% NN O
of IN O
control NN O
embryos NN O
, , O
while IN O
LpS1 NNP B-Gene
RNA NNP I-Gene
accumulation NN O
levels NNS O
dropped VBD O
to TO O
less JJR O
than IN O
5 CD O
% NN O
. . O

In IN O
recent JJ O
years NNS O
, , O
successful JJ O
physiological JJ O
models NNS O
have VBP O
been VBN O
developed VBN O
for IN O
a DT O
variety NN O
of IN O
volatile JJ O
and CC O
nonvolatile JJ O
chemicals NNS O
, , O
and CC O
their PRP$ O
ability NN O
to TO O
perform VB O
the DT O
extrapolations NNS O
needed VBN O
in IN O
risk NN O
assessment NN O
has VBZ O
been VBN O
demonstrated VBN O
. . O

This DT O
repression NN O
does VBZ O
not RB O
require VB O
the DT O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
transactivation NN O
or CC O
PEST NNP O
domains NNS O
and CC O
cannot NN O
be VB O
reversed VBN O
by IN O
p300 JJ B-Gene
expression NN O
. . O

Confocal JJ O
fluorescence NN O
microscopy NN O
in IN O
modern JJ O
cell NN O
biology NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
CAAT NNP O
- : O
region NN O
is VBZ O
involved VBN O
in IN O
upregulating VBG O
the DT O
MDR1 NNP B-Gene
promoter NN I-Gene
in IN O
HL60 NNP O
/ NNP O
VCR NNP O
cells NNS O
. . O

Autoimmune NNP O
manipulation NN O
aids NNS O
juvenile NN O
diabetes VBZ O
management NN O
. . O

Reconstitution NN O
of IN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
was VBD O
observed VBN O
only RB O
with IN O
kinase NNP O
active JJ O
Jak1 NNP B-Gene
in IN O
both DT O
cell NN O
lines NNS O
. . O

Biol NNP O
. . O

Eight CD O
of IN O
14 CD O
infectious JJ O
or CC O
inflammatory JJ O
lesions NNS O
could MD O
be VB O
detected VBN O
in IN O
the DT O
early JJ O
scan NN O
( ( O
4 CD O
- : O
6 CD O
h NN O
p NN O
. . O
i NN O
. . O
) ) O
. . O

Using VBG O
this DT O
method NN O
, , O
we PRP O
were VBD O
able JJ O
to TO O
select VB O
strong JJ O
enhancer NN O
- : O
type NN O
activation NN O
domains VBZ O
from IN O
the DT O
immediate JJ B-Gene
early JJ I-Gene
regions NNS I-Gene
of IN O
two CD O
herpesviruses NNS O
, , O
namely RB O
pseudorabies VBZ O
virus NN O
and CC O
bovine NN O
herpesvirus NN O
1 CD O
. . O

LysR NNP B-Gene
proteins NNS I-Gene
have VBP O
been VBN O
shown VBN O
to TO O
regulate VB O
urease NN B-Gene
in IN I-Gene
Klebsiella NNP I-Gene
aerogenes NNS I-Gene
( ( O
NAC NNP B-Gene
) ) O
, , O
and CC O
catalase NN B-Gene
in IN I-Gene
Escherichia NNP I-Gene
coli NN I-Gene
( ( O
OxyR NNP B-Gene
) ) O
, , O
which WDT O
offers VBZ O
the DT O
intracellular JJ O
bacterium NN O
protection NN O
from IN O
phagolysosome JJ O
damage NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
Semen NNS O
analyses NNS O
were VBD O
performed VBN O
on IN O
58 CD O
patients NNS O
with IN O
stages NNS O
I PRP O
- : O
III NNP O
HD NNP O
before IN O
, , O
during IN O
, , O
and CC O
after IN O
chemotherapy NN O
and CC O
after IN O
the DT O
sperm JJ O
count NN O
recovered VBD O
from IN O
the DT O
effects NNS O
of IN O
abdominal JJ O
radiotherapy NN O
that WDT O
was VBD O
given VBN O
after IN O
chemotherapy NN O
. . O

220 CD O
, , O
263 CD O
- : O
273 CD O
) ) O
. . O

Substitution NN O
of IN O
the DT O
DR1 NNP B-Gene
beta NN I-Gene
chain NN I-Gene
with IN O
H NNP B-Gene
- : I-Gene
2E CD I-Gene
beta NN I-Gene
k NN I-Gene
led VBD O
to TO O
a DT O
dramatic JJ O
loss NN O
of IN O
recognition NN O
; : O
alpha CC O
chain NN O
substitution NN O
had VBD O
a DT O
less RBR O
marked JJ O
effect NN O
. . O

One CD O
hundred CD O
and CC O
four CD O
( ( O
14 CD O
per IN O
cent NN O
) ) O
second JJ O
primary JJ O
tumours NNS O
were VBD O
reported VBN O
. . O

After IN O
surgery NN O
, , O
patients NNS O
self VBP O
administered JJ O
one CD O
of IN O
three CD O
possible JJ O
postsurgical JJ O
medications NNS O
, , O
which WDT O
included VBD O
placebo NN O
, , O
codeine VBP O
60 CD O
mg NN O
, , O
and CC O
ibuprofen RB O
400 CD O
mg NNS O
, , O
when WRB O
their PRP$ O
pain NN O
reached VBD O
a DT O
moderate JJ O
or CC O
severe JJ O
intensity NN O
. . O

Successive JJ O
abdominal JJ O
scintillation NN O
with IN O
131 CD O
- : O
I PRP O
- : O
tagged VBD O
BSP NNP O
- : O
- : O
description NN O
of IN O
the DT O
thyroid NN O
gland NN O
, , O
kidney NN O
and CC O
spleen NN O
( ( O
comparison NN O
with IN O
131 CD O
- : O
I PRP O
- : O
RB NN O
) ) O

VP NNP O
- : O
16 CD O
, , O
ifosfamide NN O
and CC O
cisplatin NN O
( ( O
VIP NNP O
) ) O
for IN O
extensive JJ O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

Purified NNP O
Hsk1 NNP B-Gene
phosphorylates VBZ O
the DT O
Cdc19 NNP B-Gene
( ( O
Mcm2 NNP B-Gene
) ) O
subunit NN O
of IN O
the DT O
six CD B-Gene
- : I-Gene
member NN I-Gene
minichromosome JJ I-Gene
maintenance NN I-Gene
protein NN I-Gene
complex JJ I-Gene
purified VBN O
from IN O
fission NN O
yeast NN O
. . O

This DT O
distribution NN O
implies VBZ O
that IN O
the DT O
polycistronic JJ O
precursor NN O
is VBZ O
imported VBN O
into IN O
the DT O
nucleolus NN O
for IN O
processing VBG O
to TO O
the DT O
mature NN O
snoRNAs NN O
, , O
and CC O
that IN O
the DT O
import NN O
or CC O
processing VBG O
pathway JJ O
involves NNS O
coiled VBD O
bodies NNS O
. . O

A DT O
highly RB O
significant JJ O
correlation NN O
was VBD O
found VBN O
between IN O
the DT O
presence NN O
of IN O
fibrinolytic JJ O
degradation NN O
products NNS O
( ( O
FDP NNP O
) ) O
and CC O
the DT O
incidence NN O
of IN O
nephropathy JJ O
and CC O
renal JJ O
insufficiency NN O
, , O
as RB O
well RB O
as IN O
between IN O
the DT O
presence NN O
of IN O
fibrin JJ B-Gene
monomers NNS I-Gene
( ( O
Godal NNP O
' POS O
s NN O
ethanol SYM O
- : O
gelification NN O
test NN O
) ) O
and CC O
the DT O
evolutive JJ O
signs NNS O
of IN O
the DT O
primary JJ O
disease NN O
( ( O
fever NN O
, , O
accelerated VBD O
ESR NNP O
) ) O
. . O

The DT O
kinase NN O
is VBZ O
essential JJ O
in IN O
vivo NN O
for IN O
normal JJ O
phosphorylation NN O
of IN O
the DT O
CTD NNP O
and CC O
for IN O
normal JJ O
growth NN O
and CC O
differentiation NN O
. . O

The DT O
maintenance NN O
of IN O
increased VBN O
myocardial JJ O
capillary JJ O
density NN O
required VBN O
a DT O
similar JJ O
amount NN O
of IN O
exercise NN O
, , O
and CC O
at IN O
least JJS O
1 CD O
h NN O
of IN O
exercise NN O
once RB O
a DT O
week NN O
was VBD O
necessary JJ O
to TO O
maintain VB O
the DT O
enlargement NN O
of IN O
ECA NNP O
. . O
20 CD O

Transient NNP O
co SYM O
- : O
transfection NN O
assays VBZ O
involving VBG O
NFKB2 NNP B-Gene
expression NN O
vectors NNS O
and CC O
kappa NN B-Gene
B NNP I-Gene
- : O
driven NN O
reporter NN O
plasmids NNS O
indicate VBP O
that IN O
NFKB2 NNP B-Gene
p85 NN B-Gene
has VBZ O
lost VBN O
the DT O
transcriptional JJ O
repressor NN O
functions NNS O
typical JJ O
of IN O
normal JJ O
NFKB2 NNP B-Gene
p52 NN B-Gene
. . O

Relationship NN O
of IN O
CDK NNP B-Gene
- : I-Gene
activating VBG I-Gene
kinase NN I-Gene
and CC O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
CTD NNP O
kinase NNP O
TFIIH NNP B-Gene
/ NNP O
TFIIK NNP B-Gene
. . O

Extracellular JJ O
fibril NN O
formation NN O
by IN O
neuroglial JJ O
cells NNS O
at IN O
the DT O
vitreoretinal JJ O
junction NN O
of IN O
the DT O
human JJ O
eye NN O
. . O

The DT O
region NN O
of IN O
plasmid NN O
pCM2 NN O
encoding VBG O
the DT O
pathogenicity NN B-Gene
locus NN I-Gene
pat VBD I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
mapped VBN O
by IN O
deletion NN O
analysis NN O
and CC O
complementation NN O
studies NNS O
to TO O
a DT O
1 CD O
. . O
5 CD O
- : O
kb NN O
Bg NNP B-Gene
/ NNP I-Gene
II NNP I-Gene
/ NNP O
SmaI NNP B-Gene
DNA NNP O
fragment NN O
. . O

The DT O
predicted JJ O
protein NN O
, , O
Seb1p NNP B-Gene
, , O
consists VBZ O
of IN O
82 CD O
amino JJ O
acids NNS O
and CC O
contains VBZ O
one CD O
potential JJ O
membrane NN O
- : O
spanning VBG O
region NN O
at IN O
the DT O
C NNP O
- : O
terminus NN O
but CC O
no DT O
N NNP O
- : O
terminal JJ O
signal JJ O
sequence NN O
. . O

No DT O
significant JJ O
differences NNS O
were VBD O
found VBN O
between IN O
the DT O
TS NNP O
and CC O
the DT O
PTS NNP O
. . O

The DT O
latency NN O
time NN O
for IN O
the DT O
lactate JJ O
concentration NN O
to TO O
reach VB O
the DT O
top JJ O
values NNS O
was VBD O
reduced VBN O
by IN O
aerobic JJ O
training NN O
( ( O
T2 NNP O
) ) O
. . O

The DT O
brackets NNS O
were VBD O
bonded VBN O
to TO O
100 CD O
freshly RB O
extracted VBN O
bovine NN O
incisors NNS O
, , O
and CC O
, , O
after IN O
storage NN O
in IN O
tap JJ O
water NN O
at IN O
room NN O
temperature NN O
for IN O
24 CD O
hours NNS O
, , O
they PRP O
were VBD O
subsequently RB O
tested VBN O
in IN O
a DT O
shear JJ O
mode NN O
using VBG O
a DT O
universal JJ O
testing NN O
machine NN O
. . O

In IN O
three CD O
cases NNS O
( ( O
21 CD O
. . O
4 CD O
% NN O
) ) O
, , O
the DT O
MR NNP O
imaging NN O
was VBD O
interpreted VBN O
as IN O
negative JJ O
, , O
but CC O
microscopic JJS O
tumor NN O
was VBD O
shown VBN O
around RB O
seroma NN O
on IN O
reexcision NN O
. . O

Expression NN O
of IN O
various JJ O
FAK NNP B-Gene
mutants NNS I-Gene
in IN O
the DT O
FAK NNP B-Gene
- : O
cells NNS O
showed VBD O
that IN O
FAK NNP B-Gene
kinase NN I-Gene
activity NN O
, , O
the DT O
Tyr NNP B-Gene
- : I-Gene
397 CD I-Gene
/ JJ I-Gene
SH2 NNP I-Gene
domain NN I-Gene
binding VBG I-Gene
site NN I-Gene
, , O
and CC O
the DT O
first JJ O
proline NN O
- : O
rich JJ O
SH3 NNP B-Gene
binding VBG I-Gene
region NN I-Gene
in IN O
the DT O
FAK NNP B-Gene
C NNP I-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
were VBD O
individually RB O
needed VBN O
to TO O
promote VB O
full JJ O
FAK NNP B-Gene
- : O
mediated VBD O
FAK NNP B-Gene
- : O
cell NN O
migration NN O
to TO O
FN NNP B-Gene
whereas NNS O
direct JJ O
paxillin NN B-Gene
binding VBG O
to TO O
FAK NNP B-Gene
was VBD O
not RB O
required VBN O
. . O

False NNP O
positive JJ O
PET NNP O
FDG NNP O
corresponded VBD O
to TO O
lung VB O
infection NN O
, , O
degenerative JJ O
bone NN O
disease NN O
, , O
and CC O
reconstruction NN O
artifact NN O
. . O

Transition NN O
between IN O
P NNP O
- : O
and CC O
H NNP O
- : O
BPPV NNP O
was VBD O
found VBN O
in IN O
6 CD O
cases NNS O
. . O

The DT O
transmembrane NN O
topology NN O
of IN O
Na NNP O
( ( O
+ NNP O
) ) O
/ NN O
H NNP O
( ( O
+ NNP O
) ) O
exchanger NN O
NHE3 NNP B-Gene
has VBZ O
been VBN O
studied VBN O
using VBG O
in IN O
vitro JJ O
transcription NN O
/ NNP O
translation NN O
of IN O
two CD O
types NNS O
of IN O
fusion NN O
vectors NNS O
designed VBN O
to TO O
test VB O
membrane NN O
insertion NN O
properties NNS O
of IN O
cDNA NN O
sequences NNS O
encoding VBG O
putative JJ O
NHE3 NNP B-Gene
membrane NN O
spanning VBG O
domains NNS O
( ( O
msds NN O
) ) O
. . O

The DT O
same JJ O
rhythmic JJ O
structure NN O
enables VBZ O
a DT O
prediction NN O
to TO O
be VB O
made VBN O
concerning VBG O
when WRB O
vowels NNS O
of IN O
stressed JJ O
syllables NNS O
will MD O
be VB O
auditorily RB O
perceived VBN O
. . O

Recently RB O
, , O
extremely RB O
high JJ O
levels NNS O
of IN O
endothelin NN B-Gene
- : I-Gene
1 CD I-Gene
( ( O
ET NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
were VBD O
detected VBN O
in IN O
the DT O
pericardial JJ O
fluid NN O
of IN O
patients NNS O
undergoing VBG O
cardiac JJ O
surgery NN O
. . O

Such JJ O
multisensory JJ O
interactions NNS O
can MD O
be VB O
significant JJ O
for IN O
behavior NN O
. . O

In IN O
addition NN O
, , O
IgM NNP B-Gene
can MD O
be VB O
absent VBN O
in IN O
children NNS O
with IN O
congenital JJ O
toxoplasmosis NN O
or CC O
subjects NNS O
with IN O
secondary JJ O
reactivation NN O
. . O

Glutamyl NNP B-Gene
- : I-Gene
tRNA NN I-Gene
synthetase NN I-Gene
and CC O
prolyl NN B-Gene
- : I-Gene
tRNA NN I-Gene
synthetase NN I-Gene
belong NN O
to TO O
different JJ O
classes NNS O
of IN O
aminoacyl JJ B-Gene
- : I-Gene
tRNA NN I-Gene
synthetases NNS I-Gene
that WDT O
are VBP O
thought VBN O
to TO O
have VB O
evolved VBN O
along IN O
independent JJ O
evolutionary JJ O
pathways NNS O
. . O

Biol NNP O
. . O

Following VBG O
the DT O
patients NNS O
during IN O
a DT O
course NN O
of IN O
therapy NN O
with IN O
a DT O
selective JJ O
vasodilator NN O
calcium NN O
antagonist NN O
, , O
the DT O
beta NN O
- : O
adrenergic NN O
reflex JJ O
vasodilation NN O
became VBD O
substantially RB O
attenuated VBN O
but CC O
was VBD O
preserved VBN O
during IN O
a DT O
placebo JJ O
course NN O
of IN O
therapy NN O
. . O

Further JJ O
analysis NN O
of IN O
this DT O
DNA NNP O
fragment NN O
showed VBD O
that IN O
four CD O
genes NNS O
are VBP O
present JJ O
encoding VBG O
proteins NNS O
of IN O
16 CD O
, , O
18 CD O
. . O
5 CD O
, , O
21 CD O
and CC O
89 CD O
kDal NN O
. . O

Acute NNP O
type VBZ O
A DT O
hepatitis NN O
in IN O
three CD O
patients NNS O
with IN O
chronic JJ O
HBV NNP O
infection NN O
. . O

Its PRP$ O
transcription NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
induced VBN O
40 CD O
- : O
50 CD O
- : O
fold NN O
in IN O
response NN O
to TO O
oxygen NN O
or CC O
heme NN O
deficiency NN O
, , O
in IN O
part NN O
through IN O
relief NN O
of IN O
repression NN O
exerted VBN O
by IN O
Rox1p NNP B-Gene
and CC O
in IN O
part NN O
by IN O
activation NN O
mediated VBN O
by IN O
an DT O
upstream JJ O
activation NN O
sequence NN O
( ( O
UAS NNP O
) ) O
. . O

Expression NN O
of IN O
thiamin JJ O
biosynthetic JJ O
genes NNS O
( ( O
thiCOGE NN B-Gene
) ) O
and CC O
production NN O
of IN O
symbiotic JJ B-Gene
terminal JJ I-Gene
oxidase NN I-Gene
cbb3 NN I-Gene
in IN O
Rhizobium NNP O
etli NN O
. . O

The DT O
results NNS O
obtained VBN O
are VBP O
similar JJ O
to TO O
those DT O
described VBN O
with IN O
the DT O
previous JJ O
Cremophor NNP O
formulation NN O
although IN O
greater JJR O
variability NN O
in IN O
induction NN O
and CC O
recovery NN O
times NNS O
was VBD O
noted VBN O
with IN O
the DT O
emulsion NN O
formulation NN O
. . O

Roux NNP O
- : O
en SYM O
- : O
Y JJ O
gastroenterostomy NN O
severely RB O
disturbs JJ O
emptying NN O
of IN O
the DT O
gallbladder NN O
. . O

The DT O
bactericidal JJ O
effect NN O
of IN O
disinfectants NNS O
against IN O
biofilm NN O
cells NNS O
was VBD O
found VBN O
to TO O
be VB O
considerably RB O
enhanced VBN O
by IN O
increasing VBG O
the DT O
concentrations NNS O
of IN O
the DT O
disinfectants NNS O
. . O

To TO O
evaluate VB O
the DT O
cost NN O
and CC O
benefits NNS O
of IN O
screening VBG O
tests NNS O
for IN O
Chlamydia NNP O
trachomatis NN O
in IN O
adolescent JJ O
males NNS O
, , O
we PRP O
developed VBD O
a DT O
decision NN O
analysis NN O
model NN O
and CC O
compared VBN O
the DT O
leukocyte NN B-Gene
esterase NN I-Gene
urine JJ O
dipstick JJ O
test NN O
with IN O
culture NN O
, , O
with IN O
direct JJ O
- : O
smear JJ O
fluorescent NN O
antibody NN O
( ( O
DFA NNP O
) ) O
, , O
and CC O
with IN O
the DT O
option NN O
of IN O
no DT O
screening NN O
( ( O
no DT O
treatment NN O
) ) O
. . O

There EX O
were VBD O
122 CD O
cases NNS O
of IN O
tuberculosis NN O
over IN O
an DT O
average JJ O
10 CD O
. . O
3 CD O
yr NN O
of IN O
follow JJ O
- : O
up RB O
( ( O
crude JJ O
annual JJ O
incidence NN O
, , O
76 CD O
. . O
2 CD O
/ JJ O
100 CD O
, , O
0 CD O
) ) O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
role NN O
of IN O
two CD O
recombination NN O
- : O
and CC O
repair VB O
- : O
defective JJ O
mutations NNS O
, , O
rad1 NN B-Gene
and CC O
rad52 NN B-Gene
, , O
on IN O
direct JJ O
repeat NN O
recombination NN O
in IN O
transcriptionally RB O
active JJ O
and CC O
inactive JJ O
sequences NNS O
. . O

The DT O
Caenorhabditis NNP B-Gene
elegans VBZ I-Gene
death NN I-Gene
susceptibility NN I-Gene
gene NN I-Gene
, , O
ced VBD B-Gene
- : I-Gene
3 CD I-Gene
, , O
has VBZ O
a DT O
number NN O
of IN O
homologs NNS O
in IN O
vertebrate NN O
species NNS O
, , O
including VBG O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
) ) I-Gene
- : I-Gene
converting VBG I-Gene
enzyme NN I-Gene
( ( O
ICE NNP B-Gene
) ) O
, , O
Ich NNP B-Gene
- : I-Gene
1long CD I-Gene
, , O
and CC O
CPP32 NNP B-Gene
. . O

Our PRP$ O
results NNS O
establish VB O
GKLF NNP B-Gene
as IN O
a DT O
sequence NN O
- : O
specific JJ O
transcription NN O
factor NN O
likely RB O
involved VBN O
in IN O
regulation NN O
of IN O
expression NN O
of IN O
endogenous JJ O
genes NNS O
. . O

Experiments NNS O
with IN O
epitope JJ O
- : O
tagged VBD O
proteins NNS O
show VBP O
that IN O
UEV1A NNP B-Gene
is VBZ O
a DT O
nuclear JJ O
protein NN O
, , O
whereas IN O
both DT O
Kua NNP B-Gene
and CC O
Kua NNP B-Gene
- : O
UEV NN B-Gene
localize NN O
to TO O
cytoplasmic VB O
structures NNS O
, , O
indicating VBG O
that IN O
the DT O
Kua NNP B-Gene
domain NN I-Gene
determines VBZ O
the DT O
cytoplasmic JJ O
localization NN O
of IN O
Kua NNP B-Gene
- : O
UEV NN B-Gene
. . O

Mn2 NNP O
+ NN O
increased VBD O
both DT O
the DT O
junction NN O
binding NN O
and CC O
cleaving VBG O
activities NNS O
of IN O
the DT O
mutant JJ O
proteins NNS O
. . O

At IN O
the DT O
genomic JJ O
level NN O
, , O
the DT O
sequences NNS O
of IN O
two CD O
members NNS O
of IN O
this DT O
family NN O
are VBP O
known VBN O
in IN O
the DT O
rat NN O
Rattus NNP O
norvegicus NN O
: : O
the DT O
VCSA1 NNP B-Gene
gene NN I-Gene
, , O
encoding VBG O
the DT O
prohormone NN B-Gene
- : I-Gene
like IN I-Gene
polypeptide NN I-Gene
SMR1 NNP I-Gene
, , O
and CC O
the DT O
VCSB1 NNP B-Gene
gene NN I-Gene
, , O
encoding VBG O
a DT O
salivary JJ O
Pro NNP O
- : O
rich JJ O
polypeptide NN O
. . O

It PRP O
was VBD O
not RB O
possible JJ O
to TO O
study VB O
the DT O
basis NN O
for IN O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
this DT O
gene NN O
, , O
because IN O
the DT O
beta NN B-Gene
3 CD I-Gene
gene NN I-Gene
promoter NN I-Gene
had VBD O
not RB O
been VBN O
isolated VBN O
previously RB O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
rAAV NN O
- : O
mediated VBN O
gene NN O
transfer NN O
system NN O
for IN O
the DT O
rat NN B-Gene
preproinsulin NN I-Gene
II NNP I-Gene
gene NN I-Gene
. . O

No DT O
significant JJ O
differences NNS O
could MD O
be VB O
seen VBN O
in IN O
response NN O
rates NNS O
according VBG O
to TO O
the DT O
concentration NN O
of IN O
estrogen NN B-Gene
receptors NNS I-Gene
or CC O
presence NN O
of IN O
progesteron NN B-Gene
receptors NNS I-Gene
in IN O
this DT O
group NN O
of IN O
patients NNS O
. . O

These DT O
results NNS O
suggested VBD O
the DT O
possibility NN O
that IN O
the DT O
fetus NN O
played VBD O
some DT O
role NN O
in IN O
the DT O
production NN O
of IN O
E3 NNP O
- : O
16 CD O
- : O
G NN O
in IN O
early JJ O
pregnancy NN O
. . O

Serine JJ O
528 CD O
is VBZ O
phosphorylated VBN O
in IN O
vivo NN O
in IN O
several JJ O
cell NN O
lines NNS O
, , O
and CC O
substitution NN O
of IN O
serine NN O
528 CD O
to TO O
alanine VB O
( ( O
S528A NNP O
) ) O
resulted VBD O
in IN O
an DT O
increased JJ O
ability NN O
of IN O
Myb NNP B-Gene
to TO O
transactivate VB O
a DT O
synthetic JJ O
promoter NN O
containing VBG O
five CD O
copies NNS O
of IN O
the DT O
mim NN B-Gene
- : I-Gene
1A CD I-Gene
Myb NNP B-Gene
- : O
responsive JJ O
element NN O
and CC O
a DT O
minimal JJ O
herpes NNS B-Gene
tk VBP I-Gene
promoter NN I-Gene
. . O

Viral NNP O
cell NN O
- : O
to TO O
- : O
cell NN O
movement NN O
of IN O
PVX NNP B-Gene
CP NNP I-Gene
mutant NN I-Gene
was VBD O
complemented VBN O
in IN O
Nicotiana NNP O
tabacum NN O
cv NN O
. . O

Karger NNP O
AG NNP O
, , O
Basel NNP O

The DT O
MPS1 NNP B-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
has VBZ O
been VBN O
fused VBN O
to TO O
those DT O
that WDT O
encode VBP O
the DT O
LexA NNP B-Gene
protein NN I-Gene
or CC O
the DT O
GST NNP B-Gene
protein NN I-Gene
and CC O
both DT O
of IN O
these DT O
constructs NNS O
function NN O
in IN O
yeast NN O
. . O

We PRP O
investigated VBD O
the DT O
diagnostic JJ O
value NN O
of IN O
a DT O
new JJ O
in IN O
vitro JJ O
test NN O
, , O
Pharmacia NNP O
CAP NNP O
System NNP O
( ( O
Pharmacia NNP O
Diagnostics NNP O
AB NNP O
, , O
Uppsala NNP O
, , O
Sweden NNP O
) ) O
, , O
for IN O
the DT O
quantitative JJ O
measurement NN O
of IN O
allergen NN B-Gene
- : I-Gene
specific JJ I-Gene
IgE NNP I-Gene
antibodies NNS I-Gene
by IN O
comparison NN O
with IN O
RAST NNP O
in IN O
2 CD O
groups NNS O
of IN O
patients NNS O
, , O
71 CD O
atopic NN O
and CC O
48 CD O
non JJ O
- : O
atopic NN O
. . O

Identification NN O
of IN O
eotaxin NN B-Gene
- : I-Gene
3 CD I-Gene
will MD O
further RB O
promote VB O
our PRP$ O
understanding NN O
of IN O
the DT O
control NN O
of IN O
eosinophil NN O
trafficking NN O
and CC O
other JJ O
CCR3 NNP B-Gene
- : O
mediated VBD O
biological JJ O
phenomena NN O
. . O

Heating VBG O
cells NNS O
to TO O
43 CD O
degrees NNS O
C NNP O
decreased VBD O
the DT O
amount NN O
of IN O
newly RB O
synthesized VBN O
rRNA NN O
to TO O
less JJR O
than IN O
5 CD O
% NN O
of IN O
the DT O
control NN O
level NN O
and CC O
led VBN O
to TO O
greater JJR O
than IN O
95 CD O
% NN O
inhibition NN O
of IN O
transcription NN O
termination NN O
at IN O
a DT O
region NN O
355 CD O
to TO O
362 CD O
nucleotides NNS O
downstream NN O
of IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
28S CD B-Gene
rRNA NNS I-Gene
, , O
with IN O
readthrough JJ O
continuing VBG O
into IN O
the DT O
next JJ O
transcription NN O
unit NN O
. . O

All DT O
loci NNS O
have VBP O
a DT O
similar JJ O
organization NN O
, , O
except IN O
for IN O
H1 NNP B-Gene
. . I-Gene
8 CD I-Gene
that IN O
harbors NNS O
two CD O
TcP2beta NNP B-Gene
genes NNS I-Gene
arranged VBD O
in IN O
tandem NN O
and CC O
separated VBN O
by IN O
a DT O
short JJ O
repetitive NN O
sequence NN O
, , O
named VBN O
SIRE NNP O
( ( O
short JJ O
interspersed VBN O
repetitive JJ O
element NN O
) ) O
, , O
which WDT O
is VBZ O
also RB O
found VBN O
upstream NN O
of IN O
the DT O
first JJ O
gene NN O
of IN O
the DT O
tandem NN O
and CC O
downstream NN O
of IN O
the DT O
second JJ O
. . O

Further RB O
, , O
the DT O
ability NN O
of IN O
recombinant JJ O
beta NN O
and CC O
/ NN O
or CC O
gamma NN O
chains NNS O
to TO O
function VB O
in IN O
defined JJ O
biochemical JJ O
assays NNS O
of IN O
beta NN O
gamma NN O
activity NN O
was VBD O
assessed VBN O
for IN O
membrane NN O
extracts NNS O
and CC O
supernatant JJ O
fractions NNS O
from IN O
infected VBN O
Sf9 NNP O
cells NNS O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
the DT O
rat NN O
larynx NN O
to TO O
be VB O
an DT O
important JJ O
organ NN O
in IN O
the DT O
evaluation NN O
of IN O
irritancy NN O
of IN O
inhaled JJ O
materials NNS O
. . O

The DT O
transcription NN O
factor NN O
CHOP NNP B-Gene
/ NNP O
GADD153 NNP B-Gene
gene NN O
is VBZ O
induced VBN O
by IN O
cellular JJ O
stress NN O
and CC O
is VBZ O
involved VBN O
in IN O
mediating VBG O
apoptosis NN O
. . O

Patients NNS O
with IN O
psychotropic NN O
drugs NNS O
showed VBD O
significantly RB O
higher JJR O
PRL NNP B-Gene
levels NNS O
. . O

Max NNP B-Gene
was VBD O
constantly RB O
transcribed VBN O
at IN O
a DT O
relatively RB O
low JJ O
level NN O
during IN O
cell NN O
cycle NN O
progression NN O
. . O

Patients NNS O
with IN O
apparently RB O
minor JJ O
CT NNP O
abnormalities NNS O
may MD O
have VB O
significant JJ O
epidural JJ O
disease NN O
. . O

Varieties NNS O
of IN O
envious JJ O
experience NN O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
the DT O
patch NN O
determines VBZ O
the DT O
proper JJ O
conformation NN O
of IN O
the DT O
site NN O
and CC O
thereby RB O
contributes NNS O
to TO O
recognition VB O
indirectly RB O
. . O

Model NNP O
predictions NNS O
were VBD O
in IN O
accord NN O
with IN O
the DT O
nine CD O
- : O
year NN O
survival JJ O
experience NN O
of IN O
women NNS O
in IN O
the DT O
HIP NNP O
trial NN O
, , O
and CC O
, , O
with IN O
the DT O
exception NN O
of IN O
women NNS O
40 CD O
- : O
44 CD O
years NNS O
old JJ O
, , O
with IN O
HIP NNP O
data NNS O
on IN O
18 CD O
- : O
year NN O
survival NN O
. . O

Measurements NNS O
were VBD O
done VBN O
with IN O
a DT O
commercial JJ O
haematofluorometer NN O
Buchler NNP O
ZF NNP O
which WDT O
was VBD O
calibrated VBN O
to TO O
the DT O
average JJ O
haematocrit JJ O
value NN O
of IN O
0 CD O
. . O
42 CD O
. . O

Fifty NNP O
- : O
seven CD O
patients NNS O
aged VBN O
< JJ O
55 CD O
years NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
( ( O
ALL DT O
) ) O
in IN O
second JJ O
or CC O
third JJ O
bone NN O
marrow NN O
( ( O
BM NNP O
) ) O
relapse NN O
or CC O
refractory NN O
to TO O
first VB O
- : O
line NN O
therapy NN O
were VBD O
enrolled VBN O
in IN O
an DT O
Italian JJ O
cooperative NN O
study NN O
. . O

Organisms NNS O
were VBD O
not RB O
observed VBN O
in IN O
the DT O
5 CD O
bobcats NNS O
trapped VBN O
in IN O
2 CD O
other JJ O
counties NNS O
. . O

Workers NNS O
with IN O
"""" JJ O
sensitivity NN O
"""" NN O
to TO O
toluene VB O
diisocyanate NN O
( ( O
TDI NNP O
) ) O
studied VBD O
in IN O
depth NN O
in IN O
an DT O
attempt NN O
to TO O
determine VB O
mechanisms NNS O
of IN O
bronchial JJ O
hyperreactivity NN O
. . O

Induction NN O
requires VBZ O
the DT O
ACE1 NNP B-Gene
gene NN I-Gene
product NN I-Gene
, , O
which WDT O
binds VBZ O
to TO O
specific VB O
sites NNS O
in IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
CUP1 NNP B-Gene
gene NN I-Gene
. . O

During IN O
the DT O
1980 CD O
' POS O
s NN O
, , O
quantifications NNS O
of IN O
immunoserological JJ O
testings NNS O
, , O
especially RB O
C NNP B-Gene
reactive JJ I-Gene
protein NN I-Gene
, , O
rheumatoid JJ B-Gene
factor NN I-Gene
and CC O
antistreptolysin NN B-Gene
O NNP I-Gene
, , O
progressed VBD O
rapidly RB O
. . O

D NNP O
. . O

Although IN O
no DT O
Rh NNP B-Gene
- : I-Gene
antibodies NNS I-Gene
were VBD O
demonstrable JJ O
, , O
a DT O
similar JJ O
mechanism NN O
can MD O
be VB O
postulated VBN O
for IN O
the DT O
Rh NNP O
- : O
system NN O
. . O

They PRP O
include VBP O
genes NNS O
encoding VBG O
three CD O
subunits NNS O
of IN O
the DT O
cytochrome JJ B-Gene
oxidase NN I-Gene
( ( O
cox1 NN B-Gene
to TO I-Gene
3 CD I-Gene
) ) O
, , O
apocytochrome JJ B-Gene
b NN I-Gene
( ( O
cob NN B-Gene
) ) O
, , O
seven CD O
subunits NNS O
of IN O
the DT O
NADH NNP B-Gene
dehydrogenase NN I-Gene
complex NN I-Gene
( ( O
nad1 UH B-Gene
to TO I-Gene
6 CD I-Gene
, , O
nad4L NN B-Gene
) ) O
, , O
two CD O
ATPase NNP B-Gene
subunits NNS O
( ( O
atp6 NN B-Gene
and CC O
atp9 NN B-Gene
) ) O
, , O
three CD O
ribosomal JJ O
RNAs NNP O
( ( O
rrn5 NN B-Gene
, , O
srn NN B-Gene
and CC O
lrn NN B-Gene
) ) O
, , O
23 CD O
tRNAs NN O
and CC O
four CD O
ribosomal NN O
proteins NNS O
( ( O
rps3 NN B-Gene
, , O
rps11 NN B-Gene
, , O
rps12 NN B-Gene
and CC O
rpl16 NN B-Gene
) ) O
. . O

Mutating VBG O
the DT O
E NNP O
- : O
box NN O
in IN O
the DT O
context NN O
of IN O
the DT O
3 CD O
' POS O
- : O
flanking VBG O
region NN O
confirmed VBD O
that IN O
it PRP O
contributes VBZ O
to TO O
the DT O
enhancement NN O
of IN O
transcriptional JJ O
activity NN O
of IN O
the DT O
alpha1 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
collagen NN I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

The DT O
average JJ O
birth JJ O
mass NN O
of IN O
these DT O
newborns NNS O
was VBD O
3491 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
2 CD O
SD NNP O
780 CD O
. . O
5 CD O
g NN O
and CC O
that IN O
in IN O
the DT O
control NN O
group NN O
3 CD O
, , O
767 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
2 CD O
SD NNP O
824 CD O
. . O
2 CD O
g NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Further JJ O
observations NNS O
on IN O
resorption NN O
in IN O
guinea NN O
pigs NNS O
following VBG O
injections NNS O
of IN O
trypan NN O
blue NN O
. . O

Endotoxemia NN O
induced VBN O
by IN O
gram JJ O
- : O
negative JJ O
bacteria NNS O
leads VBZ O
to TO O
endotoxic VB O
shock NN O
pathogenetically RB O
stemming VBG O
from IN O
the DT O
integral JJ O
component NN O
of IN O
the DT O
bacterial JJ O
wall NN O
- : O
- : O
lipid VBZ O
A DT O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
conservation NN O
of IN O
nucleotides NNS O
154 CD O
to TO O
156 CD O
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
consequence NN O
of IN O
their PRP$ O
role NN O
as IN O
a DT O
sequence NN O
- : O
specific JJ O
recognition NN O
element NN O
for IN O
the DT O
SRP54 NNP B-Gene
protein NN I-Gene
. . O

The DT O
indications NNS O
for IN O
its PRP$ O
use NN O
include VBP O
every DT O
primary JJ O
and CC O
secondary JJ O
rhinoplasty NN O
candidate NN O
unless IN O
tip JJ O
grafts NNS O
are VBP O
going VBG O
to TO O
be VB O
under IN O
tension NN O
or CC O
if IN O
the DT O
deformity NN O
is VBZ O
minor JJ O
. . O

Cardiac NNP O
output NN O
( ( O
CO NNP O
) ) O
was VBD O
significantly RB O
higher JJR O
( ( O
p IN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
in IN O
the DT O
MBBF NNP O
group NN O
. . O

Rabbit NNP B-Gene
skeletal JJ I-Gene
muscle NN I-Gene
glycogenin NN I-Gene
. . O

After IN O
i NN O
. . O
v NN O
. . O
administration NN O
of IN O
500 CD O
mg NNS O
acetazolamide RB O
and CC O
disinfection NN O
of IN O
the DT O
conjunctiva NN O
, , O
50 CD O
micrograms NNS O
rt VBP B-Gene
- : I-Gene
PA NN I-Gene
in IN O
0 CD O
. . O
1 CD O
ml NN O
( ( O
BSS NNP O
) ) O
and CC O
0 CD O
. . O
5 CD O
ml JJ O
SF6 NNP O
were VBD O
injected VBN O
intravitreally RB O
. . O

At IN O
least JJS O
some DT O
of IN O
the DT O
difference NN O
in IN O
stability NN O
of IN O
the DT O
two CD O
kinds NNS O
of IN O
complexes NNS O
was VBD O
due JJ O
to TO O
the DT O
fact NN O
that IN O
the DT O
dissociation NN O
rate NN O
of IN O
the DT O
A NNP O
stem NN O
substrate NN O
from IN O
the DT O
protein NN O
- : O
DNA NN O
complexes NNS O
was VBD O
approximately RB O
fourfold JJ O
faster JJR O
than IN O
that DT O
of IN O
the DT O
complete JJ O
TR NNP B-Gene
. . O

An DT O
interaction NN O
screen NN O
with IN O
the DT O
repression NN O
domain NN O
of IN O
the DT O
orphan JJ B-Gene
receptor NN I-Gene
RevErb NNP I-Gene
identified VBD O
N NNP B-Gene
- : I-Gene
CoR NN I-Gene
, , O
the DT O
corepressor NN O
for IN O
thyroid JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
( ( O
TR NNP B-Gene
) ) O
and CC O
retinoic JJ B-Gene
acid NN I-Gene
receptor NN I-Gene
( ( O
RAR NNP B-Gene
) ) O
. . O

No DT O
homologs NN O
of IN O
other JJ O
members NNS O
of IN O
the DT O
Surfeit NNP B-Gene
gene NN I-Gene
cluster NN I-Gene
were VBD O
detected VBN O
in IN O
close JJ O
proximity NN O
to TO O
the DT O
D NNP O
. . O
melanogaster NN O
Surf NNP B-Gene
- : I-Gene
3 CD I-Gene
/ JJ O
rpL7a NN B-Gene
gene NN O
. . O

The DT O
radial JJ O
forearm NN O
flap NN O
is VBZ O
used VBN O
most RBS O
commonly RB O
, , O
however RB O
the DT O
lateral JJ O
arm NN O
flap NN O
may MD O
be VB O
the DT O
flap NN O
of IN O
choice NN O
in IN O
certain JJ O
situations NNS O
. . O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
isolation NN O
of IN O
MdPin1 NNP B-Gene
, , O
a DT O
Pin1 NNP B-Gene
homologue NN O
from IN O
the DT O
plant NN O
species NNS O
apple NN O
( ( O
Malus NNP O
domestica NN O
) ) O
and CC O
show VBP O
that IN O
it PRP O
has VBZ O
the DT O
same JJ O
phosphorylation NN O
- : O
specific JJ O
substrate JJ O
specificity NN O
and CC O
can MD O
be VB O
inhibited VBN O
by IN O
juglone NN O
in IN O
vitro NN O
, , O
as IN O
is VBZ O
the DT O
case NN O
for IN O
Pin1 NNP B-Gene
. . O

In IN O
ICU NNP O
patients NNS O
, , O
the DT O
LIS NNP O
related VBN O
to TO O
the DT O
postoperative JJ O
rise NN O
in IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
level NN O
only RB O
, , O
even RB O
though IN O
the DT O
rise NN O
in IN O
plasma JJ O
concentrations NNS O
of IN O
cytokines NNS O
interrelated VBN O
. . O

As IN O
hGM JJ B-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
( ( O
hGMR NN B-Gene
) ) O
does VBZ O
not RB O
contain VB O
a DT O
consensus NN O
sequence NN O
for IN O
binding NN O
of IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
, , O
hGMR NN B-Gene
must MD O
use VB O
a DT O
distinct JJ O
mechanism NN O
for IN O
its PRP$ O
association NN O
with IN O
and CC O
activation NN O
of IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

Familial NNP O
autoimmune NN O
hepatitis NN O
and CC O
C4 NNP B-Gene
deficiency NN O

Administration NN O
of IN O
anticoagulants NNS O
, , O
i NN O
. . O
e NN O
. . O
, , O
heparin NN O
, , O
prostaglandin NN O
E1 NNP O
and CC O
ticlopidine NN O
seems VBZ O
to TO O
be VB O
effective JJ O
in IN O
alleviating VBG O
symptoms NNS O
and CC O
might MD O
prevent VB O
further JJ O
deterioration NN O
. . O

Furthermore RB O
, , O
although IN O
the DT O
regional JJ O
distribution NN O
of IN O
lean JJ O
tissue NN O
mass NN O
in IN O
the DT O
trunk NN O
and CC O
legs NNS O
remained VBD O
fairly RB O
constant JJ O
at IN O
different JJ O
pubertal JJ O
stages NNS O
, , O
the DT O
regional JJ O
distribution NN O
of IN O
fat NN O
was VBD O
altered VBN O
significantly RB O
, , O
becoming VBG O
more RBR O
central JJ O
and CC O
less RBR O
peripheral JJ O
. . O

Transcriptional JJ O
activation NN O
by IN O
thyroid JJ O
hormone NN O
( ( O
T3 NNP O
) ) O
requires VBZ O
interactions NNS O
between IN O
the DT O
T3 NNP B-Gene
receptor NN I-Gene
( ( O
TR NNP B-Gene
) ) O
and CC O
T3 NNP O
response NN O
elements NNS O
( ( O
TREs NNP O
) ) O
composed VBD O
of IN O
two CD O
copies NNS O
of IN O
sequences NNS O
related VBN O
to TO O
AGGTCA NNP O
. . O

Molecular JJ O
cloning NN O
of IN O
human JJ O
cDNA NN O
encoding VBG O
a DT O
novel JJ O
beta1 NN B-Gene
, , I-Gene
6 CD I-Gene
- : I-Gene
N NNP I-Gene
- : I-Gene
acetylglucosaminyltransferase NN I-Gene
forming VBG O
core NN O
2 CD O
and CC O
core VBD O
4 CD O
. . O

The DT O
calcium NN O
ratio NN O
( ( O
mean JJ O
ratio NN O
of IN O
the DT O
predicted VBN O
to TO O
measured VB O
TBCa NNP O
) ) O
in IN O
men NNS O
was VBD O
1 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
7 CD O
. . O
8 CD O
% NN O
and CC O
in IN O
women NNS O
0 CD O
. . O
996 CD O
+ JJ O
/ NNP O
- : O
7 CD O
. . O
1 CD O
% NN O
. . O

The DT O
evidence NN O
presented VBD O
here RB O
suggests VBZ O
that IN O
the DT O
p40 NN B-Gene
complex NN I-Gene
is VBZ O
a DT O
ribonucleoprotein NN O
complex JJ O
containing VBG O
L1Hs NNP B-Gene
RNA NNP I-Gene
( ( I-Gene
s NN I-Gene
) ) I-Gene
and CC O
that IN O
protein SYM O
- : O
protein NN O
interactions NNS O
in IN O
which WDT O
alpha VBP O
- : O
helix NN O
structures NNS O
participate VBP O
, , O
for IN O
example NN O
coiled VBD O
- : O
coils NNS O
, , O
may MD O
occur VB O
in IN O
the DT O
complex NN O
. . O

The DT O
distribution NN O
of IN O
the DT O
various JJ O
repeats NNS O
suggests VBZ O
its PRP$ O
organization NN O
is VBZ O
similar JJ O
to TO O
the DT O
beta NN O
- : O
heterochromatic JJ O
regions NNS O
near IN O
the DT O
base NN O
of IN O
the DT O
major JJ O
chromosome NN O
arms NNS O
. . O

Developmental NNP O
follow SYM O
- : O
up RB O
at IN O
age NN O
2 CD O
years NNS O
was VBD O
performed VBN O
. . O

FLP NNP B-Gene
and CC O
Cre NNP B-Gene
recombinase NN I-Gene
function NN O
in IN O
Xenopus NNP O
embryos NN O
. . O

The DT O
deduced JJ O
amino NN O
acid JJ O
sequences NNS O
of IN O
each DT O
of IN O
the DT O
W3A1 NNP B-Gene
ETF NNP I-Gene
subunits VBZ I-Gene
exhibit NN O
only RB O
approximately RB O
30 CD O
% NN O
identity NN O
with IN O
the DT O
corresponding VBG O
subunits NNS O
of IN O
the DT O
ETF NNP B-Gene
from IN O
human JJ O
, , O
rat NN O
, , O
and CC O
Paracoccus NNP O
denitrificans NNS O
, , O
which WDT O
as IN O
a DT O
group NN O
are VBP O
greater JJR O
than IN O
50 CD O
% NN O
identical JJ O
. . O

Cutis NNP O
aplasia NN O
. . O

The DT O
deduced JJ O
amino NN O
acid NN O
sequence NN O
was VBD O
highly RB O
conserved VBN O
across IN O
the DT O
wide JJ O
range NN O
of IN O
eukaryotes NNS O
( ( O
vertebrates NNS O
, , O
invertebrates NNS O
, , O
fungi NNS O
, , O
plants NNS O
and CC O
protozoa NN O
) ) O
in IN O
which WDT O
this DT O
gene NN O
has VBZ O
now RB O
been VBN O
identified VBN O
. . O

The DT O
SEN1 NNP B-Gene
gene NN I-Gene
corresponds NNS O
to TO O
a DT O
6 CD O
, , O
336 CD O
- : O
bp NN O
open JJ O
reading NN O
frame NN O
coding VBG O
for IN O
a DT O
2 CD O
, , O
112 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
( ( O
molecular JJ O
mass NN O
, , O
239 CD O
kDa NN O
) ) O
. . O

Disturbance NN O
of IN O
regeneration NN O
in IN O
the DT O
above JJ O
pathological JJ O
condition NN O
results NNS O
from IN O
the DT O
damage NN O
to TO O
tunica VB O
propria NNS O
and CC O
loss NN O
of IN O
its PRP$ O
function NN O
for IN O
the DT O
support NN O
of IN O
structural JJ O
homeostasis NN O
. . O

From IN O
day NN O
10 CD O
, , O
a DT O
significant JJ O
increase NN O
in IN O
platelet NN O
count NN O
was VBD O
observed VBN O
in IN O
eight CD O
of IN O
the DT O
ten JJ O
patients NNS O
treated VBN O
with IN O
heparin NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
, , O
with IN O
return NN O
to TO O
the DT O
initial JJ O
value NN O
after IN O
heparin JJ O
cessation NN O
in IN O
six CD O
of IN O
the DT O
responders NNS O
. . O

Importance NN O
of IN O
determining VBG O
the DT O
blood NN O
sulfhydryl NN O
groups NNS O
in IN O
fractures NNS O
of IN O
the DT O
long JJ O
tubular JJ O
bones NNS O
complicated VBN O
by IN O
infection NN O

The DT O
relationship NN O
of IN O
human JJ O
umbilical JJ O
arterial NN O
and CC O
venous JJ O
plasma NN O
levels NNS O
of IN O
corticosteroids NNS O
to TO O
gestational JJ O
age NN O
. . O

A DT O
total JJ O
number NN O
of IN O
1628 CD O
cases NNS O
were VBD O
collected VBN O
from IN O
135 CD O
medical JJ O
institutions NNS O
. . O

Ten CD O
patients NNS O
with IN O
advanced JJ O
, , O
diffuse RB O
Hodgkin NNP O
' POS O
s NN O
and CC O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphomas NN O
responding VBG O
poorly RB O
to TO O
the DT O
most RBS O
widely RB O
employed VBN O
primary JJ O
chemotherapy NN O
regimens NNS O
were VBD O
treated VBN O
with IN O
a DT O
high JJ O
- : O
dose NN O
chemotherapy NN O
( ( O
HDC NNP O
) ) O
followed VBN O
by IN O
rescue NN O
with IN O
non JJ O
- : O
frozen RB O
autologous JJ O
bone NN O
marrow NN O
infusion NN O
( ( O
ABMT NNP O
) ) O
. . O

When WRB O
overexpressed VBN O
in IN O
an DT O
appropriate JJ O
cell NN O
line NN O
, , O
TAN NNP B-Gene
- : I-Gene
1C CD I-Gene
prevented VBD O
kappa NN B-Gene
B NNP I-Gene
- : O
dependent JJ O
transactivation NN O
in IN O
transient JJ O
reporter NN O
gene NN O
assays NNS O
in IN O
a DT O
fashion NN O
similar JJ O
to TO O
the DT O
structurally RB O
related JJ O
protein NN O
, , O
Bcl NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
NZ NNP O
- : O
107 CD O
may MD O
be VB O
a DT O
useful JJ O
drug NN O
for IN O
the DT O
treatment NN O
of IN O
bronchial JJ O
asthma NN O
by IN O
reducing VBG O
late JJ O
- : O
phase NN O
airway NN O
responses NNS O
and CC O
airway JJ O
hyperreactivity NN O
. . O

Temafloxacin $ O
400 CD O
mg NN O
b NN O
. . O
i NN O
. . O
d NN O
. . O
administered VBN O
orally RB O
for IN O
28 CD O
days NNS O
represents VBZ O
a DT O
safe JJ O
and CC O
effective JJ O
treatment NN O
for IN O
chronic JJ O
bacterial JJ O
prostatitis NN O
. . O

All DT O
8 CD O
( ( O
100 CD O
% NN O
) ) O
patients NNS O
with IN O
fulminant JJ O
hepatic JJ O
failure NN O
who WP O
received VBD O
grafts NNS O
survived VBD O
, , O
including VBG O
3 CD O
who WP O
received VBD O
ABO NNP O
- : O
incompatible JJ O
grafts NNS O
, , O
though IN O
2 CD O
of IN O
these DT O
subsequently RB O
required VBN O
retransplantation NN O
. . O

No DT O
local JJ O
destruction NN O
by IN O
tumor NN O
or CC O
infection NN O
could MD O
be VB O
demonstrated VBN O
apart RB O
from IN O
HIV NNP O
infection NN O
. . O

Hovenitin NNP O
I PRP O
and CC O
( ( O
+ NN O
) ) O
- : O
ampelopsin NN O
, , O
both DT O
of IN O
which WDT O
were VBD O
principal JJ O
ingredients NNS O
of IN O
the DT O
active JJ O
fractions NNS O
from IN O
this DT O
natural JJ O
medicine NN O
, , O
were VBD O
found VBN O
to TO O
show VB O
an DT O
inhibitory JJ O
activity NN O
on IN O
the DT O
ethanol JJ O
- : O
induced JJ O
muscle NN O
relaxation NN O
in IN O
rats NNS O
. . O

These DT O
results NNS O
indicate VBP O
that DT O
inhibition NN O
of IN O
Jun NNP B-Gene
kinase NNP I-Gene
activation NN O
was VBD O
sufficient JJ O
to TO O
inhibit VB O
Ras NNP B-Gene
transformation NN O
even RB O
in IN O
the DT O
presence NN O
of IN O
activated JJ O
Erk NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

The DT O
10 CD O
kDa NNS O
polypeptide NN O
was VBD O
phosphorylated VBN O
in IN O
vitro NN O
by IN O
incubating VBG O
wheat NN O
etioplast JJ O
membranes NNS O
with IN O
[ NNP O
gamma VBP O
32P CD O
] JJ O
ATP NNP O
. . O

Karger NNP O
AG NNP O
, , O
Basel NNP O

In IN O
contrast NN O
, , O
H NNP B-Gene
- : I-Gene
NS NNP I-Gene
negative JJ O
regulation NN O
operated VBD O
only RB O
in IN O
the DT O
absence NN O
of IN O
Fur NNP B-Gene
. . O

The DT O
intensity NN O
of IN O
the DT O
SSTEs NNP O
is VBZ O
an DT O
order NN O
of IN O
magnitude NN O
larger JJR O
than IN O
that DT O
of IN O
the DT O
MSEs NNP O
and CC O
determines VBZ O
the DT O
signal JJ O
contrast NN O
if IN O
both DT O
effects NNS O
are VBP O
selected VBN O
simultaneously RB O
. . O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
PhLP NNP B-Gene
complexes NNS O
, , O
at IN O
least JJS O
partially RB O
, , O
with IN O
Gbetagamma NNP B-Gene
in IN O
vivo NN O
. . O

The DT O
Genescan NNP O
program NN O
predicted VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
a DT O
novel NN O
, , O
intron SYM O
- : O
less RBR O
gene NN O
adjacent JJ O
to TO O
the DT O
B236 NNP O
spot NN O
that WDT O
encodes VBZ O
a DT O
putative JJ O
493 CD O
- : O
amino NN O
acid JJ O
protein NN O
containing VBG O
the DT O
SNAG NNP O
repressor NN O
motif NN O
in IN O
the DT O
NH2 NNP O
- : O
terminal JJ O
region NN O
and CC O
five CD O
C2H2 NNP O
- : O
type NN O
zinc NN O
finger NN O
motifs NNS O
in IN O
the DT O
COOH NNP O
- : O
terminal JJ O
half NN O
. . O

These DT O
different JJ O
observations NNS O
exclude VBP O
a DT O
heterozygosity NN O
of IN O
the DT O
A NNP O
- : O
- : O
> NN O
G NNP O
mutation NN O
at IN O
codon NN O
beta NN O
77 CD O
, , O
as RB O
well RB O
as IN O
a DT O
deletion NN O
comparable JJ O
to TO O
that DT O
of IN O
Hbs NNP B-Gene
Lepore NNP I-Gene
or CC I-Gene
Kenya NNP I-Gene
, , O
or CC O
a DT O
beta JJ B-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
duplication NN O
, , O
and CC O
point NN O
to TO O
a DT O
nontraditional JJ O
inheritance NN O
of IN O
Hb NNP B-Gene
Costa NNP I-Gene
Rica NNP I-Gene
. . O

In IN O
the DT O
first JJ O
, , O
homologous JJ O
sequences NNS O
were VBD O
deleted VBN O
from IN O
a DT O
mouse NN O
enhancer NN O
, , O
resulting VBG O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
loss NN O
of IN O
activity NN O
when WRB O
assayed VBN O
in IN O
transgenic JJ O
mice NN O
. . O

Deletion NN O
of IN O
the DT O
RVH NNP B-Gene
domain NN I-Gene
resulted VBD O
in IN O
loss NN O
of IN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
dependent JJ O
activation NN O
. . O

Concomitantly RB O
, , O
p34CDC2 VB B-Gene
histone NN B-Gene
H1 NNP I-Gene
kinase NN O
activity NN O
increases NNS O
in IN O
the DT O
former JJ O
, , O
but CC O
not RB O
in IN O
the DT O
latter NN O
cell NN O
lines NNS O
, , O
hence RB O
suggesting VBG O
a DT O
role NN O
for IN O
this DT O
protein NN O
in IN O
radiation NN O
- : O
induced VBN O
cell NN O
death NN O
. . O

DAF NNP B-Gene
is VBZ O
a DT O
70 CD O
kD NN O
glycoprotein NN O
containing VBG O
complement JJ O
regulatory JJ O
short JJ O
consensus NN O
repeats NNS O
( ( O
SCRs NNP O
) ) O
; : O
its PRP$ O
gene NN O
is VBZ O
located VBN O
in IN O
the DT O
regulation NN B-Gene
of IN I-Gene
complement JJ I-Gene
activation NN I-Gene
( ( O
RCA NNP B-Gene
) ) O
gene NN O
cluster NN O
on IN O
chromosome NN O
1 CD O
and CC O
is VBZ O
about RB O
40 CD O
kb NNS O
in IN O
size NN O
. . O

In IN O
eukaryotic JJ O
cells NNS O
, , O
premature JJ O
termination NN O
of IN O
translation NN O
at IN O
nonsense JJ O
codons NNS O
has VBZ O
been VBN O
implicated VBN O
as IN O
the DT O
cause NN O
of IN O
a DT O
variety NN O
of IN O
posttranscriptional JJ O
events NNS O
, , O
including VBG O
rapid JJ O
mRNA NN O
decay NN O
in IN O
the DT O
cytoplasm NN O
or CC O
the DT O
nucleus NN O
, , O
altered VBD O
splice NN O
site NN O
selection NN O
, , O
and CC O
exon RB O
skipping NN O
. . O

At IN O
necropsy RB O
28 CD O
days NNS O
post SYM O
- : O
inoculation NN O
, , O
F344 NNP O
rats NNS O
had VBD O
no DT O
gross JJ O
lung NN O
lesions NNS O
, , O
even RB O
those DT O
given VBN O
the DT O
maximum JJ O
dose NN O
of IN O
1 CD O
. . O
4 CD O
X JJ O
10 CD O
( ( O
9 CD O
) ) O
colony NN O
- : O
forming VBG O
units NNS O
of IN O
M NNP O
. . O
pulmonis NN O
. . O

CONCLUSIONS NNP O
AND NNP O
CLINICAL NNP O
RELEVANCE NNP O
: : O
Increased VBD O
cortical JJ O
thickness NN O
and CC O
geometric JJ O
properties NNS O
of IN O
left NN O
MCB NNP O
- : O
IV NN O
and CC O
- : O
V NN O
of IN O
Greyhounds NNP O
, , O
together RB O
with IN O
altered VBN O
turnover NN O
and CC O
orientation NN O
of IN O
osteons NNS O
in IN O
the DT O
dorsal NN O
quadrants NNS O
of IN O
left JJ O
MCB NNP O
, , O
are VBP O
site NN O
- : O
specific JJ O
adaptive JJ O
responses NNS O
associated VBN O
with IN O
asymmetric JJ O
cyclic JJ O
loading NN O
as IN O
a DT O
result NN O
of IN O
racing VBG O
on IN O
circular JJ O
tracks NNS O
. . O

Are NNP O
low JJ O
P300 NNP O
amplitudes VBZ O
a DT O
marker NN O
for IN O
schizophrenia NN O
. . O

Northern NNP O
blot NN O
analysis NN O
revealed VBD O
the DT O
expression NN O
of IN O
LIMK NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
predominantly RB O
in IN O
the DT O
brain NN O
and CC O
the DT O
expression NN O
of IN O
LIMK NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
in IN O
various JJ O
tissues NNS O
in IN O
the DT O
rat NN O
. . O

However RB O
, , O
the DT O
N63S NNP O
mutation NN O
in IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
VP5 NNP I-Gene
background NN O
increased VBD O
the DT O
interaction NN O
, , O
as IN O
judged VBN O
by IN O
the DT O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
activity NN O
, , O
by IN O
a DT O
factor NN O
of IN O
9 CD O
relative JJ O
to TO O
when WRB O
the DT O
PR7 NNP O
mutation NN O
was VBD O
present JJ O
. . O

A DT O
constitutive JJ O
mutant JJ O
form NN O
with IN O
a DT O
single JJ O
substitution NN O
( ( O
V88A NNP O
) ) O
in IN O
the DT O
amino NN O
- : O
terminal NN O
( ( O
response NN O
regulator NN O
) ) O
region NN O
was VBD O
used VBN O
. . O

Clinical JJ O
trials NNS O
with IN O
1 CD O
, , O
3 CD O
- : O
bis NN O
( ( O
2 CD O
- : O
chloroethyl NN O
) ) O
- : O
1 CD O
- : O
nitrosourea NN O
, , O
NSC NNP O
- : O
409962 CD O
. . O

Because IN O
chromosome NN O
X NN O
is VBZ O
frequently RB O
involved VBN O
in IN O
structural JJ O
alterations NNS O
in IN O
neoplastic JJ O
Syrian JJ O
hamster NN O
cells NNS O
transformed VBN O
by IN O
chemical NN O
carcinogens NNS O
and CC O
oncogenic JJ O
viruses NNS O
, , O
the DT O
localization NN O
of IN O
the DT O
cph NN B-Gene
locus NN I-Gene
on IN O
this DT O
chromosome NN O
supports VBZ O
the DT O
notion NN O
that IN O
the DT O
cph NN B-Gene
oncogene NN I-Gene
plays VBZ O
a DT O
role NN O
in IN O
the DT O
malignant JJ O
conversion NN O
of IN O
chemically RB O
transformed VBN O
hamster NN O
fibroblasts NNS O
. . O

In IN O
human JJ O
brain NN O
, , O
contactin NN B-Gene
was VBD O
first RB O
identified VBN O
by IN O
amino JJ O
terminal NN O
and CC O
peptide JJ O
sequencing NN O
of IN O
the DT O
lentil JJ B-Gene
- : I-Gene
lectin NN I-Gene
- : I-Gene
binding NN I-Gene
glycoprotein NN I-Gene
Gp135 NNP I-Gene
. . O

The DT O
lymph NN O
nodes NNS O
from IN O
two CD O
of IN O
the DT O
patients NNS O
with IN O
rheumatoid JJ O
arthritis NN O
contained VBD O
numerous JJ O
sarcoid NNS O
like IN O
granulomata NN O
, , O
further RB O
indicating VBG O
a DT O
possible JJ O
association NN O
between IN O
sarcoidosis NN O
and CC O
rheumatoid JJ O
arthritis NN O
. . O

Pharmacoeconomic NNP O
assessment NN O
of IN O
HMG NNP B-Gene
- : I-Gene
CoA NNP I-Gene
reductase NN I-Gene
inhibitor NN O
therapy NN O
: : O
an DT O
analysis NN O
based VBN O
on IN O
the DT O
CURVES NNP O
study NN O
. . O

A DT O
major JJ O
mechanism NN O
by IN O
which WDT O
estrogens VBZ O
prevent NN O
osteoporosis NN O
seems VBZ O
to TO O
be VB O
repression NN O
of IN O
transcription NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
target NN I-Gene
genes NNS I-Gene
, , O
such JJ O
as IN O
the DT O
osteoclast NN O
- : O
activating VBG O
cytokines NNS O
interleukin SYM B-Gene
- : I-Gene
6 CD I-Gene
and CC O
interleukin VB B-Gene
- : I-Gene
1 CD I-Gene
. . O

It PRP O
can MD O
also RB O
be VB O
used VBN O
to TO O
examine VB O
various JJ O
laryngeal JJ O
parameters NNS O
obtained VBN O
from IN O
videotaped JJ O
endoscopic NN O
and CC O
stroboscopic NN O
examinations NNS O
. . O

Arsenic JJ O
contents NNS O
in IN O
native JJ O
copper NN O

Kidney NNP O
length NN O
did VBD O
not RB O
significantly RB O
differ VBP O
between IN O
right NN O
and CC O
left VBD O
, , O
however RB O
, , O
kidney NN O
width NN O
, , O
cortical JJ O
thickness NN O
and CC O
size NN O
did VBD O
( ( O
p VB O
< RB O
0 CD O
. . O
5 CD O
) ) O
. . O

We PRP O
also RB O
report VBP O
that IN O
AHR NNP B-Gene
interacts VBZ O
with IN O
COUP NNP B-Gene
- : I-Gene
TF NN I-Gene
in IN O
transfected JJ O
CV NNP O
- : O
1 CD O
cells NNS O
. . O

In IN O
vitro JJ O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
of IN O
the DT O
200 CD O
- : O
bp NN O
proximal JJ O
region NN O
of IN O
the DT O
promoter NN O
with IN O
a DT O
murine NN O
Hepa NNP O
1 CD O
- : O
6 CD O
cell NN O
nuclear JJ O
extract NN O
revealed VBD O
a DT O
clear JJ O
footprint NN O
of IN O
a DT O
region NN O
corresponding VBG O
to TO O
- : O
80 CD O
to TO O
- : O
28 CD O
bp NN O
of IN O
the DT O
murine NN B-Gene
fVII NN I-Gene
gene NN I-Gene
, , O
suggesting VBG O
that IN O
liver JJ O
factors NNS O
interact VBP O
with IN O
this DT O
region NN O
of IN O
the DT O
DNA NN O
. . O

We PRP O
couldn VBP O
' '' O
t JJ O
detect VBP O
any DT O
effect NN O
of IN O
n JJ O
- : O
3 CD O
FA NNP O
supplementation NN O
on IN O
total JJ O
cholesterol NN O
, , O
HDL NNP B-Gene
cholesterol NN I-Gene
, , O
LDL NNP B-Gene
cholesterol NN I-Gene
, , O
apo JJ B-Gene
A1 NNP I-Gene
, , O
Lp NNP B-Gene
( ( I-Gene
a DT I-Gene
) ) I-Gene
, , O
HbA1C NNP B-Gene
, , O
glucose NN O
, , O
fibrinogen NN B-Gene
, , O
factor NN B-Gene
VIII NNP I-Gene
, , O
antithrombin NN B-Gene
III NNP I-Gene
, , O
plasminogen NN B-Gene
activator NN I-Gene
inhibitor NN I-Gene
, , O
tissue NN B-Gene
plasminogen NN I-Gene
activator NN I-Gene
and CC O
von NN B-Gene
Willebrand NNP I-Gene
factor NN I-Gene
concentration NN O
, , O
on IN O
bleeding JJ O
time NN O
or CC O
on IN O
systolic JJ O
or CC O
diastolic JJ O
blood NN O
pressure NN O
. . O

A DT O
v JJ B-Gene
- : I-Gene
erbB SYM I-Gene
- : I-Gene
related JJ I-Gene
protooncogene NN I-Gene
, , O
c SYM B-Gene
- : I-Gene
erbB SYM I-Gene
- : I-Gene
2 CD I-Gene
, , O
is VBZ O
distinct JJ O
from IN O
the DT O
c NN B-Gene
- : I-Gene
erbB NN I-Gene
- : I-Gene
1 CD I-Gene
/ JJ O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
receptor NN I-Gene
gene NN O
and CC O
is VBZ O
amplified VBN O
in IN O
a DT O
human JJ O
salivary JJ O
gland NN O
adenocarcinoma NN O
. . O

Hypoglycemic NNP O
and CC O
antidiabetic JJ O
properties NNS O

A DT O
total NN O
of IN O
576 CD O
1 CD O
- : O
day NN O
- : O
old JJ O
Ross NNP O
broiler NN O
chicks NNS O
were VBD O
housed VBN O
in IN O
six CD O
treatment NN O
groups NNS O
[ VBP O
six CD O
replicates NNS O
of IN O
16 CD O
each DT O
; : O
control NN O
, , O
CLI NNP O
( ( O
15 CD O
g NN O
kg NN O
( ( O
- : O
1 CD O
) ) O
diet NN O
) ) O
, , O
50 CD O
parts NNS O
per IN O
billion CD O
( ( O
ppb NN O
) ) O
AF NNP B-Gene
, , O
50 CD O
ppb NN O
AF NNP B-Gene
plus CC O
CLI NNP O
, , O
100 CD O
ppb NN O
AF NNP B-Gene
, , O
100 CD O
ppb NN O
AF NNP B-Gene
plus CC O
CLI NNP O
] NNP O
for IN O
42 CD O
days NNS O
. . O

Here RB O
, , O
we PRP O
have VBP O
used VBN O
specific JJ O
antibody NN O
to TO O
identify VB O
and CC O
characterize VB O
the DT O
SSN6 NNP B-Gene
protein NN I-Gene
. . O

86 CD O
: : O
3199 CD O
- : O
3203 CD O
) ) O
or CC O
G1 NNP O
to TO O
S NNP O
phase NN O
( ( O
Reilly NNP O
, , O
C NNP O
. . O

Molecules NNS O
of IN O
NH3 NNP O
are VBP O
capable JJ O
of IN O
emitting VBG O
stimulated VBN O
radiation NN O
( ( O
MASER NNP O
) ) O
. . O

Studies NNS O
of IN O
lipogenesis NN O
by IN O
labelled JJ O
precursors NNS O
in IN O
the DT O
pregnant JJ O
rat NN O
. . O

To TO O
address VB O
these DT O
questions NNS O
, , O
a DT O
recombinant JJ O
FRAP NNP B-Gene
/ NNP O
mTOR NN B-Gene
protein NN O
and CC O
a DT O
FRAP NNP B-Gene
/ NNP O
mTOR NN B-Gene
immunoprecipitate NN O
were VBD O
utilized VBN O
in IN O
in IN O
vitro JJ O
kinase NN O
assays NNS O
to TO O
phosphorylate VB O
4E CD B-Gene
- : I-Gene
BP1 NN I-Gene
. . O

Amino NNP O
acid JJ O
sequence NN O
of IN O
one CD O
human JJ O
liver NN O
clone NN O
( ( O
HL NNP O
- : O
14 CD O
) ) O
was VBD O
identical JJ O
to TO O
the DT O
rabbit NN B-Gene
skeletal JJ I-Gene
muscle NN I-Gene
phosphatase NN I-Gene
2A CD I-Gene
cDNA NN I-Gene
( ( O
with IN O
97 CD O
% NN O
nucleotide JJ O
identity NN O
) ) O
. . O

The DT O
5 CD O
' POS O
region NN O
shows NNS O
strong JJ O
sequence NN O
similarity NN O
to TO O
Escherichia NNP O
coli NNS O
consensus NN O
promoters NNS O
and CC O
ribosome VB O
- : O
binding NN O
sequences NNS O
and CC O
allows VBZ O
high JJ O
levels NNS O
of IN O
expression NN O
in IN O
E NNP O
. . O
coli NN O
. . O

Synthetic JJ O
ligands NNS O
have VBP O
been VBN O
identified VBN O
that IN O
reset NN O
and CC O
amplify VB O
the DT O
cycle NN O
of IN O
pulsatile JJ O
GH NNP B-Gene
secretion NN O
by IN O
interacting VBG O
with IN O
the DT O
orphan NN B-Gene
GH NNP I-Gene
- : I-Gene
secretagogue NN I-Gene
receptor NN I-Gene
( ( O
GHS NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
. . O

This DT O
L NNP B-Gene
- : I-Gene
myc NN I-Gene
sequence NN I-Gene
is VBZ O
amplified VBN O
10 CD O
- : O
20 CD O
- : O
fold NN O
in IN O
four CD O
SCLC NNP O
cell NN O
line NN O
DNAs NNP O
and CC O
in IN O
one CD O
SCLC NNP O
tumour NN O
specimen NNS O
taken VBN O
directly RB O
from IN O
a DT O
patient NN O
. . O

Laryngographic JJ O
changes NNS O
following VBG O
endotracheal JJ O
intubation NN O
in IN O
adults NNS O
. . O

METHODS NN O
: : O
Forty NNP O
- : O
nine CD O
cases NNS O
with IN O
intrahepatic JJ O
multiple JJ O
nodules NNS O
of IN O
HCC NNP O
, , O
by IN O
gross JJ O
examination NN O
, , O
among IN O
184 CD O
consecutive JJ O
resected VBN O
HCCs NNP O
were VBD O
examined VBN O
clinicopathologically RB O
. . O

However RB O
, , O
the DT O
truncated JJ O
deer NN B-Gene
receptor NN I-Gene
lacks VBZ O
the DT O
most RBS O
C NNP O
- : O
terminal JJ O
tyrosine NN O
residue NN O
in IN O
the DT O
intracellular NN O
domain NN O
which WDT O
is VBZ O
believed VBN O
to TO O
be VB O
essential JJ O
for IN O
activation NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
casein NN I-Gene
promoter NN I-Gene
. . O

Although IN O
further JJ O
studies NNS O
are VBP O
required VBN O
to TO O
determine VB O
the DT O
precise JJ O
role NN O
of IN O
PEBP2 NNP B-Gene
in IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
activity NN O
, , O
the DT O
present JJ O
findings NNS O
suggested VBD O
the DT O
importance NN O
of IN O
the DT O
relative JJ O
ratio NN O
of IN O
different JJ O
PEBP2 NNP B-Gene
isoforms NNS I-Gene
in IN O
regulating VBG O
the DT O
levels NNS O
of IN O
the DT O
promoter NN O
activity NN O
. . O

NKX2 NNP B-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
a DT O
member NN O
of IN O
the DT O
NK2 NNP B-Gene
family NN I-Gene
of IN O
homeodomain NN B-Gene
- : I-Gene
containing VBG I-Gene
transcription NN I-Gene
factors NNS I-Gene
whose WP$ O
targeted JJ O
disruption NN O
in IN O
mouse NN O
results NNS O
in IN O
the DT O
absence NN O
of IN O
thyroid JJ O
tissue NN O
and CC O
a DT O
severely RB O
abnormal JJ O
lung NN O
phenotype NN O
. . O

The DT O
first JJ O
one NN O
is VBZ O
a DT O
TPA NNP O
- : O
responsive JJ O
element NN O
that WDT O
controls VBZ O
the DT O
base NN O
- : O
line NN O
ST3 NNP B-Gene
promoter NN I-Gene
activity NN O
but CC O
is VBZ O
not RB O
required VBN O
for IN O
its PRP$ O
activation NN O
. . O

The DT O
central JJ O
globular NN O
domain NN O
is VBZ O
highly RB O
similar JJ O
to TO O
those DT O
regions NNS O
from IN O
other JJ O
H1 NNP B-Gene
molecules NNS I-Gene
, , O
and CC O
the DT O
carboxyl NN O
- : O
terminal NN O
domain NN O
contains VBZ O
a DT O
repeating VBG O
hexapeptide NN O
motif NN O
, , O
variants NNS O
of IN O
which WDT O
are VBP O
conserved VBN O
among IN O
H1 NNP B-Gene
molecules NNS I-Gene
. . O

Time NNP O
shifts JJ O
increase NN O
growth NN B-Gene
hormone NN I-Gene
release NN O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
gene NN O
predicts VBZ O
a DT O
polypeptide NN O
of IN O
215 CD O
amino JJ O
acids NNS O
( ( O
25 CD O
. . O
2 CD O
kDa NN O
) ) O
with IN O
two CD O
putative JJ O
membrane NN O
- : O
spanning NN O
domains NNS O
. . O

Using VBG O
an DT O
RNase NNP B-Gene
H NNP I-Gene
protection NN O
assay NN O
and CC O
specific JJ O
blocking VBG O
oligonucleotides NNS O
, , O
we PRP O
find VBP O
that DT O
recognition NN O
of IN O
the DT O
5 CD O
' POS O
splice NN O
- : O
site NN O
( ( O
5 CD O
' '' O
ss NN O
) ) O
and CC O
branchpoint JJ O
sequence NN O
( ( O
BPS NNP O
) ) O
elements NNS O
by IN O
U11 NNP B-Gene
and CC O
U12 NNP B-Gene
snRNPs NN I-Gene
, , O
respectively RB O
, , O
displays NNS O
strong JJ O
cooperativity NN O
, , O
requiring VBG O
both DT O
sites NNS O
in IN O
the DT O
pre NN O
- : O
mRNA NN O
substrate NN O
for IN O
efficient JJ O
complex JJ O
formation NN O
. . O

0 LS O
. . O
61 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
) ) O
. . O

Expression NN O
of IN O
a DT O
dominant JJ O
- : O
negative JJ O
mutant NN O
of IN O
JNK1 NNP B-Gene
also RB O
suppressed VBD O
glucose JJ O
deprivation NN O
- : O
induced JJ O
JNK1 NNP B-Gene
activation NN O
as RB O
well RB O
as IN O
HSP70 NNP B-Gene
gene NN I-Gene
expression NN O
. . O

The DT O
mHIF NN B-Gene
- : I-Gene
1 CD I-Gene
alpha JJ I-Gene
structural JJ I-Gene
gene NN I-Gene
is VBZ O
composed VBN O
of IN O
15 CD O
exons NNS O
. . O

The DT O
avian JJ O
cellular JJ O
homolog NN O
of IN O
the DT O
oncogene NN B-Gene
jun NN I-Gene
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
disappearance NN O
of IN O
BOD5 NNP O
and CC O
NH3 NNP O
- : O
N NNP O
could MD O
be VB O
approximated VBN O
using VBG O
first JJ O
- : O
order NN O
kinetics NNS O
, , O
but CC O
the DT O
kinetics NNS O
of IN O
TP NNP O
removal NN O
were VBD O
unclear JJ O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
disappearance NN O
of IN O
BOD5 NNP O
and CC O
NH3 NNP O
- : O
N NNP O
could MD O
be VB O
approximated VBN O
using VBG O
first JJ O
- : O
order NN O
kinetics NNS O
, , O
but CC O
the DT O
kinetics NNS O
of IN O
TP NNP O
removal NN O
were VBD O
unclear JJ O
. . O

Mitogen NNP O
- : O
induced VBD O
lymphocyte JJ O
proliferation NN O
was VBD O
diminished VBN O
. . O

Experiments NNS O
were VBD O
performed VBN O
in IN O
which WDT O
brain NN O
- : O
stem NN O
auditory JJ O
- : O
evoked JJ O
responses NNS O
( ( O
BAERs NNP O
) ) O
were VBD O
elicited VBN O
by IN O
two CD O
types NNS O
of IN O
pseudorandom NN O
pulse JJ O
trains NNS O
: : O
maximum JJ O
length NN O
sequences NNS O
( ( O
MLS NNP O
) ) O
and CC O
Legendre NNP O
sequences NNS O
( ( O
LGS NNP O
) ) O
. . O

A DT O
heterologous JJ O
promoter NN O
construct NN O
containing VBG O
three CD O
repeats NNS O
of IN O
a DT O
consensus NN O
Sp1 NNP B-Gene
site NN I-Gene
, , O
cloned VBD O
upstream NN O
of IN O
a DT O
single JJ O
copy NN O
of IN O
the DT O
ZII NNP B-Gene
( ( O
CREB NNP B-Gene
/ NNP I-Gene
AP1 NNP I-Gene
) ) O
element NN O
from IN O
the DT O
BZLF1 NNP B-Gene
promoter NN I-Gene
linked VBD O
to TO O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
TATA NNP O
box NN O
, , O
exhibited VBD O
phorbol NN O
ester NN O
inducibility NN O
. . O

We PRP O
conclude VBP O
from IN O
these DT O
studies NNS O
that IN O
CKII NNP B-Gene
may MD O
act VB O
as IN O
a DT O
positive JJ O
regulator NN O
of IN O
myogenesis NN O
by IN O
preventing VBG O
E NNP B-Gene
protein NN I-Gene
homodimers NNS I-Gene
from IN O
binding VBG O
to TO O
muscle VB O
gene NN O
regulatory JJ O
elements NNS O
. . O

Furthermore RB O
, , O
direct JJ O
association NN O
with IN O
D3 NNP O
phosphatidylinositides NNS O
seems VBZ O
to TO O
be VB O
essential JJ O
for IN O
activation NN O
of IN O
PKB NNP B-Gene
/ NNP O
Akt NNP B-Gene
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
EKLF NNP B-Gene
provides VBZ O
a DT O
crucial JJ O
transactivation NN O
function NN O
for IN O
globin JJ B-Gene
expression NN O
and CC O
further JJ O
reinforce NN O
the DT O
idea NN O
that IN O
EKLF NNP B-Gene
is VBZ O
an DT O
important JJ O
regulator NN O
of IN O
CACCC NNP O
element NN O
- : O
directed VBN O
transcription NN O
in IN O
erythroid JJ O
cells NNS O
. . O

Effects NNS O
of IN O
cisapride NN O
on IN O
upper JJ O
- : O
gastrointestinal JJ O
motility NN O
and CC O
digestive JJ O
hormones NNS O

It PRP O
has VBZ O
repeatedly RB O
been VBN O
shown VBN O
that IN O
HCMV NNP O
IE1 NNP B-Gene
/ NNP O
IE2 NNP B-Gene
can MD O
independently RB O
transactivate VB O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
. . O

Similarly RB O
, , O
maternal JJ B-Gene
serum NN I-Gene
somatomedin VBD I-Gene
A DT I-Gene
was VBD O
significantly RB O
reduced VBN O
in IN O
rats NNS O
nursing VBG O
large JJ O
litters NNS O
. . O

It PRP O
is VBZ O
mainly RB O
transcribed VBN O
in IN O
neural JJ O
structures NNS O
and CC O
in IN O
developing VBG O
organs NNS O
characterized VBN O
by IN O
epithelial JJ O
- : O
mesenchymal JJ O
interactions NNS O
. . O

The DT O
coordinated JJ O
expression NN O
of IN O
CD4 NNP B-Gene
and CC O
CD8 NNP B-Gene
during IN O
T NNP O
- : O
cell NN O
development NN O
is VBZ O
tightly RB O
coupled VBN O
with IN O
the DT O
maturation NN O
state NN O
of IN O
the DT O
T NNP O
cell NN O
. . O

The DT O
effect NN O
of IN O
sodium NN O
18 CD O
beta NN O
- : O
glycyrrhetate NN O
( ( O
SGA NNP O
) ) O
on IN O
experimental JJ O
arrhythmia NN O
was VBD O
investigated VBN O
. . O

Am NNP O
. . O

This DT O
interaction NN O
is VBZ O
mediated VBN O
by IN O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
of IN O
Crk NNP B-Gene
and CC O
can MD O
be VB O
inhibited VBN O
with IN O
a DT O
phosphopeptide NN O
containing VBG O
the DT O
Crk NNP B-Gene
- : O
SH2 NNP B-Gene
binding VBG O
motif NN O
. . O

However RB O
, , O
five CD O
new JJ O
mutation NN O
sites NNS O
( ( O
S61 NNP B-Gene
, , O
SL1 NNP B-Gene
, , O
S29 NNP B-Gene
, , O
SL11 NNP B-Gene
, , O
SL196 NNP B-Gene
and CC O
SL126 NNP B-Gene
) ) O
are VBP O
unique JJ O
to TO O
the DT O
nrdB JJ B-Gene
intron NN O
and CC O
disrupt VB O
self PRP O
- : O
splicing NN O
. . O

In IN O
conclusion NN O
, , O
tube JJ O
size NN O
estimated VBN O
by IN O
Cole NNP O
' POS O
s JJ O
formula NN O
tends VBZ O
to TO O
be VB O
smaller JJR O
than IN O
practically RB O
appropriate JJ O
tube NNS O
size NN O
for IN O
pediatric JJ O
cardiac JJ O
anesthesia NN O
, , O
and CC O
therefore RB O
we PRP O
suggest VBP O
new JJ O
formula NN O
to TO O
estimate VB O
the DT O
tube NN O
size NN O
. . O

To TO O
test VB O
whether IN O
or CC O
not RB O
SOCS NNP B-Gene
- : I-Gene
3 CD I-Gene
also RB O
binds VBZ O
to TO O
the DT O
IGFIR NNP B-Gene
, , O
we PRP O
cloned VBD O
human JJ B-Gene
SOCS NNP I-Gene
- : I-Gene
3 CD I-Gene
by IN O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
from IN O
human JJ O
skeletal JJ O
muscle NN O
mRNA NN O
. . O

Furthermore RB O
, , O
using VBG O
transgenic JJ O
mouse NN O
technology NN O
we PRP O
localized VBD O
independent JJ O
cis NN O
- : O
regulatory JJ O
elements NNS O
controlling VBG O
the DT O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
Pax6 NNP B-Gene
. . O

Higher JJR O
CYP3A23 NNP B-Gene
basal NN O
activity NN O
appears VBZ O
to TO O
be VB O
due JJ O
to TO O
an DT O
E NNP O
- : O
box NN O
in IN O
3A23SiteA CD B-Gene
that WDT O
interacts NNS O
with IN O
USF1 NNP B-Gene
, , O
a DT O
ubiquitous JJ O
bHLH NN B-Gene
/ NNP I-Gene
leucine NN I-Gene
zipper NN I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

Fragments NNS O
and CC O
analogs NNS O
of IN O
the DT O
hormone NN O
ACTH NNP B-Gene
were VBD O
previously RB O
shown VBN O
to TO O
have VB O
beneficial JJ O
effect NN O
on IN O
the DT O
outcome NN O
of IN O
head NN O
injury NN O
, , O
while IN O
elevated VBN O
levels NNS O
of IN O
corticosterone NN O
( ( O
CS NNP O
) ) O
exacerbate VBP O
it PRP O
. . O

Salazopyrine NNP O
desensitization NN O

Shoulder NN O
forearm NN O
support NN O
for IN O
the DT O
subluxed JJ O
shoulder NN O
. . O

Unitary NNP O
- : O
group NN O
approach NN O
to TO O
spin VB O
- : O
dependent NN O
operators NNS O
. . O

This DT O
analysis NN O
revealed VBD O
that IN O
SAP NNP B-Gene
145 CD I-Gene
, , O
together RB O
with IN O
four CD O
other JJ O
SF3a NNP B-Gene
/ NNP O
SF3b NNP B-Gene
subunits NNS O
, , O
UV NNP O
cross SYM O
- : O
links NNS O
to TO O
pre VB O
- : O
mRNA NN O
in IN O
a DT O
20 CD O
- : O
nucleotide JJ O
region NN O
upstream NN O
of IN O
the DT O
BPS NNP O
. . O

Furthermore RB O
, , O
DNA NNP O
- : O
bound NN O
LAZ3 NNP B-Gene
/ NNP O
BCL6 NNP B-Gene
recruits VBZ O
SMRT NNP B-Gene
in IN O
vivo NN O
, , O
and CC O
both DT O
overexpressed JJ O
proteins NNS O
completely RB O
colocalize VBP O
in IN O
nuclear JJ O
dots NNS O
. . O

Sequences NNS O
downstream NN O
of IN O
the DT O
two CD O
human JJ B-Gene
CA NNP I-Gene
genes NNS I-Gene
, , O
possibly RB O
containing VBG O
homologous JJ O
enhancer NN O
elements NNS O
, , O
have VBP O
not RB O
yet RB O
been VBN O
reported VBN O
. . O

CONCLUSION NN O
: : O
The DT O
training NN O
of IN O
novices NNS O
using VBG O
MIST NNP O
- : O
VR NNP O
yields NNS O
quantifiable JJ O
changes NNS O
in IN O
skill NN O
that WDT O
are VBP O
transferable JJ O
to TO O
a DT O
simple JJ O
real JJ O
task NN O
and CC O
are VBP O
similar JJ O
to TO O
the DT O
results NNS O
achieved VBD O
with IN O
conventional JJ O
training NN O
. . O

Implications NNS O
in IN O
biomonitoring NN O
of IN O
the DT O
observed JJ O
accumulation NN O
patterns NNS O
, , O
especially RB O
in IN O
the DT O
different JJ O
tissues NNS O
of IN O
Posidonia NNP O
oceanica NN O
, , O
are VBP O
discussed VBN O
. . O

This DT O
is VBZ O
necessary JJ O
if IN O
psychiatric JJ O
diagnoses NNS O
are VBP O
ultimately RB O
going VBG O
to TO O
be VB O
refined VBN O
and CC O
validated VBN O
against IN O
biological JJ O
criteria NNS O
. . O

Potential JJ O
indicators NNS O
were VBD O
assessed VBN O
for IN O
the DT O
two CD O
classifications NNS O
of IN O
protein NN O
- : O
energy NN O
malnutrition NN O
in IN O
the DT O
guidelines NNS O
for IN O
integrated JJ O
management NN O
of IN O
childhood NN O
illness NN O
: : O
severe JJ O
malnutrition NN O
, , O
which WDT O
requires VBZ O
immediate JJ O
referral JJ O
to TO O
hospital VB O
, , O
and CC O
very RB O
low JJ O
weight NN O
, , O
which WDT O
calls VBZ O
for IN O
feeding VBG O
assessment NN O
, , O
nutritional JJ O
counselling NN O
and CC O
follow VB O
- : O
up RB O
. . O

An DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sequence NN I-Gene
is VBZ O
essential JJ O
for IN O
regulation NN O
of IN O
the DT O
human JJ B-Gene
alpha2 NN I-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
collagen NN I-Gene
( ( O
COL1A2 NNP B-Gene
) ) O
promoter NN O
activity NN O
by IN O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
. . O

Altogether RB O
46 CD O
phase NN O
III NNP O
activities NNS O
were VBD O
recorded VBN O
. . O

Initial JJ O
results NNS O
indicate VBP O
that IN O
this DT O
23S CD B-Gene
pre NN I-Gene
- : I-Gene
rRNA NN I-Gene
is VBZ O
the DT O
same JJ O
as IN O
the DT O
species NNS O
detected VBN O
on IN O
depletion NN O
of IN O
the DT O
small JJ B-Gene
nucleolar JJ I-Gene
RNA NNP I-Gene
- : I-Gene
associated JJ I-Gene
proteins NNS I-Gene
NOP1 NNP B-Gene
and CC O
GAR1 NNP B-Gene
and CC O
in IN O
an DT O
snr10 NN B-Gene
mutant NN I-Gene
strain NN O
. . O

Cys NNP O
- : O
757 CD O
within IN O
the DT O
( ( O
Fe4S4 NNP O
) ) O
- : O
siroheme NN O
- : O
binding NN O
domain NN O
was VBD O
essential JJ O
for IN O
native JJ O
enzyme NN O
activity NN O
. . O

2 CD O
new JJ O
Algerian JJ O
cases NNS O

In IN O
a DT O
previous JJ O
interim JJ O
report NN O
we PRP O
noted VBD O
more RBR O
prompt JJ O
resolution NN O
of IN O
dermatomal JJ O
signs NNS O
and CC O
symptoms NNS O
with IN O
acyclovir JJ O
treatment NN O
. . O

Prrp NN B-Gene
can MD O
also RB O
associate VB O
with IN O
the DT O
EVH1 NNP B-Gene
domain NN I-Gene
of IN O
Mena NNP B-Gene
, , O
another DT O
microfilament NN O
- : O
associated VBN O
protein NN O
. . O

DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
indicate VBP O
that IN O
PBP NNP B-Gene
binds VBZ O
to TO O
the DT O
half NN O
- : O
site NN O
of IN O
each DT O
palindrome NN O
with IN O
the DT O
core NN O
recognition NN O
sequence NN O
TGGGAG NNP O
. . O

A DT O
portion NN O
of IN O
p193 NN B-Gene
is VBZ O
nuclear JJ O
and CC O
localizes VBZ O
to TO O
the DT O
mitotic JJ O
spindle NN O
. . O

Krox NNP B-Gene
- : I-Gene
24 CD I-Gene
is VBZ O
therefore RB O
a DT O
sequence NN O
- : O
specific JJ O
transcriptional JJ O
activator NN O
. . O

Leads NNS O
from IN O
the DT O
MMWR NNP O
. . O

On IN O
the DT O
comparison NN O
of IN O
correlated JJ O
proportions NNS O
for IN O
clustered VBN O
data NNS O
. . O

Mutations NNS O
in IN O
the DT O
RP2 NNP B-Gene
locus NN I-Gene
at IN I-Gene
Xp11 NNP I-Gene
. . I-Gene
3 CD I-Gene
were VBD O
found VBN O
in IN O
a DT O
further JJ O
10 CD O
- : O
20 CD O
% NN O
of IN O
XLRP NNP O
patients NNS O
, , O
as IN O
predicted VBN O
from IN O
linkage NN O
studies NNS O
. . O

The DT O
effects NNS O
of IN O
anabolic JJ O
implants NNS O
on IN O
rate NN O
, , O
composition NN O
and CC O
energetic JJ O
efficiency NN O
of IN O
growth NN O
were VBD O
determined VBN O
in IN O
steers NNS O
fed VBP O
diets NNS O
varying VBG O
in IN O
forage NN O
and CC O
grain NN O
content NN O
. . O

One CD O
of IN O
its PRP$ O
lysine NN O
residues NNS O
is VBZ O
modified VBN O
by IN O
spermidine NN O
to TO O
form VB O
hypusine NN O
, , O
a DT O
posttranslational JJ O
modification NN O
unique NN O
to TO O
eIF VB B-Gene
- : I-Gene
5A CD I-Gene
. . O

After IN O
overtraining VBG O
on IN O
the DT O
original JJ O
discrimination NN O
, , O
the DT O
controls NNS O
showed VBD O
the DT O
normal JJ O
difficulty NN O
in IN O
learning VBG O
the DT O
first JJ O
reversal NN O
. . O

Cerebral NNP O
flow NN O
and CC O
resistance NN O
showed VBD O
minor JJ O
reductions NNS O
with IN O
HD NNP O
. . O

The DT O
ATR NNP O
- : O
X NN O
syndrome JJ O
results NNS O
from IN O
mutations NNS O
of IN O
the DT O
XH2 NNP B-Gene
gene NN I-Gene
, , O
located VBN O
on IN O
the DT O
X NNP O
chromosome NN O
( ( O
Xq13 NNP O
. . O
3 CD O
) ) O
and CC O
coding VBG O
for IN O
a DT O
transacting NN O
factor NN O
which WDT O
regulates VBZ O
gene NN O
expression NN O
. . O

Chemical NNP O
stability NN O
tests NNS O
and CC O
site NN O
- : O
specific JJ O
mutagenesis NN O
identified VBN O
amino JJ O
acids NNS O
H219 NNP O
and CC O
D63 NNP O
of IN O
RegS NNP B-Gene
and CC O
RegR NNP B-Gene
, , O
respectively RB O
, , O
as IN O
the DT O
phosphorylated JJ O
residues NNS O
. . O

Thyroid NNP O
disease NN O
and CC O
pregnancy NN O
. . O

Fourth NNP O
, , O
sometime RB O
between IN O
4 CD O
and CC O
24 CD O
hours NNS O
of IN O
recovery NN O
is VBZ O
necessary JJ O
to TO O
reverse VB O
the DT O
effect NN O
of IN O
chronic JJ O
hypoxia NN O
on IN O
cerebral JJ O
blood NN O
flow NN O
. . O

The DT O
new JJ O
algorithm NN O
, , O
called VBN O
RBI NNP O
- : O
MAP NNP O
, , O
is VBZ O
based VBN O
on IN O
the DT O
rescaled JJ O
block NN O
iterative JJ O
EM NNP O
( ( O
RBI NNP O
- : O
EM NN O
) ) O
algorithm NN O
. . O

Fractionation NN O
of IN O
crude JJ O
nuclear JJ O
extracts NNS O
by IN O
heparin JJ O
- : O
agarose JJ O
chromatography NN O
indicates VBZ O
that IN O
PCAT NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
more RBR O
prevalent JJ O
in IN O
extracts NNS O
prepared VBN O
from IN O
salt NN O
- : O
stressed VBD O
leaf JJ O
tissue NN O
. . O

Neurofibromatosis NN O
of IN O
the DT O
breast NN O
in IN O
a DT O
patient NN O
with IN O
Morbus NNP O
von NNP O
Recklinghausen NNP O

Whereas NNP O
MARTA1 NNP B-Gene
is VBZ O
clearly RB O
detectable JJ O
in IN O
crude NN O
lysates NNS O
, , O
cytosolic NN O
and CC O
ribosomal JJ O
salt NN O
- : O
wash NN O
fractions NNS O
, , O
and CC O
in IN O
nuclear JJ O
extracts NNS O
, , O
MARTA2 NNP B-Gene
is VBZ O
preferentially RB O
found VBN O
in IN O
the DT O
ribosomal JJ O
salt NN O
- : O
wash NN O
preparation NN O
. . O

We PRP O
isolated VBD O
a DT O
ribosomal JJ B-Gene
protein NN I-Gene
L18 NNP I-Gene
by IN O
interaction NN O
with IN O
PKR NNP B-Gene
. . O

Wild NNP O
type NN O
HA NNP B-Gene
- : O
p190 NN B-Gene
induced VBD O
a DT O
phenotype NN O
of IN O
rounded JJ O
cells NNS O
with IN O
long JJ O
, , O
beaded VBD O
extensions NNS O
similar JJ O
to TO O
that DT O
seen VBN O
when WRB O
Rho NNP B-Gene
function NN O
is VBZ O
disrupted VBN O
by IN O
ADP NNP O
- : O
ribosylation NN O
. . O

Lens NNS B-Gene
aldose JJ I-Gene
reductase NN I-Gene
in IN O
diabetic JJ O
and CC O
galactosemic JJ O
cataracts NNS O
. . O

The DT O
HBP NNP B-Gene
gene NN I-Gene
is VBZ O
composed VBN O
of IN O
eight CD O
exons NNS O
covering VBG O
19 CD O
. . O
5 CD O
kb NN O
on IN O
the DT O
short JJ O
arm NN O
of IN O
chromosome NN O
4 CD O
. . O

This DT O
distinction NN O
was VBD O
based VBN O
upon IN O
whether IN O
the DT O
diagnosis NN O
provided VBD O
a DT O
straightforward JJ O
range NN O
of IN O
prognoses NNS O
or CC O
an DT O
ambiguous JJ O
clinical JJ O
implication NN O
. . O

Demonstration NN O
of IN O
fine JJ O
structure NN O
of IN O
the DT O
guinea NN O
pig VBZ O
organ NN O
of IN O
Corti NNP O
after IN O
electron NN O
microscopic NN O
silver NN O
staining NN O

Serum NNP B-Gene
relaxin NN I-Gene
levels NNS O
in IN O
prostaglandin NN O
E2 NNP O
induced VBD O
abortions NNS O
. . O

Penicillin NNP O
- : O
G NNP O
degradation NN O
products NNS O
inhibit VBP O
in IN O
vitro JJ O
granulopoiesis NN O
. . O

A DT O
striking JJ O
feature NN O
of IN O
the DT O
recombinant JJ B-Gene
H19 NNP I-Gene
allele NN I-Gene
is VBZ O
the DT O
occurrence NN O
of IN O
a DT O
parental JJ O
imprint NN O
set VBN O
on IN O
the DT O
neo JJ B-Gene
replacement NN I-Gene
cassette NN I-Gene
. . O

We PRP O
propose VBP O
that DT O
plasmids NNS O
of IN O
the DT O
pLS1 JJ O
family NN O
( ( O
pE194 NN O
, , O
pADB201 NN O
, , O
and CC O
pLB4 NN O
) ) O
share NN O
functional JJ O
and CC O
structural JJ O
characteristics NNS O
for IN O
the DT O
regulation NN O
of IN O
their PRP$ O
copy NN O
numbers NNS O
. . O

Here RB O
we PRP O
show VBP O
that IN O
a DT O
novel JJ O
isoform NN O
of IN O
Rapl NNP B-Gene
GTPase NNP I-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
, , O
called VBN O
rap1GAPII NN B-Gene
, , O
binds VBZ O
specifically RB O
to TO O
the DT O
alpha NN O
- : O
subunits NNS O
of IN O
the DT O
G NNP B-Gene
( ( I-Gene
i NN I-Gene
) ) I-Gene
family NN I-Gene
of IN O
heterotrimeric JJ B-Gene
G NNP I-Gene
- : I-Gene
proteins NNS I-Gene
. . O

The DT O
present JJ O
data NNS O
also RB O
demonstrate VBP O
that IN O
ectopic JJ O
expression NN O
of IN O
blr1 NN B-Gene
increased VBN O
JNK NNP B-Gene
/ NNP O
SAPK NNP B-Gene
activity NN O
, , O
but CC O
JNK NNP B-Gene
/ NNP O
SAPK NNP B-Gene
activation NN O
was VBD O
not RB O
needed VBN O
for IN O
accelerated JJ O
RA NNP O
- : O
induced JJ O
differentiation NN O
and CC O
growth NN O
arrest NN O
. . O

Furthermore RB O
, , O
we PRP O
showed VBD O
that IN O
ERSF NNP B-Gene
including VBG O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
and CC O
ATF6alpha NNP B-Gene
and CC I-Gene
/ NNP I-Gene
or CC I-Gene
beta NN I-Gene
and CC O
capable JJ O
of IN O
binding VBG O
to TO O
ERSE NNP O
is VBZ O
indeed RB O
formed VBN O
when WRB O
the DT O
cellular JJ O
UPR NNP O
is VBZ O
activated VBN O
. . O

The DT O
complete JJ O
circular JJ O
TTV NNP O
genome NN O
contained VBD O
a DT O
novel JJ O
sequence NN O
of IN O
113 CD O
nt NNS O
( ( O
nt JJ O
3740 CD O
to TO O
3852 CD O
[ NNP O
= VBD O
0 CD O
] NN O
) ) O
in IN O
between IN O
the DT O
known VBN O
3 CD O
' POS O
- : O
and CC O
5 CD O
' '' O
- : O
end NN O
arms NNS O
, , O
forming VBG O
a DT O
117 CD O
- : O
nt NN O
GC NNP O
- : O
rich JJ O
stretch NN O
( ( O
GC NNP O
content NN O
, , O
90 CD O
. . O
6 CD O
% NN O
at IN O
nt JJ O
3736 CD O
to TO O
3852 CD O
) ) O
. . O

BACKGROUND NN O
: : O
The DT O
MAZE NNP O
- : O
III NN O
is VBZ O
the DT O
surgical JJ O
treatment NN O
of IN O
choice NN O
for IN O
medically RB O
refractory JJ O
atrial JJ O
fibrillation NN O
. . O

Tolterodine NN O
users NNS O
were VBD O
7 CD O
. . O
5 CD O
times NNS O
more RBR O
likely JJ O
to TO O
have VB O
received VBN O
another DT O
spasmolytic JJ O
drug NN O
( ( O
RR NNP O
7 CD O
. . O
5 CD O
, , O
95 CD O
% NN O
CI NNP O
4 CD O
. . O
8 CD O
to TO O
11 CD O
. . O
9 CD O
) ) O
. . O

Haplotype NNP O
mapping NN O
and CC O
sequence NN O
analysis NN O
of IN O
the DT O
mouse NN O
Nramp NNP B-Gene
gene NN I-Gene
predict VBP O
susceptibility NN O
to TO O
infection NN O
with IN O
intracellular JJ O
parasites NNS O
. . O

Combination NN O
of IN O
3 CD O
multiple JJ O
primary JJ O
malignant NN O
and CC O
benign JJ O
tumors NNS O
of IN O
the DT O
breasts NNS O
and CC O
uterus NN O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
largest JJS O
subunit NN O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
and CC O
TFIIB NNP B-Gene
are VBP O
important JJ O
determinants NNS O
of IN O
transcription NN O
start NN O
site NN O
selection NN O
in IN O
S NNP O
. . O
cerevisiae NN O
and CC O
suggest VBP O
that IN O
this DT O
function NN O
might MD O
be VB O
conferred VBN O
by IN O
interaction NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

Perturbation NN O
of IN O
dNTP NN O
pools NNS O
also RB O
affected VBD O
the DT O
frameshift JJ O
fidelity NN O
of IN O
the DT O
replicative JJ O
yeast NN B-Gene
DNA NNP I-Gene
polymerase NN I-Gene
alpha NN I-Gene
. . O

Sequence NNP O
determination NN O
of IN O
isolated JJ O
peptides NNS O
suggested VBD O
that IN O
Asn120 NNP O
is VBZ O
glycosylated VBN O
, , O
Asn65 NNP O
and CC O
Asn109 NNP O
glycosylated VBD O
in IN O
some DT O
molecules NNS O
but CC O
not RB O
in IN O
others NNS O
, , O
and CC O
Asn72 NNP O
not RB O
glycosylated VBD O
. . O

In IN O
contrast NN O
, , O
the DT O
CRE NNP O
of IN O
the DT O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
fos NN I-Gene
promoter NN I-Gene
located VBN O
at IN O
- : O
60 CD O
was VBD O
weakly RB O
induced VBN O
by IN O
cAMP NN O
and CC O
E1a NNP B-Gene
in IN O
both DT O
HeLa NNP O
and CC O
PC12 NNP O
cells NNS O
. . O

The DT O
calculated JJ O
values NNS O
of IN O
lambda JJ O
tb NN O
at IN O
37 CD O
degrees NNS O
C NNP O
and CC O
50 CD O
per IN O
cent NN O
haematocrit NN O
were VBD O
0 CD O
. . O
650 CD O
for IN O
the DT O
pulp NN O
, , O
0 CD O
. . O
674 CD O
for IN O
the DT O
tongue NN O
, , O
0 CD O
. . O
828 CD O
for IN O
the DT O
submandibular JJ O
gland NN O
and CC O
0 CD O
. . O
881 CD O
for IN O
the DT O
gingiva NN O
of IN O
the DT O
dog NN O
. . O
lambda JJ O
cp NN O
increased VBD O
and CC O
lambda JJ O
tp NN O
decreased VBD O
as IN O
the DT O
temperature NN O
was VBD O
reduced VBN O
from IN O
37 CD O
to TO O
4 CD O
degrees NNS O
C NNP O
. . O

Mutations NNS O
in IN O
the DT O
alpha NN B-Gene
and CC I-Gene
sigma NN I-Gene
- : I-Gene
70 CD I-Gene
subunits NNS I-Gene
of IN I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
affect JJ O
expression NN O
of IN O
the DT O
mer NN B-Gene
operon NN I-Gene
. . O

The DT O
Drosophila NNP B-Gene
insulin NN I-Gene
receptor NN I-Gene
homolog NN I-Gene
: : O
a DT O
gene NN O
essential JJ O
for IN O
embryonic JJ O
development NN O
encodes NNS O
two CD O
receptor NN O
isoforms NNS O
with IN O
different JJ O
signaling VBG O
potential NN O
. . O

Hypotension NN O
was VBD O
produced VBN O
by IN O
head NN O
up RB O
tilt RB O
. . O

Sequence NNP O
analysis NN O
of IN O
these DT O
regions NNS O
showed VBD O
a DT O
CAAT NNP O
box NN O
upstream NN O
of IN O
exon $ O
1a CD O
and CC O
high JJ O
G NNP O
- : O
C NNP O
content NN O
regions NNS O
within IN O
both DT O
P1 NNP O
and CC O
P2 NNP O
. . O

Regulation NN O
of IN O
pituitary JJ O
vasopressin NN B-Gene
V1b NNP I-Gene
receptors NNS I-Gene
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
regulating VBG O
pituitary JJ B-Gene
adrenocorticotropic NN I-Gene
hormone NN I-Gene
( ( O
ACTH NNP B-Gene
) ) O
secretion NN O
during IN O
adaptation NN O
to TO O
stress VB O
. . O

The DT O
DNA NNP O
sequence NN O
conferring VBG O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
was VBD O
located VBN O
in IN O
the DT O
proximal JJ O
promoter NN O
region NN O
. . O

Although IN O
not RB O
consistently RB O
identified VBN O
in IN O
all DT O
samples NNS O
, , O
secondary JJ O
Academic NNP O
, , O
Personal NNP O
Responsibility NNP O
, , O
and CC O
Community NNP O
/ NNP O
Vocational NNP O
dimensions NNS O
were VBD O
also RB O
identified VBN O
. . O

Treatment NN O
for IN O
this DT O
condition NN O
often RB O
involves VBZ O
use NN O
of IN O
a DT O
wax JJ O
softening NN O
or CC O
dispersing VBG O
agent NN O
( ( O
cerumenolytic JJ O
) ) O
before IN O
syringing VBG O
. . O

The DT O
frequency NN O
of IN O
PPNG NNP O
strains NNS O
increased VBD O
from IN O
1 CD O
. . O
7 CD O
% NN O
in IN O
1981 CD O
to TO O
6 CD O
. . O
7 CD O
% NN O
in IN O
1985 CD O
. . O

In IN O
all DT O
cases NNS O
the DT O
antigenemia NN O
was VBD O
transient JJ O
and CC O
cleared VBN O
by IN O
28th CD O
day NN O
post VBD O
- : O
vaccination NN O
. . O

Second JJ O
, , O
nitrate JJ O
induction NN O
of IN O
aeg JJ B-Gene
- : I-Gene
46 CD I-Gene
. . I-Gene
5 CD I-Gene
operon JJ I-Gene
expression NN O
is VBZ O
substantially RB O
enhanced VBN O
in IN O
narL JJ B-Gene
null JJ O
strains NNS O
( ( O
M NNP O
. . O
H NNP O
. . O

Evidence NN O
for IN O
two CD O
distinctive JJ O
clinical JJ O
, , O
epidemiological JJ O
, , O
and CC O
immunological JJ O
types NNS O
of IN O
infection NN O
. . O

The DT O
large JJ O
subfamily NN O
of IN O
receptor NN B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
( ( O
RTKs NNP B-Gene
) ) O
for IN O
which WDT O
EPH NNP B-Gene
is VBZ O
the DT O
prototype NN O
have VBP O
likely JJ O
roles NNS O
in IN O
intercellular JJ O
communication NN O
during IN O
normal JJ O
mammalian JJ O
development NN O
, , O
but CC O
the DT O
biochemical JJ O
signalling NN O
pathways NNS O
utilised VBN O
by IN O
this DT O
family NN O
are VBP O
poorly RB O
characterised VBN O
. . O

Visual JJ O
acuity NN O
may MD O
be VB O
decreased VBN O
by IN O
transient NN O
changes NNS O
in IN O
refractive JJ O
error NN O
caused VBN O
by IN O
sulfonamides NNS O
, , O
the DT O
antifungal JJ O
agent NN O
metronidazole NN O
, , O
thiazide IN O
diuretics NNS O
, , O
and CC O
carbonic JJ B-Gene
anhydrase NN I-Gene
inhibitors NNS O
. . O

Urine NN O
samples NNS O
collected VBN O
after IN O
the DT O
administration NN O
of IN O
these DT O
supplements NNS O
can MD O
test VB O
positive JJ O
. . O

We PRP O
report VBP O
here RB O
that IN O
a DT O
25 CD O
- : O
bp NN O
promoter NN O
element NN O
previously RB O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
the DT O
G1 NNP O
- : O
S NNP O
activation NN O
of IN O
the DT O
human JJ B-Gene
thymidine NN I-Gene
kinase NN I-Gene
( ( O
htk NN B-Gene
) ) O
promoter NN O
in IN O
growth NN O
- : O
stimulated VBN O
cells NNS O
is VBZ O
a DT O
cellular JJ O
target NN O
of IN O
cyclin NN B-Gene
A NNP I-Gene
and CC O
the DT O
p33cdk2 NN B-Gene
complexes NNS I-Gene
. . O

By IN O
comparison NN O
, , O
in IN O
nontumorigenic JJ O
Ad5 NNP O
cells NNS O
, , O
class NN O
I PRP O
expression VBP O
is VBZ O
high JJ O
due JJ O
to TO O
negligible JJ O
binding NN O
of IN O
COUP NNP B-Gene
- : I-Gene
TF NN I-Gene
and CC O
strong JJ O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

A DT O
randomized JJ O
clinical JJ O
trial NN O
in IN O
sixty JJ O
- : O
two CD O
adult NN O
patients NNS O
suffering VBG O
from IN O
typhoid JJ O
fever NN O
, , O
proved VBN O
by IN O
blood NN O
and CC O
marrow JJ O
culture NN O
, , O
showed VBD O
that IN O
amoxycillin NN O
in IN O
a DT O
dosage NN O
schedule NN O
of IN O
1 CD O
g NN O
8 CD O
- : O
hourly RB O
orally RB O
for IN O
fourteen JJ O
days NNS O
was VBD O
better JJR O
than IN O
chloramphenicol NN O
with IN O
regard NN O
to TO O
clinical JJ O
and CC O
temperature JJ O
response NN O
and CC O
in IN O
respect NN O
of IN O
carriers NNS O
and CC O
relapse NN O
rates NNS O
. . O

Human NNP O
adenovirus VBZ O
type NN O
41 CD O
contains NNS O
two CD O
fibers NNS O
. . O

The DT O
patterns NNS O
of IN O
early JJ O
mRNA NN O
and CC O
protein JJ O
expression NN O
in IN O
these DT O
seven CD O
mutants NNS O
were VBD O
examined VBN O
, , O
and CC O
it PRP O
was VBD O
found VBN O
that IN O
mutation NN O
of IN O
the DT O
T NNP B-Gene
' POS I-Gene
( ( I-Gene
135 CD I-Gene
) ) I-Gene
acceptor NN O
site NN O
resulted VBD O
in IN O
the DT O
utilization NN O
of IN O
cryptic JJ O
splice NN O
sites NNS O
and CC O
the DT O
generation NN O
of IN O
new JJ O
T NNP B-Gene
' POS I-Gene
species NNS O
. . O

The DT O
deduced JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
mouse NN B-Gene
HO NNP I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
is VBZ O
identical JJ O
to TO O
that DT O
of IN O
p32 NN B-Gene
, , O
initially RB O
identified VBN O
as IN O
a DT O
stress NN O
- : O
induced JJ O
protein NN O
in IN O
mouse NN O
BALBc NNP O
/ VBZ O
3T3 CD O
cells NNS O
. . O

Chem NNP O
. . O

The DT O
best JJS O
regression NN O
model NN O
for IN O
predicting VBG O
changes NNS O
in IN O
the DT O
WCXR NNP O
included VBD O
time NN O
to TO O
first RB O
positive JJ O
culture NN O
and CC O
antibody NN O
titer NN O
for IN O
Pa NNP B-Gene
elastase NN I-Gene
. . O

The DT O
PDH NNP B-Gene
complex JJ I-Gene
- : I-Gene
encoding VBG I-Gene
genes NNS I-Gene
were VBD O
identified VBN O
by IN O
hybridization NN O
experiments NNS O
and CC O
sequence NN O
analysis NN O
in IN O
two CD O
separate JJ O
gene NN O
regions NNS O
in IN O
the DT O
genome NN O
of IN O
Z NNP O
. . O
mobilis NN O
. . O

Of IN O
the DT O
cases NNS O
with IN O
PLD NNP O
, , O
50 CD O
% NN O
had VBD O
associated VBN O
renal JJ O
cysts NNS O
and CC O
10 CD O
% NN O
of IN O
the DT O
cases NNS O
with IN O
APCD NNP O
had VBD O
associated VBN O
liver RB O
cysts NNS O
. . O

Nucleotide NNP O
sequence NN O
of IN O
DNA NNP O
controlling VBG O
expression NN O
of IN O
genes NNS O
for IN O
maltosaccharide JJ O
utilization NN O
in IN O
Streptococcus NNP O
pneumoniae NN O
. . O

Interestingly RB O
, , O
EGF NNP B-Gene
, , O
but CC O
not RB O
insulin VB B-Gene
, , O
stimulated VBN O
tyrosine JJ O
phosphorylation NN O
of IN O
c SYM B-Gene
- : I-Gene
cbl NN I-Gene
and CC O
its PRP$ O
association NN O
with IN O
Crk NNP B-Gene
- : I-Gene
II NNP I-Gene
. . O

No DT O
specific JJ O
subgroup NN O
of IN O
clients NNS O
benefited VBN O
more RBR O
from IN O
URD NNP O
, , O
although IN O
a DT O
prospective JJ O
study NN O
employing VBG O
random JJ O
assignment NN O
might MD O
be VB O
more RBR O
successful JJ O
in IN O
identifying VBG O
such JJ O
a DT O
group NN O
. . O

Functional JJ O
domains NNS O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
promoter NN I-Gene
binding VBG I-Gene
protein JJ I-Gene
1 CD I-Gene
involved VBN O
in IN O
transcriptional JJ O
repression NN O
and CC O
cell NN O
growth NN O
regulation NN O
. . O

The DT O
PAC NNP O
clone NN O
with IN O
an DT O
insert JJ O
size NN O
of IN O
120kb CD O
was VBD O
isolated VBN O
and CC O
mapped VBN O
by IN O
restriction NN O
analysis NN O
. . O

We PRP O
have VBP O
partially RB O
sequenced VBN O
the DT O
RAP74 NNP B-Gene
protein NN I-Gene
from IN O
purified VBN O
HeLa NNP O
cells NNS O
, , O
cloned VBD O
its PRP$ O
complementary JJ O
DNA NN O
and CC O
shown VBN O
that IN O
its PRP$ O
translation NN O
product NN O
can MD O
interact VB O
with IN O
RAP30 NNP B-Gene
in IN O
vitro NN O
as RB O
well RB O
as IN O
in IN O
vivo NN O
. . O

Many JJ O
of IN O
the DT O
important JJ O
genes NNS O
associated VBN O
with IN O
G1 NNP O
regulation NN O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
key JJ O
role NN O
in IN O
proliferation NN O
, , O
differentiation NN O
and CC O
oncogenic JJ O
transformation NN O
and CC O
programmed VBD O
cell NN O
death NN O
( ( O
apoptosis NN O
) ) O
. . O

Exploratory NNP O
- : O
motor NN O
task NN O
to TO O
evaluate VB O
right JJ O
frontal JJ O
lobe NN O
damage NN O
. . O

Haploid NNP O
cells NNS O
of IN O
mating VBG O
type NN O
A DT O
of IN O
the DT O
basidiomycetous JJ O
yeast NN O
Rhodosporidium NNP O
toruloides VBZ O
secrete VB O
a DT O
mating NN O
pheromone NN O
, , O
rhodotorucine VB B-Gene
A NNP I-Gene
, , O
which WDT O
is VBZ O
an DT O
undecapeptide JJ O
containing NN O
S NNP O
- : O
farnesyl NN O
cysteine NN O
at IN O
its PRP$ O
carboxy JJ O
terminus NN O
. . O

The DT O
current JJ O
study NN O
defines VBZ O
the DT O
vinculin NN B-Gene
- : O
and CC O
FAK NNP B-Gene
- : I-Gene
interaction NN I-Gene
domains NNS I-Gene
on IN O
paxillin NN B-Gene
and CC O
identifies VBZ O
the DT O
principal JJ O
paxillin NN B-Gene
focal JJ O
adhesion NN O
targeting VBG O
motif NN O
. . O

The DT O
expression NN O
of IN O
ERV3 NNP B-Gene
env FW I-Gene
mRNA NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
differentiation JJ O
- : O
associated VBN O
, , O
with IN O
high JJ O
expression NN O
detected VBN O
in IN O
the DT O
late JJ O
stages NNS O
of IN O
monocytic JJ O
development NN O
. . O

USA NNP O
80 CD O
, , O
802 CD O
- : O
806 CD O
] NN O
was VBD O
used VBN O
to TO O
isolate VB O
a DT O
genomic JJ O
clone NN O
lambda NN O
PGK NNP B-Gene
- : I-Gene
1 CD I-Gene
containing VBG O
a DT O
portion NN O
of IN O
an DT O
autosomal JJ O
locus NN O
for IN O
phosphoglycerate JJ B-Gene
kinase NN I-Gene
( ( O
PGK NNP B-Gene
) ) O
. . O

To TO O
elucidate VB O
the DT O
functional JJ O
significance NN O
of IN O
Fyn NNP B-Gene
in IN O
the DT O
expression NN O
of IN O
viral JJ O
promoters NNS O
, , O
we PRP O
transfected VBD O
a DT O
Fyn NNP B-Gene
- : O
expression NN O
vector NN O
together RB O
with IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
gene NN I-Gene
driven VBN O
by IN O
HIV NNP B-Gene
LTR NNP I-Gene
into IN O
a DT O
human JJ O
T NNP O
cell NN O
line NN O
, , O
Jurkat NNP O
. . O

OBJECTIVES NN O
: : O
The DT O
aim NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
analyze VB O
the DT O
clinical JJ O
characteristics NNS O
, , O
treatment NN O
and CC O
outcome NN O
of IN O
310 CD O
patients NNS O
with IN O
hydatidiform JJ O
mole NN O
. . O

Two CD O
protease NN O
- : O
resistant NN O
fragments NNS O
spanning VBG O
the DT O
N NNP O
- : O
and CC O
C NNP O
- : O
terminal JJ O
halves NNS O
of IN O
the DT O
nuclease NN O
were VBD O
identified VBN O
using VBG O
different JJ O
proteases NNS O
which WDT O
cleave VBP O
the DT O
protein NN O
in IN O
the DT O
same JJ O
region NN O
. . O

The DT O
effect NN O
of IN O
iron NN O
intake NN O
on IN O
59Fe CD O
absorption NN O
throughout IN O
pregnancy NN O
, , O
and CC O
on IN O
maternal JJ O
and CC O
fetal JJ O
Fe NNP O
status NN O
towards IN O
the DT O
end NN O
of IN O
pregnancy NN O
, , O
was VBD O
investigated VBN O
in IN O
rats NNS O
. . O

BACKGROUND NN O
: : O
To TO O
determine VB O
the DT O
predictors NNS O
of IN O
desipramine NN O
- : O
refractory NN O
depression NN O
, , O
the DT O
authors NNS O
examined VBD O
the DT O
outcome NN O
in IN O
patients NNS O
with IN O
major JJ O
depression NN O
who WP O
were VBD O
admitted VBN O
to TO O
a DT O
general JJ O
hospital NN O
and CC O
treated VBN O
with IN O
desipramine NN O
adjusted VBN O
to TO O
an DT O
adequate JJ O
blood NN O
level NN O
. . O

Wave JJ O
cybernetics NNS O
: : O
A DT O
simple JJ O
model NN O
of IN O
wave NN O
- : O
controlled VBN O
nonlinear JJ O
and CC O
nonlocal JJ O
cooperative JJ O
phenomena NN O
. . O

FEV1 NNP O
did VBD O
not RB O
fall VB O
significantly RB O
in IN O
patients NNS O
without IN O
acute NN O
or CC O
chronic JJ O
GVHD NNP O
and CC O
recovered VBD O
earlier JJR O
than IN O
in IN O
patients NNS O
without IN O
posttransplant JJ O
pulmonary JJ O
infection NN O
. . O

In IN O
addition NN O
to TO O
that DT O
, , O
she PRP O
received VBD O
hepatic JJ O
intra JJ O
- : O
arterial JJ O
infusion NN O
of IN O
levoforinate NN O
( ( O
l JJ O
- : O
LV NN O
) ) O
250 CD O
mg NN O
and CC O
5 CD O
- : O
fluorouracil NN O
( ( O
5 CD O
- : O
FU NN O
) ) O
500 CD O
mg NN O
for IN O
combined JJ O
multiple JJ O
hepatic JJ O
metastases NNS O
starting VBG O
on IN O
postoperative JJ O
day NN O
14 CD O
, , O
and CC O
these DT O
medications NNS O
were VBD O
administered VBN O
over IN O
48 CD O
hours NNS O
once RB O
weekly JJ O
by IN O
infuser JJ O
pump NN O
. . O

Shc NNP B-Gene
stimulates VBZ O
Ras NNP B-Gene
/ NNP O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
through IN O
forming VBG O
a DT O
complex JJ O
with IN O
Grb2 NNP B-Gene
at IN O
the DT O
phosphorylated JJ O
tyrosine NN O
( ( O
Y NNP O
) ) O
residue VBD O
317 CD O
. . O

E NN O
. . O
, , O
Scott NNP O
, , O
J NNP O
. . O

Screening VBG O
of IN O
asthma JJ O
patients NNS O
by IN O
determination NN O
of IN O
IgE NNP B-Gene
and CC O
by IN O
comprehension NN O
of IN O
spectrum NN O
of IN O
allergospecific JJ B-Gene
IgE NNP I-Gene
antibodies NNS I-Gene

Comparative JJ O
mapping NN O
of IN O
the DT O
Brassica NNP B-Gene
S NNP I-Gene
locus POS I-Gene
region NN I-Gene
and CC O
its PRP$ O
homeolog NN O
in IN O
Arabidopsis NNP O
. . O

Significant JJ O
GMBF NNP O
reductions NNS O
occurred VBD O
in IN O
early JJ O
shock NN O
in IN O
both DT O
treatment NN O
groups NNS O
. . O

Surprisingly RB O
, , O
3 CD O
full JJ B-Gene
- : I-Gene
length NN I-Gene
murine NN I-Gene
survivin NN I-Gene
cDNA NN I-Gene
clones NNS O
were VBD O
isolated VBN O
, , O
predicting VBG O
the DT O
existence NN O
of IN O
3 CD O
distinct JJ O
survivin NN B-Gene
proteins NNS I-Gene
. . O

35 CD O
patients NNS O
with IN O
acute JJ O
arterial JJ O
occlusions NNS O
[ VBP O
27 CD O
] NN O
and CC O
graft NN O
thromboses NNS O
[ VBP O
8 CD O
] NN O
, , O
responsible JJ O
for IN O
severe JJ O
and CC O
recent JJ O
ischemia NN O
, , O
were VBD O
treated VBN O
by IN O
fibrinolytic JJ O
therapy NN O
( ( O
Urokinase NNP B-Gene
: : O
1 CD O
0 CD O
units NNS O
/ VBP O
kg JJ O
/ NNP O
hour NN O
, , O
and CC O
Lys NNP O
Plasminogen NNP B-Gene
) ) O
. . O

Denaturation NN O
of IN O
the DT O
simian JJ O
virus NN O
40 CD O
origin NN O
of IN O
replication NN O
mediated VBN O
by IN O
human JJ B-Gene
replication NN I-Gene
protein NN I-Gene
A NNP I-Gene
. . O

Similarities NNS O
between IN O
the DT O
hIGFBP NN B-Gene
- : I-Gene
1 CD I-Gene
and CC O
phosphoenolpyruvate VB B-Gene
kinase NN I-Gene
( ( O
PEPCK NNP B-Gene
) ) O
promoters NNS O
, , O
including VBG O
regions NNS O
conferring VBG O
insulin NN B-Gene
, , O
glucocorticoid NN O
, , O
and CC O
cyclic JJ O
adenosine NN O
- : O
monophosphate NN O
responses NNS O
, , O
are VBP O
consistent JJ O
with IN O
our PRP$ O
previous JJ O
hypothesis NN O
that WDT O
IGFBP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
involved VBN O
in IN O
regulation NN O
of IN O
glucose JJ O
metabolism NN O
. . O

Our PRP$ O
results NNS O
showed VBD O
that IN O
compared VBN O
to TO O
the DT O
primary JJ O
photon NN O
fluence NN O
, , O
the DT O
extra JJ O
- : O
focal JJ O
photon NN O
fluence NN O
from IN O
the DT O
primary JJ O
collimator NN O
and CC O
the DT O
flattening NN O
filter NN O
was VBD O
11 CD O
% NN O
- : O
16 CD O
% NN O
at IN O
the DT O
isocenter NN O
, , O
among IN O
which WDT O
70 CD O
% NN O
was VBD O
contributed VBN O
by IN O
the DT O
flattening NN O
filter NN O
. . O

The DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
SGC1 NNP B-Gene
gene NN I-Gene
product NN I-Gene
includes VBZ O
a DT O
region NN O
with IN O
substantial JJ O
similarity NN O
to TO O
the DT O
basic JJ O
- : O
helix NN O
- : O
loop NN O
- : O
helix NN O
domain NN O
of IN O
the DT O
Myc NNP B-Gene
family NN I-Gene
of IN O
DNA NNP O
- : O
binding NN O
proteins NNS O
. . O

I PRP O
propose VBP O
that IN O
their PRP$ O
gene NN O
products NNS O
bind VBP O
to TO O
the DT O
chromatin NN O
to TO O
establish VB O
or CC O
maintain VB O
a DT O
proper JJ O
higher JJR O
order NN O
structure NN O
as IN O
a DT O
prerequisite NN O
for IN O
a DT O
regulated JJ O
gene NN O
expression NN O
. . O

This DT O
complex JJ O
interacts NNS O
at IN O
the DT O
GTPase NNP B-Gene
domain NN I-Gene
in IN O
the DT O
large JJ O
subunit NN O
rRNA NN O
, , O
overlapping VBG O
the DT O
binding VBG O
site NN O
of IN O
the DT O
protein NN B-Gene
L11 NNP I-Gene
- : I-Gene
like IN I-Gene
eukaryotic JJ I-Gene
counterpart NN I-Gene
( ( O
Saccharomyces NNPS B-Gene
cerevisiae VBP I-Gene
protein NN I-Gene
L15 NNP I-Gene
and CC O
mammalian JJ B-Gene
protein NN I-Gene
L12 NNP I-Gene
) ) O
. . O

Gene NNP B-Gene
1 CD I-Gene
has VBZ O
been VBN O
completely RB O
sequenced VBN O
. . O

The DT O
myeloproliferative JJ O
sarcoma NN O
virus NN O
( ( O
MPSV NNP O
) ) O
was VBD O
derived VBN O
by IN O
passage NN O
of IN O
Moloney NNP O
sarcoma NN O
virus NN O
( ( O
Mo NNP O
- : O
MuSV NN O
) ) O
in IN O
adult NN O
mice NN O
. . O

The DT O
1 CD O
. . O
7 CD O
kb NN O
cloned VBD O
fragment NN O
was VBD O
sequenced VBN O
and CC O
shown VBN O
to TO O
contain VB O
the DT O
entire JJ O
fliA NN B-Gene
gene NN I-Gene
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
LBP NNP B-Gene
- : I-Gene
1 CD I-Gene
represses NNS O
HIV NNP O
- : O
1 CD O
transcription NN O
by IN O
inhibiting VBG O
the DT O
binding NN O
of IN O
TFIID NNP B-Gene
to TO O
the DT O
TATA NNP O
box NN O
. . O

Instead RB O
, , O
it PRP O
contained VBD O
two CD O
tandem NN O
kappaB NN B-Gene
elements NNS I-Gene
and CC O
a DT O
variant JJ O
activating NN B-Gene
transcription NN I-Gene
factor NN I-Gene
/ NNP I-Gene
cAMP NN I-Gene
response NN I-Gene
element NN I-Gene
site NN O
, , O
which WDT O
closely RB O
resembled VBD O
sites NNS O
in IN O
the DT O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
gene NN I-Gene
that WDT O
are VBP O
required VBN O
for IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
or CC O
LPS NNP O
- : O
inducible JJ O
expression NN O
. . O

Among IN O
known VBN O
flea NN O
larvae NN O
, , O
the DT O
genus NN O
Anomiopsyllus NNP O
( ( O
Anomiopsyllinae NNP O
, , O
Anomiopsyllini NNP O
) ) O
is VBZ O
as IN O
distinctive JJ O
in IN O
larval JJ O
form NN O
as IN O
are VBP O
the DT O
adults NNS O
. . O

B NNP B-Gene
- : I-Gene
myb NN I-Gene
is VBZ O
essential JJ O
for IN O
G1 NNP O
/ NNP O
S NNP O
transition NN O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
phosphorylated VBN O
by IN O
the DT O
cyclin NN B-Gene
A2 NNP I-Gene
/ NNP O
cdk2 NN B-Gene
complex NN O
. . O

( ( O
1980 CD O
) ) O
: : O
Science NN O
210 CD O
, , O
77 CD O
- : O
72 CD O
) ) O
that IN O
stimulating VBG O
the DT O
crossed JJ O
olivocochlear JJ O
bundle NN O
( ( O
COCB NNP O
) ) O
can MD O
change VB O
the DT O
magnitude NN O
of IN O
the DT O
distortion NN O
product NN O
( ( O
f2 JJ O
- : O
f1 NN O
) ) O
in IN O
the DT O
ear JJ O
- : O
canal JJ O
sound NN O
pressure NN O
. . O

Mutating VBG O
a DT O
potential JJ O
cleavage NN O
site NN O
located VBN O
N NNP O
- : O
terminal NN O
to TO O
the DT O
protease NN O
domain NN O
, , O
Gln2526 NNP O
- : O
Asp2527 NNP O
, , O
diminished VBD O
processing NN O
. . O

At IN O
the DT O
time NN O
of IN O
the DT O
seizure NN O
, , O
the DT O
patient NN O
was VBD O
asked VBN O
to TO O
read VB O
a DT O
test NN O
phrase NN O
aloud NN O
until IN O
it PRP O
was VBD O
read VBN O
correctly RB O
and CC O
clearly RB O
. . O

Biological JJ O
activities NNS O
of IN O
hematopoietic JJ B-Gene
growth NN I-Gene
factors NNS I-Gene
that WDT O
lead VBP O
to TO O
future JJ O
clinical JJ O
application NN O
. . O

Also RB O
discussed VBN O
is VBZ O
the DT O
possibility NN O
of IN O
a DT O
combined JJ O
genetic JJ O
and CC O
environmental JJ O
etiology NN O
. . O

Ectopic NNP O
expression NN O
of IN O
the DT O
dominant JJ B-Gene
mutant JJ I-Gene
Lg3 NNP I-Gene
allele NN I-Gene
is VBZ O
believed VBN O
to TO O
cause VB O
the DT O
phenotype NN O
. . O

The DT O
genome NN O
of IN O
avian JJ O
erythroblastosis NN O
virus NN O
contains VBZ O
two CD O
independently RB O
expressed VBN O
genetic JJ O
loci NN O
( ( O
v JJ B-Gene
- : I-Gene
erbA NN I-Gene
and CC O
v NN B-Gene
- : I-Gene
erbB NN I-Gene
) ) O
whose WP$ O
activities NNS O
are VBP O
probably RB O
responsible JJ O
for IN O
oncogenesis NN O
by IN O
the DT O
virus NN O
. . O

Mean JJ O
rCBF NN O
increased VBN O
in IN O
some DT O
patients NNS O
4 CD O
- : O
8 CD O
weeks NNS O
after IN O
surgery NN O
on IN O
the DT O
ipsilateral JJ O
side NN O
. . O

The DT O
inhibition NN O
of IN O
StAR NNP B-Gene
gene NN I-Gene
transcription NN O
by IN O
DAX NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
dose JJ O
- : O
dependent NN O
reducing VBG O
transcription NN O
to TO O
6 CD O
% NN O
of IN O
control NN O
levels NNS O
. . O

Furthermore RB O
, , O
an DT O
upstream JJ O
element NN O
, , O
collagen NN B-Gene
element NN I-Gene
I PRP I-Gene
( ( I-Gene
- : I-Gene
370 CD I-Gene
/ SYM I-Gene
- : I-Gene
344 CD I-Gene
) ) I-Gene
, , O
which WDT O
shares NNS O
homology NN O
with IN O
the DT O
LAP NNP B-Gene
binding NN O
cis NN O
- : O
element NN O
of IN O
the DT O
albumin NN B-Gene
promoter NN I-Gene
( ( O
9 CD O
of IN O
13 CD O
bp NN O
) ) O
is VBZ O
described VBN O
. . O

Cellular JJ B-Gene
Csk NNP I-Gene
was VBD O
associated VBN O
with IN O
several JJ O
phosphoproteins NNS O
, , O
some DT O
of IN O
which WDT O
were VBD O
interacting VBG O
with IN O
the DT O
Csk NNP B-Gene
SH2 NNP B-Gene
domain NN I-Gene
. . O

Complete JJ O
nucleotide JJ O
sequence NN O
of IN O
the DT O
bacteriophage NN B-Gene
K1F NNP I-Gene
tail NN I-Gene
gene NN I-Gene
encoding VBG O
endo SYM B-Gene
- : I-Gene
N NNP I-Gene
- : I-Gene
acylneuraminidase NN I-Gene
( ( O
endo JJ B-Gene
- : I-Gene
N NNP I-Gene
) ) O
and CC O
comparison NN O
to TO O
an DT O
endo JJ B-Gene
- : I-Gene
N NNP I-Gene
homolog NN I-Gene
in IN O
bacteriophage NN O
PK1E NNP O
. . O

Self NNP O
- : O
heating NN O
after IN O
deep JJ O
hypothermia NN O
( ( O
20 CD O
degrees NNS O
C NNP O
) ) O
causes VBZ O
a DT O
considerable JJ O
increase NN O
in IN O
the DT O
brain NN O
tissues NNS O
glutaminase VBP B-Gene
activity NN O
at IN O
all DT O
studied JJ O
incubation NN O
temperatures NNS O
( ( O
37 CD O
, , O
30 CD O
, , O
20 CD O
and CC O
10 CD O
degrees NNS O
C NNP O
) ) O
as IN O
compared VBN O
to TO O
control VB O
rats NNS O
and CC O
rats NNS O
under IN O
hypothermia NN O
. . O

Chronic NNP O
renal JJ O
failure NN O
patients NNS O
essentially RB O
die VBP O
from IN O
cardiovascular JJ O
causes NNS O
, , O
and CC O
the DT O
frequency NN O
of IN O
malignant JJ O
disease NN O
responsible JJ O
for IN O
death NN O
is VBZ O
estimated VBN O
to TO O
be VB O
10 CD O
% NN O
. . O

Mammalian JJ B-Gene
M NNP I-Gene
- : I-Gene
Ras NNP I-Gene
and CC O
a DT O
Caenorhabditis NNP O
elegans VBZ O
orthologue JJ O
exhibit NN O
conserved VBD O
structural JJ O
features NNS O
, , O
and CC O
these DT O
are VBP O
likely JJ O
to TO O
mediate VB O
activation NN O
of IN O
distinctive JJ O
signaling VBG O
paths NNS O
that WDT O
function VBP O
in IN O
parallel NN O
to TO O
those DT O
downstream NN O
of IN O
p21 NN B-Gene
Ras NNP I-Gene
. . O

Transient JJ O
transfection NN O
analysis NN O
with IN O
these DT O
mutations NNS O
revealed VBD O
that IN O
only RB O
a DT O
10 CD O
- : O
bp NN O
region NN O
, , O
containing VBG O
precisely RB O
the DT O
Ets NNP B-Gene
and CC O
proximal JJ O
LyF NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
was VBD O
needed VBN O
for IN O
D NNP O
' POS O
activity NN O
. . O

Here RB O
we PRP O
report VBP O
the DT O
cloning NN O
of IN O
the DT O
protein NN O
that WDT O
binds VBZ O
to TO O
enhancer VB O
site NN O
III NNP O
. . O

The DT O
transcription NN O
start NN O
point NN O
of IN O
the DT O
proximal JJ O
promoter NN O
aligns NNS O
to TO O
that DT O
of IN O
mouse NN O
promoter NN O
P3 NNP O
and CC O
lies VBZ O
within IN O
a DT O
conserved JJ O
region NN O
of IN O
sequence NN O
. . O

The DT O
BAL NNP O
- : O
to TO O
- : O
plasma NN O
specific JJ O
activity NN O
of IN O
urea NN O
was VBD O
about IN O
twice RB O
that DT O
of IN O
Na NNP O
+ NNP O
, , O
indicating VBG O
that IN O
urea JJ O
diffused VBD O
into IN O
the DT O
ELF NNP O
more RBR O
rapidly RB O
than IN O
Na NNP O
+ NNP O
during IN O
the DT O
70 CD O
s NN O
that WDT O
elapsed VBD O
between IN O
the DT O
time NN O
the DT O
radioactive JJ O
urea NN O
and CC O
Na NNP O
+ NNP O
were VBD O
injected VBN O
into IN O
the DT O
circulation NN O
and CC O
the DT O
time NN O
when WRB O
lavage NN O
was VBD O
complete JJ O
. . O

Certain NNP O
characteristics NNS O
of IN O
eye NN O
changes NNS O
in IN O
patients NNS O
with IN O
pheochromocytoma JJ O
including VBG O
Sipple NNP O
' POS O
s NN O
syndrome NN O

In IN O
10 CD O
control NN O
sheep JJ O
mean NN O
plasma NN O
TXB2 NNP O
concentration NN O
increased VBD O
from IN O
0 CD O
. . O
39 CD O
ng JJ O
/ NNP O
ml NN O
prebypass NN O
to TO O
about IN O
1 CD O
. . O
1 CD O
ng JJ O
/ NN O
ml NN O
at IN O
8 CD O
and CC O
16 CD O
min NN O
of IN O
bypass NN O
. . O

Compared VBN O
to TO O
white JJ O
- : O
on IN O
- : O
white JJ O
( ( O
W NNP O
- : O
W NNP O
) ) O
perimetry NN O
, , O
SWAP NNP O
is VBZ O
limited VBN O
clinically RB O
by IN O
: : O
greater JJR O
variability NN O
associated VBN O
with IN O
the DT O
estimation NN O
of IN O
threshold NN O
, , O
ocular JJ O
media NNS O
absorption NN O
, , O
increased VBN O
examination NN O
duration NN O
and CC O
an DT O
additional JJ O
learning NN O
effect NN O
. . O

Efficacy NN O
and CC O
safety NN O
of IN O
aspirin NN O
in IN O
the DT O
long JJ O
- : O
term NN O
management NN O
of IN O
atherothrombosis NN O
. . O

However RB O
, , O
three CD O
Hm1 NNP B-Gene
mutants NNS I-Gene
that WDT O
were VBD O
moderately RB O
deficient JJ O
in IN O
stimulating VBG O
PI NNP O
turnover RB O
displayed VBD O
normal JJ O
sequestration NN O
, , O
suggesting VBG O
distinct JJ O
mechanisms NNS O
. . O

When WRB O
the DT O
PHT NNP O
and CC O
CSA NNP O
groups NNS O
were VBD O
compared VBN O
, , O
Hyp NNP O
levels NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
PHT NNP O
- : O
GO NNP O
+ NNP O
group NN O
than IN O
in IN O
the DT O
CSA NNP O
- : O
GO NNP O
+ NNP O
group NN O
. . O

Erythromycin NNP O
and CC O
clindamycin JJ O
resistance NN O
in IN O
Corynebacterium NNP O
diphtheriae NN O
from IN O
skin JJ O
lesions NNS O
. . O

Typical JJ O
configurations NNS O
of IN O
psychosocial JJ O
stress NN O
factors NNS O
of IN O
psychiatrically RB O
conspicuous JJ O
children NNS O
and CC O
adolescents NNS O

Mutations NNS O
affecting VBG O
only RB O
CD4 NNP B-Gene
regulation NN O
mapped VBD O
to TO O
residues VB O
previously RB O
shown VBN O
to TO O
mediate VB O
the DT O
binding NN O
of IN O
Nef NNP B-Gene
to TO O
this DT O
receptor NN O
, , O
such JJ O
as IN O
W57 NNP O
and CC O
L58 NNP O
, , O
as RB O
well RB O
as IN O
to TO O
an DT O
AP NNP B-Gene
- : I-Gene
recruiting NN I-Gene
dileucine NN I-Gene
motif NN I-Gene
and CC O
to TO O
an DT O
acidic JJ O
dipeptide NN O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
protein NN O
. . O

Generally RB O
the DT O
differences NNS O
between IN O
short JJ O
gut NN O
and CC O
sham NN O
operation NN O
animals NNS O
disappeared VBD O
when WRB O
the DT O
data NNS O
were VBD O
normalised VBN O
for IN O
mucosal NN O
weight NN O
. . O

A DT O
total NN O
of IN O
281 CD O
patients NNS O
were VBD O
divided VBN O
into IN O
groups NNS O
according VBG O
to TO O
their PRP$ O
clinical JJ O
diagnosis NN O
and CC O
were VBD O
examined VBN O
using VBG O
capnography NN O
, , O
spirometry NN O
and CC O
blood NN O
- : O
gas NN O
analysis NN O
. . O

A DT O
. . O

The DT O
incompatibility NN O
group NN O
W NNP O
plasmid VBZ O
pSa JJ O
suppresses NNS O
Agrobacterium VBP O
tumefaciens NNS O
oncogenicity NN O
( ( O
J NNP O
. . O

Several JJ O
lines NNS O
of IN O
evidence NN O
demonstrate NN O
that IN O
this DT O
growth NN O
inhibition NN O
requires VBZ O
active JJ O
PKA NNP B-Gene
subunits NNS I-Gene
and CC O
cAMP NN O
: : O
( ( O
i NN O
) ) O
this DT O
phenotype NN O
is VBZ O
dependent JJ O
on IN O
cAMP NN O
since IN O
it PRP O
is VBZ O
not RB O
seen VBN O
in IN O
a DT O
strain NN O
lacking VBG O
adenylyl JJ B-Gene
cyclase NN I-Gene
activity NN O
, , O
but CC O
the DT O
growth NN O
rate NN O
of IN O
these DT O
transformants NNS O
is VBZ O
slower JJR O
when WRB O
exogenous JJ O
cAMP NN O
is VBZ O
added VBN O
; : O
( ( O
ii NN O
) ) O
normal JJ O
growth NN O
occurs VBZ O
when WRB O
wild JJ O
- : O
type NN O
RI NNP B-Gene
cDNA NN O
is VBZ O
replaced VBN O
by IN O
a DT O
mutant JJ B-Gene
RI NNP I-Gene
cDNA NN I-Gene
encoding VBG O
a DT O
RI NNP B-Gene
protein NN I-Gene
with IN O
reduced JJ O
cAMP NN O
binding NN O
; : O
and CC O
( ( O
iii NN O
) ) O
the DT O
growth NN O
- : O
inhibited VBN O
phenotype NN O
of IN O
the DT O
transformed JJ O
BL21 NNP O
( ( O
DE3 NNP O
) ) O
cells NNS O
requires VBZ O
soluble JJ O
, , O
active JJ O
C NNP B-Gene
alpha NN I-Gene
protein NN I-Gene
. . O

Molecular JJ O
characterization NN O
of IN O
malignant JJ O
melanoma NN O
of IN O
soft JJ O
parts NNS O
or CC O
soft JJ O
tissue NN O
clear JJ O
cell NN O
sarcoma NN O
which WDT O
shares NNS O
t VBP O
( ( O
12 CD O
; : O
22 CD O
) ) O
chromosome NN O
translocation NN O
revealed VBD O
fusion NN O
of IN O
EWS NNP B-Gene
with IN O
a DT O
transcriptional JJ O
factor NN O
gene NN B-Gene
ATF NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Kinetics NNS O
of IN O
the DT O
inhibition NN O
indicated VBD O
that IN O
this DT O
polymerase NN O
domain NN O
can MD O
inhibit VB O
viral JJ O
replication NN O
only RB O
during IN O
the DT O
preinitiation NN O
stage NN O
. . O

The DT O
structural JJ O
gene NN O
for IN O
copper NN B-Gene
- : I-Gene
and CC I-Gene
topa VB I-Gene
quinone NN I-Gene
- : I-Gene
containing VBG I-Gene
monoamine JJ I-Gene
oxidase NN I-Gene
( ( O
maoA NN B-Gene
) ) O
and CC O
an DT O
unknown JJ O
amine NN B-Gene
oxidase NN I-Gene
gene NN I-Gene
have VBP O
been VBN O
located VBN O
at IN O
30 CD O
. . O
9 CD O
min NN O
on IN O
the DT O
Escherichia NNP O
coli VBZ O
chromosome NN O
. . O

The DT O
natural JJ O
history NN O
of IN O
these DT O
lesions NNS O
, , O
locoregional JJ O
efficiency NN O
of IN O
the DT O
different JJ O
treatments NNS O
used VBN O
, , O
the DT O
part NN O
played VBN O
by IN O
chemotherapy NN O
, , O
survival NN O
, , O
causes NNS O
of IN O
death NN O
and CC O
therapeutic JJ O
modalities NNS O
used VBN O
as IN O
a DT O
last JJ O
measure NN O
, , O
have VBP O
been VBN O
analysed VBN O
. . O

The DT O
effects NNS O
of IN O
Codonopsis NNP O
pilosula FW O
oral JJ O
liquor NN O
( ( O
CPOL NNP O
) ) O
on IN O
tissue NN B-Gene
- : I-Gene
type NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
t JJ B-Gene
- : I-Gene
PA NN I-Gene
) ) O
and CC O
plasminogen NN B-Gene
activator NN I-Gene
inhibitor NN I-Gene
( ( O
PAI NNP B-Gene
) ) O
in IN O
the DT O
plasma NN O
of IN O
25 CD O
patients NNS O
of IN O
coronary JJ O
heart NN O
disease NN O
with IN O
blood NN O
stasis NN O
were VBD O
studied VBN O
. . O

Serum NNP O
lipid JJ O
changes NNS O
during IN O
pregnancy NN O
due JJ O
to TO O
oral JJ O
calcium NN O
administration NN O

The DT O
minimal JJ O
region NN O
of IN O
overlap NN O
of IN O
Langer NNP O
- : O
Giedion NNP O
syndrome JJ O
deletions NNS O
, , O
previously RB O
identified VBN O
by IN O
analysis NN O
of IN O
15 CD O
patients NNS O
, , O
was VBD O
placed VBN O
on IN O
the DT O
map NN O
by IN O
analysis NN O
of IN O
2 CD O
patients NNS O
whose WP$ O
deletions NNS O
define VBP O
the DT O
endpoints NNS O
. . O

ALT NNP B-Gene
levels NNS O
in IN O
responders NNS O
were VBD O
lowered VBN O
by IN O
46 CD O
% NN O
and CC O
AST NNP B-Gene
levels NNS O
were VBD O
lowered VBN O
by IN O
35 CD O
% NN O
after IN O
12 CD O
weeks NNS O
of IN O
vitamin JJ O
E NNP O
treatment NN O
. . O

The DT O
mEmBP NN B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
can MD O
activate VB O
transcription NN O
from IN O
a DT O
truncated JJ O
promoter NN O
containing VBG O
a DT O
pentamer NN O
of IN O
the DT O
O2 NNP B-Gene
site NN I-Gene
in IN O
yeast JJ O
cells NNS O
; : O
however RB O
, , O
it PRP O
inhibited VBD O
regulated JJ O
transcription NN O
of IN O
a DT O
22 CD B-Gene
kDa NN I-Gene
zein NN I-Gene
promoter NN I-Gene
in IN O
a DT O
transient JJ O
expression NN O
assay VBP O
using VBG O
cultured VBN O
maize JJ O
endosperm JJ O
cells NNS O
. . O

A DT O
region NN O
of IN O
the DT O
deduced JJ O
protein NN O
shares NNS O
extensive JJ O
homology NN O
with IN O
a DT O
catalytic JJ O
region NN O
of IN O
Raf NNP B-Gene
kinases NNS I-Gene
, , O
a DT O
feature NN O
shared VBN O
only RB O
with IN O
TFIIE NNP B-Gene
among IN O
transcription NN O
factors NNS O
. . O

Nerve NNP B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
NGF NNP B-Gene
) ) O
and CC O
retinoic JJ O
acid NN O
( ( O
RA NNP O
) ) O
exert VBP O
important JJ O
actions NNS O
on IN O
PC12 NNP O
cells NNS O
. . O

In IN O
the DT O
last JJ O
case NN O
, , O
both DT O
hydroxychloroquine NN O
, , O
carbamazepine NN O
and CC O
fluvoxamine NN O
had VBD O
a DT O
common JJ O
imputability NN O
which WDT O
was VBD O
plausible JJ O
. . O

Studies NNS O
in IN O
mammalian JJ O
cells NNS O
have VBP O
correlated VBN O
induction NN O
of IN O
inhibitory JJ O
tyrosine NN O
15 CD O
( ( O
Y15 NNP O
) ) O
phosphorylation NN O
on IN O
p34cdc2 NN B-Gene
with IN O
the DT O
response NN O
to TO O
DNA NNP O
damage NN O
. . O

The DT O
perifascicular JJ O
connective JJ O
tissue NN O
sheath NN O
is VBZ O
important JJ O
in IN O
organising VBG O
the DT O
contraction NN O
of IN O
the DT O
myocardium NN O
by IN O
preventing VBG O
lateral JJ O
spread NN O
of IN O
conduction NN O
and CC O
by IN O
permitting VBG O
transmission NN O
of IN O
the DT O
impulse JJ O
only RB O
at IN O
the DT O
termination NN O
of IN O
the DT O
purkinje NN O
fibre NN O
. . O

Using VBG O
the DT O
balloon NN O
- : O
gas NN O
procedure NN O
with IN O
a DT O
single JJ O
gas NN O
injection NN O
, , O
a DT O
bubble NN O
was VBD O
obtained VBN O
that IN O
was VBD O
large JJ O
enough RB O
to TO O
tamponade VB O
a DT O
giant JJ O
tear NN O
without IN O
prior JJ O
drainage NN O
of IN O
subretinal JJ O
fluid NN O
or CC O
vitrectomy NN O
. . O

Suppressive JJ O
therapy NN O
for IN O
thyroid JJ O
nodules NNS O
. . O

Folded VBN O
tissue NN O
and CC O
crimped VBD O
collagen NN B-Gene
fibers NNS O
in IN O
the DT O
tunica NN O
albuginea VBZ O
permit VBP O
its PRP$ O
expansion NN O
during IN O
erection NN O
. . O

This DT O
virus NN O
is VBZ O
not RB O
merely RB O
a DT O
South JJ O
African JJ O
strain NN O
of IN O
passion NN O
fruit NN O
woodiness NN O
virus NN O
( ( O
PWV NNP O
) ) O
: : O
the DT O
deduced JJ O
CP NNP B-Gene
sequence NN I-Gene
is VBZ O
only RB O
distantly RB O
related VBN O
to TO O
CPs NNP B-Gene
of IN O
other JJ O
sequenced JJ O
strains NNS O
of IN O
PWV NNP O
, , O
although IN O
it PRP O
is VBZ O
part NN O
of IN O
a DT O
distinct JJ O
subgroup NN O
of IN O
potyviruses NNS O
related VBN O
to TO O
PWV NNP O
. . O

Osteoadherin NNP B-Gene
is VBZ O
a DT O
recently RB O
described VBN O
bone NN O
proteoglycan JJ O
containing VBG O
keratan JJ O
sulfate NN O
. . O

Malonate NNP O
decarboxylation NN O
in IN O
Malonomonas NNP O
rubra NN O
involves VBZ O
the DT O
formation NN O
of IN O
malonyl JJ B-Gene
- : I-Gene
S NNP I-Gene
- : I-Gene
[ NN I-Gene
acyl SYM I-Gene
- : I-Gene
carrier NN I-Gene
protein NNS I-Gene
] VBP I-Gene
from IN O
acetyl JJ B-Gene
- : I-Gene
S NNP I-Gene
- : I-Gene
[ NN I-Gene
acyl SYM I-Gene
- : I-Gene
carrier NN I-Gene
protein NN I-Gene
] NN I-Gene
and CC O
malonate NN O
, , O
carboxyltransfer NN O
to TO O
a DT O
biotin NN B-Gene
protein NN I-Gene
and CC O
its PRP$ O
decarboxylation NN O
that DT O
is VBZ O
coupled VBN O
to TO O
delta VB O
mu VB O
Na NNP O
+ NNP O
generation NN O
. . O

No DT O
patient NN O
had VBD O
a DT O
history NN O
of IN O
excess JJ O
alcohol NN O
intake NN O
, , O
or CC O
prolonged JJ O
intake NN O
of IN O
hepatotoxic NN O
drugs NNS O
and CC O
steroids NNS O
, , O
and CC O
were VBD O
not RB O
obese JJ O
or CC O
malnourished VBN O
. . O

The DT O
results NNS O
show VBP O
that IN O
cognitive JJ O
stimulation NN O
enhanced VBD O
performance NN O
on IN O
the DT O
Boston NNP O
Naming NNP O
Test NNP O
and CC O
a DT O
Word NNP O
List NNP O
Recognition NNP O
Task NNP O
; : O
physical JJ O
intervention NN O
, , O
however RB O
, , O
did VBD O
not RB O
reach VB O
statistical JJ O
significance NN O
. . O

The DT O
effectiveness NN O
of IN O
the DT O
haemodialysate NN O
Solcoseryl NNP O
for IN O
second JJ O
- : O
intention NN O
wound IN O
healing VBG O
in IN O
horses NNS O
and CC O
ponies NNS O
. . O

The DT O
result NN O
suggests VBZ O
that IN O
this DT O
non JJ O
- : O
invasive JJ O
TTD NNP O
method NN O
is VBZ O
easily RB O
available JJ O
and CC O
useful JJ O
in IN O
monitoring VBG O
the DT O
intraoperative JJ O
cardiac NN O
output NN O
. . O

In IN O
contrast NN O
to TO O
T NNP O
cells NNS O
, , O
in IN O
fibroblasts NNS O
PILOT NNP B-Gene
gene NN I-Gene
expression NN O
requires VBZ O
only RB O
one CD O
signal NN O
( ( O
PMA NNP O
) ) O
and CC O
is VBZ O
not RB O
affected VBN O
by IN O
CyA NNP O
. . O

The DT O
interindividual JJ O
variability NN O
of IN O
the DT O
parameters NNS O
is VBZ O
taken VBN O
into IN O
consideration NN O
by IN O
interactively RB O
determining VBG O
the DT O
threshold NN O
levels NNS O
. . O

The DT O
ED30 NNP O
values NNS O
were VBD O
2 CD O
. . O
4 CD O
and CC O
2 CD O
. . O
2 CD O
mg JJ O
/ NNP O
kg NN O
and CC O
similar JJ O
to TO O
the DT O
respective JJ O
values NNS O
of IN O
nifedipine NN O
( ( O
ED JJ O
30 CD O
: : O
2 CD O
. . O
4 CD O
, , O
2 CD O
. . O
1 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
. . O

Together RB O
, , O
our PRP$ O
results NNS O
show VBP O
that IN O
tinman NN B-Gene
is VBZ O
controlled VBN O
by IN O
an DT O
array NN O
of IN O
discrete JJ O
enhancer NN O
elements NNS O
that WDT O
are VBP O
activated VBN O
successively RB O
by IN O
differential JJ O
genetic JJ O
inputs NNS O
, , O
as RB O
well RB O
as IN O
by IN O
closely RB O
linked VBN O
activator NN O
and CC O
repressor NN O
binding NN O
sites NNS O
within IN O
an DT O
early JJ O
- : O
acting VBG O
enhancer NN O
, , O
which WDT O
restrict VBP O
twist NN B-Gene
activity NN O
to TO O
specific JJ O
areas NNS O
within IN O
the DT O
twist JJ B-Gene
expression NN I-Gene
domain NN I-Gene
. . O

Choice NNP O
of IN O
vessel NN O
. . O

The DT O
ligand NN O
for IN O
RXR NNP B-Gene
, , O
9 CD O
- : O
cis NN O
retinoic NN O
acid NN O
, , O
has VBZ O
the DT O
opposite JJ O
effect NN O
of IN O
destabilizing VBG O
the DT O
heterodimeric JJ O
- : O
DNA NN O
complex NN O
. . O

The DT O
latter JJ O
method NN O
adds VBZ O
clamping VBG O
of IN O
the DT O
inferior JJ O
vena NN O
cava NN O
, , O
which WDT O
results NNS O
in IN O
hypotension NN O
, , O
requiring VBG O
invasive JJ O
anesthetic JJ O
management NN O
. . O

P NNP O
. . O
, , O
Peyron NNP O
, , O
J NNP O
. . O

The DT O
gene NN O
for IN O
the DT O
RNA NNP B-Gene
- : I-Gene
dependent NN I-Gene
eIF SYM I-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
PKR NNP B-Gene
) ) O
was VBD O
isolated VBN O
from IN O
mouse NN O
genomic JJ O
DNA NNP O
and CC O
characterized VBN O
. . O

Expression NN O
of IN O
p130 NN B-Gene
( ( O
Cas NNP B-Gene
) ) O
( ( O
Cas NNP B-Gene
) ) O
, , O
a DT O
major JJ O
binding NN O
protein NN O
for IN O
the DT O
Crk NNP B-Gene
SH2 NNP B-Gene
- : I-Gene
domain NN I-Gene
, , O
also RB O
induced VBD O
JNK NNP B-Gene
activation NN O
, , O
which WDT O
was VBD O
blocked VBN O
by IN O
the DT O
SH2 NNP B-Gene
- : I-Gene
mutant NN I-Gene
of IN O
Crk NNP B-Gene
. . O

Microvessels NNS O
were VBD O
counted VBN O
in IN O
a DT O
x200 JJ O
field NN O
( ( O
0 CD O
. . O
754 CD O
mm2 NN O
) ) O
in IN O
the DT O
area NN O
of IN O
maximal JJ O
angiogenesis NN O
. . O

Our PRP$ O
studies NNS O
also RB O
excluded VBD O
the DT O
possibility NN O
that IN O
the DT O
phosphorylation NN O
of IN O
Ser NNP O
- : O
2 CD O
, , O
Ser NNP O
- : O
123 CD O
, , O
or CC O
Ser NNP O
- : O
210 CD O
, , O
had VBD O
roles NNS O
in IN O
the DT O
trans NNS O
- : O
suppression NN O
activity NN O
of IN O
the DT O
large JJ B-Gene
HDAg NNP I-Gene
, , O
in IN O
the DT O
assembly NN O
of IN O
empty JJ O
virus FW B-Gene
- : I-Gene
like IN I-Gene
HDAg NNP I-Gene
particle NN I-Gene
, , O
and CC O
in IN O
the DT O
nuclear JJ O
transport NN O
of IN O
HDAgs NNP B-Gene
. . O

SAECG NNP O
, , O
echocardiography NN O
and CC O
thallium NN O
- : O
201 CD O
imaging NN O
were VBD O
performed VBN O
before IN O
and CC O
1 CD O
month NN O
after IN O
attempted JJ O
angioplasty NN O
. . O

Activation NN O
of IN O
transcription NN O
through IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
Jurkat NNP O
cells NNS O
by IN O
JunD NNP B-Gene
and CC O
/ NNP O
or CC O
Fra NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
weak JJ O
. . O

c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
JunB NNP B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
activation NN O
was VBD O
greater JJR O
, , O
although IN O
the DT O
level NN O
was VBD O
still RB O
less JJR O
than IN O
that DT O
with IN O
Tax NNP B-Gene
. . O

The DT O
decline NN O
in IN O
the DT O
activity NN O
of IN O
cytochrome JJ B-Gene
oxidase NN I-Gene
, , O
peroxidase NN B-Gene
and CC O
in IN O
the DT O
lipid JJ O
content NN O
of IN O
peripheral JJ O
neutrophils NNS O
was VBD O
followed VBN O
by IN O
a DT O
decrease NN O
in IN O
the DT O
phagocytic JJ O
activity NN O
. . O

For IN O
the DT O
first JJ O
time NN O
we PRP O
describe VBP O
deletion NN O
and CC O
point NN O
mutations NNS O
within IN O
the DT O
plasma NN B-Gene
membrane VBD I-Gene
family NN I-Gene
of IN I-Gene
guanylyl JJ I-Gene
cyclase NN I-Gene
receptors NNS I-Gene
that WDT O
result VBP O
in IN O
the DT O
formation NN O
of IN O
effective JJ O
dominant JJ O
negative JJ O
proteins NNS O
. . O

Both DT O
in IN O
vitro NN O
- : O
synthesized VBN O
S2 NNP B-Gene
protein NN I-Gene
and CC O
synthetic JJ O
peptides NNS O
corresponding VBG O
to TO O
S2 NNP B-Gene
are VBP O
shown VBN O
to TO O
react VB O
positively RB O
with IN O
sera NN O
obtained VBN O
from IN O
EIAV NNP O
- : O
infected JJ O
horses NNS O
, , O
providing VBG O
the DT O
first JJ O
direct JJ O
evidence NN O
of IN O
expression NN O
of IN O
this DT O
protein NN O
in IN O
infected JJ O
animals NNS O
. . O

188 CD O
patients NNS O
received VBD O
cimetidine JJ O
400 CD O
mg NN O
q NN O
. . O
i NN O
. . O
d NN O
. . O
intravenously RB O
and CC O
1 CD O
, , O
0 CD O
mg JJ O
daily JJ O
orally RB O
in IN O
divided JJ O
doses NNS O
. . O

A DT O
genetic JJ O
screen NN O
in IN O
yeast NN O
has VBZ O
allowed VBN O
us PRP O
to TO O
identify VB O
a DT O
novel JJ O
transcriptional JJ O
factor NN O
binding VBG O
to TO O
the DT O
GlRE NNP O
, , O
i NN O
. . O
e NN O
. . O
the DT O
chicken NN B-Gene
ovalbumin NN I-Gene
upstream NN I-Gene
promoter NN I-Gene
- : I-Gene
transcription NN I-Gene
factor NN I-Gene
II NNP I-Gene
( ( O
COUP NNP B-Gene
- : I-Gene
TFII NN I-Gene
) ) O
. . O

A DT O
hospital NN O
- : O
based VBN O
study NN O
of IN O
the DT O
relationship NN O
between IN O
retained VBN O
placenta NN O
and CC O
mastitis NN O
in IN O
dairy NN O
cows NNS O
. . O

The DT O
effects NNS O
of IN O
intracisternal JJ O
injection NN O
( ( O
i JJ O
. . O
c NN O
. . O
i NN O
. . O
) ) O
of IN O
clonidine NN O
( ( O
1 CD O
microgram NN O
kg SYM O
- : O
1 CD O
) ) O
on IN O
blood NN O
pressure NN O
and CC O
heart NN O
rate NN O
were VBD O
studied VBN O
in IN O
conscious JJ O
rabbits NNS O
with IN O
an DT O
implanted JJ O
catheter NN O
in IN O
the DT O
cisterna NN O
magna NN O
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

9 CD O
, , O
1498 CD O
- : O
1506 CD O
) ) O
. . O

These DT O
studies NNS O
demonstrate VBP O
that IN O
site NN O
- : O
specific JJ O
recognition NN O
of IN O
the DT O
bxd NN B-Gene
PRE NNP I-Gene
by IN O
d NN O
( ( O
GA NNP O
) ) O
( ( O
n JJ O
) ) O
repeat NN O
binding VBG O
activities NNS O
mediates VBZ O
PcG NNP B-Gene
- : O
dependent NN O
silencing NN O
. . O

Initial JJ O
experience NN O
with IN O
the DT O
new JJ O
technology NN O
indicates VBZ O
that IN O
SieScape NNP O
is VBZ O
an DT O
alternative JJ O
to TO O
other JJ O
methods NNS O
such JJ O
as IN O
CT NNP O
and CC O
MRI NNP O
. . O

BACKGROUND NN O
: : O
In IN O
the DT O
ubiquitin JJ B-Gene
- : O
dependent JJ O
proteolysis NN O
pathway NN O
, , O
a DT O
ubiquitin JJ B-Gene
ligase NN I-Gene
( ( O
E3 NNP B-Gene
) ) O
is VBZ O
responsible JJ O
for IN O
substrate JJ O
selectivity NN O
and CC O
timing NN O
of IN O
degradation NN O
. . O

Studies NNS O
using VBG O
HLA NNP B-Gene
- : I-Gene
DR NNP I-Gene
- : O
B7 NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
LFA NNP B-Gene
- : I-Gene
3 CD I-Gene
triple JJ O
transfectants NNS O
showed VBD O
that IN O
the DT O
LFA NNP B-Gene
- : I-Gene
3 CD I-Gene
- : O
induced VBN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
DNA NNP O
binding VBG O
activity NN O
was VBD O
negatively RB O
regulated VBN O
by IN O
B7 NNP B-Gene
- : I-Gene
1 CD I-Gene
costimulation NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
lesions NNS O
of IN O
the DT O
OPT NNP O
complex NN O
( ( O
the DT O
thalamic JJ O
source NN O
of IN O
afferents NNS O
to TO O
IHA NNP O
and CC O
HD NNP O
) ) O
were VBD O
found VBN O
to TO O
have VB O
no DT O
effect NN O
on IN O
color NN O
- : O
reversal NN O
learning JJ O
performance NN O
. . O

However RB O
, , O
further JJ O
analyses NNS O
of IN O
the DT O
data NNS O
indicate VBP O
that IN O
increasing VBG O
VO2 NNP O
AT NNP O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
63 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
rather RB O
than IN O
VO2max NNP O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
15 CD O
) ) O
could MD O
result VB O
in IN O
improving VBG O
the DT O
10 CD O
, , O
0 CD O
m NN O
race NN O
performance NN O
to TO O
a DT O
larger JJR O
extent NN O
, , O
and CC O
that IN O
the DT O
absolute JJ O
amount NN O
of IN O
change NN O
( ( O
delta NN O
) ) O
in IN O
the DT O
10 CD O
, , O
0 CD O
m NN O
run NN O
time NN O
is VBZ O
best RB O
accounted VBN O
for IN O
by IN O
a DT O
combination NN O
of IN O
delta JJ O
VO2 NNP O
AT NNP O
and CC O
delta JJ O
5 CD O
, , O
0 CD O
m NN O
run NN O
time NN O
. . O

By IN O
order NN O
of IN O
decreasing VBG O
rate NN O
, , O
finger NN O
flexors NNS O
, , O
jaw NN O
, , O
crossed VBD O
adductors NNS O
, , O
and CC O
triceps NNS O
reflexes NNS O
were VBD O
less RBR O
frequently RB O
elicited VBN O
in IN O
both DT O
groups NNS O
. . O

Intravenous JJ O
L NNP O
- : O
carnitine NN O
treatment NN O
increased VBD O
plasma JJ O
carnitine NN O
concentrations NNS O
, , O
improved VBN O
patient JJ O
- : O
assessed JJ O
fatigue NN O
, , O
and CC O
may MD O
prevent VB O
the DT O
decline NN O
in IN O
peak JJ O
exercise NN O
capacity NN O
in IN O
hemodialysis NN O
patients NNS O
. . O

The DT O
shift NN O
in IN O
the DT O
earliest JJS O
activation NN O
site NN O
after IN O
administration NN O
of IN O
esmolol NN O
was VBD O
compared VBN O
with IN O
the DT O
shift NN O
after IN O
RFA NNP O
. . O

RESULTS NN O
: : O
The DT O
heart NN O
rate NN O
at IN O
rest NN O
and CC O
in IN O
drug NN O
- : O
free JJ O
state NN O
ranged VBD O
between IN O
95 CD O
and CC O
125 CD O
beats NNS O
/ VBP O
min NN O
( ( O
mean JJ O
99 CD O
+ NN O
/ NNP O
- : O
14 CD O
beats NNS O
/ VBP O
min NN O
) ) O
. . O

To TO O
evaluate VB O
the DT O
gas NN O
chromatographic JJ O
electron NN O
capture NN O
detection NN O
method NN O
described VBN O
earlier RBR O
, , O
23 CD O
plasma NN O
samples NNS O
have VBP O
been VBN O
analysed VBN O
by IN O
both DT O
techniques NNS O
. . O

The DT O
TUP1 NNP B-Gene
gene NN I-Gene
was VBD O
isolated VBN O
in IN O
a DT O
screen NN O
for IN O
genes NNS O
that WDT O
regulate VBP O
mating VBG O
type NN O
( ( O
V NNP O
. . O
L NNP O
. . O

Angiography NNP O
was VBD O
performed VBN O
following VBG O
the DT O
rCBF NN O
study NN O
and CC O
the DT O
degree NN O
of IN O
vasospasm NN O
was VBD O
measured VBN O
on IN O
the DT O
angiograms NNS O
. . O

A DT O
marked JJ O
decrease NN O
in IN O
the DT O
type NN B-Gene
1 CD I-Gene
insulin NN I-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
( ( I-Gene
IGF NNP I-Gene
) ) I-Gene
receptor NN I-Gene
( ( O
IGF NNP B-Gene
- : I-Gene
IR NN I-Gene
) ) O
occurs VBZ O
in IN O
prostate JJ O
epithelial JJ O
cells NNS O
during IN O
transformation NN O
from IN O
the DT O
benign NN O
to TO O
the DT O
metastatic JJ O
state NN O
. . O

The DT O
detection NN O
of IN O
ORF NNP B-Gene
- : I-Gene
1 CD I-Gene
sequences NNS O
in IN O
human JJ O
tumors NNS O
, , O
while IN O
not RB O
proof JJ O
per IN O
se NN O
, , O
is VBZ O
a DT O
prerequisite NN O
for IN O
establishing VBG O
its PRP$ O
role NN O
in IN O
tumor NN O
development NN O
. . O

The DT O
results NNS O
revealed VBD O
a DT O
hierarchy NN O
of IN O
ligand NN O
affinities NNS O
that WDT O
mirrored VBD O
their PRP$ O
adhesive JJ O
activity NN O
( ( O
rsVCAM JJ B-Gene
- : I-Gene
1 CD I-Gene
> NN O
fibronectin NN B-Gene
variants NNS I-Gene
containing VBG O
CS1 NNP B-Gene
> NNP O
> NNP O
other JJ O
fibronectin JJ B-Gene
variants NNS I-Gene
) ) O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
proper JJ O
direct JJ O
binding NN O
of IN O
Nhp2p NNP B-Gene
to TO O
H NNP B-Gene
/ NNP I-Gene
ACA NNP I-Gene
snoRNAs NN I-Gene
is VBZ O
required VBN O
for IN O
the DT O
assembly NN O
of IN O
H NNP B-Gene
/ NNP I-Gene
ACA NNP I-Gene
snoRNPs NN I-Gene
and CC O
hence NN O
for IN O
the DT O
stability NN O
of IN O
some DT O
of IN O
their PRP$ O
components NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
p33 JJ B-Gene
subunit NN I-Gene
of IN O
eIF3 NN B-Gene
plays NNS O
an DT O
important JJ O
role NN O
in IN O
the DT O
initiation NN O
phase NN O
of IN O
protein JJ O
synthesis NN O
and CC O
that IN O
its PRP$ O
RNA NNP O
- : O
binding NN O
domain NN O
is VBZ O
required VBN O
for IN O
optimal JJ O
activity NN O
. . O

Clinicopathologic NNP O
studies NNS O
in IN O
feminizing VBG O
tumors NNS O
of IN O
the DT O
ovary JJ O
. . O

In IN O
contrast NN O
, , O
the DT O
differentiation NN O
of IN O
neoplastically RB O
transformed VBN O
cells NNS O
does VBZ O
not RB O
repress VB O
mitogenic JJ O
responsiveness NN O
or CC O
junB NN B-Gene
or CC O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
inducibility NN O
. . O

Data NNS O
from IN O
the DT O
V NNP O
- : O
HeFT NNP O
II NNP O
show NN O
that WDT O
at IN O
2 CD O
- : O
year NN O
follow SYM O
- : O
up RB O
, , O
a DT O
progressive JJ O
rise NN O
of IN O
plasma NN O
norepinephrine NN O
was VBD O
observed VBN O
in IN O
both DT O
treatment NN O
arms NNS O
, , O
suggesting VBG O
that IN O
disease NN O
progresses VBZ O
despite IN O
treatment NN O
with IN O
either DT O
an DT O
angiotensin NN B-Gene
- : I-Gene
converting VBG I-Gene
enzyme JJ I-Gene
inhibitor NN O
, , O
enalapril NN O
, , O
or CC O
vasodilator NN O
therapy NN O
with IN O
hydralazine JJ O
/ NNP O
isosorbide NN O
dinitrate NN O
. . O

Recombinant NNP B-Gene
soluble JJ I-Gene
pMCP NN I-Gene
that WDT O
lacked VBD O
transmembrane NN O
and CC O
cytoplasmic JJ O
domains NNS O
had VBD O
factor NN B-Gene
I PRP I-Gene
cofactor VBP I-Gene
activity NN O
in IN O
C3b NNP B-Gene
cleavage NN O
, , O
indicating VBG O
that IN O
it PRP O
is VBZ O
functionally RB O
, , O
as RB O
well RB O
as IN O
structurally RB O
homologous JJ O
to TO O
MCP NNP B-Gene
. . O

All DT O
89 CD O
participating VBG O
household NN O
members NNS O
were VBD O
anti JJ B-Gene
- : I-Gene
HIV NNP I-Gene
seronegative NN O
, , O
and CC O
78 CD O
who WP O
were VBD O
tested VBN O
were VBD O
serum JJ B-Gene
p24 JJ I-Gene
antigen NN I-Gene
negative JJ O
. . O

The DT O
most RBS O
important JJ O
finding NN O
, , O
however RB O
, , O
was VBD O
that IN O
IMT NNP O
values NNS O
were VBD O
related VBN O
with IN O
24 CD O
h NNS O
SBP NNP O
or CC O
PP NNP O
standard JJ O
deviation NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
a DT O
measure NN O
of IN O
overall JJ O
SBP NNP O
or CC O
PP NNP O
variability NN O
. . O

One CD O
of IN O
the DT O
most RBS O
relevant JJ O
aspects NNS O
in IN O
achieving VBG O
the DT O
consistent JJ O
survival NN O
of IN O
an DT O
animal JJ O
undergoing VBG O
the DT O
experimental JJ O
implantation NN O
of IN O
a DT O
total JJ O
artificial JJ O
heart NN O
is VBZ O
obviously RB O
related VBN O
to TO O
the DT O
correct JJ O
anatomic JJ O
placement NN O
of IN O
prosthetic JJ O
ventricles NNS O
inside IN O
the DT O
chest NN O
. . O

Phenylephrine NNP O
is VBZ O
a DT O
pure JJ O
alpha NN B-Gene
- : I-Gene
1 CD I-Gene
adrenoreceptor JJ I-Gene
agonist NN O
known VBN O
to TO O
produce VB O
marked JJ O
systemic JJ O
vasoconstriction NN O
and CC O
associated VBN O
hypertension NN O
with IN O
occasional JJ O
profound NN O
reflex JJ O
bradycardia NN O
. . O

Expression NN O
of IN O
this DT O
cDNA NN O
in IN O
vitro JJ O
yields NNS O
a DT O
peptide NN O
which WDT O
comigrates VBZ O
with IN O
natural JJ B-Gene
eIF SYM I-Gene
- : I-Gene
2B CD I-Gene
alpha NN I-Gene
in IN O
SDS NNP O
/ NNP O
polyacrylamide NN O
gels NNS O
. . O

Biological JJ O
properties NNS O
of IN O
sumithion NN O
. . O

Analysis NN O
of IN O
the DT O
sequences NNS O
with IN O
the DT O
BLAST NNP O
and CC O
GRAIL NNP O
programs NNS O
provided VBD O
additional JJ O
independent JJ O
evidence NN O
that IN O
15 CD O
of IN O
these DT O
17 CD O
clones NNS O
contain VBP O
coding VBG O
sequences NNS O
and CC O
that DT O
nine CD O
other JJ O
clones NNS O
are VBP O
likely JJ O
to TO O
contain VB O
sequences NNS O
coding VBG O
for IN O
portions NNS O
of IN O
new JJ O
genes NNS O
. . O

The DT O
interpretation NN O
of IN O
antibiotic JJ O
disc NN O
sensitivities NNS O
. . O

The DT O
data NN O
presented VBN O
in IN O
this DT O
work NN O
indicate VBP O
that IN O
thi1 NN B-Gene
may MD O
also RB O
be VB O
involved VBN O
in IN O
DNA NNP O
damage NN O
tolerance NN O
in IN O
plant NN O
cells NNS O
. . O

A DT O
comparative JJ O
analysis NN O
of IN O
the DT O
reported VBN O
MOCT NNP O
- : O
associated VBN O
malignant JJ O
melanomas NN O
emphasizes VBZ O
the DT O
singularity NN O
of IN O
our PRP$ O
case NN O
in IN O
the DT O
amelanotic JJ O
character NN O
of IN O
the DT O
melanoma NN O
, , O
its PRP$ O
lymphotropism NN O
and CC O
the DT O
coexistence NN O
of IN O
invasive JJ O
squamous JJ O
cell NN O
carcinoma NN O
. . O

If IN O
this DT O
is VBZ O
present JJ O
, , O
such JJ O
patients NNS O
should MD O
be VB O
closely RB O
monitored VBN O
, , O
and CC O
any DT O
atypical JJ O
lesions NNS O
biopsied VBD O
. . O

In IN O
Group NNP O
V NNP O
, , O
the DT O
salvaged JJ O
tissue NN O
was VBD O
primarily RB O
subepicardial JJ O
with IN O
virtually RB O
no DT O
lateral JJ O
zone NN O
of IN O
salvaged JJ O
tissue NN O
( ( O
ratio NN O
of IN O
salvaged JJ O
subepicardium NN O
to TO O
salvaged VB O
subendocardium NN O
14 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
9 CD O
to TO O
1 CD O
) ) O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate NN O
that IN O
strongyloidiasis NN O
was VBD O
the DT O
cause NN O
of IN O
sudden JJ O
death NN O
. . O

In IN O
summary JJ O
, , O
the DT O
segments NNS O
of IN O
C3 NNP B-Gene
represented VBN O
by IN O
amino NN O
acid NN O
residues NNS O
1082 CD O
- : O
1118 CD O
, , O
1117 CD O
- : O
1155 CD O
, , O
1234 CD O
- : O
1294 CD O
and CC O
1312 CD O
- : O
1404 CD O
accommodate NN O
C3 NNP B-Gene
( ( I-Gene
D NNP I-Gene
) ) I-Gene
epitopes VBZ I-Gene
that WDT O
are VBP O
expressed VBN O
by IN O
erythrocyte NN O
- : O
bound NN O
C3 NNP B-Gene
fragments NNS I-Gene
, , O
but CC O
not RB O
by IN O
the DT O
corresponding JJ O
fluid NN O
- : O
phase NN O
fragment NN O
, , O
whereas IN O
the DT O
segments NNS O
spanning VBG O
residues NNS O
973 CD O
- : O
1026 CD O
and CC O
1477 CD O
- : O
1510 CD O
contain NN O
C3 NNP B-Gene
( ( I-Gene
D NNP I-Gene
) ) I-Gene
epitopes VBZ I-Gene
that WDT O
are VBP O
exposed VBN O
exclusively RB O
in IN O
denatured JJ O
C3 NNP B-Gene
and CC O
therefore RB O
hidden JJ O
in IN O
physiological JJ O
fragments NNS O
of IN O
the DT O
protein NN O
. . O

Effects NNS O
of IN O
thromboxane NN B-Gene
synthetase NN I-Gene
inhibition NN O
on IN O
postburn NN O
mesenteric JJ O
vascular JJ O
resistance NN O
and CC O
the DT O
rate NN O
of IN O
bacterial JJ O
translocation NN O
in IN O
a DT O
chronic JJ O
porcine NN O
model NN O
. . O

Interleukin NNP B-Gene
- : I-Gene
6 CD I-Gene
may MD O
possibly RB O
potentiate VB O
metastasis NN O
of IN O
cardiac JJ O
myxoma NN O
. . O

However RB O
, , O
a DT O
> NN O
10 CD O
- : O
fold JJ O
increase NN O
in IN O
ERK3 NNP B-Gene
activity NN O
in IN O
each DT O
PKC NNP B-Gene
beta NN I-Gene
transfectant NN O
was VBD O
shown VBN O
by IN O
immunoprecipitation NN O
with IN O
anti JJ B-Gene
- : I-Gene
ERK3 NNP I-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
followed VBN O
by IN O
either DT O
immune NN O
complex JJ O
kinase NN O
assay NN O
or CC O
by IN O
in IN O
gel JJ O
kinase NN O
assay NN O
. . O

This DT O
study NN O
suggests VBZ O
that IN O
PSP NNP O
is VBZ O
more RBR O
common JJ O
than IN O
previously RB O
considered VBN O
, , O
is VBZ O
commonly RB O
misdiagnosed VBN O
and CC O
that IN O
the DT O
majority NN O
of IN O
cases NNS O
are VBP O
not RB O
initially RB O
referred VBN O
to TO O
neurologists NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
: : O
( ( O
a DT O
) ) O
proSRIF NN B-Gene
cleavage NN O
is VBZ O
initiated VBN O
in IN O
the DT O
TGN NNP O
, , O
and CC O
( ( O
b NN O
) ) O
this DT O
reaction NN O
requires VBZ O
an DT O
acidic JJ O
pH NN O
which WDT O
is VBZ O
facilitated VBN O
by IN O
a DT O
Golgi NNP B-Gene
- : I-Gene
associated VBD I-Gene
vacuolar JJ I-Gene
- : I-Gene
type NN I-Gene
ATPase NNP I-Gene
. . O

Regulated VBN O
activity NN O
of IN O
the DT O
distal JJ O
promoter NN O
- : O
like IN O
element NN O
of IN O
the DT O
human JJ B-Gene
corticotropin NN I-Gene
- : I-Gene
releasing VBG I-Gene
hormone NN I-Gene
gene NN I-Gene
and CC O
secondary JJ O
structural JJ O
features NNS O
of IN O
its PRP$ O
corresponding NN O
transcripts NNS O
. . O

After IN O
one CD O
accommodation NN O
night NN O
, , O
sleep JJ O
EEG NNP O
recordings NNS O
were VBD O
performed VBN O
during IN O
three CD O
consecutive JJ O
nights NNS O
in IN O
ten JJ O
drug NN O
- : O
free JJ O
inpatients NNS O
presenting VBG O
generalized JJ O
anxiety NN O
disorder NN O
( ( O
GAD NNP O
) ) O
with IN O
significant JJ O
depression NN O
, , O
compared VBN O
with IN O
a DT O
age NN O
- : O
and CC O
sex NN O
- : O
matched VBN O
group NN O
of IN O
patients NNS O
with IN O
GAD NNP O
and CC O
a DT O
group NN O
of IN O
primary JJ O
major JJ O
depressive JJ O
disorder NN O
( ( O
MDD NNP O
) ) O
patients NNS O
. . O

The DT O
effects NNS O
of IN O
antithrombotic JJ O
drugs NNS O
in IN O
patients NNS O
with IN O
left JJ O
ventricular JJ O
thrombi NN O
: : O
assessment NN O
with IN O
indium NN O
- : O
111 CD O
platelet NN O
imaging NN O
and CC O
two CD O
- : O
dimensional JJ O
echocardiography NN O
. . O

In IN O
this DT O
paper NN O
, , O
an DT O
analysis NN O
of IN O
the DT O
dynamics NNS O
in IN O
the DT O
closing NN O
phase NN O
of IN O
the DT O
occluder NN O
of IN O
a DT O
mechanical JJ O
monoleaflet NN O
heart NN O
valve NN O
prosthesis NN O
is VBZ O
presented VBN O
. . O

The DT O
impact NN O
of IN O
social JJ O
support NN O
on IN O
the DT O
relationships NNS O
of IN O
gay JJ O
male NN O
couples NNS O
is VBZ O
examined VBN O
. . O

TPTA NNP O
produced VBD O
brain NN O
congestion NN O
, , O
and CC O
hepatic JJ O
and CC O
pulmonary JJ O
petechial NN O
and CC O
generalized JJ O
hemorrhages NNS O
. . O

After IN O
allowing VBG O
time NN O
for IN O
absorption NN O
, , O
participants NNS O
completed VBD O
a DT O
bridge NN O
simulator NN O
task NN O
. . O

The DT O
validity NN O
of IN O
the DT O
FPS NNP O
- : O
R NN O
was VBD O
further RB O
supported VBN O
by IN O
strong JJ O
positive JJ O
correlations NNS O
with IN O
the DT O
VAS NNP O
( ( O
r VB O
= RB O
0 CD O
. . O
92 CD O
, , O
N NNP O
= NNP O
45 CD O
) ) O
and CC O
the DT O
CAS NNP O
( ( O
r VB O
= RB O
0 CD O
. . O
84 CD O
, , O
N NNP O
= NNP O
45 CD O
) ) O
in IN O
this DT O
clinical JJ O
sample NN O
. . O

Skin NNP O
and CC O
bowel NN O
TPO2 NNP O
varied VBD O
with IN O
DO2 NNP O
and CC O
each DT O
other JJ O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

Most JJS O
other JJ O
end NN O
points NNS O
were VBD O
highly RB O
significant JJ O
, , O
and CC O
death NN O
, , O
which WDT O
was VBD O
monitored VBN O
across IN O
the DT O
U NNP O
. . O
S NNP O
. . O
program NN O
, , O
was VBD O
different JJ O
with IN O
p JJ O
< $ O
0 CD O
. . O
1 CD O
. . O

Presidential NNP O
address NN O
1990 CD O
- : O
- : O
coming VBG O
in IN O
from IN O
the DT O
cold NN O
. . O

Hb NNP B-Gene
levels NNS O
remained VBN O
adequate JJ O
( ( O
Hb NNP B-Gene
= VBZ O
10 CD O
. . O
68 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
77 CD O
g JJ O
/ NNP O
dl NN O
) ) O
after IN O
14 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
7 CD O
. . O
64 CD O
months NNS O
. . O

Structure NN O
and CC O
expression NN O
of IN O
a DT O
gene NN O
from IN O
Arabidopsis NNP O
thaliana NN O
encoding VBG O
a DT O
protein NN O
related VBN O
to TO O
SNF1 NNP B-Gene
protein NN O
kinase NN O
. . O

Phase NNP O
II NNP O
trial NN O
of IN O
the DT O
anti JJ B-Gene
- : I-Gene
G NNP I-Gene
( ( I-Gene
D2 NNP I-Gene
) ) I-Gene
monoclonal VBD I-Gene
antibody NN I-Gene
3F8 CD I-Gene
and CC O
granulocyte JJ B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
for IN O
neuroblastoma NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
develop VB O
a DT O
reliable JJ O
and CC O
culturally RB O
meaningful JJ O
exercise NN O
self NN O
- : O
efficacy NN O
questionnaire NN O
for IN O
older JJR O
Mexican JJ O
American JJ O
women NNS O
. . O

Interestingly RB O
, , O
the DT O
avirulent NN O
strain NN O
H37Ra NNP O
showed VBD O
weak JJ O
hybridization NN O
with IN O
these DT O
two CD O
probes NNS O
, , O
suggesting VBG O
that IN O
these DT O
genes NNS O
might MD O
have VB O
been VBN O
deleted VBN O
in IN O
the DT O
avirulent NN O
strain NN O
or CC O
are VBP O
present JJ O
in IN O
limited JJ O
copy NN O
numbers NNS O
as IN O
opposed VBN O
to TO O
those DT O
in IN O
the DT O
virulent NN O
strain NN O
H37Rv NNP O
. . O

Two CD O
out IN O
of IN O
five CD O
patients NNS O
undergoing VBG O
selective JJ O
spinal JJ O
arteriography NN O
developed VBD O
transient JJ O
neurological JJ O
complications NNS O
during IN O
the DT O
injection NN O
of IN O
Urografin NNP O
310 CD O
M NNP O
. . O

However RB O
, , O
in IN O
some DT O
of IN O
them PRP O
either DT O
pattern NN O
may MD O
predominate VB O
or CC O
be VB O
exclusively RB O
present JJ O
. . O

Albumin JJ B-Gene
dialysis NN O
: : O
effective JJ O
removal NN O
of IN O
copper NN O
in IN O
a DT O
patient NN O
with IN O
fulminant JJ O
Wilson NNP O
disease NN O
and CC O
successful JJ O
bridging NN O
to TO O
liver VB O
transplantation NN O
: : O
a DT O
new JJ O
possibility NN O
for IN O
the DT O
elimination NN O
of IN O
protein NN O
- : O
bound NN O
toxins NNS O
. . O

Epidemiologic JJ O
evidence NN O
indicates VBZ O
that IN O
estrogen NN O
replacement NN O
therapy NN O
after IN O
menopause NN O
increases NNS O
breast VBP O
cancer NN O
risk NN O
. . O

Statokinesimetric JJ O
recording NN O
in IN O
Huntington NNP O
choreas NNS O

The DT O
yeast NN B-Gene
MMS2 NNP I-Gene
gene NN I-Gene
was VBD O
cloned VBN O
by IN O
its PRP$ O
ability NN O
to TO O
complement VB O
the DT O
methyl NN O
methanesulfonate NN O
sensitivity NN O
of IN O
the DT O
mms2 NN B-Gene
- : I-Gene
1 CD I-Gene
mutant NN I-Gene
and CC O
was VBD O
later RB O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
DNA NNP O
post NN O
- : O
replication NN O
repair NN O
. . O

RESULTS NN O
: : O
Transpulmonary JJ O
passage NN O
of IN O
contrast NN O
occurred VBD O
in IN O
sufficient JJ O
amounts NNS O
to TO O
enhance VB O
the DT O
intensity NN O
of IN O
the DT O
Doppler NNP O
signal NN O
significantly RB O
, , O
but CC O
the DT O
duration NN O
of IN O
this DT O
effect NN O
was VBD O
short JJ O
. . O

Static JJ O
orthoses NNS O
for IN O
the DT O
management NN O
of IN O
microstomia NN O
. . O

Caution NN O
should MD O
be VB O
exercised VBN O
in IN O
the DT O
use NN O
of IN O
these DT O
dyes NNS O
for IN O
lymphograms NNS O
. . O

The DT O
characterized JJ O
Aplysia NNP B-Gene
Afurin2 NNP I-Gene
is VBZ O
a DT O
candidate JJ O
PC NN B-Gene
that WDT O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
processing NN O
of IN O
egg NN B-Gene
- : I-Gene
laying VBG I-Gene
hormone NN I-Gene
( ( O
ELH NNP B-Gene
) ) O
- : O
related JJ O
precursors NNS O
in IN O
the DT O
secretory JJ O
cells NNS O
of IN O
the DT O
atrial JJ O
gland NN O
. . O

Extreme JJ O
potency NN O
of IN O
botulinum NN B-Gene
toxin NN I-Gene
. . O

Identification NN O
of IN O
an DT O
AfsA NNP B-Gene
homologue NN I-Gene
( ( O
BarX NNP B-Gene
) ) O
from IN O
Streptomyces NNP O
virginiae NN O
as IN O
a DT O
pleiotropic NN O
regulator NN O
controlling VBG O
autoregulator NN O
biosynthesis NN O
, , O
virginiamycin JJ O
biosynthesis NN O
and CC O
virginiamycin NN O
M1 NNP O
resistance NN O
. . O

Overexpression NN O
of IN O
CDP NNP B-Gene
/ NNP O
cut NN B-Gene
in IN O
ROS NNP O
17 CD O
/ NN O
2 CD O
. . O
8 CD O
osteosarcoma JJ O
cells NNS O
results NNS O
in IN O
repression NN O
of IN O
OC NNP B-Gene
promoter NN I-Gene
activity NN O
; : O
this DT O
repression NN O
is VBZ O
abrogated VBN O
by IN O
mutating VBG O
OC NNP B-Gene
box NN I-Gene
I PRP I-Gene
. . O

The DT O
amino NN O
- : O
terminal JJ O
half NN O
of IN O
1a CD B-Gene
is VBZ O
a DT O
distant JJ O
homolog NN B-Gene
of IN I-Gene
alphavirus JJ I-Gene
nonstructural JJ I-Gene
protein NN I-Gene
nsP1 NN I-Gene
, , O
which WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
capping VBG O
viral JJ O
RNAs NNP O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
: : O
Associations NNS O
of IN O
factor NN O
analysis NN O
- : O
derived VBN O
syndromes NNS O
with IN O
risk NN O
factors NNS O
for IN O
chemical NN O
interactions NNS O
that WDT O
inhibit VBP O
butyrylcholinesterase NN B-Gene
and CC O
neuropathy JJ O
target NN O
esterase NN B-Gene
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
COX12 NNP B-Gene
, , O
the DT O
nuclear JJ O
gene NN O
for IN O
subunit JJ B-Gene
VIb NNP I-Gene
of IN O
Saccharomyces NNP B-Gene
cerevisiae VBP I-Gene
cytochrome JJ I-Gene
c JJ I-Gene
oxidase NN I-Gene
. . O

Cyclin NNP B-Gene
D1 NNP I-Gene
could MD O
not RB O
be VB O
displaced VBN O
from IN O
cdk4 NN B-Gene
in IN O
the DT O
resistant JJ O
184A1L5R CD O
cell NN O
lysates NNS O
. . O

First RB O
, , O
human JJ O
erythroid NN O
K562 NNP O
cells NNS O
stably RB O
integrated VBN O
with IN O
various JJ O
HS NNP B-Gene
- : I-Gene
40 CD I-Gene
mutants NNS I-Gene
cis NN O
linked VBN O
to TO O
a DT O
human JJ B-Gene
alpha NN I-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
- : O
growth NN B-Gene
hormone NN I-Gene
hybrid JJ O
gene NN O
were VBD O
analyzed VBN O
by IN O
genomic JJ O
footprinting NN O
and CC O
expression NN O
analysis NN O
. . O

The DT O
presence NN O
of IN O
unidentified JJ O
macroscopic NN O
or CC O
microscopic NN O
clusters NNS O
of IN O
neoplastic JJ O
cells NNS O
, , O
lying VBG O
around RB O
, , O
more JJR O
or CC O
less RBR O
close JJ O
to TO O
, , O
the DT O
line NN O
of IN O
insertion NN O
of IN O
lesion NN O
, , O
could MD O
render VB O
any DT O
attempt NN O
to TO O
gain VB O
a DT O
"""" JJ O
radical JJ O
"""" NN O
excision NN O
useless NN O
. . O

By IN O
screening VBG O
a DT O
Y1 NNP O
cell NN O
cDNA NN O
library NN O
with IN O
the DT O
DNA NNP O
- : O
binding VBG O
region NN O
of IN O
the DT O
H NNP B-Gene
- : I-Gene
2RIIBP CD I-Gene
nuclear JJ I-Gene
hormone NN I-Gene
receptor NN I-Gene
cDNA NN I-Gene
, , O
we PRP O
isolated VBD O
a DT O
cDNA NN O
that WDT O
is VBZ O
selectively RB O
expressed VBN O
in IN O
steroidogenic JJ O
cells NNS O
. . O

Induction NN O
of IN O
B NNP O
cell NN O
apoptosis NN O
by IN O
co NN O
- : O
cross NN O
- : O
linking VBG O
CD23 NNP B-Gene
and CC O
sIg JJ B-Gene
involves NNS O
aberrant JJ O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
and CC O
is VBZ O
inhibited VBN O
by IN O
bcl SYM B-Gene
- : I-Gene
2 CD I-Gene
. . O

The DT O
structure NN O
has VBZ O
been VBN O
established VBN O
by IN O
a DT O
study NN O
of IN O
its PRP$ O
mono NN O
- : O
and CC O
bidimensional JJ O
NMR NNP O
spectra NN O
and CC O
mass NN O
spectrometry NN O
. . O

Increased VBN O
PTHRP NNP B-Gene
production NN O
by IN O
a DT O
tyrosine JJ B-Gene
kinase NN I-Gene
oncogene NN I-Gene
, , O
Tpr NNP B-Gene
- : I-Gene
Met NN I-Gene
: : O
role NN O
of IN O
the DT O
Ras NNP B-Gene
signaling VBG O
pathway RB O
. . O

It PRP O
was VBD O
subsequently RB O
shown VBN O
that IN O
Tip60 NNP B-Gene
had VBD O
histone VBN B-Gene
acetyltransferase NN I-Gene
( ( O
HAT NNP B-Gene
) ) O
activity NN O
. . O

The DT O
repression NN O
domain NN O
, , O
and CC O
indeed RB O
the DT O
entire JJ O
Cdc68 NNP B-Gene
protein NN I-Gene
, , O
is VBZ O
highly RB O
conserved VBN O
, , O
as IN O
shown VBN O
by IN O
the DT O
sequence NN O
of IN O
the DT O
Cdc68 NNP B-Gene
functional JJ I-Gene
homolog NN I-Gene
from IN O
the DT O
yeast NN O
Kluyveromyces NNP O
lactis NN O
and CC O
by IN O
database NN O
searches NNS O
. . O

In IN O
a DT O
retrospective JJ O
analysis NN O
of IN O
data NNS O
from IN O
35 CD O
cases NNS O
with IN O
malignant JJ O
lymphoma NN O
from IN O
a DT O
cohort NN O
of IN O
2017 CD O
HIV NNP O
- : O
infected JJ O
patients NNS O
, , O
the DT O
stage NN O
of IN O
HIV NNP O
- : O
disease NN O
, , O
the DT O
CD4 NNP B-Gene
counts VBZ O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
, , O
and CC O
the DT O
use NN O
of IN O
antineoplastic JJ O
agents NNS O
or CC O
radiotherapy NN O
were VBD O
correlated VBN O
with IN O
outcome NN O
. . O

Brain NNP B-Gene
cholinesterase NN I-Gene
activity NN O
of IN O
nestling VBG O
great JJ O
egrets NNS O
, , O
snowy JJ O
egrets NNS O
and CC O
black JJ O
- : O
crowned VBN O
night NN O
- : O
herons NNS O
. . O
inhibition NN O
of IN O
brain NN B-Gene
cholinesterase NN I-Gene
( ( O
ChE NNP B-Gene
) ) O
activity NN O
in IN O
birds NNS O
is VBZ O
often RB O
used VBN O
to TO O
diagnose VB O
exposure NN O
or CC O
death NN O
from IN O
organophosphorus NN O
or CC O
carbamate NN O
pesticides NNS O
. . O

Microwave NNP O
hyperthermia NN O
- : O
induced VBN O
blood NN O
- : O
brain NN O
barrier NN O
alterations NNS O
. . O

What WP O
to TO O
look VB O
for IN O
during IN O
a DT O
compliance NN O
review NN O
: : O
10 CD O
common JJ O
mistakes NNS O
made VBN O
by IN O
SNFs NNP O
. . O

Is VBZ O
more RBR O
better RB O
? . O

About IN O
dose JJ O
levels NNS O
of IN O
ACE NNP B-Gene
inhibitors NNS O
in IN O
chronic JJ O
heart NN O
failure NN O
. . O

The DT O
upstream JJ O
delta NN O
- : O
alpha NN O
breakpoint NN O
is VBZ O
flanked VBN O
by IN O
the DT O
direct JJ O
repeats NN O
of IN O
the DT O
acceptor NN O
splice NN O
site NN O
, , O
whereas IN O
the DT O
down JJ O
- : O
stream NN O
alpha SYM O
- : O
delta NN O
breakpoint NN O
is VBZ O
located VBN O
in IN O
the DT O
adjacent JJ O
intron NN O
. . O

By IN O
contrast NN O
, , O
PvirE NNP B-Gene
or CC O
Plac NNP B-Gene
promoter NN I-Gene
constructs NNS I-Gene
yielded VBD O
functional JJ O
VirE2 NNP B-Gene
only RB O
if IN O
virE1 NN B-Gene
was VBD O
coexpressed VBN O
with IN O
virE2 NN B-Gene
. . O

Ovaries NNS O
of IN O
10 CD O
animals NNS O
per IN O
group NN O
from IN O
16 CD O
studies NNS O
in IN O
CD NNP O
- : O
1 CD O
mice NN O
and CC O
1 CD O
study NN O
each DT O
in IN O
C3H NNP O
and CC O
C57BL NNP O
/ NNP O
6 CD O
mice NN O
were VBD O
sectioned VBN O
serially RB O
at IN O
6 CD O
microm NN O
. . O

Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
latent NN I-Gene
membrane NN I-Gene
protein NN I-Gene
1 CD I-Gene
( ( O
LMP1 NNP B-Gene
) ) O
is VBZ O
essential JJ O
for IN O
EBV NNP O
- : O
mediated VBD O
transformation NN O
of IN O
primary JJ O
B NNP O
lymphocytes NNS O
. . O

Expression NN O
is VBZ O
exclusively RB O
limited JJ O
to TO O
the DT O
CNS NNP O
at IN O
this DT O
and CC O
later RB O
stages NNS O
. . O

The DT O
DRF NNP B-Gene
- : I-Gene
2 CD I-Gene
nuclear JJ I-Gene
protein NN I-Gene
has VBZ O
characteristics NNS O
similar JJ O
to TO O
those DT O
of IN O
the DT O
muscle NN O
- : O
specific JJ O
regulatory JJ O
factor NN O
, , O
MEF NNP B-Gene
- : I-Gene
2 CD I-Gene
( ( O
Buskin NNP O
and CC O
Hauschka NNP O
1989 CD O
; : O
Gossett NNP O
et FW O
al NN O
. . O
, , O
1989 CD O
) ) O
. . O

Parathyroid NNP B-Gene
hormone NN I-Gene
regulation NN O
of IN O
bone NN B-Gene
sialoprotein NN I-Gene
( ( O
BSP NNP B-Gene
) ) O
gene NN O
transcription NN O
is VBZ O
mediated VBN O
through IN O
a DT O
pituitary JJ B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
motif NN O
in IN O
the DT O
rat NN B-Gene
BSP NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

A DT O
mail NN O
survey NN O
of IN O
Georgia NNP O
members NNS O
of IN O
the DT O
American NNP O
College NNP O
of IN O
Obstetricians NNPS O
and CC O
Gynecologists NNP O
was VBD O
conducted VBN O
. . O

Effects NNS O
of IN O
a DT O
selective JJ O
monoamine NN B-Gene
oxidase NN I-Gene
( ( I-Gene
MAO NNP I-Gene
) ) I-Gene
- : I-Gene
- : I-Gene
A DT I-Gene
inhibitor NN O
, , O
clorgyline NN O
, , O
a DT O
selective JJ O
MAO NNP B-Gene
- : I-Gene
B NNP I-Gene
inhibitor NN O
, , O
deprenyl NN O
, , O
and CC O
a DT O
non JJ O
- : O
selective JJ O
MAO NNP B-Gene
inhibitor NN O
, , O
nialamide RB O
, , O
were VBD O
investigated VBN O
on IN O
footshock NN O
- : O
induced JJ O
aggression NN O
( ( O
FIA NNP O
) ) O
in IN O
paired JJ O
rats NNS O
. . O

Proctoscopy NNP O
and CC O
roentgenographic JJ O
studies NNS O
may MD O
be VB O
an DT O
important JJ O
part NN O
of IN O
evaluation NN O
, , O
especially RB O
in IN O
patients NNS O
who WP O
present VBP O
with IN O
perianal JJ O
suppuration NN O
, , O
masses NNS O
, , O
or CC O
anal JJ O
fissures NNS O
. . O

Results NNS O
of IN O
electron JJ O
therapy NN O
of IN O
tumors NNS O
in IN O
different JJ O
sites NNS O

The DT O
96 CD O
- : O
bp NN O
insert NN O
contained VBD O
a DT O
termination NN O
signal NN O
which WDT O
caused VBD O
the DT O
premature JJ O
termination NN O
of IN O
the DT O
protein NN O
, , O
leading VBG O
to TO O
the DT O
generation NN O
of IN O
a DT O
p53 NN B-Gene
product NN I-Gene
9 CD O
amino JJ O
acids NNS O
shorter JJR O
than IN O
usual JJ O
. . O

Critical JJ O
residues NNS O
required VBN O
for IN O
repression NN O
are VBP O
located VBN O
within IN O
the DT O
C NNP O
- : O
terminal JJ O
27 CD O
amino JJ O
acids NNS O
of IN O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
since IN O
v SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
C NNP O
- : O
terminal JJ O
truncations NNS O
of IN O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
did VBD O
not RB O
down RP O
regulate NN O
. . O

Thus RB O
, , O
diamide JJ O
treatment NN O
of IN O
nuclear JJ O
extracts NNS O
strongly RB O
reduces VBZ O
the DT O
binding NN O
of IN O
NFI NNP B-Gene
proteins NNS I-Gene
, , O
and CC O
the DT O
addition NN O
of IN O
higher JJR O
concentrations NNS O
of IN O
dithiothreitol NN O
to TO O
nuclear JJ O
extracts NNS O
from IN O
TG NNP B-Gene
- : O
treated VBD O
cells NNS O
restores VBZ O
NFI NNP B-Gene
- : I-Gene
DNA NN I-Gene
binding VBG O
to TO O
levels NNS O
in IN O
extracts NNS O
from IN O
untreated JJ O
cells NNS O
. . O

These DT O
studies NNS O
indicate VBP O
that IN O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
electrical JJ O
stimulation NN O
generate NN O
reactive JJ O
oxygen NN O
species NNS O
and CC O
affect JJ O
SOD NNP B-Gene
activity NN O
, , O
which WDT O
in IN O
part NN O
are VBP O
responsible JJ O
for IN O
decreased JJ O
sperm JJ O
motion NN O
and CC O
viability NN O
. . O

These DT O
REPs NNP O
, , O
or CC O
clusters NNS O
of IN O
paralogous JJ O
loci NN O
, , O
are VBP O
15 CD O
- : O
100 CD O
kb NN O
and CC O
harbor NN O
at IN O
least JJS O
four CD O
ESTs NNP O
and CC O
an DT O
expressed JJ O
SH3GL NNP B-Gene
pseudogene NN I-Gene
. . O

METHOD NN O
: : O
50 CD O
consecutive JJ O
children NNS O
aged VBN O
from IN O
6 CD O
months NNS O
to TO O
17 CD O
years NNS O
were VBD O
included VBN O
into IN O
the DT O
study NN O
which WDT O
comprised VBD O
questionnaires NNS O
of IN O
patient NN O
and CC O
family NN O
histories NNS O
, , O
serological JJ O
screening NN O
tests NNS O
for IN O
common JJ O
inhalational JJ O
allergens NNS O
( ( O
CAP NNP O
SX1 NNP O
) ) O
, , O
and CC O
determination NN O
of IN O
total JJ O
serum NN B-Gene
immunoglobulin NN I-Gene
E NNP I-Gene
( ( O
IgE NNP B-Gene
) ) O
and CC O
of IN O
latex JJ O
- : O
specific JJ O
serum NN B-Gene
IgE NNP I-Gene
by IN O
solid JJ O
- : O
phase NN O
immunoassays NNS O
. . O

Effects NNS O
of IN O
negative JJ O
pleural JJ O
pressure NN O
on IN O
left JJ O
ventricular JJ O
hemodynamics NNS O
. . O

Cross NNP O
- : O
linking VBG O
the DT O
B NNP B-Gene
cell NN I-Gene
Ag NNP I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
to TO O
surface VB B-Gene
Fc NNP I-Gene
receptors NNS I-Gene
for IN O
IgG NNP B-Gene
( ( O
Fc NNP B-Gene
gamma NNP I-Gene
R NNP I-Gene
) ) O
inhibits VBZ O
G1 NNP O
- : O
to TO O
- : O
S NNP O
progression NN O
; : O
the DT O
mechanism NN O
by IN O
which WDT O
this DT O
occurs NN O
is VBZ O
not RB O
completely RB O
known VBN O
. . O

TE NNP O
- : O
671 CD O
cells NNS O
that WDT O
were VBD O
transfected VBN O
with IN O
cAMP JJ O
response NN O
element NN O
mutant JJ O
constructs NNS O
demonstrated VBD O
a DT O
diminished JJ O
basal NN O
activity NN O
of IN O
the DT O
GnRH NNP B-Gene
- : I-Gene
II NNP I-Gene
promoter NN I-Gene
. . O

Acupuncture NNP O
effect NN O
on IN O
deep JJ O
receptors NNS O
was VBD O
not RB O
limited VBN O
to TO O
one CD O
point NN O
but CC O
within IN O
a DT O
certain JJ O
area NN O
, , O
namely RB O
distant JJ O
effect NN O
existed VBD O
. . O

Twenty CD O
patients NNS O
aged VBD O
45 CD O
or CC O
older JJR O
with IN O
the DT O
diagnosis NN O
of IN O
endogenous JJ O
depression NN O
were VBD O
evaluated VBN O
in IN O
terms NNS O
of IN O
safety NN O
and CC O
efficacy NN O
in IN O
their PRP$ O
response NN O
to TO O
multiple VB O
monitored JJ O
electroconvulsive JJ O
therapy NN O
( ( O
MMECT NNP O
) ) O
versus NN O
single JJ O
electroconvulsive JJ O
therapy NN O
( ( O
SECT NNP O
) ) O
. . O

In IN O
wandering VBG O
stage NN O
larvae NN O
, , O
the DT O
OBP NNP B-Gene
transcript NN I-Gene
appeared VBD O
to TO O
be VB O
at IN O
least JJS O
250 CD O
- : O
fold NN O
less RBR O
abundant JJ O
than IN O
ribosomal JJ O
RNA NNP O
. . O

In IN O
C NNP O
. . O
albicans NNS O
, , O
HST6 NNP B-Gene
is VBZ O
expressed VBN O
constitutively RB O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
different JJ O
cell NN O
types NNS O
analysed VBN O
( ( O
yeast UH O
, , O
hyphae JJ O
, , O
white JJ O
and CC O
opaque NN O
) ) O
, , O
demonstrating VBG O
that IN O
HST6 NNP B-Gene
transcription NN O
is VBZ O
not RB O
repressed VBN O
in IN O
this DT O
diploid NN O
yeast NN O
, , O
unlike IN O
in IN O
diploid NN O
S NNP O
. . O
cerevisiae NN O
, , O
and CC O
suggesting VBG O
a DT O
basic JJ O
biological JJ O
function NN O
for IN O
the DT O
Hst6p NNP B-Gene
transporter NN O
in IN O
C NNP O
. . O
albicans NNS O
. . O

Using VBG O
the DT O
yeast NN O
one CD O
- : O
hybrid NN O
screen NN O
with IN O
integrated JJ O
NRE NNP O
and CC O
flanking VBG O
DNA NNP O
as IN O
bait NN O
, , O
the DT O
predominant NN O
clone NN O
obtained VBN O
was VBD O
bovine JJ B-Gene
Nrl NNP I-Gene
. . O

Serial JJ O
measurements NNS O
of IN O
total JJ O
serum NN O
IgE NNP B-Gene
appears VBZ O
to TO O
be VB O
a DT O
useful JJ O
index NN O
of IN O
disease NN O
activity NN O
in IN O
ABPA NNP O
. . O

These DT O
effects NNS O
were VBD O
not RB O
seen VBN O
with IN O
SHIP2 NNP B-Gene
possessing VBG O
a DT O
mutation NN O
in IN O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
( ( O
R47G NNP B-Gene
) ) O
. . O

Factors NNS O
affecting VBG O
the DT O
inhibition NN O
of IN O
phagocytosis NN O
by IN O
chlorpromazine NN O
. . O

The DT O
roll NN O
- : O
over IN O
test NN O
to TO O
predict VB O
toxemia NN O
in IN O
pregnancy NN O
. . O

A DT O
region NN O
in IN O
the DT O
C NNP O
- : O
terminus NN O
of IN O
adenovirus NN B-Gene
2 CD I-Gene
/ NN I-Gene
5 CD I-Gene
E1a NNP I-Gene
protein NN I-Gene
is VBZ O
required VBN O
for IN O
association NN O
with IN O
a DT O
cellular JJ O
phosphoprotein NN O
and CC O
important JJ O
for IN O
the DT O
negative JJ O
modulation NN O
of IN O
T24 NNP O
- : O
ras NN B-Gene
mediated VBN O
transformation NN O
, , O
tumorigenesis NN O
and CC O
metastasis NN O
. . O

Levels NNS O
of IN O
TSG NNP B-Gene
- : I-Gene
14 CD I-Gene
protein NN I-Gene
( ( O
also RB O
termed VBN O
PTX NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
become NN O
elevated VBN O
in IN O
the DT O
serum NN O
of IN O
mice NNS O
and CC O
humans NNS O
after IN O
injection NN O
with IN O
bacterial JJ O
lipopolysaccharide NN O
, , O
but CC O
in IN O
contrast NN O
to TO O
conventional JJ O
acute JJ O
phase NN O
proteins NNS O
, , O
the DT O
bulk NN O
of IN O
TSG NNP B-Gene
- : I-Gene
14 CD I-Gene
synthesis NN O
in IN O
the DT O
intact JJ O
organism NN O
occurs VBZ O
outside IN O
the DT O
liver NN O
. . O

The DT O
IE0 NNP B-Gene
gene NN I-Gene
product NN O
also RB O
transactivated VBD O
the DT O
IE1 NNP B-Gene
promoter NN I-Gene
but CC O
did VBD O
not RB O
affect VB O
expression NN O
from IN O
its PRP$ O
own JJ O
promoter NN O
. . O

Methods NNS O
of IN O
clinical JJ O
and CC O
experimental JJ O
algesimetry NN O
are VBP O
described VBN O
that WDT O
have VBP O
been VBN O
used VBN O
to TO O
evaluate VB O
effects NNS O
of IN O
peripherally RB O
and CC O
centrally RB O
acting VBG O
analgesics NNS O
. . O

Mutational JJ O
analysis NN O
supports VBZ O
a DT O
role NN O
for IN O
multiple JJ O
structural JJ O
features NNS O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
secretion NN O
signal NN O
of IN O
Escherichia NNP B-Gene
coli NN I-Gene
haemolysin NN I-Gene
. . O

Radioimmunoassays NNS O
of IN O
pregnenolone NN O
, , O
progesterone NN O
, , O
dehydroepiandrosterone NN O
( ( O
DHA NNP O
) ) O
16 CD O
alpha JJ O
- : O
hydroxy JJ O
- : O
DHA NN O
, , O
estriol NN O
, , O
and CC O
cortisol NN O
were VBD O
performed VBN O
on IN O
a DT O
total NN O
of IN O
0 CD O
; : O
1 CD O
ml NN O
; : O
of IN O
fetal JJ O
plasma NN O
, , O
collected VBN O
during IN O
the DT O
course NN O
of IN O
normal JJ O
vaginal JJ O
delivery NN O
. . O

The DT O
1489 CD O
- : O
base NN O
pair NN O
EFIA NNP B-Gene
cDNA NN O
encodes VBZ O
a DT O
322 CD O
- : O
amino NN O
acid NN O
protein NN O
which WDT O
is VBZ O
nearly RB O
identical JJ O
to TO O
two CD O
previously RB O
described VBN O
human JJ O
DNA NNP O
binding NN O
proteins NNS O
. . O

Twenty CD O
- : O
five CD O
patients NNS O
also RB O
received VBD O
PET NNP O
examinations NNS O
during IN O
the DT O
staging NN O
procedures NNS O
. . O

The DT O
beta NN O
subunit NN O
of IN O
the DT O
heterotrimeric JJ B-Gene
G NNP I-Gene
proteins VBZ I-Gene
that IN O
transduce NN O
signals NNS O
across IN O
the DT O
plasma NN O
membrane NN O
is VBZ O
made VBN O
up IN O
of IN O
an DT O
amino NN O
- : O
terminal NN O
alpha SYM O
- : O
helical JJ O
segment NN O
followed VBN O
by IN O
seven CD O
repeating VBG O
units NNS O
called VBN O
WD NNP O
( ( O
Trp NNP O
- : O
Asp NNP O
) ) O
repeats VBZ O
that IN O
occur NN O
in IN O
about RB O
140 CD O
different JJ O
proteins NNS O
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
CD69 NNP B-Gene
gene NN I-Gene
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
potential JJ O
TATA NNP O
element NN O
30 CD O
base NN O
pairs NNS O
upstream NN O
of IN O
the DT O
major JJ O
transcription NN O
initiation NN O
site NN O
and CC O
several JJ O
putative JJ O
binding NN O
sequences NNS O
for IN O
inducible JJ O
transcription NN O
factors NNS O
( ( O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
which WDT O
might MD O
mediate VB O
the DT O
inducible JJ O
expression NN O
of IN O
this DT O
gene NN O
. . O

The DT O
data NN O
show NN O
conclusively RB O
that IN O
phosphorylation NN O
of IN O
His PRP$ O
- : O
304 CD O
is VBZ O
not RB O
essential JJ O
for IN O
any DT O
of IN O
the DT O
known JJ O
functions NNS O
of IN O
A NNP B-Gene
. . I-Gene
vinelandii NN I-Gene
NifL NNP I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
short JJ O
synthetic JJ O
peptides NNS O
containing VBG O
the DT O
pRB NN B-Gene
- : I-Gene
binding NN I-Gene
sequences NNS I-Gene
of IN O
E1A NNP B-Gene
are VBP O
sufficient JJ O
for IN O
interaction NN O
with IN O
p107 NN B-Gene
, , O
cyclin NN B-Gene
A NNP I-Gene
, , O
and CC O
p130 NN B-Gene
. . O

Ly NNP B-Gene
- : I-Gene
49 CD I-Gene
is VBZ O
a DT O
family NN B-Gene
type NN I-Gene
II NNP I-Gene
transmembrane NN I-Gene
proteins NNS I-Gene
encoded VBN O
by IN O
a DT O
gene NN O
cluster NN O
on IN O
murine JJ O
chromosome NN O
6 CD O
. . O

2 CD O
were VBD O
nonviable JJ O
, , O
and CC O
the DT O
mutant JJ B-Gene
Vp1s NNP I-Gene
unexpectedly RB O
failed VBD O
to TO O
localize VB O
to TO O
the DT O
nucleus JJ O
though IN O
Vp2 NNP B-Gene
and CC O
Vp3 NNP B-Gene
did VBD O
, , O
suggesting VBG O
that IN O
the DT O
mutated JJ B-Gene
NLS1 NNP I-Gene
acted VBD O
as IN O
a DT O
dominant JJ O
signal NN O
for IN O
the DT O
cytoplasmic JJ O
localization NN O
of IN O
Vp1 NNP B-Gene
. . O

Furthermore RB O
, , O
the DT O
soluble JJ O
forms NNS O
of IN O
ATF6 NNP B-Gene
and CC O
the DT O
G13 NNP B-Gene
gene NN I-Gene
product NN I-Gene
are VBP O
unable JJ O
to TO O
bind VB O
to TO O
several JJ O
point NN O
mutants NNS O
of IN O
the DT O
cis NN O
- : O
acting VBG O
ER NNP O
stress NN O
response NN O
element NN O
in IN O
vitro NN O
that WDT O
hardly RB O
respond VBP O
to TO O
ER NNP O
stress NN O
in IN O
vivo NN O
. . O

To TO O
address VB O
mechanisms NNS O
that WDT O
define VBP O
interactions NNS O
of IN O
Site NNP B-Gene
II NNP I-Gene
regulatory JJ I-Gene
factors NNS I-Gene
with IN O
this DT O
cell NN O
cycle NN O
control NN O
element NN O
, , O
we PRP O
have VBP O
investigated VBN O
these DT O
determinants NNS O
of IN O
transcriptional JJ O
regulation NN O
at IN O
the DT O
G1 NNP O
/ NNP O
S NNP O
phase NN O
transition NN O
in IN O
FDC NNP O
- : O
P1 NNP O
hematopoietic JJ O
progenitor NN O
cells NNS O
. . O

The DT O
functions NNS O
of IN O
isolated JJ O
portions NNS O
of IN O
the DT O
insulin NN B-Gene
, , O
IAPP NNP B-Gene
, , O
and CC O
beta NN B-Gene
GK NNP I-Gene
promoters NNS I-Gene
were VBD O
studied VBN O
by IN O
using VBG O
transient JJ O
expression NN O
and CC O
DNA NNP O
binding NN O
assays NNS O
. . O

Bimodal NNP O
cochlear VBP O
response NN O
curves NNS O
in IN O
rodents NNS O
. . O

In IN O
short JJ O
- : O
term NN O
cotransfections NNS O
, , O
a DT O
pFRTK NN B-Gene
- : O
CAT NNP B-Gene
target NN O
containing VBG O
EBNA NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
from IN O
the DT O
EBV NNP O
origin NN O
of IN O
plasmid JJ O
replication NN O
, , O
ori SYM B-Gene
- : I-Gene
P NN I-Gene
, , O
was VBD O
transactivated VBN O
by IN O
a DT O
carboxy JJ B-Gene
- : I-Gene
terminal NN I-Gene
EBNA NNP I-Gene
- : I-Gene
1 CD I-Gene
construction NN I-Gene
( ( O
amino JJ O
acids NNS O
450 CD O
to TO O
641 CD O
) ) O
that WDT O
also RB O
carried VBD O
a DT O
c JJ B-Gene
- : I-Gene
myc NN I-Gene
nuclear JJ I-Gene
localization NN I-Gene
signal NN I-Gene
. . O

The DT O
amino NN O
- : O
terminal NN O
DNA NNP O
- : O
binding VBG O
domain NN O
of IN O
Pip NNP B-Gene
exhibits VBZ O
a DT O
high JJ O
degree NN O
of IN O
homology NN O
to TO O
the DT O
DNA NNP O
- : O
binding NN O
domains NNS O
of IN O
members NNS O
of IN O
the DT O
interferon NN B-Gene
regulatory JJ I-Gene
factor NN I-Gene
( ( O
IRF NNP B-Gene
) ) O
family NN O
, , O
which WDT O
includes VBZ O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
ICSBP NNP B-Gene
, , O
and CC O
ISGF3 NNP B-Gene
gamma NN I-Gene
. . O

This DT O
structure NN O
of IN O
cucumisin NN B-Gene
suggests VBZ O
that IN O
it PRP O
is VBZ O
probably RB O
synthesized VBN O
as IN O
an DT O
inactive JJ O
precursor NN O
. . O

Treatment NN O
and CC O
care NN O
of IN O
adult NN O
diabetes NNS O
mellitus VBP O
without IN O
coma NN O

By IN O
creating VBG O
Pax NNP B-Gene
- : I-Gene
6 CD I-Gene
- : O
BSAP NNP B-Gene
fusion NN O
proteins NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
a DT O
short JJ O
amino NN O
acid JJ O
stretch NN O
in IN O
the DT O
N NNP O
- : O
terminal JJ O
part NN O
of IN O
the DT O
paired VBN B-Gene
domain NN O
which WDT O
is VBZ O
responsible JJ O
for IN O
these DT O
differences NNS O
in IN O
DNA NNP O
- : O
binding NN O
specificity NN O
. . O

205 CD O
, , O
285 CD O
- : O
290 CD O
] NN O
and CC O
was VBD O
subsequently RB O
cloned VBN O
and CC O
sequenced VBN O
[ NNP O
J NNP O
. . O

Long NNP O
- : O
range NN O
mapping NN O
of IN O
the DT O
11q23 CD O
region NN O
involved VBN O
in IN O
chromosome NN O
aberrations NNS O
in IN O
human JJ O
tumors NNS O
by IN O
pulsed JJ O
- : O
field NN O
gel JJ O
electrophoresis NN O
with IN O
a DT O
yeast JJ O
artificial JJ O
chromosome NN O
. . O

PO2 NN O
measurements NNS O
using VBG O
a DT O
double JJ O
barrelled JJ O
recess NN O
type NN O
microelectrodes NNS O
were VBD O
measured VBN O
in IN O
the DT O
optic JJ O
nerve NN O
head NN O
of IN O
miniature NN O
pigs NNS O
in IN O
normoxia NN O
and CC O
hyperoxia NN O
. . O

O2 NNP O
and CC O
CO2 NNP O
in IN O
the DT O
tracheostomy NN O
tube NN O
were VBD O
continuously RB O
monitored VBN O
by IN O
mass NN O
spectrometry NN O
using VBG O
a DT O
special JJ O
sample NN O
- : O
hold NN O
phase NN O
- : O
locked VBN O
sampling NN O
technique NN O
. . O

Finding NNP O
of IN O
Rhodnius NNP O
prolixus NN O
Stal NNP O
, , O
1859 CD O
, , O
in IN O
babassu JJ O
palm NN O
trees NNS O

Hybridization NN O
analysis NN O
showed VBD O
that IN O
the DT O
size NN O
of IN O
the DT O
mRNA NN O
is VBZ O
about IN O
1 CD O
. . O
4 CD O
kilobases NNS O
. . O

The DT O
active JJ O
open JJ O
reading NN O
frame NN O
in IN O
the DT O
clone NN O
maps NN O
at IN O
27 CD O
min NN O
on IN O
the DT O
E NNP O
. . O
coli VB O
chromosome NN O
and CC O
is VBZ O
identical JJ O
in IN O
sequence NN O
to TO O
a DT O
wild JJ O
type JJ O
counterpart NN O
. . O

Cortisol NNP O
excretion NN O
, , O
appeared VBD O
to TO O
be VB O
markedly RB O
affected VBN O
by IN O
the DT O
season NN O
although IN O
other JJ O
factors NNS O
such JJ O
as IN O
social JJ O
and CC O
environmental JJ O
stress NN O
cannot NN O
be VB O
discounted VBN O
. . O

Two CD O
closely RB O
related JJ O
variants NNS O
of IN O
Stat5 NNP B-Gene
, , O
Stat5a NNP B-Gene
and CC O
Stat5b NNP B-Gene
, , O
are VBP O
encoded VBN O
by IN O
distinct JJ O
genes NNS O
. . O

We PRP O
could MD O
demonstrate VB O
the DT O
involvement NN O
of IN O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
PKA NNP B-Gene
) ) O
in IN O
the DT O
phosphorylation NN O
of IN O
CDC25Mm NNP B-Gene
in IN O
fibroblasts NNS O
overexpressing VBG O
this DT O
RasGEF NNP B-Gene
as RB O
well RB O
as IN O
in IN O
mouse NN O
brain NN O
synaptosomal JJ O
membranes NNS O
. . O

2 CD O
. . O

During IN O
transcript JJ O
elongation NN O
, , O
the DT O
sizes NNS O
of IN O
the DT O
DNA NNP O
footprint NN O
and CC O
the DT O
single JJ O
- : O
stranded JJ O
transcription NN O
bubble JJ O
vary JJ O
markedly RB O
among IN O
transcription NN O
complexes NNS O
halted VBN O
at IN O
different JJ O
template NN O
positions NNS O
. . O

Direct JJ O
current JJ O
polarography NN O
and CC O
differential JJ O
pulse NN O
polarographic JJ O
methods NNS O
have VBP O
been VBN O
developed VBN O
for IN O
the DT O
qualitative NN O
as RB O
well RB O
as IN O
quantitative JJ O
analysis NN O
of IN O
vitamin NN O
B1 NNP O
, , O
B2 NNP O
and CC O
B6 NNP O
. . O

Overexpressing VBG O
the DT O
coactivator NN O
, , O
SRC1a NNP B-Gene
or CC O
GRIP1 NNP B-Gene
, , O
further JJ O
enhances NNS O
ERRalpha1 NNP B-Gene
- : O
induced JJ O
transcriptional JJ O
activity NN O
. . O

3 CD O
. . O

Colorectal JJ O
polyps NNS O
should MD O
be VB O
removed VBN O
endoscopically RB O
whenever WRB O
possible JJ O
. . O

In IN O
contrast NN O
, , O
transcription NN O
initiating VBG O
from IN O
opuE JJ B-Gene
P NNP I-Gene
- : I-Gene
1 CD I-Gene
( ( O
sigma VB B-Gene
A NNP I-Gene
) ) O
rose VBD O
in IN O
proportion NN O
to TO O
the DT O
external JJ O
osmolarity NN O
and CC O
was VBD O
maintained VBN O
at IN O
high JJ O
levels NNS O
. . O

In IN O
the DT O
base NN O
- : O
case NN O
analysis NN O
, , O
total JJ O
direct JJ O
costs NNS O
per IN O
patient NN O
were VBD O
$ $ O
728 CD O
for IN O
zoledronic JJ O
acid NN O
and CC O
$ $ O
776 CD O
for IN O
pamidronate NN O
. . O

Cells NNS O
respond NN O
to TO O
the DT O
accumulation NN O
of IN O
unfolded JJ O
proteins NNS O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
( ( O
ER NNP O
) ) O
by IN O
increasing VBG O
the DT O
transcription NN O
of IN O
the DT O
genes NNS O
encoding VBG O
ER NNP B-Gene
- : I-Gene
resident NN I-Gene
chaperone NN I-Gene
proteins NNS I-Gene
. . O

CONCLUSIONS NNS O
: : O
Free JJ O
protein NN B-Gene
S NNP I-Gene
deficiency NN O
is VBZ O
common JJ O
among IN O
hospitalized JJ O
patients NNS O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
a DT O
recognized VBN O
predisposing NN O
condition NN O
. . O

At IN O
the DT O
basal NN O
unstimulated JJ O
condition NN O
, , O
Ren1d NNP B-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
sequence NN I-Gene
in IN O
the DT O
sense NN O
orientation NN O
inhibited VBD O
basal JJ O
CAT NNP B-Gene
expression NN O
from IN O
the DT O
TK NNP B-Gene
promoter NN I-Gene
of IN O
pUTKAT1 NN O
, , O
whereas IN O
the DT O
same JJ O
sequence NN O
in IN O
the DT O
antisense JJ O
orientation NN O
did VBD O
not RB O
. . O

Selection NN O
of IN O
the DT O
22 CD O
items NNS O
of IN O
the DT O
Clinical NNP O
Institute NNP O
Withdrawal NNP O
Assessment NNP O
- : O
Benzodiazepines NNS O
( ( O
CIWA NNP O
- : O
B NN O
) ) O
was VBD O
based VBN O
on IN O
statistically RB O
significant JJ O
differences NNS O
between IN O
baseline NN O
and CC O
critical JJ O
withdrawal NN O
periods NNS O
in IN O
high JJ O
- : O
dose JJ O
subjects NNS O
and CC O
between IN O
symptoms NNS O
associated VBN O
with IN O
placebo NN O
and CC O
diazepam NN O
in IN O
low JJ O
- : O
dose NN O
subjects NNS O
, , O
using VBG O
contingency NN O
tables NNS O
and CC O
logistic JJ O
regression NN O
analysis NN O
. . O

Cotransfections NNS O
with IN O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
HNF NNP B-Gene
- : I-Gene
4 CD I-Gene
expression NN O
plasmids NNS O
resulted VBD O
in IN O
additive JJ O
transactivation NN O
of IN O
the DT O
apoCIII NN B-Gene
promoter NN I-Gene
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
revealed VBD O
several JJ O
GC NNP O
boxes NNS O
but CC O
no DT O
identifiable JJ O
TATA NNP O
box NN O
. . O

The DT O
indoor JJ O
radon NN O
concentration NN O
in IN O
the DT O
summer NN O
( ( O
1990 CD O
) ) O
period NN O
ranged VBD O
between IN O
8 CD O
and CC O
81 CD O
Bq NNP O
m SYM O
- : O
3 CD O
, , O
while IN O
in IN O
the DT O
winter NN O
( ( O
1989 CD O
- : O
1990 CD O
) ) O
it PRP O
ranged VBD O
between IN O
20 CD O
and CC O
143 CD O
Bq NNP O
m SYM O
- : O
3 CD O
for IN O
the DT O
first JJ O
year NN O
of IN O
measurements NNS O
or CC O
between IN O
8 CD O
and CC O
92 CD O
Bq NNP O
m SYM O
- : O
3 CD O
in IN O
the DT O
summer NN O
( ( O
1991 CD O
) ) O
period NN O
and CC O
between IN O
12 CD O
and CC O
119 CD O
Bq NNP O
m SYM O
- : O
3 CD O
in IN O
the DT O
winter NN O
( ( O
1990 CD O
- : O
1991 CD O
) ) O
for IN O
the DT O
second JJ O
year NN O
of IN O
measurements NNS O
. . O

Clinical JJ O
research NN O
of IN O
non JJ O
- : O
A NN O
, , O
non SYM O
- : O
B NN O
post NN O
- : O
transfusion NN O
hepatitis NN O

Homozygous JJ O
individuals NNS O
usually RB O
develop VBP O
purpura JJ O
fulminans NNS O
as IN O
newborns NNS O
; : O
heterozygous JJ O
protein NN B-Gene
C NNP I-Gene
- : O
deficient NN O
individuals NNS O
are VBP O
at IN O
increased VBN O
risk NN O
for IN O
venous JJ O
thrombosis NN O
and CC O
pulmonary JJ O
embolism NN O
. . O

This DT O
accurate NN O
and CC O
rapid JJ O
method NN O
makes VBZ O
the DT O
MLPA NNP O
test NN O
logistically RB O
feasible JJ O
for IN O
large JJ O
- : O
scale NN O
screening NN O
. . O

In IN O
a DT O
series NN O
of IN O
402 CD O
consecutive JJ O
autopsies NNS O
, , O
parietal JJ O
pleural JJ O
plaques NNS O
( ( O
PP NNP O
) ) O
were VBD O
found VBN O
in IN O
68 CD O
individuals NNS O
above IN O
40 CD O
years NNS O
of IN O
age NN O
. . O

While IN O
the DT O
examiner NN O
observed VBD O
the DT O
interior NN O
of IN O
the DT O
eye NN O
with IN O
indirect JJ O
ophthalmoscopy NN O
, , O
the DT O
point NN O
source NN O
of IN O
light NN O
from IN O
the DT O
fiberoptic JJ O
light NN O
pipe NN O
was VBD O
moved VBN O
along IN O
the DT O
margins NNS O
of IN O
the DT O
episcleral JJ O
plaque NN O
. . O

Respiratory JJ O
adaptation NN O
to TO O
chronic VB O
hypoxia NN O
in IN O
newborn JJ O
rats NNS O
. . O

The DT O
amplitude NN O
of IN O
detrusor NN O
contractions NNS O
at IN O
6 CD O
, , O
12 CD O
, , O
and CC O
24 CD O
hours NNS O
showed VBD O
no DT O
significant JJ O
difference NN O
from IN O
that DT O
in IN O
the DT O
controls NNS O
. . O

2 CD O
. . O

The DT O
functional JJ O
homology NN O
of IN O
Cwg2 NNP B-Gene
with IN O
Cdc43 NNP B-Gene
, , O
which WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
control NN O
of IN O
cell NN O
polarity NN O
, , O
suggests VBZ O
a DT O
link NN O
between IN O
two CD O
morphogenetic JJ O
events NNS O
such JJ O
as IN O
establishment NN O
of IN O
cell NN O
polarity NN O
and CC O
cell NN O
wall NN O
biosynthesis NN O
. . O

Measurements NNS O
of IN O
perfusion NN O
also RB O
showed VBD O
significantly RB O
higher JJR O
values NNS O
under IN O
active JJ O
therapy NN O
. . O

The DT O
dorsal JJ O
nerves NNS O
of IN O
the DT O
penis NN O
were VBD O
anesthetized VBN O
bilaterally RB O
with IN O
lidocaine NN O
. . O

One CD O
form NN O
of IN O
the DT O
SBEI NNP B-Gene
gene NN I-Gene
transcript NN I-Gene
in IN O
12 CD O
- : O
day NN O
old JJ O
kernels NNS O
contained VBD O
the DT O
exon NN O
I PRP O
+ VBP O
II NNP O
+ NNP O
III NNP O
combination NN O
at IN O
the DT O
5 CD O
' POS O
end NN O
, , O
whereas IN O
other JJ O
forms NNS O
differed VBN O
by IN O
inclusion NN O
of IN O
intron NN O
1 CD O
or CC O
exclusion NN O
of IN O
exon JJ O
II NNP O
sequences NNS O
. . O

Age NNP O
and CC O
sex NN O
structure NN O
of IN O
the DT O
natural JJ O
population NN O
of IN O
Ornithodoros NNP O
tatarovski JJ O
Ol NNP O
. . O

Their PRP$ O
effect NN O
on IN O
the DT O
guinea NN O
pig NN O
vas NN O
deferens NNS O
. . O

In IN O
summary JJ O
, , O
the DT O
data NNS O
establish VB O
that IN O
the DT O
previously RB O
reported VBN O
human JJ B-Gene
MAdCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
cDNA NN I-Gene
does VBZ O
indeed RB O
encode VB O
the DT O
human JJ O
homologue NN O
of IN O
mouse NN B-Gene
MAdCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
despite IN O
gross JJ O
dissimilarities NNS O
in IN O
the DT O
MAdCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
C NNP O
- : O
terminal JJ O
structures NNS O
. . O

Stably RB O
transfected VBN O
human JJ O
kidney NN O
293 CD O
cells NNS O
expressing VBG O
the DT O
wild JJ B-Gene
type NN I-Gene
rat NN I-Gene
LH NNP I-Gene
/ NNP I-Gene
CG NNP I-Gene
receptor NN I-Gene
( ( O
rLHR NN B-Gene
) ) O
or CC O
receptors NNS O
with IN O
C NNP O
- : O
terminal NN O
tails NNS O
truncated VBN O
at IN O
residues NNS O
653 CD O
, , O
631 CD O
, , O
or CC O
628 CD O
( ( O
designated VBN O
rLHR NN B-Gene
- : I-Gene
t653 NN I-Gene
, , O
rLHR VB B-Gene
- : I-Gene
t631 NN I-Gene
, , O
and CC O
rLHR SYM B-Gene
- : I-Gene
t628 NN I-Gene
) ) O
were VBD O
used VBN O
to TO O
probe VB O
the DT O
importance NN O
of IN O
this DT O
region NN O
on IN O
the DT O
regulation NN O
of IN O
hormonal JJ O
responsiveness NN O
. . O

Although IN O
the DT O
RAD23 NNP B-Gene
equivalents NNS O
are VBP O
well RB O
conserved VBN O
during IN O
evolution NN O
, , O
the DT O
mammalian JJ O
genes NNS O
did VBD O
not RB O
express VB O
the DT O
UV NNP O
- : O
inducible JJ O
phenotype NN O
of IN O
their PRP$ O
yeast JJ O
counterpart NN O
. . O

Drosophila NNP B-Gene
Menin1 NNP I-Gene
gene NN I-Gene
transcripts NNS I-Gene
use VBP O
alternative JJ O
polyadenylation NN O
sites NNS O
resulting VBG O
in IN O
4 CD O
. . O
3 CD O
and CC O
5 CD O
- : O
kb NN O
messages NNS O
. . O

Frog NNP O
type NN O
I PRP O
( ( O
Ft NNP O
I PRP O
) ) O
and CC O
frog $ O
type NN O
II NNP O
( ( O
Ft NNP O
II NNP O
) ) O
slowly RB O
adapting VBG O
( ( O
SA NNP O
) ) O
units NNS O
produced VBD O
spikes NNS O
only RB O
at IN O
the DT O
indentation NN O
phase NN O
, , O
and CC O
the DT O
threshold JJ O
response NN O
phase NN O
( ( O
TRP NNP O
) ) O
, , O
i JJ O
. . O
e NN O
. . O
. . O
the DT O
phase NN O
of IN O
the DT O
first JJ O
spike NN O
was VBD O
for IN O
ca MD O
. . O

Frog NNP O
type NN O
I PRP O
( ( O
Ft NNP O
I PRP O
) ) O
and CC O
frog $ O
type NN O
II NNP O
( ( O
Ft NNP O
II NNP O
) ) O
slowly RB O
adapting VBG O
( ( O
SA NNP O
) ) O
units NNS O
produced VBD O
spikes NNS O
only RB O
at IN O
the DT O
indentation NN O
phase NN O
, , O
and CC O
the DT O
threshold JJ O
response NN O
phase NN O
( ( O
TRP NNP O
) ) O
, , O
i JJ O
. . O
e NN O
. . O
. . O
the DT O
phase NN O
of IN O
the DT O
first JJ O
spike NN O
was VBD O
for IN O
ca MD O
. . O

This DT O
agent NN O
, , O
isolated VBN O
from IN O
the DT O
fungus NN O
Streptomyces NNP O
tsukubaensis NN O
, , O
has VBZ O
a DT O
mechanism NN O
of IN O
action NN O
similar JJ O
to TO O
that DT O
of IN O
cyclosporine NN O
. . O

These DT O
cells NNS O
averaged VBD O
17 CD O
microns NNS O
in IN O
diameter NN O
and CC O
reproduced VBN O
by IN O
fission NN O
, , O
forming VBG O
clusters NNS O
of IN O
two CD O
or CC O
four CD O
daughter NN O
cells NNS O
. . O

An DT O
RME1 NNP B-Gene
- : O
independent JJ O
pathway NN O
for IN O
sporulation NN O
control NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
acts VBZ O
through IN O
IME1 NNP B-Gene
transcript NN I-Gene
accumulation NN O
. . O

To TO O
investigate VB O
the DT O
requirements NNS O
for IN O
CBF2 NNP B-Gene
binding NN O
, , O
we PRP O
synthesized VBD O
a DT O
series NN O
of IN O
oligonucleotides NNS O
carrying VBG O
double JJ O
transversion NN O
mutations NNS O
spanning VBG O
both DT O
the DT O
conserved VBN O
core NN O
sequence NN O
and CC O
outside JJ O
flanking NN O
sequences NNS O
. . O

Control NNP O
intact JJ O
rats NNS O
were VBD O
age NN O
- : O
matched VBN O
to TO O
the DT O
different JJ O
treated JJ O
groups NNS O
. . O

This DT O
region NN O
constitutes VBZ O
the DT O
DNA NNP O
- : O
binding NN O
domain NN O
with IN O
basic JJ O
- : O
helix NN O
- : O
loop NN O
- : O
helix NN O
and CC O
leucine JJ O
- : O
zipper NN O
motifs NNS O
, , O
features NNS O
common JJ O
to TO O
the DT O
myc NN B-Gene
- : I-Gene
related JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

After IN O
90 CD O
d NN O
a DT O
subsurface NN O
, , O
radiolucent NN O
caries NNS O
- : O
like IN O
lesion NN O
was VBD O
observed VBN O
in IN O
two CD O
specimens NNS O
only RB O
. . O

The DT O
metabolic JJ O
clearance NN O
rate NN O
of IN O
progesterone NN O
was VBD O
295 CD O
+ JJ O
/ NNP O
- : O
49 CD O
( ( O
S NNP O
. . O
E NNP O
. . O
) ) O
1 CD O
/ JJ O
day NN O
. . O

An DT O
F222W NN B-Gene
: : I-Gene
W21F NNP I-Gene
rGST VBZ I-Gene
A1 NNP I-Gene
- : I-Gene
1 CD I-Gene
double JJ I-Gene
mutant NN I-Gene
provides VBZ O
a DT O
direct JJ O
fluorescence NN O
probe NN O
of IN O
changes NNS O
in IN O
the DT O
environment NN O
of IN O
the DT O
C NNP O
- : O
terminal NN O
residue NN O
. . O

Identical JJ O
effects NNS O
were VBD O
obtained VBN O
when WRB O
inhibitors NNS O
and CC O
dominant JJ O
negative JJ O
mutants NNS O
were VBD O
tested VBN O
on IN O
the DT O
- : O
29 CD O
to TO O
+ VB O
139 CD O
bp JJ O
region NN O
of IN O
the DT O
cyclin NN B-Gene
D1 NNP I-Gene
promoter NN I-Gene
. . O

Deltamethrin NNP O
was VBD O
most RBS O
effective JJ O
on IN O
the DT O
thatched JJ O
surface NN O
and CC O
produced VBD O
100 CD O
% NN O
mortality NN O
of IN O
An DT O
. . O
culicifacies NNS O
adults VBP O
up RB O
to TO O
12 CD O
weeks NNS O
, , O
even RB O
when WRB O
exposed VBN O
at IN O
the DT O
lowest JJS O
dose JJ O
/ NN O
12 CD O
. . O
5 CD O
mg JJ O
/ NNP O
m2 NN O
. . O

Concerted JJ O
action NN O
of IN O
three CD O
distinct JJ O
domains NNS O
in IN O
the DT O
DNA NN O
cleaving VBG O
- : O
joining VBG O
reaction NN O
catalyzed VBN O
by IN O
relaxase NN B-Gene
( ( O
TraI NNP B-Gene
) ) O
of IN O
conjugative JJ O
plasmid NN O
RP4 NNP O
. . O

An DT O
approximately RB O
37 CD O
- : O
kDa NN O
cytoplasmic JJ O
protein NN O
is VBZ O
rapidly RB O
tyrosine JJ O
- : O
phosphorylated VBN O
in IN O
the DT O
response NN O
of IN O
mouse NN O
BAC1 NNP O
. . O
2F5 CD O
macrophages NNS O
to TO O
colony VB B-Gene
stimulating VBG I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

pp37 NN B-Gene
was VBD O
purified VBN O
from IN O
the DT O
cytosolic JJ O
fraction NN O
by IN O
anti JJ B-Gene
- : I-Gene
Tyr NN I-Gene
( ( I-Gene
P NNP I-Gene
) ) I-Gene
affinity NN O
chromatography NN O
, , O
size NN O
exclusion NN O
chromatography NN O
, , O
and CC O
C4 NNP O
reverse VB O
phase NN O
high JJ O
pressure NN O
liquid NN O
chromatography NN O
. . O

Both DT O
the DT O
MVBF NNP O
and CC O
the DT O
maximum JJ O
EMG NNP O
activity NN O
in IN O
the DT O
right JJ O
masseter NN O
and CC O
the DT O
left JJ O
anterior JJ O
temporalis NNS O
muscles NNS O
were VBD O
significantly RB O
decreased VBN O
during IN O
muscle NN O
pain NN O
when WRB O
the DT O
subjects NNS O
bit VBP O
on IN O
the DT O
painful JJ O
side NN O
. . O

Early JJ O
- : O
onset JJ O
scleral JJ O
necrosis NN O
after IN O
iodine NN O
I PRP O
125 CD O
plaque NN O
radiotherapy NN O
for IN O
ciliochoroidal JJ O
melanoma NN O
. . O

RU486 NNP O
and CC O
ONO NNP O
802 CD O
in IN O
combination NN O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
effective JJ O
in IN O
early JJ O
termination NN O
of IN O
pregnancy NN O
. . O

A DT O
preliminary JJ O
study NN O
on IN O
pyogenic JJ O
arthritis NN O
. . O

SAM NNP O
- : O
TR NNP O
- : O
68 CD O
- : O
54 CD O
. . O

A DT O
mutational JJ O
analysis NN O
has VBZ O
resolved VBN O
a DT O
region NN O
of IN O
seven CD O
amino JJ O
acids NNS O
( ( O
amino JJ O
acids NNS O
26 CD O
- : O
32 CD O
) ) O
in IN O
the DT O
N NNP O
- : O
terminus NN O
of IN O
Bob1 NNP B-Gene
that WDT O
are VBP O
important JJ O
for IN O
contacting VBG O
the DT O
DNA NN B-Gene
binding VBG I-Gene
POU NNP I-Gene
domain NN I-Gene
of IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

High JJ O
levels NNS O
of IN O
C NNP B-Gene
subunits NNS I-Gene
are VBP O
observed VBN O
in IN O
several JJ O
subsequent JJ O
larval NN O
and CC O
adult NN O
stages NNS O
of IN O
development NN O
. . O

Thirty NNP O
Class NNP O
I PRP O
and CC O
Class NNP O
II NNP O
recessions NNS O
in IN O
30 CD O
patients NNS O
were VBD O
treated VBN O
with IN O
a DT O
modified JJ O
subepithelial JJ O
connective JJ O
tissue NN O
graft NN O
procedure NN O
. . O

While IN O
important JJ O
for IN O
ligand NN O
- : O
dependent JJ O
transactivation NN O
, , O
this DT O
interaction NN O
surface NN O
is VBZ O
not RB O
directly RB O
involved VBN O
in IN O
transrepression NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
. . O

Collectively RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
HIP NNP B-Gene
is VBZ O
a DT O
membrane NN O
- : O
associated VBN O
HP NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
expressed VBD O
on IN O
the DT O
surface NN O
of IN O
normal JJ O
human JJ O
uterine NN O
epithelia NN O
and CC O
uterine JJ O
epithelial NN O
cell NN O
lines NNS O
. . O

Regression NNP O
line NN O
slopes NNS O
of IN O
IBDQ NNP O
scores NNS O
were VBD O
significantly RB O
different JJ O
in IN O
patients NNS O
who WP O
deteriorated VBD O
from IN O
those DT O
who WP O
remained VBD O
stable JJ O
( ( O
[ JJ O
b NN O
] NNP O
< VBZ O
0 CD O
. . O
15 CD O
; : O
P NNP O
< VBD O
0 CD O
. . O
1 CD O
) ) O
. . O

Further JJ O
research NN O
is VBZ O
required VBN O
to TO O
better RBR O
measure NN O
treatment NN O
effects NNS O
, , O
modification NN O
of IN O
MS NNP O
natural JJ O
history NN O
, , O
and CC O
net JJ O
societal NN O
costs NNS O
of IN O
IFN NNP B-Gene
beta SYM I-Gene
- : I-Gene
1b CD I-Gene
in IN O
RRMS NNP O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
SmSmad2 NNP B-Gene
responds VBZ O
to TO O
the DT O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
signals NNS O
by IN O
interaction NN O
with IN O
receptor NN B-Gene
I PRP I-Gene
, , O
which WDT O
phosphorylates VBZ O
it PRP O
, , O
whereupon VBZ O
it PRP O
translocates VBZ O
into IN O
the DT O
nucleus NN O
presumably RB O
to TO O
regulate VB O
target NN O
gene NN O
transcription NN O
and CC O
consequently RB O
elicit VB O
a DT O
specific JJ O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
effect NN O
. . O

Mapping VBG O
the DT O
cAMP NN B-Gene
receptor NN I-Gene
protein NN I-Gene
contact NN I-Gene
site NN I-Gene
on IN O
the DT O
alpha JJ O
subunit NN O
of IN O
Escherichia NNP B-Gene
coli NNS I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
. . O

These DT O
temperature NN O
- : O
and CC O
cold JJ O
- : O
sensitive JJ O
strains NNS O
were VBD O
used VBN O
to TO O
prepare VB O
extracts NNS O
deficient JJ O
in IN O
BRF1 NNP B-Gene
activity NN O
and CC O
were VBD O
tested VBN O
for IN O
transcriptional JJ O
activity NN O
by IN O
RNA NNP B-Gene
polymerases NNS I-Gene
I PRP I-Gene
, , I-Gene
II NNP I-Gene
, , I-Gene
and CC I-Gene
III NNP I-Gene
in IN O
vitro NN O
. . O

Blood NNP O
glucose NN O
and CC O
plasma JJ O
insulin NN B-Gene
were VBD O
measured VBN O
at IN O
zero CD O
time NN O
and CC O
then RB O
at IN O
15 CD O
, , O
30 CD O
, , O
60 CD O
, , O
90 CD O
and CC O
120 CD O
min NN O
after IN O
ingestion NN O
of IN O
25 CD O
g NNS O
glucose RB O
, , O
fructose VBD O
or CC O
lactose JJ O
, , O
or CC O
30 CD O
g JJ O
honey NN O
, , O
50 CD O
g JJ O
white JJ O
bread NN O
, , O
125 CD O
g NN O
white JJ O
rice NN O
or CC O
potatoes NNS O
, , O
150 CD O
g NN O
apples NNS O
or CC O
260 CD O
g JJ O
carrots NNS O
. . O

The DT O
preferential JJ O
heterodimerization NN O
of IN O
USF NNP B-Gene
subunits NNS I-Gene
was VBD O
reproduced VBN O
ex JJ O
vivo NNS O
, , O
while IN O
the DT O
in IN O
vitro NNP O
association NN O
of IN O
cotranslated JJ O
subunits NNS O
, , O
or CC O
recombinant JJ B-Gene
USF NNP I-Gene
proteins NNS I-Gene
, , O
appeared VBD O
to TO O
be VB O
random JJ O
. . O

Following VBG O
2 CD O
. . O
5 CD O
Gy NNP O
, , O
HbO2 NNP B-Gene
changes NNS O
were VBD O
minimal JJ O
. . O

The DT O
corticosterone NN O
synthesis NN O
inhibitor NN O
metyrapone NN O
( ( O
75 CD O
mg NN O
/ NNP O
kg NN O
i NN O
. . O
p NN O
. . O
) ) O
was VBD O
given VBN O
to TO O
attenuate VB O
the DT O
rise NN O
of IN O
corticosterone NN O
to TO O
a DT O
level JJ O
typical NN O
of IN O
stressed JJ O
males NNS O
. . O

The DT O
centromeric JJ O
YAC NNP O
contig NN O
, , O
which WDT O
consists VBZ O
of IN O
23 CD O
overlapping VBG O
YACs NN O
and CC O
orders NNS O
19 CD O
sequence NN O
- : O
tagged VBN O
sites NNS O
( ( O
STSs NNP O
) ) O
, , O
covers VBZ O
a DT O
minimum NN O
of IN O
2 CD O
. . O
2 CD O
Mb NNP O
and CC O
spans VBZ O
the DT O
Ewing NNP O
sarcoma NN O
breakpoint NN O
. . O

c SYM B-Gene
- : I-Gene
ets NNS I-Gene
1 CD I-Gene
and CC O
Fli NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
two CD O
members NNS O
of IN O
the DT O
ets NNS B-Gene
family NN I-Gene
, , O
have VBP O
been VBN O
linked VBN O
within IN O
400 CD O
kb NNS O
of IN O
intervening VBG O
DNA NNP O
within IN O
this DT O
contig NN O
, , O
which WDT O
also RB O
comprises VBZ O
a DT O
polymorphic JJ O
microsatellite NN O
, , O
D11S912 NNP B-Gene
( ( O
CA NNP O
) ) O
n NN O
, , O
which WDT O
we PRP O
have VBP O
localized VBN O
within IN O
the DT O
Fli NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
. . O

Blood NNP O
variables NNS O
measured VBD O
at IN O
eight CD O
intervals NNS O
before IN O
, , O
during IN O
, , O
and CC O
after IN O
operation NN O
were VBD O
as IN O
follows VBZ O
: : O
seven CD O
plasma NN O
proteins NNS O
, , O
free JJ O
hemoglobin NN B-Gene
, , O
formed VBD O
elements NNS O
, , O
and CC O
clotting VBG O
functions NNS O
. . O

Both DT O
antidepressants NNS O
elevated VBD O
the DT O
pain NN O
threshold NN O
acutely RB O
, , O
while IN O
pretreatment NN O
with IN O
pCPA NN O
largely RB O
blocked VBD O
the DT O
analgesia NN O
. . O

All DT O
Cu NNP O
values NNS O
obtained VBN O
from IN O
the DT O
organs NNS O
investigated VBN O
had VBD O
reached VBN O
a DT O
saturation NN O
level NN O
at IN O
8 CD O
mug NN O
Cu NNP O
/ NNP O
g VBD O
diet JJ O
with IN O
the DT O
exception NN O
of IN O
the DT O
values NNS O
for IN O
body NN O
Cu NNP O
found VBD O
in IN O
the DT O
dams NNS O
that WDT O
were VBD O
killed VBN O
on IN O
the DT O
day NN O
of IN O
delivery NN O
. . O

Precision NNP O
measurement NN O
of IN O
the DT O
pion NN O
mass NN O
difference NN O
m NN O
pi SYM O
- : O
- : O
m NN O
pi NN O
0 CD O
. . O

Gel NNP O
electrophoresis NN O
and CC O
Western JJ O
immunoblot NN O
analyses NNS O
of IN O
intracellular JJ O
fractions NNS O
derived VBN O
from IN O
infected JJ O
cells NNS O
revealed VBD O
that IN O
large JJ O
amounts NNS O
of IN O
NS53 NNP B-Gene
were VBD O
present JJ O
in IN O
the DT O
cytosol NN O
and CC O
in IN O
association NN O
with IN O
the DT O
cytoskeletal JJ O
matrix NN O
. . O

The DT O
Southern NNP O
technique NN O
allowed VBD O
a DT O
further JJ O
localization NN O
of IN O
the DT O
region NN O
of IN O
most JJS O
extensive JJ O
transcription NN O
to TO O
a DT O
1 CD O
. . O
8 CD O
kb NN O
HindIII NNP B-Gene
- : O
EcoRI NNP B-Gene
fragment NN O
. . O

Grippers NNS O
with IN O
integrated JJ O
piezoresistive JJ O
force NN O
sensors NNS O
and CC O
with IN O
attached JJ O
strain NN O
gauges NNS O
have VBP O
been VBN O
reported VBN O
. . O

Streptococcal JJ O
preparation NN O
( ( O
OK NNP O
- : O
432 CD O
) ) O
, , O
a DT O
new JJ O
type NN O
of IN O
anti JJ O
- : O
cancer NN O
agent NN O
, , O
was VBD O
given VBN O
to TO O
the DT O
patients NNS O
with IN O
advanced JJ O
cancer NN O
in IN O
combination NN O
with IN O
Mitomycin NNP O
- : O
C NNP O
, , O
5 CD O
- : O
FU NN O
and CC O
Cytosine NNP O
arabinoside NN O
. . O

Fifty NNP O
min NN O
after IN O
release NN O
from IN O
stress NN O
, , O
increases NNS O
in IN O
plasma NN O
corticosterone NN O
levels NNS O
induced VBN O
by IN O
stress NN O
recovered VBN O
in IN O
the DT O
biting NN O
group NN O
but CC O
remained VBD O
high JJ O
in IN O
the DT O
non JJ O
- : O
biting VBG O
group NN O
. . O

The DT O
critical JJ O
mutations NNS O
were VBD O
likely JJ O
to TO O
have VB O
been VBN O
multiple JJ O
and CC O
dispersed JJ O
, , O
including VBG O
elongation NN O
of IN O
the DT O
TM NNP O
and CC O
Nef NNP B-Gene
coding NN I-Gene
sequences NNS I-Gene
; : O
changes NNS O
in IN O
RNA NNP O
splice NN O
donor NN O
and CC O
acceptor NN O
sites NNS O
, , O
TATA NNP O
box NN O
sites NNS O
, , O
and CC O
Sp1 NNP B-Gene
sites NNS I-Gene
; : O
multiple JJ O
changes NNS O
in IN O
the DT O
V2 NNP B-Gene
region NN O
of IN O
SU NNP B-Gene
, , O
including VBG O
a DT O
consensus NN O
neutralization NN O
epitope NN O
; : O
and CC O
five CD O
new JJ O
N NNP O
- : O
linked VBN O
glycosylation NN O
sites NNS O
in IN O
SU NNP B-Gene
. . O

"""" NN O
Complex NNP O
partial JJ O
"""" NN O
seizures NNS O
. . O

Retreatment NN O
of IN O
these DT O
2 CD O
dogs NNS O
resulted VBD O
in IN O
a DT O
similar JJ O
, , O
but CC O
blunted VBD O
, , O
response NN O
to TO O
human JJ B-Gene
immunoglobulin NN I-Gene
. . O

Forty NNP O
- : O
one CD O
ASA NNP O
physical JJ O
status NN O
I PRP O
or CC O
II NNP O
adult NN O
patients NNS O
undergoing VBG O
a DT O
variety NN O
of IN O
1 CD O
- : O
1 CD O
. . O
5 CD O
h JJ O
surgical JJ O
procedures NNS O
were VBD O
randomly RB O
allocated VBN O
to TO O
receive VB O
CCA NNP O
with IN O
desflurane NN O
or CC O
isoflurane NN O
with IN O
ventilation NN O
being VBG O
either CC O
spontaneous JJ O
or CC O
controlled VBN O
. . O

In IN O
MCCP NNP O
functions NNS O
of IN O
the DT O
source NN O
emission NN O
, , O
surface NN O
reflection NN O
, , O
photoacceptor NN O
sensitivity NN O
are VBP O
approximated VBN O
by IN O
the DT O
normal JJ O
distribution NN O
curves NNS O
. . O

A DT O
recently RB O
described VBN O
protein NN O
, , O
metaxin NN B-Gene
1 CD I-Gene
, , O
serves VBZ O
as IN O
a DT O
component NN O
of IN O
a DT O
preprotein JJ O
import NN O
complex NN O
in IN O
the DT O
outer NN O
membrane NN O
of IN O
the DT O
mammalian JJ O
mitochondrion NN O
. . O

The DT O
metabolism NN O
and CC O
pharmacology NN O
of IN O
5 CD O
- : O
fluorouracil NN O
. . O

Jean NNP O
Klig NNP O
reviews VBZ O
recent JJ O
literature NN O
about IN O
lower JJR O
respiratory NN O
tract JJ O
infection NN O
in IN O
children NNS O
. . O

Total JJ O
PGE NNP O
levels NNS O
in IN O
synovial JJ O
fluid NN O
remained VBD O
significantly RB O
depressed VBN O
in IN O
the DT O
patient NN O
group NN O
for IN O
24 CD O
hours NNS O
after IN O
the DT O
400 CD O
- : O
mg NN O
test NN O
dose NN O
of IN O
tolmetin NN O
on IN O
day NN O
8 CD O
. . O

However RB O
, , O
both DT O
TPN NNP O
groups NNS O
showed VBD O
a DT O
marked JJ O
increase NN O
in IN O
activities NNS O
of IN O
liver NN O
lysosomal JJ B-Gene
enzymes NNS I-Gene
. . O

Overexpression NN O
of IN O
CARP NNP B-Gene
in IN O
cardiomyocytes NNS O
suppresses NNS O
cardiac VBP B-Gene
troponin NN I-Gene
C NNP I-Gene
and CC O
atrial JJ B-Gene
natriuretic JJ I-Gene
factor NN I-Gene
transcription NN O
. . O

This DT O
repressor NN O
is VBZ O
however RB O
unlikely JJ O
to TO O
mediate VB O
spi JJ B-Gene
2 CD I-Gene
. . I-Gene
3 CD I-Gene
3 CD I-Gene
' '' I-Gene
UTR NNP I-Gene
silencer NN I-Gene
action NN O
since IN O
it PRP O
was VBD O
not RB O
detected VBN O
in IN O
rat NN O
hepatocytes NNS O
. . O

Molecular JJ O
analysis NN O
of IN O
a DT O
novel JJ O
schizosaccharomyces NNS O
pombe VBP O
gene NN O
containing VBG O
two CD O
RNP NNP O
consensus NN O
- : O
sequence NN O
RNA NNP O
- : O
binding NN O
domains NNS O
. . O

The DT O
number NN O
of IN O
muricidal JJ O
rats NNS O
increased VBD O
with IN O
increase NN O
in IN O
the DT O
duration NN O
of IN O
Cd NNP O
administration NN O
in IN O
association NN O
with IN O
greater JJR O
accumulation NN O
of IN O
Cd NNP O
in IN O
the DT O
olfactory NN O
bulb NN O
than IN O
in IN O
any DT O
other JJ O
region NN O
of IN O
the DT O
brain NN O
. . O

The DT O
syndrome NN O
of IN O
resistance NN O
to TO O
thyroid VB O
hormone NN O
is VBZ O
characterized VBN O
by IN O
elevated JJ O
serum NN O
free JJ O
thyroid NN O
hormones NNS O
, , O
failure NN O
to TO O
suppress VB O
pituitary JJ B-Gene
thyrotropin NN I-Gene
secretion NN O
, , O
and CC O
variable JJ O
peripheral JJ O
refractoriness NN O
to TO O
hormone VB O
action NN O
. . O

Human NNP B-Gene
homologue NN I-Gene
of IN I-Gene
yeast NN I-Gene
Rad23 NNP I-Gene
protein VBZ I-Gene
A DT I-Gene
interacts NNS O
with IN O
p300 JJ B-Gene
/ NNP O
cyclic NN B-Gene
AMP NNP I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
binding NN I-Gene
( ( I-Gene
CREB NNP I-Gene
) ) I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
to TO O
down VB O
- : O
regulate JJ O
transcriptional JJ O
activity NN O
of IN O
p53 NN B-Gene
. . O

Can MD O
thyroglobulin VB B-Gene
assay VB O
really RB O
supplant JJ O
radioiodine NN O
scans NNS O
in IN O
patients NNS O
with IN O
differentiated JJ O
thyroid NN O
cancer NN O
? . O

A DT O
receptor NN B-Gene
- : I-Gene
like IN I-Gene
protein NN I-Gene
kinase NN I-Gene
, , O
OsPK10 NNP B-Gene
, , O
has VBZ O
been VBN O
cloned VBN O
from IN O
rice NN O
( ( O
Oryza NNP O
sativa NN O
) ) O
. . O

Effect NN O
of IN O
triftazin NN O
and CC O
aminazin NN O
on IN O
hippocampal JJ O
bioelectric JJ O
activity NN O

Analysis NN O
of IN O
strains NNS O
harboring VBG O
an DT O
mds1 NN B-Gene
null JJ I-Gene
mutation NN I-Gene
demonstrates VBZ O
that IN O
MDS1 NNP B-Gene
is VBZ O
not RB O
essential JJ O
during IN O
normal JJ O
vegetative JJ O
growth NN O
but CC O
appears VBZ O
to TO O
be VB O
required VBN O
for IN O
meiosis NN O
. . O

Autoregulation NN O
enables VBZ O
different JJ O
pathways NNS O
to TO O
control VB O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
beta NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
) ) O
transcription NN O
. . O

Bacterial JJ O
recovery NN O
of IN O
SA NNP O
from IN O
the DT O
liver NN O
/ NNP O
spleen NN O
and CC O
the DT O
cecal JJ O
tonsil NN O
in IN O
contact NN O
poults NNS O
and CC O
SG NNP O
from IN O
contact NN O
chicks NNS O
treated VBN O
with IN O
ILK NNP B-Gene
was VBD O
dramatically RB O
reduced VBN O
when WRB O
compared VBN O
to TO O
non VB O
- : O
treated VBN O
contact NN O
poults NNS O
and CC O
chicks NNS O
. . O

Clinical JJ O
chemistry NN O
. . O

Consistent JJ O
with IN O
this DT O
, , O
purified VBD O
Dlk NNP B-Gene
phosphorylated VBD O
core NN O
histones NNS B-Gene
H3 NNP I-Gene
, , O
H2A NNP B-Gene
and CC O
H4 NNP B-Gene
as IN O
exogenous JJ O
substrates NNS O
and CC O
endogenous JJ O
histone NN B-Gene
H3 NNP I-Gene
in IN O
kinase NNP O
assays NNS O
with IN O
nuclear JJ O
extracts NNS O
. . O

Transcriptional JJ O
regulation NN O
of IN O
the DT O
estrogen NN O
- : O
inducible JJ O
pS2 NN B-Gene
breast NN B-Gene
cancer NN I-Gene
marker NN I-Gene
gene NN I-Gene
by IN O
the DT O
ERR NNP B-Gene
family NN I-Gene
of IN O
orphan JJ B-Gene
nuclear JJ I-Gene
receptors NNS I-Gene
. . O

We PRP O
have VBP O
developed VBN O
a DT O
new JJ O
method NN O
for IN O
estimation NN O
of IN O
regional JJ O
CBF NNP O
( ( O
rCBF NN O
) ) O
and CC O
cerebrovascular JJ O
reserve NN O
capacity NN O
on IN O
a DT O
pixel NN O
- : O
by IN O
- : O
pixel JJ O
basis NN O
by IN O
means NNS O
of IN O
dynamic JJ O
magnetic JJ O
resonance NN O
imaging NN O
( ( O
MRI NNP O
) ) O
. . O

XXI NN O
. . O

A DT O
preliminary JJ O
study NN O
of IN O
vincristine NN O
, , O
methotrexate NN O
, , O
and CC O
prednisolone NN O
( ( O
VM NNP O
* NNP O
P NNP O
) ) O
combination NN O
chemotherapy NN O
for IN O
advanced JJ O
adult NN O
non SYM O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O

Seventeen NN O
of IN O
the DT O
35 CD O
patients NNS O
were VBD O
randomly RB O
chosen VBN O
to TO O
receive VB O
a DT O
training NN O
program NN O
( ( O
lasting VBG O
approximately RB O
1 CD O
month NN O
) ) O
designed VBD O
to TO O
establish VB O
a DT O
systematic JJ O
strategy NN O
of IN O
organizing VBG O
complex JJ O
visual JJ O
material NN O
. . O

We PRP O
have VBP O
thus RB O
identified VBN O
the DT O
first JJ O
mammalian JJ B-Gene
homolog NN I-Gene
of IN I-Gene
yeast NN I-Gene
UPF1 NNP I-Gene
, , O
a DT O
protein NN O
that WDT O
regulates VBZ O
levels NNS O
of IN O
nonsense NN O
mRNA NN O
, , O
and CC O
we PRP O
tentatively RB O
name VBP O
this DT O
protein NN O
human JJ B-Gene
HUPF1 NNP I-Gene
( ( O
for IN O
human JJ B-Gene
homolog NN I-Gene
of IN I-Gene
UPF1 NNP I-Gene
) ) O
. . O

Pathogenetic JJ O
relationships NNS O
between IN O
renal JJ O
tubular JJ O
acidosis NN O
and CC O
sodium NN O
metabolism NN O
alterations NNS O
in IN O
liver JJ O
cirrhosis NN O
. . O

CDK4 NNP B-Gene
kinase NN I-Gene
activities NNS O
were VBD O
unaffected JJ O
, , O
as IN O
were VBD O
the DT O
levels NNS O
of IN O
the DT O
CDK NNP B-Gene
inhibitor NN O
p21Cip1 NN B-Gene
present NN O
in IN O
cyclin NN B-Gene
E NNP I-Gene
immunocomplexes NNS I-Gene
. . O

The DT O
serum JJ B-Gene
insulin NN I-Gene
response NN O
cannot NN O
. . O

Data NNP O
collection NN O
was VBD O
made VBN O
with IN O
a DT O
query NN O
language NN O
, , O
and CC O
data NNS O
analysis NN O
performed VBN O
with IN O
an DT O
interactive JJ O
knowledge NN O
- : O
based VBN O
statistical JJ O
tool NN O
, , O
MAXITAB NNP O
, , O
employing VBG O
a DT O
multivariate NN O
tabular JJ O
analysis NN O
technique NN O
. . O

The DT O
objective NN O
of IN O
our PRP$ O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
age NN O
, , O
sex NN O
, , O
clinical JJ O
conditions NNS O
, , O
family NN O
history NN O
, , O
site NN O
, , O
catheter NN O
association NN O
, , O
means VBZ O
of IN O
radiologic JJ O
evaluation NN O
, , O
development NN O
of IN O
pulmonary JJ O
involvement NN O
, , O
prevalence NN O
of IN O
antithrombin NN B-Gene
III NNP I-Gene
, , O
protein NN B-Gene
C NNP I-Gene
and CC O
protein VB B-Gene
S NNP I-Gene
deficiencies NNS O
, , O
and CC O
lupus JJ O
anticoagulants NNS O
in IN O
children NNS O
who WP O
suffered VBD O
a DT O
thrombotic JJ O
event NN O
. . O

After IN O
description NN O
of IN O
his PRP$ O
short JJ O
life NN O
and CC O
an DT O
explanation NN O
of IN O
the DT O
light JJ O
conductor NN O
Bozzini NNP O
' POS O
s NN O
merit NN O
is VBZ O
emphasized VBN O
, , O
by IN O
his PRP$ O
invention NN O
as IN O
first JJ O
physician NN O
to TO O
have VB O
made VBN O
accessible JJ O
to TO O
medicine VB O
endoscopic JJ O
diagnostic JJ O
possibilities NNS O
. . O

In IN O
both DT O
groups NNS O
there EX O
were VBD O
5 CD O
management NN O
failure NN O
of IN O
therapy NN O
, , O
so IN O
that DT O
alternative JJ O
medication NN O
or CC O
a DT O
cesarean JJ O
section NN O
lead NN O
to TO O
delivery NN O
. . O

We PRP O
have VBP O
introduced VBN O
a DT O
mutation NN O
( ( O
Ser36 NNP O
- : O
- : O
> NN O
Asn NNP O
) ) O
into IN O
this DT O
domain NN O
of IN O
p190 NN B-Gene
that WDT O
decreased VBD O
its PRP$ O
ability NN O
to TO O
bind VB O
guanine JJ O
nucleotide NN O
when WRB O
expressed VBN O
as IN O
a DT O
hemagglutinin NN B-Gene
( ( O
HA NNP B-Gene
) ) O
- : O
tagged VBN O
protein NN O
in IN O
COS NNP O
cells NNS O
. . O

Laser NNP O
therapy NN O
of IN O
penile NN O
carcinoma NN O

Type $ O
2 CD O
genomes NNS O
containing VBG O
this DT O
sequence NN O
presumably RB O
more RBR O
closely RB O
reflect VB O
the DT O
structure NN O
of IN O
the DT O
infectious JJ O
, , O
replication NN O
- : O
competent NN O
retrovirus NN O
ancestors NNS O
of IN O
the DT O
HERV NNP O
- : O
K NNP O
family NN O
than IN O
do VBP O
type VB O
1 CD O
genomes NNS O
that WDT O
lack VBP O
the DT O
sequence NN O
. . O

DNA NN O
binding NN O
and CC O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
pull NN O
- : O
down RP O
assays NNS O
demonstrate VBP O
that IN O
binding VBG O
requires VBZ O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
212 CD I-Gene
) ) I-Gene
but CC O
not RB O
the DT O
C NNP O
- : O
terminal JJ O
transactivation NN O
domain NN O
. . O

One CD O
millimolar NN O
ouabain NN O
completely RB O
inhibited JJ O
net JJ O
HCO3 NNP O
- : O
secretion NN O
. . O

The DT O
psychological JJ O
tests NNS O
consisted VBD O
of IN O
a DT O
free JJ O
- : O
recall NN O
task NN O
, , O
a DT O
test NN O
for IN O
visuomotor NN O
coordination NN O
and CC O
a DT O
recognition NN O
task NN O
. . O

Of IN O
the DT O
compounds NNS O
tested VBN O
, , O
alpha SYM O
- : O
( ( O
3 CD O
- : O
methyl NN O
- : O
2 CD O
- : O
quinoxalinyl NN O
) ) O
- : O
N NNP O
- : O
methylnitrone NN O
1 CD O
, , O
4 CD O
- : O
dioxide NN O
( ( O
2 CD O
) ) O
was VBD O
the DT O
most RBS O
active JJ O
agent NN O
in IN O
vivo NN O
against IN O
the DT O
gram JJ O
- : O
negative JJ O
and CC O
the DT O
gram NN O
- : O
positive JJ O
organisms NNS O
. . O

Effects NNS O
of IN O
moderate JJ O
hypercapnia NN O
on IN O
hypothermia NN O
induced VBN O
by IN O
cold NN O
He PRP O
- : O
O2 NN O
in IN O
rats NNS O
. . O

The DT O
HSD3B1 NNP B-Gene
and CC O
HSD3B2 NNP B-Gene
genes NNS I-Gene
encoding VBG O
the DT O
types NNS B-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
3 CD I-Gene
beta NN I-Gene
- : I-Gene
HSD NNP I-Gene
isoenzymes NNS I-Gene
, , O
respectively RB O
, , O
have VBP O
been VBN O
previously RB O
assigned VBN O
by IN O
in IN O
situ JJ O
hybridization NN O
to TO O
the DT O
chromosome NN O
1p13 CD O
. . O
1 CD O
region NN O
. . O

The DT O
persistence NN O
of IN O
members NNS O
of IN O
the DT O
prostigmatid NN O
families NNS O
Tydeidae NNP O
, , O
Nanorchestidae NNP O
and CC O
Tarsonemidae NNP O
in IN O
the DT O
moisture NN O
- : O
deficient NN O
90 CD O
% NN O
- : O
concentration NN O
treatments NNS O
supports VBP O
previous JJ O
evidence NN O
of IN O
adaptations NNS O
to TO O
low VB O
- : O
water NN O
- : O
content NN O
habitats NNS O
. . O

In IN O
the DT O
intact JJ O
animal NN O
, , O
postextrasystolic JJ O
potentiation NN O
depended VBD O
on IN O
the DT O
basic JJ O
pacing NN O
interval NN O
, , O
t0 NN O
, , O
and CC O
the DT O
timing NN O
of IN O
the DT O
extrasystole NN O
, , O
t1 NN O
: : O
when WRB O
t0 NN O
was VBD O
held VBN O
constant JJ O
and CC O
t1 NN O
was VBD O
increased VBN O
, , O
potentiation NN O
decreased VBD O
; : O
when WRB O
t1 NN O
was VBD O
held VBN O
constant JJ O
and CC O
t0 NN O
was VBD O
increased VBN O
, , O
potentiation NN O
increased VBD O
. . O

Serum NNP B-Gene
beta NN I-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
levels NNS O
( ( O
beta SYM B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
M NN I-Gene
) ) O
were VBD O
studied VBN O
in IN O
150 CD O
drug NN O
addicts NNS O
, , O
50 CD O
of IN O
them PRP O
asymptomatic JJ O
carriers NNS O
of IN O
anti NN B-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
antibodies NNS I-Gene
, , O
50 CD O
symptomatic JJ O
carriers NNS O
with IN O
persistent JJ O
generalized VBN O
lymphadenopathy NN O
( ( O
P NNP O
. . O
G NNP O
. . O
L NNP O
. . O
) ) O
and CC O
50 CD O
serum NNS O
negative JJ O
patients NNS O
who WP O
had VBD O
been VBN O
living VBG O
in IN O
a DT O
closed JJ O
community NN O
for IN O
at IN O
least JJS O
2 CD O
years NNS O
. . O

Using VBG O
5 CD O
' '' O
RACE NNP O
and CC O
reverse VB O
transcription NN O
- : O
PCR NNP O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
methodologies NNS O
, , O
we PRP O
cloned VBD O
these DT O
sequences NNS O
from IN O
brain NN O
and CC O
placenta NN O
and CC O
found VBD O
this DT O
material NN O
to TO O
be VB O
composed VBN O
of IN O
alternatively RB O
spliced VBN O
exons NNS O
using VBG O
a DT O
previously RB O
reported VBN O
noncoding JJ O
exon NN O
( ( O
1A CD O
) ) O
and CC O
a DT O
novel JJ O
97 CD O
- : O
bp NN O
noncoding VBG O
exon NN O
( ( O
1B CD O
) ) O
. . O

Presentation NN O
of IN O
a DT O
horse NN B-Gene
cytochrome NN I-Gene
c NNS I-Gene
peptide RB I-Gene
by IN O
multiple JJ O
H NNP B-Gene
- : I-Gene
2b CD I-Gene
class NN I-Gene
I PRP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( O
MHC NNP B-Gene
) ) O
molecules VBZ O
to TO O
C57BL NNP O
/ NNP O
6 CD O
- : O
and CC O
bm1 VB O
- : O
derived VBN O
cytotoxic JJ O
T NNP O
lymphocytes NNS O
: : O
presence NN O
of IN O
a DT O
single JJ O
MHC NNP B-Gene
anchor NN I-Gene
residue NN I-Gene
may MD O
confer VB O
efficient JJ O
peptide NN O
- : O
specific JJ O
CTL NNP O
recognition NN O
. . O

XYL1 NN B-Gene
was VBD O
isolated VBN O
as IN O
a DT O
highly RB O
expressed VBN O
fusion NN O
clone NN O
from IN O
a DT O
' POS B-Gene
lacZ JJ I-Gene
translational JJ O
fusion NN O
library NN O
. . O

Seven VBN O
out IN O
of IN O
34 CD O
patients NNS O
died VBD O
, , O
giving VBG O
a DT O
mortality NN O
rate NN O
of IN O
21 CD O
% NN O
. . O

Phosphorylation NN O
analyses NNS O
indicated VBD O
that IN O
inhibition NN O
of IN O
ERK NNP B-Gene
- : I-Gene
1 CD I-Gene
/ $ I-Gene
2 CD I-Gene
decreased VBN O
okadaic NN O
acid SYM O
- : O
elevated JJ O
phosphorylation NN O
of IN O
JunD NNP B-Gene
and CC O
FosB NNP B-Gene
. . O

HL NNP B-Gene
- : I-Gene
A DT I-Gene
antibodies NNS I-Gene
in IN O
polytransfused JJ O
patients NNS O

These DT O
observations NNS O
, , O
together RB O
with IN O
the DT O
occurrence NN O
of IN O
putative JJ O
4 CD O
' POS O
- : O
phosphopantetheine NN O
- : O
attachment NN O
sites NNS O
and CC O
a DT O
putative JJ O
thioesterase NN B-Gene
site NN I-Gene
, , O
are VBP O
discussed VBN O
with IN O
reference NN O
to TO O
the DT O
reaction NN O
sequence NN O
leading VBG O
to TO O
production NN O
of IN O
the DT O
ACV NNP B-Gene
tripeptide NN I-Gene
. . O

RESULTS NNP O
AND CC O
CONCLUSIONS NNP O
: : O
Brandt NNP O
' POS O
s NN O
double JJ O
cuff NN O
- : O
tubes NN O
( ( O
G2 NNP O
) ) O
succeed VB O
in IN O
avoiding VBG O
uncontrolled JJ O
increase NN O
of IN O
cuff JJ O
- : O
pressure NN O
during IN O
anaesthesia NN O
with IN O
N2O NNP O
. . O

Two CD O
patients NNS O
were VBD O
treated VBN O
with IN O
both DT O
regimens NNS O
. . O

The DT O
two CD O
contiguous JJ O
IGF2 NNP B-Gene
( ( O
human JJ B-Gene
insulin NN I-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
II NNP I-Gene
) ) O
and CC O
H19 NNP B-Gene
genes NNS I-Gene
are VBP O
reciprocally RB O
imprinted VBN O
in IN O
both DT O
human JJ O
and CC O
mouse NN O
. . O

The DT O
complete JJ O
response NN O
( ( O
CR NNP O
) ) O
rate NN O
was VBD O
34 CD O
% NN O
in IN O
the DT O
CODE NNP O
with IN O
rhG JJ B-Gene
- : I-Gene
CSF NNP I-Gene
group NN O
and CC O
23 CD O
% NN O
in IN O
the DT O
CODE NNP O
alone RB O
group NN O
; : O
the DT O
median JJ O
survival NN O
was VBD O
59 CD O
and CC O
32 CD O
weeks NNS O
, , O
respectively RB O
, , O
in IN O
these DT O
groups NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
4 CD O
) ) O
. . O

The DT O
matrix NN O
surrounding VBG O
the DT O
clusters NNS O
either CC O
showed VBD O
a DT O
normal JJ O
morphology NN O
or CC O
a DT O
homogeneous JJ O
appearance NN O
, , O
within IN O
which WDT O
faint NN O
cross NN O
striations NNS O
but CC O
no DT O
distinctly RB O
fibrillar JJ O
outlines NNS O
could MD O
be VB O
identified VBN O
. . O

Sixty NNP O
- : O
nine CD O
( ( O
44 CD O
% NN O
) ) O
patients NNS O
were VBD O
administered VBN O
250 CD O
MBq NNP O
( ( O
7 CD O
mCi NN O
) ) O
99Tcm CD O
- : O
tetrofosmin NN O
at IN O
rest NN O
followed VBD O
4 CD O
h NN O
later RB O
by IN O
750 CD O
MBq NNP O
( ( O
21 CD O
mCi NN O
) ) O
during IN O
stress NN O
( ( O
the DT O
1 CD O
day NN O
protocol NN O
) ) O
, , O
whereas $ O
88 CD O
( ( O
56 CD O
% NN O
) ) O
patients NNS O
had VBD O
rest NN O
and CC O
stress NN O
imaging VBG O
studies NNS O
on IN O
two CD O
separate JJ O
days NNS O
, , O
receiving VBG O
a DT O
500 CD O
MBq NNP O
( ( O
14 CD O
mCi NN O
) ) O
dose NN O
of IN O
99Tcm CD O
- : O
tetrofosmin NN O
on IN O
each DT O
occasion NN O
( ( O
the DT O
2 CD O
day NN O
protocol NN O
) ) O
. . O

These DT O
results NNS O
indicate VBP O
a DT O
possible JJ O
involvement NN O
of IN O
endogenous JJ O
opioid JJ O
peptides NNS O
in IN O
the DT O
cardiac JJ O
effects NNS O
due JJ O
to TO O
myocardial JJ O
ischaemia NN O
and CC O
reperfusion NN O
, , O
mediated VBN O
by IN O
opiate NN B-Gene
receptors NNS I-Gene
through IN O
opiate JJ O
antagonism NN O
. . O

The DT O
effects NNS O
of IN O
taloximine NN O
and CC O
aminophylline NN O
on IN O
isolated JJ O
human JJ O
smooth JJ O
muscle NN O
. . O

Selenium NN O
status NN O
of IN O
thoroughbreds NNS O
in IN O
the DT O
United NNP O
Kingdom NNP O
. . O

Because IN O
GH NNP B-Gene
- : O
induced VBD O
Akt NNP B-Gene
activation NN O
was VBD O
completely RB O
inhibited VBN O
in IN O
both DT O
cells NNS O
by IN O
the DT O
same JJ O
concentration NN O
of IN O
LY294002 NNP O
, , O
these DT O
findings NNS O
indicate VBP O
that IN O
the DT O
wortmannin JJ O
sensitivity NN O
of IN O
both CC O
the DT O
IRS NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
independent JJ O
and CC O
- : O
dependent NN O
GH NNP B-Gene
- : O
induced VBD O
MAP NNP B-Gene
kinase NNP I-Gene
activation NN O
may MD O
reflect VB O
the DT O
activity NN O
of IN O
another DT O
wortmannin NN O
- : O
sensitive JJ O
target NN O
( ( O
s JJ O
) ) O
in IN O
addition NN O
to TO O
PI3K NNP B-Gene
in IN O
mediation NN O
of IN O
GH NNP B-Gene
- : O
induced VBD O
MAP NNP B-Gene
kinase NNP I-Gene
activation NN O
in IN O
these DT O
cells NNS O
. . O

Plasma NNP O
glucose NN O
, , O
immunoreactive JJ B-Gene
insulin NN I-Gene
( ( O
IRI NNP B-Gene
) ) O
, , O
C NNP B-Gene
- : I-Gene
peptide NN I-Gene
, , O
glucagon NN B-Gene
, , O
and CC O
GLP NNP B-Gene
- : I-Gene
1 CD I-Gene
levels NNS O
at IN O
each DT O
time NN O
point NN O
during IN O
OGTT NNP O
were VBD O
measured VBN O
. . O

Functional NNP O
magnetic JJ O
resonance NN O
imaging NN O
( ( O
fMRI NN O
) ) O
has VBZ O
been VBN O
increasingly RB O
used VBN O
in IN O
studying VBG O
human JJ O
brain NN O
function NN O
given VBN O
its PRP$ O
non JJ O
- : O
invasive JJ O
feature NN O
and CC O
good JJ O
spatial JJ O
resolution NN O
. . O

An DT O
increase NN O
in IN O
bone JJ O
mineral JJ O
density NN O
at IN O
the DT O
spine NN O
, , O
total JJ O
hip NN O
, , O
and CC O
total JJ O
body NN O
has VBZ O
been VBN O
reported VBN O
with IN O
raloxifene NN O
but CC O
seems VBZ O
to TO O
be VB O
less JJR O
than IN O
that DT O
seen VBN O
with IN O
estrogen NN O
or CC O
alendronate JJ O
therapy NN O
. . O

Transcription NN O
of IN O
the DT O
vascular NN B-Gene
cell NN I-Gene
adhesion NN I-Gene
molecule NN I-Gene
1 CD I-Gene
( ( O
VCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
gene NN O
in IN O
endothelial JJ O
cells NNS O
is VBZ O
induced VBN O
by IN O
lipopolysaccharide NN O
and CC O
the DT O
inflammatory JJ O
cytokines NNS B-Gene
interleukin VBP I-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
. . O

This DT O
in IN O
turn NN O
will MD O
further RBR O
enhance VB O
the DT O
role NN O
of IN O
meta FW O
- : O
analysis NN O
in IN O
helping VBG O
clinicians NNS O
and CC O
policy NN O
makers NNS O
answer VBP O
clinical JJ O
questions NNS O
. . O

Muscle NNP O
action NN O
potential NN O
and CC O
masticatory JJ O
rhythm NN O
of IN O
anterior JJ O
temporal JJ O
and CC O
masseter JJ O
muscles NNS O
in IN O
children NNS O
and CC O
adults NNS O

The DT O
pharmacokinetic JJ O
parameters NNS O
which WDT O
helped VBD O
predict VB O
these DT O
toxicities NNS O
included VBD O
area NN O
under IN O
the DT O
curve NN O
and CC O
peak JJ O
plasma NN O
level NN O
. . O

These DT O
early JJ O
structural NN O
processes NNS O
are VBP O
assumed VBN O
to TO O
be VB O
subserved VBN O
by IN O
the DT O
anterior JJ O
parts NNS O
of IN O
the DT O
left NN O
hemisphere RB O
, , O
as IN O
event NN O
- : O
related JJ O
brain NN O
potentials NNS O
show VBP O
this DT O
area NN O
to TO O
be VB O
maximally RB O
activated VBN O
when WRB O
phrase NN O
structure NN O
violations NNS O
are VBP O
processed VBN O
and CC O
as IN O
circumscribed JJ O
lesions NNS O
in IN O
this DT O
area NN O
lead NN O
to TO O
an DT O
impairment NN O
of IN O
the DT O
on IN O
- : O
line NN O
structural JJ O
assignment NN O
. . O

We PRP O
present JJ O
evidence NN O
that IN O
DNA NNP B-Gene
polymerase VBD I-Gene
delta NN I-Gene
of IN I-Gene
Saccharomyces NNP I-Gene
cerevisiae NN I-Gene
, , O
an DT O
enzyme NN O
that WDT O
is VBZ O
essential JJ O
for IN O
viability NN O
and CC O
chromosomal JJ O
replication NN O
, , O
is VBZ O
also RB O
required VBN O
for IN O
base JJ O
excision NN O
repair NN O
of IN O
exogenous JJ O
DNA NNP O
methylation NN O
damage NN O
. . O

Northern NNP O
blot NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
STORP NNP B-Gene
gene NN I-Gene
has VBZ O
a DT O
ubiquitous JJ O
pattern NN O
of IN O
expression NN O
similar JJ O
to TO O
that DT O
of IN O
the DT O
PML NNP B-Gene
gene NN I-Gene
. . O

Estrogen NNP B-Gene
receptor NN I-Gene
- : I-Gene
related JJ I-Gene
receptor NN I-Gene
alpha VBD I-Gene
1 CD I-Gene
interacts NNS O
with IN O
coactivator NN O
and CC O
constitutively RB O
activates VBZ O
the DT O
estrogen NN O
response NN O
elements NNS O
of IN O
the DT O
human JJ B-Gene
lactoferrin NN I-Gene
gene NN I-Gene
. . O

Another DT O
long JJ O
insertion NN O
in IN O
the DT O
cathepsin NN B-Gene
X NNP I-Gene
amino NN I-Gene
acid JJ I-Gene
sequence NN I-Gene
forms NNS O
a DT O
beta NN O
- : O
hairpin NN O
pointing VBG O
away RB O
from IN O
the DT O
active JJ O
site NN O
. . O

Structure NNP O
determination NN O
of IN O
an DT O
adsorbate JJ O
- : O
induced VBN O
multilayer JJ O
reconstruction NN O
: : O
( ( O
1 CD O
x RB O
2 CD O
) ) O
- : O
H $ O
/ JJ O
Ni NNP O
( ( O
110 CD O
) ) O
. . O

The DT O
intron NN O
RNA NNP O
consists VBZ O
of IN O
2492 CD O
nucleotides NNS O
which WDT O
can MD O
be VB O
folded VBN O
into IN O
a DT O
secondary JJ O
structure NN O
with IN O
all PDT O
the DT O
expected VBN O
sequence NN O
motifs NNS O
of IN O
subgroup NN O
- : O
IIA1 NN O
introns NNS O
( ( O
Michel NNP O
et RB O
al RB O
. . O

Cleidocranial JJ O
dysostosis NN O

Rabbits NNS O
developed VBD O
profound IN O
hypocalcemia NN O
, , O
with IN O
levels NNS O
falling VBG O
from IN O
15 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
2 CD O
to TO O
7 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
mg JJ O
/ NNP O
dl NN O
under IN O
the DT O
influence NN O
of IN O
TSST NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Generally RB O
, , O
a DT O
correlation NN O
was VBD O
observed VBN O
between IN O
highest JJS O
concentrations NNS O
of IN O
CSF NNP B-Gene
immunoglobulins NNS I-Gene
and CC O
degree NN O
of IN O
meningeal JJ O
inflammatory JJ O
response NN O
, , O
even RB O
if IN O
this DT O
was VBD O
a DT O
component NN O
of IN O
other JJ O
neurological JJ O
diseases NNS O
. . O

Citrate NNP B-Gene
synthase NN I-Gene
activity NN O
was VBD O
increased VBN O
in IN O
the DT O
medial JJ O
head NN O
( ( O
81 CD O
% NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
the DT O
red JJ O
long JJ O
head NN O
( ( O
88 CD O
% NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
of IN O
the DT O
triceps NNS O
brachii VBP O
muscle NN O
in IN O
R NNP O
rats NNS O
but CC O
not RB O
in IN O
the DT O
white JJ O
long JJ O
head NN O
( ( O
25 CD O
% NN O
, , O
P NNP O
= VBZ O
0 CD O
. . O
6 CD O
) ) O
. . O

We PRP O
find VBP O
that IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
POZ NNP O
domain NN O
mutations NNS O
that WDT O
disrupt VBP O
the DT O
interaction NN O
with IN O
N NNP B-Gene
- : I-Gene
CoR NN I-Gene
and CC O
SMRT NNP B-Gene
no RB O
longer RB O
repress VB O
transcription NN O
. . O

A DT O
mutant NN O
in IN O
the DT O
AAV NNP O
terminal JJ O
resolution NN O
site NN O
( ( O
trs NN O
) ) O
was VBD O
defective JJ O
for IN O
DNA NNP O
replication NN O
in IN O
the DT O
in IN O
vitro JJ O
assay NN O
. . O

This DT O
slow JJ O
progression NN O
through IN O
the DT O
early JJ O
G1 NNP O
- : O
phase NN O
resulted VBD O
in IN O
decreased JJ O
phosphorylation NN O
of IN O
the DT O
RB NNP B-Gene
protein NN I-Gene
and CC O
subsequent JJ O
delay NN O
into IN O
the DT O
S NNP O
phase NN O
transition NN O
. . O

At IN O
this DT O
stage NN O
, , O
the DT O
eventual JJ O
high JJ O
mortality NN O
of IN O
acute JJ O
ischemia NN O
is VBZ O
established VBN O
whatever IN O
the DT O
urgency NN O
of IN O
the DT O
operation NN O
or CC O
the DT O
skill NN O
with IN O
which WDT O
it PRP O
is VBZ O
performed VBN O
. . O

We PRP O
report VBP O
an DT O
example NN O
of IN O
an DT O
MDV NNP O
- : O
transformed VBD O
T NNP O
- : O
lymphoblastoid NN O
cell NN O
line NN O
( ( O
T9 NNP O
) ) O
expressing VBG O
high JJ O
levels NNS O
of IN O
a DT O
truncated JJ B-Gene
C NNP I-Gene
- : I-Gene
MYB NNP I-Gene
protein NN I-Gene
as IN O
a DT O
result NN O
of IN O
RAV NNP O
integration NN O
within IN O
one CD O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
allele NN I-Gene
. . O

Reovirus NNP O
mRNAs NN O
are VBP O
efficiently RB O
translated VBN O
within IN O
host NN O
cells NNS O
despite IN O
the DT O
absence NN O
of IN O
3 CD O
' POS O
polyadenylated VBN O
tails NNS O
. . O

Survival NN O
after IN O
development NN O
of IN O
symptomatic JJ O
infection NN O
( ( O
P NNP O
- : O
2 CD O
) ) O
did VBD O
not RB O
differ VB O
by IN O
transmission NN O
mode NN O
. . O

Pharmacological JJ O
desympathization NN O
leads VBZ O
to TO O
the DT O
development NN O
of IN O
hyper JJ O
- : O
reactivity NN O
of IN O
the DT O
true JJ O
pacemakers NNS O
to TO O
noradrenaline VB O
and CC O
dopamine VB O
and CC O
triggers VB O
off RP O
changes NNS O
in IN O
the DT O
regulation NN O
of IN O
the DT O
electric JJ O
activity NN O
of IN O
these DT O
cells NNS O
by IN O
catecholamines NNS O
. . O

Sequencing VBG O
of IN O
the DT O
TP53 NNP B-Gene
transcripts NNS I-Gene
from IN O
exons NNS O
2 CD O
to TO O
10 CD O
, , O
however RB O
, , O
did VBD O
not RB O
reveal VB O
mutations NNS O
of IN O
the DT O
remaining VBG O
allele NN O
in IN O
any DT O
of IN O
these DT O
tumors NNS O
. . O

Nineteen JJ O
patients NNS O
with IN O
non JJ O
- : O
visualized VBN O
gallbladder NN O
with IN O
OCG NNP O
subsequently RB O
had VBD O
Tc NNP O
- : O
99m CD O
- : O
PyG NN O
cholescintigraphy NN O
performed VBD O
. . O

Genetic NNP O
and CC O
molecular JJ O
data NNS O
indicate VBP O
that IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Pan NNP I-Gene
and CC O
CiD NNP B-Gene
compete VBP O
for IN O
binding VBG O
to TO O
Arm NNP B-Gene
, , O
leading VBG O
to TO O
a DT O
compromised JJ O
transduction NN O
of IN O
the DT O
Wg NNP B-Gene
signal NN O
in IN O
heterozygous JJ O
ciD NN B-Gene
/ NNP I-Gene
+ NNP I-Gene
animals NNS O
and CC O
to TO O
a DT O
dramatic JJ O
enhancement NN O
of IN O
the DT O
gain NN O
- : O
of IN O
- : O
function NN O
activity NN O
of IN O
CiD NNP B-Gene
in IN O
homozygous JJ O
mutants NNS O
. . O

The DT O
open JJ O
reading NN O
frames NNS O
of IN O
rbsD NN B-Gene
, , O
rbsA NN B-Gene
, , O
and CC O
rbsC VB B-Gene
encode JJ O
proteins NNS O
of IN O
139 CD O
, , O
501 CD O
, , O
and CC O
321 CD O
amino NN O
acid NN O
residues NNS O
, , O
respectively RB O
. . O

The DT O
E6 NNP B-Gene
/ NNP O
E7 NNP B-Gene
promoter NN O
of IN O
all DT O
genital JJ O
human JJ O
papillomaviruses NNS O
is VBZ O
responsible JJ O
for IN O
expression NN O
of IN O
the DT O
viral JJ O
transforming NN O
genes NNS O
. . O

Children NNP O
with IN O
ADD NNP O
showed VBD O
an DT O
attenuated JJ O
frontal NN O
CNV NNP O
- : O
1 CD O
amplitude NN O
and CC O
a DT O
trend NN O
towards NNS O
increased VBD O
CNV NNP O
- : O
1 CD O
and CC O
CNV NNP O
- : O
2 CD O
occipital JJ O
amplitudes NNS O
. . O

The DT O
transcription NN O
factor NN O
E2F NNP B-Gene
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
G NNP O
( ( O
1 CD O
) ) O
to TO O
S NNP O
phase NN O
transition NN O
in IN O
the DT O
higher JJR O
eukaryotic JJ O
cell NN O
cycle NN O
. . O

Fortunately RB O
DDT NNP O
- : O
, , O
HCH NNP O
- : O
and CC O
HCB NNP O
- : O
levels NNS O
decreased VBN O
in IN O
breast NN O
milk NN O
during IN O
the DT O
last JJ O
years NNS O
. . O

Aneurysmectomy NNP O
and CC O
the DT O
performance NN O
of IN O
CABG NNP O
were VBD O
not RB O
significantly RB O
associated VBN O
with IN O
postoperative JJ O
ECG NNP O
changes NNS O
, , O
but CC O
more JJR O
bypass NN O
grafts NNS O
per IN O
patient NN O
grafted VBN O
appeared VBD O
in IN O
the DT O
group NN O
with IN O
postoperative JJ O
ECG NNP O
changes NNS O
, , O
suggesting VBG O
that IN O
coronary JJ O
artery DT O
disease NN O
may MD O
be VB O
more JJR O
severe JJ O
in IN O
that DT O
group NN O
. . O

One CD O
complex JJ O
appears VBZ O
to TO O
be VB O
ubiquitous JJ O
but CC O
enriched VBD O
in IN O
lymphoid JJ O
cells NNS O
and CC O
represents VBZ O
the DT O
binding NN O
of IN O
a DT O
potentially RB O
novel JJ O
factor NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
approximately RB O
50 CD O
kDa NNS O
. . O

We PRP O
linked VBD O
a DT O
4 CD O
. . O
1 CD O
- : O
kilobase NN O
pair NN O
HindIII NNP B-Gene
DNA NNP I-Gene
fragment NN I-Gene
from IN O
the DT O
region NN O
upstream NN O
of IN O
the DT O
human JJ B-Gene
AP NNP I-Gene
endonuclease NN I-Gene
gene NN I-Gene
( ( O
APE NNP B-Gene
) ) O
to TO O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
gene NN O
. . O

Transient NN O
hyperammonaemia NN O
in IN O
an DT O
adult JJ O
German JJ O
shepherd NN O
dog NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
, , O
at IN O
least JJS O
at IN O
high JJ O
temperature NN O
, , O
a DT O
critical JJ O
minimal JJ O
level NN O
of IN O
Ypt NNP B-Gene
protein NN I-Gene
prenylation NN O
is VBZ O
required VBN O
for IN O
maintaining VBG O
vesicle NN O
polarization NN O
. . O

Stems NNP O
contain VBP O
distinctly RB O
less JJR O
P NNP B-Gene
protein NN I-Gene
mRNA NN I-Gene
and CC O
the DT O
relative JJ O
level NN O
in IN O
roots NNS O
is VBZ O
very RB O
low JJ O
but CC O
still RB O
clearly RB O
detectable JJ O
. . O

Interleukin NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
is VBZ O
a DT O
pleiotropic JJ O
cytokine NN O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
inflammatory NN O
and CC O
immune JJ O
responses NNS O
, , O
acute JJ O
phase NN O
reactions NNS O
, , O
and CC O
hematopoiesis NN O
. . O

Activation NN O
of IN O
alpha JJ B-Gene
4 CD I-Gene
beta NN I-Gene
1 CD I-Gene
with IN O
TS2 NNP B-Gene
/ NNP I-Gene
16 CD I-Gene
inhibited VBD O
the DT O
cytoplasmic JJ O
protrusions NNS O
and CC O
cell NN O
migration NN O
but CC O
did VBD O
not RB O
affect VB O
the DT O
pattern NN O
of IN O
phosphorylation NN O
. . O

Further RB O
, , O
intracerebroventricular JJ O
injections NNS O
of IN O
KA NNP O
resulted VBD O
in IN O
the DT O
substantial JJ O
loss NN O
of IN O
pyramidal JJ O
cells NNS O
in IN O
the DT O
whole JJ O
CA3 NNP O
field NN O
of IN O
the DT O
hippocampus NN O
. . O

Despite IN O
the DT O
small JJ O
number NN O
of IN O
patients NNS O
, , O
on IN O
the DT O
basis NN O
of IN O
this DT O
report NN O
, , O
we PRP O
can MD O
confirm VB O
that DT O
1 CD O
. . O
5 CD O
MU NNP O
/ NNP O
day NN O
of IN O
alpha JJ B-Gene
- : I-Gene
IFN NN I-Gene
is VBZ O
an DT O
adequate JJ O
treatment NN O
for IN O
patients NNS O
with IN O
hairy JJ O
cell NN O
leukemia NN O
. . O

But CC O
the DT O
application NN O
solutions NNS O
of IN O
instrument JJ O
disinfectants NNS O
should MD O
not RB O
be VB O
used VBN O
longer JJR O
than IN O
one CD O
day NN O
. . O

The DT O
SCMV NNP B-Gene
SNE NNP I-Gene
sites VBZ I-Gene
contain VBP O
potential JJ O
overlapping VBG O
core NN O
recognition NN O
binding VBG O
motifs NNS O
for IN O
SRF NNP B-Gene
, , O
Rel NNP B-Gene
/ NNP O
NFkappaB NNP B-Gene
, , O
ETS NNP B-Gene
, , O
and CC O
YY1 NNP B-Gene
class NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
but CC O
fail VBP O
to TO O
respond VB O
to TO O
either DT O
serum NN O
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
. . O

Stress NNP O
effects NNS O
on IN O
affiliation NN O
preferences NNS O
among IN O
subjects NNS O
possessing VBG O
the DT O
type NN O
A NNP O
coronary JJ O
- : O
prone NN O
behavior NN O
pattern NN O
. . O

The DT O
decay JJ O
curves NNS O
of IN O
chlorophyll NN O
fluorescence NN O
showed VBD O
a DT O
superposition NN O
of IN O
three CD O
exponentially RB O
decaying VBG O
components NNS O
with IN O
time NN O
constants NNS O
of IN O
T1 NNP O
= NNP O
100 CD O
- : O
200 CD O
ps NN O
, , O
T2 NNP O
= VBZ O
300 CD O
- : O
500 CD O
ps NN O
and CC O
T3 NNP O
= NNP O
2 CD O
. . O
0 CD O
- : O
3 CD O
. . O
5 CD O
ns NN O
. . O

The DT O
availability NN O
of IN O
sequence NN O
from IN O
multiple JJ O
species NNS O
has VBZ O
permitted VBN O
us PRP O
to TO O
determine VB O
that IN O
the DT O
UBE NNP O
site NN O
has VBZ O
close RB O
similarity NN O
to TO O
motifs VB O
that IN O
bind JJ O
members NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
1 CD I-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

The DT O
chromosomal JJ O
localization NN O
on IN O
distal JJ O
chromosome NN O
7 CD O
places NNS O
it PRP O
in IN O
a DT O
cluster NN O
of IN O
imprinted JJ O
genes NNS O
, , O
flanked VBN O
by IN O
the DT O
previously RB O
described VBN O
Tapa1 NNP B-Gene
and CC O
Kcnq1 NNP B-Gene
genes NNS I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
HAC1 NNP B-Gene
may MD O
also RB O
be VB O
one CD O
of IN O
the DT O
meiotic JJ O
genes NNS O
. . O

In IN O
order NN O
to TO O
gain VB O
deeper JJR O
insight NN O
into IN O
the DT O
role NN O
of IN O
the DT O
amino NN O
- : O
terminal JJ O
domain NN O
of IN O
the DT O
p24 NN B-Gene
( ( O
CA NNP B-Gene
) ) O
protein NN O
during IN O
viral JJ O
replication NN O
, , O
eight CD O
highly RB O
conserved VBN O
proline NN O
residues NNS O
known VBN O
to TO O
promote VB O
turns NNS O
and CC O
to TO O
terminate VB O
alpha JJ O
- : O
helices NNS O
within IN O
the DT O
p24 JJ B-Gene
tertiary JJ O
structure NN O
were VBD O
replaced VBN O
by IN O
a DT O
leucine NN O
residue NN O
( ( O
P NNP O
- : O
position NN O
- : O
L NN O
) ) O
. . O

Structural JJ O
organization NN O
and CC O
developmental JJ O
expression NN O
pattern NN O
of IN O
the DT O
mouse NN B-Gene
WD NNP I-Gene
- : I-Gene
repeat NN I-Gene
gene NN I-Gene
DMR NNP I-Gene
- : I-Gene
N9 NNP I-Gene
immediately RB O
upstream NN O
of IN O
the DT O
myotonic JJ B-Gene
dystrophy NN I-Gene
locus NN I-Gene
. . O

Furthermore IN O
it PRP O
was VBD O
suggested VBN O
that IN O
FK506 NNP O
plasma NN O
levels NNS O
were VBD O
concerned VBN O
with IN O
the DT O
appearance NN O
of IN O
side NN O
effect NN O
. . O

During IN O
exercise NN O
, , O
the DT O
Pes NNP O
- : O
Ves NNP O
relation NN O
was VBD O
shifted VBN O
toward IN O
the DT O
left NN O
and CC O
the DT O
slope NN O
[ NNP O
end NN O
- : O
systolic JJ O
elastance NN O
( ( O
Ees NNP O
) ) O
] VBP O
increased VBN O
from IN O
7 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
8 CD O
to TO O
12 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
2 CD O
( ( O
SD NNP O
) ) O
mmHg NN O
/ JJ O
ml NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
IgG NNP B-Gene
subclass NN O
profile NN O
of IN O
untreated JJ O
coeliac JJ O
disease NN O
was VBD O
found VBN O
to TO O
be VB O
the DT O
same JJ O
as IN O
in IN O
healthy JJ O
controls NNS O
( ( O
IgG1 NNP B-Gene
approximately RB O
IgG2 NNP B-Gene
> NNP O
IgG3 NNP B-Gene
> NNP O
IgG4 NNP B-Gene
) ) O
, , O
with IN O
only RB O
the DT O
magnitude NN O
of IN O
the DT O
individual JJ O
subclass NN O
responses NNS O
being VBG O
increased VBN O
in IN O
coeliac JJ O
patients NNS O
. . O

Furthermore RB O
, , O
synergistic JJ O
activation NN O
of IN O
ERK2 NNP B-Gene
occurred VBD O
in IN O
the DT O
absence NN O
of IN O
changes NNS O
in IN O
intracellular JJ O
Ca2 NNP O
+ NNP O
, , O
and CC O
was VBD O
not RB O
blocked VBN O
by IN O
inhibition NN O
of IN O
protein JJ B-Gene
kinase FW I-Gene
C NNP I-Gene
activity NN O
and CC O
represents VBZ O
a DT O
separate JJ O
pathway NN O
by IN O
which WDT O
CD19 NNP B-Gene
regulates VBZ O
B NNP O
cell NN O
function NN O
. . O

Substituting VBG O
a DT O
Ser NNP O
for IN O
Gly69 NNP O
or CC O
a DT O
Glu NNP O
for IN O
Lys NNP O
71 CD O
in IN O
the DT O
conserved JJ O
TGEK NNP B-Gene
tetrapeptide NN I-Gene
in IN O
finger NN O
II NNP O
of IN O
TFIIIA NNP B-Gene
resulted VBD O
in IN O
the DT O
loss NN O
of IN O
DNA NNP O
binding NN O
. . O

Sternocleidomastoid NNP O
, , O
neck NN O
or CC O
facial JJ O
muscles NNS O
wasting VBG O
were VBD O
also RB O
found VBN O
in IN O
three CD O
cases NNS O
. . O

Harel NNP O
, , O
E NNP O
. . O
M NNP O
. . O

The DT O
first JJ O
85 CD O
nt JJ O
upstream NN O
of IN O
the DT O
transcription NN O
initiation NN O
site NN O
of IN O
the DT O
mouse NN B-Gene
desmin NN I-Gene
gene NN I-Gene
, , O
which WDT O
contain VBP O
an DT O
E NN O
box NN O
( ( O
E1 NNP O
) ) O
, , O
the DT O
binding VBG O
site NN O
of IN O
the DT O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
myogenic JJ I-Gene
regulators NNS I-Gene
, , O
are VBP O
sufficient JJ O
to TO O
confer VB O
low JJ O
level NN O
muscle NN O
- : O
specific JJ O
expression NN O
. . O

Thus RB O
, , O
unlike IN O
other JJ O
proteins NNS O
reported VBN O
to TO O
inhibit VB O
SRF NNP B-Gene
activity NN O
, , O
the DT O
repressor NN O
activity NN O
associated VBN O
with IN O
the DT O
GC NNP O
- : O
rich JJ O
element NN O
does VBZ O
not RB O
appear VB O
to TO O
function VB O
through IN O
direct JJ O
inhibition NN O
of IN O
SRF NNP B-Gene
binding NN O
. . O

Using VBG O
backcross NN O
analysis NN O
, , O
both DT O
exons NNS O
1 CD O
and CC O
4 CD O
mapped VBD O
to TO O
a DT O
proximal JJ O
region NN O
of IN O
murine JJ O
Chromosome NNP O
4 CD O
indistinguishable NN O
from IN O
the DT O
vacillans NNS B-Gene
gene NN I-Gene
. . O

Large JJ O
and CC O
small JJ O
medullary JJ O
lesions NNS O
inhibited VBD O
the DT O
occurrence NN O
of IN O
target NN O
fibres NNS O
in IN O
the DT O
tenotomized JJ O
muscles NNS O
, , O
the DT O
smallest JJS O
one CD O
being VBG O
neurolysis NN O
of IN O
the DT O
dorsal JJ O
roots NNS O
. . O

Pups NNS O
placed VBD O
into IN O
the DT O
novel JJ O
environment NN O
with IN O
their PRP$ O
mothers NNS O
exhibited VBD O
an DT O
intermediate JJ O
level NN O
of IN O
DA NNP O
turnover NN O
. . O

Resources NNS O
for IN O
helping VBG O
patients NNS O
to TO O
quit VB O
smoking NN O
. . O

The DT O
results NNS O
show VBP O
that IN O
the DT O
structure NN O
of IN O
the DT O
decorin JJ B-Gene
gene NN I-Gene
promoter NN I-Gene
is VBZ O
different JJ O
from IN O
that DT O
of IN O
any DT O
other JJ O
proteoglycan JJ O
promoter NN O
characterized VBN O
so RB O
far RB O
and CC O
indicate VB O
that IN O
the DT O
pur NN O
/ NNP O
pyr NN O
segment NN O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
gene NN O
transcription NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
cloned VBN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Gene
nidogen NN I-Gene
gene NN I-Gene
. . O

None NN O
had VBD O
a DT O
past JJ O
history NN O
of IN O
opportunistic JJ O
infections NNS O
; : O
neither CC O
did VBD O
any DT O
have VB O
lymphopenia NN O
. . O

We PRP O
examined VBD O
the DT O
effects NNS O
of IN O
long JJ O
- : O
term NN O
perfusion NN O
with IN O
pyridoxalated JJ O
hemoglobin NN B-Gene
polyoxyethylene NN O
conjugate NN O
( ( O
PHP NNP O
) ) O
solution NN O
on IN O
cardiac JJ O
function NN O
of IN O
isolated JJ O
rat NN O
hearts NNS O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
Rat7p NNP B-Gene
/ NNP O
Nup159p NNP B-Gene
is VBZ O
anchored VBN O
within IN O
the DT O
NPC NNP O
through IN O
its PRP$ O
coiled VBN O
- : O
coil NN O
region NN O
and CC O
adjacent JJ O
sequences NNS O
. . O

Acoustic JJ O
transmission NN O
spectra NN O
in IN O
the DT O
Penrose NNP O
lattice NN O
. . O

In IN O
Cd NNP O
- : O
spiked VBD O
OECD NNP O
soil NN O
, , O
internal JJ O
Cd NN O
levels NNS O
were VBD O
linearly RB O
related VBN O
to TO O
external JJ O
Cd NNP O
concentrations NNS O
, , O
whereas IN O
the DT O
springtails NNS O
maintained VBD O
fixed VBN O
internal JJ O
levels NNS O
of IN O
Cu NNP O
and CC O
Zn NNP O
regardless RB O
of IN O
spiked JJ O
concentrations NNS O
. . O

Significantly RB O
, , O
pPKR NN B-Gene
is VBZ O
capable JJ O
of IN O
specifically RB O
phosphorylating VBG O
Ser51 NNP O
in IN O
a DT O
synthetic JJ B-Gene
eIF NN I-Gene
- : I-Gene
2alpha CD I-Gene
peptide NN I-Gene
, , O
a DT O
key JJ O
characteristic NN O
of IN O
the DT O
eIF JJ B-Gene
- : I-Gene
2alpha CD I-Gene
kinase NN I-Gene
family NN I-Gene
. . O

Many JJ O
eukaryotic JJ O
cell NN O
surface NN O
proteins NNS O
are VBP O
anchored VBN O
in IN O
the DT O
lipid JJ O
bilayer NN O
through IN O
glycosylphosphatidylinositol NN O
( ( O
GPI NNP O
) ) O
. . O

In IN O
general JJ O
, , O
the DT O
values NNS O
obtained VBN O
by IN O
the DT O
two CD O
methods NNS O
were VBD O
in IN O
agreement NN O
for IN O
each DT O
species NNS O
of IN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
and CC O
followed VBD O
the DT O
order NN O
: : O
wild JJ O
type NN O
greater JJR O
than IN O
Glu24 NNP O
- : O
- : O
- : O
- : O
Gly NN O
greater JJR O
than IN O
Asp27 NNP O
- : O
- : O
- : O
- : O
Gly NN O
much RB O
greater JJR O
than IN O
Pro7 NNP O
- : O
- : O
- : O
- : O
Thr NN O
greater JJR O
than IN O
Tyr29 NNP O
- : O
- : O
- : O
- : O
Gly NN O
greater JJR O
than IN O
Leu47 NNP O
- : O
- : O
- : O
- : O
His PRP$ O
. . O

Structure NN O
, , O
promoter NN O
analysis NN O
and CC O
chromosomal JJ O
assignment NN O
of IN O
the DT O
human JJ B-Gene
APEX NNP I-Gene
gene NN I-Gene
. . O

Compensative JJ O
justice NN O
and CC O
moral JJ O
investment NN O
among IN O
Japanese JJ O
, , O
Chinese JJ O
, , O
and CC O
Koreans NNP O
. . O

RESULTS NNS O
: : O
Among IN O
women NNS O
, , O
the DT O
age NN O
- : O
related JJ O
decline NN O
in IN O
BMD NNP O
at IN O
all DT O
non FW O
- : O
spine NN O
skeletal JJ O
sites NNS O
was VBD O
significantly RB O
different JJ O
from IN O
zero NN O
, , O
with IN O
the DT O
largest JJS O
decline NN O
seen VBN O
at IN O
the DT O
femoral JJ O
neck NN O
( ( O
- : O
. . O
38 CD O
g NN O
/ NNP O
cm2 NN O
/ NNP O
y NN O
, , O
p NN O
< NNP O
. . O
1 CD O
) ) O
and CC O
the DT O
smallest JJS O
at IN O
the DT O
trochanter NN O
of IN O
the DT O
hip NN O
( ( O
- : O
. . O
23 CD O
g NN O
/ NNP O
cm2 NN O
/ NNP O
y NN O
, , O
p NN O
= NNP O
. . O
3 CD O
) ) O
. . O

UV NNP O
cross SYM O
- : O
linking VBG O
experiments NNS O
show VBP O
that IN O
TEP NNP B-Gene
has VBZ O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
approximately RB O
65 CD O
kDa NNS O
. . O

Like IN O
other JJ O
members NNS O
of IN O
this DT O
family NN O
, , O
the DT O
AP NNP B-Gene
- : I-Gene
4 CD I-Gene
HLH NNP O
motif NN O
and CC O
the DT O
adjacent JJ O
basic JJ O
domain NN O
are VBP O
necessary JJ O
and CC O
sufficient JJ O
to TO O
confer VB O
site NN O
- : O
specific JJ O
DNA NNP O
binding NN O
. . O

The DT O
average JJ O
backscatter NN O
coefficient NN O
was VBD O
six CD O
time NN O
larger JJR O
in IN O
regions NNS O
of IN O
infarct NN O
studied VBD O
8 CD O
- : O
- : O
10 CD O
weeks NNS O
after IN O
occlusion NN O
than IN O
that DT O
in IN O
regions NNS O
of IN O
infarct NN O
studied VBD O
5 CD O
- : O
- : O
6 CD O
weeks NNS O
after IN O
occlusion NN O
. . O

Immunocytochemical JJ O
analysis NN O
demonstrated VBD O
the DT O
presence NN O
of IN O
DREF NNP B-Gene
polypeptide NN I-Gene
in IN O
nuclei NN O
after IN O
the DT O
eighth JJ O
nuclear JJ O
division NN O
cycle NN O
, , O
suggesting VBG O
that IN O
nuclear JJ O
accumulation NN O
of IN O
DREF NNP B-Gene
is VBZ O
important JJ O
for IN O
the DT O
coordinate NN O
zygotic JJ O
expression NN O
of IN O
DNA NNP O
replication NN O
- : O
related VBN O
genes NNS O
carrying VBG O
DRE NNP O
sequences NNS O
. . O

In IN O
contrast NN O
the DT O
human JJ O
and CC O
mouse NN B-Gene
BCNT NNP I-Gene
proteins VBZ I-Gene
contain VB O
one CD O
repeat NN O
unit NN O
and CC O
lack VB O
the DT O
RTE NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
derived VBN O
portion NN O
. . O

Structural JJ O
analysis NN O
and CC O
characterization NN O
of IN O
tissue NN O
and CC O
hormonal JJ O
responsive JJ O
expression NN O
of IN O
the DT O
avian JJ B-Gene
bone NN I-Gene
sialoprotein NN I-Gene
( ( O
BSP NNP B-Gene
) ) O
gene NN O
. . O

US SYM O
- : O
Doppler NN O
has VBZ O
recently RB O
gained VBN O
attention NN O
as IN O
a DT O
noninvasive JJ O
method NN O
for IN O
the DT O
functional JJ O
evaluation NN O
of IN O
arteriovenous JJ O
fistulas NNS O
( ( O
FAV NNP O
) ) O
. . O

A DT O
single JJ O
amino NN O
acid NN O
change NN O
in IN O
the DT O
CPY NNP B-Gene
vacuolar JJ I-Gene
sorting VBG I-Gene
signal JJ I-Gene
prevents NNS O
this DT O
interaction NN O
. . O

The DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
transactivator NN I-Gene
Zta NNP I-Gene
triggers VBZ O
lytic JJ O
gene NN O
expression NN O
and CC O
is VBZ O
essential JJ O
for IN O
replication NN O
of IN O
the DT O
lytic JJ O
origin NN O
, , O
oriLyt NN O
. . O

RESULTS NN O
: : O
Cholinergic JJ O
nerves NNS O
are VBP O
mainly RB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
enteric JJ O
nerve NN O
responses NNS O
to TO O
EFS NNP O
in IN O
the DT O
normal JJ O
IAS NNP O
. . O

These DT O
data NNS O
show VBP O
that IN O
heterologous JJ O
virus NN O
RNAs NNP O
( ( O
BSMV NNP O
) ) O
can MD O
serve VB O
as IN O
primer NN O
donors NNS O
for IN O
MStV NNP O
mRNA NN O
capped VBD O
RNA NNP O
- : O
primed VBD O
transcription NN O
in IN O
doubly RB O
infected JJ O
plants NNS O
. . O

Furthermore RB O
, , O
p150 JJ B-Gene
suppresses NNS O
actin JJ B-Gene
gelation NN O
, , O
which WDT O
is VBZ O
induced VBN O
by IN O
smooth JJ B-Gene
muscle NN I-Gene
alpha SYM I-Gene
- : I-Gene
actinin NN I-Gene
. . O

It PRP O
is VBZ O
clear JJ O
that IN O
subclinical JJ O
and CC O
silent JJ O
CD NN O
exist VBP O
in IN O
a DT O
large JJ O
subgroup NN O
of IN O
the DT O
celiac JJ O
population NN O
. . O

Proteins NNS O
immunoprecipitated VBN O
from IN O
lysates NNS O
of IN O
control NN O
- : O
and CC O
VEGF NNP B-Gene
- : O
stimulated VBD O
BAEC NNP O
with IN O
antisera NN O
to TO O
phospholipase VB B-Gene
C NNP I-Gene
- : I-Gene
gamma NN I-Gene
( ( O
PLC NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
were VBD O
fractionated VBN O
by IN O
SDS NNP O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
and CC O
transferred VBD O
to TO O
Immobilon NNP O
- : O
P NN O
. . O

In IN O
Xenopus NNP O
embryos NN O
, , O
the DT O
engineered JJ B-Gene
PDGF NNP I-Gene
receptor NN I-Gene
protein NN I-Gene
induced VBD O
the DT O
formation NN O
of IN O
mesoderm NN O
from IN O
animal JJ O
- : O
pole JJ O
explants NNS O
in IN O
an DT O
FK1012 NNP O
- : O
dependent JJ O
manner NN O
. . O

Southern JJ O
blotting NN O
and CC O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
analyses NNS O
did VBD O
not RB O
show VB O
tumor NN O
- : O
specific JJ O
alterations NNS O
of IN O
this DT O
gene NN O
in IN O
gliomas NN O
and CC O
RT NNP O
- : O
PCR NN O
studies NNS O
showed VBD O
expression NN O
in IN O
glioma NN O
cell NN O
lines NNS O
, , O
suggesting VBG O
that IN O
ANOVA NNP B-Gene
is VBZ O
not RB O
the DT O
chromosome NN O
19q CD O
glioma NN O
tumor NN O
suppressor NN O
gene NN O
. . O

Incidence NN O
rate NN O
ranging VBG O
between IN O
122 CD O
/ JJ O
100 CD O
, , O
0 CD O
/ JJ O
year NN O
and CC O
190 CD O
/ NN O
100 CD O
, , O
0 CD O
/ JJ O
year NN O
were VBD O
found VBN O
( ( O
minimum JJ O
, , O
estimated VBN O
and CC O
raw JJ O
datasets NNS O
) ) O
. . O

Where WRB O
UMDNJ NNP O
is VBZ O
headed VBN O
. . O

UGA NNP O
codon VBZ O
position NN O
affects VBZ O
the DT O
efficiency NN O
of IN O
selenocysteine JJ O
incorporation NN O
into IN O
glutathione NN B-Gene
peroxidase NN I-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
IC50 NNP O
values NNS O
for IN O
rat NN O
and CC O
dog NN O
urinary JJ O
bladder NN O
were VBD O
3 CD O
. . O
9 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
M NNP O
and CC O
3 CD O
. . O
8 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
M NNP O
, , O
respectively RB O
. . O

Patients NNS O
with IN O
Parkinson NNP O
' POS O
s NN O
disease NN O
showed VBD O
a DT O
relatively RB O
high JJ O
incidence NN O
to TO O
psychoses NNS O
during IN O
drug NN O
treatment NN O
( ( O
51 CD O
. . O
47 CD O
% NN O
) ) O
. . O

The DT O
deduced JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
destrin NN B-Gene
is VBZ O
165 CD O
residues NNS O
long JJ O
and CC O
is VBZ O
very RB O
similar JJ O
( ( O
71 CD O
% NN O
identical JJ O
) ) O
to TO O
that DT O
of IN O
cofilin NN B-Gene
, , O
a DT O
widely RB O
distributed VBN O
, , O
pH SYM O
- : O
sensitive JJ O
actin NN B-Gene
- : O
modulating NN O
protein NN O
. . O

The DT O
ANB1 NNP B-Gene
locus NN I-Gene
of IN O
Saccharomyces NNP O
cerevisiae NN O
encodes VBZ O
the DT O
protein NN B-Gene
synthesis NN I-Gene
initiation NN I-Gene
factor NN I-Gene
eIF VBD I-Gene
- : I-Gene
4D CD I-Gene
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
revealed VBD O
that IN O
two CD O
clusters NNS O
of IN O
basic JJ O
amino NN O
acids NNS O
within IN O
a DT O
conserved JJ O
basic JJ O
region NN O
and CC O
two CD O
amphipathic JJ O
helices NNS O
within IN O
the DT O
adjacent JJ O
HLH NNP O
domain NN O
are VBP O
essential JJ O
for IN O
sequence NN O
- : O
specific JJ O
DNA NNP O
binding NN O
and CC O
hetero NN O
- : O
oligomerization NN O
, , O
respectively RB O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
zinc NN B-Gene
finger NN I-Gene
protein NN I-Gene
Gis1 NNP I-Gene
acts VBZ O
as IN O
a DT O
dosage NN O
- : O
dependent NN O
suppressor NN O
of IN O
the DT O
rim15Delta NN B-Gene
defect NN O
in IN O
nutrient JJ O
limitation NN O
- : O
induced JJ O
transcriptional JJ O
derepression NN O
of IN O
SSA3 NNP B-Gene
. . O

Patients NNS O
with IN O
type JJ O
III NNP O
SOD NNP O
may MD O
have VB O
visceral JJ O
hyperalgesia NN O
; : O
a DT O
trial NN O
of IN O
antidepressants NNS O
or CC O
a DT O
therapeutic JJ O
trial NN O
with IN O
botulinum NN B-Gene
toxin NN I-Gene
injection NN O
into IN O
the DT O
ampulla NN O
should MD O
be VB O
considered VBN O
prior JJ O
to TO O
more RBR O
invasive JJ O
endoscopic NN O
therapy NN O
. . O

The DT O
present JJ O
study NN O
was VBD O
initiated VBN O
to TO O
explore VB O
the DT O
potential NN O
of IN O
a DT O
hybrid JJ O
biological JJ O
reactor NN O
, , O
combining VBG O
trickling VBG O
filter NN O
( ( O
TF NNP O
) ) O
and CC O
activated VBN O
sludge NN O
process NN O
( ( O
ASP NNP O
) ) O
, , O
to TO O
treat VB O
wastewater NN O
containing VBG O
trichloroethylene NN O
( ( O
TCE NNP O
) ) O
at IN O
ambient JJ O
temperature NN O
at IN O
different JJ O
hydraulic JJ O
retention NN O
time NN O
( ( O
HRT NNP O
) ) O
. . O

A DT O
microsporidian JJ O
, , O
Nosema NNP O
algerae VBZ O
Vavra NNP O
and CC O
undeen JJ O
, , O
was VBD O
found VBN O
parasitizing VBG O
larvae NN O
and CC O
adults NNS O
of IN O
a DT O
laboratory JJ O
colony NN O
of IN O
Culex NNP O
pipiens NNS O
L NNP O
. . O
originated VBN O
from IN O
Gharbia NNP O
Governorate NNP O
. . O

Using VBG O
an DT O
ELISA NNP O
, , O
we PRP O
found VBD O
that IN O
surfactant JJ B-Gene
protein NN I-Gene
A NNP I-Gene
( ( O
SP NNP B-Gene
- : I-Gene
A DT I-Gene
) ) O
was VBD O
markedly RB O
elevated VBN O
in IN O
the DT O
pneumonia NN O
patients NNS O
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
signature NN O
- : O
tagged VBN O
mutagenesis NN O
is VBZ O
a DT O
viable JJ O
approach NN O
to TO O
identify VB O
bacterial JJ O
genes NNS O
associated VBN O
with IN O
the DT O
ability NN O
to TO O
infect VB O
the DT O
urinary JJ O
tract NN O
. . O

CBT NNP O
is VBZ O
discussed VBN O
in IN O
comparison NN O
with IN O
the DT O
Wisconsin NNP O
Card NNP O
Sorting NNP O
Test NNP O
as IN O
a DT O
potential JJ O
cognitive JJ O
activation NN O
task NN O
for IN O
functional JJ O
neuroimaging NN O
of IN O
the DT O
frontal JJ O
lobes NN O
. . O

Their PRP$ O
mean JJ O
IOP NNP O
was VBD O
15 CD O
. . O
3 CD O
( ( O
SD NNP O
3 CD O
. . O
7 CD O
) ) O
mmHg NN O
prior RB O
to TO O
induction NN O
of IN O
anesthesia NN O
, , O
13 CD O
. . O
5 CD O
( ( O
SD NNP O
3 CD O
. . O
5 CD O
) ) O
mmHg NN O
after IN O
loss NN O
of IN O
eyelash JJ O
reflex NN O
following VBG O
injection NN O
of IN O
methohexitone NN O
, , O
16 CD O
. . O
1 CD O
( ( O
SD NNP O
2 CD O
. . O
4 CD O
) ) O
mmHg NN O
after IN O
cessation NN O
of IN O
muscle NN O
fasciculations NNS O
induced VBN O
by IN O
suxamethonium NN O
, , O
19 CD O
. . O
2 CD O
( ( O
SD NNP O
5 CD O
. . O
6 CD O
) ) O
mmHg NN O
after IN O
cessation NN O
of IN O
convulsion NN O
and CC O
15 CD O
. . O
5 CD O
( ( O
SD NNP O
4 CD O
. . O
4 CD O
) ) O
mmHg NN O
following VBG O
resumption NN O
of IN O
regular JJ O
spontaneous JJ O
respiration NN O
. . O

Similarly RB O
, , O
co SYM O
- : O
expression NN O
of IN O
a DT O
dominant JJ O
- : O
negative JJ O
mutant NN O
of IN O
p38alpha NN B-Gene
, , O
but CC O
not RB O
of IN O
ERK1 NNP B-Gene
, , O
ERK2 NNP B-Gene
, , O
JNK1 NNP B-Gene
, , O
or CC O
JNK2 NNP B-Gene
, , O
reduces VBZ O
basal NN O
and CC O
cadmium NN O
- : O
induced JJ O
pE1 NN B-Gene
- : I-Gene
luc NN I-Gene
activity NN O
. . O

Diminished VBN O
forearm NN O
arteriolar NN O
dilator NN O
capacity NN O
produced VBN O
by IN O
mineralocorticoid JJ O
- : O
induced JJ O
salt NN O
retention NN O
in IN O
man NN O
. . O

A DT O
new JJ O
instrument NN O
has VBZ O
been VBN O
designed VBN O
for IN O
freeze NN O
- : O
fracturing NN O
of IN O
biological JJ O
material NN O
in IN O
ultra JJ O
high JJ O
vacuum NN O
. . O

Surprisingly RB O
, , O
TFIIIC NNP B-Gene
alpha NN I-Gene
has VBZ O
no DT O
homology NN O
to TO O
any DT O
of IN O
the DT O
yeast NN B-Gene
TFIIIC NNP I-Gene
subunits VBZ I-Gene
already RB O
cloned VBN O
, , O
suggesting VBG O
a DT O
significant JJ O
degree NN O
of IN O
evolutionary JJ O
divergence NN O
for IN O
RNA NNP B-Gene
polymerase NN I-Gene
III NNP I-Gene
factors NNS I-Gene
. . O

We PRP O
found VBD O
that IN O
the DT O
expression NN O
of IN O
the DT O
protein NN O
was VBD O
maximum JJ O
in IN O
mitosis NN O
and CC O
minimum NN O
in IN O
G1 NNP O
, , O
which WDT O
correlated VBD O
with IN O
the DT O
expression NN O
of IN O
its PRP$ O
messenger NN O
RNA NNP O
. . O

In IN O
addition NN O
to TO O
a DT O
previously RB O
characterized VBN O
promoter NN O
( ( O
P1 NNP O
) ) O
, , O
we PRP O
now RB O
show VBP O
the DT O
existence NN O
of IN O
a DT O
second JJ O
promoter NN O
for IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
5Ralpha CD I-Gene
gene NN I-Gene
. . O

In IN O
synchronized JJ O
HeLa NNP O
cells NNS O
, , O
expression NN O
of IN O
luciferase NN B-Gene
activity NN O
was VBD O
induced VBN O
at IN O
the DT O
beginning NN O
of IN O
DNA NNP O
synthesis NN O
and CC O
was VBD O
dependent VBN O
on IN O
the DT O
presence NN O
of IN O
an DT O
E2F NNP B-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
the DT O
H2A NNP B-Gene
. . I-Gene
1 CD I-Gene
promoter NN I-Gene
. . O

The DT O
influence NN O
of IN O
a DT O
high JJ O
ionic JJ O
strength NN O
on IN O
the DT O
resolution NN O
was VBD O
clearly RB O
shown VBN O
. . O

Analysis NN O
of IN O
the DT O
mouse NN B-Gene
STAP NNP I-Gene
gene NN I-Gene
isolated VBD O
from IN O
the DT O
genomic JJ O
library NN O
revealed VBD O
that IN O
the DT O
STAP NNP B-Gene
gene NN I-Gene
spans VBZ O
a DT O
region NN O
of IN O
over IN O
11 CD O
kb NNS O
and CC O
comprises NNS O
eight CD O
exons NNS O
. . O

Induction NN O
of IN O
the DT O
CINC NNP B-Gene
promoter NN I-Gene
by IN O
IL NNP B-Gene
- : I-Gene
17 CD I-Gene
in IN O
IEC NNP O
- : O
6 CD O
cells NNS O
was VBD O
TNF NNP B-Gene
receptor NN I-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
- : I-Gene
6 CD I-Gene
( ( O
TRAF6 NNP B-Gene
) ) O
, , O
but CC O
not RB O
TRAF2 NNP B-Gene
, , O
dependent NN O
. . O

Furthermore RB O
, , O
we PRP O
showed VBD O
that IN O
the DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
/ JJ O
interferon NN B-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
gamma NN I-Gene
) ) O
response NN O
element NN O
in IN O
the DT O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
( ( O
IR NNP B-Gene
/ NNP O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
which WDT O
contains VBZ O
a DT O
Stat NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
and CC O
an DT O
adjacent JJ O
CRE NNP O
- : O
like IN O
site NN O
, , O
also RB O
makes VBZ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : O
induced JJ O
binding NN O
complexes NNS O
similar JJ O
to TO O
JRE NNP O
- : O
IL6 NNP B-Gene
- : O
BCs NNP O
. . O

Tumor NNP O
cell NN O
lines NNS O
transduced VBD O
at IN O
an DT O
MOI NNP O
of IN O
8 CD O
for IN O
3 CD O
days NNS O
led VBN O
to TO O
> VB O
90 CD O
% NN O
gene NN O
transfer NN O
efficiency NN O
. . O

Isoelectric NNP O
focusing NN O
of IN O
tryptic JJ O
peptides NNS O
generated VBD O
from IN O
MHC NNP B-Gene
- : I-Gene
B NNP I-Gene
phosphorylated VBD O
with IN O
cdc2 JJ B-Gene
kinase NN I-Gene
revealed VBD O
one CD O
major JJ O
phosphopeptide NN O
that WDT O
was VBD O
purified VBN O
by IN O
reverse NN O
- : O
phase NN O
high JJ O
performance NN O
liquid NN O
chromatography NN O
and CC O
sequenced VBD O
. . O

Hemodynamics NNS O
changes NNS O
in IN O
man NN O
during IN O
flight NN O

Differential NNP O
regulation NN O
of IN O
the DT O
alpha NN B-Gene
/ NNP I-Gene
beta NN I-Gene
interferon NN I-Gene
- : O
stimulated VBN O
Jak NNP B-Gene
/ NNP O
Stat NNP B-Gene
pathway NN O
by IN O
the DT O
SH2 NNP B-Gene
domain NN O
- : O
containing VBG O
tyrosine JJ B-Gene
phosphatase NN I-Gene
SHPTP1 NNP I-Gene
. . O

No DT O
positive JJ O
family NN O
history NN O
was VBD O
obtained VBN O
. . O

Hexsyn NNP O
is VBZ O
the DT O
Goodyear NNP O
Tire NNP O
and CC O
Rubber NNP O
Company NNP O
tradename NN O
for IN O
a DT O
polyolefin JJ O
rubber NN O
synthesized VBN O
from IN O
1 CD O
- : O
hexene NN O
with IN O
3 CD O
- : O
5 CD O
% NN O
methylhexadiene NN O
as IN O
the DT O
source NN O
of IN O
residual JJ O
double JJ O
bonds NNS O
for IN O
vulcanization NN O
. . O

These DT O
results NNS O
demonstrate VBP O
Ras NNP B-Gene
- : O
and CC O
Raf NNP B-Gene
- : O
independent JJ O
ERK NNP B-Gene
MAPK NNP O
activation NN O
maintains NNS O
cell VBP O
viability NN O
following VBG O
heat NN O
shock NN O
. . O

The DT O
plant NN O
protein NN O
maintains VBZ O
all PDT O
the DT O
functional JJ O
domains NNS O
found VBN O
in IN O
the DT O
other JJ O
proteins NNS O
, , O
including VBG O
nuclear JJ O
localization NN O
signal NN O
, , O
DNA NNP O
- : O
binding NN O
domain NN O
and CC O
helicase NN B-Gene
motifs NNS I-Gene
, , O
suggesting VBG O
that IN O
it PRP O
might MD O
also RB O
act VB O
as IN O
part NN O
of IN O
the DT O
RNA NNP O
transcription NN O
apparatus NN O
, , O
as RB O
well RB O
as IN O
nucleotide JJ O
excision NN O
repair NN O
in IN O
plant NN O
cells NNS O
. . O

Gluzman NNP O
, , O
EMBO NNP O
J NNP O
. . O

The DT O
receptor NN B-Gene
for IN I-Gene
hyaluronan NN I-Gene
mediated VBN I-Gene
motility NN I-Gene
( ( B-Gene
RHAMM NNP I-Gene
) ) I-Gene
gene NN I-Gene
expression NN O
is VBZ O
markedly RB O
elevated VBN O
in IN O
fibrosarcomas NN O
exposed VBN O
to TO O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta1 NN I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
) ) O
. . O

Chronic NNP O
endotoxemia NN O
appears VBZ O
to TO O
be VB O
associated VBN O
with IN O
an DT O
elevated JJ O
pulmonary JJ O
microvascular NN O
permeability NN O
and CC O
a DT O
tendency NN O
toward IN O
a DT O
hyperdynamic JJ O
circulation NN O
but CC O
with IN O
an DT O
appreciable JJ O
degree NN O
of IN O
refractoriness NN O
associated VBN O
with IN O
regional JJ O
hemodynamics NNS O
and CC O
eicosanoid JJ O
biosynthesis NN O
. . O

ERV1 NNP B-Gene
is VBZ O
involved VBN O
in IN O
the DT O
cell NN O
- : O
division NN O
cycle NN O
and CC O
the DT O
maintenance NN O
of IN O
mitochondrial JJ O
genomes NNS O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Amplification NN O
and CC O
overexpression NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
erbB SYM I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
21MT CD O
- : O
2 CD O
and CC O
21MT CD O
- : O
1 CD O
human JJ O
breast NN O
carcinoma NN O
cells NNS O
results NNS O
in IN O
progressively RB O
elevated JJ O
levels NNS O
of IN O
constitutively RB O
tyrosine JJ B-Gene
- : I-Gene
phosphorylated VBN I-Gene
p185erbB JJ I-Gene
- : I-Gene
2 CD I-Gene
and CC O
is VBZ O
associated VBN O
with IN O
progressive JJ O
insulin NN B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
IGF NNP B-Gene
) ) O
and CC O
combined VBN O
IGF NNP B-Gene
/ NNP O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
EGF NNP B-Gene
) ) O
independence NN O
in IN O
culture NN O
. . O

Steroids NNS O
in IN O
germfree NN O
and CC O
conventional JJ O
rats NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
calcium NN O
antagonist NN O
, , O
diltiazem NN O
, , O
may MD O
modify VB O
the DT O
effects NNS O
of IN O
isoflurane NN O
on IN O
myocardial JJ O
function NN O
. . O

C NNP O
. . O
elegans NNS O
embryogenesis VBP O
begins VBZ O
with IN O
a DT O
stereotyped JJ O
sequence NN O
of IN O
asymmetric JJ O
cell NN O
divisions NNS O
that WDT O
are VBP O
largely RB O
responsible JJ O
for IN O
establishing VBG O
the DT O
nematode NN O
body NN O
plan NN O
. . O

SV1 NNP B-Gene
has VBZ O
a DT O
33 CD O
- : O
amino NN O
acid NN O
insert NN O
in IN O
the DT O
S1 NNP O
transmembrane NN O
domain NN O
that WDT O
does VBZ O
not RB O
alter VB O
S1 NNP O
overall JJ O
hydrophobicity NN O
, , O
but CC O
makes VBZ O
the DT O
S0 NNP O
- : O
S1 NN O
linker NN O
longer RBR O
. . O

CONCLUSIONS NN O
: : O
In IN O
our PRP$ O
patients NNS O
and CC O
within IN O
the DT O
range NN O
of IN O
treatment NN O
variables NNS O
studied VBN O
, , O
age NN O
, , O
Karnofsky NNP O
index NN O
, , O
and CC O
graft SYM O
- : O
versus NN O
- : O
host NN O
disease NN O
are VBP O
the DT O
most RBS O
important JJ O
factors NNS O
related VBN O
with IN O
early JJ O
mortality NN O
. . O

An DT O
outbreak NN O
of IN O
hepatitis NN O
A NNP O
among IN O
homosexual JJ O
men NNS O
in IN O
Amsterdam NNP O
, , O
1991 CD O
- : O
1993 CD O
. . O

Increases NNS O
in IN O
the DT O
perfusate NN O
PCO2 NNP O
but CC O
not RB O
in IN O
the DT O
perfusate NN O
H NNP O
+ NNP O
were VBD O
highly RB O
correlated VBN O
with IN O
decreases NNS O
in IN O
both DT O
myocardial JJ O
contractility NN O
and CC O
oxygen NN O
consumption NN O
( ( O
r2 JJ O
= NNP O
. . O
88 CD O
) ) O
. . O

Truncated VBN O
forms NNS O
of IN O
a DT O
novel JJ O
yeast NN O
protein NN O
suppress VBD O
the DT O
lethality NN O
of IN O
a DT O
G NNP B-Gene
protein NN I-Gene
alpha NN I-Gene
subunit NN I-Gene
deficiency NN O
by IN O
interacting VBG O
with IN O
the DT O
beta NN O
subunit NN O
. . O

However RB O
, , O
the DT O
same JJ O
U1A NNP B-Gene
peptide NN I-Gene
, , O
when WRB O
conjugated VBN O
to TO O
BSA NNP B-Gene
, , O
inhibits VBZ O
vertebrate NN B-Gene
PAP NNP I-Gene
. . O

Direct JJ O
proof NN O
that IN O
the DT O
heightened VBN O
renal JJ O
cellular JJ O
apoptosis NN O
in IN O
PKD NNP O
is VBZ O
not RB O
occurring VBG O
through IN O
p53 NN B-Gene
was VBD O
obtained VBN O
by IN O
successive JJ O
matings NNS O
between IN O
SBM NNP O
and CC O
p53 NN B-Gene
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
. . O

The DT O
microphthalmia NN B-Gene
- : I-Gene
TFE NNP I-Gene
( ( O
MiT NNP B-Gene
) ) O
subfamily RB O
of IN O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
leucine JJ I-Gene
zipper NN I-Gene
( ( I-Gene
bHLH SYM I-Gene
- : I-Gene
ZIP NN I-Gene
) ) I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
including VBG O
TFE3 NNP B-Gene
, , O
TFEB NNP B-Gene
, , O
TFEC NNP B-Gene
, , O
and CC O
Mitf NNP B-Gene
, , O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
tissue NN O
- : O
specific JJ O
gene NN O
expression NN O
in IN O
several JJ O
cell NN O
lineages NNS O
. . O

Human NNP O
ESP1 NNP B-Gene
/ NNP O
CRP2 NNP B-Gene
protein NN O
has VBZ O
two CD O
LIM NNP B-Gene
domains NNS O
, , O
and CC O
each DT O
shares NNS O
35 CD O
. . O
1 CD O
% NN O
and CC O
77 CD O
or CC O
79 CD O
% NN O
identical JJ O
residues NNS O
with IN O
human JJ B-Gene
cysteine NN I-Gene
- : I-Gene
rich JJ I-Gene
protein NN I-Gene
( ( O
CRP NNP B-Gene
) ) O
and CC O
rat JJ B-Gene
CRIP NNP I-Gene
, , O
respectively RB O
. . O

The DT O
effect NN O
of IN O
maternal JJ O
ingestion NN O
of IN O
the DT O
reduced JJ O
energy NN O
sweetener NN O
erythritol NN O
was VBD O
investigated VBN O
in IN O
KBL NNP O
: : O
JW NNP O
strain NN O
pregnant JJ O
rabbits NNS O
. . O

Sudomoina NNP O
, , O
A NNP O
. . O

To TO O
evaluate VB O
whether IN O
the DT O
human JJ O
gene NN O
is VBZ O
also RB O
a DT O
target NN O
of IN O
thyroid JJ O
hormone NN O
we PRP O
have VBP O
searched VBN O
for IN O
T3 NNP O
- : O
responsive JJ O
elements NNS O
in IN O
NRGN NNP B-Gene
cloned VBD O
genomic JJ O
fragments NNS O
spanning VBG O
the DT O
whole JJ O
gene NN O
. . O

Such JJ O
an DT O
hemoglobin JJ B-Gene
solution NN O
was VBD O
shown VBN O
to TO O
exhibit VB O
a DT O
high JJ O
affinity NN O
for IN O
oxygen NN O
and CC O
a DT O
low JJ O
Bohr NNP O
effect NN O
( ( O
assessed VBN O
from IN O
the DT O
delta NN O
log NN O
Po2 NNP O
/ NNP O
delta NN O
pH NN O
ratio NN O
) ) O
. . O

Collectively RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
components NNS O
of IN O
the DT O
protein NN B-Gene
kinase VBD I-Gene
A NNP I-Gene
signaling VBG O
pathway NN O
are VBP O
recruited VBN O
by IN O
mIg NN B-Gene
to TO O
induce VB O
junB JJ B-Gene
transcription NN O
. . O

An DT O
expression NN O
library NN O
was VBD O
constructed VBN O
by IN O
inserting VBG O
5 CD O
' POS O
portion NN O
- : O
enriched VBN O
cDNAs NN O
from IN O
phytohemagglutinin JJ B-Gene
- : O
stimulated JJ O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
into IN O
upstream NN O
of IN O
signal JJ B-Gene
sequence NN I-Gene
- : I-Gene
deleted VBN I-Gene
CD4 NNP I-Gene
cDNA NN I-Gene
in IN O
an DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
shuttle NN O
vector NN O
. . O

When WRB O
differentiated VBN O
G0 NNP O
- : O
arrested VBD O
leaf JJ O
cells NNS O
were VBD O
induced VBN O
to TO O
resume VB O
cell NN O
division NN O
by IN O
treatment NN O
with IN O
plant NN O
hormones NNS O
, , O
cycMs4 JJ B-Gene
transcription NN O
was VBD O
induced VBN O
before IN O
the DT O
onset NN O
of IN O
DNA NNP O
synthesis NN O
. . O

METHODS NN O
: : O
A DT O
total NN O
of IN O
15 CD O
pigs NNS O
were VBD O
randomised VBN O
to TO O
ligation NN O
of IN O
left JJ O
marginal JJ O
arteries NNS O
( ( O
infarction NN O
group NN O
, , O
n RB O
= VBZ O
5 CD O
) ) O
, , O
to TO O
TMLR NNP O
of IN O
the DT O
left JJ O
lateral JJ O
wall NN O
using VBG O
a DT O
holmium NN O
: : O
yttrium NN O
- : O
aluminium NN O
garnet NN O
( ( O
Ho NNP O
: : O
YAG NN O
) ) O
laser NN O
( ( O
laser NN O
group NN O
, , O
n RB O
= VBZ O
5 CD O
) ) O
, , O
and CC O
to TO O
both DT O
( ( O
laser SYM O
- : O
infarction NN O
group NN O
, , O
n RB O
= VBZ O
5 CD O
) ) O
. . O

The DT O
potential JJ O
impact NN O
of IN O
using VBG O
a DT O
rapid JJ O
diagnostic JJ O
test NN O
( ( O
Strep NNP O
A NNP O
OIA NNP O
) ) O
on IN O
detection NN O
and CC O
treatment NN O
of IN O
group NN O
A NNP O
beta NN O
- : O
hemolytic JJ O
streptococcal JJ O
( ( O
GABHS NNP O
) ) O
pharyngitis NN O
in IN O
a DT O
large JJ O
- : O
volume NN O
pediatric JJ O
and CC O
adolescent JJ O
clinic NN O
was VBD O
examined VBN O
. . O

One CD O
site NN O
, , O
PAL NNP B-Gene
, , O
occurs VBZ O
within IN O
the DT O
10 CD O
bp NN O
sequence NN O
GGGGAGGAGG NNP O
. . O

In IN O
contrast NN O
, , O
rats NNS O
receiving VBG O
U74500A NNP O
( ( O
2 CD O
mg NN O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
infusion NN O
commencing VBG O
30 CD O
min JJ O
prior RB O
to TO O
revascularisation NN O
) ) O
exhibited VBD O
enhanced JJ O
GMBF NNP O
throughout IN O
reperfusion NN O
[ NNP O
PI NNP O
10 CD O
min NN O
: : O
3 CD O
. . O
26 CD O
( ( O
2 CD O
. . O
56 CD O
- : O
3 CD O
. . O
63 CD O
) ) O
; : O
120 CD O
min NN O
: : O
2 CD O
. . O
3 CD O
( ( O
1 CD O
. . O
73 CD O
- : O
2 CD O
. . O
25 CD O
) ) O
; : O
240 CD O
min NN O
: : O
2 CD O
. . O
13 CD O
( ( O
1 CD O
. . O
75 CD O
- : O
2 CD O
. . O
44 CD O
) ) O
, , O
p JJ O
< NN O
0 CD O
. . O
1 CD O
vs NN O
. . O
controls NNS O
and CC O
normals NNS O
] VBP O
with IN O
complete JJ O
muscle NN O
salvage NN O
[ NNP O
GMV NNP O
100 CD O
% NN O
in IN O
all DT O
reperfused JJ O
muscles NNS O
, , O
p VBP O
< JJ O
0 CD O
. . O
1 CD O
vs NN O
. . O
controls NNS O
, , O
not RB O
significant JJ O
( ( O
NS NNP O
) ) O
vs NN O
. . O
normals NNS O
and CC O
6 CD O
h NN O
ischaemia NN O
] NNP O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

However RB O
, , O
if IN O
the DT O
spatial JJ O
resolution NN O
is VBZ O
not RB O
critical JJ O
and CC O
interest NN O
is VBZ O
to TO O
compare VB O
a DT O
pathologic JJ O
area NN O
with IN O
a DT O
contralateral JJ O
VOI NNP O
, , O
then RB O
the DT O
acquisition NN O
of IN O
two CD O
single JJ O
- : O
voxel NN O
spectra NN O
may MD O
be VB O
preferred VBN O
. . O

This DT O
experimental JJ O
design NN O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
effect NN O
of IN O
displacement NN O
of IN O
the DT O
alpha NN B-Gene
4 CD I-Gene
- : I-Gene
2 CD I-Gene
binding VBG I-Gene
site NN I-Gene
on IN O
the DT O
repression NN O
of IN O
alpha $ B-Gene
4 CD I-Gene
gene NN I-Gene
transcription NN O
by IN O
ICP4 NNP B-Gene
. . O

Tests NNS O
showed VBD O
that IN O
an DT O
overall JJ O
impression NN O
of IN O
the DT O
force NN O
applied VBD O
could MD O
be VB O
obtained VBN O
from IN O
a DT O
laboratory NN O
simulation NN O
, , O
but CC O
that IN O
clearing VBG O
cement NN O
and CC O
testing VBG O
cement NN O
were VBD O
not RB O
modelled VBN O
by IN O
this DT O
method NN O
. . O

The DT O
diagnosis NN O
of IN O
amyloidosis NN O
was VBD O
determined VBN O
from IN O
a DT O
labial JJ O
salivary JJ O
gland NN O
biopsy NN O
. . O

Altogether RB O
, , O
the DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
two CD O
isoforms NNS O
elicit VBP O
similar JJ O
responses NNS O
in IN O
vivo JJ O
despite IN O
differences NNS O
in IN O
their PRP$ O
regulation NN O
. . O

A DT O
complementary JJ O
DNA NN O
was VBD O
isolated VBN O
from IN O
Caenorhabditis NNP O
elegans VBZ O
that IN O
encoded VBD O
a DT O
polypeptide NN O
of IN O
1438 CD O
amino NN O
acid NN O
residues NNS O
, , O
CeGAP NNP B-Gene
, , O
which WDT O
contains VBZ O
a DT O
domain NN O
with IN O
sequence NN O
similarity NN O
to TO O
the DT O
COOH NNP B-Gene
- : I-Gene
terminal NN I-Gene
segment NN I-Gene
( ( I-Gene
GTPase NNP I-Gene
- : I-Gene
activating VBG I-Gene
protein JJ I-Gene
region NN I-Gene
) ) I-Gene
of IN O
Bcr NNP B-Gene
and CC O
other JJ O
known VBN O
GTPase NNP B-Gene
- : I-Gene
activating VBG I-Gene
proteins NNS I-Gene
of IN O
the DT O
Rho NNP B-Gene
subfamily RB I-Gene
. . O

Low NNP O
- : O
selenium NN O
diet NN O
has VBZ O
a DT O
human JJ O
unfavourable JJ O
impact NN O
. . O

Analysis NN O
of IN O
the DT O
binding NN O
of IN O
Lrp NNP B-Gene
to TO O
a DT O
set NN O
of IN O
circularly JJ O
permuted VBN O
DNA NN O
fragments NNS O
from IN O
this DT O
region NN O
indicates VBZ O
that IN O
Lrp NNP B-Gene
induces NNS O
DNA NNP O
bending NN O
. . O

Additional JJ O
studies NNS O
with IN O
new JJ O
and CC O
reprocessed VBN O
regenerated VBN O
cellulose JJ O
dialyzers NNS O
comparing VBG O
450 CD O
and CC O
220 CD O
mL NN O
/ NNP O
min NN O
blood NN O
flow NN O
rates NNS O
at IN O
10 CD O
minutes NNS O
showed VBD O
no DT O
change NN O
in IN O
BTG NNP O
. . O

Patients NNS O
with IN O
more JJR O
than IN O
250 CD O
PVC NNP O
/ VBD O
24 CD O
hours NNS O
were VBD O
selected VBN O
for IN O
distribution NN O
of IN O
PVC NNP O
and CC O
CI NNP O
evaluation NN O
. . O

The DT O
quantity NN O
of IN O
each DT O
population NN O
( ( O
L NNP O
. . O
bulgaricus NN O
, , O
S NNP O
. . O
thermophilus NN O
) ) O
was VBD O
then RB O
estimated VBN O
in IN O
the DT O
pellet NN O
by IN O
PyMS NNP O
, , O
and CC O
the DT O
data NNS O
were VBD O
analysed VBN O
by IN O
artificial JJ O
neural JJ O
networks NNS O
( ( O
ANNs NNP O
) ) O
. . O

By IN O
analyzing VBG O
the DT O
RanGAP NNP B-Gene
activity NN O
of IN O
a DT O
series NN O
of IN O
recombinantly RB O
expressed VBN O
rna1p NN B-Gene
mutant NN I-Gene
derivatives NNS O
, , O
we PRP O
show VBP O
that IN O
the DT O
highly RB O
acidic JJ O
sequence NN O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
domain NN O
of IN O
both DT O
yeast JJ O
proteins NNS O
is VBZ O
indispensable JJ O
for IN O
activating VBG O
Ran NNP B-Gene
- : O
mediated VBD O
GTP NNP O
hydrolysis NN O
. . O

Organisms NNS O
were VBD O
recovered VBN O
from IN O
the DT O
conjunctiva NN O
for IN O
several JJ O
weeks NNS O
, , O
and CC O
persistent JJ O
genital NN O
and CC O
gastrointestinal JJ O
infection NN O
also RB O
resulted VBD O
from IN O
the DT O
ocular JJ O
infection NN O
in IN O
some DT O
cats NNS O
. . O

To TO O
establish VB O
a DT O
possible JJ O
association NN O
between IN O
familial JJ O
dysfibrinogenemia NN O
and CC O
thrombophilia NN O
, , O
data NNS O
on IN O
cases NNS O
with IN O
both DT O
affections NNS O
were VBD O
collected VBN O
in IN O
a DT O
study NN O
within IN O
the DT O
framework NN O
of IN O
the DT O
SSC NNP O
Subcommittee NNP O
on IN O
Fibrinogen NNP B-Gene
of IN O
the DT O
International NNP O
Society NNP O
on IN O
Thrombosis NNP O
and CC O
Haemostasis NNP O
. . O

The DT O
sequences NNS O
following VBG O
the DT O
X NNP O
. . O
borealis NN O
oocyte NN O
and CC O
somatic JJ O
5S CD B-Gene
genes NNS I-Gene
are VBP O
identical JJ O
in IN O
12 CD O
of IN O
the DT O
first JJ O
14 CD O
residues NNS O
and CC O
contain VB O
two CD O
or CC O
more JJR O
T JJ O
clusters NNS O
, , O
as IN O
does VBZ O
the DT O
corresponding JJ O
region NN O
of IN O
X NNP B-Gene
. . I-Gene
laevis VB I-Gene
oocyte JJ I-Gene
5S CD I-Gene
DNA NN I-Gene
. . O

Using VBG O
this DT O
method NN O
, , O
VLPs NNP O
were VBD O
obtained VBN O
in IN O
quantities NNS O
sufficient JJ O
for IN O
further JJ O
characterization NN O
. . O

The DT O
stoichiometry NN O
of IN O
the DT O
complexes NNS O
formed VBN O
with IN O
the DT O
dodeca NN O
- : O
satellite NN O
C NNP O
strand NN O
suggests VBZ O
that IN O
, , O
in IN O
DDP1 NNP B-Gene
, , O
the DT O
15 CD O
consecutive JJ O
KH NNP O
domains NNS O
are VBP O
organized VBN O
such JJ O
that IN O
they PRP O
define VBP O
two CD O
nucleic JJ O
acid NNS O
binding VBG O
surfaces NNS O
. . O

The DT O
relationships NNS O
among IN O
four CD O
descriptors NNS O
of IN O
lactate JJ O
increase NN O
: : O
lactate JJ O
threshold NN O
( ( O
LT NNP O
) ) O
( ( O
the DT O
VO2 NNP O
at IN O
which WDT O
blood NN O
lactate NN O
concentration NN O
begins VBZ O
to TO O
increase VB O
above IN O
the DT O
resting VBG O
level NN O
during IN O
an DT O
incremental JJ O
exercise NN O
test NN O
) ) O
, , O
LT1 NNP O
( ( O
the DT O
VO2 NNP O
at IN O
which WDT O
blood NN O
lactate NN O
increases VBZ O
1 CD O
mM NN O
above IN O
the DT O
resting VBG O
level NN O
) ) O
, , O
LT2 NNP O
( ( O
the DT O
VO2 NNP O
at IN O
which WDT O
blood NN O
lactate NN O
concentration NN O
reaches VBZ O
a DT O
fixed JJ O
value NN O
of IN O
2 CD O
mM NN O
) ) O
, , O
onset VBN O
of IN O
blood NN O
lactate NN O
accumulation NN O
( ( O
OBLA NNP O
; : O
the DT O
VO2 NNP O
at IN O
which WDT O
blood NN O
lactate NN O
reaches VBZ O
a DT O
concentration NN O
of IN O
4 CD O
mM NN O
) ) O
, , O
were VBD O
compared VBN O
with IN O
aerobic JJ O
capacity NN O
( ( O
VO2max NNP O
) ) O
and CC O
12 CD O
min NN O
running VBG O
performance NN O
in IN O
19 CD O
untrained JJ O
female JJ O
students NNS O
. . O

Human NNP B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
Vpr NNP I-Gene
is VBZ O
a DT O
virion NN O
- : O
associated VBN O
, , O
regulatory JJ O
protein NN O
that WDT O
is VBZ O
required VBN O
for IN O
efficient JJ O
viral JJ O
replication NN O
in IN O
monocytes NNS O
/ JJ O
macrophages NNS O
. . O

Zatebradine NNP O
weakly NN O
depressed VBD O
the DT O
ectopic JJ O
ventricular JJ O
rate NN O
but CC O
not RB O
the DT O
arrhythmic JJ O
ratio NN O
of IN O
the DT O
ventricular JJ O
arrhythmias NN O
induced VBN O
by IN O
two CD O
- : O
stage NN O
coronary JJ O
ligation NN O
24 CD O
h NN O
after IN O
the DT O
ligation NN O
in IN O
conscious JJ O
dogs NNS O
. . O

The DT O
syncytial JJ O
microvillous JJ O
projections NNS O
seemed VBD O
to TO O
be VB O
more RBR O
numerous JJ O
and CC O
longer RBR O
in IN O
CNF NNP O
, , O
otherwise RB O
the DT O
structure NN O
of IN O
the DT O
trophoblastic JJ O
layer NN O
of IN O
the DT O
villi NN O
and CC O
the DT O
lining NN O
of IN O
the DT O
subtrophoblastic JJ O
vessels NNS O
were VBD O
identical JJ O
in IN O
CNF NNP O
and CC O
controls NNS O
. . O

In IN O
addition NN O
to TO O
restoring VBG O
checkpoint NN O
control NN O
, , O
overexpression NN O
of IN O
sum1 JJ B-Gene
+ NNP I-Gene
inhibits VBZ O
the DT O
normal JJ O
cell NN O
cycle NN O
response NN O
to TO O
osmotic JJ O
stress NN O
. . O

CONCLUSION NN O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
vibration NN O
- : O
induced JJ O
neural JJ O
involvement NN O
can MD O
be VB O
considered VBN O
neither DT O
pure JJ O
digital JJ O
neuropathy NN O
, , O
nor CC O
definite JJ O
CTS NNP O
, , O
as IN O
previously RB O
described VBN O
. . O

We PRP O
show VBP O
that IN O
several JJ O
heme JJ O
- : O
responsive JJ O
mechanisms NNS O
combine VBP O
to TO O
regulate VB O
DAN NNP B-Gene
/ NNP O
TIR NNP B-Gene
gene NN O
expression NN O
. . O

The DT O
results NNS O
strengthen VBP O
the DT O
conclusion NN O
that WDT O
predominantly RB O
dynamic VBZ O
activity NN O
increases VBZ O
the DT O
G4 NNP B-Gene
content NN O
of IN O
mature NN O
innervated VBN O
fast JJ O
muscles NNS O
. . O

Acetoin NNP O
- : O
dependent JJ O
expression NN O
of IN O
the DT O
acoABCD NN B-Gene
operon NN I-Gene
could MD O
be VB O
restored VBN O
in IN O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
acoK JJ I-Gene
mutants NNS I-Gene
by IN O
supplying VBG O
a DT O
plasmid NN O
carrying VBG O
an DT O
intact JJ O
acoK NN B-Gene
, , O
suggesting VBG O
a DT O
transactivating VBG O
function NN O
of IN O
the DT O
gene NN O
product NN O
. . O

To TO O
further RBR O
characterize VB O
the DT O
structure NN O
and CC O
evolutionary JJ O
synthesis NN O
of IN O
the DT O
CMT1A NNP O
- : O
REP NNP O
repeat NN O
, , O
fluorescent NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
analysis NN O
and CC O
heterologous JJ O
PCR NNP O
- : O
based VBN O
assays NNS O
were VBD O
carried VBN O
out RP O
for IN O
a DT O
series NN O
of IN O
primates NNS O
. . O

Pregnant JJ O
women NNS O
at IN O
term NN O
had VBD O
the DT O
lowest JJS O
levels NNS O
of IN O
antithrombin NN B-Gene
III NNP I-Gene
. . O

The DT O
results NNS O
indicate VBP O
that IN O
a DT O
more RBR O
differentiated JJ O
diagnosis NN O
of IN O
the DT O
molar NN O
relationship NN O
will MD O
allow VB O
for IN O
a DT O
more RBR O
causally RB O
directed JJ O
correction NN O
of IN O
Class NNP O
II NNP O
molar NN O
relationship NN O
. . O

Thus RB O
, , O
Pet111p NNP B-Gene
could MD O
play VB O
dual JJ O
roles NNS O
in IN O
both DT O
membrane JJ O
localization NN O
and CC O
regulation NN O
of IN O
Cox2p NNP B-Gene
synthesis NN O
within IN O
mitochondria NNS O
. . O

CONCLUSION NN O
: : O
Chronic JJ O
administration NN O
of IN O
misoprostol NN O
may MD O
have VB O
caused VBN O
a DT O
negative JJ O
natriuretic JJ O
effect NN O
in IN O
cirrhotic JJ O
patients NNS O
with IN O
ascites NNS O
. . O

DNA NN O
sequence NN O
and CC O
functions NNS O
of IN O
the DT O
actVI JJ B-Gene
region NN I-Gene
of IN O
the DT O
actinorhodin JJ B-Gene
biosynthetic JJ I-Gene
gene NN I-Gene
cluster NN I-Gene
of IN I-Gene
Streptomyces NNP I-Gene
coelicolor NN I-Gene
A3 NNP I-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
. . O

The DT O
event NN O
rate NN O
in IN O
patients NNS O
with IN O
chronic JJ O
Irr NNP O
- : O
rMFP NN O
or CC O
Un NNP O
- : O
nrMFP NN O
was VBD O
markedly RB O
higher JJR O
than IN O
it PRP O
was VBD O
in IN O
those DT O
with IN O
Rev NNP O
- : O
rMFP NN O
or CC O
Sta NNP O
- : O
nrMFP NN O
. . O

The DT O
study NN O
disclosed VBD O
generalized VBN O
atrophy NN O
and CC O
diffuse NN O
symmetric JJ O
white JJ O
matter NN O
hypodensities NNS O
. . O

In IN O
addition NN O
to TO O
targeting VBG O
partially RB O
assembled VBN O
Ti NNP B-Gene
alpha SYM I-Gene
- : I-Gene
beta NN I-Gene
CD3 NNP B-Gene
gamma NN I-Gene
delta NN I-Gene
epsilon NN I-Gene
TCR NNP B-Gene
complexes NNS I-Gene
to TO O
the DT O
cell NN O
surface NN O
, , O
CD3 NNP B-Gene
zeta NN I-Gene
appears VBZ O
to TO O
be VB O
essential JJ O
for IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
production NN O
after IN O
TCR NNP B-Gene
stimulation NN O
with IN O
antigen NN B-Gene
/ NNS I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex NN I-Gene
. . O

DNase NNP B-Gene
I PRP I-Gene
footprint VBP O
analysis RB O
identified VBN O
a DT O
protected JJ O
region NN O
from IN O
- : O
37 CD O
to TO O
- : O
53 CD O
. . O

The DT O
endodontal JJ O
treatment NN O
need NN O
has VBZ O
been VBN O
forming VBG O
a DT O
clinical JJ O
order NN O
of IN O
magnitude NN O
. . O

Essentially RB O
, , O
2 CD O
' POS O
- : O
O NNP O
- : O
methyl NN O
oligoribonucleotides NNS O
( ( O
2 CD O
' '' O
OMeRNA NNP O
) ) O
were VBD O
delivered VBN O
to TO O
the DT O
nuclei NN O
of IN O
primary JJ O
mdx NN O
myoblasts NNS O
in IN O
culture NN O
. . O

Thus RB O
, , O
the DT O
interaction NN O
of IN O
Tat NNP B-Gene
with IN O
the DT O
components NNS O
of IN O
this DT O
rel NN B-Gene
/ VBZ O
AP1 NNP B-Gene
cooperative NN O
complex NN O
seems VBZ O
to TO O
induce VB O
quantitative JJ O
and CC O
qualitative JJ O
alterations NNS O
of IN O
this DT O
complex JJ O
as IN O
activation NN O
progresses VBZ O
, , O
resulting VBG O
in IN O
a DT O
decrease NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
transcription NN O
. . O

One CD O
patient NN O
only RB O
had VBD O
any DT O
test NN O
abnormalities NNS O
. . O

The DT O
authors NNS O
report VBP O
a DT O
case NN O
in IN O
which WDT O
stereotactic JJ O
irrigation NN O
of IN O
a DT O
brain NN O
cyst NN O
was VBD O
temporally RB O
associated VBN O
with IN O
respiratory NN O
distress NN O
. . O

The DT O
data NNS O
are VBP O
compatible JJ O
with IN O
the DT O
idea NN O
that WDT O
YLL031c VBZ B-Gene
transfers VBZ O
the DT O
ethanolaminephosphate NN O
to TO O
the DT O
inner NN O
alpha1 SYM O
- : O
2 CD O
- : O
linked VBN O
mannose JJ O
, , O
i JJ O
. . O
e NN O
. . O
the DT O
group NN O
that WDT O
links VBZ O
the DT O
GPI NNP O
lipid JJ O
anchor NN O
to TO O
proteins NNS O
, , O
whereas NNS O
Mcd4p NNP B-Gene
and CC O
Gpi7p NNP B-Gene
transfer VBP O
ethanolaminephosphate VB O
onto IN O
the DT O
alpha1 JJ O
- : O
4 CD O
- : O
and CC O
alpha1 VB O
- : O
6 CD O
- : O
linked VBN O
mannoses NNS O
of IN O
the DT O
GPI NNP O
anchor NN O
, , O
respectively RB O
. . O

RAS2val19 NNP B-Gene
, , O
a DT O
dominant JJ O
activated JJ O
form NN O
of IN O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
Ras2 NNP I-Gene
, , O
stimulates VBZ O
both DT O
filamentous JJ O
growth NN O
and CC O
expression NN O
of IN O
a DT O
transcriptional JJ O
reporter NN O
FG NNP B-Gene
( ( O
TyA NNP B-Gene
) ) O
: : O
: : O
lacZ NN B-Gene
but CC O
does VBZ O
not RB O
induce VB O
the DT O
mating NN B-Gene
pathway NN I-Gene
reporter NN I-Gene
FUS1 NNP I-Gene
: : O
: : O
lacZ NN B-Gene
. . O

Furthermore RB O
, , O
expression NN O
of IN O
the DT O
promoter NN O
in IN O
embryonic JJ O
Drosophila NNP O
melanogaster NN O
cells NNS O
that WDT O
lack VBP O
MyoD1 NNP B-Gene
and CC O
Sp1 NNP B-Gene
is VBZ O
strictly RB O
dependent JJ O
on IN O
all DT O
three CD O
sites NNS O
remaining VBG O
intact JJ O
and CC O
on IN O
the DT O
presence NN O
of IN O
exogenously RB O
supplied VBN O
Sp1 NNP B-Gene
and CC O
MyoD1 NNP B-Gene
. . O

Direct JJ O
superoxide NN O
scavenging VBG O
activity NN O
of IN O
nonsteroidal JJ O
anti SYM O
- : O
inflammatory JJ O
drugs NNS O
: : O
determination NN O
by IN O
electron NN O
spin NN O
resonance NN O
using VBG O
the DT O
spin NN O
trap NN O
method NN O
. . O

Direct JJ O
approach NN O
to TO O
the DT O
study NN O
of IN O
soliton NN O
perturbations NNS O
. . O

The DT O
pretransplant JJ O
regimen NNS O
consisted VBD O
of IN O
cyclophosphamide NN O
( ( O
120 CD O
mg NN O
/ NNP O
kg NN O
) ) O
and CC O
total JJ O
body NN O
irradiation NN O
. . O

It PRP O
may MD O
be VB O
time NN O
to TO O
reevaluate VB O
the DT O
dichotomy NN O
between IN O
AD NNP O
and CC O
VaD NNP O
. . O

In IN O
vitro JJ O
metabolism NN O
of IN O
progesterone NN O
by IN O
the DT O
human NN O
undescended VBD O
testis NN O
. . O

Subtraction NNP O
hybridization NN O
identified VBD O
melanoma JJ B-Gene
differentiation NN I-Gene
associated VBN I-Gene
gene NN I-Gene
- : I-Gene
7 CD I-Gene
( ( O
mda SYM B-Gene
- : I-Gene
7 CD I-Gene
) ) O
, , O
as IN O
a DT O
gene NN O
induced VBN O
during IN O
these DT O
physiological JJ O
changes NNS O
in IN O
human JJ O
melanoma NN O
cells NNS O
. . O

The DT O
across NN O
- : O
fiber NN O
pattern NN O
of IN O
the DT O
responses NNS O
to TO O
hypotonic VB O
NaCl NNP O
solutions NNS O
correlated VBD O
strongly RB O
to TO O
that DT O
elicited VBN O
by IN O
distilled JJ O
H2O NNP O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

RESULTS NN O
: : O
Looking VBG O
at IN O
the DT O
question NN O
of IN O
its PRP$ O
benefits NNS O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
find VB O
any DT O
methodologically RB O
sound JJ O
studies NNS O
that WDT O
have VBP O
shown VBN O
efficacy NN O
for IN O
EMDR NNP O
in IN O
eating VBG O
disorders NNS O
, , O
or CC O
, , O
indeed RB O
, , O
any DT O
psychiatric JJ O
disorder NN O
. . O

U24 NNP B-Gene
has VBZ O
two CD O
separate JJ O
12 CD O
nt RB O
long JJ O
complementarities NNS O
to TO O
a DT O
highly RB O
conserved VBN O
tract NN O
of IN O
28S CD B-Gene
rRNA NN I-Gene
. . O

E2 NNP B-Gene
point NN O
mutants NNS O
unable JJ O
to TO O
inhibit VB O
cell JJ O
growth NN O
did VBD O
not RB O
repress VB O
cdc25A NN B-Gene
and CC O
cdc25B NN B-Gene
expression NN O
, , O
nor CC O
did VBD O
the DT O
cell NN O
cycle NN O
inhibitors NNS O
hydroxyurea VBP O
and CC O
mimosine VBP O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
: : O
1 CD O
) ) O
the DT O
initial JJ O
response NN O
to TO O
tethering VBG O
varies NNS O
according VBG O
to TO O
previous JJ O
penning NN O
and CC O
handling VBG O
experience NN O
, , O
2 CD O
) ) O
although IN O
the DT O
circadian JJ O
rhythm NN O
of IN O
cortisol NN O
was VBD O
either RB O
altered JJ O
or CC O
disrupted VBN O
during IN O
estrus NN O
, , O
such JJ O
disruptions NNS O
were VBD O
not RB O
influenced VBN O
by IN O
type NN O
of IN O
penning NN O
and CC O
3 CD O
) ) O
tether NN O
stalls NNS O
may MD O
chronically RB O
increase VB O
cortisol NN O
concentrations NNS O
in IN O
gilts NNS O
. . O

Fifty NNP O
- : O
one CD O
patients NNS O
with IN O
primary JJ O
refractory NN O
or CC O
relapsed VBN O
malignant JJ O
lymphoma NN O
( ( O
47 CD O
non SYM O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
and CC O
four CD O
Hodgkin NNP O
' POS O
s JJ O
disease NN O
) ) O
were VBD O
treated VBN O
with IN O
a DT O
new JJ O
chemotherapeutic JJ O
regimen NNS O
( ( O
cisplatinum NN O
, , O
methyl NN O
GAG NNP O
, , O
bleomocyin NN O
, , O
methyl FW O
prednisolon NN O
) ) O
. . O

Activation NN O
was VBD O
biphasic JJ O
; : O
peaking VBG O
at IN O
5 CD O
- : O
10 CD O
min NN O
and CC O
24 CD O
h NN O
after IN O
treatment NN O
. . O

( ( O
LH NNP B-Gene
P NNP O
< VBD O
0 CD O
. . O
5 CD O
, , O
LH NNP B-Gene
/ NNP O
FSH NNP B-Gene
P NNP O
< VBD O
0 CD O
. . O
1 CD O
) ) O
. . O

Because IN O
there EX O
is VBZ O
great JJ O
need NN O
for IN O
iron NN O
in IN O
the DT O
EPO NNP B-Gene
- : O
stimulated VBD O
erythroid JJ O
progenitors NNS O
, , O
it PRP O
is VBZ O
essential JJ O
that IN O
serum NN B-Gene
ferritin NN I-Gene
and CC O
transferrin JJ B-Gene
saturation NN O
levels NNS O
should MD O
be VB O
maintained VBN O
over IN O
300 CD O
microg NNS O
/ JJ O
liter NN O
and CC O
30 CD O
% NN O
, , O
respectively RB O
. . O

The DT O
criterion NN O
was VBD O
reached VBN O
after IN O
two CD O
sessions NNS O
and CC O
generalization NN O
to TO O
a DT O
variety NN O
of IN O
pills NNS O
and CC O
capsules NNS O
occurred VBD O
. . O

The DT O
fracture NN O
groups NNS O
were VBD O
significantly RB O
older JJR O
and CC O
had VBD O
more JJR O
years NNS O
since IN O
menopause NN O
than IN O
the DT O
control NN O
groups NNS O
. . O

We PRP O
detected VBD O
no DT O
effect NN O
of IN O
deleting VBG O
YCL024W NNP B-Gene
, , O
either RB O
alone RB O
or CC O
in IN O
combination NN O
with IN O
deletion NN O
of IN O
GIN4 NNP B-Gene
. . O

At IN O
each DT O
level NN O
of IN O
PaO2 NNP O
we PRP O
obtained VBD O
simultaneous JJ O
measures NNS O
of IN O
arterial JJ O
and CC O
venous JJ O
blood NN O
gases NNS O
, , O
venous JJ O
lactate NN O
concentration NN O
, , O
and CC O
changes NNS O
in IN O
the DT O
relative JJ O
concentrations NNS O
of IN O
inorganic JJ O
phosphate NN O
, , O
phosphocreatine NN O
, , O
and CC O
ATP NNP O
measured VBD O
with IN O
31P CD O
magnetic JJ O
resonance NN O
spectroscopy NN O
. . O

Newcastle NNP B-Gene
disease NN I-Gene
antibody NN I-Gene
titre NN O
is VBZ O
dependent JJ O
on IN O
serum JJ O
calcium NN O
concentration NN O
. . O

The DT O
alpha JJ O
7A CD O
form NN O
RNA NNP O
contains VBZ O
an DT O
additional JJ O
113 CD O
nucleotides NNS O
compared VBN O
to TO O
the DT O
B NNP O
form NN O
, , O
and CC O
a DT O
common JJ O
coding NN O
region NN O
in IN O
the DT O
A NNP O
and CC O
B NNP O
form NN O
RNAs NNP O
is VBZ O
used VBN O
in IN O
alternate JJ O
reading NN O
frames NNS O
. . O

Pathological JJ O
processes NNS O
in IN O
the DT O
cervix NN O
uteri NN O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
M NNP O
. . O
jannaschii NN O
as RB O
well RB O
as IN O
related JJ O
archaeal NN B-Gene
20S CD I-Gene
proteasomes NNS I-Gene
require VBP O
a DT O
nucleotidase NN O
complex NN O
such JJ O
as IN O
PAN NNP B-Gene
to TO O
mediate VB O
the DT O
energy NN O
- : O
dependent JJ O
hydrolysis NN O
of IN O
folded JJ O
- : O
substrate NN O
proteins NNS O
and CC O
that IN O
the DT O
N NNP O
- : O
terminal JJ O
73 CD O
amino NN O
acid NN O
residues NNS O
of IN O
PAN NNP B-Gene
are VBP O
not RB O
absolutely RB O
required VBN O
for IN O
this DT O
reaction NN O
. . O

The DT O
implications NNS O
for IN O
estimates NNS O
of IN O
cortical JJ O
magnification NN O
and CC O
possible JJ O
differences NNS O
in IN O
the DT O
specializations NNS O
of IN O
foveal NN O
and CC O
peripheral JJ O
vision NN O
are VBP O
discussed VBN O
. . O

High JJ O
- : O
affinity NN O
binding NN O
sites NNS O
for IN O
both DT O
GR NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
nucleoproteins NNS I-Gene
were VBD O
identified VBN O
at IN O
adjacent JJ O
elements NNS O
within IN O
the DT O
nGRE NN O
. . O

Cardiac NNP O
output NN O
at IN O
anaerobic JJ O
threshold NN O
( ( O
COAT NNP O
) ) O
< VBD O
or CC O
= $ O
7 CD O
. . O
3 CD O
L NNP O
/ NNP O
min NN O
was VBD O
the DT O
best JJS O
cutoff NN O
value NN O
for IN O
identifying VBG O
multivessel NN O
coronary JJ O
artery NN O
disease NN O
( ( O
relative JJ O
risk NN O
, , O
3 CD O
. . O
1 CD O
) ) O
. . O

A DT O
comparison NN O
of IN O
the DT O
duplicated JJ O
Vkappa NNP B-Gene
genes NNS I-Gene
suggests VBZ O
positive JJ O
selection NN O
on IN O
the DT O
complementarity NN O
- : O
determining VBG O
regions NNS O
of IN O
the DT O
duplicated VBN O
genes NNS O
by IN O
point NN O
mutations NNS O
. . O

These DT O
data NNS O
may MD O
also RB O
aid VB O
in IN O
the DT O
localization NN O
of IN O
other JJ O
disease NN O
loci NN O
mapped VBD O
to TO O
this DT O
region NN O
, , O
including VBG O
the DT O
gene NN O
for IN O
tricho JJ O
- : O
dento NN O
- : O
osseous JJ O
syndrome NN O
and CC O
a DT O
murine NN O
locus NN O
for IN O
susceptibility NN O
to TO O
ozone VB O
- : O
induced VBN O
acute JJ O
lung NN O
injury NN O
. . O

Mutations NNS O
in IN O
three CD O
loci NN O
( ( O
SIC1 NNP B-Gene
, , O
SWI5 NNP B-Gene
, , O
and CC O
RIC3 NNP B-Gene
) ) O
were VBD O
identified VBN O
. . O

The DT O
deduced JJ O
bovine NN O
EFIA NNP B-Gene
# # I-Gene
1 CD I-Gene
amino NN O
acid NN O
( ( O
aa NN O
) ) O
sequence NN O
is VBZ O
98 CD O
% NN O
identical JJ O
to TO O
rat VB O
EFIA NNP B-Gene
and CC O
100 CD O
% NN O
identical JJ O
to TO O
human JJ O
EFIA NNP B-Gene
/ NNP O
DbpB NNP B-Gene
/ NNP O
YB NNP B-Gene
- : I-Gene
1 CD I-Gene
family NN O
member NN O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
B NNP I-Gene
( ( O
DbpB NNP B-Gene
) ) O
. . O

PRH75 NNP B-Gene
, , O
a DT O
new JJ O
nucleus JJ O
- : O
localized JJ O
member NN O
of IN O
the DT O
DEAD NNP B-Gene
- : I-Gene
box NN I-Gene
protein VBP I-Gene
family NN I-Gene
from IN O
higher JJR O
plants NNS O
. . O

The DT O
imprinted JJ O
expression NN O
of IN O
the DT O
endogenous JJ O
gene NN O
can MD O
be VB O
recapitulated VBN O
in IN O
mice NN O
by IN O
using VBG O
a DT O
14 CD O
- : O
kb NN O
transgene NN O
encompassing VBG O
4 CD O
kb NN O
of IN O
5 CD O
' POS O
- : O
flanking NN O
sequence NN O
, , O
8 CD O
kb NN O
of IN O
3 CD O
' POS O
- : O
flanking NN O
sequence NN O
, , O
which WDT O
includes VBZ O
the DT O
two CD O
endoderm SYM O
- : O
specific JJ O
enhancers NNS O
, , O
and CC O
an DT O
internally RB O
deleted JJ O
structural JJ O
gene NN O
. . O

At IN O
this DT O
timepoint NN O
, , O
many JJ O
leucocytes NNS O
in IN O
the DT O
ME NNP O
and CC O
ET NNP O
mucosa NNP O
had VBD O
incorporated VBN O
BrdU NNP O
( ( O
between IN O
15 CD O
and CC O
25 CD O
% NN O
within IN O
the DT O
subsets NNS O
) ) O
. . O

When WRB O
expressed VBN O
in IN O
and CC O
purified VBD O
from IN O
Escherichia NNP O
coli NN O
, , O
both CC O
full JJ B-Gene
- : I-Gene
length NN I-Gene
Fpr3 NNP I-Gene
and CC O
its PRP$ O
isolated JJ O
COOH NNP O
- : O
terminal NN O
domain NN O
exhibit NN O
readily RB O
detectable JJ O
PPIase NNP B-Gene
activity NN O
. . O

Cluster NNP O
formation NN O
of IN O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
on IN O
the DT O
cell NN O
surface NN O
is VBZ O
believed VBN O
to TO O
be VB O
of IN O
major JJ O
importance NN O
for IN O
cell NN O
- : O
cell NN O
adhesion NN O
. . O

We PRP O
concluded VBD O
that IN O
Ga NNP O
- : O
fbg NN O
scintigraphy NN O
is VBZ O
a DT O
very RB O
simple JJ O
method NN O
and CC O
sufficiently RB O
useful JJ O
for IN O
detecting VBG O
active JJ O
left VBD O
ventricular JJ O
thrombi NN O
and CC O
for IN O
monitoring VBG O
the DT O
effect NN O
of IN O
anticoagulant JJ O
therapy NN O
. . O

Northern NNP O
blot NN O
analysis NN O
of IN O
RNAs NNP O
from IN O
a DT O
number NN O
of IN O
mouse NN O
tissues NNS O
reveals NNS O
that IN O
Atp6i NNP B-Gene
is VBZ O
expressed VBN O
predominantly RB O
in IN O
osteoclasts NNS O
, , O
and CC O
this DT O
predominant JJ O
expression NN O
was VBD O
confirmed VBN O
by IN O
reverse NN O
- : O
transcription NN O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
assay NN O
and CC O
immunohistochemical JJ O
analysis NN O
. . O

Evidence NN O
that IN O
opiate JJ O
addiction NN O
is VBZ O
in IN O
part NN O
an DT O
immune JJ O
response NN O
. . O

Changes NNS O
following VBG O
periodontal NN O
surgery NN O
. . O

The DT O
conserved JJ O
ninth JJ O
C NNP O
- : O
terminal JJ O
heptad NN O
in IN O
thyroid JJ O
hormone NN O
and CC O
retinoic NN B-Gene
acid NN I-Gene
receptors NNS I-Gene
mediates VBZ O
diverse JJ O
responses NNS O
by IN O
affecting VBG O
heterodimer NN O
but CC O
not RB O
homodimer JJ O
formation NN O
. . O

Lymphocytes NNS O
from IN O
all DT O
3 CD O
species NNS O
yielded VBN O
maximum JJ O
responses NNS O
with IN O
a DT O
48 CD O
- : O
hour NN O
prelabel NN O
and CC O
12 CD O
- : O
to TO O
- : O
16 CD O
hour NN O
postlabel NN O
incubation NN O
period NN O
at IN O
41 CD O
C NNP O
and CC O
1 CD O
: : O
20 CD O
blood NN O
dilution NN O
. . O

The DT O
improved JJ O
CSF NNP O
outflow IN O
conductance NN O
may MD O
increase VB O
the DT O
intracranial JJ O
compliance NN O
and CC O
thereby RB O
dampen VB O
a DT O
pathological JJ O
ICP NNP O
waveform NN O
. . O

This DT O
finding NN O
represents VBZ O
both CC O
a DT O
potentially RB O
important JJ O
mechanism NN O
by IN O
which WDT O
HPV NNP O
gene NN O
expression NN O
can MD O
be VB O
regulated VBN O
and CC O
an DT O
interesting JJ O
model NN O
for IN O
the DT O
study NN O
of IN O
transcriptional JJ O
cooperativity NN O
. . O

Analysis NN O
of IN O
1 CD O
Mb NNP O
of IN O
published VBN O
sequence NN O
from IN O
the DT O
region NN O
of IN O
conserved VBN O
synteny NN O
on IN O
human JJ O
chromosome NN O
5q31 CD O
- : O
q33 NN O
identified VBD O
45 CD O
gene NN O
candidates NNS O
, , O
including VBG O
35 CD O
expressed JJ O
genes NNS O
in IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
cytokine NN I-Gene
gene NN I-Gene
cluster NN I-Gene
. . O

However RB O
, , O
one CD O
CAK NNP B-Gene
- : O
phosphorylated VBD O
phosphopeptide JJ O
comigrates NNS O
with IN O
a DT O
Cdc2 NNP B-Gene
- : O
phosphorylated VBD O
phosphopeptide RB O
previously RB O
shown VBN O
to TO O
be VB O
mitosis VBN O
- : O
specific NN O
, , O
suggesting VBG O
that IN O
, , O
in IN O
vitro NN O
, , O
CAK NNP B-Gene
is VBZ O
able JJ O
to TO O
phosphorylate VB O
at IN O
least JJS O
one CD O
site NN O
that WDT O
is VBZ O
also RB O
phosphorylated VBN O
in IN O
vivo NN O
. . O

The DT O
topology NN O
and CC O
chain NN O
folding NN O
of IN O
the DT O
beta NN O
subunits NNS O
in IN O
the DT O
artifactual JJ O
beta NN O
60 CD O
capsid NN O
are VBP O
similar JJ O
to TO O
the DT O
native JJ B-Gene
alpha NN I-Gene
3 CD I-Gene
beta NN I-Gene
60 CD I-Gene
enzyme NN I-Gene
. . O

Among IN O
100 CD O
cases NNS O
of IN O
post NN O
- : O
transfusion NN O
hepatitis NN O
, , O
10 CD O
are VBP O
due JJ O
to TO O
the DT O
hepatitis NN O
B NNP O
virus NN O
( ( O
despite IN O
systematic JJ O
search NN O
for IN O
HBs NNP B-Gene
Ag NNP I-Gene
) ) O
, , O
89 CD O
are VBP O
due JJ O
to TO O
one CD O
of IN O
the DT O
non JJ O
- : O
A DT O
non JJ O
- : O
B NN O
viruses NNS O
( ( O
not RB O
detectable JJ O
by IN O
specific JJ O
serological JJ O
tests NNS O
) ) O
and CC O
1 CD O
to TO O
several JJ O
viruses NNS O
, , O
specially RB O
CMV NNP O
. . O

Electronic JJ O
structure NN O
of IN O
a DT O
buried JJ O
NiSi2 NNP O
or CC O
CoSi2 NNP O
layer NN O
in IN O
bulk NN O
Si NNP O
. . O

The DT O
retrovesical JJ O
hydatid NN O
cyst NN O
is VBZ O
a DT O
very RB O
rare JJ O
site NN O
. . O

Thin NNP O
melanomas NN O
can MD O
metastasize VB O
and CC O
be VB O
lethal VBN O
. . O

PULSE NN O
is VBZ O
used VBN O
to TO O
set VB O
such JJ O
NMR NNP O
spectroscopic NN O
parameters NNS O
as IN O
the DT O
delay NN O
and CC O
duration NN O
of IN O
rf JJ O
transmit NN O
and CC O
receive JJ O
gates NNS O
, , O
rf JJ O
phase NN O
, , O
sampling VBG O
times NNS O
, , O
and CC O
such JJ O
imaging VBG O
parameters NNS O
as IN O
rf NN O
pulse NN O
shape NN O
and CC O
gradient NN O
waveforms NNS O
. . O

Abstracts NNS O
. . O

The DT O
MCAD NNP B-Gene
nuclear JJ I-Gene
receptor NN I-Gene
response NN I-Gene
element NN I-Gene
1 CD I-Gene
( ( O
NRRE NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
interacts NNS O
in IN O
vitro NN O
with IN O
ERR NNP B-Gene
alpha NNS I-Gene
expressed VBD O
in IN O
COS NNP O
- : O
7 CD O
cells NNS O
. . O

Four CD O
forms NNS O
of IN O
salmonellosis NN O
were VBD O
recognised VBN O
in IN O
feedlots NNS O
and CC O
during IN O
transport NN O
by IN O
sea NN O
: : O
septicaemic JJ O
, , O
and CC O
acute NN O
, , O
subacute NN O
and CC O
chronic JJ O
enteric NN O
. . O

Single NNP O
- : O
photon NN O
emission NN O
computed VBN O
tomography NN O
( ( O
SPECT NNP O
) ) O
with IN O
99mTc CD O
- : O
hexamethylpropyleneamine NN O
oxime NN O
( ( O
HMPAO NNP O
) ) O
was VBD O
used VBN O
to TO O
investigate VB O
changes NNS O
in IN O
cerebral JJ O
blood NN O
flow NN O
in IN O
seven CD O
patients NNS O
with IN O
cortical JJ O
visual JJ O
impairment NN O
. . O

Trials NNS O
of IN O
sevine JJ O
activity NN O
against IN O
mosquito NN O
larvae NN O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
well NN O
established VBN O
polarity NN O
of IN O
RXR NNP B-Gene
heterodimer NN O
binding NN O
to TO O
bipartite VB O
hormone NN O
response NN O
elements NNS O
, , O
with IN O
the DT O
VDR NNP B-Gene
recognizing VBG O
the DT O
3 CD O
' POS O
- : O
half NN O
- : O
element NN O
. . O

The DT O
actuarial JJ O
local JJ O
control NN O
rates NNS O
at IN O
10 CD O
years NNS O
for IN O
the DT O
three CD O
treatment NN O
groups NNS O
were VBD O
as IN O
follows VBZ O
: : O
subtotal JJ O
excision NN O
alone RB O
, , O
18 CD O
% NN O
; : O
subtotal JJ O
excision NN O
plus CC O
postoperative JJ O
radiation NN O
therapy NN O
, , O
82 CD O
% NN O
; : O
and CC O
total JJ O
excision NN O
alone RB O
, , O
77 CD O
% NN O
. . O

Drug NN O
and CC O
nutrient JJ O
interactions NNS O
. . O

Similarly RB O
, , O
we PRP O
examined VBD O
whether IN O
the DT O
ELK1 NNP B-Gene
, , O
SAP1a NNP B-Gene
, , O
FLI1 NNP B-Gene
, , O
EWS NNP B-Gene
- : O
FLI1 NNP B-Gene
, , O
ETS1 NNP B-Gene
, , O
ETS2 NNP B-Gene
, , O
PEA3 NNP B-Gene
and CC O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
proteins NNS I-Gene
can MD O
form VB O
ternary JJ O
complexes NNS O
with IN O
SRF NNP B-Gene
on IN O
the DT O
Egr1 NNP B-Gene
SREI NNP B-Gene
and CC I-Gene
II NNP I-Gene
. . O

The DT O
Tullio NNP O
phenomenon NN O
, , O
fistula JJ O
test NN O
, , O
and CC O
Hennebert NNP O
' POS O
s JJ O
sign NN O
: : O
clinical JJ O
significance NN O
. . O

To TO O
study VB O
the DT O
regulation NN O
of IN O
mdr2 JJ B-Gene
expression NN O
, , O
the DT O
promoter NN O
of IN O
the DT O
mdr2 NN B-Gene
gene NN I-Gene
has VBZ O
been VBN O
isolated VBN O
from IN O
a DT O
murine NN O
vinblastine NN O
- : O
resistant NN O
cell NN O
line NN O
, , O
J7 NNP O
. . O
V2 NNP O
- : O
1 CD O
, , O
and CC O
characterized VBD O
. . O

Histopathologic NNP O
observations NNS O
showed VBD O
that IN O
both DT O
somatostatin NN B-Gene
and CC O
triamcinolone NN O
acetonide RB O
reduced VBD O
the DT O
inflammatory NN O
signs NNS O
in IN O
the DT O
joint JJ O
structures NNS O
, , O
although IN O
triamcinolone NN O
acetonide RB O
appeared VBD O
to TO O
be VB O
more RBR O
effective JJ O
. . O

Prenatal JJ O
exposure NN O
to TO O
the DT O
fungicide NN O
dinocap NN O
causes VBZ O
behavioral JJ O
torticollis NNS O
, , O
ballooning NN O
and CC O
cleft NN O
palate NN O
in IN O
mice NN O
, , O
but CC O
not RB O
rats NNS O
or CC O
hamsters NNS O
. . O

The DT O
cytogenetic JJ O
expression NN O
of IN O
the DT O
folate NN O
sensitive JJ O
fragile NN O
site NN O
, , O
FRAXE NNP B-Gene
, , O
is VBZ O
due JJ O
to TO O
the DT O
expansion NN O
of IN O
a DT O
GCC NNP O
repeat NN O
in IN O
proximal JJ O
Xq28 NN O
of IN O
the DT O
human JJ O
X NNP O
chromosome NN O
and CC O
is VBZ O
associated VBN O
with IN O
a DT O
mild JJ O
form NN O
of IN O
mental JJ O
handicap NN O
. . O

Laboratory JJ O
evaluation NN O
was VBD O
normal JJ O
, , O
and CC O
neuroimaging VBG O
failed VBD O
to TO O
confirm VB O
obstruction NN O
of IN O
venous JJ O
or CC O
lymphatic JJ O
drainage NN O
. . O

The DT O
spacing NN O
of IN O
the DT O
essential JJ O
N NNP O
- : O
terminal NN O
domain NN O
( ( O
END NNP O
) ) O
relative VBP O
to TO O
the DT O
HFD NNP B-Gene
can MD O
be VB O
changed VBN O
significantly RB O
without IN O
an DT O
apparent JJ O
effect NN O
on IN O
Cse4p NNP B-Gene
function NN O
. . O

They PRP O
were VBD O
called VBN O
PACE4 NNP B-Gene
and CC O
PC4 NNP B-Gene
. . O

Histopathological JJ O
examination NN O
revealed VBD O
dose JJ O
- : O
related JJ O
proliferation NN O
of IN O
type NN O
II NNP O
pneumocytes VBZ O
in IN O
dams NNS O
and CC O
proliferation NN O
of IN O
interstitial JJ O
cells NNS O
and CC O
delayed JJ O
septal NN O
/ NNP O
capillary NN O
development NN O
in IN O
neonates NNS O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Antibodies NNS O
directed VBN O
against IN O
the DT O
SNM1 NNP B-Gene
protein NN I-Gene
immunoprecipitated VBD O
RNase NNP B-Gene
MRP NNP I-Gene
RNA NNP I-Gene
from IN O
whole JJ O
- : O
cell NN O
extracts VBZ O
without IN O
precipitating VBG O
the DT O
structurally RB O
and CC O
functionally RB O
related JJ O
RNase NNP B-Gene
P NNP I-Gene
RNA NNP I-Gene
. . O

Calcium NN O
and CC O
phosphorus NN O
metabolism NN O
in IN O
chronic JJ O
uremia NN O
. . O

Since IN O
1990 CD O
the DT O
University NNP O
Hospital NNP O
of IN O
Tromso NNP O
has VBZ O
provided VBN O
local JJ O
hospitals NNS O
in IN O
northern JJ O
Norway NNP O
with IN O
a DT O
remote JJ O
frozen JJ O
section NN O
service NN O
and CC O
with IN O
access NN O
to TO O
video VB O
conferences NNS O
for IN O
the DT O
review NN O
of IN O
microscopic JJ O
findings NNS O
and CC O
for IN O
the DT O
discussion NN O
of IN O
major JJ O
diagnostic JJ O
issues NNS O
. . O

Two CD O
hundred VBD O
forty SYM O
- : O
three CD O
patients NNS O
have VBP O
received VBN O
WR NNP O
- : O
2721 CD O
in IN O
Phase NNP O
I PRP O
- : O
II NN O
studies NNS O
. . O

Catha NNP O
edulis NN O
, , O
a DT O
plant NN O
that WDT O
has VBZ O
amphetamine JJ O
effects NNS O
. . O

Tumor NNP O
- : O
like IN O
accumulation NN O
on IN O
Tl NNP O
- : O
201 CD O
SPECT NNP O
in IN O
subacute JJ O
hemorrhagic JJ O
cerebral JJ O
infarction NN O
. . O

The DT O
effects NNS O
of IN O
two CD O
levels NNS O
of IN O
caffeine NN O
ingestion NN O
on IN O
excess JJ O
postexercise NN O
oxygen NN O
consumption NN O
in IN O
untrained JJ O
women NNS O
. . O

Collectively RB O
, , O
these DT O
and CC O
previously RB O
published VBN O
data NN O
suggest NN O
a DT O
model NN O
where WRB O
NS1 NNP B-Gene
recruits VBZ O
eIF4GI RB B-Gene
specifically RB O
to TO O
the DT O
5 CD O
' POS O
untranslated JJ O
region NN O
( ( O
5 CD O
' '' O
UTR NNP O
) ) O
of IN O
the DT O
viral JJ O
mRNA NN O
, , O
allowing VBG O
for IN O
the DT O
preferential JJ O
translation NN O
of IN O
the DT O
influenza NN O
virus NN O
messengers NNS O
. . O

Abnormalities NNS O
of IN O
plasma NN B-Gene
cholecystokinin NN I-Gene
were VBD O
observed VBN O
only RB O
in IN O
patients NNS O
with IN O
delayed JJ O
gastric NN O
emptying NN O
. . O

The DT O
pilE JJ B-Gene
gene NN I-Gene
product NN I-Gene
of IN I-Gene
Pseudomonas NNP I-Gene
aeruginosa NN I-Gene
, , O
required VBN O
for IN O
pilus JJ O
biogenesis NN O
, , O
shares NNS O
amino VBP O
acid JJ O
sequence NN O
identity NN O
with IN O
the DT O
N NNP O
- : O
termini NN O
of IN O
type NN B-Gene
4 CD I-Gene
prepilin NN I-Gene
proteins NNS I-Gene
. . O

RESULTS NN O
: : O
During IN O
the DT O
7 CD O
- : O
year NN O
period NN O
, , O
10 CD O
, , O
331 CD O
symptomatic JJ O
duodenal JJ O
ulcer NN O
diseases NNS O
were VBD O
diagnosed VBN O
. . O

The DT O
sacT JJ B-Gene
gene NN I-Gene
regulating VBG O
the DT O
sacPA NN B-Gene
operon NN I-Gene
in IN I-Gene
Bacillus NNP I-Gene
subtilis NNS I-Gene
shares NNS O
strong JJ O
homology NN O
with IN O
transcriptional JJ O
antiterminators NNS O
. . O

Bisoprolol NNP O
was VBD O
found VBN O
to TO O
be VB O
an DT O
effective JJ O
beta NN B-Gene
- : I-Gene
adrenoceptor NN I-Gene
antagonist NN O
, , O
the DT O
pA2 NN O
values NNS O
determined VBN O
against IN O
isoprenaline NN O
in IN O
guinea NN O
pig NN O
atria NN O
and CC O
tracheal JJ O
muscle NN O
being VBG O
7 CD O
. . O
45 CD O
and CC O
6 CD O
. . O
41 CD O
, , O
respectively RB O
. . O

The DT O
partial JJ O
farm NN O
budget NN O
highlighted VBD O
the DT O
importance NN O
of IN O
reducing VBG O
sub JJ O
- : O
clinical JJ O
lesions NNS O
in IN O
a DT O
feedlot NN O
. . O

Furthermore RB O
, , O
co SYM O
- : O
expression NN O
of IN O
both DT O
p46 NNS B-Gene
and CC O
p54 VB B-Gene
subunits NNS I-Gene
markedly RB O
altered VBD O
the DT O
subcellular JJ O
distribution NN O
of IN O
p46 NN B-Gene
; : O
co SYM O
- : O
expressed VBN O
p46 NN B-Gene
was VBD O
transported VBN O
into IN O
the DT O
nucleus NN O
as RB O
efficiently RB O
as IN O
p54 NN B-Gene
. . O

Timing NN O
of IN O
symptoms NNS O
and CC O
oocyst JJ O
excretion NN O
in IN O
human JJ O
cryptosporidiosis NN O
. . O

The DT O
data NN O
suggest NN O
that IN O
plasminogen NN B-Gene
, , O
alpha RB B-Gene
2AP CD I-Gene
, , O
and CC O
C1 NNP B-Gene
- : I-Gene
INH NNP I-Gene
, , O
should MD O
be VB O
considered VBN O
equine JJ O
acute JJ O
- : O
phase NN O
proteins NNS O
. . O

65 CD O
, , O
3829 CD O
- : O
3838 CD O
, , O
1991 CD O
) ) O
, , O
a DT O
truncated JJ O
form NN O
of IN O
the DT O
IE NNP B-Gene
polypeptide NN I-Gene
lacking VBG O
IE NNP B-Gene
amino NN I-Gene
acid NN I-Gene
residues VBZ I-Gene
1 CD I-Gene
- : I-Gene
322 CD I-Gene
( ( O
and CC O
, , O
therefore RB O
lacks VBZ O
the DT O
deduced JJ O
transcriptional JJ O
activation NN O
domain NN O
) ) O
, , O
fails VBZ O
to TO O
transactivate VB O
the DT O
EHV NNP B-Gene
- : I-Gene
1 CD I-Gene
tk NN I-Gene
promoter NN I-Gene
, , O
but CC O
retains VBZ O
the DT O
ability NN O
to TO O
down VB O
- : O
regulate VB O
the DT O
EHV NNP B-Gene
- : I-Gene
1 CD I-Gene
IE NNP I-Gene
promoter NN I-Gene
. . O

The DT O
elevated JJ O
Viso NNP O
V NNP O
in IN O
the DT O
RDS NNP O
group NN O
suggests VBZ O
an DT O
increase NN O
in IN O
small JJ O
airway NN O
resistance NN O
secondary JJ O
to TO O
the DT O
disease NN O
or CC O
to TO O
its PRP$ O
therapy NN O
. . O

Percentages NNS O
of IN O
recovery NN O
for IN O
overload NN O
and CC O
dilution NN O
tests NNS O
were VBD O
between IN O
87 CD O
and CC O
120 CD O
% NN O
. . O

Commonly RB O
observed JJ O
systemic JJ O
toxic NN O
effects NNS O
( ( O
bone NN O
marrow NN O
, , O
gastrointestinal JJ O
tract NN O
, , O
and CC O
heart NN O
) ) O
were VBD O
not RB O
seen VBN O
in IN O
this DT O
study NN O
. . O

Finally RB O
, , O
the DT O
pathophysiological JJ O
aspects NNS O
of IN O
urinary JJ O
acidification NN O
are VBP O
discussed VBN O
, , O
focusing VBG O
on IN O
renal JJ O
tubular JJ O
acidosis NN O
models NNS O
( ( O
induced VBN O
by IN O
maleate NN O
and CC O
amphotericin NN O
B NNP O
treatment NN O
) ) O
and CC O
their PRP$ O
cellular JJ O
mechanisms NNS O
, , O
as RB O
well RB O
as IN O
the DT O
role NN O
of IN O
adrenal JJ O
steroids NNS O
in IN O
urinary JJ O
acidification NN O
. . O

Based VBN O
on IN O
these DT O
results NNS O
, , O
a DT O
new JJ O
model NN O
for IN O
the DT O
regulation NN O
of IN O
nif JJ B-Gene
/ NNP O
fix NN B-Gene
gene NN O
expression NN O
in IN O
A NNP O
. . O
caulinodans NNS O
is VBZ O
proposed VBN O
. . O

Plasma NNP O
concentrations NNS O
of IN O
ANF NNP B-Gene
( ( O
pANF NN B-Gene
) ) O
, , O
aldosterone NN O
( ( O
PAC NNP O
) ) O
and CC O
renin NN B-Gene
( ( O
PRC NNP B-Gene
) ) O
were VBD O
measured VBN O
daily RB O
, , O
as IN O
were VBD O
hemodynamic JJ O
parameters NNS O
. . O

We PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
the DT O
GCD6 NNP B-Gene
and CC O
GCD7 NNP B-Gene
genes NNS I-Gene
and CC O
shown VBN O
that IN O
their PRP$ O
products NNS O
are VBP O
required VBN O
to TO O
repress VB O
GCN4 NNP B-Gene
translation NN O
under IN O
nonstarvation NN O
conditions NNS O
. . O

Four CD O
out IN O
of IN O
10 CD O
patients NNS O
showed VBD O
clinical JJ O
improvement NN O
according VBG O
to TO O
Ritchie NNP O
- : O
Index NN O
, , O
pain NN O
score NN O
, , O
ESR NNP O
and CC O
CRP NNP B-Gene
. . O

Using VBG O
these DT O
antibodies NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
define VB O
the DT O
conditions NNS O
to TO O
completely RB O
solubilize VB O
the DT O
Cdc25 NNP B-Gene
protein NN I-Gene
. . O

The DT O
Escherichia NNP B-Gene
coli NN I-Gene
tet NN I-Gene
- : I-Gene
repressor NN I-Gene
( ( O
TetR NNP B-Gene
) ) O
operator NN O
system NN O
was VBD O
used VBN O
to TO O
develop VB O
a DT O
variation NN O
of IN O
the DT O
yeast NN O
two CD O
- : O
hybrid JJ O
assay NN O
in IN O
which WDT O
disruptions NNS O
of IN O
protein NN O
- : O
protein NN O
interactions NNS O
can MD O
be VB O
identified VBN O
by IN O
a DT O
positive JJ O
selection NN O
. . O

Role NNP O
of IN O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
of IN O
baculovirus NN B-Gene
p10 NN I-Gene
mRNA NN I-Gene
in IN O
high JJ O
- : O
level NN O
expression NN O
of IN O
foreign JJ O
genes NNS O
. . O

Pyrethroid NNP O
insecticides NNS O
are VBP O
widely RB O
used VBN O
in IN O
agriculture NN O
and CC O
private JJ O
households NNS O
. . O

CXCR4 NNP B-Gene
is VBZ O
a DT O
chemokine JJ O
receptor NN O
and CC O
a DT O
coreceptor NN O
for IN O
T NNP O
- : O
cell NN O
- : O
line NN O
- : O
tropic NN O
( ( O
X4 NNP O
) ) O
and CC O
dual JJ O
- : O
tropic NN O
( ( O
R5X4 NNP O
) ) O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
isolates NNS O
. . O

Activation NN O
of IN O
T NNP O
cells NNS O
via IN O
the DT O
TCR NNP B-Gene
and CC O
other JJ O
costimulatory NN O
receptors NNS O
triggers VBZ O
a DT O
number NN O
of IN O
signaling VBG O
cascades NNS O
. . O

Isomers NNS O
were VBD O
differentiated VBN O
based VBN O
on IN O
the DT O
MS NNP O
- : O
MS NNP O
data NNS O
of IN O
the DT O
trofluoroacetyl NN O
- : O
biphenylol NN O
derivatives NNS O
. . O

Doxorubicin NNP O
( ( O
DOX NNP O
) ) O
is VBZ O
commonly RB O
used VBN O
for IN O
the DT O
treatment NN O
of IN O
hematological JJ O
and CC O
solid JJ O
tumors NNS O
. . O

Net JJ O
lift NN O
and CC O
combined VBN O
drag NN O
from IN O
all DT O
8 CD O
bearings NNS O
of IN O
the DT O
4 CD O
- : O
bladed VBN O
impeller NN O
are VBP O
compared VBN O
with IN O
predictions NNS O
based VBN O
on IN O
2 CD O
- : O
D NNP O
theory NN O
. . O

The DT O
proofreading VBG O
domain NN O
of IN O
Escherichia NNP B-Gene
coli NNS I-Gene
DNA NNP I-Gene
polymerase NN I-Gene
I PRP I-Gene
and CC O
other JJ O
DNA NNP B-Gene
and CC I-Gene
/ NNP I-Gene
or CC I-Gene
RNA NNP I-Gene
exonuclease NN I-Gene
domains NNS I-Gene
. . O

In IN O
the DT O
second JJ O
experiment NN O
, , O
a DT O
stable JJ O
nickel NN O
isotope NN O
, , O
61Ni CD O
, , O
was VBD O
given VBN O
in IN O
drinking NN O
water NN O
to TO O
20 CD O
nickel NNS O
- : O
sensitized VBN O
women NNS O
and CC O
20 CD O
age NN O
- : O
matched NN O
controls NNS O
, , O
both DT O
groups NNS O
having VBG O
vesicular JJ O
hand NN O
eczema NN O
of IN O
the DT O
pompholyx NN O
type NN O
. . O

When WRB O
cotransfected VBN O
in IN O
fibroblasts NNS O
with IN O
a DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha POS I-Gene
expression NN O
vector NN O
, , O
reporter NN O
gene NN O
expression NN O
increased VBD O
3 CD O
- : O
fold NN O
only RB O
in IN O
the DT O
wild JJ O
- : O
type NN O
constructs NNS O
. . O

Three CD O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
- : I-Gene
like IN I-Gene
sequences NNS I-Gene
within IN O
a DT O
48 CD O
- : O
base NN O
pair NN O
enhancer NN O
of IN O
the DT O
Col2a1 NNP B-Gene
gene NN I-Gene
are VBP O
required VBN O
for IN O
cartilage NN O
- : O
specific JJ O
expression NN O
in IN O
vivo NN O
. . O

The DT O
loop NN O
domain NN O
of IN O
heat NN B-Gene
shock NN I-Gene
transcription NN I-Gene
factor NN I-Gene
1 CD I-Gene
dictates NNS O
DNA NNP O
- : O
binding NN O
specificity NN O
and CC O
responses NNS O
to TO O
heat VB O
stress NN O
. . O

A DT O
simple JJ O
method NN O
for IN O
measuring VBG O
urinary JJ O
iron NN O
following VBG O
the DT O
administration NN O
of IN O
desferrioxamine NN O
( ( O
DF NNP O
) ) O
is VBZ O
described VBN O
. . O

Since IN O
each DT O
transcript NN O
appears VBZ O
to TO O
encode VB O
the DT O
same JJ O
protein NN O
, , O
this DT O
complexity NN O
may MD O
reflect VB O
the DT O
need NN O
for IN O
lineage NN O
- : O
specific NN O
or CC O
differentiation NN O
- : O
dependent JJ O
control NN O
of IN O
expression NN O
. . O

However RB O
, , O
with IN O
the DT O
alpha1 JJ O
antagonist NN O
prazosin NN O
( ( O
5 CD O
x RB O
10 CD O
( ( O
- : O
8 CD O
) ) O
- : O
5 CD O
x JJ O
10 CD O
( ( O
- : O
7 CD O
) ) O
M NNP O
) ) O
, , O
no DT O
relaxation NN O
occurred VBD O
. . O

Regarding VBG O
gestational JJ O
risk NN O
, , O
3 CD O
, , O
243 CD O
drugs NNS O
used VBN O
( ( O
34 CD O
% NN O
) ) O
belonged VBD O
to TO O
category VB O
A NNP O
risk NN O
, , O
1 CD O
, , O
923 CD O
( ( O
22 CD O
. . O
6 CD O
% NN O
) ) O
to TO O
category NN O
B NNP O
, , O
3 CD O
, , O
798 CD O
( ( O
39 CD O
. . O
7 CD O
% NN O
) ) O
to TO O
category JJ O
C NNP O
, , O
289 CD O
( ( O
3 CD O
. . O
0 CD O
% NN O
) ) O
to TO O
category NN O
D NNP O
, , O
and CC O
55 CD O
( ( O
0 CD O
. . O
6 CD O
% NN O
) ) O
to TO O
category JJ O
X NNP O
. . O

In IN O
a DT O
highly RB O
select JJ O
group NN O
of IN O
stable JJ O
hypertensive JJ O
patients NNS O
, , O
we PRP O
have VBP O
assessed VBN O
the DT O
strength NN O
of IN O
association NN O
between IN O
various JJ O
blood NN O
pressure NN O
measurements NNS O
( ( O
24 CD O
h NN O
average NN O
automated VBD O
ambulatory JJ O
blood NN O
pressure NN O
, , O
4 CD O
h NN O
automated JJ O
ambulatory NN O
morning NN O
average JJ O
blood NN O
pressure NN O
, , O
multiple JJ O
office NN O
visit NN O
average NN O
blood NN O
pressure NN O
, , O
and CC O
a DT O
single JJ O
office NN O
visit NN O
average NN O
blood NN O
pressure NN O
) ) O
and CC O
various JJ O
echocardiographic JJ O
indices NNS O
of IN O
hypertensive JJ O
cardiac JJ O
target NN O
organ JJ O
damage NN O
( ( O
left JJ O
atrial JJ O
diameter NN O
, , O
left VBD O
ventricular JJ O
end NN O
diastolic NN O
diameter NN O
, , O
posterior JJ O
wall NN O
thickness NN O
, , O
combined VBN O
wall NN O
thickness NN O
, , O
relative JJ O
wall NN O
thickness NN O
, , O
left VBD O
ventricular JJ O
mass NN O
and CC O
mass NN O
index NN O
, , O
and CC O
combined VBD O
wall NN O
thickness NN O
/ NN O
left VBD O
ventricular JJ O
diastolic JJ O
diameter NN O
ratio NN O
) ) O
. . O

The DT O
other JJ O
is VBZ O
located VBN O
at IN O
- : O
1335 CD O
, , O
outside IN O
this DT O
highly RB O
conserved JJ O
region NN O
. . O

Optimal JJ O
monitoring NN O
of IN O
ODA NNP O
remains NNS O
undefined JJ O
. . O

An DT O
element NN O
within IN O
the DT O
5 CD O
' POS O
untranslated JJ O
region NN O
of IN O
human JJ B-Gene
Hsp70 NNP I-Gene
mRNA NN I-Gene
which WDT O
acts VBZ O
as IN O
a DT O
general JJ O
enhancer NN O
of IN O
mRNA JJ O
translation NN O
. . O

Microcomputer NNP O
management NN O
of IN O
chronic JJ O
hepatitis NN O
B NNP O
virus NN O
asymptomatic JJ O
patients NNS O

Fourteen NNP O
different JJ O
species NNS O
( ( O
eight CD O
Platyhelmintha NNP O
, , O
one CD O
Nematoda NNP O
and CC O
five CD O
Crustacea NNP O
) ) O
have VBP O
been VBN O
inventorized VBN O
. . O

The DT O
therapeutic JJ O
protocole NN O
used VBN O
at IN O
the DT O
Gustave NNP O
Roussy NNP O
Institute NNP O
for IN O
invasive JJ O
epithelioma NN O
of IN O
the DT O
uterine JJ O
cervix NN O
rests NNS O
, , O
for IN O
limited JJ O
forms NNS O
( ( O
T1B NNP O
- : O
T2 NNP O
proximal NN O
) ) O
, , O
on IN O
combined JJ O
radiology NN O
and CC O
surgery NN O
. . O

Similarity NN O
of IN O
DNA NNP O
binding NN O
and CC O
transcriptional JJ O
regulation NN O
by IN O
Caenorhabditis NNP B-Gene
elegans NNS I-Gene
MAB NNP I-Gene
- : I-Gene
3 CD I-Gene
and CC O
Drosophila NNP B-Gene
melanogaster NN I-Gene
DSX NNP I-Gene
suggests VBZ O
conservation NN O
of IN O
sex NN O
determining VBG O
mechanisms NNS O
. . O

NGF NNP B-Gene
elicits VBZ O
a DT O
more RBR O
delayed JJ O
and CC O
sustained JJ O
ERK NNP B-Gene
phosphorylation NN O
than IN O
EGF NNP B-Gene
, , O
consistent NN O
with IN O
previous JJ O
reports NNS O
. . O

GRP78 NNP B-Gene
, , O
a DT O
molecular JJ O
chaperone NN O
expressed VBN O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
, , O
is VBZ O
a DT O
"""" NN O
glucose SYM O
- : O
regulated VBN O
protein NN O
"""" NN O
induced VBN O
by IN O
stress NN O
responses NNS O
that WDT O
deplete VBP O
glucose VB O
or CC O
intracisternal JJ O
calcium NN O
or CC O
otherwise RB O
disrupt JJ O
glycoprotein NN O
trafficking NN O
. . O

Electrocardiographic JJ O
right RB O
ventricular JJ O
hypertrophy NN O
was VBD O
seen VBN O
in IN O
4 CD O
, , O
and CC O
biventricular JJ O
hypertrophy NN O
in IN O
5 CD O
patients NNS O
. . O

Evidence NN O
from IN O
a DT O
Northern NNP O
hybridization NN O
indicated VBD O
that IN O
jadM NN B-Gene
expression NN O
is VBZ O
correlated VBN O
with IN O
jadomycin NN B-Gene
B NNP I-Gene
synthesis NN O
. . O

We PRP O
report VBP O
here RB O
on IN O
the DT O
molecular JJ O
nature NN O
of IN O
an DT O
EMS NNP O
- : O
induced VBD O
mutant JJ O
, , O
mn1 JJ B-Gene
- : I-Gene
89 CD I-Gene
, , O
a DT O
leaky JJ O
semidominant JJ O
allele NN O
of IN O
the DT O
Miniature1 NNP B-Gene
( ( O
Mn1 NNP B-Gene
) ) O
seed NN O
locus VBZ O
that IN O
encodes VBZ O
a DT O
seed NN B-Gene
- : I-Gene
specific NN I-Gene
cell NN I-Gene
wall NN I-Gene
invertase NN I-Gene
, , O
INCW2 NNP B-Gene
. . O

Practical JJ O
interest NN O
of IN O
such JJ O
studies NNS O
is VBZ O
limited JJ O
since IN O
the DT O
pharmacokinetic JJ O
parameters NNS O
are VBP O
systematically RB O
evaluated VBN O
in IN O
man NN O
during IN O
phase NN O
I PRP O
trials NNS O
. . O

In IN O
vitro JJ O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
showed VBD O
that IN O
OxyR NNP B-Gene
- : I-Gene
C199S NNP I-Gene
protected VBD O
Pmom NNP B-Gene
from IN O
- : O
104 CD O
to TO O
- : O
46 CD O
on IN O
the DT O
top JJ O
strand NN O
and CC O
produced VBD O
a DT O
protection NN O
pattern JJ O
characteristic NN O
of IN O
reduced JJ B-Gene
wild JJ I-Gene
- : I-Gene
type NN I-Gene
OxyR NNP I-Gene
. . O

The DT O
function NN O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
tail NN O
in IN O
telomere JJ O
maintenance NN O
is VBZ O
not RB O
mediated VBN O
through IN O
the DT O
RAP1 NNP B-Gene
interacting NN I-Gene
factor NN I-Gene
RIF1 NNP B-Gene
: : O
rap1 NN B-Gene
alleles NNS I-Gene
defective VBP O
in IN O
both CC O
the DT O
C NNP O
- : O
terminal JJ O
tail NN O
and CC O
RIF1 NNP B-Gene
interaction NN I-Gene
domains NNS I-Gene
have VBP O
additive JJ O
effects NNS O
on IN O
telomere JJ O
length NN O
. . O

A DT O
reduction NN O
in IN O
blood NN O
pressure NN O
was VBD O
only RB O
observed VBN O
at IN O
the DT O
end NN O
of IN O
the DT O
study NN O
, , O
from IN O
142 CD O
+ NNS O
/ SYM O
- : O
17 CD O
/ JJ O
86 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
9 CD O
. . O
1 CD O
to TO O
139 CD O
+ NNS O
/ SYM O
- : O
13 CD O
/ JJ O
82 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
8 CD O
. . O
9 CD O
mmHg NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
for IN O
DBP NNP O
) ) O
. . O

No DT O
UOxase NNP B-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
in IN O
11 CD O
nonhepatic JJ O
tissues NNS O
of IN O
rat NN O
, , O
suggesting VBG O
tissue NN O
specificity NN O
of IN O
expression NN O
of IN O
this DT O
UOxase NNP B-Gene
gene NN I-Gene
. . O

The DT O
subepicardial JJ O
lymphatic JJ O
capillaries NNS O
were VBD O
ramified VBN O
and CC O
anastomosed VBN O
with IN O
each DT O
other JJ O
to TO O
form VB O
a DT O
relatively RB O
dense NN O
network NN O
which WDT O
extended VBD O
over IN O
the DT O
entire JJ O
surface NN O
of IN O
both DT O
ventricles NNS O
. . O

This DT O
could MD O
lead VB O
to TO O
subsequent JJ O
outbreaks NNS O
if IN O
Babesia NNP O
carrier NN O
animals NNS O
were VBD O
to TO O
be VB O
introduced VBN O
into IN O
the DT O
herd NN O
. . O

The DT O
plasmatic JJ B-Gene
albumin NN I-Gene
concentration NN O
( ( O
3 CD O
. . O
5 CD O
- : O
4 CD O
. . O
5 CD O
g JJ O
/ NNP O
dl NN O
) ) O
represents VBZ O
about IN O
60 CD O
% NN O
of IN O
the DT O
total JJ O
plasma NN O
protein NN O
. . O

It PRP O
may MD O
be VB O
dependent JJ O
on IN O
location NN O
of IN O
a DT O
focus NN O
( ( O
according VBG O
to TO O
EEG NNP O
) ) O
as RB O
well RB O
as IN O
on IN O
the DT O
character NN O
and CC O
manifestation NN O
of IN O
the DT O
accompanying VBG O
neuropsychologic JJ O
symptomatology NN O
. . O

Other JJ O
assays NNS O
also RB O
distinguished VBD O
the DT O
processive JJ O
replication NN O
of IN O
pNeo NN O
. . O
Myc NNP O
- : O
2 CD O
. . O
4 CD O
from IN O
the DT O
dispersive JJ O
labeling NN O
of IN O
control NN O
plasmids NNS O
. . O

In IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
( ( O
EMSA NNP O
) ) O
, , O
this DT O
GLUT4 NNP B-Gene
repressor NN I-Gene
element NN I-Gene
( ( O
G4RE NNP B-Gene
) ) O
generated VBD O
specific JJ O
bands NNS O
with IN O
nuclear JJ O
extracts NNS O
from IN O
preadipocytes NNS O
, , O
but CC O
not RB O
from IN O
adipocytes NNS O
. . O

Saccharomyces NNS O
cerevisiae VBP O
contains VBZ O
a DT O
genetically RB O
and CC O
biochemically RB O
proven JJ O
CAK NNP B-Gene
gene NN I-Gene
, , O
CAK1 NNP B-Gene
, , O
that WDT O
encodes VBZ O
a DT O
monomeric JJ O
44 CD B-Gene
- : I-Gene
kDa NN I-Gene
Cak1p NNP I-Gene
protein RB I-Gene
unrelated VBD O
to TO O
Cdk7 NNP B-Gene
. . O

In IN O
contrast NN O
, , O
in IN O
LL NNP O
patients NNS O
during IN O
ENL NNP O
the DT O
ConA NNP B-Gene
- : O
induced VBD O
suppressor JJ O
response NN O
was VBD O
markedly RB O
reduced VBN O
. . O

In IN O
the DT O
presence NN O
of IN O
the DT O
in IN O
vivo NN O
reducing VBG O
system NN O
( ( O
thioredoxin NN B-Gene
, , O
thioredoxin NN B-Gene
reductase NN I-Gene
, , O
and CC O
NADPH NNP O
) ) O
, , O
however RB O
, , O
each DT O
of IN O
these DT O
mutants NNS O
catalyzed VBD O
the DT O
formation NN O
of IN O
only RB O
0 CD O
. . O
6 CD O
- : O
0 CD O
. . O
8 CD O
dCTPs JJ O
per IN O
mole NN O
of IN O
enzyme NN O
. . O

The DT O
SH3 NNP B-Gene
domains NNS I-Gene
of IN O
Grb2 NNP B-Gene
bound NN O
in IN O
vitro NN O
to TO O
specific JJ O
proline NN O
- : O
rich JJ O
motifs NNS O
in IN O
the DT O
HPK1 NNP B-Gene
tail NN O
and CC O
functioned VBD O
synergistically RB O
to TO O
direct VB O
the DT O
stable JJ O
binding NN O
of IN O
Grb2 NNP B-Gene
to TO O
HPK1 NNP B-Gene
in IN O
transfected JJ O
Cos1 NNP O
cells NNS O
. . O

The DT O
recombinant NN O
purified VBD O
protein NN O
expressed VBN O
in IN O
the DT O
baculovirus NN O
system NN O
had VBD O
an DT O
approximate JJ O
molecular JJ O
size NN O
20 CD O
kDa NN O
with IN O
amino JJ O
- : O
terminal JJ O
sequence NN O
of IN O
AVQGP NNP O
. . O

Cholesterol NNP B-Gene
side NN I-Gene
- : I-Gene
chain NN I-Gene
cleavage NN I-Gene
cytochrome NN I-Gene
P450 NNP I-Gene
( ( O
CYP11A NNP B-Gene
; : O
P450scc NNP B-Gene
) ) O
gene NN O
expression NN O
is VBZ O
regulated VBN O
by IN O
gonadotropins NNS B-Gene
via IN O
cAMP NN O
in IN O
the DT O
ovary JJ O
and CC O
by IN O
ACTH NNP B-Gene
via IN O
cAMP NN O
in IN O
adrenal JJ O
cortical JJ O
cells NNS O
. . O

Efficacy NN O
was VBD O
determined VBN O
by IN O
responses NNS O
to TO O
question VB O
3 CD O
( ( O
ability NN O
to TO O
achieve VB O
an DT O
erection NN O
) ) O
and CC O
question $ O
4 CD O
( ( O
ability NN O
to TO O
maintain VB O
an DT O
erection NN O
) ) O
of IN O
the DT O
15 CD O
- : O
item NN O
International NNP O
Index NNP O
of IN O
Erectile NNP O
Function NNP O
( ( O
IIEF NNP O
) ) O
. . O

Immunodepression NN O
was VBD O
combined VBN O
with IN O
the DT O
increase NN O
of IN O
glucocorticoid JJ O
activity NN O
of IN O
adrenal JJ O
cortex NN O
, , O
while IN O
no DT O
significant JJ O
changes NNS O
in IN O
thyroid JJ O
hormones NNS O
were VBD O
registered VBN O
. . O

The DT O
basal NN O
promoter NN O
elements NNS O
of IN O
murine NN B-Gene
cytochrome NN I-Gene
c NN I-Gene
oxidase NN I-Gene
subunit NN I-Gene
IV NNP I-Gene
gene NN I-Gene
consist NN O
of IN O
tandemly RB O
duplicated VBN O
ets NNS B-Gene
motifs VBP O
that IN O
bind NN O
to TO O
GABP NNP B-Gene
- : I-Gene
related JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

The DT O
trk NN B-Gene
- : I-Gene
2h CD I-Gene
oncogene NN I-Gene
, , O
isolated VBN O
from IN O
the DT O
human JJ O
breast NN O
carcinoma NN O
cell NN O
line NN O
MDA NNP O
- : O
MB NN O
231 CD O
by IN O
genomic JJ O
DNA NNP O
- : O
transfection NN O
into IN O
NIH3T3 NNP O
cells NNS O
, , O
consists NNS O
of IN O
the DT O
trk NN B-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
receptor NN I-Gene
kinase NN I-Gene
domain NN I-Gene
fused VBD O
to TO O
a DT O
N NNP O
- : O
terminal JJ O
41 CD O
amino NN O
acid NN O
activating VBG O
sequence NN O
( ( O
Kozma NNP O
, , O
S NNP O
. . O
C NNP O
. . O
, , O
Redmond NNP O
, , O
S NNP O
. . O
M NNP O
. . O
S NNP O
. . O
, , O
Xiao NNP O
- : O
Chang NNP O
, , O
F NNP O
. . O
, , O
Saurer NNP O
, , O
S NNP O
. . O
M NNP O
. . O
, , O
Groner NNP O
, , O
B NNP O
. . O
and CC O
Hynes NNP O
, , O
N NNP O
. . O
E NN O
. . O

Repeated VBN O
efforts NNS O
to TO O
isolate VB O
recombinant JJ O
baculoviruses NNS O
containing VBG O
a DT O
wild JJ O
- : O
type NN O
kinase NN O
failed VBD O
, , O
whereas JJ O
recombinants NNS O
expressing VBG O
a DT O
nonfunctional JJ O
kinase NN O
with IN O
a DT O
catalytic JJ O
domain NN O
II NNP O
mutation NN O
were VBD O
readily RB O
isolated VBN O
. . O

Serum NNP O
concentrations NNS O
of IN O
E2 NNP O
and CC O
TBOH NNP O
were VBD O
measured VBN O
on IN O
d NN O
0 CD O
, , O
1 CD O
, , O
3 CD O
, , O
5 CD O
, , O
7 CD O
, , O
13 CD O
, , O
21 CD O
, , O
28 CD O
, , O
42 CD O
, , O
56 CD O
, , O
84 CD O
, , O
112 CD O
, , O
and CC O
140 CD O
in IN O
finishing VBG O
heifers NNS O
administered VBD O
the DT O
following JJ O
treatments NNS O
: : O
1 CD O
) ) O
control NN O
; : O
2 CD O
) ) O
MGA NNP O
, , O
. . O
5 CD O
mg NN O
per IN O
heifer NN O
daily RB O
; : O
3 CD O
) ) O
Revalor NNP O
- : O
H NNP O
( ( O
140 CD O
mg NN O
TBA NNP O
+ VBZ O
14 CD O
mg NN O
E2 NNP O
) ) O
; : O
4 CD O
) ) O
Revalor NNP O
- : O
H NNP O
+ NNP O
MGA NNP O
; : O
5 CD O
) ) O
Finaplix NNP O
- : O
H NNP O
( ( O
200 CD O
mg RB O
TBA NNP O
) ) O
; : O
and CC O
6 CD O
) ) O
Finaplix NNP O
- : O
H NNP O
+ NNP O
MGA NNP O
. . O

Recombinant JJ B-Gene
human JJ I-Gene
TFIID NNP I-Gene
supported VBD O
weak JJ O
basal NN O
transcription NN O
in IN O
heat NN O
- : O
treated JJ O
nuclear JJ O
extracts NNS O
whereas VBP O
a DT O
partially RB O
purified VBN O
TFIID NNP B-Gene
fraction NN O
from IN O
HeLa NNP O
cells NNS O
reconstituted VBD O
a DT O
maximal JJ O
level NN O
of IN O
transcription NN O
. . O

Variable JJ O
FHR NNP O
decelerations NNS O
or CC O
bradycardias NNS O
were VBD O
encountered VBN O
on IN O
95 CD O
nonstress JJ O
tests NNS O
( ( O
18 CD O
. . O
8 CD O
% NN O
) ) O
in IN O
80 CD O
( ( O
33 CD O
. . O
5 CD O
% NN O
) ) O
postdate NN O
patients NNS O
. . O

The DT O
Fis NNP B-Gene
protein NN I-Gene
regulates VBZ O
site NN O
- : O
specific JJ O
DNA NNP O
inversion NN O
catalyzed VBN O
by IN O
a DT O
family NN O
of IN O
DNA NNP B-Gene
invertases NNS I-Gene
when WRB O
bound NN O
to TO O
a DT O
cis NN O
- : O
acting VBG O
recombinational JJ O
enhancer NN O
. . O

Daily JJ O
and CC O
seasonal JJ O
rhythmicity NN O
in IN O
the DT O
methylation NN O
of IN O
pineal JJ O
indolic JJ O
compounds NNS O
in IN O
adult NN O
male NN O
golden JJ O
hamsters NNS O
, , O
kept VBD O
under IN O
natural JJ O
conditions NNS O
. . O

When WRB O
the DT O
coronary JJ O
sinus NN O
pressure NN O
reached VBD O
15 CD O
torr NN O
, , O
there EX O
was VBD O
a DT O
significant JJ O
decrease NN O
in IN O
cardiac JJ O
index NN O
( ( O
3 CD O
. . O
60 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
to TO O
2 CD O
. . O
70 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
L NNP O
/ NNP O
min NNP O
/ NNP O
m2 NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
, , O
coronary JJ O
blood NN O
flow NN O
( ( O
13 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
1 CD O
to TO O
7 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
1 CD O
ml JJ O
/ NNP O
min NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
, , O
rate NN O
of IN O
rise NN O
of IN O
left JJ O
ventricular JJ O
pressure NN O
( ( O
1 CD O
, , O
567 CD O
+ NN O
/ NNP O
- : O
275 CD O
to TO O
1 CD O
, , O
331 CD O
+ NN O
/ NNP O
- : O
314 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
, , O
and CC O
an DT O
increase NN O
in IN O
coronary JJ O
arteriovenous JJ O
difference NN O
( ( O
62 CD O
. . O
8 CD O
% NN O
+ NNP O
/ NNP O
- : O
9 CD O
. . O
3 CD O
% NN O
to TO O
70 CD O
. . O
5 CD O
% NN O
+ NNP O
/ NNP O
- : O
5 CD O
. . O
4 CD O
% NN O
saturation NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
3 CD O
) ) O
. . O

Prevalence NN O
of IN O
rheumatoid JJ O
arthritis NN O
and CC O
rheumatoid JJ B-Gene
factor NN I-Gene
in IN O
women NNS O
: : O
evidence NN O
for IN O
a DT O
secular JJ O
decline NN O
. . O

New NNP O
technologies NNS O
in IN O
diagnosis NN O
and CC O
classification NN O
of IN O
malignancy NN O
. . O

Five CD O
control NN O
subjects NNS O
with IN O
COPD NNP O
, , O
who WP O
performed VBD O
the DT O
same JJ O
sequence NN O
of IN O
tests NNS O
without IN O
breathing VBG O
30 CD O
% NN O
O2 NNP O
, , O
showed VBD O
no DT O
change NN O
in IN O
flow JJ O
rates NNS O
or CC O
density NN O
dependence NN O
. . O

Note NN O
on IN O
Slot NNP O
' POS O
s NN O
method NN O
for IN O
the DT O
specific JJ O
determination NN O
of IN O
creatinine NN O
. . O

Rex NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
gene NN O
encoding VBG O
a DT O
transcription NN O
factor NN O
expressed VBN O
in IN O
the DT O
early JJ O
embryo NN O
, , O
is VBZ O
regulated VBN O
via IN O
Oct NNP B-Gene
- : I-Gene
3 CD I-Gene
/ JJ I-Gene
4 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
6 CD I-Gene
binding NN O
to TO O
an DT O
octamer JJ O
site NN O
and CC O
a DT O
novel JJ O
protein NN O
, , O
Rox NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
binding VBG O
to TO O
an DT O
adjacent JJ O
site NN O
. . O

Expression NN O
of IN O
herpes NNS O
simplex JJ O
virus NN O
beta NN O
and CC O
gamma NN O
genes NNS O
integrated VBN O
in IN O
mammalian JJ O
cells NNS O
and CC O
their PRP$ O
induction NN O
by IN O
an DT O
alpha JJ O
gene NN O
product NN O
. . O

Recombinant JJ O
AROM NNP B-Gene
- : O
p64 NN B-Gene
displayed VBD O
high JJ O
binding NN O
to TO O
single JJ O
- : O
stranded VBN O
DNA NN O
and CC O
poly NN O
( ( O
A DT O
) ) O
homopolymers NNS O
suggesting VBG O
that IN O
this DT O
protein NN O
could MD O
play VB O
a DT O
role NN O
in IN O
mRNA JJ O
maturation NN O
/ NNP O
metabolism NN O
. . O

The DT O
P13 NNP O
and CC O
N22 NNP O
of IN O
ppSEPs NN O
had VBD O
phase VBN O
reversal NN O
relationship NN O
with IN O
the DT O
P2 NNP O
and CC O
N2 NNP O
recorded VBD O
from IN O
the DT O
PES NNP O
, , O
respectively RB O
. . O

The DT O
nit JJ B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
of IN I-Gene
the DT I-Gene
filamentous JJ I-Gene
fungus NN I-Gene
Neurospora NNP I-Gene
crassa NN I-Gene
encodes NNS O
nitrate JJ B-Gene
reductase NN I-Gene
, , O
the DT O
enzyme NN O
which WDT O
catalyzes VBZ O
the DT O
first JJ O
step NN O
in IN O
nitrate JJ O
assimilation NN O
. . O

Within IN O
a DT O
135 CD O
- : O
bp NN O
core NN O
homology NN O
region NN O
, , O
the DT O
human JJ B-Gene
HS12 NNP I-Gene
enhancers NNS I-Gene
are VBP O
approximately RB O
90 CD O
% NN O
identical JJ O
to TO O
the DT O
murine NN O
homolog NN O
and CC O
include VBP O
several JJ O
motifs NNS O
previously RB O
demonstrated VBD O
to TO O
be VB O
important JJ O
for IN O
function NN O
of IN O
the DT O
murine JJ O
enhancer NN O
; : O
additional JJ O
segments NNS O
of IN O
high JJ O
sequence NN O
conservation NN O
suggest VBP O
the DT O
possibility NN O
of IN O
previously RB O
unrecognized JJ O
functional JJ O
motifs NNS O
. . O

In IN O
the DT O
first JJ O
group NN O
, , O
0 CD O
. . O
2 CD O
% NN O
Prazosin NNP O
( ( O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
was VBD O
administered VBN O
intravenously RB O
for IN O
1 CD O
. . O
5 CD O
hours NNS O
before IN O
the DT O
application NN O
of IN O
Oxy NNP O
- : O
Hb NN O
or CC O
PGF2 NNP O
alpha NN O
. . O

Tctex NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
required VBD O
the DT O
first JJ O
19 CD O
amino JJ O
acids NNS O
of IN O
Fyn NNP B-Gene
and CC O
integrity NN O
of IN O
two CD O
lysine NN O
residues NNS O
within IN O
this DT O
sequence NN O
that WDT O
were VBD O
previously RB O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
Fyn NNP B-Gene
interactions NNS O
with IN O
the DT O
immunoreceptor NN O
tyrosine NN O
- : O
based VBN O
activation NN O
motifs NNS O
( ( O
ITAMs NNP O
) ) O
of IN O
lymphocyte NN B-Gene
Ag NNP I-Gene
receptors NNS I-Gene
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
sought VBD O
to TO O
investigate VB O
whether IN O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
in IN O
chronically RB O
HIV NNP O
- : O
1 CD O
- : O
infected VBN O
promonocytic JJ O
U937 NNP O
( ( O
U9 NNP O
- : O
IIIB NN O
) ) O
and CC O
myeloblastic JJ O
PLB NNP O
- : O
985 CD O
( ( O
PLB NNP O
- : O
IIIB NN O
) ) O
cells NNS O
affects VBZ O
apoptotic JJ O
signaling NN O
. . O

Although IN O
most JJS O
SFV NNP O
genes NNS O
have VBP O
homologs NNS O
encoded VBN O
by IN O
other JJ O
Chordopoxvirinae NNP O
, , O
the DT O
SFV NNP O
genome NN O
lacks VBZ O
a DT O
key JJ O
gene NN O
required VBN O
for IN O
the DT O
production NN O
of IN O
extracellular JJ O
enveloped VBD O
virus NN O
. . O

Increased VBN O
granulocyte NN B-Gene
- : I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
levels NNS O
in IN O
neonates NNS O
with IN O
perinatal JJ O
complications NNS O
. . O

It PRP O
brings VBZ O
about IN O
fatigue NN O
, , O
negative JJ O
moods NNS O
, , O
and CC O
impaired JJ O
health NN O
, , O
sleep NN O
, , O
safety NN O
, , O
and CC O
working VBG O
capacity NN O
. . O

Interdomain NNP O
signaling VBG O
in IN O
a DT O
two CD O
- : O
domain NN O
fragment NN O
of IN O
the DT O
human JJ B-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
. . O

Basal NNP O
FVR NNP O
was VBD O
reduced VBN O
by IN O
approximately RB O
18 CD O
% NN O
by IN O
ERT NNP O
and CC O
HRT NNP O
, , O
but CC O
FVR NNP O
responses VBZ O
to TO O
noradrenaline VB O
, , O
angiotensin NN B-Gene
II NNP I-Gene
, , O
acetylcholine NN O
and CC O
nitroprusside NN O
were VBD O
unaffected VBN O
. . O

Role NNP O
of IN O
biocenosis NN O
in IN O
the DT O
manifestation NN O
of IN O
Shigella NNP O
virulence NN O

The DT O
ubiquitously RB O
expressed VBN O
E12 NNP B-Gene
bHLH NN I-Gene
protein NN I-Gene
dimerizes VBZ O
with IN O
numerous JJ O
cell NN O
- : O
specific JJ O
bHLH JJ B-Gene
factors NNS I-Gene
. . O

We PRP O
tried VBD O
amphotericin NN O
B NNP O
( ( O
AmB NNP O
) ) O
, , O
and CC O
remission NN O
of IN O
the DT O
tumor NN O
was VBD O
obtained VBN O
. . O

Homozygous JJ O
mutant JJ O
mice NN O
, , O
designated VBN O
Cux NNP B-Gene
/ NNP O
CDPDeltaCR1 NNP B-Gene
, , O
display VBD O
a DT O
phenotype NN O
characterized VBN O
by IN O
curly JJ O
vibrissae NN O
and CC O
wavy JJ O
hair NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
suppression NN O
of IN O
elevated JJ O
prolactin NN B-Gene
levels NNS O
in IN O
progressive JJ O
metastatic JJ O
breast NN O
cancer NN O
patients NNS O
is VBZ O
not RB O
effective JJ O
in IN O
restoring VBG O
tumor NN O
sensitivity NN O
to TO O
chemotherapy VB O
. . O

This DT O
protein NN O
can MD O
bind VB O
to TO O
a DT O
region NN O
of IN O
the DT O
promoter NN O
of IN O
an DT O
Arabidopsis NNP B-Gene
light NN I-Gene
- : I-Gene
harvesting NN I-Gene
chlorophyll VBZ I-Gene
a DT I-Gene
/ NN I-Gene
b NN I-Gene
protein NN I-Gene
gene NN I-Gene
, , O
Lhcb1 NNP B-Gene
* NNP I-Gene
3 CD I-Gene
, , O
which WDT O
is VBZ O
necessary JJ O
for IN O
its PRP$ O
regulation NN O
by IN O
phytochrome NN B-Gene
. . O

12 CD O
- : O
O NNP O
- : O
Tetradecanoylphorbol NN O
13 CD O
- : O
acetate NN O
was VBD O
found VBN O
to TO O
inhibit VB O
rapidly RB O
and CC O
potently RB O
the DT O
expression NN O
of IN O
mRNAs NN O
coding VBG O
for IN O
the DT O
myogenic JJ O
regulators NNS O
CMD1 NNP B-Gene
and CC O
myogenin NN B-Gene
. . O

Sequential JJ O
cleavage NN O
by IN O
metallopeptidases NNS B-Gene
and CC O
proteasomes NNS O
is VBZ O
involved VBN O
in IN O
processing VBG O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
ENV NNP I-Gene
epitope NN I-Gene
for IN O
endogenous JJ O
MHC NNP B-Gene
class NN I-Gene
I PRP I-Gene
antigen VBP I-Gene
presentation NN O
. . O

Comparison NN O
with IN O
the DT O
crystal JJ O
structure NN O
of IN O
Desulfovibrio NNP O
gigas NN O
, , O
Dg NNP O
, , O
Fd NNP B-Gene
( ( O
Kissinger NNP O
et VBZ O
al NN O
. . O
, , O
1991 CD O
) ) O
reveals VBZ O
a DT O
very RB O
similar JJ O
folding NN O
topology NN O
, , O
although IN O
several JJ O
secondary JJ O
structural JJ O
elements NNS O
are VBP O
extended VBN O
in IN O
Pf NNP O
relative VBP O
to TO O
Dg NNP O
Fd NNP B-Gene
. . O

Unified NNP O
theory NN O
of IN O
segregated VBN O
- : O
stack NN O
organic JJ O
charge NN O
- : O
transfer NN O
solids NNS O
: : O
Magnetic JJ O
properties NNS O
. . O

Sequencing VBG O
analysis NN O
has VBZ O
shown VBN O
that IN O
each DT O
rap1t NN B-Gene
allele NN I-Gene
contains VBZ O
a DT O
nonsense JJ O
mutation NN O
within IN O
a DT O
discrete JJ O
region NN O
between IN O
amino NN O
acids NNS O
663 CD O
and CC O
684 CD O
. . O

Aluminium NNP O
resin NN O
for IN O
the DT O
treatment NN O
of IN O
the DT O
hyperkalamia NN O
of IN O
renal JJ O
failure NN O
. . O

Selenium NN O
is VBZ O
an DT O
essential JJ O
element NN O
for IN O
humans NNS O
, , O
animals NNS O
and CC O
some DT O
species NNS O
of IN O
microorganisms NNS O
. . O

Saccharomyces NNS O
cerevisiae VBP O
activates VBZ O
a DT O
regulatory JJ O
network NN O
called VBN O
"""" NNP O
general JJ O
control NN O
"""" VBZ O
that WDT O
provides VBZ O
the DT O
cell NN O
with IN O
sufficient JJ O
amounts NNS O
of IN O
protein NN O
precursors NNS O
during IN O
amino JJ O
acid JJ O
starvation NN O
. . O

Results NNS O
indicate VBP O
that IN O
KNM NNP O
- : O
LU $ O
335 CD O
differs NNS O
from IN O
both DT O
human JJ O
and CC O
chimpanzee JJ O
M1s NNP O
in IN O
relative JJ O
distances NNS O
( ( O
measured VBN O
in IN O
three CD O
dimensions NNS O
) ) O
between IN O
crown JJ O
fissure NN O
termini NN O
. . O

Bacillus NNP O
cereus NN O
cross NN O
- : O
infection NN O
in IN O
a DT O
maternity NN O
- : O
unit NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
in IN O
addition NN O
to TO O
Grb2 NNP B-Gene
- : O
mediated VBD O
activation NN O
of IN O
Ras NNP B-Gene
, , O
PLC NNP B-Gene
- : I-Gene
gamma1 NN I-Gene
- : O
mediated VBN O
DAG NNP O
production NN O
is VBZ O
required VBN O
for IN O
EGF NNP B-Gene
- : O
and CC O
PDGF NNP B-Gene
- : O
induced VBD O
S NNP O
- : O
phase NN O
entry NN O
and CC O
gene NN O
expression NN O
, , O
possibly RB O
through IN O
activation NN O
of IN O
PKC NNP B-Gene
. . O

Four CD O
CsA NNP O
- : O
treated VBD O
patients NNS O
developed VBD O
persistently RB O
elevated VBN O
UAER NNP O
> $ O
30 CD O
mg NN O
/ VBD O
24 CD O
h NN O
( ( O
n JJ O
= VBZ O
3 CD O
with IN O
microalbuminuria NN O
) ) O
, , O
whereas IN O
all PDT O
the DT O
17 CD O
placebo NN O
- : O
treated JJ O
patients NNS O
had VBD O
normal JJ O
UAER NNP O
( ( O
< $ O
30 CD O
mg NN O
/ VBD O
24 CD O
h NN O
) ) O
after IN O
7 CD O
years NNS O
of IN O
follow NN O
- : O
up RB O
. . O

Weight NNP O
and CC O
height VBD O
z SYM O
- : O
scores NNS O
were VBD O
significantly RB O
associated VBN O
with IN O
BMD NNP O
z NNP O
- : O
scores NNS O
. . O

Prophylactic JJ O
lymph NN O
node JJ O
dissection NN O
or CC O
radiation NN O
therapy NN O
to TO O
the DT O
nodal NN O
chain NN O
may MD O
decrease VB O
local JJ O
recurrence NN O
but CC O
does VBZ O
not RB O
consistently RB O
affect VBP O
overall JJ O
survival NN O
. . O

Ovarian JJ O
allotransplantation NN O
in IN O
human NN O
. . O

Echinococcus NNP O
granulosus NN O
was VBD O
diagnosed VBN O
by IN O
fine JJ O
- : O
needle JJ O
aspiration NN O
cytology NN O
of IN O
a DT O
lung NN O
cyst NN O
in IN O
a DT O
6 CD O
- : O
yr NN O
- : O
old JJ O
white JJ O
female NN O
in IN O
central JJ O
Missouri NNP O
. . O

Furthermore RB O
, , O
in IN O
vitro JJ O
decay JJ O
reaction NN O
mixtures NNS O
supplemented VBN O
with IN O
the DT O
20 CD O
- : O
nt NN O
sense NN O
RNA NNP O
transcript NN O
resulted VBD O
in IN O
stabilization NN O
of IN O
R2 NNP B-Gene
message NN I-Gene
. . O

Thus RB O
, , O
the DT O
nematode NN O
genes NNS O
could MD O
be VB O
the DT O
homologs NNS B-Gene
of IN I-Gene
Hh NNP I-Gene
molecules NNS I-Gene
in IN O
other JJ O
phyla NN O
. . O

Utilizing VBG O
transient JJ O
transfection NN O
studies NNS O
in IN O
HepG2 NNP O
cells NNS O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
deletion NN O
of IN O
the DT O
factor NN B-Gene
VIII NNP I-Gene
promoter NN I-Gene
sequences NNS I-Gene
distal VBP O
to TO O
nucleotide VB O
- : O
44 CD O
results NNS O
in IN O
a DT O
significant JJ O
but CC O
small JJ O
increase NN O
in IN O
promoter NN O
activity NN O
. . O

Teicoplanin NN O
was VBD O
given VBN O
most JJS O
often RB O
because IN O
of IN O
persistent JJ O
fever NN O
or CC O
initial JJ O
Gram NNP O
- : O
positive JJ O
bacteraemia NN O
and CC O
only RB O
one CD O
- : O
third NN O
of IN O
these DT O
cases NNS O
responded VBD O
. . O

Similarly RB O
, , O
the DT O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
activator NN B-Gene
protein NN I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
modified VBN O
by IN O
a DT O
DNA NNP B-Gene
repair NN I-Gene
enzyme NN I-Gene
, , O
redox JJ B-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
Ref NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
which WDT O
is VBZ O
identical JJ O
to TO O
a DT O
DNA NNP B-Gene
repair NN I-Gene
enzyme NN I-Gene
, , O
AP NNP B-Gene
endonuclease NN I-Gene
. . O

A DT O
cdc33 NN B-Gene
- : I-Gene
1 CD I-Gene
strain NN O
expressing VBG O
either CC O
stable JJ O
Cln3p NNP B-Gene
( ( O
Cln3 NNP B-Gene
- : I-Gene
1p CD I-Gene
) ) O
or CC O
a DT O
hybrid JJ O
UBI4 NNP B-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
CLN3 NNP I-Gene
mRNA NN O
, , O
whose WP$ O
translation NN O
displays NNS O
decreased VBD O
dependence NN O
on IN O
eIF4E NN B-Gene
, , O
arrested VBD O
randomly RB O
in IN O
the DT O
cell NN O
cycle NN O
. . O

The DT O
rate NN O
- : O
decreasing NN O
effects NNS O
of IN O
morphine NN O
and CC O
U50488 NNP O
were VBD O
reversed VBN O
completely RB O
by IN O
a DT O
0 CD O
. . O
1 CD O
and CC O
1 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
dose NN O
of IN O
naloxone NN O
, , O
respectively RB O
. . O

We PRP O
have VBP O
recently RB O
identified VBN O
a DT O
mouse NN O
enzyme NN O
termed VBD O
gamma JJ B-Gene
- : I-Gene
glutamyl NN I-Gene
leukotrienase NN I-Gene
( ( O
GGL NNP B-Gene
) ) O
that WDT O
converts VBZ O
leukotriene NN O
C4 NNP O
( ( O
LTC4 NNP O
) ) O
to TO O
leukotriene VB O
D4 NNP O
( ( O
LTD4 NNP O
) ) O
. . O

[ NN O
Diabetologia NNP O
( ( O
2001 CD O
) ) O
44 CD O
[ JJ O
Suppl NNP O
3 CD O
] NN O
: : O
B37 NNP O
- : O
B44 NNP O
] NN O

Effects NNS O
of IN O
perceptual JJ O
salience NN O
on IN O
the DT O
matrix NN O
task NN O
performance NN O
of IN O
four CD O
- : O
and CC O
six CD O
- : O
year NN O
- : O
old JJ O
children NNS O
. . O

End SYM O
- : O
tidal JJ O
PO2 NNP O
and CC O
the DT O
ratio NN O
of IN O
minute NN O
ventilation NN O
to TO O
oxygen VB O
consumption NN O
( ( O
VE NNP O
/ NNP O
VO2 NNP O
) ) O
were VBD O
lower JJR O
while IN O
PETCO2 NNP O
was VBD O
higher JJR O
for IN O
Hyp NNP O
( ( O
P NNP O
< NNP O
or CC O
= $ O
0 CD O
. . O
1 CD O
) ) O
. . O

A DT O
candidate NN O
gene NN O
for IN O
Bcg NNP B-Gene
, , O
designated VBD O
natural JJ B-Gene
resistance NN I-Gene
- : I-Gene
associated VBN I-Gene
macrophage NN I-Gene
protein NN I-Gene
( ( O
Nramp NNP B-Gene
) ) O
, , O
has VBZ O
been VBN O
isolated VBN O
and CC O
shown VBN O
to TO O
encode VB O
a DT O
novel JJ O
macrophage NN O
- : O
specific JJ O
membrane NN O
protein NN O
, , O
which WDT O
is VBZ O
altered VBN O
in IN O
susceptible JJ O
animals NNS O
. . O

Initiation NN O
of IN O
translation NN O
of IN O
the DT O
human JJ O
hepatitis NN O
C NNP O
virus NN O
( ( O
HCV NNP O
) ) O
RNA NNP O
genome NN O
occurs NNS O
by IN O
internal JJ O
ribosome NN O
entry NN O
into IN O
the DT O
5 CD O
' POS O
noncoding JJ O
region NN O
( ( O
5 CD O
' '' O
NCR NNP O
) ) O
in IN O
a DT O
cap NN O
- : O
independent JJ O
manner NN O
. . O

An DT O
epidemic NN O
of IN O
hepatitis NN O
B NNP O
virus NN O
infection NN O
among IN O
intravenous JJ O
drug NN O
users NNS O
in IN O
Iceland NNP O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
TGF NNP B-Gene
- : I-Gene
betaf NN I-Gene
potentiates VBZ O
the DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
SRE NNP O
activated VBN O
by IN O
PKC NNP B-Gene
through IN O
the DT O
SRF NNP B-Gene
binding NN I-Gene
site NN I-Gene
. . O

Static JJ O
magnetic JJ O
fields NNS O
affect VBP O
the DT O
diffusion NN O
of IN O
biological JJ O
particles NNS O
in IN O
solutions NNS O
through IN O
the DT O
Lorentz NNP O
force NN O
and CC O
Maxwell NNP O
stress NN O
. . O

In IN O
addition NN O
, , O
the DT O
mouse NN O
ortholog NN O
( ( O
Mharp NNP B-Gene
/ NNP O
Smarcal1 NNP B-Gene
) ) O
was VBD O
cloned VBN O
, , O
and CC O
the DT O
Caenorhabditis NNP O
elegans NNS O
ortholog VBP O
( ( O
CEHARP NNP B-Gene
) ) O
was VBD O
identified VBN O
in IN O
the DT O
GenBank NNP O
database NN O
. . O

Since IN O
1967 CD O
at IN O
the DT O
times NNS O
of IN O
their PRP$ O
biennial JJ O
ABCC NNP O
/ NNP O
RERF NNP O
radiological JJ O
examinations NNS O
, , O
all DT O
Adult NNP O
Health NNP O
Study NNP O
( ( O
AHS NNP O
) ) O
subjects NNS O
have VBP O
been VBN O
interviewed VBN O
to TO O
determine VB O
the DT O
exposures NNS O
to TO O
medical JJ O
x NNP O
- : O
rays VBZ O
they PRP O
experienced VBD O
in IN O
institutions NNS O
other JJ O
than IN O
RERF NNP O
in IN O
order NN O
to TO O
estimate VB O
the DT O
numbers NNS O
of IN O
examinations NNS O
and CC O
corresponding VBG O
doses NNS O
which WDT O
they PRP O
received VBD O
. . O

This DT O
action NN O
is VBZ O
dependent JJ O
on IN O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
factors NNS I-Gene
bound IN O
to TO O
the DT O
E1 NNP B-Gene
element NN O
. . O

NuA4 NNP B-Gene
has VBZ O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
1 CD O
. . O
3 CD O
MDa NNP O
. . O

Four CD O
full JJ O
- : O
thickness NN O
skin JJ O
incisions NNS O
were VBD O
made VBN O
in IN O
the DT O
back NN O
of IN O
10 CD O
female JJ O
pigs NNS O
that WDT O
treated VBD O
twice RB O
a DT O
day NN O
for IN O
14 CD O
days NNS O
with IN O
2 CD O
ml NNS O
of IN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
300 CD O
ng RB O
/ NNP O
ml NN O
) ) O
or CC O
2 CD O
ml NN O
of IN O
Ringer NNP O
' POS O
s NN O
lactate NN O
solution NN O
in IN O
a DT O
single JJ O
- : O
blind NN O
, , O
randomized VBN O
fashion NN O
. . O

Recurrent NNP O
acute NN O
rhinosinusitis NN O
was VBD O
common JJ O
in IN O
both DT O
groups NNS O
of IN O
patients NNS O
, , O
but CC O
the DT O
development NN O
of IN O
chronic JJ O
rhinosinusitis NN O
was VBD O
only RB O
found VBN O
in IN O
patients NNS O
with IN O
CVID NNP O
, , O
indicating VBG O
the DT O
more RBR O
severe JJ O
nature NN O
of IN O
this DT O
condition NN O
compared VBN O
with IN O
selective JJ O
IgA NNP B-Gene
deficiency NN O
. . O

Propranolol NNP O
( ( O
Inderal NNP O
) ) O
administered VBD O
in IN O
a DT O
dose NN O
which WDT O
blocks VBZ O
the DT O
beta NN O
- : O
adrenergic JJ O
apparatus NN O
of IN O
the DT O
heart NN O
prevents VBZ O
the DT O
development NN O
of IN O
the DT O
positive JJ O
inotropic NN O
effect NN O
of IN O
therapeutic JJ O
doses NNS O
of IN O
strophanthin JJ O
K NNP O
on IN O
a DT O
hypodynamic JJ O
left NN O
ventricular JJ O
myocardium NN O
. . O

Cord NNP O
swelling NN O
was VBD O
observed VBN O
in IN O
2 CD O
patients NNS O
who WP O
developed VBD O
complete JJ O
lesions NNS O
. . O

This DT O
report NN O
presents VBZ O
an DT O
analysis NN O
of IN O
the DT O
vocal JJ O
repertoire NN O
of IN O
howler NN O
monkeys NNS O
( ( O
Alouatta NNP O
palliata NN O
) ) O
observed VBD O
during IN O
a DT O
field NN O
study NN O
in IN O
southwestern JJ O
Panama NNP O
. . O

Solving VBG O
an DT O
age NN O
old JJ O
problem NN O
. . O

The DT O
enhanced JJ O
cysteine NN O
formation NN O
in IN O
a DT O
pCSK4F NN O
plant NN O
responding VBG O
to TO O
sulfite VB O
was VBD O
also RB O
observed VBN O
in IN O
leaf JJ O
discs NN O
. . O

Comparison NNP O
was VBD O
made VBN O
with IN O
other JJ O
neuroradiological JJ O
imaging VBG O
modalities NNS O
including VBG O
CT NNP O
, , O
myelography NN O
, , O
CT NNP O
ventriculography NN O
, , O
and CC O
CT NNP O
myelocisternography NN O
. . O

Serological JJ O
studies NNS O
of IN O
antibodies NNS O
to TO O
Epstein NNP O
- : O
Barr NNP O
virus NN O
in IN O
infectious JJ O
mononucleosis NN O

Vac1p NNP B-Gene
was VBD O
found VBN O
to TO O
bind VB O
the DT O
Sec1p NNP B-Gene
homologue NN I-Gene
Vps45p NNP B-Gene
. . O

Competition NNP O
electrophoretic JJ O
mobility NN O
shift NN O
and CC O
immunoshift NN O
assays NNS O
confirmed VBD O
that IN O
NF1 NNP B-Gene
factors NNS I-Gene
present VBP O
in IN O
nuclear JJ O
extracts NNS O
of IN O
HeLa NNP O
and CC O
CV NNP O
- : O
1 CD O
cells NNS O
bind IN O
to TO O
the DT O
BKV NNP B-Gene
- : I-Gene
MLP NN I-Gene
. . O

We PRP O
analyzed VBD O
an DT O
EBV NNP O
B NNP O
- : O
cell NN O
clone NN O
, , O
E29 NNP O
. . O
1 CD O
, , O
derived VBN O
from IN O
an DT O
11 CD O
week NN O
- : O
old JJ O
embryo NN O
, , O
and CC O
secreting VBG O
both DT O
IgM NNP B-Gene
kappa NN I-Gene
and CC O
IgM NNP B-Gene
lambda NN I-Gene
. . O

Calibration NN O
and CC O
a DT O
correction NN O
of IN O
blood NN O
O2 NNP O
content NN O
measured VBN O
by IN O
Po2 NNP O
and CC O
CO NNP O
saturation NN O
. . O

A DT O
fusion NN O
protein NN O
composed VBD O
of IN O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
and CC O
full JJ B-Gene
- : I-Gene
length NN I-Gene
Ahr NNP I-Gene
translocates VBZ O
from IN O
the DT O
cytoplasm NN O
to TO O
the DT O
nucleus NN O
in IN O
a DT O
ligand NN O
- : O
dependent JJ O
manner NN O
. . O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
secretor NN O
status NN O
and CC O
clinical JJ O
status NN O
, , O
spirometry NN O
measurements NNS O
, , O
salivary JJ O
and CC O
serum JJ B-Gene
lysozyme NN I-Gene
levels NNS O
or CC O
rates NNS O
of IN O
respiratory JJ O
tract JJ O
colonization NN O
with IN O
P NNP O
. . O
aeruginosa NN O
and CC O
S NNP O
. . O
aureus NN O
. . O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
secretor NN O
status NN O
and CC O
clinical JJ O
status NN O
, , O
spirometry NN O
measurements NNS O
, , O
salivary JJ B-Gene
and CC I-Gene
serum JJ I-Gene
lysozyme NN I-Gene
levels NNS O
or CC O
rates NNS O
of IN O
respiratory JJ O
tract JJ O
colonization NN O
with IN O
P NNP O
. . O
aeruginosa NN O
and CC O
S NNP O
. . O
aureus NN O
. . O

The DT O
transposon NN O
- : O
inactivated JJ O
gene NN O
, , O
designated VBN O
pilP NN B-Gene
, , O
is VBZ O
525 CD O
bp NN O
long RB O
, , O
potentially RB O
encoding VBG O
a DT O
19 CD O
. . O
1 CD O
- : O
kDa NN O
protein NN O
precursor NN O
that WDT O
contains VBZ O
a DT O
typical JJ O
membrane NN O
lipoprotein JJ O
leader NN O
sequence NN O
. . O

We PRP O
can MD O
classify VB O
antibiotics NNS O
into IN O
two CD O
groups NNS O
based VBN O
on IN O
initial JJ O
bactericidal JJ O
activity NN O
against IN O
P NNP O
. . O
aeruginosa NN O
; : O
one CD O
class NN O
is VBZ O
antibiotics NNS O
having VBG O
rapid JJ O
initial JJ O
killing VBG O
such JJ O
as IN O
AMK NNP O
, , O
IPM NNP O
and CC O
PAPM NNP O
, , O
the DT O
other JJ O
is VBZ O
CAZ NNP O
, , O
MEPM NNP O
showing VBG O
slow JJ O
initial JJ O
killing NN O
. . O

Rinit NNP O
reflects VBZ O
the DT O
Newtonian JJ O
resistances NNS O
and CC O
Rdiff NNP O
represents VBZ O
the DT O
viscoelastic JJ O
/ NNP O
inhomogeneous JJ O
pressure NN O
dissipations NNS O
in IN O
the DT O
system NN O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
activation NN O
of IN O
HIV NNP O
- : O
1 CD O
gene NN O
expression NN O
by IN O
cytokines NNS O
and CC O
other JJ O
stimuli NNS O
, , O
but CC O
the DT O
signal JJ O
transduction NN O
pathways NNS O
that WDT O
regulate VBP O
the DT O
switch NN O
from IN O
latent NN O
to TO O
productive JJ O
infection NN O
have VBP O
not RB O
been VBN O
defined VBN O
. . O

A DT O
rabbit NN O
antiserum NN O
was VBD O
raised VBN O
against IN O
a DT O
synthetic JJ O
peptide NN O
corresponding VBG O
to TO O
a DT O
hydrophilic JJ O
portion NN O
of IN O
the DT O
translated JJ O
murine NN O
cDNA NN O
sequence NN O
. . O

Based VBN O
on IN O
these DT O
results NNS O
the DT O
minimal JJ O
control NN O
element NN O
( ( O
AX NNP O
470 CD O
) ) O
specifying VBG O
the DT O
anterior JJ O
boundary NN O
of IN O
Hox NNP B-Gene
expression NN O
was VBD O
designated VBN O
as IN O
Hoxa NNP B-Gene
- : I-Gene
7 CD I-Gene
enhancer NN I-Gene
. . O

Immediately RB O
after IN O
surgery NN O
, , O
dialysate VB O
PGE2 NNP O
and CC O
adenosine JJ O
concentrations NNS O
were VBD O
3 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
and CC O
296 CD O
+ NN O
/ NNP O
- : O
127 CD O
nM NN O
, , O
respectively RB O
. . O

1 CD O
in IN O
Ho NNP O
Chi NNP O
Minh NNP O
City NNP O
was VBD O
studied VBN O
by IN O
culture NN O
and CC O
latex JJ O
agglutination NN O
of IN O
blood NN O
, , O
cerebrospinal JJ O
fluid NN O
, , O
urine JJ O
and CC O
pleural JJ O
fluid NN O
. . O

No DT O
other JJ O
changes NNS O
in IN O
hematopoietic JJ O
differentiation NN O
status NN O
were VBD O
observed VBN O
in IN O
association NN O
with IN O
Id NNP B-Gene
- : I-Gene
SCL NNP I-Gene
expression NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
both DT O
naturally RB O
acquired VBN O
and CC O
passive JJ O
( ( O
modified VBN O
immune NN B-Gene
serum NN I-Gene
globulin NN I-Gene
) ) O
antibodies VBZ O
to TO O
type VB B-Gene
III NNP I-Gene
group NN I-Gene
B NNP I-Gene
Streptococcus NNP I-Gene
antigen NN I-Gene
are VBP O
partially RB O
protective JJ O
against IN O
intra JJ O
- : O
amniotic JJ O
infection NN O
. . O

The DT O
various JJ O
forms NNS O
of IN O
sickle NN O
cell NN O
disease NN O
share NN O
the DT O
common JJ O
feature NN O
of IN O
an DT O
abnormal JJ O
globin NN B-Gene
chain NN I-Gene
that IN O
, , O
under IN O
certain JJ O
conditions NNS O
such JJ O
as IN O
hypoxia NN O
, , O
results NNS O
in IN O
the DT O
sickling NN O
of IN O
red JJ O
blood NN O
cells NNS O
and CC O
obstruction NN O
of IN O
blood NN O
vessels NNS O
. . O

Although IN O
p48 JJ B-Gene
gene NN I-Gene
induction NN O
is VBZ O
dependent JJ O
on IN O
STAT1 NNP B-Gene
and CC O
JAK1 NNP B-Gene
, , O
activated VBD O
STAT1 NNP B-Gene
does VBZ O
not RB O
bind VB O
to TO O
GATE NNP B-Gene
. . O

Competition NN O
with IN O
a DT O
putative JJ O
MADS NNP B-Gene
box NN I-Gene
consensus NN O
binding VBG O
site NN O
from IN O
the DT O
promoter NN O
of IN O
the DT O
coordinately RB O
regulated VBN O
opaque JJ B-Gene
- : I-Gene
phase NN I-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
PEP1 NNP I-Gene
( ( O
SAP1 NNP B-Gene
) ) O
and CC O
the DT O
human JJ B-Gene
MADS NNP I-Gene
box NN I-Gene
consensus NN I-Gene
binding VBG I-Gene
site NN I-Gene
for IN O
serum JJ B-Gene
response NN I-Gene
factor NN I-Gene
demonstrated VBD O
that IN O
one CD O
of IN O
the DT O
three CD O
complexes NNS O
formed VBN O
was VBD O
specific JJ O
to TO O
the DT O
OP4 NNP B-Gene
sequence NN I-Gene
. . O

The DT O
ipsilateral JJ O
breast NN O
tumor NN O
relapse NN O
rate NN O
was VBD O
similar JJ O
between IN O
the DT O
PALP NNP O
and CC O
MGDET NNP O
groups NNS O
. . O

Plants NNS O
transformed VBN O
with IN O
the DT O
35S CD B-Gene
- : O
1 CD B-Gene
- : I-Gene
sst NN I-Gene
construct NN O
accumulated VBD O
the DT O
oligofructans NNS O
1 CD O
- : O
kestose NN O
( ( O
GF2 NNP O
) ) O
, , O
1 CD O
, , O
1 CD O
- : O
nystose NN O
( ( O
GF3 NNP O
) ) O
and CC O
1 CD O
, , O
1 CD O
, , O
1 CD O
- : O
fructosylnystose NN O
( ( O
GF4 NNP O
) ) O
. . O

We PRP O
conclude VBP O
that DT O
androgenic JJ O
hormones NNS O
reduce VB O
HDL NNP B-Gene
- : I-Gene
cholesterol NN I-Gene
concentrations NNS O
and CC O
the DT O
HDL2 NNP B-Gene
- : I-Gene
cholesterol NN I-Gene
subfraction NN O
, , O
possibly RB O
by IN O
enhancing VBG O
hepatic JJ B-Gene
triglyceride JJ I-Gene
lipase NN I-Gene
activity NN O
. . O

Nitrogen NNP O
balance NN O
was VBD O
compared VBN O
, , O
and CC O
metabolic JJ O
complications NNS O
were VBD O
monitored VBN O
by IN O
evaluating VBG O
BUN NNP O
, , O
serum NN O
creatinine NN O
, , O
creatinine JJ O
clearance NN O
, , O
serum NN O
CO2 NNP O
, , O
SGOT NNP B-Gene
, , O
SGPT NNP B-Gene
, , O
serum NN B-Gene
LDH NNP I-Gene
, , O
and CC O
serum JJ B-Gene
alkaline NN I-Gene
phosphatase NN I-Gene
. . O

We PRP O
conclude VBP O
that IN O
, , O
both DT O
in IN O
atrial JJ O
myocytes NNS O
and CC O
in IN O
Xenopus NNP O
oocytes NNS O
, , O
beta SYM O
- : O
adrenergic JJ O
stimulation NN O
potentiates VBZ O
the DT O
ACh NNP O
- : O
evoked VBD O
GIRK NNP B-Gene
channels NNS I-Gene
via IN O
a DT O
pathway NN O
that WDT O
involves VBZ O
PKA NNP B-Gene
- : O
catalyzed VBN O
phosphorylation NN O
downstream NN O
from IN O
beta NN B-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
AR NNP I-Gene
. . O

The DT O
glial JJ O
cyst NN O
wall NN O
was VBD O
lined VBN O
in IN O
part NN O
by IN O
flattened VBD O
or CC O
cuboidal JJ O
epithelium NN O
. . O

PET NNP O
activation NN O
studies NNS O
are VBP O
performed VBN O
widely RB O
to TO O
study VB O
human JJ O
brain NN O
function NN O
. . O

The DT O
avidin JJ B-Gene
- : I-Gene
biotin NN I-Gene
complex JJ I-Gene
peroxidase NN I-Gene
( ( O
ABC NNP B-Gene
- : I-Gene
P NN I-Gene
) ) O
method NN O
was VBD O
used VBN O
to TO O
detect VB O
Mycobacterium NNP O
bovis NN O
, , O
and CC O
the DT O
results NNS O
were VBD O
compared VBN O
with IN O
those DT O
obtained VBN O
by IN O
the DT O
Ziehl NNP O
- : O
Neelsen NNP O
( ( O
ZN NNP O
) ) O
technique NN O
. . O

A DT O
hypothesis NN O
. . O

Yap1p NN B-Gene
is VBZ O
constitutively RB O
nuclear JJ O
in IN O
a DT O
crm1 NN B-Gene
mutant NN I-Gene
, , O
and CC O
Crm1p NNP B-Gene
binds VBZ O
to TO O
a DT O
nuclear JJ O
export NN O
sequence NN O
( ( O
NES NNP O
) ) O
- : O
like IN O
sequence NN O
in IN O
Yap1p NNP B-Gene
in IN O
the DT O
presence NN O
of IN O
RanGTP NNP B-Gene
. . O

A DT O
small JJ O
amount NN O
of IN O
HSP81 NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
only RB O
in IN O
roots NNS O
. . O

The DT O
pCMBS NN O
- : O
reactive JJ O
sulfhydryl NN O
groups NNS O
were VBD O
located VBN O
exclusively RB O
in IN O
the DT O
exofacial JJ O
half NN O
of IN O
the DT O
plasma NN O
membrane NN O
and CC O
, , O
when WRB O
presented VBN O
in IN O
a DT O
helical JJ O
model NN O
, , O
lie RB O
along IN O
one CD O
side NN O
of IN O
the DT O
helices NNS O
. . O

Cyclin NNP B-Gene
G2 NNP I-Gene
is VBZ O
highly RB O
expressed VBN O
in IN O
the DT O
immune NN O
system NN O
where WRB O
immunologic JJ O
tolerance NN O
subjects NNS O
self PRP O
- : O
reactive JJ O
lymphocytes NNS O
to TO O
negative JJ O
selection NN O
and CC O
clonal JJ O
deletion NN O
via IN O
apoptosis NN O
. . O

The DT O
Dax NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
encodes VBZ O
a DT O
protein NN O
that WDT O
is VBZ O
structurally RB O
related VBN O
to TO O
members NNS O
of IN O
the DT O
orphan JJ B-Gene
nuclear JJ I-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

Cloning NN O
of IN O
higher JJR B-Gene
plant NN I-Gene
omega IN I-Gene
- : I-Gene
3 CD I-Gene
fatty JJ I-Gene
acid NN I-Gene
desaturases NNS I-Gene
. . O

Truncation NN O
variants NNS O
of IN O
peptides NNS O
isolated VBN O
from IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
molecules VBZ I-Gene
suggest JJS O
sequence NN O
motifs NNS O
. . O

No DT O
difference NN O
in IN O
elastin JJ B-Gene
peptide JJ I-Gene
concentration NN O
was VBD O
observed VBN O
between IN O
emphysematous JJ O
patients NNS O
and CC O
control NN O
subjects NNS O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NNP O
= VBZ O
2 CD O
. . O
39 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
18 CD O
micrograms NNS O
/ VBP O
ml NN O
in IN O
patients NNS O
versus IN O
2 CD O
. . O
55 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
34 CD O
micrograms NNS O
/ VBP O
ml NN O
in IN O
policemen NNS O
and CC O
2 CD O
. . O
59 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
20 CD O
micrograms NNS O
/ VBP O
ml NN O
in IN O
coal NN O
miners NNS O
) ) O
. . O

Newcastle NNP O
disease NN O
virus NN O
surveillance NN O
in IN O
Hong NNP O
Kong NNP O
on IN O
local JJ O
and CC O
imported JJ O
poultry NN O
. . O

STUDY NNP O
DESIGN NNP O
: : O
Salivary JJ B-Gene
immunoglobulin NN I-Gene
A NNP I-Gene
levels NNS O
of IN O
each DT O
of IN O
20 CD O
subjects NNS O
were VBD O
determined VBN O
on IN O
3 CD O
occasions NNS O
: : O
first RB O
, , O
while IN O
the DT O
subject NN O
was VBD O
still RB O
smoking VBG O
; : O
second JJ O
, , O
7 CD O
days NNS O
after IN O
cessation NN O
of IN O
smoking NN O
; : O
third JJ O
, , O
on IN O
the DT O
14th CD O
day NN O
after IN O
cessation NN O
. . O

Documentation NN O
of IN O
a DT O
successful JJ O
intrauterine JJ O
fertilization NN O
with IN O
delivery NN O
of IN O
a DT O
term NN O
baby NN O
supports VBZ O
the DT O
theoretical JJ O
feasibility NN O
of IN O
the DT O
EP NNP O
; : O
however RB O
, , O
anovulation NN O
incurred VBN O
by IN O
our PRP$ O
procedure NN O
appears VBZ O
to TO O
be VB O
the DT O
major JJ O
drawback NN O
. . O

The DT O
distinguishing NN O
features NNS O
involved VBN O
eight CD O
amino NNS O
acid JJ O
changes NNS O
, , O
including VBG O
a DT O
single JJ O
lysine NN O
deletion NN O
relative NN O
to TO O
a DT O
primate NN O
consensus NN O
sequence NN O
in IN O
the DT O
first JJ O
complementary JJ O
- : O
determing VBG O
region NN O
of IN O
V1J1 NNP B-Gene
. . O

The DT O
3 CD O
' POS O
terminus NN O
of IN O
the DT O
genome NN O
can MD O
be VB O
folded VBN O
into IN O
a DT O
tRNA JJ O
- : O
like IN O
secondary JJ O
structure NN O
that WDT O
has VBZ O
a DT O
valine JJ O
anticodon NN O
; : O
the DT O
tRNA NN O
- : O
like IN O
structure NN O
lacks VBZ O
a DT O
pseudoknot NN O
in IN O
the DT O
aminoacyl JJ O
stem NN O
, , O
a DT O
feature NN O
common JJ O
to TO O
both DT O
genera NN O
of IN O
tetraviruses NNS O
. . O

Jembrana NNP O
disease NN O
virus NN O
( ( O
JDV NNP O
) ) O
is VBZ O
a DT O
newly RB O
identified VBN O
bovine NN O
lentivirus NN O
that WDT O
is VBZ O
closely RB O
related VBN O
to TO O
the DT O
bovine NN O
immunodeficiency NN O
virus NN O
( ( O
BIV NNP O
) ) O
. . O

The DT O
eating NN O
and CC O
drinking NN O
patterns NNS O
of IN O
pygmy NN O
goats NNS O
fed VBP O
ad NN O
lib NN O
and CC O
kept VB O
on IN O
a DT O
12 CD O
h NN O
light JJ O
/ $ O
12 CD O
h NN O
dark JJ O
cycle NN O
were VBD O
recorded VBN O
and CC O
analyzed VBN O
. . O

A DT O
tobacco NN O
homologue NN O
( ( O
trolC NN B-Gene
) ) O
of IN O
the DT O
rolC JJ B-Gene
gene NN I-Gene
of IN I-Gene
the DT I-Gene
Agrobacterium NNP I-Gene
rhizogenes NNS I-Gene
Ri NNP I-Gene
- : I-Gene
plasmid NN I-Gene
was VBD O
cloned VBN O
and CC O
sequenced VBN O
from IN O
Nicotiana NNP O
tabacum NN O
L NNP O
. . O

cv NN O
. . O

Recombinant JJ O
unr JJ B-Gene
acts NNS O
synergistically RB O
with IN O
recombinant JJ O
PTB NNP B-Gene
to TO O
stimulate VB O
translation NN O
dependent NN O
on IN O
the DT O
rhinovirus NN O
IRES NNP O
. . O

Petko NNP O
, , O
and CC O
S NNP O
. . O

Studies NNS O
on IN O
the DT O
pathogenicity NN O
of IN O
ECHO NNP O
9 CD O
( ( O
HILL NNP O
) ) O
virus NN O
and CC O
its PRP$ O
mutants NNS O
for IN O
suckling VBG O
mice NN O

In IN O
E NNP O
. . O
coli NN O
, , O
CheW NNP B-Gene
mediates VBZ O
the DT O
physical JJ O
coupling NN O
of IN O
the DT O
receptors NNS O
to TO O
the DT O
kinase NN O
CheA NNP B-Gene
. . O

Nuclease NNP O
footprinting VBG O
revealed VBD O
that IN O
purified JJ O
glucocorticoid JJ B-Gene
receptor NN I-Gene
bound NN O
at IN O
multiple JJ O
discrete NN O
sites NNS O
within IN O
and CC O
at IN O
the DT O
borders NNS O
of IN O
the DT O
tandemly NN O
repeated VBD O
sequence NN O
motif NN O
that WDT O
defines VBZ O
Sa NNP B-Gene
. . O

The DT O
maximum JJ O
induction NN O
of IN O
ACC NNP B-Gene
- : I-Gene
oxidase NN I-Gene
transcripts NNS I-Gene
occurred VBD O
at IN O
about IN O
6 CD O
h NN O
after IN O
excision NN O
, , O
while IN O
the DT O
maximum JJ O
enzyme NN O
activity NN O
was VBD O
observed VBN O
at IN O
24 CD O
h NN O
. . O

A DT O
single JJ O
amino NN O
acid NN O
difference NN O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
influences NNS O
dominant JJ O
negative JJ O
activity NN O
and CC O
receptor NN O
dimer NN O
formation NN O
. . O

Svensson NNP O
et CC O
al NN O
. . O

Recording VBG O
of IN O
the DT O
digital JJ O
sphygmic JJ O
activity NN O
in IN O
the DT O
lower JJR O
extremities NNS O
with IN O
the DT O
photoplethysmographic JJ O
and CC O
strain JJ O
- : O
gauge NN O
methods NNS O
. . O

CT NNP O
abnormalities NNS O
noted VBD O
in IN O
term NN O
babies NNS O
included VBN O
hemorrhage NN O
( ( O
subarachnoid JJ O
5 CD O
. . O
8 CD O
% NN O
, , O
intracerebral JJ O
11 CD O
. . O
6 CD O
% NN O
) ) O
, , O
hypodensity NN O
( ( O
mild JJ O
23 CD O
. . O
2 CD O
% NN O
, , O
moderate JJ O
11 CD O
. . O
6 CD O
% NN O
severe JJ O
5 CD O
. . O
8 CD O
% NN O
) ) O
; : O
hypodensity NN O
with IN O
hemorrhage NN O
5 CD O
. . O
8 CD O
% NN O
and CC O
cerebral JJ O
atrophy NN O
5 CD O
. . O
8 CD O
% NN O
. . O

Furthermore RB O
, , O
a DT O
p21X NN B-Gene
protein NN I-Gene
lacking VBG O
the DT O
N NNP O
- : O
terminus NN O
of IN O
Rex1 NNP B-Gene
was VBD O
expressed VBN O
at IN O
high JJ O
levels NNS O
; : O
our PRP$ O
data NNS O
indicate VBP O
that IN O
p21X NN B-Gene
is VBZ O
translated VBN O
from IN O
the DT O
1 CD O
. . O
6 CD O
- : O
kb NN O
mRNA NN O
which WDT O
is VBZ O
derived VBN O
primarily RB O
from IN O
deleted VBN O
proviruses NNS O
. . O

Surface NNP O
- : O
coil NN O
experiments NNS O
on IN O
phantoms NNS O
and CC O
on IN O
human JJ O
calf NN O
muscles NNS O
in IN O
vivo NN O
are VBP O
presented VBN O
. . O

NERVTRACK NNP O
contains VBZ O
4000 CD O
anatomical JJ O
data NNS O
items NNS O
arranged VBN O
in IN O
a DT O
tree JJ O
- : O
like IN O
manner NN O
reflecting VBG O
structural JJ O
and CC O
functional JJ O
relationships NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
histopathological JJ O
findings NNS O
, , O
the DT O
origin NN O
of IN O
amyloid NN O
appeared VBD O
to TO O
be VB O
closely RB O
related VBN O
to TO O
the DT O
fibroblasts NNS O
. . O

Primer NNP O
extension NN O
and CC O
mung NN B-Gene
bean NN I-Gene
and CC I-Gene
S1 NNP I-Gene
nuclease NN I-Gene
mapping NN O
indicated VBD O
multiple JJ O
transcription NN O
initiation NN O
sites NNS O
and CC O
were VBD O
consistent JJ O
with IN O
Northern NNP O
analyses NNS O
. . O

Postglucose NNP O
serum JJ B-Gene
insulin NN I-Gene
levels NNS O
showed VBD O
no DT O
significant JJ O
correlations NNS O
with IN O
systolic JJ O
or CC O
diastolic JJ O
blood NN O
pressure NN O
levels NNS O
in IN O
men NNS O
, , O
but CC O
in IN O
female JJ O
diabetic JJ O
and CC O
non JJ O
- : O
diabetic JJ O
subjects NNS O
significant JJ O
correlations NNS O
were VBD O
found VBN O
in IN O
particular JJ O
with IN O
systolic JJ O
blood NN O
pressure NN O
level NN O
. . O

Taking VBG O
into IN O
consideration NN O
weight NN O
and CC O
seasonal JJ O
changes NNS O
in IN O
bone NN O
mass NN O
, , O
total JJ O
( ( O
TBBMC NNP O
) ) O
and CC O
regional JJ O
body NN O
bone JJ O
mineral JJ O
content NN O
were VBD O
measured VBN O
in IN O
38 CD O
women NNS O
treated VBN O
with IN O
GnRH NNP B-Gene
agonists NNS O
for IN O
6 CD O
months NNS O
for IN O
endometriosis NN O
or CC O
leiomyomata NN O
. . O

Of IN O
the DT O
patients NNS O
in IN O
each DT O
regimen NNS O
who WP O
reached VBD O
study NN O
end NN O
points NNS O
, , O
17 CD O
of IN O
29 CD O
( ( O
59 CD O
% NN O
) ) O
were VBD O
in IN O
regimen NNS O
A NNP O
, , O
11 CD O
of IN O
20 CD O
( ( O
55 CD O
% NN O
) ) O
were VBD O
in IN O
regimen NNS O
B NNP O
, , O
and CC O
28 CD O
of IN O
43 CD O
( ( O
65 CD O
% NN O
) ) O
were VBD O
in IN O
regimen NNS O
C NNP O
met VBD O
the DT O
treatment NN O
success NN O
criterion NN O
. . O

An DT O
analysis NN O
of IN O
the DT O
dynamics NNS O
is VBZ O
performed VBN O
of IN O
exactly RB O
solvable JJ O
models NNS O
for IN O
fragile NN O
and CC O
strong JJ O
glasses NNS O
, , O
exploiting VBG O
the DT O
partitioning NN O
of IN O
the DT O
free JJ O
- : O
energy NN O
landscape NN O
in IN O
inherent JJ O
structures NNS O
. . O

Antiviral JJ O
agents NNS O
. . O

Spontaneous JJ O
degradation NN O
of IN O
atracurium NN O
in IN O
plasma NN O
is VBZ O
the DT O
major JJ O
route NN O
of IN O
elimination NN O
in IN O
man NN O
and CC O
contributes VBZ O
to TO O
a DT O
short JJ O
elimination NN O
half NN O
- : O
life NN O
( ( O
approximatively RB O
20 CD O
min NN O
) ) O
. . O

Our PRP$ O
study NN O
cohorts NNS O
consisted VBD O
of IN O
15 CD O
patients NNS O
who WP O
received VBD O
SC NNP O
rIL VBD B-Gene
- : I-Gene
2 CD I-Gene
at IN O
doses NNS O
of IN O
4 CD O
. . O
8 CD O
- : O
14 CD O
. . O
4 CD O
million CD O
IU NNP O
/ NNP O
m2 NN O
/ NNP O
day NN O
on IN O
5 CD O
days NNS O
per IN O
week NN O
for IN O
a DT O
total NN O
of IN O
8 CD O
weeks NNS O
, , O
20 CD O
patients NNS O
who WP O
received VBD O
rIFN JJ B-Gene
- : I-Gene
alpha NN I-Gene
2b CD I-Gene
at IN O
3 CD O
. . O
0 CD O
- : O
6 CD O
. . O
0 CD O
million CD O
U NNP O
/ NNP O
m2 NN O
/ NNP O
day NN O
thrice JJ O
weekly RB O
for IN O
a DT O
total NN O
of IN O
6 CD O
weeks NNS O
, , O
and CC O
72 CD O
patients NNS O
who WP O
were VBD O
given VBN O
SC NNP O
rIFN SYM B-Gene
- : I-Gene
alpha NN I-Gene
2b CD I-Gene
at IN O
6 CD O
. . O
0 CD O
million CD O
U NNP O
/ NNP O
m2 NN O
/ NNP O
day NN O
thrice JJ O
weekly JJ O
plus CC O
SC NNP O
rIL VBP B-Gene
- : I-Gene
2 CD I-Gene
at IN O
14 CD O
. . O
4 CD O
- : O
18 CD O
. . O
0 CD O
million CD O
IU NNP O
/ NNP O
m2 NN O
/ NNP O
day NN O
on IN O
days NNS O
1 CD O
and CC O
2 CD O
, , O
followed VBN O
by IN O
4 CD O
. . O
8 CD O
million CD O
IU NNP O
/ NNP O
m2 NN O
/ NNP O
day NN O
, , O
5 CD O
days NNS O
per IN O
week NN O
for IN O
6 CD O
consecutive JJ O
weeks NNS O
. . O

Visual NNP O
averaged VBD O
evoked JJ O
responses NNS O
and CC O
platelet NN B-Gene
monoamine NN I-Gene
oxidase NN I-Gene
in IN O
patients NNS O
suffering VBG O
from IN O
alcoholism NN O
. . O

Dimerization NN O
of IN O
Myf NNP B-Gene
- : I-Gene
5 CD I-Gene
with IN O
the DT O
ubiquitously RB O
expressed VBN O
bHLH NN O
protein NN O
E12 NNP B-Gene
not RB O
only RB O
increases VBZ O
the DT O
affinity NN O
for IN O
DNA NN O
but CC O
also RB O
stimulates VBZ O
transactivation NN O
independently RB O
of IN O
DNA NNP O
binding NN O
. . O

The DT O
increase NN O
in IN O
amplitudes NNS O
of IN O
the DT O
b NN O
- : O
wave NN O
during IN O
the DT O
adaptation NN O
period NN O
was VBD O
more RBR O
prominent JJ O
in IN O
lead JJ O
- : O
exposed JJ O
subjects NNS O
than IN O
in IN O
controls NNS O
. . O

Xenopus NN B-Gene
Ran NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
1 CD I-Gene
: : O
molecular JJ O
interactions NNS O
and CC O
effects NNS O
on IN O
nuclear JJ O
assembly NN O
in IN O
Xenopus NNP O
egg NN O
extracts NNS O
. . O

At IN O
rest JJS O
AFF NNP O
was VBD O
significantly RB O
higher JJR O
in IN O
UT NNP O
( ( O
29 CD O
% NN O
) ) O
as IN O
compared VBN O
to TO O
AT NNP O
( ( O
25 CD O
% NN O
) ) O
and CC O
UEA NNP O
( ( O
25 CD O
% NN O
) ) O
. . O

Chick NNP B-Gene
brain NN I-Gene
actin NN I-Gene
depolymerizing VBG I-Gene
factor NN I-Gene
( ( O
ADF NNP B-Gene
) ) O
is VBZ O
a DT O
19 CD O
- : O
kDa NN O
protein NN O
that IN O
severs NNS O
actin VBP B-Gene
filaments NNS I-Gene
and CC O
binds NNS O
actin JJ B-Gene
monomers NNS I-Gene
. . O

Specialized NNP O
actin NN B-Gene
tails NNS O
that WDT O
propel VBP O
IEV NNP O
particles NNS O
to TO O
the DT O
periphery NN O
and CC O
virus NN O
- : O
tipped VBN O
microvilli NN O
( ( O
both DT O
common JJ O
in IN O
wild JJ O
- : O
type NN O
- : O
infected JJ O
cells NNS O
) ) O
were VBD O
absent JJ O
in IN O
cells NNS O
infected VBN O
with IN O
vA33delta NN O
. . O

Combined VBN O
immunochemotherapy NN O
with IN O
cyclophosphamide JJ O
plus CC O
BCG NNP O
gave VBD O
a DT O
better RBR O
enhancement NN O
of IN O
the DT O
antitumor JJ O
effect NN O
of IN O
the DT O
cytostatic JJ O
than IN O
that DT O
of IN O
the DT O
combination NN O
of IN O
methotrexate JJ O
plus CC O
BCG NNP O
and CC O
cyclophosphamide JJ O
plus CC O
levamisole JJ O
. . O

From IN O
March NNP O
5 CD O
through IN O
October NNP O
26 CD O
, , O
1991 CD O
, , O
eight CD O
persons NNS O
were VBD O
diagnosed VBN O
with IN O
elevated JJ O
blood NN O
lead NN O
levels NNS O
( ( O
BLLs NNP O
) ) O
at IN O
a DT O
local JJ O
hospital NN O
and CC O
were VBD O
reported VBN O
to TO O
the DT O
notifiable JJ O
disease NN O
surveillance NN O
system NN O
maintained VBN O
by IN O
the DT O
Alabama NNP O
Department NNP O
of IN O
Public NNP O
Health NNP O
( ( O
ADPH NNP O
) ) O
. . O

Histochemistry NN O
and CC O
electron NN O
microscopy NN O
of IN O
acute JJ O
liver NN O
lesions NNS O
induced VBN O
by IN O
Aflatoxin NNP O
B1 NNP O
in IN O
ducklings NNS O
. . O

To TO O
investigate VB O
the DT O
activity NN O
of IN O
TCF11 NNP B-Gene
through IN O
this DT O
selected VBN O
site NN O
, , O
both DT O
alone RB O
and CC O
in IN O
the DT O
presence NN O
of IN O
MafG NNP B-Gene
, , O
we PRP O
have VBP O
used VBN O
a DT O
transient JJ O
transfection NN O
assay NN O
. . O

A DT O
log NN O
- : O
linear NN O
dose JJ O
- : O
response NN O
was VBD O
obtained VBN O
for IN O
the DT O
average JJ O
increase NN O
in IN O
FEV1 NNP O
up RB O
to TO O
6 CD O
h NN O
( ( O
AUC0 NNP O
- : O
6 CD O
h NN O
) ) O
and CC O
peak JJ O
FEV1 NNP O
across IN O
the DT O
dose NN O
range NN O
administered VBN O
by IN O
Respimat NNP O
. . O

Circularized NNP O
Ac NNP B-Gene
/ NNP O
Ds NNP B-Gene
transposons NNS O
: : O
formation NN O
, , O
structure NN O
and CC O
fate NN O
. . O

The DT O
increased JJ O
clearance NN O
observed VBN O
in IN O
young JJ O
infants NNS O
is VBZ O
in IN O
contrast NN O
to TO O
other JJ O
opioids NNS O
. . O

The DT O
extraordinary JJ O
stability NN O
of IN O
peptide NN B-Gene
- : I-Gene
- : I-Gene
gp96 NN I-Gene
complexes NNS I-Gene
and CC O
the DT O
plasticity NN O
of IN O
the DT O
peptide NN O
- : O
binding NN O
pocket NN O
support VB O
the DT O
proposed VBN O
relay NN O
of IN O
diverse JJ O
peptides NNS O
to TO O
MHC NNP B-Gene
and CC O
/ NNP O
or CC O
other JJ O
molecules NNS O
via IN O
molecular JJ O
recognition NN O
. . O

The DT O
utilities NNS O
measured VBN O
in IN O
our PRP$ O
study NN O
can MD O
be VB O
applied VBN O
directly RB O
to TO O
quality VB O
- : O
of IN O
- : O
life NN O
determinations NNS O
in IN O
clinical JJ O
trials NNS O
of IN O
adjuvant JJ O
IFN NNP B-Gene
alpha SYM I-Gene
- : I-Gene
2b CD I-Gene
to TO O
measure VB O
the DT O
net JJ O
benefit NN O
of IN O
therapy NN O
. . O

Latexin NNP B-Gene
, , O
a DT O
carboxypeptidase NN B-Gene
A NNP I-Gene
inhibitor NN O
, , O
is VBZ O
expressed VBN O
in IN O
a DT O
cell NN O
type NN O
- : O
specific JJ O
manner NN O
in IN O
both DT O
central JJ O
and CC O
peripheral JJ O
nervous JJ O
systems NNS O
in IN O
the DT O
rat NN O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
suggest VBP O
that IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
may MD O
be VB O
regulated VBN O
by IN O
its PRP$ O
interaction NN O
with IN O
the DT O
cell NN O
cycle NN O
regulatory JJ O
protein NN O
, , O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
the DT O
Pseudomonas NNP B-Gene
putida NN I-Gene
PpG7 NNP I-Gene
salicylate NN I-Gene
hydroxylase NN I-Gene
gene NN I-Gene
( ( O
nahG JJ B-Gene
) ) O
and CC O
its PRP$ O
3 CD O
' '' O
- : O
flanking VBG O
region NN O
. . O

The DT O
relevance NN O
of IN O
these DT O
elements NNS O
in IN O
conferring VBG O
anaerobic JJ O
induction NN O
of IN O
gpc4 JJ B-Gene
gene NN I-Gene
expression NN O
is VBZ O
discussed VBN O
. . O

A DT O
new JJ O
, , O
flexible JJ O
fiberoptic JJ O
ventriculoscope NN O
for IN O
observation NN O
of IN O
the DT O
ventricles NNS O
and CC O
major JJ O
cisterns NNS O
is VBZ O
reported VBN O
. . O

Measurements NNS O
in IN O
the DT O
LWS NNP O
p NN O
. . O
a DT O
. . O

, , O
LWS NNP O
lat NN O
. . O
and CC O
at IN O
Ward NNP O
' POS O
s NN O
triangle NN O
were VBD O
made VBN O
in IN O
a DT O
total NN O
of IN O
100 CD O
patients NNS O
. . O

IST NNP B-Gene
is VBZ O
not RB O
the DT O
RNA NNP O
target NN O
( ( O
TAR NNP O
) ) O
for IN O
Tat NNP B-Gene
trans VBZ O
- : O
activation NN O
; : O
however RB O
, , O
because IN O
it PRP O
relies VBZ O
entirely RB O
on IN O
cellular JJ O
factors NNS O
for IN O
activity NN O
, , O
IST NNP B-Gene
may MD O
serve VB O
to TO O
provide VB O
abundant JJ O
RNA NNP O
targets NNS O
for IN O
Tat NNP B-Gene
trans VBZ O
- : O
activation NN O
without IN O
a DT O
requirement NN O
for IN O
full JJ O
- : O
length NN O
viral JJ O
mRNA NN O
expression NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
cloned VBN O
a DT O
region NN O
that WDT O
complements VBZ O
the DT O
exoenzyme NN B-Gene
S NNP I-Gene
- : O
deficient NN O
phenotype NN O
of IN O
strain NN O
388 CD O
exs1 NN B-Gene
: : O
: : O
Tn1 NN B-Gene
, , O
a DT O
chromosomal JJ B-Gene
Tn1 NNP I-Gene
insertional JJ I-Gene
mutation NN I-Gene
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Skn NNP B-Gene
- : I-Gene
1a CD I-Gene
lacking VBG O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
completely RB O
lost VBN O
transactivation NN O
ability NN O
, , O
irrespective NN O
of IN O
the DT O
promoter NN O
tested VBN O
, , O
and CC O
was VBD O
able JJ O
to TO O
block VB O
transactivation NN O
by IN O
normal JJ O
Skn NNP B-Gene
- : I-Gene
1a CD I-Gene
in IN O
competition NN O
assays NNS O
. . O

12 CD O
healthy JJ O
women NNS O
( ( O
age NN O
18 CD O
- : O
38 CD O
years NNS O
) ) O
were VBD O
examined VBN O
using VBG O
the DT O
2 CD O
- : O
hour NN O
' '' O
s JJ O
method NN O
of IN O
passive JJ O
leg NN O
rising VBG O
( ( O
PLR NNP O
) ) O
in IN O
follicular NN O
( ( O
FP NNP O
) ) O
and CC O
luteal JJ O
( ( O
LP NNP O
) ) O
phases VBZ O
of IN O
normal JJ O
ovulatory JJ O
cycle NN O
. . O

Output NN O
of IN O
99mTcO CD O
- : O
4 CD O
by IN O
the DT O
parotid NN O
gland NN O
closely RB O
mimicked JJ O
fluctuations NNS O
in IN O
parotid NN O
saliva NN O
flow NN O
rate NN O
. . O

Addition NN O
of IN O
sucralfate NN O
or CC O
De NNP O
- : O
Nol NNP O
resulted VBD O
in IN O
increments NNS O
of IN O
gastric JJ O
HCO3 NNP O
secretion NN O
, , O
reaching VBG O
about IN O
45 CD O
% NN O
and CC O
59 CD O
% NN O
, , O
respectively RB O
, , O
of IN O
the DT O
maximal JJ O
HCO3 NNP O
response NN O
to TO O
16 CD O
, , O
16 CD O
- : O
dimethyl NN O
PGE2 NNP O
( ( O
dmPGE2 NN O
) ) O
. . O

To TO O
facilitate VB O
the DT O
investigation NN O
of IN O
parameters NNS O
that WDT O
govern VBP O
selective JJ O
export NN O
in IN O
adenovirus JJ O
- : O
infected JJ O
cells NNS O
, , O
we PRP O
constructed VBD O
a DT O
marked JJ O
human JJ O
beta NN B-Gene
- : I-Gene
actin NN I-Gene
minigene NN I-Gene
under IN O
the DT O
control NN O
of IN O
the DT O
glucocorticoid JJ B-Gene
- : I-Gene
inducible JJ I-Gene
enhancer NN I-Gene
- : I-Gene
promoter NN I-Gene
of IN O
mouse NN O
mammary JJ O
tumor NN O
virus NN O
and CC O
introduced VBD O
it PRP O
into IN O
the DT O
left JJ O
end NN O
of IN O
the DT O
adenovirus NN O
type NN O
5 CD O
( ( O
Ad5 NNP O
) ) O
genome NN O
. . O

Microstructure NN O
and CC O
conductivity NN O
of IN O
hierarchical JJ O
laminate NN O
composites NNS O
. . O

In IN O
contrast NN O
, , O
receptor NN B-Gene
/ NNP I-Gene
G NNP I-Gene
protein NN I-Gene
coupling VBG O
appeared VBD O
unaffected JJ O
by IN O
expression NN O
of IN O
loop $ O
3i CD O
domains NNS O
derived VBN O
from IN O
two CD O
receptors NNS O
coupled VBD O
to TO O
G NNP B-Gene
( ( I-Gene
i JJ I-Gene
/ VBP I-Gene
o NN I-Gene
) ) I-Gene
proteins VBZ I-Gene
( ( O
M2Ach NNP B-Gene
- : I-Gene
muscarinic NN I-Gene
and CC I-Gene
alpha2A JJ I-Gene
- : I-Gene
adrenergic JJ I-Gene
receptors NNS I-Gene
) ) O
. . O

This DT O
dependence NN O
, , O
however RB O
, , O
can MD O
be VB O
overcome VBN O
to TO O
a DT O
large JJ O
extent NN O
by IN O
dividing VBG O
min NN O
LVdP NNP O
/ NNP O
dt NN O
by IN O
mean JJ O
aortic JJ O
pressure NN O
. . O

These DT O
adverse JJ O
effects NNS O
usually RB O
abate VBP O
with IN O
time NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
K NNP B-Gene
- : I-Gene
glypican NN I-Gene
is VBZ O
a DT O
novel JJ O
GPI NNP B-Gene
- : I-Gene
anchored VBD I-Gene
HSPG NNP I-Gene
involved VBN O
in IN O
embryonic JJ O
development NN O
. . O

The DT O
mean JJ O
blood NN O
flow NN O
in IN O
the DT O
penile NN O
foreskin NN O
was VBD O
estimated VBN O
to TO O
be VB O
15 CD O
ml JJ O
/ NNP O
min NN O
/ VBD O
100 CD O
g NN O
and CC O
it PRP O
increased VBD O
to TO O
150 CD O
- : O
200 CD O
% NN O
after IN O
the DT O
induction NN O
of IN O
anesthesia NN O
, , O
and CC O
then RB O
decreased VBD O
to TO O
72 CD O
% NN O
at IN O
the DT O
tip NN O
of IN O
the DT O
created JJ O
parameatal JJ O
foreskin NN O
flap NN O
. . O

Identification NN O
and CC O
characterization NN O
of IN O
specific JJ O
DNA NNP O
- : O
binding NN O
complexes NNS O
containing VBG O
members NNS O
of IN O
the DT O
Myc NNP B-Gene
/ NNP O
Max NNP B-Gene
/ NNP O
Mad NNP B-Gene
network NN O
of IN O
transcriptional JJ O
regulators NNS O
. . O

We PRP O
mapped VBD O
two CD O
overlapping VBG O
expressed VBN O
sequence NN O
tag NN O
clones NNS O
within IN O
a DT O
genomic JJ O
contig NN O
on IN O
human JJ O
chromosome NN O
5 CD O
, , O
band NN O
q31 NN O
. . O

The DT O
sequenced JJ O
cDNA NN O
predicts VBZ O
a DT O
704 CD O
- : O
amino NN O
acid VBP O
protein RB O
80 CD O
% NN O
identical JJ O
to TO O
human JJ B-Gene
progelatinase NN I-Gene
B NNP I-Gene
. . O

These DT O
results NNS O
provide VBP O
direct JJ O
evidence NN O
for IN O
differential JJ O
susceptibility NN O
to TO O
endonuclease VB O
- : O
mediated VBN O
mRNA NN O
decay NN O
resulting VBG O
from IN O
the DT O
differential JJ O
affinity NN O
of IN O
a DT O
RNA NNP O
- : O
binding NN O
protein NN O
for IN O
cis JJ O
- : O
acting VBG O
stability NN O
determinants NNS O
. . O

By IN O
using VBG O
reporter NN O
gene NN O
constructs NNS O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
upstream JJ O
sequences NNS O
of IN O
the DT O
P1 NNP O
promoter NN O
contain NN O
several JJ O
regions NNS O
that WDT O
modulate VBP O
the DT O
expression NN O
either CC O
positively RB O
or CC O
negatively RB O
. . O

Analysis NN O
of IN O
viral JJ O
mutants NNS O
in IN O
vivo NN O
demonstrated VBD O
that IN O
the DT O
NFIII NNP B-Gene
/ NNP O
OCT NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
site NN O
and CC O
a DT O
conserved JJ O
ATF NNP B-Gene
motif NN I-Gene
were VBD O
important JJ O
for IN O
efficient JJ O
viral JJ O
growth NN O
. . O

Results NNS O
of IN O
a DT O
controlled VBN O
study NN O

These DT O
genes NNS O
may MD O
represent VB O
interesting VBG O
targets NNS O
for IN O
new JJ O
therapeutic JJ O
strategies NNS O
. . O

These DT O
HPV16 NNP O
E6 NNP B-Gene
/ NNP O
E7 NNP B-Gene
cDNAs NN O
were VBD O
cloned VBN O
under IN O
the DT O
SV40 NNP B-Gene
enhancer NN I-Gene
/ NNP I-Gene
promoter NN I-Gene
and CC O
the DT O
MMTV NNP B-Gene
LTR NNP I-Gene
to TO O
examine VB O
the DT O
activities NNS O
of IN O
ras NNS B-Gene
- : O
collaborative JJ O
transformation NN O
and CC O
induction NN O
of IN O
cellular JJ O
DNA NNP O
synthesis NN O
, , O
both DT O
of IN O
which WDT O
depend VBP O
on IN O
the DT O
E7 NNP B-Gene
gene NN I-Gene
product NN O
. . O

Constitutive JJ O
protection NN O
of IN O
E2F NNP B-Gene
recognition NN I-Gene
sequences NNS I-Gene
in IN O
the DT O
human JJ B-Gene
thymidine NN I-Gene
kinase NN I-Gene
promoter NN I-Gene
during IN O
cell NN O
cycle NN O
progression NN O
. . O

The DT O
volume NN O
of IN O
blood NN O
to TO O
the DT O
flap NN O
ranges VBZ O
from IN O
1 CD O
to TO O
2 CD O
ml NNS O
/ JJ O
min NN O
, , O
collateral JJ O
circulation NN O
to TO O
the DT O
flap NN O
exists VBZ O
, , O
but CC O
is VBZ O
negligible JJ O
, , O
and CC O
there EX O
is VBZ O
little JJ O
change NN O
in IN O
the DT O
capillary JJ O
blood NN O
flow NN O
as IN O
the DT O
flap NN O
ages NNS O
. . O

The DT O
possible JJ O
benefits NNS O
of IN O
LMW NNP O
heparin NN O
( ( O
reduced JJ O
frequency NN O
of IN O
bleeding NN O
, , O
alleviation NN O
of IN O
hypertriglyceridemia NN O
) ) O
were VBD O
not RB O
, , O
however RB O
, , O
apparent JJ O
, , O
possibly RB O
because IN O
of IN O
the DT O
short JJ O
observation NN O
period NN O
and CC O
the DT O
low JJ O
incidence NN O
of IN O
hemorrhagic JJ O
complications NNS O
in IN O
routine JJ O
dialyses NNS O
. . O

ASL NNP O
- : O
8123 CD O
demonstrated VBD O
weak JJ O
competitive JJ O
beta NN B-Gene
- : I-Gene
adrenoreceptor NN I-Gene
blocking VBG O
activity NN O
in IN O
isolated JJ O
guinea NN O
pig NNS O
right RB O
atria VBP O
with IN O
a DT O
pA2 NN O
of IN O
3 CD O
. . O
73 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
; : O
no DT O
agonist JJ O
- : O
like IN O
activity NN O
was VBD O
observed VBN O
in IN O
this DT O
tissue NN O
at IN O
concentrations NNS O
of IN O
ASL NNP O
- : O
8123 CD O
from IN O
3 CD O
X NNS O
10 CD O
( ( O
- : O
5 CD O
) ) O
to TO O
1 CD O
X NNS O
10 CD O
( ( O
- : O
2 CD O
) ) O
M NNP O
. . O

The DT O
physical JJ O
characteristics NNS O
of IN O
these DT O
calls NNS O
vary VBP O
among IN O
species NNS O
of IN O
bat NN O
, , O
and CC O
variations NNS O
also RB O
exist VBP O
in IN O
the DT O
timing NN O
and CC O
patterns NNS O
of IN O
respiratory JJ O
muscle NN O
recruitment NN O
during IN O
echolocation NN O
. . O

With IN O
regard NN O
to TO O
the DT O
characteristic JJ O
expression NN O
pattern NN O
of IN O
DJ NNP B-Gene
protein NN I-Gene
and CC O
its PRP$ O
conspicuous JJ O
repeat NN O
units NNS O
possible JJ O
functional JJ O
roles NNS O
are VBP O
discussed VBN O
. . O

Cell NNP O
lines NNS O
are VBP O
checked VBN O
to TO O
find VB O
out RP O
whether IN O
they PRP O
develop VBP O
tumors NNS O
in IN O
nude JJ O
mice NN O
followed VBN O
by IN O
an DT O
analysis NN O
of IN O
the DT O
karyotype NN O
. . O

INTERVENTION NNP O
( ( O
S NNP O
) ) O
: : O
Twenty CD O
- : O
six CD O
hemostasis NN O
parameters NNS O
evaluated VBD O
repeatedly RB O
in IN O
patients NNS O
undergoing VBG O
IVF NNP O
- : O
ET NN O
. . O

Genomic NNP O
clones NNS O
encompassing VBG O
the DT O
human JJ B-Gene
ETS1 NNP I-Gene
gene NN I-Gene
were VBD O
isolated VBN O
and CC O
utilized JJ O
to TO O
define VB O
its PRP$ O
molecular JJ O
organization NN O
. . O

The DT O
present JJ O
studies NNS O
compare VBP O
the DT O
biochemical JJ O
characteristics NNS O
, , O
Kanagawa NNP O
hemolysin NN B-Gene
reactions NNS O
, , O
and CC O
plasmid JJ O
profiles NNS O
of IN O
13 CD O
patient NN O
and CC O
221 CD O
environmental JJ O
isolates NNS O
of IN O
the DT O
organism NN O
. . O

The DT O
Drosophila NNP B-Gene
suppressor NN I-Gene
of IN I-Gene
sable JJ I-Gene
gene NN I-Gene
encodes VBZ O
a DT O
polypeptide NN O
with IN O
regions NNS O
similar JJ O
to TO O
those DT O
of IN O
RNA NNP O
- : O
binding NN O
proteins NNS O
. . O

Although IN O
the DT O
effects NNS O
of IN O
the DT O
calcium NN O
supplement NN O
or CC O
calcium NN O
antagonist VBP O
alone RB O
were VBD O
significant JJ O
, , O
such JJ O
hypotensive JJ O
responses NNS O
were VBD O
not RB O
optimal JJ O
or CC O
predictable JJ O
or CC O
clearly RB O
dose JJ O
- : O
dependent NN O
. . O

Also RB O
, , O
HR21ap NNP B-Gene
as RB O
well RB O
as IN O
HR21Xap NNP B-Gene
are VBP O
specific JJ O
in IN O
their PRP$ O
inhibition NN O
of IN O
Sp1 NNP B-Gene
binding NN O
. . O

Deletion NN O
of IN O
both DT O
prfA NNS B-Gene
and CC O
ponA NN B-Gene
resulted VBD O
in IN O
extremely RB O
slow JJ O
growth NN O
and CC O
a DT O
reduction NN O
in IN O
sporulation NN O
efficiency NN O
. . O

Does NNP O
afferent JJ O
loop VB O
syndrome JJ O
exist NN O
? . O
] VB O
It PRP O
is VBZ O
the DT O
author NN O
' POS O
s JJ O
opinion NN O
that IN O
diagnosis NN O
of IN O
the DT O
"""" NNP O
adducent NN O
loop NN O
syndrome NN O
"""" NN O
is VBZ O
unlikely JJ O
to TO O
be VB O
correct JJ O
in IN O
patients NNS O
subjected VBN O
to TO O
Billroth NNP O
- : O
II NNP O
gastrectomy NN O
. . O

As IN O
an DT O
initial JJ O
step NN O
towards IN O
the DT O
characterization NN O
of IN O
replicative JJ O
DNA NNP B-Gene
polymerases NNS I-Gene
of IN I-Gene
trypanosomes NNS I-Gene
, , O
we PRP O
have VBP O
cloned VBN O
, , O
sequenced VBN O
and CC O
examined VBN O
the DT O
expression NN O
of IN O
the DT O
Trypanosoma NNP O
( ( O
Trypanozoon NNP O
) ) O
brucei NN O
brucei NN O
gene NN O
that WDT O
encodes VBZ O
the DT O
DNA NNP B-Gene
polymerase NN I-Gene
alpha RB I-Gene
catalytic JJ I-Gene
core NN I-Gene
( ( O
pol JJ B-Gene
alpha NN I-Gene
) ) O
. . O

Isoform NNP B-Gene
C NNP I-Gene
beta NN I-Gene
2 CD I-Gene
, , O
an DT O
unusual JJ O
form NN O
of IN O
the DT O
bovine NN O
catalytic JJ O
subunit NN O
of IN O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
. . O

The DT O
results NNS O
are VBP O
given VBN O
as IN O
: : O
flux NN O
, , O
number NN O
of IN O
stars NNS O
per IN O
cm3 NN O
, , O
charge NN O
of IN O
the DT O
ions NNS O
, , O
comparison NN O
with IN O
other JJ O
detectors NNS O
( ( O
plastics NNS O
, , O
AgCl NNP O
crystals NNS O
, , O
LiF NNP O
) ) O
, , O
energy NN O
loss NN O
, , O
hit JJ O
region NN O
in IN O
the DT O
biological JJ O
objects NNS O
. . O

Much JJ O
evidence NN O
indicates VBZ O
that IN O
p38 NN B-Gene
is VBZ O
an DT O
activator NN O
of IN O
MyoD NNP B-Gene
: : O
( ( O
i NN O
) ) O
p38 NN B-Gene
kinase NN I-Gene
activity NN O
is VBZ O
required VBN O
for IN O
the DT O
expression NN O
of IN O
MyoD NNP B-Gene
- : O
responsive JJ O
genes NNS O
, , O
( ( O
ii NN O
) ) O
enforced VBD O
induction NN O
of IN O
p38 NN B-Gene
stimulates VBZ O
the DT O
transcriptional JJ O
activity NN O
of IN O
a DT O
Gal4 NNP B-Gene
- : O
MyoD NNP B-Gene
fusion NN O
protein NN O
and CC O
allows VBZ O
efficient JJ O
activation NN O
of IN O
chromatin NN O
- : O
integrated VBN O
reporters NNS O
by IN O
MyoD NNP B-Gene
, , O
and CC O
( ( O
iii NN O
) ) O
MyoD NNP B-Gene
- : O
dependent NN O
myogenic JJ O
conversion NN O
is VBZ O
reduced VBN O
in IN O
mouse NN O
embryonic JJ O
fibroblasts NNS O
derived VBN O
from IN O
p38alpha NN B-Gene
( ( I-Gene
- : I-Gene
/ SYM I-Gene
- : I-Gene
) ) I-Gene
embryos NN O
. . O

Signal JJ O
transduction NN O
via IN O
modulation NN O
of IN O
phosphorylation NN O
after IN O
selective JJ O
inhibition NN O
of IN O
protein NN B-Gene
phosphatase NN I-Gene
( ( I-Gene
PP NNP I-Gene
) ) I-Gene
1 CD I-Gene
and CC O
/ NNP O
or CC O
PP2A NNP B-Gene
appears VBZ O
to TO O
play VB O
a DT O
role NN O
in IN O
okadaic JJ O
acid NN O
( ( O
OA NNP O
) ) O
- : O
mediated VBN O
effects NNS O
. . O

Although IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
ICRF NNP O
- : O
159 CD O
and CC O
187 CD O
has VBZ O
not RB O
been VBN O
clearly RB O
defined VBN O
, , O
it PRP O
is VBZ O
evident JJ O
from IN O
both DT O
preclinical JJ O
and CC O
early JJ O
clinical JJ O
studies NNS O
that IN O
these DT O
compounds NNS O
are VBP O
of IN O
interest NN O
. . O

Sequence NNP O
analysis NN O
of IN O
a DT O
6 CD O
. . O
3 CD O
- : O
kbp NN O
genomic JJ O
EcoRI NNP B-Gene
- : O
fragment NN O
of IN O
Alcaligenes NNP O
eutrophus NN O
, , O
which WDT O
was VBD O
recently RB O
identified VBN O
by IN O
using VBG O
a DT O
dihydrolipoamide JJ B-Gene
dehydrogenase NN I-Gene
- : O
specific JJ O
DNA NNP O
probe NN O
( ( O
A DT O
. . O

Inhibition NN O
of IN O
RNA2 NNP B-Gene
translation NN O
was VBD O
selective JJ O
, , O
with IN O
no DT O
effect NN O
on IN O
general JJ O
cellular JJ O
translation NN O
or CC O
translation NN O
of IN O
BMV NNP O
RNA1 NNP B-Gene
- : O
encoded VBD O
replication NN B-Gene
factor NN I-Gene
1a CD I-Gene
, , O
and CC O
was VBD O
independent JJ O
of IN O
p20 NN B-Gene
, , O
a DT O
cellular JJ O
antagonist NN O
of IN O
DED1 NNP B-Gene
function NN O
in IN O
translation NN O
. . O

We PRP O
have VBP O
inactivated VBN O
Krox NNP B-Gene
- : I-Gene
20 CD I-Gene
by IN O
homologous JJ O
recombination NN O
in IN O
ES NNP O
cells NNS O
and CC O
demonstrated VBD O
that IN O
the DT O
mutation NN O
leads VBZ O
to TO O
the DT O
deletion NN O
of IN O
r3 NN O
and CC O
r5 NN O
. . O

Allergenic JJ O
activity NN O
of IN O
allergen NN O
extract NN O
Ambrosia NNP O
elatior NN O
( ( O
AE NNP O
) ) O
was VBD O
tested VBN O
in IN O
fifteen JJ O
volunteers NNS O
extremely RB O
sensitive JJ O
to TO O
the DT O
allergen NN O
. . O

We PRP O
have VBP O
studied VBN O
the DT O
biokinetics NNS O
of IN O
BLM NNP O
labeled VBD O
with IN O
indium NN O
- : O
111 CD O
( ( O
In IN O
- : O
111 CD O
) ) O
. . O

To TO O
determine VB O
which WDT O
region NN O
of IN O
SulA NNP B-Gene
is VBZ O
essential JJ O
for IN O
the DT O
inhibition NN O
of IN O
cell NN O
division NN O
, , O
we PRP O
constructed VBD O
a DT O
series NN O
of IN O
N NNP O
- : O
terminal NN O
and CC O
C NNP O
- : O
terminal JJ O
deletions NNS O
of IN O
SulA NNP B-Gene
and CC O
a DT O
series NN O
of IN O
alanine JJ O
substitution NN O
mutants NNS O
. . O

Concurrent NN O
with IN O
ligand NN O
- : O
dependent JJ O
uptake NN O
, , O
we PRP O
now RB O
show VBP O
that IN O
the DT O
receptor NN O
undergoes JJ O
ligand SYM O
- : O
induced JJ O
ubiquitination NN O
, , O
suggesting VBG O
that IN O
receptor NN O
ubiquitination NN O
may MD O
function VB O
in IN O
the DT O
ligand NN O
- : O
dependent JJ O
endocytosis NN O
of IN O
the DT O
a DT B-Gene
- : I-Gene
factor NN I-Gene
receptor NN I-Gene
as RB O
well RB O
as IN O
in IN O
its PRP$ O
constitutive JJ O
endocytosis NN O
. . O

Plasma NNP O
Al NNP O
was VBD O
obtained VBN O
during IN O
each DT O
baseline NN O
and CC O
drug NN O
course NN O
. . O

All DT O
patients NNS O
were VBD O
evaluable JJ O
for IN O
toxicity NN O
and CC O
9 CD O
for IN O
response NN O
. . O

Glycogen NNP O
synthesis NN O
and CC O
catabolism NN O
, , O
gluconeogenesis NN O
, , O
glycolysis NN O
, , O
motility NN O
, , O
cell NN O
surface NN O
properties NNS O
and CC O
adherence NN O
are VBP O
modulated VBN O
by IN O
csrA NN B-Gene
in IN I-Gene
Escherichia NNP I-Gene
coli NNS I-Gene
, , O
while IN O
the DT O
production NN O
of IN O
several JJ O
secreted JJ O
virulence NN O
factors NNS O
, , O
the DT O
plant NN O
hypersensitive JJ O
response NN O
elicitor NN O
HrpN NNP B-Gene
( ( O
Ecc NNP B-Gene
) ) O
and CC O
, , O
potentially RB O
, , O
other JJ O
secondary JJ O
metabolites NNS O
are VBP O
regulated VBN O
by IN O
rsmA NN B-Gene
in IN I-Gene
Erwinia NNP I-Gene
carotovora NN I-Gene
. . O

The DT O
topography NN O
and CC O
trajectories NNS O
of IN O
the DT O
commissural JJ O
fibers NNS O
of IN O
the DT O
superior JJ O
temporal JJ O
region NN O
( ( O
STR NNP O
) ) O
are VBP O
studied VBN O
using VBG O
the DT O
autoradiographic JJ O
technique NN O
. . O

The DT O
statistical JJ O
analysis NN O
consist NN O
of IN O
the DT O
F NNP O
test NN O
followed VBN O
by IN O
Snedecor NNP O
' POS O
s NN O
contrast NN O
test NN O
. . O

Two CD O
- : O
Channel NNP O
Kondo NNP O
Lattice NNP O
: : O
An DT O
Incoherent NNP O
Metal NNP O
. . O

Sequencing VBG O
of IN O
the DT O
16p CD O
11 CD O
. . O
1 CD O
/ JJ O
Xq28 NNP O
duplication NN O
breakpoints NNS O
has VBZ O
revealed VBN O
the DT O
presence NN O
of IN O
repetitive JJ O
immunoglobulin NN B-Gene
- : I-Gene
like IN I-Gene
CAGGG NNP I-Gene
pentamer NN I-Gene
sequences NNS I-Gene
at IN O
or CC O
near IN O
the DT O
paralogy NN O
boundaries NNS O
. . O

Ultrastructural JJ O
study NN O
of IN O
polyarteritis NN O

The DT O
Ntl1 NNP B-Gene
gene NN I-Gene
is VBZ O
present JJ O
as IN O
a DT O
unique JJ O
copy NN O
in IN O
the DT O
diploid NN O
N NNP O
. . O
plumbaginifolia NN O
species NNS O
. . O

With IN O
stepwise NN O
reductions NNS O
in IN O
flow NN O
, , O
the DT O
peak NN O
( ( O
S NNP O
) ) O
and CC O
trough $ O
( ( O
D NNP O
) ) O
points NNS O
of IN O
the DT O
maximum NN O
shifted VBD O
- : O
frequency NN O
envelope NN O
fell VBD O
in IN O
parallel NN O
in IN O
a DT O
linear JJ O
fashion NN O
until IN O
D NNP O
reached VBD O
zero NN O
. . O

Thus RB O
, , O
a DT O
critical JJ O
question NN O
is VBZ O
how WRB O
HOX JJ B-Gene
proteins NNS I-Gene
select VBP O
the DT O
correct JJ O
sets NNS O
of IN O
target NN O
genes NNS O
in IN O
vivo NN O
. . O

On IN O
admission NN O
to TO O
the DT O
ICU NNP O
, , O
117 CD O
patients NNS O
( ( O
61 CD O
percent NN O
) ) O
had VBD O
hypomagnesemia VBN O
( ( O
serum JJ O
Mg NNP O
less JJR O
than IN O
1 CD O
. . O
5 CD O
mEq JJ O
/ NNP O
dl NN O
) ) O
, , O
66 CD O
patients NNS O
( ( O
34 CD O
percent NN O
) ) O
had VBD O
normomagnesemia VBN O
( ( O
1 CD O
. . O
5 CD O
to TO O
2 CD O
. . O
0 CD O
mEq JJ O
/ NNP O
dl NN O
) ) O
, , O
and CC O
ten JJ O
patients NNS O
( ( O
5 CD O
percent NN O
) ) O
had VBD O
hypermagnesemia NN O
( ( O
greater JJR O
than IN O
2 CD O
. . O
0 CD O
mEq JJ O
/ NNP O
dl NN O
) ) O
. . O

Induction NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NN O
binding VBG O
correlates NNS O
with IN O
a DT O
concomitant JJ O
GH NNP B-Gene
trans VBZ O
- : O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
genes NNS I-Gene
described VBD O
previously RB O
. . O

Comparison NNP O
of IN O
the DT O
cDNA NN O
- : O
predicted VBN O
avian JJ B-Gene
TnIcardiac NNP I-Gene
amino NN I-Gene
acid NN I-Gene
sequences NNS I-Gene
with IN O
known VBN O
TnI NNP B-Gene
sequences NNS I-Gene
indicated VBD O
1 CD O
) ) O
that IN O
the DT O
presence NN O
of IN O
an DT O
N NNP O
- : O
terminal JJ O
extension NN O
sequence NN O
carrying VBG O
a DT O
dual JJ O
protein NN B-Gene
kinase VBD I-Gene
A DT I-Gene
phosphorylation NN O
target NN O
site NN O
and CC O
an DT O
adjacent JJ O
proline NN O
- : O
rich JJ O
segment NN O
is VBZ O
an DT O
ancient JJ O
cardiac NN O
- : O
specific JJ O
feature NN O
of IN O
TnI NNP B-Gene
which WDT O
has VBZ O
been VBN O
conserved VBN O
since IN O
the DT O
bird NN O
/ NNP O
mammal JJ O
divergence NN O
, , O
2 CD O
) ) O
that WDT O
features VBZ O
of IN O
the DT O
near JJ O
- : O
N NNP O
- : O
terminal JJ O
troponin NN B-Gene
C NNP I-Gene
( ( O
TnC NNP B-Gene
) ) O
- : O
binding VBG O
site NN O
sequence NN O
suggest VBP O
isoform NN O
- : O
specific JJ O
adaptation NN O
of IN O
TnI NNP B-Gene
and CC O
TnC NNP B-Gene
, , O
and CC O
3 CD O
) ) O
that IN O
the DT O
avian JJ O
TnIcardiac NNP B-Gene
internal JJ O
actin NN B-Gene
/ NN I-Gene
TnC NNP I-Gene
- : I-Gene
binding NN I-Gene
, , I-Gene
actomyosin SYM I-Gene
- : I-Gene
inhibitory NN I-Gene
, , I-Gene
domain NN I-Gene
shows NNS O
significant JJ O
sequence NN O
divergence NN O
from IN O
mammalian JJ B-Gene
TnIcardiac NNP I-Gene
sequences NNS I-Gene
, , O
including VBG O
the DT O
absence NN O
of IN O
a DT O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
target NN O
site NN O
which WDT O
is VBZ O
a DT O
cardiac JJ O
- : O
specific JJ O
feature NN O
of IN O
TnI NNP B-Gene
in IN O
mammals NNS O
. . O

Male JJ O
Japanese JJ O
quail NN O
were VBD O
chronically RB O
exposed VBN O
to TO O
5000 CD O
ppm NN O
manganese NN O
( ( O
Mn NNP O
) ) O
as IN O
particulate NN O
manganese JJ O
oxide NN O
( ( O
Mn3O4 NNP O
) ) O
in IN O
their PRP$ O
diet NN O
from IN O
hatching VBG O
to TO O
75 CD O
days NNS O
of IN O
age NN O
. . O

The DT O
3 CD O
- : O
hour NN O
test NN O
iodine NN O
( ( O
I PRP O
- : O
132 CD O
) ) O
uptake NN O
by IN O
the DT O
thyroid NN O
in IN O
children NNS O
with IN O
growth NN O
deficiency NN O

Although IN O
Pho85 NNP B-Gene
is VBZ O
not RB O
essential JJ O
for IN O
viability NN O
, , O
Pcl1 NNP B-Gene
, , I-Gene
2 CD I-Gene
- : O
Pho85 NN B-Gene
kinase NN O
complexes VBZ O
become VBN O
essential JJ O
for IN O
Start NNP O
in IN O
the DT O
absence NN O
of IN O
Cln1 NNP B-Gene
, , I-Gene
2 CD I-Gene
- : O
Cdc28 NN B-Gene
kinases NNS O
. . O

Correlation NN O
coefficients NNS O
between IN O
the DT O
reference NN O
methods NNS O
and CC O
NIT NNP O
were VBD O
> NNP O
or CC O
= $ O
0 CD O
. . O
95 CD O
for IN O
water NN O
, , O
fat NN O
, , O
crude NN O
protein NN O
and CC O
connective JJ O
- : O
tissue NN O
- : O
protein NN O
frei JJ O
meat NN O
protein NN O
, , O
and CC O
> NNP O
or CC O
= $ O
0 CD O
. . O
86 CD O
for IN O
connective JJ O
- : O
tissue NN O
- : O
protein NN O
. . O

Applications NNS O
of IN O
three CD O
- : O
dimensional JJ O
analysis NN O
to TO O
the DT O
auditory NN O
P300 NNP O
. . O

Human NNP O
brain NN O
cDNA NN O
library JJ O
screening NN O
and CC O
5 CD O
' '' O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
yielded VBN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
DENTT NNP I-Gene
cDNA NN I-Gene
containing VBG O
an DT O
1899 CD O
- : O
bp NN O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
predicted JJ O
633 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
with IN O
four CD O
potential JJ O
nuclear JJ O
localization NN O
signals NNS O
( ( O
NLSs NNP O
) ) O
and CC O
two CD O
coiled VBD O
- : O
coil NN O
regions NNS O
. . O

Corticosteroid NNP O
therapy NN O
is VBZ O
known VBN O
to TO O
be VB O
hazardous JJ O
in IN O
patients NNS O
with IN O
occult JJ O
infection NN O
but CC O
the DT O
mechanism NN O
by IN O
which WDT O
the DT O
host NN O
parasite NN O
relationship NN O
is VBZ O
altered VBN O
by IN O
steroids NNS O
is VBZ O
not RB O
known VBN O
. . O
We PRP O
have VBP O
used VBN O
an DT O
intestinal JJ O
protozoal NN O
parasite NN O
, , O
Giardia NNP O
muris NN O
, , O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
corticosteroids NNS O
on IN O
the DT O
number NN O
of IN O
parasites NNS O
in IN O
the DT O
intestine NN O
in IN O
the DT O
course NN O
of IN O
a DT O
primary JJ O
infection NN O
. . O

Transfer NN O
also RB O
correlated VBD O
inversely RB O
with IN O
gastric JJ O
juice NN O
pH NN O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
619 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
2 CD O
) ) O
. . O

The DT O
rrd1 NN B-Gene
, , I-Gene
2delta CD I-Gene
mutant NN I-Gene
was VBD O
partially RB O
rescued VBN O
by IN O
inactivation NN O
of IN O
HOG1 NNP B-Gene
or CC O
PBS2 NNP B-Gene
, , O
suggesting VBG O
an DT O
interaction NN O
between IN O
the DT O
RRD NNP B-Gene
genes NNS I-Gene
and CC O
the DT O
Hog1p NNP B-Gene
signal JJ I-Gene
transduction NN I-Gene
pathway NN I-Gene
. . O

Sci NNP O
. . O

One CD O
chimpanzee NN O
reliably RB O
selected VBD O
the DT O
larger JJR O
numeral JJ O
4 CD O
during IN O
testing VBG O
with IN O
a DT O
nonadjacent JJ O
pair NN O
( ( O
2 CD O
- : O
4 CD O
) ) O
, , O
and CC O
2 CD O
chimps NNS O
showed VBD O
no DT O
preference NN O
. . O

At IN O
4 CD O
wk NN O
however RB O
, , O
tumor NN O
relapse NN O
was VBD O
noted VBN O
in IN O
6 CD O
of IN O
7 CD O
group NN O
4 CD O
responders NNS O
, , O
10 CD O
of IN O
12 CD O
in IN O
group NN O
5 CD O
, , O
13 CD O
of IN O
16 CD O
in IN O
group NN O
7 CD O
, , O
but CC O
only RB O
4 CD O
of IN O
19 CD O
group NN O
8 CD O
responders NNS O
( ( O
p NN O
less JJR O
than IN O
. . O
1 CD O
group NN O
8 CD O
versus NN O
4 CD O
, , O
5 CD O
, , O
7 CD O
) ) O
. . O

Three CD O
cases NNS O
of IN O
primary JJ O
signet NN O
- : O
ring NN O
cell NN O
carcinoma NN O
of IN O
the DT O
rectum NN O
are VBP O
described VBN O
. . O

Double NNP O
- : O
blind NN O
, , O
placebo SYM O
- : O
controlled VBN O
trial NN O
. . O

( ( O
GUT NNP O
) ) O
Sera NNP O
of IN O
30 CD O
montoux NNS O
negative JJ O
healthy JJ O
adults NNS O
( ( O
age NN O
/ VBZ O
sex NN O
matched VBN O
) ) O
were VBD O
taken VBN O
as IN O
control NN O
by IN O
detecting VBG O
IgG NNP B-Gene
anti JJ I-Gene
bodies NNS I-Gene
to TO O
A60 NNP B-Gene
antigen NN I-Gene
. . O

By IN O
Caveman NNP O
. . O

Porcelain NN O
to TO O
dentin VB O
bond NN O
strength NN O
with IN O
a DT O
dentin NN O
adhesive NN O
. . O

Minor JJ O
initiation NN O
sites NNS O
were VBD O
found VBN O
at IN O
positions NNS O
- : O
128 CD O
, , O
- : O
111 CD O
, , O
- : O
91 CD O
, , O
and CC O
- : O
74 CD O
. . O

The DT O
RAD18 NNP B-Gene
gene NN I-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
encodes VBZ O
a DT O
protein NN O
of IN O
487 CD O
amino NN O
acids NNS O
, , O
with IN O
a DT O
calculated JJ O
molecular JJ O
weight NN O
of IN O
55 CD O
, , O
512 CD O
. . O

Of IN O
the DT O
three CD O
known VBN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
family NN I-Gene
inhibitors NNS O
, , O
Ig NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
, , O
LIP NNP B-Gene
and CC O
CHOP NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
only RB O
Ig NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
is VBZ O
ubiquitously RB O
expressed VBN O
. . O

The DT O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
beta NN I-Gene
gene NN I-Gene
( ( O
NGFB NNP B-Gene
) ) O
belongs VBZ O
to TO O
a DT O
conserved JJ O
syntenic JJ O
group NN O
on IN O
human JJ O
chromosome NN O
1 CD O
and CC O
mouse VB O
Chromosome NNP O
3 CD O
. . O

Pharmacologic NNP O
properties NNS O
of IN O
serotonergic JJ O
agents NNS O
and CC O
antidepressant JJ O
drugs NNS O
. . O

Sixty NNP O
- : O
one CD O
cases NNS O
of IN O
cholera NN O
, , O
all DT O
caused VBN O
by IN O
V NNP O
. . O
cholerae NN O
O1 NNP O
, , O
were VBD O
reported VBN O
. . O

Thromboxane NNP O
B2 NNP O
increased VBD O
( ( O
97 CD O
+ NN O
/ NNP O
- : O
105 CD O
versus NN O
40 CD O
+ NN O
/ NNP O
- : O
26 CD O
pg NN O
/ NNP O
ml NN O
) ) O
and CC O
was VBD O
significantly RB O
higher JJR O
during IN O
heparin JJ O
free JJ O
hemodialysis NN O
than IN O
during IN O
hemodialysis NN O
with IN O
heparin NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
1 CD O
, , O
Wilcoxon NNP O
matched VBD O
pairs NNS O
signed VBD O
rank JJ O
test NN O
) ) O
. . O

Different NNP O
cortical JJ O
malformations NNS O
were VBD O
produced VBN O
in IN O
rats NNS O
by IN O
a DT O
single JJ O
dose NN O
of IN O
X NNP O
- : O
rays NNS O
( ( O
200 CD O
cGy NN O
) ) O
given VBN O
on IN O
different JJ O
days NNS O
during IN O
gestation NN O
. . O

In IN O
this DT O
report NN O
we PRP O
studied VBD O
the DT O
role NN O
of IN O
protein FW B-Gene
- : I-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
ErbB NNP B-Gene
- : O
mediated VBD O
activation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
by IN O
overexpressing VBG O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
mutants NNS I-Gene
in IN O
COS NNP O
- : O
7 CD O
cells NNS O
. . O

To TO O
further RBR O
investigate VB O
the DT O
nature NN O
of IN O
the DT O
site NN O
specificity NN O
a DT O
set NN O
of IN O
deletion NN O
mutants NNS O
of IN O
the DT O
160 CD O
bp NN O
sequence NN O
were VBD O
analysed VBN O
. . O

Isolation NN O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN O
encoding VBG O
a DT O
putative JJ O
cytokine NN O
which WDT O
is VBZ O
induced VBN O
by IN O
stimulation NN O
via IN O
the DT O
CD2 NNP B-Gene
structure NN I-Gene
on IN O
human JJ O
T NNP O
lymphocytes NNS O
. . O

GTPase NNP B-Gene
activating VBG O
specificity NN O
of IN O
RGS12 NNP B-Gene
and CC O
binding VBG O
specificity NN O
of IN O
an DT O
alternatively RB O
spliced VBN O
PDZ NNP B-Gene
( ( O
PSD NNP B-Gene
- : I-Gene
95 CD I-Gene
/ JJ O
Dlg NNP B-Gene
/ NNP O
ZO NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
domain NN O
. . O

Pentobarbital NNP O
( ( O
1 CD O
, , O
3 CD O
, , O
10 CD O
, , O
and CC O
17 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
was VBD O
also RB O
tested VBN O
in IN O
combination NN O
with IN O
rate NN O
- : O
decreasing NN O
doses NNS O
of IN O
normeperidine NN O
( ( O
17 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
, , O
anileridine NN O
( ( O
10 CD O
mg NN O
/ NNP O
kg NN O
) ) O
, , O
alphaprodine NN O
( ( O
10 CD O
mg NN O
/ NNP O
kg NN O
) ) O
, , O
and CC O
fentanyl NN O
( ( O
0 CD O
. . O
3 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
. . O

PURPOSE NN O
: : O
To TO O
determine VB O
the DT O
effects NNS O
of IN O
hypercholesterolemia NN O
and CC O
atherosclerosis NN O
- : O
induced JJ O
chronic JJ O
cavernosal NN O
arterial JJ O
insufficiency NN O
on IN O
cavernosal NN O
smooth JJ O
muscle NN O
tone NN O
, , O
nitric JJ B-Gene
oxide IN I-Gene
synthase NN I-Gene
( ( O
NOS NNP B-Gene
) ) O
activity NN O
and CC O
cavernosal NN O
tissue NN O
synthesis NN O
of IN O
constrictor NN O
eicosanoids NNS O
. . O

Serum NNP O
ascorbic JJ O
acid NN O
had VBD O
an DT O
inverse NN O
and CC O
the DT O
strongest JJS O
association NN O
with IN O
systolic JJ O
blood NN O
pressure NN O
among IN O
the DT O
risk NN O
factors NNS O
including VBG O
blood NN O
pressure NN O
, , O
total JJ O
cholesterol NN O
, , O
triglyceride NN O
, , O
gamma SYM B-Gene
- : I-Gene
GTP NN I-Gene
and CC O
obesity NN O
. . O

Similarly RB O
, , O
overexpression NN O
of IN O
increasing VBG O
concentration NN O
of IN O
COUP NNP B-Gene
- : I-Gene
TFI NN I-Gene
, , O
but CC O
not RB O
COUP NNP B-Gene
- : I-Gene
TFI NNP I-Gene
delta35 NN I-Gene
, , O
can MD O
squelch VB O
the DT O
silencing NN O
activity NN O
of IN O
the DT O
unliganded JJ O
TRbeta NNP B-Gene
. . O

Transcervical JJ O
amnioinfusion NN O
. . O

Although IN O
ANP NNP B-Gene
induced VBD O
systemic JJ O
capillary JJ O
filtration NN O
, , O
in IN O
the DT O
calf NN O
, , O
filtration NN O
was VBD O
reduced VBN O
with IN O
ANP NNP B-Gene
. . O

These DT O
findings NNS O
show VBP O
that IN O
EBP50 NNP B-Gene
is VBZ O
a DT O
physiologically RB O
relevant JJ O
ezrin NN B-Gene
binding VBG I-Gene
protein NN I-Gene
. . O

The DT O
promoter NN O
of IN O
the DT O
rat NN O
pgp2 NN B-Gene
/ NNP O
mdr1b NN B-Gene
gene NN O
has VBZ O
a DT O
GC NNP O
- : O
rich JJ O
region NN O
( ( O
pgp2GC NN B-Gene
) ) O
that WDT O
is VBZ O
highly RB O
conserved VBN O
in IN O
mdr NN B-Gene
genes NNS I-Gene
and CC O
contains VBZ O
an DT O
consensus NN O
Sp1 NNP B-Gene
site NN I-Gene
. . O

The DT O
rate NN O
- : O
limiting JJ O
step NN O
for IN O
telomerase NN B-Gene
activity NN O
seems VBZ O
to TO O
be VB O
the DT O
expression NN O
of IN O
the DT O
catalytic JJ O
subunit NN O
of IN O
the DT O
enzyme NN O
, , O
encoded VBN O
by IN O
the DT O
human JJ B-Gene
telomerase NN I-Gene
reverse NN I-Gene
transcriptase NN I-Gene
( ( O
hTERT NN B-Gene
) ) O
gene NN O
. . O

Cerebral NNP O
vasculitis NN O
secondary JJ O
to TO O
Crohn NNP O
' POS O
s NN O
disease NN O
seems VBZ O
to TO O
be VB O
a DT O
very RB O
rare JJ O
phenomenon NN O
. . O

The DT O
predicted VBN O
protein NN O
products NNS O
of IN O
ORFs NNP B-Gene
N2417 NNP I-Gene
and CC O
N2403 NNP B-Gene
present JJ O
similarities NNS O
with IN O
domains NNS O
from IN O
proteins NNS O
of IN O
other JJ O
organisms NNS O
: : O
the DT O
Candida NNP O
maltosa NN O
cycloheximide NN B-Gene
- : I-Gene
resistance NN I-Gene
protein NN I-Gene
, , O
the DT O
human JJ O
interleukin NN B-Gene
enhancer NN I-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
( ( O
ILF NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

Basal NNP O
plasma VBZ O
AVP NNP B-Gene
levels NNS O
and CC O
AVP NNP B-Gene
release NN O
after IN O
postural JJ O
change NN O
were VBD O
assessed VBN O
, , O
and CC O
plasma VB O
NPY NNP B-Gene
levels NNS O
were VBD O
measured VBN O
in IN O
the DT O
same JJ O
samples NNS O
. . O

SSeCKS NNP B-Gene
( ( O
pronounced JJ O
essex NN O
) ) O
encodes VBZ O
a DT O
major JJ O
protein NN B-Gene
kinase VBD I-Gene
C NNP I-Gene
substrate NN O
, , O
the DT O
expression NN O
of IN O
which WDT O
is VBZ O
down RP O
- : O
regulated VBN O
in IN O
src JJ B-Gene
- : O
and CC O
ras VB B-Gene
- : O
transformed VBN O
rodent JJ O
fibroblasts NNS O
but CC O
not RB O
in IN O
raf JJ O
- : O
transformed JJ O
rodent NN O
fibroblasts NNS O
( ( O
X NNP O
. . O

Aspirin NNP O
causes VBZ O
peptic JJ O
ulcers NNS O
predominately RB O
by IN O
reducing VBG O
gastric JJ B-Gene
mucosal NN I-Gene
cyclooxygenase NN I-Gene
( ( O
COX NNP B-Gene
) ) O
activity NN O
and CC O
prostaglandin NN O
synthesis NN O
. . O

With IN O
current JJ O
methodology NN O
beta NN B-Gene
- : I-Gene
2 CD I-Gene
transferrin NN I-Gene
does VBZ O
not RB O
appear VB O
to TO O
be VB O
a DT O
reliable JJ O
clinical JJ O
marker NN O
for IN O
perilymph NN O
in IN O
the DT O
operative JJ O
setting NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
description NN O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
of IN O
regulatory JJ O
elements NNS O
that WDT O
control VBP O
expression NN O
of IN O
a DT O
gene NN O
encoding VBG O
a DT O
B7 NNP B-Gene
costimulatory NN I-Gene
molecule NN I-Gene
. . O

Genitography NNP O
in IN O
intersexual JJ O
states NNS O
. . O

In IN O
each DT O
compartment NN O
O2 NNP O
is VBZ O
removed VBN O
by IN O
the DT O
tissues NNS O
as IN O
a DT O
chemical NN O
reaction NN O
takes VBZ O
place NN O
between IN O
O2 NNP O
and CC O
oxyhemoglobin NN B-Gene
( ( O
HbO2 NNP B-Gene
) ) O
. . O

Comparison NNP O
of IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
removal NN O
using VBG O
the DT O
same JJ O
polysulphone NN O
membrane NN O
for IN O
haemodialysis NN O
and CC O
haemofiltration NN O
shows NNS O
that WDT O
beta VBP B-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
is VBZ O
more RBR O
effectively RB O
removed VBN O
by IN O
convection NN O
than IN O
by IN O
diffusion NN O
when WRB O
both DT O
treatment NN O
modes NNS O
are VBP O
matched VBN O
for IN O
blood NN O
flow NN O
and CC O
urea JJ O
clearance NN O
. . O

The DT O
osmotic JJ O
diuretic JJ O
mannitol NN O
was VBD O
administered VBN O
to TO O
21 CD O
patients NNS O
. . O

In IN O
patients NNS O
, , O
the DT O
effect NN O
of IN O
CCK NNP B-Gene
- : O
PZ NN B-Gene
on IN O
the DT O
movement NN O
of IN O
the DT O
terminal JJ O
part NN O
of IN O
the DT O
bile NN O
duct NN O
was VBD O
measured VBN O
with IN O
a DT O
pressure NN O
sensor NN O
using VBG O
a DT O
duodenofiberscope NN O
. . O

In IN O
contrast NN O
, , O
the DT O
neu NN B-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
did VBD O
not RB O
show VB O
kinase JJ O
activity NN O
or CC O
transforming NN O
properties NNS O
when WRB O
expressed VBN O
at IN O
similar JJ O
levels NNS O
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Plasma NNP O
thrombomodulin NN B-Gene
: : O
a DT O
marker NN O
for IN O
microvascular JJ O
complications NNS O
in IN O
diabetes NNS O
mellitus NNS O
. . O

The DT O
sequence NN O
of IN O
the DT O
putative JJ O
RBP1 NNP B-Gene
protein NN I-Gene
contains VBZ O
two CD O
copies NNS O
of IN O
an DT O
RNA NNP O
recognition NN O
motif NN O
, , O
two CD O
glutamine NN O
stretches NNS O
, , O
an DT O
asparagine JJ O
- : O
rich JJ O
region NN O
, , O
a DT O
methionine NN O
- : O
rich JJ O
region NN O
, , O
and CC O
two CD O
long JJ O
potential JJ O
alpha NN O
- : O
helixes NNS O
. . O

During IN O
this DT O
time NN O
, , O
the DT O
patients NNS O
all DT O
had VBD O
the DT O
characteristic JJ O
plasma NN O
thyroid NN O
hormone NN O
changes NNS O
associated VBN O
with IN O
amiodarone NN O
therapy NN O
, , O
i NN O
. . O
e NN O
. . O
increased VBN O
T4 NNP O
, , O
free JJ O
T4 NNP O
, , O
and CC O
rT3 NN O
and CC O
decreased JJ O
T3 NNP O
, , O
while IN O
remaining VBG O
clinically RB O
euthyroid JJ O
. . O

Nine JJ O
strains NNS O
were VBD O
subtyped VBN O
as IN O
Camp NNP O
. . O
jejuni NN O
subsp NN O
. . O
jejuni NN O
biotype NN O
II NNP O
and CC O
the DT O
remaining VBG O
ones NNS O
as IN O
biotype NN O
I PRP O
. . O

J NNP O
. . O

However RB O
, , O
although IN O
deletion NN O
of IN O
Fp1 NNP B-Gene
in IN O
the DT O
hCRBP1 NN B-Gene
gene NN I-Gene
yielded VBN O
increased JJ O
CAT NNP B-Gene
activity NN O
, , O
pointing VBG O
toward IN O
a DT O
negative JJ O
regulatory JJ O
function NN O
exerted VBN O
by IN O
this DT O
element NN O
, , O
its PRP$ O
insertion NN O
upstream NN O
of IN O
the DT O
p12 NN B-Gene
basal NN I-Gene
promoter NN I-Gene
results NNS O
in IN O
an DT O
impressive JJ O
positive JJ O
stimulation NN O
of IN O
CAT NNP B-Gene
gene NN I-Gene
expression NN O
. . O

The DT O
in IN O
vitro JJ O
relaxivity NN O
of IN O
the DT O
complex NN O
is VBZ O
16 CD O
. . O
24 CD O
s NN O
( ( O
- : O
1 CD O
) ) O
mM NN O
( ( O
- : O
1 CD O
) ) O
. . O

Phylogenetic JJ O
analyses NNS O
of IN O
19 CD O
amino NN O
acid JJ O
sequences NNS O
of IN O
6 CD O
related JJ O
protein NN O
types NNS O
indicate VBP O
that IN O
actin SYM B-Gene
- : O
associated VBN O
proteins NNS O
related VBN O
to TO O
gelsolin NNS B-Gene
are VBP O
monophyletic JJ O
to TO O
a DT O
common JJ O
ancestor NN O
and CC O
include VBP O
flightless JJ B-Gene
proteins NNS I-Gene
. . O

This DT O
report NN O
has VBZ O
reviewed VBN O
some DT O
of IN O
the DT O
reasons NNS O
for IN O
treatment NN O
failures NNS O
and CC O
has VBZ O
presented VBN O
a DT O
philosophy NN O
for IN O
their PRP$ O
management NN O
. . O

Specimen NNP O
mass NN O
reduction NN O
increased VBD O
with IN O
irradiance NN O
from IN O
19 CD O
to TO O
72 CD O
% NN O
of IN O
the DT O
initial JJ O
mass NN O
for IN O
9 CD O
- : O
- : O
31 CD O
W NNP O
/ NNP O
cm NN O
( ( O
2 CD O
) ) O
, , O
respectively RB O
. . O

Intensive JJ O
synthesis NN O
of IN O
PNA NNP B-Gene
in IN O
the DT O
cells NNS O
of IN O
microvascular JJ O
wall NN O
evidenced VBD O
of IN O
their PRP$ O
high JJ O
functional JJ O
activity NN O
, , O
and CC O
the DT O
synthesis NN O
of IN O
DNA NN O
in IN O
them PRP O
showed VBD O
their PRP$ O
ability NN O
for IN O
proliferation NN O
, , O
i NN O
. . O
g NN O
. . O
- : O
- : O
for IN O
growth NN O
. . O

Qualitatively RB O
, , O
the DT O
results NNS O
are VBP O
similar JJ O
for IN O
the DT O
two CD O
species NNS O
: : O
Both DT O
rhesus VBP O
monkey NN O
and CC O
man NN O
have VBP O
photopic VBN O
and CC O
scotopic JJ O
branches NNS O
, , O
which WDT O
cross VBP O
at IN O
approximately RB O
the DT O
same JJ O
time NN O
in IN O
the DT O
dark NN O
and CC O
at IN O
approximately RB O
the DT O
same JJ O
background NN O
luminance NN O
. . O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
serum NN B-Gene
LH NNP I-Gene
and CC O
chronological JJ O
or CC O
bone JJ O
age NN O
in IN O
this DT O
age NN O
group NN O
, , O
which WDT O
suggests VBZ O
that IN O
the DT O
correlation NN O
found VBD O
is VBZ O
not RB O
due JJ O
to TO O
age NN O
- : O
related JJ O
parallel JJ O
phenomena NN O
. . O

CONCLUSIONS NN O
: : O
A DT O
comparison NN O
of IN O
the DT O
LysU NNP B-Gene
crystal NN O
structure NN O
with IN O
the DT O
structures NNS O
of IN O
seryl JJ B-Gene
- : I-Gene
and CC I-Gene
aspartyl VB I-Gene
- : I-Gene
tRNA NN I-Gene
synthetases VBZ I-Gene
enables VBZ O
a DT O
conserved JJ O
core NN O
to TO O
be VB O
identified VBN O
. . O

Three CD O
patients NNS O
received VBD O
additional JJ O
cycles NNS O
of IN O
5 CD O
- : O
fluorouracil NN O
+ NNP O
/ NNP O
- : O
leucovorin NN O
as IN O
maintenance NN O
chemotherapy NN O
. . O
RESULTS NN O
: : O
Thirty JJ O
males NNS O
and CC O
21 CD O
females NNS O
with IN O
a DT O
median JJ O
age NN O
of IN O
55 CD O
years NNS O
( ( O
range NN O
31 CD O
- : O
- : O
73 CD O
years NNS O
) ) O
were VBD O
treated VBN O
. . O

Effects NNS O
of IN O
activating VBG O
blood NN O
circulation NN O
to TO O
remove VB O
blood NN O
stasis NN O
on IN O
barrier JJR O
action NN O
of IN O
gastric JJ O
wall NN O
in IN O
chronic JJ O
atrophic JJ O
gastritis NN O

Consequently RB O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
how WRB O
knee JJ O
loading NN O
changes NNS O
following VBG O
ACL NNP O
transection NN O
, , O
and CC O
how WRB O
it PRP O
contributes VBZ O
to TO O
cartilage VB O
degeneration NN O
. . O

Lung NNP O
and CC O
multi SYM O
- : O
system NN O
damage NN O
were VBD O
early JJ O
indicators NNS O
of IN O
poor JJ O
outcome NN O
in IN O
severe JJ O
non JJ O
- : O
fatal JJ O
disease NN O
. . O

The DT O
experiments NNS O
show VBP O
that IN O
it PRP O
is VBZ O
the DT O
micromilieu NN O
of IN O
the DT O
alveoli NN O
and CC O
the DT O
condition NN O
of IN O
the DT O
AM NNP O
( ( O
certain JJ O
physiological JJ O
activation NN O
states NNS O
, , O
such JJ O
as IN O
phagocytic JJ O
activity NN O
) ) O
that WDT O
essentially RB O
determine VBP O
the DT O
degree NN O
of IN O
recovery NN O
. . O

RESULTS NN O
: : O
The DT O
introduction NN O
of IN O
the DT O
PAIP NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
reduction NN O
in IN O
contaminating VBG O
WBCs NNP O
( ( O
median JJ O
, , O
30 CD O
, , O
0 CD O
) ) O
from IN O
the DT O
numbers NNS O
seen VBN O
with IN O
FIP NNP O
( ( O
median JJ O
, , O
2 CD O
, , O
300 CD O
, , O
0 CD O
) ) O
while IN O
maintaining VBG O
the DT O
separation NN O
efficacy NN O
( ( O
47 CD O
% NN O
) ) O
and CC O
separation NN O
time NN O
. . O

We PRP O
also RB O
present VBD O
evidence NN O
that IN O
human JJ B-Gene
HYAL1 NNP I-Gene
is VBZ O
identical JJ O
to TO O
an DT O
uncharacterized JJ O
gene NN O
positionally RB O
cloned VBN O
by IN O
others NNS O
from IN O
chromosome NN O
3p21 CD O
. . O
3 CD O
that WDT O
is VBZ O
homozygously RB O
deleted VBN O
in IN O
several JJ O
small JJ O
- : O
cell NN O
lung NN O
carcinoma NN O
cell NN O
lines NNS O
. . O

In IN O
these DT O
cells NNS O
, , O
E2 NNP B-Gene
proteins NNS I-Gene
had VBD O
little JJ O
or CC O
no DT O
stimulatory JJ O
effect NN O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
HPV NNP B-Gene
- : I-Gene
11 CD I-Gene
enhancer SYM I-Gene
- : O
SV40 JJ B-Gene
promoter NN I-Gene
. . O

The DT O
introduction NN O
of IN O
hARF4 NN B-Gene
to TO O
the DT O
cells NNS O
maintained VBD O
the DT O
balance NN O
between IN O
cytosolic JJ O
and CC O
membrane JJ O
- : O
associated VBN O
Sec7p NNP B-Gene
pools NNS O
. . O

Determination NN O
of IN O
an DT O
RNA NNP O
structure NN O
involved VBN O
in IN O
splicing VBG O
inhibition NN O
of IN O
a DT O
muscle NN O
- : O
specific JJ O
exon NN O
. . O

Bound NNP O
- : O
exciton NN O
transfer NN O
and CC O
photoluminescence NN O
undulation NN O
spectra NN O
for IN O
acceptors NNS O
in IN O
ZnTe NNP O
. . O

The DT O
initial JJ O
inpatient NN O
experience NN O
for IN O
individuals NNS O
with IN O
HIV NNP O
- : O
related JJ O
TB NN O
may MD O
be VB O
pivotal JJ O
to TO O
the DT O
acceptance NN O
of IN O
and CC O
participation NN O
in IN O
ongoing VBG O
TB NNP O
care NN O
. . O

Sucrose NNP O
- : O
specific JJ O
regulation NN O
of IN O
scrB NN B-Gene
was VBD O
also RB O
lost VBN O
upon IN O
deletion NN O
of IN O
4 CD O
bp NN O
of IN O
a DT O
palindromic JJ O
sequence NN O
( ( O
OB NNP O
) ) O
covering VBG O
positions NNS O
+ $ O
6 CD O
to TO O
+ VB O
21 CD O
downstream NN O
of IN O
the DT O
scrB JJ B-Gene
transcriptional JJ O
start NN O
site NN O
. . O

Adrenergic NNP O
nerve NN O
function NN O
, , O
noradrenaline JJ O
level NN O
and CC O
noradrenaline JJ O
uptake NN O
in IN O
cat NN O
nictitating VBG O
membrane NN O
after IN O
reserpine JJ O
treatment NN O
. . O

Thus RB O
, , O
the DT O
PCE NNP B-Gene
binds VBZ O
a DT O
Pbx NNP B-Gene
dimer NN I-Gene
partner NN I-Gene
that WDT O
behaves VBZ O
unlike IN O
Class NN B-Gene
I PRP I-Gene
Hox VBP I-Gene
proteins NNS I-Gene
. . O

In IN O
addition NN O
to TO O
the DT O
bZIP NN B-Gene
protein NN I-Gene
Opaque2 NNP I-Gene
( ( O
O2 NNP B-Gene
) ) O
, , O
there EX O
are VBP O
other JJ O
maize JJ O
endosperm JJ O
nuclear JJ O
proteins NNS O
that WDT O
recognize VBP O
the DT O
O2 NNP B-Gene
box NN I-Gene
in IN O
22 CD O
kDa NNS O
zein CD B-Gene
gene NN O
promoters NNS O
. . O

Calcitonin NNP B-Gene
simultaneously RB O
regulates VBZ O
both DT O
periosteal JJ O
hyperostosis NN O
and CC O
trabecular JJ O
osteopenia NN O
in IN O
the DT O
spinal JJ O
hyperostotic JJ O
mouse NN O
( ( O
twy JJ B-Gene
/ NNP O
twy NN B-Gene
) ) O
in IN O
vivo NN O
. . O

A DT O
poor JJ O
correlation NN O
was VBD O
found VBN O
between IN O
a DT O
mildly RB O
- : O
atypical JJ O
( ( O
inflammatory JJ O
) ) O
cytological JJ O
result NN O
( ( O
class NN O
2 CD O
) ) O
and CC O
a DT O
benign JJ O
histological JJ O
diagnosis NN O
: : O
48 CD O
% NN O
of IN O
class NN O
- : O
2 CD O
smears NNS O
were VBD O
diagnosed VBN O
histologically RB O
as IN O
dysplasia NN O
or CC O
worse JJR O
. . O

DAF16 NNP B-Gene
is VBZ O
known VBN O
to TO O
be VB O
a DT O
component NN O
of IN O
a DT O
signaling VBG O
pathway NN O
that WDT O
has VBZ O
been VBN O
partially RB O
dissected VBN O
genetically RB O
and CC O
includes VBZ O
homologues NNS O
of IN O
the DT O
insulin NN B-Gene
/ NNP O
IGF NNP B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
, , O
PtdIns NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
and CC O
PKB NNP B-Gene
. . O

A DT O
herpesvirus JJ O
proteinase NN O
activity NN O
has VBZ O
been VBN O
identified VBN O
and CC O
partially RB O
characterized VBN O
by IN O
using VBG O
the DT O
cloned VBN O
enzyme NN O
and CC O
substrate NN O
genes NNS O
in IN O
transient JJ O
transfection NN O
assays NNS O
. . O

Insulin NNP B-Gene
- : O
stimulated VBD O
glucose JJ O
transport NN O
in IN O
adipocytes NNS O
is VBZ O
mediated VBN O
by IN O
the DT O
insulin NN B-Gene
receptor NN I-Gene
. . O

In IN O
the DT O
work NN O
reported VBD O
here RB O
, , O
we PRP O
used VBD O
peptide RB O
mapping VBG O
, , O
mass NN O
spectrometry NN O
, , O
and CC O
site NN O
- : O
directed VBN O
mutagenesis NN O
to TO O
identify VB O
two CD O
sets NNS O
of IN O
pAP JJ B-Gene
phosphorylation NN O
sites NNS O
. . O

Structural JJ O
and CC O
evolutionary JJ O
studies NNS O
on IN O
sterol NN B-Gene
14 CD I-Gene
- : I-Gene
demethylase NN I-Gene
P450 NNP I-Gene
( ( O
CYP51 NNP B-Gene
) ) O
, , O
the DT O
most RBS O
conserved JJ O
P450 NNP B-Gene
monooxygenase NN I-Gene
: : O
I PRP O
. . O

All DT O
patients NNS O
received VBD O
VCR NNP O
1 CD O
. . O
0 CD O
mg JJ O
/ NNP O
m2 NN O
weekly NN O
for IN O
6 CD O
weeks NNS O
with IN O
dose JJ O
modification NN O
for IN O
neurotoxicity NN O
. . O

AB004534 NNP B-Gene
. . O

SNAP NNP B-Gene
- : I-Gene
23 CD I-Gene
plays NNS O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
vesicle NN O
trafficking NN O
in IN O
mammalian JJ O
cells NNS O
. . O

Major JJ O
clinical JJ O
symptoms NNS O
of IN O
the DT O
disease NN O
were VBD O
defined VBN O
in IN O
this DT O
group NN O
of IN O
patients NNS O
. . O

In IN O
the DT O
past JJ O
decade NN O
, , O
there EX O
have VBP O
been VBN O
enormous JJ O
advances NNS O
in IN O
the DT O
use NN O
of IN O
Bayesian JJ O
methodology NN O
for IN O
analysis NN O
of IN O
epidemiologic JJ O
data NNS O
, , O
and CC O
there EX O
are VBP O
now RB O
many JJ O
practical JJ O
advantages NNS O
to TO O
the DT O
Bayesian JJ O
approach NN O
. . O

In IN O
view NN O
of IN O
the DT O
short JJ O
t1 NN O
/ VBD O
2 CD O
, , O
we PRP O
used VBD O
three CD O
doses NNS O
/ JJ O
day NN O
. . O

The DT O
mechanism NN O
of IN O
action NN O
is VBZ O
explored VBN O
in IN O
some DT O
detail NN O
, , O
specifically RB O
as IN O
it PRP O
relates VBZ O
to TO O
reticuloendothelial VB O
system NN O
( ( O
RES NNP O
) ) O
Fc NNP B-Gene
receptor NN I-Gene
blockade NN O
and CC O
suppression NN O
of IN O
antiplatelet NN O
antibody NN O
synthesis NN O
. . O

Sequence NN O
comparisons NNS O
have VBP O
shown VBN O
that IN O
Aps1p NNP B-Gene
is VBZ O
more RBR O
similar JJ O
to TO O
the DT O
sigma NN O
subunit NN O
of IN O
the DT O
Golgi NNP O
- : O
localized JJ O
mammalian JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complex JJ I-Gene
than IN O
Aps2p NNP B-Gene
, , O
which WDT O
is VBZ O
more RBR O
related JJ O
to TO O
the DT O
plasma NN O
membrane NN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
sigma NN I-Gene
subunit NN O
. . O

Their PRP$ O
use NN O
established VBD O
that IN O
the DT O
BrAAP NNP O
activity NN O
catalyzed VBD O
both DT O
a DT O
postproline NN O
and CC O
a DT O
postglutamate JJ O
cleavage NN O
and CC O
therefore NN O
has VBZ O
a DT O
broader JJR O
specificity NN O
than IN O
previously RB O
recognized VBN O
. . O

In IN O
addition NN O
, , O
these DT O
cells NNS O
contained VBD O
one CD O
, , O
two CD O
, , O
or CC O
multiple JJ O
nuclei JJ O
indicative NN O
of IN O
a DT O
G2 NNP O
/ NNP O
M NNP O
delay NN O
in IN O
nuclear JJ O
division NN O
and CC O
also RB O
a DT O
defect NN O
in IN O
cytokinesis NN O
and CC O
/ NN O
or CC O
cell NN O
separation NN O
. . O

When WRB O
statistically RB O
analyzed VBN O
in IN O
various JJ O
subgroupings NNS O
, , O
the DT O
obtained JJ O
average JJ O
sedimentation NN O
coefficients NNS O
and CC O
polydispersity NN O
profiles NNS O
supported VBD O
the DT O
following JJ O
conclusions NNS O
: : O
( ( O
a DT O
) ) O
loss NN O
of IN O
proteoglycan JJ O
aggregation NN O
and CC O
sedimentability NN O
is VBZ O
confirmed VBN O
to TO O
be VB O
a DT O
primary JJ O
sign NN O
of IN O
cartilage NN O
matrix JJ O
degradation NN O
; : O
( ( O
b NN O
) ) O
higher JJR O
S NNP O
values NNS O
for IN O
proteoglycans NNS O
of IN O
the DT O
high JJ O
weight NN O
( ( O
HW NNP O
) ) O
- : O
bearing VBG O
areas NNS O
and CC O
lower JJR O
values NNS O
for IN O
those DT O
of IN O
the DT O
low JJ O
weight NN O
( ( O
LW NNP O
) ) O
- : O
bearing VBG O
areas NNS O
were VBD O
a DT O
typical JJ O
finding NN O
in IN O
normal JJ O
cartilage NN O
samples NNS O
; : O
( ( O
c NN O
) ) O
inversion NN O
of IN O
this DT O
pattern NN O
was VBD O
indicative JJ O
of IN O
matrix JJ O
degradation NN O
, , O
suggesting VBG O
that IN O
the DT O
HW NNP O
regions NNS O
are VBP O
more RBR O
affected JJ O
than IN O
the DT O
LW NNP O
- : O
bearing NN O
areas NNS O
; : O
( ( O
d NN O
) ) O
the DT O
average JJ O
S NNP O
value NN O
distribution NN O
across IN O
cartilage NN O
thickness NN O
tended VBD O
to TO O
resemble VB O
the DT O
corresponding JJ O
proteoglycan JJ O
content NN O
versus NN O
distance NN O
from IN O
articular JJ O
surface NN O
; : O
and CC O
( ( O
e NN O
) ) O
the DT O
deepest JJS O
cartilage NN O
layer NN O
had VBD O
, , O
in IN O
most JJS O
cases NNS O
, , O
the DT O
smallest JJS O
amount NN O
of IN O
aggregates NNS O
while IN O
the DT O
highest JJS O
average JJ O
sedimentability NN O
was VBD O
observed VBN O
at IN O
the DT O
middle JJ O
zone NN O
of IN O
the DT O
normal JJ O
samples NNS O
. . O

The DT O
Mig1 NNP B-Gene
repressor NN I-Gene
is VBZ O
a DT O
zinc NN B-Gene
finger NN I-Gene
protein VBP I-Gene
that IN O
mediates NNS O
glucose JJ O
repression NN O
in IN O
yeast NN O
. . O

Seventy NNP O
- : O
one CD O
supplementary JJ O
doses NNS O
of IN O
vecuronium NN O
were VBD O
used VBN O
for IN O
muscle NN O
relaxation NN O
during IN O
a DT O
22 CD O
- : O
h NN O
- : O
long RB O
NLA NNP O
II NNP O
anaesthesia NN O
. . O

The DT O
nucleotide JJ O
sequences NNS O
of IN O
these DT O
genes NNS O
differ VBP O
at IN O
only RB O
nine CD O
positions NNS O
, , O
resulting VBG O
in IN O
three CD O
amino NN O
acid NN O
differences NNS O
. . O

In IN O
mammalian JJ O
tissue NN O
culture NN O
cells NNS O
, , O
overexpression NN O
of IN O
any DT O
of IN O
the DT O
four CD O
mouse NN O
deltex NN O
homologs NNS O
suppressed VBD O
the DT O
transcriptional JJ O
activity NN O
of IN O
E47 NNP B-Gene
, , O
a DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
bHLH NN I-Gene
) ) I-Gene
protein NN I-Gene
, , O
in IN O
a DT O
manner NN O
similar JJ O
to TO O
suppression NN O
by IN O
an DT O
activated JJ O
form NN O
of IN O
human JJ B-Gene
Notch1 NNP I-Gene
or CC O
human JJ B-Gene
DTX1 NNP I-Gene
. . O

We PRP O
identify VBP O
the DT O
"""" NNP O
M NNP O
region NN O
"""" NN O
of IN O
the DT O
muscle NN B-Gene
- : I-Gene
specific JJ I-Gene
Xenopus NNP I-Gene
cardiac NN I-Gene
actin NN I-Gene
gene NN I-Gene
promoter NN I-Gene
from IN O
- : O
282 CD O
to TO O
- : O
348 CD O
as IN O
necessary JJ O
for IN O
the DT O
embryonic JJ O
expression NN O
of IN O
a DT O
cardiac JJ O
actin NN B-Gene
- : O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
reporter NN O
gene NN O
injected VBD O
into IN O
fertilized VBN O
eggs NNS O
. . O

Employing VBG O
fluorescence NN O
spectroscopy NN O
and CC O
circular JJ O
dichroism NN O
, , O
we PRP O
showed VBD O
that IN O
the DT O
binding NN O
of IN O
Ca2 NNP O
+ NNP O
to TO O
ALG NNP B-Gene
- : I-Gene
2 CD I-Gene
induced JJ O
significant JJ O
conformational JJ O
changes NNS O
in IN O
both DT O
the DT O
N NNP O
- : O
terminal NN O
and CC O
C NNP O
- : O
terminal JJ O
domains NNS O
of IN O
the DT O
protein NN O
. . O

INF NNP B-Gene
- : I-Gene
alpha NN I-Gene
therapy NN O
has VBZ O
been VBN O
a DT O
major JJ O
development NN O
in IN O
the DT O
treatment NN O
of IN O
CML NNP O
. . O

There EX O
was VBD O
no DT O
difference NN O
in IN O
plasma JJ O
concentrations NNS O
of IN O
PGI2 NNP O
( ( O
figure NN O
4 CD O
) ) O
and CC O
TxA2 NNP O
in IN O
patients NNS O
with IN O
normal JJ O
blood NN O
pressure NN O
, , O
mild JJ O
preeclampsia NN O
and CC O
hypotension NN O
, , O
whereas NNS O
in IN O
severe JJ O
preeclampsia NN O
, , O
the DT O
plasma JJ O
concentration NN O
of IN O
PGI2 NNP O
was VBD O
significantly RB O
lower JJR O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
and CC O
of IN O
TxA2 NNP O
significantly RB O
higher JJR O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
. . O

This DT O
plus VBZ O
the DT O
reduced JJ O
phosphorylation NN O
of IN O
p27 NN B-Gene
by IN O
MAPK NNP B-Gene
enhanced VBD O
the DT O
stability NN O
of IN O
p27 NN B-Gene
that WDT O
associated VBD O
with IN O
nuclear JJ B-Gene
Cdk2 NNP I-Gene
at IN O
high JJ O
stoichiometry NN O
and CC O
inhibited VBD O
its PRP$ O
kinase NN O
activity NN O
. . O

G NNP O
. . O
, , O
and CC O
Hyde NNP O
, , O
C NNP O
. . O

Antenatal JJ O
diagnosis NN O
of IN O
haematological JJ O
disorders NNS O
- : O
- : O
' '' O
1978 CD O
' POS O
. . O

Expression NN O
of IN O
a DT O
dominant JJ B-Gene
negative JJ I-Gene
Smad2 NNP I-Gene
significantly RB O
reduces VBZ O
the DT O
level NN O
of IN O
luciferase JJ B-Gene
reporter NN I-Gene
activity NN O
induced VBN O
by IN O
nodal JJ O
treatment NN O
. . O

Two CD O
hundred VBD O
sixty SYM O
- : O
four CD O
patients NNS O
scheduled VBN O
for IN O
DCBM NNP O
were VBD O
randomized VBN O
to TO O
receive VB O
intravenously RB O
geG JJ O
0 CD O
. . O
25 CD O
mg NN O
( ( O
geG JJ O
- : O
25 CD O
) ) O
, , O
or CC O
geG RB O
0 CD O
. . O
5 CD O
mg NN O
( ( O
geG JJ O
- : O
50 CD O
) ) O
, , O
or CC O
HBB NNP O
20 CD O
mg NN O
as IN O
hypotonic JJ O
agent NN O
. . O

Retrogradely RB O
labelled JJ O
neurons NNS O
significantly RB O
prevailed VBN O
in IN O
the DT O
ipsilateral JJ O
substantia NN O
nigra NN O
pars NNS O
compacta VBP O
. . O

Chronic NNP O
hepatitis NN O
B NNP O
in IN O
adopted JJ O
Romanian JJ O
children NNS O
. . O

Saunders NNS O
Company NNP O
. . O

Regions NNS O
of IN O
the DT O
translated JJ O
open JJ O
reading VBG O
frames NNS O
of IN O
cobA NN B-Gene
and CC O
the DT O
third JJ O
intron NN O
of IN O
the DT O
cob NN B-Gene
gene NN I-Gene
in IN I-Gene
yeast NNP I-Gene
show VBP O
high JJ O
amino NN O
acid NN O
homology NN O
. . O

Thus RB O
, , O
patients NNS O
with IN O
metastatic JJ O
melanoma NNS O
are VBP O
not RB O
tolerant JJ O
to TO O
gp100 VB B-Gene
Ag NNP I-Gene
based VBN O
on IN O
the DT O
detection NN O
of IN O
CD8 NNP B-Gene
+ NNP I-Gene
T NNP O
cells NNS O
specific JJ O
for IN O
multiple JJ O
HLA NNP B-Gene
- : I-Gene
A DT I-Gene
* JJ I-Gene
201 CD I-Gene
- : O
restricted VBN O
, , O
gp100 SYM B-Gene
- : O
derived VBN O
epitopes NNS O
. . O

The DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
exhibited VBD O
70 CD O
% NN O
identity NN O
to TO O
that DT O
of IN O
Bacillus NNP B-Gene
stearothermophilus CC I-Gene
TyrTS NNP I-Gene
and CC O
55 CD O
% NN O
identity NN O
to TO O
that DT O
of IN O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
TyrTS NNP I-Gene
, , O
while IN O
identity NN O
to TO O
a DT O
second JJ O
cryptic JJ O
B NNP B-Gene
. . I-Gene
subtilis NN I-Gene
TyrTS NNP I-Gene
gene NN I-Gene
, , O
designated VBN O
tyrZ NN B-Gene
, , O
was VBD O
only RB O
27 CD O
% NN O
. . O

Investigated VBN O
the DT O
reliability NN O
, , O
validity NN O
and CC O
dimensionality NN O
of IN O
scores NNS O
obtained VBN O
by IN O
acute JJ O
psychiatric JJ O
inpatients NNS O
( ( O
N NNP O
= NNP O
120 CD O
) ) O
on IN O
the DT O
Michigan NNP O
Alcoholism NNP O
Screening NNP O
Test NNP O
adapted VBD O
to TO O
assess VB O
lifetime NN O
and CC O
current JJ O
symptomatology NN O
. . O

Consistent JJ O
with IN O
this DT O
finding NN O
, , O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
SAGA NNP I-Gene
inhibits VBZ O
TBP NNP B-Gene
binding VBG O
to TO O
the DT O
HIS3 NNP B-Gene
promoter NN I-Gene
in IN O
vitro NN O
, , O
while IN O
SAGA NNP B-Gene
lacking VBG O
Spt3 NNP B-Gene
or CC O
Spt8 NNP B-Gene
is VBZ O
not RB O
inhibitory JJ O
. . O

METHODS NN O
: : O
109 CD O
suspected VBD O
cases NNS O
with IN O
SS NNP O
underwent VBD O
the DT O
biopsies NNS O
. . O

The DT O
purpose NN O
of IN O
this DT O
investigation NN O
was VBD O
to TO O
describe VB O
a DT O
new JJ O
formulation NN O
of IN O
silver NN O
sulfadiazine NN O
in IN O
a DT O
water NN O
soluble JJ O
gel NN O
, , O
poloxamer NN O
188 CD O
. . O

In IN O
addition NN O
, , O
the DT O
affinities NNS O
of IN O
CBF2 NNP B-Gene
for IN O
binding VBG O
to TO O
the DT O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
LMP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
and CC O
CD23 NNP B-Gene
promoters NNS I-Gene
were VBD O
also RB O
measured VBN O
. . O

Mutations NNS O
in IN O
the DT O
alpha NN B-Gene
- : I-Gene
amanitin NN I-Gene
conserved VBD O
domain NN O
of IN O
the DT O
largest JJS O
subunit NN O
of IN O
yeast NN B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
III NNP I-Gene
affect NN O
pausing NN O
, , O
RNA NNP O
cleavage NN O
and CC O
transcriptional JJ O
transitions NNS O
. . O

Several JJ O
lines NNS O
of IN O
evidence NN O
presented VBN O
here RB O
suggest VBP O
that IN O
PKC NNP B-Gene
- : I-Gene
zeta NN I-Gene
plays VBZ O
a DT O
role NN O
in IN O
alpha JJ B-Gene
2 CD I-Gene
integrin JJ I-Gene
gene NN I-Gene
expression NN O
. . O

The DT O
319 CD O
base NN O
pair NN O
region NN O
immediately RB O
upstream NN O
of IN O
the DT O
CAP NNP O
site NN O
is VBZ O
characterized VBN O
by IN O
the DT O
lack NN O
of IN O
a DT O
proximal JJ O
TATA NNP O
box NN O
and CC O
the DT O
presence NN O
of IN O
sequences NNS O
similar JJ O
to TO O
GC NNP O
boxes NNS O
, , O
CACCC NNP O
boxes NNS O
, , O
CCAAT NNP O
boxes NNS O
, , O
activator NN B-Gene
protein NN I-Gene
2 CD I-Gene
( ( O
Ap NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
sites NNS O
, , O
partial JJ O
glucocorticoid NN O
response NN O
elements NNS O
( ( O
GREs NNP O
) ) O
, , O
and CC O
partial JJ O
cyclic NN O
AMP NNP O
response NN O
elements NNS O
( ( O
CREs NNP O
) ) O
. . O

Most JJS O
of IN O
the DT O
patients NNS O
had VBD O
locally RB O
advanced JJ O
lesions NNS O
( ( O
63 CD O
T3 NNP O
- : O
4 CD O
: : O
91 CD O
. . O
5 CD O
% NN O
) ) O
according VBG O
to TO O
the DT O
adopted VBN O
TNM NNP O
system NN O
( ( O
Lederman NNP O
- : O
Gadeberg NNP O
, , O
Sisson NNP O
- : O
Jesse NN O
) ) O
. . O

The DT O
peak JJ O
velocities NNS O
of IN O
the DT O
atrial JJ O
systolic JJ O
waves NNS O
of IN O
the DT O
transmitral JJ O
and CC O
pulmonary JJ O
venous JJ O
flow NN O
velocities NNS O
( ( O
A DT O
and CC O
PVA NNP O
, , O
respectively RB O
) ) O
and CC O
first JJ O
systolic JJ O
wave NN O
( ( O
PVS1 NNP O
) ) O
of IN O
pulmonary JJ O
venous JJ O
flow NN O
, , O
durations NNS O
of IN O
both DT O
atrial JJ O
systolic NN O
waves NNS O
, , O
and CC O
amplitude NN O
of IN O
interatrial JJ O
septal JJ O
motion NN O
during IN O
atrial JJ O
systole NN O
increased VBD O
significantly RB O
ten JJ O
days NNS O
after IN O
cardioversion NN O
compared VBN O
with IN O
those DT O
measured VBN O
within IN O
a DT O
day NN O
of IN O
cardioversion NN O
in IN O
all DT O
patients NNS O
except IN O
the DT O
5 CD O
patients NNS O
with IN O
dilated JJ O
cardiomyopathy NN O
. . O

The DT O
isoform NN O
, , O
designated VBN O
HDAC9a NNP B-Gene
, , O
is VBZ O
132 CD O
aa JJ O
shorter NN O
at IN O
the DT O
C NNP O
terminus NN O
than IN O
HDAC9 NNP B-Gene
. . O

Twelve VB O
out IN O
of IN O
43 CD O
renal JJ O
failure NN O
patients NNS O
had VBD O
troponin VBN B-Gene
I PRP I-Gene
0 CD O
. . O
13 CD O
- : O
0 CD O
. . O
9 CD O
microg JJ O
/ NNP O
l NN O
using VBG O
Axsym NNP O
method NN O
and CC O
4 CD O
had VBD O
levels NNS O
of IN O
0 CD O
. . O
7 CD O
- : O
0 CD O
. . O
13 CD O
microg JJ O
/ NNP O
l NN O
using VBG O
Immuno NNP O
1 CD O
. . O

Tumor NN O
cells NNS O
were VBD O
focally RB O
immunoreactive JJ O
for IN O
neuron NN B-Gene
- : I-Gene
specific JJ I-Gene
enolase NN I-Gene
, , O
insulin NN B-Gene
, , O
glucagon NN B-Gene
and CC O
VIP NNP B-Gene
. . O

Consistently RB O
, , O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
downstream NN O
of IN O
Rho NNP B-Gene
family NN I-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
was VBD O
also RB O
enhanced VBN O
when WRB O
Dbl NNP B-Gene
was VBD O
tyrosine JJ O
- : O
phosphorylated VBN O
. . O

Expression NN O
of IN O
the DT O
wt1 JJ B-Gene
gene NN I-Gene
via IN O
transient JJ O
transfection NN O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
revealed VBD O
a DT O
52 CD O
kDa NN O
protein NN O
which WDT O
was VBD O
immunoprecipitated VBN O
by IN O
both DT O
the DT O
N NNP O
- : O
terminal JJ O
- : O
and CC O
C NNP O
- : O
terminal JJ O
- : O
specific JJ O
antisera NN O
. . O

Lymphatics NNS O
in IN O
the DT O
aorta NN O
of IN O
rats NNS O
treated VBN O
with IN O
a DT O
soy JJ O
- : O
bean JJ O
oil NN O
extract NN O
( ( O
lipofundin NN O
) ) O
. . O

Clicking VBG O
on IN O
"""" JJ O
Examples NNS O
and CC O
Explanations NNS O
of IN O
APA NNP O
Form NNP O
"""" NNP O
provides VBZ O
a DT O
help NN O
system NN O
with IN O
examples NNS O
of IN O
the DT O
various JJ O
sections NNS O
of IN O
a DT O
review NN O
article NN O
, , O
journal JJ O
article NN O
that WDT O
has VBZ O
one CD O
experiment NN O
, , O
or CC O
journal JJ O
article NN O
that WDT O
has VBZ O
two CD O
or CC O
more JJR O
experiments NNS O
. . O

16 CD O
subjects NNS O
were VBD O
repatch RB O
tested VBN O
to TO O
ethylmercury VB O
chloride NN O
( ( O
EtHgCl NNP O
) ) O
and CC O
to TO O
solutions NNS O
containing VBG O
EtHgCl NNP O
mixed JJ O
with IN O
L NNP O
- : O
cysteine NN O
and CC O
glutathione NN O
, , O
respectively RB O
. . O

Of IN O
these DT O
proteins NNS O
, , O
five CD O
have VBP O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
phosphorylated VBN O
during IN O
mitosis NN O
( ( O
epithelial JJ B-Gene
- : I-Gene
microtubule NN I-Gene
associated VBN I-Gene
protein SYM I-Gene
- : I-Gene
115 CD I-Gene
, , O
Oct91 NNP B-Gene
, , O
Elongation NNP B-Gene
factor NN I-Gene
1gamma CD I-Gene
, , O
BRG1 NNP B-Gene
and CC O
Ribosomal NNP B-Gene
protein VBP I-Gene
L18A NNP I-Gene
) ) O
, , O
five CD O
are VBP O
related VBN O
to TO O
proteins NNS O
postulated VBN O
to TO O
have VB O
roles NNS O
in IN O
mitosis NN O
( ( O
epithelial JJ B-Gene
- : I-Gene
microtubule NN I-Gene
associated VBN I-Gene
protein SYM I-Gene
- : I-Gene
115 CD I-Gene
, , O
Schizosaccharomyces NNPS B-Gene
pombe NN I-Gene
Cdc5 NNP I-Gene
, , O
innercentrosome JJ B-Gene
protein NN I-Gene
, , O
BRG1 NNP B-Gene
and CC O
the DT O
RNA NNP B-Gene
helicase NN I-Gene
WM6 NNP I-Gene
) ) O
, , O
and CC O
nine CD O
are VBP O
related VBN O
to TO O
transcription NN O
factors NNS O
( ( O
BRG1 NNP B-Gene
, , O
negative JJ B-Gene
co NN I-Gene
- : I-Gene
factor NN I-Gene
2alpha CD I-Gene
, , O
Oct91 NNP B-Gene
, , O
S NNP O
. . O
pombe NN O
Cdc5 NNP B-Gene
, , O
HoxD1 NNP B-Gene
, , O
Sox3 NNP B-Gene
, , O
Vent2 NNP B-Gene
, , O
and CC O
two CD O
isoforms NNS O
of IN O
Xbr1b NNP B-Gene
) ) O
. . O

To TO O
determine VB O
if IN O
the DT O
NF NNP B-Gene
( ( I-Gene
H NNP I-Gene
) ) I-Gene
promoter NN I-Gene
can MD O
be VB O
activated VBN O
in IN O
a DT O
tissue NN O
specific JJ O
manner NN O
during IN O
development NN O
transgenic JJ O
mice NN O
containing VBG O
the DT O
promoter NN O
region NN O
linked VBN O
to TO O
a DT O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
reporter NN I-Gene
gene NN I-Gene
were VBD O
generated VBN O
. . O

Tcn1p NNP B-Gene
/ NNP O
Crz1p NNP B-Gene
, , O
a DT O
calcineurin NN O
- : O
dependent JJ O
transcription NN O
factor NN O
that WDT O
differentially RB O
regulates VBZ O
gene NN O
expression NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
protein NN O
kinase NN O
MEKK1 NNP B-Gene
can MD O
induce VB O
reporter JJ O
gene NN O
expression NN O
from IN O
the DT O
atrial JJ B-Gene
natriuretic JJ I-Gene
factor NN I-Gene
( ( O
ANF NNP B-Gene
) ) O
promoter NN O
, , O
a DT O
genetic JJ O
marker NN O
that WDT O
is VBZ O
activated VBN O
during IN O
in IN O
vivo JJ O
hypertrophy NN O
. . O

In IN O
order NN O
to TO O
determine VB O
which WDT O
sequences NNS O
in IN O
the DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
are VBP O
crucial JJ O
for IN O
activation NN O
by IN O
the DT O
ME26 NNP B-Gene
viral JJ I-Gene
protein NN I-Gene
, , O
we PRP O
made VBD O
deletions NNS O
of IN O
the DT O
promoter NN O
, , O
cloned VBD O
them PRP O
into IN O
a DT O
luciferase JJ B-Gene
expression NN O
vector NN O
and CC O
tested VBD O
their PRP$ O
activity NN O
in IN O
mouse NN O
fibroblasts NNS O
, , O
which WDT O
do VBP O
not RB O
express VB O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

New NNP O
- : O
onset NN O
angina IN O
preceding VBG O
acute JJ O
myocardial JJ O
infarction NN O
is VBZ O
associated VBN O
with IN O
improved VBN O
contractile NN O
recovery NN O
after IN O
thrombolysis NN O
. . O

Kinetics NNS O
of IN O
calcium NN O
metabolism NN O
. . O

Wild NNP O
- : O
type NN O
protein NN O
bound IN O
azido JJ O
- : O
ATP NNP O
well RB O
, , O
but CC O
mutants NNS O
with IN O
substitutions NNS O
in IN O
the DT O
consensus NN O
amino NN O
acids NNS O
were VBD O
unable JJ O
to TO O
bind VB O
azido JJ O
- : O
ATP NN O
. . O

The DT O
Penn NNP O
State NNP O
Worry NNP O
Questionnaire NNP O
for IN O
Children NNP O
( ( O
PSWQ NNP O
- : O
C NNP O
) ) O
is VBZ O
a DT O
14 CD O
- : O
item NN O
self PRP O
- : O
report NN O
questionnaire NN O
that WDT O
intends VBZ O
to TO O
measure VB O
the DT O
tendency NN O
of IN O
children NNS O
to TO O
engage VB O
in IN O
excessive JJ O
, , O
generalized VBN O
, , O
and CC O
uncontrollable JJ O
worry NN O
( ( O
Chorpita NNP O
et RB O
al RB O
. . O
, , O
Behav NNP O
. . O

Erythema NNP O
exsudativum CC O
multiforme NN O
induced VBN O
by IN O
granulocyte NN B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
in IN O
an DT O
allogeneic JJ O
peripheral JJ O
blood NN O
stem NN O
cell NN O
donor NN O
. . O

Fatal JJ O
apneusis NN O
was VBD O
observed VBN O
under IN O
following VBG O
conditions NNS O
: : O
( ( O
1 CD O
) ) O
Persistent NNP O
apnea NN O
was VBD O
produced VBN O
after IN O
a DT O
single JJ O
KA NNP O
microinjection NN O
in IN O
one CD O
side NN O
of IN O
the DT O
VRG NNP O
- : O
Apa NNP O
( ( O
5 CD O
animals NNS O
) ) O
. . O

The DT O
FinO NNP B-Gene
protein NN I-Gene
of IN O
IncF NNP O
plasmids NNS O
binds VBZ O
FinP NNP B-Gene
antisense NN I-Gene
RNA NNP I-Gene
and CC O
its PRP$ O
target NN O
, , O
traJ JJ B-Gene
mRNA NN I-Gene
, , O
and CC O
promotes VBZ O
duplex JJ O
formation NN O
. . O

Responses NNS O
to TO O
the DT O
Plowright NNP O
Rinderpest NNP O
vaccine NN O
by IN O
43 CD O
calves NNS O
and CC O
70 CD O
adult NN O
cattle NNS O
in IN O
Uganda NNP O
in IN O
1990 CD O
, , O
through IN O
the DT O
production NN O
of IN O
IgG NNP B-Gene
antibodies NNS I-Gene
, , O
were VBD O
monitored VBN O
for IN O
4 CD O
weeks NNS O
using VBG O
the DT O
ELISA NNP O
assay NN O
. . O

The DT O
nonconsensus NN O
TATA NNP O
box NN O
in IN O
promoter NN O
B NNP O
plays VBZ O
a DT O
more RBR O
important JJ O
role NN O
in IN O
promoter NN O
activity NN O
than IN O
the DT O
TATA NNP O
box NN O
in IN O
promoter NN O
A NNP O
. . O

The DT O
coding VBG O
region NN O
of IN O
2385 CD O
nucleotides NNS O
corresponds VBZ O
to TO O
a DT O
polypeptide NN O
chain NN O
of IN O
795 CD O
amino NN O
acids NNS O
, , O
giving VBG O
a DT O
molecular JJ O
weight NN O
of IN O
91 CD O
, , O
555 CD O
for IN O
the DT O
hsp108 NN B-Gene
protein NN I-Gene
. . O

This DT O
is VBZ O
particularly RB O
intriguing JJ O
because IN O
SKUT NNP O
- : O
1B CD O
- : O
20 CD O
cells NNS O
lack VBP O
the DT O
transcription NN O
factor NN O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

For IN O
smaller JJR O
vessels NNS O
up IN O
to TO O
a DT O
diameter NN O
of IN O
0 CD O
. . O
5 CD O
mm NN O
, , O
treatments NNS O
at IN O
16 CD O
and CC O
18 CD O
J NNP O
/ NNP O
cm2 NN O
showed VBD O
good JJ O
results NNS O
in IN O
60 CD O
and CC O
82 CD O
% NN O
respectively RB O
; : O
for IN O
vessels NNS O
up RB O
to TO O
1 CD O
mm NNS O
in IN O
27 CD O
and CC O
33 CD O
% NN O
. . O

These DT O
techniques NNS O
have VBP O
been VBN O
used VBN O
by IN O
many JJ O
people NNS O
for IN O
many JJ O
years NNS O
and CC O
no DT O
claim NN O
is VBZ O
being VBG O
made VBN O
for IN O
any DT O
innovation NN O
in IN O
this DT O
regard NN O
. . O

Hospital NN O
hit VBD O
for IN O
hiring VBG O
AHERF NNP O
physicians NNS O
. . O

However RB O
, , O
only RB O
complete JJ B-Gene
DnaJ NNP I-Gene
can MD O
cooperate VB O
with IN O
DnaK NNP B-Gene
and CC O
a DT O
third JJ O
protein NN O
, , O
GrpE NNP B-Gene
, , O
in IN O
refolding VBG O
denatured JJ B-Gene
firefly JJ I-Gene
luciferase NN I-Gene
. . O

The DT O
former JJ O
procedure NN O
is VBZ O
economical JJ O
but CC O
complicated VBD O
, , O
whereas IN O
the DT O
latter NN O
is VBZ O
simple JJ O
and CC O
labour JJ O
- : O
saving NN O
, , O
but CC O
a DT O
special JJ O
ultrafiltration NN O
tube NN O
is VBZ O
required VBN O
. . O

There EX O
are VBP O
many JJ O
different JJ O
proposals NNS O
for IN O
the DT O
statistical JJ O
analysis NN O
of IN O
data NNS O
to TO O
determine VB O
early JJ O
onset NN O
of IN O
action NN O
. . O

Similarly RB O
, , O
PCDFs NNP O
/ NNP O
PCDDs NNP O
ratio NN O
in IN O
ESP NNP O
ash NN O
was VBD O
lower JJR O
than IN O
that DT O
in IN O
boiler NN O
ash NN O
. . O

A DT O
genomic JJ O
clone NN O
, , O
pTt21 NN O
, , O
containing VBG O
DNA NNP O
apparently RB O
transcribed VBD O
specifically RB O
in IN O
Trypanosoma NNP O
cruzi NN O
trypomastigotes NNS O
, , O
was VBD O
obtained VBN O
by IN O
differentially RB O
screening VBG O
a DT O
genomic JJ O
library NN O
with IN O
trypomastigote NN O
and CC O
epimastigote NN O
cDNA NN O
. . O

The DT O
program NN O
has VBZ O
been VBN O
written VBN O
in IN O
a DT O
generic JJ O
BASIC NNP O
in IN O
order NN O
to TO O
make VB O
the DT O
procedure NN O
user SYM O
- : O
friendly RB O
. . O

Abnormal NNP O
intrapulmonary JJ O
shunting NN O
( ( O
IPS NNP O
) ) O
, , O
which WDT O
was VBD O
proved VBN O
in IN O
4 CD O
cases NNS O
by IN O
whole JJ O
- : O
body NN O
radionuclide JJ O
scanning VBG O
with IN O
99mTc CD O
- : O
MAA NN O
, , O
is VBZ O
suggested VBN O
as IN O
the DT O
major JJ O
cause NN O
of IN O
cyanosis NN O
in IN O
liver JJ O
cirrhosis NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
patients NNS O
who WP O
undergo VBP O
postoperative JJ O
irradiation NN O
for IN O
low JJ O
grade JJ O
spinal NN O
astrocytomas NN O
and CC O
localized VBD O
spinal JJ O
ependymomas NN O
achieve VBP O
excellent JJ O
survival NN O
. . O

Thus RB O
, , O
two CD O
very RB O
different JJ O
regulatory JJ O
elements NNS O
are VBP O
used VBN O
to TO O
mediate VB O
estrogen JJ O
induction NN O
of IN O
related JJ O
genes NNS O
in IN O
chickens NNS O
and CC O
amphibians NNS O
. . O

The DT O
solubility NN O
of IN O
all PDT O
the DT O
mutated JJ O
proteins NNS O
was VBD O
remarkably RB O
reduced VBN O
. . O

Together RB O
, , O
these DT O
data NNS O
support NN O
a DT O
model NN O
in IN O
which WDT O
Tax NNP B-Gene
anchors NNS O
CBP NNP B-Gene
to TO O
the DT O
HTLV NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
, , O
with IN O
strong JJ O
transcriptional JJ O
activation NN O
resulting VBG O
from IN O
the DT O
CBP NNP B-Gene
- : O
associated JJ O
activities NNS O
of IN O
nucleosome JJ O
remodeling NN O
and CC O
recruitment NN O
of IN O
the DT O
general JJ O
transcription NN O
machinery NN O
. . O

RPM NNP B-Gene
/ NNP O
RGL3 NNP B-Gene
resembled VBD O
AF NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
Nore1 NNP B-Gene
in IN O
interacting VBG O
strongly RB O
with IN O
constitutively RB O
active JJ O
M NNP B-Gene
- : I-Gene
Ras NN I-Gene
and CC O
p21 NN B-Gene
Ras NNP I-Gene
. . O

Changes NNS O
in IN O
xanthine JJ B-Gene
oxidase NN I-Gene
activity NN O
in IN O
patients NNS O
with IN O
circulatory JJ O
failure NN O

Drug NN O
effect NN O
, , O
measured VBN O
as IN O
postural JJ O
sway NN O
, , O
was VBD O
also RB O
similar JJ O
in IN O
the DT O
patients NNS O
with IN O
cirrhosis NN O
and CC O
control NN O
subjects NNS O
; : O
therefore IN O
the DT O
ratio NN O
of IN O
effect NN O
area NN O
under IN O
the DT O
curve NN O
to TO O
concentration VB O
area NN O
under IN O
the DT O
curve NN O
, , O
a DT O
measure NN O
of IN O
sensitivity NN O
, , O
did VBD O
not RB O
differ VB O
significantly RB O
between IN O
the DT O
patients NNS O
with IN O
cirrhosis NN O
and CC O
the DT O
control NN O
subjects VBZ O
. . O

Forskolin NNP O
treatment NN O
( ( O
10 CD O
microM NN O
) ) O
of IN O
the DT O
transfected JJ O
cells NNS O
for IN O
3 CD O
- : O
- : O
6 CD O
h NN O
maximally RB O
induced JJ O
luciferase NN B-Gene
threefold NN O
. . O

The DT O
behavior NN O
of IN O
suf12 JJ B-Gene
- : I-Gene
null JJ I-Gene
/ NN I-Gene
SUF12 NNP I-Gene
+ NNP I-Gene
heterozygotes VBZ I-Gene
indicates VBZ O
that IN O
suf12 NN B-Gene
is VBZ O
co JJ O
- : O
dominantly RB O
expressed VBN O
and CC O
suggests VBZ O
that IN O
suf12 NN B-Gene
allele SYM O
- : O
specific JJ O
suppression NN O
may MD O
result VB O
from IN O
functionally RB O
distinct JJ O
mutant JJ O
proteins VBZ O
rather RB O
than IN O
variation NN O
in IN O
residual JJ O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
SUF12 NNP I-Gene
+ NNP I-Gene
activity NN O
. . O

Mean NNP O
( ( O
+ NNP O
/ NNP O
- : O
SE NN O
) ) O
measurements NNS O
of IN O
clearance NN O
( ( O
24 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
6 CD O
v JJ O
26 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
5 CD O
mL JJ O
/ NNP O
min NN O
/ NNP O
m2 NN O
) ) O
, , O
half PDT O
- : O
life NN O
( ( O
5 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
v JJ O
6 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
hours NNS O
) ) O
, , O
and CC O
volume NN O
of IN O
distribution NN O
( ( O
12 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
1 CD O
v JJ O
13 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
6 CD O
L NNP O
/ NNP O
m2 NN O
) ) O
were VBD O
not RB O
significantly RB O
different JJ O
in IN O
patients NNS O
with IN O
jaundice NN O
when WRB O
compared VBN O
with IN O
controls NNS O
. . O

This DT O
points VBZ O
to TO O
a DT O
specific JJ O
interference NN O
with IN O
HSV NNP O
- : O
induced VBD O
DNA NNP O
amplification NN O
. . O

Oestrogen NNP O
implant NN O
overdose NN O
. . O

We PRP O
show VBP O
that DT O
stabilization NN O
of IN O
the DT O
hairpin NN O
reduced VBD O
the DT O
amount NN O
of IN O
tRNA NN O
primer NN O
that WDT O
is VBZ O
annealed VBN O
to TO O
the DT O
PBS NNP O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
SIMV NNP O
is VBZ O
useful JJ O
in IN O
weaning VBG O
neonates NNS O
from IN O
the DT O
ventilator NN O
. . O

The DT O
costs NNS O
were VBD O
DM NNP O
11 CD O
, , O
562 CD O
for IN O
a DT O
PE NNP O
, , O
DM NNP O
12 CD O
, , O
477 CD O
for IN O
a DT O
VR NNP O
and CC O
DM NNP O
7 CD O
, , O
532 CD O
for IN O
a DT O
MR NNP O
. . O

The DT O
localization NN O
of IN O
this DT O
proteoglycan JJ O
locus NN O
in IN O
the DT O
human JJ O
genome NN O
and CC O
the DT O
availability NN O
of IN O
new JJ O
RFLPs NNP O
provide VBP O
the DT O
tools NNS O
for IN O
future JJ O
studies NNS O
of IN O
human JJ O
diseases NNS O
where WRB O
the DT O
HSPG2 NNP B-Gene
proteoglycan JJ I-Gene
gene NN I-Gene
is VBZ O
suspected VBN O
to TO O
be VB O
involved VBN O
. . O

Analysis NN O
of IN O
liver NN O
biopsy NN O
specimens NNS O
from IN O
patients NNS O
with IN O
hepatitis NN O
showed VBD O
a DT O
large JJ O
variation NN O
in IN O
the DT O
mean NN O
iron NN O
content NN O
of IN O
the DT O
liver NN O
ferritin NN B-Gene
molecules NNS O
. . O

A DT O
third JJ O
ORF NNP O
, , O
ORF5 NNP O
, , O
shows VBZ O
homology NN O
with IN O
gene NN B-Gene
agrB NN I-Gene
from IN O
Staphylococcus NNP O
aureus NN O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
mechanism NN O
of IN O
regulation NN O
of IN O
the DT O
virulence NN O
phenotype NN O
in IN O
this DT O
species NNS O
. . O

Other JJ O
properties NNS O
of IN O
Hg NNP O
- : O
and CC O
Cd NNP O
- : O
spores NNS O
were VBD O
similar JJ O
to TO O
those DT O
of IN O
control NN O
spores NNS O
. . O

Oncogenic NNP B-Gene
Raf NNP I-Gene
- : I-Gene
1 CD I-Gene
activates NNS O
p70 VBP B-Gene
S6 NNP I-Gene
kinase NN I-Gene
via IN O
a DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinase SYM I-Gene
- : O
independent JJ O
pathway NN O
. . O

Characterization NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Gene
multidrug NN I-Gene
resistance NN I-Gene
protein NN I-Gene
2 CD I-Gene
( ( O
MRP2 NNP B-Gene
) ) O
gene NN O
and CC O
its PRP$ O
regulation NN O
in IN O
comparison NN O
withthe JJ O
multidrug NN B-Gene
resistance NN I-Gene
protein NN I-Gene
3 CD I-Gene
( ( O
MRP3 NNP B-Gene
) ) O
gene NN O
. . O

Mutation NN O
of IN O
TTF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
( ( I-Gene
TBE NNP I-Gene
) ) I-Gene
1 CD I-Gene
, , I-Gene
3 CD I-Gene
, , I-Gene
and CC I-Gene
4 CD I-Gene
in IN O
combination NN O
markedly RB O
decreased VBD O
transcriptional JJ O
activity NN O
of IN O
SP NNP B-Gene
- : I-Gene
A DT I-Gene
promoter NN O
- : O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
constructs VBZ O
containing VBG O
SP NNP B-Gene
- : I-Gene
A DT I-Gene
gene NN I-Gene
sequences NNS O
from IN O
- : O
256 CD O
to TO O
+ VB O
45 CD O
. . O

Infants NNS O
of IN O
this DT O
sample NN O
had VBD O
monocular JJ O
PL NNP O
visual JJ O
acuities NNS O
similar JJ O
to TO O
those DT O
established VBN O
by IN O
McDonald NNP O
et CC O
al NN O
. . O
in IN O
a DT O
laboratory NN O
setting NN O
. . O

A DT O
cDNA NN O
encoding VBG O
the DT O
amino NN O
- : O
terminal JJ O
17 CD O
% NN O
of IN O
apoB NN B-Gene
( ( O
apoB17 NN B-Gene
) ) O
was VBD O
fused VBN O
to TO O
a DT O
cDNA NN O
coding VBG O
for IN O
the DT O
last JJ O
37 CD O
amino JJ O
acids NNS O
of IN O
decay JJ B-Gene
- : I-Gene
accelerating VBG I-Gene
factor NN I-Gene
( ( O
DAF NNP B-Gene
) ) O
, , O
which WDT O
contains VBZ O
the DT O
signal NN O
for IN O
glycosylphosphatidylinositol NN O
anchor NN O
attachment NN O
. . O

Two CD O
distinct JJ O
Salmonella NNP B-Gene
fimbrins NNS I-Gene
, , O
AgfA NNP B-Gene
and CC O
SefA NNP B-Gene
, , O
comprising VBG O
thin JJ O
aggregative JJ O
fimbriae NN O
SEF17 NNP B-Gene
and CC O
SEF14 NNP B-Gene
, , O
respectively RB O
, , O
were VBD O
each DT O
genetically RB O
engineered VBN O
to TO O
carry VB O
PT3 NNP B-Gene
, , O
an DT O
alpha JJ O
- : O
helical JJ O
16 CD O
- : O
amino NN O
acid NN O
Leishmania NNP O
T NNP O
- : O
cell NN O
epitope VBP O
derived VBN O
from IN O
the DT O
metalloprotease NN B-Gene
gp63 NN B-Gene
. . O

Hypercalcemia NNP O
associated VBD O
with IN O
elevated JJ O
serum NN B-Gene
PTH NNP I-Gene
concentration NN O
indicating VBG O
primary JJ O
hyperparathyroidism NN O
was VBD O
found VBN O
in IN O
7 CD O
BC NNP O
patients NNS O
( ( O
7 CD O
% NN O
) ) O
and CC O
in IN O
none NN O
of IN O
healthy JJ O
women NNS O
or CC O
patients NNS O
with IN O
thyroid JJ O
cancer NN O
. . O

The DT O
workup NN O
included VBD O
skin JJ O
tests NNS O
( ( O
up IN O
to TO O
1 CD O
microgram NNS O
/ JJ O
ml NN O
, , O
Pharmacia NNP O
) ) O
, , O
measurement NN O
of IN O
specific JJ O
serum NN O
IgE NNP B-Gene
with IN O
RAST NNP O
- : O
CAP NNP O
( ( O
Pharmacia NNP O
) ) O
, , O
and CC O
CAST NNP O
with IN O
three CD O
concentrations NNS O
of IN O
bee NN O
( ( O
Apis NNP O
mellifera NN O
) ) O
and CC O
wasp $ O
( ( O
Vespula NNP O
spec RB O
. . O
) ) O
venom NN O
( ( O
Aquagen NNP O
ALK NNP O
) ) O
. . O

Our PRP$ O
data NNS O
showed VBD O
that IN O
activation NN O
of IN O
the DT O
raf NN B-Gene
- : O
ERK NNP B-Gene
pathway RB O
led VBD O
to TO O
activation NN O
of IN O
TF NNP B-Gene
expression NN O
in IN O
breast NN O
carcinoma NN O
cells NNS O
and CC O
suggested VBD O
that IN O
constitutive JJ O
activation NN O
of IN O
this DT O
pathway NN O
leads VBZ O
to TO O
high VB O
TF NNP B-Gene
expression NN O
in IN O
MDA NNP O
- : O
MB NNP O
- : O
231 CD O
cells NNS O
. . O

Recombinant NN B-Gene
I PRP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
alpha NN I-Gene
inhibited VBD O
kappa NN B-Gene
B NNP I-Gene
motif NN I-Gene
binding NN O
by IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
, , O
RelA NNP B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
as IN O
indicated VBN O
by IN O
studies NNS O
using VBG O
UV NNP O
radiation NN O
- : O
induced JJ O
covalent NN O
cross NN O
- : O
linking NN O
to TO O
a DT O
bromodeoxyuridine NN O
- : O
substituted VBN O
kappa NN B-Gene
B NNP I-Gene
oligonucleotide NN I-Gene
. . O

SUMMARY NNP O
OF NNP O
REVIEW NNP O
: : O
We PRP O
discuss VBP O
the DT O
criteria NNS O
that WDT O
make VBP O
such JJ O
studies NNS O
comparable JJ O
, , O
drawing VBG O
on IN O
the DT O
experiences NNS O
of IN O
recent JJ O
studies NNS O
performed VBN O
around IN O
the DT O
world NN O
. . O

When WRB O
transfected VBN O
into IN O
Drosophila NNP O
SL NNP O
- : O
2 CD O
cells NNS O
, , O
pCAT NN O
plasmid NN O
containing VBG O
2 CD O
, , O
90 CD O
bp NN O
of IN O
5 CD O
' POS O
- : O
flanking NN O
region NN O
shows VBZ O
a DT O
3 CD O
. . O
0 CD O
- : O
to TO O
3 CD O
. . O
5 CD O
- : O
fold JJ O
increase NN O
in IN O
chloramphenicol JJ B-Gene
acetyltransferase NN I-Gene
activity NN O
after IN O
induction NN O
with IN O
retinoic JJ O
acid NN O
and CC O
/ NN O
or CC O
8 CD O
- : O
bromo NN O
- : O
cAMP NN O
. . O

We PRP O
analysed VBD O
two CD O
regions NNS O
involved VBN O
in IN O
preS2 NN B-Gene
/ NNP O
S NNP B-Gene
gene NN I-Gene
transcription NN O
of IN O
the DT O
HBV NNP O
adw NN O
subtype NN O
: : O
the DT O
diverged JJ O
TATA NNP O
box NN O
and CC O
a DT O
putative JJ O
initiator NN O
element NN O
. . O

BACKGROUND NN O
: : O
Chemicals NNS O
vary VBP O
considerably RB O
in IN O
their PRP$ O
intrinsic JJ O
ability NN O
to TO O
cause VB O
allergic JJ O
contact NN O
dermatitis NN O
. . O

Results NNS O
have VBP O
surprisingly RB O
revealed VBN O
the DT O
presence NN O
of IN O
three CD O
U14 NNP B-Gene
snRNA SYM I-Gene
- : I-Gene
homologous JJ I-Gene
regions NNS I-Gene
positioned VBD O
within IN O
introns NNS O
5 CD O
, , O
6 CD O
, , O
and CC O
8 CD O
of IN O
the DT O
mouse NN O
cognate NN O
hsc70 NN B-Gene
heat NN O
shock NN O
gene NN O
. . O

Change NN O
in IN O
the DT O
makeup NN O
of IN O
the DT O
blood NN O
following VBG O
a DT O
short JJ O
- : O
term NN O
local JJ O
action NN O
of IN O
a DT O
permanent JJ O
magnetic JJ O
field NN O
on IN O
the DT O
human JJ O
body NN O

The DT O
12 CD B-Gene
, , I-Gene
0 CD I-Gene
MW NNP I-Gene
( ( I-Gene
12K CD I-Gene
) ) I-Gene
IE NNP I-Gene
polypeptide NN I-Gene
encoded VBN O
by IN O
IEmRNA NNP B-Gene
- : I-Gene
5 CD I-Gene
is VBZ O
translated VBN O
from IN O
an DT O
88 CD O
codon NN O
open JJ O
reading NN O
frame NN O
, , O
leaving VBG O
a DT O
1200 CD O
base NN O
3 CD O
' '' O
non JJ O
- : O
translated JJ O
region NN O
. . O

BACKGROUND NN O
: : O
Defensins NNS B-Gene
, , O
also RB O
known VBN O
as IN O
human JJ B-Gene
neutrophil NN I-Gene
peptides NNS I-Gene
, , O
are VBP O
antimicrobial JJ O
peptides NNS O
present JJ O
in IN O
the DT O
azurophil JJ O
granules NNS O
of IN O
neutrophils NNS O
. . O

Isolation NN O
and CC O
characterization NN O
of IN O
SRF NNP B-Gene
accessory NN I-Gene
proteins NNS I-Gene
. . O

The DT O
authors NNS O
evaluate VBP O
the DT O
clinical JJ O
efficacy NN O
of IN O
EMB NNP O
AZS NNP O
in IN O
recurrent NN O
ulcer NN O
after IN O
operation NN O
on IN O
the DT O
stomach NN O
caused VBN O
by IN O
a DT O
high JJ O
level NN O
of IN O
acid JJ O
production NN O
and CC O
ulcerative JJ O
gastroduodenal JJ O
bleeding NN O
. . O

Our PRP$ O
findings NNS O
support VBP O
the DT O
view NN O
of IN O
a DT O
multifactorial JJ O
genesis NN O
of IN O
the DT O
cardiac JJ O
involvement NN O
in IN O
uremic JJ O
patients NNS O
. . O

Osmotic JJ O
shock NN O
stimulates NNS O
GLUT4 NNP B-Gene
translocation NN O
in IN O
3T3L1 CD O
adipocytes NNS O
by IN O
a DT O
novel JJ O
tyrosine NN B-Gene
kinase NN I-Gene
pathway NN O
. . O

The DT O
percentages NNS O
of IN O
formed JJ O
cysts NNS O
and CC O
growth NN O
rates NNS O
were VBD O
monthly RB O
estimated VBN O
and CC O
analyzed VBN O
rhythmometrically RB O
by IN O
cosinor NN O
for IN O
5 CD O
clonal JJ O
cultures NNS O
of IN O
Scripsiella NNP O
trochoidea NN O
Stein NNP O
grown NN O
for IN O
2 CD O
years NNS O
under IN O
laboratory NN O
conditions NNS O
, , O
rended VBD O
as RB O
constant JJ O
as IN O
possible JJ O
from IN O
the DT O
view NN O
point NN O
of IN O
environmental JJ O
temperature NN O
( ( O
24 CD O
+ NN O
/ NNP O
- : O
1 CD O
degree JJ O
C NNP O
) ) O
, , O
lighting VBG O
( ( O
25 CD O
microEin NN O
m SYM O
- : O
2 CD O
s JJ O
- : O
1 CD O
) ) O
, , O
and CC O
artificial JJ O
seawater NN O
. . O

Inspection NN O
of IN O
enhancer NN O
mutants NNS O
suggests VBZ O
that IN O
trans VBZ O
- : O
activation NN O
by IN O
hLEF NN B-Gene
/ NNP O
GAL4 NNP B-Gene
is VBZ O
especially RB O
dependent JJ O
on IN O
TCF NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
a DT O
distinct JJ O
T NNP O
- : O
cell NN O
- : O
enriched VBN O
protein NN O
that WDT O
binds VBZ O
to TO O
sequences NNS O
flanking VBG O
the DT O
hLEF NN B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
in IN O
the DT O
enhancer NN O
. . O

In IN O
mammals NNS O
, , O
the DT O
Rb NNP B-Gene
protein NN I-Gene
interacts VBZ O
specifically RB O
with IN O
D NNP B-Gene
- : I-Gene
type NN I-Gene
cyclins NNS I-Gene
and CC O
regulates NNS O
cell VBP O
proliferation NN O
by IN O
binding VBG O
and CC O
inhibiting VBG O
E2F NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
calpeptin NN B-Gene
inhibits NNS O
tyrosine VBP B-Gene
phosphatases NNS I-Gene
, , O
enhancing VBG O
tyrosine JJ O
phosphorylation NN O
particularly RB O
of IN O
paxillin NN B-Gene
. . O

However RB O
, , O
mutations NNS O
in IN O
the DT O
HNF NNP B-Gene
- : I-Gene
4 CD I-Gene
binding VBG I-Gene
site NN I-Gene
on IN O
element JJ B-Gene
CIIB NNP I-Gene
and CC O
inhibition NN O
of IN O
HNF NNP B-Gene
- : I-Gene
4 CD I-Gene
synthesis NN O
in IN O
HepG2 NNP O
cells NNS O
by IN O
antisense NN O
HNF NNP B-Gene
- : I-Gene
4 CD I-Gene
constructs NNS I-Gene
decreased VBD O
the DT O
apoCII JJ B-Gene
promoter NN I-Gene
activity NN O
to TO O
25 CD O
- : O
40 CD O
% NN O
of IN O
the DT O
control NN O
, , O
indicating VBG O
that IN O
HNF NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
a DT O
positive JJ O
regulator NN O
of IN O
the DT O
apoCII JJ B-Gene
gene NN I-Gene
. . O

Outflow NNP O
obstruction NN O
of IN O
pancreatic JJ O
juice NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
"""" JJ O
relative JJ O
stenosis NN O
of IN O
the DT O
minor JJ O
papilla NN O
, , O
"""" NN O
was VBD O
considered VBN O
to TO O
be VB O
present JJ O
in IN O
the DT O
patients NNS O
with IN O
type JJ O
II NNP O
papilla NN O
, , O
and CC O
, , O
therefore RB O
, , O
the DT O
patients NNS O
with IN O
type JJ O
II NNP O
papilla NN O
might MD O
suffer VB O
from IN O
acute JJ O
pancreatitis NN O
resulting VBG O
from IN O
poor JJ O
drainage NN O
of IN O
pancreatic JJ O
juice NN O
and CC O
excessive JJ O
pressure NN O
in IN O
the DT O
dorsal NN O
duct NN O
. . O

The DT O
in IN O
vitro JJ O
antibacterial JJ O
potency NN O
is VBZ O
greatest JJS O
when WRB O
the DT O
1 CD O
- : O
substituent NN O
is VBZ O
2 CD O
, , O
4 CD O
- : O
difluorophenyl NN O
and CC O
the DT O
7 CD O
- : O
substituent NN O
is VBZ O
a DT O
3 CD O
- : O
amino NN O
- : O
1 CD O
- : O
pyrrolidinyl NN O
group NN O
. . O

METHODS NN O
: : O
Sixteen JJ O
pigs NNS O
were VBD O
assigned VBN O
randomly RB O
to TO O
control VB O
and CC O
shock VB O
groups NNS O
. . O

Since IN O
myoglobin NN B-Gene
is VBZ O
co JJ O
- : O
extracted VBN O
with IN O
the DT O
hemoglobin NN B-Gene
, , O
the DT O
2 CD O
heme NN O
pigments NNS O
are VBP O
separated VBN O
in IN O
one CD O
portion NN O
of IN O
the DT O
extract NN O
by IN O
precipitating VBG O
the DT O
hemoglobin NN B-Gene
in IN O
an DT O
85 CD O
% NN O
( ( O
NH4 NNP O
) ) O
2SO4 CD O
solution NN O
. . O

The DT O
role NN O
of IN O
intraoperative JJ O
echocardiography NN O
in IN O
surgery NN O
of IN O
the DT O
heart NN O
and CC O
large JJ O
vessels NNS O

PMEK1 NNP B-Gene
displays VBZ O
96 CD O
and CC O
80 CD O
% NN O
identity NN O
respectively RB O
with IN O
the DT O
tobacco NN B-Gene
NTF3 NNP I-Gene
and CC O
Arabidopsis NNP B-Gene
ATMPK1 NNP I-Gene
kinases NNS I-Gene
, , O
and CC O
only RB O
50 CD O
% NN O
to TO O
the DT O
more RBR O
distantly RB O
related VBN O
plant NN O
MAP NNP O
kinase NNP O
MsERK1 NNP B-Gene
from IN O
alfalfa NN O
. . O

These DT O
regions NNS O
contain VBP O
inverted JJ O
E NNP O
- : O
box NN O
palindromic JJ O
or CC O
direct JJ O
repeat NN O
motifs NNS O
and CC O
bind NN O
SREBP NNP B-Gene
- : I-Gene
1 CD I-Gene
with IN O
different JJ O
affinities NNS O
. . O

After IN O
i NN O
. . O
v NN O
. . O

Cardiac NNP B-Gene
myosin NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
C NNP I-Gene
( ( O
MyBP NNP B-Gene
- : I-Gene
C NN I-Gene
) ) O
: : O
identification NN O
of IN O
protein NN B-Gene
kinase VB I-Gene
A NNP I-Gene
and CC O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
phosphorylation NN O
sites NNS O
. . O

The DT O
most RBS O
common JJ O
grade NN O
3 CD O
toxicity NN O
was VBD O
neutropenia RB O
, , O
thrombocytopenia NN O
, , O
and CC O
parasthesias NN O
( ( O
observed VBN O
in IN O
< JJ O
10 CD O
% NN O
of IN O
cycles NNS O
) ) O
. . O

We PRP O
have VBP O
therefore RB O
studied VBN O
the DT O
molecular JJ O
mechanisms NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
action NN O
on IN O
thyroglobulin NN B-Gene
( ( O
TG NNP B-Gene
) ) O
gene NN O
expression NN O
by IN O
focusing VBG O
our PRP$ O
attention NN O
on IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
regulation NN O
of IN O
thyroid JJ O
- : O
specific JJ O
transcription NN O
factors NNS O
. . O

Approximately RB O
50 CD O
% NN O
of IN O
the DT O
ribosomal JJ O
DNA NNP O
( ( O
rDNA NN O
) ) O
units NNS O
of IN O
Drosophila NNP O
melanogaster NN O
are VBP O
inactivated VBN O
by IN O
two CD O
different JJ O
28 CD B-Gene
S NNP I-Gene
RNA NNP I-Gene
ribosomal JJ I-Gene
gene NN I-Gene
insertions NNS O
( ( O
type NN O
I PRP O
and CC O
type VB O
II NNP O
) ) O
. . O

Receptors NNS O
for IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
10 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
type NN I-Gene
cytokines NNS I-Gene
use VBP O
similar JJ O
signaling NN O
mechanisms NN O
for IN O
inducing VBG O
transcription NN O
through IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
response NN O
elements NNS O
. . O

Expression NN O
of IN O
thymidine JJ B-Gene
kinase NN I-Gene
gene NN I-Gene
in IN O
normal JJ O
human JJ O
diploid NN O
cells NNS O
is VBZ O
both DT O
cell NN O
cycle NN O
- : O
and CC O
age NN O
- : O
dependent NN O
and CC O
appears VBZ O
to TO O
be VB O
transcriptionally RB O
regulated VBN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
intrathecal JJ O
administration NN O
( ( O
i JJ O
. . O
t NN O
. . O
) ) O
of IN O
D2 NNP B-Gene
receptor NN I-Gene
agonist NN O
LY171555 NNP O
or CC O
D1 NNP B-Gene
/ NNP I-Gene
D2 NNP I-Gene
receptor NN I-Gene
agonist JJ O
apomorphine NN O
increased VBD O
pain NN O
threshold NN O
and CC O
had VBD O
a DT O
potentiating JJ O
effect NN O
on IN O
AA NNP O
. . O

This DT O
region NN O
binds VBZ O
two CD O
ubiquitous JJ O
nuclear JJ O
factors NNS O
, , O
USF NNP B-Gene
/ NNP O
MLTF NNP B-Gene
and CC O
the DT O
CAAT NNP B-Gene
- : I-Gene
binding VBG I-Gene
transcription NN I-Gene
factor NN I-Gene
/ JJ O
nuclear JJ B-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
CTF NNP B-Gene
/ NNP O
NF1 NNP B-Gene
) ) O
. . O

In IN O
15 CD O
ventilator NN O
- : O
dependent NN O
, , O
SB NNP O
, , O
and CC O
actively RB O
expiring VBG O
patients NNS O
, , O
we PRP O
found VBD O
that IN O
the DT O
difference NN O
PEEP NNP O
( ( O
i NN O
) ) O
, , O
dyn SYM O
- : O
Pga NN O
, , O
total JJ O
decay NN O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NNP O
, , O
5 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
9 CD O
cm NN O
H NNP O
( ( O
2 CD O
) ) O
O NNP O
) ) O
was VBD O
quite RB O
similar JJ O
to TO O
PEEP NNP O
( ( O
i NN O
) ) O
, , O
dyn JJ O
ref NN O
( ( O
5 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
9 CD O
cm NN O
H NNP O
( ( O
2 CD O
) ) O
O NNP O
) ) O
. . O

Naloxone NNP O
( ( O
2 CD O
mg NN O
/ NNP O
kg NN O
bolus NN O
+ $ O
2 CD O
mg NN O
X NNP O
kg NNP O
- : O
1 CD O
X NN O
h NN O
- : O
1 CD O
) ) O
was VBD O
given VBN O
with IN O
one CD O
of IN O
the DT O
two CD O
doses NNS O
of IN O
the DT O
lipopolysaccharide NN O
. . O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
complexes NNS O
similar JJ O
to TO O
the DT O
C25 NNP B-Gene
, , O
C30 NNP B-Gene
and CC O
C35 NNP B-Gene
complexes NNS I-Gene
are VBP O
formed VBN O
by IN O
rat NN O
cortex NN O
nuclear JJ O
extracts NNS O
and CC O
the DT O
SAA NNP O
element NN O
in IN O
EMSA NNP O
experiments NNS O
, , O
suggesting VBG O
the DT O
relevance NN O
of IN O
our PRP$ O
in IN O
vitro JJ O
observations NNS O
to TO O
the DT O
in IN O
vivo JJ O
functioning NN O
of IN O
the DT O
rat NN B-Gene
APP NNP I-Gene
promoter NN I-Gene
. . O

Nucleoprotein NNP O
( ( O
N NNP O
) ) O
expressed VBN O
by IN O
both DT O
recombinant JJ O
vaccinia NN O
virus NN O
and CC O
TGEV NNP O
had VBD O
a DT O
relative JJ O
molecular JJ O
mass NN O
( ( O
Mr NNP O
) ) O
of IN O
47 CD O
, , O
0 CD O
and CC O
was VBD O
susceptible JJ O
to TO O
degradation NN O
at IN O
the DT O
C NNP O
- : O
terminus NN O
yielding VBG O
discrete JJ O
breakdown NN O
products NNS O
. . O

PURPOSE NN O
: : O
To TO O
evaluate VB O
the DT O
disease NN O
- : O
free JJ O
survival NN O
( ( O
DFS NNP O
) ) O
and CC O
overall JJ O
survival NN O
( ( O
OS NNP O
) ) O
, , O
prognostic JJ O
factors NNS O
, , O
and CC O
treatment NN O
- : O
related JJ O
mortality NN O
of IN O
women NNS O
with IN O
stage NN O
IIIB NNP O
inflammatory NN O
breast NN O
cancer NN O
( ( O
IBC NNP O
) ) O
treated VBD O
with IN O
combined JJ O
modality NN O
therapy NN O
( ( O
CMT NNP O
) ) O
and CC O
high JJ O
- : O
dose NN O
chemotherapy NN O
( ( O
HDCT NNP O
) ) O
with IN O
autologous JJ O
stem NN O
- : O
cell NN O
transplantation NN O
. . O

Our PRP$ O
findings NNS O
further RBR O
our PRP$ O
understanding NN O
of IN O
how WRB O
ZBP NNP B-Gene
- : I-Gene
89 CD I-Gene
modulates NNS O
cell VBP O
proliferation NN O
and CC O
reveals VBZ O
a DT O
novel JJ O
mechanism NN O
by IN O
which WDT O
the DT O
p53 NN B-Gene
protein NN I-Gene
is VBZ O
stabilized VBN O
. . O

Nuclear NNP B-Gene
beta NN I-Gene
II NNP I-Gene
PKC NNP I-Gene
, , O
like IN O
p34cdc2 JJ B-Gene
kinase NN I-Gene
, , O
may MD O
function VB O
to TO O
regulate VB O
nuclear JJ O
lamina JJ O
structural JJ O
stability NN O
during IN O
cell NN O
cycle NN O
. . O

The DT O
latter JJ O
domain NN O
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
targeting VBG O
Num1p NNP B-Gene
to TO O
the DT O
mother NN O
cell NN O
cortex NN O
. . O

Managing VBG O
vertigo NN O
and CC O
vertigo NN O
syndromes NNS O
in IN O
the DT O
elderly JJ O

Moreover RB O
, , O
in IN O
one CD O
patient NN O
with IN O
a DT O
sarcoma NN O
who WP O
underwent VBD O
a DT O
leg NN O
- : O
sparing NN O
procedure NN O
, , O
no DT O
sciatic JJ O
nerve NN O
enlargement NN O
was VBD O
seen VBN O
postoperatively RB O
. . O

Dermoid NNP O
cyst NN O
in IN O
a DT O
free JJ O
skin NN O
flap NN O
as IN O
the DT O
complication NN O
after IN O
treatment NN O
of IN O
recurring VBG O
hernia NN O

The DT O
performance NN O
of IN O
three CD O
commonly NNS O
used VBD O
chemical NN O
cartridge NN O
respirators NNS O
for IN O
SO2 NNP O
was VBD O
measured VBN O
under IN O
working VBG O
conditions NNS O
in IN O
a DT O
copper NN O
smelter NN O
. . O

The DT O
identity NN O
between IN O
hnRNPs NN B-Gene
H NNP I-Gene
and CC O
H NNP B-Gene
' '' I-Gene
is VBZ O
96 CD O
% NN O
, , O
between IN O
H NNP B-Gene
and CC O
F NNP B-Gene
78 CD O
% NN O
, , O
and CC O
between IN O
H NNP B-Gene
' POS I-Gene
and CC O
F NNP B-Gene
75 CD O
% NN O
, , O
respectively RB O
. . O

TCR NNP B-Gene
alpha NN I-Gene
and CC I-Gene
beta NN I-Gene
gene NN I-Gene
expression NN O
may MD O
be VB O
regulated VBN O
by IN O
a DT O
common JJ O
set NN O
of IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
nuclear JJ I-Gene
proteins NNS I-Gene
in IN O
that DT O
the DT O
T NNP B-Gene
beta NN I-Gene
2 CD I-Gene
element NN I-Gene
binding VBG O
a DT O
set NN O
of IN O
cyclic JJ B-Gene
AMP NNP I-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
that WDT O
are VBP O
also RB O
bound VBN O
by IN O
the DT O
T NNP B-Gene
alpha VBD I-Gene
1 CD I-Gene
element NN I-Gene
of IN O
the DT O
human JJ O
TCR NNP B-Gene
alpha NN I-Gene
enhancer NN O
and CC O
the DT O
decamer NN O
element NN O
present NN O
in IN O
a DT O
large JJ O
number NN O
of IN O
human JJ O
and CC O
murine JJ O
TCR NNP B-Gene
beta NN I-Gene
promoters NNS O
. . O

However RB O
, , O
in IN O
TF NNP O
- : O
1 CD O
cells NNS O
grown VBN O
on IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
before IN O
starvation NN O
, , O
CREB NNP B-Gene
phosphorylation NN O
was VBD O
observed VBN O
10 CD O
minutes NNS O
after IN O
PIXY321 NNP B-Gene
stimulation NN O
. . O

When WRB O
combined VBN O
with IN O
serum NN O
ferritin NN B-Gene
and CC O
hemoglobin NN B-Gene
determinations NNS O
, , O
the DT O
serum NN O
transferrin NN B-Gene
receptor NN I-Gene
assay NN O
is VBZ O
a DT O
valuable JJ O
addition NN O
in IN O
epidemiologic JJ O
surveys NNS O
because IN O
it PRP O
provides VBZ O
a DT O
quantitative JJ O
measure NN O
of IN O
functional JJ O
iron NN O
deficiency NN O
and CC O
it PRP O
distinguishes VBZ O
true JJ O
IDA NNP O
from IN O
the DT O
anemia NN O
of IN O
chronic JJ O
disease NN O
. . O

The DT O
absence NN O
of IN O
H4PteGlun NNP O
bound NN O
to TO O
the DT O
T NNP B-Gene
protein NN I-Gene
in IN O
our PRP$ O
experimental JJ O
conditions NNS O
demonstrates VBZ O
that IN O
H4PteGlun NNP O
is VBZ O
not RB O
covalently RB O
linked VBN O
to TO O
the DT O
T NNP B-Gene
protein NN I-Gene
. . O

A DT O
case NN O
of IN O
a DT O
dense NN O
epidermoid JJ O
cyst NN O
of IN O
the DT O
suprasellar JJ O
cistern NN O
is VBZ O
presented VBN O
. . O

Resultant JJ O
activation NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
/ NNP O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
/ NNP O
SAPK NNP B-Gene
) ) O
. . O

For IN O
colostral JJ O
milk NN O
there EX O
was VBD O
a DT O
significant JJ O
correlation NN O
of IN O
vitamin NN O
K1 NNP O
to TO O
cholesterol VB O
( ( O
r VB O
= RB O
0 CD O
. . O
62 CD O
) ) O
but CC O
not RB O
to TO O
total JJ O
lipid JJ O
or CC O
phospholipid JJ O
suggesting VBG O
a DT O
role NN O
for IN O
cholesterol NN O
in IN O
the DT O
secretion NN O
of IN O
vitamin NN O
K1 NNP O
into IN O
colostral JJ O
milk NN O
. . O

Members NNS O
of IN O
the DT O
MAPK NNP B-Gene
family NN I-Gene
include VBP O
the DT O
extracellular JJ B-Gene
response NN I-Gene
kinases NNS I-Gene
( ( O
ERKs NNP B-Gene
or CC O
p42 VB B-Gene
/ JJ I-Gene
44 CD I-Gene
( ( O
MAPK NNP B-Gene
) ) O
) ) O
, , O
the DT O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
amino SYM I-Gene
- : I-Gene
terminal JJ I-Gene
kinases NNS I-Gene
( ( O
JNKs NNP B-Gene
) ) O
, , O
and CC O
the DT O
p38 NN B-Gene
/ NNP O
Hog NNP B-Gene
1 CD I-Gene
protein NN O
kinases NNS O
. . O

Two CD O
additional JJ O
cis NN O
- : O
acting NN O
sequences NNS O
, , O
conserved VBN O
in IN O
both DT O
the DT O
region NN O
1 CD O
and CC O
3 CD O
promoters NNS O
, , O
were VBD O
identified VBN O
, , O
suggesting VBG O
a DT O
role NN O
for IN O
these DT O
sequences NNS O
in IN O
the DT O
coordinate NN O
regulation NN O
of IN O
transcription NN O
from IN O
these DT O
promoters NNS O
. . O

Diagnosis NN O
of IN O
primary JJ O
sclerosing VBG O
cholangitis NN O
in IN O
a DT O
blood NN O
donor NN O
with IN O
elevated JJ O
serum NN B-Gene
alanine NN I-Gene
aminotransferase NN I-Gene
. . O

Mutational JJ O
analysis NN O
shows VBZ O
that IN O
both DT O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
like IN I-Gene
sequence NN I-Gene
( ( O
- : O
294 CD O
/ SYM O
- : O
285 CD O
, , O
TGAATCATCA NNP O
) ) O
and CC O
an DT O
A NNP O
/ NN O
T NNP O
- : O
rich JJ O
myocyte NN B-Gene
enhancer NN I-Gene
factor NN I-Gene
( ( I-Gene
MEF NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
like IN I-Gene
sequence NN I-Gene
( ( O
- : O
310 CD O
/ SYM O
- : O
298 CD O
, , O
TTAAAAATAAAAA NNP O
) ) O
in IN O
the DT O
33 CD O
- : O
bp NN O
region NN O
are VBP O
necessary JJ O
for IN O
the DT O
OP NNP B-Gene
- : I-Gene
1 CD I-Gene
effect NN O
. . O

The DT O
partial JJ O
sequence NN O
of IN O
the DT O
62 CD B-Gene
- : I-Gene
kDa NN I-Gene
nuclear JJ I-Gene
pore NN I-Gene
glycoprotein NN I-Gene
shows VBZ O
little JJ O
similarity NN O
to TO O
other JJ O
characterized JJ O
proteins NNS O
and CC O
elucidates VBZ O
structural JJ O
features NNS O
of IN O
a DT O
member NN O
of IN O
the DT O
family NN O
of IN O
nuclear JJ B-Gene
pore NN I-Gene
glycoproteins NNS I-Gene
. . O

Based VBN O
on IN O
sequence NN O
homology NN O
, , O
the DT O
genes NNS O
were VBD O
identified VBN O
as IN O
TEF NNP B-Gene
, , O
encoding VBG O
translation NN B-Gene
elongation NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
and CC O
RPS7 NNP B-Gene
, , O
encoding VBG O
ribosomal JJ O
protein NN O
S7 NNP B-Gene
. . O

In IN O
18 CD O
% NN O
lymphography NN O
was VBD O
clearly RB O
positive JJ O
and CC O
CT NNP O
negative JJ O
. . O

The DT O
results NNS O
indicated VBD O
that IN O
two CD O
genes NNS O
( ( O
citA NN B-Gene
and CC O
citB NN B-Gene
) ) O
have VBP O
separate JJ O
promoters NNS O
, , O
and CC O
the DT O
location NN O
of IN O
the DT O
promoter NN O
for IN O
the DT O
citB NN B-Gene
gene NN I-Gene
in IN O
the DT O
Tn3411 NNP B-Gene
nucleotide JJ O
sequence NN O
was VBD O
different JJ O
from IN O
that DT O
in IN O
pMS185 NN O
. . O

The DT O
oral JJ O
temperature NN O
rose VBD O
and CC O
the DT O
serum NN B-Gene
creatine NN I-Gene
kinase NN I-Gene
levels NNS O
fell VBD O
only RB O
in IN O
those DT O
patients NNS O
who WP O
were VBD O
actively RB O
warmed VBN O
. . O

The DT O
mechanism NN O
of IN O
peroxisome JJ O
proliferation NN O
is VBZ O
poorly RB O
understood JJ O
. . O

In IN O
fact NN O
, , O
families NNS O
of IN O
polypeptides NNS O
were VBD O
produced VBN O
by IN O
initiation NN O
of IN O
translation NN O
at IN O
AUG NNP O
codons NNS O
within IN O
sequences NNS O
coding VBG O
for IN O
VP1 NNP B-Gene
and CC O
T NNP B-Gene
, , O
presumably RB O
as IN O
a DT O
result NN O
of IN O
transcription NN O
initiation NN O
events NNS O
that WDT O
generated VBD O
5 CD O
' '' O
ends NNS O
immediately RB O
upstream VBP O
from IN O
these DT O
AUGs NNP O
. . O

Comparison NNP O
of IN O
sequences NNS O
from IN O
- : O
215 CD O
to TO O
+ VB O
1 CD O
bp NNS O
identified VBN O
consensus NN O
binding VBG O
sites NNS O
for IN O
the DT O
homeodomain NN B-Gene
transcription NN I-Gene
factor NN I-Gene
thyroid JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TTF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Lac NN B-Gene
operators NNS O
were VBD O
introduced VBN O
into IN O
several JJ O
positions NNS O
within IN O
the DT O
CAB NNP B-Gene
promoter NN I-Gene
and CC O
operator NN O
- : O
free JJ O
plasmid NN O
was VBD O
used VBN O
as IN O
control NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
Gab1 NNP B-Gene
is VBZ O
involved VBN O
in IN O
the DT O
control NN O
of IN O
egr JJ B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
regulated VBN O
by IN O
insulin NN B-Gene
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
paxillin NN B-Gene
localizes VBZ O
to TO O
focal JJ O
adhesions NNS O
independent JJ O
of IN O
interactions NNS O
with IN O
vinculin NN B-Gene
and CC O
/ NN O
or CC O
FAK NNP B-Gene
, , O
and CC O
represents VBZ O
the DT O
first JJ O
definitive JJ O
demonstration NN O
of IN O
LIM NNP B-Gene
domains VBZ I-Gene
functioning VBG O
as IN O
a DT O
primary JJ O
determinant NN O
of IN O
protein NN O
subcellular JJ O
localization NN O
to TO O
focal JJ O
adhesions NNS O
. . O

It PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
insulin NN B-Gene
resistance NN O
( ( O
IR NNP O
) ) O
underlies VBZ O
a DT O
cluster NN O
of IN O
cardiovascular JJ O
disease NN O
( ( O
CVD NNP O
) ) O
risk NN O
factors NNS O
constituting VBG O
a DT O
"""" JJ O
metabolic JJ O
syndrome NN O
. . O
"""" JJ O
CVD NNP O
is VBZ O
a DT O
leading VBG O
cause NN O
of IN O
premature JJ O
mortality NN O
among IN O
indigenous JJ O
Australians NNPS O
. . O

Comparison NNP O
to TO O
other JJ O
coxI JJ B-Gene
genes NNS I-Gene
revealed VBD O
a DT O
966 CD O
- : O
bp NN O
group NN O
I PRP O
intron VBP O
, , O
which WDT O
, , O
based VBN O
on IN O
homology NN O
with IN O
the DT O
related JJ O
yeast NN B-Gene
coxI NN I-Gene
intron NN I-Gene
aI4 NN I-Gene
, , O
potentially RB O
encodes VBZ O
a DT O
279 CD O
- : O
amino NN O
- : O
acid NN O
site NN O
- : O
specific JJ O
DNA NNP B-Gene
endonuclease NN I-Gene
. . O

The DT O
electromyographically RB O
recorded JJ O
responses NNS O
consisted VBD O
of IN O
an DT O
early JJ O
R1 NNP O
response NN O
in IN O
the DT O
orbicularis JJ O
oculi JJ O
muscle NN O
ipsilateral JJ O
to TO O
the DT O
side NN O
of IN O
stimulation NN O
, , O
a DT O
bilateral JJ O
late JJ O
response NN O
( ( O
ipsilateral JJ O
R2 NNP O
and CC O
contralateral JJ O
Rc NNP O
) ) O
and CC O
a DT O
third JJ O
, , O
R3 NNP O
response NN O
, , O
in IN O
the DT O
ipsilateral JJ O
orbicularis NN O
oculi JJ O
muscle NN O
. . O

The DT O
Abbreviated NNP O
Injury NNP O
Scale NNP O
( ( O
AIS NNP O
) ) O
, , O
Injury NNP O
Severity NNP O
Scale NNP O
and CC O
TRISS NNP O
methodology NN O
comprise NN O
a DT O
mathematically RB O
sound JJ O
system NN O
for IN O
the DT O
analysis NN O
of IN O
injuries NNS O
and CC O
injured JJ O
patients NNS O
. . O

Platelet NNP O
aggregation NN O
in IN O
response NN O
to TO O
10 CD O
micrograms NNS O
collagen VBP B-Gene
/ JJ O
ml NN O
was VBD O
decreased VBN O
in IN O
parallel NN O
after IN O
treatment NN O
with IN O
ASA NNP O
. . O

Cervicovaginal NNP O
foetal JJ B-Gene
fibronectin NN I-Gene
in IN O
the DT O
prediction NN O
of IN O
preterm JJ O
labour NN O
in IN O
a DT O
low JJ O
- : O
risk NN O
population NN O
. . O

The DT O
systolic JJ O
pressure NN O
gradient NN O
( ( O
SPG NNP O
) ) O
between IN O
the DT O
left JJ O
ventricle NN O
( ( O
LV NNP O
) ) O
and CC O
left JJ O
atrium NN O
( ( O
LA NNP O
) ) O
was VBD O
obtained VBN O
from IN O
high JJ O
- : O
fidelity NN O
pressure NN O
transducers NNS O
. . O

The DT O
main JJ O
aim NN O
of IN O
the DT O
contribution NN O
, , O
which WDT O
opens VBZ O
an DT O
arena NN O
for IN O
discussion NN O
on IN O
the DT O
Rivista NNP O
dell NN O
' '' O
Infermiere NNP O
is VBZ O
to TO O
critically RB O
appraise VB O
published VBN O
research NN O
works VBZ O
focusing VBG O
both DT O
on IN O
strengths NNS O
and CC O
novelty NN O
and CC O
weaknesses NNS O
in IN O
the DT O
hypothesis NN O
formulation NN O
, , O
methods NNS O
and CC O
instruments NNS O
used VBN O
, , O
discussion NN O
of IN O
results NNS O
. . O

This DT O
site NN O
acts VBZ O
as IN O
a DT O
negative JJ O
element NN O
when WRB O
transferred VBN O
to TO O
the DT O
thymidine NN B-Gene
kinase NN I-Gene
promoter NN I-Gene
, , O
but CC O
does VBZ O
not RB O
confer VB O
inducibility NN O
. . O

In IN O
conclusion NN O
, , O
obesity NN O
, , O
alcohol NN O
intake NN O
, , O
and CC O
multimetabolic JJ O
disorders NNS O
were VBD O
determined VBN O
to TO O
be VB O
independent JJ O
predictors NNS O
for IN O
the DT O
development NN O
of IN O
hyperuricemia NN O
. . O

When WRB O
the DT O
73 CD O
- : O
bp NN O
fragment NN O
was VBD O
fused VBN O
to TO O
an DT O
alpha1 JJ B-Gene
- : I-Gene
globin NN I-Gene
promoter NN O
- : O
CAT NNP B-Gene
construct NN O
and CC O
cotransfected VBN O
with IN O
CCAAT NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
CTF1 NNP B-Gene
) ) O
/ FW O
NF1 NNP B-Gene
into IN O
Drosophila NNP O
Schneider NNP O
SL2 NNP O
insect NN O
cells NNS O
( ( O
which WDT O
lack VBP O
NF1 NNP B-Gene
- : I-Gene
like IN I-Gene
proteins NNS I-Gene
) ) O
trans VBZ O
- : O
activation NN O
of IN O
CAT NNP B-Gene
activity NN O
was VBD O
observed VBN O
. . O

We PRP O
conclude VBP O
that IN O
pancreatic JJ O
polypeptide NN O
and CC O
motilin NN B-Gene
responses NNS O
to TO O
a DT O
meal NN O
are VBP O
different JJ O
in IN O
encopretic JJ O
children NNS O
than IN O
in IN O
children NNS O
in IN O
the DT O
control NN O
group NN O
. . O

An DT O
integrated VBN O
RTC NNP O
algorithm NN O
for IN O
the DT O
urban JJ O
wastewater NN O
system NN O
is VBZ O
formulated VBN O
, , O
the DT O
parameters NNS O
of IN O
which WDT O
are VBP O
optimized VBN O
using VBG O
various JJ O
global JJ O
optimization NN O
routines NNS O
. . O

Attitudes NNS O
were VBD O
found VBN O
to TO O
be VB O
multidimensional JJ O
, , O
with IN O
similar JJ O
dimensions NNS O
being VBG O
identified VBN O
in IN O
both DT O
samples NNS O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
the DT O
ORF NNP O
of IN O
hAMPK NN B-Gene
encodes NNS O
552 CD O
amino JJ O
acids NNS O
( ( O
aa NN O
) ) O
( ( O
62 CD O
. . O
250 CD O
kDa NN O
) ) O
and CC O
is VBZ O
highly RB O
conserved VBN O
with IN O
rAMPK NN B-Gene
with IN O
identities NNS O
of IN O
97 CD O
. . O
3 CD O
and CC O
90 CD O
% NN O
at IN O
the DT O
aa NN O
and CC O
nt NN O
levels NNS O
, , O
respectively RB O
. . O

Moreover RB O
, , O
we PRP O
found VBD O
that IN O
cyclin NN B-Gene
E NNP I-Gene
, , O
in IN O
contrast NN O
to TO O
cyclin VB B-Gene
D1 NNP I-Gene
, , O
was VBD O
required VBN O
for IN O
the DT O
G1 NNP O
/ NNP O
S NNP O
transition NN O
even RB O
in IN O
cells NNS O
lacking VBG O
retinoblastoma NN B-Gene
protein NN I-Gene
function NN O
. . O

PaO2 NNP O
threshold NN O
was VBD O
determined VBN O
through IN O
an DT O
indwelling NN O
O2 NNP O
sensor NN O
catheter NN O
. . O

The DT O
active JJ O
site NN O
includes VBZ O
the DT O
acidic JJ O
triad NN O
Asp53 NNP O
( ( O
the DT O
site NN O
of IN O
phosphorylation NN O
) ) O
, , O
Asp10 NNP O
and CC O
Glu9 NNP O
. . O

Physiology NNP O
and CC O
Physiopathology NNP O

The DT O
examination NN O
must MD O
include VB O
T1 NNP O
and CC O
T2 NNP O
sequences NNS O
and CC O
scans NNS O
in IN O
three CD O
planes NNS O
. . O

Effects NNS O
of IN O
temperature NN O
and CC O
moulting VBG O
cycle NN O
on IN O
melanin NN O
synthesis NN O
in IN O
the DT O
newt NN O
, , O
Triturus NNP O
cristatus NN O
. . O

To TO O
begin VB O
to TO O
examine VB O
the DT O
mechanism NN O
controlling VBG O
expression NN O
of IN O
this DT O
gene NN O
during IN O
the DT O
cell NN O
- : O
cycle NN O
, , O
a DT O
mouse NN B-Gene
B NNP I-Gene
- : I-Gene
myb NN I-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
sequence NN I-Gene
was VBD O
isolated VBN O
from IN O
a DT O
cosmid JJ O
library NN O
and CC O
shown VBN O
to TO O
promote VB O
efficiently RB O
the DT O
transcription NN O
of IN O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
when WRB O
transfected VBN O
into IN O
NIH3T3 NNP O
fibroblasts NNS O
. . O

A DT O
clinically RB O
useful JJ O
diagnostic JJ O
method NN O
has VBZ O
been VBN O
developed VBN O
for IN O
detecting VBG O
and CC O
quantitating VBG O
periods NNS O
of IN O
apnea NN O
in IN O
pediatric JJ O
patients NNS O
. . O

Simultaneous JJ O
determination NN O
of IN O
theophylline NN O
and CC O
its PRP$ O
metabolites NNS O
by IN O
HPLC NNP O
] NNP O
A NNP O
high JJ O
performance NN O
liquid NN O
chromatography NN O
( ( O
HPLC NNP O
) ) O
method NN O
has VBZ O
been VBN O
developed VBN O
for IN O
the DT O
simultaneous JJ O
determination NN O
of IN O
theophylline NN O
and CC O
its PRP$ O
metabolites NNS O
, , O
with IN O
caffeine NN O
and CC O
its PRP$ O
metabolites NNS O
. . O

Greater NNP O
attenuation NN O
of IN O
the DT O
N1 NNP O
- : O
P2 NN O
and CC O
baseline NN O
- : O
P2 NNP O
amplitude NN O
of IN O
the DT O
probe NN O
EPs NNP O
was VBD O
observed VBN O
when WRB O
the DT O
probe NN O
stimulus NN O
was VBD O
presented VBN O
to TO O
the DT O
right JJ O
ear NN O
and CC O
the DT O
verbal JJ O
material NN O
presented VBN O
to TO O
the DT O
left NN O
ear NN O
than IN O
when WRB O
the DT O
opposite JJ O
stimulation NN O
arrangement NN O
was VBD O
used VBN O
. . O

This DT O
effect NN O
and CC O
the DT O
fact NN O
that IN O
all DT O
three CD O
doses NNS O
were VBD O
toxic JJ O
to TO O
the DT O
dams NNS O
dictated VBD O
that IN O
a DT O
second JJ O
experiment NN O
be VB O
carried VBN O
out RP O
at IN O
lower JJR O
doses NNS O
. . O

Histological NNP O
slides NNS O
of IN O
one CD O
biopsy NN O
of IN O
each DT O
patient NN O
( ( O
formalin JJ O
- : O
fixed VBN O
and CC O
paraffin SYM O
- : O
embedded VBN O
) ) O
were VBD O
stained VBN O
with IN O
a DT O
Modified NNP O
Giemsa NNP O
( ( O
MG NNP O
) ) O
, , O
the DT O
Warthin NNP O
- : O
Starry NNP O
( ( O
WS NNP O
) ) O
, , O
and CC O
an DT O
immunohistochemical JJ O
method NN O
( ( O
IMM NNP O
) ) O
using VBG O
purified JJ O
polyclonal JJ O
H NNP O
. . O
pylori NN O
antiserum NN O
( ( O
DAKO NNP O
B471 NNP O
) ) O
. . O

An DT O
examination NN O
was VBD O
performed VBN O
in IN O
15 CD O
patients NNS O
who WP O
had VBD O
developed VBN O
pronounced VBN O
osteomalacia IN O
following VBG O
gastric JJ O
resection NN O
. . O

Intravenous JJ O
gamma NN B-Gene
globulins NNS I-Gene

Year IN O
one CD O
of IN O
the DT O
first JJ O
general JJ O
practitioner NN O
medical JJ O
unit NN O
in IN O
the DT O
greater JJR O
Glasgow NNP O
area NN O
. . O

The DT O
sequenced JJ O
genomic JJ O
region NN O
thus RB O
accounts NNS O
for IN O
essentially RB O
all DT O
of IN O
the DT O
longest JJS O
known VBN O
transcript NN O
( ( O
4 CD O
. . O
5 CD O
kb NN O
) ) O
, , O
although IN O
the DT O
precise JJ O
ends NNS O
of IN O
this DT O
transcript NN O
have VBP O
not RB O
been VBN O
defined VBN O
. . O

This DT O
conclusion NN O
was VBD O
confirmed VBN O
by IN O
Northern NNP O
blotting VBG O
analysis NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
CAD NNP B-Gene
gene NN I-Gene
. . O

OBJECTIVES NN O
: : O
To TO O
assess VB O
the DT O
ability NN O
of IN O
pretreatment NN O
and CC O
post NN O
- : O
treatment NN O
prostate NN B-Gene
- : I-Gene
specific JJ I-Gene
antigen NN I-Gene
( ( O
PSA NNP B-Gene
) ) O
measurements NNS O
, , O
clinical JJ O
tumor NN O
stage NN O
, , O
tumor NN O
grade NN O
, , O
Gleason NNP O
sum NN O
, , O
race NN O
, , O
age NN O
, , O
and CC O
radiation NN O
dose NN O
to TO O
predict VB O
the DT O
recurrence NN O
of IN O
prostate JJ O
cancer NN O
following VBG O
external JJ O
beam NN O
radiation NN O
therapy NN O
( ( O
XRT NNP O
) ) O
since IN O
the DT O
introduction NN O
of IN O
PSA NNP B-Gene
as IN O
a DT O
tumor NN O
marker NN O
at IN O
one CD O
tertiary JJ O
care NN O
center NN O
. . O

The DT O
acfD JJ B-Gene
gene NN I-Gene
encompasses VBZ O
254 CD O
nt NN O
that WDT O
are VBP O
predicted VBN O
to TO O
encode VB O
an DT O
88 CD O
- : O
amino NN O
- : O
acid NN O
( ( O
aa NN O
) ) O
protein NN O
. . O

The DT O
effect NN O
of IN O
emotional JJ O
- : O
painful JJ O
stress NN O
( ( O
EPS NNP O
) ) O
on IN O
myocardial JJ O
extensibility NN O
and CC O
contractility NN O
was VBD O
studied VBN O
on IN O
an DT O
isolated JJ O
rat NN O
atrium NN O
. . O

Previous JJ O
experience NN O
and CC O
contextual JJ O
cues NNS O
are VBP O
essential JJ O
elements NNS O
in IN O
the DT O
generation NN O
of IN O
a DT O
subjective JJ O
prediction NN O
. . O

Since IN O
August NNP O
1994 CD O
, , O
the DT O
ENRP NNP O
has VBZ O
retained VBN O
70 CD O
. . O
3 CD O
metric JJ O
tons NNS O
of IN O
TP NNP O
that WDT O
otherwise RB O
would MD O
have VB O
entered VBN O
the DT O
Everglades NNP O
. . O

Molecular JJ O
characterization NN O
of IN O
a DT O
large JJ O
Borrelia NNP O
burgdorferi NN O
motility NN O
operon NN O
which WDT O
is VBZ O
initiated VBN O
by IN O
a DT O
consensus NN O
sigma70 NN B-Gene
promoter NN I-Gene
. . O

Interestingly RB O
, , O
in IN O
the DT O
adult NN O
, , O
transgene JJ O
expression NN O
patterns NNS O
within IN O
the DT O
cerebellum NN O
in IN O
two CD O
lines NNS O
appeared VBD O
to TO O
mark VB O
distinct JJ O
anterior JJ O
- : O
posterior JJ O
compartments NNS O
. . O

Furthermore RB O
, , O
this DT O
element NN O
confers NNS O
p53 VBP B-Gene
induction NN O
to TO O
the DT O
otherwise RB O
nonresponsive JJ O
adenovirus NN O
major JJ O
late JJ O
promoter NN O
. . O

The DT O
elm1 JJ B-Gene
kinase NN I-Gene
functions NNS O
in IN O
a DT O
mitotic JJ O
signaling NN O
network NN O
in IN O
budding VBG O
yeast NN O
. . O

A DT O
further JJ O
mechanism NN O
increasing VBG O
specific JJ O
activation NN O
was VBD O
cooperation NN O
of IN O
receptors NNS O
at IN O
multiple JJ O
and CC O
weak JJ O
HREs NNP O
, , O
which WDT O
was VBD O
accentuated VBN O
in IN O
the DT O
presence NN O
of IN O
both CC O
the DT O
AR NNP B-Gene
N NNP O
terminus NN O
and CC O
ligand NN O
binding NN O
domain NN O
. . O

3600 CD O
- : O
fold NN O
to TO O
apparent JJ O
homogeneity NN O
with IN O
a DT O
41 CD O
% NN O
yield NN O
by IN O
affinity NN O
chromatography NN O
utilizing VBG O
DNA NNP O
- : O
cellulose NN O
; : O
the DT O
purity NN O
of IN O
the DT O
final JJ O
preparation NN O
was VBD O
assessed VBN O
by IN O
SDS NNP O
/ NNP O
PAGE NNP O
, , O
lack NN O
of IN O
contamination NN O
by IN O
other JJ O
nucleases NNS O
and CC O
production NN O
of IN O
a DT O
monospecific JJ O
antibody NN O
against IN O
the DT O
enzyme NN O
. . O

Some DT O
strains NNS O
of IN O
A NNP O
. . O
parasiticus NN O
produced VBD O
all DT O
four CD O
aflatoxins NNS O
B1 NNP O
B2 NNP O
G1 NNP O
G2 NNP O
, , O
while IN O
the DT O
other JJ O
ones NNS O
produced VBN O
AF NNP O
B1 NNP O
+ NNP O
G1 NNP O
only RB O
, , O
with IN O
concentrations NNS O
of IN O
aflatoxins NNS O
from IN O
0 CD O
. . O
1 CD O
to TO O
450 CD O
mg NNS O
/ JJ O
kg NN O
. . O

Possible JJ O
roles NNS O
of IN O
RAD5 NNP B-Gene
putative JJ O
ATPase NNP B-Gene
/ NNP O
DNA NNP B-Gene
helicase NN I-Gene
activity NN O
in IN O
DNA NNP O
repair NN O
and CC O
in IN O
the DT O
maintenance NN O
of IN O
wild JJ O
- : O
type NN O
rates NNS O
of IN O
instability NN O
of IN O
simple JJ O
repetitive JJ O
sequences NNS O
are VBP O
discussed VBN O
. . O

Interaction NN O
was VBD O
apparently RB O
determined VBN O
by IN O
the DT O
N NNP O
- : O
terminal JJ O
splice JJ O
region NN O
of IN O
RPDE NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
as IN O
the DT O
PDE4A NNP B-Gene
splice NN O
variant NN O
RPDE NNP B-Gene
- : I-Gene
39 CD I-Gene
, , O
which WDT O
differs VBZ O
from IN O
RPDE NNP B-Gene
- : I-Gene
6 CD I-Gene
at IN O
the DT O
extreme JJ O
N NNP O
- : O
terminus NN O
, , O
failed VBD O
to TO O
associate VB O
with IN O
v JJ B-Gene
- : I-Gene
Src NNP I-Gene
- : O
SH3 NN B-Gene
; : O
met26RD1 NN B-Gene
( ( O
where WRB O
RD1 NNP B-Gene
is VBZ O
rat VBN B-Gene
' '' I-Gene
dunc JJ I-Gene
- : I-Gene
like IN I-Gene
' '' I-Gene
PDE NNP I-Gene
) ) O
, , O
which WDT O
has VBZ O
the DT O
N NNP O
- : O
terminal JJ O
splice NN O
region NN O
deleted VBN O
, , O
failed VBD O
to TO O
associate VB O
with IN O
v JJ B-Gene
- : I-Gene
Src NNP I-Gene
- : O
SH3 NN B-Gene
, , O
and CC O
the DT O
association NN O
of IN O
RPDE NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
v SYM B-Gene
- : I-Gene
Src NNP I-Gene
- : O
SH3 NN B-Gene
was VBD O
blocked VBN O
by IN O
a DT O
fusion NN O
protein NN O
formed VBD O
from IN O
the DT O
N NNP O
- : O
terminal JJ O
splice NN O
region NN O
. . O

All PDT O
these DT O
processes NNS O
were VBD O
fully RB O
developed VBN O
during IN O
the DT O
last JJ O
month NN O
of IN O
pregnancy NN O
, , O
offering VBG O
the DT O
same JJ O
picture NN O
as IN O
the DT O
controls NNS O
. . O

Vitrectomy NNP O
with IN O
an DT O
alternative JJ O
instrument NN O
system NN O
. . O

FZD4 NNP B-Gene
is VBZ O
homologous JJ O
to TO O
FZD9 NNP B-Gene
and CC O
FZD10 NNP B-Gene
, , O
and CC O
overall JJ O
amino NN O
acid NN O
identity NN O
is VBZ O
as IN O
follows VBZ O
: : O
FZD4 NNP B-Gene
vs NN O
FZD9 NNP B-Gene
, , O
51 CD O
. . O
6 CD O
% NN O
; : O
FZD4 NNP B-Gene
vs FW O
FZD10 NNP B-Gene
, , O
51 CD O
. . O
2 CD O
% NN O
; : O
FZD9 NNP B-Gene
vs FW O
FZD10 NNP B-Gene
, , O
65 CD O
. . O
7 CD O
% NN O
. . O

Intracranial JJ O
arachnoid JJ O
cyst NN O
of IN O
the DT O
middle JJ O
fossa NN O
demonstrated VBN O
by IN O
positive JJ O
99mTc CD O
brainscintigraphy NN O
. . O

The DT O
mean JJ O
change NN O
in IN O
HbA1 NNP B-Gene
, , O
adjusted VBN O
for IN O
the DT O
initial JJ O
value NN O
, , O
was VBD O
- : O
0 CD O
. . O
4 CD O
% NN O
in IN O
the DT O
experimental JJ O
and CC O
+ JJ O
0 CD O
. . O
5 CD O
% NN O
in IN O
the DT O
control NN O
group NN O
( ( O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

SECONDARY NNP O
OUTCOME NNP O
MEASURE NNP O
- : O
- : O
Double JJ O
- : O
blind NN O
caffeine NN O
- : O
withdrawal NN O
evaluation NN O
. . O

Patch NNP O
test NN O
results NNS O
obtained VBD O
with IN O
corticosteroid JJ O
allergic JJ O
patients NNS O
tested VBN O
with IN O
a DT O
large JJ O
corticosteroid NN O
series NN O
validated VBD O
the DT O
earlier JJR O
classification NN O
of IN O
corticosteroid JJ O
molecules NNS O
in IN O
four CD O
groups NNS O
of IN O
cross NN O
- : O
reacting VBG O
molecules NNS O
: : O
i NN O
. . O
e NN O
. . O
, , O
group NN O
A NNP O
( ( O
hydrocortisone NN O
type NN O
) ) O
, , O
group NN O
B NNP O
( ( O
acetonides NNS O
) ) O
, , O
group NN O
C NNP O
( ( O
betamethasone NN O
type NN O
- : O
non RB O
esterified VBN O
) ) O
and CC O
group NN O
D NNP O
( ( O
esters NNS O
) ) O
. . O

In IN O
the DT O
absence NN O
of IN O
other JJ O
stabilizers NNS O
, , O
increased VBD O
sucrose RB O
can MD O
provide VB O
increased VBD O
thermoresistance NN O
to TO O
the DT O
virus NN O
in IN O
2 CD O
. . O
5 CD O
% NN O
albumin NN B-Gene
. . O

The DT O
underlying JJ O
cirrhosis NN O
was VBD O
alcoholic JJ O
in IN O
11 CD O
( ( O
53 CD O
. . O
3 CD O
% NN O
) ) O
, , O
cryptogenic JJ O
in IN O
5 CD O
( ( O
23 CD O
. . O
8 CD O
% NN O
) ) O
, , O
and CC O
hepatitis NN O
B NNP O
chronic JJ O
infection NN O
related VBN O
in IN O
5 CD O
( ( O
23 CD O
. . O
8 CD O
% NN O
) ) O
. . O

Partial JJ O
correction NN O
of IN O
anemia NN O
with IN O
recombinant JJ B-Gene
human JJ I-Gene
erythropoietin NN I-Gene
likely JJ O
reduces NNS O
left VBD O
ventricular JJ O
mass NN O
and CC O
volume NN O
. . O

Some DT O
of IN O
the DT O
peptide NN B-Gene
: : I-Gene
MBP JJ I-Gene
fusions NNS I-Gene
were VBD O
also RB O
analyzed VBN O
using VBG O
surface NN O
plasmon NN O
resonance NN O
. . O

To TO O
discern VB O
whether IN O
these DT O
disorders NNS O
of IN O
GnRH NNP B-Gene
deficiency NN O
are VBP O
associated VBN O
with IN O
altered JJ O
melatonin NN O
secretion NN O
profiles NNS O
, , O
we PRP O
compared VBN O
untreated JJ O
young JJ O
males NNS O
IGD NNP O
( ( O
n JJ O
= NNP O
7 CD O
) ) O
and CC O
DP NNP O
( ( O
n JJ O
= NNP O
7 CD O
) ) O
to TO O
normal JJ O
pubertal JJ O
male NN O
controls NNS O
( ( O
n JJ O
= NNP O
6 CD O
) ) O
. . O

The DT O
manifestations NNS O
often RB O
include VBP O
a DT O
moderate JJ O
thrombocytopenia NN O
and CC O
, , O
less JJR O
commonly RB O
, , O
hemolysis NN O
. . O

Epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
transcriptionally RB O
up RP O
- : O
regulates NNS O
vascular JJ B-Gene
endothelial JJ I-Gene
growth NN I-Gene
factor NN I-Gene
expression NN O
in IN O
human JJ O
glioblastoma NN O
cells NNS O
via IN O
a DT O
pathway NN O
involving VBG O
phosphatidylinositol JJ B-Gene
3 CD I-Gene
' POS I-Gene
- : I-Gene
kinase NN I-Gene
and CC O
distinct NN O
from IN O
that DT O
induced VBN O
by IN O
hypoxia NN O
. . O

Animal NNP O
experimental NN O
and CC O
clinical JJ O
applications NNS O
of IN O
plates NNS O
, , O
screws NNS O
and CC O
spinal JJ O
segmental JJ O
replacement NN O
implants NNS O
made VBN O
of IN O
this DT O
composite JJ O
material NN O
have VBP O
shown VBN O
good JJ O
results NNS O
so RB O
far RB O
. . O

In IN O
the DT O
absence NN O
of IN O
enhancer NN O
sequences NNS O
, , O
the DT O
adenovirus NN B-Gene
E1A NNP I-Gene
gene NN I-Gene
can MD O
not RB O
stimulate VB O
CATase NNP B-Gene
synthesis NN O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
the DT O
results NNS O
indicate VBP O
that IN O
p53 NN B-Gene
plays VBZ O
a DT O
defensive JJ O
role NN O
against IN O
HBV NNP O
by IN O
transcriptionally RB O
repressing VBG O
the DT O
HBV NNP B-Gene
core NN I-Gene
promoter NN I-Gene
through IN O
liver NN B-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
II NNP I-Gene
and CC O
HBx NNP B-Gene
is VBZ O
required VBN O
to TO O
counteract VB O
this DT O
inhibitory JJ O
function NN O
of IN O
p53 NN B-Gene
. . O

This DT O
paper NN O
brings VBZ O
together RB O
data NNS O
, , O
obtained VBN O
from IN O
a DT O
variety NN O
of IN O
sources NNS O
, , O
on IN O
the DT O
extent NN O
of IN O
prescription NN O
and CC O
use NN O
of IN O
psychotropic NN O
drugs NNS O
in IN O
the DT O
late JJ O
1960s NNS O
and CC O
early JJ O
1970s CD O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
cis NN O
elements NNS O
positioned VBD O
between IN O
the DT O
alpha NN B-Gene
3 CD I-Gene
and CC O
beta $ B-Gene
4 CD I-Gene
coding NN O
regions NNS O
are VBP O
important JJ O
for IN O
establishing VBG O
part NN O
of IN O
the DT O
restricted VBN O
CNS NNP O
patterns NNS O
of IN O
beta NN B-Gene
4 CD I-Gene
, , O
alpha RB B-Gene
3 CD I-Gene
, , O
and CC O
alpha RB B-Gene
5 CD I-Gene
gene NN I-Gene
transcription NN O
. . O

In IN O
vitro JJ O
translation NN O
and CC O
in IN O
vivo JJ O
polysome NN O
profile NN O
analysis NN O
indicated VBD O
that IN O
transcripts NNS B-Gene
C NNP I-Gene
and CC I-Gene
E NNP I-Gene
were VBD O
translated VBN O
with IN O
similar JJ O
translational JJ O
efficiencies NNS O
that WDT O
are VBP O
substantially RB O
greater JJR O
than IN O
that DT O
of IN O
transcript NN B-Gene
D NNP I-Gene
, , O
suggesting VBG O
that IN O
5 CD O
' '' O
- : O
untranslated JJ O
regions NNS O
play VBP O
a DT O
role NN O
in IN O
translational JJ O
control NN O
. . O

Dsh NNP B-Gene
is VBZ O
required VBN O
for IN O
two CD O
different JJ O
pathways NNS O
, , O
the DT O
Wnt NNP B-Gene
pathway NN O
and CC O
planar NN O
polarity NN O
pathway NN O
in IN O
Drosophila NNP O
. . O

When WRB O
normalized VBN O
for IN O
imaging VBG O
time NN O
, , O
all DT O
parameters NNS O
are VBP O
significantly RB O
higher JJR O
with IN O
RASE NNP O
, , O
with IN O
a DT O
C NNP O
/ VBZ O
A DT O
per IN O
unit NN O
time NN O
that WDT O
was VBD O
338 CD O
% NN O
higher JJR O
. . O

An DT O
in IN O
vitro NN O
binding NN O
site NN O
selection NN O
procedure NN O
was VBD O
used VBN O
to TO O
determine VB O
DNA NNP O
sequences NNS O
preferentially RB O
bound VBN O
by IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
HLF NNP I-Gene
and CC O
chimeric JJ O
E2A NNP B-Gene
- : O
HLF NNP B-Gene
proteins NNS O
isolated VBN O
from IN O
various JJ O
t NN O
( ( O
17 CD O
; : O
19 CD O
) ) O
- : O
bearing NN O
leukemias NN O
. . O

First RB O
, , O
the DT O
finding NN O
of IN O
a DT O
monomeric JJ O
Alu NNP B-Gene
family NN O
repeat NN O
at IN O
the DT O
junction NN O
between IN O
nonhomology NN O
block NN O
I PRP O
and CC O
homology NN O
block NN O
Y NNP O
of IN O
the DT O
alpha NN B-Gene
2 CD I-Gene
gene NN I-Gene
- : I-Gene
containing VBG I-Gene
unit NN I-Gene
in IN I-Gene
rhesus NN I-Gene
macaque NN I-Gene
suggests VBZ O
that IN O
the DT O
dimeric JJ O
Alu NNP B-Gene
family NN O
repeat NN O
, , O
Alu NNP B-Gene
3 CD I-Gene
, , O
at IN O
the DT O
orthologous JJ O
position NN O
in IN O
human NN O
was VBD O
generated VBN O
by IN O
insertion NN O
of IN O
a DT O
monomeric JJ O
Alu NNP B-Gene
family NN O
repeat NN O
into IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
another DT O
preexisting VBG O
Alu NNP B-Gene
family NN O
repeat NN O
. . O

An DT O
E NNP O
box NN O
element NN O
is VBZ O
required VBN O
for IN O
the DT O
expression NN O
of IN O
the DT O
ad4bp JJ B-Gene
gene NN I-Gene
, , O
a DT O
mammalian JJ B-Gene
homologue NN I-Gene
of IN I-Gene
ftz JJ I-Gene
- : I-Gene
f1 NN I-Gene
gene NN I-Gene
, , O
which WDT O
is VBZ O
essential JJ O
for IN O
adrenal JJ O
and CC O
gonadal JJ O
development NN O
. . O

Sequence NN O
analysis NN O
revealed VBD O
that IN O
in IN O
addition NN O
to TO O
the DT O
non JJ O
- : O
spliced VBN O
variant NN O
, , O
multiple JJ O
mRNA NN O
species NNS O
were VBD O
generated VBN O
by IN O
alternative JJ O
splicing VBG O
resulting VBG O
in IN O
the DT O
exclusion NN O
of IN O
92 CD O
, , O
166 CD O
, , O
170 CD O
, , O
174 CD O
and CC O
263 CD O
nucleotides NNS O
( ( O
nt NN O
) ) O
, , O
respectively RB O
, , O
from IN O
exon JJ O
1 CD O
. . O

The DT O
majority NN O
of IN O
the DT O
cases NNS O
with IN O
0 CD O
- : O
I PRP O
or CC O
0 CD O
- : O
III NN O
components NNS O
were VBD O
sm JJ O
. . O
cancer NN O
. . O

The DT O
role NN O
of IN O
ascorbic JJ O
acid NN O
in IN O
the DT O
prevention NN O
of IN O
bladder NN O
tumor NN O
formation NN O
. . O

Using VBG O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
we PRP O
analyzed VBD O
the DT O
U6 NNP B-Gene
RNA NNP I-Gene
genes NNS I-Gene
of IN O
52 CD O
organisms NNS O
. . O

One CD O
missense NN O
allele NN O
( ( O
P236S NNP O
) ) O
with IN O
complete JJ O
loss NN O
of IN O
function NN O
at IN O
30 CD O
degreesC NNS O
and CC O
four CD O
missense NN O
alleles NNS O
( ( O
L173F NNP O
, , O
E225K NNP O
, , O
S269L NNP O
and CC O
E274K NNP O
) ) O
that WDT O
conferred VBD O
a DT O
temperature NN O
sensitive JJ O
phenotype NN O
were VBD O
identified VBN O
. . O

A DT O
genomic JJ O
clone NN O
was VBD O
isolated VBN O
that IN O
contained VBD O
12 CD O
. . O
5 CD O
kb NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
and CC O
the DT O
first JJ O
exon NN O
of IN O
the DT O
p69 NN B-Gene
/ VBD I-Gene
71 CD I-Gene
2 CD I-Gene
- : I-Gene
5A CD I-Gene
synthetase NN I-Gene
gene NN I-Gene
. . O

ANIMALS NNS O
: : O
Fifty NNP O
dogs NNS O
with IN O
naturally RB O
developing VBG O
DM NNP O
. . O

Polyclonal JJ O
antibodies NNS O
against IN O
the DT O
N NNP O
- : O
terminal JJ O
part NN O
( ( O
amino JJ O
acids NNS O
12 CD O
- : O
363 CD O
) ) O
and CC O
the DT O
C NNP O
- : O
terminal JJ O
part NN O
( ( O
amino JJ O
acids NNS O
330 CD O
- : O
730 CD O
) ) O
of IN O
rainbow NN B-Gene
trout NN I-Gene
HIF NNP I-Gene
- : I-Gene
1alpha CD I-Gene
protein NN I-Gene
recognized VBN O
rainbow NN B-Gene
trout NN I-Gene
and CC I-Gene
chinook NN I-Gene
salmon NN I-Gene
HIF NNP I-Gene
- : I-Gene
1alpha CD I-Gene
protein NN I-Gene
in IN O
Western JJ O
blot NN O
analysis NN O
. . O

CNS NNP O
effects NNS O
of IN O
local JJ O
anesthetics NNS O
only RB O
partially RB O
dependent JJ O
on IN O
biogenic JJ O
amine NN O
mechanisms NNS O
. . O

Large JJ B-Gene
T NNP I-Gene
antigen NN I-Gene
was VBD O
coimmunoprecipitated VBN O
by IN O
antibodies NNS O
to TO O
epitope VB O
- : O
tagged VBN O
TBP NNP B-Gene
, , O
endogenous JJ O
TBP NNP B-Gene
, , O
hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
100 CD I-Gene
, , O
hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
130 CD I-Gene
, , O
and CC O
hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
250 CD I-Gene
, , O
under IN O
conditions NNS O
where WRB O
holo NN B-Gene
- : I-Gene
TFIID NNP I-Gene
would MD O
be VB O
precipitated VBN O
. . O

Replacing VBG O
residues NNS O
405 CD O
- : O
419 CD O
on IN O
delta419 NN O
with IN O
the DT O
conserved VBN O
AF NNP O
- : O
2 CD O
domain NN O
from IN O
the DT O
vitamin NN B-Gene
D3 NNP I-Gene
receptor NN I-Gene
or CC O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
results NNS O
in IN O
a DT O
receptor NN O
with IN O
wild JJ O
- : O
type NN O
or CC O
low JJ O
transcriptional JJ O
activity NN O
, , O
respectively RB O
. . O

In IN O
addition NN O
, , O
media NNS O
containing VBG O
F NNP B-Gene
beta NN I-Gene
alpha NN I-Gene
/ NNP O
CG NNP B-Gene
beta NN I-Gene
displayed VBD O
high JJ O
- : O
affinity NN O
binding NN O
to TO O
both DT O
CG NNP B-Gene
and CC I-Gene
FSH NNP I-Gene
receptors NNS I-Gene
. . O

The DT O
downstream NN O
, , O
TATA NNP O
- : O
less NN O
promoter NN O
has VBZ O
high JJ O
G NNP O
+ NNP O
C NNP O
content NN O
, , O
and CC O
exon RB O
1b CD O
predominates NNS O
among IN O
abundantly RB O
expressed VBN O
mRNA NN O
species NNS O
. . O

Ask NNP O
AONE NNP O
' POS O
s NN O
experts NNS O
. . O
. . O
. . O
about IN O
productivity NN O
indicators NNS O
. . O

Polyvinyl NNP O
alcohol NN O
as IN O
a DT O
solution NN O
mediator NN O

Paroxysmal JJ O
fluctuations NNS O
in IN O
observed JJ O
parasitemia NN O
in IN O
Plasmodium NNP O
falciparum NN O
malaria NN O
. . O

The DT O
C18 NNP O
: : O
1 CD O
: : O
C10 NNP O
value NN O
is VBZ O
a DT O
convenient JJ O
measure NN O
of IN O
these DT O
changes NNS O
and CC O
can MD O
be VB O
determined VBN O
more RBR O
rapidly RB O
than IN O
determining VBG O
all PDT O
the DT O
lower JJR O
fatty JJ O
acids NNS O
. . O

The DT O
effect NN O
of IN O
a DT O
beta NN B-Gene
- : I-Gene
adrenoceptor NN I-Gene
antagonist NN O
, , O
pindolol NN O
, , O
on IN O
uterine JJ O
smooth JJ O
muscle NN O
in IN O
term NN O
pregnant JJ O
women NNS O
was VBD O
studied VBN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
( ( O
in IN O
hypertensive JJ O
women NNS O
) ) O
. . O

Steroidogenic NNP B-Gene
factor NN I-Gene
1 CD I-Gene
, , O
an DT O
orphan JJ B-Gene
nuclear JJ I-Gene
receptor NN I-Gene
, , O
regulates VBZ O
the DT O
expression NN O
of IN O
the DT O
rat NN B-Gene
aromatase NN I-Gene
gene NN I-Gene
in IN O
gonadal JJ O
tissues NNS O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
of IN O
residues NNS O
in IN O
this DT O
domain NN O
( ( O
R82A NNP O
, , O
K85A NNP O
, , O
K88A NNP O
, , O
and CC O
V89A NNP O
) ) O
resulted VBD O
in IN O
proteins NNS O
which WDT O
failed VBD O
to TO O
transactivate VB O
from IN O
the DT O
HTLV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
in IN O
vivo NN O
. . O

The DT O
14 CD B-Gene
. . I-Gene
1 CD I-Gene
( ( I-Gene
IGLL1 NNP I-Gene
) ) I-Gene
gene NN I-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
lineage NN O
- : O
and CC O
stage VB O
- : O
restricted JJ O
manner NN O
. . O

Nasal NNP O
absorption NN O
was VBD O
rapid JJ O
, , O
nasal JJ O
bioavailability NN O
was VBD O
43 CD O
% NN O
, , O
and CC O
the DT O
iv NN O
and CC O
nasal JJ O
elimination NN O
profiles NNS O
were VBD O
similar JJ O
. . O

The DT O
level NN O
of IN O
contamination NN O
in IN O
the DT O
wound NN O
can MD O
be VB O
determined VBN O
with IN O
the DT O
rapid JJ O
biopsy NN O
fixation NN O
technique NN O
. . O

Regulation NN O
of IN O
mitochondrial JJ O
single JJ O
- : O
stranded VBD O
DNA NNP O
- : O
binding NN O
protein JJ O
gene NN O
expression NN O
links NNS O
nuclear JJ O
and CC O
mitochondrial JJ O
DNA NNP O
replication NN O
in IN O
drosophila NN O
. . O

The DT O
influence NN O
of IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
seropositivity NN O
on IN O
the DT O
efficacy NN O
of IN O
intravenous JJ O
immune JJ B-Gene
globulin NN I-Gene
in IN O
children NNS O
with IN O
immune JJ O
thrombocytopenic JJ O
purpura NN O
. . O

These DT O
results NNS O
indicate VBP O
that DT O
evaluation NN O
of IN O
exposure NN O
to TO O
S NNP O
. . O
neurona NN O
by IN O
WB NNP O
analysis NN O
of IN O
serum NN O
may MD O
be VB O
misleading VBG O
in IN O
young JJ O
horses NNS O
. . O

The DT O
prevalence NN O
of IN O
malnutrition NN O
was VBD O
30 CD O
% NN O
in IN O
the DT O
47 CD O
patients NNS O
without IN O
CVD NNP O
and CC O
was VBD O
significantly RB O
higher JJR O
( ( O
70 CD O
% NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
in IN O
the DT O
70 CD O
patients NNS O
with IN O
CVD NNP O
, , O
who WP O
also RB O
had VBD O
lower JJR O
tHcy NN O
, , O
SAlb NNP O
, , O
plasma NN B-Gene
IGF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
serum NN O
creatinine NN O
( ( O
SCr NNP O
) ) O
, , O
and CC O
blood NN B-Gene
hemoglobin NN I-Gene
. . O

We PRP O
demonstrated VBD O
that IN O
, , O
under IN O
serum SYM O
- : O
starved JJ O
conditions NNS O
, , O
KMS NNP O
- : O
11 CD O
and CC O
OPM NNP O
- : O
2 CD O
cells NNS O
express RBR O
appreciable JJ O
levels NNS O
of IN O
phosphorylated VBN O
FGFR3 NNP B-Gene
mutants NNS I-Gene
indicating VBG O
a DT O
constitutive JJ O
activation NN O
of IN O
the DT O
Y373C NNP B-Gene
and CC I-Gene
K650E NNP I-Gene
receptors NNS I-Gene
; : O
the DT O
addition NN O
of IN O
the DT O
aFGF NN B-Gene
ligand NN I-Gene
further RBR O
increased VBD O
the DT O
level NN O
of IN O
receptor NN O
phosphorylation NN O
. . O

Isolation NN O
of IN O
a DT O
novel JJ O
TP53 NNP B-Gene
target NN I-Gene
gene NN I-Gene
from IN O
a DT O
colon NN O
cancer NN O
cell NN O
line NN O
carrying VBG O
a DT O
highly RB O
regulated VBN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
TP53 NNP I-Gene
expression NN O
system NN O
. . O

The DT O
presence NN O
of IN O
locus NN O
- : O
specific NN O
residues NNS O
throughout IN O
the DT O
entire JJ O
promoter NN O
region NN O
strongly RB O
suggests VBZ O
that IN O
the DT O
various JJ O
HLA NNP B-Gene
class NN I-Gene
I PRP I-Gene
loci VBP I-Gene
are VBP O
differentially RB O
regulated VBN O
. . O

Treatment NN O
and CC O
staining NN O
of IN O
smears NNS O
and CC O
sections NNS O
for IN O
detection NN O
of IN O
microorganisms NNS O

The DT O
first JJ O
transfusion NN O
resulted VBD O
in IN O
a DT O
platelet NN O
increment NN O
to TO O
32 CD O
Gpt NNP O
/ NNP O
l NN O
( ( O
CCI NNP O
11 CD O
) ) O
. . O

Tyrosine NN O
1356 CD O
forms VBZ O
a DT O
multisubstrate NN O
binding NN O
site NN O
for IN O
the DT O
Grb2 NNP B-Gene
and CC O
Shc NNP B-Gene
adaptor NN I-Gene
proteins NNS I-Gene
, , O
the DT O
p85 JJ B-Gene
subunit NN I-Gene
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
' '' I-Gene
- : I-Gene
kinase NN I-Gene
, , O
phospholipase NN B-Gene
Cgamma NNP I-Gene
, , O
and CC O
a DT O
phosphatase NN O
, , O
SHP2 NNP B-Gene
. . O

This DT O
is VBZ O
in IN O
contrast NN O
to TO O
PPARgamma2 NNP B-Gene
, , O
which WDT O
was VBD O
previously RB O
shown VBN O
to TO O
be VB O
phosphorylated VBN O
at IN O
a DT O
single JJ O
site NN O
in IN O
a DT O
motif NN O
that WDT O
is VBZ O
not RB O
homologous JJ O
to TO O
the DT O
sites NNS O
now RB O
described VBN O
in IN O
PPARalpha NNP B-Gene
. . O

Seventeen NNP O
of IN O
them PRP O
were VBD O
on IN O
treatment NN O
with IN O
systemic JJ O
steroids NNS O
. . O

Nocodazole NNP O
arrest NN O
of IN O
DU249 NNP O
cells NNS O
was VBD O
exploited VBN O
for IN O
the DT O
detection NN O
of IN O
an DT O
M NNP O
- : O
phase NN O
- : O
activated VBN O
MBP NNP B-Gene
kinase NN I-Gene
that WDT O
was VBD O
resolved VBN O
from IN O
p41 NN B-Gene
MAP NNP I-Gene
kinase NN I-Gene
by IN O
phenyl JJ O
- : O
Superose JJ O
chromatography NN O
. . O

Cross NNP O
reactivity NN O
in IN O
theophylline NN O
RIA NNP O
kit NN O
decreased VBD O
. . O

SIM1 NNP B-Gene
and CC O
SIM2 NNP B-Gene
do VBP O
not RB O
form VB O
homodimers NNS O
, , O
and CC O
they PRP O
do VBP O
not RB O
interact VB O
with IN O
AHR NNP B-Gene
. . O

In IN O
contrast NN O
, , O
the DT O
action NN O
of IN O
GLP NNP B-Gene
- : I-Gene
1 CD I-Gene
at IN O
the DT O
CRE NNP O
was VBD O
not RB O
blocked VBN O
by IN O
cotransfection NN O
with IN O
M1 NNP B-Gene
- : I-Gene
CREB NNP I-Gene
, , O
an DT O
isoform NN O
that WDT O
lacks VBZ O
a DT O
consensus NN O
serine NN O
residue JJ O
serving NN O
as IN O
substrate NN O
for IN O
PKA NNP B-Gene
- : O
mediated VBN O
phosphorylation NN O
. . O

Escherichia NNP O
of IN O
a DT O
single JJ O
sero NN O
- : O
anzymatic JJ O
type NN O
( ( O
06a6b CD O
: : O
K13 NN O
: : O
H1 NN O
) ) O
were VBD O
isolated VBN O
in IN O
a DT O
group NN O
affection NN O
. . O

Toxicity NN O
during IN O
the DT O
therapeutic JJ O
period NN O
was VBD O
not RB O
significant JJ O
in IN O
the DT O
study NN O
group NN O
compared VBN O
with IN O
the DT O
historical JJ O
control NN O
, , O
treated VBN O
with IN O
the DT O
same JJ O
regimen NNS O
without IN O
G NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

Strategic NNP O
change NN O
in IN O
the DT O
NHS NNP O
. . O

Serum NNP B-Gene
response NN I-Gene
factor NN I-Gene
( ( O
SRF NNP B-Gene
) ) O
, , O
a DT O
member NN O
of IN O
an DT O
ancient JJ O
family NN O
of IN O
DNA NNP O
- : O
binding NN O
proteins NNS O
, , O
is VBZ O
generally RB O
assumed VBN O
to TO O
be VB O
a DT O
ubiquitous JJ O
transcription NN O
factor NN O
involved VBN O
in IN O
regulating VBG O
growth NN O
factor NN O
- : O
responsive JJ O
genes NNS O
. . O

Comments NNS O
are VBP O
given VBN O
on IN O
the DT O
present JJ O
status NN O
of IN O
regulations NNS O
concerning VBG O
water NN O
in IN O
swimming NN O
pools NNS O
and CC O
baths NNS O
- : O
- : O
1991 CD O
- : O
- : O
( ( O
in IN O
connection NN O
with IN O
the DT O
KOK NNP O
regulations NNS O
- : O
- : O
1972 CD O
- : O
- : O
and CC O
the DT O
Federal JJ O
German NNP O
standard NN O
[ NNP O
DIN NNP O
] NNP O
No NNP O
. . O

This DT O
region NN O
includes VBZ O
verA NN B-Gene
, , O
a DT O
structural JJ O
gene NN O
previously RB O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
ST NNP O
biosynthesis NN O
, , O
and CC O
24 CD O
additional JJ O
closely RB O
spaced JJ O
transcripts NNS O
ranging VBG O
in IN O
size NN O
from IN O
0 CD O
. . O
6 CD O
to TO O
7 CD O
. . O
2 CD O
kb NN O
that WDT O
are VBP O
coordinately RB O
induced VBN O
only RB O
under IN O
ST NNP O
- : O
producing VBG O
conditions NNS O
. . O

Because IN O
of IN O
the DT O
increased JJ O
CPK NNP B-Gene
activity NN O
found VBD O
in IN O
normal JJ O
newborns NNS O
, , O
screening VBG O
for IN O
Duchenne NNP O
- : O
type NN O
muscular JJ O
dystrophy NN O
should MD O
be VB O
postponed VBN O
for IN O
a DT O
few JJ O
weeks NNS O
after IN O
delivery NN O
. . O

The DT O
mRNA NN O
identified VBN O
in IN O
both DT O
human JJ O
and CC O
rat NN O
cells NNS O
with IN O
the DT O
human JJ B-Gene
clathrin NN I-Gene
clone NN O
revealed VBD O
transcripts NNS O
of IN O
approximately RB O
6 CD O
. . O
5 CD O
kb NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
the DT O
predicted JJ O
180 CD O
kDa NN O
molecular JJ O
weight NN O
of IN O
the DT O
clathrin NN B-Gene
heavy JJ I-Gene
chain NN I-Gene
. . O

Development NNP O
of IN O
a DT O
provisional JJ O
information NN O
- : O
retrieval NN O
descriptor NN O
language NN O
for IN O
"""" NNP O
Roentgenology NNP O
and CC O
Medical NNP O
Radiology NNP O
"""" NNP O
for IN O
use NN O
in IN O
the DT O
Medinform NNP O
system NN O

33 CD O
out IN O
of IN O
90 CD O
neurons NNS O
of IN O
the DT O
cat NN O
medial JJ O
geniculate NN O
body NN O
revealed VBD O
the DT O
selectivity NN O
of IN O
their PRP$ O
afterdischarges NNS O
to TO O
movement NN O
of IN O
sound NN O
when WRB O
velocity NN O
of IN O
the DT O
movement NN O
changed VBD O
from IN O
30 CD O
to TO O
180 CD O
deg NNS O
/ JJ O
s NN O
. . O

We PRP O
conclude VBP O
that DT O
at IN O
these DT O
low JJ O
levels NNS O
studied VBN O
, , O
aluminum NN O
accumulates NNS O
in IN O
intestinal JJ O
tissue NN O
, , O
and CC O
that IN O
this DT O
accumulation NN O
is VBZ O
enhanced VBN O
by IN O
citrate NN O
ligand NN O
. . O

In IN O
the DT O
group NN O
of IN O
asthmatics NNS O
statistically RB O
significant JJ O
correlation NN O
was VBD O
found VBN O
between IN O
PC20 NNP O
PGF2 NNP O
alpha NN O
and CC O
histamine NN O
values NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
538 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Suppression NN O
of IN O
food NN O
intake NN O
in IN O
the DT O
rat NN O
by IN O
tung JJ O
oil NN O
. . O

A DT O
1 CD O
. . O
8 CD O
- : O
kb NN O
cDNA NN O
clone NN O
( ( O
designed VBN O
hKID NN B-Gene
, , O
gene NN B-Gene
symbol NN I-Gene
AQP2L NNP I-Gene
) ) O
with IN O
homology NN O
to TO O
the DT O
aquaporins NNS B-Gene
was VBD O
isolated VBN O
from IN O
a DT O
human JJ O
kidney NN O
cDNA NN O
library NN O
. . O

The DT O
protein NN O
encoded VBN O
by IN O
ORF113 NNP B-Gene
contains VBZ O
a DT O
transmembrane NN O
domain NN O
. . O

Transcriptional JJ O
regulation NN O
of IN O
fbp1 JJ B-Gene
promoter NN I-Gene
constructs NNS I-Gene
containing VBG O
only RB O
UAS1 NNP O
or CC O
UAS2 NNP O
confirms VBZ O
that IN O
the DT O
PKA NNP B-Gene
and CC O
MAPK NNP B-Gene
regulation NN O
is VBZ O
targeted VBN O
to TO O
both DT O
sites NNS O
. . O

3 CD O
cases NNS O

Functional JJ O
analysis NN O
of IN O
the DT O
mutant JJ B-Gene
desmin NN I-Gene
in IN O
SW13 NNP O
( ( O
vim FW B-Gene
- : O
) ) O
cells NNS O
showed VBD O
aggregation NN O
of IN O
abnormal JJ O
coarse JJ O
clumps NNS O
of IN O
desmin NN B-Gene
positive JJ O
material NN O
dispersed VBD O
throughout IN O
the DT O
cytoplasm NN O
. . O

The DT O
antibody NN O
titer NN O
of IN O
202 CD O
chickens NNS O
to TO O
SA NNP O
- : O
11 CD O
rotavirus NN O
was VBD O
determined VBN O
by IN O
enzyme JJ O
- : O
linked VBN O
immunosorbent JJ O
blocking VBG O
assay NN O
. . O

OBJECTIVE NN O
: : O
Our PRP$ O
goal NN O
was VBD O
to TO O
determine VB O
whether IN O
chlamydia JJ O
- : O
infected JJ O
women NNS O
have VBP O
a DT O
higher JJR O
rate NN O
of IN O
febrile NN O
complications NNS O
after IN O
postpartum NN O
tubal JJ O
ligation NN O
. . O

To TO O
study VB O
the DT O
significance NN O
of IN O
these DT O
domains NNS O
and CC O
the DT O
overall JJ O
evolutionary JJ O
conservation NN O
of IN O
the DT O
gene NN O
, , O
the DT O
homolog NN O
from IN O
Drosophila NNP O
melanogaster NN O
was VBD O
isolated VBN O
by IN O
low JJ O
stringency NN O
hybridizations NNS O
using VBG O
two CD O
flanking VBG O
probes NNS O
of IN O
the DT O
human JJ B-Gene
ERCC3 NNP I-Gene
cDNA NN I-Gene
. . O

Results NNS O
confirmed VBD O
that IN O
stress NN O
produced VBD O
CA3 NNP O
dendritic JJ O
atrophy NN O
and CC O
tianeptine NN O
prevented VBD O
it PRP O
. . O

In IN O
49 CD O
patients NNS O
in IN O
whom WP O
gated VBD O
equilibrium NN O
ventriculography NN O
and CC O
cardiac JJ O
catheterization NN O
were VBD O
performed VBN O
within IN O
a DT O
6 CD O
day NN O
interval NN O
, , O
total JJ O
and CC O
fractional JJ O
portions NNS O
of IN O
global JJ O
and CC O
regional JJ O
right NN O
ventricular NN O
ejection NN O
fraction NN O
( ( O
RVEF NNP O
) ) O
were VBD O
correlated VBN O
with IN O
pulmonary JJ O
arterial JJ O
systolic JJ O
pressure NN O
. . O

The DT O
epitope NN O
- : O
protected VBN O
lysine NN O
( ( O
K NNP O
) ) O
was VBD O
present JJ O
in IN O
a DT O
30 CD B-Gene
- : I-Gene
aa NN I-Gene
TPO NNP I-Gene
fragment NN I-Gene
that IN O
, , O
by IN O
N NNP O
- : O
terminal NN O
sequencing NN O
, , O
was VBD O
found VBN O
to TO O
be VB O
K713 NNP O
. . O

Special JJ O
issues NNS O
devoted VBN O
to TO O
the DT O
biosynthesis NN O
of IN O
woody NN O
plant NN O
biopolymers NNS O
and CC O
related JJ O
substances NNS O
. . O

TaV NNP O
particles NNS O
have VBP O
a DT O
buoyant JJ O
density NN O
of IN O
1 CD O
. . O
296 CD O
g JJ O
/ NNP O
cm3 NN O
in IN O
CsCl NNP O
and CC O
consist NN O
of IN O
two CD O
capsid JJ B-Gene
proteins NNS I-Gene
of IN O
56 CD O
and CC O
6 CD O
kDa NN O
. . O

Adult NNP O
H NNP O
, , O
but CC O
not RB O
R NNP O
, , O
manifested VBD O
the DT O
burrowing NN O
preference NN O
whenever WDT O
offered VBD O
the DT O
opportunity NN O
. . O

Plasma NNP B-Gene
renin NN I-Gene
concentration NN O
is VBZ O
significantly RB O
higher RBR O
in IN O
the DT O
subcapsular JJ O
venous JJ O
outflow NN O
, , O
which WDT O
drains VBZ O
the DT O
superficial JJ O
cortex NN O
, , O
than IN O
in IN O
the DT O
deep JJ O
venous JJ O
outflow NN O
, , O
which WDT O
drains VBZ O
the DT O
inner JJ O
half NN O
of IN O
the DT O
cortex NN O
and CC O
medulla NN O
of IN O
the DT O
cat NN O
kidney NN O
. . O

No DT O
ISREs NNP B-Gene
could MD O
be VB O
identified VBN O
in IN O
the DT O
mouse NN O
promoter NN O
. . O

Papers NNS O
of IN O
the DT O
Society NNP O
for IN O
Clinical NNP O
Vascular NNP O
Surgery NNP O
. . O

Serum NNP B-Gene
amylase NN I-Gene
became VBD O
markedly RB O
elevated VBN O
( ( O
2 CD O
, , O
624 CD O
CU NNP O
/ VBD O
100 CD O
ml NN O
) ) O
, , O
as IN O
did VBD O
the DT O
serum NN O
FFA NNP O
( ( O
29 CD O
. . O
19 CD O
mEq JJ O
/ NNP O
liter NN O
) ) O
. . O

RESULTS NN O
: : O
Of IN O
the DT O
24 CD O
patients NNS O
, , O
6 CD O
had VBD O
Grade VBN O
1 CD O
pneumonitis NN O
, , O
and CC O
13 CD O
had VBD O
Grade VBN O
2 CD O
pneumonitis NN O
. . O

The DT O
human JJ B-Gene
p100 NN I-Gene
protein NN I-Gene
was VBD O
recently RB O
identified VBN O
as IN O
a DT O
coactivator NN O
of IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
2 CD I-Gene
. . O

There EX O
were VBD O
3 CD O
/ JJ O
32 CD O
( ( O
9 CD O
. . O
4 CD O
per IN O
cent NN O
) ) O
adverse JJ O
reactions NNS O
( ( O
ADRs NNP O
) ) O
, , O
and CC O
one CD O
case NN O
each DT O
of IN O
nausea NN O
, , O
dizziness NN O
and CC O
increased VBD O
menstrual JJ O
flow NN O
. . O

Ultrastructural JJ O
studies NNS O
of IN O
retinopathy NN O
of IN O
premature NN O
infants NNS O

The DT O
genes NNS O
encoding VBG O
the DT O
transcription NN B-Gene
factor NN I-Gene
yTAFII60 NN I-Gene
, , O
the DT O
G4p1 NNP B-Gene
protein NN I-Gene
and CC O
a DT O
putative JJ O
glucose NN O
transporter NN O
are VBP O
contained VBN O
in IN O
a DT O
12 CD O
. . O
3 CD O
kb JJ O
DNA NNP O
fragment NN O
on IN O
the DT O
left JJ O
arm NN O
of IN O
Saccharomyces NNP O
cerevisiae VBP O
chromosome NN O
VII NNP O
. . O

Fetal JJ O
lung NN O
volume NN O
: : O
estimation NN O
at IN O
MR NNP O
imaging VBG O
- : O
initial JJ O
results NNS O
. . O

A DT O
constitutive JJ O
allele NN O
of IN O
GPA2 NNP B-Gene
could MD O
stimulate VB O
growth NN O
of IN O
a DT O
strain NN O
lacking VBG O
both DT O
RAS NNP B-Gene
genes NNS I-Gene
. . O

Finally RB O
, , O
we PRP O
determined VBD O
that IN O
the DT O
P68 NNP B-Gene
amino NN O
terminus NN O
was VBD O
both DT O
necessary JJ O
and CC O
sufficient JJ O
for IN O
binding VBG O
dsRNA NN O
as IN O
we PRP O
were VBD O
able JJ O
to TO O
transfer VB O
dsRNA JJ O
- : O
binding NN O
properties NNS O
to TO O
a DT O
reporter NN O
gene NN O
product NN O
previously RB O
unable JJ O
to TO O
bind VB O
RNA NNP O
. . O

Urological JJ O
complications NNS O
are VBP O
frequent JJ O
during IN O
and CC O
after IN O
the DT O
treatment NN O
of IN O
gynecological JJ O
malignancy NN O
. . O

The DT O
following JJ O
technique NN O
describes VBZ O
a DT O
modification NN O
to TO O
a DT O
bar NN O
superstructure NN O
that WDT O
provided VBD O
the DT O
advantages NNS O
of IN O
convenience NN O
, , O
security NN O
, , O
and CC O
consistent JJ O
positioning VBG O
even RB O
though IN O
one CD O
implant NN O
was VBD O
lost VBN O
and CC O
the DT O
angulation NN O
of IN O
implants NNS O
limited JJ O
accuracy NN O
. . O

To TO O
characterize VB O
the DT O
O7 NNP B-Gene
- : I-Gene
LPS NNP I-Gene
region NN I-Gene
, , O
the DT O
recombinant JJ O
cosmids NNS O
pJHCV31 NN O
and CC O
pJHCV32 NN O
were VBD O
mutagenized VBN O
by IN O
transposon JJ O
mutagenesis NN O
with IN O
Tn3HoHo1 NNP B-Gene
, , O
which WDT O
carries VBZ O
a DT O
promoterless NN O
lac NN B-Gene
operon NN I-Gene
and CC O
can MD O
therefore VB O
generate JJ O
lacZ JJ B-Gene
transcriptional JJ O
fusions NNS O
with IN O
target NN O
DNA NNP O
sequences NNS O
. . O

Disulfiram NNP O
and CC O
the DT O
drug NN O
- : O
induced JJ O
effects NNS O
on IN O
motility NN O
. . O

Tendon NNP O
also RB O
shows VBZ O
a DT O
degree NN O
of IN O
extensibility NN O
. . O

These DT O
observations NNS O
have VBP O
led VBN O
us PRP O
to TO O
conclude VB O
that IN O
an DT O
elevated JJ O
VIII NNP O
- : O
ratio NN O
is VBZ O
a DT O
very RB O
sensitive JJ O
indicator NN O
of IN O
intravascular JJ O
coagulation NN O
. . O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
define VB O
the DT O
mechanism NN O
for IN O
the DT O
respiratory NN O
inhibition NN O
observed VBD O
during IN O
high JJ O
- : O
frequency NN O
oscillatory JJ O
ventilation NN O
( ( O
HFOV NNP O
) ) O
. . O

In IN O
controls NNS O
, , O
only RB O
modest JJ O
differences NNS O
were VBD O
observed VBN O
. . O

Three CD O
mutants NNS O
were VBD O
isolated VBN O
from IN O
the DT O
widely RB O
used VBN O
strain NN O
, , O
PAO1 NNP O
. . O

A DT O
coiled JJ B-Gene
- : I-Gene
coil NN I-Gene
related JJ I-Gene
protein NN I-Gene
specific NN O
for IN O
synapsed JJ O
regions NNS O
of IN O
meiotic JJ O
prophase NN O
chromosomes NNS O
. . O

In IN O
group NN O
I PRP O
adults VBP O
both DT O
of IN O
these DT O
variables NNS O
increased VBD O
. . O

Alignment NN O
of IN O
the DT O
selected VBN O
sequences NNS O
allowed VBD O
us PRP O
to TO O
predict VB O
a DT O
consensus NN O
sequence NN O
for IN O
binding NN O
of IN O
the DT O
individual JJ O
homodimeric NN O
Rel NNP B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
, , O
and CC O
DNA NNP O
- : O
protein NN O
binding VBG O
analysis NN O
of IN O
the DT O
selected VBN O
DNA NNP O
sequences NNS O
revealed VBD O
sequence NN O
specificity NN O
of IN O
the DT O
proteins NNS O
. . O

We PRP O
have VBP O
previously RB O
isolated VBN O
a DT O
cDNA NN O
for IN O
a DT O
transcription NN O
factor NN O
referred VBD O
to TO O
as IN O
Zfhep NNP B-Gene
( ( O
zinc NNP B-Gene
finger NN I-Gene
homeodomain NN I-Gene
enhancer SYM I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
) ) O
containing VBG O
two CD O
separate JJ O
zinc NN O
finger NN O
domains NNS O
, , O
ZD1 NNP B-Gene
and CC O
ZD2 NNP B-Gene
, , O
each DT O
of IN O
which WDT O
binds VBZ O
DNA NNP O
, , O
and CC O
a DT O
homeodomain NN O
. . O

No DT O
apparent JJ O
clinical JJ O
signs NNS O
indicative NN O
of IN O
systemic JJ O
toxicity NN O
were VBD O
observed VBN O
in IN O
the DT O
F0 NNP O
and CC O
F1 NNP O
animals NNS O
of IN O
either DT O
sex NN O
. . O

Once RB O
NGF NNP B-Gene
administration NN O
is VBZ O
proven RB O
effective JJ O
it PRP O
will MD O
be VB O
possible JJ O
to TO O
develop VB O
alternative JJ O
ways NNS O
of IN O
NGF NNP B-Gene
administration NN O
. . O

Mutating VBG O
the DT O
Fcp1p NNP B-Gene
- : O
binding NN O
motif NN O
KEFGK NNP O
in IN O
the DT O
RAP74 NNP B-Gene
( ( O
Tfg1p NNP B-Gene
) ) O
subunit NN O
of IN O
TFIIF NNP B-Gene
to TO O
EEFGE NNP O
led VBN O
to TO O
both DT O
synthetic JJ O
phenotypes NNS O
in IN O
certain JJ O
fcp1 JJ B-Gene
tfg1 NN B-Gene
double JJ O
mutants NNS O
and CC O
a DT O
reduced JJ O
ability NN O
of IN O
Fcp1p NNP B-Gene
to TO O
activate VB O
transcription NN O
when WRB O
it PRP O
is VBZ O
artificially RB O
tethered VBN O
to TO O
a DT O
promoter NN O
. . O

We PRP O
conclude VBP O
that IN O
sequences NNS O
outside IN O
of IN O
the DT O
hLEF NN B-Gene
HMG NNP I-Gene
box NN I-Gene
mediate NN O
cell NN O
- : O
and CC O
context VB O
- : O
specific JJ O
activation NN O
of IN O
the DT O
TCR NNP B-Gene
alpha NN I-Gene
enhancer NN I-Gene
and CC O
may MD O
facilitate VB O
interactions NNS O
between IN O
hLEF NN B-Gene
and CC O
other JJ O
T NNP O
- : O
cell NN O
- : O
specific JJ O
factors NNS O
recruited VBD O
to TO O
the DT O
enhancer NN O
. . O

Therapeutic JJ O
effects NNS O
of IN O
cefpirome NN O
( ( O
HR NNP O
810 CD O
) ) O
on IN O
experimental JJ O
mixed JJ O
infections NNS O
with IN O
Enterococcus NNP O
faecalis NNS O
and CC O
Escherichia NNP O
coli VBP O
in IN O
mice NN O
. . O

The DT O
intracellular JJ O
basic JJ B-Gene
region NN I-Gene
/ NNP I-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
( ( I-Gene
bHLH NN I-Gene
) ) I-Gene
dioxin NN I-Gene
receptor NN I-Gene
mediates VBZ O
signal JJ O
transduction NN O
by IN O
dioxin NN O
( ( O
2 CD O
, , O
3 CD O
, , O
7 CD O
, , O
8 CD O
- : O
tetrachlorodibenzo NN O
- : O
p NN O
- : O
dioxin NN O
) ) O
and CC O
functions NNS O
as IN O
a DT O
ligand NN O
- : O
activated VBN O
DNA NNP O
binding VBG O
protein RB O
directly RB O
interacting VBG O
with IN O
target NN O
genes NNS O
by IN O
binding VBG O
to TO O
dioxin VB O
response NN O
elements NNS O
. . O

Therefore RB O
, , O
it PRP O
was VBD O
concluded VBN O
that IN O
thrombotic JJ O
tendency NN O
certainly RB O
existed VBD O
in IN O
patients NNS O
with IN O
MS NNP O
compared VBN O
to TO O
those DT O
with IN O
non JJ O
RHD NNP O
and CC O
that IN O
it PRP O
was VBD O
one CD O
of IN O
the DT O
causes NNS O
of IN O
the DT O
significantly RB O
high JJ O
incidence NN O
of IN O
thromboembolism NN O
in IN O
comparison NN O
with IN O
non JJ O
RHD NNP O
. . O

In IN O
the DT O
matched JJ O
control NN O
group NN O
the DT O
acquisition NN O
- : O
rate NN O
of IN O
both DT O
symptomatic JJ O
and CC O
asymptomatic JJ O
0acteriuria CD O
was VBD O
over RB O
12 CD O
% NN O
, , O
a DT O
figure NN O
similar JJ O
to TO O
the DT O
percentage NN O
of IN O
women NNS O
present JJ O
in IN O
the DT O
practice NN O
population NN O
during IN O
one CD O
year NN O
with IN O
transient NN O
, , O
symptomatic JJ O
, , O
and CC O
persistent VBD O
A NNP O
. . O
B NNP O
. . O

Also RB O
, , O
the DT O
BALB NNP B-Gene
/ NNP I-Gene
c VBZ I-Gene
gene NN I-Gene
contains VBZ O
a DT O
single JJ O
substitution NN O
in IN O
a DT O
conserved JJ O
octamer NN O
sequence NN O
approximately RB O
equal JJ O
to TO O
100 CD O
nucleotides NNS O
upstream NN O
of IN O
the DT O
coding VBG O
region NN O
, , O
which WDT O
could MD O
affect VB O
its PRP$ O
expression NN O
. . O

The DT O
cellular JJ O
part NN O
of IN O
the DT O
third JJ O
chimeric JJ O
clone NN O
shows VBZ O
significant JJ O
homology NN O
to TO O
an DT O
exon NN O
of IN O
the DT O
human JJ B-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
1 CD I-Gene
gene NN I-Gene
, , O
although IN O
oriented VBN O
in IN O
the DT O
antisense JJ O
direction NN O
compared VBN O
to TO O
the DT O
adjacent JJ O
LTR NNP O
. . O

A DT O
survey NN O
is VBZ O
given VBN O
of IN O
the DT O
pharmacological JJ O
backgrounds NNS O
that WDT O
are VBP O
relevant JJ O
for IN O
the DT O
drug NN O
treatment NN O
of IN O
essential JJ O
hypertension NN O
in IN O
the DT O
elderly JJ O
. . O

The DT O
expression NN O
analysis NN O
of IN O
the DT O
KlHIS4 NNP B-Gene
gene NN I-Gene
under IN O
phosphate JJ O
starvation NN O
or CC O
high JJ O
adenine NN O
supply NN O
shows VBZ O
that IN O
factors NNS O
, , O
such JJ O
as IN O
Bas1 NNP B-Gene
or CC O
Bas2 NNP B-Gene
, , O
involved VBN O
in IN O
the DT O
basal NN O
control NN O
may MD O
also RB O
operate VB O
in IN O
a DT O
different JJ O
way NN O
in IN O
K NNP O
. . O
lactis NN O
. . O

The DT O
method NN O
is VBZ O
applied VBN O
to TO O
determine VB O
aberration NN O
constants NNS O
of IN O
a DT O
CM300 NNP O
FEG NNP O
/ NNP O
UT NNP O
microscope NN O
with IN O
correction NN O
of IN O
the DT O
three CD O
- : O
fold JJ O
astigmatism NN O
. . O

The DT O
tetraphasic JJ O
action NN O
of IN O
lidocaine NN O
on IN O
CNS NNP O
electrical JJ O
activity NN O
and CC O
behavior NN O
in IN O
cats NNS O
. . O

L NNP O
. . O
, , O
Stange NNP O
, , O
G NNP O
. . O
, , O
Markovich NNP O
, , O
D NNP O
. . O
, , O
Biber NNP O
, , O
J NNP O
. . O
, , O
Testar NNP O
, , O
X NNP O
. . O
, , O
Zorzano NNP O
, , O
A NNP O
. . O
, , O
Palacin NNP O
, , O
M NNP O
. . O
, , O
and CC O
Murer NNP O
, , O
H NNP O
. . O

No DT O
significant JJ O
correlations NNS O
of IN O
peak NN O
VO2 NNP O
were VBD O
observed VBN O
between IN O
the DT O
3 CD O
tests NNS O
. . O

Abstracts NNS O
. . O

Next RB O
, , O
to TO O
identify VB O
regions NNS O
of IN O
the DT O
promoter NN O
involved VBN O
, , O
we PRP O
examined VBD O
a DT O
series NN O
of IN O
tenascin JJ B-Gene
- : I-Gene
C NNP I-Gene
promoter NN I-Gene
constructs NNS I-Gene
with IN O
5 CD O
' POS O
deletions NNS O
and CC O
showed VBD O
that IN O
denatured VBD O
collagen SYM B-Gene
- : I-Gene
dependent JJ I-Gene
promoter NN I-Gene
activity NN O
was VBD O
retained VBN O
by IN O
a DT O
122 CD O
- : O
base NN O
pair NN O
element NN O
, , O
located VBN O
- : O
43 CD O
to TO O
- : O
165 CD O
bp JJ O
upstream NN O
of IN O
the DT O
RNA NNP O
start NN O
site NN O
. . O

Inhibition NN O
of IN O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activity NN O
results NNS O
in IN O
cell JJ O
death NN O
of IN O
TT NNP O
cells NNS O
and CC O
blocks NNS O
focus VBP O
formation NN O
induced VBN O
by IN O
oncogenic JJ O
forms NNS O
of IN O
RET NNP B-Gene
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

The DT O
MRS NNP O
II NNP O
meets VBZ O
a DT O
high JJ O
methodological JJ O
standard NN O
as IN O
an DT O
instrument NN O
standardized VBN O
in IN O
the DT O
population NN O
. . O

Doppler NNP O
ultrasound JJ O
studies NNS O
of IN O
long JJ O
- : O
term NN O
follow SYM O
- : O
up IN O
of IN O
children NNS O
with IN O
hemolytic JJ O
- : O
uremic JJ O
syndrome NN O

Diagnosis NN O
and CC O
treatment NN O
of IN O
insulin NN B-Gene
- : O
secreting NN O
tumours NNS O
. . O

Endocytosis NN O
and CC O
vacuolar JJ O
degradation NN O
of IN O
the DT O
plasma NN O
membrane SYM O
- : O
localized VBN O
Pdr5 NNP B-Gene
ATP NNP I-Gene
- : I-Gene
binding NN I-Gene
cassette NN I-Gene
multidrug NN I-Gene
transporter NN I-Gene
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Recent JJ O
investigations NNS O
have VBP O
shown VBN O
that IN O
Grenz NNP O
rays NNS O
can MD O
suppress VB O
the DT O
allergic JJ O
contact NN O
dermatitis NN O
reaction NN O
completely RB O
and CC O
that IN O
Langerhans NNP O
cells NNS O
, , O
identified VBN O
by IN O
OKT6 NNP B-Gene
antibodies NNS I-Gene
and CC O
electron NN O
microscopy NN O
, , O
disappear VBP O
from IN O
the DT O
epidermis NN O
at IN O
the DT O
same JJ O
time NN O
. . O

Mesial JJ O
temporal JJ O
sclerosis NN O
was VBD O
characterized VBN O
by IN O
severe JJ O
neuronal JJ O
loss NN O
accompanied VBN O
by IN O
gliosis NN O
occurring VBG O
in IN O
the DT O
CA1 NNP O
/ NNP O
prosubiculum NN O
( ( O
27 CD O
patients NNS O
, , O
100 CD O
% NN O
) ) O
, , O
focally RB O
in IN O
the DT O
dentate NN O
gyrus NN O
( ( O
12 CD O
patients NNS O
, , O
44 CD O
% NN O
) ) O
, , O
and CC O
in IN O
the DT O
CA4 NNP O
region NN O
( ( O
11 CD O
patients NNS O
, , O
41 CD O
% NN O
) ) O
. . O

In IN O
the DT O
commercially RB O
available JJ O
intravenous JJ O
formulation NN O
of IN O
Cyclosporin NNP O
A NNP O
( ( O
Sandimmun NNP O
) ) O
, , O
polyoxyethylated VBD O
castor NN O
oil NN O
( ( O
Cremophor NNP O
EL NNP O
) ) O
is VBZ O
used VBN O
as IN O
a DT O
solubilizing NN O
agent NN O
. . O

By IN O
using VBG O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
- : O
dependent NN O
cells NNS O
that WDT O
ectopically RB O
express VBP O
the DT O
three CD O
ErbB NNP B-Gene
proteins NNS I-Gene
or CC O
their PRP$ O
combinations NNS O
, , O
we PRP O
found VBD O
that IN O
ErbB NNP B-Gene
- : I-Gene
3 CD I-Gene
is VBZ O
devoid NN O
of IN O
any DT O
biological JJ O
activity NN O
but CC O
both DT O
ErbB NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
ErbB NNP B-Gene
- : I-Gene
2 CD I-Gene
can MD O
reconstitute VB O
its PRP$ O
extremely RB O
potent JJ O
mitogenic JJ O
activity NN O
. . O

In IN O
an DT O
effort NN O
to TO O
separate VB O
domains NNS O
of IN O
FadR NNP B-Gene
required VBD O
for IN O
DNA NNP O
binding NN O
, , O
dimerization NN O
, , O
and CC O
ligand NN O
binding NN O
, , O
chimeric JJ O
protein NN O
fusions NNS O
between IN O
the DT O
DNA NNP O
binding VBG O
domain NN O
of IN O
LexA NNP B-Gene
and CC O
different JJ O
regions NNS O
of IN O
FadR NNP B-Gene
were VBD O
constructed VBN O
. . O

After IN O
phosphorylation NN O
, , O
STAT NNP B-Gene
proteins NNS I-Gene
are VBP O
transported VBN O
into IN O
the DT O
nucleus NN O
and CC O
exhibit JJ O
transcriptional JJ O
activity NN O
. . O

The DT O
protein NN O
encoded VBN O
by IN O
the DT O
fruA NN B-Gene
transcript NN I-Gene
is VBZ O
well RB O
conserved VBN O
with IN O
the DT O
D NNP B-Gene
. . I-Gene
melanogaster NN I-Gene
type VBD I-Gene
A NNP I-Gene
protein NN I-Gene
, , O
particularly RB O
the DT O
BTB NNP B-Gene
protein SYM I-Gene
- : O
protein NN O
- : O
binding NN O
domain NN O
, , O
which WDT O
is VBZ O
encoded VBN O
by IN O
exons NNS O
I PRP O
and CC O
II NNP O
and CC O
is VBZ O
100 CD O
% NN O
conserved VBN O
. . O

The DT O
mortality NN O
rate NN O
and CC O
histopathological JJ O
features NNS O
of IN O
Nocardia NNP O
asteroides NNS O
and CC O
Nocardia NNP O
brasiliensis NN O
infections NNS O
in IN O
congenitally RB O
athymic JJ O
( ( O
nude JJ O
) ) O
mice NN O
of IN O
ICR NNP O
and CC O
C3H NNP O
/ NNP O
eB NN O
origins NNS O
were VBD O
quite RB O
different JJ O
from IN O
what WP O
we PRP O
found VBD O
for IN O
Swiss NNP O
white JJ O
mice NNS O
and CC O
other JJ O
inbred JJ O
mouse NN O
strains NNS O
( ( O
namely RB O
, , O
C57 NNP O
/ NNP O
BL NNP O
/ NNP O
6J CD O
, , O
New NNP O
Zealand NNP O
Black NNP O
, , O
BALB NNP O
/ NNP O
c NN O
, , O
CBA NNP O
/ NNP O
LAC NNP O
, , O
and CC O
C3H NNP O
/ NNP O
eB NN O
) ) O
. . O

This DT O
E NNP O
box NN O
sequence NN O
( ( O
CACGTG NNP O
) ) O
is VBZ O
identical JJ O
to TO O
the DT O
binding NN O
element NN O
for IN O
USF NNP B-Gene
( ( O
upstream JJ B-Gene
stimulatory NN I-Gene
factor NN I-Gene
) ) O
, , O
a DT O
member NN O
of IN O
the DT O
helix NN B-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

Our PRP$ O
findings NNS O
provide VBP O
the DT O
first JJ O
evidence NN O
that IN O
the DT O
function NN O
of IN O
WT1 NNP B-Gene
can MD O
be VB O
modulated VBN O
by IN O
its PRP$ O
phosphorylation NN O
in IN O
vivo NN O
. . O

Efficacy NN O
of IN O
a DT O
three CD O
- : O
versus NN O
a DT O
five CD O
- : O
week NN O
alcohol NN O
treatment NN O
program NN O
. . O

A DT O
transparent JJ O
overlay NN O
for IN O
assessing VBG O
amplitude NN O
of IN O
ECG NNP O
wave VBP O
forms NNS O
. . O

Studies NNS O
using VBG O
a DT O
reporter NN O
plasmid NN O
with IN O
a DT O
functionally RB O
disrupted VBN O
sterol NN O
- : O
responsive JJ O
element NN O
( ( O
SRE NNP O
) ) O
- : O
1 CD O
revealed VBD O
a DT O
reduced JJ O
stimulatory NN O
response NN O
to TO O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
. . O

Interestingly RB O
, , O
however RB O
, , O
it PRP O
is VBZ O
homologous JJ O
to TO O
several JJ O
expressed VBN O
sequence NN O
tags NN O
( ( O
EST NNP O
) ) O
of IN O
unknown JJ O
function NN O
from IN O
Caenorhabditis NNP O
elegans NNS O
, , O
Oryza NNP O
sativa NN O
and CC O
Homo NNP O
sapiens NNS O
. . O

Among IN O
these DT O
are VBP O
: : O
( ( O
1 CD O
) ) O
Is VBZ O
there JJ O
sufficient JJ O
understanding NN O
of IN O
family NN O
pathophysiology NN O
, , O
of IN O
the DT O
sensitivity NN O
and CC O
specificity NN O
of IN O
diagnostic JJ O
techniques NNS O
and CC O
of IN O
the DT O
safety NN O
and CC O
efficacy NN O
of IN O
therapeutic JJ O
modalities NNS O
to TO O
make VB O
true JJ O
family NN O
health NN O
care NN O
possible JJ O
? . O

( ( O
2 CD O
) ) O
If IN O
this DT O
type NN O
of IN O
care NN O
is VBZ O
possible JJ O
, , O
how WRB O
are VBP O
the DT O
needs NNS O
of IN O
the DT O
family NN O
and CC O
its PRP$ O
individual JJ O
members NNS O
met VBD O
, , O
or CC O
value NN O
judgements NNS O
made VBN O
about IN O
their PRP$ O
relative JJ O
importance NN O
? . O
and CC O
( ( O
3 CD O
) ) O
What WP O
are VBP O
the DT O
consequences NNS O
for IN O
the DT O
health NN O
care NN O
delivery NN O
system NN O
of IN O
this DT O
type NN O
of IN O
care NN O
? . O

An DT O
extensive JJ O
literature NN O
review NN O
is VBZ O
used VBN O
in IN O
an DT O
attempt NN O
to TO O
answer VB O
these DT O
queries NNS O
, , O
from IN O
which WDT O
questions NNS O
for IN O
further JJ O
study NN O
are VBP O
posed VBN O
. . O

The DT O
short JJ O
- : O
term NN O
synthesis NN O
and CC O
infant JJ O
- : O
regulated JJ O
removal NN O
of IN O
milk NN O
in IN O
lactating VBG O
women NNS O
. . O

To TO O
explore VB O
the DT O
mechanism NN O
of IN O
RSK NNP B-Gene
activation NN O
, , O
a DT O
cloned JJ O
human JJ O
RSK NNP B-Gene
cDNA NN O
( ( O
RSK3 NNP B-Gene
) ) O
was VBD O
used VBN O
to TO O
generate VB O
and CC O
characterize VB O
several JJ O
site NN O
- : O
directed VBN O
RSK NNP B-Gene
mutants NNS I-Gene
; : O
K91A NNP O
( ( O
N NNP O
- : O
Lys NNP O
, , O
NH2 NNP O
- : O
terminal NN O
ATP NNP O
- : O
binding NN O
mutant NN O
) ) O
, , O
K444A NNP O
( ( O
C NNP O
- : O
Lys NNP O
, , O
COOH NNP O
- : O
terminal NN O
ATP NNP O
- : O
binding NN O
mutant NN O
) ) O
, , O
N NNP O
/ NNP O
C NNP O
- : O
Lys NNP O
( ( O
double JJ O
ATP NNP O
- : O
binding NN O
mutant NN O
) ) O
T570A NNP O
( ( O
C NNP O
- : O
Thr NN O
, , O
mutant NN O
of IN O
the DT O
putative JJ O
MAPK NNP B-Gene
phosphorylation NN O
site NN O
in IN O
subdomain JJ O
VIII NNP O
of IN O
the DT O
C NNP O
- : O
domain NN O
) ) O
, , O
S218A NNP O
( ( O
N NNP O
- : O
Ser NNP O
, , O
mutant NN O
of IN O
the DT O
corresponding JJ O
NH2 NNP O
- : O
terminal NN O
residue NN O
) ) O
. . O

Characterization NN O
of IN O
a DT O
Xenopus NNP B-Gene
laevis NN I-Gene
CXC NNP I-Gene
chemokine NN I-Gene
receptor NN I-Gene
4 CD I-Gene
: : O
implications NNS O
for IN O
hematopoietic JJ O
cell NN O
development NN O
in IN O
the DT O
vertebrate NN O
embryo NN O
. . O

DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
with IN O
rat NN O
liver NN O
nuclear JJ O
extracts NNS O
identified VBD O
7 CD O
major JJ O
protein NN O
- : O
binding NN O
domains NNS O
termed VBD O
P1 NNP O
through IN O
P7 NNP O
in IN O
a DT O
796 CD O
base NN O
pair NN O
DNA NNP O
fragment NN O
( ( O
base NN O
pairs VBZ O
- : O
763 CD O
to TO O
+ VB O
33 CD O
) ) O
. . O

In IN O
some DT O
of IN O
the DT O
cases NNS O
of IN O
solitary JJ O
lesion NN O
, , O
serum JJ B-Gene
TSH NNP I-Gene
levels NNS O
, , O
serum NN B-Gene
thyroglobulin NN I-Gene
values NNS O
, , O
and CC O
131I CD O
protein NN O
bounded VBD O
iodine NN O
( ( O
131I CD O
- : O
PBI NN O
) ) O
were VBD O
measured VBN O
, , O
but CC O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
between IN O
successful JJ O
and CC O
unsuccessful JJ O
therapy NN O
. . O

Marked JJ O
sedative JJ O
activity NN O
was VBD O
observed VBN O
with IN O
9 CD O
- : O
methoxy NN O
- : O
5 CD O
- : O
phenylpyrrolo NN O
[ VBZ O
2 CD O
, , O
1 CD O
- : O
d NN O
] NNP O
[ NNP O
1 CD O
, , O
5 CD O
] NN O
benzothiazepin SYM O
- : O
6 CD O
, , O
6 CD O
- : O
dioxide NN O
( ( O
NF19 NNP O
) ) O
and CC O
9 CD O
- : O
chloro NN O
- : O
5 CD O
- : O
p NN O
- : O
nitrophenylpyrrolo NN O
[ VBZ O
2 CD O
, , O
1 CD O
- : O
d NN O
] NNP O
[ NNP O
1 CD O
, , O
5 CD O
] NN O
benzothiazepin SYM O
- : O
6 CD O
, , O
6 CD O
- : O
dioxide NN O
( ( O
NF20 NNP O
) ) O
. . O

Patients NNS O
with IN O
moderate JJ O
PDDAT NNP O
were VBD O
impaired VBN O
on IN O
all DT O
serial JJ O
positions NNS O
for IN O
both DT O
spatial JJ O
order NN O
and CC O
spatial JJ O
recognition NN O
memory NN O
. . O

Subdural NNP O
electrodes NNS O
may MD O
yield VB O
larger JJR O
VEP NNP O
amplitudes NNS O
than IN O
skull NN O
or CC O
scalp NN O
electrodes NNS O
. . O

To TO O
gain VB O
insight NN O
into IN O
the DT O
possible JJ O
involvement NN O
of IN O
p21 NN B-Gene
in IN O
liver NN O
cell NN O
growth NN O
, , O
the DT O
expression NN O
and CC O
regulation NN O
of IN O
the DT O
p21 NN B-Gene
gene NN I-Gene
was VBD O
evaluated VBN O
in IN O
rodent JJ O
models NNS O
of IN O
liver JJ O
regeneration NN O
and CC O
specimens NNS O
of IN O
human JJ O
liver NN O
diseases NNS O
. . O

The DT O
mature NN O
chromosome NN O
4 CD O
FRG1 NNP B-Gene
transcript NN I-Gene
is VBZ O
1042 CD O
bp NN O
in IN O
length NN O
and CC O
contains NNS O
nine CD O
exons NNS O
which WDT O
encode VBP O
a DT O
putative JJ O
protein NN O
of IN O
258 CD O
amino NN O
acid NN O
residues NNS O
. . O

In IN O
untransformed JJ O
cells NNS O
, , O
three CD O
major JJ O
proteins NNS O
coprecipitated VBN O
with IN O
CRKL NNP B-Gene
, , O
identified VBD O
as IN O
C3G NNP B-Gene
, , O
SOS NNP B-Gene
and CC O
c SYM B-Gene
- : I-Gene
ABL NN I-Gene
. . O

Application NN O
of IN O
different JJ O
criteria NNS O
of IN O
cure NN O
revealed VBD O
that IN O
19 CD O
patients NNS O
( ( O
66 CD O
% NN O
) ) O
had VBD O
basal VBN O
GH NNP B-Gene
levels NNS O
below IN O
5 CD O
ng JJ O
/ NNP O
ml NN O
, , O
17 CD O
patients NNS O
( ( O
59 CD O
% NN O
) ) O
had VBD O
normal JJ O
somatomedin JJ B-Gene
- : I-Gene
C NN I-Gene
values NNS O
, , O
16 CD O
patients NNS O
( ( O
55 CD O
% NN O
) ) O
had VBD O
complete JJ O
GH NNP B-Gene
suppression NN O
( ( O
less JJR O
than IN O
1 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
during IN O
OGTT NNP O
, , O
and CC O
13 CD O
patients NNS O
( ( O
45 CD O
% NN O
) ) O
met VBD O
the DT O
above IN O
- : O
mentioned VBD O
criteria NNS O
with IN O
disappearance NN O
of IN O
the DT O
paradoxical JJ O
GH NNP B-Gene
response NN O
to TO O
TRH NNP B-Gene
/ NNP O
GnRH NNP B-Gene
test NN O
. . O

The DT O
5 CD O
' POS O
external JJ O
transcribed NNS O
spacer NN O
( ( O
ETS NNP O
) ) O
region NN O
of IN O
the DT O
pre NN O
- : O
rRNA NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
contains VBZ O
a DT O
sequence NN O
with IN O
10 CD O
bp NN O
of IN O
perfect JJ O
complementarity NN O
to TO O
the DT O
U3 NNP B-Gene
snoRNA NN I-Gene
. . O

Experimental JJ O
study NN O
of IN O
ta NN O
chengchi NN O
tang NN O
decoction NN O
for IN O
relieving VBG O
lung JJ O
injury NN O
during IN O
acute JJ O
necrotizing VBG O
pancreatitis NN O
] VBD O
The DT O
objectives NNS O
of IN O
the DT O
study NN O
were VBD O
to TO O
investigate VB O
the DT O
changes NNS O
of IN O
leukocyte NN O
adhesiveness NN O
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
in IN O
the DT O
early JJ O
stage NN O
of IN O
acute JJ O
necrotizing VBG O
pancreatitis NN O
( ( O
ANP NNP O
) ) O
, , O
to TO O
go VB O
further RB O
into IN O
the DT O
relation NN O
of IN O
those DT O
changes NNS O
to TO O
lung VB O
injury NN O
of IN O
ANP NNP O
, , O
and CC O
to TO O
evaluate VB O
the DT O
prohibitive JJ O
effect NN O
of IN O
ta NN O
chengchi NN O
tang NN O
Decoction NNP O
on IN O
leukocyte JJ O
adhesion NN O
and CC O
TNF NNP B-Gene
secretion NN O
. . O

The DT O
mean JJ O
serum NN O
creatinine NN O
level NN O
did VBD O
not RB O
change NN O
during IN O
the DT O
first JJ O
6 CD O
months NNS O
after IN O
withdrawal NN O
of IN O
MMF NNP O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
a DT O
range NN O
of IN O
microenvironmental JJ O
conditions NNS O
exist VBP O
within IN O
purified JJ O
water NN O
systems NNS O
, , O
leading VBG O
to TO O
variable JJ O
populations NNS O
of IN O
bacteria NNS O
. . O

I PRP O
. . O

Nursing NN O
of IN O
patients NNS O
with IN O
gynecological JJ O
diseases NNS O

Here RB O
, , O
we PRP O
report VBP O
the DT O
complete JJ O
structure NN O
of IN O
the DT O
human JJ B-Gene
topoisomerase NN I-Gene
IIalpha NNP I-Gene
gene NN I-Gene
, , O
which WDT O
consists VBZ O
of IN O
35 CD O
exons NNS O
spanning VBG O
27 CD O
. . O
5 CD O
kb NN O
. . O

METHODS NNS O
: : O
We PRP O
retrospectively RB O
selected VBD O
13 CD O
TFCD NNP O
patients NNS O
who WP O
underwent VBP O
surgery NN O
for IN O
intractable JJ O
epilepsy NN O
with IN O
the DT O
aim NN O
of IN O
removing VBG O
the DT O
magnetic JJ O
resonance NN O
( ( O
MR NNP O
) ) O
- : O
detectable JJ O
lesion NN O
and CC O
/ NN O
or CC O
the DT O
epileptogenic JJ O
zone NN O
defined VBN O
by IN O
stereoelectroencephalographic JJ O
recordings NNS O
. . O

The DT O
protein NN O
expressed VBN O
by IN O
F2771 NNP B-Gene
cDNA NN I-Gene
in IN O
transfected JJ O
COS NNP O
cells NNS O
is VBZ O
localized VBN O
in IN O
the DT O
cytoplasm NN O
. . O

Although IN O
elevated VBN O
serum NN O
levels NNS O
of IN O
antibodies NNS O
to TO O
the DT O
nicotinic JJ B-Gene
acetylcholine NN I-Gene
receptor NN I-Gene
( ( O
nAChR NN B-Gene
) ) O
have VBP O
been VBN O
reported VBN O
in IN O
neuroleptic JJ O
treated VBD O
patients NNS O
with IN O
tardive JJ O
dyskinesia NN O
, , O
such JJ O
antibodies NNS O
have VBP O
not RB O
been VBN O
determined VBN O
in IN O
comparable JJ O
nondyskinetic JJ O
patients NNS O
. . O

An DT O
end NN O
- : O
to TO O
- : O
end NN O
pancreaticojejunostomy NN O
using VBG O
a DT O
mechanical JJ O
purse NN O
- : O
string NN O
device NN O
. . O

Molecular JJ O
mimicry NN O
of IN O
human JJ O
cytokine NN O
and CC O
cytokine NN O
response NN O
pathway NN O
genes NNS O
by IN O
KSHV NNP O
. . O

Stimulation NN O
of IN O
the DT O
caudate NN O
nucleus NN O
' '' O
dophamine JJ O
- : O
reactive JJ O
system NN O
in IN O
dogs NNS O
by IN O
means NNS O
of IN O
administration NN O
of IN O
dophamine NN O
( ( O
60 CD O
micrograms NNS O
) ) O
and CC O
phenamine NN O
led VBN O
to TO O
deterioration NN O
of IN O
conditioned VBN O
and CC O
unconditioned JJ O
components NNS O
of IN O
feeding VBG O
behaviour NN O
. . O

Although IN O
the DT O
fertility NN O
decline NN O
in IN O
the DT O
black JJ O
population NN O
in IN O
the DT O
Mississippi NNP O
Delta NNP O
between IN O
the DT O
late JJ O
1870 CD O
' POS O
s NN O
and CC O
early JJ O
1930 CD O
' POS O
s NN O
closely RB O
paralleled VBD O
that IN O
of IN O
the DT O
national JJ O
black JJ O
population NN O
, , O
it PRP O
rose VBD O
much RB O
more RBR O
dramatically RB O
in IN O
the DT O
1940 CD O
' POS O
s NN O
and CC O
1950 CD O
' '' O
s NN O
to TO O
almost RB O
1880 CD O
levels NNS O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
investigate VBP O
the DT O
mechanism NN O
underlying VBG O
Ras NNP B-Gene
activation NN O
upon IN O
stimulation NN O
of IN O
these DT O
two CD O
types NNS O
of IN O
receptors NNS O
in IN O
hematopoietic JJ O
cells NNS O
. . O

The DT O
lengths NNS O
of IN O
the DT O
complete JJ O
polypeptide NN O
chain NN O
of IN O
the DT O
recombinant JJ O
enzyme NN O
and CC O
its PRP$ O
transit NN O
peptide NN O
are VBP O
388 CD O
and CC O
53 CD O
residues NNS O
, , O
respectively RB O
. . O

Immunochemotherapy NN O
with IN O
schizophyllan NN O
( ( O
SPG NNP O
) ) O
combined VBD O
with IN O
chemotherapeutic JJ O
agents NNS O
was VBD O
evaluated VBN O
in IN O
two CD O
syngeneic JJ O
tumor NN O
- : O
C3H NNP O
/ IN O
He PRP O
mouse RB O
systems NNS O
. . O

HuEpo NNP B-Gene
- : I-Gene
R NNP I-Gene
Ab NNP I-Gene
inhibited VBD O
Epo NNP B-Gene
- : O
induced VBD O
parental JJ O
UT NNP O
- : O
7 CD O
cell NN O
growth NN O
, , O
but CC O
not RB O
that IN O
of IN O
cells NNS O
of IN O
clone NN O
12 CD O
, , O
suggesting VBG O
that IN O
the DT O
muEpo NN B-Gene
- : I-Gene
R NN I-Gene
is VBZ O
able JJ O
to TO O
induce VB O
human JJ O
UT NNP O
- : O
7 CD O
cell NN O
proliferation NN O
. . O

Ligation NN O
of IN O
CD40 NNP B-Gene
rescues NNS O
Ramos NNP O
- : O
Burkitt NNP O
lymphoma NN O
B NNP O
cells NNS O
from IN O
calcium NN O
ionophore NN O
- : O
and CC O
antigen VB O
receptor NN O
- : O
triggered VBN O
apoptosis NN O
by IN O
inhibiting VBG O
activation NN O
of IN O
the DT O
cysteine NN B-Gene
protease NN I-Gene
CPP32 NNP B-Gene
/ NNP O
Yama NNP B-Gene
and CC O
cleavage NN O
of IN O
its PRP$ O
substrate NN O
PARP NNP B-Gene
. . O

The DT O
unique JJ O
nature NN O
and CC O
arrangement NN O
of IN O
the DT O
ANT1 NNP B-Gene
transcriptional JJ I-Gene
control NN I-Gene
elements NNS I-Gene
may MD O
account VB O
for IN O
this DT O
differential JJ O
expression NN O
. . O

G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
activates VBZ O
multiple JJ O
signaling VBG O
molecules NNS O
, , O
including VBG O
the DT O
JAK1 NNP B-Gene
and CC O
JAK2 NNP B-Gene
kinases NNS I-Gene
and CC O
the DT O
STAT NNP B-Gene
transcription NN O
factors NNS O
. . O

The DT O
strategy NN O
has VBZ O
been VBN O
used VBN O
to TO O
determine VB O
2 CD O
. . O
6 CD O
kilobases NNS O
of IN O
nucleotide JJ O
sequence NN O
in IN O
the DT O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
ADE NNP I-Gene
1 CD I-Gene
locus NN I-Gene
. . O

In IN O
analyses NNS O
with IN O
control NN O
for IN O
multiple JJ O
variables NNS O
, , O
relative JJ O
risk NN O
for IN O
microalbuminuria NN O
( ( O
urinary JJ O
albumin NN B-Gene
excretion NN O
, , O
20 CD O
- : O
199 CD O
microg NN O
/ NNP O
min NN O
) ) O
in IN O
men NNS O
and CC O
women NNS O
was VBD O
2 CD O
. . O
51 CD O
and CC O
1 CD O
. . O
62 CD O
, , O
respectively RB O
, , O
with IN O
18 CD O
mm NNS O
Hg NNP O
higher JJR O
( ( O
1 CD O
SD NNP O
) ) O
systolic VBD O
blood NN O
pressure NN O
; : O
2 CD O
. . O
25 CD O
and CC O
2 CD O
. . O
10 CD O
, , O
respectively RB O
, , O
with IN O
1 CD O
. . O
0 CD O
- : O
mmol NN O
/ NN O
L NNP O
( ( O
40 CD O
mg NN O
/ NNP O
dL NN O
) ) O
higher JJR O
plasma NN O
cholesterol NN O
level NN O
; : O
1 CD O
. . O
99 CD O
and CC O
1 CD O
. . O
91 CD O
, , O
respectively RB O
, , O
for IN O
smokers NNS O
vs JJ O
nonsmokers NNS O
; : O
and CC O
1 CD O
. . O
83 CD O
and CC O
1 CD O
. . O
33 CD O
, , O
respectively RB O
, , O
with IN O
4 CD O
kg NNS O
/ JJ O
m2 NN O
higher JJR O
body NN O
mass NN O
index NN O
. . O

Among IN O
38 CD O
patients NNS O
with IN O
inducible JJ O
reentrant JJ O
VTs NNP O
who WP O
underwent VBD O
electrophysiologic JJ O
study NN O
( ( O
EPS NNP O
) ) O
, , O
10 CD O
VTs NNP O
of IN O
six CD O
patients NNS O
were VBD O
selected VBN O
. . O

EXERCISE NN O
IN NNP O
THE NNP O
TERRESTRIAL NNP O
CHRISTMAS NNP O
ISLAND NNP O
RED NNP O
CRAB NNP O
GECARCOIDEA NNP O
NATALIS NNP O
- : O
ENERGETICS NN O
OF IN O
LOCOMOTION NNP O

Purification NN O
of IN O
MvaT NNP B-Gene
enriched VBD O
for IN O
two CD O
polypeptides NNS O
of IN O
approximate JJ O
molecular JJ O
mass NN O
15 CD O
kDa NN O
and CC O
16 CD O
kDa NN O
, , O
designated VBN O
P15 NNP B-Gene
and CC O
P16 NNP B-Gene
. . O

Immediately RB O
before IN O
surgery NN O
patients NNS O
received VBD O
either RB O
intravenous JJ O
hydrocortisone NN O
100 CD O
mg NN O
or CC O
placebo NN O
in IN O
random NN O
, , O
double JJ O
- : O
blind NN O
order NN O
. . O

ZK7 NNP B-Gene
and CC O
HZF16 NNP B-Gene
genes NNS I-Gene
appear VBP O
to TO O
be VB O
the DT O
splice NN O
variants NNS O
transcribed VBN O
from IN O
the DT O
same JJ O
gene NN O
. . O

This DT O
Mr NNP O
is VBZ O
similar JJ O
to TO O
those DT O
of IN O
the DT O
purified JJ B-Gene
smg NN I-Gene
p25A NN I-Gene
GDI NNP I-Gene
estimated VBN O
by IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
and CC O
sucrose JJ O
density NN O
gradient NN O
ultracentrifugation NN O
, , O
which WDT O
are VBP O
about IN O
54 CD O
, , O
0 CD O
and CC O
65 CD O
, , O
0 CD O
, , O
respectively RB O
. . O

Administration NN O
of IN O
growth NN B-Gene
hormone NN I-Gene
leads VBZ O
to TO O
faster VB O
growth NN O
, , O
but CC O
also RB O
faster VBP O
bone CD O
maturation NN O
. . O

Recurrent NNP O
G NNP O
- : O
to TO O
- : O
A DT O
substitution NN O
in IN O
a DT O
single JJ O
codon NN O
of IN O
SREBP NNP B-Gene
cleavage NN I-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
causes VBZ O
sterol JJ O
resistance NN O
in IN O
three CD O
mutant JJ O
Chinese JJ O
hamster NN O
ovary JJ O
cell NN O
lines NNS O
. . O

Whereas IN O
a DT O
PR55 NNP B-Gene
beta NN I-Gene
transcript NN I-Gene
of IN O
about IN O
2 CD O
. . O
3 CD O
kb NN O
was VBD O
detected VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
neuroblastoma NN O
derived VBD O
cell NN O
line NN O
LA NNP O
- : O
N NNP O
- : O
1 CD O
, , O
the DT O
level NN O
of IN O
the DT O
mRNA NN O
was VBD O
very RB O
low JJ O
in IN O
the DT O
other JJ O
human JJ O
cell NN O
lines NNS O
analyzed VBN O
. . O

Thus RB O
, , O
the DT O
P NNP O
. . O
aeruginosa NN O
orfX NN O
and CC O
vfr NN B-Gene
promoters NNS I-Gene
are VBP O
arranged VBN O
in IN O
a DT O
back JJ O
- : O
to TO O
- : O
back VB O
orientation NN O
rather RB O
than IN O
the DT O
face NN O
- : O
to TO O
- : O
face NN O
orientation NN O
of IN O
the DT O
dorf NN O
and CC O
crp NN B-Gene
promoters NNS I-Gene
. . O

The DT O
C4BP NNP B-Gene
alpha NN I-Gene
gene NN I-Gene
is VBZ O
organized VBN O
as IN O
follows VBZ O
: : O
the DT O
first JJ O
exon NN O
codes NNS O
for IN O
the DT O
first JJ O
198 CD O
nucleotides NNS O
of IN O
the DT O
5 CD O
' POS O
UTR NNP O
. . O

These DT O
regions NNS O
may MD O
be VB O
differentially RB O
involved VBN O
in IN O
tissue NN O
- : O
specificity NN O
, , O
and CC O
/ NNP O
or CC O
circadian JJ O
regulation NN O
, , O
of IN O
the DT O
human JJ B-Gene
hPer1 NN I-Gene
gene NN I-Gene
transcription NN O
. . O

Studying VBG O
intracellular JJ O
signaling NN O
pathways NNS O
, , O
which WDT O
may MD O
be VB O
involved VBN O
in IN O
malignant JJ O
transformation NN O
of IN O
Ret NNP B-Gene
- : I-Gene
9bp CD I-Gene
expressing VBG O
NIH3T3 NNP O
cells NNS O
, , O
we PRP O
could MD O
demonstrate VB O
Ret NNP B-Gene
- : I-Gene
9bp CD I-Gene
dependent JJ O
phosphorylation NN O
of IN O
insulin NN B-Gene
receptor NN I-Gene
substrate VBP I-Gene
- : I-Gene
2 CD I-Gene
( ( O
IRS NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
with IN O
consecutive JJ O
activation NN O
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
and CC O
protein JJ B-Gene
kinase NN I-Gene
B NNP I-Gene
( ( O
PKB NNP B-Gene
/ NNP O
AKT NNP B-Gene
) ) O
. . O

It PRP O
is VBZ O
the DT O
human JJ O
homolog NN O
of IN O
the DT O
mouse NN B-Gene
Mx NNP I-Gene
protein NN I-Gene
involved VBN O
in IN O
resistance NN O
to TO O
influenza VB O
virus NN O
. . O

In IN O
the DT O
single JJ O
case NN O
the DT O
restoration NN O
of IN O
a DT O
structured JJ O
daily JJ O
routine NN O
represents VBZ O
the DT O
presupposition NN O
for IN O
a DT O
cognitive JJ O
therapy NN O
. . O

The DT O
effect NN O
of IN O
echothiophate NN O
on IN O
the DT O
biphasic JJ O
response NN O
of IN O
rabbit NN O
ocular JJ O
pressure NN O
to TO O
dipivefrin VB O
. . O

We PRP O
have VBP O
subcloned VBN O
into IN O
pBR322 JJ O
deoxyribonucleic JJ O
acid NN O
( ( O
DNA NNP O
) ) O
sequences VBZ O
mapping VBG O
either CC O
in IN O
the DT O
coding NN O
region NN O
, , O
the DT O
5 CD O
' POS O
spacer NN O
, , O
or CC O
the DT O
3 CD O
' POS O
spacer NN O
of IN O
the DT O
H2B NNP B-Gene
histone NN I-Gene
gene NN I-Gene
. . O

The DT O
role NN O
of IN O
the DT O
Vp1 NNP B-Gene
DBD NNP I-Gene
during IN O
infection NN O
was VBD O
investigated VBN O
by IN O
taking VBG O
advantage NN O
of IN O
NLS NNP O
phenotypic NN O
complementation NN O
( ( O
N NNP O
. . O

In IN O
the DT O
artificial JJ O
lung NN O
, , O
like IN O
in IN O
the DT O
natural JJ O
lung NN O
and CC O
peripheral JJ O
tissues NNS O
, , O
gas NN O
exchanges NNS O
depend VBP O
on IN O
several JJ O
parameters NNS O
: : O
blood NN O
inlet NN O
conditions NNS O
, , O
blood NN O
flow NN O
rate NN O
, , O
temperature NN O
, , O
composition NN O
of IN O
the DT O
gas NN O
mixture NN O
used VBN O
for IN O
ventilation NN O
, , O
blood NN O
tissue NN O
perfusion NN O
, , O
O2 NNP O
consumption NN O
, , O
etc FW O
. . O

Cortical JJ O
dysplasias NN O
, , O
genetics NNS O
, , O
and CC O
epileptogenesis NN O
. . O

BACKGROUND NNP O
/ NNP O
PURPOSE NNP O
: : O
Anomalous JJ O
arrangement NN O
of IN O
the DT O
pancreaticobiliary JJ O
duct NN O
( ( O
AAPBD NNP O
) ) O
is VBZ O
closely RB O
related VBN O
to TO O
congenital JJ O
biliary JJ O
dilatation NN O
and CC O
frequently RB O
associated VBN O
with IN O
biliary JJ O
tract NN O
malignancy NN O
. . O

Mouse NNP B-Gene
mast NN I-Gene
cell NN I-Gene
protease NN I-Gene
9 CD I-Gene
, , O
a DT O
novel JJ O
member NN O
of IN O
the DT O
chromosome NN O
14 CD O
family NN O
of IN O
serine NN B-Gene
proteases NNS I-Gene
that WDT O
is VBZ O
selectively RB O
expressed VBN O
in IN O
uterine JJ O
mast NN O
cells NNS O
. . O

The DT O
v NN B-Gene
- : I-Gene
Src NNP I-Gene
SH3 NNP B-Gene
domain NN I-Gene
facilitates VBZ O
a DT O
cell NN O
adhesion NN O
- : O
independent JJ O
association NN O
with IN O
focal JJ B-Gene
adhesion NN I-Gene
kinase NN I-Gene
. . O

Co NNP O
- : O
immunoprecipitation NN O
and CC O
DNA NNP O
affinity NN O
chromatography NN O
prove VBP O
that IN O
Sp1 NNP B-Gene
heterodimerizes VBZ O
with IN O
ZBP NNP B-Gene
- : I-Gene
89 CD I-Gene
when WRB O
bound NN O
to TO O
the DT O
silencer NN O
element NN O
to TO O
yield VB O
a DT O
DNA NNP O
- : O
protein NN O
complex JJ O
whose WP$ O
mobility NN O
is VBZ O
indistinguishable JJ O
from IN O
that DT O
displayed VBN O
by IN O
HeLa NNP O
nuclear JJ O
extract NN O
in IN O
band NN O
shift NN O
assays NNS O
. . O

Mucolipidosis NNP O
type NN O
IV NNP O
: : O
clinical JJ O
spectrum NN O
and CC O
natural JJ O
history NN O
. . O

It PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
the DT O
parCBA NN B-Gene
operon NN I-Gene
encodes VBZ O
a DT O
plasmid NN O
partitioning NN O
system NN O
( ( O
M NNP O
. . O

Albumin NNP B-Gene
and CC O
cyclic JJ O
AMP NNP O
levels NNS O
in IN O
peritoneal JJ O
fluids NNS O
in IN O
the DT O
child NN O

A DT O
combination NN O
of IN O
comparative JJ O
sequence NN O
analysis NN O
and CC O
thermodynamic JJ O
methods NNS O
reveals VBZ O
the DT O
conservation NN O
of IN O
tertiary JJ O
structure NN O
elements NNS O
in IN O
the DT O
5 CD O
' POS O
untranslated JJ O
region NN O
( ( O
UTR NNP O
) ) O
of IN O
human JJ O
enteroviruses NNS O
and CC O
rhinoviruses NNS O
. . O

No DT O
difference NN O
in IN O
the DT O
clinical JJ O
acceptability NN O
could MD O
be VB O
ascertained VBN O
between IN O
the DT O
two CD O
groups NNS O
. . O

Competition NN O
analysis NN O
by IN O
gel JJ O
mobility NN O
shift NN O
electrophoresis NN O
indicates VBZ O
that IN O
this DT O
DNA NNP O
- : O
protein NN O
interaction NN O
is VBZ O
novel JJ O
and CC O
not RB O
related VBN O
to TO O
many JJ O
transcription NN O
factors NNS O
previously RB O
reported VBD O
. . O

The DT O
RMRI NNP O
was VBD O
tested VBN O
for IN O
interrater NN O
reliability NN O
using VBG O
three CD O
simulated JJ O
and CC O
10 CD O
actual JJ O
patients NNS O
. . O

Replacement NN O
of IN O
residues NNS O
in IN O
positions NNS O
+ VBP O
3 CD O
( ( O
His128Asn NNP O
) ) O
and CC O
+ $ O
2 CD O
( ( O
Gln155Lys NNP O
) ) O
of IN O
the DT O
reading NN O
helices NNS O
of IN O
fingers NNS O
2 CD O
and CC O
3 CD O
, , O
respectively RB O
, , O
prevented VBD O
binding NN O
. . O

BIAcore IN O
analysis NN O
gave VBD O
a DT O
Kaff NNP O
of IN O
4 CD O
. . O
4 CD O
x JJ O
10 CD O
( ( O
10 CD O
) ) O
M NNP O
- : O
1 CD O
for IN O
the DT O
binding NN O
of IN O
N NNP B-Gene
- : I-Gene
A3 NN I-Gene
to TO O
T84 NNP B-Gene
. . I-Gene
1 CD I-Gene
and CC O
2 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
10 CD O
) ) O
M NNP O
- : O
1 CD O
for IN O
the DT O
binding NN O
of IN O
N NNP B-Gene
- : I-Gene
A3 NN I-Gene
to TO O
T84 NNP B-Gene
. . I-Gene
66 CD I-Gene
. . O

The DT O
emerging VBG O
complexity NN O
of IN O
the DT O
5 CD O
' POS O
regulatory JJ O
region NN O
of IN O
the DT O
GH NNP B-Gene
receptor NN I-Gene
gene NN I-Gene
was VBD O
emphasised VBN O
by IN O
the DT O
observation NN O
that IN O
probes VBZ O
derived VBN O
from IN O
exon JJ O
1B CD O
and CC O
the DT O
distal JJ O
3 CD O
' POS O
intron NN O
boundary NN O
do VBP O
not RB O
hybridise VB O
with IN O
previously RB O
cloned VBN O
genomic JJ O
sequences NNS O
that WDT O
span VBP O
the DT O
liver NN O
- : O
specific JJ O
P1 NNP O
promoter NN O
and CC O
exon $ O
2 CD O
. . O

OBJECTIVE NN O
: : O
To TO O
follow VB O
- : O
up RP O
prospectively RB O
patients NNS O
with IN O
arthritis NN O
after IN O
infection NN O
with IN O
beta NN O
- : O
haemolytic JJ O
streptococci NN O
of IN O
Lancefield NNP O
group NN O
A NNP O
( ( O
beta JJ O
HSA NNP O
) ) O
, , O
with IN O
emphasis NN O
on IN O
clinical JJ O
characteristics NNS O
and CC O
serological JJ O
features NNS O
. . O

Acute JJ O
pancreatitis NN O
: : O
a DT O
multisystem NN O
disease NN O
. . O

The DT O
effect NN O
of IN O
ethanol NN O
on IN O
human JJ O
sensorimotor NN O
reactivity NN O
was VBD O
assessed VBN O
by IN O
examining VBG O
the DT O
acoustic JJ O
startle NN O
response NN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
primary JJ O
visual JJ O
cortex NN O
of IN O
the DT O
rat NN O
is VBZ O
asymmetrical JJ O
in IN O
volume NN O
, , O
and CC O
that IN O
the DT O
asymmetry NN O
reflects VBZ O
side JJ O
differences NNS O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
also RB O
constructed VBD O
and CC O
expressed VBD O
chimeric JJ O
fusion NN O
protein NN O
that WDT O
contains VBZ O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
gag NN I-Gene
with IN O
V3 NNP B-Gene
domains NNS O
of IN O
HIV NNP O
- : O
1IIIB CD O
, , O
HIV NNP O
- : O
1MN CD O
, , O
HIV NNP O
- : O
1SF2 CD O
and CC O
HIV NNP O
- : O
1RF CD O
. . O

The DT O
DHEAS NNP O
levels NNS O
in IN O
all DT O
stages NNS O
of IN O
decreased JJ O
BMD NNP O
were VBD O
significantly RB O
lower JJR O
than IN O
those DT O
in IN O
the DT O
group NN O
with IN O
normal JJ O
BMD NNP O
. . O

Nuclear JJ O
receptors NNS O
( ( O
NRs NNP O
) ) O
can MD O
function VB O
as IN O
ligandinducible JJ O
transregulators NNS O
in IN O
both DT O
mammalian JJ O
and CC O
yeast JJ O
cells NNS O
, , O
indicating VBG O
that IN O
important JJ O
features NNS O
of IN O
transcriptional JJ O
control NN O
have VBP O
been VBN O
conserved VBN O
throughout IN O
evolution NN O
. . O

OUTCOME NN O
: : O
Acetylcholine NNP B-Gene
receptor NN I-Gene
antibodies NNS I-Gene
and CC O
single JJ O
- : O
fibre NN O
electromyogram NN O
were VBD O
useful JJ O
in IN O
the DT O
diagnosis NN O
of IN O
myasthenia NN O
gravis NN O
. . O

Binding NNP O
of IN O
U2 NNP B-Gene
small JJ I-Gene
nuclear JJ I-Gene
ribonucleoprotein NN I-Gene
was VBD O
partially RB O
inhibited VBN O
. . O

Paradoxically RB O
, , O
however RB O
, , O
the DT O
GH NNP B-Gene
receptor NN I-Gene
cloned VBD O
from IN O
liver NN O
exhibits VBZ O
no DT O
sequence NN O
similarity NN O
to TO O
receptors NNS O
with IN O
known JJ O
signal JJ O
transduction NN O
mechanisms NNS O
, , O
including VBG O
those DT O
exhibiting VBG O
ligand SYM O
- : O
activated VBN O
tyrosine JJ B-Gene
kinase NN I-Gene
activity NN O
. . O

Thiopentone CD O
sodium NN O
administered VBN O
at IN O
30 CD O
and CC O
10 CD O
min NN O
before IN O
or CC O
5 CD O
, , O
10 CD O
and CC O
15 CD O
min NN O
after IN O
exposure NN O
to TO O
NOC NNP O
- : O
5 CD O
, , O
but CC O
not RB O
thereafter RB O
, , O
significantly RB O
attenuated VBD O
NO NNP O
- : O
induced VBD O
neurotoxicity NN O
compared VBN O
with IN O
controls NNS O
. . O

Concordance NN O
of IN O
IBDQ NNP O
scores NNS O
was VBD O
tested VBN O
in IN O
280 CD O
stable JJ O
subjects NNS O
. . O

HER2 NNP B-Gene
overexpressing VBG O
cells NNS O
showed VBD O
a DT O
single JJ O
prominent JJ O
DNase NNP B-Gene
I PRP I-Gene
hypersensitive VBP O
site NN O
near IN O
a DT O
conserved VBN O
and CC O
hitherto JJ O
unrecognized JJ O
ets NNS B-Gene
response NN O
element NN O
( ( O
GAGGAA NNP O
) ) O
, , O
located VBN O
38 CD O
bases NNS O
down RP O
- : O
stream NN O
from IN O
the DT O
CAAT NNP O
box NN O
and CC O
directly RB O
5 CD O
' '' O
of IN O
the DT O
TATA NNP O
box NN O
in IN O
the DT O
human JJ B-Gene
HER2 NNP I-Gene
promoter NN I-Gene
. . O

Underlying VBG O
the DT O
clustering NN O
of IN O
these DT O
risk NN O
variables NNS O
were VBD O
three CD O
factors NNS O
. . O

Thus RB O
, , O
the DT O
predicted JJ O
CD30v NNP B-Gene
protein NN I-Gene
retains VBZ O
most JJS O
of IN O
the DT O
cytoplasmic JJ O
region NN O
, , O
but CC O
lacks VBZ O
the DT O
extracellular NN O
and CC O
transmembrane NN O
domains NNS O
. . O

The DT O
0 CD O
. . O
22 CD O
- : O
kb NN O
NheI NNP B-Gene
/ NNP O
BglII NNP B-Gene
promoter NN O
exhibited VBD O
PMA NNP O
inducibility NN O
in IN O
myeloid JJ O
cells NNS O
and CC O
contained VBD O
a DT O
PMA NNP O
- : O
responsive JJ O
element NN O
recognized VBN O
by IN O
Sp1 NNP B-Gene
and CC O
EGR NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

Induction NN O
of IN O
AtP5CS1 NNP B-Gene
mRNA FW I-Gene
accumulation NN O
in IN O
salt NN O
- : O
treated JJ O
seedlings NNS O
involves VBZ O
an DT O
immediate JJ O
early JJ O
transcriptional JJ O
response NN O
regulated VBN O
by IN O
ABA NNP O
signalling VBG O
that DT O
is VBZ O
not RB O
inhibited VBN O
by IN O
cycloheximide NN O
, , O
but CC O
abolished VBN O
by IN O
the DT O
deficiency NN O
of IN O
ABA NNP O
biosynthesis NN O
in IN O
the DT O
aba1 JJ B-Gene
Arabidopsis NNP I-Gene
mutant NN I-Gene
. . O

The DT O
eluent NN O
from IN O
the DT O
column NN O
was VBD O
mixed JJ O
with IN O
the DT O
chemiluminescent JJ O
solution NN O
containing VBG O
lucigenin NN B-Gene
and CC O
Triton NNP O
X NNP O
- : O
100 CD O
and CC O
a DT O
0 CD O
. . O
28 CD O
M NNP O
KOH NNP O
solution NN O
by IN O
pumps NNS O
and CC O
monitored VBN O
by IN O
a DT O
chemiluminescence NN O
detector NN O
. . O

Keratoconjunctivitis NNP O
sicca NN O
appears VBZ O
to TO O
be VB O
a DT O
common JJ O
ocular JJ O
complication NN O
and CC O
all DT O
children NNS O
with IN O
JRA NNP O
should MD O
be VB O
screened VBN O
for IN O
it PRP O
with IN O
a DT O
comprehensive JJ O
battery NN O
of IN O
tests NNS O
. . O

To TO O
determine VB O
whether IN O
the DT O
excess JJ O
prevalence NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
infection NN O
in IN O
US NNP O
black JJ O
and CC O
Hispanic JJ O
homosexual JJ O
men NNS O
relative VBP O
to TO O
white JJ O
men NNS O
can MD O
be VB O
explained VBN O
by IN O
differences NNS O
in IN O
sociodemographic JJ O
factors NNS O
, , O
history NN O
of IN O
sexually RB O
transmitted VBN O
diseases NNS O
, , O
or CC O
sexual JJ O
and CC O
drug NN O
- : O
use NN O
behaviors NNS O
, , O
the DT O
authors NNS O
conducted VBD O
a DT O
cross NN O
- : O
sectional JJ O
analysis NN O
of IN O
baseline NN O
HIV NNP O
- : O
1 CD O
seroprevalence NN O
and CC O
HIV NNP O
- : O
1 CD O
risk NN O
factors NNS O
among IN O
4 CD O
, , O
475 CD O
non SYM O
- : O
Hispanic JJ O
white JJ O
, , O
234 CD O
Hispanic NNP O
white JJ O
, , O
and CC O
194 CD O
black JJ O
homosexual JJ O
men NNS O
from IN O
four CD O
centers NNS O
in IN O
the DT O
United NNP O
States NNPS O
( ( O
Baltimore NNP O
/ NNP O
Washington NNP O
, , O
DC NNP O
, , O
Pittsburgh NNP O
, , O
Chicago NNP O
, , O
and CC O
Los NNP O
Angeles NNP O
) ) O
. . O

The DT O
yeast NN B-Gene
SSS1 NNP I-Gene
gene NN I-Gene
is VBZ O
essential JJ O
for IN O
secretory JJ O
protein JJ O
translocation NN O
and CC O
encodes VBZ O
a DT O
conserved JJ O
protein NN O
of IN O
the DT O
endoplasmic JJ O
reticulum NN O
. . O

Slowly RB O
adapting VBG O
type NN O
I PRP O
mechanoreceptor VBP O
discharge NN O
as IN O
a DT O
function NN O
of IN O
dynamic JJ O
force NN O
versus NN O
dynamic JJ O
displacement NN O
of IN O
glabrous JJ O
skin NN O
of IN O
raccoon NN O
and CC O
squirrel NN O
monkey JJ O
hand NN O
. . O

The DT O
main JJ O
advantages NNS O
of IN O
Multi NNP O
- : O
MUP NN O
analysis NN O
are VBP O
: : O
( ( O
1 CD O
) ) O
quick JJ O
acquisition NN O
of IN O
many JJ O
MUPs NNP O
; : O
( ( O
2 CD O
) ) O
simultaneous JJ O
collection NN O
of IN O
several JJ O
MUPs NNP O
at IN O
one CD O
recording VBG O
site NN O
; : O
( ( O
3 CD O
) ) O
possibility NN O
to TO O
analyze VB O
not RB O
only RB O
low JJ O
threshold JJ O
MUPs NNP O
; : O
( ( O
4 CD O
) ) O
less JJR O
bias NN O
in IN O
the DT O
selection NN O
of IN O
MUPs NNP O
and CC O
( ( O
5 CD O
) ) O
the DT O
reproducibility NN O
of IN O
the DT O
results NNS O
that WDT O
allow VBP O
the DT O
same JJ O
reference NN O
values NNS O
to TO O
be VB O
used VBN O
in IN O
different JJ O
laboratories NNS O
. . O

The DT O
median JJ O
preoperative NN O
best JJS O
- : O
corrected VBN O
visual JJ O
acuity NN O
of IN O
0 CD O
. . O
8 CD O
( ( O
range NN O
hand NN O
motions NNS O
/ VBP O
0 CD O
. . O
3 CD O
to TO O
0 CD O
. . O
4 CD O
) ) O
, , O
improved VBN O
by IN O
5 CD O
lines NNS O
to TO O
a DT O
median JJ O
final JJ O
postoperative NN O
best JJS O
- : O
corrected VBN O
visual JJ O
acuity NN O
of IN O
0 CD O
. . O
25 CD O
( ( O
range NN O
0 CD O
. . O
25 CD O
- : O
0 CD O
. . O
5 CD O
) ) O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Selection NN O
was VBD O
based VBN O
on IN O
expression NN O
of IN O
an DT O
integrated VBN O
DNA NNP O
fragment NN O
containing VBG O
the DT O
con NN B-Gene
- : I-Gene
10 CD I-Gene
promoter NN I-Gene
- : I-Gene
regulatory JJ I-Gene
region NN I-Gene
followed VBN O
by IN O
the DT O
initial JJ O
segment NN O
of IN O
the DT O
con NN B-Gene
- : I-Gene
10 CD I-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
fused VBN O
in IN O
frame NN O
with IN O
the DT O
bacterial JJ B-Gene
hygromycin NN I-Gene
B NNP I-Gene
phosphotransferase NN I-Gene
structural JJ I-Gene
gene NN I-Gene
( ( O
con10 NN B-Gene
' '' I-Gene
- : I-Gene
' POS I-Gene
hph NN I-Gene
) ) O
. . O

Bilateral NNP O
basal NN O
arteries NNS O
were VBD O
measured VBN O
by IN O
the DT O
transtemporal JJ O
approach NN O
with IN O
a DT O
2 CD O
MHz NNP O
pulsed VBD O
Doppler NNP O
instrument NN O
( ( O
TC NNP O
- : O
2 CD O
64B CD O
EME NNP O
) ) O
. . O

A DT O
diagnosis NN O
of IN O
MS NNP O
was VBD O
made VBN O
based VBN O
on IN O
subtle JJ O
neurologic JJ O
signs NNS O
, , O
spinal JJ O
fluid NN O
gamma NN B-Gene
globulin NN I-Gene
elevations NNS O
, , O
and CC O
abnormalities NNS O
in IN O
neuropsychological JJ O
testing NN O
. . O

A DT O
prospective JJ O
trail NN O
comparing VBG O
hysterectomy NN O
, , O
hysterectomy JJ O
plus CC O
vaginal JJ O
radium NN O
, , O
and CC O
uterine JJ O
radium NN O
plus CC O
hysterectomy NN O
in IN O
stage NN O
I PRP O
endometrial JJ O
carcinoma NN O
. . O

In IN O
order NN O
to TO O
delineate VB O
structural JJ O
motifs NNS O
regulating VBG O
substrate JJ O
affinity NN O
and CC O
recognition NN O
for IN O
the DT O
human JJ B-Gene
dopamine NN I-Gene
transporter NN I-Gene
( ( O
DAT NNP B-Gene
) ) O
, , O
we PRP O
assessed VBD O
[ $ O
3H CD O
] NNP O
dopamine NN O
uptake NN O
kinetics NNS O
and CC O
[ $ O
3H CD O
] NNP O
CFT NNP O
binding VBG O
characteristics NNS O
of IN O
COS NNP O
- : O
7 CD O
cells NNS O
transiently RB O
expressing VBG O
mutant JJ B-Gene
DATs NNP I-Gene
in IN O
which WDT O
the DT O
COOH NNP O
terminus NN O
was VBD O
truncated VBN O
or CC O
substituted VBN O
. . O

A DT O
recombinant JJ O
vector NN O
, , O
p410 NN O
+ NN O
, , O
was VBD O
constructed VBN O
which WDT O
carried VBD O
the DT O
BamHI NNP B-Gene
- : I-Gene
K NNP I-Gene
fragment NN I-Gene
( ( O
nucleotides JJ O
107565 CD O
to TO O
112625 CD O
of IN O
the DT O
B95 NNP O
- : O
8 CD O
strain NN O
, , O
encoding VBG O
the DT O
EBV NNP O
- : O
associated VBN O
nuclear JJ O
antigen NN O
EBNA NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
the DT O
cis NN O
- : O
acting VBG O
sequence NN O
from IN O
the DT O
BamHI NNP B-Gene
- : I-Gene
C NNP I-Gene
fragment NN I-Gene
, , O
and CC O
a DT O
dominant JJ O
selectable JJ O
marker NN O
gene NN O
encoding VBG O
G NNP O
- : O
418 CD O
resistance NN O
in IN O
animal JJ O
cells NNS O
. . O

As IN O
well RB O
, , O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : O
induced JJ O
expression NN O
of IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
its PRP$ O
binding NN O
to TO O
the DT O
IRF NNP B-Gene
element NN I-Gene
is VBZ O
inhibited VBN O
. . O

Range NNP O
, , O
variations NNS O
and CC O
neoplastic JJ O
potential NN O
. . O

Studies NNS O
on IN O
powdered JJ O
preparations NNS O
. . O

Two CD O
new JJ O
glucosidase NN B-Gene
inhibitors NNS O
( ( O
BAY NNP O
m NN O
1099 CD O
and CC O
BAY NNP O
o IN O
1248 CD O
) ) O
were VBD O
studied VBN O
in IN O
volunteers NNS O
and CC O
type NN O
II NNP O
diabetics NNS O
under IN O
various JJ O
conditions NNS O
. . O

cDNA NN O
cloning NN O
, , O
expression NN O
analysis NN O
, , O
and CC O
chromosomal JJ O
localization NN O
of IN O
a DT O
gene NN O
with IN O
high JJ O
homology NN O
to TO O
wheat VB B-Gene
eIF JJ I-Gene
- : I-Gene
( ( I-Gene
iso NN I-Gene
) ) I-Gene
4F CD I-Gene
and CC O
mammalian JJ B-Gene
eIF NN I-Gene
- : I-Gene
4G CD I-Gene
. . O

Specifically RB O
, , O
by IN O
the DT O
type NN O
of IN O
adjuvant JJ O
therapy NN O
, , O
the DT O
median JJ O
disease NN O
- : O
free JJ O
interval NN O
and CC O
survival NN O
from IN O
stage NN O
IVA NNP O
for IN O
23 CD O
patients NNS O
receiving VBG O
Corynebacterium NNP O
parvum NN O
were VBD O
6 CD O
. . O
9 CD O
and CC O
19 CD O
months NNS O
; : O
for IN O
39 CD O
patients NNS O
receiving VBG O
BCG NNP O
, , O
eight CD O
months NNS O
and CC O
26 CD O
months NNS O
; : O
for IN O
24 CD O
patients NNS O
receiving VBG O
BCG NNP O
+ NNP O
DTIC NNP O
, , O
eight CD O
and CC O
17 CD O
. . O
4 CD O
months NNS O
; : O
and CC O
for IN O
all DT O
51 CD O
DTIC NNP O
treated VBD O
patients NNS O
6 CD O
. . O
3 CD O
and CC O
17 CD O
. . O
8 CD O
months NNS O
, , O
respectively RB O
. . O

We PRP O
have VBP O
screened VBN O
the DT O
elastin NN B-Gene
gene NN I-Gene
for IN O
mutations NNS O
responsible JJ O
for IN O
supravalvular JJ O
aortic JJ O
stenosis NN O
( ( O
SVAS NNP O
) ) O
in IN O
two CD O
large JJ O
, , O
independently RB O
collected VBN O
families NNS O
with IN O
isolated JJ O
( ( O
nonsyndromic JJ O
) ) O
SVAS NNP O
. . O

Native JJ O
human JJ B-Gene
fibrinogen NN I-Gene
was VBD O
brought VBN O
to TO O
coagulation NN O
by IN O
adding VBG O
thrombin NN B-Gene
. . O

Ultrastructure NN O
of IN O
the DT O
tumor NN O
in IN O
1 CD O
patient NN O
in IN O
whom WP O
transurethral JJ O
resection NN O
was VBD O
performed VBN O
2 CD O
weeks NNS O
after IN O
alum JJ O
irrigation NN O
revealed VBD O
well RB O
preserved VBN O
nuclear JJ O
chromatin NN O
, , O
thus RB O
, , O
suggesting VBG O
that IN O
whatever WDT O
changes NNS O
occur VBP O
after IN O
alum NN O
irrigation NN O
are VBP O
short JJ O
- : O
lived VBD O
. . O

Use NNP O
of IN O
a DT O
dual JJ O
- : O
pulse NN O
lithotripter NN O
to TO O
generate VB O
a DT O
localized JJ O
and CC O
intensified JJ O
cavitation NN O
field NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
DNA NNP O
methylation NN O
, , O
chromatin NN O
structure NN O
, , O
and CC O
transactivation NN O
at IN O
an DT O
Sp1 NNP B-Gene
site NN I-Gene
contribute NN O
to TO O
the DT O
highly RB O
restricted JJ O
expression NN O
of IN O
this DT O
myelomonocytic JJ O
lineage NN O
specific JJ O
gene NN O
. . O

A DT O
twelfth JJ O
insertion NN O
disrupts NNS O
two CD O
genes NNS O
, , O
Nrk NNP B-Gene
, , O
a DT O
"""" NN B-Gene
neurospecific JJ I-Gene
"""" NNP I-Gene
receptor NN I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
, , O
and CC O
Tpp NNP B-Gene
, , O
which WDT O
encodes VBZ O
a DT O
neuropeptidase NN B-Gene
. . O

We PRP O
tested VBD O
10 CD O
rats NNS O
with IN O
electrophysiologically RB O
guided VBN O
, , O
ibotenic JJ O
acid NN O
lesions NNS O
of IN O
the DT O
PBN NNP O
( ( O
PBNx NNP O
) ) O
to TO O
determine VB O
whether IN O
they PRP O
could MD O
acquire VB O
a DT O
LiCl NNP O
- : O
induced VBD O
CTA NNP O
to TO O
l VB O
- : O
alanine NN O
( ( O
0 CD O
. . O
3 CD O
M NNP O
) ) O
or CC O
demonstrate VB O
a DT O
sodium NN O
appetite NN O
following VBG O
furosemide JJ O
treatment NN O
and CC O
overnight JJ O
access NN O
to TO O
sodium VB O
deficient JJ O
chow NN O
. . O

However RB O
, , O
the DT O
published VBN O
reports NNS O
consist NN O
of IN O
a DT O
small JJ O
number NN O
of IN O
patients NNS O
and CC O
limited JJ O
data NNS O
. . O

Exposure NN O
to TO O
hepatitis VB O
B NNP O
virus NN O
in IN O
the DT O
general JJ O
population NN O
of IN O
Hisayama NNP O
, , O
Japan NNP O
: : O
significance NN O
of IN O
isolated JJ O
antibody NN O
to TO O
hepatitis VB B-Gene
B NNP I-Gene
surface NN I-Gene
antigen NN I-Gene
in IN O
general JJ O
population NN O
. . O

This DT O
motif NN O
is VBZ O
similar JJ O
to TO O
but CC O
distinct JJ O
from IN O
the DT O
LIM NNP B-Gene
domain NN I-Gene
and CC O
the DT O
RING NNP B-Gene
finger NN I-Gene
family NN I-Gene
, , O
and CC O
is VBZ O
reminiscent JJ O
of IN O
known VBN O
metal NN O
- : O
binding NN O
regions NNS O
. . O

Transfection NN O
and CC O
in IN O
vitro JJ O
binding NN O
studies NNS O
identified VBN O
within IN O
HEFT1 NNP B-Gene
a DT I-Gene
promoter NN I-Gene
whose WP$ O
basal NN O
activity NN O
required VBD O
a DT O
GC NNP O
box NN O
activated VBN O
by IN O
Sp1 NNP B-Gene
or CC O
Sp3 NNP B-Gene
. . O

Synovial JJ O
cysts NNS O
of IN O
the DT O
hip NN O
joint NN O

A DT O
protein NN O
footprint NN O
also RB O
was VBD O
identified VBN O
for IN O
a DT O
GC NNP O
box NN O
element NN O
at IN O
nucleotides NNS O
- : O
59 CD O
to TO O
- : O
45 CD O
. . O

ORFA NNP O
and CC O
ccdA NN B-Gene
were VBD O
constitutively RB O
cotranscribed VBN O
as IN O
determined VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
. . O

Identification NN O
of IN O
Ets NNP B-Gene
- : O
and CC O
notch VB B-Gene
- : O
related JJ O
subunits NNS O
in IN O
GA NNP B-Gene
binding VBG I-Gene
protein NN I-Gene
. . O

Fourth NN O
, , O
the DT O
3 CD O
' POS O
- : O
region NN O
splice NN O
junctions NNS O
of IN O
the DT O
MSRs NNP B-Gene
during IN O
latent NN O
and CC O
productive JJ O
infection NN O
were VBD O
determined VBN O
by IN O
sequencing VBG O
RNA NNP O
- : O
PCR NN O
products NNS O
generated VBN O
with IN O
primers NNS O
that WDT O
flank VBD O
the DT O
3 CD O
' POS O
splice JJ O
region NN O
. . O

Significantly RB O
greater JJR O
improvement NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
in IN O
the DT O
sertraline NN O
group NN O
first RB O
became VBD O
apparent JJ O
by IN O
the DT O
end NN O
of IN O
week NN O
3 CD O
on IN O
the DT O
Y NNP O
- : O
BOCS NNP O
and CC O
the DT O
CGI NNP O
Improvement NNP O
scale NN O
, , O
and CC O
by IN O
the DT O
end NN O
of IN O
weeks NNS O
6 CD O
and CC O
8 CD O
, , O
respectively RB O
, , O
on IN O
the DT O
NIMH NNP O
and CC O
CGI NNP O
Severity NNP O
scale NN O
. . O

Although IN O
within IN O
normal JJ O
limits NNS O
, , O
latency NN O
was VBD O
high JJ O
. . O

Km NNP O
values NNS O
for IN O
ammonium NN O
, , O
2 CD O
- : O
oxoglutarate NN O
, , O
NADH NNP O
, , O
glutamate NN O
and CC O
NAD NNP O
+ NNP O
were VBD O
6 CD O
. . O
5 CD O
, , O
3 CD O
. . O
5 CD O
, , O
0 CD O
. . O
6 CD O
, , O
37 CD O
. . O
1 CD O
and CC O
0 CD O
. . O
46 CD O
mM NN O
, , O
respectively RB O
. . O

Chronotherapeutics NNS O
in IN O
cardiovascular JJ O
disease NN O
. . O

In IN O
contrast NN O
, , O
both DT O
Sp1 NNP B-Gene
and CC O
ETS NNP B-Gene
proteins NNS I-Gene
are VBP O
required VBN O
to TO O
bring VB O
about RP O
full JJ O
promoter NN O
activity NN O
in IN O
the DT O
Surf NNP B-Gene
- : I-Gene
1 CD I-Gene
direction NN O
. . O

Translation NN O
of IN O
the DT O
coding NN O
segment NN O
, , O
which WDT O
was VBD O
designated VBN O
MsPRP2 NNP B-Gene
, , O
suggested VBD O
it PRP O
encodes VBZ O
a DT O
chimeric JJ O
40 CD O
, , O
569 CD O
Da NNP O
cell NN O
wall NN O
protein NN O
with IN O
an DT O
amino NN O
- : O
terminal JJ O
signal JJ O
sequence NN O
, , O
a DT O
repetitive JJ O
proline NN O
- : O
rich JJ O
sequence NN O
, , O
and CC O
a DT O
cysteine NN O
- : O
rich JJ O
carboxyl NN O
- : O
terminal JJ O
sequence NN O
homologous JJ O
to TO O
nonspecific JJ O
lipid JJ O
transfer NN O
proteins NNS O
. . O

In IN O
patients NNS O
resistant JJ O
to TO O
VAD NNP O
, , O
high JJ O
- : O
dose JJ O
therapies NNS O
with IN O
intravenous JJ O
melphalan NN O
, , O
a DT O
CBV NNP O
combination NN O
( ( O
cyclophosphamide JJ O
- : O
BCNU NNP O
- : O
VP NNP O
- : O
16 CD O
) ) O
or CC O
an DT O
EDAP JJ O
regimen NNS O
( ( O
VP NNP O
- : O
16 CD O
- : O
platinum NN O
) ) O
produced VBD O
responses NNS O
in IN O
about RB O
40 CD O
% NN O
of IN O
patients NNS O
. . O

These DT O
results NNS O
establish VB O
that DT O
hydroquinones NNS O
lead VBP O
to TO O
mutagenicity NN O
and CC O
carcinogenicity NN O
. . O

Calmodulin NNP B-Gene
- : I-Gene
binding NN I-Gene
peptide NN I-Gene
( ( O
CBP NNP B-Gene
) ) O
, , O
a DT O
peptide NN O
of IN O
26 CD O
amino JJ O
acids NNS O
derived VBN O
from IN O
muscle NN B-Gene
myosin NN I-Gene
light NN I-Gene
chain NN I-Gene
kinase NN I-Gene
( ( O
MLCK NNP B-Gene
) ) O
, , O
binds VBZ O
to TO O
calmodulin VB B-Gene
with IN O
nanomolar JJ O
affinity NN O
. . O

The DT O
full JJ O
protocol NN O
was VBD O
completed VBN O
by IN O
33 CD O
patients NNS O
( ( O
45 CD O
% NN O
of IN O
original JJ O
cohort NN O
) ) O
. . O

The DT O
effect NN O
of IN O
site NN O
- : O
specific JJ O
mutations NNS O
in IN O
the DT O
mouse NN B-Gene
platelet NN I-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( I-Gene
PDGF NNP I-Gene
) ) I-Gene
beta SYM I-Gene
- : I-Gene
receptor NN I-Gene
on IN O
activation NN O
of IN O
the DT O
Na NNP B-Gene
+ NNP I-Gene
/ NNP I-Gene
H NNP I-Gene
+ NNP I-Gene
exchanger NN I-Gene
was VBD O
examined VBN O
in IN O
normal JJ O
murine NN O
mammary JJ O
gland NN O
epithelial NN O
( ( O
NMuMG NNP O
) ) O
and CC O
Chinese JJ O
hamster NN O
ovary JJ O
( ( O
CHO NNP O
) ) O
cells NNS O
. . O

In IN O
AcMNPV NNP O
- : O
infected VBD O
Sf9 NNP O
cells NNS O
, , O
late JJ O
transcription NN O
initiation NN O
is VBZ O
detected VBN O
from IN O
only RB O
two CD O
upstream JJ O
TAAG NNP O
sites NNS O
and CC O
not RB O
from IN O
three CD O
downstream NN O
TAAG NNP O
sites VBZ O
. . O

Radiogallium NN O
imaging NN O
is VBZ O
thus RB O
of IN O
limited JJ O
use NN O
in IN O
evaluation NN O
of IN O
suspected JJ O
giant JJ O
cell NN O
tumors NNS O
of IN O
bone NN O
. . O

ACTH NNP B-Gene
release NN O
is VBZ O
transiently RB O
suppressed VBN O
in IN O
some DT O
children NNS O
after IN O
exogenous JJ O
ACTH NNP B-Gene
treatment NN O
. . O

Finally RB O
, , O
a DT O
chromogenic JJ O
method NN O
was VBD O
used VBN O
, , O
based VBN O
on IN O
thrombin JJ B-Gene
inhibition NN O
and CC O
the DT O
substrate NN O
S NNP O
- : O
2238 CD O
. . O

Cardiovascular JJ O
risk NN O
factors NNS O
and CC O
antihypertensive JJ O
treatment NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
BACM NNP O
has VBZ O
antiplaque NN O
and CC O
stronger JJR O
antidegradation NN O
effects NNS O
than IN O
GLCM NNP O
. . O

DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
of IN O
the DT O
proximal JJ O
promoter NN O
revealed VBD O
four CD O
regions NNS O
of IN O
protection NN O
. . O

Thus RB O
, , O
quantitative JJ O
analysis NN O
of IN O
thallium NN O
- : O
201 CD O
uptake NN O
and CC O
washout NN O
provided VBD O
objective JJ O
evidence NN O
for IN O
improved JJ O
myocardial JJ O
perfusion NN O
after IN O
coronary JJ O
angioplasty NN O
. . O

Severe JJ O
hemolysis NN O
resulted VBD O
in IN O
statistically RB O
significant JJ O
changes NNS O
in IN O
the DT O
mean JJ O
values NNS O
of IN O
the DT O
above JJ O
analytes NNS O
in IN O
addition NN O
to TO O
the DT O
following JJ O
increases NNS O
: : O
alanine NN B-Gene
aminotransferase NN I-Gene
, , O
calcium NN O
, , O
and CC O
serum NN B-Gene
globulins NNS I-Gene
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
albumin $ B-Gene
and CC O
total JJ O
protein NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Theories NNS O
proffered VBD O
to TO O
account VB O
for IN O
the DT O
modality NN O
shift NN O
effect NN O
are VBP O
critically RB O
evaluated VBN O
. . O

Infect NNP O
. . O

TB NNP O
bone NN O
area NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
height NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
years NNS O
in IN O
present JJ O
colony NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
3 CD O
) ) O
, , O
and CC O
menses NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
predicted VBD O
TB NNP O
BMC NNP O
. . O

Current JJ O
status NN O
of IN O
telepathology NN O
. . O

Although IN O
noninhibitory JJ O
fluid NN O
had VBD O
higher JJR O
mean JJ O
concentrations NNS O
of IN O
phosphorus NN O
and CC O
zinc NN O
, , O
these DT O
differences NNS O
did VBD O
not RB O
hold VB O
after IN O
meconium JJ O
- : O
stained VBN O
samples NNS O
were VBD O
excluded VBN O
. . O

The DT O
second JJ O
group NN O
of IN O
homologous JJ O
elements NNS O
is VBZ O
present JJ O
in IN O
the DT O
upstream JJ O
region NN O
of IN O
both DT O
genes NNS O
. . O

Thus RB O
, , O
blocks NNS O
in IN O
the DT O
RARalpha NNP B-Gene
- : O
specific JJ O
pathway NN O
of IN O
retinoid JJ O
- : O
induced JJ O
differentiation NN O
may MD O
be VB O
bypassed VBN O
during IN O
retinoid JJ O
induction NN O
of IN O
FR NNP B-Gene
- : I-Gene
beta NN I-Gene
expression NN O
. . O

While IN O
the DT O
latter NN O
corresponded VBD O
to TO O
a DT O
protein NN O
of IN O
824 CD O
amino NN O
acids NNS O
, , O
an DT O
upstream JJ O
open JJ O
reading NN O
frame NN O
( ( O
uORF JJ O
) ) O
within IN O
the DT O
5 CD O
' POS O
leader NN O
could MD O
potentially RB O
encode VB O
a DT O
54 CD O
amino NN O
acid NN O
peptide NN O
. . O

A DT O
38 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
ulcerative JJ O
colitis NN O
subsequently RB O
developed VBD O
sarcoidosis NN O
. . O

Diltiazem NNP O
caused VBD O
significant JJ O
decrease NN O
in IN O
the DT O
ventricular JJ O
response NN O
without IN O
conversion NN O
to TO O
sinus VB O
rhythm NN O
. . O

Several JJ O
features NNS O
of IN O
10 CD O
. . O
24 CD O
. . O
6 CD O
cells NNS O
suggest VBP O
that IN O
the DT O
mutation NN O
disrupts VBZ O
normal JJ O
intracellular JJ O
formation NN O
of IN O
peptide NN B-Gene
/ NNP I-Gene
DR NNP I-Gene
complexes NNS I-Gene
. . O

cDNA NN O
clones NNS O
encoding VBG O
Arabidopsis NNP O
thaliana NN O
and CC O
Zea NNP B-Gene
mays VBZ I-Gene
mitochondrial JJ I-Gene
chaperonin NN I-Gene
HSP60 NNP B-Gene
and CC O
gene NN O
expression NN O
during IN O
seed NN O
germination NN O
and CC O
heat NN O
shock NN O
. . O

Competitionsupershift NNP O
EMSA NNP O
assays VBZ O
revealed VBD O
that IN O
multiple JJ O
proteins NNS O
were VBD O
involved VBN O
in IN O
bandshift NN O
complex JJ O
formation NN O
with IN O
KCS NNP B-Gene
, , O
one CD O
of IN O
which WDT O
was VBD O
identified VBN O
as IN O
factor NN O
Sp1 NNP O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
identify VBP O
and CC O
characterize VBP O
two CD O
overlapping VBG O
ELL NNP B-Gene
functional JJ I-Gene
domains NNS I-Gene
that WDT O
govern VBP O
its PRP$ O
interaction NN O
with IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
and CC O
the DT O
ternary JJ O
elongation NN O
complex NN O
. . O

In IN O
patients NNS O
who WP O
were VBD O
not RB O
vented VBN O
, , O
there EX O
was VBD O
overall JJ O
significant JJ O
depression NN O
of IN O
function NN O
( ( O
67 CD O
+ NN O
/ NNP O
- : O
5 CD O
% NN O
of IN O
control NN O
; : O
range NN O
, , O
91 CD O
- : O
- : O
45 CD O
% NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Sequencing VBG O
analysis NN O
revealed VBD O
that IN O
the DT O
0 CD O
. . O
54 CD O
- : O
and CC O
0 CD O
. . O
4 CD O
- : O
kb NN O
fragments NNS O
are VBP O
identical JJ O
except IN O
for IN O
150 CD O
nucleotides NNS O
missing VBG O
at IN O
the DT O
5 CD O
' POS O
region NN O
of IN O
the DT O
0 CD O
. . O
4 CD O
- : O
kb NN O
fragment NN O
. . O

Furthermore RB O
, , O
hormonal JJ O
regulation NN O
of IN O
G NNP O
( ( O
1 CD O
) ) O
gene NN O
transcription NN O
can MD O
occur VB O
even RB O
without IN O
additional JJ O
activation NN O
of IN O
the DT O
Mek NNP B-Gene
- : O
Erk1 NNP B-Gene
/ VBZ I-Gene
2 CD I-Gene
pathway NN O
by IN O
estrogen NN B-Gene
receptors NNS I-Gene
. . O

The DT O
end NN O
- : O
stage NN O
or CC O
involutional JJ O
phase NN O
of IN O
proliferative JJ O
diabetic JJ O
retinopathy NN O
may MD O
result VB O
in IN O
stabilization NN O
of IN O
vision NN O
for IN O
long JJ O
periods NNS O
of IN O
time NN O
. . O

Cerebro NNP O
- : O
oculo SYM O
- : O
facioskeletal JJ O
syndrome NN O
( ( O
Pena NNP O
- : O
Shokeir NNP O
syndrome VB O
II NNP O
) ) O

Psychological JJ O
examinations NNS O
in IN O
patients NNS O
with IN O
chronic JJ O
kidney NN O
insufficiency NN O

VP5 NNP B-Gene
, , O
which WDT O
encodes VBZ O
the DT O
major JJ B-Gene
capsid NN I-Gene
protein NN I-Gene
, , O
each DT O
fused VBN O
to TO O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
gene NN I-Gene
. . O

For IN O
the DT O
study NN O
of IN O
the DT O
transition NN O
of IN O
long JJ O
to TO O
short VB O
waves NNS O
( ( O
deep JJ O
- : O
water NN O
waves NNS O
) ) O
a DT O
closed JJ O
- : O
form NN O
solution NN O
is VBZ O
advantageous JJ O
; : O
this DT O
can MD O
, , O
however RB O
, , O
only RB O
be VB O
obtained VBN O
at IN O
the DT O
cost NN O
of IN O
further JJ O
simplification NN O
. . O

The DT O
association NN O
of IN O
p255 NN B-Gene
with IN O
splicing VBG O
complexes NNS O
is VBZ O
suggested VBN O
by IN O
the DT O
finding NN O
that WDT O
mAb VBZ B-Gene
CC3 NNP I-Gene
can MD O
inhibit VB O
in IN O
vitro JJ O
splicing NN O
and CC O
immunoprecipitate NN O
pre NN O
- : O
messenger NN O
RNA NNP O
and CC O
splicing VBG O
products NNS O
. . O

To TO O
our PRP$ O
knowledge NN O
, , O
type NN O
IV NNP O
renal JJ O
tubular NN O
acidosis NN O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
in IN O
association NN O
with IN O
Alport NNP O
' POS O
s JJ O
syndrome NN O
in IN O
an DT O
adult NN O
patient NN O
. . O

Expression NN O
and CC O
characterization NN O
of IN O
recombinant JJ B-Gene
single JJ I-Gene
- : I-Gene
chain NN I-Gene
Fv NNP I-Gene
and CC O
Fv NNP B-Gene
fragments NNS I-Gene
derived VBN O
from IN O
a DT O
set NN O
of IN O
catalytic JJ O
antibodies NNS O
. . O

Retinoids NNS O
participate NN O
in IN O
the DT O
onset NN O
of IN O
differentiation NN O
, , O
apoptosis NN O
and CC O
the DT O
inhibition NN O
of IN O
growth NN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
normal JJ O
and CC O
cancerous JJ O
cells NNS O
. . O

Furthermore RB O
, , O
experiments NNS O
with IN O
32D CD O
temperature NN O
- : O
sensitive JJ O
p53 NN B-Gene
cells NNS O
indicate VBP O
that IN O
aberrant JJ O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
at IN O
the DT O
permissive JJ O
temperature NN O
does VBZ O
not RB O
exert VB O
a DT O
proliferative JJ O
effect NN O
but CC O
causes VBZ O
p53 JJ B-Gene
- : O
mediated VBN O
apoptosis NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
the DT O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
proliferative JJ O
effect NN O
depends VBZ O
on IN O
the DT O
integrity NN O
of IN O
the DT O
cell NN O
cycle NN O
checkpoints NNS O
of IN O
the DT O
host NN O
cell NN O
, , O
as IN O
observed VBN O
for IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
and CC O
other JJ O
oncogenes NNS O
. . O

tal JJ B-Gene
- : I-Gene
1 CD I-Gene
mutant JJ I-Gene
experiments NNS O
indicate VBP O
that IN O
ectopic NN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
effects NNS O
are VBP O
mediated VBN O
by IN O
both DT O
the DT O
DNA NNP O
- : O
binding NN O
and CC O
the DT O
heterodimerization NN O
domains NNS O
, , O
while IN O
the DT O
N NNP B-Gene
- : I-Gene
terminally RB I-Gene
truncated VBN I-Gene
tal JJ I-Gene
- : I-Gene
1 CD I-Gene
variant NN I-Gene
( ( O
M3 NNP B-Gene
) ) O
expressed VBD O
in IN O
T NNP O
- : O
ALL DT O
malignant JJ O
cells NNS O
mimics VBZ O
the DT O
effects NNS O
of IN O
the DT O
wild JJ O
- : O
type NN O
protein NN O
. . O

Mobilization NN O
with IN O
cyclophosphamide NN O
and CC O
granulocyte NN B-Gene
- : I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
was VBD O
effective JJ O
in IN O
terms NNS O
of IN O
CD34 NNP B-Gene
+ NNP I-Gene
cell NN O
shift NN O
to TO O
peripheral JJ O
blood NN O
and CC O
the DT O
good JJ O
quality NN O
autograft NN O
reliably RB O
led VBD O
to TO O
haematopoetic JJ O
recovery NN O
after IN O
megachemotherapy NN O
. . O

Experimental JJ O
reproduction NN O
of IN O
malignant JJ O
catarrhal NN O
fever NN O
in IN O
Bali NNP O
cattle NNS O

The DT O
corn NN O
and CC O
mineral JJ O
oil NN O
emulsions NNS O
were VBD O
almost RB O
as RB O
effective JJ O
as IN O
milk NN O
but CC O
less RBR O
effective JJ O
than IN O
sucrose RB O
( ( O
0 CD O
. . O
3M CD O
) ) O
in IN O
stimulating VBG O
ingestion NN O
. . O

The DT O
results NNS O
show VBP O
that IN O
nerve NN O
and CC O
roots NNS O
differ VBP O
considerably RB O
both DT O
in IN O
the DT O
force NN O
they PRP O
sustain VBP O
before IN O
failure NN O
and CC O
in IN O
the DT O
other JJ O
biomechanics NNS O
they PRP O
exhibit VBP O
. . O

In IN O
addition NN O
, , O
the DT O
regulation NN O
of IN O
Glvr NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
expression NN O
also RB O
has VBZ O
potential JJ O
applications NNS O
to TO O
gene NN O
therapy NN O
, , O
since IN O
retroviral JJ O
vectors NNS O
carrying VBG O
gibbon NN B-Gene
ape NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
envelope NN I-Gene
proteins NNS I-Gene
are VBP O
used VBN O
for IN O
gene NN O
delivery NN O
into IN O
different JJ O
cell NN O
types NNS O
. . O

Temperature NN O
measurement NN O
in IN O
microfluidic JJ O
systems NNS O
using VBG O
a DT O
temperature NN O
- : O
dependent JJ O
fluorescent NN O
dye NN O
. . O

Nucleotide NNP O
sequence NN O
, , O
transcription NN O
map NN O
, , O
and CC O
mutation NN O
analysis NN O
of IN O
the DT O
13q14 CD O
chromosomal JJ O
region NN O
deleted VBN O
in IN O
B NNP O
- : O
cell NN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
. . O

Male JJ B-Gene
- : I-Gene
enhanced VBN I-Gene
antigen JJ I-Gene
gene NN I-Gene
is VBZ O
phylogenetically RB O
conserved VBN O
and CC O
expressed VBN O
at IN O
late JJ O
stages NNS O
of IN O
spermatogenesis NN O
. . O

The DT O
incidence NN O
of IN O
DNCB NNP O
reactions NNS O
was VBD O
78 CD O
per IN O
cent NN O
for IN O
Stage NNP O
I PRP O
and CC O
II NNP O
cancers NNS O
( ( O
37 CD O
patinets NNS O
) ) O
, , O
73 CD O
per IN O
cent NN O
for IN O
resectable JJ O
Stage NNP O
III NNP O
cancer NN O
( ( O
22 CD O
patients NNS O
) ) O
, , O
and CC O
66 CD O
per IN O
cent NN O
in IN O
patients NNS O
with IN O
unresectable JJ O
or CC O
inoperable JJ O
Stage NNP O
III NNP O
cancer NN O
. . O

The DT O
decrements NNS O
in IN O
cerebrovascular JJ O
resistance NN O
induced VBN O
by IN O
hexamethonium NN O
, , O
in IN O
mm JJ O
Hg NNP O
ml NN O
( ( O
- : O
1 CD O
) ) O
. . O
min NN O
( ( O
- : O
1 CD O
) ) O
, , O
were VBD O
: : O
under IN O
control NN O
. . O

Treatment NN O
of IN O
human JJ O
myeloid NN O
cell NN O
lines NNS O
HL NNP O
- : O
60 CD O
and CC O
U937 NNP O
with IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
increased VBD O
within IN O
2 CD O
h NNS O
cellular JJ O
levels NNS O
of IN O
the DT O
RNA NNP O
hybridizable JJ O
to TO O
LD78 NNP B-Gene
cDNA NN I-Gene
. . O

After IN O
6 CD O
months NNS O
, , O
definite JJ O
improvement NN O
in IN O
strength NN O
occurred VBD O
in IN O
4 CD O
of IN O
7 CD O
carnitine NN O
- : O
treated JJ O
patients NNS O
and CC O
in IN O
none NN O
of IN O
7 CD O
controls NNS O
. . O

Responsibility NN O
matters NNS O
- : O
- : O
this DT O
is VBZ O
a DT O
scientific JJ O
council NN O

We PRP O
have VBP O
utilized VBN O
the DT O
human JJ B-Gene
4F2 CD I-Gene
heavy NN I-Gene
chain NN I-Gene
( ( O
4F2HC CD B-Gene
) ) O
gene NN O
as IN O
a DT O
model NN O
system NN O
in IN O
studies NNS O
designed VBN O
to TO O
elucidate VB O
the DT O
molecular JJ O
events NNS O
involved VBN O
in IN O
regulating VBG O
inducible JJ O
gene NN O
expression NN O
during IN O
normal JJ O
human JJ O
T NNP O
- : O
cell NN O
activation NN O
. . O

Isolation NN O
of IN O
a DT O
near JJ O
full JJ O
- : O
length NN O
cDNA NN O
from IN O
a DT O
human JJ O
fetal NN O
brain NN O
cDNA NN O
library NN O
revealed VBD O
a DT O
protein NN B-Gene
serine NN I-Gene
- : I-Gene
threonine NN I-Gene
phosphatase NN I-Gene
with IN O
a DT O
tetratricopeptide NN O
motif NN O
, , O
almost RB O
identical JJ O
to TO O
human JJ B-Gene
PPP5C NNP I-Gene
( ( O
PP5 NNP B-Gene
) ) O
and CC O
highly RB O
homologous JJ O
to TO O
rat VB B-Gene
PPT NNP I-Gene
. . O

CONCLUSION NN O
: : O
SPT NN O
is VBZ O
more RBR O
useful JJ O
than IN O
WST NNP O
in IN O
differentiating VBG O
patients NNS O
predisposed VBN O
to TO O
aspiration NN O
. . O

In IN O
vitro JJ O
transcription NN O
extracts NNS O
from IN O
ret1 JJ B-Gene
- : I-Gene
1 CD I-Gene
cells NNS O
terminate JJ O
less RBR O
efficiently RB O
at IN O
weak JJ O
transcription NN O
termination NN O
signals NNS O
than IN O
those DT O
from IN O
RET1 NNP B-Gene
cells NNS O
, , O
using VBG O
a DT O
variety NN O
of IN O
tRNA JJ O
templates NNS O
. . O

In IN O
order NN O
to TO O
better JJR O
characterize VB O
the DT O
distribution NN O
of IN O
ML NNP O
and CC O
MAP NNP O
estimates NNS O
under IN O
these DT O
conditions NNS O
, , O
we PRP O
derive VBP O
a DT O
point NN O
approximation NN O
to TO O
density NN O
values NNS O
of IN O
the DT O
conditional JJ O
distribution NN O
of IN O
such JJ O
estimates NNS O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURE NNP O
: : O
A DT O
positive JJ O
test NN O
result NN O
for IN O
gonococcal JJ O
or CC O
chlamydial JJ O
infection NN O
by IN O
the DT O
ligase NN B-Gene
chain NN O
reaction NN O
assay VBP O
; : O
secondary JJ O
outcome NN O
measure NN O
was VBD O
a DT O
positive JJ O
test NN O
result NN O
for IN O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
. . O

Phylogenetic JJ O
position NN O
of IN O
the DT O
Phacotaceae NNP O
within IN O
the DT O
Chlamydophyceaeas NNP O
revealed VBN O
by IN O
analysis NN O
of IN O
18S CD B-Gene
rDNA NN I-Gene
and CC O
rbcL NN B-Gene
sequences NNS I-Gene
. . O

Stress NNP B-Gene
- : I-Gene
activated VBD I-Gene
protein JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
( ( O
SAPK1 NNP B-Gene
) ) O
, , O
also RB O
called VBD O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
, , O
becomes RB O
activated VBN O
in IN O
vivo NN O
in IN O
response NN O
to TO O
pro VB O
- : O
inflammatory NN O
cytokines NNS O
or CC O
cellular JJ O
stresses NNS O
. . O

Gene NNP O
constructs NNS O
consisting VBG O
of IN O
human JJ B-Gene
growth NN I-Gene
hormone NN I-Gene
( ( O
hGH NN B-Gene
) ) O
gene NN O
driven VBN O
by IN O
promoter NN O
/ NNP O
regulatory JJ O
sequence NN O
of IN O
mouse NN B-Gene
metallothionein NN I-Gene
( ( O
mMT NN B-Gene
) ) O
, , O
viral JJ B-Gene
thymidine NN I-Gene
kinase NN I-Gene
( ( O
vTK NN B-Gene
) ) O
, , O
rat FW B-Gene
cholecystokinin NN I-Gene
( ( O
rCCK NN B-Gene
) ) O
, , O
or CC O
chicken VB B-Gene
beta SYM I-Gene
- : I-Gene
actin NN I-Gene
( ( O
cBA NN B-Gene
) ) O
gene NN O
were VBD O
injected VBN O
into IN O
the DT O
cytoplasm NN O
of IN O
fertilized JJ O
medaka NN O
eggs NNS O
via IN O
the DT O
micropyle NN O
. . O

Transient NNP O
tyrosine JJ O
phosphorylation NN O
of IN O
Crk NNP B-Gene
in IN O
fibroblast JJ B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
2 CD I-Gene
- : O
stimulated VBN O
endothelial JJ O
cells NNS O
was VBD O
dependent JJ O
on IN O
the DT O
juxtamembrane NN O
tyrosine NN O
residue JJ O
463 CD O
in IN O
FGFR NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
a DT O
Crk NNP B-Gene
SH2 NNP B-Gene
domain NN I-Gene
precipitated VBD O
FGFR NNP B-Gene
- : I-Gene
1 CD I-Gene
via IN O
phosphorylated VBN O
Tyr NNP O
- : O
463 CD O
, , O
indicating VBG O
direct JJ O
complex JJ O
formation NN O
between IN O
Crk NNP B-Gene
and CC O
FGFR NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
perioperative JJ O
mortality NN O
of IN O
all DT O
patients NNS O
was VBD O
1 CD O
. . O
9 CD O
% NN O
, , O
the DT O
mortality NN O
of IN O
patients NNS O
older JJR O
than IN O
70 CD O
years NNS O
was VBD O
4 CD O
. . O
3 CD O
% NN O
. . O

Based VBN O
on IN O
213 CD O
determinations NNS O
, , O
the DT O
control NN O
mean JJ O
serum NN B-Gene
CPK NNP I-Gene
activity NN O
was VBD O
262 CD O
+ JJ O
/ NNP O
- : O
113 CD O
I PRP O
. . O
U NNP O
. . O
/ NN O
liter NN O
. . O

Interestingly RB O
, , O
the DT O
similarities NNS O
with IN O
the DT O
endophilin NN B-Gene
proteins VBZ I-Gene
cover VB O
the DT O
entire JJ O
sequence NN O
of IN O
the DT O
SH3GLB NNP B-Gene
family NN I-Gene
, , O
suggesting VBG O
a DT O
common JJ O
fold NN O
and CC O
presumably RB O
a DT O
common JJ O
mode NN O
of IN O
action NN O
. . O

The DT O
plateau NN O
MO2 NNP O
value NN O
was VBD O
that IN O
predicted VBN O
by IN O
allometric JJ O
relation NN O
. . O

The DT O
marker NN O
orders NNS O
from IN O
the DT O
genetic JJ O
and CC O
RH NNP O
maps NNS O
were VBD O
consistent JJ O
. . O

Additionally RB O
, , O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
beta NN I-Gene
, , O
but CC O
not RB O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
also RB O
prevented VBD O
the DT O
binding NN O
of IN O
Rel NNP B-Gene
to TO O
the DT O
kappa NN B-Gene
B NNP I-Gene
site NN I-Gene
. . O

The DT O
phosphotransferase NN O
system NN O
( ( O
PTS NNP O
) ) O
of IN O
Streptomyces NNP O
coelicolor NN O
identification NN O
and CC O
biochemical JJ O
analysis NN O
of IN O
a DT O
histidine NN B-Gene
phosphocarrier NN I-Gene
protein NN I-Gene
HPr NNP B-Gene
encoded VBN O
by IN O
the DT O
gene NN O
ptsH NN B-Gene
. . O

Thus RB O
, , O
the DT O
class NN B-Gene
C NNP I-Gene
- : O
Vps NNP B-Gene
complex JJ O
directs NNS O
multiple JJ O
reactions NNS O
during IN O
the DT O
docking NN O
and CC O
fusion NN O
of IN O
vesicles NNS O
with IN O
the DT O
vacuole NN O
, , O
each DT O
of IN O
which WDT O
contributes VBZ O
to TO O
the DT O
overall JJ O
specificity NN O
and CC O
efficiency NN O
of IN O
this DT O
transport NN O
process NN O
. . O

Rainbow NN O
trout NN O
were VBD O
obtained VBN O
from IN O
a DT O
commercial JJ O
trout NN O
farm NN O
, , O
kept VBD O
in IN O
running VBG O
water NN O
and CC O
feeding NN O
in IN O
experimental JJ O
pellets NNS O
for IN O
4 CD O
to TO O
8 CD O
weeks NNS O
. . O

The DT O
rate NN O
of IN O
decrement NN O
in IN O
DPOAE NNP O
amplitude NN O
over IN O
a DT O
prescribed JJ O
time NN O
period NN O
was VBD O
utilized VBN O
as IN O
a DT O
measure NN O
of IN O
susceptibility NN O
to TO O
the DT O
acoustic JJ O
trauma NN O
. . O

Most JJS O
of IN O
the DT O
expressed JJ O
human JJ B-Gene
E3 NNP I-Gene
polypeptides NNS I-Gene
( ( O
five CD O
bands NNS O
) ) O
were VBD O
found VBN O
in IN O
the DT O
insoluble JJ O
pellet NN O
while IN O
primarily RB O
full JJ B-Gene
- : I-Gene
length NN I-Gene
mature NN I-Gene
E3 NNP I-Gene
was VBD O
found VBN O
in IN O
the DT O
soluble JJ O
fraction NN O
. . O

Molecular JJ O
cloning NN O
of IN O
mouse NN B-Gene
thioredoxin NN I-Gene
reductases NNS I-Gene
. . O

The DT O
maximal JJ O
effect NN O
was VBD O
seen VBN O
at IN O
100 CD O
ng JJ O
/ NNP O
ml NN O
EGF NNP B-Gene
, , O
with IN O
a DT O
time NN O
lag NN O
of IN O
about IN O
5 CD O
h NN O
. . O

Cdc2 NNP B-Gene
co SYM O
- : O
precipitates NNS O
with IN O
Pch1 NNP B-Gene
in IN O
S NNP O
. . O
pombe NN O
cell NN O
lysates VBZ O
, , O
although IN O
Cdc2 NNP B-Gene
may MD O
not RB O
be VB O
the DT O
major JJ O
catalytic JJ O
partner NN O
of IN O
a DT O
Pch1 NNP B-Gene
kinase NN I-Gene
in IN O
vivo NN O
. . O

Sodium NNP O
- : O
taurocholate NN O
- : O
induced JJ O
acute NN O
necrotizing VBG O
pancreatitis NN O
does VBZ O
not RB O
affect VB O
jejunal JJ O
oxygenation NN O
in IN O
pigs NNS O
. . O

Production NN O
of IN O
C NNP B-Gene
mu NNP I-Gene
RNAs NNP I-Gene
, , O
unlike IN O
mu NN B-Gene
mRNAs NN I-Gene
, , O
does VBZ O
not RB O
require VB O
recombination NN O
with IN O
the DT O
joining VBG B-Gene
region NN I-Gene
( ( O
JH NNP B-Gene
) ) O
locus NN O
. . O

In IN O
addition NN O
, , O
the DT O
time NN O
to TO O
engraftment VB O
was VBD O
significantly RB O
shorter JJR O
in IN O
the DT O
amifostine NN O
arm NN O
in IN O
both DT O
cohorts NNS O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
shown VBN O
that IN O
a DT O
variety NN O
of IN O
extracellular JJ O
factors NNS O
stimulate VBP O
a DT O
pair NN O
of IN O
MAPK NNP O
p44 NN B-Gene
and CC O
MAPK NNP O
p42 NN B-Gene
of IN O
MAPK NNP B-Gene
family NN I-Gene
members NNS I-Gene
. . O

Consistent JJ O
with IN O
the DT O
in IN O
vivo NN O
result NN O
, , O
the DT O
pseudorevertant NN O
endonucleases VBZ O
in IN O
the DT O
crude NN O
cell NN O
extract JJ O
display NN O
site NN O
- : O
specific JJ O
partial JJ O
DNA NNP O
cleavage NN O
activity NN O
. . O

Azithromycin NNP O
is VBZ O
a DT O
new JJ O
generation NN O
macrolide RBR O
antibiotic JJ O
with IN O
unusual JJ O
and CC O
favorable JJ O
pharmacokinetics NNS O
, , O
and CC O
seems VBZ O
to TO O
be VB O
a DT O
very RB O
promising JJ O
agent NN O
for IN O
innovative JJ O
anti NNS O
- : O
H NNP O
. . O
pylori NN O
regimens NNS O
. . O

The DT O
progression NN O
of IN O
acute JJ O
bronchitis NN O
is VBZ O
associated VBN O
with IN O
elevated JJ O
blood NN O
concentrations NNS O
of IN O
acute JJ O
- : O
phase NN O
proteins NNS O
, , O
KKS NNP B-Gene
activation NN O
in IN O
the DT O
blood NN O
and CC O
high JJ O
serotonin NN O
and CC O
lactic JJ O
acid NN O
content NN O
in IN O
the DT O
humor NN O
condensated VBD O
from IN O
the DT O
exhaled JJ O
air NN O
. . O

For IN O
higher JJR O
expression NN O
of IN O
lipA NN B-Gene
in IN O
S NNP O
. . O
lividans NNS O
, , O
the DT O
gene NN O
was VBD O
cloned VBN O
next JJ O
to TO O
the DT O
strong JJ O
aphII NN B-Gene
promoter NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
decreased JJ O
class NN O
I PRP O
enhancer VBP O
activity NN O
in IN O
Ad12 NNP O
- : O
transformed VBD O
cells NNS O
may MD O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
be VB O
due JJ O
to TO O
the DT O
higher JJR O
levels NNS O
of IN O
an DT O
enhancer NN O
- : O
specific JJ O
factor NN O
, , O
possibly RB O
acting VBG O
as IN O
a DT O
repressor NN O
. . O

Differential JJ O
screening NN O
of IN O
mitochondrial JJ O
cDNA NN O
libraries NNS O
from IN O
male JJ O
- : O
fertile NN O
and CC O
cytoplasmic JJ O
male NN O
- : O
sterile NN O
sugar NN O
- : O
beet NN O
reveals NNS O
genome JJ O
rearrangements NNS O
at IN O
atp6 NN B-Gene
and CC O
atpA JJ B-Gene
loci NN I-Gene
. . O

The DT O
results NNS O
demonstrate VBP O
( ( O
i NN O
) ) O
that IN O
the DT O
selenocysteine NN O
- : O
specific JJ O
UGA NNP O
codon NN O
is VBZ O
readily RB O
suppressed VBN O
under IN O
conditions NNS O
where WRB O
the DT O
homologous JJ B-Gene
SelB NNP I-Gene
protein NN I-Gene
is VBZ O
absent JJ O
and CC O
( ( O
ii NN O
) ) O
that WDT O
apart RB O
from IN O
the DT O
specificity NN O
of IN O
the DT O
SelB NNP B-Gene
- : I-Gene
mRNA NN I-Gene
interaction NN O
, , O
a DT O
structural JJ O
compatibility NN O
of IN O
the DT O
quaternary JJ O
complex NN O
with IN O
the DT O
ribosome NN O
is VBZ O
required VBN O
. . O

Rapid JJ O
evolution NN O
of IN O
the DT O
DNA NNP O
- : O
binding VBG O
site NN O
in IN O
LAGLIDADG NNP B-Gene
homing NN I-Gene
endonucleases NNS I-Gene
. . O

Adverse JJ O
foetal JJ O
outcome NN O
in IN O
specific JJ O
IgM NNP B-Gene
positive JJ O
Chlamydia NNP O
trachomatis NN O
infection NN O
in IN O
pregnancy NN O
. . O

This DT O
negative JJ O
regulatory JJ O
pathway NN O
may MD O
be VB O
important JJ O
for IN O
determining VBG O
cell NN O
fate NN O
or CC O
maintaining VBG O
an DT O
inducible JJ O
state NN O
in IN O
the DT O
ventroposterior JJ O
region NN O
of IN O
the DT O
embryo NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
for IN O
expression NN O
of IN O
snRNA JJ O
genes NNS O
in IN O
maize NN O
, , O
a DT O
monocotyledonous JJ O
plant NN O
, , O
the DT O
USE NNP O
and CC O
TATA NNP O
elements NNS O
are VBP O
essential JJ O
, , O
but CC O
not RB O
sufficient JJ O
, , O
for IN O
transcription NN O
. . O

The DT O
hematopoietic JJ B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factors NNS I-Gene
( ( O
CSF NNP B-Gene
) ) O
have VBP O
been VBN O
introduced VBN O
into IN O
clinical JJ O
practice NN O
as IN O
additional JJ O
supportive JJ O
measures NNS O
that WDT O
can MD O
reduce VB O
the DT O
incidence NN O
of IN O
infectious JJ O
complications NNS O
in IN O
patients NNS O
with IN O
cancer NN O
and CC O
neutropenia NN O
. . O

ATP NNP O
- : O
dependent NN O
assembly NN O
of IN O
a DT O
ternary JJ O
complex JJ O
consisting NN O
of IN O
a DT O
DNA NNP O
mismatch NN O
and CC O
the DT O
yeast NN O
MSH2 NNP B-Gene
- : O
MSH6 NN B-Gene
and CC O
MLH1 NNP B-Gene
- : O
PMS1 NNP B-Gene
protein NN O
complexes NNS O
. . O

Surprisingly RB O
, , O
the DT O
Xenopus NNP B-Gene
U7 NNP I-Gene
gene NN I-Gene
contains NNS O
two CD O
adjacent JJ O
octamer SYM O
- : O
binding VBG O
motifs NNS O
located VBN O
only RB O
12 CD O
and CC O
24 CD O
bp NN O
upstream NN O
from IN O
the DT O
PSE NNP B-Gene
, , O
instead RB O
of IN O
the DT O
usual JJ O
location NN O
around IN O
150 CD O
- : O
200 CD O
bp NN O
upstream NN O
. . O

Mean NNP O
Hg NNP O
concentrations NNS O
in IN O
the DT O
livers NNS O
of IN O
mice NN O
at IN O
some DT O
sites NNS O
in IN O
Isle NNP O
Royale NNP O
are VBP O
not RB O
significantly RB O
lower JJR O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
62 CD O
) ) O
than IN O
Hg NNP O
concentrations NNS O
considered VBN O
by IN O
some DT O
government NN O
agencies NNS O
to TO O
be VB O
unhealthy JJ O
for IN O
human JJ O
consumption NN O
. . O

Not RB O
even RB O
extensive JJ O
pancreatic JJ O
resection NN O
could MD O
prevent VB O
pancreatic JJ O
remnant JJ O
infection NN O
. . O

The DT O
structural JJ O
changes NNS O
in IN O
intra JJ O
- : O
acinar NN O
artery NN O
manifested VBN O
mainly RB O
by IN O
an DT O
increase NN O
in IN O
number NN O
of IN O
muscular JJ O
artery NN O
resulting VBG O
from IN O
muscularization NN O
of IN O
precursor NN O
cells NNS O
( ( O
pericytes NNS O
and CC O
intermediate JJ O
cells NNS O
) ) O
located VBN O
within IN O
partially RB O
muscular JJ O
and CC O
nonmuscular JJ O
arterial NN O
wall NN O
to TO O
smooth VB O
muscle NN O
cell NN O
, , O
and CC O
by IN O
the DT O
medial JJ O
wall NN O
thickened VBD O
due JJ O
to TO O
hypertrophy VB O
and CC O
hyperplasia VB O
of IN O
smooth JJ O
muscle NN O
cells NNS O
as RB O
well RB O
as IN O
accumulation NN O
of IN O
a DT O
large JJ O
amount NN O
of IN O
collagen NN B-Gene
, , O
especially RB O
the DT O
type NN B-Gene
1 CD I-Gene
collagen NN I-Gene
. . O

In IN O
addition NN O
, , O
TRP1 NNP B-Gene
RI NNP O
Circle NNP O
DNA NNP O
is VBZ O
organized VBN O
into IN O
nucleosomes NNS O
whose WP$ O
size NN O
and CC O
spacing NN O
are VBP O
indistinguishable JJ O
from IN O
that DT O
of IN O
bulk NN O
yeast NN O
chromatin NN O
. . O

We PRP O
took VBD O
advantage NN O
of IN O
the DT O
high JJ O
degree NN O
of IN O
aa NN O
sequence NN O
homology NN O
between IN O
DAHPSs NNP B-Gene
from IN O
several JJ O
species NNS O
to TO O
isolate VB O
ARO3 NNP B-Gene
homologues NNS I-Gene
from IN O
the DT O
pathogenic JJ O
yeast NN O
Candida NNP O
albicans NNS O
. . O

100 CD O
of IN O
the DT O
patients NNS O
who WP O
would MD O
have VB O
died VBN O
survive JJ O
. . O

In IN O
agreement NN O
with IN O
previous JJ O
in IN O
vitro NN O
data NNS O
, , O
we PRP O
have VBP O
shown VBN O
that IN O
UmuD NNP B-Gene
and CC O
UmuD NNP B-Gene
' POS I-Gene
are VBP O
able JJ O
to TO O
form VB O
both DT O
homodimers NNS O
( ( O
UmuD NNP B-Gene
- : O
UmuD NN B-Gene
and CC O
UmuD NNP B-Gene
' POS I-Gene
- : O
UmuD NNP B-Gene
' POS I-Gene
) ) O
and CC O
a DT O
heterodimer NN O
( ( O
UmuD NNP B-Gene
- : O
UmuD NNP B-Gene
' POS I-Gene
) ) O
. . O

The DT O
human JJ O
pathogenic JJ O
bacterium NN O
group NN O
A NNP O
Streptococcus NNP O
produces VBZ O
an DT O
extracellular JJ O
cysteine NN B-Gene
protease NN I-Gene
[ NNP O
streptococcal JJ B-Gene
pyrogenic NN I-Gene
exotoxin NN I-Gene
B NNP I-Gene
( ( O
SpeB NNP B-Gene
) ) O
] NN O
that WDT O
is VBZ O
a DT O
critical JJ O
virulence NN O
factor NN O
for IN O
invasive JJ O
disease NN O
episodes NNS O
. . O

According VBG O
to TO O
the DT O
laboratory NN O
results NNS O
, , O
the DT O
application NN O
of IN O
neural JJ O
network NN O
can MD O
solve VB O
the DT O
problem NN O
successfully RB O
. . O

Comparison NNP O
of IN O
patients NNS O
receiving VBG O
phenytoin NN O
and CC O
those DT O
who WP O
were VBD O
not RB O
showed VBN O
significantly RB O
lower JJR O
serum NN O
folate NN O
in IN O
the DT O
sub JJ O
- : O
group NN O
receiving VBG O
phenytoin NN O
, , O
but CC O
there EX O
was VBD O
no DT O
significant JJ O
difference NN O
between IN O
the DT O
sub NN O
- : O
groups NNS O
with IN O
respect NN O
to TO O
vitamin VB O
B12 NNP O
or CC O
behaviour PRP$ O
problem NN O
rating NN O
. . O

In IN O
contrast NN O
, , O
we PRP O
observed VBD O
high JJ O
concentrations NNS O
in IN O
29 CD O
of IN O
75 CD O
patients NNS O
with IN O
tumors NNS O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
especially RB O
in IN O
meningioma NN O
( ( O
6 CD O
/ RB O
9 CD O
) ) O
, , O
glioblastoma NN O
( ( O
9 CD O
/ RB O
23 CD O
) ) O
, , O
and CC O
neurinoma NN O
( ( O
5 CD O
/ RB O
5 CD O
) ) O
. . O

Endostatin NNP O
treatment NN O
for IN O
10 CD O
minutes NNS O
or CC O
24 CD O
hours NNS O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
Shb NNP B-Gene
and CC O
formation NN O
of IN O
multiprotein NN O
complexes NNS O
. . O

Surgical JJ O
treatment NN O
of IN O
pathologic JJ O
scars NNS O
of IN O
myocardial JJ O
infarct NN O

Familial NNP O
juvenile NN O
nephronophthisis NN O

Mutation NN O
of IN O
Enh4 NNP B-Gene
, , O
an DT O
essential JJ O
GT NNP B-Gene
- : I-Gene
IIC NNP I-Gene
- : I-Gene
like IN I-Gene
enhanson NN I-Gene
in IN O
the DT O
context NN O
of IN O
the DT O
intact JJ O
enhancer NN O
, , O
abolishes VBZ O
silencer NN O
activity NN O
, , O
and CC O
multimerized VBD O
GT NNP B-Gene
- : I-Gene
IIC NNP I-Gene
enhansons NNS I-Gene
mimic VBP O
the DT O
intact JJ O
CSEn NNP B-Gene
enhancer NN I-Gene
/ NNP I-Gene
silencer NN I-Gene
activities NNS O
in IN O
BeWo NNP O
and CC O
GC NNP O
cells NNS O
, , O
respectively RB O
. . O

Stable JJ O
transfection NN O
of IN O
human JJ B-Gene
CHOP NNP I-Gene
cDNA NN I-Gene
into IN O
mammary JJ O
carcinoma NN O
cells NNS O
demonstrated VBD O
that IN O
CHOP NNP B-Gene
functioned VBD O
not RB O
as IN O
a DT O
mediator NN O
of IN O
hGH JJ B-Gene
- : O
stimulated JJ O
mitogenesis NN O
but CC O
rather RB O
enhanced VBD O
the DT O
protection NN O
from IN O
apoptosis NN O
afforded VBN O
by IN O
hGH NN B-Gene
in IN O
a DT O
p38 NN B-Gene
MAPK NNP O
- : O
dependent JJ O
manner NN O
. . O

We PRP O
previously RB O
demonstrated VBD O
that IN O
acute JJ O
expression NN O
of IN O
the DT O
bovine NN O
papillomavirus NN O
type NN O
1 CD O
( ( O
BPV1 NNP O
) ) O
E2 NNP B-Gene
protein NN I-Gene
in IN O
HeLa NNP O
and CC O
HT NNP O
- : O
3 CD O
cervical JJ O
carcinoma NN O
cell NN O
lines NNS O
greatly RB O
reduced VBD O
cellular JJ O
proliferation NN O
by IN O
imposing VBG O
a DT O
specific JJ O
G1 NNP O
/ NNP O
S NNP O
phase NN O
growth NN O
arrest NN O
. . O

The DT O
penicillin NN B-Gene
binding NN I-Gene
proteins NNS I-Gene
( ( O
PBPs NNP B-Gene
) ) O
synthesize NN O
and CC O
remodel NN O
peptidoglycan NN O
, , O
the DT O
structural JJ O
component NN O
of IN O
the DT O
bacterial JJ O
cell NN O
wall NN O
. . O

A DT O
degenerate NN O
DNA NNP O
transposon NN O
, , O
Pat NNP B-Gene
, , O
was VBD O
identified VBN O
in IN O
the DT O
genomes NNS O
of IN O
various JJ O
wild JJ O
- : O
type NN O
strains NNS O
of IN O
the DT O
filamentous JJ O
fungus NN O
Podospora NNP O
anserina NN O
. . O

Both DT O
normal JJ O
and CC O
transforming VBG O
PCPH NNP B-Gene
proteins NNS I-Gene
have VBP O
guanosine JJ B-Gene
diphosphatase NN I-Gene
activity NN O
but CC O
only RB O
the DT O
oncoprotein NN O
cooperates VBZ O
with IN O
Ras NNP B-Gene
in IN O
activating VBG O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
ERK1 NNP B-Gene
. . O

On IN O
the DT O
basis NN O
of IN O
S1 NNP B-Gene
nuclease NN I-Gene
protection NN O
analysis NN O
of IN O
RNA NNP O
preparations NNS O
from IN O
several JJ O
mouse NN O
tissues NNS O
, , O
both DT O
dhfr NNS B-Gene
and CC O
divergent NN O
genes NNS O
showed VBD O
similar JJ O
levels NNS O
of IN O
expression NN O
but CC O
did VBD O
show VB O
some DT O
specificity NN O
in IN O
start JJ O
site NN O
utilization NN O
. . O

The DT O
US NNP O
National NNP O
Institute NNP O
on IN O
Alcohol NNP O
Abuse NNP O
and CC O
Alcoholism NNP O
( ( O
NIAAA NNP O
) ) O
recognizes VBZ O
two CD O
forms NNS O
of IN O
problematic JJ O
drinking NN O
: : O
' POS O
willful JJ O
alcohol NN O
abuse NN O
' '' O
, , O
a DT O
behavioural JJ O
problem NN O
, , O
and CC O
' POS O
alcohol NN O
dependence NN O
' '' O
, , O
a DT O
true JJ O
medical JJ O
disorder NN O
, , O
which WDT O
includes VBZ O
a DT O
genetic JJ O
component NN O
, , O
that WDT O
can MD O
be VB O
scientifically RB O
understood JJ O
and CC O
medically RB O
treated VBN O
. . O

Scalp NNP O
flaps NNS O
can MD O
be VB O
expanded VBN O
just RB O
to TO O
the DT O
point NN O
of IN O
becoming VBG O
noticeable JJ O
over IN O
4 CD O
to TO O
6 CD O
weeks NNS O
followed VBN O
by IN O
scalp NN O
flap NN O
transposition NN O
and CC O
easy JJ O
closure NN O
of IN O
the DT O
donor NN O
site NN O
. . O

HEF1 NNP B-Gene
, , O
p130 NN B-Gene
( ( O
Cas NNP B-Gene
) ) O
, , O
and CC O
Efs NNP B-Gene
/ NNP O
Sin NNP B-Gene
constitute VBP O
a DT O
family NN O
of IN O
multidomain NN O
docking VBG O
proteins NNS O
that WDT O
have VBP O
been VBN O
implicated VBN O
in IN O
coordinating VBG O
the DT O
regulation NN O
of IN O
cell NN O
adhesion NN O
. . O

( ( O
1998 CD O
) ) O
J NNP O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
there EX O
may MD O
be VB O
a DT O
relationship NN O
between IN O
the DT O
pathogenesis NN O
of IN O
MAL NNP O
, , O
narcolepsy NN O
, , O
and CC O
OSA NNP O
. . O

The DT O
efficacy NN O
of IN O
a DT O
Propionibacterium NNP O
acnes NNS O
product NN O
for IN O
treatment NN O
of IN O
coliform NN O
mastitis NN O
was VBD O
evaluated VBN O
following VBG O
intramammary JJ O
infusion NN O
of IN O
Escherichia NNP O
coli NN O
. . O

Axillary NNP O
nodal NN O
status NN O
, , O
tumour VBP O
progesterone NN B-Gene
receptor NN I-Gene
status NN O
, , O
and CC O
season NN O
of IN O
tumour JJ O
detection NN O
significantly RB O
influenced VBD O
survival NN O
in IN O
both DT O
older JJR O
( ( O
greater JJR O
than IN O
50 CD O
yrs NN O
) ) O
and CC O
younger JJR O
( ( O
less JJR O
than IN O
50 CD O
yrs NNS O
) ) O
patients NNS O
. . O

Although IN O
the DT O
terminase NN B-Gene
apparently RB O
interacts VBZ O
with IN O
this DT O
gp20 NN B-Gene
portal JJ I-Gene
peptide NN I-Gene
, , O
polyclonal JJ O
antibody NN O
against IN O
the DT O
portal JJ O
peptide NN O
appears VBZ O
unable JJ O
to TO O
access NN O
it PRP O
in IN O
the DT O
native JJ O
structure NN O
, , O
suggesting VBG O
intimate JJ O
association NN O
of IN O
gp20 NN B-Gene
and CC O
gp17 NN B-Gene
possibly RB O
internalizes VBZ O
terminase NN B-Gene
regions NNS I-Gene
within IN O
the DT O
portal NN O
in IN O
the DT O
packasome NN O
complex NN O
. . O

Intestinal JJ O
adaptation NN O
( ( O
first JJ O
of IN O
two CD O
parts NNS O
) ) O
. . O

The DT O
initial JJ O
patients NNS O
treated VBN O
with IN O
AZQ NNP O
and CC O
mitroxantrone NN O
experienced VBD O
prolonged JJ O
bone NN O
marrow NN O
suppression NN O
and CC O
, , O
therefore RB O
, , O
subsequent JJ O
cohorts NNS O
were VBD O
treated VBN O
with IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
, , O
5 CD O
micrograms NNS O
/ JJ O
kg NN O
, , O
beginning VBG O
the DT O
day NN O
after IN O
completion NN O
of IN O
the DT O
third JJ O
cycle NN O
of IN O
chemotherapy NN O
. . O

We PRP O
now RB O
show VBP O
that IN O
gp200 SYM B-Gene
- : O
MR6 JJ B-Gene
ligation NN O
can MD O
also RB O
mimic VB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
have VBP O
an DT O
anti JJ O
- : O
proliferative JJ O
pro JJ O
- : O
maturational JJ O
influence NN O
within IN O
the DT O
immune NN O
system NN O
, , O
causing VBG O
up RP O
- : O
regulation NN O
of IN O
co NN O
- : O
stimulatory NN O
molecules NNS O
on IN O
B NNP O
lymphocytes NNS O
. . O

CDDP NNP O
is VBZ O
active JJ O
as IN O
a DT O
single JJ O
agent NN O
in IN O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
. . O

Evaluation NN O
of IN O
the DT O
new JJ O
Gravigard NNP O
IUCD NNP O
inserter NN O
. . O

A DT O
3 CD O
- : O
yr NN O
retrospective JJ O
review NN O
is VBZ O
effective JJ O
and CC O
detects VBZ O
94 CD O
% NN O
of IN O
the DT O
undercalls NNS O
. . O

The DT O
spectrum NN O
of IN O
phenotypes NNS O
caused VBN O
by IN O
these DT O
mutations NNS O
was VBD O
strikingly RB O
different JJ O
than IN O
mutations NNS O
in IN O
the DT O
adaptor NN O
for IN O
the DT O
VP16 NNP B-Gene
activation NN I-Gene
domain NN I-Gene
. . O

The DT O
proliferation NN B-Gene
potential NN I-Gene
protein NN I-Gene
- : I-Gene
related VBN I-Gene
( ( O
P2P NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
gene NN O
with IN O
domains NNS O
encoding VBG O
heterogeneous JJ O
nuclear JJ O
ribonucleoprotein NN O
association NN O
and CC O
Rb1 NNP B-Gene
binding NN O
shows NNS O
repressed VBD O
expression NN O
during IN O
terminal JJ O
differentiation NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
constitutively RB O
active JJ O
Mek1 NNP B-Gene
could MD O
activate VB O
p96h2bk NNS B-Gene
in IN O
the DT O
absence NN O
of IN O
oncogenic JJ B-Gene
Ras NNP I-Gene
. . O

The DT O
molecular JJ O
mechanism NN O
of IN O
Tax NNP B-Gene
- : O
mediated VBD O
trans NNS O
- : O
activation NN O
has VBZ O
been VBN O
well RB O
investigated VBN O
. . O

Embryo NNP O
coculture NN O
system NN O
may MD O
contribute VB O
to TO O
understand VB O
the DT O
mechanisms NN O
underlying VBG O
the DT O
decrease NN O
of IN O
fertility NN O
with IN O
aging VBG O
. . O

Eleven RB O
healthy JJ O
, , O
normotensive JJ O
males NNS O
undergoing VBG O
routine JJ O
restorative JJ O
dental NN O
care NN O
were VBD O
evaluated VBN O
during IN O
treatment NN O
for IN O
possible JJ O
hemodynamic JJ O
alterations NNS O
in IN O
response NN O
to TO O
potential JJ O
sympathetic JJ O
nervous JJ O
system NN O
stimulation NN O
. . O

Quantitative JJ O
analysis NN O
of IN O
DNA NNP O
using VBG O
flow JJ O
cytometry NN O
and CC O
immunocytochemical JJ O
findings NNS O
in IN O
16 CD O
cases NNS O
of IN O
cardiac JJ O
myxomas NN O

Human NNP B-Gene
bcl3 NN I-Gene
protein NN I-Gene
specifically RB O
displaces NNS O
( ( B-Gene
p50 NN I-Gene
) ) I-Gene
2 CD I-Gene
- : I-Gene
DNA NN I-Gene
complexes NNS I-Gene
. . O

Anti NNP B-Gene
- : I-Gene
B NNP I-Gene
. . I-Gene
burgdorferi NN I-Gene
, , O
anti SYM B-Gene
- : I-Gene
B NN I-Gene
. . I-Gene
turicatae NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
B NN I-Gene
. . I-Gene
parkeri NN I-Gene
antibodies NNS I-Gene
, , O
tested VBN O
by IN O
the DT O
indirect JJ O
immunofluorescent NN O
assay NN O
( ( O
IFA NNP O
) ) O
, , O
were VBD O
detected VBN O
in IN O
10 CD O
. . O
8 CD O
, , O
16 CD O
. . O
1 CD O
and CC O
8 CD O
. . O
2 CD O
% NN O
of IN O
the DT O
serum NN O
samples NNS O
tested VBN O
, , O
and CC O
confirmed VBN O
by IN O
IFA NNP O
- : O
ABS NNP O
in IN O
1 CD O
. . O
3 CD O
, , O
1 CD O
. . O
3 CD O
and CC O
1 CD O
. . O
0 CD O
% NN O
, , O
respectively RB O
. . O

Of IN O
the DT O
153 CD O
patients NNS O
studied VBN O
, , O
CK NNP B-Gene
- : I-Gene
MB NN I-Gene
results NNS O
were VBD O
positive JJ O
in IN O
91 CD O
( ( O
59 CD O
% NN O
) ) O
patients NNS O
; : O
ECG NNP O
revealed VBD O
AMI NNP O
in IN O
72 CD O
( ( O
47 CD O
% NN O
) ) O
patients NNS O
. . O

Homodimers NNS O
of IN O
the DT O
three CD O
proteins NNS O
specifically RB O
recognize VBP O
the DT O
G NNP O
- : O
box NN O
motif NN O
, , O
with IN O
GBF1 NNP B-Gene
and CC O
GBF3 NNP B-Gene
binding VBG O
symmetrically RB O
to TO O
this DT O
palindromic JJ O
sequence NN O
. . O

METHODS NNS O
: : O
We PRP O
studied VBD O
the DT O
clinical JJ O
benefit NN O
of IN O
depth NN O
- : O
dependent NN O
RR NNP O
, , O
nonuniform NN O
AC NNP O
using VBG O
a DT O
scanning JJ O
line NN O
source NN O
, , O
and CC O
scatter JJR O
correction NN O
( ( O
photon VB O
energy NN O
recovery NN O
[ NNP O
PER NNP O
] NNP O
) ) O
compared VBN O
with IN O
filtered JJ O
backprojection NN O
alone RB O
. . O

A DT O
cluster NN O
of IN O
basic JJ O
amino NN O
acids NNS O
, , O
KKKR NNP O
, , O
generated VBN O
by IN O
joining VBG O
of IN O
the DT O
sequences NNS O
encoded VBN O
by IN O
the DT O
constitutive JJ O
exon NN O
13 CD O
and CC O
the DT O
alternative JJ O
exon NN O
16 CD O
, , O
is VBZ O
necessary JJ O
for IN O
the DT O
nuclear JJ O
targeting NN O
of IN O
4 CD B-Gene
. . I-Gene
1H CD I-Gene
, , O
as IN O
demonstrated VBN O
by IN O
site NN O
- : O
directed VBN O
mutagenesis NN O
analysis NN O
. . O

Repair NN O
of IN O
a DT O
cosmetic JJ O
defect NN O
of IN O
the DT O
lower JJR O
leg NN O
with IN O
a DT O
myocutaneous JJ O
free JJ O
flap NN O
. . O

The DT O
5 CD O
' POS O
region NN O
of IN O
ADH5 NNP B-Gene
contains VBZ O
consensus NN O
binding VBG O
sites NNS O
for IN O
the DT O
transcriptional JJ O
regulatory JJ O
proteins NNS O
, , O
Sp1 NNP B-Gene
, , O
AP2 NNP B-Gene
, , O
LF NNP B-Gene
- : I-Gene
A1 NNP I-Gene
, , O
NF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
A2 NNP I-Gene
, , O
and CC O
NF NNP B-Gene
- : I-Gene
E1 NN I-Gene
. . O

This DT O
study NN O
describes VBZ O
a DT O
new JJ O
MADS NNP B-Gene
box NN I-Gene
gene NN I-Gene
, , O
nmhC5 NN B-Gene
, , O
which WDT O
along RB O
with IN O
nmh7 NN B-Gene
( ( O
J NNP O
. . O

One CD O
of IN O
these DT O
, , O
the DT O
origin NN O
core NN O
, , O
is VBZ O
required VBN O
only RB O
for IN O
DNA NNP O
replication NN O
. . O

Furthermore RB O
, , O
this DT O
study NN O
demonstrates VBZ O
that IN O
reduced VBD O
inotropy NN O
with IN O
timolol NN O
helped VBD O
uniform VB O
local JJ O
contraction NN O
as IN O
estimated VBN O
by IN O
the DT O
increased VBN O
LONG NNP O
/ NNP O
CIRC NNP O
ratio NN O
, , O
a DT O
transition NN O
that WDT O
could MD O
improve VB O
contraction NN O
efficacy NN O
. . O

Eighteen JJ O
patients NNS O
were VBD O
untreated JJ O
, , O
and CC O
8 CD O
had VBD O
been VBN O
given VBN O
previous JJ O
treatment NN O
with IN O
depot NN O
testosterone NN O
100 CD O
mg NN O
intramuscularly RB O
every DT O
2 CD O
- : O
3 CD O
weeks NNS O
for IN O
an DT O
average JJ O
duration NN O
of IN O
4 CD O
. . O
7 CD O
years NNS O
. . O

To TO O
evaluate VB O
the DT O
effects NNS O
of IN O
propranolol NN O
on IN O
myocardial JJ O
metabolism NN O
after IN O
coronary JJ O
reperfusion NN O
, , O
serial JJ O
measurements NNS O
of IN O
myocardial JJ B-Gene
creatine NN I-Gene
kinase NN I-Gene
( ( O
CK NNP B-Gene
) ) O
and CC O
calcium NN O
( ( O
Ca NNP O
) ) O
contents NNS O
and CC O
CK NNP B-Gene
and CC O
lactic JJ O
acid NN O
( ( O
LA NNP O
) ) O
concentrations NNS O
in IN O
coronary JJ O
sinus NN O
blood NN O
were VBD O
carried VBN O
out IN O
in IN O
33 CD O
open JJ O
- : O
chest JJS O
dogs NNS O
. . O

GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
was VBD O
present JJ O
in IN O
equivalent JJ O
levels NNS O
in IN O
both DT O
erythroid FW O
cell NN O
lines NNS O
, , O
but CC O
at IN O
a DT O
low JJ O
level NN O
in IN O
FDC NNP O
- : O
P1 NNP O
cells NNS O
. . O

To TO O
study VB O
the DT O
in IN O
vivo JJ O
role NN O
of IN O
p16 NN B-Gene
. . I-Gene
7 CD I-Gene
, , O
a DT O
phi29 NN O
mutant NN O
containing VBG O
a DT O
suppressible JJ O
mutation NN O
in IN O
gene NN B-Gene
16 CD I-Gene
. . I-Gene
7 CD I-Gene
was VBD O
constructed VBN O
. . O

In IN O
addition NN O
, , O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
gamma VBD I-Gene
readily RB O
heterodimerize VB O
with IN O
each DT O
other JJ O
as RB O
well RB O
as IN O
with IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
. . O

These DT O
experiments NNS O
delineate VBP O
a DT O
186 CD O
- : O
bp NN O
, , O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
responsive NN O
cell NN O
DNA NNP O
fragment NN O
and CC O
provide VB O
firm JJ O
evidence NN O
that IN O
EBNA NNP B-Gene
- : I-Gene
2 CD I-Gene
transactivates NNS O
transcription NN O
of IN O
cell NN O
genes NNS O
. . O

The DT O
preferential JJ O
serum NN B-Gene
IgA NNP I-Gene
response NN O
observed VBD O
in IN O
the DT O
patient JJ O
population NN O
suggests VBZ O
that IN O
bronchial NN O
associated VBN O
lymphoid JJ O
tissue NN O
in IN O
the DT O
diseased JJ O
lung NN O
is VBZ O
an DT O
important JJ O
source NN O
of IN O
circulating VBG O
IgA NNP B-Gene
. . O

To TO O
the DT O
best JJS O
of IN O
our PRP$ O
knowledge NN O
, , O
SNTCS NNP O
is VBZ O
highly RB O
malignant JJ O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
of IN O
the DT O
traI JJ B-Gene
structural JJ I-Gene
gene NN I-Gene
and CC O
application NN O
of IN O
purified JJ O
mutant JJ O
TraI NNP B-Gene
proteins NNS I-Gene
for IN O
in IN O
vitro NN O
assays NNS O
served VBD O
to TO O
evaluate VB O
the DT O
functional JJ O
importance NN O
of IN O
conserved VBN O
amino NN O
acid NN O
residues NNS O
. . O

A DT O
transcription NN O
factor NN O
exclusion NN O
assay NN O
was VBD O
used VBN O
to TO O
show VB O
that IN O
the DT O
PCF1 NNP B-Gene
mutation NN I-Gene
affects VBZ O
two CD O
distinct JJ O
stages NNS O
in IN O
transcription NN O
: : O
one CD O
prior NN O
to TO O
and CC O
one CD O
after IN O
stable JJ O
complex JJ O
formation NN O
; : O
and CC O
that IN O
these DT O
effects NNS O
are VBP O
mediated VBN O
by IN O
a DT O
component NN O
of IN O
the DT O
stable JJ O
complex NN O
. . O

Changes NNS O
in IN O
tissue NN O
PCO2 NNP O
were VBD O
less RBR O
dramatic JJ O
and CC O
did VBD O
not RB O
vary JJ O
significantly RB O
from IN O
those DT O
recorded VBN O
in IN O
venous JJ O
blood NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
This DT O
study NN O
is VBZ O
a DT O
retrospective JJ O
cohort NN O
study NN O
of IN O
all DT O
children NNS O
with IN O
cancer NN O
admitted VBN O
to TO O
a DT O
single JJ O
institution NN O
with IN O
fever NN O
and CC O
neutropenia NN O
( ( O
defined VBN O
as IN O
an DT O
absolute NN O
neutrophil NN O
count NN O
< VBD O
500 CD O
cells NNS O
/ JJ O
mm3 NN O
) ) O
in IN O
a DT O
1 CD O
- : O
year NN O
period NN O
. . O

Gel NNP O
shift NN O
analysis NN O
indicates VBZ O
that IN O
the DT O
full JJ B-Gene
- : I-Gene
length NN I-Gene
ERM NNP I-Gene
protein NN I-Gene
is VBZ O
able JJ O
to TO O
bind VB O
specifically RB O
to TO O
an DT O
oligonucleotide NN O
containing VBG O
the DT O
consensus NN O
nucleotide RB O
core VBD O
sequence NN O
GGAA NNP O
recognized VBN O
by IN O
the DT O
Ets NNP B-Gene
proteins VBZ O
. . O

Regulation NN O
of IN O
embryonic JJ O
growth NN O
and CC O
lysosomal JJ O
targeting NN O
by IN O
the DT O
imprinted JJ O
Igf2 NNP B-Gene
/ NNP O
Mpr NNP B-Gene
gene NN O
. . O

The DT O
mean JJ O
values NNS O
of IN O
protease NN O
activity NN O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
test NN O
groups NNS O
than IN O
in IN O
the DT O
control NN O
group NN O
at IN O
baseline NN O
. . O

A DT O
human JJ O
recombinant NN O
cDNA NN O
clone NN O
that WDT O
encoded VBD O
253 CD O
amino NN O
acids NNS O
residues NNS O
of IN O
a DT O
zinc NN B-Gene
- : I-Gene
finger NN I-Gene
protein NN I-Gene
( ( O
THZif NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
was VBD O
cloned VBN O
by IN O
screening VBG O
a DT O
cDNA NN O
library NN O
prepared VBD O
from IN O
human JJ O
promyelocytic JJ O
leukemia NN O
HL60 NNP O
cells NNS O
with IN O
synthetic JJ O
oligodeoxynucleotide NN O
probes NNS O
that WDT O
corresponded VBD O
to TO O
the DT O
amino NN O
acid JJ O
sequences NNS O
of IN O
tryptic JJ O
peptides NNS O
derived VBN O
from IN O
the DT O
DNA NNP O
- : O
binding NN O
protein NN O
specific NN O
for IN O
the DT O
nuclease NN B-Gene
- : I-Gene
hypersensitive JJ I-Gene
element NN I-Gene
( ( O
NHE NNP B-Gene
) ) O
of IN O
the DT O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
myc JJ I-Gene
gene NN I-Gene
. . O

According VBG O
to TO O
the DT O
changes NNS O
of IN O
perfusion NN O
defects NNS O
between IN O
Ex NNP O
, , O
RD NNP O
and CC O
ReI NNP O
images NNS O
, , O
they PRP O
were VBD O
classified VBN O
into IN O
3 CD O
types NNS O
: : O
Type NN O
I PRP O
; : O
perfusion NN O
defect NN O
on IN O
the DT O
RD NNP O
image NN O
was VBD O
identical JJ O
to TO O
ReI NNP O
image NN O
( ( O
75 CD O
% NN O
) ) O
Type NN O
I PRP O
was VBD O
divided VBN O
into IN O
2 CD O
subgroups NNS O
whether IN O
perfusion NN O
defect NN O
at IN O
Ex NNP O
was VBD O
unchanged JJ O
( ( O
Ia NNP O
, , O
42 CD O
% NN O
) ) O
or CC O
improved VBN O
( ( O
Ib NNP O
, , O
33 CD O
% NN O
) ) O
on IN O
the DT O
RD NNP O
image NN O
. . O

Overall JJ O
prevalences NNS O
of IN O
antibody NN O
were VBD O
70 CD O
per IN O
cent NN O
in IN O
cattle NNS O
, , O
67 CD O
per IN O
cent NN O
in IN O
sheep NN O
and CC O
76 CD O
per IN O
cent NN O
in IN O
goats NNS O
as IN O
assessed VBN O
by IN O
an DT O
immunodiffusion NN O
test NN O
. . O

The DT O
protein NN O
sequence NN O
contains NNS O
seven CD O
potential JJ O
N NNP O
- : O
linked VBN O
glycosylation NN O
sites NNS O
and CC O
a DT O
threonine NN O
/ NN O
serine NN O
- : O
rich JJ O
region NN O
which WDT O
is VBZ O
a DT O
potential JJ O
site NN O
for IN O
attachment NN O
of IN O
O NNP O
- : O
linked VBN O
carbohydrate NN O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
optimization NN O
and CC O
characterization NN O
of IN O
a DT O
140 CD O
- : O
residue JJ O
fragment NN O
, , O
containing VBG O
the DT O
Runt NNP B-Gene
domain NN I-Gene
of IN O
AML1 NNP B-Gene
, , O
which WDT O
is VBZ O
suitable JJ O
for IN O
structural JJ O
studies NNS O
. . O

Multiple NNP O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
signaling VBG O
pathways NNS O
connect VBP O
the DT O
cot NN B-Gene
oncoprotein NN I-Gene
to TO O
the DT O
c NN B-Gene
- : I-Gene
jun NN I-Gene
promoter NN I-Gene
and CC O
to TO O
cellular JJ O
transformation NN O
. . O

The DT O
procedure NN O
is VBZ O
less RBR O
aggressive JJ O
and CC O
painful JJ O
than IN O
sternotomy NN O
. . O

These DT O
data NNS O
demonstrate VBP O
the DT O
presence NN O
of IN O
a DT O
single JJ O
binding NN O
site NN O
for IN O
vinculin NN B-Gene
, , O
and CC O
at IN O
least JJS O
two CD O
binding VBG O
sites NNS O
for IN O
FAK NNP B-Gene
that WDT O
are VBP O
separated VBN O
by IN O
an DT O
intervening JJ O
stretch NN O
of IN O
100 CD O
amino JJ O
acids NNS O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
the DT O
successful JJ O
resection NN O
of IN O
a DT O
MFH NNP O
originating NN O
in IN O
the DT O
renal JJ O
capsular JJ O
tissue NN O
and CC O
extending VBG O
into IN O
the DT O
inferior JJ O
vena NN O
cava NN O
. . O

Age NNP O
at IN O
POI NNP O
and CC O
asymptote VB O
were VBD O
achieved VBN O
later RB O
for IN O
Line NNP O
RBC2 NNP O
than IN O
for IN O
Line NNP O
F NNP O
. . O

Fewer JJR O
recombination NN O
events NNS O
are VBP O
detected VBN O
in IN O
four CD O
different JJ O
B NNP O
and CC O
T NNP O
cell NN O
lines NNS O
that WDT O
do VBP O
not RB O
undergo VB O
switch JJ O
recombination NN O
of IN O
their PRP$ O
endogenous JJ O
genes NNS O
. . O

Direct JJ O
binding NN O
and CC O
competition NN O
assays NNS O
using VBG O
30 CD O
- : O
mer NN O
oligonucleotide IN O
probes NNS O
representing VBG O
the DT O
individual JJ O
CBF1 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
indicated VBD O
that IN O
CBF1 NNP B-Gene
bound VBD O
less RBR O
efficiently RB O
to TO O
the DT O
CD23 NNP B-Gene
promoter NN I-Gene
and CC O
the DT O
EBV NNP B-Gene
LMP NNP I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
sites NNS I-Gene
than IN O
to TO O
the DT O
Cp NNP B-Gene
site NN I-Gene
. . O

The DT O
% NN O
SVend NNP O
of IN O
HCM NNP O
- : O
I PRP O
was VBD O
significantly RB O
lower JJR O
than IN O
the DT O
respective JJ O
values NNS O
of IN O
the DT O
HCM NNP O
- : O
II NNP O
and CC O
Control NNP O
groups NNS O
. . O

Hierarchy NNP O
of IN O
protein NN B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
in IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
signaling NN O
: : O
activation NN O
of IN O
syk JJ B-Gene
depends NNS O
on IN O
Jak3 NNP B-Gene
; : O
however RB O
, , O
neither CC O
Syk NNP B-Gene
nor CC O
Lck NNP B-Gene
is VBZ O
required VBN O
for IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
mediated VBN O
STAT NNP B-Gene
activation NN O
. . O

Mental JJ O
rotation NN O
of IN O
paired JJ O
figures NNS O
engendered VBN O
activation NN O
in IN O
the DT O
left NN O
superior JJ O
parietal JJ O
lobule NN O
and CC O
the DT O
right JJ O
frontal JJ O
medial JJ O
gyrus NN O
. . O

RESULTS NN O
: : O
The DT O
bovine NN O
cDNA NN O
insert JJ O
sequence NN O
was VBD O
273 CD O
nucleotides NNS O
in IN O
length NN O
for IN O
the DT O
entire JJ O
mRNA NN O
coding VBG O
region NN O
, , O
212 CD O
nucleotides NNS O
in IN O
the DT O
5 CD O
' POS O
untranslated JJ O
region NN O
, , O
83 CD O
nucleotides NNS O
in IN O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
and CC O
a DT O
poly NN O
( ( O
A DT O
) ) O
tail NN O
. . O

Losartan NNP O
Intervention NNP O
For IN O
Endpoint NNP O
. . O

Management NNP O
often RB O
involves VBZ O
beta SYM O
- : O
and CC O
calcium JJ O
channel NNS O
blocking VBG O
drugs NNS O
or CC O
type NN O
IC NNP O
antiarrhythmic JJ O
drugs NNS O
. . O

Residual JJ O
urinary JJ O
abnormalities NNS O
were VBD O
significantly RB O
more RBR O
frequent JJ O
in IN O
patients NNS O
with IN O
type NN O
III NNP O
than IN O
type NN O
I PRP O
MPGN NNP O
. . O

It PRP O
contains VBZ O
a DT O
5 CD O
' POS O
- : O
noncoding JJ O
region NN O
( ( O
NCR NNP O
) ) O
of IN O
73 CD O
nucleotides NNS O
, , O
five CD O
open JJ O
reading NN O
frames NNS O
( ( O
ORFs $ O
1 CD O
to TO O
5 CD O
) ) O
which WDT O
encode VBP O
proteins NNS O
with IN O
M NNP O
( ( O
r NN O
) ) O
160 CD B-Gene
kDa NN I-Gene
RNA NNP I-Gene
- : I-Gene
dependent NN I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
( ( I-Gene
ORF1 NNP I-Gene
) ) I-Gene
, , O
26 CD B-Gene
kDa NN I-Gene
movement NN I-Gene
protein NN I-Gene
1 CD I-Gene
( ( I-Gene
ORF2 NNP I-Gene
) ) I-Gene
, , O
13 CD B-Gene
kDa NN I-Gene
movement NN I-Gene
protein NN I-Gene
2 CD I-Gene
( ( I-Gene
ORF3 NNP I-Gene
) ) I-Gene
, , O
10 CD B-Gene
kDa NN I-Gene
movement NN I-Gene
protein NN I-Gene
3 CD I-Gene
( ( I-Gene
ORF4 NNP I-Gene
) ) I-Gene
, , O
24 CD B-Gene
kDa NN I-Gene
coat NN I-Gene
protein NN I-Gene
( ( I-Gene
OFR5 NNP I-Gene
) ) I-Gene
, , O
and CC O
a DT O
3 CD O
' POS O
NCR NNP O
of IN O
76 CD O
nucleotides NNS O
. . O

( ( O
1988 CD O
) ) O
J NNP O
. . O

We PRP O
also RB O
raised VBD O
a DT O
polyclonal JJ O
antibody NN O
against IN O
the DT O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
fusion NN I-Gene
protein NN I-Gene
containing VBG O
the DT O
NH2 NNP O
- : O
terminal JJ O
86 CD O
amino JJ O
acids NNS O
of IN O
human JJ B-Gene
NRAMP2 NNP I-Gene
. . O

We PRP O
estimate VBP O
that IN O
the DT O
protease NN O
activity NN O
is VBZ O
at IN O
least JJS O
35 CD O
- : O
fold NN O
greater JJR O
in IN O
mature NN O
B NNP O
cells NNS O
than IN O
in IN O
pre JJ O
- : O
B NNP O
cells NNS O
. . O

3D CD O
image NN O
- : O
processing NN O
permits NNS O
to TO O
analyse VB O
ultrasound JJ O
data NNS O
interactively RB O
in IN O
three CD O
orthogonal JJ O
planes NNS O
( ( O
section NN O
mode NN O
) ) O
or CC O
in IN O
realistic JJ O
3D CD O
views NNS O
( ( O
rendering VBG O
mode NN O
) ) O
. . O

The DT O
linear JJ O
plasmid NN O
pCLU1 NN O
from IN O
the DT O
yeast NN O
Kluyveromyces NNP O
lactis NN O
normally RB O
replicates VBZ O
in IN O
the DT O
cytoplasm NN O
, , O
with IN O
the DT O
aid NN O
of IN O
the DT O
helper NN O
linear NN O
plasmid NN O
pGKL2 NN O
, , O
using VBG O
terminal JJ B-Gene
protein NN I-Gene
( ( O
TP NNP B-Gene
) ) O
as IN O
a DT O
primer NN O
. . O

Thus RB O
, , O
although IN O
p28 NN B-Gene
may MD O
play VB O
only RB O
a DT O
limited JJ O
role NN O
during IN O
the DT O
early JJ O
embryonic NN O
cleavages NNS O
, , O
it PRP O
may MD O
function VB O
later RB O
in IN O
development NN O
to TO O
establish VB O
a DT O
somatic JJ O
type NN O
of IN O
cell NN O
cycle NN O
. . O

Studies NNS O
using VBG O
an DT O
inhibitor NN O
or CC O
a DT O
mutant JJ B-Gene
Lb NNP I-Gene
proteinase NN I-Gene
indicated VBD O
that IN O
stimulation NN O
of IN O
IRES NNP O
- : O
driven JJ O
translation NN O
is VBZ O
mediated VBN O
via IN O
proteolysis NN O
of IN O
some DT O
cellular JJ O
component NN O
( ( O
s NN O
) ) O
. . O

In IN O
addition NN O
, , O
a DT O
wild JJ O
- : O
type NN O
strain NN O
containing VBG O
a DT O
temperature NN B-Gene
- : I-Gene
sensitive JJ I-Gene
threonyl NN I-Gene
- : I-Gene
tRNA NN I-Gene
synthetase NN I-Gene
mutation NN I-Gene
showed VBD O
increased VBN O
thr NN B-Gene
operon NN I-Gene
expression NN O
at IN O
the DT O
non JJ O
- : O
permissive JJ O
temperature NN O
, , O
whereas IN O
none NN O
of IN O
the DT O
mutants NNS O
showed VBD O
any DT O
change NN O
. . O

Protein NNP B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
( ( O
PTKs NNP B-Gene
) ) O
are VBP O
implicated VBN O
in IN O
the DT O
control NN O
of IN O
cell NN O
growth NN O
by IN O
virtue NN O
of IN O
their PRP$ O
frequent JJ O
appearance NN O
as IN O
products NNS O
of IN O
retroviral JJ O
oncogenes NNS O
, , O
as IN O
intracellular JJ O
signal NN O
transducers NNS O
, , O
and CC O
as IN O
growth NN B-Gene
factor NN I-Gene
receptors NNS I-Gene
or CC O
components NNS O
thereof NN O
. . O

To TO O
determine VB O
what WP O
role NN O
eIF4E NN B-Gene
might MD O
play VB O
in IN O
c JJ B-Gene
- : I-Gene
myc NN I-Gene
expression NN O
, , O
the DT O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
5 CD I-Gene
' '' I-Gene
untranslated JJ I-Gene
region NN I-Gene
( ( I-Gene
UTR NNP I-Gene
) ) I-Gene
was VBD O
fused VBN O
in IN O
- : O
frame NN O
to TO O
CAT NNP B-Gene
reporters NNS I-Gene
, , O
and CC O
several JJ O
more RBR O
derivative JJ O
constructs NNS O
were VBD O
made VBN O
. . O

When WRB O
introduced VBN O
into IN O
recJ JJ B-Gene
+ NN I-Gene
strains NNS O
, , O
srjA JJ B-Gene
mutations NNS O
conferred VBD O
hyperrecombinational JJ O
and CC O
hyper JJ B-Gene
- : I-Gene
UVr JJ I-Gene
phenotypes NNS O
. . O

We PRP O
report VBP O
the DT O
isolation NN O
of IN O
human JJ O
cDNAs NN O
homologous NN O
to TO O
the DT O
Drosophila NNP B-Gene
dishevelled VBD I-Gene
( ( O
dsh NN B-Gene
) ) O
segment NN O
- : O
polarity NN O
gene NN O
. . O

The DT O
regions NNS O
of IN O
the DT O
tooth JJ O
fracture NN O
are VBP O
determined VBN O
. . O

Pharmacological JJ O
action NN O
of IN O
eptazocine NN O
( ( O
l JJ O
- : O
1 CD O
, , O
4 CD O
- : O
dimethyl NN O
- : O
10 CD O
- : O
hydroxy NN O
- : O
2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
, , O
6 CD O
, , O
7 CD O
- : O
hexahydro NN O
- : O
1 CD O
, , O
6 CD O
- : O
methano NN O
- : O
1H CD O
- : O
4 CD O
- : O
benz NN O
azonine NN O
) ) O
. . O

Reverse NNP O
transcription NN O
- : O
PCR NN O
was VBD O
then RB O
used VBN O
to TO O
clone VB O
from IN O
human JJ O
poly NN O
( ( O
A DT O
) ) O
+ NN O
RNA NNP O
the DT O
cDNA NN O
corresponding VBG O
to TO O
the DT O
expressed VBN O
homolog NN O
of IN O
psi NN B-Gene
ARF NNP I-Gene
4 CD I-Gene
, , O
referred VBD O
to TO O
as IN O
human JJ B-Gene
ARF NNP I-Gene
4 CD I-Gene
. . O

S1 NNP B-Gene
nuclease JJ I-Gene
analysis NN O
of IN O
RNA NNP O
from IN O
chemically RB O
induced VBN O
B95 NNP O
- : O
8 CD O
cells NNS O
and CC O
from IN O
Vero NNP O
cells NNS O
cotransfected VBN O
with IN O
NotI NNP B-Gene
repeat NN I-Gene
promoter NN I-Gene
- : O
CAT NN B-Gene
and CC O
Z NNP B-Gene
showed VBD O
that IN O
Z NNP B-Gene
transactivation NN O
increased VBD O
the DT O
level NN O
of IN O
correctly RB O
initiated VBN O
, , O
stable JJ O
RNA NNP O
transcripts NNS O
. . O

They PRP O
were VBD O
then RB O
subjected VBN O
to TO O
whole VB O
- : O
body NN O
heat NN O
stress NN O
( ( O
water NN O
- : O
perfused JJ O
suits NNS O
) ) O
, , O
and CC O
the DT O
3 CD O
minutes NNS O
of IN O
LBNP NNP O
was VBD O
repeated VBN O
. . O

This DT O
emancipation NN O
of IN O
the DT O
ability NN O
to TO O
copulate VB O
from IN O
hormonal JJ O
influence NN O
makes VBZ O
female JJ O
sexual JJ O
motivation NN O
the DT O
primary JJ O
regulator NN O
of IN O
mating VBG O
in IN O
primates NNS O
. . O

In IN O
a DT O
similar JJ O
experiment NN O
, , O
simultaneous JJ O
nitrofurazone NN O
administration NN O
and CC O
S NNP O
. . O
enteritidis NN O
challenge NN O
resulted VBD O
in IN O
no DT O
significant JJ O
differences NNS O
in IN O
S NNP O
. . O
enteritidis CC O
isolation JJ O
frequency NN O
. . O

The DT O
effects NNS O
of IN O
procedural JJ O
variations NNS O
on IN O
lateralized JJ O
Stroop NNP O
effects NNS O
. . O

Teratogenic JJ O
effects NNS O
of IN O
actinomycin JJ O
D NNP O
in IN O
rats NNS O

Repair NN O
of IN O
this DT O
insertion NN O
by IN O
homologous JJ O
recombination NN O
restores VBZ O
the DT O
activity NN O
of IN O
the DT O
hprt NN B-Gene
locus NN I-Gene
, , O
thus RB O
confirming VBG O
the DT O
site NN O
of IN O
mutation NN O
. . O

Comparative NNP O
study NN O
on IN O
acute JJ O
oral JJ O
overload NN O
using VBG O
tolbutamide NN O
and CC O
tolazamide NN O
in IN O
normal JJ O
and CC O
diabetic JJ O
subjects NNS O
. . O

Benefits NNS O
of IN O
obtaining VBG O
board NN O
certification NN O
in IN O
pharmacotherapy NN O
. . O

Here RB O
we PRP O
suggest VBP O
that IN O
uvrA NN B-Gene
and CC O
the DT O
nucleotide JJ O
excision NN O
repair NN O
pathway NN O
are VBP O
involved VBN O
in IN O
the DT O
repair NN O
of IN O
acid JJ O
- : O
induced JJ O
DNA NNP O
damage NN O
and CC O
are VBP O
associated VBN O
with IN O
successful JJ O
adaptation NN O
of IN O
S NNP O
. . O
mutans NNS O
to TO O
low JJ O
pH NN O
. . O

Administration NN O
of IN O
RIFA NNP O
at IN O
200 CD O
mg NN O
/ NNP O
kg NN O
/ NNP O
day NN O
in IN O
combination NN O
with IN O
ATO NNP O
at IN O
100 CD O
mg NN O
/ NNP O
kg NN O
/ NNP O
day NN O
resulted VBD O
in IN O
a DT O
marked JJ O
prolongation NN O
of IN O
survival NN O
compared VBN O
with IN O
that DT O
for IN O
mice NN O
that WDT O
received VBD O
ATO NNP O
or CC O
RIFA NNP O
alone RB O
. . O

Comparison NNP O
of IN O
data NNS O
obtained VBN O
with IN O
the DT O
results NNS O
of IN O
chronic JJ O
treatment NN O
with IN O
the DT O
opioid JJ O
antagonist NN O
permits NNS O
to TO O
conclude VB O
that IN O
the DT O
chronic JJ O
blockade NN O
increases VBZ O
the DT O
fatiguability NN O
to TO O
a DT O
great JJ O
extent NN O
than IN O
chronic JJ O
activation NN O
of IN O
opioid JJ O
system NN O
. . O

Previously RB O
, , O
we PRP O
characterized VBD O
a DT O
DNA NNP O
- : O
binding NN O
protein NN O
, , O
HS2NF5 NNP B-Gene
, , O
that WDT O
bound VBZ O
tightly RB O
to TO O
a DT O
conserved JJ O
region NN O
within IN O
hypersensitive JJ O
site NN O
2 CD O
( ( O
HS2 NNP O
) ) O
of IN O
the DT O
human JJ B-Gene
beta NN I-Gene
- : I-Gene
globin NN I-Gene
locus NN I-Gene
control NN I-Gene
region NN I-Gene
( ( O
LCR NNP O
) ) O
( ( O
Lam NNP O
, , O
L NNP O
. . O

The DT O
pyramidal JJ O
tract NN O
and CC O
Mesencephalic NNP O
Reticular NNP O
Formation NNP O
( ( O
MRF NNP O
) ) O
were VBD O
stimulated VBN O
before IN O
and CC O
after IN O
the DT O
transection NN O
. . O

RNase NNP B-Gene
protection NN O
assays NNS O
revealed VBD O
a DT O
correlation NN O
between IN O
the DT O
levels NNS O
of IN O
dorsal NN O
and CC O
ventral JJ O
skin NN O
expression NN O
with IN O
pigmentation NN O
/ NNP O
phaeomelanin NN O
phenotypes NNS O
. . O

High JJ O
- : O
resolution NN O
computed VBD O
tomography NN O
in IN O
the DT O
diagnosis NN O
of IN O
miliary JJ O
tuberculosis NN O
. . O

The DT O
retention NN O
index NN O
of IN O
201Tl CD O
SPECT NNP O
is VBZ O
a DT O
useful JJ O
indicator NN O
of IN O
metastatic JJ O
potential NN O
, , O
thereby RB O
facilitating VBG O
the DT O
prediction NN O
of IN O
prognosis NN O
, , O
and CC O
provides VBZ O
insight NN O
into IN O
the DT O
relationship NN O
between IN O
201Tl CD O
uptake NN O
and CC O
malignancy NN O
. . O

Routine NNP O
psychometric JJ O
screening NN O
of IN O
IHD NNP O
patients NNS O
may MD O
provide VB O
a DT O
cost NN O
- : O
effective JJ O
means NNS O
of IN O
alerting VBG O
cardiologists NNS O
and CC O
internists NNS O
to TO O
the DT O
relatively RB O
high JJ O
levels NNS O
of IN O
distress NN O
among IN O
their PRP$ O
patients NNS O
. . O

II NNP O
. . O

Induced NNP O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
is VBZ O
likely JJ O
to TO O
contribute VB O
to TO O
the DT O
proliferation NN O
of IN O
Stat1 NNP B-Gene
- : O
null NN O
cells NNS O
in IN O
response NN O
to TO O
IFNs NNP B-Gene
. . O

Insulin NNP B-Gene
receptor NN I-Gene
substrate NN I-Gene
- : I-Gene
1 CD I-Gene
- : O
mediated VBN O
enhancement NN O
of IN O
growth NN B-Gene
hormone NN I-Gene
- : O
induced JJ O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
activation NN O
. . O

Eleven NNP O
strains NNS O
of IN O
Fusarium NNP O
poae NN O
and CC O
F NNP O
. . O
sporotrichioides NNS O
from IN O
the DT O
U NNP O
. . O
S NNP O
. . O
S NNP O
. . O
R NNP O
. . O
and CC O
7 CD O
strains NNS O
of IN O
these DT O
species NNS O
and CC O
one CD O
of IN O
F NNP O
. . O
sporotrichioides NNS O
var VBP O
. . O
tricinctum NN O
from IN O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
and CC O
France NNP O
have VBP O
been VBN O
compared VBN O
as IN O
to TO O
their PRP$ O
capacity NN O
to TO O
yield VB O
T NNP B-Gene
- : I-Gene
2 CD I-Gene
toxin NN I-Gene
. . O

Cell NNP O
viability NN O
and CC O
lysosomal JJ B-Gene
enzymes NNS I-Gene

Spleen JJ O
weight NN O
in IN O
rats NNS O
during IN O
tumour JJ O
growth NN O
and CC O
in IN O
homograft NN O
rejection NN O
. . O

The DT O
Wilms NNP B-Gene
' POS I-Gene
tumour NN I-Gene
suppressor NN I-Gene
protein NN I-Gene
( ( O
WT1 NNP B-Gene
) ) O
is VBZ O
a DT O
putative JJ O
transcriptional JJ O
regulatory JJ O
protein NN O
with IN O
four CD O
zinc NN O
fingers NNS O
, , O
the DT O
last JJ O
three CD O
of IN O
which WDT O
have VBP O
extensive JJ O
sequence NN O
homology NN O
to TO O
the DT O
early JJ B-Gene
growth NN I-Gene
response NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
EGR NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
protein NN O
. . O

Our PRP$ O
data NNS O
therefore RB O
indicate VBP O
that IN O
it PRP O
is VBZ O
possible JJ O
to TO O
engineer VB O
the DT O
HA NNP B-Gene
envelope NN I-Gene
glycoprotein NN I-Gene
by IN O
fusing VBG O
ligands NNS O
to TO O
its PRP$ O
amino NN O
- : O
terminal JJ O
end NN O
without IN O
affecting VBG O
its PRP$ O
fusion NN O
activity NN O
. . O

Very RB O
good JJ O
accuracy NN O
( ( O
r NN O
greater JJR O
than IN O
0 CD O
. . O
9 CD O
) ) O
was VBD O
found VBN O
when WRB O
except IN O
comparing VBG O
H NNP O
* $ O
2 CD O
with IN O
the DT O
other JJ O
machine NN O
and CC O
the DT O
reference NN O
methods NNS O
, , O
except IN O
for IN O
MCHCH NNP O
and CC O
basophil NN O
count NN O
. . O

Soluble JJ O
FasR NNP B-Gene
ligand NN O
- : O
binding NN O
domain NN O
: : O
high JJ O
- : O
yield NN O
production NN O
of IN O
active JJ O
fusion NN O
and CC O
non JJ O
- : O
fusion NN O
recombinant JJ O
proteins VBZ O
using VBG O
the DT O
baculovirus NN O
/ NNP O
insect NN O
cell NN O
system NN O
. . O

To TO O
avoid VB O
misinterpretations NNS O
, , O
special JJ O
reference NN O
values NNS O
should MD O
be VB O
applied VBN O
for IN O
preadolescents NNS O
, , O
at IN O
least JJS O
with IN O
regard NN O
to TO O
FVC NNP O
and CC O
FEV1 NNP O
. . O

Cosmid NNP O
clones NNS O
containing VBG O
both DT O
VNTR NNP O
sequences NNS O
were VBD O
identified VBN O
, , O
and CC O
restriction NN O
mapping NN O
showed VBD O
them PRP O
to TO O
be VB O
less JJR O
than IN O
15 CD O
kb JJ O
apart RB O
. . O

DNA NN O
from IN O
PCR NNP O
was VBD O
labeled VBN O
and CC O
used VBN O
to TO O
isolate VB O
several JJ O
lambda NNS O
gt11 VBP O
cDNA NN O
clones NNS O
, , O
including VBG O
one CD O
full JJ O
- : O
length NN O
one CD O
( ( O
Dd NNP B-Gene
kinase NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

Letter NN O
: : O
Is VBZ O
actinic JJ O
( ( O
solar JJ O
) ) O
damage NN O
the DT O
provoking NN O
cause NN O
of IN O
' '' O
post NN O
- : O
inflammatory NN O
elastolysis NN O
and CC O
cutis NN O
laxa NN O
( ( O
PECL NNP O
) ) O
' POS O
? . O

Consistent JJ O
with IN O
the DT O
specificity NN O
observed VBD O
for IN O
the DT O
interaction NN O
of IN O
DmCKIIalpha NNP B-Gene
with IN O
these DT O
bHLH NNS B-Gene
proteins NNS I-Gene
, , O
sequence NN O
alignment NN O
suggests VBZ O
that IN O
only RB O
m5 NN B-Gene
, , O
m7 NN B-Gene
, , O
and CC O
m8 RB B-Gene
contain VB O
a DT O
consensus NN O
site NN O
for IN O
phosphorylation NN O
by IN O
CKII NNP B-Gene
within IN O
a DT O
subdomain NN O
unique NN O
to TO O
these DT O
three CD O
proteins NNS O
. . O

These DT O
mutations NNS O
are VBP O
localized VBN O
in IN O
the DT O
same JJ O
region NN O
where WRB O
the DT O
HSV NNP B-Gene
transactivator NN I-Gene
VP16 NNP I-Gene
binds VBZ O
, , O
but CC O
did VBD O
not RB O
coincide VB O
with IN O
the DT O
VP16 NNP B-Gene
contacts NNS O
. . O

Examination NN O
of IN O
the DT O
mitochondrial JJ B-Gene
bc1 NN I-Gene
complex JJ I-Gene
crystal NN I-Gene
structure NN I-Gene
[ NNP O
Zhang NNP O
, , O
Z NNP O
. . O
, , O
Huang NNP O
, , O
L NNP O
. . O
, , O
Shulmeister NNP O
, , O
V NNP O
. . O

Testing VBG O
was VBD O
associated VBN O
with IN O
a DT O
history NN O
of IN O
nonsexual JJ O
risk NN O
behavior NN O
, , O
increased VBD O
knowledge NN O
of IN O
the DT O
hepatitis NN O
C NNP O
virus NN O
, , O
and CC O
healthcare JJ O
provider NN O
communication NN O
. . O

In IN O
the DT O
COPD NNP O
patients NNS O
, , O
the DT O
variability NN O
of IN O
Delta NNP O
- : O
inst NN O
Rrs NNP O
( ( O
30 CD O
% NN O
) ) O
was VBD O
greater JJR O
than IN O
that DT O
of IN O
FOT NNP O
Rrs NNP O
( ( O
21 CD O
% NN O
) ) O
. . O

The DT O
novel JJ O
protein NN O
kinases NNS O
, , O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
NH2 NNP I-Gene
- : I-Gene
terminal NN I-Gene
kinases NNS I-Gene
( ( O
JNKs NNP B-Gene
) ) O
/ NNP O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinases NNS I-Gene
, , O
are VBP O
also RB O
activated VBN O
by IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
CD28 NNP B-Gene
costimulation NN O
. . O

Whereas NNP O
Smad2 NNP B-Gene
was VBD O
rapidly RB O
phosphorylated VBN O
by IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
and CC O
involved VBN O
in IN O
the DT O
initial JJ O
activation NN O
of IN O
Agc NNP B-Gene
expression NN O
in IN O
confluent NN O
cells NNS O
, , O
Smad2 NNP B-Gene
activation NN O
was VBD O
not RB O
required VBN O
for IN O
maintaining VBG O
the DT O
high JJ O
level NN O
of IN O
Agc NNP B-Gene
expression NN O
. . O

All DT O
pigs NNS O
had VBD O
significant JJ O
regional JJ O
LV NNP O
dysfunction NN O
and CC O
reduced JJ O
LV NNP O
ejection NN O
fraction NN O
( ( O
41 CD O
+ NN O
/ NNP O
- : O
11 CD O
% NN O
) ) O
. . O

Besides IN O
, , O
we PRP O
found VBD O
in IN O
3 CD O
patients NNS O
increased VBD O
serum JJ B-Gene
immunoglobulins NNS I-Gene
, , O
chiefly NN O
IgG NNP B-Gene
, , O
as IN O
first JJ O
Russe NNP O
, , O
Busey NNP O
and CC O
Barbeau NNP O
demonstrated VBD O
in IN O
a DT O
large JJ O
French JJ O
- : O
Canadian JJ O
family NN O
. . O

Hepatic JJ O
oxygen NN O
supply NN O
and CC O
selected VBN O
blood NN O
parameters NNS O
were VBD O
recorded VBN O
in IN O
fasted JJ O
male NN O
rates NNS O
given VBN O
20 CD O
- : O
- : O
30 CD O
mg NN O
/ NNP O
kg NNP O
Escherichia NNP B-Gene
coli NN I-Gene
endotoxin NN I-Gene
intraperitoneally RB O
. . O

Another DT O
segment NN O
of IN O
CRL3 NNP B-Gene
( ( O
- : O
296 CD O
to TO O
- : O
184 CD O
) ) O
, , O
also RB O
displaying VBG O
enhancer NN O
function NN O
, , O
contained VBN O
tandem NN O
repeated VBN O
sequences NNS O
( ( O
DR NNP O
- : O
A1 NNP O
and CC O
DR NNP O
- : O
A2 NN O
) ) O
. . O

The DT O
xylose JJ B-Gene
isomerase NN I-Gene
- : I-Gene
encoding VBG I-Gene
gene NN I-Gene
( ( O
xylA NNP B-Gene
) ) O
of IN O
Clostridium NNP O
thermosaccharolyticum NN O
: : O
cloning NN O
, , O
sequencing VBG O
and CC O
phylogeny NN O
of IN O
XylA NNP B-Gene
enzymes NNS I-Gene
. . O

Rho NNP B-Gene
GDP NNP I-Gene
/ NNP I-Gene
GTP NNP I-Gene
exchange NN I-Gene
inhibitor NN I-Gene
, , O
Rho NNP B-Gene
GDI NNP I-Gene
, , O
comigrated VBD O
with IN O
Rac2 NNP B-Gene
and CC O
RhoA NNP B-Gene
, , O
but CC O
not RB O
Rac1 NNP B-Gene
. . O

The DT O
tyrosine NN O
- : O
phosphorylated JJ O
state NN O
of IN O
CAK NNP B-Gene
beta NN I-Gene
was VBD O
not RB O
reduced VBN O
on IN O
trypsinization NN O
, , O
nor CC O
enhanced VBD O
in IN O
response NN O
to TO O
plating VBG O
3Y1 CD O
cells NNS O
onto IN O
fibronectin NN B-Gene
. . O

An DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
protein NN O
which WDT O
shows VBZ O
significant JJ O
similarity NN O
to TO O
invertases NNS B-Gene
and CC O
resolvases NNS B-Gene
was VBD O
located VBN O
immediately RB O
upstream NN O
of IN O
the DT O
Pac25I NNP B-Gene
R NNP B-Gene
- : I-Gene
M NNP I-Gene
operon NN I-Gene
. . O

In IN O
a DT O
112 CD O
- : O
d NN O
feedlot NN O
trial NN O
, , O
105 CD O
heifers NNS O
were VBD O
assigned VBN O
to TO O
light NN O
, , O
medium NN O
and CC O
heavy JJ O
weight NN O
blocks NNS O
on IN O
five CD O
treatments NNS O
: : O
dietary JJ O
MGA NNP O
( ( O
. . O
5 CD O
mg NN O
. . O
hd VB O
- : O
1 CD O
. . O
d VB O
- : O
1 CD O
) ) O
, , O
control NN O
( ( O
no DT O
MGA NNP O
) ) O
or CC O
DEPO NNP O
- : O
MGA NN O
on IN O
d NN O
1 CD O
at IN O
. . O
5 CD O
, , O
1 CD O
. . O
0 CD O
or CC O
1 CD O
. . O
5 CD O
ml JJ O
/ NN O
hd NN O
( ( O
30 CD O
, , O
60 CD O
or CC O
90 CD O
mg NNS O
MGA NNP O
/ NNP O
hd NN O
, , O
respectively RB O
) ) O
. . O

Obesity NN O
was VBD O
strongly RB O
associated VBN O
with IN O
the DT O
proportions NNS O
of IN O
nonprotein JJ O
- : O
bound NN O
and CC O
albumin JJ B-Gene
- : O
bound NN O
estradiol NN O
, , O
and CC O
inversely RB O
associated VBN O
with IN O
sex NN B-Gene
hormone NN I-Gene
binding VBG I-Gene
globulin NN I-Gene
( ( O
SHBG NNP B-Gene
) ) O
levels NNS O
and CC O
the DT O
proportion NN O
of IN O
SHBG NNP B-Gene
- : O
bound NN O
estradiol NN O
. . O

Acta NNP O
572 CD O
, , O
113 CD O
- : O
120 CD O
] NN O
. . O

The DT O
expression NN O
pattern NN O
of IN O
GL2 NNP B-Gene
, , O
as IN O
demonstrated VBN O
by IN O
in IN O
situ JJ O
hybridization NN O
, , O
indicated VBD O
that IN O
the DT O
gene NN O
is VBZ O
expressed VBN O
in IN O
trichome JJ O
progenitor NN O
cells NNS O
and CC O
at IN O
stages NNS O
associated VBN O
with IN O
trichome NN O
development NN O
. . O

Radiative JJ O
corrections NNS O
to TO O
beta VB O
decay NN O
and CC O
the DT O
possibility NN O
of IN O
a DT O
fourth JJ O
generation NN O
. . O

Integrin NNP B-Gene
adhesion NN I-Gene
receptors NNS I-Gene
transduce VBP O
signals NNS O
that WDT O
control VBP O
complex JJ O
cell NN O
functions NNS O
which WDT O
require VBP O
the DT O
regulation NN O
of IN O
gene NN O
expression NN O
, , O
such JJ O
as IN O
proliferation NN O
, , O
differentiation NN O
and CC O
survival NN O
. . O

Compared VBN O
with IN O
normal JJ O
control NN O
subjects NNS O
, , O
all DT O
74 CD O
TOF NNP O
patients NNS O
had VBD O
decreased VBN O
systolic JJ O
and CC O
diastolic JJ O
myocardial JJ O
velocities NNS O
and CC O
a DT O
longer RBR O
isovolumic JJ O
relaxation NN O
time NN O
. . O

In IN O
fact NN O
, , O
SPT NNP B-Gene
activity NN O
in IN O
the DT O
fly NN O
expressing VBG O
epitope SYM O
- : O
tagged VBD O
Lace NNP B-Gene
was VBD O
absorbed VBN O
by IN O
epitope NN O
- : O
specific JJ O
antibody NN O
. . O

Per NNP O
kg NN O
FFM NNP O
SMR NNP O
was VBD O
almost RB O
restored VBN O
to TO O
baseline VB O
values NNS O
for IN O
the DT O
EX NNP O
group NN O
, , O
whereas IN O
the DT O
non JJ O
- : O
exercising NN O
subjects NNS O
still RB O
showed VBD O
depressed JJ O
values NNS O
( ( O
EX NNP O
3 CD O
. . O
7 CD O
per IN O
cent NN O
and CC O
D NNP O
+ NNP O
DE NNP O
15 CD O
. . O
8 CD O
per IN O
cent NN O
lower JJR O
than IN O
before RB O
treatment NN O
; : O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Bailey NNP O
Instruments NNS O
and CC O
Owen NNP O
Mumford NNP O
filaments NNS O
were VBD O
the DT O
most RBS O
accurate JJ O
with IN O
100 CD O
% NN O
buckling NN O
within IN O
+ NNP O
/ NNP O
- : O
1 CD O
. . O
0 CD O
g NN O
of IN O
10 CD O
g NN O
. . O

Tributyltin NNP O
and CC O
its PRP$ O
breakdown NN O
products NNS O
, , O
mono FW O
- : O
and CC O
di VB O
- : O
butyltin NN O
, , O
were VBD O
determined VBN O
in IN O
water NN O
birds NNS O
collected VBN O
from IN O
Lake NNP O
Huron NNP O
( ( O
the DT O
Great NNP O
Lakes NNP O
) ) O
, , O
marine JJ O
coastal NN O
United NNP O
States NNPS O
, , O
and CC O
the DT O
west JJS O
coast NN O
of IN O
British NNP O
Columbia NNP O
, , O
Canada NNP O
. . O

LMP2A NNP B-Gene
enhances VBZ O
Lyn NNP B-Gene
and CC O
Syk NNP B-Gene
ubiquitination NN O
in IN O
vivo NN O
in IN O
a DT O
fashion NN O
that WDT O
depends VBZ O
on IN O
the DT O
activity NN O
of IN O
Nedd4 NNP B-Gene
family NN O
members NNS O
and CC O
correlates NNS O
with IN O
destabilization NN O
of IN O
the DT O
Lyn NNP B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
. . O

From IN O
the DT O
15 CD O
- : O
kb NN O
clone NN O
a DT O
4 CD B-Gene
- : I-Gene
kb NN I-Gene
EcoRI NNP I-Gene
fragment NN I-Gene
containing VBG O
the DT O
first JJ O
two CD O
exons NNS O
and CC O
2 CD O
. . O
6 CD O
kb NN O
of IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
opn JJ B-Gene
gene NN I-Gene
was VBD O
sequenced VBN O
, , O
and CC O
the DT O
transcriptional JJ O
start NN O
site NN O
determined VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
and CC O
S1 NNP B-Gene
nuclease NN I-Gene
mapping NN O
. . O

The DT O
effect NN O
of IN O
salmon NN B-Gene
calcitonin NN I-Gene
nasal NN O
spray NN O
in IN O
women NNS O
with IN O
established VBN O
osteoporosis NN O
has VBZ O
also RB O
been VBN O
studied VBN O
. . O

Superoxide JJ B-Gene
dismutase NN I-Gene
( ( O
SOD NNP B-Gene
) ) O
activity NN O
decreased VBN O
significantly RB O
in IN O
sperm NN O
subjected VBN O
to TO O
direct VB O
electric JJ O
current JJ O
in IN O
comparison NN O
to TO O
the DT O
control NN O
or CC O
the DT O
sample NN O
incubated VBN O
with IN O
electrolyzed JJ O
medium NN O
. . O

The DT O
derivatives NNS O
of IN O
the DT O
latter JJ O
two CD O
cell NN O
lines NNS O
showed VBD O
increased JJ O
expression NN O
of IN O
the DT O
p27Kip1 NN B-Gene
protein NN I-Gene
and CC O
inhibition NN O
of IN O
cell NN O
growth NN O
. . O

In IN O
all DT O
eight CD O
cases NNS O
, , O
neither CC O
FL NNP O
nor CC O
DLL NNP O
cells NNS O
showed VBD O
alterations NNS O
of IN O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
sequences NNS I-Gene
in IN O
the DT O
breakpoint NN O
region NN O
, , O
suggesting VBG O
high JJ O
conservation NN O
of IN O
the DT O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
during IN O
both DT O
t NNP O
( ( O
14 CD O
; : O
18 CD O
) ) O
translocation NN O
and CC O
morphologic JJ O
transformation NN O
of IN O
the DT O
FL NNP O
cells NNS O
. . O

The DT O
clinico NN O
- : O
pathological JJ O
data NNS O
from IN O
a DT O
patient NN O
with IN O
irreversible JJ O
post NN O
- : O
partum NN O
renal JJ O
failure NN O
( ( O
IPRF NNP O
) ) O
are VBP O
presented VBN O
. . O

The DT O
1 CD O
. . O
1 CD O
- : O
and CC O
1 CD O
. . O
3 CD O
- : O
kb NN O
mRNA NN O
species NNS O
were VBD O
found VBN O
only RB O
in IN O
the DT O
heart NN O
, , O
and CC O
the DT O
2 CD O
. . O
6 CD O
- : O
kb NN O
species NNS O
was VBD O
found VBN O
in IN O
the DT O
heart NN O
, , O
kidney NN O
and CC O
brain NN O
, , O
but CC O
not RB O
in IN O
skeletal JJ O
muscle NN O
or CC O
liver NN O
. . O

Mg NNP B-Gene
- : I-Gene
chelatase NN I-Gene
of IN O
tobacco NN O
: : O
identification NN O
of IN O
a DT O
Chl NNP B-Gene
D NNP I-Gene
cDNA NN I-Gene
sequence NN I-Gene
encoding VBG O
a DT O
third JJ O
subunit NN O
, , O
analysis NN O
of IN O
the DT O
interaction NN O
of IN O
the DT O
three CD O
subunits NNS O
with IN O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
, , O
and CC O
reconstitution NN O
of IN O
the DT O
enzyme NN O
activity NN O
by IN O
co NN O
- : O
expression NN O
of IN O
recombinant JJ B-Gene
CHL NNP I-Gene
D NNP I-Gene
, , O
CHL NNP B-Gene
H NNP I-Gene
and CC O
CHL NNP B-Gene
I PRP I-Gene
. . O

To TO O
study VB O
the DT O
functional JJ O
differences NNS O
between IN O
cutaneous JJ O
HPV5 NNP O
and CC O
HPV8 NNP O
E7s NNP B-Gene
and CC O
genital JJ B-Gene
HPV16 NNP I-Gene
E7 NNP I-Gene
, , O
we PRP O
cloned VBD O
each DT O
of IN O
the DT O
E7 NNP B-Gene
open JJ O
reading NN O
frames NNS O
and CC O
tested VBD O
their PRP$ O
immortalizing NN O
and CC O
transforming NN O
activities NNS O
, , O
the DT O
binding VBG O
ability NN O
of IN O
their PRP$ O
products NNS O
with IN O
retinoblastoma NN B-Gene
protein NN I-Gene
( ( O
RB NNP B-Gene
) ) O
and CC O
their PRP$ O
complementation NN O
activity NN O
of IN O
a DT O
RB NNP B-Gene
- : I-Gene
nonbinding VBG I-Gene
adenovirus NN I-Gene
E1A NNP I-Gene
mutant NN I-Gene
. . O

The DT O
expressed VBN O
G1 NNP B-Gene
- : O
G2 NNP B-Gene
bound NN O
to TO O
both DT O
hyaluronan NN O
and CC O
link NN B-Gene
protein NN I-Gene
indicating VBG O
that IN O
the DT O
immunoglobulin NN B-Gene
- : I-Gene
fold NN I-Gene
motif NN I-Gene
and CC O
proteoglycan JJ O
tandem NN O
repeat NN O
loops NNS O
of IN O
the DT O
G1 NNP B-Gene
domain NN I-Gene
were VBD O
correctly RB O
folded VBN O
. . O

Hepatitis NN O
B NNP O
vaccine NN O
: : O
still RB O
has VBZ O
its PRP$ O
problems NNS O
. . O

High JJ O
- : O
resolution NN O
structure NN O
of IN O
the DT O
diphtheria NN B-Gene
toxin NN I-Gene
repressor NN I-Gene
complexed VBN O
with IN O
cobalt NN O
and CC O
manganese JJ O
reveals NNS O
an DT O
SH3 NNP B-Gene
- : I-Gene
like IN I-Gene
third JJ O
domain NN O
and CC O
suggests VBZ O
a DT O
possible JJ O
role NN O
of IN O
phosphate NN O
as IN O
co JJ O
- : O
corepressor NN O
. . O

Do VB O
overall JJ O
treatment NN O
time NN O
, , O
field NN O
size NN O
, , O
and CC O
treatment NN O
energy NN O
influence NN O
local JJ O
control NN O
of IN O
T1 NNP O
- : O
T2 NNP O
squamous JJ O
cell NN O
carcinomas NN O
of IN O
the DT O
glottic JJ O
larynx NN O
? . O

PURPOSE NN O
: : O
To TO O
evaluate VB O
treatment NN O
and CC O
patient NN O
related VBN O
prognostic JJ O
factors NNS O
that WDT O
may MD O
influence VB O
local JJ O
control NN O
in IN O
the DT O
treatment NN O
of IN O
T1 NNP O
- : O
T2 NNP O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
glottic JJ O
larynx NN O
. . O

A DT O
review NN O
of IN O
studies NNS O
published VBN O
between IN O
1983 CD O
and CC O
1995 CD O
shows NNS O
that IN O
there EX O
are VBP O
some DT O
common JJ O
factors NNS O
as IN O
regards NNS O
the DT O
psychological JJ O
distress NN O
and CC O
social JJ O
and CC O
functional JJ O
limitations NNS O
this DT O
group NN O
of IN O
patients NNS O
has VBZ O
to TO O
deal VB O
with IN O
. . O

Contagious JJ O
bovine NN O
pleuropneumonia NN O
is VBZ O
a DT O
major JJ O
threat NN O
for IN O
cattle NNS O
in IN O
Africa NNP O
. . O

RNP1 NNP B-Gene
, , O
a DT O
new JJ O
ribonucleoprotein JJ O
gene NN O
of IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
yeast NN B-Gene
LPD1 NNP I-Gene
gene NN I-Gene
encoding VBG O
lipoamide JJ B-Gene
dehydrogenase NN I-Gene
is VBZ O
subject JJ O
to TO O
the DT O
general JJ O
control NN O
of IN O
amino NN O
acid JJ O
biosynthesis NN O
mediated VBN O
by IN O
the DT O
GCN4 NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

Well RB O
- : O
visualised JJ O
arteriograms NNS O
of IN O
the DT O
limbs NNS O
can MD O
be VB O
obtained VBN O
by IN O
xeroradiography NN O
after IN O
rapid JJ O
manual JJ O
injection NN O
of IN O
contrast NN O
- : O
medium NN O
into IN O
an DT O
arm NN O
vein NN O
, , O
as IN O
demonstrated VBN O
in IN O
28 CD O
patients NNS O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
the DT O
Src NNP B-Gene
homology NN I-Gene
- : I-Gene
2 CD I-Gene
( ( O
SH2 NNP B-Gene
) ) O
domain VBP O
- : O
containing VBG O
protein SYM B-Gene
- : I-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
, , O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
associates NNS O
with IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
PECAM NNP B-Gene
- : I-Gene
1 CD I-Gene
as IN O
it PRP O
becomes VBZ O
tyrosine JJ O
- : O
phosphorylated VBN O
during IN O
platelet JJ O
aggregation NN O
: : O
a DT O
process NN O
that WDT O
can MD O
be VB O
mimicked VBN O
in IN O
part NN O
by IN O
small JJ O
synthetic JJ O
phosphopeptides NNS O
corresponding VBG O
to TO O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
PECAM NNP B-Gene
- : I-Gene
1 CD I-Gene
encompassing VBG O
tyrosine NN O
residues NNS O
Tyr NNP O
- : O
663 CD O
or CC O
Tyr NNP O
- : O
686 CD O
. . O

Serum NNP O
HBV NNP O
- : O
DNA NN O
, , O
viral JJ O
serology NN O
, , O
and CC O
liver RB O
enzymes NNS O
were VBD O
measured VBN O
sequentially RB O
; : O
liver CC O
histology NN O
was VBD O
taken VBN O
before RB O
and CC O
during IN O
treatment NN O
in IN O
12 CD O
patients NNS O
. . O

NIRS NNP O
was VBD O
used VBN O
for IN O
the DT O
quantitative JJ O
measurement NN O
of IN O
muscle NN O
O NNP O
( ( O
2 CD O
) ) O
consumption NN O
( ( O
mV NN O
. . O
O NNP O
( ( O
2 CD O
) ) O
) ) O
and CC O
forearm JJ O
blood NN O
flow NN O
( ( O
FBF NNP O
) ) O
in IN O
78 CD O
healthy JJ O
subjects NNS O
. . O

CONCLUSION NN O
: : O
Our PRP$ O
findings NNS O
suggest VBP O
that IN O
endometriosis NN O
increases NNS O
soluble JJ O
CD23 NNP B-Gene
levels NNS O
, , O
which WDT O
can MD O
be VB O
suppressed VBN O
with IN O
either DT O
danazol NN O
or CC O
leuprolide JJ O
acetate JJ O
injection NN O
. . O

Keck NNP O
, , O
C NNP O
. . O
J NNP O
. . O

Data NNS O
on IN O
prosthesis NN O
use NN O
are VBP O
encouraging VBG O
, , O
although IN O
a DT O
follow JJ O
- : O
up RB O
study NN O
is VBZ O
required VBN O
to TO O
determine VB O
the DT O
functional JJ O
outcome NN O
for IN O
prosthesis NN O
users NNS O
and CC O
non JJ O
- : O
users NNS O
. . O

SPP41 NNP B-Gene
was VBD O
cloned VBN O
and CC O
sequenced VBN O
and CC O
found VBN O
to TO O
be VB O
essential JJ O
. . O

spp43 NN B-Gene
is VBZ O
allelic JJ O
to TO O
the DT O
previously RB O
identified VBN O
suppressor NN B-Gene
srn1 NN I-Gene
, , O
which WDT O
encodes VBZ O
a DT O
negative JJ O
regulator NN O
of IN O
gene NN O
expression NN O
. . O

The DT O
RPO1 NNP B-Gene
of IN O
LCDV NNP O
shows VBZ O
the DT O
highest JJS O
similarity NN O
to TO O
the DT O
RPO1 NNP B-Gene
of IN O
IIV6 NNP O
and CC O
significant JJ O
lower JJR O
similarity NN O
to TO O
the DT O
eukaryotic JJ B-Gene
polymerases NNS I-Gene
II NNP I-Gene
and CC I-Gene
III NNP I-Gene
as RB O
well RB O
as IN O
to TO O
the DT O
archaebacteral JJ O
subunit NN O
. . O

The DT O
human JJ O
coreceptor NN O
was VBD O
as RB O
active JJ O
as IN O
the DT O
simian NN O
for IN O
SIV NNP O
entry NN O
. . O

The DT O
N NNP O
- : O
terminal JJ O
domain NN O
of IN O
approximately RB O
70 CD O
kDa VBD O
exhibits NNS O
11 CD O
imperfect JJ O
amino NN O
acid NN O
repeats VBZ O
that IN O
show VB O
some DT O
homology NN O
to TO O
promastigote VB O
surface NN O
glycoproteins NNS O
of IN O
the DT O
psa2 NN B-Gene
/ NNP O
gp46 NN B-Gene
complex NN O
. . O

Comparison NNP O
of IN O
promoters NNS O
repressed VBN O
by IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
reveals VBZ O
a DT O
weak JJ O
consensus NN O
sequence NN O
of IN O
the DT O
initiator NN O
( ( O
Inr NNP O
) ) O
element NN O
: : O
TCA NNP O
( ( O
+ NNP O
1 CD O
) ) O
YYYNY NN O
. . O

We PRP O
have VBP O
identified VBN O
and CC O
characterized VBN O
a DT O
vitamin NN O
D NNP O
response NN O
element NN O
( ( O
VDRE NNP O
) ) O
in IN O
the DT O
promoter NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
. . O

Nine NNP O
cases NNS O
of IN O
GBS NNP O
and CC O
five CD O
of IN O
TM NN O
reported VBN O
to TO O
the DT O
active JJ O
AFP NNP O
surveillance NN O
were VBD O
not RB O
found VBN O
in IN O
the DT O
hospital NN O
searches NNS O
. . O

Examination NN O
of IN O
nuclear JJ O
magnetic JJ O
resonance NN O
( ( O
NMR NNP O
) ) O
spectra NN O
of IN O
a DT O
series NN O
of IN O
N NNP B-Gene
- : I-Gene
terminally RB I-Gene
truncated VBN I-Gene
MIP NNP I-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
variants NNS I-Gene
reveals VBZ O
that IN O
these DT O
proteins NNS O
possess VBP O
a DT O
range NN O
of IN O
ability NN O
to TO O
dimerize VB O
. . O

Subsequent JJ O
experiments NNS O
showed VBD O
that IN O
motoric JJ O
tasks NNS O
rather RB O
than IN O
cognitive JJ O
aspects NNS O
of IN O
the DT O
COWA NNP O
task NN O
were VBD O
critical JJ O
in IN O
potentiating VBG O
finger NN O
- : O
tapping NN O
performance NN O
. . O

The DT O
complete JJ O
exon SYM O
- : O
intron NN O
organization NN O
of IN O
the DT O
murine NN O
gene NN O
encoding VBG O
M NNP B-Gene
- : I-Gene
protein NN I-Gene
, , O
a DT O
structural JJ O
protein NN O
of IN O
sarcomeric JJ O
myofibrils NNS O
, , O
was VBD O
determined VBN O
. . O

The DT O
low JJ O
molecular JJ O
mass NN O
polypeptide NN O
complex NN O
is VBZ O
assumed VBN O
to TO O
be VB O
involved VBN O
in IN O
antigen NN O
presentation NN O
, , O
generating VBG O
peptides NNS O
from IN O
cytosolic JJ O
protein NN O
antigens NNS O
, , O
which WDT O
are VBP O
subsequently RB O
presented VBN O
to TO O
cytotoxic VB O
T NNP O
- : O
lymphocytes VBZ O
on IN O
the DT O
cell NN O
surface NN O
. . O

The DT O
odds NNS O
ratio NN O
for IN O
CHD NNP O
was VBD O
1 CD O
. . O
21 CD O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
0 CD O
. . O
84 CD O
- : O
1 CD O
. . O
75 CD O
) ) O
given VBN O
a DT O
positive JJ O
serostatus NN O
of IN O
specific JJ O
IgG NNP B-Gene
antibodies NNS O
after IN O
adjustment NN O
for IN O
covariates NNS O
. . O

The DT O
available JJ O
data NNS O
suggest VBP O
that IN O
the DT O
NF NNP B-Gene
kappa NNP I-Gene
B2 NNP I-Gene
nucleoprotein RB I-Gene
complex JJ I-Gene
may MD O
cooperate VB O
with IN O
DNA NNP O
- : O
bound NN O
STAT6 NNP B-Gene
to TO O
achieve VB O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
dependent JJ O
activation NN O
of IN O
the DT O
human JJ B-Gene
IgE NNP I-Gene
germline NN I-Gene
gene NN I-Gene
. . O

Human JJ O
isoforms NNS O
, , O
designated VBD O
1 CD O
to TO O
4 CD O
, , O
differ NN O
from IN O
each DT O
other JJ O
by IN O
the DT O
start NN O
codon NN O
used VBN O
. . O

Effect NN O
of IN O
biliary JJ O
obstruction NN O
and CC O
cholangitis NN O
on IN O
serum NN B-Gene
SPan NNP I-Gene
- : I-Gene
1 CD I-Gene
level NN O

The DT O
microdensitometric JJ O
scores NNS O
and CC O
their PRP$ O
side NN O
- : O
to TO O
- : O
side NN O
differences NNS O
in IN O
patients NNS O
correlated VBN O
negatively RB O
with IN O
the DT O
serum NN O
25 CD O
- : O
OHD NN O
concentration NN O
and CC O
positively RB O
with IN O
the DT O
degree NN O
of IN O
paralysis NN O
. . O

RESULTS NN O
: : O
Acetabular JJ O
index NN O
returned VBD O
to TO O
normal JJ O
gradually RB O
as IN O
the DT O
time NN O
went VBD O
by IN O
and CC O
significantly RB O
within IN O
one CD O
year NN O
after IN O
the DT O
reduction NN O
of IN O
developmental JJ O
dislocation NN O
of IN O
the DT O
hip NN O
. . O

The DT O
paper NN O
is VBZ O
concerned VBN O
with IN O
the DT O
data NNS O
on IN O
change NN O
in IN O
the DT O
blood NN O
level NN O
of IN O
ACTH NNP B-Gene
, , O
STH NNP B-Gene
, , O
TSH NNP B-Gene
, , O
cortisol NN O
, , O
T3 NNP O
, , O
insulin NN B-Gene
, , O
C NNP B-Gene
- : I-Gene
peptide NN I-Gene
during IN O
a DT O
25 CD O
- : O
minute NN O
session NN O
of IN O
respiration NN O
using VBG O
a DT O
gaseous JJ O
hypoxic NN O
mixture NN O
with IN O
10 CD O
% NN O
oxygen NN O
( ( O
GHM NNP O
- : O
10 CD O
) ) O
. . O

Human NNP B-Gene
LTBP NNP I-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
known VBN O
to TO O
exist VB O
in IN O
different JJ O
forms NNS O
. . O

The DT O
cochlear JJ O
compromise NN O
. . O

Three CD O
chromosomal JJ B-Gene
crsA NN I-Gene
mutations NNS I-Gene
, , O
crsA1 NN B-Gene
, , O
crsA4 NN B-Gene
, , O
and CC O
crsA47 NN B-Gene
, , O
were VBD O
transferred VBN O
by IN O
the DT O
"""" NNP O
gene NN O
conversion NN O
"""" NNP O
process NN O
to TO O
B NNP O
. . O
subtilis NN O
plasmid NN O
pRPD11 NN O
, , O
which WDT O
consists VBZ O
of IN O
the DT O
entire JJ O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
rpoD NN I-Gene
coding VBG I-Gene
sequence NN I-Gene
, , O
encoding VBG O
the DT O
major JJ B-Gene
sigma NN I-Gene
43 CD I-Gene
factor NN I-Gene
of IN I-Gene
B NNP I-Gene
. . I-Gene
subtilis NN I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
, , O
and CC O
pUB110 NN O
. . O

In IN O
Experiment NNP O
II NNP O
, , O
as IN O
performing VBG O
moderate JJ O
supine NN O
cycling NN O
( ( O
55 CD O
% NN O
VO2 NNP O
max NN O
) ) O
for IN O
50 CD O
minutes NNS O
under IN O
several JJ O
LBNP NNP O
conditions NNS O
in IN O
5 CD O
sedentary JJ O
women NNS O
, , O
there EX O
were VBD O
correspondingly RB O
similar JJ O
changing VBG O
manners NNS O
of IN O
the DT O
cardiovascular JJ O
adjustments NNS O
to TO O
each DT O
of IN O
the DT O
phases NNS O
given VBN O
in IN O
Experiment NNP O
I PRP O
. . O

The DT O
RNA NNP O
transcripts NNS O
structurally RB O
equivalent JJ O
to TO O
I PRP B-Gene
( ( I-Gene
2 CD I-Gene
) ) I-Gene
sgRNAs NN I-Gene
of IN O
TMV NNP B-Gene
U1 NNP I-Gene
and CC O
crTMV NN O
, , O
but CC O
containing VBG O
a DT O
hairpin NN O
structure NN O
( ( O
H NNP O
) ) O
immediately RB O
upstream NN O
of IN O
IRES NNP B-Gene
( ( I-Gene
MP NNP I-Gene
, , I-Gene
75 CD I-Gene
) ) I-Gene
( ( I-Gene
HIRES NNP I-Gene
( ( I-Gene
MP NNP I-Gene
) ) I-Gene
, , I-Gene
( ( I-Gene
75 CD I-Gene
) ) I-Gene
( ( I-Gene
CR NNP I-Gene
) ) I-Gene
- : I-Gene
MP NNP I-Gene
- : I-Gene
CP NNP I-Gene
- : I-Gene
3 CD I-Gene
' '' I-Gene
UTR NNP I-Gene
; : O
HIRES NNP B-Gene
( ( I-Gene
MP NNP I-Gene
, , I-Gene
75 CD I-Gene
) ) I-Gene
( ( I-Gene
U1 NNP I-Gene
) ) I-Gene
- : I-Gene
MP NNP I-Gene
- : I-Gene
CP NNP I-Gene
- : I-Gene
3 CD I-Gene
' '' I-Gene
UTR NNP I-Gene
) ) O
, , O
were VBD O
able JJ O
to TO O
express VB O
the DT O
MP NNP B-Gene
gene NN I-Gene
in IN O
vitro NN O
. . O

Positive JJ O
shifts NNS O
of IN O
basal NN O
skin JJ O
potentials NNS O
during IN O
human JJ O
sleep NN O
. . O

GafChromic NNP O
( ( O
MD NNP O
- : O
55 CD O
- : O
2 CD O
) ) O
radiochromic NN O
film NN O
has VBZ O
become VBN O
increasingly RB O
popular JJ O
for IN O
medical JJ O
applications NNS O
and CC O
has VBZ O
proven VBN O
to TO O
be VB O
useful JJ O
for IN O
brachytherapy NN O
dosimetry NN O
. . O

Although IN O
olfactory JJ O
associative JJ O
conditioning NN O
in IN O
newborn JJ O
rats NNS O
produces VBZ O
marked JJ O
structural JJ O
and CC O
functional JJ O
changes NNS O
in IN O
the DT O
olfactory NN O
bulb NN O
, , O
recent JJ O
evidence NN O
suggests VBZ O
that IN O
extrabulbar NN O
circuits NNS O
must MD O
be VB O
involved VBN O
in IN O
storing VBG O
these DT O
early JJ O
memories NNS O
. . O

CYP2C19 NNP B-Gene
genotype NN I-Gene
was VBD O
determined VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
- : O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
method NN O
. . O

Evolutionary JJ O
relationships NNS O
among IN O
putative JJ O
RNA NNP B-Gene
- : I-Gene
dependent NN I-Gene
RNA NNP I-Gene
polymerases NNS I-Gene
encoded VBN O
by IN O
a DT O
mitochondrial JJ O
virus NN O
- : O
like IN O
RNA NNP O
in IN O
the DT O
Dutch JJ O
elm NN O
disease NN O
fungus NN O
, , O
Ophiostoma NNP O
novo SYM O
- : O
ulmi NN O
, , O
by IN O
other JJ O
viruses NNS O
and CC O
virus SYM O
- : O
like IN O
RNAs NNP O
and CC O
by IN O
the DT O
Arabidopsis NNP O
mitochondrial JJ O
genome NN O
. . O

Abp1 NNP B-Gene
preferentially RB O
binds VBZ O
to TO O
multiple VB O
sites NNS O
in IN O
ARS NNP B-Gene
3002 CD I-Gene
and CC O
to TO O
the DT O
DNA NNP O
polymer NN O
poly NN O
[ NNP O
d NN O
( ( O
A NNP O
. . O
T NNP O
) ) O
] NN O
. . O

Both DT O
tear JJ O
volume NN O
and CC O
tear JJ O
flow NN O
were VBD O
found VBN O
to TO O
be VB O
significantly RB O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
decreased VBD O
up RB O
to TO O
6 CD O
h NN O
after IN O
instillation NN O
, , O
reaching VBG O
a DT O
minimum JJ O
90 CD O
min NN O
after IN O
application NN O
( ( O
tear JJ O
volume NN O
: : O
- : O
63 CD O
% NN O
; : O
tear JJ O
flow NN O
: : O
- : O
71 CD O
% NN O
) ) O
. . O

A DT O
population NN O
pharmacokinetic JJ O
study NN O
of IN O
cyclosporin NN O
in IN O
organ JJ O
transplant NN O
patients NNS O
, , O
including VBG O
elderly JJ O
allograft NN O
recipients VBZ O
up IN O
to TO O
75 CD O
years NNS O
of IN O
age NN O
, , O
did VBD O
not RB O
identify VB O
age NN O
as IN O
a DT O
covariable JJ O
influencing NN O
cyclosporin NN O
pharmacokinetics NNS O
. . O

Primer NNP O
extension NN O
analysis NN O
and CC O
RNA NNP O
sequencing VBG O
demonstrates NNS O
that IN O
the DT O
transcription NN O
start NN O
point NN O
of IN O
rat NN B-Gene
ODC NNP I-Gene
mRNA NN I-Gene
is VBZ O
located VBN O
303 CD O
nt JJ O
upstream NN O
from IN O
the DT O
A NNP O
residue NN O
in IN O
the DT O
start NN O
codon NN O
. . O

GRFI NNP B-Gene
bound NN O
to TO O
sequences NNS O
at IN O
the DT O
negative JJ O
regulatory JJ O
elements NNS O
( ( O
silencers NNS O
) ) O
of IN O
the DT O
silent JJ B-Gene
mating NN I-Gene
type NN I-Gene
loci NN I-Gene
HML NNP B-Gene
E NNP I-Gene
and CC O
HMR NNP B-Gene
E NNP I-Gene
and CC O
to TO O
the DT O
upstream JJ O
activating NN O
sequence NN O
( ( O
UAS NNP O
) ) O
required VBD O
for IN O
transcription NN O
of IN O
the DT O
MAT NNP B-Gene
alpha NN I-Gene
genes NNS I-Gene
. . O

Cumulated VBN O
maximum JJ O
lod JJ O
scores NNS O
between IN O
FRDA NNP B-Gene
and CC O
D9S5 NNP B-Gene
and CC O
between IN O
FRDA NNP B-Gene
and CC O
D9S15 NNP B-Gene
are VBP O
above IN O
36 CD O
and CC O
61 CD O
, , O
respectively RB O
, , O
at IN O
a DT O
recombination NN O
fraction NN O
of IN O
0 CD O
, , O
indicating VBG O
that IN O
recombination NN O
events NNS O
needed VBN O
to TO O
orient VB O
the DT O
search NN O
of IN O
the DT O
gene NN O
are VBP O
very RB O
difficult JJ O
to TO O
identify VB O
and CC O
ascertain VB O
. . O

The DT O
smallest JJS O
of IN O
the DT O
mini NN O
- : O
Mu JJ O
elements NNS O
is VBZ O
only RB O
7 CD O
. . O
9 CD O
kilobase NN O
pairs NNS O
long RB O
, , O
allowing VBG O
the DT O
cloning NN O
of IN O
DNA NNP O
fragments NNS O
of IN O
up IN O
to TO O
31 CD O
. . O
1 CD O
kilobase NN O
pairs NNS O
, , O
and CC O
the DT O
largest JJS O
of IN O
them PRP O
is VBZ O
21 CD O
. . O
7 CD O
kilobase NN O
pairs NNS O
, , O
requiring VBG O
that IN O
clones NNS O
carry VBP O
insertions NNS O
of IN O
less JJR O
than IN O
17 CD O
. . O
3 CD O
kilobase NN O
pairs NNS O
. . O

We PRP O
also RB O
mapped VBD O
a DT O
3 CD O
' POS O
- : O
polyadenylation NN O
site NN O
504bp CD O
downstream NN O
of IN O
the DT O
TGA NNP O
stop NN O
codon NN O
, , O
consistent JJ O
with IN O
the DT O
2 CD O
. . O
5kb CD O
transcript JJ O
size NN O
. . O

Its PRP$ O
early JJ O
lesions NNS O
were VBD O
characterized VBN O
by IN O
angiomatosis NN O
, , O
vasculopathy NN O
, , O
and CC O
proliferation NN O
of IN O
synoviocytes NNS O
and CC O
fibroblasts NNS O
. . O

Bone NN O
and CC O
bones NNS O
. . O

If IN O
this DT O
is VBZ O
the DT O
case NN O
, , O
identification NN O
and CC O
characterization NN O
of IN O
transcripts NNS O
from IN O
the DT O
Ig NNP B-Gene
loci NN I-Gene
should MD O
permit VB O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
gene NN O
rearrangement JJ O
process NN O
. . O

Bandshift NNP O
experiments NNS O
demonstrate VBP O
that IN O
BmHR3A NNP B-Gene
binds VBZ O
specifically RB O
to TO O
RORE NNP B-Gene
( ( O
Retinoic NNP B-Gene
acid VBZ I-Gene
- : I-Gene
related VBN I-Gene
Orphan NNP I-Gene
receptor NN I-Gene
Response NNP I-Gene
Element NNP I-Gene
) ) O
- : O
like IN O
sequences NNS O
in IN O
the DT O
promoters NNS O
of IN O
both DT O
genes NNS O
, , O
thus RB O
suggesting VBG O
a DT O
direct JJ O
role NN O
for IN O
BmHR3A NNP B-Gene
in IN O
regulating VBG O
the DT O
expression NN O
of IN O
BmGATAbeta NNP B-Gene
and CC O
ESP NNP B-Gene
genes NNS I-Gene
during IN O
vitellogenesis NN O
. . O

Ig NNP B-Gene
heavy JJ I-Gene
chain NN I-Gene
class NN O
switching NN O
is VBZ O
directed VBN O
by IN O
cytokines NNS O
inducing VBG O
transcription NN O
from IN O
unrearranged JJ O
CH NNP B-Gene
genes NNS I-Gene
. . O

In IN O
addition NN O
, , O
these DT O
patients NNS O
show VBP O
both DT O
quantitative JJ O
and CC O
qualitative JJ O
differences NNS O
in IN O
their PRP$ O
infectious JJ O
microbiological JJ O
spectrum NN O
, , O
mainly RB O
in IN O
clean JJ O
- : O
contaminated VBN O
, , O
contaminated VBN O
and CC O
dirty JJ O
surgical JJ O
procedures NNS O
. . O

This DT O
finding NN O
suggested VBD O
that IN O
the DT O
PI3K NNP B-Gene
- : O
Akt NNP B-Gene
activation NN O
pathway NN O
plays VBZ O
some DT O
role NN O
in IN O
the DT O
antiapoptotic JJ O
effect NN O
of IN O
EPO NNP B-Gene
. . O

The DT O
desirability NN O
function NN O
is VBZ O
based VBN O
on IN O
the DT O
search NN O
for IN O
a DT O
global JJ O
optimum NN O
[ NNP O
D NNP O
= NNP O
f NN O
( ( O
Y1 NNP O
, , O
Y2 NNP O
, , O
. . O
. . O
. . O
, , O
Yn NNP O
) ) O
] NN O
by IN O
the DT O
transformation NN O
of IN O
the DT O
measured JJ O
property NN O
to TO O
a DT O
dimensionless NN O
scale NN O
for IN O
each DT O
criterion NN O
. . O

Both DT O
HERV NNP O
- : O
K NNP O
type VBZ O
1 CD O
and CC O
2 CD O
clones NNS O
were VBD O
isolated VBN O
. . O

The DT O
use NN O
of IN O
the DT O
PLCgamma NNP B-Gene
inhibitory NN I-Gene
peptide NN I-Gene
, , O
neomycin NN O
and CC O
the DT O
calcium NN O
chelator NN O
BAPTA NNP O
- : O
AM VBP O
on IN O
oocytes NNS O
expressing VBG O
FGFR1 NNP B-Gene
or CC O
the DT O
stimulation NN O
by IN O
PDGF NNP B-Gene
- : I-Gene
BB NN I-Gene
of IN O
oocytes NNS O
expressing VBG O
PDGFR NNP B-Gene
- : O
FGFR1 NNP B-Gene
mutated VBD O
on IN O
the DT O
PLCgamma NNP B-Gene
binding NN I-Gene
site NN I-Gene
, , O
prevented VBN O
GVBD NNP O
and CC O
ERK2 NNP B-Gene
phosphorylation NN O
. . O

Acetoin NNP O
can MD O
be VB O
reused VBN O
by IN O
the DT O
bacteria NNS O
during IN O
stationary JJ O
phase NN O
when WRB O
other JJ O
carbon NN O
sources NNS O
have VBP O
been VBN O
depleted VBN O
. . O

The DT O
therapy NN O
time NN O
to TO O
deliver VB O
the DT O
NCS NNP O
therapeutic JJ O
dose NN O
of IN O
10000 CD O
RBE NNP O
- : O
cGy NN O
, , O
is VBZ O
27 CD O
times NNS O
longer RB O
when WRB O
157Gd CD O
is VBZ O
used VBN O
instead RB O
of IN O
10B CD O
. . O

As IN O
normal JJ O
B NNP O
cells NNS O
also RB O
present VBP O
this DT O
variant NN O
, , O
the DT O
mechanism NN O
of IN O
CD79b NNP B-Gene
posttranscriptional JJ O
regulation NN O
might MD O
reflect VB O
the DT O
activation NN O
stage NN O
of IN O
the DT O
normal JJ O
B NNP O
cell NN O
from IN O
which WDT O
B NNP O
- : O
CLL NN O
derives NNS O
. . O

( ( O
1991 CD O
) ) O
. . O

C NNP O
. . O

13 CD O
men NNS O
with IN O
a DT O
history NN O
of IN O
recurrent JJ O
genital JJ O
herpes NNS O
simplex JJ O
virus NN O
type NN O
2 CD O
( ( O
HSV NNP O
- : O
2 CD O
) ) O
infection NN O
were VBD O
followed VBN O
daily RB O
for IN O
4 CD O
weeks NNS O
with IN O
samples NNS O
taken VBN O
from IN O
the DT O
urethra NN O
for IN O
virus NN O
isolation NN O
. . O

RESULTS NN O
: : O
The DT O
diagnostic JJ O
quality NN O
of IN O
FDG NNP O
images NNS O
was VBD O
at IN O
least JJS O
as RB O
good JJ O
as IN O
that DT O
of IN O
their PRP$ O
Tl NNP O
- : O
201 CD O
counterparts NNS O
, , O
with IN O
less JJR O
liver NN O
background NN O
in IN O
all DT O
but CC O
one CD O
FDG NNP O
study NN O
. . O

When WRB O
two CD O
determinations NNS O
were VBD O
performed VBN O
on IN O
12 CD O
samples NNS O
of IN O
plasma NN O
taken VBN O
from IN O
normal JJ O
adults NNS O
in IN O
October NNP O
, , O
the DT O
values NNS O
were VBD O
22 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
8 CD O
and CC O
21 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
6 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
ng NN O
/ NNP O
ml NN O
, , O
respectively RB O
. . O

In IN O
this DT O
paper NN O
, , O
such JJ O
lesions NNS O
in IN O
two CD O
cases NNS O
were VBD O
evaluated VBN O
by IN O
ultrasonography NN O
. . O

Cbl NNP B-Gene
constitutively RB O
interacts VBZ O
with IN O
the DT O
SH3 NNP B-Gene
domains NNS I-Gene
of IN O
Grb2 NNP B-Gene
, , O
with IN O
a DT O
preference NN O
for IN O
the DT O
amino NN O
- : O
terminal NN O
domain NN O
, , O
and CC O
is VBZ O
in IN O
this DT O
way NN O
recruited VBD O
to TO O
Shc NNP B-Gene
upon IN O
BCR NNP B-Gene
stimulation NN O
. . O

A DT O
1 CD O
. . O
5 CD O
- : O
kb NN O
HindIII NNP B-Gene
genomic JJ O
fragment NN O
carrying VBG O
the DT O
vspA JJ B-Gene
gene NN O
from IN O
M NNP O
. . O
bovis NN O
PG45 NNP O
was VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

Moreover RB O
, , O
an DT O
in IN O
vitro NN O
pull NN O
- : O
down IN O
assay NN O
showed VBD O
that IN O
Os NNP B-Gene
; : I-Gene
CycH NNP I-Gene
; : I-Gene
1 CD I-Gene
specifically RB O
bound VBN O
to TO O
R2 NNP B-Gene
but CC O
not RB O
to TO O
other JJ O
rice NN B-Gene
CDKs NNP I-Gene
. . O

Early JJ O
cirrhosis NN O
, , O
an DT O
early JJ O
modality NN O
of IN O
the DT O
evolution NN O
of IN O
acute JJ O
hepatitis NN O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
accepted VBN O
as IN O
a DT O
standard JJ O
treatment NN O
used VBN O
alone RB O
, , O
or CC O
in IN O
combination NN O
with IN O
chemotherapy NN O
or CC O
biotherapy NN O
in IN O
the DT O
management NN O
of IN O
metastatic JJ O
melanoma NN O
and CC O
metastatic JJ O
renal NN O
cell NN O
carcinoma NN O
. . O

Alveolar JJ O
lymphocytes NNS O
were VBD O
surprisingly RB O
increased VBN O
in IN O
most JJS O
patients NNS O
with IN O
AIDS NNP O
( ( O
mean JJ O
26 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
21 CD O
. . O
9 CD O
% NN O
; : O
range NN O
1 CD O
- : O
76 CD O
% NN O
) ) O
and CC O
CGL NNP O
( ( O
mean JJ O
26 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
22 CD O
. . O
6 CD O
% NN O
; : O
range NN O
3 CD O
- : O
76 CD O
% NN O
) ) O
with IN O
criteria NNS O
of IN O
activation NN O
contrasting VBG O
with IN O
the DT O
blood NN O
lymphopenia NN O
. . O

After IN O
peripheral JJ O
administration NN O
of IN O
both DT O
CRF NNP B-Gene
and CC O
TRH NNP B-Gene
, , O
ACTH NNP B-Gene
levels NNS O
were VBD O
significantly RB O
higher JJR O
on IN O
the DT O
tumor NN O
side NN O
in IN O
all DT O
patients NNS O
. . O

The DT O
presence NN O
of IN O
visna JJ O
- : O
maedi NN O
in IN O
Italy NNP O
is VBZ O
reported VBN O
for IN O
the DT O
first JJ O
time NN O
. . O

The DT O
subjects NNS O
of IN O
the DT O
study NN O
were VBD O
10 CD O
normal JJ O
subjects NNS O
and CC O
64 CD O
patients NNS O
with IN O
gastroduodenal JJ O
disease NN O
. . O

Altogether RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
Cut NNP B-Gene
proteins NNS I-Gene
is VBZ O
modulated VBN O
by IN O
PKC NNP B-Gene
. . O

( ( O
3 CD O
) ) O
This DT O
effect NN O
occurs VBZ O
without IN O
removing VBG O
TRs NNP B-Gene
from IN O
the DT O
TRE NNP O
. . O

Acute JJ O
effects NNS O
of IN O
LI NNP O
160 CD O
( ( O
extract NN O
of IN O
Hypericum NNP O
perforatum NN O
, , O
St NNP O
John NNP O
' POS O
s JJ O
wort NN O
) ) O
and CC O
two CD O
of IN O
its PRP$ O
constituents NNS O
on IN O
neuroendocrine JJ O
responses NNS O
in IN O
the DT O
rat NN O
. . O

Greater NNP O
rupture NN O
force NN O
was VBD O
required VBN O
in IN O
the DT O
adult NN O
pigs NNS O
than IN O
in IN O
the DT O
young JJ O
pigs NNS O
. . O

The DT O
kinase NN O
activity NN O
of IN O
PfPK6 NNP B-Gene
is VBZ O
sensitive JJ O
to TO O
CDK NNP B-Gene
inhibitors NNS O
such JJ O
as IN O
olomoucine NN O
and CC O
roscovitine NN O
. . O

Angina NNP O
haemorrhagica VBD O
bullosa RP O
causing VBG O
respiratory JJ O
obstruction NN O
postoperatively RB O
. . O

Interestingly RB O
, , O
highly RB O
charged VBN O
residues NNS O
were VBD O
abundantly RB O
possessed VBN O
in IN O
the DT O
carboxy JJ O
- : O
terminal JJ O
part NN O
of IN O
the DT O
MDV2 NNP B-Gene
UL10 NNP I-Gene
protein NN I-Gene
. . O

We PRP O
and CC O
others NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
c SYM B-Gene
- : I-Gene
cbl NN I-Gene
proto NN I-Gene
- : I-Gene
oncogene JJ I-Gene
product NN I-Gene
is VBZ O
one CD O
of IN O
the DT O
earliest JJS O
targets NNS O
of IN O
tyrosine JJ O
phosphorylation NN O
upon IN O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
stimulation NN O
. . O

INTERVENTIONS NN O
: : O
Subcutaneous JJ O
tissue NN O
PO2 NNP O
and CC O
PCO2 NNP O
tensions NNS O
were VBD O
measured VBN O
directly RB O
in IN O
patients NNS O
with IN O
necrotising JJ O
fasciitis NN O
and CC O
in IN O
healthy JJ O
volunteers NNS O
during IN O
normobaric JJ O
and CC O
hyperbaric JJ O
conditions NNS O
. . O

The DT O
platelet NN O
adhesion NN O
rate NN O
on IN O
these DT O
layers NNS O
were VBD O
tested VBN O
concerning VBG O
the DT O
valuation NN O
of IN O
the DT O
haemocompatibility NN O
of IN O
the DT O
basic JJ O
- : O
polymers NNS O
polyurethane VBP O
( ( O
PUR NNP O
) ) O
, , O
polyvinylchloride RB O
( ( O
PVC NNP O
) ) O
, , O
and CC O
polystyrene NN O
( ( O
PS NNP O
) ) O
in IN O
two CD O
different JJ O
worked VBD O
test NN O
chambers NNS O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
observed JJ O
clinical JJ O
phenomena NNS O
in IN O
response NN O
to TO O
morphine VB O
can MD O
be VB O
explained VBN O
by IN O
differences NNS O
in IN O
expression NN O
and CC O
sensitivity NN O
of IN O
some DT O
opioid JJ B-Gene
receptor NN I-Gene
subtypes NNS O
in IN O
migraine NN O
. . O

Systemic NNP O
lupus NN O
erythematosus NN O
was VBD O
diagnosed VBN O
. . O

Parodoxical JJ O
rise NN O
in IN O
urinary JJ B-Gene
albumin NN I-Gene
levels NNS O
after IN O
treatment NN O
of IN O
essential JJ O
hypertension NN O
. . O

In IN O
summary JJ O
, , O
the DT O
no DT O
- : O
adverse JJ O
- : O
effect NN O
- : O
level NN O
for IN O
this DT O
study NN O
was VBD O
determined VBN O
to TO O
be VB O
1000 CD O
ppm NN O
, , O
based VBN O
on IN O
decreased JJ O
weight NN O
gain NN O
in IN O
female JJ O
rats NNS O
, , O
and CC O
on IN O
slight JJ O
organ JJ O
weight NN O
changes NNS O
in IN O
both DT O
sexes NNS O
at IN O
3000 CD O
ppm NN O
. . O

Mean NNP O
intake NN O
of IN O
vitamin NN O
A NNP O
amounted VBD O
to TO O
1 CD O
. . O
1 CD O
and CC O
0 CD O
. . O
9 CD O
mg JJ O
RE NNP O
/ NNP O
day NN O
for IN O
men NNS O
and CC O
women NNS O
, , O
respectively RB O
; : O
the DT O
contributions NNS O
of IN O
meat NN O
, , O
fats NNS O
and CC O
oils NNS O
, , O
vegetables NNS O
and CC O
dairy NN O
products NNS O
to TO O
total JJ O
intake NN O
were VBD O
35 CD O
% NN O
, , O
24 CD O
% NN O
, , O
16 CD O
% NN O
, , O
and CC O
16 CD O
% NN O
, , O
respectively RB O
. . O

Renal NNP O
pathology NN O
and CC O
long JJ O
- : O
term NN O
outcome NN O
in IN O
childhood NN O
SLE NNP O
. . O

Persistence NN O
of IN O
toxaphene NN O
in IN O
treated JJ O
lakes NNS O
. . O

Domains NNS O
I PRP O
and CC O
II NNP O
of IN O
B NNP B-Gene
"""" NNP I-Gene
are VBP O
buried VBN O
upon IN O
assembly NN O
of IN O
the DT O
TFIIIB NNP B-Gene
- : I-Gene
DNA NN I-Gene
complex NN I-Gene
, , O
as IN O
determined VBN O
by IN O
protein NN O
footprinting NN O
. . O

In IN O
endemic JJ O
BL NNP O
, , O
the DT O
RB2 NNP B-Gene
/ NNP O
p130 NN B-Gene
gene NN O
is VBZ O
mutated VBN O
in IN O
most JJS O
of IN O
the DT O
cases NNS O
, , O
and CC O
the DT O
protein NN O
is VBZ O
restricted VBN O
to TO O
the DT O
cytoplasm NN O
. . O

2 CD O
- : O
Chemical NNP O
occlusion NN O
of IN O
vas NN O
is VBZ O
quite RB O
effective JJ O
in IN O
producing VBG O
a DT O
block NN O
in IN O
the DT O
vas NN O
deferens NNS O
of IN O
dogs NNS O
. . O

According VBG O
to TO O
pilot NN O
experiments NNS O
which WDT O
considered VBD O
various JJ O
durations NNS O
of IN O
global JJ O
no DT O
- : O
flow NN O
ischemia NN O
ranging VBG O
from IN O
10 CD O
to TO O
20 CD O
minutes NNS O
, , O
two CD O
durations NNS O
were VBD O
chosen VBN O
for IN O
the DT O
present JJ O
study NN O
: : O
20 CD O
minutes NNS O
( ( O
group NN O
20 CD O
) ) O
in IN O
which WDT O
ventricular JJ O
fibrillation NN O
( ( O
VF NNP O
) ) O
was VBD O
the DT O
predominant JJ O
form NN O
of IN O
arrhythmias NN O
, , O
and CC O
18 CD O
minutes NNS O
( ( O
group NN O
18 CD O
) ) O
in IN O
which WDT O
the DT O
prevalence NN O
of IN O
VF NNP O
was VBD O
markedly RB O
lower JJR O
despite IN O
the DT O
small JJ O
difference NN O
in IN O
the DT O
duration NN O
of IN O
ischemia NN O
. . O

With IN O
only RB O
purified JJ O
T NNP B-Gene
antigen NN I-Gene
in IN O
the DT O
presence NN O
of IN O
topoisomerase NN B-Gene
I PRP I-Gene
to TO O
unwind VB O
purified JJ O
DNA NNP O
, , O
ori SYM O
- : O
auxiliary JJ O
sequences NNS O
strongly RB O
facilitated VBD O
T NNP B-Gene
- : I-Gene
antigen NN I-Gene
- : O
dependent JJ O
DNA NNP O
conformational NN O
changes NNS O
consistent VBP O
with IN O
melting VBG O
the DT O
first JJ O
50 CD O
base NN O
pairs NN O
. . O

Salivary JJ O
estradiol VBD O
17 CD O
beta NN O
( ( O
E2 NNP O
- : O
17 CD O
beta NN O
) ) O
and CC O
progesterone NN O
( ( O
P NNP O
) ) O
were VBD O
determined VBN O
by IN O
using VBG O
radioimmunoassay NN O
techniques NNS O
in IN O
30 CD O
pregnant JJ O
females NNS O
in IN O
the DT O
first JJ O
, , O
second JJ O
and CC O
third JJ O
trimesters NNS O
as RB O
well RB O
as IN O
in IN O
10 CD O
non JJ O
- : O
pregnant JJ O
controls NNS O
during IN O
the DT O
luteal JJ O
phase NN O
of IN O
the DT O
menstrual JJ O
cycle NN O
. . O

Spectrophotometric JJ O
microanalysis NN O
of IN O
ethylenediaminotetracetic JJ O
acid NN O
in IN O
pharmaceutical JJ O
preparations NNS O

State NNP O
- : O
approved VBD O
schools NNS O
of IN O
nursing VBG O
R NNP O
. . O
N NNP O
. . O

We PRP O
have VBP O
recently RB O
discovered VBN O
that IN O
CCAAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
- : I-Gene
beta NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
beta NN I-Gene
) ) O
induces VBZ O
gene NN O
transcription NN O
through IN O
a DT O
novel JJ O
IFN NNP B-Gene
response NN I-Gene
element NN I-Gene
called VBD O
the DT O
gamma NN B-Gene
- : I-Gene
IFN NNP I-Gene
- : I-Gene
activated VBD I-Gene
transcriptional JJ I-Gene
element NN I-Gene

Antibodies NNS O
specific VBP O
to TO O
rE12 VB B-Gene
and CC O
rNFIL VB B-Gene
- : I-Gene
6 CD I-Gene
disrupt JJ O
nucleoprotein NN O
complexes NNS O
with IN O
these DT O
DNA NNP O
- : O
binding NN O
sites NNS O
, , O
confirming VBG O
the DT O
interaction NN O
of IN O
native JJ O
in IN O
vivo JJ O
factors NNS O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
abilities NNS O
of IN O
constitutive JJ O
and CC O
conditional JJ O
forms NNS O
of IN O
the DT O
three CD O
Raf NNP B-Gene
kinases NNS I-Gene
to TO O
abrogate VB O
the DT O
cytokine NN O
dependency NN O
of IN O
FDC NNP O
- : O
P1 NNP O
cells NNS O
were VBD O
examined VBN O
. . O

However RB O
, , O
when WRB O
directed VBN O
to TO O
the DT O
nucleosome NN O
by IN O
fusion NN O
to TO O
core VB B-Gene
histone NN I-Gene
H2A NNP I-Gene
or CC O
H2B NNP B-Gene
, , O
the DT O
non JJ O
- : O
histone NN B-Gene
tail NN O
forms NNS O
an DT O
MCB NNP O
that WDT O
appears VBZ O
identical JJ O
to TO O
that DT O
of IN O
the DT O
endogenous JJ O
protein NN O
. . O

In IN O
Ka13 NNP O
cells NNS O
, , O
CoCl NNP O
( ( O
2 CD O
) ) O
stimulated VBN O
expression NN O
of IN O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
under IN O
the DT O
control NN O
of IN O
a DT O
15 CD B-Gene
- : I-Gene
kilobase NN I-Gene
pair NN I-Gene
mouse NN I-Gene
ho VBD I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
( ( O
pHO15luc NN B-Gene
) ) O
. . O

OBJECTIVE NN O
: : O
1998 CD O
Surveillance NNP O
, , O
Epidemiology NNP O
, , O
and CC O
End NNP O
Results NNP O
( ( O
SEER NNP O
) ) O
data NN O
estimate NN O
an DT O
83 CD O
. . O
1 CD O
% NN O
5 CD O
- : O
year NN O
survival NN O
rate NN O
for IN O
corpus NN O
uteri JJ O
adenocarcinoma NN O
FIGO NNP O
stage NN O
II NNP O
. . O

The DT O
thrombolytic JJ O
effects NNS O
of IN O
native JJ O
tissue NN B-Gene
- : I-Gene
type NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
AK NNP B-Gene
- : I-Gene
124 CD I-Gene
) ) O
on IN O
experimental JJ O
canine NN O
coronary JJ O
thrombosis NN O
. . O

Statement NN O
on IN O
the DT O
development NN O
of IN O
guidelines NNS O
for IN O
the DT O
prevention NN O
of IN O
AIDS NNP O
transmission NN O
in IN O
the DT O
workplace NN O
. . O

The DT O
members NNS O
of IN O
the DT O
Myb NNP B-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
are VBP O
defined VBN O
by IN O
homology NN O
in IN O
the DT O
DNA NNP O
- : O
binding NN O
domain NN O
; : O
all DT O
bind IN O
the DT O
Myb NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
( ( O
MBS NNP B-Gene
) ) O
sequence NN O
( ( O
YG NNP O
( ( O
A NNP O
/ NNP O
G NNP O
) ) O
C NNP O
( ( O
A NNP O
/ NNP O
C NNP O
/ NNP O
G NNP O
) ) O
GTT NNP O
( ( O
G NNP O
/ NNP O
A NNP O
) ) O
) ) O
. . O

KAR1 NNP B-Gene
encodes VBZ O
an DT O
essential JJ O
component NN O
of IN O
the DT O
yeast NN O
spindle JJ O
pole NN O
body NN O
( ( O
SPB NNP O
) ) O
that WDT O
is VBZ O
required VBN O
for IN O
karyogamy NN O
and CC O
SPB NNP O
duplication NN O
. . O

An DT O
intralobar NN O
change NN O
in IN O
temperature NN O
above IN O
or CC O
below IN O
36 CD O
degrees NNS O
C NNP O
decreases VBZ O
only RB O
the DT O
lobar NN O
bronchial JJ O
blood NN O
flow NN O
and CC O
does VBZ O
not RB O
influence VB O
blood NN O
flow NN O
to TO O
other JJ O
nearby JJ O
tissues NNS O
including VBG O
those DT O
vascularized VBN O
by IN O
the DT O
bronchial JJ O
circulation NN O
. . O

This DT O
molecule NN O
, , O
wH22xeGFP NN B-Gene
, , O
consists VBZ O
of IN O
the DT O
entire JJ B-Gene
humanized VBN I-Gene
anti NN I-Gene
- : I-Gene
FcgammaRI NNP I-Gene
mAb VBZ I-Gene
H22 NNP B-Gene
with IN O
eGFP NNP B-Gene
genetically RB O
fused VBD O
to TO O
the DT O
C NNP O
- : O
terminal JJ O
end NN O
of IN O
each DT O
CH3 NNP B-Gene
domain NN I-Gene
. . O

wH22xeGFP NN B-Gene
binds NNS O
within IN O
the DT O
ligand NN O
- : O
binding NN O
region NN O
by IN O
its PRP$ O
Fc NNP B-Gene
end NN O
, , O
as RB O
well RB O
as IN O
outside IN O
the DT O
ligand NN O
- : O
binding NN O
region NN O
by IN O
its PRP$ O
Fab NNP B-Gene
ends VBZ O
, , O
thereby RB O
cross SYM O
- : O
linking VBG O
FcgammaRI NNP B-Gene
. . O

Interestingly RB O
, , O
the DT O
CYP71D20 NNP B-Gene
- : I-Gene
encoded VBD I-Gene
enzyme JJ I-Gene
activity NN O
was VBD O
capable JJ O
of IN O
converting VBG O
both DT O
5 CD O
- : O
epi NN O
- : O
aristolochene NN O
and CC O
1 CD O
- : O
deoxycapsidiol NN O
to TO O
capsidiol VB O
in IN O
vitro NN O
, , O
consistent JJ O
with IN O
the DT O
notion NN O
that IN O
this DT O
P450 NNP B-Gene
enzyme NN I-Gene
catalyzes VBZ O
both DT O
hydroxylations NNS O
of IN O
its PRP$ O
hydrocarbon NN O
substrate NN O
. . O

METHODS NN O
: : O
TBN NN O
measurements NNS O
were VBD O
performed VBN O
in IN O
31 CD O
female JJ O
outpatients NNS O
with IN O
breast NN O
carcinoma NN O
who WP O
were VBD O
undergoing VBG O
standard JJ O
cyclophosphamide NN O
, , O
methotrexate NN O
, , O
and CC O
5 CD O
- : O
fluorouracil NN O
( ( O
CMF NNP O
) ) O
- : O
based VBN O
chemotherapy NN O
( ( O
median JJ O
age NN O
, , O
48 CD O
years NNS O
; : O
range NN O
, , O
26 CD O
- : O
77 CD O
years NNS O
) ) O
. . O

Comparison NNP O
with IN O
a DT O
recently RB O
described VBN O
c SYM B-Gene
- : I-Gene
sis NN I-Gene
cDNA NN I-Gene
clone NN I-Gene
( ( O
Collins NNP O
et CC O
al NN O
. . O
, , O
Nature NNP O
316 CD O
, , O
748 CD O
- : O
750 CD O
( ( O
1985 CD O
) ) O
) ) O
revealed VBD O
that IN O
the DT O
1 CD O
. . O
9 CD O
kbp JJ O
DNA NNP O
region NN O
contained VBD O
a DT O
large JJ O
5 CD B-Gene
' POS I-Gene
c SYM I-Gene
- : I-Gene
sis NN I-Gene
exon NN I-Gene
of IN O
at IN O
least JJS O
1050 CD O
bp NN O
. . O

Members NNS O
of IN O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
family NN I-Gene
of IN O
basic JJ B-Gene
- : I-Gene
leucine NN I-Gene
zipper NN I-Gene
( ( I-Gene
bZip NN I-Gene
) ) I-Gene
transcription NN I-Gene
factors NNS I-Gene
form VBP O
heterodimers NNS O
and CC O
bind NN O
to TO O
the DT O
CAAT NNP O
box NN O
and CC O
other JJ O
sequence NN O
- : O
related JJ O
enhancer NN O
motifs NNS O
. . O

In IN O
all DT O
tissues NNS O
examined VBN O
only RB O
transcripts NNS O
positive JJ O
for IN O
insert JJ O
3 CD O
, , O
an DT O
18 CD O
bp NN O
insertion NN O
in IN O
repeat NN O
21 CD O
, , O
were VBD O
amplified VBN O
, , O
even RB O
under IN O
conditions NNS O
in IN O
which WDT O
a DT O
30 CD O
% NN O
level NN O
of IN O
insert JJ O
3 CD O
negative JJ O
transcript NN O
could MD O
be VB O
easily RB O
detected VBN O
in IN O
artificially RB O
prepared JJ O
control NN O
samples NNS O
. . O

Plasma NNP B-Gene
leptin NN I-Gene
concentrations NNS O
were VBD O
higher JJR O
in IN O
women NNS O
than IN O
men NNS O
, , O
even RB O
after IN O
the DT O
adjustment NN O
for IN O
differences NNS O
in IN O
fat JJ O
mass NN O
( ( O
28 CD O
+ NN O
/ NNP O
- : O
3 CD O
ng JJ O
/ NNP O
ml NN O
for IN O
women NNS O
vs NNS O
. . O

Systemic NNP O
impact NN O
of IN O
risk NN O
- : O
sharing VBG O
arrangements NNS O
. . O

A DT O
lambda JJ O
gt10 NN O
cDNA NN O
library NN O
was VBD O
constructed VBN O
from IN O
poly NN O
( ( O
A DT O
) ) O
+ FW O
RNA NNP O
of IN O
young JJ O
green JJ O
leaves NNS O
of IN O
spinach NN O
. . O

Transduction NN O
of IN O
the DT O
human JJ O
leukemic JJ O
cell NN O
line NN O
K562 NNP O
showed VBD O
that IN O
viral JJ O
MRP1 NNP B-Gene
- : O
PG13 NN O
supernatants NNS O
routinely RB O
transfer VBP O
the DT O
MRP1 NNP B-Gene
gene NN I-Gene
to TO O
approximately RB O
35 CD O
% NN O
of IN O
target NN O
K562 NNP O
cells NNS O
, , O
of IN O
which WDT O
at IN O
least JJS O
one CD O
third WDT O
are VBP O
capable JJ O
of IN O
proliferating VBG O
in IN O
the DT O
presence NN O
of IN O
otherwise RB O
toxic JJ O
concentrations NNS O
of IN O
etoposide NN O
. . O

The DT O
relative JJ O
risk NN O
of IN O
graft NN O
loss NN O
after IN O
conversion NN O
to TO O
azathioprine VB O
compared VBN O
with IN O
graft NN O
loss NN O
after IN O
conversion NN O
to TO O
azathioprine VB O
compared VBN O
with IN O
cyclosporin JJ O
maintenance NN O
was VBD O
0 CD O
. . O
71 CD O
( ( O
0 CD O
. . O
37 CD O
- : O
1 CD O
. . O
38 CD O
) ) O
and CC O
the DT O
relative JJ O
risk NN O
of IN O
patient JJ O
death NN O
was VBD O
0 CD O
. . O
57 CD O
( ( O
0 CD O
. . O
23 CD O
- : O
1 CD O
. . O
41 CD O
) ) O
. . O

RESULTS NN O
: : O
The DT O
analyzed JJ O
fragment NN O
has VBZ O
significant JJ O
activity NN O
in IN O
EpCAM NNP B-Gene
positive JJ O
cells NNS O
, , O
and CC O
it PRP O
is VBZ O
regulated VBN O
negatively RB O
by IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNFalpha NNP B-Gene
) ) O
. . O

Surprisingly RB O
, , O
nuclear JJ O
forms NNS O
of IN O
IE110 NNP B-Gene
were VBD O
found VBN O
to TO O
move VB O
a DT O
cytoplasmic JJ O
form NN O
of IN O
IE175 NNP B-Gene
into IN O
nuclear JJ O
punctate NN O
structures NNS O
, , O
and CC O
a DT O
cytoplasmic JJ O
form NN O
of IN O
IE110 NNP B-Gene
was VBD O
able JJ O
to TO O
retain VB O
nuclear JJ O
forms NNS O
of IN O
IE175 NNP B-Gene
in IN O
cytoplasmic JJ O
punctate NN O
structures NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
an DT O
intracellular JJ O
WT NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ O
HSAL2 NNP B-Gene
pathway NN O
may MD O
play VB O
a DT O
role NN O
in IN O
development NN O
and CC O
hematopoiesis NN O
. . O

Far RB O
from IN O
this DT O
being VBG O
the DT O
case NN O
, , O
however RB O
, , O
the DT O
measurement NN O
of IN O
apo NN B-Gene
B NNP I-Gene
has VBZ O
met VBN O
every DT O
reasonable JJ O
standard NN O
of IN O
laboratory NN O
precision NN O
and CC O
reliability NN O
to TO O
allow VB O
its PRP$ O
widespread JJ O
introduction NN O
in IN O
clinical JJ O
laboratories NNS O
. . O

A DT O
drug NN O
with IN O
ISA NNP O
"""" NNP O
down RB O
regulates VBZ O
"""" JJ O
beta NN B-Gene
receptors NNS I-Gene
; : O
thus RB O
, , O
when WRB O
the DT O
drug NN O
is VBZ O
withdrawn VBN O
there EX O
is VBZ O
no DT O
post NN O
- : O
beta NN O
- : O
blocking VBG O
drug NN O
hypersensitivity NN O
in IN O
contrast NN O
to TO O
agents NNS O
without IN O
ISA NNP O
. . O

Routinely RB O
collected VBN O
, , O
processed VBN O
and CC O
stored VBN O
breast NN O
cancer NN O
tissue NN O
blocks NNS O
recovered VBN O
from IN O
the DT O
archives NNS O
of IN O
the DT O
Pathology NNP O
laboratory NN O
in IN O
Dar NNP O
es NN O
Salaam NNP O
after IN O
storage NN O
of IN O
up IN O
to TO O
3 CD O
years NNS O
were VBD O
analysed VBN O
by IN O
a DT O
flow JJ O
cytometry NN O
for IN O
DNA NNP O
ploidy NN O
and CC O
S NNP O
- : O
phase NN O
fraction NN O
. . O

Large JJ O
- : O
scale NN O
sequencing NN O
of IN O
two CD O
regions NNS O
in IN O
human JJ O
chromosome NN O
7q22 CD O
: : O
analysis NN O
of IN O
650 CD O
kb NNS O
of IN O
genomic JJ O
sequence NN O
around IN O
the DT O
EPO NNP B-Gene
and CC O
CUTL1 NNP B-Gene
loci VBP I-Gene
reveals NNS O
17 CD O
genes NNS O
. . O

Two CD O
basic JJ O
patterns NNS O
of IN O
locomotor NN O
behavior NN O
and CC O
corresponding VBG O
torso JJ O
morphology NNS O
exist VBP O
among IN O
extant JJ O
anthropoids NNS O
. . O

Specific JJ O
requirements NNS O
for IN O
branched JJ O
- : O
chain NN O
amino JJ O
acids NNS O
, , O
glutamine NN O
, , O
and CC O
arginine NN O
are VBP O
evaluated VBN O
. . O

The DT O
abundance NN O
of IN O
transcripts NNS O
from IN O
several JJ O
unrelated JJ O
genes NNS O
is VBZ O
decreased VBN O
in IN O
cdc68 NN B-Gene
- : I-Gene
1 CD I-Gene
mutant NN I-Gene
cells NNS O
after IN O
transfer NN O
to TO O
the DT O
restrictive JJ O
temperature NN O
, , O
while IN O
at IN O
least JJS O
one CD O
transcript NN O
, , O
from IN O
the DT O
HSP82 NNP B-Gene
gene NN I-Gene
, , O
persists NNS O
in IN O
an DT O
aberrant JJ O
fashion NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
Between NNP O
June NNP O
1991 CD O
and CC O
December NNP O
1996 CD O
, , O
we PRP O
administered VBD O
the DT O
nucleoside JJ O
analog NN O
2 CD O
- : O
chlorodeoxyadenosine NN O
( ( O
2 CD O
- : O
CDA NN O
) ) O
to TO O
73 CD O
children NNS O
with IN O
primary JJ O
AML NNP O
and CC O
20 CD O
children NNS O
with IN O
secondary JJ O
AML NNP O
or CC O
myelodysplastic JJ O
syndrome NN O
( ( O
MDS NNP O
) ) O
. . O

TAR NNP B-Gene
and CC O
Sp1 NNP B-Gene
- : O
independent JJ O
transactivation NN O
of IN O
HIV NNP B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
by IN O
the DT O
Tat NNP B-Gene
protein NN I-Gene
in IN O
the DT O
presence NN O
of IN O
human JJ O
cytomegalovirus NN O
IE1 NNP B-Gene
/ NNP O
IE2 NNP B-Gene
. . O

Ultimate NNP O
strengthes NNS O
seem VBP O
to TO O
be VB O
reached VBN O
for IN O
cast NN O
cobalt NN O
alloys VBZ O
, , O
whereas JJ O
titanium NN O
alloys NNS O
, , O
such JJ O
as IN O
Ta NNP O
6 CD O
V NNP O
, , O
present JJ O
very RB O
high JJ O
fatigue NN O
limit NN O
under IN O
corrosion NN O
. . O

Both DT O
groups NNS O
then RB O
underwent JJ O
hypnotic JJ O
induction NN O
, , O
and CC O
completed VBD O
the DT O
test NN O
again RB O
( ( O
R2 NNP O
) ) O
. . O

A DT O
complementary JJ O
study NN O
, , O
showing VBG O
a DT O
good JJ O
agreement NN O
between IN O
surface NN O
and CC O
oesophageal JJ O
EMGd NNP O
seems VBZ O
to TO O
confirm VB O
that DT O
surface NN O
EMGd NNP O
is VBZ O
a DT O
useful JJ O
and CC O
promising JJ O
tool NN O
for IN O
clinical JJ O
investigation NN O
. . O

We PRP O
observed VBD O
NP NNP B-Gene
/ NNP O
NMP4 NNP B-Gene
/ NNP O
CIZ NNP B-Gene
expression NN O
in IN O
osteocytes NNS O
, , O
osteoblasts NNS O
, , O
and CC O
chondrocytes NNS O
in IN O
rat NN O
bone NN O
. . O

The DT O
alternative JJ O
sigma NN B-Gene
factor NN I-Gene
sigmaB NN I-Gene
in IN I-Gene
Staphylococcus NNP I-Gene
aureus NN I-Gene
: : O
regulation NN O
of IN O
the DT O
sigB NN B-Gene
operon NN I-Gene
in IN O
response NN O
to TO O
growth NN O
phase NN O
and CC O
heat NN O
shock NN O

Rearrangements NNS O
of IN O
the DT O
NFKB2 NNP B-Gene
gene NN I-Gene
are VBP O
associated VBN O
with IN O
lymphoid JJ O
malignancies NNS O
, , O
but CC O
the DT O
functional JJ O
significance NN O
of IN O
these DT O
alterations NNS O
is VBZ O
not RB O
known VBN O
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
47 CD B-Gene
- : I-Gene
kilodalton NN I-Gene
major JJ I-Gene
integral JJ I-Gene
membrane NN I-Gene
immunogen NN I-Gene
of IN I-Gene
Treponema NNP I-Gene
pallidum NN I-Gene
. . O

A DT O
novel JJ O
pleckstrin NN B-Gene
homology NN I-Gene
- : I-Gene
related JJ I-Gene
gene NN I-Gene
family NN I-Gene
defined VBN O
by IN O
Ipl NNP B-Gene
/ NNP O
Tssc3 NNP B-Gene
, , O
TDAG51 NNP B-Gene
, , O
and CC O
Tih1 NNP B-Gene
: : O
tissue NN O
- : O
specific JJ O
expression NN O
, , O
chromosomal JJ O
location NN O
, , O
and CC O
parental JJ O
imprinting NN O
. . O

Thus RB O
the DT O
present JJ O
data NNS O
also RB O
suggest VBP O
that IN O
BP NNP O
and CC O
HR NNP O
measurements NNS O
are VBP O
influenced VBN O
not RB O
only RB O
by IN O
state NN O
- : O
dependent JJ O
factors NNS O
but CC O
also RB O
by IN O
at IN O
least JJS O
three CD O
different JJ O
factors NNS O
that WDT O
are VBP O
each DT O
independent JJ O
of IN O
the DT O
state NN O
: : O
one CD O
leads VBZ O
to TO O
BP NNP O
and CC O
HR NNP O
values NNS O
that WDT O
are VBP O
influenced VBN O
by IN O
the DT O
cycle NN O
the DT O
animal NN O
is VBZ O
in IN O
and CC O
the DT O
other JJ O
two CD O
influence NN O
, , O
respectively RB O
, , O
the DT O
ranking NN O
of IN O
the DT O
individual NN O
' POS O
s NN O
BP NNP O
and CC O
HR NNP O
levels NNS O
within IN O
the DT O
population NN O
. . O

Most JJS O
patients NNS O
harboring VBG O
metronidazole JJ O
- : O
and CC O
clarithromycin VB O
- : O
resistant NN O
strains NNS O
were VBD O
eradicated VBN O
at IN O
an DT O
equal JJ O
rate NN O
by IN O
each DT O
of IN O
the DT O
three CD O
regimens NNS O
. . O

METHODS NN O
: : O
The DT O
most RBS O
distal JJ O
muscle NN O
fibres NNS O
from IN O
the DT O
deep JJ O
and CC O
superficial JJ O
finger NN O
flexors NNS O
were VBD O
measured VBN O
relative JJ O
to TO O
the DT O
pisiform NN O
bone NN O
in IN O
18 CD O
cadaveric JJ O
specimens NNS O
. . O

We PRP O
found VBD O
that IN O
the DT O
SOCS NNP B-Gene
box NN I-Gene
interacted VBN O
with IN O
Cullin NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
promoted JJ O
ubiquitination NN O
of IN O
TEL NNP B-Gene
- : O
JAK2 NN B-Gene
. . O

We PRP O
confirmed VBD O
the DT O
interaction NN O
between IN O
TLS NNP B-Gene
and CC O
p65 NN B-Gene
by IN O
the DT O
pull NN O
- : O
down RP O
assay VBP O
in IN O
vitro NN O
and CC O
by IN O
a DT O
coimmunoprecipitation NN O
experiment NN O
followed VBN O
by IN O
Western JJ O
blot NN O
of IN O
the DT O
cultured VBN O
cell NN O
in IN O
vivo NN O
. . O

Our PRP$ O
results NNS O
suggested VBD O
that IN O
the DT O
hexamer NN O
and CC O
the DT O
octamer JJR O
motifs NNS O
may MD O
play VB O
important JJ O
role NN O
( ( O
s PRP O
) ) O
in IN O
regulation NN O
of IN O
replication NN O
- : O
dependent NN O
but CC O
not RB O
of IN O
replication NN O
- : O
independent JJ O
expression NN O
of IN O
the DT O
wheat NN B-Gene
histone NN I-Gene
H3 NNP I-Gene
gene NN I-Gene
. . O

Two CD O
distinct JJ O
recessive JJ O
susceptibility NN O
loci NN O
for IN O
vasculitis NN O
were VBD O
mapped VBN O
on IN O
chromosome NN O
( ( O
Chr NNP O
) ) O
4 CD O
at IN O
D4Mit89 NNP B-Gene
and CC O
D4Mit147 NNP B-Gene
in IN O
both DT O
progenies NNS O
. . O

Restarting VBG O
time NN O
was VBD O
not RB O
affected VBN O
by IN O
magnesium NN O
cardioplegia NN O
. . O

In IN O
the DT O
mouse NN O
, , O
both DT O
genes NNS O
reside VBP O
in IN O
the DT O
syntenic JJ O
region NN O
80 CD O
on IN O
chromosome NN O
8 CD O
. . O

Functional JJ O
analysis NN O
of IN O
aryl JJ B-Gene
hydrocarbon NN I-Gene
receptor NN I-Gene
nuclear JJ I-Gene
translocator NN I-Gene
interactions NNS O
with IN O
aryl JJ B-Gene
hydrocarbon NN I-Gene
receptor NN I-Gene
in IN O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
. . O

Isolation NN O
of IN O
tha NN O
avian JJ O
reticuloendothelial JJ O
virus NN O
( ( O
strain JJ O
T NNP O
) ) O
. . O

The DT O
patients NNS O
in IN O
one CD O
group NN O
had VBD O
intrauterine JJ O
catheters NNS O
inserted VBN O
and CC O
oxytocin NN B-Gene
was VBD O
titrated VBN O
to TO O
achieve VB O
the DT O
75th CD O
percentile NN O
of IN O
uterine JJ O
activity NN O
observed VBN O
in IN O
spontaneous JJ O
normal JJ O
labour NN O
according VBG O
to TO O
parity NN O
. . O

Amiodarone NNP O
, , O
seldom RB O
used VBD O
as IN O
first JJ O
- : O
line NN O
treatment NN O
, , O
appears VBZ O
to TO O
be VB O
the DT O
most RBS O
effective JJ O
drug NN O
. . O

We PRP O
have VBP O
cloned VBN O
a DT O
kinase NN O
, , O
Nlk NNP B-Gene
, , O
that WDT O
is VBZ O
a DT O
murine JJ B-Gene
homolog NN I-Gene
of IN I-Gene
the DT I-Gene
Drosophila NNP I-Gene
nemo NN I-Gene
( ( O
nmo JJ B-Gene
) ) O
gene NN O
. . O

MpB NNP B-Gene
GroEL NNP I-Gene
has VBZ O
extensive JJ O
sequence NN O
similarity NN O
( ( O
92 CD O
% NN O
) ) O
with IN O
Escherichia NNP B-Gene
coli NNS I-Gene
GroEL NNP I-Gene
and CC O
other JJ O
members NNS O
of IN O
the DT O
chaperonin NN B-Gene
- : I-Gene
60 CD I-Gene
family NN I-Gene
. . O

The DT O
patients NNS O
and CC O
their PRP$ O
families NNS O
were VBD O
closely RB O
questioned VBN O
, , O
and CC O
full JJ O
clinical JJ O
examination NN O
included VBD O
a DT O
test NN O
for IN O
orthostasia NN O
. . O

Like IN O
DNA NNP O
binding NN O
, , O
transcriptional JJ O
enhancement NN O
required VBN O
amino SYM O
- : O
terminally RB O
located VBN O
basic JJ O
amino NN O
acid NN O
residues NNS O
but CC O
not RB O
the DT O
carboxyl NN O
- : O
terminal JJ O
portion NN O
of IN O
Hap46 NNP B-Gene
known VBN O
to TO O
participate VB O
in IN O
hsp70 JJ B-Gene
interaction NN O
. . O

A DT O
new JJ O
generation NN O
of IN O
information NN O
retrieval NN O
tools NNS O
for IN O
biologists NNS O
: : O
the DT O
example NN O
of IN O
the DT O
ExPASy NNP O
WWW NNP O
server NN O
. . O

The DT O
purified JJ O
recombinant NN O
enzyme NN O
catalyzed VBN O
specific JJ O
phosphoryl NN O
transfer NN O
from IN O
ATP NNP O
to TO O
UMP NNP O
and CC O
CMP NNP O
. . O

Position NN O
22 CD O
is VBZ O
an DT O
isoleucine NN O
in IN O
the DT O
complete JJ B-Gene
SsoL12 NNP I-Gene
protein NN I-Gene
sequence NN I-Gene
, , O
coded VBN O
by IN O
an DT O
AUA NNP O
codon NN O
. . O

In IN O
doses NNS O
of IN O
0 CD O
. . O
3 CD O
- : O
0 CD O
. . O
3 CD O
mg JJ O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
, , O
SG NNP O
- : O
75 CD O
did VBD O
not RB O
significantly RB O
affect JJ O
pulse JJ O
pressure NN O
, , O
heart NN O
rate NN O
, , O
aortic JJ O
blood NN O
flow NN O
, , O
left VBD O
ventricular JJ O
pressure NN O
( ( O
LVP NNP O
) ) O
and CC O
LVdP NNP O
/ NNP O
dt NN O
max NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
plasma NN B-Gene
prolactin NN I-Gene
response NN O
to TO O
12 CD O
. . O
5 CD O
micrograms NN O
i NN O
. . O
v NN O
. . O

Structural JJ O
analysis NN O
of IN O
the DT O
5 CD O
' POS O
- : O
regulatory JJ O
region NN O
reveals NNS O
that IN O
the DT O
c SYM B-Gene
- : I-Gene
met VBN I-Gene
promoter NN I-Gene
lacks VBZ O
TATA NNP O
or CC O
CAAT NNP O
elements NNS O
but CC O
has VBZ O
an DT O
extremely RB O
high JJ O
G NNP O
- : O
C NNP O
content NN O
and CC O
multiple JJ O
Sp1 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Magnetic JJ O
resonance NN O
imaging NN O
in IN O
coccidioidal JJ O
arthritis NN O
. . O

Transcriptional JJ O
activation NN O
by IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
Tat NNP I-Gene
protein NN I-Gene
requires VBZ O
specific JJ O
residues NNS O
in IN O
the DT O
hexanucleotide NN O
loop NN O
and CC O
trinucleotide JJ O
bulge NN O
of IN O
the DT O
TAR NNP B-Gene
RNA NNP O
stem NN O
- : O
loop NN O
structure NN O
found VBN O
in IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
leader NN O
of IN O
all DT O
viral JJ O
transcripts NNS O
. . O

These DT O
transcripts NNS O
contain VBP O
the DT O
5 CD O
' POS O
ends NNS O
of IN O
mature NN O
UbCRBP NNP B-Gene
mRNAs NN I-Gene
; : O
extend CC O
through IN O
UbCRBP NNP B-Gene
, , O
across IN O
the DT O
intergenic JJ O
region NN O
, , O
and CC O
a DT O
significant JJ O
distance NN O
3 CD O
' '' O
into IN O
the DT O
enolase JJ B-Gene
gene NN I-Gene
. . O

The DT O
Saccharomyces NNPS B-Gene
cerevisiae NN I-Gene
APS1 NNP I-Gene
gene NN I-Gene
encodes VBZ O
a DT O
homolog NN O
of IN O
the DT O
small JJ O
subunit NN O
of IN O
the DT O
mammalian JJ B-Gene
clathrin NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complex JJ I-Gene
: : O
evidence NN O
for IN O
functional JJ O
interaction NN O
with IN O
clathrin NN B-Gene
at IN O
the DT O
Golgi NNP O
complex NN O
. . O

Finally RB O
, , O
Cas NNP B-Gene
existed VBD O
mainly RB O
in IN O
cytosol NN O
and CC O
membrane NN O
cytoskeleton NN O
fractions NNS O
in IN O
the DT O
resting NN O
state NN O
, , O
and CC O
remained VBD O
unchanged JJ O
during IN O
platelet JJ O
aggregation NN O
, , O
when WRB O
FAK NNP B-Gene
translocated VBD O
to TO O
the DT O
cytoskeletal JJ O
fraction NN O
. . O

On IN O
Cox NNP O
proportional JJ O
hazards NNS O
regression NN O
adenocarcinoma NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
6 CD O
) ) O
, , O
the DT O
development NN O
of IN O
BPF NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
, , O
older JJR O
age NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
and CC O
higher JJR O
pathological JJ O
stage NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
2 CD O
) ) O
were VBD O
independent JJ O
adverse JJ O
predictors NNS O
of IN O
survival NN O
. . O

Interestingly RB O
, , O
following VBG O
induction NN O
of IN O
stress NN O
by IN O
heat NN O
shock NN O
, , O
high JJ O
salt NN O
, , O
or CC O
ethanol NN O
, , O
conditions NNS O
under IN O
which WDT O
most JJS O
mRNA JJ O
export NN O
is VBZ O
blocked VBN O
, , O
Npl3p NNP B-Gene
is VBZ O
still RB O
exported VBN O
from IN O
the DT O
nucleus NN O
. . O

Many JJ O
canonical JJ O
TATA NNP O
sequences NNS O
are VBP O
present JJ O
upstream NN O
from IN O
these DT O
VZV NNP O
transcriptional JJ O
start NN O
sites NNS O
but CC O
, , O
apparently RB O
, , O
are VBP O
not RB O
used VBN O
. . O

When WRB O
O2 NNP O
therapy NN O
was VBD O
controlled VBN O
for IN O
, , O
the DT O
association NN O
between IN O
RBT NNP O
and CC O
RLF NNP O
did VBD O
not RB O
achieve VB O
statistical JJ O
significance NN O
( ( O
P NNP O
= NNP O
. . O
7 CD O
) ) O
. . O

An DT O
analysis NN O
of IN O
sequence NN O
of IN O
the DT O
mutant JJ B-Gene
recN NN I-Gene
gene NN I-Gene
revealed VBD O
a DT O
G NNP O
: : O
C NNP O
to TO O
T VB O
: : O
A DT O
transversion NN O
near IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
coding VBG O
region NN O
. . O

Unexpectedly RB O
, , O
ALK7 NNP B-Gene
signaling VBG O
produced VBD O
a DT O
remarkable JJ O
change NN O
in IN O
cell NN O
morphology NN O
characterized VBN O
by IN O
cell NN O
flattening NN O
and CC O
elaboration NN O
of IN O
blunt NN O
, , O
short JJ O
cell NN O
processes NNS O
. . O

Identification NN O
and CC O
characterization NN O
of IN O
IS2404 NNP B-Gene
and CC O
IS2606 NNP B-Gene
: : O
two CD O
distinct NN O
repeated VBD O
sequences NNS O
for IN O
detection NN O
of IN O
Mycobacterium NNP O
ulcerans NNS O
by IN O
PCR NNP O
. . O

Regulation NN O
of IN O
HIV NNP O
- : O
1 CD O
transcription NN O
. . O

There EX O
was VBD O
a DT O
statistically RB O
significant JJ O
correlation NN O
between IN O
simultaneous JJ O
weekly JJ O
average NN O
pollen NN O
levels NNS O
in IN O
Philadelphia NNP O
and CC O
in IN O
Cherry NNP O
Hill NNP O
( ( O
Acer NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
987 CD O
, , O
Quercus NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
645 CD O
, , O
Betula NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
896 CD O
, , O
Pinus NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
732 CD O
, , O
Cupressaceae NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
695 CD O
, , O
Poaceae NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
950 CD O
, , O
Ambrosia NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
903 CD O
, , O
and CC O
Rumex NNP O
, , O
r NN O
( ( O
p NN O
) ) O
= VBZ O
0 CD O
. . O
572 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

REM NNP O
sleep JJ O
deprivation NN O
was VBD O
performed VBN O
using VBG O
the DT O
platform NN O
technique NN O
. . O

If IN O
hnRNP JJ B-Gene
K NNP I-Gene
is VBZ O
a DT O
transcription NN O
factor NN O
, , O
then RB O
interactions NNS O
with IN O
the DT O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
transcription NN O
apparatus NN O
are VBP O
predicted VBN O
. . O

The DT O
degree NN O
of IN O
hypoperfusion NN O
was VBD O
slightly RB O
related VBN O
to TO O
decrease VB O
in IN O
FEV1 NNP O
. . O
0 CD O
% NN O
, , O
V25 NNP O
and CC O
PaO2 NNP O
and CC O
increase VB O
in IN O
circulating VBG O
blood NN O
volume NN O
and CC O
peripheral JJ O
red JJ O
blood NN O
cell NN O
counts NNS O
. . O

Angionephroscintigraphy NN O
in IN O
the DT O
diagnosis NN O
of IN O
diseases NNS O
of IN O
the DT O
kidney NN O

The DT O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
binding VBG I-Gene
site NN I-Gene
was VBD O
also RB O
required VBN O
for IN O
TCR NNP B-Gene
alpha JJ I-Gene
enhancer NN I-Gene
activity NN O
in IN O
transcriptionally RB O
active JJ O
extracts NNS O
from IN O
Jurkat NNP O
but CC O
not RB O
HeLa NNP O
cells NNS O
, , O
confirming VBG O
that IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
is VBZ O
a DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
. . O

Serum NNP O
and CC O
peritoneal JJ O
dialysis NN O
fluid NN O
( ( O
PDF NNP O
) ) O
were VBD O
collected VBN O
for IN O
assay NN O
throughout IN O
the DT O
course NN O
of IN O
the DT O
study NN O
and CC O
for IN O
5 CD O
days NNS O
thereafter RB O
. . O

[ JJ O
figure NN O
: : O
see NN O
text IN O
] PDT O
The DT O
Stille NNP O
coupling VBG O
reaction NN O
has VBZ O
been VBN O
performed VBN O
in IN O
1 CD O
- : O
butyl NN O
- : O
3 CD O
- : O
methylimidazolium NN O
tetrafluoroborate NN O
( ( O
BMIM NNP O
BF4 NNP O
) ) O
, , O
a DT O
room NN O
- : O
temperature NN O
ionic JJ O
liquid NN O
( ( O
RTIL NNP O
) ) O
. . O

SIP1 NNP B-Gene
( ( O
Smad NNP B-Gene
interacting VBG I-Gene
protein RB I-Gene
1 CD I-Gene
) ) O
and CC O
deltaEF1 NN B-Gene
( ( O
delta JJ B-Gene
- : I-Gene
crystallin NN I-Gene
enhancer NN I-Gene
binding VBG I-Gene
factor NN I-Gene
) ) O
are VBP O
structurally RB O
similar JJ O
transcriptional JJ O
repressors NNS O
. . O

We PRP O
also RB O
studied VBD O
a DT O
new JJ O
parameter NN O
: : O
the DT O
angle NN O
to TO O
maximal VB O
peak JJ O
torque NN O
( ( O
APT NNP O
) ) O
. . O

A DT O
36 CD O
- : O
kDa NN O
protein NN O
that WDT O
was VBD O
localized VBN O
to TO O
the DT O
membrane NN O
fraction NN O
was VBD O
detected VBN O
in IN O
minicells NNS O
containing VBG O
plasmids NNS O
with IN O
the DT O
ftsN JJ B-Gene
gene NN I-Gene
, , O
confirming VBG O
that IN O
FtsN NNP B-Gene
was VBD O
a DT O
membrane NN O
protein NN O
. . O

Over IN O
- : O
expression NN O
of IN O
Azf1p NNP B-Gene
in IN O
the DT O
yeast NN O
cell NN O
does VBZ O
not RB O
influence VB O
the DT O
expression NN O
level NN O
of IN O
the DT O
mitochondrial JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
Mtf1p NNP I-Gene
, , O
indicating VBG O
that IN O
the DT O
influence NN O
of IN O
Azf1p NNP B-Gene
on IN O
the DT O
suppression NN O
of IN O
the DT O
special JJ O
mitochondrial JJ B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
mutant NN I-Gene
is VBZ O
an DT O
indirect JJ O
one CD O
. . O

The DT O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
CREB NNP I-Gene
is VBZ O
regulated VBN O
by IN O
extracellular JJ O
stimuli NNS O
that WDT O
result VBP O
in IN O
its PRP$ O
phosphorylation NN O
at IN O
a DT O
critical JJ O
serine NN O
residue NN O
, , O
Ser133 NNP O
. . O

Oligonucleotide NNP O
- : O
directed VBD O
mutagenesis NN O
was VBD O
used VBN O
to TO O
create VB O
an DT O
NdeI NNP B-Gene
restriction NN I-Gene
site NN I-Gene
at IN O
the DT O
natural JJ O
ATG NNP O
of IN O
the DT O
yeast NN O
R NNP O
. . O

To TO O
understand VB O
further RB O
the DT O
expression NN O
and CC O
regulation NN O
of IN O
the DT O
V1aR NNP B-Gene
, , O
we PRP O
now RB O
describe VBP O
the DT O
genomic JJ O
characteristics NNS O
, , O
tissue NN O
expression NN O
, , O
chromosomal JJ O
localization NN O
, , O
and CC O
regional JJ O
mapping NN O
of IN O
the DT O
human JJ B-Gene
V1aR NNP I-Gene
gene NN I-Gene
, , O
AVPR1A NNP B-Gene
. . O

Paxillin NNP B-Gene
acts VBZ O
as IN O
an DT O
adaptor NN O
molecule NN O
in IN O
integrin JJ B-Gene
signaling NN O
. . O

Thus RB O
, , O
hypoxia SYM O
- : O
inducible JJ O
nuclear JJ O
import NN O
and CC O
transactivation NN O
by IN O
recruitment NN O
of IN O
CBP NNP B-Gene
can MD O
be VB O
functionally RB O
separated VBN O
from IN O
one CD O
another DT O
and CC O
play VB O
critical JJ O
roles NNS O
in IN O
signal JJ O
transduction NN O
by IN O
HIF NNP B-Gene
- : I-Gene
1alpha CD I-Gene
. . O

Catalytic JJ O
activation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinase NN I-Gene
phosphatase NN I-Gene
- : I-Gene
1 CD I-Gene
by IN O
binding VBG O
to TO O
p38 VB B-Gene
MAP NNP I-Gene
kinase NN I-Gene
: : O
critical JJ O
role NN O
of IN O
the DT O
p38 NN B-Gene
C NNP I-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
in IN O
its PRP$ O
negative JJ O
regulation NN O
. . O

While IN O
this DT O
Saccharomyces VBZ O
cerevisiae JJ O
SIN4 NNP B-Gene
gene NN I-Gene
product NN I-Gene
is VBZ O
a DT O
component NN O
of IN O
a DT O
mediator NN O
complex NN O
associated VBN O
with IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
, , O
various JJ O
studies NNS O
suggest VBP O
the DT O
involvement NN O
of IN O
Sin4 NNP B-Gene
in IN O
the DT O
alteration NN O
of IN O
higher JJR O
- : O
order NN O
chromatin NN O
structure NN O
. . O

3 CD O
' '' O
RNA NNP O
boundary JJ O
experiments NNS O
indicate VBP O
that IN O
the DT O
5 CD O
' POS O
structure NN O
reduces VBZ O
the DT O
number NN O
of IN O
( ( O
G NNP O
/ NNP O
U NNP O
) ) O
AG NNP O
repeats NNS O
required VBD O
for IN O
stable JJ O
TRAP NNP B-Gene
- : O
trp NN B-Gene
leader NN O
RNA NNP O
association NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
STAT NNP B-Gene
activation NN O
in IN O
a DT O
panel NN O
of IN O
rodent NN O
fibroblast NN O
cell NN O
lines NNS O
stably RB O
transformed VBN O
by IN O
diverse JJ O
viral JJ O
oncoproteins NNS O
. . O

Electrical JJ O
activity NN O
was VBD O
evaluated VBN O
by IN O
monitoring VBG O
the DT O
general JJ O
electrocorticogram NN O
( ( O
ECoG NNP O
) ) O
as RB O
well RB O
as IN O
local JJ O
DC NNP O
steady JJ O
potential NN O
( ( O
two CD O
sites NNS O
) ) O
. . O

Further JJ O
studies NNS O
in IN O
T NNP O
- : O
24 CD O
cells NNS O
demonstrated VBD O
that IN O
HA NNP O
fragments NNS O
also RB O
induced VBD O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
phosphorylation NN O
and CC O
degradation NN O
, , O
kappa NN B-Gene
B NNP I-Gene
- : I-Gene
linked VBN I-Gene
reporter NN I-Gene
gene NN I-Gene
expression NN O
, , O
and CC O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
an DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
dependent JJ O
manner NN O
. . O

Groups NNP O
dicker NN O
for IN O
price NN O
breaks NNS O
as IN O
anesthetic JJ O
gas NN O
goes VBZ O
multi SYM O
- : O
source NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
microinjection NN O
of IN O
an DT O
anti JJ B-Gene
- : I-Gene
CBP NN I-Gene
antiserum NN I-Gene
into IN O
fibroblasts NNS O
can MD O
inhibit VB O
transcription NN O
from IN O
a DT O
cAMP NN O
responsive JJ O
promoter NN O
. . O

This DT O
utilization NN O
of IN O
an DT O
intronic JJ O
polyadenylation NN O
site NN O
without IN O
alternative JJ O
exon NN O
usage NN O
is VBZ O
comparable JJ O
to TO O
the DT O
mechanism NN O
whereby WRB O
both DT O
secreted VBN O
and CC O
membrane SYM O
- : O
bound NN O
forms NNS O
of IN O
the DT O
immunoglobulin NN B-Gene
mu NN I-Gene
heavy NN I-Gene
chain NN I-Gene
are VBP O
made VBN O
from IN O
a DT O
single JJ O
genetic JJ O
locus NN O
. . O

Vbeta NN B-Gene
segments NNS O
are VBP O
appended VBN O
to TO O
DJbeta NNP B-Gene
rearrangements NNS O
, , O
with IN O
little JJ O
or CC O
no DT O
direct JJ O
Vbeta NNP B-Gene
to TO O
Jbeta NNP B-Gene
joining NN O
, , O
despite IN O
12 CD O
/ JJ O
23 CD O
compatibility NN O
of IN O
Vbeta NNP B-Gene
23 CD I-Gene
- : I-Gene
RSSs NN I-Gene
and CC O
Jbeta12 NNP B-Gene
- : I-Gene
RSSs NN I-Gene
. . O

The DT O
pattern NN O
for IN O
catalytic JJ O
zinc NN O
sites NNS O
included VBD O
two CD O
ligands NNS O
close RB O
in IN O
sequence NN O
, , O
a DT O
sequence NN O
- : O
distant JJ O
ligand NN O
, , O
and CC O
a DT O
main JJ O
- : O
chain NN O
hydrogen NN O
bond NN O
joining VBG O
two CD O
ligands NNS O
. . O

French JJ O
, , O
M NNP O
. . O

The DT O
structure NN O
of IN O
the DT O
enhancer NN O
was VBD O
also RB O
probed VBN O
by IN O
inserting VBG O
a DT O
pair NN O
of IN O
complementary JJ O
synthetic JJ O
oligodeoxynucleotides NNS O
which WDT O
represented VBD O
the DT O
region NN O
between IN O
nt JJ O
positions NNS O
- : O
235 CD O
and CC O
- : O
215 CD O
into IN O
a DT O
truncated JJ O
template NN O
which WDT O
lacked VBD O
the DT O
enhancer NN O
. . O

In IN O
a DT O
series NN O
of IN O
16 CD O
full JJ O
- : O
scale NN O
fire NN O
tests NNS O
, , O
investigators NNS O
at IN O
the DT O
IIT NNP O
Research NNP O
Institute NNP O
have VBP O
concluded VBN O
that IN O
automatic JJ O
door NN O
control NN O
in IN O
the DT O
room NN O
of IN O
fire NN O
origin NN O
can MD O
significantly RB O
reduce VB O
the DT O
spread NN O
of IN O
toxic JJ O
smoke NN O
and CC O
gases NNS O
. . O

Retroviral JJ O
replication NN O
requires VBZ O
that IN O
a DT O
portion NN O
of IN O
the DT O
primary JJ O
transcripts NNS O
generated VBN O
from IN O
proviral JJ O
DNA NNP O
be VB O
spliced VBN O
to TO O
serve VB O
as IN O
mRNA NN O
for IN O
the DT O
envelope NN B-Gene
protein NN I-Gene
and CC O
in IN O
Rous NNP O
sarcoma NN O
virus NN O
as IN O
src JJ B-Gene
mRNA NN I-Gene
. . O

As IN O
in IN O
S NNP O
. . O
cerevisiae NN O
, , O
the DT O
sequence NN O
of IN O
rhp51 NN B-Gene
+ NN I-Gene
showed VBD O
two CD O
MluI NNP B-Gene
cell NN I-Gene
- : I-Gene
cycle NN I-Gene
boxes NNS I-Gene
and CC O
a DT O
putative JJ O
DNA NN O
damage NN O
- : O
responsive JJ O
element NN O
in IN O
its PRP$ O
upstream JJ O
region NN O
. . O

16 CD O
, , O
99 CD O
- : O
104 CD O
) ) O
. . O

The DT O
role NN O
of IN O
saliva NN O
in IN O
sour JJ O
taste NN O
perception NN O
was VBD O
investigated VBN O
in IN O
a DT O
series NN O
of IN O
4 CD O
experiments NNS O
. . O

Recent JJ O
literature NN O
has VBZ O
suggested VBN O
that IN O
beta NN B-Gene
- : I-Gene
2 CD I-Gene
transferrin NN I-Gene
can MD O
also RB O
be VB O
used VBN O
as IN O
a DT O
clinical JJ O
marker NN O
for IN O
perilymph NN O
. . O

Next JJ O
, , O
we PRP O
stably RB O
overexpressed VBD O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Shc NNP I-Gene
or CC O
Y317F NNP B-Gene
mutant JJ I-Gene
Shc NNP I-Gene
into IN O
HIRc NNP O
cells NNS O
. . O

Continued NNP O
development NN O
of IN O
the DT O
rat NN O
conditioning VBG O
paradigm NN O
is VBZ O
especially RB O
warranted JJ O
because IN O
of IN O
the DT O
ability NN O
to TO O
record VB O
sympathetic JJ O
nerve NN O
activity NN O
in IN O
intact JJ O
, , O
awake JJ O
subjects NNS O
and CC O
the DT O
large JJ O
number NN O
of IN O
readily RB O
available JJ O
genetic JJ O
strains NNS O
, , O
which WDT O
model VBZ O
human JJ O
pathological JJ O
states NNS O
. . O

His PRP$ O
HC NNP B-Gene
II NNP I-Gene
activity NN O
and CC O
antigen NN O
levels NNS O
were VBD O
49 CD O
% NN O
and CC O
50 CD O
% NN O
, , O
respectively RB O
, , O
and CC O
his PRP$ O
daughter NN O
also RB O
showed VBD O
similar JJ O
low JJ O
levels NNS O
. . O

BACKGROUND NN O
: : O
The DT O
Bazett NNP O
- : O
corrected VBN O
QT NNP O
( ( O
QTc NNP O
) ) O
interval NN O
during IN O
exercise NN O
has VBZ O
been VBN O
used VBN O
as IN O
a DT O
marker NN O
for IN O
ischemic JJ O
disease NN O
, , O
arrhythmogenic JJ O
substrate NN O
and CC O
the DT O
long JJ O
QT NNP O
syndrome NN O
. . O

PDGF VB B-Gene
A DT I-Gene
- : I-Gene
chain NN I-Gene
levels NNS O
increase NN O
in IN O
cultured JJ O
vascular JJ O
smooth JJ O
muscle NN O
cells NNS O
( ( O
SMCs NNP O
) ) O
exposed VBD O
to TO O
ATII NNP B-Gene
. . O

Similarly RB O
, , O
actuarial JJ O
interpretations NNS O
for IN O
the DT O
second JJ O
protocols NNS O
were VBD O
not RB O
more RBR O
frequently RB O
selected VBN O
by IN O
therapists NNS O
as IN O
more RBR O
valid JJ O
, , O
regardless RB O
of IN O
treatment NN O
condition NN O
and CC O
elevation NN O
of IN O
the DT O
F NNP O
and CC O
F NNP O
- : O
K NNP O
indices NNS O
on IN O
the DT O
first JJ O
MMPI NNP O
profile NN O
. . O

Studies NNS O
are VBP O
necessary JJ O
to TO O
assess VB O
the DT O
source NN O
of IN O
contamination NN O
and CC O
potential JJ O
role NN O
of IN O
MRSA NNP O
- : O
contaminated VBN O
milk NN O
in IN O
the DT O
transmission NN O
of IN O
MRSA NNP O
to TO O
neonates NNS O
. . O

However RB O
, , O
the DT O
ratio NN O
M NNP O
/ NNP O
Pc NNP O
provides VBZ O
a DT O
useful JJ O
index NN O
that WDT O
seems VBZ O
to TO O
be VB O
independent JJ O
of IN O
the DT O
metabolic JJ O
demand NN O
. . O

Short JJ O
- : O
course NN O
amphotericin NN O
B NNP O
therapy NN O
for IN O
candidemia NN O
in IN O
pediatric JJ O
patients NNS O
. . O

An DT O
important JJ O
mechanism NN O
by IN O
which WDT O
the DT O
tumor NN O
suppressor NN O
p53 NN B-Gene
maintains NNS O
genomic JJ O
stability NN O
is VBZ O
to TO O
induce VB O
cell NN O
cycle NN O
arrest NN O
through IN O
activation NN O
of IN O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN O
p21 NN B-Gene
( ( O
WAF1 NNP B-Gene
/ NNP O
Cip1 NNP B-Gene
) ) O
gene NN O
. . O

SKP1 NNP B-Gene
- : O
SnRK NNP B-Gene
protein NN O
kinase NN O
interactions NNS O
mediate VBP O
proteasomal JJ O
binding NN O
of IN O
a DT O
plant NN O
SCF NNP B-Gene
ubiquitin JJ I-Gene
ligase NN I-Gene
. . O

It PRP O
contains VBZ O
three CD O
putative JJ O
binding VBG O
sites NNS O
for IN O
transcription NN B-Gene
factor NN I-Gene
Sp1 NNP I-Gene
as RB O
well RB O
as IN O
several JJ O
short JJ O
sequences NNS O
that WDT O
are VBP O
similar JJ O
to TO O
known VB O
cis JJ O
- : O
acting VBG O
enhancers NNS O
or CC O
binding VBG O
sites NNS O
for IN O
transcription NN O
factors NNS O
. . O

Its PRP$ O
role NN O
in IN O
these DT O
processes NNS O
suggests VBZ O
that IN O
the DT O
function NN O
of IN O
c SYM B-Gene
- : I-Gene
Myb NN I-Gene
may MD O
be VB O
important JJ O
early JJ O
in IN O
the DT O
establishment NN O
of IN O
the DT O
hematopoietic JJ O
lineage NN O
. . O

To TO O
understand VB O
the DT O
molecular JJ O
regulation NN O
of IN O
these DT O
genes NNS O
in IN O
thyroid NN O
cells NNS O
, , O
the DT O
effect NN O
of IN O
thyroid JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
TTF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
the DT O
paired JJ B-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
protein NN I-Gene
8 CD I-Gene
( ( O
Pax NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
deiodinase NN B-Gene
promoters NNS I-Gene
were VBD O
studied VBN O
. . O

The DT O
observation NN O
that IN O
beta VBZ B-Gene
2m CD I-Gene
with IN O
covalently RB O
attached VBN O
peptide NN O
can MD O
effectively RB O
create VB O
CTL NNP O
target NN O
structures NNS O
in IN O
vitro NN O
offers NNS O
new JJ O
possibilities NNS O
for IN O
the DT O
in IN O
vivo JJ O
induction NN O
of IN O
epitope NN O
- : O
specific JJ O
CTL NNP O
responses NNS O
by IN O
either DT O
DNA NNP O
immunization NN O
or CC O
injection NN O
of IN O
the DT O
purified VBN O
epitope NN O
- : O
linked VBN O
beta NN B-Gene
2m CD I-Gene
. . O

Activation NN O
of IN O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
is VBZ O
correlated VBN O
with IN O
induction NN O
of IN O
the DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
response NN I-Gene
genes NNS I-Gene
. . O

The DT O
1 CD O
. . O
9 CD O
- : O
kb NN O
C NNP B-Gene
mu NN I-Gene
RNA NNP O
contains VBZ O
the DT O
3 CD O
' POS O
sequence NN O
characteristic NN O
of IN O
secreted JJ O
mu NN B-Gene
chain NN I-Gene
, , O
whereas IN O
the DT O
longer JJR O
species NNS O
bear VBP O
that IN O
of IN O
membrane NN O
- : O
bound NN O
mu NN B-Gene
chin NN O
. . O

These DT O
patients NNS O
failed VBD O
to TO O
respond VB O
to TO O
intravenous JJ O
cyclophosphamide NN O
and CC O
steroids NNS O
and CC O
were VBD O
then RB O
changed VBN O
to TO O
receive VB O
oral JJ O
cyclosporine NN O
A NNP O
, , O
at IN O
a DT O
dose NN O
of IN O
5 CD O
mg NNS O
/ JJ O
kg JJ O
/ NNP O
day NN O
. . O

The DT O
background NN O
processes VBZ O
depending VBG O
on IN O
the DT O
etiological JJ O
factor NN O
and CC O
the DT O
character NN O
of IN O
lesion NN O
of IN O
the DT O
epithelium NN O
are VBP O
divided VBN O
into IN O
dyshormonal JJ O
, , O
inflammatory JJ O
, , O
and CC O
posttraumatic JJ O
. . O

The DT O
active JJ O
state NN O
is VBZ O
terminated VBN O
by IN O
hydrolysis NN O
of IN O
bound NN O
GTP NNP O
, , O
producing VBG O
inactive JJ O
ARF NNP B-Gene
- : I-Gene
GDP NNP I-Gene
. . O

Elimination NN O
of IN O
ETH1 NNP B-Gene
in IN O
apn1 NN B-Gene
strains NNS O
also RB O
increased VBD O
spontaneous JJ O
mutation NN O
rates NNS O
9 CD O
- : O
or CC O
31 CD O
- : O
fold NN O
compared VBN O
to TO O
the DT O
wild JJ O
type NN O
as IN O
determined VBN O
by IN O
reversion NN O
to TO O
adenine VB O
or CC O
lysine VB O
prototrophy NN O
, , O
respectively RB O
. . O

After IN O
the DT O
meal NN O
containing VBG O
potato NN O
, , O
plasma VBP O
glucose JJ O
levels NNS O
rose VBD O
sharply RB O
, , O
peaked VBD O
at IN O
30 CD O
- : O
45 CD O
min NN O
and CC O
fell VBD O
below IN O
initial JJ O
levels NNS O
2 CD O
to TO O
3 CD O
h NN O
later RB O
. . O

Automatic NNP O
view NN O
box NN O
. . O

In IN O
experiment JJ O
2 CD O
the DT O
rats NNS O
had VBD O
free JJ O
access NN O
to TO O
two CD O
bottles NNS O
, , O
one CD O
of IN O
which WDT O
contained VBD O
tap JJ O
water NN O
, , O
and CC O
the DT O
other JJ O
contained VBD O
either DT O
an DT O
ethanol NN O
( ( O
6 CD O
% NN O
) ) O
or CC O
a DT O
sucrose JJ O
( ( O
5 CD O
% NN O
) ) O
solution NN O
. . O

Their PRP$ O
biosynthesis NN O
proceeds NNS O
via IN O
linear JJ O
precursors NNS O
that IN O
become VBP O
branched VBN O
by IN O
beta1 NN B-Gene
, , I-Gene
6 CD I-Gene
- : I-Gene
GlcNAc NN I-Gene
transferases NNS I-Gene
( ( O
IGnT6 NNP O
, , O
GlcNAc NNP O
to TO O
Gal NNP O
) ) O
. . O

The DT O
pentafluorobenzyl JJ O
derivative NN O
of IN O
clonidine NN O
yields NNS O
an DT O
intense JJ O
ion NN O
fragment NN O
at IN O
m NN O
/ NNP O
z NN O
354 CD O
, , O
and CC O
the DT O
lower JJR O
limit NN O
of IN O
detection NN O
is VBZ O
0 CD O
. . O
25 CD O
ng JJ O
/ NNP O
ml NN O
for IN O
a DT O
1 CD O
- : O
ml NN O
plasma JJ O
sample NN O
. . O

Modulation NN O
of IN O
human JJ B-Gene
heat NN I-Gene
shock NN I-Gene
factor NN I-Gene
trimerization NN O
by IN O
the DT O
linker NN O
domain NN O
. . O

Although IN O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
it PRP O
is VBZ O
possible JJ O
to TO O
use VB O
orally RB O
administered VBN O
testosterone NN O
to TO O
maintain VB O
se JJ O
- : O
T NN O
levels NNS O
in IN O
the DT O
normal JJ O
male NN O
range NN O
, , O
the DT O
convenience NN O
to TO O
the DT O
patient NN O
must MD O
be VB O
balanced VBN O
against IN O
the DT O
cost NN O
and CC O
possible JJ O
side NN O
effects NNS O
of IN O
the DT O
large JJ O
doses NNS O
required VBN O
. . O

The DT O
variable JJ O
HMG NNP B-Gene
dosage NN O
regimen NN O
was VBD O
found VBN O
to TO O
offer VB O
no DT O
advantages NNS O
when WRB O
compared VBN O
with IN O
our PRP$ O
standard JJ O
daily JJ O
dosage NN O
regimen NNS O
. . O

The DT O
p20 NN B-Gene
- : I-Gene
CGGBP NNP I-Gene
gene NN I-Gene
is VBZ O
conserved VBN O
among IN O
mammals NNS O
but CC O
shows VBZ O
no DT O
homology NN O
to TO O
non VB O
- : O
vertebrate NN O
species NNS O
. . O

Promoter NNP O
transcriptional JJ O
activity NN O
was VBD O
determined VBN O
for IN O
a DT O
wide JJ O
5 CD O
' POS O
portion NN O
of IN O
the DT O
human JJ O
annexin NN B-Gene
A5 NNP I-Gene
gene NN I-Gene
, , O
from IN O
bp SYM O
- : O
1275 CD O
to TO O
+ VB O
79 CD O
relative JJ O
to TO O
the DT O
most RBS O
5 CD O
' '' O
of IN O
several JJ O
discrete JJ O
transcription NN O
start NN O
points NNS O
. . O

Both DT O
TRE NNP O
- : O
like IN O
elements NNS O
were VBD O
capable JJ O
of IN O
binding VBG O
AP1 NNP B-Gene
. . O

Degradation NN O
of IN O
the DT O
soybean NN B-Gene
ribulose VBD I-Gene
- : I-Gene
1 CD I-Gene
, , I-Gene
5 CD I-Gene
- : I-Gene
bisphosphate NN I-Gene
carboxylase NN I-Gene
small JJ I-Gene
- : I-Gene
subunit NN I-Gene
mRNA NN I-Gene
, , O
SRS4 NNP B-Gene
, , O
initiates VBZ O
with IN O
endonucleolytic JJ O
cleavage NN O
. . O

A DT O
DNA NNP O
motif NN O
related VBN O
to TO O
the DT O
cAMP NN O
- : O
responsive JJ O
element NN O
and CC O
an DT O
exon JJ B-Gene
- : I-Gene
located VBN I-Gene
activator NN I-Gene
protein NN I-Gene
- : I-Gene
2 CD I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
the DT O
human JJ B-Gene
tissue NN I-Gene
- : I-Gene
type NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
gene NN I-Gene
promoter NN I-Gene
cooperate NN O
in IN O
basal JJ O
expression NN O
and CC O
convey JJ O
activation NN O
by IN O
phorbol NN O
ester NN O
and CC O
cAMP NN O
. . O

The DT O
percentage NN O
RFR NNP O
reduction NN O
at IN O
the DT O
end NN O
of IN O
CPB NNP O
showed VBD O
significant JJ O
correlation NN O
with IN O
1 CD O
) ) O
CPB NNP O
duration NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
49 CD O
) ) O
, , O
2 CD O
) ) O
oxygen NN O
flow NN O
rate NN O
index NN O
( ( O
OFRI NNP O
) ) O
, , O
i JJ O
. . O
e NN O
. . O
flow JJ O
/ NN O
min NN O
in IN O
the DT O
bubble JJ O
oxygenator NN O
/ NNP O
m2 NN O
bsa NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
38 CD O
) ) O
, , O
and CC O
3 CD O
) ) O
blood NN O
flow NN O
rate NN O
index NN O
( ( O
BFRI NNP O
) ) O
, , O
i JJ O
. . O
e NN O
. . O
average JJ O
volume NN O
of IN O
blood NN O
pumped VBN O
through IN O
the DT O
heart NN O
- : O
lung NN O
machine NN O
/ NNP O
min NN O
CPB NNP O
time NN O
/ NNP O
m2 NN O
bsa NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
51 CD O
) ) O
. . O

Cell NNP O
survival NN O
by IN O
Epo NNP B-Gene
did VBD O
not RB O
require VB O
activation NN O
of IN O
other JJ O
known VBN O
signaling VBG O
pathways NNS O
including VBG O
PI NNP B-Gene
- : I-Gene
3 CD I-Gene
kinase NN I-Gene
, , O
PLC NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
Ras NNP B-Gene
or CC O
Stats NNP B-Gene
. . O

Identity NN O
elements NNS O
in IN O
tRNA NN O
for IN O
mono FW O
- : O
and CC O
dimethylation NN O
reactions NNS O
by IN O
the DT O
recombinant JJ B-Gene
pfTrm1p NN I-Gene
were VBD O
identified VBN O
using VBG O
in IN O
vitro JJ O
T7 NNP O
transcripts NNS O
of IN O
33 CD O
variants NNS O
of IN O
tRNA NN B-Gene
( ( I-Gene
Asp NNP I-Gene
) ) I-Gene
and CC O
tRNA $ B-Gene
( ( I-Gene
Phe NNP I-Gene
) ) I-Gene
from IN O
yeast NN O
. . O

Issues NNS O
of IN O
distribution NN O
of IN O
kinetic JJ O
energy NN O
of IN O
traumatizing VBG O
object NN O
in IN O
direct JJ O
contact NN O
interaction NN O
with IN O
head NN O
during IN O
impact NN O
are VBP O
discussed VBN O
from IN O
position NN O
of IN O
biomechanics NNS O
. . O

Reciprocally RB O
, , O
HMGI NNP B-Gene
- : I-Gene
C NNP I-Gene
expression NN O
also RB O
coordinately RB O
enhances VBZ O
PIAS3 NNP B-Gene
- : O
mediated VBD O
repression NN O
of IN O
STAT3 NNP B-Gene
- : O
dependent JJ O
transactivation NN O
. . O

In IN O
the DT O
control NN O
group NN O
, , O
platelet NN O
markers NNS O
increased VBD O
1 CD O
h NN O
after IN O
surgery NN O
. . O

Although IN O
% NN O
BF NNP O
was VBD O
correlated VBN O
with IN O
all PDT O
the DT O
BMIs NNP O
( ( O
r VB O
= RB O
0 CD O
. . O
60 CD O
- : O
0 CD O
. . O
82 CD O
) ) O
, , O
applying VBG O
objective JJ O
definitions NNS O
of IN O
obesity NN O
based VBN O
on IN O
BMIs NNP O
or CC O
% NN O
BF NNP O
by IN O
densitometry NN O
often RB O
produced VBD O
conflicting VBG O
results NNS O
. . O

These DT O
case NN O
reports NNS O
provide VBP O
further JJ O
evidence NN O
that IN O
LiCO3 NNP O
can MD O
be VB O
a DT O
useful JJ O
medication NN O
in IN O
the DT O
treatment NN O
of IN O
aggressive JJ O
behavior NN O
and CC O
affective JJ O
instability NN O
after IN O
brain NN O
injury NN O
, , O
but CC O
that IN O
it PRP O
has VBZ O
significant JJ O
potential NN O
for IN O
neurotoxicity NN O
in IN O
this DT O
population NN O
, , O
particularly RB O
when WRB O
used VBN O
in IN O
conjunction NN O
with IN O
neuroleptic JJ O
agents NNS O
. . O

The DT O
mouse NN B-Gene
platelet NN I-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( I-Gene
PDGF NNP I-Gene
) ) I-Gene
beta SYM I-Gene
- : I-Gene
receptor NN I-Gene
promoter NN I-Gene
contains VBZ O
a DT O
CCAAT NNP O
motif NN O
, , O
and CC O
NF NNP B-Gene
- : I-Gene
Y NNP I-Gene
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
its PRP$ O
transcription NN O
. . O

Other JJ O
parameters NNS O
of IN O
iron NN O
metabolism NN O
, , O
including VBG O
ferritin NN B-Gene
, , O
were VBD O
not RB O
found VBN O
to TO O
contribute VB O
to TO O
the DT O
risk NN O
. . O

Enhancement NN O
of IN O
the DT O
immune JJ O
response NN O
by IN O
aspecific JJ O
action NN O
of IN O
vaccine NN O
additives NNS O
in IN O
the DT O
aerogenic JJ O
immunization NN O
of IN O
swine NN O
against IN O
swine NN O
plague NN O

The DT O
lysozyme NN B-Gene
FEF NNP B-Gene
site NN O
is VBZ O
immediately RB O
5 CD O
' '' O
to TO O
a DT O
PU NNP B-Gene
. . O

Scotchbond NN O
2 CD O
showed VBD O
the DT O
least JJS O
dye JJ O
penetration NN O
but CC O
not RB O
statistically RB O
less JJR O
than IN O
the DT O
XR NNP O
bond NN O
/ NNP O
Silus NNP O
Plus NNP O
combination NN O
. . O

Successful JJ O
treatment NN O
of IN O
candidiasis NN O
with IN O
transfer NN B-Gene
factor NN I-Gene
. . O

Adult NNP O
Amblyomma NNP O
lepidum NN O
ticks NNS O
fed VBN O
as IN O
nymphs NN O
on IN O
this DT O
goat NN O
transmitted VBD O
heartwater NN O
to TO O
a DT O
Friesian NNP O
( ( O
Bos NNP O
taurus NN O
) ) O
calf NN O
. . O

Molecular JJ O
cloning NN O
and CC O
expression NN O
of IN O
RPE65 NNP B-Gene
, , O
a DT O
novel JJ O
retinal JJ O
pigment NN O
epithelium NN O
- : O
specific JJ O
microsomal JJ O
protein NN O
that WDT O
is VBZ O
post VBN O
- : O
transcriptionally RB O
regulated VBN O
in IN O
vitro NN O
. . O

Like IN O
the DT O
consensus NN B-Gene
mammalian JJ I-Gene
LHbeta NNP I-Gene
gene NN I-Gene
, , O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
gpLH NN B-Gene
/ NNP O
CGbeta NNP B-Gene
gene NN O
contains VBZ O
a DT O
single JJ O
TATA NNP O
sequence NN O
37 CD O
bp JJ O
upstream NN O
of IN O
the DT O
translation NN O
start NN O
codon NN O
. . O

The DT O
method NN O
also RB O
eliminates VBZ O
tagging VBG O
of IN O
venous JJ O
spins NNS O
and CC O
concern NN O
about IN O
asymmetric JJ O
magnetization NN O
transfer NN O
effects NNS O
. . O

Preservatives NNS O
are VBP O
an DT O
important JJ O
component NN O
of IN O
ophthalmic JJ O
preparations NNS O
, , O
providing VBG O
antimicrobial JJ O
activity NN O
in IN O
the DT O
bottle NN O
and CC O
preventing VBG O
decomposition NN O
of IN O
active JJ O
drug NN O
. . O

Genetic JJ O
experiments NNS O
using VBG O
mutants NNS O
defective JJ O
in IN O
apontic JJ B-Gene
and CC O
bruno JJ B-Gene
reveal NN O
a DT O
functional JJ O
interaction NN O
between IN O
these DT O
genes NNS O
. . O

This DT O
effect NN O
required VBN O
( ( O
i NN O
) ) O
IR NNP B-Gene
activation NN O
since IN O
it PRP O
was VBD O
abrogated VBN O
by IN O
IR NNP B-Gene
mutation NN O
at IN O
tyrosines NNS O
1162 CD O
and CC O
1163 CD O
and CC O
( ( O
ii NN O
) ) O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
since IN O
it PRP O
was VBD O
abolished VBN O
by IN O
overexpression NN O
of IN O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
IkappaB NNP I-Gene
- : I-Gene
alpha NN I-Gene
( ( I-Gene
A32 NNP I-Gene
/ NNP I-Gene
36 CD I-Gene
) ) I-Gene
and CC O
mimicked VBN O
by IN O
overexpression NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
c SYM B-Gene
- : I-Gene
Rel JJ I-Gene
subunit NN I-Gene
. . O

A DT O
study NN O
of IN O
human JJ O
genes NNS O
coding VBG O
for IN O
U4 NNP B-Gene
small JJ I-Gene
nuclear JJ I-Gene
RNA NNP I-Gene
is VBZ O
presented VBN O
. . O

The DT O
inner JJ O
ears NNS O
were VBD O
exposed VBN O
by IN O
microdissection NN O
, , O
and CC O
the DT O
vestibular JJ O
sensory NN O
regions NNS O
were VBD O
either RB O
sectioned VBN O
and CC O
studied VBN O
with IN O
light NN O
or CC O
electron NN O
microscopy NN O
, , O
or CC O
prepared JJ O
and CC O
studied VBN O
with IN O
the DT O
surface NN O
specimen NN O
technique NN O
. . O

After IN O
6 CD O
h NN O
of IN O
reperfusion NN O
, , O
PO2 NNP O
/ NNP O
FlO2 NNP O
ratio NN O
was VBD O
significantly RB O
better JJR O
after IN O
Combined VBN O
Therapy NNP O
( ( O
372 CD O
+ NN O
/ NNP O
- : O
52 CD O
mm NN O
Hg NNP O
) ) O
than IN O
in IN O
the DT O
Recipient NNP O
Instilled NNP O
( ( O
117 CD O
+ NN O
/ NNP O
- : O
47 CD O
mm NN O
Hg NNP O
) ) O
and CC O
Control NNP O
groups NNS O
( ( O
87 CD O
+ NN O
/ NNP O
- : O
26 CD O
mm NN O
Hg NNP O
) ) O
, , O
with IN O
intermediate JJ O
values NNS O
in IN O
Donor NNP O
Aerosol NNP O
dogs NNS O
( ( O
232 CD O
+ NN O
/ NNP O
- : O
64 CD O
mm NN O
Hg NNP O
) ) O
. . O

Nearly RB O
all DT O
isolates NNS O
of IN O
S NNP O
. . O
intermedius NN O
and CC O
most JJS O
isolates NNS O
of IN O
S NNP O
. . O
constellatus NN O
, , O
but CC O
only RB O
19 CD O
% NN O
of IN O
those DT O
of IN O
S NNP O
. . O
anginosus NN O
, , O
were VBD O
associated VBN O
with IN O
abscess NN O
. . O

The DT O
relative JJ O
importance NN O
of IN O
these DT O
two CD O
mechanisms NNS O
differed VBN O
in IN O
a DT O
response NN O
element NN O
- : O
specific JJ O
manner NN O
. . O

Effects NNS O
of IN O
nitrogen NN O
( ( O
PN2 NNP O
: : O
5 CD O
and CC O
14 CD O
MPa NNP O
) ) O
and CC O
helium NN O
( ( O
PHe NNP O
: : O
13 CD O
and CC O
14 CD O
MPa NNP O
) ) O
were VBD O
also RB O
tested VBN O
. . O

Histological JJ O
evaluation NN O
revealed VBD O
a DT O
more RBR O
than IN O
twofold JJ O
increase NN O
in IN O
the DT O
number NN O
of IN O
interepithelial JJ O
mononuclear NN O
cells NNS O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
, , O
while IN O
the DT O
number NN O
of IN O
epithelial JJ O
cells NNS O
/ VBP O
100 CD O
microns NNS O
of IN O
villous JJ O
mucosa NN O
and CC O
the DT O
mean JJ O
height NN O
of IN O
the DT O
epithelial JJ O
cells NNS O
were VBD O
comparable JJ O
in IN O
both DT O
groups NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
ATF4 NNP B-Gene
regulates VBZ O
basal NN O
and CC O
CdCl NNP O
( ( O
2 CD O
) ) O
- : O
induced JJ O
expression NN O
of IN O
the DT O
ho NN B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
in IN O
a DT O
cell NN O
- : O
specific JJ O
manner NN O
and CC O
possibly RB O
in IN O
a DT O
complex JJ O
with IN O
Nrf2 NNP B-Gene
. . O

HVH2 NNP B-Gene
mRNA NN I-Gene
showed VBD O
an DT O
expression NN O
pattern NN O
distinct NN O
from IN O
CL100 NNP B-Gene
( ( O
human JJ B-Gene
homologue NN I-Gene
of IN I-Gene
mouse NN I-Gene
MKP1 NNP I-Gene
) ) O
and CC O
PAC1 NNP B-Gene
, , O
two CD O
previously RB O
identified VBN O
MAP NNP B-Gene
kinase NN I-Gene
phosphatases NNS I-Gene
. . O

We PRP O
report VBP O
here RB O
the DT O
cloning NN O
of IN O
the DT O
human JJ B-Gene
goosecoid NN I-Gene
gene NN I-Gene
( ( O
GSC NNP B-Gene
) ) O
from IN O
a DT O
genomic JJ O
library NN O
and CC O
the DT O
sequence NN O
of IN O
its PRP$ O
encoded JJ O
protein NN O
. . O

( ( O
2 CD O
) ) O
The DT O
inappropriateness NN O
of IN O
adaptive JJ O
segmentation NN O
for IN O
the DT O
isolation NN O
of IN O
spikes NNS O
and CC O
sharp JJ O
waves NNS O
, , O
which WDT O
had VBD O
been VBN O
anticipated VBN O
in IN O
view NN O
of IN O
the DT O
short JJ O
duration NN O
of IN O
such JJ O
transients NNS O
in IN O
relation NN O
to TO O
the DT O
length NN O
of IN O
the DT O
window NN O
( ( O
1 CD O
. . O
2 CD O
sec NN O
) ) O
used VBD O
for IN O
the DT O
autocorrelation NN O
functions NNS O
employed VBN O
in IN O
the DT O
segmentation NN O
algorithm NN O
, , O
was VBD O
confirmed VBN O
. . O

Nhp2p NNP B-Gene
is VBZ O
a DT O
highly RB O
basic JJ O
protein NN O
that WDT O
belongs VBZ O
to TO O
a DT O
family NN O
of IN O
putative JJ O
RNA NNP O
- : O
binding NN O
proteins NNS O
. . O

New NNP O
diagnostic JJ O
strategies NNS O
for IN O
lupus JJ O
anticoagulants NNS O
and CC O
antiphospholipid JJ O
antibodies NNS O
. . O

The DT O
PDGFR NNP B-Gene
mutants NNS I-Gene
that WDT O
failed VBD O
to TO O
associate VB O
with IN O
PLC NNP B-Gene
gamma NNS I-Gene
were VBD O
not RB O
able JJ O
to TO O
mediate VB O
the DT O
PDGF NNP B-Gene
- : O
dependent JJ O
production NN O
of IN O
inositol NN O
phosphates NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
isolated VBN O
a DT O
genomic JJ O
fragment NN O
containing VBG O
the DT O
most RBS O
distal JJ O
5 CD O
' POS O
sequences NNS O
of IN O
the DT O
major JJ O
GGT NNP B-Gene
mRNA NN I-Gene
in IN O
HepG2 NNP O
cells NNS O
. . O

C NNP O
. . O
D2 NNP O
- : O
Chr NN O
4 CD O
congenic JJ O
strains NNS O
harboring VBG O
DBA NNP O
/ $ O
2 CD O
alleles NNS O
associated VBN O
with IN O
the DT O
Pctr1 NNP B-Gene
locus NN I-Gene
contained VBD O
DBA NNP O
/ NNP O
2 CD O
"""" NNP O
resistant JJ O
"""" NNP O
alleles NNS O
of IN O
the DT O
CDK4 NNP B-Gene
/ NNP O
CDK6 NNP B-Gene
inhibitors NNS O
p16 VBP B-Gene
and CC O
p15 VBP B-Gene
. . O

The DT O
ability NN O
of IN O
SMRT NNP B-Gene
to TO O
associate VB O
with IN O
these DT O
transcription NN O
factors NNS O
and CC O
thereby NN O
to TO O
mediate VB O
repression NN O
is VBZ O
strongly RB O
inhibited VBN O
by IN O
activation NN O
of IN O
tyrosine JJ B-Gene
kinase NN I-Gene
signaling VBG O
pathways NNS O
, , O
such JJ O
as IN O
that DT O
represented VBN O
by IN O
the DT O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
. . O

We PRP O
found VBD O
strand RB O
selective JJ O
repair NN O
in IN O
DNA NN O
fragments NNS O
within IN O
two CD O
active JJ O
genes NNS O
, , O
DHFR NNP B-Gene
and CC O
an DT O
unknown JJ O
gene NN O
adjacent JJ O
to TO O
DHFR NNP B-Gene
. . O

Significant NNP O
treatment NN O
- : O
related JJ O
problems NNS O
appeared VBD O
during IN O
the DT O
second JJ O
decade NN O
in IN O
5 CD O
patients NNS O
, , O
including VBG O
one CD O
chest JJS O
wall NN O
sarcoma NN O
; : O
all DT O
of IN O
these DT O
patients NNS O
had VBD O
received VBN O
at IN O
least JJS O
60 CD O
Gy NNP O
to TO O
breast VB O
and CC O
regional JJ O
nodal JJ O
areas NNS O
. . O

It PRP O
is VBZ O
shown VBN O
that IN O
, , O
for IN O
any DT O
periodic JJ O
input NN O
, , O
the DT O
map NN O
representing VBG O
the DT O
relation NN O
between IN O
input NN O
phases NNS O
at IN O
consecutive JJ O
discharge NN O
times NNS O
can MD O
be VB O
restricted VBN O
to TO O
a DT O
piecewise NN O
continuous JJ O
, , O
orientation NN O
preserving VBG O
circle NN O
map NN O
. . O

There EX O
were VBD O
gene NN O
clusters NNS O
encoding VBG O
photosynthesis NN O
components NNS O
such JJ O
as IN O
the DT O
psbB NN B-Gene
- : O
psbH NN B-Gene
- : O
petB NN B-Gene
- : O
petD NN B-Gene
and CC O
the DT O
psbE NN O
- : O
psbF NN O
clusters NNS O
. . O

This DT O
last JJ O
includes VBZ O
tissue NN O
O2 NNP O
transfer NN O
( ( O
Ft NNP O
' POS O
) ) O
and CC O
mitochondrial JJ O
O2 NNP O
utilization NN O
( ( O
Fm NNP O
' POS O
) ) O
. . O

The DT O
maximum JJ O
amplitude NN O
of IN O
evoked JJ O
responses NNS O
in IN O
the DT O
cervical JJ O
sympathetic JJ O
trunk NN O
was VBD O
obtained VBN O
when WRB O
the DT O
T2 NNP O
white JJ O
ramus NN O
was VBD O
stimulated VBN O
and CC O
decreased VBN O
gradually RB O
when WRB O
followed VBN O
by IN O
the DT O
stimulation NN O
of IN O
T1 NNP O
, , O
T3 NNP O
, , O
T4 NNP O
and CC O
T5 NNP O
white JJ O
rami NN O
. . O

The DT O
presence NN O
of IN O
PDZ NNP B-Gene
and CC O
SAM NNP O
domains NNS O
in IN O
the DT O
KS5 NNP B-Gene
protein NN I-Gene
suggests VBZ O
that IN O
it PRP O
may MD O
act VB O
as IN O
a DT O
molecular JJ O
adaptor NN O
, , O
promoting VBG O
and CC O
relaying VBG O
information NN O
in IN O
a DT O
signal JJ O
transduction NN O
pathway NN O
. . O

Phosphatidylinositol NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
potentiates NNS O
, , O
but CC O
does VBZ O
not RB O
trigger VB O
, , O
T NNP O
cell NN O
proliferation NN O
mediated VBN O
by IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
. . O

CPAP NNP O
reduced VBD O
isotime NN O
( ( O
defined VBN O
as IN O
the DT O
last JJ O
common JJ O
minute NN O
of IN O
exercise NN O
) ) O
VO2 NNP O
and CC O
dyspnea NN O
in IN O
those DT O
patients NNS O
with IN O
more RBR O
severe JJ O
lung NN O
disease NN O
, , O
but CC O
these DT O
values NNS O
tended VBD O
to TO O
increase VB O
slightly RB O
in IN O
the DT O
patients NNS O
with IN O
only JJ O
mild NN O
lung NN O
disease NN O
. . O

Genoa NNP O
, , O
Italy NNP O
, , O
24 CD O
- : O
28 CD O
August NNP O
1997 CD O
. . O

The DT O
site NN O
- : O
specific JJ O
DNA NNP O
inversion NN O
system NN O
Cin NNP B-Gene
encoded VBN O
by IN O
the DT O
bacteriophage NN O
P1 NNP O
consists VBZ O
of IN O
a DT O
recombinase NN B-Gene
, , O
two CD O
inverted VBD O
crossing VBG O
- : O
over IN O
sites NNS O
and CC O
a DT O
recombinational JJ O
enhancer NN O
. . O

MEF NNP B-Gene
and CC O
AML1B NNP B-Gene
synergistically RB O
transactivated VBD O
an DT O
interleukin JJ B-Gene
3 CD I-Gene
promoter NN I-Gene
reporter NN I-Gene
gene NN I-Gene
construct NN I-Gene
, , O
yet CC O
the DT O
activating NN O
activity NN O
of IN O
MEF NNP B-Gene
was VBD O
abolished VBN O
when WRB O
MEF NNP B-Gene
was VBD O
coexpressed VBN O
with IN O
AML1 NNP B-Gene
/ NNP O
ETO NNP B-Gene
. . O

Use NNP O
of IN O
prostaglandin NN O
F2 NNP O
alpha NN O
( ( O
PGF2 NNP O
alpha RB O
) ) O
in IN O
cattle JJ O
breeding NN O
. . O

Band NNP O
structure NN O
effects NNS O
of IN O
transport NN O
properties NNS O
in IN O
icosahedral JJ O
quasicrystals NNS O
. . O

Accepting VBG O
arbitrarily RB O
chosen VBN O
limits NNS O
of IN O
maximized JJ O
errors NNS O
of IN O
+ NNP O
/ NNP O
- : O
10 CD O
% NN O
, , O
it PRP O
could MD O
be VB O
shown VBN O
that IN O
the DT O
system NN O
did VBD O
not RB O
work VB O
acceptably RB O
when WRB O
the DT O
mean JJ O
carbon NN O
dioxide NN O
concentration NN O
was VBD O
below IN O
1 CD O
. . O
5 CD O
vol NN O
. . O
% NN O
within IN O
the DT O
fresh JJ O
gas NN O
flow NN O
rates NNS O
( ( O
2 CD O
. . O
2 CD O
- : O
- : O
7 CD O
. . O
7 CD O
1 CD O
min NN O
- : O
1 CD O
) ) O
and CC O
the DT O
range NN O
of IN O
minute NN O
ventilation NN O
( ( O
4 CD O
- : O
- : O
10 CD O
1 CD O
min NN O
- : O
1 CD O
) ) O
employed VBN O
. . O

This DT O
suggests VBZ O
that IN O
the DT O
DcuS NNP B-Gene
- : O
DcuR NNP B-Gene
system NN O
responds VBZ O
to TO O
external VB O
substrates NNS O
. . O

Replacement NN B-Gene
variant NN I-Gene
histone NN I-Gene
genes NNS I-Gene
contain VBP O
intervening JJ O
sequences NNS O
. . O

10 CD O
long JJ O
- : O
term NN O
hemodialysis NN O
patients NNS O
had VBD O
immediate JJ O
and CC O
redistribution NN O
thallium NN O
- : O
201 CD O
myocardial JJ O
imaging NN O
performed VBN O
after IN O
a DT O
course NN O
of IN O
hemodialysis NN O
. . O

This DT O
sequence NN O
is VBZ O
very RB O
similar JJ O
to TO O
the DT O
insulin NN B-Gene
response NN I-Gene
sequence NN I-Gene
found VBD O
in IN O
the DT O
regulatory JJ O
region NN O
of IN O
other JJ O
genes NNS O
negatively RB O
regulated VBN O
by IN O
insulin NN B-Gene
such JJ O
as IN O
those DT O
encoding VBG O
phosphoenolpyruvate JJ B-Gene
carboxykinase NN I-Gene
, , O
tyrosine JJ B-Gene
aminotransferase NN I-Gene
, , O
and CC O
insulin SYM B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
1 CD I-Gene
. . O

These DT O
studies NNS O
identify VBP O
several JJ O
of IN O
the DT O
signal JJ O
- : O
transduction NN O
events NNS O
involved VBN O
in IN O
the DT O
apoptosis NN O
of IN O
malignant JJ O
B NNP O
cells NNS O
that WDT O
transpire VBP O
following VBG O
ligation NN O
of IN O
CD20 NNP B-Gene
by IN O
anti JJ B-Gene
- : I-Gene
CD20 NN I-Gene
antibodies NNS I-Gene
in IN O
the DT O
presence NN O
of IN O
Fc NNP B-Gene
- : I-Gene
receptor NN I-Gene
- : O
expressing VBG O
cells NNS O
or CC O
secondary JJ O
goat NN O
anti SYM B-Gene
- : I-Gene
( ( I-Gene
mouse IN I-Gene
Ig NNP I-Gene
) ) I-Gene
antibodies NNS I-Gene
and CC O
which WDT O
may MD O
contribute VB O
to TO O
the DT O
tumor NN O
regressions NNS O
observed VBD O
in IN O
mouse NN O
models NNS O
and CC O
clinical JJ O
trials NNS O
. . O

The DT O
nifJ NN B-Gene
and CC O
nifH JJ B-Gene
promoters NNS I-Gene
of IN I-Gene
Klebsiella NNP I-Gene
pneumoniae NN I-Gene
are VBP O
divergently RB O
transcribed VBN O
sigma NN B-Gene
54 CD I-Gene
- : I-Gene
dependent NN I-Gene
promoters NNS I-Gene
that WDT O
are VBP O
positively RB O
activated VBN O
by IN O
the DT O
NifA NNP B-Gene
protein NN I-Gene
. . O

The DT O
remaining VBG O
80 CD O
patients NNS O
underwent JJ O
recordings NNS O
of IN O
ECG NNP O
, , O
beat VBD O
- : O
to TO O
- : O
beat NN O
arterial JJ O
oxygen NN O
saturation NN O
( ( O
SaO2 NNP O
) ) O
, , O
and CC O
respiration NN O
during IN O
both DT O
spontaneous JJ O
and CC O
controlled VBD O
breathing NN O
. . O

Biochemical JJ O
studies NNS O
revealed VBD O
the DT O
expected JJ O
loss NN O
of IN O
ChAT NNP B-Gene
activity NN O
in IN O
the DT O
dorsal NN O
and CC O
ventral JJ O
hippocampi NN O
of IN O
lesioned JJ O
animals NNS O
along IN O
with IN O
elevated JJ O
levels NNS O
of IN O
norepinephrine NN O
( ( O
NE NNP O
) ) O
in IN O
the DT O
dorsal NN O
hippocampus NN O
of IN O
MS NNP O
/ NNP O
HSI NNP O
animals NNS O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

When WRB O
blood NN O
samples NNS O
of IN O
patients NNS O
with IN O
hyperbilirubinemia NN O
were VBD O
analyzed VBN O
, , O
direct JJ O
measurement NN O
of IN O
ZPP NNP O
by IN O
this DT O
fluorimeter NN O
yielded VBD O
significantly RB O
higher JJR O
levels NNS O
than IN O
did VBD O
an DT O
alternate NN O
extraction NN O
method NN O
. . O

The DT O
data NN O
indicate NN O
a DT O
three CD O
- : O
phase NN O
reaction NN O
after IN O
B1 NNP O
injection NN O
: : O
Phase NN O
1 CD O
- : O
- : O
shortly RB O
after IN O
injection NN O
there EX O
is VBZ O
a DT O
drop NN O
of IN O
all DT O
parameters NNS O
lasting VBG O
for IN O
30 CD O
sec NN O
. . O

The DT O
distribution NN O
of IN O
red JJ O
rice NN O
cultivation NN O
in IN O
Sri NNP O
Lanka NNP O
is VBZ O
coincident JJ O
with IN O
the DT O
HIDD NNP O
villages NNS O
. . O

The DT O
present JJ O
study NN O
sought VBD O
to TO O
develop VB O
an DT O
equation NN O
to TO O
estimate VB O
VO2peak NNP O
in IN O
peripheral JJ O
arterial JJ O
occlusive JJ O
disease NN O
( ( O
PAOD NNP O
) ) O
patients NNS O
with IN O
intermittent JJ O
claudication NN O
and CC O
to TO O
determine VB O
independent JJ O
predictors NNS O
of IN O
VO2peak NNP O
in IN O
this DT O
population NN O
. . O

Northern NNP O
and CC O
Western NNP O
blot NN O
analyses NNS O
demonstrated VBD O
that IN O
Graf2 NNP B-Gene
is VBZ O
expressed VBN O
in IN O
several JJ O
tissues NNS O
, , O
with IN O
the DT O
highest JJS O
expression NN O
in IN O
skeletal JJ O
muscle NN O
. . O

Increasing VBG O
mean JJ O
arterial JJ O
pressure NN O
by IN O
phenylephrine JJ O
infusion NN O
to TO O
levels NNS O
much RB O
greater JJR O
than IN O
produced VBN O
by IN O
NMA NNP O
and CC O
NNA NNP O
caused VBD O
only RB O
small JJ O
reductions NNS O
in IN O
cardiac JJ O
output NN O
. . O

Near IN O
a DT O
third JJ O
( ( O
31 CD O
. . O
6 CD O
% NN O
) ) O
of IN O
Insulin NNP B-Gene
Dependent NNP O
and CC O
a DT O
third JJ O
( ( O
33 CD O
. . O
41 CD O
% NN O
) ) O
for IN O
Non NNP O
Insulin NNP B-Gene
Dependent NNP O
were VBD O
of IN O
D NNP O
, , O
F NNP O
, , O
H NNP O
White NNP O
' POS O
s JJ O
Class NN O
. . O

The DT O
fourth JJ O
dose NN O
produced VBD O
favorable JJ O
results NNS O
( ( O
66 CD O
. . O
7 CD O
% NN O
) ) O
in IN O
individuals NNS O
with IN O
HB NNP B-Gene
antibodies NNS I-Gene
between IN O
10 CD O
and CC O
100 CD O
IU NNP O
/ NNP O
ml NN O
and CC O
unfavorable JJ O
ones NNS O
( ( O
3 CD O
. . O
8 CD O
% NN O
) ) O
where WRB O
the DT O
HB NNP B-Gene
antibodies NNS I-Gene
were VBD O
below IN O
10 CD O
IU NNP O
/ NNP O
ml NN O
. . O

Commutative JJ O
saccadic JJ O
generator NN O
is VBZ O
sufficient JJ O
to TO O
control VB O
a DT O
3 CD O
- : O
D NNP O
ocular JJ O
plant NN O
with IN O
pulleys NNS O
. . O

Two CD O
phosphopeptides NNS O
, , O
identified VBN O
as IN O
RS NNP O
- : O
[ NN O
32P CD O
] NN O
SGASGLLTSEHHSR NNP O
and CC O
S NNP O
- : O
[ NN O
32P CD O
] NN O
SGASGLLTSEHHSR NNP O
, , O
were VBD O
obtained VBN O
after IN O
stoichiometric JJ O
phosphorylation NN O
and CC O
trypsinization NN O
of IN O
the DT O
peptide NN O
. . O

Estrus NNP O
and CC O
copulative JJ O
abilities NNS O
of IN O
androgen NN O
- : O
sterilized VBN O
rats NNS O

Interestingly RB O
, , O
although IN O
E NNP O
domains NNS O
of IN O
these DT O
two CD O
receptors NNS O
are VBP O
much RB O
less JJR O
conserved JJ O
, , O
replacement NN O
of IN O
this DT O
domain NN O
in IN O
rtER NN B-Gene
by IN O
its PRP$ O
human JJ O
counterpart NN O
resulted VBD O
in IN O
higher JJR O
estradiol NN O
sensitivity NN O
but CC O
no DT O
increase NN O
in IN O
the DT O
magnitude NN O
of IN O
transactivation NN O
. . O

Based VBN O
on IN O
these DT O
data NNS O
, , O
we PRP O
conclude VBP O
that DT O
transcription NN O
of IN O
prgX NN B-Gene
is VBZ O
initiated VBN O
from IN O
the DT O
Qa NNP B-Gene
promoter NN I-Gene
in IN O
prgQ NN B-Gene
, , O
and CC O
PrgX NNP B-Gene
autoregulates VBZ O
its PRP$ O
transcription NN O
either DT O
by IN O
mediating VBG O
transcriptional JJ O
readthrough NN O
or CC O
increasing VBG O
mRNA JJ O
stability NN O
. . O

Based VBN O
on IN O
the DT O
occurrence NN O
of IN O
several JJ O
transcription NN O
signals NNS O
in IN O
the DT O
Thermus NNP B-Gene
pyr NN I-Gene
promoter NN I-Gene
region NN I-Gene
and CC O
strong JJ O
amino NN O
acid NN O
sequence NN O
identities NNS O
( ( O
about IN O
60 CD O
% NN O
) ) O
between IN O
Thermus NNP B-Gene
PyrR NNP I-Gene
and CC O
the DT O
PyrR NNP B-Gene
attenuation NN I-Gene
proteins NNS I-Gene
of IN O
two CD O
Bacillus NNP O
sp NNS O
. . O
, , O
we PRP O
propose VBP O
a DT O
regulatory JJ O
mechanism NN O
involving VBG O
transcriptional JJ O
attenuation NN O
to TO O
control VB O
pyr JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
Thermus NNP O
. . O

Analysis NN O
of IN O
glucocorticoid JJ O
unresponsive JJ O
cell NN O
variants NNS O
using VBG O
a DT O
mouse NN B-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
complementary JJ O
DNA NNP O
clone NN O
. . O

The DT O
method NN O
involved VBN O
deproteinizing VBG O
samples NNS O
with IN O
two CD O
volumes NNS O
of IN O
acetonitrile NN O
followed VBN O
by IN O
injection NN O
of IN O
5 CD O
microliters NNS O
of IN O
deproteinized JJ O
supernatant NN O
onto IN O
a DT O
C18 NNP O
reversed VBD O
- : O
phase NN O
column NN O
. . O

At IN O
43 CD O
% NN O
blood NN O
pressure NN O
reduction NN O
, , O
PCO2 NNP O
fell VBD O
by IN O
0 CD O
. . O
53 CD O
kPa NN O
, , O
a DT O
decrease NN O
which WDT O
could MD O
not RB O
explain VB O
the DT O
observed JJ O
CBF NNP O
fall NN O
of IN O
27 CD O
% NN O
. . O

Treatment NN O
with IN O
amphotericin NN O
B NNP O
and CC O
flucytosine NN O
led VBN O
to TO O
improvement NN O
of IN O
the DT O
symptoms NNS O
but CC O
did VBD O
not RB O
eradicate VB O
the DT O
micro NN O
- : O
organisms NN O
from IN O
the DT O
cerebrospinal JJ O
fluid NN O
( ( O
CSF NNP O
) ) O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
that IN O
cell NN O
- : O
specific JJ O
suppression NN O
of IN O
RA NNP O
- : O
stimulated VBD O
zif268 JJ B-Gene
gene NN I-Gene
expression NN O
can MD O
be VB O
attributed VBN O
to TO O
a DT O
29 CD O
base NN O
pair NN O
nucleotide JJ O
sequence NN O
, , O
located VBN O
downstream NN O
of IN O
the DT O
RA NNP O
- : O
responsive JJ O
region NN O
in IN O
the DT O
zif268 NN B-Gene
gene NN I-Gene
. . O

These DT O
responses NNS O
were VBD O
compared VBN O
with IN O
others NNS O
in IN O
the DT O
same JJ O
subjects NNS O
under IN O
the DT O
same JJ O
conditions NNS O
and CC O
it PRP O
was VBD O
concluded VBN O
that IN O
the DT O
antihypertensive JJ O
effect NN O
of IN O
labetalol NN O
is VBZ O
explained VBN O
by IN O
concurrent NN O
blockade NN O
of IN O
alpha JJ B-Gene
- : I-Gene
and CC I-Gene
beta VB I-Gene
- : I-Gene
adrenoceptors NNS I-Gene
. . O

A DT O
case NN O
of IN O
Goodpasture NNP O
' POS O
s JJ O
syndrome NN O
. . O

Based VBN O
on IN O
a DT O
morphological JJ O
study NN O
of IN O
the DT O
resin NN O
- : O
dentine NN O
interface NN O
, , O
a DT O
broad JJ O
selection NN O
of IN O
dentine JJ O
adhesive JJ O
systems NNS O
was VBD O
classified VBN O
following VBG O
their PRP$ O
adhesion NN O
- : O
strategy NN O
. . O

An DT O
economic JJ O
analysis NN O
using VBG O
West NNP O
of IN O
Scotland NNP O
Coronary NNP O
Prevention NNP O
Study NNP O
( ( O
WOSCOPS NNP O
) ) O
findings NNS O
indicates VBZ O
that IN O
statin NN B-Gene
treatment NN O
would MD O
have VB O
prevented VBN O
318 CD O
events NNS O
per IN O
10 CD O
, , O
0 CD O
patients NNS O
in IN O
a DT O
population NN O
similar JJ O
to TO O
that DT O
in IN O
WOSCOPS NNP O
( ( O
average JJ O
1 CD O
. . O
5 CD O
% NN O
annual JJ O
risk NN O
of IN O
a DT O
cardiovascular JJ O
event NN O
) ) O
at IN O
a DT O
discounted JJ O
cost NN O
per IN O
life NN O
- : O
year NN O
gained VBN O
of IN O
20 CD O
, , O
375 CD O
pounds NNS O
( ( O
$ $ O
31 CD O
, , O
818 CD O
) ) O
. . O

Thromboplastin NNP B-Gene
time NN O
, , O
partial JJ O
thromboplastin NN B-Gene
time NN O
, , O
thrombin JJ B-Gene
time NN O
, , O
heat NN O
- : O
dependent NN O
fibrin NN B-Gene
, , O
clot NN O
retraction NN O
, , O
and CC O
clotting VBG B-Gene
factors NNS I-Gene
II NNP I-Gene
, , I-Gene
V NNP I-Gene
, , I-Gene
VIII NNP I-Gene
, , I-Gene
IX NNP I-Gene
, , I-Gene
X NNP I-Gene
, , O
and CC O
the DT O
platelet NN O
count NN O
were VBD O
determined VBN O
. . O

During IN O
the DT O
following JJ O
pregnancy NN O
ultrasonographic JJ O
studies NNS O
of IN O
the DT O
male NN O
fetus NN O
in IN O
the DT O
16th CD O
week NN O
of IN O
gestation NN O
revealed VBN O
severe JJ O
micrognathia NN O
, , O
short JJ O
and CC O
wide JJ O
thumbs NN O
, , O
and CC O
big JJ O
toes NNS O
, , O
and CC O
bowed VBD O
tibiae NNS O
. . O

This DT O
transition NN O
is VBZ O
regulated VBN O
positively RB O
by IN O
G1 NNP B-Gene
- : I-Gene
specific JJ I-Gene
cyclin NN I-Gene
- : I-Gene
dependent NN I-Gene
kinases NNS I-Gene
( ( O
cdks NN B-Gene
) ) O
and CC O
negatively RB O
by IN O
the DT O
product NN O
of IN O
the DT O
retinoblastoma NN B-Gene
tumour NN I-Gene
suppressor NN I-Gene
gene NN I-Gene
, , O
pRb NN B-Gene
. . O

A DT O
unique JJ O
leucine NN O
- : O
proline NN O
repeat NN O
element NN O
found VBD O
N NNP O
- : O
terminal NN O
to TO O
the DT O
DNA NNP O
- : O
binding VBG O
domain NN O
of IN O
EmBP NNP B-Gene
- : I-Gene
1 CD I-Gene
does VBZ O
not RB O
appear VB O
to TO O
play VB O
a DT O
role NN O
in IN O
DNA NNP O
- : O
binding NN O
or CC O
dimerization NN O
. . O

Mechanism NN O
of IN O
immunogenesis NN O
in IN O
vaccination NN O
with IN O
streptomycin JJ O
- : O
dependent JJ O
mutants NNS O
of IN O
salmonellae NN O
and CC O
shigellae NN O
. . O

We PRP O
previously RB O
delineated VBD O
a DT O
region NN O
in IN O
the DT O
fatty JJ B-Gene
- : I-Gene
acid NN I-Gene
synthase NN I-Gene
promoter NN I-Gene
, , O
which WDT O
was VBD O
responsible JJ O
for IN O
obesity NN O
- : O
related JJ O
overexpression NN O
of IN O
the DT O
fatty JJ B-Gene
- : I-Gene
acid NN I-Gene
synthase NN I-Gene
( ( O
FAS NNP B-Gene
) ) O
gene NN O
, , O
by IN O
negatively RB O
regulating VBG O
the DT O
activity NN O
of IN O
the DT O
downstream NN O
promoter NN O
in IN O
lean JJ O
but CC O
not RB O
obese JJ O
rat NNS O
fat JJ O
cells NNS O
. . O

We PRP O
have VBP O
isolated VBN O
and CC O
sequenced VBN O
two CD O
overlapping VBG O
cDNA NN O
fragments NNS O
which WDT O
could MD O
encode VB O
the DT O
complete JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
rat NN B-Gene
testis NN I-Gene
fructose VBD I-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
phosphate NN I-Gene
, , I-Gene
2 CD I-Gene
- : I-Gene
kinase NN I-Gene
: : O
fructose JJ B-Gene
- : I-Gene
2 CD I-Gene
, , I-Gene
6 CD I-Gene
- : I-Gene
bisphosphatase NN I-Gene
. . O

It PRP O
was VBD O
shown VBN O
that IN O
administration NN O
of IN O
immunomodulator NN O
neurotropin NN B-Gene
( ( O
NSP NNP B-Gene
) ) O
results NNS O
in IN O
more JJR O
steady JJ O
consolidation NN O
and CC O
retention NN O
of IN O
feeding NN O
and CC O
avoidance NN O
behavior NN O
, , O
and CC O
some DT O
neurophysiological JJ O
mechanisms NNS O
of IN O
that DT O
phenomena NN O
were VBD O
revealed VBN O
. . O

We PRP O
also RB O
observed VBD O
that IN O
cell NN O
surface NN O
CD4 NNP B-Gene
( ( O
- : O
) ) O
CD8 NNP B-Gene
( ( O
- : O
) ) O
CD3 NNP B-Gene
( ( O
- : O
) ) O
cells NNS O
with IN O
rearranged JJ B-Gene
TCR NNP I-Gene
genes NNS I-Gene
developed VBD O
from IN O
Id3 NNP B-Gene
- : O
transduced VBD O
but CC O
not RB O
from IN O
control NN O
- : O
transduced VBN O
pre IN O
- : O
T NNP O
cells NNS O
in IN O
an DT O
FTOC NNP O
. . O

In IN O
patients NNS O
with IN O
osteomyelitis NN O
and CC O
joint JJ O
empyema NN O
( ( O
n JJ O
= NNP O
48 CD O
) ) O
PMN NNP B-Gene
elastase NN I-Gene
had VBD O
a DT O
sensitivity NN O
of IN O
77 CD O
% NN O
, , O
which WDT O
was VBD O
only RB O
exceeded VBN O
by IN O
that DT O
of IN O
the DT O
unspecific JJ O
erythrocyte JJ O
sedimentation NN O
rate NN O
( ( O
sensitivity JJ O
89 CD O
% NN O
) ) O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
demonstrate VBP O
that DT O
expression NN O
of IN O
TD NNP B-Gene
- : I-Gene
IkappaBalpha NNP I-Gene
blocked VBD O
phorbol JJ O
myristate NN O
acetate NN B-Gene
- : I-Gene
phytohemagglutinin NN I-Gene
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha IN I-Gene
- : O
induced JJ O
IkappaBalpha NNP B-Gene
gene NN I-Gene
transcription NN O
and CC O
abolished VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NNP O
binding NN O
activity NN O
, , O
due JJ O
to TO O
the DT O
continued VBN O
cytoplasmic JJ O
sequestration NN O
of IN O
RelA NNP B-Gene
( ( O
p65 NN B-Gene
) ) O
by IN O
TD NNP B-Gene
- : I-Gene
IkappaBalpha NN I-Gene
. . O

There EX O
was VBD O
no DT O
significant JJ O
difference NN O
in IN O
developmental JJ O
scores NNS O
at IN O
9 CD O
or CC O
18 CD O
months NNS O
, , O
although IN O
PDF NNP O
infants NNS O
had VBD O
a DT O
2 CD O
. . O
8 CD O
( ( O
- : O
1 CD O
. . O
3 CD O
- : O
6 CD O
. . O
8 CD O
) ) O
point NN O
advantage NN O
in IN O
Bayley NNP O
motor NN O
score NN O
scales NNS O
. . O

The DT O
dual JJ O
specificity NN O
kinases VBZ O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( I-Gene
MAPK NNP I-Gene
) ) I-Gene
kinase NN I-Gene
( ( I-Gene
MKK NNP I-Gene
) ) I-Gene
7 CD I-Gene
and CC O
MKK4 NNP B-Gene
are VBP O
the DT O
only JJ O
molecules NNS O
known VBN O
to TO O
directly RB O
activate VB O
the DT O
stress NN O
kinases VBZ O
stress JJ B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinases NNS I-Gene
( ( O
SAPKs NNP B-Gene
) ) O
/ VBP O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal NN I-Gene
kinases NNS I-Gene
( ( O
JNKs NNP B-Gene
) ) O
in IN O
response NN O
to TO O
environmental JJ O
or CC O
mitogenic JJ O
stimuli NNS O
. . O

We PRP O
recommend VBP O
that DT O
ovarian JJ O
stimulation NN O
is VBZ O
done VBN O
only RB O
if IN O
there EX O
is VBZ O
a DT O
valid JJ O
indication NN O
after IN O
proper JJ O
assessment NN O
of IN O
the DT O
ovaries NNS O
, , O
and CC O
that IN O
women NNS O
who WP O
have VBP O
had VBN O
ovarian JJ O
stimulation NN O
are VBP O
followed VBN O
for IN O
longer JJR O
than IN O
at IN O
present JJ O
. . O

The DT O
small JJ B-Gene
monomeric NN I-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
of IN O
the DT O
RAB NNP B-Gene
subfamily NN I-Gene
are VBP O
key JJ O
regulatory JJ O
elements NNS O
of IN O
the DT O
machinery NN O
that IN O
controls VBZ O
membrane NN O
traffic NN O
in IN O
eukaryotic JJ O
cells NNS O
. . O

Antivitamin NNP O
K NNP O
agents NNS O

Electrocardiograms NNS O
of IN O
the DT O
month NN O
. . O

Supplementation NN O
was VBD O
stopped VBN O
when WRB O
pl JJ B-Gene
- : I-Gene
ALB NNP I-Gene
reached VBD O
2 CD O
. . O
0 CD O
g JJ O
/ NNP O
dL NN O
. . O

Adapromine NN O
was VBD O
established VBN O
to TO O
evoke VB O
a DT O
decrease NN O
of IN O
the DT O
amplitude NN O
of IN O
the DT O
dominant JJ O
peak NN O
and CC O
dominant JJ O
theta JJ O
- : O
activity NN O
in IN O
power NN O
spectra NN O
of IN O
the DT O
EEG NNP O
in IN O
the DT O
cortex NN O
and CC O
hippocamp NN O
, , O
with IN O
an DT O
increase NN O
of IN O
rapid JJ O
wave NN O
activity NN O
in IN O
the DT O
beta NN O
2 CD O
range NN O
in IN O
the DT O
right JJ O
cortex NN O
and CC O
hippocamp NN O
. . O

The DT O
negative JJ O
predictive JJ O
value NN O
is VBZ O
92 CD O
% NN O
, , O
vs RB O
80 CD O
% NN O
for IN O
the DT O
NCEP NNP O
I PRP O
. . O

The DT O
Italian JJ O
Lung NNP O
Cancer NNP O
Task NNP O
Force NNP O
( ( O
FONICAP NNP O
) ) O
. . O

METHODS NNS O
: : O
Experiments NNS O
testing VBG O
the DT O
new JJ O
catheter NN O
and CC O
comparing VBG O
it PRP O
to TO O
the DT O
existing VBG O
catheter NN O
included VBD O
: : O
( ( O
1 CD O
) ) O
measurement NN O
of IN O
the DT O
laser NN O
output NN O
beam NN O
sizes NNS O
and CC O
divergences NNS O
; : O
( ( O
2 CD O
) ) O
evaluation NN O
of IN O
particulate JJ O
matter NN O
generation NN O
during IN O
ablation NN O
of IN O
atherosclerotic JJ O
tissue NN O
; : O
( ( O
3 CD O
) ) O
measurement NN O
of IN O
ablation NN O
hole NN O
sizes NNS O
and CC O
tissue NN O
penetration NN O
rates NNS O
; : O
( ( O
4 CD O
) ) O
histopathologic NN O
examination NN O
of IN O
laser NN O
- : O
induced VBN O
in IN O
vivo JJ O
vessel NN O
wall NN O
injury NN O
. . O

This DT O
study NN O
was VBD O
designed VBN O
to TO O
assess VB O
and CC O
compare VB O
the DT O
ability NN O
of IN O
three CD O
different JJ O
forms NNS O
of IN O
DSG NNP O
to TO O
block VB O
EIB NNP O
. . O

T1 NNP O
- : O
weighted VBD O
MRI NNP O
on IN O
the DT O
49th CD O
postoperative JJ O
day NN O
demonstrated VBD O
bilateral JJ O
and CC O
symmetrical JJ O
hyperintense NN O
lesions NNS O
in IN O
the DT O
globus NN O
pallidus NN O
. . O

In IN O
group NN O
III NNP O
, , O
patients NNS O
also RB O
received VBD O
their PRP$ O
own JJ O
mediastinal JJ O
drainage NN O
blood NN O
, , O
shed VBD O
for IN O
6 CD O
hours NNS O
after IN O
operation NN O
, , O
after IN O
concentration NN O
and CC O
washing NN O
in IN O
a DT O
MBRS NNP O
. . O

Allelic JJ O
variation NN O
in IN O
HLA NNP B-Gene
- : I-Gene
B NN I-Gene
and CC O
HLA NNP B-Gene
- : I-Gene
C NNP I-Gene
sequences NNS I-Gene
and CC O
the DT O
evolution NN O
of IN O
the DT O
HLA NNP B-Gene
- : I-Gene
B NN I-Gene
alleles NNS I-Gene
. . O

Electrocardiographic JJ O
QRS NNP O
complexes NNS O
and CC O
vectorcardiographic JJ O
QRS NNP O
loop NN O

We PRP O
further VBP O
show VB O
that IN O
proteolytic JJ O
targeting NN O
by IN O
calpain NN B-Gene
II NNP I-Gene
and CC O
the DT O
proteasome JJ O
involves NNS O
different JJ O
structural JJ O
elements NNS O
of IN O
YY1 NNP B-Gene
. . O

SAPK NNP B-Gene
/ NNP O
JNK NNP B-Gene
activation NN O
was VBD O
completely RB O
abolished VBN O
in IN O
the DT O
absence NN O
of IN O
MKK7 NNP B-Gene
, , O
even RB O
though IN O
expression NN O
of IN O
MKK4 NNP B-Gene
was VBD O
strongly RB O
upregulated VBN O
in IN O
mkk7 NN B-Gene
( ( I-Gene
- : I-Gene
/ SYM I-Gene
- : I-Gene
) ) I-Gene
mast NN O
cell NN O
lines NNS O
, , O
and CC O
phosphorylation NN O
of IN O
MKK4 NNP B-Gene
occurred VBD O
normally RB O
in IN O
response NN O
to TO O
multiple VB O
stress JJ O
stimuli NNS O
. . O

The DT O
mean JJ O
minimum NN O
steady JJ O
- : O
state NN O
concentration NN O
after IN O
the DT O
oral JJ O
regimen NNS O
( ( O
23 CD O
micrograms NNS O
. . O
l SYM O
- : O
1 CD O
) ) O
was VBD O
78 CD O
% NN O
of IN O
that DT O
after IN O
the DT O
intramuscular JJ O
regime NN O
( ( O
29 CD O
micrograms NNS O
. . O
l SYM O
- : O
1 CD O
) ) O
. . O

Low JJ O
PbrO2 NNP O
readings NNS O
, , O
however RB O
, , O
could MD O
be VB O
caused VBN O
by IN O
local JJ O
microhemorrhages NNS O
, , O
undetectable JJ O
on IN O
CT NNP O
or CC O
MRI NNP O
. . O

The DT O
protein NN O
encoded VBD O
is VBZ O
114 CD O
kDa NN O
and CC O
contains NNS O
eight CD O
zinc NN O
finger NN O
motifs NNS O
, , O
seven CD O
of IN O
which WDT O
are VBP O
present JJ O
in IN O
two CD O
clusters NNS O
at IN O
opposite JJ O
ends NNS O
of IN O
the DT O
molecule NN O
. . O

The DT O
expression NN O
of IN O
the DT O
first JJ O
two CD O
genes NNS O
located VBN O
in IN O
this DT O
unit NN O
( ( O
c SYM B-Gene
- : I-Gene
gvpD NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
gvpE NN I-Gene
) ) O
was VBD O
also RB O
monitored VBN O
by IN O
Western JJ O
blot NN O
( ( O
immunoblot NN O
) ) O
analyses VBZ O
using VBG O
antisera NNS O
raised VBN O
against IN O
these DT O
proteins NNS O
synthesized VBN O
in IN O
Escherichia NNP O
coli NN O
. . O

Interaction NN O
of IN O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
the DT O
POU NNP B-Gene
- : I-Gene
homeodomain NN I-Gene
protein NN I-Gene
GHF NNP B-Gene
- : I-Gene
1 CD I-Gene
/ NN O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
reconstitutes NNS O
pituitary JJ O
- : O
specific JJ O
gene NN O
expression NN O
. . O

Montelukast NNP O
reduces VBZ O
airway RB O
eosinophilic JJ O
inflammation NN O
in IN O
asthma NN O
: : O
a DT O
randomized NN O
, , O
controlled VBN O
trial NN O
. . O

Vitrectomy NNP O
was VBD O
still RB O
a DT O
significant JJ O
risk NN O
factor NN O
when WRB O
macular JJ O
holes NNS O
were VBD O
excluded VBN O
. . O

Significant NNP O
intergroup NN O
differences NNS O
are VBP O
highlighted VBN O
for IN O
both DT O
selected VBN O
dentoskeletal NN O
and CC O
soft JJ O
tissue NN O
profile NN O
variables NNS O
. . O

Identification NN O
of IN O
the DT O
region NN O
in IN O
actin JJ B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
that WDT O
binds VBZ O
to TO O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
glycoprotein NN B-Gene
IBalpha NNP I-Gene
. . O

The DT O
terminator NN O
region NN O
supported VBD O
termination NN O
of IN O
transcripts NNS O
initiated VBN O
by IN O
RNA NNP B-Gene
polymerase NN I-Gene
I PRP I-Gene
in IN O
vivo NN O
. . O

Although IN O
upstream JJ O
regulators NNS O
of IN O
Tec NNP B-Gene
family NN I-Gene
kinases NNS I-Gene
are VBP O
relatively RB O
well RB O
characterized VBN O
, , O
little JJ O
is VBZ O
known VBN O
of IN O
the DT O
downstream NN O
effectors NNS O
of IN O
these DT O
enzymes NNS O
. . O

In IN O
terms NNS O
of IN O
sequence NN O
repetitions NNS O
, , O
seven CD O
tandemly RB O
repeated JJ O
copies NNS O
of IN O
the DT O
hexanucleotide NN O
ATTGTT NNP O
and CC O
three CD O
flanking VBG O
regions NNS O
of IN O
dyad JJ O
symmetry NN O
were VBD O
detected VBN O
, , O
all DT O
in IN O
ORF NNP O
T3C NNP O
. . O

The DT O
usefulness NN O
of IN O
the DT O
lambda NN O
PG15 NNP O
and CC O
the DT O
lambda NN O
AD5 NNP O
cloning VBG O
vectors NNS O
was VBD O
demonstrated VBN O
by IN O
constructing VBG O
large JJ O
Neurospora NNP O
crassa NN O
cDNA NN O
libraries NNS O
. . O

As IN O
a DT O
sequence NN O
- : O
specific JJ O
DNA NNP O
binding NN O
transcription NN O
factor NN O
, , O
p53 NN B-Gene
specifically RB O
binds VBZ O
to TO O
a DT O
20 CD O
- : O
bp NN O
consensus NN O
motif VBD O
5 CD O
' '' O
- : O
PuPuPuC NNP O
( ( O
A NNP O
/ NNP O
T NNP O
) ) O
( ( O
T NNP O
/ NNP O
A NNP O
) ) O
GPyPyPyPuPuPuC NNP O
( ( O
A NNP O
/ NNP O
T NNP O
) ) O
( ( O
T NNP O
/ NNP O
A NNP O
) ) O
GPyPyPy NNP O
- : O
3 CD O
' POS O
. . O

A DT O
database NN O
search NN O
has VBZ O
revealed VBN O
as IN O
the DT O
most RBS O
significative JJ O
homology NN O
a DT O
match NN O
with IN O
the DT O
human JJ B-Gene
mitochondrial JJ I-Gene
transcription NN I-Gene
termination NN I-Gene
factor NN I-Gene
( ( O
mTERF NN B-Gene
) ) O
, , O
a DT O
protein NN O
that WDT O
also RB O
binds VBZ O
DNA NNP O
as IN O
a DT O
monomer NN O
and CC O
contains NNS O
three CD O
leucine NN O
zippers NNS O
forming VBG O
intramolecular JJ O
interactions NNS O
. . O

They PRP O
are VBP O
present JJ O
in IN O
many JJ O
kinds NNS O
of IN O
living NN O
things NNS O
, , O
but CC O
their PRP$ O
functions NNS O
, , O
especially RB O
those DT O
in IN O
humans NNS O
, , O
are VBP O
unclear JJ O
. . O

Cramps NNS O
in IN O
extrapyramidal JJ O
disorders NNS O
. . O

The DT O
high JJ O
degree NN O
of IN O
conservation NN O
between IN O
NQO2 NNP B-Gene
and CC O
NQO1 NNP B-Gene
gene NN I-Gene
organization NN O
and CC O
sequence NN O
confirmed VBD O
that IN O
NQO2 NNP B-Gene
gene NN I-Gene
encodes NNS O
for IN O
a DT O
second JJ O
member NN O
of IN O
the DT O
NQO NNP B-Gene
gene NN I-Gene
family NN I-Gene
in IN O
human NN O
. . O

The DT O
smaller JJR O
uptake JJ O
rate NN O
and CC O
faster JJR O
clearance NN O
rate NN O
resulted VBD O
in IN O
the DT O
lower JJR O
BCF NNP O
for IN O
SWA NNP O
killifish NN O
. . O

The DT O
disease NN O
ran VBD O
an DT O
atypical JJ O
course NN O
; : O
with IN O
early JJ O
jaundice NN O
syndrome NN O
, , O
severe JJ O
enterorrhagia NN O
and CC O
late JJ O
appearance NN O
of IN O
roseola NN O
. . O

In IN O
serum JJ O
- : O
free JJ O
media NNS O
, , O
p50E4F NN B-Gene
accelerated VBD O
E1A NNP B-Gene
- : O
induced JJ O
apoptosis NN O
. . O

EUK NNP O
- : O
8 CD O
is VBZ O
a DT O
novel NN O
, , O
synthetic JJ O
, , O
low JJ O
- : O
molecular JJ O
- : O
weight NN O
salen SYM O
- : O
manganese JJ O
complex JJ O
that IN O
exhibits VBZ O
both DT O
superoxide JJ B-Gene
dismutase NN I-Gene
and CC O
catalase NN B-Gene
activities NNS O
in IN O
vitro NN O
. . O

Selected VBN O
topics NNS O
in IN O
pediatric JJ O
ultrasonography NN O
- : O
- : O
1992 CD O
. . O

Selenium NN O
( ( O
. . O
1 CD O
ppm NN O
) ) O
and CC O
E NNP O
( ( O
50 CD O
IU NNP O
/ NNP O
kg NN O
) ) O
supplementation NN O
of IN O
the DT O
diet NN O
of IN O
the DT O
sow NN O
increased VBD O
plasma NN O
tocopherol NN O
and CC O
Se NNP O
concentrations NNS O
, , O
but CC O
did VBD O
not RB O
increase VB O
plasma NN B-Gene
glutathione NN I-Gene
peroxidase NN I-Gene
( ( O
GSH NNP B-Gene
- : I-Gene
Px NNP I-Gene
) ) O
activity NN O
. . O

Indeed RB O
, , O
mutation NN O
of IN O
two CD O
of IN O
these DT O
motifs NNS O
, , O
known VBN O
to TO O
be VB O
important JJ O
to TO O
regulation NN O
of IN O
sid1 NN B-Gene
, , O
altered VBD O
the DT O
differential JJ O
regulation NN O
of IN O
sid2 NN B-Gene
by IN O
iron NN O
. . O

An DT O
immunologic JJ O
test NN O
using VBG O
stomach NN O
and CC O
tumor NN O
antigens NNS O
for IN O
screening NN O
of IN O
those DT O
at IN O
high JJ O
risk NN O
for IN O
stomach NN O
cancer NN O
is VBZ O
suggested VBN O
. . O

In IN O
a DT O
man NN O
with IN O
myelomonocytic JJ O
leukemia NN O
, , O
the DT O
association NN O
of IN O
increased VBN O
prostatic JJ B-Gene
acid JJ I-Gene
phosphatase NN I-Gene
activity NN O
in IN O
serum NN O
and CC O
the DT O
presence NN O
of IN O
typical JJ O
bone NN O
lesions NNS O
on IN O
roentgenography NN O
suggested VBD O
the DT O
existence NN O
of IN O
disseminated VBN O
prostatic JJ O
carcinoma NN O
. . O

A DT O
cDNA NN O
encoding VBG O
a DT O
new JJ O
human JJ O
lymphocyte NN O
cell NN O
surface NN O
molecule NN O
has VBZ O
been VBN O
isolated VBN O
and CC O
shown VBN O
to TO O
identify VB O
a DT O
fourth JJ O
member NN O
of IN O
a DT O
recently RB O
discovered VBN O
family NN O
of IN O
adhesion NN O
proteins NNS O
. . O

Comparative NNP O
study NN O
of IN O
the DT O
differential JJ O
white JJ O
blood NN O
cell NN O
count NN O
using VBG O
three CD O
automated JJ O
analyzers NNS O
: : O
Coulter NNP O
STKS NNP O
, , O
Sysmex NNP O
NE NNP O
8000 CD O
and CC O
Technicon NNP O
H NNP O
- : O
1 CD O
. . O

The DT O
vigilance NN O
task NN O
and CC O
the DT O
measurement NN O
of IN O
attentional JJ O
deficits NNS O
. . O

In IN O
an DT O
effort NN O
to TO O
identify VB O
the DT O
USH1C NNP B-Gene
disease NN I-Gene
gene NN I-Gene
we PRP O
have VBP O
isolated VBN O
the DT O
region NN O
between IN O
these DT O
markers NNS O
in IN O
yeast JJ O
artificial JJ O
chromosomes NNS O
( ( O
YACs NNP O
) ) O
using VBG O
a DT O
combination NN O
of IN O
STS NNP O
content NN O
mapping NN O
and CC O
Alu NNP B-Gene
- : O
PCR NNP O
hybridization NN O
. . O

Pet NNP B-Gene
- : I-Gene
1 CD I-Gene
can MD O
bind VB O
specifically RB O
to TO O
a DT O
PEA3 NNP B-Gene
ETS NNP B-Gene
DNA NNP O
- : O
binding NN O
motif NN O
and CC O
can MD O
modulate VB O
transcription NN O
of IN O
synthetic JJ O
promoter NN O
constructs NNS O
in IN O
a DT O
sequence NN O
- : O
specific JJ O
manner NN O
. . O

These DT O
results NNS O
may MD O
suggest VB O
involvement NN O
of IN O
peripheral JJ O
enkephalins NNS O
in IN O
pain NN O
modulation NN O
in IN O
patients NNS O
with IN O
episodic JJ O
cluster NN O
headache NN O
. . O

In IN O
children NNS O
unable JJ O
to TO O
perform VB O
forced JJ O
expiratory NN O
maneuvers NNS O
( ( O
n JJ O
= NNP O
25 CD O
) ) O
, , O
FOT NNP O
, , O
contrary JJ O
to TO O
the DT O
interrupter NN O
technique NN O
, , O
clearly RB O
identified VBN O
a DT O
subgroup NN O
of IN O
young JJ O
children NNS O
with IN O
high JJ O
resistance NN O
values NNS O
at IN O
baseline NN O
, , O
which WDT O
returned VBD O
to TO O
normal JJ O
after IN O
bronchodilation NN O
. . O

Cholesteryl NNP B-Gene
ester NN I-Gene
transfer NN I-Gene
protein NN I-Gene
and CC O
atherosclerosis NN O
in IN O
Japanese JJ O
subjects NNS O
: : O
a DT O
study NN O
based VBN O
on IN O
coronary JJ O
angiography NN O
. . O

Responses NNS O
to TO O
brainstem NN O
of IN O
nuclei JJ O
medialis NN O
dorsalis NN O
, , O
lateralis JJ O
posterior NN O
were VBD O
of IN O
considerably RB O
longer RBR O
latency NN O
. . O

The DT O
catenins NNS B-Gene
bind VBP O
to TO O
APC NNP B-Gene
and CC O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
in IN O
a DT O
similar JJ O
fashion NN O
, , O
but CC O
APC NNP B-Gene
and CC O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
do VBP O
not RB O
associate VB O
with IN O
each DT O
other JJ O
either CC O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
catenins NNS B-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
these DT O
sequences NNS O
located VBD O
immediately RB O
3 CD O
' '' O
to TO O
the DT O
breakpoint NN O
of IN O
the DT O
HPFH NNP B-Gene
- : I-Gene
3 CD I-Gene
deletion NN I-Gene
, , O
exhibit NN O
both CC O
the DT O
structure NN O
and CC O
the DT O
function NN O
of IN O
an DT O
enhancer NN O
, , O
and CC O
can MD O
modify VB O
the DT O
developmental JJ O
specificity NN O
of IN O
the DT O
fetal JJ B-Gene
gamma NN I-Gene
- : I-Gene
globin NN I-Gene
genes NNS I-Gene
, , O
resulting VBG O
in IN O
their PRP$ O
continued JJ O
expression NN O
during IN O
adult JJ O
life NN O
. . O

Sixteen NNP O
other JJ O
normal JJ O
subjects NNS O
with IN O
2 CD O
g NN O
of IN O
Metyrapone NNP O
are VBP O
best JJS O
responses NNS O
. . O

Changes NNS O
in IN O
muscarinic JJ B-Gene
acetylcholine NN I-Gene
receptors NNS I-Gene
in IN O
guinea NN O
- : O
pig NN O
lung NN O
: : O
effects NNS O
of IN O
aging VBG O
, , O
inhalation NN O
of IN O
an DT O
allergen NN O
, , O
administration NN O
of IN O
drugs NNS O
, , O
and CC O
vagotomy NN O
. . O

Twelve CD O
patients NNS O
without IN O
abnormalities NNS O
in IN O
the DT O
PTT NNP O
are VBP O
assumed VBN O
to TO O
harbor VB O
missense JJ O
mutations NNS O
, , O
probably RB O
in IN O
TSC2 NNP B-Gene
. . O

With IN O
aging VBG O
, , O
many JJ O
aspects NNS O
of IN O
immune JJ O
function NN O
change NN O
. . O

5 CD O
) ) O
We PRP O
' '' O
ve NN O
noticed VBD O
that IN O
the DT O
mean JJ O
value NN O
of IN O
the DT O
cost NN O
for IN O
episode NN O
of IN O
pnx NN O
s NN O
. . O
in IN O
class NN O
A NNP O
was VBD O
more JJR O
than IN O
15 CD O
% NN O
compared VBN O
to TO O
class NN O
B NNP O
and CC O
the DT O
cost NN O
for IN O
patient NN O
in IN O
class NN O
A NNP O
was VBD O
nearly RB O
double RB O
than IN O
in IN O
class NN O
B NNP O
. . O

We PRP O
report VBP O
here RB O
the DT O
molecular JJ O
cloning NN O
of IN O
a DT O
putative JJ O
adhesive JJ O
molecule NN O
from IN O
P NNP O
. . O
falciparum NN O
that WDT O
shares NNS O
both DT O
sequence NN O
and CC O
structural JJ O
similarities NNS O
with IN O
a DT O
sporozoite JJ O
surface NN O
molecule NN O
from IN O
Plasmodium NNP O
termed VBD O
the DT O
thrombospondin NN B-Gene
- : I-Gene
related VBN I-Gene
anonymous JJ I-Gene
protein NN I-Gene
( ( O
TRAP NNP B-Gene
) ) O
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
with IN O
the DT O
circumsporozoite NN B-Gene
( ( I-Gene
CS NNP I-Gene
) ) I-Gene
protein NN I-Gene
. . O

The DT O
Cox NNP O
proportional JJ O
hazards NNS O
model NN O
was VBD O
applied VBN O
to TO O
the DT O
data NNS O
in IN O
order NN O
to TO O
determine VB O
the DT O
prognostic JJ O
factors NNS O
for IN O
long JJ O
- : O
term NN O
survival NN O
. . O

An DT O
interatrial JJ O
communication NN O
mitigates VBZ O
the DT O
impairment NN O
of IN O
LV NNP O
function NN O
after IN O
an DT O
acute NN O
and CC O
sustained VBD O
drop NN O
of IN O
intrathoracic JJ O
pressure NN O
. . O

EMSA NN O
showed VBD O
that IN O
nuclear JJ O
proteins NNS O
from IN O
PC12 NNP O
but CC O
not RB O
C6 NNP O
or CC O
Rat2 NNP O
cells NNS O
bind IN O
the DT O
CRE NNP O
as IN O
a DT O
complex JJ O
containing NN O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
( ( I-Gene
ATF NNP I-Gene
) ) I-Gene
- : I-Gene
4 CD I-Gene
and CC O
CCAAT NNP B-Gene
enhancer VBP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
beta NN I-Gene
, , O
while IN O
both DT O
PC12 NNP O
and CC O
C6 NNP O
cell VBP O
nuclear JJ O
extracts NNS O
were VBD O
recruited VBN O
by IN O
the DT O
CCAAT NNP O
- : O
box NN O
as IN O
a DT O
complex JJ O
containing NN O
nuclear JJ B-Gene
factor NN I-Gene
Y NNP I-Gene
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
alpha NN I-Gene
) ) O
is VBZ O
one CD O
of IN O
several JJ O
autocrine JJ O
/ JJ O
paracrine NN O
factors NNS O
known VBN O
to TO O
exert VB O
potent JJ O
inhibitory JJ O
effects NNS O
on IN O
bone NN O
. . O

Specific JJ O
hyperimmune NN B-Gene
globulins NNS I-Gene
to TO O
pathogens NNS O
such JJ O
as IN O
Haemophilus NNP O
influenzae NN O
and CC O
Streptococcus NNP O
pneumoniae NNS O
have VBP O
also RB O
been VBN O
studied VBN O
. . O

E1A NNP B-Gene
autoactivation NN O
mediated VBN O
by IN O
these DT O
sites NNS O
was VBD O
about IN O
twofold JJ O
compared VBN O
with IN O
a DT O
ninefold JJ O
activation NN O
described VBD O
for IN O
the DT O
complete JJ O
E1A NNP B-Gene
promoter NN I-Gene
. . O

A DT O
causal JJ O
analysis NN O
of IN O
secondary JJ O
variables NNS O
showed VBD O
that IN O
the DT O
formation NN O
of IN O
FB NNP O
memories NNS O
was VBD O
primarily RB O
associated VBN O
with IN O
the DT O
level NN O
of IN O
importance NN O
attached VBN O
to TO O
the DT O
event NN O
and CC O
level NN O
of IN O
affective JJ O
response NN O
to TO O
the DT O
news NN O
. . O

In IN O
the DT O
lattice NN O
, , O
23 CD O
% NN O
of IN O
the DT O
sites NNS O
are VBP O
occupied VBN O
, , O
95 CD O
% NN O
of IN O
the DT O
atoms NNS O
are VBP O
in IN O
the DT O
lowest JJS O
energy NN O
magnetic JJ O
sublevel NN O
, , O
and CC O
37 CD O
% NN O
are VBP O
in IN O
the DT O
lowest JJS O
3D CD O
vibrational JJ O
state NN O
. . O

The DT O
zta NN B-Gene
transactivator NN I-Gene
involved VBN O
in IN O
induction NN O
of IN O
lytic JJ O
cycle NN O
gene NN O
expression NN O
in IN O
Epstein NNP O
- : O
Barr NNP O
virus SYM O
- : O
infected VBN O
lymphocytes VBZ O
binds NNS O
to TO O
both DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
ZRE NNP B-Gene
sites NNS I-Gene
in IN O
target NN O
promoter NN O
and CC O
enhancer NN O
regions NNS O
. . O

A DT O
prospective JJ O
trial NN O
was VBD O
undertaken VBN O
to TO O
determine VB O
( ( O
1 CD O
) ) O
clinical JJ O
characteristics NNS O
of IN O
patients NNS O
with IN O
chest JJ O
pain NN O
; : O
( ( O
2 CD O
) ) O
value NN O
of IN O
cardiac JJ O
markers NNS O
troponin VBP B-Gene
T NNP I-Gene
, , O
myoglobin NN B-Gene
and CC O
CK NNP B-Gene
- : O
MB NNP B-Gene
mass NN O
in IN O
differentiating VBG O
cardiac NN O
and CC O
noncardiac JJ O
chest NN O
pain NN O
; : O
( ( O
3 CD O
) ) O
the DT O
proportion NN O
of IN O
patients NNS O
with IN O
ACS NNP O
in IN O
whom WP O
these DT O
markers NNS O
provided VBD O
helpful JJ O
additional JJ O
information NN O
on IN O
admission NN O
and CC O
afterwards NNS O
. . O

Delayed VBN O
gallbladder NN O
visualization NN O
and CC O
reduction NN O
in IN O
ejection NN O
fraction NN O
were VBD O
sensitive JJ O
but CC O
nonspecific JJ O
indicators NNS O
of IN O
biliary JJ O
disease NN O
. . O

Our PRP$ O
previous JJ O
study NN O
suggested VBD O
that IN O
pertussis NN B-Gene
toxin NN I-Gene
( ( O
IAP NNP B-Gene
) ) O
- : O
sensitive JJ O
GTP NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( I-Gene
s PRP I-Gene
) ) I-Gene
( ( O
G NNP B-Gene
- : I-Gene
protein NN I-Gene
) ) O
is VBZ O
involved VBN O
in IN O
the DT O
process NN O
of IN O
differentiation NN O
by IN O
hormones NNS O
/ NNP O
IBMX NNP O
, , O
accompanied VBN O
by IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
induction NN O
. . O

After IN O
successful JJ O
subtotal JJ O
parathyroidectomy NN O
, , O
evident JJ O
by IN O
the DT O
decrease NN O
of IN O
serum NN O
iPTH NN B-Gene
levels NNS O
, , O
both CC O
the DT O
CL NNP O
of IN O
group NN O
2 CD O
PMNs NNP O
and CC O
the DT O
ability NN O
of IN O
group NN O
2 CD O
sera NN O
to TO O
induce VB O
augmented JJ O
CL NNP O
in IN O
normal JJ O
PMNs NNP O
decreased VBD O
( ( O
p JJ O
< NN O
0 CD O
. . O
25 CD O
) ) O
. . O

Southern JJ O
blotting VBG O
analysis NN O
implied VBD O
the DT O
occurrence NN O
of IN O
multiple JJ O
COXVb NNP B-Gene
genes NNS I-Gene
in IN O
the DT O
rat NN O
genome NN O
. . O

We PRP O
present JJ O
evidence NN O
that IN O
YY1 NNP B-Gene
, , O
a DT O
ubiquitously RB O
expressed VBN O
DNA NNP O
- : O
binding NN O
protein NN O
, , O
regulates VBZ O
the DT O
activity NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
promoter NN I-Gene
primarily RB O
through IN O
an DT O
effect NN O
on IN O
DNA NN O
structure NN O
. . O

A DT O
deletion NN O
mutation NN O
analysis NN O
of IN O
the DT O
recombinant NN O
protein NN O
has VBZ O
shown VBN O
that IN O
the DT O
N NNP O
- : O
terminal JJ O
region NN O
and CC O
the DT O
two CD O
leucine NN O
zippers NNS O
are VBP O
necessary JJ O
for IN O
the DT O
binding NN O
. . O

FOG NNP B-Gene
is VBZ O
coexpressed VBN O
with IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
during IN O
embryonic JJ O
development NN O
and CC O
in IN O
erythroid NN O
and CC O
megakaryocytic JJ O
cells NNS O
. . O

BACKGROUND NN O
: : O
Checkpoint NN O
pathways NNS O
prevent VBP O
cell NN O
- : O
cycle NN O
progression NN O
in IN O
the DT O
event NN O
of IN O
DNA NNP O
lesions NNS O
. . O

Two CD O
episodes NNS O
of IN O
peritonitis NN O
occurred VBD O
while IN O
the DT O
patient NN O
received VBD O
CAPD NNP O
( ( O
1 CD O
episode NN O
/ VBD O
3 CD O
. . O
5 CD O
patient JJ O
- : O
months NNS O
) ) O
. . O

The DT O
presence NN O
of IN O
an DT O
unusual JJ O
transcript NN O
possessing VBG O
IVS2C NNP B-Gene
beta NN I-Gene
1 CD I-Gene
at IN O
the DT O
5 CD O
' POS O
terminus NN O
suggests VBZ O
that IN O
cleavage NN O
of IN O
its PRP$ O
splice NN O
acceptor NN O
is VBZ O
inefficient JJ O
or CC O
negatively RB O
regulated VBN O
. . O

Recurrence NN O
of IN O
bladder NN O
tumors NNS O
among IN O
the DT O
original JJ O
9 CD O
cases NNS O
has VBZ O
occurred VBN O
only RB O
among IN O
the DT O
5 CD O
whose WP$ O
properdin NN B-Gene
levels NNS O
remained VBN O
below IN O
the DT O
median NN O
. . O

Preparation NN O
of IN O
a DT O
stable JJ O
phospholipid JJ O
reagent NN O
for IN O
coagulation NN O
assays NNS O
. . O

Assuming VBG O
O2 NNP O
consumption NN O
of IN O
the DT O
isolated JJ O
skin NN O
to TO O
be VB O
same JJ O
as IN O
in IN O
situ NN O
, , O
calculations NNS O
showed VBD O
that IN O
when WRB O
water NN O
PO2 NNP O
was VBD O
high JJ O
( ( O
150 CD O
mm RB O
Hg NNP O
) ) O
, , O
about RB O
40 CD O
% NN O
of IN O
total JJ O
cutaneous JJ O
O2 NNP O
uptake NN O
was VBD O
consumed VBN O
by IN O
the DT O
skin NN O
. . O

Intron NNP O
8 CD O
harbored VBD O
a DT O
strong JJ O
erythroid NN O
- : O
specific JJ O
enhancer NN O
activity NN O
which WDT O
was VBD O
orientation NN O
- : O
dependent NN O
. . O

Comprehensive NNP O
care NN O
of IN O
the DT O
patient NN O
exposed VBD O
to TO O
a DT O
human JJ O
teratogen NN O
may MD O
also RB O
include VB O
discussion NN O
of IN O
prenatal JJ O
diagnostic JJ O
procedures NNS O
and CC O
other JJ O
pregnancy NN O
management NN O
options NNS O
. . O

In IN O
Malmo NNP O
, , O
Sweden NNP O
, , O
17 CD O
, , O
181 CD O
school NN O
children NNS O
born VBN O
in IN O
the DT O
years NNS O
1961 CD O
- : O
1965 CD O
were VBD O
screened VBN O
for IN O
scoliosis NN O
once RB O
a DT O
year NN O
between IN O
the DT O
ages NNS O
of IN O
7 CD O
and CC O
16 CD O
years NNS O
, , O
during IN O
1971 CD O
- : O
1980 CD O
. . O

A DT O
putative JJ O
inhibitor NN O
( ( O
s PRP O
) ) O
appears VBZ O
to TO O
co VB O
- : O
elute NN O
in IN O
the DT O
inactive JJ O
fraction NN O
that WDT O
blocked VBD O
the DT O
L NNP B-Gene
( ( I-Gene
alpha NN I-Gene
) ) I-Gene
activity NN O
. . O

Biochemical JJ O
analysis NN O
shows VBZ O
that IN O
Ssm1p NNP B-Gene
is VBZ O
a DT O
structural JJ O
protein NN O
that WDT O
forms VBZ O
part NN O
of IN O
the DT O
largest JJS O
60S CD B-Gene
ribosomal JJ I-Gene
subunit NN I-Gene
, , O
which WDT O
does VBZ O
not RB O
exist VB O
in IN O
a DT O
pool NN O
of IN O
free JJ O
proteins NNS O
. . O

We PRP O
found VBD O
in IN O
the DT O
control NN O
subjects VBZ O
rCBF JJ O
increases NNS O
in IN O
regions NNS O
associated VBN O
with IN O
the DT O
meso NN O
- : O
striatal NN O
and CC O
meso SYM O
- : O
corticolimbic JJ O
circuits NNS O
in IN O
response NN O
to TO O
both DT O
monetary JJ O
reward NN O
and CC O
nonmonetary JJ O
reinforcement NN O
. . O

All PDT O
the DT O
women NNS O
received VBD O
13 CD O
. . O
5 CD O
mg NN O
plain NN O
bupivacaine NN O
via IN O
subarachnoid JJ O
injection NN O
at IN O
the DT O
L2 NNP O
- : O
3 CD O
interspace NN O
. . O

In IN O
F42A NNP O
- : O
stimulated VBN O
internalization NN O
assays NNS O
on IN O
forskolin NN O
- : O
induced JJ O
YT NNP O
- : O
1 CD O
cells NNS O
, , O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
chain NN I-Gene
is VBZ O
consistently RB O
endocytosed VBN O
together RB O
with IN O
the DT O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
subunit NN I-Gene
indicating VBG O
that IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
is VBZ O
stably RB O
associated VBN O
with IN O
the DT O
F42A NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
complex JJ I-Gene
even RB O
though IN O
the DT O
alpha JJ O
- : O
subunit NN O
contributes VBZ O
little RB O
if IN O
any DT O
affinity NN O
to TO O
the DT O
F42A NNP O
binding NN O
reaction NN O
. . O

Our PRP$ O
results NNS O
implicate VBP O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
RII NNP I-Gene
as IN O
a DT O
direct JJ O
target NN O
of IN O
EWS NNP B-Gene
- : O
FLI1 NN B-Gene
. . O

Molecular JJ O
cloning NN O
of IN O
a DT O
P NNP B-Gene
- : I-Gene
type NN I-Gene
ATPase NNP I-Gene
gene NN I-Gene
from IN O
the DT O
cyanobacterium NN O
Synechocystis NNP O
sp NN O
. . O

We PRP O
conclude VBP O
that IN O
this DT O
new JJ O
measurement NN O
technique NN O
provides VBZ O
an DT O
easy JJ O
and CC O
accurate JJ O
P0 NNP O
. . O
1 CD O
measurement NN O
using VBG O
standard JJ O
respiratory NN O
equipment NN O
when WRB O
tested VBN O
in IN O
a DT O
lung NN O
model NN O
. . O

A DT O
significant JJ O
herd NN O
X NNP O
period NN O
interaction NN O
existed VBD O
for IN O
liver NN O
TG NNP O
and CC O
serum NN O
dextran NN O
precipitable JJ O
cholesterol NN O
concentrations NNS O
. . O

A DT O
combined JJ O
series NN O
of IN O
patients NNS O
experienced VBD O
a DT O
TOL NNP O
after IN O
two CD O
or CC O
more JJR O
previous JJ O
cesarean NN O
deliveries NNS O
; : O
the DT O
rate NN O
of IN O
vaginal JJ O
delivery NN O
was VBD O
66 CD O
% NN O
, , O
and CC O
there RB O
was VBD O
virtually RB O
no DT O
morbidity NN O
. . O

The DT O
major JJ O
inserted VBN O
DNA NNP O
has VBZ O
no DT O
significant JJ O
homology NN O
to TO O
published VBN O
human JJ O
nucleic JJ O
acid NN O
sequences NNS O
. . O

However RB O
, , O
there EX O
was VBD O
a DT O
difference NN O
in IN O
the DT O
quality NN O
of IN O
immunity NN O
: : O
fever NN O
and CC O
body NN O
weight JJ O
loss NN O
were VBD O
seen VBN O
in IN O
hamsters NNS O
vaccinated VBN O
with IN O
the DT O
killed VBN O
- : O
toxoplasma NN O
vaccine NN O
after IN O
they PRP O
were VBD O
challenge NNS O
exposed VBN O
with IN O
T NNP O
- : O
1 CD O
strain NN O
, , O
whereas IN O
these DT O
changes NNS O
were VBD O
rarely RB O
seen VBN O
in IN O
hamsters NNS O
given VBN O
the DT O
live JJ O
- : O
toxoplasma NN O
vaccine NN O
and CC O
then RB O
challenge VB O
exposed VBN O
with IN O
RH NNP O
strain NN O
. . O

Heterozygous JJ O
mutation NN O
in IN O
the DT O
G NNP O
+ NNP O
5 CD O
position NN O
of IN O
intron NN O
33 CD O
of IN O
the DT O
pro JJ B-Gene
- : I-Gene
alpha NN I-Gene
2 CD I-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
gene NN I-Gene
( ( O
COL1A2 NNP B-Gene
) ) O
that WDT O
causes VBZ O
aberrant JJ O
RNA NNP O
splicing NN O
and CC O
lethal JJ O
osteogenesis NN O
imperfecta NN O
. . O

In IN O
a DT O
model NN O
of IN O
the DT O
ternary JJ O
complex NN O
, , O
the DT O
segment NN O
of IN O
NFAT NNP B-Gene
nearest JJS O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
the DT O
Rel NNP B-Gene
insert JJ O
region NN O
( ( O
RIR NNP O
) ) O
, , O
a DT O
feature NN O
that WDT O
is VBZ O
notable JJ O
for IN O
its PRP$ O
hypervariability NN O
in IN O
size NN O
and CC O
in IN O
sequence NN O
amongst JJ O
members NNS O
of IN O
the DT O
Rel NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

Troglitazone NN O
also RB O
induced VBD O
an DT O
endogenous JJ B-Gene
PPARgamma NNP I-Gene
target NN I-Gene
gene NN I-Gene
in IN O
T24 NNP O
cells NNS O
, , O
adipocyte SYM B-Gene
- : I-Gene
type NN I-Gene
fatty JJ I-Gene
acid NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
A DT B-Gene
- : I-Gene
FABP NN I-Gene
) ) O
, , O
the DT O
expression NN O
of IN O
which WDT O
correlates VBZ O
with IN O
bladder NN O
cancer NN O
differentiation NN O
. . O

Deletions NNS O
in IN O
each DT O
of IN O
these DT O
regions NNS O
abolish VBP O
membrane JJ O
localization NN O
of IN O
Tiam1 NNP B-Gene
and CC O
membrane NN O
ruffling NN O
, , O
suggesting VBG O
that IN O
they PRP O
function VBP O
cooperatively RB O
. . O

Strikingly RB O
, , O
this DT O
subdomain NN O
is VBZ O
also RB O
present JJ O
in IN O
the DT O
otherwise RB O
unrelated JJ O
N NNP O
- : O
terminal NN O
activating VBG O
region NN O
of IN O
p58c NN B-Gene
- : I-Gene
ets VBZ I-Gene
- : I-Gene
2 CD I-Gene
and CC O
was VBD O
thus RB O
named VBN O
BEC NNP B-Gene
for IN O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
beta NN I-Gene
/ JJ O
Ets NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
Conserved VBN I-Gene
sequence NN I-Gene
. . O

The DT O
E NNP O
- : O
box NN O
sequence NN O
in IN O
the DT O
SE2 NNP B-Gene
fragment NN I-Gene
of IN O
the DT O
transferrin NN B-Gene
promoter NN I-Gene
was VBD O
CATCTG NNP O
and CC O
was VBD O
similar JJ O
in IN O
gel JJ O
shifts NNS O
to TO O
the DT O
consensus NN O
E NNP O
- : O
box NN O
elements NNS O
( ( O
CANNTG NNP O
) ) O
previously RB O
characterized VBN O
. . O

The DT O
apparent JJ O
Kd NNP O
of IN O
the DT O
MetRS NNP B-Gene
/ NNP I-Gene
CAU NNP I-Gene
operator NN I-Gene
complex NN I-Gene
is VBZ O
one CD O
order NN O
magnitude NN O
higher JJR O
than IN O
that DT O
of IN O
the DT O
ThrRS NNP B-Gene
/ NNP I-Gene
CGU NNP I-Gene
operator NN I-Gene
complex NN I-Gene
. . O

Our PRP$ O
findings NNS O
also RB O
provide VBP O
the DT O
basis NN O
for IN O
the DT O
development NN O
of IN O
assays NNS O
to TO O
screen VB O
for IN O
the DT O
ligands NNS O
to TO O
testis VB B-Gene
receptor NN I-Gene
2 CD I-Gene
and CC O
hERR1 NN B-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
virulence NN O
- : O
associated VBN O
genes NNS O
and CC O
their PRP$ O
overall JJ O
chromosomal JJ O
arrangement NN O
are VBP O
relatively RB O
well RB O
conserved VBN O
between IN O
B NNP O
. . O
henselae NN O
and CC O
other JJ O
gram NN O
- : O
negative JJ O
bacteria NNS O
such JJ O
as IN O
A NNP O
. . O
tumefaciens NNS O
. . O

This DT O
association NN O
was VBD O
independently RB O
significant JJ O
for IN O
patients NNS O
treated VBN O
primarily RB O
( ( O
not RB O
for IN O
recurrence NN O
) ) O
. . O

On IN O
the DT O
basis NN O
of IN O
a DT O
patient NN O
' POS O
s JJ O
report NN O
of IN O
one CD O
inaccurate NN O
Clinitemp NNP O
, , O
we PRP O
undertook VBP O
to TO O
investigate VB O
the DT O
accuracy NN O
of IN O
this DT O
thermometer NN O
. . O

Using VBG O
an DT O
audiotape NN O
cassette NN O
and CC O
headphones VBZ O
the DT O
duration NN O
of IN O
the DT O
hallucinations NNS O
decreased VBD O
significantly RB O
. . O

Replicating VBG O
simian JJ O
virus NN O
40 CD O
( ( O
SV40 NNP O
) ) O
chromosomes NNS O
were VBD O
found VBN O
to TO O
be VB O
similar JJ O
to TO O
other JJ O
eukaryotic JJ O
chromosomes NNS O
in IN O
that DT O
the DT O
rate NN O
and CC O
extent NN O
of IN O
micrococcal JJ B-Gene
nuclease NN I-Gene
( ( O
MNase NNP B-Gene
) ) O
digestion NN O
were VBD O
greater JJR O
with IN O
replicating VBG O
than IN O
with IN O
nonreplicating JJ O
mature NN O
SV40 NNP O
chromatin NN O
. . O

Treatment NN O
of IN O
suppurative JJ O
peritonitis NN O

CIITA NNP B-Gene
mRNA NN I-Gene
is VBZ O
normally RB O
inducible JJ O
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
class NN O
II NNP O
non SYM O
- : O
inducible JJ O
, , O
RB NNP O
- : O
defective JJ O
lines NNS O
, , O
and CC O
in IN O
one CD O
line NN O
, , O
re VB O
- : O
expression NN O
of IN O
RB NNP B-Gene
has VBZ O
no DT O
effect NN O
on IN O
CIITA NNP B-Gene
mRNA NN I-Gene
induction NN O
levels NNS O
. . O

A DT O
cDNA NN O
encoding VBG O
a DT O
putative JJ O
RNA NNP B-Gene
and CC I-Gene
/ NNP I-Gene
or CC I-Gene
DNA NNP I-Gene
helicase NN I-Gene
has VBZ O
been VBN O
isolated VBN O
from IN O
Arabidopsis NNP O
thaliana NN O
cDNA NN O
libraries NNS O
. . O

Cortisone NN O
induced VBD O
bone NN O
changes NNS O
and CC O
its PRP$ O
response NN O
to TO O
lipid VB O
clearing VBG O
agents NNS O
. . O

Of IN O
110 CD O
previously RB O
untreated JJ O
patients NNS O
who WP O
had VBD O
entered VBN O
the DT O
study NN O
of IN O
protocol NN O
TCL821 NNP O
, , O
96 CD O
were VBD O
evaluable JJ O
. . O

Finally RB O
, , O
the DT O
recovery NN O
indexes NNS O
represented VBN O
by IN O
the DT O
times NNS O
required VBN O
for IN O
T1 NNP O
/ NNP O
T0 NNP O
and CC O
T4 NNP O
/ NNP O
T1 NNP O
to TO O
rise VB O
from IN O
25 CD O
% NN O
to TO O
75 CD O
% NN O
respectively RB O
were VBD O
studied VBN O
. . O

X LS O
- : O
linked VBN O
liver JJ O
glycogenosis NN O
: : O
localization NN O
and CC O
isolation NN O
of IN O
a DT O
candidate NN O
gene NN O
. . O

In IN O
most JJS O
cases NNS O
of IN O
acute JJ O
transmural JJ O
infarction NN O
, , O
the DT O
reciprocal JJ O
ST NNP O
segment NN O
depressions NNS O
observed VBD O
in IN O
contralateral JJ O
leads NNS O
are VBP O
less RBR O
marked JJ O
than IN O
the DT O
primary JJ O
ST NNP O
segment NN O
elevations NNS O
. . O

Comparison NNP O
of IN O
the DT O
genomes NNS O
of IN O
PMTV NNP O
, , O
BNYVV NNP O
, , O
and CC O
SBWMV NNP O
shows VBZ O
that IN O
furoviruses VBZ O
exhibit NN O
considerable JJ O
heterogeneity NN O
in IN O
genome JJ O
organization NN O
. . O

The DT O
exon JJ O
- : O
intron NN O
distribution NN O
of IN O
Cdebp NNP B-Gene
appears VBZ O
strikingly RB O
similar JJ O
to TO O
that DT O
of IN O
the DT O
App NNP B-Gene
gene NN I-Gene
in IN O
the DT O
regions NNS O
encoding VBG O
the DT O
conserved JJ O
domains NNS O
, , O
with IN O
a DT O
divergent NN O
structure NN O
in IN O
the DT O
other JJ O
parts NNS O
. . O

Therefore RB O
, , O
the DT O
positive JJ O
cAMP NN O
control NN O
of IN O
the DT O
hypoxic NN O
SRP1 NNP B-Gene
and CC O
HEM13 NNP B-Gene
genes NNS I-Gene
was VBD O
uncoupled VBN O
from IN O
the DT O
HOG NNP B-Gene
pathway NN O
. . O

These DT O
cell NN O
lines NNS O
displayed VBD O
methylation NN O
of IN O
the DT O
CpG NNP O
island NN O
surrounding VBG O
the DT O
first JJ O
exon NN O
of IN O
p16INK4A NN B-Gene
and CC O
expressed VBD O
abundant JJ O
levels NNS O
of IN O
a DT O
nontranslated JJ O
mRNA NN O
containing VBG O
an DT O
alternative JJ O
first JJ O
exon NN O
( ( O
E1 NNP O
beta NN O
) ) O
, , O
as IN O
did VBD O
all DT O
other JJ O
cell NN O
lines NNS O
in IN O
which WDT O
the DT O
p16INK4A NN B-Gene
locus NN I-Gene
was VBD O
not RB O
deleted VBN O
. . O

CONCLUSION NN O
: : O
The DT O
results NNS O
demonstrate VBP O
that IN O
at IN O
the DT O
site NN O
of IN O
lumbar NN O
disc NN O
herniation NN O
, , O
inflammatory JJ O
cytokines NNS O
such JJ O
as IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
alpha NNS I-Gene
are VBP O
produced VBN O
, , O
which WDT O
increases VBZ O
prostaglandin NN O
E2 NNP O
production NN O
. . O

In IN O
vitro JJ O
affinity NN O
analyses NNS O
demonstrated VBD O
that IN O
recombinant JJ O
130 CD O
- : O
kD NN O
protein NN O
directly RB O
interacts VBZ O
with IN O
ZO NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
occludin NN B-Gene
, , O
but CC O
not RB O
with IN O
ZO NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

We PRP O
now RB O
report VBP O
the DT O
isolation NN O
and CC O
expression NN O
of IN O
cDNAs NN O
encoding VBG O
PTF NNP B-Gene
gamma NN I-Gene
and CC O
PTF NNP B-Gene
delta NN I-Gene
, , O
as RB O
well RB O
as IN O
functional JJ O
studies NNS O
with IN O
cognate NN O
antibodies NNS O
that WDT O
recognize VBP O
the DT O
native JJ O
PTF NNP B-Gene
complex NN I-Gene
in IN O
HeLa NNP O
extracts NNS O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
endogenous JJ O
N NNP O
- : O
methylation NN O
of IN O
salsolinol NN O
into IN O
N NNP O
- : O
methylsalsolinol NN O
occurs VBZ O
in IN O
the DT O
brain NN O
in IN O
vivo NN O
. . O

Two CD O
soybean JJ O
cDNA NN O
clones NNS O
, , O
SPK NNP B-Gene
- : I-Gene
3 CD I-Gene
and CC O
SPK NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
encoding VBG O
putative JJ O
protein NN O
kinases NNS O
were VBD O
isolated VBN O
and CC O
characterized VBN O
. . O

TH NNP B-Gene
- : O
SH3 NN B-Gene
binding NN O
in IN O
vitro NN O
is VBZ O
abolished VBN O
by IN O
specific JJ O
, , O
single JJ O
amino NN O
acid NN O
substitutions NNS O
within IN O
the DT O
Btk NNP B-Gene
TH NNP B-Gene
domain NN I-Gene
or CC O
the DT O
Fyn NNP B-Gene
SH3 NNP B-Gene
domain NN I-Gene
. . O

All DT O
our PRP$ O
patients NNS O
had VBD O
polyps NNS O
, , O
23 CD O
( ( O
54 CD O
% NN O
) ) O
had VBD O
asthma VBN O
, , O
12 CD O
( ( O
27 CD O
% NN O
) ) O
had VBD O
aspirin JJ O
sensitivity NN O
, , O
20 CD O
( ( O
65 CD O
% NN O
) ) O
had VBD O
eosinophilia VBN O
, , O
and CC O
9 CD O
( ( O
69 CD O
% NN O
) ) O
had VBD O
increased VBN O
total JJ O
IgE NNP B-Gene
levels NNS O
. . O

Serum NNP O
ferritin NN B-Gene
concentration NN O
and CC O
bone NN O
marrow NN O
iron NN O
stores NNS O
. . O

Ammonia NNP O
concentration NN O
dropped VBD O
significantly RB O
in IN O
all DT O
treatments NNS O
, , O
a DT O
finding NN O
which WDT O
suggests VBZ O
a DT O
protective JJ O
effect NN O
on IN O
protein NN O
nitrogen NN O
degradation NN O
to TO O
non VB O
- : O
protein NN O
nitrogen NN O
( ( O
NH3 NNP O
) ) O
. . O

In IN O
some DT O
cases NNS O
, , O
the DT O
aberrant JJ O
methylation NN O
of IN O
CpGs NNP O
within IN O
5 CD O
' POS O
regulatory JJ O
regions NNS O
has VBZ O
led VBN O
to TO O
suppression NN O
of IN O
gene NN O
activity NN O
. . O

In IN O
order NN O
to TO O
investigate VB O
how WRB O
these DT O
expression NN O
patterns NNS O
are VBP O
established VBN O
, , O
we PRP O
fused VBD O
promoter NN O
regions NNS O
of IN O
an DT O
acidic JJ O
and CC O
a DT O
basic JJ O
glucanase NN B-Gene
gene NN I-Gene
to TO O
the DT O
beta NN B-Gene
- : I-Gene
glucuronidase NN I-Gene
( ( O
GUS NNP B-Gene
) ) O
reporter NN O
gene NN O
and CC O
examined JJ O
expression NN O
of IN O
these DT O
constructs NNS O
in IN O
transgenic JJ O
tobacco NN O
plants NNS O
. . O

The DT O
roles NNS O
of IN O
phorbol NN O
esters NNS O
and CC O
cyclic JJ O
AMP NNP O
in IN O
mediating VBG O
the DT O
GnRH NNP B-Gene
response NN O
were VBD O
also RB O
investigated VBN O
. . O

The DT O
Ras NNP B-Gene
guanine NN I-Gene
nucleotide IN I-Gene
- : I-Gene
binding NN I-Gene
protein JJ I-Gene
functions NNS O
as IN O
a DT O
molecular JJ O
switch NN O
in IN O
signalling VBG O
downstream NN O
of IN O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
. . O

Chordoma NNP O
of IN O
the DT O
spinal JJ O
cord NN O
in IN O
a DT O
F344 NNP O
rat NN O
. . O

Furthermore RB O
, , O
the DT O
initial JJ O
plasma NN O
retinol NN O
level NN O
in IN O
conjunction NN O
with IN O
RBP NNP B-Gene
was VBD O
found VBN O
to TO O
be VB O
even RB O
lower JJR O
in IN O
12 CD O
patients NNS O
( ( O
35 CD O
. . O
1 CD O
micrograms NNS O
dl VBP O
- : O
1 CD O
, , O
3 CD O
. . O
7 CD O
mg NN O
dl NN O
- : O
1 CD O
) ) O
who WP O
subsequently RB O
had VBD O
cancer NN O
recurrence NN O
than IN O
in IN O
those DT O
who WP O
remained VBD O
free JJ O
of IN O
apparent JJ O
cancer NN O
( ( O
44 CD O
. . O
5 CD O
micrograms NNS O
dl VBP O
- : O
1 CD O
, , O
4 CD O
. . O
6 CD O
mg NN O
dl NN O
- : O
1 CD O
) ) O
. . O

Vascular JJ O
responses NNS O
to TO O
reactive VB O
hyperemia NN O
( ( O
with IN O
flow NN O
increase NN O
leading VBG O
to TO O
endothelium VB O
- : O
dependent JJ O
dilation NN O
) ) O
and CC O
to TO O
sublingual VB O
glyceryl NN O
trinitrate NN O
( ( O
GTN NNP O
; : O
endothelium SYM O
- : O
independent JJ O
dilation NN O
) ) O
were VBD O
recorded VBN O
. . O

The DT O
fepA JJ B-Gene
- : O
entD NN B-Gene
and CC O
fes JJ B-Gene
- : O
entF NN B-Gene
operons NNS O
in IN O
the DT O
enterobactin JJ O
synthesis NN O
and CC O
transport NN O
system NN O
are VBP O
divergently RB O
transcribed VBN O
from IN O
overlapping VBG O
promoters NNS O
, , O
and CC O
both DT O
are VBP O
inhibited VBN O
by IN O
the DT O
Fur NNP B-Gene
repressor NN I-Gene
protein NN I-Gene
under IN O
iron NN O
- : O
replete JJ O
conditions NNS O
. . O

Although IN O
the DT O
extracellular JJ O
domain NN O
of IN O
the DT O
TSH NNP B-Gene
- : I-Gene
R NN I-Gene
is VBZ O
sufficient JJ O
for IN O
high JJ O
affinity NN O
binding NN O
of IN O
TSH NNP B-Gene
, , O
we PRP O
conclude VBP O
that IN O
the DT O
hyt NN O
mutation NN O
in IN O
the DT O
fourth JJ O
transmembrane NN O
domain NN O
eliminates VBZ O
TSH NNP B-Gene
binding NN O
. . O

Selective JJ O
visual JJ O
attention NN O
involves VBZ O
dynamic JJ O
interplay NN O
between IN O
attentional JJ O
control NN O
systems NNS O
and CC O
sensory JJ O
brain NN O
structures NNS O
. . O

Colorimetric JJ O
determination NN O
of IN O
urinary JJ O
iron NN O
, , O
chelated VBN O
with IN O
deferoxamine NN O
B NNP O
, , O
using VBG O
a DT O
single JJ O
reagent NN O

In IN O
the DT O
absence NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
, , O
purified VBD B-Gene
soluble JJ I-Gene
D10 NNP I-Gene
TCR NNP I-Gene
bound NN O
to TO O
Staphylococcus NNP B-Gene
aureus NN I-Gene
enterotoxin NN I-Gene
C2 NNP I-Gene
with IN O
an DT O
association NN O
rate NN O
of IN O
1 CD O
. . O
69 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
12 CD O
x JJ O
10 CD O
( ( O
4 CD O
) ) O
M NNP O
( ( O
- : O
1 CD O
) ) O
sec NN O
( ( O
- : O
1 CD O
) ) O
and CC O
a DT O
dissociation NN O
rate NN O
of IN O
1 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
47 CD O
x JJ O
10 CD O
( ( O
- : O
2 CD O
) ) O
sec NN O
( ( O
- : O
1 CD O
) ) O
, , O
giving VBG O
a DT O
dissociation NN O
constant NN O
of IN O
1 CD O
. . O
1 CD O
microM NN O
. . O

Routine JJ O
clinical JJ O
analysis NN O
revealed VBD O
lower JJR O
hematocrit NN O
and CC O
hemoglobin NN B-Gene
, , O
and CC O
elevated VBD O
BUN NNP O
and CC O
alkaline JJ B-Gene
phosphatase NN I-Gene
in IN O
the DT O
treated JJ O
group NN O
. . O

Two CD O
major JJ O
and CC O
one CD O
minor JJ O
transcription NN O
initiation NN O
sites NNS O
were VBD O
assigned VBN O
to TO O
positions NNS O
+ $ O
1 CD O
and CC O
+ $ O
24 CD O
and CC O
position NN O
+ RB O
14 CD O
, , O
respectively RB O
, , O
by IN O
a DT O
combination NN O
of IN O
ribonuclease NN O
protection NN O
, , O
primer JJ O
extension NN O
, , O
and CC O
5 CD O
' '' O
RACE NNP O
analyses NNS O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
the DT O
pro JJ O
- : O
inflammatory NN O
cytokines NNS O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
and CC O
interferon NN B-Gene
gamma NN I-Gene
reduce VB O
the DT O
expression NN O
of IN O
the DT O
cystic JJ B-Gene
fibrosis NN I-Gene
transmembrane NN I-Gene
conductance NN I-Gene
regulator NN I-Gene
( ( O
CFTR NNP B-Gene
) ) O
gene NN O
( ( O
CFTR NNP B-Gene
) ) O
in IN O
HT NNP O
- : O
29 CD O
and CC O
T84 NNP O
cells NNS O
by IN O
acting VBG O
post NN O
- : O
transcriptionally RB O
. . O

In IN O
Group NNP O
IV NNP O
dogs VBZ O
that IN O
received VBD O
alpha JJ B-Gene
- : I-Gene
MSH NNP I-Gene
only RB O
during IN O
reperfusion NN O
, , O
BAEPs NNP O
were VBD O
increased VBN O
approximately RB O
10 CD O
to TO O
14 CD O
% NN O
more JJR O
than IN O
in IN O
Group NNP O
II NNP O
during IN O
the DT O
late JJ O
reperfusion NN O
period NN O
. . O

Hepatitis NN O
B NNP O
virus NN O
and CC O
hepatoma NN O
. . O

Pulmonary JJ O
vascular NN O
resistance NN O
was VBD O
not RB O
altered VBN O
, , O
ejection NN O
fraction NN O
remained VBD O
unchanged JJ O
and CC O
isovolumic JJ O
relaxation NN O
period NN O
was VBD O
lengthened VBN O
( ( O
119 CD O
+ NN O
/ NNP O
- : O
20 CD O
. . O
1 CD O
to TO O
147 CD O
. . O
39 CD O
+ JJ O
/ NNP O
- : O
21 CD O
. . O
15 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

T NNP O
cells NNS O
express RB O
two CD O
isoforms NNS O
of IN O
S6k1 NNP B-Gene
: : O
a DT O
70 CD O
kDa NN O
cytoplasmic JJ O
kinase NN O
and CC O
an DT O
85 CD O
kDa NN O
isoform NN O
that WDT O
has VBZ O
a DT O
classic JJ O
nuclear JJ O
localisation NN O
. . O

Disruption NN O
demonstrates VBZ O
that IN O
CDC14 NNP B-Gene
is VBZ O
an DT O
essential JJ O
gene NN O
. . O

Germ NNP O
- : O
free JJ O
rabbits NNS O
given VBN O
mouse VBP O
CRF NNP O
- : O
flora NN O
showed VBD O
values NNS O
quite RB O
different JJ O
from IN O
control NN O
animals NNS O
for IN O
most JJS O
parameters NNS O
, , O
indicating VBG O
unsuitability NN O
of IN O
mouse NN O
CRF NNP O
flora NN O
to TO O
' '' O
normalize NNS O
' POS O
rabbits NNS O
. . O

However RB O
, , O
patients NNS O
with IN O
isolated JJ O
office NN O
hypertension NN O
had VBD O
fewer JJR O
previous JJ O
cardiovascular JJ O
complications NNS O
. . O

In IN O
the DT O
treatment NN O
of IN O
opioid JJ O
naive JJ O
patients NNS O
who WP O
underwent VBP O
surgery NN O
and CC O
received VBD O
opioids NNS O
for IN O
acute NN O
pain NN O
, , O
oral JJ O
ADL NNP O
8 CD O
- : O
2698 CD O
( ( O
6 CD O
. . O
0 CD O
mg NN O
) ) O
improved VBD O
the DT O
management NN O
of IN O
postoperative JJ O
ileus NN O
( ( O
POI NNP O
) ) O
by IN O
shortening VBG O
the DT O
time NN O
to TO O
achieve VB O
normal JJ O
bowel NN O
function NN O
and CC O
, , O
ultimately RB O
, , O
hospital JJ O
stay NN O
. . O

Each DT O
mRNA NN O
contained VBD O
five CD O
or CC O
six CD O
internal JJ O
uridine NN O
residues NNS O
, , O
which WDT O
were VBD O
transcribed VBN O
using VBG O
a DT O
mixture NN O
of IN O
UTP NNP O
and CC O
thio SYM O
- : O
UTP NN O
. . O

In IN O
cell NN O
lines NNS O
transformed VBN O
by IN O
BCR NNP B-Gene
/ NNP O
ABL NNP B-Gene
, , O
CRKL NNP B-Gene
was VBD O
tyrosine JJ O
phosphorylated VBN O
, , O
while IN O
CRK NNP B-Gene
was VBD O
not RB O
. . O

However RB O
, , O
parallax NN O
measurements NNS O
showed VBD O
that IN O
at IN O
150K CD O
, , O
collapse NN O
of IN O
Epon NNP O
sections NNS O
does VBZ O
not RB O
take VB O
place NN O
. . O

3 CD O
activities NNS O
of IN O
the DT O
factor NN B-Gene
II NNP I-Gene
molecule NN O
in IN O
the DT O
newborn JJ O
infant NN O
at IN O
term NN O

The DT O
General NNP O
Practice NNP O
Research NNP O
Database NNP O
( ( O
GPRD NNP O
) ) O
is VBZ O
the DT O
world NN O
' POS O
s NN O
largest JJS O
computerized JJ O
database NN O
of IN O
anonymized JJ O
longitudinal JJ O
patient NN O
records NNS O
from IN O
general JJ O
practice NN O
and CC O
is VBZ O
a DT O
unique JJ O
public JJ O
health NN O
research NN O
tool NN O
. . O

Serum NNP B-Gene
ACTH NNP I-Gene
did VBD O
not RB O
respond VB O
to TO O
insulin VB B-Gene
and CC O
metyrapone NN O
. . O

As IN O
determined VBN O
in IN O
a DT O
modified VBN O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
, , O
mIRS3 FW B-Gene
bound RB O
strongly RB O
to TO O
the DT O
p85 JJ B-Gene
subunit NN I-Gene
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

Pituitary JJ O
adenylate NN B-Gene
cyclase NN I-Gene
- : I-Gene
activating VBG I-Gene
polypeptide NN I-Gene
regulates VBZ O
prolactin JJ B-Gene
promoter NN I-Gene
activity NN O
via IN O
a DT O
protein NN B-Gene
kinase NN I-Gene
A NNP I-Gene
- : O
mediated VBN O
pathway NN O
that WDT O
is VBZ O
independent JJ O
of IN O
the DT O
transcriptional JJ O
pathway NN O
employed VBN O
by IN O
thyrotropin NN B-Gene
- : I-Gene
releasing VBG I-Gene
hormone NN I-Gene
. . O

This DT O
suggests VBZ O
that IN O
alaproclate NN O
acutely RB O
increases VBZ O
the DT O
responsiveness NN O
of IN O
postsynaptic JJ O
muscarinic NN B-Gene
and CC I-Gene
alpha $ I-Gene
1 CD I-Gene
adrenoceptors NNS I-Gene
. . O

Single NNP O
photon NN O
emission NN O
computerized VBN O
tomography NN O
( ( O
SPECT NNP O
) ) O
, , O
by IN O
providing VBG O
three CD O
- : O
dimensional JJ O
representation NN O
of IN O
myocardial JJ O
Tl NNP O
- : O
201 CD O
, , O
offers NNS O
promise VBP O
for IN O
improved JJ O
localization NN O
of IN O
CAD NNP O
. . O

These DT O
data NNS O
provide VBP O
the DT O
molecular JJ O
tools NNS O
for IN O
the DT O
final JJ O
identification NN O
of IN O
the DT O
MKS NNP B-Gene
and CC O
the DT O
MUL NNP B-Gene
genes NNS I-Gene
. . O

Various JJ O
treatment NN O
modalities NNS O
are VBP O
reviewed VBN O
in IN O
the DT O
context NN O
of IN O
the DT O
psychology NN O
as RB O
well RB O
as IN O
the DT O
physiology NN O
of IN O
severe JJ O
intractable JJ O
pain NN O
. . O

Accumulation NN O
of IN O
the DT O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
duplex NN O
was VBD O
relieved VBN O
by IN O
overexpression NN O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Prp44p NNP I-Gene
. . O

Serum NNP O
lactate NN B-Gene
dehydrogenase NN I-Gene
and CC O
haptoglobin NN B-Gene
levels NNS O
were VBD O
normal JJ O
, , O
and CC O
total JJ O
bilirubin NN O
was VBD O
only RB O
slightly RB O
elevated VBN O
. . O

The DT O
addition NN O
of IN O
zidovudine NN O
did VBD O
not RB O
influence VB O
this DT O
transfer NN O
. . O

Five CD O
different JJ O
subtypes NNS O
of IN O
spondyloarthropathy NN O
( ( O
SpA NNP O
) ) O
are VBP O
now RB O
recognized VBN O
. . O

However RB O
, , O
limited JJ O
comparisons NNS O
reveal VBP O
domains NNS O
in IN O
the DT O
NH2 NNP O
and CC O
COOH NNP O
termini VBP O
that WDT O
have VBP O
a DT O
high JJ O
degree NN O
of IN O
similarity NN O
suggesting VBG O
functional JJ O
conservation NN O
. . O

The DT O
results NNS O
obtained VBN O
were VBD O
as IN O
follows VBZ O
: : O
The DT O
mitral JJ O
valve NN O
orifice NN O
area NN O
( ( O
MVA NNP O
) ) O
was VBD O
significantly RB O
smaller JJR O
in IN O
patients NNS O
with IN O
type JJ O
III NNP O
of IN O
the DT O
LVIT NNP O
flow NN O
velocity NN O
pattern NN O
than IN O
in IN O
patients NNS O
with IN O
type NN O
I PRP O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

BACKGROUND NNP O
/ NNP O
AIMS NNP O
: : O
Hepatitis NNP O
C NNP O
and CC O
nonalcoholic JJ O
fatty NN O
liver NN O
disease NN O
( ( O
NAFL NNP O
) ) O
are VBP O
the DT O
two CD O
most JJS O
common JJ O
forms NNS O
of IN O
liver JJ O
disease NN O
in IN O
the DT O
United NNP O
States NNPS O
. . O

It PRP O
is VBZ O
postulated VBN O
that IN O
altered VBD O
blood NN O
flow NN O
, , O
mediated VBN O
through IN O
the DT O
well NN O
- : O
known VBN O
prostaglandin JJ B-Gene
synthetase NN I-Gene
inhibitory JJ O
effects NNS O
of IN O
ibuprofen NN O
, , O
resulted VBD O
in IN O
tubular JJ O
necrosis NN O
. . O

On IN O
the DT O
basis NN O
of IN O
its PRP$ O
bZIP JJ O
structural JJ O
homology NN O
, , O
meq NN B-Gene
is VBZ O
perhaps RB O
the DT O
only JJ O
member NN O
of IN O
the DT O
jun NN B-Gene
- : O
fos NN B-Gene
gene NN O
family NN O
completely RB O
viral JJ O
in IN O
origin NN O
. . O

Prediction NN O
of IN O
the DT O
times NNS O
of IN O
sandfly NN O
development NN O

This DT O
effect NN O
was VBD O
abolished VBN O
once RB O
the DT O
EM NNP O
motif NN O
in IN O
the DT O
promoter NN O
- : O
reporter NN O
construct NN O
was VBD O
mutated VBN O
, , O
thus RB O
suggesting VBG O
that IN O
the DT O
synergistic JJ O
transactivation NN O
function NN O
of IN O
the DT O
TEF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
Max NNP B-Gene
heterotypic NN O
complex NN O
is VBZ O
mediated VBN O
through IN O
binding NN O
of IN O
the DT O
complex NN O
to TO O
the DT O
EM NNP O
motif NN O
. . O

Clone NN O
39 CD O
was VBD O
a DT O
homolog NN O
of IN O
CONSTANS NNP B-Gene
, , O
which WDT O
is VBZ O
a DT O
gene NN O
involved VBN O
in IN O
controlling VBG O
the DT O
flowering NN O
time NN O
in IN O
Arabidopsis NNP O
. . O

In IN O
general JJ O
, , O
however RB O
, , O
this DT O
study NN O
provided VBD O
little JJ O
evidence NN O
of IN O
any DT O
effect NN O
of IN O
supplementation NN O
to TO O
athletic JJ O
performance NN O
for IN O
athletes NNS O
consuming VBG O
the DT O
dietary JJ O
RDIs NNP O
. . O

Rev NNP B-Gene
- : O
erbAalpha NN B-Gene
/ NNP I-Gene
beta NN I-Gene
) ) O
, , O
Mxi NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Mad NNP B-Gene
bHLH SYM O
- : O
zip NN O
proteins NNS O
and CC O
the DT O
oncoproteins NNS O
PLZF NNP B-Gene
and CC O
LAZ3 NNP B-Gene
/ NNP O
BCL6 NNP B-Gene
is VBZ O
mediated VBN O
by IN O
the DT O
corepressors NNS O
N NNP B-Gene
- : I-Gene
CoR NN I-Gene
and CC O
SMRT NNP B-Gene
. . O

Pitfalls NNS O
in IN O
the DT O
use NN O
of IN O
chromosome NN O
aberration NN O
analysis NN O
for IN O
biological JJ O
radiation NN O
dosimetry NN O
. . O

Substantial JJ O
amounts NNS O
of IN O
liposomal JJ O
ampicillin NNS O
were VBD O
recovered VBN O
from IN O
isolated JJ O
Kupffer NNP O
cells NNS O
, , O
the DT O
target NN O
cells NNS O
of IN O
L NNP O
. . O
monocytogenes NNS O
after IN O
intravenous JJ O
inoculation NN O
. . O

The DT O
results NNS O
supported VBD O
the DT O
therapeutic JJ O
principle NN O
of IN O
TCM NNP O
: : O
Treating NN O
patients NNS O
according VBG O
to TO O
their PRP$ O
pathophysiological JJ O
patterns NNS O
. . O

The DT O
degree NN O
of IN O
lung NN O
destruction NN O
, , O
reflected VBN O
by IN O
interstitial JJ O
hemorrhage NN O
was VBD O
assessed VBN O
by IN O
measuring VBG O
hemoglobin NN B-Gene
content NN O
in IN O
the DT O
fluid NN O
of IN O
the DT O
lavaged JJ O
lungs NNS O
. . O

These DT O
CTD NNP B-Gene
kinases NNS I-Gene
, , O
designated VBN O
CTDK1 NNP B-Gene
and CC O
CTDK2 NNP B-Gene
, , O
are VBP O
fractionated VBN O
by IN O
chromatography NN O
on IN O
Mono NNP O
Q NNP O
. . O

Ras2p NNP B-Gene
activates VBZ O
invasive JJ O
growth NN O
using VBG O
either CC O
of IN O
two CD O
downstream NN O
signaling VBG O
pathways NNS O
, , O
the DT O
filamentation NN O
MAPK NNP B-Gene
( ( O
Cdc42p NNP B-Gene
/ NNP O
Ste20p NNP B-Gene
/ NNP O
MAPK NNP B-Gene
) ) O
cascade VBD O
or CC O
the DT O
cAMP JJ B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
Cyr1p NNP B-Gene
/ NNP O
cAMP NN O
/ NNP O
PKA NNP B-Gene
) ) O
pathway NN O
. . O

Immunolocalization NN O
of IN O
Sop1p NNP B-Gene
revealed VBD O
a DT O
cytoplasmic JJ O
distribution NN O
and CC O
cell NN O
fractionation NN O
studies NNS O
showed VBD O
that IN O
a DT O
significant JJ O
fraction NN O
of IN O
Sop1p NNP B-Gene
was VBD O
recovered VBN O
in IN O
a DT O
sedimentable JJ O
fraction NN O
of IN O
the DT O
cytosolic JJ O
material NN O
. . O

Susceptibility NN O
to TO O
ischemia VB O
- : O
induced JJ O
arrhythmias NN O
was VBD O
lower JJR O
in IN O
1 CD O
- : O
week NN O
diabetics NNS O
: : O
only RB O
42 CD O
% NN O
of IN O
diabetic JJ O
hearts NNS O
exhibited VBD O
ventricular JJ O
tachycardia NN O
( ( O
VT NNP O
) ) O
and CC O
16 CD O
% NN O
had VBD O
short JJ O
episodes NNS O
of IN O
ventricular JJ O
fibrillation NN O
( ( O
VF NNP O
) ) O
as IN O
compared VBN O
to TO O
VT VB O
100 CD O
% NN O
and CC O
VF NNP O
70 CD O
% NN O
( ( O
including VBG O
sustained VBN O
VF NNP O
36 CD O
% NN O
) ) O
in IN O
the DT O
non JJ O
- : O
diabetics NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

A DT O
synergistic JJ O
effect NN O
on IN O
HCK NNP B-Gene
promoter NN I-Gene
activity NN O
was VBD O
observed VBN O
at IN O
high JJ O
concentrations NNS O
of IN O
Sp1 NNP B-Gene
. . O

A DT O
pyrazolo JJ O
- : O
quinoline NN O
compound NN O
, , O
6 CD O
- : O
methoxy NN O
- : O
4 CD O
- : O
[ NN O
2 CD O
- : O
[ NN O
( ( O
2 CD O
- : O
hydroxyethoxyl NN O
) ) O
- : O
ethyl NN O
] NNP O
amino NN O
] NNP O
- : O
3 CD O
- : O
methyl NN O
- : O
1M CD O
- : O
pyrazo NN O
lo NN O
[ VBD O
3 CD O
, , O
4 CD O
- : O
b NN O
] NN O
quinoline NN O
( ( O
SCH NNP O
51344 CD O
) ) O
, , O
was VBD O
identified VBN O
based VBN O
on IN O
its PRP$ O
ability NN O
to TO O
derepress VB O
human JJ O
smooth JJ O
muscle NN O
alpha SYM B-Gene
- : I-Gene
actin JJ I-Gene
promoter NN I-Gene
activity NN O
in IN O
ras JJ B-Gene
- : O
transformed JJ O
cells NNS O
. . O

The DT O
247 CD O
- : O
kDa NN O
complex JJ O
appears VBZ O
to TO O
contain VB O
two CD O
distinct JJ O
protein SYM O
- : O
DNA NN O
complexes NNS O
of IN O
approximately RB O
232 CD O
and CC O
256 CD O
kDa NN O
and CC O
represents VBZ O
two CD O
proteins NNS O
covalently RB O
cross VBP O
- : O
linked VBN O
to TO O
a DT O
single JJ O
DRE NNP O
oligonucleotide NN O
, , O
while IN O
the DT O
97 CD O
, , O
105 CD O
, , O
and CC O
115 CD O
- : O
kDa NN O
complexes NNS O
represent VBP O
single JJ O
protein NN O
- : O
DRE NNP O
cross SYM O
- : O
links NNS O
. . O

Group NNP O
A NNP O
( ( O
68 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
7 CD O
years NNS O
) ) O
consisted VBD O
of IN O
patients NNS O
with IN O
0 CD O
or CC O
1 CD O
risk NN O
factors NNS O
; : O
B NNP O
( ( O
68 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
2 CD O
years NNS O
) ) O
those DT O
with IN O
2 CD O
risk NN O
factors NNS O
; : O
and CC O
C NNP O
( ( O
69 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
6 CD O
years NNS O
) ) O
those DT O
with IN O
3 CD O
or CC O
more JJR O
risk NN O
factors NNS O
. . O

There EX O
is VBZ O
no DT O
correlation NN O
between IN O
C2 NNP O
- : O
C3 NNP O
disk NN O
morphology NN O
and CC O
the DT O
diskographically RB O
provoked VBN O
response NN O
. . O

Inherent JJ O
hematology NN O
of IN O
old JJ O
age NN O

Accurate NNP O
pathologic NN O
staging VBG O
identifies NNS O
patients NNS O
who WP O
are VBP O
potentially RB O
curable JJ O
with IN O
radiotherapy NN O
. . O

Retrograde NNP O
filling VBG O
consists NNS O
in IN O
sealing VBG O
endodontics NNS O
system NN O
directly RB O
at IN O
the DT O
apical JJ O
zone NN O
after IN O
surgical JJ O
approach NN O
. . O

The DT O
gray JJ O
matter NN O
NAA NNP O
/ NNP O
mI NN O
ratio NN O
clearly RB O
separated VBD O
the DT O
two CD O
groups NNS O
. . O

L NNP O
- : O
canavanine NN O
, , O
a DT O
selective JJ O
inhibitor NN O
of IN O
the DT O
inducible JJ O
nitric JJ B-Gene
oxide NN I-Gene
synthase NN I-Gene
, , O
increases VBZ O
the DT O
mean JJ O
systemic JJ O
filling NN O
pressure NN O
, , O
thereby RB O
improving VBG O
venous JJ O
return NN O
, , O
under IN O
these DT O
conditions NNS O
. . O

The DT O
centromedial JJ O
amygdala NN O
and CC O
gastric JJ O
pathology NN O
in IN O
rats NNS O
. . O

Only RB O
two CD O
of IN O
the DT O
isoforms NNS O
possess VBP O
the DT O
N NNP O
- : O
terminal NN O
zinc NN O
finger NN O
domain NN O
that WDT O
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
TdT NNP B-Gene
promoter NN I-Gene
binding NN O
. . O

In IN O
both DT O
cities NNS O
, , O
HTLV NNP O
- : O
I PRP O
/ VBP O
II JJ O
prevalence NN O
increased VBD O
significantly RB O
with IN O
age NN O
, , O
and CC O
the DT O
New NNP O
Orleans NNP O
age NN O
- : O
and CC O
sex NN O
- : O
adjusted VBN O
HTLV NNP O
- : O
I PRP O
/ VBP O
II NNP O
prevalence NN O
was VBD O
significantly RB O
higher JJR O
than IN O
that DT O
of IN O
Baltimore NNP O
( ( O
P NNP O
less JJR O
than IN O
. . O
1 CD O
) ) O
. . O

Moreover RB O
, , O
PTax NNP B-Gene
expressed VBD O
higher JJR O
background NN O
activities NNS O
than IN O
PTF NNP B-Gene
, , O
indicating VBG O
that IN O
the DT O
sequence NN O
of IN O
the DT O
synthetic JJ O
regulatory JJ O
region NN O
can MD O
influence VB O
background NN O
levels NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
members NNS O
of IN O
the DT O
ATF NNP B-Gene
family NN I-Gene
are VBP O
involved VBN O
in IN O
mediating VBG O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
KGF NNP B-Gene
gene NN I-Gene
in IN O
response NN O
to TO O
extracellular JJ O
stimuli NNS O
via IN O
a DT O
novel JJ O
CRE NNP O
regulatory JJ O
element NN O
. . O

Previous JJ O
transactivation NN O
experiments NNS O
indicated VBD O
that IN O
three CD O
amino NN O
acids NNS O
residing VBG O
in IN O
this DT O
region NN O
, , O
Gly NNP O
, , O
Ser NNP O
and CC O
Val NNP O
, , O
appear VBP O
to TO O
be VB O
critical JJ O
for IN O
target NN O
- : O
site NN O
discrimination NN O
. . O

CONCLUSION NN O
: : O
The DT O
alpha2 NN O
- : O
adrenergic JJ O
antagonist JJ O
idazoxan NN O
increases NNS O
glucose VBP O
- : O
induced JJ O
sympathetic JJ O
activity NN O
but CC O
not RB O
energy NN O
expenditure NN O
in IN O
obese JJ O
subjects NNS O
. . O

E2F NNP B-Gene
- : I-Gene
6 CD I-Gene
shares NNS O
significant JJ O
homology NN O
with IN O
E2Fs NNP B-Gene
1 CD I-Gene
- : I-Gene
5 CD I-Gene
, , O
especially RB O
within IN O
the DT O
DNA NN O
binding NN O
, , O
heterodimerization NN O
and CC O
marked VBD O
box NN O
domains NNS O
. . O

Therefore RB O
, , O
the DT O
amino NN O
- : O
terminal JJ O
sequence NN O
of IN O
the DT O
purified JJ O
carA NN B-Gene
product NN I-Gene
is VBZ O
identical JJ O
to TO O
that DT O
derived VBN O
from IN O
the DT O
nucleotide JJ O
sequence NN O
in IN O
both DT O
organisms NNS O
, , O
P NNP O
. . O
stutzeri VB O
having VBG O
four CD O
additional JJ O
amino NN O
acids NNS O
. . O

However RB O
, , O
calphostin JJ O
C NNP O
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
PKC NNP B-Gene
, , O
abolished VBD O
the DT O
TPA NNP O
- : O
induced JJ O
increase NN O
in IN O
CFI NNP B-Gene
mRNA NN I-Gene
levels NNS O
. . O

The DT O
NR2 NNP O
hybrid NN O
is VBZ O
a DT O
powerful JJ O
tool NN O
for IN O
the DT O
mapping NN O
of IN O
new JJ O
probes NNS O
of IN O
this DT O
region NN O
, , O
as RB O
well RB O
as IN O
for IN O
obtaining VBG O
new JJ O
informative JJ O
probes NNS O
specific JJ O
for IN O
the DT O
deletion NN O
by IN O
subtractive JJ O
cloning NN O
of IN O
the DT O
region NN O
. . O

Genetic NNP O
and CC O
molecular JJ O
complexity NN O
of IN O
the DT O
position NN O
effect NN O
variegation NN O
modifier NN O
mod NN B-Gene
( ( O
mdg4 NN B-Gene
) ) O
in IN O
Drosophila NNP O
. . O

mod NN B-Gene
( ( O
mdg4 NN B-Gene
) ) O
, , O
also RB O
known VBN O
as IN O
E NNP B-Gene
( ( I-Gene
var NN I-Gene
) ) I-Gene
3 CD I-Gene
- : I-Gene
93D CD I-Gene
, , O
is VBZ O
involved VBN O
in IN O
a DT O
variety NN O
of IN O
processes NNS O
, , O
such JJ O
as IN O
gene NN O
silencing VBG O
in IN O
position NN O
effect NN O
variegation NN O
( ( O
PEV NNP O
) ) O
, , O
the DT O
control NN O
of IN O
gypsy NN B-Gene
insulator NN I-Gene
sequences NNS I-Gene
, , O
regulation NN O
of IN O
homeotic JJ B-Gene
gene NN I-Gene
expression NN O
, , O
and CC O
programmed VBD O
cell NN O
death NN O
. . O

A DT O
rat NN O
cDNA NN O
that WDT O
encodes VBZ O
eIF SYM B-Gene
- : I-Gene
5 CD I-Gene
has VBZ O
been VBN O
isolated VBN O
and CC O
expressed VBN O
in IN O
Escherichia NNP O
coli NN O
to TO O
yield VB O
a DT O
catalytically RB O
active JJ O
eIF SYM B-Gene
- : I-Gene
5 CD I-Gene
protein NN I-Gene
. . O

Examples NNS O
are VBP O
using VBG O
more RBR O
subjects NNS O
or CC O
an DT O
improved JJ O
research NN O
design NN O
, , O
developing VBG O
consensus NN O
statements NNS O
or CC O
using VBG O
meta JJ O
- : O
analysis NN O
. . O

The DT O
antibodies NNS O
inhibited VBN O
specifically RB O
the DT O
transcription NN O
of IN O
DNA NNP B-Gene
polymerase NN I-Gene
alpha NN I-Gene
promoter NN O
in IN O
vitro NN O
. . O

The DT O
Hagen NNP O
- : O
Poiseuille NNP O
equation NN O
is VBZ O
used VBN O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
attached JJ O
parasites NNS O
in IN O
the DT O
foregut NN O
of IN O
Leishmania NNP O
- : O
infected JJ O
sandflies NNS O
on IN O
blood NN O
flow NN O
. . O

Among IN O
the DT O
few JJ O
proteins NNS O
of IN O
the DT O
eukaryotic JJ O
nucleolus NN O
that WDT O
have VBP O
been VBN O
characterized VBN O
, , O
four CD O
proteins NNS O
, , O
nucleolin RB B-Gene
, , O
fibrillarin NN B-Gene
, , O
SSB1 NNP B-Gene
and CC O
NSR1 NNP B-Gene
, , O
possess NN O
a DT O
common JJ O
structural JJ O
motif NN O
, , O
the DT O
GAR NNP O
domain NN O
, , O
which WDT O
is VBZ O
rich JJ O
in IN O
glycine NN O
and CC O
arginine NN O
residues NNS O
. . O

Total JJ O
cumulative JJ O
doses NNS O
of IN O
doxorubicin NNS O
ranged VBN O
from IN O
145 CD O
to TO O
625 CD O
mg NN O
. . O
/ JJ O
m NN O
. . O
2 CD O
. . O

Influence NN O
of IN O
diet NN O
on IN O
urinary JJ O
VMA NNP O
excretion NN O
. . O

REV NN O
I PRP O
: : O
All DT O
vessels NNS O
up IN O
to TO O
50 CD O
% NN O
stenosed VBN O
have VBP O
a DT O
patent NN O
graft NN O
. . O

Through IN O
transient JJ O
transfection NN O
of IN O
NIH3T3 NNP O
fibroblast NN O
cells NNS O
and CC O
gel JJ O
mobility NN O
shift NN O
assays NNS O
, , O
the DT O
functional JJ O
binding NN O
site NN O
was VBD O
localized VBN O
to TO O
a DT O
short JJ O
region NN O
( ( O
- : O
318 CD O
to TO O
- : O
303 CD O
bp NN O
from IN O
the DT O
transcription NN O
start VB O
site NN O
) ) O
which WDT O
has VBZ O
a DT O
CTCCC NNP O
sequence NN O
. . O

The DT O
mean JJ O
value NN O
of IN O
the DT O
CD79b NNP B-Gene
to TO O
the DT O
CD79b NNP B-Gene
internally RB O
deleted VBD O
ratio NN O
was VBD O
0 CD O
. . O
64 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
20 CD O
SD NNP O
in IN O
normal JJ O
donors NNS O
and CC O
0 CD O
. . O
44 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
27 CD O
SD NNP O
in IN O
B NNP O
- : O
CLL NNP O
( ( O
P NNP O
= NNP O
. . O
1 CD O
) ) O
. . O

Concomitant NNP O
chronic JJ O
lymphocytic JJ O
leukemia NN O
, , O
acute JJ O
myeloid NN O
leukemia NN O
, , O
and CC O
thrombosis NN O
with IN O
protein JJ B-Gene
C NNP I-Gene
deficiency NN O
. . O

GAP NNP B-Gene
- : I-Gene
N NNP I-Gene
bound VBD O
constitutively RB O
to TO O
p190 VB B-Gene
in IN O
both DT O
serum JJ O
- : O
deprived VBN O
and CC O
growth NN O
factor NN O
- : O
stimulated JJ O
cells NNS O
. . O

The DT O
technical JJ O
construction NN O
of IN O
the DT O
mouth NN O
protectors NNS O
is VBZ O
illustrated JJ O
, , O
as IN O
is VBZ O
the DT O
need NN O
for IN O
instrumentation NN O
and CC O
its PRP$ O
costs NNS O
and CC O
the DT O
materials NNS O
required VBN O
to TO O
manufacture VB O
these DT O
mouth JJ O
protectors NNS O
. . O

First RB O
, , O
a DT O
pet54 NN B-Gene
: : O
: : O
LEU2 NNP B-Gene
cytoductant NN O
bearing VBG O
the DT O
' '' O
short JJ O
' POS O
mitochondrial JJ O
genome NN O
that WDT O
lacks VBZ O
both DT O
COX1 NNP B-Gene
introns NNS I-Gene
aI5 VBP B-Gene
alpha NN I-Gene
and CC O
aI5 NN B-Gene
beta NN I-Gene
is VBZ O
defective JJ O
only RB O
in IN O
COX3 NNP B-Gene
gene NN I-Gene
expression NN O
and CC O
not RB O
in IN O
COX1 NNP B-Gene
mRNA NN I-Gene
splicing NN O
or CC O
mRNA JJ O
translation NN O
. . O

The DT O
patient NN O
' POS O
s JJ O
role NN O
, , O
organized VBN O
by IN O
the DT O
prerequisites NNS O
of IN O
expressive JJ O
freedom NN O
, , O
is VBZ O
counter RB O
posed VBN O
with IN O
the DT O
psychoanalyst NN O
' POS O
s NN O
, , O
which WDT O
is VBZ O
structured VBN O
to TO O
empower VB O
listening NN O
and CC O
understanding NN O
. . O

A DT O
novel JJ O
phosphotyrosine NN O
- : O
binding NN O
domain NN O
in IN O
the DT O
N NNP O
- : O
terminal NN O
transforming VBG O
region NN O
of IN O
Cbl NNP B-Gene
interacts NNS O
directly RB O
and CC O
selectively RB O
with IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
in IN O
T NNP O
cells NNS O
. . O

GCD10 NNP B-Gene
binds VBZ O
RNA NNP O
in IN O
vitro NN O
and CC O
we PRP O
present VBP O
strong JJ O
biochemical JJ O
evidence NN O
that IN O
it PRP O
is VBZ O
identical JJ O
to TO O
the DT O
RNA NNP O
- : O
binding VBG O
subunit NN O
of IN O
yeast JJ B-Gene
initiation NN I-Gene
factor NN I-Gene
- : I-Gene
3 CD I-Gene
( ( O
eIF SYM B-Gene
- : I-Gene
3 CD I-Gene
) ) O
. . O

eIF SYM B-Gene
- : I-Gene
3 CD I-Gene
is VBZ O
a DT O
multisubunit NN O
complex NN O
that WDT O
stimulates VBZ O
translation NN O
initiation NN O
in IN O
vitro NN O
at IN O
several JJ O
different JJ O
steps NNS O
. . O

Its PRP$ O
expression NN O
pattern NN O
is VBZ O
representative JJ O
of IN O
many JJ O
B NNP O
cell NN O
- : O
specific JJ O
proteins NNS O
, , O
which WDT O
are VBP O
essential JJ O
for IN O
B NNP O
cell NN O
development NN O
and CC O
activation NN O
but CC O
are VBP O
down RP O
- : O
regulated VBN O
after IN O
B NNP O
cells NNS O
become VBP O
terminally RB O
differentiated JJ O
plasma NN O
cells NNS O
. . O

Overexpression NN O
of IN O
SCS1 NNP B-Gene
could MD O
not RB O
complement VB O
an DT O
HSP60 NNP B-Gene
- : I-Gene
null NN I-Gene
allele NN I-Gene
, , O
indicating VBG O
that IN O
suppression NN O
was VBD O
not RB O
due JJ O
to TO O
the DT O
bypassing NN O
of IN O
Hsp60 NNP B-Gene
activity NN O
. . O

Administration NN O
of IN O
adrenaline NN O
resulted VBN O
in IN O
a DT O
large JJ O
overestimation NN O
of IN O
the DT O
SaO2 NNP O
in IN O
6 CD O
of IN O
the DT O
7 CD O
measurements NNS O
. . O

During IN O
challenge NN O
, , O
rebiopsy NN O
was VBD O
done VBN O
when WRB O
reticulin NN B-Gene
antibodies NNS I-Gene
turned VBD O
positive JJ O
( ( O
mean JJ O
0 CD O
. . O
6 CD O
years NNS O
, , O
range NN O
0 CD O
. . O
2 CD O
- : O
2 CD O
. . O
0 CD O
) ) O
or CC O
at IN O
the DT O
end NN O
of IN O
the DT O
two CD O
year NN O
study NN O
. . O

Postdocs NNP O
face NN O
hardship NN O
across IN O
mainland NNP O
Europe NNP O
. . O

Seventy NNP O
- : O
one CD O
percent NN O
of IN O
patients NNS O
treated VBN O
with IN O
ticarcillin NN O
alone RB O
responded VBD O
favorably RB O
. . O

Significance NN O
of IN O
delta JJ O
- : O
aminolevulinic JJ O
acid NN O
analysis NN O
in IN O
clinical JJ O
tests NNS O

Alternatively RB O
, , O
loss NN O
- : O
of IN O
- : O
function NN O
alleles NNS O
of IN O
genes NNS O
that WDT O
inhibit VBP O
cAPK JJ B-Gene
lead NN O
to TO O
the DT O
inability NN O
to TO O
undergo VB O
sexual JJ O
differentiation NN O
. . O

The DT O
effect NN O
of IN O
the DT O
Ca NNP O
entry NN O
blocker NN O
nitrendipine NN O
, , O
the DT O
antioxidant JJ O
superoxide NN B-Gene
dismutase NN I-Gene
( ( O
SOD NNP B-Gene
) ) O
, , O
and CC O
a DT O
combination NN O
of IN O
nitrendipine NN O
and CC O
superoxide JJ B-Gene
dismutase NN I-Gene
on IN O
postischemic JJ O
renal JJ O
function NN O
was VBD O
studied VBN O
in IN O
four CD O
groups NNS O
( ( O
n JJ O
= NNP O
24 CD O
) ) O
of IN O
rats NNS O
. . O

Both DT O
domains NNS O
were VBD O
required VBN O
for IN O
specific JJ O
DNA NNP O
binding NN O
to TO O
the DT O
beta NN B-Gene
- : I-Gene
retinoic NN I-Gene
acid NN I-Gene
receptor NN I-Gene
element NN I-Gene
, , O
producing VBG O
a DT O
DNase NNP B-Gene
I PRP I-Gene
footprint VBP O
covering VBG O
predominantly RB O
one CD O
strand NN O
. . O

In IN O
Mv1Lu NNP O
lung NN O
epithelial JJ O
cells NNS O
, , O
ActR NNP B-Gene
- : I-Gene
IB NN I-Gene
and CC O
T NNP B-Gene
beta NN I-Gene
R NNP I-Gene
- : I-Gene
I PRP I-Gene
signal VBP O
a DT O
common JJ O
set NN O
of IN O
growth NN O
- : O
inhibitory NN O
and CC O
transcriptional JJ O
responses NNS O
in IN O
association NN O
with IN O
their PRP$ O
corresponding JJ O
ligands NNS O
and CC O
type NN B-Gene
II NNP I-Gene
receptors NNS I-Gene
. . O

These DT O
changes NNS O
may MD O
be VB O
the DT O
result NN O
of IN O
, , O
on IN O
the DT O
one CD O
hand NN O
, , O
an DT O
increased JJ O
sensitivity NN O
of IN O
the DT O
neuromuscular JJ O
transmission NN O
and CC O
/ NN O
or CC O
decreased VBN O
muscle NN O
contractility NN O
and CC O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
result NN O
of IN O
a DT O
reduced JJ O
plasma JJ O
clearance NN O
during IN O
hypothermia NN O
. . O

Study NN O
on IN O
the DT O
evagination NN O
of IN O
Cysticercus NNP O
pisiformis NN O
. . O

RESULTS NN O
: : O
In IN O
vivo NN O
, , O
there EX O
was VBD O
a DT O
wide JJ O
distribution NN O
with IN O
the DT O
coefficient NN O
of IN O
variation NN O
( ( O
SD NNP O
/ NNP O
mean VBP O
x JJ O
100 CD O
% NN O
) ) O
for IN O
different JJ O
valve NN O
sizes NNS O
ranging VBG O
from IN O
21 CD O
% NN O
to TO O
39 CD O
% NN O
in IN O
the DT O
St NNP O
Jude NNP O
Medical NNP O
valve NN O
and CC O
from IN O
25 CD O
% NN O
to TO O
33 CD O
% NN O
in IN O
the DT O
Omnicarbon NNP O
valve NN O
. . O

The DT O
proposed VBN O
algorithm NN O
consists VBZ O
of IN O
several JJ O
steps NNS O
. . O

In IN O
support NN O
of IN O
clinical JJ O
antianginal JJ O
studies NNS O
, , O
the DT O
vasodilator NN O
nicorandil NN O
( ( O
NIC NNP O
) ) O
was VBD O
combined VBN O
with IN O
the DT O
beta NN B-Gene
- : I-Gene
adrenergic JJ I-Gene
receptor NN I-Gene
antagonists NNS O
propranolol VBP O
( ( O
PRO NNP O
) ) O
and CC O
atenolol $ O
( ( O
ATN NNP O
) ) O
and CC O
with IN O
the DT O
calcium NN O
channel NN O
blocker NN O
diltiazem NN O
( ( O
DTZ NNP O
) ) O
to TO O
determine VB O
their PRP$ O
cardiovascular NN O
and CC O
pharmacokinetic JJ O
interactions NNS O
. . O

Proceedings NNS O
: : O
Reversible JJ O
complete JJ O
heart NN O
block NN O
following VBG O
surgery NN O
of IN O
congenital JJ O
heart NN O
defects NNS O

Although IN O
isl JJ B-Gene
- : I-Gene
1 CD I-Gene
binds NNS O
to TO O
both DT O
the DT O
insulin NN B-Gene
and CC O
amylin JJ B-Gene
gene NN I-Gene
promoter NN I-Gene
elements NNS I-Gene
in IN O
vitro NN O
, , O
these DT O
sequences NNS O
display VBP O
marked JJ O
differences NNS O
in IN O
their PRP$ O
relative JJ O
transcriptional NN O
properties NNS O
when WRB O
ligated VBN O
adjacent NN O
to TO O
a DT O
heterologous JJ O
promoter NN O
and CC O
transfected VBD O
into IN O
InR1 NNP O
- : O
G9 NNP O
islet NN O
cells NNS O
. . O

Bacteriol NNP O
. . O

RESULTS NN O
: : O
Sixty NNP O
per IN O
cent NN O
of IN O
African JJ O
Americans NNPS O
exposed VBN O
in IN O
26 CD O
community NN O
outbreaks NNS O
were VBD O
TST NNP O
positive JJ O
compared VBN O
to TO O
only RB O
40 CD O
% NN O
of IN O
whites NNS O
following VBG O
comparable JJ O
exposures NNS O
. . O

Its PRP$ O
cognate NN O
binding NN O
protein NN O
, , O
REST NNP B-Gene
/ NNP O
NRSF NNP B-Gene
, , O
is VBZ O
an DT O
essential JJ O
transcription NN O
factor NN O
; : O
its PRP$ O
null JJ O
mutations NNS O
result VBP O
in IN O
embryonic JJ O
lethality NN O
, , O
and CC O
its PRP$ O
dominant JJ O
negative JJ O
mutants NNS O
produce VBP O
aberrant JJ O
expression NN O
of IN O
neuron NN O
- : O
specific JJ O
genes NNS O
. . O

Previous JJ O
studies NNS O
demonstrated VBD O
that IN O
the DT O
flavin JJ B-Gene
- : I-Gene
containing NN I-Gene
monooxygenases NNS I-Gene
( ( O
FMO NNP B-Gene
) ) O
are VBP O
expressed VBN O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
manner NN O
. . O

The DT O
method NN O
has VBZ O
been VBN O
routinely RB O
used VBN O
in IN O
our PRP$ O
laboratory NN O
for IN O
1 CD O
year NN O
and CC O
has VBZ O
proven VBN O
to TO O
be VB O
a DT O
reliable JJ O
procedure NN O
for IN O
the DT O
biological JJ O
control NN O
of IN O
occupational JJ O
exposure NN O
to TO O
toluene VB O
and CC O
/ VB O
or CC O
xylene VB O
. . O

The DT O
coating NN O
materials NNS O
were VBD O
poloxamine JJ O
904 CD O
, , O
poloxamine NN O
908 CD O
, , O
poloxamine NN O
1508 CD O
, , O
poloxamer VBZ O
338 CD O
, , O
and CC O
Brij NNP O
35 CD O
. . O

Several JJ O
dozen NN O
HIF NNP B-Gene
- : I-Gene
1 CD I-Gene
targets NNS I-Gene
are VBP O
known VBN O
, , O
including VBG O
the DT O
gene NN O
encoding VBG O
vascular JJ B-Gene
endothelial JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
VEGF NNP B-Gene
) ) O
. . O

Characterization NN O
and CC O
hormonal JJ O
regulation NN O
of IN O
the DT O
promoter NN O
of IN O
the DT O
rat NN B-Gene
prostaglandin NN I-Gene
endoperoxide IN I-Gene
synthase NN I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
granulosa JJ O
cells NNS O
. . O

Transcription NN O
of IN O
the DT O
six CD O
EBNA NNP B-Gene
genes NNS I-Gene
, , O
which WDT O
are VBP O
expressed VBN O
in IN O
EBV NNP O
- : O
immortalized JJ O
primary NN O
B NNP O
cells NNS O
, , O
arises NNS O
from IN O
one CD O
of IN O
two CD O
promoters NNS O
, , O
Cp NNP B-Gene
and CC O
Wp NNP B-Gene
, , O
located VBN O
near IN O
the DT O
left JJ O
end NN O
of IN O
the DT O
viral JJ O
genome NN O
. . O

The DT O
ZNF274 NNP B-Gene
gene NN I-Gene
is VBZ O
mapped VBN O
distal JJ O
to TO O
marker VB O
RP NNP O
S28 NNP O
1 CD O
in IN O
the DT O
human JJ O
chromosome NN O
19qter CD O
region NN O
, , O
by IN O
RH NNP O
mapping NN O
. . O

The DT O
status NN O
of IN O
education NN O
and CC O
training NN O
programs NNS O
in IN O
speech NN O
pathology NN O
and CC O
audiology NN O
- : O
- : O
1971 CD O
- : O
72 CD O
. . O

An DT O
N NNP O
- : O
terminal JJ O
arm NN O
from IN O
each DT O
subunit NN O
wraps VBZ O
around IN O
the DT O
dinucleotide NN O
- : O
binding NN O
domain NN O
of IN O
an DT O
adjacent JJ O
subunit NN O
, , O
covering VBG O
the DT O
adenine JJ O
ring NN O
of IN O
NADP NNP O
. . O

Treatment NN O
also RB O
led VBD O
to TO O
a DT O
significant JJ O
dose JJ O
dependent JJ O
reduction NN O
in IN O
the DT O
sum NN O
of IN O
ST NNP O
segment NN O
depression NN O
at IN O
both DT O
trough NN O
and CC O
peak JJ O
concentrations NNS O
. . O

DNA NN O
methylation NN O
, , O
especially RB O
of IN O
either CC O
one CD O
or CC O
both DT O
of IN O
the DT O
deoxyadenosines NNS O
at IN O
the DT O
two CD O
GATC NNP O
motifs NNS O
( ( O
one CD O
in IN O
the DT O
first JJ O
exon NN O
and CC O
the DT O
other JJ O
in IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
rice NN O
CatA NNP B-Gene
gene NN I-Gene
) ) O
, , O
appeared VBD O
to TO O
be VB O
responsible JJ O
for IN O
the DT O
CatA NNP B-Gene
promoter NN I-Gene
activity NN O
identified VBN O
in IN O
the DT O
transient NN O
assay NN O
. . O

The DT O
long JJ O
- : O
term NN O
prediction NN O
is VBZ O
based VBN O
on IN O
an DT O
algorithm NN O
for IN O
R NNP O
- : O
R NN O
interval JJ O
estimation NN O
. . O

In IN O
budding VBG O
yeast NN O
, , O
the DT O
protein NN O
Skp1p NNP B-Gene
, , O
the DT O
cullin NN B-Gene
- : I-Gene
family NN I-Gene
member NN I-Gene
Cdc53p NNP B-Gene
, , O
and CC O
the DT O
F NNP O
- : O
box NN O
/ NN O
WD NNP O
- : O
repeat NN O
protein NN O
Cdc4p NNP B-Gene
form VBZ O
the DT O
SCFCdc4p NNP B-Gene
ubiquitin JJ B-Gene
ligase NN I-Gene
complex NN O
, , O
which WDT O
targets VBZ O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
( ( O
Cdk NNP B-Gene
) ) O
inhibitor NN O
Sic1p NNP B-Gene
for IN O
proteolysis NN O
[ $ O
3 CD O
] NNP O
[ VBD O
4 CD O
] NNP O
[ VBD O
5 CD O
] NNP O
[ VBD O
6 CD O
] NNP O
[ VBD O
7 CD O
] NNP O
[ VBD O
8 CD O
] NN O
. . O

This DT O
caused VBD O
severe JJ O
cortical JJ O
damage NN O
and CC O
neuronal JJ O
loss NN O
in IN O
hippocampus NN O
subfields NNS O
CA1 NNP O
, , O
CA3 NNP O
, , O
and CC O
hilus NN O
. . O

Comparison NNP O
of IN O
the DT O
nucleotide JJ O
sequences NNS O
between IN O
the DT O
human JJ O
and CC O
bovine NN O
DNA NN O
showed VBD O
that IN O
the DT O
sequence NN O
similarity NN O
extended VBD O
2400 CD O
bp NN O
downstream NN O
from IN O
the DT O
coding VBG O
region NN O
. . O

The DT O
rad9 NN B-Gene
. . I-Gene
192 CD I-Gene
DNA NNP I-Gene
repair NN I-Gene
mutant NN I-Gene
from IN I-Gene
the DT I-Gene
fission NN I-Gene
yeast NN I-Gene
, , I-Gene
Schizosaccharomyces NNP I-Gene
pombe NN I-Gene
, , O
is VBZ O
sensitive JJ O
to TO O
both DT O
UV NNP O
and CC O
ionising VBG O
radiation NN O
. . O

Measurements NNS O
were VBD O
obtained VBN O
: : O
( ( O
i NN O
) ) O
just RB O
after IN O
the DT O
traumatic JJ O
exposure NN O
( ( O
D0 NNP O
) ) O
; : O
( ( O
ii NN O
) ) O
3 CD O
days NNS O
after IN O
this DT O
first JJ O
measurement NN O
( ( O
D3 NNP O
) ) O
; : O
and CC O
( ( O
iii NN O
) ) O
30 CD O
days NNS O
after IN O
( ( O
D30 NNP O
) ) O
. . O

Northern NNP O
blot NN O
analysis NN O
of IN O
LeMT NNP B-Gene
( ( I-Gene
A NNP I-Gene
) ) I-Gene
and CC O
LeMT NNP B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
showed VBD O
that IN O
transcripts NNS O
of IN O
both DT O
MT NNP B-Gene
- : I-Gene
like IN I-Gene
genes NNS I-Gene
were VBD O
more RBR O
abundant JJ O
in IN O
leaves NNS O
than IN O
roots NNS O
in IN O
tomato NN O
plants NNS O
grown VBN O
without IN O
addition NN O
of IN O
extra JJ O
metal NN O
ions NNS O
, , O
a DT O
characteristic NN O
of IN O
type NN B-Gene
II NNP I-Gene
MTs NNP I-Gene
. . O

Its PRP$ O
application NN O
in IN O
Madagascar NNP O
: : O
advantages NNS O
and CC O
disadvantages NNS O

Recombinant JJ B-Gene
human JJ I-Gene
serum NN I-Gene
albumin NN I-Gene
( ( O
rHSA NN B-Gene
) ) O
produced VBN O
by IN O
cultured JJ O
fermentation NN O
has VBZ O
been VBN O
prepared VBN O
in IN O
the DT O
form NN O
of IN O
microcapsules NNS O
nominally RB O
3 CD O
- : O
5 CD O
microns NNS O
in IN O
diameter NN O
and CC O
radiolabelled VBN O
with IN O
technetium NN O
- : O
99m CD O
following VBG O
reduction NN O
with IN O
stannous JJ O
chloride NN O
. . O

19 CD O
- : O
32 CD O
. . O

METHODS NN O
: : O
126 CD O
patients NNS O
with IN O
histologically RB O
confirmed VBN O
MFH NNP O
were VBD O
analyzed VBN O
. . O

Statistics NNS O
for IN O
nurse NN O
managers NNS O
- : O
- : O
3 CD O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
the DT O
STR NNP B-Gene
family NN I-Gene
of IN O
genes NNS O
is VBZ O
represented VBN O
in IN O
a DT O
nematode NN O
whose WP$ O
ancestor NN O
appeared VBD O
well RB O
before IN O
the DT O
branching NN O
that WDT O
gave VBD O
rise NN O
to TO O
the DT O
Arthropoda NNP O
and CC O
Chordata NNP O
. . O

The DT O
physical JJ O
linkage NN O
of IN O
the DT O
FHR2 NNP B-Gene
and CC O
the DT O
factor NN B-Gene
H NNP I-Gene
genes NNS I-Gene
provides VBZ O
additional JJ O
evidence NN O
for IN O
a DT O
close JJ O
relatedness NN O
of IN O
complement JJ B-Gene
factor NN I-Gene
H NNP I-Gene
and CC O
the DT O
factor NN B-Gene
H NNP I-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
. . O

A DT O
patient NN O
with IN O
an DT O
infected JJ O
wound NN O
or CC O
one CD O
on IN O
a DT O
primary JJ O
area NN O
( ( O
hands NNS O
, , O
feet NNS O
, , O
face NN O
, , O
or CC O
perineum NN O
) ) O
may MD O
have VB O
to TO O
be VB O
hospitalized VBN O
to TO O
ensure VB O
proper JJ O
care NN O
. . O

The DT O
RFX NNP B-Gene
protein VBD I-Gene
family NN I-Gene
includes VBZ O
members NNS O
from IN O
yeast NN O
to TO O
humans NNS O
, , O
which WDT O
function NN O
in IN O
various JJ O
biological JJ O
systems NNS O
, , O
and CC O
share NN O
a DT O
DNA NNP O
- : O
binding NN O
domain NN O
and CC O
a DT O
conserved JJ O
C NNP O
- : O
terminal JJ O
region NN O
. . O

Organization NN O
of IN O
the DT O
bovine NN O
gene NN O
encoding VBG O
the DT O
endothelial JJ B-Gene
nitric JJ I-Gene
oxide NN I-Gene
synthase NN I-Gene
. . O

Autopsy NNP O
demonstrated VBD O
good JJ O
survival NN O
of IN O
the DT O
transplanted JJ O
cells NNS O
with IN O
good JJ O
integration NN O
with IN O
the DT O
brain NN O
of IN O
the DT O
recipient NN O
and CC O
traces NNS O
of IN O
positive JJ O
immunocytochemical JJ O
reaction NN O
for IN O
tyrosine JJ B-Gene
hydroxylase NN I-Gene
. . O

Overproduction NN O
of IN O
HrcA NNP B-Gene
protein NN I-Gene
from IN O
a DT O
second JJ O
copy NN O
of IN O
hrcA NN B-Gene
derived VBN O
from IN O
a DT O
plasmid NN O
( ( O
phrcA JJ B-Gene
+ NN O
) ) O
in IN O
B NNP O
. . O
subtilis NN O
wild JJ O
- : O
type NN O
and CC O
delta NN O
hrcA NN B-Gene
strains NNS O
prevented VBD O
heat NN O
shock NN O
induction NN O
of IN O
the DT O
dnaK NN B-Gene
and CC O
groE JJ B-Gene
operons NNS I-Gene
at IN O
the DT O
level NN O
of IN O
transcription NN O
almost RB O
completely RB O
and CC O
strongly RB O
reduced VBD O
the DT O
amounts NNS O
of IN O
mRNA NN O
at IN O
a DT O
low JJ O
temperature NN O
as RB O
well RB O
. . O

Inhibition NN O
of IN O
the DT O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
kinase NN I-Gene
by IN O
cyclic JJ O
AMP NNP O
agonists VBZ O
causes VBZ O
apoptosis NN O
of IN O
v JJ B-Gene
- : I-Gene
abl NN I-Gene
- : O
transformed JJ O
cells NNS O
. . O

We PRP O
reviewed VBD O
the DT O
records NNS O
of IN O
151 CD O
patients NNS O
with IN O
optic JJ O
neuritis NN O
examined VBD O
over IN O
an DT O
eight CD O
- : O
year NN O
period NN O
. . O

Although IN O
inactive JJ O
in IN O
cells NNS O
under IN O
normal JJ O
conditions NNS O
, , O
the DT O
CHOP NNP B-Gene
gene NN I-Gene
is VBZ O
markedly RB O
induced VBN O
by IN O
a DT O
variety NN O
of IN O
cellular JJ O
stresses NNS O
, , O
including VBG O
nutrient JJ O
deprivation NN O
and CC O
metabolic JJ O
perturbations NNS O
. . O

Among IN O
blood NN O
donors NNS O
in IN O
the DT O
Republic NNP O
of IN O
Serbia NNP O
, , O
regardless RB O
the DT O
number NN O
of IN O
blood NN O
donations NNS O
, , O
the DT O
percentage NN O
of IN O
female JJ O
donors NNS O
is VBZ O
significantly RB O
lower JJR O
compared VBN O
to TO O
the DT O
percentage NN O
of IN O
male NN O
blood NN O
donors NNS O
. . O

The DT O
gp330 NN B-Gene
/ NNP O
Megalin NNP B-Gene
/ NNP O
LRP NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN O
belongs NNS O
to TO O
the DT O
low JJ B-Gene
- : I-Gene
density NN I-Gene
lipoprotein NN I-Gene
receptor NN I-Gene
gene NN I-Gene
family NN I-Gene
and CC O
is VBZ O
believed VBN O
to TO O
function VB O
as IN O
an DT O
endocytic JJ O
receptor NN O
for IN O
the DT O
uptake NN O
of IN O
lipoproteins NNS O
and CC O
many JJ O
other JJ O
ligands NNS O
. . O

CONCLUSION NN O
: : O
More JJR O
than IN O
50 CD O
% NN O
of IN O
patients NNS O
with IN O
perennial JJ O
rhinitis NN O
and CC O
CRS NNP O
do VBP O
not RB O
improve VB O
after IN O
surgery NN O
, , O
a DT O
response NN O
that WDT O
may MD O
be VB O
predicted VBN O
by IN O
more JJR O
cells NNS O
expressing VBG O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
mRNA NN I-Gene
in IN O
the DT O
ethmoid JJ O
sinuses NNS O
. . O

Monitoring VBG O
changes NNS O
in IN O
the DT O
heart NN O
rate NN O
of IN O
the DT O
premature NN O
fetus NN O
during IN O
tocolysis NN O
with IN O
the DT O
beta NN O
- : O
adrenomimetics NNS O
partusisten VBP O
and CC O
Pre NNP O
- : O
par NN O

The DT O
11 CD O
; : O
22 CD O
chromosomal JJ O
translocation NN O
specifically RB O
linked VBN O
to TO O
Ewing NNP O
sarcoma NN O
and CC O
primitive JJ O
neuroectodermal JJ O
tumor NN O
results NNS O
in IN O
a DT O
chimeric JJ O
molecule NN O
fusing VBG O
the DT O
amino NN O
- : O
terminal JJ O
- : O
encoding VBG O
portion NN O
of IN O
the DT O
EWS NNP B-Gene
gene NN I-Gene
to TO O
the DT O
carboxyl NN O
- : O
terminal NN O
DNA NNP O
- : O
binding NN O
domain NN O
encoded VBN O
by IN O
the DT O
FLI1 NNP B-Gene
gene NN I-Gene
. . O

Predictors NNS O
of IN O
success NN O
in IN O
pharmacy JJ O
school NN O
: : O
PCAT NNP O
vs NN O
. . O
other JJ O
admission NN O
criteria NNS O
. . O

Myocardial JJ O
interstitial JJ O
edema NN O
is VBZ O
more RBR O
likely JJ O
a DT O
potential JJ O
mechanism NN O
of IN O
diastolic JJ O
dysfunction NN O
after IN O
DC NNP O
shocks NNS O
. . O

Cognitive JJ O
visual JJ O
dysfunction NN O
in IN O
a DT O
child NN O
with IN O
cerebral JJ O
damage NN O
. . O

Rss1p NNP B-Gene
encodes VBZ O
a DT O
novel JJ O
essential JJ O
protein NN O
of IN O
538 CD O
amino NN O
acids NNS O
, , O
which WDT O
contains VBZ O
an DT O
extended JJ O
predicted VBD O
coiled JJ O
- : O
coil NN O
domain NN O
and CC O
is VBZ O
located VBN O
both DT O
at IN O
nuclear JJ O
pore NN O
complexes NNS O
( ( O
NPCs NNP O
) ) O
and CC O
in IN O
the DT O
cytoplasm NN O
. . O

Rep63A NNP B-Gene
( ( I-Gene
513 CD I-Gene
amino NN I-Gene
acids NNS I-Gene
[ VBP I-Gene
aa JJ I-Gene
] NN I-Gene
) ) I-Gene
, , O
encoded VBN O
by IN O
the DT O
largest JJS O
ORF NN O
, , O
displayed VBN O
strong JJ O
similarity NN O
( ( O
40 CD O
% NN O
identity NN O
) ) O
to TO O
the DT O
replication NN O
proteins VBZ O
from IN O
plasmids NNS O
pAMbeta1 NN O
, , O
pIP501 NN O
, , O
and CC O
pSM19035 NN O
, , O
indicating VBG O
that IN O
the DT O
pAW63 NN O
replicon NN O
belongs NNS O
to TO O
the DT O
pAMbeta1 JJ O
family NN O
of IN O
gram NN O
- : O
positive JJ O
theta NN O
- : O
replicating NN O
plasmids NNS O
. . O

In IN O
addition NN O
, , O
our PRP$ O
results NNS O
show VBP O
that IN O
ERKs NNP B-Gene
and CC O
PI3Ks NNP B-Gene
can MD O
synergise VB O
to TO O
convert VB O
ectoderm NN O
into IN O
mesoderm NN O
. . O

One CD O
enigmatic JJ O
aspect NN O
of IN O
GATA NNP B-Gene
factor NN I-Gene
expression NN O
is VBZ O
that IN O
several JJ O
GATA NNP B-Gene
proteins NNS I-Gene
, , O
which WDT O
ostensibly RB O
share NN O
the DT O
same JJ O
DNA NNP O
- : O
binding NN O
site NN O
specificity NN O
, , O
are VBP O
coexpressed VBN O
in IN O
erythroid JJ O
cells NNS O
. . O

The DT O
P NNP B-Gene
- : I-Gene
wr NN I-Gene
and CC O
P NNP B-Gene
- : I-Gene
rr NN I-Gene
cDNA NN I-Gene
sequences NNS I-Gene
are VBP O
very RB O
similar JJ O
in IN O
their PRP$ O
5 CD O
' POS O
regions NNS O
. . O

Biochemical JJ O
characterization NN O
of IN O
valosin NN B-Gene
- : I-Gene
containing NN I-Gene
protein NN I-Gene
, , O
a DT O
protein NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
substrate NN O
in IN O
hematopoietic JJ O
cells NNS O
. . O

Furthermore RB O
, , O
rhoA SYM B-Gene
- : O
mediated VBN O
SRE NNP O
activation NN O
was VBD O
blocked VBN O
by IN O
dominant JJ O
negative JJ O
mutants NNS O
of IN O
PKC NNP B-Gene
- : I-Gene
alpha NN I-Gene
or CC O
PKC NNP B-Gene
- : I-Gene
epsilon NN I-Gene
. . O

Identity NN O
of IN O
GABP NNP B-Gene
with IN O
NRF NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
a DT O
multisubunit NN O
activator NN O
of IN O
cytochrome JJ B-Gene
oxidase NN I-Gene
expression NN O
, , O
reveals VBZ O
a DT O
cellular JJ O
role NN O
for IN O
an DT O
ETS NNP B-Gene
domain NN I-Gene
activator NN O
of IN O
viral JJ O
promoters NNS O
. . O

The DT O
main JJ O
issues NNS O
are VBP O
the DT O
need NN O
to TO O
explain VB O
a DT O
number NN O
of IN O
still RB O
unknown JJ O
mechanisms NNS O
, , O
to TO O
determine VB O
which WDT O
"""" NNP O
natural JJ O
diet NN O
"""" NN O
carries VBZ O
the DT O
minimum JJ O
coronary JJ O
risk NN O
and CC O
whether IN O
"""" JJ O
new JJ O
"""" NNP O
foods NNS O
produced VBN O
by IN O
modern JJ O
technology NN O
are VBP O
really RB O
needed VBN O
to TO O
contrast VB O
this DT O
epidemic NN O
. . O

Paper NNP O
alert NN O
. . O

Polymerase NNP O
chain NN O
reaction NN O
analysis NN O
of IN O
ETS1 NNP B-Gene
cDNA NN I-Gene
identified VBD O
several JJ O
amplified JJ O
products NNS O
, , O
indicating VBG O
alternative JJ O
splicing NN O
. . O

Regional JJ O
blood NN O
blow NN O
was VBD O
measured VBN O
by IN O
means NNS O
of IN O
microspheres NNS O
in IN O
predefined JJ O
regions NNS O
of IN O
the DT O
C6 NNP O
, , O
T11 NNP O
, , O
and CC O
L6 NNP O
vertebrae NN O
. . O

Eight CD O
patients NNS O
with IN O
ARC NNP O
and CC O
renal JJ O
failure NN O
were VBD O
recently RB O
evaluated VBN O
. . O

This DT O
conclusion NN O
is VBZ O
based VBN O
on IN O
the DT O
observations NNS O
of IN O
the DT O
immunologic JJ O
changes NNS O
that WDT O
characterize VBP O
the DT O
acute JJ O
stages NNS O
of IN O
illness NN O
as RB O
well RB O
as IN O
on IN O
the DT O
demonstrated VBN O
association NN O
with IN O
toxin NN O
- : O
producing VBG O
bacteria NNS O
in IN O
the DT O
pharynx NN O
and CC O
gastrointestinal JJ O
tract NN O
. . O

Copyright JJ O
2000 CD O
Academic NNP O
Press NNP O
. . O

A DT O
model NN O
with IN O
age NN O
and CC O
weight NN O
described VBD O
the DT O
best JJS O
fit NN O
for IN O
TBBMD NNP O
, , O
whereas JJ O
age NN O
, , O
weight NN O
, , O
and CC O
height VBD O
described VBN O
the DT O
best JJS O
fit NN O
for IN O
total JJ O
body NN O
TBBMC NNP O
. . O

The DT O
ORF NNP O
was VBD O
analyzed VBN O
for IN O
secondary JJ O
structural JJ O
features NNS O
, , O
and CC O
the DT O
sequence NN O
data NNS O
bases NNS O
were VBD O
searched VBN O
for IN O
homologies NNS O
. . O

The DT O
intensity NN O
of IN O
myocardial JJ O
uptake NN O
of IN O
Tc NNP O
- : O
99m CD O
- : O
PYP NN O
in IN O
patients NNS O
with IN O
echocardiographic JJ O
left VBD O
ventricular JJ O
hypertrophy NN O
and CC O
/ NN O
or CC O
highly RB O
refractile JJ O
myocardial NN O
echoes NNS O
, , O
so IN O
- : O
called VBD O
granular JJ O
sparkling NN O
appearance NN O
( ( O
GS NNP O
) ) O
was VBD O
slightly RB O
greater JJR O
than IN O
that DT O
in IN O
patients NNS O
with IN O
neither DT O
myocardial JJ O
hypertrophy NN O
nor CC O
GS NNP O
. . O

We PRP O
have VBP O
addressed VBN O
these DT O
issues NNS O
by IN O
reconstituting VBG O
and CC O
characterizing VBG O
the DT O
KRAB NNP B-Gene
: : O
KAP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
RBCC NNP B-Gene
interaction NN O
using VBG O
purified JJ O
components NNS O
. . O

When WRB O
extracorporeal JJ O
CO2 NNP O
removal NN O
approximated VBD O
CO2 NNP O
production NN O
( ( O
VCO2 NNP O
) ) O
, , O
alveolar JJ O
ventilation NN O
almost RB O
ceased VBD O
. . O

Air NNP O
ion NN O
action NN O
on IN O
bacteria NNS O
. . O

A DT O
comprehensive JJ O
neuropsychological JJ O
battery NN O
was VBD O
administered VBN O
to TO O
48 CD O
veterans NNS O
with IN O
Gulf NNP O
War NNP O
Illness NNP O
( ( O
GWI NNP O
) ) O
characterized VBN O
by IN O
severe JJ O
fatigue NN O
( ( O
GV NNP O
- : O
F NN O
) ) O
and CC O
39 CD O
healthy JJ O
veterans NNS O
( ( O
GV NNP O
- : O
H NN O
) ) O
. . O

To TO O
test VB O
promotor NN O
function NN O
, , O
chimeric JJ O
genes NNS O
were VBD O
constructed VBN O
linking VBG O
fragments NNS O
of IN O
chicken NN O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
5 CD O
' '' O
- : O
flanking VBG O
DNA NN O
to TO O
a DT O
promoterless NN O
reporter NN O
plasmid NN O
. . O

Taken VBN O
together RB O
, , O
differences NNS O
in IN O
signaling VBG O
and CC O
tissue NN O
expression NN O
suggest VBP O
that IN O
the DT O
human JJ B-Gene
intermediate NN I-Gene
PRLr NNP I-Gene
differs NNS O
from IN O
the DT O
long JJ B-Gene
PRLr NNP I-Gene
in IN O
physiological JJ O
function NN O
. . O

CONCLUSIONS NN O
: : O
A DT O
50 CD O
- : O
mg JJ O
daily JJ O
dose NN O
of IN O
bicalutamide NN O
is VBZ O
sufficient JJ O
when WRB O
given VBN O
in IN O
combination NN O
with IN O
an DT O
agent NN O
, , O
such JJ O
as IN O
a DT O
LHRH NNP B-Gene
- : O
A NN O
, , O
that IN O
lowers NNS O
serum VBP O
testosterone NN O
, , O
but CC O
higher JJR O
doses NNS O
of IN O
bicalutamide NN O
may MD O
be VB O
needed VBN O
when WRB O
the DT O
drug NN O
is VBZ O
given VBN O
as IN O
monotherapy NN O
. . O

The DT O
"""" NN O
28 CD O
percent NN O
"""" NNP O
Venturi NNP O
mask NN O
in IN O
obstructive JJ O
airway NN O
disease NN O
. . O

To TO O
elucidate VB O
the DT O
regulatory JJ O
mechanism NN O
of IN O
human JJ B-Gene
AM NNP I-Gene
gene NN I-Gene
expression NN O
, , O
functional JJ O
elements NNS O
of IN O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
AM NNP B-Gene
gene NN I-Gene
were VBD O
studied VBN O
in IN O
human JJ O
aortic JJ O
endothelial NN O
cells NNS O
( ( O
HAEC NNP O
) ) O
. . O

These DT O
two CD O
mAbs NNS O
used VBD O
the DT O
same JJ O
V NNP O
( ( O
H NNP O
) ) O
and CC O
J NNP O
( ( O
H NNP O
) ) O
gene NN O
segments NNS O
, , O
but CC O
different JJ O
D NNP O
, , O
Vkappa NNP O
, , O
and CC O
Jkappa NNP O
genes NNS O
. . O

Three CD O
different JJ O
site NN O
- : O
directed JJ O
mutations NNS O
of IN O
the DT O
cyclic JJ O
AMP NNP O
response NN O
element NN O
each DT O
reduced VBD O
the DT O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
effect NN O
by IN O
> $ O
90 CD O
% NN O
. . O

Flurazepam NNP O
thus RB O
appears VBZ O
to TO O
be VB O
an DT O
effective JJ O
hypnotic JJ O
drug NN O
with IN O
the DT O
optimum NN O
dose NN O
for IN O
use NN O
in IN O
general JJ O
practice NN O
being VBG O
15 CD O
mg NN O
at IN O
night NN O
. . O

Expression NN O
of IN O
the DT O
CYP11A1 NNP B-Gene
gene NN I-Gene
is VBZ O
increased VBN O
by IN O
hormones NNS O
, , O
such JJ O
as IN O
adrenocorticotropin NN B-Gene
and CC O
luteinizing VBG B-Gene
hormone NN I-Gene
, , O
as RB O
well RB O
as IN O
by IN O
a DT O
number NN O
of IN O
growth NN O
factors NNS O
, , O
suggesting VBG O
that IN O
its PRP$ O
promoter NN O
may MD O
contain VB O
regulatory JJ O
elements NNS O
that WDT O
respond VBP O
to TO O
multiple VB O
signal JJ O
transduction NN O
pathways NNS O
. . O

The DT O
authors NNS O
concluded VBD O
that IN O
ultrasonic JJ O
Doppler NNP O
- : O
cardiography NN O
can MD O
be VB O
used VBN O
for IN O
measuring VBG O
the DT O
relative JJ O
changes NNS O
in IN O
the DT O
stroke NN O
volume NN O
. . O

Sings NNS O
which WDT O
are VBP O
indicative JJ O
of IN O
metaplastic JJ O
erythropoiesis NN O
are VBP O
absent JJ O
. . O

We PRP O
have VBP O
used VBN O
a DT O
full JJ O
- : O
length NN O
cDNA NN O
clone NN O
of IN O
a DT O
mouse NN O
hepatitis NN O
virus NN O
strain NN O
A59 NNP O
defective JJ O
interfering NN O
( ( O
DI NNP O
) ) O
RNA NNP O
, , O
pMIDI SYM B-Gene
- : I-Gene
C NNP I-Gene
, , O
and CC O
cassette NN O
mutagenesis NN O
to TO O
study VB O
the DT O
mechanism NN O
of IN O
coronavirus NN O
subgenomic JJ O
mRNA NN O
synthesis NN O
. . O

In IN O
contrast NN O
, , O
dig1 VBP B-Gene
dig2 JJ B-Gene
cells NNS O
constitutively RB O
invade VBP O
agar JJ O
medium NN O
, , O
whereas IN O
a DT O
dig1 NN B-Gene
dig2 NN B-Gene
ste12 NN B-Gene
triple JJ O
mutant NN O
does VBZ O
not RB O
, , O
indicating VBG O
that IN O
Dig1 NNP B-Gene
and CC O
Dig2 NNP B-Gene
share NN O
a DT O
role NN O
in IN O
negatively RB O
regulating VBG O
the DT O
invasive JJ O
growth NN O
pathway NN O
. . O

Depending VBG O
on IN O
treatment NN O
exposures NNS O
, , O
this DT O
at IN O
- : O
risk NN O
population NN O
may MD O
experience VB O
life NN O
- : O
threatening VBG O
late JJ O
effects NNS O
, , O
such JJ O
as IN O
cirrhosis NN O
secondary JJ O
to TO O
hepatitis VB O
C NNP O
or CC O
late JJ O
- : O
onset NN O
anthracycline NN O
- : O
induced VBN O
cardiomyopathy NN O
, , O
or CC O
life NN O
- : O
changing VBG O
late JJ O
effects NNS O
, , O
such JJ O
as IN O
cognitive JJ O
dysfunction NN O
. . O

The DT O
architecture NN O
of IN O
microvasculature NN O
in IN O
these DT O
two CD O
regions NNS O
was VBD O
also RB O
examined VBN O
by IN O
scanning VBG O
electron NN O
microscopy NN O
, , O
using VBG O
the DT O
resin NN O
casting VBG O
method NN O
. . O

However RB O
, , O
after IN O
repeated VBN O
infections NNS O
, , O
hypobiotic JJ O
larvae NN O
were VBD O
numerous JJ O
. . O

RESULTS NN O
: : O
Coronary JJ O
mortality NN O
during IN O
the DT O
median JJ O
follow NN O
- : O
up IN O
time NN O
of IN O
17 CD O
months NNS O
was VBD O
6 CD O
- : O
fold NN O
higher JJR O
in IN O
the DT O
highest JJS O
tertile NN O
for IN O
CRP NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
and CC O
3 CD O
. . O
5 CD O
- : O
fold NN O
higher JJR O
in IN O
the DT O
highest JJS O
tertile NN O
for IN O
fibrinogen NN B-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
than IN O
in IN O
the DT O
respective NN O
combined VBD O
lower JJR O
tertiles NNS O
. . O

Quinone SYM O
- : O
binding NN O
domain NN O
and CC O
amino NN O
acid NN O
residues NNS O
involved VBN O
in IN O
quinone NN O
binding NN O
. . O

These DT O
analyses NNS O
demonstrate VBP O
that IN O
the DT O
dUTPase NN B-Gene
isoforms NNS O
are VBP O
encoded VBN O
by IN O
the DT O
same JJ O
gene NN O
with IN O
isoform JJ O
- : O
specific JJ O
transcripts NNS O
arising VBG O
through IN O
the DT O
use NN O
of IN O
alternative JJ O
5 CD O
' POS O
exons NNS O
. . O

The DT O
gene NN O
organization NN O
of IN O
CRSV NNP B-Gene
RNA NNP I-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
similar JJ O
to TO O
those DT O
of IN O
red JJ O
clover NN O
necrotic JJ O
mosaic NN O
( ( O
RCNMV NNP O
) ) O
and CC O
sweet JJ O
clover NN O
necrotic JJ O
mosaic NN O
( ( O
SCNMV NNP O
) ) O
dianthoviruses VBZ O
with IN O
the DT O
exception NN O
that IN O
CRSV NNP B-Gene
RNA NNP I-Gene
- : I-Gene
1 CD I-Gene
contains VBZ O
the DT O
additional JJ O
3 CD O
' POS O
- : O
terminal NN O
ORF NNP O
. . O

The DT O
effect NN O
of IN O
low JJ O
- : O
profile NN O
serine NN O
substitutions NNS O
in IN O
the DT O
V3 NNP B-Gene
loop NN O
of IN O
HIV NNP O
- : O
1 CD O
gp120 NN B-Gene
IIIB NNP I-Gene
/ NNP O
LAI NNP B-Gene
on IN O
the DT O
immunogenicity NN O
of IN O
the DT O
envelope NN B-Gene
protein NN O
. . O

Hantaan NNP O
virus NN O
. . O

In IN O
addition NN O
, , O
lexical JJ O
priming NN O
was VBD O
examined VBN O
by IN O
presenting VBG O
an DT O
identity NN O
prime JJ O
earlier RBR O
in IN O
the DT O
text NN O
. . O

3 LS O
- : O
- : O
It PRP O
is VBZ O
necessary JJ O
to TO O
think VB O
about IN O
cosmetic JJ O
consequences NNS O
of IN O
the DT O
chinese JJ O
flap NN O
and CC O
consider VB O
other JJ O
possibilities NNS O
of IN O
the DT O
flap NN O
choice NN O
. . O

Expression NN O
of IN O
six CD O
genes NNS O
, , O
ipaB NN B-Gene
, , O
ipaC NN B-Gene
, , O
invE NN B-Gene
, , O
invG NN B-Gene
, , O
invJ NN B-Gene
, , O
and CC O
invK NN B-Gene
, , O
was VBD O
apparently RB O
regulated VBN O
by IN O
the DT O
positive JJ O
regulator NN O
virF NN B-Gene
. . O

This DT O
element NN O
, , O
termed VBD O
CREsp NNP O
- : O
a DT O
( ( O
TGACCTCA NNP O
) ) O
, , O
differs NNS O
by IN O
one CD O
nucleotide NN O
from IN O
a DT O
palindromic JJ O
CRE NNP O
( ( O
CREpal NNP O
, , O
TGACGTCA NNP O
) ) O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
bind VB O
CREB NNP B-Gene
as IN O
a DT O
homodimer NN O
. . O

The DT O
term NN O
osteomesopycnosis NN O
is VBZ O
proposed VBN O
for IN O
a DT O
sclerosing VBG O
bone NN O
disease NN O
with IN O
dominant JJ O
inheritance NN O
that WDT O
has VBZ O
been VBN O
discovered VBN O
in IN O
five CD O
members NNS O
of IN O
four CD O
different JJ O
families NNS O
. . O

Group NNP O
A NNP O
was VBD O
treated VBN O
with IN O
three CD O
or CC O
four CD O
doses NNS O
of IN O
hepatitis NN B-Gene
B NNP I-Gene
immune NN I-Gene
globulin NN I-Gene
( ( O
HBIG NNP B-Gene
) ) O
in IN O
one CD O
of IN O
three CD O
different JJ O
schedules NNS O
. . O

RNase NNP B-Gene
protection NN O
experiments NNS O
confirmed VBD O
the DT O
presence NN O
of IN O
the DT O
GHR1 NNP B-Gene
- : I-Gene
279 CD I-Gene
variant NN I-Gene
in IN O
IM NNP O
- : O
9 CD O
cells NNS O
and CC O
human JJ O
liver NN O
. . O

High JJ O
- : O
affinity NN O
site NN O
- : O
specific JJ O
DNA NNP O
binding NN O
by IN O
POU NNP B-Gene
domain NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
requires VBZ O
both DT O
the DT O
POU NNP B-Gene
- : I-Gene
specific NN I-Gene
and CC O
the DT O
POU NNP B-Gene
- : I-Gene
homeodomain NN I-Gene
. . O

The DT O
65 CD O
- : O
bp NN O
sequence NN O
contains VBZ O
the DT O
octameric JJ O
cAMP NN O
- : O
responsive JJ O
enhancer NN O
( ( O
CRE NNP O
) ) O
TGACGTCA NNP O
( ( O
nucleotides IN O
- : O
48 CD O
to TO O
- : O
41 CD O
) ) O
. . O

CONCLUSIONS NN O
: : O
Pretreatment NN O
with IN O
OCs NNP O
prior RB O
to TO O
pituitary JJ O
suppression NN O
in IN O
the DT O
early JJ O
follicular JJ O
phase NN O
decreases VBZ O
ovarian JJ O
cyst NN O
formation NN O
, , O
without IN O
an DT O
apparent JJ O
effect NN O
on IN O
subsequent JJ O
follicular JJ O
recruitment NN O
or CC O
pregnancy NN O
rates NNS O
. . O

Unfolding VBG O
can MD O
be VB O
described VBN O
by IN O
a DT O
two CD O
- : O
state NN O
process NN O
since IN O
a DT O
ratio NN O
of IN O
delta NN O
Hcalorimetric NNP O
to TO O
delta VB O
Hvan NNP O
' POS O
t NN O
Hoff NNP O
equals VBZ O
0 CD O
. . O
96 CD O
. . O

CONCLUSION NN O
: : O
Local JJ O
control NN O
was VBD O
highest JJS O
with IN O
Preop NNP O
in IN O
patients NNS O
presenting VBG O
primarily RB O
with IN O
gross JJ O
disease NN O
, , O
and CC O
with IN O
Postop NNP O
in IN O
patients NNS O
presenting VBG O
primarily RB O
following VBG O
gross JJ O
total JJ O
excision NN O
. . O

Etiopathogenetic JJ O
and CC O
therapeutic JJ O
problems NNS O
in IN O
acute JJ O
orbital JJ O
inflammation NN O

Bioplastique NNP O
granuloma NN O
presents NNS O
with IN O
irregularly JJ O
shaped VBN O
cystic JJ O
spaces NNS O
of IN O
varying VBG O
size NN O
containing VBG O
jagged VBN O
, , O
translucent NN O
, , O
nonbirefringent JJ O
foreign JJ O
bodies NNS O
whereas VBP O
Artecoll NNP O
granuloma NN O
shows VBZ O
numerous JJ O
round NN O
vacuoles NNS O
nearly RB O
identical JJ O
in IN O
size NN O
and CC O
shape NN O
enclosing VBG O
round NN O
and CC O
sharply RB O
circumscribed JJ O
, , O
translucent JJ O
, , O
nonbirefringent JJ O
foreign JJ O
bodies NNS O
. . O

Pseudocontact NNP O
shifts NNS O
arise VBP O
from IN O
the DT O
isotropic JJ O
reorientational JJ O
average NN O
of IN O
the DT O
dipolar JJ O
coupling NN O
between IN O
unpaired JJ O
electron NN O
and CC O
nuclei NN O
, , O
in IN O
the DT O
presence NN O
of IN O
magnetic JJ O
susceptibility NN O
anisotropy NN O
. . O

Histological JJ O
signs NNS O
of IN O
the DT O
flare NN O
- : O
up IN O
reaction NN O
were VBD O
already RB O
present JJ O
at IN O
6 CD O
hr NN O
after IN O
i NN O
. . O
v NN O
. . O
challenge NN O
and CC O
lasted VBD O
for IN O
at IN O
least JJS O
4 CD O
days NNS O
. . O

In IN O
contrast NN O
to TO O
this DT O
mRNA NN O
, , O
90 CD O
% NN O
of IN O
alpha NN B-Gene
and CC I-Gene
beta NN I-Gene
actin NNS I-Gene
mRNAs VBP I-Gene
were VBD O
translated VBN O
in IN O
both DT O
myoblasts NNS O
and CC O
myotubes NNS O
. . O

Using VBG O
Ki NNP B-Gene
- : I-Gene
ras NN I-Gene
- : O
transformed VBD O
3T3 CD O
cells NNS O
as IN O
a DT O
model NN O
system NN O
, , O
we PRP O
show VBP O
that IN O
both DT O
RA NNP O
and CC O
the DT O
' '' O
dissociating VBG O
' '' O
retinoids NNS O
inhibit VBP O
anchorage JJ O
- : O
independent JJ O
cell NN O
proliferation NN O
, , O
suggesting VBG O
that IN O
retinoid JJ O
- : O
induced JJ O
growth NN O
inhibition NN O
may MD O
be VB O
related VBN O
to TO O
AP1 NNP B-Gene
transrepression NN O
. . O

Independent JJ O
protrudor NN O
muscle NN O
stimulation NN O
increased VBD O
VI NNP O
, , O
max NN O
( ( O
peak JJ O
increase VB O
61 CD O
% NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
, , O
did VBD O
not RB O
change VB O
Pcrit NNP O
, , O
and CC O
decreased VBD O
Rn NNP O
( ( O
peak JJ O
decrease NN O
of IN O
41 CD O
% NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
two CD O
different JJ O
phosphoforms NNS O
of IN O
STAT5 NNP B-Gene
have VBP O
identical VBN O
in IN O
vitro JJ O
DNA NNP O
binding NN O
specificity NN O
and CC O
reactivity NN O
with IN O
tyrosine NN O
phosphopeptides NNS O
, , O
but CC O
differ VBP O
in IN O
their PRP$ O
cellular JJ O
localization NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
characterized VBD O
cis SYM O
- : O
elements NNS O
of IN O
the DT O
human JJ B-Gene
PCI NNP I-Gene
gene NN I-Gene
required VBN O
for IN O
expression NN O
in IN O
the DT O
hepatoma NN O
- : O
derived VBN O
cell NN O
line NN O
, , O
HepG2 NNP O
cells NNS O
, , O
and CC O
also RB O
evaluated VBD O
rat NN B-Gene
PCI NNP I-Gene
mRNA NN I-Gene
expression NN O
, , O
particularly RB O
on IN O
the DT O
effect NN O
of IN O
androgen NN O
in IN O
rat NN O
reproductive JJ O
tissues NNS O
. . O

Members NNS O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
superfamily NN I-Gene
of IN I-Gene
basic JJ I-Gene
- : I-Gene
leucine JJ I-Gene
zipper NN I-Gene
factors NNS I-Gene
bind VBP O
to TO O
the DT O
StRE NNP O
. . O

The DT O
sequence NN O
of IN O
the DT O
repressor NN O
locus NN O
, , O
c NN O
, , O
of IN O
the DT O
Streptomyces NNP O
temperate NN O
phage NN O
, , O
phi NN O
C31 NNP O
, , O
was VBD O
shown VBN O
previously RB O
to TO O
contain VB O
an DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
74 CD O
kDa NN O
protein NN O
. . O

To TO O
examine VB O
the DT O
role NN O
of IN O
this DT O
CE2 NNP O
element NN O
in IN O
regulating VBG O
Hoxa1 NNP B-Gene
expression NN O
in IN O
vivo NN O
, , O
transgenic JJ O
mice NN O
were VBD O
generated VBN O
which WDT O
express VBP O
a DT O
Hoxa1 NNP B-Gene
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
reporter NN O
gene NN O
that WDT O
contains VBZ O
a DT O
mutation NN O
in IN O
the DT O
CE2 NNP O
element NN O
. . O

Sensory JJ O
kindling NN O
: : O
implications NNS O
for IN O
development NN O
of IN O
sensory JJ O
prostheses NNS O
. . O

Histological JJ O
observations NNS O
on IN O
the DT O
decidua NN O
in IN O
the DT O
second JJ O
half NN O
of IN O
pregnancy NN O

The DT O
science NN O
of IN O
tissue NN O
engineering NN O
. . O

On IN O
line NN O
calculation NN O
of IN O
steroid JJ O
concentrations NNS O
by IN O
radioimmunoassay NN O

Phosphocreatine JJ O
hydrolysis NN O
during IN O
submaximal JJ O
exercise NN O
: : O
the DT O
effect NN O
of IN O
FIO2 NNP O
. . O

The DT O
DNA NN O
sequences VBZ O
upstream NN O
of IN O
these DT O
termini JJ O
exhibit NN O
homology NN O
to TO O
plant NN O
mitochondrial JJ O
- : O
processing NN O
sites NNS O
, , O
therefore IN O
the DT O
proximal JJ O
5 CD O
' POS O
ends NNS O
are VBP O
most RBS O
probably RB O
generated VBN O
by IN O
RNA NNP O
processing NN O
. . O

Biochemical JJ O
examinations NNS O
of IN O
calcium NN O
- : O
phosphorus NN O
metabolism NN O
included VBD O
ions NNS O
and CC O
PTH NNP B-Gene
concentrations NNS O
in IN O
blood NN O
serum NN O
, , O
and CC O
the DT O
activity NN O
of IN O
bone NN O
isoenzyme NN O
of IN O
AP NNP B-Gene
. . O

Derivatives NNS O
of IN O
fluorene NN O
. . O

The DT O
M NNP B-Gene
reading NN I-Gene
frame NN I-Gene
differed VBD O
from IN O
the DT O
reported VBN O
sequence NN O
by IN O
a DT O
single JJ O
nucleotide NN O
corresponding VBG O
to TO O
a DT O
conservative JJ O
lysine NN O
to TO O
arginine VB O
amino NN O
acid JJ O
substitution NN O
near IN O
the DT O
carboxy JJ O
- : O
terminus NN O
conserved VBD O
among IN O
the DT O
M NNP B-Gene
proteins NNS I-Gene
of IN O
paramyxoviruses NNS O
. . O

Inhibition NN O
of IN O
JNK1 NNP B-Gene
and CC O
ERK NNP B-Gene
kinase NNP O
activities NNS O
either CC O
by IN O
expression NN O
of IN O
the DT O
dominant JJ O
negative JJ O
mutant NN O
JNK1 NNP B-Gene
or CC O
by IN O
treatment NN O
with IN O
a DT O
selective JJ O
chemical NN O
inhibitor NN O
of IN O
ERK NNP B-Gene
( ( O
PD098059 NNP O
) ) O
substantially RB O
abrogates VBZ O
the DT O
UV NNP O
induction NN O
of IN O
the DT O
GADD45 NNP B-Gene
promoter NN I-Gene
. . O

The DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
contains NNS O
regions NNS O
identical JJ O
to TO O
the DT O
sequences NNS O
of IN O
peptides NNS O
derived VBN O
from IN O
bovine NN B-Gene
liver NN I-Gene
eIF SYM I-Gene
- : I-Gene
2B CD I-Gene
alpha JJ I-Gene
subunit NN I-Gene
. . O

Addition NN O
of IN O
Rap NNP O
or CC O
KN62 NNP O
after IN O
exposure NN O
of IN O
cells NNS O
to TO O
progesterone VB O
agonist NN O
Org NNP O
2058 CD O
had VBD O
no DT O
effect NN O
on IN O
induction NN O
of IN O
CAT NNP B-Gene
activity NN O
. . O

This DT O
gene NN O
joins VBZ O
the DT O
group NN O
of IN O
genes NNS O
whose WP$ O
members NNS O
are VBP O
rapidly RB O
transcribed VBN O
in IN O
response NN O
to TO O
insulin NN B-Gene
and CC O
other JJ O
mitogens NNS O
. . O

The DT O
PEBP2 NNP B-Gene
alpha NN I-Gene
proteins VBZ I-Gene
contain VBP O
a DT O
128 CD O
- : O
amino NN O
- : O
acid NN O
( ( O
aa NN O
) ) O
region NN O
highly RB O
homologous JJ O
to TO O
the DT O
Drosophila NNP B-Gene
melanogaster NN I-Gene
segmentation NN I-Gene
gene NN I-Gene
runt NN I-Gene
. . O

Together RB O
these DT O
data NNS O
imply VBP O
that IN O
the DT O
HFV NNP B-Gene
R NNP I-Gene
region NN I-Gene
acts NNS O
in IN O
the DT O
nucleus NN O
to TO O
modify VB O
the DT O
cytoplasmic JJ O
fate NN O
of IN O
target NN O
HFV NNP O
mRNA NN O
. . O

The DT O
rho NN B-Gene
genes NNS I-Gene
comprise VBP O
an DT O
evolutionarily RB O
conserved VBN O
family NN O
with IN O
significant JJ O
homology NN O
to TO O
the DT O
ras NNS B-Gene
oncogene VBP I-Gene
family NN I-Gene
. . O

The DT O
persistent JJ O
fetal JJ O
dispersion NN O
of IN O
nodal JJ O
and CC O
Hiss NNP O
bundle NN O
fragments NNS O
within IN O
the DT O
ventricular JJ O
septum NN O
is VBZ O
proposed VBN O
as IN O
a DT O
possible JJ O
explanation NN O
. . O

Acute NNP O
inhalation NN O
toxicity NN O
of IN O
T NNP O
- : O
2 CD O
mycotoxin NN O
in IN O
mice NN O
. . O

Patulin NNP O
is VBZ O
extracted VBN O
from IN O
apple NN O
butter NN O
samples NNS O
with IN O
ethyl JJ O
acetate NN O
and CC O
the DT O
extract NN O
is VBZ O
cleaned VBN O
up RP O
on IN O
a DT O
silica NN O
gel NN O
column NN O
, , O
using VBG O
benzene SYM O
- : O
ethyl NN O
acetate NN O
( ( O
75 CD O
+ RB O
25 CD O
) ) O
as IN O
the DT O
eluant NN O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that DT O
expression NN O
of IN O
a DT O
tumour NN O
derived VBN O
brk JJ B-Gene
cDNA NN I-Gene
in IN O
mouse NN O
embryonic JJ O
fibroblasts NNS O
and CC O
human JJ O
mammary JJ O
epithelial NN O
cells NNS O
supports VBZ O
anchorage NN O
independent JJ O
growth NN O
, , O
and CC O
in IN O
the DT O
latter JJ O
potentiates VBZ O
the DT O
mitogenic JJ O
response NN O
to TO O
epidermal VB B-Gene
growth NN I-Gene
factor NN I-Gene
. . O

Prostaglandins NNS O
and CC O
gallstones NNS O

Coexposure NN O
to TO O
FP NNP O
also RB O
resulted VBD O
in IN O
a DT O
more RBR O
pronounced JJ O
and CC O
sustained JJ O
activation NN O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
/ NNP O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
cascade NN O
after IN O
PMA NNP O
treatment NN O
, , O
although IN O
disruption NN O
of IN O
this DT O
pathway NN O
by IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase VBD I-Gene
1 CD I-Gene
inhibitor NN O
U0126 NNP O
did VBD O
not RB O
prevent JJ O
potentiation NN O
of IN O
apoptosis NN O
. . O

Biol NNP O
. . O

Examination NN O
of IN O
various JJ O
promoter NN O
deletion NN O
mutants NNS O
indicated VBD O
that IN O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
acts NNS O
through IN O
the DT O
proximal JJ O
promoter NN O
region NN O
and CC O
upstream JJ O
promoter NN O
sequences NNS O
. . O

The DT O
therapeutic JJ O
use NN O
of IN O
botulinum NN B-Gene
toxin NN I-Gene
( ( O
Botox NNP B-Gene
) ) O
is VBZ O
increasing VBG O
in IN O
popularity NN O
. . O

Identical JJ O
components NNS O
of IN O
yeast JJ O
transcription NN B-Gene
factor NN I-Gene
IIIB NNP I-Gene
are VBP O
required VBN O
and CC O
sufficient JJ O
for IN O
transcription NN O
of IN O
TATA NNP O
box NN O
- : O
containing NN O
and CC O
TATA NNP O
- : O
less JJR O
genes NNS O
. . O

Expression NN O
from IN O
this DT O
element NN O
is VBZ O
regulated VBN O
by IN O
a DT O
heteromeric JJ O
protein NN O
complex JJ O
containing VBG O
ubiquitous JJ O
( ( O
i JJ O
. . O
e NN O
. . O
the DT O
E2A NNP B-Gene
- : O
and CC O
HEB NNP B-Gene
- : I-Gene
encoded VBD I-Gene
proteins NNS I-Gene
) ) O
and CC O
islet $ O
- : O
enriched JJ O
members NNS O
of IN O
the DT O
bHLH JJ B-Gene
family NN I-Gene
. . O

Among IN O
mammalian JJ B-Gene
HSFs NNP I-Gene
, , O
HSF1 NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
regulation NN O
of IN O
the DT O
heat NN O
- : O
induced JJ O
stress NN O
gene NN O
expression NN O
, , O
whereas IN O
the DT O
function NN O
of IN O
HSF2 NNP B-Gene
in IN O
stress NN O
response NN O
is VBZ O
unclear JJ O
. . O

TPA NNP O
and CC O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
1 CD I-Gene
did VBD O
not RB O
markedly RB O
affect VBP O
the DT O
activities NNS O
of IN O
the DT O
72 CD O
- : O
kDa NN O
enzyme NN O
. . O

The DT O
control NN O
group NN O
included VBD O
8 CD O
afterbirth NN O
samples NNS O
from IN O
physiological JJ O
full JJ O
- : O
term NN O
pregnancies NNS O
. . O

In IN O
addition NN O
, , O
in IN O
vitro JJ O
mutagenesis NN O
of IN O
both DT O
Engrailed NNP B-Gene
and CC O
Pbx1 NNP B-Gene
sites NNS I-Gene
indicated VBD O
that IN O
other JJ O
unidentified JJ O
sites NNS O
are VBP O
responsible JJ O
for IN O
the DT O
transcriptional JJ O
enhancement NN O
observed VBN O
with IN O
the DT O
intronic JJ O
fragment NN O
. . O

In IN O
studies NNS O
of IN O
many JJ O
different JJ O
phenotypically RB O
distinct JJ O
cells NNS O
, , O
the DT O
CRE NNP O
of IN O
the DT O
somatostatin JJ B-Gene
gene NN I-Gene
promoter NN I-Gene
is VBZ O
a DT O
prototype NN O
of IN O
a DT O
highly RB O
cAMP JJ O
- : O
responsive JJ O
element NN O
regulated VBN O
by IN O
CREB NNP B-Gene
. . O

Forskolin NNP O
significantly RB O
enhanced VBD O
heregulin JJ B-Gene
- : O
stimulated JJ O
expression NN O
of IN O
cyclin NN B-Gene
D NNP I-Gene
and CC O
phosphorylation NN O
of IN O
the DT O
retinoblastoma NN B-Gene
gene NN I-Gene
product NN I-Gene
. . O

Tumour CD B-Gene
necrosis NN I-Gene
factor NN I-Gene
and CC O
adult NN O
respiratory NN O
distress JJ O
syndrome NN O
. . O

CONCLUSION NN O
: : O
Vitrectomy NN O
for IN O
vitreous JJ O
hemorrhage NN O
in IN O
Terson NNP O
syndrome NN O
is VBZ O
a DT O
safe JJ O
and CC O
effective JJ O
procedure NN O
, , O
offering VBG O
a DT O
rapid JJ O
and CC O
prolonged JJ O
improvement NN O
in IN O
vision NN O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
R NNP O
has VBZ O
revealed VBN O
similarities NNS O
to TO O
the DT O
R1 NNP O
plasmid NN O
found VBD O
in IN O
some DT O
South JJ O
American JJ O
maize NN O
races NNS O
with IN O
RU NNP O
cytoplasm NN O
, , O
to TO O
the DT O
M1 NNP O
plasmid NN O
found VBD O
in IN O
one CD O
source NN O
of IN O
Zea NNP O
luxurians NNPS O
teosinte NN O
, , O
to TO O
the DT O
atp9 JJ B-Gene
mitochondrial JJ I-Gene
gene NN I-Gene
and CC O
its PRP$ O
3 CD O
' '' O
flanking VBG O
sequence NN O
, , O
and CC O
also RB O
to TO O
a DT O
region NN O
3 CD O
' '' O
to TO O
the DT O
orf221 JJ B-Gene
gene NN I-Gene
. . O

When WRB O
the DT O
downstream NN O
operator NN O
was VBD O
altered VBN O
, , O
there EX O
was VBD O
a DT O
fourfold JJ O
reduction NN O
in IN O
reporter NN O
enzyme NN O
levels NNS O
. . O

Our PRP$ O
results NNS O
, , O
when WRB O
combined VBN O
with IN O
previously RB O
published VBN O
in IN O
vitro JJ O
results NNS O
, , O
support VB O
a DT O
direct JJ O
role NN O
for IN O
Prp44p NNP B-Gene
in IN O
unwinding NN O
of IN O
the DT O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
helix NN O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
strong JJ O
Tas NNP B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
, , O
designated VBN O
TRE NNP B-Gene
( ( O
GP NNP B-Gene
) ) O
, , O
near IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
gag JJ B-Gene
gene NN I-Gene
and CC O
preceding VBG O
the DT O
pol JJ B-Gene
gene NN I-Gene
of IN O
SFV NNP O
- : O
1 CD O
. . O

A DT O
quantitative JJ O
analysis NN O
of IN O
the DT O
diffraction NN O
intensity NN O
as IN O
function NN O
of IN O
the DT O
accumulated JJ O
electron NN O
dose NN O
suggests VBZ O
the DT O
possibility NN O
of IN O
recording VBG O
up RP O
to TO O
250 CD O
diffraction NN O
patterns NNS O
with IN O
3 CD O
. . O
5 CD O
A DT O
resolution NN O
from IN O
a DT O
single JJ O
crotoxin NN O
complex JJ O
crystal NN O
128 CD O
A NNP O
thick NN O
. . O

Typical JJ O
and CC O
atypical JJ O
clinical JJ O
features NNS O
of IN O
this DT O
lacrimal JJ O
sac NN O
cyst NN O
are VBP O
emphasized VBN O
. . O

Disrupted VBN O
vaccines NNS O
and CC O
whole JJ O
- : O
virus NN O
vaccines NNS O
containing VBG O
type NN B-Gene
B NNP I-Gene
antigen NN I-Gene
only RB O
did VBD O
not RB O
cause VB O
significant JJ O
reactivity NN O
. . O

Coexpression NN O
studies NNS O
indicate VBP O
that IN O
insulin NN B-Gene
and CC O
PKB NNP B-Gene
suppress NN O
transactivation NN O
by IN O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
, , O
but CC O
not RB O
C NNP B-Gene
/ NNP I-Gene
EBPalpha NNP I-Gene
, , O
and CC O
that IN O
N NNP O
- : O
terminal JJ O
transactivation NN O
domains NNS O
in IN O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
are VBP O
required VBN O
. . O

The DT O
results NNS O
of IN O
a DT O
quantitative JJ O
study NN O
of IN O
vasculosyncytial JJ O
membranes NNS O
in IN O
123 CD O
placentas NNS O
are VBP O
presented VBN O
. . O

The DT O
growth NN O
- : O
promoting NN O
properties NNS O
of IN O
the DT O
retroviral JJ B-Gene
v NN I-Gene
- : I-Gene
erbA NN I-Gene
oncogene NN I-Gene
, , O
a DT O
highly RB O
mutated JJ O
version NN O
of IN O
the DT O
chicken NN B-Gene
thyroid NN I-Gene
hormone NN I-Gene
receptor NN I-Gene
( ( I-Gene
TR NNP I-Gene
) ) I-Gene
alpha NN I-Gene
, , O
have VBP O
so RB O
far RB O
exclusively RB O
been VBN O
linked VBN O
to TO O
dominant JJ O
repression NN O
of IN O
the DT O
antimitogenic JJ O
roles NNS O
of IN O
TR NNP B-Gene
and CC O
retinoic JJ B-Gene
acid NN I-Gene
receptors NNS I-Gene
. . O

The DT O
genes NNS O
at IN O
each DT O
locus NN O
are VBP O
divergently RB O
transcribed VBN O
and CC O
the DT O
coding NN O
sequences NNS O
are VBP O
separated VBN O
by IN O
646 CD O
base NN O
- : O
pairs NN O
at IN O
one CD O
locus NN O
and CC O
676 CD O
base NN O
- : O
pairs NN O
at IN O
the DT O
other JJ O
. . O

Nitric NNP O
oxide MD O
inhalation VB O
selectively RB O
reduces NNS O
pulmonary JJ O
hypertension NN O
in IN O
porcine NN O
endotoxin NN O
shock NN O
and CC O
improves VBZ O
arterial JJ O
oxygenation NN O
and CC O
pH NN O
with IN O
a DT O
marked JJ O
attenuation NN O
of IN O
sympathetic JJ O
activation NN O
. . O

A DT O
single JJ O
N NNP O
- : O
glycosylation NN O
site NN O
present NN O
in IN O
chicken NN B-Gene
gp42 NN I-Gene
is VBZ O
conserved VBN O
among IN O
all DT O
five CD O
of IN O
these DT O
proteins NNS O
: : O
carbohydrate NN O
analysis NN O
of IN O
gp42 NN B-Gene
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
complex JJ O
type NN O
glycan NN O
chain NN O
at IN O
this DT O
site NN O
. . O

The DT O
three CD O
isoforms NNS O
purified VBN O
with IN O
anti JJ B-Gene
- : I-Gene
FLAG NN I-Gene
antibody NN I-Gene
affinity NN O
column NN O
transferred VBD O
sulfate NN O
to TO O
heparan VB O
sulfate NN O
and CC O
heparin NN O
but CC O
not RB O
to TO O
other JJ O
glycosaminoglycans NNS O
. . O

Analysis NN O
of IN O
the DT O
deduced JJ O
amino NN O
acid NN O
sequence NN O
suggests VBZ O
that IN O
CHIP28 NNP B-Gene
protein NN I-Gene
contains VBZ O
six CD O
bilayer NN O
- : O
spanning NN O
domains NNS O
, , O
two CD O
exofacial JJ O
potential JJ O
N NNP O
- : O
glycosylation NN O
sites NNS O
, , O
and CC O
intracellular JJ O
N NNP O
and CC O
C NNP O
termini NN O
. . O

Both DT O
mu NN B-Gene
and CC I-Gene
gamma NN I-Gene
2b CD I-Gene
heavy JJ I-Gene
chain NN I-Gene
genes NNS I-Gene
cause VBP O
this DT O
feedback JJ O
inhibition NN O
of IN O
heavy JJ O
chain NN O
gene NN O
rearrangement NN O
. . O

Spinal NNP O
cord NN O
representation NN O
of IN O
the DT O
micturition NN O
reflex NN O
. . O

In IN O
contrast NN O
, , O
high JJ O
COUP NNP B-Gene
- : I-Gene
TFI NNP I-Gene
expression NN O
impeded VBD O
the DT O
neuronal JJ O
differentiation NN O
of IN O
P19 NNP O
cells NNS O
induced VBD O
with IN O
RA NNP O
, , O
resulting VBG O
in IN O
cell NN O
cultures NNS O
lacking VBG O
neurons NNS O
. . O

A DT O
further JJ O
subdivision NN O
of IN O
Category NNP O
pN1 NN O
into IN O
pN1a NN O
( ( O
metastasis NN O
in IN O
single JJ O
node NN O
) ) O
and CC O
pN1b $ O
( ( O
two CD O
or CC O
more JJR O
nodes NNS O
) ) O
is VBZ O
recommended VBN O
. . O

The DT O
RING NNP O
finger NN O
, , O
B2 NNP O
box NN O
, , O
and CC O
coiled VBD O
- : O
coil NN O
region NN O
are VBP O
required VBN O
for IN O
oligomerization NN O
of IN O
KAP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
RBCC NN B-Gene
and CC O
KRAB NNP B-Gene
binding NN O
, , O
as IN O
mutations NNS O
in IN O
these DT O
domains NNS O
concomitantly RB O
abolished VBN O
these DT O
functions NNS O
. . O

The DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Gene
lactoferrin NN I-Gene
gene NN I-Gene
was VBD O
isolated VBN O
from IN O
a DT O
human JJ O
placental JJ O
genomic JJ O
library NN O
. . O

Northern NNP O
analysis NN O
indicated VBD O
differential JJ O
expression NN O
by IN O
tissue NN O
with IN O
highest JJS O
expression NN O
in IN O
the DT O
heart NN O
. . O

Atrial JJ O
fibrillation NN O
and CC O
the DT O
autonomic JJ O
nervous JJ O
system NN O

Therefore RB O
, , O
use NN O
of IN O
presaturation NN O
is VBZ O
recommended VBN O
for IN O
myocardial JJ O
motion NN O
studies NNS O
using VBG O
cine JJ O
PC NN O
velocity NN O
data NNS O
. . O

Groups NNP O
of IN O
male NN O
and CC O
female JJ O
Fischer NNP O
344 CD O
rats NNS O
, , O
B6C3F1 NNP O
mice NN O
, , O
and CC O
Hartley NNP O
guinea NN O
pigs NNS O
were VBD O
exposed VBN O
once RB O
for IN O
6 CD O
hr NN O
to TO O
mean VB O
concentrations NNS O
of IN O
10 CD O
. . O
5 CD O
, , O
5 CD O
. . O
4 CD O
, , O
2 CD O
. . O
4 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
0 CD O
( ( O
control NN O
) ) O
ppm NN O
of IN O
methyl NN O
isocyanate NN O
( ( O
MIC NNP O
) ) O
vapor NN O
. . O

In IN O
7 CD O
of IN O
9 CD O
cases NNS O
, , O
the DT O
enhancer NN O
is VBZ O
fused VBN O
to TO O
the DT O
c NN B-Gene
- : I-Gene
myc NN I-Gene
bearing NN I-Gene
sequences NNS I-Gene
of IN O
chromosome NN O
8 CD O
. . O

Cerebrospinal NNP O
fluid NN O
transferrin NN B-Gene
II NNP I-Gene
studies NNS O
in IN O
ischemic JJ O
disorders NNS O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

All DT O
control NN O
persons NNS O
had VBD O
a DT O
normal JJ O
reaction NN O
to TO O
DNFB NNP O
. . O

In IN O
addition NN O
to TO O
the DT O
signals NNS O
obtained VBN O
by IN O
ligation NN O
of IN O
the DT O
TCR NNP B-Gene
, , O
T NNP O
cells NNS O
need VBP O
additional JJ O
, , O
co JJ O
- : O
stimulatory NN O
signals NNS O
to TO O
be VB O
activated VBN O
. . O

To TO O
determine VB O
if IN O
signing NN O
, , O
when WRB O
established VBN O
, , O
would MD O
compete VB O
with IN O
SIB NNP O
when WRB O
both DT O
were VBD O
reinforced VBN O
, , O
extinction NN O
was VBD O
then RB O
withdrawn NN O
. . O

After IN O
two CD O
successive JJ O
rounds NNS O
of IN O
selection NN O
by IN O
focus NN O
formation NN O
assay NN O
, , O
a DT O
transforming NN O
ribozyme NN O
( ( O
Rz007 NNP B-Gene
) ) O
was VBD O
identified VBN O
. . O

Dry NNP O
matter NN O
intake NN O
, , O
apparent JJ O
nutrient NN O
digestibilities NNS O
, , O
serum JJ O
chemistry NN O
profiles NNS O
, , O
sphingolipid JJ O
concentrations NNS O
, , O
and CC O
persistency NN O
of IN O
FB1 NNP O
in IN O
tissues NNS O
were VBD O
evaluated VBN O
. . O

This DT O
300 CD O
bp NN O
5 CD O
' '' O
- : O
upstream JJ O
sequence NN O
of IN O
K3 NNP B-Gene
keratin NNP I-Gene
gene NN I-Gene
, , O
which WDT O
can MD O
function VB O
in IN O
vitro NN O
as IN O
a DT O
keratinocyte NN O
- : O
specific JJ O
promoter NN O
, , O
contains VBZ O
two CD O
clusters NNS O
of IN O
partially RB O
overlapping VBG O
motifs NNS O
, , O
one CD O
with IN O
an DT O
NFkB NNP B-Gene
consensus NN O
sequence NN O
and CC O
another DT O
with IN O
a DT O
GC NNP O
box NN O
. . O

Anamnestic JJ O
data NNS O
were VBD O
obtained VBN O
from IN O
case NN O
history NN O
, , O
smoking VBG O
habits NNS O
were VBD O
not RB O
known VBN O
in IN O
collective NN O
A NN O
and CC O
C NNP O
. . O

Strontium NNP O
- : O
90 CD O
was VBD O
inject JJ O
i NN O
. . O
v NN O
. . O
into IN O
pregnant JJ O
rats NNS O
on IN O
day NN O
18 CD O
post NN O
conception NN O
( ( O
p NN O
. . O
c NN O
. . O
) ) O
. . O

The DT O
plasma NN O
half NN O
- : O
life NN O
of IN O
slow JJ O
disposition NN O
phase NN O
t1 NN O
/ VBD O
2 CD O
beta NN O
, , O
increases VBZ O
from IN O
0 CD O
. . O
26 CD O
hour NN O
in IN O
rabbits NNS O
with IN O
normal JJ O
renal JJ O
function NN O
to TO O
5 CD O
. . O
41 CD O
hours NNS O
in IN O
rabbits NNS O
with IN O
severe JJ O
renal JJ O
impairment NN O
. . O

Analysis NN O
of IN O
one CD O
cDNA NN O
revealed VBD O
an DT O
unusual JJ O
splicing NN O
event NN O
involving VBG O
EZH1 NNP B-Gene
and CC O
a DT O
tandemly NN O
linked VBN O
gene NN O
GPR2 NNP B-Gene
and CC O
suggests VBZ O
a DT O
potential JJ O
mechanism NN O
for IN O
modifying VBG O
the DT O
EZH1 NNP B-Gene
protein NN I-Gene
in IN O
the DT O
conserved JJ O
C NNP O
- : O
terminal NN O
domain NN O
. . O

Northern NNP O
blot NN O
analysis NN O
demonstrated VBD O
the DT O
ubiquitous JJ O
expression NN O
of IN O
2 CD O
. . O
9 CD O
kb NN O
and CC O
3 CD O
. . O

The DT O
segmental NN O
and CC O
regional JJ O
projections NNS O
of IN O
the DT O
sciatic JJ O
, , O
tibial JJ O
and CC O
common JJ O
peroneal NN O
nerves NNS O
to TO O
the DT O
substantia NN O
gelatinosa NN O
of IN O
the DT O
spinal JJ O
cord NN O
in IN O
rats NNS O
- : O
- : O
an DT O
experimental JJ O
study NN O
by IN O
means NNS O
of IN O
an DT O
acid JJ B-Gene
phosphatase NN I-Gene
( ( O
ACP NNP B-Gene
) ) O
method NN O
. . O

Insulin NNP B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
I PRP I-Gene
induces VBP O
bcl SYM B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
through IN O
the DT O
transcription NN O
factor NN O
cAMP SYM B-Gene
- : I-Gene
response NN I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

The DT O
p34 NN B-Gene
. . I-Gene
8 CD I-Gene
gene NN I-Gene
has VBZ O
a DT O
strong JJ O
codon NN O
usage NN O
bias NN O
which WDT O
is VBZ O
strikingly RB O
different JJ O
from IN O
that DT O
of IN O
the DT O
polyhedrin JJ B-Gene
gene NN I-Gene
. . O

In IN O
the DT O
studies NNS O
reported VBN O
here RB O
, , O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Gene
gp130 NN I-Gene
gene NN I-Gene
was VBD O
isolated VBN O
and CC O
the DT O
transcription NN O
initiation NN O
sites NNS O
were VBD O
mapped VBN O
. . O

Sequence NN O
analysis NN O
indicates VBZ O
that IN O
RBP21 NNP B-Gene
shares NNS O
homology NN O
with IN O
other JJ O
retinoblastoma NN B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
in IN O
the DT O
pRb NN B-Gene
- : I-Gene
binding NN I-Gene
motif NN I-Gene
LxCxE NNP O
at IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
. . O

The DT O
promoter NN O
mutation NN O
is VBZ O
complemented VBN O
in IN O
trans NNS O
by IN O
E1A NNP B-Gene
products NNS O
of IN O
the DT O
heterologous JJ O
helper NN O
adenovirus NN O
type NN O
5 CD O
( ( O
Ad5 NNP O
) ) O
. . O

In IN O
this DT O
report NN O
, , O
almost RB O
6 CD O
kb NN O
of IN O
DNA NNP O
sequence NN O
is VBZ O
presented VBN O
, , O
including VBG O
1251 CD O
bp NN O
5 CD O
' '' O
to TO O
the DT O
gene NN O
, , O
over IN O
4 CD O
kb NNS O
of IN O
exon NN O
and CC O
exon VB O
- : O
intron NN O
junctions NNS O
, , O
and CC O
583 CD O
bp NN O
3 CD O
' '' O
to TO O
the DT O
gene NN O
. . O

Delayed NNP O
or CC O
paradoxically RB O
emptying JJ O
regions NNS O
of IN O
the DT O
left JJ O
ventricle NN O
were VBD O
detected VBN O
by IN O
a DT O
relatively RB O
new JJ O
nuclear JJ O
technique NN O
- : O
- : O
phase NN O
imaging NN O
. . O

The DT O
potentially RB O
SLE NNP O
- : O
inducing NN O
drugs NNS O
are VBP O
reviewed VBN O
. . O

However RB O
, , O
the DT O
relative JJ O
positions NNS O
of IN O
the DT O
VV NNP O
genes NNS O
( ( O
genus JJ O
Orthopoxvirus NNP O
) ) O
are VBP O
different JJ O
than IN O
those DT O
of IN O
the DT O
corresponding JJ O
ORFs NNP O
in IN O
SFV NNP O
( ( O
genus FW O
Leporipoxvirus NNP O
) ) O
, , O
indicating VBG O
complex JJ O
rearrangements NNS O
of IN O
DNA NN O
in IN O
the DT O
genome NN O
of IN O
one CD O
or CC O
both DT O
of IN O
these DT O
viruses NNS O
subsequent VBP O
to TO O
their PRP$ O
divergence NN O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

Expression NN O
of IN O
the DT O
proapoptotic JJ B-Gene
protein NN I-Gene
Bax NNP I-Gene
under IN O
the DT O
control NN O
of IN O
a DT O
GAL10 NNP B-Gene
promoter NN I-Gene
in IN O
Saccharomyces NNP O
cerevisiae NN O
resulted VBD O
in IN O
galactose JJ O
- : O
inducible JJ O
cell NN O
death NN O
. . O

Accurate NNP O
evaluation NN O
of IN O
the DT O
treatment NN O
results NNS O
in IN O
unresectable JJ O
lung NN O
cancer NN O
patients NNS O
must MD O
take VB O
the DT O
strong JJ O
prognostic JJ O
factors NNS O
into IN O
account NN O
. . O

Body NNP O
fat JJ O
distribution NN O
was VBD O
determined VBN O
by IN O
abdominal JJ O
computed VBN O
tomography NN O
. . O

Grasso NNP O
, , O
and CC O
A NNP O
. . O

The DT O
mean JJ O
plasma NN O
sodium NN O
concentration NN O
which WDT O
was VBD O
135 CD O
. . O
95 CD O
( ( O
+ JJ O
/ NNP O
- : O
SD NN O
4 CD O
. . O
14 CD O
) ) O
mEq NN O
/ NNP O
kg NN O
before IN O
diuretic JJ O
treatment NN O
was VBD O
significantly RB O
decreased VBN O
during IN O
treatment NN O
to TO O
129 CD O
. . O
19 CD O
( ( O
+ JJ O
/ NNP O
- : O
SD NN O
2 CD O
. . O
77 CD O
) ) O
mEq NN O
/ NNP O
kg NN O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
. . O

HL $ O
2 CD O
type NN O
oculomotor NN O
stimulator NN O
. . O

Several JJ O
cDNAs NNS O
corresponding VBG O
to TO O
the DT O
human JJ B-Gene
PWP2 NNP I-Gene
gene NN I-Gene
were VBD O
identified VBN O
and CC O
partially RB O
sequenced VBN O
. . O

After IN O
clofelin JJ O
administration NN O
the DT O
autoregulation NN O
borders NNS O
shifted VBD O
to TO O
the DT O
right NN O
i NN O
. . O
e NN O
. . O
towards NNS O
higher RBR O
AP NNP O
levels NNS O
. . O

Their PRP$ O
studies NNS O
have VBP O
revealed VBN O
a DT O
considerable JJ O
increase NN O
of IN O
CSF NNP B-Gene
AP NNP I-Gene
activity NN O
in IN O
purulent NN O
meningitides NNS O
whereas VBP O
in IN O
serous JJ O
meningitides NNS O
it PRP O
grows VBZ O
negligibly RB O
. . O

The DT O
hepatocyte NN B-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
3 CD I-Gene
( ( O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
/ NN O
forkhead NN B-Gene
( ( O
fkh NN B-Gene
) ) O
proteins VBZ O
consist NN O
of IN O
an DT O
extensive JJ O
family NN O
of IN O
tissue NN O
- : O
specific NN O
and CC O
developmental JJ O
gene NN O
regulators NNS O
which WDT O
share NN O
homology NN O
within IN O
the DT O
winged JJ O
helix NN O
DNA NNP O
binding NN O
motif NN O
. . O

The DT O
solution NN O
structure NN O
of IN O
the DT O
adduct NN O
derived VBN O
from IN O
the DT O
covalent NN O
bonding NN O
of IN O
the DT O
fjord JJ O
region NN O
( ( O
+ NN O
) ) O
- : O
( ( O
11S CD O
, , O
12R CD O
, , O
13R CD O
, , O
14S CD O
) ) O
stereoisomer NN O
of IN O
anti JJ O
- : O
11 CD O
, , O
12 CD O
- : O
dihydroxy NN O
- : O
13 CD O
, , O
14 CD O
- : O
epoxy JJ O
- : O
11 CD O
, , O
12 CD O
, , O
13 CD O
, , O
14 CD O
- : O
tetrahydrobenzo NN O
[ JJ O
g NN O
] NNP O
chrysene NN O
, , O
( ( O
+ NN O
) ) O
- : O
anti NN O
- : O
B NNP O
[ NNP O
g NN O
] NNP O
CDE NNP O
, , O
to TO O
the DT O
exocyclic JJ O
N NNP O
( ( O
6 CD O
) ) O
amino NN O
group NN O
of IN O
the DT O
adenine NN O
residue JJ O
dA6 NN O
, , O
( ( O
designated VBN O
( ( O
+ NN O
) ) O
- : O
trans VBZ O
- : O
anti NN O
- : O
( ( O
B NNP O
[ NNP O
g NN O
] NNP O
C NNP O
) ) O
dA6 NN O
) ) O
, , O
positioned VBD O
opposite RP O
a DT O
thymine NN O
residue JJ O
dT17 NN O
in IN O
the DT O
DNA NNP O
sequence NN O
context NN O
d NN O
( ( O
C1 NNP O
- : O
T2 NNP O
- : O
C3 NNP O
- : O
T4 NNP O
- : O
C5 NNP O
- : O
( ( O
B NNP O
[ NNP O
g NN O
] NNP O
C NNP O
) ) O
A6 NNP O
- : O
C7 NNP O
- : O
T8 NNP O
- : O
T9 NNP O
- : O
C10 NNP O
- : O
C11 NN O
) ) O
. . O

d NN O
( ( O
G12 NNP O
- : O
G13 NNP O
- : O
A14 NNP O
- : O
A15 NNP O
- : O
G16 NNP O
- : O
T17 NNP O
- : O
G18 NNP O
- : O
A19 NNP O
- : O
G20 NNP O
+ NNP O
+ NNP O
+ NNP O
- : O
A21 NNP O
- : O
G22 NN O
) ) O
( ( O
designated VBN O
( ( O
B NNP O
[ NNP O
g NN O
] NNP O
C NNP O
) ) O
dA NN O
. . O
dT VB O
11 CD O
- : O
mer NN O
duplex NN O
) ) O
, , O
has VBZ O
been VBN O
studied VBN O
using VBG O
structural JJ O
information NN O
derived VBN O
from IN O
NMR NNP O
data NNS O
in IN O
combination NN O
with IN O
molecular JJ O
dynamics NNS O
( ( O
MD NNP O
) ) O
calculations NNS O
. . O

Atomic NNP O
absorption NN O
spectrophotometry NN O
applied VBD O
to TO O
bacterially RB O
expressed VBN O
E1A NNP B-Gene
proteins NNS I-Gene
revealed VBD O
that IN O
the DT O
289 CD O
- : O
amino NN O
acid JJ O
protein NN O
binds VBZ O
one CD O
zinc NN O
ion NN O
, , O
whereas IN O
the DT O
243 CD O
- : O
amino NN O
acid JJ O
protein NN O
binds VBZ O
no DT O
zinc NN O
. . O

Among IN O
82 CD O
superficial JJ O
lesions NNS O
34 CD O
were VBD O
classified VBN O
as IN O
showing VBG O
CR NNP O
and CC O
another DT O
23 CD O
as IN O
showing VBG O
PR NNP O
, , O
with IN O
a DT O
response NN O
rate NN O
of IN O
69 CD O
. . O
5 CD O
% NN O
. . O

Analysis NN O
of IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
mouse NN B-Gene
Elavl1 NNP I-Gene
( ( O
mHuA NN B-Gene
) ) O
gene NN O
reveals VBZ O
a DT O
transcriptional JJ O
regulatory JJ O
element NN O
and CC O
evidence NN O
for IN O
conserved JJ O
genomic JJ O
organization NN O
. . O

mHuA NN B-Gene
( ( O
Elavl1 NNP B-Gene
) ) O
belongs VBZ O
to TO O
a DT O
highly RB O
conserved VBN O
family NN O
of IN O
genes NNS O
encoding VBG O
RNA NNP O
- : O
binding NN O
proteins NNS O
and CC O
has VBZ O
been VBN O
linked VBN O
to TO O
cell VB O
growth NN O
and CC O
proliferation NN O
through IN O
its PRP$ O
regulation NN O
of IN O
mRNA JJ O
stability NN O
. . O

The DT O
results NNS O
also RB O
imply VBP O
that IN O
the DT O
absence NN O
of IN O
perforin JJ B-Gene
expression NN O
in IN O
non JJ O
- : O
cytotoxic NN O
cells NNS O
may MD O
be VB O
due JJ O
to TO O
the DT O
suppression NN O
of IN O
the DT O
induction NN O
of IN O
the DT O
killer NN O
- : O
cell NN O
- : O
specific JJ O
trans NNS O
- : O
acting VBG O
factor NN O
NF NNP B-Gene
- : I-Gene
P2 NN I-Gene
. . O

Cloning VBG O
and CC O
sequencing VBG O
revealed VBD O
that IN O
dMax NN B-Gene
contains VBZ O
a DT O
deletion NN O
spanning VBG O
the DT O
basic JJ O
region NN O
and CC O
helix NN O
1 CD O
and CC O
the DT O
loop NN O
of IN O
the DT O
helix NN O
- : O
loop NN O
- : O
helix NN O
region NN O
, , O
presumably RB O
as IN O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
of IN O
max NN B-Gene
RNA NNP I-Gene
. . O

Intron NNP O
1 CD O
is VBZ O
6 CD O
. . O
5 CD O
kb NN O
long RB O
, , O
and CC O
the DT O
minimal JJ O
sizes NNS O
of IN O
introns NNS O
2 CD O
and CC O
3 CD O
are VBP O
estimated VBN O
to TO O
be VB O
32 CD O
kb JJ O
each DT O
. . O

It PRP O
may MD O
also RB O
be VB O
suggested VBN O
that IN O
particular JJ O
care NN O
should MD O
be VB O
taken VBN O
when WRB O
such JJ O
a DT O
trans NNS O
- : O
dominant JJ O
Rev NNP B-Gene
mutant NN I-Gene
is VBZ O
considered VBN O
to TO O
be VB O
used VBN O
as IN O
a DT O
genetic JJ O
therapy NN O
against IN O
HIV NNP O
- : O
I PRP O
infection VBP O
, , O
in IN O
individuals NNS O
infected VBN O
with IN O
both DT O
HIV NNP O
- : O
I PRP O
and CC O
HTLV NNP O
- : O
1 CD O
. . O

Molecular JJ O
cloning NN O
of IN O
the DT O
cDNA NN O
for IN O
the DT O
human JJ B-Gene
U2 NNP I-Gene
snRNA NN I-Gene
- : I-Gene
specific NN I-Gene
A NNP I-Gene
' POS I-Gene
protein NN I-Gene
. . O

Transcription NN O
readthrough NN O
into IN O
the DT O
inverted JJ O
repeats NN O
has VBZ O
little JJ O
effect NN O
on IN O
this DT O
event NN O
. . O

An DT O
ASSEMBLER NNP O
routine NN O
for IN O
on IN O
- : O
line NN O
graphic JJ O
display NN O
and CC O
averaging NN O
of IN O
data NNS O
acquired VBN O
on IN O
a DT O
personal JJ O
microcomputer NN O
. . O

The DT O
human JJ B-Gene
RAD30B NNP I-Gene
and CC O
mouse VB B-Gene
Rad30b NNP I-Gene
mRNA NN I-Gene
transcripts NNS I-Gene
, , O
like IN O
many JJ O
repair NN O
proteins NNS O
, , O
are VBP O
highly RB O
expressed VBN O
in IN O
the DT O
testis NN O
. . O

The DT O
experiment NN O
included VBD O
6 CD O
male NN O
and CC O
4 CD O
female JJ O
healthy JJ O
subjects NNS O
who WP O
, , O
during IN O
a DT O
24 CD O
- : O
hour NN O
stay NN O
in IN O
the DT O
respiration NN O
chambers NNS O
, , O
performed VBN O
, , O
in IN O
the DT O
morning NN O
and CC O
afternoon NN O
, , O
15 CD O
min NN O
cycling NN O
with IN O
the DT O
total JJ O
work NN O
of IN O
6 CD O
, , O
750 CD O
kg NN O
m NN O
. . O

Pronounced NNP O
microangiopathy MD O
characterized VBN O
by IN O
avascular JJ O
fields NNS O
, , O
enlarged VBD O
and CC O
tortuous JJ O
capillaries NNS O
and CC O
increased VBD O
transcapillary JJ O
diffusion NN O
of IN O
sodium NN O
fluorescein NN O
, , O
was VBD O
clearly RB O
demonstrable JJ O
in IN O
the DT O
area NN O
of IN O
the DT O
nodules NNS O
. . O

Amino NNP O
acid JJ O
sequence NN O
comparisons NNS O
of IN O
the DT O
E74A NNP B-Gene
protein NN I-Gene
reveal VBD O
a DT O
highly RB O
conserved VBN O
C NNP O
- : O
terminal JJ O
region NN O
that WDT O
is VBZ O
rich JJ O
in IN O
basic JJ O
amino NN O
acid NN O
residues NNS O
and CC O
which WDT O
has VBZ O
been VBN O
proposed VBN O
to TO O
possess VB O
sequence NN O
- : O
specific JJ O
DNA NNP O
binding NN O
activity NN O
. . O

Secondary JJ O
pancreatic JJ O
involvement NN O
of IN O
mycosis NN O
fungoides NNS O
detected VBN O
by IN O
a DT O
clinically RB O
palpable JJ O
mass NN O
. . O

EM NNP O
analysis NN O
demonstrated VBD O
that IN O
only RB O
one CD O
Rep NNP B-Gene
- : I-Gene
DNA NN I-Gene
complex NN I-Gene
was VBD O
formed VBN O
on IN O
ch NN O
- : O
19 CD O
target NN O
DNA NNP O
. . O

Two CD O
such JJ O
genes NNS O
, , O
designated VBN O
hsiggll150 NN B-Gene
and CC O
hsiggll295 NN B-Gene
, , O
were VBD O
cloned VBN O
and CC O
sequenced VBN O
from IN O
genomic JJ O
DNA NN O
. . O

Induction NN O
of IN O
CD86 NNP B-Gene
expression NN O
by IN O
stimulation NN O
of IN O
U937 NNP O
cells NNS O
with IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
revealed VBD O
the DT O
presence NN O
of IN O
two CD O
functional JJ O
GAS NNP B-Gene
( ( O
gamma JJ B-Gene
- : I-Gene
interferon NN I-Gene
activation NN I-Gene
site NN I-Gene
) ) O
elements NNS O
. . O

Residual JJ O
amphotericin NN O
B NNP O
was VBD O
detected VBN O
in IN O
the DT O
feces NNS O
of IN O
the DT O
mice NN O
only RB O
while IN O
they PRP O
were VBD O
receiving VBG O
the DT O
0 CD O
. . O
3 CD O
mg JJ O
/ NNP O
ml NN O
dose NN O
level NN O
. . O

In IN O
addition NN O
, , O
we PRP O
find VBP O
that IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
can MD O
cause VB O
apoptosis NN O
in IN O
p53 NN B-Gene
- : I-Gene
/ SYM I-Gene
- : I-Gene
tumour NN O
cells NNS O
and CC O
further JJ O
p300 NN B-Gene
, , O
which WDT O
also RB O
functions VBZ O
as IN O
a DT O
co NN O
- : O
activator NN O
for IN O
the DT O
E2F NNP B-Gene
/ NNP O
DP NNP B-Gene
heterodimer NN O
, , O
enhances VBZ O
the DT O
apoptotic JJ O
activity NN O
of IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Previously RB O
, , O
we PRP O
showed VBD O
that IN O
SNF2 NNP B-Gene
, , O
SNF5 NNP B-Gene
, , O
and CC O
SNF6 NNP B-Gene
function NN O
interdependently RB O
in IN O
transcriptional JJ O
activation NN O
, , O
possibly RB O
forming VBG O
a DT O
heteromeric JJ O
complex NN O
. . O

Intermediate NNP O
levels NNS O
of IN O
gene NN O
activity NN O
were VBD O
observed VBN O
for IN O
TnI NNP B-Gene
enhancers NNS I-Gene
containing VBG O
E NNP O
- : O
boxes NNS O
derived VBN O
from IN O
the DT O
MCK NNP B-Gene
left VBD I-Gene
E NNP I-Gene
- : I-Gene
box NN I-Gene
site NN I-Gene
or CC O
from IN O
the DT O
Ig NNP B-Gene
kappa NNP I-Gene
E2 NNP I-Gene
E NNP I-Gene
- : I-Gene
box NN I-Gene
. . O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
OsPSK NNP B-Gene
, , O
a DT O
gene NN O
encoding VBG O
a DT O
precursor NN O
for IN O
phytosulfokine JJ B-Gene
- : I-Gene
alpha NN I-Gene
, , O
required VBN O
for IN O
rice NN O
cell NN O
proliferation NN O
. . O

There EX O
was VBD O
evidence NN O
of IN O
attenuated JJ O
regression NN O
slopes NNS O
relating VBG O
recalled VBD O
to TO O
observed JJ O
portion NN O
sizes NNS O
for IN O
4 CD O
of IN O
the DT O
10 CD O
food NN O
groups NNS O
; : O
adjusted VBN O
r2 NN O
values NNS O
for IN O
the DT O
recalled JJ O
portion NN O
sizes NNS O
ranged VBD O
from IN O
0 CD O
. . O
2 CD O
to TO O
0 CD O
. . O
94 CD O
. . O

A DT O
promoter NN O
sequence NN O
( ( O
Goldberg NNP O
- : O
Hogness NN O
or CC O
TATA NNP O
box NN O
) ) O
is VBZ O
situated VBN O
28 CD O
base NN O
pairs NNS O
upstream RB O
from IN O
the DT O
point NN O
of IN O
initiation NN O
of IN O
transcription NN O
which WDT O
was VBD O
found VBN O
by IN O
S1 NNP B-Gene
nuclease NN I-Gene
mapping NN O
and CC O
by IN O
oligonucleotide JJ O
- : O
primed JJ O
reverse JJ O
transcription NN O
of IN O
rat NN B-Gene
PTH NNP I-Gene
mRNA NN I-Gene
. . O

A DT O
single JJ O
- : O
case NN O
experimental JJ O
ABAB NNP O
multiple NN O
baseline NN O
design NN O
was VBD O
employed VBN O
to TO O
test VB O
for IN O
treatment NN O
effectiveness NN O
. . O

Replacement NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
5 CD O
' '' O
- : O
regulatory JJ O
region NN O
with IN O
either DT O
of IN O
the DT O
mutants NNS O
' POS O
cis NN O
- : O
acting VBG O
regulatory JJ O
element NN O
resulted VBD O
in IN O
the DT O
anaerobic JJ O
expression NN O
of IN O
active JJ B-Gene
Mn NNP I-Gene
- : I-Gene
superoxide NN I-Gene
dismutase NN I-Gene
. . O

We PRP O
determined VBD O
whether IN O
a DT O
single JJ O
injection NN O
of IN O
slow JJ O
- : O
release NN O
estradiol SYM O
- : O
17beta CD O
( ( O
SRE2 NNP O
) ) O
would MD O
induce VB O
pseudopregnancy NN O
in IN O
gilts NNS O
and CC O
whether IN O
PGF2alpha NNP O
would MD O
regress VB O
the DT O
corpora NN O
lutea NN O
( ( O
CL NNP O
) ) O
of IN O
pseudopregnancy NN O
. . O

The DT O
state NN O
of IN O
the DT O
liver NN O
in IN O
generalized JJ O
forms NNS O
of IN O
meningococcal JJ O
infection NN O

By IN O
analyzing VBG O
5 CD O
' '' O
- : O
deletion NN O
insulin NN B-Gene
promoter NN I-Gene
- : I-Gene
reporter NN I-Gene
constructs NNS I-Gene
in IN O
transient JJ O
transfections NNS O
of IN O
clonal JJ O
INS NNP B-Gene
- : I-Gene
1 CD I-Gene
beta SYM I-Gene
- : O
cells NNS O
, , O
we PRP O
located VBD O
activating VBG O
Hh NNP B-Gene
- : O
responsive JJ O
regions NNS O
within IN O
the DT O
rat NN B-Gene
insulin NN I-Gene
I PRP I-Gene
promoter VBP I-Gene
that WDT O
include VBP O
the DT O
glucose JJ O
- : O
response NN O
elements NNS O
Far NNP O
( ( O
E2 NNP O
) ) O
and CC O
Flat NNP O
( ( O
A2 NNP O
/ NNP O
A3 NNP O
) ) O
. . O

Articles NNS O
addressing VBG O
valvular JJ O
heart NN O
disease NN O
or CC O
heart NN O
failure NN O
secondary JJ O
to TO O
acute VB O
myocardial JJ O
infarction NN O
or CC O
Chagas NNP O
' POS O
disease NN O
were VBD O
excluded VBN O
. . O

During IN O
the DT O
dose JJ O
- : O
finding NN O
, , O
two CD O
patients NNS O
were VBD O
temporarily RB O
withdrawn VBN O
from IN O
medication NN O
and CC O
one CD O
patient NN O
was VBD O
excluded VBN O
because IN O
of IN O
elevated JJ O
levels NNS O
of IN O
liver NN O
enzymes NNS O
. . O

The DT O
Sp1 NNP B-Gene
region NN I-Gene
, , O
however RB O
, , O
is VBZ O
converted VBN O
to TO O
a DT O
functionally RB O
strong JJ O
TRE NNP O
by IN O
the DT O
viral JJ B-Gene
tat NN I-Gene
factor NN I-Gene
. . O

Thus RB O
, , O
NART NNP O
- : O
R NNP O
performance NN O
may MD O
not RB O
be VB O
a DT O
valid JJ O
estimate NN O
of IN O
baseline NN O
IQ NNP O
for IN O
patients NNS O
with IN O
neurologic JJ O
disorders NNS O
with IN O
suspected JJ O
language NN O
impairment NN O
. . O

Type $ B-Gene
2 CD I-Gene
deiodinase NN I-Gene
( ( O
D2 NNP B-Gene
) ) O
catalyzes VBZ O
the DT O
5 CD O
' POS O
- : O
deiodination NN O
of IN O
thyroxine NN O
to TO O
form VB O
3 CD O
, , O
5 CD O
, , O
3 CD O
' POS O
- : O
triiodothyronine NN O
. . O

A DT O
mutation NN O
linked VBN O
to TO O
the DT O
SOC1 NNP B-Gene
gene NN I-Gene
, , O
previously RB O
defined VBN O
by IN O
recessive JJ O
mutations NNS O
that WDT O
suppress VBP O
cbp1 JJ B-Gene
ts NN I-Gene
alleles NNS I-Gene
and CC O
stabilize VB O
many JJ O
mitochondrial JJ O
mRNAs NN O
, , O
was VBD O
also RB O
isolated VBN O
. . O

However RB O
, , O
multiple JJ O
alanine JJ O
substitutions NNS O
or CC O
proline NN O
( ( O
helix JJ O
- : O
destabilizing NN O
) ) O
substitutions NNS O
disrupted VBD O
both DT O
oligomerization NN O
and CC O
transport NN O
of IN O
GP64 NNP B-Gene
EFP NNP I-Gene
. . O

It PRP O
is VBZ O
useful JJ O
as IN O
an DT O
adjunct NN O
to TO O
mammography NN O
in IN O
those DT O
patients NNS O
with IN O
radiographically RB O
dense JJ O
breasts NNS O
for IN O
the DT O
characterization NN O
of IN O
palpable JJ O
masses NNS O
. . O

Sulfhydryl NNP O
titration NN O
with IN O
iodoacetamide NN O
, , O
monitored VBN O
by IN O
quantitating VBG O
the DT O
residual JJ O
thiols NNS O
after IN O
reaction NN O
with IN O
a DT O
maleimide JJ O
derivative NN O
of IN O
biotin NN O
, , O
revealed VBD O
a DT O
striking JJ O
difference NN O
in IN O
the DT O
apparent JJ O
pK NN O
( ( O
a DT O
) ) O
values NNS O
of IN O
the DT O
cysteines NNS O
at IN O
the DT O
two CD O
splice NN O
junctions NNS O
. . O

When WRB O
phencyclidine NN O
was VBD O
administered VBN O
alone RB O
, , O
overall JJ O
response NN O
rate NN O
decreased VBN O
and CC O
percent JJ O
errors NNS O
increased VBD O
with IN O
increasing VBG O
doses NNS O
. . O

Constitutive JJ O
function NN O
of IN O
a DT O
positively RB O
regulated VBN O
promoter NN O
reveals VBZ O
new JJ O
sequences NNS O
essential JJ O
for IN O
activity NN O
. . O

Furthermore RB O
, , O
ICER NNP B-Gene
negatively RB O
autoregulates VBZ O
the DT O
alternative JJ O
promoter NN O
, , O
thus RB O
generating VBG O
a DT O
feedback NN O
loop NN O
. . O

Furthermore RB O
, , O
bone NN O
marrow SYM O
- : O
derived VBN O
macrophages NNS O
from IN O
LAT NNP B-Gene
- : O
deficient NN O
mice NN O
displayed VBD O
reduced VBN O
phagocytic JJ O
efficiency NN O
in IN O
comparison NN O
to TO O
the DT O
macrophages NNS O
from IN O
wild JJ O
- : O
type NN O
mice NN O
. . O

Increased VBN O
p53 NN B-Gene
activity NN O
induced VBN O
by IN O
OP NNP O
is VBZ O
not RB O
due JJ O
to TO O
elevated VBN O
p53 NN B-Gene
mRNA NNS I-Gene
nor CC O
to TO O
protein NN O
levels NNS O
. . O

MBI NNP O
and CC O
MMBI NNP O
showed VBD O
similar JJ O
Cmax NNP O
values NNS O
, , O
but CC O
the DT O
former JJ O
disappeared VBD O
slower JJR O
in IN O
the DT O
serum NN O
than IN O
the DT O
latter JJ O
and CC O
resulted VBD O
in IN O
its PRP$ O
larger JJR O
AUC NNP O
values NNS O
. . O

The DT O
sequence NN O
was VBD O
determined VBN O
for IN O
a DT O
4024 CD O
- : O
base NN O
pair NN O
( ( O
bp NN O
) ) O
segment NN O
that WDT O
extends VBZ O
from IN O
149 CD O
bp NN O
5 CD O
' '' O
to TO O
the DT O
cap NN O
site NN O
of IN O
alpha JJ B-Gene
1 CD I-Gene
to TO O
207 CD O
bp NN O
3 CD O
' '' O
to TO O
psi VB B-Gene
alpha NN I-Gene
. . O

A DT O
study NN O
of IN O
the DT O
comparative JJ O
efficacy NN O
of IN O
diflucortolone NN O
valerate NN O
0 CD O
. . O
3 CD O
% NN O
ointment NN O
and CC O
clobetasol NN O
propionate NN O
0 CD O
. . O
5 CD O
% NN O
ointment NN O
. . O

Therefore RB O
, , O
recombinant JJ O
human JJ O
Ads NN O
that WDT O
express RB O
noninfectious JJ O
HIV NNP O
or CC O
other JJ O
microbial JJ O
proteins NNS O
are VBP O
attractive JJ O
vaccine NN O
candidates NNS O
. . O

Utero NNP O
- : O
placental JJ O
blood NN O
flow NN O
and CC O
the DT O
effect NN O
of IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
adrenoceptor NN I-Gene
stimulating VBG O
drugs NNS O
. . O

Deletion NN O
and CC O
site NN O
- : O
directed VBN O
mutagenesis NN O
localized VBD O
a DT O
novel JJ O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
regulatory JJ I-Gene
element NN I-Gene
( ( O
TCA NNP O
GGGCCA NNP O
; : O
- : O
137 CD O
to TO O
- : O
129 CD O
) ) O
adjacent NN O
to TO O
a DT O
variant NN O
cAMP SYM O
- : O
response NN O
element NN O
( ( O
CRE NNP O
; : O
- : O
120 CD O
to TO O
- : O
114 CD O
) ) O
. . O

The DT O
full JJ O
length NN O
cDNA NN O
sequence NN O
of IN O
a DT O
Type NNP B-Gene
I PRP I-Gene
transforming VBG I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
( ( I-Gene
TGF NNP I-Gene
- : I-Gene
beta NN I-Gene
) ) I-Gene
receptor NN I-Gene
has VBZ O
been VBN O
isolated VBN O
from IN O
the DT O
filarial JJ O
parasitic JJ O
nematode NN O
Brugia NNP O
pahangi NN O
. . O

In IN O
8 CD O
healthy JJ O
volunteers NNS O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
AUC NNP O
, , O
peak NN O
plasma NN O
concentrations NNS O
or CC O
time NN O
to TO O
peak VB O
concentration NN O
when WRB O
OXC NNP O
was VBD O
administered VBN O
either RB O
with IN O
or CC O
without IN O
ERY NNP O
. . O

Diallylnitrosamine NNP O
( ( O
DAN NNP O
) ) O
, , O
one CD O
of IN O
the DT O
few JJ O
nitrosamines NNS O
tested VBN O
thus RB O
far RB O
that DT O
has VBZ O
not RB O
induced VBN O
neoplasms NNS O
in IN O
rats NNS O
, , O
caused VBD O
a DT O
high JJ O
incidence NN O
of IN O
respiratory NN O
tract NN O
tumors NNS O
in IN O
Syrian JJ O
golden JJ O
hamsters NNS O
treated VBD O
sc NN O
with IN O
single JJ O
or CC O
weekly JJ O
doses NNS O
of IN O
the DT O
compound NN O
. . O

Unlike IN O
P135gag NNP B-Gene
- : O
myb NN B-Gene
- : O
ets NNS B-Gene
and CC O
the DT O
Mr NNP O
75 CD O
, , O
0 CD O
translation NN O
product NN O
of IN O
c JJ B-Gene
- : I-Gene
myb NN I-Gene
( ( O
P75c NNP B-Gene
- : I-Gene
myb NN I-Gene
) ) O
, , O
which WDT O
are VBP O
nuclear JJ O
proteins NNS O
, , O
P54c NNP B-Gene
- : I-Gene
ets NNS I-Gene
was VBD O
found VBN O
to TO O
be VB O
predominantly RB O
cytoplasmic JJ O
. . O

Two CD O
of IN O
the DT O
three CD O
groups NNS O
were VBD O
administered VBN O
dauricine NN O
, , O
as IN O
a DT O
new JJ O
calcium NN O
channel NN O
blocker NN O
, , O
and CC O
verapamil RB O
, , O
as IN O
a DT O
generally RB O
recognized VBN O
calcium NN O
channel NN O
blocker NN O
, , O
respectively RB O
, , O
from IN O
15 CD O
minutes NNS O
pre VBP O
- : O
bypass NN O
to TO O
the DT O
end NN O
of IN O
the DT O
bypass NN O
procedure NN O
( ( O
a DT O
period NN O
of IN O
95 CD O
minutes NNS O
) ) O
. . O

In IN O
particular JJ O
, , O
71 CD O
and CC O
69 CD O
% NN O
amino NN O
acid JJ O
sequence NN O
similarities NNS O
were VBD O
identified VBN O
with IN O
hsp70 NN B-Gene
of IN I-Gene
Escherichia NNP I-Gene
coli NNS I-Gene
and CC I-Gene
Bacillus NNP I-Gene
megaterium NN I-Gene
, , O
respectively RB O
. . O

Whole JJ O
blood NN O
serotonin NN O
levels NNS O
were VBD O
investigated VBN O
in IN O
a DT O
control NN O
group NN O
( ( O
n JJ O
= NNP O
35 CD O
) ) O
and CC O
in IN O
a DT O
group NN O
of IN O
chronic JJ O
renal JJ O
failure NN O
patients NNS O
( ( O
n JJ O
= NNP O
127 CD O
) ) O
on IN O
various JJ O
treatment NN O
regimen NNS O
i VBP O
. . O
e NN O
. . O
conservative JJ O
treatment NN O
( ( O
n JJ O
= NNP O
39 CD O
) ) O
, , O
maintenance NN O
haemodialysis NN O
( ( O
n JJ O
= NNP O
35 CD O
) ) O
and CC O
after IN O
renal JJ O
transplantation NN O
( ( O
n JJ O
= NNP O
53 CD O
) ) O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
rep VBP B-Gene
strongly RB O
enhances VBZ O
the DT O
function NN O
of IN O
negative JJ O
regulatory JJ O
elements NNS O
of IN O
the DT O
LTR NNP O
. . O

These DT O
differences NNS O
involve VBP O
specific JJ O
hydrogen NN O
- : O
bonding NN O
interactions NNS O
between IN O
the DT O
protein NN O
and CC O
DNA NNP O
, , O
including VBG O
guanine NN O
N7 NNP O
sites VBZ O
in IN O
the DT O
major JJ O
groove NN O
of IN O
DNA NNP O
, , O
and CC O
alterations NNS O
in IN O
DNA NNP O
phosphodiester NN O
conformation NN O
induced VBN O
by IN O
protein NN O
binding NN O
. . O

Effect NN O
of IN O
immune NN O
lymphocytes NNS O
and CC O
of IN O
rabbit NN B-Gene
- : I-Gene
anti NN I-Gene
- : I-Gene
lymphocyte NN I-Gene
globulin NN I-Gene
( ( O
RAMLG NNP B-Gene
) ) O
on IN O
infected VBN O
macrophages NNS O
exposed VBN O
to TO O
increased VBN O
incubation NN O
temperature NN O
in IN O
vitro NN O
. . O

Neurons NNS O
were VBD O
held VBN O
at IN O
- : O
67 CD O
mV NN O
to TO O
equate VB O
voltage NN O
- : O
dependent JJ O
effects NNS O
. . O

However RB O
, , O
when WRB O
domain NN O
I PRP O
and CC O
domain VB O
II NNP O
were VBD O
linked VBN O
on IN O
the DT O
same JJ O
plasmid NN O
, , O
high JJ O
levels NNS O
of IN O
replication NN O
were VBD O
observed VBN O
. . O

The DT O
gene NN O
encodes VBZ O
an DT O
ATP NNP B-Gene
- : I-Gene
binding NN I-Gene
cassette NN I-Gene
, , O
ABC NNP B-Gene
transporter NN I-Gene
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
prostate NN O
carcinomas NN O
with IN O
the DT O
Ras NNP B-Gene
/ NNP O
MAPK NNP B-Gene
pathway POS O
activation NN O
might MD O
have VB O
a DT O
selective JJ O
growth NN O
advantage NN O
by IN O
autocrine NN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
production NN O
. . O

Homograft NNP O
response NN O
and CC O
hemagglutinin NN B-Gene
production NN O
by IN O
sensitized JJ O
thymectomized VBN O
irradiated JJ O
adult NN O
mice NN O
. . O

In IN O
order NN O
to TO O
quantify VB O
these DT O
effects NNS O
, , O
tests NNS O
were VBD O
conducted VBN O
in IN O
the DT O
NASA NNP O
MSFC NNP O
Neutral NNP O
Buoyancy NNP O
Simulator NNP O
, , O
in IN O
the DT O
NASA NNP O
KC NNP O
- : O
135 CD O
in IN O
parabolic JJ O
flight NN O
, , O
and CC O
in IN O
space NN O
with IN O
the DT O
EASE NNP O
program NN O
during IN O
the DT O
Shuttle NNP O
Atlantis NNP O
mission NN O
61 CD O
- : O
B NN O
. . O

These DT O
results NNS O
suggested VBD O
that IN O
the DT O
GG NNP O
motifs NNS O
contributed VBD O
to TO O
the DT O
cell NN O
- : O
specific JJ O
transcription NN O
of IN O
the DT O
human JJ B-Gene
insulin NN I-Gene
gene NN I-Gene
in IN O
association NN O
with IN O
the DT O
binding NN O
of IN O
the DT O
sequence NN O
- : O
specific JJ O
nuclear JJ O
factor NN O
. . O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN O
, , O
CHEMR1 NNP B-Gene
, , O
encoding VBG O
a DT O
chemokine NN O
receptor NN O
with IN O
a DT O
homology NN O
to TO O
the DT O
human JJ B-Gene
C NNP I-Gene
- : I-Gene
C NNP I-Gene
chemokine NN I-Gene
receptor NN I-Gene
, , O
CCR NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

This DT O
phenomenon NN O
may MD O
be VB O
regarded VBN O
as IN O
a DT O
variant NN O
of IN O
selective JJ O
individual JJ O
cell NN O
death NN O
, , O
currently RB O
referred VBN O
to TO O
as IN O
apoptosis NN O
, , O
which WDT O
has VBZ O
not RB O
been VBN O
previously RB O
reported VBN O
in IN O
a DT O
case NN O
of IN O
embryonal JJ O
rhabdomyosarcoma NN O
. . O

Rheumatoid NNP B-Gene
factor NN I-Gene
and CC O
antinuclear JJ O
antibody NN O
tests NNS O
were VBD O
frequently RB O
positive JJ O
, , O
and CC O
reactions NNS O
to TO O
gold VB O
therapy NN O
were VBD O
more RBR O
frequent JJ O
than IN O
in IN O
other JJ O
rheumatoid JJ O
populations NNS O
. . O

Specifically RB O
, , O
they PRP O
were VBD O
performed VBN O
to TO O
determine VB O
whether IN O
detection NN O
of IN O
envelope NN O
phase NN O
disparity NN O
was VBD O
consistent JJ O
with IN O
processing NN O
within IN O
a DT O
single JJ O
channel NN O
in IN O
which WDT O
the DT O
AM NNP O
tones NNS O
were VBD O
simply RB O
added VBN O
. . O

Ten CD O
males NNS O
performed VBD O
both DT O
test NN O
conditions NNS O
and CC O
oxygen NN O
uptake JJ O
VO2 NNP O
, , O
heart NN O
rate NN O
, , O
minute NN O
ventilation NN O
VE NNP O
, , O
perceived VBD O
exertion NN O
and CC O
spinal JJ O
shrinkage NN O
were VBD O
recorded VBN O
. . O

By IN O
sequence NN O
comparison NN O
, , O
42 CD O
blocks NNS O
of IN O
homology NN O
are VBP O
defined VBN O
in IN O
the DT O
5 CD O
' POS O
- : O
terminal JJ O
region NN O
, , O
of IN O
which WDT O
36 CD O
appear NN O
in IN O
the DT O
CpG NNP O
island NN O
and CC O
contain VBP O
numerous JJ O
conserved VBN O
CpG NNP O
dinucleotides NNS O
. . O

Characterization NN O
of IN O
polymorphic JJ O
TNRs NNP O
in IN O
novel NN O
and CC O
even RB O
known VBN O
genes NNS O
expressed VBN O
in IN O
human JJ O
spinal JJ O
cord NN O
is VBZ O
likely JJ O
to TO O
help VB O
in IN O
the DT O
identification NN O
of IN O
new JJ O
candidates NNS O
for IN O
genes NNS O
involved VBN O
in IN O
neurodegenerative JJ O
disorders NNS O
. . O

Tumor NN O
stages NNS O
were VBD O
IIB NNP O
( ( O
T3 NNP O
N0 NNP O
) ) O
in IN O
52 CD O
% NN O
, , O
IIIA NNP O
in IN O
15 CD O
% NN O
, , O
and CC O
IIIB NNP O
in IN O
27 CD O
% NN O
of IN O
patients NNS O
. . O

All DT O
patients NNS O
had VBD O
abnormal JJ O
von NNS B-Gene
Willebrand NNP I-Gene
factor NN I-Gene
( ( O
vWF NN B-Gene
) ) O
fragmentation NN O
as IN O
reflected VBN O
by IN O
decreased JJ O
high JJ O
molecular JJ O
weight NN O
and CC O
increased VBD O
low JJ O
molecular JJ O
weight NN O
vWF NN B-Gene
multimers NNS I-Gene
in IN O
the DT O
circulation NN O
. . O

Indeed RB O
, , O
A DT O
- : O
MuLV NN O
pseudotyped VBD O
with IN O
some DT O
viruses NNS O
, , O
such JJ O
as IN O
the DT O
Moloney NNP O
MuLV NNP O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
highly RB O
lymphogenic JJ O
, , O
whereas IN O
A NNP O
- : O
MuLV NNP O
pseudotyped VBD O
with IN O
other JJ O
viruses NNS O
, , O
such JJ O
as IN O
the DT O
BALB NNP O
/ NNP O
c VBP O
endogenous JJ O
N NNP O
- : O
tropic NN O
MuLV NNP O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
devoid NN O
of IN O
lymphogenic JJ O
potential NN O
( ( O
N NNP O
. . O

The DT O
two CD O
cysteine NN O
residues NNS O
located VBN O
in IN O
this DT O
additional JJ O
region NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
formation NN O
of IN O
a DT O
disulfide NN O
bridge NN O
associated VBN O
with IN O
the DT O
activation NN O
process NN O
of IN O
the DT O
catalytic JJ O
activity NN O
. . O

Blood NN O
levels NNS O
of IN O
melatonin NN O
, , O
serotonin NN O
, , O
cortisol NN O
, , O
and CC O
prolactin NN B-Gene
in IN O
relation NN O
to TO O
the DT O
circadian JJ O
rhythm NN O
of IN O
platelet NN O
serotonin NN O
uptake NN O
. . O

Raes NNP O
, , O
P NNP O
. . O

One CD O
unit NN O
encodes VBZ O
traA NN B-Gene
, , O
traF NN B-Gene
, , O
and CC O
traB NNS B-Gene
, , O
while IN O
the DT O
second JJ O
encodes NNS O
traC NN B-Gene
, , O
traD NN B-Gene
, , O
and CC O
traG NN B-Gene
. . O

Thus RB O
, , O
the DT O
B NNP O
- : O
S NN O
mutant NN O
does VBZ O
not RB O
mimic VB O
efficiently RB O
the DT O
chloroplastic JJ B-Gene
GAPDHs NNP I-Gene
, , O
and CC O
long RB O
- : O
range NN O
and CC O
/ NN O
or CC O
second JJ O
- : O
layer NN O
effects NNS O
, , O
not RB O
easily RB O
predictable JJ O
from IN O
visual JJ O
inspection NN O
of IN O
three CD O
- : O
dimensional JJ O
structures NNS O
, , O
need VBP O
to TO O
be VB O
taken VBN O
into IN O
account NN O
for IN O
designing VBG O
a DT O
true JJ O
"""" NNP O
chloroplastic JJ O
- : O
like IN O
"""" NNP O
mutant NN O
of IN O
cytosolic JJ B-Gene
GAPDH NNP I-Gene
. . O

Max NN B-Gene
: : O
functional JJ O
domains NNS O
and CC O
interaction NN O
with IN O
c JJ B-Gene
- : I-Gene
Myc NN I-Gene
. . O

In IN O
humans NNS O
, , O
four CD O
AMP NNP B-Gene
deaminase NN I-Gene
variants NNS I-Gene
, , O
termed VBN O
M NNP B-Gene
( ( O
muscle NN O
) ) O
, , O
L NNP B-Gene
( ( O
liver NN O
) ) O
, , O
E1 NNP B-Gene
, , O
and CC O
E2 NNP B-Gene
( ( O
erythrocyte NN O
) ) O
can MD O
be VB O
distinguished VBN O
by IN O
a DT O
variety NN O
of IN O
biochemical JJ O
and CC O
immunological JJ O
criteria NNS O
. . O

To TO O
assess VB O
the DT O
function NN O
( ( O
s JJ O
) ) O
of IN O
E74 NNP B-Gene
during IN O
metamorphosis NN O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
recessive JJ O
loss NN O
- : O
of IN O
- : O
function NN O
mutations NNS O
specific VBP O
to TO O
each DT O
transcription NN O
unit NN O
. . O

The DT O
O2 NNP O
deficit NN O
was VBD O
not RB O
related VBN O
to TO O
blood VB O
lactate NN O
during IN O
submaximal JJ O
exercise NN O
, , O
muscle NN O
enzyme NN O
activity NN O
( ( O
citrate JJ B-Gene
synthase NN I-Gene
, , O
3 CD B-Gene
- : I-Gene
hydroxyacyl NN I-Gene
- : I-Gene
CoA NNP I-Gene
- : I-Gene
dehydrogenase NN I-Gene
, , O
lactate JJ B-Gene
dehydrogenase NN I-Gene
) ) O
, , O
number NN O
of IN O
muscle NN O
capillaries NNS O
, , O
% NN O
ST NNP O
fibres VBZ O
or CC O
muscle NN O
buffer VBP O
capacity NN O
. . O

This DT O
study NN O
examined VBD O
the DT O
role NN O
of IN O
cholesteryl NN O
ester NN O
transfer NN O
( ( O
CET NNP O
) ) O
, , O
cholesteryl JJ B-Gene
ester NN I-Gene
transfer NN I-Gene
protein NN I-Gene
( ( O
CETP NNP B-Gene
) ) O
activity NN O
, , O
and CC O
phospholipid JJ B-Gene
transfer NN I-Gene
protein NN I-Gene
( ( O
PLTP NNP B-Gene
) ) O
activity NN O
in IN O
the DT O
increased JJ O
prevalence NN O
of IN O
coronary JJ O
artery NN O
calcification NN O
( ( O
CAC NNP O
) ) O
in IN O
diabetic JJ O
subjects NNS O
compared VBN O
with IN O
nondiabetic JJ O
subjects NNS O
and CC O
in IN O
the DT O
loss NN O
of IN O
the DT O
sex NN O
difference NN O
in IN O
CAC NNP O
in IN O
diabetes NNS O
. . O

Whether NNP O
or CC O
not RB O
there EX O
are VBP O
sequences NNS O
conferring VBG O
cAMP NN O
responsiveness NN O
which WDT O
are VBP O
common JJ O
both DT O
to TO O
P NNP B-Gene
- : I-Gene
450scc CD I-Gene
and CC O
the DT O
other JJ O
steroidogenic JJ O
P NNP B-Gene
- : I-Gene
450 CD I-Gene
genes NNS I-Gene
remains VBZ O
to TO O
be VB O
established VBN O
. . O

Decreased VBN O
serum NN B-Gene
ceruloplasmin NN I-Gene
and CC O
copper NN O
levels NNS O
in IN O
cervical JJ O
dystonia NN O
. . O

Here RB O
, , O
we PRP O
describe VBP O
directional JJ O
chromosome NN O
walking VBG O
studies NNS O
starting VBG O
from IN O
D8S260 NNP B-Gene
as RB O
well RB O
as IN O
D8S285 NNP B-Gene
. . O

Transcription NN O
factors NNS O
of IN O
the DT O
Stat NNP B-Gene
family NN I-Gene
are VBP O
controlled VBN O
by IN O
protein NN O
kinases NNS O
. . O

Exogenous JJ O
LHRH NNP B-Gene
is VBZ O
also RB O
known VBN O
to TO O
facilitate VB O
mating VBG O
behavior RB O
in IN O
several JJ O
species NNS O
. . O

From IN O
the DT O
Icelandic NNP O
Red NNP O
Cross NNP O
activities NNS O

The DT O
obvious JJ O
functional JJ O
necessity NN O
for IN O
editing VBG O
in IN O
kinetoplastid NN O
mitochondria NN O
is VBZ O
the DT O
formation NN O
of IN O
translatable JJ O
mRNAs NN O
. . O

Chagas NNP O
' POS O
disease NN O
, , O
visceral JJ O
leishmaniasis NN O
, , O
anti SYM B-Gene
- : I-Gene
nuclear JJ I-Gene
factor NN I-Gene
, , O
schistosomiasis NN O
, , O
rheumatoid JJ B-Gene
factor NN I-Gene
and CC O
normal JJ O
controls NNS O
. . O

y NN O
. . O

( ( O
5 CD O
) ) O
An DT O
increase NN O
in IN O
leukocyte JJ O
- : O
counts NNS O
occurred VBD O
on IN O
the DT O
administration NN O
of IN O
serum NN O
obtained VBN O
from IN O
rabbit NN O
during IN O
phase NN O
- : O
2 CD O
. . O

Computer NNP O
assisted VBD O
mapping NN O
in IN O
quantitative JJ O
analysis NN O
of IN O
cerebral JJ O
positron NN O
emission NN O
tomograms NNS O
. . O

We PRP O
have VBP O
isolated VBN O
and CC O
analyzed VBN O
human JJ B-Gene
CTCF NNP I-Gene
cDNA NN I-Gene
clones NNS O
and CC O
show NN O
here RB O
that IN O
the DT O
ubiquitously RB O
expressed VBN O
11 CD B-Gene
- : I-Gene
zinc NN I-Gene
- : I-Gene
finger NN I-Gene
factor NN I-Gene
CTCF NNP I-Gene
is VBZ O
an DT O
exceptionally RB O
highly RB O
conserved VBN O
protein NN O
displaying VBG O
93 CD O
% NN O
identity NN O
between IN O
avian JJ O
and CC O
human JJ O
amino NN O
acid NN O
sequences NNS O
. . O

To TO O
avoid VB O
complications NNS O
, , O
accurate JJ O
quantitative JJ O
analysis NN O
of IN O
NO NNP O
and CC O
NO2 NNP O
is VBZ O
necessary JJ O
during IN O
this DT O
therapy NN O
. . O

Specimens NNS O
were VBD O
assayed VBN O
for IN O
alpha JJ B-Gene
- : I-Gene
fetoprotein NN I-Gene
, , O
unconjugated JJ O
estriol NN O
, , O
free JJ O
alpha NN B-Gene
hCG NN I-Gene
, , O
and CC O
total JJ O
hCG NN B-Gene
. . O

Anesthesiologists NNS O
often RB O
use VBP O
more JJR O
than IN O
one CD O
drug NN O
in IN O
a DT O
patient NN O
to TO O
achieve VB O
a DT O
target NN O
response NN O
, , O
such JJ O
as IN O
a DT O
desired JJ O
blood NN O
pressure NN O
. . O

However RB O
, , O
the DT O
history NN O
of IN O
acute NN O
severe JJ O
complications NNS O
from IN O
otitis JJ O
media NNS O
revealed VBD O
a DT O
higher JJR O
frequency NN O
in IN O
those DT O
individuals NNS O
with IN O
alpha NN B-Gene
1 CD I-Gene
- : I-Gene
antitrypsin NN I-Gene
deficiency NN O
as IN O
compared VBN O
to TO O
normals NNS O
. . O

MR NNP O
imaging NN O
of IN O
traumatic JJ O
head NN O
injuries NNS O
using VBG O
FLAIR NNP O
technique NN O

In IN O
this DT O
study NN O
, , O
we PRP O
report VBP O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
the DT O
entire JJ O
rat NN B-Gene
GSTA3 NNP I-Gene
( ( O
rGST VB B-Gene
Yc1 NNP I-Gene
) ) O
subunit NN O
gene NN O
. . O

These DT O
indications NNS O
of IN O
deregulated JJ O
signalling NN O
in IN O
the DT O
absence NN O
of IN O
tyrosine NN O
118 CD O
were VBD O
substantiated VBN O
by IN O
sustained JJ O
activation NN O
of IN O
STAT3 NNP B-Gene
. . O

DNA NNP B-Gene
- : I-Gene
STAT NN I-Gene
complexes NNS I-Gene
were VBD O
detected VBN O
in IN O
all DT O
Bcr NNP B-Gene
/ NNP O
Abl NNP B-Gene
- : O
transformed VBD O
cell NN O
lines NNS O
and CC O
they PRP O
were VBD O
supershifted VBN O
by IN O
antibodies NNS O
against IN O
STAT1 NNP B-Gene
and CC O
STAT5 NNP B-Gene
. . O

A DT O
double JJ O
- : O
blind IN O
trial NN O
of IN O
half JJ O
- : O
strength NN O
Polybactrin NNP O
Soluble NNP O
GU NNP O
bladder NN O
irrigation NN O
in IN O
cystoscopy NN O
. . O

Abnormal JJ O
technetium NN O
Tc NNP O
99m CD O
medronate NN O
scans NNS O
in IN O
patients NNS O
with IN O
previously RB O
undiagnosed VBN O
polyarthralgias NN O
suggested VBD O
inflammatory JJ O
arthropathy NN O
and CC O
influenced JJ O
management NN O
decisions NNS O
with IN O
favorable JJ O
therapeutic JJ O
outcomes NNS O
. . O

A DT O
new JJ O
method NN O
for IN O
the DT O
quantitative JJ O
analysis NN O
of IN O
sleep JJ O
spindles NNS O
during IN O
continuous JJ O
overnight JJ O
EEG NNP O
recordings NNS O
. . O

To TO O
examine VB O
the DT O
biochemical JJ O
basis NN O
of IN O
the DT O
end NN O
joining NN O
, , O
nuclear JJ O
extracts NNS O
were VBD O
prepared VBN O
from IN O
a DT O
wide JJ O
variety NN O
of IN O
mammalian JJ O
cell NN O
lines NNS O
and CC O
tested VBN O
for IN O
their PRP$ O
ability NN O
to TO O
join VB O
test NN O
plasmid NN O
substrates NNS O
. . O

In IN O
order NN O
to TO O
investigate VB O
to TO O
what WP O
extent NN O
this DT O
interaction NN O
might MD O
contribute VB O
to TO O
tumor VB O
induction NN O
by IN O
the DT O
virus NN O
, , O
we PRP O
have VBP O
introduced VBN O
two CD O
different JJ O
point NN O
mutations NNS O
within IN O
the DT O
putative JJ O
pRb NN B-Gene
- : I-Gene
binding VBG I-Gene
sequence NN I-Gene
of IN O
large JJ B-Gene
T NNP I-Gene
antigen NN I-Gene
, , O
and CC O
as IN O
a DT O
preliminary JJ O
to TO O
in IN O
vivo JJ O
experiments NNS O
we PRP O
have VBP O
studied VBN O
their PRP$ O
effects NNS O
in IN O
vitro NN O
on IN O
some DT O
biological JJ O
activities NNS O
relevant VBP O
to TO O
tumor VB O
induction NN O
. . O

Eighty JJ O
patients NNS O
presenting VBG O
to TO O
HGGM NNP O
with IN O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphomas NN O
between IN O
1962 CD O
and CC O
1986 CD O
, , O
were VBD O
reviewed VBN O
. . O

Transient JJ O
transfection NN O
experiments NNS O
revealed VBD O
that IN O
Pax NNP B-Gene
- : I-Gene
8 CD I-Gene
isoforms NNS I-Gene
a DT I-Gene
and CC I-Gene
b NN I-Gene
, , O
but CC O
not RB O
c JJ O
and CC O
d JJ O
, , O
strongly RB O
stimulate JJ O
transcription NN O
from IN O
a DT O
promoter NN O
containing VBG O
six CD O
copies NNS O
of IN O
a DT O
paired JJ B-Gene
- : I-Gene
domain NN I-Gene
recognition NN I-Gene
sequence NN I-Gene
. . O

Blood NNP O
eosinophils NNS O
in IN O
patients NNS O
with IN O
Taenia NNP O
saginata NN O
taeniasis NN O
. . O

The DT O
linear JJ O
plasmid NN O
pDHL1 NN O
from IN O
Debaryomyces NNP O
hansenii NN O
encodes VBZ O
a DT O
protein NN O
highly RB O
homologous JJ O
to TO O
the DT O
pGKL1 NN B-Gene
- : I-Gene
plasmid NN I-Gene
DNA NNP I-Gene
polymerase NN I-Gene
. . O

RESULTS NN O
: : O
The DT O
overall JJ O
FNF NNP O
for IN O
1992 CD O
was VBD O
12 CD O
. . O
3 CD O
% NN O
and CC O
was VBD O
19 CD O
. . O
1 CD O
% NN O
, , O
22 CD O
. . O
2 CD O
% NN O
, , O
3 CD O
. . O
8 CD O
% NN O
and CC O
6 CD O
. . O
1 CD O
% NN O
per IN O
successive JJ O
quarters NNS O
in IN O
1992 CD O
. . O

Third NNP O
, , O
consistent JJ O
with IN O
these DT O
data NNS O
, , O
N NNP O
- : O
acetylcysteine NN O
reduced VBD O
the DT O
stimulatory JJ O
effect NN O
of IN O
HGF NNP B-Gene
on IN O
stress JJ B-Gene
kinase NN I-Gene
activities NNS O
, , O
while IN O
p42 JJ B-Gene
/ $ I-Gene
44 CD I-Gene
mitogen NN O
activated VBN O
kinase NN O
( ( O
MAPK NNP O
) ) O
was VBD O
unmodified JJ O
, , O
suggesting VBG O
an DT O
involvement NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
- : I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
and CC O
p38 JJ B-Gene
MAPK NNP O
in IN O
HIF NNP B-Gene
- : I-Gene
1 CD I-Gene
activation NN O
. . O

The DT O
site NN O
of IN O
autophosphorylation NN O
is VBZ O
Tyr397 NNP O
which WDT O
corresponds VBZ O
to TO O
the DT O
consensus NN O
autophosphorylation NN O
site NN O
of IN O
other JJ O
Src NNP B-Gene
family NN I-Gene
tyrosine NN B-Gene
kinases NNS I-Gene
. . O

C NNP O
. . O
, , O
Sun NNP O
, , O
J NNP O
. . O
, , O
Hsu NNP O
, , O
M NNP O
. . O
- : O
Y NN O
. . O
, , O
Vallejo NNP O
- : O
Ramirez NNP O
, , O
J NNP O
. . O
, , O
Inouye NNP O
, , O
S NNP O
. . O
, , O
and CC O
Inouye NNP O
, , O
M NNP O
. . O

Diagnostic JJ O
value NN O
of IN O
cerebrospinal JJ B-Gene
fluid NN I-Gene
immunoglobulin NN I-Gene
G NNP I-Gene
( ( O
IgG NNP B-Gene
) ) O
in IN O
pediatric JJ O
neurological JJ O
diseases NNS O
. . O

The DT O
cellular JJ O
sequences NNS O
5 CD O
' '' O
to TO O
the DT O
viral JJ O
integration NN O
site NN O
exhibited VBD O
85 CD O
to TO O
97 CD O
% NN O
identity NN O
to TO O
several JJ O
sequences NNS O
belonging VBG O
to TO O
the DT O
mouse NN B-Gene
L1 NNP I-Gene
family NN I-Gene
of IN O
long RB O
interspersed JJ O
repetitive JJ O
sequences NNS O
. . O

( ( O
iv NN O
) ) O
Although IN O
UCRBP NNP B-Gene
has VBZ O
been VBN O
previously RB O
shown VBN O
to TO O
act VB O
as IN O
a DT O
transcriptional JJ O
repressor NN O
, , O
we PRP O
show VBP O
here RB O
that IN O
UCRBP NNP B-Gene
can MD O
also RB O
act VB O
as IN O
a DT O
positive JJ O
transactivator NN O
of IN O
a DT O
reporter NN O
driven VBN O
by IN O
UCR NNP O
elements NNS O
when WRB O
used VBN O
in IN O
co JJ O
- : O
transfection NN O
assays NNS O
. . O

Immunologically RB O
reactive JJ O
insulin NN B-Gene
levels NNS O
were VBD O
determined VBN O
in IN O
freely RB O
- : O
moving VBG O
normal JJ O
rats NNS O
offered VBD O
three CD O
different JJ O
test NN O
- : O
meals NNS O
. . O

There EX O
was VBD O
a DT O
gradual JJ O
increase NN O
in IN O
the DT O
myocyte NN O
diameter NN O
according VBG O
to TO O
age NN O
in IN O
the DT O
biopsy NN O
and CC O
autopsy NN O
specimens NNS O
. . O

In IN O
CV NNP O
- : O
1 CD O
cells NNS O
, , O
cotransfection NN O
of IN O
the DT O
retinoid NN B-Gene
and CC I-Gene
estrogen NN I-Gene
receptors NNS I-Gene
led VBD O
to TO O
mutual JJ O
inhibition NN O
of IN O
the DT O
other JJ O
' POS O
s NN O
activity NN O
, , O
while IN O
an DT O
RA NNP O
- : O
dependent JJ O
inhibition NN O
of IN O
ER NNP B-Gene
activity NN O
was VBD O
observed VBN O
in IN O
breast NN O
cancer NN O
cells NNS O
. . O

Holliday NNP B-Gene
junction NN I-Gene
resolvase NN I-Gene
in IN O
Schizosaccharomyces NNP O
pombe NN O
has VBZ O
identical JJ O
endonuclease NN O
activity NN O
to TO O
the DT O
CCE1 NNP B-Gene
homologue NN O
YDC2 NNP B-Gene
. . O

Intact JJ O
Flag NNP O
- : O
tagged VBD O
protein JJ O
products NNS O
from IN O
all DT O
six CD O
were VBD O
produced VBN O
from IN O
genomic JJ O
expression NN O
vectors NNS O
, , O
although IN O
the DT O
ORF40 NNP O
/ NNP O
41 CD O
transcript NN O
encoding VBG O
a DT O
primase NN B-Gene
- : O
helicase NN B-Gene
component NN O
proved VBD O
to TO O
be VB O
spliced VBN O
with IN O
a DT O
127 CD O
- : O
bp NN O
intron NN O
. . O

Together RB O
with IN O
a DT O
considerably RB O
shortened VBN O
and CC O
interrupted VBN O
aromatic JJ O
aa NN O
stretch NN O
in IN O
this DT O
region NN O
, , O
these DT O
differences NNS O
are VBP O
discussed VBN O
in IN O
terms NNS O
of IN O
the DT O
peculiar JJ O
affinity NN O
of IN O
cyanobacterial JJ B-Gene
cytochrome NN I-Gene
oxidases NNS I-Gene
for IN O
acidic JJ O
c SYM B-Gene
- : I-Gene
type NN I-Gene
cytochromes NNS I-Gene
. . O

Sequence NN O
analysis NN O
reveals NNS O
that IN O
the DT O
DNA NNP O
binding VBG O
domain NN O
of IN O
ILF NNP B-Gene
has VBZ O
strong JJ O
homology NN O
to TO O
the DT O
recently RB O
described VBN O
fork NN B-Gene
head NN I-Gene
DNA NNP I-Gene
binding NN I-Gene
domain NN I-Gene
found VBD O
in IN O
the DT O
Drosophila NNP B-Gene
homeotic JJ I-Gene
protein NN I-Gene
fork NN I-Gene
head NN I-Gene
and CC O
a DT O
family NN O
of IN O
hepatocyte JJ B-Gene
nuclear JJ I-Gene
factors NNS I-Gene
, , O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

RESULTS NN O
: : O
Each DT O
year NN O
, , O
on IN O
average JJ O
39 CD O
% NN O
of IN O
cases NNS O
seen VBN O
in IN O
Sardinia NNP O
are VBP O
notified VBN O
; : O
646 CD O
( ( O
40 CD O
% NN O
) ) O
of IN O
the DT O
1591 CD O
patients NNS O
notified VBN O
during IN O
the DT O
study NN O
period NN O
were VBD O
never RB O
seen VBN O
by IN O
regional JJ O
medical JJ O
centres NNS O
. . O

Elevation NN O
of IN O
the DT O
tissues NNS O
of IN O
the DT O
face NN O
is VBZ O
essentially RB O
vertical JJ O
and CC O
acts VBZ O
on IN O
the DT O
forehead NN O
, , O
temporal JJ O
region NN O
, , O
gaze NN O
and CC O
cheekbones NNS O
. . O

Thus RB O
, , O
IRF NNP B-Gene
- : I-Gene
7 CD I-Gene
exhibits NNS O
functional JJ O
similarity NN O
to TO O
IRF NNP B-Gene
- : I-Gene
3 CD I-Gene
; : O
however RB O
, , O
the DT O
preferential JJ O
expression NN O
of IN O
IRF NNP B-Gene
- : I-Gene
7 CD I-Gene
in IN O
lymphoid JJ O
cells NNS O
( ( O
the DT O
cell NN O
type NN O
that WDT O
expresses VBZ O
IFNA NNP B-Gene
) ) O
suggests VBZ O
that IN O
IRF NNP B-Gene
- : I-Gene
7 CD I-Gene
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
regulating VBG O
the DT O
IFNA NNP B-Gene
gene NN I-Gene
expression NN O
. . O

Five CD O
out IN O
of IN O
eight CD O
consecutive JJ O
cases NNS O
with IN O
initial JJ O
symptoms NNS O
of IN O
a DT O
' POS O
midline JJ O
granuloma NN O
' POS O
were VBD O
identified VBN O
as IN O
malignant JJ O
histiocytosis NN O
( ( O
histiocytic JJ O
sarcoma NN O
) ) O
which WDT O
within IN O
5 CD O
months NNS O
to TO O
4 CD O
years NNS O
led VBD O
to TO O
generalization NN O
and CC O
death NN O
. . O

A DT O
technique NN O
for IN O
thermal JJ O
imaging NN O
of IN O
the DT O
animal NN O
and CC O
human JJ O
brain NN O
cortex NN O
using VBG O
an DT O
infrared JJ O
optical JJ O
system NN O
is VBZ O
described VBN O
. . O

In IN O
addition NN O
, , O
computer NN O
analysis NN O
suggests VBZ O
that IN O
sequences NNS O
similar JJ O
to TO O
the DT O
A NNP O
stem NN O
element NN O
are VBP O
present JJ O
within IN O
the DT O
three CD O
AAV NNP B-Gene
promoter NN I-Gene
regions NNS O
. . O

HIV NNP O
infectiousness NN O
and CC O
the DT O
AIDS NNP O
epidemic NN O
. . O

Once RB O
HIT NNP O
II NNP O
is VBZ O
suspected VBN O
, , O
heparin NN O
( ( O
and CC O
low JJ O
- : O
molecular JJ O
- : O
weight NN O
heparins NNS O
) ) O
should MD O
be VB O
stopped VBN O
immediately RB O
. . O

The DT O
HMG NNP B-Gene
CoA NNP I-Gene
reductase NN I-Gene
inhibitors NNS O
are VBP O
the DT O
most RBS O
effective JJ O
cholesterol NN O
- : O
lowering VBG O
agents NNS O
currently RB O
available JJ O
. . O

At IN O
the DT O
same JJ O
time NN O
we PRP O
obtained VBD O
easily RB O
understandable JJ O
EEG NNP O
- : O
information NN O
which WDT O
has VBZ O
never RB O
previously RB O
been VBN O
available JJ O
to TO O
us PRP O
. . O

Two CD O
predominant JJ O
effects NNS O
were VBD O
noted VBN O
: : O
( ( O
i NN O
) ) O
the DT O
Xaa NNP O
residue NN O
in IN O
the DT O
dual JJ O
phosphorylation NN O
motif NN O
Thr NNP O
- : O
Xaa SYM O
- : O
Tyr NN O
as RB O
well RB O
as IN O
the DT O
length NN O
of IN O
L12 NNP O
influence NN O
p38 NN B-Gene
substrate NN O
specificity NN O
, , O
and CC O
( ( O
ii NN O
) ) O
the DT O
length NN O
of IN O
L12 NNP O
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
controlling VBG O
autophosphorylation NN O
. . O

Prolonged VBN O
suspension NN O
induced VBD O
a DT O
significant JJ O
change NN O
in IN O
the DT O
geometric JJ O
configuration NN O
of IN O
the DT O
femur JJ O
middiaphysis NN O
by IN O
increasing VBG O
the DT O
minimum NN O
diameter NN O
( ( O
12 CD O
% NN O
) ) O
without IN O
any DT O
significant JJ O
alterations NNS O
in IN O
cortical JJ O
area NN O
, , O
density NN O
, , O
mineral NN O
, , O
and CC O
collagen NN B-Gene
concentrations NNS O
. . O

A DT O
method NN O
for IN O
determining VBG O
optimal JJ O
development NN O
conditions NNS O
by IN O
summary JJ O
oxygen NN O
consumption NN O

High JJ O
dosages NNS O
of IN O
D NNP O
- : O
penicillamine NN O
in IN O
pulmonary JJ O
fibroses NNS O

Acad NNP O
. . O

However RB O
, , O
the DT O
BCH NNP O
group NN O
showed VBD O
inferior JJ O
gross JJ O
motor NN O
performance NN O
on IN O
the DT O
Bruininks NNP O
- : O
Oseretsky JJ O
Test NNP O
of IN O
Motor NNP O
Proficiency NNP O
( ( O
Bruininks NNP O
1978 CD O
) ) O
. . O

We PRP O
also RB O
found VBD O
an DT O
eIF JJ B-Gene
- : I-Gene
4A CD I-Gene
intronless NN O
retroposon NN O
which WDT O
, , O
when WRB O
compared VBN O
to TO O
the DT O
cDNA NN O
, , O
contains VBZ O
a DT O
single JJ O
nucleotide NN O
difference NN O
. . O

The DT O
results NNS O
of IN O
replicase NN B-Gene
assays NNS O
performed VBN O
with IN O
mutant JJ B-Gene
VP2 NNP I-Gene
containing VBG O
a DT O
deletion NN O
in IN O
its PRP$ O
RNA NNP O
- : O
binding NN O
domain NN O
suggests VBZ O
that IN O
the DT O
essential JJ O
role NN O
for IN O
VP2 NNP B-Gene
in IN O
replication NN O
is VBZ O
linked VBN O
to TO O
the DT O
protein NN O
' POS O
s JJ O
ability NN O
to TO O
bind VB O
the DT O
mRNA NN O
template NN O
for IN O
minus NN O
- : O
strand NN O
synthesis NN O
. . O

The DT O
SH2 NNP B-Gene
and CC O
SH3 NNP B-Gene
domains NNS I-Gene
of IN O
pp60src NN B-Gene
direct JJ O
stable JJ O
association NN O
with IN O
tyrosine NN O
phosphorylated VBN O
proteins NNS O
p130 NNS B-Gene
and CC O
p110 NN B-Gene
. . O

In IN O
throttling VBG O
valves NNS O
, , O
the DT O
aim NN O
is VBZ O
to TO O
correlate VB O
the DT O
effect NN O
of IN O
shear NN O
to TO O
a DT O
parameter NN O
related VBN O
to TO O
the DT O
inner JJ O
geometry NN O
of IN O
the DT O
valve NN O
and CC O
to TO O
operating VBG O
conditions NNS O
. . O

Osteosarcoma NNP O
caused VBN O
by IN O
3 CD O
, , O
4 CD O
- : O
benzopyrene NN O

In IN O
this DT O
study NN O
, , O
a DT O
common JJ O
mechanism NN O
has VBZ O
been VBN O
identified VBN O
to TO O
coordinate VB O
the DT O
growth NN O
- : O
and CC O
FC NNP O
- : O
dependent JJ O
expression NN O
of IN O
caveolin NN B-Gene
. . O

Such JJ O
a DT O
change NN O
may MD O
involve VB O
increased VBD O
mammary JJ O
utilization NN O
of IN O
pre JJ O
- : O
formed VBN O
long JJ O
- : O
chain NN O
fatty JJ O
acid NN O
and CC O
increased VBD O
metabolism NN O
of IN O
glucose JJ O
via IN O
glycolysis NN O
. . O

Each DT O
immunoprecipitate NN O
contained VBD O
a DT O
complex NN O
of IN O
N1 NNP B-Gene
( ( I-Gene
deltaEC NN I-Gene
) ) I-Gene
and CC O
CBF1 NNP B-Gene
. . O

Premature JJ O
initiation NN O
of IN O
mitosis NN O
in IN O
yeast NN O
lacking NN O
RCC1 NNP B-Gene
or CC O
an DT O
interacting JJ O
GTPase NNP B-Gene
. . O

Granisetron NNP O
, , O
but CC O
not RB O
saline VB O
, , O
abolished VBN O
vomiting NN O
and CC O
nausea NN O
when WRB O
given VBN O
as IN O
intervention NN O
after IN O
this DT O
combined JJ O
emetic JJ O
regimen NNS O
. . O

Compared VBN O
to TO O
those DT O
with IN O
normal JJ O
renal JJ O
functions NNS O
, , O
these DT O
patients NNS O
were VBD O
older JJR O
( ( O
P NNP O
< NNP O
or CC O
= $ O
0 CD O
. . O
1 CD O
) ) O
, , O
had VBD O
significantly RB O
elevated VBN O
blood NN O
pressures NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
or CC O
P NNP O
= $ O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
in IN O
the DT O
case NN O
of IN O
Type NNP O
1 CD O
DM NNP O
, , O
with IN O
a DT O
higher JJR O
body NN O
mass NN O
index NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
waist JJ O
- : O
hip NN O
ratio NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

We PRP O
have VBP O
found VBN O
a DT O
satisfactory JJ O
reproducibility NN O
in IN O
vitro NN O
( ( O
T1 NNP O
: : O
1 CD O
. . O
9 CD O
% NN O
; : O
T2 NNP O
: : O
6 CD O
. . O
2 CD O
% NN O
) ) O
, , O
while IN O
the DT O
reproducibility NN O
was VBD O
less RBR O
satisfactory JJ O
in IN O
vivo NN O
( ( O
T1 NNP O
: : O
16 CD O
. . O
4 CD O
% NN O
; : O
T2 NNP O
: : O
13 CD O
. . O
4 CD O
% NN O
) ) O
. . O

We PRP O
thus RB O
conclude VBP O
that IN O
the DT O
NFAT NNP B-Gene
RIR NNP I-Gene
plays VBZ O
an DT O
essential JJ O
dual JJ O
role NN O
in IN O
DNA NNP O
recognition NN O
and CC O
cooperative JJ O
binding NN O
to TO O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
family NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

The DT O
prothrombin NN B-Gene
gene NN I-Gene
G20210A NNP I-Gene
mutation NN I-Gene
is VBZ O
not RB O
found VBN O
among IN O
Japanese JJ O
patients NNS O
with IN O
deep JJ O
vein NN O
thrombosis NN O
and CC O
healthy JJ O
individuals NNS O
. . O

Nonteratogenicity NN O
in IN O
rats NNS O
of IN O
blighted VBN O
potatoes NNS O
and CC O
compounds NNS O
contained VBN O
in IN O
them PRP O
. . O

This DT O
cluster NN O
consisted VBD O
of IN O
four CD O
apparently RB O
unrelated JJ O
ESTs NNP O
and CC O
two CD O
genes NNS O
, , O
pregnancy NN B-Gene
- : I-Gene
associated VBN I-Gene
plasma NN I-Gene
protein NN I-Gene
- : I-Gene
A DT I-Gene
( ( O
PAPP NNP B-Gene
- : I-Gene
A DT I-Gene
) ) O
and CC O
a DT O
novel JJ O
gene NN O
( ( O
tentatively RB O
named VBN O
EST NNP B-Gene
- : I-Gene
YD1 NN I-Gene
) ) O
. . O

Although IN O
there EX O
is VBZ O
little JJ O
evidence NN O
that IN O
diet JJ O
composition NN O
plays VBZ O
a DT O
clinically RB O
important JJ O
role NN O
in IN O
the DT O
absorption NN O
or CC O
expenditure NN O
of IN O
energy NN O
, , O
it PRP O
does VBZ O
appear VB O
to TO O
play VB O
a DT O
role NN O
in IN O
food NN O
intake NN O
. . O

The DT O
size NN O
discrepancy NN O
is VBZ O
not RB O
due JJ O
to TO O
glycosylation NN O
or CC O
phosphorylation NN O
of IN O
Ag35 NNP B-Gene
but CC O
may MD O
result VB O
from IN O
a DT O
proline NN O
- : O
rich JJ O
sequence NN O
which WDT O
occurs VBZ O
in IN O
this DT O
polypeptide NN O
. . O

Thus RB O
, , O
chronic JJ O
hematocrit NN O
decrease NN O
induced VBN O
by IN O
H NNP O
or CC O
P NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
fall NN O
in IN O
blood NN O
pressure NN O
compared VBN O
to TO O
control VB O
( ( O
201 CD O
+ NN O
/ NNP O
- : O
3 CD O
v NN O
175 CD O
+ NN O
/ NNP O
- : O
4 CD O
, , O
167 CD O
+ NN O
/ NNP O
- : O
4 CD O
mm NN O
Hg NNP O
, , O
respectively RB O
; : O
P NNP O
< NNP O
. . O
5 CD O
) ) O
. . O

Based VBN O
on IN O
the DT O
estimated VBN O
values NNS O
of IN O
divergence NN O
of IN O
apobec1 JJ B-Gene
sequences NNS I-Gene
in IN O
terms NNS O
of IN O
the DT O
numbers NNS O
of IN O
synonymous JJ O
and CC O
non JJ O
- : O
synonymous JJ O
suhstitutions NNS O
per IN O
site NN O
, , O
we PRP O
found VBD O
that IN O
apobec1 NN B-Gene
is VBZ O
a DT O
fairly RB O
rapidly RB O
evolving VBG O
protein NN O
. . O

The DT O
afferents NNS O
' POS O
phase NN O
of IN O
response NN O
was VBD O
unmodified VBN O
by IN O
electrical JJ O
EVS NNP O
stimulation NN O
. . O

The DT O
Dox NNP B-Gene
- : I-Gene
A2 NNP I-Gene
locus NN I-Gene
is VBZ O
within IN O
3 CD O
. . O
4 CD O
to TO O
4 CD O
. . O
4 CD O
kb NN O
of IN O
the DT O
Df NNP B-Gene
( ( I-Gene
2L CD I-Gene
) ) I-Gene
OD15 NNP I-Gene
breakpoint NN I-Gene
, , O
placing VBG O
four CD O
of IN O
the DT O
vital JJ O
loci NN O
within IN O
a DT O
maximum NN O
of IN O
15 CD O
. . O
5 CD O
kb NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
haloperidol NN O
selectively RB O
reduced VBD O
the DT O
animal NN O
' POS O
s JJ O
capacity NN O
to TO O
' POS O
programme NN O
non SYM O
- : O
stimulus NN O
directed VBD O
motor NN O
behaviour NN O
' POS O
. . O

These DT O
studies NNS O
demonstrate VBP O
that IN O
both DT O
G NNP B-Gene
alpha NN I-Gene
i NN I-Gene
genes NNS I-Gene
are VBP O
dynamically RB O
regulated VBN O
in IN O
LLC NNP O
- : O
PK1 NNP O
cells NNS O
by IN O
both DT O
growth NN O
, , O
differentiation NN O
, , O
and CC O
hormone NN O
signals NNS O
. . O

A DT O
2 CD O
. . O
3 CD O
- : O
kb NN O
full JJ O
- : O
length NN O
cDNA NN O
clone NN O
of IN O
an DT O
Atlantic NNP B-Gene
halibut NN I-Gene
Mx NNP I-Gene
gene NN I-Gene
was VBD O
isolated VBN O
from IN O
a DT O
liver NN O
cDNA NN O
library NN O
. . O

Transient NN O
, , O
high JJ O
- : O
level NN O
Ras NNP B-Gene
- : O
expression NN O
induces NNS O
transcriptional JJ O
activation NN O
of IN O
p21 NN B-Gene
mediated VBN O
by IN O
a DT O
GC NNP O
- : O
rich JJ O
region NN O
in IN O
p21 NN B-Gene
promoter NN I-Gene
- : O
83 CD O
- : O
54 CD O
bp NN O
relative NN O
to TO O
the DT O
transcription NN O
initiation NN O
site NN O
containing VBG O
binding VBG O
sites NNS O
for IN O
Sp1 NNP B-Gene
- : I-Gene
family NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

Normocapnic NNP O
( ( O
PACO2 NNP O
= VBZ O
40 CD O
mm NN O
Hg NNP O
) ) O
ventilatory NN O
drive NN O
increased VBN O
significantly RB O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
in IN O
six CD O
subjects NNS O
( ( O
Type NNP O
1 CD O
response NN O
) ) O
and CC O
decreased VBN O
substantially RB O
in IN O
the DT O
others NNS O
( ( O
Type VB O
2 CD O
response NN O
) ) O
; : O
with IN O
hypercapnia NN O
, , O
the DT O
changes NNS O
in IN O
drive NN O
were VBD O
attenuated VBN O
in IN O
both DT O
groups NNS O
. . O

Two CD O
scintigraphic JJ O
methods NNS O
, , O
resting VBG O
dipyridamole NN O
and CC O
exercise NN O
thallium NN O
- : O
201 CD O
myocardial JJ O
perfusion NN O
imaging NN O
, , O
to TO O
detect VB O
and CC O
localize VB O
coronary JJ O
artery NN O
stenosis NN O
were VBD O
compared VBN O
in IN O
32 CD O
patients NNS O
suffering VBG O
from IN O
coronary JJ O
artery NN O
disease NN O
. . O

The DT O
uteroglobin JJ B-Gene
promoter NN I-Gene
contains VBZ O
a DT O
noncanonical JJ O
estrogen NN O
responsive JJ O
element NN O
. . O

The DT O
examinations NNS O
were VBD O
performed VBN O
on IN O
two CD O
groups NNS O
of IN O
20 CD O
( ( O
using VBG O
AmF NNP O
/ NNP O
SnF2 NNP O
) ) O
- : O
, , O
resp NN O
. . O

Wild NNP O
- : O
type NN O
and CC O
mutant JJ O
MyoD NNP B-Gene
were VBD O
introduced VBN O
into IN O
cells NNS O
using VBG O
an DT O
E1 NNP B-Gene
, , O
E3 NNP B-Gene
- : O
deleted VBD O
adenoviral JJ O
vector NN O
. . O

Consistent JJ O
with IN O
its PRP$ O
role NN O
in IN O
p53 NN B-Gene
ubiquitination NN O
, , O
mE6 SYM B-Gene
- : I-Gene
AP NN I-Gene
was VBD O
found VBN O
both DT O
in IN O
the DT O
nucleus NN O
and CC O
cytosol NN O
, , O
while IN O
Nedd NNP B-Gene
- : I-Gene
4 CD I-Gene
was VBD O
found VBN O
only RB O
in IN O
the DT O
cytosol NN O
. . O

However RB O
, , O
one CD O
3 CD O
' POS O
splice NN O
site NN O
, , O
located VBN O
at IN O
nucleotide RB O
( ( O
nt NN O
) ) O
3225 CD O
, , O
is VBZ O
used VBN O
for IN O
the DT O
processing NN O
of IN O
most JJS O
BPV NNP O
- : O
1 CD O
pre NN O
- : O
mRNAs NN O
in IN O
BPV NNP O
- : O
1 CD O
- : O
transformed VBN O
C127 NNP O
cells NNS O
and CC O
at IN O
early RB O
to TO O
intermediate VB O
times NNS O
in IN O
productively RB O
infected JJ O
warts NNS O
. . O

It PRP O
was VBD O
proposed VBN O
that IN O
the DT O
synthetase NN O
- : O
related JJ O
sequences NNS O
of IN O
GCN2 NNP B-Gene
stimulate VBP O
the DT O
activity NN O
of IN O
the DT O
kinase NN O
by IN O
interacting VBG O
directly RB O
with IN O
uncharged JJ O
tRNA NN O
that WDT O
accumulates VBZ O
during IN O
amino NN O
acid JJ O
limitation NN O
. . O

The DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
responsive JJ O
reporter NN O
construct NN O
, , O
( ( B-Gene
PRDII NNP I-Gene
) ) I-Gene
( ( I-Gene
4 CD I-Gene
) ) I-Gene
- : O
CAT NN B-Gene
, , O
was VBD O
used VBN O
to TO O
explore VB O
transcription NN O
resulting VBG O
from IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activated VBN O
by IN O
Tat NNP B-Gene
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
: : O
Systemic NNP O
and CC O
pulmonary JJ O
hemodynamics NNS O
, , O
arterial JJ O
blood NN O
gas NN O
determination NN O
, , O
bronchoalveolar JJ O
lavage NN O
protein NN O
and CC O
neutrophil JJ O
content NN O
, , O
neutrophil JJ O
oxidant JJ O
burst NN O
, , O
lung NN B-Gene
myeloperoxidase NN I-Gene
content NN O
, , O
and CC O
scanning VBG O
electron NN O
micrographic JJ O
studies NNS O
. . O

We PRP O
find VBP O
that IN O
beta NN B-Gene
II NNP I-Gene
PKC NNP I-Gene
phosphorylates VBZ O
nuclear JJ B-Gene
envelope NN I-Gene
lamin NN I-Gene
B NNP I-Gene
at IN O
10 CD O
- : O
20 CD O
times NNS O
the DT O
rate NN O
of IN O
alpha NN B-Gene
PKC NNP I-Gene
, , O
whereas IN O
both DT O
kinases NNS O
phosphorylate VBP O
soluble JJ B-Gene
lamin NN I-Gene
B NNP I-Gene
at IN O
similar JJ O
rates NNS O
. . O

The DT O
mechanism NN O
by IN O
which WDT O
E2 NNP B-Gene
- : I-Gene
C NNP I-Gene
represses VBZ O
E2 NNP B-Gene
- : I-Gene
dependent JJ I-Gene
enhancer NN I-Gene
activity NN O
most RBS O
likely JJ O
involves VBZ O
competition NN O
with IN O
E2 NNP B-Gene
for IN O
binding VBG O
to TO O
a DT O
common JJ O
transcriptional JJ O
regulatory JJ O
site NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

We PRP O
have VBP O
recently RB O
detected VBN O
high JJ O
levels NNS O
of IN O
CKB NNP B-Gene
mRNA NN I-Gene
in IN O
HeLa NNP O
cells NNS O
and CC O
, , O
in IN O
this DT O
study NN O
, , O
have VBP O
tested VBN O
whether IN O
this DT O
may MD O
be VB O
due JJ O
to TO O
the DT O
extremely RB O
low JJ O
amounts NNS O
of IN O
p53 NN B-Gene
protein NN I-Gene
present NN O
in IN O
HeLa NNP O
cells NNS O
. . O

These DT O
and CC O
other JJ O
data NNS O
presented VBN O
suggest VBP O
that IN O
TAg NNP B-Gene
' POS O
re NN O
- : O
models NNS O
' POS O
host NN O
cell NN O
transcription NN O
factors NNS O
that WDT O
are VBP O
used VBN O
early RB O
in IN O
viral JJ O
infection NN O
, , O
and CC O
thereby RB O
mimics NNS O
an DT O
event NN O
that WDT O
naturally RB O
occurs VBZ O
during IN O
transformation NN O
. . O

The DT O
expression NN O
of IN O
the DT O
pilin NN B-Gene
gene NN I-Gene
, , O
tcpA NN B-Gene
, , O
is VBZ O
dependent JJ O
upon IN O
ToxR NNP B-Gene
and CC O
upon IN O
ToxT NNP B-Gene
. . O

The DT O
sequencing NN O
of IN O
Stellate NNP B-Gene
copies NNS O
located VBN O
along IN O
the DT O
discontinuous JJ O
cluster NN O
revealed VBD O
a DT O
complex JJ O
pattern NN O
of IN O
diversification NN O
. . O

Little JJ O
is VBZ O
known VBN O
about IN O
the DT O
mechanism NN O
, , O
but CC O
the DT O
availability NN O
of IN O
rapid JJ O
facile JJ O
assays NNS O
for IN O
monitoring VBG O
immunoglobulin JJ B-Gene
hypermutation NN O
would MD O
greatly RB O
aid VB O
the DT O
development NN O
of IN O
culture NN O
systems NNS O
for IN O
hypermutating VBG O
B NNP O
cells NNS O
as RB O
well RB O
as IN O
the DT O
screening NN O
for IN O
individuals NNS O
deficient NN O
in IN O
the DT O
process NN O
. . O

It PRP O
has VBZ O
come VBN O
out RP O
that IN O
CAEC NNP O
is VBZ O
between IN O
CC NNP O
and CC O
CIEC NNP O
and CC O
that IN O
attacks NNS O
of IN O
biliary JJ O
fever NN O
and CC O
high JJ O
levels NNS O
of IN O
alkaline JJ B-Gene
phosphatase NN I-Gene
and CC O
transaminases NNS O
in IN O
the DT O
serum NN O
are VBP O
the DT O
helpful JJ O
findings NNS O
for IN O
preoperative JJ O
diagnosis NN O
. . O

When WRB O
CSF NNP O
[ NNP O
HCO3 NNP O
- : O
] NN O
is VBZ O
shown VBN O
as IN O
a DT O
function NN O
of IN O
CSF NNP O
PCO2 NNP O
the DT O
data NN O
of IN O
K NNP O
- : O
depleted VBN O
rats NNS O
are VBP O
no RB O
longer RB O
displaced VBD O
when WRB O
compared VBN O
to TO O
controls NNS O
but CC O
still RB O
have VBP O
a DT O
significantly RB O
greater JJR O
slope NN O
( ( O
1 CD O
. . O
21 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
23 CD O
vs NN O
. . O

Identification NN O
and CC O
estimation NN O
of IN O
monosaccharides NNS O
and CC O
disaccharides NNS O
in IN O
urine NN O
by IN O
gas NN O
- : O
liquid NN O
chromatography NN O
. . O

There EX O
was VBD O
a DT O
positive JJ O
correlation NN O
between IN O
pyridinium NN O
cross NN O
- : O
link NN O
excretion NN O
and CC O
thyroid VB O
hormone NN O
concentrations NNS O
. . O

A DT O
combination NN O
of IN O
cisplatin NN O
and CC O
5 CD O
- : O
fluorouracil NN O
, , O
both DT O
administered VBD O
4 CD O
days NNS O
continuously RB O
as IN O
infusion NN O
, , O
was VBD O
assessed VBN O
in IN O
advanced JJ O
head NN O
and CC O
neck NN O
cancer NN O
. . O

Furthermore RB O
, , O
phosphatidylinositol NN O
( ( O
3 CD O
, , O
4 CD O
, , O
5 CD O
) ) O
trisphosphate NN O
specifically RB O
stimulates VBZ O
the DT O
activity NN O
of IN O
ILK NNP B-Gene
in IN O
vitro NN O
, , O
and CC O
in IN O
addition NN O
, , O
membrane NN O
targetted VBD O
constitutively RB O
active JJ O
Pi NNP B-Gene
( ( I-Gene
3 CD I-Gene
) ) I-Gene
K NNP I-Gene
activates VBZ O
ILK NNP B-Gene
in IN O
vivo NN O
. . O

The DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
SAP NNP B-Gene
- : I-Gene
1 CD I-Gene
cDNA NN I-Gene
showed VBD O
that IN O
mature NN B-Gene
SAP NNP I-Gene
- : I-Gene
1 CD I-Gene
consisted VBN O
of IN O
1093 CD O
amino NN O
acids NNS O
and CC O
a DT O
transmembrane NN B-Gene
- : I-Gene
type NN I-Gene
PTP NNP I-Gene
, , O
which WDT O
possessed VBD O
a DT O
single JJ O
PTP NNP B-Gene
- : I-Gene
conserved VBD I-Gene
domain NN I-Gene
in IN O
the DT O
cytoplasmic JJ O
region NN O
. . O

Incidence NN O
correlated VBN O
with IN O
the DT O
grade NN O
of IN O
oral JJ O
hygiene NN O
und IN O
periodontal JJ O
disease NN O
. . O

Endonuclease NNP B-Gene
III NNP I-Gene
( ( O
Nth NNP B-Gene
) ) O
of IN O
Escherichia NNP O
coli NN O
is VBZ O
a DT O
DNA NN B-Gene
glycosylase NN I-Gene
essential JJ O
for IN O
the DT O
removal NN O
of IN O
oxidised JJ O
pyrimidine NN O
base NN O
residues NNS O
from IN O
DNA NNP O
. . O

Mammalian JJ O
sperm NN O
motility NN O
is VBZ O
regulated VBN O
by IN O
a DT O
cascade NN O
of IN O
cAMP NN O
- : O
dependent JJ O
protein NN O
phosphorylation NN O
events NNS O
mediated VBN O
by IN O
protein NN B-Gene
kinase NN I-Gene
A NNP I-Gene
. . O

This DT O
approach NN O
was VBD O
examined VBN O
utilizing VBG O
the DT O
fetal JJ O
protein NN O
, , O
HGB NNP B-Gene
F NNP I-Gene
. . O

An DT O
undilated JJ O
type NN O
of IN O
APBD NNP O
is VBZ O
frequently RB O
associated VBN O
with IN O
AMT NNP O
and CC O
we PRP O
believe VBP O
, , O
therefore RB O
, , O
that IN O
clinicians NNS O
should MD O
be VB O
aware JJ O
of IN O
a DT O
possible JJ O
coexistence NN O
of IN O
APBD NNP O
and CC O
AMT NNP O
. . O

Nevertheless RB O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
entire JJ O
three CD O
- : O
component NN O
yeast NN O
capping NN O
apparatus NN O
, , O
consisting VBG O
of IN O
RNA NNP B-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
triphosphatase NN I-Gene
( ( O
Cet1p NNP B-Gene
) ) O
, , O
RNA NNP B-Gene
guanylyltransferase NN I-Gene
( ( O
Ceg1p NNP B-Gene
) ) O
, , O
and CC O
Abd1p NNP B-Gene
could MD O
be VB O
replaced VBN O
in IN O
vivo NN O
by IN O
the DT O
two CD O
- : O
component NN O
mammalian JJ O
apparatus NN O
consisting NN O
of IN O
a DT O
bifunctional JJ O
triphosphatase NN B-Gene
- : I-Gene
guanylyltransferase NN I-Gene
Mce1p NNP I-Gene
and CC O
the DT O
methyltransferase NN B-Gene
Hcm1 NNP I-Gene
( ( I-Gene
121 CD I-Gene
- : I-Gene
476 CD I-Gene
) ) I-Gene
p NN I-Gene
. . O

Evaluation NN O
of IN O
myocardial JJ O
perfusion NN O
by IN O
99mTc CD O
- : O
tetrofosmin NN O
SPECT NNP O
before IN O
and CC O
after IN O
emergent JJ O
percutaneous JJ O
transluminal JJ O
coronary NN O
angioplasty NN O
for IN O
acute JJ O
myocardial JJ O
infarction NN O

With IN O
steady JJ O
illumination NN O
, , O
outer JJ O
retinal NN O
( ( O
photoreceptor NN O
) ) O
QO2 NNP O
decreased VBD O
to TO O
1 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
ml JJ O
O2 NNP O
/ NNP O
( ( O
100 CD O
g NN O
. . O
min NN O
) ) O
, , O
but CC O
inner JJ O
retinal JJ O
QO2 NNP O
remained VBD O
unchanged JJ O
at IN O
3 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
5 CD O
ml JJ O
O2 NNP O
/ NNP O
( ( O
100 CD O
g NN O
. . O
min NN O
) ) O
( ( O
5 CD O
cats NNS O
) ) O
. . O

The DT O
lowest JJS O
culture NN O
failure NN O
rate NN O
of IN O
0 CD O
. . O
2 CD O
per IN O
cent NN O
was VBD O
found VBN O
after IN O
EAF NNP O
compared VBN O
with IN O
0 CD O
. . O
9 CD O
per IN O
cent NN O
among IN O
CVS NNP O
. . O

We PRP O
conclude VBP O
that IN O
class NN O
I PRP O
cytologic VBP O
smears NNS O
with IN O
moderate JJ O
to TO O
severe JJ O
inflammation NN O
may MD O
be VB O
associated VBN O
with IN O
findings NNS O
of IN O
condylomata NN O
and CC O
cervical JJ O
dysplasia NN O
. . O

Physical JJ O
analysis NN O
maps NNS O
SAL6 NNP B-Gene
to TO O
chromosome VB O
XVI NNP O
between IN O
TPK2 NNP B-Gene
and CC O
spt14 NN B-Gene
. . O

Results NNS O
obtained VBD O
for IN O
chloramphenicol NN O
- : O
containing NN O
preparations NNS O
are VBP O
presented VBN O
, , O
and CC O
both DT O
dissolution NN O
curves NNS O
and CC O
cup SYM O
- : O
plate NN O
assays NNS O
demonstrate VBP O
that IN O
chloramphenicol NN O
has VBZ O
far RB O
superior JJ O
release NN O
( ( O
and CC O
hence RB O
activity NN O
) ) O
from IN O
creams JJR O
than IN O
from IN O
ophthalmic JJ O
ointments NNS O
. . O

However RB O
, , O
when WRB O
combined VBN O
with IN O
mitomycin JJ O
C NNP O
given VBN O
with IN O
1 CD O
to TO O
5 CD O
- : O
days NNS O
interval NN O
, , O
the DT O
concurrent JJ O
administration NN O
of IN O
SPG NNP O
prolonged VBD O
significantly RB O
the DT O
life NN O
- : O
span NN O
of IN O
the DT O
tumor NN O
- : O
bearing NN O
mice NN O
. . O

Nipponbare NN O
as RB O
well RB O
as IN O
O NNP O
. . O
australiensis NN O
. . O

Its PRP$ O
transcription NN O
in IN O
vitro NN O
by IN O
pol NN B-Gene
III NNP I-Gene
requires VBZ O
the DT O
same JJ O
factors NNS O
as IN O
the DT O
U6 NNP B-Gene
gene NN I-Gene
with IN O
the DT O
major JJ O
exception NN O
that IN O
the DT O
modified VBN O
TATA NNP O
- : O
box NN O
of IN O
this DT O
construct NN O
only RB O
interacts VBZ O
with IN O
a DT O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
TBP NNP B-Gene
) ) O
mutant NN O
( ( O
TBP NNP B-Gene
- : I-Gene
DR2 NN I-Gene
) ) O
but CC O
not RB O
with IN O
TBP NNP B-Gene
wild SYM I-Gene
- : I-Gene
type NN I-Gene
( ( O
TBPwt NNP B-Gene
) ) O
. . O

Mining VBG O
the DT O
diagnostic JJ O
iron NN O
ore NN O
. . O

OBJECTIVE NN O
: : O
To TO O
determine VB O
the DT O
association NN O
of IN O
depressive JJ O
symptoms NNS O
with IN O
HIV NNP O
- : O
related JJ O
mortality NN O
and CC O
decline NN O
in IN O
CD4 NNP B-Gene
lymphocyte JJ O
counts NNS O
among IN O
women NNS O
with IN O
HIV NNP O
. . O

The DT O
p55 NN B-Gene
mRNA NN I-Gene
is VBZ O
undetectable JJ O
in IN O
non JJ O
- : O
EBV NNP O
- : O
infected VBD O
B NNP O
- : O
and CC O
T NNP O
- : O
cell NN O
lines NNS O
or CC O
in IN O
a DT O
myelomonocytic JJ O
cell NN O
line NN O
( ( O
U937 NNP O
) ) O
. . O

GCD10 NNP B-Gene
was VBD O
first RB O
identified VBN O
genetically RB O
as IN O
a DT O
translational JJ O
repressor NN O
of IN O
GCN4 NNP B-Gene
. . O

The DT O
UV NNP O
absorption NN O
spectrum NN O
revealed VBD O
a DT O
shoulder NN O
at IN O
250 CD O
nm NNS O
, , O
characteristic NN O
of IN O
CysS NNP O
- : O
Cd NN O
( ( O
II NNP O
) ) O
ligand VBP O
- : O
to TO O
- : O
metal NN O
charge NN O
- : O
transfer NN O
transitions NNS O
, , O
and CC O
the DT O
difference NN O
absorption NN O
coefficient NN O
after IN O
acidification NN O
( ( O
delta JJ O
epsilon NN O
248 CD O
, , O
24 CD O
mM SYM O
- : O
1 CD O
cm NN O
- : O
1 CD O
) ) O
indicated VBD O
the DT O
presence NN O
of IN O
a DT O
Cd NNP O
( ( O
Cys NNP O
- : O
S NNP O
) ) O
4 CD O
center NN O
. . O

It PRP O
was VBD O
also RB O
suggested VBN O
that IN O
the DT O
biological JJ O
activities NNS O
of IN O
5 CD O
- : O
FU NN O
, , O
ADM NNP O
and CC O
MMC NNP O
in IN O
FAMLIP NNP O
were VBD O
stable JJ O
in IN O
FULIP NNP O
, , O
ADRLIP NNP O
and CC O
MMCLIP NNP O
. . O

DNA NN O
binding VBG O
assays NNS O
confirmed VBD O
the DT O
interference NN O
of IN O
p30 NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
with IN O
the DT O
assembly NN O
of IN O
CREB NNP B-Gene
- : O
Tax NNP B-Gene
- : O
p300 NN B-Gene
/ JJ O
CBP NNP B-Gene
multiprotein NN O
complexes NNS O
on IN O
21 CD O
- : O
bp NN O
repeat NN O
oligonucleotides NNS O
in IN O
vitro NN O
. . O

This DT O
stimulatory JJ O
effect NN O
could MD O
also RB O
be VB O
elicited VBN O
by IN O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
, , O
which WDT O
interacts VBZ O
with IN O
topo NN B-Gene
II NNP I-Gene
, , O
but CC O
not RB O
by IN O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
, , O
which WDT O
does VBZ O
not RB O
bind VB O
topo JJ B-Gene
II NNP I-Gene
in IN O
our PRP$ O
in IN O
vitro NN O
assay NN O
. . O

Thus RB O
, , O
MKK7 NNP B-Gene
is VBZ O
an DT O
essential JJ O
and CC O
specific JJ O
regulator NN O
of IN O
stress NN O
- : O
induced JJ O
SAPK NNP B-Gene
/ NNP O
JNK NNP B-Gene
activation NN O
in IN O
mast NN O
cells NNS O
and CC O
MKK7 NNP B-Gene
negatively RB O
regulates VBZ O
growth NN O
factor NN O
and CC O
antigen NN O
receptor NN O
- : O
driven JJ O
proliferation NN O
in IN O
hematopoietic JJ O
cells NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
AP NNP B-Gene
- : I-Gene
A NN I-Gene
may MD O
be VB O
potentially RB O
useful JJ O
in IN O
the DT O
management NN O
of IN O
heart NN O
failure NN O
. . O

The DT O
first JJ O
hypothesis NN O
was VBD O
supported VBN O
in IN O
the DT O
sense NN O
that WDT O
stimulus NN O
differences NNS O
might MD O
affect VB O
behaviour VB O
even RB O
without IN O
their PRP$ O
successful JJ O
attentive JJ O
processing NN O
in IN O
normal JJ O
participants NNS O
. . O

Family RB O
planning VBG O
continues VBZ O
to TO O
play VB O
a DT O
minor JJ O
role NN O
, , O
and CC O
only RB O
25 CD O
. . O
3 CD O
per IN O
cent NN O
of IN O
all DT O
patients NNS O
reviewed VBD O
took VBD O
to TO O
oral JJ O
contraceptives NNS O
for IN O
shorter JJR O
or CC O
longer JJR O
periods NNS O
of IN O
time NN O
. . O

- : O
The DT O
percentages NNS O
of IN O
primiparae NN O
and CC O
secundiparae NN O
in IN O
all DT O
births NNS O
as RB O
well RB O
as IN O
the DT O
high JJ O
percentage NN O
of IN O
multigravidity NN O
are VBP O
parameters NNS O
by IN O
which WDT O
the DT O
approach NN O
to TO O
reproduction NN O
differs NNS O
substantively RB O
from IN O
behaviour NN O
patterns NNS O
in IN O
Europe NNP O
. . O

Element NN O
B NNP O
( ( O
- : O
249 CD O
/ SYM O
- : O
229 CD O
) ) O
shows VBZ O
more JJR O
than IN O
80 CD O
% NN O
homology NN O
to TO O
a DT O
consensus NN B-Gene
c SYM I-Gene
- : I-Gene
myb NN I-Gene
element NN I-Gene
, , O
but CC O
formed VBD O
two CD O
specific JJ O
complexes NNS O
that WDT O
differed VBD O
from IN O
that IN O
of IN O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
in IN O
the DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

Current JJ O
clinical JJ O
trials NNS O
should MD O
answer VB O
the DT O
question NN O
of IN O
which WDT O
of IN O
the DT O
therapeutic JJ O
options NNS O
impairs VBP O
quality NN O
of IN O
life NN O
less RBR O
. . O

In IN O
the DT O
TVD NNP O
- : O
patients NNS O
decreases VBZ O
in IN O
skin NN O
blood NN O
flow NN O
were VBD O
similar JJ O
compared VBN O
with IN O
the DT O
healthy JJ O
controls NNS O
. . O

The DT O
serine NN B-Gene
- : I-Gene
threonine NN I-Gene
kinase NN I-Gene
gene NN I-Gene
is VBZ O
likely JJ O
functional JJ O
, , O
whereas IN O
the DT O
zinc NN O
finger NN O
motif NN O
is VBZ O
likely JJ O
nonfunctional JJ O
. . O

Two CD O
putative JJ O
12 CD O
- : O
O NNP O
- : O
tetradecanoyl NN O
- : O
phorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
response NN O
elements NNS O
, , O
that WDT O
might MD O
serve VB O
as IN O
binding NN O
sites NNS O
for IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
a DT O
consensus NN O
sequence NN O
of IN O
a DT O
transforming JJ B-Gene
growth NN I-Gene
factor NN I-Gene
beta NN I-Gene
1 CD I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
1 CD I-Gene
) ) O
inhibitory NN O
element NN O
were VBD O
found VBN O
in IN O
the DT O
promoter NN O
region NN O
. . O

Fregnac NNP O
, , O
M NNP O
. . O

APETALA3 NNP B-Gene
transcripts NNS I-Gene
are VBP O
first RB O
detected VBN O
in IN O
a DT O
meristematic JJ O
region NN O
that WDT O
will MD O
give VB O
rise NN O
to TO O
the DT O
petal NN O
and CC O
stamen NNS O
primordia VBP O
, , O
and CC O
expression NN O
is VBZ O
maintained VBN O
in IN O
this DT O
region NN O
during IN O
subsequent JJ O
development NN O
of IN O
these DT O
organs NNS O
. . O

Further JJ O
support NN O
for IN O
a DT O
direct JJ O
interaction NN O
of IN O
Tub4p NNP B-Gene
, , O
Spc98p NNP B-Gene
and CC O
Spc97p NNP B-Gene
comes VBZ O
from IN O
the DT O
toxicity NN O
of IN O
strong JJ O
SPC97 NNP B-Gene
overexpression NN O
which WDT O
is VBZ O
suppressed VBN O
by IN O
co NN O
- : O
overexpression NN O
of IN O
TUB4 NNP B-Gene
or CC O
SPC98 NNP B-Gene
. . O

Time NNP O
- : O
activity NN O
curves NNS O
from IN O
the DT O
gastric JJ O
region NN O
of IN O
interest NN O
were VBD O
used VBN O
, , O
after IN O
subjection NN O
to TO O
appropriate VB O
corrective JJ O
procedures NNS O
, , O
to TO O
calculate VB O
the DT O
mean NN O
gastric JJ O
transit NN O
time NN O
( ( O
MTT NNP O
90 CD O
) ) O
and CC O
the DT O
fraction NN O
of IN O
the DT O
test NN O
meal NN O
retained VBN O
in IN O
the DT O
stomach NN O
after IN O
90 CD O
min NN O
( ( O
F90 NNP O
) ) O
. . O

Phenotypic NNP O
changes NNS O
induced VBN O
by IN O
wild JJ B-Gene
type NN I-Gene
and CC I-Gene
variant JJ I-Gene
c SYM I-Gene
- : I-Gene
src NN I-Gene
genes NNS I-Gene
carrying VBG O
C NNP O
- : O
terminal JJ O
sequence NN O
alterations NNS O
. . O

Significant JJ O
correlations NNS O
between IN O
mental JJ O
status NN O
as IN O
measured VBN O
by IN O
the DT O
Mini NNP O
- : O
Mental JJ O
State NNP O
Examination NNP O
and CC O
null NNP O
/ NNP O
mI NN O
, , O
mI FW O
/ FW O
Cr NNP O
and CC O
null NNP O
were VBD O
found VBN O
. . O

By IN O
site NN O
- : O
specific JJ O
mutagenesis NN O
, , O
we PRP O
also RB O
show VBP O
that IN O
individual JJ O
ICP27 NNP B-Gene
C NNP I-Gene
- : I-Gene
terminal NN I-Gene
amino NN I-Gene
acid NN I-Gene
residues NNS I-Gene
that WDT O
are VBP O
positionally RB O
conserved VBN O
in IN O
ICP27 NNP B-Gene
homologs NNS I-Gene
in IN O
other JJ O
herpesviruses NNS O
( ( O
D NNP O
- : O
357 CD O
, , O
E NNP O
- : O
358 CD O
, , O
H NNP O
- : O
479 CD O
, , O
C NNP O
- : O
400 CD O
, , O
C NNP O
- : O
483 CD O
, , O
and CC O
C NNP O
- : O
488 CD O
) ) O
are VBP O
critical JJ O
for IN O
trans NNS O
- : O
regulatory JJ O
activity NN O
. . O

The DT O
role NN O
of IN O
transport NN O
by IN O
sea NN O
ice NN O
from IN O
the DT O
Kara NNP O
Sea NNP O
into IN O
the DT O
Arctic NNP O
Ocean NNP O
was VBD O
assessed VBN O
by IN O
a DT O
small JJ O
subgroup NN O
at IN O
GEOMAR NNP O
. . O

Cotransfection NN O
of IN O
the DT O
coactivator NN O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
relieved VBD O
the DT O
transcriptional JJ O
repression NN O
of IN O
PPARalphawt NNP B-Gene
by IN O
PPARalphatr NNP B-Gene
, , O
suggesting VBG O
that IN O
the DT O
dominant JJ O
negative JJ O
effect NN O
of IN O
PPARalphatr NNP B-Gene
might MD O
occur VB O
through IN O
competition NN O
for IN O
essential JJ O
coactivators NNS O
. . O

Blood NNP B-Gene
serum NN I-Gene
erythropoietin NN I-Gene
level NN O
and CC O
basic JJ O
hematological JJ O
indices NNS O
during IN O
the DT O
adaptation NN O
of IN O
healthy JJ O
newborn JJ O
infants NNS O

Objective NN O
: : O
To TO O
evaluate VB O
endometrial JJ O
thickness NN O
and CC O
the DT O
incidence NN O
of IN O
uterine JJ O
bleeding NN O
in IN O
postmenopausal JJ O
women NNS O
using VBG O
either CC O
tibolone JJ O
2 CD O
. . O
5 CD O
mg NN O
or CC O
continuous JJ O
combined VBN O
2 CD O
mg JJ O
estradiol NN O
and CC O
1 CD O
mg NN O
norethisterone NN O
acetate NN O
( ( O
E NNP O
+ NNP O
NETA NNP O
) ) O
daily RB O
as IN O
hormone NN O
replacement NN O
therapy NN O
. . O

Ovulation NN O
was VBD O
induced VBN O
in IN O
8 CD O
( ( O
56 CD O
. . O
7 CD O
% NN O
) ) O
patients NNS O
who WP O
conceived VBD O
. . O

Thomas NNP O
' POS O
Hospital NNP O
solution NN O
( ( O
with IN O
95 CD O
% NN O
O2 NNP O
: : O
5 CD O
% NN O
CO2 NNP O
) ) O
can MD O
meet VB O
the DT O
metabolic JJ O
demand NN O
of IN O
the DT O
ischaemic JJ O
myocardium NN O
and CC O
thus RB O
increase VB O
the DT O
safe JJ O
duration NN O
of IN O
cardiac JJ O
arrest NN O
. . O

Myocardial JJ O
antioxidant NN O
enzymes NNS O
, , O
catalase NN B-Gene
, , O
glutathione NN B-Gene
peroxidase NN I-Gene
and CC O
superoxide JJ B-Gene
dismutase NN I-Gene
, , O
in IN O
the DT O
MCT NNP O
- : O
treated VBD O
rats NNS O
were VBD O
not RB O
different JJ O
compared VBN O
to TO O
control VB O
rats NNS O
. . O

New NNP O
and CC O
successful JJ O
steps NNS O
have VBP O
been VBN O
made VBN O
in IN O
immunodiagnostics NNS O
, , O
immunotherapy NN O
, , O
and CC O
immunoprophylaxis NN O
of IN O
immunologically RB O
conditioned VBN O
infertility NN O
. . O

In IN O
17 CD O
patients NNS O
with IN O
deletions NNS O
, , O
the DT O
parental JJ O
origin NN O
of IN O
deletion NN O
was VBD O
determined VBN O
. . O

Within IN O
Stage NNP O
IA NNP O
, , O
141 CD O
patients NNS O
had VBD O
well RB O
differentiated VBN O
tumor NN O
( ( O
G1 NNP O
) ) O
, , O
20 CD O
had VBD O
moderately RB O
well RB O
differentiated JJ O
tumor NN O
( ( O
G2 NNP O
) ) O
, , O
and CC O
12 CD O
patients NNS O
had VBD O
poorly RB O
differentiated VBN O
( ( O
G3 NNP O
) ) O
. . O

A DT O
strong JJ O
correlation NN O
exists NNS O
between IN O
the DT O
numbers NNS O
of IN O
CFU NNP O
- : O
GM NNP O
transfused VBD O
and CC O
the DT O
rate NN O
of IN O
granulocytes NNS O
and CC O
platelets NNS O
recovery NN O
. . O

To TO O
determine VB O
the DT O
genetic JJ O
basis NN O
for IN O
the DT O
differences NNS O
between IN O
the DT O
cardiac NN O
and CC O
brain NN B-Gene
AE3 NNP I-Gene
variants NNS I-Gene
, , O
we PRP O
isolated VBD O
and CC O
characterized VBD O
the DT O
rat NN O
gene NN O
. . O

High JJ O
ATP NNP O
/ NNP O
GTP NNP O
ratios NNS O
promoted VBD O
initiation NN O
of IN O
RNA NNP O
primer NN O
synthesis NN O
at IN O
3 CD O
' POS O
- : O
dCTTT NN O
sites NNS O
, , O
whereas RB O
low JJ O
ATP NNP O
/ NNP O
GTP NNP O
ratios NNS O
promoted VBD O
initiation NN O
at IN O
3 CD O
' POS O
- : O
dCCC NN O
sites NNS O
. . O

To TO O
explore VB O
the DT O
functional JJ O
relationship NN O
between IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
Rb NNP B-Gene
, , O
a DT O
eukaryotic JJ O
expression NN O
plasmid NN O
was VBD O
constructed VBN O
containing VBG O
the DT O
c NN B-Gene
- : I-Gene
fos JJ I-Gene
gene NN I-Gene
under IN O
control NN O
of IN O
the DT O
SV40 NNP B-Gene
promoter NN I-Gene
complex NN O
. . O

The DT O
pexB NN B-Gene
upstream JJ I-Gene
region NN I-Gene
contained VBD O
245 CD O
nucleotides NNS O
within IN O
which WDT O
sequences VBZ O
approximating VBG O
the DT O
consensus NN O
for IN O
cyclic JJ B-Gene
AMP NNP I-Gene
receptor NN I-Gene
protein NN I-Gene
and CC O
integration NN B-Gene
host NN I-Gene
factor NN I-Gene
binding VBG O
sites NNS O
were VBD O
discernible JJ O
. . O

Substitution NN O
of IN O
serine NN O
residues NNS O
at IN O
the DT O
C NNP O
- : O
terminus NN O
indicated VBD O
that IN O
loss NN O
of IN O
phosphorylation NN O
sites NNS O
did VBD O
not RB O
appear VB O
to TO O
have VB O
any DT O
effect NN O
on IN O
transcription NN O
and CC O
replication NN O
. . O

The DT O
protein NN O
is VBZ O
composed VBN O
of IN O
a DT O
central JJ O
alpha NN O
- : O
helical JJ O
portion NN O
with IN O
globular JJ O
domains NNS O
at IN O
both DT O
NH2 NNP O
and CC O
COOH NNP O
termini NN O
, , O
and CC O
the DT O
epitope NN O
to TO O
the DT O
monoclonal JJ O
antibody NN O
resides NNS O
in IN O
the DT O
central JJ O
alpha NN O
- : O
helical JJ O
stalk NN O
. . O

RBP56 NNP B-Gene
protein NN I-Gene
turned VBD O
out RP O
to TO O
be VB O
hTAFII68 JJ B-Gene
which WDT O
was VBD O
isolated VBN O
as IN O
a DT O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
associated VBN I-Gene
factor NN I-Gene
( ( O
TAF NNP B-Gene
) ) O
from IN O
a DT O
sub JJ O
- : O
population NN O
of IN O
TFIID NNP B-Gene
complexes NNS I-Gene
( ( O
Bertolotti NNP O
A NNP O
. . O
, , O
Lutz NNP O
, , O
Y NNP O
. . O
, , O
Heard NNP O
, , O
D NNP O
. . O
J NNP O
. . O
, , O
Chambon NNP O
, , O
P NNP O
. . O
, , O
Tora NNP O
, , O
L NNP O
. . O
, , O
1996 CD O
. . O

hTAFII68 NN B-Gene
, , O
a DT O
novel JJ O
RNA NNP O
/ NNP O
ssDNA VBD O
- : O
binding NN O
protein NN O
with IN O
homology NN O
to TO O
the DT O
proto NN O
- : O
oncoproteins VBZ O
TLS NNP B-Gene
/ NNP O
FUS NNP B-Gene
and CC O
EWS NNP B-Gene
is VBZ O
associated VBN O
with IN O
both DT O
TFIID NNP B-Gene
and CC O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
. . O

Interestingly RB O
, , O
this DT O
activation NN O
occurred VBD O
only RB O
when WRB O
the DT O
regions NNS O
were VBD O
cloned VBN O
in IN O
the DT O
same JJ O
relative JJ O
orientation NN O
in IN O
which WDT O
they PRP O
exist VBP O
on IN O
wild JJ O
- : O
type NN O
pCF10 NN O
. . O

Their PRP$ O
hydropathic JJ O
plots NNS O
are VBP O
very RB O
similar JJ O
and CC O
both DT O
possess JJ O
three CD O
hydrophobic JJ O
segments NNS O
that WDT O
are VBP O
likely JJ O
alpha IN O
- : O
helical JJ O
transmembrane NN O
segments NNS O
. . O

These DT O
results NNS O
illuminate VBP O
a DT O
hitherto NN O
unanticipated JJ O
function NN O
of IN O
U6 NNP B-Gene
RNA NNP I-Gene
: : O
the DT O
modulation NN O
of IN O
a DT O
phosphorylation NN O
- : O
dephosphorylation NN O
cycle NN O
of IN O
C1 NNP B-Gene
hnRNP NN I-Gene
protein NN I-Gene
that WDT O
influences VBZ O
the DT O
binding VBG O
affinity NN O
of IN O
this DT O
protein NN O
for IN O
pre JJ O
- : O
mRNA NN O
. . O

Binding VBG O
to TO O
sulphatides NNS O
and CC O
the DT O
alpha JJ B-Gene
- : I-Gene
dystroglycan JJ I-Gene
receptor NN I-Gene
was VBD O
much RB O
stronger JJR O
and CC O
required VBN O
at IN O
least JJS O
two CD O
LG NNP B-Gene
modules NNS I-Gene
. . O

Particles NNS O
resembling VBG O
microbodies NNS O
in IN O
normal JJ O
and CC O
neoplastic JJ O
perianal JJ O
glands NNS O
of IN O
dogs NNS O
. . O

The DT O
influence NN O
of IN O
a DT O
mobile JJ O
pupil NN O
on IN O
the DT O
response NN O
in IN O
the DT O
DC NNP O
- : O
ERG NN O
is VBZ O
demonstrated VBN O
. . O

Interdigitated VBN O
residues NNS O
within IN O
a DT O
small JJ O
region NN O
of IN O
VP16 NNP B-Gene
interact NN O
with IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
HCF NNP B-Gene
, , O
and CC O
DNA NNP O
. . O

The DT O
C NNP O
- : O
terminal JJ O
end NN O
of IN O
this DT O
polypeptide NN O
harbors VBZ O
three CD O
types NNS O
of IN O
repeated JJ O
sequences NNS O
. . O

Study NN O
groups NNS O
were VBD O
control NN O
, , O
and CC O
those DT O
treated VBN O
with IN O
the DT O
alpha1 NN B-Gene
- : I-Gene
adrenoceptor NN I-Gene
- : I-Gene
subtype NN I-Gene
blockers NNS O
WB4101 NNP O
( ( O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
or CC O
chloroethylclonidine NN O
( ( O
1 CD O
. . O
9 CD O
mg JJ O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
. . O

This DT O
study NN O
provides VBZ O
direct JJ O
evidence NN O
that IN O
USF NNP B-Gene
, , O
a DT O
member NN O
of IN O
the DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
leucine JJ I-Gene
zipper NNP I-Gene
family NN I-Gene
, , O
binds VBZ O
to TO O
MLE1 NNP B-Gene
, , O
HF NNP B-Gene
- : I-Gene
1a CD I-Gene
, , O
and CC O
PRE NNP B-Gene
B NNP I-Gene
sites NNS I-Gene
and CC O
suggests VBZ O
that IN O
it PRP O
is VBZ O
a DT O
component NN O
of IN O
protein NN O
complexes NNS O
that WDT O
may MD O
coordinately RB O
control VB O
the DT O
expression NN O
of IN O
MLC NNP B-Gene
- : I-Gene
2v CD I-Gene
and CC O
alpha JJ B-Gene
- : I-Gene
myosin NN I-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
genes NNS I-Gene
. . O

Surprisingly RB O
, , O
double JJ O
mutants NNS O
of IN O
the DT O
shy2 NN B-Gene
- : I-Gene
1D CD I-Gene
mutant NN I-Gene
with IN O
the DT O
phytochrome JJ B-Gene
- : O
deficient NN O
mutants NNS O
hy2 NN B-Gene
, , O
hy3 NN B-Gene
( ( O
phyB JJ B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
fre1 JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
phyA JJ B-Gene
- : I-Gene
201 CD I-Gene
) ) O
showed VBD O
reduced VBN O
photomorphogenic JJ O
response NN O
in IN O
darkness NN O
with IN O
a DT O
longer RBR O
hypocotyl NN O
, , O
a DT O
longer JJR O
inflorescence NN O
stem NN O
, , O
and CC O
a DT O
lower JJR O
level NN O
expression NN O
of IN O
the DT O
CAB NNP B-Gene
gene NN I-Gene
than IN O
the DT O
shy2 JJ B-Gene
- : I-Gene
1D CD I-Gene
single JJ I-Gene
mutant NN I-Gene
. . O

The DT O
gcd2 NN B-Gene
- : I-Gene
503 CD I-Gene
mutation NN O
also RB O
results NNS O
in IN O
polysome JJ O
runoff NN O
, , O
accumulation NN O
of IN O
inactive JJ O
80S CD B-Gene
ribosomal JJ I-Gene
couples NNS I-Gene
, , O
and CC O
accumulation NN O
of IN O
at IN O
least JJS O
one CD O
of IN O
the DT O
subunits NNS O
of IN O
the DT O
general JJ B-Gene
translation NN I-Gene
initiation NN I-Gene
factor NN I-Gene
2 CD I-Gene
( ( O
eIF SYM B-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
) ) O
in IN O
43S CD B-Gene
- : O
48S CD B-Gene
particles NNS O
following VBG O
a DT O
shift NN O
to TO O
the DT O
restrictive JJ O
temperature NN O
. . O

Auditory NN O
clicks NNS O
were VBD O
given VBN O
at IN O
a DT O
rate NN O
of IN O
20 CD O
s NN O
( ( O
- : O
1 CD O
) ) O
. . O

Removal NN O
of IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
by IN O
hemodialysis NN O
and CC O
hemofiltration NN O
: : O
a DT O
four CD O
year NN O
follow VBP O
up RP O
. . O

However RB O
, , O
excretion NN O
of IN O
6 CD O
- : O
keto NN O
- : O
prostaglandin NN O
F1 NNP O
alpha NN O
was VBD O
further RBR O
reduced VBN O
in IN O
the DT O
smokers NNS O
who WP O
used VBD O
oral JJ O
contraceptives NNS O
( ( O
133 CD O
+ NN O
/ NNP O
- : O
20 CD O
to TO O
86 CD O
+ NNS O
/ SYM O
- : O
9 CD O
ng JJ O
/ NNP O
gm NN O
of IN O
creatinine NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Disturbances NNS O
of IN O
placental JJ O
maturation NN O
, , O
2 CD O
. . O

Removal NN O
of IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
by IN O
hemodialysis NN O
and CC O
hemofiltration NN O
: : O
a DT O
four CD O
year NN O
follow VBP O
up RP O
. . O

The DT O
effect NN O
of IN O
sodium NN O
saccharin NN O
in IN O
the DT O
diet NN O
on IN O
caecal JJ O
microflora NN O
. . O

Indium NNP O
- : O
111 CD O
OncoScint NNP O
CR NNP O
/ NNP O
OV NNP O
and CC O
F NNP O
- : O
18 CD O
FDG NNP O
in IN O
colorectal NN O
and CC O
ovarian JJ O
carcinoma NN O
recurrences NNS O
. . O

All DT O
anti SYM B-Gene
- : I-Gene
I PRP I-Gene
and CC O
anti VB B-Gene
- : I-Gene
i NN I-Gene
CA NNP I-Gene
were VBD O
shown VBN O
to TO O
express VB O
VH4 NNP B-Gene
heavy JJ I-Gene
chains NNS I-Gene
, , O
and CC O
14 CD O
of IN O
17 CD O
CA NNP B-Gene
expressed VBD O
a DT O
previously RB O
described VBN O
VH4 NNP B-Gene
second JJ O
hypervariable JJ O
region NN O
determinant NN O
, , O
termed VBD O
VH4 NNP B-Gene
- : I-Gene
HV2a NN I-Gene
. . O

Continued JJ O
absorption NN O
of IN O
amino NN O
acids NNS O
by IN O
the DT O
NBB NNP O
carrier NN O
( ( O
for IN O
neutral JJ O
amino NN O
acids NNS O
) ) O
, , O
the DT O
Y NNP O
+ NNP O
system NN O
( ( O
for IN O
dibasic NN O
amino NN O
acids NNS O
) ) O
, , O
and CC O
the DT O
PHE NNP O
carrier NN O
were VBD O
operative JJ O
even RB O
during IN O
the DT O
actively RB O
purging JJ O
stage NN O
of IN O
watery NN O
diarrhoea NN O
due JJ O
to TO O
cholera VB O
. . O

Is VBZ O
criticism NN O
of IN O
patient NN O
care NN O
justified JJ O
and CC O
does VBZ O
it PRP O
have VB O
educational JJ O
value NN O
? . O

Patients NNS O
' POS O
criticism NN O
contributes NNS O
to TO O
improved VB O
patient NN O
care NN O

CD7 NNP B-Gene
+ NNP O
/ NNP O
CD3 NNP B-Gene
- : O
T NNP O
- : O
cell NN O
precursors NNS O
exhibit VBP O
V NNP B-Gene
delta NN I-Gene
2D CD I-Gene
delta NN I-Gene
3 CD I-Gene
rearrangements NNS I-Gene
. . O

METHODS NNS O
: : O
Four CD O
hundred VBD O
fifty JJ O
patients NNS O
with IN O
the DT O
diagnosis NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
oral JJ O
cavity NN O
received VBD O
their PRP$ O
primary JJ O
treatment NN O
at IN O
Roswell NNP O
Park NNP O
Cancer NNP O
Center NNP O
( ( O
RPCI NNP O
) ) O
from IN O
1971 CD O
to TO O
1991 CD O
. . O

In IN O
reperfusion NN O
B NNP O
, , O
only RB O
the DT O
diabetic JJ O
group NN O
demonstrated VBD O
a DT O
significant JJ O
increase NN O
in IN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
concentrations NNS O
at IN O
1 CD O
and CC O
15 CD O
min NNS O
compared VBN O
to TO O
nondiabetics NNS O
. . O

When WRB O
Hy NNP O
- : O
Vac NNP O
SPF NNP O
type NN O
V NNP O
embryos NN O
were VBD O
exposed VBN O
to TO O
either DT O
0 CD O
. . O
20 CD O
ml JJ O
50 CD O
% NN O
ethanol NN O
in IN O
CRS NNP O
or CC O
to TO O
0 CD O
. . O
20 CD O
ml NN O
CRS NNP O
( ( O
controls NNS O
) ) O
, , O
ethanol SYM O
- : O
treated VBN O
embryos NN O
showed VBD O
a DT O
VSD NNP O
incidence NN O
of IN O
34 CD O
. . O
1 CD O
% NN O
compared VBN O
with IN O
a DT O
3 CD O
. . O
6 CD O
% NN O
incidence NN O
in IN O
the DT O
controls NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
17 CD O
) ) O
. . O

The DT O
injection NN O
of IN O
XDRP1 NNP B-Gene
protein NN I-Gene
into IN O
fertilized VBN O
Xenopus NNP O
eggs NNS O
blocked VBD O
embryonic JJ O
cell NN O
division NN O
. . O

( ( O
1986 CD O
) ) O
method NN O
of IN O
separation NN O
of IN O
Cryptosporidium NNP O
spp NN O
. . O
oocysts NNS O
from IN O
feces NNS O
by IN O
using VBG O
a DT O
percoll NN O
discontinuous JJ O
density NN O
gradient NN O
appeared VBD O
a DT O
method NN O
of IN O
choice NN O
for IN O
obtaining VBG O
large JJ O
numbers NNS O
of IN O
oocysts NNS O
of IN O
C NNP O
. . O
parvum JJ O
free JJ O
of IN O
fecal JJ O
contamination NN O
. . O

The DT O
ARG NNP B-Gene
SH2 NNP B-Gene
domain NN I-Gene
exhibited VBD O
relatively RB O
weak JJ O
affinity NN O
for IN O
BCR NNP B-Gene
and CC O
was VBD O
determined VBN O
to TO O
bind VB O
about IN O
10 CD O
- : O
fold NN O
less JJR O
strongly RB O
than IN O
the DT O
ABL NNP B-Gene
SH2 NNP B-Gene
domain NN I-Gene
. . O

The DT O
pulmonary JJ O
toxic NN O
events NNS O
induced VBN O
by IN O
acute JJ O
nitrogen NN O
dioxide NN O
( ( O
NO NNP O
) ) O
2 CD O
exposure NN O
were VBD O
studied VBN O
in IN O
the DT O
rat NN O
to TO O
develop VB O
an DT O
inhalation NN O
model NN O
to TO O
investigate VB O
therapeutic JJ O
measures NNS O
. . O

The DT O
adenovirus NN B-Gene
E1A NNP I-Gene
gene NN I-Gene
encodes VBZ O
a DT O
protein NN O
that WDT O
transcriptionally RB O
activates VBZ O
viral JJ B-Gene
early JJ I-Gene
genes NNS I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
XAB1 NNP B-Gene
is VBZ O
a DT O
novel JJ O
cytoplasmic JJ B-Gene
GTPase NNP I-Gene
involved VBN O
in IN O
nuclear JJ O
localization NN O
of IN O
XPA NNP B-Gene
. . O

Using VBG O
a DT O
degenerate NN O
oligodeoxyribonucleotide NN O
( ( O
oligo PRP O
) ) O
based VBN O
on IN O
the DT O
N NNP O
- : O
terminal JJ O
aa NN O
sequence NN O
, , O
plus CC O
an DT O
internal JJ O
oligo NN O
homologous JJ O
to TO O
a DT O
conserved JJ O
region NN O
within IN O
the DT O
portion NN O
of IN O
CYP1 NNP B-Gene
and CC O
CYP2 NNP B-Gene
that WDT O
had VBD O
been VBN O
deleted VBN O
in IN O
the DT O
genome NN O
, , O
a DT O
CYP3 NNP B-Gene
- : I-Gene
specific JJ I-Gene
DNA NNP I-Gene
fragment NN I-Gene
was VBD O
generated VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
using VBG O
GL81 NNP O
genomic JJ O
DNA NNP O
as IN O
a DT O
substrate NN O
. . O

The DT O
multiple JJ O
factors NNS O
affecting VBG O
plasma JJ O
renin NN B-Gene
activity NN O
in IN O
essential JJ O
hypertension NN O
. . O

The DT O
smallest JJS O
active JJ B-Gene
FecR NNP I-Gene
derivative NN I-Gene
contained VBD O
59 CD O
amino NN O
acid NN O
residues NNS O
as IN O
compared VBN O
to TO O
the DT O
317 CD O
residues NNS O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
FecR NNP I-Gene
. . O

Ti NNP O
exhibited VBD O
a DT O
feather JJ O
- : O
like IN O
morphology NN O
. . O

Utilization NN O
of IN O
alternative JJ O
polyadenylation NN O
signals NNS O
was VBD O
previously RB O
shown VBN O
to TO O
generate VB O
two CD O
sialophorin JJ B-Gene
mRNAs NN I-Gene
of IN I-Gene
1 CD I-Gene
. . I-Gene
9 CD I-Gene
and CC I-Gene
4 CD I-Gene
. . I-Gene
3 CD I-Gene
kb NN I-Gene
, , O
which WDT O
differ VBP O
in IN O
the DT O
length NN O
of IN O
their PRP$ O
3 CD O
' '' O
untranslated JJ O
regions NNS O
. . O

Is VBZ O
nisoldipine JJ O
capable JJ O
of IN O
reducing VBG O
left JJ O
ventricular JJ O
preload NN O
? . O

In IN O
ten JJ O
anesthetized JJ O
pigs NNS O
, , O
nisoldipine NN O
( ( O
2 CD O
- : O
4 CD O
micrograms NNS O
X NNP O
kg VBD O
- : O
1 CD O
X NNP O
min SYM O
- : O
1 CD O
) ) O
, , O
a DT O
calcium NN O
channel NN O
blocker NN O
structurally RB O
related VBN O
to TO O
nifedipine VB O
, , O
reduced VBN O
left VBD O
ventricular JJ O
systolic JJ O
pressure NN O
( ( O
40 CD O
% NN O
) ) O
and CC O
systemic JJ O
vascular NN O
resistance NN O
( ( O
35 CD O
% NN O
) ) O
, , O
whereas JJ O
maxLVdP NN O
/ NNP O
dt NN O
decreased VBN O
by IN O
20 CD O
% NN O
and CC O
cardiac JJ O
output NN O
was VBD O
unchanged JJ O
. . O

With IN O
the DT O
modified VBN O
fingertip NN O
- : O
to TO O
- : O
floor NN O
( ( O
MFTF NNP O
) ) O
method NN O
, , O
patients NNS O
stand VBP O
on IN O
a DT O
stool NN O
and CC O
forward RB O
bend VB O
so RB O
that IN O
measurements NNS O
can MD O
be VB O
taken VBN O
on IN O
patients NNS O
who WP O
are VBP O
able JJ O
to TO O
touch VB O
the DT O
floor NN O
or CC O
reach VB O
beyond IN O
the DT O
level NN O
of IN O
the DT O
floor NN O
. . O

An DT O
explanation NN O
explored VBD O
for IN O
this DT O
lack NN O
of IN O
gene NN O
expression NN O
was VBD O
that IN O
increased JJ O
levels NNS O
of IN O
RAR NNP B-Gene
alpha NN I-Gene
or CC O
PML NNP B-Gene
might MD O
suppress VB O
APL NNP O
cell NN O
growth NN O
. . O

Spliced NNP O
exons NNS O
of IN O
adenovirus NN O
late JJ O
RNAs NNP O
colocalize NN O
with IN O
snRNP NN O
in IN O
a DT O
specific JJ O
nuclear JJ O
domain NN O
. . O

Despite IN O
the DT O
existence NN O
of IN O
30 CD O
cysteine NN O
residues NNS O
, , O
carboxymethylation NN O
prevented VBD O
the DT O
formation NN O
of IN O
most JJS O
if IN O
not RB O
all DT O
disulfide JJ O
bonds NNS O
that WDT O
otherwise RB O
occurred VBD O
when WRB O
the DT O
cells NNS O
were VBD O
sonicated VBN O
. . O

To TO O
determine VB O
the DT O
true JJ O
molecular JJ O
identity NN O
of IN O
SFD NNP B-Gene
, , O
both VBD O
the DT O
50 CD O
- : O
and CC O
57 CD O
- : O
kDa NN O
polypeptides NNS O
were VBD O
directly RB O
sequenced VBN O
. . O

The DT O
lines NNS O
also RB O
differed VBN O
in IN O
postsynaptic JJ O
, , O
but CC O
not RB O
presynaptic JJ O
, , O
5 CD B-Gene
- : I-Gene
HT1A NN I-Gene
receptors NNS I-Gene
. . O

The DT O
C NNP O
- : O
terminal NN O
domains NNS O
( ( O
CTDs NNP O
) ) O
of IN O
the DT O
RPase NNP B-Gene
beta NN I-Gene
subunit NN I-Gene
and CC O
DNA NNP B-Gene
primase NN I-Gene
( ( O
dnaG JJ B-Gene
protein NN I-Gene
) ) O
were VBD O
not RB O
only RB O
strongly RB O
homologous JJ O
to TO O
each DT O
other JJ O
but CC O
also RB O
considerably RB O
homologous JJ O
to TO O
the DT O
RPase NNP B-Gene
alpha NN I-Gene
, , O
suggesting VBG O
that IN O
an DT O
alpha NN O
subunit SYM O
- : O
like IN O
enzyme NN O
must MD O
have VB O
been VBN O
commonly RB O
ancestral JJ O
to TO O
core VB B-Gene
enzyme JJ I-Gene
subunits NNS I-Gene
and CC O
primase NN B-Gene
. . O

Thus RB O
, , O
the DT O
L45 NNP O
sequence NN O
between IN O
kinase NN O
subdomains NNS O
IV NNP O
and CC O
V NNP O
specifies NNS O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
responsiveness NN O
of IN O
the DT O
type NN B-Gene
I PRP I-Gene
receptor VBP I-Gene
. . O

Moreover RB O
, , O
xTAK1KN NNP B-Gene
could MD O
block VB O
the DT O
expression NN O
of IN O
ventral JJ O
mesoderm NN O
marker NN O
genes NNS O
induced VBN O
by IN O
Smad1 NNP B-Gene
or CC I-Gene
5 CD I-Gene
. . O

On IN O
Days NNP O
1 CD O
and CC O
14 CD O
, , O
most RBS O
young JJ O
and CC O
elderly JJ O
subjects NNS O
exhibited VBN O
monoexponential JJ O
decline NN O
in IN O
bevantolol JJ O
plasma NN O
concentrations NNS O
after IN O
absorption NN O
phase NN O
. . O

The DT O
pp90rsk NN B-Gene
- : I-Gene
protein JJ I-Gene
kinase NN I-Gene
activity NN O
( ( O
referred VBN O
to TO O
as IN O
rsk JJ B-Gene
- : I-Gene
kinase NN I-Gene
) ) O
is VBZ O
also RB O
not RB O
related VBN O
to TO O
cofactor VB O
- : O
dependent JJ O
signal JJ O
transducing NN O
protein NN O
kinases NNS O
such JJ O
as IN O
the DT O
cyclic NN B-Gene
AMP NNP I-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinases NNS I-Gene
, , O
members NNS O
of IN O
the DT O
protein NN B-Gene
kinase VBD I-Gene
C NNP I-Gene
family NN I-Gene
, , O
or CC O
other JJ O
Ca2 NNP B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinases NNS I-Gene
. . O

Improvement NN O
of IN O
nursing VBG O
instruction NN O
to TO O
be VB O
given VBN O
at IN O
the DT O
time NN O
of IN O
discharge NN O
from IN O
the DT O
ward NN O
for IN O
premature NN O
infants NNS O

The DT O
primary JJ O
structure NN O
of IN O
a DT O
2671 CD O
bp NN O
DNA NNP O
fragment NN O
between IN O
the DT O
pla NN B-Gene
gene NN I-Gene
( ( O
encoding VBG O
plasminogen NN B-Gene
activator NN I-Gene
) ) O
and CC O
the DT O
origin NN O
of IN O
replication NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
Yersinia NNP O
pestis NN O
plasmid NN O
pYP358 NN O
was VBD O
determined VBN O
. . O

Group NNP O
psychometric JJ O
functions NNS O
for IN O
listeners NNS O
with IN O
hearing JJ O
loss NN O
do VBP O
not RB O
show VB O
a DT O
decrease NN O
in IN O
performance NN O
at IN O
the DT O
largest JJS O
values NNS O
of IN O
delta NN O
f NN O
included VBD O
in IN O
this DT O
study NN O
. . O

To TO O
date NN O
, , O
two CD O
such JJ O
proteins NNS O
, , O
PLZF NNP B-Gene
and CC O
LAZ NNP B-Gene
- : I-Gene
3 CD I-Gene
/ NN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
have VBP O
been VBN O
implicated VBN O
in IN O
oncogenesis NN O
. . O

There EX O
is VBZ O
general JJ O
agreement NN O
that IN O
the DT O
hepatitis NN O
C NNP O
virus NN O
is VBZ O
efficiently RB O
transmitted VBN O
parenterally RB O
, , O
while IN O
data NNS O
on IN O
viral JJ O
transmission NN O
from IN O
mothers NNS O
to TO O
babies NNS O
or CC O
by IN O
sexual JJ O
or CC O
non JJ O
- : O
sexual JJ O
household NN O
contact NN O
are VBP O
conflicting VBG O
. . O

1993 CD O
. . O

APC NNP B-Gene
- : O
resistance NN O
was VBD O
determined VBN O
with IN O
a DT O
functional JJ O
method NN O
with IN O
high JJ O
sensitivity NN O
and CC O
specificity NN O
for IN O
the DT O
factor NN B-Gene
V NNP I-Gene
Leiden NNP I-Gene
mutation NN I-Gene
. . O

The DT O
Drosophila NNP B-Gene
melanogaster NN I-Gene
Gart NNP I-Gene
gene NN I-Gene
encodes NNS O
three CD O
enzymatic JJ O
activities NNS O
in IN O
the DT O
pathway NN O
for IN O
purine NN O
de FW O
novo FW O
synthesis NN O
. . O

Lacrimal JJ O
secretion NN O
in IN O
hyperthyroidism NN O

Conditions NNS O
influencing VBG O
inhibitors NNS O
of IN O
the DT O
colony NN B-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
CSF NNP B-Gene
) ) O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
indoramin NN O
may MD O
have VB O
Class NNP O
III NNP O
antiarrhythmic JJ O
activity NN O
. . O

Although IN O
Micrococcus NNP B-Gene
luteus VBD I-Gene
UV NNP I-Gene
endonuclease NN I-Gene
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
an DT O
18 CD O
- : O
kDa NN O
enzyme NN O
with IN O
possible JJ O
homology NN O
to TO O
the DT O
16 CD B-Gene
- : I-Gene
kDa NN I-Gene
endonuclease NN I-Gene
V NNP I-Gene
from IN I-Gene
bacteriophage NN I-Gene
T4 NNP I-Gene
( ( O
Gordon NNP O
, , O
L NNP O
. . O

Another DT O
common JJ O
mutation NN O
involved VBN O
amino JJ O
acids NNS O
that WDT O
are VBP O
thought VBN O
to TO O
make VB O
specific JJ O
contacts NNS O
with IN O
DNA NNP O
. . O

GTRE NNP O
, , O
TRE NNP O
, , O
and CC O
CRE NNP O
oligonucleotides IN O
all DT O
compete VBP O
more RBR O
efficiently RB O
for IN O
protein NN O
binding VBG O
to TO O
their PRP$ O
labeled VBN O
congeners NNS O
than IN O
for IN O
protein NN O
binding NN O
to TO O
either DT O
of IN O
the DT O
other JJ O
labeled VBD O
oligonucleotides NNS O
, , O
suggesting VBG O
that IN O
the DT O
GTRE NNP O
, , O
TRE NNP O
, , O
and CC O
CRE NNP O
oligonucleotides NNS O
, , O
suggesting VBG O
that IN O
the DT O
GTRE NNP O
, , O
TRE NNP O
, , O
and CC O
CRE NNP O
oligonucleotides VBZ O
each DT O
bind NN O
unique NN O
as RB O
well RB O
as IN O
common JJ O
proteins NNS O
, , O
likely RB O
to TO O
be VB O
members NNS O
of IN O
the DT O
Jun NNP B-Gene
/ NNP O
Fos NNP B-Gene
and CC O
cAMP SYM B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
/ VBD O
activating VBG B-Gene
transcription NN I-Gene
factors NNS I-Gene
( ( O
CREB NNP B-Gene
/ NNP O
ATF NNP B-Gene
) ) O
families NNS O
of IN O
transcription NN O
factors NNS O
, , O
in IN O
chromaffin NN O
cells NNS O
. . O

To TO O
explore VB O
the DT O
functional JJ O
significance NN O
of IN O
these DT O
subdomains NNS O
in IN O
PRL NNP B-Gene
binding NN O
and CC O
signal JJ O
transduction NN O
, , O
deletion NN O
mutants NNS O
of IN O
S1 NNP O
or CC O
/ NNP O
and CC O
S2 NNP O
subdomains NNS O
were VBD O
constructed VBN O
. . O

Interference NN O
with IN O
rheumatoid JJ B-Gene
factor NN I-Gene
was VBD O
only RB O
observed VBN O
in IN O
the DT O
ELISA NNP O
enzygnost NN O
if IN O
sera NNS O
were VBD O
not RB O
pretreated VBN O
with IN O
latex JJ O
adsorbents NNS O
. . O

Patients NNS O
with IN O
low JJ O
probability NN O
of IN O
having VBG O
aluminum NN O
overload NN O
( ( O
serum JJ O
iron NN O
levels NNS O
< VBP O
40 CD O
micrograms NNS O
/ VBP O
L NNP O
and CC O
DAI NNP O
< NNP O
150 CD O
micrograms NNS O
/ NNP O
L NNP O
) ) O
had VBD O
significantly RB O
higher JJR O
values NNS O
of IN O
serum NN O
iron NN O
, , O
iron NN O
transferrin NN B-Gene
saturation NN O
, , O
and CC O
serum VB B-Gene
ferritin NN I-Gene
levels NNS O
compared VBN O
with IN O
those DT O
patients NNS O
with IN O
a DT O
high JJ O
probability NN O
of IN O
having VBG O
aluminum NN O
overload NN O
( ( O
serum JJ O
aluminum NN O
levels NNS O
> VBP O
40 CD O
micrograms NNS O
/ VBP O
L NNP O
and CC O
DAI NNP O
> NNP O
150 CD O
micrograms NNS O
/ NNP O
L NNP O
) ) O
. . O

A DT O
variety NN O
of IN O
receptor NN O
- : O
mediated VBN O
signaling NN O
pathways NNS O
are VBP O
controlled VBN O
by IN O
both DT O
positive JJ O
and CC O
negative JJ O
extracellular JJ O
regulators NNS O
. . O

The DT O
artery NN O
cuff NN O
was VBD O
slightly RB O
superior JJ O
to TO O
the DT O
fat JJ O
wrap NN O
, , O
particularly RB O
in IN O
having VBG O
fewer JJR O
adhesions NNS O
and CC O
a DT O
better JJR O
histological JJ O
picture NN O
. . O

The DT O
position NN O
, , O
transcription NN O
orientation NN O
, , O
and CC O
imprinted VBD O
status NN O
of IN O
the DT O
genes NNS O
immediately RB O
flanking VBG O
Igf2r NNP B-Gene
have VBP O
been VBN O
assessed VBN O
. . O

Furthermore RB O
, , O
the DT O
DNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
complex NN I-Gene
was VBD O
difficult JJ O
to TO O
obtain VB O
from IN O
dpb2 JJ B-Gene
- : I-Gene
1 CD I-Gene
mutant JJ O
cells NNS O
, , O
suggesting VBG O
that IN O
a DT O
stable JJ O
DNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
complex NN I-Gene
requires VBZ O
DPB2 NNP B-Gene
and CC O
is VBZ O
essential JJ O
for IN O
chromosomal JJ O
replication NN O
. . O

A DT O
developmentally RB O
regulated VBN O
4 CD O
. . O
6 CD O
kb NN O
mRNA NN O
is VBZ O
recognized VBN O
on IN O
Northern NNP O
blots NNS O
of IN O
oocyte NN O
RNA NNP O
using VBG O
the DT O
X NNP O
. . O
laevis JJ O
cDNA NN O
. . O

We PRP O
show VBP O
that DT O
stimulation NN O
of IN O
resting VBG O
splenic JJ O
B NNP O
cells NNS O
with IN O
CD40L NNP B-Gene
- : O
expressing VBG O
Sf9 NNP O
cells NNS O
induces VBZ O
germ JJ O
- : O
line NN O
gamma NN O
1 CD O
and CC O
epsilon VB O
transcripts NNS O
independently RB O
of IN O
cytokines NNS O
. . O

The DT O
positive JJ O
- : O
acting VBG O
global JJ O
sulfur NN O
regulatory JJ O
protein NN O
, , O
CYS3 NNP B-Gene
, , O
of IN O
Neurospora NNP O
crassa NN O
turns VBZ O
on IN O
the DT O
expression NN O
of IN O
a DT O
family NN O
of IN O
unlinked JJ O
structural JJ O
genes NNS O
that WDT O
encode VBP O
enzymes NNS O
of IN O
sulfur JJ O
catabolism NN O
. . O

Molecular JJ O
cloning NN O
of IN O
a DT O
cysteine JJ B-Gene
synthase NN I-Gene
cDNA NN I-Gene
from IN O
Citrullus NNP O
vulgaris NNP O
( ( O
watermelon NN O
) ) O
by IN O
genetic JJ O
complementation NN O
in IN O
an DT O
Escherichia NNP O
coli NN O
Cys NNP O
- : O
auxotroph NN O
. . O

In IN O
a DT O
randomized JJ O
single JJ O
- : O
blind NN O
3 CD O
x $ O
3 CD O
Latin NNP O
- : O
square NN O
study NN O
with IN O
corrections NNS O
for IN O
any DT O
carryover NN O
effects NNS O
, , O
27 CD O
males NNS O
and CC O
30 CD O
females NNS O
consumed VBN O
supplements NNS O
containing VBG O
glucose NN O
or CC O
resistant JJ O
starch NN O
( ( O
RS NNP O
) ) O
from IN O
raw JJ O
high JJ O
- : O
amylose JJ O
cornstarch NN O
( ( O
RS2 NNP O
) ) O
or CC O
from IN O
retrograded VBN O
high JJ O
- : O
amylose JJ O
cornstarch NN O
( ( O
RS3 NNP O
) ) O
. . O

The DT O
cytoprotective NN O
and CC O
antiulcer NN O
activities NNS O
of IN O
the DT O
antacid NN O
magaldrate NN O
( ( O
ES NNP O
Riopan NNP O
) ) O
as RB O
well RB O
as IN O
its PRP$ O
effects NNS O
on IN O
gastric JJ O
mucosal NN O
blood NN O
flow NN O
and CC O
mucus NN O
secretions NNS O
, , O
were VBD O
determined VBN O
in IN O
the DT O
rat NN O
. . O

Antithrombin NNP B-Gene
III NNP I-Gene
prevents VBZ O
60 CD O
min NN O
warm JJ O
intestinal JJ O
ischemia NN O
reperfusion NN O
injury NN O
in IN O
rats NNS O
. . O

Sibling VBG O
aggregation NN O
of IN O
low JJ B-Gene
- : I-Gene
and CC I-Gene
high JJ I-Gene
- : I-Gene
density NN I-Gene
lipoprotein VBP I-Gene
cholesterol NN I-Gene
and CC O
apolipoproteins VBZ B-Gene
B NNP I-Gene
and CC I-Gene
A NNP I-Gene
- : I-Gene
I PRP I-Gene
levels NNS O
in IN O
black JJ O
and CC O
white JJ O
children NNS O
: : O
the DT O
Bogalusa NNP O
Heart NNP O
Study NNP O
. . O

The DT O
effect NN O
of IN O
dietary JJ O
zinc NN O
deficiency NN O
on IN O
the DT O
mossy JJ O
fiber NN O
zinc NN O
content NN O
of IN O
the DT O
rat NN O
hippocampus NN O
. . O

RNase NNP B-Gene
protection NN O
and CC O
primer NN O
extension NN O
assays NNS O
confirmed VBD O
that IN O
the DT O
5 CD O
' POS O
non JJ O
- : O
coding VBG O
exon NN O
is VBZ O
included VBN O
in IN O
the DT O
DDT1 NNP O
aFGF NN B-Gene
mRNA NN I-Gene
and CC O
that IN O
a DT O
major JJ O
transcription NN O
start NN O
site NN O
is VBZ O
approximately RB O
136 CD O
bp JJ O
upstream NN O
of IN O
the DT O
5 CD O
' POS O
non JJ O
- : O
coding VBG O
splice JJ O
junction NN O
of IN O
this DT O
exon NN O
. . O

Two CD O
other JJ O
peptides NNS O
, , O
either CC O
partially RB O
or CC O
totally RB O
lacking VBG O
the DT O
basic JJ O
region NN O
, , O
but CC O
containing VBG O
the DT O
intact JJ O
leucine JJ O
zipper NN O
domain NN O
, , O
readily RB O
form JJ O
dimers NNS O
but CC O
do VBP O
not RB O
bind VB O
to TO O
the DT O
CRE NNP O
. . O

However RB O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
identify VB O
a DT O
p4 NN B-Gene
molecule NN O
. . O

There EX O
were VBD O
minimal JJ O
negative JJ O
effects NNS O
on IN O
hematological JJ O
parameters NNS O
, , O
acid SYM O
- : O
base NN O
status NN O
, , O
and CC O
blood NN O
gases NNS O
. . O

ERK NNP B-Gene
MAP NNP B-Gene
kinase VBD I-Gene
links NNS O
cytokine NN O
signals NNS O
to TO O
activation NN O
of IN O
latent NN O
HIV NNP O
- : O
1 CD O
infection NN O
by IN O
stimulating VBG O
a DT O
cooperative JJ O
interaction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

CONCLUSIONS NNS O
: : O
Two CD O
consecutive JJ O
sets NNS O
of IN O
transrectal JJ O
ultrasound NN O
guided VBD O
sextant JJ O
biopsies NNS O
of IN O
the DT O
prostate NN O
performed VBN O
in IN O
a DT O
single JJ O
office NN O
visit NN O
represent VBP O
a DT O
cost NN O
- : O
effective JJ O
biopsy NN O
strategy NN O
for IN O
men NNS O
presenting VBG O
with IN O
an DT O
abnormal JJ O
digital JJ O
rectal JJ O
examination NN O
and CC O
/ NN O
or CC O
elevated VBN O
serum JJ B-Gene
PSA NNP I-Gene
. . O

At IN O
20 CD O
days NNS O
( ( O
D NNP O
) ) O
and CC O
at IN O
3 CD O
months NNS O
post VBN O
- : O
TBI NN O
, , O
irradiated JJ O
rats NNS O
had VBD O
a DT O
significantly RB O
lower JJR O
percentage NN O
of IN O
avoidance NN O
than IN O
controls NNS O
but CC O
no DT O
statistical JJ O
difference NN O
was VBD O
found VBN O
at IN O
5 CD O
months NNS O
post VBN O
- : O
TBI NN O
. . O

b SYM O
/ CD O
Two CD O
- : O
way NN O
avoidance JJ O
test NN O
: : O
this DT O
test NN O
was VBD O
performed VBN O
only RB O
after IN O
TBI NNP O
. . O

The DT O
data NNS O
normally RB O
available JJ O
are VBP O
insufficient JJ O
and CC O
take VB O
no DT O
account NN O
of IN O
the DT O
direction NN O
of IN O
recirculation NN O
, , O
which WDT O
may MD O
be VB O
a DT O
determining JJ O
factor NN O
. . O

In IN O
addition NN O
, , O
two CD O
internal JJ O
promoters NNS O
, , O
PmiaA NNP B-Gene
and CC O
P1hfq NNP B-Gene
were VBD O
identified VBN O
and CC O
mapped VBN O
to TO O
201 CD O
and CC O
837 CD O
nucleotides NNS O
upstream RB O
from IN O
the DT O
respective JJ O
translation NN O
start NN O
sites NNS O
. . O

Internally RB O
oriented VBN O
patients NNS O
' POS O
scores NNS O
on IN O
Rotter NNP O
' POS O
s NN O
Internal NNP O
- : O
External JJ O
Locus NNP O
of IN O
Control NNP O
Scale NNP O
remained VBD O
the DT O
same JJ O
over IN O
treatment NN O
but CC O
those DT O
of IN O
externally RB O
oriented VBN O
patients NNS O
shifted VBD O
toward IN O
greater JJR O
internal JJ O
control NN O
. . O

Long NNP O
- : O
latency NN O
: : O
locked VBN O
units NNS O
responded VBD O
to TO O
shocks NNS O
with IN O
little JJ O
jitter NN O
and CC O
long JJ O
latency NN O
( ( O
4 CD O
- : O
11 CD O
ms NN O
) ) O
. . O

Two CD O
new JJ O
temperature NN O
- : O
sensitive JJ O
alleles NNS O
of IN O
SEC3 NNP B-Gene
, , O
1 CD O
of IN O
10 CD O
late JJ O
- : O
acting VBG O
SEC NNP B-Gene
genes NNS I-Gene
required VBD O
for IN O
targeting VBG O
or CC O
fusion NN O
of IN O
post NN O
- : O
Golgi NNP O
secretory NN O
vesicles NNS O
to TO O
the DT O
plasma NN O
membrane NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
were VBD O
isolated VBN O
in IN O
a DT O
screen NN O
for IN O
temperature NN O
- : O
sensitive JJ O
secretory NN O
mutants NNS O
that WDT O
are VBP O
synthetically RB O
lethal JJ O
with IN O
sec4 JJ B-Gene
- : I-Gene
8 CD I-Gene
. . O

The DT O
relative JJ O
tumor NN O
FDG NNP O
- : O
uptake NN O
( ( O
Q NNP O
- : O
MRGlu NN O
) ) O
( ( O
tumor NN O
/ NNP O
contralateral JJ O
cortex NN O
) ) O
of IN O
all DT O
meningiomas NN O
was VBD O
calculated VBN O
with IN O
0 CD O
. . O
73 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
37 CD O
( ( O
0 CD O
. . O
24 CD O
- : O
1 CD O
. . O
79 CD O
) ) O
. . O

Gab2 NNP B-Gene
, , O
a DT O
new JJ O
pleckstrin NN B-Gene
homology NN O
domain NN O
- : O
containing NN O
adapter NN O
protein NN O
, , O
acts VBZ O
to TO O
uncouple VB O
signaling VBG O
from IN O
ERK NNP B-Gene
kinase NN I-Gene
to TO O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

In IN O
earlier JJR O
studies NNS O
we PRP O
identified VBD O
several JJ O
regulatory JJ O
elements NNS O
that WDT O
control VBP O
transcriptional JJ O
activation NN O
and CC O
aerobic JJ O
repression NN O
of IN O
one CD O
of IN O
these DT O
genes NNS O
, , O
COX5b NNP B-Gene
. . O

Neuro NNP O
- : O
otological JJ O
examinations NNS O
revealed VBD O
spontaneous JJ O
downbeat NN O
nystagmus NN O
, , O
bilateral JJ O
gaze NN O
nystagmus NN O
and CC O
rebound NN O
nystagmus NN O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
( ( O
EMSAs NNP O
) ) O
using VBG O
purified VBN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
DNA NNP I-Gene
binding NN I-Gene
domain NN I-Gene
( ( O
DBD NNP O
) ) O
demonstrated VBD O
that IN O
both DT O
GRE NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC I-Gene
- : I-Gene
3 CD I-Gene
motifs NNS I-Gene
interact JJ O
with IN O
DBD NNP O
and CC O
oligonucleotide JJ O
competition NN O
experiments NNS O
established VBD O
that IN O
these DT O
have VBP O
different JJ O
affinities NNS O
for IN O
DBD NNP O
. . O

W NNP O
. . O

These DT O
modifications NNS O
may MD O
improve VB O
the DT O
interlaboratory JJ O
reproducibility NN O
of IN O
CD34 NNP B-Gene
determinations NNS O
due JJ O
to TO O
the DT O
reduction NN O
in IN O
sample NN O
handling NN O
and CC O
calculation NN O
of IN O
results NNS O
. . O

In IN O
group NN O
B NNP O
37 CD O
MBq NNP O
in IN O
150 CD O
microL NN O
of IN O
99mTc CD O
- : O
HSA NNP O
nanocolloid NN O
was VBD O
additionally RB O
injected VBN O
intradermally RB O
18 CD O
h NN O
before IN O
surgery NN O
( ( O
3 CD O
- : O
6 CD O
aliquots NNS O
injected VBN O
perilesionally RB O
) ) O
. . O

Familial NNP O
glutathione NN B-Gene
reductase NN I-Gene
deficiency NN O
and CC O
disorder NN O
of IN O
glutathione NN O
synthesis NN O
in IN O
the DT O
erythrocyte NN O

Homozygous JJ O
protein NN B-Gene
C NNP I-Gene
( ( O
PC NN B-Gene
) ) O
deficiency NN O
is VBZ O
reported VBN O
in IN O
two CD O
siblings NNS O
( ( O
girl NN O
and CC O
boy NN O
) ) O
who WP O
received VBD O
their PRP$ O
proper JJ O
diagnoses NNS O
at IN O
the DT O
ages NNS O
of IN O
7 CD O
4 CD O
/ NN O
12 CD O
and CC O
1 CD O
3 CD O
/ JJ O
12 CD O
years NNS O
respectively RB O
. . O

267 CD O
, , O
4870 CD O
- : O
4877 CD O
) ) O
) ) O
indicates VBZ O
an DT O
overall JJ O
identity NN O
of IN O
58 CD O
and CC O
56 CD O
% NN O
, , O
respectively RB O
, , O
with IN O
a DT O
91 CD O
and CC O
92 CD O
% NN O
identity NN O
in IN O
the DT O
highly RB O
conserved VBN O
transmembrane NN O
and CC O
cytoplasmic JJ O
domains NNS O
. . O

Taxonomically RB O
significant JJ O
colour NN O
changes NNS O
in IN O
Brevibacterium NNP O
linens VBZ O
probably RB O
associated VBN O
with IN O
a DT O
carotenoid JJ O
- : O
like IN O
pigment NN O
. . O

The DT O
findings NNS O
demonstrate VBP O
that IN O
AMPH NNP O
administration NN O
induces VBZ O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
height NN O
of IN O
a DT O
major JJ O
electroactive JJ O
peak NN O
in IN O
the DT O
caudate NN O
nucleus NN O
of IN O
pigtail NN O
monkeys NNS O
, , O
and CC O
further RB O
that IN O
such JJ O
amphetamine JJ O
- : O
induced JJ O
increases NNS O
can MD O
be VB O
manipulated VBN O
by IN O
altering VBG O
the DT O
affective JJ O
and CC O
/ JJ O
or CC O
emotional JJ O
state NN O
of IN O
the DT O
animal NN O
. . O

Recently RB O
, , O
cell NN O
- : O
surface NN O
TRAIL NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
expressed VBN O
by IN O
activated JJ O
human JJ O
and CC O
mouse NN O
T NNP O
lymphocytes VBZ O
, , O
raising VBG O
the DT O
possibility NN O
that IN O
TRAIL NNP B-Gene
might MD O
be VB O
involved VBN O
in IN O
T NNP O
cell NN O
- : O
mediated VBN O
cytotoxicity NN O
and CC O
/ NN O
or CC O
immune JJ O
regulation NN O
. . O

UVA NNP O
- : O
induced VBD O
melanocytic JJ O
lesions NNS O
. . O

Contingency NN O
contracting VBG O
between IN O
clients NNS O
and CC O
their PRP$ O
parents NNS O
/ IN O
caregivers NNS O
was VBD O
used VBN O
to TO O
specify VB O
consequences NNS O
for IN O
daily JJ O
self PRP O
- : O
monitoring NN O
, , O
reduced VBD O
caloric JJ O
intake NN O
, , O
weight JJ O
loss NN O
, , O
and CC O
exercise NN O
. . O

Mutations NNS O
within IN O
human JJ O
UTR1 NNP O
modulate NN O
NRF NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
by IN O
interfering VBG O
with IN O
mRNA JJ O
translational JJ O
efficiency NN O
in IN O
transfected JJ O
cells NNS O
and CC O
in IN O
an DT O
in IN O
vitro NN O
translation NN O
system NN O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
organization NN O
of IN O
functional JJ O
units NNS O
of IN O
the DT O
72 CD O
- : O
bp NN O
repeat NN O
required VBN O
for IN O
transcriptional JJ O
enhancement NN O
of IN O
the DT O
early JJ O
promoter NN O
is VBZ O
different JJ O
from IN O
that DT O
required VBD O
for IN O
late JJ O
promoter NN O
function NN O
. . O

If IN O
, , O
however RB O
, , O
the DT O
mean JJ O
temperature NN O
rise NN O
was VBD O
higher JJR O
( ( O
0 CD O
. . O
57 CD O
degrees NNS O
C NNP O
or CC O
0 CD O
. . O
69 CD O
degrees NNS O
C NNP O
) ) O
, , O
such PDT O
a DT O
selection NN O
practically RB O
resulted VBD O
in IN O
the DT O
disappearance NN O
of IN O
' '' O
passable JJ O
' POS O
qualifications NNS O
in IN O
the DT O
triplet NN O
groups NNS O
and CC O
a DT O
great JJ O
predominance NN O
of IN O
' '' O
to TO O
be VB O
rejected VBN O
' '' O
qualifications NNS O
in IN O
the DT O
large JJ O
groups NNS O
. . O

Low JJ O
affinity NN O
binding NN O
of IN O
Rab6A NNP B-Gene
- : I-Gene
GTP NN I-Gene
was VBD O
also RB O
observed VBN O
( ( O
K NNP O
( ( O
d NN O
) ) O
= VBZ O
16 CD O
microm NN O
) ) O
, , O
whereas JJ O
Rab1B NNP B-Gene
, , I-Gene
- : I-Gene
5 CD I-Gene
, , I-Gene
- : I-Gene
7 CD I-Gene
, , I-Gene
- : I-Gene
8 CD I-Gene
, , I-Gene
or CC I-Gene
- : I-Gene
11A CD I-Gene
did VBD O
not RB O
bind VB O
. . O

RESULTS NN O
: : O
At IN O
the DT O
beginning NN O
of IN O
the DT O
QA NNP O
/ NNP O
QI NNP O
process NN O
, , O
monitoring NN O
of IN O
blood NN O
administration NN O
practices NNS O
revealed VBD O
that IN O
a DT O
variance NN O
from IN O
institutional JJ O
blood NN O
administration NN O
policy NN O
occurred VBD O
during IN O
50 CD O
percent NN O
of IN O
blood NN O
and CC O
component JJ O
transfusions NNS O
. . O

The DT O
AL NNP O
- : O
R8 NNP O
SI NNP O
: : O
the DT O
next JJ O
generation NN O
staging VBG O
container NN O
for IN O
plutonium NN O
pits NNS O
at IN O
the DT O
USDOE NNP O
Pantex NNP O
Plant NNP O
. . O

Four CD O
transcription NN O
initiation NN O
sites NNS O
have VBP O
been VBN O
identified VBN O
by IN O
full JJ O
- : O
length NN O
RNA NNP B-Gene
ligase NN I-Gene
- : O
mediated VBN O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
( ( O
RLM NNP O
- : O
RACE NN O
) ) O
between IN O
- : O
61 CD O
and CC O
- : O
32 CD O
bp NN O
from IN O
the DT O
translation NN O
initiation NN O
codon NN O
. . O
Reverse NNP O
transcription NN O
- : O
PCR NN O
analysis NN O
revealed VBD O
that IN O
PFK NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
PFK NNP B-Gene
- : I-Gene
B NN I-Gene
and CC O
PFK NNP B-Gene
- : I-Gene
C NNP I-Gene
genes NNS I-Gene
were VBD O
expressed VBN O
, , O
in IN O
all DT O
mouse NN O
tissues NNS O
tested VBN O
, , O
at IN O
varying NN O
levels NNS O
. . O

Tissue NNP O
- : O
specific JJ O
expression NN O
of IN O
the DT O
diazepam NN B-Gene
- : I-Gene
binding NN I-Gene
inhibitor NN I-Gene
in IN O
Drosophila NNP O
melanogaster NN O
: : O
cloning NN O
, , O
structure NN O
, , O
and CC O
localization NN O
of IN O
the DT O
gene NN O
. . O

Since IN O
MEK NNP B-Gene
acts VBZ O
as IN O
a DT O
cytoplasmic JJ O
anchor NN O
for IN O
the DT O
ERKs NNP B-Gene
, , O
the DT O
lack NN O
of IN O
a DT O
MEK NNP B-Gene
interaction NN O
resulted VBD O
in IN O
the DT O
aberrant JJ O
nuclear JJ O
localization NN O
of IN O
ERK2 NNP B-Gene
- : O
Delta19 NNP B-Gene
- : I-Gene
25 CD I-Gene
mutants NNS O
in IN O
serum JJ O
- : O
starved JJ O
cells NNS O
. . O

Differential JJ O
signaling NN O
and CC O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
activation NN O
by IN O
four CD O
splice NN O
variants NNS O
of IN O
the DT O
human JJ B-Gene
pituitary JJ I-Gene
adenylate NN I-Gene
cyclase NN I-Gene
- : I-Gene
activating VBG I-Gene
polypeptide JJ I-Gene
receptor NN I-Gene
( ( O
hPACAP JJ B-Gene
- : I-Gene
R NN I-Gene
) ) O
. . O

Selective JJ O
bronchial JJ O
intubation NN O
in IN O
the DT O
management NN O
of IN O
unilateral JJ O
pulmonary JJ O
interstitial JJ O
emphysema NN O
. . O

These DT O
results NNS O
also RB O
suggest VBP O
the DT O
involvement NN O
of IN O
additional JJ O
elements NNS O
in IN O
the DT O
UPR NNP O
. . O

Furthermore RB O
, , O
unlike IN O
the DT O
case NN O
for IN O
HIS3 NNP B-Gene
where WRB O
only RB O
a DT O
limited JJ O
subset NN O
of IN O
TATA NNP O
- : O
like IN O
sequences NNS O
can MD O
activate VB O
transcription NN O
in IN O
conjunction NN O
with IN O
GCN4p NNP B-Gene
, , O
many JJ O
divergent NN O
TATA NNP O
- : O
like IN O
sequences NNS O
allowed VBN O
GCN4p NNP B-Gene
activation NN O
of IN O
TRP3 NNP B-Gene
. . O

With IN O
this DT O
GH NNP B-Gene
and CC O
estrogen VB O
treatment NN O
regimen NNS O
, , O
most JJS O
girls NNS O
with IN O
TS NNP O
can MD O
grow VB O
and CC O
develop VB O
much RB O
more RBR O
in IN O
conformity NN O
with IN O
their PRP$ O
healthy JJ O
peers NNS O
. . O

After IN O
14 CD O
d NN O
of IN O
overfeeding VBG O
, , O
hepatic JJ O
PL NNP O
profiles NNS O
were VBD O
identical JJ O
in IN O
the DT O
two CD O
breeds NNS O
and CC O
similar JJ O
to TO O
that DT O
in IN O
control NN O
livers NNS O
; : O
choline VB O
- : O
containing VBG O
PL NNP O
accounted VBD O
for IN O
95 CD O
% NN O
of IN O
total JJ O
PL NNP O
. . O

Modifications NNS O
of IN O
the DT O
involuntary JJ O
postcontraction NN O
in IN O
diseased JJ O
people NNS O
. . O

The DT O
cpc NN B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
encoded VBN I-Gene
transcript NN I-Gene
contains NNS O
three CD O
open JJ O
reading VBG O
frames NNS O
, , O
two CD O
of IN O
which WDT O
are VBP O
located VBN O
in IN O
the DT O
720 CD O
- : O
nucleotide JJ O
leader NN O
segment NN O
preceding VBG O
the DT O
cpc NN B-Gene
- : I-Gene
1 CD I-Gene
coding VBG I-Gene
region NN I-Gene
. . O

Commonly RB O
used VBN O
stressors NNS O
are VBP O
mental JJ O
arithmetics NNS O
, , O
speech NN O
tasks NNS O
, , O
the DT O
Stroop NNP O
test NN O
, , O
videogame NN O
playing NN O
, , O
films NNS O
or CC O
videotapes NNS O
and CC O
interviews NNS O
. . O

Spatial JJ O
zones NNS O
for IN O
muscle NN O
coactivation NN O
and CC O
the DT O
control NN O
of IN O
postural JJ O
stability NN O
. . O

In IN O
strains NNS O
lacking VBG O
tup11 NN B-Gene
and CC O
tup12 NN B-Gene
, , O
the DT O
atf1 NN B-Gene
- : O
pcr1 JJ B-Gene
transcriptional JJ O
activator NN O
continues VBZ O
to TO O
play VB O
a DT O
central JJ O
role NN O
in IN O
fbp1 JJ B-Gene
- : O
lacZ JJ B-Gene
expression NN O
; : O
however RB O
, , O
spc1 JJ B-Gene
MAPK NNP I-Gene
phosphorylation NN O
of IN O
atf1 NN B-Gene
is VBZ O
no RB O
longer RBR O
essential JJ O
for IN O
its PRP$ O
activation NN O
. . O

As IN O
extensively RB O
examined VBN O
with IN O
the DT O
myogenin NN B-Gene
promoter NN I-Gene
, , O
presence NN O
of IN O
one CD O
or CC O
multiple JJ O
copies NNS O
of IN O
Me NNP B-Gene
in IN O
the DT O
vectors NNS O
elevated VBD O
the DT O
expression NN O
activity NN O
in IN O
myotubes NNS O
by IN O
4 CD O
. . O
5 CD O
- : O
to TO O
19 CD O
- : O
fold NN O
over IN O
those DT O
without IN O
Me NNP B-Gene
, , O
but CC O
not RB O
significantly RB O
in IN O
myoblasts NNS O
. . O

The DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
Cdk2 NNP I-Gene
truncations NNS O
, , O
however RB O
, , O
were VBD O
non JJ O
- : O
functional NN O
in IN O
these DT O
strains NNS O
and CC O
thus RB O
dependent JJ O
for IN O
activity NN O
on IN O
the DT O
pho85 NN B-Gene
coding VBG I-Gene
region NN I-Gene
which WDT O
remained VBD O
in IN O
the DT O
mutant JJ B-Gene
pho85 NN I-Gene
: : O
: : O
HIS3 NNP B-Gene
chromosomal JJ I-Gene
locus NN I-Gene
. . O

Treatment NN O
of IN O
N18TG NNP O
- : O
2 CD O
cells NNS O
with IN O
a DT O
demethylating NN O
agent NN O
, , O
5 CD O
- : O
aza NN O
- : O
deoxycytidine NN O
, , O
resulted VBD O
in IN O
an DT O
expression NN O
of IN O
mlt NN B-Gene
1 CD I-Gene
, , O
indicating VBG O
that IN O
the DT O
repression NN O
of IN O
mlt NN B-Gene
1 CD I-Gene
is VBZ O
attributable JJ O
to TO O
methylation VB O
Thus NNP O
, , O
mlt NN B-Gene
1 CD I-Gene
is VBZ O
a DT O
novel JJ O
target NN O
gene NN O
that WDT O
is VBZ O
silenced VBN O
by IN O
methylation NN O
during IN O
liver JJ O
tumorigenesis NN O
initiated VBN O
by IN O
SV40 NNP B-Gene
T NNP I-Gene
antigen NN I-Gene
. . O

SPECT NNP O
is VBZ O
an DT O
important JJ O
aid NN O
in IN O
the DT O
diagnosis NN O
of IN O
AIDS NNP O
dementia NN O
complex NN O
and CC O
contributes VBZ O
to TO O
the DT O
understanding NN O
of IN O
the DT O
pathophysiological JJ O
mechanisms NN O
of IN O
this DT O
disorder NN O
. . O

Studies NNS O
have VBP O
substantiated VBN O
the DT O
involvement NN O
of IN O
numerous JJ O
loci NNS O
on IN O
certain JJ O
chromosomes NNS O
; : O
in IN O
excess NN O
of IN O
10 CD O
chromosomes NNS O
are VBP O
thought VBN O
to TO O
be VB O
involved VBN O
. . O

Eight CD O
CAD NNP O
patients NNS O
who WP O
were VBD O
matched VBN O
to TO O
the DT O
treated JJ O
patients NNS O
for IN O
age NN O
( ( O
+ JJ O
/ NNP O
- : O
3 CD O
years NNS O
) ) O
, , O
baseline JJ O
low JJ B-Gene
density NN I-Gene
lipoprotein NN I-Gene
( ( O
+ JJ O
/ NNP O
- : O
5 CD O
mg NN O
/ NNP O
dL NN O
) ) O
, , O
and CC O
triglycerides NNS O
( ( O
+ JJ O
/ NNP O
- : O
50 CD O
mg NN O
/ NNP O
dL NN O
) ) O
but CC O
who WP O
had VBD O
never RB O
been VBN O
treated VBN O
with IN O
lipid JJ O
- : O
lowering VBG O
drugs NNS O
were VBD O
selected VBN O
as IN O
controls NNS O
. . O

Review NN O
of IN O
the DT O
literature NN O
and CC O
report NN O
of IN O
a DT O
case NN O
of IN O
a DT O
dermoid JJ O
cyst NN O
. . O

An DT O
intact JJ O
5 CD O
. . O
7 CD O
- : O
kb NN O
provirus NN O
of IN O
the DT O
avian JJ O
erythroblastosis NN O
virus NN O
E26 NNP O
has VBZ O
been VBN O
molecularly RB O
cloned VBN O
for IN O
comparisons NNS O
with IN O
avian JJ O
myeloblastosis NN O
virus NN O
( ( O
AMV NNP O
) ) O
and CC O
other JJ O
avian JJ O
tumor NN O
viruses NNS O
. . O

Thyrotropin NNP B-Gene
- : O
induced JJ O
expression NN O
of IN O
a DT O
gene NN O
for IN O
a DT O
ribosomal JJ B-Gene
protein NN I-Gene
related VBN O
to TO O
the DT O
trk JJ B-Gene
oncogene NN I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
F NNP O
- : O
wave NN O
may MD O
be VB O
elicited VBN O
in IN O
motoneuron NN O
of IN O
different JJ O
depolarization NN O
threshold NN O
but CC O
primarily RB O
in IN O
larger JJR O
and CC O
faster RBR O
nerve NN O
fibers NNS O
, , O
with IN O
a DT O
lower JJR O
threshold NN O
of IN O
depolarization NN O
. . O

The DT O
molecular JJ O
weight NN O
of IN O
in IN O
vivo JJ O
- : O
labeled JJ O
proteins NNS O
was VBD O
increased VBN O
relative JJ O
to TO O
that DT O
of IN O
in IN O
vitro JJ O
- : O
translated JJ O
proteins NNS O
, , O
indicating VBG O
that IN O
a DT O
posttranslational JJ O
modification NN O
had VBD O
occurred VBN O
. . O

Change NN O
in IN O
plasma NN B-Gene
cystyl NN I-Gene
aminopeptidase NN I-Gene
( ( O
oxytocinase NN B-Gene
) ) O
between IN O
30 CD O
- : O
34 CD O
weeks NNS O
' POS O
gestation NN O
as IN O
a DT O
predictor NN O
of IN O
pregnancy NN O
- : O
induced JJ O
hypertension NN O
. . O

Sterol NNP O
analysis NN O
of IN O
the DT O
disrupted VBN O
mutant NN O
demonstrated VBD O
the DT O
accumulation NN O
of IN O
ignosterol NN O
, , O
indicating VBG O
a DT O
loss NN O
of IN O
Erg24p NNP B-Gene
activity NN O
. . O

However RB O
, , O
ICK1 NNP B-Gene
was VBD O
induced VBN O
by IN O
ABA NNP O
, , O
and CC O
along IN O
with IN O
ICK1 NNP B-Gene
induction NN O
there RB O
was VBD O
a DT O
decrease NN O
in IN O
Cdc2 NNP B-Gene
- : I-Gene
like IN I-Gene
histone NN B-Gene
H1 NNP I-Gene
kinase NN I-Gene
activity NN O
. . O

Light NNP B-Gene
regulatory JJ I-Gene
unit NN I-Gene
1 CD I-Gene
( ( O
LRU1 NNP B-Gene
) ) O
is VBZ O
necessary JJ O
for IN O
and CC O
sufficient JJ O
to TO O
mediate VB O
light JJ O
- : O
dependent JJ O
activation NN O
of IN O
the DT O
chalcone NN B-Gene
synthase NN I-Gene
( ( I-Gene
CHS NNP I-Gene
) ) I-Gene
minimal VBP I-Gene
promoter NN I-Gene
in IN O
Petroselinum NNP O
crispum NN O
. . O

Althoug NNP O
RBF NNP O
tended VBD O
to TO O
increase VB O
after IN O
the DT O
therapy NN O
, , O
there EX O
was VBD O
no DT O
statistically RB O
significant JJ O
change NN O
in IN O
RBF NNP O
, , O
GFR NNP O
and CC O
cardiac JJ O
output NN O
. . O

Problems NNS O
remain VBP O
to TO O
be VB O
resolved VBN O
in IN O
the DT O
area NN O
of IN O
quantitative JJ O
risk NN O
assessment NN O
. . O

We PRP O
propose VBP O
that IN O
Mnt NNP B-Gene
: : O
Max NN B-Gene
: : O
Sin3 NNP B-Gene
complexes NNS O
normally RB O
function VBP O
to TO O
restrict VB O
Myc NNP B-Gene
: : O
Max NNP B-Gene
activities NNS O
associated VBN O
with IN O
cell NN O
proliferation NN O
. . O

The DT O
variable JJ O
regions NNS O
of IN O
vertebrate NN O
striated VBN O
TnT NNP B-Gene
isoforms NNS I-Gene
reflect VBP O
the DT O
subsequent JJ O
addition NN O
and CC O
modification NN O
of IN O
genomic JJ O
sequences NNS O
to TO O
give VB O
rise NN O
to TO O
members NNS O
of IN O
the DT O
TnT NNP B-Gene
multigene NNP I-Gene
family NN I-Gene
. . O

METHODS NN O
: : O
Von NNP B-Gene
Willebrand NNP I-Gene
factor NN I-Gene
( ( O
vWF NN B-Gene
) ) O
and CC O
the DT O
fibrinolytic JJ O
factors NNS O
tissue VBP B-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
tPA NN B-Gene
) ) O
, , O
measured VBN O
as IN O
tPA NN B-Gene
capacity NN O
, , O
and CC O
plasminogen NN B-Gene
activator NN I-Gene
inhibitor NN I-Gene
1 CD I-Gene
( ( O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
platelets NNS O
, , O
fibrinogen NN B-Gene
, , O
and CC O
inflammatory JJ O
markers NNS O
were VBD O
measured VBN O
in IN O
74 CD O
patients NNS O
with IN O
active JJ O
seropositive JJ O
RA NNP O
. . O

DNA NN B-Gene
polymerase NN I-Gene
E NNP I-Gene
, , O
DNA NNP B-Gene
ligase NN I-Gene
III NNP I-Gene
and CC O
a DT O
DNA NN O
structure NN O
- : O
specific JJ O
endonuclease NN O
co SYM O
- : O
purify NN O
with IN O
the DT O
five CD O
polypeptide NN O
complex NN O
. . O

In IN O
vitro NN O
, , O
Arix NNP B-Gene
and CC O
NBPhox NNP B-Gene
form NN O
DNA NNP O
- : O
independent JJ O
multimers NNS O
and CC O
exhibit NN O
cooperative JJ O
binding NN O
to TO O
the DT O
DB1 NNP B-Gene
regulatory JJ I-Gene
element NN I-Gene
, , O
which WDT O
contains VBZ O
two CD O
homeodomain NN B-Gene
recognition NN I-Gene
sites NNS I-Gene
. . O

The DT O
levels NNS O
of IN O
galactosyltransferase NN B-Gene
activity NN O
in IN O
sera NN O
from IN O
normal JJ O
children NNS O
and CC O
patients NNS O
with IN O
cystic JJ O
fibrosis NN O
. . O

Paraneoplastic JJ O
rheumatic JJ O
syndromes NNS O
. . O

The DT O
amino NN O
- : O
terminal JJ O
third NN O
of IN O
the DT O
protein NN O
contains VBZ O
a DT O
high JJ B-Gene
- : I-Gene
mobility NN I-Gene
- : I-Gene
group NN I-Gene
motif VBZ I-Gene
characteristic JJ O
of IN O
DNA NNP O
- : O
binding NN O
proteins NNS O
. . O

We PRP O
analyzed VBD O
data NNS O
from IN O
56 CD O
patients NNS O
with IN O
Systemic NNP O
Lupus NNP O
Erythematosus NNP O
( ( O
SLE NNP O
) ) O
in IN O
whom WP O
renal JJ O
biopsies NNS O
were VBD O
done VBN O
systematically RB O
. . O

Computer NNP O
software NN O
assisted VBD O
ordering VBG O
( ( O
CSAO NNP O
) ) O
was VBD O
developed VBN O
to TO O
integrate VB O
PN NNP O
Ca NNP O
: : O
P NNP O
solubility NN O
with IN O
clinical JJ O
data NNS O
to TO O
improve VB O
parenteral JJ O
Ca NNP O
and CC O
P NNP O
administration NN O
. . O

Convulsive JJ O
seizure NN O
during IN O
a DT O
treatment NN O
with IN O
interferon NN B-Gene
alpha NN I-Gene
for IN O
chronic JJ O
viral JJ O
hepatitis NN O
C NNP O

We PRP O
failed VBD O
to TO O
find VB O
these DT O
data NNS O
to TO O
be VB O
useful JJ O
in IN O
predicting VBG O
the DT O
time NN O
of IN O
onset NN O
of IN O
initial JJ O
seizures NNS O
after IN O
acute JJ O
ischemic JJ O
stroke NN O
and CC O
recurrence NN O
. . O

The DT O
transcription NN O
and CC O
alternative JJ O
splicing NN O
of IN O
human JJ B-Gene
ORL1 NNP I-Gene
and CC O
GAIP NNP B-Gene
are VBP O
cell SYM O
- : O
type NN O
specific NN O
. . O

The DT O
single JJ O
- : O
stranded VBD O
DNA NNP O
Pur NNP B-Gene
alpha POS I-Gene
recognition NN I-Gene
element NN I-Gene
disrupts VBZ O
these DT O
complexes NNS O
. . O

Of IN O
419 CD O
persons NNS O
surveyed VBN O
, , O
207 CD O
( ( O
49 CD O
. . O
4 CD O
% NN O
) ) O
were VBD O
antigen JJ O
- : O
positive JJ O
with IN O
the DT O
Og4C3 NNP B-Gene
assay NN O
. . O

Whereas IN O
the DT O
muscle NN O
isoform NN O
consists VBZ O
of IN O
997 CD O
amino JJ O
acids NNS O
and CC O
terminates NNS O
with IN O
the DT O
sequence NN O
Ala NNP O
- : O
Ile NNP O
- : O
Leu NNP O
- : O
Glu NNP O
, , O
the DT O
second JJ O
isoform NN O
is VBZ O
1043 CD O
amino NN O
acids NNS O
in IN O
length NN O
due JJ O
to TO O
the DT O
replacement NN O
of IN O
these DT O
last JJ O
4 CD O
amino JJ O
acids NNS O
with IN O
a DT O
50 CD O
- : O
amino NN O
acid JJ O
sequence NN O
that WDT O
contains VBZ O
a DT O
potential JJ O
transmembrane NN O
domain NN O
followed VBN O
by IN O
a DT O
consensus NN O
sequence NN O
for IN O
an DT O
N NNP O
- : O
linked VBN O
glycosylation NN O
site NN O
. . O

Identification NN O
and CC O
characterization NN O
of IN O
the DT O
promoter NN O
for IN O
the DT O
cytotactin NN B-Gene
gene NN I-Gene
. . O

The DT O
double JJ O
- : O
stranded VBD O
RNA NNP O
binding VBG O
domain NN O
( ( O
dsRBD NN O
) ) O
is VBZ O
an DT O
approximately RB O
65 CD O
amino JJ O
acid NN O
motif NN O
that WDT O
is VBZ O
found VBN O
in IN O
a DT O
variety NN O
of IN O
proteins NNS O
that WDT O
interact VBP O
with IN O
double JJ O
- : O
stranded VBN O
( ( O
ds NN O
) ) O
RNA NNP O
, , O
such JJ O
as IN O
Escherichia NNP O
coli VBP O
RNase NNP B-Gene
III NNP I-Gene
and CC O
the DT O
dsRNA NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
, , O
PKR NNP B-Gene
. . O

On IN O
the DT O
basis NN O
of IN O
serum NN B-Gene
alpha1AT NN I-Gene
quantitation NN O
, , O
newborn JJ O
infants NNS O
may MD O
be VB O
separated VBN O
into IN O
two CD O
groups NNS O
, , O
characterized VBN O
respectively RB O
by IN O
concentrations NNS O
above IN O
or CC O
below IN O
150 CD O
mg NN O
% NN O
. . O

B NNP O
cell NN O
- : O
specific JJ O
mb SYM B-Gene
- : I-Gene
1 CD I-Gene
and CC O
B29 NNP B-Gene
genes NNS I-Gene
encode VBD O
the DT O
alpha NN O
/ NNP O
beta NN O
components NNS O
of IN O
the DT O
BCR NNP B-Gene
- : I-Gene
associated VBN I-Gene
complex JJ I-Gene
in IN O
mature NN O
sIgM NN B-Gene
+ NN I-Gene
B NNP O
cells NNS O
. . O

Interestingly RB O
, , O
segment NN O
nesting VBG O
differentially RB O
increases VBZ O
the DT O
copy NN O
number NN O
of IN O
genes NNS O
encoded VBN O
by IN O
segment NN O
W NNP O
, , O
suggesting VBG O
that IN O
the DT O
unusual JJ O
genomic JJ O
organization NN O
of IN O
PDVs NNP O
may MD O
be VB O
directly RB O
linked VBN O
to TO O
the DT O
unique JJ O
functions NNS O
of IN O
this DT O
virus NN O
in IN O
its PRP$ O
obligate NN O
mutualistic JJ O
association NN O
with IN O
parasitic JJ O
wasps NN O
. . O

Exon NNP O
- : O
intron NN O
junctions NNS O
in IN O
the DT O
human JJ O
and CC O
rat NN B-Gene
AdoMet NNP I-Gene
decarboxylase NN I-Gene
genes NNS I-Gene
were VBD O
in IN O
identical JJ O
positions NNS O
except IN O
that DT O
exons VBZ O
6 CD O
and CC O
7 CD O
of IN O
the DT O
human JJ O
gene NN O
formed VBD O
a DT O
single JJ O
exon NN O
in IN O
the DT O
rat NN O
gene NN O
. . O

Dual JJ O
innervation NN O
of IN O
fast JJ O
fibers NNS O
in IN O
trunk NN O
muscles NNS O
of IN O
lamprey NN O
larvae NN O

Model NNP O
IV NNP O
: : O
primary JJ O
abutments NNS O
with IN O
the DT O
lateral JJ O
incisor NN O
and CC O
the DT O
second JJ O
molar NN O
as IN O
secondary JJ O
abutments NNS O
. . O

Two CD O
potential JJ O
regulatory JJ O
sequences NNS O
for IN O
DNA NNP O
binding VBG O
proteins NNS O
were VBD O
found VBN O
in IN O
the DT O
non JJ O
- : O
coding VBG O
5 CD O
' POS O
region NN O
: : O
a DT O
HAP2 NNP B-Gene
/ NNP O
HAP3 NNP B-Gene
consensus NN O
recognition NN O
sequence NN O
at IN O
nucleotide JJ O
- : O
154 CD O
and CC O
a DT O
BAF1 NNP B-Gene
consensus NN I-Gene
recognition NN I-Gene
sequence NN I-Gene
at IN O
nucleotide JJ O
- : O
136 CD O
. . O

He PRP O
is VBZ O
well RB O
, , O
five CD O
years NNS O
after IN O
relapse NN O
. . O

The DT O
absorbable JJ O
perisplenic JJ O
mesh NN O
is VBZ O
an DT O
important JJ O
improvement NN O
, , O
and CC O
in IN O
some DT O
cases NNS O
it PRP O
may MD O
replace VB O
other JJ O
techniques NNS O
for IN O
arresting VBG O
splenic JJ O
bleeding NN O
. . O

Functional JJ O
characterization NN O
of IN O
a DT O
fraction NN O
identified VBN O
by IN O
its PRP$ O
activity NN O
in IN O
a DT O
second JJ O
template NN O
rescue NN O
assay NN O
. . O

This DT O
fraction NN O
is VBZ O
resistant JJ O
to TO O
digestions NNS O
by IN O
DNase NNP B-Gene
I PRP I-Gene
and CC O
RNase NNP B-Gene
T1 NNP I-Gene
and CC O
disappears VBZ O
completely RB O
upon JJ O
alkali JJ O
hydrolysis NN O
. . O

The DT O
MAP NNP B-Gene
kinase NN I-Gene
cascade NN O
is VBZ O
highly RB O
conserved VBN O
in IN O
all DT O
eukaryotes NNS O
and CC O
involved VBN O
in IN O
numerous JJ O
cellular JJ O
responses NNS O
. . O

A DT O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
bulbospinal JJ O
micturition NN O
reflex NN O
evoked VBN O
by IN O
bladder NN O
filling NN O
and CC O
L NNP O
- : O
dopa NN O
involves VBZ O
a DT O
descending NN O
pathway NN O
where WRB O
transmission NN O
is VBZ O
partly RB O
mediated VBN O
by IN O
spinal JJ B-Gene
alpha NN I-Gene
1 CD I-Gene
- : I-Gene
adrenoceptors NNS I-Gene
. . O

The DT O
cysteine NN O
- : O
rich JJ O
region NN O
of IN O
raf NN B-Gene
- : I-Gene
1 CD I-Gene
kinase NN I-Gene
contains NNS O
zinc VBP O
, , O
translocates VBZ O
to TO O
liposomes VB O
, , O
and CC O
is VBZ O
adjacent JJ O
to TO O
a DT O
segment NN O
that WDT O
binds VBZ O
GTP NNP B-Gene
- : I-Gene
ras NN I-Gene
. . O

A DT O
comparison NN O
of IN O
the DT O
predicted VBN O
amino NN O
acid JJ O
sequences NNS O
of IN O
the DT O
two CD O
human JJ B-Gene
PKC NNP I-Gene
- : I-Gene
delta NN I-Gene
clones NNS O
with IN O
the DT O
rat NN O
and CC O
mouse NN O
homologues NNS O
indicated VBD O
a DT O
greater JJR O
degree NN O
of IN O
sequence NN O
divergence NN O
( ( O
89 CD O
- : O
90 CD O
% NN O
homology NN O
) ) O
compared VBN O
to TO O
the DT O
high JJ O
degree NN O
of IN O
sequence NN O
conservation NN O
observed VBN O
with IN O
other JJ O
human JJ B-Gene
PKC NNP I-Gene
family NN I-Gene
members NNS I-Gene
and CC O
their PRP$ O
mammalian JJ O
counterparts NNS O
. . O

Studies NNS O
also RB O
have VBP O
alluded VBN O
to TO O
a DT O
relationship NN O
between IN O
the DT O
MSMR NNP O
cyst NN O
and CC O
certain JJ O
signs NNS O
or CC O
symptoms NNS O
of IN O
disease NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
phenotype NN O
of IN O
XLP NNP O
may MD O
result VB O
from IN O
perturbed NN O
signaling VBG O
not RB O
only RB O
through IN O
SLAM NNP B-Gene
, , O
but CC O
also RB O
other JJ O
cell NN O
surface NN O
molecules VBZ O
that IN O
utilize JJ O
SAP NNP B-Gene
as IN O
a DT O
signaling VBG O
adaptor NN O
protein NN O
. . O

Subsequently RB O
, , O
these DT O
coordinates NNS O
must MD O
be VB O
interpreted VBN O
to TO O
define VB O
particular JJ O
tissues NNS O
and CC O
organs NNS O
. . O

Most JJS O
patients NNS O
preferred JJ O
tablets NNS O
to TO O
injection VB O
both DT O
on IN O
day NN O
1 CD O
( ( O
313 CD O
v RB O
200 CD O
) ) O
and CC O
at IN O
follow VB O
up RP O
( ( O
373 CD O
v RB O
104 CD O
) ) O
. . O

The DT O
epidemic JJ O
occurred VBD O
in IN O
a DT O
group NN O
of IN O
26 CD O
community NN O
members NNS O
( ( O
23 CD O
men NNS O
and CC O
3 CD O
women NNS O
, , O
mean JJ O
age NN O
, , O
28 CD O
. . O
9 CD O
- : O
- : O
3 CD O
years NNS O
) ) O
living NN O
and CC O
working VBG O
together RB O
, , O
who WP O
underwent VBD O
acute NN O
and CC O
convalescent JJ O
serologic NN O
tests NNS O
for IN O
Mycoplasma NNP O
pneumoniae NN O
, , O
Legionella NNP O
pneumophila NN O
, , O
cytomegalovirus NN O
, , O
adenovirus NN O
, , O
Coxiella NNP O
burnetii NN O
, , O
and CC O
Chlamydia NNP O
pneumoniae NN O
. . O

Transformed VBN O
bacterial JJ O
colonies NNS O
were VBD O
screened VBN O
for IN O
recombinant JJ O
plasmids NNS O
containing VBG O
cDNA NN O
coding VBG O
for IN O
BiP NNP B-Gene
by IN O
hybrid JJ O
- : O
selected VBN O
mRNA JJ O
translation NN O
. . O

Branch JJ O
occlusion NN O
of IN O
Heubner NNP O
' POS O
s NN O
artery NN O
, , O
or CC O
perforators NNS O
from IN O
the DT O
proximal JJ O
anterior NN O
or CC O
middle JJ O
cerebral JJ O
arteries NNS O
were VBD O
the DT O
posited JJ O
mechanism NN O
of IN O
infarction NN O
. . O

Similarly RB O
, , O
the DT O
N NNP O
- : O
terminal JJ O
cytoplasmic JJ O
domain NN O
of IN O
the DT O
latent JJ B-Gene
membrane NN I-Gene
protein NN I-Gene
2A CD I-Gene
( ( O
LMP2A NNP B-Gene
) ) O
of IN O
the DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
contains VBZ O
a DT O
single JJ O
copy NN O
of IN O
the DT O
Tyr NNP O
- : O
X SYM O
- : O
X SYM O
- : O
Leu NNP O
/ NNP O
Ile NNP O
- : O
containing NN O
motif NN O
which WDT O
could MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
B NNP O
cell NN O
transformation NN O
. . O

Crystal JJ O
structure NN O
of IN O
an DT O
oligomer NN O
of IN O
proteolytic JJ O
zymogens NNS O
: : O
detailed JJ O
conformational JJ O
analysis NN O
of IN O
the DT O
bovine JJ O
ternary JJ O
complex NN O
and CC O
implications NNS O
for IN O
their PRP$ O
activation NN O
. . O

As IN O
retinoic JJ O
acid NN O
and CC O
thyroid VB O
hormone NN O
are VBP O
frequently RB O
involved VBN O
in IN O
developmental JJ O
regulatory JJ O
processes NNS O
, , O
it PRP O
is VBZ O
possible JJ O
that IN O
this DT O
element NN O
may MD O
be VB O
important JJ O
in IN O
the DT O
process NN O
of IN O
islet NN O
cell NN O
differentiation NN O
. . O

The DT O
occurrence NN O
of IN O
multiple JJ O
malignancy NN O
was VBD O
studied VBN O
in IN O
674 CD O
patients NNS O
with IN O
hematologic JJ O
malignancies NNS O
who WP O
were VBD O
admitted VBN O
to TO O
this DT O
department NN O
during IN O
the DT O
past JJ O
10 CD O
years NNS O
. . O

In IN O
two CD O
- : O
field NN O
nodal JJ O
dissection NN O
, , O
two CD O
components NNS O
are VBP O
included VBN O
with IN O
( ( O
modern JJ O
two CD O
- : O
field NN O
) ) O
or CC O
without IN O
( ( O
traditional JJ O
two CD O
- : O
field NN O
) ) O
nodal JJ O
dissection NN O
around IN O
both DT O
recurrent JJ O
laryngeal NN O
nerve NN O
chains NNS O
in IN O
the DT O
upper JJ O
mediastinum NN O
. . O

S6K2 NNP B-Gene
is VBZ O
highly RB O
homologous JJ O
to TO O
S6K1 NNP B-Gene
in IN O
the DT O
core NN O
kinase NN O
and CC O
linker NN O
regulatory JJ O
domains NNS O
but CC O
differs NNS O
from IN O
S6K1 NNP B-Gene
in IN O
the DT O
N NNP O
- : O
and CC O
C NNP O
- : O
terminal JJ O
regions NNS O
and CC O
is VBZ O
differently RB O
localized VBN O
primarily RB O
to TO O
the DT O
nucleus NN O
because IN O
of IN O
a DT O
C NNP O
- : O
terminal JJ O
nuclear JJ O
localization NN O
signal NN O
unique NN O
to TO O
S6K2 NNP B-Gene
. . O

The DT O
coordinate NN O
increase NN O
in IN O
cyclin JJ B-Gene
D1 NNP I-Gene
and CC O
p21 NN B-Gene
had VBD O
the DT O
effect NN O
of IN O
decreasing VBG O
the DT O
specific NN O
but CC O
not RB O
absolute JJ O
activity NN O
of IN O
cyclin NN B-Gene
D1 NNP I-Gene
/ NNP O
cdk4 NN B-Gene
. . O

p53 NN B-Gene
was VBD O
not RB O
involved VBN O
since IN O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
induction NN O
of IN O
p21 NN B-Gene
was VBD O
unaffected VBN O
by IN O
dominant JJ B-Gene
- : I-Gene
negative JJ I-Gene
p53 NN I-Gene
expression NN O
. . O

A DT O
series NN O
of IN O
amino JJ O
terminal JJ O
deletion NN O
mutants NNS O
( ( O
d10 NN O
, , O
d20 NN O
, , O
d27 NN O
, , O
d31 NN O
, , O
d40 NN O
, , O
d44 NN O
, , O
and CC O
d73 NN O
) ) O
were VBD O
compared VBN O
for IN O
processing NN O
, , O
cell NN O
surface NN O
expression NN O
, , O
and CC O
maintenance NN O
of IN O
their PRP$ O
biological JJ O
attributes NNS O
by IN O
recombinant JJ O
expression NN O
of IN O
mutant JJ O
genes NNS O
using VBG O
a DT O
plasmid NN O
vector NN O
( ( O
pcDL JJ O
- : O
SR NNP O
alpha VBZ O
- : O
296 CD O
) ) O
in IN O
CV NNP O
- : O
1 CD O
and CC O
HeLa NNP O
cells NNS O
. . O

We PRP O
show VBP O
that IN O
LexA NNP B-Gene
- : O
GAL4 NNP B-Gene
and CC O
LexA NNP B-Gene
- : O
Bicoid NNP B-Gene
fusion NN O
proteins NNS O
are VBP O
both DT O
dependent JJ O
on IN O
SNF2 NNP B-Gene
, , O
SNF5 NNP B-Gene
, , O
and CC O
SNF6 NNP B-Gene
for IN O
activation NN O
of IN O
target NN O
genes NNS O
containing VBG O
one CD O
or CC O
multiple JJ O
lexA NN B-Gene
operators NNS I-Gene
. . O

The DT O
mutation NN O
experiments NNS O
showed VBD O
that IN O
the DT O
most RBS O
critical JJ O
sequence NN O
for IN O
the DT O
repression NN O
of IN O
PTH NNP B-Gene
was VBD O
5 CD O
' '' O
- : O
GGGGGAGGGGAG NNP O
- : O
3 CD O
' '' O
( ( O
+ $ O
1 CD O
to TO O
+ VB O
12 CD O
) ) O
of IN O
PTHSR NNP B-Gene
. . O

Number NNP O
and CC O
size NN O
of IN O
silver NN O
- : O
stained VBN O
nucleoli NNS O
( ( O
Ag NNP O
- : O
NOR NNP O
clusters NNS O
) ) O
in IN O
canine NN O
seminomas NN O
: : O
correlation NN O
with IN O
histological JJ O
features NNS O
and CC O
tumour VB O
behaviour NN O
. . O

Factor NNP B-Gene
XI NNP I-Gene
deficiency NN O
is VBZ O
a DT O
rare JJ O
hereditary JJ O
bleeding NN O
disorder NN O
affecting VBG O
the DT O
intrinsic JJ O
pathway NN O
. . O

Of IN O
those DT O
injuries NNS O
, , O
143 CD O
cases NNS O
were VBD O
snowboard RB O
related VBN O
and CC O
158 CD O
cases NNS O
were VBD O
ski JJ O
related VBN O
. . O

These DT O
data NNS O
showed VBD O
: : O
that IN O
progesterone NN O
secretion NN O
is VBZ O
pulsatile JJ O
throughout IN O
the DT O
human JJ O
luteal NN O
phase NN O
, , O
with IN O
maximum JJ O
frequency NN O
in IN O
the DT O
mid NN O
- : O
luteal JJ O
phase NN O
; : O
that WDT O
during IN O
the DT O
mid JJ O
- : O
luteal JJ O
phase NN O
most JJS O
subjects NNS O
had VBD O
progesterone NN O
levels NNS O
both DT O
above IN O
and CC O
below IN O
currently RB O
accepted VBN O
ovulatory JJ O
thresholds NNS O
; : O
the DT O
use NN O
of IN O
a DT O
single JJ O
measurement NN O
of IN O
progesterone NN O
in IN O
the DT O
mid NN O
- : O
luteal JJ O
phase NN O
is VBZ O
not RB O
always RB O
a DT O
reliable JJ O
indicator NN O
of IN O
ovulation NN O
; : O
a DT O
threshold NN O
greater JJR O
than IN O
20 CD O
nmol JJ O
/ NNP O
l NN O
may MD O
yield VB O
an DT O
unacceptable JJ O
number NN O
of IN O
false JJ O
negative JJ O
results NNS O
. . O

This DT O
study NN O
determined VBD O
the DT O
arthritogenic JJ O
potential NN O
of IN O
silicone NN O
gel NN O
by IN O
either DT O
mixing VBG O
it PRP O
with IN O
bovine NN B-Gene
collagen NN I-Gene
II NNP I-Gene
( ( O
BII NNP B-Gene
) ) O
or CC O
by IN O
injecting VBG O
silicone NN O
gel NN O
alone RB O
in IN O
DA NNP O
rats NNS O
. . O

Mutations NNS O
in IN O
a DT O
region NN O
located VBN O
15 CD O
to TO O
30 CD O
bp NNS O
downstream NN O
from IN O
the DT O
major JJ O
transcription NN O
start NN O
site NN O
that WDT O
shows VBZ O
good JJ O
homology NN O
to TO O
a DT O
sequence NN O
in IN O
the DT O
first JJ O
exon NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
implicated VBN O
as IN O
a DT O
negative JJ O
regulatory JJ O
element NN O
resulted VBD O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
basal JJ O
gene NN O
expression NN O
but CC O
did VBD O
not RB O
affect VB O
regulation NN O
. . O

In IN O
a DT O
control NN O
group NN O
both DT O
common JJ O
carotid NN O
arteries NNS O
( ( O
CCA NNP O
) ) O
were VBD O
ligated VBN O
. . O

To TO O
determine VB O
the DT O
effects NNS O
on IN O
the DT O
pulmonary JJ O
barrier NN O
of IN O
several JJ O
surface NN O
active JJ O
agents NNS O
, , O
a DT O
series NN O
of IN O
metered VBN O
dose JJ O
inhalers NNS O
( ( O
MDIs NNP O
) ) O
was VBD O
prepared VBN O
and CC O
used VBN O
to TO O
dose VB O
aerosolized JJ O
surfactant NN O
to TO O
the DT O
airways NNS O
of IN O
isolated JJ O
perfused JJ O
rat NN O
lungs NNS O
. . O

During IN O
a DT O
single JJ O
LAD NNP O
occlusion NN O
lasting VBG O
35 CD O
minutes NNS O
( ( O
series NN O
I PRP O
, , O
n RB O
= VBZ O
10 CD O
) ) O
9 CD O
microns NNS O
TMs NNP O
were VBD O
infused VBN O
immediately RB O
and CC O
30 CD O
minutes NNS O
after IN O
ligation NN O
, , O
15 CD O
microns NNS O
TMs NNP O
being VBG O
infused VBN O
after IN O
15 CD O
- : O
20 CD O
minutes NNS O
. . O

The DT O
results NNS O
presented VBN O
in IN O
this DT O
report NN O
suggest VBP O
that IN O
the DT O
SV40 NNP O
G NNP O
- : O
C NNP O
- : O
rich JJ O
sequences NNS O
can MD O
function VB O
as IN O
independent JJ O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
transcriptional JJ O
- : O
control NN O
elements NNS O
. . O

BACKGROUND NN O
: : O
Mitosis NN O
is VBZ O
regulated VBN O
by IN O
MPF NNP B-Gene
( ( O
maturation NN B-Gene
promoting VBG I-Gene
factor NN I-Gene
) ) O
, , O
the DT O
active JJ O
form NN O
of IN O
Cdc2 NNP B-Gene
/ NNP I-Gene
28 CD I-Gene
- : O
cyclin NN B-Gene
B NNP I-Gene
complexes NN O
. . O

There EX O
was VBD O
an DT O
increase NN O
in IN O
protein JJ O
binding VBG O
onto IN O
this DT O
element NN O
only RB O
after IN O
peptide JJ O
treatment NN O
. . O

Of IN O
its PRP$ O
gene NN O
products NNS O
, , O
E6 NNP B-Gene
binds VBZ O
to TO O
and CC O
inactivates NNS O
p53 VBP B-Gene
tumor NN I-Gene
suppressor NN I-Gene
protein NN I-Gene
by IN O
ubiquitin JJ B-Gene
/ JJ O
proteasome NN O
- : O
dependent JJ O
degradation NN O
. . O

Arnt3 NNP B-Gene
mRNA NN I-Gene
was VBD O
expressed VBN O
in IN O
brain NN O
, , O
skeletal JJ O
muscle NN O
, , O
13 CD O
. . O
5 CD O
- : O
day NN O
embryos VB O
, , O
and CC O
P19 NNP O
cells NNS O
treated VBD O
with IN O
retinoic JJ O
acid NN O
. . O

G NNP O
. . O

Eight CD O
of IN O
the DT O
non JJ O
- : O
acceptable JJ O
inlays NNS O
/ VBP O
onlays NNS O
and CC O
five CD O
of IN O
the DT O
direct JJ O
restorations NNS O
were VBD O
replaced VBN O
, , O
while IN O
the DT O
other JJ O
ones NNS O
were VBD O
repaired VBN O
with IN O
resin NN O
composite NN O
. . O

Two CD O
- : O
dimensional JJ O
phosphotryptic JJ O
analyses NNS O
indicate VBP O
that DT O
phosphorylation NN O
on IN O
Ser NNP O
- : O
12 CD O
and CC O
Ser NNP O
- : O
48 CD O
in IN O
unstimulated JJ O
cells NNS O
is VBZ O
associated VBN O
with IN O
the DT O
ability NN O
of IN O
overexpressed JJ O
pp60c NN B-Gene
- : I-Gene
src NN I-Gene
to TO O
potentiate VB O
beta SYM O
- : O
adrenergic JJ O
signalling NN O
. . O

Importantly RB O
, , O
in IN O
HeLa NNP O
and CC O
293 CD O
cells NNS O
, , O
endogenous JJ O
and CC O
transfected VBD O
I PRP B-Gene
kappaB VBP I-Gene
alpha RB I-Gene
coimmunoprecipitated VBN O
with IN O
Myc NNP B-Gene
- : O
tagged VBD O
or CC O
endogenous JJ O
Dlc NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Recipients NNS O
with IN O
acute JJ O
leukaemia NN O
in IN O
first JJ O
remission NN O
or CC O
chronic JJ O
myeloid NN O
leukaemia NN O
in IN O
first JJ O
chronic JJ O
phase NN O
were VBD O
analysed VBN O
as RB O
good JJ O
risk NN O
, , O
and CC O
those DT O
beyond IN O
these DT O
stages NNS O
, , O
as IN O
poor JJ O
risk NN O
patients NNS O
. . O

In IN O
transient JJ O
cotransfections NNS O
E1A NNP B-Gene
could MD O
induce VB O
the DT O
activity NN O
of IN O
the DT O
p53 NN B-Gene
promoter NN I-Gene
to TO O
a DT O
high JJ O
level NN O
; : O
12S CD B-Gene
E1A NNP I-Gene
was VBD O
threefold VBN O
as RB O
efficient JJ O
as IN O
13S CD B-Gene
E1A NNP I-Gene
in IN O
this DT O
activity NN O
, , O
and CC O
YY1 NNP B-Gene
bound NN O
to TO O
the DT O
composite JJ O
element NN O
was VBD O
shown VBN O
to TO O
mediate VB O
55 CD O
% NN O
of IN O
this DT O
induction NN O
. . O

It PRP O
suggests VBZ O
a DT O
sequence NN O
of IN O
surgical JJ O
planning NN O
that WDT O
can MD O
prevent VB O
them PRP O
and CC O
also RB O
offers VBZ O
ways NNS O
of IN O
dealing VBG O
with IN O
the DT O
problems NNS O
should MD O
they PRP O
occur VB O
. . O

The DT O
parameters NNS O
of IN O
nonspecific JJ O
humoral JJ O
immunity NN O
- : O
- : O
serum NN B-Gene
immunoglobulins NNS I-Gene
and CC O
immune NN O
complexes NNS O
- : O
- : O
were VBD O
evaluated VBN O
in IN O
irradiated JJ O
group NN O
of IN O
patients NNS O
with IN O
uterine JJ O
cervix NN O
carcinoma NN O
( ( O
Stages NNP O
IIB NNP O
and CC O
IIIB NNP O
) ) O
, , O
during IN O
one CD O
year NN O
follow VB O
up RP O
. . O

The DT O
HGF NNP B-Gene
- : O
induced VBD O
cell NN O
motility NN O
was VBD O
mimicked VBN O
by IN O
12 CD O
- : O
0 CD O
- : O
tetradecanoyl NN O
- : O
phorbol NN O
- : O
13 CD O
- : O
acetate NN O
, , O
a DT O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
- : O
activating VBG O
phorbol NN O
ester NN O
, , O
but CC O
not RB O
by IN O
Ca2 NNP O
+ NNP O
ionophore NN O
. . O

Group NNP O
I PRP O
consisted VBD O
of IN O
six CD O
noncholestatic JJ O
patients NNS O
; : O
group NN O
II NNP O
consisted VBD O
of IN O
nine CD O
mildly RB O
cholestatic JJ O
patients NNS O
with IN O
mild JJ O
hepatic JJ O
impairment NN O
( ( O
conjugated JJ O
bilirubin NN O
, , O
47 CD O
mumol NN O
liter NN O
- : O
1 CD O
; : O
alkaline JJ B-Gene
phosphatase NN I-Gene
, , O
280 CD O
IU NNP O
liter NN O
- : O
1 CD O
; : O
gamma SYM B-Gene
- : I-Gene
glutamyltranspeptidase NN I-Gene
, , O
190 CD O
IU NNP O
liter NN O
- : O
1 CD O
) ) O
; : O
group NN O
III NNP O
consisted VBD O
of IN O
six CD O
benign JJ O
intrahepatic JJ O
cholestatic JJ O
patients NNS O
with IN O
high JJ O
isolated VBN O
conjugated JJ O
hyperbilirubinemia NN O
( ( O
98 CD O
. . O
1 CD O
mumol NN O
liter NN O
- : O
1 CD O
) ) O
. . O

It PRP O
has VBZ O
a DT O
grave JJ O
prognosis NN O
with IN O
> JJ O
70 CD O
% NN O
mortality NN O
in IN O
3 CD O
months NNS O
, , O
despite IN O
mechanical JJ O
ventilation NN O
. . O

Mortality NN O
on IN O
the DT O
last JJ O
ranch NN O
was VBD O
particularly RB O
severe JJ O
among IN O
certain JJ O
segregated VBD O
groups NNS O
of IN O
turkeys NNS O
that WDT O
included VBD O
toms NNS O
, , O
heavier JJR O
birds NNS O
, , O
and CC O
birds NNS O
undergoing VBG O
a DT O
stressful JJ O
event NN O
such JJ O
as IN O
artificial JJ O
insemination NN O
. . O

The DT O
promoter NN O
segment NN O
was VBD O
inactive JJ O
when WRB O
introduced VBN O
into IN O
the DT O
rat NN O
glioma NN O
cell NN O
line NN O
C6B4 NNP O
, , O
the DT O
rat NN O
submandibular JJ O
cell NN O
line NN O
RSMT NNP O
- : O
A5 NNP O
, , O
and CC O
the DT O
rat NN O
pancreatic JJ O
beta NN O
cell NN O
line NN O
RIN NNP O
- : O
5AH CD O
, , O
all DT O
of IN O
which WDT O
do VBP O
not RB O
express VB O
the DT O
endogenous JJ O
alpha2c NN B-Gene
- : I-Gene
AR NNP I-Gene
gene NN I-Gene
. . O

Thus RB O
, , O
the DT O
synergistic JJ O
effects NNS O
of IN O
HNF NNP B-Gene
- : I-Gene
1beta CD I-Gene
and CC O
the DT O
GR NNP B-Gene
on IN O
dexamethasone NN O
- : O
stimulated JJ O
promoter NN O
activity NN O
require VBP O
that IN O
they PRP O
are VBP O
bound VBN O
to TO O
the DT O
HNF NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
and CC O
the DT O
GRE NNP O
, , O
respectively RB O
, , O
and CC O
may MD O
involve VB O
protein SYM O
- : O
protein NN O
interactions NNS O
between IN O
the DT O
transcription NN O
factors NNS O
, , O
or CC O
between IN O
them PRP O
and CC O
the DT O
basal NN O
transcription NN O
machinery NN O
or CC O
a DT O
steroid JJ B-Gene
receptor NN I-Gene
coactivator NN I-Gene
. . O

These DT O
exons NNS O
were VBD O
identified VBN O
by IN O
cloning VBG O
and CC O
sequencing VBG O
cDNAs NN O
obtained VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
of IN O
a DT O
fibroblast JJ O
cDNA NN O
library NN O
. . O

The DT O
kinetics NNS O
of IN O
kinase NN O
activity NN O
within IN O
these DT O
complexes NNS O
compared VBN O
to TO O
CheA NNP B-Gene
alone RB O
indicate VBP O
approximately RB O
a DT O
50 CD O
% NN O
decrease NN O
in IN O
the DT O
KM NNP O
for IN O
ATP NNP O
and CC O
a DT O
100 CD O
- : O
fold JJ O
increase NN O
in IN O
the DT O
Vmax NNP O
. . O

Molecular JJ O
neurochemistry NN O
of IN O
addictive JJ O
drugs NNS O
. . O

The DT O
5 CD O
- : O
year NN O
overall JJ O
survival NN O
( ( O
OS NNP O
) ) O
and CC O
progression NN O
- : O
free JJ O
survival NN O
( ( O
PFS NNP O
) ) O
rates NNS O
were VBD O
58 CD O
. . O
9 CD O
% NN O
and CC O
55 CD O
. . O
4 CD O
% NN O
for IN O
arm NN O
A NNP O
and CC O
44 CD O
. . O
5 CD O
% NN O
and CC O
41 CD O
. . O
3 CD O
% NN O
for IN O
arm NN O
B NNP O
( ( O
P NNP O
= NNP O
. . O
7 CD O
and CC O
P NNP O
= NNP O
. . O
2 CD O
) ) O
, , O
respectively RB O
. . O

The DT O
effects NNS O
of IN O
chlordiazepoxide NN O
( ( O
2 CD O
. . O
5 CD O
- : O
15 CD O
. . O
0mg CD O
/ JJ O
kg NN O
) ) O
, , O
a DT O
full JJ O
benzodiazepine NN B-Gene
receptor NN I-Gene
agonist NN O
, , O
and CC O
bretazenil NN O
( ( O
5 CD O
. . O
0 CD O
- : O
30 CD O
. . O
0mg CD O
/ JJ O
kg NN O
) ) O
, , O
a DT O
partial JJ O
benzodiazepine NN B-Gene
receptor NN I-Gene
agonist NN O
, , O
were VBD O
examined VBN O
in IN O
the DT O
murine NN O
elevated VBD O
plus CC O
- : O
maze NN O
paradigm NN O
. . O

Various JJ O
assays NNS O
demonstrate VBP O
promoter NN O
activity NN O
in IN O
this DT O
sequence NN O
that WDT O
reproduces VBZ O
the DT O
normal JJ O
control NN O
of IN O
E2F2 NNP B-Gene
expression NN O
during IN O
a DT O
growth NN O
stimulation NN O
. . O

Respondents NNS O
who WP O
lived VBD O
with IN O
a DT O
spouse NN O
/ NN O
partner NN O
only RB O
were VBD O
less RBR O
likely JJ O
to TO O
have VB O
an DT O
unfavorable JJ O
BMI NNP O
status NN O
than IN O
people NNS O
in IN O
the DT O
other JJ O
two CD O
groups NNS O
. . O

This DT O
phosphorylation NN O
can MD O
be VB O
catalyzed VBN O
by IN O
a DT O
break JJ O
- : O
ended VBD O
double JJ O
- : O
stranded VBD O
DNA NNP O
- : O
activated VBD O
protein JJ O
kinase NN O
activity NN O
from IN O
the DT O
sea NN O
urchin JJ O
nucleus NN O
in IN O
vitro NN O
. . O

Carnitine NNP B-Gene
palmitoyltransferase NN I-Gene
( ( I-Gene
CPT NNP I-Gene
) ) I-Gene
II NNP I-Gene
deficiency NN O
is VBZ O
the DT O
most RBS O
common JJ O
inherited JJ O
disorder NN O
of IN O
lipid JJ O
metabolism NN O
affecting VBG O
skeletal JJ O
muscle NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
this DT O
difference NN O
is VBZ O
due JJ O
to TO O
the DT O
presence NN O
of IN O
a DT O
Mot3 NNP B-Gene
binding NN I-Gene
site NN I-Gene
in IN O
OpA NNP B-Gene
. . O

We PRP O
studied VBD O
the DT O
human JJ O
vestibulo NN O
- : O
ocular JJ O
reflex NN O
( ( O
VOR NNP O
) ) O
in IN O
response NN O
to TO O
head NN O
' '' O
impulses NNS O
' POS O
: : O
brief NN O
, , O
unpredictable JJ O
, , O
passive JJ O
, , O
high JJ O
- : O
acceleration NN O
( ( O
up IN O
to TO O
4000 CD O
degrees NNS O
/ VBP O
s2 NN O
) ) O
, , O
low JJ O
- : O
amplitude NN O
( ( O
20 CD O
- : O
30 CD O
degrees NNS O
) ) O
head VBP O
rotations NNS O
. . O

Upstream IN O
activating VBG O
sequences NNS O
( ( O
UASs NNP O
) ) O
derived VBD O
from IN O
known VBN O
Ste12p NNP B-Gene
- : O
dependent NN O
genes NNS O
have VBP O
previously RB O
been VBN O
characterized VBN O
to TO O
require VB O
either DT O
multiple JJ O
PREs NNP O
or CC O
a DT O
single JJ O
PRE NNP O
coupled VBD O
to TO O
a DT O
binding NN O
site NN O
for IN O
a DT O
second JJ O
protein NN O
. . O

This DT O
article NN O
will MD O
briefly VB O
review VB O
the DT O
published VBN O
data NNS O
on IN O
the DT O
morphology NN O
, , O
function NN O
, , O
and CC O
biochemistry NN O
of IN O
the DT O
normal JJ O
renal JJ O
medulla NN O
and CC O
the DT O
pathology NN O
associated VBN O
with IN O
RPN NNP O
, , O
together RB O
with IN O
the DT O
secondary JJ O
changes NNS O
which WDT O
give VBP O
rise NN O
to TO O
cortical JJ O
degeneration NN O
or CC O
epithelial JJ O
carcinoma NN O
. . O

The DT O
PI3K NNP B-Gene
_ NNP I-Gene
68D CD I-Gene
cDNA NN I-Gene
encodes VBZ O
a DT O
protein NN O
of IN O
210 CD O
kDa NNS O
, , O
which WDT O
lacks VBZ O
sequences NNS O
implicated VBN O
in IN O
linking VBG O
p110 NN B-Gene
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinases NNS I-Gene
to TO O
p85 VB B-Gene
adaptor NN I-Gene
proteins NNS I-Gene
, , O
but CC O
contains VBZ O
an DT O
amino NN O
- : O
terminal JJ O
proline NN O
- : O
rich JJ O
sequence NN O
, , O
which WDT O
could MD O
bind VB O
to TO O
SH3 NNP B-Gene
domains NNS I-Gene
, , O
and CC O
a DT O
carboxy JJ O
- : O
terminal JJ O
C2 NNP B-Gene
domain NN O
. . O

The DT O
upTRE JJ O
binds VBZ O
more RBR O
T3R JJ B-Gene
homodimers NNS I-Gene
and CC O
less JJR O
T3R NNP B-Gene
- : O
RXR NN B-Gene
heterodimers NNS O
than IN O
the DT O
dnTRE NN O
, , O
and CC O
T3 NNP O
more JJR O
readily RB O
facilitates VBZ O
heterodimer JJ O
binding NN O
to TO O
the DT O
dn NN O
- : O
than IN O
to TO O
the DT O
upTRE NN O
. . O

The DT O
prevalence NN O
of IN O
opportunistic JJ O
infection NN O
among IN O
surviving VBG O
AIDS NNP O
patients NNS O
and CC O
the DT O
probability NN O
of IN O
being VBG O
in IN O
tumour JJ O
response NN O
following VBG O
cancer NN O
therapy NN O
conditional NN O
on IN O
being VBG O
alive JJ O
are VBP O
two CD O
examples NNS O
of IN O
such JJ O
functions NNS O
. . O

Glutamic NNP O
acid NN O
in IN O
a DT O
dose NN O
of IN O
1 CD O
/ JJ O
100 CD O
of IN O
the DT O
LD50 NNP O
was VBD O
injected VBN O
in IN O
the DT O
form NN O
of IN O
sodium NN O
salt NN O
into IN O
male NN O
and CC O
female JJ O
Wistar NNP O
rats NNS O
for IN O
7 CD O
days NNS O
after IN O
8 CD O
- : O
and CC O
12 CD O
- : O
day NN O
injections NNS O
of IN O
dexazone NN O
. . O

Foxp1 NNP B-Gene
and CC O
Foxp2 NNP B-Gene
are VBP O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
lung NN O
as RB O
early RB O
as IN O
E12 NNP O
. . O
5 CD O
of IN O
mouse NN O
development NN O
with IN O
Foxp2 NNP B-Gene
expression NN O
restricted VBD O
to TO O
the DT O
airway NN O
epithelium NN O
. . O

Cooperative JJ O
dimerization NN O
of IN O
paired JJ B-Gene
class NN O
homeo NN O
domains VBZ O
on IN O
DNA NN O
. . O

In IN O
spite NN O
of IN O
this DT O
and CC O
other JJ O
complications NNS O
of IN O
corticosteroids NNS O
, , O
she PRP O
made VBD O
a DT O
full JJ O
recovery NN O
from IN O
the DT O
fungal JJ O
infection NN O
following VBG O
treatment NN O
with IN O
amphotericin NN O
B NNP O
and CC O
surgical JJ O
excision NN O
of IN O
the DT O
lung NN O
abscess NN O
. . O

Constructs NNS O
designed VBN O
and CC O
expressed VBN O
were VBD O
E2L1 NNP B-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
98 CD I-Gene
) ) I-Gene
, , O
E2L1 NNP B-Gene
. . I-Gene
H1 NNP I-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
128 CD I-Gene
) ) I-Gene
, , O
E2L2 NNP B-Gene
( ( I-Gene
120 CD I-Gene
- : I-Gene
233 CD I-Gene
) ) I-Gene
, , O
E2H1 NNP B-Gene
. . I-Gene
L2 NNP I-Gene
( ( I-Gene
98 CD I-Gene
- : I-Gene
233 CD I-Gene
) ) I-Gene
, , O
and CC O
E2L1 NNP B-Gene
. . I-Gene
H1 NNP I-Gene
. . I-Gene
L2 NNP I-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
233 CD I-Gene
) ) I-Gene
, , O
where WRB O
numbers NNS O
in IN O
parentheses NNS O
give VBP O
the DT O
amino NN O
acid NN O
sequence NN O
for IN O
the DT O
portions NNS O
of IN O
the DT O
E2 NNP B-Gene
component NN O
incorporated VBN O
into IN O
a DT O
construct NN O
. . O

Lipiodol NNP O
was VBD O
covalently RB O
conjugated VBN O
with IN O
EDTB NNP O
. . O

After IN O
measuring VBG O
baseline NN O
Vmca NNP O
at IN O
a DT O
partial JJ O
pressure NN O
of IN O
carbon NN O
dioxide NN O
in IN O
arterial JJ O
blood NN O
( ( O
PaCO2 NNP O
) ) O
of IN O
37 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
5 CD O
mmHg NN O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
, , O
measurements NNS O
were VBD O
repeated VBN O
at IN O
a DT O
PaCO NNP O
of IN O
44 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
8 CD O
mmHg NN O
, , O
and CC O
the DT O
carbon NN O
dioxide NN O
reactivity NN O
( ( O
absolute JJ O
value NN O
: : O
cm NN O
x NN O
s NN O
( ( O
- : O
1 CD O
) ) O
x NN O
mmHg NN O
( ( O
- : O
1 CD O
) ) O
; : O
relative JJ O
value NN O
: : O
percentage NN O
of IN O
baseline NN O
Vmca NNP O
/ NNP O
mmHg NN O
) ) O
was VBD O
calculated VBN O
. . O

GAP NNP O
JUNCTIONS NNP O
IN NNP O
THE NNP O
BRAIN NNP O
: : O
PREFACE NN O
. . O

Enhanced NNP O
period NN O
- : O
peak JJ O
analysis NN O
of IN O
electro JJ O
- : O
encephalograms NNS O
using VBG O
a DT O
fast JJ O
sinc NN O
function NN O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
report VBP O
a DT O
detailed JJ O
study NN O
of IN O
the DT O
structure NN O
and CC O
the DT O
functional JJ O
role NN O
of IN O
the DT O
MalT NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
located VBN O
in IN O
the DT O
adjacent JJ O
and CC O
divergent JJ O
pulAp NN B-Gene
and CC O
pulCp NN B-Gene
promoters NNS I-Gene
. . O

The DT O
standard JJ O
method NN O
for IN O
calculating VBG O
the DT O
composite JJ O
score NN O
on IN O
the DT O
S NNP O
- : O
B NNP O
IV NNP O
excludes VBZ O
subtests NNS O
with IN O
a DT O
raw JJ O
score NN O
of IN O
0 CD O
, , O
which WDT O
overestimates VBZ O
cognitive JJ O
functioning NN O
in IN O
young JJ O
biologically RB O
high JJ O
risk NN O
children NNS O
. . O

We PRP O
conclude VBP O
that IN O
for IN O
mono NN O
- : O
intronic JJ O
precursors NNS O
in IN O
which WDT O
there EX O
is VBZ O
only RB O
one CD O
choice NN O
of IN O
splice NN O
sites NNS O
, , O
most JJS O
of IN O
the DT O
exon NN O
sequences NNS O
are VBP O
not RB O
mechanistically RB O
involved VBN O
in IN O
the DT O
splicing NN O
process NN O
. . O

Relative JJ O
to TO O
coherent VB O
control NN O
words NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
quick JJ O
) ) O
, , O
these DT O
discourse SYM O
- : O
dependent JJ O
semantic JJ O
anomalies NNS O
elicited VBD O
a DT O
large JJ O
N400 NNP O
effect NN O
that WDT O
began VBD O
at IN O
about RB O
200 CD O
to TO O
250 CD O
msec NN O
after IN O
word NN O
onset NN O
. . O

The DT O
gene NN B-Gene
lac SYM I-Gene
- : I-Gene
1 CD I-Gene
, , O
encoding VBG O
the DT O
enzyme NN O
laccase NN B-Gene
, , O
is VBZ O
the DT O
best JJS O
characterized NN O
of IN O
a DT O
number NN O
of IN O
genes NNS O
in IN O
the DT O
chestnut NN O
blight NN O
fungus NN O
, , O
Cryphonectria NNP O
parasitica NN O
, , O
that WDT O
are VBP O
repressed VBN O
by IN O
hypoviruses NNS O
, , O
a DT O
group NN O
of IN O
virulence NN O
- : O
attenuating NN O
mycoviruses NNS O
. . O

lac SYM B-Gene
- : I-Gene
1 CD I-Gene
has VBZ O
also RB O
been VBN O
shown VBN O
to TO O
be VB O
transcriptionally RB O
activated VBN O
by IN O
low JJ O
concentrations NNS O
of IN O
the DT O
translational JJ O
inhibitor NN O
cycloheximide NN O
( ( O
CHX NNP O
) ) O
and CC O
by IN O
the DT O
immunosuppressant JJ O
cyclosporin NN O
A NNP O
. . O

Escherichia NNP O
coli NN O
JRG582 NNP O
is VBZ O
an DT O
ampD JJ B-Gene
ampE NN B-Gene
deletion NN O
derivative NN O
of IN O
strain NN O
HfrH NNP O
and CC O
accordingly RB O
it PRP O
is VBZ O
derepressed VBN O
for IN O
expression NN O
of IN O
the DT O
cloned VBN O
inducible JJ O
beta NN B-Gene
- : I-Gene
lactamase NN I-Gene
gene NN I-Gene
of IN O
Citrobacter NNP O
freundii NN O
, , O
carried VBD O
on IN O
plasmid NN O
pNU305 NN O
. . O

Consistent JJ O
with IN O
this DT O
possibility NN O
, , O
a DT O
non JJ O
- : O
MBD JJ B-Gene
region NN O
of IN O
Bin1 NNP B-Gene
was VBD O
sufficient JJ O
to TO O
recruit VB O
a DT O
repression NN O
function NN O
to TO O
DNA VB O
that DT O
was VBD O
unrelated JJ O
to TO O
histone VB B-Gene
deacetylase NN I-Gene
. . O

A DT O
haemolytic JJ O
enterotoxigenic JJ O
strain NN O
of IN O
E NNP O
. . O
coli NN O
( ( O
O149 NNP O
: : O
K88 NN O
: : O
H10 NNP O
) ) O
was VBD O
regularly RB O
recovered VBN O
from IN O
piglets NNS O
with IN O
PWD NNP O
while IN O
rotavirus NN O
was VBD O
demonstrated VBN O
on IN O
a DT O
number NN O
of IN O
occasions NNS O
. . O

Glycogen NNP O
utilization NN O
was VBD O
increased VBN O
, , O
but CC O
tissue NN O
levels NNS O
of IN O
creatine NN O
phosphate NN O
, , O
ATP NNP O
, , O
and CC O
lactate NN O
were VBD O
similar JJ O
to TO O
those DT O
in IN O
hearts NNS O
receiving VBG O
normal JJ O
flow NN O
. . O

In IN O
addition NN O
, , O
we PRP O
sought VBD O
to TO O
test VB O
the DT O
hypothesis NN O
that IN O
, , O
when WRB O
equal JJ O
volumes NNS O
are VBP O
administered VBN O
intrathecally RB O
, , O
significant JJ O
differences NNS O
exist VBP O
in IN O
the DT O
potential NN O
to TO O
three CD O
commonly RB O
used VBN O
anesthetic JJ O
solutions NNS O
to TO O
induce VB O
sensory JJ O
impairment NN O
. . O

Resolution NN O
of IN O
thermographic JJ O
asymmetry NN O
and CC O
/ NN O
or CC O
decrease NN O
in IN O
Delta NNP O
T NNP O
was VBD O
demonstrated VBN O
in IN O
approximately RB O
81 CD O
% NN O
of IN O
the DT O
post NN O
- : O
treatment NN O
population NN O
. . O

Video NNP O
images NNS O
of IN O
the DT O
nostrils NNS O
were VBD O
captured VBN O
and CC O
then RB O
analyzed VBD O
for IN O
area NN O
, , O
perimeter NN O
, , O
centroid NN O
, , O
principal JJ O
axis NN O
, , O
moments NNS O
about IN O
the DT O
major JJ O
and CC O
minor JJ O
axes NNS O
( ( O
I11 NNP O
, , O
I22 NNP O
) ) O
, , O
anisometry NN O
, , O
bulkiness NN O
, , O
lateral JJ O
offset NN O
, , O
internostril JJ O
angle NN O
, , O
and CC O
rotational JJ O
angle NN O
. . O

In IN O
this DT O
report NN O
we PRP O
describe VBP O
the DT O
isolation NN O
of IN O
a DT O
Fab NNP B-Gene
fragment NN I-Gene
( ( O
Fab NNP B-Gene
A8 NNP I-Gene
) ) O
showing VBG O
a DT O
high JJ O
relative JJ O
affinity NN O
for IN O
the DT O
receptor NN O
( ( O
0 CD O
. . O
5 CD O
nM NN O
) ) O
. . O

Reverse NNP B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP B-Gene
- : O
PCR NN O
) ) O
was VBD O
performed VBN O
using VBG O
eyestalk NN O
complementary JJ O
DNA NN O
of IN O
the DT O
sand NN O
shrimp NN O
Metapenaeus NNP O
ensis NN O
. . O

We PRP O
show VBP O
that IN O
other JJ O
cdc33 NN B-Gene
mutants NNS I-Gene
also RB O
arrest VBP O
in IN O
G1 NNP O
. . O

In IN O
Klinefelter NNP O
' POS O
s JJ O
syndrome NN O
( ( O
47XXY CD O
) ) O
, , O
serum VBP O
testosterone NN O
levels NNS O
are VBP O
at IN O
the DT O
lower JJR O
end NN O
of IN O
the DT O
normal JJ O
range NN O
and CC O
dihydrotestosterone NN O
levels NNS O
are VBP O
low JJ O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
carbon NN O
- : O
perfused VBN O
areas NNS O
and CC O
MBF NNP O
in IN O
the DT O
liver NN O
, , O
renal JJ O
cortex NN O
, , O
spleen NN O
, , O
and CC O
small JJ O
intestinal JJ O
serosa NN O
( ( O
only RB O
MBF NNP O
) ) O
increased VBD O
significantly RB O
5 CD O
h NN O
after IN O
CLP NNP O
. . O

Abnormal NNP O
urinary JJ O
coproporphyrin NN O
levels NNS O
in IN O
patients NNS O
infected VBN O
by IN O
hepatitis NN O
C NNP O
virus NN O
with IN O
or CC O
without IN O
human JJ O
immunodeficiency NN O
virus NN O
. . O

These DT O
data NNS O
will MD O
help VB O
us PRP O
to TO O
better JJR O
detail VB O
the DT O
CXCR4 NNP B-Gene
structural JJ O
requirements NNS O
exhibited VBN O
by IN O
different JJ O
HIV NNP O
- : O
1 CD O
strains NNS O
and CC O
will MD O
direct VB O
further JJ O
mutagenesis NN O
efforts NNS O
aimed VBN O
at IN O
better JJR O
defining VBG O
the DT O
domains NNS O
in IN O
CXCR4 NNP B-Gene
involved VBN O
in IN O
the DT O
HIV NNP O
- : O
1 CD O
Env NNP B-Gene
- : O
mediated VBD O
fusion NN O
process NN O
. . O

Displacement NNP O
thresholds NNS O
of IN O
peripheral JJ O
sites NNS O
in IN O
monocular JJ O
human JJ O
vision NN O
were VBD O
obtained VBN O
. . O

This DT O
protein NN O
with IN O
a DT O
hydrophobic JJ O
amino NN O
terminus NN O
appears VBZ O
to TO O
be VB O
a DT O
secreted JJ O
protein NN O
. . O

Solitary JJ O
thyroid NN O
nodule NN O
. . O

In IN O
this DT O
situation NN O
the DT O
convlusion NN O
threshold NN O
for IN O
the DT O
8 CD O
substances NNS O
is VBZ O
as IN O
follows VBZ O
: : O
pethidine NN O
20 CD O
mg NN O
. . O
kg VB O
- : O
1 CD O
I PRP O
. . O
V NNP O
. . O
, , O
piritramide RB O
30 CD O
, , O
morphine NN O
180 CD O
, , O
phenoperidine NN O
4 CD O
, , O
R NNP O
39 CD O
209 CD O
5 CD O
, , O
fentanyl RB O
4 CD O
, , O
sufentanil VBD O
4 CD O
and CC O
R NNP O
34 CD O
995 CD O
10 CD O
mg NN O
. . O
kg VB O
- : O
1 CD O
I PRP O
. . O
V NNP O
. . O

Positron NNP O
emission NN O
tomography NN O
radioligands VBZ O
for IN O
dopamine NN B-Gene
transporters NNS I-Gene
and CC O
studies NNS O
in IN O
human JJ O
and CC O
nonhuman JJ O
primates NNS O
. . O

After IN O
2 CD O
min NN O
of IN O
dobutamine NN O
injection NN O
, , O
or CC O
after IN O
20 CD O
min NN O
of IN O
pimobendan NN O
injection NN O
, , O
the DT O
myocardium NN O
was VBD O
removed VBN O
, , O
and CC O
used VBD O
for IN O
determination NN O
of IN O
the DT O
tissue NN O
levels NNS O
of IN O
metabolites NNS O
of IN O
energy NN O
and CC O
carbohydrate JJ O
metabolism NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
sought VBD O
to TO O
identify VB O
mechanisms NNS O
that WDT O
could MD O
account VB O
for IN O
the DT O
antimitogenic JJ O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

Although IN O
E2FBP1 NNP B-Gene
lacks VBZ O
the DT O
transactivation NN O
domain NN O
, , O
it PRP O
stimulates VBZ O
E2F NNP B-Gene
site NN O
- : O
dependent JJ O
transcription NN O
in IN O
cooperation NN O
with IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

In IN O
vitro JJ O
transcription NN O
results NNS O
indicate VBP O
that IN O
this DT O
5 CD O
' POS O
structure NN O
functions NNS O
in IN O
the DT O
attenuation NN O
mechanism NN O
, , O
since IN O
deletion NN O
of IN O
the DT O
stem NN O
- : O
loop NN O
caused VBD O
an DT O
increase NN O
in IN O
transcription NN O
readthrough NN O
. . O

Serum NNP O
IgG NNP B-Gene
was VBD O
initially RB O
elevated VBN O
in IN O
6 CD O
patients NNS O
. . O

RESULTS NN O
: : O
Neither CC O
basal JJ O
FSH NNP B-Gene
level NN O
nor CC O
stimulated JJ O
FSH NNP B-Gene
level NN O
alone RB O
were VBD O
statistically RB O
significant JJ O
predictors NNS O
of IN O
IVF NNP O
success NN O
; : O
however RB O
, , O
no DT O
patient NN O
with IN O
a DT O
day NN O
3 CD O
FSH NNP B-Gene
level NN O
> VBD O
11 CD O
. . O
1 CD O
mIU JJ O
/ NNP O
ml NN O
or CC O
a DT O
stimulated JJ O
day NN O
10 CD O
FSH NNP B-Gene
level NN O
> VBD O
13 CD O
. . O
5 CD O
mIU JJ O
/ NNP O
ml NN O
conceived VBD O
and CC O
carried VBD O
a DT O
pregnancy NN O
. . O

Using VBG O
an DT O
oligomer NN O
duplex NN O
5 CD O
' '' O
- : O
A DT O
( ( O
GGGTTA NNP O
) ) O
( ( O
5 CD O
) ) O
- : O
3 CD O
' POS O
/ JJ O
5 CD O
' POS O
- : O
( ( O
TAACCC NNP O
) ) O
( ( O
5 CD O
) ) O
T NNP O
- : O
3 CD O
' '' O
as IN O
a DT O
template NN O
- : O
primer NN O
, , O
we PRP O
show VBP O
that IN O
both DT O
the DT O
Klenow NNP B-Gene
fragment NN I-Gene
of IN I-Gene
Escherichia NNP I-Gene
coli NNS I-Gene
DNA NNP I-Gene
polymerase NN I-Gene
I PRP I-Gene
and CC O
HIV NNP B-Gene
reverse NN I-Gene
transcriptase NN I-Gene
could MD O
expand VB O
telomere RB O
DNA NNP O
sequences NNS O
as RB O
well RB O
, , O
giving VBG O
products NNS O
greater JJR O
than IN O
the DT O
size NN O
of IN O
the DT O
template NN O
DNA NNP O
. . O

The DT O
genomic JJ O
structure NN O
of IN O
the DT O
human JJ B-Gene
SPEC1 NNP I-Gene
gene NN I-Gene
reveals NNS O
complex JJ O
splicing NN O
and CC O
close JJ O
promoter NN O
proximity NN O
to TO O
the DT O
AF1q NNP B-Gene
translocation NN I-Gene
gene NN I-Gene
. . O

DNA NN O
sequence NN O
analysis NN O
has VBZ O
confirmed VBN O
that IN O
this DT O
mutation NN O
affects VBZ O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
alpha NN O
subunit NN O
, , O
changing VBG O
a DT O
leucine JJ O
residue NN O
at IN O
position NN O
290 CD O
to TO O
a DT O
histidine NN O
( ( O
rpoAL290H NN B-Gene
) ) O
. . O

202 CD O
- : O
8 CD O
. . O

The DT O
location NN O
and CC O
approximate JJ O
length NN O
of IN O
the DT O
intron NN O
are VBP O
conserved VBN O
in IN O
both DT O
the DT O
tomato NN O
and CC O
Arabidopsis NNP O
genes NNS O
, , O
with IN O
the DT O
intron NN O
separating VBG O
the DT O
' '' O
nose JJ O
' POS O
region NN O
( ( O
encoded VBN O
by IN O
exon $ O
1 CD O
) ) O
from IN O
the DT O
central JJ O
globular NN O
domain NN O
( ( O
exon JJ O
2 CD O
) ) O
. . O

Binding NNP O
of IN O
serum NN B-Gene
response NN I-Gene
factor NN I-Gene
to TO O
CArG NNP O
box NN O
sequences NNS O
is VBZ O
necessary JJ O
but CC O
not RB O
sufficient JJ O
to TO O
restrict VB O
gene NN O
expression NN O
to TO O
arterial JJ O
smooth JJ O
muscle NN O
cells NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
intraarterial JJ O
neoadjuvant JJ O
chemotherapy NN O
should MD O
be VB O
effective JJ O
on IN O
advanced JJ O
cervical JJ O
cancer NN O
. . O

With IN O
each DT O
of IN O
the DT O
three CD O
pairs NNS O
of IN O
isolates NNS O
( ( O
case NN O
and CC O
suspicious JJ O
case NN O
) ) O
, , O
identical JJ O
IS6110 NNP O
banding NN O
patterns NNS O
were VBD O
found VBN O
suggesting VBG O
identical JJ O
MTB NNP O
strains NNS O
. . O

To TO O
study VB O
a DT O
possible JJ O
functional JJ O
role NN O
of IN O
this DT O
putative JJ O
chicken NN O
ICS NNP B-Gene
, , O
an DT O
oligonucleotide JJ O
spanning VBG O
the DT O
upstream JJ O
sequences NNS O
of IN O
the DT O
BF NNP B-Gene
- : I-Gene
IV NNP I-Gene
gene NN I-Gene
( ( O
- : O
174 CD O
/ SYM O
- : O
194 CD O
) ) O
was VBD O
cloned VBN O
singly RB O
or CC O
in IN O
multiple JJ O
copies NNS O
before IN O
the DT O
herpes NNS O
TK NNP B-Gene
promoter NN I-Gene
controlling VBG O
the DT O
chloramphenicol NN B-Gene
acetyl NN I-Gene
transferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
gene NN O
( ( O
pBLCAT2 NN B-Gene
) ) O
. . O

Reye NNP O
' POS O
s JJ O
syndrome NN O
: : O
reports NNS O
of IN O
7 CD O
cases NNS O
in IN O
the DT O
period NN O
1982 CD O
- : O
1987 CD O

Abnormal JJ O
characteristics NNS O
and CC O
verticillation NN O
in IN O
Platynothrus NNP O
peltifer NN O

All DT O
stimulations NNS O
were VBD O
down RB O
- : O
regulated VBN O
with IN O
GnRH NNP B-Gene
- : I-Gene
a DT I-Gene
commenced JJ O
on IN O
day NN O
21 CD O
in IN O
a DT O
long JJ O
protocol NN O
before IN O
gonadotropin JJ B-Gene
stimulation NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
native JJ B-Gene
MRCK NNP I-Gene
exists VBZ O
in IN O
high JJ O
- : O
molecular JJ O
- : O
weight NN O
complexes NNS O
. . O

In IN O
addition NN O
to TO O
its PRP$ O
effect NN O
in IN O
augmenting VBG O
the DT O
neutrophil JJ O
response NN O
to TO O
eccentric JJ O
exercise NN O
, , O
vitamin NN O
E NNP O
causes VBZ O
a DT O
greater JJR O
increase NN O
in IN O
circulating VBG O
creatine JJ B-Gene
kinase NN I-Gene
activity NN O
, , O
perhaps RB O
indicating VBG O
increased VBN O
skeletal JJ O
muscle NN O
repair NN O
. . O

Based VBN O
on IN O
subcellular JJ O
fractionation NN O
, , O
the DT O
47 CD B-Gene
- : I-Gene
kDa NN I-Gene
P NNP I-Gene
- : I-Gene
CIP2 NNP I-Gene
protein NN I-Gene
is VBZ O
mostly RB O
cytosolic JJ O
. . O

These DT O
motifs NNS O
include VBP O
a DT O
Chi NNP O
motif NN O
and CC O
a DT O
Chi NNP O
- : O
like IN O
element NN O
previously RB O
found VBN O
in IN O
the DT O
recombination NN O
hotspot NN O
region NN O
of IN O
the DT O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
and CC O
close NN O
to TO O
chromosomal JJ O
breakpoints NNS O
in IN O
T NNP O
- : O
ALL DT O
lines NNS O
. . O

The DT O
revitalization NN O
of IN O
surgery NN O
for IN O
Parkinson NNP O
' POS O
s NN O
disease NN O
( ( O
PD NNP O
) ) O
has VBZ O
fueled VBN O
discussion NN O
about IN O
the DT O
best JJS O
methodology NN O
to TO O
define VB O
the DT O
target NN O
. . O

A DT O
transformation NN O
- : O
competent NN O
mutant NN O
, , O
like IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
E5 NNP I-Gene
protein NN I-Gene
, , O
bound IN O
the DT O
receptor NN O
and CC O
induced JJ O
receptor NN O
tyrosine NN O
phosphorylation NN O
and CC O
down IN O
- : O
regulation NN O
. . O

We PRP O
suppose VBP O
that IN O
this DT O
injection NN O
speed NN O
( ( O
0 CD O
. . O
1 CD O
- : O
0 CD O
. . O
2 CD O
ml NN O
. . O
s VB O
- : O
1 CD O
) ) O
is VBZ O
suitable JJ O
for IN O
spinal JJ O
anesthesia NN O
. . O

The DT O
differences NNS O
in IN O
the DT O
CPIgG NNP B-Gene
, , O
CRP NNP B-Gene
, , O
and CC O
fibrinogen NN B-Gene
levels NNS O
in IN O
patients NNS O
who WP O
were VBD O
diagnosed VBN O
with IN O
ACS NNP O
versus VBP O
those DT O
who WP O
were VBD O
not RB O
( ( O
non JJ O
- : O
ACS NN O
) ) O
were VBD O
evaluated VBN O
. . O

The DT O
androgen NN B-Gene
receptor NN I-Gene
( ( O
AR NNP B-Gene
) ) O
amino NN O
- : O
terminus NN O
imposes VBZ O
androgen SYM O
- : O
specific JJ O
regulation NN O
of IN O
AR NNP B-Gene
gene NN I-Gene
expression NN O
via IN O
an DT O
exonic JJ O
enhancer NN O
. . O

Effect NN O
of IN O
trauma NN O
on IN O
plasma NN B-Gene
glucagon NN I-Gene
and CC O
insulin NN B-Gene
concentrations NNS O
in IN O
sheep NN O
. . O

In IN O
addition NN O
, , O
npm3 NN B-Gene
, , O
which WDT O
is VBZ O
usually RB O
coactivated VBN O
with IN O
fgf8 NN B-Gene
by IN O
MMTV NNP O
insertion NN O
, , O
was VBD O
not RB O
up RP O
- : O
regulated VBN O
by IN O
androgens NNS O
in IN O
SC NNP O
- : O
3 CD O
cells NNS O
. . O

The DT O
ratio NN O
of IN O
P NNP O
- : O
31 CD O
NMR NNP O
- : O
S NNP O
derived VBD O
inorganic JJ O
phosphates NNS O
[ VBP O
Pi NNP O
] NNP O
to TO O
phosphocreatine VB O
[ NNP O
PCr NNP O
] NNP O
was VBD O
significantly RB O
greater JJR O
at IN O
rest NN O
in IN O
LVH NNP O
baboons NNS O
[ VBP O
0 CD O
. . O
53 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
versus NN O
controls NNS O
= VBP O
0 CD O
. . O
41 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
17 CD O
; : O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
] NN O
. . O

The DT O
importance NN O
of IN O
temporal JJ O
factors NNS O
on IN O
the DT O
presence NN O
and CC O
severity NN O
of IN O
ethanol NN O
withdrawal NN O
signs NNS O
in IN O
the DT O
rat NN O
was VBD O
quantified VBN O
using VBG O
rating NN O
scale NN O
, , O
tremor NN O
, , O
and CC O
acoustic JJ O
startle NN O
paradigms NN O
. . O

Using VBG O
the DT O
postural JJ O
and CC O
force NN O
data NNS O
as IN O
input NN O
to TO O
a DT O
3 CD O
- : O
D NNP O
biomechanical JJ O
model NN O
, , O
the DT O
lumbosacral JJ O
spinal JJ O
compression NN O
was VBD O
calculated VBN O
. . O

Ultrastructure NN O
of IN O
the DT O
heart NN O
muscle NN O
in IN O
experimental JJ O
myocardial JJ O
infarct NN O
following VBG O
physical JJ O
training NN O

Gimpl NNP O
, , O
F NNP O
. . O

All DT O
radiologists NNS O
using VBG O
the DT O
machine NN O
found VBD O
that IN O
the DT O
reporting NN O
terminal NN O
was VBD O
simple JJ O
to TO O
operate VB O
, , O
but CC O
found VBD O
that IN O
reporting VBG O
abnormalities NNS O
caused VBD O
an DT O
increased JJ O
effort NN O
and CC O
took VBD O
a DT O
longer JJR O
time NN O
. . O

The DT O
titer NN O
of IN O
TSH NNP B-Gene
binding VBG I-Gene
inhibitor NN I-Gene
immunoglobulin NN I-Gene
( ( O
TBII NNP B-Gene
) ) O
, , O
which WDT O
had VBD O
been VBN O
8 CD O
. . O
6 CD O
% NN O
at IN O
initial JJ O
presentation NN O
, , O
rose VBD O
to TO O
14 CD O
. . O
9 CD O
% NN O
in IN O
2 CD O
weeks NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
a DT O
VT NNP O
+ NNP O
peptide NN O
was VBD O
specifically RB O
phosphorylated VBN O
by IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
in IN O
vitro NN O
, , O
but CC O
not RB O
by IN O
protein JJ B-Gene
kinase NN I-Gene
A NNP I-Gene
( ( O
PKA NNP B-Gene
) ) O
. . O

The DT O
' '' O
field NN O
of IN O
stress NN O
' '' O
of IN O
the DT O
supervisory NN O
nurse NN O

Body NN O
temperature NN O
and CC O
overall JJ O
conductance NN O
in IN O
the DT O
cold JJ O
appear NN O
to TO O
be VB O
more RBR O
variable JJ O
in IN O
P NNP O
. . O

s NN O
. . O
campbelli NN O
than IN O
in IN O
nominative JJ O
sp NN O
. . O

Genomic NNP O
structure NN O
and CC O
chromosomal JJ O
location NN O
of IN O
the DT O
mouse NN B-Gene
pre SYM I-Gene
- : I-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
alpha JJ I-Gene
gene NN I-Gene
. . O

These DT O
sequence NN O
analyses VBZ O
suggest VBP O
that IN O
xIRS NNP B-Gene
- : I-Gene
u NN I-Gene
is VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
IRS NNP B-Gene
family NN I-Gene
rather RB O
than IN O
a DT O
Xenopus NNP O
homolog NN O
of IN O
an DT O
existing VBG O
member NN O
. . O

The DT O
functional JJ O
mature NN O
domain NN O
of IN O
pediocin JJ B-Gene
AcH NNP I-Gene
( ( I-Gene
Lys NNP I-Gene
+ VBZ I-Gene
1 CD I-Gene
to TO I-Gene
Cys NNP I-Gene
+ NNP I-Gene
44 CD I-Gene
) ) I-Gene
is VBZ O
targeted VBN O
into IN O
the DT O
E NNP O
. . O
coli NN O
sec JJ O
machinery NN O
and CC O
secreted VBD O
to TO O
the DT O
periplasm NN O
in IN O
active JJ O
form NN O
when WRB O
fused VBN O
in IN O
frame NN O
to TO O
the DT O
COOH NNP O
terminus NN O
of IN O
the DT O
secretory NN B-Gene
protein NN I-Gene
maltose VBD I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
MBP NNP B-Gene
) ) O
. . O

To TO O
search VB O
for IN O
genes NNS O
that WDT O
interact VBP O
with IN O
the DT O
SLK1 NNP B-Gene
- : O
SLT2 NNP B-Gene
pathway RB O
, , O
a DT O
synthetic JJ O
lethal NN O
suppression NN O
screen NN O
was VBD O
carried VBN O
out RP O
. . O

This DT O
study NN O
assesses VBZ O
the DT O
feasibility NN O
and CC O
toxicity NN O
of IN O
adoptive JJ O
immunotherapy NN O
with IN O
tumor NN O
infiltrating VBG O
lymphocytes NNS O
and CC O
recombinant JJ B-Gene
interleukin NN I-Gene
- : I-Gene
2 CD I-Gene
in IN O
29 CD O
patients NNS O
who WP O
underwent JJ O
resection NN O
for IN O
stage NN O
III NNP O
non SYM O
- : O
small JJ O
- : O
cell NN O
lung NN O
cancer NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
demonstrate VBP O
that IN O
CAP1 NNP B-Gene
is VBZ O
involved VBN O
in IN O
multidrug JJ O
resistance NN O
and CC O
oxidative JJ O
stress NN O
response NN O
in IN O
C NNP O
. . O
albicans NNS O
. . O

These DT O
observations NNS O
of IN O
elevated JJ O
serum NN B-Gene
lipase NN I-Gene
and CC O
serum NN O
CA NNP B-Gene
19 CD I-Gene
- : I-Gene
9 CD I-Gene
in IN O
Sjogren NNP O
' POS O
s JJ O
syndrome NN O
without IN O
evidence NN O
of IN O
malignancy NN O
may MD O
reflect VB O
pancreatic JJ O
involvement NN O
in IN O
this DT O
disorder NN O
. . O

Identification NN O
of IN O
a DT O
spliced JJ O
gene NN O
from IN O
Kaposi NNP O
' POS O
s NN O
sarcoma NN O
- : O
associated VBN O
herpesvirus NN O
encoding VBG O
a DT O
protein NN O
with IN O
similarities NNS O
to TO O
latent VB B-Gene
membrane NN I-Gene
proteins NNS I-Gene
1 CD I-Gene
and CC I-Gene
2A CD I-Gene
of IN I-Gene
Epstein NNP I-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
. . O

Mutational JJ O
studies NNS O
revealed VBD O
that IN O
it PRP O
was VBD O
the DT O
homeodomain NN B-Gene
binding VBG I-Gene
site NN I-Gene
II NNP I-Gene
sequence NN I-Gene
that WDT O
was VBD O
required VBN O
for IN O
this DT O
regulation NN O
. . O

We PRP O
examined VBD O
Akt NNP B-Gene
activation NN O
in IN O
Lyn NNP B-Gene
- : O
, , O
Syk NNP B-Gene
- : O
and CC O
Btk NNP B-Gene
- : O
deficient NN O
DT40 NNP O
cells NNS O
and CC O
B NNP O
cells NNS O
from IN O
Lyn NNP B-Gene
( ( I-Gene
- : I-Gene
/ SYM I-Gene
- : I-Gene
) ) I-Gene
mice NN O
. . O

The DT O
latent NN O
periods NNS O
from IN O
the DT O
antral JJ O
exclusion NN O
to TO O
the DT O
occurrence NN O
of IN O
anastomotic JJ O
ulcers NNS O
after IN O
a DT O
subtotal JJ O
gastrectomy NN O
with IN O
Billroth NNP O
' POS O
s NN O
type NN O
II NNP O
reconstruction NN O
varied VBD O
from IN O
a DT O
few JJ O
days NNS O
to TO O
19 CD O
years NNS O
, , O
with IN O
an DT O
average NN O
of IN O
2 CD O
. . O
8 CD O
years NNS O
. . O

TFEC NNP B-Gene
, , O
a DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
protein NN I-Gene
, , O
forms VBZ O
heterodimers NNS O
with IN O
TFE3 NNP B-Gene
and CC O
inhibits NNS O
TFE3 NNP B-Gene
- : O
dependent JJ O
transcription NN O
activation NN O
. . O

Conjugated VBN O
estrogens NNS O
shorten VB O
bleeding JJ O
time NN O
in IN O
uraemia NN O
: : O
a DT O
possible JJ O
role NN O
of IN O
serotonin NN O
? . O

Through IN O
two CD O
novel JJ O
mechanisms NNS O
, , O
Arf NNP B-Gene
inhibits VBZ O
the DT O
oncoprotein NN B-Gene
Hdm2 NNP I-Gene
, , O
a DT O
negative JJ O
regulator NN O
of IN O
p53 NN B-Gene
. . O

Definite NNP O
JPsA NNP O
( ( O
24 CD O
patients NNS O
) ) O
was VBD O
defined VBN O
as IN O
arthritis NN O
associated VBN O
, , O
but CC O
not RB O
necessarily RB O
coincident NN O
, , O
with IN O
a DT O
typical JJ O
psoriatic JJ O
rash NN O
, , O
or CC O
arthritis NN O
plus CC O
at IN O
least JJS O
3 CD O
of IN O
4 CD O
minor JJ O
criteria NNS O
: : O
dactylitis NN O
, , O
nail JJ O
pitting NN O
, , O
psoriasis NN O
- : O
like IN O
rash NN O
, , O
or CC O
family NN O
history NN O
of IN O
psoriasis NN O
. . O

E1 NNP B-Gene
, , O
a DT O
DNA NN B-Gene
helicase NN I-Gene
, , O
collaborates VBZ O
with IN O
the DT O
HPV NNP B-Gene
E2 NNP I-Gene
protein NN I-Gene
in IN O
ori JJ O
- : O
dependent JJ O
replication NN O
. . O

Serum NNP B-Gene
creatine NN I-Gene
kinase NN I-Gene
( ( O
SCK NNP B-Gene
) ) O
was VBD O
measured VBN O
in IN O
ten JJ O
subjects NNS O
in IN O
the DT O
laboratory NN O
before IN O
and CC O
after IN O
the DT O
performance NN O
of IN O
bicycle NN O
ergometry NN O
and CC O
a DT O
lifting NN O
task NN O
. . O

However RB O
, , O
the DT O
requirement NN O
of IN O
rev3 NN B-Gene
for IN O
the DT O
production NN O
of IN O
G NNP O
. . O
C NNP O
- : O
- : O
> NN O
T NNP O
. . O
A DT O
transversions NNS O
by IN O
the DT O
rad18 NN B-Gene
mutator NN I-Gene
, , O
which WDT O
induces VBZ O
only RB O
these DT O
substitutions NNS O
, , O
was VBD O
similar JJ O
to TO O
that DT O
for IN O
rad6 NN B-Gene
- : O
mediated VBN O
G NNP O
. . O
C NNP O
- : O
- : O
> NN O
T NNP O
. . O
A DT O
transversion NN O
. . O

We PRP O
cloned VBD O
a DT O
DNA NN O
fragment NN O
encoding VBG O
the DT O
N NNP O
- : O
terminal JJ O
part NN O
of IN O
a DT O
protein NN O
with IN O
significant JJ O
similarity NN O
to TO O
members NNS O
of IN O
the DT O
LysR NNP B-Gene
family NN I-Gene
of IN I-Gene
transcriptional JJ I-Gene
regulators NNS I-Gene
( ( O
LTTRs NNP B-Gene
) ) O
. . O

The DT O
biology NN O
of IN O
Hyostrongylus NNP O
ruidus NN O
. . O

A DT O
limited JJ O
sampling NN O
strategy NN O
was VBD O
used VBN O
based VBN O
on IN O
a DT O
bayesian JJ O
parameter NN O
estimation NN O
algorithm NN O
that WDT O
is VBZ O
part NN O
of IN O
the DT O
ADAPT NNP O
II NNP O
software NN O
package NN O
. . O

A DT O
P22 NNP O
R17 NNP O
derivative NN O
with IN O
an DT O
OcRNA NNP O
site NN O
( ( O
P22 NNP O
R17 NNP O
[ VBZ O
A NNP O
( ( O
- : O
10 CD O
) ) O
U NNP O
] NNP O
) ) O
develops VBZ O
lytically RB O
following JJ O
infection NN O
of IN O
these DT O
strains NNS O
. . O

Transcriptional NNP O
control NN O
of IN O
a DT O
nuclear JJ O
gene NN O
encoding VBG O
a DT O
mitochondrial JJ O
fatty JJ O
acid JJ O
oxidation NN O
enzyme NN O
in IN O
transgenic JJ O
mice NN O
: : O
role NN O
for IN O
nuclear JJ O
receptors NNS O
in IN O
cardiac NN O
and CC O
brown JJ O
adipose JJ O
expression NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
phosphorylation NN O
of IN O
M NNP B-Gene
protein NN I-Gene
at IN O
the DT O
major JJ O
in IN O
vivo NN O
sites NNS O
is VBZ O
not RB O
essential JJ O
for IN O
virus NN O
assembly NN O
. . O

BACKGROUND NN O
: : O
Hepatic JJ O
encephalopathy NN O
is VBZ O
a DT O
neuropsychiatric JJ O
syndrome NN O
associated VBN O
with IN O
acute JJ O
liver NN O
failure NN O
, , O
chronic JJ O
parenchymal NN O
liver NN O
disease NN O
or CC O
portal JJ O
systemic JJ O
anastomosis NN O
. . O

The DT O
reconstituted JJ O
RNA NNP B-Gene
polymerases VBZ I-Gene
containing VBG O
the DT O
mutant JJ O
alpha NN O
subunits NNS O
were VBD O
examined VBN O
for IN O
their PRP$ O
response NN O
to TO O
transcription NN O
activation NN O
by IN O
cAMP NN B-Gene
- : I-Gene
CRP NN I-Gene
and CC O
the DT O
rrnBP1 NN B-Gene
UP NNP I-Gene
element NN I-Gene
. . O

The DT O
incidence NN O
of IN O
cardiac JJ O
death NN O
( ( O
one CD O
per IN O
group NN O
) ) O
, , O
Q NNP O
wave VBP O
MI NNP O
( ( O
propofol NN O
, , O
n JJ O
= VBP O
7 CD O
; : O
midazolam NN O
, , O
n JJ O
= VBP O
3 CD O
; : O
P NNP O
= VBD O
0 CD O
. . O
27 CD O
) ) O
, , O
or CC O
non RB O
Q NNP O
wave VBP O
MI NNP O
( ( O
propofol NN O
, , O
n JJ O
= VBP O
16 CD O
; : O
midazolam NN O
, , O
n JJ O
= VBP O
18 CD O
; : O
P NNP O
= VBD O
0 CD O
. . O
81 CD O
) ) O
did VBD O
not RB O
differ VB O
between IN O
treatment NN O
groups NNS O
. . O

METHODS NNS O
: : O
All PDT O
these DT O
30 CD O
non SYM O
- : O
responders NNS O
received VBD O
an DT O
extra JJ O
dose NN O
of IN O
the DT O
same JJ O
vaccine NN O
2 CD O
months NNS O
after IN O
primary JJ O
immunization NN O
and CC O
a DT O
booster NN O
dose NN O
with IN O
a DT O
yeast NN O
- : O
derived VBN O
vaccine JJ O
6 CD O
years NNS O
later RB O
. . O

A DT O
transgenic JJ O
complementation NN O
assay NN O
was VBD O
used VBN O
to TO O
test VB O
whether IN O
NIa NNP B-Gene
supplied VBD O
in IN O
trans NNS O
could MD O
rescue VB O
amplification NN O
- : O
defective JJ O
viral JJ O
genomes NNS O
encoding VBG O
altered VBD O
NIa NNP B-Gene
proteins NNS I-Gene
. . O

Plasmids NNP O
pAMS12 NN O
, , O
pAMS13 NN O
and CC O
pAMS14 NN O
were VBD O
transformed VBN O
into IN O
a DT O
laboratory NN O
strain NN O
of IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
whereas WP O
pAMS15 NN O
was VBD O
stably RB O
introduced VBN O
into IN O
two CD O
commercial JJ O
wine NN O
yeast NN O
strains NNS O
. . O

The DT O
sequence NN O
analysis NN O
of IN O
both DT O
products NNS O
of IN O
individual JJ O
phi NN O
80 CD O
site NN O
- : O
specific JJ O
recombination NN O
events NNS O
in IN O
vivo NN O
shows NNS O
that IN O
recombination NN O
with IN O
a DT O
secondary JJ O
attachment NN O
( ( O
att NN O
) ) O
site NN O
generates VBZ O
several JJ O
different JJ O
novel JJ O
joints NNS O
at IN O
the DT O
mismatched JJ O
position NN O
: : O
one CD O
recombination NN O
event NN O
resulted VBD O
in IN O
a DT O
single JJ O
base NN O
- : O
pair NN O
deletion NN O
and CC O
two CD O
other JJ O
recombination NN O
events NNS O
resulted VBD O
in IN O
two CD O
different JJ O
single JJ O
base NN O
- : O
pair NN O
substitutions NNS O
. . O

Second JJ O
, , O
plasmid JJ O
- : O
derived VBN O
transgenes NNS O
and CC O
gene NN O
targeting NN O
of IN O
the DT O
endogenous JJ B-Gene
Hnf3g NNP I-Gene
gene NN I-Gene
locus NN I-Gene
were VBD O
used VBN O
to TO O
demonstrate VB O
that IN O
the DT O
3 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
gene NN O
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
to TO O
direct VB O
reporter NN O
gene NN O
expression NN O
in IN O
liver NN O
, , O
pancreas NNS O
, , O
stomach NN O
and CC O
small JJ O
intestine NN O
. . O

High JJ O
plasma NN O
concentrations NNS O
of IN O
soluble JJ O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
were VBD O
closely RB O
associated VBN O
with IN O
multiple JJ O
- : O
organ JJ O
dysfunction NN O
and CC O
death NN O
. . O

Paralemmin NNP B-Gene
is VBZ O
also RB O
phosphorylated VBN O
, , O
and CC O
its PRP$ O
mRNA NN O
is VBZ O
differentially RB O
spliced VBN O
in IN O
a DT O
tissue NN O
- : O
specific NN O
and CC O
developmentally RB O
regulated JJ O
manner NN O
. . O

After IN O
hemodynamic JJ O
stabilization NN O
, , O
the DT O
goal NN O
of IN O
therapy NN O
is VBZ O
to TO O
diminish VB O
the DT O
chance NN O
that IN O
an DT O
ulcer NN O
will MD O
continue VB O
to TO O
bleed VB O
or CC O
will MD O
rebleed VB O
. . O

8 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
, , O
21 CD O
. . O
3 CD O
- : O
44 CD O
. . O
3 CD O
% NN O
) ) O
. . O

Thus RB O
, , O
the DT O
inhibition NN O
of IN O
pepsin NN B-Gene
in IN O
human JJ O
gastric JJ O
juice NN O
does VBZ O
not RB O
appear VB O
to TO O
have VB O
a DT O
major JJ O
influence NN O
on IN O
the DT O
healing NN O
of IN O
duodenal JJ O
ulcer NN O
. . O

Using VBG O
purified VBN O
recombinant JJ B-Gene
HMG NNP I-Gene
I PRP I-Gene
, , O
we PRP O
have VBP O
identified VBN O
several JJ O
high JJ O
- : O
affinity NN O
binding NN O
sites NNS O
which WDT O
overlap VBP O
important JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

Stable JJ O
expression NN O
of IN O
truncated JJ B-Gene
inositol NN I-Gene
1 CD I-Gene
, , I-Gene
4 CD I-Gene
, , I-Gene
5 CD I-Gene
- : I-Gene
trisphosphate NN I-Gene
receptor NN I-Gene
subunits NNS I-Gene
in IN O
3T3 CD O
fibroblasts NNS O
. . O

Therefore RB O
, , O
vitamin FW O
D3 NNP O
analogues NNS O
have VBP O
a DT O
substantial JJ O
antipsoriatic JJ O
effect NN O
. . O

Mutation NN O
of IN O
KRKR NNP O
to TO O
NGER NNP O
retains VBZ O
MO15 NNP B-Gene
in IN O
the DT O
cytoplasmic JJ O
compartment NN O
, , O
whilst VBP O
the DT O
wild JJ O
- : O
type NN O
protein NN O
is VBZ O
detected VBN O
exclusively RB O
in IN O
the DT O
nucleus NN O
. . O

The DT O
native JJ O
enzyme NN O
purified VBN O
from IN O
protease NN B-Gene
- : I-Gene
B NNP I-Gene
- : O
deficient NN O
URA2 NNP B-Gene
- : O
transformed VBD O
cells NNS O
, , O
was VBD O
phosphorylated VBN O
in IN O
vitro NN O
using VBG O
catalytic JJ O
subunits NNS O
of IN O
pure NN O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
. . O

INTERVENTIONS NNP O
- : O
- : O
Patients NNS O
allocated VBN O
to TO O
treatment NN O
with IN O
levodopa JJ B-Gene
/ NNP I-Gene
dopa NN I-Gene
decarboxylase NN I-Gene
inhibitor NN O
alone RB O
( ( O
arm JJ O
1 CD O
) ) O
, , O
levodopa JJ B-Gene
/ NNP I-Gene
decarboxylase NN I-Gene
inhibitor NN O
/ NNP O
selegiline NN O
in IN O
combination NN O
( ( O
arm JJ O
2 CD O
) ) O
, , O
or CC O
bromocriptine NN O
( ( O
arm JJ O
3 CD O
) ) O
. . O

The DT O
binding NN O
site NN O
for IN O
OxyR NNP B-Gene
overlapped VBD O
P1oxyR NNP B-Gene
, , O
reminiscent NN O
of IN O
the DT O
autoregulatory NN O
loops VBZ O
controlling VBG O
expression NN O
of IN O
oxyR NN B-Gene
in IN O
enteric JJ O
bacteria NNS O
and CC O
characteristic NN O
of IN O
the DT O
LysR NNP B-Gene
superfamily RB I-Gene
in IN O
general JJ O
. . O

A DT O
reversed JJ O
- : O
phase NN O
high JJ O
- : O
performance NN O
liquid NN O
chromatographic NN O
( ( O
HPLC NNP O
) ) O
method NN O
for IN O
the DT O
determination NN O
of IN O
cocaine NN O
metabolites NNS O
produced VBN O
in IN O
vitro NN O
by IN O
serum NN B-Gene
and CC I-Gene
liver NN I-Gene
esterases NNS I-Gene
is VBZ O
described VBN O
. . O

On IN O
the DT O
basis NN O
of IN O
this DT O
anatomic JJ O
concept NN O
, , O
the DT O
brachioplasty JJ O
procedure NN O
was VBD O
modified VBN O
to TO O
provide VB O
secure NN O
anchoring NN O
of IN O
the DT O
arm NN O
flap NN O
to TO O
the DT O
axillary JJ O
fascia NN O
along IN O
with IN O
strong JJ O
superficial JJ O
fascial JJ O
system NN O
repair NN O
of IN O
incisions NNS O
, , O
reducing VBG O
the DT O
risk NN O
of IN O
widening VBG O
or CC O
migration NN O
of IN O
scars NNS O
and CC O
unnatural JJ O
contours NNS O
. . O

Hydrocortisone NN O
caused VBD O
lymphopenia NN O
and CC O
inhibited VBD O
the DT O
blastogenic JJ O
response NN O
of IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
to TO O
phytohemagglutinin VB B-Gene
and CC O
concanavalin VB B-Gene
A DT I-Gene
mitogens NNS O
. . O

RESULTS NN O
: : O
Prevalence NN O
of IN O
obesity NN O
( ( O
BMI NNP O
SDS NNP O
> VBD O
2 CD O
. . O
0 CD O
) ) O
was VBD O
< JJ O
2 CD O
% NN O
at IN O
diagnosis NN O
, , O
but CC O
increased VBD O
to TO O
16 CD O
% NN O
at IN O
3y CD O
. . O

In IN O
the DT O
study NN O
on IN O
PCI NNP B-Gene
mRNA NN I-Gene
expression NN O
in IN O
the DT O
reproductive JJ O
organs NNS O
, , O
we PRP O
first RB O
cloned VBD O
rat NN B-Gene
PCI NNP I-Gene
cDNA NN I-Gene
and CC O
then RB O
evaluated VBD O
the DT O
effect NN O
of IN O
androgen NN O
on IN O
the DT O
PCI NNP B-Gene
mRNA NN I-Gene
expression NN O
. . O

Two CD O
independent JJ O
transgenic JJ O
lines NNS O
were VBD O
produced VBN O
, , O
and CC O
both DT O
showed VBD O
expression NN O
of IN O
the DT O
Gus NNP B-Gene
gene NN I-Gene
specifically RB O
in IN O
the DT O
endosperm NN O
during IN O
mid JJ O
- : O
development NN O
( ( O
first RB O
detected VBN O
10 CD O
- : O
12 CD O
d NN O
after IN O
anthesis NN O
) ) O
. . O

Cognate NNP O
promoter NN O
elements NNS O
implicated VBN O
in IN O
glucocorticoid JJ O
- : O
and CC O
cAMP VB O
- : O
mediated VBN O
regulation NN O
as RB O
well RB O
as IN O
in IN O
liver NN O
- : O
, , O
myeloid SYM O
- : O
, , O
and CC O
lymphocyte SYM O
- : O
specific JJ O
expression NN O
are VBP O
located VBN O
within IN O
the DT O
5 CD O
' POS O
flanking JJ O
sequence NN O
. . O

Transcription NNP O
start VBP O
sites NNS O
of IN O
the DT O
plastid JJ O
ACCase NNP B-Gene
genes NNS I-Gene
were VBD O
estimated VBN O
from IN O
the DT O
longest JJS O
cDNA NN O
clones NNS O
obtained VBN O
by IN O
5 CD O
' POS O
- : O
RACE NNP O
( ( O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
) ) O
. . O

We PRP O
report VBP O
the DT O
preliminary JJ O
biochemical JJ O
characterization NN O
of IN O
the DT O
T NNP B-Gene
antigens NNS I-Gene
encoded VBN O
by IN O
three CD O
SV40 NNP O
mutants NNS O
, , O
5030 CD O
, , O
5031 CD O
, , O
and CC O
5061 CD O
, , O
each DT O
of IN O
which WDT O
have VBP O
altered VBN O
residues NNS O
within IN O
or CC O
near IN O
the DT O
ATP NNP O
binding NN O
pocket NN O
. . O

Multiparity NNP O
had VBD O
a DT O
protective JJ O
effect NN O
with IN O
0 CD O
. . O
66 CD O
less JJR O
risk NN O
( ( O
95 CD O
% NN O
CI NNP O
0 CD O
. . O
44 CD O
- : O
0 CD O
. . O
99 CD O
) ) O
. . O

The DT O
predicted VBN O
DNA NNP O
- : O
binding NN O
, , O
zinc NN B-Gene
finger NN I-Gene
domain VBP I-Gene
protein JJ I-Gene
sequence NN O
was VBD O
strictly RB O
conserved VBN O
. . O

Genomic NNP O
Southern NNP O
blot NN O
analysis NN O
and CC O
chromosome NN O
mapping NN O
showed VBD O
that IN O
GPRK6 NNP B-Gene
hybridizes VBZ O
to TO O
two CD O
closely RB O
related JJ O
genes NNS O
located VBN O
on IN O
chromosomes NNS O
5 CD O
and CC O
13 CD O
and CC O
are VBP O
, , O
therefore RB O
, , O
distinct NN O
from IN O
the DT O
GPRK NNP B-Gene
located VBD O
near IN O
the DT O
Huntington NNP B-Gene
disease NN I-Gene
locus NN I-Gene
on IN O
chromosome NN O
4 CD O
. . O

Atopic NNP O
dermatitis NN O
is VBZ O
an DT O
"""" NN O
itch NN O
which WDT O
rashes NNS O
and CC O
not RB O
a DT O
rash NN O
which WDT O
itches VBZ O
"""" NN O
and CC O
therefore RB O
, , O
any DT O
patient JJ O
treatment NN O
program NN O
should MD O
address VB O
the DT O
multiplicity NN O
of IN O
potential JJ O
trigger NN O
factors NNS O
that WDT O
provoke VBD O
this DT O
itching NN O
. . O

Disruption NN O
mutations NNS O
have VBP O
been VBN O
constructed VBN O
in IN O
the DT O
SLK1 NNP B-Gene
gene NN I-Gene
. . O

slk1 JJ B-Gene
null JJ I-Gene
mutants NNS I-Gene
cannot JJ O
grow VB O
at IN O
37 CD O
degrees NNS O
C NNP O
, , O
but CC O
many JJ O
cells NNS O
can MD O
grow VB O
at IN O
30 CD O
, , O
24 CD O
, , O
and CC O
17 CD O
degrees NNS O
C NNP O
. . O

Patients NNS O
subsequently RB O
returned VBN O
to TO O
the DT O
clinic JJ O
every DT O
3 CD O
days NNS O
to TO O
have VB O
the DT O
wounds NNS O
checked VBD O
and CC O
dressings NNS O
changed VBD O
. . O

Fundus NNP O
changes NNS O
in IN O
( ( O
type JJ O
II NNP O
) ) O
mesangiocapillary VBP O
glomerulonephritis NN O
simulating VBG O
drusen NN O
: : O
a DT O
histopathological JJ O
report NN O
. . O

However RB O
, , O
experiments NNS O
with IN O
S1 NNP B-Gene
mapping NN O
of IN O
in IN O
vivo NN O
transcripts NNS O
, , O
gene NN O
disruptions NNS O
in IN O
the DT O
alpha JJ O
region NN O
, , O
and CC O
a DT O
single JJ O
- : O
copy NN O
transcriptional JJ O
fusion NN O
vector NN O
all DT O
suggested VBD O
that IN O
these DT O
possible JJ O
promoters NNS O
were VBD O
largely RB O
inactive JJ O
during IN O
logarithmic JJ O
growth NN O
, , O
that IN O
the DT O
major JJ O
promoter NN O
for IN O
the DT O
alpha NN O
operon NN O
lay VBD O
upstream RB O
from IN O
the DT O
region NN O
cloned VBN O
, , O
and CC O
that IN O
the DT O
genes NNS O
in IN O
the DT O
IF1 NNP B-Gene
to TO O
L17 NNP B-Gene
interval NN O
were VBD O
cotranscribed VBN O
. . O

Consistent JJ O
with IN O
this DT O
similarity NN O
, , O
the DT O
cdc28 NN B-Gene
- : O
P8 NNP O
mutant JJ O
accumulates NNS O
unspliced JJ O
precursors NNS O
at IN O
the DT O
restrictive JJ O
temperature NN O
. . O

Prostacyclin NNP O
formation NN O
, , O
reflected VBN O
by IN O
the DT O
excretion NN O
rate NN O
of IN O
its PRP$ O
stable JJ O
metabolite NN O
6 CD O
- : O
keto NN O
- : O
prostaglandin NN O
F1 NNP O
alpha NN O
, , O
was VBD O
measured VBN O
by IN O
means NNS O
of IN O
radioimmunoassay NN O
in IN O
4 CD O
- : O
hour NN O
urine JJ O
specimens NNS O
obtained VBN O
during IN O
a DT O
smoking NN O
- : O
free JJ O
period NN O
and CC O
after IN O
participants NNS O
had VBD O
inhaled VBN O
smoke NN O
from IN O
four CD O
high JJ O
- : O
nicotine NN O
cigarettes NNS O
. . O

Stable JJ O
patients NNS O
have VBP O
mucous JJ O
hypersecretion NN O
and CC O
little JJ O
evidence NN O
of IN O
acute JJ O
inflammation NN O
. . O

Deletions NNS O
were VBD O
examined VBN O
in IN O
the DT O
LYS2 NNP B-Gene
gene NN I-Gene
, , O
using VBG O
a DT O
set NN O
of IN O
31 CD O
- : O
to TO O
156 CD O
- : O
bp NN O
inserts NNS O
that WDT O
included VBD O
inserts NNS O
with IN O
no DT O
apparent JJ O
potential NN O
for IN O
secondary JJ O
structure NN O
as RB O
well RB O
as IN O
two CD O
quasipalindromes NNS O
. . O

This DT O
sequence NN O
also RB O
confers VBZ O
VDR NNP B-Gene
and CC O
vitamin NNP O
D NNP O
responsiveness NN O
to TO O
a DT O
heterologous JJ O
promoter NN O
. . O

Myocardial JJ O
infarction NN O
in IN O
patients NNS O
with IN O
previous JJ O
bypass NN O
surgery NN O
. . O

However RB O
, , O
the DT O
serum NN B-Gene
TNF NNP I-Gene
- : I-Gene
a DT I-Gene
concentration NN O
decreased VBN O
significantly RB O
in IN O
patients NNS O
receiving VBG O
pentoxifylline NN O
( ( O
basal JJ O
623 CD O
+ NN O
/ NNP O
- : O
366 CD O
pg NN O
/ NNP O
ml NN O
; : O
6th CD O
month NN O
562 CD O
+ NN O
/ NNP O
- : O
358 CD O
pg NN O
/ NNP O
ml NN O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
, , O
but CC O
not RB O
in IN O
the DT O
control NN O
group NN O
. . O

Conservation NN O
of IN O
function NN O
of IN O
Drosophila NNP B-Gene
melanogaster NN I-Gene
abl NN I-Gene
and CC O
murine NN B-Gene
v NN I-Gene
- : I-Gene
abl NN I-Gene
proteins NNS I-Gene
in IN O
transformation NN O
of IN O
mammalian JJ O
cells NNS O
. . O

Hepatitis NN O
B NNP O
vaccination NN O
strategy NN O
for IN O
health NN O
- : O
care NN O
workers NNS O
in IN O
a DT O
country NN O
of IN O
intermediate JJ O
hepatitis NN O
B NNP O
endemicity NN O
. . O

Analysis NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
/ NN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
homodimerization NN O
using VBG O
both DT O
in IN O
vitro NN O
binding NN O
assays NNS O
as RB O
well RB O
as IN O
a DT O
yeast NN O
two CD O
- : O
hybrid JJ O
method NN O
provided VBD O
evidence NN O
in IN O
support NN O
of IN O
a DT O
head NN O
- : O
to TO O
- : O
tail NN O
model NN O
for IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
/ NN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
homodimerization NN O
and CC O
revealed VBD O
that IN O
sequences NNS O
within IN O
the DT O
NH2 NNP O
- : O
terminal NN O
A DT O
domain NN O
interact NN O
with IN O
a DT O
structure NN O
that WDT O
requires VBZ O
the DT O
presence NN O
of IN O
both CC O
the DT O
carboxyl NN O
B NNP O
and CC O
C NNP O
domains NNS O
in IN O
combination NN O
. . O

The DT O
5 CD O
' POS O
untranslated JJ O
and CC O
coding JJ O
regions NNS O
are VBP O
contained VBN O
within IN O
12 CD O
exons NNS O
, , O
with IN O
the DT O
translation NN O
start NN O
site NN O
located VBN O
within IN O
the DT O
first JJ O
exon NN O
. . O

Ninety NNP O
- : O
four CD O
percent NN O
of IN O
the DT O
EPs NNP O
were VBD O
tubal JJ O
, , O
and CC O
90 CD O
% NN O
of IN O
the DT O
tubes NNS O
exhibited VBD O
some DT O
pathologic JJ O
changes NNS O
, , O
including VBG O
chronic JJ O
salpingitis NN O
( ( O
49 CD O
. . O
5 CD O
% NN O
) ) O
and CC O
follicular JJ O
salpingitis NN O
( ( O
10 CD O
% NN O
) ) O
, , O
among IN O
others NNS O
. . O

An DT O
ion NN O
chromatographic JJ O
method NN O
was VBD O
used VBN O
to TO O
determine VB O
Br NNP O
ion NN O
in IN O
the DT O
urine NN O
of IN O
Greyhounds NNP O
. . O

Polyhomeotic JJ B-Gene
and CC I-Gene
Posterior NNP I-Gene
Sex NNP I-Gene
Combs NNP I-Gene
may MD O
participate VB O
in IN O
a DT O
more RBR O
general JJ O
transcriptional JJ O
mechanism NN O
that WDT O
causes VBZ O
modulated VBN O
gene NN O
repression NN O
, , O
whereas IN O
the DT O
inclusion NN O
of IN O
Polycomb NNP B-Gene
protein NN I-Gene
in IN O
the DT O
complex NN O
at IN O
PREs NNP B-Gene
leads VBZ O
to TO O
stable JJ O
silencing NN O
. . O

This DT O
mutation NN O
no RB O
longer RBR O
repressed VBD O
the DT O
HPV NNP O
- : O
11 CD O
upstream JJ O
regulatory JJ O
region NN O
- : O
controlled VBN O
reporter NN O
expression NN O
. . O

PATIENTS NNS O
OR CC O
OTHER JJ O
PARTICIPANTS NNS O
: : O
Twenty NNP O
children NNS O
met VBD O
the DT O
criteria NNS O
for IN O
being VBG O
learning VBG O
disabled VBN O
. . O

A DT O
simple JJ O
analytical JJ O
method NN O
for IN O
l NN O
- : O
menthol NN O
by IN O
high JJ O
- : O
performance NN O
liquid NN O
chromatography NN O
with IN O
a DT O
polarized JJ O
photometric NN O
detector NN O
was VBD O
established VBN O
. . O

Five CD O
healthy JJ O
male NN O
subjects NNS O
inspired VBD O
air NN O
for IN O
20 CD O
min NNS O
and CC O
then RB O
5 CD O
% NN O
CO2 NNP O
/ NNP O
95 CD O
% NN O
O2 NNP O
for IN O
30 CD O
min NN O
, , O
of IN O
which WDT O
the DT O
first JJ O
10 CD O
min NN O
was VBD O
used VBN O
to TO O
achieve VB O
a DT O
steady JJ O
- : O
state NN O
end NN O
- : O
tidal JJ O
CO2 NNP O
measurement NN O
. . O

Scratching VBG O
during IN O
sleep NN O
in IN O
children NNS O
with IN O
atopic NN O
dermatitis NN O
is VBZ O
associated VBN O
with IN O
increased JJ O
VO2 NNP O
. . O

Effect NN O
of IN O
chronic JJ O
undernutrition NN O
on IN O
susceptibility NN O
to TO O
cold VB O
stress NN O
in IN O
young JJ O
adult NN O
and CC O
aged VBD O
rats NNS O
. . O

However RB O
, , O
if IN O
EMPD NNP O
involves VBZ O
the DT O
glans NNS O
penis VBP O
or CC O
perianal JJ O
area NN O
, , O
a DT O
search NN O
for IN O
internal JJ O
malignancy NN O
is VBZ O
still RB O
warranted VBN O
. . O

The DT O
deduced JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
CBP90 NNP B-Gene
had VBD O
no DT O
significant JJ O
similarity NN O
to TO O
any DT O
other JJ O
protein NN O
, , O
but CC O
it PRP O
had VBD O
a DT O
proline JJ O
- : O
rich JJ O
domain NN O
at IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
. . O

Penicillin NNP B-Gene
acylase NN I-Gene
( ( O
PA NNP B-Gene
) ) O
from IN O
Escherichia NNP O
coli NN O
ATCC11105 NNP O
is VBZ O
a DT O
periplasmic JJ O
heterodimer NN O
consisting NN O
of IN O
a DT O
24 CD O
kDa NN O
small JJ O
subunit NN O
and CC O
a DT O
65 CD O
kDa NN O
large JJ O
subunit NN O
. . O

To TO O
determine VB O
the DT O
genomic JJ O
complexity NN O
of IN O
the DT O
deleted JJ O
region NN O
shared VBN O
among IN O
tumors NNS O
, , O
we PRP O
assembled VBD O
a DT O
physical JJ O
map NN O
of IN O
the DT O
I PRP O
Mbp NNP O
SRO NNP O
consisting VBG O
predominantly RB O
of IN O
bacteriophage NN O
P1 NNP O
- : O
derived VBD O
artificial JJ O
chromosome NN O
( ( O
PAC NNP O
) ) O
clones NNS O
. . O

The DT O
electrically RB O
induced VBN O
motile JJ O
responses NNS O
were VBD O
not RB O
suppressed VBN O
in IN O
the DT O
presence NN O
of IN O
dinitrophenol NN O
or CC O
cytochalasin NN O
B NNP O
. . O

We PRP O
previously RB O
showed VBD O
that IN O
v FW B-Gene
- : I-Gene
Rel NN I-Gene
, , O
the DT O
oncoprotein NN O
of IN O
the DT O
avian JJ O
retrovirus NN O
Rev NNP O
- : O
T NN O
, , O
can MD O
increase VB O
expression NN O
from IN O
promoters NNS O
containing VBG O
binding NN O
sites NNS O
for IN O
the DT O
cellular JJ O
transcription NN O
factor NN O
Sp1 NNP B-Gene
in IN O
chicken NN O
embryo NN O
fibroblasts NNS O
( ( O
S NNP O
. . O

The DT O
upstream JJ O
promoter NN O
is VBZ O
located VBN O
within IN O
the DT O
coding VBG O
sequence NN O
of IN O
a DT O
divergent JJ O
gene NN O
expressing VBG O
a DT O
protein NN O
of IN O
Mr NNP O
39 CD O
kDa NN O
of IN O
unknown JJ O
function NN O
. . O

Using VBG O
an DT O
image NN O
- : O
processing NN O
computer NN O
, , O
regional JJ O
LV NNP O
time NN O
- : O
density NN O
curves NNS O
were VBD O
constructed VBN O
for IN O
one CD O
cardiac JJ O
cycle NN O
. . O

RESULTS NN O
: : O
Within JJ O
7 CD O
days NNS O
, , O
all DT O
groups NNS O
re VBP O
- : O
acquired VBD O
responding VBG O
for IN O
heroin NN O
under IN O
CRF NNP O
at IN O
rates NNS O
similar JJ O
to TO O
their PRP$ O
pre NN O
- : O
lesion NN O
performance NN O
. . O

Demonstration NN O
of IN O
the DT O
agent NN O
was VBD O
performed VBN O
from IN O
the DT O
6th CD O
to TO O
the DT O
11th CD O
day NN O
p NN O
. . O
i NN O
. . O
by IN O
direct JJ O
microscopic NN O
methods NNS O
( ( O
Stamp NNP O
and CC O
auramine JJ O
staining NN O
, , O
fluorescent JJ O
antibody NN O
technique NN O
) ) O
; : O
the DT O
Coxiella NNP O
content NN O
was VBD O
determined VBN O
by IN O
titration NN O
in IN O
embryonated JJ O
hen NN O
' POS O
s NN O
eggs NNS O
. . O

The DT O
concentration NN O
of IN O
alpha $ B-Gene
2 CD I-Gene
- : I-Gene
macroglobulin NN I-Gene
, , O
alpha RB B-Gene
1 CD I-Gene
- : I-Gene
antitrypsin NN I-Gene
, , O
plasminogen NN B-Gene
, , O
C3 NNP B-Gene
- : I-Gene
complement NN I-Gene
, , O
fibrinogen NN B-Gene
degradation NN I-Gene
products NNS I-Gene
( ( O
FDP NNP B-Gene
) ) O
and CC O
fibrinolytic JJ O
activity NN O
, , O
were VBD O
studied VBN O
in IN O
the DT O
aqueous JJ O
humour NN O
and CC O
serum NN O
from IN O
nine CD O
patients NNS O
with IN O
Fuchs NNP O
' POS O
endothelial JJ O
dystrophy NN O
, , O
17 CD O
patients NNS O
with IN O
uncomplicated JJ O
senile NN O
cataract NN O
and CC O
in IN O
the DT O
secondary JJ O
aqueous JJ O
from IN O
six CD O
cataract JJ O
patients NNS O
. . O

Nutritional JJ O
status NN O
in IN O
adults NNS O
on IN O
an DT O
alternative NN O
or CC O
traditional JJ O
diet JJ O
] NN O
BACKGROUND NNP O
: : O
Plant NN O
food NN O
lacks NNS O
vitamin VBP O
B12 NNP O
, , O
vitamin NN O
D NNP O
and CC O
higher JJR O
n SYM O
- : O
3 CD O
polyunsaturated JJ O
fatty JJ O
acids NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
purified VBD O
and CC O
characterized VBD O
the DT O
recombinant JJ B-Gene
furin NN I-Gene
from IN O
the DT O
conditioned JJ O
medium NN O
of IN O
these DT O
cells NNS O
. . O

After IN O
age NN O
30 CD O
, , O
mean JJ O
hemoglobin NN B-Gene
levels NNS O
for IN O
men NNS O
gradually RB O
declined VBD O
, , O
while IN O
those DT O
in IN O
women NNS O
rose VBD O
, , O
so IN O
that IN O
the DT O
sex NN O
difference NN O
diminished VBD O
after IN O
60 CD O
years NNS O
of IN O
age NN O
. . O

The DT O
prognosis NN O
of IN O
seven CD O
patients NNS O
who WP O
received VBD O
ABSCT NNP O
was VBD O
significantly RB O
better JJR O
than IN O
that DT O
of IN O
13 CD O
patients NNS O
who WP O
received VBD O
conventional JJ O
therapy NN O
alone RB O
. . O

While IN O
interactions NNS O
of IN O
WT NNP O
and CC O
variant JJ O
TGF NNP B-Gene
- : I-Gene
alpha NN I-Gene
with IN O
the DT O
ErbBs NNP B-Gene
all DT O
result NN O
in IN O
ErbB2 NNP B-Gene
activation NN O
, , O
they PRP O
produce VBP O
different JJ O
biological JJ O
consequences NNS O
, , O
suggesting VBG O
that IN O
the DT O
various JJ O
TGF NNP B-Gene
- : I-Gene
alpha NN I-Gene
precursors NNS I-Gene
differentially RB O
modulate VBP O
ErbB NNP B-Gene
signaling NN O
. . O

The DT O
DSF NNP O
regimen NNS O
appears VBZ O
to TO O
have VB O
significant JJ O
activity NN O
in IN O
patients NNS O
who WP O
have VBP O
metastatic JJ O
pancreatic JJ O
islet NN O
- : O
cell NN O
carcinoma NN O
, , O
and CC O
patient JJ O
tolerance NN O
of IN O
the DT O
regimen NNS O
is VBZ O
excellent JJ O
, , O
thus RB O
warranting VBG O
further JJ O
investigation NN O
. . O

Cross NNP O
- : O
linking VBG O
FcalphaR NNP B-Gene
on IN O
wt SYM B-Gene
- : I-Gene
ITAM NN I-Gene
or CC O
IIA NNP B-Gene
- : I-Gene
ITAM NNP I-Gene
cells NNS O
triggered VBD O
equivalent JJ O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
- : O
dependent JJ O
activation NN O
of IN O
PKBalpha NNP B-Gene
. . O

Increased VBN O
plasma NN O
IgE NNP B-Gene
was VBD O
also RB O
confirmed VBN O
in IN O
the DT O
NC NNP O
mice NN O
, , O
and CC O
treatment NN O
with IN O
FK506 NNP O
ointment NN O
reduced VBD O
the DT O
plasma NN O
IgE NNP B-Gene
level NN O
. . O

For IN O
this DT O
purpose NN O
, , O
a DT O
segment NN O
of IN O
dxr NN B-Gene
was VBD O
amplified VBN O
from IN O
Synechococcus NNP O
leopoliensis NN O
SAUG NNP O
1402 CD O
- : O
1 CD O
DNA NN O
via IN O
PCR NNP O
using VBG O
oligonucleotides NNS O
for IN O
conserved JJ O
regions NNS O
. . O

The DT O
Fyn NNP B-Gene
NH2 NNP I-Gene
terminus NN I-Gene
was VBD O
necessary JJ O
but CC O
not RB O
sufficient JJ O
for IN O
interaction NN O
with IN O
zeta NN O
and CC O
both DT O
Fyn NNP B-Gene
kinase NN I-Gene
and CC O
SH2 NNP B-Gene
domains NNS I-Gene
were VBD O
required VBN O
, , O
directing VBG O
phosphorylation NN O
of IN O
zeta NN B-Gene
ITAM NNP I-Gene
tyrosines NNS O
and CC O
binding VBG O
to TO O
zeta VB B-Gene
ITAM NNP I-Gene
phosphotyrosines NNS O
. . O

Production NN O
costs NNS O
included VBD O
feed NN O
, , O
non SYM O
- : O
feed NN O
operating NN O
, , O
fixed VBN O
, , O
and CC O
replacement NN O
stock NN O
costs NNS O
. . O

Electrochemical JJ O
detection NN O
of IN O
depressed JJ O
circulating NN O
levels NNS O
of IN O
vitamin NN O
K1 NNP O
in IN O
osteoporosis NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
QLMI NNP O
questionnaire NN O
has VBZ O
good JJ O
potential NN O
as IN O
an DT O
instrument NN O
for IN O
assessing VBG O
QL NNP O
in IN O
post NN O
- : O
AMI NN O
patients NNS O
and CC O
that IN O
it PRP O
can MD O
be VB O
successfully RB O
self JJ O
- : O
administered VBN O
. . O

HIV NNP O
- : O
1 CD O
and CC O
hepatitis NN O
B NNP O
virus NN O
infections NNS O
in IN O
adolescents NNS O
lodged VBN O
in IN O
security NN O
institutes NNS O
of IN O
Buenos NNP O
Aires NNP O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
role NN O
of IN O
cellular JJ B-Gene
p21ras NNS I-Gene
protein VBP I-Gene
in IN O
insulin NN B-Gene
and CC O
insulin NN B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
I PRP I-Gene
( ( O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
) ) O
signaling VBG O
pathways NNS O
. . O

With IN O
exon JJ O
trapping NN O
, , O
we PRP O
could MD O
isolate VB O
five CD O
potential JJ O
exons NNS O
from IN O
the DT O
YAC NNP O
946000000000000 CD O
that WDT O
spans VBZ O
the DT O
region NN O
, , O
four CD O
of IN O
which WDT O
could MD O
be VB O
placed VBN O
in IN O
the DT O
contig NN O
in IN O
the DT O
vicinity NN O
of IN O
the DT O
breakpoints NNS O
. . O

Eliminating VBG O
any DT O
subset NN O
of IN O
ASCUS NNP O
reduces VBZ O
the DT O
ASCUS NNP O
/ NNP O
SIL NNP O
ratio NN O
but CC O
also RB O
significantly RB O
diminishes VBZ O
the DT O
sensitivity NN O
of IN O
the DT O
Papanicolaou NNP O
test NN O
. . O

The DT O
detectability NN O
of IN O
the DT O
defects NNS O
in IN O
RCA NNP O
or CC O
LAD NNP O
region NN O
was VBD O
80 CD O
% NN O
in IN O
single JJ O
- : O
position NN O
scans NNS O
in IN O
stress NN O
studies NNS O
. . O

Structural JJ O
organization NN O
and CC O
expression NN O
of IN O
the DT O
mouse NN B-Gene
estrogen NN I-Gene
receptor NN I-Gene
. . O

These DT O
results NNS O
suggested VBD O
a DT O
critical JJ O
role NN O
for IN O
tyrosine NN O
residue JJ O
1229 CD O
in IN O
the DT O
regulation NN O
of IN O
L1 NNP B-Gene
endocytosis NN O
. . O

We PRP O
suggest VBP O
that IN O
MotA NNP B-Gene
and CC O
AsiA NNP B-Gene
may MD O
function VB O
like IN O
certain JJ O
eukaryotic JJ B-Gene
TAFs NNP I-Gene
( ( O
TATA NNP B-Gene
binding VBG I-Gene
protein NN I-Gene
( ( I-Gene
TBP NNP I-Gene
) ) I-Gene
associated VBD I-Gene
factors NNS I-Gene
) ) O
whose WP$ O
binding VBG O
to TO O
TBP NNP B-Gene
results NNS O
in IN O
transcription NN O
from IN O
new JJ O
core NN O
promoter NN O
sequences NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
) ) O
is VBZ O
an DT O
important JJ O
transcription NN O
factor NN O
for IN O
the DT O
genes NNS O
of IN O
many JJ O
pro FW O
- : O
inflammatory NN O
proteins NNS O
and CC O
is VBZ O
strongly RB O
activated VBN O
by IN O
the DT O
cytokines NNS O
interleukin VBP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
alpha NN I-Gene
under IN O
various JJ O
pathological JJ O
conditions NNS O
. . O

A DT O
decanucleotide JJ O
promoter NN O
sequence NN O
homologous JJ O
to TO O
those DT O
found VBN O
in IN O
humans NNS O
and CC O
mice NN O
was VBD O
located VBN O
in IN O
the DT O
5 CD O
' POS O
untranslated JJ O
region NN O
of IN O
one CD O
horse NN O
gene NN O
. . O

In IN O
this DT O
paper NN O
, , O
characterization NN O
is VBZ O
given VBN O
of IN O
clinical JJ O
and CC O
biochemical JJ O
features NNS O
of IN O
VH NNP O
B NNP O
course NN O
against IN O
the DT O
background NN O
of IN O
narcomania NN O
. . O

To TO O
study VB O
retinoid JJ O
signalling VBG O
in IN O
zebrafish JJ O
embryos NN O
, , O
we PRP O
developed VBD O
a DT O
novel JJ O
method NN O
to TO O
detect VB O
endogenous JJ O
retinoids NNS O
in IN O
situ NN O
in IN O
embryos NN O
, , O
using VBG O
a DT O
fusion NN O
protein NN O
of IN O
the DT O
ligand NN O
inducible JJ O
transactivation NN O
domain NN O
of IN O
a DT O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
and CC O
a DT O
heterologous JJ O
DNA NN O
binding VBG O
domain NN O
. . O

The DT O
sign NN O
of IN O
Leser NNP O
- : O
Trelat NN O
: : O
does VBZ O
it PRP O
exist VB O
? . O

The DT O
sign NN O
of IN O
Leser NNP O
- : O
Trelat NN O
is VBZ O
usually RB O
regarded VBN O
as IN O
a DT O
reliable JJ O
cutaneous JJ O
marker NN O
of IN O
internal JJ O
malignancy NN O
. . O

The DT O
5 CD O
' POS O
flanking VBG O
sequence NN O
of IN O
the DT O
3B CD B-Gene
gene NN I-Gene
is VBZ O
extremely RB O
A NNP O
+ NNP O
T NNP O
rich JJ O
but CC O
contains VBZ O
five CD O
G NNP O
/ NNP O
C NNP O
rich JJ O
stretches NNS O
, , O
each DT O
approximately RB O
7bp CD O
long NNS O
, , O
which WDT O
have VBP O
strong JJ O
sequence NN O
similarity NN O
to TO O
the DT O
G NNP O
boxes NNS O
found VBD O
upstream RB O
of IN O
other JJ O
developmentally RB O
regulated VBN O
Dictyostelium NNP O
genes NNS O
. . O

Removal NN O
of IN O
the DT O
carboxyl JJ O
region NN O
severely RB O
reduced VBD O
transcriptional JJ O
activation NN O
. . O

Unlike IN O
most JJS O
other JJ O
small JJ B-Gene
G NNP I-Gene
proteins NNS I-Gene
which WDT O
are VBP O
expressed VBN O
ubiquitously RB O
, , O
TTF NNP B-Gene
was VBD O
transcribed VBN O
only RB O
in IN O
hemopoietic JJ O
cells NNS O
as IN O
a DT O
2 CD O
. . O
2 CD O
kb JJ O
transcript NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
possibility NN O
that IN O
p202 VBZ B-Gene
protein RB I-Gene
contributes NNS O
to TO O
the DT O
cell NN O
growth NN O
retardation NN O
activity NN O
of IN O
the DT O
IFNs NNP B-Gene
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
by IN O
modulating VBG O
p21 JJ B-Gene
protein NN I-Gene
levels NNS O
. . O

Alternative JJ O
splicing NN O
of IN O
CDC25B NNP B-Gene
may MD O
therefore VB O
contribute NN O
to TO O
the DT O
control NN O
of IN O
cell NN O
proliferation NN O
. . O

Various JJ O
transcripts NNS O
are VBP O
generated VBN O
from IN O
the DT O
VCSA1 NNP B-Gene
gene NN I-Gene
by IN O
alternative JJ O
splicing NN O
and CC O
poly NN O
( ( O
A NNP O
) ) O
processing NN O
in IN O
the DT O
rat NN O
submandibular JJ O
gland NN O
. . O

Differential JJ O
activation NN O
of IN O
the DT O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
, , O
Jun NNP B-Gene
kinase NN I-Gene
and CC O
Janus NNP B-Gene
kinase NNP I-Gene
- : O
Stat NNP B-Gene
pathways NNS O
by IN O
oncostatin JJ B-Gene
M NNP I-Gene
and CC O
basic JJ B-Gene
fibroblast NN I-Gene
growth NN I-Gene
factor NN I-Gene
in IN O
AIDS NNP O
- : O
derived VBD O
Kaposi NNP O
' POS O
s NN O
sarcoma NN O
cells NNS O
. . O

The DT O
complement NN B-Gene
C3a NNP I-Gene
anaphylatoxin NN I-Gene
receptor NN I-Gene
( ( O
C3aR NNP B-Gene
) ) O
is VBZ O
a DT O
seven CD B-Gene
- : I-Gene
transmembrane NN I-Gene
G NNP I-Gene
- : I-Gene
protein NN I-Gene
coupled VBD I-Gene
chemoattractant JJ I-Gene
receptor NN I-Gene
that WDT O
on IN O
binding VBG O
the DT O
C3a NNP B-Gene
peptide NN I-Gene
ligand NN I-Gene
mediates VBZ O
numerous JJ O
cellular JJ O
responses NNS O
, , O
including VBG O
histamine JJ O
release NN O
from IN O
mast NN O
cells NNS O
. . O
smooth JJ O
muscle NN O
contraction NN O
, , O
and CC O
the DT O
directed JJ O
migration NN O
of IN O
eosinophils NNS O
. . O

IL NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
TNF NNP B-Gene
increase NN O
AND NNP B-Gene
- : I-Gene
34 CD I-Gene
transcript NN I-Gene
levels NNS O
in IN O
thymic JJ O
cortical JJ O
reticular NN O
, , O
thymic JJ O
nurse NN O
, , O
and CC O
fibroblast RB O
cell NN O
lines NNS O
. . O

At IN O
baseline NN O
, , O
serum NN O
levels NNS O
of IN O
lycopene NN O
and CC O
FLOP NNP O
were VBD O
abnormally RB O
high JJ O
and CC O
serum JJ O
FLOP NNP O
was VBD O
correlated VBN O
significantly RB O
with IN O
plasma JJ O
cyclosporine NN O
levels NNS O
( ( O
r NN O
= VBZ O
0 CD O
. . O
646 CD O
, , O
p NN O
= VBD O
0 CD O
. . O
16 CD O
) ) O
. . O

The DT O
effects NNS O
of IN O
tap NN O
( ( O
TW NNP O
) ) O
or CC O
carbonated VBN O
( ( O
CW NNP O
) ) O
water NN O
on IN O
arterial JJ O
pH NN O
, , O
partial JJ O
pressure NN O
of IN O
carbon NN O
dioxide NN O
( ( O
PCO2 NNP O
) ) O
and CC O
plasma JJ O
lactate NN O
were VBD O
determined VBN O
in IN O
heat NN O
- : O
stressed JJ O
broilers NNS O
. . O

Shear JJ O
bond NN O
strength NN O
of IN O
a DT O
composite JJ O
resin NN O
to TO O
an DT O
etched JJ O
glass NN O
ionomer NN O
. . O

The DT O
present JJ O
study NN O
investigates VBZ O
whether IN O
prostaglandins NNS O
"""" VBP O
cytoprotect JJ O
"""" IN O
the DT O
gastric JJ O
mucosa NN O
against IN O
hemorrhage NN O
- : O
induced JJ O
stress NN O
ulceration NN O
by IN O
assessing VBG O
the DT O
influence NN O
of IN O
16 CD O
, , O
16 CD O
- : O
dimethyl NN O
prostaglandin NN O
E2 NNP O
( ( O
16 CD O
, , O
16 CD O
- : O
dm NN O
PGE2 NNP O
) ) O
on IN O
gross JJ O
and CC O
microscopic JJ O
lesion NN O
formation NN O
, , O
intramucosal JJ O
tissue NN O
pH NN O
, , O
H NNP O
+ NNP O
back RB O
- : O
diffusion NN O
, , O
and CC O
mucosal NN O
blood NN O
flow NN O
in IN O
rat NN O
gastric JJ O
mucosa NN O
exposed VBD O
to TO O
luminal JJ O
acid NN O
( ( O
100 CD O
mM RB O
HCl NNP O
) ) O
during IN O
hemorrhagic NN O
shock NN O
( ( O
13 CD O
ml NN O
/ NNP O
kg NN O
for IN O
20 CD O
min NN O
) ) O
. . O

After IN O
cells NNS O
were VBD O
stably RB O
transfected VBN O
with IN O
CIITA NNP B-Gene
, , O
endogenous JJ O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
were VBD O
constitutively RB O
expressed VBN O
, , O
and CC O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
promoters NNS I-Gene
, , O
delivered VBN O
by IN O
transfection NN O
, , O
were VBD O
actively RB O
transcribed VBN O
in IN O
CIITA NNP B-Gene
- : O
expressing VBG O
cells NNS O
. . O

The DT O
reduced JJ O
efficiency NN O
in IN O
the DT O
glycosylase NN B-Gene
activity NN O
is VBZ O
also RB O
reflected VBN O
in IN O
a DT O
reduced JJ O
ability NN O
of IN O
S120K NNP B-Gene
MutY NNP I-Gene
to TO O
prevent VB O
DNA NNP O
mutations NNS O
in IN O
vivo NN O
. . O

Intra NNP O
- : O
articular JJ O
dislocation NN O
of IN O
the DT O
patella NN O
. . O

However RB O
, , O
bilateral JJ O
diffuse NN O
pulmonary JJ O
infiltrations NNS O
developed VBD O
21 CD O
days NNS O
later RB O
. . O

The DT O
present JJ O
data NNS O
also RB O
suggest VBP O
that IN O
when WRB O
compared VBN O
to TO O
the DT O
systemic JJ O
vascular NN O
bed NN O
, , O
the DT O
pulmonary JJ O
vascular NN O
bed NN O
is VBZ O
less RBR O
responsive JJ O
to TO O
bolus VB O
administration NN O
of IN O
ET NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Both DT O
functional JJ O
analyses NNS O
in IN O
undifferentiated JJ O
and CC O
differentiated JJ O
F9 NNP O
cells NNS O
and CC O
characterization NN O
of IN O
DNA NNP O
- : O
protein NN O
complexes NNS O
in IN O
vitro NN O
have VBP O
identified VBN O
the DT O
sequence NN O
motifs NNS O
GTGACT NNP O
( ( O
C NNP O
) ) O
, , O
ATTGT NNP O
, , O
and CC O
GATA NNP O
as IN O
the DT O
key JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

Recombinant JJ O
plasmids NNS O
containing VBG O
the DT O
entire JJ O
322 CD O
nt RB O
5 CD O
' '' O
UTR NNP O
of IN O
exon $ O
1 CD O
and CC O
a DT O
1630 CD O
nt JJ O
segment NN O
of IN O
5 CD O
' POS O
flanking VBG O
sequence NN O
stimulated VBD O
luciferase JJ B-Gene
activity NN O
nearly RB O
70 CD O
times NNS O
higher JJR O
than IN O
a DT O
promoterless NN O
control NN O
plasmid NN O
. . O

A DT O
global JJ O
response NN O
rate NN O
was VBD O
17 CD O
% NN O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
( ( O
95 CD O
% NN O
CI NNP O
) ) O
: : O
2 CD O
% NN O
- : O
32 CD O
% NN O
) ) O
and CC O
the DT O
median JJ O
overall JJ O
survival NN O
was VBD O
12 CD O
months NNS O
. . O

Mutagenesis NN O
of IN O
the DT O
pecT NN B-Gene
regulatory JJ O
region NN O
revealed VBD O
the DT O
presence NN O
of IN O
two CD O
sites NNS O
in IN O
which WDT O
insertions NNS O
reproduced VBD O
the DT O
pec NN B-Gene
- : I-Gene
1 CD I-Gene
phenotype NN O
. . O

In IN O
control NN O
patients NNS O
, , O
baseline JJ O
images NNS O
presented VBN O
Type NNP O
I PRP O
in IN O
25 CD O
, , O
Type NNP O
II NNP O
in IN O
7 CD O
, , O
and CC O
the DT O
Type NNP O
III NNP O
& CC O
IV NNP O
in IN O
0 CD O
, , O
and CC O
the DT O
Type NNP O
after IN O
loading VBG O
was VBD O
the DT O
same JJ O
as IN O
the DT O
Type NN O
at IN O
baseline NN O
. . O

The DT O
lytic JJ O
cycle NN O
of IN O
KSHV NNP O
, , O
probably RB O
under IN O
the DT O
initial JJ O
control NN O
of IN O
the DT O
KSHV NNP B-Gene
/ NNP I-Gene
Rta NNP I-Gene
gene NN I-Gene
, , O
may MD O
directly RB O
contribute VB O
to TO O
tumor VB O
pathogenesis NN O
. . O

The DT O
multidomain NN O
structure NN O
includes VBZ O
a DT O
cysteine NN O
- : O
rich JJ O
motif NN O
resembling VBG O
those DT O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
and CC O
n JJ B-Gene
- : I-Gene
chimaerin NN I-Gene
and CC O
a DT O
putative JJ O
pleckstrin NN B-Gene
homology NN I-Gene
domain NN I-Gene
. . O

In IN O
addition NN O
to TO O
the DT O
nine CD O
and CC O
51 CD O
terminal JJ O
amino NN O
acid NN O
forms NNS O
already RB O
known VBN O
, , O
we PRP O
identified VBD O
a DT O
third JJ O
with IN O
43 CD O
terminal JJ O
amino NN O
acids NNS O
predicted VBD O
to TO O
encode VB O
a DT O
novel JJ O
RET NNP B-Gene
protein NN I-Gene
isoform NN I-Gene
. . O

Telomeres NNS O
prevent VBP O
end VB O
- : O
to TO O
- : O
end NN O
fusions NNS O
and CC O
exonucleolytic JJ O
degradation NN O
, , O
enable VB O
the DT O
end NN O
of IN O
the DT O
linear JJ O
DNA NNP O
molecule NN O
to TO O
replicate VB O
, , O
and CC O
function NN O
in IN O
cell NN O
division NN O
. . O

The DT O
purified JJ O
recombinant NN O
protein NN O
was VBD O
assayed VBN O
for IN O
its PRP$ O
enzyme NN O
activity NN O
by IN O
monitoring VBG O
transfer NN O
of IN O
[ $ O
3H CD O
] NNP O
methyl NN O
groups NNS O
from IN O
the DT O
substrate NN O
DNA NN O
to TO O
the DT O
MGMT NNP B-Gene
protein NN I-Gene
; : O
the DT O
activity NN O
was VBD O
found VBN O
to TO O
be VB O
stable JJ O
at IN O
90 CD O
degrees NNS O
C NNP O
for IN O
at IN O
least JJS O
30 CD O
min NN O
. . O

A DT O
group NN O
of IN O
66 CD O
DSM NNP O
- : O
IV NNP O
paranoid VBP O
schizophrenic NN O
in IN O
- : O
patients NNS O
were VBD O
assessed VBN O
three CD O
times NNS O
using VBG O
the DT O
SAPS NNP O
, , O
SANS NNP O
, , O
BPRS NNP O
and CC O
PAS NNP O
. . O

However RB O
, , O
in IN O
contrast NN O
with IN O
previous JJ O
in IN O
vitro NN O
cell NN O
- : O
free JJ O
integration NN O
studies NNS O
, , O
alteration NN O
of IN O
the DT O
highly RB O
conserved VBN O
CA NNP O
dinucleotide RB O
resulted VBD O
in IN O
a DT O
mutant NN O
which WDT O
still RB O
retained VBD O
40 CD O
% NN O
of IN O
wild JJ O
- : O
type NN O
integration NN O
activity NN O
. . O

DDP1 NNP B-Gene
also RB O
localizes VBZ O
to TO O
heterochromatin VB O
in IN O
interphase JJ O
nuclei NN O
of IN O
larval JJ O
neuroblasts NNS O
. . O

Moreover RB O
, , O
the DT O
reconstitution NN O
of IN O
eUSF NN B-Gene
and CC O
TFIID NNP B-Gene
- : O
depleted VBN O
transcription NN O
complexes NNS O
with IN O
purified JJ O
protein NN O
fractions NNS O
demonstrate VBP O
that IN O
not RB O
only RB O
TFIID NNP B-Gene
but CC O
also RB O
eUSF VBP B-Gene
essentially RB O
participates NNS O
in IN O
complex JJ O
formation NN O
even RB O
on IN O
H5 NNP B-Gene
promoter NN I-Gene
mutations NNS O
lacking VBG O
the DT O
TATA NNP O
- : O
box NN O
. . O

These DT O
exons NNS O
, , O
further RB O
identified VBN O
as IN O
exons NNS O
9 CD O
, , O
10 CD O
, , O
and CC O
11 CD O
, , O
together RB O
encode VBD O
the DT O
37 CD O
amino NN O
acid NN O
residues NNS O
present VBP O
in IN O
alpha NN B-Gene
s1 NN I-Gene
- : I-Gene
casein NN I-Gene
variant VBP I-Gene
A DT I-Gene
but CC O
missing VBG O
in IN O
variant JJ O
F NNP O
. . O

We PRP O
specially RB O
devised VBD O
3 CD O
types NNS O
of IN O
turbo NN O
pumps NNS O
, , O
a DT O
centrifugal JJ O
pump NN O
( ( O
CFP NNP O
) ) O
, , O
a DT O
mixed JJ O
flow NN O
pump NN O
( ( O
MFP NNP O
) ) O
, , O
and CC O
an DT O
axial JJ O
flow NN O
pump NN O
( ( O
AFP NNP O
) ) O
, , O
and CC O
analyzed VBD O
their PRP$ O
in IN O
vitro JJ O
performance NN O
. . O

With IN O
a DT O
BMI NNP O
cutoff NN O
of IN O
27 CD O
, , O
mean JJ O
cardiac JJ O
NE NNP O
spillover NN O
was VBD O
46 CD O
% NN O
lower JJR O
in IN O
the DT O
obese JJ O
subjects NNS O
when WRB O
compared VBN O
with IN O
the DT O
lean JJ O
subjects NNS O
( ( O
P NNP O
= NNP O
. . O
17 CD O
) ) O
. . O

Of IN O
the DT O
single JJ O
- : O
stranded VBD O
DNA NN O
transformants NNS O
, , O
65 CD O
% NN O
resulted VBD O
from IN O
replacement NN O
of IN O
the DT O
resident NN O
met2 NN B-Gene
mutation NN I-Gene
by IN O
the DT O
exogenous JJ O
wild JJ O
- : O
type NN O
allele NN O
. . O

In IN O
TNF NNP B-Gene
- : O
resistant JJ O
T24 NNP O
bladder NN O
carcinoma NN O
cells NNS O
, , O
TNF NNP B-Gene
failed VBD O
to TO O
alter VB O
EGF NNP B-Gene
- : I-Gene
R NNP I-Gene
tyrosine NN B-Gene
protein NN I-Gene
kinase NN I-Gene
activity NN O
although IN O
both DT O
EGF NNP B-Gene
and CC O
phorbol NN O
ester NN O
were VBD O
shown VBN O
to TO O
modulate VB O
the DT O
enzymatic JJ O
activity NN O
of IN O
the DT O
receptor NN O
in IN O
these DT O
cells NNS O
. . O

Genotoxic NNP O
activity NN O
of IN O
a DT O
tobacco NN O
- : O
specific JJ O
nitrosamine NN O
. . O

A DT O
multicentre NN O
study NN O
involving VBG O
9 CD O
Italian JJ O
institutions NNS O
was VBD O
carried VBN O
out IN O
to TO O
compare VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
ranitidine NN O
150 CD O
mg NN O
b NN O
. . O
i NN O
. . O
d NN O
. . O
and CC O
ranitidine VB O
300 CD O
mg NN O
nocte NN O
in IN O
the DT O
treatment NN O
of IN O
reflux NN O
oesophagitis NN O
. . O

Both DT O
proprioceptive JJ O
and CC O
electroreceptive JJ O
units NNS O
showed VBD O
a DT O
progression NN O
of IN O
receptive JJ O
fields NNS O
from IN O
anterior JJ O
to TO O
posterior VB O
body NN O
in IN O
the DT O
rostral JJ O
to TO O
caudal VB O
direction NN O
along IN O
the DT O
length NN O
of IN O
DGR NNP O
. . O

Ultrastructural JJ O
and CC O
morphometric JJ O
study NN O
of IN O
the DT O
myeloid NN O
parenchyma NN O
cells NNS O
of IN O
mice NN O
prior RB O
and CC O
after IN O
X NNP O
- : O
ray NN O
exposure NN O

In IN O
nondiabetics NNS O
the DT O
response NN O
of IN O
tcPO2 NN O
but CC O
not RB O
of IN O
LDF NNP O
was VBD O
influenced VBN O
by IN O
the DT O
values NNS O
at IN O
rest NN O
. . O

Regulators NNS O
of IN O
G NNP B-Gene
protein NN I-Gene
signaling VBG I-Gene
( ( I-Gene
RGS NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
that IN O
contain NN O
DEP NNP B-Gene
( ( O
disheveled VBN B-Gene
, , O
EGL NNP B-Gene
- : I-Gene
10 CD I-Gene
, , O
pleckstrin NN B-Gene
) ) O
and CC O
GGL NNP B-Gene
( ( O
G NNP B-Gene
protein RB I-Gene
gamma VBD I-Gene
subunit JJ I-Gene
- : I-Gene
like IN I-Gene
) ) O
domains VBZ O
form VB O
a DT O
subfamily NN O
that WDT O
includes VBZ O
the DT O
mammalian JJ B-Gene
RGS NNP I-Gene
proteins VBZ I-Gene
RGS6 NNP B-Gene
, , O
RGS7 NNP B-Gene
, , O
RGS9 NNP B-Gene
, , O
and CC O
RGS11 NNP B-Gene
. . O

The DT O
27 CD O
- : O
base NN O
element NN O
interacts VBZ O
with IN O
a DT O
PDGF NNP B-Gene
- : O
activated VBD O
serine JJ O
/ NNP O
threonine NN O
phosphoprotein NN O
that WDT O
is VBZ O
detected VBN O
only RB O
within IN O
the DT O
nucleus NN O
of IN O
PDGF NNP O
- : O
treated VBD O
3T3 CD O
cells NNS O
. . O

The DT O
amplitudes NNS O
of IN O
DPOAE NNP O
also RB O
recovered VBD O
to TO O
a DT O
greater JJR O
extent NN O
and CC O
outer NN O
hair NN O
cell NN O
losses NNS O
were VBD O
less JJR O
severe JJ O
in IN O
the DT O
R NNP O
- : O
PIA NNP O
- : O
treated VBD O
ears NNS O
. . O

In IN O
contrast NN O
, , O
Y239 NNP B-Gene
/ VBZ I-Gene
240F CD I-Gene
Shc NNP I-Gene
, , O
but CC O
not RB O
Y317F NNP B-Gene
Shc NNP I-Gene
, , O
reduced VBD O
the DT O
EGF NNP B-Gene
- : O
induced VBD O
c SYM B-Gene
- : I-Gene
myc JJ I-Gene
message NN O
. . O

The DT O
most RBS O
striking JJ O
difference NN O
in IN O
the DT O
birch NN B-Gene
NAD NNP I-Gene
( ( I-Gene
P NNP I-Gene
) ) I-Gene
H NNP I-Gene
- : I-Gene
NR NNP I-Gene
sequence NN I-Gene
in IN O
comparison NN O
to TO O
NADH NNP B-Gene
- : I-Gene
NR NN I-Gene
sequences NNS I-Gene
was VBD O
found VBN O
at IN O
the DT O
putative JJ O
pyridine NN O
nucleotide IN O
binding VBG O
site NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
binding NN O
of IN O
C1F NNP B-Gene
in IN O
vitro NN O
is VBZ O
sensitive JJ O
to TO O
the DT O
concentration NN O
of IN O
calcium NN O
ions NNS O
. . O

Moreover RB O
, , O
LD50 NNP O
in IN O
mice NN O
of IN O
RP NNP O
- : O
170 CD O
( ( O
4 CD O
. . O
3 CD O
g JJ O
/ NNP O
kg NN O
on IN O
i NN O
. . O
v NN O
. . O
) ) O
was VBD O
increased VBN O
to TO O
5 CD O
. . O
2 CD O
g JJ O
/ NNP O
kg NN O
by IN O
oral JJ O
administration NN O
. . O

Whereas NNP O
creatine JJ B-Gene
kinase NN I-Gene
activity NN O
declined VBD O
exponentially RB O
from IN O
a DT O
single JJ O
peak NN O
, , O
myoglobin NN B-Gene
appeared VBD O
in IN O
multiple JJ O
episodes NNS O
inadequately RB O
represented VBN O
by IN O
a DT O
single JJ O
peak NN O
value NN O
and CC O
having VBG O
no DT O
clear JJ O
clinical JJ O
correlation NN O
. . O

Recognition NNP O
mechanisms NNS O
of IN O
the DT O
minus NN O
- : O
strand NN O
origin NN O
of IN O
phage NN O
f1 NN O
by IN O
Escherichia NNP B-Gene
coli NNS I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
. . O

Cranio NNP O
- : O
caudal NN O
differences NNS O
in IN O
granulation NN O
tissue NN O
formation NN O
: : O
an DT O
experimental JJ O
study NN O
in IN O
the DT O
rat NN O
. . O

Methoxyflurane NNP O
and CC O
renal JJ O
function NN O

Furthermore RB O
, , O
the DT O
PH NNP B-Gene
and CC O
PTB NNP O
domains NNS O
are VBP O
highly RB O
homologous JJ O
( ( O
at IN O
least JJS O
40 CD O
% NN O
identical JJ O
) ) O
to TO O
those DT O
found VBN O
in IN O
insulin NN B-Gene
receptor NN I-Gene
substrates VBZ I-Gene
1 CD I-Gene
, , I-Gene
2 CD I-Gene
, , I-Gene
and CC I-Gene
3 CD I-Gene
( ( O
IRS NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
IRS NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
and CC O
IRS NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
. . O

In IN O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
protection NN O
analysis NN O
, , O
both DT O
SFRE NNP B-Gene
and CC O
ERE NNP O
regions NNS O
were VBD O
protected VBN O
by IN O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
- : O
ERRalpha1 NNP B-Gene
fusion NN O
protein NN O
. . O

W NNP O
. . O

In IN O
this DT O
study NN O
, , O
to TO O
characterize VB O
the DT O
gene NN O
for IN O
protein JJ B-Gene
Z NNP I-Gene
, , O
its PRP$ O
organization NN O
and CC O
structure NN O
were VBD O
determined VBN O
by IN O
a DT O
combination NN O
of IN O
PCR NNP O
amplification NN O
of IN O
leukocyte JJ O
DNA NNP O
and CC O
isolation NN O
of IN O
phage NN O
clones NNS O
from IN O
a DT O
human JJ O
genomic JJ O
library NN O
. . O

The DT O
patient NN O
was VBD O
homozygous JJ O
for IN O
the DT O
underlying JJ O
mutation NN O
, , O
which WDT O
was VBD O
found VBN O
to TO O
be VB O
a DT O
G NNP O
- : O
- : O
> NN O
T NNP O
transversion NN O
within IN O
the DT O
acceptor NN O
splice NN O
site NN O
between IN O
intron NN O
e NN O
and CC O
exon $ O
6 CD O
, , O
abolishing VBG O
normal JJ O
RNA NNP O
splicing NN O
. . O

An DT O
in IN O
vivo NN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
substrate NN O
, , O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
, , O
implicated VBN O
in IN O
Erk NNP B-Gene
activation NN O
, , O
also RB O
became VBD O
rapidly RB O
tyrosine JJ O
- : O
phosphorylated VBN O
in IN O
Jurkat NNP O
cells NNS O
, , O
but CC O
not RB O
in IN O
P116 NNP O
cells NNS O
, , O
upon IN O
treatment NN O
with IN O
H2O2 NNP O
. . O

By IN O
treating VBG O
monkey JJ O
COS NNP O
cells NNS O
with IN O
oligonucleotides NNS O
linked VBN O
to TO O
psoralen VB O
, , O
we PRP O
have VBP O
generated VBN O
targeted JJ O
mutations NNS O
in IN O
a DT O
simian JJ O
virus NN O
40 CD O
( ( O
SV40 NNP O
) ) O
vector NN O
contained VBD O
within IN O
the DT O
cells NNS O
via IN O
intracellular JJ O
triple JJ O
helix NN O
formation NN O
. . O

T NNP B-Gene
antigen NN I-Gene
contains VBZ O
four CD O
H NNP O
- : O
2Db CD O
- : O
restricted VBN O
cytotoxic JJ O
T NNP O
lymphocyte NN O
( ( O
CTL NNP O
) ) O
recognition NN O
epitopes NNS O
that WDT O
are VBP O
targets NNS O
for IN O
CTL NNP O
clones NNS O
Y NNP O
- : O
1 CD O
, , O
Y NNP O
- : O
2 CD O
, , O
Y NNP O
- : O
3 CD O
, , O
and CC O
Y NNP O
- : O
5 CD O
. . O

No DT O
definite JJ O
conclusions NNS O
are VBP O
possible JJ O
because IN O
of IN O
the DT O
small JJ O
number NN O
of IN O
patients NNS O
involved VBN O
in IN O
this DT O
phase NN O
II NNP O
trial NN O
. . O

Positive JJ O
and CC O
significant JJ O
correlations NNS O
were VBD O
found VBN O
between IN O
the DT O
weeks NNS O
of IN O
pregnancy NN O
and CC O
Se NNP O
levels NNS O
in IN O
kidney NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
433 CD O
, , O
P NNP O
= VBZ O
0 CD O
. . O
23 CD O
) ) O
and CC O
heart NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
313 CD O
, , O
P NNP O
= VBZ O
0 CD O
. . O
30 CD O
) ) O
. . O

Cotransfection NN O
analyses NNS O
of IN O
the DT O
T NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
promoter NN I-Gene
- : I-Gene
reporter NN I-Gene
constructs NNS I-Gene
with IN O
a DT O
T NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
expression NN O
vector NN O
into IN O
human JJ O
HepG2 NNP O
cells NNS O
, , O
which WDT O
do VBP O
not RB O
express VB O
T NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
, , O
suggested VBD O
that IN O
autoregulation NN O
may MD O
be VB O
involved VBN O
in IN O
controlling VBG O
both DT O
rat NN O
and CC O
human JJ B-Gene
T NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
gene NN I-Gene
expression NN O
. . O

At IN O
maximum JJ O
photosensitivity NN O
the DT O
inhibitory NN O
amino NN O
acids NNS O
gamma VBP O
- : O
aminobutyric JJ O
acid NN O
and CC O
taurine NN O
were VBD O
lower JJR O
, , O
and CC O
those DT O
of IN O
asparagine NN O
( ( O
metabolite NN O
of IN O
the DT O
excitatory NN O
amino NN O
acid JJ O
aspartate NN O
) ) O
were VBD O
higher JJR O
, , O
than IN O
when WRB O
the DT O
animals NNS O
were VBD O
not RB O
photosensitive JJ O
. . O

The DT O
pseudolymphoma NN O
syndrome NN O
is VBZ O
a DT O
reversible JJ O
reactive JJ O
condition NN O
consisting VBG O
of IN O
fever NN O
, , O
lymphadenopathy JJ O
and CC O
generalized JJ O
rash NN O
. . O

Thus RB O
, , O
Fis NNP B-Gene
acts VBZ O
as IN O
an DT O
accessory JJ O
transcriptional JJ O
activator NN O
at IN O
the DT O
mar NN B-Gene
promoter NN I-Gene
. . O

Comparison NNP O
of IN O
German JJ O
language NN O
versions NNS O
of IN O
the DT O
QWB NNP O
- : O
SA NNP O
and CC O
SF NNP O
- : O
36 CD O
evaluating VBG O
outcomes NNS O
for IN O
patients NNS O
with IN O
prostate JJ O
disease NN O
. . O

Overexpression NN O
of IN O
POG1 NNP B-Gene
inhibits NNS O
alpha VBP B-Gene
- : I-Gene
factor NN I-Gene
- : O
induced JJ O
G1 NNP O
arrest NN O
and CC O
transcriptional JJ O
repression NN O
of IN O
the DT O
CLN1 NNP B-Gene
and CC O
CLN2 NNP B-Gene
genes NNS I-Gene
. . O

MVR NNP O
typing NN O
of IN O
rare JJ O
- : O
length NN O
alleles NNS O
indicates VBZ O
that IN O
they PRP O
are VBP O
comprised VBN O
of IN O
disorganized JJ O
sequences NNS O
, , O
although IN O
they PRP O
usually RB O
bear VBP O
a DT O
resemblance NN O
to TO O
one CD O
of IN O
the DT O
common JJ O
alleles NNS O
at IN O
the DT O
5 CD O
' POS O
- : O
most JJS O
end NN O
. . O

In IN O
contrast NN O
, , O
both DT O
C NNP O
- : O
Lys NNP O
and CC O
C NNP O
- : O
Thr NN O
retained VBD O
high JJ O
levels NNS O
of IN O
kinase NN O
activity NN O
and CC O
were VBD O
capable JJ O
of IN O
responding VBG O
to TO O
stimulation NN O
. . O

Objective JJ O
responses NNS O
also RB O
occurred VBD O
in IN O
studies NNS O
that WDT O
explored VBD O
sequential JJ O
use NN O
of IN O
exemestane NN O
after IN O
failure NN O
of IN O
aminoglutethimide NN O
( ( O
26 CD O
% NN O
with IN O
exemestane NN O
200 CD O
mg NN O
/ NNP O
day NN O
) ) O
or CC O
other JJ O
nonsteroidal JJ O
aromatase NN B-Gene
inhibitors NNS O
( ( O
6 CD O
. . O
6 CD O
% NN O
with IN O
exemestane NN O
25 CD O
mg NN O
/ NNP O
day NN O
) ) O
. . O

Cam NNP B-Gene
kinase NNP I-Gene
II NNP I-Gene
induces NNS O
in IN O
vivo JJ O
phosphorylation NN O
of IN O
Smad2 NNP B-Gene
and CC O
Smad4 NNP B-Gene
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
Smad3 NNP B-Gene
. . O

Chimaeric NNP O
VP16 NNP B-Gene
- : O
E2 NN B-Gene
molecules NNS O
suggest VBP O
that IN O
the DT O
epithelial JJ O
specific JJ O
transcriptional JJ O
activation NN O
of IN O
the DT O
BPV NNP B-Gene
- : I-Gene
4 CD I-Gene
LCR NNP I-Gene
promoter NN I-Gene
is VBZ O
mediated VBN O
by IN O
the DT O
E2 NNP B-Gene
transactivation NN I-Gene
domain NN I-Gene
. . O

About IN O
20 CD O
kb NNS O
upstream NN O
of IN O
LAMB2 NNP B-Gene
we PRP O
found VBD O
a DT O
gene NN O
encoding VBG O
a DT O
transcribed NN O
, , O
non SYM O
- : O
processed VBN O
LAMB2 NNP B-Gene
- : I-Gene
like IN I-Gene
pseudogene NN I-Gene
( ( O
LAMB2L NNP B-Gene
) ) O
. . O

Four CD O
putative JJ O
positive JJ O
cDNA NN O
clones NNS O
were VBD O
isolated VBN O
, , O
and CC O
the DT O
largest JJS O
insert NN O
( ( O
pASB JJ B-Gene
- : I-Gene
1 CD I-Gene
) ) O
was VBD O
sequenced VBN O
in IN O
both DT O
orientations NNS O
. . O

The DT O
effects NNS O
of IN O
high JJ O
intensity NN O
light JJ O
emissions NNS O
, , O
produced VBN O
by IN O
a DT O
novel NN O
pulsed JJ O
power NN O
energization NN O
technique NN O
( ( O
PPET NNP O
) ) O
, , O
on IN O
the DT O
survival NN O
of IN O
bacterial JJ O
populations NNS O
of IN O
verocytotoxigenic JJ O
Escherichia NNP O
coli NN O
( ( O
serotype JJ O
157 CD O
: : O
H7 NNP O
) ) O
and CC O
Listeria NNP O
monocytogenes NNS O
( ( O
serotype JJ O
4b CD O
) ) O
were VBD O
investigated VBN O
. . O

The DT O
pWP NN B-Gene
- : I-Gene
19 CD I-Gene
also RB O
encodes VBZ O
the DT O
AAV NNP O
inverted VBD O
terminal JJ O
repeats NNS O
for IN O
integration NN O
and CC O
replication NN O
and CC O
the DT O
herpes NNS O
virus VBP O
thymidine JJ B-Gene
kinase NN I-Gene
promoter NN O
- : O
driven VBN O
gene NN O
for IN O
neomycin JJ O
resistance NN O
( ( O
neoR JJ B-Gene
) ) O
. . O

CONCLUSION NN O
: : O
In IN O
Cdks NNP B-Gene
functioning VBG O
throughout IN O
the DT O
cell NN O
cycle NN O
, , O
tyrosine JJ O
phosphorylation NN O
is VBZ O
inhibitory JJ O
to TO O
the DT O
activation NN O
of IN O
kinase NN O
, , O
whereas IN O
the DT O
phosphorylation NN O
of IN O
threonine NN O
in IN O
the DT O
T NNP O
- : O
loop NN O
is VBZ O
essential JJ O
for IN O
activation NN O
. . O

Myogenic JJ O
differentiation NN O
can MD O
be VB O
inhibited VBN O
by IN O
the DT O
adenovirus NN O
E1a NNP B-Gene
protein NN I-Gene
in IN O
the DT O
rat NN O
L6 NNP O
muscle NN O
cell NN O
line NN O
. . O

Primer NNP O
extension NN O
and CC O
cDNA NN O
cloning NN O
were VBD O
used VBN O
to TO O
isolate VB O
the DT O
complete JJ O
5 CD O
' POS O
end NN O
of IN O
the DT O
Nramp1 NNP B-Gene
mRNA NN I-Gene
. . O

Peripheral JJ O
visual JJ O
stimuli NN O
and CC O
monoaural JJ O
auditory NN O
stimuli NNS O
were VBD O
used VBN O
as IN O
targets NNS O
. . O

When WRB O
the DT O
entire JJ O
diet NN O
consisted VBD O
of IN O
SBF NNP O
, , O
voluntary JJ O
feed NN O
intake NN O
was VBD O
reduced VBN O
, , O
indicating VBG O
that IN O
SBF NNP O
should MD O
not RB O
be VB O
fed VBN O
to TO O
ponies NNS O
as IN O
the DT O
sole JJ O
dietary JJ O
ingredient NN O
. . O

We PRP O
conducted VBD O
a DT O
prospective JJ O
, , O
randomized VBD O
controlled VBN O
trial NN O
of IN O
metoprolol NN O
, , O
a DT O
selective JJ O
beta NN O
- : O
blocker NN O
for IN O
prevention NN O
of IN O
gastrointestinal JJ O
bleeding NN O
from IN O
portal JJ O
hypertension NN O
in IN O
29 CD O
non JJ O
- : O
selected VBN O
patients NNS O
with IN O
liver JJ O
disease NN O
and CC O
previous JJ O
gastrointestinal JJ O
bleeding NN O
. . O

Differences NNS O
in IN O
profiles NNS O
of IN O
viscosity NN O
variables NNS O
between IN O
subgroups NNS O
of IN O
EAD NNP O
in IN O
RA NNP O
patients NNS O
were VBD O
observed VBN O
. . O

Cyclophilins NNS B-Gene
are VBP O
cis JJ B-Gene
- : I-Gene
trans NNS I-Gene
- : I-Gene
peptidyl NN I-Gene
- : I-Gene
prolyl NN I-Gene
isomerases VBZ I-Gene
that IN O
bind NN O
to TO O
and CC O
are VBP O
inhibited VBN O
by IN O
the DT O
immunosuppressant JJ O
cyclosporin NN O
A NNP O
( ( O
CsA NNP O
) ) O
. . O

Three CD O
mog SYM B-Gene
- : I-Gene
1 CD I-Gene
alleles NNS I-Gene
possess JJ O
premature JJ O
stop JJ O
codons NNS O
and CC O
are VBP O
likely JJ O
to TO O
be VB O
null JJ O
alleles NNS O
, , O
and CC O
one CD O
is VBZ O
a DT O
missense JJ O
mutation NN O
and CC O
is VBZ O
likely JJ O
to TO O
retain VB O
residual JJ O
activity NN O
. . O

mog SYM B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
is VBZ O
expressed VBN O
in IN O
both DT O
germ JJ O
line NN O
and CC O
somatic JJ O
tissues NNS O
and CC O
appears VBZ O
to TO O
be VB O
ubiquitous JJ O
. . O

During IN O
surgery NN O
bone NN O
cysts NNS O
were VBD O
excised VBN O
and CC O
filled VBN O
by IN O
bone NN O
grafts NNS O
. . O

The DT O
effects NNS O
produced VBN O
by IN O
oral JJ O
administration NN O
of IN O
500 CD O
mg NNS O
/ JJ O
kg NN O
p SYM O
- : O
xylene NN O
or CC O
toluene NN O
lasted VBN O
at IN O
least JJS O
8 CD O
hr NNS O
, , O
while IN O
the DT O
effect NN O
of IN O
inhaled JJ O
p NN O
- : O
xylene NN O
dissipated VBD O
within IN O
75 CD O
min NN O
of IN O
removal NN O
from IN O
the DT O
exposure NN O
. . O

DESIGN NN O
: : O
Prospective JJ O
cohort NN O
study NN O
with IN O
a DT O
20 CD O
y NN O
follow SYM O
- : O
up RB O
period NN O
, , O
the DT O
First NNP O
National NNP O
Health NNP O
and CC O
Examination NNP O
Survey NNP O
( ( O
NHANES NNP O
1 CD O
) ) O
Epidemiologic NNP O
Follow NNP O
- : O
up RB O
Study NNP O
( ( O
NHEFS NNP O
) ) O
. . O

This DT O
approach NN O
enables VBZ O
the DT O
sources NNS O
of IN O
error NN O
in IN O
the DT O
calculation NN O
of IN O
nutrient JJ O
utilization NN O
to TO O
be VB O
readily RB O
identified VBN O
, , O
and CC O
their PRP$ O
effect NN O
on IN O
precision NN O
to TO O
be VB O
assessed VBN O
in IN O
different JJ O
nutritional JJ O
and CC O
metabolic JJ O
states NNS O
. . O

We PRP O
show VBP O
that IN O
in IN O
contrast NN O
to TO O
SRC1 NNP B-Gene
, , O
direct JJ O
binding NN O
of IN O
CBP NNP B-Gene
to TO O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
is VBZ O
weak JJ O
, , O
suggesting VBG O
that IN O
SRC1 NNP B-Gene
functions NNS O
primarily RB O
as IN O
an DT O
adaptor NN O
to TO O
recruit VB O
CBP NNP B-Gene
and CC O
p300 NN B-Gene
. . O

However RB O
, , O
conversions NNS O
of IN O
12 CD O
mm NN O
or CC O
more JJR O
from IN O
a DT O
documented VBN O
negative JJ O
result NN O
indicated VBD O
spread NN O
of IN O
infection NN O
. . O

The DT O
protein NN O
mixtures NNS O
of IN O
sesame JJ O
flour NN O
and CC O
soybean VB O
flour NN O
were VBD O
well RB O
accepted VBN O
. . O

PPAR NNP B-Gene
gamma NN I-Gene
mRNA NN I-Gene
levels NNS O
were VBD O
reduced VBN O
by IN O
95 CD O
% NN O
with IN O
3 CD O
nM NNS O
TNF NNP B-Gene
alpha VBP I-Gene
treatment NN O
for IN O
24 CD O
h NN O
. . O

Induction NN O
of IN O
Fas NNP B-Gene
ligand NN I-Gene
expression NN O
by IN O
HIV NNP O
involves VBZ O
the DT O
interaction NN O
of IN O
Nef NNP B-Gene
with IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
zeta NN I-Gene
chain NN I-Gene
. . O

Sodium JJ O
restriction NN O
in IN O
cardiac JJ O
failure NN O
. . O

Moreover RB O
, , O
a DT O
high JJ O
proportion NN O
of IN O
blood NN O
samples NNS O
from IN O
a DT O
random JJ O
sample NN O
of IN O
the DT O
rest NN O
of IN O
the DT O
suspects NNS O
tested VBD O
positive JJ O
for IN O
trypanosome JJ O
- : O
specific JJ O
DNA NN O
by IN O
PCR NNP O
( ( O
79 CD O
. . O
9 CD O
% NN O
for IN O
T NNP O
. . O
b NN O
. . O
gambiense NN O
and CC O
13 CD O
. . O
9 CD O
% NN O
for IN O
T NNP O
. . O
b NN O
. . O
rhodesiense NN O
) ) O
. . O

Although IN O
basal NN O
vessels NNS O
may MD O
constrict VB O
distal JJ O
parenchymal JJ O
vessels NNS O
tend VBP O
to TO O
dilate VB O
after IN O
SAH NNP O
. . O

We PRP O
have VBP O
used VBN O
a DT O
site NN O
- : O
directed VBN O
mutagenesis NN O
approach NN O
to TO O
examine VB O
how WRB O
the DT O
Xaa NNP O
and CC O
hydroxy NN O
( ( O
Ser NNP O
/ NNP O
Thr NNP O
) ) O
amino NN O
acid NN O
residues NNS O
in IN O
sequons NNS O
influence NN O
core NN O
- : O
glycosylation NN O
efficiency NN O
. . O

Physical JJ O
principles NNS O
in IN O
therapeutic JJ O
apheresis NN O
. . O

Several JJ O
PTPases NNS B-Gene
were VBD O
expressed VBN O
abundantly RB O
in IN O
the DT O
5 CD O
- : O
FU NNP O
- : O
treated VBD O
bone NN O
marrow NN O
stem NN O
cells NNS O
. . O

Sequence NN O
analysis NN O
indicates VBZ O
that IN O
in IN O
addition NN O
to TO O
an DT O
ATA NNP O
and CC O
GC NNP O
box NN O
, , O
this DT O
region NN O
contains VBZ O
domains NNS O
that WDT O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
other JJ O
muscle NN O
- : O
specific JJ O
genes NNS O
: : O
a DT O
CArG NNP O
box NN O
at IN O
- : O
91 CD O
bp NN O
; : O
myocyte CC B-Gene
- : I-Gene
specific JJ I-Gene
enhancer SYM I-Gene
- : I-Gene
binding VBG I-Gene
nuclear JJ I-Gene
factor NN I-Gene
1 CD I-Gene
binding NN I-Gene
site NN I-Gene
homologies NNS O
at IN O
- : O
58 CD O
, , O
- : O
535 CD O
, , O
and CC O
- : O
583 CD O
bp NN O
; : O
and CC O
a DT O
muscle NN O
- : O
CAAT NNP O
consensus NN O
sequence NN O
at IN O
- : O
394 CD O
bp NN O
relative NN O
to TO O
the DT O
cap NN O
site NN O
. . O

We PRP O
have VBP O
also RB O
tested VBN O
Src NNP B-Gene
SH2 NNP B-Gene
mutants NNS O
for IN O
their PRP$ O
binding NN O
properties NNS O
and CC O
have VBP O
interpreted VBN O
our PRP$ O
results NNS O
in IN O
light NN O
of IN O
the DT O
recent JJ O
crystal NN O
structure NN O
solution NN O
for IN O
the DT O
Src NNP B-Gene
SH2 NNP B-Gene
domain NN O
. . O

Furthermore RB O
, , O
a DT O
pTyr317 NN B-Gene
Shc NNP I-Gene
phosphopeptide NN I-Gene
selectively RB O
recognized VBN O
Grb2 NNP B-Gene
, , O
Sos1 NNP B-Gene
, , O
SHIP NNP B-Gene
, , O
and CC O
the DT O
p85 JJ B-Gene
subunit NN I-Gene
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
' '' I-Gene
kinase NN I-Gene
from IN O
mast NN O
cells NNS O
, , O
as IN O
characterized VBN O
by IN O
mass NN O
spectrometry NN O
. . O

All DT O
clinical JJ O
isolates NNS O
were VBD O
concomitantly RB O
tested VBN O
by IN O
disk NN O
diffusion NN O
and CC O
agar JJ O
dilution NN O
procedures NNS O
as IN O
outlined VBN O
by IN O
the DT O
National NNP O
Committee NNP O
for IN O
Clinical NNP O
Laboratory NNP O
Standards NNP O
. . O

The DT O
hydropathy NN O
plot NN O
revealed VBD O
a DT O
rather RB O
hydrophilic JJ O
N NNP O
- : O
terminal JJ O
region NN O
and CC O
the DT O
absence NN O
of IN O
a DT O
hydrophobic JJ O
signal JJ O
peptide NN O
. . O

But CC O
no DT O
influence NN O
was VBD O
observed VBN O
at IN O
lower JJR O
concentrations NNS O
than IN O
1 CD O
/ JJ O
4 CD O
MIC NNP O
of IN O
AMK NNP O
. . O

Low NNP O
null NNP O
and CC O
A NNP O
may MD O
participate VB O
in IN O
lowering VBG O
the DT O
plasma JJ B-Gene
renin NN I-Gene
activity NN O
which WDT O
in IN O
PA NNP O
in IN O
suppressed VBN O
, , O
sometimes RB O
disproportionately RB O
to TO O
the DT O
actual JJ O
body NN O
sodium NN O
content NN O
. . O

COUP NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
is VBZ O
a DT O
member NN O
of IN O
the DT O
steroid JJ B-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

The DT O
c SYM B-Gene
- : I-Gene
Ets NNP I-Gene
- : I-Gene
1 CD I-Gene
oncoprotein NN I-Gene
is VBZ O
a DT O
transcription NN O
activator NN O
that WDT O
specifically RB O
binds VBZ O
to TO O
DNA NNP O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
novel JJ O
protein NN O
from IN O
Drosophila NNP O
nuclear JJ O
extracts NNS O
which WDT O
binds VBZ O
specifically RB O
to TO O
a DT O
site NN O
in IN O
this DT O
second JJ O
region NN O
. . O

Supraventricular JJ O
arrhythmias SYM O
- : O
- : O
digoxin NN O
and CC O
quinidine NN O
revisited VBN O
. . O

These DT O
residues NNS O
, , O
Ile244 NNP O
at IN O
the DT O
extracellular JJ O
end NN O
of IN O
transmembrane NN O
helix NN O
3 CD O
, , O
and CC O
Tyr318 NNP O
at IN O
the DT O
COOH NNP O
- : O
terminal JJ O
portion NN O
of IN O
extracellular JJ O
loop NN O
2 CD O
, , O
are VBP O
replaced VBN O
by IN O
Leu NNP O
and CC O
Ile NNP O
in IN O
the DT O
PTH NNP B-Gene
- : I-Gene
1 CD I-Gene
receptor NN I-Gene
, , O
respectively RB O
. . O

Elevated VBN O
maternal JJ B-Gene
alpha NN I-Gene
fetoproteins NNS I-Gene
and CC O
oligoamnios NNS O
: : O
fetal JJ O
prognosis NN O

Hyperprolactinaemia NNP O
, , O
moderate JJ O
hypogonadism NN O
, , O
infraclinical JJ O
neuropathies NNS O
, , O
arterial JJ O
stenoses NNS O
and CC O
moderate JJ O
venous JJ O
leakages NNS O
seem VBP O
to TO O
play VB O
a DT O
partial JJ O
role NN O
of IN O
organic JJ O
starter NN O
or CC O
cofactor NN O
, , O
the DT O
sexual JJ O
consequences NNS O
of IN O
which WDT O
are VBP O
amplified VBN O
by IN O
psychological JJ O
factors NNS O
, , O
partly RB O
secondary JJ O
to TO O
the DT O
initial JJ O
sexual JJ O
failures NNS O
. . O

We PRP O
enrolled VBD O
253 CD O
HIV NNP B-Gene
- : I-Gene
antibody NN I-Gene
positive JJ O
heroin NN O
addicts NNS O
without IN O
HIV NNP O
- : O
related JJ O
disease NN O
( ( O
n JJ O
= NNP O
81 CD O
) ) O
or CC O
with IN O
persistent JJ O
generalized VBN O
lymphadenopathy NN O
( ( O
n JJ O
= NNP O
172 CD O
) ) O
in IN O
a DT O
prospective JJ O
study NN O
to TO O
evaluate VB O
clinical JJ O
progression NN O
to TO O
AIDS NNP O
related VBN O
complex NN O
( ( O
ARC NNP O
) ) O
or CC O
AIDS NNP O
and CC O
to TO O
identify VB O
factors NNS O
of IN O
possible JJ O
prognostic JJ O
relevance NN O
. . O

Estradiol NNP O
is VBZ O
known VBN O
to TO O
induce VB O
expression NN O
of IN O
certain JJ O
proto NN O
- : O
oncogenes NNS O
, , O
and CC O
this DT O
led VBD O
us PRP O
to TO O
examine VB O
potential JJ O
regulatory JJ O
regions NNS O
of IN O
the DT O
cellular JJ B-Gene
c SYM I-Gene
- : I-Gene
fos JJ I-Gene
oncogene NN I-Gene
. . O

Although IN O
it PRP O
is VBZ O
well RB O
known VBN O
that IN O
calcium NN O
channel NN O
blockers NNS O
can MD O
influence VB O
contraction NN O
of IN O
vascular JJ O
smooth JJ O
muscle NN O
, , O
there EX O
is VBZ O
less JJR O
knowledge NN O
on IN O
its PRP$ O
effect NN O
on IN O
excitation NN O
contraction NN O
coupling VBG O
in IN O
the DT O
endocrine NN O
glands NNS O
and CC O
more JJR O
specifically RB O
on IN O
insulin NN B-Gene
and CC O
glucagon NN B-Gene
release NN O
. . O

The DT O
Tax NNP B-Gene
/ NNP O
IKKgamma NNP B-Gene
interaction NN O
serves NNS O
to TO O
recruit VB O
Tax NNP B-Gene
to TO O
the DT O
IKK NNP B-Gene
catalytic JJ I-Gene
subunits NNS I-Gene
, , O
IKKalpha NNP B-Gene
and CC O
IKKbeta NNP B-Gene
, , O
and CC O
this DT O
recruitment NN O
appears VBZ O
to TO O
be VB O
an DT O
essential JJ O
mechanism NN O
by IN O
which WDT O
Tax NNP B-Gene
stimulates VBZ O
the DT O
activity NN O
of IN O
IKK NNP B-Gene
. . O

Transcription NNP O
start VBP O
site NN O
mapping NN O
identified VBD O
the DT O
presence NN O
of IN O
an DT O
aphidicolin JJ O
- : O
sensitive JJ O
late JJ O
transcript NN O
arising VBG O
from IN O
a DT O
TAAG NNP O
motif NN O
located VBN O
at IN O
- : O
352 CD O
nucleotides NNS O
and CC O
an DT O
aphidicolin JJ O
- : O
insensitive JJ O
early JJ O
transcript NN O
originating VBG O
from IN O
a DT O
TTGT NNP O
motif NN O
located VBD O
35 CD O
nucleotides NNS O
downstream NN O
to TO O
a DT O
TATA NNP O
box NN O
at IN O
- : O
312 CD O
nucleotides NNS O
, , O
with IN O
respect NN O
to TO O
the DT O
+ NN O
1 CD O
ATG NNP O
of IN O
lef2 NN B-Gene
. . O

With IN O
constructs NNS O
containing VBG O
the DT O
binding VBG O
site NN O
of IN O
one CD O
gene NN O
fused VBD O
to TO O
the DT O
promoter NN O
of IN O
the DT O
other JJ O
, , O
we PRP O
demonstrated VBD O
that IN O
the DT O
positional JJ O
requirements NNS O
are VBP O
a DT O
function NN O
of IN O
the DT O
specific JJ O
binding NN O
site NN O
, , O
not RB O
the DT O
promoter NN O
. . O

To TO O
evaluate VB O
the DT O
hepatic JJ O
regenerative JJ O
response NN O
in IN O
patients NNS O
with IN O
alcoholic JJ O
liver NN O
disease NN O
, , O
sera NN O
from IN O
263 CD O
patients NNS O
with IN O
severe JJ O
alcoholic JJ O
hepatitis NN O
and CC O
/ NN O
or CC O
cirrhosis NN O
were VBD O
analyzed VBN O
for IN O
hepatocyte NN B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
HGF NNP B-Gene
) ) O
and CC O
alpha $ B-Gene
- : I-Gene
fetoprotein NN I-Gene
( ( O
AFP NNP B-Gene
) ) O
. . O

Data NNS O
are VBP O
presented VBN O
hinting VBG O
that IN O
the DT O
15 CD O
beta NN O
- : O
hydroxy NN O
- : O
, , O
metabolite NN O
of IN O
CPA NNP O
may MD O
actually RB O
be VB O
the DT O
biologically RB O
active JJ O
agent NN O
. . O

Transformation NN O
blocks NNS O
differentiation VBP O
- : O
induced JJ O
inhibition NN O
of IN O
serum JJ B-Gene
response NN I-Gene
factor NN I-Gene
interactions NNS O
with IN O
serum JJ O
response NN O
elements NNS O
. . O

This DT O
study NN O
investigated VBD O
whether IN O
boron NN O
would MD O
enhance VB O
the DT O
ability NN O
of IN O
17beta CD O
- : O
estradiol NN O
( ( O
E2 NNP O
) ) O
or CC O
parathyroid VB B-Gene
hormone NN I-Gene
( ( O
PTH NNP B-Gene
) ) O
to TO O
improve VB O
bone NN O
quality NN O
in IN O
ovariectomized JJ O
OVX NNP O
rats NNS O
. . O

The DT O
results NNS O
of IN O
these DT O
studies NNS O
demonstrate VBP O
that IN O
the DT O
rat NN O
HDL NNP O
receptor NN O
SR NNP B-Gene
- : I-Gene
BI NNP I-Gene
promoter NN O
contains VBZ O
two CD O
sterol NN O
response NN O
elements NNS O
( ( O
pSRE NN O
and CC O
dSRE NN O
) ) O
through IN O
which WDT O
SREBP NNP B-Gene
- : I-Gene
1a CD I-Gene
can MD O
bind VB O
and CC O
activate VB O
transcription NN O
of IN O
this DT O
gene NN O
. . O

This DT O
motif NN O
, , O
first RB O
described VBN O
for IN O
the DT O
Drosophila NNP B-Gene
homeobox NN I-Gene
activator NN I-Gene
DEAF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
identifies NNS O
an DT O
emerging VBG O
group NN O
of IN O
metazoan NN O
transcriptional JJ O
modulators NNS O
. . O

Control NN O
of IN O
transcription NN O
of IN O
the DT O
erbB JJ B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
is VBZ O
an DT O
important JJ O
determinant NN O
of IN O
receptor NN O
expression NN O
. . O

Here RB O
, , O
the DT O
PEX5 NNP B-Gene
- : O
TPR NN O
domains NNS O
from IN O
human JJ O
, , O
tobacco NN O
, , O
and CC O
nematode NNS O
were VBD O
inserted VBN O
into IN O
a DT O
TPR NNP O
- : O
less JJR O
yeast JJ O
Pex5p NNP B-Gene
construct NN O
to TO O
generate VB O
Pex5p NNP B-Gene
chimaeras NNS O
. . O

The DT O
sample NN O
is VBZ O
deproteinized VBN O
and CC O
after IN O
centrifugation NN O
valproic NN O
acid NN O
in IN O
the DT O
supernatant NN O
is VBZ O
measured VBN O
in IN O
the DT O
free JJ O
form NN O
by IN O
direct JJ O
injection NN O
into IN O
the DT O
gas NN O
chromatograph NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
MAP NNP B-Gene
kinase NNP I-Gene
activator NN I-Gene
/ NNP O
MAP NNP B-Gene
kinase NN I-Gene
system NN O
may MD O
be VB O
the DT O
downstream JJ O
components NNS O
of IN O
ras JJ B-Gene
signal JJ O
transduction NN O
pathways NNS O
. . O

Evaluating VBG O
dietary JJ O
department NN O
management NN O
. . O

Ume6p NNP B-Gene
, , O
which WDT O
also RB O
controls VBZ O
the DT O
expression NN O
of IN O
early JJ O
meiotic JJ O
genes NNS O
, , O
represses NNS O
CAR1 NNP B-Gene
expression NN O
through IN O
a DT O
sequence NN O
called VBN O
URS NNP O
, , O
as IN O
a DT O
function NN O
of IN O
nitrogen JJ O
availability NN O
. . O

A DT O
phylogenetic JJ O
analysis NN O
of IN O
the DT O
reverse NN B-Gene
transcriptase NN I-Gene
domain NN I-Gene
confirms VBZ O
our PRP$ O
differential JJ O
genetic JJ O
assessment NN O
that WDT O
Cyclops VBZ B-Gene
from IN O
pea NN O
is VBZ O
a DT O
novel JJ O
element NN O
with IN O
no DT O
specific JJ O
relationship NN O
to TO O
the DT O
previously RB O
described VBN O
Gypsy NNP B-Gene
- : I-Gene
like IN I-Gene
elements NNS I-Gene
from IN O
plants NNS O
. . O

J NNP O
. . O

Exchanging VBG O
the DT O
human JJ O
propeptide NN O
in IN O
this DT O
chimera NN O
with IN O
either CC O
the DT O
murine NN B-Gene
MIC NNP I-Gene
- : I-Gene
1 CD I-Gene
or CC O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
propeptide NN I-Gene
resulted VBD O
in IN O
secretion NN O
of IN O
the DT O
unprocessed JJ O
, , O
monomeric JJ O
chimera NN O
, , O
suggesting VBG O
a DT O
specific JJ O
interaction NN O
between IN O
the DT O
human JJ B-Gene
MIC NNP I-Gene
- : I-Gene
1 CD I-Gene
propeptide NN I-Gene
and CC O
mature NN O
peptide NN O
. . O

Four CD O
cases NNS O
of IN O
synovial JJ O
chondromatosis NN O
are VBP O
presented VBN O
. . O

Titration NN O
of IN O
the DT O
human JJ O
and CC O
porcine JJ O
proteins NNS O
with IN O
2 CD O
- : O
nitro NN O
- : O
5 CD O
- : O
thiosulfabenzoate NN O
indicates VBZ O
that IN O
membrane NN B-Gene
dipeptidase NN I-Gene
additionally RB O
possesses VBZ O
two CD O
intrachain NN O
disulfide JJ O
bonds NNS O
. . O

This DT O
study NN O
evaluates VBZ O
the DT O
feasibility NN O
of IN O
indirect JJ O
mesenteric JJ O
lymphangiography NN O
as IN O
a DT O
colonoscopic NN O
technique NN O
in IN O
a DT O
canine NN O
model NN O
. . O

Gel NNP O
- : O
mobility NN O
shift NN O
analysis NN O
was VBD O
also RB O
performed VBN O
for IN O
the DT O
CCAAT NNP O
motif NN O
at IN O
- : O
67 CD O
. . O

The DT O
isolated JJ O
plasmin NN B-Gene
fragments NNS O
of IN O
VEGF NNP B-Gene
were VBD O
compared VBN O
with IN O
respect NN O
to TO O
heparin VB O
binding NN O
, , O
interaction NN O
with IN O
soluble JJ O
VEGF NNP B-Gene
receptors NNS I-Gene
, , O
and CC O
ability NN O
to TO O
promote VB O
endothelial JJ O
cell NN O
mitogenesis NN O
. . O

Structure NNP O
- : O
function NN O
analysis NN O
of IN O
the DT O
Z NNP O
- : O
DNA NN O
- : O
binding NN O
domain NN O
Zalpha NNP O
of IN O
dsRNA JJ B-Gene
adenosine JJ I-Gene
deaminase NN I-Gene
type NN I-Gene
I PRP I-Gene
reveals VBP O
similarity NN O
to TO O
the DT O
( ( B-Gene
alpha JJ I-Gene
+ NNP I-Gene
beta NN I-Gene
) ) I-Gene
family NN I-Gene
of IN O
helix NN B-Gene
- : I-Gene
turn NN I-Gene
- : I-Gene
helix NN I-Gene
proteins NNS I-Gene
. . O

We PRP O
isolated VBD O
several JJ O
overlapping VBG O
A DT O
- : O
phage NN O
and CC O
cosmid NN O
clones NNS O
that WDT O
cover VBP O
more JJR O
than IN O
100 CD O
kb NN O
of IN O
human JJ O
DNA NNP O
and CC O
contained VBD O
the DT O
entire JJ O
VDR NNP B-Gene
gene NN I-Gene
. . O

Upon IN O
UV NNP O
damage NN O
, , O
Crb2 NNP B-Gene
is VBZ O
transiently RB O
modified VBN O
, , O
probably RB O
phosphorylated VBD O
, , O
with IN O
a DT O
similar JJ O
timing NN O
of IN O
phosphorylation NN O
in IN O
Chk1 NNP B-Gene
kinase NN I-Gene
, , O
which WDT O
is VBZ O
reported VBN O
to TO O
restrain VB O
Cdc2 NNP B-Gene
activation NN O
. . O

A DT O
high JJ O
reactor NN O
pH NN O
( ( O
+ JJ O
/ NNP O
- : O
8 CD O
) ) O
, , O
a DT O
short JJ O
solid JJ O
retention NN O
time NN O
( ( O
< JJ O
150 CD O
days NNS O
) ) O
, , O
and CC O
the DT O
presence NN O
of IN O
a DT O
substantial JJ O
SRB NNP O
population NN O
in IN O
the DT O
inoculum NN O
may MD O
considerably RB O
reduce VB O
the DT O
time NN O
required VBN O
for IN O
acetate JJ O
- : O
utilising VBG O
SRB NNP O
to TO O
outcompete VB O
MB NNP O
. . O

The DT O
human JJ O
gene NN O
fragment NN O
ligated VBN O
to TO O
the DT O
minimal JJ O
rat NN O
liver NN O
glucokinase NN B-Gene
promoter NN O
was VBD O
shown VBN O
to TO O
work VB O
as IN O
an DT O
enhancer NN O
in IN O
the DT O
hepatocyte NN O
transfection NN O
system NN O
. . O

In IN O
insulin JJ B-Gene
- : O
responsive JJ O
cells NNS O
, , O
Akt NNP B-Gene
phosphorylates VBZ O
and CC O
inactivates VBZ O
the DT O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
kinase NN I-Gene
glycogen NN B-Gene
synthase NN I-Gene
kinase VBD I-Gene
- : I-Gene
3 CD I-Gene
( ( O
GSK NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
. . O

Copyright JJ O
2000 CD O
Academic NNP O
Press NNP O
. . O

Students NNS O
, , O
parents NNS O
, , O
teachers NNS O
and CC O
hearing NN O
disorders NNS O

Both DT O
inserts NNS O
are VBP O
larger JJR O
than IN O
their PRP$ O
homologues NNS O
in IN O
eIF JJ B-Gene
- : I-Gene
2alpha CD I-Gene
kinases NNS I-Gene
. . O

Both DT O
resting VBG O
blood NN O
flow NN O
( ( O
RBF NNP O
) ) O
and CC O
maximal JJ O
blood NN O
flow NN O
( ( O
NBF NNP O
) ) O
were VBD O
studied VBN O
by IN O
Xenon NNP O
133 CD O
clearance NN O
. . O

Induction NN O
of IN O
correctly RB O
spliced VBN O
germline NN O
transcripts NNS O
is VBZ O
necessary JJ O
to TO O
target VB O
a DT O
switch JJ O
region NN O
for IN O
recombination NN O
and CC O
switching NN O
. . O

Dynamic NNP O
decision NN O
making NN O
: : O
human JJ O
control NN O
of IN O
complex JJ O
systems NNS O
. . O

In IN O
this DT O
respect NN O
C NNP B-Gene
reactive JJ I-Gene
protein NN I-Gene
concentrations NNS O
are VBP O
superior JJ O
to TO O
white JJ O
cell NN O
count NN O
, , O
erythrocyte JJ O
sedimentation NN O
rate NN O
, , O
and CC O
temperature NN O
and CC O
the DT O
concentrations NNS O
of IN O
antiproteases NNS O
. . O

Purified NNP B-Gene
P7 NNP I-Gene
could MD O
be VB O
assembled VBN O
onto IN O
particles NNS O
lacking VBG O
P7 NNP B-Gene
and CC O
particles NNS O
lacking VBG O
both DT O
P2 NNP B-Gene
( ( O
RNA NNP B-Gene
polymerase NN I-Gene
) ) O
and CC O
P7 NNP B-Gene
. . O

A DT O
new JJ O
set NN O
of IN O
cDNA NN O
clones NNS O
spanning VBG O
approximately RB O
3 CD O
. . O
2 CD O
kb NN O
was VBD O
isolated VBN O
from IN O
a DT O
lambda JJ O
- : O
ZAP NNP O
goose VBP O
liver JJ O
cDNA NN O
library NN O
using VBG O
the DT O
5 CD O
' POS O
- : O
most JJS O
exon JJ O
- : O
containing VBG O
fragment NN O
of IN O
the DT O
5 CD O
' POS O
- : O
most JJS O
genomic JJ O
DNA NN O
clone NN O
. . O

An DT O
experiment NN O
was VBD O
carried VBN O
on IN O
133 CD O
grown VBN O
up RB O
fowls JJ O
and CC O
broilers NNS O
from IN O
4 CD O
industrial JJ O
farms NNS O
, , O
vaccinated VBN O
with IN O
spray NN O
lento NN O
and CC O
mesogenic JJ O
vaccines NNS O
for IN O
straining VBG O
the DT O
immunity NN O
against IN O
pseodopest JJS O
through IN O
RIHA NNP O
and CC O
provoking VBG O
pseudoplague NN O
with IN O
a DT O
pathogenic JJ O
virus NN O
. . O

Correlating VBG O
with IN O
the DT O
previous JJ O
observation NN O
that IN O
CBF NNP B-Gene
binding VBG O
to TO O
the DT O
78C1 CD O
site NN O
is VBZ O
enhanced VBN O
by IN O
EGTA NNP O
and CC O
EDTA NNP O
, , O
these DT O
divalent JJ O
cation NN O
chelators NNS O
specifically RB O
stimulate VBP O
78C1 CD O
- : O
directed VBN O
transcription NN O
. . O

Deglycosylation NN O
with IN O
endoglycosidase NN B-Gene
H NNP I-Gene
showed VBD O
that IN O
the DT O
mutant JJ O
receptors NNS O
had VBD O
mainly RB O
high JJ O
- : O
mannose JJ O
oligosaccharide NN O
chains NNS O
. . O

RNase NNP B-Gene
protection NN O
assays NNS O
reveal VBP O
that IN O
this DT O
gene NN O
, , O
unr JJ B-Gene
, , O
is VBZ O
transcribed VBN O
in IN O
the DT O
same JJ O
direction NN O
as IN O
N NNP B-Gene
- : I-Gene
ras NN I-Gene
and CC O
that IN O
its PRP$ O
3 CD O
' POS O
end NN O
is VBZ O
located VBN O
just RB O
130 CD O
base NN O
pairs VB O
away RB O
from IN O
the DT O
point NN O
at IN O
which WDT O
N NNP B-Gene
- : I-Gene
ras NN I-Gene
transcription NN O
begins VBZ O
. . O

Although IN O
popular JJ O
this DT O
hypothesis NN O
is VBZ O
far RB O
from IN O
explaining VBG O
all PDT O
the DT O
clinical JJ O
facts NNS O
, , O
namely RB O
that DT O
rigidity NN O
is VBZ O
equal JJ O
in IN O
extensor NN O
and CC O
flexor NN O
, , O
proximal JJ O
and CC O
distal JJ O
muscles NNS O
. . O

Five CD O
of IN O
the DT O
patients NNS O
with IN O
increased JJ O
L NNP O
- : O
L NNP O
size NN O
had VBD O
a DT O
normal JJ O
A NNP O
- : O
P NN O
diameter NN O
. . O

Immunohistochemical JJ O
analysis NN O
of IN O
several JJ O
rat NNS O
organs NNS O
also RB O
showed VBD O
staining VBG O
in IN O
epithelial JJ O
cells NNS O
. . O

Morphine NNP O
- : O
dependent NN O
and CC O
control NN O
rats NNS O
in IN O
an DT O
oral JJ O
free JJ O
- : O
choice NN O
protocol NN O
were VBD O
treated VBN O
with IN O
gamma JJ O
- : O
vinyl NN O
GABA NNP O
( ( O
GVG NNP O
) ) O
, , O
60 CD O
, , O
120 CD O
and CC O
240 CD O
mg NN O
/ NNP O
kg NN O
IP NNP O
, , O
for IN O
3 CD O
days NNS O
over IN O
three CD O
successive JJ O
periods NNS O
. . O

Patients NNS O
with IN O
types NNS O
I PRP O
and CC O
III NNP O
MPGN NNP O
did VBD O
not RB O
differ VB O
in IN O
age NN O
at IN O
apparent JJ O
onset NN O
, , O
age NN O
at IN O
diagnosis NN O
, , O
or CC O
interval NN O
from IN O
apparent JJ O
onset NN O
of IN O
symptoms NNS O
to TO O
diagnosis VB O
( ( O
biopsy NN O
) ) O
. . O

Twenty CD O
- : O
five CD O
patients NNS O
( ( O
80 CD O
, , O
6 CD O
% NN O
) ) O
with IN O
mixed JJ O
neoplasms NNS O
were VBD O
operated VBN O
on IN O
by IN O
total JJ O
conservative JJ O
parotidectomy NN O
( ( O
T NNP O
. . O
C NNP O
. . O
P NNP O
. . O
) ) O
, , O
3 CD O
( ( O
9 CD O
, , O
7 CD O
% NN O
) ) O
by IN O
S NNP O
. . O
P NNP O
. . O
and CC O
3 CD O
( ( O
9 CD O
, , O
7 CD O
% NN O
) ) O
by IN O
En NNP O
. . O

The DT O
importance NN O
of IN O
selective JJ O
renal JJ O
vein NN O
phlebography NN O
in IN O
the DT O
evaluation NN O
of IN O
unexplained JJ O
hematuria NNS O
and CC O
filing VBG O
defects NNS O
in IN O
the DT O
excretory NN O
urogram NN O
is VBZ O
illustrated VBN O
. . O

FN NNP B-Gene
- : O
stimulated VBD O
c SYM B-Gene
- : I-Gene
Src JJ I-Gene
PTK NNP B-Gene
activity NN O
was VBD O
enhanced VBN O
by IN O
wild JJ O
type NN O
FAK NNP B-Gene
expression NN O
, , O
whereas WP O
FN NNP B-Gene
- : O
stimulated VBD O
activation NN O
of IN O
ERK2 NNP B-Gene
was VBD O
blocked VBN O
by IN O
expression NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
Src NN I-Gene
binding VBG I-Gene
site NN I-Gene
Phe NNP I-Gene
- : I-Gene
397 CD I-Gene
mutant NN I-Gene
of IN O
FAK NNP B-Gene
. . O

The DT O
therapy NN O
with IN O
a DT O
H2 NNP B-Gene
- : I-Gene
receptor NN I-Gene
antagonist NN O
is VBZ O
less RBR O
effective JJ O
than IN O
the DT O
triple JJ O
therapies NNS O
with IN O
omeprazole NN O
or CC O
lansoprazole NN O
. . O

These DT O
findings NNS O
indicate VBP O
the DT O
involvement NN O
of IN O
Sp1 NNP B-Gene
and CC O
an DT O
Inr NNP O
in IN O
non JJ O
- : O
cell NN O
- : O
specific JJ O
regulation NN O
and CC O
a DT O
Kruppel NNP B-Gene
- : I-Gene
like IN I-Gene
transcription NN I-Gene
factor NN I-Gene
and CC O
Sp1 NNP B-Gene
in IN O
the DT O
cell NN O
- : O
specific JJ O
regulation NN O
of IN O
the DT O
LTC NNP B-Gene
( ( I-Gene
4 CD I-Gene
) ) I-Gene
S NNP I-Gene
gene NN I-Gene
. . O

Beta NNP O
blocking VBG O
agents NNS O
. . O

The DT O
patient NN O
was VBD O
a DT O
78 CD O
- : O
year NN O
- : O
old JJ O
male NN O
in IN O
whom WP O
skin JJ O
lesions NNS O
preceded VBD O
the DT O
diagnosis NN O
of IN O
myelofibrosis NN O
. . O

The DT O
changes NNS O
after IN O
treatment NN O
were VBD O
observed VBN O
chiefly NN O
by IN O
electromyography NN O
while IN O
sensory JJ O
and CC O
motor NN O
improvement NN O
were VBD O
also RB O
recorded VBN O
as IN O
auxiliary JJ O
indicators NNS O
. . O

Is VBZ O
radical JJ O
trachelectomy NN O
a DT O
safe JJ O
alternative NN O
to TO O
radical JJ O
hysterectomy NN O
for IN O
patients NNS O
with IN O
stage NN O
IA NNP O
- : O
B NNP O
carcinoma NN O
of IN O
the DT O
cervix NN O
? . O

BACKGROUND NN O
: : O
The DT O
prognosis NN O
associated VBN O
with IN O
lymph JJ O
node JJ O
negative JJ O
, , O
early JJ O
stage NN O
carcinoma NN O
of IN O
the DT O
cervix NN O
is VBZ O
excellent JJ O
, , O
with IN O
5 CD O
- : O
year NN O
survival NN O
rates NNS O
greater JJR O
than IN O
90 CD O
% NN O
. . O

To TO O
study VB O
the DT O
sensitivity NN O
of IN O
some DT O
central JJ O
brain NN O
structures NNS O
to TO O
the DT O
action NN O
of IN O
an DT O
electromagnetic JJ O
field NN O
of IN O
decimeter NN O
waves NNS O
( ( O
EMF NNP O
of IN O
DW NNP O
) ) O
a DT O
dynamic JJ O
investigation NN O
of IN O
single JJ O
unit NN O
activity NN O
was VBD O
undertaken VBN O
. . O

Cell NNP O
adhesion NN O
and CC O
migration NN O
assays NNS O
demonstrate VBP O
that IN O
alpha VBZ B-Gene
6 CD I-Gene
beta NN I-Gene
1 CD I-Gene
is VBZ O
the DT O
major JJ O
laminin NN B-Gene
receptor NN I-Gene
in IN O
undifferentiated JJ O
F9 NNP O
cells NNS O
as RB O
well RB O
as IN O
F9 NNP O
- : O
derived VBD O
PE NNP O
cells NNS O
. . O

Using VBG O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
, , O
we PRP O
mapped VBD O
the DT O
chromosome NN O
- : O
17 CD O
breakpoint NN O
in IN O
a DT O
patient NN O
with IN O
acampomelic JJ O
CMPD NNP O
and CC O
sex NN O
reversal NN O
, , O
who WP O
carries VBZ O
a DT O
de FW O
novo FW O
constitutional JJ O
t NN O
( ( O
12 CD O
; : O
17 CD O
) ) O
translocation NN O
, , O
between IN O
two CD O
known VBN O
cosmid NN O
markers NNS O
in IN O
the DT O
17q24 CD O
- : O
q25 JJ O
region NN O
. . O

The DT O
median JJ O
levels NNS O
of IN O
particles NNS O
with IN O
50 CD O
% NN O
cut NN O
- : O
off IN O
aerodynamic JJ O
diameters NNS O
of IN O
10 CD O
( ( O
PM10 NNP O
) ) O
and CC O
2 CD O
. . O
5 CD O
microm NN O
( ( O
PM2 NNP O
. . O
5 CD O
) ) O
were VBD O
170 CD O
( ( O
range NN O
103 CD O
- : O
613 CD O
) ) O
and CC O
95 CD O
( ( O
range NN O
61 CD O
- : O
218 CD O
) ) O
micro NN O
x NNP O
m NNP O
- : O
3 CD O
, , O
respectively RB O
. . O

The DT O
more RBR O
traditional JJ O
SERMS NNP O
, , O
clomiphene NN O
citrate NN O
and CC O
tamoxifen NN O
, , O
will MD O
be VB O
reviewed VBN O
along IN O
with IN O
such JJ O
modern JJ O
drugs NNS O
as IN O
raloxifene NN O
and CC O
faslodex NN O
, , O
with IN O
emphasis NN O
upon IN O
their PRP$ O
actions NNS O
on IN O
breast NN O
, , O
uterus NN O
, , O
bone NN O
and CC O
lipids NNS O
. . O

Biliary NNP O
- : O
enteric JJ O
fistulas NNS O

The DT O
effect NN O
of IN O
feeding VBG O
patterns NNS O
on IN O
fat JJ O
deposition NN O
in IN O
mice NN O
. . O

Drug NN O
use NN O
in IN O
trauma NN O
victims NNS O
. . O

In IN O
vivo NN O
, , O
CARbeta NNP B-Gene
/ NNP O
RXRalpha NNP B-Gene
activated VBD O
transcription NN O
from IN O
an DT O
HD NNP B-Gene
- : O
PPRE NNP O
luciferase NN B-Gene
reporter NN I-Gene
construct NN I-Gene
. . O

We PRP O
have VBP O
found VBN O
that IN O
mcs4 SYM B-Gene
- : O
cells NNS O
are VBP O
defective JJ O
at IN O
activation NN O
of IN O
Spc1 NNP B-Gene
in IN O
response NN O
to TO O
various JJ O
forms NNS O
of IN O
stress NN O
. . O

Basic JJ B-Gene
fibroblast NN I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
bFGF NN B-Gene
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
induce VB O
angiogenesis NN O
in IN O
various JJ O
animal JJ O
models NNS O
, , O
but CC O
the DT O
methods NNS O
of IN O
administration NN O
used VBN O
experimentally RB O
are VBP O
not RB O
clinically RB O
feasible JJ O
. . O

The DT O
number NN O
of IN O
crystalline NN O
deposits NNS O
is VBZ O
less RBR O
in IN O
the DT O
advanced JJ O
atrophic JJ O
areas NNS O
of IN O
the DT O
RPE NNP O
- : O
choriocapillaris NN O
complex NN O
. . O

Resting VBG O
VE NNP O
in IN O
the DT O
luteal JJ O
phase NN O
was VBD O
7 CD O
. . O
8 CD O
% NN O
greater JJR O
than IN O
that DT O
in IN O
the DT O
follicular JJ O
phase NN O
. . O

Chronic JJ O
administration NN O
of IN O
sodium JJ O
cyanate NN O
decreases NNS O
O2 NNP O
extraction NN O
ratio NN O
in IN O
dogs NNS O
. . O

Subsequently RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
reexpression NN O
of IN O
the DT O
r NN B-Gene
- : I-Gene
PTPeta NNP I-Gene
gene NN I-Gene
in IN O
highly RB O
malignant JJ O
rat NN O
thyroid NN O
cells NNS O
transformed VBN O
by IN O
retroviruses NNS O
carrying VBG O
the DT O
v NN B-Gene
- : I-Gene
mos NN I-Gene
and CC O
v NN B-Gene
- : I-Gene
ras NN I-Gene
- : I-Gene
Ki NNP I-Gene
oncogenes NNS I-Gene
suppresses VBZ O
their PRP$ O
malignant JJ O
phenotype NN O
. . O

The DT O
efficacy NN O
of IN O
these DT O
immunosuppressive JJ O
drugs NNS O
is VBZ O
clinical JJ O
proven NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
assess VB O
the DT O
reproducibility NN O
of IN O
a DT O
number NN O
of IN O
simplified JJ O
clearance NN O
methods NNS O
using VBG O
chromium NN O
- : O
51 CD O
ethylenediamine JJ O
tetraacetic JJ O
acid NN O
( ( O
51Cr CD O
- : O
EDTA NN O
) ) O
and CC O
to TO O
compare VB O
these DT O
with IN O
the DT O
multiple JJ O
blood NN O
sample NN O
technique NN O
. . O

The DT O
relatively RB O
scanty JJ O
number NN O
of IN O
examples NNS O
, , O
which WDT O
could MD O
be VB O
justified VBN O
by IN O
the DT O
variety NN O
and CC O
complexity NN O
of IN O
combined JJ O
exposure NN O
, , O
allows VBZ O
to TO O
conclude VB O
that DT O
life NN O
- : O
style NN O
factors NNS O
have VBP O
considerable JJ O
influence NN O
on IN O
interindividual JJ O
differences NNS O
in IN O
susceptibility NN O
to TO O
xenobiotics NNS O
toxicity NN O
. . O

Studies NNS O
on IN O
the DT O
intracutaneous JJ O
infection NN O
of IN O
rabbits NNS O
by IN O
Staphylococcus NNP O
aureus NN O
. . O

Despite IN O
abundant JJ O
expression NN O
of IN O
NtmybAS NNP B-Gene
transcripts NNS I-Gene
in IN O
mature NN O
pollen NN O
, , O
gPAL1 NN B-Gene
transcripts NNS I-Gene
were VBD O
not RB O
detectable JJ O
in IN O
pollen NN O
. . O

Brain NNP O
scan JJ O
with IN O
99mTc CD O
- : O
labelled VBN O
macroaggregated VBN B-Gene
albumin NN I-Gene
( ( O
MAA NNP B-Gene
brain NN O
scan NN O
) ) O
and CC O
computed VBN O
tomography NN O
studies NNS O
( ( O
CT NNP O
) ) O
were VBD O
performed VBN O
on IN O
78 CD O
patients NNS O
with IN O
intracranial JJ O
diseases NNS O
. . O

These DT O
protective JJ O
influences NNS O
were VBD O
observed VBN O
throughout IN O
the DT O
range NN O
of IN O
filling VBG O
pressures NNS O
measured VBN O
, , O
from IN O
0 CD O
to TO O
30 CD O
mmHg NNS O
. . O

To TO O
account VB O
for IN O
this DT O
observation NN O
, , O
other JJ O
possible JJ O
causes NNS O
include VBP O
increased VBN O
CSF NNP O
pulsation NN O
in IN O
children NNS O
creating VBG O
motion NN O
artifact NN O
, , O
changes NNS O
in IN O
arterial JJ O
oxygen NN O
concentration NN O
intrinsic JJ O
to TO O
propofol VB O
or CC O
related VBN O
to TO O
the DT O
supplemental JJ O
oxygen NN O
normally RB O
administered VBN O
, , O
or CC O
changes NNS O
in IN O
CSF NNP O
protein NN O
levels NNS O
related VBN O
to TO O
propofol VB O
binding VBG O
to TO O
proteins NNS O
for IN O
uptake JJ O
into IN O
CSF NNP O
. . O

ISS NNP O
and CC O
the DT O
acute JJ O
physiology NN O
and CC O
chronic JJ O
health NN O
evaluation NN O
( ( O
APACHE NNP O
II NNP O
) ) O
calculated VBD O
on IN O
admission NN O
. . O

CONCLUSION NN O
: : O
The DT O
probability NN O
of IN O
cardiopulmonary JJ O
complications NNS O
increases VBZ O
significantly RB O
when WRB O
patients NNS O
develop VBP O
class NN O
1 CD O
HELLP NNP O
syndrome NN O
. . O

The DT O
combination NN O
PIP NNP O
64 CD O
micrograms NNS O
- : O
PEF NNP O
4 CD O
micrograms NN O
prevents VBZ O
the DT O
frequent JJ O
secondary JJ O
regrowth NN O
seen VBN O
after IN O
6 CD O
hours NNS O
with IN O
the DT O
antibiotics NNS O
used VBD O
alone RB O
. . O

The DT O
virus NN O
encodes VBZ O
a DT O
40 CD O
- : O
kDa NN O
protein NN O
, , O
tax NN B-Gene
, , O
that WDT O
is VBZ O
important JJ O
for IN O
the DT O
immortalization NN O
of IN O
T NNP O
cells NNS O
. . O

We PRP O
have VBP O
obtained VBN O
the DT O
human JJ B-Gene
EP4 NNP I-Gene
receptor NN I-Gene
gene NN I-Gene
sequence NN I-Gene
and CC O
determined VBD O
its PRP$ O
structure NN O
relative NN O
to TO O
EP4R NNP B-Gene
cDNA NN I-Gene
synthesized VBN O
from IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

Both DT O
reduced VBD O
spontaneous JJ O
locomotor NN O
activity NN O
in IN O
mice NN O
, , O
protected VBD O
them PRP O
from IN O
death NN O
from IN O
amphetamine NN O
induced VBN O
toxicity NN O
, , O
prolonged VBD O
hexobarbitone NN O
sleeping NN O
time NN O
and CC O
caused VBD O
a DT O
depletion NN O
of IN O
catecholamines NNS O
from IN O
various JJ O
organs NNS O
of IN O
the DT O
rat NN O
. . O

Ectopic NNP O
ACTH NNP B-Gene
syndrome NN O
and CC O
medullary JJ O
thyroid NN O
carcinoma NN O
. . O

Information NN O
on IN O
conserved JJ O
noncoding JJ O
sequences NNS O
will MD O
help VB O
in IN O
studies NNS O
on IN O
the DT O
regulation NN O
of IN O
the DT O
pro JJ B-Gene
alpha NN I-Gene
1 CD I-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
collagen NN I-Gene
gene NN I-Gene
. . O

Follow NNP O
- : O
up RB O
controls NNS O
of IN O
luteinizing VBG B-Gene
hormone NN I-Gene
( ( O
LH NNP B-Gene
) ) O
, , O
follicle NN B-Gene
stimulating VBG I-Gene
hormone NN I-Gene
( ( O
FSH NNP B-Gene
) ) O
, , O
prolactin FW B-Gene
( ( O
HPRL NNP B-Gene
) ) O
, , O
oestradiol FW O
( ( O
E2 NNP O
) ) O
, , O
progesterone NN O
( ( O
P NNP O
) ) O
and CC O
testosterone NN O
( ( O
T NNP O
) ) O
in IN O
the DT O
catabolic NN O
and CC O
healing VBG O
phase NN O
of IN O
burn NN O
disease NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
a DT O
transfected JJ O
Chinese JJ O
hamster NN O
ovary JJ O
( ( O
CHO NNP O
) ) O
cell VBP O
line NN O
expressing VBG O
a DT O
murine NN B-Gene
CD4 NNP I-Gene
fragment NN I-Gene
containing VBG O
the DT O
first JJ O
two CD O
N NNP O
- : O
terminal NN O
domains NNS O
secretes VBZ O
both DT O
monomeric JJ O
molecules NNS O
and CC O
disulfide VB O
- : O
linked VBN O
multimers NNS O
. . O

Dissociative JJ O
anesthetics NNS O
2 CD O
- : O
( ( O
o JJ O
- : O
chlorophenyl NN O
) ) O
- : O
2 CD O
- : O
methyl NN O
- : O
amino NN O
cyclohexane NN O
HCL NNP O
( ( O
CI NNP O
- : O
581 CD O
) ) O

In IN O
addition NN O
, , O
this DT O
kinase NN O
is VBZ O
well RB O
conserved VBN O
evolutionarily RB O
, , O
ubiquitously RB O
expressed VBN O
, , O
and CC O
its PRP$ O
genes NNS O
map VBP O
to TO O
a DT O
position NN O
on IN O
human JJ O
chromosome NN O
1 CD O
frequently RB O
deleted VBN O
in IN O
the DT O
late JJ O
stages NNS O
of IN O
tumorigenesis NN O
. . O

Selective JJ O
effect NN O
of IN O
pulmonary JJ O
oedema NN O
on IN O
prostaglandin NN O
E2 NNP O
pharmacokinetics NNS O
in IN O
rat NN O
lung NN O
. . O

The DT O
Man9 NNP B-Gene
- : I-Gene
mannosidase NN I-Gene
specificity NN O
of IN O
the DT O
cDNA NN O
construct NN O
was VBD O
verified VBN O
by IN O
the DT O
observation NN O
that IN O
all DT O
peptide JJ O
sequences NNS O
derived VBN O
from IN O
a DT O
previously RB O
purified VBN O
, , O
catalytically RB O
active JJ O
49 CD O
- : O
kDa NN O
fragment NN O
were VBD O
found VBN O
within IN O
the DT O
coding VBG O
region NN O
. . O

A DT O
comparison NN O
of IN O
the DT O
clinical JJ O
profile NN O
of IN O
cavernous JJ O
malformations NNS O
with IN O
and CC O
without IN O
associated VBN O
venous JJ O
malformations NNS O
. . O

The DT O
amino NN O
acid JJ O
sequences NNS O
of IN O
the DT O
known VBN O
largest JJS O
subunits NNS O
of IN O
DdRPs NNP B-Gene
from IN O
different JJ O
species NNS O
contain VBP O
highly RB O
conserved VBN O
regions NNS O
. . O

When WRB O
tested VBN O
with IN O
wild JJ O
- : O
type NN O
( ( O
DBA NNP O
/ NNP O
2 CD O
) ) O
p16 NN B-Gene
, , O
both DT O
A134C NNP O
and CC O
G232A NNP O
BALB NNP O
/ NNP O
c SYM O
- : O
specific JJ O
variants NNS O
of IN O
p16 NN B-Gene
were VBD O
inefficient JJ O
in IN O
their PRP$ O
ability NN O
to TO O
inhibit VB O
the DT O
activity NN O
of IN O
cyclin NN B-Gene
D2 NNP I-Gene
/ NNP O
CDK4 NNP B-Gene
in IN O
kinase NNP O
assays NNS O
with IN O
retinoblastoma NN B-Gene
protein NN I-Gene
, , O
suggesting VBG O
this DT O
defective JJ O
, , O
inherited JJ O
allele NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
genetic JJ O
susceptibility NN O
of IN O
BALB NNP O
/ NNP O
c NN O
mice NN O
for IN O
plasmacytoma JJ O
induction NN O
and CC O
that IN O
p16 NN B-Gene
( ( O
INK4a NNP B-Gene
) ) O
is VBZ O
a DT O
strong JJ O
candidate NN O
for IN O
the DT O
Pctr1 NNP B-Gene
locus NN I-Gene
. . O

The DT O
combination NN O
of IN O
hydralazine JJ O
hydrochloride NN O
and CC O
isosorbide NN O
dinitrate NN O
also RB O
improves VBZ O
survival JJ O
, , O
but CC O
direct JJ O
comparison NN O
of IN O
both DT O
regimens NNS O
provided VBD O
evidence NN O
for IN O
a DT O
less RBR O
favourable JJ O
effect NN O
than IN O
that DT O
of IN O
the DT O
ACE NNP B-Gene
inhibitors NNS O
. . O

No DT O
' '' O
TATA NNP O
' POS O
motif NN O
was VBD O
identified VBN O
near IN O
either CC O
the DT O
GABPalpha NNP B-Gene
or CC O
ATPsynCF6 NNP B-Gene
transcription JJ O
start NN O
sites NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
direct JJ O
cDNA NN O
mapping VBG O
using VBG O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
provides VBZ O
an DT O
accurate NN O
and CC O
rapid JJ O
approach NN O
to TO O
the DT O
definition NN O
of IN O
a DT O
transcribed JJ O
map NN O
of IN O
the DT O
human JJ O
genome NN O
. . O

Use NNP O
of IN O
serum NN O
thyroglobulin NN B-Gene
determination NN O
in IN O
the DT O
follow NN O
- : O
up IN O
of IN O
differentiated JJ O
carcinomas NN O
of IN O
the DT O
thyroid NN O

The DT O
data NN O
imply NN O
that WDT O
JAK NNP B-Gene
/ NNP O
STAT NNP B-Gene
signaling NN O
has VBZ O
a DT O
role NN O
in IN O
EBV NNP O
- : O
associated JJ O
malignancies NNS O
. . O

The DT O
high JJ O
degree NN O
of IN O
sequence NN O
identity NN O
( ( O
96 CD O
% NN O
) ) O
between IN O
hydrolase NN B-Gene
B NNP I-Gene
and CC I-Gene
C NNP I-Gene
, , O
particularly RB O
in IN O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
, , O
suggests VBZ O
that IN O
the DT O
genes NNS O
encoding VBG O
these DT O
two CD O
carboxylesterases NNS B-Gene
evolved VBN O
by IN O
duplication NN O
and CC O
divergence NN O
of IN O
a DT O
common JJ O
ancestral JJ O
gene NN O
. . O

Thin NNP O
- : O
layer NN O
chromatographic JJ O
methods NNS O
were VBD O
up RB O
- : O
dated VBN O
for IN O
pharmacokinetic JJ O
studies NNS O
of IN O
imipramine NN O
in IN O
plasma NN O
and CC O
urine NN O
. . O

Identification NN O
of IN O
a DT O
proline NN O
- : O
rich JJ O
sequence NN O
in IN O
the DT O
CD2 NNP B-Gene
cytoplasmic JJ I-Gene
domain NN I-Gene
critical JJ O
for IN O
regulation NN O
of IN O
integrin JJ B-Gene
- : O
mediated VBN O
adhesion NN O
and CC O
activation NN O
of IN O
phosphoinositide NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

65 CD O
- : O
kilodalton NN O
protein NN O
phosphorylated VBN O
by IN O
interleukin JJ B-Gene
2 CD I-Gene
stimulation NN O
bears NNS O
two CD O
putative JJ O
actin NNS B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
and CC O
two CD O
calcium NN O
- : O
binding NN O
sites NNS O
. . O

A DT O
study NN O
of IN O
the DT O
E NNP O
. . O
O NNP O
. . O
R NNP O
. . O
T NNP O
. . O
C NNP O
. . O

Finally RB O
, , O
over IN O
a DT O
similar JJ O
range NN O
of IN O
QO2 NNP O
, , O
oxygen NN O
extraction NN O
was VBD O
greater JJR O
in IN O
patients NNS O
with IN O
ARDS NNP O
compared VBN O
to TO O
patients NNS O
with IN O
non JJ O
- : O
ARDS NNP O
respiratory NN O
failure NN O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
67 CD O
and CC O
slope VB O
= NNP O
- : O
0 CD O
. . O
62 CD O
vs JJ O
r NN O
= NNP O
- : O
0 CD O
. . O
45 CD O
and CC O
slope VB O
= NNP O
- : O
0 CD O
. . O
35 CD O
; : O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Because IN O
of IN O
a DT O
rapid JJ O
development NN O
of IN O
the DT O
connective JJ O
tissue NN O
scars NNS O
, , O
however RB O
, , O
at IN O
the DT O
place NN O
of IN O
the DT O
destroyed JJ O
glandular NN O
parenchyma NN O
areas NNS O
, , O
there EX O
is VBZ O
no DT O
normalization NN O
of IN O
the DT O
organ NN O
' POS O
s NN O
structure NN O
and CC O
function NN O
by IN O
the DT O
42d CD O
day NN O
. . O

Alena NNP O
is VBZ O
a DT O
nurse NN O
in IN O
Prague NNP O
- : O
- : O
she PRP O
dreams VBZ O
of IN O
higher JJR O
wages NNS O
and CC O
a DT O
trip NN O
across IN O
the DT O
ocean NN O

Hyperthyroidism NN O
is VBZ O
one CD O
of IN O
the DT O
numerous JJ O
causes NNS O
of IN O
infertility NN O
and CC O
recurrent JJ O
abortion NN O
. . O

Estrogen NNP O
treatment NN O
in IN O
high JJ O
doses NNS O
is VBZ O
effective JJ O
in IN O
reducing VBG O
adult NN O
stature NN O
in IN O
constitutionally RB O
tall JJ O
girls NNS O
. . O

A DT O
similar JJ O
phenomenon NN O
has VBZ O
been VBN O
reported VBN O
in IN O
a DT O
few JJ O
humans NNS O
. . O

We PRP O
discuss VBP O
these DT O
results NNS O
with IN O
respect NN O
to TO O
the DT O
transcriptional JJ O
induction NN O
of IN O
the DT O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
alpha JJ I-Gene
gene NN I-Gene
in IN O
respiratory JJ O
epithelium NN O
during IN O
embryogenesis NN O
. . O

Moreover RB O
, , O
glucan JJ B-Gene
synthase NN I-Gene
activity NN O
, , O
which WDT O
is VBZ O
activated VBN O
by IN O
Rho1p NNP B-Gene
, , O
was VBD O
significantly RB O
reduced VBN O
in IN O
the DT O
deltabem4 NN B-Gene
mutant NN I-Gene
. . O

Homology NNP O
was VBD O
also RB O
detected VBN O
between IN O
the DT O
putative JJ O
transit NN O
peptide JJ O
sequence NN O
of IN O
cysteine JJ B-Gene
synthase NN I-Gene
C NNP I-Gene
and CC O
other JJ O
mitochondrion NN O
- : O
targeting VBG O
leader NN O
sequences NNS O
. . O

In IN O
vitro JJ O
translation NN O
of IN O
the DT O
mTRF1 NN B-Gene
cDNA NN I-Gene
resulted VBD O
in IN O
a DT O
56 CD O
kDa NN O
protein NN O
that WDT O
binds VBZ O
to TO O
TTAGGG NNP O
repeat NN O
arrays NNS O
. . O

mTRF1 NN B-Gene
displayed VBD O
the DT O
same JJ O
sequence NN O
specificity NN O
as IN O
hTRF1 NN B-Gene
, , O
preferring VBG O
arrays NNS O
of IN O
TTAGGG NNP O
repeats NNS O
as IN O
a DT O
binding NN O
substrate NN O
over IN O
TTAGGC NNP O
and CC O
TTGGGG NNP O
repeats NNS O
. . O

CTF1alpha NNP B-Gene
, , O
expressed VBD O
in IN O
Escherichia NNP O
coli NN O
, , O
showed VBD O
specific JJ O
binding VBG O
to TO O
the DT O
palindrome NN O
2 CD O
DNA NNP O
fragment NN O
but CC O
not RB O
to TO O
palindrome VB O
1 CD O
or CC O
mutant JJ O
palindrome JJ O
2 CD O
DNA NN O
fragments NNS O
, , O
suggesting VBG O
specific JJ O
binding NN O
of IN O
CTF1alpha NNP B-Gene
to TO O
palindrome VB O
2 CD O
. . O

STUDY NNP O
DESIGN NNP O
: : O
Fine NNP O
needle JJ O
aspiration NN O
cytologic NN O
smears NNS O
from IN O
21 CD O
cases NNS O
of IN O
invasive JJ O
lobular JJ O
carcinoma NN O
( ( O
ILC NNP O
) ) O
of IN O
breast NN O
were VBD O
subjected VBN O
to TO O
detailed VB O
cytomorphologic JJ O
analysis NN O
. . O

A DT O
highly RB O
hydrophobic JJ O
sequence NN O
located VBN O
near IN O
the DT O
carboxyl NN O
- : O
terminal JJ O
extremity NN O
of IN O
the DT O
molecule NN O
most RBS O
likely JJ O
constitutes VBZ O
the DT O
anchor NN O
to TO O
the DT O
plasma NN O
membrane NN O
. . O

In IN O
order NN O
to TO O
overcome VB O
the DT O
false JJ O
positive JJ O
readings NNS O
that WDT O
are VBP O
possible JJ O
in IN O
sphincter NN O
manometry NN O
, , O
we PRP O
proposed VBD O
to TO O
use VB O
secretin NN B-Gene
stimulated VBN O
endoscopic NN O
ultrasound NN O
( ( O
SSEUS NNP O
) ) O
to TO O
measure VB O
pancreatic JJ O
ductal JJ O
response NN O
as IN O
an DT O
adjunctive JJ O
method NN O
to TO O
aid NN O
and CC O
supplement VBD O
the DT O
diagnosis NN O
. . O

RESULTS NN O
: : O
The DT O
medians NNS O
of IN O
average JJ O
daily JJ O
CD34 NNP B-Gene
+ NNP I-Gene
cell NN O
yields NNS O
for IN O
patients NNS O
who WP O
received VBD O
paclitaxel JJ O
plus CC O
CY NNP O
, , O
CE NNP O
, , O
and CC O
CEP NNP O
with IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
were VBD O
12 CD O
. . O
9 CD O
, , O
11 CD O
. . O
3 CD O
, , O
and CC O
5 CD O
. . O
37 CD O
x JJ O
10 CD O
( ( O
6 CD O
) ) O
/ NN O
kg NN O
, , O
respectively RB O
, , O
compared VBN O
with IN O
2 CD O
. . O
2 CD O
x JJ O
10 CD O
( ( O
6 CD O
) ) O
/ NN O
kg NN O
in IN O
the DT O
reference NN O
group NN O
that WDT O
received VBD O
CY NNP O
with IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
( ( O
P NNP O
= NNP O
< NNP O
. . O
1 CD O
, , O
. . O
2 CD O
, , O
and CC O
. . O
9 CD O
, , O
respectively RB O
) ) O
. . O

The DT O
already RB O
elevated VBN O
prolactin NN B-Gene
levels NNS O
in IN O
nursing VBG O
women NNS O
were VBD O
not RB O
influenced VBN O
by IN O
chronic JJ O
oestradiol JJ O
administration NN O
. . O

Changing VBG O
and CC O
predicting VBG O
doses NNS O
of IN O
Cs137 NNP O
irradiation NN O

The DT O
induction NN O
by IN O
pseudorabies NNS O
virus NN O
of IN O
an DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
construct NN I-Gene
containing VBG O
the DT O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
TATA NNP I-Gene
box NN I-Gene
and CC O
the DT O
RNA NNP O
start NN O
site NN O
( ( O
"""" JJ O
initiator NN O
"""" NN O
or CC O
Inr NNP O
element NN O
) ) O
but CC O
not RB O
the DT O
MRE NNP O
region NN O
was VBD O
also RB O
repressed VBN O
by IN O
Dex NNP O
in IN O
the DT O
presence NN O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
GR NNP I-Gene
. . O

Account NNP O
was VBD O
taken VBN O
of IN O
noncellular JJ O
and CC O
nonhuman JJ O
elements NNS O
in IN O
the DT O
smears NNS O
; : O
they PRP O
included VBD O
mucus NN O
, , O
Charcot NNP O
- : O
Layden JJ O
crystals NNS O
, , O
pollen NN O
grains NNS O
, , O
vegetal JJ O
fragments NNS O
and CC O
fungi NNS O
. . O

The DT O
rat NN B-Gene
aldolase NN I-Gene
C NNP I-Gene
gene NN I-Gene
encodes VBZ O
a DT O
glycolytic JJ O
enzyme NN O
strongly RB O
expressed VBN O
in IN O
adult NN O
brain NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
four CD O
distinct JJ O
E2F NNP B-Gene
complexes NNS I-Gene
present NN O
in IN O
aged VBN O
and CC O
senescent JJ O
normal JJ O
, , O
human JJ O
diploid NN O
fibroblasts NNS O
. . O

Thus RB O
, , O
this DT O
reading NN O
frame NN O
was VBD O
concluded VBN O
to TO O
encode VB O
the DT O
precursor NN O
of IN O
mitochondrial JJ B-Gene
fumarase NN I-Gene
. . O

These DT O
contain VBP O
a DT O
single JJ O
1977 CD O
- : O
bp NN O
exon VBZ O
that IN O
encodes VBZ O
900 CD O
bp NN O
of IN O
the DT O
5 CD O
' POS O
and CC O
3 CD O
' '' O
untranslated JJ O
sequences NNS O
in IN O
addition NN O
to TO O
a DT O
1077 CD O
- : O
bp NN O
open JJ O
reading NN O
frame NN O
identical JJ O
to TO O
that DT O
found VBN O
in IN O
vascular JJ B-Gene
smooth JJ I-Gene
muscle NN I-Gene
cell NN I-Gene
AT1a NNP I-Gene
receptor NN I-Gene
cDNAs NN I-Gene
. . O

In IN O
this DT O
way NN O
it PRP O
is VBZ O
possible JJ O
to TO O
simulate VB O
the DT O
growth NN O
function NN O
of IN O
the DT O
embryofetal JJ O
curve NN O
of IN O
the DT O
length NN O
' POS O
increase NN O
of IN O
man NN O
and CC O
the DT O
curve NN O
of IN O
the DT O
mass NN O
' POS O
increase NN O
of IN O
rat NN O
. . O

In IN O
serum JJ O
- : O
stimulated JJ O
cells NNS O
, , O
the DT O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
/ VBZ O
CBF NNP B-Gene
to TO O
TKC1 NNP B-Gene
increased VBD O
gradually RB O
, , O
reaching VBG O
a DT O
plateau NN O
at IN O
the DT O
S NNP O
phase NN O
. . O

The DT O
respiratory NN O
rate NN O
was VBD O
13 CD O
+ JJ O
/ NNP O
- : O
1 CD O
breaths NNS O
/ JJ O
min NN O
with IN O
52 CD O
+ NNS O
/ SYM O
- : O
4 CD O
% NN O
of IN O
the DT O
respiratory JJ O
cycle NN O
spent VBN O
in IN O
inspiration NN O
; : O
end CC O
- : O
tidal JJ O
CO2 NNP O
pressure NN O
increased VBN O
by IN O
3 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
0 CD O
Torr NNP O
during IN O
runs NNS O
at IN O
SIP NNP O
. . O

Alveolar JJ O
growth NN O
, , O
contemporary JJ O
with IN O
dental JJ O
eruption NN O
, , O
is VBZ O
sufficient JJ O
to TO O
compensate VB O
possible JJ O
hypotrophy NN O
of IN O
maxillary JJ O
bone NN O
bases NNS O
. . O

Beg2 NNP B-Gene
and CC O
Beg1 NNP B-Gene
are VBP O
regulated VBN O
differently RB O
which WDT O
may MD O
indicate VB O
variation NN O
in IN O
storage NN O
or CC O
utilization NN O
properties NNS O
among IN O
the DT O
barley NN B-Gene
globulins NNS I-Gene
. . O

Until IN O
now RB O
, , O
each DT O
of IN O
these DT O
loci NN O
was VBD O
considered VBN O
to TO O
contain VB O
three CD O
genes NNS O
( ( O
for IN O
regulator NN B-Gene
, , O
permease NN B-Gene
and CC O
alpha JJ B-Gene
- : I-Gene
glucosidase NN I-Gene
) ) O
, , O
but CC O
a DT O
fourth JJ O
gene NN O
, , O
presumably RB O
an DT O
extra JJ O
alpha NN B-Gene
- : I-Gene
glucosidase NN I-Gene
gene NN I-Gene
, , O
was VBD O
found VBN O
at IN O
MAL1 NNP B-Gene
adjacent NN O
to TO O
the DT O
usual JJ O
cluster NN O
of IN O
three CD O
genes NNS O
. . O

RESULTS NN O
: : O
Statistically RB O
significant JJ O
differences NNS O
were VBD O
obtained VBN O
between IN O
group NN O
I PRP O
and CC O
II NNP O
concerning VBG O
the DT O
number NN O
of IN O
patients NNS O
in IN O
whom WP O
induced JJ O
atrial JJ O
fibrillation NN O
with IN O
conduction NN O
by IN O
the DT O
accessory JJ O
pathway NN O
and CC O
RR NNP O
< NNP O
or CC O
= $ O
250 CD O
msec NN O
was VBD O
found VBN O
( ( O
0 CD O
vs NN O
6 CD O
, , O
p NN O
= VBD O
0 CD O
. . O
45 CD O
) ) O
. . O

These DT O
findings NNS O
were VBD O
reinforced VBN O
by IN O
an DT O
analysis NN O
that WDT O
was VBD O
restricted VBN O
to TO O
living VBG O
donor JJ O
transplants NNS O
without IN O
acute JJ O
rejection NN O
. . O

Transcriptional JJ O
regulation NN O
of IN O
the DT O
vacuolar JJ B-Gene
H NNP I-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
- : I-Gene
ATPase NNP I-Gene
B2 NNP I-Gene
subunit NN I-Gene
gene NN I-Gene
in IN O
differentiating VBG O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Alternative JJ O
splicing NN O
of IN O
RNA NNP O
transcripts NNS O
encoded VBN O
by IN O
the DT O
murine NN O
p105 NN B-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
gene NN O
generates NNS O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
gamma NN I-Gene
isoforms NNS I-Gene
with IN O
different JJ O
inhibitory NN O
activities NNS O
. . O

Mutagenesis NN O
of IN O
SNT1 NNP B-Gene
( ( O
IRS NNP B-Gene
) ) O
CX NNP B-Gene
identified VBD O
three CD O
classes NNS O
of IN O
effector NN O
motifs NNS O
within IN O
SNT NNP B-Gene
critical JJ O
for IN O
both DT O
sustained VBN O
ERK NNP B-Gene
activation NN O
and CC O
neuronal JJ O
differentiation NN O
: : O
1 CD O
) ) O
four CD O
phosphotyrosine NN O
motifs NNS O
that WDT O
mediate VBP O
recruitment NN O
of IN O
Grb2 NNP B-Gene
, , O
2 CD O
) ) O
two CD O
phosphotyrosine NN O
motifs NNS O
that WDT O
mediate VBP O
recruitment NN O
of IN O
Shp2 NNP B-Gene
, , O
and CC O
3 CD O
) ) O
a DT O
C NNP O
- : O
terminal JJ O
motif NN O
that IN O
functions NNS O
by IN O
helping VBG O
to TO O
recruit VB O
Sos NNP B-Gene
. . O

Glucocorticoid NNP O
induced VBD O
hypertension NN O
has VBZ O
been VBN O
regarded VBN O
as IN O
independent JJ O
of IN O
sodium NN O
( ( O
Na NNP O
) ) O
, , O
in IN O
contrast NN O
to TO O
mineralocorticoid VB O
induced JJ O
hypertension NN O
, , O
which WDT O
is VBZ O
Na NNP O
+ NNP O
- : O
dependent NN O
. . O

In IN O
26 CD O
patients NNS O
with IN O
angina JJ O
pectoris NN O
, , O
the DT O
changes NNS O
of IN O
LVEF NNP O
, , O
LVESV NNP O
and CC O
PSP NNP O
/ NNP O
LVESV NNP O
were VBD O
more RBR O
sensitive JJ O
for IN O
the DT O
detection NN O
of IN O
exercise NN O
- : O
induced VBD O
ischemia NN O
than IN O
the DT O
appearance NN O
of IN O
chest NN O
pain NN O
and CC O
the DT O
changes NNS O
of IN O
ECG NNP O
. . O

Cloning NN O
of IN O
a DT O
human JJ B-Gene
phosphoinositide NN I-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
with IN O
a DT O
C2 NNP B-Gene
domain NN O
that WDT O
displays VBZ O
reduced VBN O
sensitivity NN O
to TO O
the DT O
inhibitor NN O
wortmannin NN O
. . O

Anoxia NNP O
was VBD O
introduced VBN O
by IN O
perfusing VBG O
the DT O
gill NN O
with IN O
water NN O
deprived VBN O
of IN O
oxygen NN O
or CC O
by IN O
halting VBG O
the DT O
water NN O
flow NN O
to TO O
the DT O
gill NN O
. . O

Using VBG O
an DT O
interspecific JJ O
backcross NN O
panel NN O
, , O
we PRP O
localized VBD O
both DT O
Gng3 NNP B-Gene
and CC O
Gng3lg NNP B-Gene
to TO O
the DT O
same JJ O
locus NN O
on IN O
chromosome NN O
19 CD O
. . O

Widening NN O
of IN O
the DT O
abdominal JJ O
aortic JJ O
wall NN O
on IN O
an DT O
ultrasound JJ O
examination NN O
was VBD O
the DT O
key NN O
to TO O
the DT O
incidental JJ O
diagnosis NN O
of IN O
a DT O
clinically RB O
unsuspected JJ O
type NN O
B NNP O
dissection NN O
. . O

Additional JJ O
deletion NN O
mutations NNS O
revealed VBD O
a DT O
new JJ O
, , O
67 CD O
- : O
amino NN O
- : O
acid JJ O
functional JJ O
domain NN O
within IN O
the DT O
proline NN O
- : O
rich JJ O
region NN O
of IN O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
, , O
which WDT O
we PRP O
have VBP O
termed VBN O
the DT O
P NNP O
- : O
1 CD O
domain NN O
. . O

As IN O
an DT O
alternative JJ O
approach NN O
to TO O
this DT O
question NN O
, , O
we PRP O
have VBP O
studied VBN O
the DT O
effects NNS O
of IN O
ectopically RB O
expressed VBN O
SHIP NNP B-Gene
, , O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
or CC O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
SH2 NNP O
- : O
containing VBG O
decoy JJ O
proteins NNS O
on IN O
Fc NNP B-Gene
gamma NN I-Gene
RIIB1 NNP I-Gene
signaling NN O
. . O

Reperfusion NN O
caused VBD O
a DT O
transient JJ O
reduction NN O
in IN O
lactate JJ O
production NN O
and CC O
a DT O
significant JJ O
increase NN O
in IN O
LDH NNP B-Gene
release NN O
. . O

The DT O
authors NNS O
proposed VBD O
that IN O
the DT O
highly RB O
convergent JJ O
inputs NNS O
to TO O
the DT O
entorhinal JJ O
cortex NN O
indicate VBP O
this DT O
region NN O
may MD O
be VB O
particularly RB O
important JJ O
for IN O
selecting VBG O
or CC O
compressing VBG O
information NN O
. . O

Transcriptional JJ O
repression NN O
mediated VBN O
by IN O
LysR NNP B-Gene
- : I-Gene
type NN I-Gene
regulator NN I-Gene
CatR NNP I-Gene
bound NN O
at IN O
multiple JJ O
binding VBG O
sites NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
beta SYM B-Gene
- : I-Gene
1 CD I-Gene
may MD O
act VB O
as IN O
a DT O
tissue NN O
- : O
specific NN O
, , O
trans VBZ O
- : O
acting VBG O
regulator NN O
of IN O
the DT O
expression NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
zein NN I-Gene
gene NN I-Gene
in IN O
developing VBG O
maize JJ O
endosperm NN O
. . O

The DT O
splice NN O
acceptor NN O
site NN O
is VBZ O
ca MD O
. . O

HRES NNP O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
clinically RB O
useful JJ O
in IN O
assessing VBG O
histologic JJ O
damage NN O
following VBG O
pneumatic JJ O
dilatation NN O
and CC O
in IN O
localizing VBG O
the DT O
LES NNP O
during IN O
the DT O
administration NN O
of IN O
intrasphincter JJ O
botulinum NN B-Gene
toxin NN I-Gene
injection NN O
in IN O
the DT O
treatment NN O
of IN O
achalasia NN O
. . O

( ( O
anti SYM B-Gene
- : I-Gene
IIa NN I-Gene
) ) O
and CC O
Holmer NNP O
et VBP O
al NN O
. . O

Regulation NN O
of IN O
avian JJ B-Gene
fibroblast NN I-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
1 CD I-Gene
( ( O
FGFR NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
gene NN O
expression NN O
during IN O
skeletal JJ O
muscle NN O
differentiation NN O
. . O

Similarly RB O
approximately RB O
300 CD O
bp NN O
of IN O
sequence NN O
downstream NN O
of IN O
the DT O
translation NN O
terminator NN O
TGA NNP O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
tubulin NN I-Gene
2 CD I-Gene
( ( O
BTU2 NNP B-Gene
) ) O
gene NN O
could MD O
substitute VB O
for IN O
the DT O
3 CD O
' POS O
region NN O
of IN O
the DT O
H4 NNP B-Gene
- : I-Gene
I PRP I-Gene
gene NN I-Gene
. . O

Results NNS O
were VBD O
supported VBN O
by IN O
the DT O
agar NN O
diffusion NN O
method NN O
for IN O
Y NNP O
. . O
enterocolitica NN O
, , O
whereas JJ O
inhibition NN O
activity NN O
was VBD O
not RB O
found VBN O
for IN O
A NNP O
. . O
hydrophila NN O
. . O

Two CD O
related JJ O
studies NNS O
conducted VBN O
over IN O
a DT O
five CD O
week NN O
period NN O
measured VBD O
and CC O
typed VBD O
HLA NNP B-Gene
- : I-Gene
DQA1 NN I-Gene
from IN O
accumulated VBN O
DNA NN O
on IN O
autopsy NN O
room NN O
and CC O
Forensic NNP O
DNA NNP O
Laboratory NNP O
structures NNS O
. . O

After IN O
nitric JJ O
oxide JJ O
inhalation NN O
, , O
the DT O
results NNS O
showed VBD O
moderate JJ O
increases NNS O
in IN O
PaO2 NNP O
and CC O
SaO2 NNP O
( ( O
P NNP O
> VBZ O
0 CD O
. . O
5 CD O
) ) O
and CC O
a DT O
significant JJ O
decrease NN O
in IN O
Qs NNP O
/ NNP O
Q NNP O
tau NN O
ratio NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

This DT O
element NN O
was VBD O
used VBN O
to TO O
screen VB O
an DT O
EMBL3 NNP O
mouse NN O
genomic JJ O
library NN O
. . O

The DT O
DAP5 NNP B-Gene
/ NNP O
p86 VBZ B-Gene
apoptotic JJ O
form NN O
was VBD O
more RBR O
potent JJ O
than IN O
DAP5 NNP B-Gene
/ NNP O
p97 NN B-Gene
in IN O
these DT O
functional JJ O
assays NNS O
. . O

In IN O
contrast NN O
to TO O
the DT O
signaling NN O
triggered VBN O
by IN O
surface NN O
Ig NNP B-Gene
engagement NN O
in IN O
B NNP O
lymphocytes NNS O
, , O
CD38 NNP B-Gene
ligation NN O
did VBD O
not RB O
appear VB O
to TO O
induce VB O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
src JJ B-Gene
- : I-Gene
like IN I-Gene
protein NN I-Gene
tyrosine NN I-Gene
kinases VBZ I-Gene
lyn RB B-Gene
, , O
fyn NN B-Gene
, , O
and CC O
btk NN B-Gene
, , O
or CC O
of IN O
vav JJ B-Gene
- : I-Gene
and CC I-Gene
ras VB I-Gene
- : I-Gene
GTPase NNP I-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
, , O
nor CC O
did VBD O
it PRP O
induce VB O
detectable JJ O
changes NNS O
in IN O
cytosolic JJ O
CA2 NNP O
+ NNP O
concentrations NNS O
. . O

Since IN O
the DT O
morphology NN O
of IN O
the DT O
lesions NNS O
can MD O
mimic VB O
that DT O
of IN O
other JJ O
cutaneous JJ O
disorders NNS O
, , O
Bowen NNP O
' POS O
s JJ O
disease NN O
is VBZ O
often RB O
not RB O
recognized VBN O
initially RB O
. . O

However RB O
the DT O
sequence NN O
surrounding VBG O
the DT O
transcription NN O
start NN O
site NN O
CTCA NNP O
( ( O
+ NNP O
1 CD O
) ) O
TTCC NNP O
was VBD O
similar JJ O
to TO O
the DT O
consensus NN O
CTCA NNP O
( ( O
+ NNP O
1 CD O
) ) O
NTCT NNP O
( ( O
N NNP O
is VBZ O
any DT O
nucleoside RB O
) ) O
for IN O
an DT O
initiator NN O
element NN O
found VBN O
in IN O
terminal JJ B-Gene
deoxynucleotidyltransferase NN I-Gene
and CC O
a DT O
number NN O
of IN O
other JJ O
highly RB O
regulated VBN O
genes NNS O
. . O

Three CD O
monopolar JJ O
electrodes NNS O
were VBD O
inserted VBN O
into IN O
the DT O
left NN O
and CC O
right JJ O
lateral JJ O
vestibulospinal JJ O
tract NN O
( ( O
LVST NNP O
) ) O
and CC O
medial JJ O
vestibulospinal JJ O
tract NN O
( ( O
MVST NNP O
) ) O
of IN O
the DT O
C1 NNP O
segment NN O
, , O
to TO O
determine VB O
the DT O
pathway NN O
of IN O
axons NNS O
. . O

Effect NN O
of IN O
phenformin NN O
on IN O
gluconeogenesis NN O
in IN O
perfused JJ O
rat NN O
liver NN O
. . O

Studies NNS O
on IN O
Coxsackie NNP O
B NNP O
Type NNP O
5 CD O
virus NN O
infections NNS O
. . O

An DT O
alternative JJ O
method NN O
of IN O
UKM NNP O
is VBZ O
proposed VBN O
based VBN O
on IN O
collecting VBG O
a DT O
small JJ O
fraction NN O
of IN O
spent JJ O
dialysate NN O
flow NN O
for IN O
3 CD O
consecutive JJ O
dialyses NNS O
. . O

The DT O
patient NN O
initially RB O
attained VBD O
complete JJ O
remission NN O
( ( O
CR1 NNP O
) ) O
with IN O
conventional JJ O
chemotherapy NN O
and CC O
then RB O
relapsed VBD O
14 CD O
months NNS O
later RB O
. . O

Transfection NN O
of IN O
increasing VBG O
amounts NNS O
of IN O
delta5ERalpha NN B-Gene
expression NN O
vector NN O
into IN O
[ JJ O
ERalpha NNP B-Gene
+ NNP O
] NNP O
OS NNP O
cells NNS O
resulted VBD O
in IN O
potentiation NN O
of IN O
E2 NNP O
- : O
stimulated VBD O
ERELuc NNP B-Gene
activity NN O
in IN O
a DT O
synergistic JJ O
, , O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

1 CD O
. . O

Fentanyl NNP O
, , O
a DT O
prototypic NN O
mu SYM B-Gene
- : I-Gene
opiate NN I-Gene
receptor NN I-Gene
agonist NN O
, , O
has VBZ O
been VBN O
previously RB O
shown VBN O
to TO O
produce VB O
a DT O
syndrome JJ O
characterized VBN O
by IN O
marked JJ O
analgesia NN O
and CC O
locomotor NN O
stimulation NN O
as RB O
well RB O
as IN O
tachycardia NN O
, , O
tachypnoea NN O
and CC O
behavioural JJ O
arousal NN O
. . O

Cell NNP O
49 CD O
, , O
753 CD O
- : O
761 CD O
] NN O
. . O

An DT O
egg NN O
protein NN O
, , O
lysozyme NN B-Gene
, , O
is VBZ O
a DT O
still RB O
unlabeled JJ O
additive JJ O
currently RB O
used VBN O
in IN O
cheese JJ O
preparation NN O
. . O

Instead RB O
, , O
TRPS1 NNP B-Gene
potently RB O
and CC O
specifically RB O
represses VBZ O
transcriptional JJ O
activation NN O
mediated VBN O
by IN O
other JJ O
GATA NNP B-Gene
factors NNS I-Gene
. . O

Transient JJ O
expression NN O
of IN O
human JJ B-Gene
and CC I-Gene
chicken VB I-Gene
progesterone NN I-Gene
receptors NNS I-Gene
does VBZ O
not RB O
support VB O
alternative JJ O
translational JJ O
initiation NN O
from IN O
a DT O
single JJ O
mRNA NN O
as IN O
the DT O
mechanism NN O
generating VBG O
two CD O
receptor NN O
isoforms NNS O
. . O

The DT O
corresponding JJ O
gene NN O
was VBD O
identified VBN O
in IN O
the DT O
GenBankTM NNP O
data NNS O
base NN O
by IN O
sequence NN O
alignment NN O
and CC O
termed VBD O
RPS30A NNP B-Gene
. . O

The DT O
percutaneous JJ O
absorption NN O
of IN O
clindamycin NN O
was VBD O
studied VBN O
in IN O
healthy JJ O
male NN O
volunteers NNS O
, , O
comparing VBG O
two CD O
investigative JJ O
clindamycin NNS O
( ( O
% NN O
w NN O
/ NNP O
v NN O
) ) O
/ NN O
tretinoin NN O
( ( O
0 CD O
. . O
25 CD O
% NN O
w NN O
/ NNP O
v NN O
) ) O
gels NNS O
, , O
containing VBG O
clindamycin NN O
phosphate NN O
ester NN O
and CC O
clindamycin NN O
HCl NNP O
, , O
respectively RB O
, , O
relative JJ O
to TO O
a DT O
clindamycin NN O
phosphate NN O
lotion NN O
( ( O
1 CD O
% NN O
clindamycin NN O
; : O
Dalacin NNP O
T NNP O
) ) O
. . O

Further RB O
, , O
mutational JJ O
analysis NN O
of IN O
NS5A NNP B-Gene
assigned VBD O
the DT O
SH3 NNP B-Gene
- : I-Gene
binding VBG I-Gene
region NN I-Gene
to TO O
a DT O
proline NN O
- : O
rich JJ O
motif NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
among IN O
HCV NNP O
genotypes NNS O
. . O

Most JJS O
of IN O
the DT O
patients NNS O
presented VBN O
with IN O
Transient NNP O
Ischemic NNP O
Attacks NNP O
( ( O
64 CD O
% NN O
) ) O
or CC O
Reversible JJ O
Ischemic NNP O
Neurologic NNP O
Deficits NNP O
( ( O
19 CD O
% NN O
) ) O
. . O

A DT O
one CD O
- : O
week NN O
ulcer JJ O
therapy NN O
with IN O
atropine NN O
and CC O
Vikalin NNP O
( ( O
Roter NNP O
) ) O
led VBD O
to TO O
a DT O
significant JJ O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
reduction NN O
of IN O
the DT O
nocturnal JJ O
proteolytic JJ O
activity NN O
. . O

Characterization NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
MTF NNP I-Gene
- : I-Gene
1 CD I-Gene
from IN O
the DT O
Japanese JJ O
pufferfish NN O
( ( O
Fugu NNP O
rubripes VBZ O
) ) O
reveals NNS O
evolutionary JJ O
conservation NN O
of IN O
heavy JJ O
metal NN O
stress NN O
response NN O
. . O

Gene NNP O
expression NN O
occurs VBZ O
in IN O
a DT O
circadian JJ O
rhythm NN O
and CC O
induced VBN O
by IN O
light NN O
in IN O
leaves NNS O
of IN O
dark JJ O
- : O
adapted JJ O
plants NNS O
. . O

The DT O
temporal JJ O
component NN O
lacked VBD O
a DT O
mandibular JJ O
fossa NN O
as RB O
well RB O
as IN O
articular JJ O
eminence NN O
. . O

Surprisingly RB O
, , O
a DT O
C NNP O
to TO O
G NNP O
transversion NN O
at IN O
the DT O
first JJ O
residue NN O
of IN O
the DT O
CAT NNP B-Gene
pentanucleotide NN I-Gene
, , O
which WDT O
severely RB O
impairs VBZ O
the DT O
activity NN O
of IN O
both DT O
promoters NNS O
, , O
appears VBZ O
to TO O
increase VB O
affinity NN O
of IN O
the DT O
CAT NNP B-Gene
binding NN I-Gene
protein NN I-Gene
. . O

Immunofixation NN O
experiments NNS O
of IN O
C4A NNP B-Gene
and CC O
C4B NNP B-Gene
demonstrate VBP O
> $ O
41 CD O
allotypes NNS O
in IN O
the DT O
two CD O
classes NNS O
of IN O
proteins NNS O
. . O

Ultraviolet NNP O
light VBD O
- : O
induced JJ O
kinin NN B-Gene
formation NN O
in IN O
human JJ O
skin NN O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
of IN O
binding VBG O
sites NNS O
for IN O
the DT O
repressor NN B-Gene
proteins VBZ I-Gene
BP1 NNP I-Gene
and CC O
BP2 NNP B-Gene
in IN O
the DT O
upstream JJ O
portion NN O
of IN O
the DT O
beta NN B-Gene
globin NN I-Gene
gene NN I-Gene
flanking VBG I-Gene
region NN I-Gene
led VBD O
to TO O
a DT O
4 CD O
- : O
6 CD O
fold JJ O
increase NN O
in IN O
promoter NN O
activity NN O
. . O

To TO O
further RBR O
define VB O
the DT O
structural JJ O
requirements NNS O
for IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
interaction NN O
with IN O
the DT O
TCR NNP B-Gene
, , O
we PRP O
developed VBD O
a DT O
binding NN O
assay NN O
using VBG O
immobilized JJ O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
fusion NN I-Gene
proteins VBZ I-Gene
containing VBG O
the DT O
NH2 NNP O
- : O
and CC O
/ VB O
or CC O
COOH NNP B-Gene
- : I-Gene
terminal JJ I-Gene
SH2 NNP I-Gene
domains NNS I-Gene
of IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
, , O
and CC O
soluble JJ O
synthetic JJ O
peptides NNS O
with IN O
the DT O
sequence NN O
of IN O
the DT O
cytoplasmic JJ O
region NN O
of IN O
the DT O
TCR NNP B-Gene
zeta NN I-Gene
chain NN I-Gene
( ( O
TCR NNP B-Gene
zeta NNP I-Gene
cyt NN I-Gene
) ) O
or CC O
individual JJ O
TCR NNP B-Gene
zeta NN I-Gene
and CC O
CD3 NNP B-Gene
epsilon VBP I-Gene
TAM NNP I-Gene
motifs NNS I-Gene
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
while IN O
many JJ O
muscle NN O
gene NN O
E NNP O
- : O
boxes NNS O
are VBP O
capable JJ O
of IN O
binding VBG O
the DT O
previously RB O
characterized VBN O
spectrum NN O
of IN O
MDF NNP B-Gene
/ NNP I-Gene
bH SYM I-Gene
- : I-Gene
L NNP I-Gene
- : I-Gene
H NN I-Gene
heterodimers NNS I-Gene
in IN O
vitro NN O
, , O
MCK NNP B-Gene
- : I-Gene
L NNP I-Gene
type NN O
E NNP O
- : O
boxes NNS O
probably RB O
bind VBP O
qualitatively RB O
different JJ O
factors NNS O
in IN O
vivo NN O
. . O

The DT O
incidence NN O
of IN O
fetal JJ O
breathing NN O
movements NNS O
( ( O
6 CD O
. . O
0 CD O
- : O
10 CD O
. . O
0 CD O
h NN O
) ) O
decreased VBD O
with IN O
increasing VBG O
gestational JJ O
age NN O
while IN O
fetal JJ O
arterial JJ O
concentrations NNS O
of IN O
plasma JJ O
PGE NNP O
increased VBD O
significantly RB O
over IN O
the DT O
same JJ O
period NN O
of IN O
gestation NN O
. . O

NIK NNP O
- : O
244 CD O
suppressed VBD O
coronary JJ O
ligation NN O
- : O
and CC O
digitalis VB O
- : O
induced JJ O
arrhythmias NN O
, , O
and CC O
the DT O
minimum JJ O
effective JJ O
plasma NN O
concentrations NNS O
for IN O
arrhythmias NN O
induced VBN O
by IN O
24 CD O
- : O
h NN O
and CC O
48 CD O
- : O
h NN O
coronary JJ O
ligation NN O
and CC O
digitalis NN O
were VBD O
0 CD O
. . O
41 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
10 CD O
( ( O
by IN O
1 CD O
mg NNS O
/ JJ O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
, , O
0 CD O
. . O
70 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
13 CD O
( ( O
by IN O
1 CD O
mg NNS O
/ JJ O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
, , O
and CC O
0 CD O
. . O
21 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
( ( O
by IN O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
i NN O
. . O
v NN O
. . O
) ) O
microgram NN O
/ NNP O
ml NN O
, , O
respectively RB O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
of IN O
the DT O
mean NN O
, , O
n RB O
= VBZ O
6 CD O
) ) O
. . O

The DT O
present JJ O
study NN O
examined VBD O
the DT O
effect NN O
of IN O
intensity NN O
, , O
rate NN O
, , O
and CC O
polarity NN O
on IN O
the DT O
spectral JJ O
content NN O
of IN O
ABRs NNP O
of IN O
15 CD O
normal JJ O
- : O
hearing NN O
subjects NNS O
. . O

Large JJ O
scale JJ O
electronic JJ O
structure NN O
calculations NNS O
. . O

Inhibition NN O
of IN O
phosphatidylinositol NN B-Gene
- : I-Gene
3 CD I-Gene
kinase NN I-Gene
did VBD O
not RB O
have VB O
a DT O
significant JJ O
effect NN O
on IN O
p53 NN B-Gene
conformation NN O
but CC O
did VBD O
have VB O
a DT O
weak JJ O
but CC O
significant JJ O
effect NN O
on IN O
Tpo NNP B-Gene
- : O
enhanced VBD O
viability NN O
. . O

Improving VBG O
fissure NN O
sealant JJ O
quality NN O
: : O
mechanical JJ O
preparation NN O
and CC O
filling VBG O
level NN O
. . O

Transcription NN O
from IN O
the DT O
promoter NN O
containing VBG O
the DT O
mutated VBN O
direct JJ O
repeats NN O
was VBD O
increased VBN O
greatly RB O
, , O
consistent JJ O
with IN O
the DT O
conclusion NN O
that IN O
these DT O
motifs NNS O
functions NNS O
in IN O
vivo NN O
to TO O
repress VB O
GPT NNP B-Gene
gene NN I-Gene
expression NN O
. . O

Therefore RB O
, , O
magnetic JJ O
resonance NN O
imaging NN O
was VBD O
used VBN O
to TO O
determine VB O
liver NN O
volume NN O
in IN O
pediatric JJ O
and CC O
adolescent JJ O
patients NNS O
, , O
in IN O
whom WP O
systemic JJ O
clearance NN O
of IN O
three CD O
model NN O
substrates VBZ O
[ JJ O
lorazepam NN O
( ( O
0 CD O
. . O
3 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
, , O
antipyrine NN O
( ( O
10 CD O
mg NN O
/ NNP O
kg NN O
) ) O
, , O
and CC O
indocyanine NN O
green NN O
( ( O
ICG NNP O
; : O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
] NN O
was VBD O
also RB O
determined VBN O
. . O

Elimination NN O
of IN O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
meningitis NN O
after IN O
introduction NN O
of IN O
vaccination NN O

Evidence NN O
is VBZ O
presented VBN O
that IN O
Leber NNP O
' POS O
s JJ O
military JJ O
aneurysm NN O
retinitis NN O
is VBZ O
not RB O
a DT O
separate JJ O
entity NN O
but CC O
a DT O
special JJ O
form NN O
of IN O
Coats NNP O
' POS O
disease NN O
. . O

They PRP O
also RB O
indicate VBP O
that IN O
direct JJ O
interactions NNS O
between IN O
C NNP B-Gene
/ NNP I-Gene
EBPs NNP I-Gene
and CC O
specific JJ O
Ets NNP B-Gene
family NN O
members NNS O
, , O
together RB O
with IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
are VBP O
important JJ O
for IN O
eosinophil JJ O
lineage NN O
determination NN O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
22 CD O
, , O
846 CD O
bp NN O
of IN O
the DT O
left JJ O
arm NN O
of IN O
chromosome NN O
IV NNP O
is VBZ O
described VBN O
. . O

In IN O
retrospect NN O
, , O
the DT O
diagnoses NNS O
were VBD O
reconsidered VBN O
applying VBG O
strict JJ O
criteria NNS O
. . O

The DT O
MVV NNP O
- : O
value NN O
is VBZ O
under IN O
the DT O
predicted JJ O
level NN O
in IN O
the DT O
case NN O
of IN O
67 CD O
- : O
76 CD O
percent NN O
. . O

Sequences NNS O
required VBN O
for IN O
interaction NN O
of IN O
mu2 NN B-Gene
and CC O
CTLA NNP B-Gene
- : I-Gene
4 CD I-Gene
were VBD O
localized VBN O
to TO O
residues NNS O
, , O
161TTGVY CD O
in IN O
CTLA NNP B-Gene
- : I-Gene
4 CD I-Gene
; : O
this DT O
sequence NN O
is VBZ O
N NNP O
- : O
terminal NN O
to TO O
, , O
but CC O
overlaps NNS O
with IN O
, , O
a DT O
previously RB O
identified VBN O
SH2 NNP B-Gene
binding VBG I-Gene
motif NN I-Gene
, , O
165YVKM CD O
, , O
involved VBN O
in IN O
CTLA NNP B-Gene
- : I-Gene
4 CD I-Gene
signaling NN O
. . O

Use NNP O
of IN O
radioactive JJ O
isotopes NNS O
in IN O
the DT O
chemistry NN O
of IN O
proteins NNS O

Ca2 NNP O
+ NNP O
decreased VBD O
Zn2 NNP O
+ NNP O
binding NN O
in IN O
S100 NNP B-Gene
beta NN I-Gene
but CC O
it PRP O
did VBD O
not RB O
influence VB O
binding VBG O
to TO O
MRP14 NNP B-Gene
, , O
suggesting VBG O
that IN O
the DT O
Zn2 NNP O
+ NNP O
binding VBG O
site NN O
was VBD O
distinct JJ O
from IN O
and CC O
independent JJ O
of IN O
the DT O
two CD O
Ca2 NNP O
+ VBD O
binding VBG O
domains NNS O
. . O

We PRP O
conclude VBP O
that IN O
DNA NNP O
ploidy NN O
is VBZ O
a DT O
major JJ O
objective JJ O
prognostic JJ O
factor NN O
and CC O
therapeutic JJ O
determinant NN O
for IN O
endometrial JJ O
carcinoma NN O
. . O

A DT O
liquid JJ O
chromatographic JJ O
method NN O
is VBZ O
described VBN O
for IN O
analysis NN O
of IN O
beta NN O
- : O
carotene NN O
in IN O
medical JJ O
food NN O
. . O

DMCM NNP O
also RB O
permits VBZ O
extension NN O
of IN O
the DT O
possibilities NNS O
of IN O
obtaining VBG O
and CC O
transplanting VBG O
donor JJ O
organs NNS O
. . O

Transactivation NN O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
by IN O
T3R NNP B-Gene
alpha NN I-Gene
and CC O
several JJ O
receptor NN O
mutants NNS O
revealed VBD O
that IN O
the DT O
50 CD O
- : O
amino NN O
- : O
acid NN O
N NNP O
- : O
terminal NN O
A DT O
/ NN O
B NNP O
region NN O
of IN O
T3R NNP B-Gene
alpha NN I-Gene
, , O
known VBN O
to TO O
interact VB O
with IN O
the DT O
basal NN B-Gene
transcription NN I-Gene
factor NN I-Gene
TFIIB NNP I-Gene
, , O
is VBZ O
critical JJ O
for IN O
activation NN O
of IN O
both DT O
Tat NNP B-Gene
- : O
dependent NN O
and CC O
Tat NNP B-Gene
- : O
independent JJ O
responsive JJ O
sequences NNS O
of IN O
the DT O
LTR NNP O
. . O

Substitution NN O
of IN O
bulky NN O
hydrophobic NN O
residues NNS O
with IN O
charged VBN O
residues NNS O
within IN O
PEP1 NNP B-Gene
affects VBZ O
the DT O
fusion NN O
activity NN O
of IN O
the DT O
S NNP B-Gene
protein NN I-Gene
without IN O
affecting VBG O
processing NN O
and CC O
surface NN O
expression NN O
. . O

The DT O
author NN O
gives VBZ O
an DT O
account NN O
of IN O
antipsychotic JJ O
, , O
analgetic JJ O
, , O
myorelaxing VBG O
and CC O
vasodilatating VBG O
effects NNS O
of IN O
some DT O
calcium NN O
antagonists NNS O
, , O
and CC O
their PRP$ O
clinical JJ O
application NN O
is VBZ O
discussed VBN O
. . O

The DT O
residue JJ O
functions NNS O
, , O
R NNP O
( ( O
t NN O
) ) O
, , O
for IN O
C NNP O
- : O
11 CD O
CPZ NNP O
and CC O
In IN O
- : O
113m CD O
transferrin NN B-Gene
were VBD O
plotted VBN O
against IN O
time NN O
for IN O
selected VBN O
areas NNS O
of IN O
interest NN O
, , O
and CC O
the DT O
CPZ NNP O
area NN O
- : O
weighted JJ O
extraction NN O
, , O
E NNP O
( ( O
t NN O
) ) O
, , O
was VBD O
computed VBN O
for IN O
the DT O
same JJ O
areas NNS O
every DT O
250 CD O
msec NN O
using VBG O
the DT O
formula NN O
: : O
E NN O
( ( O
t NN O
) ) O
= VBZ O
[ JJ O
RT NNP O
( ( O
t NN O
) ) O
- : O
RR NNP O
( ( O
t NN O
) ) O
] VBZ O
/ JJ O
[ $ O
1 CD O
- : O
RR NN O
( ( O
t NN O
) ) O
] NN O
, , O
where WRB O
RT NNP O
and CC O
RR NNP O
are VBP O
the DT O
normalized JJ O
residue JJ O
functions NNS O
for IN O
CPZ NNP O
and CC O
transferrin NN B-Gene
, , O
respectively RB O
. . O

Dorsal NNP O
foot NN O
TcpO2 NNP O
was VBD O
measured VBN O
by IN O
using VBG O
oxygen NN O
- : O
sensing VBG O
electrodes NNS O
with IN O
surface NN O
temperatures NNS O
of IN O
42 CD O
degrees NNS O
C NNP O
and CC O
45 CD O
degrees NNS O
C NNP O
; : O
in IN O
theory NN O
, , O
changes NNS O
in IN O
sympathetic JJ O
activity NN O
should MD O
affect VB O
vasomotor NN O
tone NN O
and CC O
TcpO2 NNP O
in IN O
skin NNP O
beneath NN O
an DT O
electrode NN O
at IN O
42 CD O
degrees NNS O
C NNP O
( ( O
submaximal JJ O
vasodilation NN O
) ) O
, , O
but CC O
not RB O
at IN O
45 CD O
degrees NNS O
C NNP O
( ( O
maximal JJ O
vasodilation NN O
) ) O
. . O

Unrecognized VBN O
amnionitis NN O
and CC O
prematurity NN O
: : O
a DT O
preliminary JJ O
report NN O
. . O

CPT NNP O
- : O
11 CD O
was VBD O
administered VBN O
as IN O
a DT O
30 CD O
- : O
minute NN O
i NN O
. . O
v NN O
. . O
infusion NN O
at IN O
a DT O
dose NN O
of IN O
350 CD O
mg NNS O
/ JJ O
m2 NN O
diluted VBN O
in IN O
250 CD O
ml NNS O
normal JJ O
saline JJ O
every DT O
3 CD O
weeks NNS O
. . O

Eucaryotic JJ O
transcription NN O
factors NNS O
that WDT O
stimulate VBP O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
by IN O
increasing VBG O
the DT O
efficiency NN O
of IN O
elongation NN O
of IN O
specifically RB O
or CC O
randomly RB O
initiated VBN O
RNA NNP O
chains NNS O
have VBP O
been VBN O
isolated VBN O
and CC O
characterized VBN O
. . O

Supplementary JJ O
Phase NNP O
Contraste NNP O
RSE NNP O
( ( O
"""" NNP O
Rapid NNP O
Sequential NNP O
Excitation NNP O
"""" NNP O
) ) O
sequences NNS O
were VBD O
carried VBN O
out IN O
in IN O
29 CD O
patients NNS O
. . O

Thrombophlebitis NN O
and CC O
pulmonary JJ O
embolism NN O
in IN O
congenital JJ O
factor NN B-Gene
XII NNP I-Gene
deficiency NN O

In IN O
this DT O
paper NN O
the DT O
tyrosine NN O
dephosphorylating VBG O
enzymes NNS O
, , O
the DT O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
phosphatases NNS I-Gene
( ( O
PTPs NNP B-Gene
) ) O
, , O
are VBP O
studied VBN O
which WDT O
can MD O
be VB O
grouped VBN O
into IN O
two CD O
subfamilies NNS O
, , O
the DT O
soluble JJ B-Gene
PTPs NNP I-Gene
and CC O
the DT O
receptor NN B-Gene
PTPs NNP I-Gene
( ( O
RPTPs NNP B-Gene
) ) O
. . O

The DT O
moduli NN O
of IN O
elasticity NN O
of IN O
the DT O
gray JJ O
and CC O
white JJ O
matter NN O
were VBD O
3 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
kPa NN O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
standard JJ O
deviation NN O
) ) O
and CC O
3 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
kPa NN O
in IN O
the DT O
axial JJ O
section NN O
, , O
3 CD O
+ NN O
/ NNP O
- : O
0 CD O
. . O
3 CD O
kPa NN O
and CC O
3 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
kPa NN O
in IN O
the DT O
frontal JJ O
section NN O
, , O
and CC O
3 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
kPa NN O
and CC O
2 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
kPa NN O
in IN O
the DT O
sagittal JJ O
section NN O
, , O
respectively RB O
. . O

Hematopoietic JJ O
system NN O
in IN O
streptococcal JJ O
allergy NN O
. . O

Collectively RB O
, , O
our PRP$ O
findings NNS O
demonstrate VBP O
that IN O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
controlling VBG O
the DT O
basal NN O
and CC O
cAMP NN O
- : O
stimulated JJ O
expression NN O
of IN O
the DT O
StAR NNP B-Gene
gene NN I-Gene
. . O

Following VBG O
seven CD O
days NNS O
' POS O
incubation NN O
both DT O
at IN O
20 CD O
degrees NNS O
C NNP O
and CC O
28 CD O
degrees NNS O
C NNP O
, , O
Ae NNP O
. . O
vexans NNS O
nip JJ O
. . O
was VBD O
capable JJ O
of IN O
transmitting VBG O
the DT O
virus NN O
. . O

Analysis NN O
of IN O
cell NN O
cycle NN O
proteins VBZ O
showed VBD O
that IN O
24 CD O
h NN O
of IN O
lovastatin JJ O
treatment NN O
in IN O
the DT O
control NN O
cells NNS O
caused VBD O
an DT O
elevation NN O
in IN O
the DT O
levels NNS O
of IN O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN O
p27 NN B-Gene
( ( O
kip1 NN B-Gene
) ) O
, , O
inhibition NN O
of IN O
both DT O
cyclin NN B-Gene
E NNP I-Gene
- : I-Gene
and CC I-Gene
cyclin VB I-Gene
A NNP I-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
activity NN O
, , O
and CC O
decreased JJ O
levels NNS O
of IN O
hyperphosphorylated VBN O
retinoblastoma NN B-Gene
protein NN I-Gene
( ( O
pRb NN B-Gene
) ) O
. . O

Our PRP$ O
data NNS O
, , O
combined VBN O
with IN O
those DT O
of IN O
Hershey NNP O
and CC O
co SYM O
- : O
workers NNS O
, , O
suggest VBP O
that IN O
mammalian JJ B-Gene
eIF3 NN I-Gene
is VBZ O
composed VBN O
of IN O
at IN O
least JJS O
10 CD O
subunits NNS O
: : O
p170 NN B-Gene
, , O
p116 NN B-Gene
( ( O
hPrt1 NN B-Gene
) ) O
, , O
p110 NN B-Gene
, , O
p66 NN B-Gene
, , O
p48 NN B-Gene
, , O
p47 NN B-Gene
, , O
p44 NN B-Gene
, , O
p40 NN B-Gene
, , O
p36 NN B-Gene
, , O
and CC O
p35 NN B-Gene
. . O

Using VBG O
a DT O
polymerase NN O
chain NN O
reaction NN O
- : O
based VBN O
approach NN O
, , O
we PRP O
cloned VBD O
a DT O
150 CD O
- : O
base NN O
pair NN O
fragment NN O
of IN O
a DT O
new JJ O
sialymotif NN O
from IN O
human JJ O
placenta NN O
mRNA NN O
, , O
which WDT O
was VBD O
then RB O
used VBN O
as IN O
a DT O
probe NN O
to TO O
clone VB O
the DT O
complete JJ O
coding VBG O
sequence NN O
of IN O
the DT O
corresponding JJ O
gene NN O
from IN O
a DT O
cDNA NN O
library NN O
. . O

Deletion NN O
analysis NN O
was VBD O
carried VBN O
out RP O
within IN O
a DT O
part NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
showing VBG O
homology NN O
to TO O
the DT O
upstream JJ O
region NN O
of IN O
the DT O
yeast NN B-Gene
CYC1 NNP I-Gene
gene NN I-Gene
. . O

The DT O
effect NN O
of IN O
MIB NNP O
on IN O
the DT O
dose JJ O
- : O
response NN O
curve NN O
of IN O
externally RB O
applied VBN O
noradrenaline NN O
was VBD O
also RB O
studied VBN O
. . O

Analysis NN O
of IN O
the DT O
rate NN O
constants NNS O
indicated VBD O
that IN O
the DT O
isomerization NN O
rate NN O
k12 NN O
was VBD O
approximately RB O
equal JJ O
to TO O
the DT O
apparent JJ O
degradation NN O
rate NN O
of IN O
the DT O
delta NN O
3 CD O
ester NN O
kdeg NN O
, , O
and CC O
slower JJR O
than IN O
the DT O
hydrolysis NN O
rate NN O
of IN O
the DT O
delta NN O
2 CD O
ester NN O
k24 NN O
. . O

Primary JJ O
infection NN O
is VBZ O
usually RB O
managed VBN O
conservatively RB O
. . O

Clin NNP O
. . O

To TO O
assess VB O
the DT O
maximum JJ O
oxygen NN O
uptake NN O
( ( O
V NNP O
' POS O
O2 NNP O
max NN O
) ) O
of IN O
Hong NNP O
Kong NNP O
Chinese JJ O
children NNS O
and CC O
to TO O
explore VB O
its PRP$ O
association NN O
with IN O
respiratory NN O
illnesses NNS O
, , O
we PRP O
conducted VBD O
the DT O
Multistage NNP O
Fitness NNP O
Test NNP O
( ( O
MFT NNP O
) ) O
, , O
a DT O
20 CD O
- : O
m NN O
shuttle JJ O
run NN O
test NN O
, , O
in IN O
1 CD O
, , O
427 CD O
schoolchildren NNS O
aged VBN O
between IN O
8 CD O
- : O
12 CD O
years NNS O
. . O

When WRB O
phosphorylation NN O
of IN O
exogenous JJ O
peptide NN O
substrates NNS O
was VBD O
measured VBN O
as IN O
a DT O
function NN O
of IN O
receptor NN O
self PRP O
- : O
phosphorylation NN O
, , O
tyrosine JJ B-Gene
kinase NN I-Gene
activity NN O
was VBD O
found VBN O
to TO O
be VB O
enhanced VBN O
two CD O
to TO O
threefold VB O
at IN O
1 CD O
- : O
2 CD O
mol NN O
of IN O
phosphate NN O
per IN O
mol NN O
of IN O
receptor NN O
. . O

M NNP O
. . O
M NNP O
. . O
C NNP O
. . O
was VBD O
used VBN O
for IN O
2 CD O
. . O
5 CD O
minutes NNS O
in IN O
44 CD O
cases NNS O
( ( O
20 CD O
HR NNP O
patients NNS O
, , O
24 CD O
LR NNP O
patients NNS O
) ) O
, , O
and CC O
for IN O
5 CD O
minutes NNS O
in IN O
66 CD O
cases NNS O
( ( O
46 CD O
HR NNP O
patients NNS O
, , O
20 CD O
LR NNP O
patients NNS O
) ) O
. . O

Our PRP$ O
results NNS O
are VBP O
reassuring VBG O
and CC O
we PRP O
therefore VBP O
advise RP O
that DT O
in IN O
patients NNS O
undergoing JJ O
free JJ O
jejunum NN O
flap JJ O
reconstruction NN O
of IN O
the DT O
hypopharyngo NN O
- : O
esophageal NN O
tract JJ O
voice NN O
restoration NN O
should MD O
be VB O
attempted VBN O
by IN O
placing VBG O
a DT O
voice NN O
prosthesis NN O
through IN O
a DT O
secondary JJ O
tracheo NN O
- : O
esophageal JJ O
puncture NN O
and CC O
providing VBG O
intensive JJ O
speech NN O
training NN O
. . O

The DT O
TATA NNP B-Gene
box NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
TBP NNP B-Gene
) ) O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
transcription NN O
by IN O
all DT O
three CD O
eukaryotic JJ O
nuclear JJ B-Gene
RNA NNP I-Gene
polymerases NNS I-Gene
, , O
polymerases NNS B-Gene
( ( I-Gene
Pol NNP I-Gene
) ) I-Gene
I PRP I-Gene
, , I-Gene
II NNP I-Gene
, , I-Gene
and CC I-Gene
III NNP I-Gene
. . O

In IN O
an DT O
attempt NN O
to TO O
investigate VB O
whether IN O
the DT O
intergenic JJ O
region NN O
between IN O
the DT O
oleosin NN B-Gene
and CC O
a DT O
second JJ O
open JJ O
reading NN O
frame NN O
( ( O
ORFII NNP O
) ) O
in IN O
Brassica NNP O
napus NN O
( ( O
L NNP O
. . O
) ) O
is VBZ O
a DT O
divergent JJ O
promoter NN O
, , O
and CC O
also RB O
to TO O
characterize VB O
the DT O
ORFII NNP B-Gene
, , O
cDNA NN B-Gene
clones NNS I-Gene
homologous JJ I-Gene
to TO I-Gene
ORFII NNP I-Gene
were VBD O
isolated VBN O
from IN O
a DT O
leaf NN O
cDNA NN O
library NN O
. . O

Histiocytic JJ O
panniculitis NN O
was VBD O
observed VBN O
in IN O
biopsy NN O
specimens NNS O
with IN O
cytophagocytosis NN O
. . O

A DT O
correlation NN O
coefficient NN O
was VBD O
used VBN O
for IN O
assessing VBG O
the DT O
similarity NN O
of IN O
each DT O
map NN O
pattern NN O
with IN O
the DT O
normal JJ O
mean JJ O
IQRST NNP O
map NN O
. . O

Here RB O
, , O
we PRP O
have VBP O
more RBR O
closely RB O
investigated JJ O
transactivation NN O
of IN O
the DT O
human JJ B-Gene
HSP70 NNP I-Gene
promoter NN I-Gene
by IN O
Myb NNP B-Gene
proteins NNS I-Gene
. . O

Penicillinase NNP B-Gene
production NN O
in IN O
Staphylococcus NNP O
aureus VBP O
strains NNS O
of IN O
clinical JJ O
importance NN O
. . O

Northern NNP O
blot NN O
analysis NN O
indicates VBZ O
that IN O
AHA2 NNP B-Gene
mRNA RBS I-Gene
relative JJ O
to TO O
total JJ O
cellular JJ O
RNA NNP O
is VBZ O
expressed VBN O
at IN O
significantly RB O
higher JJR O
levels NNS O
in IN O
root NN O
tissue NN O
as IN O
compared VBN O
with IN O
shoot JJ O
tissue NN O
. . O

Sequence NN O
analyses NNS O
of IN O
sos2 NN B-Gene
mutant JJ I-Gene
alleles NNS I-Gene
reveal VBP O
that IN O
both DT O
the DT O
N NNP O
- : O
terminal JJ O
catalytic JJ O
domain NN O
and CC O
the DT O
C NNP O
- : O
terminal JJ O
regulatory JJ O
domain NN O
of IN O
SOS2 NNP B-Gene
are VBP O
functionally RB O
essential JJ O
. . O

The DT O
mobility NN O
shift NN O
of IN O
both DT O
of IN O
these DT O
proteins NNS O
is VBZ O
abolished VBN O
by IN O
treatment NN O
with IN O
inhibitors NNS O
of IN O
PKC NNP B-Gene
or CC O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
/ NNP O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
related JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
. . O

Both DT O
HEF1 NNP B-Gene
and CC O
Cas NNP B-Gene
were VBD O
found VBN O
to TO O
complex VB O
with IN O
the DT O
related JJ B-Gene
adhesion NN I-Gene
focal JJ I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( O
RAFTK NNP B-Gene
) ) O
, , O
and CC O
when WRB O
tyrosine NN O
phosphorylated VBN O
, , O
with IN O
the DT O
adapter NN O
molecule NN O
CrkL NNP B-Gene
. . O

A DT O
consensus NN O
sequence NN O
indicates VBZ O
a DT O
highly RB O
conserved VBN O
lysine NN O
residue NN O
, , O
K120 NNP O
of IN O
endonuclease NN B-Gene
III NNP I-Gene
or CC O
K241 NNP O
of IN O
Ogg1 NNP B-Gene
, , O
respectively RB O
. . O

In IN O
contrast NN O
, , O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
binding NN O
activity NN O
was VBD O
significantly RB O
greater JJR O
in IN O
T47D NNP O
cells NNS O
, , O
and CC O
Western JJ O
blots NNS O
confirmed VBD O
increased VBN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
levels NNS O
in IN O
these DT O
cells NNS O
. . O

Serum NNP B-Gene
gamma NN I-Gene
glutamyltransferase NN I-Gene
in IN O
the DT O
diagnosis NN O
of IN O
liver JJ O
disease NN O
in IN O
cattle NNS O
. . O

When WRB O
the DT O
E1A NNP B-Gene
N NNP I-Gene
- : I-Gene
terminus NN I-Gene
is VBZ O
used VBN O
as IN O
a DT O
competitor NN O
in IN O
squelshing VBG O
experiments NNS O
it PRP O
abolishes VBZ O
CBP NNP B-Gene
- : O
induced JJ O
activation NN O
of IN O
E2F1 NNP B-Gene
/ NNP O
DP1 NNP B-Gene
, , O
whereas IN O
an DT O
E1A NNP B-Gene
mutant NN I-Gene
lacking VBG O
CBP NNP B-Gene
binding VBG O
ability NN O
fails NNS O
to TO O
do VB O
so RB O
. . O

Antibodies NNS O
raised VBN O
against IN O
a DT O
C NNP O
- : O
terminal JJ O
portion NN O
of IN O
Sec31A NNP B-Gene
co SYM O
- : O
precipitate NN O
Sec13 NNP B-Gene
and CC O
inhibit VB O
ER NNP O
- : O
Golgi NNP O
transport NN O
of IN O
temperature NN O
- : O
arrested VBN O
vesicular JJ O
stomatitis NN B-Gene
G NNP I-Gene
protein NN I-Gene
in IN O
a DT O
semi JJ O
- : O
intact JJ O
cell NN O
assay NN O
. . O

We PRP O
observed VBD O
that DT O
dephosphorylation NN O
severely RB O
inhibits VBZ O
the DT O
DNA NNP O
- : O
binding VBG O
ability NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
delta NN I-Gene
and CC O
its PRP$ O
transactivating VBG O
potential JJ O
increases NNS O
in IN O
the DT O
presence NN O
of IN O
cellular JJ O
phosphatase NN O
inhibitors NNS O
, , O
such JJ O
as IN O
okadaic JJ O
acid NN O
and CC O
sodium NN O
orthovanadate NN O
. . O

The DT O
cellular JJ O
rate NN O
of IN O
anticoagulant JJ B-Gene
heparan NN I-Gene
sulfate NN I-Gene
proteoglycan NN I-Gene
( ( O
HSPGact NNP B-Gene
) ) O
generation NN O
is VBZ O
determined VBN O
by IN O
the DT O
level NN O
of IN O
a DT O
kinetically RB O
limiting VBG O
microsomal JJ O
activity NN O
, , O
HSact NNP O
conversion NN O
activity NN O
, , O
which WDT O
is VBZ O
predominantly RB O
composed VBN O
of IN O
the DT O
long JJ O
sought NN O
heparan NN B-Gene
sulfate NN I-Gene
D NNP I-Gene
- : I-Gene
glucosaminyl NN I-Gene
3 CD I-Gene
- : I-Gene
O NNP I-Gene
- : I-Gene
sulfotransferase NN I-Gene
( ( O
3 CD B-Gene
- : I-Gene
OST NN I-Gene
) ) O
( ( O
Shworak NNP O
, , O
N NNP O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
hypocitraturia NN O
in IN O
type NN O
I PRP O
renal VBP O
tubular JJ O
acidosis NN O
may MD O
be VB O
due JJ O
to TO O
a DT O
defect NN O
in IN O
proximal JJ O
tubule NN O
function NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
subjects NNS O
with IN O
air NN O
trapping VBG O
( ( O
residual JJ O
volume NN O
( ( O
RV NNP O
) ) O
/ VBP O
total JJ O
lung NN O
capacity NN O
( ( O
TLC NNP O
) ) O
> VBD O
37 CD O
% NN O
) ) O
disclosed VBD O
not RB O
only RB O
a DT O
higher JJR O
n NN O
( ( O
mit NN O
) ) O
( ( O
0 CD O
. . O
63 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
17 CD O
versus NN O
0 CD O
. . O
43 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
mt JJ O
x NN O
microm NN O
( ( O
- : O
2 CD O
) ) O
, , O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
but CC O
shorter JJR O
sarcomeres NNS O
( ( O
L NNP O
( ( O
sar NN O
) ) O
) ) O
than IN O
subjects NNS O
without IN O
this DT O
functional JJ O
abnormality NN O
( ( O
2 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
16 CD O
to TO O
2 CD O
. . O
27 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
15 CD O
microm NN O
, , O
p NN O
< VBD O
0 CD O
. . O
5 CD O
) ) O
. . O

Determination NN O
of IN O
aortic JJ O
distensibility NN O
and CC O
its PRP$ O
variations NNS O
in IN O
arterial JJ O
hypertension NN O
. . O

The DT O
incidence NN O
of IN O
tumours NNS O
in IN O
young JJ O
chickens NNS O
. . O

In IN O
a DT O
Hoosier NNP O
Oncology NNP O
Group NNP O
randomized VBD O
study NN O
involving VBG O
extensive JJ O
- : O
disease NN O
SCLC NNP O
patients NNS O
, , O
VIP NNP O
was VBD O
superior JJ O
to TO O
etoposide VB O
/ NNP O
cisplatin NN O
with IN O
regard NN O
to TO O
median JJ O
time NN O
to TO O
progression NN O
( ( O
6 CD O
. . O
6 CD O
v JJ O
5 CD O
. . O
8 CD O
months NNS O
) ) O
, , O
median JJ O
survival NN O
times NNS O
( ( O
9 CD O
. . O
1 CD O
v JJ O
7 CD O
. . O
3 CD O
months NNS O
) ) O
, , O
and CC O
2 CD O
- : O
and CC O
3 CD O
- : O
year NN O
survival NN O
rates NNS O
( ( O
13 CD O
% NN O
v JJ O
5 CD O
% NN O
and CC O
5 CD O
% NN O
v JJ O
0 CD O
% NN O
, , O
respectively RB O
) ) O
. . O

In IN O
summary JJ O
, , O
DDC NNP O
express NN O
receptors NNS O
for IN O
a DT O
broad JJ O
panel NN O
of IN O
cytokines NNS O
, , O
even RB O
receptors NNS O
for IN O
cytokines NNS O
whose WP$ O
effects NNS O
on IN O
DC NNP O
are VBP O
still RB O
unknown JJ O
( ( O
i JJ O
. . O
e NN O
. . O

Survival NN O
of IN O
111 CD O
Indium NNP O
- : O
labelled VBD O
autologous JJ O
platelets NNS O
was VBD O
studied VBN O
in IN O
2 CD O
patients NNS O
after IN O
correction NN O
of IN O
platelet NN O
count NN O
and CC O
was VBD O
still RB O
found VBN O
shortened VBN O
. . O

All DT O
corneal JJ O
buttons NNS O
were VBD O
processed VBN O
for IN O
histopathologic NN O
and CC O
electron NN O
microscopic NN O
studies NNS O
. . O

To TO O
identify VB O
these DT O
sites NNS O
, , O
Cdk2 NNP B-Gene
- : O
phosphorylated VBD O
MARCKS NNP B-Gene
was VBD O
digested VBN O
with IN O
lysyl JJ B-Gene
endoprotease NN I-Gene
and CC O
analysed VBN O
by IN O
electrospray NN O
MS NNP O
. . O

This DT O
result NN O
suggests VBZ O
that IN O
phosphorylation NN O
of IN O
Thr NNP O
14 CD O
and CC O
/ NNP O
or CC O
Tyr NNP O
15 CD O
inhibits NNS O
p34cdc2 JJ B-Gene
kinase NN I-Gene
activity NN O
, , O
in IN O
line NN O
with IN O
the DT O
location NN O
of IN O
these DT O
residues NNS O
within IN O
the DT O
putative JJ O
ATP NNP O
binding VBG O
site NN O
of IN O
the DT O
kinase NN O
. . O

Three CD O
ORFs NNP O
( ( O
9765orfR002 CD O
, , O
9765orfR011 CD O
and CC O
9765orfR013 CD O
) ) O
were VBD O
found VBN O
to TO O
be VB O
homologous JJ O
with IN O
Schizosaccharomyces NNP O
pombe NN O
polyadenylate NN B-Gene
binding NN I-Gene
protein NN I-Gene
, , O
Escherichia NNP O
coli VBD O
hypothetical JJ O
38 CD O
. . O
1 CD O
- : O
kDa NN O
protein NN O
in IN O
the DT O
BCR NNP B-Gene
5 CD O
' POS O
region NN O
, , O
and CC O
transcription NN O
regulatory JJ O
protein NN O
Swi3 NNP B-Gene
, , O
respectively RB O
. . O

Enhancer NNP O
activity NN O
requires VBZ O
both DT O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
and CC O
these DT O
adjacent JJ O
sequences NNS O
. . O

However RB O
, , O
F NNP B-Gene
- : I-Gene
SRC NNP I-Gene
- : I-Gene
1 CD I-Gene
mutant JJ I-Gene
lacking VBG O
CBP NNP B-Gene
- : I-Gene
interacting NN I-Gene
domain NN I-Gene
still RB O
preserved VBD O
enhancing JJ O
activity NN O
. . O

The DT O
present JJ O
investigation NN O
has VBZ O
revealed VBN O
that IN O
the DT O
distribution NN O
of IN O
the DT O
main JJ O
fatty JJ O
acids NNS O
in IN O
Leptospira NNP O
phospholipids NNS O
is VBZ O
similar JJ O
to TO O
their PRP$ O
distribution NN O
in IN O
Leptospira NNP O
neutral JJ O
lipids NNS O
with IN O
the DT O
exception NN O
of IN O
unsaturated JJ O
fatty JJ O
acid NN O
with IN O
14 CD O
carbon NN O
atoms NNS O
, , O
occurring VBG O
mainly RB O
in IN O
phospholipids NNS O
. . O

The DT O
eukaryotic JJ O
cell NN O
cycle NN O
is VBZ O
governed VBN O
in IN O
part NN O
by IN O
the DT O
periodic JJ O
transcription NN O
of IN O
cyclin NN B-Gene
genes NNS I-Gene
, , O
whose WP$ O
protein NN O
products NNS O
associate VBP O
with IN O
and CC O
positively RB O
regulate VB O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent NN I-Gene
kinases NNS I-Gene
. . O

This DT O
report NN O
presents VBZ O
state NN O
- : O
specific JJ O
MMRs NNP O
for IN O
1987 CD O
- : O
1996 CD O
, , O
focusing VBG O
on IN O
persistent JJ O
disparities NNS O
in IN O
maternal JJ O
mortality NN O
between IN O
black JJ O
and CC O
white JJ O
women NNS O
. . O

Characteristics NNS O
of IN O
anesthesia NN O
and CC O
resuscitation NN O
in IN O
emergency NN O
lung NN O
surgery NN O

The DT O
vaccine NN O
used VBN O
was VBD O
known VBN O
to TO O
be VB O
immunogenic JJ O
for IN O
older JJR O
children NNS O
and CC O
adults NNS O
. . O

The DT O
human JJ O
protein NN O
sequence NN O
exhibits VBZ O
a DT O
putative JJ O
DNA NNP O
- : O
binding NN O
domain NN O
similar JJ O
to TO O
that DT O
seen VBN O
in IN O
rat NN B-Gene
HBP1 NNP I-Gene
and CC O
shows VBZ O
homology NN O
with IN O
the DT O
activation NN O
and CC O
repressor NN O
domains NNS O
previously RB O
demonstrated VBN O
in IN O
the DT O
rat NN O
protein NN O
. . O

To TO O
this DT O
end NN O
, , O
we PRP O
analyzed VBD O
the DT O
phosphorylation NN O
status NN O
of IN O
a DT O
universal JJ O
tyrosine JJ B-Gene
kinase NN I-Gene
substrate NN O
, , O
the DT O
transforming VBG O
Shc NNP B-Gene
adapter NN I-Gene
protein NN I-Gene
, , O
in IN O
fibroblasts NNS O
expressing VBG O
the DT O
viral JJ O
oncogene NN O
. . O

18F CD O
and CC O
85Sr CD O
scintimetry NN O
in IN O
the DT O
study NN O
of IN O
primary JJ O
arthropathies NNS O
. . O

Thus RB O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
GRE NNP O
sufficient NN O
to TO O
account VB O
for IN O
full JJ O
glucocorticoid NN O
inducibility NN O
and CC O
an DT O
HNF NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
close RB O
to TO O
the DT O
promoter NN O
that WDT O
are VBP O
major JJ O
determinants NNS O
of IN O
transcriptional JJ O
control NN O
of IN O
the DT O
Xenopus NNP B-Gene
fibrinogen NN I-Gene
B NNP I-Gene
beta NN I-Gene
subunit NN I-Gene
gene NN I-Gene
in IN O
cells NNS O
from IN O
normal JJ O
liver JJ O
tissue NN O
. . O

Transcripts NNS O
from IN O
a DT O
second JJ O
POU NNP B-Gene
- : I-Gene
domain NN I-Gene
gene NN I-Gene
, , O
Oct NNP B-Gene
- : I-Gene
25 CD I-Gene
, , O
were VBD O
present JJ O
at IN O
low JJ O
levels NNS O
in IN O
oocytes NNS O
and CC O
early JJ O
embryos NN O
and CC O
were VBD O
dramatically RB O
upregulated JJ O
during IN O
early JJ O
gastrulation NN O
. . O

Lewis NNP O
, , O
N NNP O
. . O

Most JJS O
of IN O
the DT O
phenomena NN O
of IN O
azotaemic JJ O
osteodystrophy NN O
are VBP O
encountered VBN O
in IN O
simple JJ O
vitamin NN O
D NNP O
deficiency NN O
; : O
as IN O
in IN O
that DT O
condition NN O
, , O
deficiency NN O
of IN O
1 CD O
, , O
25 CD O
- : O
dihydroxycholecalciferol NN O
may MD O
be VB O
of IN O
primary JJ O
significance NN O
in IN O
causing VBG O
secondary JJ O
hyperparathyroidism NN O
in IN O
renal JJ O
failure NN O
. . O

However RB O
, , O
vancomycin NN O
and CC O
fosfomycin NN O
, , O
which WDT O
revealed VBD O
suboptimal NN O
in IN O
vitro JJ O
bactericidal NN O
activity NN O
, , O
proved VBD O
as RB O
efficacious JJ O
as IN O
penicillin NN O
G NNP O
and CC O
imipenem NN O
in IN O
an DT O
experimental JJ O
mode NN O
of IN O
murine NN O
gas NN O
gangrene NN O
. . O

R NN O
. . O

Histone CD B-Gene
acetylation NN O
levels NNS O
in IN O
cells NNS O
result VBP O
from IN O
a DT O
dynamic JJ O
equilibrium NN O
between IN O
competing VBG O
histone NN B-Gene
acetylases NNS I-Gene
and CC I-Gene
deacetylases NNS I-Gene
. . O

The DT O
design NN O
principle NN O
based VBN O
on IN O
a DT O
uniform JJ O
vibration NN O
mode NN O
is VBZ O
presented VBN O
. . O

The DT O
mustard NN B-Gene
chloroplast NN I-Gene
gene NN I-Gene
rps16 NN I-Gene
is VBZ O
split VBN O
by IN O
an DT O
887 CD O
bp NN O
group NN O
II NNP O
( ( O
or CC O
III NNP O
) ) O
intron NN O
. . O

With IN O
regard NN O
to TO O
nonhematologic JJ O
toxicities NNS O
, , O
diarrhea NN O
, , O
infection NN O
and CC O
elevated VBD O
serum JJ B-Gene
alkaline JJ I-Gene
phosphatase NN I-Gene
of IN O
grade NN O
3 CD O
or CC O
over WDT O
were VBD O
observed VBN O
in IN O
2 CD O
% NN O
of IN O
cycles NNS O
, , O
but CC O
were VBD O
tolerable JJ O
and CC O
reversible JJ O
. . O

The DT O
cell NN O
cycle NN O
and CC O
transcriptional JJ O
defects NNS O
caused VBN O
by IN O
taf17 NN B-Gene
( ( O
slm7 JJ B-Gene
- : I-Gene
1 CD I-Gene
) ) O
are VBP O
consistent JJ O
with IN O
the DT O
role NN O
of IN O
TAF NNP B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
s NN I-Gene
as IN O
modulators NNS O
of IN O
transcriptional JJ O
activation NN O
and CC O
may MD O
reflect VB O
a DT O
role NN O
for IN O
TAF17 NNP B-Gene
in IN O
regulating VBG O
activation NN O
by IN O
SBF NNP B-Gene
and CC O
MBF NNP B-Gene
. . O

Giant NNP O
pilomatrix NN O
carcinoma NN O
: : O
report NN O
and CC O
review NN O
of IN O
the DT O
literature NN O
. . O

Unexpectedly RB O
, , O
Arg1 NNP B-Gene
- : O
expressing VBG O
COS1 NNP O
cells NNS O
showed VBD O
no DT O
significant JJ O
proteinase NN O
activity NN O
to TO O
various JJ O
synthesized VBN O
substrates NNS O
under IN O
neutral JJ O
or CC O
acidic JJ O
conditions NNS O
in IN O
this DT O
study NN O
. . O

The DT O
proteins NNS O
encoded VBD O
downstream NN O
of IN O
rpoN NN B-Gene
are VBP O
known VBN O
to TO O
negatively RB O
regulate VB O
sigma NN B-Gene
54 CD I-Gene
activity NN O
. . O

In IN O
rats NNS O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
an DT O
omentum NN O
wrapping VBG O
on IN O
the DT O
vascularization NN O
of IN O
the DT O
trachea NN O
and CC O
on IN O
regeneration NN O
of IN O
the DT O
mucosal NN O
epithelium NN O
in IN O
the DT O
very RB O
early JJ O
stage NN O
after IN O
free JJ O
tracheal NN O
grafting NN O
. . O

Remarkably RB O
, , O
both DT O
TTD NNP O
- : O
A DT O
and CC O
XP NNP O
- : O
D NN O
defects NNS O
are VBP O
associated VBN O
with IN O
subunits NNS O
of IN O
TFIIH NNP B-Gene
, , O
a DT O
basal NN O
transcription NN O
factor NN O
with IN O
a DT O
second JJ O
function NN O
in IN O
DNA NNP O
repair NN O
. . O

Kf NNP O
, , O
c NN O
and CC O
CT NNP O
( ( O
referenced VBN O
to TO O
the DT O
initial JJ O
lung NN O
mass NN O
) ) O
decreased VBD O
linearly RB O
with IN O
reductions NNS O
in IN O
lung NN O
mass NN O
% NN O
delta JJ O
Kf NNP O
, , O
c VBD O
= JJ O
1 CD O
. . O
26 CD O
- : O
0 CD O
. . O
98 CD O
% NN O
mass NN O
removed VBN O
( ( O
r VB O
= RB O
0 CD O
. . O
90 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
% NN O
delta NN O
CT NNP O
= NNP O
- : O
3 CD O
. . O
99 CD O
- : O
0 CD O
. . O
98 CD O
% NN O
mass NN O
removed VBN O
( ( O
r VB O
= RB O
0 CD O
. . O
82 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
relationships NNS O
that WDT O
were VBD O
not RB O
altered VBN O
by IN O
blocker NN O
pretreatment NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

The DT O
accuracies NNS O
of IN O
presence NN O
or CC O
absence NN O
of IN O
neuroblastoma NN O
were VBD O
compared VBN O
between IN O
131I CD O
- : O
MIBG NN O
imaging NN O
and CC O
several JJ O
tumor NN O
markers NNS O
. . O

Inhibitor NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
I PRP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
inhibitor JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
I PRP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
selectively RB O
inhibit JJ O
type JJ B-Gene
1 CD I-Gene
protein NN I-Gene
serine NN I-Gene
/ NNP I-Gene
threonine NN I-Gene
phosphatases NNS I-Gene
( ( O
PP1 NNP B-Gene
) ) O
. . O

Our PRP$ O
study NN O
shows VBZ O
that IN O
the DT O
area NN O
of IN O
Alcoy NNP O
is VBZ O
a DT O
medium NN O
MS NNP O
risk NN O
region NN O
according VBG O
to TO O
the DT O
thesis NN O
of IN O
Kurzke NNP O
, , O
although IN O
high JJ O
MS NNP O
areas NNS O
may MD O
be VB O
found VBN O
, , O
thus RB O
confirming VBG O
that IN O
MS NNP O
distribution NN O
in IN O
southern JJ O
Europe NNP O
is VBZ O
not RB O
uniform JJ O
. . O

We PRP O
speculate VBP O
that IN O
mast NN O
cell NN O
degranulation NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
necrobiosis NN O
by IN O
altering VBG O
fibroblast JJ O
enzyme JJ O
activity NN O
and CC O
/ NN O
or CC O
producing VBG O
prolonged JJ O
inflammatory JJ O
reactions NNS O
. . O

Nursing NNP O
home NN O
discharges NNS O
in IN O
clinical JJ O
practice NN O
. . O

Besides IN O
, , O
it PRP O
was VBD O
considered VBN O
that IN O
the DT O
NPF NNP O
was VBD O
a DT O
useful JJ O
tool NN O
for IN O
activation NN O
of IN O
velopharyngeal NN O
activity NN O
by IN O
way NN O
of IN O
visual JJ O
feed NN O
- : O
back RB O
control NN O
. . O

K NNP O
. . O

Alginate NNP O
biosynthesis NN O
is VBZ O
controlled VBN O
by IN O
a DT O
complex JJ O
regulatory JJ O
mechanism NN O
. . O

Amisulpride RB O
400 CD O
mg NNS O
had VBD O
several JJ O
adverse JJ O
effects NNS O
on IN O
psychomotor NN O
and CC O
, , O
although IN O
less JJR O
severe JJ O
, , O
on IN O
cognitive JJ O
performance NN O
on IN O
the DT O
fifth JJ O
day NN O
only RB O
. . O

Circulating VBG O
thrombomodulin NN B-Gene
: : O
current JJ O
knowledge NN O
and CC O
future JJ O
prospects NNS O

RESULTS NN O
: : O
There EX O
is VBZ O
a DT O
considerable JJ O
amount NN O
of IN O
variation NN O
between IN O
the DT O
results NNS O
of IN O
TRA1 NNP O
and CC O
TRA2 NNP O
and CC O
between IN O
the DT O
results NNS O
of IN O
both DT O
TRA NNP O
' POS O
s NN O
and CC O
the DT O
door NN O
- : O
to TO O
- : O
door NN O
survey NN O
. . O

Northern NNP O
analysis NN O
, , O
to TO O
search VB O
for IN O
a DT O
pcbAB NN B-Gene
transcript NN I-Gene
, , O
showed VBD O
no DT O
distinct JJ O
transcript NN O
and CC O
indicated VBD O
severely RB O
degraded JJ O
mRNA NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
LIM NNP B-Gene
domain NN I-Gene
homeobox NN B-Gene
protein NN I-Gene
isl VBZ B-Gene
- : I-Gene
1 CD I-Gene
activates VBZ O
the DT O
rat NN B-Gene
amylin NN I-Gene
promoter NN I-Gene
in IN O
both DT O
fibroblast NN O
and CC O
islet NN O
cell NN O
lines NNS O
. . O

The DT O
results NNS O
revealed VBD O
increased JJ O
blood NN O
lead NN O
level NN O
associated VBN O
with IN O
decreased JJ O
blood NN B-Gene
haemoglobin NN I-Gene
and CC O
increased VBD O
urinary JJ O
excretion NN O
of IN O
delta NN O
amino NN O
levulinic JJ O
acid NN O
. . O

Multi NNP O
drug NN O
regimens NNS O
like IN O
C NNP O
- : O
MOPP NNP O
, , O
CHOP NNP O
and CC O
BACOP NNP O
led VBD O
to TO O
high JJ O
remission NN O
rates NNS O
and CC O
in IN O
some DT O
cases NNS O
probably RB O
also RB O
to TO O
a DT O
cure NN O
of IN O
the DT O
disease NN O
. . O

A DT O
G22V NNP B-Gene
mutant NN I-Gene
of IN O
M NNP B-Gene
- : I-Gene
Ras NN I-Gene
was VBD O
constitutively RB O
active JJ O
and CC O
its PRP$ O
expression NN O
in IN O
an DT O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
- : O
dependent JJ O
mast NN O
cell NN O
/ NNP O
megakaryocyte NN O
cell NN O
line NN O
resulted VBD O
in IN O
increased JJ O
survival NN O
in IN O
the DT O
absence NN O
of IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
increased VBD O
growth NN O
in IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
and CC O
, , O
at IN O
high JJ O
expression NN O
levels NNS O
, , O
in IN O
factor NN O
- : O
independent JJ O
growth NN O
. . O

A DT O
comparison NN O
among IN O
the DT O
5 CD O
' POS O
flanking NN O
regions NNS O
encompassing VBG O
the DT O
presumptive JJ O
HS NNP B-Gene
promoter NN I-Gene
of IN O
the DT O
soybean NN B-Gene
HS NNP I-Gene
- : I-Gene
protein NN I-Gene
genes NNS I-Gene
demonstrated VBD O
this DT O
region NN O
to TO O
be VB O
extremely RB O
homologous JJ O
. . O

Pharmacokinetic JJ O
parameters NNS O
were VBD O
similar JJ O
to TO O
values VB O
given VBN O
in IN O
the DT O
literature NN O
for IN O
intravenous JJ O
( ( O
IV NNP O
) ) O
or CC O
intraarterial JJ O
( ( O
IA NNP O
) ) O
bolus NN O
MMC NNP O
injections NNS O
( ( O
Tmax NNP O
= VBZ O
7 CD O
. . O
0 CD O
min NN O
following VBG O
the DT O
beginning NN O
of IN O
MMC NNP O
infusion NN O
, , O
Vss NNP O
= VBZ O
0 CD O
. . O
57 CD O
1 CD O
/ NN O
kg NN O
, , O
C1 NNP O
= VBZ O
8 CD O
. . O
9 CD O
ml JJ O
/ NNP O
min NN O
. . O
kg NN O
, , O
T1 NNP O
/ VBZ O
2 CD O
alpha NN O
= VBD O
8 CD O
. . O
3 CD O
min NN O
, , O
T1 NNP O
/ VBZ O
2 CD O
beta NN O
= NN O
58 CD O
. . O
6 CD O
min NN O
) ) O
. . O

The DT O
stimulus NN O
threshold NN O
for IN O
EER NNP O
showed VBD O
a DT O
less RBR O
individual JJ O
variation NN O
than IN O
amplitude NN O
. . O

The DT O
author NN O
analyzes VBZ O
extensive JJ O
own JJ O
data NNS O
based VBN O
on IN O
study NN O
into IN O
particular JJ O
features NNS O
of IN O
cardiovascular JJ O
disorders NNS O
in IN O
chronic JJ O
renal JJ O
impairement NN O
with IN O
making VBG O
use NN O
of IN O
modern JJ O
diagnostic JJ O
tools NNS O
. . O

Unlike IN O
other JJ O
progenitor NN O
cells NNS O
of IN O
the DT O
brain NN O
, , O
SVZa NNP O
progenitor NN O
cells NNS O
have VBP O
the DT O
capacity NN O
to TO O
divide VB O
even RB O
though IN O
they PRP O
express VBP O
a DT O
neuronal JJ O
phenotype NN O
. . O

No DT O
post NN O
- : O
operative JJ O
haemorrhages NNS O
from IN O
the DT O
prostheses NNS O
were VBD O
observed VBN O
. . O

Time NNP O
delay NN O
effects NNS O
on IN O
the DT O
tensile JJ O
bond NN O
strength NN O
developed VBN O
by IN O
the DT O
Silicoater NNP O
. . O

For IN O
228 CD O
of IN O
425 CD O
deaths NNS O
( ( O
54 CD O
% NN O
) ) O
occurring NN O
among IN O
26 CD O
100 CD O
people NNS O
of IN O
known VBN O
age NN O
in IN O
the DT O
Malumfashi NNP O
area NN O
of IN O
northern JJ O
Nigeria NNP O
, , O
data NNS O
were VBD O
collected VBN O
on IN O
symptoms NNS O
present JJ O
prior RB O
to TO O
death NN O
. . O

Interferon NNP B-Gene
Regulatory NNP I-Gene
Factor NNP I-Gene
( ( I-Gene
IRF NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
has VBZ O
been VBN O
characterized VBN O
as IN O
an DT O
important JJ O
growth NN O
regulatory JJ O
and CC O
immunomodulatory JJ O
transcription NN O
factor NN O
. . O

3 CD O
' '' O
- : O
Methyl NNP O
, , O
8 CD O
- : O
methyl NN O
, , O
and CC O
8 CD O
- : O
phenyl NN O
derivatives NNS O
of IN O
5 CD O
, , O
9 CD O
- : O
dimethyl NN O
- : O
6 CD O
, , O
7 CD O
- : O
benzomorphans NNS O
. . O

The DT O
number NN O
of IN O
bacteria NNS O
in IN O
the DT O
lung NN O
, , O
peripheral JJ O
white JJ O
blood NN O
cell NN O
and CC O
BAL NNP O
fluid NN O
cell NN O
also RB O
decreased VBN O
by IN O
the DT O
administration NN O
of IN O
FN NNP B-Gene
. . O

Holger NNP O
v NN O
. . O

An DT O
analysis NN O
of IN O
synthetic JJ O
peptides NNS O
revealed VBD O
a DT O
minimal JJ O
CTD NNP O
sequence NN O
that WDT O
is VBZ O
sufficient JJ O
to TO O
bind VB O
to TO O
the DT O
second JJ O
Rsp5 NNP B-Gene
WW NNP I-Gene
domain NN I-Gene
( ( O
Rsp5 NNP B-Gene
WW2 NNP I-Gene
) ) O
in IN O
vitro NN O
and CC O
in IN O
yeast NN O
two CD O
- : O
hybrid JJ O
assays NNS O
. . O

Shift NNP O
- : O
down JJ O
experiments NNS O
indicated VBD O
that IN O
the DT O
10 CD O
( ( O
4 CD O
) ) O
- : O
to TO O
10 CD O
( ( O
5 CD O
) ) O
- : O
fold JJ O
reduction NN O
in IN O
virus JJ O
yield NN O
at IN O
the DT O
nonpermissive JJ O
temperature NN O
was VBD O
due JJ O
to TO O
the DT O
disfunction NN O
of IN O
alpha JJ B-Gene
TIF NNP I-Gene
late RB O
in IN O
infection NN O
, , O
presumably RB O
in IN O
virion NN O
maturation NN O
. . O

We PRP O
now RB O
show VBP O
that IN O
regulation NN O
of IN O
flaN JJ B-Gene
transcription NN O
in IN O
vivo JJ O
depends NNS O
on IN O
a DT O
sigma NN B-Gene
54 CD I-Gene
promoter NN I-Gene
and CC O
two CD O
ftr JJ O
elements NNS O
located VBN O
downstream NN O
of IN O
the DT O
transcription NN O
start VB O
site NN O
at IN O
+ $ O
86 CD O
( ( O
ftr2 NN O
) ) O
and CC O
+ $ O
120 CD O
( ( O
ftr3 NN O
) ) O
. . O

These DT O
cells NNS O
were VBD O
able JJ O
to TO O
present VB O
influenza JJ O
virus NN O
particles NNS O
to TO O
HLA NNP B-Gene
- : I-Gene
DR1 NNP I-Gene
- : O
restricted VBD O
T NNP O
cell NN O
clones NNS O
. . O

Expression NN O
of IN O
the DT O
human JJ B-Gene
papillomavirus NN I-Gene
type NN I-Gene
11 CD I-Gene
E5A NNP I-Gene
protein NN I-Gene
from IN O
the DT O
E1E4 NNP B-Gene
, , I-Gene
E5 NNP I-Gene
transcript NN I-Gene
. . O

After IN O
taking VBG O
smears NNS O
from IN O
lesions NNS O
of IN O
the DT O
oral JJ O
mucosa NN O
( ( O
tongue NN O
, , O
cheeks NN O
, , O
palate NN O
) ) O
and CC O
the DT O
contiguous JJ O
denture NN O
surface NN O
by IN O
cotton NN O
wool NN O
swabs NN O
and CC O
inoculating VBG O
them PRP O
onto IN O
Sabouraud NNP O
glucose JJ O
agar NN O
and CC O
CHROMagar NNP O
Candida NNP O
, , O
individual JJ O
yeast NN O
species NNS O
were VBD O
identified VBN O
by IN O
a DT O
germ JJ O
tube NN O
, , O
filamentous JJ O
, , O
and CC O
assimilation NN O
tests NNS O
employing VBG O
the DT O
commercial JJ O
kit NN O
AuxaColor NNP O
. . O

Competition NN O
needs VBZ O
to TO O
be VB O
better JJR O
studied VBN O
, , O
since IN O
in IN O
Central NNP O
America NNP O
and CC O
Caribean NNP O
islands VBZ O
this DT O
kind NN O
of IN O
study NN O
has VBZ O
favored VBN O
the DT O
biological JJ O
control NN O
of IN O
planorbid NN O
species NNS O
. . O

Their PRP$ O
chemical NN O
structures NNS O
were VBD O
elucidated VBN O
as IN O
1 CD O
alpha NN O
, , O
2 CD O
alpha SYM O
- : O
diacetoxy JJ O
- : O
8 CD O
beta SYM O
- : O
isobutanoyloxy JJ O
- : O
9 CD O
alpha SYM O
- : O
benzoyloxy JJ O
- : O
13 CD O
- : O
( ( O
alpha JJ O
- : O
methyl NN O
) ) O
butanoyloxy SYM O
- : O
4 CD O
beta NN O
, , O
6 CD O
beta SYM O
- : O
dihydroxy JJ O
- : O
beta NN O
- : O
dihydroagarofuran NN O
( ( O
1 CD O
) ) O
, , O
1 CD O
alpha NN O
, , O
2 CD O
alpha SYM O
- : O
diacetoxy JJ O
- : O
8 CD O
beta NN O
- : O
( ( O
beta SYM O
- : O
furancarbonyloxy NN O
) ) O
- : O
9 CD O
alpha SYM O
- : O
benzoyloxy JJ O
- : O
13 CD O
- : O
isobutanoyloxy JJ O
- : O
4 CD O
beta NN O
, , O
6 CD O
beta SYM O
- : O
dihydroxy JJ O
- : O
beta NN O
- : O
dihydroagarofuran NN O
( ( O
2 CD O
) ) O
and CC O
1 CD O
alpha NN O
, , O
6 CD O
beta NN O
, , O
8 CD O
alpha NN O
, , O
13 CD O
- : O
tetraacetoxy NN O
- : O
9 CD O
alpha SYM O
- : O
benzoyloxy JJ O
- : O
2 CD O
alpha SYM O
- : O
hydroxy JJ O
- : O
beta NN O
- : O
dihydroagarofuran NN O
( ( O
3 CD O
) ) O
mainly RB O
by IN O
analyses NNS O
NMR NNP O
and CC O
MS NNP O
spectral JJ O
data NNS O
. . O

Pao2 NNS O
increased VBD O
from IN O
15 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
5 CD O
. . O
6 CD O
kPa NN O
( ( O
116 CD O
+ NN O
/ NNP O
- : O
42 CD O
mm NN O
Hg NNP O
) ) O
to TO O
17 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
3 CD O
kPa NN O
( ( O
130 CD O
+ NN O
/ NNP O
- : O
47 CD O
mm NN O
Hg NNP O
) ) O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

Characterization NN O
of IN O
an DT O
EcR NNP B-Gene
/ NNP O
USP NNP B-Gene
heterodimer NN O
target NN O
site NN O
that WDT O
mediates VBZ O
ecdysone JJ O
responsiveness NN O
of IN O
the DT O
Drosophila NNP B-Gene
Lsp NNP I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

The DT O
flux JJ O
rates NNS O
of IN O
p JJ O
- : O
toluidine NN O
decreased VBN O
as IN O
the DT O
pH NN O
value NN O
in IN O
the DT O
donor JJ O
solution NN O
increased VBD O
. . O

2001 CD O
. . O

Elevated VBN O
IOP NNP O
developed VBD O
in IN O
35 CD O
patients NNS O
( ( O
44 CD O
eyes NNS O
) ) O
during IN O
the DT O
study NN O
. . O

Letter NN O
: : O
Salmonella NN O
detection NN O

OBJECTIVES NN O
: : O
The DT O
objective NN O
of IN O
this DT O
review NN O
was VBD O
to TO O
compare VB O
the DT O
effectiveness NN O
, , O
safety NN O
and CC O
acceptability NN O
of IN O
the DT O
diaphragm NN O
with IN O
and CC O
without IN O
spermicide NN O
. . O

This DT O
paper NN O
describes VBZ O
the DT O
advantages NNS O
and CC O
limitations NNS O
of IN O
the DT O
main JJ O
study NN O
approaches NNS O
used VBN O
. . O

Consequently RB O
functional JJ O
mRNAs NN O
can MD O
be VB O
produced VBN O
by IN O
endogenous JJ B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
I PRP O
. . O

The DT O
distribution NN O
of IN O
the DT O
sites NNS O
of IN O
recombinational JJ O
resolution NN O
is VBZ O
inversely RB O
correlated VBN O
with IN O
that DT O
of IN O
the DT O
gradient NN O
of IN O
sequence NN O
divergence NN O
, , O
with IN O
only RB O
approximately RB O
7 CD O
% NN O
of IN O
the DT O
X NNP O
recombinants NNS O
resolved VBD O
within IN O
the DT O
3 CD O
' POS O
third NN O
of IN O
the DT O
X NN O
blocks NNS O
where WRB O
two CD O
diverged VBD O
Alu NNP B-Gene
family NN O
repeats NNS O
reside VBP O
. . O

Western JJ O
blot NN O
analysis NN O
of IN O
various JJ O
bovine NN O
tissues NNS O
with IN O
human JJ O
NMT NNP B-Gene
peptide NN I-Gene
antibody NN I-Gene
indicated VBD O
a DT O
common JJ O
prominent JJ O
immunoreactive JJ O
band NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
48 CD O
. . O
5 CD O
- : O
50 CD O
kDa NN O
in IN O
all DT O
tissues NNS O
. . O

To TO O
evaluate VB O
the DT O
effect NN O
of IN O
altitude NN O
on IN O
adolescent JJ O
growth NN O
and CC O
development NN O
, , O
three CD O
groups NNS O
of IN O
healthy JJ O
, , O
well RB O
- : O
nourished VBN O
youth NN O
of IN O
similar JJ O
socioeconomic JJ O
status NN O
and CC O
ethnic JJ O
grouping NN O
who WP O
resided VBD O
at IN O
sea NN O
level NN O
( ( O
n JJ O
= NN O
1262 CD O
subjects NNS O
) ) O
, , O
mid SYM O
- : O
altitude NN O
( ( O
n JJ O
= NN O
1743 CD O
subjects NNS O
) ) O
, , O
and CC O
high JJ O
altitude NN O
( ( O
n JJ O
= NN O
1137 CD O
subjects NNS O
) ) O
were VBD O
studied VBN O
. . O

Schnell NNP O
, , O
J NNP O
. . O

The DT O
backbone NN O
dynamics NNS O
of IN O
residues NNS O
located VBN O
in IN O
the DT O
folded JJ O
part NN O
of IN O
CRP2 NNP B-Gene
( ( O
LIM2 NNP B-Gene
) ) O
R122A NNP B-Gene
have VBP O
been VBN O
characterized VBN O
by IN O
proton NN O
- : O
detected VBN O
( ( O
15 CD O
) ) O
N NNP O
NMR NNP O
spectroscopy NN O
. . O

State NN O
of IN O
the DT O
body NN O
in IN O
disorders NNS O
of IN O
diurnal JJ O
physiological JJ O
rhythms NN O
and CC O
long JJ O
- : O
term NN O
hypokinesia NN O

RESULTS NN O
: : O
CK NNP B-Gene
- : O
MB NNP B-Gene
elevation NN O
was VBD O
detected VBN O
in IN O
313 CD O
patients NNS O
( ( O
18 CD O
. . O
7 CD O
% NN O
) ) O
, , O
with IN O
1 CD O
- : O
3x CD O
in IN O
12 CD O
. . O
8 CD O
% NN O
, , O
3 CD O
- : O
5x CD O
in IN O
3 CD O
. . O
5 CD O
% NN O
and CC O
> $ O
5x CD O
normal JJ O
in IN O
2 CD O
. . O
4 CD O
% NN O
of IN O
patients NNS O
. . O

Animals NNS O
that WDT O
received VBD O
DSP NNP O
- : O
4 CD O
were VBD O
significantly RB O
retarded VBN O
in IN O
motor NN O
recovery NN O
compared VBN O
with IN O
the DT O
saline NN O
group NN O
. . O

To TO O
analyze VB O
the DT O
regulatory JJ O
activity NN O
of IN O
Gtx NNP B-Gene
, , O
we PRP O
first RB O
identified VBD O
the DT O
optimal JJ O
Gtx NNP B-Gene
- : I-Gene
binding NN I-Gene
sequence NN I-Gene
using VBG O
an DT O
in IN O
vitro NN O
DNA NNP O
- : O
binding NN O
assay NN O
. . O

In IN O
reconstitution NN O
experiments NNS O
, , O
we PRP O
first RB O
showed VBD O
that IN O
expression NN O
in IN O
the DT O
RAW NNP O
264 CD O
. . O
7 CD O
cell NN O
line NN O
of IN O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
Src NNP I-Gene
kinase NN I-Gene
( ( O
Csk NNP B-Gene
) ) O
inhibited VBD O
and CC O
that IN O
of IN O
a DT O
membrane NN O
- : O
anchored VBN O
, , O
gain VB O
- : O
of IN O
- : O
function NN O
Csk NNP B-Gene
abolished VBD O
the DT O
Fc NNP B-Gene
gamma NN I-Gene
R NNP I-Gene
- : O
mediated VBD O
signaling VBG O
that DT O
leads VBZ O
to TO O
phagocytosis VB O
in IN O
a DT O
kinase NN O
- : O
dependent JJ O
manner NN O
. . O

The DT O
domains NNS O
involved VBN O
in IN O
superactivation NN O
appear VBP O
to TO O
be VB O
a DT O
subset NN O
of IN O
those DT O
necessary JJ O
to TO O
achieve VB O
synergistic JJ O
activation NN O
. . O

Using VBG O
one CD O
of IN O
the DT O
six CD O
fragments NNS O
( ( O
CPK3 NNP B-Gene
- : I-Gene
8 CD I-Gene
) ) O
, , O
we PRP O
isolated VBD O
a DT O
2022 CD B-Gene
bp NN I-Gene
cDNA NN I-Gene
( ( I-Gene
VrCDPK NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
from IN O
a DT O
Vigna NNP O
radiata NN O
lambda NN O
gt11 NN O
library NN O
. . O

51 CD O
. . O
9 CD O
% NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
6 CD O
) ) O
in IN O
the DT O
MMF NNP O
versus IN O
the DT O
AZA NNP O
groups NNS O
, , O
respectively RB O
. . O

Clone NNP O
pSRc200 NN O
hybrid NN O
selected VBD O
an DT O
mRNA NN O
that WDT O
on IN O
cell NN O
- : O
free JJ O
translation NN O
produced VBD O
a DT O
38 CD O
- : O
kDa NN O
polypeptide NN O
. . O

The DT O
detection NN O
success NN O
rate NN O
was VBD O
determined VBN O
for IN O
different JJ O
markers NNS O
using VBG O
this DT O
MEK NNP B-Gene
. . O

The DT O
induction NN O
of IN O
seizures NNS O
in IN O
"""" NNP O
Papio NNP O
papio NN O
"""" NN O
following VBG O
allylglycine JJ O
alone RB O
or CC O
in IN O
combination NN O
with IN O
intermittent JJ O
photic JJ O
stimulation NN O

Argatroban NNP O
may MD O
be VB O
more RBR O
effective JJ O
under IN O
low JJ O
HC NNP B-Gene
II NNP I-Gene
conditions NNS O
because IN O
of IN O
its PRP$ O
potent JJ O
inhibition NN O
of IN O
thrombin NN B-Gene
activity NN O
at IN O
sites NNS O
of IN O
vascular JJ O
wall NN O
damage NN O
. . O

In IN O
previous JJ O
work NN O
( ( O
E NNP O
. . O

One CD O
cDNA NN O
clone NN O
designated VBN O
NCoA NNP O
- : O
62 CD O
, , O
encoded VBD O
a DT O
62 CD O
, , O
0 CD O
- : O
Da NNP O
protein NN O
that WDT O
is VBZ O
highly RB O
related VBN O
to TO O
BX42 NNP B-Gene
, , O
a DT O
Drosophila NNP O
melanogaster NN O
nuclear JJ O
protein NN O
involved VBN O
in IN O
ecdysone NN O
- : O
stimulated VBN O
gene NN O
expression NN O
. . O

The DT O
present JJ O
study NN O
describes VBZ O
the DT O
cell NN O
volume NN O
dynamics NNS O
in IN O
intact JJ O
rat NN O
hearts NNS O
, , O
during IN O
ischemia NN O
and CC O
after IN O
reperfusion NN O
. . O

Experience NN O
with IN O
the DT O
restoration NN O
of IN O
agglutination NN O
properties NNS O
of IN O
non JJ O
- : O
agglutinating VBG O
dysenterial JJ O
cultures NNS O
with IN O
the DT O
use NN O
of IN O
Rzhaninov NNP O
' POS O
s NN O
method NN O

However RB O
, , O
the DT O
increase NN O
in IN O
biliary JJ O
excretion NN O
did VBD O
not RB O
compensate VB O
for IN O
the DT O
reduced JJ O
elimination NN O
of IN O
bretylium NN O
and CC O
hexylsalicylic JJ O
acid NN O
via IN O
the DT O
kidney NN O
. . O

Up IN O
to TO O
now RB O
the DT O
number NN O
of IN O
patients NNS O
examined VBN O
is VBZ O
about IN O
300 CD O
, , O
additionally RB O
6 CD O
persons NNS O
who WP O
underwent VBP O
binephrectomy NN O
. . O

Amongst NNP O
other JJ O
qualities NNS O
, , O
the DT O
book NN O
' POS O
s JJ O
importance NN O
lies VBZ O
in IN O
the DT O
fact NN O
that IN O
it PRP O
associates VBZ O
an DT O
elaborate JJ O
theoretical JJ O
construction NN O
with IN O
the DT O
empirical JJ O
data NNS O
, , O
working VBG O
within IN O
the DT O
possibilities NNS O
provided VBN O
by IN O
late JJ O
19th CD O
- : O
century NN O
moral JJ O
statistics NNS O
. . O

A DT O
limiting JJ O
factor NN O
were VBD O
disturbances NNS O
in IN O
the DT O
system NN O
of IN O
energy NN O
transport NN O
( ( O
creatine JJ O
phosphate NN O
, , O
creatine JJ B-Gene
phosphokinase NN I-Gene
) ) O
and CC O
of IN O
the DT O
calcium NN O
pump NN O
( ( O
Ca NNP B-Gene
+ NNP I-Gene
+ NNP I-Gene
- : I-Gene
ATPase NN I-Gene
of IN O
the DT O
sarcoplasmic JJ O
reticulum NN O
, , O
SPR NNP O
) ) O
, , O
which WDT O
evidently RB O
led VBD O
to TO O
a DT O
decrease NN O
of IN O
the DT O
inotropic NN O
properties NNS O
of IN O
the DT O
myocardium NN O
at IN O
70 CD O
% NN O
restriction NN O
of IN O
coronary JJ O
blood NN O
flow NN O
. . O

Aspirin JJ O
intolerance NN O
: : O
unaltered JJ O
susceptibility NN O
of IN O
platelet NN B-Gene
cyclo SYM I-Gene
- : I-Gene
oxygenase NN I-Gene
to TO O
inhibition NN O
by IN O
aspirin NN O
in IN O
vitro NN O
. . O

Furthermore RB O
, , O
addition NN O
of IN O
B NNP B-Gene
- : I-Gene
Myb NNP I-Gene
- : O
glutathionine NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
fusion NN O
protein NN O
inhibited VBD O
complex JJ O
formation NN O
. . O

The DT O
minimum NN O
and CC O
essential JJ O
subunits NNS O
for IN O
RNA NNP O
synthesis NN O
have VBP O
not RB O
yet RB O
been VBN O
identified VBN O
. . O

This DT O
article NN O
describes VBZ O
the DT O
collaborative JJ O
care NN O
of IN O
the DT O
woman NN O
participating VBG O
in IN O
maternal JJ O
blood NN O
donation NN O
for IN O
intrauterine JJ O
transfusion NN O
. . O

SRFDelta5 JJ B-Gene
acts NNS O
as IN O
a DT O
naturally RB O
occurring VBG O
dominant JJ O
negative JJ O
regulatory JJ O
mutant NN O
that WDT O
blocks VBZ O
SRF NNP B-Gene
- : O
dependent JJ O
skeletal JJ B-Gene
alpha NN I-Gene
- : I-Gene
actin NN I-Gene
, , O
cardiac JJ B-Gene
alpha SYM I-Gene
- : I-Gene
actin NN I-Gene
, , O
smooth CC B-Gene
alpha SYM I-Gene
- : I-Gene
actin NN I-Gene
, , O
SM22alpha NNP B-Gene
, , O
and CC O
SRF NNP B-Gene
promoter NN O
- : O
luciferase NN B-Gene
reporter NN O
activities NNS O
. . O

The DT O
failures NNS O
frequently RB O
were VBD O
related VBN O
to TO O
patient JJ O
intolerance NN O
or CC O
poor JJ O
mechanical JJ O
fit NN O
and CC O
occurred VBD O
in IN O
the DT O
first JJ O
few JJ O
days NNS O
or CC O
first JJ O
few JJ O
months NNS O
after IN O
insertion NN O
. . O

A DT O
neonatal JJ O
alloimmune NN O
thrombocytopenia NN O
with IN O
an DT O
HPA NNP B-Gene
- : I-Gene
3a CD I-Gene
( ( O
Baka NNP O
) ) O
incompatibility NN O
was VBD O
confirmed VBN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
mutL NN B-Gene
, , O
miaA NN B-Gene
, , O
and CC O
hfq JJ B-Gene
expression NN O
could MD O
be VB O
regulated VBN O
by IN O
multiple JJ O
mechanisms NNS O
, , O
including VBG O
degree NN O
of IN O
cotranscription NN O
from IN O
upstream JJ O
genes NNS O
, , O
modulation NN O
of IN O
internal JJ O
promoter NN O
strength NN O
, , O
and CC O
by IN O
RNase NNP B-Gene
E NNP I-Gene
activity NN O
. . O

These DT O
women NNS O
should MD O
not RB O
be VB O
given VBN O
the DT O
current JJ O
estrogen NN O
PPI NNP O
, , O
which WDT O
was VBD O
designed VBN O
to TO O
warn VB O
women NNS O
of IN O
the DT O
risks NNS O
of IN O
long JJ O
- : O
term NN O
estrogen NN O
use NN O
; : O
a DT O
PPI NNP O
should MD O
be VB O
written VBN O
specifically RB O
for IN O
patients NNS O
receiving VBG O
short JJ O
courses NNS O
. . O

The DT O
DNA NN O
binding VBG O
domain NN O
of IN O
NirA NNP B-Gene
was VBD O
expressed VBN O
as IN O
a DT O
fusion NN O
protein NN O
with IN O
the DT O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
of IN O
Schistosoma NNP O
japonicum NN O
. . O

Mutation NN O
of IN O
either CC O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
the DT O
ets NNS B-Gene
component NN O
of IN O
this DT O
site NN O
also RB O
prevented VBD O
promoter NN O
activity NN O
in IN O
SMCs NNP O
. . O

Fifty NNP O
- : O
eight CD O
RMI NNP O
' POS O
s NN O
occurred VBD O
in IN O
the DT O
placebo NN O
group NN O
as IN O
compared VBN O
to TO O
only RB O
twenty VB O
in IN O
the DT O
AC NNP O
group NN O
( ( O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
response NN O
chain NN O
in IN O
each DT O
component NN O
was VBD O
maintained VBN O
by IN O
food NN O
presentation NN O
under IN O
a DT O
fixed JJ O
- : O
ratio NN O
schedule NN O
. . O

To TO O
examine VB O
the DT O
basis NN O
for IN O
the DT O
apparent JJ O
differences NNS O
in IN O
postsegregational JJ O
killing NN O
between IN O
the DT O
two CD O
E NNP O
. . O
coli NN O
strains NNS O
, , O
transformation NN O
assays NNS O
were VBD O
carried VBN O
out IN O
to TO O
determine VB O
the DT O
relative JJ O
sensitivities NNS O
of IN O
the DT O
strains NNS O
to TO O
the DT O
ParE NNP B-Gene
toxin NN I-Gene
protein NN I-Gene
. . O

This DT O
information NN O
, , O
together RB O
with IN O
estimation NN O
of IN O
the DT O
size NN O
of IN O
the DT O
deglycosylated VBN O
A NNP O
subunit JJ O
relative NN O
to TO O
a DT O
series NN O
of IN O
C NNP B-Gene
- : I-Gene
terminal NN I-Gene
truncated VBD I-Gene
TSHR NNP I-Gene
ectodomain NN I-Gene
variants NNS I-Gene
, , O
places NNS O
cleavage VBP O
Site JJ O
1 CD O
in IN O
the DT O
vicinity NN O
of IN O
, , O
or CC O
closely RB O
upstream JJ O
to TO O
, , O
residue JJ O
317 CD O
. . O

Proximal NNP O
CBD NNP O
was VBD O
inversely RB O
correlated VBN O
with IN O
bone NN B-Gene
alkaline NN I-Gene
phosphatase NN I-Gene
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
71 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
and CC O
intact JJ O
PTH NNP B-Gene
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
59 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
5 CD O
) ) O
. . O

Traditional JJ O
surgical JJ O
exploration NN O
was VBD O
followed VBN O
by IN O
survey NN O
with IN O
a DT O
gamma NN O
- : O
detecting NN O
probe NN O
. . O

cDNA NN O
encoding VBG O
a DT O
functional JJ O
feline NN B-Gene
liver NN I-Gene
/ NNP I-Gene
bone NN I-Gene
/ NNP I-Gene
kidney NNP I-Gene
- : I-Gene
type NN I-Gene
alkaline NN I-Gene
phosphatase NN I-Gene
. . O

The DT O
alterations NNS O
of IN O
5 CD O
- : O
HT NN O
and CC O
5 CD O
- : O
HIAA NN O
levels NNS O
in IN O
several JJ O
regions NNS O
of IN O
the DT O
brain NN O
under IN O
the DT O
conditions NNS O
examined VBD O
may MD O
indicate VB O
that IN O
IDPN NNP O
' POS O
s JJ O
neurotoxicity NN O
primarily RB O
affects VBZ O
5 CD O
- : O
HT NNP O
- : O
containing VBG O
neurones NNS O
. . O

We PRP O
propose VBP O
that IN O
Gly84 NNP O
is VBZ O
part NN O
of IN O
a DT O
putative JJ O
"""" NN O
oxyanion NN O
hole NN O
"""" NN O
involved VBN O
in IN O
the DT O
stabilization NN O
of IN O
the DT O
transition NN O
state NN O
similar JJ O
to TO O
the DT O
C NNP B-Gene
group NN I-Gene
of IN O
the DT O
esterase NN B-Gene
/ NNP O
lipase VBD B-Gene
family NN O
. . O

Finally RB O
, , O
the DT O
stability NN O
of IN O
the DT O
nucleotide JJ O
binding NN O
function NN O
of IN O
the DT O
two CD O
proteins NNS O
is VBZ O
similar JJ O
as IN O
assessed VBN O
by IN O
sensitivity NN O
to TO O
urea VB O
. . O

The DT O
most RBS O
common JJ O
types NNS O
of IN O
malformations NNS O
were VBD O
eye NN O
defects NNS O
and CC O
open JJ O
coeloms NNS O
. . O

Ruddell NNP O
, , O
M NNP O
. . O

The DT O
SEB1 NNP B-Gene
homologue NN O
thus RB O
isolated VBN O
, , O
SEB2 NNP B-Gene
, , O
encodes VBZ O
a DT O
protein JJ O
53 CD O
% NN O
identical JJ O
to TO O
Seb1p NNP B-Gene
. . O

We PRP O
show VBP O
that IN O
the DT O
5 CD O
' POS O
UTR NNP O
characteristic NN O
of IN O
testis NN B-Gene
- : I-Gene
specific JJ I-Gene
c SYM I-Gene
- : I-Gene
mos NN I-Gene
mRNA NN I-Gene
strongly RB O
represses VBZ O
translation NN O
relative NN O
to TO O
the DT O
translation NN O
of IN O
transcripts NNS O
that WDT O
contain VBP O
a DT O
5 CD O
' POS O
UTR NNP O
derived VBD O
from IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN I-Gene
, , O
and CC O
this DT O
is VBZ O
mainly RB O
due JJ O
to TO O
the DT O
four CD O
uORFs NN O
. . O

BACKGROUND NN O
: : O
Delineation NN O
of IN O
the DT O
morphologic JJ O
aspects NNS O
of IN O
age NN O
- : O
related JJ O
macular JJ O
degeneration NN O
( ( O
ARMD NNP O
) ) O
is VBZ O
helpful JJ O
in IN O
correlation NN O
with IN O
the DT O
clinical JJ O
features NNS O
and CC O
may MD O
contribute VB O
to TO O
understanding VBG O
the DT O
pathogenesis NN O
. . O

The DT O
GAC1 NNP B-Gene
gene NN I-Gene
encodes VBZ O
the DT O
regulatory JJ O
subunit NN O
for IN O
a DT O
type NN B-Gene
1 CD I-Gene
serine NN I-Gene
/ NNP I-Gene
threonine NN I-Gene
phosphoprotein NN I-Gene
phosphatase NN I-Gene
, , O
Glc7 NNP B-Gene
. . O

No DT O
increased VBD O
tumor NN O
- : O
related JJ O
mortality NN O
was VBD O
observed VBN O
after IN O
a DT O
mean NN O
follow SYM O
- : O
up IN O
of IN O
44 CD O
months NNS O
. . O

The DT O
shift NN O
to TO O
the DT O
nonpermissive JJ O
temperature NN O
is VBZ O
accompanied VBN O
by IN O
the DT O
loss NN O
of IN O
guanyl JJ O
nucleotide JJ O
- : O
dependent JJ O
activity NN O
of IN O
adenylylcyclase NN B-Gene
in IN O
vitro NN O
. . O

Considering VBG O
that IN O
the DT O
reactor NN O
is VBZ O
thoroughly RB O
mixed JJ O
during IN O
each DT O
discharge NN O
and CC O
that IN O
LD50 NNP O
= VBD O
0 CD O
. . O
9 CD O
values NNS O
are VBP O
nearly RB O
independent JJ O
of IN O
E NNP O
. . O
coli NN O
concentrations NNS O
in IN O
the DT O
range NN O
of IN O
2 CD O
x NNS O
10 CD O
( ( O
3 CD O
) ) O
< NN O
or CC O
= VB O
E NNP O
coli NNS O
/ NNP O
cfu NN O
mL NN O
( ( O
- : O
1 CD O
) ) O
< NN O
or CC O
= $ O
3 CD O
x $ O
10 CD O
( ( O
6 CD O
) ) O
, , O
we PRP O
ascribe VBP O
the DT O
nonexponential JJ O
Pn NNP O
decay NN O
of IN O
single JJ O
- : O
strain NN O
E NNP O
. . O
coli NN O
colonies NNS O
to TO O
a DT O
shielding NN O
phenomenon NN O
where WRB O
inactive JJ O
cells NNS O
protect VBP O
the DT O
successively RB O
smaller JJR O
numbers NNS O
of IN O
viable JJ O
cells NNS O
in IN O
the DT O
EHD NNP O
. . O

The DT O
level NN O
of IN O
subclinical JJ O
infection NN O
was VBD O
75 CD O
% NN O
among IN O
seropositive JJ O
dogs NNS O
. . O

The DT O
interaction NN O
of IN O
zf4 NNP B-Gene
- : I-Gene
6 CD I-Gene
with IN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
5 CD I-Gene
S NNP I-Gene
RNA NNP I-Gene
was VBD O
far RB O
more RBR O
sensitive JJ O
to TO O
non VB O
- : O
specific JJ O
competitor NN O
concentration NN O
than IN O
was VBD O
the DT O
zf4 NNP B-Gene
- : I-Gene
7 CD I-Gene
: : O
5 CD B-Gene
S NNP I-Gene
RNA NNP I-Gene
interaction NN O
, , O
suggesting VBG O
that IN O
finger NN O
seven CD O
contributes NNS O
to TO O
both DT O
affinity NN O
and CC O
specificity NN O
in IN O
this DT O
protein NN O
: : O
RNA JJ O
interaction NN O
. . O

The DT O
extraction NN O
recovery NN O
of IN O
Amphotericin NNP O
B NNP O
from IN O
the DT O
cerebrospinal JJ O
fluid NN O
is VBZ O
higher JJR O
than IN O
90 CD O
% NN O
over IN O
the DT O
entire JJ O
linear JJ O
range NN O
. . O

CONCLUSIONS NN O
: : O
This DT O
retrospective NN O
uncontrolled VBD O
study NN O
shows NNS O
that IN O
in IN O
patients NNS O
with IN O
type JJ O
1 CD O
HRS NNP O
, , O
terlipressin SYM O
- : O
induced VBN O
improved JJ O
renal JJ O
function NN O
is VBZ O
associated VBN O
with IN O
an DT O
increase NN O
in IN O
survival NN O
. . O

We PRP O
analyzed VBD O
the DT O
modular JJ O
organization NN O
of IN O
DNA NNP B-Gene
polymerase NN I-Gene
beta NN I-Gene
and CC O
found VBD O
that IN O
residues NNS O
making VBG O
contact NN O
with IN O
DNA NNP O
phosphates NNS O
were VBD O
localized VBN O
to TO O
five CD O
modules NNS O
. . O

Digitalis NNP O
glycosides NNS O
or CC O
beta SYM B-Gene
- : I-Gene
receptor NN I-Gene
antagonists NNS O
are VBP O
not RB O
helpful JJ O
in IN O
the DT O
therapy NN O
of IN O
this DT O
form NN O
of IN O
atrial JJ O
fibrillation NN O
whereas IN O
class NN O
I PRP O
antiarrhythmic VBP O
drugs NNS O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
more RBR O
effective JJ O
. . O

ESS NNP O
type NN O
1 CD O
, , O
with IN O
FT3 NNP O
low JJ O
and CC O
FT4 NNP O
and CC O
TSH NNP B-Gene
normal JJ O
, , O
is VBZ O
the DT O
most RBS O
frequent JJ O
form NN O
. . O

A DT O
total NN O
of IN O
1459 CD O
men NNS O
aged VBD O
48 CD O
to TO O
84 CD O
years NNS O
, , O
who WP O
were VBD O
diagnosed VBN O
for IN O
the DT O
first JJ O
time NN O
by IN O
physicians NNS O
as IN O
having VBG O
BPH NNP O
in IN O
1994 CD O
and CC O
who WP O
had VBD O
not RB O
received VBN O
treatment NN O
, , O
participated VBN O
in IN O
the DT O
study NN O
. . O

Most JJS O
apneic JJ O
events NNS O
occurred VBD O
during IN O
Stages NNP O
I PRP O
and CC O
II NNP O
, , O
and CC O
REM NNP O
, , O
but CC O
this DT O
proportion NN O
was VBD O
less RBR O
during IN O
the DT O
gamma NN O
OH NNP O
study NN O
( ( O
77 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
8 CD O
. . O
9 CD O
% NN O
) ) O
than IN O
during IN O
the DT O
control NN O
studies NNS O
( ( O
92 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
9 CD O
and CC O
95 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
2 CD O
% NN O
) ) O
, , O
apneas VBP O
occurring VBG O
even RB O
during IN O
SWS NNP O
with IN O
gamma JJ O
OH NNP O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

A DT O
data NN O
base NN O
homology NN O
search NN O
revealed VBD O
that IN O
the DT O
predicted JJ O
ER1 NNP B-Gene
amino NN O
acid NN O
sequence NN O
contains NNS O
three CD O
regions NNS O
of IN O
similarity NN O
to TO O
the DT O
rat NN O
and CC O
human JJ O
proteins NNS O
encoded VBN O
by IN O
the DT O
metastasis NN O
- : O
associated VBN O
gene NN O
, , O
mta1 NN B-Gene
, , O
and CC O
two CD O
regions NNS O
of IN O
similarity NN O
to TO O
the DT O
Caenorhabditis NNP O
elegans VBZ O
sequence NN O
that WDT O
is VBZ O
similar JJ O
to TO O
mta1 VB B-Gene
. . O

The DT O
homologies NNS O
between IN O
RAD16 NNP B-Gene
, , O
RAD54 NNP B-Gene
and CC O
SNF2 NNP B-Gene
are VBP O
also RB O
shared VBN O
by IN O
several JJ O
additional JJ O
, , O
recently RB O
isolated VBN O
yeast NN O
and CC O
Drosophila NNP O
genes NNS O
. . O

The DT O
subjects NNS O
were VBD O
diagnosed VBN O
on IN O
the DT O
basis NN O
of IN O
DSM NNP O
- : O
IV NNP O
pathological JJ O
gambling VBG O
criteria NNS O
and CC O
completed VBD O
the DT O
Turkish JJ O
Version NNP O
of IN O
South NNP O
Oaks NNPS O
Gambling VBG O
Screen NNP O
( ( O
SOGS NNP O
) ) O
. . O

Regional JJ O
cerebral JJ O
blood NN O
flow NN O
was VBD O
measured VBN O
using VBG O
N NNP O
- : O
isopropyl NN O
- : O
123I CD O
- : O
iodoamphetamine NN O
with IN O
single JJ O
- : O
photon NN O
emission NN O
computed VBN O
tomography NN O
( ( O
CT NNP O
) ) O
in IN O
16 CD O
aged JJ O
patients NNS O
with IN O
noninsulin JJ O
- : O
dependent NN O
diabetes VBZ O
mellitus NNS O
( ( O
NIDDM NNP O
, , O
average JJ O
age NN O
72 CD O
. . O
8 CD O
years NNS O
, , O
average JJ O
fasting VBG O
plasma NN O
glucose VBD O
7 CD O
. . O
7 CD O
mmol JJ O
/ NNP O
L NNP O
) ) O
, , O
and CC O
12 CD O
nondiabetic JJ O
subjects NNS O
( ( O
71 CD O
. . O
6 CD O
years NNS O
, , O
5 CD O
. . O
3 CD O
mmol JJ O
/ NNP O
L NNP O
) ) O
. . O

AIM NN O
: : O
To TO O
understand VB O
the DT O
role NN O
of IN O
nutritional JJ O
status NN O
in IN O
cirrhotic JJ O
patients NNS O
without IN O
clinical JJ O
porto NN O
- : O
systemic JJ O
encephalopathy NN O
( ( O
PSE NNP O
) ) O
. . O
METHODS NN O
: : O
Fifty NNP O
- : O
one CD O
non NN O
- : O
alcoholic JJ O
patients NNS O
with IN O
cirrhosis NN O
without IN O
PSE NNP O
were VBD O
studied VBN O
prospectively RB O
and CC O
compared VBN O
with IN O
20 CD O
healthy JJ O
volunteers NNS O
. . O

This DT O
report NN O
describes VBZ O
the DT O
identification NN O
of IN O
a DT O
gene NN O
of IN O
related JJ O
function NN O
, , O
SMD1 NNP B-Gene
, , O
located VBN O
immediately RB O
3 CD O
' '' O
to TO O
PRP38 NNP B-Gene
. . O

Using VBG O
a DT O
battery NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
mutants NNS I-Gene
, , O
we PRP O
show VBP O
that IN O
( ( O
i NN O
) ) O
a DT O
dimer NN O
binds VBZ O
a DT O
single JJ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
molecule NN I-Gene
, , O
( ( O
ii NN O
) ) O
the DT O
acidic JJ O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
is VBZ O
not RB O
required VBN O
for IN O
protein JJ O
- : O
protein NN O
binding NN O
and CC O
does VBZ O
not RB O
mask VB O
the DT O
nuclear JJ O
localization NN O
signal NN O
of IN O
the DT O
dimer NN O
, , O
( ( O
iii NN O
) ) O
the DT O
same JJ O
C NNP O
- : O
terminal JJ O
region NN O
is VBZ O
required VBN O
for IN O
inhibition NN O
of IN O
DNA NNP O
binding NN O
, , O
and CC O
( ( O
iv NN O
) ) O
this DT O
inhibition NN O
may MD O
be VB O
accomplished VBN O
by IN O
direct JJ O
interaction NN O
between IN O
the DT O
PEST NNP O
- : O
like IN O
region NN O
and CC O
the DT O
DNA NNP O
- : O
binding VBG O
region NN O
of IN O
one CD O
of IN O
the DT O
subunits NNS O
of IN O
the DT O
dimer NN O
. . O

The DT O
calcitonin NN B-Gene
- : O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
HEF1 NNP B-Gene
increased VBD O
in IN O
a DT O
time NN O
- : O
and CC O
dose VB O
- : O
dependent JJ O
manner NN O
. . O

Adrenergic NNP O
system NN O
activation NN O
, , O
indicated VBN O
by IN O
metanephrine NN O
/ NNP O
epinephrine NN O
ratio NN O
, , O
increased VBN O
with IN O
time NN O
in IN O
losing VBG O
males NNS O
, , O
except IN O
that DT O
after IN O
one CD O
month NN O
of IN O
cohabitation NN O
, , O
turnover NN O
returned VBD O
to TO O
levels NNS O
that WDT O
equaled VBD O
those DT O
of IN O
control NN O
animals NNS O
. . O

Two CD O
experiments NNS O
were VBD O
conducted VBN O
to TO O
study VB O
the DT O
vacuous JJ O
jaw NN O
movements NNS O
induced VBN O
in IN O
rats NNS O
by IN O
acute JJ O
administration NN O
of IN O
the DT O
monoamine NN O
- : O
depleting NN O
agent NN O
reserpine NN O
. . O

Approximately RB O
65 CD O
% NN O
of IN O
the DT O
total JJ O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
phosphotransferase NN I-Gene
activity NN O
is VBZ O
recovered VBN O
in IN O
particulate JJ O
fractions NNS O
of IN O
homogenates NNS O
prepared VBN O
from IN O
asynchronous JJ O
populations NNS O
of IN O
C NNP O
. . O
elegans NNS O
. . O

These DT O
show NN O
that IN O
the DT O
collagen NN B-Gene
in IN O
this DT O
tissue NN O
is VBZ O
modified VBN O
compared VBN O
with IN O
that DT O
in IN O
tendon NN O
. . O

Herceptin NNP O
, , O
which WDT O
recognizes VBZ O
the DT O
HER NNP B-Gene
- : I-Gene
2 CD I-Gene
/ JJ O
neu JJ B-Gene
antigen NN O
and CC O
has VBZ O
similar JJ O
size NN O
( ( O
10 CD O
nm RB O
) ) O
to TO O
G6 NNP O
- : O
( ( O
1B4M CD O
- : O
Gd NN O
) ) O
( ( O
256 CD O
) ) O
, , O
accumulated VBN O
and CC O
internalized VBN O
in IN O
the DT O
WIBC NNP O
- : O
9 CD O
tumors NNS O
more RBR O
quickly RB O
than IN O
in IN O
the DT O
control NN O
MC NNP O
- : O
5 CD O
tumors NNS O
that IN O
progress NN O
with IN O
normal JJ O
angiogenesis NN O
. . O

In IN O
this DT O
study NN O
we PRP O
describe VBP O
that IN O
platelet NN B-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
PDGF NNP B-Gene
) ) O
, , O
12 CD O
- : O
O NNP O
- : O
tetradecanoyl NN O
- : O
phorbol NN O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
, , O
and CC O
forskolin NN O
induced VBN O
CREB NNP B-Gene
( ( O
cAMP SYM B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
) ) O
Ser NNP O
- : O
133 CD O
phosphorylation NN O
with IN O
comparable JJ O
magnitude NN O
and CC O
kinetics NNS O
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

The DT O
majority NN O
of IN O
tumors NNS O
occurred VBD O
in IN O
the DT O
nasal NN O
cavities NNS O
, , O
although IN O
significant JJ O
incidences NNS O
were VBD O
also RB O
found VBN O
in IN O
the DT O
larynx NN O
, , O
trachea NN O
and CC O
stem NN O
bronchi NN O
. . O

Determination NN O
of IN O
transaminases NNS O
with IN O
an DT O
autoanalyzer NN O

With IN O
the DT O
exception NN O
of IN O
mutants NNS O
that WDT O
remove VBP O
the DT O
membrane NN O
anchor NN O
domain NN O
, , O
all DT O
of IN O
the DT O
mutant JJ O
glycoproteins NNS O
retained VBD O
the DT O
ability NN O
to TO O
cause VB O
fusion NN O
of IN O
CD4 NNP B-Gene
- : O
bearing NN O
cells NNS O
. . O

In IN O
conclusion NN O
, , O
USPIO NNP O
- : O
enhanced VBD O
MRI NNP O
data NNS O
were VBD O
capable JJ O
to TO O
characterize VB O
tumor NN O
microvessel NN O
properties NNS O
in IN O
this DT O
breast NN O
cancer NN O
model NN O
: : O
microvascular JJ O
permeability NN O
( ( O
determined VBN O
using VBG O
USPIO NNP O
) ) O
correlated VBD O
significantly RB O
with IN O
tumor NN O
grade NN O
. . O

Furthermore RB O
, , O
our PRP$ O
data NNS O
also RB O
show VBP O
that IN O
, , O
in IN O
addition NN O
to TO O
TEF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
another DT O
HF NNP B-Gene
- : I-Gene
1a CD I-Gene
- : I-Gene
related JJ I-Gene
factor NN I-Gene
may MD O
be VB O
recognized VBN O
by IN O
the DT O
alpha JJ B-Gene
- : I-Gene
MHC NNP I-Gene
gene NN I-Gene
EM NNP O
element NN O
. . O

Further RB O
, , O
Tax NNP B-Gene
- : O
mediated VBD O
apoptosis NN O
was VBD O
effectively RB O
prevented VBN O
by IN O
ectopic JJ O
expression NN O
of IN O
the DT O
p300 NN B-Gene
coactivator NN I-Gene
. . O

Human NNP B-Gene
thyroid NN I-Gene
stimulator NN I-Gene
( ( O
HTS NNP B-Gene
) ) O
in IN O
thyroid NN O
diseases NNS O

The DT O
encoded JJ O
polypeptide NN O
is VBZ O
similar JJ O
in IN O
sequence NN O
to TO O
the DT O
ABA NNP B-Gene
- : I-Gene
1 CD I-Gene
allergen NN I-Gene
of IN I-Gene
Ascaris NNP I-Gene
, , O
the DT O
gp15 NN B-Gene
/ VBD I-Gene
400 CD I-Gene
' '' I-Gene
ladder NN I-Gene
' POS I-Gene
protein NN I-Gene
of IN I-Gene
Brugia NNP I-Gene
malayi NN I-Gene
, , I-Gene
Brugia NNP I-Gene
pahangi NN I-Gene
and CC I-Gene
Wuchereria NNP I-Gene
bancrofti NN I-Gene
, , O
and CC O
a DT O
15 CD B-Gene
- : I-Gene
kDa NN I-Gene
antigen NN I-Gene
of IN I-Gene
Dirofilaria NNP I-Gene
immitis NN I-Gene
. . O

Specifically RB O
, , O
recombination NN O
at IN O
HMR NNP B-Gene
was VBD O
used VBN O
to TO O
produce VB O
rings NNS O
that WDT O
lacked VBD O
the DT O
E NNP O
and CC O
I PRP O
silencers NNS O
. . O

These DT O
mutations NNS O
, , O
when WRB O
placed VBN O
in IN O
a DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
fliF NN I-Gene
background NN O
, , O
had VBD O
no DT O
mutant JJ O
phenotype NN O
. . O

We PRP O
conclude VBP O
that IN O
, , O
with IN O
autonomic JJ O
nervous JJ O
system NN O
activity NN O
intact JJ O
, , O
carotid JJ O
chemoreceptor NN O
reflex JJ O
activation NN O
can MD O
elicit VB O
an DT O
absolute JJ O
reflexly NN O
mediated VBN O
reduction NN O
in IN O
coronary JJ O
blood NN O
flow NN O
in IN O
the DT O
normal JJ O
, , O
conscious JJ O
dog NN O
, , O
despite IN O
an DT O
increase NN O
in IN O
arterial JJ O
pressure NN O
. . O

Within IN O
the DT O
Strep NNP O
. . O
mutans NNS O
group NN O
there EX O
was VBD O
a DT O
highly RB O
- : O
significant JJ O
difference NN O
between IN O
Strep NNP O
. . O

mutans NNS O
/ VBP O
Strep NNP O
. . O
cricetus NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
with IN O
respect NN O
to TO O
mean VB O
clump NN O
size NN O
. . O

A DT O
new JJ O
Onchocerca NNP O
species NNS O
, , O
a DT O
parasite NN O
of IN O
domestic JJ O
cattle NNS O
, , O
in IN O
Senegal NNP O

Results NNS O
from IN O
the DT O
mechanism NN O
study NN O
have VBP O
revealed VBN O
that IN O
YY1 NNP B-Gene
is VBZ O
able JJ O
to TO O
inhibit VB O
transactivation NN O
mediated VBN O
by IN O
either DT O
AP1 NNP B-Gene
or CC O
the DT O
Sp1 NNP B-Gene
- : I-Gene
related JJ I-Gene
protein NN I-Gene
, , O
and CC O
YY1 NNP B-Gene
suppressive JJ O
activity NN O
is VBZ O
DNA NNP O
binding VBG O
dependent NN O
. . O

Reperfusion NN O
with IN O
normal JJ O
blood NN O
in IN O
the DT O
beating NN O
, , O
working VBG O
hearts NNS O
caused VBD O
extensive JJ O
structural JJ O
damage NN O
, , O
reduced VBD O
reflow NN O
, , O
and CC O
failed VBD O
to TO O
restore VB O
contractility NN O
in IN O
any DT O
instance NN O
( ( O
- : O
27 CD O
% NN O
systolic JJ O
shortening NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
primary JJ O
pancreatic JJ O
insult NN O
seemed VBD O
to TO O
be VB O
unaffected VBN O
by IN O
the DT O
treatment NN O
, , O
because IN O
neither CC O
the DT O
rise NN O
in IN O
plasma JJ B-Gene
lipase NN I-Gene
nor CC O
the DT O
development NN O
of IN O
ascites NNS O
or CC O
the DT O
extension NN O
of IN O
the DT O
pancreatic JJ O
necrosis NN O
were VBD O
diminished VBN O
. . O

Hp NNP O
positive JJ O
relatives NNS O
of IN O
gastric JJ O
cancer NN O
had VBD O
a DT O
markedly RB O
higher JJR O
prevalence NN O
of IN O
atrophy NN O
than IN O
those DT O
with IN O
Hp NNP O
negativity NN O
without IN O
cancer NN O
relatives NNS O
( ( O
29 CD O
vs NN O
. . O

Kodak NNP O
XV NNP O
- : O
2 CD O
film NN O
is VBZ O
wrapped VBN O
around IN O
a DT O
cylindrical JJ O
water NN O
- : O
filled VBN O
phantom NN O
and CC O
the DT O
dose JJ O
distribution NN O
is VBZ O
recorded VBN O
. . O

In IN O
humans NNS O
, , O
three CD O
tissue NN B-Gene
- : I-Gene
specific JJ I-Gene
plastin NN I-Gene
isoforms NNS I-Gene
have VBP O
been VBN O
identified VBN O
. . O

Monospecific NNP O
antibodies NNS O
, , O
eluted VBN O
from IN O
the DT O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
fusion NN O
protein NN O
of IN O
either CC O
clone NN O
reacted VBD O
with IN O
the DT O
U1 NNP B-Gene
snRNP NN I-Gene
- : O
specific NN O
A DT B-Gene
antigen NN I-Gene
. . O

Their PRP$ O
afterglows NNS O
are VBP O
brighter JJR O
than IN O
supernovae NN O
and CC O
therefore NN O
are VBP O
called VBN O
hypernovae NN O
. . O

These DT O
findings NNS O
suggest VBP O
a DT O
novel JJ O
ankyrin NN B-Gene
- : O
independent JJ O
role NN O
for IN O
LAD NNP B-Gene
- : I-Gene
1 CD I-Gene
related VBN O
to TO O
FGFR NNP B-Gene
signaling NN O
. . O

Delta NNP O
- : O
aminolevulinic JJ O
acid NN O
in IN O
physiological JJ O
conditions NNS O
and CC O
some DT O
diseases NNS O
in IN O
children NNS O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
nebulized JJ O
ipratropium NN O
in IN O
patients NNS O
with IN O
acute JJ O
asthma NN O
in IN O
order NN O
to TO O
determine VB O
whether IN O
it PRP O
augments VBZ O
the DT O
bronchodilator NN O
effect NN O
of IN O
a DT O
beta JJ O
agonist JJ O
drug NN O
. . O

Measurement NN O
of IN O
the DT O
time NN O
constant NN O
of IN O
VO2 NNP O
and CC O
oxygen NN O
pulse NN O
during IN O
constant JJ O
work NN O
rate NN O
exercise NN O
are VBP O
useful JJ O
for IN O
the DT O
objective JJ O
evaluation NN O
of IN O
the DT O
training NN O
effect NN O
of IN O
patients NNS O
with IN O
COPD NNP O
. . O

Polyprotein NNP O
processing NN O
in IN O
Southampton NNP O
virus NN O
: : O
identification NN O
of IN O
3C CD B-Gene
- : I-Gene
like IN I-Gene
protease NN I-Gene
cleavage NN O
sites NNS O
by IN O
in IN O
vitro JJ O
mutagenesis NN O
. . O

Response JJ O
durations NNS O
were VBD O
short JJ O
. . O

A DT O
gapped JJ O
search NN O
with IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
CDED NNP B-Gene
/ NNP O
LIOR NNP B-Gene
revealed VBD O
a DT O
36 CD O
- : O
41 CD O
% NN O
similarity NN O
to TO O
several JJ O
proteins NNS O
related VBN O
to TO O
signal JJ O
transduction NN O
and CC O
cell NN O
replication NN O
, , O
such JJ O
as IN O
ORC1 NNP B-Gene
and CC O
KSR NNP B-Gene
. . O

Serum NNP B-Gene
alkaline JJ I-Gene
phosphatase NN I-Gene
activity NN O
, , O
bone NN O
mass NN O
measurements NNS O
, , O
dual JJ O
energy NN O
x NNP O
- : O
ray NN O
absortiometric JJ O
analysis NN O
of IN O
mineral JJ O
density NN O
, , O
and CC O
mechanical JJ O
testing VBG O
values NNS O
in IN O
vertebrae NN O
and CC O
femora NN O
of IN O
the DT O
- : O
D NN O
Sal NNP O
animals NNS O
did VBD O
not RB O
significantly RB O
differ VBP O
from IN O
those DT O
in IN O
+ NNP O
D NNP O
Sal NNP O
animals NNS O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
a DT O
raised JJ O
hydroxykynurenine NN O
/ NNP O
hydroxyanthranilic JJ O
acid NNS O
ratio NN O
does VBZ O
not RB O
necessarily RB O
indicate VB O
vitamin NN O
B6 NNP O
deficiency NN O
but CC O
may MD O
represent VB O
a DT O
nonspecific JJ O
response NN O
of IN O
tryptophan JJ O
metabolism NN O
to TO O
stress VB O
. . O

Removal NN O
of IN O
each DT O
of IN O
three CD O
contiguous JJ O
segments NNS O
from IN O
the DT O
N NNP O
- : O
terminal JJ O
half NN O
specifically RB O
inhibits VBZ O
the DT O
formation NN O
of IN O
5 CD B-Gene
. . I-Gene
8Ss CD I-Gene
rRNA NN I-Gene
, , O
whereas IN O
deleting VBG O
part NN O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
protein NN O
only RB O
blocks VBZ O
the DT O
production NN O
of IN O
18S CD B-Gene
rRNA NN I-Gene
. . O

As IN O
in IN O
the DT O
other JJ O
three CD O
members NNS O
whose WP$ O
gene NN O
expression NN O
is VBZ O
altered VBN O
during IN O
tumorigenesis NN O
, , O
PI12 NNP B-Gene
expression NN O
was VBD O
found VBN O
to TO O
be VB O
down RP O
- : O
regulated VBN O
in IN O
tumor NN O
brain NN O
tissues NNS O
and CC O
in IN O
two CD O
brain NN O
cancer NN O
cell NN O
lines NNS O
: : O
U NNP O
- : O
87 CD O
MG NNP O
and CC O
H4 NNP O
. . O

After IN O
1 CD O
. . O
5 CD O
years NNS O
of IN O
such JJ O
photoperiodic JJ O
control NN O
, , O
all DT O
ewes NNS O
were VBD O
blinded VBN O
by IN O
bilateral JJ O
orbital JJ O
enucleation NN O
. . O

Among IN O
mucus SYM O
- : O
secreting VBG O
cells NNS O
, , O
the DT O
gastric JJ O
gland NN O
mucous JJ O
cells NNS O
, , O
Brunner NNP O
' POS O
s NN O
glands NNS O
, , O
accessory JJ O
glands NNS O
of IN O
pancreaticobiliary JJ O
tract NN O
, , O
and CC O
pancreatic JJ O
ducts NNS O
exhibiting VBG O
gastric JJ O
metaplasia NN O
are VBP O
unique JJ O
in IN O
that DT O
they PRP O
express VBP O
class NN B-Gene
III NNP I-Gene
mucin NN I-Gene
identified VBN O
by IN O
paradoxical JJ O
Con NNP B-Gene
A NNP I-Gene
staining VBG O
composed VBN O
of IN O
periodate NN O
oxidation NN O
, , O
sodium NN O
borohydride NN O
reduction NN O
, , O
Con NNP B-Gene
A NNP I-Gene
, , O
and CC O
horseradish JJ B-Gene
peroxidase NN I-Gene
reaction NN O
. . O

Here RB O
we PRP O
have VBP O
determined VBN O
the DT O
nucleotide JJ O
sequence NN O
of IN O
3 CD O
. . O
5 CD O
kb NN O
from IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
delta JJ B-Gene
gag NN I-Gene
to TO O
the DT O
3 CD O
' POS O
end NN O
of IN O
molecularly JJ O
cloned VBN O
proviral JJ O
MH2 NNP O
DNA NNP O
, , O
in IN O
order NN O
to TO O
elucidate VB O
the DT O
genetic JJ O
structure NN O
of IN O
the DT O
virus NN O
and CC O
to TO O
compare VB O
it PRP O
with IN O
other JJ O
mht JJ B-Gene
- : O
and CC O
myc VB B-Gene
- : O
containing VBG O
oncogenic JJ O
viruses NNS O
as RB O
well RB O
as IN O
with IN O
the DT O
chicken NN B-Gene
proto NN I-Gene
- : I-Gene
myc NN I-Gene
gene NN I-Gene
. . O

Overexpression NN O
of IN O
mcl NN B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
sufficient JJ O
to TO O
protect VB O
against IN O
apoptosis NN O
, , O
while IN O
transfection NN O
of IN O
a DT O
mcl NN B-Gene
- : I-Gene
1 CD I-Gene
antisense NN O
plasmid NN O
causes VBZ O
cell VBP O
death NN O
. . O

Analysis NN O
of IN O
electrically RB O
evoked VBN O
response NN O
( ( O
EER NNP O
) ) O
in IN O
relation NN O
to TO O
the DT O
central JJ O
visual JJ O
pathway NN O
of IN O
the DT O
cat NN O
( ( O
1 CD O
) ) O
. . O

Mutational JJ O
analysis NN O
of IN O
mammalian JJ B-Gene
translation NN I-Gene
initiation NN I-Gene
factor NN I-Gene
5 CD I-Gene
( ( O
eIF5 NN B-Gene
) ) O
: : O
role NN O
of IN O
interaction NN O
between IN O
the DT O
beta NN O
subunit NN O
of IN O
eIF2 NN B-Gene
and CC O
eIF5 NN B-Gene
in IN O
eIF5 JJ B-Gene
function NN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Before IN O
this DT O
date NN O
, , O
the DT O
drug NN O
directly RB O
inhibits VBZ O
fetal JJ O
weight NN O
gain NN O
, , O
whereas IN O
the DT O
sensitivity NN O
of IN O
the DT O
placenta NN O
is VBZ O
only RB O
transient JJ O
at IN O
day NN O
16 CD O
resulting VBG O
in IN O
maximum JJ O
weight JJ O
decrease NN O
of IN O
this DT O
organ JJ O
24 CD O
h NN O
later RB O
. . O

The DT O
order NN O
of IN O
the DT O
helicase NN B-Gene
motif NN I-Gene
and CC O
the DT O
nsP3 JJ B-Gene
homology NN I-Gene
region NN I-Gene
in IN O
the DT O
RUB NNP O
genome NN O
is VBZ O
reversed VBN O
with IN O
respect NN O
to TO O
the DT O
alphavirus NN O
genome NN O
indicating NN O
that IN O
a DT O
genetic JJ O
rearrangement NN O
has VBZ O
occurred VBN O
during IN O
the DT O
evolution NN O
of IN O
these DT O
viruses NNS O
. . O

Although IN O
both DT O
transcripts NNS O
share NN O
the DT O
first JJ O
nine CD O
exons NNS O
, , O
exon VBP O
10 CD O
of IN O
ZIS NNP B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
lacking VBG O
in IN O
ZIS NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
instead RB O
, , O
exon VBZ O
11 CD O
( ( O
10th CD O
exon NN O
) ) O
of IN O
ZIS NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
larger JJR O
in IN O
size NN O
, , O
leading VBG O
to TO O
the DT O
longer RB O
3 CD O
' '' O
- : O
UTR NN O
. . O

Comparisons NNS O
of IN O
the DT O
four CD O
operon NN O
control NN O
regions NNS O
studied VBD O
indicate NN O
that IN O
the DT O
NarL NNP B-Gene
heptamers NNS I-Gene
are VBP O
arranged VBN O
with IN O
diverse JJ O
orientations NNS O
and CC O
spacing NN O
. . O

SETTING NN O
- : O
- : O
Women NNS O
, , O
Infants NNS O
, , O
and CC O
Children NNP O
clinics NNS O
in IN O
Minneapolis NNP O
, , O
Minn NNP O
. . O

Serum NNP O
- : O
ferritin NN B-Gene
in IN O
diagnosis NN O
of IN O
haemochromatosis NN O
. . O

Endocytosis NN O
and CC O
lysosomal JJ O
targeting NN O
of IN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
receptors NNS I-Gene
are VBP O
mediated VBN O
by IN O
distinct JJ O
sequences NNS O
independent JJ O
of IN O
the DT O
tyrosine JJ B-Gene
kinase NN I-Gene
domain NN I-Gene
. . O

What WP O
young JJ O
people NNS O
think VBP O
and CC O
do VBP O
when WRB O
the DT O
option NN O
for IN O
cystic JJ O
fibrosis NN O
carrier NN O
testing NN O
is VBZ O
available JJ O
. . O

The DT O
POEMS NNP O
syndrome NN O
( ( O
Polyneuropathy NNP O
, , O
Organomegaly NNP O
, , O
Endocrinopathy NNP O
, , O
Monoclonal NNP O
component NN O
, , O
Skin NNP O
) ) O
. . O

In IN O
patients NNS O
with IN O
myalgia NN O
, , O
Raynaud NNP O
' POS O
s JJ O
syndrome NN O
, , O
skin FW O
vasculitis NN O
and CC O
vascular JJ O
diseases NNS O
WFAg VBP B-Gene
concentrations NNS O
were VBD O
higher JJR O
than IN O
in IN O
patients NNS O
without IN O
them PRP O
. . O

For IN O
symptomatic JJ O
relief NN O
and CC O
inhibition NN O
of IN O
the DT O
growth NN O
of IN O
the DT O
metastases NNS O
interferon VBP B-Gene
- : I-Gene
a DT I-Gene
and CC O
somatostatin NN B-Gene
analogues NNS O
can MD O
be VB O
employed VBN O
. . O

A DT O
total NN O
of IN O
112 CD O
patients NNS O
received JJ O
anistreplase NN O
and CC O
119 CD O
received VBD O
heparin NN O
within IN O
a DT O
mean JJ O
period NN O
of IN O
188 CD O
+ NNS O
/ SYM O
- : O
62 CD O
min NN O
following VBG O
the DT O
onset NN O
of IN O
symptoms NNS O
. . O

Air NNP O
lead NN O
was VBD O
not RB O
a DT O
significant JJ O
explanatory NN O
variable NN O
. . O

One CD O
of IN O
these DT O
genes NNS O
, , O
REC114 NNP B-Gene
, , O
is VBZ O
described VBN O
here RB O
, , O
and CC O
the DT O
data NNS O
confirm VBP O
that IN O
REC114 NNP B-Gene
is VBZ O
a DT O
meiosis NN O
- : O
specific JJ O
recombination NN O
gene NN O
with IN O
no DT O
detectable JJ O
function NN O
in IN O
mitosis NN O
. . O

CMV NNP O
hyperimmunoglobulin NN B-Gene
treatment NN O
( ( O
Cytotect NNP O
, , O
Biotest NNP O
) ) O
was VBD O
started VBN O
( ( O
2 CD O
ml NN O
/ NNP O
kg NNP O
bw NN O
on IN O
day NN O
1 CD O
and CC O
3 CD O
, , O
and CC O
1 CD O
ml NN O
/ NNP O
kg NN O
on IN O
days NNS O
5 CD O
, , O
7 CD O
and CC O
9 CD O
) ) O
, , O
which WDT O
led VBD O
to TO O
the DT O
eradication NN O
of IN O
the DT O
residual JJ O
infiltrate NN O
and CC O
CMV NNP O
- : O
DNA NN O
in IN O
the DT O
myocardium NN O
. . O

OBJECTIVE NN O
: : O
This DT O
meta NN O
- : O
analysis NN O
of IN O
67 CD O
controlled JJ O
trials NNS O
was VBD O
performed VBN O
to TO O
quantify VB O
the DT O
cholesterol NN O
- : O
lowering VBG O
effect NN O
of IN O
major JJ O
dietary JJ O
fibers NNS O
. . O

The DT O
Drosophila NNP O
clathrin NN B-Gene
heavy NN I-Gene
chain NN I-Gene
gene NN O
: : O
clathrin JJ B-Gene
function NN O
is VBZ O
essential JJ O
in IN O
a DT O
multicellular JJ O
organism NN O
. . O

The DT O
RNA NNP O
aptamer NN O
contains NNS O
three CD O
stems NNS O
separated VBN O
by IN O
a DT O
pair NN O
of IN O
two CD O
- : O
base NN O
bulges NNS O
, , O
and CC O
adopts VBZ O
an DT O
unanticipated JJ O
fold NN O
in IN O
which WDT O
both DT O
junctional NN O
sites NNS O
are VBP O
anchored VBN O
through IN O
base NN O
triple JJ O
formation NN O
. . O

Neither DT O
is VBZ O
it PRP O
a DT O
major JJ O
cause NN O
of IN O
rehydration NN O
- : O
induced JJ O
renal JJ O
Na NNP O
retention NN O
. . O

Microdetermination NN O
of IN O
adrenocortical JJ O
steroids NNS O
by IN O
double JJ O
isotope NN O
method NN O
. . O

As IN O
an DT O
extension NN O
of IN O
our PRP$ O
structural JJ O
characterization NN O
of IN O
the DT O
exon JJ O
- : O
intron NN O
organization NN O
of IN O
the DT O
mouse NN B-Gene
Pkr NNP I-Gene
gene NN I-Gene
, , O
we PRP O
now RB O
have VBP O
isolated VBN O
and CC O
characterized VBN O
the DT O
mouse NN B-Gene
Pkr NNP I-Gene
promoter NN I-Gene
region NN I-Gene
required VBN O
for IN O
IFN NNP B-Gene
- : O
inducible JJ O
transcription NN O
. . O

Corticostriatal NNP O
and CC O
corticosubthalamic JJ O
input NN O
zones NNS O
from IN O
the DT O
presupplementary JJ O
motor NN O
area NN O
in IN O
the DT O
macaque NN O
monkey NN O
: : O
comparison NN O
with IN O
the DT O
input NN O
zones NNS O
from IN O
the DT O
supplementary JJ O
motor NN O
area NN O
. . O

Non NNP O
- : O
poliomyelitis NN O
AFP NNP O
rate NN O
had VBD O
increased VBN O
from IN O
0 CD O
. . O
9 CD O
in IN O
1997 CD O
to TO O
2 CD O
. . O
8 CD O
in IN O
1998 CD O
. . O

Resistance NN O
training NN O
shifts VBD O
the DT O
power NN O
curve NN O
in IN O
a DT O
positive JJ O
direction NN O
when WRB O
the DT O
measurements NNS O
are VBP O
determined VBN O
with IN O
absolute JJ O
loads NNS O
, , O
but CC O
the DT O
increased JJ O
power NN O
may MD O
not RB O
be VB O
transferred VBN O
to TO O
an DT O
absolute JJ O
performance NN O
task NN O
like IN O
the DT O
SSP NNP O
. . O

This DT O
suggested VBD O
that IN O
baboon NN B-Gene
liver IN I-Gene
class NN I-Gene
I PRP I-Gene
ADH NNP I-Gene
is VBZ O
of IN O
the DT O
same JJ O
ancestral JJ O
lineage NN O
as IN O
the DT O
human JJ B-Gene
ADH NNP I-Gene
- : I-Gene
beta NN I-Gene
. . O

The DT O
results NNS O
of IN O
the DT O
ISIS NNP O
- : O
2 CD O
trial NN O
and CC O
the DT O
data NN O
from IN O
the DT O
Antiplatelet NNP O
Trialists NNP O
' POS O
Collaboration NNP O
indicated VBD O
that IN O
aspirin NN O
is VBZ O
mandatory JJ O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
and CC O
for IN O
secondary JJ O
prevention NN O
. . O

The DT O
mammalian JJ B-Gene
phosphoinositide NN I-Gene
3 CD I-Gene
- : I-Gene
kinases NNS I-Gene
( ( O
PI3Ks NNP B-Gene
) ) O
p110alpha NN B-Gene
, , I-Gene
beta NN I-Gene
, , I-Gene
and CC I-Gene
delta JJ I-Gene
form NN O
heterodimers NNS O
with IN O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
( ( O
SH2 NNP B-Gene
) ) O
domain VBP O
- : O
containing VBG O
adaptors NNS O
such JJ O
as IN O
p85alpha NN B-Gene
or CC O
p55 NN B-Gene
( ( O
PIK NNP B-Gene
) ) O
. . O

DNase NNP B-Gene
I PRP I-Gene
and CC O
1 CD O
, , O
10 CD O
- : O
phenanthroline NN O
- : O
copper NN O
footprinting NN O
of IN O
MURA NNP B-Gene
- : O
Mu1 NNP B-Gene
TIR NNP O
complexes NNS O
indicate VBP O
that IN O
MURA NNP B-Gene
binds VBZ O
to TO O
a DT O
conserved VBN O
approximately RB O
32 CD O
- : O
bp NN O
region NN O
in IN O
the DT O
TIR NNP O
of IN O
Mu1 NNP B-Gene
. . O

There EX O
have VBP O
been VBN O
five CD O
problems NNS O
( ( O
extravasation NN O
2 CD O
, , O
suspected VBD O
sepsis NN O
1 CD O
, , O
and CC O
hematoma $ O
2 CD O
) ) O
during IN O
a DT O
total NN O
of IN O
2 CD O
, , O
927 CD O
days NNS O
of IN O
exposure NN O
. . O

The DT O
findings NNS O
suggest VBP O
that IN O
ERP NNP O
effects NNS O
of IN O
distinct JJ O
memory NN O
processes NNS O
are VBP O
differentially RB O
influenced VBN O
by IN O
the DT O
encoding NN O
instructions NNS O
. . O

Update NN O
: : O
diphtheria NN O
epidemic NN O
in IN O
the DT O
newly RB O
independent JJ O
states NNS O
of IN O
the DT O
former JJ O
USSR NNP O
, , O
January NNP O
1995 CD O
- : O
March NNP O
1996 CD O
. . O

Mutation NN O
of IN O
the DT O
P450BM NNP B-Gene
- : I-Gene
3 CD I-Gene
Barbie NNP I-Gene
box NN I-Gene
significantly RB O
increased VBD O
the DT O
expression NN O
of IN O
both DT O
P450BM NNP B-Gene
- : I-Gene
3 CD I-Gene
and CC O
Bm3P1 NNP B-Gene
( ( O
another DT O
small JJ O
gene NN O
located VBN O
upstream NN O
of IN O
the DT O
P450BM NNP B-Gene
- : I-Gene
3 CD I-Gene
gene NN I-Gene
that WDT O
encodes VBZ O
a DT O
second JJ O
putative JJ O
regulatory JJ O
protein NN O
) ) O
in IN O
response NN O
to TO O
pentobarbital JJ O
induction NN O
but CC O
left VBD O
the DT O
basal NN O
levels NNS O
unaffected VBN O
. . O

Apropos NNP O
of IN O
a DT O
case NN O

A DT O
cDNA NN O
clone NN O
encoding VBG O
C2H2 NNP B-Gene
- : I-Gene
type NN I-Gene
zinc NN I-Gene
finger NN I-Gene
protein NN I-Gene
, , O
SCOF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
was VBD O
isolated VBN O
from IN O
soybean NN O
. . O

Connector NNP B-Gene
enhancer NN I-Gene
of IN I-Gene
KSR NNP I-Gene
( ( O
CNK NNP B-Gene
) ) O
is VBZ O
a DT O
multidomain JJ O
protein NN O
required VBN O
for IN O
RAS NNP B-Gene
signaling VBG O
. . O

Reactive JJ O
lymphoid NN O
hyperplasia NN O
was VBD O
found VBN O
in IN O
15 CD O
cases NNS O
, , O
2 CD O
cases NNS O
had VBD O
angiofollicular JJ O
lymphoid JJ O
hyperplasia NN O
or CC O
Castleman NNP O
' POS O
s NN O
disease NN O
, , O
atypical JJ O
lymphoid NN O
hyperplasia NN O
suggestive NN O
of IN O
malignant JJ O
lymphoma NN O
was VBD O
observed VBN O
in IN O
3 CD O
cases NNS O
, , O
and CC O
malignant JJ O
lymphoma NN O
was VBD O
diagnosed VBN O
in IN O
the DT O
remaining VBG O
4 CD O
cases NNS O
. . O

This DT O
survey NN O
included VBD O
3000 CD O
randomly RB O
selected VBN O
Norwegians NNPS O
above IN O
18 CD O
years NNS O
of IN O
age NN O
who WP O
received VBD O
the DT O
European JJ O
Organization NNP O
for IN O
Research NNP O
and CC O
Treatment NNP O
of IN O
Cancer NNP O
Core NNP O
Quality NNP O
of IN O
Life NNP O
Questionnaire NNP O
( ( O
EORTC NNP O
QLQ NNP O
- : O
C30 NNP O
( ( O
+ NNP O
3 CD O
) ) O
by IN O
mail NN O
. . O

The DT O
interferon NN B-Gene
( ( O
IFN NNP B-Gene
) ) O
- : O
induced VBN O
double JJ B-Gene
- : I-Gene
stranded VBN I-Gene
RNA NNP I-Gene
( ( I-Gene
dsRNA NN I-Gene
) ) I-Gene
- : I-Gene
activated VBN I-Gene
Ser NNP I-Gene
/ NNP I-Gene
Thr NNP I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
PKR NNP B-Gene
) ) O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
antiviral JJ O
and CC O
antiproliferative JJ O
effects NNS O
of IN O
IFN NNP B-Gene
. . O

Antithrombin NNP B-Gene
III NNP I-Gene
in IN O
hip NN O
surgery NN O

A DT O
further JJ O
analysis NN O
has VBZ O
been VBN O
performed VBN O
using VBG O
the DT O
series NN O
of IN O
maximum JJ O
intensity NN O
for IN O
fixed VBN O
duration NN O
( ( O
1 CD O
, , O
3 CD O
, , O
6 CD O
, , O
12 CD O
, , O
24 CD O
hrs NN O
) ) O
and CC O
annual JJ O
daily JJ O
maxima NN O
. . O

The DT O
use NN O
of IN O
primary JJ O
GE NNP O
cells NNS O
thus RB O
provides VBZ O
a DT O
convenient NN O
in IN O
vitro NN O
system NN O
for IN O
further JJ O
study NN O
of IN O
the DT O
endocrine NN O
, , O
paracrine NN O
, , O
and CC O
autocrine JJ O
factors NNS O
regulating VBG O
endometrial JJ O
gene NN O
expression NN O
during IN O
pregnancy NN O
. . O

M NNP B-Gene
. . I-Gene
leprae NN I-Gene
OxyR NNP I-Gene
was VBD O
overproduced VBN O
and CC O
purified VBN O
, , O
and CC O
its PRP$ O
binding NN O
to TO O
the DT O
oxyR JJ B-Gene
- : O
ahpC NN B-Gene
intergenic JJ O
region NN O
of IN O
M NNP O
. . O
leprae NN O
was VBD O
demonstrated VBN O
. . O

The DT O
N3 NNP O
wave NN O
of IN O
the DT O
SSEP NNP O
' POS O
s NN O
, , O
which WDT O
has VBZ O
been VBN O
found VBN O
to TO O
correlate VB O
best JJS O
with IN O
neurological JJ O
recovery NN O
, , O
returned VBD O
to TO O
65 CD O
% NN O
+ NNP O
/ NNP O
- : O
48 CD O
% NN O
of IN O
the DT O
preischemia NN O
amplitude NN O
in IN O
the DT O
insulin NN B-Gene
- : O
treated JJ O
animals NNS O
, , O
compared VBN O
to TO O
40 CD O
% NN O
+ NNP O
/ NNP O
- : O
34 CD O
% NN O
in IN O
the DT O
fasted VBN O
group NN O
and CC O
26 CD O
% NN O
+ NNP O
/ NNP O
- : O
24 CD O
% NN O
in IN O
the DT O
control NN O
animals NNS O
. . O

It PRP O
seems VBZ O
that IN O
the DT O
way NN O
in IN O
which WDT O
drugs NNS O
modify VBP O
a DT O
patient NN O
' POS O
s NN O
serum NNS O
chemistry NN O
may MD O
be VB O
used VBN O
to TO O
assess VB O
the DT O
efficacy NN O
with IN O
which WDT O
they PRP O
control VBP O
the DT O
inflammatory JJ O
process NN O
. . O

The DT O
duration NN O
of IN O
diabetes NNS O
mellitus VBP O
in IN O
these DT O
patients NNS O
was VBD O
from IN O
5 CD O
months NNS O
to TO O
6 CD O
years NNS O
, , O
and CC O
in IN O
all DT O
patients NNS O
this DT O
was VBD O
the DT O
first JJ O
myocardial JJ O
infarction NN O
. . O

To TO O
assess VB O
the DT O
effects NNS O
of IN O
alveolar JJ O
hypoxia NN O
and CC O
angiotensin NN B-Gene
II NNP I-Gene
infusion NN O
on IN O
distribution NN O
of IN O
blood NN O
flow NN O
to TO O
the DT O
lung NN O
we PRP O
performed VBD O
perfusion NN O
lung NN O
scans NNS O
on IN O
anesthetized VBN O
mechanically RB O
ventilated JJ O
lambs NNS O
. . O

In IN O
contrast NN O
, , O
tobacco NN B-Gene
GS NNP I-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
composed VBN O
of IN O
subunits NNS O
of IN O
identical JJ O
size NN O
in IN O
all DT O
organs NNS O
examined VBN O
. . O

The DT O
described JJ O
results NNS O
show VBP O
that IN O
DTD NNP O
is VBZ O
fast RB O
, , O
simple JJ O
, , O
and CC O
easy JJ O
to TO O
automate VB O
; : O
requires VBZ O
only RB O
a DT O
small JJ O
amount NN O
of IN O
sample NN O
( ( O
approximately RB O
50 CD O
mg NN O
) ) O
; : O
and CC O
affords NNS O
quantitative JJ O
information NN O
about IN O
the DT O
main JJ O
groups NNS O
of IN O
compounds NNS O
present JJ O
in IN O
cheeses NNS O
. . O

The DT O
FCMS NNP O
conditions NNS O
were VBD O
as IN O
follows VBZ O
: : O
2 CD O
kW NNS O
maximum JJ O
electrical JJ O
power NN O
consumption NN O
, , O
800 CD O
V NNP O
maximum JJ O
capacitor NN O
voltage NN O
, , O
720 CD O
microseconds NNS O
pulsewidth JJ O
( ( O
180 CD O
microseconds NNS O
rise JJ O
time NN O
) ) O
, , O
and CC O
5 CD O
- : O
30 CD O
Hz NNP O
frequency NN O
. . O

RESULTS NN O
: : O
The DT O
subjects NNS O
in IN O
the DT O
augmented JJ O
feedback NN O
group NN O
significantly RB O
reduced VBD O
their PRP$ O
peak JJ O
vertical JJ O
ground NN O
reaction NN O
force NN O
in IN O
both DT O
post NN O
- : O
test NN O
conditions NNS O
( ( O
2 CD O
- : O
minute NN O
post NN O
- : O
test NN O
reduction NN O
, , O
0 CD O
. . O
85 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
62 CD O
; : O
1 CD O
- : O
week NN O
post NN O
- : O
test NN O
reduction NN O
, , O
0 CD O
. . O
74 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
58 CD O
) ) O
as IN O
compared VBN O
to TO O
the DT O
sensory JJ O
, , O
control NN O
I PRP O
, , O
and CC O
control VB O
II NNP O
feedback NN O
groups NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
HAPE NNP O
- : O
S NNP O
- : O
S NN O
are VBP O
prone NN O
to TO O
irregular JJ O
nocturnal JJ O
breathing NN O
patterns NNS O
at IN O
high JJ O
altitude NN O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
the DT O
development NN O
of IN O
AMS NNP O
, , O
but CC O
it PRP O
was VBD O
not RB O
possible JJ O
to TO O
determine VB O
whether IN O
these DT O
abnormal JJ O
breathing NN O
patterns NNS O
are VBP O
a DT O
cause NN O
or CC O
an DT O
effect NN O
of IN O
AMS NNP O
. . O

Optical JJ O
CD NN O
, , O
and CC O
spectral JJ O
and CC O
activity NN O
analyses NNS O
were VBD O
used VBN O
to TO O
examine VB O
reactivity NN O
of IN O
HO NNP B-Gene
isozymes NNS I-Gene
with IN O
NO NNP O
species NNS O
produced VBN O
by IN O
NO DT O
donors NNS O
. . O

Effects NNS O
of IN O
ketamine NN O
on IN O
the DT O
circulatory NN O
functions NNS O
and CC O
body NN O
tissue NN O
oxygenation NN O
in IN O
dogs NNS O
under IN O
normal JJ O
and CC O
hypovolemic JJ O
conditions NNS O
. . O

One CD O
of IN O
the DT O
conserved JJ O
RNA NNP O
subdomains NNS O
, , O
designated VBN O
P3 NNP B-Gene
, , O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
nucleolar JJ O
localization NN O
. . O

Selective JJ O
activation NN O
of IN O
adrenaline JJ O
secretion NN O
by IN O
the DT O
rat NN O
adrenal JJ O
in IN O
neuroglycopenia NN O
detected VBN O
via IN O
microdialysis NN O

PRDII NNP B-Gene
- : I-Gene
BF1 NNP I-Gene
- : I-Gene
derived VBD I-Gene
cDNAs NNS I-Gene
did VBD O
not RB O
result VB O
in IN O
stimulation NN O
of IN O
either DT O
basal NN O
or CC O
tat VB B-Gene
- : O
induced VBN O
activated JJ O
gene NN O
expression NN O
. . O

In IN O
part NN O
as IN O
a DT O
result NN O
of IN O
its PRP$ O
inability NN O
to TO O
sustain VB O
radiative JJ O
loses NNS O
, , O
the DT O
BB NNP O
resonator NN O
has VBZ O
extremely RB O
low JJ O
RF NNP O
power NN O
requirements NNS O
. . O

The DT O
general JJ O
recombination NN O
at IN O
a DT O
polarizing JJ O
voltage NN O
of IN O
300 CD O
V NNP O
is VBZ O
less JJR O
than IN O
2 CD O
% NN O
for IN O
dose JJ O
- : O
rates NNS O
up RB O
to TO O
about IN O
100 CD O
mGy NNS O
min SYM O
- : O
1 CD O
. . O

CONCLUSIONS NN O
: : O
The DT O
methodology NN O
of IN O
LHR NNP O
measurement NN O
significantly RB O
influences VBZ O
the DT O
clinical JJ O
contribution NN O
of IN O
Tl NNP O
- : O
201 CD O
lung NN O
uptake JJ O
evaluation NN O
. . O

The DT O
plexiform NN O
neurofibroma NN O
and CC O
multiple JJ O
localized VBN O
neurofibromas NN O
are VBP O
characteristic JJ O
of IN O
NF1 NNP B-Gene
. . O

Both DT O
the DT O
Cmax NNP O
and CC O
AUC NNP O
values NNS O
were VBD O
almost RB O
doubled VBN O
with IN O
doubling VBG O
the DT O
dose NN O
. . O

This DT O
study NN O
shows VBZ O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
is VBZ O
the DT O
predominant JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
isoform NN I-Gene
found VBD O
in IN O
activated JJ O
stellate NN O
cells NNS O
and CC O
that DT O
increased VBD O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
protein NN I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
binding VBG O
to TO O
a DT O
proximal JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
the DT O
promoter NN O
mediates VBZ O
the DT O
activating VBG O
effect NN O
of IN O
acetaldehyde NN O
. . O

Interpersonal JJ O
style NN O
differences NNS O
among IN O
drug NN O
abusers NNS O
were VBD O
explored VBN O
using VBG O
Ryan NNP O
' POS O
s NN O
( ( O
1977 CD O
) ) O
typological JJ O
system NN O
of IN O
FIRO NNP O
- : O
B NNP O
interpretation NN O
. . O

Because IN O
the DT O
high JJ B-Gene
- : I-Gene
density NN I-Gene
lipoprotein NN I-Gene
receptor NN I-Gene
( ( O
HDL NNP B-Gene
- : I-Gene
R NN I-Gene
) ) O
is VBZ O
a DT O
key JJ O
element NN O
in IN O
cholesterol NN O
homeostasis NN O
and CC O
a DT O
potential JJ O
therapeutic JJ O
target NN O
for IN O
hypercholesterolemic JJ O
drugs NNS O
, , O
an DT O
understanding NN O
of IN O
HDL NNP B-Gene
- : I-Gene
R NN I-Gene
regulation NN O
is VBZ O
essential JJ O
. . O

ST NNP O
elevation NN O
occurs VBZ O
in IN O
5 CD O
patients NNS O
( ( O
55 CD O
. . O
5 CD O
% NN O
) ) O
of IN O
subgroup NN O
A NNP O
and CC O
in IN O
no DT O
patient NN O
of IN O
the DT O
subgroup NN O
B NNP O
. . O

The DT O
active JJ O
derivatives NNS O
of IN O
the DT O
present JJ O
series NN O
were VBD O
also RB O
tested VBN O
for IN O
their PRP$ O
analgesic JJ O
activity NN O
against IN O
aconitine JJ O
- : O
induced JJ O
writhing NN O
in IN O
albino NN O
mice NN O
and CC O
ulcerogenic JJ O
activity NN O
in IN O
albino NN O
rats NNS O
. . O

Assay NNP O
of IN O
serum NN B-Gene
immunoreactive JJ I-Gene
trypsin NN I-Gene
in IN O
dried JJ O
blood NN O
spots NNS O
and CC O
the DT O
early JJ O
detection NN O
of IN O
cystic JJ O
fibrosis NN O
. . O

There EX O
was VBD O
significant JJ O
correlation NN O
of IN O
LVM NNP O
/ NNP O
M2 NNP O
and CC O
PWVn NNP O
for IN O
pre NN O
- : O
AVR NNP O
and CC O
post NN O
AVR NNP O
studies NNS O
. . O

All DT O
subjects NNS O
were VBD O
submitted VBN O
to TO O
ECG NNP O
and CC O
arterial JJ O
blood NN O
pressure NN O
determination NN O
and CC O
were VBD O
assayed VBN O
for IN O
TSH NNP B-Gene
, , O
thyroid NN O
hormone NN O
, , O
PRL NNP B-Gene
, , O
glucose NN O
, , O
creatinine NN O
, , O
nitrogen NN O
, , O
glutamine JJ B-Gene
transaminase NN I-Gene
, , O
cholesterol NN O
and CC O
triglycerides NNS O
plasma VBP O
levels NNS O
before IN O
therapy NN O
( ( O
T0 NNP O
) ) O
, , O
after IN O
30 CD O
treatment NN O
days NNS O
( ( O
T30 NNP O
) ) O
and CC O
after IN O
a DT O
15 CD O
days NNS O
washout IN O
( ( O
T45 NNP O
) ) O
. . O

The DT O
results NNS O
showed VBD O
that IN O
the DT O
sensitivity NN O
of IN O
the DT O
3 CD O
given VBN O
guinea NN O
pig NN O
strains NNS O
was VBD O
comparable JJ O
. . O

Among IN O
the DT O
LE6 NNP B-Gene
deletions NNS O
, , O
only RB O
one CD O
had VBD O
a DT O
reduced VBN O
transformation NN O
efficiency NN O
, , O
while IN O
seven CD O
transformed VBD O
cells NNS O
at IN O
least JJS O
as RB O
efficiently RB O
as IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
LE6 NNP I-Gene
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
of IN O
CAR NNP B-Gene
revealed VBD O
that IN O
CAR NNP B-Gene
residues NNS O
Leu73 NNP O
and CC O
Lys121 NNP O
and CC O
/ NNP O
or CC O
Lys123 NNP O
are VBP O
critical JJ O
contact NN O
residues NNS O
, , O
with IN O
Tyr80 NNP O
and CC O
Tyr83 NNP O
being VBG O
peripherally RB O
involved VBN O
in IN O
the DT O
binding NN O
interaction NN O
with IN O
the DT O
Ad5 NNP B-Gene
, , I-Gene
Ad9 NNP I-Gene
, , I-Gene
Ad12 NNP I-Gene
, , I-Gene
and CC I-Gene
Ad41L NNP I-Gene
fiber NNP I-Gene
knobs NN I-Gene
. . O

In IN O
addition NN O
, , O
the DT O
ketamine NN O
- : O
treated JJ O
rats NNS O
had VBD O
more JJR O
neurons NNS O
and CC O
glial JJ O
cells NNS O
surrounding VBG O
the DT O
ventricles NNS O
. . O

The DT O
glomerular JJ O
filtration NN O
rate NN O
did VBD O
not RB O
change VB O
but CC O
lithium JJ O
clearance NN O
fell VBD O
by IN O
30 CD O
% NN O
. . O

Disruption NN O
of IN O
ARF2 NNP B-Gene
causes VBZ O
no DT O
detectable JJ O
phenotype NN O
. . O

Similar JJ O
data NNS O
were VBD O
also RB O
obtained VBN O
when WRB O
either DT O
dominant JJ O
negative JJ O
EGFR NNP B-Gene
- : O
CD533 NN B-Gene
or CC O
dominant JJ B-Gene
negative JJ I-Gene
Ras NNP I-Gene
N17 NNP I-Gene
were VBD O
used VBN O
to TO O
block VB O
MAPK NNP B-Gene
activation NN O
. . O

Proteolysis NN O
of IN O
Mbp1 NNP B-Gene
and CC O
Swi4 NNP B-Gene
DNA NNP I-Gene
- : I-Gene
protein NN I-Gene
complexes NNS I-Gene
has VBZ O
revealed VBN O
the DT O
extent NN O
of IN O
these DT O
sequences NNS O
, , O
and CC O
C NNP O
- : O
terminally RB O
extended VBD O
molecules NNS O
with IN O
substantially RB O
enhanced VBN O
DNA NNP O
binding VBG O
activity NN O
compared VBN O
to TO O
the DT O
core NN O
domains VBZ O
alone RB O
have VBP O
been VBN O
produced VBN O
. . O

This DT O
suggests VBZ O
roles NNS O
for IN O
both DT O
the DT O
CE1 NNP O
and CC O
CE2 NNP O
elements NNS O
in IN O
regulating VBG O
Hoxb1 NNP B-Gene
gene NN I-Gene
expression NN O
during IN O
development NN O
. . O

The DT O
conservation NN O
of IN O
both CC O
the DT O
G NNP O
- : O
box NN O
and CC O
H NNP O
- : O
box NN O
in IN O
different JJ O
CHS NNP B-Gene
promoters NNS I-Gene
emphasizes VBP O
their PRP$ O
importance NN O
as IN O
regulatory JJ O
motifs NNS O
. . O

Notably RB O
, , O
SRF NNP B-Gene
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
a DT O
key JJ O
regulator NN O
of IN O
members NNS O
of IN O
a DT O
class NN O
of IN O
cellular JJ O
response NN O
genes NNS O
termed VBD O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
genes NNS I-Gene
( ( O
IEGs NNP B-Gene
) ) O
, , O
many JJ O
of IN O
which WDT O
are VBP O
believed VBN O
to TO O
be VB O
involved VBN O
in IN O
regulating VBG O
cell NN O
growth NN O
and CC O
differentiation NN O
. . O

One CD O
group NN O
of IN O
six CD O
cDNA NN O
clones NNS O
was VBD O
derived VBN O
from IN O
a DT O
2 CD O
. . O
9 CD O
- : O
kilobase NN O
early JJ O
transcript NN O
encoded VBN O
by IN O
the DT O
IR2 NNP O
repeat NN O
element NN O
and CC O
showed VBD O
restriction NN O
site NN O
polymorphism NN O
for IN O
the DT O
enzyme NN B-Gene
SmaI NNP I-Gene
. . O

Oxygen NN O
profiles NNS O
calculated VBN O
for IN O
the DT O
Krogh NNP O
model NN O
with IN O
excentric JJ O
diffusion NN O
were VBD O
similar JJ O
to TO O
those DT O
derived VBN O
for IN O
the DT O
two CD O
models NNS O
of IN O
concentric JJ O
diffusion NN O
. . O

Liver NNP O
injuries NNS O

Zinc JJ O
fingers NNS O
( ( O
Zf NNP O
) ) O
are VBP O
a DT O
common JJ O
structural JJ O
motif NN O
found VBD O
in IN O
many JJ O
nucleic JJ O
acid SYM O
- : O
binding NN O
proteins NNS O
. . O

A DT O
new JJ O
UASH NNP O
consensus NN O
sequence NN O
derived VBN O
from IN O
this DT O
mutational JJ O
analysis NN O
closely RB O
matches VBZ O
a DT O
consensus NN O
Abf1 NNP B-Gene
binding NN I-Gene
site NN I-Gene
. . O

Unlike IN O
p59v SYM B-Gene
- : O
rel NN B-Gene
, , O
which WDT O
is VBZ O
a DT O
nuclear JJ O
protein NN O
in IN O
CEF NNP O
, , O
indirect JJ O
immunofluorescence NN O
showed VBD O
that IN O
p68c SYM B-Gene
- : O
rel NN B-Gene
in IN O
JD214c NNP O
- : O
rel NN O
infected JJ O
CEF NNP O
is VBZ O
located VBN O
exclusively RB O
in IN O
the DT O
cytoplasm NN O
of IN O
these DT O
cells NNS O
, , O
even RB O
though IN O
the DT O
sequence NN O
of IN O
p68c JJ B-Gene
- : O
rel NN B-Gene
showed VBD O
that IN O
it PRP O
contains VBZ O
a DT O
nuclear JJ O
localizing NN O
sequence NN O
identical JJ O
to TO O
the DT O
one CD O
previously RB O
identified VBN O
in IN O
p59v JJ B-Gene
- : O
rel NN B-Gene
. . O

Either DT O
20 CD O
mg NN O
mitomycin NN O
/ VBD O
20 CD O
ml NN O
distilled JJ O
water NN O
or CC O
40 CD O
mg NNS O
/ VBD O
40 CD O
ml NN O
distilled VBD O
water NN O
was VBD O
locally RB O
instilled VBN O
into IN O
the DT O
bladder NN O
with IN O
a DT O
catheter NN O
after IN O
emptying VBG O
it PRP O
and CC O
was VBD O
left VBN O
for IN O
about IN O
25 CD O
- : O
l20 NN O
min NN O
. . O

Role NNP O
of IN O
secondary JJ O
structure NN O
in IN O
discrimination NN O
between IN O
constitutive JJ O
and CC O
inducible JJ O
activators NNS O
. . O

While IN O
fusion NN O
to TO O
the DT O
N NNP O
- : O
terminus NN O
required VBD O
a DT O
linker NN O
to TO O
become VB O
surface NN O
accessible JJ O
, , O
both DT O
fusion NN O
to TO O
the DT O
N NNP O
- : O
terminus NN O
and CC O
to TO O
the DT O
C NNP O
- : O
terminus NN O
was VBD O
compatible JJ O
with IN O
particle NN O
assembly NN O
and CC O
preserved VBD O
the DT O
native JJ O
antigenicity NN O
and CC O
immunogenicity NN O
of IN O
HBcAg NNP B-Gene
. . O

The DT O
origins NNS O
of IN O
reflected JJ O
light JJ O
changes NNS O
associated VBN O
with IN O
neuronal JJ O
activity NN O
( ( O
optical JJ O
signals NNS O
) ) O
were VBD O
investigated VBN O
in IN O
rat NN O
somatosensory NN O
cortex NN O
with IN O
optical JJ O
imaging NN O
, , O
microspectrophotometry NN O
, , O
and CC O
laser SYM O
- : O
Doppler NNP O
flowmetry NN O
, , O
and CC O
dynamic JJ O
changes NNS O
in IN O
local JJ O
hemoglobin NN B-Gene
concentration NN O
and CC O
oxygenation NN O
were VBD O
focused VBN O
on IN O
. . O

The DT O
effect NN O
of IN O
L NNP O
- : O
methionine NN O
supplementation NN O
on IN O
the DT O
utilization NN O
of IN O
a DT O
soy JJ O
protein NN O
isolate NN O
( ( O
SPI NNP O
) ) O
was VBD O
evaluated VBN O
by IN O
short JJ O
- : O
term NN O
nitrogen JJ O
balance NN O
studies NNS O
in IN O
young JJ O
women NNS O
. . O

The DT O
interleukin JJ B-Gene
2 CD I-Gene
receptor NN I-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) O
gene NN O
is VBZ O
rapidly RB O
and CC O
potently RB O
induced VBN O
in IN O
T NNP O
cells NNS O
in IN O
response NN O
to TO O
mitogenic JJ O
stimuli NNS O
. . O

These DT O
risk NN O
factors NNS O
can MD O
be VB O
divided VBN O
into IN O
2 CD O
groups NNS O
: : O
local JJ O
vessel NN O
wall SYM O
- : O
related JJ O
factors NNS O
, , O
and CC O
local JJ O
( ( O
focal JJ O
action NN O
) ) O
systemic JJ O
factors NNS O
. . O

Copyright JJ O
2000 CD O
Academic NNP O
Press NNP O
. . O

Our PRP$ O
results NNS O
support VB O
a DT O
model NN O
where WRB O
both DT O
E2F NNP B-Gene
- : O
and CC O
CDE NNP O
- : O
mediated VBN O
repression NN O
, , O
acting VBG O
at IN O
different JJ O
stages NNS O
in IN O
the DT O
cell NN O
cycle NN O
, , O
are VBP O
dependent JJ O
on IN O
promoter NN O
- : O
specific JJ O
CHR NNP O
elements NNS O
. . O

We PRP O
produced VBD O
transgenic JJ O
plants NNS O
expressing VBG O
the DT O
antisense JJ B-Gene
Arabidopsis NNP I-Gene
HD NNP I-Gene
( ( O
AtHD1 NNP B-Gene
) ) O
gene NN O
. . O

Male JJ O
contraception NN O
: : O
ideas NNS O
for IN O
the DT O
future NN O
. . O

Growth NNP O
factor NN O
allows VBZ O
effective JJ O
dose JJ O
- : O
intensive JJ O
regimen NNS O
in IN O
advanced JJ O
breast NN O
cancer NN O
patients NNS O
. . O

Advances NNS O
in IN O
the DT O
management NN O
of IN O
gynecologic NN O
cancer NN O
- : O
- : O
radiation NN O
therapy NN O
. . O

These DT O
data NNS O
support VBP O
the DT O
idea NN O
that IN O
the DT O
repression NN O
activity NN O
of IN O
NRSF NNP B-Gene
/ NNP O
REST NNP B-Gene
depends VBZ O
upon IN O
the DT O
species NNS O
of IN O
promoter NN O
to TO O
which WDT O
it PRP O
is VBZ O
linked VBN O
and CC O
upon IN O
the DT O
proteins NNS O
that WDT O
bind VBP O
to TO O
those DT O
promoters NNS O
. . O

The DT O
Cut9 NNP B-Gene
subunit NN I-Gene
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
target NN O
for IN O
regulating VBG O
APC NNP B-Gene
/ NNP I-Gene
cyclosome NN I-Gene
function NN O
through IN O
protein NN O
- : O
protein NN O
interactions NNS O
and CC O
phosphorylation NN O
. . O

To TO O
address VB O
the DT O
biological JJ O
effect NN O
of IN O
specific JJ O
isoform NN O
expression NN O
, , O
NIH3T3 NNP O
cells NNS O
were VBD O
transfected VBN O
with IN O
a DT O
eukaryotic JJ O
expression NN O
vector NN O
containing VBG O
cDNA NN O
for IN O
FGF8a NNP B-Gene
, , O
FGF8b NNP B-Gene
, , O
or CC O
FGF8e NNP B-Gene
. . O

Editorial NN O
: : O
Low JJ O
- : O
dose NN O
heparin NN O
and CC O
the DT O
prevention NN O
of IN O
venous JJ O
thromboembolic JJ O
disease NN O
. . O

Time NN O
to TO O
progression NN O
was VBD O
6 CD O
months NNS O
( ( O
5 CD O
- : O
7 CD O
months NNS O
) ) O
with IN O
a DT O
median JJ O
survival NN O
from IN O
registration NN O
of IN O
9 CD O
. . O
6 CD O
months NNS O
( ( O
95 CD O
% NN O
CI NNP O
8 CD O
- : O
12 CD O
months NNS O
) ) O
. . O

Replacing VBG O
the DT O
aspartic JJ O
acid NN O
with IN O
a DT O
lysine NN O
but CC O
not RB O
with IN O
an DT O
alanine NN O
or CC O
valine NN O
residue JJ O
allowed VBN O
formation NN O
of IN O
disulfide JJ O
- : O
linked VBN O
dimers NNS O
. . O

All DT O
members NNS O
are VBP O
also RB O
capable JJ O
of IN O
activating VBG O
in IN O
vivo JJ O
transcription NN O
from IN O
promoters NNS O
that WDT O
contain VBP O
a DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
. . O

Critical NNP O
study NN O

The DT O
N NNP O
terminus NN O
of IN O
beta NN O
( ( O
95 CD O
kDa NN O
) ) O
corresponds VBZ O
to TO O
alpha VB O
with IN O
the DT O
integrase NN B-Gene
domain NN I-Gene
attached VBD O
to TO O
the DT O
C NNP O
terminus NN O
( ( O
32 CD O
kDa NN O
) ) O
. . O

Analysis NN O
of IN O
ace2Delta JJ O
cells NNS O
reveals NNS O
that IN O
Ace2p NNP B-Gene
is VBZ O
required VBN O
for IN O
cell NN O
separation NN O
but CC O
not RB O
for IN O
polarized JJ O
growth NN O
. . O

In IN O
the DT O
meantime NN O
, , O
one CD O
has VBZ O
succeeded VBN O
to TO O
establish VB O
the DT O
deammonification NN O
processes VBZ O
in IN O
a DT O
continuous JJ O
flow NN O
moving VBG O
- : O
bed NN O
pilot NN O
plant NN O
. . O

Recognition NN O
of IN O
emphysema NN O
was VBD O
poor JJ O
when WRB O
radiographs NN O
of IN O
inadequate JJ O
quality NN O
were VBD O
included VBN O
( ( O
anteroposterior JJ O
films NNS O
or CC O
films NNS O
from IN O
patients NNS O
with IN O
acute JJ O
or CC O
chronic JJ O
lung NN O
disease NN O
) ) O
. . O

Private JJ O
hospital NN O
accreditation NN O
. . O

Another DT O
element NN O
necessary JJ O
for IN O
augmenting VBG O
the DT O
amplitude NN O
of IN O
the DT O
oscillation NN O
lies VBZ O
between IN O
- : O
178 CD O
and CC O
- : O
264 CD O
. . O

When WRB O
the DT O
coding NN O
segments NNS O
, , O
including VBG O
both DT O
framework NN O
and CC O
complementarity NN O
- : O
determining NN O
regions NNS O
, , O
of IN O
these DT O
genes NNS O
and CC O
the DT O
murine NN O
probe NN O
sequences NNS O
are VBP O
compared VBN O
by IN O
metric JJ O
analysis NN O
, , O
it PRP O
is VBZ O
apparent JJ O
that IN O
the DT O
caiman NN O
genes NNS O
are VBP O
only RB O
slightly RB O
more RBR O
related JJ O
to TO O
each DT O
other JJ O
than IN O
to TO O
the DT O
mammalian JJ O
sequence NN O
, , O
consistent JJ O
with IN O
significant JJ O
preservation NN O
of IN O
nucleotide JJ O
sequence NN O
over IN O
an DT O
extended JJ O
period NN O
of IN O
phylogenetic JJ O
time NN O
. . O

100 CD O
years NNS O
of IN O
dentistry NN O
at IN O
the DT O
Friedrich NNP O
Schiller NNP O
University NNP O
in IN O
Jena NNP O

Ang NNP B-Gene
II NNP I-Gene
- : O
induced VBD O
fibronectin JJ B-Gene
mRNA NN O
was VBD O
not RB O
affected VBN O
by IN O
PKC NNP B-Gene
inhibitors NNS O
or CC O
PKC NNP B-Gene
depletion NN O
, , O
whereas WP O
specific JJ O
inhibition NN O
of IN O
EGF NNP B-Gene
- : I-Gene
R NN I-Gene
function NN O
by IN O
a DT O
dominant JJ B-Gene
negative JJ I-Gene
EGF NNP I-Gene
- : I-Gene
R NN I-Gene
mutant NN I-Gene
and CC O
tyrphostin NN O
AG1478 NNP O
abolished VBD O
induction NN O
of IN O
fibronectin NN B-Gene
mRNA NN I-Gene
. . O

Positive JJ O
CRP NNP B-Gene
test NN O
were VBD O
seen VBN O
. . O

Setting VBG O
takes VBZ O
place NN O
through IN O
complex JJ O
formation NN O
of IN O
( ( O
NH4Mg NNP O
PO4 NNP O
. . O
6H2O CD O
) ) O
n NN O
, , O
excess JJ O
reactants NNS O
, , O
and CC O
water NN O
. . O

There EX O
has VBZ O
been VBN O
similar JJ O
improvement NN O
in IN O
treating VBG O
ampullary JJ O
and CC O
periampullary JJ O
cancer NN O
, , O
gallbladder NN O
cancer NN O
, , O
or CC O
extrahepatic JJ O
bile NN O
duct NN O
cancer NN O
. . O

The DT O
relatively RB O
high JJ O
level NN O
transcription NN O
from IN O
this DT O
gene NN O
shows VBZ O
that IN O
the DT O
polymorphic JJ O
chromosome NN O
ends NNS O
of IN O
P NNP O
. . O
falciparum NN O
, , O
which WDT O
have VBP O
been VBN O
proposed VBN O
to TO O
be VB O
transcriptionally RB O
silent JJ O
, , O
can MD O
be VB O
active JJ O
expression NN O
sites NNS O
for IN O
var NN B-Gene
genes NNS I-Gene
. . O

Effects NNS O
of IN O
chronic JJ O
metaraminol NN O
treatment NN O
on IN O
the DT O
sympathetic JJ O
activity NN O
of IN O
intact JJ O
and CC O
adrenal JJ O
demedullated JJ O
rats NNS O
kept VBD O
in IN O
warm JJ O
or CC O
cold JJ O
environments NNS O
. . O

This DT O
inhibition NN O
can MD O
be VB O
overcome VBN O
by IN O
mutating VBG O
either CC O
the DT O
exon NN O
' POS O
s JJ O
5 CD O
' POS O
or CC O
3 CD O
' '' O
splice NN O
site NN O
to TO O
make VB O
it PRP O
correspond VB O
more RBR O
closely RB O
to TO O
the DT O
relevant JJ O
consensus NN O
sequence NN O
. . O

The DT O
modalities NNS O
for IN O
using VBG O
reference NN O
values NNS O
for IN O
individual JJ O
subjects NNS O
as RB O
well RB O
as IN O
for IN O
groups NNS O
are VBP O
then RB O
discussed VBN O
and CC O
the DT O
main JJ O
points NNS O
of IN O
research NN O
which WDT O
must MD O
be VB O
faced VBN O
in IN O
the DT O
near JJ O
future NN O
regarding VBG O
reference NN O
values NNS O
are VBP O
highlighted VBN O
. . O

Stoichiometric JJ O
phosphorylation NN O
of IN O
human JJ B-Gene
p53 NN I-Gene
at IN O
Ser315 NNP O
stimulates VBZ O
p53 SYM B-Gene
- : O
dependent JJ O
transcription NN O
. . O

p53 NN B-Gene
protein NN I-Gene
activity NN O
as IN O
a DT O
transcription NN O
factor NN O
can MD O
be VB O
activated VBN O
in IN O
vivo NN O
by IN O
antibodies NNS O
that WDT O
target VBP O
its PRP$ O
C NNP O
- : O
terminal JJ O
negative JJ O
regulatory JJ O
domain NN O
suggesting VBG O
that IN O
cellular JJ O
enzymes NNS O
that WDT O
target VBP O
this DT O
domain NN O
may MD O
play VB O
a DT O
role NN O
in IN O
stimulating VBG O
p53 NN B-Gene
- : O
dependent JJ O
gene NN O
expression NN O
. . O

Nucleotide NNP O
sequences NNS O
of IN O
the DT O
clones NNS O
revealed VBD O
that IN O
one CD O
clone NN O
, , O
cap3 NN B-Gene
, , O
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
( ( O
ORF NNP O
) ) O
that WDT O
would MD O
code VB O
for IN O
a DT O
26 CD O
- : O
amino NN O
acid NN O
, , O
cysteine VB O
- : O
rich JJ O
peptide NN O
with IN O
significant JJ O
homology NN O
to TO O
Neurospora NNP B-Gene
crassa NN I-Gene
copper NN I-Gene
metallothionein NN I-Gene
. . O

Human NNP B-Gene
ULK1 NNP I-Gene
, , O
a DT O
novel JJ O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
kinase NN I-Gene
related VBN O
to TO O
UNC NNP B-Gene
- : I-Gene
51 CD I-Gene
kinase NN I-Gene
of IN O
Caenorhabditis NNP O
elegans NNS O
: : O
cDNA NN O
cloning NN O
, , O
expression NN O
, , O
and CC O
chromosomal JJ O
assignment NN O
. . O

The DT O
Y NNP O
- : O
type JJ O
structural JJ O
motif NN O
is VBZ O
also RB O
conserved VBN O
among IN O
a DT O
number NN O
of IN O
divergent JJ O
BiP NNP B-Gene
mRNAs NN I-Gene
. . O

However RB O
, , O
in IN O
a DT O
new JJ O
experiment NN O
in IN O
which WDT O
the DT O
deletion NN O
task NN O
was VBD O
presented VBN O
as IN O
a DT O
puppet NN O
game NN O
, , O
and CC O
with IN O
pretraining NN O
and CC O
selection NN O
on IN O
vowel NN O
deletion NN O
, , O
a DT O
significantly RB O
higher JJR O
level NN O
of IN O
success NN O
was VBD O
achieved VBN O
by IN O
the DT O
children NNS O
working VBG O
with IN O
the DT O
CVCC NNP O
material NN O
. . O

In IN O
one CD O
of IN O
these DT O
tumors NNS O
the DT O
observed JJ O
rearrangement NN O
was VBD O
not RB O
due JJ O
to TO O
the DT O
insertion NN O
of IN O
an DT O
intact JJ O
MoMuLV NNP O
provirus NN O
. . O

Less NNP O
antibacterial JJ O
activity NN O
was VBD O
shown VBN O
toward IN O
the DT O
Gram NNP O
- : O
negative JJ O
bacilli NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
Pseudomonas NNP O
, , O
Klebsiella NNP O
- : O
Enterobacter NN O
, , O
Shigella NNP O
, , O
Escherichia NNP O
coli NN O
, , O
Serratia NNP O
marcescens NNS O
and CC O
Proteus NNP O
. . O

Mapping VBG O
features NNS O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
integrase NN I-Gene
near IN O
selected VBN O
sites NNS O
on IN O
viral JJ O
and CC O
target NN O
DNA NNP O
molecules NNS O
in IN O
an DT O
active JJ O
enzyme NN O
- : O
DNA NN O
complex JJ O
by IN O
photo NN O
- : O
cross NN O
- : O
linking NN O
. . O

The DT O
scores NNS O
are VBP O
dependent JJ O
in IN O
part NN O
on IN O
the DT O
reliability NN O
of IN O
faculty NN O
evaluations NNS O
. . O

Both DT O
variants NNS O
display VBP O
the DT O
seven CD O
- : O
transmembrane NN O
topology NN O
that WDT O
is VBZ O
typical JJ O
for IN O
G NNP B-Gene
protein SYM I-Gene
- : I-Gene
coupled VBN I-Gene
receptors NNS I-Gene
. . O

However RB O
, , O
the DT O
mouse NN O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
possess VB O
only RB O
three CD O
forms NNS O
of IN O
ADH NNP B-Gene
. . O

Electrophoretic JJ O
characteriaztion NN O
of IN O
virus NN O
- : O
induced JJ O
interferon NN B-Gene
of IN O
the DT O
blood NN O
and CC O
urine NN O
in IN O
rabbits NNS O

One CD O
was VBD O
allowed VBN O
fresh JJ O
drinking NN O
water NN O
ad NN O
libitum NN O
whilst VBP O
the DT O
other JJ O
received VBD O
Aludrox NNP O
in IN O
their PRP$ O
drinking NN O
water NN O
. . O

Nuclear JJ O
spin NN O
of IN O
249Bk CD O
from IN O
the DT O
hyperfine NN O
structure NN O
in IN O
its PRP$ O
emission NN O
spectrum NN O
. . O

A DT O
newly RB O
developed VBN O
broad JJ O
- : O
spectrum NN O
fluoroquinolone NN O
, , O
levofloxacin NN O
( ( O
LVFX NNP O
, , O
DR NNP O
- : O
3355 CD O
) ) O
, , O
was VBD O
evaluated VBN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
in IN O
comparison NN O
with IN O
ciprofloxacin NN O
( ( O
CPFX NNP O
) ) O
, , O
ofloxacin FW O
( ( O
OFLX NNP O
) ) O
and CC O
norfloxacin $ O
( ( O
NFLX NNP O
) ) O
. . O

The DT O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
DP NNP B-Gene
family NN I-Gene
members NNS I-Gene
suggests VBZ O
that IN O
the DT O
combination NN O
of IN O
DP NNP B-Gene
/ NNP O
E2F NNP B-Gene
heterodimers NNS O
that WDT O
constitute VBP O
DRTF1 NNP B-Gene
/ NNP O
E2F NNP B-Gene
is VBZ O
influenced VBN O
by IN O
the DT O
phenotype NN O
of IN O
the DT O
cell NN O
. . O

To TO O
determine VB O
whether IN O
interaction NN O
of IN O
arsenite NN O
with IN O
the DT O
hormone NN O
- : O
binding NN O
domain NN O
results NNS O
in IN O
receptor NN O
activation NN O
, , O
COS NNP O
- : O
1 CD O
cells NNS O
were VBD O
transiently RB O
cotransfected VBN O
with IN O
the DT O
chimeric JJ B-Gene
receptors NNS I-Gene
GAL NNP I-Gene
- : I-Gene
ER NNP I-Gene
, , O
which WDT O
contains VBZ O
the DT O
hormone NN O
- : O
binding NN O
domain NN O
of IN O
ERalpha NNP B-Gene
and CC O
the DT O
DNA NNP O
- : O
binding VBG O
domain NN O
of IN O
the DT O
transcription NN O
factor NN O
GAL4 NNP B-Gene
, , O
and CC O
a DT O
GAL4 NNP B-Gene
- : O
responsive JJ O
CAT NNP B-Gene
reporter NN I-Gene
gene NN I-Gene
. . O

Primary JJ O
invasive JJ O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
disease NN O
: : O
a DT O
population NN O
- : O
based VBN O
assessment NN O
of IN O
risk NN O
factors NNS O
. . O

Serum NNP B-Gene
IgE NNP I-Gene
levels NNS O
in IN O
Tauranga NNP O
children NNS O
. . O

Tracheal NNP O
transsection NN O
combined VBN O
with IN O
hilar JJ O
ligation NN O
( ( O
TL NNP O
& CC O
PL NNP O
) ) O
effected VBD O
a DT O
reduction NN O
of IN O
19 CD O
. . O
9 CD O
% NN O
( ( O
n JJ O
. . O
s NN O
. . O
) ) O
. . O

Fifty NNP O
- : O
six CD O
semen NNS O
samples NNS O
were VBD O
included VBN O
in IN O
this DT O
study NN O
; : O
18 CD O
were VBD O
subnormal JJ O
( ( O
G1 NNP O
) ) O
and CC O
38 CD O
were VBD O
normal JJ O
( ( O
G2 NNP O
) ) O
based VBN O
on IN O
World NNP O
Health NNP O
Organization NNP O
criteria NNS O
, , O
except IN O
for IN O
morphology NN O
, , O
which WDT O
was VBD O
evaluated VBN O
according VBG O
to TO O
strict JJ O
criteria NNS O
. . O

The DT O
assay NN O
exhibits VBZ O
a DT O
dynamic JJ O
range NN O
of IN O
0 CD O
. . O
1 CD O
- : O
100 CD O
micrograms NNS O
l VBD O
- : O
1 CD O
using VBG O
a DT O
monoclonal JJ O
antibody NN O
or CC O
alternatively RB O
10 CD O
micrograms NNS O
l VBD O
- : O
1 CD O
to TO O
10 CD O
mg NNS O
l JJ O
- : O
1 CD O
using VBG O
commercially RB O
available JJ O
antiserum NN O
. . O

Thus RB O
, , O
the DT O
presence NN O
of IN O
the DT O
Cln2 NNP B-Gene
PEST NNP I-Gene
domain NN I-Gene
was VBD O
sufficient JJ O
to TO O
destabilize VB O
a DT O
heterologous JJ O
protein NN O
. . O

Growth NNP O
curves NNS O
indicated VBD O
that IN O
proliferation NN O
of IN O
clone NN O
CA9 NNP O
in IN O
the DT O
presence NN O
of IN O
10 CD O
% NN O
serum NN O
was VBD O
reduced VBN O
by IN O
60 CD O
% NN O
compared VBN O
with IN O
clone NN O
ME10 NNP O
. . O

In IN O
men NNS O
with IN O
BMI NNP O
< NNP O
30 CD O
, , O
the DT O
OR NNP O
was VBD O
1 CD O
. . O
83 CD O
for IN O
postprandial JJ O
TG NNP O
( ( O
P NNP O
= NNP O
. . O
41 CD O
) ) O
and CC O
2 CD O
. . O
77 CD O
for IN O
postprandial JJ O
RP NNP O
( ( O
P NNP O
= NNP O
. . O
32 CD O
) ) O
in IN O
models NNS O
that WDT O
included VBD O
fasting VBG O
TG NNP O
, , O
LDL NNP B-Gene
- : I-Gene
C NNP I-Gene
, , O
and CC O
hypertension NN O
. . O

OBJECTIVES NN O
: : O
1 CD O
) ) O
to TO O
determine VB O
serum JJ B-Gene
ACE NNP I-Gene
activity NN O
in IN O
patients NNS O
with IN O
COPD NNP O
treated VBD O
with IN O
and CC O
without IN O
continuous JJ O
ambulatory NN O
oxygen NN O
therapy NN O
( ( O
CAOT NNP O
) ) O
; : O
2 CD O
) ) O
to TO O
verify VB O
whether IN O
there EX O
is VBZ O
a DT O
correlation NN O
between IN O
ACE NNP B-Gene
and CC O
any DT O
hematological JJ O
, , O
spirometric JJ O
or CC O
gasometric JJ O
parameter NN O
. . O

A DT O
16 CD O
- : O
year NN O
follow SYM O
- : O
up IN O
study NN O
of IN O
69 CD O
paraplegics NNS O
with IN O
complete JJ O
lesions NNS O
from IN O
T1 NNP O
- : O
L3 NNP O
is VBZ O
presented VBN O
. . O

The DT O
case NN O
described VBD O
is VBZ O
that IN O
of IN O
a DT O
72 CD O
- : O
year NN O
- : O
old JJ O
man NN O
with IN O
ochronosis NN O
who WP O
suffered VBD O
a DT O
hyperextension NN O
injury NN O
to TO O
his PRP$ O
spine NN O
in IN O
a DT O
fall NN O
, , O
resulting VBG O
in IN O
a DT O
fracture NN O
through IN O
an DT O
ankylosed JJ O
L2 NNP O
- : O
L3 NNP O
disk NN O
space NN O
. . O

We PRP O
conclude VBP O
that DT O
transcription NN O
activation NN O
by IN O
LEF NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
vitro NN O
is VBZ O
a DT O
chromatin JJ O
- : O
dependent JJ O
process NN O
that WDT O
requires VBZ O
a DT O
functional JJ O
trans NNS O
- : O
activation NN O
domain NN O
in IN O
addition NN O
to TO O
the DT O
HMG NNP B-Gene
domain NN I-Gene
. . O

Whereas NNP O
cDNA NN O
hybridization NN O
to TO O
genomic VB O
DNA NNP O
blots NNS O
indicated VBD O
a DT O
small JJ O
subfamily NN O
of IN O
G0S19 NNP B-Gene
genes NNS I-Gene
, , O
simple JJ O
patterns NNS O
of IN O
bands NNS O
indicated VBN O
that IN O
most JJS O
cDNAs NNS O
, , O
including VBG O
G0S30 NNP B-Gene
cDNA NN I-Gene
, , O
corresponded VBD O
to TO O
single JJ O
- : O
copy NN O
genes NNS O
. . O

By IN O
directly RB O
interacting VBG O
with IN O
both DT O
Arfs NNP B-Gene
and CC O
tyrosine JJ B-Gene
kinases NNS I-Gene
involved VBN O
in IN O
regulating VBG O
cell NN O
growth NN O
and CC O
cytoskeletal JJ O
organization NN O
, , O
ASAP1 NNP B-Gene
could MD O
coordinate VB O
membrane NN O
remodeling VBG O
events NNS O
with IN O
these DT O
processes NNS O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
role NN O
of IN O
NGF NNP B-Gene
in IN O
regulating VBG O
gene NN O
transcription NN O
in IN O
PC12 NNP O
and CC O
INS NNP O
- : O
1 CD O
cells NNS O
, , O
in IN O
order NN O
to TO O
define VB O
if IN O
there EX O
are VBP O
NGF NNP B-Gene
- : O
regulated VBN O
genes NNS O
per IN O
se NN O
. . O

Recovery NN O
was VBD O
characterized VBN O
by IN O
rapid JJ O
improvement NN O
such JJ O
that IN O
all DT O
measured VBD O
parameters NNS O
normalized VBN O
by IN O
1 CD O
week NN O
, , O
except IN O
for IN O
cross NN O
- : O
sectional JJ O
cardiac JJ O
area NN O
which WDT O
remained VBD O
dilated VBD O
up RB O
to TO O
4 CD O
weeks NNS O
( ( O
14 CD O
+ NN O
/ NNP O
- : O
3 CD O
cm2 NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
versus IN O
control NN O
) ) O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Late JJ O
complications NNS O
of IN O
catheterisation NN O
for IN O
intravenous JJ O
nutrition NN O
. . O

Hyperthyroidism NN O

Mean NNP O
ROI NNP O
- : O
A DT O
/ NN O
B NNP O
ratio NN O
was VBD O
49 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
7 CD O
% NN O
in IN O
the DT O
diabetic JJ O
group NN O
, , O
significantly RB O
lower JJR O
than IN O
the DT O
57 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
6 CD O
% NN O
at IN O
the DT O
nondiabetic JJ O
group NN O
( ( O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Transcription NNP O
factor NN O
recognition NN O
surface NN O
on IN O
the DT O
RNA NNP B-Gene
polymerase NN I-Gene
alpha NN I-Gene
subunit NN I-Gene
is VBZ O
involved VBN O
in IN O
contact NN O
with IN O
the DT O
DNA NNP O
enhancer NN O
element NN O
. . O

The DT O
three CD O
- : O
dimensional JJ O
structure NN O
of IN O
RT NNP B-Gene
shows VBZ O
that IN O
it PRP O
is VBZ O
a DT O
strikingly RB O
asymmetric JJ O
heterodimer NN O
consisting VBG O
of IN O
two CD O
differently RB O
folded VBN O
subunits NNS O
( ( O
molecular JJ O
weights NNS O
66 CD O
kDa NN O
and CC O
51 CD O
kDa NNS O
) ) O
with IN O
identical JJ O
amino NN O
- : O
terminal NN O
amino NN O
acid NN O
sequences NNS O
( ( O
residues NNS O
1 CD O
- : O
428 CD O
) ) O
. . O

No DT O
correlation NN O
between IN O
the DT O
age NN O
of IN O
the DT O
horses NNS O
and CC O
the DT O
antibody NN O
level NN O
could MD O
be VB O
found VBN O
. . O

As IN O
shown VBN O
previously RB O
, , O
EBNA2 NNP B-Gene
transactivates VBZ O
the DT O
promoters NNS O
of IN O
the DT O
viral JJ B-Gene
latent NN I-Gene
membrane NN I-Gene
proteins NNS I-Gene
. . O

We PRP O
conclude VBP O
that IN O
the DT O
gp54 JJ B-Gene
structural JJ I-Gene
gene NN I-Gene
is VBZ O
required VBN O
for IN O
initiation NN O
or CC O
amplification NN O
of IN O
the DT O
splenic JJ O
erythroblast NN O
hyperplasia NN O
which WDT O
characterizes VBZ O
the DT O
preleukemic JJ O
phase NN O
of IN O
Rauscher NNP O
disease NN O
. . O

In IN O
spite NN O
of IN O
much JJ O
effort NN O
, , O
no DT O
one NN O
has VBZ O
succeeded VBN O
in IN O
isolating VBG O
and CC O
characterizing VBG O
the DT O
enzyme NN O
( ( O
s PRP O
) ) O
responsible JJ O
for IN O
synthesis NN O
of IN O
cellulose NN O
, , O
the DT O
major JJ O
cell NN O
wall NN O
polymer NN O
of IN O
plants NNS O
. . O

The DT O
present JJ O
study NN O
investigated VBD O
dose JJ O
dependence NN O
and CC O
time NN O
course NN O
effects NNS O
of IN O
the DT O
benzodiazepine NN O
( ( O
BDZ NNP O
) ) O
partial JJ O
inverse JJ O
agonist NN O
, , O
RO19 NNP O
- : O
4603 CD O
( ( O
0 CD O
. . O
5 CD O
- : O
0 CD O
. . O
30 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
alone RB O
, , O
and CC O
in IN O
combination NN O
with IN O
the DT O
BDZ NNP B-Gene
receptor NN I-Gene
antagonists NNS O
flumazenil VBP O
, , O
ZK NNP O
93426 CD O
, , O
and CC O
CGS NNP O
8216 CD O
( ( O
20 CD O
mg NN O
/ NNP O
kg NN O
) ) O
in IN O
selectively RB O
bred VBN O
alcohol NN O
- : O
preferring NN O
( ( O
P NNP O
) ) O
rats VBZ O
provided VBD O
a DT O
two CD O
- : O
bottle NN O
choice NN O
test NN O
between IN O
ethanol NN O
( ( O
EtOH NNP O
) ) O
( ( O
10 CD O
% NN O
v NN O
/ NNP O
v NN O
) ) O
, , O
and CC O
a DT O
palatable JJ O
saccharin NN O
( ( O
0 CD O
. . O
125 CD O
% NN O
g JJ O
/ NNP O
v NN O
) ) O
solution NN O
. . O

Mitochondria NNP O
- : O
lytic JJ O
action NN O
of IN O
warfarin NN O
in IN O
lymphocytes NNS O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBD O
a DT O
3574 CD O
- : O
bp NN O
Bacillus NN O
subtilis NNS O
( ( O
Bs NNP O
) ) O
DNA NNP O
fragment NN O
located VBN O
between IN O
the DT O
nrdA NN B-Gene
and CC O
citB NN B-Gene
genes NNS I-Gene
at IN O
about IN O
169 CD O
degrees NNS O
on IN O
the DT O
chromosome NN O
. . O

Injection NN O
of IN O
double JJ O
- : O
stranded VBN O
RNA NNP O
into IN O
C NNP O
. . O
elegans NNS O
results NNS O
in IN O
embryonic JJ O
lethality NN O
; : O
thus RB O
, , O
the DT O
SF1 NNP B-Gene
gene NN I-Gene
is VBZ O
essential JJ O
not RB O
only RB O
in IN O
yeast NN O
but CC O
also RB O
in IN O
at IN O
least JJS O
one CD O
metazoan NN O
. . O

If IN O
we PRP O
apply VBP O
the DT O
finding NN O
of IN O
non JJ O
- : O
visualization NN O
of IN O
the DT O
GB NNP O
at IN O
4 CD O
h NN O
post NN O
injection NN O
as IN O
the DT O
criterion NN O
for IN O
the DT O
diagnosis NN O
of IN O
AC NNP O
, , O
the DT O
diagnostic JJ O
accuracy NN O
was VBD O
only RB O
40 CD O
. . O
7 CD O
% NN O
( ( O
11 CD O
/ RB O
27 CD O
) ) O
. . O

Recently RB O
, , O
we PRP O
have VBP O
reported VBN O
the DT O
cloning NN O
of IN O
the DT O
germ NN O
cell NN O
- : O
specific NN O
, , O
nuclear JJ O
orphan IN O
receptor NN O
germ NN B-Gene
cell NN I-Gene
nuclear JJ I-Gene
factor NN I-Gene
( ( O
GCNF NNP B-Gene
) ) O
/ VBP O
RTR NNP B-Gene
. . O

Both DT O
quantitative JJ O
and CC O
qualitative JJ O
analysis NN O
of IN O
individual JJ O
cytoarchitectonic JJ O
peculiarities NNS O
of IN O
Meynart NNP O
' POS O
s NN O
nucleus NN O
as RB O
well RB O
as IN O
of IN O
external JJ O
part NN O
of IN O
dorsomedial JJ O
nucleus NN O
of IN O
thalamus NN O
was VBD O
performed VBN O
in IN O
mentally RB O
normal JJ O
individuals NNS O
. . O

Structure NN O
and CC O
regulation NN O
of IN O
a DT O
nuclear JJ O
gene NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
that WDT O
specifies VBZ O
MRP13 NNP B-Gene
, , O
a DT O
protein NN O
of IN O
the DT O
small JJ O
subunit NN O
of IN O
the DT O
mitochondrial JJ O
ribosome NN O
. . O

At IN O
the DT O
time NN O
of IN O
the DT O
13 CD O
latest JJS O
BPVs NNP O
, , O
age NN O
ranged VBD O
from IN O
three CD O
days NNS O
to TO O
13 CD O
. . O
1 CD O
years NNS O
( ( O
mean JJ O
5 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
SD NN O
4 CD O
. . O
8 CD O
years NNS O
) ) O
. . O

One CD O
is VBZ O
to TO O
act VB O
within IN O
the DT O
visceral JJ O
endoderm NN O
to TO O
promote VB O
proper JJ O
streak JJ O
morphogenesis NN O
. . O

One CD O
R NNP O
- : O
EST NN O
and CC O
one CD O
Pto NNP B-Gene
- : I-Gene
like IN I-Gene
sequence NN I-Gene
each DT O
mapped VBD O
to TO O
two CD O
locations NNS O
. . O

An DT O
IgG NNP B-Gene
monoclonal NN O
gammopathy NN O
was VBD O
present JJ O
in IN O
the DT O
serum NN O
of IN O
4 CD O
patients NNS O
and CC O
Bence NNP O
- : O
Joanes NNS O
proteinuria NN O
was VBD O
found VBN O
in IN O
1 CD O
patient NN O
. . O

Human NNP B-Gene
GATA NNP I-Gene
- : I-Gene
3 CD I-Gene
: : O
a DT O
lineage NN O
- : O
restricted VBN O
transcription NN O
factor NN O
that WDT O
regulates VBZ O
the DT O
expression NN O
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
alpha JJ I-Gene
gene NN I-Gene
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
ARNO NNP B-Gene
localizes VBZ O
to TO O
the DT O
plasma NN O
membrane NN O
in IN O
vivo NN O
and CC O
efficiently RB O
catalyzes VBZ O
ARF6 NNP B-Gene
nucleotide JJ O
exchange NN O
in IN O
vitro NN O
. . O

Comparison NNP O
of IN O
frequencies NNS O
of IN O
atrial JJ O
fibrillation NN O
after IN O
coronary JJ O
artery NN O
bypass NN O
grafting VBG O
with IN O
and CC O
without IN O
the DT O
use NN O
of IN O
cardiopulmonary JJ O
bypass NN O
. . O

Cbf3 NNP B-Gene
contains VBZ O
three CD O
proteins NNS O
, , O
Cbf3a NNP B-Gene
, , O
Cbf3b NNP B-Gene
and CC O
Cbf3c NNP B-Gene
. . O

Lipoprotein NNP B-Gene
lipase NN I-Gene
( ( O
LPL NNP B-Gene
) ) O
, , O
a DT O
key JJ O
enzyme NN O
in IN O
normal JJ O
lipoprotein JJ O
metabolism NN O
, , O
has VBZ O
a DT O
complex JJ O
pattern NN O
of IN O
regulation NN O
and CC O
tissue NN O
- : O
specific JJ O
expression NN O
. . O

Initial JJ O
experience NN O
with IN O
a DT O
microprocessor NN O
controlled VBN O
current JJ O
based VBN O
defibrillator NN O
. . O

The DT O
incidence NN O
of IN O
HSV NNP O
- : O
2 CD O
positive JJ O
subjects NNS O
( ( O
HSV NNP B-Gene
- : I-Gene
2 CD I-Gene
/ NN I-Gene
HSV NNP I-Gene
- : I-Gene
1 CD I-Gene
antibody NN I-Gene
ratio NN O
> NN O
or CC O
= VB O
1 CD O
) ) O
was VBD O
low JJ O
in IN O
the DT O
Jewish JJ O
Israeli NNP O
population NN O
, , O
compared VBN O
to TO O
other JJ O
demographic JJ O
areas NNS O
. . O

Wnt NNP B-Gene
- : I-Gene
1 CD I-Gene
overexpression NN O
in IN O
mammary JJ O
epithelial JJ O
cells NNS O
induced VBN O
cyclin JJ B-Gene
D1 NNP I-Gene
mRNA NN I-Gene
and CC O
targeted JJ O
overexpression NN O
of IN O
Wnt NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
the DT O
mammary JJ O
gland NN O
of IN O
transgenic JJ O
mice NN O
increased VBD O
both DT O
ILK NNP B-Gene
activity NN O
and CC O
cyclin NN B-Gene
D1 NNP I-Gene
levels NNS O
. . O

Interestingly RB O
, , O
the DT O
positions NNS O
of IN O
these DT O
introns NNS O
have VBP O
been VBN O
conserved VBN O
in IN O
comparison NN O
with IN O
the DT O
genes NNS O
of IN O
two CD O
other JJ O
transglutaminase VBD O
- : O
like IN O
activities NNS O
described VBN O
in IN O
the DT O
literature NN O
, , O
but CC O
the DT O
TGM1 NNP B-Gene
gene NN I-Gene
is VBZ O
by IN O
far RB O
the DT O
smallest JJS O
characterized VBN O
to TO O
date NN O
because IN O
its PRP$ O
introns NNS O
are VBP O
relatively RB O
smaller JJR O
. . O

The DT O
newly RB O
devised VBN O
DCT NNP O
method NN O
yields NNS O
reliable JJ O
data NNS O
in IN O
measuring VBG O
TBF NNP O
. . O

We PRP O
conclude VBP O
that IN O
common JJ O
upstream JJ O
signals NNS O
cause VBP O
activation NN O
of IN O
Ras NNP B-Gene
and CC O
TC21 NNP B-Gene
, , O
but CC O
activated VBD O
TC21 NNP B-Gene
controls NNS O
cell VBP O
growth NN O
via IN O
distinct JJ O
Raf NNP B-Gene
- : O
independent JJ O
downstream NN O
signaling VBG O
pathways NNS O
. . O

RESULTS NN O
: : O
Of IN O
the DT O
patients NNS O
with IN O
IS NNP O
, , O
67 CD O
% NN O
had VBD O
significantly RB O
greater JJR O
values NNS O
of IN O
directional JJ O
preponderance NN O
on IN O
the DT O
OVAR NNP O
test NN O
( ( O
a DT O
measure NN O
of IN O
otolith NN O
system NN O
imbalance NN O
) ) O
compared VBN O
with IN O
control NN O
subjects NNS O
. . O

The DT O
murine NN B-Gene
facilitative JJ I-Gene
glucose NN I-Gene
transporter NN I-Gene
isoform NN I-Gene
3 CD I-Gene
( ( O
Glut NNP B-Gene
3 CD I-Gene
) ) O
is VBZ O
developmentally RB O
regulated VBN O
and CC O
is VBZ O
predominantly RB O
expressed VBN O
in IN O
neurons NNS O
and CC O
trophoblasts NNS O
. . O

With IN O
the DT O
increasing VBG O
use NN O
of IN O
ACE NNP B-Gene
inhibitors NNS O
, , O
the DT O
incidence NN O
of IN O
rare JJ O
adverse JJ O
effects NNS O
such JJ O
as IN O
potentially RB O
lethal JJ O
pancreatitis NN O
is VBZ O
likely JJ O
to TO O
increase VB O
. . O

These DT O
results NNS O
suggest VBP O
KCC3 NNP B-Gene
is VBZ O
a DT O
new JJ O
member NN O
of IN O
the DT O
KCC NNP B-Gene
family NN I-Gene
that WDT O
is VBZ O
under IN O
distinct JJ O
regulation NN O
from IN O
KCC1 NNP B-Gene
. . O

OBJECTIVE NN O
: : O
To TO O
determine VB O
the DT O
impact NN O
of IN O
the DT O
introduction NN O
of IN O
clarithromycin NN O
and CC O
azithromycin NN O
on IN O
the DT O
treatment NN O
and CC O
survival NN O
of IN O
patients NNS O
with IN O
AIDS NNP O
and CC O
disseminated VBD O
Mycobacterium NNP O
avium NN O
complex NN O
( ( O
DMAC NNP O
) ) O
. . O

Piroximone NN O
is VBZ O
a DT O
new JJ O
phosphodiesterase NN B-Gene
III NNP I-Gene
inhibitor NN O
that WDT O
combines VBZ O
inotropic NN O
and CC O
vasodilator NN O
properties NNS O
. . O

Feed NNP O
intake NN O
and CC O
BW NNP O
gains NNS O
were VBD O
decreased VBN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
by IN O
dietary JJ O
treatments NNS O
containing VBG O
M NNP O
. . O

The DT O
aspirate NN O
from IN O
a DT O
parathyroid JJ O
cyst NN O
was VBD O
watery JJ O
clear JJ O
and CC O
contained VBN O
high JJ O
amount NN O
of IN O
parathyroid NN B-Gene
hormone NN I-Gene
. . O

These DT O
transcripts NNS O
have VBP O
a DT O
unique JJ O
5 CD O
' POS O
untranslated JJ O
region NN O
and CC O
NH2 NNP O
- : O
terminal JJ O
sequence NN O
and CC O
encode VB O
a DT O
predicted JJ O
protein NN O
of IN O
121 CD O
kD NNS O
. . O

This DT O
makes VBZ O
these DT O
compounds NNS O
attractive VBP O
as IN O
vehicles NNS O
for IN O
these DT O
and CC O
other JJ O
gases NNS O
in IN O
- : O
vivo NN O
and CC O
in IN O
- : O
vitro NN O
. . O

This DT O
paper NN O
gives VBZ O
an DT O
overview NN O
of IN O
the DT O
global JJ O
pattern NN O
of IN O
casualties NNS O
in IN O
earthquakes NNS O
which WDT O
occurred VBD O
during IN O
the DT O
30 CD O
- : O
month NN O
period NN O
from IN O
1 CD O
September NNP O
1993 CD O
to TO O
29 CD O
February NNP O
1996 CD O
. . O

Serotonin NNP B-Gene
5 CD I-Gene
- : I-Gene
HT2 NNP I-Gene
receptor NN I-Gene
binding VBG O
on IN O
blood NN O
platelets NNS O
as IN O
a DT O
state NN O
dependent JJ O
marker NN O
in IN O
major JJ O
affective JJ O
disorder NN O
. . O

There EX O
was VBD O
no DT O
evident JJ O
inciting VBG O
agent NN O
of IN O
the DT O
disease NN O
. . O

RNase NNP B-Gene
MRP NNP I-Gene
is VBZ O
a DT O
ribonucleoprotein JJ O
endoribonuclease NN O
that WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
have VB O
roles NNS O
in IN O
both DT O
mitochondrial JJ O
DNA NNP O
replication NN O
and CC O
nuclear JJ B-Gene
5 CD I-Gene
. . I-Gene
8S CD I-Gene
rRNA NN I-Gene
processing NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
gene NN O
segment NN O
containing VBG O
the DT O
mu NN O
m NN O
poly NN O
( ( O
A DT O
) ) O
signals NNS O
, , O
along IN O
with IN O
536 CD O
bp NN O
of IN O
downstream NN O
flanking VBG O
sequence NN O
, , O
acted VBD O
as IN O
a DT O
transcription NN O
terminator NN O
in IN O
both DT O
myeloma NNP O
cells NNS O
and CC O
L NNP O
cell NN O
fibroblasts NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
serum NN B-Gene
BGP NNP I-Gene
is VBZ O
a DT O
valuable JJ O
measurement NN O
of IN O
bone NN O
metabolism NN O
. . O

For IN O
this DT O
, , O
cDNAs NN O
containing VBG O
the DT O
60K CD O
, , O
87K CD O
, , O
110K CD O
and CC O
170K CD O
protein NN O
coding VBG O
sequences NNS O
were VBD O
each DT O
provided VBN O
with IN O
an DT O
ATG NNP O
start NN O
codon NN O
and CC O
the DT O
cDNA NN O
containing VBG O
the DT O
60K CD O
coding VBG O
sequence NN O
with IN O
a DT O
TAA NNP O
stop NN O
codon NN O
immediately RB O
downstream NN O
of IN O
the DT O
coding NN O
sequence NN O
. . O

We PRP O
propose VBP O
that IN O
epigenetic JJ O
features NNS O
of IN O
tissue NN O
- : O
specific JJ O
control NN O
and CC O
of IN O
the DT O
control NN O
of IN O
allelic JJ O
expression NN O
are VBP O
intricately RB O
linked VBN O
. . O

Upon IN O
serum NN O
withdrawal NN O
at IN O
the DT O
permissive JJ O
temperature NN O
, , O
p53 NN B-Gene
- : O
mediated JJ O
apoptosis NN O
was VBD O
induced VBN O
in IN O
50 CD O
to TO O
60 CD O
% NN O
of IN O
the DT O
cells NNS O
. . O

Here RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
TAFII250 NNP B-Gene
, , O
the DT O
largest JJS O
subunit NN O
of IN O
TFIID NNP B-Gene
, , O
contains VBZ O
two CD O
tandem NN O
bromodomain NN O
modules NNS O
that WDT O
bind VBP O
selectively RB O
to TO O
multiply VB O
acetylated JJ O
histone NN B-Gene
H4 NNP I-Gene
peptides NNS I-Gene
. . O

Inspired NNP O
CO2 NNP O
causing VBG O
changes NNS O
from IN O
hypo NN O
- : O
to TO O
normocapnia VB O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
improve VB O
arterial JJ O
O2 NNP O
tension NN O
( ( O
PaO2 NNP O
) ) O
and CC O
to TO O
reduce VB O
alveolar JJ O
- : O
arterial JJ O
O2 NNP O
difference NN O
. . O

Genetic JJ O
studies NNS O
in IN O
Drosophila NNP O
have VBP O
led VBN O
to TO O
the DT O
identification NN O
of IN O
several JJ O
components NNS O
of IN O
the DT O
Notch NNP B-Gene
pathway NN O
. . O

To TO O
minimize VB O
reflux NN O
into IN O
the DT O
blind NN O
loop NN O
, , O
a DT O
number NN O
of IN O
technical JJ O
steps NNS O
are VBP O
considered VBN O
indispensable JJ O
: : O
1 CD O
) ) O
fluted VBN O
section NN O
of IN O
the DT O
jejunal JJ O
stump NN O
; : O
2 CD O
) ) O
isoperistaltic JJ O
construction NN O
of IN O
the DT O
anastomosis NN O
and CC O
, , O
particularly RB O
, , O
3 CD O
) ) O
the DT O
creation NN O
of IN O
a DT O
single JJ O
or CC O
double JJ O
valve NN O
system NN O
upstream NN O
from IN O
the DT O
anastomosis NN O
by IN O
spiral JJ O
introflexion NN O
of IN O
the DT O
mucosa NN O
using VBG O
seroserous JJ O
stitches NNS O
parallel RB O
and CC O
perpendicular JJ O
to TO O
the DT O
ileal JJ O
lumen NNS O
. . O

Sensitivity NN O
and CC O
specificity NN O
was VBD O
established VBN O
for IN O
the DT O
Pharmacia NNP O
CAP NNP O
System NNP O
and CC O
the DT O
DPC NNP O
AlaSTAT NNP O
System NNP O
by IN O
comparison NN O
with IN O
results NNS O
of IN O
the DT O
skin NN O
prick JJ O
test NN O
. . O

Inactivation NN O
of IN O
the DT O
Neurospora NNP B-Gene
crassa NN I-Gene
mitochondrial JJ I-Gene
outer NN I-Gene
membrane NN I-Gene
protein NN I-Gene
TOM70 NNP I-Gene
by IN O
repeat NN O
- : O
induced JJ O
point NN O
mutation NN O
( ( O
RIP NNP O
) ) O
causes VBZ O
defects NNS O
in IN O
mitochondrial JJ O
protein NN O
import NN O
and CC O
morphology NN O
. . O

In IN O
memory NN O
of IN O
Magdelaine NNP O
Comtesse NNP O

A DT O
cDNA NN O
clone NN O
was VBD O
isolated VBN O
from IN O
a DT O
chicken JJ O
embryo NN O
cDNA NN O
library JJ O
employing VBG O
a DT O
PCR NNP O
- : O
generated VBD O
radiolabeled JJ O
probe NN O
specific NN O
for IN O
the DT O
U3 NNP B-Gene
region NN I-Gene
of IN O
the DT O
Rous NNP B-Gene
sarcoma NN I-Gene
virus NN I-Gene
LTR NNP I-Gene
. . O

Following VBG O
the DT O
results NNS O
of IN O
toxicological JJ O
experiments NNS O
in IN O
the DT O
target NN O
animals NNS O
"""" VBP O
Toxicological JJ O
Drinking NNP O
Water NNP O
Standards NNPS O
for IN O
Animals NNS O
"""" NNS O
can MD O
be VB O
established VBN O
. . O

Chlamydia NNP O
and CC O
cervical JJ O
cancer NN O
: : O
a DT O
real JJ O
association NN O
? . O

55 CD O
+ JJ O
/ NNP O
- : O
11 CD O
% NN O
) ) O
, , O
all DT O
other JJ O
parameters NNS O
showed VBD O
a DT O
significant JJ O
increase NN O
: : O
RS NNP O
index NN O
5 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
mVolt NN O
to TO O
6 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
7 CD O
mVolt NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
; : O
EDD $ O
6 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
to TO O
6 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
cm NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
; : O
HV NNP O
1017 CD O
+ NNP O
/ NNP O
- : O
151 CD O
ml NN O
to TO O
1099 CD O
+ NNP O
/ NNP O
- : O
261 CD O
ml NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
; : O
EDV $ O
371 CD O
+ NNP O
/ NNP O
- : O
131 CD O
ml NN O
to TO O
441 CD O
+ NNS O
/ SYM O
- : O
175 CD O
ml NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
; : O
RBV $ O
117 CD O
+ NNP O
/ NNP O
- : O
57 CD O
ml NN O
to TO O
151 CD O
+ NNS O
/ SYM O
- : O
77 CD O
ml NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

These DT O
results NNS O
confirming VBG O
the DT O
high JJ O
validity NN O
of IN O
NOM NNP O
inhibiting VBG O
test NN O
in IN O
the DT O
diagnosis NN O
of IN O
tumoural JJ O
hyperprolactinemic JJ O
states NNS O
, , O
reveal VBP O
contradictory JJ O
responses NNS O
to TO O
CD VB O
/ NNP O
LD NNP O
, , O
LD NNP O
and CC O
DOM NNP O
, , O
with IN O
sustain PDT O
the DT O
existence NN O
of IN O
2 CD O
sub JJ O
- : O
group NN O
of IN O
Prolactinomas NNP O
: : O
with IN O
or CC O
without IN O
a DT O
maintained VBN O
DA NNP O
central JJ O
tonus NN O
supporting VBG O
the DT O
possibility NN O
of IN O
different JJ O
etiopathogenetical JJ O
factors NNS O
in IN O
inducing VBG O
a DT O
tumoural JJ O
hyperprolactinemic JJ O
states NNS O
. . O

This DT O
multimodality NN O
treatment NN O
for IN O
locally RB O
advanced JJ O
gynecologic NN O
tumors NNS O
appears VBZ O
feasible JJ O
with IN O
modification NN O
, , O
and CC O
continued VBD O
work NN O
exploring VBG O
this DT O
approach NN O
is VBZ O
encouraged VBN O
. . O

Consanguinity NN O
and CC O
migration NN O
in IN O
the DT O
marriages NNS O
of IN O
the DT O
region NN O
of IN O
Nunoa NNP O
, , O
Santiago NNP O
, , O
1850 CD O
- : O
1960 CD O

Responses NNS O
of IN O
TLD NNP O
Mg2SiO4 NNP O
: : O
Tb NN O
and CC O
radiophotoluminescent NN O
glass NN O
to TO O
heavy VB O
charged VBN O
particles NNS O
and CC O
space NN O
radiation NN O
. . O

Drosophila NNP B-Gene
orthodenticle NN I-Gene
( ( O
otd NN B-Gene
) ) O
and CC O
murine JJ B-Gene
Otx NNP I-Gene
genes NNS I-Gene
exemplify VB O
this DT O
, , O
both DT O
in IN O
terms NNS O
of IN O
expression NN O
patterns NNS O
and CC O
mutant JJ O
phenotypes NNS O
. . O

Under IN O
halothane NN O
anesthesia NN O
, , O
the DT O
flow NN O
pneumocardiogram NN O
( ( O
PnCG NNP O
) ) O
and CC O
its PRP$ O
time NN O
derivative JJ O
( ( O
acceleration JJ O
pneumocardiogram NN O
or CC O
dPn NN O
/ NNP O
dt NN O
) ) O
were VBD O
transduced VBN O
during IN O
apnea NN O
by IN O
a DT O
small JJ O
high JJ O
- : O
gain NN O
pneumotachograph NN O
. . O

Possible JJ O
factors NNS O
for IN O
the DT O
development NN O
of IN O
psychotic JJ O
symptomatology NN O
during IN O
group NN O
activities NNS O
and CC O
the DT O
role NN O
of IN O
group NN O
dynamics NNS O
acting VBG O
as IN O
stress JJ O
factors NNS O
precipitating VBG O
functional JJ O
psychoses NNS O
, , O
especially RB O
bipolar JJ O
manifestations NNS O
, , O
are VBP O
discussed VBN O
. . O

The DT O
frequency NN O
of IN O
SPs NNP O
for IN O
both DT O
the DT O
moderate JJ O
and CC O
severe JJ O
groups NNS O
was VBD O
significantly RB O
higher JJR O
than IN O
that DT O
in IN O
patients NNS O
with IN O
a DT O
normal JJ O
MMFCV NNP O
( ( O
p JJ O
< NNP O
. . O
1 CD O
) ) O
; : O
of IN O
154 CD O
arms NNS O
with IN O
a DT O
normal JJ O
MMFCV NNP O
, , O
only RB O
9 CD O
( ( O
6 CD O
% NN O
) ) O
had VBD O
an DT O
SP NNP O
. . O

Patterns NNS O
defined VBN O
by IN O
combinations NNS O
of IN O
normal JJ O
and CC O
abnormal JJ O
laboratory NN O
results NNS O
had VBD O
decreased VBN O
the DT O
likelihood NN O
of IN O
PEM NNP O
from IN O
an DT O
all DT O
- : O
2 CD O
to TO O
all DT O
- : O
0 CD O
pattern NN O
. . O

In IN O
the DT O
current JJ O
model NN O
, , O
Wingless NNP B-Gene
/ NNP O
Wnt NNP B-Gene
signal NN O
stabilizes NNS O
Armadillo NNP B-Gene
/ NNP O
beta SYM B-Gene
- : I-Gene
catenin NN I-Gene
, , O
which WDT O
then RB O
accumulates VBZ O
in IN O
nuclei NN O
and CC O
binds VBZ O
TCF NNP B-Gene
/ NNP O
LEF NNP B-Gene
family NN O
proteins NNS O
, , O
forming VBG O
bipartite JJ O
transcription NN O
factors NNS O
which WDT O
activate VBP O
transcription NN O
of IN O
Wingless NNP B-Gene
/ NNP O
Wnt NNP B-Gene
responsive JJ O
genes NNS O
. . O

Increased VBN O
levels NNS O
of IN O
anticardiolipin NN B-Gene
immunoglobulin NN I-Gene
G NNP I-Gene
may MD O
also RB O
cause VB O
bleeding NN O
. . O

We PRP O
studied VBD O
120 CD O
male NN O
and CC O
42 CD O
female JJ O
patients NNS O
with IN O
early JJ O
CAD NN O
who WP O
were VBD O
unrelated JJ O
to TO O
each DT O
other JJ O
but CC O
were VBD O
from IN O
families NNS O
in IN O
which WDT O
at IN O
least JJS O
one CD O
other JJ O
sibling VBG O
had VBD O
early JJ O
CAD NNP O
. . O

LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
targeted VBN O
to TO O
the DT O
plasma NN O
membrane NN O
, , O
where WRB O
it PRP O
binds VBZ O
TRAF NNP B-Gene
, , O
TRADD NNP B-Gene
, , O
and CC O
JAK NNP B-Gene
molecules NNS I-Gene
to TO O
activate VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
, , O
and CC O
STAT NNP B-Gene
- : O
dependent NN O
pathways NNS O
as IN O
does VBZ O
CD40 NNP B-Gene
. . O

Activation NN O
of IN O
the DT O
aboral JJ O
ectoderm NN B-Gene
- : I-Gene
specific JJ I-Gene
Spec2a NNP I-Gene
gene NN I-Gene
in IN O
blastula JJ O
- : O
stage NN O
sea NN O
urchin JJ O
embryos NN O
requires VBZ O
an DT O
upstream JJ O
regulatory JJ O
region NN O
that WDT O
is VBZ O
part NN O
of IN O
a DT O
repetitive JJ O
sequence NN O
element NN O
( ( O
RSR NNP O
) ) O
associated VBN O
with IN O
all DT O
Spec1 NNP B-Gene
/ NNP O
Spec2 NNP B-Gene
genes NNS O
. . O

The DT O
DNA NNP O
sequencing NN O
of IN O
the DT O
recombinant JJ O
clones NNS O
revealed VBD O
the DT O
expression NN O
of IN O
RXR NNP B-Gene
alpha NN I-Gene
and CC O
RXR NNP B-Gene
beta NN I-Gene
. . O

Biometric JJ O
analysis NN O
of IN O
intraocular JJ O
lens NNS O
power NN O
required VBN O
to TO O
produce VB O
emmetropia NNS O
: : O
results NNS O
of IN O
450 CD O
implants NNS O
. . O

Next JJ O
, , O
with IN O
carcinoma NN O
presenting VBG O
a DT O
leather NN O
bottle NN O
( ( O
linitis NN O
plastica NN O
type NN O
) ) O
of IN O
the DT O
stomach NN O
itself PRP O
, , O
the DT O
II NNP O
c JJ O
portion NN O
of IN O
the DT O
stomach NN O
consisted VBD O
of IN O
fundic JJ O
glands NNS O
( ( O
undifferentiated JJ O
carcinoma NN O
) ) O
shall MD O
become VB O
the DT O
primary JJ O
focus NN O
supporting VBG O
Nakamura NNP O
' POS O
s NN O
theory NN O
. . O

The DT O
DNA NNP O
sequence NN O
of IN O
the DT O
sulfate JJ B-Gene
activation NN I-Gene
locus NN I-Gene
from IN O
Escherichia NNP O
coli NN O
K NNP O
- : O
12 CD O
has VBZ O
been VBN O
determined VBN O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
swa5 VBZ B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
a DT O
new JJ O
temperature NN O
- : O
sensitive JJ O
allele NN O
of IN O
the DT O
clathrin NN B-Gene
heavy NN I-Gene
chain NN I-Gene
gene NN I-Gene
( ( O
chc1 JJ B-Gene
- : I-Gene
5 CD I-Gene
) ) O
, , O
which WDT O
carries VBZ O
a DT O
frameshift NN O
mutation NN O
near IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
CHC1 NNP B-Gene
open JJ O
reading NN O
frame NN O
. . O

Mutations NNS O
in IN O
genes NNS O
encoding VBG O
PR65 NNP B-Gene
/ VBZ I-Gene
A NNP I-Gene
subunits NNS I-Gene
have VBP O
been VBN O
identified VBN O
in IN O
several JJ O
different JJ O
human JJ O
cancers NNS O
and CC O
the DT O
PP2A NNP B-Gene
inhibitor NN O
, , O
termed VBD O
fostriecin NN O
, , O
is VBZ O
being VBG O
tested VBN O
as IN O
an DT O
anticancer JJ O
drug NN O
. . O

Genomic NNP O
organization NN O
of IN O
the DT O
human JJ B-Gene
beta NN I-Gene
- : I-Gene
catenin NN I-Gene
gene NN I-Gene
( ( O
CTNNB1 NNP B-Gene
) ) O
. . O

The DT O
construct NN O
was VBD O
introduced VBN O
into IN O
BW2001 NNP O
( ( O
xth NNP O
- : O
11 CD O
, , O
nfo SYM O
- : O
2 CD O
) ) O
strain NN O
cells NNS O
of IN O
Escherichia NNP O
coli NN O
. . O

Interspecific JJ O
complementation NN O
tests NNS O
showed VBD O
that IN O
the DT O
P7 NNP B-Gene
proteins NNS I-Gene
are VBP O
unable JJ O
to TO O
complement VB O
P1 NNP B-Gene
parA NN B-Gene
or CC O
parB NN B-Gene
mutants NNS I-Gene
, , O
and CC O
the DT O
P1 NNP B-Gene
proteins VBZ I-Gene
fail VBP O
to TO O
complement VB O
the DT O
P7 NNP B-Gene
mutations NNS I-Gene
. . O

The DT O
oxygen NN O
uptake NN O
( ( O
VO2 NNP O
) ) O
, , O
carbon NN O
dioxide NN O
output NN O
( ( O
VCO2 NNP O
) ) O
, , O
respiratory JJ O
rate NN O
( ( O
fR NN O
) ) O
, , O
minute JJ O
ventilation NN O
( ( O
VE NNP O
) ) O
, , O
alveolar JJ O
ventilation NN O
( ( O
VA NNP O
) ) O
, , O
alveolar JJ O
oxygen NN O
pressure NN O
( ( O
PAO2 NNP O
) ) O
, , O
and CC O
VE NNP O
/ NNP O
VO2 NNP O
ratio NN O
were VBD O
higher JJR O
in IN O
the DT O
cows NNS O
, , O
while IN O
the DT O
tidal JJ O
volume NN O
( ( O
VT NNP O
) ) O
and CC O
physiological JJ O
dead JJ O
space NN O
( ( O
VD NNP O
) ) O
were VBD O
larger JJR O
in IN O
the DT O
horses NNS O
. . O

26 CD O
micrograms NNS O
PAF NNP B-Gene
or CC O
placebo NN O
was VBD O
sprayed VBN O
into IN O
each DT O
nasal JJ O
cavity NN O
8 CD O
h NN O
and CC O
1 CD O
h NN O
before IN O
a DT O
nasal JJ O
allergen NN O
challenge NN O
. . O

Patients NNS O
and CC O
their PRP$ O
relatives NNS O
must MD O
be VB O
informed VBN O
about IN O
the DT O
available JJ O
effective JJ O
treatment NN O
possibilities NNS O
and CC O
about IN O
the DT O
right JJ O
moment NN O
for IN O
their PRP$ O
application NN O
in IN O
an DT O
individual JJ O
patient NN O
. . O

Mild NNP O
orbital JJ O
discomfort NN O
occurred VBD O
in IN O
some DT O
patients NNS O
. . O

The DT O
Lm NNP O
increased VBD O
and CC O
the DT O
alveoli JJ O
/ NNP O
mm2 NN O
and CC O
elastic JJ O
recoil NN O
pressure NN O
decreased VBN O
. . O

The DT O
patient NN O
had VBD O
developed VBN O
left VBN O
- : O
sided VBD O
low JJ O
- : O
frequency NN O
tremor NN O
and CC O
hemidystonia NN O
after IN O
a DT O
severe JJ O
head NN O
trauma NN O
sustained VBD O
at IN O
15 CD O
years NNS O
of IN O
age NN O
. . O

Hybridization NNP O
data NNS O
indicate VBP O
that IN O
6F6 CD B-Gene
. . I-Gene
2 CD I-Gene
corresponds NNS O
to TO O
the DT O
previously RB O
characterized VBN O
m6F6 NN B-Gene
cDNA NN I-Gene
clone NN I-Gene
and CC O
that DT O
6F6 CD B-Gene
. . I-Gene
1 CD I-Gene
and CC O
6F6 CD B-Gene
. . I-Gene
3 CD I-Gene
, , O
but CC O
not RB O
6F6 CD B-Gene
. . I-Gene
2 CD I-Gene
, , O
are VBP O
adjacent JJ O
to TO O
alpha VB B-Gene
- : I-Gene
type NN I-Gene
genes NNS I-Gene
. . O

Middle NNP O
- : O
latency NN O
auditory NN O
evoked VBN O
potentials NNS O
( ( O
MAEPs NNP O
) ) O
were VBD O
recorded VBN O
in IN O
controls NNS O
and CC O
patients NNS O
with IN O
focal JJ O
lesions NNS O
in IN O
dorsolateral JJ O
prefrontal JJ O
cortex NN O
. . O

Tissue NN O
necrosis NN O
was VBD O
evaluated VBN O
using VBG O
triphenyltetrazolium NN O
staining NN O
and CC O
was VBD O
related VBN O
to TO O
two CD O
major JJ O
baseline NN O
predictors NNS O
of IN O
infarct JJ O
size NN O
: : O
anatomic JJ O
risk NN O
zone NN O
size NN O
and CC O
coronary JJ O
collateral NN O
flow NN O
. . O

The DT O
human JJ B-Gene
gp39 NN I-Gene
promoter NN I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
adapter NN O
Gab1 NNP B-Gene
may MD O
redirect VB O
c SYM B-Gene
- : I-Gene
Met NN I-Gene
signaling VBG O
through IN O
PI3K NNP B-Gene
away RB O
from IN O
a DT O
c JJ B-Gene
- : I-Gene
Akt NNP I-Gene
/ NNP O
Pak1 NNP B-Gene
cell NN O
survival NN O
pathway NN O
. . O

The DT O
cell NN O
cycle NN O
- : O
regulated VBN O
transcription NN O
factor NN O
E2F NNP B-Gene
is VBZ O
also RB O
known VBN O
to TO O
bend VB O
DNA NNP O
upon IN O
binding NN O
. . O

Carboxy NNP O
- : O
terminal JJ O
Spc110p NNP B-Gene
truncations NNS O
lacking VBG O
the DT O
calmodulin NN B-Gene
binding VBG O
site NN O
can MD O
support VB O
growth NN O
and CC O
are VBP O
also RB O
phosphorylated VBN O
in IN O
a DT O
cell NN O
cycle NN O
- : O
specific JJ O
manner NN O
. . O

The DT O
organization NN O
of IN O
SPP1 NNP B-Gene
genes NNS I-Gene
involved VBN O
in IN O
the DT O
replication NN O
, , O
DNA NNP O
packaging NN O
and CC O
phage NN O
assembly RB O
proteins VBZ O
resembles VBZ O
the DT O
organization NN O
of IN O
genes NNS O
of IN O
equivalent JJ O
regions NNS O
of IN O
different JJ O
E NNP O
. . O
coli NN O
double JJ O
- : O
stranded VBD O
DNA NNP O
phages NNS O
. . O

To TO O
test VB O
whether IN O
Sp1 NNP B-Gene
and CC O
zif268 NNP B-Gene
/ NNP O
egr VBD B-Gene
- : I-Gene
1 CD I-Gene
interact NN O
with IN O
this DT O
motif NN O
, , O
gel JJ O
retardation NN O
assays NNS O
were VBD O
performed VBN O
. . O

Methysergide NNP O
is VBZ O
a DT O
serotonin JJ O
antagonist NN O
and CC O
has VBZ O
been VBN O
demonstrated VBN O
to TO O
reduce VB O
wound NN O
blood NN O
flow NN O
and CC O
edema JJ O
formation NN O
. . O

The DT O
prevalence NN O
and CC O
incidence NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
types VBZ O
1 CD O
and CC O
2 CD O
( ( O
HIV NNP O
- : O
1 CD O
, , O
HIV NNP O
- : O
2 CD O
) ) O
, , O
human JJ O
T NNP O
- : O
lymphotropic NN O
virus NN O
types NNS O
I PRP O
and CC O
II NNP O
( ( O
HTLV NNP O
- : O
I PRP O
/ VBP O
II NNP O
) ) O
, , O
and CC O
syphilitic JJ O
infections NNS O
and CC O
the DT O
association NN O
between IN O
these DT O
infections NNS O
were VBD O
determined VBN O
in IN O
a DT O
cohort NN O
of IN O
police NN O
officers NNS O
in IN O
Guinea NNP O
- : O
Bissau NNP O
. . O

This DT O
report NN O
presents VBZ O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
( ( O
1 CD O
. . O
2 CD O
kb NN O
) ) O
and CC O
exon $ O
1 CD O
of IN O
the DT O
human JJ B-Gene
RII NNP I-Gene
alpha NN I-Gene
gene NN I-Gene
. . O

Doctor NNP O
Berglund NNP O
warns VBZ O
members NNS O
of IN O
union NN O
pitfalls NNS O
. . O

The DT O
human JJ B-Gene
2 CD I-Gene
' '' I-Gene
, , I-Gene
5 CD I-Gene
' POS I-Gene
- : I-Gene
oligoadenylate NN I-Gene
( ( I-Gene
2 CD I-Gene
- : I-Gene
5A CD I-Gene
) ) I-Gene
synthetases NNS I-Gene
are VBP O
members NNS O
of IN O
a DT O
family NN O
interferon NN B-Gene
( ( O
IFN NNP B-Gene
) ) O
- : O
inducible JJ O
anti JJ B-Gene
- : I-Gene
viral JJ I-Gene
proteins NNS I-Gene
. . O

All DT O
problems NNS O
were VBD O
associated VBN O
with IN O
fractured VBN O
or CC O
lost VBN O
screws NNS O
. . O

R NN O
. . O

Functional NNP O
and CC O
regulatory JJ O
analysis NN O
of IN O
the DT O
two CD O
copies NNS O
of IN O
the DT O
fixNOQP JJ B-Gene
operon NN I-Gene
of IN O
Rhizobium NNP O
leguminosarum NN O
strain NN O
VF39 NNP O
. . O

Albumin NNP O
expression NN O
is VBZ O
maintained VBN O
in IN O
the DT O
liver NN O
by IN O
a DT O
combination NN O
of IN O
liver JJ O
- : O
enriched JJ O
transcription NN O
factors NNS O
such JJ O
as IN O
CAAT NNP B-Gene
enhancer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) I-Gene
alpha NN I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBPbeta NNP I-Gene
. . O

Replacement NN O
of IN O
the DT O
CRE NNP O
with IN O
a DT O
second JJ O
copy NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
results NNS O
in IN O
a DT O
level NN O
of IN O
transcriptional JJ O
activity NN O
comparable JJ O
with IN O
that DT O
of IN O
the DT O
wild JJ O
- : O
type NN O
sequence NN O
, , O
but CC O
replacement NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
with IN O
a DT O
CRE NNP O
abolishes VBZ O
activity NN O
. . O

The DT O
two CD O
- : O
wave NN O
, , O
1995 CD O
- : O
1996 CD O
National NNP O
Longitudinal NNP O
Study NNP O
of IN O
Adolescent NNP O
Health NNP O
uses VBZ O
a DT O
measure NN O
of IN O
depressive JJ O
symptomatology NN O
across IN O
a DT O
12 CD O
- : O
month NN O
interval NN O
. . O

Although IN O
eight CD O
contiguous JJ O
genes NNS O
necessary JJ O
for IN O
urease JJ B-Gene
activity NN O
have VBP O
been VBN O
cloned VBN O
and CC O
sequenced VBN O
, , O
the DT O
transcriptional JJ O
organization NN O
and CC O
regulation NN O
of IN O
specific JJ O
genes NNS O
within IN O
the DT O
Proteus NNP B-Gene
gene NN I-Gene
cluster NN I-Gene
has VBZ O
not RB O
been VBN O
investigated VBN O
in IN O
detail NN O
. . O

Insert2 NNP O
contains VBZ O
repetitive JJ O
non SYM O
- : O
Ig NNP B-Gene
- : O
related JJ O
sequences NNS O
and CC O
a DT O
small JJ B-Gene
Ig NNP I-Gene
- : I-Gene
related JJ I-Gene
sequence NN I-Gene
. . O

For IN O
various JJ O
dog NN O
vessels NNS O
in IN O
vivo NN O
, , O
Q NNP O
/ NNP O
Dk NNP O
ranged VBD O
from IN O
0 CD O
. . O
15 CD O
to TO O
47 CD O
X NNS O
10 CD O
( ( O
5 CD O
) ) O
Torr NNP O
/ NNP O
cm2 NN O
. . O

Cloning VBG O
and CC O
characterization NN O
of IN O
the DT O
murine NN B-Gene
beta NN I-Gene
( ( I-Gene
3 CD I-Gene
) ) I-Gene
integrin NN I-Gene
gene NN I-Gene
promoter NN O
: : O
identification NN O
of IN O
an DT O
interleukin JJ B-Gene
- : I-Gene
4 CD I-Gene
responsive JJ I-Gene
element NN I-Gene
and CC O
regulation NN O
by IN O
STAT NNP B-Gene
- : I-Gene
6 CD I-Gene
. . O

Isolation NN O
and CC O
characterization NN O
of IN O
a DT O
vinculin NN B-Gene
cDNA NN I-Gene
from IN I-Gene
chick JJ I-Gene
- : I-Gene
embryo NN I-Gene
fibroblasts NNS I-Gene
. . O

To TO O
improve VB O
test NN O
efficiency NN O
, , O
we PRP O
modified VBD O
our PRP$ O
previously RB O
introduced VBN O
contrast NN O
/ NNP O
color NN O
card NN O
test NN O
by IN O
including VBG O
a DT O
patterned JJ O
test NN O
stimulus NN O
and CC O
reducing VBG O
the DT O
number NN O
of IN O
stimuli NN O
in IN O
both DT O
experimental JJ O
phases NNS O
. . O

Most JJS O
patients NNS O
with IN O
high JJ O
blood NN O
pressure NN O
( ( O
BP NNP O
) ) O
can MD O
be VB O
managed VBN O
by IN O
using VBG O
one CD O
of IN O
4 CD O
classes NNS O
of IN O
compounds NNS O
: : O
a DT O
diuretic JJ O
, , O
beta JJ O
blocker NN O
, , O
converting VBG O
enzyme JJ O
inhibitor NN O
or CC O
calcium NN O
antagonist NN O
. . O

I PRP O
. . O

Agranulocytosis NNP O
treatment NN O
with IN O
rhGM JJ B-Gene
- : I-Gene
CSF NN I-Gene

Transient JJ O
transfection NN O
assays NNS O
using VBG O
reporter NN O
gene NN O
constructs NNS O
containing VBG O
various JJ O
lengths NNS O
of IN O
the DT O
5 CD B-Gene
' POS I-Gene
mdr1b NN I-Gene
sequences NNS I-Gene
revealed VBD O
that IN O
the DT O
sequence NN O
located VBN O
between IN O
- : O
247 CD O
to TO O
- : O
126 CD O
bp NN O
was VBD O
important JJ O
for IN O
the DT O
expression NN O
of IN O
the DT O
reporter NN O
gene NN O
in IN O
many JJ O
different JJ O
cell NN O
lines NNS O
. . O

Immunophenotyping VBG O
in IN O
four CD O
cases NNS O
, , O
demonstrated VBD O
non SYM O
- : O
B NN O
, , O
non SYM O
- : O
T NN O
cell NN O
origin NN O
in IN O
three CD O
and CC O
pre VB O
- : O
B NNP O
cell NN O
origin NN O
in IN O
one CD O
. . O

In IN O
contrast NN O
, , O
the DT O
MAN NNP O
showed VBD O
a DT O
unimodal JJ O
, , O
skewed JJ O
distribution NN O
, , O
with IN O
a DT O
range NN O
from IN O
approximately RB O
1 CD O
to TO O
14 CD O
micron NN O
and CC O
a DT O
maximum NN O
at IN O
3 CD O
- : O
4 CD O
micron NN O
. . O

Treatment NN O
of IN O
ovarian JJ O
neoplasms NNS O

In IN O
rats NNS O
bearing VBG O
Walker NNP O
- : O
256 CD O
- : O
carcinosarcoma NN O
4 CD O
- : O
EPI NN O
was VBD O
effective JJ O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

DNA NN O
sequencing NN O
of IN O
the DT O
DPM1 NNP B-Gene
gene NN I-Gene
revealed VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
801 CD O
bases NNS O
. . O

Unfortunately RB O
, , O
these DT O
preservatives NNS O
may MD O
also RB O
interfere VB O
with IN O
microbiological JJ O
assays NNS O
used VBN O
to TO O
determine VB O
product NN O
sterility NN O
or CC O
bioburden NN O
levels NNS O
. . O

Early JJ O
heparin NN O
therapy NN O
in IN O
60 CD O
children NNS O
with IN O
acute JJ O
meningococcemia NN O
. . O

Baseline NNP O
variables NNS O
associated VBN O
with IN O
CD NNP O
included VBD O
a DT O
less RBR O
frequent JJ O
use NN O
of IN O
prestroke NN O
aspirin NN O
and CC O
a DT O
higher JJR O
incidence NN O
of IN O
early JJ O
CT NNP O
changes NNS O
of IN O
edema NN O
or CC O
mass NN O
effect NN O
or CC O
dense NN O
middle JJ O
cerebral JJ O
artery NN O
sign NN O
. . O

Genetic JJ O
analysis NN O
has VBZ O
subsequently RB O
identified VBN O
subpathways NNS O
of IN O
the DT O
DNA NN O
structure NN O
checkpoints NNS O
, , O
including VBG O
the DT O
reversible JJ O
arrest NN O
of IN O
DNA NNP O
synthesis NN O
. . O

Nernst NNP O
- : O
- : O
Planck NN O
analog NN O
equations NNS O
and CC O
stationary JJ O
state NN O
membrane NN O
electric JJ O
potentials NNS O
. . O

Genomic NNP O
and CC O
functional JJ O
characterization NN O
of IN O
the DT O
oas JJ B-Gene
gene NN I-Gene
family NN I-Gene
encoding VBG O
O NNP B-Gene
- : I-Gene
acetylserine NN I-Gene
( ( I-Gene
thiol NN I-Gene
) ) I-Gene
lyases VBZ I-Gene
, , O
enzymes VBZ O
catalyzing VBG O
the DT O
final JJ O
step NN O
in IN O
cysteine JJ O
biosynthesis NN O
in IN O
Arabidopsis NNP O
thaliana NN O
. . O

A DT O
stochastic JJ O
version NN O
of IN O
Kernell NNP O
' POS O
s NN O
( ( O
1968 CD O
, , O
1972 CD O
) ) O
model NN O
with IN O
cumulative JJ O
afterhyperpolarization NN O
( ( O
AHP NNP O
) ) O
was VBD O
simulated VBN O
. . O

He PRP O
visited VBD O
our PRP$ O
hospital NN O
and CC O
left VBD O
solitary JJ O
renal JJ O
cyst NN O
was VBD O
suspected VBN O
. . O

Chem NNP O
. . O

HSF NNP B-Gene
binds VBZ O
DNA NNP O
as IN O
a DT O
trimer NN O
, , O
and CC O
additional JJ O
trimers NNS O
can MD O
bind VB O
DNA NNP O
co SYM O
- : O
operatively RB O
. . O

This DT O
reveals VBZ O
a DT O
new JJ O
test NN O
for IN O
short JJ O
saphenous JJ O
incompetence NN O
and CC O
shows VBZ O
that IN O
14 CD O
per IN O
cent NN O
of IN O
varices NNS O
stem VBP O
from IN O
a DT O
saphenopopliteal JJ O
reflux NN O
. . O

RPS14 NNP B-Gene
introns NNS O
3 CD O
and CC O
4 CD O
both DT O
contain NN O
Alu NNP B-Gene
sequences NNS O
. . O

MPO NNP B-Gene
was VBD O
labeled VBN O
with IN O
1 CD O
mCi NNS O
125I CD O
by IN O
a DT O
technique NN O
of IN O
self JJ O
- : O
labeling NN O
in IN O
the DT O
presence NN O
of IN O
10 CD O
( ( O
- : O
4 CD O
) ) O
M NNP O
hydrogen NN O
peroxide NN O
. . O

Twenty NNP O
- : O
six CD O
( ( O
55 CD O
% NN O
) ) O
( ( O
95 CD O
% NN O
CI NNP O
, , O
41 CD O
- : O
69 CD O
% NN O
) ) O
patients NNS O
experienced JJ O
> NNP O
or CC O
= NNP O
grade VBD O
3 CD O
acute JJ O
toxicity NN O
( ( O
RTOG NNP O
) ) O
. . O

Of IN O
7 CD O
patients NNS O
treated VBN O
with IN O
cyclophosphamide NN O
, , O
hexamethylmelamine NN O
, , O
adriamycin NN O
and CC O
cisplatin NN O
( ( O
CHAP NNP O
- : O
5 CD O
) ) O
, , O
6 CD O
had VBD O
measurable JJ O
disease NN O
, , O
of IN O
whom WP O
5 CD O
yielded VBD O
a DT O
response NN O
( ( O
2 CD O
complete JJ O
responses NNS O
for IN O
19 CD O
+ NNS O
and CC O
40 CD O
months NNS O
and CC O
3 CD O
partial JJ O
responses NNS O
for IN O
4 CD O
, , O
7 CD O
and CC O
8 CD O
months NNS O
) ) O
. . O

Experimental JJ O
cardiotoxicity NN O
of IN O
adriamycin NN O

In IN O
the DT O
rat NN B-Gene
rnu NN I-Gene
allele NN I-Gene
described VBD O
here RB O
, , O
a DT O
nonsense JJ O
mutation NN O
in IN O
exon JJ O
8 CD O
of IN O
the DT O
whn JJ B-Gene
gene NN I-Gene
was VBD O
identified VBN O
. . O

The DT O
cyclins NNS B-Gene
bind VBP O
to TO O
and CC O
activate VB O
the DT O
CDK NNP B-Gene
, , O
which WDT O
leads VBZ O
to TO O
phosphorylation NN O
( ( O
and CC O
then RB O
inhibition NN O
) ) O
of IN O
the DT O
tumor NN O
suppressor NN O
protein NN O
, , O
pRb NN B-Gene
. . O

pRb NN B-Gene
controls NNS O
commitment NN O
to TO O
progress NN O
from IN O
the DT O
G1 NNP O
to TO O
S NNP O
phase NN O
, , O
at IN O
least JJS O
in IN O
part NN O
by IN O
repressing VBG O
the DT O
activity NN O
of IN O
the DT O
E2F NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
known VBN O
to TO O
promote VB O
cell NN O
proliferation NN O
. . O

Clinical JJ O
implication NN O
of IN O
protein NN O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
in IN O
induced JJ O
sputum NN O
in IN O
asthmatic JJ O
patients NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
regulation NN O
of IN O
B NNP B-Gene
- : I-Gene
Myb NN I-Gene
activity NN O
by IN O
cyclin NN B-Gene
- : O
Cdks NN B-Gene
. . O

Scientific NNP O
cooperation NN O
of IN O
CMEA NNP O
member NN O
countries NNS O
has VBZ O
been VBN O
carried VBN O
out IN O
since IN O
1974 CD O
under IN O
the DT O
sponsorship NN O
of IN O
the DT O
Cancer NNP O
Research NNP O
Institute NNP O
, , O
Slovak NNP O
Academy NNP O
of IN O
Sciences NNP O
( ( O
Czechoslovakia NNP O
) ) O
within IN O
the DT O
framework NN O
of IN O
CMEA NNP O
. . O

National NNP O
abortion NN O
laws NNS O
usually RB O
do VBP O
not RB O
allow VB O
abortion NN O
when WRB O
a DT O
foetus NN O
is VBZ O
independently RB O
viable JJ O
, , O
i JJ O
. . O
e NN O
. . O
from IN O
a DT O
gestational JJ O
age NN O
of IN O
about RB O
24 CD O
weeks NNS O
. . O

Antibodies NNS O
raised VBD O
to TO O
the DT O
expressed VBN O
NS3 NNP B-Gene
by IN O
immunization NN O
of IN O
mice NN O
detected VBN O
both DT O
NS3 NNP B-Gene
and CC O
NS3A NNP B-Gene
in IN O
BTV NNP O
- : O
10 CD O
- : O
infected VBN O
BHK NNP O
cells NNS O
but CC O
not RB O
in IN O
purified VBN O
BTV NNP O
- : O
10 CD O
virus NN O
particles NNS O
. . O

A DT O
hydrodynamic JJ O
description NN O
of IN O
the DT O
osmotic JJ O
reflection NN O
coefficient NN O
with IN O
application NN O
to TO O
the DT O
pore NN O
theory NN O
of IN O
transcapillary JJ O
exchange NN O
. . O

The DT O
differentiation NN O
and CC O
maintenance NN O
of IN O
a DT O
neurotransmitter NN O
phenotype NN O
is VBZ O
guided VBN O
by IN O
the DT O
interaction NN O
of IN O
exogenous JJ O
cues NNS O
with IN O
intrinsic JJ O
genetic JJ O
machinery NN O
. . O

Mutations NNS O
at IN O
the DT O
suf12 NN B-Gene
locus NN I-Gene
were VBD O
isolated VBN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
as IN O
extragenic JJ O
suppressors NNS O
of IN O
+ $ O
1 CD O
frameshift NN O
mutations NNS O
in IN O
glycine NN O
( ( O
GGX NNP O
) ) O
and CC O
proline NN O
( ( O
CCX NNP O
) ) O
codons NNS O
, , O
as RB O
well RB O
as IN O
UGA NNP O
and CC O
UAG NNP O
nonsense JJ O
mutations NNS O
. . O

The DT O
viral JJ B-Gene
LTR NNP I-Gene
was VBD O
used VBN O
as IN O
the DT O
promoter NN O
. . O

An DT O
18 CD O
- : O
kb NN O
genomic JJ O
clone NN O
including VBG O
sequences NNS O
encoding VBG O
for IN O
the DT O
two CD O
GHS NNP B-Gene
- : I-Gene
R NN I-Gene
variants NNS I-Gene
was VBD O
isolated VBN O
. . O

A DT O
possible JJ O
mechanism NN O
is VBZ O
that IN O
elevated JJ O
alveolar JJ O
pressure NN O
and CC O
decreased JJ O
cardiac NN O
output NN O
eliminate VB O
blood NN O
flow NN O
from IN O
corner NN O
vessels NNS O
in IN O
nondependent JJ O
high JJ O
VA NNP O
/ NNP O
Q NNP O
regions NNS O
. . O

BACKGROUND NN O
: : O
Diazepam NNP O
, , O
one CD O
of IN O
the DT O
benzodiazepine NN O
group NN O
of IN O
tranquilizers NNS O
, , O
is VBZ O
used VBN O
as IN O
an DT O
adjunctive JJ O
drug NN O
for IN O
sedation NN O
and CC O
for IN O
relief NN O
of IN O
anxiety NN O
in IN O
the DT O
treatment NN O
of IN O
epilepsy NN O
. . O

The DT O
predictive JJ O
value NN O
of IN O
a DT O
positive JJ O
flag NN O
was VBD O
77 CD O
. . O
7 CD O
% NN O
. . O

Natural JJ O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
capsular JJ O
polysaccharide NN O
antibodies NNS O
in IN O
412 CD O
infants NNS O
and CC O
children NNS O
from IN O
West NNP O
Africa NNP O
( ( O
Burkina NNP O
- : O
Faso NN O
) ) O
and CC O
France NNP O
: : O
a DT O
cross NN O
- : O
sectional JJ O
serosurvey NN O
. . O

A DT O
comparative JJ O
study NN O
by IN O
holographic JJ O
interferometry NN O
of IN O
ten JJ O
porcine JJ O
bioprosthetic JJ O
valves NNS O
( ( O
seven CD O
Carpentier NNP O
- : O
Edwards NNS O
SAV NNP O
, , O
two CD O
BioImplant NNP O
and CC O
one CD O
Valcor NNP O
) ) O
with IN O
five CD O
human JJ O
aortic JJ O
valves NNS O
before IN O
and CC O
after IN O
glutaraldehyde JJ O
treatment NN O
is VBZ O
presented VBN O
. . O

Simulating VBG O
the DT O
impact NN O
during IN O
human JJ O
jumping NN O
by IN O
means NNS O
of IN O
a DT O
4 CD O
- : O
degrees NNS O
- : O
of IN O
- : O
freedom NN O
model NN O
with IN O
time NN O
- : O
dependent NN O
properties NNS O
. . O

Treatment NN O
includes VBZ O
both DT O
medical JJ O
and CC O
surgical JJ O
options NNS O
, , O
with IN O
medical JJ O
therapy NN O
further RBR O
subclassified VBD O
into IN O
pharmacologic NN O
and CC O
pneumatic JJ O
dilation NN O
. . O

A DT O
central JJ O
finding NN O
is VBZ O
the DT O
identification NN O
of IN O
a DT O
GC NNP O
- : O
rich JJ O
sequence NN O
in IN O
the DT O
- : O
99 CD O
/ SYM O
- : O
91 CD O
Cp NNP B-Gene
region NN O
that WDT O
is VBZ O
essential JJ O
for IN O
oriPI JJ O
- : O
EBNA1 SYM B-Gene
- : O
independent JJ O
as RB O
well RB O
as IN O
oriPI JJ O
- : O
EBNA1 NNP B-Gene
- : O
dependent JJ O
activity NN O
of IN O
the DT O
promoter NN O
. . O

One CD O
possible JJ O
solution NN O
is VBZ O
a DT O
thin JJ O
radial JJ O
forearm NN O
free JJ O
flap NN O
. . O

In IN O
vivo JJ O
epiluminescence NN O
microscopy NN O
of IN O
pigmented JJ O
skin JJ O
lesions NNS O
. . O

Finally RB O
, , O
a DT O
complementary JJ O
footprinting NN O
analysis NN O
of IN O
the DT O
upstream JJ O
region NN O
of IN O
the DT O
constitutively RB O
expressed VBN O
HSC82 NNP B-Gene
gene NN I-Gene
reveals VBZ O
the DT O
presence NN O
of IN O
three CD O
discrete JJ O
protein NN O
complexes NNS O
. . O

Ventilatory NNP O
management NN O
casebook NN O
. . O

European JJ O
Community NNP O
Huntington NNP O
' POS O
s JJ O
Disease NNP O
Collaborative NNP O
Study NNP O
Group NNP O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
cells NNS O
containing VBG O
a DT O
PTP1C NNP B-Gene
in IN O
which WDT O
the DT O
catalytic JJ O
site NN O
had VBD O
been VBN O
inactivated VBN O
through IN O
mutagenesis NN O
, , O
stably RB O
phosphorylated VBD O
the DT O
phosphatase NN O
. . O

Heterogeneity NN O
of IN O
human JJ B-Gene
serum NN I-Gene
albumin NN I-Gene
. . O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
graft NN O
survival NN O
between IN O
groups NNS O
with IN O
early JJ O
graft NN O
function NN O
( ( O
EGF NNP O
) ) O
and CC O
DGF NNP O
, , O
either RB O
in IN O
first JJ O
transplantations NNS O
or CC O
retransplantations NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
expression NN O
of IN O
Cktsf1b1 NNP B-Gene
, , O
a DT O
gene NN O
associated VBN O
with IN O
early JJ O
development NN O
and CC O
cell NN O
transformation NN O
, , O
is VBZ O
sensitive JJ O
to TO O
MKK NNP B-Gene
levels NNS O
and CC O
may MD O
be VB O
regulated VBN O
via IN O
multiple JJ O
transcription NN O
factor NN O
complexes NNS O
. . O

Fgd3 NNP B-Gene
and CC O
FGD1 NNP B-Gene
share NN O
a DT O
high JJ O
degree NN O
of IN O
sequence NN O
identity NN O
that WDT O
spans VBZ O
> JJ O
560 CD O
contiguous JJ O
amino NN O
acid NN O
residues NNS O
. . O

For IN O
the DT O
first JJ O
30 CD O
min NN O
following VBG O
insulin JJ B-Gene
administration NN O
, , O
the DT O
rate NN O
of IN O
change NN O
in IN O
glucose NN O
levels NNS O
was VBD O
significantly RB O
less JJR O
among IN O
the DT O
patients NNS O
with IN O
major JJ O
depressive JJ O
disorder NN O
than IN O
among IN O
either CC O
the DT O
patients NNS O
with IN O
dysthymic JJ O
disorder NN O
or CC O
the DT O
normal JJ O
control NN O
subjects NNS O
. . O

We PRP O
found VBD O
that IN O
RhoA NNP B-Gene
can MD O
initiate VB O
a DT O
linear JJ O
kinase NN O
cascade VBD O
leading VBG O
to TO O
the DT O
activation NN O
of IN O
ERK6 NNP B-Gene
( ( O
p38 JJ B-Gene
gamma NN I-Gene
) ) O
, , O
a DT O
recently RB O
identified VBN O
member NN O
of IN O
the DT O
p38 JJ B-Gene
family NN I-Gene
of IN O
MAPKs NNP O
. . O

Hence NNP O
follows VBZ O
Kurti NNP O
' POS O
s JJ O
demand NN O
to TO O
mete VB O
out RP O
appropriate JJ O
importance NN O
to TO O
the DT O
arguments NNS O
. . O

BCL6 NNP B-Gene
encodes VBZ O
a DT O
POZ NNP B-Gene
/ NNP I-Gene
Zn NNP I-Gene
finger NN I-Gene
protein NN I-Gene
, , O
a DT O
structure NN O
similar JJ O
to TO O
that DT O
of IN O
many JJ O
Drosophila NNP O
developmental JJ O
regulators NNS O
and CC O
to TO O
another DT O
protein NN O
involved VBN O
in IN O
a DT O
human JJ O
hematopoietic JJ O
malignancy NN O
, , O
PLZF NNP B-Gene
. . O

The DT O
efficacy NN O
of IN O
quantitative JJ O
and CC O
qualitative JJ O
chloride NN O
titrators NNS O
in IN O
the DT O
estimation NN O
of IN O
human JJ O
salt NN O
intake NN O
. . O

Advances NNS O
in IN O
hemophilia JJ O
treatment NN O
: : O
a DT O
hepatitis NN O
- : O
safe JJ O
factor NN B-Gene
VIII NNP I-Gene
concentrate NN O

Such JJ O
knowledge NN O
could MD O
advance VB O
diagnosis NN O
and CC O
treatment NN O
of IN O
the DT O
patient NN O
and CC O
counseling NN O
of IN O
the DT O
affected JJ O
family NN O
. . O

The DT O
mRNAs NN O
of IN O
these DT O
genes NNS O
contain VBP O
respectively RB O
one CD O
( ( O
YAP1 NNP B-Gene
uORF NN I-Gene
) ) O
and CC O
two CD O
( ( O
YAP2 NNP B-Gene
uORF1 RB I-Gene
and CC O
uORF2 JJ O
) ) O
upstream NN O
open JJ O
reading NN O
frames NNS O
. . O

uORF JJ O
- : O
mediated VBN O
modulation NN O
of IN O
post NN O
- : O
termination NN O
events NNS O
on IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
( ( O
5 CD O
' '' O
- : O
UTR NN O
) ) O
directs VBZ O
differential JJ O
control NN O
not RB O
only RB O
of IN O
translation NN O
but CC O
also RB O
of IN O
mRNA NN O
decay NN O
. . O

Sci NNP O
. . O

Methisergide NNP O
( ( O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
, , O
i NN O
. . O
p NN O
. . O
) ) O
, , O
a DT O
blocker NN O
of IN O
serotonin NN B-Gene
receptors NNS I-Gene
, , O
prevented VBD O
the DT O
development NN O
of IN O
the DT O
antinociceptive JJ O
effect NN O
of IN O
serotonin NN O
. . O

The DT O
adeno JJ B-Gene
- : I-Gene
associated VBN I-Gene
virus NN I-Gene
( ( I-Gene
AAV NNP I-Gene
) ) I-Gene
rep VBP I-Gene
gene NN I-Gene
encodes NNS O
four CD O
proteins NNS O
( ( O
Rep78 NNP B-Gene
, , O
Rep68 NNP B-Gene
, , O
Rep52 NNP B-Gene
, , O
and CC O
Rep40 NNP B-Gene
) ) O
required VBD O
for IN O
AAV NNP O
DNA NNP O
replication NN O
and CC O
AAV NNP O
gene NN O
regulation NN O
. . O

The DT O
N NNP O
- : O
terminal NN O
amino NN O
acid JJ O
sequence NN O
of IN O
Mop NNP B-Gene
has VBZ O
sequence NN O
homology NN O
with IN O
DNA NNP O
binding VBG O
proteins NNS O
. . O

This DT O
article NN O
reviews VBZ O
recent JJ O
information NN O
on IN O
the DT O
frequency NN O
, , O
characteristics NNS O
, , O
and CC O
possible JJ O
pathogenic JJ O
mechanisms NNS O
of IN O
the DT O
vasculitides NNS O
occurring VBG O
in IN O
patients NNS O
with IN O
the DT O
main JJ O
connective JJ O
tissue NN O
diseases NNS O
. . O

Expression NN O
of IN O
the DT O
mouse NN B-Gene
TSH NNP I-Gene
beta NN I-Gene
gene NN I-Gene
, , O
therefore RB O
, , O
gives VBZ O
rise NN O
to TO O
multiple VB O
mRNAs NN O
, , O
each DT O
with IN O
a DT O
unique JJ O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
. . O

The DT O
course NN O
of IN O
endotoxin NN O
fever NN O
remained VBD O
uninfluenced JJ O
by IN O
ALS NNP O
. . O

Cloning VBG O
and CC O
sequencing NN O
of IN O
the DT O
corresponding JJ O
cDNAs NN O
indicates VBZ O
that IN O
, , O
via IN O
alternative JJ O
splicing NN O
, , O
the DT O
rearranged VBN O
gene NN O
codes NNS O
for IN O
two CD O
proteins NNS O
of IN O
84 CD O
and CC O
85 CD O
kD NN O
( ( O
p84 JJ B-Gene
/ NNP I-Gene
85 CD I-Gene
) ) O
which WDT O
retain VBP O
the DT O
DNA NNP O
- : O
binding NN O
rel NN B-Gene
domain NN I-Gene
and CC O
the DT O
first JJ O
five CD O
ankyrin NN B-Gene
repeats NNS O
, , O
but CC O
have VBP O
lost VBN O
their PRP$ O
carboxy JJ O
- : O
terminus NN O
including VBG O
the DT O
seventh JJ O
ankyrin NN B-Gene
repeat NN O
. . O

After IN O
10 CD O
months NNS O
of IN O
treatment NN O
with IN O
the DT O
conjugated JJ O
estrogen NN O
, , O
both DT O
his PRP$ O
height NN O
and CC O
weight NN O
showed VBD O
improvement NN O
, , O
while IN O
his PRP$ O
bone NN O
mineral NN O
density NN O
and CC O
bone NN O
age NN O
were VBD O
increased VBN O
. . O

Northern NNP O
blot NN O
analysis NN O
revealed VBD O
multiple JJ O
oIGF IN B-Gene
- : I-Gene
I PRP I-Gene
transcripts VBP I-Gene
in IN O
a DT O
broad JJ O
band NN O
at IN O
800 CD O
- : O
1 CD O
, , O
100 CD O
nucleotides NNS O
and CC O
other JJ O
transcripts NNS O
of IN O
higher JJR O
molecular JJ O
weight NN O
in IN O
liver NN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
kinase SYM O
- : O
dead JJ O
but CC O
not RB O
wild JJ O
- : O
type NN O
forms NNS O
of IN O
Fyn NNP B-Gene
, , O
Lck NNP B-Gene
, , O
and CC O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
block NN O
70Z CD O
Cbl NNP B-Gene
- : O
mediated VBD O
NFAT NNP B-Gene
activation NN O
. . O

The DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
mouse NN B-Gene
Met NNP I-Gene
- : I-Gene
ase NN I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
also RB O
shares NNS O
considerable JJ O
regions NNS O
of IN O
identity NN O
with IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
rat NN B-Gene
Met NNP I-Gene
- : I-Gene
ase NN I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
. . O

Human NNP O
neutrophil VBZ O
response NN O
to TO O
short VB O
- : O
term NN O
exposure NN O
to TO O
F NNP O
- : O
75 CD O
cobalt NN O
- : O
based VBN O
alloy NN O
. . O

Both DT O
betaAPP JJ B-Gene
mRNA NN I-Gene
and CC O
Abeta NNP B-Gene
levels NNS O
are VBP O
increased VBN O
in IN O
trisomy NN O
21 CD O
. . O

After IN O
infection NN O
of IN O
293 CD O
cells NNS O
( ( O
which WDT O
provide VBP O
complementary JJ O
E1a NNP B-Gene
- : O
E1b NNP B-Gene
functions NNS O
) ) O
, , O
both DT O
viruses NNS O
directed VBD O
equal JJ O
amounts NNS O
of IN O
P NNP B-Gene
/ NNP I-Gene
C NNP I-Gene
- : I-Gene
specific JJ I-Gene
mRNA JJ I-Gene
transcription NN O
. . O

Evolutive JJ O
morphology NN O
of IN O
the DT O
olfactory NN O
bulb NN O
in IN O
man NN O
and CC O
certain JJ O
non JJ O
- : O
human JJ O
mammals NNS O

In IN O
contrast NN O
to TO O
full JJ B-Gene
- : I-Gene
length NN I-Gene
E2F NNP I-Gene
- : I-Gene
3 CD I-Gene
, , O
which WDT O
is VBZ O
expressed VBN O
only RB O
at IN O
the DT O
G1 NNP O
/ NNP O
S NNP O
boundary NN O
, , O
E2F NNP B-Gene
- : I-Gene
3B CD I-Gene
is VBZ O
detected VBN O
throughout IN O
the DT O
cell NN O
cycle NN O
with IN O
peak NN O
levels NNS O
in IN O
GO NNP O
where WRB O
it PRP O
is VBZ O
associated VBN O
with IN O
Rb NNP B-Gene
. . O

Molecular JJ O
cloning NN O
and CC O
characterisation NN O
of IN O
the DT O
two CD O
homologous JJ O
genes NNS O
coding VBG O
for IN O
nitrate JJ B-Gene
reductase NN I-Gene
in IN I-Gene
tobacco NN I-Gene
. . O

The DT O
MICs NNP O
of IN O
this DT O
compound NN O
against IN O
90 CD O
% NN O
of IN O
these DT O
organisms NNS O
, , O
except IN O
for IN O
methicillin NN O
- : O
resistant JJ O
S NNP O
. . O
aureus NN O
, , O
ranged VBD O
from IN O
less JJR O
than IN O
or CC O
equal JJ O
to TO O
0 CD O
. . O
6 CD O
to TO O
3 CD O
. . O
13 CD O
micrograms NNS O
/ JJ O
ml NN O
. . O

Ultrasonography NNP O
provides VBZ O
excellent JJ O
intraoperative JJ O
evaluation NN O
of IN O
spinal JJ O
cord NN O
injury NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
study NN O
in IN O
which WDT O
mutation NN O
screening NN O
has VBZ O
been VBN O
performed VBN O
for IN O
both DT O
the DT O
EXT1 NNP B-Gene
and CC O
EXT2 NNP B-Gene
genes NNS I-Gene
prior RB O
to TO O
any DT O
linkage NN O
analysis NN O
. . O

Salivary JJ O
sodium NN O
, , O
calcium NN O
, , O
and CC O
magnesium NN O
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
SLE NNP O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
, , O
whereas JJ O
potassium NN O
and CC O
total JJ O
protein NN O
concentrations NNS O
and CC O
amylase NN B-Gene
activity NN O
did VBD O
not RB O
differ VB O
significantly RB O
from IN O
the DT O
controls NNS O
. . O

A DT O
cDNA NN O
clone NN O
pCZ1 NN O
, , O
with IN O
a DT O
1 CD O
. . O
1 CD O
kb NN O
insert NN O
, , O
was VBD O
isolated VBN O
from IN O
a DT O
NaCl NNP O
- : O
adapted VBD O
tobacco NN O
cell NN O
cDNA NN O
library NN O
that WDT O
encodes VBZ O
an DT O
apparently RB O
full JJ O
- : O
length NN O
29 CD O
kDa NN O
protein NN O
( ( O
251 CD O
amino NN O
acids NNS O
) ) O
with IN O
a DT O
calculated JJ O
pI NN O
of IN O
5 CD O
. . O
7 CD O
. . O

Hops NNP O
, , O
and CC O
L NNP O
. . O

However RB O
, , O
the DT O
rtFc NN B-Gene
gamma NN I-Gene
R NNP I-Gene
alpha NN I-Gene
cDNA NN I-Gene
clone NN O
is VBZ O
complementary JJ O
to TO O
at IN O
least JJS O
two CD O
different JJ O
- : O
sized VBN O
mRNAs NNS O
expressed VBN O
by IN O
CRNK NNP O
- : O
16 CD O
cells NNS O
, , O
contrasting VBG O
the DT O
single JJ O
Fc NNP B-Gene
gamma NN I-Gene
R NNP I-Gene
- : I-Gene
related JJ I-Gene
mRNA NN I-Gene
species NNS O
expressed VBN O
by IN O
human NN O
and CC O
mouse VB O
natural JJ O
killer NN O
cells NNS O
. . O

In IN O
agreement NN O
with IN O
these DT O
data NNS O
, , O
western JJ O
blot NN O
experiments NNS O
using VBG O
an DT O
antibody NN O
directed VBN O
against IN O
the DT O
carboxy JJ O
- : O
terminal JJ O
portion NN O
of IN O
the DT O
mouse NN O
c SYM B-Gene
- : I-Gene
kit NN I-Gene
protein NN I-Gene
showed VBD O
that IN O
a DT O
polypeptide NN O
, , O
of IN O
the DT O
size NN O
predicted VBN O
by IN O
the DT O
open JJ O
reading NN O
frame NN O
of IN O
the DT O
spermatid NN B-Gene
- : I-Gene
specific JJ I-Gene
c SYM I-Gene
- : I-Gene
kit NN I-Gene
cDNA NN I-Gene
, , O
accumulates VBZ O
in IN O
the DT O
latest JJS O
stages NNS O
of IN O
spermatogenesis NN O
and CC O
in IN O
epididymal JJ O
spermatozoa NN O
. . O

Class NN B-Gene
I PRP I-Gene
alpha1 VBP I-Gene
, , I-Gene
2 CD I-Gene
- : I-Gene
mannosidases NNS I-Gene
play VBP O
an DT O
essential JJ O
role NN O
in IN O
the DT O
elaboration NN O
of IN O
complex JJ O
and CC O
hybrid JJ O
N NNP O
- : O
glycans NNS O
in IN O
mammalian JJ O
cells NNS O
. . O

In IN O
addition NN O
to TO O
DNA NNP O
- : O
protein NN O
interactions NNS O
, , O
protein SYM O
- : O
protein NN O
interactions NNS O
with IN O
partner NN O
proteins NNS O
often RB O
play VBP O
major JJ O
roles NNS O
in IN O
targeting VBG O
ETS NNP B-Gene
- : I-Gene
domain NN I-Gene
proteins NNS I-Gene
to TO O
specific JJ O
promoters NNS O
. . O

A DT O
cDNA NN O
, , O
cak1At NN B-Gene
, , O
was VBD O
isolated VBN O
that IN O
suppressed VBD O
the DT O
CAK NNP B-Gene
mutation NN I-Gene
in IN O
budding VBG O
yeast NN O
, , O
and CC O
it PRP O
also RB O
complemented VBD O
a DT O
fission NN B-Gene
yeast NN I-Gene
CAK NNP I-Gene
mutant NN I-Gene
. . O

cak1At NN B-Gene
encodes VBZ O
a DT O
protein NN O
related VBN O
to TO O
animal JJ B-Gene
CAKs NNP I-Gene
. . O

The DT O
region NN O
containing VBG O
both DT O
serines NNS O
is VBZ O
homologous JJ O
to TO O
the DT O
N NNP O
- : O
terminal JJ O
destruction NN O
box NN O
of IN O
IkappaBalpha NNP B-Gene
, , I-Gene
- : I-Gene
beta NN I-Gene
, , I-Gene
and CC I-Gene
- : I-Gene
epsilon NN I-Gene
. . O

Autoionization NN O
rates NNS O
and CC O
energy NN O
levels NNS O
of IN O
triplet NN O
nf NN O
, , O
v NN O
= VBD O
1 CD O
Rydberg NNP O
states NNS O
of IN O
H2 NNP O
. . O

Human NNP O
and CC O
Chinese NNP B-Gene
hamster VBP I-Gene
S14 NNP I-Gene
protein NN I-Gene
sequences NNS I-Gene
deduced VBD O
from IN O
the DT O
cDNAs NN O
are VBP O
identical JJ O
. . O

In IN O
the DT O
formalin JJ O
test NN O
, , O
however RB O
, , O
naloxone RB O
attenuated JJ O
morphine NN O
analgesia NN O
at IN O
the DT O
lower JJR O
doses NNS O
( ( O
0 CD O
. . O
1 CD O
and CC O
0 CD O
. . O
3 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
and CC O
potentiated VBN O
morphine NN O
analgesia NN O
at IN O
the DT O
highest JJS O
dose NN O
( ( O
10 CD O
mg NN O
/ NNP O
kg NN O
) ) O
. . O

Maximum JJ O
number NN O
of IN O
strains NNS O
( ( O
39 CD O
. . O
1 CD O
% NN O
) ) O
were VBD O
resistant JJ O
in IN O
S NNP O
. . O
bareilly RB O
serotype JJ O
, , O
followed VBN O
by IN O
S NNP O
. . O
typhimurium NN O
( ( O
21 CD O
. . O
7 CD O
% NN O
) ) O
and CC O
least JJS O
in IN O
S NNP O
. . O
typhi NN O
( ( O
17 CD O
. . O
4 CD O
% NN O
) ) O
. . O

An DT O
open JJ O
- : O
label NN O
, , O
placebo SYM O
- : O
controlled VBN O
, , O
randomized VBN O
, , O
two CD O
- : O
way NN O
crossover NN O
study NN O
was VBD O
performed VBN O
in IN O
12 CD O
healthy JJ O
volunteers NNS O
( ( O
between IN O
20 CD O
and CC O
44 CD O
years NNS O
of IN O
age NN O
) ) O
to TO O
assess VB O
the DT O
effect NN O
of IN O
orlistat NN O
, , O
a DT O
gastrointestinal JJ B-Gene
lipase NN I-Gene
inhibitor NN O
that WDT O
reduces VBZ O
dietary JJ O
fat JJ O
absorption NN O
and CC O
is VBZ O
being VBG O
developed VBN O
for IN O
weight NN O
control NN O
in IN O
obesity NN O
, , O
on IN O
the DT O
absorption NN O
of IN O
vitamins NNS O
A NNP O
and CC O
E NNP O
. . O

In IN O
Arabidopsis NNP O
, , O
the DT O
induction NN O
of IN O
a DT O
dehydration NN O
- : O
responsive JJ O
gene NN O
, , O
rd22 NN B-Gene
, , O
is VBZ O
mediated VBN O
by IN O
abscisic JJ O
acid NN O
( ( O
ABA NNP O
) ) O
and CC O
requires VBZ O
protein JJ O
biosynthesis NN O
for IN O
ABA NNP O
- : O
dependent JJ O
gene NN O
expression NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
residue JJ O
266 CD O
serves NNS O
as IN O
a DT O
"""" JJ O
protein NN O
sensor NN O
"""" NN O
of IN O
altered JJ O
minor JJ O
groove NN O
interactions NNS O
and CC O
identifies NNS O
which WDT O
base VBP O
pair NN O
interactions NNS O
are VBP O
altered VBN O
by IN O
these DT O
lesions NNS O
. . O

SV NNP O
increased VBD O
less RBR O
in IN O
SHR NNP O
, , O
mainly RB O
reflecting VBG O
the DT O
reduced VBN O
diastolic JJ O
compliance NN O
of IN O
the DT O
hypertrophied JJ O
SHR NNP O
left VBD O
ventricle NN O
and CC O
the DT O
consequent JJ O
rightward NN O
shift NN O
of IN O
its PRP$ O
Frank NNP O
- : O
Starling VBG O
curve NN O
. . O

Multiple JJ O
chemical NN O
sensitivity NN O
( ( O
MCS NNP O
) ) O
is VBZ O
a DT O
syndrome NN O
in IN O
which WDT O
multiple NN O
symptoms NNS O
reportedly RB O
occur VBP O
with IN O
low JJ O
- : O
level NN O
chemical NN O
exposure NN O
. . O

However RB O
, , O
besides IN O
the DT O
kinase NN O
catalytic JJ O
domain NN O
and CC O
double JJ O
leucine NN O
/ NNP O
isoleucine NN O
zippers NNS O
, , O
there EX O
was VBD O
no DT O
significant JJ O
homology NN O
with IN O
known JJ O
proteins NNS O
. . O

The DT O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinase NN I-Gene
fer NN B-Gene
associates VBZ O
with IN O
signaling VBG O
complexes NNS O
containing VBG O
insulin NN B-Gene
receptor NN I-Gene
substrate VBP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
phosphatidylinositol VB B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

The DT O
cis NN O
- : O
acting VBG O
regulatory JJ O
properties NNS O
of IN O
an DT O
872 CD O
bp NN O
promoter NN O
fragment NN O
of IN O
a DT O
B NNP O
. . O
napus NN O
oleosin IN B-Gene
gene NN I-Gene
were VBD O
examined VBN O
by IN O
analysis NN O
of IN O
beta NN B-Gene
- : I-Gene
glucuronidase NN I-Gene
( ( O
GUS NNP B-Gene
) ) O
expression NN O
in IN O
transgenic JJ O
tobacco NN O
plants NNS O
containing VBG O
an DT O
oleosin NN B-Gene
promoter NN I-Gene
- : O
GUS NNP B-Gene
transcriptional JJ O
fusion NN O
. . O

Because IN O
of IN O
the DT O
probable JJ O
causal NN O
relationship NN O
between IN O
constitutive JJ O
p210 NN B-Gene
( ( O
bcr JJ B-Gene
/ NNP O
abl NN B-Gene
) ) O
protein NN B-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
activity NN O
and CC O
manifestations NNS O
of IN O
chronic JJ O
- : O
phase NN O
chronic JJ O
myelogenous JJ O
leukemia NN O
( ( O
CML NNP O
; : O
myeloid JJ O
expansion NN O
) ) O
, , O
a DT O
key JJ O
goal NN O
is VBZ O
to TO O
identify VB O
relevant JJ O
p210 NN B-Gene
substrates NNS O
in IN O
primary JJ O
chronic JJ O
- : O
phase NN O
CML NNP O
hematopoietic JJ O
progenitor NN O
cells NNS O
. . O

The DT O
low JJ O
number NN O
of IN O
false JJ O
positives NNS O
indicates VBZ O
that IN O
our PRP$ O
scheme NN O
would MD O
not RB O
confuse VB O
the DT O
radiologist NN O
by IN O
suggesting VBG O
normal JJ O
regions NNS O
as IN O
suspicious JJ O
. . O

Recommendations NNS O
to TO O
deal VB O
with IN O
these DT O
and CC O
related JJ O
issues NNS O
are VBP O
presented VBN O
. . O

Influence NN O
of IN O
metoprolol NN O
treatment NN O
on IN O
sympatho JJ O
- : O
adrenal JJ O
activation NN O
of IN O
fibrinolysis NN O
. . O

MICs NNP O
of IN O
four CD O
antifungal JJ O
agents NNS O
( ( O
5 CD O
- : O
fluorocytosine NN O
, , O
miconazole NN O
, , O
ketoconazole NN O
, , O
and CC O
amphotericin RB O
B NNP O
) ) O
for IN O
84 CD O
clinical JJ O
isolates NNS O
of IN O
various JJ O
Candida NNP O
species NNS O
were VBD O
then RB O
determined VBN O
with IN O
both DT O
media NNS O
in IN O
agar JJ O
dilution NN O
and CC O
microtiter NN O
broth DT O
dilution NN O
systems NNS O
. . O

This DT O
concept NN O
is VBZ O
supported VBN O
by IN O
the DT O
identification NN O
of IN O
RH NNP B-Gene
- : I-Gene
like IN I-Gene
genes NNS I-Gene
in IN O
non JJ O
human JJ O
primates NNS O
. . O

Forty NNP O
- : O
eight CD O
sequences NNS O
, , O
30 CD O
not RB O
previously RB O
identified VBN O
as IN O
IR NNP O
- : O
responsive NN O
, , O
were VBD O
significantly RB O
regulated VBN O
by IN O
IR NNP O
. . O

Since IN O
only RB O
58 CD O
% NN O
of IN O
our PRP$ O
sample NN O
could MD O
be VB O
adequately RB O
classified VBN O
with IN O
one CD O
diagnosis NN O
, , O
we PRP O
expect VBP O
that IN O
the DT O
ASDC NNP O
nosology NN O
will MD O
need VB O
to TO O
evolve VB O
further RB O
. . O

E NN O
50 CD O
, , O
843 CD O
( ( O
1994 CD O
) ) O
] NN O
. . O

In IN O
adult NN O
tissues NNS O
, , O
it PRP O
was VBD O
less RBR O
restricted JJ O
, , O
indicating VBG O
that IN O
RAFTK NNP B-Gene
expression NN O
is VBZ O
developmentally RB O
up RP O
- : O
regulated VBN O
. . O

Preventive JJ O
effect NN O
of IN O
ONO NNP O
- : O
3708 CD O
on IN O
thrombosis NN O
and CC O
vasospasms NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Proteasomes NNS O
are VBP O
the DT O
multisubunit JJ O
protease NN O
involved VBN O
in IN O
the DT O
generation NN O
of IN O
peptides NNS O
presented VBN O
by IN O
MHC NNP B-Gene
class NN I-Gene
I PRP I-Gene
molecules NNS I-Gene
. . O

Finally RB O
, , O
profiling VBG O
of IN O
a DT O
gcn4Delta NN B-Gene
mutant NN I-Gene
uncovered VBD O
an DT O
alternative JJ O
induction NN O
pathway NN O
operating VBG O
at IN O
many JJ O
Gcn4p NNP B-Gene
target NN I-Gene
genes NNS I-Gene
in IN O
histidine NN O
- : O
starved JJ O
cells NNS O
. . O

Collectively RB O
, , O
these DT O
experiments NNS O
demonstrate VBP O
that IN O
CFTR NNP B-Gene
' POS I-Gene
s NN I-Gene
NBF1 NNP I-Gene
+ NNP I-Gene
R NNP I-Gene
region NN I-Gene
and CC O
its PRP$ O
NBF2 NNP B-Gene
domain NN I-Gene
, , O
after IN O
folding VBG O
separately RB O
as IN O
distinct JJ O
units NNS O
, , O
have VBP O
a DT O
strong JJ O
propensity NN O
to TO O
interact VB O
and CC O
that IN O
this DT O
interaction NN O
is VBZ O
stable JJ O
in IN O
the DT O
absence NN O
of IN O
added JJ O
nucleotides NNS O
or CC O
exogenously RB O
induced JJ O
phosphorylation NN O
. . O

The DT O
standard JJ O
principles NNS O
of IN O
surgical JJ O
management NN O
must MD O
be VB O
adhered VBN O
to TO O
when WRB O
using VBG O
Sandostatin NNP O
to TO O
treat VB O
patients NNS O
with IN O
these DT O
disorders NNS O
. . O

Validity NN O
of IN O
immunohistology NN O
and CC O
in IN O
situ JJ O
hybridization NN O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
cytomegalovirus NN O
pneumonia NN O
and CC O
idiopathic JJ O
interstitial JJ O
pneumonia NN O
after IN O
allogenic JJ O
bone NN O
marrow NN O
transplantation NN O

The DT O
monoclonal JJ O
immunoglobulin NN B-Gene
products NNS O
of IN O
plasma NN O
cell NN O
neoplasm NNS O
can MD O
give VB O
rise NN O
to TO O
a DT O
variety NN O
of IN O
manifestations NNS O
including VBG O
hyperviscosity NN O
, , O
amyloidosis NN O
, , O
cryoglobulinemia NN O
, , O
neuropathy JJ O
, , O
and CC O
renal JJ O
failure NN O
. . O

GW NNP O
Gamma NNP O
approximation NN O
for IN O
electron NN O
self NN O
- : O
energies NNS O
in IN O
semiconductors NNS O
and CC O
insulators NNS O
. . O

Current JJ O
world NN O
literature NN O
. . O

G NNP O
- : O
DNA NN O
is VBZ O
a DT O
four CD O
- : O
stranded VBD O
DNA NN O
structure NN O
with IN O
diverse JJ O
putative JJ O
biological JJ O
roles NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
functional JJ O
role NN O
of IN O
the DT O
other JJ O
MAP NNP B-Gene
kinases NNS I-Gene
in IN O
PDGF NNP B-Gene
- : O
mediated VBD O
cellular JJ O
responses NNS O
. . O

An DT O
increase NN O
in IN O
the DT O
level NN O
of IN O
serum NN O
enzymes NNS O
, , O
such JJ O
as IN O
aspartate JJ B-Gene
transaminase NN I-Gene
, , O
alkaline JJ B-Gene
phosphatase NN I-Gene
, , O
creatine JJ B-Gene
phosphokinase NN I-Gene
, , O
lactate JJ B-Gene
dehydrogenase NN I-Gene
after IN O
D NNP O
. . O
russelli VB O
venom JJ O
injection NN O
in IN O
albino NN O
rats NNS O
is VBZ O
indicative JJ O
of IN O
cell NN O
or CC O
tissue NN O
damage NN O
. . O

Each DT O
causative JJ O
organism NN O
has VBZ O
a DT O
species NNS O
- : O
specific JJ O
preference NN O
and CC O
requirement NN O
for IN O
temperature NN O
, , O
salinity NN O
, , O
pH NN O
, , O
the DT O
basic JJ O
nutrients NNS O
, , O
and CC O
growth NN O
factors NNS O
, , O
and CC O
the DT O
toxin NN O
formation NN O
is VBZ O
affected VBN O
by IN O
these DT O
environmental JJ O
factors NNS O
. . O

CONCLUSIONS NNS O
: : O
While IN O
INR NNP O
correction NN O
may MD O
be VB O
achieved VBN O
by IN O
all PDT O
the DT O
above JJ O
methods NNS O
, , O
that IN O
relating VBG O
log NN O
reference NN O
INR NNP O
to TO O
log VB O
local JJ O
prothrombin NN B-Gene
time NN O
by IN O
linear JJ O
regression NN O
analysis NN O
is VBZ O
the DT O
simplest JJS O
to TO O
perform VB O
. . O

METHODS NNS O
: : O
We PRP O
obtained VBD O
maximal JJ O
inspiratory NN O
and CC O
expiratory NN O
flow JJ O
- : O
volume NN O
curves NNS O
in IN O
41 CD O
unselected JJ O
patients NNS O
with IN O
essential JJ O
tremor NN O
( ( O
14 CD O
males NNS O
, , O
27 CD O
females NNS O
, , O
age NN O
61 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
14 CD O
years NNS O
) ) O
. . O

Courses NNS O
were VBD O
repeated VBN O
monthly RB O
upon JJ O
recovery NN O
of IN O
myelosuppression NN O
. . O

In IN O
contrast NN O
, , O
injection NN O
of IN O
a DT O
plasmid NN O
encoding VBG O
simian JJ B-Gene
virus NN I-Gene
40 CD I-Gene
small JJ I-Gene
t NN I-Gene
antigen NN I-Gene
, , O
which WDT O
interacts VBZ O
with IN O
PP2A NNP B-Gene
to TO O
inhibit VB O
its PRP$ O
activity NN O
towards IN O
several JJ O
phosphoprotein NN O
substrates NNS O
, , O
had VBD O
no DT O
effect NN O
on IN O
the DT O
phosphorylation NN O
state NN O
of IN O
CREB NNP B-Gene
in IN O
stimulated VBD O
or CC O
unstimulated JJ O
NIH NNP O
3T3 CD O
cells NNS O
. . O

To TO O
examine VB O
whether IN O
thiamine NN O
( ( O
vitamin JJ O
B1 NNP O
) ) O
deficiency NN O
is VBZ O
associated VBN O
with IN O
recurrent NN O
aphthous JJ O
stomatitis NN O
, , O
we PRP O
studied VBD O
vitamin JJ O
B1 NNP O
levels NNS O
in IN O
70 CD O
patients NNS O
with IN O
recurrent JJ O
aphthous JJ O
stomatitis NN O
and CC O
in IN O
50 CD O
members NNS O
of IN O
a DT O
control NN O
group NN O
. . O

Genetic JJ O
interactions NNS O
between IN O
BCK2 NNP B-Gene
and CC O
other JJ O
pathway NN O
components NNS O
suggested VBD O
that IN O
BCK2 NNP B-Gene
functions NNS O
on IN O
a DT O
common JJ O
pathway NN O
branch NN O
with IN O
PPZ1 NNP B-Gene
and CC O
PPZ2 NNP B-Gene
. . O

This DT O
region NN O
of IN O
60 CD O
amino JJ O
acids NNS O
may MD O
be VB O
involved VBN O
in IN O
coiled JJ O
- : O
coil NN O
interactions NNS O
similar JJ O
to TO O
those DT O
that WDT O
facilitate VBP O
the DT O
filament JJ O
formation NN O
in IN O
the DT O
rod JJ O
region NN O
. . O

One CD O
air NN O
embolism NN O
occurred VBD O
; : O
this DT O
was VBD O
the DT O
only JJ O
filter NN O
- : O
or CC O
retrieval VB O
- : O
related JJ O
complication NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
Thr115 NNP O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
MyoD NNP B-Gene
function NN O
under IN O
conditions NNS O
of IN O
high JJ O
mitogenesis NN O
. . O

IA NNP O
- : O
CT NN O
with IN O
cisplatin NN O
50 CD O
mg NN O
and CC O
doxorubicin NN O
30 CD O
mg NN O
was VBD O
administered VBN O
by IN O
one CD O
shot NN O
method NN O
in IN O
bilateral JJ O
internal JJ O
iliac NN O
arteries NNS O
. . O

A DT O
tyrosine NN O
- : O
based VBN O
sorting VBG O
signal NN O
in IN O
the DT O
beta2 NN B-Gene
integrin JJ I-Gene
cytoplasmic JJ I-Gene
domain NN I-Gene
mediates VBZ O
its PRP$ O
recycling NN O
to TO O
the DT O
plasma NN O
membrane NN O
and CC O
is VBZ O
required VBN O
for IN O
ligand NN O
- : O
supported VBN O
migration NN O
. . O

Although IN O
antisperm JJ O
antibodies NNS O
are VBP O
associated VBN O
with IN O
infertility NN O
, , O
many JJ O
hospital NN O
laboratories NNS O
do VBP O
not RB O
test VB O
for IN O
these DT O
antibodies NNS O
. . O

NSCL NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
larger JJR O
number NN O
of IN O
these DT O
cell NN O
lines NNS O
. . O

In IN O
summary JJ O
, , O
WT1 NNP B-Gene
is VBZ O
enriched VBN O
by IN O
oligo NN O
( ( O
dT NN O
) ) O
chromatography NN O
, , O
as IN O
are VBP O
U2AF65 NNP B-Gene
, , O
the DT O
U5 NNP B-Gene
small JJ I-Gene
nuclear JJ I-Gene
RNP NNP I-Gene
- : I-Gene
associated VBN I-Gene
protein NN I-Gene
p116 NN B-Gene
and CC O
hnRNP NN O
A1 NNP B-Gene
. . O

Alternative JJ O
transcript NN O
of IN O
the DT O
nonselective JJ O
- : O
type NN O
endothelin NN B-Gene
receptor NN I-Gene
from IN O
rat NN O
brain NN O
. . O

At IN O
termination NN O
( ( O
gd JJ O
20 CD O
) ) O
, , O
confirmed VBD O
- : O
pregnant NN O
females NNS O
( ( O
21 CD O
to TO O
25 CD O
per IN O
group NN O
) ) O
were VBD O
evaluated VBN O
for IN O
clinical JJ O
status NN O
and CC O
gestational JJ O
outcome NN O
; : O
live JJ O
fetuses NNS O
were VBD O
examined VBN O
for IN O
external JJ O
, , O
visceral JJ O
, , O
and CC O
skeletal JJ O
malformations NNS O
. . O

Similarly RB O
, , O
a DT O
human JJ O
but CC O
not RB O
a DT O
bovine NN B-Gene
alpha JJ I-Gene
transgene NN I-Gene
was VBD O
expressed VBN O
in IN O
placenta NN O
in IN O
transgenic JJ O
mice NN O
. . O

After IN O
treatment NN O
with IN O
tunicamycin NN O
, , O
the DT O
transfectants NNS O
secreted VBD O
unglycosylated JJ O
18 CD O
- : O
kDa NN O
polypeptides NNS O
which WDT O
could MD O
also RB O
bind VB O
IgE NNP B-Gene
. . O

Once RB O
P NNP B-Gene
- : I-Gene
450scc CD I-Gene
mRNA NN I-Gene
is VBZ O
induced VBN O
as IN O
a DT O
consequence NN O
of IN O
the DT O
LH NNP B-Gene
/ NNP O
hCG NN B-Gene
surge NN O
it PRP O
is VBZ O
constitutively RB O
maintained VBN O
by IN O
luteinized JJ O
cells NNS O
in IN O
vivo NN O
( ( O
0 CD O
- : O
4 CD O
days NNS O
) ) O
and CC O
in IN O
vitro NN O
( ( O
0 CD O
- : O
9 CD O
days NNS O
) ) O
in IN O
the DT O
absence NN O
of IN O
gonadotropins NNS B-Gene
, , O
is VBZ O
susceptible JJ O
to TO O
modulation NN O
by IN O
prolactin NN B-Gene
and CC O
is VBZ O
no DT O
longer RB O
regulated VBN O
by IN O
cAMP NN O
. . O

The DT O
dnaK NN B-Gene
operon NN I-Gene
of IN I-Gene
Bacillus NN I-Gene
subtilis NNS I-Gene
is VBZ O
heptacistronic JJ O
. . O

OKT3 NNP B-Gene
prophylaxis NN O
improves VBZ O
long RB O
- : O
term NN O
renal JJ O
graft NN O
survival NN O
in IN O
high JJ O
- : O
risk NN O
patients NNS O
as IN O
compared VBN O
to TO O
cyclosporine VB O
: : O
combined VBN O
results NNS O
from IN O
the DT O
prospective JJ O
, , O
randomized JJ O
Belgian NN O
and CC O
US NNP O
studies NNS O
. . O

Facts NNS O
on IN O
the DT O
Economic NNP O
Recovery NNP O
Tax NNP O
Act NNP O
of IN O
1981 CD O
for IN O
speech NN O
- : O
language NN O
pathologists NNS O
and CC O
audiologists NNS O
. . O

Consistent JJ O
with IN O
this DT O
, , O
we PRP O
show VBP O
that DT O
peptides VBZ O
representing VBG O
docking VBG O
sites NNS O
within IN O
the DT O
target NN O
substrates VBZ O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
p90 NN B-Gene
( ( O
rsk NN B-Gene
) ) O
inhibit NN O
ERK NNP B-Gene
- : O
dependent JJ O
activation NN O
of IN O
MKP NNP B-Gene
- : I-Gene
3 CD I-Gene
. . O

After IN O
the DT O
first JJ O
28 CD O
patients NNS O
vincristine NN O
was VBD O
replaced VBN O
by IN O
teniposide NN O
( ( O
VM NNP O
- : O
26 CD O
) ) O
due JJ O
to TO O
neurotoxicity NN O
. . O

The DT O
pre NN O
- : O
mRNA NN O
splicing VBG O
factor NN O
U2AF NNP B-Gene
( ( O
U2 NNP B-Gene
small JJ I-Gene
nuclear JJ I-Gene
ribonucleoprotein NN I-Gene
particle NN I-Gene
[ NNP I-Gene
snRNP NN I-Gene
] NNP I-Gene
auxiliary JJ I-Gene
factor NN I-Gene
) ) O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
3 CD O
' POS O
splice NN O
site NN O
selection NN O
. . O

Following VBG O
extended JJ O
recovery NN O
hippocampal NN O
EEG NNP O
was VBD O
normal JJ O
despite IN O
extensive JJ O
cellular JJ O
loss NN O
in IN O
areas NNS O
CA3 NNP O
and CC O
CA4 NNP O
. . O

We PRP O
identified VBD O
telSMN JJ B-Gene
mutations NNS O
in IN O
11 CD O
of IN O
these DT O
unrelated JJ O
SMA NNP O
- : O
like IN O
individuals NNS O
who WP O
carry VBP O
a DT O
single JJ O
copy NN O
of IN O
telSMN NN B-Gene
: : O
these DT O
include VBP O
two CD O
frameshift JJ O
mutations NNS O
( ( O
800ins11 CD O
and CC O
542delGT CD O
) ) O
and CC O
three CD O
missense NN O
mutations NNS O
( ( O
A2G NNP O
, , O
S262I NNP O
, , O
and CC O
T274I NNP O
) ) O
. . O

D NNP B-Gene
- : I-Gene
cyclin NN I-Gene
- : O
cdk NN B-Gene
activity NN O
is VBZ O
required VBN O
for IN O
Rb NNP B-Gene
phosphorylation NN O
in IN O
v JJ B-Gene
- : I-Gene
Jun NNP I-Gene
- : O
transformed VBD O
cells NNS O
, , O
since IN O
ectopic JJ O
expression NN O
of IN O
the DT O
cdk4 NN B-Gene
- : O
and CC O
cdk6 VB B-Gene
- : O
specific JJ O
inhibitor NN O
p16 NN B-Gene
( ( O
INK4A NNP B-Gene
) ) O
inhibits VBZ O
both DT O
DNA NNP O
synthesis NN O
and CC O
cell NN O
proliferation NN O
. . O

Deletion NN O
analysis NN O
showed VBD O
that IN O
the DT O
NF NNP B-Gene
- : I-Gene
4FA CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
4FB CD I-Gene
, , O
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
sequences NNS O
are VBP O
each DT O
necessary JJ O
for IN O
full JJ O
enhancer NN O
activity NN O
. . O

A DT O
15 CD O
. . O
1 CD O
kb JJ O
fragment NN O
of IN O
the DT O
yeast JJS O
genome NN O
was VBD O
allocated VBN O
to TO O
the DT O
centromeric JJ O
region NN O
of IN O
chromosome NN O
XIV NN O
by IN O
genetic JJ O
mapping NN O
. . O

The DT O
deleted JJ O
nucleotide JJ O
sequence NN O
corresponded VBD O
to TO O
sequences NNS O
that IN O
, , O
by IN O
analogy NN O
to TO O
the DT O
organization NN O
of IN O
the DT O
type NN B-Gene
I PRP I-Gene
collagen VBP I-Gene
genes NNS I-Gene
, , O
should MD O
be VB O
precisely RB O
encoded VBN O
by IN O
exon JJ O
41 CD O
of IN O
the DT O
COL3A1 NNP B-Gene
gene NN I-Gene
. . O

The DT O
interaction NN O
does VBZ O
not RB O
depend VB O
on IN O
the DT O
presence NN O
of IN O
the DT O
correct NN O
amino SYM O
- : O
terminal JJ O
DNA NNP O
binding NN O
domain NN O
or CC O
the DT O
amino JJ O
acid NN O
sequences NNS O
between IN O
the DT O
DNA NNP O
binding NN O
domain NN O
and CC O
the DT O
last JJ O
ten JJ O
amino JJ O
acids NNS O
. . O

The DT O
COOH NNP O
- : O
terminal JJ O
46 CD O
codons NNS O
of IN O
slyD NN B-Gene
encode NN O
a DT O
remarkable JJ O
histidine NN O
- : O
rich JJ O
peptide NN O
sequence NN O
which WDT O
is VBZ O
at IN O
least JJS O
partly RB O
dispensable JJ O
for IN O
slyD JJ B-Gene
function NN O
in IN O
E NNP B-Gene
- : O
mediated VBD O
lysis NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
ICBP90 NNP B-Gene
gene NN I-Gene
structure NN O
by IN O
screening VBG O
of IN O
a DT O
human JJ O
placenta NN O
genomic JJ O
library NN O
and CC O
PCR NNP O
analysis NN O
. . O

During IN O
the DT O
cloning NN O
by IN O
reverse NN B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
of IN O
the DT O
human JJ B-Gene
HIF NNP I-Gene
- : I-Gene
1alpha CD I-Gene
subunit NN I-Gene
, , O
we PRP O
isolated VBD O
two CD O
cDNA NN O
clones NNS O
which WDT O
corresponded VBD O
to TO O
alternative VB O
splicing NN O
of IN O
the DT O
HIF NNP B-Gene
- : I-Gene
1alpha CD I-Gene
gene NN I-Gene
. . O

Crossover NN O
in IN O
the DT O
specific JJ O
heat NN O
of IN O
dilute JJ O
magnets NNS O
induced VBN O
by IN O
critical JJ O
spin NN O
- : O
wave NN O
dynamics NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examine VBP O
the DT O
effects NNS O
of IN O
Msx2 NNP B-Gene
expression NN O
on IN O
OC NNP B-Gene
promoter NN I-Gene
activation NN O
( ( O
luciferase JJ B-Gene
reporter NN I-Gene
) ) O
by IN O
FGF2 NNP B-Gene
/ NNP O
FSK NNP B-Gene
and CC O
calcitriol NN O
in IN O
MC3T3 NNP O
- : O
E1 NN O
osteoblasts NNS O
. . O

Roentgenographically RB O
, , O
the DT O
lesion NN O
was VBD O
usually RB O
a DT O
well NN O
- : O
defined VBN O
and CC O
benign JJ O
appearing VBG O
one CD O
, , O
either CC O
purely RB O
lytic JJ O
( ( O
3 CD O
cases NNS O
) ) O
or CC O
with IN O
central JJ O
radiodensity NN O
( ( O
2 CD O
cases NNS O
) ) O
. . O

Ras NNP B-Gene
is VBZ O
not RB O
associated VBN O
with IN O
the DT O
tegument NN O
. . O

Baseline NNP O
electrocorticography NN O
over IN O
the DT O
surface NN O
of IN O
the DT O
temporal JJ O
lobe NN O
and CC O
depth NN O
electrode NN O
recordings NNS O
in IN O
the DT O
amygdala NN O
and CC O
hippocampus NN O
were VBD O
obtained VBN O
, , O
followed VBN O
by IN O
10 CD O
min NNS O
of IN O
recording VBG O
before IN O
and CC O
after IN O
the DT O
i NN O
. . O
v NN O
. . O
administration NN O
of IN O
both DT O
alfentanil JJ O
50 CD O
microg NN O
/ NNP O
kg NN O
and CC O
fentanyl $ O
10 CD O
microg NN O
/ NNP O
kg NN O
. . O

Recombinant JJ B-Gene
erythropoietin NN I-Gene
( ( O
r JJ B-Gene
- : I-Gene
HuEPO NN I-Gene
) ) O
in IN O
the DT O
treatment NN O
of IN O
anemia NN O
in IN O
multiple JJ O
myeloma NN O

Studies NNS O
on IN O
the DT O
life NN O
cycle NN O
of IN O
Haplorchis NNP O
pumilio NN O
( ( O
Looss NNP O
, , O
1896 CD O
) ) O
Looss NNP O
, , O
1899 CD O
with IN O
morphological JJ O
redescription NN O
of IN O
larval NN O
and CC O
adult NN O
stages NNS O
. . O

Anti NNP O
- : O
anxiety NN O
action NN O
of IN O
diazepam NN O
after IN O
intra JJ O
- : O
amygdaloid JJ O
application NN O
in IN O
the DT O
rat NN O
. . O

In IN O
addition NN O
, , O
the DT O
consensus NN O
amino NN O
acid VBP O
motif NN O
for IN O
serine JJ B-Gene
threonine NN I-Gene
receptor NN I-Gene
kinases NNS I-Gene
was VBD O
also RB O
present JJ O
. . O

Lymphocyte NNP O
subpopulations NNS O
, , O
serum NN B-Gene
IgE NNP I-Gene
and CC O
total JJ O
eosinophil NN O
counts NNS O
in IN O
patients NNS O
with IN O
bronchial JJ O
asthma NN O
. . O

To TO O
understand VB O
the DT O
regulatory JJ O
mechanism NN O
controlling VBG O
its PRP$ O
expression NN O
at IN O
low JJ O
temperature NN O
, , O
the DT O
promoter NN O
region NN O
has VBZ O
been VBN O
characterized VBN O
. . O

The DT O
capacity NN O
to TO O
repair VB O
8 CD O
- : O
OxoG NN O
has VBZ O
been VBN O
measured VBN O
in IN O
cell NN O
- : O
free JJ O
extracts NNS O
of IN O
wild JJ O
- : O
type NN O
and CC O
ogg1 NN B-Gene
strains NNS O
using VBG O
a DT O
34mer CD O
DNA NNP O
fragment NN O
containing VBG O
a DT O
single JJ O
8 CD O
- : O
OxoG NN O
residue JJ O
paired VBN O
with IN O
a DT O
cytosine NN O
( ( O
8 CD O
- : O
OxoG NN O
/ NNP O
C NNP O
) ) O
as IN O
a DT O
substrate NN O
. . O

STAT5A NNP B-Gene
mutations NNS O
in IN O
the DT O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
( ( O
SH2 NNP B-Gene
) ) O
and CC O
SH3 NNP B-Gene
domains NNS I-Gene
did VBD O
not RB O
alter VB O
the DT O
BTK NNP B-Gene
- : O
mediated VBD O
tyrosine JJ O
phosphorylation NN O
. . O

OBJECTIVE NN O
: : O
To TO O
investigate VB O
the DT O
association NN O
between IN O
complete JJ O
congenital JJ O
heart NN O
block NN O
( ( O
CCHB NNP O
) ) O
in IN O
the DT O
fetus NN O
and CC O
adult NN O
disease NN O
. . O

Immunostaining NN O
of IN O
cells NNS O
transfected VBN O
with IN O
these DT O
constructs NNS O
revealed VBD O
that IN O
both DT O
the DT O
myristoylated VBN O
and CC O
nonmyristoylated VBN O
mutants NNS O
were VBD O
localized VBN O
in IN O
nuclei NN O
, , O
whereas WP O
wild SYM B-Gene
- : I-Gene
type NN I-Gene
PKC NNP I-Gene
alpha NN I-Gene
was VBD O
primarily RB O
cytoplasmic JJ O
and CC O
perinuclear JJ O
. . O

The DT O
12S CD B-Gene
E1A NNP I-Gene
product NN I-Gene
does VBZ O
not RB O
activate VB O
a DT O
TRE NNP O
sequence NN O
, , O
but CC O
cotransfection NN O
with IN O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
circumvents VBZ O
this DT O
lack NN O
of IN O
stimulation NN O
. . O

Cytogenetic JJ O
studies NNS O
were VBD O
performed VBN O
in IN O
lymphocytes NNS O
from IN O
hospital JJ O
workers NNS O
exposed VBD O
to TO O
low JJ O
doses NNS O
of IN O
radiation NN O
( ( O
1 CD O
. . O
6 CD O
- : O
42 CD O
. . O
71 CD O
mSv NN O
) ) O
. . O

Therefore RB O
, , O
the DT O
molecular JJ O
mechanisms NN O
of IN O
the DT O
estrogen NN O
action NN O
that WDT O
govern VBZ O
the DT O
lactoferrin JJ B-Gene
gene NN I-Gene
expression NN O
differ VBP O
between IN O
mouse NN O
and CC O
human NN O
. . O

TT NNP O
cells NNS O
, , O
a DT O
human JJ O
MTC NNP O
cell NN O
line NN O
expressing VBG O
MEN NNP B-Gene
2A CD I-Gene
type NN I-Gene
RET NNP I-Gene
, , O
display NN O
transcriptionally RB O
active JJ O
RelA NNP B-Gene
( ( I-Gene
p65 NN I-Gene
) ) I-Gene
in IN O
the DT O
nucleus NN O
. . O

PBSX NNP B-Gene
is VBZ O
induced VBN O
by IN O
agents NNS O
which WDT O
elicit VBP O
the DT O
SOS NNP O
response NN O
. . O

Alignment NN O
of IN O
the DT O
amino NN O
acid NN O
sequences NNS O
surrounding VBG O
Tyr NNP O
- : O
766 CD O
with IN O
corresponding VBG O
regions NNS O
of IN O
other JJ O
FGFRs NNP B-Gene
revealed VBD O
conserved JJ O
tyrosine NN O
residues NNS O
in IN O
all DT O
known JJ O
members NNS O
of IN O
the DT O
FGFR NNP B-Gene
family NN I-Gene
. . O

Human NNP B-Gene
PDK1 NNP I-Gene
is VBZ O
homologous JJ O
to TO O
the DT O
Drosophila NNP B-Gene
protein NN I-Gene
kinase NN I-Gene
DSTPK61 NNP I-Gene
, , O
which WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
sex NN O
differentiation NN O
, , O
oogenesis NN O
and CC O
spermatogenesis NN O
. . O

Human NNP B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
I PRP I-Gene
( ( I-Gene
HTLV NNP I-Gene
- : I-Gene
I PRP I-Gene
) ) I-Gene
Tax NNP I-Gene
is VBZ O
a DT O
potent JJ O
transcriptional JJ O
regulator NN O
that WDT O
can MD O
activate VB O
or CC O
repress VB O
specific JJ O
cellular JJ O
genes NNS O
and CC O
that DT O
has VBZ O
been VBN O
proposed VBN O
to TO O
contribute VB O
to TO O
leukemogenesis VB O
in IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
. . O

Persistent JJ O
activation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinases VBZ I-Gene
p42 NN I-Gene
and CC O
p44 NN B-Gene
and CC O
ets VBZ B-Gene
- : I-Gene
2 CD I-Gene
phosphorylation NN O
in IN O
response NN O
to TO O
colony VB B-Gene
- : I-Gene
stimulating VBG I-Gene
factor NN I-Gene
1 CD I-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
fms NN I-Gene
signaling NN O
. . O

Ethylene NNP O
glycol NN O
and CC O
diethylene NN O
glycol NNS O
were VBD O
each DT O
administered VBN O
once RB O
weekly JJ O
subcutaneously RB O
to TO O
groups NNS O
of IN O
100 CD O
female JJ O
NMRI NNP O
mice NN O
at IN O
3 CD O
dosages NNS O
( ( O
30 CD O
; : O
10 CD O
und IN O
3 CD O
mg NNS O
single JJ O
dose JJ O
per IN O
mouse NN O
) ) O
. . O

The DT O
financial JJ O
impact NN O
of IN O
childhood NN O
asthma NN O
has VBZ O
not RB O
been VBN O
assessed VBN O
since IN O
Vance NNP O
and CC O
Taylor NNP O
reported VBD O
their PRP$ O
data NNS O
in IN O
Annals NNP O
of IN O
Allergy NNP O
13 CD O
years NNS O
ago RB O
. . O

Bulbar NN O
pouches NNS O
were VBD O
perfused VBN O
with IN O
solutions NNS O
of IN O
0 CD O
. . O
9 CD O
% NN O
Na NNP O
C1 NNP O
, , O
0 CD O
. . O
1 CD O
N NNP O
HC1 NNP O
, , O
40 CD O
% NN O
glucose NN O
, , O
40 CD O
% NN O
NaC1 NNP O
, , O
and CC O
40 CD O
% NN O
peptone NN O
or CC O
with IN O
0 CD O
. . O
1 CD O
% NN O
solutions NNS O
of IN O
acetylcholine JJ O
chloride NN O
. . O

Many JJ O
children NNS O
with IN O
BGC NNP O
are VBP O
delayed VBN O
in IN O
their PRP$ O
development NN O
, , O
but CC O
calcifications NNS O
are VBP O
not RB O
directly RB O
related VBN O
to TO O
specific JJ O
forms NNS O
of IN O
neurologic JJ O
dysfunction NN O
. . O

Lyn NNP B-Gene
kinase NN I-Gene
immunoprecipitated VBD O
from IN O
lysates NNS O
of IN O
irradiated JJ O
BCP NNP O
as RB O
well RB O
as IN O
a DT O
full JJ O
- : O
length NN O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
( ( O
GST NNP B-Gene
) ) O
- : O
Lyn JJ B-Gene
fusion NN O
protein SYM O
- : O
phosphorylated VBN O
recombinant JJ B-Gene
human JJ I-Gene
p34cdc2 NN I-Gene
on IN O
tyrosine NN O
15 CD O
. . O

RESULTS NN O
: : O
In IN O
the DT O
AGA NNP O
group NN O
, , O
both DT O
fetal JJ O
and CC O
maternal JJ O
serum NN O
prolactin JJ B-Gene
concentration NN O
increased VBD O
significantly RB O
with IN O
gestation NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
and CC O
P NNP O
< NNP O
0 CD O
. . O
1 CD O
, , O
respectively RB O
) ) O
. . O

2 CD O
patients NNS O
( ( O
11 CD O
% NN O
) ) O
had VBD O
significant JJ O
morbidity NN O
502 CD O
and CC O
529 CD O
days NNS O
respectively RB O
after IN O
transplantation NN O
. . O

The DT O
cis NN O
- : O
acting VBG O
element NN O
, , O
identified VBN O
as IN O
CACGTGACCCG NNP O
, , O
is VBZ O
located VBN O
34 CD O
bp JJ O
upstream NN O
from IN O
the DT O
transcription NN O
initiation NN O
site NN O
, , O
and CC O
contains VBZ O
the DT O
core NN O
sequence NN O
of IN O
the DT O
upstream JJ O
promoter NN O
sequence NN O
of IN O
Ad2MLP NNP B-Gene
. . O

Ha NNP B-Gene
- : I-Gene
RasV12 NN I-Gene
and CC O
activated JJ O
proteins NNS O
in IN O
both DT O
the DT O
extra JJ B-Gene
- : I-Gene
cellular JJ I-Gene
regulated JJ I-Gene
kinase NN I-Gene
( ( O
ERK NNP B-Gene
) ) O
and CC O
the DT O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
SAPK NNP B-Gene
) ) O
or CC O
Jun NNP B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
cascades VBZ O
independently RB O
stimulated VBN O
PEA3 NNP B-Gene
- : O
mediated VBD O
gene NN O
expression NN O
. . O

In IN O
the DT O
ISO NNP O
group NN O
, , O
at IN O
pre SYM O
- : O
DEX NN O
, , O
CBF NNP O
increased VBD O
from IN O
86 CD O
+ NNS O
/ SYM O
- : O
8 CD O
to TO O
166 CD O
+ NNS O
/ SYM O
- : O
19 CD O
mL NN O
. . O
min SYM O
- : O
1 CD O
. . O
100 CD O
g JJ O
- : O
1 CD O
in IN O
response NN O
to TO O
hypercapnia VB O
( ( O
PCO2 NNP O
approximately RB O
90 CD O
mmHg NN O
) ) O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Like IN O
pineal NN O
melatonin NN O
, , O
serum NN O
melatonin NN O
was VBD O
high JJ O
at IN O
mid JJ O
- : O
dark NN O
and CC O
low JJ O
at IN O
mid JJ O
- : O
light NN O
. . O

Reporter NNP O
constructs NNS O
function NN O
in IN O
a DT O
parallel JJ O
manner NN O
, , O
demonstrating VBG O
the DT O
key JJ O
role NN O
of IN O
the DT O
AhR NNP B-Gene
in IN O
constitutive NN O
as RB O
well RB O
as IN O
TCDD NNP O
- : O
induced JJ O
expression NN O
of IN O
Cyp1B1 NNP B-Gene
in IN O
mouse NN O
embryo NN O
fibroblasts NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
attention NN O
to TO O
these DT O
issues NNS O
can MD O
substantially RB O
improve VB O
the DT O
quality NN O
of IN O
research NN O
on IN O
AIDS NNP O
related JJ O
behaviors NNS O
on IN O
Black NNP O
communities NNS O
. . O

These DT O
results NNS O
illustrate VBP O
an DT O
important JJ O
role NN O
for IN O
La NNP B-Gene
in IN O
RNA NNP O
production NN O
by IN O
demonstrating VBG O
its PRP$ O
ability NN O
to TO O
clear VB O
the DT O
termination NN O
sites VBZ O
of IN O
class NN O
III NNP O
templates VBZ O
, , O
thereby RB O
promoting VBG O
efficient JJ O
use NN O
of IN O
transcription NN O
complexes NNS O
by IN O
pol NN B-Gene
III NNP I-Gene
. . O

The DT O
correct JJ O
termination NN O
of IN O
retroviral JJ O
transcripts NNS O
at IN O
the DT O
3 CD O
' POS O
LTR NNP O
R NNP O
/ NNP O
U5 NNP O
junction NN O
is VBZ O
primarily RB O
dependent JJ O
on IN O
the DT O
canonical JJ O
AAUAAA NNP O
polyadenylation NN O
signal NN O
, , O
so IN O
we PRP O
have VBP O
analyzed VBN O
the DT O
effect NN O
of IN O
mutating VBG O
the DT O
polyadenylation NN O
signal JJ O
sequences NNS O
on IN O
the DT O
properties NNS O
of IN O
a DT O
selectable JJ O
murine JJ O
retroviral JJ O
vector NN O
. . O

313 CD O
, , O
98 CD O
- : O
102 CD O
) ) O
. . O

For IN O
the DT O
sample NN O
of IN O
systematic JJ O
reviews NNS O
drawn VBN O
from IN O
ACP NNP O
Journal NNP O
Club NNP O
( ( O
n JJ O
= NNP O
103 CD O
) ) O
, , O
the DT O
PubMed NNP O
strategy NN O
achieved VBD O
a DT O
sensitivity NN O
of IN O
97 CD O
% NN O
( ( O
CI NNP O
, , O
91 CD O
% NN O
to TO O
99 CD O
% NN O
) ) O
. . O

I PRP O
. . O

3 LS O
- : O
( ( O
N NNP O
- : O
Alkyl NNP O
- : O
N NNP O
- : O
2 CD O
- : O
chloroethylaminomethyl NN O
) ) O
- : O
5 CD O
- : O
or CC O
7 CD O
- : O
halogenobenzo NN O
[ NN O
b NN O
] NN O
thiophen NN O
hydrochlorides NNS O
. . O

In IN O
30 CD O
dogs NNS O
the DT O
left NN O
limb NN O
( ( O
tail NN O
) ) O
of IN O
the DT O
pancreas NN O
was VBD O
removed VBN O
but CC O
left VBN O
in IN O
the DT O
abdominal JJ O
cavity NN O
after IN O
cessation NN O
of IN O
blood NN O
flow NN O
to TO O
produce VB O
warm JJ O
ischemia NN O
for IN O
30 CD O
, , O
60 CD O
, , O
and CC O
120 CD O
min NN O
( ( O
10 CD O
dogs NNS O
at IN O
each DT O
time NN O
point NN O
) ) O
, , O
and CC O
then RB O
was VBD O
flushed VBN O
with IN O
cold JJ O
Ringers NNP O
' POS O
lactate NN O
and CC O
transplanted VBD O
to TO O
the DT O
iliac NN O
vessels NNS O
. . O

The DT O
population NN O
studied VBD O
comprised JJ O
4472 CD O
men NNS O
and CC O
5212 CD O
women NNS O
aged VBD O
30 CD O
- : O
74 CD O
years NNS O
, , O
without IN O
coronary JJ O
heart NN O
disease NN O
, , O
who WP O
had VBD O
CRP NNP B-Gene
measurements NNS O
in IN O
the DT O
Third NNP O
National NNP O
Health NNP O
and CC O
Nutrition NNP O
Examination NNP O
Survey NNP O
( ( O
NHANES NNP O
III NNP O
) ) O
. . O

RESULTS NN O
: : O
Nodular JJ O
opacities NNS O
, , O
mainly RB O
centrilobular NN O
in IN O
distribution NN O
, , O
were VBD O
the DT O
most RBS O
common JJ O
finding NN O
, , O
seen VBN O
in IN O
21 CD O
( ( O
72 CD O
% NN O
) ) O
and CC O
15 CD O
( ( O
65 CD O
% NN O
) ) O
of IN O
patients NNS O
with IN O
MTB NNP O
and CC O
NTMB NNP O
, , O
respectively RB O
. . O

BACKGROUND NN O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
and CC O
compare VB O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
levels NNS O
in IN O
gingival NN O
crevicular JJ O
fluid NN O
( ( O
GCF NNP O
) ) O
and CC O
clinical JJ O
periodontal JJ O
findings NNS O
in IN O
patients NNS O
with IN O
rheumatoid JJ O
arthritis NN O
( ( O
RA NNP O
) ) O
and CC O
adult NN O
periodontitis NN O
( ( O
AP NNP O
) ) O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
presence NN O
or CC O
absence NN O
per IN O
se NN O
of IN O
keratan JJ O
sulfate NN O
on IN O
native JJ O
G1 NNP O
- : O
G2 NN O
does VBZ O
not RB O
affect VB O
the DT O
activity NN O
of IN O
atrolysin NN O
C NNP O
toward IN O
the DT O
two CD O
sites NNS O
. . O

However RB O
, , O
it PRP O
was VBD O
synthesized VBN O
at IN O
both DT O
temperatures NNS O
after IN O
addition NN O
of IN O
A23187 NNP O
. . O

The DT O
ARF NNP B-Gene
promoter NN I-Gene
was VBD O
also RB O
found VBN O
to TO O
be VB O
highly RB O
responsive JJ O
to TO O
E2F1 NNP B-Gene
expression NN O
, , O
in IN O
keeping VBG O
with IN O
previous JJ O
results NNS O
at IN O
the DT O
RNA NNP O
level NN O
. . O

In IN O
subjects NNS O
( ( O
n JJ O
= NNP O
5 CD O
) ) O
with IN O
quadriplegia NN O
and CC O
reduced JJ O
sympathetic JJ O
tone NN O
secondary JJ O
to TO O
cervical JJ O
cord NN O
trauma NN O
, , O
TcpO2 NNP O
at IN O
42 CD O
degrees NNS O
C NNP O
and CC O
vasodilation NN O
index NN O
were VBD O
increased VBN O
( ( O
45 CD O
. . O
0 CD O
mmHg NN O
and CC O
0 CD O
. . O
61 CD O
) ) O
; : O
TcpO2 NNP O
at IN O
45 CD O
degrees NNS O
C NNPS O
did VBD O
not RB O
change NN O
. . O

This DT O
hypothesis NN O
was VBD O
tested VBN O
by IN O
introducing VBG O
mutations NNS O
at IN O
each DT O
of IN O
the DT O
three CD O
histidine NN O
pairs NNS O
, , O
the DT O
H382 NNP O
- : O
X2 SYM O
- : O
H385 NNP O
pair NN O
, , O
the DT O
H411 NNP O
- : O
X2 SYM O
- : O
H414 NNP O
pair NN O
and CC O
the DT O
H430 NNP O
- : O
X5 SYM O
- : O
H436 NNP O
pair NN O
, , O
which WDT O
constitute VBP O
the DT O
histidine NN O
- : O
rich JJ O
region NN O
near IN O
the DT O
C NNP O
terminus NN O
of IN O
gp17 NN B-Gene
. . O

The DT O
potential JJ O
for IN O
highly RB O
reactive JJ O
nanoparticles NNS O
( ( O
RNP NNP O
) ) O
to TO O
absorb VB O
destructively RB O
, , O
i NN O
. . O
e NN O
. . O
to TO O
neutralize VB O
highly RB O
toxic JJ O
substances NNS O
such JJ O
as IN O
the DT O
warfare NN O
agents NNS O
GA NNP O
, , O
GB NNP O
, , O
HD NNP O
and CC O
VX NNP O
, , O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
the DT O
laboratory NN O
. . O

The DT O
region NN O
that WDT O
imparts VBZ O
inducibility NN O
by IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
TNF NNP B-Gene
( ( O
positions NNS O
- : O
165 CD O
to TO O
- : O
58 CD O
) ) O
contains VBZ O
potential JJ O
binding NN O
sites NNS O
for IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC I-Gene
- : I-Gene
2 CD I-Gene
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
. . O

Fast NNP O
goal NN O
- : O
directed VBD O
voluntary JJ O
movements NNS O
of IN O
the DT O
human JJ O
upper JJ O
extremity NN O
are VBP O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
three CD O
distinct JJ O
bursts NNS O
of IN O
EMG NNP O
activity NN O
in IN O
antagonistic JJ O
muscles NNS O
. . O

The DT O
levels NNS O
of IN O
both DT O
MAP1 NNP B-Gene
- : I-Gene
specific NN I-Gene
and CC I-Gene
MAP2 NNP I-Gene
- : I-Gene
specific JJ I-Gene
mRNAs JJ I-Gene
decline NN O
in IN O
the DT O
postnatal JJ O
developing NN O
brain NN O
; : O
the DT O
level NN O
of IN O
MAP1 NNP B-Gene
- : I-Gene
specific JJ I-Gene
mRNA NN I-Gene
also RB O
increases VBZ O
slightly RB O
in IN O
rat NN O
PC12 NNP O
cells NNS O
upon IN O
exposure NN O
to TO O
nerve VB B-Gene
growth NN I-Gene
factor NN I-Gene
. . O

Sequence NN O
analysis NN O
showed VBD O
that IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
upstream NN O
to TO O
the DT O
ATG NNP O
codon NN O
did VBD O
not RB O
contain VB O
a DT O
conventional JJ O
TATA NNP O
box NN O
. . O

Positioning VBG O
this DT O
uORF NN O
, , O
together RB O
with IN O
its PRP$ O
accompanying VBG O
Kozak NNP O
sequences NNS O
, , O
between IN O
a DT O
heterologous JJ O
promoter NN O
from IN O
SV40 NNP O
and CC O
a DT O
CAT NNP B-Gene
reporter NN I-Gene
gene NN I-Gene
resulted VBD O
in IN O
marked JJ O
inhibition NN O
of IN O
CAT NNP B-Gene
protein NN I-Gene
production NN O
without IN O
a DT O
decrease NN O
in IN O
CAT NNP B-Gene
mRNA NN I-Gene
. . O

The DT O
pattern NN O
of IN O
RNase NNP B-Gene
E NNP I-Gene
digestion NN O
of IN O
finP305 JJ B-Gene
RNA NNP I-Gene
differed VBD O
from IN O
FinP NNP B-Gene
, , O
and CC O
GST NNP B-Gene
- : O
FinO NN B-Gene
did VBD O
not RB O
protect VB O
finP305 JJ B-Gene
RNA NNP I-Gene
from IN O
cleavage NN O
in IN O
vitro NN O
. . O

272 CD O
, , O
1904 CD O
] NN O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
, , O
the DT O
cytokine NN O
that WDT O
participates VBZ O
in IN O
the DT O
autocrine JJ O
growth NN O
control NN O
of IN O
hairy NN O
cell NN O
leukemia NN O
has VBZ O
strong JJ O
bone RB O
resorptive JJ O
properties NNS O
. . O

A DT O
partial JJ O
cDNA NN O
sequence NN O
indicated VBD O
that IN O
the DT O
T NNP B-Gene
lymphocyte VBD I-Gene
early JJ I-Gene
- : I-Gene
activation NN I-Gene
gene NN I-Gene
( ( O
Tea NNP B-Gene
) ) O
encodes VBZ O
a DT O
protein NN O
related VBN O
to TO O
the DT O
dual JJ O
- : O
function NN O
ecotropic NN B-Gene
retrovirus NN I-Gene
receptor NN I-Gene
/ NNP O
cationic NN B-Gene
amino NN I-Gene
acid NN I-Gene
transporter NN I-Gene
( ( O
ecoR JJ B-Gene
/ NNP O
CAT1 NNP B-Gene
) ) O
, , O
and CC O
RNA NNP O
blots NNS O
suggested VBD O
highest JJS O
Tea NNP B-Gene
expression NN O
in IN O
T NNP O
lymphocytes NNS O
and CC O
liver NN O
( ( O
MacLeod NNP O
, , O
C NNP O
. . O
L NNP O
. . O
, , O
Finley NNP O
, , O
K NNP O
. . O
, , O
Kakuda NNP O
, , O
D NNP O
. . O

The DT O
fragments NNS O
are VBP O
separated VBN O
and CC O
directly RB O
sized VBN O
by IN O
agarose JJ O
gel JJ O
electrophoresis NN O
. . O

Though IN O
hepatomegaly NN O
and CC O
mild JJ O
elevation NN O
of IN O
enzymes NNS O
can MD O
be VB O
observed VBN O
in IN O
a DT O
significant JJ O
proportion NN O
of IN O
patients NNS O
, , O
involvement NN O
of IN O
liver NN O
leading VBG O
to TO O
acute VB O
hepatitis NN O
or CC O
liver NN O
cell NN O
necrosis NN O
is VBZ O
a DT O
relatively RB O
uncommon JJ O
complication NN O
in IN O
P NNP O
. . O
falciparum NN O
malaria NN O
. . O

LON NNP O
- : O
72 CD O
( ( O
34 CD O
isolates NNS O
) ) O
, , O
LON NNP O
- : O
73 CD O
( ( O
1 CD O
) ) O
, , O
LON NNP O
- : O
71 CD O
( ( O
2 CD O
) ) O
and CC O
LON NNP O
- : O
10 CD O
( ( O
2 CD O
) ) O
were VBD O
found VBN O
at IN O
altitudes NNS O
around IN O
2000 CD O
m NN O
, , O
3 CD O
of IN O
them PRP O
in IN O
a DT O
single JJ O
village NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
as IN O
major JJ O
factors NNS O
binding VBG O
to TO O
the DT O
Sp1 NNP B-Gene
sites NNS I-Gene
of IN O
the DT O
p21 NN B-Gene
/ NNP O
WAF1 NNP B-Gene
/ NNP O
Cip1 NNP B-Gene
promoter NN O
in IN O
MG63 NNP O
cells NNS O
through IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
and CC O
showed VBD O
that IN O
TSA NNP O
treatment NN O
did VBD O
not RB O
change VB O
their PRP$ O
binding NN O
activities NNS O
. . O

Truncated VBN O
mammalian JJ B-Gene
Notch1 NNP I-Gene
activates VBZ O
CBF1 NNP B-Gene
/ NNP O
RBPJk NNP B-Gene
- : O
repressed VBN O
genes NNS O
by IN O
a DT O
mechanism NN O
resembling VBG O
that IN O
of IN O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
EBNA2 NNP I-Gene
. . O

We PRP O
studied VBD O
the DT O
GR NNP B-Gene
in IN O
DMS NNP O
- : O
79 CD O
cells NNS O
derived VBN O
from IN O
a DT O
human JJ O
ACTH NNP B-Gene
- : O
secreting VBG O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

N NNP O
. . O
van NN O
Hoek NNP O
, , O
and CC O
M NNP O
. . O

Clones NNS O
33F CD O
and CC O
34B CD O
encoded VBD O
identical JJ O
aromatase NN B-Gene
proteins NNS I-Gene
of IN O
503 CD O
amino NN O
acids NNS O
, , O
but CC O
differed VBD O
in IN O
size NN O
due JJ O
to TO O
alternative JJ O
polyadenylation NN O
signal JJ O
usage NN O
for IN O
the DT O
corresponding JJ O
mRNAs NN O
. . O

Functional JJ O
tests NNS O
using VBG O
a DT O
reporter NN O
gene NN O
, , O
containing VBG O
Stat5 NNP B-Gene
- : I-Gene
binding NN I-Gene
elements NNS I-Gene
, , O
confirmed VBD O
that IN O
while IN O
the DT O
variant JJ O
form NN O
was VBD O
inactive JJ O
by IN O
itself PRP O
, , O
it PRP O
could MD O
inhibit VB O
the DT O
function NN O
of IN O
the DT O
full JJ O
- : O
length NN O
receptor NN O
. . O

The DT O
"""" NNP O
tobacco NN O
issue NN O
"""" NNP O
. . O

Oncostatin NNP B-Gene
M NNP I-Gene
stimulates VBZ O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
to TO O
bind VB O
a DT O
transcriptionally RB O
responsive JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
element NN I-Gene
within IN O
the DT O
tissue NN B-Gene
inhibitor NN I-Gene
of IN I-Gene
metalloproteinase NN I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
. . O

This DT O
fragment NN O
can MD O
bind VB O
several JJ O
trans NNS O
- : O
acting VBG O
factors NNS O
in IN O
vitro NN O
, , O
including VBG O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
members NNS O
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
. . O

These DT O
cognitive JJ O
deficits NNS O
were VBD O
prevented VBN O
in IN O
animals NNS O
treated VBN O
with IN O
MK NNP O
- : O
801 CD O
during IN O
SE NNP O
. . O

Serum NNP O
gastrin NN B-Gene
and CC O
AFP NNP B-Gene
levels NNS O
had VBD O
the DT O
same JJ O
evolution NN O
and CC O
appear VBP O
to TO O
have VB O
the DT O
same JJ O
interest NN O
to TO O
follow VB O
the DT O
course NN O
of IN O
the DT O
disease NN O
. . O

Phenobarbital NNP O
- : O
induced JJ O
alterations NNS O
in IN O
the DT O
metabolism NN O
of IN O
[ $ O
3H CD O
] NNP O
vitamin NN O
D3 NNP O
by IN O
the DT O
perfused JJ O
rachitic JJ O
rat NN O
liver NN O
in IN O
vitro NN O
. . O

Not RB O
Available JJ O

POU NNP B-Gene
- : O
specific NN O
and CC O
POU NNP B-Gene
- : O
homeo NN O
domains NNS O
of IN O
Oct3 NNP B-Gene
were VBD O
produced VBN O
in IN O
Echerichia NNP O
coli NN O
for IN O
characterization NN O
of IN O
DNA NNP O
binding VBG O
to TO O
the DT O
octamer JJ O
sequence NN O
. . O

Cytogenetic JJ O
and CC O
molecular JJ O
characterization NN O
of IN O
random NN O
chromosomal JJ O
rearrangements NNS O
activating VBG O
the DT O
drug NN O
resistance NN O
gene NN O
, , O
MDR1 NNP B-Gene
/ NNP O
P NNP B-Gene
- : I-Gene
glycoprotein NN I-Gene
, , O
in IN O
drug NN O
- : O
selected VBN O
cell NN O
lines NNS O
and CC O
patients NNS O
with IN O
drug NN O
refractory NN O
ALL NNP O
. . O

A DT O
narrow JJ O
zone NN O
of IN O
myelin NN O
- : O
axonal JJ O
dissociation NN O
was VBD O
also RB O
observed VBN O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
the DT O
temperature NN B-Gene
- : I-Gene
sensitive JJ I-Gene
rad54 NN I-Gene
- : I-Gene
3 CD I-Gene
allele NN I-Gene
blocks NNS O
mitotic JJ O
recombination NN O
between IN O
tandemly RB O
repeated VBN O
DYZ3 NNP B-Gene
satellite NN I-Gene
sequences NNS I-Gene
and CC O
significantly RB O
stabilizes VBZ O
a DT O
human JJ B-Gene
DYZ5 NNP I-Gene
satellite NN O
- : O
containing VBG O
YAC NNP O
clone NN O
. . O

Insulin NNP B-Gene
stimulation NN O
promoted VBD O
the DT O
association NN O
of IN O
mIRS3 NN B-Gene
with IN O
p85 NN B-Gene
, , O
SHP2 NNP B-Gene
, , O
Nck NNP B-Gene
, , O
and CC O
Shc NNP B-Gene
. . O

PFK NNP B-Gene
- : I-Gene
A DT I-Gene
mRNA NN O
was VBD O
more RBR O
abundantly RB O
expressed VBN O
in IN O
all DT O
tissues NNS O
than IN O
were VBD O
the DT O
PFK NNP B-Gene
- : I-Gene
B NN I-Gene
and CC O
PFK NNP B-Gene
- : I-Gene
C NNP I-Gene
genes NNS I-Gene
. . O

( ( O
1998 CD O
) ) O
FASEB NNP O
J NNP O
. . O

Modification NN O
by IN O
this DT O
latter JJ O
compound NN O
was VBD O
so RB O
extensive JJ O
that IN O
the DT O
amount NN O
of IN O
membrane NN O
- : O
associated VBN O
N NNP O
- : O
myristoylated VBD O
protein NN O
was VBD O
decreased VBN O
. . O

Amikacin NNP O
concentrations NNS O
in IN O
serum NN O
and CC O
blister NN O
fluid NN O
in IN O
healthy JJ O
volunteers NNS O
and CC O
in IN O
patients NNS O
with IN O
renal JJ O
impairment NN O
. . O

The DT O
duration NN O
of IN O
reactive JJ O
hyperemia NN O
decreased VBN O
with IN O
aging VBG O
, , O
but CC O
the DT O
difference NN O
between IN O
males NNS O
and CC O
females NNS O
was VBD O
not RB O
significant JJ O
at IN O
any DT O
age NN O
. . O

A DT O
cDNA NN O
encoding VBG O
a DT O
MYC NNP B-Gene
- : I-Gene
related JJ I-Gene
DNA NN I-Gene
binding VBG I-Gene
protein NN I-Gene
was VBD O
isolated VBN O
by IN O
DNA NNP O
- : O
ligand NN O
binding VBG O
screening NN O
, , O
using VBG O
the DT O
67 CD O
- : O
bp NN O
region NN O
as IN O
a DT O
probe NN O
, , O
and CC O
designated VBD O
rd22BP1 NN B-Gene
. . O

Ampicillin NNP O
( ( O
AMP NNP O
) ) O
alone RB O
or CC O
with IN O
an DT O
aminoglycoside NN O
( ( O
AMI NNP O
) ) O
was VBD O
the DT O
treatment NN O
in IN O
9 CD O
and CC O
16 CD O
cases NNS O
, , O
respectively RB O
. . O

Brain NNP O
pH NN O
following VBG O
3 CD O
h NN O
of IN O
cerebral JJ O
focal JJ O
ischemia NN O
changed VBD O
from IN O
a DT O
normal JJ O
value NN O
of IN O
7 CD O
. . O
0 CD O
to TO O
6 CD O
. . O
5 CD O
and CC O
6 CD O
. . O
2 CD O
in IN O
animals NNS O
studied VBN O
under IN O
barbiturate NN O
and CC O
halothane NN O
anesthesia NN O
, , O
respectively RB O
. . O

Here RB O
we PRP O
report VBP O
the DT O
full JJ O
- : O
length NN O
coding VBG O
cDNA JJ O
sequence NN O
of IN O
the DT O
mouse NN B-Gene
homologue NN I-Gene
of IN I-Gene
MPP3 NNP I-Gene
. . O

Proteomic NNP O
patterns NNS O
of IN O
nipple JJ O
aspirate JJ O
fluids NNS O
obtained VBN O
by IN O
SELDI NNP O
- : O
TOF NN O
: : O
potential NN O
for IN O
new JJ O
biomarkers NNS O
to TO O
aid VB O
in IN O
the DT O
diagnosis NN O
of IN O
breast NN O
cancer NN O
. . O

Exercise NN O
training NN O
has VBZ O
become VBN O
increasingly RB O
important JJ O
in IN O
the DT O
treatment NN O
of IN O
heart NN O
failure NN O
patients NNS O
. . O

Characterization NN O
of IN O
FIII NNP B-Gene
/ NNP O
YY1 NNP B-Gene
, , O
a DT O
Xenopus NNP B-Gene
laevis NN I-Gene
conserved VBD I-Gene
zinc SYM I-Gene
- : I-Gene
finger NN I-Gene
protein NN I-Gene
binding VBG O
to TO O
the DT O
first JJ O
exon NN O
of IN O
L1 NNP B-Gene
and CC O
L14 NNP B-Gene
ribosomal JJ I-Gene
protein NN I-Gene
genes NNS I-Gene
. . O

In IN O
addition NN O
, , O
we PRP O
also RB O
show VBP O
that IN O
cdk7 NN B-Gene
may MD O
phosphorylate VB O
the DT O
carboxy JJ O
- : O
terminal NN O
domain NN O
( ( O
CTD NNP O
) ) O
of IN O
RNA NNP B-Gene
pol NN I-Gene
II NNP I-Gene
in IN O
the DT O
absence NN O
of IN O
promoter NN O
opening NN O
. . O

Sixty NNP O
days NNS O
after IN O
the DT O
intervention NN O
, , O
twitch NN O
and CC O
tetanic JJ O
tensions NNS O
remained VBD O
dependent JJ O
upon IN O
the DT O
extracellular JJ O
Ca2 NNP O
+ NNP O
concentration NN O
( ( O
[ JJ O
Ca NNP O
] NNP O
o NN O
) ) O
both DT O
in IN O
groups NNS O
A NNP O
and CC O
B NNP O
. . O

Gel NNP O
- : O
mobility NN O
- : O
shift NN O
assays NNS O
confirmed VBD O
that IN O
the DT O
Raji NNP O
nuclear JJ O
proteins NNS O
that WDT O
bound VBP O
to TO O
W NNP O
and CC O
V NNP O
elements NNS O
were VBD O
competed VBN O
with IN O
by IN O
an DT O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
X NNP I-Gene
- : I-Gene
box NN I-Gene
oligonucleotide NN I-Gene
. . O

Strategies NNS O
for IN O
blood NN O
screening NN O
for IN O
the DT O
hepatitis NN O
C NNP O
virus NN O
and CC O
for IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
in IN O
high JJ O
risk NN O
groups NNS O
. . O

To TO O
understand VB O
the DT O
basis NN O
for IN O
the DT O
increased VBN O
cell NN O
surface NN O
stability NN O
compared VBN O
with IN O
wild JJ O
- : O
type NN O
peptide NN O
and CC O
to TO O
understand VB O
the DT O
differences NNS O
in IN O
T NNP O
cell NN O
recognition NN O
between IN O
I1Y NNP B-Gene
and CC O
I1F NNP B-Gene
, , O
we PRP O
determined VBD O
the DT O
x NNP O
- : O
ray NN O
crystal JJ O
structures NNS O
of IN O
the DT O
two CD O
class NN B-Gene
I PRP I-Gene
MHC NNP I-Gene
- : I-Gene
peptide NN I-Gene
complexes NNS I-Gene
. . O

Variations NNS O
in IN O
the DT O
5 CD O
' POS O
half NN O
of IN O
U3 NNP O
were VBD O
primarily RB O
due JJ O
to TO O
insertions NNS O
and CC O
deletions NNS O
. . O

Study NN O
of IN O
the DT O
energy NN O
metabolism NN O
of IN O
the DT O
sensomotor NN O
cortex NN O
and CC O
hippocampus NN O
by IN O
the DT O
( ( O
14C CD O
) ) O
2 CD O
- : O
deoxyglucose JJ O
method NN O
during IN O
the DT O
development NN O
of IN O
dissociated JJ O
states NNS O

All DT O
patients NNS O
had VBD O
the DT O
CA NNP B-Gene
125 CD I-Gene
assay NN O
performed VBD O
within IN O
one CD O
week NN O
before IN O
their PRP$ O
second JJ O
- : O
look NN O
operation NN O
. . O

Manifest JJS O
anxiety NN O
of IN O
Vietnam NNP O
returnees NNS O
and CC O
undergraduates NNS O
. . O

Substitution NN O
of IN O
either DT O
Val33 NNP O
( ( O
by IN O
Gly NNP O
) ) O
or CC O
Gly28 NNP O
( ( O
by IN O
Ser NNP O
) ) O
, , O
two CD O
of IN O
the DT O
most RBS O
conserved JJ O
residues NNS O
in IN O
all DT O
protein NN O
kinases NNS O
, , O
resulted VBD O
in IN O
enzyme NN O
with IN O
marginally RB O
detectable JJ O
activity NN O
. . O

Palindromic JJ O
rheumatism NN O

We PRP O
report VBP O
here RB O
the DT O
discovery NN O
of IN O
a DT O
new JJ O
actin NN B-Gene
- : I-Gene
related JJ I-Gene
gene NN I-Gene
in IN O
this DT O
organism NN O
, , O
which WDT O
we PRP O
have VBP O
named VBN O
ACT4 NNP B-Gene
. . O

In IN O
girls NNS O
prolactin NN B-Gene
levels NNS O
rise VBP O
at IN O
stage NN O
2 CD O
, , O
and CC O
are VBP O
higher JJR O
after IN O
menarche NN O
; : O
in IN O
boys NNS O
there EX O
is VBZ O
no DT O
change NN O
in IN O
prolactin NN B-Gene
levels NNS O
. . O

However RB O
, , O
a DT O
specific JJ O
ICE NNP B-Gene
/ NNP O
caspase VBD B-Gene
- : I-Gene
1 CD I-Gene
inhibitor NN O
called VBN O
N1445 NNP O
completely RB O
abolished VBD O
the DT O
CK NNP B-Gene
- : O
induced VBN O
apoptosis NN O
by IN O
reactivating VBG O
PKB NNP B-Gene
, , O
but CC O
without IN O
affecting VBG O
the DT O
CK NNP B-Gene
- : O
induced JJ O
suppression NN O
of IN O
Ras NNP B-Gene
transformation NN O
. . O

272 CD O
, , O
19107 CD O
- : O
19110 CD O
) ) O
. . O

MOP5 NNP B-Gene
contained VBD O
the DT O
characteristic JJ O
PAS NNP B-Gene
domain NN O
and CC O
a DT O
variable JJ O
C NNP O
terminus NN O
; : O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
cDNA NN O
contains VBZ O
a DT O
bHLH NN O
domain NN O
, , O
but CC O
the DT O
entire JJ O
open JJ O
reading NN O
frame NN O
has VBZ O
yet RB O
to TO O
be VB O
completed VBN O
. . O

Scaling VBG O
of IN O
fluctuations NNS O
in IN O
one CD O
- : O
dimensional JJ O
interface NN O
and CC O
hopping NN O
models NNS O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
characterized VBN O
a DT O
55 CD O
- : O
kb JJ O
region NN O
of IN O
DNA NNP O
surrounding VBG O
HRAS1 NNP B-Gene
. . O

BACKGROUND NN O
: : O
Studies NNS O
in IN O
lean JJ O
men NNS O
show VBP O
poor JJ O
regulation NN O
of IN O
energy NN O
( ( O
EB NNP O
) ) O
and CC O
fat JJ O
balance NN O
( ( O
FB NNP O
) ) O
during IN O
manipulation NN O
of IN O
dietary JJ O
ratios NNS O
of IN O
fat NN O
to TO O
carbohydrate VB O
. . O

The DT O
5 CD O
' POS O
flanking JJ O
regions NNS O
of IN O
both DT O
pelA NNS B-Gene
and CC O
pelB NNS B-Gene
were VBD O
translationally RB O
fused VBN O
to TO O
the DT O
beta NN B-Gene
- : I-Gene
glucuronidase NN I-Gene
gene NN I-Gene
and CC O
introduced VBN O
into IN O
F NNP O
. . O
solani NN O
f NN O
. . O

sp NN O
. . O
pisi NN O
, , O
and CC O
beta SYM B-Gene
- : I-Gene
glucuronidase NN I-Gene
activities NNS O
of IN O
the DT O
transformants NNS O
were VBD O
measured VBN O
. . O

Eight CD O
induced VBN O
cDNA NN O
sequences NNS O
were VBD O
identified VBN O
and CC O
designated VBN O
message NN B-Gene
up RP I-Gene
- : I-Gene
regulated VBN I-Gene
during IN I-Gene
death NN I-Gene
( ( B-Gene
mud NN I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
8 CD I-Gene
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
periseizure NN O
lipid JJ O
accumulation NN O
is VBZ O
related VBN O
to TO O
cortical JJ O
oxygenation NN O
. . O

In IN O
vitro JJ O
binding NN O
studies NNS O
demonstrate VBP O
that IN O
eIF SYM B-Gene
- : I-Gene
5A CD I-Gene
is VBZ O
required VBN O
for IN O
efficient JJ O
interaction NN O
of IN O
Rev NNP B-Gene
- : O
NES NN B-Gene
with IN O
CRM1 NNP B-Gene
/ NNP O
exportin1 NN B-Gene
and CC O
that IN O
eIF VBP B-Gene
- : I-Gene
5A CD I-Gene
interacts NNS O
with IN O
the DT O
nucleoporins NNS O
CAN NNP B-Gene
/ NNP O
nup214 RB B-Gene
, , O
nup153 RB B-Gene
, , O
nup98 UH B-Gene
, , O
and CC O
nup62 RB B-Gene
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
We PRP O
prospectively RB O
compared VBN O
the DT O
automated JJ O
measurements NNS O
of IN O
left JJ O
ventricular JJ O
ejection NN O
fraction NN O
( ( O
LVEF NNP O
) ) O
and CC O
volumes NNS O
from IN O
rest NN O
- : O
injected VBN O
gated JJ O
Technetium NN O
99m CD O
( ( O
Tc99m NNP O
) ) O
perfusion NN O
SPECT NNP O
with IN O
equilibrium NN O
radionuclide NN O
angiocardiography NN O
( ( O
ERNA NNP O
) ) O
in IN O
62 CD O
patients NNS O
and CC O
the DT O
assessment NN O
of IN O
regional JJ O
function NN O
with IN O
echocardiography NN O
in IN O
22 CD O
patients NNS O
. . O

The DT O
effective JJ O
and CC O
low JJ O
toxic NN O
dose NN O
schedules NNS O
of IN O
KW NNP O
- : O
2083 CD O
should MD O
be VB O
investigated VBN O
further RBR O
. . O

PowerBLAST NNP O
analysis NN O
identified VBD O
six CD O
clusters NNS O
of IN O
expressed JJ O
sequence NN O
tags NNS O
( ( O
ESTs NNP O
) ) O
, , O
two CD O
known VBN O
genes NNS O
( ( O
BIR NNP B-Gene
, , O
SUR1 NNP B-Gene
) ) O
mapped VBD O
previously RB O
to TO O
this DT O
region NN O
, , O
and CC O
a DT O
previously RB O
characterized VBN O
but CC O
unmapped JJ O
gene NN B-Gene
NEFA NNP I-Gene
( ( O
DNA NNP B-Gene
binding VBG I-Gene
/ JJ I-Gene
EF NNP I-Gene
hand NN I-Gene
/ NNP I-Gene
acidic NN I-Gene
amino NN I-Gene
- : I-Gene
acid NN I-Gene
- : I-Gene
rich NN I-Gene
) ) O
. . O

VirD2 NNP B-Gene
is VBZ O
one CD O
of IN O
the DT O
key JJ O
Agrobacterium NNP O
tumefaciens VBZ O
proteins NNS O
involved VBN O
in IN O
T NNP O
- : O
DNA NN O
processing NN O
and CC O
transfer NN O
. . O

The DT O
history NN O
of IN O
exposure NN O
and CC O
carboxyhemoglobin NN B-Gene
levels NNS O
should MD O
alert VB O
the DT O
physician NN O
to TO O
this DT O
diagnosis NN O
. . O

The DT O
steepness NN O
of IN O
the DT O
standard JJ O
O2 NNP O
dissociation NN O
curve NN O
becomes VBZ O
greater JJR O
during IN O
the DT O
training NN O
period NN O
( ( O
increase NN O
in IN O
Hill NNP O
' POS O
s NN O
n NN O
from IN O
2 CD O
. . O
68 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
10 CD O
to TO O
2 CD O
. . O
96 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
15 CD O
) ) O
. . O

The DT O
highest JJS O
doses NNS O
were VBD O
found VBN O
for IN O
drivers NNS O
who WP O
transported VBD O
large JJ O
numbers NNS O
of IN O
99Mo CD O
generators NNS O
. . O

During IN O
the DT O
program NN O
' POS O
s NN O
use NN O
at IN O
the DT O
RSNA NNP O
meeting NN O
, , O
the DT O
program NN O
selected VBD O
the DT O
correct JJ O
diagnosis NN O
in IN O
the DT O
top JJ O
five CD O
22 CD O
% NN O
of IN O
the DT O
time NN O
. . O

The DT O
two CD O
most RBS O
recent JJ O
patients NNS O
( ( O
35 CD O
and CC O
132 CD O
days NNS O
) ) O
received VBD O
only RB O
oral JJ O
dipyridamole NN O
( ( O
75 CD O
mg NN O
X NNP O
3 CD O
/ NNP O
day NN O
) ) O
and CC O
aspirin NN O
( ( O
80 CD O
mg NNS O
/ JJ O
day NN O
) ) O
after IN O
the DT O
early JJ O
recovery NN O
period NN O
( ( O
four CD O
- : O
six CD O
days NNS O
) ) O
, , O
resulting VBG O
in IN O
normal JJ O
prothrombin NN B-Gene
and CC O
partial JJ O
thromboplastin NN B-Gene
times NNS O
. . O

The DT O
mitochondrial JJ B-Gene
regulatory JJ I-Gene
region NN I-Gene
( ( O
mrr NN B-Gene
) ) O
located VBD O
between IN O
the DT O
tRNAPhe NN B-Gene
and CC O
tRNAPro JJ B-Gene
genes NNS I-Gene
of IN O
mitochondrial JJ O
DNA NNP O
( ( O
mtDNA NN O
) ) O
is VBZ O
essential JJ O
for IN O
regulation NN O
of IN O
replication NN O
and CC O
transcription NN O
of IN O
the DT O
mitochondrial JJ O
genome NN O
. . O

The DT O
exploratory JJ O
behaviour NN O
in IN O
normal JJ O
and CC O
aggressive JJ O
mice NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
the DT O
Mif2 NNP B-Gene
protein NN I-Gene
interacts VBZ O
with IN O
Cep1p NNP B-Gene
at IN O
the DT O
centromere NN O
and CC O
that IN O
the DT O
yeast NN O
centromere JJ O
indeed RB O
exists VBZ O
as IN O
a DT O
higher JJR O
order NN O
protein SYM O
- : O
DNA NN O
complex NN O
. . O

During IN O
the DT O
biosynthesis NN O
of IN O
all DT O
three CD O
mutant NN O
polypeptides NNS O
, , O
the DT O
signal JJ O
peptide NN O
is VBZ O
efficiently RB O
and CC O
accurately RB O
cleaved VBN O
from IN O
the DT O
nascent JJ O
protein NN O
, , O
even RB O
though IN O
in IN O
mutants NNS O
X2 NNP O
and CC O
X3 NNP O
the DT O
cleavage NN O
site NN O
itself PRP O
has VBZ O
been VBN O
altered VBN O
. . O

Activated VBN O
PKR NNP B-Gene
may MD O
exist VB O
as IN O
a DT O
dimer NN O
and CC O
phosphorylates VBZ O
the DT O
eukaryotic JJ B-Gene
translation NN I-Gene
initiation NN I-Gene
factor NN I-Gene
2 CD I-Gene
alpha NN I-Gene
subunit NN I-Gene
( ( O
cIF JJ B-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
) ) O
to TO O
inhibit VB O
polypeptide JJ O
chain NN O
initiation NN O
. . O

Testing VBG O
blood NN O
donors NNS O
for IN O
non JJ O
- : O
A NN O
, , O
non SYM O
- : O
B NN O
hepatitis NN O
: : O
irrational JJ O
, , O
perhaps RB O
, , O
but CC O
inescapable JJ O
. . O

The DT O
risk NN O
factors NNS O
studied VBN O
were VBD O
male JJ O
sex NN O
, , O
hypertension NN O
, , O
diabetes VBZ O
mellitus NN O
, , O
hypercholesterolemia NN O
, , O
cigarette NN O
smoking NN O
, , O
sedentary JJ O
life NN O
- : O
style NN O
, , O
and CC O
family NN O
history NN O
. . O

Moreover RB O
, , O
following VBG O
a DT O
single JJ O
intravenous JJ O
injection NN O
of IN O
the DT O
bicistronic JJ O
vector NN O
complexed VBD O
to TO O
cationic VB O
liposomes NNS O
into IN O
recipient JJ O
mice NN O
, , O
delivery NN O
of IN O
MDR1 NNP B-Gene
and CC O
GC NNP B-Gene
cDNAs NN I-Gene
was VBD O
achieved VBN O
in IN O
all PDT O
the DT O
organs NNS O
we PRP O
tested VBD O
. . O

Three CD O
sequence NN O
elements NNS O
are VBP O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
accurate NN O
and CC O
efficient JJ O
transcription NN O
termination NN O
by IN O
RNA NNP B-Gene
polymerase NN I-Gene
I PRP I-Gene
( ( O
pol IN B-Gene
I PRP I-Gene
) ) O
assayed VBD O
both DT O
in IN O
a DT O
cell NN O
- : O
free JJ O
transcription NN O
system NN O
and CC O
in IN O
vivo NN O
after IN O
transfection NN O
of IN O
rDNA NN O
minigene NN O
constructs VBZ O
into IN O
3T6 CD O
cells NNS O
. . O

Treatment NN O
is VBZ O
instituted VBN O
with IN O
prednisone NN O
and CC O
cyclophosphamide NN O
. . O

An DT O
intravenous JJ O
drip NN O
infusion NN O
of IN O
AMK NNP O
in IN O
adequate JJ O
dosage NN O
would MD O
be VB O
beneficial JJ O
to TO O
use VB O
against IN O
some DT O
infectious JJ O
diseases NNS O
of IN O
otorhinolaryngologic JJ O
field NN O
. . O

Potentially RB O
load JJ O
- : O
insensitive JJ O
measures NNS O
of IN O
ventricular JJ O
performance NN O
were VBD O
therefore RB O
evaluated VBN O
in IN O
10 CD O
open JJ O
- : O
and CC O
closed VBD O
- : O
chested VBN O
, , O
anesthetized JJ O
rabbits NNS O
. . O

CONCLUSIONS NN O
: : O
LSCC NNP O
malformation NN O
, , O
like IN O
other JJ O
inner JJ O
ear JJ O
malformations NNS O
such JJ O
as IN O
large JJ O
vestibular JJ O
aqueduct NN O
and CC O
X NNP O
- : O
linked VBD O
mixed JJ O
deafness NN O
with IN O
perilymph NN O
gusher NN O
, , O
can MD O
be VB O
associated VBN O
with IN O
CHL NNP O
, , O
SNHL NNP O
, , O
or CC O
normal JJ O
hearing NN O
. . O

The DT O
distribution NN O
of IN O
their PRP$ O
fibrinogen NN B-Gene
levels NNS O
was VBD O
Gaussian JJ O
, , O
but CC O
more JJR O
wide JJ O
- : O
based VBN O
than IN O
the DT O
distribution NN O
of IN O
our PRP$ O
normal JJ O
controls NNS O
. . O

This DT O
- : O
2485 CD O
/ SYM O
- : O
2458 CD O
element NN O
bound NN O
PPARalpha NNP B-Gene
and CC O
PPARgamma NNP B-Gene
from IN O
brown JJ O
fat JJ O
nuclei NN O
. . O

Moreover RB O
, , O
the DT O
effect NN O
exerted VBN O
by IN O
TIS1 NNP B-Gene
appeared VBD O
to TO O
be VB O
selective JJ O
for IN O
the DT O
MCK NNP B-Gene
promoter NN I-Gene
. . O

The DT O
presence NN O
of IN O
the DT O
corresponding JJ O
mature NN O
mRNA NN O
transcripts NNS O
( ( O
3 CD O
. . O
2 CD O
- : O
3 CD O
. . O
5 CD O
kilobase NN O
pairs NNS O
( ( O
kb VB O
] NN O
in IN O
human JJ O
fibroblasts NNS O
was VBD O
shown VBN O
by IN O
Northern NNP O
blot NN O
hybridization NN O
, , O
S1 NNP B-Gene
nuclease NN I-Gene
protection NN O
assay NN O
, , O
and CC O
the DT O
polymerase NN O
chain NN O
reaction NN O
. . O

Toluene NNP O
is VBZ O
the DT O
chemical NN O
most RBS O
frequently RB O
present JJ O
in IN O
cases NNS O
involving VBG O
volatile JJ O
solvents NNS O
. . O

Insulin NNP B-Gene
regulation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
( ( O
MEK NNP B-Gene
) ) O
, , O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
and CC O
casein NN B-Gene
kinase NN I-Gene
in IN O
the DT O
cell NN O
nucleus NN O
: : O
a DT O
possible JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

Adduction NN O
of IN O
the DT O
human JJ B-Gene
N NNP I-Gene
- : I-Gene
ras NN I-Gene
codon VBZ I-Gene
61 CD I-Gene
sequence NN I-Gene
with IN O
( ( O
- : O
) ) O
- : O
( ( O
7S CD O
, , O
8R CD O
, , O
9R CD O
, , O
10S CD O
) ) O
- : O
7 CD O
, , O
8 CD O
- : O
dihydroxy NN O
- : O
9 CD O
, , O
10 CD O
- : O
epoxy JJ O
- : O
7 CD O
, , O
8 CD O
, , O
9 CD O
, , O
10 CD O
- : O
tetrahydrobenzo NN O
[ VBZ O
a DT O
] JJ O
pyrene NN O
: : O
structural JJ O
refinement NN O
of IN O
the DT O
intercalated JJ O
SRSR NNP O
( ( O
61 CD O
, , O
2 CD O
) ) O
( ( O
- : O
) ) O
- : O
( ( O
7S CD O
, , O
8R CD O
, , O
9S CD O
, , O
10R CD O
) ) O
- : O
N6 NNP O
- : O
[ NN O
10 CD O
- : O
( ( O
7 CD O
, , O
8 CD O
, , O
9 CD O
, , O
10 CD O
- : O
tetrahydrobenzo NN O
[ VBZ O
a DT O
] JJ O
pyrenyl NN O
) ) O
] VBZ O
- : O
2 CD O
' '' O
- : O
deoxyadenosyl NN O
adduct NN O
from IN O
1H CD O
NMR NNP O
. . O

A DT O
gas NN O
- : O
liquid NN O
chromatographic JJ O
method NN O
for IN O
the DT O
determination NN O
of IN O
p JJ O
- : O
chlorophenoxyisobutyric NN O
( ( O
CPIB NNP O
) ) O
acid NN O
in IN O
blood NN O
plasma NN O
is VBZ O
described VBN O
. . O

As IN O
the DT O
half NN O
- : O
life NN O
of IN O
the DT O
compound NN O
did VBD O
never RB O
exceed VB O
8 CD O
- : O
9 CD O
h NN O
, , O
the DT O
data NNS O
do VBP O
not RB O
support VB O
any DT O
change NN O
of IN O
pidotimod JJ O
administration NN O
schedule NN O
( ( O
every DT O
24 CD O
- : O
12 CD O
h NN O
) ) O
. . O

Src NNP B-Gene
activation NN O
induced VBN O
by IN O
FGF1 NNP B-Gene
was VBD O
blocked VBN O
by IN O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
of IN O
Src NNP B-Gene
and CC O
PP2 NNP B-Gene
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
Src NNP B-Gene
. . O

AGO1 NNP B-Gene
is VBZ O
similar JJ O
to TO O
QDE NNP B-Gene
- : I-Gene
2 CD I-Gene
required VBN O
for IN O
quelling VBG O
and CC O
RDE NNP B-Gene
- : I-Gene
1 CD I-Gene
required VBN O
for IN O
RNAi NNP O
. . O

( ( O
2 CD O
) ) O
Diffusion NN O
limitation NN O
in IN O
the DT O
heterogeneous JJ O
model NN O
sets NNS O
in IN O
at IN O
a DT O
lower JJR O
O2 NNP O
requirement NN O
value NN O
, , O
and CC O
increases VBZ O
more RBR O
gradually RB O
with IN O
increasing VBG O
O2 NNP O
requirement NN O
, , O
than IN O
in IN O
the DT O
corresponding JJ O
homogeneous JJ O
models NNS O
with IN O
the DT O
same JJ O
average JJ O
cylinder NN O
diameter NN O
. . O

To TO O
assess VB O
the DT O
relationship NN O
between IN O
G NNP B-Gene
( ( I-Gene
q NN I-Gene
) ) I-Gene
/ NN O
G NNP B-Gene
( ( I-Gene
11 CD I-Gene
) ) I-Gene
function NN O
with IN O
the DT O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
dependent JJ O
pathway NN O
, , O
expression NN O
of IN O
a DT O
dominant JJ O
- : O
interfering NN O
p85 JJ B-Gene
regulatory JJ I-Gene
subunit NN I-Gene
, , O
as RB O
well RB O
as IN O
wortmannin NN O
treatment NN O
inhibited VBD O
insulin JJ B-Gene
- : O
stimulated VBN O
but CC O
not RB O
G NNP B-Gene
( ( I-Gene
q NN I-Gene
) ) I-Gene
/ NN I-Gene
Q209L NNP I-Gene
- : O
stimulated VBD O
GLUT4 NNP B-Gene
- : O
EGFP NNP B-Gene
translocation NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
characterization NN O
of IN O
an DT O
alternatively RB O
processed JJ O
form NN O
of IN O
AFAP NNP B-Gene
- : I-Gene
110 CD I-Gene
that WDT O
encodes VBZ O
an DT O
additional JJ O
258 CD O
base NN O
pair NN O
( ( O
bp NN O
) ) O
of IN O
open JJ O
reading NN O
frame NN O
. . O

Incidental JJ O
findings NNS O
in IN O
the DT O
epidermis NN O
and CC O
in IN O
the DT O
intraepidermal JJ O
eccrine NN O
sweat NN O
duct NN O
units NNS O
. . O

Recently RB O
, , O
the DT O
3 CD B-Gene
. . I-Gene
6 CD I-Gene
- : I-Gene
kb NN I-Gene
full JJ I-Gene
- : I-Gene
length NN I-Gene
alpha SYM I-Gene
- : I-Gene
GalNAc NNP I-Gene
cDNA NN I-Gene
sequence NN I-Gene
was VBD O
isolated VBN O
and CC O
found VBN O
to TO O
have VB O
remarkable JJ O
nucleotide NN O
and CC O
predicted VBD O
amino NN O
acid NN O
homology NN O
( ( O
55 CD O
. . O
8 CD O
and CC O
46 CD O
. . O
9 CD O
% NN O
, , O
respectively RB O
) ) O
with IN O
the DT O
human JJ B-Gene
alpha NN I-Gene
- : I-Gene
galactosidase NN I-Gene
A NNP I-Gene
( ( O
alpha JJ B-Gene
- : I-Gene
Gal VB I-Gene
A DT I-Gene
) ) O
cDNA NN O
. . O

This DT O
repression NN O
was VBD O
mediated VBN O
through IN O
binding NN O
to TO O
the DT O
E2 NNP B-Gene
DNA NNP I-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
immediately RB O
upstream JJ O
of IN O
the DT O
P105 NNP B-Gene
promoter NN O
TATA NNP O
box NN O
and CC O
could MD O
be VB O
abrogated VBN O
by IN O
preincubation NN O
of IN O
the DT O
HPV NNP B-Gene
- : I-Gene
18 CD I-Gene
P105 NNP I-Gene
promoter NN I-Gene
template NN O
with IN O
the DT O
nuclear JJ O
extract NN O
allowing VBG O
the DT O
formation NN O
of IN O
the DT O
preinitiation NN O
complex NN O
. . O

Modulation NN O
of IN O
25 CD B-Gene
- : I-Gene
hydroxyvitamin NN I-Gene
D3 NNP I-Gene
- : I-Gene
24 CD I-Gene
- : I-Gene
hydroxylase NN I-Gene
by IN O
aminophylline NN O
: : O
a DT O
cytochrome NN B-Gene
P NNP I-Gene
- : I-Gene
450 CD I-Gene
monooxygenase NN I-Gene
system NN O
. . O

One CD O
of IN O
these DT O
factors NNS O
, , O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
was VBD O
initially RB O
cloned VBN O
as IN O
an DT O
antagonistic JJ O
counterpart NN O
to TO O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
with IN O
oncogenic JJ O
potential NN O
. . O

Finally RB O
, , O
we PRP O
determined VBD O
the DT O
genomic JJ O
organization NN O
of IN O
the DT O
human JJ B-Gene
TrxR2 NNP I-Gene
gene NN I-Gene
, , O
which WDT O
consists VBZ O
of IN O
18 CD O
exons NNS O
spanning VBG O
about IN O
67 CD O
kb NNS O
, , O
and CC O
its PRP$ O
chromosomal JJ O
localization NN O
at IN O
position NN O
22q11 CD O
. . O
2 CD O
. . O

In IN O
conclusion NN O
, , O
to TO O
study VB O
and CC O
overcome VB O
TI NNP O
region NN O
- : O
based VBN O
expression NN O
problems NNS O
it PRP O
is VBZ O
worthwhile JJ O
to TO O
start VB O
out RP O
with IN O
a DT O
versatile JJ O
vector NN O
containing VBG O
exhaustive JJ O
mutations NNS O
in IN O
the DT O
periShine NN O
- : O
Dalgarno NNP O
sequences NNS O
; : O
as IN O
a DT O
rule NN O
the DT O
coding NN O
MTI NNP O
subregion NN O
can MD O
be VB O
kept VBN O
unchanged JJ O
. . O

Electromagnetic JJ O
blood NN O
flow NN O
( ( O
BF NNP O
) ) O
probe NN O
was VBD O
applied VBN O
on IN O
the DT O
left NN O
anterior JJ O
descending VBG O
artery NN O
( ( O
LAD NNP O
) ) O
. . O

DESIGN NN O
: : O
A DT O
retrospective JJ O
chart NN O
review NN O
of IN O
9 CD O
, , O
322 CD O
patients NNS O
undergoing JJ O
surgical JJ O
procedures NNS O
in IN O
the DT O
period NN O
January NNP O
1993 CD O
to TO O
December NNP O
1998 CD O
. . O

This DT O
locus NN O
maps VBZ O
approximately RB O
160 CD O
kbp NNS O
from IN O
the DT O
genes NNS O
encoding VBG O
cytadherence NN O
- : O
associated JJ O
proteins NNS O
HMW1 NNP B-Gene
and CC O
HMW3 NNP B-Gene
, , O
and CC O
yet RB O
insertions NNS O
therein VBP O
result NN O
in IN O
loss NN O
of IN O
these DT O
proteins NNS O
and CC O
a DT O
hemadsorption NN O
- : O
negative JJ O
( ( O
HA NNP O
- : O
) ) O
phenotype NN O
, , O
prompting VBG O
the DT O
designation NN O
cytadherence NN B-Gene
- : I-Gene
regulatory JJ I-Gene
locus NN I-Gene
( ( O
crl NN B-Gene
) ) O
. . O

Value NNP O
of IN O
determination NN O
of IN O
alkaline JJ B-Gene
phosphatase NN I-Gene
isoenzymes NNS I-Gene
for IN O
differential JJ O
diagnosis NN O
of IN O
obstructive JJ O
jaundice NN O
and CC O
biliary JJ O
liver NN O
cirrhosis NN O

There EX O
was VBD O
however RB O
, , O
no DT O
significant JJ O
difference NN O
in IN O
the DT O
prevalence NN O
of IN O
chronic JJ O
respiratory NN O
symptoms NNS O
between IN O
animal JJ O
food NN O
workers NNS O
with IN O
positive JJ O
and CC O
negative JJ O
skin NN O
tests NNS O
to TO O
house NN O
dust NN O
or CC O
to TO O
fish VB O
flour NNS O
or CC O
among IN O
those DT O
with IN O
increased JJ O
or CC O
normal JJ O
IgE NNP B-Gene
( ( O
except IN O
for IN O
dyspnea NN O
) ) O
. . O

The DT O
CANNTG NNP O
motifs NNS O
were VBD O
found VBN O
to TO O
bind VB O
MyoD NNP B-Gene
and CC O
myogenin JJ B-Gene
fusion NN I-Gene
proteins NNS I-Gene
and CC O
to TO O
interact VB O
with IN O
proteins NNS O
in IN O
nuclear JJ O
extracts NNS O
from IN O
cultured VBN O
myotubes NNS O
. . O

The DT O
bZP2 NN B-Gene
cDNA NN I-Gene
( ( I-Gene
115 CD I-Gene
- : I-Gene
1914 CD I-Gene
nt NN I-Gene
, , I-Gene
1 CD I-Gene
. . I-Gene
8 CD I-Gene
kb NN I-Gene
) ) I-Gene
, , O
excluding VBG O
sequences NNS O
coding VBG O
for IN O
N NNP O
- : O
terminal JJ O
signal JJ O
sequence NN O
and CC O
C NNP O
- : O
terminal NN O
transmembranelike NN O
domain NN O
, , O
was VBD O
PCR NNP O
amplified VBD O
and CC O
Sac1 NNP B-Gene
- : O
Sal1 NNP B-Gene
restricted VBD O
fragment NN O
cloned VBN O
in IN O
frame JJ O
downstream NN O
of IN O
the DT O
T5 NNP O
promoter NN O
under IN O
the DT O
lac NN B-Gene
operator NN I-Gene
control NN O
in IN O
a DT O
pQE NN O
- : O
30 CD O
vector NN O
. . O

Angiotensin NNP B-Gene
converting VBG I-Gene
enzyme JJ I-Gene
inhibitors NNS O
enhance VBP O
the DT O
antihypertensive JJ O
efficacy NN O
of IN O
diuretics NNS O
and CC O
blunt NN O
or CC O
prevent NN O
adverse JJ O
metabolic JJ O
effects NNS O
. . O

We PRP O
have VBP O
earlier JJR O
evolved VBN O
an DT O
experimental JJ O
model NN O
by IN O
means NNS O
of IN O
which WDT O
changes VBZ O
identical JJ O
to TO O
the DT O
microembolism NN O
syndrome NN O
can MD O
be VB O
induced VBN O
from IN O
a DT O
reproducible JJ O
musculo NN O
- : O
skeletal JJ O
trauma NN O
in IN O
pigs NNS O
observed VBN O
under IN O
long JJ O
- : O
term NN O
anesthesia NN O
under IN O
standardized JJ O
conditions NNS O
. . O

By IN O
using VBG O
lambda JJ O
gt11 JJ O
expression NN O
cloning VBG O
with IN O
oligonucleotides NNS O
corresponding VBG O
to TO O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
1 CD O
TATA NNP O
element NN O
, , O
we PRP O
report VBP O
the DT O
identification NN O
of IN O
a DT O
cellular JJ O
protein NN O
with IN O
a DT O
calculated JJ O
molecular JJ O
mass NN O
of IN O
123 CD O
kDa NNS O
that IN O
we PRP O
designate VBP O
TATA NNP B-Gene
element NN I-Gene
modulatory NN I-Gene
factor NN I-Gene
( ( O
TMF NNP B-Gene
) ) O
. . O

Position NNP O
- : O
independent JJ O
expression NN O
of IN O
a DT O
human JJ O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
- : O
luciferase NN B-Gene
reporter NN O
gene NN O
cloned VBN O
on IN O
a DT O
yeast JJ O
artificial JJ O
chromosome NN O
vector NN O
. . O

Antibodies NNS O
raised VBN O
against IN O
a DT O
bacterially RB O
produced VBN O
beta NN B-Gene
gal SYM I-Gene
- : O
trk NN B-Gene
receptor NN O
kinase NN O
fusion NN O
protein NN O
recognized VBD O
a DT O
44 CD O
kd NN O
phosphoprotein NN O
phosphorylated VBD O
on IN O
serine NN O
, , O
threonine NN O
and CC O
tyrosine NN O
in IN O
extracts NNS O
of IN O
trk JJ B-Gene
- : I-Gene
2h CD I-Gene
transformed VBD O
NIH3T3 NNP O
cells NNS O
. . O

Inhibition NN O
of IN O
the DT O
Mek NNP B-Gene
/ NNP O
Erk NNP B-Gene
pathway NN O
in IN O
Rat1 NNP O
/ NNP O
ras NN B-Gene
cells NNS O
, , O
using VBG O
the DT O
Mek NNP B-Gene
inhibitor NN O
, , O
PD98059 NNP O
, , O
resulted VBD O
in IN O
complete JJ O
cytoskeletal JJ O
recovery NN O
, , O
indistinguishable JJ O
from IN O
that DT O
induced VBN O
by IN O
HR12 NNP O
. . O

To TO O
define VB O
transcriptional JJ O
control NN O
elements VBZ O
responsible JJ O
for IN O
muscle NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
human JJ B-Gene
myoglobin NN I-Gene
gene NN I-Gene
, , O
we PRP O
performed VBD O
mutational JJ O
analysis NN O
of IN O
upstream JJ O
sequences NNS O
( ( O
nucleotide JJ O
positions NNS O
- : O
373 CD O
to TO O
+ VB O
7 CD O
relative JJ O
to TO O
the DT O
transcriptional JJ O
start NN O
site NN O
) ) O
linked VBD O
to TO O
a DT O
firefly JJ B-Gene
luciferase NN I-Gene
gene NN I-Gene
. . O

Determinants NNS O
of IN O
recurrent NN O
ischaemia NN O
and CC O
revascularisation NN O
procedures NNS O
after IN O
thrombolysis NN O
with IN O
recombinant JJ O
tissue NN B-Gene
plasminogen NN I-Gene
activator NN I-Gene
in IN O
primary JJ O
coronary JJ O
occlusion NN O
. . O

The DT O
recovery NN O
value NN O
of IN O
systolic JJ O
pressure NN O
was VBD O
higher JJR O
than IN O
diastolic JJ O
pressure NN O
and CC O
pulse JJ O
pressure NN O
increased VBD O
. . O

These DT O
issues NNS O
include VBP O
the DT O
use NN O
of IN O
LMWHs NNP O
in IN O
patients NNS O
with IN O
arterial JJ O
thrombosis NN O
or CC O
myocardial JJ O
infarction NN O
( ( O
e NN O
. . O
g NN O
. . O
in IN O
conjunction NN O
with IN O
thrombolytic JJ O
treatment NN O
) ) O
, , O
and CC O
in IN O
patients NNS O
with IN O
pulmonary JJ O
embolism NN O
. . O

In IN O
the DT O
current JJ O
study NN O
, , O
the DT O
roles NNS O
of IN O
two CD O
putative JJ O
cis NNS O
- : O
acting VBG O
elements NNS O
within IN O
the DT O
- : O
73 CD O
to TO O
+ VB O
44 CD O
region NN O
in IN O
basal NN O
exon VBP O
2 CD O
promoter NN O
activity NN O
were VBD O
evaluated VBN O
using VBG O
mutagenesis NN O
and CC O
nuclear JJ O
protein NN O
- : O
DNA NN O
binding NN O
assays NNS O
. . O

In IN O
the DT O
ileum NN O
, , O
enterotoxin NN O
increased VBD O
the DT O
luminal JJ O
disappearance NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
and CC O
peripheral JJ O
blood NN O
appearance NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
of IN O
chloroquine NN O
. . O

The DT O
elements NNS O
responsible JJ O
for IN O
glucocorticoid JJ O
stimulation NN O
of IN O
ADH NNP B-Gene
gene NN I-Gene
transcription NN O
appear VBP O
to TO O
reside VB O
outside IN O
of IN O
this DT O
region NN O
. . O

The DT O
mean JJ O
day NN O
of IN O
diagnosis NN O
of IN O
periventricular JJ O
echodensities NNS O
was VBD O
3 CD O
+ JJ O
/ NNP O
- : O
2 CD O
days NNS O
( ( O
range NN O
1 CD O
- : O
11 CD O
days NNS O
) ) O
, , O
and CC O
of IN O
cystic JJ O
PVL NNP O
21 CD O
+ NNP O
/ NNP O
- : O
8 CD O
days NNS O
( ( O
range NN O
2 CD O
- : O
47 CD O
days NNS O
) ) O
. . O

Inactivation NN O
of IN O
MAP NNP B-Gene
kinases VBZ I-Gene
occurs VBZ O
via IN O
a DT O
specific JJ O
phosphatase NN O
, , O
MKP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Development NNP O
of IN O
basophilic JJ O
leukemia NN O
with IN O
trisomy JJ O
8 CD O
and CC O
atypical JJ O
erythroblastosis NN O
in IN O
a DT O
patient NN O
with IN O
a DT O
history NN O
of IN O
aplastic JJ O
anemia NN O
22 CD O
years NNS O
earlier RBR O

cDNA NN O
and CC O
structural JJ O
organization NN O
of IN O
the DT O
gene NN B-Gene
Pole1 NNP I-Gene
for IN O
the DT O
mouse NN B-Gene
DNA NNP I-Gene
polymerase NN I-Gene
epsilon NN I-Gene
catalytic JJ I-Gene
subunit NN I-Gene
. . O

In IN O
addition NN O
, , O
anti SYM B-Gene
- : I-Gene
phosphotyrosine NN I-Gene
antibodies NNS I-Gene
immunoprecipitated VBD O
80K CD B-Gene
- : I-Gene
H NN I-Gene
from IN O
cell NN O
lysates NNS O
of IN O
FGF NNP B-Gene
- : O
stimulated VBD O
but CC O
not RB O
from IN O
control NN O
fibroblasts NNS O
. . O

The DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
Glc7 NNP B-Gene
phosphatase NN I-Gene
and CC O
its PRP$ O
Gac1 NNP B-Gene
regulatory JJ O
subunit NN O
play NN O
positive JJ O
roles NNS O
in IN O
HSF NNP B-Gene
activation NN O
of IN O
CUP1 NNP B-Gene
transcription NN O
. . O

The DT O
core NN B-Gene
enzyme NN I-Gene
is VBZ O
homologous JJ O
to TO O
those DT O
of IN O
bacteriophages NNS O
T3 NNP O
, , O
T7 NNP O
and CC O
SP6 NNP O
whereas VBP O
the DT O
specificity NN O
factor NN O
shows VBZ O
similarities NNS O
with IN O
bacterial JJ B-Gene
sigma NN I-Gene
factors NNS I-Gene
. . O

ZIOS NNP O
was VBD O
significantly RB O
more RBR O
sensitive JJ O
than IN O
all DT O
subsequent JJ O
methods NNS O
, , O
and CC O
Ptc NNP O
, , O
O2 NNP O
was VBD O
significantly RB O
more RBR O
sensitive JJ O
than IN O
FEV1 NNP O
. . O

The DT O
factor NN O
which WDT O
binds VBZ O
to TO O
the DT O
TR NNP B-Gene
promoter NN I-Gene
co NN O
- : O
sedimented VBN O
with IN O
SV40 NNP O
chromosomes NNS O
extracted VBD O
late JJ O
in IN O
infection NN O
. . O

These DT O
results NNS O
with IN O
clozapine JJ O
illustrate NN O
that IN O
LI NNP O
is VBZ O
sensitive JJ O
to TO O
antipsychotics NNS O
which WDT O
differ VBP O
in IN O
their PRP$ O
mode NN O
of IN O
action NN O
and CC O
furthermore RB O
emphasize VB O
the DT O
value NN O
of IN O
LI NNP O
as IN O
a DT O
test NN O
model NN O
for IN O
detecting VBG O
the DT O
antipsychotic JJ O
potential NN O
of IN O
novel JJ O
drugs NNS O
. . O

Urinary JJ O
urate JJ O
excretion NN O
, , O
urate JJ O
clearance NN O
, , O
and CC O
fractional JJ O
excretion NN O
of IN O
urate JJ O
all DT O
increased VBN O
significantly RB O
during IN O
water NN O
immersion NN O
, , O
and CC O
decreased VBN O
in IN O
the DT O
hour NN O
following VBG O
water NN O
immersion NN O
. . O

Growth NNP O
factors NNS O
induce VBP O
the DT O
expression NN O
of IN O
the DT O
immediate JJ B-Gene
early JJ I-Gene
gene NN I-Gene
products NNS I-Gene
MAP NNP B-Gene
kinase NN I-Gene
phosphatase NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
MKP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
. . O

The DT O
aims NNS O
of IN O
this DT O
study NN O
were VBD O
to TO O
determine VB O
and CC O
rank VB O
the DT O
frequency NN O
of IN O
self NN O
reported VBN O
visual JJ O
disability NN O
in IN O
daily JJ O
tasks NNS O
performed VBN O
by IN O
glaucoma NN O
patients NNS O
; : O
to TO O
examine VB O
the DT O
interrelation NN O
between IN O
disabilities NNS O
using VBG O
factor NN O
analysis NN O
; : O
to TO O
study VB O
the DT O
relation NN O
between IN O
perceived VBN O
visual JJ O
difficulty NN O
and CC O
a DT O
measure NN O
of IN O
the DT O
severity NN O
of IN O
visual JJ O
field NN O
loss NN O
; : O
to TO O
develop VB O
a DT O
glaucoma NN O
specific JJ O
subgroup NN O
of IN O
questions NNS O
; : O
and CC O
examine VB O
the DT O
validity NN O
and CC O
reliability NN O
of IN O
this DT O
subgroup NN O
of IN O
questions NNS O
. . O

This DT O
report NN O
provides VBZ O
further JJ O
evidence NN O
for IN O
the DT O
riMLF NN O
in IN O
the DT O
control NN O
of IN O
downgaze NN O
, , O
and CC O
a DT O
synkinesis NN O
is VBZ O
postulated VBN O
for IN O
the DT O
development NN O
of IN O
the DT O
convergence NN O
retraction NN O
nystagmus NN O
. . O

Sensing VBG O
with IN O
chemically RB O
and CC O
biologically RB O
modified VBN O
carbon NN O
electrodes NNS O
. . O

All DT O
ABFI NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
regardless RB O
of IN O
origin NN O
, , O
provided VBN O
weak JJ O
UAS NNP O
function NN O
in IN O
vivo NN O
when WRB O
examined VBN O
in IN O
test NN O
plasmids NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
the DT O
protein NN O
is VBZ O
a DT O
murine JJ B-Gene
homologue NN I-Gene
of IN I-Gene
SAF NNP I-Gene
- : I-Gene
A DT I-Gene
which WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
bind VB O
selectively RB O
to TO O
MARs NNP O
and CC O
is VBZ O
responsible JJ O
for IN O
the DT O
satMa NN B-Gene
- : O
binding NN O
activity NN O
in IN O
the DT O
chromatographic JJ O
fractions NNS O
. . O

31 CD O
, , O
1997 CD O
, , O
40 CD O
patients NNS O
had VBD O
died VBN O
( ( O
35 CD O
in IN O
the DT O
ERA NNP O
- : O
II NNP O
group NN O
and CC O
5 CD O
in IN O
the DT O
ERA NNP O
- : O
III NNP O
group NN O
) ) O
, , O
for IN O
a DT O
crude JJ O
mortality NN O
rate NN O
of IN O
8 CD O
. . O
0 CD O
% NN O
. . O

There EX O
was VBD O
no DT O
significant JJ O
correlation NN O
between IN O
baseline NN O
PC40 NNP O
methacholine NN O
and CC O
the DT O
maximal JJ O
fall NN O
in IN O
Vp30 NNP O
after IN O
either CC O
the DT O
first JJ O
( ( O
12 CD O
micrograms NNS O
) ) O
or CC O
the DT O
second JJ O
dose NN O
( ( O
24 CD O
micrograms NNS O
) ) O
of IN O
platelet NN B-Gene
activating VBG I-Gene
factor NN I-Gene
. . O

Retrospective JJ O
analyses NNS O
of IN O
this DT O
death NN O
revealed VBD O
a DT O
significant JJ O
decrease NN O
of IN O
the DT O
left NN O
ventricular NN O
( ( O
LV NNP O
) ) O
end VBP O
- : O
diastolic JJ O
volume NN O
index NN O
( ( O
EDVI NNP O
) ) O
of IN O
21 CD O
ml NNS O
/ JJ O
m2 NN O
( ( O
36 CD O
% NN O
of IN O
normal JJ O
) ) O
. . O

The DT O
structure NN O
of IN O
the DT O
free JJ O
SH2 NNP B-Gene
domain NN I-Gene
has VBZ O
been VBN O
compared VBN O
to TO O
that DT O
of IN O
the DT O
SH2 NNP B-Gene
complexed NN O
with IN O
a DT O
doubly RB O
phosphorylated VBN O
peptide RB O
derived VBN O
from IN O
polyomavirus NN B-Gene
middle JJ I-Gene
T NNP I-Gene
antigen NN I-Gene
( ( O
MT NNP B-Gene
) ) O
. . O

METHODS NN O
: : O
Millipore NNP O
ultrafiltration NN O
membranes NNS O
of IN O
three CD O
different JJ O
pore RB O
sizes NNS O
were VBD O
used VBN O
as IN O
model NN O
lenticule NN O
materials NNS O
. . O
The DT O
nominal JJ O
membrane NN O
pore NN O
sizes NNS O
were VBD O
0 CD O
. . O
1 CD O
microm NN O
, , O
0 CD O
. . O
45 CD O
microm NN O
, , O
and CC O
3 CD O
microm NN O
; : O
the DT O
surface NN O
roughness NN O
increased VBD O
in IN O
the DT O
same JJ O
order NN O
The DT O
membranes NNS O
were VBD O
coated VBN O
with IN O
a DT O
thin JJ O
layer NN O
of IN O
collagen NN B-Gene
I PRP I-Gene
and CC O
implanted VBN O
in IN O
a DT O
circular JJ O
pocket NN O
of IN O
the DT O
anterior JJ O
cornea NN O
of IN O
adult NN O
cats NNS O
, , O
and CC O
were VBD O
clinically RB O
evaluated VBN O
for IN O
the DT O
extent NN O
of IN O
epithelialization NN O
and CC O
the DT O
persistence NN O
of IN O
epithelial JJ O
attachment NN O
. . O

We PRP O
suggest VBP O
that IN O
the DT O
ER NNP O
lumenal JJ O
variable JJ O
domain NN O
of IN O
gp19K NN B-Gene
has VBZ O
a DT O
specific JJ O
tertiary JJ O
structure NN O
that WDT O
is VBZ O
important JJ O
for IN O
binding VBG O
to TO O
the DT O
polymorphic JJ O
alpha NN O
1 CD O
and CC O
alpha $ O
2 CD O
domains NNS O
of IN O
class NN B-Gene
I PRP I-Gene
heavy VBP I-Gene
( ( I-Gene
alpha JJ I-Gene
) ) I-Gene
chains NNS I-Gene
. . O

Whereas NNP O
p82 NN B-Gene
expression NN O
had VBD O
no DT O
effect NN O
on IN O
ERK2 NNP B-Gene
activation NN O
by IN O
p126 NN B-Gene
, , O
p70 NN B-Gene
completely RB O
abrogated VBD O
this DT O
activity NN O
. . O

However RB O
, , O
despite IN O
its PRP$ O
relationship NN O
to TO O
the DT O
TR NNP B-Gene
, , O
Rev NNP B-Gene
- : O
Erb NNP B-Gene
bound VBD O
poorly RB O
to TO O
TR NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
. . O

To TO O
isolate VB O
this DT O
gene NN O
, , O
a DT O
P NNP O
- : O
1 CD O
artificial JJ O
chromosome NN O
( ( O
PAC NNP O
) ) O
library NN O
was VBD O
screened VBN O
with IN O
a DT O
full JJ B-Gene
length NN I-Gene
UGT2B7 NNP I-Gene
probe NN O
and CC O
a DT O
clone NN O
of IN O
approximately RB O
100 CD O
kb NNS O
in IN O
length NN O
was VBD O
isolated VBN O
. . O

"""" JJ O
Let VB O
the DT O
hundred JJ O
flowers NNS O
bloom VBP O
"""" NN O
. . O

Transgenic NNP O
tobacco NN O
plants NNS O
( ( O
ppa VB B-Gene
- : I-Gene
1 CD I-Gene
) ) O
constitutively RB O
expressing VBG O
Escherichia NNP B-Gene
coli NN I-Gene
pyrophosphatase NN I-Gene
behind IN O
the DT O
35S CD B-Gene
CaMV NNP I-Gene
promoter NN I-Gene
accumulate VBP O
high JJ O
levels NNS O
of IN O
soluble JJ O
sugars NNS O
in IN O
their PRP$ O
leaves NNS O
[ VBP O
27 CD O
] NN O
. . O

Among IN O
the DT O
remaining VBG O
22 CD O
sites NNS O
, , O
six CD O
are VBP O
in IN O
the DT O
promoters NNS O
of IN O
known VBN O
alpha NN O
- : O
specific JJ O
genes NNS O
and CC O
two CD O
other JJ O
sites NNS O
have VBP O
an DT O
alpha2 JJ B-Gene
- : O
Mcm1 NNP B-Gene
- : O
dependent JJ O
role NN O
in IN O
determining VBG O
the DT O
direction NN O
of IN O
mating VBG O
type NN O
switching NN O
. . O

Cataract JJ O
extraction NN O
in IN O
primary JJ O
glaucoma NN O

Azygos NNP O
vein NN O
abutting VBG O
the DT O
posterior JJ O
wall NN O
of IN O
the DT O
right NN O
main JJ O
and CC O
upper JJ O
lobe NN O
bronchi NN O
: : O
a DT O
normal JJ O
CT NNP O
variant NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
inducible JJ O
expression NN O
of IN O
the DT O
flt JJ B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
during IN O
the DT O
activation NN O
of IN O
THP NNP O
- : O
1 CD O
cells NNS O
. . O

Moreover RB O
, , O
the DT O
Rho NNP B-Gene
family NN I-Gene
protein NN I-Gene
Cdc42 NNP B-Gene
, , O
a DT O
conserved VBN O
morphogenetic JJ B-Gene
G NNP I-Gene
protein NN I-Gene
, , O
is VBZ O
also RB O
a DT O
potent JJ O
regulator NN O
of IN O
filamentous JJ O
growth NN O
and CC O
FG NNP B-Gene
( ( O
TyA NNP B-Gene
) ) O
: : O
: : O
lacZ NN B-Gene
expression NN O
in IN O
S NNP O
. . O
cerevisiae NN O
. . O

In IN O
support NN O
of IN O
a DT O
role NN O
at IN O
the DT O
spindle NN O
, , O
two CD O
- : O
hybrid JJ O
library JJ O
screening NN O
with IN O
HEF1 NNP B-Gene
identifies VBZ O
the DT O
human JJ O
homolog NN O
of IN O
the DT O
G2 NNP B-Gene
/ NNP I-Gene
M NNP I-Gene
spindle JJ I-Gene
- : I-Gene
regulatory JJ I-Gene
protein NN I-Gene
Dim1p NNP I-Gene
as IN O
a DT O
specific JJ O
interactor NN O
with IN O
a DT O
region NN O
of IN O
HEF1 NNP B-Gene
encompassed VBD O
in IN O
p55 NN B-Gene
( ( O
HEF1 NNP B-Gene
) ) O
. . O

At IN O
visit NN O
5 CD O
, , O
the DT O
isokinetic JJ O
test NN O
showed VBD O
impaired JJ O
muscle NN O
function NN O
recovery NN O
from IN O
23 CD O
% NN O
to TO O
32 CD O
% NN O
, , O
while IN O
the DT O
manual JJ O
test NN O
showed VBD O
almost RB O
full JJ O
recovery NN O
. . O

We PRP O
also RB O
found VBD O
that IN O
the DT O
same JJ O
males NNS O
, , O
breeding VBG O
in IN O
different JJ O
years NNS O
on IN O
the DT O
same JJ O
territories NNS O
, , O
had VBD O
significantly RB O
larger JJR O
harems NNS O
in IN O
the DT O
years NNS O
they PRP O
had VBD O
familiar JJ O
neighbors NNS O
. . O

Enzyme NNP B-Gene
I PRP I-Gene
of IN O
the DT O
phosphoenolpyruvate NN B-Gene
: : I-Gene
sugar NN I-Gene
phosphotransferase NN I-Gene
system NN O
. . O

A DT O
total NN O
of IN O
125 CD O
acute JJ O
leukemia NN O
adult NN O
patients NNS O
were VBD O
autografted VBN O
with IN O
bone NN O
marrow NN O
( ( O
BM NNP O
) ) O
purged VBN O
by IN O
mafosfamide NN O
( ( O
ASTA NNP O
Z NNP O
) ) O
during IN O
the DT O
period NN O
of IN O
January NNP O
1983 CD O
to TO O
January NNP O
1993 CD O
. . O

The DT O
high JJ O
density NN O
of IN O
tegumental JJ O
spines NNS O
on IN O
posterior JJ O
half NN O
of IN O
the DT O
body NN O
and CC O
the DT O
distribution NN O
of IN O
type NN O
II NNP O
papillae NN O
on IN O
dorsal NN O
surface NN O
are VBP O
considered VBN O
to TO O
be VB O
characteristic JJ O
of IN O
C NNP O
. . O
armatus NN O
. . O

Logistic JJ O
regression NN O
analysis NN O
revealed VBD O
that IN O
physicians NNS O
were VBD O
3 CD O
. . O
6 CD O
times NNS O
more RBR O
likely JJ O
to TO O
detect VB O
thin JJ O
lesions NNS O
( ( O
< JJ O
/ NNP O
= NNP O
0 CD O
. . O
75 CD O
mm NN O
) ) O
compared VBN O
with IN O
nonphysician JJ O
detectors NNS O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
[ VBD O
95 CD O
% NN O
CI NNP O
] NNP O
, , O
2 CD O
. . O
1 CD O
, , O
6 CD O
. . O
5 CD O
; : O
P NNP O
= VBD O
0 CD O
. . O
1 CD O
) ) O
. . O

Sp1 NNP B-Gene
' POS O
s JJ O
role NN O
in IN O
transactivation NN O
of IN O
the DT O
pgp2 NN B-Gene
/ NNP O
mdr1b NN B-Gene
promoter NN O
was VBD O
tested VBN O
in IN O
Drosophila NNP O
Schneider NNP O
cells NNS O
. . O

A DT O
protocol NN O
is VBZ O
elaborated VBN O
for IN O
the DT O
preparation NN O
and CC O
characterization NN O
of IN O
a DT O
quality NN O
control NN O
material NN O
( ( O
QCM NNP O
) ) O
containing VBG O
intrinsic JJ O
concentration NN O
of IN O
cadmium NN O
( ( O
Cd NNP O
) ) O
( ( O
0 CD O
. . O
8 CD O
microgram JJ O
/ NNP O
L NNP O
) ) O
and CC O
lead JJ O
( ( O
Pb NNP O
) ) O
( ( O
13 CD O
. . O
4 CD O
micrograms NNS O
/ NNP O
dL NN O
) ) O
from IN O
bovine NN O
blood NN O
and CC O
an DT O
elevated JJ O
QCM NNP O
containing VBG O
Cd NNP O
( ( O
5 CD O
. . O
0 CD O
micrograms NNS O
/ NNP O
L NNP O
) ) O
, , O
mercury NN O
( ( O
Hg NNP O
) ) O
( ( O
11 CD O
. . O
2 CD O
micrograms NNS O
/ NNP O
L NNP O
) ) O
, , O
and CC O
Pb NNP O
( ( O
34 CD O
. . O
5 CD O
micrograms NNS O
/ NNP O
dL NN O
) ) O
from IN O
bovine NN O
blood NN O
spiked VBN O
with IN O
aqueous JJ O
spiking VBG O
- : O
solutions NNS O
prepared VBN O
with IN O
salts NNS O
of IN O
Cd NNP O
, , O
Hg NNP O
, , O
and CC O
Pb NNP O
. . O

On IN O
histologic JJ O
examination NN O
the DT O
cuboidal JJ O
epithelium NN O
of IN O
the DT O
mucous JJ O
membrane NN O
was VBD O
found VBN O
to TO O
be VB O
changed VBN O
into IN O
columnar NN O
epithelium NN O
, , O
with IN O
uneven JJ O
distribution NN O
of IN O
enlarged JJ O
nuclei NN O
in IN O
the DT O
vacuolized JJ O
cytoplasm NN O
. . O

High JJ O
- : O
affinity NN O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
1 CD I-Gene
to TO O
PSE NNP B-Gene
- : I-Gene
B NN I-Gene
, , O
but CC O
not RB O
to TO O
PSE NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
was VBD O
confirmed VBN O
by IN O
competition NN O
of IN O
DNA NNP O
- : O
protein NN O
interactions NNS O
by IN O
using VBG O
NF NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NN O
elements NNS O
and CC O
antibodies NNS O
. . O

The DT O
contribution NN O
of IN O
skin NN O
flow NN O
to TO O
the DT O
changes NNS O
in IN O
760 CD O
- : O
800 CD O
nm JJ O
absorption NN O
was VBD O
investigated VBN O
by IN O
simultaneous JJ O
measurement NN O
of IN O
skin NN O
flow NN O
by IN O
laser NN O
flow NN O
Doppler NNP O
and CC O
NIR NNP O
recordings NNS O
during IN O
hot JJ O
water NN O
immersion NN O
. . O

However RB O
, , O
no DT O
studies NNS O
have VBP O
been VBN O
conducted VBN O
to TO O
further RBR O
investigate VB O
this DT O
potentially RB O
hazardous JJ O
effect NN O
of IN O
lidocaine NN O
. . O

Compensatory NNP O
renal JJ O
hypertrophy NN O
in IN O
parabiotic JJ O
rats NNS O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
third JJ O
SH3 NNP B-Gene
domain NN I-Gene
binds NNS O
to TO O
Sos NNP B-Gene
, , O
a DT O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factor NN I-Gene
for IN O
Ras NNP B-Gene
and CC O
Rac NNP B-Gene
, , O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Mechanistically RB O
, , O
the DT O
presence NN O
of IN O
the DT O
GRR NNP O
appears VBZ O
to TO O
stop VB O
further JJ O
degradation NN O
of IN O
p50 NN B-Gene
and CC O
to TO O
stabilize VB O
the DT O
molecule NN O
. . O

Menstrual JJ O
- : O
cycle NN O
phase NN O
did VBD O
not RB O
significantly RB O
affect JJ O
personality NN O
variables NNS O
in IN O
either DT O
group NN O
. . O

Mutation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
site NN I-Gene
in IN O
the DT O
Mdr1b NNP B-Gene
promoter NN I-Gene
prevents VBZ O
its PRP$ O
induction NN O
by IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
. . O

Immunofluorescence NNP O
microscopy NN O
and CC O
cell NN O
fractionation NN O
analyses VBZ O
showed VBD O
that IN O
the DT O
110 CD O
- : O
kDa NN O
protein NN O
was VBD O
exclusively RB O
nuclear JJ O
, , O
whereas IN O
the DT O
150 CD O
- : O
kDa NN O
protein NN O
was VBD O
present JJ O
in IN O
both DT O
the DT O
cytoplasm NN O
and CC O
nucleus NN O
of IN O
human JJ O
cells NNS O
. . O

Method NNP O
of IN O
synthesis NN O
of IN O
the DT O
rheumatoid JJ B-Gene
factor NN I-Gene
in IN O
clinico NN O
- : O
immunological JJ O
studies NNS O

The DT O
FAS NNP B-Gene
promoter NN I-Gene
was VBD O
up RB O
- : O
regulated VBN O
by IN O
insulin NN B-Gene
through IN O
the DT O
proximal JJ O
insulin NN B-Gene
response NN I-Gene
sequence NN I-Gene
containing VBG O
an DT O
E NNP O
- : O
box NN O
motif NN O
at IN O
the DT O
- : O
65 CD O
- : O
base NN O
pair NN O
position NN O
. . O

Deletion NN O
of IN O
the DT O
POR2 NNP B-Gene
gene NN I-Gene
alone RB O
had VBD O
no DT O
detectable JJ O
phenotype NN O
, , O
while IN O
yeasts NNS O
with IN O
deletions NNS O
of IN O
both DT O
the DT O
POR1 NNP B-Gene
and CC O
POR2 NNP B-Gene
genes NNS I-Gene
were VBD O
viable JJ O
and CC O
able JJ O
to TO O
grow VB O
on IN O
glycerol NN O
at IN O
30 CD O
degrees NNS O
C NNP O
, , O
albeit IN O
more RBR O
slowly RB O
than IN O
delta JJ B-Gene
por1 NN I-Gene
single JJ I-Gene
mutants NNS I-Gene
. . O

The DT O
appearance NN O
of IN O
dyskinetic JJ O
movement NN O
disorders NNS O
in IN O
humans NNS O
following VBG O
the DT O
chronic JJ O
use NN O
of IN O
levodopa NN O
or CC O
amphetamine NN O
may MD O
be VB O
a DT O
manifestation NN O
of IN O
similarly RB O
increased VBN O
dopamine NN B-Gene
receptor NN I-Gene
site NN I-Gene
sensitivity NN O
within IN O
the DT O
striatum NN O
. . O

Similar JJ O
mechanisms NNS O
leading VBG O
to TO O
deregulation NN O
of IN O
Tcf NNP B-Gene
target NN I-Gene
gene NN I-Gene
activity NN O
are VBP O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
melanoma NN O
and CC O
other JJ O
forms NNS O
of IN O
cancer NN O
. . O

Muscular JJ O
pathology NN O

We PRP O
have VBP O
identified VBN O
SWI5 NNP B-Gene
' POS O
s JJ O
nuclear JJ O
localization NN O
signal NN O
( ( O
NLS NNP O
) ) O
and CC O
show VBP O
that IN O
it PRP O
can MD O
confer VB O
cell NN O
cycle NN O
- : O
dependent JJ O
nuclear JJ O
entry NN O
to TO O
a DT O
heterologous JJ O
protein NN O
. . O

The DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
preferentially RB O
infects VBZ O
CD4 NNP B-Gene
+ NNP I-Gene
T NNP O
lymphocytes NNS O
and CC O
may MD O
exist VB O
as IN O
a DT O
latent NN O
provirus NN O
within IN O
these DT O
cells NNS O
for IN O
extended VBN O
periods NNS O
. . O

One CD O
of IN O
these DT O
, , O
an DT O
AACA NNP O
motif NN O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
negative JJ O
regulator NN O
in IN O
non JJ O
- : O
seed NN O
tissues NNS O
and CC O
has VBZ O
a DT O
similarity NN O
to TO O
the DT O
barley NN O
gibberellin NN O
responsive JJ O
element NN O
recognized VBN O
by IN O
MYB NNP B-Gene
- : I-Gene
like IN I-Gene
DNA NNP I-Gene
binding VBG I-Gene
proteins NNS I-Gene
. . O

Pregnant JJ O
rats NNS O
were VBD O
exposed VBN O
to TO O
one CD O
of IN O
the DT O
following NN O
: : O
( ( O
1 CD O
) ) O
10 CD O
% NN O
O2 NNP O
in IN O
N2 NNP O
or CC O
100 CD O
% NN O
O2 NNP O
for IN O
2 CD O
days NNS O
beginning VBG O
at IN O
day NN O
7 CD O
, , O
11 CD O
, , O
14 CD O
, , O
or CC O
18 CD O
of IN O
pregnancy NN O
; : O
( ( O
2 CD O
) ) O
10 CD O
% NN O
O2 NNP O
in IN O
N2 NNP O
or CC O
100 CD O
% NN O
O2 NNP O
for IN O
10 CD O
h JJ O
/ JJ O
day NN O
beginning VBG O
at IN O
day NN O
7 CD O
; : O
or CC O
( ( O
3 CD O
) ) O
14 CD O
- : O
11 CD O
% NN O
O2 NNP O
in IN O
N2 NNP O
continuously RB O
beginning VBG O
at IN O
day NN O
14 CD O
till NN O
day NN O
21 CD O
when WRB O
they PRP O
were VBD O
sacrificed VBN O
. . O

In IN O
reviewing VBG O
a DT O
number NN O
of IN O
the DT O
most RBS O
intensely RB O
studied VBN O
environmentally RB O
inducible JJ O
promoters NNS O
it PRP O
becomes VBZ O
clear JJ O
that IN O
the DT O
presence NN O
of IN O
two CD O
cis SYM O
- : O
acting JJ O
elements NNS O
are VBP O
critical JJ O
for IN O
promoter NN O
activity NN O
, , O
one CD O
of IN O
which WDT O
is VBZ O
the DT O
G NNP O
- : O
box NN O
( ( O
CCACGTGG NNP O
) ) O
. . O

Cleavage NN O
by IN O
the DT O
intron NN O
- : O
encoded VBN O
enzyme NN O
( ( O
I PRP B-Gene
- : I-Gene
CreI NN I-Gene
) ) O
occurs VBZ O
5 CD O
bp NN O
and CC O
1 CD O
bp NN O
3 CD O
' '' O
to TO O
the DT O
intron NN O
insertion NN O
site NN O
( ( O
in IN O
the DT O
3 CD O
' POS O
- : O
exon NN O
) ) O
in IN O
the DT O
top JJ O
( ( O
/ JJ O
) ) O
and CC O
bottom NN O
( ( O
, , O
) ) O
strands VBZ O
, , O
respectively RB O
, , O
resulting VBG O
in IN O
4 CD O
- : O
nt NN O
single JJ O
- : O
stranded VBD O
overhangs NNS O
with IN O
3 CD O
' POS O
- : O
OH NN O
termini NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
dopaminergic JJ O
regulation NN O
of IN O
adrenal JJ O
zona NN O
glomerulosa NN O
corticosteroid NN O
and CC O
renal JJ B-Gene
renin NN I-Gene
secretion NN O
is VBZ O
absent JJ O
in IN O
patients NNS O
with IN O
high JJ O
spinal JJ O
cord NN O
transections NNS O
, , O
suggesting VBG O
that IN O
intact JJ O
neural JJ O
pathways NNS O
from IN O
the DT O
central JJ O
nervous JJ O
system NN O
are VBP O
necessary JJ O
for IN O
metoclopramide JJ O
stimulation NN O
of IN O
aldosterone NN O
and CC O
renin NN B-Gene
secretion NN O
in IN O
men NNS O
. . O

Cattaneo NNP O
, , O
and CC O
J NNP O
. . O

BIM NNP O
130 CD O
. . O

We PRP O
found VBD O
that IN O
the DT O
relative JJ O
strengths NNS O
of IN O
the DT O
promoters NNS O
were VBD O
similar JJ O
in IN O
different JJ O
contexts NN O
. . O

Isopenicillin NNP B-Gene
N NNP I-Gene
isomerase NN I-Gene
( ( O
epimerase NN B-Gene
) ) O
has VBZ O
been VBN O
purified VBN O
from IN O
Streptomyces NNP O
clavuligerus NN O
, , O
and CC O
the DT O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
N NNP O
- : O
terminus NN O
has VBZ O
been VBN O
determined VBN O
. . O

On IN O
an DT O
antithrombin JJ B-Gene
unit NN O
basis NN O
, , O
CY NNP O
216 CD O
and CC O
CY NNP O
222 CD O
were VBD O
equivalent JJ O
and CC O
more RBR O
potent JJ O
than IN O
UH NNP O
. . O

This DT O
intracellular JJ O
signaling NN O
, , O
known VBN O
as IN O
the DT O
unfolded JJ O
protein NN O
response NN O
( ( O
UPR NNP O
) ) O
, , O
is VBZ O
mediated VBN O
by IN O
the DT O
cis NN O
- : O
acting VBG O
ER NNP O
stress NN O
response NN O
element NN O
( ( O
ERSE NNP O
) ) O
in IN O
mammals NNS O
. . O

On IN O
Day NNP O
8 CD O
, , O
the DT O
CIDR NNP O
- : O
B NN O
was VBD O
removed VBN O
and CC O
500 CD O
micrograms NNS O
cloprostenol RB O
injected VBN O
, , O
IM NNP O
. . O

The DT O
exonic JJ O
sequence NN O
encodes VBZ O
a DT O
protein NN O
of IN O
495 CD O
amino NN O
acids NNS O
that WDT O
is VBZ O
nearly RB O
identical JJ O
to TO O
the DT O
previously RB O
reported VBN O
protein JJ O
sequence NN O
of IN O
human JJ B-Gene
GPT NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

BACKGROUND NN O
: : O
The DT O
effectiveness NN O
of IN O
monoamine JJ B-Gene
oxidase NN I-Gene
inhibitors NNS O
( ( O
MAOIs NNP O
) ) O
in IN O
tricyclic JJ O
resistant JJ O
depression NN O
has VBZ O
received VBN O
surprisingly RB O
little JJ O
systematic JJ O
study NN O
. . O

The DT O
inspiratory NN O
oxygen NN O
concentration NN O
needed VBN O
( ( O
FiO2 NNP O
) ) O
and CC O
the DT O
Horowitz NNP O
quotient NN O
differed VBD O
in IN O
a DT O
highly RB O
significant JJ O
manner NN O
beginning VBG O
on IN O
the DT O
1st CD O
day NN O
after IN O
trauma NN O
. . O

No DT O
significant JJ O
differences NNS O
between IN O
the DT O
two CD O
treatment NN O
groups NNS O
were VBD O
found VBN O
, , O
but CC O
rapid JJ O
responders NNS O
had VBD O
a DT O
smaller JJR O
mean JJ O
initial JJ O
platelet NN B-Gene
- : I-Gene
associated VBN I-Gene
IgG NNP I-Gene
index NN O
which WDT O
returned VBD O
more RBR O
rapidly RB O
and CC O
more RBR O
permanently RB O
to TO O
normal JJ O
than IN O
that DT O
of IN O
slow JJ O
responders NNS O
. . O

Further RB O
, , O
we PRP O
show VBP O
that IN O
this DT O
EIA NNP B-Gene
- : O
inducible JJ O
CBF NNP O
/ NNP O
cdc2 NN B-Gene
is VBZ O
related VBN O
to TO O
the DT O
CBF NNP B-Gene
which WDT O
was VBD O
shown VBN O
to TO O
activate VB O
the DT O
heat NN B-Gene
shock NN I-Gene
protein VBD I-Gene
70 CD I-Gene
promoter NN I-Gene
. . O

Vasopressin NNP B-Gene
( ( O
AVP NNP B-Gene
) ) O
, , O
the DT O
antidiuretic JJ O
hormone NN O
, , O
is VBZ O
a DT O
cyclic JJ O
nonapeptide NN O
that WDT O
acts VBZ O
through IN O
binding VBG O
to TO O
G NNP B-Gene
protein NN I-Gene
- : I-Gene
coupled VBN I-Gene
specific JJ I-Gene
membrane NN I-Gene
receptors NNS I-Gene
pharmacologically RB O
divided VBD O
into IN O
three CD O
subtypes NNS O
( ( O
V1a NNP B-Gene
, , O
V1b NNP B-Gene
, , O
and CC O
V2 NNP B-Gene
) ) O
linked VBD O
to TO O
distinct VB O
second JJ O
messengers NNS O
. . O

In IN O
all DT O
trials NNS O
, , O
antigen NN O
challenge NN O
followed VBD O
1 CD O
h NN O
after IN O
the DT O
last JJ O
treatment NN O
. . O

Similarly RB O
, , O
we PRP O
observed VBD O
synthetic JJ O
phenotypes NNS O
between IN O
mutations NNS O
in IN O
MIF2 NNP B-Gene
and CC O
trans VBZ O
- : O
acting VBG O
mutations NNS O
in IN O
three CD O
known VBN O
yeast RB O
centromere JJ O
protein NN O
genes NNS O
- : O
CEP1 NNP B-Gene
/ NNP O
CBF1 NNP B-Gene
/ NNP O
CPF1 NNP B-Gene
, , O
NDC10 NNP B-Gene
/ NNP O
CBF2 NNP B-Gene
, , O
and CC O
CEP3 NNP B-Gene
/ NNP O
CBF3B NNP B-Gene
. . O

Some DT O
of IN O
the DT O
mutations NNS O
obtained VBN O
do VBP O
not RB O
contain VB O
a DT O
copy NN O
of IN O
the DT O
Ulysses NNP B-Gene
element NN I-Gene
at IN O
the DT O
mutant JJ O
locus NN O
, , O
suggesting VBG O
that IN O
a DT O
different JJ O
transposable JJ O
element NN O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
mutation NN O
. . O

There EX O
is VBZ O
growing VBG O
evidence NN O
that IN O
mammalian JJ B-Gene
AMP NNP I-Gene
- : I-Gene
activated VBD I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
AMPK NNP B-Gene
) ) O
plays VBZ O
a DT O
role NN O
in IN O
protecting VBG O
cells NNS O
from IN O
stresses NNS O
that WDT O
cause VBP O
ATP NNP O
depletion NN O
by IN O
switching VBG O
off RP O
ATP NNP O
- : O
consuming VBG O
biosynthetic JJ O
pathways NNS O
. . O

Two CD O
experiments NNS O
( ( O
N NNP O
= RB O
20 CD O
each DT O
) ) O
were VBD O
carried VBN O
out IN O
to TO O
explore VB O
the DT O
nature NN O
of IN O
ERP NNP O
negativities NNS O
in IN O
a DT O
visuospatial JJ O
memory NN O
task NN O
and CC O
in IN O
an DT O
auditory JJ O
spatial JJ O
memory NN O
task NN O
, , O
respectively RB O
. . O

Is VBZ O
desensitization NN O
' '' O
for IN O
ragweed NN O
hay NN O
fever NN O
immunologically RB O
specific JJ O
? . O

An DT O
ELISA NNP O
procedure NN O
was VBD O
developed VBN O
for IN O
monitoring VBG O
the DT O
specific JJ O
IgE NNP B-Gene
response NN O
in IN O
dogs NNS O
to TO O
Dirofilaria NNP O
immitis NN O
infection NN O
. . O

However RB O
, , O
while IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
both DT O
induced JJ O
nuclear JJ O
binding NN O
of IN O
the DT O
Rel NNP B-Gene
proteins VBZ I-Gene
p50 NN B-Gene
and CC O
p65 NN B-Gene
to TO O
an DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
consensus NN I-Gene
oligonucleotide NN I-Gene
in IN O
gel JJ O
shift NN O
assays NNS O
and CC O
caused VBD O
transient JJ O
degradation NN O
of IN O
inhibitor NN B-Gene
of IN I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
in IN O
the DT O
cytoplasm NN O
of IN O
myofibroblasts NNS O
, , O
only RB O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
upregulated JJ O
PDGF NNP B-Gene
- : I-Gene
Ralpha NN I-Gene
. . O

The DT O
presence NN O
of IN O
AS NNP O
- : O
oligo NN O
had VBD O
no DT O
further JJ O
effect NN O
on IN O
the DT O
FSH NNP B-Gene
- : O
mediated VBD O
activation NN O
of IN O
the DT O
EB NNP O
* NNP O
- : O
mTf NN B-Gene
- : O
CAT NNP B-Gene
construct NN O
but CC O
reduced VBD O
cAMP SYM O
- : O
mediated VBN O
activation NN O
. . O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
EF NNP O
between IN O
the DT O
two CD O
studies NNS O
, , O
both DT O
at IN O
rest NN O
( ( O
56 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
13 CD O
. . O
8 CD O
% NN O
vs NN O
58 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
11 CD O
. . O
7 CD O
% NN O
, , O
p NN O
= NNP O
NS NNP O
) ) O
and CC O
with IN O
exercise NN O
( ( O
51 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
17 CD O
. . O
6 CD O
% NN O
vs NN O
54 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
17 CD O
. . O
6 CD O
% NN O
, , O
p NN O
= NNP O
NS NNP O
) ) O
and CC O
a DT O
highly RB O
significant JJ O
correlation NN O
was VBD O
shown VBN O
between IN O
the DT O
two CD O
groups NNS O
of IN O
values NNS O
( ( O
rest VB O
r NN O
= NNP O
0 CD O
. . O
90 CD O
, , O
exercise NN O
r NN O
= VBD O
0 CD O
. . O
93 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Here RB O
we PRP O
report VBP O
the DT O
complete JJ O
6 CD O
- : O
kilobase NN O
cDNA NN O
sequence NN O
coding VBG O
for IN O
a DT O
chain NN O
of IN O
1775 CD O
amino NN O
acids NNS O
, , O
as RB O
well RB O
as IN O
the DT O
genomic JJ O
structure NN O
. . O

A DT O
chromosome NN B-Gene
transmission NN I-Gene
fidelity NN I-Gene
( ( O
ctf NN B-Gene
) ) O
mutant NN O
, , O
s138 NN O
, , O
of IN O
Saccharomyces NNP O
cerevisiae NN O
was VBD O
identified VBN O
by IN O
its PRP$ O
centromere NN O
( ( O
CEN NNP O
) ) O
transcriptional JJ O
readthrough NN O
phenotype NN O
, , O
suggesting VBG O
perturbed VBN O
kinetochore JJ O
integrity NN O
in IN O
vivo NN O
. . O

This DT O
association NN O
appears VBZ O
to TO O
be VB O
mediated VBN O
by IN O
Src NNP B-Gene
- : O
SH2 NNP B-Gene
domain NN O
, , O
because IN O
PECAM NNP B-Gene
- : I-Gene
1 CD I-Gene
can MD O
be VB O
precipitated VBN O
by IN O
a DT O
GST NNP B-Gene
- : O
Src NNP B-Gene
- : O
SH2 NNP B-Gene
affinity NN O
matrix NN O
. . O

Either DT O
two CD O
or CC O
more JJR O
different JJ O
sequences NNS O
can MD O
promote VB O
cleavage NN O
, , O
or CC O
a DT O
single JJ O
element NN O
exists NNS O
which WDT O
is VBZ O
long JJ O
and CC O
diffuse NN O
. . O

Platelet NNP O
number NN O
and CC O
life NN O
span NNS O
were VBD O
determined VBN O
in IN O
the DT O
last JJ O
trimester NN O
of IN O
pregnancy NN O
in IN O
22 CD O
women NNS O
who WP O
were VBD O
delivered VBN O
of IN O
small JJ O
- : O
for IN O
- : O
gestational JJ O
age NN O
( ( O
SGA NNP O
) ) O
infants NNS O
and CC O
in IN O
21 CD O
women NNS O
with IN O
infants NNS O
having VBG O
normal JJ O
birth JJ O
weights NNS O
. . O

The DT O
article NN O
deals NNS O
with IN O
the DT O
diagnosing NN O
and CC O
correction NN O
of IN O
reversible JJ O
ischemia NN O
of IN O
the DT O
intestine NN O
. . O

In IN O
assays NNS O
with IN O
purified JJ O
enzymes NNS O
, , O
wild JJ O
- : O
type NN O
but CC O
not RB O
PTPS NNP B-Gene
- : O
S19A NN B-Gene
was VBD O
a DT O
specific JJ O
substrate NN O
for IN O
the DT O
cGMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( I-Gene
cGK NN I-Gene
) ) I-Gene
type NN I-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
. . O

HA NNP O
resulted VBD O
in IN O
decreased JJ O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
Tre NNP O
( ( O
0 CD O
. . O
4 CD O
degrees NNS O
C NNP O
) ) O
and CC O
HR NNP O
( ( O
17 CD O
b NN O
X NNP O
min NNP O
- : O
1 CD O
) ) O
, , O
and CC O
increased VBD O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
Msw NNP O
( ( O
16 CD O
g NN O
X NNP O
m NNP O
- : O
2 CD O
X NN O
h NN O
- : O
1 CD O
) ) O
during IN O
the DT O
saline JJ O
experiments NNS O
. . O

In IN O
one CD O
patient NN O
with IN O
severe JJ O
diarrhea VBP O
the DT O
estriol JJ O
concentration NN O
in IN O
serum NN O
was VBD O
low JJ O
until IN O
the DT O
intestinal JJ O
function NN O
normalised VBN O
and CC O
the DT O
estriol NN O
concentration NN O
went VBD O
up RP O
exactly RB O
when WRB O
the DT O
diarrhea NN O
stopped VBD O
. . O

Preflight NNP O
, , O
inflight NN O
, , O
and CC O
postflight VBD O
exercise NN O
response NN O
tests NNS O
were VBD O
conducted VBN O
on IN O
the DT O
astronauts NNS O
of IN O
the DT O
second JJ O
Skylab NNP O
mission NN O
( ( O
Skylab NNP O
3 CD O
) ) O
as IN O
part NN O
of IN O
an DT O
evaluation NN O
of IN O
physiological JJ O
adaptation NN O
to TO O
long VB O
- : O
term NN O
weightlessness NN O
. . O

When WRB O
expressed VBN O
alone RB O
in IN O
test NN O
cells NNS O
, , O
Atr NNP B-Gene
- : I-Gene
I PRP I-Gene
is VBZ O
unable JJ O
to TO O
bind VB O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
, , O
activin NN B-Gene
, , O
or CC O
bone RB B-Gene
morphogenetic JJ I-Gene
protein NN I-Gene
2 CD I-Gene
. . O

C NNP O
. . O
elegans NNS O
KLP NNP B-Gene
- : I-Gene
11 CD I-Gene
/ NN O
OSM NNP B-Gene
- : I-Gene
3 CD I-Gene
/ NN O
KAP NNP B-Gene
- : I-Gene
1 CD I-Gene
: : O
orthologs NNS O
of IN O
the DT O
sea NN B-Gene
urchin JJ I-Gene
kinesin NNP I-Gene
- : I-Gene
II NNP I-Gene
, , O
and CC O
mouse RB O
KIF3A NNP B-Gene
/ NNP O
KIFB NNP B-Gene
/ NNP O
KAP3 NNP B-Gene
kinesin NN B-Gene
complexes NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
full JJ O
mu NN O
- : O
opioid JJ O
agonists NNS O
fentanyl VBP O
, , O
morphine NN O
, , O
I PRP O
- : O
methadone NN O
and CC O
levorphanol NN O
produced VBD O
50 CD O
% NN O
fentanyl JJ O
- : O
appropriate JJ O
responding NN O
at IN O
doses VBZ O
only RB O
1 CD O
. . O
3 CD O
to TO O
10 CD O
. . O
9 CD O
times NNS O
smaller JJR O
than IN O
those DT O
required VBN O
to TO O
decrease VB O
response NN O
rates NNS O
by IN O
50 CD O
% NN O
. . O

The DT O
long JJ O
terminal JJ O
repeat NN O
( ( O
LTR NNP O
) ) O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
contains VBZ O
three CD O
binding NN O
sites NNS O
for IN O
the DT O
transcriptional JJ O
factor NN O
Sp1 NNP B-Gene
. . O

Effect NN O
of IN O
enteral JJ O
nutritional JJ O
products NNS O
differing VBG O
in IN O
carbohydrate NN O
and CC O
fat NN O
on IN O
indices NNS O
of IN O
carbohydrate NN O
and CC O
lipid JJ O
metabolism NN O
in IN O
patients NNS O
with IN O
NIDDM NNP O
. . O

Letter NN O
: : O
Perspectives NNS O
in IN O
bone NN O
marrow NN O
transplantation NN O
. . O

Furthermore RB O
, , O
as IN O
in IN O
the DT O
human JJ O
gene NN O
, , O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
Cacna1f NNP B-Gene
gene NN I-Gene
maps NNS O
within IN O
5 CD O
kb NN O
of IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
mouse NN B-Gene
synaptophysin NN I-Gene
gene NN I-Gene
in IN O
a DT O
region NN O
orthologous JJ O
to TO O
Xp11 VB O
. . O
23 CD O
. . O

A DT O
secondary JJ O
spread NN O
of IN O
an DT O
imported VBN O
methicillin NN O
- : O
resistant JJ O
Staphylococcus NNP O
aureus NN O
strain NN O
( ( O
MRSA NNP O
) ) O
to TO O
two CD O
other JJ O
patients NNS O
occurred VBD O
within IN O
a DT O
Danish JJ O
surgical JJ O
ward NN O
in IN O
spite NN O
of IN O
isolation NN O
of IN O
a DT O
multitraumatized JJ O
index NN O
- : O
patient NN O
immediately RB O
after IN O
arrival NN O
from IN O
a DT O
hospital NN O
in IN O
the DT O
Mediterranean NNP O
area NN O
. . O

In IN O
the DT O
SPP2 NNP O
screening VBG O
test NN O
, , O
a DT O
few JJ O
plates NNS O
were VBD O
not RB O
seen VBN O
in IN O
both DT O
groups NNS O
. . O

The DT O
co NN O
- : O
existence NN O
of IN O
TE NNP B-Gene
domains NNS I-Gene
within IN O
modular JJ O
PKSs NNP B-Gene
along IN O
with IN O
physically RB O
separated VBN O
, , O
monofunctional JJ O
TEs NNP B-Gene
( ( O
TE NNP B-Gene
IIs NNP I-Gene
) ) O
has VBZ O
been VBN O
reported VBN O
for IN O
a DT O
number NN O
of IN O
modular JJ O
polyketide NN O
and CC O
non JJ B-Gene
- : I-Gene
ribosomal JJ I-Gene
peptide NN I-Gene
synthases NNS I-Gene
( ( O
NRPS NNP B-Gene
) ) O
. . O

Cost NNP O
- : O
effectiveness NN O
of IN O
interferon NN B-Gene
beta NN I-Gene
- : I-Gene
1b CD I-Gene
in IN O
slowing VBG O
multiple JJ O
sclerosis NN O
disability NN O
progression NN O
. . O

The DT O
incidence NN O
of IN O
early JJ O
neonatal JJ O
convulsions NNS O
for IN O
inborn JJ O
babies NNS O
was VBD O
3 CD O
. . O
0 CD O
/ JJ O
1000 CD O
live JJ O
births NNS O
. . O

An DT O
immunoperoxidase NN B-Gene
reaction NN O
, , O
PAP NNP B-Gene
method NN O
, , O
with IN O
the DT O
antiserum NN O
of IN O
Factor NNP B-Gene
VIII NNP I-Gene
as IN O
the DT O
primary JJ O
antibody NN O
, , O
was VBD O
carried VBN O
out RP O
in IN O
the DT O
endometrial JJ O
biopsies NNS O
to TO O
detect VB O
the DT O
Factor NNP B-Gene
VIII NNP I-Gene
activity NN O
in IN O
the DT O
endometrial JJ O
endothelium NN O
before IN O
and CC O
after IN O
insertion NN O
of IN O
LNG NNP O
- : O
IUD NNP O
- : O
20 CD O
. . O

HupI NNP B-Gene
showed VBD O
strong JJ O
identity NN O
to TO O
rubredoxin VB B-Gene
and CC O
rubredoxin VB B-Gene
- : I-Gene
like IN I-Gene
proteins NNS I-Gene
from IN O
many JJ O
other JJ O
bacteria NNS O
. . O

In IN O
XO NNP O
males NNS O
, , O
two CD O
her PRP$ B-Gene
- : I-Gene
1 CD I-Gene
mRNAs NN I-Gene
, , O
her PRP$ B-Gene
- : I-Gene
1a CD I-Gene
and CC O
her PRP$ B-Gene
- : I-Gene
1b CD I-Gene
, , O
are VBP O
transcribed VBN O
from IN O
two CD O
separate JJ O
promoters NNS O
: : O
P1 NNP O
, , O
located VBN O
in IN O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
, , O
and CC O
P2 NNP O
, , O
located VBN O
in IN O
the DT O
large JJ O
second JJ O
intron NN O
. . O

These DT O
human JJ O
IFN NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
transformed VBN O
cell NN O
populations NNS O
have VBP O
acquired VBN O
a DT O
low JJ O
, , O
constitutive JJ O
production NN O
of IN O
human JJ B-Gene
IFN NNP I-Gene
, , O
while IN O
replicating VBG O
at IN O
a DT O
rate NN O
similar JJ O
to TO O
that DT O
of IN O
untransformed JJ O
cells NNS O
and CC O
of IN O
cells NNS O
transformed VBN O
with IN O
the DT O
control NN O
vector NN O
carrying VBG O
a DT O
human JJ B-Gene
IFN NNP I-Gene
- : I-Gene
beta NN I-Gene
sequence NN I-Gene
encoding VBG O
an DT O
inactive JJ O
, , O
mutated VBD O
protein NN O
. . O

The DT O
PC2 NNP B-Gene
protein NN I-Gene
also RB O
shows VBZ O
great JJ O
similarity NN O
to TO O
the DT O
incomplete JJ O
NH2 NNP O
- : O
terminal JJ O
sequence NN O
of IN O
the DT O
human JJ B-Gene
furin NN I-Gene
gene NN I-Gene
product NN I-Gene
, , O
a DT O
putative JJ O
membrane NN O
- : O
inserted VBN O
receptor NN O
- : O
like IN O
molecule NN O
. . O

Platelet NNP O
serotonin NN O
( ( O
5 CD O
- : O
HT NN O
) ) O
and CC O
5 CD B-Gene
- : I-Gene
HT NN I-Gene
releasing VBG I-Gene
factor NN I-Gene
in IN O
plasma NN O
of IN O
migrainous JJ O
patients NNS O
. . O

Formation NN O
of IN O
hyphae NN O
and CC O
chlamydospores NNS O
by IN O
Cryptococcus NNP O
laurentii NN O
. . O

Through IN O
Southern NNP O
blot NN O
analyses NNS O
of IN O
DNA NN O
from IN O
backcross NN O
and CC O
cogenic JJ O
mice NN O
, , O
recombinant JJ O
inbred JJ O
strains NNS O
, , O
and CC O
somatic JJ O
cell NN O
hybrids NNS O
, , O
the DT O
genetic JJ O
loci NN O
that WDT O
produce VBP O
the DT O
cyclin NN B-Gene
B1 NNP I-Gene
- : I-Gene
related JJ I-Gene
sequences NNS I-Gene
( ( O
designated VBN O
loci NN B-Gene
Cycb1 NNP I-Gene
- : I-Gene
rs1 NN I-Gene
to TO O
Cycb1 NNP B-Gene
- : I-Gene
rs9 NN I-Gene
) ) O
were VBD O
mapped VBN O
on IN O
mouse NN O
chromosomes NNS O
5 CD O
, , O
1 CD O
, , O
17 CD O
, , O
4 CD O
, , O
14 CD O
, , O
13 CD O
, , O
7 CD O
, , O
X NNP O
, , O
and CC O
8 CD O
, , O
respectively RB O
. . O

Temperature NN O
- : O
shift NN O
experiments NNS O
using VBG O
synchronously RB O
grown JJ O
cells NNS O
of IN O
a DT O
delta NN B-Gene
top1 NN I-Gene
top2 NN B-Gene
temperature NN I-Gene
- : I-Gene
sensitive JJ I-Gene
( ( I-Gene
ts NN I-Gene
) ) I-Gene
double NN I-Gene
mutant NN I-Gene
and CC O
its PRP$ O
isogenic JJ O
top2 NN B-Gene
ts NN O
strain NN O
show NN O
that IN O
, , O
whereas EX O
mitotic JJ O
blocks NNS O
can MD O
prevent VB O
killing NN O
of IN O
the DT O
top2 NN B-Gene
ts NN I-Gene
mutant NN I-Gene
at IN O
a DT O
nonpermissive JJ O
temperature NN O
, , O
the DT O
same JJ O
treatments NNS O
are VBP O
ineffective JJ O
in IN O
preventing VBG O
cell NN O
death NN O
of IN O
the DT O
delta NN B-Gene
top1 NN I-Gene
top2 NN B-Gene
ts NN I-Gene
double JJ I-Gene
mutant NN I-Gene
. . O

To TO O
facilitate VB O
the DT O
availability NN O
of IN O
important JJ O
new JJ O
therapeutic JJ O
agents NNS O
, , O
the DT O
Food NNP O
and CC O
Drug NNP O
Administration NNP O
( ( O
FDA NNP O
) ) O
in IN O
the DT O
mid NN O
- : O
1970s CD O
began VBD O
assigning VBG O
therapeutic JJ O
ratings NNS O
to TO O
investigational VB O
new JJ O
drugs NNS O
and CC O
holding VBG O
end JJ O
- : O
of IN O
- : O
phase NN O
II NNP O
conferences NNS O
with IN O
drug NN O
sponsors NNS O
. . O

Mesial JJ O
temporal JJ O
sclerosis NN O
. . O

Furthermore RB O
, , O
no DT O
Shine NNP O
- : O
Dalgarno NN O
sequences NNS O
are VBP O
present JJ O
upstream NN O
of IN O
the DT O
presumed JJ O
translational JJ O
start NN O
codons NNS O
. . O

Pancreaticoduodenal NNP O
lymph NN O
node NN O
enlargement NN O
, , O
regardless RB O
of IN O
cause NN O
, , O
has VBZ O
been VBN O
a DT O
source NN O
of IN O
imaging VBG O
confusion NN O
because IN O
of IN O
its PRP$ O
propensity NN O
to TO O
mimic VB O
pancreatic JJ O
malignancy NN O
yet RB O
not RB O
cause VB O
biliary JJ O
obstruction NN O
. . O

Neuregulin NNP B-Gene
stimulates VBZ O
ErbB2 NNP B-Gene
, , O
ErbB3 NNP B-Gene
, , O
and CC O
ErbB4 NNP B-Gene
, , O
members NNS O
of IN O
the DT O
ErbB NNP B-Gene
family NN I-Gene
of IN O
receptor NN B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
. . O

We PRP O
characterized VBD O
cDNA NN O
clones NNS O
specific NN O
for IN O
the DT O
extracellular JJ O
matrix NN O
glycoprotein NN O
undulin NN B-Gene
. . O

Here RB O
we PRP O
characterize VBP O
an DT O
S NNP B-Gene
. . I-Gene
cerevisiae NN I-Gene
Swi3 NNP I-Gene
homolog NN I-Gene
( ( O
Swh3 NNP B-Gene
) ) O
and CC O
present JJ O
evidence NN O
that IN O
it PRP O
associates VBZ O
in IN O
a DT O
complex JJ O
with IN O
a DT O
Snf2 NNP B-Gene
homolog NN I-Gene
, , O
Sthl NNP B-Gene
. . O

Using VBG O
various JJ O
techniques NNS O
, , O
we PRP O
have VBP O
undertaken VBN O
a DT O
systematic JJ O
analysis NN O
of IN O
the DT O
natural JJ O
TATA NNP O
- : O
less JJR O
human JJ B-Gene
DNA NNP I-Gene
polymerase NN I-Gene
beta NN I-Gene
( ( O
beta SYM B-Gene
- : I-Gene
pol NN I-Gene
) ) O
gene NN O
promoter NN O
. . O

In IN O
human JJ O
proliferative JJ O
cells NNS O
, , O
the DT O
NADP NNP O
- : O
dependent JJ O
ME NNP B-Gene
activity NN O
is VBZ O
poorly RB O
expressed VBN O
and CC O
barely RB O
inducible JJ O
by IN O
thyroid JJ O
hormones NNS O
. . O

The DT O
T NNP B-Gene
- : I-Gene
cyt NN I-Gene
promoter NN I-Gene
, , O
although IN O
of IN O
bacterial JJ O
origin NN O
is VBZ O
active JJ O
in IN O
planta NN O
and CC O
the DT O
30 CD B-Gene
bp NN I-Gene
cyt NN I-Gene
- : I-Gene
1 CD I-Gene
element NN I-Gene
is VBZ O
located VBN O
within IN O
a DT O
region NN O
that WDT O
is VBZ O
essential JJ O
for IN O
T NNP B-Gene
- : I-Gene
cyt NN I-Gene
promotor NN I-Gene
activity NN O
in IN O
leaf NN O
, , O
stem NN O
and CC O
root NN O
cells NNS O
of IN O
tobacco NN O
plants NNS O
. . O

The DT O
development NN O
and CC O
histostructural JJ O
organization NN O
of IN O
intrahepatic JJ O
biliary JJ O
ducts NNS O
were VBD O
studied VBN O
on IN O
a DT O
human JJ O
embryofetal JJ O
material NN O
6 CD O
to TO O
32 CD O
weeks NNS O
old JJ O
. . O

Thus RB O
, , O
the DT O
effects NNS O
of IN O
father NN O
absence NN O
under IN O
routine JJ O
conditions NNS O
in IN O
relatively RB O
healthy JJ O
samples NNS O
may MD O
exert VB O
no DT O
significant JJ O
effects NNS O
independent JJ O
of IN O
intervening VBG O
family NN O
stressors NNS O
or CC O
maternal JJ O
psychopathology NN O
. . O

RESULTS NN O
: : O
Plasma NNP B-Gene
AVP NNP I-Gene
responses VBZ O
to TO O
osmotic JJ O
stimulation NN O
, , O
and CC O
non SYM O
- : O
osmotic JJ O
inhibition NN O
by IN O
drinking NN O
, , O
were VBD O
normal JJ O
in IN O
patients NNS O
with IN O
compulsive JJ O
water NN O
drinking NN O
. . O

( ( O
i NN O
) ) O
Complete NNP O
Grb10 NNP B-Gene
expression NN O
from IN O
cDNA NN O
with IN O
an DT O
ecdysone NN O
- : O
regulated VBN O
transient JJ O
expression NN O
system NN O
stimulated VBD O
PDGF NNP B-Gene
- : I-Gene
BB NNP I-Gene
- : O
, , O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
, , O
and CC O
insulin SYM B-Gene
- : O
but CC O
not RB O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
EGF NNP B-Gene
) ) O
- : O
induced VBN O
DNA NNP O
synthesis NN O
in IN O
an DT O
ecdysone NN O
dose NN O
- : O
responsive JJ O
fashion NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
cis NN O
- : O
regulatory JJ O
elements NNS O
required VBN O
for IN O
developmental JJ O
control NN O
of IN O
the DT O
HaG3 NNP B-Gene
- : I-Gene
A DT I-Gene
helianthinin JJ I-Gene
gene NN I-Gene
are VBP O
located VBN O
in IN O
a DT O
2 CD O
. . O
4 CD O
kb JJ O
upstream JJ O
region NN O
of IN O
this DT O
gene NN O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
a DT O
model NN O
proposing VBG O
that IN O
SSV NNP O
was VBD O
generated VBN O
by IN O
recombination NN O
between IN O
proviral JJ O
DNA NNP O
of IN O
a DT O
simian JJ O
sarcoma NN O
associated VBN O
virus NN O
and CC O
proto NN B-Gene
- : I-Gene
sis NN I-Gene
and CC O
that IN O
introns NNS O
were VBD O
spliced VBN O
out RP O
subsequently RB O
from IN O
a DT O
fused JJ O
viral JJ B-Gene
- : I-Gene
sis NN I-Gene
messenger NN I-Gene
RNA NNP I-Gene
. . O

In IN O
addition NN O
, , O
mutation NN O
of IN O
the DT O
Sp1 NNP B-Gene
site NN I-Gene
also RB O
significantly RB O
reduced VBN O
promoter NN O
activity NN O
. . O

Early JJ O
treatment NN O
mechanics NNS O
of IN O
the DT O
Class NNP O
II NNP O
division NN O
2 CD O
malocclusion NN O
. . O

Melatonin NNP O
and CC O
seasonality NN O
: : O
filling VBG O
the DT O
gap NN O
. . O

Clinical JJ O
aspects NNS O
and CC O
therapy NN O

Hemodynamic NNP O
assessment NN O
was VBD O
obtained VBN O
before IN O
and CC O
following VBG O
administration NN O
of IN O
digoxin NN O
10 CD O
micrograms NNS O
/ VBP O
kg JJ O
IV NNP O
or CC O
dopamine NN O
, , O
5 CD O
to TO O
12 CD O
micrograms NNS O
/ VBP O
kg JJ O
/ NNP O
min NN O
IV NNP O
. . O

Additionally RB O
, , O
deletion NN O
analysis NN O
of IN O
the DT O
UCP2 NNP B-Gene
promoter NN O
- : O
PLAP NNP B-Gene
constructs NNS O
indicated VBD O
that IN O
the DT O
minimal JJ O
region NN O
exhibiting VBG O
the DT O
promoter NN O
activity NN O
was VBD O
located VBN O
between IN O
nt JJ O
- : O
33 CD O
and CC O
+ $ O
100 CD O
, , O
and CC O
that IN O
a DT O
strong JJ O
enhancer NN O
was VBD O
present JJ O
within IN O
601 CD O
bp NN O
of IN O
the DT O
5 CD O
' POS O
- : O
promoter NN O
region NN O
. . O

The DT O
antilog NN O
transformation NN O
of IN O
pH NN O
did VBD O
not RB O
improve VB O
the DT O
results NNS O
. . O

Epitope NNP O
mapping NN O
revealed VBD O
that IN O
these DT O
three CD O
clones NNS O
appear VBP O
to TO O
recognize VB O
an DT O
identical JJ O
epitope NN O
domain NN O
present NN O
on IN O
the DT O
C NNP O
- : O
terminal JJ O
RNP NNP O
motif NN O
of IN O
the DT O
U1A NNP B-Gene
protein NN I-Gene
. . O

Conversely RB O
, , O
treatment NN O
of IN O
human JJ B-Gene
protein NN I-Gene
- : I-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
alpha SYM I-Gene
- : O
overexpressing VBG O
cells NNS O
with IN O
phenylarsine JJ O
oxide NN O
led VBD O
to TO O
a DT O
loss NN O
of IN O
the DT O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
. . O

Sequence NNP O
comparison NN O
between IN O
the DT O
translated VBN O
ORF NNP O
and CC O
a DT O
protein JJ O
database NN O
reveal NN O
between IN O
26 CD O
. . O
5 CD O
and CC O
23 CD O
. . O
4 CD O
% NN O
aa JJ O
sequence NN O
homology NN O
to TO O
bacterial JJ B-Gene
transmembrane NN I-Gene
( ( I-Gene
TM NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
including VBG O
those DT O
mediating VBG O
chloramphenicol NN O
( ( O
Cm NNP O
) ) O
and CC O
tetracycline NN O
( ( O
Tc NNP O
) ) O
resistance NN O
and CC O
an DT O
arabinose JJ O
- : O
proton NN O
symport NN O
protein NN O
. . O

Tightly RB O
ordered VBN O
proteasomal JJ O
degradation NN O
of IN O
proteins NNS O
critical JJ O
for IN O
cell NN O
cycle NN O
control NN O
implies VBZ O
a DT O
role NN O
of IN O
the DT O
proteasome NN O
in IN O
maintaining VBG O
cell NN O
proliferation NN O
and CC O
cell NN O
survival NN O
. . O

Two CD O
transcripts NNS O
of IN O
1 CD O
. . O
6 CD O
kb NN O
and CC O
5 CD O
. . O
8 CD O
kb NNS O
are VBP O
5 CD O
' POS O
coterminal JJ O
and CC O
may MD O
both DT O
encode VB O
the DT O
novel JJ O
glycoprotein NN B-Gene
gene NN I-Gene
EUS4 NNP I-Gene
. . O

Characterization NN O
of IN O
the DT O
alpha NN B-Gene
4 CD I-Gene
integrin JJ I-Gene
gene NN I-Gene
promoter NN I-Gene
. . O

XII NN O
. . O

Galoyan NNP O
has VBZ O
summarized VBN O
the DT O
results NNS O
of IN O
his PRP$ O
discovery NN O
of IN O
cardioactive JJ O
neurohormones NNS O
. . O

Interactions NNS O
between IN O
the DT O
checkpoint NN O
abrogator NN O
UCN NNP O
- : O
1 CD O
and CC O
several JJ O
pharmacological JJ O
inhibitors NNS O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( I-Gene
MAPK NNP I-Gene
) ) I-Gene
kinase NN I-Gene
( ( O
MEK NNP B-Gene
) ) O
/ VBP O
MAPK NNP B-Gene
pathway NN O
have VBP O
been VBN O
examined VBN O
in IN O
a DT O
variety NN O
of IN O
human JJ O
leukemia NN O
cell NN O
lines NNS O
. . O

A DT O
rate NN O
- : O
decreasing VBG O
dose NN O
of IN O
physostigmine NN O
, , O
an DT O
acetylcholinesterase NN B-Gene
inhibitor NN O
, , O
was VBD O
studied VBN O
in IN O
combination NN O
with IN O
the DT O
range NN O
of IN O
atropine NN O
doses NNS O
. . O

The DT O
C NNP O
- : O
terminal JJ O
peptide NN O
sequences NNS O
of IN O
the DT O
human JJ B-Gene
lymphocyte NN I-Gene
- : I-Gene
specific JJ I-Gene
high JJ I-Gene
mobility NN I-Gene
group NN I-Gene
( ( I-Gene
HMG NNP I-Gene
) ) I-Gene
- : I-Gene
box NN I-Gene
transcription NN I-Gene
factor NN I-Gene
TCF NNP I-Gene
- : I-Gene
1 CD I-Gene
are VBP O
determined VBN O
by IN O
alternative JJ O
splice NN O
mechanisms NNS O
affecting VBG O
the DT O
exons NNS O
VIII NNP O
to TO O
X VB O
. . O

An DT O
experiment NN O
examined VBD O
the DT O
effects NNS O
of IN O
treatment NN O
with IN O
gonadotrophin JJ B-Gene
releasing VBG I-Gene
hormone NN I-Gene
( ( O
100 CD O
micrograms NNS O
GnRH NNP B-Gene
injected VBD O
24 CD O
h NN O
after IN O
progestagen NN O
sponge NN O
removal NN O
) ) O
, , O
season NN O
of IN O
treatment NN O
( ( O
autumn JJ O
v NN O
. . O
spring NN O
) ) O
, , O
the DT O
effect NN O
of IN O
supplementary JJ O
feeding NN O
with IN O
lupin NN O
grain NN O
( ( O
in IN O
autumn NN O
only RB O
, , O
from IN O
12 CD O
days NNS O
before IN O
until IN O
8 CD O
days NNS O
after IN O
sponge NN O
removal NN O
) ) O
on IN O
the DT O
time NN O
of IN O
ovulation NN O
in IN O
182 CD O
mature NN O
Merino NNP O
ewes VBZ O
superovulated VBN O
with IN O
a DT O
combination NN O
of IN O
400 CD O
I PRP O
. . O
U NNP O
. . O
pregnant JJ B-Gene
mare NN I-Gene
serum NN I-Gene
gonadotrophin NN I-Gene
( ( O
PMSG NNP B-Gene
) ) O
and CC O
12 CD O
mg NNS O
follicle NN B-Gene
stimulating VBG I-Gene
hormone NN I-Gene
( ( O
FSH NNP B-Gene
- : I-Gene
P NN I-Gene
) ) O
. . O

Therapeutic JJ O
use NN O
of IN O
continuous JJ O
subcutaneous JJ O
infusion NN O
of IN O
recombinant JJ B-Gene
human JJ I-Gene
erythropoietin NN I-Gene
in IN O
malnourished JJ O
predialysis NN O
anemic JJ O
patients NNS O
with IN O
diabetic JJ O
nephropathy NNS O
. . O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
the DT O
influence NN O
of IN O
HHCA NNP O
and CC O
other JJ O
serological JJ O
factors NNS O
upon IN O
the DT O
development NN O
of IN O
VGS NNP O
. . O

In IN O
this DT O
paper NN O
, , O
a DT O
comparison NN O
between IN O
the DT O
number NN O
and CC O
shape NN O
of IN O
corneal JJ O
endothelial JJ O
cells NNS O
has VBZ O
been VBN O
performed VBN O
in IN O
25 CD O
patients NNS O
before IN O
and CC O
6 CD O
months NNS O
after IN O
PRK NNP O
. . O

Serine NNP O
phosphorylation NN O
of IN O
STAT3 NNP B-Gene
was VBD O
only RB O
apparent JJ O
after IN O
somatostatin JJ B-Gene
treatment NN O
and CC O
was VBD O
abolished VBN O
by IN O
pertussis NN B-Gene
toxin NN I-Gene
or CC O
PD NNP O
98059 CD O
, , O
together RB O
with IN O
the DT O
associated JJ O
increases NNS O
in IN O
proliferation NN O
. . O

Replacement NN O
of IN O
the DT O
spacer NN O
sequence NN O
between IN O
the DT O
two CD O
ARMs NNP O
with IN O
a DT O
shorter JJR O
stretch NN O
of IN O
sequence NN O
also RB O
reduced VBD O
RNA NNP O
binding NN O
in IN O
vitro NN O
. . O

Similar JJ O
synergistic JJ O
activation NN O
was VBD O
observed VBN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
promoter NN I-Gene
, , O
which WDT O
also RB O
contains VBZ O
both DT O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Products NNS O
of IN O
immune JJ O
cells NNS O
such JJ O
as IN O
transfer NN B-Gene
factor NN I-Gene
and CC O
lymphokines NNS O
form VBP O
the DT O
third JJ O
and CC O
possibly RB O
most RBS O
important JJ O
group NN O
of IN O
immune JJ O
- : O
stimulating NN O
agents NNS O
. . O

A DT O
short JJ O
history NN O
of IN O
dermatology NN O
in IN O
Lagos NNP O
, , O
Nigeria NNP O
. . O

Thirty NNP O
seven CD O
patients NNS O
( ( O
amitriptyline JJ O
n NN O
= VBD O
16 CD O
, , O
moclobemide RB O
n JJ O
= NNP O
21 CD O
) ) O
completed VBD O
the DT O
six CD O
week NN O
protocol NN O
, , O
which WDT O
was VBD O
conducted VBN O
under IN O
double JJ O
blind JJ O
conditions NNS O
. . O

Thus RB O
in IN O
this DT O
region NN O
of IN O
the DT O
vessel NN O
pyridinoline NN O
represents VBZ O
the DT O
major JJ O
stabilising VBG O
crosslink NN O
of IN O
collagen NN B-Gene
. . O

This DT O
region NN O
does VBZ O
not RB O
contain VB O
an DT O
identifiable JJ O
TATA NNP O
element NN O
, , O
indicating VBG O
that IN O
transcription NN O
of IN O
the DT O
glutaminase NN B-Gene
gene NN I-Gene
is VBZ O
driven VBN O
by IN O
a DT O
TATA NNP O
- : O
less JJR O
promoter NN O
. . O

The DT O
effect NN O
of IN O
anticonvulsants NNS O
on IN O
sodium NN B-Gene
- : I-Gene
potassium NN I-Gene
- : I-Gene
activated JJ I-Gene
ATPase NNP I-Gene
, , O
sodium NN O
, , O
and CC O
potassim NN O
in IN O
cortex NN O
. . O

In IN O
order NN O
to TO O
evaluate VB O
the DT O
function NN O
of IN O
the DT O
hypothalamic JJ O
- : O
pituitary JJ O
- : O
thyroid NN O
( ( O
HPT NNP O
) ) O
- : O
axis NN O
in IN O
unipolar JJ O
depression NN O
, , O
the DT O
authors NNS O
measured VBD O
basal JJ O
0800h CD O
plasma NN O
levels NNS O
of IN O
free JJ O
thyroxine NN O
( ( O
FT4 NNP O
) ) O
, , O
free JJ O
triiodothyronine NN O
( ( O
FT3 NNP O
) ) O
, , O
and CC O
thyroid JJ B-Gene
stimulating VBG I-Gene
hormone NN I-Gene
( ( O
TSH NNP B-Gene
) ) O
by IN O
means NNS O
of IN O
the DT O
new JJ O
, , O
ultrasensitive JJ O
assays NNS O
( ( O
TSH NNP O
- : O
IRMA NN O
) ) O
in IN O
69 CD O
healthy JJ O
controls NNS O
, , O
62 CD O
minor NN O
, , O
101 CD O
simple JJ O
major JJ O
, , O
and CC O
57 CD O
melancholic NN O
depressed JJ O
subjects NNS O
. . O

Plasma NNP B-Gene
histaminase NN I-Gene
in IN O
patients NNS O
of IN O
bronchial JJ O
asthma NN O
and CC O
the DT O
effect NN O
of IN O
prednisolone NN O
administration NN O
on IN O
it PRP O
. . O

Strain NNP O
CFN037 NNP O
is VBZ O
an DT O
R NNP O
. . O
etli NN O
mutant NN O
induced VBN O
by IN O
a DT O
single JJ O
Tn5mob NNP B-Gene
insertion NN O
in IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
thiCOGE JJ B-Gene
gene NN I-Gene
cluster NN I-Gene
. . O

Analysis NN O
of IN O
intron NN O
/ NNP O
exon NN O
boundaries NNS O
of IN O
the DT O
genomic JJ O
BAC NNP O
clones NNS O
demonstrate VBP O
that IN O
junctin NN B-Gene
, , O
junctate NN B-Gene
, , O
and CC O
aspartyl RB B-Gene
beta SYM I-Gene
- : I-Gene
hydroxylase NN I-Gene
result NN O
from IN O
alternative JJ O
splicing NN O
of IN O
the DT O
same JJ O
gene NN O
. . O

The DT O
maximum JJ O
period NN O
of IN O
treatment NN O
was VBD O
73 CD O
( ( O
oral JJ O
) ) O
, , O
73 CD O
( ( O
intraperitoneal NN O
) ) O
or CC O
75 CD O
( ( O
dermal JJ O
) ) O
weeks NNS O
. . O

3 CD O
Significant JJ O
reductions NNS O
in IN O
lying VBG O
mean JJ O
arterial JJ O
blood NN O
pressure NN O
were VBD O
observed VBN O
with IN O
daily JJ O
doses NNS O
of IN O
200 CD O
mg NN O
( ( O
- : O
9 CD O
% NN O
) ) O
, , O
400 CD O
mg NN O
( ( O
- : O
10 CD O
% NN O
) ) O
and CC O
800 CD O
mg NN O
( ( O
- : O
14 CD O
% NN O
) ) O
, , O
and CC O
were VBD O
associated VBN O
with IN O
significant JJ O
decreases NNS O
in IN O
heart NN O
rate NN O
and CC O
plasma NN B-Gene
renin NN I-Gene
activity NN O
. . O

A DT O
semiautomatic JJ O
digital NN O
system NN O
( ( O
Videoplan NNP O
2 CD O
) ) O
was VBD O
used VBN O
. . O

No DT O
TATA NNP O
or CC O
Inr NNP O
sequence NN O
was VBD O
found VBN O
. . O

We PRP O
found VBD O
that IN O
virulent JJ O
Ngo NNP O
strains VBZ O
induce VB O
phosphorylation NN O
and CC O
activation NN O
of IN O
JNK NNP B-Gene
but CC O
not RB O
of IN O
p38 JJ B-Gene
kinase NN O
. . O

Mis3 NNP B-Gene
is VBZ O
needed VBN O
for IN O
the DT O
formation NN O
of IN O
18S CD B-Gene
ribosome JJ I-Gene
RNA NNP I-Gene
, , O
and CC O
may MD O
hence VB O
direct JJ O
the DT O
level NN O
of IN O
proteins NNS O
required VBN O
for IN O
the DT O
coupling NN O
. . O

The DT O
possible JJ O
mechanisms NNS O
underlying VBG O
differences NNS O
in IN O
post NN O
- : O
tetanic JJ O
effects NNS O
from IN O
muscle NN O
and CC O
cutaneous JJ O
afferents NNS O
in IN O
adults NNS O
and CC O
neonates NNS O
are VBP O
discussed VBN O
. . O

Who WP O
says VBZ O
' POS O
National NNP O
Health NNP O
Dis NNP O
- : O
service NN O
' '' O
. . O

Bronchial NNP O
mucosa NN O
tattooing VBG O
in IN O
persons NNS O
exposed VBN O
to TO O
different JJ O
industrial JJ O
aerosols NNS O
did VBD O
not RB O
depend VB O
on IN O
the DT O
forms NNS O
of IN O
PC NN O
, , O
DB NNP O
and CC O
the DT O
diseases NNS O
' POS O
stages NNS O
. . O

A DT O
new JJ O
intron NN O
of IN O
476 CD O
base NN O
pairs NN O
was VBD O
found VBN O
in IN O
the DT O
middle NN O
of IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
leader NN O
sequence NN O
and CC O
was VBD O
shown VBN O
to TO O
robustly VB O
enhance VB O
the DT O
promoter NN O
activity NN O
. . O

Indeed RB O
, , O
significant JJ O
level NN O
of IN O
CAT NNP B-Gene
activity NN O
was VBD O
observed VBN O
in IN O
human JJ O
lung NN O
adenocarcinoma NN O
( ( O
A549 NNP O
- : O
1 CD O
) ) O
cells NNS O
which WDT O
had VBD O
been VBN O
incubated VBN O
with IN O
a DT O
complex NN O
of IN O
T7 NNP B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
, , O
pT7 SYM B-Gene
- : I-Gene
EMC NNP I-Gene
- : I-Gene
CAT NNP I-Gene
DNA NNP I-Gene
and CC O
DC NNP O
- : O
chol NN O
cationic JJ O
liposomes NNS O
. . O

Spfkh1 NNP B-Gene
is VBZ O
transcribed VBN O
in IN O
one CD O
open JJ O
reading NN O
frame NN O
that WDT O
contains VBZ O
the DT O
DNA NN O
binding VBG O
domain NN O
, , O
nuclear JJ O
localization NN O
signal NN O
and CC O
transactivation NN O
domain NN O
. . O

Both DT O
methods NNS O
were VBD O
employed VBN O
for IN O
various JJ O
focal JJ O
- : O
film NN O
distances NNS O
, , O
image NN O
intensifier NN O
tube NN O
modes NNS O
and CC O
laser NN O
printer NN O
formats NNS O
. . O

We PRP O
also RB O
examined VBD O
the DT O
effect NN O
of IN O
proteolytic JJ O
processing NN O
in IN O
the DT O
MVE NNP O
nonstructural JJ O
polyprotein NN O
segment NN O
mediated VBN O
by IN O
the DT O
viral JJ B-Gene
proteinase NN I-Gene
NS3 NNP I-Gene
on IN O
antigen NN O
processing NN O
and CC O
presentation NN O
of IN O
the DT O
MVE NNP O
H NNP O
- : O
2Kk CD O
- : O
restricted VBN O
T NNP O
cell NN O
determinant NN O
. . O

These DT O
data NNS O
do VBP O
not RB O
support VB O
the DT O
use NN O
of IN O
LDD NNP O
to TO O
reduce VB O
risk NN O
of IN O
progression NN O
to TO O
MSOF NNP O
in IN O
sepsis NN O
. . O

Renal NNP O
cell NN O
carcinoma NN O
in IN O
children NNS O
: : O
a DT O
single JJ O
institution NN O
' POS O
s JJ O
experience NN O
. . O

This DT O
suggests VBZ O
that IN O
cardiovascular JJ O
magnetic JJ O
resonance NN O
is VBZ O
the DT O
preferred JJ O
technique NN O
for IN O
volume NN O
and CC O
ejection NN O
fraction NN O
estimation NN O
in IN O
heart NN O
failure NN O
patients NNS O
, , O
because IN O
of IN O
its PRP$ O
3D CD O
approach NN O
for IN O
non JJ O
- : O
symmetric JJ O
ventricles NNS O
and CC O
superior JJ O
image NN O
quality NN O
. . O

RA NNP O
- : O
treatment NN O
of IN O
these DT O
transfectants NNS O
induced VBD O
morphologic JJ O
and CC O
immunophenotypic JJ O
maturation NN O
, , O
changes NNS O
in IN O
RA NNP O
- : O
regulated VBN O
genes NNS O
, , O
and CC O
a DT O
G1 NNP O
cell NN O
cycle NN O
arrest NN O
in IN O
a DT O
manner NN O
similar JJ O
to TO O
parental JJ O
NT2 NNP O
/ NNP O
D1 NNP O
cells NNS O
. . O

One CD O
defective JJ O
RNA NNP O
with IN O
a DT O
large JJ O
deletion NN O
in IN O
the DT O
p70 NN B-Gene
coding VBG I-Gene
region NN I-Gene
was VBD O
able JJ O
to TO O
replicate VB O
efficiently RB O
, , O
both DT O
when WRB O
inoculated VBN O
with IN O
the DT O
helper NN O
genome NN O
and CC O
when WRB O
inoculated VBN O
with IN O
a DT O
second JJ O
complementing NN O
defective JJ O
RNA NNP O
that WDT O
supplied VBD O
a DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
p70 NN I-Gene
. . O

Dynamic NNP O
and CC O
static JJ O
scintigrams NNS O
, , O
using VBG O
99mtechnetium CD O
methylene JJ O
diphosphonate NN O
, , O
were VBD O
obtained VBN O
at IN O
zero CD O
, , O
six CD O
, , O
and CC O
12 CD O
weeks NNS O
after IN O
fracture NN O
. . O

Perceptual JJ O
learning NN O
for IN O
a DT O
pattern JJ O
discrimination NN O
task NN O
. . O

Northern NNP O
blot NN O
analyses VBZ O
show VBP O
that IN O
the DT O
hBub1 NN B-Gene
mRNA NN I-Gene
level NN O
is VBZ O
abundantly RB O
expressed VBN O
in IN O
tissues NNS O
or CC O
cells NNS O
with IN O
a DT O
high JJ O
mitotic JJ O
index NN O
. . O

Alternative JJ O
splicing NN O
of IN O
the DT O
cytoplasmic JJ O
tail NN O
appears VBZ O
to TO O
generate VB O
multiple JJ O
PECAM NNP B-Gene
- : I-Gene
1 CD I-Gene
isoforms NNS I-Gene
that WDT O
may MD O
regulate VB O
phosphorylation NN O
, , O
cytoskeletal JJ O
association NN O
, , O
and CC O
affinity NN O
modulation NN O
of IN O
the DT O
mature NN O
protein NN O
. . O

Clear JJ O
and CC O
evidenced VBD O
- : O
based VBN O
information NN O
should MD O
be VB O
provided VBN O
to TO O
patients NNS O
as IN O
to TO O
the DT O
means NNS O
of IN O
prevention NN O
with IN O
special JJ O
attention NN O
to TO O
individual JJ O
risk NN O
groups NNS O
such JJ O
as IN O
IV NNP O
drug NN O
abusers NNS O
. . O

Activation NN O
of IN O
the DT O
mitogen NN B-Gene
activated VBD I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinase NN I-Gene
is VBZ O
a DT O
primary JJ O
consequence NN O
of IN O
Ras NNP B-Gene
activation NN O
and CC O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
mediating VBG O
Ras NNP B-Gene
signal JJ O
transduction NN O
. . O

Using VBG O
site NN O
- : O
directed JJ O
mutagenesis NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
RAREoct NNP B-Gene
contributes VBZ O
to TO O
the DT O
transcriptional JJ O
activation NN O
of IN O
Oct NNP B-Gene
- : I-Gene
3 CD I-Gene
/ $ I-Gene
4 CD I-Gene
promoter NN I-Gene
in IN O
P19 NNP O
cells NNS O
and CC O
, , O
most RBS O
interestingly RB O
, , O
mediates VBZ O
the DT O
RA NNP O
- : O
induced JJ O
repression NN O
in IN O
RA NNP O
- : O
differentiated VBD O
EC NNP O
cells NNS O
. . O

In IN O
addition NN O
, , O
narZ JJ B-Gene
expression NN O
was VBD O
induced VBN O
approximately RB O
20 CD O
- : O
fold NN O
intracellularly RB O
in IN O
Madin NNP O
- : O
Darby NNP O
canine NN O
kidney NN O
epithelial JJ O
cells NNS O
and CC O
16 CD O
- : O
fold NN O
in IN O
intracellular JJ O
salts NNS O
medium NN O
, , O
which WDT O
is VBZ O
believed VBN O
to TO O
mimic VB O
the DT O
intracellular JJ O
milieu NN O
. . O

Surprisingly RB O
, , O
however RB O
, , O
TCR NNP B-Gene
- : O
mediated VBD O
tyrosine JJ O
phosphorylation NN O
of IN O
phospholipase NN B-Gene
C NNP I-Gene
gamma VBZ I-Gene
1 CD I-Gene
remains NNS O
intact JJ O
in IN O
the DT O
Jurkat NNP O
cells NNS O
expressing VBG O
the DT O
A2 NNP B-Gene
/ NNP O
HCP NNP B-Gene
chimera NN O
. . O

In IN O
addition NN O
, , O
mapping NN O
of IN O
the DT O
promoter NN O
region NN O
and CC O
the DT O
identification NN O
of IN O
putative JJ O
promoter NN O
regulatory JJ O
sequences NNS O
should MD O
give VB O
insight NN O
into IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
UCP2 NNP B-Gene
expression NN O
- : O
- : O
in IN O
particular JJ O
by IN O
anyone NN O
of IN O
the DT O
above NN O
mentioned VBD O
factors NNS O
- : O
- : O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

The DT O
sequence NN O
has VBZ O
a DT O
1092 CD O
- : O
bp NN O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
protein NN O
of IN O
364 CD O
amino JJ O
acids NNS O
. . O

The DT O
subjects NNS O
received VBD O
a DT O
single JJ O
500 CD O
mg NN O
dose NN O
of IN O
acetaminophen NN O
i NN O
. . O
v NN O
. . O
and CC O
concentrations NNS O
in IN O
plasma NN O
were VBD O
measured VBN O
for IN O
360 CD O
minutes NNS O
and CC O
in IN O
urine NN O
for IN O
24 CD O
h NN O
in IN O
order NN O
to TO O
estimate VB O
the DT O
production NN O
of IN O
metabolites NNS O
. . O

Two CD O
siblings NNS O
with IN O
hemolytic JJ O
anemia NN O
caused VBN O
by IN O
triosephosphate JJ B-Gene
isomerase NN I-Gene
deficiency NN O
developed VBD O
a DT O
progressive JJ O
neurological JJ O
syndrome NN O
featuring VBG O
dystonic JJ O
movements NNS O
, , O
tremor NN O
, , O
pyramidal JJ O
tract NN O
signs NNS O
, , O
and CC O
evidence NN O
of IN O
spinal JJ O
motor NN O
neuron NN O
involvement NN O
. . O

An DT O
inverted JJ O
Alu NNP B-Gene
repeat NN O
element NN O
, , O
flanked VBN O
by IN O
nonamer JJ O
direct JJ O
repeats NNS O
, , O
was VBD O
identified VBN O
within IN O
the DT O
region NN O
- : O
913 CD O
/ SYM O
- : O
620 CD O
, , O
relative JJ O
to TO O
the DT O
cap NN O
site NN O
. . O

Enoxacin NNP O
appears VBZ O
to TO O
be VB O
well RB O
suited VBN O
for IN O
the DT O
treatment NN O
of IN O
complicated JJ O
UTI NNP O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
effect NN O
of IN O
acute JJ O
administration NN O
of IN O
various JJ O
doses NNS O
of IN O
malathion NN O
via IN O
oral JJ O
and CC O
dermal JJ O
routes NNS O
to TO O
mice NNS O
and CC O
rats NNS O
on IN O
serum NN O
levels NNS O
of IN O
histamine NN O
was VBD O
evaluated VBN O
. . O

When WRB O
a DT O
plateau NN O
of IN O
enhancement NN O
was VBD O
reached VBN O
, , O
a DT O
single JJ O
lesion NN O
in IN O
each DT O
patient NN O
was VBD O
imaged VBN O
using VBG O
five CD O
different JJ O
continuous JJ O
scanning VBG O
modes NNS O
, , O
fundamental JJ O
grey NN O
scale NN O
( ( O
FGS NNP O
) ) O
; : O
fundamental JJ O
colour NN O
Doppler NNP O
( ( O
FCD NNP O
) ) O
; : O
fundamental JJ O
power NN O
Doppler NNP O
( ( O
FPD NNP O
) ) O
; : O
second JJ O
harmonic JJ O
grey NN O
scale NN O
( ( O
HGS NNP O
) ) O
; : O
and CC O
pulse VB O
inversion NN O
mode NN O
( ( O
Pim NNP O
) ) O
using VBG O
an DT O
HDI5000 NNP O
scanner NN O
and CC O
C5 NNP O
- : O
2 CD O
probe NN O
( ( O
ATL NNP O
, , O
Bothell NNP O
, , O
WA NNP O
) ) O
. . O

Varicella NNP B-Gene
- : I-Gene
zoster NN I-Gene
virus NN I-Gene
( ( I-Gene
VZV NNP I-Gene
) ) I-Gene
glycoprotein NN I-Gene
gI NN I-Gene
is VBZ O
a DT O
type NN B-Gene
1 CD I-Gene
transmembrane NN I-Gene
glycoprotein NN I-Gene
which WDT O
is VBZ O
one CD O
component NN O
of IN O
the DT O
heterodimeric JJ O
gE NN B-Gene
: : O
gI NN B-Gene
Fc NNP I-Gene
receptor NN I-Gene
complex NN O
. . O

A DT O
genomic JJ O
clone NN O
for IN O
the DT O
cyc07 NN B-Gene
gene NN I-Gene
, , O
which WDT O
is VBZ O
expressed VBN O
specifically RB O
at IN O
the DT O
S NNP O
phase NN O
during IN O
the DT O
cell NN O
cycle NN O
in IN O
synchronous JJ O
cultures NNS O
of IN O
periwinkle NN O
( ( O
Catharanthus NNP O
roseus NN O
) ) O
cells NNS O
, , O
was VBD O
isolated VBN O
. . O

3 CD O
. . O

NO DT O
metabolites NNS O
were VBD O
determined VBN O
by IN O
the DT O
measurement NN O
of IN O
nitrate JJ O
/ NNP O
nitrite NN O
( ( O
NOx NNP O
, , O
micromol NN O
/ NNP O
mmol NNP O
creatinine NN O
) ) O
and CC O
cyclic JJ O
guanosine NN O
monophosphate NN O
( ( O
cGMP NN O
, , O
nmol JJ O
/ NNP O
mmol NNP O
creatinine NN O
) ) O
in IN O
plasma NN O
and CC O
urine NN O
. . O

In IN O
this DT O
study NN O
the DT O
splenectomized VBN O
captive NN O
born VBN O
cynomolgus NN O
appeared VBD O
to TO O
be VB O
capable JJ O
of IN O
supplementing VBG O
rhesus NN O
as IN O
an DT O
antimalarial JJ O
drug NN O
testing VBG O
model NN O
. . O

Disruption NN O
of IN O
re NN O
- : O
replication NN O
control NN O
by IN O
overexpression NN O
of IN O
human JJ B-Gene
ORC1 NNP I-Gene
in IN O
fission NN O
yeast NN O
. . O

Since IN O
high JJ O
levels NNS O
of IN O
immunoglobulin NN B-Gene
G NNP I-Gene
were VBD O
demonstrated VBN O
against IN O
the DT O
surface NN O
of IN O
the DT O
NVS NNP O
after IN O
immunization NN O
, , O
passive JJ O
transfer NN O
experiments NNS O
were VBD O
initiated VBN O
. . O

A DT O
case NN O
report NN O
with IN O
angiographic JJ O
follow VBP O
- : O
up RB O
study NN O
. . O

Polypeptides NNS O
of IN O
the DT O
same JJ O
apparent JJ O
sizes NNS O
are VBP O
detected VBN O
in IN O
spores NNS O
of IN O
a DT O
cotE NN B-Gene
null NN O
mutant NN O
, , O
on IN O
which WDT O
basis NN O
we PRP O
infer VBP O
that IN O
the DT O
products NNS O
of IN O
the DT O
cotJ NN B-Gene
operon NN I-Gene
are VBP O
required VBN O
for IN O
the DT O
normal JJ O
formation NN O
of IN O
the DT O
inner JJ O
layers NNS O
of IN O
the DT O
coat NN O
or CC O
are VBP O
themselves PRP O
structural JJ O
components NNS O
of IN O
the DT O
coat NN O
. . O

We PRP O
find VBP O
that IN O
3T1 CD O
- : O
3T2 CD O
mixing NN O
has VBZ O
a DT O
pronounced JJ O
effect NN O
on IN O
the DT O
line NN O
shape NN O
and CC O
radiative JJ O
decay NN O
rate NN O
of IN O
emission NN O
from IN O
the DT O
3T2 CD O
state NN O
and CC O
that IN O
the DT O
extent NN O
of IN O
mixing VBG O
depends NNS O
critically RB O
on IN O
the DT O
magnitude NN O
of IN O
nontetrahedral JJ O
distortions NNS O
. . O

Moreover RB O
, , O
Western JJ O
blots NNS O
demonstrated VBN O
at IN O
least JJS O
six CD O
types NNS O
of IN O
Ypt NN B-Gene
in IN O
both DT O
Cr NNP O
and CC O
Vc NNP O
, , O
suggesting VBG O
that IN O
these DT O
Ypt NNP B-Gene
are VBP O
used VBN O
for IN O
household NN O
functions NNS O
responsible JJ O
for IN O
vesicle NN O
transport NN O
rather RB O
than IN O
for IN O
cellular JJ O
differentiation NN O
. . O

Alternatively RB O
, , O
the DT O
similarity NN O
in IN O
apparent JJ O
regulatory JJ O
action NN O
of IN O
the DT O
genes NNS O
may MD O
indicate VB O
allelic JJ O
differences NNS O
wherein VBP O
the DT O
IS1112C NNP B-Gene
Rf3 NNP B-Gene
allele NN I-Gene
may MD O
differ VB O
from IN O
alleles NNS O
of IN O
maintainer NN O
lines NNS O
by IN O
the DT O
capability NN O
to TO O
regulate VB O
both DT O
orf107 FW B-Gene
and CC O
urf209 JJ B-Gene
processing NN O
activities NNS O
. . O

The DT O
LAMMER NNP B-Gene
protein NN O
kinase NN O
encoded VBN O
by IN O
the DT O
Doa NNP B-Gene
locus NN I-Gene
of IN O
Drosophila NNP O
is VBZ O
required VBN O
in IN O
both DT O
somatic JJ O
and CC O
germline JJ O
cells NNS O
and CC O
is VBZ O
expressed VBN O
as IN O
both DT O
nuclear JJ O
and CC O
cytoplasmic JJ O
isoforms NNS O
throughout IN O
development NN O
. . O

This DT O
cohort NN O
of IN O
patients NNS O
was VBD O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
clinical JJ O
stage NN O
. . O

Polyadenylation NN O
of IN O
B4 NNP B-Gene
RNA NNP I-Gene
, , O
which WDT O
occurs VBZ O
very RB O
early JJ O
during IN O
maturation NN O
, , O
is VBZ O
limited VBN O
to TO O
150 CD O
residues NNS O
, , O
and CC O
it PRP O
is VBZ O
this DT O
number NN O
that WDT O
is VBZ O
required VBN O
for IN O
polysomal JJ O
recruitment NN O
. . O

The DT O
results NNS O
indicate VBP O
considerable JJ O
flexibility NN O
in IN O
the DT O
spacing NN O
between IN O
DH NNP B-Gene
regulatory JJ O
sites NNS O
. . O

We PRP O
also RB O
recovered VBD O
mutations NNS O
in IN O
the DT O
60A CD B-Gene
gene NN I-Gene
which WDT O
encodes VBZ O
another DT O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
related JJ I-Gene
factor NN I-Gene
in IN O
Drosophila NNP O
. . O

The DT O
standard JJ O
dosage NN O
of IN O
anti JJ B-Gene
- : I-Gene
D NNP I-Gene
currently RB O
given VBN O
at IN O
all DT O
gestational JJ O
ages NNS O
is VBZ O
1 CD O
ampoule NN O
containing VBG O
125 CD O
micrograms NNS O
of IN O
anti JJ B-Gene
- : I-Gene
D NN I-Gene
. . O

The DT O
transcriptional JJ O
unit NN O
spans VBZ O
a DT O
chromosomal JJ O
region NN O
of IN O
about IN O
55 CD O
kilobase NN O
pairs NNS O
( ( O
kbp NN O
) ) O
. . O

The DT O
CRE NNP O
, , O
5 CD O
' POS O
- : O
TGACGTCA NNP O
- : O
3 CD O
' '' O
, , O
has VBZ O
been VBN O
described VBN O
as IN O
the DT O
consensus NN O
sequence NN O
for IN O
the DT O
cis NN O
- : O
element NN O
that WDT O
directs VBZ O
cAMP SYM O
- : O
regulated VBN O
gene NN O
expression NN O
. . O

Beyond IN O
the DT O
Tower NNP O
of IN O
Babel NNP O
: : O
a DT O
nomenclature NN O
for IN O
suicidology NN O
. . O

1 CD O
A NNP O
colonic JJ O
delivery NN O
system NN O
is VBZ O
described VBN O
to TO O
deliver VB O
orally RB O
ingested VBN O
drugs NNS O
to TO O
the DT O
colon NN O
and CC O
release VB O
them PRP O
at IN O
that DT O
site NN O
by IN O
coating VBG O
with IN O
an DT O
acrylic NN O
based VBN O
resin NN O
( ( O
Eudragit NNP O
S NNP O
) ) O
. . O

Keeping VBG O
in IN O
mind NN O
the DT O
limited JJ O
range NN O
of IN O
age NN O
and CC O
dosages NNS O
, , O
advantages NNS O
and CC O
disadvantages NNS O
of IN O
the DT O
drug NN O
are VBP O
discussed VBN O
, , O
comparing VBG O
the DT O
experimental JJ O
results NNS O
with IN O
those DT O
derived VBN O
from IN O
the DT O
literature NN O
. . O

Transcription NNP O
factor NN O
binding VBG O
sites NNS O
downstream NN O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
transcription NN O
start NN O
site NN O
are VBP O
important JJ O
for IN O
virus JJ O
infectivity NN O
. . O

We PRP O
also RB O
reported VBD O
the DT O
identification NN O
of IN O
three CD O
corresponding VBG O
alternative JJ O
first JJ O
exons NNS O
and CC O
an DT O
intronic JJ O
promoter NN O
in IN O
the DT O
human JJ B-Gene
PDE5A NNP I-Gene
gene NN I-Gene
. . O

Corneal NNP O
scrapping NN O
and CC O
deep JJ O
stromal NN O
biopsy NN O
were VBD O
obtained VBN O
and CC O
stained VBN O
for IN O
microscopic NN O
evaluation NN O
with IN O
periodic JJ O
acid SYM O
- : O
Schiff NN O
, , O
Giemsa NNP O
, , O
and CC O
Gomori NNP O
' POS O
s JJ O
methenamine NN O
silver NN O
stains NNS O
. . O

Identification NN O
of IN O
p40x JJ O
- : O
responsive JJ O
regulatory JJ O
sequences NNS O
within IN O
the DT O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
long JJ O
terminal JJ O
repeat NN O
. . O

Peptide NNP O
sequences NNS O
of IN O
the DT O
zinc NN B-Gene
finger NN I-Gene
protein NN I-Gene
Ttk NNP I-Gene
and CC O
the DT O
transcription NN B-Gene
factor NN I-Gene
Adf NNP I-Gene
- : I-Gene
1 CD I-Gene
were VBD O
obtained VBN O
. . O

The DT O
Ras NNP B-Gene
- : I-Gene
related JJ I-Gene
GTPases NNS I-Gene
are VBP O
small JJ O
, , O
20 CD O
- : O
to TO O
25 CD O
- : O
kDa NN O
proteins NNS O
which WDT O
cycle NN O
between IN O
an DT O
inactive JJ O
GDP NNP O
- : O
bound NN O
form NN O
and CC O
an DT O
active JJ O
GTP NNP O
- : O
bound NN O
state NN O
. . O

An DT O
analysis NN O
of IN O
the DT O
steady JJ O
state NN O
RNA NNP O
levels NNS O
in IN O
T NNP O
- : O
lymphoid NN O
cell NN O
lines NNS O
showed VBD O
that IN O
at IN O
least JJS O
three CD O
different JJ O
incomplete JJ O
proviral JJ O
transcripts NNS O
and CC O
their PRP$ O
spliced JJ O
products NNS O
made VBN O
up RP O
the DT O
majority NN O
of IN O
expressed VBN O
RD NNP B-Gene
- : I-Gene
114 CD I-Gene
mRNA NN I-Gene
, , O
and CC O
further RB O
demonstrated VBD O
that IN O
partially RB O
deleted VBN O
proviral JJ O
loci NNS O
have VBP O
the DT O
potential JJ O
to TO O
be VB O
transcriptionally RB O
vigorous JJ O
in IN O
certain JJ O
feline NN O
cell NN O
types NNS O
. . O

Demyelinating VBG O
diseases NNS O
involving VBG O
the DT O
grey JJ O
matter NN O
were VBD O
very RB O
rare JJ O
, , O
but CC O
we PRP O
must MD O
consider VB O
the DT O
presence NN O
of IN O
symmetrical JJ O
thalamic JJ O
involvement NN O
in IN O
patients NNS O
with IN O
ADEM NNP O
. . O

Three CD O
- : O
dimensional JJ O
structural JJ O
studies NNS O
using VBG O
electron NN O
cryomicroscopy NN O
showed VBD O
that IN O
the DT O
binding NN O
of IN O
one CD O
Fab NNP B-Gene
( ( O
8H2 CD O
/ NNP O
G5 NNP O
) ) O
does VBZ O
not RB O
affect VB O
the DT O
conformation NN O
of IN O
the DT O
capsid NN O
, , O
and CC O
the DT O
efficiency NN O
of IN O
mRNA JJ O
production NN O
is VBZ O
similar JJ O
to TO O
that DT O
of IN O
the DT O
native JJ O
subviral JJ O
particle NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
PecS NNP B-Gene
attenuates VBZ O
pelD NNS B-Gene
and CC O
pelE JJ B-Gene
expression NN O
rather RB O
than IN O
acting VBG O
as IN O
a DT O
true JJ O
repressor NN O
like IN O
KdgR NNP B-Gene
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
Between NNP O
January NNP O
1992 CD O
and CC O
June NNP O
1994 CD O
at IN O
St NNP O
. . O

The DT O
overall JJ O
prevalence NN O
of IN O
HBV NNP O
markers NNS O
was VBD O
higher JJR O
among IN O
staff NN O
members NNS O
than IN O
in IN O
the DT O
blood NN O
donors NNS O
of IN O
our PRP$ O
area NN O
. . O

In IN O
several JJ O
studies NNS O
the DT O
RDFS NNP O
has VBZ O
shown VBN O
evidence NN O
of IN O
reliability NN O
and CC O
validity NN O
. . O

The DT O
sensitivity NN O
of IN O
human JJ O
neuroblastoma NN O
cells NNS O
SK NNP O
- : O
N NNP O
- : O
SH NN O
to TO O
undergo VB O
apoptosis NN O
induced VBN O
by IN O
thapsigargin NN O
was VBD O
examined VBN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
another DT O
cellular JJ O
protein NN O
linked VBD O
to TO O
BCR NNP B-Gene
/ NNP O
ABL NNP B-Gene
through IN O
the DT O
CRKL NNP B-Gene
- : O
SH2 NN B-Gene
domain NN O
is VBZ O
p130 JJ B-Gene
( ( O
CAS NNP B-Gene
) ) O
. . O

p130 NN B-Gene
( ( O
CAS NNP B-Gene
) ) O
was VBD O
found VBN O
to TO O
be VB O
tyrosine JJ O
phosphorylated VBN O
and CC O
associated VBN O
with IN O
CRKL NNP B-Gene
in IN O
BCR NNP B-Gene
/ NNP O
ABL NNP B-Gene
expressing VBG O
cell NN O
lines NNS O
and CC O
in IN O
samples NNS O
obtained VBN O
from IN O
CML NNP O
and CC O
ALL NNP O
patients NNS O
, , O
but CC O
not RB O
in IN O
samples NNS O
from IN O
controls NNS O
. . O

Immunological JJ O
and CC O
biochemical JJ O
characterization NN O
of IN O
streptococcal JJ B-Gene
pyrogenic NN I-Gene
exotoxins NNS I-Gene
I PRP I-Gene
and CC I-Gene
J NNP I-Gene
( ( O
SPE NNP B-Gene
- : I-Gene
I PRP I-Gene
and CC O
SPE NNP B-Gene
- : I-Gene
J NN I-Gene
) ) O
from IN O
Streptococcus NNP O
pyogenes NNS O
. . O

A DT O
number NN O
of IN O
serological JJ O
tests NNS O
measuring VBG O
the DT O
presence NN O
of IN O
Helicobacter NNP O
pylori FW O
- : O
specific JJ O
serum NN O
immunoglobulin NN B-Gene
G NNP I-Gene
( ( O
IgG NNP B-Gene
) ) O
are VBP O
now RB O
commercially RB O
available JJ O
. . O

Slowed NNP O
lysosomal JJ B-Gene
enzyme NN I-Gene
release NN O
and CC O
its PRP$ O
normalization NN O
by IN O
drugs NNS O
in IN O
adjuvant JJ O
- : O
induced JJ O
polyarthritis NN O
. . O

Among IN O
the DT O
total JJ O
CDSs NNP O
, , O
8 CD O
. . O
8 CD O
% NN O
match NN O
sequences NNS O
of IN O
proteins NNS O
found VBN O
only RB O
in IN O
Bacillus NNP O
subtilis NNS O
and CC O
66 CD O
. . O
7 CD O
% NN O
are VBP O
widely RB O
conserved VBN O
in IN O
comparison NN O
with IN O
the DT O
proteins NNS O
of IN O
various JJ O
organisms NNS O
, , O
including VBG O
B NNP O
. . O
subtilis NN O
. . O

The DT O
cDNA NN O
clone NN O
was VBD O
used VBN O
as IN O
a DT O
homologous JJ O
probe NN O
to TO O
isolate VB O
a DT O
truncated JJ O
genomic JJ O
clone NN O
encoding VBG O
H2A1 NNP B-Gene
. . O

CONCLUSION NN O
: : O
In IN O
women NNS O
who WP O
want VBP O
or CC O
require VBP O
conservative JJ O
management NN O
of IN O
grade NN O
4 CD O
prolapse NN O
and CC O
are VBP O
unable JJ O
to TO O
retain VB O
a DT O
single JJ O
pessary NN O
, , O
the DT O
placement NN O
of IN O
two CD O
pessaries NNS O
often RB O
will MD O
be VB O
successful JJ O
. . O

Furthermore RB O
, , O
Zelen NNP O
' POS O
s NN O
method NN O
is VBZ O
used VBN O
to TO O
balance VB O
the DT O
number NN O
of IN O
patients NNS O
allocated VBN O
to TO O
the DT O
two CD O
groups NNS O
within IN O
each DT O
institution NN O
( ( O
M NNP O
. . O

This DT O
alternatively RB O
spliced JJ O
transcript NN O
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
extending VBG O
from IN O
the DT O
upstream JJ O
J NNP O
alpha NN O
11 CD O
- : O
2 CD O
region NN O
to TO O
82 CD O
nucleotides NNS O
downstream NN O
of IN O
the DT O
beginning NN O
of IN O
the DT O
TCR NNP B-Gene
C NNP I-Gene
alpha JJ I-Gene
region NN I-Gene
, , O
and CC O
potentially RB O
encoded VBD O
a DT O
36 CD O
amino NN O
acid NN O
polypeptide NN O
. . O

The DT O
cis NN O
- : O
acting VBG O
element NN O
mediating VBG O
glucocorticoid JJ O
inducibility NN O
of IN O
the DT O
chicken NN B-Gene
glutamine NN I-Gene
synthetase NN I-Gene
gene NN I-Gene
has VBZ O
been VBN O
identified VBN O
. . O

TREB7 NNP B-Gene
and CC O
TREB36 NNP B-Gene
protected VBD O
all DT O
three CD O
repeats NNS O
of IN O
the DT O
21 CD O
bp NN O
, , O
but CC O
TREB5 NNP B-Gene
protected VBD O
only RB O
the DT O
second JJ O
repeat NN O
. . O

Although IN O
the DT O
expression NN O
of IN O
the DT O
4E CD B-Gene
- : I-Gene
BP1 NNP I-Gene
gene NN I-Gene
alone RB O
has VBZ O
not RB O
yet RB O
been VBN O
accomplished VBN O
, , O
the DT O
gene NN O
was VBD O
expressed VBN O
in IN O
Escherichia NNP O
coli VBP O
[ NNP O
BL21 NNP O
( ( O
DE3 NNP O
) ) O
] VBP O
as IN O
a DT O
fusion NN O
gene NN O
with IN O
the DT O
glutathione NN B-Gene
- : I-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
( ( O
GST NNP B-Gene
) ) O
gene NN O
using VBG O
a DT O
prokaryotic JJ O
gene NN O
fusion NN O
vector NN O
( ( O
pGEX JJ O
- : O
4T CD O
- : O
2 CD O
) ) O
, , O
which WDT O
contains VBZ O
a DT O
gene NN O
sequence NN O
coding VBG O
the DT O
cleavage NN O
site NN O
for IN O
a DT O
specific JJ O
protease NN O
, , O
alpha SYM B-Gene
- : I-Gene
thrombin NN I-Gene
. . O

Immunofluorescence NNP O
microscopy NN O
revealed VBD O
extensive JJ O
deposition NN O
of IN O
such JJ O
extracellular JJ O
matrices NNS O
as IN O
type NN B-Gene
IV NNP I-Gene
collagen NN I-Gene
and CC O
laminin NN B-Gene
in IN O
the DT O
vascular JJ O
wall NN O
. . O

Absorption NN O
of IN O
electrolytes NNS O
from IN O
the DT O
colon NN O
in IN O
cases NNS O
of IN O
ulcerative JJ O
colitis NN O
and CC O
in IN O
control NN O
subjects NNS O
. . O

Transfecting VBG O
the DT O
cloned JJ O
bovine NN O
PBR NNP B-Gene
/ NNP O
IBP NNP B-Gene
cDNA NN O
into IN O
COS NNP O
- : O
7 CD O
cells NNS O
resulted VBD O
in IN O
an DT O
11 CD O
- : O
fold JJ O
increase NN O
in IN O
the DT O
density NN O
of IN O
high JJ O
affinity NN O
[ VBP O
3H CD O
] NNP O
PK NNP O
11195 CD O
binding NN O
sites NNS O
which WDT O
had VBD O
only RB O
low JJ O
affinity NN O
for IN O
Ro5 NNP O
- : O
4864 CD O
. . O

It PRP O
was VBD O
also RB O
found VBN O
that IN O
there EX O
is VBZ O
no DT O
significant JJ O
difference NN O
between IN O
the DT O
prevalence NN O
of IN O
nasal JJ O
carriage NN O
of IN O
S NNP O
. . O
aureus NN O
amongst IN O
the DT O
hospital JJ O
staff NN O
and CC O
the DT O
patients NNS O
. . O

We PRP O
found VBD O
that IN O
TCR NNP B-Gene
signaling VBG O
induces NNS O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
to TO O
this DT O
site NN O
and CC O
regulates VBZ O
the DT O
fasl NN B-Gene
promoter NN I-Gene
function NN O
in IN O
a DT O
fashion NN O
dependent NN O
on IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
. . O

The DT O
decrease NN O
in IN O
HDL NNP B-Gene
- : I-Gene
cholesterol NN I-Gene
with IN O
increasing VBG O
VLDL NNP B-Gene
- : I-Gene
triglycerides NNS I-Gene
was VBD O
relatively RB O
much JJ O
larger JJR O
than IN O
the DT O
concomitant JJ O
decrease NN O
in IN O
apo NN B-Gene
A NNP I-Gene
- : I-Gene
I PRP I-Gene
. . O

To TO O
define VB O
the DT O
number NN O
and CC O
nature NN O
of IN O
the DT O
E6 NNP B-Gene
and CC O
E7 NNP B-Gene
gene NN I-Gene
products NNS O
expressed VBN O
in IN O
BPV NNP O
- : O
1 CD O
- : O
transformed NN O
cells NNS O
, , O
we PRP O
performed VBD O
immunoprecipitation NN O
experiments NNS O
with IN O
antisera NNS O
raised VBN O
to TO O
bacterially RB O
expressed VBN O
BPV NNP B-Gene
- : I-Gene
1 CD I-Gene
E6 NNP I-Gene
and CC O
E7 NNP B-Gene
fusion NN I-Gene
proteins NNS I-Gene
. . O

Promoter NNP O
region NN O
of IN O
the DT O
transcriptional JJ O
unit NN O
for IN O
human JJ B-Gene
alpha NN I-Gene
1 CD I-Gene
- : I-Gene
chimaerin NN I-Gene
, , O
a DT O
neuron NN B-Gene
- : I-Gene
specific JJ I-Gene
GTPase NNP I-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
for IN O
p21rac NN B-Gene
. . O
alpha VB B-Gene
1 CD I-Gene
- : I-Gene
chimaerin NN I-Gene
is VBZ O
a DT O
neuron JJ B-Gene
- : I-Gene
specific JJ I-Gene
GTPase NNP I-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
for IN O
p21rac NN B-Gene
, , O
a DT O
protein NN O
involved VBN O
in IN O
morphological JJ O
events NNS O
. . O

We PRP O
propose VBP O
that IN O
Mad NNP B-Gene
and CC O
Medea NNP B-Gene
encode NN O
rate NN O
- : O
limiting NN O
components NNS O
integral JJ O
to TO O
dpp VB B-Gene
pathways NNS O
throughout IN O
development NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
thrombin SYM B-Gene
- : O
stimulated VBN O
vascular JJ O
smooth JJ O
muscle NN O
proliferation NN O
is VBZ O
delayed VBN O
and CC O
requires VBZ O
the DT O
de FW O
novo FW O
expression NN O
of IN O
one CD O
or CC O
more JJR O
autocrine JJ O
mitogens NNS O
. . O

Interventions NNS O
aimed VBN O
at IN O
these DT O
specific JJ O
mediators NNS O
and CC O
processes NNS O
may MD O
be VB O
successful JJ O
in IN O
reducing VBG O
the DT O
very RB O
significant JJ O
human NN O
and CC O
economic JJ O
costs NNS O
of IN O
vascular JJ O
access NN O
dysfunction NN O
. . O

An DT O
even RB O
greater JJR O
inflammatory JJ O
response NN O
was VBD O
observed VBN O
after IN O
intratracheal JJ O
instillation NN O
of IN O
ufCB JJ O
, , O
but CC O
not RB O
after IN O
CB NNP O
instillation NN O
. . O

Using VBG O
either CC O
a DT O
p50 JJ B-Gene
- : O
or CC O
p65 VB B-Gene
- : I-Gene
selected VBN I-Gene
kappa NN I-Gene
B NNP I-Gene
motif NN I-Gene
, , O
which WDT O
displayed VBD O
differential JJ O
binding NN O
with IN O
respect NN O
to TO O
the DT O
other JJ O
protein NN O
, , O
little JJ O
to TO O
no DT O
binding NN O
was VBD O
observed VBN O
with IN O
the DT O
heterodimeric JJ B-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
complex NN I-Gene
. . O

Poliomyelitis NN O
from IN O
a DT O
vaccine NN O
. . O

The DT O
other JJ O
model NN O
was VBD O
a DT O
continuous JJ O
exponential JJ O
plus CC O
constant JJ O
of IN O
the DT O
form NN O
La NNP O
- : O
= VBZ O
a DT O
+ NN O
b NN O
[ NN O
exp NN O
( ( O
cVO2 NN O
) ) O
] NN O
. . O

DESIGN NN O
: : O
Retrospective JJ O
study NN O
. . O

Interaction NN O
of IN O
H NNP B-Gene
- : I-Gene
2Eb CD I-Gene
with IN O
an DT O
IAP NNP B-Gene
retrotransposon NN I-Gene
in IN O
the DT O
A20 NNP O
/ NNP O
2J CD O
B NNP O
cell NN O
lymphoma NN O
. . O

Improved VBN O
methods NNS O
have VBP O
been VBN O
developed VBN O
for IN O
maintaining VBG O
and CC O
breeding VBG O
the DT O
neotropical JJ O
short JJ O
- : O
tailed JJ O
fruit NN O
bat NN O
, , O
Carollia NNP O
perspicillata NN O
, , O
in IN O
an DT O
easily RB O
- : O
reproduced VBN O
, , O
laboratory JJ O
setting NN O
. . O

In IN O
only RB O
two CD O
patients NNS O
were VBD O
we PRP O
able JJ O
to TO O
demonstrate VB O
changes NNS O
suggestive CD O
of IN O
pulmonary JJ O
metastases NNS O
any DT O
earlier JJR O
with IN O
a DT O
99mTc CD O
- : O
EHDP NN O
scan JJ O
than IN O
with IN O
chest JJ O
radiographs NN O
and CC O
one CD O
of IN O
these DT O
resolved VBN O
spontaneously RB O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
further RB O
investigated VBD O
the DT O
regulation NN O
of IN O
the DT O
synthesis NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
mos JJ I-Gene
oncogene JJ I-Gene
product NN I-Gene
, , O
which WDT O
is VBZ O
necessary JJ O
for IN O
the DT O
activation NN O
of IN O
Cdc2 NNP B-Gene
. . O

The DT O
kinase NN O
inhibitor NN O
staurosporine NN O
( ( O
1 CD O
microM NN O
) ) O
blocks VBZ O
LPA NNP O
- : O
induced JJ O
, , O
but CC O
not RB O
epidermal JJ O
growth NN O
factor NN O
- : O
induced VBN O
, , O
activation NN O
of IN O
p21ras NNS B-Gene
and CC O
MAP NNP B-Gene
kinase NNP I-Gene
, , O
consistent NN O
with IN O
an DT O
intermediate JJ O
protein NN O
kinase NN O
linking VBG O
the DT O
LPA NNP B-Gene
receptor NN I-Gene
to TO O
p21ras VB B-Gene
activation NN O
. . O

The DT O
final JJ O
screening NN O
yielded VBD O
a DT O
clone NN O
containing VBG O
a DT O
2 CD O
kilobase NN O
( ( O
kb NN O
) ) O
insert NN O
. . O

Two CD O
evolutionarily RB O
conserved VBN O
kinases NNS O
, , O
the DT O
cyclin NN B-Gene
B NNP I-Gene
( ( O
Clb NNP B-Gene
) ) O
/ NNP O
cyclin SYM B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
( ( O
Cdk NNP B-Gene
/ NNP O
Cdc28p NNP B-Gene
) ) O
and CC O
Cdc7p NNP B-Gene
along IN O
with IN O
its PRP$ O
interacting VBG O
factor NN O
Dbf4p NNP B-Gene
, , O
are VBP O
required VBN O
late RB O
in IN O
G1 NNP O
to TO O
initiate VB O
DNA NNP O
replication NN O
. . O

Moreover RB O
, , O
radiolabeled VBD O
EFI NNP B-Gene
, , O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
, , O
or CC O
CBF NNP B-Gene
DNAs NNP I-Gene
give VBP O
rise NN O
to TO O
identical JJ O
gel NN O
retardation NN O
patterns NNS O
in IN O
extracts NNS O
from IN O
a DT O
variety NN O
of IN O
different JJ O
cell NN O
types NNS O
. . O

Laboratory NN O
aspects NNS O
with IN O
particular JJ O
reference NN O
to TO O
chemotherapy VB O
and CC O
control VB O
. . O

When WRB O
expressed VBN O
per IN O
kilogram NN O
body NN O
weight NN O
, , O
mean JJ O
GIT NNP O
increased VBD O
in IN O
the DT O
dF NN O
group NN O
from IN O
0 CD O
. . O
14 CD O
% NN O
to TO O
0 CD O
. . O
16 CD O
% NN O
above IN O
RMR NNP O
, , O
with IN O
a DT O
significant JJ O
decrease NN O
from IN O
0 CD O
. . O
15 CD O
% NN O
to TO O
0 CD O
. . O
13 CD O
% NN O
in IN O
the DT O
P NNP O
group NN O
. . O

However RB O
, , O
plasmids NNS O
carrying VBG O
the DT O
yeast NN B-Gene
TyrRS NNP I-Gene
gene NN I-Gene
could MD O
not RB O
be VB O
stably RB O
maintained VBN O
in IN O
E NNP O
. . O
coli NN O
. . O

Despite IN O
total JJ O
tumor NN O
resection NN O
, , O
multiple JJ O
intraperitoneal JJ O
tumor NN O
nodules NNS O
of IN O
varying VBG O
sizes NNS O
were VBD O
found VBN O
and CC O
resected VBN O
six CD O
months NNS O
and CC O
one CD O
year NN O
later RB O
. . O

SPECT NNP O
examination NN O
of IN O
the DT O
TMJ NNP O
using VBG O
99m CD O
Tc NNP O
- : O
MDP NN O
was VBD O
performed VBN O
in IN O
43 CD O
patients NNS O
with IN O
arthrographically RB O
proven VBN O
anterior JJ O
dislocation NN O
of IN O
the DT O
disc NN O
and CC O
in IN O
30 CD O
normals NNS O
. . O

Thus RB O
, , O
the DT O
induction NN O
of IN O
E2F NNP B-Gene
binding VBG O
to TO O
the DT O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
by IN O
the DT O
E4 NNP B-Gene
- : I-Gene
6 CD I-Gene
/ $ I-Gene
7 CD I-Gene
protein NN I-Gene
observed VBD O
in IN O
vitro NN O
correlates NNS O
with IN O
transactivation NN O
of IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
vivo NN O
. . O

The DT O
murine NN O
chromosomal JJ O
locations NNS O
of IN O
the DT O
five CD O
NMDA NNP B-Gene
receptor NN I-Gene
channel NN I-Gene
subunits NNS I-Gene
, , O
the DT O
epsilon NN B-Gene
1 CD I-Gene
( ( O
Grin2a NNP B-Gene
) ) O
, , O
epsilon $ B-Gene
2 CD I-Gene
( ( O
Grin2b NNP B-Gene
) ) O
, , O
epsilon $ B-Gene
3 CD I-Gene
( ( O
Grin2c NNP B-Gene
) ) O
, , O
epsilon $ B-Gene
4 CD I-Gene
( ( O
Grin2d NNP B-Gene
) ) O
and CC O
zeta $ B-Gene
1 CD I-Gene
( ( O
Grinl NNP B-Gene
) ) O
subunits NNS O
, , O
were VBD O
determined VBN O
using VBG O
an DT O
interspecific JJ O
backcross NN O
mapping NN O
panel NN O
derived VBN O
from IN O
crosses NNS O
of IN O
[ NNP O
( ( O
C57BL NNP O
/ VBZ O
6JxM CD O
. . O
spretus NN O
) ) O
F1xC57BL NNP O
/ $ O
6J CD O
] NNP O
mice NN O
. . O

Thus RB O
, , O
our PRP$ O
studies NNS O
suggest VBP O
that IN O
pV SYM O
- : O
mediated VBN O
activation NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
activity NN O
is VBZ O
controlled VBN O
by IN O
the DT O
nuclear JJ O
translocation NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
which WDT O
is VBZ O
mediated VBN O
by IN O
IkappaBalpha NNP B-Gene
serine NN O
phosphorylation NN O
and CC O
degradation NN O
, , O
but CC O
also RB O
by IN O
a DT O
still RB O
undefined JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
independent JJ O
pathway NN O
. . O

In IN O
situ JJ O
hybridization NN O
analysis NN O
in IN O
adult NN O
rat NN O
tissue NN O
reveals NNS O
good JJ O
correlation NN O
with IN O
this DT O
pattern NN O
and CC O
indicates VBZ O
that IN O
drm NN B-Gene
mRNA NN I-Gene
is VBZ O
most RBS O
highly RB O
expressed VBN O
in IN O
nondividing NN O
and CC O
terminally RB O
differentiated JJ O
cells NNS O
, , O
such JJ O
as IN O
neurons NNS O
, , O
type NN O
1 CD O
lung NN O
cells NNS O
, , O
and CC O
goblet NN O
cells NNS O
. . O

Because IN O
decreases NNS O
in IN O
the DT O
disfluency NN O
rates NNS O
of IN O
stutterers NNS O
were VBD O
observed VBN O
during IN O
the DT O
presentation NN O
of IN O
all DT O
three CD O
stimulus NN O
words NNS O
, , O
the DT O
data NNS O
failed VBD O
to TO O
support VB O
the DT O
operant JJ O
model NN O
. . O

The DT O
films NNS O
were VBD O
analyzed VBN O
using VBG O
a DT O
scanning VBG O
helium NN O
- : O
neon NN O
laser NN O
densitometer NN O
with IN O
a DT O
small JJ O
aperture NN O
of IN O
5 CD O
- : O
10 CD O
microns NNS O
. . O

These DT O
widely RB O
expressed VBN O
proteins NNS O
share NN O
a DT O
C NNP O
- : O
terminal JJ O
region NN O
that IN O
bears VBZ O
significant JJ O
sequence NN O
homology NN O
to TO O
a DT O
group NN O
of IN O
GDP NNP B-Gene
/ NNP I-Gene
GTP NNP I-Gene
exchange NN I-Gene
proteins NNS I-Gene
for IN O
the DT O
Rab3 NNP B-Gene
family NN I-Gene
of IN O
small JJ B-Gene
GTP NNP I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

Despite IN O
the DT O
high JJ O
frequency NN O
of IN O
natural JJ O
infection NN O
, , O
the DT O
seropositive JJ O
rates NNS O
of IN O
JEV NNP O
antibody NN O
still RB O
correlated VBN O
well RB O
with IN O
the DT O
dose NN O
of IN O
vaccine NN O
received VBN O
, , O
i NN O
. . O
e NN O
. . O
, , O
67 CD O
% NN O
( ( O
1122 CD O
/ IN O
1664 CD O
) ) O
, , O
66 CD O
% NN O
( ( O
65 CD O
/ RB O
97 CD O
) ) O
, , O
33 CD O
% NN O
( ( O
4 CD O
/ RB O
12 CD O
) ) O
and CC O
40 CD O
% NN O
( ( O
19 CD O
/ RB O
47 CD O
) ) O
for IN O
children NNS O
receiving VBG O
3 CD O
, , O
2 CD O
, , O
1 CD O
, , O
and CC O
0 CD O
dose NN O
of IN O
JE NNP O
vaccines NNS O
, , O
respectively RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
Chi NNP O
- : O
square NN O
for IN O
trend NN O
test NN O
) ) O
. . O

Urease NNP B-Gene
activity NN O
, , O
judged VBN O
as IN O
the DT O
amount NN O
of IN O
ammonia JJ O
production NN O
from IN O
urea JJ O
, , O
could MD O
be VB O
measured VBN O
at IN O
25 CD O
ng JJ O
per IN O
tube NN O
( ( O
S NNP O
/ NNP O
N NNP O
= VBD O
1 CD O
. . O
5 CD O
) ) O
with IN O
Jack NNP B-Gene
bean JJ I-Gene
meal NN I-Gene
urease NN I-Gene
. . O

The DT O
diagnostic JJ O
value NN O
of IN O
blood NN O
serum NN O
and CC O
urinary JJ B-Gene
amylase NN I-Gene
, , O
lipase NN B-Gene
, , O
and CC O
trypsin NN B-Gene
in IN O
exacerbations NNS O
of IN O
chronic JJ O
relapsing VBG O
pancreatitis NN O
is VBZ O
discussed VBN O
. . O

Evaluation NN O
of IN O
left JJ O
ventricular JJ O
function NN O
using VBG O
gated VBN O
planar JJ O
myocardial JJ O
imaging NN O
with IN O
Tc NNP O
- : O
99m CD O
- : O
MIBI NN O

Thirty NNP O
percent NN O
of IN O
patients NNS O
were VBD O
tapered VBN O
off RP O
all DT O
steroids NNS O
, , O
and CC O
the DT O
average JJ O
steroid NN O
dose NN O
in IN O
the DT O
group NN O
who WP O
received VBD O
steroids NNS O
was VBD O
8 CD O
. . O
6 CD O
mg NN O
of IN O
prednisone NN O
per IN O
day NN O
. . O

Codon NNP O
optimization NN O
for IN O
high JJ O
- : O
level NN O
expression NN O
of IN O
human JJ B-Gene
erythropoietin NN I-Gene
( ( O
EPO NNP B-Gene
) ) O
in IN O
mammalian JJ O
cells NNS O
. . O

The DT O
invasive JJ O
pattern NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
in IN O
the DT O
mandibular JJ O
gingiva NN O

In IN O
ICE NNP B-Gene
gamma NN I-Gene
, , O
most JJS O
of IN O
the DT O
propeptide NN O
( ( O
amino JJ O
acids NNS O
20 CD O
- : O
112 CD O
) ) O
is VBZ O
deleted VBN O
, , O
which WDT O
suggests VBZ O
that IN O
it PRP O
may MD O
function VB O
as IN O
a DT O
catalyst NN O
for IN O
ICE NNP B-Gene
autoprocessing VBG O
in IN O
vivo NN O
. . O

Role NNP O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
in IN O
simian JJ B-Gene
virus NN I-Gene
40 CD I-Gene
large JJ I-Gene
tumor NN I-Gene
antigen NN I-Gene
- : O
induced JJ O
DNA NNP O
synthesis NN O
in IN O
quiescent NN O
3T3 CD O
- : O
L1 NN O
mouse NN O
fibroblasts NNS O
. . O

A DT O
diagnosis NN O
of IN O
IgA NNP B-Gene
lambda FW I-Gene
multiple JJ O
myeloma NN O
with IN O
peritoneal JJ O
involvement NN O
was VBD O
made VBN O
. . O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
activated JJ O
GH NNP B-Gene
receptor NN I-Gene
can MD O
stimulate VB O
Stat1 NNP B-Gene
, , O
a DT O
cytoplasmic JJ O
transcription NN O
factor NN O
that WDT O
becomes VBZ O
tyrosine JJ O
phosphorylated VBN O
and CC O
translocates VBZ O
to TO O
the DT O
nucleus NN O
, , O
where WRB O
it PRP O
can MD O
interact VB O
with IN O
specific JJ O
DNA NNP O
sequences NNS O
to TO O
modulate VB O
gene NN O
expression NN O
. . O

The DT O
sequence NN O
of IN O
this DT O
region NN O
shows VBZ O
high JJ O
G NNP O
+ NNP O
C NNP O
content NN O
( ( O
62 CD O
% NN O
) ) O
, , O
which WDT O
is VBZ O
particularly RB O
emphasized VBN O
in IN O
the DT O
200 CD O
bp NN O
upstream NN O
from IN O
the DT O
mRNA JJ O
start NN O
( ( O
80 CD O
% NN O
G NNP O
+ NNP O
C NNP O
) ) O
. . O

Deglutition NN O
is VBZ O
considered VBN O
to TO O
be VB O
immature NN O
in IN O
infants NNS O
and CC O
to TO O
mature VB O
postnatally RB O
. . O

The DT O
IPL1 NNP B-Gene
gene NN I-Gene
is VBZ O
required VBN O
for IN O
high JJ O
- : O
fidelity NN O
chromosome NN O
segregation NN O
in IN O
the DT O
budding NN O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Previous JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
moderate JJ O
cooling NN O
increases VBZ O
the DT O
responsiveness NN O
of IN O
vascular JJ B-Gene
alpha2 SYM I-Gene
- : I-Gene
adrenoceptors NNS I-Gene
. . O

Efficacy NN O
of IN O
first JJ O
- : O
generation NN O
Cavermap NNP O
to TO O
verify VB O
location NN O
and CC O
function NN O
of IN O
cavernous JJ O
nerves NNS O
during IN O
radical JJ O
prostatectomy NN O
: : O
a DT O
multi JJ O
- : O
institutional JJ O
evaluation NN O
by IN O
experienced JJ O
surgeons NNS O
. . O

The DT O
consensus NN O
gene NN O
order NN O
deduced VBN O
by IN O
combining VBG O
data NNS O
from IN O
both DT O
crosses NNS O
is VBZ O
D2Mit1 NNP B-Gene
- : O
( ( O
Dbh NNP B-Gene
, , O
Notch1 NNP B-Gene
) ) O
- : O
( ( O
Col5a1 NNP B-Gene
, , O
Rxra NNP B-Gene
) ) O
- : O
Spna2 NNP B-Gene
- : O
Ab NNP B-Gene
l SYM I-Gene
- : O
( ( O
Ak1 NNP B-Gene
, , O
Fpgs NNP B-Gene
) ) O
- : O
( ( O
Grp78 NNP B-Gene
, , O
Pbx3 NNP B-Gene
) ) O
- : O
( ( O
Epb7 NNP B-Gene
. . I-Gene
2 CD I-Gene
, , I-Gene
Hc NNP I-Gene
, , I-Gene
Gsn NNP I-Gene
) ) O
- : O
Acra NN B-Gene
. . O

Thus RB O
, , O
the DT O
screen NN O
for IN O
toxic JJ O
p53 NN B-Gene
mutants NNS I-Gene
in IN O
yeast NN O
can MD O
identify VB O
novel JJ O
p53 NN B-Gene
variants NNS O
that WDT O
may MD O
be VB O
useful JJ O
in IN O
dissecting VBG O
p53 NN B-Gene
regulated VBD O
cellular JJ O
responses NNS O
and CC O
in IN O
developing VBG O
p53 NN B-Gene
- : O
based VBN O
cancer NN O
therapies NNS O
. . O

Sixteen NNP O
out IN O
of IN O
52 CD O
seropositive JJ O
MS NNP O
patients NNS O
( ( O
30 CD O
. . O
8 CD O
% NN O
) ) O
showed VBD O
intrathecal JJ O
synthesis NN O
of IN O
C NNP B-Gene
. . I-Gene
pneumoniae NN I-Gene
- : I-Gene
specific JJ I-Gene
IgG NNP I-Gene
but CC O
only RB O
one CD O
of IN O
43 CD O
seropositive JJ O
controls NNS O
( ( O
2 CD O
. . O
3 CD O
% NN O
) ) O
. . O

C3 NNP B-Gene
toxin NN I-Gene
completely RB O
inhibited VBD O
RhoA NNP B-Gene
function NN O
, , O
partially RB O
inhibited VBN O
SRE NNP O
: : O
Luc NNP B-Gene
activity NN O
, , O
but CC O
had VBD O
no DT O
effect NN O
on IN O
LPA NNP O
- : O
stimulated VBD O
c SYM B-Gene
- : I-Gene
Fos JJ I-Gene
expression NN O
. . O

The DT O
effectiveness NN O
of IN O
NRT NNP O
appears VBZ O
to TO O
be VB O
largely RB O
independent JJ O
of IN O
the DT O
intensity NN O
of IN O
additional JJ O
support NN O
provided VBD O
to TO O
the DT O
smoker NN O
. . O

Binding NNP O
of IN O
cell NN O
type NN O
- : O
specific JJ O
nuclear JJ O
proteins NNS O
to TO O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
maize NN B-Gene
C4 NNP I-Gene
phosphoenolpyruvate NN I-Gene
carboxylase NN I-Gene
gene NN I-Gene
confers NNS O
its PRP$ O
differential JJ O
transcription NN O
in IN O
mesophyll NN O
cells NNS O
. . O

The DT O
MMA NNP B-Gene
, , I-Gene
DMA NNP I-Gene
, , I-Gene
and CC I-Gene
TMA NNP I-Gene
methyltransferases NNS I-Gene
are VBP O
not RB O
homologs NNS O
; : O
however RB O
, , O
like IN O
the DT O
MMA NNP B-Gene
methyltransferase NN I-Gene
gene NN I-Gene
, , O
the DT O
genes NNS O
encoding VBG O
the DT O
DMA NNP B-Gene
and CC I-Gene
TMA NNP I-Gene
methyltransferases VBZ I-Gene
each DT O
contain NN O
a DT O
single JJ O
in IN O
- : O
frame NN O
amber JJ O
codon NN O
. . O

The DT O
first JJ O
exon NN O
encodes VBZ O
66 CD O
bp NN O
of IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
sequence NN O
, , O
while IN O
exon JJ O
2 CD O
encodes IN O
the DT O
coding NN O
and CC O
3 CD O
' '' O
- : O
untranslated JJ O
sequences NNS O
. . O

The DT O
coding NN O
sequence NN O
for IN O
a DT O
260 CD O
- : O
amino NN O
- : O
acid NN O
residue JJ O
polypeptide NN O
was VBD O
interrupted VBN O
by IN O
a DT O
single JJ O
short JJ O
intron NN O
of IN O
60 CD O
base NN O
pairs NN O
( ( O
bp NN O
) ) O
, , O
and CC O
about IN O
70 CD O
% NN O
of IN O
the DT O
deduced JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
Drosophila NNP B-Gene
PCNA NNP I-Gene
was VBD O
identical JJ O
to TO O
the DT O
rat NN O
and CC O
human JJ B-Gene
PCNA NNP I-Gene
polypeptides NNS I-Gene
, , O
with IN O
conserved VBN O
unique JJ O
repeats NNS O
of IN O
leucine NN O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
. . O

When WRB O
multiple JJ O
copies NNS O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
were VBD O
linked VBN O
to TO O
an DT O
enhancerless NN O
simian JJ B-Gene
virus NN I-Gene
40 CD I-Gene
promoter NN I-Gene
, , O
this DT O
element NN O
was VBD O
able JJ O
to TO O
mediate VB O
phorbol NN O
ester SYM O
- : O
or CC O
lipopolysaccharide VB O
- : O
inducible JJ O
gene NN O
expression NN O
. . O

Results NNS O
of IN O
the DT O
ECAT NNP O
Angina NNP O
Pectoris NNP O
Study NNP O
Group NNP O
. . O

V NNP O
. . O

We PRP O
report VBP O
here RB O
the DT O
cloning NN O
of IN O
the DT O
murine NN O
p44 NN B-Gene
MAP NNP B-Gene
kinase NN I-Gene
( ( O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
) ) O
gene NN O
, , O
the DT O
determination NN O
of IN O
its PRP$ O
intron NN O
/ NN O
exon NN O
boundaries NNS O
, , O
and CC O
the DT O
characterization NN O
of IN O
its PRP$ O
promoter NN O
. . O

The DT O
minimal JJ O
promoter NN O
of IN O
the DT O
RII NNP B-Gene
beta NN I-Gene
gene NN I-Gene
was VBD O
composed VBN O
of IN O
two CD O
adjacent JJ O
functional JJ O
elements NNS O
. . O

Iodine NNP O
deficiency NN O
disorders NNS O
in IN O
Bangladesh NNP O
. . O

These DT O
results NNS O
indicate VBP O
the DT O
presence NN O
of IN O
TATA NNP O
- : O
unified JJ O
transcription NN O
systems NNS O
in IN O
contemporary JJ O
eukaryotes NNS O
and CC O
provide VB O
insight NN O
into IN O
the DT O
residual JJ O
need NN O
for IN O
TBP NNP B-Gene
by IN O
all DT O
three CD O
Pols NNP B-Gene
in IN O
other JJ O
eukaryotes NNS O
despite IN O
a DT O
lack NN O
of IN O
TATA NNP O
elements NNS O
in IN O
their PRP$ O
promoters NNS O
. . O

We PRP O
showed VBD O
previously RB O
that IN O
a DT O
fusion NN O
protein NN O
( ( O
GAL4 NNP B-Gene
- : O
p40 NN B-Gene
) ) O
containing VBG O
the DT O
DNA NNP O
- : O
binding VBG O
domain NN O
of IN O
GAL4 NNP B-Gene
and CC O
sequences NNS O
of IN O
chicken NN B-Gene
l NN I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
p40 NN B-Gene
) ) O
inhibits VBZ O
growth NN O
in IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Oral JJ O
candidiasis NN O

Such JJ O
an DT O
intervention NN O
may MD O
be VB O
of IN O
considerable JJ O
use NN O
for IN O
the DT O
treatment NN O
of IN O
angiogenesis NN O
- : O
dependent NN O
diseases VBZ O
involving VBG O
FGF NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

The DT O
cleavage NN O
site NN O
between IN O
VPg NNP B-Gene
and CC O
RNA NNP B-Gene
dependent JJ I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
was VBD O
predicted VBN O
to TO O
be VB O
E445 NNP O
- : O
T446 NN O
based VBN O
on IN O
the DT O
amino NN O
acid JJ O
sequence NN O
analysis NN O
of IN O
the DT O
polyprotein NN O
from IN O
different JJ O
sobemoviruses NNS O
. . O

Regional JJ O
cerebral JJ O
blood NN O
flow NN O
( ( O
rCBF NN O
) ) O
measurements NNS O
and CC O
psychiatric JJ O
ratings NNS O
were VBD O
performed VBN O
on IN O
seven CD O
schizophrenic JJ O
patients NNS O
( ( O
mean JJ O
age NN O
= VBD O
41 CD O
. . O
4 CD O
years NNS O
) ) O
who WP O
had VBD O
been VBN O
examined VBN O
18 CD O
years NNS O
previously RB O
in IN O
a DT O
study NN O
that WDT O
used VBD O
similar JJ O
psychiatric JJ O
ratings NNS O
and CC O
a DT O
comparable JJ O
rCBF NN O
technique NN O
. . O

Analysis NN O
of IN O
the DT O
sequence NN O
identified VBD O
four CD O
open JJ O
reading VBG O
frames NNS O
( ( O
ORFs NNP O
) ) O
which WDT O
are VBP O
designated VBN O
UL1 NNP B-Gene
, , O
UL2 NNP B-Gene
, , O
UL3 NNP B-Gene
, , O
and CC O
UL3 NNP B-Gene
. . I-Gene
5 CD I-Gene
based VBN O
on IN O
their PRP$ O
homology NN O
with IN O
proteins NNS O
of IN O
herpes NNS O
simplex JJ O
virus SYM O
- : O
1 CD O
( ( O
HSV NNP O
- : O
1 CD O
) ) O
, , O
pseudorabies NNS O
virus VBP O
( ( O
PRV NNP O
) ) O
, , O
equine JJ O
herpesvirus NN O
- : O
1 CD O
, , O
and CC O
varicella SYM O
- : O
zoster NN O
virus NN O
. . O

Consistent JJ O
with IN O
the DT O
protein NN O
expression NN O
data NNS O
, , O
V NNP B-Gene
beta VBD I-Gene
8 CD I-Gene
. . I-Gene
3 CD I-Gene
gene NN I-Gene
transcripts NNS I-Gene
were VBD O
found VBN O
only RB O
in IN O
the DT O
transgenic JJ O
lines NNS O
with IN O
the DT O
wild JJ O
- : O
type NN O
promoter NN O
. . O

Cytochrome NNP B-Gene
b NN I-Gene
in IN O
human JJ B-Gene
complex JJ I-Gene
II NNP I-Gene
( ( O
succinate JJ B-Gene
- : I-Gene
ubiquinone JJ I-Gene
oxidoreductase NN I-Gene
) ) O
: : O
cDNA NN O
cloning NN O
of IN O
the DT O
components NNS O
in IN O
liver NN O
mitochondria NN O
and CC O
chromosome JJ O
assignment NN O
of IN O
the DT O
genes NNS O
for IN O
the DT O
large JJ O
( ( O
SDHC NNP B-Gene
) ) O
and CC O
small JJ O
( ( O
SDHD NNP B-Gene
) ) O
subunits VBZ O
to TO O
1q21 CD O
and CC O
11q23 CD O
. . O

Apo IN B-Gene
A NNP I-Gene
- : I-Gene
I PRP I-Gene
level VBP O
was VBD O
unrelated JJ O
to TO O
age NN O
, , O
but CC O
increased VBD O
with IN O
ethanol JJ O
consumption NN O
and CC O
decreased VBN O
with IN O
adiposity NN O
. . O

A DT O
great JJ O
deal NN O
of IN O
information NN O
is VBZ O
available JJ O
on IN O
the DT O
morphology NN O
of IN O
the DT O
claustrum NN O
in IN O
various JJ O
animal JJ O
species NNS O
, , O
as RB O
well RB O
as IN O
on IN O
its PRP$ O
neuronal JJ O
distribution NN O
and CC O
relationships NNS O
with IN O
the DT O
cerebral JJ O
cortex NN O
and CC O
other JJ O
nuclei NN O
. . O

The DT O
diabetic JJ O
state NN O
was VBD O
characterized VBN O
by IN O
mild JJ O
insulin NN B-Gene
deficiency NN O
, , O
plasma NN O
levels NNS O
being VBG O
73 CD O
% NN O
of IN O
controls NNS O
, , O
and CC O
mild JJ O
hyperglycemia NN O
, , O
with IN O
nonfasting JJ O
plasma NNS O
glucose JJ O
levels NNS O
of IN O
1 CD O
. . O
5 CD O
times NNS O
normal JJ O
. . O

Lesion NNP O
diameters NNS O
of IN O
greater JJR O
than IN O
20 CD O
mm NN O
and CC O
the DT O
large JJ O
sessile JJ O
- : O
type NN O
configurations NNS O
were VBD O
factors NNS O
that WDT O
were VBD O
associated VBN O
with IN O
incomplete JJ O
removal NN O
. . O

Here RB O
, , O
the DT O
cloning NN O
and CC O
characterization NN O
of IN O
S NNP B-Gene
- : I-Gene
RNase NNP I-Gene
genes NNS I-Gene
from IN O
two CD O
species NNS O
of IN O
Rosaceae NNP O
, , O
apple NN O
( ( O
Malus NNP O
x NNP O
domestica NN O
) ) O
and CC O
Japanese JJ O
pear NN O
( ( O
Pyrus NNP O
serotina NN O
) ) O
is VBZ O
described VBN O
and CC O
these DT O
sequences NNS O
are VBP O
compared VBN O
with IN O
those DT O
of IN O
other JJ O
T2 NNP B-Gene
- : I-Gene
type NN I-Gene
RNases NNS I-Gene
. . O

In IN O
a DT O
randomised JJ O
double JJ O
- : O
blind NN O
study NN O
, , O
46 CD O
first JJ O
episode NN O
schizophrenics NNS O
were VBD O
given VBN O
pimozide RB O
or CC O
flupenthixol NN O
for IN O
up IN O
to TO O
5 CD O
weeks NNS O
; : O
the DT O
mean JJ O
daily JJ O
dose NN O
at IN O
the DT O
end NN O
was VBD O
18 CD O
. . O
8 CD O
mg JJ O
pimozide NN O
and CC O
20 CD O
mg NN O
flupenthixol NN O
. . O

The DT O
PDE4A NNP B-Gene
- : I-Gene
subfamily RB I-Gene
- : I-Gene
specific JJ I-Gene
linker NN I-Gene
region NN I-Gene
LR1 NNP O
, , O
which WDT O
joins VBZ O
UCR1 NNP O
and CC O
UCR2 NNP O
, , O
is VBZ O
encoded VBN O
by IN O
two CD O
exons NNS O
, , O
whereas NNS O
LR2 NNP O
, , O
which WDT O
joins VBZ O
UCR2 NNP O
to TO O
the DT O
catalytic JJ O
unit NN O
, , O
is VBZ O
encoded VBN O
by IN O
a DT O
single JJ O
exon NN O
. . O

We PRP O
have VBP O
determined VBN O
that IN O
several JJ O
E1 NNP B-Gene
mutants NNS I-Gene
mapping VBG O
in IN O
both CC O
the DT O
M NNP O
and CC O
R NNP O
regions NNS O
and CC O
a DT O
single JJ O
mutant NN O
of IN O
the DT O
upstream JJ O
regulatory JJ O
region NN O
have VBP O
a DT O
higher JJR O
transforming NN O
activity NN O
on IN O
mouse NN O
C127 NNP O
cells NNS O
than IN O
the DT O
wild JJ O
- : O
type NN O
genome NN O
does VBZ O
. . O

Viral JJ O
infections NNS O
have VBP O
long RB O
been VBN O
suspected VBN O
to TO O
be VB O
causative JJ O
agents NNS O
in IN O
a DT O
number NN O
of IN O
inner JJ O
ear JJ O
dysfunctions NNS O
. . O

A DT O
second JJ O
even RB O
more RBR O
significant JJ O
match NN O
to TO O
this DT O
E NNP O
. . O
coli JJ O
region NN O
was VBD O
found VBN O
in IN O
the DT O
retroviral JJ B-Gene
ribonuclease NN I-Gene
H NNP I-Gene
( ( O
RNase NNP B-Gene
H NNP I-Gene
) ) O
domain NN O
, , O
and CC O
corresponds VBZ O
precisely RB O
to TO O
a DT O
region NN O
that WDT O
has VBZ O
been VBN O
aligned VBN O
by IN O
previous JJ O
investigators NNS O
with IN O
the DT O
E NNP B-Gene
. . I-Gene
coli VB I-Gene
RNase NNP I-Gene
H NNP I-Gene
, , O
suggesting VBG O
that IN O
Pol NNP B-Gene
I PRP I-Gene
helices VBP O
O NNP O
and CC O
P NNP O
are VBP O
homologous JJ O
to TO O
helices VB O
A NNP O
and CC O
D NNP O
of IN O
the DT O
RNase NNP B-Gene
H NNP I-Gene
crystal JJ O
structure NN O
, , O
respectively RB O
. . O

Demographic NNP O
and CC O
clinical JJ O
data NNS O
were VBD O
compared VBN O
with IN O
a DT O
control NN O
group NN O
of IN O
339 CD O
healthy JJ O
age NN O
- : O
matched VBN O
women NNS O
and CC O
with IN O
a DT O
sample NN O
of IN O
224 CD O
women NNS O
with IN O
wrist JJ O
fracture NN O
. . O

The DT O
pre NN O
- : O
and CC O
postoperative JJ O
haemoglobin NN B-Gene
concentrations NNS O
in IN O
the DT O
autologous JJ O
group NN O
were VBD O
lower JJR O
by IN O
15 CD O
and CC O
10 CD O
g NN O
/ NNP O
L NNP O
, , O
respectively RB O
, , O
after IN O
primary JJ O
THR NNP O
and CC O
by IN O
10 CD O
g NNS O
/ JJ O
L NNP O
in IN O
both DT O
instances NNS O
after IN O
revision NN O
THR NNP O
. . O

The DT O
pharmacokinetic JJ O
profiles NNS O
of IN O
digoxin NN O
and CC O
warfarin NN O
were VBD O
not RB O
altered VBN O
by IN O
the DT O
simultaneous JJ O
and CC O
continued JJ O
administration NN O
of IN O
sevelamer NN O
. . O

Oligonucleotides NNS O
, , O
designed VBN O
on IN O
the DT O
basis NN O
of IN O
conserved JJ O
flanking NN O
amino NN O
acid JJ O
sequence NN O
segments NNS O
within IN O
the DT O
catalytic JJ O
domain NN O
of IN O
eukaryotic JJ B-Gene
protein NN I-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
proteins NNS O
, , O
were VBD O
used VBN O
as IN O
primers NNS O
for IN O
polymerase NN O
chain NN O
reactions NNS O
to TO O
amplify VB O
a DT O
427 CD O
- : O
bp NN O
chromosomal JJ O
DNA NNP O
fragment NN O
from IN O
the DT O
filamentous JJ O
fungus NN O
Trichoderma NNP O
reesei NN O
. . O

Below IN O
50 CD O
% NN O
decrease NN O
of IN O
PaO2 NNP O
, , O
NADH NNP O
was VBD O
reduced VBN O
largely RB O
. . O

These DT O
and CC O
other JJ O
comparisons NNS O
suggest VBP O
that IN O
, , O
during IN O
evolution NN O
, , O
both CC O
the DT O
RNA NNP B-Gene
- : I-Gene
polymerase NN I-Gene
specificity NN O
of IN O
telomerase NN B-Gene
RNA NNP I-Gene
- : I-Gene
gene NN I-Gene
promoters NNS I-Gene
and CC O
, , O
more RBR O
recently RB O
, , O
the DT O
position NN O
of IN O
the DT O
template NN O
sequence NN O
in IN O
the DT O
telomerase NN B-Gene
RNA NNP I-Gene
changed VBD O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
show VBP O
that IN O
, , O
like IN O
BAP2 NNP B-Gene
, , O
the DT O
expression NN O
of IN O
the DT O
BAP3 NNP B-Gene
gene NN I-Gene
in IN O
S NNP O
. . O
cerevisiae NN O
is VBZ O
induced VBN O
by IN O
the DT O
addition NN O
of IN O
branched VBN O
- : O
chain NN O
amino JJ O
acids NNS O
to TO O
the DT O
medium NN O
. . O

Mutations NNS O
in IN O
the DT O
yeast NN B-Gene
RNA14 NNP I-Gene
and CC O
RNA15 NNP B-Gene
genes NNS I-Gene
result NN O
in IN O
an DT O
abnormal JJ O
mRNA NN O
decay NN O
rate NN O
; : O
sequence NN O
analysis NN O
reveals VBZ O
an DT O
RNA NNP O
- : O
binding NN O
domain NN O
in IN O
the DT O
RNA15 NNP B-Gene
protein NN I-Gene
. . O

One CD O
gene NN O
appears VBZ O
ubiquitously RB O
expressed VBN O
while IN O
the DT O
other JJ O
is VBZ O
prominently RB O
expressed VBN O
in IN O
muscle NN O
. . O

Batch NNP O
cultures NNS O
of IN O
S NNP O
. . O
mutans NNS O
serotype VBP O
a DT O
demonstrated JJ O
no DT O
growth NN O
on IN O
MSB NNP O
agar NN O
. . O

VaI NNP O
and CC O
VaII NNP O
co VBP O
- : O
immunoprecipitated VBN O
with IN O
ErbB2 NNP B-Gene
, , O
but CC O
not RB O
with IN O
ErbB1 NNP B-Gene
, , O
ErbB3 NNP B-Gene
, , O
or CC O
ErbB4 NNP B-Gene
. . O

Restriction NN O
mapping VBG O
analysis NN O
localized VBD O
this DT O
cDNA NN O
to TO O
the DT O
HHV NNP B-Gene
- : I-Gene
6A CD I-Gene
( ( I-Gene
U1102 NNP I-Gene
) ) I-Gene
genomic VBP I-Gene
BamHI NNP I-Gene
G NNP I-Gene
fragment NN I-Gene
, , O
at IN O
the DT O
right JJ O
end NN O
of IN O
the DT O
unique JJ O
long JJ O
segment NN O
of IN O
the DT O
genome NN O
and CC O
to TO O
the DT O
SalI NNP B-Gene
L NNP I-Gene
and CC O
SalI NNP B-Gene
O NNP I-Gene
fragments NNS I-Gene
within IN O
the DT O
left NN O
and CC O
right JJ O
terminal NN O
direct JJ O
repeat NN O
regions NNS O
, , O
respectively RB O
. . O

Assembly RB O
of IN O
a DT O
complex JJ O
between IN O
FAK NNP B-Gene
and CC O
Src NNP B-Gene
kinases NNS I-Gene
may MD O
serve VB O
to TO O
regulate VB O
the DT O
subcellular JJ O
localization NN O
and CC O
the DT O
enzymatic JJ O
activity NN O
of IN O
members NNS O
of IN O
the DT O
Src NNP B-Gene
family NN I-Gene
of IN O
kinases NNS O
. . O

Adaptation NN O
of IN O
taurocholate JJ O
transport NN O
maximum NN O
to TO O
increased VBN O
secretory NN O
load NN O
in IN O
the DT O
rat NN O
. . O

The DT O
level NN O
of IN O
carboxyl JJ B-Gene
- : I-Gene
terminal JJ I-Gene
parathyroid NN I-Gene
hormone NN I-Gene
in IN O
the DT O
patients NNS O
with IN O
thyroid JJ O
carcinoma NN O
was VBD O
higher JJR O
than IN O
that DT O
in IN O
the DT O
patients NNS O
without IN O
thyroid JJ O
carcinoma NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
Euglena NNP B-Gene
ribosomal NN I-Gene
protein NN I-Gene
gene NN I-Gene
cluster NN I-Gene
resembles VBZ O
the DT O
S NNP B-Gene
- : I-Gene
10 CD I-Gene
ribosomal JJ I-Gene
protein NN I-Gene
operon NN I-Gene
of IN I-Gene
Escherichia NNP I-Gene
coli NNS I-Gene
in IN O
gene NN O
organization NN O
and CC O
follows VBZ O
the DT O
exact JJ O
linear JJ O
order NN O
of IN O
the DT O
analogous JJ O
genes NNS O
in IN O
the DT O
tobacco NN O
and CC O
liverwort NN O
chloroplast NN O
genomes NNS O
. . O

HTLV NNP O
- : O
1 CD O
gene NN O
expression NN O
by IN O
defective JJ O
proviruses NNS O
in IN O
an DT O
infected JJ O
T NNP O
- : O
cell NN O
line NN O
. . O

HCV NNP O
infection NN O
acquired VBD O
during IN O
or CC O
after IN O
BMT NNP O
caused VBD O
only RB O
mild JJ O
acute JJ O
hepatitis NN O
C NNP O
, , O
which WDT O
progressed VBD O
to TO O
chronic VB O
hepatitis NN O
C NNP O
in IN O
one CD O
patient NN O
surviving VBG O
10 CD O
years NNS O
after IN O
BMT NNP O
. . O

Hepatocellular JJ O
injury NN O
during IN O
preservation NN O
of IN O
human JJ O
livers NNS O
with IN O
UW NNP O
and CC O
HTK NNP O
solution NN O
. . O

Sequence NN O
analysis NN O
reveals NNS O
that IN O
the DT O
newly RB O
discovered VBN O
oasA2 JJ B-Gene
gene NN I-Gene
represents VBZ O
a DT O
pseudogene NN O
that WDT O
is VBZ O
still RB O
transcribed VBN O
, , O
but CC O
is VBZ O
not RB O
functionally RB O
translated VBN O
. . O

Moreover RB O
, , O
in IN O
transient JJ O
transfection NN O
assays NNS O
, , O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
alone RB O
activated JJ O
reporter NN O
constructs NNS O
containing VBG O
the DT O
JB NNP O
cis SYM O
- : O
element NN O
, , O
and CC O
the DT O
activation NN O
was VBD O
shown VBN O
to TO O
be VB O
dependent JJ O
on IN O
a DT O
glutamine NN O
- : O
rich JJ O
sequence NN O
in IN O
the DT O
amino NN O
- : O
terminal JJ O
portion NN O
of IN O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
. . O

Brucellosis NNP O
- : O
- : O
1990 CD O

H NNP O
- : O
7 CD O
, , O
which WDT O
specifically RB O
, , O
although IN O
weakly NN O
, , O
inhibited VBN O
PKC NNP B-Gene
activation NN O
, , O
had VBD O
no DT O
effect NN O
on IN O
tyrosine NN O
phosphorylation NN O
and CC O
PtdIns NNP O
( ( O
3 CD O
, , O
4 CD O
) ) O
P2 NNP O
production NN O
. . O

It PRP O
is VBZ O
also RB O
homologous JJ O
to TO O
other JJ O
sugar NN O
carriers NNS O
from IN O
human JJ O
, , O
mouse NN O
and CC O
Escherichia NNP O
coli NNS O
. . O

Adjustment NN O
for IN O
age NN O
, , O
total JJ O
cholesterol NN O
, , O
HDL NNP B-Gene
cholesterol NN I-Gene
, , O
triglycerides NNS O
, , O
current JJ O
smoking NN O
, , O
and CC O
systolic JJ O
pressure NN O
slightly RB O
reduced VBD O
the DT O
association NN O
between IN O
fibrinogen NN B-Gene
and CC O
atherosclerosis NN O
. . O

Although IN O
we PRP O
predicted VBD O
that IN O
overexpression NN O
of IN O
the DT O
COOH NNP O
- : O
terminal NN O
domains NNS O
, , O
which WDT O
were VBD O
thought VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
SREBP NNP B-Gene
processing NN O
, , O
would MD O
result VB O
in IN O
disruption NN O
of IN O
the DT O
SREBP NNP B-Gene
- : O
dependent JJ O
transcriptional JJ O
regulation NN O
of IN O
several JJ O
genes NNS O
, , O
the DT O
mRNA NN O
levels NNS O
for IN O
3 CD B-Gene
- : I-Gene
hydroxy NN I-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
methylglutaryl NN I-Gene
coenzyme VBZ I-Gene
A NNP I-Gene
( ( I-Gene
HMG NNP I-Gene
CoA NNP I-Gene
) ) I-Gene
synthase NN I-Gene
in IN O
these DT O
two CD O
cell NN O
lines NNS O
were VBD O
regulated VBN O
in IN O
a DT O
sterol NN O
- : O
dependent JJ O
manner NN O
. . O

A DT O
statistically RB O
significant JJ O
improvement NN O
due JJ O
to TO O
the DT O
administration NN O
of IN O
Bromergon NNP O
was VBD O
observed VBN O
in IN O
symptoms NNS O
associated VBN O
with IN O
overreactiveness NN O
to TO O
normal JJ O
prolactin NN B-Gene
levels NNS O
, , O
i NN O
. . O
e NN O
. . O
abdominal JJ O
tension NN O
, , O
edema NN O
, , O
weight VBD O
gain NN O
and CC O
breast NN O
tenderness NN O
. . O

Liver NNP O
dysfunction NN O
in IN O
the DT O
presence NN O
of IN O
different JJ O
adverse JJ O
reactions NNS O
presented VBN O
with IN O
a DT O
higher JJR O
activity NN O
in IN O
the DT O
blood NN O
serum NN O
of IN O
indicator NN O
liver NN O
enzymes NNS O
and CC O
its PRP$ O
impaired JJ O
protein NN O
- : O
forming NN O
function NN O
. . O

However RB O
, , O
unlike IN O
the DT O
SIN3 NNP B-Gene
gene NN I-Gene
of IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
pst1 NN B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
is VBZ O
essential JJ O
for IN O
cell NN O
viability NN O
. . O

Importantly RB O
, , O
concomitant JJ O
expression NN O
of IN O
constitutive JJ O
activated VBN O
Raf NNP B-Gene
and CC O
V12N38 NNP B-Gene
Ras NNP I-Gene
results NNS O
in IN O
almost RB O
complete JJ O
loss NN O
of IN O
TTF NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
. . O

The DT O
peroxisome JJ O
biogenesis NN O
disorders NNS O
( ( O
PBDs NNP O
) ) O
are VBP O
a DT O
set NN O
of IN O
lethal JJ O
genetic JJ O
diseases NNS O
characterized VBN O
by IN O
peroxisomal JJ O
metabolic JJ O
deficiencies NNS O
, , O
multisystem NN O
abnormalities NNS O
, , O
mental JJ O
retardation NN O
, , O
and CC O
premature JJ O
death NN O
. . O

The DT O
sub NN O
- : O
acute JJ O
inhalation NN O
toxicity NN O
of IN O
furfural NN O
was VBD O
studied VBN O
in IN O
Syrian JJ O
golden JJ O
hamsters NNS O
. . O

A DT O
. . O

Here RB O
we PRP O
report VBP O
that IN O
in IN O
cultured JJ O
cells NNS O
from IN O
Drosophila NNP O
melanogaster NN O
human JJ B-Gene
Sp1 NNP I-Gene
efficiently RB O
activates VBZ O
transcription NN O
from IN O
synthetic JJ O
promoters NNS O
containing VBG O
TATA NNP O
boxes NNS O
, , O
but CC O
not RB O
from IN O
promoters NNS O
that WDT O
contain VBP O
an DT O
initiator NN O
instead RB O
of IN O
a DT O
TATA NNP O
box NN O
. . O

D3S1261 NNP B-Gene
is VBZ O
physically RB O
located VBN O
at IN O
or CC O
near IN O
the DT O
MITF NNP B-Gene
locus NN I-Gene
, , O
while IN O
D3S2465 NNP B-Gene
and CC O
D3S1766 NNP B-Gene
are VBP O
flanking VBG O
the DT O
locus NN O
at IN O
about IN O
17 CD O
. . O
5 CD O
cM JJ O
genetic JJ O
distance NN O
each DT O
side NN O
. . O

Altogether RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
Ypt51p NNP B-Gene
, , O
Ypt52p NNP B-Gene
, , O
and CC O
Ypt53p NNP B-Gene
are VBP O
required VBN O
for IN O
transport NN O
in IN O
the DT O
endocytic JJ O
pathway NN O
and CC O
for IN O
correct JJ O
sorting NN O
of IN O
vacuolar JJ B-Gene
hydrolases NNS I-Gene
suggesting VBG O
a DT O
possible JJ O
intersection NN O
of IN O
the DT O
endocytic JJ O
with IN O
the DT O
vacuolar JJ O
sorting VBG O
pathway NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
both DT O
PKC NNP B-Gene
alpha NN I-Gene
( ( O
calcium JJ O
dependent NN O
) ) O
and CC O
PKC NNP B-Gene
delta NN I-Gene
( ( O
calcium JJ O
independent JJ O
) ) O
may MD O
mediate VB O
the DT O
transcription NN O
of IN O
TPA NNP O
- : O
inducible JJ O
genes NNS O
through IN O
both DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
non JJ O
- : O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
sequences NNS O
. . O

Endometrial JJ O
biopsies NNS O
and CC O
plasma NN O
oestradiol NN O
( ( O
E2 NNP O
) ) O
and CC O
progesterone NN O
( ( O
P4 NNP O
) ) O
levels NNS O
in IN O
23 CD O
patients NNS O
were VBD O
evaluated VBN O
during IN O
26 CD O
replacement NN O
therapy NN O
cycles NNS O
for IN O
premature NN O
ovarian JJ O
failure NN O
. . O

Mapping NN O
of IN O
the DT O
DNA NNP O
binding VBG O
domain NN O
of IN O
the DT O
copper NN O
- : O
responsive JJ O
transcription NN O
factor NN O
Mac1 NNP B-Gene
from IN I-Gene
Saccharomyces NNP I-Gene
cerevisiae NN I-Gene
. . O

Tiaprofenic JJ O
acid NN O
overdose NN O
. . O

Mean NNP O
weighted VBD O
skin JJ O
temperature NN O
( ( O
Tsk NNP O
) ) O
was VBD O
lower JJR O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
following VBG O
acclimation NN O
than IN O
before RB O
, , O
and CC O
acclimation NN O
resulted VBD O
in IN O
a DT O
larger JJR O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
Tre NNP O
- : O
to TO O
- : O
Tsk NNP O
gradient NN O
. . O

In IN O
addition NN O
, , O
we PRP O
identified VBD O
a DT O
novel JJ O
type NN O
of IN O
inhibitory NN O
domain NN O
in IN O
the DT O
N NNP O
- : O
terminal JJ O
60 CD O
amino JJ O
acids NNS O
of IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
which WDT O
strongly RB O
inhibits VBZ O
its PRP$ O
transcriptional JJ O
activity NN O
. . O

Several JJ O
free JJ O
2nd CD O
- : O
generation NN O
schizonts NNS O
, , O
which WDT O
varied VBD O
in IN O
diameter NN O
from IN O
11 CD O
to TO O
21 CD O
. . O
6 CD O
micrometer NN O
, , O
were VBD O
found VBN O
on IN O
the DT O
epithelial JJ O
surface NN O
of IN O
the DT O
cecum NN O
. . O

A DT O
new JJ O
echocardiographic JJ O
technique NN O
is VBZ O
described VBN O
with IN O
a DT O
conventional JJ O
M NNP O
mode NN O
, , O
digitalised VBD O
2D CD O
and CC O
tissular JJ O
Doppler NNP O
which WDT O
has VBZ O
a DT O
comparable JJ O
ability NN O
to TO O
identify VB O
the DT O
anomalous JJ O
pathways NNS O
of IN O
electric JJ O
conduction NN O
using VBG O
a DT O
non JJ O
- : O
invasive JJ O
method NN O
. . O

In IN O
the DT O
Center NNP O
for IN O
Human NNP O
Genetics NNP O
in IN O
Leuven NNP O
, , O
predictive JJ O
DNA NNP O
- : O
testing VBG O
for IN O
Huntington NNP O
' POS O
s JJ O
disease NN O
is VBZ O
available JJ O
as IN O
a DT O
clinical JJ O
service NN O
since IN O
November NNP O
1987 CD O
, , O
initially RB O
by IN O
DNA NNP O
- : O
linkage NN O
and CC O
since IN O
mid NN O
1993 CD O
by IN O
direct JJ O
mutation NN O
analysis NN O
. . O

Contrary JJ O
to TO O
the DT O
observation NN O
made VBN O
with IN O
other JJ O
S NNP O
. . O
pombe NN O
genes NNS O
transcribed VBN O
in IN O
the DT O
budding NN O
yeast NN O
, , O
the DT O
heterologous JJ O
actin NN B-Gene
gene NN I-Gene
transcript NN I-Gene
is VBZ O
initiated VBN O
39 CD O
nucleotides NNS O
upstream NN O
of IN O
the DT O
initiation NN O
start NN O
site NN O
used VBN O
in IN O
the DT O
homologous JJ O
yeast NN O
. . O

Calcifications NNS O
in IN O
the DT O
thoracic NN O
aorta NN O
at IN O
the DT O
level NN O
of IN O
the DT O
11th CD O
and CC O
the DT O
12th CD O
thoracic NN O
vertebrae NN O
in IN O
592 CD O
men NNS O
and CC O
333 CD O
women NNS O
were VBD O
studied VBN O
using VBG O
computed JJ O
tomography NN O
. . O

Inactivation NN O
of IN O
Ulp2 NNP B-Gene
also RB O
suppresses VBZ O
several JJ O
ulp1 NNS B-Gene
( ( I-Gene
ts NN I-Gene
) ) I-Gene
defects NNS O
, , O
and CC O
the DT O
double JJ O
mutant NN O
accumulates VBZ O
far RB O
fewer JJR O
Smt3 NNP B-Gene
- : I-Gene
protein NN I-Gene
conjugates VBZ O
than IN O
either DT O
single JJ O
mutant NN O
. . O

In IN O
order NN O
to TO O
study VB O
the DT O
structural JJ O
and CC O
functional JJ O
organization NN O
of IN O
the DT O
eukaryotic JJ O
nucleolus NN O
, , O
we PRP O
have VBP O
started VBN O
to TO O
isolate VB O
and CC O
characterize VB O
nucleolar JJ O
components NNS O
of IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Two CD O
variant JJ O
PRP NNP B-Gene
- : I-Gene
precursor NN I-Gene
alleles NNS I-Gene
occur VBP O
which WDT O
slightly RB O
differ VBP O
in IN O
the DT O
number NN O
of IN O
repeats NNS O
in IN O
domain NN O
C NNP O
. . O

Elledge NNP O
, , O
P NNP O
. . O

Against IN O
200 CD O
strains NNS O
of IN O
methicillin NN O
- : O
resistant JJ O
Staphylococcus NNP O
aureus NN O
( ( O
MRSA NNP O
) ) O
isolated VBD O
from IN O
1990 CD O
to TO O
1991 CD O
, , O
minimum JJ O
inhibitory JJ O
concentrations NNS O
( ( O
MICs NNP O
) ) O
of IN O
a DT O
total NN O
of IN O
15 CD O
antibacterial JJ O
agents NNS O
including VBG O
arbekacin NN O
( ( O
ABK NNP O
) ) O
were VBD O
determined VBN O
. . O

Dr NNP O
. . O

Epithelial JJ O
damage NN O
was VBD O
not RB O
observed VBN O
in IN O
any DT O
controls NNS O
but CC O
was VBD O
in IN O
all DT O
tissues NNS O
exposed VBN O
to TO O
SO2 NNP O
. . O

The DT O
mobility NN O
of IN O
the DT O
upper JJ O
and CC O
lower JJR O
premolars NNS O
under IN O
load NN O
was VBD O
investigated VBN O
in IN O
relation NN O
to TO O
the DT O
interproximal JJ O
contact NN O
and CC O
occlusal JJ O
facets NNS O
. . O

Binding NNP O
specificity NN O
and CC O
modulation NN O
of IN O
the DT O
ApoA NNP B-Gene
- : I-Gene
I PRP I-Gene
promoter VBP I-Gene
activity NN O
by IN O
homo NN O
- : O
and CC O
heterodimers NNS O
of IN O
nuclear JJ O
receptors NNS O
. . O

Paleoceanographic NNP O
data NNS O
from IN O
the DT O
Laurentian JJ O
Fan NNP O
, , O
used VBD O
as IN O
a DT O
proxy NN O
for IN O
sea NN O
surface NN O
temperature NN O
, , O
reveal NN O
that WDT O
surface VBP O
slope VBP O
waters NNS O
north RB O
of IN O
the DT O
Gulf NNP O
Stream NNP O
experienced VBD O
warming VBG O
during IN O
the DT O
Little NNP O
Ice NNP O
Age NNP O
of IN O
the DT O
16th CD O
to TO O
19th CD O
centuries NNS O
and CC O
support VB O
the DT O
notion NN O
of IN O
an DT O
NAO NNP O
- : O
driven NN O
coupled VBD O
system NN O
. . O

The DT O
Aa NNP B-Gene
- : I-Gene
Pri2 NNP I-Gene
gene NN I-Gene
, , O
specifically RB O
expressed VBN O
during IN O
basidiocarp JJ O
differentiation NN O
of IN O
the DT O
mushroom NN O
Agrocybe NNP O
aegerita NN O
, , O
was VBD O
cloned VBN O
. . O

A DT O
long JJ O
follow NN O
- : O
up RB O
study NN O
revealed VBD O
that IN O
convalescent NN O
stage NN O
children NNS O
still RB O
have VBP O
the DT O
potency NN O
to TO O
have VB O
an DT O
immediate JJ O
type NN O
hypersensitivity NN O
reaction NN O
on IN O
exposure NN O
to TO O
mite VB O
antigen NN O
, , O
with IN O
a DT O
high JJ O
titer NN O
of IN O
mite NN B-Gene
specific JJ I-Gene
IgE NNP I-Gene
in IN O
their PRP$ O
sera NN O
, , O
but CC O
they PRP O
are VBP O
free JJ O
from IN O
asthmatic JJ O
attacks NNS O
because IN O
of IN O
the DT O
reduction NN O
in IN O
the DT O
amount NN O
of IN O
mite JJ O
antigen NN O
in IN O
the DT O
body NN O
, , O
as IN O
shown VBN O
by IN O
the DT O
reduction NN O
in IN O
the DT O
amount NN O
of IN O
mite NN B-Gene
specific JJ I-Gene
IgG NNP I-Gene
. . O

Previous JJ O
studies NNS O
characterized VBD O
a DT O
cytokine NN O
- : O
inducible JJ O
, , O
functional JJ O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
consensus NN I-Gene
element NN I-Gene
in IN O
the DT O
immediate JJ O
5 CD O
' POS O
regulatory JJ O
region NN O
of IN O
the DT O
MGSA NNP B-Gene
/ NNP O
GRO NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN O
at IN O
- : O
78 CD O
bp NN O
. . O

Rapamycin NNP O
( ( O
FRAP NNP B-Gene
/ NNP O
mTOR NNP B-Gene
inhibitor NN O
) ) O
blocked VBD O
4E CD B-Gene
- : I-Gene
BP1 NNP I-Gene
phosphorylation NN O
causing VBG O
a DT O
predominance NN O
of IN O
the DT O
alpha NN O
( ( O
hypophosphorylated VBN O
) ) O
band NN O
. . O

The DT O
metabolic JJ O
events NNS O
occurring VBG O
at IN O
or CC O
near IN O
that DT O
structure NN O
and CC O
involving VBG O
cyclin NN B-Gene
D3 NNP I-Gene
cause NN O
the DT O
translocation NN O
of IN O
ICP0 NNP B-Gene
to TO O
the DT O
cytoplasm NN O
. . O

The DT O
Menopause NNP O
- : O
Rating VBG O
- : O
Scale NN O
( ( O
MRS NNP O
I PRP O
) ) O
was VBD O
used VBN O
in IN O
clinical JJ O
practice NN O
since IN O
1992 CD O
. . O

Transcription NN O
of IN O
the DT O
metH NN B-Gene
gene NN I-Gene
in IN I-Gene
Salmonella NNP I-Gene
typhimurium NN I-Gene
and CC I-Gene
Escherichia NNP I-Gene
coli NN I-Gene
is VBZ O
positively RB O
regulated VBN O
by IN O
the DT O
metR JJ B-Gene
gene NN I-Gene
product NN I-Gene
, , O
a DT O
DNA NN O
binding VBG O
protein NN O
. . O

A DT O
distinct JJ O
staining NN O
pattern NN O
for IN O
the DT O
N NNP B-Gene
- : I-Gene
utrophin NN I-Gene
was VBD O
not RB O
detectable JJ O
, , O
although IN O
it PRP O
was VBD O
expected VBN O
to TO O
localise VB O
at IN O
the DT O
actin NN B-Gene
stress NN O
fibers NNS O
. . O

Moreover RB O
, , O
the DT O
major JJ O
site NN O
of IN O
transcriptional JJ O
initiation NN O
, , O
which WDT O
was VBD O
localized VBN O
by IN O
primer JJ O
extension NN O
250 CD O
bp NN O
upstream NN O
of IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
cDNA NN I-Gene
clone NN I-Gene
, , O
was VBD O
shown VBN O
to TO O
be VB O
identical JJ O
in IN O
normal JJ O
cells NNS O
and CC O
tumors NNS O
carrying VBG O
a DT O
provirus NN O
in IN O
the DT O
Tpl NNP B-Gene
- : I-Gene
1 CD I-Gene
locus NN I-Gene
. . O

Neurospora NNP O
crassa NN O
CYT NNP B-Gene
- : I-Gene
18 CD I-Gene
, , O
can MD O
rescue VB O
the DT O
exonic JJ O
trap NN O
and CC O
intron NN O
mutants NNS O
which WDT O
cause VBP O
a DT O
structural JJ O
defect NN O
. . O

Animals NNS O
may MD O
be VB O
immunized VBN O
by IN O
oral JJ O
vaccination NN O
, , O
but CC O
natural JJ O
mechanisms NNS O
that IN O
also RB O
can MD O
terminate VB O
outbreaks NNS O
are VBP O
discussed VBN O
. . O

Likewise RB O
, , O
at IN O
150 CD O
degrees NNS O
C NNP O
with IN O
2 CD O
% NN O
APS NNP O
the DT O
surface NN O
density NN O
of IN O
NH2 NNP O
groups NNS O
reached VBD O
a DT O
maximum NN O
at IN O
24 CD O
hr NN O
and CC O
remained VBD O
relatively RB O
constant JJ O
up IN O
to TO O
96 CD O
hr NN O
. . O

Long NNP O
- : O
range NN O
comparison NN O
of IN O
human JJ B-Gene
and CC I-Gene
mouse NN I-Gene
SCL NNP I-Gene
loci NN I-Gene
: : O
localized JJ O
regions NNS O
of IN O
sensitivity NN O
to TO O
restriction NN O
endonucleases NNS O
correspond VBP O
precisely RB O
with IN O
peaks NNS O
of IN O
conserved JJ O
noncoding JJ O
sequences NNS O
. . O

Because IN O
of IN O
its PRP$ O
great JJ O
reliability NN O
, , O
conventional JJ O
arteriography NN O
occupies VBZ O
a DT O
place NN O
of IN O
choice NN O
among IN O
the DT O
medical JJ O
imaging NN O
techniques NNS O
. . O

To TO O
investigate VB O
the DT O
regulation NN O
of IN O
Spec NNP B-Gene
gene NN I-Gene
activity NN O
, , O
the DT O
region NN O
around IN O
the DT O
Spec1 NNP B-Gene
transcriptional JJ I-Gene
initiation NN I-Gene
site NN I-Gene
was VBD O
analyzed VBN O
for IN O
sites NNS O
of IN O
protein NN O
- : O
DNA NN O
interaction NN O
. . O

Phosphoamino NNP O
acid JJ O
analysis NN O
of IN O
radiolabeled JJ O
ASGPR NNP B-Gene
subunits NNS I-Gene
identified VBN O
Ser NNP O
( ( O
P NNP O
) ) O
as IN O
the DT O
predominant NN O
( ( O
approximately RB O
95 CD O
% NN O
) ) O
and CC O
Thr NNP O
( ( O
P NNP O
) ) O
as IN O
a DT O
minor NN O
( ( O
approximately RB O
5 CD O
% NN O
) ) O
phosphoamino NN O
acid NN O
in IN O
each DT O
polypeptide NN O
and CC O
confirmed VBD O
the DT O
presence NN O
of IN O
Tyr NNP O
( ( O
P NNP O
) ) O
( ( O
approximately RB O
1 CD O
% NN O
) ) O
in IN O
RHL1 NNP B-Gene
. . O

Neonatal JJ O
lupus NN O
erythematosus NN O
is VBZ O
most RBS O
often RB O
associated VBN O
with IN O
autoantibodies NNS O
against IN O
Ro NNP B-Gene
and CC O
La NNP B-Gene
antigens NNS O
. . O

Two CD O
sterol NN O
regulatory JJ O
element JJ O
- : O
like IN O
sequences NNS O
mediate VBP O
up RP O
- : O
regulation NN O
of IN O
caveolin NN B-Gene
gene NN I-Gene
transcription NN O
in IN O
response NN O
to TO O
low JJ B-Gene
density NN I-Gene
lipoprotein RB I-Gene
free JJ O
cholesterol NN O
. . O

In IN O
the DT O
face NN O
of IN O
the DT O
outbreak NN O
, , O
there EX O
was VBD O
a DT O
delay NN O
before IN O
vaccination NN O
was VBD O
able JJ O
to TO O
stop VB O
deaths NNS O
. . O

Myocardial JJ O
SPET NNP O
imaging VBG O
with IN O
99Tcm CD O
- : O
tetrofosmin NN O
in IN O
clinical JJ O
practice NN O
: : O
comparison NN O
of IN O
a DT O
1 CD O
day NN O
and CC O
a DT O
2 CD O
day NN O
imaging VBG O
protocol NN O
. . O

The DT O
amino NN O
acid NN O
changes NNS O
D206A NNP O
and CC O
D208A NNP O
abolish JJ O
singly RB O
or CC O
in IN O
combination NN O
the DT O
exonuclease NN O
activity NN O
in IN O
vivo NN O
. . O

Subcutaneous JJ O
administration NN O
of IN O
the DT O
somatostatin NN B-Gene
analogue NN O
, , O
octreotide RB O
, , O
100 CD O
micrograms NNS O
thrice JJ O
daily RB O
, , O
resulted VBD O
in IN O
a DT O
sustained JJ O
improvement NN O
in IN O
diarrhoea NN O
and CC O
disappearance NN O
of IN O
faecal JJ O
incontinence NN O
without IN O
reducing VBG O
calcitonin NN B-Gene
levels NNS O
. . O

Human NNP B-Gene
cytomegalovirus NN I-Gene
immediate NN I-Gene
- : I-Gene
early JJ I-Gene
protein NN I-Gene
IE2 NNP I-Gene
tethers VBZ O
a DT O
transcriptional JJ O
repression NN O
domain NN O
to TO O
p53 NN B-Gene
. . O

Epileptiform NN O
activity NN O
recorded VBN O
from IN O
superficial JJ O
laminae NN O
bordering VBG O
layer NN O
4 CD O
, , O
and CC O
into IN O
which WDT O
layer VBD O
4 CD O
' '' O
s JJ O
primary JJ O
projections NNS O
terminate NN O
, , O
is VBZ O
suppressed VBN O
preferentially RB O
by IN O
phenytoin NN O
. . O

Antibodies NNS O
raised VBN O
against IN O
GST NNP B-Gene
mSH2 SYM I-Gene
- : I-Gene
B NNP I-Gene
identified VBD O
a DT O
cellular JJ O
protein NN O
of IN O
92 CD O
kDa NNS O
that WDT O
was VBD O
not RB O
found VBN O
to TO O
be VB O
phosphorylated VBN O
on IN O
Tyr NNP O
. . O

Transactivation NN O
domain NN O
is VBZ O
located VBN O
downstream NN O
of IN O
the DT O
128 CD B-Gene
- : I-Gene
amino NN I-Gene
- : I-Gene
acid NN I-Gene
runt NN I-Gene
homology NN I-Gene
region NN I-Gene
, , O
referred VBD O
to TO O
as IN O
the DT O
Runt NNP B-Gene
domain NN I-Gene
. . O

In IN O
cerebrospinal JJ O
fluid NN O
, , O
an DT O
ADA NNP B-Gene
catalytic JJ O
concentration NN O
above IN O
0 CD O
. . O
15 CD O
mu JJ O
kat NN O
/ NNP O
L NNP O
strongly RB O
suggests VBZ O
tuberculous JJ O
meningitis NN O
in IN O
patients NNS O
older JJR O
than IN O
7 CD O
years NNS O
( ( O
sensitivity NN O
1 CD O
. . O
0 CD O
, , O
specificity NN O
0 CD O
. . O
99 CD O
and CC O
efficiency NN O
0 CD O
. . O
99 CD O
) ) O
. . O

Studies NNS O
of IN O
lipoproteins NNS O
should MD O
, , O
however RB O
, , O
be VB O
made VBN O
in IN O
children NNS O
from IN O
families NNS O
known VBN O
to TO O
have VB O
FH NNP O
or CC O
early JJ O
coronary JJ O
heart NN O
disease NN O
. . O

Their PRP$ O
circadian JJ O
responses NNS O
to TO O
both DT O
photic JJ O
and CC O
non JJ O
- : O
photic JJ O
cues NNS O
were VBD O
then RB O
tested VBN O
. . O

Beta NNP B-Gene
1 CD I-Gene
integrin NN I-Gene
- : O
and CC O
proteoglycan JJ O
- : O
mediated JJ O
stimulation NN O
of IN O
T NNP O
lymphoma NN O
cell NN O
adhesion NN O
and CC O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
signaling VBG O
by IN O
thrombospondin JJ B-Gene
- : I-Gene
1 CD I-Gene
and CC O
thrombospondin VB B-Gene
- : I-Gene
1 CD I-Gene
peptides NNS I-Gene
. . O

Most JJS O
of IN O
the DT O
prepeptide JJ O
portion NN O
of IN O
the DT O
precursor NN O
polypeptide NN O
is VBZ O
encoded VBN O
by IN O
the DT O
next JJ O
three CD O
exons NNS O
, , O
and CC O
the DT O
mature JJ O
form NN O
of IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
is VBZ O
encoded VBN O
by IN O
the DT O
remaining VBG O
three CD O
exons NNS O
. . O

Many JJ O
studies NNS O
have VBP O
pointed VBN O
out RP O
the DT O
possibility NN O
of IN O
"""" NNP O
masked VBD O
"""" NNP O
organic JJ O
factors NNS O
in IN O
erectile JJ O
impotence NN O
, , O
detectable JJ O
only RB O
by IN O
means NNS O
of IN O
laboratory JJ O
investigations NNS O
: : O
mild JJ O
hypogonadism NN O
, , O
hyperprolactinemia NN O
, , O
occlusions NNS O
selectively RB O
located VBN O
at IN O
the DT O
site NN O
of IN O
the DT O
sexual JJ O
arteries NNS O
, , O
venous JJ O
incompetence NN O
, , O
subclinical JJ O
neuropathies NNS O
. . O

Consumption NN O
of IN O
4 CD O
% NN O
sucrose NN O
was VBD O
not RB O
affected VBN O
by IN O
excitotoxic JJ O
lesions NNS O
of IN O
the DT O
PPTg NNP O
, , O
but CC O
PPTg NNP O
lesioned VBD O
rats NNS O
consumed VBN O
significantly RB O
more RBR O
12 CD O
% NN O
and CC O
20 CD O
% NN O
sucrose JJR O
than IN O
sham NN O
controls NNS O
. . O

Eleven RB O
biopsy NN O
specimens NNS O
( ( O
five CD O
papules NNS O
and CC O
six CD O
dusky NN O
or CC O
crusted VBN O
lesions NNS O
) ) O
from IN O
four CD O
patients NNS O
with IN O
pityriasis NN O
lichenoides NNS O
et VBP O
varioliformis JJ O
acuta NN O
( ( O
PLEVA NNP O
) ) O
were VBD O
studied VBN O
by IN O
direct JJ O
immunofluorescence NN O
and CC O
immunoperoxidase NN B-Gene
technics NNS O
. . O

Both DT O
the DT O
intact JJ B-Gene
A1 NNP I-Gene
protein NN I-Gene
and CC O
its PRP$ O
proteolytic JJ O
fragment NN O
, , O
the DT O
UP1 NNP B-Gene
protein NN I-Gene
, , O
can MD O
be VB O
cleaved VBN O
by IN O
Staphylococcus NNP B-Gene
aureus NN I-Gene
V NNP I-Gene
- : I-Gene
8 CD I-Gene
protease NN I-Gene
to TO O
produce VB O
two CD O
polypeptides NNS O
of IN O
92 CD O
amino JJ O
acids NNS O
. . O

The DT O
second JJ O
and CC O
third JJ O
responded VBD O
similarly RB O
to TO O
either VB O
a DT O
combined JJ O
cyclophosphamide NN O
+ NNP O
antilymphocyte NN B-Gene
globulin NN I-Gene
( ( O
ALG NNP B-Gene
) ) O
treatment NN O
or CC O
to TO O
ALG NNP B-Gene
administration NN O
preceded VBN O
by IN O
a DT O
small JJ O
dosage NN O
of IN O
cyclophosphamide NN O
, , O
which WDT O
had VBD O
proved VBN O
ineffective JJ O
when WRB O
administered VBN O
alone RB O
. . O

Blocked VBN O
shift NN O
/ NNP O
supershift NN O
analysis NN O
indicates VBZ O
that IN O
Fos NNP B-Gene
family NN I-Gene
member NN O
proteins VBZ O
especially RB O
Fra NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Fra NNP B-Gene
- : I-Gene
2 CD I-Gene
are VBP O
related VBN O
to TO O
progression NN O
and CC O
no DT O
changes NNS O
found VBN O
in IN O
the DT O
Jun NNP B-Gene
family NN I-Gene
member NN O
proteins NNS O
although IN O
they PRP O
are VBP O
present JJ O
in IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
DNA NNP I-Gene
binding NN I-Gene
complex NN I-Gene
. . O

Having VBG O
an DT O
LRR NNP B-Gene
domain NN I-Gene
and CC O
an DT O
SH3 NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
, , O
Acan125 NNP B-Gene
and CC O
the DT O
C NNP O
. . O
elegans NNS O
homologue VBP O
define VB O
a DT O
novel JJ O
family NN O
of IN O
bifunctional JJ O
binding NN O
proteins NNS O
. . O

Structure NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
human JJ O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN O
p18 NN B-Gene
and CC O
mutational JJ O
analysis NN O
in IN O
breast NN O
cancer NN O
. . O

ICA NNP O
in IN O
the DT O
reference NN O
solution NN O
was VBD O
characterised VBN O
by IN O
LC NNP O
and CC O
time NN O
- : O
of IN O
- : O
flight NN O
( ( O
TOF NNP O
) ) O
MS NNP O
and CC O
quantified VBN O
by IN O
LC NNP O
chemiluminescent NN O
nitrogen NN O
detection NN O
( ( O
LC NNP O
- : O
CLND NN O
) ) O
. . O

In IN O
most JJS O
cases NNS O
, , O
DR4 NNP B-Gene
- : O
homozygous JJ O
, , O
DRB1 NNP B-Gene
- : O
heterozygous JJ O
individuals NNS O
could MD O
be VB O
genotyped VBN O
with IN O
the DT O
panel NN O
of IN O
probes NNS O
. . O

A DT O
total NN O
of IN O
117 CD O
EVS JJ O
treatments NNS O
were VBD O
performed VBN O
on IN O
34 CD O
patients NNS O
. . O

Ang NNP B-Gene
II NNP I-Gene
significantly RB O
induced VBD O
Ang2 NNP B-Gene
mRNA NN I-Gene
accumulations NNS O
without IN O
affecting VBG O
Ang1 NNP B-Gene
or CC O
Tie2 NNP B-Gene
expression NN O
, , O
which WDT O
was VBD O
inhibited VBN O
by IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
inhibitors NNS O
and CC O
by IN O
intracellular JJ O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
chelating VBG O
agents NNS O
. . O

Northern NNP O
blotting NN O
showed VBD O
that IN O
MDMX NNP B-Gene
, , O
like IN O
MDM2 NNP B-Gene
, , O
is VBZ O
expressed VBN O
in IN O
all DT O
tissues NNS O
tested VBN O
, , O
and CC O
that IN O
several JJ O
mRNAs NNS O
for IN O
MDMX NNP B-Gene
can MD O
be VB O
detected VBN O
. . O

The DT O
nucleotide JJ O
sequence NN O
alignment NN O
between IN O
mouse NN O
and CC O
human JJ B-Gene
CA NNP I-Gene
IV NNP I-Gene
shows VBZ O
69 CD O
% NN O
identity NN O
in IN O
the DT O
coding NN O
region NN O
and CC O
all DT O
of IN O
the DT O
exon JJ O
- : O
intron NN O
boundaries NNS O
are VBP O
conserved VBN O
, , O
as IN O
are VBP O
the DT O
sizes NNS O
of IN O
the DT O
introns NNS O
. . O

Out IN O
of IN O
these DT O
families NNS O
74 CD O
, , O
3 CD O
% NN O
planned VBN O
next JJ O
pregnancy NN O
( ( O
table JJ O
IX NNP O
) ) O
, , O
57 CD O
, , O
6 CD O
% NN O
wanted VBD O
to TO O
have VB O
prenatal JJ O
diagnosis NN O
( ( O
table JJ O
VI NNP O
) ) O
. . O

A DT O
major JJ O
pool NN O
of IN O
Dsg NNP B-Gene
- : O
plakoglobin NN B-Gene
complexes NNS O
sedimented VBD O
at IN O
8S CD O
and CC O
exhibited VBD O
a DT O
1 CD O
: : O
1 CD O
stoichiometry NN O
. . O

Videonystagmoscopy NNP O
has VBZ O
been VBN O
used VBN O
to TO O
subjectively RB O
observe VB O
the DT O
responses NNS O
of IN O
the DT O
vestibular JJ O
system NN O
in IN O
a DT O
population NN O
of IN O
patients NNS O
with IN O
vestibular JJ O
deficits NNS O
. . O

Pretreatment NN O
of IN O
cells NNS O
with IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein IN I-Gene
- : I-Gene
extracellular JJ I-Gene
signal JJ I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
( ( O
MEK NNP B-Gene
) ) O
inhibitor NN O
U0126 NNP O
inhibited VBD O
S6K2 NNP B-Gene
activation NN O
to TO O
a DT O
greater JJR O
extent NN O
than IN O
S6K1 NNP B-Gene
. . O

Can MD O
survival VB O
be VB O
prolonged VBN O
for IN O
patients NNS O
with IN O
hormone JJ O
- : O
resistant JJ O
prostate NN O
cancer NN O
? . O

Here RB O
we PRP O
have VBP O
tested VBN O
the DT O
hypothesis NN O
that IN O
the DT O
short JJ O
transcripts NNS O
, , O
or CC O
proteins NNS O
translated VBN O
from IN O
the DT O
short JJ O
transcripts NNS O
, , O
are VBP O
also RB O
required VBN O
for IN O
respiration NN O
. . O

Radionuclide NNP O
angiography NN O
and CC O
static JJ O
whole NN O
body NN O
imaging VBG O
performed VBN O
with IN O
technetium NN O
- : O
99m CD O
- : O
labeled VBN O
particulates NNS O
can MD O
clearly RB O
demonstrate VB O
differential JJ O
shunting NN O
in IN O
patients NNS O
with IN O
patent NN O
ductus NN O
arteriosus NN O
( ( O
PDA NNP O
) ) O
with IN O
Eisenmenger NNP O
physiology NN O
. . O

In IN O
contrast NN O
, , O
peak JJ O
filling VBG O
rate NN O
( ( O
PFR NNP O
) ) O
, , O
normalized VBN O
to TO O
end VB O
diastolic JJ O
volume NN O
( ( O
EDV NNP O
) ) O
, , O
or CC O
stroke NN O
volume NN O
( ( O
SV NNP O
) ) O
, , O
or CC O
expressed VBN O
as IN O
the DT O
ratio NN O
of IN O
PFR NNP O
- : O
to TO O
- : O
PER NN O
was VBD O
reduced VBN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
time NN O
to TO O
PFR NNP O
( ( O
TPFR NNP O
) ) O
was VBD O
prolonged VBN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
echocardiographic JJ O
left VBD O
ventricular JJ O
mass NN O
index NN O
was VBD O
higher JJR O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
in IN O
patients NNS O
with IN O
acromegaly JJ O
compared VBN O
to TO O
normals NNS O
. . O

With IN O
a DT O
GC NNP O
content NN O
of IN O
45 CD O
% NN O
the DT O
one CD O
segment NN O
would MD O
correspond VB O
to TO O
"""" VB B-Gene
isochore RB I-Gene
H1 NNP I-Gene
"""" NNP I-Gene
and CC O
the DT O
other JJ O
segment NN O
( ( O
39 CD O
% NN O
GC NNP O
in IN O
human JJ O
, , O
40 CD O
% NN O
GC NNP O
in IN O
mouse NN O
) ) O
to TO O
"""" VB O
isochore RB O
L1 NNP B-Gene
/ NNP O
L2 NNP B-Gene
"""" NNP O
. . O

Some DT O
users NNS O
will MD O
willingly VB O
comply VB O
with IN O
management NN O
measures NNS O
, , O
other JJ O
users NNS O
will MD O
comply VB O
in IN O
response NN O
to TO O
education NN O
, , O
but CC O
there EX O
will MD O
be VB O
another DT O
group NN O
who WP O
will MD O
only RB O
respond VB O
to TO O
enforcement VB O
activities NNS O
. . O

Second JJ O
, , O
the DT O
transcription NN B-Gene
factor NN I-Gene
Gal NNP I-Gene
- : I-Gene
ER NN I-Gene
was VBD O
rendered VBN O
more RBR O
potent JJ O
and CC O
less RBR O
susceptible JJ O
to TO O
cell VB O
type JJ O
- : O
specific JJ O
variation NN O
by IN O
fusing VBG O
the DT O
strong JJ O
activating NN O
domain NN O
of IN O
the DT O
herpesvirus NN B-Gene
protein NN I-Gene
VP16 NNP I-Gene
onto IN O
its PRP$ O
C NNP O
terminus NN O
. . O

All DT O
tumors NNS O
proved VBD O
histologically RB O
to TO O
be VB O
neuroendocrine JJ O
in IN O
origin NN O
. . O

Epithelial JJ O
cytotoxicity NN O
of IN O
combined JJ O
antibiotics NNS O
was VBD O
additive JJ O
, , O
with IN O
no DT O
evidence NN O
of IN O
competition NN O
or CC O
synergism NN O
. . O

In IN O
addition NN O
, , O
the DT O
transcription NN O
of IN O
c SYM B-Gene
- : I-Gene
IAP2 NNP I-Gene
promoter NN I-Gene
was VBD O
strongly RB O
up IN O
- : O
regulated VBN O
when WRB O
CD40 NNP B-Gene
or CC O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
latent NN I-Gene
membrane NN I-Gene
protein VBD I-Gene
1 CD I-Gene
was VBD O
overexpressed VBN O
. . O

Sequence NN O
requirements NNS O
for IN O
premature JJ O
transcription NN O
arrest NN O
within IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
mouse NN B-Gene
c SYM I-Gene
- : I-Gene
fos JJ I-Gene
gene NN I-Gene
. . O

The DT O
retention NN O
of IN O
75SeHCAT CD O
was VBD O
low JJ O
. . O

To TO O
evaluate VB O
the DT O
effects NNS O
of IN O
HRT NNP O
on IN O
those DT O
factors NNS O
in IN O
end NN O
- : O
stage NN O
renal JJ O
disease NN O
( ( O
ESRD NNP O
) ) O
patients NNS O
, , O
we PRP O
evaluated VBD O
the DT O
changes NNS O
of IN O
lipid JJ O
profile NN O
, , O
coagulation NN O
and CC O
fibrinolysis NN O
markers NNS O
, , O
and CC O
plasma JJ O
homocysteine NN O
levels NNS O
after IN O
treatment NN O
. . O

Vibrio NNP O
cholerae NN O
O139 NNP O
in IN O
Calcutta NNP O
. . O

RESULT NNP O
( ( O
S NNP O
) ) O
: : O
In IN O
patients NNS O
with IN O
elevated JJ O
FSH NNP B-Gene
levels NNS O
on IN O
cycle NN O
day NN O
3 CD O
, , O
a DT O
low JJ O
oocyte JJ O
yield NN O
was VBD O
achieved VBN O
( ( O
7 CD O
versus IN O
11 CD O
) ) O
and CC O
a DT O
high JJ O
number NN O
of IN O
ampules NNS O
of IN O
hMG NN B-Gene
was VBD O
necessary JJ O
( ( O
56 CD O
versus IN O
33 CD O
) ) O
. . O

A DT O
panel NN O
of IN O
pharmacologic JJ O
inhibitors NNS O
was VBD O
used VBN O
to TO O
investigate VB O
the DT O
signal JJ O
transduction NN O
pathways NNS O
involved VBN O
in IN O
TRAIL NNP B-Gene
gene NN I-Gene
induction NN O
following VBG O
T NNP O
lymphocyte JJ O
activation NN O
. . O

Retention NNP O
behavior NN O
of IN O
steroids NNS O
in IN O
gas NN O
chromatography NN O
with IN O
a DT O
series NN O
of IN O
combination NN O
columns NN O
. . O

We PRP O
studied VBD O
the DT O
effect NN O
of IN O
skinfold JJ O
thickness NN O
on IN O
the DT O
correlation NN O
between IN O
serum JJ O
total JJ O
bilirubin NN O
level NN O
and CC O
transcutaneous JJ O
bilirubin NN O
( ( O
TcB NNP O
) ) O
readings NNS O
. . O

The DT O
rates NNS O
of IN O
total JJ O
energy NN O
use NN O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NNP O
= VBZ O
39 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
2 CD O
vs JJ O
35 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
3 CD O
kJ JJ O
X NNP O
min NNP O
- : O
1 CD O
; : O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
were VBD O
significantly RB O
higher JJR O
at IN O
- : O
10 CD O
degrees NNS O
C NNP O
than IN O
at IN O
22 CD O
degrees NNS O
C NNP O
. . O

The DT O
availability NN O
of IN O
cryoprecipitate NN O
and CC O
DDAVP NNP O
offers VBZ O
an DT O
alternative NN O
and CC O
effective JJ O
treatment NN O
for IN O
the DT O
temporary JJ O
reversal NN O
of IN O
uremic JJ O
bleeding NN O
in IN O
patients NNS O
who WP O
require VBP O
urgent JJ O
invasive JJ O
procedures NNS O
. . O

CONCLUSIONS NN O
: : O
Under IN O
current JJ O
immunization NN O
practices NNS O
, , O
the DT O
authors NNS O
estimate VBP O
that IN O
nearly RB O
13 CD O
, , O
0 CD O
Asian JJ O
and CC O
Pacific NNP O
Islander NNP O
children NNS O
living VBG O
in IN O
the DT O
United NNP O
States NNPS O
today NN O
will MD O
become VB O
infected JJ O
with IN O
HBV NNP O
in IN O
the DT O
future NN O
, , O
resulting VBG O
in IN O
more JJR O
than IN O
600 CD O
liver JJ O
carcinoma NN O
deaths NNS O
. . O

Hodgkin NNP O
' POS O
s JJ O
disease NN O
. . O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
linkage NN O
disequilibrium NN O
between IN O
the DT O
polymorphic JJ O
site NN O
in IN O
the DT O
B NNP O
cell NN O
specific JJ O
promoter NN O
and CC O
those DT O
in IN O
the DT O
3 CD O
' POS O
UTR NNP O
. . O

Measurements NNS O
were VBD O
compared VBN O
with IN O
two CD O
computerised JJ O
treatment NN O
planning VBG O
systems NNS O
- : O
- : O
Theraplan NN O
VO5B NNP O
and CC O
ADAC NNP O
Pinnacle3 NNP O
V4 NNP O
. . O
0b CD O
. . O

To TO O
gain VB O
further JJ O
insight NN O
into IN O
the DT O
pathogenesis NN O
of IN O
the DT O
adult NN O
respiratory NN O
distress NN O
syndrome NN O
( ( O
ARDS NNP O
) ) O
, , O
the DT O
authors NNS O
studied VBD O
possible JJ O
relationships NNS O
among IN O
the DT O
activation NN O
status NN O
of IN O
circulating VBG O
polymorphonuclear JJ O
neutrophils NNS O
( ( O
PMN NNP O
) ) O
, , O
cytokine JJ O
levels NNS O
, , O
and CC O
the DT O
severity NN O
of IN O
lung NN O
injury NN O
in IN O
31 CD O
patients NNS O
: : O
15 CD O
with IN O
ARDS NNP O
, , O
9 CD O
with IN O
severe JJ O
pneumonia NN O
uncomplicated VBN O
by IN O
ARDS NNP O
, , O
and CC O
7 CD O
mechanically RB O
ventilated JJ O
patients NNS O
with IN O
neither DT O
ARDS NNP O
nor CC O
pneumonia NN O
. . O

For IN O
85Sr CD O
, , O
larger JJR O
- : O
than IN O
- : O
expected VBN O
distribution NN O
coefficients NNS O
were VBD O
obtained VBN O
in IN O
the DT O
desorption NN O
experiments NNS O
, , O
an DT O
indication NN O
of IN O
the DT O
irreversible JJ O
formation NN O
of IN O
metal NN O
- : O
oxyhydroxides NNS O
during IN O
a DT O
slow JJ O
reaction NN O
. . O

There EX O
were VBD O
5 CD O
treatments NNS O
: : O
control NN O
( ( O
C NNP O
) ) O
; : O
a DT O
wooden JJ O
surround NN O
in IN O
one CD O
rear NN O
corner NN O
of IN O
the DT O
cage NN O
( ( O
S NNP O
) ) O
; : O
a DT O
fiberglass NN O
rollaway NN O
hollow NN O
in IN O
one CD O
rear NN O
corner NN O
of IN O
the DT O
cage NN O
( ( O
H NNP O
) ) O
; : O
a DT O
hollow NN O
and CC O
a DT O
surround NN O
( ( O
H NNP O
/ NNP O
S NNP O
) ) O
; : O
a DT O
nest JJS O
box NN O
attached VBN O
to TO O
the DT O
back NN O
of IN O
the DT O
cage NN O
, , O
containing VBG O
a DT O
hollow NN O
( ( O
N NNP O
) ) O
. . O

Pharmacologic NNP O
doses NNS O
of IN O
vitamin NN O
B6 NNP O
administered VBD O
to TO O
lactating VBG O
women NNS O
have VBP O
been VBN O
reported VBN O
to TO O
suppress VB O
plasma JJ B-Gene
prolactin NN I-Gene
. . O

METHODS NN O
: : O
In IN O
the DT O
current JJ O
study NN O
the DT O
authors NNS O
reported VBD O
on IN O
PPB NNP O
cases NNS O
from IN O
a DT O
national JJ O
retrospective NN O
search NN O
performed VBD O
in IN O
18 CD O
Italian JJ O
Associations NNP O
for IN O
Pediatric NNP O
Hematology NNP O
and CC O
Oncology NNP O
centers NNS O
. . O

Univariate NNP O
statistical JJ O
analysis NN O
based VBN O
on IN O
Kaplan NNP O
- : O
Meier NNP O
- : O
estimates NNS O
and CC O
Log NNP O
- : O
Rank NNP O
- : O
Test NN O
showed VBD O
the DT O
following VBG O
prognostically RB O
beneficial JJ O
factors NNS O
: : O
Limited JJ O
disease NN O
stage NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
9 CD O
) ) O
, , O
NSE NNP B-Gene
serum VBD O
level NN O
less JJR O
than IN O
25 CD O
micrograms NNS O
/ JJ O
l NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
16 CD O
) ) O
, , O
serum JJ O
alkaline JJ B-Gene
phosphatase NN I-Gene
less JJR O
than IN O
200 CD O
U NNP O
/ NNP O
l NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
35 CD O
) ) O
, , O
normal JJ O
serum NN O
albumin NN B-Gene
( ( O
p JJ O
= NN O
0 CD O
. . O
3 CD O
) ) O
and CC O
activity NN O
index NN O
of IN O
minimum NN O
of IN O
70 CD O
( ( O
p NN O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

A DT O
rather RB O
similar JJ O
pattern NN O
of IN O
results NNS O
was VBD O
obtained VBN O
with IN O
respect NN O
to TO O
LMP2B NNP B-Gene
mRNA NN I-Gene
expression NN O
, , O
such JJ O
transcripts NNS O
being VBG O
detectable JJ O
only RB O
in IN O
a DT O
subset NN O
of IN O
tumors NNS O
, , O
and CC O
then RB O
at IN O
apparently RB O
low JJ O
levels NNS O
. . O

The DT O
ORF3 NNP O
mutant NN O
produced VBD O
reduced JJ O
levels NNS O
of IN O
tabtoxin NN B-Gene
, , O
indicating VBG O
that IN O
ORF3 NNP O
may MD O
have VB O
a DT O
role NN O
in IN O
T NNP B-Gene
beta NN I-Gene
L NNP I-Gene
biosynthesis NN O
. . O

While IN O
daily JJ O
food NN O
intake NN O
was VBD O
almost RB O
constant JJ O
regardless NN O
of IN O
the DT O
dietary JJ O
protein NN O
level NN O
, , O
water NN O
intake NN O
and CC O
urine JJ O
volume NN O
increased VBD O
with IN O
increasing VBG O
the DT O
dietary JJ O
protein NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
lack NN O
of IN O
conservation NN O
of IN O
the DT O
membrane NN O
attachment NN O
sequence NN O
arginine NN O
- : O
glycine NN O
- : O
aspartic JJ O
acid NN O
argues VBZ O
against IN O
its PRP$ O
functional JJ O
importance NN O
in IN O
CgA NNP B-Gene
. . O

Radioligand NNP O
binding NN O
was VBD O
indistinguishable JJ O
for IN O
both DT O
transiently RB O
expressed VBN O
constructs NNS O
. . O

Exons NNS O
III NNP O
to TO O
VIII NNP O
, , O
which WDT O
cover VBP O
the DT O
coding JJ O
region NN O
and CC O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
, , O
are VBP O
almost RB O
identical JJ O
in IN O
all DT O
types NNS O
of IN O
PST NNP B-Gene
or CC O
AST NNP B-Gene
cDNAs NN I-Gene
. . O

Simple JJ O
method NN O
for IN O
determination NN O
of IN O
the DT O
cephalosporin NN O
DQ NNP O
- : O
2556 CD O
in IN O
biological JJ O
fluids NNS O
by IN O
high JJ O
- : O
performance NN O
liquid NN O
chromatography NN O
. . O

Viral NNP O
RNA NNP O
, , O
molecularly RB O
cloned VBN O
proviral JJ O
DNA NNP O
, , O
and CC O
virus SYM O
- : O
specific JJ O
protein NN O
of IN O
avian JJ O
retrovirus NN O
MH2 NNP O
were VBD O
analyzed VBN O
. . O

Diagnosis NN O
of IN O
FHCS NNP O
has VBZ O
been VBN O
weighed VBN O
upon IN O
laparoscopic JJ O
findings NNS O
. . O

We PRP O
critically RB O
assess VBP O
current JJ O
systematic JJ O
uncertainties NNS O
and CC O
determine VB O
the DT O
primordial JJ O
Li NNP O
abundance NN O
within IN O
new JJ O
, , O
much JJ O
tighter JJR O
limits NNS O
: : O
& CC O
amp NN O
; : O
parl0 CC O
; : O
Li NNP O
& CC O
amp NN O
; : O
solm0 CC O
; : O
H NNP O
& CC O
amp NN O
; : O
parr0 CC O
; : O
p CC O
= $ O
1 CD O
. . O
23 CD O
+ JJ O
0 CD O
. . O
68 CD O
- : O
0 CD O
. . O
32x10 CD O
- : O
10 CD O
. . O

Deletion NN O
mapping VBG O
studies NNS O
revealed VBD O
that IN O
the DT O
upstream JJ O
DNA NN O
sequences VBZ O
up RP O
to TO O
- : O
86 CD O
were VBD O
sufficient JJ O
for IN O
the DT O
optimal JJ O
basal NN O
level NN O
transcription NN O
in IN O
HeLa NNP O
cells NNS O
and CC O
also RB O
for IN O
the DT O
EIA NNP B-Gene
- : O
induced JJ O
transcription NN O
. . O

Influence NN O
of IN O
different JJ O
methods NNS O
of IN O
chemical JJ O
disinfection NN O
on IN O
the DT O
physical JJ O
properties NNS O
of IN O
type NN O
IV NNP O
and CC O
V NNP O
gypsum NN O
dies VBZ O
] NNP O
Several NNP O
instruments NNS O
and CC O
materials NNS O
frequently RB O
used VBN O
in IN O
prosthodontics NNS O
- : O
- : O
such JJ O
as IN O
stone NN O
casts NNS O
, , O
dental JJ O
impressions NNS O
, , O
interocclusal NN O
records NNS O
- : O
- : O
are VBP O
classified VBN O
, , O
by IN O
the DT O
dental JJ O
literature NN O
, , O
as IN O
vehicles NNS O
of IN O
transmission NN O
of IN O
infectious JJ O
diseases NNS O
to TO O
those DT O
who WP O
handle VBP O
them PRP O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
analyze VB O
the DT O
temporal JJ O
characteristics NNS O
and CC O
the DT O
spatial JJ O
mapping NN O
of IN O
the DT O
independent JJ O
components NNS O
identified VBN O
by IN O
ICA NNP O
when WRB O
the DT O
subject NN O
performs VBZ O
a DT O
finger NN O
- : O
tapping NN O
task NN O
. . O

A DT O
transcript NN O
of IN O
about IN O
2 CD O
kb NN O
is VBZ O
expected VBN O
for IN O
each DT O
PPO NNP B-Gene
. . O

No DT O
therapy NN O
exists VBZ O
for IN O
halting VBG O
the DT O
progression NN O
of IN O
the DT O
disease NN O
with IN O
the DT O
possible JJ O
exception NN O
of IN O
laser NN O
photocoagulation NN O
treatment NN O
used VBN O
to TO O
ablate VB O
subretinal JJ O
neovascular JJ O
membranes NNS O
in IN O
an DT O
attempt NN O
to TO O
avoid VB O
complications NNS O
of IN O
subretinal JJ O
hemorrhages NNS O
. . O

The DT O
nucleotide JJ O
sequence NN O
consists VBZ O
of IN O
48 CD O
bp NN O
of IN O
5 CD O
' POS O
- : O
end NN O
non SYM O
- : O
coding VBG O
region NN O
, , O
1695 CD O
bp NN O
of IN O
coding VBG O
region NN O
and CC O
212 CD O
bp NN O
of IN O
3 CD O
' POS O
- : O
end NN O
non SYM O
- : O
coding VBG O
region NN O
including VBG O
a DT O
20 CD O
bp NN O
poly NN O
( ( O
A DT O
) ) O
tail NN O
. . O

The DT O
population NN O
of IN O
between IN O
75 CD O
, , O
0 CD O
and CC O
100 CD O
, , O
0 CD O
was VBD O
largely RB O
unstable JJ O
, , O
and CC O
cost NN O
per IN O
capita NN O
was VBD O
$ $ O
0 CD O
. . O
95 CD O
to TO O
$ $ O
1 CD O
. . O
21 CD O
. . O

We PRP O
recently RB O
found VBD O
that IN O
17 CD O
beta SYM O
- : O
estradiol NN O
( ( O
E2 NNP O
) ) O
not RB O
only RB O
suppresses VBZ O
bone JJ O
resorption NN O
but CC O
also RB O
stimulates VBZ O
bone CD O
formation NN O
in IN O
the DT O
cancellous JJ O
bone NN O
of IN O
female JJ O
rats NNS O
. . O

Some DT O
of IN O
the DT O
PCR NNP O
products NNS O
contained VBD O
mutations NNS O
in IN O
ATG1 NNP B-Gene
and CC O
/ NNP O
or CC O
ATG2 NNP B-Gene
. . O

CONCLUSIONS NN O
: : O
The DT O
surgical JJ O
or CC O
multimodality NN O
treatment NN O
of IN O
MSGT NNP O
has VBZ O
provided VBN O
a DT O
good JJ O
locoregional NN O
control NN O
( ( O
78 CD O
% NN O
) ) O
and CC O
68 CD O
% NN O
10 CD O
- : O
year NN O
survival NN O
in IN O
a DT O
series NN O
of IN O
patients NNS O
treated VBN O
at IN O
the DT O
oncology NN O
department NN O
of IN O
a DT O
general JJ O
hospital NN O
in IN O
Quito NNP O
, , O
Ecuador NNP O
. . O

To TO O
those DT O
of IN O
us PRP O
who WP O
are VBP O
not RB O
satisfied VBN O
with IN O
the DT O
present JJ O
outlook NN O
there EX O
is VBZ O
much JJ O
to TO O
be VB O
investigated VBN O
and CC O
much JJ O
to TO O
be VB O
contributed VBN O
. . O

Riboflavin NNP O
did VBD O
not RB O
affect VB O
the DT O
percentage NN O
of IN O
aflatoxin NN O
- : O
treated VBN O
animals NNS O
with IN O
abnormal JJ O
urinary JJ O
excretion NN O
patterns NNS O
, , O
but CC O
did VBD O
increase VB O
the DT O
magnitude NN O
of IN O
the DT O
disturbances NNS O
in IN O
elimination NN O
of IN O
kynurenic JJ O
and CC O
xanthurenic JJ O
acids NNS O
. . O

Treatment NN O
of IN O
2 CD O
patients NNS O
with IN O
pseudohypoparathyroidism NN O
type NN O
I PRP O
with IN O
vitamin NN O
- : O
D NNP O
- : O
3 CD O
and CC O
1 CD O
alpha SYM O
- : O
Hydroxycholecalciferol NNP O
consecutively RB O
resulted VBD O
in IN O
a DT O
nonuniform JJ O
response NN O
with IN O
regard NN O
to TO O
the DT O
normalisation NN O
of IN O
serum NN O
- : O
calcium NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
D NNP O
( ( O
4 CD O
) ) O
and CC O
D NNP O
( ( O
2L CD O
) ) O
receptors NNS O
activate VBP O
the DT O
ERK NNP B-Gene
kinase NN I-Gene
cascade NN O
by IN O
first JJ O
mobilizing VBG O
signaling NN O
by IN O
the DT O
PDGF NNP B-Gene
receptor NN I-Gene
, , O
followed VBN O
by IN O
the DT O
subsequent JJ O
activation NN O
of IN O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
by IN O
pathways NNS O
associated VBN O
with IN O
this DT O
receptor NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
. . O

Body NN O
weight VBD O
reduction NN O
increases NNS O
insulin VBP B-Gene
sensitivity NN O
and CC O
improves VBZ O
both DT O
blood NN O
glucose NN O
and CC O
blood NN O
pressure NN O
control NN O
. . O

No DT O
consistent JJ O
correlation NN O
between IN O
blood NN O
pressure NN O
change NN O
and CC O
SCR NNP O
- : O
change NN O
was VBD O
seen VBN O
. . O

Salient JJ O
applications NNS O
of IN O
PB NNP O
- : O
PK NN O
modeling VBG O
to TO O
toxicological JJ O
problems NNS O
are VBP O
illustrated VBN O
with IN O
examples NNS O
. . O

The DT O
TIMP NNP B-Gene
( ( O
- : O
59 CD O
/ SYM O
- : O
53 CD O
) ) O
AP1 NNP B-Gene
site NN O
is VBZ O
a DT O
promiscuous JJ O
motif NN O
that WDT O
binds VBZ O
c SYM B-Gene
- : I-Gene
Fos NNP I-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
AP1 NNP B-Gene
translated VBD O
in IN O
vitro NN O
and CC O
is VBZ O
an DT O
effective JJ O
competitor NN O
for IN O
binding NN O
of IN O
nuclear JJ B-Gene
AP1 NNP I-Gene
factors NNS I-Gene
to TO O
the DT O
consensus NN O
TRE NNP O
, , O
but CC O
in IN O
addition NN O
it PRP O
binds VBZ O
factors NNS O
that WDT O
do VBP O
not RB O
associate VB O
with IN O
the DT O
consensus NN O
TRE NNP O
. . O

In IN O
protocol NN O
2 CD O
, , O
eight CD O
different JJ O
subjects NNS O
performed VBN O
Con NNP O
and CC O
Ecc NNP O
arm NN O
curls NN O
to TO O
fatigue VB O
, , O
followed VBN O
by IN O
postexercise NN O
muscle NN O
ischemia NN O
, , O
by IN O
using VBG O
the DT O
same JJ O
resistance NN O
as IN O
in IN O
protocol NN O
1 CD O
. . O

Liver NNP O
regional JJ O
blood NN O
volume NN O
( ( O
LRBV NNP O
) ) O
is VBZ O
altered VBN O
by IN O
several JJ O
disease NN O
states NNS O
and CC O
various JJ O
drugs NNS O
. . O

In IN O
the DT O
tissues NNS O
tested VBN O
, , O
except IN O
brain NN O
, , O
the DT O
message NN O
for IN O
CLIP NNP B-Gene
- : I-Gene
170 CD I-Gene
was VBD O
more RBR O
abundant JJ O
than IN O
that DT O
for IN O
Restin NNP B-Gene
. . O

To TO O
identify VB O
factors NNS O
that WDT O
may MD O
modify VB O
the DT O
heterosexual JJ O
transmission NN O
of IN O
human JJ O
T NNP O
cell NN O
leukemia NN O
/ NNP O
lymphoma NN O
virus NN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
, , O
534 CD O
married VBD O
couples NNS O
enrolled VBN O
in IN O
the DT O
Miyazaki NNP O
Cohort NNP O
Study NNP O
between IN O
November NNP O
1984 CD O
and CC O
April NNP O
1989 CD O
were VBD O
studied VBN O
: : O
95 CD O
husband NN O
HTLV NNP O
- : O
I PRP O
- : O
seropositive NN O
( ( O
H NNP O
+ NNP O
) ) O
/ VBP O
wife NN O
seropositive NN O
( ( O
W NNP O
+ NNP O
) ) O
, , O
33 CD O
H NNP O
+ NNP O
/ NNP O
W NNP O
- : O
, , O
64 CD O
H NNP O
- : O
/ NN O
W NNP O
+ NNP O
, , O
and CC O
342 CD O
H NNP O
- : O
/ NN O
W NNP O
- : O
. . O

Lack NN O
of IN O
sufficient JJ O
data NNS O
on IN O
vibration NN O
measurements NNS O
and CC O
employment NN O
durations NNS O
add VBP O
to TO O
the DT O
uncertainty NN O
, , O
as IN O
do JJ O
variations NNS O
in IN O
tool NN O
conditions NNS O
( ( O
grinder NN O
wheels NNS O
, , O
etc FW O
) ) O
and CC O
inherent JJ O
difficulties NNS O
in IN O
measurement NN O
. . O

The DT O
prominent JJ O
lesions NNS O
were VBD O
confined VBN O
to TO O
the DT O
cerebral JJ O
surface NN O
layer NN O
and CC O
leptomeningeal JJ O
tissue NN O
including VBG O
the DT O
arachnoid NN O
vessels NNS O
, , O
which WDT O
were VBD O
all DT O
bathed VBN O
in IN O
the DT O
cerebrospinal JJ O
fluid NN O
, , O
suggesting VBG O
that IN O
some DT O
necrotizing NN O
toxins NNS O
had VBD O
been VBN O
secreted VBN O
into IN O
the DT O
fluid NN O
by IN O
the DT O
B NNP O
. . O
cereus NN O
. . O

Effect NN O
of IN O
succimer NN O
on IN O
the DT O
intensity NN O
of IN O
tricarboxylic JJ B-Gene
acid JJ I-Gene
dehydrogenase NN I-Gene
reactions NNS O
in IN O
the DT O
brain NN O
of IN O
rats NNS O
poisoned VBN O
with IN O
mercuric JJ O
chloride NN O

The DT O
antihypertensive JJ O
effect NN O
of IN O
Estulic NNP O
has VBZ O
been VBN O
examined VBN O
over IN O
a DT O
12 CD O
- : O
month NN O
period NN O
in IN O
101 CD O
hypertensive JJ O
patients NNS O
. . O

During IN O
this DT O
period NN O
, , O
administration NN O
of IN O
additional JJ O
exogenous JJ B-Gene
PRL NNPS I-Gene
did VBD O
not RB O
stimulate VB O
further JJ O
activation NN O
( ( O
binding VBG O
) ) O
of IN O
the DT O
Stat NNP B-Gene
factors NNS I-Gene
. . O

This DT O
study NN O
analyzed VBD O
whether IN O
the DT O
localization NN O
of IN O
an DT O
accessory JJ O
pathway NN O
could MD O
be VB O
predicted VBN O
by IN O
using VBG O
the DT O
polarity NN O
of IN O
the DT O
QRS NNP O
complex NN O
during IN O
sinus NN O
rhythm NN O
on IN O
the DT O
surface NN O
ECG NNP O
, , O
instead RB O
of IN O
the DT O
delta NN O
wave VBP O
polarity NN O
as IN O
used VBN O
in IN O
many JJ O
reports NNS O
. . O

Moreover RB O
, , O
increasing VBG O
the DT O
dosage NN O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
Fus3 NNP I-Gene
intensifies VBZ O
the DT O
inhibition NN O
of IN O
both DT O
Ty1 NNP B-Gene
transposition NN O
and CC O
invasive JJ O
growth NN O
. . O

After IN O
recovery NN O
, , O
a DT O
hypertonic JJ O
saline NN O
challenge NN O
was VBD O
performed VBN O
. . O

Acoust NNP O
. . O

Considering VBG O
these DT O
sources NNS O
of IN O
error NN O
some DT O
of IN O
the DT O
variability NN O
in IN O
the DT O
present JJ O
investigation NN O
might MD O
be VB O
avoided VBN O
by IN O
systematic JJ O
instructions NNS O
. . O

We PRP O
have VBP O
mutated VBN O
to TO O
cysteine VB O
, , O
one CD O
at IN O
a DT O
time NN O
, , O
21 CD O
consecutive JJ O
residues NNS O
in IN O
the DT O
fourth JJ O
TMS NNP O
( ( O
TM4 NNP O
) ) O
. . O

No DT O
case NN O
of IN O
SMF NNP O
demonstrated VBD O
expansive JJ O
tumorous JJ O
growth NN O
. . O

Mutants NNS O
lacking VBG O
the DT O
3 CD O
' POS O
stem NN O
- : O
loop NN O
exhibited VBD O
a DT O
75 CD O
% NN O
reduction NN O
in IN O
the DT O
level NN O
of IN O
psaB JJ B-Gene
mRNA NN O
. . O

Fulminant NNP O
hepatitis VBD O
A NNP O
in IN O
chronic JJ O
HBV NNP O
carrier NN O
. . O

The DT O
major JJ O
RNase NNP B-Gene
E NNP I-Gene
cleavage NN O
product NN O
( ( O
denoted JJ O
pSok NN B-Gene
- : I-Gene
6 CD I-Gene
) ) O
is VBZ O
rapidly RB O
degraded VBN O
by IN O
polynucleotide JJ B-Gene
phosphorylase NN I-Gene
( ( O
PNPase NNP B-Gene
) ) O
. . O

No DT O
symptoms NNS O
other JJ O
than IN O
hot JJ O
flush NN O
showed VBD O
such JJ O
significant JJ O
correlation NN O
with IN O
plasma JJ O
epinephrine NN O
or CC O
norepinephrine NN O
levels NNS O
. . O

The DT O
5 CD O
' POS O
flanking JJ O
region NN O
is VBZ O
highly RB O
GC NNP O
rich JJ O
, , O
with IN O
multiple JJ O
CpG NNP O
doublets NNS O
, , O
and CC O
contains VBZ O
multiple JJ O
binding NN O
sites NNS O
for IN O
Sp1 NNP B-Gene
. . O

We PRP O
have VBP O
cloned VBN O
a DT O
novel JJ O
mouse NN O
protein NN O
, , O
TAF NNP B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
140 CD I-Gene
, , O
containing VBG O
an DT O
HFD NNP B-Gene
and CC O
a DT O
plant NN B-Gene
homeodomain NN I-Gene
( ( O
PHD NNP B-Gene
) ) O
finger NN O
, , O
which WDT O
we PRP O
demonstrated VBD O
by IN O
immunoprecipitation NN O
to TO O
be VB O
a DT O
mammalian JJ B-Gene
TFIID NNP I-Gene
component NN I-Gene
. . O

However RB O
, , O
addition NN O
of IN O
core NN B-Gene
DNA NNP I-Gene
polymerase NN I-Gene
III NNP I-Gene
to TO O
preinitiation NN O
complex NN O
, , O
fully RB O
reconstituting VBG O
holoenzyme NN O
resulted VBD O
in IN O
replacement NN O
of IN O
gamma NN O
by IN O
alpha NN O
at IN O
the DT O
primer NN O
terminus NN O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
new JJ O
human JJ B-Gene
RING NNP I-Gene
- : I-Gene
finger NN I-Gene
gene NN I-Gene
( ( O
RNF4 NNP B-Gene
) ) O
that WDT O
encodes VBZ O
a DT O
190 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
. . O

Measurement NN O
of IN O
gastric JJ O
acid JJ O
secretion NN O
by IN O
conductivity NN O
. . O

M NNP O
. . O
, , O
and CC O
D NNP O
. . O

Kinetic NNP O
coupling NN O
and CC O
requirement NN O
for IN O
ATP NNP O
hydrolysis NN O
. . O

Standard NNP O
reference NN O
sources NNS O
indicate VBP O
that IN O
an DT O
able JJ O
- : O
bodied VBD O
11 CD O
- : O
year NN O
- : O
old JJ O
child NN O
of IN O
comparable JJ O
height NN O
requires VBZ O
1 CD O
, , O
493 CD O
kcal JJ O
/ NNP O
d NN O
for IN O
support NN O
of IN O
basal NN O
metabolic JJ O
functions NNS O
. . O

The DT O
response NN O
of IN O
the DT O
plasma NN B-Gene
fibrinogen NN I-Gene
level NN O
to TO O
the DT O
subucutaneous JJ O
injection NN O
of IN O
turpentine NN O
and CC O
to TO O
the DT O
intravenous JJ O
injection NN O
of IN O
endotoxin NN O
was VBD O
measured VBN O
in IN O
normal JJ O
rabbits NNS O
and CC O
in IN O
rabbits NNS O
made VBN O
granulocytopenic JJ O
and CC O
thrombocytopenic JJ O
with IN O
busulfan NN O
. . O

A DT O
9 CD O
. . O
5 CD O
- : O
kb NN O
KpnI NNP B-Gene
- : O
SalI NNP B-Gene
fragment NN O
, , O
where WRB O
all PDT O
the DT O
DNA NNP O
changes NNS O
associated VBN O
with IN O
su NN B-Gene
( ( I-Gene
Hw NNP I-Gene
) ) I-Gene
mutations NNS I-Gene
were VBD O
mapped VBN O
, , O
was VBD O
able JJ O
to TO O
rescue VB O
the DT O
su NN B-Gene
( ( I-Gene
Hw NNP I-Gene
) ) I-Gene
mutant NN I-Gene
phenotype NN O
after IN O
P NNP O
- : O
element NN O
- : O
mediated VBN O
germ JJ O
- : O
line NN O
transformation NN O
. . O

We PRP O
generated VBD O
transformed VBN O
B NNP O
lymphoblast NN O
cell NN O
lines NNS O
from IN O
controls NNS O
, , O
from IN O
four CD O
patients NNS O
with IN O
p47 JJ B-Gene
- : O
phox NN B-Gene
- : O
deficient NN O
chronic JJ O
granulomatous JJ O
disease NN O
, , O
and CC O
from IN O
three CD O
parents NNS O
. . O

Thus RB O
, , O
these DT O
studies NNS O
on IN O
rat NN B-Gene
Std NNP I-Gene
promoter NN I-Gene
function NN O
indicate VBP O
that IN O
( ( O
i NN O
) ) O
HNF1 NNP B-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
are VBP O
responsible JJ O
for IN O
liver JJ O
specificity NN O
of IN O
the DT O
rat NN B-Gene
Std NNP I-Gene
gene NN I-Gene
; : O
( ( O
ii NN O
) ) O
androgenic JJ O
repression NN O
of IN O
the DT O
gene NN O
requires VBZ O
the DT O
presence NN O
of IN O
all DT O
of IN O
the DT O
OCT NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
elements NNS I-Gene
between IN O
positions NNS O
- : O
231 CD O
and CC O
- : O
292 CD O
; : O
and CC O
( ( O
iii NN O
) ) O
AR NNP B-Gene
may MD O
exert VB O
its PRP$ O
negative JJ O
regulatory JJ O
effect NN O
indirectly RB O
through IN O
transcriptional JJ O
interference NN O
of IN O
OCT NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
rather RB O
than IN O
through IN O
a DT O
direct JJ O
DNA NNP B-Gene
- : I-Gene
AR NNP I-Gene
interaction NN O
. . O

They PRP O
observed VBD O
depressed JJ O
protein JJ B-Gene
C NNP I-Gene
activity NN O
that WDT O
significantly RB O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
increased VBN O
and CC O
became VBD O
normal JJ O
immediately RB O
after IN O
hemodialysis NN O
while IN O
factor NN B-Gene
X NNP I-Gene
and CC O
factor NN B-Gene
VII NNP I-Gene
increased VBD O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
; : O
p NN O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
despite IN O
heparinization NN O
together RB O
with IN O
amount NN O
of IN O
serum NN B-Gene
lipoprotein NN I-Gene
( ( I-Gene
a DT I-Gene
) ) I-Gene
. . O

In IN O
10 CD O
pentobarbitalized JJ O
dogs NNS O
, , O
plasma JJ O
viscosity NN O
( ( O
Ep NNP O
) ) O
was VBD O
raised VBN O
fourfold RB O
while IN O
apparent JJ O
blood NN O
viscosity NN O
( ( O
Ea NNP O
) ) O
increased VBD O
about IN O
twofold VBN O
by IN O
two CD O
steps NNS O
of IN O
exchange NN O
transfusion NN O
of IN O
200 CD O
ml NN O
of IN O
plasma NN O
with IN O
plasma NN O
containing VBG O
high JJ O
molecular JJ O
weight NN O
dextran NN O
( ( O
mol JJ O
wt NN O
500 CD O
, , O
0 CD O
, , O
20 CD O
% NN O
wt NN O
/ NNP O
vol NN O
) ) O
. . O

Because IN O
of IN O
differences NNS O
in IN O
patient JJ O
characteristics NNS O
, , O
control NN O
measurements NNS O
were VBD O
obtained VBN O
from IN O
normal JJ O
muscle NN O
in IN O
all DT O
patients NNS O
. . O

Analysis NN O
of IN O
cell NN O
cycle NN O
regulation NN O
in IN O
the DT O
budding NN O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
has VBZ O
shown VBN O
that IN O
a DT O
central JJ O
regulatory JJ O
protein NN O
kinase NN O
, , O
Cdc28 NNP B-Gene
, , O
undergoes JJ O
changes NNS O
in IN O
activity NN O
through IN O
the DT O
cell NN O
cycle NN O
by IN O
associating VBG O
with IN O
distinct JJ O
groups NNS O
of IN O
cyclins NNS B-Gene
that WDT O
accumulate VBP O
at IN O
different JJ O
times NNS O
. . O

By IN O
comparing VBG O
the DT O
abundances NNS O
of IN O
many JJ O
yeast NN O
transcripts NNS O
in IN O
isogenic JJ O
wild JJ O
- : O
type NN O
and CC O
paf1 NN B-Gene
mutant NN I-Gene
strains NNS O
, , O
we PRP O
have VBP O
identified VBN O
genes NNS O
whose WP$ O
expression NN O
is VBZ O
affected VBN O
by IN O
PAF1 NNP B-Gene
. . O

Fenfluramine NNP O
( ( O
in IN O
doses NNS O
ranging VBG O
from IN O
0 CD O
. . O
625 CD O
- : O
4 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
infusion NN O
) ) O
did VBD O
not RB O
maintain VB O
self PRP O
- : O
administration NN O
behavior NN O
at IN O
or CC O
above IN O
the DT O
minimum JJ O
requirement NN O
( ( O
FR NNP O
30 CD O
) ) O
. . O

Novel NNP O
8 CD O
- : O
base NN O
pair NN O
sequence NN O
( ( O
Drosophila NNP O
DNA NNP O
replication NN O
- : O
related JJ O
element NN O
) ) O
and CC O
specific JJ O
binding VBG O
factor NN O
involved VBN O
in IN O
the DT O
expression NN O
of IN O
Drosophila NNP O
genes NNS O
for IN O
DNA NNP B-Gene
polymerase NN I-Gene
alpha NN I-Gene
and CC O
proliferating VBG B-Gene
cell NN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
. . O

Isolation NN O
of IN O
a DT O
temperature NN O
- : O
sensitive JJ O
mutant NN O
with IN O
an DT O
altered JJ O
tRNA NN B-Gene
nucleotidyltransferase NN I-Gene
and CC O
cloning NN O
of IN O
the DT O
gene NN B-Gene
encoding VBG I-Gene
tRNA JJ I-Gene
nucleotidyltransferase NN I-Gene
in IN I-Gene
the DT I-Gene
yeast NN I-Gene
Saccharomyces NNP I-Gene
cerevisiae NN I-Gene
. . O

The DT O
responsive JJ O
region NN O
of IN O
the DT O
alpha NN B-Gene
2 CD I-Gene
( ( I-Gene
V NNP I-Gene
) ) I-Gene
collagen NN I-Gene
gene NN I-Gene
was VBD O
localized VBN O
to TO O
a DT O
fragment NN O
including VBG O
100 CD O
bp NN O
of IN O
basal NN O
promoter NN O
and CC O
150 CD O
bp NN O
of IN O
exon $ O
1 CD O
sequences NNS O
, , O
which WDT O
contained VBD O
two CD O
CRE NNP O
- : O
like IN O
elements NNS O
. . O

PIP2 NNP O
, , O
when WRB O
incorporated VBN O
into IN O
phosphatidylcholine NN O
carrier NN O
vesicles NNS O
, , O
binds VBZ O
tightly RB O
to TO O
the DT O
guanine NN O
nucleotide IN O
- : O
depleted JJ O
form NN O
of IN O
Cdc42Hs NNP B-Gene
and CC O
weakly RB O
to TO O
the DT O
GDP NNP O
- : O
bound NN O
form NN O
of IN O
the DT O
GTP NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
but CC O
does VBZ O
not RB O
bind VB O
to TO O
GTP NNP O
- : O
bound NN O
Cdc42Hs NNP B-Gene
, , O
similar JJ O
to TO O
what WP O
was VBD O
observed VBN O
for IN O
the DT O
Dbl NNP B-Gene
oncoprotein NN I-Gene
. . O

Comparison NNP O
of IN O
sequences NNS O
of IN O
ovine NN O
and CC O
bovine NN O
, , O
rat NN O
and CC O
guinea NN B-Gene
- : I-Gene
pig NN I-Gene
alpha NN I-Gene
s1 SYM I-Gene
- : I-Gene
casein NN I-Gene
mRNAs NN I-Gene
has VBZ O
revealed VBN O
a DT O
greater JJR O
homology NN O
in IN O
the DT O
3 CD O
' POS O
and CC O
especially RB O
5 CD O
' '' O
non JJ O
coding VBG O
regions NNS O
. . O

The DT O
optimal JJ O
sequence NN O
for IN O
interaction NN O
with IN O
mu JJ B-Gene
2 CD I-Gene
and CC O
with IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
has VBZ O
tyrosine VBN O
as IN O
an DT O
anchor NN O
and CC O
prefers NNS O
arginine VBP O
at IN O
position NN O
Y NNP O
+ VBZ O
2 CD O
and CC O
leucine NN O
at IN O
position NN O
Y NNP O
+ VBZ O
3 CD O
. . O

The DT O
induction NN O
of IN O
RNKP NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
in IN O
the DT O
Con NNP B-Gene
A NNP I-Gene
- : O
cultured VBD O
spleen JJ O
cells NNS O
is VBZ O
accompanied VBN O
by IN O
increases NNS O
in IN O
both DT O
NK NNP O
and CC O
lymphokine JJ O
- : O
activated VBN O
killer NN O
lymphocyte NN O
activities NNS O
. . O

Alpha NNP B-Gene
- : I-Gene
1 CD I-Gene
antitrypsin NN I-Gene
and CC O
Indian JJ O
childhood NN O
cirrhosis NN O
. . O

The DT O
RNA NNP O
genome NN O
of IN O
rabbit NN O
hemorrhagic JJ O
disease NN O
virus NN O
( ( O
RHDV NNP O
) ) O
was VBD O
molecularly RB O
cloned VBN O
. . O

To TO O
assess VB O
the DT O
functional JJ O
importance NN O
of IN O
these DT O
NBS NNP O
in IN O
the DT O
overall JJ O
drug NN O
resistance NN O
phenotype NN O
conferred VBN O
by IN O
mdr1 NN B-Gene
, , O
we PRP O
introduced VBD O
amino JJ O
acid JJ O
substitutions NNS O
in IN O
the DT O
core NN O
consensus NN O
sequence NN O
for IN O
nucleotide JJ O
binding NN O
, , O
GXGKST NNP O
. . O

The DT O
hit1 NN B-Gene
- : I-Gene
1 CD I-Gene
mutation NN O
caused VBD O
a DT O
defect NN O
in IN O
synthesis NN O
of IN O
a DT O
74 CD B-Gene
- : I-Gene
kD NN I-Gene
heat NN I-Gene
shock NN I-Gene
protein NN I-Gene
. . O

All DT O
other JJ O
changes NNS O
at IN O
the DT O
3 CD O
- : O
, , O
5 CD O
- : O
, , O
and CC O
6 CD O
- : O
positions NNS O
, , O
as RB O
well RB O
as IN O
the DT O
replacement NN O
of IN O
the DT O
phenyl NN O
group NN O
at IN O
position NN O
2 CD O
, , O
caused VBD O
a DT O
marked JJ O
decrease NN O
of IN O
activity NN O
. . O

The DT O
levels NNS O
of IN O
transactivation NN O
are VBP O
correlated VBN O
with IN O
the DT O
respective JJ O
binding NN O
affinities NNS O
of IN O
the DT O
response NN O
elements NNS O
( ( O
IRper NNP O
- : O
1 CD O
> NN O
DR NNP O
- : O
4 CD O
> NN O
IRhsp NNP O
- : O
1 CD O
) ) O
. . O

An DT O
anchored JJ O
AFLP NNP O
- : O
and CC O
retrotransposon VB O
- : O
based VBN O
map NN O
of IN O
diploid JJ O
Avena NNP O
. . O

These DT O
data NNS O
confirm VBP O
the DT O
existence NN O
of IN O
hyperlipemic JJ O
abdominal JJ O
crisis NN O
as IN O
a DT O
distinct JJ O
entity NN O
and CC O
testify VB O
to TO O
the DT O
importance NN O
of IN O
recognizing VBG O
this DT O
syndrome NN O
in IN O
order NN O
to TO O
avoid VB O
the DT O
occurrence NN O
of IN O
acute JJ O
pancreatitis NN O
and CC O
the DT O
performance NN O
of IN O
unnecessary JJ O
and CC O
potentially RB O
harmful JJ O
surgery NN O
. . O

The DT O
Siglecs NNP B-Gene
are VBP O
a DT O
subfamily NN O
of IN O
I PRP B-Gene
- : I-Gene
type NN I-Gene
lectins NNS I-Gene
( ( O
immunoglobulin JJ B-Gene
superfamily RB I-Gene
proteins VBZ I-Gene
that IN O
bind NN O
sugars NNS O
) ) O
that WDT O
specifically RB O
recognize VBP O
sialic JJ O
acids NNS O
. . O

Information NN O
about IN O
immunologic JJ O
drug NN O
interactions NNS O
is VBZ O
needed VBN O
by IN O
pharmacists NNS O
to TO O
make VB O
rational JJ O
drug NN O
- : O
use NN O
decisions NNS O
. . O

The DT O
sympathetic JJ O
neuroeffector NN O
influence NN O
on IN O
the DT O
myocardium NN O
with IN O
ATCI NNP O
depends VBZ O
to TO O
a DT O
large JJ O
measure NN O
on IN O
the DT O
intensity NN O
of IN O
the DT O
neurotransmitter JJ O
biosynthesis NN O
and CC O
function NN O
of IN O
cardiomyocyte NN O
adrenoreceptors NNS O
. . O

Urinary JJ O
LTE4 NNP O
increased VBD O
after IN O
both DT O
challenges VBZ O
the DT O
rise NN O
being VBG O
higher JJR O
following VBG O
oral JJ O
as IN O
compared VBN O
to TO O
inhalation VB O
provocation NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
1 CD O
) ) O
. . O

Digestion NN O
of IN O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
with IN O
endoprotease NN B-Gene
Asp NNP I-Gene
- : I-Gene
N NNP I-Gene
produced VBD O
a DT O
domain NN O
smaller JJR O
than IN O
the DT O
TCD NNP B-Gene
( ( O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
bZIP NN I-Gene
domains NNS I-Gene
( ( O
NFBD NNP B-Gene
) ) O
( ( O
272 CD O
- : O
345 CD O
) ) O
) ) O
, , O
a DT O
domain NN O
identified VBN O
either RB O
in IN O
the DT O
absence NN O
or CC O
the DT O
presence NN O
of IN O
DNA NNP O
. . O

Thus RB O
, , O
as IN O
expected VBN O
, , O
trans VBZ O
- : O
splicing VBG O
depends NNS O
on IN O
the DT O
integrity NN O
of IN O
U2 NNP B-Gene
, , O
U4 NNP B-Gene
, , O
and CC O
U6 NNP B-Gene
snRNAs NN I-Gene
. . O

Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
a DT O
tissue NN O
- : O
specific JJ O
POU NNP B-Gene
domain NN I-Gene
factor NN I-Gene
obligatory NN O
for IN O
the DT O
appearance NN O
of IN O
three CD O
cell NN O
phenotypes NNS O
in IN O
the DT O
anterior JJ O
pituitary JJ O
gland NN O
. . O

Based VBN O
on IN O
the DT O
sequence NN O
of IN O
the DT O
conRTRE NN B-Gene
, , O
we PRP O
located VBD O
a DT O
putative JJ O
RTRE NNP B-Gene
, , O
referred VBD O
to TO O
as IN O
P2 NNP B-Gene
- : I-Gene
RE NN I-Gene
, , O
in IN O
the DT O
5 CD O
' POS O
promoter NN O
- : O
flanking JJ O
region NN O
of IN O
the DT O
mouse NN B-Gene
protamine NN I-Gene
2 CD I-Gene
gene NN I-Gene
, , O
which WDT O
is VBZ O
induced VBN O
during IN O
the DT O
same JJ O
stage NN O
of IN O
spermatogenesis NN O
as IN O
RTR NNP B-Gene
. . O

The DT O
bHLH NN B-Gene
proteins VBZ I-Gene
function NN O
as IN O
potent JJ O
transcriptional JJ O
activators NNS O
of IN O
tissue NN O
- : O
specific JJ O
genes NNS O
by IN O
forming VBG O
heterodimers NNS O
between IN O
ubiquitous JJ O
and CC O
cell NN O
- : O
restricted VBN O
family NN O
members NNS O
. . O

The DT O
determination NN O
of IN O
immunoglobulin NN B-Gene
E NNP I-Gene
( ( O
IgE NNP B-Gene
) ) O
antibodies NNS O
by IN O
one CD O
of IN O
several JJ O
laboratory NN O
tests NNS O
, , O
by IN O
skin JJ O
- : O
prick NN O
tests NNS O
or CC O
by IN O
appropriate JJ O
challenge NN O
procedures NNS O
is VBZ O
useful JJ O
either RB O
to TO O
identify VB O
atopic JJ O
individuals NNS O
or CC O
as IN O
outcome JJ O
predictors NNS O
in IN O
wheezy JJ O
children NNS O
. . O

These DT O
results NNS O
provide VBP O
the DT O
first JJ O
demonstration NN O
that IN O
an DT O
SR NNP B-Gene
protein NN I-Gene
can MD O
influence VB O
splicing NN O
of IN O
specific JJ O
pre FW O
- : O
mRNAs NN O
in IN O
vivo NN O
. . O

Only RB O
after IN O
a DT O
pretreatment NN O
aimed VBN O
at IN O
increasing VBG O
its PRP$ O
oxide NN O
surface NN O
layer NN O
was VBD O
titanium JJ O
powder NN O
found VBD O
to TO O
accelerate VB O
the DT O
precipitation NN O
from IN O
solutions NNS O
containing VBG O
2 CD O
mmol JJ O
/ NNP O
L NNP O
CaCl2 NNP O
, , O
2 CD O
mmol NN O
/ NNP O
L NNP O
KH2PO4 NNP O
, , O
50 CD O
mmol NN O
/ NNP O
L NNP O
Hepes NNP O
, , O
pH VBD O
7 CD O
. . O
2 CD O
, , O
and CC O
to TO O
induce VB O
precipitation NN O
from IN O
metastable JJ O
solutions NNS O
containing VBG O
1 CD O
. . O
2 CD O
mmol JJ O
/ NNP O
L NNP O
CaCl2 NNP O
, , O
1 CD O
. . O
2 CD O
mmol JJ O
/ NNP O
L NNP O
KH2PO4 NNP O
, , O
50 CD O
mmol NN O
/ NNP O
L NNP O
Hepes NNP O
, , O
pH VBD O
7 CD O
. . O
2 CD O
, , O
at IN O
37 CD O
degrees NNS O
C NNP O
. . O

Audiological JJ O
findings NNS O
in IN O
pregnancy NN O
. . O

Irradiation NN O
of IN O
human JJ O
blood NN O
platelets NNS O
with IN O
UV NNP O
- : O
A NN O
in IN O
vitro NN O
impairs VBP O
their PRP$ O
ability NN O
to TO O
aggregate VB O
after IN O
challenge NN O
with IN O
collagen NN B-Gene
. . O

National NNP O
certification NN O
: : O
a DT O
vital JJ O
component NN O
of IN O
quality NN O
assurance NN O
. . O

One CD O
skull NN O
does VBZ O
not RB O
a DT O
species NNS O
make VBP O
. . O

Purple NNP O
photosynthetic JJ O
bacteria NNS O
are VBP O
capable JJ O
of IN O
generating VBG O
cellular JJ O
energy NN O
from IN O
several JJ O
sources NNS O
, , O
including VBG O
photosynthesis NN O
, , O
respiration NN O
, , O
and CC O
H NNP O
( ( O
2 CD O
) ) O
oxidation NN O
. . O

The DT O
cDNA NN O
sequence NN O
has VBZ O
an DT O
813 CD O
- : O
bp NN O
open JJ O
reading NN O
frame NN O
( ( O
ORF NNP O
) ) O
whose WP$ O
predicted VBN O
amino NN O
acid NN O
sequence NN O
is VBZ O
97 CD O
. . O
6 CD O
% NN O
identical JJ O
to TO O
the DT O
272 CD O
carboxy JJ O
- : O
terminal NN O
amino NN O
acids NNS O
of IN O
the DT O
human JJ B-Gene
ets VBZ I-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
. . O

The DT O
new JJ O
FIGO NNP O
definition NN O
of IN O
cervical JJ O
cancer NN O
stage NN O
IA NNP O
: : O
a DT O
critique NN O
. . O

Recurrence NN O
of IN O
oxalate JJ O
deposition NN O
in IN O
a DT O
renal JJ O
transplant NN O
during IN O
ciclosporin NN O
A NNP O
therapy NN O
. . O

Self NNP O
- : O
emasculation NN O
is VBZ O
the DT O
end NN O
result NN O
of IN O
an DT O
unusual JJ O
psychiatric JJ O
disorder NN O
, , O
which WDT O
initially RB O
requires VBZ O
surgical JJ O
treatment NN O
. . O

The DT O
site NN O
- : O
directed JJ O
mutation NN O
of IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
motif NN I-Gene
in IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
/ JJ O
CAT NNP B-Gene
plasmid NN O
resulted VBD O
in IN O
the DT O
complete JJ O
abrogation NN O
of IN O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
these DT O
cells NNS O
. . O

Crohn NNP O
' POS O
s JJ O
disease NN O
in IN O
prolonged JJ O
remission NN O
: : O
should MD O
one CD O
augment NN O
protein NN O
- : O
calorie NN O
intake NN O
as IN O
compared VBN O
to TO O
healthy JJ O
subjects NNS O
? . O
] VBP O
The DT O
aim NN O
of IN O
our PRP$ O
two CD O
year NN O
prospective JJ O
study NN O
was VBD O
to TO O
evaluate VB O
whether IN O
adult NN O
Crohn NNP O
' POS O
s JJ O
disease NN O
patients NNS O
in IN O
prolonged JJ O
remission NN O
( ( O
CDAI NNP O
< NNP O
150 CD O
) ) O
, , O
in IN O
order NN O
to TO O
maintain VB O
their PRP$ O
body NN O
weight VBD O
as RB O
close RB O
as IN O
possible JJ O
to TO O
the DT O
ideal NN O
one CD O
, , O
need VBP O
a DT O
protein NN O
- : O
calorie NN O
intake NN O
higher JJR O
than IN O
the DT O
predicted JJ O
one CD O
and CC O
that IN O
of IN O
healthy JJ O
controls NNS O
. . O

Stroop JJ O
interference NN O
: : O
aging JJ O
effects NNS O
assessed VBN O
with IN O
the DT O
Stroop NNP O
Color NNP O
- : O
Word NNP O
Test NNP O
. . O

In IN O
contrast NN O
to TO O
MPc3 NNP B-Gene
, , O
data NNS O
indicate VBP O
that IN O
the DT O
Pc NNP B-Gene
protein NN I-Gene
M33 NNP B-Gene
does VBZ O
not RB O
interact VB O
with IN O
AF9 NNP B-Gene
. . O

RESULTS NN O
: : O
At IN O
latest JJS O
examination NN O
, , O
mean JJ O
UPDRS NNP O
II NNP O
and CC O
III NNP O
scores NNS O
had VBD O
improved VBN O
by IN O
30 CD O
% NN O
( ( O
on IN O
stimulation NN O
, , O
off RB O
therapy NN O
) ) O
with IN O
mean JJ O
50 CD O
% NN O
reduction NN O
in IN O
daily JJ O
off IN O
time NN O
. . O

Western JJ O
analyses NNS O
with IN O
antisera NN O
raised VBN O
against IN O
Lu NNP B-Gene
- : I-Gene
ECAM NNP I-Gene
- : I-Gene
1 CD I-Gene
peptides NNS I-Gene
show VBP O
that IN O
the DT O
N NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
predicted JJ O
open JJ O
reading NN O
frame NN O
is VBZ O
present JJ O
only RB O
in IN O
the DT O
larger JJR O
size NN O
proteins NNS O
( ( O
i NN O
. . O
e NN O
. . O

These DT O
introns NNS O
belong VBP O
to TO O
the DT O
class NN O
of IN O
nuclear JJ O
pre NN O
- : O
mRNA NN O
introns NNS O
and CC O
contain VB O
typical JJ O
5 CD O
' POS O
- : O
and CC O
3 CD O
' '' O
- : O
consensus NN O
sequences NNS O
, , O
as RB O
well RB O
as IN O
unique JJ O
features NNS O
. . O

Endorphins NNS B-Gene
at IN O
the DT O
approach NN O
of IN O
death NN O
. . O

In IN O
these DT O
vectors NNS O
the DT O
chimeric NN B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
chLTR NN B-Gene
) ) O
drives VBZ O
the DT O
expression NN O
of IN O
the DT O
chloramphenicol NN B-Gene
acetyl NN I-Gene
transferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
reporter NN O
gene NN O
that WDT O
is VBZ O
followed VBN O
by IN O
an DT O
internal JJ O
SV40 NNP B-Gene
virus NN I-Gene
early JJ I-Gene
region NN I-Gene
promoter NN I-Gene
linked VBN O
to TO O
the DT O
neomycin JJ B-Gene
phosphotransferase NN I-Gene
II NNP I-Gene
( ( O
NEO NNP B-Gene
) ) O
gene NN O
. . O

Of IN O
600 CD O
mediastinoscopies NNS O
carried VBD O
out IN O
from IN O
1966 CD O
to TO O
1973 CD O
, , O
479 CD O
were VBD O
performed VBN O
to TO O
assess VB O
the DT O
operability NN O
of IN O
a DT O
pulmonary JJ O
carcinoma NN O
. . O

This DT O
philosophy NN O
was VBD O
instituted VBN O
for IN O
the DT O
compound NN O
RP NNP O
73401 CD O
, , O
a DT O
specific JJ O
phosphodiesterase NN B-Gene
IV NNP I-Gene
inhibitor NN O
, , O
that WDT O
was VBD O
being VBG O
developed VBN O
simultaneously RB O
for IN O
delivery NN O
by IN O
both DT O
oral JJ O
and CC O
pulmonary JJ O
routes NNS O
of IN O
administration NN O
. . O

The DT O
3ASubE CD O
cells NNS O
expressing VBG O
CXCR2 NNP B-Gene
with IN O
mutation NN O
of IN O
Ser NNP O
- : O
346 CD O
, , O
- : O
347 CD O
, , O
and CC O
- : O
348 CD O
to TO O
alanine VB O
, , O
or CC O
with IN O
mutation NN O
of IN O
only RB O
one CD O
serine NN O
in IN O
this DT O
domain NN O
, , O
continue VBP O
to TO O
be VB O
phosphorylated VBN O
in IN O
response NN O
to TO O
ligand VB O
and CC O
are VBP O
60 CD O
- : O
70 CD O
% NN O
desensitized VBN O
following VBG O
the DT O
initial JJ O
ligand NN O
challenge NN O
. . O

OBJECTIVE NN O
: : O
Although IN O
the DT O
preponderance NN O
of IN O
findings NNS O
offer VBP O
support NN O
for IN O
transient NN O
( ( O
where WRB O
is VBZ O
it PRP O
? . O
) ) O
as IN O
opposed VBN O
to TO O
sustained VBN O
( ( O
what WP O
is VBZ O
it PRP O
? . O
) ) O
deficit NN O
, , O
a DT O
need NN O
remains VBZ O
for IN O
specific JJ O
depiction NN O
of IN O
the DT O
deficit NN O
. . O

A DT O
value NN O
of IN O
1 CD O
. . O
1 CD O
l JJ O
/ NNP O
kg NN O
was VBD O
used VBN O
for IN O
V NNP O
in IN O
calculating VBG O
all DT O
single JJ O
sample NN O
estimates NNS O
of IN O
clearance NN O
( ( O
CL NNP O
) ) O
, , O
and CC O
a DT O
value NN O
of IN O
4 CD O
. . O
3 CD O
l JJ O
/ NNP O
kg NN O
was VBD O
used VBN O
to TO O
calculate VB O
single JJ O
sample NN O
estimates NNS O
of IN O
clearance NN O
of IN O
plasma JJ O
unbound JJ O
drug NN O
( ( O
CLunb NNP O
) ) O
. . O

The DT O
effect NN O
of IN O
crude NN O
oil NN O
spillage NN O
on IN O
growth NN O
, , O
productivity NN O
and CC O
nutrient JJ O
uptake NN O
of IN O
maize NN O
( ( O
Zea NNP O
mays VBZ O
L NNP O
. . O
) ) O
was VBD O
assessed VBN O
in IN O
a DT O
pot NN O
experiment NN O
using VBG O
an DT O
Evwreni NNP O
manifold JJ O
sample NN O
of IN O
a DT O
petroleum NN O
development NN O
company NN O
, , O
which WDT O
had VBD O
a DT O
specific JJ O
gravity NN O
of IN O
0 CD O
. . O
8778 CD O
. . O

Also RB O
in IN O
the DT O
spectrum NN O
of IN O
mutants NNS O
with IN O
TGN NNP O
sorting VBG O
defects NNS O
are VBP O
isolates VBZ O
with IN O
mutations NNS O
in IN O
the DT O
following NN O
: : O
RIC1 NNP B-Gene
, , O
encoding VBG O
a DT O
product NN O
originally RB O
proposed VBN O
to TO O
participate VB O
in IN O
ribosome JJ O
biogenesis NN O
; : O
LUV1 NNP B-Gene
, , O
encoding VBG O
a DT O
product NN O
potentially RB O
involved VBN O
in IN O
vacuole NN O
and CC O
microtubule NN O
organization NN O
; : O
and CC O
INP53 NNP B-Gene
, , O
encoding VBG O
a DT O
synaptojanin JJ B-Gene
- : I-Gene
like IN I-Gene
inositol NN I-Gene
polyphosphate NN I-Gene
5 CD I-Gene
- : I-Gene
phosphatase NN I-Gene
. . O

HIV NNP O
- : O
1 CD O
infection NN O
in IN O
rural JJ O
Africa NNP O
: : O
is VBZ O
there EX O
a DT O
difference NN O
in IN O
median JJ O
time NN O
to TO O
AIDS NNP O
and CC O
survival NN O
compared VBN O
with IN O
that DT O
in IN O
industrialized JJ O
countries NNS O
? . O

OBJECTIVES NN O
: : O
To TO O
describe VB O
the DT O
progression NN O
times NNS O
of IN O
HIV NNP O
- : O
1 CD O
infection NN O
from IN O
seroconversion NN O
to TO O
AIDS NNP O
and CC O
to TO O
death NN O
, , O
and CC O
time NN O
from IN O
first JJ O
developing VBG O
AIDS NNP O
to TO O
death NN O
in IN O
rural JJ O
Uganda NNP O
. . O

A DT O
decrease NN O
in IN O
insulin NN B-Gene
- : O
induced JJ O
receptor NN O
kinase NN O
activity NN O
was VBD O
observed VBN O
for IN O
solubilized JJ O
chimeric JJ O
receptors NNS O
. . O

Similar JJ O
waves NNS O
were VBD O
seen VBN O
on IN O
cross NN O
- : O
correlating VBG O
a DT O
motor NN O
unit NN O
with IN O
an DT O
electronic JJ O
oscillator NN O
, , O
confirming VBG O
that IN O
their PRP$ O
occurrence NN O
does VBZ O
not RB O
necessarily RB O
demonstrate VB O
the DT O
existence NN O
of IN O
active JJ O
neural JJ O
interactions NNS O
. . O

Since IN O
the DT O
early JJ O
1980s CD O
there EX O
has VBZ O
been VBN O
increasing VBG O
awareness NN O
of IN O
the DT O
importance NN O
of IN O
quantifying VBG O
health NN O
- : O
related JJ O
quality NN O
of IN O
life NN O
( ( O
HRQL NNP O
) ) O
in IN O
patients NNS O
with IN O
chronic JJ O
respiratory NN O
disorders NNS O
included VBD O
in IN O
clinical JJ O
trials NNS O
. . O

We PRP O
found VBD O
that IN O
the DT O
amplitude NN O
of IN O
the DT O
cortical JJ O
evoked JJ O
potentials NNS O
( ( O
amplitude NN O
of IN O
the DT O
N2 NNP O
/ NNP O
P2 NNP O
peak NN O
) ) O
increased VBD O
from IN O
5 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
microV NN O
at IN O
5 CD O
mA NN O
to TO O
16 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
1 CD O
microV NN O
at IN O
20 CD O
mA NN O
. . O

Karger NNP O
AG NNP O
, , O
Basel NNP O

In IN O
addition NN O
a DT O
significant JJ O
Treatment NNP O
X NNP O
Strain NNP O
interaction NN O
was VBD O
due JJ O
to TO O
the DT O
larger JJR O
defecation NN O
numbers NNS O
displayed VBN O
by IN O
the DT O
taurine NN O
- : O
injected VBN O
MR NNP O
rats NNS O
relative VBP O
to TO O
the DT O
saline NN O
- : O
injected VBN O
MR NNP O
rats NNS O
. . O

The DT O
SUP44 NNP B-Gene
suppressor NN I-Gene
mutation NN I-Gene
occurs VBZ O
near IN O
a DT O
region NN O
of IN O
the DT O
protein NN O
that WDT O
corresponds VBZ O
to TO O
the DT O
known VBN O
positions NNS O
of IN O
alterations NNS O
in IN O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
S5 NNP I-Gene
ram NN I-Gene
mutations NNS I-Gene
. . O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
may MD O
exacerbate VB O
cryoblobulinemia NN O
- : O
related JJ O
ischemic JJ O
manifestations NNS O
: : O
an DT O
adverse JJ O
effect NN O
potentially RB O
related VBN O
to TO O
its PRP$ O
anti JJ O
- : O
angiogenic JJ O
activity NN O
. . O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
may MD O
exacerbate VB O
cryoblobulinemia NN O
- : O
related JJ O
ischemic JJ O
manifestations NNS O
: : O
an DT O
adverse JJ O
effect NN O
potentially RB O
related VBN O
to TO O
its PRP$ O
anti JJ O
- : O
angiogenic JJ O
activity NN O
. . O

The DT O
December NNP O
armed VBD O
revolt NN O
in IN O
Moscow NNP O
and CC O
the DT O
paramedical JJ O
personnel NNS O

By IN O
negatively RB O
regulating VBG O
GRK NNP B-Gene
- : O
mediated VBD O
receptor NN O
phosphorylation NN O
, , O
beta SYM B-Gene
- : I-Gene
arrestin NN I-Gene
- : O
mediated VBN O
processes NNS O
such JJ O
as IN O
Src NNP B-Gene
recruitment NN O
and CC O
clathrin NN B-Gene
- : O
mediated VBN O
internalization NN O
, , O
which WDT O
are VBP O
required VBN O
for IN O
GPCR NNP B-Gene
- : O
mediated VBD O
ERK NNP B-Gene
activation NN O
, , O
are VBP O
inhibited VBN O
, , O
thus RB O
dampening VBG O
further JJ O
ERK NNP B-Gene
activation NN O
. . O

GnRH NNP B-Gene
treatment NN O
was VBD O
found VBN O
to TO O
increase VB O
the DT O
phosphorylation NN O
of IN O
tyrosine NN O
residues NNS O
of IN O
MAPK NNP B-Gene
and CC O
to TO O
increase VB O
MAPK NNP B-Gene
activity NN O
, , O
as IN O
determined VBN O
by IN O
an DT O
immune NN O
complex JJ O
kinase NN O
assay NN O
. . O

In IN O
this DT O
paper NN O
we PRP O
describe VBP O
properties NNS O
of IN O
the DT O
cdc10 NN B-Gene
- : O
C4 NNP O
mutant NN O
of IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe NN O
. . O

Glutathione NNP B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
( ( O
GST NNP B-Gene
) ) O
- : O
E2F NN B-Gene
and CC O
GST NNP B-Gene
- : O
DP NNP B-Gene
fusion NN O
proteins NNS O
were VBD O
found VBN O
to TO O
cooperate VB O
in IN O
binding VBG O
to TO O
the DT O
three CD O
E2F NNP B-Gene
sites NNS I-Gene
in IN O
the DT O
DNA NNP B-Gene
polymerase NN I-Gene
alpha NN I-Gene
gene NN I-Gene
promoter NN I-Gene
in IN O
vitro NN O
. . O

The DT O
complete JJ O
exon SYM O
- : O
intron NN O
structure NN O
of IN O
the DT O
156 CD B-Gene
- : I-Gene
kb NN I-Gene
human JJ I-Gene
gene NN I-Gene
NFKB1 NNP I-Gene
, , O
which WDT O
encodes VBZ O
the DT O
p105 NN B-Gene
and CC O
p50 JJ B-Gene
proteins NNS I-Gene
of IN O
transcription NN O
factors NNS O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : I-Gene
gamma NN I-Gene
: : O
implications NNS O
for IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : O
mediated VBD O
signal JJ O
transduction NN O
. . O

The DT O
risk NN O
factors NNS O
for IN O
hematuria NN O
in IN O
patients NNS O
with IN O
renal JJ O
hypouricemia NN O
are VBP O
the DT O
elevation NN O
of IN O
urinary JJ O
urate JJ O
concentration NN O
and CC O
the DT O
subtypes NNS O
of IN O
Post NNP O
and CC O
Secretion NNP O
. . O

The DT O
effects NNS O
of IN O
oral JJ O
vanadyl NN O
sulfate NN O
( ( O
VOSO4 NNP O
) ) O
( ( O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
day NN O
) ) O
on IN O
anthropometry NN O
, , O
body NN O
composition NN O
, , O
and CC O
performance NN O
were VBD O
investigated VBN O
in IN O
a DT O
12 CD O
- : O
week NN O
, , O
double JJ O
- : O
blind NN O
, , O
placebo SYM O
- : O
controlled VBN O
trial NN O
involving VBG O
weight JJ O
- : O
training NN O
volunteers NNS O
. . O

Molecular JJ O
cloning NN O
of IN O
a DT O
cDNA NN O
encoding VBG O
rat NN B-Gene
NADH NNP I-Gene
- : I-Gene
cytochrome NN I-Gene
b5 NN I-Gene
reductase NN I-Gene
and CC O
the DT O
corresponding JJ O
gene NN O
. . O

This DT O
gene NN O
spans VBZ O
23 CD O
kb NN O
and CC O
is VBZ O
composed VBN O
of IN O
five CD O
exons NNS O
and CC O
four CD O
introns NNS O
. . O

Identification NN O
of IN O
five CD O
new JJ O
genes NNS O
, , O
closely RB O
related VBN O
to TO O
the DT O
interleukin JJ B-Gene
- : I-Gene
1beta CD I-Gene
converting VBG I-Gene
enzyme JJ I-Gene
gene NN I-Gene
, , O
that WDT O
do VBP O
not RB O
encode VB O
functional JJ O
proteases NNS O
. . O

These DT O
overall JJ O
results NNS O
indicate VBP O
that IN O
there EX O
is VBZ O
generally RB O
one CD O
PERV NNP O
copy NN O
per IN O
integration NN O
site NN O
. . O

Clinical JJ O
method NN O
for IN O
the DT O
treatment NN O
of IN O
Class NNP O
II NNP O
occlusal NN O
anomalies NNS O
with IN O
open JJ O
bite NN O

However RB O
, , O
unlike IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
the DT O
E1B NNP B-Gene
19K CD I-Gene
proteins NNS I-Gene
, , O
which WDT O
completely RB O
block VBP O
apoptosis NN O
but CC O
not RB O
p53 VB B-Gene
- : O
dependent JJ O
growth NN O
arrest NN O
, , O
H NNP B-Gene
- : I-Gene
ras NN I-Gene
expression NN O
permitted VBD O
DNA NNP O
synthesis NN O
and CC O
cell NN O
proliferation NN O
in IN O
the DT O
presence NN O
of IN O
high JJ O
levels NNS O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
p53 NN I-Gene
. . O

Dynamic NNP O
imaging NN O
of IN O
nuclear JJ O
wave NN O
functions NNS O
with IN O
ultrashort JJ O
UV NNP O
laser NN O
pulses NNS O
. . O

Three CD O
separate JJ O
activation NN O
subdomains NNS O
, , O
and CC O
one CD O
negative JJ O
- : O
acting VBG O
region NN O
, , O
which WDT O
function NN O
in IN O
yeast NN O
were VBD O
located VBN O
in IN O
the DT O
carboxyl NN O
- : O
terminal JJ O
region NN O
of IN O
NIT4 NNP B-Gene
. . O

Polyglactin NNP O
910 CD O
suture NN O
absorption NN O
and CC O
the DT O
role NN O
of IN O
cellular JJ O
enzymes NNS O
. . O

These DT O
data NNS O
provide VBP O
evidence NN O
that IN O
the DT O
2 CD B-Gene
. . I-Gene
0 CD I-Gene
- : I-Gene
kb NN I-Gene
LAT NNP I-Gene
is VBZ O
an DT O
intron NN O
of IN O
the DT O
mLAT NN B-Gene
pre SYM I-Gene
- : I-Gene
mRNA NN I-Gene
with IN O
a DT O
unique JJ O
branch NN O
point NN O
. . O

All DT O
subsequent JJ O
patients NNS O
were VBD O
treated VBN O
at IN O
the DT O
maximal NN O
tolerated VBD O
dose NN O
of IN O
EDXR NNP O
( ( O
35 CD O
mg NN O
/ NNP O
m2 NN O
/ NNP O
day NN O
) ) O
. . O

The DT O
primer NN O
is VBZ O
generated VBN O
by IN O
a DT O
cleavage NN O
that WDT O
occurs VBZ O
between IN O
bases NNS O
11 CD O
and CC O
12 CD O
of IN O
the DT O
Tf1 NNP B-Gene
mRNA NN I-Gene
. . O

An DT O
exaggerated JJ O
tissue NN O
response NN O
adjacent NN O
to TO O
the DT O
cyanoacrylate NN O
site NN O
suggested VBD O
a DT O
potential JJ O
toxic NN O
chemical NN O
or CC O
thermal JJ O
reaction NN O
, , O
or CC O
both DT O
, , O
to TO O
the DT O
tissue NN O
adhesive JJ O
, , O
but CC O
there EX O
was VBD O
no DT O
evidence NN O
of IN O
any DT O
distant JJ O
ocular JJ O
effects NNS O
. . O

The DT O
activation NN O
of IN O
the DT O
HIV NNP O
promoter NN O
required VBD O
the DT O
nuclear JJ O
localization NN O
of IN O
c SYM B-Gene
- : I-Gene
Abl NN I-Gene
and CC O
could MD O
be VB O
correlated VBN O
with IN O
increased JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
simplified VBN O
methods NNS O
for IN O
estimation NN O
of IN O
Technetium NNP O
Tc NNP O
99m CD O
( ( O
99mTc CD O
) ) O
- : O
pentetate NN O
and CC O
orthoiodohippurate NN O
I PRP O
131 CD O
( ( O
131I CD O
- : O
OIH NN O
) ) O
plasma NN O
clearance NN O
in IN O
dogs NNS O
and CC O
cats NNS O
with IN O
1 CD O
and CC O
2 CD O
blood NN O
samples NNS O
. . O

Intracellular JJ O
pH NN O
, , O
H NNP O
ion NN O
flux NN O
and CC O
H NNP O
ion NN O
permeability NN O
coefficient NN O
in IN O
bullfrog NN O
toe NN O
muscle NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
CSFHU NNP B-Gene
can MD O
increase VB O
neutrophil JJ O
counts NNS O
by IN O
increasing VBG O
the DT O
number NN O
and CC O
maturity NN O
of IN O
the DT O
marrow NN O
neutrophil JJ O
precursors NNS O
in IN O
some DT O
types NNS O
of IN O
childhood NN O
chronic JJ O
neutropenia NN O
. . O

In IN O
the DT O
Rett NNP O
syndrome NN O
we PRP O
, , O
therefore RB O
, , O
suspect VB O
there EX O
are VBP O
disturbances NNS O
in IN O
the DT O
brain NN O
stem NN O
functions NNS O
especially RB O
in IN O
the DT O
ascending VBG O
reticular JJ O
activating NN O
system NN O
which WDT O
is VBZ O
related VBN O
to TO O
elevation NN O
of IN O
the DT O
conscious JJ O
level NN O
. . O

The DT O
JS78 NNP O
mutation NN O
changes NNS O
Gln243 NNP O
in IN O
gp0 NN O
. . O
7 CD O
to TO O
an DT O
amber NN O
codon NN O
, , O
which WDT O
explains VBZ O
the DT O
production NN O
of IN O
the DT O
truncated VBN O
, , O
30 CD B-Gene
- : I-Gene
kDa NN I-Gene
gp0 NN I-Gene
. . I-Gene
7 CD I-Gene
- : I-Gene
related VBN I-Gene
polypeptide NN I-Gene
, , O
and CC O
implicates VBZ O
the DT O
11 CD O
- : O
kDa NN O
C NNP O
- : O
terminal NN O
domain NN O
in IN O
host NN O
transcription NN O
shut VBD O
- : O
off NN O
. . O

In IN O
contrast NN O
, , O
we PRP O
did VBD O
not RB O
detect VB O
a DT O
significant JJ O
correlation NN O
between IN O
plasma NN B-Gene
TNFalpha NNP I-Gene
and CC O
radiation NN O
pneumonitis NN O
. . O

Value NNP O
of IN O
the DT O
EMG NNP O
in IN O
the DT O
diagnosis NN O
of IN O
a DT O
cardiomyopathy NN O
associated VBN O
with IN O
a DT O
myotonic JJ O
myopathy NN O
. . O

Cost NNP O
- : O
effectiveness NN O
analysis NN O
provides VBZ O
a DT O
rational JJ O
means NN O
of IN O
allocating VBG O
limited JJ O
health NN O
care NN O
resources NNS O
by IN O
allowing VBG O
the DT O
comparison NN O
of IN O
the DT O
costs NNS O
of IN O
lipid JJ O
- : O
lowering VBG O
therapy NN O
, , O
in IN O
particular JJ O
, , O
therapy NN O
with IN O
beta NN B-Gene
- : I-Gene
hydroxy JJ I-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
methylglutaryl NN I-Gene
- : I-Gene
CoA NNP I-Gene
( ( I-Gene
coenzyme VB I-Gene
A NNP I-Gene
) ) I-Gene
reductase NN I-Gene
inhibitors NNS O
( ( O
statins NNS O
) ) O
, , O
with IN O
the DT O
costs NNS O
of IN O
atherosclerosis NN O
that WDT O
could MD O
be VB O
prevented VBN O
by IN O
lowering VBG O
cholesterol NN O
. . O

Copper NN O
treatments NNS O
were VBD O
assigned VBN O
to TO O
simulate VB O
the DT O
different JJ O
levels NNS O
of IN O
copper NN O
intake NN O
that WDT O
might MD O
result VB O
from IN O
differences NNS O
in IN O
daily JJ O
feed NN O
intake VBP O
similar JJ O
to TO O
the DT O
practice NN O
followed VBD O
with IN O
commercial JJ O
industry NN O
. . O

Functional JJ O
analysis NN O
of IN O
the DT O
sGTH NN B-Gene
alpha NN I-Gene
subunit NN I-Gene
promoter NN I-Gene
by IN O
the DT O
transient JJ O
transfection NN O
of IN O
several JJ O
sGTH NNS B-Gene
alpha VBP I-Gene
/ JJ O
CAT NNP B-Gene
chimeric NN O
plasmids NNS O
into IN O
rainbow NN O
trout IN O
pituitary JJ O
cells NNS O
suggests VBZ O
that IN O
its PRP$ O
pituitary JJ O
- : O
specific JJ O
expression NN O
is VBZ O
GSE NNP B-Gene
- : O
dependent NN O
. . O

Transfection NN O
studies NNS O
also RB O
showed VBD O
that IN O
3 CD O
' '' O
- : O
deletion NN O
of IN O
sequences NNS O
downstream NN O
of IN O
the DT O
transcriptional JJ O
start NN O
site NN O
( ( O
+ JJ O
1 CD O
/ JJ O
+ NNP O
47 CD O
) ) O
markedly RB O
reduced VBD O
OSM NNP B-Gene
- : O
fold JJ O
induction NN O
. . O

Intrathecal JJ O
acetyl NN B-Gene
cholinesterase NN I-Gene
inhibitors NNS O
produce VBP O
analgesia NN O
that WDT O
is VBZ O
synergistic JJ O
with IN O
morphine NN O
and CC O
clonidine NN O
in IN O
rats NNS O
. . O

The DT O
murine NN B-Gene
int NN I-Gene
- : I-Gene
6 CD I-Gene
locus NN I-Gene
, , O
identified VBN O
as IN O
a DT O
frequent JJ O
integration NN O
site NN O
of IN O
mouse NN O
mammary JJ O
tumor NN O
viruses NNS O
, , O
encodes VBZ O
the DT O
48 CD B-Gene
- : I-Gene
kDa NN I-Gene
eIF3e JJ I-Gene
subunit NN I-Gene
of IN I-Gene
translation NN I-Gene
initiation NN I-Gene
factor NN I-Gene
eIF3 NN I-Gene
. . O

We PRP O
examined VBD O
the DT O
binding NN O
of IN O
purified JJ O
T3 NNP B-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( O
T3R NNP B-Gene
alpha RB I-Gene
) ) O
, , O
overexpressed VBN O
in IN O
Escherichia NNP O
coli NN O
, , O
to TO O
wild VB O
- : O
type NN O
and CC O
up RB O
and CC O
down IN O
mutations NNS O
of IN O
the DT O
rGH NN B-Gene
T3RE NNP B-Gene
to TO O
evaluate VB O
whether IN O
transcriptional JJ O
potency NN O
correlates VBZ O
with IN O
changes NNS O
in IN O
T3R NNP B-Gene
binding NN O
. . O

RESULTS NN O
: : O
The DT O
LV NNP O
maximum JJ O
brightness NN O
and CC O
area NN O
under IN O
the DT O
curve NN O
showed VBD O
significant JJ O
negative JJ O
correlations NNS O
( ( O
p JJ O
= NNP O
< NNP O
0 CD O
. . O
4 CD O
) ) O
with IN O
the DT O
FIO2 NNP O
, , O
while IN O
the DT O
minimum JJ O
brightness NN O
showed VBD O
a DT O
significant JJ O
positive JJ O
correlation NN O
( ( O
p JJ O
= NNP O
< NNP O
0 CD O
. . O
2 CD O
) ) O
. . O

Herein NNP O
PPARgamma NNP B-Gene
, , O
liganded VBN O
by IN O
either DT O
natural JJ O
( ( O
15d CD O
- : O
PGJ NN O
( ( O
2 CD O
) ) O
and CC O
PGD NNP O
( ( O
2 CD O
) ) O
) ) O
or CC O
synthetic JJ O
ligands NNS O
( ( O
BRL49653 NNP O
and CC O
troglitazone NN O
) ) O
, , O
selectively RB O
inhibited JJ O
expression NN O
of IN O
the DT O
cyclin NN B-Gene
D1 NNP I-Gene
gene NN I-Gene
. . O

Therefore RB O
, , O
the DT O
strD NN B-Gene
and CC O
strE NN B-Gene
genes NNS I-Gene
could MD O
serve VB O
as IN O
universal JJ O
probes NNS O
indicative NN O
of IN O
the DT O
presence NN O
of IN O
biosynthetic JJ O
capacity NN O
for IN O
6 CD O
- : O
deoxyhexose NN O
moieties NNS O
. . O

In IN O
the DT O
region NN O
Walgau NNP O
with IN O
mixed JJ O
industrial JJ O
- : O
rural JJ O
population NN O
an DT O
iodine JJ O
deficiency NN O
I PRP O
was VBD O
found VBN O
in IN O
81 CD O
% NN O
and CC O
an DT O
iodine JJ O
deficiency NN O
II NNP O
in IN O
45 CD O
% NN O
. . O

CONCLUSIONS NN O
: : O
In IN O
healthy JJ O
individuals NNS O
, , O
whole JJ O
body NN O
insulin JJ B-Gene
sensitivity NN O
is VBZ O
related VBN O
, , O
or CC O
"""" NN O
coupled VBN O
, , O
"""" UH O
to TO O
the DT O
anaerobic JJ O
threshold NN O
. . O

DATA NNP O
SYNTHESIS NNP O
: : O
Intracoronary NNP O
ultrasound NN O
has VBZ O
been VBN O
shown VBN O
to TO O
improve VB O
upon RB O
demonstrated JJ O
weaknesses NNS O
of IN O
coronary JJ O
angiography NN O
. . O

ATX NNP B-Gene
, , O
like IN O
PC NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
was VBD O
found VBN O
to TO O
hydrolyze VB O
the DT O
type NN B-Gene
I PRP I-Gene
phosphodiesterase VBP I-Gene
substrate JJ O
p NN O
- : O
nitrophenyl NN O
thymidine NN O
- : O
5 CD O
' '' O
- : O
monophosphate NN O
. . O

An DT O
alternatively RB O
spliced VBN O
MAdCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
variant NN O
was VBD O
identified VBN O
that IN O
lacks VBZ O
exon RB O
4 CD O
encoding VBG O
the DT O
mucin NN B-Gene
domain NN O
, , O
and CC O
may MD O
mediate VB O
leukocyte JJ O
adhesion NN O
to TO O
LPAM NNP B-Gene
- : I-Gene
1 CD I-Gene
without IN O
adhesion NN O
to TO O
the DT O
alternate NN O
receptor NN O
, , O
L NNP B-Gene
- : I-Gene
selectin NN I-Gene
. . O

MKK3 NNP B-Gene
autophosphorylation NN O
and CC O
activation NN O
of IN O
p38 NN B-Gene
was VBD O
also RB O
observed VBN O
following VBG O
coexpression NN O
of IN O
MKK3 NNP B-Gene
with IN O
MEKK3 NNP B-Gene
, , O
but CC O
not RB O
with IN O
MEKK2 NNP B-Gene
. . O

Assay NNP O
of IN O
urea JJ O
by IN O
immobilized JJ O
urease NN B-Gene
coupled VBN O
to TO O
a DT O
differential JJ O
pH NN O
- : O
meter NN O
. . O

Observers NNS O
with IN O
brain NN O
injury NN O
and CC O
control NN O
participants NNS O
performed VBD O
a DT O
vigilance NN O
task NN O
during IN O
which WDT O
they PRP O
received VBD O
periodic JJ O
whiffs NNS O
of IN O
unscented JJ O
air NN O
or CC O
air NN O
scented VBN O
with IN O
peppermint NN O
. . O

An DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
was VBD O
performed VBN O
to TO O
characterize VB O
the DT O
binding VBG O
property NN O
of IN O
TR2 NNP B-Gene
and CC O
its PRP$ O
truncated JJ O
isoform NN O
. . O

Nonreplicating VBG O
vaccinia NN O
vector NN O
efficiently RB O
expresses VBZ O
recombinant JJ O
genes NNS O
. . O

Recurrent JJ O
arterial JJ O
thrombotic JJ O
disease NN O
on IN O
young JJ O
onset NN O
and CC O
protein NN B-Gene
S NNP I-Gene
deficiency NN O
. . O

The DT O
distal JJ O
portion NN O
of IN O
the DT O
rat NN B-Gene
insulin NN I-Gene
I PRP I-Gene
gene NN I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
flanking VBG I-Gene
DNA NN I-Gene
contains NNS O
two CD O
sequence NN O
elements NNS O
, , O
the DT O
Far NNP O
and CC O
FLAT NNP O
elements NNS O
, , O
that WDT O
can MD O
function VB O
in IN O
combination NN O
, , O
but CC O
not RB O
separately RB O
, , O
as IN O
a DT O
beta NN O
- : O
cell NN O
- : O
specific JJ O
transcriptional JJ O
enhancer NN O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
MAPK NNP B-Gene
acts NNS O
by IN O
stimulating VBG O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
a DT O
subsequent JJ O
physical NN O
and CC O
functional JJ O
interaction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
with IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
resulting VBG O
in IN O
a DT O
complex JJ O
that WDT O
synergistically RB O
transactivates VBZ O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
. . O

Analysis NN O
of IN O
the DT O
intact JJ O
hGH JJ B-Gene
gene NN I-Gene
or CC O
hGH VB B-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
flanking VBG I-Gene
DNA NNP I-Gene
( ( I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
FR NN I-Gene
) ) I-Gene
coupled VBD O
to TO O
the DT O
hGh NN B-Gene
cDNA NN I-Gene
or CC O
chloramphenicol JJ B-Gene
acetyltransferase NN I-Gene
or CC O
luciferase NN B-Gene
genes NNS I-Gene
, , O
indicated VBD O
that IN O
cAMP NN O
primarily RB O
stimulated VBD O
hGH JJ B-Gene
promoter NN I-Gene
activity NN O
. . O

The DT O
availability NN O
of IN O
potent JJ O
regulatory JJ O
DNA NNP O
cassettes VBZ O
harboring VBG O
the DT O
murine NN B-Gene
D1A NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
could MD O
aid VB O
testing VBG O
the DT O
neuronal JJ O
- : O
specific JJ O
expression NN O
of IN O
transgenes NNS O
in IN O
vivo NN O
. . O

The DT O
data NN O
indicate NN O
that IN O
Bmp2 NNP B-Gene
is VBZ O
directly RB O
regulated VBN O
by IN O
retinoic NN O
acid SYM O
- : O
bound NN O
receptors NNS O
and CC O
Sp1 NNP B-Gene
. . O

Oleate NNP O
induced VBD O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
M NNP B-Gene
- : I-Gene
CPT NN I-Gene
I PRP I-Gene
mRNA VBP I-Gene
4 CD O
. . O
5 CD O
- : O
fold NN O
. . O

Additional JJ O
education NN O
and CC O
research NN O
is VBZ O
needed VBN O
to TO O
provide VB O
further JJ O
direction NN O
for IN O
intervention NN O
and CC O
incorporation NN O
into IN O
practice NN O
. . O

These DT O
studies NNS O
serve VBP O
as IN O
the DT O
basis NN O
for IN O
the DT O
further JJ O
characterization NN O
of IN O
the DT O
regulatory JJ O
mechanism NN O
of IN O
aromatase JJ B-Gene
expression NN O
in IN O
human JJ O
breast NN O
cancer NN O
and CC O
ASCs NNP O
. . O

Promoter NN O
activity NN O
was VBD O
dose JJ O
- : O
dependently RB O
inhibited VBN O
by IN O
cotransfection NN O
with IN O
either DT O
ras NNS B-Gene
or CC O
mos NN B-Gene
oncogenes NNS I-Gene
, , O
but CC O
oncogene JJ O
inhibition NN O
was VBD O
reversed VBN O
and CC O
the DT O
overall JJ O
activity NN O
increased VBD O
when WRB O
cells NNS O
were VBD O
treated VBN O
with IN O
the DT O
MAP NNP B-Gene
kinase NN I-Gene
kinase NN I-Gene
( ( O
MKK NNP B-Gene
) ) O
inhibitor NN O
PD98059 NNP O
. . O

These DT O
fusions NNS O
are VBP O
contained VBN O
on IN O
plasmids NNS O
which WDT O
have VBP O
both DT O
yeast NN O
and CC O
E NNP O
. . O
coli VB O
replication NN O
origins NNS O
and CC O
selectable JJ O
markers NNS O
and CC O
, , O
therefore RB O
, , O
can MD O
be VB O
used VBN O
to TO O
transform VB O
either DT O
yeast NN O
or CC O
E NNP O
. . O
coli NN O
cells NNS O
. . O

During IN O
chronic JJ O
treatment NN O
, , O
when WRB O
plasma NN O
concentrations NNS O
fluctuated VBD O
between IN O
23 CD O
. . O
5 CD O
ng NN O
. . O
ml SYM O
- : O
1 CD O
at IN O
8 CD O
h NN O
and CC O
14 CD O
ng NN O
. . O
ml SYM O
- : O
1 CD O
at IN O
24 CD O
h NN O
post NN O
- : O
dosing NN O
, , O
ST NNP O
segment NN O
depression NN O
at IN O
an DT O
individually RB O
comparable JJ O
workload NN O
was VBD O
significantly RB O
decreased VBN O
by IN O
28 CD O
% NN O
compared VBN O
with IN O
placebo NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
at IN O
both DT O
points NNS O
in IN O
time NN O
. . O

Feed NNP O
intake NN O
was VBD O
not RB O
affected VBN O
by IN O
dietary JJ O
KCl NNP O
or CC O
NaHCO3 NNP O
supplementation NN O
, , O
but CC O
average JJ O
daily JJ O
gain NN O
increased VBD O
with IN O
increased JJ O
K NNP O
and CC O
tended VBD O
to TO O
be VB O
reduced VBN O
by IN O
dietary JJ O
NaHCO3 NNP O
. . O

Each DT O
expressed VBD O
domain NN O
, , O
as RB O
well RB O
as IN O
FKBP NNP B-Gene
- : I-Gene
33 CD I-Gene
itself PRP O
, , O
possesses VBZ O
peptidyl SYM B-Gene
- : I-Gene
prolyl NN I-Gene
cis SYM I-Gene
- : I-Gene
trans NNS I-Gene
isomerase VBP I-Gene
activity NN O
, , O
though IN O
with IN O
much JJ O
lower JJR O
specific JJ O
activities NNS O
than IN O
FKBP NNP B-Gene
- : I-Gene
12 CD I-Gene
. . O

We PRP O
conclude VBP O
that IN O
the DT O
' '' O
morning NN O
dip NN O
' '' O
observed VBN O
in IN O
asthmatic JJ O
patients NNS O
cannot VBP O
simply RB O
be VB O
explained VBN O
by IN O
changes NNS O
in IN O
cell NN O
receptor NN O
number NN O
or CC O
affinity NN O
, , O
as IN O
our PRP$ O
results NNS O
suggest VBP O
that IN O
both DT O
groups NNS O
have VBP O
intact JJ O
beta SYM B-Gene
- : I-Gene
adrenoceptor NN I-Gene
function NN O
. . O

Mono NNP O
- : O
ADP NNP O
- : O
ribosylation NN O
is VBZ O
a DT O
reversible JJ O
modification NN O
of IN O
proteins NNS O
, , O
with IN O
NAD NNP O
: : O
arginine NN B-Gene
ADP NNP I-Gene
- : I-Gene
ribosyltransferases NNS I-Gene
( ( O
EC NNP B-Gene
2 CD I-Gene
. . I-Gene
4 CD I-Gene
. . I-Gene
2 CD I-Gene
. . I-Gene
31 CD I-Gene
) ) O
and CC O
ADP NNP B-Gene
- : I-Gene
ribosylarginine NN I-Gene
hydrolases NNS I-Gene
( ( O
EC NNP B-Gene
3 CD I-Gene
. . I-Gene
2 CD I-Gene
. . I-Gene
2 CD I-Gene
. . I-Gene
19 CD I-Gene
) ) O
catalyzing VBG O
the DT O
opposing VBG O
reactions NNS O
in IN O
an DT O
ADP NNP O
- : O
ribosylation NN O
cycle NN O
. . O

These DT O
children NNS O
were VBD O
grouped VBN O
into IN O
four CD O
diagnostic JJ O
categories NNS O
: : O
1 CD O
) ) O
idiopathic JJ O
GH NNP B-Gene
deficiency NN O
( ( O
n JJ O
= NNP O
10 CD O
) ) O
; : O
2 CD O
) ) O
organic JJ O
hypopituitarism NN O
( ( O
n JJ O
= NNP O
7 CD O
) ) O
; : O
3 CD O
) ) O
intrauterine NN O
growth NN O
retardation NN O
( ( O
n JJ O
= NNP O
5 CD O
) ) O
; : O
and CC O
4 CD O
) ) O
constitutional JJ O
delay NN O
of IN O
growth NN O
and CC O
/ NN O
or CC O
familial JJ O
short JJ O
stature NN O
( ( O
n JJ O
= NNP O
18 CD O
) ) O
, , O
by IN O
standard JJ O
clinical JJ O
criteria NNS O
and CC O
physiological JJ O
and CC O
pharmacological JJ O
tests NNS O
of IN O
GH NNP B-Gene
reserve NN O
. . O

After IN O
dopamine JJ O
infusion NN O
in IN O
women NNS O
with IN O
polycystic JJ O
ovary JJ O
syndrome NN O
and CC O
in IN O
matched JJ O
controls NNS O
, , O
steady JJ O
state NN O
levels NNS O
of IN O
plasma NN O
dopamine NN O
, , O
norepinephrine NN O
, , O
and CC O
the DT O
ratio NN O
of IN O
dopamine NN O
/ NNP O
norepinephrine NN O
were VBD O
similar JJ O
in IN O
the DT O
two CD O
groups NNS O
. . O

Three CD O
missense NN O
mutants NNS O
in IN O
subunit NN O
a DT O
of IN O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
F1F0 NNP I-Gene
- : I-Gene
ATPase NNP I-Gene
were VBD O
isolated VBN O
and CC O
characterized VBN O
after IN O
hydroxylamine JJ O
mutagenesis NN O
of IN O
a DT O
plasmid NN O
carrying VBG O
the DT O
uncB NN B-Gene
( ( I-Gene
subunit VB I-Gene
a DT I-Gene
) ) I-Gene
gene NN I-Gene
. . O

Thus RB O
, , O
despite IN O
the DT O
potential NN O
for IN O
common JJ O
regulatory JJ O
mechanisms NNS O
, , O
the DT O
available JJ O
evidence NN O
indicates VBZ O
that IN O
the DT O
Mtx NNP B-Gene
minimal JJ I-Gene
promoter NN I-Gene
does VBZ O
not RB O
significantly RB O
affect JJ O
Thbs3 NNP B-Gene
gene NN I-Gene
expression NN O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
new JJ O
, , O
larger JJR O
rat NN B-Gene
B NNP I-Gene
- : I-Gene
myc NN I-Gene
genomic JJ I-Gene
clone NN I-Gene
. . O

On IN O
d NN O
112 CD O
, , O
progesterone NN O
was VBD O
higher JJR O
( ( O
P NNP O
less JJR O
than IN O
. . O
5 CD O
) ) O
in IN O
hysterectomized JJ O
heifers NNS O
than IN O
in IN O
other JJ O
treatment NN O
groups NNS O
. . O

39 LS O
- : O
47 CD O
. . O

The DT O
SV40 NNP B-Gene
enhancer NN I-Gene
augmented VBD O
replication NN O
1 CD O
. . O
5 CD O
- : O
10 CD O
fold NN O
. . O

Such JJ O
a DT O
concept NN O
is VBZ O
crucial JJ O
to TO O
our PRP$ O
understanding NN O
of IN O
the DT O
pathology NN O
of IN O
ageing VBG O
in IN O
general JJ O
. . O

Rapid JJ O
detection NN O
of IN O
this DT O
mutation NN O
is VBZ O
achieved VBN O
by IN O
restriction NN O
digestion NN O
of IN O
PCR NNP O
- : O
amplified JJ O
genomic JJ O
DNA NN O
; : O
a DT O
mismatch NN O
primer NN O
combined VBN O
with IN O
the DT O
point NN O
mutation NN O
creates VBZ O
a DT O
Tru9I NNP B-Gene
restriction NN I-Gene
site NN I-Gene
. . O

Differences NNS O
in IN O
the DT O
clinical JJ O
presentation NN O
and CC O
the DT O
gross JJ O
appearance NN O
of IN O
the DT O
two CD O
cases NNS O
are VBP O
described VBN O
, , O
and CC O
similarities NNS O
in IN O
the DT O
microscopic NN O
features NNS O
are VBP O
discussed VBN O
. . O

Histopathology NNP O
and CC O
pathogenesis NN O
of IN O
exanthematous JJ O
viroses NNS O

By IN O
contrast NN O
, , O
d NN B-Gene
( ( I-Gene
T2AG3T NNP I-Gene
) ) I-Gene
and CC O
d NN B-Gene
( ( I-Gene
T2G4T NNP I-Gene
) ) I-Gene
form NN O
only RB O
the DT O
G NNP O
- : O
quadruplex JJ O
monomer NN O
structures NNS O
independent JJ O
of IN O
K NNP O
cation NN O
concentration NN O
as IN O
reported VBN O
previously RB O
[ JJ O
Sen NNP O
, , O
D NNP O
. . O
, , O
& CC O
Gilbert NNP O
, , O
W NNP O
. . O

Refractory NNP O
periods NNS O
of IN O
the DT O
AV NNP O
junction NN O
were VBD O
altered VBN O
in IN O
a DT O
comparable JJ O
fashion NN O
to TO O
conduction NN O
through IN O
the DT O
AV NNP O
node NN O
. . O

We PRP O
have VBP O
designated VBN O
the DT O
protein NN O
"""" NNP B-Gene
cellular JJ I-Gene
NBP NNP I-Gene
"""" NNP I-Gene
( ( O
CNBP NNP B-Gene
) ) O
. . O

Helicobacter NNP O
pylori NN O
and CC O
stomach NN O
diseases NNS O
: : O
from IN O
clinical JJ O
point NN O
of IN O
view NN O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
protein NN O
binding VBG O
to TO O
the DT O
E2F NNP B-Gene
- : I-Gene
like IN I-Gene
sequences NNS I-Gene
may MD O
act VB O
to TO O
reduce VB O
expression NN O
. . O

To TO O
explore VB O
the DT O
functional JJ O
properties NNS O
of IN O
the DT O
protein NN O
encoded VBN O
by IN O
neu NN B-Gene
, , O
we PRP O
created VBD O
a DT O
fusion NN O
gene NN O
that WDT O
joins VBZ O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
neu NN B-Gene
to TO O
the DT O
extracellular JJ O
portion NN O
of IN O
an DT O
immunoglobulin JJ B-Gene
heavy NN I-Gene
chain NN I-Gene
. . O

Range NNP O
behavior NN O
of IN O
Hereford NNP O
, , O
Hereford NNP O
x NNP O
Holstein NNP O
and CC O
Holstein NNP O
non SYM O
- : O
lactating VBG O
heifers NNS O
. . O

Yang NNP O
and CC O
H NNP O
. . O

The DT O
non JJ O
- : O
homologous JJ O
sequences NNS O
in IN O
the DT O
5 CD O
' POS O
untranslated JJ O
regions NNS O
might MD O
be VB O
acquired VBN O
at IN O
or CC O
after IN O
transcription NN O
during IN O
retrotransposition NN O
of IN O
the DT O
ATLN NNP O
elements NNS O
. . O

A DT O
leucine JJ O
zipper NN O
domain NN O
of IN O
the DT O
suppressor NN B-Gene
of IN I-Gene
Hairy NNP I-Gene
- : I-Gene
wing VBG I-Gene
protein NN I-Gene
mediates VBZ O
its PRP$ O
repressive JJ O
effect NN O
on IN O
enhancer NN O
function NN O
. . O

Like IN O
humans NNS O
, , O
the DT O
PITSLRE NNP B-Gene
PK NNP I-Gene
genes NNS I-Gene
in IN I-Gene
chickens NNS I-Gene
must MD O
be VB O
closely RB O
linked VBN O
, , O
based VBN O
on IN O
fluorescent NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
localization NN O
of IN O
these DT O
genes NNS O
to TO O
a DT O
single JJ O
chicken NN O
microchromosome NN O
. . O

On IN O
a DT O
separate JJ O
occasion NN O
the DT O
T1 NNP O
weighted VBD O
and CC O
T2 NNP O
weighted VBD O
sagittal JJ O
and CC O
T2 NNP O
weighted VBD O
axial JJ O
sequences NNS O
were VBD O
reported VBN O
blind NN O
in IN O
relation NN O
to TO O
the DT O
initial JJ O
assessment NN O
. . O

This DT O
prospective JJ O
study NN O
compared VBN O
the DT O
measured VBN O
energy NN O
expenditures NNS O
of IN O
30 CD O
patients NNS O
using VBG O
indirect JJ O
calorimetry NN O
with IN O
their PRP$ O
predicted VBN O
basal NN O
energy NN O
expenditure NN O
according VBG O
to TO O
the DT O
Harris NNP O
- : O
Benedict NNP O
equation NN O
, , O
or CC O
their PRP$ O
calculated JJ O
energy NN O
expenditure NN O
derived VBN O
from IN O
basal NN O
energy NN O
expenditure NN O
times NNS O
, , O
an DT O
activity NN O
factor NN O
, , O
and CC O
a DT O
stress JJ O
factor NN O
. . O

Sequence NNP O
comparison NN O
of IN O
cytochromes NNS B-Gene
bd NNS I-Gene
and CC O
their PRP$ O
homologs NNS O
from IN O
various JJ O
organisms NNS O
demonstrates VBZ O
that IN O
the DT O
proteins NNS O
can MD O
be VB O
classified VBN O
into IN O
two CD O
subfamilies NNS O
, , O
a DT O
proteobacterial JJ O
type NN O
including VBG O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
bd NN I-Gene
and CC O
a DT O
more RBR O
widely RB O
distributed VBN O
type NN O
including VBG O
the DT O
B NNP O
. . O
stearothermophilus NN O
enzyme NN O
, , O
suggesting VBG O
that IN O
the DT O
latter JJ O
type NN O
is VBZ O
evolutionarily RB O
older JJR O
. . O

Apparent JJ O
loss NN O
of IN O
differentiation NN O
markers NNS O
characterizes VBP O
advanced JJ O
malignant JJ O
neoplasms NNS O
. . O

In IN O
10 CD O
patients NNS O
with IN O
subacute JJ O
cardiac JJ O
tamponade NN O
, , O
pulmonary JJ O
wedge NN O
pressure NN O
( ( O
PWP NNP O
) ) O
, , O
RAP NNP O
, , O
and CC O
IPP NNP O
were VBD O
measured VBN O
along IN O
with IN O
indexes NNS O
of IN O
systolic JJ O
function NN O
. . O

In IN O
conclusion NN O
, , O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
and CC O
Sp1 NNP B-Gene
binding NN O
sites NNS O
play VBP O
a DT O
decisive JJ O
role NN O
in IN O
the DT O
basal JJ O
expression NN O
of IN O
the DT O
rat NN B-Gene
mrp2 NN I-Gene
gene NN I-Gene
, , O
while IN O
the DT O
human JJ B-Gene
MRP2 NNP I-Gene
gene NN I-Gene
is VBZ O
regulated VBN O
differently RB O
. . O

Re NNP O
- : O
examination NN O
of IN O
the DT O
ED01 NNP O
study NN O
. . O

Diary NNP O
. . O

Effect NN O
of IN O
thrombotic JJ O
and CC O
antithrombotic JJ O
drugs NNS O
on IN O
the DT O
surface NN O
charge NN O
characteristics NNS O
of IN O
canine NN O
blood NN O
vessels NNS O
: : O
in IN O
vivo NN O
and CC O
in IN O
vitro JJ O
studies NNS O
. . O

The DT O
mechanisms NN O
that WDT O
govern VBZ O
the DT O
activation NN O
or CC O
suppression NN O
of IN O
the DT O
CD8 NNP B-Gene
gene NN I-Gene
are VBP O
likely JJ O
to TO O
be VB O
central JJ O
to TO O
the DT O
T NNP O
cell NN O
development NN O
program NN O
. . O

It PRP O
was VBD O
shown VBN O
by IN O
transient JJ O
expression NN O
assay VBP O
that IN O
HS NNP B-Gene
- : I-Gene
40 CD I-Gene
behaved VBD O
as IN O
an DT O
authentic JJ O
enhancer NN O
for IN O
high JJ O
- : O
level NN O
zeta NN B-Gene
2 CD I-Gene
globin JJ I-Gene
promoter NN I-Gene
activity NN O
in IN O
K562 NNP O
cells NNS O
, , O
an DT O
erythroid NN O
cell NN O
line NN O
of IN O
embryonic JJ O
and CC O
/ JJ O
or CC O
fetal JJ O
origin NN O
. . O

Since IN O
very RB O
recent JJ O
scanning VBG O
- : O
deletion NN O
analysis NN O
indicates VBZ O
that IN O
there EX O
is VBZ O
a DT O
critical JJ O
region NN O
for IN O
activity NN O
near IN O
Cys NNP O
- : O
118 CD O
and CC O
that DT O
Cys NNP O
- : O
118 CD O
is VBZ O
necessary JJ O
for IN O
maximal JJ O
activity NN O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
Cys NNP O
- : O
118 CD O
residue NN O
is VBZ O
necessary JJ O
for IN O
proper JJ O
glycosylation NN O
and CC O
maximal JJ O
biologic NN O
activity NN O
of IN O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
. . O

A DT O
prospective JJ O
trial NN O
was VBD O
carried VBN O
out RP O
in IN O
156 CD O
unselected JJ O
patients NNS O
( ( O
41 CD O
men NNS O
, , O
mean JJ O
age NN O
67 CD O
. . O
5 CD O
years NNS O
, , O
115 CD O
women NNS O
, , O
mean JJ O
age NN O
71 CD O
. . O
4 CD O
years NNS O
) ) O
who WP O
had VBD O
undergone JJ O
total JJ O
hip NN O
joint JJ O
replacement NN O
because IN O
of IN O
degenerative JJ O
or CC O
inflammatory JJ O
arthritis NN O
or CC O
fracture NN O
of IN O
the DT O
neck NN O
of IN O
the DT O
femur NN O
. . O

In IN O
contrast NN O
, , O
a DT O
Maf NNP B-Gene
- : I-Gene
related JJ I-Gene
protein NN I-Gene
, , O
Nrl NNP B-Gene
, , O
completely RB O
mimicked VBD O
c SYM B-Gene
- : I-Gene
Maf JJ I-Gene
actions NNS O
. . O

Blood NNP O
platelets NNS O
, , O
coagulation NN O
factors NNS O
and CC O
morphologic JJ O
organ JJ O
changes NNS O
following VBG O
scalding VBG O
shock NN O
in IN O
rhesus NN O
monkeys NNS O

Managing VBG O
dysphagia NN O
in IN O
a DT O
chronic JJ O
care NN O
setting NN O
: : O
an DT O
introduction NN O
. . O

The DT O
C2C NNP B-Gene
- : O
Prx NN B-Gene
is VBZ O
encoded VBN O
as IN O
a DT O
preprotein NN O
of IN O
273 CD O
amino JJ O
acids NNS O
containing VBG O
a DT O
putative JJ O
chloroplast NN O
- : O
targeting VBG O
signal NN O
of IN O
65 CD O
amino JJ O
acids NNS O
at IN O
its PRP$ O
N NNP O
- : O
terminus NN O
. . O

A DT O
major JJ O
mechanism NN O
whereby WRB O
steroid JJ B-Gene
hydroxylase NN I-Gene
gene NN I-Gene
transcription NN O
is VBZ O
regulated VBN O
in IN O
the DT O
adrenal JJ O
cortex NN O
requires VBZ O
the DT O
pituitary JJ O
peptide NN O
hormone NN O
, , O
ACTH NNP B-Gene
, , O
which WDT O
acts VBZ O
via IN O
cAMP NN O
. . O

Insulin NNP B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
II NNP I-Gene
( ( O
IGFII NNP B-Gene
) ) O
is VBZ O
a DT O
mitogenic JJ O
polypeptide NN O
, , O
the DT O
mRNAs NN O
of IN O
which WDT O
are VBP O
present JJ O
in IN O
multiple JJ O
forms NNS O
, , O
despite IN O
derivation NN O
from IN O
a DT O
single JJ O
gene NN O
. . O

HS NNP O
inducibility NN O
required VBD O
the DT O
HSE NNP O
which WDT O
was VBD O
bound VBN O
by IN O
HS NNP B-Gene
transcription NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
HSF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
present NN O
in IN O
extracts NNS O
prepared VBN O
from IN O
cells NNS O
exposed VBN O
to TO O
HS NNP O
. . O

The DT O
deduced JJ O
protein NN O
sequence NN O
was VBD O
88 CD O
% NN O
homologous JJ O
to TO O
that DT O
of IN O
hNUC NN B-Gene
I PRP I-Gene
, , O
isolated VBD O
from IN O
human JJ O
osteosarcoma NN O
cells NNS O
. . O

An DT O
additional JJ O
advantage NN O
is VBZ O
that IN O
the DT O
resin NN O
can MD O
be VB O
removed VBN O
and CC O
the DT O
immunoperoxidase NN B-Gene
technique NN O
carried VBD O
out RP O
on IN O
thin JJ O
sections NNS O
. . O

COGLAB NNP O
includes VBZ O
measures NNS O
of IN O
preattentional NN O
, , O
attentional JJ O
, , O
conceptual JJ O
, , O
and CC O
psychomotor NN O
performance NN O
. . O

We PRP O
isolated VBD O
a DT O
complementary JJ O
DNA NN O
( ( O
cDNA NN O
) ) O
clone NN O
from IN O
an DT O
RL95 NNP O
- : O
2 CD O
expression NN O
library NN O
that WDT O
encodes VBZ O
the DT O
C1 NNP B-Gene
site NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
. . O

Here RB O
, , O
we PRP O
evidence NN O
that IN O
the DT O
developmental JJ O
functions NNS O
of IN O
the DT O
family NN O
of IN O
transcription NN O
factors NNS O
characterized VBN O
by IN O
the DT O
POU NNP B-Gene
DNA NNP I-Gene
binding VBG I-Gene
motif JJ I-Gene
exerts NNS O
roles NNS O
in IN O
mammalian JJ O
development NN O
. . O

The DT O
expression NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
enzyme NN O
( ( O
CYP19 NNP B-Gene
) ) O
is VBZ O
regulated VBN O
, , O
in IN O
part NN O
, , O
by IN O
tissue NN O
- : O
specific JJ O
promoters NNS O
through IN O
the DT O
use NN O
of IN O
alternative JJ O
- : O
splicing VBG O
mechanisms NNS O
. . O

Under IN O
these DT O
conditions NNS O
, , O
transfections NNS O
with IN O
cDNAs NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
p50 NN B-Gene
and CC O
serum NN B-Gene
response NN I-Gene
factor NN I-Gene
( ( O
SRF NNP B-Gene
) ) O
produced VBD O
a DT O
factor NN O
( ( O
s NN O
) ) O
that WDT O
mediated VBD O
Tax NNP B-Gene
binding NN O
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
and CC O
the DT O
CArG NNP O
box NN O
respectively RB O
. . O

In IN O
addition NN O
, , O
5 CD O
' POS O
deletions NNS O
removing VBG O
all DT O
but CC O
34 CD O
bp JJ O
upstream NN O
of IN O
the DT O
transcription NN O
start NN O
point NN O
retained VBD O
greater JJR O
than IN O
90 CD O
% NN O
promoter NN O
activity NN O
, , O
suggesting VBG O
that IN O
the DT O
- : O
35 CD O
hexamer NN O
was VBD O
not RB O
essential JJ O
for IN O
promoter NN O
activity NN O
. . O

Patients NNS O
enrolled VBN O
in IN O
the DT O
Integrilin NNP O
to TO O
Minimize VB O
Platelet NNP O
Aggregation NNP O
and CC O
Coronary NNP O
Thrombosis NNP O
- : O
II NNP O
( ( O
IMPACT NNP O
- : O
II NN O
) ) O
trial NN O
were VBD O
analyzed VBN O
. . O

Four CD O
patients NNS O
( ( O
group NN O
1 CD O
) ) O
had VBD O
type NN O
I PRP O
basement VBP O
membrane NN O
nephropathy NN O
, , O
characterized VBN O
by IN O
marked JJ O
thickening NN O
and CC O
lamellation NN O
of IN O
the DT O
basement NN O
membrane NN O
in IN O
a DT O
pattern NN O
resembling VBG O
that IN O
of IN O
Alport NNP O
' POS O
s JJ O
syndrome NN O
. . O

With IN O
the DT O
exception NN O
of IN O
virus NN O
assay NN O
and CC O
quantitation NN O
, , O
these DT O
methods NNS O
are VBP O
simple JJ O
and CC O
inexpensive JJ O
enough RB O
to TO O
be VB O
done VBN O
in IN O
typical JJ O
shellfish JJ O
microbiology NN O
laboratories NNS O
. . O

The DT O
beta NN O
subunit NN O
of IN O
the DT O
Fc NNP B-Gene
epsilon NN I-Gene
R1 NNP I-Gene
is VBZ O
a DT O
33 CD O
- : O
kDa NN O
tyrosine NN O
phosphoprotein NN O
, , O
but CC O
the DT O
p33 NN B-Gene
Grb2 NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
described VBD O
in IN O
the DT O
present JJ O
report NN O
is VBZ O
not RB O
the DT O
Fc NNP B-Gene
epsilon NN I-Gene
R1 NNP I-Gene
beta NN I-Gene
chain NN I-Gene
and CC O
its PRP$ O
identity NN O
is VBZ O
unknown JJ O
. . O

A DT O
Y NNP B-Gene
. . I-Gene
lipolytica NN I-Gene
Kar2p NNP I-Gene
mutant NN I-Gene
was VBD O
isolated VBN O
that IN O
restored JJ O
interaction NN O
with IN O
an DT O
Sls1p NNP B-Gene
mutant NN I-Gene
, , O
suggesting VBG O
that IN O
the DT O
interaction NN O
with IN O
Sls1p NNP B-Gene
could MD O
be VB O
nucleotide RB O
and CC O
/ VB O
or CC O
conformation VB O
dependent NN O
. . O

Retinoid NNP O
- : O
dependent JJ O
activation NN O
of IN O
the DT O
tissue NN B-Gene
transglutaminase NN I-Gene
promoter NN I-Gene
depends VBZ O
on IN O
both DT O
a DT O
proximal JJ O
regulatory JJ O
region NN O
containing VBG O
sequences NNS O
highly RB O
conserved VBD O
between IN O
the DT O
human JJ O
and CC O
the DT O
mouse NN B-Gene
tissue NN I-Gene
transglutaminase NN I-Gene
promoters NNS I-Gene
and CC O
a DT O
distal JJ O
region NN O
that WDT O
includes VBZ O
a DT O
30 CD O
- : O
base NN O
pair NN O
retinoid JJ O
response NN O
element NN O
( ( O
mTGRRE1 NN O
) ) O
. . O

mTGRRE1 NN O
contains NNS O
three CD O
hexanucleotide NN O
half NN O
- : O
sites NNS O
( ( O
two CD O
canonical NN O
and CC O
one CD O
non NN O
- : O
canonical NN O
) ) O
in IN O
a DT O
DR7 NNP B-Gene
/ NNP O
DR5 NNP B-Gene
motif NN O
that WDT O
bind VBZ O
both DT O
RAR NNP B-Gene
* NNP O
RXR NNP B-Gene
heterodimers NNS O
and CC O
RXR NNP B-Gene
homodimers NNS I-Gene
. . O

The DT O
arginyl JJ O
peptide NN O
bonds NNS O
that WDT O
are VBP O
cleaved VBN O
in IN O
the DT O
conversion NN O
of IN O
human JJ B-Gene
factor NN I-Gene
IX NNP I-Gene
to TO O
factor VB B-Gene
IXa NNP I-Gene
by IN O
factor NN B-Gene
XIa NNP I-Gene
were VBD O
identified VBN O
as IN O
Arg145 NNP O
- : O
Ala146 NNP O
and CC O
Arg180 NNP O
- : O
Val181 NN O
. . O

Four CD O
short JJ O
nucleotide NN O
sequences NNS O
( ( O
boxes NNS O
I PRP O
to TO O
IV NNP O
) ) O
contribute NN O
to TO O
the DT O
light JJ O
responsiveness NN O
of IN O
the DT O
parsley NN B-Gene
chalcone NN I-Gene
synthase NN I-Gene
promoter NN I-Gene
. . O

CONCLUSION NN O
: : O
Monitoring NN O
SpO2 NNP O
at IN O
the DT O
nasal NN O
septum NN O
site NN O
is VBZ O
more RBR O
reliable JJ O
than IN O
monitoring VBG O
it PRP O
at IN O
the DT O
finger NN O
site NN O
in IN O
hypothermic JJ O
patients NNS O
. . O

The DT O
swa2 NN B-Gene
- : I-Gene
1 CD I-Gene
allele NNS I-Gene
recovered VBN O
from IN O
the DT O
original JJ O
screen NN O
carries VBZ O
a DT O
point NN O
mutation NN O
in IN O
its PRP$ O
tetratricopeptide NN O
repeat NN O
( ( O
TPR NNP O
) ) O
domain NN O
, , O
a DT O
motif NN O
not RB O
found VBN O
in IN O
auxilin NN B-Gene
but CC O
known VBN O
in IN O
other JJ O
proteins NNS O
to TO O
mediate VB O
interaction NN O
with IN O
heat NN B-Gene
- : I-Gene
shock NN I-Gene
proteins NNS I-Gene
. . O

The DT O
Community NNP O
Adjustment NNP O
Scale NNP O
provided VBD O
outcome RP O
data NNS O
related VBN O
to TO O
the DT O
subjects NNS O
' POS O
degree NN O
of IN O
productivity NN O
, , O
ability NN O
to TO O
maintain VB O
close JJ O
relationships NNS O
, , O
and CC O
presence NN O
/ JJ O
absence NN O
of IN O
symptomatology NN O
an DT O
average NN O
of IN O
32 CD O
years NNS O
after IN O
initial JJ O
admission NN O
. . O

Further JJ O
studies NNS O
established VBD O
that IN O
the DT O
Ep NNP B-Gene
- : O
induced JJ O
increase NN O
in IN O
beta JJ B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN I-Gene
could MD O
be VB O
inhibited VBN O
by IN O
the DT O
tyrosine NN B-Gene
kinase NN I-Gene
inhibitor NN O
genistein NN O
and CC O
the DT O
protein NN B-Gene
kinase VBD I-Gene
C NNP I-Gene
inhibitor NN O
Compound NNP O
3 CD O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

B NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
- : O
induced VBN O
apoptosis NN O
in IN O
the DT O
WEHI NNP O
- : O
231 CD O
B NNP O
lymphoma NN O
cell NN O
line NN O
can MD O
be VB O
prevented VBN O
by IN O
engaging VBG O
CD40 NNP B-Gene
. . O

Five CD O
of IN O
these DT O
have VBP O
ocular NN O
or CC O
oculocutaneous JJ O
albinism NN O
. . O

This DT O
structure NN O
interconnects VBZ O
specific JJ O
triplets NNS O
of IN O
the DT O
basal NN O
bodies VBZ O
with IN O
the DT O
microtubular JJ O
bundles NNS O
that WDT O
emerge VBP O
from IN O
the DT O
basal NN O
apparatus NN O
. . O

A DT O
sharp JJ O
outbreak NN O
of IN O
influenza NN O
A NNP O
occurred VBD O
on IN O
the DT O
base NN O
during IN O
February NNP O
that WDT O
was VBD O
due JJ O
to TO O
an DT O
A NNP O
/ NNP O
Texas NNP O
/ NNP O
1 CD O
/ NN O
77 CD O
- : O
like IN O
virus NN O
, , O
a DT O
variant NN O
of IN O
the DT O
A NNP O
/ NNP O
Victoria NNP O
/ VBD O
3 CD O
/ JJ O
75 CD O
prototpye NN O
. . O

Here RB O
we PRP O
present JJ O
evidence NN O
that IN O
major JJ B-Gene
IE NNP I-Gene
proteins VBZ I-Gene
IE86 NNP B-Gene
, , O
IE72 NNP B-Gene
, , O
and CC O
IE55 NNP B-Gene
are VBP O
capable JJ O
of IN O
trans NNS O
- : O
activating VBG O
the DT O
HIV NNP B-Gene
LTR NNP I-Gene
in IN O
a DT O
T NNP O
- : O
cell NN O
line NN O
, , O
HUT NNP O
- : O
78 CD O
. . O

Closure NN O
of IN O
an DT O
open JJ O
high NN O
below IN O
- : O
knee NN O
guillotine JJ O
amputation NN O
wound IN O
using VBG O
a DT O
skin JJ O
- : O
stretching VBG O
device NN O
. . O

Application NN O
of IN O
the DT O
2 CD O
- : O
deoxy NN O
- : O
D NNP O
- : O
glucose NN O
method NN O
to TO O
the DT O
coupling NN O
of IN O
cerebral JJ O
metabolism NN O
and CC O
blood NN O
flow NN O
. . O

Morphological JJ O
features NNS O
of IN O
Jat NNP O
dentition NN O
. . O

In IN O
addition NN O
, , O
the DT O
overall JJ O
chance NN O
that IN O
a DT O
patient NN O
would MD O
undergo VB O
ET NNP O
was VBD O
greater JJR O
in IN O
a DT O
cycle NN O
in IN O
which WDT O
more JJR O
than IN O
one CD O
follicle NN O
20 CD O
mm NN O
or CC O
larger JJR O
was VBD O
developing VBG O
than IN O
in IN O
a DT O
cycle NN O
in IN O
which WDT O
a DT O
single JJ O
large JJ O
follicle NN O
was VBD O
developing VBG O
. . O

This DT O
correlated VBN O
with IN O
reduced JJ O
levels NNS O
of IN O
secreted VBN O
hepatitis NN B-Gene
B NNP I-Gene
e NN I-Gene
antigen NN I-Gene
and CC O
increased VBD O
intracellular JJ O
levels NNS O
of IN O
core NN B-Gene
and CC O
Pol NNP B-Gene
proteins NNS I-Gene
and CC O
replicative JJ O
HBV NNP O
DNA NNP O
intermediates VBZ O
. . O

These DT O
striations NNS O
were VBD O
caused VBN O
by IN O
contact NN O
between IN O
the DT O
sharp JJ O
edge NN O
of IN O
the DT O
upper JJ O
canine NN O
and CC O
the DT O
P3 NNP O
during IN O
honing VBG O
( ( O
canine JJ O
/ NNP O
premolar NN O
complex NN O
) ) O
. . O

Molecular JJ O
characterization NN O
of IN O
type NN O
- : O
specific JJ O
capsular JJ O
polysaccharide NN O
biosynthesis NN O
genes NNS O
of IN O
Streptococcus NNP O
agalactiae FW O
type NN O
Ia NNP O
. . O

With IN O
0 CD O
. . O
5 CD O
vol NN O
. . O
- : O
% NN O
, , O
the DT O
corresponding JJ O
values NNS O
were VBD O
345 CD O
mumol NNS O
/ JJ O
1 CD O
( ( O
5 CD O
. . O
72 CD O
mg JJ O
/ $ O
100 CD O
ml NN O
) ) O
and CC O
137 CD O
mumol NN O
/ NN O
1 CD O
( ( O
2 CD O
. . O
25 CD O
mg JJ O
/ $ O
100 CD O
ml NN O
) ) O
respectively RB O
. . O

T NNP O
cell NN O
leukemia SYM O
- : O
associated VBN O
human JJ O
Notch NNP B-Gene
/ NNP O
translocation NN O
- : O
associated VBN O
Notch NNP B-Gene
homologue NN O
has VBZ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
- : O
like IN O
activity NN O
and CC O
physically RB O
interacts NNS O
with IN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
proteins VBZ O
in IN O
T NNP O
cells NNS O
. . O

CONCLUSIONS NN O
: : O
The DT O
special JJ O
clinical JJ O
presentation NN O
of IN O
our PRP$ O
case NN O
of IN O
possible JJ O
Gardner NNP O
' POS O
s JJ O
syndrome NN O
is VBZ O
discussed VBN O
. . O

Ischemia NNP O
and CC O
reperfusion NN O
markedly RB O
increased VBD O
the DT O
release NN O
of IN O
6 CD O
- : O
keto NN O
- : O
PGF1 NNP O
alpha NN O
and CC O
TXB2 NNP O
. . O

Estimated VBN O
daily JJ O
intakes NNS O
( ( O
EDIs NNP O
) ) O
per IN O
person NN O
were VBD O
0 CD O
. . O
56 CD O
microgram NN O
for IN O
total JJ O
HCH NNP O
, , O
0 CD O
. . O
20 CD O
microgram NN O
for IN O
gamma NN O
- : O
HCH NNP O
, , O
0 CD O
. . O
9 CD O
microgram NN O
for IN O
dieldrin NN O
, , O
1 CD O
. . O
42 CD O
micrograms NNS O
for IN O
total JJ O
DDT NNP O
, , O
and CC O
0 CD O
. . O
15 CD O
microgram NN O
for IN O
HCB NNP O
. . O

The DT O
cryptococcal JJ B-Gene
antigen NN I-Gene
test NN O
was VBD O
positive JJ O
at IN O
1 CD O
: : O
125 CD O
by IN O
latex JJ O
agglutination NN O
. . O

Six NNP O
tandem NN O
repeats NNS O
of IN O
the DT O
P NNP B-Gene
element NN I-Gene
linked VBD O
to TO O
the DT O
SV40 NNP B-Gene
promoter NN I-Gene
responded VBD O
to TO O
phorbol VB O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
, , O
while IN O
that DT O
of IN O
other JJ O
elements NNS O
did VBD O
not RB O
. . O

A DT O
significant JJ O
degree NN O
of IN O
homology NN O
was VBD O
also RB O
found VBN O
among IN O
these DT O
genes NNS O
and CC O
the DT O
Mtase NNP B-Gene
gene NN I-Gene
of IN O
related JJ O
phage NN O
SPR NNP O
, , O
which WDT O
codes VBZ O
for IN O
an DT O
enzyme NN O
with IN O
different JJ O
modification NN O
specificity NN O
. . O

NMR NNP O
of IN O
diffusing VBG O
atoms NNS O
in IN O
a DT O
periodic JJ O
porous JJ O
medium NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
nonuniform JJ O
magnetic JJ O
field NN O
. . O

Expression NN O
, , O
cellular JJ O
localization NN O
and CC O
in IN O
vitro JJ O
transcription NN O
studies NNS O
establish VB O
that DT O
cloned VBD B-Gene
hUBF NN I-Gene
encodes VBZ O
a DT O
nucleolar JJ O
factor NN O
that WDT O
binds VBZ O
specifically RB O
to TO O
the DT O
upstream JJ O
control NN O
element NN O
and CC O
core NN O
of IN O
the DT O
rRNA NN O
gene NN O
promoter NN O
to TO O
activate VB O
transcription NN O
in IN O
a DT O
binding NN O
site NN O
- : O
dependent JJ O
manner NN O
. . O

Additionally RB O
, , O
putative JJ O
CF1 NNP B-Gene
/ NNP O
USP NNP B-Gene
and CC O
Broad NNP B-Gene
Complex NNP I-Gene
Z2 NNP I-Gene
transcription NN O
factor NN O
elements NNS O
were VBD O
found VBN O
in IN O
the DT O
upstream JJ O
regions NNS O
of IN O
MIH NNP B-Gene
and CC O
MO NNP B-Gene
- : I-Gene
IH NNP I-Gene
genes NNS O
respectively RB O
. . O

The DT O
envelope NN B-Gene
glycoproteins NNS I-Gene
of IN I-Gene
Rous NNP I-Gene
sarcoma NN I-Gene
virus NN I-Gene
( ( I-Gene
RSV NNP I-Gene
) ) I-Gene
, , O
gp85 NN B-Gene
and CC O
gp37 NN B-Gene
, , O
are VBP O
anchored VBN O
in IN O
the DT O
membrane NN O
by IN O
a DT O
27 CD O
- : O
amino NN O
acid NN O
, , O
hydrophobic JJ O
domain NN O
that IN O
lies VBZ O
adjacent JJ O
to TO O
a DT O
22 CD O
- : O
amino NN O
acid NN O
, , O
cytoplasmic JJ O
domain NN O
at IN O
the DT O
carboxy JJ O
terminus NN O
of IN O
gp37 NN B-Gene
. . O

The DT O
encoded JJ O
protein NN O
has VBZ O
a DT O
leader NN O
sequence NN O
of IN O
27 CD O
amino JJ O
acids NNS O
. . O

Radiation NN O
decreased VBD O
the DT O
levels NNS O
of IN O
T4 NNP O
and CC O
T3 NNP O
6 CD O
h NN O
and CC O
72 CD O
h NN O
in IN O
group NN O
C NNP O
, , O
in IN O
group NN O
A NNP O
at IN O
72 CD O
h NN O
, , O
in IN O
group NN O
B NNP O
at IN O
24 CD O
h JJ O
postexposure NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
PKC NNP B-Gene
and CC O
p44 VB B-Gene
/ NNP O
p42MAPK JJ B-Gene
signalings NNS O
are VBP O
required VBN O
for IN O
the DT O
HBx NNP B-Gene
- : O
induced VBD O
Sp1 NNP B-Gene
- : O
mediated VBD O
IGF NNP B-Gene
- : I-Gene
II NNP I-Gene
P4 NNP I-Gene
transcriptional JJ O
activity NN O
since IN O
( ( O
i NN O
) ) O
PKC NNP B-Gene
activation NN O
by IN O
PMA NNP O
or CC O
PKC NNP B-Gene
expression NN O
vector NN O
increases VBZ O
Sp1 NNP B-Gene
phosphorylation NN O
and CC O
P4 NNP B-Gene
activity NN O
in IN O
HBx NNP B-Gene
- : O
transfected VBD O
HepG2 NNP O
cells NNS O
; : O
( ( O
ii NN O
) ) O
PKC NNP B-Gene
inhibition NN O
by IN O
PKC NNP B-Gene
inhibitor NN O
Go6976 NNP O
reduces VBZ O
Sp1 NNP B-Gene
phosphorylation NN O
, , O
P4 NNP B-Gene
activity NN O
, , O
and CC O
IGF NNP B-Gene
- : I-Gene
II NNP I-Gene
mRNA NN I-Gene
in IN O
HBx NNP B-Gene
- : O
transfected VBD O
HepG2 NNP O
cells NNS O
; : O
and CC O
( ( O
iii NN O
) ) O
the DT O
inhibition NN O
of IN O
MEK NNP B-Gene
activation NN O
by IN O
U0126 NNP O
reduces NNS O
Sp1 NNP B-Gene
phosphorylation NN O
, , O
P4 NNP B-Gene
activity NN O
and CC O
IGF NNP B-Gene
- : I-Gene
II NNP I-Gene
mRNA NN I-Gene
in IN O
HBx NNP B-Gene
- : O
transfected VBD O
HepG2 NNP O
cells NNS O
. . O

Addition NN O
of IN O
soluble JJ O
recombinant JJ B-Gene
human JJ I-Gene
SLF NNP I-Gene
to TO O
SI4 NNP O
- : O
h220 NN O
cultures NNS O
enhanced VBD O
reduction NN O
of IN O
cell NN O
- : O
surface NN O
c SYM B-Gene
- : I-Gene
kit NN I-Gene
expression NN O
and CC O
its PRP$ O
protein NN O
degradation NN O
. . O

This DT O
study NN O
confirms VBZ O
, , O
although IN O
individual JJ O
reaction NN O
is VBZ O
remarkably RB O
different JJ O
, , O
transportation NN O
as IN O
a DT O
potent NN O
stressor NN O
for IN O
Beagle NNP O
dogs NNS O
. . O

Among IN O
the DT O
v NN B-Gene
- : I-Gene
myc NN I-Gene
codons NNS O
, , O
the DT O
first JJ O
5 CD O
are VBP O
derived VBN O
from IN O
the DT O
noncoding VBG O
5 CD O
' '' O
terminus NN O
of IN O
the DT O
second JJ O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
exon NN O
, , O
and CC O
412 CD O
codons NNS O
correspond NN O
to TO O
the DT O
c NN B-Gene
- : I-Gene
myc NN I-Gene
coding VBG O
region NN O
. . O

The DT O
Aie1 NNP B-Gene
locus NN I-Gene
was VBD O
mapped VBN O
to TO O
mouse VB O
chromosome NN O
7A2 CD O
- : O
A3 NN O
by IN O
fluorescent NN O
in IN O
situ JJ O
hybridization NN O
. . O

The DT O
pigment NN O
intensity NN O
of IN O
both DT O
melanized JJ O
colonies NNS O
and CC O
appressoria NNS O
of IN O
CAL NNP O
transformants NNS O
was VBD O
weaker JJR O
than IN O
that DT O
of IN O
the DT O
wild JJ O
type NN O
. . O

Expression NN O
was VBD O
cell JJ O
cycle NN O
controlled VBD O
, , O
with IN O
steady JJ O
- : O
state NN O
RNA NNP O
levels NNS O
significantly RB O
higher RBR O
in IN O
growth NN O
- : O
arrested VBN O
than IN O
in IN O
growth NN O
- : O
stimulated VBN O
cells NNS O
. . O

Although IN O
the DT O
gene NN O
is VBZ O
substantially RB O
smaller JJR O
than IN O
the DT O
human JJ O
genes NNS O
for IN O
other JJ O
mitochondrial JJ O
enzymes NNS O
, , O
its PRP$ O
intron NN O
/ NN O
exon JJ O
organization NN O
is VBZ O
very RB O
similar JJ O
, , O
especially RB O
to TO O
that DT O
of IN O
P450scc NNP B-Gene
. . O

Disruption NN O
of IN O
RB NNP B-Gene
/ NNP O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
interaction NN O
by IN O
single JJ O
point NN O
mutations NNS O
in IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
enhances NNS O
S NNP O
- : O
phase NN O
entry NN O
and CC O
apoptosis NN O
. . O

Dual JJ O
roles NNS O
of IN O
p82 NN B-Gene
, , O
the DT O
clam NN O
CPEB NNP B-Gene
homolog NN I-Gene
, , O
in IN O
cytoplasmic JJ O
polyadenylation NN O
and CC O
translational JJ O
masking NN O
. . O

Distribution NN O
and CC O
correlations NNS O
of IN O
serum NN O
uric JJ O
- : O
acid NN O
in IN O
two CD O
French JJ O
adult NN O
populations NNS O
: : O
13 CD O
, , O
885 CD O
men NNS O
and CC O
6 CD O
, , O
861 CD O
women NNS O

Patterns NNS O
of IN O
connections NNS O
underlying VBG O
cross NN O
- : O
modality NN O
integration NN O
were VBD O
studied VBN O
by IN O
injecting VBG O
distinguishable JJ O
, , O
retrograde JJ O
tracers NNS O
( ( O
Fluoro NNP O
- : O
Gold NN O
and CC O
diamidino NN O
yellow NN O
) ) O
in IN O
pairwise NN O
manner NN O
into IN O
different JJ O
sensory JJ O
representations NNS O
( ( O
visual JJ O
, , O
somatosensory JJ O
, , O
and CC O
auditory NN O
) ) O
in IN O
the DT O
cerebral JJ O
cortex NN O
of IN O
the DT O
rat NN O
. . O

Bacterially RB O
expressed VBN O
protein NN O
, , O
as RB O
well RB O
as IN O
the DT O
in IN O
vitro JJ O
reticulocyte NN O
lysate NN O
translation NN O
product NN O
, , O
comigrated VBN O
with IN O
the DT O
purified JJ O
37 CD O
- : O
kDa NN O
protein NN O
on IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gels NNS O
. . O

Induction NN O
of IN O
both DT O
potential JJ O
transcripts NNS O
follows VBZ O
heat NN O
shock NN O
in IN O
vivo NN O
. . O

On IN O
the DT O
transport NN O
of IN O
mucus NN O
and CC O
its PRP$ O
rheologic JJ O
simulants NNS O
in IN O
ciliated JJ O
systems NNS O
. . O

Survey NNP O
on IN O
antibody NN O
against IN O
egg NN O
drop NN O
syndrome VBD O
- : O
1976 CD O
virus NN O
among IN O
chicken JJ O
flocks NNS O
in IN O
Japan NNP O
. . O

This DT O
is VBZ O
the DT O
first JJ O
determination NN O
of IN O
the DT O
complete JJ O
secondary JJ O
structure NN O
of IN O
an DT O
RNA NNP O
spliced VBD O
in IN O
a DT O
spliceosome NN O
. . O

Furthermore RB O
, , O
both DT O
rhHR23 VBP B-Gene
proteins NNS I-Gene
function VBP O
in IN O
a DT O
defined JJ O
NER NNP O
system NN O
reconstituted VBD O
with IN O
purified JJ O
proteins NNS O
, , O
indicating VBG O
direct JJ O
involvement NN O
of IN O
hHR23 NN B-Gene
proteins NNS I-Gene
in IN O
the DT O
DNA NNP O
repair NN O
reaction NN O
via IN O
interaction NN O
with IN O
XPC NNP B-Gene
. . O

Influence NN O
of IN O
compression NN O
therapy NN O
on IN O
symptoms NNS O
following VBG O
soft JJ O
tissue JJ O
injury NN O
from IN O
maximal JJ O
eccentric JJ O
exercise NN O
. . O

The DT O
predicted VBN O
amino NN O
acid NN O
sequence NN O
is VBZ O
78 CD O
. . O
0 CD O
% NN O
identical JJ O
to TO O
the DT O
cytoplasmic JJ B-Gene
dynein NN I-Gene
heavy JJ I-Gene
chain NN I-Gene
of IN I-Gene
Neurospora NNP I-Gene
crassa NN I-Gene
, , O
70 CD O
. . O
2 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
Aspergillus NNP O
nidulans NNS O
and CC O
24 CD O
. . O
8 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
SH2 NNP O
- : O
containing VBG O
adapter NN O
protein NN O
GRB10 NNP B-Gene
interacts VBZ O
with IN O
BCR NNP B-Gene
- : O
ABL NN B-Gene
. . O

Identification NN O
and CC O
nucleotide JJ O
sequence NN O
of IN O
Rhizobium NNP B-Gene
meliloti FW I-Gene
insertion NN I-Gene
sequence NN I-Gene
ISRm3 NNP I-Gene
: : O
similarity NN O
between IN O
the DT O
putative JJ O
transposase NN B-Gene
encoded VBN O
by IN O
ISRm3 NNP B-Gene
and CC O
those DT O
encoded VBN O
by IN O
Staphylococcus NNP B-Gene
aureus NN I-Gene
IS256 NNP I-Gene
and CC O
Thiobacillus NNP B-Gene
ferrooxidans NNS I-Gene
IST2 NNP I-Gene
. . O

The DT O
requirement NN O
for IN O
proteolytic JJ O
activity NN O
of IN O
both DT O
FVIIa NNP B-Gene
and CC O
FXa NNP B-Gene
suggests VBZ O
that IN O
protease NN O
- : O
activated JJ O
receptors NNS O
may MD O
be VB O
involved VBN O
. . O

Cowpox NNP O
virus NN O
contains VBZ O
two CD O
copies NNS O
of IN O
an DT O
early JJ B-Gene
gene NN I-Gene
encoding VBG O
a DT O
soluble JJ O
secreted JJ O
form NN O
of IN O
the DT O
type NN B-Gene
II NNP I-Gene
TNF NNP I-Gene
receptor NN I-Gene
. . O

Multivariate NNP O
Cox NNP O
survival NN O
analysis NN O
identified VBN O
baseline NN O
EF NNP O
< NNP O
or CC O
= VB O
30 CD O
% NN O
, , O
presence NN O
of IN O
significant JJ O
mitral JJ O
regurgitation NN O
( ( O
> JJ O
2 CD O
+ NN O
) ) O
before IN O
ablation NN O
, , O
and CC O
failure NN O
to TO O
exhibit VB O
improved JJ O
cardiac JJ O
performance NN O
by IN O
1 CD O
month NN O
after IN O
ablation NN O
as IN O
the DT O
only JJ O
independent JJ O
predictors NNS O
of IN O
death NN O
. . O

The DT O
4 CD O
patients NNS O
with IN O
carboxyhemoglobin JJ B-Gene
levels NNS O
in IN O
excess NN O
of IN O
10 CD O
% NN O
may MD O
represent VB O
occult NN O
carbon NN O
monoxide NN O
poisoning NN O
in IN O
this DT O
population NN O
. . O

Possibilities NNS O
of IN O
needleless JJ O
administration NN O
of IN O
various JJ O
substances NNS O
to TO O
animals NNS O

Inductively RB O
coupled VBN O
plasma JJ O
atomic JJ O
emission NN O
spectroscopy NN O
was VBD O
employed VBN O
to TO O
obtain VB O
the DT O
tissue NN O
silicon NN O
measurements NNS O
. . O

Previous JJ O
studies NNS O
have VBP O
indicated VBN O
that IN O
a DT O
hamster NN O
cell NN O
line NN O
( ( O
ts13 NN O
) ) O
with IN O
a DT O
point NN O
mutation NN O
in IN O
the DT O
TAF NNP B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
250 CD I-Gene
/ JJ O
CCG1 NNP B-Gene
( ( O
TAF NNP B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
250 CD I-Gene
) ) O
gene NN O
shows VBZ O
temperature SYM O
- : O
sensitive JJ O
expression NN O
of IN O
a DT O
subset NN O
of IN O
genes NNS O
and CC O
arrests NNS O
in IN O
late JJ O
G1 NNP O
at IN O
39 CD O
. . O
5 CD O
degrees NNS O
C NNP O
. . O

Determination NN O
of IN O
lead NN O
in IN O
blood NN O
. . O

DNA NN O
sequence NN O
analysis NN O
reveals NNS O
that IN O
the DT O
gene NN O
encodes VBZ O
a DT O
protein NN O
highly RB O
homologous JJ O
to TO O
rat VB B-Gene
CRP1 NNP I-Gene
. . O

Radiosensitive JJ O
nature NN O
of IN O
paravascular JJ O
infiltrate NN O
- : O
producing VBG O
potential NN O
of IN O
parental JJ O
spleen JJ O
cells NNS O
. . O

The DT O
weak JJ O
base NN O
ketoconazole NN O
showed VBD O
complete JJ O
dissolution NN O
from IN O
a DT O
tablet NN O
formulation NN O
in IN O
Simulated NNP O
Gastric NNP O
Fluid NNP O
without IN O
pepsin NN B-Gene
( ( O
SGFsp NNP O
) ) O
within IN O
30 CD O
minutes NNS O
, , O
70 CD O
% NN O
dissolution NN O
in IN O
2 CD O
hours NNS O
under IN O
fed JJ O
state NN O
simulated VBD O
upper JJ O
jejunal JJ O
conditions NNS O
but CC O
only RB O
6 CD O
% NN O
dissolution NN O
in IN O
2 CD O
hours NNS O
under IN O
fasted JJ O
state NN O
conditions NNS O
. . O

Within IN O
12 CD O
hours NNS O
after IN O
MR NNP O
tomography VBD O
the DT O
patients NNS O
were VBD O
surgically RB O
explored VBN O
, , O
biopsied VBN O
and CC O
if IN O
necessary JJ O
orchiectomised VBD O
. . O

Using VBG O
an DT O
RNase NNP B-Gene
H NNP I-Gene
- : O
mediated VBD O
mapping NN O
technique NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
64 CD O
- : O
kDa NN O
subunit NN O
of IN O
CstF NNP B-Gene
can MD O
be VB O
photo VBN O
cross SYM O
- : O
linked VBN O
to TO O
pre VB O
- : O
mRNAs NN O
at IN O
U NNP O
- : O
rich JJ O
regions NNS O
located VBN O
downstream NN O
of IN O
the DT O
cleavage NN O
site NN O
of IN O
the DT O
simian JJ O
virus NN O
40 CD O
late JJ O
and CC O
adenovirus JJ B-Gene
L3 NNP I-Gene
pre NN I-Gene
- : I-Gene
mRNAs NN I-Gene
. . O

Dopamine NNP O
caused VBD O
a DT O
prominent JJ O
potassium NN O
efflux NN O
measured VBD O
as IN O
86Rb CD O
+ JJ O
efflux NN O
from IN O
control NN O
glands NNS O
, , O
but CC O
was VBD O
without IN O
effect NN O
in IN O
denervated JJ O
glands NNS O
. . O

Two CD O
specific JJ O
DNA NNP O
- : O
protein NN O
complexes NNS O
were VBD O
identified VBN O
in IN O
gel JJ O
retardation NN O
assays NNS O
using VBG O
HeLa NNP O
cell NN O
nuclear JJ O
extracts NNS O
and CC O
an DT O
oligonucleotide JJ O
probe NN O
spanning VBG O
the DT O
footprinted JJ O
region NN O
. . O

The DT O
R NNP B-Gene
. . I-Gene
meliloti NN I-Gene
nifH JJ I-Gene
promoter NN I-Gene
but CC O
not RB O
the DT O
K NNP B-Gene
. . I-Gene
pneumoniae NN I-Gene
nifH JJ I-Gene
promoter NN I-Gene
showed VBD O
sigma JJ B-Gene
54 CD I-Gene
- : O
dependent JJ O
methylation NN O
protection NN O
of IN O
guanine NN O
residues NNS O
at IN O
- : O
14 CD O
, , O
- : O
25 CD O
and CC O
- : O
26 CD O
, , O
the DT O
most RBS O
conserved JJ O
nucleotides NNS O
characteristic JJ O
of IN O
sigma NN B-Gene
54 CD I-Gene
- : I-Gene
dependent NN I-Gene
promoters NNS I-Gene
. . O

A DT O
previous JJ O
report NN O
described VBD O
that IN O
a DT O
548 CD O
- : O
bp NN O
BglII NNP B-Gene
- : O
SmaI NNP B-Gene
fragment NN O
has VBZ O
an DT O
SSO NNP O
activity NN O
( ( O
ori2 NN O
; : O
Kataoka NNP O
et FW O
al NN O
. . O
, , O
Mol NNP O
. . O

None NN O
of IN O
the DT O
five CD O
proprotein NN O
processing NN O
proteases NNS O
tested VBN O
were VBD O
capable JJ O
of IN O
cleaving VBG O
human JJ B-Gene
pro FW I-Gene
- : I-Gene
LPH NN I-Gene
, , O
strongly RB O
suggesting VBG O
that IN O
they PRP O
are VBP O
not RB O
involved VBN O
in IN O
the DT O
maturation NN O
of IN O
this DT O
enzyme NN O
. . O

This DT O
combined VBN O
intravenous JJ O
anaesthetic JJ O
regimen NNS O
gave VBD O
good JJ O
anaesthesia NN O
and CC O
analgesia NN O
to TO O
pigs NNS O
for IN O
up IN O
to TO O
2 CD O
h NN O
as IN O
monitored VBN O
by IN O
clinical JJ O
signs NNS O
. . O

For IN O
wild JJ O
type NN O
MutT NNP B-Gene
and CC O
its PRP$ O
E53D NNP B-Gene
and CC O
E44D NNP B-Gene
mutants NNS I-Gene
, , O
plots NNS O
of IN O
log NN O
( ( O
k NN O
( ( O
cat NN O
) ) O
) ) O
versus NN O
pH NN O
exhibited VBD O
a DT O
limiting VBG O
slope NN O
of IN O
1 CD O
on IN O
the DT O
ascending VBG O
limb NN O
and CC O
then RB O
a DT O
hump NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
a DT O
sharply RB O
defined VBN O
maximum NN O
near IN O
pH NN O
8 CD O
followed VBN O
by IN O
a DT O
plateau NN O
, , O
yielding VBG O
apparent JJ O
pK NN O
( ( O
a DT O
) ) O
values NNS O
of IN O
7 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
and CC O
8 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
for IN O
an DT O
essential JJ O
base NN O
and CC O
a DT O
nonessential JJ O
acid NN O
catalyst NN O
, , O
respectively RB O
, , O
in IN O
the DT O
active JJ O
quaternary JJ O
MutT NNP B-Gene
- : O
Mg NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
dGTP NN O
- : O
Mg NNP O
( ( O
2 CD O
+ NN O
) ) O
complex NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
unique JJ O
suppository JJ O
formulation NN O
of IN O
CZX NNP O
- : O
S NN O
is VBZ O
useful JJ O
in IN O
the DT O
treatment NN O
of IN O
infections NNS O
in IN O
children NNS O
with IN O
heavy JJ O
psychophysiologic NN O
disorders NNS O
and CC O
in IN O
children NNS O
who WP O
cannot VBP O
take VB O
oral JJ O
drugs NNS O
because IN O
of IN O
severe JJ O
vomiting NN O
. . O

In IN O
calves NNS O
receiving VBG O
milk NN O
- : O
substitute NN O
diets NNS O
containing VBG O
80 CD O
- : O
260 CD O
g NN O
DM NNP O
/ NNP O
kg NN O
, , O
milk NN O
intakes NNS O
were VBD O
reduced VBN O
by IN O
up IN O
to TO O
30 CD O
% NN O
on IN O
the DT O
1st CD O
day NN O
that WDT O
calves VBZ O
were VBD O
fed VBN O
once RB O
daily JJ O
instead RB O
of IN O
twice JJ O
daily JJ O
. . O

Thus RB O
, , O
BALB NNP O
/ NNP O
c JJ O
mice NN O
appear VBP O
to TO O
be VB O
the DT O
most RBS O
appropriate JJ O
strain NN O
of IN O
mice NNS O
to TO O
perform VB O
studies NNS O
on IN O
the DT O
possible JJ O
connection NN O
between IN O
infection NN O
with IN O
T NNP O
. . O
canis NN O
and CC O
allergic JJ O
asthma NN O
. . O

Two CD O
alternatively RB O
spliced VBD O
5 CD O
' '' O
UTRs NNP O
, , O
designated VBD O
type NN O
I PRP O
and CC O
type VB O
II NNP O
, , O
of IN O
222 CD O
and CC O
115 CD O
bp NN O
, , O
respectively RB O
, , O
were VBD O
found VBN O
associated VBN O
with IN O
PFP NNP B-Gene
. . O

Cotransfection NN O
with IN O
the DT O
ie1 JJ B-Gene
gene NN I-Gene
resulted VBD O
in IN O
a DT O
dramatic JJ O
increase NN O
in IN O
the DT O
amount NN O
of IN O
the DT O
two CD O
enzymes NNS O
expressed VBN O
in IN O
the DT O
transfected JJ O
cells NNS O
. . O

Moreover RB O
, , O
by IN O
complementation NN O
of IN O
the DT O
WA NNP B-Gene
fyuA NN I-Gene
mutant NN I-Gene
by IN O
the DT O
cloned VBN O
fyuA NN B-Gene
gene NN I-Gene
, , O
yersiniabactin CC O
uptake JJ O
and CC O
mouse JJ O
virulence NN O
were VBD O
restored VBN O
. . O

However RB O
, , O
Southern NNP O
blot NN O
and CC O
karyotype NN O
analyses NNS O
did VBD O
not RB O
reveal VB O
any DT O
significant JJ O
changes NNS O
in IN O
copy NN O
number NN O
or CC O
gross JJ O
rearrangements NNS O
of IN O
the DT O
p53 NN B-Gene
gene NN I-Gene
in IN O
any DT O
of IN O
the DT O
p53 NN B-Gene
- : I-Gene
cell NN O
lines NNS O
. . O

A DT O
murine NN O
expressed VBN O
sequence NN O
tag NN O
( ( O
EST NNP O
) ) O
showing VBG O
homology NN O
with IN O
erythropoietin JJ B-Gene
receptor NN I-Gene
( ( O
EPOR NNP B-Gene
) ) O
was VBD O
identified VBN O
in IN O
the DT O
EST NNP O
database NN O
. . O

The DT O
distribution NN O
and CC O
organization NN O
of IN O
projections NNS O
from IN O
the DT O
spinal JJ O
cervical JJ O
enlargement NN O
to TO O
subnucleus VB O
reticularis NN O
dorsalis NN O
( ( O
SRD NNP O
) ) O
and CC O
the DT O
neighbouring JJ O
Cuneate NNP O
nucleus NN O
( ( O
Cu NNP O
) ) O
area NN O
was VBD O
studied VBN O
in IN O
the DT O
rat NN O
by IN O
using VBG O
microinjections NNS O
of IN O
Phaseolus NNP B-Gene
vulgaris FW I-Gene
leucoagglutinin NN I-Gene
( ( O
PHA NNP B-Gene
- : I-Gene
L NN I-Gene
) ) O
into IN O
different JJ O
laminae NN O
around IN O
the DT O
C7 NNP O
level NN O
. . O

Ritanserin NNP O
is VBZ O
a DT O
new JJ O
substance NN O
with IN O
highly RB O
selective JJ O
blocking NN O
activity NN O
on IN O
S2 NNP B-Gene
receptors NNS I-Gene
for IN O
5 CD O
- : O
HT NN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

The DT O
generally RB O
adopted VBN O
criteria NNS O
enabling VBG O
to TO O
classify VB O
the DT O
examined JJ O
persons NNS O
into IN O
the DT O
following JJ O
3 CD O
groups NNS O
have VBP O
been VBN O
used VBN O
: : O
( ( O
a DT O
) ) O
diseased VBN O
of IN O
BEN NNP O
; : O
( ( O
b NN O
) ) O
suspect NN O
to TO O
be VB O
diseased VBN O
of IN O
BEN NNP O
, , O
and CC O
( ( O
c NN O
) ) O
individuals NNS O
without IN O
signs NNS O
of IN O
a DT O
renal JJ O
disease NN O
. . O

Protease NNP O
activities NNS O
in IN O
cultures NNS O
of IN O
the DT O
streptococcal JJ O
strains NNS O
were VBD O
associated VBN O
with IN O
species NNS O
of IN O
different JJ O
molecular JJ O
masses NNS O
ranging VBG O
from IN O
130 CD O
to TO O
200 CD O
kDa NNS O
, , O
suggesting VBG O
posttranslational JJ O
processing NN O
possibly RB O
as IN O
a DT O
result NN O
of IN O
autoproteolysis NN O
at IN O
post NN O
- : O
proline NN O
peptide JJ O
bonds NNS O
in IN O
the DT O
N NNP O
- : O
terminal JJ O
parts NNS O
of IN O
the DT O
molecules NNS O
. . O

Despite IN O
this DT O
DNA NNP O
binding NN O
activity NN O
, , O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
reporter NN I-Gene
activity NN O
was VBD O
suppressed VBN O
in IN O
these DT O
cells NNS O
. . O

The DT O
exon NN O
: : O
intron NN O
structure NN O
of IN O
chicken NN B-Gene
IL8 NNP I-Gene
corresponds VBZ O
almost RB O
exactly RB O
to TO O
that DT O
of IN O
human JJ B-Gene
IL8 NNP I-Gene
and CC O
differs NNS O
from IN O
those DT O
of IN O
other JJ O
known VBN O
mammalian JJ B-Gene
CXC NNP I-Gene
chemokine NN I-Gene
genes NNS I-Gene
. . O

In IN O
slightly RB O
older JJR O
embryos NN O
, , O
the DT O
expression NN O
was VBD O
skewed VBN O
to TO O
one CD O
side NN O
of IN O
the DT O
embryo NN O
and CC O
by IN O
E6 NNP O
. . O
5 CD O
, , O
at IN O
the DT O
onset NN O
of IN O
gastrulation NN O
, , O
expression NN O
was VBD O
seen VBN O
in IN O
the DT O
epiblast NN O
, , O
visceral JJ O
endoderm NN O
, , O
nascent JJ O
mesoderm NN O
, , O
and CC O
the DT O
primitive JJ O
streak NN O
. . O

The DT O
CBF1 NNP B-Gene
site NN I-Gene
within IN O
HS2 NNP O
resides NNS O
near IN O
sites NNS O
for IN O
hematopoietic JJ O
regulators NNS O
such JJ O
as IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
NF NNP B-Gene
- : I-Gene
E2 NN I-Gene
, , O
and CC O
TAL1 NNP B-Gene
. . O

Reverse NNP O
transcription NN O
- : O
PCR NNP O
analysis NN O
of IN O
mRNA NN O
from IN O
patients NNS O
shows NNS O
that IN O
each DT O
of IN O
these DT O
five CD O
mutations NNS O
results NNS O
in IN O
aberrant JJ O
splicing NN O
. . O

Conversely RB O
, , O
E1A NNP B-Gene
binding VBG O
to TO O
only RB O
p300 VB B-Gene
/ NNP O
CBP NNP B-Gene
results NNS O
in IN O
an DT O
increase NN O
in IN O
PARP NNP B-Gene
enzyme NN I-Gene
activity NN O
and CC O
consequently RB O
in IN O
cell NN O
death NN O
susceptibility NN O
to TO O
irradiation NN O
, , O
which WDT O
is VBZ O
effectively RB O
counteracted VBN O
by IN O
the DT O
PARP NNP B-Gene
chemical NN O
inhibitor NN O
3 CD O
- : O
aminobenzamide NN O
. . O

The DT O
FFA NNP O
levels NNS O
were VBD O
not RB O
affected VBN O
( ( O
P NNP O
greater JJR O
than IN O
. . O
1 CD O
) ) O
by IN O
meal NN O
interval NN O
. . O

In IN O
addition NN O
to TO O
the DT O
previously RB O
identified VBN O
and CC O
characterized VBN O
attenuator NN B-Gene
1 CD I-Gene
situated VBD O
93 CD O
nucleotides NNS O
downstream NN O
from IN O
the DT O
major JJ O
late JJ O
transcription NN O
start NN O
site NN O
, , O
a DT O
second JJ O
attenuator NN O
, , O
attenuator NN B-Gene
2 CD I-Gene
, , O
situated VBD O
55 CD O
nucleotides NNS O
downstream NN O
from IN O
it PRP O
, , O
has VBZ O
been VBN O
identified VBN O
. . O

Toward NNP O
absolute NN O
methods NNS O
in IN O
clinical JJ O
chemistry NN O
: : O
application NN O
of IN O
mass NN O
fragmentography NN O
to TO O
high JJ O
- : O
accuracy NN O
analyses NNS O
. . O

George NNP O
T NNP O
. . O

We PRP O
previously RB O
showed VBD O
that IN O
the DT O
N NNP O
- : O
terminal JJ O
portion NN O
common JJ O
to TO O
various JJ O
chimeric JJ B-Gene
MLL NNP I-Gene
products NNS I-Gene
, , O
as RB O
well RB O
as IN O
to TO O
MLL NNP B-Gene
- : I-Gene
LTG9 NNP I-Gene
and CC O
MLL NNP B-Gene
- : I-Gene
LTG19 NNP I-Gene
, , O
localizes VBZ O
in IN O
the DT O
nuclei NN O
, , O
and CC O
therefore RB O
suggested VBD O
that IN O
it PRP O
might MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
leukemogenesis NN O
. . O

The DT O
IDF NNP O
standard NN O
method NN O
for IN O
the DT O
detection NN O
of IN O
penicillin NN O
in IN O
milk NN O
is VBZ O
not RB O
suitable JJ O
for IN O
the DT O
detection NN O
of IN O
sulphonamide NN O
residues NNS O
in IN O
milk NN O
. . O

However RB O
, , O
D8 NNP B-Gene
binding NN O
was VBD O
observed VBN O
by IN O
nuclease JJ O
protection NN O
with IN O
lactotroph JJ B-Gene
- : I-Gene
as RB I-Gene
well RB I-Gene
as IN I-Gene
somatotroph JJ I-Gene
- : I-Gene
like IN I-Gene
cell NN I-Gene
nuclear JJ I-Gene
protein NN I-Gene
. . O

Substitutions NNS O
of IN O
region NN O
I PRP O
with IN O
synthetic JJ O
sequences NNS O
showed VBD O
that IN O
no DT O
specific JJ O
sequence NN O
but CC O
rather RB O
repeats NNS O
of IN O
three CD O
or CC O
more JJR O
consecutive JJ O
adenines NNS O
or CC O
thymines NNS O
, , O
without IN O
interruption NN O
by IN O
guanine NN O
or CC O
cytosine NN O
, , O
are VBP O
required VBN O
for IN O
the DT O
ARS NNP O
activity NN O
. . O

Several JJ O
distinct JJ O
apoptotic JJ O
stimuli NNS O
induce VBP O
the DT O
expression NN O
and CC O
caspase NN B-Gene
- : O
dependent JJ O
cleavage NN O
of IN O
hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
80 CD I-Gene
delta NN I-Gene
. . O

hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
80 CD I-Gene
delta NN I-Gene
, , O
unlike IN O
hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
80 CD I-Gene
, , O
forms VBZ O
a DT O
TFIID NNP B-Gene
- : I-Gene
like IN I-Gene
complex JJ I-Gene
lacking VBG O
hTAF NN B-Gene
( ( I-Gene
II NNP I-Gene
) ) I-Gene
31 CD I-Gene
. . O

The DT O
American JJ O
Burkitt NNP O
Lymphoma NNP O
Registry NNP O
: : O
a DT O
progress NN O
report NN O
. . O

A DT O
third JJ O
series NN O
of IN O
mice NNS O
were VBD O
given VBN O
a DT O
single JJ O
injection NN O
of IN O
5 CD O
- : O
OH NNP O
- : O
DA NNP O
, , O
sacrificed VBD O
, , O
and CC O
prepared VBD O
for IN O
ultrastructural JJ O
study NN O
. . O

The DT O
selective JJ O
5 CD B-Gene
- : I-Gene
HT3 NNP I-Gene
receptor NN I-Gene
antagonists NNS O
ramosetron VBP O
( ( O
YM060 NNP O
) ) O
, , O
YM114 NNP O
( ( O
KAE NNP O
- : O
393 CD O
) ) O
, , O
granisetron NN O
and CC O
ondansetron NN O
, , O
and CC O
the DT O
substituted VBN O
benzamides NNS O
( ( O
5 CD B-Gene
- : I-Gene
HT4 NNP I-Gene
receptor NN I-Gene
agonist NN O
/ VBD O
5 CD B-Gene
- : I-Gene
HT3 NNP I-Gene
receptor NN I-Gene
antagonists NNS O
) ) O
cisapride VBP O
mosapride NN O
and CC O
SC NNP O
- : O
53116 CD O
dose JJ O
- : O
dependently RB O
enhanced VBD O
gastric JJ O
emptying NN O
in IN O
normal JJ O
rats NNS O
. . O

To TO O
determine VB O
whether IN O
food NN O
and CC O
/ NN O
or CC O
water NN O
in IN O
the DT O
gastrointestinal JJ O
tract NN O
affects VBZ O
restitution NN O
of IN O
blood NN O
volume NN O
and CC O
plasma NN O
protein NN O
after IN O
hemorrhage NN O
, , O
fed VBN O
and CC O
24 CD O
- : O
h NN O
- : O
fasted VBN O
awake NN O
rats NNS O
received VBD O
a DT O
20 CD O
ml NN O
. . O
kg VB O
- : O
1 CD O
x $ O
3 CD O
min SYM O
- : O
1 CD O
hemorrhage NN O
, , O
and CC O
restitution NN O
of IN O
blood NN O
volume NN O
was VBD O
measured VBN O
by IN O
Evans NNP O
blue JJ O
dye NN O
and CC O
dilution NN O
of IN O
hematocrit NN O
. . O

We PRP O
compared VBN O
previously RB O
the DT O
methylation NN O
status NN O
between IN O
normal JJ O
liver NN O
and CC O
liver NN O
tumors NNS O
in IN O
SV40 NNP B-Gene
T NNP I-Gene
/ NNP I-Gene
t NN I-Gene
antigen NN I-Gene
transgenic JJ O
mice NN O
( ( O
MT NNP O
- : O
D2 NNP O
mice NN O
) ) O
using VBG O
Restriction NNP O
Landmark NNP O
Genomic NNP O
Scanning NNP O
for IN O
Methylation NNP O
( ( O
RLGS NNP O
- : O
M NN O
) ) O
and CC O
identified VBN O
several JJ O
loci NNS O
/ JJ O
spots NNS O
that WDT O
appeared VBD O
to TO O
be VB O
methylated VBN O
frequently RB O
in IN O
liver NN O
tumors NNS O
. . O

Biochemical JJ O
analysis NN O
demonstrates VBZ O
that IN O
the DT O
BJ1 NNP B-Gene
protein NN I-Gene
is VBZ O
associated VBN O
with IN O
nucleosomes NNS O
and CC O
is VBZ O
released VBN O
from IN O
chromatin NN O
by IN O
agents NNS O
which WDT O
intercalate VBP O
into IN O
DNA NNP O
, , O
as IN O
previously RB O
shown VBN O
for IN O
the DT O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
proteins VBZ I-Gene
( ( O
HMGs NNP B-Gene
) ) O
. . O

Cryoglobulinemia NN O
in IN O
Raynaud NNP O
' POS O
s NN O
syndrome NN O

U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
snRNP NN O
is VBZ O
one CD O
of IN O
four CD O
essential JJ O
small JJ O
nuclear JJ O
ribonucleoprotein NN O
( ( O
snRNP NN O
) ) O
particles NNS O
( ( O
U1 NNP B-Gene
, , O
U2 NNP B-Gene
, , O
U5 NNP B-Gene
and CC O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
) ) O
present NN O
in IN O
the DT O
spliceosome NN O
. . O

However RB O
, , O
there EX O
is VBZ O
still RB O
a DT O
subset NN O
of IN O
tumors NNS O
that WDT O
displayed VBD O
no DT O
changes NNS O
in IN O
these DT O
genes NNS O
. . O

PrpB NNP B-Gene
showed VBD O
homology NN O
to TO O
carboxyphosphonoenolpyruvate VB B-Gene
phosphonomutase NN I-Gene
of IN I-Gene
Streptomyces NNP I-Gene
hygroscopicus NN I-Gene
and CC O
to TO O
its PRP$ O
homolog NN O
in IN O
the DT O
carnation NN O
Dianthus NNP O
caryophyllus NN O
; : O
PrpC NNP B-Gene
was VBD O
homologous JJ O
to TO O
both DT O
archaeal NN B-Gene
and CC I-Gene
bacterial JJ I-Gene
citrate NN I-Gene
synthases NNS I-Gene
; : O
PrpD NNP B-Gene
showed VBD O
homology NN O
to TO O
yeast VB O
and CC O
Bacillus NNP O
subtilis VBP O
proteins NNS O
of IN O
unknown JJ O
function NN O
; : O
PrpE NNP B-Gene
showed VBD O
homology NN O
to TO O
acetyl VB B-Gene
coenzyme VB I-Gene
A DT I-Gene
synthetases NNS I-Gene
. . O

This DT O
brief JJ O
hypercapnic JJ O
challenge NN O
induced VBD O
a DT O
rapid JJ O
increase NN O
in IN O
CBF NNP O
in IN O
the DT O
absence NN O
of IN O
any DT O
change NN O
in IN O
MABP NNP O
. . O

We PRP O
show VBP O
that IN O
the DT O
en NN B-Gene
stripes VBZ O
expand VBP O
anteriorly RB O
in IN O
slp NN B-Gene
mutant NN O
embryos NN O
and CC O
that DT O
slp NN B-Gene
activity NN O
is VBZ O
an DT O
absolute JJ O
requirement NN O
for IN O
maintenance NN O
of IN O
wg JJ B-Gene
expression NN O
at IN O
the DT O
same JJ O
time NN O
that IN O
wg JJ B-Gene
transcription NN O
is VBZ O
dependent JJ O
on IN O
hh NN B-Gene
. . O

In IN O
nine CD O
patients NNS O
with IN O
renal JJ O
failure NN O
routine JJ O
haemodialysis NN O
was VBD O
accompanied VBN O
by IN O
a DT O
30 CD O
per IN O
cent NN O
reduction NN O
in IN O
plasma NN O
ANP NNP B-Gene
concentration NN O
. . O

The DT O
most RBS O
common JJ O
characteristics NNS O
of IN O
VRE NNP O
patients NNS O
were VBD O
recent JJ O
prior RB O
vancomycin NN O
use NN O
, , O
recent JJ O
prior RB O
susceptible JJ O
enterococcal JJ O
infection NN O
, , O
coinfection NN O
with IN O
other JJ O
microbial JJ O
pathogens NNS O
, , O
and CC O
concurrent JJ O
fungal JJ O
infection NN O
. . O

METHODS NN O
: : O
9 CD O
cases NNS O
of IN O
conventional JJ O
intermittent JJ O
tissue NN O
expansion NN O
( ( O
CITE NNP O
) ) O
and CC O
9 CD O
cases NNS O
of IN O
continuous JJ O
pressure NN O
- : O
controlled VBN O
tissue NN O
expansion NN O
( ( O
CPTE NNP O
) ) O
were VBD O
chosen VBN O
for IN O
the DT O
study NN O
. . O

Descriptions NNS O
of IN O
this DT O
locus NN O
would MD O
allow VB O
comparison NN O
with IN O
functionally RB O
relevant JJ O
molecular JJ O
genetic JJ O
features NNS O
of IN O
other JJ O
species NNS O
' POS O
homologous JJ O
loci NNS O
including VBG O
the DT O
single JJ O
- : O
copy NN O
equid NN O
LH NNP B-Gene
/ NNP O
CGbeta NNP B-Gene
gene NN O
and CC O
the DT O
primate NN O
LHbeta NNP B-Gene
- : O
CGbeta NNP B-Gene
gene NN O
cluster NN O
locus NN O
. . O

Under IN O
resting VBG O
conditions NNS O
, , O
activity NN O
levels NNS O
of IN O
cardiac JJ O
vagal NN O
and CC O
sympathetic JJ O
outflows NNS O
are VBP O
not RB O
related VBN O
across IN O
young JJ O
, , O
healthy JJ O
human JJ O
subjects NNS O
and CC O
peripheral JJ O
interaction NN O
is VBZ O
not RB O
manifest JJS O
between IN O
the DT O
autonomic JJ O
divisions NNS O
. . O

Assessment NN O
of IN O
the DT O
carcinogenicity NN O
of IN O
non JJ O
- : O
nutritive JJ O
sweetners NNS O
II NNP O
: : O
Cyclamates NNS O
and CC O
cyclohexylamine NN O
. . O

The DT O
genome NN O
of IN O
Thogoto NNP O
virus NN O
comprises VBZ O
six CD O
segments NNS O
of IN O
single JJ O
- : O
stranded VBN O
, , O
negative JJ O
sense NN O
RNA NNP O
. . O

The DT O
range NN O
of IN O
serum NN O
concentrations NNS O
, , O
mean JJ O
values NNS O
, , O
median JJ O
values NNS O
, , O
and CC O
standard JJ O
deviations NNS O
for IN O
each DT O
analyte NN O
are VBP O
reported VBN O
for IN O
males NNS O
and CC O
females NNS O
and CC O
for IN O
three CD O
age NN O
groups NNS O
( ( O
25 CD O
- : O
44 CD O
, , O
45 CD O
- : O
59 CD O
, , O
60 CD O
- : O
70 CD O
) ) O
. . O

The DT O
two CD O
genes NNS O
code NN O
for IN O
polypeptides NNS B-Gene
of IN I-Gene
420 CD I-Gene
amino JJ I-Gene
acids NNS I-Gene
( ( I-Gene
M NNP I-Gene
. . I-Gene
HgiCI NNP I-Gene
) ) I-Gene
and CC O
345 CD B-Gene
amino NN I-Gene
acids NNS I-Gene
( ( I-Gene
R NNP I-Gene
. . I-Gene
HgiCI NNP I-Gene
) ) I-Gene
. . O

In IN O
contrast NN O
, , O
COUP NNP B-Gene
- : I-Gene
TF NNP I-Gene
alone RB O
had VBD O
no DT O
effect NN O
on IN O
repCRS2 NN O
- : O
dependent JJ O
reporter NN O
gene NN O
activity NN O
. . O

Nip7p NNP B-Gene
- : O
depleted VBD O
cells NNS O
exhibited VBD O
the DT O
same JJ O
defects NNS O
as IN O
Nop8p NNP B-Gene
- : O
depleted VBD O
cells NNS O
, , O
except IN O
that IN O
they PRP O
accumulated VBD O
27S CD B-Gene
precursors NNS I-Gene
. . O

Partial JJ O
sequencing NN O
of IN O
the DT O
region NN O
downstream NN O
of IN O
ORF NNP B-Gene
- : I-Gene
Pto NNP I-Gene
revealed VBD O
homology NN O
to TO O
the DT O
ru NN B-Gene
/ NNP I-Gene
AB NNP I-Gene
genes NNS I-Gene
, , O
involved VBN O
in IN O
UV NNP O
resistance NN O
, , O
from IN O
plasmid JJ O
pPSR1 NN O
. . O

It PRP O
is VBZ O
exclusively RB O
observed VBN O
in IN O
smooth JJ O
muscle NN O
cells NNS O
by IN O
Northern NNP O
blotting NN O
and CC O
immunohistochemical JJ O
analysis NN O
and CC O
therefore RB O
designated VBD O
"""" NNP B-Gene
smoothelin NN I-Gene
. . I-Gene
"""" VB I-Gene
A DT O
human JJ O
smooth JJ O
muscle NN O
cDNA NN O
library NN O
was VBD O
screened VBN O
with IN O
the DT O
monoclonal JJ B-Gene
antibody NN I-Gene
R4A NNP I-Gene
, , O
and CC O
a DT O
full JJ O
- : O
size NN O
cDNA NN O
of IN O
the DT O
protein NN O
was VBD O
selected VBN O
. . O

GETS NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
expressed VBN O
in IN O
many JJ O
tissues NNS O
, , O
but CC O
is VBZ O
enriched VBN O
in IN O
retina NN O
and CC O
brain NN O
. . O

Methylation NN O
at IN O
both DT O
cytosine NN O
residues NNS O
in IN O
the DT O
E2F NNP B-Gene
element NN O
( ( O
( ( O
m NN O
) ) O
CG NNP O
( ( O
m NN O
) ) O
CG NNP O
) ) O
generated VBD O
a DT O
new JJ O
methylcytosine NN O
- : O
specific JJ O
DNA NNP O
- : O
protein NN O
complex NN O
. . O

CONCLUSION NN O
: : O
Presence NN O
of IN O
APOE NNP B-Gene
epsilon4 FW I-Gene
/ NNP I-Gene
* NNP I-Gene
seems VBZ O
to TO O
increase VB O
the DT O
risk NN O
for IN O
dementia NN O
and CC O
AD NNP O
independently RB O
of IN O
its PRP$ O
effect NN O
on IN O
dyslipidemia NN O
and CC O
atherogenesis NN O
. . O

How WRB O
plants NNS O
respond VBP O
to TO O
attack VB O
by IN O
the DT O
range NN O
of IN O
herbivores NNS O
and CC O
pathogens NNS O
that WDT O
confront VBP O
them PRP O
in IN O
the DT O
field NN O
is VBZ O
the DT O
subject NN O
of IN O
considerable JJ O
research NN O
by IN O
both DT O
molecular JJ O
biologists NNS O
and CC O
ecologists NNS O
. . O

Mapping NN O
of IN O
the DT O
human JJ B-Gene
Voltage NNP I-Gene
- : I-Gene
Dependent JJ I-Gene
Anion NNP I-Gene
Channel NNP I-Gene
isoforms VBZ I-Gene
1 CD I-Gene
and CC I-Gene
2 CD I-Gene
reconsidered VBN O
. . O

The DT O
observed JJ O
incidence NN O
rates NNS O
were VBD O
compared VBN O
to TO O
expected VBN O
rates NNS O
in IN O
the DT O
general JJ O
population NN O
. . O

In IN O
transient NN O
assays NNS O
, , O
using VBG O
rice NN O
suspension NN O
- : O
cultured JJ O
cells NNS O
transformed VBN O
by IN O
particle NN O
bombardment NN O
, , O
we PRP O
showed VBD O
previously RB O
that IN O
Oshox1 NNP B-Gene
can MD O
transcriptionally RB O
repress VB O
the DT O
activity NN O
of IN O
reporter NN O
gene NN O
constructs NNS O
with IN O
upstream JJ O
HD NNP B-Gene
- : I-Gene
Zip NN I-Gene
binding NN O
sites NNS O
. . O

The DT O
other JJ O
inhibitor NN O
was VBD O
a DT O
single JJ O
TAR NNP B-Gene
decoy NN O
, , O
driven VBN O
by IN O
the DT O
U6 NNP B-Gene
small JJ I-Gene
nuclear JJ I-Gene
RNA NNP I-Gene
promoter NN I-Gene
( ( O
U6 NNP B-Gene
- : I-Gene
P NN I-Gene
) ) O
. . O

Therefore RB O
more RBR O
active JJ O
and CC O
tolerable JJ O
salvage NN O
regimens NNS O
are VBP O
needed VBN O
. . O

Here RB O
, , O
we PRP O
report VBP O
theoretical JJ O
models NNS O
for IN O
the DT O
Gla NNP O
and CC O
EGF NNP B-Gene
- : I-Gene
1 CD I-Gene
modules NNS I-Gene
of IN O
human JJ B-Gene
PS NNP I-Gene
constructed VBD O
using VBG O
prothrombin NN B-Gene
and CC O
factor NN B-Gene
X NNP I-Gene
experimental JJ O
structures NNS O
. . O

Furthermore RB O
, , O
we PRP O
demonstrate VBP O
that DT O
transcription NN O
from IN O
the DT O
MMTV NNP B-Gene
5 CD I-Gene
' '' I-Gene
LTR NNP I-Gene
is VBZ O
highly RB O
active JJ O
in IN O
the DT O
absence NN O
of IN O
Stat5a NNP B-Gene
, , O
a DT O
transcription NN O
factor NN O
that WDT O
had VBD O
been VBN O
shown VBN O
previously RB O
to TO O
be VB O
required VBN O
for IN O
transcription NN O
from IN O
the DT O
MMTV NNP B-Gene
LTR NNP I-Gene
. . O

There EX O
was VBD O
a DT O
significant JJ O
but CC O
similar JJ O
elevation NN O
of IN O
mean JJ O
O2 NNP O
uptake NN O
during IN O
40 CD O
min NNS O
postexercise NN O
by IN O
13 CD O
. . O
6 CD O
% NN O
in IN O
both CC O
the DT O
fasted VBN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
fed VBN O
state NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Prostate NNP B-Gene
- : I-Gene
specific JJ I-Gene
antigen NN I-Gene
( ( O
PSA NNP B-Gene
) ) O
promoter NN O
- : O
driven NN O
androgen SYM O
- : O
inducible JJ O
expression NN O
of IN O
sodium NN B-Gene
iodide NN I-Gene
symporter NN I-Gene
in IN O
prostate NN O
cancer NN O
cell NN O
lines NNS O
. . O

Pigs NNS O
were VBD O
switched VBN O
from IN O
the DT O
growing VBG O
to TO O
the DT O
finishing NN O
diet NN O
at IN O
57 CD O
and CC O
61 CD O
kg NN O
in IN O
Exp NNP O
. . O

Prostaglandins NNS O
F NNP O
( ( O
PGF NNP O
) ) O
were VBD O
measured VBN O
in IN O
uterine JJ O
vein NN O
, , O
ovarian JJ O
artery NN O
, , O
and CC O
jugular JJ O
vein NN O
plasma NN O
and CC O
in IN O
the DT O
endometrial JJ O
tissues NNS O
at IN O
various JJ O
times NNS O
during IN O
the DT O
bovine NN O
estrous JJ O
cycle NN O
, , O
and CC O
were VBD O
compared VBN O
to TO O
peripheral VB O
plasma VB O
progesterone NN O
levels NNS O
. . O

They PRP O
also RB O
occur VBP O
in IN O
similar JJ O
locations NNS O
in IN O
the DT O
promoters NNS O
of IN O
several JJ O
other JJ O
ribosomal JJ B-Gene
protein NN I-Gene
genes NNS I-Gene
. . O

An DT O
automated JJ O
method NN O
for IN O
the DT O
quantitative JJ O
analysis NN O
of IN O
the DT O
polyamines NNS O
putrescine NN O
, , O
spermidine NN O
and CC O
spermine NN O
in IN O
cerebrospinal JJ O
fluid NN O
( ( O
CSF NNP O
) ) O
was VBD O
used VBN O
to TO O
analyze VB O
CSF NNP O
samples NNS O
from IN O
37 CD O
patients NNS O
with IN O
central JJ O
nervous JJ O
system NN O
( ( O
CNS NNP O
) ) O
tumors NNS O
and CC O
from IN O
13 CD O
patients NNS O
without IN O
tumors NNS O
. . O

Chimeras NNP O
containing VBG O
IE1 NNP B-Gene
peptides NNS I-Gene
dramatically RB O
activated VBN O
transcription NN O
of IN O
the DT O
basal NN O
promoter NN O
only RB O
when WRB O
lac NN B-Gene
operator NN I-Gene
sequences NNS I-Gene
were VBD O
present JJ O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
the DT O
t NN O
( ( O
4 CD O
; : O
14 CD O
) ) O
( ( O
p16 NN O
. . O
3 CD O
; : O
q32 NN O
) ) O
represents VBZ O
a DT O
novel NN O
, , O
recurrent NN O
chromosomal JJ O
translocation NN O
in IN O
MM NNP O
, , O
and CC O
suggest VBP O
that IN O
the DT O
FGFR3 NNP B-Gene
gene NN I-Gene
may MD O
be VB O
the DT O
target NN O
of IN O
this DT O
abnormality NN O
and CC O
thus RB O
contribute VB O
to TO O
tumorigenesis VB O
in IN O
MM NNP O
. . O

What WP O
' '' O
s JJ O
new JJ O
in IN O
gynecologic NN O
and CC O
obstetrical JJ O
surgery NN O
. . O

This DT O
study NN O
demonstrates VBZ O
secretion NN O
of IN O
bicarbonate NN O
by IN O
the DT O
human JJ O
stomach NN O
in IN O
vivo NN O
at IN O
a DT O
rate NN O
equivalent NN O
to TO O
10 CD O
- : O
- : O
20 CD O
% NN O
of IN O
basal NN O
acid JJ O
secretion NN O
. . O

Long NNP O
- : O
term NN O
results NNS O
with IN O
MACOP NNP O
- : O
B NN O
and CC O
radiation NN O
therapy NN O
for IN O
aggressive JJ O
lymphomas NN O
] NN O
BACKGROUND NNP O
: : O
Long JJ O
- : O
term NN O
results NNS O
are VBP O
needed VBN O
to TO O
evaluate VB O
chemotherapy NN O
regimens NNS O
and CC O
prognostic JJ O
factors NNS O
in IN O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphomas NN O
( ( O
NHL NNP O
) ) O
. . O

Mutagenesis NN O
of IN O
the DT O
CDE NNP O
/ NNP O
CHR NNP O
elements NNS O
and CC O
Sp1 NNP B-Gene
sites VBZ I-Gene
in IN O
this DT O
region NN O
, , O
alone RB O
or CC O
in IN O
combination NN O
, , O
reduced VBD O
transcriptional JJ O
activity NN O
by IN O
40 CD O
- : O
60 CD O
% NN O
in IN O
asynchronously RB O
growing VBG O
cells NNS O
and CC O
abolished VBN O
cell NN O
cycle NN O
periodicity NN O
in IN O
G2 NNP O
- : O
M NNP O
- : O
synchronized JJ O
cells NNS O
. . O

The DT O
transcriptional JJ O
activities NNS O
of IN O
the DT O
full JJ O
- : O
length NN O
promoter NN O
( ( O
- : O
295 CD O
to TO O
+ VB O
85 CD O
) ) O
and CC O
of IN O
three CD O
deletion NN O
constructs NNS O
( ( O
- : O
197 CD O
, , O
- : O
154 CD O
and CC O
- : O
74 CD O
to TO O
+ VB O
85 CD O
) ) O
were VBD O
significantly RB O
down JJ O
- : O
regulated VBN O
in IN O
resistant JJ O
cells NNS O
. . O

Our PRP$ O
data NNS O
indicate VBP O
that IN O
SIP1 NNP B-Gene
is VBZ O
required VBN O
to TO O
confine VB O
XBra NNP B-Gene
gene NN I-Gene
expression NN O
to TO O
the DT O
mesoderm NN O
. . O

After IN O
determining VBG O
isoflurane NN O
MAC NNP O
in IN O
triplicate NN O
, , O
birds NNS O
were VBD O
given VBN O
a DT O
mu NN O
- : O
opioid JJ O
agonist NN O
( ( O
morphine NN O
, , O
n JJ O
= NNP O
9 CD O
) ) O
or CC O
a DT O
kappa JJ O
- : O
opioid JJ O
agonist NN O
( ( O
U50488H NNP O
, , O
n JJ O
= NNP O
9 CD O
) ) O
. . O

Respiratory NNP O
chain NN O
enzyme NN O
activity NN O
was VBD O
normal JJ O
. . O

Reporting NN O
of IN O
adverse JJ O
events NNS O
occurring VBG O
during IN O
clinical JJ O
trials NNS O
of IN O
investigational JJ O
drugs NNS O
is VBZ O
a DT O
complex JJ O
and CC O
controversial JJ O
issue NN O
. . O

Thus RB O
, , O
SAG NNP B-Gene
appears VBZ O
to TO O
control VB O
cell NN O
cycle NN O
progression NN O
in IN O
yeast NN O
by IN O
promoting VBG O
ubiquitination NN O
and CC O
degradation NN O
of IN O
cell NN O
cycle NN O
regulatory JJ O
proteins NNS O
. . O

Vitiligo NNP O
in IN O
diabetes NNS O
mellitus NNS O
. . O

Previous JJ O
studies NNS O
indicated VBD O
that IN O
the DT O
20S CD B-Gene
proteasome NN I-Gene
is VBZ O
a DT O
catalytic JJ O
core NN O
of IN O
the DT O
26S CD B-Gene
proteolytic JJ I-Gene
complex NN I-Gene
that WDT O
possesses VBZ O
a DT O
latent JJ O
multicatalytic JJ O
proteinase NN O
activity NN O
and CC O
catalyzes VBZ O
an DT O
ATP NNP O
- : O
dependent NN O
, , O
selective JJ O
breakdown NN O
of IN O
proteins NNS O
ligated VBN O
to TO O
ubiquitin VB B-Gene
. . O

Subsequent JJ O
cloning NN O
and CC O
nucleotide JJ O
sequence NN O
analysis NN O
of IN O
the DT O
S NNP B-Gene
. . I-Gene
pombe NN I-Gene
adenylate JJ I-Gene
kinase NN I-Gene
gene NN I-Gene
, , O
adk1 RB B-Gene
, , O
revealed VBD O
a DT O
coding JJ O
region NN O
of IN O
660 CD O
nucleotides NNS O
. . O

For IN O
HeLa NNP O
, , O
293 CD O
, , O
U937 NNP O
, , O
and CC O
A549 NNP O
cells NNS O
, , O
participation NN O
of IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
DP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
cyclin NN B-Gene
A NNP I-Gene
, , O
and CC O
RB NNP B-Gene
was VBD O
involved VBN O
in IN O
formation NN O
of IN O
some DT O
complexes NNS O
only RB O
, , O
assuming VBG O
participation NN O
of IN O
factors NNS O
different JJ O
from IN O
E2F NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
DP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
others NNS O
. . O

The DT O
activity NN O
of IN O
serum NN B-Gene
lipase NN I-Gene
and CC O
amylase NN B-Gene
distinctly RB O
increased VBD O
at IN O
3 CD O
h NN O
and CC O
went VBD O
up RB O
to TO O
the DT O
maximum NN O
at IN O
12 CD O
h NN O
after IN O
injection NN O
of IN O
Na NNP O
- : O
Tc NN O
. . O

Because IN O
of IN O
the DT O
potential JJ O
implications NNS O
of IN O
these DT O
findings NNS O
in IN O
human JJ O
physiology NN O
, , O
we PRP O
cloned VBD O
the DT O
hPACAP NN B-Gene
- : I-Gene
R NNP I-Gene
gene NN I-Gene
. . O

However RB O
, , O
the DT O
elderly JJ O
group NN O
showed VBD O
significantly RB O
longer RBR O
mean JJ O
residence NN O
times NNS O
( ( O
MRTs NNP O
) ) O
and CC O
lower JJR O
plasma NN O
clearance NN O
of IN O
lidocaine NN O
during IN O
the DT O
period NN O
compared VBN O
with IN O
the DT O
adult NN O
group NN O
( ( O
P NNP O
< NNP O
. . O
5 CD O
) ) O
. . O

Members NNS O
of IN O
the DT O
mitogen NN B-Gene
activated VBD I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinase VBD I-Gene
family NN I-Gene
, , O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
, , O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinase NN I-Gene
- : I-Gene
1 CD I-Gene
/ NN O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
NH2 NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
, , O
and CC O
p38 NN B-Gene
, , O
are VBP O
central JJ O
elements NNS O
that WDT O
transduce VBP O
the DT O
signal NN O
generated VBN O
by IN O
growth NN O
factors NNS O
, , O
cytokines NNS O
, , O
and CC O
stressing VBG O
agents NNS O
. . O

Diltiazem NNP O
resulted VBD O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
epicardial JJ O
diameter NN O
( ( O
+ JJ O
10 CD O
% NN O
; : O
p CC O
= $ O
0 CD O
. . O
1 CD O
) ) O
and CC O
in IN O
coronary JJ O
blood NN O
flow NN O
( ( O
CBF NNP O
) ) O
( ( O
+ $ O
30 CD O
% NN O
; : O
p CC O
= $ O
0 CD O
. . O
1 CD O
) ) O
. . O

Clinical JJ O
and CC O
haematological JJ O
signs NNS O
are VBP O
not RB O
specific JJ O
in IN O
this DT O
setting NN O
, , O
and CC O
the DT O
diagnosis NN O
relies NNS O
on IN O
histological JJ O
features NNS O
, , O
mainly RB O
bone NN O
marrow NN O
examination NN O
. . O

Here RB O
we PRP O
show VBP O
that DT O
phosphorylation NN O
- : O
induced JJ O
loss NN O
of IN O
the DT O
protein JJ O
kinase NN O
activity NN O
of IN O
DNA NNP B-Gene
- : I-Gene
PK NN I-Gene
is VBZ O
restored VBN O
by IN O
the DT O
addition NN O
of IN O
the DT O
purified JJ O
catalytic JJ O
subunit NN O
of IN O
either DT O
protein JJ B-Gene
phosphatase NN I-Gene
1 CD I-Gene
or CC O
protein VB B-Gene
phosphatase JJ I-Gene
2A CD I-Gene
( ( O
PP2A NNP B-Gene
) ) O
and CC O
that IN O
this DT O
reactivation NN O
is VBZ O
blocked VBN O
by IN O
the DT O
potent NN O
protein NN O
phosphatase NN O
inhibitor NN O
, , O
microcystin NN O
. . O

Therefore RB O
the DT O
procedure NN O
of IN O
Lich NNP O
- : O
Gregoir NNP O
is VBZ O
not RB O
to TO O
be VB O
recommended VBN O
in IN O
adults NNS O
. . O

The DT O
remaining VBG O
six CD O
patients NNS O
had VBD O
slightly RB O
decreased VBN O
( ( O
n JJ O
= NNP O
3 CD O
) ) O
or CC O
normal JJ O
( ( O
n JJ O
= NNP O
3 CD O
) ) O
seminal JJ O
parameters NNS O
. . O

The DT O
Saccharomyces NNPS B-Gene
cerevisiae NN I-Gene
RAD30 NNP I-Gene
gene NN I-Gene
, , O
a DT O
homologue NN B-Gene
of IN I-Gene
Escherichia NNP I-Gene
coli NNS I-Gene
dinB NN I-Gene
and CC O
umuC NN B-Gene
, , O
is VBZ O
DNA NNP O
damage NN O
inducible JJ O
and CC O
functions NNS O
in IN O
a DT O
novel JJ O
error NN O
- : O
free JJ O
postreplication NN O
repair NN O
mechanism NN O
. . O

Despite IN O
the DT O
activation NN O
of IN O
these DT O
intracellular JJ O
signaling NN O
molecules NNS O
, , O
PDGF NNP B-Gene
beta NN I-Gene
receptor NN I-Gene
activation NN O
elicited VBD O
no DT O
detectable JJ O
effect NN O
on IN O
cell NN O
proliferation NN O
or CC O
differentiation NN O
. . O

The DT O
mapping NN O
was VBD O
completed VBN O
with IN O
Southern NNP O
blotting NN O
and CC O
restriction NN O
analysis NN O
. . O

And CC O
the DT O
natural JJ O
barriers NNS O
? . O

Dual JJ O
radionuclide NN O
subtraction NN O
imaging NN O
of IN O
the DT O
spleen JJ O
using VBG O
67Ga CD O
citrate NN O
and CC O
99mTc CD O
is VBZ O
useful JJ O
in IN O
further JJ O
delineating NN O
lesions NNS O
that WDT O
are VBP O
identified VBN O
on IN O
either CC O
a DT O
routine JJ O
radiogallium NN O
survey NN O
or CC O
on IN O
a DT O
conventional JJ O
sulfur NN O
colloid NN O
liver SYM O
- : O
spleen JJ O
image NN O
. . O

Genesis NN O
of IN O
foam JJ O
cells NNS O
: : O
study NN O
in IN O
rats NNS O
after IN O
administration NN O
of IN O
Cloforex NNP O
. . O

Sip1 NNP B-Gene
was VBD O
initially RB O
identified VBN O
by IN O
virtue NN O
of IN O
its PRP$ O
interaction NN O
with IN O
SC35 NNP B-Gene
, , O
a DT O
splicing VBG O
factor NN O
of IN O
the DT O
SR NNP B-Gene
family NN I-Gene
. . O

Histopathologically RB O
, , O
a DT O
cystic JJ O
lymphangioma NN O
was VBD O
diagnosed VBN O
because IN O
of IN O
the DT O
morphological JJ O
features NNS O
and CC O
the DT O
immunohistochemical JJ O
stainings NNS O
of IN O
CD34 NNP B-Gene
and CC O
Factor NNP B-Gene
VIII NNP I-Gene
related VBD I-Gene
antigen NN I-Gene
which WDT O
were VBD O
observed VBN O
positive JJ O
reactions NNS O
in IN O
endothelial JJ O
cells NNS O
of IN O
the DT O
cysts NNS O
. . O

Toxicity NN O
was VBD O
mild JJ O
, , O
mainly RB O
consisting VBG O
of IN O
emesis NN O
( ( O
81 CD O
% NN O
of IN O
the DT O
patients NNS O
; : O
66 CD O
% NN O
of IN O
the DT O
courses NNS O
) ) O
, , O
leukopenia NN O
of IN O
World NNP O
Health NNP O
Organization NNP O
( ( O
WHO NNP O
) ) O
grade VBD O
1 CD O
to TO O
2 CD O
( ( O
47 CD O
% NN O
of IN O
the DT O
patients NNS O
; : O
18 CD O
% NN O
of IN O
the DT O
courses NNS O
) ) O
, , O
and CC O
thrombocytopenia NN O
( ( O
12 CD O
% NN O
of IN O
the DT O
patients NNS O
; : O
3 CD O
% NN O
of IN O
the DT O
courses NNS O
) ) O
. . O

This DT O
function NN O
requires VBZ O
not RB O
only RB O
the DT O
kinase NN O
domain NN O
of IN O
Csk NNP B-Gene
, , O
but CC O
also RB O
its PRP$ O
Src NNP B-Gene
homology NN I-Gene
3 CD I-Gene
( ( O
SH3 NNP B-Gene
) ) O
and CC O
SH2 NNP B-Gene
regions NNS O
. . O

Complete JJ O
recovery NN O
of IN O
liver NN O
function NN O
after IN O
this DT O
surgery NN O
tended VBD O
to TO O
be VB O
slow JJ O
. . O

These DT O
synergistic JJ O
effects NNS O
were VBD O
strongly RB O
Jem NNP B-Gene
- : I-Gene
1 CD I-Gene
dose JJ O
- : O
dependent NN O
. . O

The DT O
initial JJ O
phase NN O
of IN O
increased JJ O
vascular JJ O
permeability NN O
in IN O
the DT O
peritoneal JJ O
cavity NN O
and CC O
LTB4 NNP O
production NN O
was VBD O
dose JJ O
dependently RB O
inhibited VBN O
by IN O
the DT O
5 CD O
- : O
LO NN O
inhibitors NNS O
phenidone VBP O
, , O
BW NNP O
A4C NNP O
, , O
A63162 NNP O
, , O
and CC O
ICI NNP O
207 CD O
968 CD O
but CC O
not RB O
by IN O
dexamethasone NN O
or CC O
colchicine NN O
. . O

CsA NNP O
alone RB O
resulted VBD O
in IN O
elevated JJ O
bone NN O
turnover NN O
. . O

The DT O
sample NN O
includes VBZ O
all PDT O
the DT O
HIV NNP O
- : O
infected VBD O
- : O
patients NNS O
continuously RB O
referred VBD O
to TO O
the DT O
Outpatient NNP O
Service NNP O
of IN O
the DT O
Infectious NNP O
Diseases NNP O
dept NN O
. . O
of IN O
Bologna NNP O
' POS O
s NN O
"""" NNP O
Ospedale NNP O
Maggiore NNP O
"""" NNP O
General NNP O
Hospital NNP O
during IN O
some DT O
five CD O
days NNS O
( ( O
19 CD O
- : O
23rd CD O
, , O
July NNP O
1993 CD O
) ) O
. . O

Benztropine NNP O
for IN O
venlafaxine NN O
- : O
induced JJ O
night NN O
sweats NNS O
. . O

Sequential JJ O
MR NNP O
examinations NNS O
of IN O
the DT O
nasal JJ O
cavity NN O
and CC O
paranasal NN O
sinuses NNS O
were VBD O
performed VBN O
within IN O
a DT O
6 CD O
- : O
8 CD O
h JJ O
period NN O
in IN O
five CD O
normal JJ O
volunteers NNS O
. . O

Analysis NN O
in IN O
3 CD O
groups NNS O
of IN O
patients NNS O
suffering VBG O
from IN O
simple JJ O
acute NN O
and CC O
pernicious JJ O
malarial NN O
flare NN O
- : O
ups NNS O

Moreover RB O
, , O
unlike IN O
control NN O
rats NNS O
operated VBD O
animals NNS O
did VBD O
not RB O
show VB O
aversion NN O
to TO O
the DT O
highest JJS O
concentrations NNS O
of IN O
saccharin JJ O
solutions NNS O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
have VBP O
analyzed VBN O
the DT O
structure NN O
of IN O
human JJ O
gene NN O
for IN O
Gx NNP B-Gene
alpha NN I-Gene
, , O
which WDT O
spans VBZ O
more JJR O
than IN O
60 CD O
kilobases NNS O
. . O

ICP4 NNP B-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
form VB O
tripartite NN O
complexes NNS O
cooperatively RB O
with IN O
the DT O
TATA NNP B-Gene
box NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
and CC O
TFIIB NNP B-Gene
on IN O
DNA NNP O
containing VBG O
an DT O
ICP4 NNP B-Gene
binding NN I-Gene
site NN I-Gene
and CC O
a DT O
TATA NNP O
box NN O
( ( O
C NNP O
. . O

This DT O
differential JJ O
sensitivity NN O
to TO O
DB NNP O
, , O
as IN O
measured VBN O
by IN O
a DT O
lower JJR O
concentration NN O
of IN O
DB NNP O
which WDT O
caused VBD O
loss NN O
of IN O
righting VBG O
in IN O
LS NNP O
, , O
was VBD O
accompanied VBN O
by IN O
an DT O
equal JJ O
rate NN O
of IN O
water NN O
- : O
soluble JJ O
barbiturate NN O
brain NN O
distribution NN O
and CC O
elimination NN O
in IN O
the DT O
two CD O
lines NNS O
. . O

NF NNP B-Gene
- : I-Gene
HB NNP I-Gene
( ( O
BSAP NNP B-Gene
) ) O
is VBZ O
a DT O
repressor NN O
of IN O
the DT O
murine NN B-Gene
immunoglobulin NN I-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
3 CD I-Gene
' '' I-Gene
alpha JJ I-Gene
enhancer NN I-Gene
at IN O
early JJ O
stages NNS O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
. . O

The DT O
NIT2 NNP B-Gene
protein NN I-Gene
is VBZ O
localised VBN O
in IN O
nuclei NN O
and CC O
could MD O
not RB O
be VB O
detected VBN O
in IN O
the DT O
cytoplasmic JJ O
fraction NN O
of IN O
cells NNS O
subjected VBN O
to TO O
nitrogen VB O
derepression NN O
or CC O
nitrogen NN O
repression NN O
, , O
indicating VBG O
that IN O
the DT O
nuclear JJ O
import NN O
of IN O
NIT2 NNP B-Gene
is VBZ O
not RB O
regulated VBN O
. . O

After IN O
7 CD O
days NNS O
, , O
a DT O
spontaneous JJ O
regression NN O
of IN O
the DT O
morphologic JJ O
alterations NNS O
caused VBN O
by IN O
caerulein NN O
- : O
induced JJ O
acute NN O
pancreatitis NN O
occurs VBZ O
; : O
however RB O
, , O
recovery NN O
of IN O
the DT O
secretory JJ O
function NN O
of IN O
the DT O
pancreas NN O
was VBD O
only RB O
reached VBN O
after IN O
this DT O
period NN O
of IN O
time NN O
when WRB O
L NNP O
- : O
364 CD O
, , O
718 CD O
was VBD O
administered VBN O
therapeutically RB O
( ( O
0 CD O
. . O
1 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
day NN O
) ) O
. . O

Using VBG O
a DT O
previously RB O
published VBN O
two CD O
- : O
frequency NN O
( ( O
AC NNP O
excitation NN O
) ) O
three CD O
- : O
electrode NN O
method NN O
, , O
the DT O
admittance NN O
locus NN O
plot NN O
( ( O
ALP NNP O
) ) O
in IN O
the DT O
low JJ O
- : O
frequency NN O
region NN O
( ( O
< JJ O
1000 CD O
Hz NNP O
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
very RB O
well RB O
approximated VBN O
by IN O
a DT O
straight JJ O
line NN O
and CC O
can MD O
be VB O
described VBN O
with IN O
frequency NN O
- : O
independent JJ O
parameters NNS O
; : O
phase VB O
angle JJ O
alpha NN O
pi NN O
/ VBD O
2 CD O
, , O
conductance NN O
at IN O
extrapolated JJ O
zero CD O
frequency NN O
G0 NNP O
= VBZ O
1 CD O
/ NN O
R0 NNP O
, , O
and CC O
ion NN O
relaxation NN O
time NN O
tau NN O
. . O

This DT O
motif NN O
has VBZ O
been VBN O
shown VBN O
to TO O
mediate VB O
protein JJ O
interactions NNS O
in IN O
the DT O
case NN O
of IN O
ankyrin NN B-Gene
as RB O
well RB O
as IN O
several JJ O
other JJ O
repeat NN O
- : O
bearing NN O
proteins NNS O
. . O

To TO O
examine VB O
transcriptional JJ O
regulation NN O
of IN O
the DT O
rat NN B-Gene
eIF4E JJ I-Gene
gene NN I-Gene
, , O
2 CD O
. . O
1 CD O
kB NN O
of IN O
the DT O
rat NN B-Gene
eIF4E VBP I-Gene
promoter NN I-Gene
region NN I-Gene
was VBD O
cloned VBN O
and CC O
the DT O
contribution NN O
of IN O
specific JJ O
elements NNS O
in IN O
regulating VBG O
transcription NN O
was VBD O
determined VBN O
in IN O
primary JJ O
cultures NNS O
of IN O
rat NN O
cardiocytes NNS O
and CC O
in IN O
a DT O
murine NN O
C NNP O
( ( O
2 CD O
) ) O
C NNP O
( ( O
12 CD O
) ) O
myoblast NN O
cell NN O
line NN O
. . O

Therefore RB O
, , O
Mxi1 NNP B-Gene
and CC O
Mad NNP B-Gene
might MD O
antagonize VB O
Myc NNP B-Gene
function NN O
and CC O
are VBP O
candidate JJ O
tumor NN O
suppressor NN O
genes NNS O
. . O

The DT O
clinical JJ O
application NN O
of IN O
the DT O
antibody NN O
- : O
targeted JJ O
Phthalocyanine NNP O
was VBD O
performed VBN O
in IN O
3 CD O
patients NNS O
suffering VBG O
from IN O
an DT O
advanced JJ O
ovarian JJ O
carcinoma NN O
( ( O
FIGO NNP O
III NNP O
) ) O
. . O

Recent JJ O
target NN O
BP NNP O
goals NNS O
promulgated VBN O
by IN O
the DT O
Sixth NNP O
Report NNP O
from IN O
the DT O
Joint NNP O
National NNP O
Committee NNP O
( ( O
JNC NNP O
VI NNP O
) ) O
are VBP O
based VBN O
on IN O
the DT O
premise NN O
that IN O
the DT O
intensity NN O
of IN O
treatment NN O
directly RB O
corresponds VBZ O
to TO O
the DT O
magnitude NN O
of IN O
pretreatment NN O
risk NN O
. . O

We PRP O
describe VBP O
a DT O
novel JJ O
zinc NN B-Gene
finger NN I-Gene
protein NN I-Gene
, , O
dsRBP SYM B-Gene
- : I-Gene
ZFa NNP I-Gene
, , O
isolated VBN O
by IN O
screening VBG O
an DT O
expression NN O
library NN O
with IN O
dsRNA NN O
. . O

NPT NNP B-Gene
II NNP I-Gene
synthesis NN O
, , O
measured VBN O
by IN O
agar NN O
plate NN O
assays NNS O
of IN O
kanamycin NN O
resistance NN O
and CC O
by IN O
immunoprecipitation NN O
of IN O
the DT O
NPT NNP B-Gene
II NNP I-Gene
protein NN I-Gene
, , O
was VBD O
repressed VBN O
in IN O
the DT O
presence NN O
of IN O
cysteine NN O
and CC O
derepressed VBN O
in IN O
its PRP$ O
absence NN O
. . O

Young NNP O
fish NN O
( ( O
Oreochromis NNP O
mossambicus NN O
) ) O
were VBD O
exposed VBN O
to TO O
microgravity NN O
( ( O
micro JJ O
g NN O
) ) O
for IN O
9 CD O
to TO O
10 CD O
days NNS O
during IN O
space NN O
missions NNS O
STS NNP O
- : O
55 CD O
and CC O
STS NNP O
- : O
84 CD O
, , O
or CC O
to TO O
hypergravity NN O
( ( O
hg NN O
) ) O
for IN O
9 CD O
days NNS O
. . O

Neither DT O
RD19 NNP B-Gene
nor CC O
RD21 NNP B-Gene
mRNA VBP I-Gene
synthesis NN O
was VBD O
responsive JJ O
to TO O
cold VB O
or CC O
to TO O
heat VB O
stress NN O
. . O

Studies NNS O
on IN O
immunoglobulin JJ B-Gene
E NN I-Gene
: : O
the DT O
impact NN O
of IN O
a DT O
sojourn NN O
with IN O
Professor NNP O
Dan NNP O
H NNP O
. . O

More RBR O
mRNA JJ O
corresponding VBG O
to TO O
nagB VB B-Gene
and CC O
nagA FW B-Gene
is VBZ O
detected VBN O
than IN O
that DT O
corresponding VBG O
to TO O
the DT O
distal JJ O
genes NNS O
, , O
nagC NN B-Gene
and CC O
nagD NN B-Gene
. . O

Correlation NN O
of IN O
skin NN O
disorders NNS O
with IN O
CD4 NNP B-Gene
lymphocyte NN O
counts NNS O
in IN O
patients NNS O
with IN O
HIV NNP O
/ NNP O
AIDS NNP O
. . O

Identification NN O
of IN O
a DT O
new JJ O
gene NN O
in IN O
the DT O
streptococcal JJ O
plasmid NN O
pLS1 NN O
: : O
the DT O
rnaI NN B-Gene
gene NN I-Gene
. . O

So RB O
far RB O
15 CD O
children NNS O
have VBP O
been VBN O
studied VBN O
. . O

Waves NNS O
N1 NNP O
, , O
P3 NNP O
and CC O
CNV NNP O
were VBD O
recorded VBN O
during IN O
a DT O
CNV NNP O
paradigm NN O
in IN O
a DT O
simple JJ O
reaction NN O
time NN O
task NN O
with IN O
a DT O
constant JJ O
interstimulus NN O
interval NN O
( ( O
ISI NNP O
) ) O
of IN O
1 CD O
sec NN O
. . O

Preface NN O
. . O

In IN O
the DT O
former JJ O
cells NNS O
, , O
ets VBZ B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
a DT O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
immediate JJ O
- : O
early JJ O
response NN O
gene NN O
, , O
and CC O
phosphorylated VBD O
ets NNS B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
detected VBN O
after IN O
2 CD O
to TO O
4 CD O
h NN O
, , O
coincident NN O
with IN O
expression NN O
of IN O
ets NNS B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
. . O

These DT O
results NNS O
would MD O
suggest VB O
that IN O
a DT O
high JJ O
UV NNP O
sensitivity NN O
is VBZ O
associated VBN O
with IN O
high JJ O
phaeomelanin NN O
and CC O
low JJ O
eumelanin NN O
levels NNS O
, , O
and CC O
point NN O
to TO O
the DT O
eumelanin NN O
/ NNP O
phaeomelanin NN O
ratio NN O
as IN O
a DT O
novel JJ O
chemical NN O
parameter NN O
that WDT O
could MD O
be VB O
used VBN O
for IN O
predicting VBG O
individuals NNS O
at IN O
high JJ O
risk NN O
for IN O
skin JJ O
cancer NN O
and CC O
melanoma NN O
. . O

Rhizobium NNP O
meliloti VBZ O
large JJ O
plasmid NN O
pRmeGR4b NN O
carries VBZ O
the DT O
nodulation NN O
competitiveness NN O
locus NN O
nfe NN B-Gene
responsible JJ O
for IN O
the DT O
nodulation NN O
efficiency NN O
and CC O
competitive JJ O
ability NN O
of IN O
strain NN O
GR4 NNP O
on IN O
alfalfa JJ O
roots NNS O
. . O

A DT O
computerized JJ O
method NN O
of IN O
determining VBG O
the DT O
focal JJ O
point NN O
of IN O
electrical JJ O
activity NN O
in IN O
the DT O
pallidum NN O
of IN O
parkinsonian JJ O
patients NNS O
was VBD O
developed VBN O
using VBG O
on IN O
- : O
line NN O
quantitative JJ O
physiological JJ O
data NN O
analysis NN O
. . O

The DT O
radiation NN O
burden NN O
associated VBN O
with IN O
the DT O
majority NN O
of IN O
examinations NNS O
in IN O
nuclear JJ O
medicine NN O
expressed VBN O
as IN O
the DT O
effective JJ O
dose NN O
is VBZ O
comparable JJ O
with IN O
the DT O
radiation NN O
burden NN O
of IN O
radiodiagnostic JJ O
examinations NNS O
, , O
only RB O
after IN O
administration NN O
of IN O
preparations NNS O
with IN O
131I CD O
, , O
201Tl CD O
, , O
67Ga CD O
and CC O
111In CD O
it PRP O
is VBZ O
markedly RB O
higher JJR O
. . O

These DT O
cells NNS O
produce VBP O
a DT O
low JJ O
level NN O
of IN O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
when WRB O
stimulated VBN O
with IN O
PMA NNP O
alone RB O
; : O
however RB O
, , O
N6 NNP O
, , O
O2 NNP O
- : O
dibutyryl NN O
cAMP NN O
( ( O
Bt2cAMP NNP O
) ) O
, , O
in IN O
combination NN O
with IN O
PMA NNP O
, , O
augmented VBN O
by IN O
more JJR O
than IN O
tenfold VB O
the DT O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
production NN O
at IN O
the DT O
mRNA NN O
and CC O
the DT O
protein NN O
levels NNS O
. . O

Specialist NN O
in IN O
family NN O
practice NN O
- : O
- : O
prototype NN O
of IN O
a DT O
doctor NN O
. . O

In IN O
addition NN O
, , O
a DT O
21 CD O
- : O
mer NN O
subrepeat NN O
structure NN O
is VBZ O
also RB O
present JJ O
in IN O
each DT O
unit NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
fludarabine NN O
is VBZ O
a DT O
highly RB O
useful JJ O
agent NN O
in IN O
CLL NNP O
. . O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
induced JJ O
gene NN O
expression NN O
: : O
evidence NN O
for IN O
a DT O
selective JJ O
effect NN O
of IN O
ouabain NN O
on IN O
activation NN O
of IN O
the DT O
ISGF3 NNP B-Gene
transcription NN I-Gene
complex NN I-Gene
. . O

The DT O
DNA NNP O
sequence NN O
immediately RB O
upstream JJ O
from IN O
the DT O
- : O
10 CD O
hexamer NN O
contained VBD O
the DT O
TGn NNP O
motif NN O
described VBD O
as IN O
an DT O
extended JJ O
- : O
10 CD O
region NN O
in IN O
prokaryotic JJ O
promoters NNS O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
CHOP NNP I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
homologous JJ I-Gene
protein RB I-Gene
10 CD I-Gene
) ) O
is VBZ O
a DT O
bZIP JJ B-Gene
protein NN I-Gene
induced VBN O
by IN O
a DT O
variety NN O
of IN O
stimuli NNS O
that WDT O
evoke VBD O
cellular JJ O
stress NN O
responses NNS O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
arrest VB O
cell NN O
growth NN O
and CC O
to TO O
promote VB O
programmed JJ O
cell NN O
death NN O
. . O

Open JJ O
reading VBG O
frames NNS O
in IN O
a DT O
4556 CD O
nucleotide NN O
sequence NN O
within IN O
MDV NNP B-Gene
- : I-Gene
1 CD I-Gene
BamHI NNP I-Gene
- : I-Gene
D NNP I-Gene
DNA NNP I-Gene
fragment NN I-Gene
: : O
evidence NN O
for IN O
splicing VBG O
of IN O
mRNA NN O
from IN O
a DT O
new JJ O
viral JJ O
glycoprotein NN O
gene NN O
. . O

The DT O
systolic JJ O
peak NN O
of IN O
pulmonary JJ O
vein NN O
was VBD O
higher JJR O
than IN O
the DT O
diastolic JJ O
peak NN O
in IN O
45 CD O
out IN O
of IN O
56 CD O
cases NNS O
. . O

To TO O
identify VB O
critical JJ O
regions NNS O
mediating VBG O
growth NN O
signal JJ O
transduction NN O
by IN O
hG JJ B-Gene
- : I-Gene
CSFR NN I-Gene
, , O
deletions NNS O
or CC O
site NN O
- : O
directed VBN O
amino NN O
acid JJ O
substitutions NNS O
were VBD O
introduced VBN O
into IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
hG JJ B-Gene
- : I-Gene
CSFR NN I-Gene
, , O
and CC O
the DT O
mutant JJ O
cDNAs NN O
were VBD O
transfected VBN O
into IN O
the DT O
murine NN B-Gene
interleukin SYM I-Gene
- : I-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
- : O
dependent JJ O
Ba NNP O
/ NNP O
F3 NNP O
and CC O
FDCP NNP O
cell NN O
lines NNS O
. . O

Structural JJ O
organization NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
human JJ B-Gene
lipocalin NN I-Gene
tear IN I-Gene
prealbumin NN I-Gene
and CC O
synthesis NN O
of IN O
the DT O
recombinant JJ O
protein NN O
in IN O
Escherichia NNP O
coli NN O
. . O

CONCLUSIONS NNP O
. . O

Since IN O
the DT O
latter NN O
is VBZ O
very RB O
small JJ O
for IN O
physiological JJ O
flows NNS O
, , O
the DT O
result NN O
is VBZ O
that IN O
alpha JJ O
< VBP O
1 CD O
even RB O
at IN O
relatively RB O
high JJ O
values NNS O
of IN O
the DT O
Reynolds NNP O
number NN O
( ( O
i JJ O
. . O
e NN O
. . O
, , O
for IN O
non JJ O
- : O
negligible JJ O
inertia NN O
) ) O
and CC O
we PRP O
validate VBP O
our PRP$ O
perturbation NN O
theory NN O
results NNS O
by IN O
comparison NN O
with IN O
a DT O
numerical JJ O
integration NN O
of IN O
the DT O
full JJ O
model NN O
. . O

Twenty CD O
- : O
two CD O
of IN O
the DT O
24 CD O
patients NNS O
had VBD O
a DT O
rise NN O
in IN O
the DT O
total JJ O
serum JJ O
amylase NN B-Gene
following VBG O
ERCP NNP O
. . O

X LS O
- : O
ray NN O
crystallographic JJ O
data NNS O
show VBP O
that IN O
the DT O
PLZF NNP B-Gene
BTB NNP B-Gene
/ NNP O
POZ NNP O
domain NN O
forms NNS O
an DT O
obligate JJ O
homodimer NN O
via IN O
an DT O
extensive JJ O
interface NN O
. . O

Letter NN O
: : O
Aryl NNP B-Gene
hydrocarbon NN I-Gene
hydroxylase NN I-Gene
and CC O
smoking NN O
. . O

( ( O
1992 CD O
) ) O
Genomics NNPS O
12 CD O
, , O
58 CD O
- : O
62 CD O
) ) O
. . O

Rad6 NNP B-Gene
mutants NNS I-Gene
display VBP O
a DT O
remarkably RB O
pleiotropic NN O
phenotype NN O
, , O
implicating VBG O
the DT O
protein NN O
in IN O
DNA NNP O
damage NN O
- : O
induced JJ O
mutagenesis NN O
, , O
postreplication NN O
repair NN O
, , O
repression NN O
of IN O
retrotransposition NN O
, , O
and CC O
sporulation NN O
. . O

DNA NN O
sequencing NN O
and CC O
Southern NNP O
blot NN O
analyses NNS O
established VBD O
that IN O
the DT O
cDNA NN O
clones NNS O
are VBP O
derived VBN O
from IN O
two CD O
different JJ O
genes NNS O
. . O

Postprandial JJ O
plasma NN B-Gene
enteroglucagon NN I-Gene
concentration NN O
after IN O
90 CD O
minutes NNS O
in IN O
untreated JJ O
patients NNS O
correlated VBD O
positively RB O
to TO O
the DT O
faecal JJ O
fat NN O
excretion NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
58 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
. . O

The DT O
5 CD O
' POS O
- : O
nontranslated JJ O
sequences NNS O
and CC O
parts NNS O
of IN O
the DT O
coding VBG O
sequences NNS O
of IN O
various JJ O
yeast NN O
genes NNS O
have VBP O
been VBN O
cloned VBN O
into IN O
representative JJ O
lacZ JJ B-Gene
fusion NN O
vectors NNS O
. . O

Here RB O
we PRP O
show VBP O
that IN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
or CC O
platelet NN B-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
stimulation NN O
of IN O
intact JJ O
human JJ O
or CC O
murine JJ O
cells NNS O
leads VBZ O
to TO O
phosphorylation NN O
of IN O
Nck NNP B-Gene
protein NN I-Gene
on IN O
tyrosine NN O
, , O
serine NN O
, , O
and CC O
threonine NN O
residues NNS O
. . O

It PRP O
has VBZ O
been VBN O
established VBN O
that IN O
preoperative JJ O
irradiation NN O
in IN O
the DT O
form NN O
of IN O
the DT O
fractionation NN O
of IN O
a DT O
single JJ O
focal JJ O
dose NN O
of IN O
6 CD O
Gy NNP O
every DT O
other JJ O
day NN O
, , O
the DT O
summary JJ O
dose NN O
of IN O
24 CD O
Gy NNP O
within IN O
8 CD O
- : O
10 CD O
days NNS O
followed VBN O
by IN O
surgery NN O
1 CD O
- : O
3 CD O
days NNS O
after IN O
irradiation NN O
does VBZ O
not RB O
either VB O
complicate VB O
its PRP$ O
performance NN O
or CC O
the DT O
course NN O
of IN O
the DT O
postoperative JJ O
period NN O
, , O
and CC O
by IN O
the DT O
short JJ O
- : O
and CC O
long JJ O
- : O
term NN O
results NNS O
it PRP O
is VBZ O
no DT O
worse JJR O
than IN O
the DT O
routine JJ O
dose NN O
fractionation NN O
. . O

This DT O
region NN O
, , O
however RB O
, , O
contains VBZ O
a DT O
CCAATC NNP O
box NN O
in IN O
the DT O
reverse NN O
complement NN O
and CC O
several JJ O
GC NNP O
boxes NNS O
that WDT O
are VBP O
recognition NN O
sites NNS O
for IN O
SP1 NNP B-Gene
. . O

One CD O
hundred CD O
twenty JJ O
units NNS O
of IN O
deglycerolized JJ O
red JJ O
blood NN O
cells NNS O
, , O
some DT O
with IN O
glycerol NN O
added VBD O
so RB O
as IN O
to TO O
exceed VB O
an DT O
acceptable JJ O
1 CD O
% NN O
glycerol NN O
content NN O
, , O
had VBD O
measurements NNS O
made VBN O
of IN O
the DT O
post NN O
- : O
wash NN O
supernatant JJ O
fluid NN O
by IN O
refractive JJ O
index NN O
and CC O
osmometry NN O
. . O

Analysis NN O
of IN O
intragenic JJ O
revertants NNS O
shows VBZ O
that IN O
this DT O
function NN O
depends VBZ O
on IN O
the DT O
amino NN O
acid NN O
preceding VBG O
the DT O
first JJ O
cysteine NN O
residue NN O
of IN O
the DT O
DNA NNP O
- : O
binding VBG O
domain NN O
of IN O
Hap1p NNP B-Gene
. . O

This DT O
sequence NN O
possessed VBD O
homology NN O
with IN O
a DT O
methylation NN O
- : O
sensitive JJ O
promoter NN O
element NN O
, , O
Enh2 NNP O
, , O
present NN O
in IN O
the DT O
LTR NNP O
of IN O
mouse NNP O
intractisternal VBZ O
A NNP O
- : O
particles NNS O
. . O

Cis NNP O
- : O
acting VBG O
CCAAT NNP O
elements NNS O
are VBP O
frequently RB O
found VBN O
in IN O
eukaryotic JJ O
promoter NN O
regions NNS O
. . O

METHODS NN O
: : O
Fifty NNP O
- : O
eight CD O
patients NNS O
who WP O
underwent VBP O
a DT O
curative JJ O
hepatic JJ O
resection NN O
for IN O
HCC NNP O
and CC O
whose WP$ O
preoperative JJ O
AFP NNP B-Gene
levels NNS O
were VBD O
> RB O
100 CD O
ng JJ O
/ NNP O
ml NN O
, , O
were VBD O
selected VBN O
for IN O
this DT O
study NN O
. . O

Tobramycin NNP O
- : O
loaded VBD O
SLN NNP O
administered VBD O
i NN O
. . O
v NN O
. . O
showed VBD O
a DT O
prolonged JJ O
circulation NN O
time NN O
compared VBN O
to TO O
the DT O
i NN O
. . O
v NN O
. . O
administered VBN O
tobramycin JJ O
solution NN O
. . O

The DT O
future NN O
of IN O
research NN O
with IN O
interferon NN B-Gene
may MD O
be VB O
divided VBN O
into IN O
three CD O
areas NNS O
: : O
Efforts NNS O
must MD O
be VB O
made VBN O
to TO O
determine VB O
how WRB O
best JJS O
to TO O
translate VB O
the DT O
in IN O
vitro NN O
synergy NN O
into IN O
clinically RB O
meaningful JJ O
terms NNS O
; : O
in IN O
order NN O
to TO O
exploit VB O
the DT O
fullest JJS O
potential NN O
of IN O
IFN NNP B-Gene
, , O
research NN O
is VBZ O
moving VBG O
toward IN O
using VBG O
this DT O
agent NN O
earlier RBR O
in IN O
disease NN O
either CC O
as IN O
an DT O
adjuvant NN O
after IN O
tumor NN O
debulking NN O
or CC O
after IN O
initial JJ O
diagnosis NN O
; : O
the DT O
medical JJ O
community NN O
must MD O
rethink VB O
the DT O
natural JJ O
history NN O
of IN O
some DT O
diseases NNS O
, , O
because IN O
the DT O
fullest JJS O
potential NN O
of IN O
the DT O
biologic NN O
agents NNS O
will MD O
most RBS O
likely JJ O
manifest JJS O
itself PRP O
when WRB O
these DT O
agents NNS O
are VBP O
used VBN O
together RB O
. . O

We PRP O
used VBD O
a DT O
rev JJ B-Gene
- : O
and CC O
RRE NNP B-Gene
- : O
defective JJ O
HIV NNP O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
molecular NN O
clone NN O
in IN O
complementation NN O
experiments NNS O
to TO O
establish VB O
a DT O
method NN O
for IN O
the DT O
rapid JJ O
isolation NN O
of IN O
posttranscriptional JJ O
regulatory JJ O
elements NNS O
from IN O
the DT O
mammalian JJ O
genome NN O
by IN O
selecting VBG O
for IN O
rescue NN O
of IN O
virus JJ O
replication NN O
. . O

This DT O
sequence NN O
similarity NN O
raises VBZ O
the DT O
possibility NN O
that IN O
GCN1 NNP B-Gene
interacts VBZ O
with IN O
ribosomes NNS O
or CC O
tRNA NN O
molecules NNS O
and CC O
functions NNS O
in IN O
conjunction NN O
with IN O
GCN2 NNP B-Gene
in IN O
monitoring VBG O
uncharged JJ O
tRNA NN O
levels NNS O
during IN O
the DT O
process NN O
of IN O
translation NN O
elongation NN O
. . O

The DT O
combination NN O
of IN O
ifosfamide NN O
, , O
epirubicin NN O
and CC O
etoposide NN O
( ( O
IEV NNP O
) ) O
is VBZ O
an DT O
effective JJ O
salvage NN O
regimen NNS O
for IN O
lymphoproliferative JJ O
disease NN O
. . O

RNase NNP B-Gene
protection NN O
analyses NNS O
indicate VBP O
that IN O
either DT O
61 CD B-Gene
- : I-Gene
kDa NN I-Gene
CaM NNP I-Gene
PDE NNP I-Gene
mRNA NN I-Gene
or CC O
structurally RB O
related JJ O
transcripts NNS O
encoding VBG O
different JJ O
CaM NNP B-Gene
PDE NNP I-Gene
isoforms NNS I-Gene
are VBP O
expressed VBN O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
manner NN O
. . O

Plasma NNP O
lipid NN O
and CC O
lipoprotein NN O
profiles NNS O
were VBD O
compared VBN O
in IN O
elderly JJ O
female NN O
runners NNS O
( ( O
RU NNP O
: : O
n JJ O
= NN O
15 CD O
, , O
aged VBD O
66 CD O
+ NNP O
/ NNP O
- : O
5 CD O
years NNS O
, , O
body NN O
fat JJ O
20 CD O
+ NN O
/ NNP O
- : O
4 CD O
% NN O
, , O
training VBG O
distance NN O
35 CD O
+ NN O
/ NNP O
- : O
15 CD O
km NN O
week NN O
- : O
1 CD O
, , O
VO2max NNP O
36 CD O
+ NNP O
/ NNP O
- : O
4 CD O
ml NN O
kg SYM O
- : O
1 CD O
min SYM O
- : O
1 CD O
, , O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
and CC O
age NN O
- : O
matched VBN O
untrained JJ O
women NNS O
( ( O
UT IN O
: : O
n JJ O
= NN O
28 CD O
, , O
66 CD O
+ NN O
/ NNP O
- : O
4 CD O
years NNS O
, , O
body NN O
fat JJ O
26 CD O
+ NN O
/ NNP O
- : O
6 CD O
% NN O
, , O
VO2max NNP O
26 CD O
+ NNP O
/ NNP O
- : O
3 CD O
ml NN O
kg SYM O
- : O
1 CD O
min SYM O
- : O
1 CD O
) ) O
. . O

Since IN O
glutathione NN B-Gene
peroxidase NN I-Gene
( ( O
GPX NNP B-Gene
) ) O
and CC O
superoxide JJ B-Gene
dismutase NN I-Gene
( ( O
SOD NNP B-Gene
) ) O
play VBP O
a DT O
significant JJ O
role NN O
in IN O
erythrocyte JJ O
antioxidative JJ O
defence NN O
, , O
it PRP O
is VBZ O
very RB O
important JJ O
to TO O
determine VB O
their PRP$ O
activity NN O
in IN O
occupationally RB O
exposed JJ O
workers NNS O
. . O

The DT O
mMIWC1 NN B-Gene
promoter NN I-Gene
was VBD O
identified VBN O
and CC O
contained VBN O
TATA NNP O
, , O
CAAT NNP O
, , O
GATA NNP O
, , O
and CC O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
elements NNS I-Gene
; : O
primer CC O
extension NN O
revealed VBD O
mMIWC JJ B-Gene
transcription NN O
initiation NN O
at IN O
621 CD O
bp JJ O
upstream NN O
from IN O
the DT O
mMIWC1 JJ B-Gene
translational JJ O
initiation NN O
site NN O
. . O

We PRP O
therefore RB O
applied VBD O
a DT O
radiolabelled JJ O
serumalbumin NN B-Gene
method NN O
to TO O
determine VB O
blood NN O
volume NN O
after IN O
haemodilution NN O
with IN O
crosslinked JJ O
or CC O
conjugated JJ O
haemoglobin NN B-Gene
, , O
in IN O
comparison NN O
with IN O
a DT O
reference NN O
solution NN O
of IN O
hydroxyethyl NN O
starch NN O
( ( O
HES NNP O
) ) O
. . O

Moreover RB O
, , O
expression NN O
of IN O
CBF1 NNP B-Gene
in IN O
yeast NN O
was VBD O
found VBN O
to TO O
activate VB O
transcription NN O
of IN O
reporter NN O
genes NNS O
containing VBG O
the DT O
C NNP O
- : O
repeat NN O
/ JJ O
DRE NNP O
as IN O
an DT O
upstream JJ O
activator NN O
sequence NN O
but CC O
not RB O
mutant JJ O
versions NNS O
of IN O
the DT O
DNA NNP O
element NN O
. . O

At IN O
some DT O
sites NNS O
, , O
% NN O
T NNP O
is VBZ O
greatly RB O
increased VBN O
by IN O
Cl NNP O
- : O
concentrations NNS O
up IN O
to TO O
1 CD O
M NNP O
, , O
while IN O
at IN O
other JJ O
sites NNS O
% NN O
T NNP O
is VBZ O
reduced VBN O
or CC O
unaffected VBN O
by IN O
these DT O
conditions NNS O
. . O

Retroviral JJ B-Gene
nucleocapsid NN I-Gene
proteins NNS I-Gene
( ( O
NCPs NNP B-Gene
) ) O
are VBP O
CCHC NNP B-Gene
- : I-Gene
type NN I-Gene
zinc NN I-Gene
finger NN I-Gene
proteins VBZ I-Gene
that IN O
mediate NN O
virion NN O
RNA NNP O
binding NN O
activities NNS O
associated VBN O
with IN O
retrovirus NN O
assembly NN O
and CC O
genomic JJ O
RNA NNP O
encapsidation NN O
. . O

They PRP O
correspond VBP O
to TO O
nucleotides VB O
equivalent JJ O
to TO O
base VB O
- : O
pair NN O
C1 NNP O
- : O
G72 NNP O
and CC O
discriminator NN O
base NN O
A73 NNP O
in IN O
the DT O
amino NN O
acid SYM O
- : O
acceptor NN O
branch NN O
of IN O
the DT O
molecule NN O
. . O

The DT O
protein NN O
expressed VBD O
from IN O
the DT O
cloned VBN O
cDNA NN O
is VBZ O
secreted VBN O
into IN O
the DT O
culture NN O
medium NN O
and CC O
yields NNS O
of IN O
up IN O
to TO O
40 CD O
mg NNS O
per IN O
litre NN O
have VBP O
been VBN O
obtained VBN O
. . O

Small JJ O
Maf NNP B-Gene
proteins NNS I-Gene
interact NN O
with IN O
the DT O
human JJ O
transcription NN O
factor NN O
TCF11 NNP B-Gene
/ NNP O
Nrf1 NNP B-Gene
/ NNP O
LCR NNP B-Gene
- : I-Gene
F1 NN I-Gene
. . O

Antithrombin NNP B-Gene
III NNP I-Gene
deficiency NN O
: : O
when WRB O
substitute NN O
, , O
when WRB O
heparin NN O
? . O

Thrombosis NNP O
ABC NNP O
, , O
3 CD O
: : O
The DT O
role NN O
of IN O
antithrombin NN B-Gene
III NNP I-Gene

Although IN O
no DT O
statistical JJ O
significance NN O
was VBD O
achieved VBN O
, , O
it PRP O
is VBZ O
remarkable JJ O
that IN O
there EX O
was VBD O
a DT O
clear JJ O
trend NN O
for IN O
the DT O
superiority NN O
of IN O
Galphimia NNP O
D6 NNP O
while IN O
the DT O
Galphimia NNP O
dilution NN O
10 CD O
( ( O
- : O
6 CD O
) ) O
was VBD O
about IN O
equally RB O
effective JJ O
compared VBN O
with IN O
placebo NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
a DT O
cDNA NN O
that WDT O
encodes VBZ O
a DT O
new JJ O
member NN O
of IN O
the DT O
GTPase NNP B-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
( ( O
GAP NNP B-Gene
) ) O
family NN O
of IN O
GTPase NNP B-Gene
regulators NNS O
. . O

The DT O
partial JJ O
ORF NNP O
was VBD O
found VBN O
to TO O
be VB O
identical JJ O
to TO O
the DT O
C NNP O
terminus NN O
of IN O
HrpJ2 NNP B-Gene
. . O

The DT O
partial JJ O
ORF NNP O
was VBD O
found VBN O
to TO O
be VB O
identical JJ O
to TO O
the DT O
C NNP O
terminus NN O
of IN O
HrpJ2 NNP B-Gene
. . O

The DT O
treatment NN O
of IN O
hydronephrosis NN O
in IN O
children NNS O

By IN O
adapting VBG O
a DT O
method NN O
for IN O
DNA NNP O
- : O
footprinting VBG O
using VBG O
impure JJ O
extracts NNS O
of IN O
ner NN B-Gene
overproducing VBG O
cells NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
determine VB O
that IN O
the DT O
ner NN B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
are VBP O
located VBN O
between IN O
nucleotides NNS O
1026 CD O
and CC O
1058 CD O
from IN O
the DT O
Mu NNP O
left VBD O
end NN O
. . O

The DT O
effects NNS O
of IN O
glutaraldehyde NN O
on IN O
dimensions NNS O
and CC O
ultrastructure NN O
of IN O
microvascular JJ O
beds NNS O
in IN O
rat NN O
mesentery NN O
were VBD O
studied VBN O
in IN O
two CD O
kinds NNS O
of IN O
experiment NN O
, , O
administering VBG O
the DT O
fixative JJ O
by IN O
intra JJ O
- : O
arterial JJ O
perfusion NN O
at IN O
a DT O
pressure NN O
of IN O
80 CD O
mm NNS O
Hg NNP O
and CC O
by IN O
superfusion NN O
of IN O
the DT O
exteriorized JJ O
mesenteric JJ O
membrane NN O
. . O

A DT O
surgical JJ O
technique NN O
for IN O
correcting VBG O
this DT O
problem NN O
is VBZ O
described VBN O
. . O

Drosophila NNP O
230 CD O
- : O
kD NN O
TFIID NNP B-Gene
subunit NN O
, , O
a DT O
functional JJ O
homolog NN O
of IN O
the DT O
human JJ O
cell NN O
cycle NN O
gene NN O
product NN O
, , O
negatively RB O
regulates VBZ O
DNA NNP O
binding NN O
of IN O
the DT O
TATA NNP B-Gene
box NN I-Gene
- : I-Gene
binding VBG I-Gene
subunit NN I-Gene
of IN I-Gene
TFIID NNP I-Gene
. . O

In IN O
HeLa NNP O
cells NNS O
, , O
the DT O
JNKK2 NNP B-Gene
- : O
JNK1 NNP B-Gene
fusion NN O
protein NN O
showed VBD O
significant JJ O
JNK NNP B-Gene
activity NN O
, , O
which WDT O
was VBD O
comparable JJ O
with IN O
that DT O
of IN O
JNK1 NNP B-Gene
activated VBN O
by IN O
many JJ O
stimuli NNS O
and CC O
activators NNS O
, , O
including VBG O
EGF NNP B-Gene
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
anisomycin NN O
, , O
UV NNP O
irradiation NN O
, , O
MEKK1 NNP B-Gene
, , O
and CC O
small JJ B-Gene
GTP NNP I-Gene
binding NN I-Gene
proteins NNS I-Gene
Rac1 NNP I-Gene
and CC O
Cdc42Hs NNP B-Gene
. . O

Incorporation NN O
of IN O
the DT O
polyene NN O
antibiotic JJ O
amphotericin NN O
B NNP O
( ( O
AMB NNP O
) ) O
in IN O
liposomes JJ O
results NNS O
in IN O
a DT O
marked JJ O
reduction NN O
in IN O
drug NN O
toxicity NN O
with IN O
no DT O
loss NN O
of IN O
antifungal JJ O
potency NN O
. . O

Pathways NNS O
linking VBG O
the DT O
olfactory NN O
bulbs NN O
with IN O
the DT O
medial JJ O
preoptic JJ O
anterior NN O
hypothalamus NN O
are VBP O
important JJ O
for IN O
intermale JJ O
aggression NN O
in IN O
mice NN O
. . O

There EX O
were VBD O
18 CD O
patients NNS O
with IN O
Group NNP O
II NNP O
( ( O
a DT O
) ) O
tumors NNS O
; : O
although IN O
tumor NN O
biopsy NN O
was VBD O
attempted VBN O
on IN O
eight CD O
of IN O
these DT O
, , O
pathological JJ O
diagnosis NN O
at IN O
the DT O
time NN O
of IN O
surgery NN O
was VBD O
made VBN O
in IN O
only RB O
one CD O
case NN O
. . O

The DT O
high JJ O
conservation NN O
of IN O
the DT O
3 CD O
' POS O
terminus NN O
suggests VBZ O
that IN O
this DT O
region NN O
directs VBZ O
the DT O
assembly NN O
of IN O
proteins NNS O
required VBN O
for IN O
the DT O
initiation NN O
of IN O
RNA NNP O
replication NN O
. . O

Vector NN O
stocks NNS O
containing VBG O
envelope NN B-Gene
proteins NNS I-Gene
from IN O
three CD O
different JJ O
SIVmac NNP O
clones NNS O
, , O
namely RB O
, , O
SIVmac239 NNP O
( ( O
T NNP O
- : O
lymphocyte NN O
tropic NN O
[ NNP O
T NNP O
- : O
tropic NN O
] NN O
) ) O
, , O
SIVmac316 NNP O
( ( O
macrophage NN O
tropic NN O
[ NNP O
M NNP O
- : O
tropic NN O
] NN O
) ) O
, , O
and CC O
SIVmac1A11 NNP O
( ( O
dualtropic NN O
) ) O
, , O
were VBD O
tested VBN O
. . O

The DT O
weight NN O
- : O
bearing NN O
surface NN O
of IN O
the DT O
PE NNP O
head NN O
became VBD O
smoother RB O
with IN O
time NN O
after IN O
THA NNP O
, , O
and CC O
the DT O
friction NN O
coefficient NN O
did VBD O
not RB O
differ VB O
significantly RB O
from IN O
that IN O
of IN O
an DT O
unused JJ O
PE NNP O
head NN O
. . O

The DT O
goal NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
determine VB O
the DT O
feasibility NN O
of IN O
retrovirus NN O
mediated VBN O
expression NN O
of IN O
rp47phox NN B-Gene
in IN O
the DT O
HL60 NNP O
and CC O
U937 NNP O
human JJ O
hematopoietic NN O
cell NN O
lines NNS O
, , O
and CC O
in IN O
an DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
transformed VBD O
B NNP O
- : O
lymphocyte NN O
cell NN O
line NN O
( ( O
EBV NNP O
- : O
BCL NNP O
) ) O
derived VBD O
from IN O
a DT O
p47phox NN B-Gene
- : O
deficient NN O
CGD NNP O
patient NN O
. . O

With IN O
respect NN O
to TO O
the DT O
distribution NN O
of IN O
active JJ O
MREs NNP O
over IN O
the DT O
promoter NN O
region NN O
, , O
the DT O
hMT NN B-Gene
- : I-Gene
IIA NNP I-Gene
gene NN I-Gene
is VBZ O
largely RB O
different JJ O
from IN O
the DT O
mouse NN O
metallothionein SYM B-Gene
- : I-Gene
I PRP I-Gene
gene NN I-Gene
, , O
suggesting VBG O
that IN O
MRE NNP O
arrangement NN O
is VBZ O
not RB O
an DT O
important JJ O
factor NN O
for IN O
metal NN O
regulation NN O
. . O

Re NN O
: : O
A DT O
modified JJ O
method NN O
for IN O
the DT O
in IN O
vivo JJ O
labeling NN O
of IN O
red JJ O
blood NN O
cells NNS O
with IN O
Tc NNP O
- : O
99m CD O
. . O

Object JJ O
relations NNS O
, , O
affect JJ O
management NN O
, , O
and CC O
psychic JJ O
structure NN O
formation NN O
. . O

Atheroma NNP O
appears VBZ O
as IN O
a DT O
very RB O
low JJ O
signal NN O
intensity NN O
area NN O
on IN O
2 CD O
- : O
dimensional JJ O
time NN O
- : O
of IN O
- : O
flight NN O
( ( O
TOF NNP O
) ) O
magnetic JJ O
resonance NN O
( ( O
MR NNP O
) ) O
images VBZ O
, , O
and CC O
its PRP$ O
components NNS O
have VBP O
various JJ O
signal JJ O
intensities NNS O
on IN O
spin NN O
- : O
echo NN O
( ( O
SE NNP O
) ) O
images NNS O
. . O

The DT O
yeast JJ O
silent JJ B-Gene
information NN I-Gene
regulator NN I-Gene
Sir4p NNP I-Gene
anchors NNS O
and CC O
partitions NNS O
plasmids NNS O
. . O

The DT O
zona NN O
pellucida NN O
( ( O
ZP NNP O
) ) O
, , O
the DT O
extracellular JJ O
glycocalyx NN O
that WDT O
surrounds VBZ O
the DT O
oocyte NN O
, , O
is VBZ O
well RB O
known VBN O
to TO O
mediate VB O
homologous JJ O
gamete JJ O
interaction NN O
. . O

However RB O
, , O
C3 NNP B-Gene
toxin NN I-Gene
alone RB O
or CC O
in IN O
combination NN O
with IN O
growth NN O
factors NNS O
did VBD O
not RB O
stimulate VB O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
: : O
Luc JJ B-Gene
activity NN O
and CC O
actually RB O
antagonized VBD O
the DT O
synergistic JJ O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
: : O
Luc NNP B-Gene
observed VBD O
in IN O
response NN O
to TO O
co VB O
- : O
stimulation NN O
with IN O
growth NN O
factors NNS O
and CC O
Ro NNP O
- : O
31 CD O
- : O
8220 CD O
. . O

This DT O
indicates VBZ O
that IN O
the DT O
mechanism NN O
by IN O
which WDT O
CX NNP O
blocks VBZ O
rapid JJ O
degradation NN O
of IN O
tubulin NN B-Gene
mRNA NN I-Gene
in IN O
vivo NN O
is VBZ O
not RB O
simply RB O
by IN O
preventing VBG O
its PRP$ O
translation NN O
and CC O
suggests VBZ O
the DT O
involvement NN O
of IN O
an DT O
altered JJ O
trans NNS O
- : O
factor NN O
. . O

Metabolism NN O
of IN O
calcium NN O
and CC O
vitamin NN O
D3 NNP O
in IN O
patients NNS O
with IN O
acute JJ O
tubulointerstitial JJ O
nephritis NN O
: : O
a DT O
study NN O
of IN O
41 CD O
patients NNS O
with IN O
nephropathia JJ O
epidemica NN O
. . O

Eliminating VBG O
any DT O
subset NN O
of IN O
ASCUS NNP O
reduces VBZ O
the DT O
ASCUS NNP O
/ NNP O
SIL NNP O
ratio NN O
but CC O
also RB O
significantly RB O
diminishes VBZ O
the DT O
sensitivity NN O
of IN O
the DT O
Papanicolaou NNP O
test NN O
. . O

The DT O
other JJ O
patients NNS O
continued VBD O
the DT O
trial NN O
with IN O
single JJ O
daily JJ O
doses NNS O
of IN O
monotherapy NN O
. . O

Thirty NNP O
- : O
five CD O
strains NNS O
of IN O
Legionnaires NNP O
' POS O
disease NN O
bacteria NNS O
were VBD O
shown VBN O
to TO O
belong VB O
in IN O
four CD O
distinct JJ O
serologic NN O
groups NNS O
on IN O
the DT O
basis NN O
of IN O
findings NNS O
obtained VBN O
with IN O
direct JJ O
fluorescent NN O
antibody NN O
testing VBG O
. . O

Mapping NN O
of IN O
RNA NNP O
- : O
temperature NN B-Gene
- : I-Gene
sensitive JJ I-Gene
mutants NNS I-Gene
of IN I-Gene
Sindbis NNP I-Gene
virus NN I-Gene
: : I-Gene
complementation NN I-Gene
group NN I-Gene
F NNP I-Gene
mutants NNS I-Gene
have VBP O
lesions NNS O
in IN O
nsP4 NN B-Gene
. . O

Interestingly RB O
, , O
this DT O
amino NN O
- : O
terminal NN O
determinant NN O
appears VBZ O
not RB O
to TO O
reside VB O
in IN O
the DT O
HSV NNP O
- : O
alpha NN B-Gene
TIF NNP I-Gene
, , O
which WDT O
displays VBZ O
no DT O
independent JJ O
amino NN O
- : O
terminal JJ O
activity NN O
. . O

A DT O
comparison NN O
of IN O
the DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
p54 JJ B-Gene
gene NN I-Gene
carried VBN O
by IN O
two CD O
virulent NN O
ASFV NNP O
strains NNS O
( ( O
E70 NNP O
and CC O
E75 NNP O
) ) O
with IN O
that DT O
obtained VBN O
from IN O
virus NN O
Ba71V NNP O
showed VBD O
100 CD O
% NN O
similarity NN O
. . O

The DT O
fibrinogen NN B-Gene
, , O
serum NN O
proteins NNS O
, , O
sodium NN O
heparin NN O
and CC O
membrane NN O
contributed VBD O
to TO O
Cm NNP O
by IN O
20 CD O
% NN O
, , O
14 CD O
% NN O
, , O
2 CD O
% NN O
and CC O
64 CD O
% NN O
, , O
respectively RB O
. . O

A DT O
MEK NNP B-Gene
- : O
specific JJ O
inhibitor NN O
( ( O
PD098059 NNP O
) ) O
( ( O
Dudley NNP O
, , O
D NNP O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
interaction NN O
of IN O
eIF4A NN B-Gene
with IN O
the DT O
middle JJ O
region NN O
of IN O
eIF4GI NN B-Gene
is VBZ O
necessary JJ O
for IN O
translation NN O
, , O
whereas IN O
the DT O
interaction NN O
of IN O
eIF4A NN B-Gene
with IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
plays VBZ O
a DT O
modulatory JJ O
role NN O
. . O

Marked JJ O
elevation NN O
of IN O
creatine JJ B-Gene
kinase NN I-Gene
was VBD O
observed VBN O
while IN O
serum NN O
albumin NN B-Gene
, , O
immunoglobulin NN B-Gene
, , O
and CC O
complement NN O
were VBD O
decreased VBN O
. . O

Plasma NNP B-Gene
secretin NN I-Gene
levels NNS O
also RB O
augmented VBD O
after IN O
the DT O
administration NN O
of IN O
ethanol JJ O
solutions NNS O
, , O
with IN O
a DT O
delay NN O
of IN O
about IN O
one CD O
hour NN O
after IN O
the DT O
onset NN O
of IN O
acid JJ O
secretion NN O
. . O

Characterization NN O
of IN O
these DT O
R NNP O
subunits NNS O
by IN O
their PRP$ O
8 CD O
- : O
azido NN O
- : O
cAMP NN O
photoaffinity NN O
labeling NN O
and CC O
immunoreactivity NN O
, , O
as RB O
well RB O
as IN O
by IN O
a DT O
phosphorylation NN O
- : O
dependent JJ O
mobility NN O
shift NN O
on IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
( ( O
SDS NNP O
- : O
PAGE NN O
) ) O
, , O
indicated VBD O
subunit NN O
sizes NNS O
of IN O
RII NNP B-Gene
beta NN I-Gene
( ( O
53 CD O
kDa NN O
) ) O
greater JJR O
than IN O
RII NNP B-Gene
alpha JJ I-Gene
dephosphoform NN O
( ( O
51 CD O
kDa NN O
) ) O
greater JJR O
than IN O
RI NNP B-Gene
alpha NN I-Gene
( ( O
49 CD O
kDa NN O
) ) O
. . O

Platelet NNP B-Gene
activating VBG I-Gene
factor NN I-Gene
was VBD O
given VBN O
in IN O
six CD O
doses NNS O
at IN O
15 CD O
minute NN O
intervals NNS O
and CC O
airway JJ O
response NN O
measured VBD O
as IN O
change NN O
in IN O
partial JJ O
expiratory NN O
flow NN O
at IN O
30 CD O
% NN O
of IN O
vital JJ O
capacity NN O
( ( O
Vp30 NNP O
) ) O
. . O

The DT O
CNXA NNP O
domain NN O
is VBZ O
similar JJ O
at IN O
the DT O
amino NN O
acid VBP O
level NN O
to TO O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
moaA NN I-Gene
gene NN I-Gene
product NN I-Gene
, , O
while IN O
CNXC NNP O
is VBZ O
similar JJ O
to TO O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
moaC JJ I-Gene
product NN I-Gene
, , O
with IN O
both DT O
E NNP O
. . O
coli NN O
products NNS O
encoded VBN O
by IN O
different JJ O
cistrons NNS O
. . O

However RB O
, , O
a DT O
cosmid NN O
clone NN O
containing VBG O
the DT O
entire JJ O
mouse NN B-Gene
alpha NN I-Gene
1 CD I-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
gene NN I-Gene
, , O
including VBG O
3 CD O
. . O
7 CD O
kb NN O
of IN O
5 CD O
' POS O
- : O
and CC O
4 CD O
kb NN O
of IN O
3 CD O
' POS O
- : O
flanking NN O
DNA NN O
, , O
was VBD O
expressed VBN O
at IN O
reduced JJ O
levels NNS O
in IN O
fibroblasts NNS O
overexpressing VBG O
oncogenic JJ B-Gene
ras NNS I-Gene
. . O

The DT O
tramtrack NN B-Gene
( ( O
ttk NN B-Gene
) ) O
gene NN O
of IN O
Drosophila NNP O
encodes VBZ O
69 CD O
- : O
kDa NN O
and CC O
88 CD O
- : O
kDa NN O
proteins VBZ O
through IN O
alternative JJ O
splicing NN O
of IN O
the DT O
primary JJ O
ttk NN B-Gene
transcript NN I-Gene
. . O

The DT O
optimum NN O
technique NN O
for IN O
the DT O
pathological JJ O
examination NN O
of IN O
sentinel NN O
lymph NN O
nodes NNS O
( ( O
SLNs NNP O
) ) O
is VBZ O
still RB O
under IN O
debate NN O
. . O

RESULTS NN O
: : O
Auditory JJ O
thresholds NNS O
collected VBN O
during IN O
audiometric JJ O
tests NNS O
increased VBD O
gradually RB O
in IN O
proportion NN O
with IN O
age NN O
, , O
especially RB O
in IN O
the DT O
hypertensive JJ O
group NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
. . O

Investigation NN O
on IN O
the DT O
exchange NN O
of IN O
Ca45 NNP O
in IN O
intact JJ O
and CC O
burned VBN O
rats NNS O
by IN O
the DT O
kinetic JJ O
analysis NN O
method NN O

Osteocalcin NNP B-Gene
( ( O
and CC O
urinary JJ O
hydroxyproline NN O
) ) O
were VBD O
not RB O
elevated VBN O
in IN O
isolated JJ O
hyperphosphatasaemia NN O
, , O
indicating VBG O
that IN O
mechanisms VBZ O
other JJ O
than IN O
increased VBN O
bone NN O
turnover NN O
may MD O
account VB O
for IN O
the DT O
markedly RB O
elevated JJ O
serum NN B-Gene
alkaline JJ I-Gene
phosphatase NN I-Gene
activity NN O
in IN O
these DT O
subjects NNS O
. . O

Space NN O
limitations NNS O
prevent VBP O
an DT O
exhaustive JJ O
review NN O
of IN O
all DT O
biologic JJ O
pharmaceuticals NNS O
, , O
such JJ O
as IN O
tissue NN B-Gene
plasminogen NN I-Gene
activating VBG I-Gene
substance NN I-Gene
, , O
hormones NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
thyroid JJ O
, , O
insulin NN B-Gene
, , O
growth NN B-Gene
hormone NN I-Gene
, , O
erythropoietin NN B-Gene
) ) O
, , O
clotting VBG O
factors NNS O
, , O
and CC O
blood NN O
products NNS O
. . O

Critique NNP O
of IN O
"""" NNP O
Interactive NNP O
Effects NNPS O
of IN O
Test NNP O
Anxiety NNP O
and CC O
Credit NNP O
/ NNP O
No NNP O
Credit NNP O
or CC O
A NNP O
- : O
F NNP O
Grade NNP O
Condition NNP O
upon IN O
Short NNP O
- : O
term NN O
and CC O
Long NNP O
- : O
term NN O
Recall NNP O
of IN O
Course NNP O
Information NNP O
. . O

Acquired VBN O
bile JJ O
duct NN O
blockage NN O
: : O
entry NN O
of IN O
hepatobiliary JJ O
agent NN O
into IN O
an DT O
intrahepatic JJ O
abscess NN O
. . O

Reduced VBN O
NK NNP O
activity NN O
correlates VBZ O
with IN O
active JJ O
disease NN O
in IN O
HIV NNP O
- : O
patients NNS O
with IN O
multidrug JJ O
- : O
resistant JJ O
pulmonary JJ O
tuberculosis NN O
. . O

A DT O
cytosolic JJ O
variant NN O
of IN O
the DT O
protein NN O
underwent JJ O
efficient JJ O
transphosphorylation NN O
, , O
yet RB O
failed VBN O
to TO O
activate VB O
appreciably RB O
either DT O
p70 NN B-Gene
( ( O
S6k NNP B-Gene
) ) O
or CC O
MAP NNP B-Gene
kinase NN I-Gene
following VBG O
treatment NN O
with IN O
FK1012 NNP O
. . O

Using VBG O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
Whipple NNP O
- : O
specific JJ O
DNA NNP O
fragments NNS O
of IN O
284 CD O
base NN O
pairs NN O
from IN O
the DT O
genome NN O
of IN O
the DT O
Whipple NNP O
bacterium NN O
( ( O
Tropheryma NNP O
whippelii NN O
) ) O
were VBD O
demonstrated VBN O
. . O

Haemodynamic JJ O
responses NNS O
to TO O
antagonism NN O
of IN O
bocurarine NN O
block NN O
with IN O
atropine JJ O
- : O
neostigmine JJ O
mixture NN O
in IN O
children NNS O
. . O

His PRP$ O
carnitine NN B-Gene
palmitoyltransferase NN I-Gene
( ( I-Gene
CPT NNP I-Gene
) ) I-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
activities NNS O
were VBD O
0 CD O
. . O
6 CD O
and CC O
0 CD O
. . O
12 CD O
nmol JJ O
/ NNP O
min NN O
/ NNP O
mg NN O
protein NN O
, , O
as IN O
compared VBN O
with IN O
a DT O
mean JJ O
value NN O
of IN O
0 CD O
. . O
22 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
14 CD O
and CC O
0 CD O
. . O
27 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
nmol JJ O
/ NNP O
min NN O
/ NNP O
mg NN O
protein NN O
, , O
respectively RB O
, , O
in IN O
control NN O
subjects NNS O
. . O

This DT O
study NN O
represents VBZ O
the DT O
first JJ O
published VBN O
long RB O
- : O
term NN O
follow SYM O
- : O
up RB O
regarding VBG O
this DT O
mode NN O
of IN O
treatment NN O
in IN O
patients NNS O
with IN O
alveolar JJ O
hypoventilation NN O
. . O

The DT O
relationships NNS O
between IN O
the DT O
partial JJ O
pressures NNS O
of IN O
O2 NNP O
and CC O
CO2 NNP O
as RB O
well RB O
as IN O
between IN O
their PRP$ O
gradients NNS O
, , O
become VBN O
stronger NN O
with IN O
the DT O
increase NN O
of IN O
the DT O
ventilation NN O
- : O
perfusion NN O
ratio NN O
. . O

We PRP O
have VBP O
recently RB O
shown VBN O
that IN O
the DT O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
RAR NNP B-Gene
beta NN I-Gene
2 CD I-Gene
gene NN I-Gene
in IN I-Gene
mouse NN I-Gene
embryos NN I-Gene
is VBZ O
regulated VBN O
at IN O
the DT O
translational JJ O
level NN O
by IN O
short JJ O
upstream NN O
open JJ O
reading NN O
frames NNS O
( ( O
uORFs JJ O
) ) O
In IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
( ( O
Zimmer NNP O
, , O
A NNP O
. . O
, , O
A DT O
. . O
M NNP O
. . O

The DT O
presence NN O
of IN O
type NN O
I PRP O
hypersensitivity VBP O
in IN O
a DT O
subgroup NN O
of IN O
aspergillomas NN O
suggests VBZ O
an DT O
immunoallergic JJ O
component NN O
to TO O
this DT O
disease NN O
which WDT O
could MD O
contribute VB O
to TO O
a DT O
chronic JJ O
inflammatory NN O
response NN O
to TO O
Aspergillus NNP O
in IN O
some DT O
aspergillomas NN O
. . O

Angiography NN O
of IN O
aneurysmal JJ O
bone NN O
cyst NN O
. . O

Although IN O
Grice NNP O
' POS O
s NN O
operation NN O
has VBZ O
been VBN O
used VBN O
all DT O
over IN O
the DT O
world NN O
, , O
no DT O
systematic JJ O
account NN O
of IN O
it PRP O
has VBZ O
been VBN O
found VBN O
in IN O
the DT O
literature NN O
( ( O
including VBG O
publications NNS O
dealing VBG O
with IN O
technique NN O
) ) O
, , O
which WDT O
presents VBZ O
it PRP O
in IN O
terms NNS O
related VBN O
to TO O
the DT O
basic JJ O
"""" NNP O
classical JJ O
"""" NNP O
principles NNS O
on IN O
which WDT O
the DT O
operation NN O
was VBD O
conceived VBN O
. . O

Chernoff NNP O
, , O
submitted VBD O
for IN O
publication NN O
) ) O
. . O

Testing VBG O
for IN O
serum NN B-Gene
IgM NNP I-Gene
binding NN O
to TO O
GM1 NNP O
ganglioside NN O
in IN O
clinical JJ O
practice NN O
. . O

Breast NNP O
cancer NN O
risk NN O
assessment NN O
: : O
Who WP O
holds VBZ O
the DT O
magic JJ O
crystal NN O
ball NN O
? . O

This DT O
study NN O
demonstrated VBD O
that IN O
the DT O
PFA NNP O
- : O
100 CD O
analyzer NN O
can MD O
accurately RB O
assess VB O
vWF SYM B-Gene
- : O
dependent JJ O
platelet NN O
function NN O
and CC O
detect VB O
other JJ O
platelet NN O
defects NNS O
under IN O
high JJ O
shear JJ O
stress NN O
in IN O
complex JJ O
patient NN O
populations NNS O
. . O

However RB O
, , O
after IN O
PRK NNP O
at IN O
5 CD O
weeks NNS O
of IN O
age NN O
, , O
partial JJ O
retreatment NN O
may MD O
be VB O
necessary JJ O
due JJ O
to TO O
regression NN O
of IN O
the DT O
PRK NNP O
effect NN O
. . O

Invertases NNS B-Gene
are VBP O
responsible JJ O
for IN O
the DT O
breakdown NN O
of IN O
sucrose NN O
to TO O
fructose VB O
and CC O
glucose VB O
. . O

Clinical JJ O
evaluation NN O
of IN O
the DT O
Allergan NNP O
Humphrey NNP O
500 CD O
autorefractor NN O
and CC O
the DT O
Nidek NNP O
AR NNP O
- : O
1000 CD O
autorefractor NN O
. . O

Rhesus NNP O
macaques NNS O
and CC O
BALB NNP O
/ NNP O
c NN O
mice NN O
inoculated VBN O
with IN O
the DT O
Mengo NNP O
virus NN O
SIV NNP O
recombinants NNS O
failed VBD O
to TO O
develop VB O
CTL NNP O
responses NNS O
against IN O
the DT O
SIV NNP O
gene NN O
products NNS O
, , O
while IN O
one CD O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
Nef NN I-Gene
recombinants NNS I-Gene
induced VBD O
a DT O
weak JJ O
CTL NNP O
response NN O
in IN O
mice NN O
directed VBD O
to TO O
an DT O
HIV1 NNP B-Gene
Nef NNP I-Gene
peptide IN I-Gene
spanning VBG O
positions NNS O
182 CD O
- : O
198 CD O
. . O

In IN O
contrast NN O
, , O
mutations NNS O
affecting VBG O
the DT O
other JJ O
two CD O
Nim1p NNP B-Gene
- : I-Gene
related JJ I-Gene
kinases NNS I-Gene
in IN O
S NNP O
. . O
cerevisiae NN O
, , O
Hsl1p NNP B-Gene
and CC O
Kcc4p NNP B-Gene
, , O
produce VBP O
no DT O
detectable JJ O
effect NN O
on IN O
septin NN B-Gene
organization NN O
. . O

Triton NNP O
- : O
disrupted VBD O
cells NNS O
retained VBN O
capacity NN O
for IN O
activation NN O
of IN O
the DT O
pathway NN O
by IN O
both DT O
peptide JJ O
growth NN O
factors NNS O
and CC O
by IN O
addition NN O
of IN O
GTP NNP O
- : O
loaded VBD O
p21 JJ B-Gene
rasVal12 NN B-Gene
. . O

A DT O
miracle NN O
cure NN O
and CC O
its PRP$ O
solution NN O

In IN O
a DT O
prospective JJ O
randomized NN O
study NN O
, , O
287 CD O
patients NNS O
with IN O
advanced JJ O
non JJ O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
( ( O
NSCLC NNP O
) ) O
stage NN O
IIIb NNP O
or CC O
IV NNP O
with IN O
ECOG NNP O
performance NN O
status NN O
( ( O
PS NNP O
) ) O
0 CD O
- : O
1 CD O
or CC O
2 CD O
were VBD O
randomly RB O
assigned VBN O
to TO O
receive VB O
either RB O
best RBS O
supportive JJ O
care NN O
( ( O
BSC NNP O
) ) O
or CC O
supportive JJ O
care NN O
plus CC O
combination NN O
chemotherapy NN O
( ( O
IEP JJ O
regimen NNS O
: : O
ifosfamide RB O
3 CD O
gm NNS O
/ JJ O
m2 NNS O
IV NNP O
with IN O
mesna JJ O
uroprotection NN O
, , O
epirubicin VBZ O
60 CD O
mg NN O
/ NNP O
m2 NN O
IV NNP O
on IN O
day NN O
1 CD O
and CC O
cisplatin VB O
60 CD O
mg NN O
/ NNP O
m2 NN O
IV NNP O
on IN O
day NN O
2 CD O
; : O
or CC O
MVP NNP O
regimen NNS O
: : O
mitomycin NN O
- : O
C $ O
8 CD O
mg NN O
/ NNP O
m2 NN O
, , O
cisplatin NN O
100 CD O
mg NN O
/ NNP O
m2 NN O
IV NNP O
on IN O
day NN O
1 CD O
, , O
vinblastine NN O
4 CD O
mg NN O
/ NNP O
m2 NN O
IV NNP O
on IN O
days NNS O
1 CD O
and CC O
15 CD O
) ) O
. . O

Online JJ O
teaching NN O
: : O
design NN O
and CC O
techniques NNS O
. . O

In IN O
myometrial JJ O
SMC NNP O
, , O
both DT O
isoforms NNS O
of IN O
the DT O
progesterone NN B-Gene
receptor NN I-Gene
, , O
PR NNP B-Gene
- : I-Gene
B NN I-Gene
and CC O
PR NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
caused VBD O
a DT O
ligand NN O
- : O
dependent JJ O
activation NN O
of IN O
PGDH NNP B-Gene
- : I-Gene
2368 CD I-Gene
/ NN O
luc3 NN B-Gene
. . O

Carcinoembryonic JJ B-Gene
antigen NN I-Gene
( ( O
CEA NNP B-Gene
) ) O
procedures NNS O
and CC O
clinical JJ O
evaluation NN O
. . O

Comparative JJ O
studies NNS O
of IN O
the DT O
antithrombin JJ B-Gene
III NNP I-Gene
level NN O
and CC O
plasminogen NN B-Gene
activator NN I-Gene
activity NN O
in IN O
patients NNS O
with IN O
thrombophlebitis NN O

Human NNP B-Gene
rIL VBZ I-Gene
- : I-Gene
3 CD I-Gene
expressed VBN O
in IN O
COS7 NNP O
cells NNS O
has VBZ O
multipotential JJ O
CSF NNP B-Gene
activity NN O
in IN O
semisolid JJ O
cultures NNS O
of IN O
bone NN O
marrow NN O
cells NNS O
, , O
and CC O
selectively RB O
induced VBD O
the DT O
proliferation NN O
of IN O
My NNP O
- : O
10 CD O
+ JJ O
marrow NN O
or CC O
cord NN O
blood NN O
cells NNS O
in IN O
liquid NN O
cultures NNS O
. . O

The DT O
plasmid NN O
shuffle NN O
technique NN O
was VBD O
used VBN O
to TO O
replace VB O
the DT O
wild JJ O
- : O
type NN O
gene NN O
with IN O
the DT O
mutant JJ O
form NN O
, , O
resulting VBG O
in IN O
failure NN O
of IN O
the DT O
yeast NN O
cells NNS O
to TO O
grow VB O
. . O

Increased VBN O
urinary JJ O
riboflavin NN O
excretion NN O
resulting VBG O
from IN O
boric JJ O
acid NN O
ingestion NN O
. . O

The DT O
VirR NNP B-Gene
response NN I-Gene
regulator NN I-Gene
from IN O
Clostridium NNP O
perfringens VBZ O
binds NNS O
independently RB O
to TO O
two CD O
imperfect JJ O
direct JJ O
repeats NNS O
located VBN O
upstream NN O
of IN O
the DT O
pfoA NN B-Gene
promoter NN I-Gene
. . O

Grade $ O
3 CD O
- : O
4 CD O
mucositis NN O
was VBD O
present JJ O
in IN O
13 CD O
% NN O
of IN O
the DT O
cycles NNS O
. . O

Similarly RB O
, , O
expression NN O
of IN O
a DT O
transiently RB O
transfected VBN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
prothymosin NN I-Gene
alpha RB I-Gene
gene NN I-Gene
as IN O
the DT O
reporter NN O
was VBD O
not RB O
affected VBN O
by IN O
a DT O
repertoire NN O
of IN O
myc JJ B-Gene
- : I-Gene
derived VBN I-Gene
genes NNS I-Gene
, , O
including VBG O
myc NN B-Gene
itself PRP O
and CC O
dominant VB O
or CC O
recessive VB O
negative JJ O
myc NN B-Gene
mutants NNS I-Gene
. . O

Transabdominal NNP O
repair NN O
of IN O
type NN O
IV NNP O
thoraco SYM O
- : O
abdominal JJ O
aortic JJ O
aneurysms NNS O
. . O

Although IN O
L NNP O
- : O
threo NN O
- : O
dihydroxyphenylserine NN O
( ( O
DOPS NNP O
) ) O
, , O
an DT O
artificial JJ O
norepinephrine NN O
( ( O
NE NNP O
) ) O
precursor NN O
, , O
did VBD O
not RB O
change VB O
immobility NN O
in IN O
intact JJ O
mice NN O
, , O
DOPS NNP O
significantly RB O
reduced VBD O
immobility NN O
in IN O
mice NN O
pretreated VBN O
with IN O
the DT O
selective JJ O
NE NNP O
neurotoxin NN O
DSP4 NNP O
. . O

It PRP O
consists VBZ O
of IN O
2185 CD O
amino NN O
acid NN O
residues NNS O
encoded VBN O
by IN O
a DT O
9 CD O
- : O
kilobase NN O
pair NN O
mRNA NN O
; : O
several JJ O
splice NN O
variants NNS O
have VBP O
been VBN O
detected VBN O
in IN O
human JJ O
and CC O
rat NN O
cDNA NN O
libraries NNS O
. . O

This DT O
animal JJ O
model NN O
of IN O
dystonia NN O
appears VBZ O
to TO O
be VB O
a DT O
model NN O
of IN O
NAD NNP O
in IN O
man NN O
from IN O
the DT O
viewpoint NN O
of IN O
treatment NN O
- : O
response NN O
. . O

Fibrin NNP B-Gene
gels NNS O
and CC O
their PRP$ O
possible JJ O
implication NN O
for IN O
surface NN O
hemorheology NN O
in IN O
health NN O
and CC O
disease NN O
. . O

A DT O
mutant JJ O
form NN O
of IN O
Vps1p NNP B-Gene
lacking VBG O
the DT O
entire JJ O
GTP NNP O
- : O
binding NN O
domain NN O
interfered VBD O
with IN O
vacuolar JJ O
protein NN O
sorting VBG O
in IN O
wild JJ O
- : O
type NN O
cells NNS O
. . O

In IN O
budding VBG O
yeast NN O
, , O
this DT O
latter JJ O
checkpoint NN O
response NN O
involves VBZ O
the DT O
proteins NNS O
Mad1 NNP B-Gene
, , I-Gene
2 CD I-Gene
, , I-Gene
3 CD I-Gene
, , O
Bub1 NNP B-Gene
and CC O
Bub3 NNP B-Gene
, , O
whose WP$ O
vertebrate NN O
counterparts NNS O
localize VBP O
to TO O
unattached JJ O
kinetochores NNS O
. . O

Sequence NNP O
comparisons NNS O
of IN O
prokaryotic JJ B-Gene
RCR NNP I-Gene
initiators NNS I-Gene
has VBZ O
revealed VBN O
a DT O
set NN O
of IN O
three CD O
common JJ O
motifs NNS O
, , O
two CD O
of IN O
which WDT O
, , O
a DT O
putative JJ O
metal NN O
coordination NN O
site NN O
and CC O
a DT O
downstream NN O
active JJ O
- : O
site NN O
tyrosine NN O
motif NN O
, , O
could MD O
be VB O
tentatively RB O
identified VBN O
in IN O
parvoviral JJ B-Gene
replicator NN I-Gene
proteins NNS I-Gene
. . O

This DT O
investigation NN O
was VBD O
undertaken VBN O
to TO O
determine VB O
whether IN O
consuming VBG O
several JJ O
small JJ O
feedings NNS O
of IN O
preexercise NN O
carbohydrate NN O
( ( O
CHO NNP O
) ) O
, , O
rather RB O
than IN O
a DT O
single JJ O
bolus NN O
, , O
would MD O
affect VB O
blood NN O
glucose NN O
and CC O
insulin NN B-Gene
responses NNS O
during IN O
rest NN O
and CC O
exercise NN O
. . O

Using VBG O
the DT O
two CD O
- : O
hybrid NN O
system NN O
, , O
we PRP O
show VBP O
that IN O
nonprenylated JJ O
Rac1 NNP B-Gene
interacts VBZ O
very RB O
weakly JJ O
with IN O
Rho NNP B-Gene
- : I-Gene
GDI NNP I-Gene
, , O
pointing VBG O
to TO O
the DT O
predominant JJ O
role NN O
of IN O
protein FW O
- : O
isoprene NN O
interaction NN O
in IN O
complex JJ O
formation NN O
. . O

Thus RB O
, , O
SOX8 NNP B-Gene
is VBZ O
a DT O
good JJ O
candidate NN O
gene NN O
contributing VBG O
to TO O
the DT O
mental JJ O
retardation NN O
phenotype NN O
seen VBN O
in IN O
ATR NNP O
- : O
16 CD O
patients NNS O
. . O

Among IN O
eight CD O
graminaceous JJ O
species NNS O
tested VBN O
, , O
Ids3 NNP B-Gene
expression NN O
was VBD O
observed VBN O
only RB O
in IN O
Fe NNP O
- : O
deficient JJ O
roots NNS O
of IN O
H NNP O
. . O
vulgare NN O
and CC O
Secale NNP O
cereale NN O
. . O
which WDT O
not RB O
only RB O
secrete JJ O
2 CD O
' POS O
- : O
deoxymugineic NN O
acid NN O
( ( O
DMA NNP O
) ) O
, , O
but CC O
also RB O
mugineic JJ O
acid NN O
( ( O
MA NNP O
) ) O
and CC O
3 CD O
- : O
epihydroxymugineic NN O
acid NN O
( ( O
epiHMA JJ O
, , O
H NNP O
. . O
vulgare NN O
) ) O
, , O
and CC O
3 CD O
- : O
hydroxymugineic NN O
acid NN O
( ( O
HMA NNP O
, , O
S NNP O
. . O
cereale NN O
) ) O
. . O

To TO O
elucidate VB O
whether IN O
potential JJ O
endocrine NN O
changes NNS O
resulted VBD O
from IN O
acute JJ O
hypoxaemia NN O
alone RB O
, , O
the DT O
underlying JJ O
disease NN O
, , O
or CC O
unspecific JJ O
influences NNS O
connected VBN O
with IN O
the DT O
ICU NNP O
setting NN O
, , O
all DT O
measurements NNS O
were VBD O
compared VBN O
to TO O
those DT O
of IN O
a DT O
completely RB O
healthy JJ O
reference NN O
group NN O
( ( O
REF NNP O
) ) O
with IN O
comparable JJ O
acute JJ O
experimental JJ O
hypoxaemia NN O
. . O

Coexpression NN O
of IN O
mouse NN O
PKR NNP B-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
515 CD I-Gene
) ) I-Gene
WT NNP I-Gene
as IN O
a DT O
Gal4 NNP B-Gene
DNA NNP O
- : O
binding NN O
domain NN O
fusion NN O
with IN O
either CC O
the DT O
catalytic JJ O
- : O
deficient NN O
human JJ O
PKR NNP B-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
551 CD I-Gene
) ) I-Gene
K296R NNP O
mutant NN O
, , O
the DT O
RNA NNP O
- : O
binding VBG O
- : O
deficient NN O
human JJ O
PKR NNP B-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
551 CD I-Gene
) ) I-Gene
K64E NNP I-Gene
/ NNP I-Gene
K296R NNP I-Gene
double JJ O
mutant NN O
, , O
or CC O
wild SYM O
- : O
type NN O
mouse NN O
PKR NNP B-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
515 CD I-Gene
) ) I-Gene
WT NNP I-Gene
as IN O
full JJ O
- : O
length NN O
PKR NNP B-Gene
- : O
Gal4 NNP B-Gene
activation NN O
domain NN O
fusions NNS O
resulted VBD O
in IN O
activation NN O
of IN O
the DT O
HIS3 NNP B-Gene
and CC O
lacZ JJ B-Gene
reporters NNS O
. . O

Fraction NN O
2 CD O
contains VBZ O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2 CD O
- : O
vitamin NN O
D3 NNP O
, , O
vitamin NN O
D3 NNP O
, , O
25 CD O
( ( O
OH NNP O
) ) O
- : O
vitamin NN O
D3 NNP O
and CC O
1 CD O
, , O
24 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
3 CD O
- : O
vitamin NN O
D3 NNP O
. . O

While IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
does VBZ O
not RB O
alter VB O
the DT O
mitogen NN O
- : O
induced JJ O
expression NN O
and CC O
abundance NN O
of IN O
G1 NNP O
phase NN O
cyclin NN B-Gene
D1 NNP I-Gene
and CC O
cdks VB B-Gene
4 CD I-Gene
and CC I-Gene
2 CD I-Gene
in IN O
MCs NNP O
, , O
it PRP O
inhibits VBZ O
cyclin NN B-Gene
E NNP I-Gene
- : O
cdk NN B-Gene
2 CD I-Gene
activity NN O
, , O
thus RB O
preventing VBG O
mitogen NN O
- : O
elicited VBN O
phosphorylation NN O
and CC O
inactivation NN O
of IN O
pRb NN B-Gene
in IN O
G1 NNP O
phase NN O
and CC O
transition NN O
to TO O
S NNP O
phase NN O
. . O

A DT O
human JJ O
SPT3 NNP B-Gene
- : O
TAFII31 NNP B-Gene
- : O
GCN5 NNP B-Gene
- : O
L JJ B-Gene
acetylase NN I-Gene
complex JJ O
distinct NN O
from IN O
transcription NN B-Gene
factor NN I-Gene
IID NNP I-Gene
. . O

Rep NNP B-Gene
- : O
Rep NNP B-Gene
protein NN O
interaction NN O
was VBD O
confirmed VBN O
in IN O
vitro NN O
through IN O
coimmunoprecipitation NN O
experiments NNS O
with IN O
a DT O
bacterially RB O
expressed VBN O
maltose JJ B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
- : O
Rep78 NNP B-Gene
fusion NN O
protein NN O
in IN O
combination NN O
with IN O
[ JJ O
35S CD O
] JJ O
methionine NN O
- : O
labeled VBN O
Rep78 NNP B-Gene
synthesized VBN O
in IN O
a DT O
coupled VBN O
in IN O
vitro JJ O
transcription NN O
- : O
translation NN O
system NN O
. . O

We PRP O
argue VBP O
that IN O
this DT O
is VBZ O
the DT O
general JJ O
property NN O
of IN O
QSAR NNP O
models NNS O
developed VBD O
using VBG O
LOO NNP O
cross NN O
- : O
validation NN O
. . O

Steal NNP O
is VBZ O
a DT O
pathophysiological JJ O
process NN O
in IN O
which WDT O
increased VBD O
blood NN O
flow NN O
through IN O
a DT O
low JJ O
- : O
resistance NN O
vascular JJ O
bed NN O
is VBZ O
sufficient JJ O
to TO O
divert VB O
flow VB O
away RB O
from IN O
a DT O
region NN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

Together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
TR2 NNP B-Gene
orphan MD I-Gene
receptor VB I-Gene
may MD O
be VB O
a DT O
master NN O
regulator NN O
in IN O
modulating VBG O
the DT O
activation NN O
of IN O
two CD O
key JJ O
HREs NNP O
, , O
RARE NNP O
beta NN O
and CC O
CRBPIIp NNP O
, , O
involved VBN O
in IN O
the DT O
retinoic NN O
acid JJ O
signal JJ O
transduction NN O
pathway NN O
. . O

Amounts NNS O
of IN O
glucose NN O
infused VBN O
during IN O
the DT O
last JJ O
20 CD O
min NN O
of IN O
each DT O
2 CD O
hour NN O
insulin NN B-Gene
infusion NN O
were VBD O
( ( O
at IN O
1 CD O
and CC O
10 CD O
m NN O
/ NNP O
kg NNP O
/ NNP O
min NNP O
respectively RB O
) ) O
: : O
before IN O
treatment NN O
( ( O
K NNP O
+ NNP O
= VBZ O
2 CD O
. . O
7 CD O
mmol JJ O
/ NNP O
l NN O
) ) O
: : O
2 CD O
. . O
4 CD O
and CC O
8 CD O
. . O
4 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
min NN O
; : O
after IN O
spironolactone NN O
( ( O
K NNP O
+ NNP O
= VBZ O
3 CD O
. . O
9 CD O
mmol JJ O
/ NNP O
l NN O
) ) O
: : O
3 CD O
. . O
3 CD O
and CC O
15 CD O
. . O
4 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
min NN O
; : O
after IN O
indomethacine NN O
( ( O
K NNP O
+ NNP O
= VBZ O
3 CD O
. . O
7 CD O
mmol JJ O
/ NNP O
l NN O
) ) O
: : O
5 CD O
and CC O
19 CD O
mg NN O
/ NNP O
kg NNP O
/ NNP O
min NN O
after IN O
stopping VBG O
drugs NNS O
( ( O
K NNP O
+ NNP O
= VBZ O
2 CD O
. . O
9 CD O
mmol JJ O
/ NNP O
l NN O
) ) O
: : O
2 CD O
. . O
5 CD O
and CC O
5 CD O
. . O
3 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
min NN O
. . O

Frozen NNP O
/ NNP O
thawed VBD O
extensor JJ O
digitorum NN O
longus JJ O
muscle NN O
tendon VB O
units NNS O
had VBD O
significantly RB O
lower JJR O
values NNS O
for IN O
load NN O
to TO O
failure NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
energy NN O
absorbed VBD O
to TO O
failure NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
strain NN O
at IN O
failure NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
they PRP O
tended VBD O
to TO O
fail VB O
at IN O
a DT O
different JJ O
anatomic JJ O
location NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
( ( O
broadly RB O
at IN O
the DT O
fascia NN O
- : O
muscle NN O
interface NN O
as IN O
compared VBN O
with IN O
horizontally RB O
at IN O
the DT O
musculotendinous JJ O
junction NN O
) ) O
than IN O
fresh JJ O
units NNS O
. . O

Our PRP$ O
results NNS O
demonstrate VB O
the DT O
importance NN O
of IN O
phosphate NN O
and CC O
calcium NN O
in IN O
influencing VBG O
the DT O
secretion NN O
of IN O
PTH NNP B-Gene
and CC O
CT NNP B-Gene
in IN O
uremia NN O
. . O

We PRP O
conclude VBP O
that DT O
cAMP NN O
, , O
acting VBG O
through IN O
PKA NNP B-Gene
, , O
is VBZ O
an DT O
essential JJ O
regulator NN O
of IN O
basal NN O
CFTR NNP B-Gene
gene NN I-Gene
expression NN O
and CC O
may MD O
mediate VB O
an DT O
induction NN O
of IN O
CFTR NNP B-Gene
in IN O
responsive JJ O
cell NN O
types NNS O
. . O

Erythrocyte NNP B-Gene
delta NN I-Gene
- : I-Gene
aminolevulinic JJ I-Gene
acid NN I-Gene
dehydratase NN I-Gene
( ( O
ALAD NNP B-Gene
) ) O
activity NN O
, , O
erythrocyte NN O
zinc NN O
protoporphyrin NN O
( ( O
ZPP NNP O
) ) O
/ VBP O
heme JJ O
ratio NN O
, , O
and CC O
urinary JJ O
coproporphyrin NN O
( ( O
UC NNP O
) ) O
concentration NN O
have VBP O
been VBN O
employed VBN O
as IN O
biological JJ O
indicators NNS O
of IN O
moderate JJ O
- : O
to TO O
high JJ O
- : O
level NN O
lead NN O
exposure NN O
, , O
corresponding VBG O
to TO O
blood NN O
levels NNS O
in IN O
excess NN O
of IN O
50 CD O
micrograms NNS O
/ JJ O
dl NN O
, , O
in IN O
human JJ O
subjects NNS O
. . O

Disruption NN O
of IN O
any DT O
one CD O
of IN O
the DT O
four CD O
genes NNS O
encoding VBG O
the DT O
newly RB O
identified VBN O
SRP NNP B-Gene
proteins VBZ I-Gene
results NNS O
in IN O
slow JJ O
cell NN O
growth NN O
and CC O
inefficient JJ O
protein NN O
translocation NN O
across IN O
the DT O
ER NNP O
membrane NN O
. . O

Stimulation NN O
with IN O
MCh NNP O
produced VBD O
a DT O
Ca NNP O
- : O
dependent JJ O
transient JJ O
elevation NN O
of IN O
cGMP JJ O
level NN O
from IN O
10 CD O
to TO O
80 CD O
fmol NNS O
/ JJ O
gland NN O
, , O
peaking VBG O
at IN O
1 CD O
- : O
2 CD O
min NN O
but CC O
returning VBG O
to TO O
the DT O
basal NN O
level NN O
by IN O
5 CD O
min NNS O
. . O

Catecholamines NNS O
and CC O
aversive JJ O
learning NN O
: : O
a DT O
review NN O
. . O

Determination NN O
of IN O
diquat NN O
in IN O
biological JJ O
materials NNS O
by IN O
electron NN O
spin NN O
resonance NN O
spectroscopy NN O
. . O

The DT O
effect NN O
of IN O
desipramine NN O
probably RB O
represents VBZ O
inhibition NN O
of IN O
neuronal JJ O
uptake NN O
and CC O
that IN O
of IN O
amitriptyline NN O
and CC O
mianserin NN O
blockade NN O
of IN O
neuronal JJ O
uptake NN O
and CC O
prejunctional JJ O
alpha NN B-Gene
2 CD I-Gene
- : I-Gene
adrenoreceptors NNS I-Gene
. . O

Rac NNP B-Gene
causes VBZ O
uncapping NN O
of IN O
actin NN B-Gene
filaments NNS I-Gene
( ( O
F NNP B-Gene
- : I-Gene
actin NN I-Gene
) ) O
at IN O
the DT O
plus JJ O
- : O
ends NNS O
, , O
through IN O
phosphatidylinositol NN O
4 CD O
, , O
5 CD O
bisphosphate NN O
( ( O
PIP2 NNP O
) ) O
, , O
and CC O
eventually RB O
induces NNS O
membrane VBP O
ruffling VBG O
. . O

We PRP O
now RB O
describe VBP O
the DT O
identification NN O
of IN O
DEK NNP B-Gene
as IN O
this DT O
43 CD B-Gene
- : I-Gene
kDa NN I-Gene
pets NNS I-Gene
factor NN I-Gene
. . O

The DT O
activity NN O
of IN O
6 CD O
- : O
fluoroquinolones NNS O
and CC O
their PRP$ O
nonfluorinated JJ O
derivatives NNS O
is VBZ O
compared VBN O
in IN O
general JJ O
. . O

An DT O
apparent JJ O
N NNP O
- : O
terminal JJ O
transit NN O
peptide NN O
in IN O
the DT O
coding NN O
region NN O
and CC O
a DT O
3 CD O
' POS O
poly NN O
( ( O
A DT O
) ) O
tail NN O
exist NN O
in IN O
the DT O
cDNA NN O
clone NN O
indicated VBD O
that IN O
this DT O
chloroplast NN O
protein NN O
as IN O
nuclear JJ O
encoded VBD O
. . O

It PRP O
is VBZ O
considered VBN O
that IN O
the DT O
recurrent NN O
annular JJ O
erythema NN O
is VBZ O
a DT O
specific JJ O
skin JJ O
manifestation NN O
of IN O
SjS NNP O
with IN O
anti JJ B-Gene
SS NNP I-Gene
- : I-Gene
A DT I-Gene
/ JJ O
SS NNP B-Gene
- : I-Gene
B NNP I-Gene
antibodies NNS I-Gene
. . O

Several JJ O
highly RB O
conserved VBN O
regions NNS O
were VBD O
identified VBN O
at IN O
the DT O
near JJ O
N NNP O
terminus NN O
, , O
middle JJ O
and CC O
C NNP O
terminus NN O
. . O

Standard NNP O
curve NN O
correlation NN O
coefficients NNS O
of IN O
0 CD O
. . O
995 CD O
or CC O
greater JJR O
were VBD O
obtained VBN O
during IN O
validation NN O
experiments NNS O
and CC O
analysis NN O
of IN O
study NN O
samples NNS O
. . O

Cardiac JJ O
disease NN O
was VBD O
not RB O
detected VBN O
with IN O
M NNP O
- : O
mode NN O
, , O
2 CD O
- : O
dimensional JJ O
real JJ O
- : O
time NN O
or CC O
pulsed VBN O
- : O
wave VBP O
Doppler NNP O
echocardiography NN O
. . O

Recent JJ O
developments NNS O
in IN O
drugs NNS O
antagonistic JJ O
to TO O
factors NNS O
causing VBG O
peptic JJ O
ulcer NN O
- : O
- : O
clinical JJ O
efficacy NN O
and CC O
problems NNS O
; : O
gastrin VB B-Gene
receptor NN I-Gene
blockaders NNS O

With IN O
a DT O
sample NN O
of IN O
mothers NNS O
of IN O
healthy JJ O
infants NNS O
, , O
all DT O
three CD O
subscales NNS O
of IN O
the DT O
revised VBN O
instrument NN O
, , O
WPL NNP O
- : O
R NN O
, , O
had VBD O
acceptable JJ O
levels NNS O
of IN O
internal JJ O
consistency NN O
at IN O
7 CD O
, , O
30 CD O
, , O
and CC O
90 CD O
days NNS O
postpartum NN O
, , O
and CC O
stability NN O
across IN O
administrations NNS O
. . O

Stringent JJ O
hybridization NN O
of IN O
EHS NNP B-Gene
- : I-Gene
1 CD I-Gene
back RB O
to TO O
primate VB O
genomic JJ O
DNA NNP O
indicates VBZ O
two CD O
distinct JJ O
EHS NNP B-Gene
- : I-Gene
1 CD I-Gene
loci NN I-Gene
in IN O
normal JJ O
human JJ O
DNA NNP O
, , O
an DT O
identical JJ O
band NN O
pattern NN O
in IN O
chimpanzee NN O
DNA NNP O
, , O
and CC O
a DT O
single JJ O
locus NN O
in IN O
rhesus NN O
monkey NN O
DNA NNP O
. . O

This DT O
article NN O
reports VBZ O
the DT O
design NN O
and CC O
development NN O
of IN O
an DT O
ECG NNP O
simulator NN O
intended VBD O
for IN O
use NN O
in IN O
the DT O
testing NN O
, , O
calibration NN O
and CC O
maintenance NN O
of IN O
electrocardiographic JJ O
equipment NN O
. . O

The DT O
spectrum NN O
of IN O
age NN O
- : O
associated VBN O
brain NN O
abnormalities NNS O
: : O
their PRP$ O
measurement NN O
and CC O
histopathological JJ O
correlates NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
size NN O
, , O
the DT O
CRS NNP O
sequence NN O
to TO O
which WDT O
it PRP O
binds VBZ O
, , O
and CC O
its PRP$ O
tentative JJ O
identification NN O
as IN O
a DT O
zinc NN B-Gene
finger NN I-Gene
protein NN I-Gene
, , O
Adx NNP B-Gene
factor NN I-Gene
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
Kruppel NNP B-Gene
- : I-Gene
like IN I-Gene
zinc NN I-Gene
finger NN I-Gene
protein NN I-Gene
( ( O
a DT O
mouse NN B-Gene
ZBP NNP I-Gene
- : I-Gene
89 CD I-Gene
homologue NN I-Gene
) ) O
. . O

Phenazone NN O
potentiates VBZ O
the DT O
local JJ O
anaesthetic JJ O
effect NN O
of IN O
lidocaine NN O
in IN O
mice NN O
. . O

Although IN O
the DT O
molecular JJ O
mechanisms NNS O
involved VBN O
in IN O
this DT O
regulation NN O
are VBP O
currently RB O
being VBG O
elucidated VBN O
, , O
very RB O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
trans NNS O
- : O
acting VBG O
factors NNS O
that IN O
allow JJ O
expression NN O
of IN O
the DT O
nitrate NN B-Gene
and CC I-Gene
nitrite JJ I-Gene
reductase NN I-Gene
genes NNS I-Gene
which WDT O
code VBP O
for IN O
the DT O
first JJ O
enzymes NNS O
in IN O
the DT O
pathway NN O
. . O

As IN O
with IN O
the DT O
murine NN B-Gene
and CC I-Gene
human JJ I-Gene
mb NN I-Gene
- : I-Gene
1 CD I-Gene
genes NNS I-Gene
, , O
the DT O
5 CD O
' POS O
region NN O
of IN O
the DT O
bovine NN B-Gene
mb SYM I-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
lacked VBD O
a DT O
TATA NNP O
box NN O
. . O

H19 NNP B-Gene
and CC O
Igf2 NNP B-Gene
monoallelic JJ O
expression NN O
is VBZ O
regulated VBN O
in IN O
two CD O
distinct JJ O
ways NNS O
by IN O
a DT O
shared VBN O
cis NN O
acting VBG O
regulatory JJ O
region NN O
upstream NN O
of IN O
H19 NNP B-Gene
. . O

A DT O
role NN O
for IN O
the DT O
small JJ B-Gene
GTPase NNP I-Gene
Rac NNP I-Gene
in IN O
polyomavirus NN B-Gene
middle JJ I-Gene
- : I-Gene
T NN I-Gene
antigen NN I-Gene
- : O
mediated VBN O
activation NN O
of IN O
the DT O
serum NN O
response NN O
element NN O
and CC O
in IN O
cell NN O
transformation NN O
. . O

The DT O
predominant JJ O
binding NN O
activity NN O
was VBD O
not RB O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
but CC O
rather RB O
two CD O
independent JJ O
DNA NNP O
- : O
protein NN O
complexes NNS O
that WDT O
comigrated VBD O
in IN O
mobility NN O
shift NN O
assays NNS O
. . O

Blood NNP O
flow NN O
and CC O
velocity NN O
( ( O
measured VBN O
using VBG O
Doppler NNP O
ultrasound NN O
) ) O
gradually RB O
decreased VBN O
during IN O
diastole NN O
and CC O
ultimately RB O
reversed VBN O
in IN O
direction NN O
as IN O
cotyledon NN O
resistance NN O
was VBD O
increased VBN O
up RB O
to TO O
14 CD O
fold NN O
. . O

In IN O
contrast NN O
, , O
the DT O
deduced JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
a DT O
second JJ O
family NN O
( ( O
ART5 NNP B-Gene
) ) O
of IN O
transferases NNS O
, , O
cloned VBN O
from IN O
murine JJ O
lymphoma NN O
cells NNS O
and CC O
expressed VBN O
in IN O
high JJ O
abundance NN O
in IN O
testis NN O
, , O
displays VBZ O
a DT O
hydrophobic JJ O
amino NN O
terminus NN O
, , O
consistent JJ O
with IN O
a DT O
signal JJ O
sequence NN O
, , O
but CC O
lacks VBZ O
a DT O
hydrophobic JJ O
signal JJ O
sequence NN O
at IN O
its PRP$ O
carboxyl NN O
terminus NN O
, , O
suggesting VBG O
that IN O
the DT O
protein NN O
is VBZ O
destined VBN O
for IN O
export NN O
. . O

The DT O
hp55 NN B-Gene
gamma NN I-Gene
protein NN I-Gene
interacts VBZ O
strongly RB O
with IN O
the DT O
activated JJ O
IGFIR NNP B-Gene
but CC O
not RB O
with IN O
the DT O
kinase NN O
- : O
negative JJ O
mutant JJ O
receptor NN O
. . O

hp55 NN B-Gene
gamma NN I-Gene
also RB O
interacts VBZ O
with IN O
the DT O
insulin NN B-Gene
receptor NN I-Gene
( ( O
IR NNP B-Gene
) ) O
in IN O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
. . O

This DT O
vector NN O
transfected VBD O
into IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
directs VBZ O
expression NN O
of IN O
a DT O
secreted JJ O
mature NN O
protein NN O
at IN O
levels NNS O
up RB O
to TO O
200 CD O
mg NN O
of IN O
LAPP NNP O
/ NNP O
liter NN O
of IN O
culture NN O
medium NN O
. . O

Regulation NN O
of IN O
parathyroid NN B-Gene
hormone NN I-Gene
- : I-Gene
related VBN I-Gene
protein NN I-Gene
( ( O
PTHrP NNP B-Gene
) ) O
gene NN O
expression NN O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
region NN O
upstream NN O
from IN O
M NNP B-Gene
. . I-Gene
voltae NN I-Gene
ORFtrpA NNP I-Gene
was VBD O
determined VBN O
and CC O
revealed VBD O
the DT O
presence NN O
of IN O
an DT O
ORF NNP O
of IN O
1227 CD O
nucleotides NNS O
( ( O
ORFtrpB NNP B-Gene
) ) O
encoding VBG O
a DT O
409 CD O
amino NN O
acid JJ O
polypeptide NN O
of IN O
mol NN O
. . O

wt NN O
. . O

Specific JJ O
binding NN O
of IN O
the DT O
protein NN O
factors NNS O
to TO O
the DT O
sites NNS O
, , O
possibly RB O
to TO O
the DT O
three CD O
Mt NNP O
sequences NNS O
, , O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
coordinate NN O
regulation NN O
of IN O
the DT O
transcription NN O
of IN O
nuclear JJ O
genes NNS O
encoding VBG O
subunits NNS O
responsible JJ O
for IN O
mitochondrial JJ O
oxidative JJ O
phosphorylation NN O
. . O

Use NNP O
of IN O
the DT O
immunofluorescence NN O
method NN O
for IN O
identification NN O
of IN O
enteroviruses NNS O
in IN O
cell NN O
cultures NNS O

With IN O
a DT O
view NN O
to TO O
identifying VBG O
other JJ O
important JJ O
U14 NNP B-Gene
interactions NNS O
, , O
a DT O
stem NN O
- : O
loop NN O
domain NN O
required VBN O
for IN O
activity NN O
of IN O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
U14 NNP I-Gene
RNAs NNP I-Gene
( ( O
the DT O
Y NNP O
domain NN O
) ) O
was VBD O
first RB O
subjected VBN O
to TO O
detailed VB O
mutational JJ O
analysis NN O
. . O

This DT O
study NN O
investigated VBD O
the DT O
degree NN O
to TO O
which WDT O
racial JJ O
identity NN O
influences NNS O
Mexican NNP O
- : O
Americans NNPS O
' POS O
performance NN O
on IN O
the DT O
L NNP O
, , O
K NNP O
, , O
and CC O
MF NNP O
scales NNS O
of IN O
the DT O
MMPI NNP O
- : O
2 CD O
. . O

Auditory NNP O
- : O
visual JJ O
interaction NN O
in IN O
the DT O
generation NN O
of IN O
saccades NNS O
in IN O
man NN O
. . O

Acute NNP O
feasibility NN O
and CC O
safety NN O
of IN O
a DT O
smoking NN O
reduction NN O
strategy NN O
for IN O
smokers NNS O
with IN O
schizophrenia NN O
. . O

Propafenone NN O
is VBZ O
well RB O
tolerated VBN O
in IN O
the DT O
majority NN O
of IN O
young JJ O
patients NNS O
. . O

Binding VBG O
affinities NNS O
of IN O
these DT O
recombinant JJ O
phages NNS O
as IN O
determined VBN O
by IN O
the DT O
retention NN O
of IN O
these DT O
phages NNS O
by IN O
a DT O
His PRP$ O
- : O
tag NN O
immobilized JJ O
gp17 NN B-Gene
column NN O
, , O
and CC O
by IN O
co JJ O
- : O
immunoprecipitation NN O
with IN O
purified JJ O
terminase NN B-Gene
supported VBD O
the DT O
specific JJ O
nature NN O
of IN O
the DT O
portal JJ B-Gene
protein NN I-Gene
and CC O
terminase NN B-Gene
interaction NN I-Gene
sites NNS I-Gene
. . O

Effect NN O
of IN O
indoramin NN O
in IN O
small JJ O
doses NNS O
on IN O
the DT O
central JJ O
vasomotor NN O
loci NN O
has VBZ O
been VBN O
studied VBN O
in IN O
chloralose JJ O
anesthetized JJ O
cats NNS O
by IN O
localizing VBG O
it PRP O
to TO O
the DT O
central JJ O
sites NNS O
. . O

Their PRP$ O
function NN O
is VBZ O
not RB O
only RB O
to TO O
recruit VB O
Pho2 NNP B-Gene
to TO O
the DT O
promoter NN O
but CC O
to TO O
allow VB O
cooperative JJ O
binding NN O
of IN O
Pho4 NNP B-Gene
together RB O
with IN O
Pho2 NNP B-Gene
. . O

Furthermore RB O
, , O
microinjection NN O
of IN O
dominant JJ O
negative JJ O
forms NNS O
of IN O
Rac NNP B-Gene
and CC O
Cdc42 NNP B-Gene
or CC O
of IN O
the DT O
Rho NNP B-Gene
inhibitor NN O
C3 NNP B-Gene
transferase NN I-Gene
blocked VBD O
serum JJ O
- : O
induced JJ O
DNA NNP O
synthesis NN O
. . O

The DT O
mass NN O
of IN O
UO2 NNP O
in IN O
the DT O
extrapulmonary JJ O
bronchi NN O
and CC O
first JJ O
bifurcation NN O
decreased VBD O
more RBR O
slowly RB O
over IN O
0 CD O
- : O
- : O
8 CD O
d NN O
after IN O
inhalation NN O
than IN O
the DT O
corresponding JJ O
mass NN O
on IN O
the DT O
trachea NN O
. . O

Analysis NN O
of IN O
proteins NNS O
synthesized VBN O
by IN O
plasmids NNS O
containing VBG O
deleted VBD O
forms NNS O
of IN O
the DT O
trfA JJ B-Gene
region NN I-Gene
indicates VBZ O
that IN O
the DT O
A2 NNP B-Gene
protein NN I-Gene
is VBZ O
the DT O
essential JJ O
trfA NN B-Gene
- : I-Gene
encoded VBN I-Gene
replication NN I-Gene
protein NN I-Gene
of IN O
plasmid JJ O
RK2 NNP O
. . O

4 CD O
. . O

Western JJ O
blot NN O
analyses NNS O
detect VBP O
anti JJ B-Gene
- : I-Gene
E NN I-Gene
- : O
specific JJ O
immunoreactivity NN O
in IN O
affinity NN O
- : O
purified JJ O
extracts NNS O
derived VBN O
from IN O
the DT O
bacterial JJ O
expression NN O
of IN O
a DT O
truncated JJ B-Gene
AMPD3 NNP I-Gene
cDNA NN I-Gene
. . O

In IN O
the DT O
infected JJ O
neonates NNS O
serum VBP O
alpha JJ B-Gene
- : I-Gene
amylase NN I-Gene
value NN O
, , O
as IN O
determined VBN O
by IN O
the DT O
blue JJ O
starch NN O
method NN O
, , O
was VBD O
only RB O
40 CD O
% NN O
that IN O
of IN O
healthy JJ O
controls NNS O
; : O
the DT O
mean JJ O
value NN O
of IN O
175 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
64 CD O
. . O
9 CD O
IU NNP O
/ NNP O
l NN O
for IN O
healthy JJ O
neonates NNS O
was VBD O
significantly RB O
higher JJR O
( ( O
p IN O
less JJR O
than IN O
0 CD O
. . O
10 CD O
) ) O
than IN O
the DT O
value NN O
of IN O
82 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
44 CD O
. . O
4 CD O
IU NNP O
/ NNP O
l NN O
for IN O
the DT O
infected JJ O
neonates NNS O
. . O

The DT O
p73pct1 NN B-Gene
/ NNP O
p85cdc10 NN B-Gene
complex NN O
binds VBZ O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
to TO O
MCB NNP B-Gene
but CC O
not RB O
SCB NNP B-Gene
or CC O
E2F NNP B-Gene
sites NNS I-Gene
. . O

Role NNP O
of IN O
estrogen NN B-Gene
receptor NN I-Gene
ligand NN O
and CC O
estrogen NN O
response NN O
element NN O
sequence NN O
on IN O
interaction NN O
with IN O
chicken NN B-Gene
ovalbumin NN I-Gene
upstream JJ I-Gene
promoter NN I-Gene
transcription NN I-Gene
factor NN I-Gene
( ( O
COUP NNP B-Gene
- : I-Gene
TF NN I-Gene
) ) O
. . O

Heart NNP O
rate NN O
( ( O
HR NNP O
) ) O
, , O
rectal JJ O
temperature NN O
( ( O
Tre NNP O
) ) O
, , O
blood NN O
pressure NN O
, , O
temperature NN O
and CC O
relative JJ O
humidity NN O
changes NNS O
inside IN O
clothing NN O
were VBD O
measured VBN O
on IN O
18 CD O
professional JJ O
firemen NNS O
( ( O
mean JJ O
age NN O
29 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
7 CD O
. . O
4 CD O
yr NN O
, , O
VO2 NNP O
max VBD O
41 CD O
. . O
4 CD O
+ JJ O
8 CD O
. . O
8 CD O
ml NN O
kg SYM O
- : O
1 CD O
min SYM O
- : O
1 CD O
) ) O
wearing VBG O
fire NN O
fighter NN O
' '' O
s JJ O
uniforms NNS O
( ( O
SU NNP O
) ) O
or CC O
aluminized VBN O
, , O
fire NN O
resistant NN O
, , O
impermeable JJ O
clothing NN O
with IN O
self NN O
contained VBN O
breathing VBG O
apparatus NN O
( ( O
FE NNP O
) ) O
. . O

Amikacin NNP O
was VBD O
used VBN O
in IN O
the DT O
treatment NN O
of IN O
56 CD O
serious JJ O
gram NN O
- : O
negative JJ O
infections NNS O
in IN O
54 CD O
patients NNS O
of IN O
whom WP O
47 CD O
survived VBD O
. . O

A DT O
mixture NN O
of IN O
human JJ B-Gene
albumin VBP I-Gene
5 CD O
% NN O
and CC O
hydroxy JJ O
- : O
ethyl NN O
- : O
starch NN O
was VBD O
used VBN O
as IN O
a DT O
solution NN O
for IN O
dilution NN O
. . O

Response NNP O
was VBD O
extremely RB O
poor JJ O
in IN O
African JJ O
Americans NNPS O
and CC O
those DT O
with IN O
HCV NNP O
genotype NN O
1 CD O
. . O

During IN O
early JJ O
neurogenesis NN O
, , O
Vnd NNP B-Gene
protein NN I-Gene
is VBZ O
restricted VBN O
to TO O
ventral JJ O
column NN O
neuroectoderm NN O
and CC O
neuroblasts NNS O
; : O
later JJR O
it PRP O
is VBZ O
detected VBN O
in IN O
a DT O
complex JJ O
pattern NN O
of IN O
neurons NNS O
. . O

Here RB O
we PRP O
present VBP O
genetic JJ O
evidence NN O
suggesting VBG O
that IN O
PP2A NNP B-Gene
functions NNS O
downstream NN O
of IN O
Ras1 NNP B-Gene
in IN O
the DT O
Sevenless NNP B-Gene
receptor NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
( ( O
RTK NNP B-Gene
) ) O
signal NN O
transduction NN O
pathway NN O
that IN O
specifies VBZ O
R7 NNP O
photoreceptor NN O
cell NN O
fate NN O
in IN O
the DT O
developing NN O
Drosophila NNP O
eye NN O
. . O

This DT O
interaction NN O
is VBZ O
reciprocal JJ O
, , O
since IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
dimer NN I-Gene
binding NN O
to TO O
a DT O
strong JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
site NN I-Gene
leads VBZ O
to TO O
enhanced VB O
CREB NNP B-Gene
- : I-Gene
1 CD I-Gene
recruitment NN O
to TO O
ATF NNP B-Gene
/ NNP O
CREB NNP B-Gene
sites VBZ O
that WDT O
are VBP O
weakly JJ O
bound IN O
by IN O
CREB NNP B-Gene
. . O

Epitopes NNS O
of IN O
adhesion NN O
- : O
perturbing VBG O
monoclonal JJ O
antibodies NNS O
map VBP O
within IN O
a DT O
predicted JJ O
alpha NN O
- : O
helical JJ O
domain NN O
of IN O
the DT O
integrin NN B-Gene
beta NN I-Gene
1 CD I-Gene
subunit NN I-Gene
. . O

The DT O
transcriptional JJ O
activity NN O
of IN O
PPARgamma NNP B-Gene
is VBZ O
positively RB O
modulated VBN O
by IN O
ligand NN O
binding NN O
and CC O
negatively RB O
regulated VBN O
by IN O
phosphorylation NN O
mediated VBN O
by IN O
the DT O
MEK NNP B-Gene
/ NNP O
ERK NNP B-Gene
signaling VBG O
pathway RB O
. . O

An DT O
InlC NNP B-Gene
deletion NN I-Gene
mutant NN I-Gene
shows NNS O
reduced VBD O
virulence NN O
when WRB O
tested VBN O
in IN O
an DT O
intravenous JJ O
mouse NN O
model NN O
, , O
but CC O
intracellular JJ O
replication NN O
of IN O
the DT O
mutant NN O
in IN O
Caco NNP O
- : O
2 CD O
and CC O
J774 NNP O
cells NNS O
appears VBZ O
to TO O
be VB O
comparable JJ O
with IN O
that DT O
of IN O
the DT O
wild JJ O
- : O
type NN O
strain NN O
. . O

BACKGROUND NN O
: : O
It PRP O
is VBZ O
generally RB O
accepted VBN O
that IN O
smoking VBG O
increases NNS O
blood NN O
pressure NN O
and CC O
inhibits NNS O
muscle VBP O
sympathetic JJ O
nerve NN O
activity NN O
( ( O
SNA NNP O
) ) O
. . O

Lowering VBG O
of IN O
the DT O
renal JJ O
blood NN O
flow NN O
alters VBZ O
the DT O
glomerular NN O
and CC O
tubular JJ O
excretion NN O
processes NNS O
. . O

Direct JJ O
and CC O
inverted JJ O
repeat NN O
elements NNS O
of IN O
10 CD O
, , O
11 CD O
, , O
16 CD O
, , O
19 CD O
, , O
and CC O
22 CD O
nucleotides NNS O
( ( O
nt NN O
) ) O
flank VBD O
the DT O
promoter NN O
site NN O
. . O

CONCLUSIONS NN O
: : O
Fission NN B-Gene
yeast NN I-Gene
SCF NNP I-Gene
is VBZ O
composed VBN O
of IN O
Pop1 NNP B-Gene
and CC O
Pop2 NNP B-Gene
, , O
two CD O
structurally RB O
related VBN O
but CC O
functionally RB O
independent JJ O
F NNP B-Gene
- : I-Gene
box NN I-Gene
/ NN I-Gene
WD NNP I-Gene
- : I-Gene
repeat NN I-Gene
proteins NNS I-Gene
. . O

IFI16 NNP B-Gene
consists VBZ O
of IN O
ten JJ O
exons NNS O
and CC O
nine CD O
intervening VBG O
introns NNS O
spanning VBG O
at IN O
least JJS O
28 CD O
kilobases NNS O
( ( O
kb NN O
) ) O
of IN O
DNA NN O
. . O

Differential JJ O
expression NN O
of IN O
the DT O
"""" NN O
B NNP O
"""" NNP O
subunit NN O
of IN O
the DT O
vacuolar JJ B-Gene
H NNP I-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
- : I-Gene
ATPase NN I-Gene
in IN O
bovine NN O
tissues NNS O
. . O

Treatment NN O
of IN O
recurrent NN O
FSGS NNP O
has VBZ O
included VBN O
high JJ O
- : O
dose JJ O
steroids NNS O
, , O
high JJ O
- : O
dose JJ O
cyclosporine NN O
( ( O
CSA NNP O
) ) O
, , O
plasmapheresis NN O
, , O
and CC O
ACE NNP B-Gene
inhibitors NNS O
with IN O
mixed JJ O
results NNS O
. . O

Seventy NNP O
- : O
two CD O
hours NNS O
after IN O
administration NN O
of IN O
vitamin JJ O
K1 NNP O
, , O
plasma JJ O
concentrations NNS O
of IN O
the DT O
vitamin NN O
were VBD O
not RB O
different JJ O
from IN O
normal JJ O
. . O

The DT O
Schizosaccharomyces NNPS B-Gene
pombe NN I-Gene
rad1 NN I-Gene
+ NNP I-Gene
cell NN I-Gene
cycle NN I-Gene
checkpoint NN I-Gene
control NN I-Gene
gene NN I-Gene
is VBZ O
required VBN O
for IN O
S NNP O
- : O
phase NN O
and CC O
G2 NNP O
/ NNP O
M NNP O
arrest NN O
in IN O
response NN O
to TO O
both DT O
DNA NNP O
damage NN O
and CC O
incomplete JJ O
DNA NNP O
replication NN O
. . O

Specifically RB O
, , O
I PRP O
use VBP O
molecular JJ O
markers NNS O
that WDT O
identify VBP O
particular JJ O
neuroectodermal JJ O
domains NNS O
, , O
all DT O
neuroblasts NNS O
or CC O
individual JJ O
neuroblasts NNS O
, , O
to TO O
show VB O
that IN O
in IN O
DER NNP B-Gene
mutant NN I-Gene
embryos NN O
( ( O
1 CD O
) ) O
intermediate JJ O
column NN O
neuroblasts NNS O
do VBP O
not RB O
form VB O
, , O
( ( O
2 CD O
) ) O
medial JJ O
column NN O
neuroblasts NNS O
often RB O
acquire VB O
identities NNS O
inappropriate VBP O
for IN O
their PRP$ O
position NN O
, , O
while IN O
( ( O
3 CD O
) ) O
lateral JJ O
neuroblasts NNS O
develop VBP O
normally RB O
. . O

Both DT O
receptors NNS O
utilize VBP O
protein JJ B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
( ( O
PTKs NNP B-Gene
) ) O
for IN O
the DT O
phosphorylation NN O
of IN O
various JJ O
signaling VBG O
molecules NNS O
, , O
a DT O
process NN O
that WDT O
is VBZ O
critical JJ O
for IN O
the DT O
function NN O
of IN O
both DT O
receptors NNS O
. . O

Copper NN O
and CC O
ceruloplasmin NN B-Gene
content NN O
in IN O
pregnant JJ O
women NNS O
and CC O
in IN O
women NNS O
with IN O
certain JJ O
gynecological JJ O
diseases NNS O

We PRP O
previously RB O
described VBD O
the DT O
purification NN O
of IN O
an DT O
83 CD B-Gene
- : I-Gene
kDa NN I-Gene
phosphatidic JJ I-Gene
acid JJ I-Gene
phosphatase NN I-Gene
( ( O
PAP NNP B-Gene
) ) O
from IN O
the DT O
porcine NN O
thymus NN O
membranes NNS O
( ( O
Kanoh NNP O
, , O
H NNP O
. . O
, , O
Imai NNP O
, , O
S NNP O
. . O
- : O
i NN O
. . O
, , O
Yamada NNP O
, , O
K NNP O
. . O
and CC O
Sakane NNP O
, , O
F NNP O
. . O
( ( O
1992 CD O
) ) O
J NNP O
. . O

The DT O
records NNS O
from IN O
1948 CD O
through IN O
1967 CD O
of IN O
344 CD O
previously RB O
untreated JJ O
patients NNS O
with IN O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
oral JJ O
cavity NN O
, , O
oropharynx NN O
, , O
supraglottic JJ O
larynx NN O
and CC O
hypopharynx NN O
who WP O
had VBD O
clinically RB O
positive JJ O
cervical JJ O
lymph NN O
node NN O
metastases NNS O
staged VBD O
N1 NNP O
, , O
N2A NNP O
, , O
or CC O
N2B NNP O
, , O
and CC O
whose WP$ O
initial JJ O
neck NN O
treatment NN O
consisted VBD O
of IN O
external JJ O
radiation NN O
therapy NN O
alone RB O
were VBD O
reviewed VBN O
. . O

Testing VBG O
gravity NN O
to TO O
second VB O
post NN O
- : O
Newtonian JJ O
order NN O
: : O
A DT O
field NN O
- : O
theory NN O
approach NN O
. . O

This DT O
shows VBZ O
that IN O
in IN O
situations NNS O
of IN O
separated JJ O
breaks NNS O
, , O
NHEJ NNP O
deficiency NN O
leads VBZ O
to TO O
genomic VB O
rearrangements NNS O
, , O
in IN O
agreement NN O
with IN O
chromosomal JJ O
studies NNS O
. . O

An DT O
exon NN O
that WDT O
prevents VBZ O
transport NN O
of IN O
a DT O
mature NN O
mRNA NN O
. . O

Oligosynaptic JJ O
EPSP NNP O
components NNS O
were VBD O
consistently RB O
modulated VBN O
only RB O
in IN O
the DT O
superficial JJ O
peroneal NN O
responses NNS O
in IN O
flexor JJ O
motoneurons NNS O
, , O
which WDT O
exhibited VBD O
enhanced JJ O
amplitude NN O
during IN O
the DT O
flexion NN O
phase NN O
. . O

Silencing VBG O
can MD O
be VB O
restored VBN O
by IN O
creation NN O
of IN O
a DT O
telomere NN O
at IN O
13 CD O
kb NN O
from IN O
the DT O
reporter NN O
construct NN O
, , O
or CC O
by IN O
insertion NN O
of IN O
340 CD O
bp NN O
of IN O
yeast NN O
telomeric JJ O
repeat NN O
sequence NN O
at IN O
this DT O
site NN O
without IN O
chromosomal JJ O
truncation NN O
. . O

The DT O
pharmacokinetic JJ O
patterns NNS O
of IN O
estradiol NN O
( ( O
CAS NNP O
50 CD O
- : O
28 CD O
- : O
2 CD O
) ) O
and CC O
of IN O
estrone NN O
( ( O
CAS NNP O
53 CD O
- : O
16 CD O
- : O
7 CD O
) ) O
were VBD O
investigated VBN O
in IN O
18 CD O
women NNS O
in IN O
natural JJ O
or CC O
surgical JJ O
menopause NN O
during IN O
the DT O
application NN O
of IN O
a DT O
new JJ O
estradiol NN O
transdermal JJ O
patch NN O
with IN O
active JJ O
matrix NN O
and CC O
without IN O
absorption NN O
enhancers NNS O
designed VBN O
for IN O
epicutaneous JJ O
applications NNS O
of IN O
7 CD O
days NNS O
( ( O
hereinafter NN O
called VBN O
"""" NNP O
patch NN O
7D CD O
"""" NN O
) ) O
. . O

Cooperative JJ O
roles NNS O
of IN O
Bozozok NNP B-Gene
/ NNP O
Dharma NNP B-Gene
and CC O
Nodal NNP B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
in IN O
the DT O
formation NN O
of IN O
the DT O
dorsal NN O
organizer NN O
in IN O
zebrafish NN O
. . O

At IN O
the DT O
end NN O
of IN O
each DT O
day NN O
of IN O
migration NN O
the DT O
pulmonary JJ O
hemolymph NN O
PO2 NNP O
decreased VBN O
by IN O
1 CD O
- : O
2 CD O
. . O
5 CD O
kPa NN O
, , O
but CC O
the DT O
hemocyanin NN O
remained VBD O
saturated JJ O
with IN O
O2 NNP O
and CC O
the DT O
venous JJ O
reserve NN O
was VBD O
largely RB O
unchanged JJ O
( ( O
O2 NNP O
> VBZ O
0 CD O
. . O
4 CD O
mmol JJ O
x NN O
l NN O
( ( O
- : O
1 CD O
) ) O
) ) O
. . O

Endovascular JJ O
aneurysm NNS O
repair NN O
with IN O
the DT O
AneuRx NNP O
stent NN O
- : O
graft NN O
is VBZ O
safe JJ O
, , O
but CC O
is VBZ O
it PRP O
effective JJ O
? . O

Uracil NNP B-Gene
DNA NNP I-Gene
glycosylase NN I-Gene
catalyzes VBZ O
the DT O
initial JJ O
step NN O
in IN O
the DT O
repair NN O
pathway NN O
that WDT O
removes VBZ O
potentially RB O
mutagenic JJ O
uracil NN O
from IN O
duplex JJ O
DNA NNP O
. . O

The DT O
concentration NN O
of IN O
mite JJ O
allergen NN O
was VBD O
very RB O
low JJ O
( ( O
mean JJ O
0 CD O
. . O
18 CD O
micrograms NNS O
Der NNP O
p NN O
milligrams NNS O
sieved VBD O
house NN O
dust NN O
) ) O
, , O
whereas VBP O
that IN O
of IN O
cat NN O
allergen NN O
was VBD O
high JJ O
in IN O
homes NNS O
with IN O
a DT O
cat NN O
( ( O
80 CD O
. . O
8 CD O
micrograms NNS O
Fel NNP O
d VBP O
milligrams NNS O
) ) O
but CC O
also RB O
in IN O
homes NNS O
with IN O
no DT O
cat NN O
( ( O
3 CD O
. . O
2 CD O
micrograms NNS O
Fel NNP O
d VBP O
milligrams NNS O
) ) O
. . O

The DT O
Cr NNP B-Gene
. . I-Gene
psbA VB I-Gene
- : I-Gene
4 CD I-Gene
ORF NNP I-Gene
contains VBZ O
an DT O
H NNP O
- : O
N NNP O
- : O
H NNP O
motif NN O
, , O
and CC O
possibly RB O
a DT O
GIY NNP O
- : O
YIG NN O
motif NN O
. . O

Isolation NN O
of IN O
T NNP O
. . O
gambiense NN O
strains NNS O
in IN O
Zaire NNP O
and CC O
their PRP$ O
adaptation NN O
to TO O
laboratory NN O
animals NNS O

A DT O
patient NN O
of IN O
Group NNP O
B NNP O
had VBD O
severe JJ O
athetoid JJ O
CP NNP O
with IN O
spasticity NN O
, , O
being VBG O
unable JJ O
to TO O
right VB O
his PRP$ O
trunk NN O
and CC O
neck NN O
. . O

The DT O
subgroup NN O
innervating VBG O
the DT O
medial JJ O
rectus NN O
lies VBZ O
exclusively RB O
along IN O
the DT O
medial JJ O
face NN O
of IN O
the DT O
oculomotor NN O
nucleus NN O
, , O
with IN O
no DT O
aberrant JJ O
neurons NNS O
in IN O
the DT O
medial JJ O
longitudinal JJ O
fasciculus NN O
, , O
as IN O
have VBP O
been VBN O
found VBN O
in IN O
other JJ O
mammals NNS O
. . O

The DT O
use NN O
of IN O
highly RB O
active JJ O
antiretroviral JJ O
therapy NN O
( ( O
HAART NNP O
) ) O
has VBZ O
resulted VBN O
in IN O
significant JJ O
improvements NNS O
in IN O
the DT O
treatment NN O
of IN O
HIV NNP O
infection NN O
, , O
including VBG O
a DT O
decrease NN O
in IN O
the DT O
incidence NN O
and CC O
severity NN O
of IN O
several JJ O
acquired VBN O
immune JJ O
deficiency NN O
syndrome NN O
( ( O
AIDS NNP O
) ) O
- : O
related JJ O
malignancies NNS O
. . O

Hepatitis NN O
B NNP O
and CC O
liver JJ O
transplantation NN O
. . O

Combined VBN O
therapy NN O
with IN O
MK NNP O
- : O
801 CD O
and CC O
nimodipine VB O
for IN O
protection NN O
of IN O
ischemic JJ O
brain NN O
damage NN O
. . O

The DT O
students NNS O
who WP O
had VBD O
abnormal JJ O
urine JJ O
screening NN O
results NNS O
at IN O
the DT O
first JJ O
time NN O
received VBD O
a DT O
second JJ O
urine JJ O
analysis NN O
10 CD O
to TO O
15 CD O
days NNS O
later RB O
to TO O
confirm VB O
the DT O
abnormal JJ O
urine JJ O
analysis NN O
. . O

These DT O
losses NNS O
account VBP O
for IN O
the DT O
resistance NN O
of IN O
EDS NNP O
- : O
IV NNP O
collagen NN B-Gene
to TO O
cyanogen VB O
bromide NN O
and CC O
mammalian JJ B-Gene
collagenase NN I-Gene
digestion NN O
. . O

Heterodimers NNS O
of IN O
myogenin NN B-Gene
and CC O
E12 NNP B-Gene
( ( O
or CC O
MyoD NNP B-Gene
and CC O
E12 NNP B-Gene
) ) O
specifically RB O
bound IN O
a DT O
restriction NN O
fragment NN O
extending VBG O
from IN O
- : O
200 CD O
to TO O
- : O
103 CD O
relative NN O
to TO O
the DT O
start NN O
of IN O
cardiac JJ B-Gene
alpha NN I-Gene
- : I-Gene
actin NN I-Gene
transcription NN O
. . O

To TO O
define VB O
the DT O
minimal JJ O
VDRE NNP O
binding NN O
domain NN O
for IN O
human JJ B-Gene
VDR NNP I-Gene
( ( O
hVDR NN B-Gene
) ) O
, , O
a DT O
series NN O
of IN O
C NNP O
- : O
terminally RB O
truncated VBN O
hVDR NN B-Gene
mutants NNS I-Gene
( ( O
Delta134 NNP O
, , O
Delta113 NNP O
, , O
Delta102 NNP O
, , O
Delta90 NNP O
, , O
Delta84 NNP O
, , O
Delta80 NNP O
, , O
and CC O
Delta60 NNP O
) ) O
was VBD O
generated VBN O
and CC O
expressed VBN O
in IN O
bacteria NNS O
. . O

We PRP O
identify VBP O
considerable JJ O
spatio JJ O
- : O
temporal JJ O
similarities NNS O
between IN O
reported VBN O
expression NN O
patterns NNS O
of IN O
Ypr10 NNP B-Gene
genes NNS I-Gene
and CC O
ribonuclease NN O
genes NNS O
, , O
which WDT O
, , O
together RB O
with IN O
the DT O
significant JJ O
sequence NN O
similarity NN O
to TO O
the DT O
ginseng NN B-Gene
ribonuclease NN I-Gene
, , O
support VB O
the DT O
hypothesis NN O
of IN O
a DT O
ribonuclease NN O
function NN O
for IN O
PR NNP B-Gene
- : I-Gene
10 CD I-Gene
proteins NNS I-Gene
and CC O
allow VB O
the DT O
prediction NN O
of IN O
possible JJ O
biological JJ O
roles NNS O
. . O

The DT O
mean NN O
body NN O
mass NN O
index NN O
( ( O
BMI NNP O
) ) O
was VBD O
31 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
3 CD O
kg JJ O
/ NNP O
m2 NN O
and CC O
28 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
3 CD O
kg JJ O
/ NNP O
m2 NN O
in IN O
women NNS O
and CC O
men NNS O
, , O
respectively RB O
. . O

1st CD O
data NNS O
on IN O
the DT O
immunosuppressive JJ O
therapy NN O
of IN O
scleroderma NN O

To TO O
measure VB O
the DT O
enhancer NN O
activity NN O
of IN O
DR60 NNP B-Gene
, , O
a DT O
reporter NN O
plasmid NN O
was VBD O
constructed VBN O
that IN O
contained VBD O
DR60 NNP B-Gene
cloned VBD O
upstream NN O
of IN O
the DT O
reporter NN O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
gene NN I-Gene
under IN O
the DT O
control NN O
of IN O
the DT O
delayed VBN O
- : O
early JJ O
39K CD O
promoter NN O
. . O

Partial JJ O
engorgement NN O
was VBD O
higher RBR O
in IN O
the DT O
treatments NNS O
. . O

IL NNP B-Gene
- : I-Gene
12 CD I-Gene
production NN O
was VBD O
correlated VBN O
with IN O
C3a NNP O
concentration NN O
measured VBD O
at IN O
the DT O
outlet NN O
of IN O
hemodialyzer NN O
after IN O
15 CD O
min NN O
of IN O
dialysis NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
69 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

PRL NNP B-Gene
receptor NN I-Gene
also RB O
activates VBZ O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
a DT O
cytosolic JJ B-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
. . O

In IN O
a DT O
second JJ O
series NN O
of IN O
experiments NNS O
, , O
the DT O
efficacy NN O
of IN O
PDC NNP O
/ NNP O
HDC NNP O
Ac NNP O
was VBD O
evaluated VBN O
in IN O
both DT O
single JJ O
and CC O
multiple JJ O
dose JJ O
regiments NNS O
. . O

The DT O
ultrastructural JJ O
findings NNS O
, , O
as RB O
well RB O
as IN O
the DT O
urinary JJ O
C NNP B-Gene
- : I-Gene
peptide NN I-Gene
excretion NN O
, , O
confirmed VBD O
that IN O
the DT O
glycemic JJ O
effects NNS O
should MD O
not RB O
be VB O
thought VBN O
to TO O
be VB O
due JJ O
to TO O
a DT O
direct JJ O
action NN O
of IN O
the DT O
drugs NNS O
used VBN O
on IN O
the DT O
endocrine NN O
pancreas NN O
. . O

Expression NN O
of IN O
the DT O
human JJ B-Gene
heat NN I-Gene
shock NN I-Gene
protein NN I-Gene
70 CD I-Gene
gene NN I-Gene
( ( O
hsp70 NN B-Gene
) ) O
is VBZ O
induced VBN O
by IN O
various JJ O
kinds NNS O
of IN O
stress NN O
and CC O
by IN O
oncogenes NNS O
. . O

Those DT O
radiological JJ O
aspects NNS O
were VBD O
distributed VBN O
in IN O
two CD O
categories NNS O
: : O
1 CD O
) ) O
type NN O
I PRP O
- : O
presenting VBG O
variable JJ O
sinusoidal JJ O
filling NN O
. . O

This DT O
unique JJ O
work NN O
needs NNS O
to TO O
be VB O
edited VBN O
critically RB O
and CC O
afterwards NNS O
translated VBN O
into IN O
Urdu NNP O
and CC O
other JJ O
languages NNS O
for IN O
the DT O
benefit NN O
of IN O
the DT O
present JJ O
day NN O
students NNS O
and CC O
scholars NNS O
. . O

We PRP O
conclude VBP O
that IN O
c SYM B-Gene
- : I-Gene
Abl NNP I-Gene
activates VBZ O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
transcription NN O
indirectly RB O
with IN O
no DT O
requirement NN O
for IN O
DNA NNP O
binding NN O
by IN O
c SYM B-Gene
- : I-Gene
Abl NN I-Gene
. . O

After IN O
an DT O
initial JJ O
titration NN O
period NN O
and CC O
adjustment NN O
of IN O
the DT O
therapeutic JJ O
dose NN O
, , O
the DT O
individual JJ O
doses NNS O
were VBD O
from IN O
21 CD O
to TO O
500 CD O
micrograms NNS O
/ VBP O
24 CD O
hrs NN O
( ( O
mean JJ O
160 CD O
micrograms NNS O
/ VBP O
24 CD O
hrs NN O
) ) O
. . O

HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
amino NN I-Gene
- : I-Gene
terminal JJ I-Gene
sequences NNS I-Gene
defined VBN O
by IN O
conserved JJ O
region NN O
IV NNP O
also RB O
contributed VBD O
to TO O
transactivation NN O
, , O
but CC O
region NN O
IV NNP O
activity NN O
required VBD O
the DT O
participation NN O
of IN O
the DT O
region NN O
II NNP O
- : O
III NNP O
domain NN O
. . O

The DT O
ability NN O
of IN O
spt2 JJ B-Gene
mutations NNS I-Gene
to TO O
suppress VB O
the DT O
transcriptional JJ O
interference NN O
caused VBN O
by IN O
the DT O
delta NN B-Gene
promoter NN I-Gene
insertion NN I-Gene
his PRP$ I-Gene
- : I-Gene
4 CD I-Gene
- : I-Gene
912 CD I-Gene
delta NN I-Gene
correlates NNS O
with IN O
an DT O
increase NN O
in IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
HIS4 NNP I-Gene
mRNA NN I-Gene
levels NNS O
. . O

Epidemiology NN O
and CC O
prevention NN O
of IN O
hospital JJ O
infections NNS O
in IN O
the DT O
Local NNP O
Health NNP O
Unit NNP O
of IN O
Sassari NNP O
: : O
profile NN O
of IN O
bacterial JJ O
resistance NN O
and CC O
antimicrobial JJ O
agents NNS O
of IN O
large JJ O
usage NN O
. . O

Inhibition NN O
of IN O
the DT O
apolipoprotein NN B-Gene
B NNP I-Gene
mRNA NN I-Gene
editing VBG O
enzyme JJ O
- : O
complex JJ O
by IN O
hnRNP NN B-Gene
C1 NNP I-Gene
protein NN I-Gene
and CC O
40S CD B-Gene
hnRNP NN I-Gene
complexes NNS I-Gene
. . O

NiCl NNP O
( ( O
2 CD O
) ) O
- : O
induced VBN O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
synthesis NN O
required VBN O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
since IN O
mutation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
in IN O
the DT O
promoter NN O
resulted VBD O
in IN O
complete JJ O
loss NN O
of IN O
inducible JJ O
promoter NN O
activity NN O
. . O

Thirty NNP O
cadaver NN O
brains NNS O
were VBD O
examined VBN O
under IN O
X $ O
6 CD O
to TO O
16 CD O
magnification NN O
in IN O
order NN O
to TO O
define VB O
the DT O
microsurgical JJ O
anatomy NN O
of IN O
the DT O
pineal JJ O
region NN O
, , O
particularly RB O
the DT O
relationship NN O
of IN O
the DT O
pineal NN O
body NN O
, , O
posterior JJ O
cerebral JJ O
artery NN O
, , O
superior JJ O
cerebellar JJ O
artery NN O
, , O
vein NN O
of IN O
Galen NNP O
, , O
basal NN O
vein NN O
of IN O
Rosenthal NNP O
, , O
internal JJ O
cerebral JJ O
vein NN O
, , O
straight JJ O
sinus NN O
, , O
bridging VBG O
vein NN O
, , O
the DT O
size NN O
of IN O
the DT O
tentorial JJ O
notch NN O
, , O
and CC O
the DT O
third JJ O
and CC O
the DT O
fourth JJ O
cranial JJ O
nerves NNS O
. . O

Another DT O
mutant NN O
, , O
T255A NNP O
, , O
lost VBD O
the DT O
ability NN O
to TO O
bind VB O
E4orf6 NNP B-Gene
, , O
but CC O
unexpectedly RB O
, , O
viral JJ O
late JJ O
- : O
gene NN O
expression NN O
was VBD O
not RB O
affected VBN O
. . O

The DT O
ORFII NNP B-Gene
gene NN I-Gene
product NN I-Gene
is VBZ O
targeted VBN O
to TO O
the DT O
chloroplast NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
previous JJ O
data NNS O
indicating VBG O
the DT O
presence NN O
of IN O
PMSR NNP B-Gene
activity NN O
in IN O
the DT O
chloroplast NN O
. . O

Bacterial NNP O
meningitis NN O
secondary JJ O
to TO O
abscess VB O
of IN O
the DT O
nasal JJ O
septum NN O
. . O

Heterogeneous NNP O
electron NN O
transfer NN O
of IN O
cytochrome JJ B-Gene
c NNS I-Gene
facilitated VBN O
by IN O
polypyrrole NN O
and CC O
methylene NN O
blue JJ O
polypyrrole NN O
film NN O
modified VBD O
electrodes NNS O
. . O

The DT O
pathophysiology NN O
and CC O
clinical JJ O
management NN O
of IN O
acute NN O
brain NN O
injury NN O
in IN O
infancy NN O
and CC O
childhood NN O
are VBP O
presented VBN O
using VBG O
acute JJ O
traumatic JJ O
brain NN O
injury NN O
as IN O
a DT O
model NN O
. . O

The DT O
relative JJ O
toxicity NN O
of IN O
nickel JJ O
oxide NN O
( ( O
NiO NNP O
) ) O
, , O
nickel JJ O
sulfate NN O
hexahydrate NN O
( ( O
NiSO4 NNP O
. . O
6H2O CD O
) ) O
, , O
and CC O
nickel JJ O
subsulfide NN O
( ( O
Ni3S2 NNP O
) ) O
was VBD O
studied VBN O
in IN O
F344 NNP O
/ NNP O
N NNP O
rats NNS O
and CC O
B6C3F1 NNP O
mice NN O
after IN O
inhalation NN O
exposure NN O
for IN O
6 CD O
hr JJ O
/ NNP O
day NN O
, , O
5 CD O
days NNS O
/ JJ O
week NN O
, , O
for IN O
13 CD O
weeks NNS O
. . O

When WRB O
BFDS NNP O
was VBD O
taken VBN O
as IN O
the DT O
reference NN O
, , O
W NNP O
/ VBZ O
A NNP O
Z NNP O
scores VBZ O
showed VBD O
consistent JJ O
positive JJ O
increments NNS O
, , O
from IN O
birth NN O
in IN O
girls NNS O
and CC O
1 CD O
mo NN O
in IN O
boys NNS O
. . O

We PRP O
measured VBD O
basal JJ O
plasma NN O
prolactin NN B-Gene
concentrations NNS O
( ( O
in IN O
samples NNS O
obtained VBN O
during IN O
the DT O
early JJ O
follicular JJ O
phase NN O
) ) O
in IN O
25 CD O
normal JJ O
( ( O
control NN O
) ) O
women NNS O
and CC O
in IN O
a DT O
similar JJ O
group NN O
of IN O
40 CD O
patients NNS O
with IN O
a DT O
long JJ O
- : O
standing VBG O
history NN O
of IN O
infertility NN O
. . O

Antibodies NNS O
affinity VBP O
- : O
purified VBN O
using VBG O
the DT O
bacterially RB O
expressed VBN O
recombinant JJ O
protein NN O
recognized VBD O
the DT O
56K CD B-Gene
autoantigen NN I-Gene
in IN O
a DT O
HeLa NNP O
cell NN O
extract NN O
. . O

cDNA NN O
sequencing VBG O
revealed VBD O
that IN O
the DT O
56K CD B-Gene
cDNA NN I-Gene
shares NNS O
a DT O
high JJ O
degree NN O
of IN O
homology NN O
in IN O
both DT O
nucleotide JJ O
( ( O
87 CD O
% NN O
) ) O
and CC O
amino JJ O
acid NN O
sequence NN O
( ( O
92 CD O
. . O
5 CD O
% NN O
) ) O
with IN O
bovine NN B-Gene
annexin NN I-Gene
XI NNP I-Gene
, , O
indicating VBG O
that IN O
the DT O
56K CD B-Gene
cDNA NN I-Gene
encodes VBZ O
the DT O
human JJ B-Gene
homologue NN I-Gene
of IN I-Gene
annexin NN I-Gene
XI NNP I-Gene
, , O
a DT O
member NN O
of IN O
the DT O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
dependent JJ I-Gene
phospholipid JJ I-Gene
binding VBG I-Gene
protein JJ I-Gene
family NN I-Gene
. . O

In IN O
addition NN O
to TO O
its PRP$ O
elongation NN O
activity NN O
, , O
ELL NNP B-Gene
contains VBZ O
a DT O
novel JJ O
type NN O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
interaction NN I-Gene
domain NN I-Gene
that WDT O
is VBZ O
capable JJ O
of IN O
repressing VBG O
polymerase NN O
activity NN O
in IN O
promoter NN O
- : O
specific JJ O
transcription NN O
. . O

Studies NNS O
suggest VBP O
that IN O
the DT O
DGOR NNP O
without IN O
acid JJ O
reflux NN O
may MD O
result VB O
in IN O
symptoms NNS O
but CC O
unless IN O
acid JJ O
reflux NN O
is VBZ O
present JJ O
simultaneously RB O
, , O
it PRP O
does VBZ O
not RB O
cause VB O
oesophagitis NN O
. . O

Acquired NNP O
antithrombin JJ B-Gene
deficiency NN O
in IN O
sepsis NN O
. . O

59 CD O
cases NNS O
of IN O
surgically RB O
resectable JJ O
cancers NNS O
( ( O
T1 NNP O
, , O
T2 NNP O
, , O
T3 NNP O
, , O
N0 NNP O
, , O
N1 NNP O
) ) O
had VBD O
a DT O
minimum JJ O
followup NN O
of IN O
two CD O
years NNS O
( ( O
average JJ O
4 CD O
years NNS O
+ RB O
/ VBP O
- : O
3 CD O
months NNS O
) ) O
. . O

This DT O
rapid JJ O
and CC O
extensive JJ O
penetration NN O
of IN O
intrathecally RB O
administered VBN O
chemotherapy NN O
may MD O
offer VB O
insight NN O
into IN O
the DT O
myelopathy JJ O
observed VBN O
with IN O
these DT O
treatments NNS O
. . O

The DT O
evaluation NN O
of IN O
amniotic JJ O
fluid NN O
delta NN O
OD450 NNP O
is VBZ O
considered VBN O
to TO O
be VB O
the DT O
cornerstone NN O
of IN O
clinical JJ O
management NN O
. . O

Dotarizine NNP O
produced VBD O
arterial JJ O
dilation NN O
in IN O
both DT O
systemic JJ O
and CC O
pulmonary JJ O
circulation NN O
: : O
the DT O
total JJ O
peripheral JJ O
resistance NN O
dropped VBD O
, , O
and CC O
femoral JJ O
artery NN O
flow NN O
rose VBD O
; : O
aortic JJ O
and CC O
pulmonary JJ O
artery NN O
mean NN O
and CC O
diastolic JJ O
pressures NNS O
declined VBD O
, , O
and CC O
systolic JJ O
pressures NNS O
remained VBD O
almost RB O
stable JJ O
. . O

Patients NNS O
received VBD O
either RB O
diltiazem JJ O
CD NN O
180 CD O
mg NN O
or CC O
placebo NN O
once RB O
/ JJ O
day NN O
in IN O
combination NN O
with IN O
existing VBG O
antianginal JJ O
therapy NN O
. . O

When WRB O
combined VBN O
with IN O
independent JJ O
activating VBG O
mutations NNS O
in IN O
the DT O
c NN B-Gene
- : I-Gene
abl JJ I-Gene
kinase NN I-Gene
domain NN I-Gene
or CC O
NH2 NNP O
- : O
terminus NN O
, , O
the DT O
G128R NNP B-Gene
mutation NN O
blocked VBD O
transformation NN O
by IN O
the DT O
double JJ O
mutant NN O
, , O
suggesting VBG O
that IN O
the DT O
G128R NNP B-Gene
mutant NN I-Gene
was VBD O
unable JJ O
to TO O
transform VB O
cells NNS O
for IN O
trivial JJ O
reasons NNS O
. . O

Transactivation NN O
of IN O
naturally RB O
occurring VBG O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeats NNS I-Gene
by IN O
the DT O
JNK NNP B-Gene
signaling VBG O
pathway RB O
. . O

Three CD O
pyridoxine NN O
derivatives NNS O
have VBP O
been VBN O
isolated VBN O
from IN O
the DT O
fresh JJ O
stem NN O
bark NN O
of IN O
Albizzia NNP O
julibrissin NN O
DURAZZ NNP O
. . O
. . O

Growth NNP B-Gene
hormone NN I-Gene
and CC O
insulin NN B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
I PRP I-Gene
receptors NNS I-Gene
in IN O
the DT O
temporomandibular JJ O
joint NN O
of IN O
the DT O
rat NN O
. . O

Isolation NN O
of IN O
Proteus NNP O
vulgaris FW O
MC NNP O
- : O
63 CD O
from IN O
carcinoma NN O
63 CD O
and CC O
its PRP$ O
antitumor NN O
effect NN O
on IN O
Crocker NNP O
sarcoma VBD O
180 CD O
and CC O
Ehrlich NNP O
carcinoma NN O
. . O

When WRB O
the DT O
first JJ O
twitch NN O
of IN O
TOF NNP O
spontaneously RB O
recovered VBD O
to TO O
10 CD O
% NN O
of IN O
control NN O
value NN O
, , O
neostigmine NN O
was VBD O
injected VBN O
( ( O
40 CD O
micrograms NNS O
/ VBP O
kg NN O
in IN O
adults NNS O
, , O
30 CD O
micrograms NNS O
/ VBP O
kg NN O
in IN O
infants NNS O
and CC O
children NNS O
) ) O
. . O

We PRP O
cloned VBD O
a DT O
complete JJ O
cDNA NN O
( ( O
2 CD O
. . O
9 CD O
kb NN O
) ) O
for IN O
HET NNP B-Gene
from IN O
an DT O
MCF NNP O
- : O
7 CD O
cDNA NN O
library NN O
. . O

Likewise RB O
, , O
whether IN O
or CC O
not RB O
the DT O
hypotensive JJ O
action NN O
of IN O
converting VBG O
enzyme JJ O
inhibitors NNS O
is VBZ O
age NN O
- : O
related VBN O
is VBZ O
as IN O
yet RB O
unknown JJ O
. . O

Thyreoliberin NNP B-Gene
VUFB NNP O
in IN O
thyroid NN O
gammagraphy NN O

This DT O
R NNP O
- : O
domain NN O
may MD O
modulate VB O
the DT O
interaction NN O
with IN O
SRF NNP B-Gene
, , O
providing VBG O
a DT O
mechanism NN O
that WDT O
would MD O
be VB O
unique JJ O
to TO O
FLI1 NNP B-Gene
and CC O
EWS NNP B-Gene
- : O
FLI1 NNP B-Gene
, , O
thus RB O
implicating VBG O
a DT O
novel JJ O
function NN O
for IN O
these DT O
ETS NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
the DT O
regulation NN O
of IN O
the DT O
Egr1 NNP B-Gene
gene NN I-Gene
. . O

Cyclins NNS B-Gene
are VBP O
one CD O
of IN O
the DT O
pivotal JJ O
determinants NNS O
regulating VBG O
cell NN O
cycle NN O
progression NN O
. . O

Analysis NN O
of IN O
RAR NNP B-Gene
alpha NN I-Gene
mutants NNS I-Gene
in IN O
transfection NN O
studies NNS O
reveals VBZ O
that IN O
the DT O
DNA NNP O
binding NN O
domain NN O
is VBZ O
sufficient JJ O
for IN O
inhibition NN O
of IN O
BZLF1 NNP B-Gene
activity NN O
. . O

Simian JJ O
parainfluenza NN O
virus NN O
5 CD O
( ( O
SV5 NNP O
) ) O
is VBZ O
a DT O
prototype NN O
of IN O
the DT O
Paramyxoviridae NNP O
family NN O
of IN O
nonsegmented JJ O
negative JJ O
- : O
sense NN O
RNA NNP O
viruses NNS O
. . O

A DT O
DNA NN O
fragment NN O
encoding VBG O
the DT O
DNA NNP O
- : O
binding NN O
domain NN O
( ( O
amino JJ O
acids NNS O
1 CD O
- : O
60 CD O
) ) O
of IN O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
fru VBD I-Gene
transcriptional JJ I-Gene
regulator NN I-Gene
was VBD O
cloned VBN O
into IN O
the DT O
pGEX NN O
- : O
KT NNP O
vector NN O
and CC O
expressed VBN O
in IN O
frame NN O
with IN O
the DT O
fused JJ O
gene NN O
encoding VBG O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
. . O

A DT O
hybridoma NN O
clone NN O
( ( O
7H1 CD O
) ) O
resulting VBG O
from IN O
the DT O
fusion NN O
between IN O
CEMLAI NNP O
/ NNP O
NP NNP O
and CC O
human JJ O
embryonic JJ O
fibroblasts NNS O
MRC5 NNP O
cells NNS O
produced VBD O
very RB O
large JJ O
amounts NNS O
of IN O
P47 NNP B-Gene
that WDT O
was VBD O
purified VBN O
using VBG O
Jacalin NNP B-Gene
lectin NN I-Gene
( ( O
specific JJ O
for IN O
O NNP O
- : O
glycans NNS O
) ) O
and CC O
microsequenced VBN O
. . O

In IN O
the DT O
course NN O
of IN O
Hepatitis NNP B-Gene
A NNP I-Gene
HBs NNP I-Gene
- : I-Gene
and CC I-Gene
HBe NNP I-Gene
- : I-Gene
antigen NN I-Gene
as RB O
well RB O
as IN O
HBc NNP B-Gene
( ( I-Gene
IgM NNP I-Gene
and CC I-Gene
IgG NNP I-Gene
) ) I-Gene
- : I-Gene
, , I-Gene
HBs NNP I-Gene
- : I-Gene
and CC I-Gene
HBe NNP I-Gene
- : I-Gene
antibodies NNS I-Gene
can MD O
be VB O
detected VBN O
. . O

Mutational JJ O
analysis NN O
of IN O
the DT O
L1 NNP B-Gene
binding VBG I-Gene
site NN I-Gene
of IN O
23S CD B-Gene
rRNA NN I-Gene
in IN I-Gene
Escherichia NNP I-Gene
coli NN I-Gene
. . O

Seventy NNP O
- : O
five CD O
percent NN O
of IN O
children NNS O
who WP O
received VBD O
a DT O
second JJ O
transplant NN O
for IN O
HCV NNP O
hepatitis NN O
had VBD O
early JJ O
histologic JJ O
recurrence NN O
that WDT O
led VBD O
to TO O
liver VB O
failure NN O
and CC O
death NN O
. . O

A DT O
human JJ B-Gene
Raf NNP I-Gene
- : I-Gene
responsive NN I-Gene
zinc NN I-Gene
- : I-Gene
finger NN I-Gene
protein NN I-Gene
that WDT O
binds VBZ O
to TO O
divergent VB O
sequences NNS O
. . O

Tissue NN O
samples NNS O
were VBD O
obtained VBN O
either RB O
from IN O
rats NNS O
that WDT O
had VBD O
been VBN O
exposed VBN O
to TO O
opiate VB O
withdrawal NN O
following VBG O
a DT O
seven CD O
day NN O
morphine VB O
infusion NN O
or CC O
sham NN O
treated VBN O
control NN O
subjects NNS O
. . O

Together RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
induces NNS O
VEGF NNP B-Gene
gene NN I-Gene
expression NN O
at IN O
both DT O
transcriptional JJ O
and CC O
post NN O
- : O
transcriptional NN O
levels NNS O
, , O
and CC O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
evokes NNS O
p38 VBP B-Gene
MAPK NNP O
and CC O
JNK NNP B-Gene
signalings NNS O
, , O
which WDT O
in IN O
turn NN O
stimulate VBP O
the DT O
transcription NN O
of IN O
the DT O
VEGF NNP B-Gene
gene NN I-Gene
through IN O
Sp1 NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

The DT O
rhabdomyosarcoma NN O
R1H NNP O
growing VBG O
on IN O
the DT O
right JJ O
flank NN O
of IN O
male JJ O
WAG NNP O
/ NNP O
Rij NNP O
rats NN O
was VBD O
clamped VBN O
for IN O
2 CD O
or CC O
4 CD O
h NN O
at IN O
20 CD O
degrees NNS O
C NNP O
or CC O
37 CD O
degrees NNS O
C NNP O
. . O

The DT O
IA4 NNP B-Gene
mAb NN I-Gene
was VBD O
identified VBN O
among IN O
a DT O
series NN O
of IN O
antibodies NNS O
raised VBN O
in IN O
BALB NNP O
/ NNP O
c NN O
mice NN O
after IN O
immunization NN O
against IN O
a DT O
HLA NNP B-Gene
class NN O
I PRP O
- : O
deficient NN O
, , O
lymphokine JJ O
- : O
activated VBN O
killer NN O
( ( O
LAK NNP O
) ) O
- : O
susceptible JJ O
EBV NNP O
- : O
B NNP O
lymphocyte NN O
line NN O
. . O

Thus RB O
, , O
while IN O
the DT O
genomic JJ O
organization NN O
of IN O
mHuA NN B-Gene
is VBZ O
similar JJ O
to TO O
the DT O
neural JJ O
- : O
restricted JJ O
members NNS O
of IN O
the DT O
Elav NNP B-Gene
family NN I-Gene
, , O
the DT O
promoter NN O
element NN O
differs NNS O
substantially RB O
both DT O
by IN O
sequence NN O
analysis NN O
and CC O
transcriptional JJ O
activity NN O
in IN O
non JJ O
- : O
neural JJ O
cell NN O
types NNS O
. . O

Four CD O
of IN O
these DT O
five CD O
subjects NNS O
also RB O
performed VBD O
mixed JJ O
sequences NNS O
under IN O
conditional JJ O
control NN O
of IN O
the DT O
words NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
A1 NNP O
- : O
- : O
- : O
- : O
B2 SYM O
- : O
- : O
- : O
- : O
A3 SYM O
- : O
- : O
- : O
- : O
B4 NNP O
- : O
- : O
- : O
- : O
A5 NN O
and CC O
its PRP$ O
reversal NN O
) ) O
, , O
verifying VBG O
that IN O
the DT O
stimuli NN O
which WDT O
occupied VBD O
the DT O
same JJ O
position NN O
in IN O
each DT O
sequence NN O
were VBD O
members NNS O
of IN O
the DT O
same JJ O
class NN O
. . O

L3 NNP O
- : O
L4 NNP O
compressive JJ O
load NN O
was VBD O
calculated VBN O
using VBG O
a DT O
model NN O
of IN O
the DT O
anatomy NN O
of IN O
the DT O
trunk NN O
musculoskeletal NN O
system NN O
. . O

A DT O
sequence NN O
representing VBG O
about IN O
50 CD O
% NN O
of IN O
the DT O
expected JJ O
complete JJ O
sequence NN O
was VBD O
obtained VBN O
by IN O
translation NN O
of IN O
the DT O
two CD O
open JJ O
reading VBG O
frames RB O
present JJ O
on IN O
a DT O
1 CD O
. . O
6 CD O
kb JJ O
DNA NNP O
genomic JJ O
fragment NN O
. . O

McCann NNP O
III NNP O
, , O
F NNP O
. . O

The DT O
relationships NNS O
among IN O
blood NN O
concentrations NNS O
of IN O
thyroid JJ O
hormones NNS O
and CC O
selenium NN O
, , O
zinc NN O
, , O
retinol NN O
, , O
and CC O
alpha SYM O
- : O
tocopherol NN O
were VBD O
studied VBN O
in IN O
44 CD O
healthy JJ O
Northern NNP O
Italian NNP O
oldest JJS O
- : O
old JJ O
subjects NNS O
( ( O
age NN O
range NN O
, , O
90 CD O
- : O
107 CD O
yr NN O
) ) O
, , O
selected VBN O
by IN O
the DT O
criteria NNS O
of IN O
the DT O
SENIEUR NNP O
protocol NN O
. . O

Eight CD O
highly RB O
trained JJ O
male NN O
kayakers NNS O
were VBD O
studied VBN O
to TO O
determine VB O
the DT O
relationship NN O
between IN O
critical JJ O
power NN O
( ( O
CP NNP O
) ) O
and CC O
the DT O
onset NN O
of IN O
blood NN O
lactate NN O
accumulation NN O
( ( O
OBLA NNP O
) ) O
. . O

Mutant NNP O
enzyme NN O
forms NNS O
were VBD O
prepared VBN O
to TO O
eliminate VB O
the DT O
initial JJ O
autoprocessing NN O
site NN O
and CC O
thus RB O
form VB O
an DT O
active JJ O
single JJ O
- : O
chain NN O
protein NN O
for IN O
structure NN O
- : O
function NN O
studies NNS O
. . O

The DT O
COOH NNP O
- : O
terminus NN O
of IN O
this DT O
new JJ O
isoform NN O
, , O
which WDT O
we PRP O
designate VBP O
beta JJ B-Gene
4 CD I-Gene
, , O
lacks VBZ O
a DT O
22 CD O
amino NN O
acid NN O
lysine NN O
- : O
rich JJ O
sequence NN O
common JJ O
to TO O
both DT O
the DT O
human JJ B-Gene
red JJ I-Gene
cell NN I-Gene
alpha SYM I-Gene
- : I-Gene
and CC I-Gene
beta VB I-Gene
- : I-Gene
adducin NN I-Gene
subunits NNS I-Gene
and CC O
homologous JJ O
to TO O
a DT O
highly RB O
conserved JJ O
region NN O
in IN O
MARCKS NNP B-Gene
, , O
a DT O
filamentous JJ O
actin NN B-Gene
- : O
cross NN O
linking VBG O
protein NN O
regulated VBN O
by IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
and CC O
calcium NN O
/ NNP O
calmodulin NN B-Gene
. . O
beta NN B-Gene
4 CD I-Gene
- : I-Gene
adducin NN I-Gene
preserves VBZ O
a DT O
previously RB O
identified VBN O
calmodulin NN B-Gene
binding VBG I-Gene
domain NN I-Gene
. . O

Covalent JJ O
modification NN O
of IN O
the DT O
transactivator NN O
protein NN O
IE2 NNP B-Gene
- : O
p86 NN B-Gene
of IN O
human JJ O
cytomegalovirus NN O
by IN O
conjugation NN O
to TO O
the DT O
ubiquitin JJ B-Gene
- : I-Gene
homologous JJ I-Gene
proteins NNS I-Gene
SUMO NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
hSMT3b NN B-Gene
. . O

The DT O
BAL NNP O
concentrations NNS O
of IN O
the DT O
nine CD O
cytokines NNS O
evaluated VBN O
for IN O
the DT O
more JJR O
and CC O
less RBR O
affected JJ O
lungs NNS O
were VBD O
compared VBN O
: : O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
and CC O
interferon VB B-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
showed VBD O
significant JJ O
differences NNS O
( ( O
p VB O
ranged VBN O
between IN O
0 CD O
. . O

These DT O
are VBP O
the DT O
long JJ O
terminal JJ O
repeat NN O
( ( O
LTR NNP O
) ) O
promoter NN O
, , O
which WDT O
regulates VBZ O
expression NN O
of IN O
the DT O
viral JJ O
structural JJ O
proteins NNS O
, , O
and CC O
a DT O
second JJ O
internal JJ O
promoter NN O
, , O
located VBN O
towards IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
env JJ B-Gene
gene NN I-Gene
, , O
that WDT O
directs VBZ O
expression NN O
of IN O
the DT O
viral JJ O
auxiliary JJ O
proteins NNS O
. . O

No DT O
reflow NN O
occurred VBD O
in IN O
approximately RB O
30 CD O
percent NN O
of IN O
the DT O
muscle NN O
microvasculature NN O
upon IN O
reperfusion NN O
. . O

When WRB O
desipramine NN O
was VBD O
injected VBN O
16 CD O
hrs NN O
after IN O
fluoxetine JJ O
injection NN O
, , O
brain NN O
levels NNS O
of IN O
desipramine NN O
were VBD O
no RB O
longer RB O
elevated VBN O
. . O

Catheter NNP O
transit NN O
slows VBZ O
the DT O
response NN O
to TO O
a DT O
step NN O
increase NN O
in IN O
concentration NN O
by IN O
about IN O
0 CD O
. . O
13 CD O
s NN O
( ( O
from IN O
10 CD O
per IN O
cent NN O
- : O
90 CD O
per IN O
cent NN O
) ) O
and CC O
prolongs VBZ O
the DT O
transit NN O
time NN O
through IN O
the DT O
catheter NN O
for IN O
a DT O
volatile JJ O
anesthetic JJ O
by IN O
about IN O
0 CD O
. . O
4 CD O
s VBD O
more JJR O
than IN O
N2 NNP O
. . O

The DT O
range NN O
of IN O
eosinophils NNS O
was VBD O
22 CD O
- : O
56 CD O
% NN O
of IN O
the DT O
number NN O
of IN O
peripheral JJ O
white JJ O
blood NN O
cells NNS O
( ( O
mean JJ O
nadir RB O
33 CD O
% NN O
) ) O
. . O

The DT O
reduction NN O
in IN O
saturated JJ O
fatty JJ O
acids NNS O
intake VBP O
led VBN O
to TO O
modest JJ O
( ( O
but CC O
in IN O
group NN O
1 CD O
significant JJ O
) ) O
0 CD O
. . O
15 CD O
mmol JJ O
/ NN O
l NN O
( ( O
2 CD O
. . O
5 CD O
% NN O
) ) O
reduction NN O
in IN O
total JJ O
serum NN O
cholesterol NN O
level NN O
. . O

Environmental JJ O
factors NNS O
were VBD O
more RBR O
important JJ O
in IN O
the DT O
older JJR O
cohorts NNS O
( ( O
perhaps RB O
because IN O
of IN O
less JJR O
reliable JJ O
recall NN O
) ) O
. . O

For IN O
signal JJ O
durations NNS O
less JJR O
than IN O
10 CD O
ms NN O
, , O
however RB O
, , O
the DT O
SoNo NNP O
and CC O
S NNP O
pi VBP O
No NNP O
threshold JJ O
functions NNS O
converged VBD O
and CC O
the DT O
masking VBG O
- : O
level NN O
difference NN O
decreased VBN O
. . O

Recent JJ O
molecular JJ O
analysis NN O
has VBZ O
revealed VBN O
that IN O
the DT O
S NNP B-Gene
locus NN I-Gene
is VBZ O
highly RB O
polymorphic JJ O
and CC O
contains VBZ O
several JJ O
genes NNS O
, , O
i NN O
. . O
e NN O
. . O
, , O
SLG NNP B-Gene
, , O
SRK NNP B-Gene
, , O
the DT O
as IN O
- : O
yet RB O
- : O
unidentified JJ O
pollen NN B-Gene
S NNP I-Gene
gene NN I-Gene
( ( I-Gene
s PRP I-Gene
) ) I-Gene
, , O
and CC O
other JJ O
linked VBN O
genes NNS O
. . O

But CC O
, , O
as IN O
Theriault NNP O
explains VBZ O
, , O
improvements NNS O
in IN O
assessing VBG O
exposure NN O
have VBP O
not RB O
yet RB O
translated VBN O
into IN O
clear JJ O
and CC O
consistent JJ O
findings NNS O
. . O

We PRP O
suggest VBP O
that DT O
sensitivity NN O
to TO O
photoperiod VB O
in IN O
pallid JJ O
bats NNS O
, , O
as IN O
in IN O
several JJ O
other JJ O
mammals NNS O
, , O
is VBZ O
mediated VBN O
by IN O
the DT O
pineal NN O
gland NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
V3 NNP B-Gene
peptides NNS O
from IN O
all DT O
major JJ O
clades NNS O
of IN O
HIV NNP O
- : O
1 CD O
carried VBN O
by IN O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
gag NN I-Gene
can MD O
be VB O
used VBN O
as IN O
a DT O
potential JJ O
HIV NNP O
/ NNP O
AIDS NNP O
vaccine NN O
. . O

Studies NNS O
on IN O
alcoholic JJ O
liver JJ O
injury NN O
. . O

The DT O
murine NN B-Gene
mutation NN I-Gene
dominant JJ I-Gene
white JJ I-Gene
spotting NN I-Gene
( ( O
W NNP B-Gene
) ) O
is VBZ O
in IN O
the DT O
proto NN O
- : O
oncogene NN O
, , O
c SYM B-Gene
- : I-Gene
kit NN I-Gene
. . O

The DT O
first JJ O
involved JJ O
measurements NNS O
of IN O
the DT O
steady JJ O
state NN O
levels NNS O
of IN O
mRNAs NN O
for IN O
subunit JJ O
5 CD O
of IN O
cytochrome JJ B-Gene
oxidase NN I-Gene
and CC O
the DT O
beta NN O
subunit NN O
of IN O
F1 NNP B-Gene
ATPase NNP I-Gene
in IN O
wild JJ O
type NN O
and CC O
in IN O
a DT O
hem2 NN B-Gene
mutant NN I-Gene
. . O

Capsular JJ O
antigens NNS O
of IN O
Staphylococcus NNP O
aureus NN O

Localization NN O
of IN O
the DT O
cytokine NN O
response NN O
element NN O
by IN O
5 CD O
' POS O
- : O
deletion NN O
analysis NN O
and CC O
site NN O
- : O
directed VBN O
mutagenesis NN O
revealed VBD O
a DT O
cis NN O
- : O
acting VBG O
binding VBG O
site NN O
for IN O
activated JJ O
STAT NNP B-Gene
complexes NNS O
. . O

Using VBG O
in IN O
organello JJ O
footprint NN O
analysis NN O
, , O
we PRP O
demonstrate VBP O
that IN O
within IN O
human JJ O
placental JJ O
mitochondria NN O
there EX O
is VBZ O
a DT O
high JJ O
level NN O
of IN O
protein JJ O
- : O
DNA NN O
binding NN O
at IN O
regularly RB O
phased VBN O
intervals NNS O
throughout IN O
a DT O
500 CD O
- : O
bp NN O
region NN O
encompassing VBG O
the DT O
D NNP O
- : O
loop NN O
DNA NN O
origins NNS O
and CC O
two CD O
promoter NN O
regions NNS O
. . O

The DT O
sequence NN O
up RB O
to TO O
- : O
267 CD O
bp NN O
relative NN O
to TO O
the DT O
transcription NN O
start NN O
site NN O
was VBD O
sufficient JJ O
to TO O
enhance VB O
reporter NN O
gene NN O
expression NN O
depending VBG O
on IN O
the DT O
mesodermal JJ O
differentiation NN O
of IN O
P19 NNP O
cells NNS O
. . O

17 CD O
volunteer NN O
deaf NN O
Ss NNP O
were VBD O
compared VBN O
with IN O
18 CD O
volunteer NN O
hearing NN O
Ss NNP O
on IN O
the DT O
Stanford NNP O
Hypnotic NNP O
Clinical NNP O
Scale NNP O
( ( O
SHCS NNP O
) ) O
of IN O
Morgan NNP O
and CC O
J NNP O
. . O

There EX O
were VBD O
no DT O
instances NNS O
of IN O
major JJ O
flap JJ O
necrosis NN O
although IN O
two CD O
flaps NNS O
showed VBD O
tip JJ O
ischaemia NN O
. . O

CDC31 NNP B-Gene
is VBZ O
required VBN O
for IN O
SPB NNP O
duplication NN O
and CC O
encodes VBZ O
a DT O
calmodulin JJ B-Gene
- : I-Gene
like IN I-Gene
protein NN I-Gene
that WDT O
is VBZ O
most RBS O
closely RB O
related VBN O
to TO O
caltractin VB B-Gene
/ JJ O
centrin NN B-Gene
, , O
a DT O
protein NN O
associated VBN O
with IN O
the DT O
Chlamydomonas NNP O
basal NN O
body NN O
. . O

The DT O
decrease NN O
in IN O
left JJ O
ventricular NN O
( ( O
LV NNP O
) ) O
stroke VBD O
volume NN O
during IN O
positive JJ O
end NN O
- : O
expiratory JJ O
pressure NN O
( ( O
PEEP NNP O
) ) O
has VBZ O
been VBN O
attributed VBN O
to TO O
reduced VB O
LV NNP O
filling NN O
and CC O
a DT O
decreased VBN O
contractile NN O
state NN O
. . O

When WRB O
a DT O
tumour NN O
is VBZ O
present JJ O
nipple JJ O
discharge NN O
is VBZ O
of IN O
little JJ O
importance NN O
for IN O
the DT O
diagnosis NN O
and CC O
treatment NN O
. . O

Constantly RB O
rectilinear JJ O
pressure NN O
curves NNS O
without IN O
uterine JJ O
activities NNS O
are VBP O
interpreted VBN O
as IN O
characteristic JJ O
tocographic JJ O
criteria NNS O
of IN O
an DT O
advanced JJ O
ectopic NN O
gravidity NN O
. . O

Syndecan JJ B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
a DT O
focal JJ O
adhesion NN O
component NN O
, , O
and CC O
this DT O
interaction NN O
may MD O
both DT O
localize VB O
PKC NNP B-Gene
and CC O
amplify VB O
its PRP$ O
activity NN O
at IN O
sites NNS O
of IN O
forming VBG O
adhesions NNS O
. . O

Tolerance NN O
to TO O
ADAL NNP O
- : O
2 CD O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
Vicryl NNP O
suture NN O
and CC O
tolerance NN O
to TO O
ADAL NNP O
- : O
2 CD O
was VBD O
superior JJ O
to TO O
that DT O
to TO O
Tisuacryl NNP O
. . O

RNA NNP O
of IN O
GBV NNP O
- : O
C NNP O
was VBD O
detected VBN O
in IN O
14 CD O
( ( O
18 CD O
% NN O
) ) O
patients NNS O
before IN O
BMT NNP O
. . O

No DT O
symptomatic JJ O
abnormality NN O
has VBZ O
been VBN O
noted VBN O
in IN O
the DT O
neonatal JJ O
period NN O
except IN O
periventricular JJ O
calcifications NNS O
. . O

Liquid NNP O
chromatographic JJ O
separation NN O
was VBD O
achieved VBN O
on IN O
a DT O
Zorbax NNP O
RX NNP O
C8 NNP O
analytical JJ O
column NN O
using VBG O
gradient JJ O
elution NN O
. . O

The DT O
scr NN B-Gene
regulon NN I-Gene
of IN O
pUR400 NN O
and CC O
the DT O
chromosomally RB B-Gene
encoded VBN I-Gene
scr NN I-Gene
regulon NN I-Gene
of IN I-Gene
Klebsiella NNP I-Gene
pneumoniae NN I-Gene
KAY2026 NNP I-Gene
are VBP O
both DT O
negatively RB O
controlled VBN O
by IN O
a DT O
specific JJ O
repressor NN O
( ( O
ScrR NNP B-Gene
) ) O
. . O

Mutations NNS O
in IN O
the DT O
small JJ O
subunit NN O
of IN O
ribulosebisphosphate JJ B-Gene
carboxylase NN I-Gene
affect JJ O
subunit NN O
binding NN O
and CC O
catalysis NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
negative JJ O
inotropic JJ O
action NN O
of IN O
nicorandil NN O
is VBZ O
caused VBN O
by IN O
inhibition NN O
of IN O
Ca NNP O
influx NN O
and CC O
intracellular JJ O
mobilization NN O
of IN O
Ca NNP O
. . O

Sexually RB O
conditioned VBN O
incentives NNS O
: : O
attenuation NN O
of IN O
motivational JJ O
impact NN O
during IN O
dopamine JJ B-Gene
receptor NN I-Gene
antagonism NN O
. . O

Mechanism NN O
of IN O
the DT O
t NN O
( ( O
14 CD O
; : O
18 CD O
) ) O
chromosomal JJ O
translocation NN O
: : O
structural JJ O
analysis NN O
of IN O
both DT O
derivative JJ O
14 CD O
and CC O
18 CD O
reciprocal JJ O
partners NNS O
. . O

We PRP O
then RB O
studied VBD O
four CD O
unrelated JJ O
Japanese JJ O
families NNS O
with IN O
GSD NNP O
- : O
Ib NNP O
, , O
and CC O
found VBD O
three CD O
novel JJ O
mutations NNS O
: : O
a DT O
four CD O
- : O
base NN O
deletion NN O
/ NNP O
two CD O
- : O
base NN O
insertion NN O
, , O
a DT O
point NN O
mutation NN O
within IN O
a DT O
consensus NN O
splicing VBG O
donor JJ O
site NN O
, , O
and CC O
a DT O
missense JJ O
mutation NN O
( ( O
W118R NNP O
) ) O
. . O

At IN O
different JJ O
times NNS O
of IN O
the DT O
surgical JJ O
procedures NNS O
( ( O
thorax VB O
opening NN O
and CC O
closure NN O
, , O
period NN O
of IN O
cardiopulmonary JJ O
bypass NN O
) ) O
67 CD O
to TO O
100 CD O
% NN O
of IN O
the DT O
patients NNS O
in IN O
group NN O
1 CD O
had VBD O
vancomycin VBN O
concentrations NNS O
in IN O
the DT O
studied JJ O
tissues NNS O
above IN O
the DT O
MIC NNP O
90 CD O
for IN O
Staphylococcus NNP O
aureus NN O
( ( O
1 CD O
microgram NN O
/ NNP O
g NN O
) ) O
and CC O
Staphylococcus NNP O
epidermidis VBP O
( ( O
2 CD O
micrograms NNS O
/ NNP O
g NN O
) ) O
. . O

This DT O
study NN O
was VBD O
performed VBN O
to TO O
assess VB O
the DT O
role NN O
of IN O
additional JJ O
diagnostic JJ O
laparoscopy NN O
in IN O
the DT O
preoperative JJ O
staging NN O
of IN O
patients NNS O
with IN O
adenocarcinoma NN O
of IN O
the DT O
esophagus NN O
, , O
gastric JJ O
cancer NN O
and CC O
pancreatic JJ O
cancer NN O
prior RB O
to TO O
intended VB O
curative JJ O
surgery NN O
. . O

In IN O
insects NNS O
, , O
arylalkylamine NN B-Gene
N NNP I-Gene
- : I-Gene
acetyltransferases NNS I-Gene
( ( O
AANATs NNP B-Gene
) ) O
have VBP O
been VBN O
implicated VBN O
in IN O
several JJ O
physiological JJ O
processes NNS O
, , O
including VBG O
sclerotization NN O
, , O
inactivation NN O
of IN O
certain JJ O
neurotransmitters NNS O
, , O
and CC O
, , O
similar JJ O
to TO O
the DT O
function NN O
in IN O
vertebrates NNS O
, , O
catalysis NN O
of IN O
the DT O
rate NN O
- : O
limiting VBG O
step NN O
in IN O
melatonin JJ O
biosynthesis NN O
. . O

The DT O
flow JJ O
rate NN O
of IN O
phosphate NN O
buffered VBN O
saline NN O
through IN O
dermis NN O
was VBD O
measured VBN O
as IN O
a DT O
function NN O
of IN O
applied JJ O
pressure NN O
. . O

Processivity NN O
of IN O
DNA NNP O
synthesis NN O
by IN O
the DT O
mutant JJ O
holoenzyme NN O
containing VBG O
pcna JJ B-Gene
- : I-Gene
79 CD I-Gene
was VBD O
unaffected VBN O
on IN O
poly NN O
( ( O
dA NN O
) ) O
x NN O
oligo NN O
( ( O
dT NN O
) ) O
but CC O
was VBD O
dramatically RB O
reduced VBN O
on IN O
a DT O
natural JJ O
template NN O
with IN O
secondary JJ O
structure NN O
. . O

The DT O
effect NN O
of IN O
the DT O
fatty JJ B-Gene
acid NN I-Gene
cyclo SYM I-Gene
- : I-Gene
oxygenase NN I-Gene
inhibitor NN O
indomethacin NN O
on IN O
cerebral JJ O
blood NN O
flow NN O
( ( O
CBF NNP O
) ) O
and CC O
the DT O
metabolic JJ O
rate NN O
for IN O
oxygen NN O
( ( O
CMRO2 NNP O
) ) O
was VBD O
studied VBN O
in IN O
paralyzed JJ O
and CC O
artificially RB O
ventilated JJ O
rats NNS O
. . O

We PRP O
evaluated VBD O
regional JJ O
right NN O
ventricular NN O
wall NN O
motion NN O
during IN O
systole NN O
in IN O
patients NNS O
with IN O
surgically RB O
repaired VBN O
tetralogy NN O
of IN O
Fallot NNP O
( ( O
TOF NNP O
) ) O
using VBG O
color NN O
kinesis NN O
imaging NN O
. . O

In IN O
contrast NN O
, , O
deletion NN O
of IN O
the DT O
upstream JJ O
portion NN O
of IN O
the DT O
delta NN O
promoter NN O
led VBD O
to TO O
a DT O
10 CD O
fold JJ O
decrease NN O
in IN O
expression NN O
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
Palmaz NNP O
- : O
Schatz JJ O
stents NNS O
were VBD O
dip JJ O
- : O
coated VBN O
with IN O
paclitaxel NN O
( ( O
0 CD O
, , O
0 CD O
. . O
2 CD O
, , O
15 CD O
, , O
or CC O
187 CD O
microgram NNS O
/ JJ O
stent NN O
) ) O
by IN O
immersion NN O
in IN O
ethanolic JJ O
paclitaxel NN O
and CC O
evaporation NN O
of IN O
the DT O
solvent NN O
. . O

The DT O
effect NN O
of IN O
diffusion NN O
limitation NN O
was VBD O
quantified VBN O
in IN O
terms NNS O
of IN O
the DT O
ratio NN O
O2 NNP O
uptake NN O
/ NNP O
O2 NNP O
requirement NN O
( ( O
= JJ O
fraction NN O
of IN O
cross NN O
- : O
sectional JJ O
area NN O
supplied VBN O
with IN O
O2 NNP O
) ) O
, , O
assuming VBG O
local JJ O
O2 NNP O
requirement NN O
per IN O
unit NN O
volume NN O
to TO O
be VB O
constant JJ O
and CC O
independent JJ O
of IN O
PO2 NNP O
at IN O
PO2 NNP O
greater JJR O
than IN O
0 CD O
. . O

Sequence NNP O
analysis NN O
of IN O
this DT O
region NN O
revealed VBD O
three CD O
eight CD O
- : O
bp NN O
repetitive JJ O
elements NNS O
, , O
the DT O
deletion NN O
of IN O
which WDT O
restored VBD O
wild JJ O
- : O
type NN O
levels NNS O
of IN O
luciferase NN B-Gene
activity NN O
to TO O
the DT O
- : O
916 CD O
- : O
bp NN O
reporter NN O
plasmid NN O
. . O

The DT O
introduction NN O
of IN O
an DT O
acidic JJ O
residue NN O
at IN O
the DT O
second JJ O
site NN O
was VBD O
essential JJ O
for IN O
suppression NN O
of IN O
the DT O
Asn NNP O
- : O
285 CD O
mutation NN O
because IN O
Lys NNP O
- : O
220 CD O
and CC O
Gln NNP O
- : O
220 CD O
second JJ O
- : O
site NN O
mutants NNS O
of IN O
the DT O
Asn NNP O
- : O
285 CD O
mutant NN O
showed VBD O
very RB O
low JJ O
tetracycline NN O
resistance NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Moreover RB O
, , O
the DT O
mass NN O
estimated VBN O
with IN O
the DT O
QCM NNP O
response NN O
through IN O
the DT O
Sauerbrey NNP O
equation NN O
and CC O
the DT O
mass NN O
which WDT O
can MD O
be VB O
measured VBN O
thanks NNS O
to TO O
other JJ O
analytical JJ O
techniques NNS O
, , O
in IN O
our PRP$ O
case NN O
an DT O
enzymatic JJ O
assay NN O
, , O
are VBP O
different JJ O
: : O
the DT O
deposited JJ O
mass NN O
is VBZ O
generally RB O
overestimated VBN O
by IN O
the DT O
QCM NNP O
. . O

These DT O
included VBD O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
, , O
HFH NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
HFH NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
HFH NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
, , O
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
, , O
all DT O
of IN O
which WDT O
are VBP O
consistent JJ O
with IN O
the DT O
tissue NN O
- : O
specific JJ O
expression NN O
profiles NNS O
of IN O
the DT O
gene NN O
. . O

The DT O
promoter NN O
activity NN O
was VBD O
measured VBN O
by IN O
a DT O
transient JJ O
expression NN O
of IN O
a DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
gene NN O
connected VBN O
with IN O
various JJ O
5 CD O
' POS O
- : O
deletion NN O
mutants NNS O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
the DT O
VirD2 NNP B-Gene
omega NN I-Gene
domain NN I-Gene
is VBZ O
important JJ O
for IN O
efficient JJ O
T NNP O
- : O
DNA NN O
integration NN O
. . O

In IN O
addition NN O
, , O
and CC O
in IN O
support NN O
of IN O
a DT O
mediating JJ O
role NN O
of IN O
STATs NNP B-Gene
in IN O
the DT O
activation NN O
of IN O
the DT O
p21 NN B-Gene
promoter NN I-Gene
, , O
overexpression NN O
of IN O
Stat3 NNP B-Gene
potentiated VBD O
the DT O
cytokine NN O
effect NN O
on IN O
the DT O
p21 NN B-Gene
promoter NN I-Gene
; : O
whereas CC O
a DT O
dominant JJ B-Gene
negative JJ I-Gene
Stat3 NNP I-Gene
, , O
or CC O
a DT O
mutation NN O
of IN O
the DT O
STAT NNP B-Gene
response NN I-Gene
element NN I-Gene
on IN O
the DT O
promoter NN O
, , O
significantly RB O
reduced VBD O
the DT O
cytokine NN O
effect NN O
. . O

The DT O
major JJ O
type NN O
involves VBZ O
activator JJ O
proteins NNS O
that WDT O
bind VBP O
to TO O
DNA NNP O
adjacent NN O
to TO O
where WRB O
the DT O
RNA NNP B-Gene
polymerase NN I-Gene
( ( O
RNAP NNP B-Gene
) ) O
holoenzyme NN O
binds NNS O
, , O
usually RB O
assisting VBG O
in IN O
recruitment NN O
of IN O
the DT O
RNAP NNP B-Gene
to TO O
the DT O
promoter NN O
. . O

CONCLUSIONS NN O
: : O
Our PRP$ O
meta NN O
- : O
analysis NN O
of IN O
randomized VBN O
controlled JJ O
trials NNS O
of IN O
HRT NNP O
noted VBD O
a DT O
statistically RB O
significant JJ O
reduction NN O
in IN O
nonvertebral JJ O
fractures NNS O
. . O

Analysis NN O
of IN O
mCTR NN B-Gene
mRNAs NN I-Gene
has VBZ O
revealed VBN O
that IN O
the DT O
three CD O
alternative JJ O
promoters NNS O
give VBP O
rise NN O
to TO O
at IN O
least JJS O
seven CD O
mCTR JJ B-Gene
isoforms NNS I-Gene
in IN O
the DT O
5 CD O
' POS O
region NN O
of IN O
the DT O
gene NN O
and CC O
generate VB O
5 CD O
' '' O
- : O
untranslated JJ O
regions NNS O
of IN O
very RB O
different JJ O
lengths NNS O
. . O

An DT O
int6 JJ B-Gene
deletion NN I-Gene
( ( O
int6Delta NN B-Gene
) ) O
mutant NN O
was VBD O
viable JJ O
but CC O
grew VBD O
slowly RB O
in IN O
minimal JJ O
medium NN O
. . O

Pmt2 NNP B-Gene
is VBZ O
a DT O
member NN O
of IN O
a DT O
six CD O
- : O
protein NN O
family NN O
in IN O
yeast NN O
that WDT O
catalyzes VBZ O
the DT O
first JJ O
step NN O
in IN O
O NNP O
mannosylation NN O
of IN O
target NN O
proteins NNS O
. . O

There EX O
was VBD O
a DT O
close JJ O
correlation NN O
between IN O
plasma JJ O
clearance NN O
of IN O
NT NNP O
by IN O
10 CD O
- : O
hydroxylation NN O
and CC O
the DT O
D NNP O
metabolic NN O
ratio NN O
( ( O
D NNP O
/ VBZ O
4 CD O
- : O
OH NNP O
- : O
D NN O
in IN O
urine NN O
) ) O
in IN O
the DT O
Ghanaians NNP O
( ( O
rs VB O
= NNP O
- : O
0 CD O
. . O
95 CD O
; : O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
Swedes NNP O
( ( O
rs VB O
= NNP O
- : O
0 CD O
. . O
84 CD O
; : O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

A DT O
high JJ O
mean JJ O
intensity NN O
of IN O
CLTPA NNP O
( ( O
standardized JJ O
multivariate NN O
regression NN O
coefficient NN O
beta SYM O
- : O
0 CD O
. . O
59 CD O
, , O
p NN O
= VBD O
0 CD O
. . O
20 CD O
) ) O
and CC O
a DT O
high JJ O
maximal NN O
oxygen NN O
uptake NN O
( ( O
beta SYM O
- : O
0 CD O
. . O
163 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
were VBD O
associated VBN O
with IN O
reduced JJ O
plasma NNS B-Gene
fibrinogen NN I-Gene
when WRB O
adjusting VBG O
for IN O
the DT O
strongest JJS O
covariates NNS O
. . O

The DT O
deduced JJ O
96 CD O
- : O
residue NN O
amino NN O
acid IN O
coding VBG O
sequence NN O
of IN O
the DT O
murine NN O
HMG NNP B-Gene
- : I-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
cDNA NN O
is VBZ O
very RB O
similar JJ O
to TO O
the DT O
reported VBN O
amino NN O
acid JJ O
sequence NN O
of IN O
human JJ O
HMG NNP B-Gene
- : I-Gene
I PRP I-Gene
, , O
except IN O
that IN O
it PRP O
lacks VBZ O
11 CD O
internal JJ O
amino NN O
acids NNS O
reported VBD O
in IN O
the DT O
human JJ O
protein NN O
. . O

Disorders NNS O
of IN O
platelet NN O
function NN O
in IN O
chronic JJ O
myeloid NN O
leukemias NN O

To TO O
derive VB O
quantitative JJ O
concentration NN O
changes NNS O
from IN O
measurements NNS O
of IN O
light JJ O
attenuation NN O
, , O
the DT O
optical JJ O
path NN O
length NN O
must MD O
be VB O
known VBN O
. . O

Double NNP O
- : O
staining NN O
confirmed VBD O
that IN O
there EX O
were VBD O
separate JJ O
populations NNS O
of IN O
CD68 NNP B-Gene
- : O
positive JJ O
macrophages NNS O
and CC O
XIIIa NNP B-Gene
- : O
positive JJ O
dendrocytes NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
both DT O
in IN O
the DT O
early JJ O
stages NNS O
( ( O
0T CD O
, , O
0N CD O
) ) O
and CC O
in IN O
more RBR O
severe JJ O
stages NNS O
of IN O
VWF NNP O
( ( O
stages VBZ O
1 CD O
- : O
2 CD O
) ) O
cold NN O
induced VBN O
hyperreactivity NN O
in IN O
the DT O
digital JJ O
vessels NNS O
and CC O
Raynaud NNP O
' POS O
s JJ O
syndrome NN O
are VBP O
vascular JJ O
disorders NNS O
of IN O
functional JJ O
origin NN O
occurring VBG O
without IN O
any DT O
prethrombotic JJ O
alterations NNS O
. . O

The DT O
activation NN O
and CC O
injury NN O
of IN O
endothelial JJ O
cells NNS O
induced VBN O
by IN O
TNF NNP B-Gene
and CC O
other JJ O
proinflammatory NN O
cytokines NNS O
may MD O
underlie VB O
the DT O
local JJ O
effects NNS O
of IN O
these DT O
mediators NNS O
in IN O
vivo NN O
. . O

The DT O
alpha NN B-Gene
inhibin NN I-Gene
promoter NN I-Gene
containing VBG O
a DT O
mutated JJ O
CRE NNP O
was VBD O
not RB O
regulated VBN O
by IN O
forskolin NN O
in IN O
granulosa NN O
cells NNS O
and CC O
did VBD O
not RB O
bind VB O
the DT O
CREB NNP B-Gene
protein NN I-Gene
. . O

However RB O
, , O
overexpression NN O
of IN O
both CC O
the DT O
STE4 NNP B-Gene
and CC O
STE18 NNP B-Gene
proteins NNS I-Gene
did VBD O
not RB O
generate VB O
a DT O
stronger JJR O
pheromone NN O
response NN O
than IN O
overexpression NN O
of IN O
STE4 NNP B-Gene
in IN O
the DT O
presence NN O
of IN O
wild JJ O
- : O
type NN O
levels NNS O
of IN O
STE18 NNP B-Gene
. . O

S1 NNP B-Gene
nuclease JJ I-Gene
analysis NN O
of IN O
RNA NNP O
prepared VBD O
after IN O
transfection NN O
of IN O
these DT O
HIV NNP O
constructs NNS O
into IN O
HeLa NNP O
cells NNS O
infected VBN O
with IN O
wild JJ O
- : O
type NN O
adenovirus NN O
indicated VBD O
that IN O
the DT O
enhancer NN O
, , O
SP1 NNP B-Gene
, , O
TATA NNP O
, , O
and CC O
a DT O
portion NN O
of IN O
the DT O
transactivation NN O
- : O
responsive JJ O
element NN O
were VBD O
each DT O
required VBN O
for IN O
complete JJ O
E1A NNP B-Gene
/ NNP O
E1B NNP B-Gene
- : O
mediated VBD O
activation NN O
of IN O
the DT O
HIV NNP B-Gene
LTR NNP I-Gene
. . O

Transcripts NNS O
for IN O
both DT O
ODV NNP B-Gene
- : I-Gene
E18 NN I-Gene
and CC O
ODV NNP B-Gene
- : I-Gene
EC27 NN I-Gene
initiate NN O
from IN O
conserved VBN O
TAAG NNP O
motifs NNS O
, , O
and CC O
transcripts NNS O
are VBP O
detected VBN O
from IN O
16 CD O
through IN O
72 CD O
hr NN O
p NN O
. . O
i NN O
. . O

In IN O
DNA NNP O
strand VBP O
exchange NN O
reactions NNS O
using VBG O
oligonucleotides NNS O
, , O
we PRP O
found VBD O
that IN O
Rec2 NNP B-Gene
exhibited VBD O
a DT O
pairing NN O
bias NN O
that WDT O
is VBZ O
opposite JJ O
that IN O
of IN O
RecA NNP B-Gene
. . O

During IN O
BH NNP O
the DT O
ventilator NN O
was VBD O
disconnected VBN O
and CC O
a DT O
bias NN O
flow NN O
of IN O
50 CD O
% NN O
O2 NNP O
at IN O
4 CD O
- : O
5 CD O
l NN O
/ NNP O
min NN O
was VBD O
delivered VBN O
through IN O
the DT O
side NN O
ports NNS O
of IN O
a DT O
small JJ O
catheter NN O
whose WP$ O
tip NN O
was VBD O
positioned VBN O
1 CD O
cm JJ O
cephalad NN O
of IN O
the DT O
carina NN O
. . O

In IN O
cells NNS O
limited VBN O
for IN O
His PRP$ O
, , O
increased JJ O
expression NN O
of IN O
arg JJ B-Gene
- : I-Gene
2 CD I-Gene
and CC O
cpc VB B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
decreased JJ O
expression NN O
of IN O
cox NN B-Gene
- : I-Gene
5 CD I-Gene
, , O
also RB O
had VBD O
translational JJ O
and CC O
transcriptional JJ O
components NNS O
. . O

We PRP O
speculate VBP O
that IN O
the DT O
human JJ O
papillomavirus NN O
late JJ O
mRNAs NN O
, , O
produced VBN O
from IN O
several JJ O
hundred CD O
copies NNS O
of IN O
the DT O
virus NN O
genome JJ O
present NN O
in IN O
infected JJ O
cells NNS O
, , O
compete NN O
with IN O
the DT O
c NN B-Gene
- : I-Gene
fos NN I-Gene
mRNAs NN I-Gene
for IN O
destabilizing VBG O
cellular JJ O
factors NNS O
and CC O
that IN O
this DT O
may MD O
lead VB O
to TO O
elevated JJ O
Fos NNP B-Gene
protein NN I-Gene
levels NNS O
in IN O
human JJ O
papillomavirus NN O
infected VBD O
cells NNS O
. . O

The DT O
csbA NN B-Gene
fusion NN I-Gene
was VBD O
maximally RB O
expressed VBN O
during IN O
early JJ O
stationary JJ O
phase NN O
in IN O
cells NNS O
grown VBN O
in IN O
Luria NNP O
broth CC O
containing VBG O
5 CD O
% NN O
glucose NN O
and CC O
0 CD O
. . O
2 CD O
% NN O
glutamine NN O
. . O

We PRP O
conclude VBP O
that DT O
CPET NNP O
is VBZ O
a DT O
useful JJ O
investigation NN O
in IN O
the DT O
management NN O
of IN O
patients NNS O
with IN O
cardiopulmonary JJ O
disease NN O
and CC O
complements VBZ O
the DT O
various JJ O
other JJ O
investigations NNS O
offered VBN O
by IN O
a DT O
pulmonary JJ O
function NN O
laboratory NN O
. . O

We PRP O
have VBP O
also RB O
found VBN O
that IN O
the DT O
in IN O
vitro JJ O
interaction NN O
between IN O
the DT O
SV40 NNP O
octamer MD O
motif VB O
and CC O
the DT O
lymphoid NN B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
protein NN I-Gene
oct SYM I-Gene
- : I-Gene
B2 NN I-Gene
was VBD O
negatively RB O
modulated VBN O
by IN O
a DT O
component JJ O
present NN O
in IN O
the DT O
nuclear JJ O
extracts NNS O
from IN O
several JJ O
lymphoid NN O
cell NN O
lines NNS O
. . O

The DT O
protein NN O
kinase NN O
domains NNS O
of IN O
LIMK1 NNP B-Gene
and CC O
LIMK2 NNP B-Gene
are VBP O
unique JJ O
in IN O
that DT O
they PRP O
contain VBP O
an DT O
unusual JJ O
sequence NN O
motif NN O
Asp NNP O
- : O
Leu NNP O
- : O
Asn NNP O
- : O
Ser NNP O
- : O
His PRP$ O
- : O
Asn NN O
in IN O
subdomain NN O
VIB NNP O
and CC O
a DT O
highly RB O
basic JJ O
insert NN O
between IN O
subdomains NNS O
VII NNP O
and CC O
VIII NNP O
. . O

The DT O
diagnosis NN O
of IN O
metachromatic JJ O
leukodystrophy NN O
( ( O
MLD NNP O
) ) O
was VBD O
confirmed VBN O
by IN O
the DT O
finding NN O
of IN O
low JJ O
arylsulfatase NN B-Gene
A NNP I-Gene
( ( O
ASA NNP B-Gene
) ) O
levels NNS O
in IN O
cultured JJ O
fibroblasts NNS O
in IN O
both DT O
sisters NNS O
. . O

This DT O
interaction NN O
involved VBD O
the DT O
SH3 NNP B-Gene
region NN I-Gene
of IN O
p50 NN B-Gene
( ( O
csk NN B-Gene
) ) O
and CC O
a DT O
proline NN O
- : O
rich JJ O
region NN O
( ( O
PPPLPERTPESFVLADM NNP O
) ) O
outside IN O
the DT O
catalytic JJ O
region NN O
of IN O
PTP NNP B-Gene
- : O
PEST NN O
. . O

IFN NNP B-Gene
- : I-Gene
stimulated VBD I-Gene
gene NN I-Gene
factor NN I-Gene
- : I-Gene
3 CD I-Gene
and CC O
STAT1 NNP B-Gene
homodimers NNS I-Gene
formed VBD O
and CC O
bound VBD O
an DT O
IFN NNP B-Gene
- : I-Gene
stimulated VBN I-Gene
response NN I-Gene
element NN I-Gene
( ( O
ISRE NNP B-Gene
) ) O
and CC O
gamma $ B-Gene
- : I-Gene
activated VBN I-Gene
sequence NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
element NN O
, , O
respectively RB O
. . O

Multidrug NNP O
resistance NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
mainly RB O
results NNS O
from IN O
the DT O
overexpression NN O
of IN O
genes NNS O
coding VBG O
for IN O
the DT O
membrane NN O
efflux NN O
pumps NNS O
, , O
the DT O
major JJ O
facilitators NNS O
and CC O
the DT O
ABC NNP B-Gene
binding NN I-Gene
cassette NN I-Gene
transporters NNS I-Gene
, , O
under IN O
the DT O
control NN O
of IN O
key JJ O
transcription NN O
regulators NNS O
encoded VBN O
by IN O
the DT O
PDR1 NNP B-Gene
and CC O
PDR3 NNP B-Gene
genes NNS I-Gene
. . O

Immunogenicity NN O
of IN O
various JJ O
mycobacteria NNS O
and CC O
the DT O
corresponding JJ O
levels NNS O
of IN O
cross NN O
- : O
protection NN O
developed VBD O
between IN O
species NNS O
. . O

The DT O
exogenous JJ O
fos NN B-Gene
gene NN I-Gene
was VBD O
rapidly RB O
induced VBN O
to TO O
maximal JJ O
levels NNS O
within IN O
1 CD O
- : O
2 CD O
hr NN O
of IN O
estrogen NN O
addition NN O
. . O

The DT O
importin NN B-Gene
alpha NN I-Gene
. . I-Gene
beta VB I-Gene
heterodimer NN I-Gene
mediates NNS O
nuclear JJ O
import NN O
of IN O
proteins NNS O
containing VBG O
classical JJ O
nuclear JJ O
localization NN O
signals NNS O
. . O

A DT O
reduced JJ O
matrix NN O
distribution NN O
and CC O
enhanced VBD O
cell NN O
density NN O
were VBD O
observed VBN O
as IN O
the DT O
biofilm NN O
aged VBD O
. . O

The DT O
Myc NNP B-Gene
LZ NNP I-Gene
was VBD O
found VBN O
to TO O
prevent VB O
homodimeric JJ O
interactions NNS O
, , O
thus RB O
explaining VBG O
Myc NNP B-Gene
inability NN O
to TO O
homodimerize VB O
efficiently RB O
. . O

However RB O
, , O
division NN O
of IN O
the DT O
chest JJS O
wall NN O
muscles NNS O
, , O
usually RB O
with IN O
diathermy NN O
, , O
contributes VBZ O
to TO O
prolonged VB O
pain NN O
and CC O
morbidity NN O
. . O

Results NNS O
from IN O
in IN O
vitro JJ O
transcription NN O
- : O
translation NN O
analysis NN O
and CC O
maxicell NN O
experiments NNS O
suggested VBD O
that IN O
the DT O
447 CD O
- : O
bp NN O
ORF NNP O
was VBD O
the DT O
one CD O
being VBG O
actively RB O
expressed VBN O
. . O

DNA NN O
sequence NN O
analysis NN O
showed VBD O
that IN O
the DT O
gene NN O
was VBD O
525 CD O
bp NN O
long RB O
and CC O
encoded VBD O
a DT O
175 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
with IN O
a DT O
molecular JJ O
weight NN O
of IN O
19 CD O
, , O
94 CD O
containing VBG O
a DT O
21 CD O
- : O
residue JJ O
typical JJ O
lipoprotein JJ O
signal JJ O
peptide NN O
and CC O
consensus NN O
prolipoprotein NN O
processing VBG O
site NN O
. . O

According VBG O
to TO O
the DT O
results NNS O
of IN O
assays NNS O
obtained VBN O
with IN O
the DT O
use NN O
of IN O
assay JJ O
systems NNS O
ORTHO NNP O
ELISA NNP O
and CC O
ABBOTT NNP O
HCV NNP O
EIA NNP O
( ( O
USA NNP O
) ) O
, , O
the DT O
detection NN O
rate NN O
of IN O
anti JJ B-Gene
- : I-Gene
HCV NNP I-Gene
- : I-Gene
C100 NNP I-Gene
- : I-Gene
3 CD I-Gene
among IN O
primary JJ O
blood NN O
donors NNS O
in IN O
Moscow NNP O
was VBD O
1 CD O
. . O
37 CD O
% NN O
and CC O
was VBD O
not RB O
different JJ O
from IN O
that IN O
among IN O
HBsAg NNP B-Gene
carriers NNS O
( ( O
1 CD O
. . O
8 CD O
% NN O
) ) O
and CC O
among IN O
donors NNS O
with IN O
anti JJ B-Gene
- : I-Gene
HCV NNP I-Gene
- : I-Gene
C100 NNP I-Gene
- : I-Gene
3 CD I-Gene
in IN O
the DT O
blood NN O
( ( O
1 CD O
. . O
6 CD O
% NN O
) ) O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
. . O

For IN O
this DT O
purpose NN O
, , O
the DT O
writhing VBG O
test NN O
, , O
capsaicin NN O
and CC O
formalin NN O
induced VBD O
- : O
pain NN O
in IN O
mice NN O
were VBD O
used VBN O
. . O

Standardized VBN O
gastric JJ O
wall NN O
specimens NNS O
from IN O
the DT O
area NN O
of IN O
grossly RB O
healed VBN O
ulcers NNS O
were VBD O
obtained VBN O
, , O
processed VBN O
, , O
and CC O
evaluated VBN O
by IN O
light JJ O
microscopy NNS O
and CC O
by IN O
transmission NN O
electron NN O
microscopy NN O
. . O

The DT O
GT NNP O
- : O
foreign JJ O
- : O
pictures NNS O
showed VBD O
that IN O
the DT O
judgment NN O
of IN O
other JJ O
subjects NNS O
changed VBN O
toward IN O
hedonic NN O
and CC O
permeability NN O
directions NNS O
. . O

Myelomatous JJ O
pleural JJ O
effusion NN O
as IN O
presentation NN O
form NN O
of IN O
multiple JJ O
myeloma NN O

Examination NN O
of IN O
the DT O
sequence NN O
of IN O
the DT O
Punta NNP B-Gene
Toro NNP I-Gene
M NNP I-Gene
gene NN I-Gene
product NN I-Gene
reveals VBZ O
the DT O
presence NN O
of IN O
multiple JJ O
hydrophobic JJ O
sequences NNS O
including VBG O
a DT O
19 CD O
- : O
amino NN O
acid NN O
, , O
carboxy JJ O
- : O
proximal NN O
, , O
hydrophobic JJ O
region NN O
( ( O
G2 NNP O
) ) O
. . O

In IN O
addition NN O
to TO O
the DT O
significant JJ O
reduction NN O
in IN O
blood NN O
pressure NN O
, , O
the DT O
angiotensin NN B-Gene
converting VBG I-Gene
enzyme NN I-Gene
( ( O
ACE NNP B-Gene
) ) O
inhibitor NN O
ramipril NN O
caused VBD O
a DT O
significant JJ O
regression NN O
of IN O
pathologic NN O
left VBD O
ventricular JJ O
hypertrophy NN O
demonstrated VBN O
by IN O
magnetic JJ O
resonance NN O
imaging NN O
and CC O
echocardiography NN O
. . O

Although IN O
linker NN O
regions NNS O
in IN O
transcription NN O
factors NNS O
are VBP O
known VBN O
to TO O
modulate VB O
DNA NNP O
binding VBG O
specificity NN O
, , O
our PRP$ O
studies NNS O
suggest VBP O
that IN O
the DT O
human JJ B-Gene
HSF1 NNP I-Gene
linker NN O
plays VBZ O
no DT O
role NN O
in IN O
determining VBG O
HSF1 NNP B-Gene
binding VBG O
preferences NNS O
in IN O
vivo NN O
but CC O
is VBZ O
a DT O
critical JJ O
determinant NN O
in IN O
regulating VBG O
the DT O
HSF1 NNP B-Gene
monomer SYM I-Gene
- : I-Gene
trimer NN I-Gene
equilibrium NN O
. . O

Multiple JJ O
regression NN O
analysis NN O
performed VBD O
between IN O
these DT O
long JJ O
- : O
term NN O
abiotic JJ O
factors NNS O
and CC O
nymphal JJ O
abundance NN O
in IN O
positive JJ O
sites NNS O
showed VBD O
high JJ O
relationship NN O
( ( O
R2 NNP O
coefficients NNS O
) ) O
for IN O
every DT O
habitat NN O
category NN O
and CC O
explained VBD O
> RB O
50 CD O
% NN O
of IN O
the DT O
variation NN O
in IN O
tick JJ O
abundance NN O
. . O

Twenty NNP O
- : O
nine CD O
days NNS O
after IN O
injection NN O
of IN O
5 CD O
. . O
8 CD O
mCi NN O
of IN O
Tc NNP O
- : O
99m CD O
, , O
which WDT O
gives VBZ O
28 CD O
rads NNS O
to TO O
the DT O
testis NN O
, , O
the DT O
number NN O
of IN O
sperm JJ O
hads NNS O
decreased VBD O
to TO O
70 CD O
% NN O
of IN O
control NN O
. . O

The DT O
unilateral JJ O
vestibular JJ O
hypofunction NN O
. . O

A DT O
new JJ O
physiopathological JJ O
treatment NN O
of IN O
HBV NNP O
- : O
related JJ O
polyarteritis NN O
inspired VBN O
by IN O
advances NNS O
in IN O
the DT O
treatment NN O
of IN O
chronic JJ O
active JJ O
hepatitis NN O
B NNP O
was VBD O
tested VBN O
in IN O
7 CD O
patients NNS O
. . O

Most JJS O
yeast JJ B-Gene
peroxisomal JJ I-Gene
matrix NN I-Gene
proteins NNS I-Gene
contain VBP O
a DT O
type NN O
1C CD O
- : O
terminal NN O
peroxisomal JJ O
targeting VBG O
signal NN O
( ( O
PTS1 NNP O
) ) O
consisting NN O
of IN O
the DT O
tripeptide JJ O
SKL NNP O
or CC O
a DT O
conservative JJ O
variant NN O
thereof NN O
. . O

Moxidectin NNP O
( ( O
at IN O
3 CD O
times NNS O
the DT O
therapeutic JJ O
dose NN O
) ) O
did VBD O
not RB O
have VB O
deleterious JJ O
effects NNS O
on IN O
cow JJ O
reproductive JJ O
performance NN O
as IN O
examined VBN O
( ( O
eg JJ O
, , O
at IN O
folliculogenesis NN O
, , O
ovulation NN O
, , O
and CC O
the DT O
early JJ O
embryonic JJ O
phase NN O
of IN O
development NN O
) ) O
. . O

We PRP O
conclude VBP O
that DT O
, , O
in IN O
AIDS NNP O
patients NNS O
with IN O
cryptococcosis NN O
, , O
tolerance NN O
to TO O
ILd NNP O
- : O
AmB NNP O
was VBD O
acceptable JJ O
when WRB O
the DT O
daily JJ O
dosage NN O
did VBD O
not RB O
exceed VB O
1 CD O
mg JJ O
/ NNP O
kg NN O
, , O
but CC O
the DT O
higher JJR O
1 CD O
. . O
5 CD O
mg JJ O
/ NNP O
kg VBD O
daily JJ O
dosage NN O
was VBD O
associated VBN O
with IN O
an DT O
unacceptable JJ O
rate NN O
of IN O
nephrotoxicity NN O
. . O

The DT O
frequency NN O
of IN O
integrations NNS O
that WDT O
led VBD O
to TO O
transcription NN O
of IN O
the DT O
lacZ JJ B-Gene
gene NN I-Gene
was VBD O
estimated VBN O
to TO O
be VB O
0 CD O
. . O
5 CD O
% NN O
of IN O
all DT O
integrations NNS O
, , O
of IN O
which WDT O
14 CD O
% NN O
were VBD O
downregulated VBN O
on IN O
differentiation NN O
of IN O
32D CD O
cells NNS O
towards NNS O
neutrophils NNS O
. . O

We PRP O
report VBP O
the DT O
use NN O
of IN O
a DT O
new JJ O
technetium NN O
- : O
99m CD O
- : O
albumin NN B-Gene
colloid JJ O
white JJ O
blood NN O
cell NN O
( ( O
TAC NNP O
- : O
WBC NNP O
) ) O
scan NN O
in IN O
the DT O
evaluation NN O
of IN O
appendicitis NN O
. . O

Dietary JJ O
supplement NN O
with IN O
fish JJ O
oil NN O
and CC O
related JJ O
n JJ O
- : O
3 CD O
EFAs NNP O
has VBZ O
been VBN O
used VBN O
to TO O
study VB O
their PRP$ O
antihypertensive JJ O
property NN O
in IN O
animals NNS O
and CC O
humans NNS O
with IN O
borderline NN O
and CC O
essential JJ O
hypertension NN O
. . O

The DT O
comparisons NNS O
revealed VBD O
that IN O
female JJ O
homicide NN O
- : O
suicide NN O
perpetrators NNS O
were VBD O
more RBR O
likely JJ O
than IN O
female JJ O
homicide JJ O
- : O
suicide NN O
victims NNS O
to TO O
live VB O
in IN O
mobile JJ O
homes NNS O
, , O
kill VB O
their PRP$ O
lover NN O
or CC O
ex VB O
- : O
lover NN O
, , O
have VBP O
their PRP$ O
crime NN O
accidentally RB O
discovered VBD O
, , O
leave VBP O
a DT O
suicide JJ O
note NN O
, , O
kill VB O
on IN O
a DT O
weekend NN O
, , O
and CC O
be VB O
depressed VBN O
, , O
but CC O
are VBP O
less RBR O
likely JJ O
than IN O
female JJ O
homicide JJ O
- : O
suicide NN O
victims NNS O
to TO O
live VB O
with IN O
a DT O
spouse NN O
. . O

This DT O
study NN O
reports VBZ O
the DT O
isolation NN O
of IN O
a DT O
P NNP O
. . O
hybrida NN O
gene NN O
, , O
jaf13 NN B-Gene
, , O
encoding VBG O
a DT O
basic JJ B-Gene
helix NN I-Gene
- : I-Gene
loop NN I-Gene
- : I-Gene
helix NN I-Gene
protein NN I-Gene
that WDT O
, , O
on IN O
the DT O
basis NN O
of IN O
sequence NN O
homology NN O
and CC O
intron NN O
/ VBP O
exon NN O
structure NN O
, , O
represents VBZ O
the DT O
P NNP O
. . O
hybrida NN O
orthologue NN O
of IN O
the DT O
Z NNP B-Gene
. . I-Gene
mays NNS I-Gene
r VBP I-Gene
genes NNS I-Gene
. . O

[ JJ O
Clinical NNP O
and CC O
epidemiological JJ O
characteristics NNS O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
oral JJ O
cavity NN O
in IN O
women NNS O
] JJ O
BACKGROUND NNP O
: : O
Squamous JJ O
cell NN O
carcinoma NN O
( ( O
SCC NNP O
) ) O
of IN O
the DT O
oral JJ O
cavity NN O
occurs VBZ O
mainly RB O
in IN O
the DT O
male JJ O
population NN O
. . O

5 CD O
- : O
( ( O
Dimethylaminopropyl NNP O
) ) O
- : O
19 CD O
, , O
11 CD O
- : O
dihydro NN O
- : O
5H CD O
- : O
benzo NN O
[ VBZ O
2 CD O
, , O
3 CD O
] NN O
pyrido NN O
[ VBD O
6 CD O
, , O
7 CD O
- : O
b NN O
] JJ O
azepine NN O
. . O

According VBG O
to TO O
their PRP$ O
functional JJ O
properties NNS O
the DT O
latter JJ O
neurons NNS O
were VBD O
subdivided VBN O
into IN O
: : O
( ( O
a DT O
) ) O
neurons NNS O
responding VBG O
to TO O
stimuli VB O
near IN O
the DT O
eyes NNS O
; : O
( ( O
b NN O
) ) O
neurons NNS O
triggered VBN O
by IN O
complex JJ O
visual JJ O
stimuli NN O
; : O
( ( O
c NN O
) ) O
neurons NNS O
inhibited VBN O
by IN O
visual JJ O
stimuli NNS O
. . O

To TO O
determine VB O
the DT O
function NN O
of IN O
VZV NNP B-Gene
gK NN I-Gene
in IN O
virus NN O
growth NN O
, , O
a DT O
series NN O
of IN O
gK JJ B-Gene
deletion NN I-Gene
mutants NNS I-Gene
were VBD O
constructed VBN O
with IN O
VZV NNP O
cosmid NN O
DNA NNP O
derived VBD O
from IN O
the DT O
Oka NNP O
strain NN O
. . O

Contributions NNS O
from IN O
pairs NNS O
of IN O
source NN O
and CC O
target NN O
volume NN O
elements NNS O
are VBP O
summed VBN O
for IN O
the DT O
S NNP O
values NNS O
between IN O
the DT O
tumor NN O
and CC O
itself PRP O
, , O
between IN O
the DT O
remaining VBG O
healthy JJ O
host NN O
organ NN O
and CC O
itself PRP O
, , O
and CC O
between IN O
the DT O
tumor NN O
and CC O
the DT O
remaining VBG O
healthy JJ O
host NN O
organ NNS O
, , O
with IN O
the DT O
reciprocity NN O
theorem NN O
assumed VBD O
for IN O
the DT O
last JJ O
. . O

This DT O
protein NN O
is VBZ O
present JJ O
in IN O
both DT O
HeLa NNP O
nuclear JJ O
extracts NNS O
and CC O
S100 NNP B-Gene
extracts NNS O
but CC O
absent NN O
from IN O
SR NNP B-Gene
protein NN I-Gene
preparations NNS O
, , O
suggesting VBG O
that IN O
it PRP O
is VBZ O
not RB O
a DT O
classical JJ O
SR NNP B-Gene
protein NN I-Gene
. . O

The DT O
transcript NN O
was VBD O
initially RB O
identified VBN O
as IN O
a DT O
partial JJ O
cDNA NN O
sequence NN O
in IN O
the DT O
course NN O
of IN O
constructing VBG O
a DT O
transcript NN O
map NN O
of IN O
the DT O
region NN O
between IN O
markers NNS O
D11S1765 NNP B-Gene
and CC O
uteroglobin JJ B-Gene
known VBN O
to TO O
encompass VB O
the DT O
gene NN O
causing VBG O
Best NNP O
disease NN O
. . O

The DT O
26S CD B-Gene
rRNA NN I-Gene
binding VBG I-Gene
ribosomal JJ I-Gene
protein NN I-Gene
equivalent NN O
to TO O
bacterial JJ B-Gene
protein NN I-Gene
L11 NNP I-Gene
is VBZ O
encoded VBN O
by IN O
unspliced JJ O
duplicated VBN O
genes NNS O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

We PRP O
conclude VBP O
that DT O
administration NN O
of IN O
the DT O
calcium NN O
antagonist NN O
Verapamil NNP O
is VBZ O
of IN O
no DT O
additional JJ O
value NN O
in IN O
tocolytic JJ O
treatment NN O
with IN O
beta NN O
- : O
mimetics NNS O
. . O

It PRP O
encodes VBZ O
a DT O
protein NN O
with IN O
three CD O
zinc NN O
fingers NNS O
similar JJ O
to TO O
those DT O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
Sp1 NNP I-Gene
. . O

In IN O
vitro JJ O
transcription NN O
assays NNS O
demonstrate VBP O
that IN O
the DT O
TCA NNP O
- : O
cycle NN O
intermediate NN O
, , O
fumarate NN O
, , O
directly RB O
and CC O
specifically RB O
inhibits VBZ O
the DT O
formation NN O
of IN O
the DT O
clcA NN B-Gene
transcript NN I-Gene
. . O

Addition NN O
of IN O
synthetic JJ O
tyrosine NN O
- : O
phosphorylated VBN O
peptides NNS O
derived VBN O
from IN O
betac JJ O
cytoplasmic JJ O
tyrosines NNS O
prior RB O
to TO O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
stimulation NN O
inhibited VBD O
the DT O
in IN O
vitro JJ O
activation NN O
of IN O
STAT5 NNP B-Gene
. . O

METHODS NNS O
: : O
We PRP O
determined VBD O
an DT O
odds NNS O
ratio NN O
( ( O
OR NNP O
) ) O
, , O
as IN O
a DT O
measure NN O
of IN O
the DT O
relative JJ O
risk NN O
of IN O
being VBG O
exposed VBN O
to TO O
a DT O
potential JJ O
interaction NN O
, , O
comparing VBG O
the DT O
use NN O
of IN O
the DT O
H2 NNP B-Gene
- : I-Gene
receptor NN I-Gene
antagonist NN O
, , O
cimetidine NN O
, , O
with IN O
that DT O
of IN O
the DT O
noninteracting JJ O
agents NNS O
ranitidine NN O
, , O
famotidine NN O
and CC O
nizatidine NN O
in IN O
users NNS O
and CC O
nonusers NNS O
of IN O
warfarin NN O
, , O
phenytoin NN O
and CC O
theophylline NN O
. . O

However RB O
these DT O
search NN O
engines NNS O
respond NN O
with IN O
such JJ O
cumbersome JJ O
results NNS O
that WDT O
domain VBP O
specific JJ O
experts NNS O
can MD O
not RB O
tolerate VB O
. . O

Expression NN O
of IN O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
type NN I-Gene
2 CD I-Gene
US3 NNP I-Gene
affects VBZ O
the DT O
Cdc42 NNP B-Gene
/ NNP O
Rac NNP B-Gene
pathway NN O
and CC O
attenuates VBZ O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
activation NN O
. . O

Pathol NNP O
. . O

Results NNS O
support VBD O
the DT O
hypothesis NN O
that WDT O
endogenous JJ B-Gene
corticotropin NN I-Gene
- : I-Gene
releasing NN I-Gene
factor NN I-Gene
, , O
perhaps RB O
acting VBG O
at IN O
a DT O
peripheral JJ O
binding NN O
site NN O
, , O
suppresses VBZ O
the DT O
active JJ O
behavioral JJ O
response NN O
characteristic NN O
of IN O
pups NNS O
during IN O
the DT O
early JJ O
phase NN O
of IN O
isolation NN O
in IN O
novel JJ O
surroundings NNS O
. . O

Localization NN O
of IN O
the DT O
intronless JJ O
gene NN O
coding VBG O
for IN O
calmodulin JJ B-Gene
- : I-Gene
like IN I-Gene
protein NN I-Gene
CLP NNP B-Gene
to TO O
human JJ O
chromosome NN O
10p13 CD O
- : O
ter NN O
. . O

A DT O
local JJ O
, , O
high JJ O
- : O
density NN O
, , O
single JJ O
- : O
nucleotide JJ O
polymorphism NN O
map NN O
used VBN O
to TO O
clone VB O
Caenorhabditis NNP B-Gene
elegans NNPS I-Gene
cdf VBP I-Gene
- : I-Gene
1 CD I-Gene
. . O

EGV NNP O
had VBD O
no DT O
detectable JJ O
effect NN O
on IN O
PP NNP B-Gene
secretion NN O
under IN O
basal NN O
or CC O
stimulated VBN O
conditions NNS O
. . O

Late JJ O
mRNA NN O
selected VBN O
by IN O
a DT O
cDNA NN O
homologous JJ O
to TO O
the DT O
HindIII NNP B-Gene
- : I-Gene
P NNP I-Gene
/ NNP O
EcoRI NNP B-Gene
- : I-Gene
B NNP I-Gene
region NN O
of IN O
the DT O
AcNPV NNP O
map NN O
directed VBD O
the DT O
synthesis NN O
of IN O
31K CD O
and CC O
30K CD O
proteins NNS O
which WDT O
comigrated VBD O
with IN O
the DT O
31K CD O
and CC O
30K CD O
proteins NNS O
translated VBN O
from IN O
RNA NNP O
selected VBN O
by IN O
the DT O
HindIII NNP B-Gene
- : I-Gene
A DT I-Gene
/ JJ O
EcoRI NNP B-Gene
- : I-Gene
C NNP I-Gene
/ NNP O
SstI NNP B-Gene
- : I-Gene
G NNP I-Gene
cDNA NN O
. . O

The DT O
COP NNP O
- : O
PAWP NNP O
gradient NN O
was VBD O
markedly RB O
decreased VBN O
in IN O
both DT O
shock NN O
and CC O
non JJ O
- : O
shock NN O
patients NNS O
with IN O
pulmonary JJ O
edema NN O
. . O

Based VBN O
on IN O
our PRP$ O
observations NNS O
, , O
we PRP O
propose VBP O
a DT O
model NN O
whereby WRB O
inactive JJ O
precursor NN O
molecules NNS O
produced VBN O
from IN O
the DT O
PEP4 NNP B-Gene
gene NN I-Gene
self PRP O
- : O
activate NN O
within IN O
the DT O
yeast JJ O
vacuole NN O
and CC O
subsequently RB O
activate VB O
other JJ O
vacuolar JJ B-Gene
hydrolases NNS I-Gene
. . O

No DT O
significant JJ O
correlation NN O
was VBD O
found VBN O
between IN O
LVM NNP O
or CC O
wall VB O
thickness NN O
and CC O
body NN O
surface JJ O
area NN O
, , O
age NN O
, , O
blood NN O
pressure NN O
, , O
heart NN O
rate NN O
, , O
cardiac JJ O
output NN O
, , O
total JJ O
peripheral JJ O
resistance NN O
and CC O
left VBD O
ventricular JJ O
systolic JJ O
wall NN O
stress NN O
, , O
whereas WP O
CD25 NNP O
was VBD O
correlated VBN O
with IN O
urinary JJ O
catecholamines NNS O
only RB O
in IN O
hypertensive JJ O
patients NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
606 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Although IN O
human JJ O
infections NNS O
with IN O
bacteraemia NN O
due JJ O
to TO O
Pasteurella NNP O
multocida NNS O
are VBP O
not RB O
uncommon JJ O
, , O
endocarditis RB O
associated VBN O
with IN O
P NNP O
. . O
haemolytica NN O
is VBZ O
rare JJ O
. . O

Cytoplasmic NNP B-Gene
dynein NN I-Gene
is VBZ O
a DT O
multisubunit NN O
, , O
microtubule NN O
- : O
dependent JJ O
mechanochemical JJ O
enzyme NN O
that WDT O
has VBZ O
been VBN O
proposed VBN O
to TO O
function NN O
in IN O
a DT O
variety NN O
of IN O
intracellular JJ O
movements NNS O
, , O
including VBG O
minus SYM O
- : O
end NN O
- : O
directed JJ O
transport NN O
of IN O
organelles NNS O
. . O

Despite IN O
its PRP$ O
requirement NN O
for IN O
enhancer NN O
- : O
dependent JJ O
splicing NN O
activity NN O
in IN O
vitro NN O
, , O
the DT O
dU2AF38 NN B-Gene
RS NNP I-Gene
domain NN I-Gene
was VBD O
also RB O
inessential JJ O
in IN O
vivo NN O
. . O

This DT O
repression NN O
was VBD O
reversed JJ O
agonists NNS O
of IN O
either DT O
receptor NN O
demonstrating VBG O
a DT O
functional JJ O
interaction NN O
between IN O
NCoR NNP B-Gene
and CC O
PPARalpha NNP B-Gene
. . O
RXRalpha NNP B-Gene
heterodimeric JJ O
complexes NNS O
in IN O
mammalian JJ O
cells NNS O
. . O

16 CD O
percent NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
sustained VBD O
normalization NN O
of IN O
serum JJ B-Gene
alanine JJ I-Gene
aminotransferase NN I-Gene
levels NNS O
( ( O
41 CD O
percent NN O
vs NN O
. . O

A DT O
simplified VBN O
thin JJ O
- : O
layer NN O
chromatographic JJ O
determination NN O
of IN O
hippuric JJ O
acid NN O
and CC O
methylhippuric JJ O
acids NNS O
. . O

Modern JJ O
studies NNS O
, , O
conducted VBN O
with IN O
Delta NNP O
- : O
9 CD O
- : O
THC NN O
, , O
in IN O
healthy JJ O
voluntaries NNS O
, , O
again RB O
suggest VBP O
the DT O
comparison NN O
or CC O
even RB O
the DT O
identity NN O
of IN O
the DT O
modifications NNS O
caused VBN O
by IN O
cannabis NN O
with IN O
sleep NN O
and CC O
dream NN O
. . O

Characterization NN O
of IN O
the DT O
promoter NN O
for IN O
the DT O
human JJ B-Gene
85 CD I-Gene
kDa NN I-Gene
cytosolic JJ I-Gene
phospholipase NN I-Gene
A2 NNP I-Gene
gene NN I-Gene
. . O

We PRP O
further RB O
studied VBD O
the DT O
effects NNS O
of IN O
SIE NNP B-Gene
- : I-Gene
1 CD I-Gene
hypermethylation NN O
on IN O
p21WAF1 JJ B-Gene
induction NN O
by IN O
STAT NNP B-Gene
activation NN O
. . O

RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
inhibition NN O
increased VBD O
the DT O
binding NN O
of IN O
ARE NNP O
( ( O
AUBP NNP O
activity NN O
) ) O
and CC O
poly NN O
( ( O
U NNP O
) ) O
- : O
Sepharose NN O
by IN O
cytoplasmic JJ B-Gene
hnRNP NN I-Gene
A1 NNP I-Gene
, , O
while IN O
nuclear JJ B-Gene
hnRNP NN I-Gene
A1 NNP I-Gene
binding NN O
was VBD O
unaffected VBN O
. . O

A DT O
38 CD O
- : O
bp NN O
poly NN O
( ( O
dA JJ O
- : O
dT NN O
) ) O
region NN O
was VBD O
found VBN O
to TO O
be VB O
a DT O
positive JJ O
regulator NN O
of IN O
Act1 NNP B-Gene
promoter NN I-Gene
activity NN O
. . O

The DT O
results NNS O
support VBP O
earlier JJR O
reports NNS O
that IN O
collagenase NN B-Gene
inhibitors NNS O
are VBP O
useful JJ O
in IN O
controlling VBG O
blister NN O
formation NN O
in IN O
recessive JJ O
dystrophic JJ O
epidermolysis NN O
bullosa NN O
. . O

RESULTS NN O
: : O
Total JJ O
IgE NNP B-Gene
levels NNS O
showed VBD O
a DT O
tendency NN O
to TO O
diminish VB O
. . O

The DT O
concentrations NNS O
of IN O
plasma NN O
ACTH NNP B-Gene
and CC O
cortisol NN O
increased VBN O
by IN O
40 CD O
% NN O
and CC O
60 CD O
% NN O
after IN O
MPTP NNP O
treatment NN O
, , O
respectively RB O
. . O

The DT O
role NN O
of IN O
calcitonin NN B-Gene
, , O
and CC O
other JJ O
agonists NNS O
which WDT O
activate VBP O
the DT O
cAMP NN O
pathway NN O
, , O
in IN O
regulating VBG O
transcription NN O
of IN O
the DT O
human JJ B-Gene
parathyroid NN I-Gene
hormone NN I-Gene
- : I-Gene
related VBN I-Gene
protein NN I-Gene
( ( O
PTHrP NNP B-Gene
) ) O
gene NN O
was VBD O
investigated VBN O
in IN O
a DT O
human JJ O
lung NN O
cancer NN O
cell NN O
line NN O
( ( O
BEN NNP O
) ) O
. . O

67 CD O
393 CD O
bp NN O
of IN O
contiguous JJ O
DNA NNP O
located VBD O
between IN O
markers NNS O
cdc18 NNS B-Gene
and CC O
cdc14 NN B-Gene
on IN O
the DT O
right JJ O
arm NN O
of IN O
fission NN O
yeast FW O
chromosome NN O
II NNP O
has VBZ O
been VBN O
sequenced VBN O
as IN O
part NN O
of IN O
the DT O
European NNP O
Union NNP O
Schizosaccharomyces NNP O
pombe VBD O
genome JJ O
sequencing NN O
project NN O
. . O

Resistance NN O
to TO O
thyroid VB O
hormone NN O
: : O
implications NNS O
for IN O
neurodevelopmental JJ O
research NN O
on IN O
the DT O
effects NNS O
of IN O
thyroid JJ O
hormone NN O
disruptors NNS O
. . O

Substitutions NNS O
introduced VBN O
at IN O
bases NNS O
surrounding VBG O
the DT O
ICR2 NNP B-Gene
motif NN I-Gene
yielded VBN O
levels NNS O
of IN O
pRNA NN O
replication NN O
that WDT O
differed VBD O
, , O
depending VBG O
on IN O
the DT O
maintenance NN O
of IN O
a DT O
putative JJ O
5 CD O
' POS O
stem NN O
- : O
loop NN O
structure NN O
in IN O
the DT O
positive JJ O
strand NN O
of IN O
the DT O
viral JJ O
genome NN O
. . O

Individuals NNS O
attending VBG O
the DT O
GUM NNP O
Department NNP O
in IN O
the DT O
Royal NNP O
Infirmary NNP O
of IN O
Edinburgh NNP O
between IN O
1990 CD O
and CC O
1994 CD O
with IN O
the DT O
diagnosis NN O
of IN O
HIV NNP O
infection NN O
, , O
genital JJ O
warts NNS O
, , O
genital JJ O
herpes NNS O
, , O
non SYM O
- : O
specific JJ O
genital JJ O
infection NN O
( ( O
NSGI NNP O
) ) O
, , O
gonorrhoea NN O
and CC O
syphilis NN O
were VBD O
included VBN O
in IN O
the DT O
study NN O
. . O

Prominent JJ O
findings NNS O
were VBD O
chronic JJ O
pancreatitis NN O
with IN O
acinar NN O
and CC O
ductal JJ O
plugs NNS O
, , O
granulomatous JJ O
and CC O
necrotizing JJ O
peripancreatic JJ O
steatitis NN O
, , O
degenerative JJ O
myopathy NN O
, , O
testicular JJ O
atrophy NN O
, , O
candidiasis NN O
and CC O
bacterial JJ O
necrotizing NN O
glossitis NN O
. . O

The DT O
most RBS O
likely JJ O
explanation NN O
for IN O
this DT O
is VBZ O
that IN O
gold NN O
principally RB O
accumulates VBZ O
in IN O
the DT O
Kupffer NNP O
cells NNS O
and CC O
renal JJ O
cortex NN O
and CC O
these DT O
cells NNS O
do VBP O
not RB O
express VB O
Type NNP B-Gene
I PRP I-Gene
deiodinase VBP I-Gene
. . O

It PRP O
has VBZ O
been VBN O
previously RB O
shown VBN O
that IN O
genes NNS O
transcribed VBN O
by IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
( ( O
RNAP NNP B-Gene
II NNP I-Gene
) ) O
are VBP O
subject JJ O
to TO O
position NN O
effect NN O
variegation NN O
when WRB O
located VBN O
near IN O
yeast NN O
telomeres NNS O
. . O

RESULTS NN O
: : O
In IN O
an DT O
18 CD O
moth JJ O
period NN O
and CC O
out IN O
of IN O
a DT O
total NN O
of IN O
284 CD O
positive JJ O
blood NN O
cultures NNS O
( ( O
154 CD O
significant JJ O
isolations NNS O
) ) O
14 CD O
episodes NNS O
of IN O
bacteremia NN O
by IN O
M NNP O
. . O
tuberculosis NN O
were VBD O
studied VBN O
in IN O
12 CD O
prison NN O
patients NNS O
coinfected VBN O
by IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
with IN O
associated VBN O
severe JJ O
immunosuppression NN O
( ( O
mean NN O
of IN O
CD4 NNP B-Gene
= NNP O
0 CD O
. . O
68 CD O
x JJ O
10 CD O
( ( O
9 CD O
) ) O
/ FW O
l NN O
) ) O
. . O

Such JJ O
a DT O
mechanism NN O
may MD O
allow VB O
acceleration NN O
of IN O
degenerative JJ O
joint JJ O
conditions NNS O
, , O
and CC O
may MD O
account VB O
for IN O
the DT O
increased JJ O
prevalence NN O
of IN O
such JJ O
conditions NNS O
seen VBN O
with IN O
HMS NNP O
subjects NNS O
. . O

Identification NN O
of IN O
a DT O
cis NN O
- : O
acting VBG O
element NN O
in IN O
the DT O
class NN B-Gene
I PRP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
gene NN I-Gene
promoter NN I-Gene
responsive VBP O
to TO O
activation NN O
by IN O
retroviral JJ O
sequences NNS O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
demonstrate VBP O
that DT O
hGCN5 NN B-Gene
is VBZ O
also RB O
an DT O
HAT NNP B-Gene
and CC O
has VBZ O
the DT O
same JJ O
substrate NN O
specificity NN O
as IN O
yGCN5 NN B-Gene
. . O

A DT O
normal JJ O
systemic JJ O
response NN O
was VBD O
obtained VBN O
after IN O
IF NNP O
, , O
indicating VBG O
that IN O
rhG NN B-Gene
- : I-Gene
CSF NNP I-Gene
retains VBZ O
activity NN O
in IN O
the DT O
solid JJ O
state NN O
. . O

Among IN O
the DT O
H NNP B-Gene
/ NNP I-Gene
ACA NNP I-Gene
snoRNAs NN I-Gene
associated VBN O
with IN O
Gar1p NNP B-Gene
, , O
one CD O
can MD O
distinguish VB O
a DT O
large JJ O
group NN O
of IN O
snoRNAs NN O
that WDT O
are VBP O
not RB O
essential JJ O
in IN O
yeast NN O
and CC O
serve NN O
as IN O
guides NNS O
for IN O
pseudouridine JJ O
synthesis NN O
onto IN O
the DT O
pre JJ O
- : O
rRNA NN O
molecule NN O
. . O

The DT O
decrease NN O
of IN O
TNF NNP B-Gene
receptors NNS I-Gene
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
was VBD O
accompanied VBN O
by IN O
down IN O
- : O
regulation NN O
of IN O
TNF NNP B-Gene
- : O
induced JJ O
activities NNS O
, , O
including VBG O
cytotoxicity NN O
, , O
caspase VB B-Gene
- : I-Gene
3 CD I-Gene
activation NN O
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
activation NN O
, , O
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
induction NN O
. . O

Overall JJ O
agreement NN O
between IN O
rest NN O
/ NNP O
postnitroglycerin NN O
technetium NN O
- : O
99m CD O
tetrofosmin NN O
SPET NNP O
studies NNS O
and CC O
rest VB O
/ JJ O
redistribution NN O
or CC O
rest NN O
/ JJ O
reinjection NN O
thallium NN O
- : O
201 CD O
SPET NNP O
studies NNS O
, , O
regarding VBG O
the DT O
presence NN O
of IN O
myocardial JJ O
viability NN O
, , O
was VBD O
87 CD O
% NN O
and CC O
90 CD O
% NN O
, , O
respectively RB O
. . O

These DT O
data NNS O
show VBP O
that IN O
the DT O
spv JJ B-Gene
virulence NN I-Gene
genes NNS I-Gene
belong RB O
simultaneously RB O
to TO O
several JJ O
regulons NNS O
in IN O
the DT O
cell NN O
, , O
raising VBG O
the DT O
possibility NN O
that IN O
spv JJ B-Gene
expression NN O
can MD O
be VB O
fine JJ O
- : O
tuned VBN O
in IN O
response NN O
to TO O
multiple VB O
environmental JJ O
inputs NNS O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
activation NN O
of IN O
these DT O
enzymes NNS O
is VBZ O
not RB O
sufficient JJ O
for IN O
the DT O
acute JJ O
stimulation NN O
of IN O
glucose JJ O
transport NN O
. . O

The DT O
infected VBN B-Gene
cell NN I-Gene
protein VBZ I-Gene
no DT I-Gene
. . I-Gene
0 CD I-Gene
( ( O
ICP0 NNP B-Gene
) ) O
of IN O
herpes NNS O
simplex JJ O
virus NN O
1 CD O
is VBZ O
a DT O
promiscuous JJ O
transactivator NN O
shown VBN O
to TO O
enhance VB O
the DT O
expression NN O
of IN O
genes NNS O
introducted VBN O
into IN O
cells NNS O
by IN O
infection NN O
or CC O
transfection NN O
. . O

Herein NNP O
, , O
we PRP O
show VBP O
that IN O
Smad3 NNP B-Gene
physically RB O
interacts VBZ O
with IN O
the DT O
HMG NNP B-Gene
box NN O
domain NN O
of IN O
LEF1 NNP B-Gene
and CC O
that IN O
TGFbeta NNP B-Gene
and CC O
Wnt NNP B-Gene
pathways NNS O
synergize VBP O
to TO O
activate VB O
transcription NN O
of IN O
the DT O
Xenopus NNP O
homeobox NN O
gene NN O
twin NN B-Gene
( ( O
Xtwn NNP B-Gene
) ) O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
binding NN O
of IN O
CBF NNP B-Gene
/ NNP O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
to TO O
the DT O
inverted JJ O
CCAAT NNP O
box NN O
is VBZ O
responsible JJ O
for IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
nTPH JJ B-Gene
gene NN I-Gene
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
dopamine NN B-Gene
receptor NN I-Gene
stimulation NN O
by IN O
different JJ O
dopamine NN O
agonists NNS O
produces VBZ O
a DT O
different JJ O
pattern NN O
of IN O
effects NNS O
on IN O
the DT O
characteristics NNS O
of IN O
the DT O
reaction NN O
time NN O
response NN O
. . O

In IN O
contrast NN O
to TO O
some DT O
results NNS O
previously RB O
published VBN O
for IN O
a DT O
very RB O
close JJ O
sequence NN O
variant NN O
( ( O
see VB O
ref NN O
. . O

Thus RB O
analysis NN O
indicated VBD O
no DT O
reliable JJ O
evidence NN O
that IN O
conscious JJ O
presleep JJ O
suggestions NNS O
become VBP O
incorporated VBN O
into IN O
dream NN O
content NN O
. . O

Collaborative NNP O
study NN O
of IN O
Japanese JJ O
Pharmacopoeia NNP O
Heparin NNP O
Sodium NNP O
Reference NNP O
Standard NNP O

Topoisomerase NNP B-Gene
II NNP I-Gene
is VBZ O
a DT O
major JJ O
target NN O
of IN O
the DT O
protein NN B-Gene
kinase NN I-Gene
casein NN I-Gene
kinase VBD I-Gene
2 CD I-Gene
( ( O
PK NNP B-Gene
CK2 NNP I-Gene
) ) O
in IN O
vivo NN O
. . O

EMBO NNP O
J NNP O
. . O

One CD O
hundred CD O
fifty JJ O
patients NNS O
were VBD O
reviewed VBN O
at IN O
1 CD O
year NN O
after IN O
arthroplasty NN O
. . O

When WRB O
given VBN O
the DT O
choice NN O
between IN O
an DT O
estrous JJ O
female NN O
and CC O
a DT O
sexually RB O
active JJ O
male NN O
in IN O
the DT O
AOF NNP O
, , O
flutamide NN O
females NNS O
, , O
as RB O
well RB O
as IN O
controls NNS O
, , O
preferred VBD O
the DT O
male NN O
partner NN O
. . O

Studies NNS O
of IN O
lipoprotein JJ B-Gene
- : I-Gene
X NN I-Gene
( ( O
LP NNP B-Gene
- : I-Gene
X NN I-Gene
) ) O
and CC O
bile JJ O
acids NNS O
in IN O
familial JJ O
LCAT NNP B-Gene
deficiency NN O
. . O

To TO O
further RBR O
understand VB O
the DT O
role NN O
of IN O
cis JJ O
- : O
acting VBG O
elements NNS O
in IN O
these DT O
regulatory JJ O
mechanisms NNS O
, , O
we PRP O
have VBP O
characterized VBN O
a DT O
transcriptional JJ O
promoter NN O
that WDT O
drives VBZ O
germline JJ O
expression NN O
of IN O
TCR NNP B-Gene
beta NN I-Gene
gene NN I-Gene
segments NNS I-Gene
in IN O
vivo NN O
. . O

CONCLUSION NN O
: : O
MMF NNP O
( ( O
2 CD O
- : O
3 CD O
g JJ O
/ NNP O
day NN O
) ) O
is VBZ O
unable JJ O
to TO O
control VB O
the DT O
signs NNS O
of IN O
mucocutaneous JJ O
Adamantiades NNP O
- : O
Behcet NNP O
' POS O
s JJ O
disease NN O
. . O

Immunoprecipitation NN O
experiments NNS O
using VBG O
DokR NNP B-Gene
- : I-Gene
specific JJ I-Gene
antibodies NNS I-Gene
revealed VBD O
an DT O
interaction NN O
between IN O
endogenous JJ B-Gene
DokR NNP I-Gene
and CC O
a DT O
150 CD O
- : O
kDa NN O
protein NN O
that WDT O
is VBZ O
tyrosine JJ O
- : O
phosphorylated VBN O
in IN O
EGF NNP B-Gene
- : O
stimulated VBD O
BaF NNP O
/ NNP O
3 CD O
cells NNS O
. . O

A DT O
retrospective JJ O
epidemiological JJ O
study NN O
is VBZ O
reported VBN O
concerning VBG O
burn NN O
injuries NNS O
in IN O
775 CD O
children NNS O
hospitalized VBN O
at IN O
the DT O
unit NN O
of IN O
burn NN O
care NN O
of IN O
Casablanca NNP O
between IN O
1985 CD O
and CC O
1993 CD O
. . O

Interestingly RB O
, , O
dTFIIA SYM B-Gene
- : I-Gene
L NNP I-Gene
/ NNP I-Gene
S NNP I-Gene
is VBZ O
also RB O
able JJ O
to TO O
significantly RB O
enhance VB O
transcriptional JJ O
activation NN O
by IN O
upstream JJ O
transcription NN O
factors NNS O
including VBG O
Sp1 NNP B-Gene
, , O
VP16 NNP B-Gene
, , O
and CC O
NTF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

The DT O
computer NN O
- : O
programmed JJ O
cytocentrifuge NN O
is VBZ O
currently RB O
most RBS O
popular JJ O
. . O

The DT O
effects NNS O
of IN O
cardioselective JJ O
beta NN O
- : O
1 CD O
adrenergic JJ O
agonist NN O
, , O
1 CD O
- : O
( ( O
4 CD O
- : O
hydroxyphenoxy NN O
) ) O
- : O
isopropylamino NN O
- : O
2 CD O
- : O
propanol NN O
) ) O
, , O
i JJ O
. . O
e NN O
. . O
, , O
prenalterol NN O
, , O
were VBD O
examined VBN O
on IN O
direct JJ O
and CC O
continuous JJ O
measurements NNS O
of IN O
left JJ O
ventricular NN O
( ( O
LV NNP O
) ) O
pressure NN O
, , O
diameter NN O
, , O
dP NN O
/ NNP O
dt NN O
, , O
velocity NN O
of IN O
shortening NN O
, , O
arterial JJ O
pressure NN O
, , O
iliac JJ O
blood NN O
flow NN O
and CC O
heart NN O
rate NN O
in IN O
10 CD O
conscious JJ O
dogs NNS O
. . O

Analysis NN O
of IN O
homologous JJ O
DNA NNP O
sequences NNS O
within IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
mouse NN B-Gene
and CC I-Gene
human JJ I-Gene
mts1 NN I-Gene
genes NNS I-Gene
: : O
kB VB B-Gene
- : I-Gene
like IN I-Gene
site NN I-Gene
and CC O
microsatellite JJ O
DNA NN O

When WRB O
the DT O
l NN O
- : O
methadone NN O
- : O
sensitive JJ O
, , O
opioid JJ B-Gene
receptor NN I-Gene
is VBZ O
blocked VBN O
by IN O
naloxone NN O
or CC O
tolerance NN O
has VBZ O
developed VBN O
, , O
than IN O
l SYM O
- : O
methadone NN O
can MD O
produce VB O
behavioral JJ O
effects NNS O
by IN O
a DT O
nonopioid JJ O
mechanism NN O
. . O

Filter NNP O
and CC O
cytocentrifuge JJ O
preparations NNS O
of IN O
the DT O
urine NN O
were VBD O
studied VBN O
and CC O
all DT O
cases NNS O
displayed VBD O
numerous JJ O
scattered JJ O
aggregates NNS O
or CC O
single JJ O
tumor NN O
cells NNS O
in IN O
an DT O
inflammatory NN O
background NN O
. . O

Only RB O
one CD O
of IN O
these DT O
bands NNS O
was VBD O
supershifted VBN O
by IN O
antibody NN O
to TO O
p50 VB B-Gene
, , O
whereas JJ O
antibodies NNS O
to TO O
p65 VB B-Gene
or CC O
other JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
proteins NNS I-Gene
had VBD O
no DT O
effect NN O
. . O

Temporal NNP O
control NN O
of IN O
GUS NNP B-Gene
expression NN O
was VBD O
found VBN O
to TO O
involve VB O
two CD O
negative JJ O
regulatory JJ O
sequences NNS O
, , O
NRS1 NNP O
( ( O
- : O
391 CD O
to TO O
- : O
295 CD O
) ) O
and CC O
NRS2 NNP O
( ( O
- : O
518 CD O
to TO O
- : O
418 CD O
) ) O
, , O
as RB O
well RB O
as IN O
the DT O
positive JJ O
domain NN O
UAS1 NNP O
. . O

Partial JJ O
characterization NN O
of IN O
the DT O
active JJ O
site NN O
human JJ B-Gene
platelet NN I-Gene
cAMP NN I-Gene
phosphodiesterase NN I-Gene
, , O
PDE3A NNP B-Gene
, , O
by IN O
site NN O
- : O
directed JJ O
mutagenesis NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
focus VBP O
on IN O
the DT O
genetics NNS O
of IN O
the DT O
region NN O
of IN O
the DT O
17 CD B-Gene
hep NN I-Gene
syn NN I-Gene
gB NN I-Gene
gene NN I-Gene
that WDT O
conferred VBD O
both DT O
the DT O
syncytial NN O
and CC O
pathogenic JJ O
phenotypes NNS O
to TO O
17 CD B-Gene
syn NN I-Gene
+ NN I-Gene
. . O

These DT O
latter JJ O
results NNS O
showed VBD O
that IN O
the DT O
ABFI NNP B-Gene
protein NN I-Gene
, , O
like IN O
the DT O
RAP1 NNP B-Gene
protein NN I-Gene
, , O
bound JJ O
sequences NNS O
required VBN O
for IN O
positive JJ O
as RB O
well RB O
as IN O
negative JJ O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

The DT O
MABP NNP O
and CC O
MCBFV NNP O
signals NNS O
were VBD O
bandpass NN O
filtered VBN O
in IN O
the DT O
very RB O
low JJ O
- : O
frequency NN O
range NN O
( ( O
VLF NNP O
, , O
0 CD O
. . O
15 CD O
- : O
0 CD O
. . O
7 CD O
Hz NNP O
) ) O
, , O
low JJ O
- : O
frequency NN O
range NN O
( ( O
LF NNP O
, , O
0 CD O
. . O
7 CD O
- : O
0 CD O
. . O
15 CD O
Hz NNP O
) ) O
and CC O
high JJ O
- : O
frequency NN O
range NN O
( ( O
HF NNP O
, , O
0 CD O
. . O
15 CD O
- : O
0 CD O
. . O
40 CD O
Hz NNP O
) ) O
before IN O
applying VBG O
CCF NNP O
for IN O
the DT O
purpose NN O
of IN O
studying VBG O
the DT O
effect NN O
of IN O
different JJ O
bandwidths NNS O
on IN O
the DT O
resulting VBG O
mean JJ O
CCFs NNP O
. . O

Thus RB O
, , O
the DT O
characterization NN O
of IN O
the DT O
promoter NN O
region NN O
should MD O
help VB O
to TO O
define VB O
regulatory JJ O
elements NNS O
that WDT O
control VBP O
neuron SYM O
- : O
specific JJ O
and CC O
developmental JJ O
expression NN O
of IN O
the DT O
MAP1B NNP B-Gene
gene NN I-Gene
. . O

Strikingly RB O
, , O
stoichiometric JJ O
association NN O
of IN O
p107 NN B-Gene
or CC O
p130 NN B-Gene
with IN O
either DT O
cyclin NN B-Gene
E NNP I-Gene
- : O
cdk2 NN B-Gene
or CC O
cyclin VB B-Gene
A DT I-Gene
- : O
cdk2 NN B-Gene
negated VBD O
the DT O
activities NNS O
of IN O
these DT O
kinases NNS O
. . O

However RB O
, , O
the DT O
presence NN O
of IN O
Tax NNP B-Gene
I PRP I-Gene
increased VBD O
the DT O
extent NN O
and CC O
altered VBD O
the DT O
profile NN O
of IN O
proteins NNS O
binding VBG O
TRE NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
vivo NN O
. . O

In IN O
Schizosaccharomyces NNP O
pombe NN O
, , O
the DT O
activity NN O
of IN O
the DT O
M NNP O
- : O
phase NN O
- : O
inducing NN O
Cdc2 NNP B-Gene
/ NNP O
Cdc13 NNP B-Gene
cyclin SYM O
- : O
dependent JJ O
kinase NN O
is VBZ O
inhibited VBN O
by IN O
Wee1 NNP B-Gene
and CC O
Mik1 NNP B-Gene
tyrosine NN B-Gene
kinases NNS I-Gene
, , O
and CC O
activated VBN O
by IN O
Cdc25 NNP B-Gene
and CC O
Pyp3 NNP B-Gene
tyrosine NN B-Gene
phosphatases NNS I-Gene
. . O

Vestibular JJ O
adaptation NN O
exercises NNS O
and CC O
recovery NN O
: : O
acute NN O
stage NN O
after IN O
acoustic JJ O
neuroma JJ O
resection NN O
. . O

The DT O
histologic NN O
grade NN O
for IN O
the DT O
same JJ O
anatomic JJ O
site NN O
varied VBD O
among IN O
hearts NNS O
and CC O
among IN O
different JJ O
anatomic JJ O
sites NNS O
in IN O
the DT O
same JJ O
heart NN O
. . O

We PRP O
have VBP O
identified VBN O
amino JJ O
acid NN O
sequences NNS O
in IN O
mammalian JJ O
and CC O
Xenopus NNP O
NeuroD1 NNP B-Gene
/ NNP O
BETA2 NNP B-Gene
that WDT O
are VBP O
necessary JJ O
for IN O
insulin JJ B-Gene
gene NN I-Gene
expression NN O
and CC O
ectopic JJ O
neurogenesis NN O
. . O

Orientation NN O
of IN O
the DT O
nuclear JJ O
spin NN O
system NN O
by IN O
optical JJ O
pumping NN O
causes VBZ O
an DT O
Overhauser NNP O
shift NN O
of IN O
the DT O
excitonic JJ O
energy NN O
levels NNS O
proportional JJ O
to TO O
the DT O
degree NN O
of IN O
nuclear JJ O
orientation NN O
. . O

Corticosteroid NNP O
- : O
mediated VBD O
transcriptional JJ O
inhibition NN O
was VBD O
greater JJR O
for IN O
MR NNP B-Gene
/ NNP O
GR NNP B-Gene
in IN O
combination NN O
than IN O
for IN O
MR NNP B-Gene
or CC O
GR NNP B-Gene
alone RB O
. . O

Hepatitis WRB O
A DT O
infected VBN O
food NN O
handler NN O
at IN O
an DT O
Edmonton NNP O
, , O
Alberta NNP O
retail JJ O
food NN O
facility NN O
: : O
public JJ O
health NN O
protection NN O
strategies NNS O
. . O

In IN O
this DT O
study NN O
we PRP O
have VBP O
investigated VBN O
the DT O
role NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
in IN O
initiating VBG O
the DT O
adipogenic JJ O
program NN O
by IN O
overexpressing VBG O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
in IN O
multipotential JJ O
NIH NNP O
- : O
3T3 CD O
fibroblasts NNS O
. . O

Fasting VBG O
plasma NN O
and CC O
lipoprotein NN O
lipid JJ O
concentrations NNS O
, , O
adipose JJ B-Gene
tissue NN I-Gene
lipoprotein JJ I-Gene
lipase NN I-Gene
activity NN O
, , O
anthropometric JJ O
data NNS O
, , O
alcohol NN O
consumption NN O
, , O
smoking VBG O
habits NNS O
, , O
weekly JJ O
mileage NN O
run NN O
and CC O
performance NN O
on IN O
a DT O
bicycle NN O
ergometer NN O
were VBD O
recorded VBN O
before IN O
and CC O
after IN O
the DT O
training NN O
period NN O
. . O

Intravenous JJ O
administration NN O
( ( O
25 CD O
mg NN O
/ NNP O
kg NN O
) ) O
of IN O
carbonic JJ B-Gene
anhydrase NN I-Gene
inhibitors NNS O
( ( O
acetazolamide RB O
, , O
methazolamide RB O
, , O
dichlorphenamide NN O
, , O
sulthiame NN O
) ) O
induced VBD O
an DT O
early JJ O
important JJ O
rise NN O
of IN O
cortical JJ O
p NN O
O2 NNP O
, , O
which WDT O
is VBZ O
not RB O
dependent JJ O
on IN O
increase NN O
of IN O
p JJ O
O2 NNP O
and CC O
p VB O
CO2 NNP O
and CC O
decrease NN O
of IN O
pH NN O
in IN O
arterial JJ O
blood NN O
. . O

Although IN O
stone NN O
- : O
formers NNS O
were VBD O
not RB O
found VBN O
to TO O
display VB O
any DT O
features NNS O
of IN O
magnesium NN O
metabolism NN O
that WDT O
were VBD O
different JJ O
from IN O
those DT O
in IN O
the DT O
control NN O
group NN O
, , O
their PRP$ O
lower JJR O
urinary JJ O
excretion NN O
of IN O
magnesium NN O
in IN O
relation NN O
to TO O
calcium NN O
may MD O
be VB O
a DT O
factor NN O
in IN O
their PRP$ O
increased JJ O
stone NN O
- : O
forming NN O
propensity NN O
. . O

The DT O
baroreflex JJ O
latency NN O
( ( O
from IN O
the DT O
ECG NNP O
R NNP O
- : O
wave NN O
to TO O
the DT O
integrated VBN O
MSNA NNP O
burst RB O
peak NN O
) ) O
was VBD O
constant JJ O
at IN O
approximately RB O
1 CD O
. . O
20 CD O
s NN O
during IN O
sleep NN O
, , O
suggesting VBG O
that IN O
pulse JJ O
- : O
synchronicity NN O
was VBD O
maintained VBN O
. . O

The DT O
duration NN O
and CC O
the DT O
amplitude NN O
of IN O
the DT O
negative JJ O
potential NN O
were VBD O
greatest JJS O
for IN O
completely RB O
regenerating VBG O
ears NNS O
with IN O
overgrowth NN O
, , O
smaller JJR O
for IN O
partially RB O
regenerating VBG O
ears NNS O
, , O
and CC O
smallest JJS O
for IN O
the DT O
nonregenerating JJ O
ears NNS O
. . O

Protein NNP B-Gene
kinase VBD I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
, , O
a DT O
widely RB O
- : O
distributed VBN O
enzyme NN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
many JJ O
physiological JJ O
processes NNS O
, , O
consists NNS O
of IN O
a DT O
family NN O
of IN O
at IN O
least JJS O
twelve NN O
isoenzymes NNS O
which WDT O
differ VBP O
in IN O
tissue NN O
distribution NN O
, , O
subcellular JJ O
localization NN O
, , O
regulatory JJ O
properties NNS O
, , O
etc FW O
. . O

Further JJ O
investigation NN O
on IN O
the DT O
chemotactic JJ O
influence NN O
of IN O
thymic JJ B-Gene
hormone NN I-Gene
on IN O
lymphocytes NNS O

Coliphage NN B-Gene
186 CD I-Gene
B NNP I-Gene
is VBZ O
a DT O
72 CD O
- : O
amino NN O
acid JJ O
protein NN O
belonging VBG O
to TO O
the DT O
Ogr NNP B-Gene
family NN O
of IN O
analogous JJ O
transcription NN O
factors NNS O
present VBP O
in IN O
P2 NNP O
- : O
like IN O
phage NN O
, , O
which WDT O
contain VBP O
a DT O
Cys NNP O
- : O
X2 SYM O
- : O
Cys NNP O
- : O
X22 SYM O
- : O
Cys NNP O
- : O
X4 SYM O
- : O
Cys NNP O
presumptive JJ O
zinc NN O
- : O
finger NN O
motif NN O
. . O

The DT O
reduced JJ O
rate NN O
of IN O
F NNP O
absorption NN O
and CC O
slower JJR O
rise NN O
in IN O
plasma NN O
F NNP O
concentration NN O
accompanying VBG O
delayed VBN O
gastric JJ O
emptying VBG O
indicate NN O
that IN O
passage NN O
of IN O
F NNP O
into IN O
the DT O
small JJ O
intestine NN O
is VBZ O
the DT O
major JJ O
factor NN O
in IN O
rapid JJ O
F NNP O
absorption NN O
. . O

The DT O
juxtamembrane NN O
region NN O
of IN O
the DT O
insulin NN B-Gene
receptor NN I-Gene
( ( I-Gene
IR NNP I-Gene
) ) I-Gene
beta SYM I-Gene
- : I-Gene
subunit NN I-Gene
contains VBZ O
an DT O
unphosphorylated JJ O
tyrosyl NN O
residue NN O
( ( O
Tyr960 NNP O
) ) O
that WDT O
is VBZ O
essential JJ O
for IN O
insulin NN B-Gene
- : O
stimulated VBN O
tyrosyl JJ O
phosphorylation NN O
of IN O
some DT O
endogenous JJ O
substrates NNS O
and CC O
certain JJ O
biological JJ O
responses NNS O
( ( O
White NNP O
, , O
M NNP O
. . O
F NNP O
. . O
, , O
Livingston NNP O
, , O
J NNP O
. . O
N NNP O
. . O
, , O
Backer NNP O
, , O
J NNP O
. . O
M NNP O
. . O
, , O
Lauris NNP O
, , O
V NNP O
. . O
, , O
Dull NNP O
, , O
T NNP O
. . O
J NNP O
. . O
, , O
Ullrich NNP O
, , O
A NNP O
. . O
, , O
and CC O
Kahn NNP O
, , O
C NNP O
. . O
R NNP O
. . O

The DT O
products NNS O
of IN O
the DT O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
CIN1 NNP I-Gene
, , O
CIN2 NNP B-Gene
and CC O
CIN4 NNP B-Gene
genes NNS I-Gene
participate VB O
in IN O
a DT O
nonessential JJ O
pathway NN O
required VBN O
for IN O
normal JJ O
microtubule NN O
function NN O
. . O

Investigation NN O
of IN O
the DT O
structural JJ O
basis NN O
of IN O
the DT O
interaction NN O
between IN O
human JJ B-Gene
Igs NNP I-Gene
and CC O
gp120 NN B-Gene
shows NNS O
that IN O
the DT O
viral JJ B-Gene
gp120 NN I-Gene
SAg NNP I-Gene
can MD O
interact VB O
only RB O
with IN O
a DT O
subset NN O
of IN O
human JJ B-Gene
V NNP I-Gene
( ( I-Gene
H NNP I-Gene
) ) I-Gene
3 CD I-Gene
+ JJ I-Gene
Igs NNP I-Gene
. . O

This DT O
failure NN O
to TO O
execute VB O
regulated JJ O
G1 NNP O
/ NNP O
S NNP O
arrest NN O
is VBZ O
correlated VBN O
with IN O
enhanced JJ O
thermosensitivity NN O
of IN O
colony NN O
- : O
forming NN O
ability NN O
. . O

DESIGN NN O
: : O
Comparison NN O
of IN O
number NN O
of IN O
women NNS O
with IN O
PKU NNP O
aged VBD O
15 CD O
- : O
44 CD O
years NNS O
on IN O
the DT O
NSW NNP O
PKU NNP O
database NN O
( ( O
observed JJ O
number NN O
) ) O
with IN O
expected VBN O
number NN O
derived VBN O
from IN O
population NN O
data NNS O
. . O

Northern NNP O
blot NN O
and CC O
reverse VB O
transcription NN O
- : O
PCR NNP O
analyses NNS O
of IN O
human JJ O
mRNA NN O
samples NNS O
demonstrate VBP O
that IN O
RNR NNP B-Gene
is VBZ O
expressed VBN O
exclusively RB O
in IN O
the DT O
retina NN O
, , O
with IN O
transcripts NNS O
of IN O
approximately RB O
7 CD O
. . O
5 CD O
kb NN O
, , O
approximately RB O
3 CD O
. . O
0 CD O
kb NN O
, , O
and CC O
approximately RB O
2 CD O
. . O
3 CD O
kb NN O
by IN O
Northern NNP O
blot NN O
analysis NN O
. . O

Results NNS O
of IN O
the DT O
long JJ O
- : O
term NN O
observation NN O
and CC O
treatment NN O
of IN O
patients NNS O
with IN O
arterial JJ O
hypertension NN O

62 CD O
: : O
2491 CD O
- : O
2499 CD O
, , O
1987 CD O
) ) O
. . O

The DT O
mechanism NN O
whereby WRB O
zeta NN B-Gene
PKC NNP I-Gene
regulates VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
most RBS O
probably RB O
involves VBZ O
the DT O
activation NN O
of IN O
a DT O
putative JJ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
kinase NN I-Gene
of IN O
molecular JJ O
mass NN O
approximately RB O
50 CD O
kDa NNS O
, , O
which WDT O
phosphorylates VBZ O
and CC O
inactivates VBZ O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
. . O

Serum NNP O
gastrin NN B-Gene
levels NNS O
did VBD O
not RB O
change VB O
in IN O
either DT O
group NN O
; : O
however RB O
, , O
background IN O
serum JJ O
gastrin JJ B-Gene
concentrations NNS O
were VBD O
significantly RB O
greater JJR O
for IN O
V NNP O
& CC O
P NNP O
patients NNS O
than IN O
V NNP O
& CC O
A NNP O
patients NNS O
throughout IN O
the DT O
study NN O
. . O

KRN2391 NNP O
and CC O
cromakalim NN O
produced VBD O
a DT O
dose JJ O
- : O
dependent JJ O
increase NN O
in IN O
aortic JJ O
and CC O
coronary JJ O
blood NN O
flow NN O
. . O

Clinical JJ O
differentiation NN O
of IN O
patients NNS O
with IN O
mild JJ O
diplegic JJ O
cerebral JJ O
palsy NN O
( ( O
CP NNP O
) ) O
and CC O
idiopathic JJ O
toe NN O
walking NN O
( ( O
ITW NNP O
) ) O
can MD O
be VB O
difficult JJ O
. . O

An DT O
overexpression NN O
of IN O
the DT O
betaAPP NN B-Gene
gene NN I-Gene
in IN O
certain JJ O
areas NNS O
of IN O
the DT O
AD NNP O
brain NN O
has VBZ O
been VBN O
suggested VBN O
to TO O
be VB O
an DT O
important JJ O
factor NN O
in IN O
the DT O
neuropathology NN O
of IN O
AD NNP O
. . O

The DT O
primary JJ O
structure NN O
of IN O
each DT O
of IN O
the DT O
three CD O
proteins NNS O
has VBZ O
about RB O
70 CD O
% NN O
homology NN O
with IN O
that DT O
of IN O
mouse NN B-Gene
contrapsin NN I-Gene
, , O
in IN O
contrast NN O
to TO O
43 CD O
- : O
46 CD O
% NN O
homology NN O
with IN O
that DT O
of IN O
rat NN B-Gene
alpha NN I-Gene
1 CD I-Gene
- : I-Gene
protease NN I-Gene
inhibitor NN O
. . O

Subacute NNP O
diencephalic NN O
angioencephalopathy NN O
( ( O
SDAE NNP O
) ) O
is VBZ O
a DT O
rare JJ O
and CC O
fatal JJ O
disease NN O
of IN O
unknown JJ O
etiology NN O
that WDT O
involves VBZ O
the DT O
thalami NN O
bilaterally RB O
. . O

Consistent JJ O
with IN O
this DT O
interpretation NN O
, , O
a DT O
mutant JJ O
form NN O
of IN O
XRN1 NNP B-Gene
, , O
which WDT O
encodes VBZ O
a DT O
5 CD O
' POS O
- : O
3 CD O
' '' O
exonuclease NN O
, , O
was VBD O
identified VBN O
as IN O
an DT O
extragenic JJ O
suppressor NN O
that WDT O
increases VBZ O
the DT O
half NN O
- : O
life NN O
of IN O
rhis4 NN B-Gene
mRNA NN I-Gene
, , O
leading VBG O
to TO O
a DT O
10 CD O
- : O
fold JJ O
increase NN O
in IN O
steady JJ O
- : O
state NN O
mRNA NN O
levels NNS O
compared VBN O
to TO O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
HIS4 NNP I-Gene
mRNA NN I-Gene
level NN O
. . O

BYV NNP O
, , O
citrus NN O
tristeza NN O
virus NN O
( ( O
CTV NNP O
) ) O
, , O
beet RB O
yellow JJ O
stunt NN O
virus NN O
( ( O
BYSV NNP O
) ) O
and CC O
carnation NN O
necrotic JJ O
fleck NN O
virus NN O
templates NNS O
produced VBD O
1 CD O
kb NNS O
amplification NN O
products NNS O
, , O
which WDT O
were VBD O
shown VBN O
by IN O
sequencing VBG O
to TO O
represent VB O
fragments NNS O
of IN O
the DT O
respective JJ O
HSP70 NNP B-Gene
genes NNS I-Gene
. . O

Further JJ O
investigations NNS O
are VBP O
necessary JJ O
to TO O
elucidate VB O
the DT O
biochemical JJ O
and CC O
physiological JJ O
properties NNS O
of IN O
DLIS NNP O
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
haemodialysis NN O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
C NNP O
respond NN O
well RB O
to TO O
interferon VB B-Gene
treatment NN O
and CC O
that IN O
a DT O
long JJ O
- : O
term NN O
response NN O
is VBZ O
achieved VBN O
in IN O
a DT O
high JJ O
proportion NN O
of IN O
patients NNS O
. . O

We PRP O
found VBD O
that IN O
total JJ O
PSA NNP B-Gene
can MD O
be VB O
detected VBN O
in IN O
all DT O
cyst NN O
fluids NNS O
and CC O
in IN O
about RB O
75 CD O
% NN O
of IN O
female JJ O
sera NN O
. . O

The DT O
investigation NN O
was VBD O
thereafter RB O
continued VBN O
in IN O
an DT O
open JJ O
fashion NN O
by IN O
administering VBG O
a DT O
single JJ O
10 CD O
mg NN O
dose NN O
of IN O
the DT O
MAO NNP B-Gene
- : I-Gene
B NNP I-Gene
inhibitor NN O
deprenyl NN O
to TO O
the DT O
same JJ O
subjects NNS O
. . O

Paf1p NNP B-Gene
may MD O
therefore RB O
be VB O
required VBN O
for IN O
both DT O
positive JJ O
and CC O
negative JJ O
regulation NN O
of IN O
subsets NNS O
of IN O
yeast NN O
genes NNS O
. . O

BACKGROUND NN O
: : O
Measurement NN O
of IN O
stereoacuity NN O
at IN O
varying VBG O
distances NNS O
, , O
by IN O
real JJ O
or CC O
simulated VBN O
depth JJ O
stereoacuity NN O
tests NNS O
, , O
is VBZ O
helpful JJ O
in IN O
the DT O
evaluation NN O
of IN O
patients NNS O
with IN O
binocular JJ O
imbalance NN O
or CC O
strabismus NN O
. . O

The DT O
immunophilin NN B-Gene
, , O
which WDT O
can MD O
be VB O
of IN O
the DT O
FK506 NNP O
- : O
or CC O
cyclosporin VB O
A DT O
- : O
binding NN O
class NN O
, , O
binds VBZ O
to TO O
hsp90 VB B-Gene
via IN O
its PRP$ O
tetratricopeptide JJ O
repeat NN O
( ( O
TPR NNP O
) ) O
domain NN O
, , O
and CC O
different JJ O
receptor NN O
heterocomplexes NNS O
exist VBP O
depending VBG O
upon IN O
which WDT O
immunophilin NN B-Gene
occupies VBZ O
the DT O
TPR NNP O
- : O
binding VBG O
region NN O
of IN O
hsp90 NN B-Gene
. . O

We PRP O
report VBP O
a DT O
case NN O
of IN O
vasculitis NN O
( ( O
cutaneous JJ O
and CC O
neurologic NN O
) ) O
which WDT O
led VBD O
to TO O
the DT O
discovery NN O
of IN O
a DT O
selective JJ O
immunodeficit NN O
towards NNS O
EBV NNP O
, , O
similar JJ O
to TO O
Purtilo NNP O
' POS O
s JJ O
syndrome NN O
. . O

The DT O
structural JJ O
similarity NN O
between IN O
Vav NNP B-Gene
and CC O
other JJ O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factors NNS I-Gene
for IN O
small JJ B-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
, , O
together RB O
with IN O
the DT O
recent JJ O
identification NN O
of IN O
biochemical JJ O
routes NNS O
specific JJ O
for IN O
members NNS O
of IN O
the DT O
Ras NNP B-Gene
and CC O
Rho NNP B-Gene
family NN I-Gene
of IN O
GTPases NNP B-Gene
, , O
prompted VBD O
us PRP O
to TO O
explore VB O
whether IN O
MAPK NNP B-Gene
or CC O
JNK NNP B-Gene
are VBP O
downstream JJ O
components NNS O
of IN O
the DT O
Vav NNP B-Gene
signaling NN O
pathways NNS O
. . O

Further JJ O
characterization NN O
of IN O
these DT O
putative JJ O
Hoxa NNP B-Gene
- : I-Gene
1 CD I-Gene
target NN I-Gene
genes NNS I-Gene
will MD O
aid VB O
in IN O
delineating VBG O
the DT O
functions NNS O
of IN O
the DT O
Hoxa NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
in IN O
the DT O
differentiation NN O
processes VBZ O
which WDT O
occur VBP O
during IN O
embryogenesis NN O
. . O

The DT O
observation NN O
of IN O
late JJ O
effects NNS O
after IN O
irradiations NNS O
or CC O
after IN O
space NN O
flights NNS O
show VBP O
the DT O
difficulties NNS O
encountered VBN O
in IN O
assessing VBG O
radiative JJ O
risks NNS O
during IN O
long JJ O
duration NN O
space NN O
flights NNS O
. . O

High JJ O
fibrinogen NN B-Gene
levels NNS O
could MD O
thus RB O
be VB O
a DT O
risk NN O
for IN O
perioperative JJ O
thrombosis NN O
. . O

Evidence NN O
suggests VBZ O
that IN O
PHACES NNP O
syndrome NN O
is VBZ O
not RB O
a DT O
random JJ O
association NN O
but CC O
a DT O
true JJ O
phakomatosis NN O
; : O
further JJ O
studies NNS O
are VBP O
awaited VBN O
to TO O
shed VB O
light NN O
on IN O
a DT O
possible JJ O
genetic JJ O
background NN O
. . O

Its PRP$ O
C NNP O
- : O
terminal JJ O
catalytic JJ O
domain NN O
was VBD O
found VBN O
to TO O
be VB O
highly RB O
conserved VBN O
in IN O
the DT O
homologues NNS O
p140 VBP B-Gene
( ( O
ras VB B-Gene
- : O
GRF NNP B-Gene
) ) O
and CC O
Sos NNP B-Gene
. . O

Eight CD O
hours NNS O
after IN O
the DT O
administration NN O
of IN O
colchicine NN O
, , O
the DT O
serum NN B-Gene
ceruloplasmin VBP I-Gene
level NN O
began VBD O
to TO O
rise VB O
again RB O
in IN O
female JJ O
rats NNS O
, , O
but CC O
not RB O
in IN O
male JJ O
rats NNS O
. . O

Looming VBG O
detectors NNS O
in IN O
the DT O
human JJ O
visual JJ O
pathway NN O
. . O

Six CD O
patients NNS O
with IN O
human JJ O
T NNP O
- : O
cell NN O
lymphotropic VBZ O
virus IN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
- : O
associated VBN O
myelopathy NN O
( ( O
HAM NNP O
) ) O
were VBD O
studied VBN O
by IN O
electrophysiologic JJ O
methods NNS O
. . O

There EX O
is VBZ O
a DT O
cysteine NN O
clustering VBG O
region NN O
in IN O
an DT O
N NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
raf NN I-Gene
( ( I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
product NN I-Gene
deduced VBN O
from IN O
the DT O
nucleotide JJ O
sequence NN O
, , O
and CC O
this DT O
cysteine NN O
clustering VBG O
region NN O
was VBD O
found VBN O
to TO O
be VB O
highly RB O
homologous JJ O
to TO O
that DT O
present JJ O
in IN O
an DT O
N NNP O
- : O
terminal JJ O
region NN O
of IN O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
, , O
although IN O
, , O
in IN O
the DT O
latter JJ O
cysteine NN O
clusters NNS O
are VBP O
present JJ O
in IN O
duplicate NN O
. . O

Normal JJ O
rates NNS O
of IN O
weight JJ O
gain NN O
were VBD O
seen VBN O
once RB O
absorbed JJ O
energy NN O
intakes NNS O
reached VBD O
100 CD O
- : O
110 CD O
% NN O
of IN O
requirements NNS O
. . O

CASE JJ O
REPORT NNP O
: : O
Referred NNP O
because IN O
of IN O
a DT O
right JJ O
corneal NN O
perforation NN O
with IN O
cellular JJ O
reaction NN O
in IN O
anterior JJ O
chamber NN O
, , O
a DT O
patient NN O
was VBD O
sutured VBN O
and CC O
treated VBN O
with IN O
a DT O
single JJ O
intravitreal NN O
injection NN O
of IN O
0 CD O
. . O
2 CD O
ml NN O
( ( O
1 CD O
mg NN O
) ) O
Amikacin NNP O
and CC O
0 CD O
. . O
2 CD O
ml NN O
( ( O
1 CD O
mg NN O
) ) O
Vancomycin NNP O
. . O

The DT O
phosphorylation NN O
efficiency NN O
is VBZ O
improved VBN O
by IN O
increasing VBG O
the DT O
number NN O
of IN O
N NNP O
- : O
terminal JJ O
arginine NN O
residues NNS O
and CC O
by IN O
moving VBG O
the DT O
arginyl NN O
cluster NN O
one CD O
residue NN O
further RB O
away RB O
from IN O
the DT O
serine NN O
, , O
the DT O
nonapeptide NN O
( ( O
Arg NNP O
) ) O
4 CD O
- : O
Ala NNP O
- : O
Ala NNP O
- : O
Ser NNP O
- : O
Val NNP O
- : O
Ala NNP O
being VBG O
the DT O
best JJS O
substrate NN O
among IN O
all PDT O
the DT O
short JJ O
peptides NNS O
tested VBN O
( ( O
Km NNP O
= VBZ O
15 CD O
microM NN O
) ) O
. . O

Overexpression NN O
of IN O
MDR1 NNP B-Gene
has VBZ O
been VBN O
demonstrated VBN O
in IN O
many JJ O
cancers NNS O
, , O
both DT O
in IN O
patient NN O
tumors NNS O
and CC O
in IN O
cell NN O
lines NNS O
selected VBN O
with IN O
a DT O
variety NN O
of IN O
chemotherapeutic JJ O
agents NNS O
. . O

However RB O
, , O
neu JJ B-Gene
differentiation NN O
factor NN O
- : O
induced JJ O
heterodimers NNS O
of IN O
ErbB2 NNP B-Gene
and CC O
ErbB4 NNP B-Gene
activated VBD O
Stat5 NNP B-Gene
. . O

We PRP O
have VBP O
mapped VBN O
the DT O
human JJ B-Gene
STAG3 NNP I-Gene
gene NN I-Gene
to TO O
the DT O
7q22 CD O
region NN O
of IN O
chromosome NN O
7 CD O
; : O
six CD O
human JJ B-Gene
STAG3 NNP I-Gene
- : I-Gene
related VBN I-Gene
genes NNS I-Gene
have VBP O
also RB O
been VBN O
mapped VBN O
: : O
two CD O
at IN O
7q22 CD O
near IN O
the DT O
functional JJ O
gene NN O
, , O
one CD O
at IN O
7q11 CD O
. . O
22 CD O
, , O
and CC O
three CD O
at IN O
7q11 CD O
. . O
23 CD O
, , O
two CD O
of IN O
them PRP O
flanking VBG O
the DT O
breakpoints NNS O
commonly RB O
associated VBN O
with IN O
the DT O
Williams NNP B-Gene
- : I-Gene
Beuren NNP I-Gene
syndrome NN I-Gene
( ( I-Gene
WBS NNP I-Gene
) ) I-Gene
deletion NN I-Gene
. . O

TPO NN B-Gene
by IN O
itself PRP O
did VBD O
not RB O
activate VB O
ERK1 NNP B-Gene
, , O
ERK2 NNP B-Gene
and CC O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
, , O
whereas JJ O
TPO NNP B-Gene
directly RB O
enhanced VBD O
the DT O
PKC NNP B-Gene
- : O
dependent JJ O
activation NN O
of IN O
ERKs NNP B-Gene
induced VBN O
by IN O
other JJ O
agonists NNS O
including VBG O
thrombin NN B-Gene
and CC O
phorbol NN O
esters NNS O
, , O
without IN O
affecting VBG O
the DT O
PKC NNP B-Gene
activation NN O
by IN O
those DT O
agonists NNS O
. . O

Sequencing VBG O
the DT O
gene NN O
for IN O
an DT O
imipenem JJ O
- : O
cefoxitin NN O
- : O
hydrolyzing NN O
enzyme NN O
( ( O
CfiA NNP B-Gene
) ) O
from IN O
Bacteroides NNP O
fragilis VBP O
TAL2480 NNP O
reveals NNS O
strong JJ O
similarity NN O
between IN O
CfiA NNP B-Gene
and CC O
Bacillus NNP B-Gene
cereus VBP I-Gene
beta SYM I-Gene
- : I-Gene
lactamase NN I-Gene
II NNP I-Gene
. . O

In IN O
mouse NN O
, , O
Mmip1 NNP B-Gene
( ( O
Mad NNP B-Gene
member NN I-Gene
interacting VBG I-Gene
protein RB I-Gene
1 CD I-Gene
) ) O
and CC O
Smc3 NNP B-Gene
share NN O
99 CD O
% NN O
sequence NN O
identity NN O
and CC O
are VBP O
products NNS O
of IN O
the DT O
same JJ O
gene NN O
. . O

NGF NNP B-Gene
, , O
but CC O
not RB O
EGF NNP B-Gene
, , O
enhances VBZ O
the DT O
upper JJ O
bands NNS O
, , O
corresponding VBG O
to TO O
phosphorylated VBN B-Gene
Fra NNP I-Gene
- : I-Gene
2 CD I-Gene
. . O

Renal JJ O
response NN O
to TO O
captopril VB O
in IN O
severe JJ O
heart NN O
failure NN O
: : O
role NN O
of IN O
furosemide NN O
in IN O
natriuresis NN O
and CC O
reversal NN O
of IN O
hyponatremia NN O
. . O

High JJ O
trough IN O
serum NN O
TOB NNP O
concentrations NNS O
were VBD O
associated VBN O
with IN O
death NN O
and CC O
very RB O
low JJ O
levels NNS O
with IN O
recovery NN O
. . O

2 CD O
. . O

The DT O
acids NNS O
were VBD O
obtained VBN O
by IN O
hydrolysis NN O
of IN O
the DT O
corresponding JJ O
esters NNS O
, , O
and CC O
their PRP$ O
anti JJ O
- : O
inflammatory NN O
activity NN O
was VBD O
tested VBN O
. . O

Constrictive JJ O
pericarditis NN O
and CC O
pleuropulmonary JJ O
disease NN O
linked VBD O
to TO O
ergot VB O
dopamine JJ O
agonist NN O
therapy NN O
( ( O
cabergoline NN O
) ) O
for IN O
Parkinson NNP O
' POS O
s JJ O
disease NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
find VB O
out RP O
whether IN O
it PRP O
was VBD O
possible JJ O
to TO O
detect VB O
normal JJ O
lymph NN O
nodes NNS O
by IN O
high JJ O
- : O
resolution NN O
mediastinal JJ O
US NNP O
. . O

The DT O
[ NN O
18F CD O
] NN O
FMISO NNP O
TMRR NNP O
is VBZ O
a DT O
simple JJ O
and CC O
clinically RB O
useful JJ O
index NN O
for IN O
detecting VBG O
tumour JJ O
hypoxia NN O
in IN O
NPC NNP O
. . O

The DT O
characterization NN O
of IN O
the DT O
promoter NN O
region NN O
indicated VBD O
that IN O
three CD O
distinct JJ O
regulatory JJ O
elements NNS O
corresponding VBG O
to TO O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
site NN I-Gene
( ( O
or CC O
TRE NNP O
) ) O
, , O
a DT O
PRDII NNP B-Gene
/ NNP O
kappaB NN B-Gene
domain NN O
, , O
and CC O
a DT O
CAAT NNP O
box NN O
are VBP O
involved VBN O
in IN O
the DT O
activation NN O
by IN O
pp60 NN B-Gene
( ( B-Gene
v JJ I-Gene
- : I-Gene
) ) I-Gene
src NN I-Gene
. . O

The DT O
Mean NNP O
was VBD O
74 CD O
, , O
3 CD O
+ NN O
/ NNP O
- : O
53 CD O
, , O
6 CD O
micrograms NNS O
J NNP O
/ NNP O
g NN O
Cr NNP O
, , O
the DT O
Median JJ O
61 CD O
micrograms NNS O
J NNP O
/ NNP O
g NN O
Cr NNP O
. . O

Records NNS O
of IN O
31 CD O
children NNS O
with IN O
AIDS NNP O
or CC O
AIDS NNP O
- : O
related VBN O
complex JJ O
admitted VBN O
to TO O
the DT O
pediatric JJ O
intensive JJ O
care NN O
unit NN O
for IN O
acute JJ O
respiratory NN O
failure NN O
throughout IN O
a DT O
46 CD O
- : O
month NN O
period NN O
were VBD O
reviewed VBN O
. . O

And CC O
, , O
most RBS O
importantly RB O
, , O
reconstitution NN O
of IN O
a DT O
consensus NN O
CRE NNP O
, , O
within IN O
the DT O
21 CD O
- : O
bp NN O
enhancers NNS O
increases VBZ O
binding NN O
of IN O
CREB NNP B-Gene
/ NNP O
ATF NNP B-Gene
proteins NNS O
but CC O
abrogates VBZ O
basal JJ O
repression NN O
of IN O
LTR NNP O
- : O
directed VBD O
transcription NN O
in IN O
vitro NN O
. . O

A DT O
22K CD O
polypeptide NN O
was VBD O
detected VBN O
as IN O
a DT O
translation NN O
product NN O
of IN O
late JJ O
RNA NNP O
that WDT O
hybridized VBD O
to TO O
this DT O
DNA NNP O
fragment NN O
. . O

Analysis NN O
of IN O
the DT O
consensus NN O
binding VBG O
sequence NN O
and CC O
the DT O
DNA NNP O
- : O
binding VBG O
domain NN O
of IN O
ZF5 NNP B-Gene
. . O

This DT O
would MD O
have VB O
had VBD O
the DT O
effect NN O
of IN O
positioning VBG O
the DT O
genes NNS O
currently RB O
on IN O
the DT O
long JJ O
arm NN O
adjacent NN O
to TO O
the DT O
centromeric JJ O
heterochromatin NN O
, , O
perhaps RB O
resulting VBG O
in IN O
a DT O
"""" JJ O
position NN O
effect NN O
"""" NN O
on IN O
transcription NN O
of IN O
these DT O
genes NNS O
. . O

Retransformation NN O
of IN O
uvsH77 JJ B-Gene
mutants NNS I-Gene
with IN O
the DT O
rescued JJ O
cosmids NNS O
from IN O
the DT O
MMS NNP O
- : O
resistant JJ O
transformants NNS O
resulted VBD O
in IN O
restoration NN O
of IN O
both DT O
UV NNP O
and CC O
MMS NNP O
resistance NN O
to TO O
wild VB O
- : O
type NN O
levels NNS O
. . O

Multiparous JJ O
women NNS O
presented VBD O
higher JJR O
BMI NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
PBF NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
compared VBN O
with IN O
primi JJ O
- : O
and CC O
nulliparous JJ O
groups NNS O
. . O

The DT O
significance NN O
of IN O
structural JJ O
integrity NN O
of IN O
lymphoid JJ O
tissue NN O
for IN O
antibody NN O
production NN O
in IN O
culture NN O
in IN O
vivo NN O

METHODS NNS O
: : O
We PRP O
retrospectively RB O
reviewed VBD O
242 CD O
adult NN O
cadaveric JJ O
renal JJ O
transplant NN O
recipients NNS O
treated VBD O
between IN O
11 CD O
/ $ O
91 CD O
and CC O
5 CD O
/ JJ O
97 CD O
. . O

The DT O
effect NN O
of IN O
these DT O
cell NN O
cycle NN O
regulators NNS O
is VBZ O
not RB O
specific JJ O
to TO O
the DT O
rap1s NN B-Gene
or CC O
hmr NN B-Gene
delta NN I-Gene
A DT I-Gene
mutation NN I-Gene
, , O
since IN O
swi6 NN B-Gene
, , O
swi4 NN B-Gene
, , O
and CC O
clb5 NN B-Gene
mutations NNS I-Gene
also RB O
suppress VBP O
mutations NNS O
in IN O
SIR1 NNP B-Gene
, , O
another DT O
gene NN O
implicated VBN O
in IN O
the DT O
establishment NN O
of IN O
silencing NN O
. . O

Successful JJ O
interaction NN O
of IN O
ARF NNP B-Gene
and CC O
PKC NNP B-Gene
- : I-Gene
alpha NN I-Gene
with IN O
PLD1 NNP B-Gene
was VBD O
not RB O
achieved VBN O
, , O
but CC O
a DT O
C NNP O
- : O
terminal JJ O
fragment NN O
of IN O
human JJ B-Gene
PLD1 NNP I-Gene
( ( O
denoted VBN O
"""" NNP O
D4 NNP O
"""" NNP O
) ) O
interacted VBD O
with IN O
the DT O
active JJ O
mutant NN O
of IN O
RhoA NNP B-Gene
, , O
RhoAVal NNP B-Gene
- : I-Gene
14 CD I-Gene
. . O

In IN O
the DT O
multivariate NN O
analysis NN O
, , O
six CD O
variables NNS O
were VBD O
independently RB O
correlated VBN O
with IN O
survival NN O
: : O
blood NN O
urea JJ O
nitrogen NN O
level NN O
, , O
serum JJ B-Gene
aspartate NN I-Gene
aminotransferase NN I-Gene
level NN O
, , O
community NN O
- : O
acquired VBN O
vs NN O
. . O
hospital JJ O
- : O
acquired VBN O
peritonitis NN O
, , O
age NN O
, , O
Child NNP O
- : O
Pugh NNP O
score NN O
and CC O
ileus NN O
. . O

Genomic JJ O
libraries NNS O
were VBD O
stored VBN O
as IN O
frozen JJ O
cultures NNS O
in IN O
a DT O
96 CD O
- : O
well RB O
format RB O
, , O
each DT O
well RB O
containing VBG O
approximately RB O
300 CD O
- : O
600 CD O
colonies NNS O
( ( O
12 CD O
plates NNS O
for IN O
small JJ O
library NN O
, , O
four CD O
for IN O
medium NN O
- : O
size NN O
library NN O
and CC O
four CD O
for IN O
large JJ O
library NN O
) ) O
. . O

Efferent JJ O
projections NNS O
of IN O
the DT O
ventral JJ O
portion NN O
of IN O
the DT O
putamen NNS O
to TO O
the DT O
frontal NN O
, , O
parietal JJ O
and CC O
temporal JJ O
regions NNS O
of IN O
the DT O
cat JJ O
cerebral JJ O
cortex NN O

Productive JJ O
growth NN O
of IN O
phage NN O
P22 NNP O
in IN O
wild JJ O
- : O
type NN O
Salmonella NNP O
typhimurium NN O
correlates VBZ O
with IN O
the DT O
presence NN O
of IN O
Abc2 NNP B-Gene
, , O
but CC O
is VBZ O
independent JJ O
of IN O
the DT O
absolute JJ O
level NN O
of IN O
ATP NNP B-Gene
- : I-Gene
dependent JJ I-Gene
nuclease NN I-Gene
activity NN O
, , O
suggesting VBG O
a DT O
qualitative JJ O
change NN O
in IN O
the DT O
nature NN O
of IN O
Abc2 NNP B-Gene
- : O
modified VBD O
RecBCD NNP B-Gene
nuclease NN I-Gene
activity NN O
relative VBP O
to TO O
the DT O
native JJ O
enzyme NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
significant JJ O
pulmonary JJ O
metabolism NN O
of IN O
5 CD O
- : O
HT NN O
followed VBN O
by IN O
efflux NN O
of IN O
5 CD O
- : O
HIAA NN O
into IN O
venous JJ O
output NN O
occurs NNS O
during IN O
single JJ O
- : O
pass NN O
circulation NN O
. . O

Quantitative JJ O
predictions NNS O
are VBP O
confirmed VBN O
for IN O
the DT O
positive JJ O
responses NNS O
, , O
but CC O
not RB O
for IN O
the DT O
negatives NNS O
, , O
suggesting VBG O
that IN O
the DT O
SSTS NNP O
model NN O
is VBZ O
incorrect JJ O
. . O

Among IN O
three CD O
isoforms NNS O
, , O
the DT O
beta NN O
isoform NN O
has VBZ O
the DT O
greatest JJS O
Vmax NNP O
value NN O
for IN O
the DT O
PtdIns NNP B-Gene
( ( I-Gene
4 CD I-Gene
) ) I-Gene
P NNP I-Gene
kinase NN I-Gene
activity NN O
and CC O
the DT O
gamma NN O
isoform NN O
is VBZ O
most RBS O
markedly RB O
stimulated VBN O
by IN O
phosphatidic JJ O
acid NN O
. . O

Clinical JJ O
and CC O
anatomical JJ O
considerations NNS O

In IN O
these DT O
experiments NNS O
we PRP O
begin VBP O
to TO O
study VB O
the DT O
potential JJ O
functions NNS O
of IN O
the DT O
alpha NN B-Gene
7 CD I-Gene
cytoplasmic JJ I-Gene
domain NN I-Gene
by IN O
analyzing VBG O
homologies NNS O
between IN O
the DT O
rat NN O
and CC O
human JJ O
sequences NNS O
, , O
by IN O
immunologic JJ O
studies NNS O
using VBG O
an DT O
anti JJ O
- : O
cytoplasmic JJ O
domain NN O
antiserum NN O
, , O
and CC O
by IN O
identifying VBG O
two CD O
alternate JJ O
forms NNS O
. . O

These DT O
results NNS O
show VBP O
that IN O
targeting VBG O
of IN O
Ras NNP B-Gene
- : O
GAP NN B-Gene
could MD O
represent VB O
a DT O
novel JJ O
anticancer NN O
approach NN O
. . O

Multiresistant JJ O
strains NNS O
isolated VBN O
from IN O
humans NNS O
in IN O
enteral JJ O
toxico NN O
- : O
infections NNS O
kill VBP O
orally RB O
infected JJ O
mice NN O
more RBR O
frequently RB O
than IN O
strains NNS O
isolated VBN O
in IN O
hospital JJ O
infections NNS O
. . O

One CD O
phage NN O
clone NN O
contains VBZ O
a DT O
junction NN O
between IN O
alpha JJ O
satellite NN O
DNA NN O
and CC O
a DT O
novel JJ O
low JJ O
- : O
copy NN O
repeated VBD O
sequence NN O
. . O

An DT O
abundant JJ O
1 CD O
. . O
1 CD O
- : O
kb NN O
virion NN O
- : O
sense NN O
polyadenylated VBD O
RNA NNP O
and CC O
four CD O
complementary JJ O
- : O
sense NN O
polyadenylated VBD O
RNAs NNP O
of IN O
1 CD O
. . O
7 CD O
, , O
1 CD O
. . O
5 CD O
, , O
1 CD O
. . O
3 CD O
, , O
and CC O
0 CD O
. . O
7 CD O
kb NNS O
have VBP O
been VBN O
identified VBN O
by IN O
northern JJ O
blot NN O
hybridization NN O
, , O
confirming VBG O
the DT O
bidirectional JJ O
transcription NN O
strategy NN O
implied VBN O
by IN O
the DT O
arrangement NN O
of IN O
ORFs NNP O
. . O

A DT O
variety NN O
of IN O
professional JJ O
and CC O
self PRP O
- : O
applied VBN O
fluoride JJ O
products NNS O
are VBP O
available JJ O
and CC O
new JJ O
fluoride JJ O
delivery NN O
systems NNS O
have VBP O
recently RB O
entered VBN O
the DT O
market NN O
. . O

The DT O
p53 NN B-Gene
tumor NN I-Gene
suppressor NN I-Gene
gene NN I-Gene
product NN I-Gene
, , O
a DT O
sequence NN O
- : O
specific JJ O
DNA NNP O
- : O
binding NN O
protein NN O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
act VB O
as IN O
a DT O
transcriptional JJ O
activator NN O
and CC O
repressor VB O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Twenty NNP O
- : O
three CD O
sequence NN O
- : O
tagged VBN O
sites NNS O
( ( O
STSs NNP O
) ) O
were VBD O
mapped VBN O
within IN O
the DT O
contig NN O
, , O
a DT O
density NN O
of IN O
approximately RB O
1 CD O
per IN O
200 CD O
kb NN O
. . O

Granulocyte NNP B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
administration NN O
in IN O
vivo NN O
has VBZ O
been VBN O
shown VBN O
to TO O
improve VB O
the DT O
defence NN O
mechanisms NN O
against IN O
infection NN O
by IN O
different JJ O
microbes NNS O
. . O

No DT O
homology NN O
was VBD O
found VBN O
between IN O
the DT O
36K CD O
protein NN O
and CC O
known JJ O
structures NNS O
of IN O
proteins NNS O
. . O

Differentiating VBG O
among IN O
renal JJ O
stones NNS O
. . O

RESULTS NN O
: : O
Fournier NNP O
' POS O
s NN O
gangrene NN O
occurs VBZ O
worldwide RB O
. . O

Wnt NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
int NN B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
a DT O
cellular JJ O
oncogene NN O
often RB O
activated VBN O
by IN O
insertion NN O
of IN O
proviral JJ O
DNA NNP O
of IN O
the DT O
mouse NN O
mammary JJ O
tumor NN O
virus NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
N NNP O
- : O
nitroso JJ O
compounds NNS O
can MD O
be VB O
formed VBN O
in IN O
vivo NN O
in IN O
the DT O
infected JJ O
bladder NN O
, , O
which WDT O
could MD O
explain VB O
the DT O
association NN O
between IN O
urinary JJ O
- : O
tract NN O
infections NNS O
and CC O
increased VBD O
risk NN O
for IN O
bladder NN O
cancer NN O
. . O

We PRP O
describe VBP O
49 CD O
cases NNS O
with IN O
papillary JJ O
tumor NN O
< VBD O
1 CD O
cm NN O
. . O

In IN O
a DT O
blind NN O
controlled VBN O
trial NN O
, , O
15 CD O
patients NNS O
with IN O
COCM NNP O
( ( O
NYHA NNP O
II NNP O
- : O
III NN O
) ) O
with IN O
sinus NN O
rhythm NN O
and CC O
a DT O
left JJ O
ventricular JJ O
ejection NN O
fraction NN O
( ( O
LV NNP O
- : O
EF NNP O
) ) O
of IN O
34 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
6 CD O
% NN O
received VBD O
consecutively RB O
D NNP O
( ( O
0 CD O
. . O
25 CD O
- : O
0 CD O
. . O
5 CD O
mg JJ O
/ NNP O
d NN O
) ) O
, , O
placebo FW O
( ( O
PLAC NNP O
) ) O
, , O
P NNP O
( ( O
slow JJ O
releases NNS O
= VBP O
SR NNP O
) ) O
( ( O
80 CD O
mg NN O
/ NNP O
d NN O
SR NNP O
) ) O
and CC O
both DT O
drugs NNS O
combined VBN O
in IN O
respective JJ O
doses NNS O
. . O

We PRP O
discuss VBP O
the DT O
need NN O
to TO O
use VB O
animals NNS O
older JJR O
than IN O
3 CD O
months NNS O
for IN O
the DT O
study NN O
of IN O
' '' O
adult NN O
' POS O
regeneration NN O
phenomena NNS O
since IN O
3 CD O
- : O
month NN O
- : O
old JJ O
rats NNS O
may MD O
be VB O
somewhat RB O
immature JJ O
. . O

Hematocrit NNP O
and CC O
PaO2 NNP O
did VBD O
not RB O
change NN O
. . O

Overexpression NN O
of IN O
H411 NNP B-Gene
cDNA NN I-Gene
in IN O
the DT O
RAW NNP O
264 CD O
. . O
7 CD O
macrophage NN O
cell NN O
line NN O
promoted VBD O
an DT O
increased JJ O
growth NN O
rate NN O
, , O
suggesting VBG O
that IN O
expression NN O
of IN O
H411 NNP B-Gene
is VBZ O
part NN O
of IN O
the DT O
proliferative JJ O
cell NN O
response NN O
to TO O
LPS NNP O
. . O

Peripheral NNP O
polyneuropathy NN O
associated VBN O
with IN O
multiple JJ O
myeloma NN O
. . O

Molecular JJ O
cloning NN O
of IN O
the DT O
human JJ O
homolog NN O
of IN O
a DT O
striatum NN B-Gene
- : I-Gene
enriched JJ I-Gene
phosphatase NN I-Gene
( ( B-Gene
STEP NNP I-Gene
) ) I-Gene
gene NN I-Gene
and CC O
chromosomal JJ O
mapping NN O
of IN O
the DT O
human JJ O
and CC O
murine JJ O
loci NN O
. . O

Ten CD O
days NNS O
of IN O
cefadroxil JJ O
therapy NN O
was VBD O
used VBN O
to TO O
treat VB O
44 CD O
children NNS O
with IN O
urinary JJ O
tract NN O
infection NN O
and CC O
CRP NNP B-Gene
values NNS O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
28 CD O
microgram NNS O
/ JJ O
ml NN O
( ( O
CRP NNP B-Gene
- : O
positive JJ O
group NN O
) ) O
. . O

Among IN O
the DT O
patients NNS O
grades VBZ O
1 CD O
- : O
2 CD O
- : O
3 CD O
, , O
81 CD O
% NN O
had VBD O
a DT O
good JJ O
out RP O
come VBN O
without IN O
any DT O
neurological JJ O
abnormality NN O
, , O
among IN O
the DT O
patients NNS O
graded VBD O
4 CD O
- : O
5 CD O
, , O
only RB O
27 CD O
% NN O
had VBD O
a DT O
fair JJ O
out RP O
come NN O
. . O

Structure NN O
of IN O
the DT O
EMAPII NNP B-Gene
domain NN I-Gene
of IN O
human JJ B-Gene
aminoacyl SYM I-Gene
- : I-Gene
tRNA JJ I-Gene
synthetase NN I-Gene
complex JJ I-Gene
reveals NNS O
evolutionary JJ O
dimer NN O
mimicry NN O
. . O

Phase NNP O
II NNP O
study NN O
of IN O
VP NNP O
- : O
16 CD O
( ( O
capsule NN O
) ) O
in IN O
solid JJ O
tumors NNS O
. . O

Quantitative JJ O
evaluation NN O
of IN O
magneto NN O
- : O
optical JJ O
parameters NNS O
is VBZ O
necessary JJ O
in IN O
order NN O
to TO O
apply VB O
scanning VBG O
near IN O
- : O
field NN O
optical JJ O
microscope NN O
( ( O
SNOM NNP O
) ) O
technology NN O
to TO O
the DT O
study NN O
of IN O
magnetism NN O
on IN O
the DT O
mesoscopic NN O
scale NN O
. . O

Interestingly RB O
, , O
the DT O
activity NN O
of IN O
IkappaB NNP B-Gene
kinase NNP I-Gene
( ( O
IKK NNP B-Gene
- : I-Gene
beta NN I-Gene
) ) O
, , O
which WDT O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
through IN O
IkappaB NNP B-Gene
phosphorylation NN O
, , O
was VBD O
largely RB O
enhanced VBN O
in IN O
paclitaxel NN O
- : O
treated JJ O
cells NNS O
, , O
detected VBD O
as IN O
IkappaBalpha NNP B-Gene
phosphorylation NN O
. . O

During IN O
a DT O
disease NN O
remission NN O
there EX O
was VBD O
an DT O
increase NN O
in IN O
GAG NNP O
secretion NN O
with IN O
urine JJ O
, , O
linked VBN O
with IN O
hyperheparinuria NN O
( ( O
13 CD O
. . O
1 CD O
- : O
fold NN O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
ubiquitous JJ O
transcription NN O
factor NN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
forms NNS O
complexes NNS O
with IN O
an DT O
octamer NN O
motif NN O
present NN O
within IN O
FPIV NNP O
by IN O
gel NN O
shift NN O
analysis NN O
with IN O
liver NN O
and CC O
kidney NN O
extracts NNS O
, , O
making VBG O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
an DT O
intriguing JJ O
candidate NN O
for IN O
partnership NN O
in IN O
androgen NN O
regulation NN O
. . O

Renal JJ O
clearance NN O
fell VBD O
from IN O
19 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
9 CD O
ml JJ O
/ NNP O
min NN O
/ VBD O
1 CD O
. . O
73 CD O
m2 NN O
( ( O
group NN O
I PRP O
) ) O
to TO O
1 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
ml JJ O
/ NNP O
min NN O
/ VBD O
1 CD O
. . O
73 CD O
m2 NN O
( ( O
group NN O
IV NNP O
) ) O
. . O

At IN O
the DT O
end NN O
of IN O
the DT O
experiment NN O
the DT O
urinary JJ O
porphyrin NN O
excretion NN O
and CC O
the DT O
porphyrin NN O
content NN O
in IN O
lijver NN O
and CC O
skin NN O
were VBD O
diminished VBN O
in IN O
HCB NNP O
- : O
CQ NNP O
- : O
treated VBN O
animals NNS O
by IN O
about IN O
50 CD O
% NN O
compared VBN O
to TO O
the DT O
HCB NNP O
controls NNS O
. . O

A DT O
second JJ O
hydrophobic NN O
domain NN O
, , O
bordered VBN O
by IN O
two CD O
hydrophilic JJ O
regions NNS O
strongly RB O
suggests VBZ O
a DT O
transmembrane JJ O
region NN O
. . O

The DT O
data NN O
indicates VBZ O
the DT O
presence NN O
of IN O
5 CD B-Gene
- : I-Gene
HT2 NNP I-Gene
serotonergic JJ I-Gene
receptors NNS I-Gene
in IN O
the DT O
bronchial JJ O
artery NN O
of IN O
these DT O
species NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
retroplasmid JJ O
reverse NN B-Gene
transcriptase NN I-Gene
is VBZ O
uniquely RB O
adapted VBN O
to TO O
initiate VB O
cDNA NN O
synthesis NN O
by IN O
recognizing VBG O
a DT O
3 CD O
' POS O
CCA NNP O
sequence NN O
. . O

Thrombocyte NNP O
function NN O
was VBD O
impaired VBN O
in IN O
all DT O
patients NNS O
, , O
characterized VBN O
by IN O
a DT O
diminished JJ O
platelet NN O
shape NN O
change NN O
. . O

These DT O
single JJ O
mutational NN O
defects NNS O
in IN O
the DT O
eRF1 NN B-Gene
- : O
eRF3 JJ B-Gene
interaction NN O
became VBD O
evident JJ O
when WRB O
either RB O
truncated VBD O
protein JJ O
eRF3C NN B-Gene
or CC O
C NNP O
- : O
terminally RB O
altered VBD O
eRF1 JJ B-Gene
proteins NNS O
were VBD O
used VBN O
for IN O
the DT O
authentic JJ O
protein NN O
, , O
providing VBG O
further JJ O
support NN O
for IN O
the DT O
presence NN O
of IN O
a DT O
C NNP O
- : O
terminal JJ O
interaction NN O
. . O

Lck NNP B-Gene
has VBZ O
been VBN O
postulated VBN O
to TO O
dimerize VB O
through IN O
the DT O
SH2 NNP B-Gene
and CC O
SH3 NNP B-Gene
domains NNS I-Gene
. . O

For IN O
pressure NN O
greater JJR O
than IN O
121 CD O
atm JJ O
abs NN O
, , O
an DT O
increased JJ O
excitability NN O
of IN O
the DT O
tadpoles NNS O
made VBD O
it PRP O
difficult JJ O
to TO O
distinguish VB O
the DT O
righting VBG O
reflex NN O
from IN O
involuntary JJ O
movements NNS O
. . O

It PRP O
appears VBZ O
that IN O
the DT O
pulmonary JJ O
gas NN O
exchange NN O
parenchyma NN O
of IN O
these DT O
smallest JJS O
mammals NNS O
is VBZ O
well RB O
suited VBN O
to TO O
supply VB O
the DT O
organism NN O
with IN O
the DT O
comparatively RB O
high JJ O
levels NNS O
of IN O
O2 NNP O
required VBN O
by IN O
the DT O
high JJ O
metabolic NN O
rates NNS O
, , O
exhibiting VBG O
a DT O
structural JJ O
adaptation NN O
of IN O
the DT O
lung NN O
to TO O
higher JJR O
VO2 NNP O
. . O

Renin NNP B-Gene
secretion NN O
in IN O
essential JJ O
and CC O
accelerated JJ O
hypertension NN O
. . O

Atopic NNP O
allergy NN O
and CC O
other JJ O
hypersensitivities NNS O
. . O

Isolation NN O
and CC O
characterization NN O
of IN O
a DT O
TATA NNP O
- : O
less JJR O
promoter NN O
for IN O
the DT O
human JJ B-Gene
beta NN I-Gene
3 CD I-Gene
integrin JJ I-Gene
gene NN I-Gene
. . O

Preliminary JJ O
experiments NNS O
demonstrated VBD O
that IN O
it PRP O
was VBD O
possible JJ O
to TO O
produce VB O
fasD JJ B-Gene
mutants NNS I-Gene
, , O
whose WP$ O
products NNS O
remain VBP O
functional JJ O
for IN O
fimbrial JJ O
export NN O
and CC O
assembly NN O
. . O

AF154055 NNP B-Gene
. . O

Vivid NNP O
visual JJ O
hallucinations NNS O
without IN O
other JJ O
psychopathology NN O
have VBP O
been VBN O
reported VBN O
for IN O
several JJ O
hundred CD O
years NNS O
. . O

One CD O
of IN O
the DT O
sequelae NN O
of IN O
the DT O
antiphospholipid JJ O
- : O
antibodies NNS O
is VBZ O
an DT O
impaired JJ O
uteroplacental JJ O
circulation NN O
. . O

Furthermore RB O
, , O
SB203580 NNP O
inhibited VBD O
LPS NNP O
- : O
induced JJ O
activation NN O
of IN O
Sp1 NNP B-Gene
, , O
as RB O
well RB O
as IN O
the DT O
promoter NN O
activity NN O
in IN O
cells NNS O
transfected VBN O
with IN O
a DT O
plasmid NN O
containing VBG O
the DT O
Sp1 NNP B-Gene
consensus NN O
sequence NN O
. . O

Pb NNP O
foil NN O
( ( O
0 CD O
. . O
55 CD O
gcm JJ O
- : O
2 CD O
) ) O
provided VBD O
the DT O
best JJS O
overall JJ O
improvement NN O
. . O

Finally RB O
, , O
we PRP O
compared VBN O
the DT O
differential JJ O
screening NN O
techniques NNS O
in IN O
terms NNS O
of IN O
sensitivity NN O
, , O
efficiency NN O
and CC O
occurrence NN O
of IN O
false JJ O
positives NNS O
. . O

Only RB O
two CD O
patients NNS O
( ( O
0 CD O
. . O
3 CD O
% NN O
) ) O
had VBD O
a DT O
CA NNP B-Gene
125 CD I-Gene
response NN O
at IN O
the DT O
time NN O
of IN O
clinical JJ O
progression NN O
. . O

In IN O
1990 CD O
, , O
an DT O
International NNP O
Commission NNP O
for IN O
the DT O
Certification NNP O
of IN O
Eradication NNP O
of IN O
Poliomyelitis NNP O
Eradication NNP O
( ( O
ICCPE NNP O
) ) O
was VBD O
established VBN O
by IN O
the DT O
Pan NNP O
American NNP O
Health NNP O
Organization NNP O
to TO O
eventually RB O
determine VB O
if IN O
transmission NN O
was VBD O
interrupted VBN O
. . O

A DT O
split NN O
motor NN O
domain NN O
in IN O
a DT O
cytoplasmic JJ B-Gene
dynein NN I-Gene
. . O

The DT O
present JJ O
research NN O
evaluated VBD O
the DT O
possibility NN O
that IN O
polyethylene VBZ O
glycol JJ O
400 CD O
( ( O
PEG NNP O
400 CD O
) ) O
might MD O
be VB O
efficacious JJ O
, , O
toxic JJ O
, , O
or CC O
both DT O
. . O

We PRP O
found VBD O
14 CD O
protein NN O
binding VBG O
sites NNS O
that WDT O
were VBD O
occupied VBN O
in IN O
vivo NN O
. . O

The DT O
binary JJ O
and CC O
tertiary JJ O
combinations NNS O
of IN O
plant NN O
- : O
derived VBN O
molluscicides NNS O
Azadirachta NNP O
indica NN O
and CC O
Cedrus NNP O
deodara VB O
oil NN O
with IN O
synergists NNS O
MGK NNP O
- : O
264 CD O
, , O
piperonyl NN O
butoxide NN O
( ( O
PB NNP O
) ) O
and CC O
fruit JJ O
powder NN O
of IN O
Embelia NNP O
ribes NNS O
were VBD O
used VBN O
against IN O
the DT O
Lymnaea NNP O
acuminata NN O
. . O

Overall JJ O
least JJS O
- : O
squares NNS O
means VBZ O
for IN O
uncooked JJ O
and CC O
cooked VBD O
longissimus JJ O
muscle NN O
and CC O
subcutaneous JJ O
fat NN O
were VBD O
63 CD O
. . O
32 CD O
, , O
80 CD O
. . O
27 CD O
and CC O
98 CD O
. . O
90 CD O
mg NN O
of IN O
cholesterol NN O
/ $ O
100 CD O
g NN O
of IN O
tissue NN O
, , O
respectively RB O
. . O

Poor NNP O
response NN O
when WRB O
laboratory NN O
recommended VBD O
range NN O
for IN O
serum NN O
lithium NN O
is VBZ O
changed VBN O
. . O

We PRP O
found VBD O
sequences NNS O
related VBN O
to TO O
this DT O
insertion NN O
in IN O
wild JJ O
- : O
type NN O
strains NNS O
of IN O
N NNP O
. . O
crassa NN O
and CC O
other JJ O
Neurospora NNP O
species NNS O
. . O

Other JJ O
hemostatic JJ O
values NNS O
evaluated VBN O
were VBD O
activated VBN O
partial JJ O
thromboplastin NN B-Gene
times NNS O
, , O
prothrombin NN B-Gene
times NNS O
, , O
thrombin NN B-Gene
times NNS O
, , O
fibrinogen NN B-Gene
, , O
platelet NN O
counts NNS O
, , O
and CC O
fibrin JJ B-Gene
/ NNP O
fibrinogen NN B-Gene
degradation NN O
products NNS O
. . O

Basal NNP O
promoter NN O
activity NN O
is VBZ O
enhanced VBN O
by IN O
a DT O
functional JJ O
M1 NNP O
domain NN O
in IN O
LHR NNP B-Gene
- : O
expressing NN O
mouse NN O
Leydig NNP O
tumor NN O
cells NNS O
( ( O
MLTC NNP O
) ) O
but CC O
not RB O
in IN O
non JJ O
- : O
expressing VBG O
CHO NNP O
cells NNS O
. . O

Number NNP O
of IN O
patients NNS O
infected VBN O
with IN O
nontuberculous JJ O
mycobacteria NNS O
( ( O
NTM NNP O
) ) O
is VBZ O
increasing VBG O
world NN O
- : O
wide JJ O
in IN O
recent JJ O
years NNS O
. . O

The DT O
operation NN O
recommended VBD O
is VBZ O
excision NN O
of IN O
3 CD O
mm NN O
of IN O
central JJ O
slip NN O
followed VBN O
by IN O
end NN O
- : O
to TO O
- : O
end VB O
repair NN O
of IN O
the DT O
tendon NN O
. . O

Those DT O
dosages NNS O
that WDT O
inhibited VBD O
mean JJ O
NTE NNP B-Gene
activity NN O
in IN O
spinal JJ O
cord NN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
72 CD O
% NN O
and CC O
brain NN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
66 CD O
% NN O
of IN O
control NN O
values NNS O
within IN O
44 CD O
hr JJ O
postexposure NN O
produced VBN O
marked VBD O
spinal JJ O
cord NN O
pathology NN O
14 CD O
days NNS O
postexposure NN O
in IN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
90 CD O
% NN O
of IN O
similarly RB O
dosed VBN O
animals NNS O
. . O

Specific JJ O
IgG NNP B-Gene
, , O
specific JJ O
IgE NNP B-Gene
and CC O
total JJ O
IgE NNP B-Gene
immunoglobulins NNS I-Gene
against IN O
Toxocara NNP B-Gene
canis NN I-Gene
excretory NN I-Gene
/ NNP I-Gene
secretory NN I-Gene
antigens NNS I-Gene
( ( O
TES NNP B-Gene
) ) O
were VBD O
detected VBN O
by IN O
using VBG O
ELISA NNP O
technique NN O
. . O

Two CD O
of IN O
seven CD O
initiation NN O
sites NNS O
were VBD O
flanked VBN O
by IN O
a DT O
sequence NN O
homologous JJ O
to TO O
the DT O
consensus NN O
promoter NN O
motif NN O
that WDT O
includes VBZ O
the DT O
CRTA NNP O
motif NN O
( ( O
where WRB O
R NNP O
is VBZ O
A DT O
or CC O
G NNP O
) ) O
of IN O
the DT O
rice NN O
mitochondrion NN O
. . O

Changes NNS O
in IN O
ionic JJ O
content NN O
of IN O
the DT O
mucous JJ O
suggest NN O
that IN O
cholinergic JJ O
mechanisms NNS O
affect JJ O
pressure NN O
in IN O
the DT O
excretory JJ O
duct NN O
of IN O
the DT O
gland NN O
. . O

To TO O
quantify VB O
any DT O
mechanical JJ O
inhibitory NN O
effect NN O
of IN O
nasal JJ O
intermittent JJ O
positive JJ O
pressure NN O
ventilation NN O
( ( O
IPPV NNP O
) ) O
on IN O
inspiratory NN O
activity NN O
of IN O
the DT O
diaphragm NN O
we PRP O
ventilated VBD O
five CD O
conscious JJ O
relaxed NN O
subjects NNS O
on IN O
two CD O
occasions NNS O
at IN O
respiratory NN O
rates NNS O
similar JJ O
to TO O
quiet JJ O
breathing NN O
( ( O
QB NNP O
) ) O
and CC O
at IN O
three CD O
levels NNS O
of IN O
applied JJ O
pressure NN O
( ( O
Pappl NNP O
) ) O
- : O
- : O
6 CD O
, , O
9 CD O
and CC O
12 CD O
cmH2O NN O
, , O
each DT O
during IN O
hypocapnia NN O
( ( O
P NNP O
( ( O
CO2 NNP O
) ) O
allowed VBD O
to TO O
decrease VB O
) ) O
and CC O
eucapnia $ O
( ( O
CO2 NNP O
added VBD O
to TO O
inspired VB O
gas NN O
) ) O
. . O

Therefore RB O
, , O
in IN O
a DT O
large JJ O
animal JJ O
model NN O
of IN O
permanent JJ O
focal JJ O
ischemia NN O
in IN O
which WDT O
transfusion NN O
starts VBZ O
30 CD O
min NN O
after IN O
ischemia NN O
, , O
tetrameric JJ O
cross NN O
- : O
linked VBN O
hemoglobin JJ B-Gene
transfusion NN O
can MD O
augment VB O
oxygen NN O
transport NN O
to TO O
the DT O
ischemic JJ O
cortex NN O
, , O
but CC O
the DT O
increase NN O
can MD O
be VB O
delayed VBN O
and CC O
not RB O
necessarily RB O
provide VB O
protection NN O
. . O

Furthermore RB O
, , O
45Ca CD O
- : O
binding NN O
assays NNS O
revealed VBD O
that IN O
CCaMK NNP B-Gene
directly RB O
binds VBZ O
Ca2 NNP O
+ NNP O
. . O

Constipation NN O
is VBZ O
not RB O
a DT O
risk NN O
factor NN O
for IN O
hemorrhoids NNS O
: : O
a DT O
case NN O
- : O
control NN O
study NN O
of IN O
potential JJ O
etiological JJ O
agents NNS O
. . O

The DT O
test NN O
was VBD O
not RB O
performed VBN O
in IN O
3923 CD O
patients NNS O
because IN O
of IN O
contraindications NNS O
. . O

In IN O
addition NN O
, , O
the DT O
gcd1 NN B-Gene
- : I-Gene
101 CD I-Gene
mutation NN I-Gene
suppressed VBD O
the DT O
low JJ O
translational JJ O
efficiency NN O
of IN O
GCN4 NNP B-Gene
- : O
lacZ NN B-Gene
mRNA NN O
observed VBN O
in IN O
gcn2 JJ B-Gene
- : I-Gene
and CC O
gcn3 VB B-Gene
- : I-Gene
cells NNS O
. . O

The DT O
skin NN O
site NN O
, , O
6 CD O
- : O
cm NN O
- : O
distal NN O
and CC O
- : O
proximal NN O
subcutaneous JJ O
segments NNS O
of IN O
the DT O
catheter NN O
, , O
exudates VBZ O
, , O
and CC O
blood NN O
were VBD O
cultured VBN O
. . O

It PRP O
then RB O
merged VBD O
with IN O
right JJ O
ventricular JJ O
wavefronts NNS O
ending VBG O
along IN O
the DT O
right JJ O
ventricular NN O
anterior RB O
atrioventricular JJ O
groove NN O
and CC O
outflow JJ O
tract NN O
. . O

These DT O
mutants NNS O
were VBD O
tested VBN O
for IN O
ability NN O
to TO O
bind VB O
each DT O
of IN O
the DT O
Site NNP B-Gene
II NNP I-Gene
cognate NN I-Gene
proteins NNS I-Gene
, , O
and CC O
subsequently RB O
evaluated VBN O
for IN O
ability NN O
to TO O
confer VB O
H4 NNP B-Gene
transcriptional JJ O
activity NN O
using VBG O
chimeric JJ O
H4 NNP B-Gene
promoter NN O
/ NNP O
CAT NNP B-Gene
fusion NN O
constructs NNS O
in IN O
different JJ O
cell NN O
types NNS O
. . O

PNT NNP O
, , O
ADD NNP O
and CC O
BSS NNP O
in IN O
the DT O
initial JJ O
stage NN O
of IN O
kindling NN O
, , O
kindling VBG O
rate NN O
for IN O
the DT O
stage NN O
- : O
3 CD O
and CC O
- : O
5 CD O
seizures NNS O
, , O
seizure NN O
parameters NNS O
at IN O
the DT O
first JJ O
stage NN O
- : O
3 CD O
and CC O
- : O
5 CD O
were VBD O
recorded VBN O
and CC O
compared VBN O
to TO O
the DT O
values NNS O
of IN O
saline JJ O
- : O
treated VBN O
, , O
control NN O
group NN O
. . O

Moreover RB O
, , O
elderly JJ O
men NNS O
with IN O
bioavailable JJ O
estradiol NN O
levels NNS O
below IN O
the DT O
median JJ O
[ NN O
40 CD O
pmol NN O
/ NN O
liter NN O
( ( O
11 CD O
pg NN O
/ NNP O
ml NN O
) ) O
] NN O
had VBD O
significantly RB O
higher JJR O
rates NNS O
of IN O
bone NN O
loss NN O
and CC O
levels NNS O
of IN O
bone NN O
resorption NN O
markers NNS O
than IN O
men NNS O
with IN O
bioavailable JJ O
estradiol NN O
levels NNS O
above IN O
40 CD O
pmol NN O
/ NN O
liter NN O
. . O

Primer NNP O
extension NN O
experiments NNS O
showed VBD O
that IN O
there EX O
are VBP O
two CD O
transcription NN O
initiation NN O
sites VBZ O
16 CD O
bp JJ O
apart RB O
in IN O
the DT O
mouse NN B-Gene
type NN I-Gene
2 CD I-Gene
receptor NN I-Gene
gene NN I-Gene
. . O

The DT O
procedure NN O
facilitated VBD O
the DT O
retention NN O
of IN O
a DT O
mandibular JJ O
molar NN O
with IN O
a DT O
Class NN O
III NNP O
FI NNP O
in IN O
a DT O
manner NN O
acceptable JJ O
to TO O
both DT O
the DT O
patient NN O
and CC O
the DT O
clinician NN O
. . O

By IN O
contrast NN O
, , O
deletion NN O
of IN O
this DT O
Ras NNP B-Gene
- : I-Gene
binding VBG I-Gene
site NN I-Gene
did VBD O
not RB O
diminish JJ O
activation NN O
of IN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
kinase NN I-Gene
by IN O
Src NNP B-Gene
, , O
implying VBG O
that IN O
Src NNP B-Gene
and CC O
Ras NNP B-Gene
can MD O
activate VB O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
through IN O
independent JJ O
mechanisms NNS O
. . O

The DT O
major JJ O
neurological JJ O
manifestations NNS O
of IN O
brain NN O
injury NN O
in IN O
these DT O
babies NNS O
are VBP O
spastic JJ O
motor NN O
deficits NNS O
. . O

Translational JJ O
fusions NNS O
of IN O
the DT O
aroF JJ B-Gene
regulatory JJ I-Gene
regions NNS I-Gene
to TO O
lacZ VB B-Gene
were VBD O
constructed VBN O
and CC O
then RB O
introduced VBN O
in IN O
single JJ O
copy NN O
into IN O
the DT O
E NNP O
. . O
coli JJ O
chromosome NN O
. . O

beta SYM B-Gene
- : I-Gene
Galactosidase NNP I-Gene
assays VBZ O
for IN O
tyrR NN O
- : O
mediated VBN O
regulation NN O
of IN O
aroF JJ B-Gene
- : O
lacZ JJ B-Gene
expression NN O
revealed VBD O
that IN O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
TyrR NNP I-Gene
repressor NN I-Gene
apparently RB O
recognizes VBZ O
the DT O
operators NNS O
of IN O
both DT O
organisms NNS O
with IN O
about IN O
equal JJ O
efficiency NN O
. . O

Cyclin NNP B-Gene
D1 NNP I-Gene
promoter NN I-Gene
activity NN O
was VBD O
stimulated VBN O
by IN O
overexpression NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
p41MAPK NN B-Gene
) ) O
or CC O
c SYM B-Gene
- : I-Gene
Ets NNP I-Gene
- : I-Gene
2 CD I-Gene
through IN O
the DT O
proximal JJ O
22 CD O
base NN O
pairs NN O
. . O

The DT O
ESEM NNP O
differs NNS O
from IN O
conventional JJ O
SEM NNP O
in IN O
that DT O
no DT O
sample JJ O
preparation NN O
is VBZ O
needed VBN O
, , O
eliminating VBG O
artifactual JJ O
changes NNS O
. . O

Crisis NN O
of IN O
the DT O
therapeutic JJ O
community NN O
in IN O
Great NNP O
Britain NNP O

A DT O
cDNA NN O
cloning VBG O
vector NN O
that IN O
permits VBZ O
expression NN O
of IN O
cDNA NN O
inserts NNS O
in IN O
mammalian JJ O
cells NNS O
. . O

Facioscapulohumeral NNP O
muscular JJ O
dystrophy NN O
( ( O
FSHD NNP O
) ) O
is VBZ O
an DT O
autosomal JJ O
dominant NN O
, , O
neuromuscular JJ O
disorder NN O
characterized VBN O
by IN O
progressive JJ O
weakness NN O
of IN O
muscles NNS O
in IN O
the DT O
face NN O
, , O
shoulder NN O
and CC O
upper JJ O
arm NN O
. . O

Experiment NN O
3 CD O
showed VBD O
that IN O
the DT O
long JJ O
- : O
term NN O
analgesic JJ O
reaction NN O
could MD O
also RB O
be VB O
reduced VBN O
by IN O
administration NN O
of IN O
naltrexone JJ O
prior JJ O
to TO O
reexposure VB O
to TO O
shock VB O
. . O

New NNP O
alkaloids NNS O
from IN O
bark NN O
of IN O
Erythrophleum NNP O
ivorense NN O
. . O

The DT O
DNA NNP O
binding NN O
activities NNS O
of IN O
the DT O
three CD O
repressor NN O
preparations NNS O
were VBD O
studied VBN O
using VBG O
fragments NNS O
containing VBG O
CIRs NNP O
( ( O
CIR3 NNP O
- : O
CIR6 NN O
) ) O
from IN O
the DT O
essential JJ O
early JJ O
region NN O
as IN O
templates NNS O
for IN O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
. . O

The DT O
mass NN O
- : O
specific JJ O
resting VBG O
minute JJ O
ventilation NN O
( ( O
E NNP O
) ) O
and CC O
the DT O
ventilatory NN O
equivalent NN O
( ( O
VE NNP O
/ NNP O
( ( O
O NNP O
( ( O
2 CD O
) ) O
) ) O
) ) O
were VBD O
approximately RB O
the DT O
same JJ O
at IN O
the DT O
two CD O
ages NNS O
, , O
with IN O
a DT O
breathing NN O
pattern NN O
significantly RB O
deeper JJR O
and CC O
slower JJR O
at IN O
day NN O
1 CD O
. . O

At IN O
all DT O
time NN O
- : O
points NNS O
, , O
most JJS O
patients NNS O
( ( O
> JJ O
/ NNP O
= NNP O
87 CD O
% NN O
) ) O
were VBD O
receiving VBG O
irbesartan JJ O
/ NNP O
HCTZ NNP O
alone RB O
. . O

SCL NNP O
prolonged VBD O
promptly RB O
after IN O
verapamil NN O
, , O
and CC O
sinus NN O
arrest NN O
developed VBN O
in IN O
two CD O
of IN O
10 CD O
group NN O
2 CD O
and CC O
two CD O
of IN O
five CD O
group NN O
3 CD O
animals NNS O
. . O

A DT O
randomized VBN O
, , O
multicenter RBR O
study NN O
comparing VBG O
the DT O
efficacy NN O
and CC O
tolerability NN O
of IN O
tropisetron NN O
, , O
a DT O
new JJ O
5 CD B-Gene
- : I-Gene
HT3 NNP I-Gene
receptor NN I-Gene
antagonist NN O
, , O
with IN O
a DT O
metoclopramide JJ O
- : O
containing VBG O
antiemetic JJ O
cocktail NN O
in IN O
the DT O
prevention NN O
of IN O
cisplatin NN O
- : O
induced JJ O
emesis NN O
. . O

Adenyl NNP B-Gene
cyclase NN I-Gene
activity NN O
of IN O
gastric JJ O
mucosa NN O
in IN O
patients NNS O
with IN O
duodenal JJ O
ulcer NN O
before IN O
and CC O
after IN O
treatment NN O

A DT O
high JJ O
- : O
efficiency NN O
cross NN O
- : O
flow JJ O
micronebulizer NN O
interface NN O
for IN O
capillary JJ O
electrophoresis NN O
and CC O
inductively RB O
coupled VBN O
plasma JJ O
mass NN O
spectrometry NN O
. . O

The DT O
data NN O
indicate NN O
that IN O
the DT O
minimal JJ O
catalytic JJ O
domain NN O
of IN O
Nmt1p NNP B-Gene
is VBZ O
located VBN O
between IN O
Ile59 NNP O
- : O
- : O
> NN O
Phe96 NNP O
and CC O
Gly451 NNP O
- : O
- : O
> NN O
Leu455 NNP O
. . O

This DT O
negative JJ O
element NN O
may MD O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
be VB O
responsible JJ O
for IN O
the DT O
cell NN O
type SYM O
- : O
specific JJ O
expression NN O
of IN O
the DT O
DGK NNP B-Gene
gene NN I-Gene
. . O

Horseradish JJ B-Gene
peroxidase NN I-Gene
as IN O
a DT O
permeability NN O
marker NN O
in IN O
injured JJ O
rat NN O
caudal NN O
and CC O
iliac JJ O
arteries NNS O
. . O

Reaction NN O
time NN O
( ( O
RT NNP O
) ) O
and CC O
P300 NNP O
were VBD O
collected VBN O
simultaneously RB O
. . O

Following VBG O
treatment NN O
, , O
serum JJ O
estradiol NN O
levels NNS O
were VBD O
higher JJR O
in IN O
groups NNS O
E NNP O
+ NNP O
T NNP O
and CC O
E NNP O
than IN O
in IN O
group NN O
C NNP O
. . O

Northern NNP O
blot NN O
analysis NN O
revealed VBD O
that IN O
mlt NN B-Gene
1 CD I-Gene
is VBZ O
normally RB O
expressed VBN O
in IN O
brain NN O
, , O
spleen JJ O
, , O
stom JJ O
ach NN O
, , O
and CC O
liver RB O
. . O

Inhibition NN O
of IN O
erythromycin JJ O
synthesis NN O
by IN O
disruption NN O
of IN O
malonyl JJ B-Gene
- : I-Gene
coenzyme NN I-Gene
A DT I-Gene
decarboxylase NN I-Gene
gene NN I-Gene
eryM NN B-Gene
in IN O
Saccharopolyspora NNP O
erythraea NN O
. . O

In IN O
addition NN O
, , O
the DT O
DNA NNP O
- : O
binding NN O
experiments NNS O
show VBP O
that IN O
either DT O
one CD O
of IN O
the DT O
two CD O
MADS NNP B-Gene
domains NNS I-Gene
of IN O
a DT O
dimer NN O
can MD O
be VB O
sufficient JJ O
to TO O
confer VB O
a DT O
particular JJ O
DNA NNP O
- : O
binding VBG O
specificity NN O
to TO O
the DT O
complex NN O
and CC O
that IN O
sequences NNS O
outside IN O
the DT O
amino NN O
- : O
terminal JJ O
basic JJ O
region NN O
of IN O
the DT O
MADS NNP B-Gene
domain NN O
can MD O
, , O
in IN O
some DT O
cases NNS O
, , O
contribute NN O
to TO O
the DT O
DNA NNP O
- : O
binding VBG O
specificity NN O
of IN O
the DT O
proteins NNS O
. . O

The DT O
integration NN O
at IN O
the DT O
VIP NNP B-Gene
CyRE NNP B-Gene
of IN O
the DT O
Jak NNP B-Gene
- : O
Stat NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
signaling VBG O
pathways NNS O
with IN O
other JJ O
pre JJ O
- : O
existing VBG O
proteins NNS O
provides VBZ O
a DT O
cellular JJ O
mechanism NN O
for IN O
cell NN O
- : O
and CC O
cytokine VB O
- : O
specific JJ O
signaling NN O
. . O

All DT O
13 CD O
patients NNS O
showed VBD O
endoscopic JJ O
evidence NN O
of IN O
oesophagitis NN O
, , O
moderate VB O
in IN O
4 CD O
and CC O
severe JJ O
in IN O
9 CD O
. . O

Therefore RB O
, , O
both PDT O
the DT O
Chilean NNP O
and CC O
the DT O
Japanese JJ O
samples NNS O
collected VBN O
in IN O
high JJ O
- : O
risk NN O
areas NNS O
showed VBD O
higher JJR O
mutagenic NN O
rates NNS O
than IN O
the DT O
Japanese JJ O
ones NNS O
in IN O
a DT O
low JJ O
- : O
risk NN O
area NN O
, , O
with IN O
a DT O
statistical JJ O
significance NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
, , O
chi SYM O
- : O
square JJ O
test NN O
) ) O
. . O

The DT O
substrates NNS O
for IN O
glycan JJ O
synthesis NN O
in IN O
the DT O
lumen NNS O
of IN O
the DT O
Golgi NNP O
are VBP O
nucleotide JJ O
sugars NNS O
that WDT O
must MD O
be VB O
transported VBN O
from IN O
the DT O
cytosol NN O
by IN O
specific JJ O
membrane NN O
- : O
bound NN O
transporters NNS O
. . O

The DT O
hexanucleotide NN O
5 CD O
' '' O
- : O
TGTCCT NNP O
- : O
3 CD O
' '' O
, , O
thought VBD O
to TO O
be VB O
important JJ O
for IN O
GRE NNP O
activity NN O
, , O
not RB O
only RB O
was VBD O
found VBN O
in IN O
this DT O
sequence NN O
and CC O
in IN O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
, , O
but CC O
also RB O
was VBD O
present JJ O
twice RB O
in IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
gene NN O
that WDT O
did VBD O
not RB O
show VB O
specific JJ O
receptor NN O
binding NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
opiate JJ B-Gene
receptors NNS I-Gene
bordering VBG O
the DT O
fourth JJ O
cerebral JJ O
ventricle NN O
mediate VBP O
the DT O
cardiovascular NN O
and CC O
hypnotic JJ O
action NN O
of IN O
fentanyl NN O
. . O

Association NNP O
of IN O
human JJ B-Gene
Pur NNP I-Gene
alpha NN I-Gene
with IN O
the DT O
retinoblastoma NN B-Gene
protein NN I-Gene
, , O
Rb NNP B-Gene
, , O
regulates VBZ O
binding VBG O
to TO O
the DT O
single JJ O
- : O
stranded VBD O
DNA NNP O
Pur NNP B-Gene
alpha POS I-Gene
recognition NN I-Gene
element NN I-Gene
. . O

Here RB O
we PRP O
investigate VBP O
the DT O
role NN O
of IN O
c SYM B-Gene
- : I-Gene
Cbl NN I-Gene
in IN O
development NN O
and CC O
homeostasis NN O
in IN O
mice NN O
by IN O
targeted JJ O
disruption NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
Cbl JJ I-Gene
locus NN I-Gene
. . O

c SYM B-Gene
- : I-Gene
Cbl NNP I-Gene
- : O
deficient NN O
mice NN O
were VBD O
viable JJ O
, , O
fertile JJ O
, , O
and CC O
outwardly RB O
normal JJ O
in IN O
appearance NN O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
cyclic JJ O
variations NNS O
in IN O
heme NN O
turnover NN O
are VBP O
related VBN O
to TO O
changes NNS O
in IN O
erythrocyte JJ O
characteristics NNS O
during IN O
the DT O
progesterone NN O
phase NN O
. . O

A DT O
total NN O
of IN O
90 CD O
patients NNS O
were VBD O
randomly RB O
allocated VBN O
either RB O
to TO O
an DT O
MY NNP O
- : O
1 CD O
treated VBD O
or CC O
an DT O
untreated JJ O
group NN O
. . O

The DT O
molecular JJ O
associations NNS O
dictating VBG O
INCENP NNP B-Gene
behavior NN O
during IN O
mitosis NN O
are VBP O
currently RB O
unknown JJ O
. . O

For IN O
comparison JJ O
conventional JJ O
heparin NN O
was VBD O
used VBN O
during IN O
18 CD O
dialyses NNS O
in IN O
the DT O
same JJ O
patients NNS O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays RB O
demonstrated VBD O
specific JJ O
nuclear JJ O
protein NN O
binding VBG O
to TO O
- : O
85 CD O
/ SYM O
- : O
64 CD O
, , O
and CC O
single JJ O
point NN O
mutations NNS O
suggested VBD O
important JJ O
binding VBG O
nucleotides NNS O
between IN O
- : O
79 CD O
/ SYM O
- : O
68 CD O
with IN O
five CD O
critical JJ O
bases NNS O
between IN O
- : O
74 CD O
/ SYM O
- : O
70 CD O
( ( O
5 CD O
' '' O
- : O
CTCCT NNP O
- : O
3 CD O
' '' O
) ) O
. . O

To TO O
study VB O
the DT O
structure NN O
- : O
function NN O
of IN O
the DT O
gene NN B-Gene
5 CD I-Gene
product NN I-Gene
, , O
wild JJ O
- : O
type NN O
and CC O
mutant JJ O
forms NNS O
of IN O
NS53 NNP B-Gene
were VBD O
produced VBN O
by IN O
using VBG O
a DT O
recombinant JJ O
baculovirus NN O
expression NN O
system NN O
and CC O
a DT O
recombinant JJ O
vaccinia NN O
virus NN O
/ NNP O
T7 NNP O
( ( O
vTF7 SYM O
- : O
3 CD O
) ) O
expression NN O
system NN O
. . O

Notice NNP O
of IN O
retraction NN O
. . O

The DT O
difference NN O
of IN O
hardness NN O
over IN O
time NN O
of IN O
composite JJ O
specimens NNS O
was VBD O
measured VBN O
using VBG O
Knoop NNP O
hardness NN O
measurements NNS O
taken VBN O
at IN O
the DT O
top JJ O
and CC O
bottom JJ O
surfaces NNS O
of IN O
resin NN O
specimens NNS O
made VBN O
in IN O
a DT O
Teflon NNP O
mold VBD O
the DT O
same JJ O
dimensions NNS O
as IN O
the DT O
cavity NN O
prepared VBN O
in IN O
dentin NN O
. . O

Using VBG O
16 CD O
strains NNS O
of IN O
C NNP O
. . O
trachomatis NN O
in IN O
triplicate NN O
assays NNS O
, , O
we PRP O
found VBD O
the DT O
RT NNP O
- : O
PCR NNP O
method VBZ O
consistently RB O
more RBR O
sensitive JJ O
than IN O
the DT O
conventional JJ O
technique NN O
for IN O
all DT O
eight CD O
antimicrobials NNS O
tested VBN O
, , O
with IN O
resultant JJ O
MICs NNP O
determined VBN O
by IN O
RT NNP O
- : O
PCR NN O
ranging VBG O
from IN O
1 CD O
. . O
6 CD O
- : O
fold NN O
higher JJR O
( ( O
erythromycin NN O
) ) O
to TO O
> VB O
/ NNP O
= NNP O
195 CD O
- : O
fold NN O
higher JJR O
( ( O
amoxicillin NN O
) ) O
. . O

Suggestive JJ O
evidence NN O
was VBD O
obtained VBN O
that IN O
cstA NN B-Gene
is VBZ O
involved VBN O
in IN O
peptide JJ O
utilization NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
combined JJ O
lesions NNS O
of IN O
cholinergic NN O
and CC O
serotonergic JJ O
neurons NNS O
in IN O
the DT O
rat NN O
brain NN O
do VBP O
not RB O
alter VB O
olfactory JJ O
perception NN O
or CC O
olfactory NN O
short JJ O
- : O
term NN O
memory NN O
. . O

The DT O
gene NN O
contains VBZ O
six CD O
exons NNS O
separated VBN O
by IN O
1 CD O
. . O
1 CD O
- : O
5 CD O
. . O
8 CD O
kb JJ O
introns NNS O
and CC O
has VBZ O
been VBN O
localized VBN O
to TO O
the DT O
murine NN O
chromosome NN O
2 CD O
by IN O
linkage NN O
analysis NN O
. . O

Characterization NN O
of IN O
LRP NNP B-Gene
, , O
a DT O
leucine JJ B-Gene
- : I-Gene
rich JJ I-Gene
repeat NN I-Gene
( ( I-Gene
LRR NNP I-Gene
) ) I-Gene
protein NN I-Gene
from IN I-Gene
tomato NN I-Gene
plants NNS I-Gene
that WDT O
is VBZ O
processed VBN O
during IN O
pathogenesis NN O
. . O

The DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
CD1 NNP B-Gene
gene NN I-Gene
contained VBD O
the DT O
binding NN O
motifs NNS O
for IN O
two CD O
cytokine NN O
- : O
inducible JJ O
transcription NN O
factors NNS O
, , O
NF NNP B-Gene
- : I-Gene
IL2 NNP I-Gene
- : I-Gene
A DT I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
. . O

HexA71 NNP B-Gene
negatively RB O
affects VBZ O
RpoS NNP B-Gene
, , O
as IN O
the DT O
levels NNS O
of IN O
this DT O
alternative JJ O
sigma NN B-Gene
factor NN I-Gene
are VBP O
higher JJR O
in IN O
the DT O
HexA NNP B-Gene
- : I-Gene
mutant NN I-Gene
than IN O
in IN O
the DT O
HexA NNP B-Gene
+ NNP I-Gene
strain NN O
. . O

Each DT O
parent NN O
interacted VBN O
with IN O
their PRP$ O
4 CD O
- : O
or CC O
5 CD O
- : O
year NN O
- : O
old JJ O
son NN O
or CC O
daughter NN O
in IN O
each DT O
of IN O
two CD O
conversations NNS O
- : O
- : O
unstructured JJ O
( ( O
social JJ O
conversation NN O
) ) O
and CC O
structured VBN O
( ( O
task JJ O
activity NN O
) ) O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
3874 CD O
bp NN O
of IN O
cloned JJ O
R NNP O
. . O
sphaeroides NNS O
chromosomal JJ O
DNA NNP O
, , O
including VBG O
the DT O
three CD O
structural JJ O
genes NNS O
fbcF NNS B-Gene
, , O
fbcB NN B-Gene
and CC O
fbcC NN B-Gene
has VBZ O
been VBN O
determined VBN O
. . O

Our PRP$ O
findings NNS O
confirm VBP O
the DT O
high JJ O
frequency NN O
of IN O
proximal JJ O
nerve NN O
lesions NNS O
in IN O
early JJ O
GBS NNP O
and CC O
CIDP NNP O
, , O
not RB O
all DT O
of IN O
which WDT O
are VBP O
associated VBN O
with IN O
distal JJ O
motor NN O
conduction NN O
abnormalities NNS O
, , O
and CC O
suggest VBP O
that IN O
assessment NN O
of IN O
multiple JJ O
F NNP O
wave NN O
parameters NNS O
, , O
in IN O
particular JJ O
chronodispersion NN O
, , O
mean JJ O
latency NN O
and CC O
mean JJ O
amplitude NN O
( ( O
in IN O
addition NN O
to TO O
absence NN O
and CC O
minimum JJ O
latency NN O
) ) O
, , O
increases VBZ O
the DT O
yield NN O
of IN O
F NNP O
wave NN O
studies NNS O
. . O

The DT O
structural JJ O
genes NNS O
encoding VBG O
glyceraldehyde NN B-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
phosphate NN I-Gene
dehydrogenase NN I-Gene
( ( O
GAPDH NNP B-Gene
) ) O
, , O
3 CD B-Gene
- : I-Gene
phosphoglycerate NN I-Gene
kinase NN I-Gene
( ( O
PGK NNP B-Gene
) ) O
and CC O
the DT O
N NNP O
- : O
terminal JJ O
part NN O
of IN O
triosephosphate NN B-Gene
isomerase NN I-Gene
( ( O
TIM NNP B-Gene
) ) O
from IN O
mesophilic JJ O
Bacillus NNP O
megaterium NN O
DSM319 NNP O
have VBP O
been VBN O
cloned VBN O
as IN O
a DT O
gene NN O
cluster NN O
( ( O
gap JJ B-Gene
operon NN I-Gene
) ) O
by IN O
complementation NN O
of IN O
an DT O
Escherichia NNP O
coli NN O
gap NN B-Gene
amber NN I-Gene
mutant NN I-Gene
. . O

Moreover RB O
, , O
moderate JJ O
overexpression NN O
of IN O
Chk1 NNP B-Gene
suppresses VBZ O
the DT O
phenotypes NNS O
of IN O
cut5 NN B-Gene
and CC O
crb2 NN B-Gene
mutants NNS I-Gene
. . O

Requirements NNS O
for IN O
the DT O
nuclear JJ O
- : O
cytoplasmic JJ O
translocation NN O
of IN O
infected JJ B-Gene
- : I-Gene
cell NN I-Gene
protein VBZ I-Gene
0 CD I-Gene
of IN O
herpes NNS O
simplex JJ O
virus NN O
1 CD O
. . O

The DT O
methylation NN O
of IN O
nuclear JJ O
and CC O
chloroplast JJ O
DNAs NNP O
has VBZ O
been VBN O
examined VBN O
in IN O
relation NN O
to TO O
the DT O
known VBN O
differential JJ O
expression NN O
of IN O
C4 NNP B-Gene
photosynthesis NN I-Gene
genes NNS I-Gene
in IN O
the DT O
bundle JJ O
sheath NN O
and CC O
mesophyll NN O
cells NNS O
of IN O
etiolated VBN O
, , O
greening VBG O
, , O
and CC O
fully RB O
green JJ O
maize NN O
leaves NNS O
. . O

The DT O
mature NN O
protein NN O
also RB O
contains VBZ O
a DT O
cysteine NN O
- : O
rich JJ O
, , O
highly RB O
hydrophilic JJ O
region NN O
homologous JJ O
to TO O
the DT O
ovomucoid JJ B-Gene
serine NN I-Gene
protease NN I-Gene
inhibitors NNS I-Gene
( ( O
residues NNS O
76 CD O
- : O
132 CD O
) ) O
. . O

The DT O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
protein NN O
in IN O
the DT O
region NN O
of IN O
the DT O
specificity NN O
pocket NN O
is VBZ O
similar JJ O
to TO O
that DT O
of IN O
S NNP B-Gene
. . I-Gene
griseus NN I-Gene
proteases VBZ I-Gene
A NNP I-Gene
, , I-Gene
B NNP I-Gene
, , I-Gene
and CC I-Gene
C NNP I-Gene
. . O

State NNP O
- : O
approved VBD O
schools NNS O
of IN O
nursing VBG O
- : O
- : O
R NN O
. . O
N NNP O
. . O
, , O
1972 CD O
. . O

The DT O
complete JJ O
cDNA NN O
sequence NN O
of IN O
human JJ B-Gene
betaV NN I-Gene
spectrin NN I-Gene
is VBZ O
available JJ O
from IN O
GenBank NNP O
( ( O
TM NNP O
) ) O
as IN O
accession NN O
number NN O
. . O

The DT O
results NNS O
show VBP O
that IN O
ROS NNP O
production NN O
by IN O
viable JJ O
spermatozoa NN O
is VBZ O
highly RB O
correlated VBN O
with IN O
the DT O
concentration NN O
of IN O
PMN NNP B-Gene
elastase NN I-Gene
and CC O
the DT O
number NN O
of IN O
both DT O
peroxidase FW B-Gene
- : O
positive JJ O
and CC O
round JJ O
cells NNS O
. . O

Orthop NNP O
. . O

Deletion NN O
of IN O
a DT O
53 CD O
- : O
bp NN O
early JJ O
promoter NN O
region NN O
containing VBG O
the DT O
transcription NN O
start NN O
site NN O
and CC O
a DT O
putative JJ O
TATA NNP O
box NN O
completely RB O
abolishes VBZ O
the DT O
ability NN O
of IN O
upstream JJ O
elements NNS O
to TO O
drive VB O
transcription NN O
of IN O
the DT O
luciferase NN B-Gene
cDNA NN I-Gene
. . O

The DT O
corresponding JJ O
inhibition NN O
of IN O
acid JJ B-Gene
phosphatase NN I-Gene
activity NN O
in IN O
control NN O
male NN O
and CC O
female JJ O
guinea NN O
pigs NNS O
was VBD O
15 CD O
. . O
91 CD O
% NN O
and CC O
20 CD O
. . O
33 CD O
% NN O
respectively RB O
. . O

Natl NNP O
. . O

We PRP O
also RB O
present VBD O
evidence NN O
for IN O
a DT O
negative JJ O
regulatory JJ O
element NN O
in IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
Mlu NNP B-Gene
I PRP I-Gene
upstream VBP I-Gene
activation NN I-Gene
sequence NN I-Gene
. . O

The DT O
requirement NN O
of IN O
Tyr NNP O
- : O
19 CD O
dephosphorylation NN O
for IN O
spindle NN O
assembly NN O
is VBZ O
also RB O
observed VBN O
under IN O
conditions NNS O
in IN O
which WDT O
spindle JJ O
formation NN O
is VBZ O
independent JJ O
of IN O
mitosis NN O
, , O
suggesting VBG O
that IN O
the DT O
involvement NN O
of IN O
Cdc28 NNP B-Gene
/ NNP O
Clb NNP B-Gene
kinase NN O
in IN O
SPB NNP O
separation NN O
is VBZ O
direct JJ O
. . O

Light NNP O
microscopical JJ O
and CC O
routine JJ O
immunohistochemical JJ O
studies NNS O
of IN O
a DT O
cervical JJ O
neoplasm NN O
in IN O
a DT O
32 CD O
year NN O
old JJ O
woman NN O
initially RB O
suggested VBD O
a DT O
histiocytic JJ O
lymphoma NN O
, , O
but CC O
histochemical JJ O
staining NN O
for IN O
chloroacetate NN B-Gene
esterase NN I-Gene
established VBD O
the DT O
correct JJ O
diagnosis NN O
. . O

Km NNP O
and CC O
Vmax NNP O
for IN O
two CD O
substrates NNS O
, , O
src SYM B-Gene
- : I-Gene
related VBN I-Gene
peptide NN I-Gene
and CC O
poly NN O
( ( O
Glu NNP O
, , O
Tyr NNP O
) ) O
( ( O
4 CD O
: : O
1 CD O
) ) O
, , O
were VBD O
2 CD O
. . O
4 CD O
mM NN O
and CC O
2 CD O
. . O
5 CD O
mumol NN O
min SYM O
- : O
1 CD O
mg SYM O
- : O
1 CD O
and CC O
0 CD O
. . O
26 CD O
mM NN O
and CC O
1 CD O
. . O
2 CD O
mumol NN O
min SYM O
- : O
1 CD O
mg SYM O
- : O
1 CD O
, , O
respectively RB O
. . O

A DT O
single JJ O
i NN O
. . O
p NN O
. . O
injection NN O
of IN O
d NN O
, , O
l SYM O
- : O
baclofen NN O
10 CD O
mg NN O
/ NN O
kg VB O
both DT O
reduced VBN O
noradrenaline NN O
( ( O
null NNP O
) ) O
biosynthesis NN O
in IN O
vivo NN O
( ( O
31 CD O
% NN O
) ) O
and CC O
the DT O
endogenous JJ O
concentration NN O
of IN O
normetanephrine NN O
( ( O
NMN NNP O
) ) O
( ( O
32 CD O
% NN O
) ) O
and CC O
increased VBD O
null NNP O
levels NNS O
( ( O
28 CD O
% NN O
) ) O
. . O

Distribution NN O
and CC O
changing VBG O
morphological JJ O
course NN O

Molecular JJ O
cloning NN O
, , O
expression NN O
pattern NN O
, , O
and CC O
chromosomal JJ O
localization NN O
of IN O
human JJ O
CDKN2D NNP B-Gene
/ NNP O
INK4d NNP B-Gene
, , O
an DT O
inhibitor NN O
of IN O
cyclin NN B-Gene
D NNP I-Gene
- : I-Gene
dependent NN I-Gene
kinases NNS I-Gene
. . O

TCZ NNP O
provides VBZ O
quick JJ O
, , O
inexpensive JJ O
, , O
noninvasive JJ O
indication NN O
of IN O
tissue NN O
necrosis NN O
, , O
moderate JJ O
- : O
to TO O
- : O
severe JJ O
intracranial JJ O
hemorrhage NN O
, , O
and CC O
delayed VBD O
brain NN O
maturation NN O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
N NNP O
- : O
glycans NNS O
flanking VBG O
the DT O
receptor NN O
- : O
binding VBG O
site NN O
of IN O
the DT O
HA NNP B-Gene
molecule NN I-Gene
are VBP O
potent JJ O
regulators NNS O
of IN O
influenza NN O
virus NN O
growth NN O
, , O
with IN O
the DT O
glycan NN O
at IN O
Asn149 NNP O
being VBG O
dominant JJ O
and CC O
that DT O
at IN O
Asn123 NNP O
being VBG O
less RBR O
effective JJ O
. . O

Impaction NN O
of IN O
gastrostomy NN O
tube NN O
in IN O
the DT O
abdominal JJ O
wall NN O
. . O

A DT O
genetic JJ O
complementation NN O
system NN O
was VBD O
developed VBN O
in IN O
which WDT O
tobacco NN B-Gene
etch NN I-Gene
virus NN I-Gene
( ( I-Gene
TEV NNP I-Gene
) ) I-Gene
polymerase NN I-Gene
( ( O
NIb NNP B-Gene
) ) O
- : O
expressing VBG O
transgenic JJ O
plants NNS O
or CC O
protoplasts NNS O
were VBD O
inoculated VBN O
with IN O
NIb NNP B-Gene
- : O
defective JJ O
TEV NNP B-Gene
mutants NNS I-Gene
. . O

Purified NNP O
CarP NNP B-Gene
binds VBZ O
in IN O
vitro NN O
to TO O
the DT O
carAB NN B-Gene
control NN I-Gene
region NN I-Gene
and CC O
protects NNS O
against IN O
DNase NNP B-Gene
I PRP I-Gene
two CD O
approximately RB O
25 CD O
bp NNS O
long JJ O
stretches NNS O
, , O
one CD O
of IN O
which WDT O
is VBZ O
located VBN O
just RB O
downstream NN O
of IN O
the DT O
GATC NNP O
sequence NN O
. . O

Lysosomal JJ O
enzymes NNS O
that WDT O
degrade VBP O
cartilage NN O
are VBP O
released VBN O
. . O

UPMC NNP O
is VBZ O
not RB O
the DT O
only JJ O
organization NN O
pursuing VBG O
controlled VBN O
NHBC NNP O
organ JJ O
procurement NN O
, , O
however RB O
. . O

Here RB O
we PRP O
report VBP O
that DT O
expression NN O
of IN O
the DT O
I PRP B-Gene
- : I-Gene
POU NN I-Gene
/ NN O
tI SYM B-Gene
- : I-Gene
POU JJ I-Gene
message NN O
is VBZ O
maximal JJ O
late RB O
in IN O
the DT O
embryonic JJ O
phase NN O
of IN O
Drosophila NNP O
development NN O
, , O
and CC O
I PRP B-Gene
- : I-Gene
POU NN I-Gene
is VBZ O
the DT O
preferred JJ O
splice NN O
variant NN O
. . O

In IN O
some DT O
cases NNS O
, , O
factor NN O
- : O
induced JJ O
Rac NNP B-Gene
activation NN O
results NNS O
in IN O
Rho NNP B-Gene
activation NN O
, , O
and CC O
factor NN O
- : O
induced JJ O
Cdc42 NNP B-Gene
activation NN O
leads VBZ O
to TO O
Rac NNP B-Gene
activation NN O
, , O
as IN O
determined VBN O
by IN O
specific JJ O
morphological JJ O
changes NNS O
. . O

According VBG O
to TO O
out RP O
field NN O
research NN O
, , O
the DT O
tick NN O
fauna NN O
was VBD O
very RB O
rich JJ O
throughout IN O
that DT O
area NN O
, , O
and CC O
it PRP O
was VBD O
permissible JJ O
enough RB O
to TO O
determine VB O
ticks NNS O
as IN O
the DT O
vectors NNS O
, , O
based VBN O
on IN O
arising NN O
of IN O
anti JJ B-Gene
- : I-Gene
SF NNP I-Gene
group NN I-Gene
rickettsiae NN I-Gene
( ( O
SFGR NNP B-Gene
) ) O
antibody NN O
in IN O
mice NN O
inoculated VBN O
with IN O
some DT O
tick JJ O
emulsions NNS O
, , O
findings NNS O
of IN O
rickettsiae NN O
reactive NN O
to TO O
patient VB O
sera NN O
or CC O
a DT O
species NNS O
- : O
specific JJ O
monoclonal JJ O
antibody NN O
to TO O
JSFR NNP B-Gene
in IN O
the DT O
hemolymph NN O
cells NNS O
of IN O
some DT O
ticks NNS O
, , O
and CC O
electron RB O
microscopical JJ O
observations NNS O
of IN O
SFGR NNP B-Gene
in IN O
various JJ O
internal JJ O
organs NNS O
including VBG O
the DT O
salivary JJ O
gland NN O
of IN O
ticks NNS O
. . O

An DT O
unusual JJ O
complication NN O
in IN O
an DT O
unsuitable JJ O
patient NN O
. . O

We PRP O
conclude VBP O
that IN O
cephalothin JJ O
clearance NN O
of IN O
S NNP O
. . O
aureus NN O
from IN O
a DT O
site NN O
accessible JJ O
to TO O
phagocytes NNS O
was VBD O
delayed VBN O
when WRB O
compared VBN O
to TO O
a DT O
phagocyte NN O
- : O
inaccessible JJ O
site NN O
. . O

Despite IN O
resolution NN O
of IN O
the DT O
solid JJ O
portion NN O
of IN O
the DT O
tumor NN O
, , O
serial JJ O
MRI NNP O
showed VBD O
enlargement NN O
of IN O
a DT O
bilobar NN O
tumor NN O
cyst NN O
3 CD O
years NNS O
after IN O
the DT O
original JJ O
diagnosis NN O
. . O

The DT O
protein NN O
predicted VBN O
by IN O
the DT O
sequence NN O
of IN O
the DT O
human JJ B-Gene
pim NN I-Gene
- : I-Gene
1 CD I-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
shares NNS O
extensive JJ O
homology NN O
with IN O
known JJ O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
protein NN I-Gene
kinases NNS I-Gene
, , O
and CC O
yet RB O
the DT O
human JJ B-Gene
Pim NNP I-Gene
- : I-Gene
1 CD I-Gene
enzyme NN I-Gene
has VBZ O
previously RB O
been VBN O
reported VBN O
to TO O
exhibit VB O
protein JJ B-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
activity NN O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Controlled VBN O
versus NN O
uncontrolled JJ O
reperfusion NN O
of IN O
ischemic JJ O
myocardium NN O
after IN O
experimental JJ O
coronary JJ O
artery NN O
occlusion NN O
was VBD O
studied VBN O
to TO O
determine VB O
the DT O
effect NN O
on IN O
regional JJ O
ventricular NN O
wall NN O
motion NN O
and CC O
associated JJ O
biochemical JJ O
alterations NNS O
. . O

These DT O
results NNS O
strongly RB O
suggest VBP O
that IN O
locally RB O
- : O
applied VBN O
TTC NNP O
in IN O
combination NN O
with IN O
FDBA NNP O
enhances VBZ O
new JJ O
bone NN O
formation NN O
in IN O
experimental JJ O
alveolar JJ O
bone NN O
defects NNS O
. . O

Morphine NNP O
injected VBD O
into IN O
the DT O
lateral JJ O
ventricle NN O
of IN O
the DT O
rat NN O
produced VBD O
unilateral JJ O
analgesia NN O
in IN O
the DT O
formalin JJ O
test NN O
, , O
which WDT O
involves VBZ O
continuous JJ O
, , O
moderate JJ O
pain NN O
. . O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
two CD O
genes NNS B-Gene
encoding VBG I-Gene
gp138 NN I-Gene
, , O
a DT O
cell NN O
surface NN O
glycoprotein NN O
involved VBN O
in IN O
the DT O
sexual JJ O
cell NN O
fusion NN O
of IN O
Dictyostelium NNP O
discoideum NN O
. . O

As IN O
a DT O
consequence NN O
of IN O
dark JJ O
rearing NN O
, , O
the DT O
numerical JJ O
density NN O
of IN O
cortical JJ O
neurons NNS O
in IN O
area NN O
17 CD O
amounted VBD O
to TO O
about IN O
double NN O
of IN O
the DT O
value NN O
observed VBN O
in IN O
normally RB O
reared VBN O
kittens NNS O
and CC O
was VBD O
also RB O
significantly RB O
higher JJR O
in IN O
area NN O
18 CD O
. . O

Synchronous JJ O
extracts NNS O
showed VBD O
no DT O
significant JJ O
migration NN O
inhibition NN O
in IN O
allogeneic JJ O
assays NNS O
. . O

This DT O
interaction NN O
occurs VBZ O
over RP O
a DT O
wide JJ O
range NN O
of IN O
both DT O
parameters NNS O
; : O
for IN O
charge NN O
density NN O
from IN O
at IN O
least JJS O
10 CD O
to TO O
800 CD O
microC NNS O
/ JJ O
cm2 NN O
and CC O
, , O
for IN O
charge NN O
per IN O
phase NN O
, , O
from IN O
at IN O
least JJS O
0 CD O
. . O
5 CD O
to TO O
5 CD O
. . O
0 CD O
microC NN O
per IN O
phase NN O
. . O

Evidence NN O
forthe JJ O
electroosmosis NN O
theory NN O
of IN O
transport NN O
in IN O
the DT O
phloem NN O
. . O

The DT O
first JJ O
algorithm NN O
, , O
FOREPROJ NNP O
, , O
is VBZ O
a DT O
fast JJ O
- : O
forward NN O
projection NN O
algorithm NN O
that WDT O
allows VBZ O
calculation NN O
of IN O
the DT O
3 CD O
- : O
D NNP O
attenuation NN O
correction NN O
factors NNS O
( ( O
ACF NNP O
' POS O
s NN O
) ) O
directly RB O
from IN O
a DT O
two CD O
- : O
dimensional NN O
( ( O
2 CD O
- : O
D NN O
) ) O
transmission NN O
scan JJ O
, , O
without IN O
first JJ O
reconstructing VBG O
the DT O
attenuation NN O
map NN O
and CC O
then RB O
performing VBG O
a DT O
3 CD O
- : O
D NNP O
forward RB O
projection NN O
. . O

The DT O
rCBF NN O
ratio NN O
was VBD O
mainly RB O
reduced VBN O
in IN O
frontal JJ O
lobes NN O
( ( O
65 CD O
% NN O
) ) O
. . O

Platelet NNP O
function NN O
and CC O
platelet NN O
- : O
polymorphonuclear JJ O
- : O
neutrophil JJ O
interaction NN O
in IN O
patients NNS O
with IN O
deficient JJ O
platelet NN B-Gene
lipoxygenase NN I-Gene
activity NN O
. . O

The DT O
clinical JJ O
and CC O
laboratory JJ O
features NNS O
of IN O
72 CD O
children NNS O
with IN O
Henoch NNP O
- : O
Schonlein NNP O
purpura NN O
( ( O
HSP NNP O
) ) O
were VBD O
examined VBN O
to TO O
determine VB O
if IN O
there EX O
were VBD O
associations NNS O
between IN O
the DT O
laboratory NN O
indices VBZ O
- : O
- : O
including VBG O
white JJ O
blood NN O
cell NN O
( ( O
WBC NNP O
) ) O
counts VBZ O
, , O
serum VB B-Gene
C NNP I-Gene
- : I-Gene
reactive JJ I-Gene
protein NN I-Gene
( ( O
CRP NNP B-Gene
) ) O
levels NNS O
, , O
platelet NN O
( ( O
PLT NNP O
) ) O
counts VBZ O
- : O
- : O
and CC O
the DT O
clinical JJ O
manifestations NNS O
of IN O
acute JJ O
HSP NNP O
. . O

The DT O
sequences NNS O
showed VBD O
extensive JJ O
homologies NNS O
with IN O
squalene JJ B-Gene
synthase NN I-Gene
genes NNS I-Gene
and CC O
enzymes NNS O
from IN O
a DT O
number NN O
of IN O
other JJ O
organisms NNS O
and CC O
extreme JJ O
amino NN O
acid NN O
conservation NN O
within IN O
the DT O
binding NN O
and CC O
catalytic JJ O
domains NNS O
. . O

We PRP O
introduced VBD O
the DT O
gel NN O
technique NN O
as IN O
a DT O
routine JJ O
assay NN O
for IN O
antibody NN O
detection NN O
and CC O
identification NN O
in IN O
1993 CD O
. . O

Selection NN O
using VBG O
SC NNP O
EPD NNP O
was VBD O
more RBR O
effective JJ O
than IN O
phenotypic NN O
selection NN O
in IN O
reducing VBG O
age NN O
at IN O
puberty NN O
in IN O
daughters NNS O
. . O

Materials NNS O
science NN O
studies NNS O
on IN O
the DT O
soldering NN O
of IN O
different JJ O
orthodontic JJ O
wires NNS O

In IN O
contrast NN O
, , O
the DT O
loss NN O
of IN O
MAD2 NNP B-Gene
staining VBG O
in IN O
meiosis NN O
was VBD O
not RB O
correlated VBN O
with IN O
initial JJ O
microtubule NN O
attachment NN O
but CC O
was VBD O
correlated VBN O
with IN O
a DT O
measure NN O
of IN O
tension NN O
: : O
the DT O
distance NN O
between IN O
homologous JJ O
or CC O
sister JJ O
kinetochores NNS O
( ( O
in IN O
meiosis NN O
I PRP O
and CC O
II NNP O
, , O
respectively RB O
) ) O
. . O

The DT O
uterine JJ O
response NN O
to TO O
prostaglandin VB O
E2 NNP O
( ( O
PGE2 NNP O
) ) O
and CC O
prostaglandin JJ O
F2alpha NNP O
( ( O
administered VBN O
by IN O
intravenous JJ O
and CC O
intrauterine JJ O
routes NNS O
) ) O
was VBD O
evaluated VBN O
during IN O
different JJ O
phases NNS O
of IN O
the DT O
menstrual JJ O
cycle NN O
in IN O
five CD O
functionally RB O
infertile JJ O
women NNS O
. . O

AIMS NNS O
: : O
To TO O
establish VB O
a DT O
baseline NN O
and CC O
intraindividual JJ O
fluctuations NNS O
of IN O
the DT O
tumour NN O
markers NNS O
CEA NNP B-Gene
, , O
CA NNP B-Gene
50 CD I-Gene
and CC O
CA NNP B-Gene
242 CD I-Gene
in IN O
patients NNS O
cured VBN O
from IN O
colorectal JJ O
cancer NN O
, , O
and CC O
to TO O
test VB O
the DT O
hypothesis NN O
that WDT O
serum JJ O
concentrations NNS O
and CC O
intraindividual JJ O
fluctuations NNS O
do VBP O
not RB O
differ VB O
from IN O
the DT O
concentrations NNS O
in IN O
cancer NN O
- : O
free JJ O
individuals NNS O
. . O

ROS NNP B-Gene
x NNP O
SRC NNP B-Gene
( ( O
R NNP B-Gene
) ) O
contains VBZ O
a DT O
16 CD O
- : O
amino NN O
- : O
acid NN O
deletion NN O
that WDT O
includes VBZ O
the DT O
3 CD O
' POS O
half NN O
of IN O
the DT O
transmembrane NN O
domain NN O
of IN O
ros NN B-Gene
. . O

Phosphate NNP B-Gene
glucose JJ I-Gene
dehydrogenase NN I-Gene
deficiency NN O
causing VBG O
hyperbilirubinemia NN O
in IN O
the DT O
newborn NN O

Survival JJ O
rates NNS O
for IN O
the DT O
original JJ O
treatment NN O
group NN O
were VBD O
84 CD O
. . O
5 CD O
% NN O
and CC O
57 CD O
. . O
6 CD O
% NN O
at IN O
12 CD O
and CC O
21 CD O
months NNS O
, , O
respectively RB O
; : O
for IN O
the DT O
delayed JJ O
treatment NN O
group NN O
, , O
78 CD O
. . O
8 CD O
% NN O
and CC O
64 CD O
. . O
6 CD O
% NN O
at IN O
12 CD O
and CC O
21 CD O
months NNS O
, , O
respectively RB O
, , O
and CC O
78 CD O
. . O
8 CD O
% NN O
and CC O
47 CD O
. . O
5 CD O
% NN O
at IN O
12 CD O
and CC O
21 CD O
months NNS O
, , O
respectively RB O
, , O
for IN O
77 CD O
subjects NNS O
with IN O
AIDS NNP O
and CC O
93 CD O
. . O
0 CD O
% NN O
and CC O
71 CD O
. . O
8 CD O
% NN O
, , O
respectively RB O
, , O
for IN O
50 CD O
subjects NNS O
with IN O
AIDS NNP O
- : O
related VBN O
complex JJ O
in IN O
the DT O
original JJ O
treatment NN O
group NN O
. . O

Interspecific NNP O
mouse NN O
back RB O
- : O
cross NN O
analysis NN O
identified VBD O
the DT O
loci NN O
for IN O
mouse NN B-Gene
3Ost CD I-Gene
genes NNS I-Gene
and CC O
syntenic JJ O
assignments NNS O
of IN O
corresponding VBG O
human JJ O
isologs NNS O
were VBD O
confirmed VBN O
by IN O
the DT O
identification NN O
of IN O
mapped JJ O
sequence NN O
- : O
tagged VBN O
site NN O
markers NNS O
. . O

We PRP O
speculate VBP O
that IN O
these DT O
tumors NNS O
may MD O
represent VB O
congenital JJ O
hamartomatous JJ O
growths NNS O
. . O

To TO O
lower VB O
the DT O
current JJ O
high JJ O
incidence NN O
of IN O
NANB NNP O
- : O
induced JJ O
PTH NNP O
, , O
in IN O
1986 CD O
, , O
the DT O
American NNP O
Association NNP O
of IN O
Blood NNP O
Banks NNP O
( ( O
AABB NNP O
) ) O
recommended VBD O
testing VBG O
for IN O
these DT O
PTH NNP O
- : O
associated VBN O
"""" JJ O
surrogate NN O
"""" NN O
markers NNS O
on IN O
all DT O
donated VBN O
units NNS O
of IN O
blood NN O
. . O

Isolation NN O
of IN O
Aeromonas NNP O
from IN O
faeces NNS O
. . O

The DT O
uptake NN O
of IN O
fluorine JJ O
- : O
18 CD O
fluorodeoxyglucose NN O
( ( O
F NNP O
- : O
18 CD O
FDG NNP O
) ) O
by IN O
a DT O
malignant JJ O
tumor NN O
depends VBZ O
on IN O
the DT O
blood NN O
glucose JJ O
level NN O
. . O

Fine JJ O
analysis NN O
at IN O
the DT O
nucleotide JJ O
level NN O
of IN O
the DT O
early JJ O
events NNS O
in IN O
the DT O
digestion NN O
with IN O
nuclease NN B-Gene
S1 NNP I-Gene
shows VBZ O
that IN O
the DT O
enzyme NN O
attacks VBZ O
preferentially RB O
the DT O
sequence NN O
( ( O
G NNP O
- : O
A NN O
) ) O
12 CD O
on IN O
the DT O
message NN O
complementary JJ O
strand NN O
. . O

Renal JJ O
excretion NN O
of IN O
sulphadimidine NN O
in IN O
normal JJ O
and CC O
uraemic JJ O
subjects NNS O
. . O

Mean NNP O
corpuscular JJ B-Gene
hemoglobin NN I-Gene
concentrations NNS O
remained VBD O
normal JJ O
for IN O
48 CD O
h NN O
and CC O
then RB O
decreased VBN O
in IN O
both DT O
groups NNS O
, , O
the DT O
CO2 NNP O
group NN O
showing VBG O
the DT O
larger JJR O
decrease NN O
. . O

A DT O
total NN O
of IN O
174 CD O
primer JJ O
pairs NNS O
gave VBD O
interpretable JJ O
banding NN O
patterns NNS O
, , O
137 CD O
( ( O
79 CD O
% NN O
) ) O
of IN O
which WDT O
revealed VBD O
at IN O
least JJS O
two CD O
alleles NNS O
on IN O
native JJ O
polyacrylamide NN O
gels NNS O
. . O

CONCLUSIONS NN O
: : O
Adding NNP O
MMF NNP O
, , O
a DT O
potent JJ O
topical JJ O
corticosteroid NN O
, , O
to TO O
an DT O
emollient JJ O
cream NN O
is VBZ O
statistically RB O
significantly RB O
more RBR O
effective JJ O
than IN O
emollient JJ O
cream NN O
alone RB O
in IN O
reducing VBG O
acute JJ O
radiation NN O
dermatitis NN O
. . O

In IN O
invertebrates NNS O
, , O
Fhit NNP B-Gene
is VBZ O
encoded VBN O
as IN O
a DT O
fusion NN O
protein NN O
with IN O
Nit NNP B-Gene
, , O
a DT O
member NN O
of IN O
the DT O
nitrilase JJ B-Gene
superfamily RB I-Gene
. . O

In IN O
one CD O
mechanism NN O
, , O
a DT O
specialized JJ O
ubiquitin JJ B-Gene
- : O
dependent NN O
proteolytic JJ O
system NN O
( ( O
called VBN O
the DT O
APC NNP O
- : O
dependent JJ O
proteolysis NN O
machinery NN O
) ) O
degrades VBZ O
the DT O
mitotic JJ O
( ( O
Clb NNP B-Gene
) ) O
cyclin NN B-Gene
subunit NN I-Gene
. . O

However RB O
, , O
the DT O
promoter NN O
region NN O
contains VBZ O
several JJ O
potential JJ O
cis NN O
- : O
regulatory JJ O
elements NNS O
such JJ O
as IN O
Sp1 NNP B-Gene
, , O
early JJ B-Gene
growth NN I-Gene
response NN I-Gene
- : I-Gene
1 CD I-Gene
, , O
activator NN B-Gene
protein SYM I-Gene
- : I-Gene
2 CD I-Gene
, , O
MyoD NNP B-Gene
, , O
p300 NN B-Gene
, , O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
, , O
myeloid JJ B-Gene
zinc NN I-Gene
finger NN I-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
, , O
caudal SYM B-Gene
- : I-Gene
related VBN I-Gene
homeobox NN I-Gene
( ( I-Gene
Cdx NNP I-Gene
) ) I-Gene
gene NN I-Gene
A NNP I-Gene
, , O
and CC O
Cdx NNP B-Gene
protein VBP I-Gene
- : I-Gene
2 CD I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Smoking NN O
was VBD O
regarded VBN O
as IN O
the DT O
major JJ O
contribution NN O
to TO O
pulmonary JJ O
dysfunction NN O
. . O

SGPT NNP B-Gene
, , O
SGOT NNP B-Gene
, , O
and CC O
alkaline JJ B-Gene
phosphatase NN I-Gene
concentrations NNS O
were VBD O
essentially RB O
normal JJ O
in IN O
all DT O
subjects NNS O
. . O

Deformities NNS O
of IN O
the DT O
tip NN O
of IN O
the DT O
olecranon NN O
and CC O
of IN O
the DT O
coronoid NN O
process NN O
are VBP O
also RB O
described VBN O
( ( O
De NNP O
Palma NNP O
1956 CD O
, , O
Jordan NNP O
1958 CD O
, , O
Ahlberg NNP O
1965 CD O
, , O
Weseloh NNP O
1973 CD O
) ) O
. . O

Antidromic NNP O
invasion NN O
of IN O
impulses NNS O
and CC O
recurrent JJ O
collateral NN O
inhibition NN O
in IN O
pyramidal JJ O
tract NN O
neurones NNS O
. . O

IFI NNP B-Gene
16 CD I-Gene
mRNA NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
constitutively RB O
expressed VBN O
in IN O
lymphoid JJ O
cells NNS O
and CC O
in IN O
cell NN O
lines NNS O
of IN O
both DT O
the DT O
T NNP O
and CC O
B NNP O
lineages NNS O
. . O

JNK NNP B-Gene
is VBZ O
additionally RB O
regulated VBN O
by IN O
the DT O
Ras NNP B-Gene
- : O
related JJ O
G NNP B-Gene
proteins VBZ I-Gene
Rac NNP B-Gene
and CC O
Cdc42 NNP B-Gene
. . O

Interestingly RB O
, , O
addition NN O
of IN O
purified JJ O
CBP NNP B-Gene
to TO O
the DT O
nuclear JJ O
extracts NNS O
of IN O
T47D NNP O
cells NNS O
markedly RB O
stimulated VBD O
progesterone NN O
- : O
and CC O
PR NNP B-Gene
- : O
dependent JJ O
transcription NN O
from IN O
a DT O
nucleosome JJ O
- : O
free JJ O
, , O
progesterone JJ O
response NN O
element NN O
( ( O
PRE NNP O
) ) O
- : O
linked VBN O
reporter NN O
DNA NNP O
template NN O
. . O

The DT O
data NN O
indicate NN O
that IN O
calcitonin NN B-Gene
induced VBD O
a DT O
beta NN B-Gene
- : I-Gene
endorphin JJ I-Gene
increase NN O
independent JJ O
of IN O
enhanced JJ O
corticotrophin JJ B-Gene
- : O
cortisol NN O
release NN O
. . O

LA NNP O
- : O
3848 CD O
- : O
MS NN O
. . O

Two CD O
experiments NNS O
investigating VBG O
the DT O
effects NNS O
of IN O
short JJ O
- : O
term NN O
spaceflight NN O
on IN O
cancellous JJ O
bone NN O
turnover NN O
were VBD O
carried VBN O
out IN O
: : O
Physiological JJ O
Systems NNP O
Experiment NNP O
- : O
1 CD O
( ( O
PSE NNP O
- : O
1 CD O
) ) O
( ( O
a DT O
4 CD O
- : O
d NN O
orbital JJ O
spaceflight NN O
) ) O
and CC O
PSE NNP O
- : O
2 CD O
( ( O
a DT O
10 CD O
- : O
d NN O
flight NN O
) ) O
. . O

However RB O
, , O
the DT O
presence NN O
of IN O
effacement NN O
seems VBZ O
to TO O
be VB O
a DT O
more RBR O
reliable JJ O
and CC O
practical JJ O
parameter NN O
that WDT O
will MD O
be VB O
preferred VBN O
in IN O
that DT O
prediction NN O
. . O

Cloning VBG O
and CC O
expression NN O
of IN O
a DT O
specific JJ O
human JJ B-Gene
alpha NN I-Gene
1 CD I-Gene
, , I-Gene
2 CD I-Gene
- : I-Gene
mannosidase NN I-Gene
that IN O
trims VBZ O
Man9GlcNAc2 NNP O
to TO O
Man8GlcNAc2 NNP O
isomer NN O
B NNP O
during IN O
N NNP O
- : O
glycan JJ O
biosynthesis NN O
. . O

In IN O
vivo NN O
, , O
selective JJ O
activation NN O
of IN O
SAPKs NNP B-Gene
stimulates VBZ O
formation NN O
of IN O
the DT O
ternary JJ O
complex NN O
containing VBG O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
serum NN B-Gene
response NN I-Gene
factor NN I-Gene
and CC O
the DT O
serum NN O
response NN O
element NN O
, , O
and CC O
enhances NNS O
Elk NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
transcription NN O
. . O

A DT O
phylogenetic JJ O
tree NN O
of IN O
members NNS O
of IN O
the DT O
T2 NNP B-Gene
/ NNP I-Gene
S NNP I-Gene
- : I-Gene
RNase NNP I-Gene
superfamily RB I-Gene
in IN O
plants NNS O
was VBD O
obtained VBN O
. . O

The DT O
plasma NN B-Gene
growth NN I-Gene
hormone CD I-Gene
concentration NN O
of IN O
the DT O
foetal JJ O
lamb NN O
. . O

Deletion NN O
of IN O
the DT O
potential JJ O
initiator NN O
element NN O
does VBZ O
not RB O
affect VB O
repression NN O
of IN O
the DT O
p21 NN B-Gene
promoter NN I-Gene
by IN O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
. . O

Complexes NNP O
containing VBG O
wild JJ O
- : O
type NN O
and CC O
either DT O
his175 NN B-Gene
or CC I-Gene
his273 NN I-Gene
mutant JJ I-Gene
p53 NN I-Gene
proteins NNS I-Gene
are VBP O
completely RB O
unable JJ O
to TO O
bind VB O
to TO O
the DT O
RGC NNP B-Gene
DNA NNP I-Gene
sequence NN I-Gene
. . O

In IN O
particular JJ O
, , O
the DT O
S1 NNP B-Gene
' POS I-Gene
specificity NN I-Gene
site NN I-Gene
is VBZ O
a DT O
deep JJ O
and CC O
highly RB O
hydrophobic JJ O
cavity NN O
. . O

Ab NNP O
- : O
MLV NNP O
strains VBZ O
expressing VBG O
P70 NNP B-Gene
/ NNP O
S2 NNP B-Gene
failed VBD O
to TO O
transform VB O
NIH NNP O
3T3 CD O
cells NNS O
and CC O
demonstrated VBD O
a DT O
greatly RB O
reduced VBN O
capacity NN O
to TO O
mediate VB O
signaling VBG O
events NNS O
associated VBN O
with IN O
the DT O
Ras NNP B-Gene
- : O
dependent NN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinase VBD I-Gene
pathway NN O
. . O

Courses NNS O
were VBD O
repeated VBN O
every DT O
four CD O
weeks NNS O
. . O

A DT O
triple JJ B-Gene
- : I-Gene
mutant NN I-Gene
TBP NNP I-Gene
( ( O
R231E NNP O
+ NNP O
R235E NNP O
+ NNP O
R239S NNP O
) ) O
had VBD O
greatly RB O
reduced VBN O
activity NN O
for IN O
yeast NN B-Gene
U6 NNP I-Gene
snRNA NN I-Gene
gene NN I-Gene
transcription NN O
while IN O
remaining VBG O
active JJ O
for IN O
Pol NNP B-Gene
II NNP I-Gene
basal NN O
transcription NN O
. . O

In IN O
the DT O
present JJ O
experiments NNS O
, , O
we PRP O
investigate VBP O
the DT O
role NN O
played VBN O
by IN O
the DT O
temporal JJ O
pattern NN O
of IN O
neural JJ O
activity NN O
during IN O
the DT O
ontogeny NN O
of IN O
frequency NN O
tuning VBG O
in IN O
the DT O
mouse NN O
central JJ O
auditory NN O
system NN O
. . O

In IN O
all DT O
experimental JJ O
eyes NNS O
, , O
there EX O
was VBD O
a DT O
marked JJ O
reduction NN O
, , O
but CC O
never RB O
a DT O
complete JJ O
absence NN O
of IN O
adrenergic JJ O
nerves NNS O
in IN O
the DT O
iris NN O
. . O

The DT O
protector NN O
doubled VBD O
the DT O
estimated VBN O
fall NN O
distance NN O
for IN O
fracture NN O
of IN O
the DT O
trochanter NN O
. . O

The DT O
role NN O
of IN O
supercritical JJ O
fluid NN O
chromatography NN O
( ( O
SFC NNP O
) ) O
as IN O
a DT O
viable JJ O
technique NN O
for IN O
analyzing VBG O
agricultural JJ O
products NNS O
has VBZ O
been VBN O
investigated VBN O
using VBG O
packed JJ O
and CC O
capillary JJ O
column NN O
methodology NN O
. . O

Large JJ O
genomic JJ O
constructs NNS O
integrate VBP O
at IN O
the DT O
endogenous JJ O
locus NN O
by IN O
homologous JJ O
recombination NN O
, , O
but CC O
cDNA SYM O
- : O
derived VBN O
sequences NNS O
lacking VBG O
long JJ O
stretches NNS O
of IN O
contiguous JJ O
genomic JJ O
DNA NN O
( ( O
due JJ O
to TO O
intron VB O
excision NN O
) ) O
typically RB O
integrate VBP O
into IN O
chromosomal JJ O
DNA NN O
by IN O
nonhomologous JJ O
recombination NN O
. . O

Surprisingly RB O
, , O
the DT O
CSF1R NNP B-Gene
/ NNP O
IRDelta960 NNP B-Gene
was VBD O
as RB O
effective JJ O
as IN O
the DT O
CSF1R NNP B-Gene
/ NNP O
IR NNP B-Gene
in IN O
mediating VBG O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
protection NN O
of IN O
cells NNS O
from IN O
staurosporine JJ O
- : O
induced JJ O
apoptosis NN O
. . O

Oxfendazole NNP O
, , O
which WDT O
was VBD O
active JJ O
for IN O
the DT O
shortest JJ O
time NN O
( ( O
about IN O
65 CD O
days NNS O
) ) O
from IN O
the DT O
start NN O
of IN O
grazing NN O
( ( O
May NNP O
1 CD O
) ) O
, , O
produced VBD O
a DT O
78 CD O
. . O
1 CD O
per IN O
cent NN O
reduction NN O
in IN O
Ostertagia NNP O
species NNS O
and CC O
an DT O
84 CD O
. . O
4 CD O
per IN O
cent NN O
reduction NN O
in IN O
D NNP O
viviparus NN O
. . O

Recently RB O
, , O
a DT O
human JJ B-Gene
transcription NN I-Gene
elongation NN I-Gene
factor NN I-Gene
P NNP I-Gene
- : I-Gene
TEFb NN I-Gene
, , O
consisting VBG O
of IN O
CDK9 NNP B-Gene
kinase NN I-Gene
, , O
cyclin NN B-Gene
T NNP I-Gene
and CC O
other JJ O
associated JJ O
factors NNS O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
Tat NNP B-Gene
to TO O
restore VB O
Tat NNP B-Gene
activation NN O
in IN O
HeLa NNP O
nuclear JJ O
extract NN O
depleted VBN O
of IN O
P NNP B-Gene
- : I-Gene
TEFb NN I-Gene
. . O

Open JJ O
head NN O
- : O
brain NN O
injuries NNS O

NUP145 NNP B-Gene
was VBD O
previously RB O
identified VBN O
by IN O
using VBG O
a DT O
genetic JJ O
synthetic JJ O
lethal NN O
screen NN O
( ( O
E NNP O
. . O

Linear JJ O
extrapolation NN O
is VBZ O
used VBN O
below IN O
the DT O
experimental JJ O
data NN O
range NN O
to TO O
establish VB O
an DT O
upper JJ O
bound NN O
on IN O
carcinogenic JJ O
risk NN O
at IN O
low JJ O
doses NNS O
. . O

Plots NNS O
of IN O
RV NNP O
, , O
LV NNP O
+ NNP O
S NNP O
and CC O
2A CD O
weight NN O
vs NN O
real JJ O
hematocrit NN O
showed VBD O
sharp JJ O
upward JJ O
inflections NNS O
at IN O
real JJ O
hematocrit JJ O
65 CD O
% NN O
, , O
suggesting VBG O
a DT O
possible JJ O
role NN O
of IN O
increased JJ O
viscosity NN O
in IN O
CO NNP O
cardiomegaly NN O
at IN O
the DT O
higher JJR O
hematocrit NN O
. . O

Multiple NNP O
dosing VBG O
four CD O
times NNS O
daily RB O
for IN O
7 CD O
days NNS O
of IN O
indoprofen JJ O
200 CD O
mg NN O
, , O
a DT O
non JJ O
- : O
steroidal NN O
anti SYM O
- : O
inflammatory JJ O
drug NN O
with IN O
a DT O
short JJ O
half NN O
- : O
life NN O
( ( O
t1 JJ O
/ NNP O
2 CD O
) ) O
, , O
revealed VBD O
drug NN O
accumulation NN O
in IN O
eight CD O
elderly JJ O
subjects NNS O
. . O

In IN O
a DT O
prospective JJ O
, , O
randomized JJ O
clinical JJ O
trial NN O
we PRP O
compared VBN O
the DT O
efficacy NN O
of IN O
subcutaneously RB O
( ( O
SC NNP O
) ) O
administered VBD O
( ( O
every DT O
8 CD O
h NN O
) ) O
calcium NN O
heparin NN O
to TO O
intravenous JJ O
( ( O
IV NNP O
) ) O
sodium NN O
heparin NN O
in IN O
the DT O
treatment NN O
of IN O
proximal JJ O
deep JJ O
- : O
vein NN O
thrombosis NN O
( ( O
DVT NNP O
) ) O
. . O

A DT O
330 CD O
- : O
kb NN O
YAC NNP O
, , O
A148A7 NNP O
, , O
spanned VBD O
from IN O
the DT O
HLA NNP B-Gene
- : O
DQA1 NN B-Gene
locus NN O
through IN O
the DT O
Y3 NNP B-Gene
/ NNP O
Ring NNP B-Gene
4 CD I-Gene
locus NN O
and CC O
extended VBN O
at IN O
least JJS O
130 CD O
kb JJ O
centromeric NN O
of IN O
YAC NNP O
B1D12 NNP O
. . O

The DT O
present JJ O
study NN O
highlights VBD O
the DT O
improvement NN O
in IN O
sputum NN O
amoxycillin NN O
( ( O
amoxy JJ O
) ) O
levels NNS O
when WRB O
a DT O
combination NN O
tablet NN O
, , O
amoxy JJ O
500 CD O
mg NN O
plus CC O
bromhexeine JJ O
8 CD O
mg NN O
, , O
is VBZ O
administered VBN O
as IN O
compared VBN O
to TO O
plain VB O
amoxy JJ O
500 CD O
mg NN O
. . O

High JJ O
- : O
level NN O
gains NNS O
( ( O
HLGs NNP O
) ) O
indicative NN O
of IN O
gene NN O
amplifications NNS O
were VBD O
identified VBN O
at IN O
11q13 CD O
in IN O
two CD O
cases NNS O
, , O
and CC O
in IN O
one CD O
case NN O
each DT O
at IN O
2q33 CD O
- : O
34 CD O
, , O
3q25 CD O
- : O
29 CD O
, , O
5p15 CD O
. . O
1 CD O
- : O
15 CD O
. . O
2 CD O
, , O
7q21 CD O
- : O
22 CD O
, , O
11p11 CD O
. . O
2 CD O
, , O
12p11 CD O
. . O
2 CD O
- : O
12 CD O
, , O
and CC O
13q34 CD O
. . O

Band NNP O
- : O
shift NN O
assays NNS O
were VBD O
performed VBN O
using VBG O
the DT O
LPS NNP B-Gene
- : I-Gene
and CC I-Gene
IL NNP I-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
( ( O
LILRE NNP B-Gene
) ) O
oligonucleotide RB O
, , O
a DT O
gamma NN B-Gene
interferon NN I-Gene
activation NN I-Gene
site NN I-Gene
- : I-Gene
like IN I-Gene
site NN I-Gene
that WDT O
is VBZ O
present JJ O
in IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
1beta CD I-Gene
promoter NN I-Gene
. . O

Interestingly RB O
, , O
Csx NNP B-Gene
/ NNP O
Nkx2 NNP B-Gene
. . O

A DT O
flow JJ O
rate NN O
of IN O
at IN O
least JJS O
5 CD O
mL JJ O
/ NN O
h NN O
is VBZ O
required VBN O
through IN O
the DT O
receptor NN O
( ( O
volume NN O
, , O
0 CD O
. . O
4 CD O
mL NN O
) ) O
for IN O
accurate JJ O
results NNS O
. . O

Data NNS O
were VBD O
obtained VBN O
from IN O
2 CD O
undergraduate JJ O
student NN O
samples NNS O
, , O
a DT O
self JJ O
- : O
report NN O
group NN O
( ( O
n JJ O
= NNP O
132 CD O
) ) O
who WP O
provided VBD O
NEO NNP O
- : O
PI NNP O
- : O
R NN O
self PRP O
- : O
ratings NNS O
on IN O
2 CD O
occasions NNS O
separated VBN O
by IN O
a DT O
7 CD O
- : O
to TO O
14 CD O
- : O
day NN O
interval NN O
and CC O
an DT O
informant JJ O
group NN O
( ( O
n JJ O
= NNP O
109 CD O
) ) O
who WP O
provided VBD O
ratings NNS O
of IN O
well RB O
- : O
known VBN O
friends NNS O
or CC O
relatives NNS O
on IN O
2 CD O
occasions NNS O
separated VBN O
by IN O
a DT O
6 CD O
month NN O
interval NN O
. . O

The DT O
rci NN B-Gene
gene NN I-Gene
was VBD O
fused VBN O
with IN O
lacZ NN B-Gene
and CC O
its PRP$ O
gene NN O
product NN O
was VBD O
identified VBN O
by IN O
Western JJ O
blot NN O
analysis NN O
. . O

This DT O
analysis NN O
supports VBZ O
the DT O
use NN O
of IN O
fluticasone NN O
propionate NN O
88 CD O
microg NN O
twice RB O
daily RB O
as IN O
first JJ O
- : O
line NN O
treatment NN O
in IN O
patients NNS O
with IN O
persistent JJ O
asthma NN O
previously RB O
treated VBN O
with IN O
short JJ O
- : O
acting VBG O
beta2 SYM B-Gene
- : O
agonist NN O
alone RB O
. . O

The DT O
application NN O
of IN O
these DT O
instruments NNS O
allows VBZ O
occlusion NN O
of IN O
the DT O
ascending VBG O
aorta NN O
traversed VBN O
by IN O
the DT O
perfusion NN O
cannula NN O
inserted VBN O
directly RB O
or CC O
through IN O
the DT O
apex NN O
of IN O
the DT O
heart NN O
as RB O
well RB O
as IN O
simultaneous JJ O
left VBD O
ventricular JJ O
venting NN O
. . O

Because IN O
of IN O
this DT O
latter JJ O
phenomenon NN O
, , O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
a DT O
particular JJ O
cysteine NN O
motif NN O
that WDT O
was VBD O
repeated VBN O
multiple JJ O
times NNS O
in IN O
Dfurin2 NNP B-Gene
but CC O
present JJ O
only RB O
twice RB O
in IN O
mammalian JJ B-Gene
furin NN I-Gene
. . O

Comprising VBG O
a DT O
126 CD O
- : O
nucleotide RB O
5 CD O
' '' O
untranscribed JJ O
genomic JJ O
sequence NN O
and CC O
a DT O
466 CD O
- : O
nucleotide RB O
5 CD O
' '' O
noncoding VBG O
cDNA NN O
sequence NN O
, , O
the DT O
592 CD O
- : O
nucleotide RB O
5 CD O
' '' O
CpG NNP O
island NN O
lacked VBD O
TATA NNP O
and CC O
CAAT NNP O
boxes NNS O
but CC O
displayed VBD O
a DT O
high JJ O
G NNP O
+ NNP O
C NNP O
content NN O
, , O
was VBD O
enriched VBN O
for IN O
CpG NNP O
dinucleotides NNS O
, , O
and CC O
contained VBD O
a DT O
potential JJ O
Sp1 NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
, , O
i NN O
. . O
e NN O
. . O
, , O
features VBZ O
compatible JJ O
with IN O
a DT O
housekeeping NN O
gene NN O
. . O

They PRP O
were VBD O
checked VBN O
for IN O
anti JJ B-Gene
- : I-Gene
HCV NNP I-Gene
( ( O
anti SYM B-Gene
- : I-Gene
C100 NNP I-Gene
- : I-Gene
3 CD I-Gene
) ) O
with IN O
HCV NNP O
EIA NNP O
kit NN O
( ( O
Abbott NNP O
Lab NNP O
. . O
, , O
North NNP O
Chicago NNP O
, , O
IL NNP O
) ) O
. . O

We PRP O
isolated VBD O
the DT O
human JJ B-Gene
FGF NNP I-Gene
- : I-Gene
BP NNP I-Gene
promoter NN I-Gene
and CC O
determined VBN O
by IN O
deletion NN O
analysis NN O
that WDT O
TPA NNP O
regulatory JJ O
elements NNS O
were VBD O
all DT O
contained VBN O
in IN O
the DT O
first JJ O
118 CD O
base NN O
pairs NNS O
upstream NN O
of IN O
the DT O
transcription NN O
start NN O
site NN O
. . O

Type NNP O
IV NNP O
splice NN O
pattern NN O
, , O
containing VBG O
exon NN O
U3 NNP O
and CC O
S NNP O
was VBD O
found VBN O
both DT O
in IN O
kidney NN O
and CC O
ovary JJ O
. . O

Using VBG O
himA NN B-Gene
mutants NNS I-Gene
, , O
we PRP O
confirmed VBD O
that IN O
IHF NNP B-Gene
plays VBZ O
a DT O
role NN O
in IN O
the DT O
molybdate NN O
- : O
dependent JJ O
regulation NN O
of IN O
dmsA JJ B-Gene
- : O
lacZ JJ B-Gene
expression NN O
in IN O
vivo NN O
. . O

Nonsynonymous JJ O
substitution NN O
in IN O
abalone JJ O
sperm JJ O
fertilization NN O
genes NNS O
exceeds VBZ O
substitution NN O
in IN O
introns NNS O
and CC O
mitochondrial JJ O
DNA NNP O
. . O

Kinetic JJ O
experiments NNS O
revealed VBD O
that IN O
within IN O
10 CD O
min NN O
this DT O
radiolabeled VBD O
precursor NN O
protein NN O
was VBD O
converted VBN O
in IN O
HL NNP O
- : O
60 CD O
cells NNS O
into IN O
an DT O
Mr NNP O
approximately RB O
150 CD O
, , O
0 CD O
chondroitin NN O
sulfate NN O
proteoglycan JJ O
intermediate NN O
. . O

Dose NNP O
standardisation NN O
of IN O
botulinum NN B-Gene
toxin NN I-Gene
. . O

Diuresis NN O
was VBD O
induced VBN O
by IN O
scheduled JJ O
drinking NN O
of IN O
tea NN O
( ( O
150 CD O
ml NN O
/ NNP O
h NN O
) ) O
. . O

Specific JJ O
clotting VBG O
factor NN O
assays NNS O
showed VBD O
an DT O
isolated JJ O
deficiency NN O
of IN O
factor NN B-Gene
X NNP I-Gene
ranging VBG O
from IN O
7 CD O
to TO O
12 CD O
per IN O
cent NN O
on IN O
three CD O
determinations NNS O
. . O

Although IN O
a DT O
great JJ O
deal NN O
is VBZ O
understood VBN O
about IN O
how WRB O
bHLH JJ B-Gene
factors NNS I-Gene
activate VBP O
gene NN O
transcription NN O
via IN O
E NNP O
- : O
box NN O
DNA NNP O
consensus NN O
sequences NNS O
, , O
studies NNS O
of IN O
bHLH JJ B-Gene
factor NN I-Gene
function NN O
in IN O
higher JJR O
eukaryotes NNS O
often RB O
have VBP O
been VBN O
hindered VBN O
by IN O
the DT O
presence NN O
of IN O
multiple JJ O
family NN O
members NNS O
. . O

To TO O
determine VB O
if IN O
CYC2 NNP B-Gene
is VBZ O
found VBN O
in IN O
a DT O
complex JJ O
with IN O
previously RB O
identified VBN O
trypanosome NN B-Gene
cdc2 SYM I-Gene
- : I-Gene
related JJ I-Gene
kinases NNS I-Gene
( ( O
CRKs NNP B-Gene
) ) O
, , O
the DT O
CYC2 NNP B-Gene
gene NN I-Gene
was VBD O
fused VBN O
to TO O
the DT O
TY NNP B-Gene
epitope NN I-Gene
tag NN O
, , O
integrated VBN O
into IN O
the DT O
trypanosome JJ O
genome NN O
, , O
and CC O
expressed VBD O
under IN O
inducible JJ O
control NN O
. . O

This DT O
region NN O
is VBZ O
required VBN O
for IN O
activation NN O
of IN O
DNA NNP O
binding NN O
of IN O
MyoD NNP B-Gene
and CC O
E12 NNP B-Gene
homodimers NNS I-Gene
and CC O
E12 NNP B-Gene
/ NNP O
MyoD NNP B-Gene
heterodimers NNS O
. . O

Administration NN O
of IN O
a DT O
second JJ O
dose NN O
of IN O
vaccine NN O
during IN O
the DT O
outbreak NN O
was VBD O
not RB O
protective JJ O
. . O

By IN O
contrast NN O
, , O
their PRP$ O
basal JJ O
adrenal JJ O
androgen NN O
levels NNS O
were VBD O
significantly RB O
decreased VBN O
compared VBN O
to TO O
those DT O
in IN O
normal JJ O
subjects NNS O
on IN O
both DT O
the DT O
day NN O
on IN O
and CC O
the DT O
day NN O
off IN O
prednisone NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Using VBG O
immunolocalization NN O
, , O
we PRP O
observe VBP O
that DT O
ACE3 NNP B-Gene
, , O
a DT O
440 CD O
- : O
bp NN O
chorion NN O
element NN O
that WDT O
contains VBZ O
information NN O
sufficient NN O
to TO O
drive VB O
amplification NN O
, , O
directs VBZ O
DmORC NNP B-Gene
localization NN O
in IN O
follicle NN O
cells NNS O
. . O

S NNP O
. . O
, , O
K NNP O
. . O

DNA NNP O
- : O
binding NN O
activity NN O
was VBD O
not RB O
increased VBN O
by IN O
the DT O
addition NN O
of IN O
forskolin NN O
to TO O
thecal JJ O
or CC O
luteal JJ O
cells NNS O
. . O

( ( O
Emeritus NNP O
) ) O
John NNP O
Henri NNP O
Roosegaarde NNP O
Bisschop NNP O

Legionella NNP O
, , O
microbial JJ O
ecology NN O
, , O
and CC O
inconspicuous JJ O
consumption NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
present VBP O
two CD O
lines NNS O
of IN O
evidence NN O
that IN O
all DT O
ribosomes NNS O
which WDT O
synthesize VBP O
GCN4 NNP B-Gene
have VBP O
previously RB O
translated VBN O
uORF1 NN O
, , O
resumed VBD O
scanning NN O
, , O
and CC O
reinitiated VBD O
at IN O
the DT O
GCN4 NNP B-Gene
start NN O
site NN O
. . O

Whole JJ O
bowel NN O
irrigation NN O
is VBZ O
a DT O
recently RB O
described VBN O
technique NN O
to TO O
enhance VB O
the DT O
passage NN O
of IN O
drugs NNS O
already RB O
beyond IN O
the DT O
pylorus NN O
. . O

This DT O
suggests VBZ O
that IN O
helicase NN B-Gene
- : I-Gene
like IN I-Gene
genes NNS I-Gene
may MD O
be VB O
involved VBN O
in IN O
the DT O
biosynthesis NN O
of IN O
nucleic JJ O
acids NNS O
and CC O
proteins NNS O
, , O
and CC O
that IN O
the DT O
genes NNS O
can MD O
be VB O
transcriptionally RB O
activated VBN O
by IN O
heat NN O
shock NN O
to TO O
compensate VB O
for IN O
the DT O
repressed JJ O
synthesis NN O
of IN O
mRNA NN O
and CC O
protein NN O
. . O

Hybridization NN O
of IN O
plasmid JJ O
- : O
transformed VBN O
Escherichia NNP O
coli NNS O
RR1 NNP O
colonies NNS O
with IN O
32P CD O
- : O
labeled VBN O
viral JJ O
genome NN O
RNAs NNP O
demonstrated VBD O
the DT O
presence NN O
of IN O
DNA NNP O
clones NNS O
representative NN O
of IN O
each DT O
of IN O
the DT O
10 CD O
reovirus NN O
RNAs NNP O
and CC O
10 CD O
of IN O
the DT O
11 CD O
constituent JJ O
segments NNS O
of IN O
the DT O
rotavirus NN O
genome NN O
. . O

Two CD O
related JJ O
cDNAs NNS O
were VBD O
isolated VBN O
that IN O
encode JJ O
proteins NNS O
that WDT O
recognize VBP O
the DT O
XMyoDa NNP B-Gene
TATA NNP I-Gene
motif NN I-Gene
. . O

In IN O
a DT O
similar JJ O
fashion NN O
to TO O
adipose VB O
stromal JJ O
cells NNS O
, , O
serum NN O
potentiated VBD O
the DT O
response NN O
to TO O
dexamethasone VB O
but CC O
had VBD O
no DT O
effect NN O
on IN O
phorbol NN O
ester NN O
- : O
stimulated VBN O
activity NN O
. . O

The DT O
mouse NN B-Gene
beta NN I-Gene
2 CD I-Gene
- : I-Gene
syntrophin JJ I-Gene
gene NN I-Gene
( ( O
> JJ O
33 CD O
kilobases NNS O
) ) O
contains VBZ O
seven CD O
exons NNS O
, , O
all DT O
of IN O
which WDT O
have VBP O
homologues NNS O
at IN O
the DT O
corresponding JJ O
position NN O
in IN O
the DT O
alpha NN B-Gene
1 CD I-Gene
- : I-Gene
syntrophin JJ I-Gene
gene NN I-Gene
. . O

Problems NNS O
in IN O
the DT O
determination NN O
of IN O
the DT O
antigenic JJ O
content NN O
of IN O
influenza JJ O
vaccines NNS O
. . O

Re NNP O
- : O
evaluation NN O
of IN O
the DT O
biopsy NN O
specimen NNS O
from IN O
the DT O
right JJ O
hip NN O
taken VBN O
at IN O
the DT O
time NN O
of IN O
the DT O
initial JJ O
operation NN O
showed VBD O
areas NNS O
of IN O
chondrosarcoma NN O
arising VBG O
in IN O
the DT O
background NN O
of IN O
synovial JJ O
chondromatosis NN O
. . O

The DT O
hcKrox NN B-Gene
gene NN O
family NN O
regulates VBZ O
multiple JJ O
extracellular JJ O
matrix NN O
genes NNS O
. . O

This DT O
exon NN O
, , O
here RB O
named VBN O
exon RB O
0 CD O
, , O
contained VBD O
the DT O
entire JJ O
5 CD O
' POS O
untranslated JJ O
region NN O
and CC O
the DT O
N NNP O
- : O
terminal JJ O
signal JJ O
sequence NN O
of IN O
the DT O
polypeptide NN O
. . O

Atmospheric NNP O
benzene NN O
, , O
urinary JJ O
muconic NN O
acid NN O
( ( O
tt JJ O
- : O
MA NN O
) ) O
and CC O
leukocyte JJ B-Gene
alkaline JJ I-Gene
phosphatase NN I-Gene
activity NN O
( ( O
LAPA NNP O
) ) O
were VBD O
evaluated VBN O
among IN O
66 CD O
car NN O
mechanics NNS O
, , O
34 CD O
road NN O
tanker NN O
drivers NNS O
, , O
and CC O
28 CD O
nonexposed JJ O
workers NNS O
. . O

Deletion NNP O
analyses NNS O
of IN O
the DT O
construct NN O
revealed VBD O
that IN O
the DT O
transcription NN O
of IN O
BOXF1 NNP B-Gene
gene NN I-Gene
is VBZ O
regulated VBN O
by IN O
BOX NNP O
DNA NNP O
, , O
preferentially RB O
in IN O
undifferentiated JJ O
EC NNP O
cells NNS O
versus NN O
differentiated VBD O
cells NNS O
. . O

A DT O
. . O

KFC NNP B-Gene
, , O
a DT O
Ste20 NNP B-Gene
- : I-Gene
like IN I-Gene
kinase NN I-Gene
with IN O
mitogenic JJ O
potential NN O
and CC O
capability NN O
to TO O
activate VB O
the DT O
SAPK NNP B-Gene
/ NNP O
JNK NNP B-Gene
pathway NN O
. . O

Cytoprotection NN O
with IN O
amifostine NN O
in IN O
radiotherapy NN O
or CC O
radio NN O
- : O
chemotherapy NN O
of IN O
head NN O
and CC O
neck NN O
tumors NNS O

Exons NNS O
A1a NNP O
and CC O
A1b NNP O
are VBP O
separated VBN O
from IN O
each DT O
other JJ O
by IN O
a DT O
124 CD O
- : O
nucleotide NN O
intron NN O
. . O

The DT O
half NN O
- : O
life NN O
of IN O
the DT O
serum NN O
- : O
induced JJ O
CBP NNP B-Gene
/ NNP O
tk VBD B-Gene
binding VBG O
activity NN O
was VBD O
estimated VBN O
to TO O
be VB O
less JJR O
than IN O
1 CD O
h NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

Measurement NN O
of IN O
open JJ O
- : O
loop NN O
responses NNS O
to TO O
electrical JJ O
stimulation NN O
in IN O
olfactory JJ O
bulb NN O
of IN O
cat NN O
. . O

The DT O
dynamic JJ O
properties NNS O
of IN O
this DT O
protein NN O
fragment NN O
were VBD O
measured VBN O
and CC O
analyzed VBN O
using VBG O
both DT O
isotropic NN O
and CC O
anisotropic JJ O
models NNS O
of IN O
molecular JJ O
motion NN O
. . O

Franz NNP O
Schubert NNP O
- : O
- : O
his PRP$ O
life NN O
, , O
music NN O
and CC O
diseases NNS O

This DT O
suggested VBD O
that IN O
delta NN O
6 CD O
and CC O
delta JJ O
5 CD O
desaturation NN O
activities NNS O
are VBP O
normal JJ O
in IN O
these DT O
conditions NNS O
with IN O
this DT O
C18 NNP O
: : O
2w6 CD O
supply NN O
. . O

Biopsies NNS O
of IN O
the DT O
jejunal JJ O
mucosa NN O
have VBP O
shown VBN O
abnormal JJ O
enzyme NN O
activity NN O
or CC O
deficiencies NNS O
in IN O
transport NN O
mechanisms NNS O
. . O

Thus RB O
, , O
these DT O
studies NNS O
indicate VBP O
that IN O
the DT O
104 CD O
- : O
kDa NN O
isoform NN O
is VBZ O
required VBN O
for IN O
normal JJ O
proliferation NN O
of IN O
female JJ O
germline NN O
cells NNS O
and CC O
perhaps RB O
for IN O
oocyte JJ O
differentiation NN O
. . O

Oligodeoxynucleotides NNS O
antisense VBP O
to TO O
the DT O
predicted VBN O
translation NN O
initiation NN O
regions NNS O
of IN O
ICP4 NNP B-Gene
and CC O
pp38 VB B-Gene
mRNAs NN I-Gene
inhibited JJ O
proliferation NN O
of IN O
MSB1 NNP O
cells NNS O
but CC O
not RB O
MDCC NNP O
- : O
CU91 NNP O
( ( O
CU91 NNP O
) ) O
reticuloendotheliosis NN O
virus SYM O
- : O
transformed JJ O
cells NNS O
. . O

A DT O
second JJ O
aim NN O
was VBD O
to TO O
determine VB O
whether IN O
the DT O
decrease NN O
in IN O
muscle NN O
- : O
tendon NN O
unit NN O
rest NN O
length NN O
produced VBN O
by IN O
prolonged JJ O
immobilisation NN O
in IN O
a DT O
shortened JJ O
position NN O
is VBZ O
mediated VBN O
primarily RB O
by IN O
adaptations NNS O
of IN O
the DT O
muscle NN O
or CC O
tendon NN O
. . O

Inhibition NN O
appears VBZ O
to TO O
result VB O
from IN O
titration NN O
of IN O
general JJ O
transcription NN O
factors NNS O
because IN O
MDM2 NNP B-Gene
overexpression NN O
inhibits NNS O
c VBP B-Gene
- : I-Gene
fos NN I-Gene
as RB O
well RB O
as IN O
other JJ O
promoters NNS O
in IN O
vivo NN O
and CC O
basal NN O
transcription NN O
in IN O
vitro NN O
. . O

Cases NNS O
of IN O
lung NN O
cancer NN O
with IN O
intramedullary JJ O
metastasis NN O
are VBP O
rare JJ O
, , O
especially RB O
those DT O
diagnosed VBN O
before IN O
death NN O
. . O

Seven CD O
patients NNS O
( ( O
8 CD O
. . O
3 CD O
percent NN O
) ) O
had VBD O
latent JJ O
hypothyroidism NN O
only RB O
discovered VBN O
by IN O
hormonal JJ O
determinations NNS O
. . O

Furthermore RB O
, , O
MOM NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
TAK1 NNP B-Gene
bind NN O
related JJ O
proteins NNS O
that WDT O
promote VBP O
their PRP$ O
kinase NN O
activities NNS O
. . O

DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
analysis NN O
indicated VBD O
that IN O
DREF NNP B-Gene
binds VBZ O
to TO O
the DT O
24 CD O
- : O
bp NN O
DRE NNP O
region NN O
of IN O
the DT O
DNA NNP B-Gene
polymerase NN I-Gene
alpha NN I-Gene
gene NN I-Gene
in IN O
which WDT O
8 CD O
- : O
bp NN O
palindromic JJ O
sequences NNS O
are VBP O
centered VBN O
. . O

Both DT O
PPC NNP O
- : O
1 CD O
and CC O
ALVA NNP O
- : O
31 CD O
cells NNS O
display JJ O
tumorigenesis NN O
and CC O
invasiveness NN O
in IN O
nude JJ O
mice NN O
, , O
whereas JJ O
LNCap NNP O
cells NNS O
exhibit VBP O
a DT O
less RBR O
malignant JJ O
phenotype NN O
, , O
suggesting VBG O
a DT O
correlation NN O
between IN O
CD44 NNP B-Gene
variant NN I-Gene
( ( O
CD44v NNP B-Gene
) ) O
expression NN O
and CC O
aggressive JJ O
prostate NN O
tumor NN O
behavior NN O
. . O

Doxorubicin NNP O
, , O
dacarbazine NN O
, , O
vincristine NN O
, , O
and CC O
cyclophosphamide NN O
in IN O
the DT O
treatment NN O
of IN O
advanced JJ O
gastrointestinal JJ O
leiomyosarcoma NN O
. . O

Multizone NNP O
PRK NNP O
has VBZ O
been VBN O
suggested VBN O
to TO O
increase VB O
the DT O
predictability NN O
of IN O
higher JJR O
myopic NN O
corrections NNS O
. . O

Dorsal NNP O
root NN O
ganglia NN O
neuron SYM O
- : O
specific JJ O
promoter NN O
activity NN O
of IN O
the DT O
rabbit NN B-Gene
beta SYM I-Gene
- : I-Gene
galactoside NN I-Gene
alpha1 NN I-Gene
, , I-Gene
2 CD I-Gene
- : I-Gene
fucosyltransferase NN I-Gene
gene NN I-Gene
. . O

DATA NNP O
SOURCES NNS O
: : O
Epidemiologic NNP O
studies NNS O
, , O
research NN O
studies NNS O
, , O
review NN O
articles NNS O
, , O
and CC O
government NN O
reports NNS O
pertaining VBG O
to TO O
epidemiology NN O
of IN O
lung NN O
cancer NN O
. . O

Similar JJ O
results NNS O
were VBD O
also RB O
obtained VBN O
with IN O
a DT O
HepG2 NNP O
hepatoblastoma NN O
cell NN O
line NN O
carrying VBG O
wt JJ B-Gene
p53 NN I-Gene
. . O

Vitamin NNP O
D3 NNP O
and CC O
calcium NN O
absorption NN O
in IN O
the DT O
chick NN O
. . O

Furthermore RB O
, , O
the DT O
identification NN O
of IN O
a DT O
Dr1 NNP B-Gene
- : I-Gene
like IN I-Gene
protein NN I-Gene
in IN O
A NNP O
. . O
thaliana NN O
strongly RB O
argues VBZ O
for IN O
the DT O
ubiquity NN O
of IN O
this DT O
protein NN O
among IN O
eukaryotic JJ O
genera NN O
and CC O
for IN O
a DT O
conserved JJ O
mechanism NN O
to TO O
regulate VB O
transcription NN O
initiation NN O
that WDT O
involves VBZ O
Dr1 NNP B-Gene
. . O

The DT O
exodomain NN O
alone RB O
has VBZ O
the DT O
high JJ O
affinity NN O
hormone NN O
binding VBG O
site NN O
but CC O
is VBZ O
not RB O
capable JJ O
of IN O
generating VBG O
hormonal JJ O
signal NN O
. . O

The DT O
accumulated JJ O
products NNS O
of IN O
ancient JJ O
duplication NN O
events NNS O
can MD O
be VB O
readily RB O
observed VBN O
among IN O
the DT O
genes NNS O
encoding VBG O
voltage NN O
- : O
dependent NN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
ion NN O
channels NNS O
. . O

It PRP O
was VBD O
possible JJ O
to TO O
classify VB O
the DT O
animals NNS O
into IN O
high JJ O
and CC O
low JJ O
responders NNS O
according VBG O
to TO O
the DT O
pattern NN O
of IN O
humoral JJ O
immune JJ O
response NN O
. . O

We PRP O
report VBP O
the DT O
isolation NN O
of IN O
genomic JJ O
and CC O
cDNA JJ O
clones NNS O
of IN O
the DT O
light JJ O
- : O
independent JJ O
Sn NN B-Gene
: : I-Gene
bol3 NN I-Gene
allele NN I-Gene
. . O

Of IN O
848 CD O
patients NNS O
, , O
819 CD O
cases NNS O
with IN O
complete JJ O
description NN O
of IN O
patient NN O
' '' O
s JJ O
background NN O
were VBD O
evaluable JJ O
: : O
Group NNP O
A NNP O
( ( O
surgery NN O
+ RB O
MMC NNP O
+ VBD O
5 CD O
- : O
FU NN O
: : O
chemotherapy NN O
) ) O
253 CD O
cases NNS O
, , O
group NN O
B NNP O
( ( O
surgery NN O
+ RB O
MMC NNP O
+ VBD O
5 CD O
- : O
FU NNP O
+ NNP O
OK NNP O
- : O
432 CD O
or CC O
PSK NNP O
: : O
immunochemotherapy NN O
) ) O
282 CD O
and CC O
group NN O
C NNP O
( ( O
surgery VB O
alone RB O
) ) O
284 CD O
. . O

This DT O
gave VBD O
rise NN O
to TO O
RNA NNP O
molecules NNS O
with IN O
3 CD O
' POS O
- : O
untranslated JJ O
regions NNS O
of IN O
roughly RB O
375 CD O
, , O
655 CD O
, , O
and CC O
945 CD O
base NN O
pairs NN O
. . O

Serodiagnosis NN O
of IN O
trypanosomiasis NN O
in IN O
dromedary JJ O
camels NNS O
using VBG O
a DT O
card NN O
agglutination NN O
test NN O
set NN O
( ( O
Testryp NNP O
CATT NNP O
) ) O
. . O

Pyk2 NNP B-Gene
phosphorylation NN O
increased VBD O
upon JJ O
adherence NN O
of IN O
FLG NNP O
29 CD O
. . O
1 CD O
cells NNS O
to TO O
fibronectin VB B-Gene
and CC O
to TO O
ST2 NNP O
stromal JJ O
cells NNS O
. . O

No DT O
significant JJ O
differences NNS O
were VBD O
found VBN O
in IN O
relation NN O
to TO O
Type VB O
A DT O
behaviour NN O
and CC O
beta NN B-Gene
- : I-Gene
adrenoceptor NN I-Gene
blockade NN O
. . O

Electronic JJ O
structure NN O
of IN O
delta JJ O
- : O
plutonium NN O
and CC O
of IN O
single JJ O
Al NNP O
, , O
Ga NNP O
, , O
and CC O
Sc NNP O
impurities NNS O
in IN O
delta JJ O
- : O
plutonium NN O
. . O

The DT O
cloned VBN O
genes NNS O
were VBD O
identified VBN O
in IN O
genetic JJ O
libraries NNS O
by IN O
hybridization NN O
screening VBG O
using VBG O
four CD O
deoxyoligonucleotide NN O
probes NNS O
which WDT O
corresponded VBD O
to TO O
the DT O
partial JJ O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
purified JJ O
enzyme NN O
. . O

Ex NNP O
vivo NN O
MAO NNP B-Gene
inhibition NN O
data NNS O
indicated VBD O
DPGPEA NNP O
to TO O
be VB O
an DT O
inhibitor NN O
of IN O
MAO NNP B-Gene
- : I-Gene
B NNP I-Gene
, , O
although IN O
the DT O
effect NN O
was VBD O
much RB O
weaker JJR O
than IN O
seen VBN O
with IN O
tranylcypromine NN O
or CC O
pargyline NN O
. . O

Multifunctional NNP B-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
MFPK NNP B-Gene
) ) O
phosphorylates VBZ O
ATP NNP B-Gene
- : I-Gene
citrate NN I-Gene
lyase NN I-Gene
on IN O
peptide NN B-Gene
B NNP I-Gene
on IN O
two CD O
sites NNS O
, , O
BT NNP O
and CC O
BS NNP O
, , O
on IN O
threonine NN O
and CC O
serine NN O
, , O
respectively RB O
, , O
inhibitor NN B-Gene
2 CD I-Gene
on IN O
a DT O
threonyl NN O
residue NN O
, , O
and CC O
glycogen NN B-Gene
synthase NN I-Gene
at IN O
sites NNS O
2 CD O
and CC O
3 CD O
. . O

This DT O
distribution NN O
parallels VBZ O
that IN O
of IN O
the DT O
neurotransmitters NNS O
glutamate VBP O
and CC O
aspartate VBP O
; : O
however RB O
, , O
neither DT O
of IN O
these DT O
excitatory JJ O
amino NN O
acids NNS O
is VBZ O
a DT O
substrate NN O
for IN O
transport NN O
. . O

Domain NNP O
switch NN O
experiments NNS O
reveal VBP O
that IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
proteins NNS I-Gene
containing VBG O
either CC O
the DT O
leucine JJ O
zipper NN O
or CC O
the DT O
activation NN O
domain NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
are VBP O
unable JJ O
to TO O
stimulate VB O
the DT O
2D5 CD B-Gene
promoter NN I-Gene
yet RB O
are VBP O
fully RB O
capable JJ O
of IN O
transactivating VBG O
an DT O
artificial JJ O
promoter NN O
bearing VBG O
a DT O
high JJ O
- : O
affinity NN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
site NN I-Gene
. . O

These DT O
"""" NNP O
nucleocapsid SYM O
- : O
like IN O
"""" JJ O
structures NNS O
were VBD O
readily RB O
purified VBN O
by IN O
density NN O
gradient NN O
centrifugation NN O
. . O

A DT O
total NN O
of IN O
7 CD O
( ( O
4 CD O
males NNS O
and CC O
3 CD O
females NNS O
) ) O
patients NNS O
were VBD O
included VBN O
in IN O
this DT O
retrospective JJ O
study NN O
to TO O
determine VB O
the DT O
sensitivity NN O
of IN O
radioimmunoscintigraphy NN O
with IN O
I PRP O
- : O
131 CD O
labeled VBD O
anti NN B-Gene
CEA NNP I-Gene
/ NNP O
CA NNP B-Gene
19 CD I-Gene
- : I-Gene
9 CD I-Gene
monoclonal JJ O
antibodies NNS O
. . O

Poly NNP O
( ( O
dT NN O
) ) O
and CC O
denatured VBN O
calf NN O
thymus NN O
DNA NNP O
were VBD O
more RBR O
effective JJ O
than IN O
were VBD O
other JJ O
polynucleotides NNS O
tested VBN O
in IN O
promoting VBG O
accumulation NN O
of IN O
19 CD O
HDP NNP B-Gene
* NN I-Gene
; : O
( ( O
dT NN O
) ) O
8 CD O
was VBD O
as RB O
effective JJ O
as IN O
were VBD O
longer JJR O
molecules NNS O
of IN O
( ( O
dT NN O
) ) O
n NN O
, , O
but CC O
( ( O
dT NN O
) ) O
4 CD O
and CC O
( ( O
dT NN O
) ) O
6 CD O
were VBD O
much RB O
less RBR O
effective JJ O
, , O
indicating VBG O
that IN O
the DT O
binding NN O
site NN O
involved VBN O
in IN O
19 CD O
HDP NNP B-Gene
* NNP I-Gene
accumulation NN O
covered VBD O
between IN O
6 CD O
and CC O
8 CD O
residues NNS O
of IN O
( ( O
dT NN O
) ) O
n NN O
. . O

The DT O
human JJ B-Gene
papillomavirus NN I-Gene
type NN I-Gene
16 CD I-Gene
E7 NNP I-Gene
protein NN I-Gene
complements NNS O
adenovirus VBP B-Gene
type JJ I-Gene
5 CD I-Gene
E1A NNP I-Gene
amino NN O
- : O
terminus NN O
- : O
dependent JJ O
transactivation NN O
of IN O
adenovirus NN B-Gene
type NN I-Gene
5 CD I-Gene
early JJ I-Gene
genes NNS I-Gene
and CC O
increases NNS O
ATF NNP B-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NNP O
binding NN O
activity NN O
. . O

The DT O
heterogeneity NN O
of IN O
bovine NN B-Gene
IgG2 NNP I-Gene
- : I-Gene
- : I-Gene
VIII NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
FK NNP O
506 CD O
is VBZ O
a DT O
useful JJ O
immunosuppressive JJ O
agent NN O
in IN O
kidney NN O
transplantation NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
T NNP O
. . O
C NNP O
. . O
, , O
LDL NNP B-Gene
- : I-Gene
C NNP I-Gene
. . O
, , O
HDL NNP B-Gene
- : I-Gene
C NNP I-Gene
. . O
, , O
HDL2 NNP B-Gene
- : I-Gene
C NNP I-Gene
. . O
, , O
apo NN B-Gene
B NNP I-Gene
, , O
apo VBZ B-Gene
A NNP I-Gene
- : I-Gene
I PRP I-Gene
/ VBP I-Gene
B NNP I-Gene
ratio NN O
and CC O
apo VB B-Gene
A NNP I-Gene
- : I-Gene
II NNP I-Gene
/ NNP I-Gene
B NNP I-Gene
ratio NN O
are VBP O
predictive JJ O
risk NN O
factors NNS O
of IN O
the DT O
coronary JJ O
heart NN O
disease NN O
. . O

In IN O
particular JJ O
, , O
the DT O
highly RB O
expressed VBN O
ADH1 NNP B-Gene
gene NN I-Gene
is VBZ O
represented VBN O
in IN O
this DT O
database NN O
by IN O
no DT O
less JJR O
than IN O
20 CD O
EST JJ O
sequences NNS O
. . O

Using VBG O
transgenic JJ O
Xenopus NN O
embryos NN O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
integrity NN O
of IN O
these DT O
two CD O
sequences NNS O
is VBZ O
necessary JJ O
for IN O
correct JJ O
spatial JJ O
expression NN O
of IN O
a DT O
Xbra2 NNP B-Gene
promoter NN I-Gene
- : I-Gene
driven VBN I-Gene
reporter JJ I-Gene
gene NN I-Gene
. . O

Peripheral NNP O
vitreochorioretinal JJ O
dystrophies NNS O
in IN O
myopia NN O
patients NNS O

Characterization NN O
of IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
growth NN O
- : O
regulated VBN O
Syrian JJ B-Gene
hamster NN I-Gene
CAD NNP I-Gene
gene NN I-Gene
. . O

Recombinant JJ B-Gene
FVIIa NNP I-Gene
was VBD O
stable JJ O
in IN O
the DT O
infusion NN O
pump NN O
for IN O
several JJ O
days NNS O
at IN O
room NN O
temperature NN O
and CC O
for IN O
24 CD O
h NN O
at IN O
body NN O
temperature NN O
. . O

IV NNP O
. . O

Like IN O
their PRP$ O
yeast JJ O
counterpart NN O
, , O
the DT O
mouse NN O
GCN2 NNP B-Gene
isoforms VBZ O
contain VBP O
HisRS NNP B-Gene
- : I-Gene
related JJ I-Gene
sequences NNS I-Gene
juxtaposed VBN O
to TO O
the DT O
kinase NN O
catalytic JJ O
domain NN O
. . O

The DT O
highest JJS O
postoperative JJ O
CK NNP B-Gene
- : I-Gene
MB NNP I-Gene
level NN O
was VBD O
less RBR O
after IN O
BC NNP O
( ( O
BC NNP O
, , O
31 CD O
+ NN O
/ NNP O
- : O
17 CD O
U NNP O
/ NNP O
L NNP O
; : O
CC NNP O
, , O
56 CD O
+ NN O
/ NNP O
- : O
13 CD O
U NNP O
/ NNP O
L NNP O
; : O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Quantitative JJ O
assays NNS O
in IN O
which WDT O
the DT O
activity NN O
of IN O
the DT O
synthetic JJ B-Gene
alpha NN I-Gene
s VBD I-Gene
- : I-Gene
1 CD I-Gene
was VBD O
compared VBN O
to TO O
that DT O
of IN O
native JJ O
purified JJ O
human JJ B-Gene
erythrocyte NN I-Gene
type NN I-Gene
- : I-Gene
1 CD I-Gene
Gs NNP I-Gene
, , O
indicated VBD O
that IN O
the DT O
two CD O
products NNS O
are VBP O
equipotent JJ O
within IN O
a DT O
2 CD O
- : O
fold JJ O
margin NN O
of IN O
error NN O
. . O

High JJ O
concentrations NNS O
of IN O
tumor NN O
- : O
associated VBN O
trypsin NN B-Gene
inhibitor NN O
in IN O
hemodialyzed JJ O
patients NNS O
. . O

Thirty NNP O
isolates NNS O
of IN O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
were VBD O
obtained VBN O
during IN O
an DT O
outbreak NN O
of IN O
invasive JJ O
H NNP O
. . O
influenzae NN O
type NN O
b NN O
disease NN O
and CC O
were VBD O
classified VBN O
by IN O
the DT O
electrophoretic JJ O
profile NN O
of IN O
their PRP$ O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
. . O

A DT O
progressive JJ O
growth NN O
of IN O
blood NN O
erythrocyte NN O
membrane NN O
injury NN O
has VBZ O
been VBN O
demonstrated VBN O
after IN O
rats NNS O
were VBD O
exposed VBN O
to TO O
gamma VB O
- : O
irradiaton NN O
at IN O
a DT O
dose NN O
of IN O
100 CD O
to TO O
500 CD O
Gy NNP O
. . O

Sixty NNP O
months NNS O
after IN O
the DT O
initial JJ O
vaccination NN O
, , O
all DT O
vaccinees NNS O
who WP O
received VBD O
annual JJ O
follow NN O
- : O
up RB O
still RB O
had VBD O
protective JJ O
levels NNS O
of IN O
anti JJ B-Gene
- : I-Gene
HAV NN I-Gene
. . O

The DT O
mucosal NN O
defence NN O
capacity NN O
against IN O
proteolytic JJ O
leukocyte NN O
enzymes NNS O
. . O

Mutations NNS O
in IN O
either DT O
gene NN O
block NN O
some DT O
crucial JJ O
late JJ O
step NN O
in IN O
assembly NN O
of IN O
F1 NNP B-Gene
, , O
causing VBG O
the DT O
alpha NN O
and CC O
beta NN O
subunits NNS O
to TO O
accumulate VB O
in IN O
mitochondria NN O
as IN O
inactive JJ O
aggregates NNS O
( ( O
Ackerman NNP O
, , O
S NNP O
. . O

Hybrid NNP O
- : O
selection NN O
experiments NNS O
against IN O
total JJ O
PB NNP O
- : O
inducible JJ O
RNA NNP O
were VBD O
performed VBN O
with IN O
plasmid JJ O
DNA NNP O
derived VBD O
from IN O
clones NNS O
enriched VBN O
in IN O
PB NNP O
- : O
inducible JJ O
information NN O
. . O

Secondary JJ O
cleavage NN O
of IN O
RT NNP B-Gene
at IN O
Trp NNP O
- : O
595 CD O
- : O
Tyr NNP O
- : O
596 CD O
of IN O
Pol NNP B-Gene
yields NNS O
a DT O
truncated JJ O
form NN O
lacking VBG O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
RNase NNP I-Gene
H NNP I-Gene
domain NN I-Gene
. . O

The DT O
experimentally RB O
mapped JJ O
regions NNS O
of IN O
RPB5 NNP B-Gene
involved VBN O
in IN O
these DT O
interactions NNS O
correspond VBP O
to TO O
distinct VB O
and CC O
surface VB O
- : O
exposed VBN O
alpha IN O
- : O
helical JJ O
structures NNS O
. . O

A DT O
method NN O
is VBZ O
described VBN O
for IN O
the DT O
simultaneous JJ O
determination NN O
of IN O
1 CD O
, , O
alpha SYM O
- : O
acetylmethadol NN O
( ( O
LAAM NNP O
) ) O
and CC O
five CD O
active JJ O
metabolites NNS O
- : O
- : O
noracetylmethadol NN O
, , O
dinoracetylmethadol NN O
, , O
methadol NN O
, , O
normethadol NN O
, , O
and CC O
dinormethadol SYM O
- : O
- : O
in IN O
biofluids NNS O
by IN O
high JJ O
- : O
performance NN O
liquid NN O
chromatography NN O
using VBG O
a DT O
normal JJ O
- : O
phase NN O
column NN O
and CC O
a DT O
UV NNP O
detector NN O
at IN O
218 CD O
nm NNS O
. . O

During IN O
IC NNP O
breaths NNS O
and CC O
following VBG O
EC NNP O
and CC O
VC NNP O
breaths NNS O
at IN O
rest NN O
, , O
end VB O
- : O
tidal JJ O
CO2 NNP O
pressure NN O
( ( O
PET NNP O
, , O
CO2 NNP O
) ) O
fell VBD O
by IN O
7 CD O
. . O
5 CD O
, , O
8 CD O
. . O
5 CD O
and CC O
9 CD O
. . O
5 CD O
mmHg NN O
, , O
respectively RB O
. . O

All DT O
patients NNS O
had VBD O
elevated VBN O
levels NNS O
of IN O
serum NN B-Gene
IgE NNP I-Gene
antibodies VBZ I-Gene
to TO O
the DT O
crude NN O
soybean JJ O
extract NN O
; : O
binding VBG O
values NNS O
ranged VBD O
from IN O
2 CD O
. . O
3 CD O
to TO O
28 CD O
. . O
1 CD O
times NNS O
that IN O
of IN O
a DT O
negative JJ O
control NN O
serum NN O
. . O

This DT O
study NN O
examines VBZ O
the DT O
effects NNS O
of IN O
hypovolemia NN O
on IN O
the DT O
extracellular JJ O
ptO2 NN O
and CC O
ptH JJ O
distributions NNS O
at IN O
multiple JJ O
tissue NN O
sites VBZ O
using VBG O
a DT O
recently RB O
developed VBN O
multipoint NN O
microelectrode NN O
, , O
that WDT O
provides VBZ O
simultaneous JJ O
measurements NNS O
of IN O
ptO2 NN O
and CC O
ptH NN O
. . O

A DT O
subset NN O
of IN O
patients NNS O
( ( O
n JJ O
= NNP O
30 CD O
) ) O
underwent JJ O
multichannel NN O
pressure NN O
flow NN O
studies NNS O
, , O
which WDT O
demonstrated VBD O
that IN O
transrectal JJ O
HIFU NNP O
reduces NNS O
bladder VBP O
outflow JJ O
obstruction NN O
. . O

These DT O
effects NNS O
were VBD O
abrogated VBN O
by IN O
co NN O
- : O
expression NN O
of IN O
kinase NN B-Gene
- : I-Gene
deficient NN I-Gene
PKC NNP I-Gene
zeta NN I-Gene
and CC O
inhibition NN O
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
p85alpha SYM B-Gene
- : O
p110 NN B-Gene
by IN O
wortmannin NN O
, , O
LY294002 NNP O
and CC O
a DT O
dominant JJ O
- : O
negative JJ O
mutant NN O
of IN O
p85alpha NN B-Gene
. . O

Innervation NN O
of IN O
the DT O
ventral JJ O
diaphragm NN O
of IN O
the DT O
locust NN O
( ( O
Locusta NNP O
migratoria NN O
) ) O
. . O

ECP NNP B-Gene
and CC O
tryptase NN B-Gene
levels NNS O
in IN O
serum NN O
were VBD O
measured VBN O
before IN O
and CC O
after IN O
the DT O
last JJ O
oral JJ O
challenge NN O
. . O

Sodium NNP O
polystyrene NN O
sulfonate NN O
treatment NN O
for IN O
lithium JJ O
toxicity NN O
: : O
effects NNS O
on IN O
serum NN O
potassium NN O
concentrations NNS O
. . O

Gap1 NNP B-Gene
( ( I-Gene
IP4BP NNP I-Gene
) ) I-Gene
, , O
one CD O
of IN O
a DT O
member NN O
of IN O
Ras NNP B-Gene
GTPase NNP I-Gene
- : I-Gene
activating NN I-Gene
proteins NNS I-Gene
, , O
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
specific JJ O
inositol NN B-Gene
1 CD I-Gene
, , I-Gene
3 CD I-Gene
, , I-Gene
4 CD I-Gene
, , I-Gene
5 CD I-Gene
- : I-Gene
tetrakisphosphate NN I-Gene
( ( I-Gene
IP4 NNP I-Gene
) ) I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
Cullen NNP O
, , O
P NNP O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
showed VBD O
that IN O
two CD O
adjacent JJ O
SP1 NNP B-Gene
sites VBZ I-Gene
proximal JJ O
to TO O
exon VB O
1 CD O
were VBD O
equally RB O
important JJ O
in IN O
sustaining VBG O
basal JJ O
promoter NN O
activity NN O
. . O

RESULTS NN O
: : O
The DT O
target NN O
dose NN O
was VBD O
comparable JJ O
in IN O
the DT O
3D CD O
- : O
CRT NN O
and CC O
IMRT NNP O
plans NNS O
, , O
although IN O
improvements NNS O
were VBD O
seen VBN O
when WRB O
seven CD O
and CC O
nine CD O
IMRT NNP O
fields NNS O
were VBD O
used VBN O
. . O

Diacylglycerol NNP B-Gene
kinase NN I-Gene
( ( O
DGK NNP B-Gene
) ) O
attenuates VBZ O
levels NNS O
of IN O
second JJ O
messenger NN O
diacylglycerol NN O
in IN O
cells NNS O
and CC O
produces VBZ O
another DT O
( ( O
putative NN O
) ) O
messenger NN O
, , O
phosphatidic JJ O
acid NN O
. . O

Characterization NN O
of IN O
the DT O
regulatory JJ O
regions NNS O
of IN O
the DT O
human JJ B-Gene
aromatase NN I-Gene
( ( O
P450arom NNP B-Gene
) ) O
gene NN O
involved VBN O
in IN O
placenta NN O
- : O
specific JJ O
expression NN O
. . O

Intravenous JJ O
injections NNS O
of IN O
SG NNP O
- : O
75 CD O
( ( O
0 CD O
. . O
3 CD O
- : O
1 CD O
mg NN O
/ NNP O
kg NN O
) ) O
decreased VBD O
systemic JJ O
blood NN O
pressure NN O
( ( O
SBP NNP O
) ) O
and CC O
increased JJ O
peripheral NN O
( ( O
coronary JJ O
, , O
renal JJ O
, , O
mesenteric JJ O
and CC O
femoral JJ O
) ) O
blood NN O
flow NN O
( ( O
PBF NNP O
) ) O
dose VBP O
- : O
dependently RB O
. . O

Basal NNP O
FSH NNP B-Gene
and CC O
LH NNP B-Gene
levels NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
addicts NNS O
; : O
after IN O
GnRH NNP B-Gene
stimulation NN O
the DT O
addicts NNS O
' POS O
FSH NNP B-Gene
and CC O
LH NNP B-Gene
values NNS O
increased VBD O
but CC O
not RB O
significantly RB O
compared VBN O
to TO O
controls NNS O
. . O

The DT O
transforming VBG O
gene NN O
of IN O
the DT O
avian JJ B-Gene
sarcoma NN I-Gene
virus NN I-Gene
CT10 NNP I-Gene
encodes VBZ O
a DT O
fusion NN O
protein NN O
( ( O
p47gag JJ B-Gene
- : O
crk NN B-Gene
or CC O
v NN B-Gene
- : I-Gene
Crk NN I-Gene
) ) O
containing VBG O
viral JJ B-Gene
Gag NNP I-Gene
sequences NNS I-Gene
fused VBD O
to TO O
cellular JJ O
sequences NNS O
consisting VBG O
primarily RB O
of IN O
Src NNP B-Gene
homology NN I-Gene
regions NNS I-Gene
2 CD I-Gene
and CC I-Gene
3 CD I-Gene
( ( O
SH2 NNP B-Gene
and CC O
SH3 NNP B-Gene
sequences NNS I-Gene
) ) O
. . O

Comparison NNP O
of IN O
three CD O
different JJ O
preparations NNS O
of IN O
disodium NN O
cromoglycate NN O
in IN O
the DT O
prevention NN O
of IN O
exercise NN O
- : O
induced JJ O
bronchospasm NN O
: : O
a DT O
double JJ O
- : O
blind NN O
study NN O
. . O

The DT O
effect NN O
of IN O
water NN O
deprivation NN O
for IN O
19 CD O
h NN O
on IN O
renal JJ O
Na NNP O
excretion NN O
of IN O
conscious JJ O
adrenalectomized VBN O
( ( O
ADX NNP O
) ) O
sheep VBP O
maintained VBN O
on IN O
a DT O
constant JJ O
intravenous JJ O
infusion NN O
of IN O
aldosterone NN O
and CC O
cortisol NN O
( ( O
ADX NNP O
- : O
constant JJ O
steroid JJ O
sheep NN O
) ) O
was VBD O
investigated VBN O
. . O

Similar JJ O
to TO O
Hp140 NNP B-Gene
, , O
isolated VBD O
Hp55 NNP B-Gene
binds NNS O
DNA NNP O
with IN O
moderate JJ O
strength NN O
and CC O
was VBD O
a DT O
specificity NN O
for IN O
double JJ O
- : O
stranded VBD O
primer JJ O
- : O
template NN O
DNA NN O
. . O

BRCA1 NNP B-Gene
protein NN I-Gene
contains VBZ O
an DT O
amino NN O
- : O
terminal JJ O
zinc NN O
finger NN O
motif NN O
and CC O
a DT O
carboxy JJ O
- : O
terminal JJ O
acidic JJ O
region NN O
. . O

Since IN O
we PRP O
have VBP O
observed VBN O
effects NNS O
of IN O
growth NN O
factors NNS O
and CC O
cAMP NN O
as RB O
well RB O
as IN O
estradiol NN O
( ( O
E2 NNP O
) ) O
on IN O
regulation NN O
of IN O
expression NN O
of IN O
some DT O
genes NNS O
stimulated VBN O
by IN O
the DT O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
, , O
we PRP O
have VBP O
undertaken VBN O
studies NNS O
to TO O
examine VB O
directly RB O
whether IN O
activators NNS O
of IN O
protein NN O
kinases NNS O
can MD O
modulate VB O
transcriptional JJ O
activity NN O
of IN O
the DT O
ER NNP B-Gene
. . O

During IN O
the DT O
aftermath NN O
of IN O
excitation NN O
of IN O
the DT O
skin JJ O
sympathetic JJ O
nerve NN O
by IN O
mental JJ O
arithmetics NNS O
, , O
3 CD O
/ NN O
12 CD O
A NNP O
delta JJ O
units NNS O
were VBD O
turned VBN O
to TO O
the DT O
active JJ O
state NN O
with IN O
decreased JJ O
mechanical JJ O
threshold NN O
. . O

CONCLUSION NN O
: : O
Extrusion NN O
cooking NN O
is VBZ O
effective JJ O
for IN O
the DT O
inactivation NN O
of IN O
DON NNP O
but CC O
is VBZ O
of IN O
limited JJ O
value NN O
for IN O
AFB1 NNP B-Gene
, , O
even RB O
if IN O
metabisulphite NN O
is VBZ O
added VBN O
. . O

Significant JJ O
correlations NNS O
existed VBD O
between IN O
FEV1 NNP O
and CC O
the DT O
corresponding JJ O
values NNS O
of IN O
Raw NNP O
, , O
MEF50 NNP O
and CC O
MEF25 NNP O
, , O
although IN O
there EX O
were VBD O
considerable JJ O
individual JJ O
differences NNS O
between IN O
test NN O
results NNS O
. . O

The DT O
pathogenicity NN O
of IN O
Achromobacter NNP O
puntatum NN O
for IN O
cold NN O
blooded VBN O
and CC O
warm JJ O
blooded VBN O
animals NNS O

Effect NN O
of IN O
corticosteroid NN O
- : O
containing VBG O
antirheumatic JJ O
combination NN O
drugs NNS O
on IN O
endogenous JJ O
ACTH NNP B-Gene
and CC O
cortisol JJ O
production NN O
. . O

Chaotic JJ O
electron NN O
dynamics NNS O
around IN O
a DT O
single JJ O
elliptically RB O
shaped JJ O
antidot NN O
. . O

We PRP O
have VBP O
determined VBN O
that IN O
the DT O
mutants NNS O
define VBP O
two CD O
complementation NN O
groups NNS O
, , O
designated VBN O
cgs1 NN B-Gene
+ NN I-Gene
and CC O
cgs2 NN B-Gene
+ NNP I-Gene
( ( O
continues VBZ O
to TO O
grow VB O
in IN O
stationary JJ O
) ) O
. . O

81 CD O
milk NN O
samples NNS O
collected VBN O
from IN O
35 CD O
donors NNS O
3 CD O
days NNS O
to TO O
7 CD O
months NNS O
after IN O
delivery NN O
were VBD O
examined VBN O
for IN O
the DT O
occurrence NN O
of IN O
cytomegalovirus NN O
( ( O
CMV NNP O
) ) O
. . O

Reaction NNP O
times NNS O
to TO O
tachistoscopically RB O
presented VBN O
stimuli NN O
in IN O
diabetics NNS O

Dermal NNP O
toxicity NN O
and CC O
carcinogenicity NN O
of IN O
4 CD O
- : O
vinyl NN O
- : O
1 CD O
- : O
cyclohexene NN O
diepoxide NN O
in IN O
Fischer NNP O
rats NNS O
and CC O
B6C3F1 NNP O
mice NN O
. . O

We PRP O
have VBP O
found VBN O
out RP O
that IN O
one CD O
- : O
year NN O
- : O
old JJ O
carps NN O
are VBP O
extremely RB O
sensitive JJ O
to TO O
ichthiomycin VB O
in IN O
concentrations NNS O
between IN O
25 CD O
- : O
125 CD O
micrograms NNS O
/ JJ O
dm3 NN O
. . O

The DT O
factor NN O
designated VBD O
B NNP O
formed VBD O
a DT O
complex JJ O
centered VBN O
on IN O
the DT O
sequence NN O
TGTGGT NNP O
, , O
a DT O
core NN O
motif NN O
recognized VBN O
by IN O
members NNS O
of IN O
the DT O
AML NNP B-Gene
/ NNP I-Gene
CBFalpha NNP I-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

Linking VBG O
continuous JJ O
community NN O
- : O
based VBN O
morbidity NN O
recording NN O
of IN O
influenza JJ O
- : O
like IN O
illness NN O
( ( O
ILI NNP O
) ) O
with IN O
virological JJ O
sampling NN O
has VBZ O
consistently RB O
proved VBN O
its PRP$ O
value NN O
as IN O
one CD O
of IN O
the DT O
earliest JJS O
indicators NNS O
of IN O
circulating VBG O
influenza JJ O
activity NN O
. . O

By IN O
150 CD O
minutes NNS O
after IN O
Cr2O3 NNP O
inhalation NN O
, , O
FEV1 NNP O
. . O
0 CD O
had VBD O
decreased VBN O
by IN O
32 CD O
% NN O
. . O

The DT O
Og4C3 NNP B-Gene
enzyme SYM O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
( ( O
ELISA NNP O
) ) O
to TO O
detect VB O
circulating VBG O
Wuchereria NNP B-Gene
bancrofti NN I-Gene
antigen NN I-Gene
uses VBZ O
50 CD O
microL NN O
of IN O
serum NN O
. . O

Using VBG O
a DT O
v NN B-Gene
- : I-Gene
erbA NN I-Gene
probe NN O
, , O
we PRP O
obtained VBD O
a DT O
cDNA NN O
which WDT O
encodes VBZ O
a DT O
novel JJ O
445 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
, , O
RLD NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
that WDT O
contains VBZ O
the DT O
characteristic JJ O
domains NNS O
of IN O
nuclear JJ O
receptors NNS O
. . O

In IN O
the DT O
posthospital JJ O
phase NN O
of IN O
AMI NNP O
, , O
as RB O
well RB O
as IN O
in IN O
CCHD NNP O
, , O
the DT O
occurrence NN O
of IN O
high JJ O
- : O
grade NN O
VPBs NNP O
usually RB O
indicates VBZ O
more RBR O
advanced JJ O
degrees NNS O
of IN O
both DT O
coronary JJ O
and CC O
left VBD O
ventricular JJ O
disease NN O
as RB O
well RB O
as IN O
the DT O
possibility NN O
of IN O
cardiac NN O
and CC O
/ NN O
or CC O
sudden JJ O
death NN O
. . O

These DT O
sites NNS O
are VBP O
also RB O
potential JJ O
keratan NN O
sulfate NN O
attachment NN O
sites NNS O
. . O

Upstream NN O
from IN O
the DT O
transcription NN O
start NN O
point NN O
( ( O
tsp NN O
) ) O
, , O
a DT O
nucleotide JJ O
sequence NN O
highly RB O
homologous JJ O
to TO O
the DT O
consensus NN B-Gene
sequence NN I-Gene
motif NN I-Gene
for IN I-Gene
the DT I-Gene
sigma NN I-Gene
35 CD I-Gene
- : I-Gene
recognized VBN I-Gene
promoters NNS I-Gene
was VBD O
found VBN O
. . O

Molecular JJ O
and CC O
functional JJ O
characterization NN O
of IN O
the DT O
promoter NN O
of IN O
ETS2 NNP B-Gene
, , O
the DT O
human JJ O
c SYM B-Gene
- : I-Gene
ets NNS I-Gene
- : I-Gene
2 CD I-Gene
gene NN O
. . O

Chlorambucil NNP O
and CC O
interferon NN B-Gene
for IN O
low JJ O
grade NN O
non SYM O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
. . O

Thus RB O
, , O
the DT O
multidomained VBN O
ROK NNP B-Gene
alpha JJ I-Gene
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
reorganization NN O
of IN O
the DT O
cytoskeleton NN O
, , O
with IN O
the DT O
N NNP O
and CC O
C NNP O
termini VBP O
acting VBG O
as IN O
positive JJ O
and CC O
negative JJ O
regulators NNS O
, , O
respectively RB O
, , O
of IN O
the DT O
kinase NN O
domain NN O
whose WP$ O
activity NN O
is VBZ O
crucial JJ O
for IN O
formation NN O
of IN O
stress NN O
fibers NNS O
and CC O
focal JJ O
adhesion NN O
complexes NNS O
. . O

Autotransplantation NN O
of IN O
a DT O
vein NN O
segment NN O
with IN O
valve NN O
in IN O
the DT O
treatment NN O
of IN O
deep JJ O
vein NN O
valvular JJ O
insufficiency NN O
of IN O
the DT O
lower JJR O
extremity NN O

In IN O
the DT O
DNA NNP O
recognition NN O
helix NN O
of IN O
finger NN O
II NNP O
, , O
the DT O
conserved JJ O
Arg NNP O
at IN O
position NN O
62 CD O
( ( O
N NNP O
- : O
terminal JJ O
side NN O
of IN O
the DT O
first JJ O
zinc NN O
- : O
coordinating VBG O
histidine NN O
) ) O
was VBD O
changed VBN O
to TO O
a DT O
Leu NNP O
or CC O
Gln NNP O
. . O

One CD O
of IN O
its PRP$ O
unique JJ O
features NNS O
appears VBZ O
to TO O
be VB O
the DT O
unusually RB O
short JJ O
5 CD O
' POS O
- : O
untranslated JJ O
regions NNS O
( ( O
UTR NNP O
) ) O
( ( O
1 CD O
- : O
6 CD O
nucleotides NNS O
( ( O
nts NNS O
) ) O
) ) O
and CC O
the DT O
apparent JJ O
absence NN O
of IN O
5 CD O
' POS O
- : O
cap NN O
structures VBZ O
from IN O
its PRP$ O
mRNAs NN O
. . O

With IN O
a DT O
population NN O
of IN O
853 CD O
million CD O
there EX O
should MD O
be VB O
51 CD O
, , O
204 CD O
patients NNS O
with IN O
hemophilia PDT O
A NNP O
in IN O
India NNP O
assuming VBG O
a DT O
prevalence NN O
of IN O
6 CD O
/ JJ O
100 CD O
, , O
0 CD O
population NN O
. . O

The DT O
stereoselectivity NN O
of IN O
drug NN O
action NN O
. . O

Both DT O
4 CD O
, , O
8 CD O
- : O
DiMeIQx NN O
and CC O
A NNP O
alpha JJ O
C NNP O
were VBD O
found VBN O
at IN O
< JJ O
1 CD O
p NN O
. . O
p NN O
. . O
b NN O
. . O

To TO O
identify VB O
the DT O
DNA NN O
sequences VBZ O
that IN O
cis NN O
- : O
regulate VB O
the DT O
expression NN O
of IN O
the DT O
rat NN B-Gene
liver NN I-Gene
pyruvate NN I-Gene
kinase NN I-Gene
( ( O
L NNP B-Gene
- : I-Gene
PK NN I-Gene
) ) O
genes NNS O
, , O
a DT O
series NN O
of IN O
constructs NNS O
in IN O
which WDT O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
reporter NN I-Gene
genes NNS I-Gene
is VBZ O
driven VBN O
by IN O
various JJ O
deleted JJ O
fragments NNS O
of IN O
the DT O
3200 CD O
base NN O
pairs NN O
( ( O
bp NN O
) ) O
upstream NN O
of IN O
the DT O
L NNP B-Gene
- : I-Gene
PK NNP I-Gene
gene NN I-Gene
cap NN I-Gene
site NN I-Gene
have VBP O
been VBN O
assayed VBN O
for IN O
transient NN O
expression NN O
after IN O
introduction NN O
into IN O
hepatoma NN O
HepG2 NNP O
cells NNS O
, , O
rat NN O
hepatocytes NNS O
in IN O
primary JJ O
culture NN O
, , O
fibroblast NN O
LTK NNP O
- : O
cells NNS O
, , O
myogenic JJ O
C2C12 NNP O
cells NNS O
, , O
and CC O
CHO NNP O
cells NNS O
. . O

Defective JJ O
provirus NN O
genomes NNS O
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
are VBP O
frequently RB O
detected VBN O
in IN O
lymphocytes NNS O
from IN O
infected JJ O
individuals NNS O
and CC O
in IN O
infected VBN O
cell NN O
lines NNS O
. . O

Following VBG O
chondroitinase NN B-Gene
AC NNP I-Gene
and CC I-Gene
ABC NNP I-Gene
digestion NN O
, , O
staining VBG O
reactions NNS O
suggested VBD O
that IN O
the DT O
highest JJS O
levels NNS O
of IN O
dermatan NN O
sulfate NN O
were VBD O
in IN O
the DT O
diabetes NNS O
resistant VBP O
group NN O
( ( O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
1 CD O
compared VBN O
to TO O
diabetic VB O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
compared VBN O
to TO O
diabetes VB O
prone NN O
) ) O
and CC O
the DT O
highest JJS O
levels NNS O
of IN O
chondroitin NN O
sulfates NNS O
were VBD O
in IN O
the DT O
diabetes NNS O
prone VBP O
group NN O
( ( O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

During IN O
heat NN O
exposure NN O
, , O
chicks NNS O
that WDT O
had VBD O
been VBN O
subjected VBN O
to TO O
early RB O
60 CD O
% NN O
restriction NN O
with IN O
non JJ O
- : O
metyrapone NN O
- : O
treated VBN O
food NN O
had VBD O
lower JJR O
H NNP O
/ NNP O
L NNP O
ratios NNS O
and CC O
improved VBD O
resistance NN O
to TO O
marble VB O
spleen JJ O
disease NN O
infection NN O
. . O

The DT O
ubiquitously RB O
expressed VBN O
hypoxia NN B-Gene
- : I-Gene
inducible JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
HIF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
is VBZ O
involved VBN O
in IN O
expression NN O
of IN O
a DT O
large JJ O
number NN O
of IN O
oxygen NN O
- : O
regulated VBN O
genes NNS O
. . O

Competitive JJ O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
and CC O
HPLC NNP O
analysis NN O
showed VBD O
that IN O
RUSH NNP B-Gene
- : I-Gene
1alpha CD I-Gene
is VBZ O
the DT O
progesterone NN O
- : O
dependent JJ O
splice NN O
variant NN O
. . O

We PRP O
inserted VBD O
genes NNS O
or CC O
gene NN O
segments NNS O
, , O
that WDT O
code NN O
for IN O
the DT O
bacterial JJ B-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
, , O
the DT O
bacterial JJ O
gene NN O
conferring VBG O
resistance NN O
against IN O
hygromycin NN O
, , O
and CC O
the DT O
ORF NNP O
E7 NNP B-Gene
of IN O
the DT O
human JJ O
papillomavirus NN O
type NN O
18 CD O
into IN O
these DT O
vectors NNS O
. . O

In IN O
conclusion NN O
, , O
primary JJ O
chemotherapy NN O
based VBN O
on IN O
high JJ O
dose NN O
MTX NNP O
and CC O
ara SYM O
- : O
C NNP O
is VBZ O
highly RB O
efficient JJ O
in IN O
PCNSL NNP O
. . O

Western JJ O
blot NN O
analysis NN O
showed VBD O
a DT O
rapid JJ O
corresponding JJ O
increase NN O
in IN O
p21WAF1 JJ B-Gene
/ NNP O
CIP1 NNP B-Gene
protein NN O
, , O
whereas JJ O
protein NN O
levels NNS O
of IN O
another DT O
member NN O
of IN O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitor NN I-Gene
family NN I-Gene
, , O
p27kip1 NN B-Gene
, , O
were VBD O
unchanged JJ O
. . O

We PRP O
report VBP O
here RB O
that IN O
, , O
for IN O
a DT O
constant JJ O
amount NN O
of IN O
transfected JJ O
DNA NNP O
, , O
the DT O
level NN O
of IN O
chloramphenicol JJ B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
mRNA NN O
is VBZ O
increased VBN O
in IN O
Vpr NNP B-Gene
- : O
expressing VBG O
cells NNS O
using VBG O
either CC O
HIV NNP O
- : O
1 CD O
or CC O
a DT O
murine JJ O
leukemia NN B-Gene
virus NN I-Gene
( ( I-Gene
MLV NNP I-Gene
) ) I-Gene
SL3 NNP I-Gene
- : I-Gene
3 CD I-Gene
LTR NNP I-Gene
- : O
CAT NNP B-Gene
reporter NN O
construct NN O
. . O

Relation NN O
between IN O
mixing VBG O
ratio NN O
of IN O
raw JJ O
materials NNS O
and CC O
composition NN O
of IN O
products NNS O
in IN O
the DT O
synthesis NN O
of IN O
aluminosilicates NNS O

A DT O
brief JJ O
discussion NN O
of IN O
color NN O
deficiencies NNS O
. . O

Transcriptional JJ O
regulation NN O
of IN O
SUP35 NNP B-Gene
and CC O
SUP45 NNP B-Gene
in IN I-Gene
Saccharomyces NNP I-Gene
cerevisiae NN I-Gene
. . O

METHODS NN O
: : O
Humphrey NNP O
Field NNP O
Analyzer NNP O
model NN O
630 CD O
( ( O
HFA NNP O
I PRP O
, , O
program NN O
30 CD O
- : O
2 CD O
with IN O
a DT O
rectangular JJ O
6 CD O
degrees NNS O
x VBP O
6 CD O
degrees NNS O
grid JJ O
) ) O
was VBD O
used VBN O
as IN O
the DT O
conventional JJ O
perimetric JJ O
method NN O
. . O

Salzburg NNP O
, , O
9 CD O
- : O
12 CD O
September NNP O
1987 CD O
. . O

Risks NNS O
of IN O
chronicity NN O
following VBG O
acute JJ O
hepatitis NN O
B NNP O
virus NN O
infection NN O
: : O
a DT O
review NN O
. . O

Therefore RB O
, , O
we PRP O
have VBP O
developed VBN O
a DT O
system NN O
to TO O
study VB O
nuclear JJ O
targeting VBG O
in IN O
plants NNS O
and CC O
have VBP O
established VBN O
that IN O
the DT O
nuclear JJ O
transport NN O
machinery NN O
is VBZ O
similar JJ O
in IN O
monocots NNS O
and CC O
dicots NNS O
. . O

AIMS NNP O
/ NNP O
METHODS NNP O
: : O
Reticuloendothelial JJ O
system NN O
function NN O
, , O
as IN O
assessed VBN O
by IN O
clearance NN O
of IN O
radiolabelled JJ O
bacteria NNS O
, , O
was VBD O
evaluated VBN O
in IN O
acute JJ O
liver JJ O
injury NN O
induced VBN O
by IN O
D NNP O
- : O
galactosamine NN O
in IN O
rats NNS O
, , O
and CC O
compared VBN O
with IN O
that DT O
after IN O
70 CD O
% NN O
liver JJ O
resection NN O
model NN O
. . O

The DT O
corresponding JJ O
differences NNS O
in IN O
FVIIa NNP B-Gene
and CC O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
were VBD O
not RB O
statistically RB O
significant JJ O
. . O

Hybrid NNP O
female JJ O
mice NN O
( ( O
C57BL NNP O
x NNP O
CBA NNP O
) ) O
were VBD O
paired VBN O
with IN O
breeder NN O
males NNS O
( ( O
CD NNP O
- : O
1 CD O
) ) O
and CC O
LNG NNP O
pellets NNS O
were VBD O
implanted VBN O
on IN O
day NN O
0 CD O
, , O
the DT O
day NN O
on IN O
which WDT O
copulation NN O
plugs NNS O
were VBD O
found VBN O
, , O
or CC O
on IN O
day NN O
2 CD O
or CC O
day NN O
3 CD O
in IN O
the DT O
postcoital JJ O
period NN O
. . O

The DT O
sequence NN O
upstream NN O
of IN O
the DT O
rhlA NN B-Gene
promoter NN I-Gene
contains VBZ O
two CD O
inverted JJ O
repeats NNS O
which WDT O
define VBP O
putative JJ O
binding NN O
sites NNS O
for IN O
the DT O
RhlR NNP B-Gene
regulator NN I-Gene
. . O

Indeed RB O
, , O
ERM NNP B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
synergistically RB O
activated VBD O
the DT O
EBS NNP O
- : O
CRE NN O
without IN O
making VBG O
an DT O
apparent JJ O
ternary NN O
complex NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
regulation NN O
of IN O
the DT O
FGFR NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
( ( O
cek JJ B-Gene
- : I-Gene
1 CD I-Gene
) ) O
in IN O
avian JJ O
myogenic JJ O
cultures NNS O
by IN O
immunocytochemistry NN O
and CC O
Northern NNP O
blot NN O
analysis NN O
. . O

In IN O
the DT O
37 CD O
patients NNS O
without IN O
lung NN O
disease NN O
respiratory NN O
muscle NN O
weakness NN O
was VBD O
accompanied VBN O
by IN O
significant JJ O
decreases NNS O
in IN O
vital JJ O
capacity NN O
, , O
total JJ O
lung NN O
capacity NN O
, , O
and CC O
maximum JJ O
voluntary JJ O
ventilation NN O
; : O
by IN O
significant JJ O
increases NNS O
in IN O
residual JJ O
volume NN O
and CC O
arterial JJ O
carbon NN O
dioxide NN O
tension NN O
( ( O
PaCO2 NNP O
) ) O
; : O
and CC O
greater JJR O
likelihood NN O
of IN O
dependence NN O
on IN O
ventilators NNS O
, , O
atelectasis NN O
, , O
and CC O
pneumonia NN O
. . O

Clinical JJ O
accuracy NN O
of IN O
updated JJ O
version NN O
of IN O
the DT O
Phadebas NNP O
RAST NNP O
test NN O
. . O

Solution NN O
structure NN O
of IN O
the DT O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
: : O
a DT O
novel JJ O
subgroup NN O
of IN O
the DT O
winged JJ B-Gene
helix NN I-Gene
- : I-Gene
turn NN I-Gene
- : I-Gene
helix NN I-Gene
family NN I-Gene
. . O

Post NNP O
- : O
transcriptional JJ O
regulation NN O
of IN O
ribosomal JJ B-Gene
protein NN I-Gene
gene NN I-Gene
expression NN O
during IN O
development NN O
in IN O
Dictyostelium NNP O
discoideum NN O
. . O

These DT O
results NNS O
imply VBP O
that IN O
the DT O
GCN3 NNP B-Gene
product NN I-Gene
can MD O
promote VB O
either DT O
repression NN O
or CC O
activation NN O
of IN O
GCN4 NNP B-Gene
expression NN O
depending VBG O
on IN O
amino NN O
acid JJ O
availability NN O
. . O

The DT O
CD4 NNP B-Gene
count NN O
at IN O
which WDT O
remission NN O
occurs VBZ O
may MD O
reflect VB O
severe JJ O
immunodeficiency NN O
such JJ O
that IN O
risk NN O
for IN O
AIDS NNP O
- : O
related JJ O
infection NN O
is VBZ O
high JJ O
. . O

The DT O
results NNS O
point NN O
to TO O
the DT O
effectiveness NN O
of IN O
the DT O
educational JJ O
intervention NN O
. . O

In IN O
patients NNS O
with IN O
complete JJ O
or CC O
partial JJ O
remission NN O
of IN O
the DT O
tumor NN O
, , O
the DT O
neopterine JJ O
excretion NN O
dropped VBD O
to TO O
normal JJ O
values NNS O
. . O

Thus RB O
, , O
both DT O
YY1 NNP B-Gene
and CC O
CDP NNP B-Gene
appear VBP O
to TO O
be VB O
negative JJ O
regulators NNS O
of IN O
the DT O
differentiation NN O
- : O
induced JJ O
HPV NNP B-Gene
- : I-Gene
6 CD I-Gene
E1 NNP I-Gene
promoter NN I-Gene
and CC O
thereby RB O
the DT O
HPV NNP O
life NN O
cycle NN O
. . O

Cholinesterase NN B-Gene

In IN O
this DT O
study NN O
, , O
we PRP O
describe VBP O
a DT O
mammalian JJ O
cell NN O
- : O
free JJ O
transcription NN O
system NN O
reconstituted VBD O
with IN O
only JJ O
recombinant JJ O
proteins NNS O
and CC O
epitope VB O
- : O
tagged VBN O
multiprotein NN O
complexes NNS O
. . O

Occupational NNP O
asthma NN O
and CC O
rhinoconjunctivitis NN O
from IN O
inhalation NN O
of IN O
crystalline JJ O
bovine NN B-Gene
serum NN I-Gene
albumin NN I-Gene
powder NN O
. . O

This DT O
and CC O
previous JJ O
results NNS O
suggest VBP O
that IN O
the DT O
CRE NNP O
and CC O
Sp1 NNP B-Gene
site NN I-Gene
may MD O
synergistically RB O
activate VB O
TH NNP B-Gene
transcription NN O
in IN O
a DT O
promoter NN O
context NN O
- : O
dependent JJ O
manner NN O
. . O

A DT O
dose NN O
of IN O
3 CD O
and CC O
6 CD O
micrograms NNS O
/ VBP O
kg JJ O
/ NNP O
day NN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
reduces VBZ O
the DT O
severity NN O
of IN O
neutropenia NN O
and CC O
thrombocytopenia NN O
after IN O
carboplatin NN O
- : O
cyclophosphamide NN O
chemotherapy NN O
, , O
which WDT O
may MD O
lead VB O
to TO O
more RBR O
effective JJ O
chemotherapy NN O
for IN O
ovarian JJ O
cancer NN O
in IN O
the DT O
future NN O
. . O

HFA $ O
134a CD O
had VBD O
a DT O
greater JJR O
tendency NN O
to TO O
take VB O
up RP O
moisture NN O
from IN O
the DT O
environment NN O
than IN O
did VBD O
HFA NNP O
227 CD O
. . O

Comparative JJ O
analysis NN O
of IN O
various JJ O
techniques NNS O
of IN O
prostatic JJ O
drainage NN O
in IN O
patients NNS O
with IN O
chronic JJ O
obstructive JJ O
prostatitis NN O
] VBD O
The DT O
efficacy NN O
of IN O
prostatic JJ O
drainage NN O
using VBG O
transurethral JJ O
vacuum NN O
aspiration NN O
( ( O
Introl NNP O
- : O
4 CD O
unit NN O
) ) O
and CC O
transrectal JJ O
pneumovibromassage NN O
( ( O
PVM NNP O
- : O
R NNP O
- : O
1 CD O
) ) O
was VBD O
compared VBN O
in IN O
1511 CD O
patients NNS O
with IN O
chronic JJ O
obstructive JJ O
prostatitis NN O
. . O

Serial JJ O
US NNP O
images NNS O
were VBD O
obtained VBN O
before IN O
and CC O
20 CD O
, , O
30 CD O
, , O
40 CD O
, , O
50 CD O
, , O
60 CD O
, , O
90 CD O
, , O
120 CD O
, , O
150 CD O
, , O
180 CD O
, , O
240 CD O
, , O
and CC O
300 CD O
s NN O
after IN O
intravenous JJ O
injection NN O
of IN O
2 CD O
g NN O
of IN O
contrast NN O
agent NN O
using VBG O
conventional JJ O
and CC O
harmonic JJ O
PD NNP O
US NNP O
. . O

Results NNS O
showed VBD O
that IN O
the DT O
mean JJ O
bond NN O
strength NN O
of IN O
H NNP O
. . O
T NNP O
. . O
V NNP O
. . O
specimens NNS O
ranged VBD O
from IN O
9 CD O
. . O
6 CD O
to TO O
13 CD O
. . O
12 CD O
kg JJ O
/ NNP O
cm2 NN O
, , O
while IN O
the DT O
mean JJ O
bond NN O
strength NN O
of IN O
R NNP O
. . O
T NNP O
. . O
V NNP O
. . O
specimens NNS O
ranged VBD O
from IN O
0 CD O
. . O
36 CD O
to TO O
1 CD O
. . O
75 CD O
kg JJ O
/ NNP O
cm2 NN O
. . O

The DT O
pulmonary JJ O
effects NNS O
observed VBN O
, , O
became VBD O
more RBR O
pronounced JJ O
with IN O
increasing VBG O
NO2 NNP O
concentrations NNS O
( ( O
0 CD O
, , O
25 CD O
, , O
75 CD O
, , O
125 CD O
, , O
175 CD O
or CC O
200 CD O
ppm NN O
, , O
1 CD O
ppm NN O
NO2 NNP O
= VBZ O
1 CD O
. . O
88 CD O
mg NN O
m SYM O
- : O
3 CD O
NO2 NNP O
) ) O
and CC O
exposure NN O
times NNS O
( ( O
5 CD O
, , O
10 CD O
, , O
20 CD O
or CC O
30 CD O
min NN O
) ) O
. . O

Transient JJ O
transfections NNS O
of IN O
a DT O
construct NN O
expressing VBG O
the DT O
RNA NNP O
transcript NN O
defined VBN O
by IN O
clone NN O
B1 NNP O
. . O
1 CD O
into IN O
D17 NNP O
cells NNS O
led VBD O
to TO O
the DT O
expression NN O
of IN O
an DT O
Env NNP B-Gene
/ NNP O
Mlvi NNP B-Gene
- : I-Gene
4 CD I-Gene
fusion NN O
protein NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
33 CD O
kDa NNS O
. . O

The DT O
front NN O
( ( O
F NNP O
) ) O
interaction NN O
occurs VBZ O
ahead RB O
of IN O
the DT O
growing VBG O
end NN O
of IN O
RNA NNP O
. . O

Lack NN O
of IN O
cyclin NN B-Gene
D NNP I-Gene
- : O
Cdk NN B-Gene
complexes NNS O
in IN O
Rb NNP B-Gene
- : O
negative JJ O
cells NNS O
correlates VBZ O
with IN O
high JJ O
levels NNS O
of IN O
p16INK4 NN B-Gene
/ NNP O
MTS1 NNP B-Gene
tumour NN O
suppressor NN O
gene NN O
product NN O
. . O

The DT O
number NN O
of IN O
elements NNS O
and CC O
their PRP$ O
sizes NNS O
relative VBP O
to TO O
the DT O
configuration NN O
were VBD O
varied VBN O
in IN O
a DT O
series NN O
of IN O
five CD O
experiments NNS O
. . O

In IN O
a DT O
randomized JJ O
study NN O
on IN O
150 CD O
patients NNS O
( ( O
ASA NNP O
1 CD O
) ) O
undergoing VBG O
induction NN O
of IN O
anaesthesia NN O
, , O
the DT O
effects NNS O
of IN O
Fentanyl NNP O
( ( O
0 CD O
. . O
1 CD O
mg NN O
) ) O
, , O
the DT O
combination NN O
of IN O
Fentanyl NNP O
( ( O
0 CD O
. . O
1 CD O
mg NN O
) ) O
and CC O
Droperidol NNP O
( ( O
5 CD O
mg NN O
) ) O
( ( O
Innovar NNP O
, , O
Thalamonal NNP O
) ) O
and CC O
Atropine NNP O
( ( O
0 CD O
. . O
1 CD O
mg JJ O
/ NNP O
kg NN O
b NN O
. . O
w NN O
. . O
) ) O
alone RB O
on IN O
cardiocirculatory JJ O
parameters NNS O
were VBD O
studied VBN O
. . O

Vaccinia NNP O
virus NN O
( ( O
VV NNP O
) ) O
is VBZ O
a DT O
potent JJ O
immunogen NN O
, , O
but CC O
the DT O
nature NN O
of IN O
VV NNP O
proteins NNS O
involved VBN O
in IN O
the DT O
activation NN O
of IN O
the DT O
immune JJ O
response NN O
of IN O
the DT O
host NN O
is VBZ O
not RB O
yet RB O
known VBN O
. . O

Measurement NN O
of IN O
anti JJ B-Gene
- : I-Gene
HCV NNP I-Gene
IgM NNP I-Gene
antibodies VBZ I-Gene
with IN O
an DT O
experimental JJ O
kit NN O

EIAV NNP B-Gene
LTR NNP I-Gene
sequence NN I-Gene
variability NN O
is VBZ O
confined VBN O
mostly RB O
to TO O
a DT O
small JJ O
portion NN O
of IN O
the DT O
enhancer NN O
within IN O
the DT O
U3 NNP O
segment NN O
of IN O
the DT O
LTR NNP O
. . O

In IN O
transformed JJ O
E NNP O
. . O
coli NN O
, , O
constitutive JJ B-Gene
CAT NNP I-Gene
expression NN O
is VBZ O
maintained VBN O
when WRB O
as RB O
little JJ O
as IN O
0 CD O
. . O
3 CD O
kilobase NN O
of IN O
DNA NN O
from IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
1 CD O
. . O
6 CD O
- : O
kilobase NN O
segment NN O
is VBZ O
inserted VBN O
in IN O
the DT O
correct JJ O
orientation NN O
in IN O
front NN O
of IN O
the DT O
CAT NNP B-Gene
gene NN I-Gene
. . O

Mutational JJ O
analysis NN O
of IN O
the DT O
- : O
84 CD O
/ SYM O
- : O
55 CD O
DNA NN O
showed VBD O
that IN O
JEG NNP O
- : O
3 CD O
nuclear JJ O
proteins NNS O
bound VBN O
to TO O
a DT O
site NN O
containing NN O
, , O
but CC O
not RB O
identical JJ O
to TO O
, , O
the DT O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
sequence NN I-Gene
. . O

Dentalplaque NNP O
was VBD O
controlled VBN O
by IN O
the DT O
oral JJ O
higienic JJ O
index NN O
of IN O
the DT O
whole JJ O
dentition NN O
daily RB O
, , O
after IN O
staining VBG O
with IN O
1 CD O
per IN O
cent NN O
alkaline NN O
fuxin NN O
. . O

Reproductive JJ O
period NN O
affects NNS O
water NN O
intake VBP O
in IN O
heat NN O
- : O
stressed VBN O
dehydrated JJ O
goats NNS O
. . O

This DT O
protein VBZ O
- : O
protein NN O
interaction NN O
does VBZ O
not RB O
require VB O
the DT O
simultaneous JJ O
binding NN O
of IN O
Oct NNP B-Gene
proteins NNS I-Gene
to TO O
DNA NNP O
, , O
and CC O
high JJ O
resolution NN O
footprinting NN O
of IN O
the DT O
Oct NNP B-Gene
- : I-Gene
DNA NN I-Gene
interaction NN O
reveals NNS O
that IN O
binding NN O
of IN O
BOB NNP B-Gene
. . I-Gene
1 CD I-Gene
/ JJ O
OBF NNP B-Gene
. . I-Gene
1 CD I-Gene
to TO O
Oct1 NNP B-Gene
or CC O
Oct2 NNP B-Gene
does VBZ O
not RB O
alter VB O
the DT O
interaction NN O
with IN O
DNA NNP O
. . O

The DT O
observed JJ O
sequence NN O
variation NN O
disrupts VBZ O
the DT O
first JJ O
ORF NNP O
in IN O
many JJ O
Y NNP B-Gene
' POS O
s NN O
while IN O
most JJS O
of IN O
the DT O
second JJ O
ORF NNP O
including VBG O
the DT O
putative JJ O
helicase NN B-Gene
region NN I-Gene
is VBZ O
unaffected VBN O
. . O

Significant JJ O
immunoglobulinuria NN O
developed VBD O
prior RB O
to TO O
the DT O
development NN O
of IN O
azotemia NN O
, , O
significantly RB O
decreased VBN O
creatinine JJ O
clearance NN O
, , O
significant JJ O
proteinuria NN O
( ( O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
3 CD O
+ NNS O
dipstick NN O
or CC O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
5 CD O
gm NNS O
per IN O
24 CD O
- : O
hour NN O
urine JJ O
collection NN O
) ) O
, , O
or CC O
oliguria NNS O
. . O

Chemotherapy NNP O
was VBD O
administered VBN O
without IN O
altering VBG O
the DT O
course NN O
of IN O
the DT O
disorder NN O
. . O

Quantum NNP O
- : O
statistical JJ O
theory NN O
of IN O
high JJ O
- : O
field NN O
transport NN O
phenomena NN O
. . O

Gestational NNP O
trophoblastic JJ O
diseases NNS O
: : O
recent JJ O
advances NNS O
in IN O
the DT O
understanding NN O
of IN O
cytogenetics NNS O
, , O
histopathology NN O
, , O
and CC O
natural JJ O
history NN O
. . O

Fast RB O
continuous JJ O
expansion NN O
. . O

Serum NNP O
concentrations NNS O
of IN O
bone NN B-Gene
specific JJ I-Gene
alkaline JJ I-Gene
phosphatase NN I-Gene
( ( O
BALP NNP B-Gene
) ) O
and CC O
osteocalcin $ B-Gene
( ( O
bone NN B-Gene
Gla NNP I-Gene
protein NN I-Gene
, , O
BGP NNP B-Gene
) ) O
, , O
urinary JJ O
levels NNS O
of IN O
pyridinoline NN O
( ( O
Pyr NNP O
) ) O
and CC O
deoxypyridinoline NN O
( ( O
Dpyr NNP O
) ) O
and CC O
computed VBN O
tomography NN O
( ( O
CT NNP O
) ) O
measurements NNS O
of IN O
the DT O
cross NN O
- : O
sectional JJ O
areas NNS O
of IN O
the DT O
vertebrae NN O
and CC O
the DT O
femurs NN O
, , O
the DT O
apparent JJ O
density NN O
of IN O
cancellous JJ O
bone NN O
in IN O
the DT O
vertebrae NN O
, , O
and CC O
the DT O
volume NN O
and CC O
the DT O
material JJ O
density NN O
of IN O
cortical JJ O
bone NN O
in IN O
the DT O
femurs NNS O
were VBD O
determined VBN O
in IN O
126 CD O
boys NNS O
and CC O
143 CD O
girls NNS O
, , O
ages VBZ O
7 CD O
- : O
18 CD O
years NNS O
. . O

PPD NNP B-Gene
- : O
specific JJ O
IgG NNP B-Gene
subclass NN O
responses NNS O
were VBD O
evident JJ O
to TO O
all DT O
four CD O
IgG NNP B-Gene
subclasses NNS O
. . O

Cyclin NNP B-Gene
A DT I-Gene
expression NN O
is VBZ O
repressed VBN O
in IN O
quiescent NN O
cells NNS O
by IN O
E2F NNP B-Gene
acting VBG O
in IN O
conjunction NN O
with IN O
its PRP$ O
pocket NN O
protein NN O
partners NNS O
Rb NNP B-Gene
, , O
p107 NN B-Gene
, , O
and CC O
p130 NN B-Gene
; : O
however RB O
, , O
v SYM B-Gene
- : I-Gene
Jun NNP I-Gene
overrides IN O
this DT O
control NN O
, , O
causing VBG O
phosphorylated VBN O
Rb NNP B-Gene
and CC O
proliferation NN O
- : O
specific JJ O
E2F NNP B-Gene
- : O
p107 NN B-Gene
complexes NNS O
to TO O
persist VB O
after IN O
mitogen NN O
withdrawal NN O
. . O

The DT O
Jenkins NNP O
Activity NNP O
Survey NNP O
and CC O
the DT O
CPI NNP O
- : O
revised VBN O
: : O
further JJ O
evidence NN O
of IN O
adaptive JJ O
and CC O
maladaptive JJ O
type NN O
A DT O
traits NNS O
. . O

However RB O
, , O
subcutaneously RB O
administered VBN O
pneumococci NN O
gave VBD O
a DT O
lower JJR O
mortality NN O
than IN O
pneumococci VB O
given VBN O
intravenously RB O
or CC O
intraperitoneally RB O
. . O

Chronic NNP O
nutritional JJ O
diseases NNS O
of IN O
infectious JJ O
origin NN O
: : O
an DT O
assessment NN O
of IN O
a DT O
nascent JJ O
field NN O
. . O

7 CD O
. . O

This DT O
study NN O
examines VBZ O
the DT O
cooperative JJ O
effects NNS O
of IN O
a DT O
human JJ O
estrogen NN B-Gene
receptor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
ERalpha NNP B-Gene
) ) O
isoform NN O
on IN O
estrogen NN O
( ( O
E2 NNP O
) ) O
- : O
mediated VBN O
gene NN O
activation NN O
in IN O
U2 NNP O
- : O
OS NNP O
osteosarcoma NN O
cells NNS O
. . O

Val NNP O
- : O
- : O
> NN O
Ala NNP O
mutations NNS O
selectively RB O
alter VBP O
helix SYM O
- : O
helix NN O
packing NN O
in IN O
the DT O
transmembrane NN O
segment NN O
of IN O
phage NN B-Gene
M13 NNP I-Gene
coat NN I-Gene
protein NN I-Gene
. . O

Furthermore RB O
, , O
the DT O
insertion NN O
of IN O
the DT O
ColE1 NNP B-Gene
cer NN I-Gene
site NN I-Gene
into IN O
the DT O
RK2 NNP O
plasmid NN O
deleted VBD O
for IN O
the DT O
par JJ O
region NN O
failed VBD O
to TO O
stabilize VB O
the DT O
plasmid NN O
in IN O
the DT O
MC1061K NNP O
strain NN O
, , O
indicating VBG O
that IN O
the DT O
multimer JJR O
resolution NN O
activity NN O
encoded VBN O
by IN O
parCBA NN B-Gene
is VBZ O
not RB O
by IN O
itself PRP O
responsible JJ O
for IN O
the DT O
stabilization NN O
activity NN O
observed VBD O
for IN O
this DT O
operon NN O
. . O

We PRP O
show VBP O
that IN O
CBF NNP B-Gene
- : I-Gene
A DT I-Gene
and CC O
CBF NNP B-Gene
- : I-Gene
C NNP I-Gene
interact NN O
with IN O
each DT O
other JJ O
to TO O
form VB O
a DT O
CBF NNP B-Gene
- : I-Gene
A DT I-Gene
- : O
CBF NNP B-Gene
- : I-Gene
C NNP I-Gene
complex NN O
and CC O
that IN O
CBF NNP B-Gene
- : I-Gene
B NN I-Gene
does VBZ O
not RB O
interact VB O
with IN O
CBF NNP B-Gene
- : I-Gene
A DT I-Gene
or CC O
CBF NNP B-Gene
- : I-Gene
C NNP I-Gene
individually RB O
but CC O
that IN O
it PRP O
associates VBZ O
with IN O
the DT O
CBF NNP B-Gene
- : I-Gene
A DT I-Gene
- : O
CBF NNP B-Gene
- : I-Gene
C NNP I-Gene
complex NN O
. . O

In IN O
on IN O
- : O
going VBG O
screening VBG O
programmes NNS O
, , O
the DT O
Haemoccult NNP O
test NN O
consists VBZ O
of IN O
six CD O
slides NNS O
and CC O
a DT O
test NN O
is VBZ O
considered VBN O
positive JJ O
if IN O
at IN O
least JJS O
one CD O
slide NN O
is VBZ O
coloured VBN O
. . O

Fission NNP B-Gene
yeast PRP I-Gene
mal2 JJ I-Gene
+ NNP I-Gene
is VBZ O
required VBN O
for IN O
chromosome NN O
segregation NN O
. . O

The DT O
eluting VBG O
solvent NN O
was VBD O
methanol JJ O
- : O
chloroform NN O
( ( O
10 CD O
+ RB O
90 CD O
) ) O
at IN O
a DT O
flow JJ O
rate NN O
of IN O
2 CD O
. . O
0 CD O
ml JJ O
/ NNP O
min NN O
. . O

Viral JJ O
genomic JJ O
RNA NNP O
for IN O
these DT O
reactions NNS O
was VBD O
obtained VBN O
directly RB O
from IN O
fecal JJ O
specimens NNS O
of IN O
infected JJ O
infant NN O
rats NNS O
. . O

In IN O
summary JJ O
, , O
at IN O
equianesthetic JJ O
concentrations NNS O
, , O
desflurane NN O
and CC O
isoflurane NN O
produced VBD O
similar JJ O
hemodynamic JJ O
effects NNS O
; : O
however RB O
, , O
in IN O
the DT O
absence NN O
of IN O
drugs NNS O
that WDT O
inhibit VBP O
autonomic JJ O
reflexes NNS O
, , O
desflurane NN O
had VBD O
less RBR O
negative JJ O
inotropic NN O
activity NN O
and CC O
produced VBD O
less JJR O
decrease NN O
in IN O
arterial JJ O
pressure NN O
. . O

A DT O
stretch NN O
of IN O
16 CD O
nucleotides NNS O
just RB O
upstream RB O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4RE CD I-Gene
contributed VBD O
to TO O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
inducibility NN O
and CC O
formed VBD O
nucleoprotein NNS O
complexes NNS O
with IN O
constitutive JJ O
factors NNS O
. . O

In IN O
two CD O
experiments NNS O
, , O
neonatal JJ O
female NN O
BALB NNP O
/ NNP O
cCrgl NN O
or CC O
BALB NNP O
/ NNP O
cfC3HCrgl NN O
mice NN O
were VBD O
given VBN O
subcutaneous JJ O
injections NNS O
of IN O
5 CD O
micrograms NNS O
17 CD O
beta SYM O
- : O
estradiol NN O
or CC O
sesame NN O
oil NN O
for IN O
the DT O
first JJ O
3 CD O
days NNS O
of IN O
life NN O
and CC O
were VBD O
ovariectomized VBN O
at IN O
60 CD O
days NNS O
of IN O
age NN O
, , O
at IN O
which WDT O
time NN O
vaginal JJ O
concretions NNS O
( ( O
Experiments NNS O
I PRP O
and CC O
II NNP O
) ) O
or CC O
silica NN O
( ( O
Experiment NNP O
II NNP O
) ) O
were VBD O
implanted VBN O
intravaginally RB O
. . O

Post NNP O
- : O
translational JJ O
modifications NNS O
such JJ O
as IN O
glycosylation NN O
and CC O
phosphorylation NN O
could MD O
be VB O
excluded VBN O
as IN O
potential JJ O
explanations NNS O
for IN O
the DT O
protein NN O
heterogeneity NN O
. . O

Recovery NN O
of IN O
radiolabelled JJ O
BA NNP O
through IN O
urine NN O
( ( O
28 CD O
% NN O
) ) O
and CC O
faeces NNS O
( ( O
22 CD O
% NN O
) ) O
up RB O
to TO O
96 CD O
hrs NNS O
averaged VBD O
50 CD O
% NN O
, , O
whereas JJ O
residual JJ O
radioactivity NN O
in IN O
liver NN O
and CC O
testis NN O
experienced VBD O
a DT O
recovery NN O
of IN O
29 CD O
% NN O
in IN O
scorbutic JJ O
animals NNS O
. . O

During IN O
the DT O
febrile JJ O
period NN O
, , O
pleocytosis NN O
was VBD O
associated VBN O
with IN O
high JJ O
levels NNS O
of IN O
IgG NNP B-Gene
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
and CC O
PGE2 NNP O
in IN O
the DT O
cerebrospinal JJ O
fluid NN O
. . O

Observations NNS O
on IN O
the DT O
flight NN O
activities NNS O
of IN O
Chrysops NNP O
caecutiens NNS O
L NNP O
. . O

A DT O
cDNA JJ O
library NN O
of IN O
tumour NN O
cells NNS O
was VBD O
screened VBN O
with IN O
an DT O
interleukin JJ B-Gene
2 CD I-Gene
gene NN O
- : O
specific JJ O
probe NN O
. . O

The DT O
microcirculatory NN O
dynamics NNS O
of IN O
prostaglandin NN O
E1 NNP O
and CC O
/ NNP O
or CC O
nicardipine NN O
and CC O
their PRP$ O
different JJ O
reactions NNS O
in IN O
the DT O
hyper NN O
- : O
and CC O
hypodynamic JJ O
state NN O
of IN O
septic JJ O
shock NN O
in IN O
a DT O
rat NN O
model NN O

The DT O
effect NN O
of IN O
pure JJ O
natural JJ O
porcine NN B-Gene
secretin NN I-Gene
on IN O
endocrine NN O
and CC O
exocrine JJ O
pancreatic JJ O
secretion NN O
was VBD O
studied VBN O
in IN O
the DT O
totally RB O
isolated JJ O
perfused JJ O
porcine NN O
pancreas NNS O
. . O

Candidate NNP O
tumor NN O
suppressor NN O
genes NNS O
, , O
Mts1 NNP B-Gene
( ( O
p16INK4a NN B-Gene
) ) O
and CC O
Mts2 NNP B-Gene
( ( O
p15INK4b NN B-Gene
) ) O
, , O
have VBP O
been VBN O
mapped VBN O
to TO O
this DT O
region NN O
, , O
but CC O
by IN O
Southern NNP O
blot NN O
analysis NN O
, , O
no DT O
homozygous JJ O
deletions NNS O
were VBD O
detected VBN O
in IN O
either DT O
gene NN O
. . O

The DT O
pen NN O
can MD O
heal VB O
. . O

Furthermore RB O
, , O
analysis NN O
of IN O
deletion NN O
promoter NN O
- : O
reporter NN O
constructs NNS O
found VBD O
that IN O
the DT O
basal NN O
activity NN O
of IN O
P2 NNP O
resided VBD O
in IN O
the DT O
proximal JJ O
region NN O
of IN O
P2 NNP O
. . O

We PRP O
used VBD O
deletion NN O
analysis NN O
and CC O
transfection NN O
assays NNS O
with IN O
reporter NN O
gene NN O
constructs NNS O
to TO O
examine VB O
the DT O
transcription NN O
control NN O
elements VBZ O
in IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
human JJ B-Gene
EpoR NNP I-Gene
gene NN I-Gene
. . O

The DT O
disturbance NN O
of IN O
pulmonary JJ O
gas NN O
exchange NN O
, , O
as IN O
revealed VBN O
by IN O
the DT O
high JJ O
value NN O
of IN O
AaDO2 NNP O
, , O
existed VBD O
without IN O
left JJ O
ventricular JJ O
dysfunction NN O
, , O
and CC O
AaDO2 NNP O
had VBD O
no DT O
significant JJ O
relationship NN O
with IN O
any DT O
of IN O
the DT O
hemodynamic JJ O
parameters NNS O
including VBG O
the DT O
difference NN O
between IN O
plasma NN O
colloid NN O
osmotic JJ O
pressure NN O
and CC O
PCW NNP O
. . O

The DT O
addition NN O
of IN O
an DT O
equimolar JJ O
complex NN O
of IN O
the DT O
fourth JJ O
and CC O
seventh JJ O
largest JJS O
subunits NNS O
, , O
purified VBN O
from IN O
pol NN B-Gene
II NNP I-Gene
holoenzyme NN I-Gene
by IN O
ion NN O
- : O
exchange NN O
chromatography NN O
in IN O
the DT O
presence NN O
of IN O
urea JJ O
, , O
restored VBD O
promoter NN O
- : O
directed JJ O
initiation NN O
activity NN O
to TO O
pol VB B-Gene
II NNP I-Gene
delta NN I-Gene
4 CD I-Gene
/ NN I-Gene
7 CD I-Gene
. . O

Since IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
this DT O
gene NN O
is VBZ O
likely JJ O
involved VBN O
in IN O
hormonal JJ O
regulation NN O
of IN O
its PRP$ O
expression NN O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
partially RB O
characterized VBD O
an DT O
avian JJ O
fatty NN B-Gene
acid JJ I-Gene
synthase NN I-Gene
gene NN O
. . O

Behind IN O
the DT O
ATPase NNP B-Gene
cluster NN I-Gene
, , O
two CD O
open JJ O
reading VBG O
frames NNS O
were VBD O
detected VBN O
that WDT O
are VBP O
not RB O
homologous JJ O
to TO O
any DT O
known VBN O
chloroplast NN O
gene NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
expansion NN O
of IN O
the DT O
dodecamer NN O
repeat NN O
located VBN O
in IN O
the DT O
proximal JJ O
promoter NN O
of IN O
CSTB NNP B-Gene
severely RB O
disrupts VBZ O
the DT O
function NN O
of IN O
the DT O
promoter NN O
and CC O
thereby NN O
reduces NNS O
transcription NN O
of IN O
CSTB NNP B-Gene
. . O

We PRP O
have VBP O
screened VBN O
the DT O
mouse NN O
cDNA NN O
library NN O
of IN O
an DT O
MIN6 NNP O
cell NN O
line NN O
, , O
derived VBD O
from IN O
pancreatic JJ O
beta NN O
cells NNS O
, , O
for IN O
its PRP$ O
novel JJ O
isoform NN O
and CC O
have VBP O
identified VBN O
a DT O
cDNA NN O
encoding VBG O
a DT O
593 CD O
- : O
amino NN O
acid NN O
protein NN O
having VBG O
63 CD O
, , O
53 CD O
, , O
and CC O
30 CD O
% NN O
identity NN O
with IN O
munc JJ B-Gene
- : I-Gene
18 CD I-Gene
/ NN I-Gene
n SYM I-Gene
- : I-Gene
Sec1 NNP I-Gene
/ NNP I-Gene
rbSec1 NN I-Gene
, , O
Caenorhabditis NNP B-Gene
elegans VBZ I-Gene
unc18 JJ I-Gene
, , O
and CC O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
Sec1p NNP I-Gene
, , O
respectively RB O
. . O

The DT O
importance NN O
of IN O
this DT O
new JJ O
epidemiological JJ O
profile NN O
of IN O
schistosomiasis NN O
in IN O
the DT O
State NNP O
of IN O
Pernambuco NNP O
relies NNS O
on IN O
the DT O
fact NN O
that IN O
it PRP O
can MD O
be VB O
related VBN O
with IN O
the DT O
drastic JJ O
human JJ O
interference NN O
on IN O
the DT O
environment NN O
. . O

Of IN O
208 CD O
eligible JJ O
subjects NNS O
, , O
82 CD O
received VBD O
supervised JJ O
IPT NNP O
at IN O
a DT O
dose NN O
of IN O
900 CD O
mg NN O
twice RB O
weekly RB O
for IN O
6 CD O
mo NN O
( ( O
Regimen NNP O
A NNP O
) ) O
, , O
73 CD O
received VBD O
unsupervised JJ O
IPT NNP O
900 CD O
mg NN O
twice RB O
weekly RB O
for IN O
6 CD O
mo NN O
( ( O
Regimen NNP O
B NNP O
) ) O
, , O
and CC O
53 CD O
received VBD O
unsupervised JJ O
IPT NNP O
300 CD O
mg NNS O
daily RB O
for IN O
6 CD O
mo NN O
( ( O
Regimen NNP O
C NNP O
) ) O
. . O

Other JJ O
therapies NNS O
are VBP O
also RB O
available JJ O
, , O
including VBG O
hypertonic JJ O
saline NN O
solution NN O
, , O
THAM NNP O
( ( O
Tris NNP O
- : O
hydroxy NN O
- : O
methyl NN O
- : O
aminomethane NN O
) ) O
buffer NN O
, , O
and CC O
high JJ O
- : O
dose NN O
barbiturates NNS O
. . O

Effects NNS O
of IN O
estradiol NN O
on IN O
worm NN O
burden NN O
and CC O
peripheral JJ O
leukocytes NNS O
in IN O
Parastrongylus NNP O
malaysiensis NN O
- : O
infected JJ O
rats NNS O
. . O

In IN O
contrast NN O
, , O
resensitization NN O
of IN O
a DT O
sequestration NN O
- : O
impaired JJ O
beta2AR NN B-Gene
mutant NN O
( ( O
Y326A NNP O
) ) O
was VBD O
reestablished VBN O
following VBG O
the DT O
overexpression NN O
of IN O
either DT O
GRK2 NNP B-Gene
or CC O
beta SYM B-Gene
- : I-Gene
arrestin NN I-Gene
1 CD I-Gene
. . O

For IN O
sputum NN B-Gene
interleukin JJ I-Gene
- : I-Gene
8 CD I-Gene
there EX O
was VBD O
an DT O
estimated JJ O
true JJ O
treatment NN O
median JJ O
difference NN O
of IN O
142 CD O
pg NNS O
/ JJ O
ml NN O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
( ( O
CI NNP O
) ) O
8 CD O
to TO O
2866 CD O
pg NN O
/ NNP O
ml NN O
) ) O
in IN O
favour NN O
of IN O
placebo NN O
; : O
while IN O
for IN O
maximal JJ O
expiratory NN O
flow NN O
at IN O
25 CD O
% NN O
( ( O
MEF25 NNP O
% NN O
) ) O
remaining VBG O
forced VBN O
vital JJ O
capacity NN O
predicted VBD O
for IN O
sex NN O
and CC O
height NN O
there RB O
was VBD O
a DT O
15 CD O
percentage NN O
points NNS O
( ( O
pp NN O
) ) O
( ( O
95 CD O
% NN O
CI NNP O
4 CD O
to TO O
26 CD O
pp NN O
) ) O
mean FW O
treatment NN O
difference NN O
in IN O
favour NN O
of IN O
placebo NN O
. . O

The DT O
Psc2 NNP B-Gene
cDNA NN I-Gene
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
homologous JJ O
to TO O
CP2 NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
. . O

The DT O
technique NN O
of IN O
the DT O
TEE NNP O
visualization NN O
of IN O
the DT O
proximal JJ O
coronary JJ O
arteries NNS O
is VBZ O
described VBN O
. . O

The DT O
C NNP O
- : O
terminal NN O
approximately RB O
50 CD O
amino JJ O
acids NNS O
of IN O
Bel NNP B-Gene
- : I-Gene
1 CD I-Gene
are VBP O
shown VBN O
to TO O
be VB O
essential JJ O
for IN O
Bel NNP B-Gene
- : I-Gene
1 CD I-Gene
activity NN O
but CC O
can MD O
be VB O
effectively RB O
substituted VBN O
by IN O
the DT O
C NNP O
- : O
terminal JJ O
activation NN O
domain NN O
of IN O
VP16 NNP B-Gene
. . O

The DT O
importance NN O
of IN O
posttranslational JJ O
regulation NN O
of IN O
p15INK4B NN B-Gene
by IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
is VBZ O
underlined VBN O
by IN O
the DT O
observation NN O
that IN O
in IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
resistant JJ O
184A1L5R CD O
, , O
although IN O
the DT O
p15 JJ B-Gene
transcript NN I-Gene
increased VBD O
, , O
p15INK4B FW B-Gene
protein NN I-Gene
was VBD O
not RB O
stabilized VBN O
and CC O
did VBD O
not RB O
accumulate VB O
, , O
and CC O
cyclin NN B-Gene
D1 NNP I-Gene
- : O
cdk NN B-Gene
association NN O
and CC O
kinase VB O
activation NN O
were VBD O
not RB O
inhibited VBN O
. . O

The DT O
binding VBG O
specificity NN O
of IN O
this DT O
protein NN O
was VBD O
compared VBN O
to TO O
that DT O
of IN O
human JJ B-Gene
E2F NNP I-Gene
using VBG O
a DT O
number NN O
of IN O
mutant JJ B-Gene
E2F NNP I-Gene
sites VBZ I-Gene
as IN O
competitors NNS O
. . O

Northern NNP O
blot NN O
analyses NNS O
demonstrate VBP O
that IN O
3 CD O
. . O
9 CD O
- : O
and CC O
5 CD O
- : O
kilobase NN O
mRNAs NN O
corresponding VBG O
to TO O
the DT O
cDNA NN O
were VBD O
present JJ O
in IN O
all DT O
tissues NNS O
examined VBN O
, , O
suggesting VBG O
that IN O
the DT O
protein NN O
it PRP O
encodes VBZ O
performs VBZ O
a DT O
housekeeping NN O
function NN O
. . O

The DT O
case NN O
for IN O
neutrinos NNS O
from IN O
SN NNP O
1987A CD O
. . O

Somatostatin NNP B-Gene
gene NN I-Gene
expression NN O
in IN O
pancreatic JJ O
islet NN O
cells NNS O
is VBZ O
directed VBN O
by IN O
cell NN O
- : O
specific JJ O
DNA NNP O
control NN O
elements NNS O
and CC O
DNA NNP O
- : O
binding NN O
proteins NNS O
. . O

( ( O
1995 CD O
) ) O
J NNP O
. . O

A DT O
bovine NN O
abomasum NN O
lambda NN O
gt11 NN O
cDNA NN O
library NN O
was VBD O
screened VBN O
with IN O
a DT O
monoclonal JJ O
antibody NN O
raised VBN O
against IN O
the DT O
rabbit NN B-Gene
H NNP I-Gene
, , I-Gene
K NNP I-Gene
- : I-Gene
ATPase NNP I-Gene
beta NN I-Gene
subunit NN I-Gene
. . O

The DT O
data NN O
further RB O
indicate VB O
that IN O
the DT O
IL NNP B-Gene
- : I-Gene
7R CD I-Gene
alpha NN I-Gene
chains NNS I-Gene
are VBP O
directly RB O
involved VBN O
in IN O
the DT O
activation NN O
of IN O
JAKs NNP B-Gene
and CC O
STATs NNP B-Gene
and CC O
have VBP O
a DT O
major JJ O
role NN O
in IN O
proliferative JJ O
signaling NN O
in IN O
precursor NN O
B NNP O
cells NNS O
. . O

TSC1 NNP B-Gene
mutations NNS I-Gene
include VBP O
two CD O
nonsense JJ O
mutations NNS O
, , O
four CD O
insertions NNS O
, , O
and CC O
three CD O
splice NN O
mutations NNS O
. . O

PROCEDURE NN O
: : O
Cannulas NNS O
were VBD O
surgically RB O
positioned VBN O
in IN O
the DT O
abomasal NN O
body NN O
and CC O
pyloric JJ O
antrum NN O
of IN O
each DT O
calf NN O
. . O

Effect NN O
of IN O
ingestion NN O
of IN O
Norbiogest NNP O
during IN O
the DT O
quiescent JJ O
period NN O
of IN O
the DT O
genital JJ O
organs NNS O

Expression NN O
in IN O
established VBN O
LCLs NNP O
, , O
occurring VBG O
irrespective NN O
of IN O
virus NN O
producer NN O
status NN O
, , O
was VBD O
not RB O
a DT O
consequence NN O
of IN O
continued VBN O
in IN O
vitro JJ O
passage NN O
; : O
thus RB O
, , O
appropriately RB O
spliced VBD O
BamHI NNP B-Gene
- : I-Gene
A DT I-Gene
transcripts NNS I-Gene
could MD O
be VB O
amplified VBN O
from IN O
normal JJ O
B NNP O
cells NNS O
within IN O
1 CD O
day NN O
of IN O
their PRP$ O
experimental JJ O
infection NN O
in IN O
vitro NN O
, , O
along IN O
with IN O
BamHI NNP B-Gene
- : I-Gene
C NNP I-Gene
/ NNP I-Gene
W NNP I-Gene
promoter NN O
- : O
initiated VBN O
but CC O
not RB O
BamHI NNP B-Gene
- : I-Gene
F NNP I-Gene
promoter NN I-Gene
- : I-Gene
initiated VBN I-Gene
mRNAs NN I-Gene
. . O

Effect NN O
of IN O
proteolytic JJ O
enzymes NNS O
and CC O
polypeptides NNS O
on IN O
the DT O
antacid JJ O
activity NN O
of IN O
almagate NN O
and CC O
other JJ O
antacids NNS O
. . O

Characterization NN O
of IN O
fus1 NN B-Gene
of IN O
Schizosaccharomyces NNS O
pombe NNS O
: : O
a DT O
developmentally RB O
controlled VBN O
function NN O
needed VBN O
for IN O
conjugation NN O
. . O

IgE NN B-Gene
levels NNS O
showed VBD O
higher JJR O
values NNS O
compared VBN O
to TO O
normal JJ O
individuals NNS O
and CC O
IgE NNP B-Gene
levels NNS O
were VBD O
higher JJR O
in IN O
children NNS O
groups NNS O
than IN O
in IN O
adults JJ O
regardless NN O
of IN O
the DT O
intensity NN O
of IN O
infection NN O
. . O

The DT O
nature NN O
of IN O
the DT O
process NN O
formed VBN O
by IN O
the DT O
successive JJ O
occurrences NNS O
of IN O
this DT O
arrhythmia NN O
was VBD O
studied VBN O
in IN O
8 CD O
patients NNS O
with IN O
a DT O
history NN O
of IN O
symptomatic JJ O
paroxysmal JJ O
AF NNP O
. . O

This DT O
effect NN O
was VBD O
not RB O
seen VBN O
in IN O
conjunction NN O
with IN O
oxycodone NN O
, , O
a DT O
morphine JJ B-Gene
- : I-Gene
like IN I-Gene
mu SYM I-Gene
- : I-Gene
receptor NN I-Gene
agonist NN O
. . O

RNAs NNP O
are VBP O
not RB O
only RB O
essential JJ O
components NNS O
of IN O
both DT O
ribosomal JJ O
subunits NNS O
but CC O
also RB O
transiently RB O
interacting VBG O
factors NNS O
during IN O
particle NN O
formation NN O
. . O

We PRP O
found VBD O
a DT O
direct JJ O
correlation NN O
between IN O
the DT O
levels NNS O
of IN O
transcription NN O
of IN O
the DT O
acc NN B-Gene
genes NNS I-Gene
and CC O
the DT O
rate NN O
of IN O
cellular JJ O
growth NN O
. . O

This DT O
tendency NN O
is VBZ O
likely JJ O
due JJ O
to TO O
the DT O
biased VBN O
nucleotide JJ O
composition NN O
of IN O
the DT O
asparagus JJ O
genome NN O
, , O
rather RB O
than IN O
to TO O
the DT O
translational JJ O
selection NN O
for IN O
specific JJ O
codons NNS O
. . O

A DT O
role NN O
for IN O
RalGDS NNP B-Gene
and CC O
a DT O
novel JJ O
Ras NNP B-Gene
effector NN O
in IN O
the DT O
Ras NNP B-Gene
- : O
mediated VBD O
inhibition NN O
of IN O
skeletal JJ O
myogenesis NN O
. . O

Icterus NNP O
and CC O
beta SYM O
- : O
thalassemia NN O
in IN O
Congolese JJ O
children NNS O
in IN O
Brazzaville NNP O

In IN O
the DT O
pRb NN B-Gene
( ( I-Gene
- : I-Gene
) ) I-Gene
SAOS NNP O
- : O
2 CD O
cell NN O
line NN O
transiently RB O
transfected VBD O
with IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
six CD O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
site NN I-Gene
, , O
pRb JJ B-Gene
enhances VBZ O
the DT O
transcriptional JJ O
activity NN O
of IN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
- : O
E12 NNP B-Gene
- : O
Lmo2 NNP B-Gene
and CC O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
- : O
E12 NNP B-Gene
- : O
Lmo2 NNP B-Gene
- : O
Ldb1 NN B-Gene
complexes NNS O
but CC O
not RB O
that IN O
of IN O
a DT O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
- : O
E12 NN B-Gene
heterodimer NN O
. . O

Increasing VBG O
the DT O
phosphorus NN O
content NN O
of IN O
the DT O
diet JJ O
improved VBD O
the DT O
reabsorption NN O
of IN O
calcium NN O
and CC O
magnesium NN O
. . O

Comparison NN O
with IN O
the DT O
bovine NN O
gene NN O
showed VBD O
that IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
hATP1 NN B-Gene
gene NN I-Gene
has VBZ O
an DT O
unconserved JJ O
guanine NN O
- : O
cytosine NN O
( ( O
GC NNP O
) ) O
rich JJ O
region NN O
, , O
including VBG O
several JJ O
binding VBG O
motifs NNS O
of IN O
transcriptional JJ O
factors NNS O
, , O
such JJ O
as IN O
Sp1 NNP B-Gene
, , O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
and CC O
GCF NNP B-Gene
. . O

IGF NNP B-Gene
I PRP I-Gene
and CC O
insulin JJ B-Gene
receptors NNS I-Gene
are VBP O
homologous JJ O
proteins NNS O
that WDT O
function VBP O
in IN O
distinct JJ O
physiological JJ O
pathways NNS O
. . O

Drugs NNS O
that WDT O
are VBP O
transformed VBN O
via IN O
phase NN O
II NNP O
reactions NNS O
usually RB O
do VBP O
not RB O
require VB O
dosage NN O
adjustment NN O
. . O

PNRC NN B-Gene
: : O
a DT O
proline NN O
- : O
rich JJ O
nuclear JJ O
receptor NN O
coregulatory NN O
protein NN O
that WDT O
modulates VBZ O
transcriptional JJ O
activation NN O
of IN O
multiple JJ O
nuclear JJ O
receptors NNS O
including VBG O
orphan JJ O
receptors NNS O
SF1 NNP B-Gene
( ( O
steroidogenic JJ B-Gene
factor NN I-Gene
1 CD I-Gene
) ) O
and CC O
ERRalpha1 NNP B-Gene
( ( O
estrogen NN B-Gene
related VBN I-Gene
receptor NN I-Gene
alpha SYM I-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Research NN O
on IN O
ethylene NN O
glycol NN O
and CC O
diethylene NN O
glycol NN O
for IN O
carcinogenic JJ O
effects NNS O

Carbon NNP O
catabolite JJ O
repression NN O
of IN O
the DT O
gnt NN B-Gene
operon NN I-Gene
of IN I-Gene
Bacillus NN I-Gene
subtilis NNS I-Gene
is VBZ O
mediated VBN O
by IN O
the DT O
catabolite NN O
control NN O
protein NN O
CcpA NNP B-Gene
and CC O
by IN O
HPr NNP B-Gene
, , O
a DT O
phosphocarrier JJR O
protein NN O
of IN O
the DT O
phosphotransferase NN O
system NN O
. . O

The DT O
need NN O
for IN O
including VBG O
forensic JJ O
medical JJ O
expertise NN O
in IN O
the DT O
list NN O
of IN O
urgent JJ O
criminal JJ O
investigative JJ O
actions NNS O

Patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
had VBD O
higher JJR O
plasma JJ O
concentrations NNS O
of IN O
neutrophil JJ B-Gene
elastase NN I-Gene
and CC O
the DT O
non JJ O
- : O
peroxide NN O
diene NN O
conjugated VBD O
isomer NN O
of IN O
linoleic NN O
acid NN O
than IN O
normal JJ O
volunteers NNS O
or CC O
patients NNS O
with IN O
stable JJ O
ischaemic JJ O
heart NN O
disease NN O
. . O

Each DT O
binding NN O
site NN O
, , O
however RB O
, , O
was VBD O
different JJ O
in IN O
its PRP$ O
preference NN O
for IN O
binding VBG O
partners NNS O
. . O

The DT O
TEA1 NNP B-Gene
( ( O
Ty NNP B-Gene
enhancer NNP I-Gene
activator NN I-Gene
) ) O
gene NN O
sequence NN O
predicts VBZ O
a DT O
protein NN O
of IN O
86 CD O
. . O
9 CD O
kDa NN O
whose WP$ O
N NNP O
terminus NN O
contains VBZ O
a DT O
zinc NN O
cluster NN O
and CC O
dimerization NN O
motif FW O
typical JJ O
of IN O
the DT O
Gal4 NNP B-Gene
- : I-Gene
type JJ I-Gene
family NN I-Gene
of IN O
DNA NNP O
- : O
binding NN O
proteins NNS O
. . O

Chemical NNP O
uptake NN O
into IN O
human JJ O
stratum NN O
corneum NN O
in IN O
vivo NN O
from IN O
volatile JJ O
and CC O
non JJ O
- : O
volatile JJ O
solvents NNS O
. . O

On IN O
the DT O
trail NN O
of IN O
Dr NNP O
. . O

We PRP O
have VBP O
cloned VBN O
a DT O
novel JJ O
protein NN O
kinase NN O
, , O
termed VBD O
hematopoietic JJ B-Gene
progenitor NN I-Gene
kinase NN I-Gene
1 CD I-Gene
( ( O
HPK1 NNP B-Gene
) ) O
, , O
that WDT O
is VBZ O
expressed VBN O
predominantly RB O
in IN O
hematopoietic JJ O
cells NNS O
, , O
including VBG O
early JJ O
progenitor NN O
cells NNS O
. . O

Histological JJ O
analysis NN O
showed VBD O
that IN O
the DT O
neuronal JJ O
loss NN O
in IN O
the DT O
DHED NNP O
- : O
treated VBD O
group NN O
was VBD O
notably RB O
reduced VBN O
in IN O
the DT O
hippocampal JJ O
area NN O
( ( O
CA1 NNP O
) ) O
of IN O
ischemic JJ O
rats NNS O
and CC O
in IN O
the DT O
dentate NN O
gyrus NN O
and CC O
hippocampal JJ O
area NN O
( ( O
CA1 NNP O
and CC O
CA3 NNP O
) ) O
of IN O
EC NNP O
- : O
lesioned VBD O
rats NNS O
compared VBN O
with IN O
the DT O
nontreated JJ O
group NN O
. . O

These DT O
well SYM O
- : O
characterized VBN O
brain NN O
regions NNS O
may MD O
provide VB O
a DT O
basis NN O
for IN O
future JJ O
studies NNS O
of IN O
RPTP NNP B-Gene
- : I-Gene
kappa NN I-Gene
function NN O
. . O

From NN O
May NNP O
1985 CD O
to TO O
May NNP O
1989 CD O
, , O
126 CD O
necropsies NNS O
were VBD O
performed VBN O
at IN O
the DT O
Sao NNP O
Paulo NNP O
City NNP O
Morgue NNP O
on IN O
cadavers NNS O
of IN O
individuals NNS O
AIDS NNP O
victims NNS O
whose WP$ O
unnatural JJ O
deaths NNS O
had VBD O
prompted VBN O
police JJ O
investigations NNS O
. . O

In IN O
a DT O
longitudinal JJ O
study NN O
, , O
14 CD O
low JJ O
- : O
risk NN O
fetuses NNS O
were VBD O
studied VBN O
at IN O
2 CD O
- : O
week NN O
intervals NNS O
from IN O
32 CD O
weeks NNS O
of IN O
gestation NN O
onward NN O
. . O

Our PRP$ O
results NNS O
also RB O
indicate VBP O
the DT O
existence NN O
of IN O
sequences NNS O
downstream NN O
of IN O
- : O
0 CD O
. . O
11 CD O
kb NN O
which WDT O
can MD O
influence VB O
the DT O
pattern NN O
of IN O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
HLA NNP B-Gene
- : I-Gene
B7 NNP I-Gene
gene NN I-Gene
and CC O
the DT O
ability NN O
of IN O
this DT O
gene NN O
to TO O
respond VB O
to TO O
gamma VB B-Gene
interferon NN I-Gene
. . O

The DT O
astronaut NN O
crew NN O
operates VBZ O
the DT O
payload NN O
and CC O
documents NNS O
its PRP$ O
operation NN O
. . O

The DT O
human JJ B-Gene
T NNP I-Gene
cell NN I-Gene
leukemia NN I-Gene
/ NNP I-Gene
lymphotropic NN I-Gene
virus NN I-Gene
type VBD I-Gene
1 CD I-Gene
Tax NNP I-Gene
protein NN I-Gene
represses VBZ O
MyoD NNP B-Gene
- : O
dependent JJ O
transcription NN O
by IN O
inhibiting VBG O
MyoD NNP B-Gene
- : O
binding NN O
to TO O
the DT O
KIX NNP B-Gene
domain NN I-Gene
of IN O
p300 NN B-Gene
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
the DT O
promoter NN O
and CC O
enhancer NN O
regions NNS O
identified VBN O
here RB O
are VBP O
essential JJ O
for IN O
maintaining VBG O
the DT O
efficient JJ O
promoter NN O
activity NN O
of IN O
the DT O
human JJ B-Gene
activin NN I-Gene
betaA NN I-Gene
subunit NN I-Gene
gene NN I-Gene
. . O

None NN O
of IN O
the DT O
patients NNS O
was VBD O
obese JJ O
. . O

The DT O
bases NNS O
of IN O
this DT O
comparison NN O
are VBP O
reviewed VBN O
and CC O
discussed VBN O
. . O

Point NNP O
mutations NNS O
of IN O
the DT O
five CD O
tyrosine NN O
residues NNS O
in IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
the DT O
receptor NN O
were VBD O
subsequently RB O
used VBN O
to TO O
confirm VB O
our PRP$ O
conclusions NNS O
. . O

A DT O
range NN O
of IN O
normal JJ O
ventricular JJ O
measurements NNS O
for IN O
the DT O
EMI NNP O
scan NN O
is VBZ O
suggested VBN O
. . O

Sequence NN O
analysis NN O
identified VBD O
some DT O
of IN O
these DT O
cDNA NN O
clones NNS O
as IN O
Dlc NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
sequence NN O
encoding VBG O
a DT O
small JJ O
, , O
9 CD B-Gene
- : I-Gene
kDa NN I-Gene
human JJ I-Gene
homolog NN I-Gene
of IN I-Gene
the DT I-Gene
outer NN I-Gene
- : I-Gene
arm NN I-Gene
dynein NN I-Gene
light VBD I-Gene
- : I-Gene
chain NN I-Gene
protein NN O
. . O

Increasing VBG O
the DT O
extracellular JJ O
calcium NN O
concentration NN O
enhanced VBD O
detrusor JJ O
contractility NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
in IN O
both DT O
control NN O
and CC O
obstructed VBD O
bladders NNS O
. . O

With IN O
this DT O
bisected VBN O
diastolic JJ O
driving NN O
, , O
the DT O
abnormal JJ O
echo NN O
disappeared VBD O
completely RB O
. . O

Effect NN O
of IN O
nitrous JJ O
oxide NN O
( ( O
N2O NNP O
) ) O
on IN O
the DT O
somatosympathetic NN O
A NNP O
- : O
and CC O
C NNP O
- : O
reflexes NN O
was VBD O
investigated VBN O
using VBG O
artificially RB O
ventilated VBN O
rats NNS O
anesthetized VBN O
with IN O
alpha JJ O
- : O
chloralose NN O
and CC O
urethane NN O
. . O

Mean NNP O
longitudinal JJ O
extension NN O
of IN O
the DT O
epidural JJ O
lesion NN O
was VBD O
2 CD O
. . O
6 CD O
vertebral JJ O
segments NNS O
. . O

Sensitivities NNS O
of IN O
thromboplastins NNS B-Gene
to TO O
factor VB B-Gene
VII NNP I-Gene
deficiency NN O
. . O

Since IN O
the DT O
RINX NNP B-Gene
gene NN I-Gene
is VBZ O
likely JJ O
an DT O
ortholog NN O
of IN O
the DT O
goldfish JJ B-Gene
Vsx1 NNP I-Gene
gene NN I-Gene
, , O
it PRP O
has VBZ O
been VBN O
named VBN O
VSX1 NNP B-Gene
by IN O
the DT O
Human NNP O
Gene NNP O
Nomenclature NNP O
Committee NNP O
. . O

These DT O
changes NNS O
weren VBP O
' '' O
t NNS O
so RB O
significant JJ O
in IN O
the DT O
group NN O
of IN O
obese JJ O
children NNS O
who WP O
didn VBP O
' '' O
t NN O
lose JJ O
weight NN O
. . O

Thus RB O
, , O
VF NNP O
resistant NN O
to TO O
defibrillation NN O
is VBZ O
not RB O
necessarily RB O
associated VBN O
with IN O
both DT O
toxic JJ O
plasma JJ O
drug NN O
level NN O
and CC O
remarkably RB O
decreased JJ O
conduction NN O
. . O

Antibiotic JJ O
effect NN O
of IN O
the DT O
mud NN O
from IN O
heviz NN O

Promoter NNP O
recognition NN O
algorithms NN O
identified VBD O
divergent JJ O
promoter NN O
elements NNS O
within IN O
the DT O
CpG NNP O
island NN O
, , O
which WDT O
lies VBZ O
between IN O
the DT O
ATM NNP B-Gene
and CC O
E14 NNP B-Gene
/ NNP O
NPAT NNP B-Gene
genes NNS O
, , O
and CC O
provide VB O
evidence NN O
for IN O
a DT O
putative JJ O
second JJ O
ATM NNP B-Gene
promoter NN I-Gene
located VBN O
within IN O
intron NN O
3 CD O
, , O
immediately RB O
upstream NN O
of IN O
the DT O
first JJ O
coding NN O
exon NN O
. . O

The DT O
amount NN O
of IN O
these DT O
factors NNS O
was VBD O
reduced VBN O
in IN O
GEO NNP O
cells NNS O
in IN O
which WDT O
the DT O
u JJ B-Gene
- : I-Gene
PAR NNP I-Gene
gene NN I-Gene
is VBZ O
only RB O
weakly JJ O
transcriptionally RB O
activated VBN O
. . O

It PRP O
contains VBZ O
three CD O
putative JJ O
TATA NNP O
boxes NNS O
far RB O
upstream RB O
of IN O
the DT O
main JJ O
start NN O
sites VBZ O
region NN O
, , O
one CD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
box NN I-Gene
, , O
one CD O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
box NN I-Gene
, , O
one CD O
Malt NNP B-Gene
box NN I-Gene
, , O
one CD O
GAGA NNP O
box NN O
, , O
one CD O
half NN O
serum SYM O
- : O
responsive JJ O
element NN O
, , O
and CC O
putative JJ O
binding NN O
sites NNS O
for IN O
Sp1 NNP B-Gene
( ( O
five CD O
) ) O
, , O
GC NNP B-Gene
- : I-Gene
rich JJ I-Gene
binding NN I-Gene
factor NN I-Gene
( ( O
five CD O
) ) O
, , O
CTF NNP B-Gene
- : I-Gene
NF1 NNP I-Gene
( ( O
one CD O
) ) O
, , O
Myb NNP B-Gene
( ( O
one CD O
) ) O
, , O
p53 FW B-Gene
( ( O
two CD O
) ) O
, , O
Ets NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
one CD O
) ) O
, , O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
( ( O
two CD O
) ) O
, , O
MyoD NNP B-Gene
( ( O
two CD O
) ) O
, , O
Zeste NNP B-Gene
( ( O
one CD O
) ) O
, , O
and CC O
hepatocyte JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
5 CD I-Gene
( ( O
one CD O
) ) O
. . O

Cross NNP O
- : O
linking VBG O
the DT O
B NNP B-Gene
cell NN I-Gene
Ag NNP I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
to TO O
surface VB B-Gene
Fc NNP I-Gene
receptors NNS I-Gene
for IN O
IgG NNP B-Gene
( ( O
Fc NNP B-Gene
gamma NNP I-Gene
R NNP I-Gene
) ) O
inhibits VBZ O
G1 NNP O
- : O
to TO O
- : O
S NNP O
progression NN O
; : O
the DT O
mechanism NN O
by IN O
which WDT O
this DT O
occurs NN O
is VBZ O
not RB O
completely RB O
known VBN O
. . O

Terazosin NNP O
, , O
a DT O
structural JJ O
analog NN O
of IN O
prazosin NN O
, , O
also RB O
inhibits VBZ O
alpha RB B-Gene
1 CD I-Gene
adrenoceptors NNS I-Gene
and CC O
is VBZ O
recommended VBN O
as IN O
once RB O
or CC O
twice RB O
- : O
daily JJ O
therapy NN O
. . O

Rip1p NNP B-Gene
is VBZ O
inessential JJ O
, , O
associated VBN O
with IN O
nuclear JJ O
pore NN O
complexes NNS O
, , O
and CC O
structurally RB O
related VBN O
to TO O
the DT O
FG NNP B-Gene
- : I-Gene
nucleoporin JJ I-Gene
family NN I-Gene
of IN O
pore NN O
proteins NNS O
. . O

BCR NNP B-Gene
- : O
ABL NNP B-Gene
and CC O
v SYM B-Gene
- : I-Gene
abl NN I-Gene
oncogenes NNS I-Gene
induce VBP O
distinct JJ O
patterns NNS O
of IN O
thymic JJ O
lymphoma NN O
involving VBG O
different JJ O
lymphocyte JJ O
subsets NNS O
. . O

Chenodeoxycholic JJ O
acid NN O
( ( O
cheno NN O
) ) O
and CC O
ursodeoxycholic JJ O
acid NN O
( ( O
urso JJ O
) ) O
dissolve VBP O
cholesterol NN O
gallstones NNS O
in IN O
man NN O
. . O

TIEG NNP B-Gene
expression NN O
in IN O
hFOB NN O
cells NNS O
was VBD O
highly RB O
induced VBN O
by IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
and CC O
bone NN B-Gene
morphogenetic JJ I-Gene
protein NN I-Gene
- : I-Gene
2 CD I-Gene
( ( O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
, , O
with IN O
a DT O
moderate JJ O
induction NN O
by IN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
EGF NNP B-Gene
) ) O
, , O
but CC O
no DT O
induction NN O
by IN O
other JJ O
growth NN O
factors NNS O
/ VBP O
cytokines NNS O
was VBD O
observed VBN O
. . O

Concussion NN O
of IN O
the DT O
spinal JJ O
cord NN O

T2 NN O
cancers NNS O
should MD O
not RB O
be VB O
excluded VBN O
from IN O
the DT O
benefit NN O
of IN O
preoperative JJ O
irradiation NN O
. . O

Lethal NNP O
Tachmalcor NNP O
( ( O
4 CD O
- : O
( ( O
3 CD O
' '' O
- : O
diethylamino NN O
- : O
2 CD O
' '' O
- : O
hydroxypropyl NN O
) ) O
- : O
ajmaline NN O
) ) O
poisoning NN O
in IN O
childhood NN O

Unusual JJ O
two CD B-Gene
- : I-Gene
domain NN I-Gene
arginine JJ I-Gene
kinases NNS I-Gene
( ( O
AKs NNP B-Gene
) ) O
arose VBD O
independently RB O
at IN O
least JJS O
two CD O
times NNS O
during IN O
molecular JJ O
evolution NN O
of IN O
phosphagen NN B-Gene
kinases NNS I-Gene
: : O
AKs NN B-Gene
from IN O
the DT O
primitive JJ O
sea NN O
anemone NN O
Anthopleurura NNP O
japonicus NN O
and CC O
from IN O
the DT O
clam NN O
Pseudocardium NNP O
sachalinensis NN O
. . O

In IN O
broken JJ O
L NNP O
- : O
cell NN O
membranes NNS O
expressing VBG O
wild JJ O
type NN O
or CC O
mutant JJ B-Gene
M6P NNP I-Gene
/ NNP I-Gene
IGF NNP I-Gene
II NNP I-Gene
receptors NNS I-Gene
, , O
30 CD O
nM NN O
IGF NNP B-Gene
II NNP I-Gene
also RB O
failed VBD O
to TO O
affect VB O
the DT O
pertussis NN B-Gene
toxin NN I-Gene
substrate NN O
activity NN O
. . O

The DT O
mRNA NN O
from IN O
this DT O
gene NN O
, , O
termed VBD O
HES1 NNP B-Gene
, , O
is VBZ O
ubiquitously RB O
expressed VBN O
, , O
but CC O
strongly RB O
so RB O
in IN O
heart NN O
and CC O
skeletal JJ O
muscle NN O
. . O

Molecular JJ O
characterization NN O
and CC O
expression NN O
of IN O
the DT O
Erwinia NNP B-Gene
carotovora NN I-Gene
hrpNEcc NN I-Gene
gene NN I-Gene
, , O
which WDT O
encodes VBZ O
an DT O
elicitor NN O
of IN O
the DT O
hypersensitive JJ O
reaction NN O
. . O

Static JJ O
and CC O
dynamic JJ O
compliance NN O
was VBD O
measured VBN O
after IN O
induction NN O
of IN O
anesthesia NN O
, , O
before IN O
and CC O
immediately RB O
after IN O
filtration NN O
in IN O
the DT O
operating NN O
theater NN O
, , O
1 CD O
hour NN O
after IN O
return NN O
to TO O
the DT O
pediatric JJ O
intensive JJ O
care NN O
unit NN O
, , O
and CC O
24 CD O
hours NNS O
after IN O
the DT O
operation NN O
. . O

When WRB O
used VBN O
subcutaneously RB O
or CC O
intravenously RB O
in IN O
maximum NN O
tolerated JJ O
doses VBZ O
the DT O
antibiotic JJ O
inhibited VBD O
the DT O
development NN O
of IN O
lymphadenosis NN O
NK NNP O
/ NNP O
Li NNP O
by IN O
90 CD O
and CC O
70 CD O
per IN O
cent NN O
respectively RB O
. . O

HYPOTHESIS NN O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
oxidative JJ O
susceptibility NN O
of IN O
apolipoprotein NN B-Gene
B NNP I-Gene
- : I-Gene
containing NN I-Gene
lipoproteins NNS I-Gene
and CC O
antioxidant JJ O
status NN O
in IN O
patients NNS O
with IN O
acute JJ O
coronary JJ O
syndromes NNS O
and CC O
chronic JJ O
stable JJ O
angina NN O
pectoris NN O
. . O

The DT O
clinical JJ O
stage NN O
was VBD O
I PRP O
( ( O
T1N0M0 NNP O
) ) O
, , O
and CC O
S2 NNP O
sleeve VBP O
segmentectomy NN O
with IN O
lymph JJ O
node JJ O
dissection NN O
( ( O
R NNP O
2 CD O
b NN O
) ) O
was VBD O
performed VBN O
. . O

As IN O
expected VBN O
, , O
glycosylation NN O
of IN O
Env NNP B-Gene
produced VBD O
from IN O
mutants NNS O
was VBD O
affected JJ O
but CC O
, , O
irrespective JJ O
of IN O
the DT O
glycosylation NN O
phenotype NN O
, , O
( ( O
i NN O
) ) O
similar JJ O
quantities NNS O
of IN O
Env NNP B-Gene
were VBD O
synthesized VBN O
, , O
( ( O
ii NN O
) ) O
the DT O
immunoreactivity NN O
of IN O
V3 NNP B-Gene
was VBD O
similar JJ O
, , O
( ( O
iii NN O
) ) O
gp160 NN B-Gene
was VBD O
efficiently RB O
cleaved VBN O
into IN O
gp120 NN B-Gene
and CC O
gp41 NN B-Gene
, , O
( ( O
vi NN O
) ) O
Env NNP B-Gene
was VBD O
exposed VBN O
at IN O
the DT O
cell NN O
membrane NN O
, , O
( ( O
v NN O
) ) O
secreted VBD O
gp120 JJ B-Gene
bound NN O
CD4 NNP B-Gene
, , O
and CC O
( ( O
vi NN O
) ) O
membrane NN O
gp41 NN B-Gene
was VBD O
able JJ O
to TO O
induce VB O
membrane JJ O
fusion NN O
with IN O
CD4 NNP B-Gene
+ NNP I-Gene
cells NNS O
. . O

By IN O
screening VBG O
a DT O
cDNA NN O
library NN O
with IN O
a DT O
probe NN O
derived VBN O
from IN O
sequences NNS O
downstream NN O
of IN O
the DT O
p53p2 JJ B-Gene
start NN O
site NN O
, , O
we PRP O
have VBP O
cloned VBN O
and CC O
characterized VBN O
a DT O
cDNA NN O
that WDT O
represents VBZ O
a DT O
mRNA NN O
that WDT O
appears VBZ O
to TO O
have VB O
been VBN O
initiated VBN O
from IN O
the DT O
p53p2 NN B-Gene
promoter NN I-Gene
. . O

GLRaV NNP O
- : O
2 CD O
is VBZ O
the DT O
only JJ O
closterovirus NN O
, , O
so RB O
far RB O
, , O
that IN O
matches VBZ O
the DT O
genome JJ O
organization NN O
of IN O
the DT O
type JJ O
member NN O
of IN O
the DT O
group NN O
, , O
BYV NNP O
, , O
and CC O
thus RB O
can MD O
be VB O
unambiguously RB O
classified VBN O
as IN O
a DT O
definitive JJ O
member NN O
of IN O
the DT O
genus NN O
Closterovirus NNP O
. . O

The DT O
requirement NN O
of IN O
different JJ O
essential JJ O
fatty JJ O
acids NNS O
in IN O
patients NNS O
with IN O
total JJ O
parenteral JJ O
nutrition NN O
after IN O
heavy JJ O
injury NN O
is VBZ O
of IN O
special JJ O
interest NN O
with IN O
respect NN O
to TO O
the DT O
development NN O
and CC O
prognosis NN O
of IN O
shock NN O
, , O
sepsis NN O
or CC O
adult NN O
respiratory JJ O
distress JJ O
syndrome NN O
. . O

A DT O
comparative JJ O
study NN O
of IN O
the DT O
effects NNS O
of IN O
carbamazepine NN O
and CC O
the DT O
NMDA NNP B-Gene
receptor NN I-Gene
antagonist NN O
remacemide NN O
on IN O
road NN O
tracking NN O
and CC O
car NN O
- : O
following VBG O
performance NN O
in IN O
actual JJ O
traffic NN O
. . O

Both DT O
inhaled JJ O
and CC O
superfused VBD O
isoflurane NN O
dilated VBD O
the DT O
baseline NN O
vein NN O
diameter NN O
before IN O
stimulation NN O
. . O

The DT O
Gap69C NNP B-Gene
is VBZ O
a DT O
single JJ O
- : O
copy NN O
gene NN O
producing VBG O
a DT O
major JJ O
2 CD O
. . O
1 CD O
- : O
kb NN O
mRNA NN O
throughout IN O
development NN O
, , O
but CC O
its PRP$ O
amount NN O
is VBZ O
decreased VBN O
in IN O
larvae NN O
. . O

Mutants NNS O
lacking VBG O
any DT O
tyrosine NN O
residues NNS O
in IN O
the DT O
cytoplasmic JJ O
domain NN O
maintain VBP O
their PRP$ O
ability NN O
to TO O
activate VB O
STAT5 NNP B-Gene
and CC O
STAT1 NNP B-Gene
but CC O
cannot JJ O
activate NN O
STAT3 NNP B-Gene
, , O
implying VBG O
that IN O
STAT5 NNP B-Gene
and CC O
STAT1 NNP B-Gene
activation NN O
does VBZ O
not RB O
require VB O
receptor NN O
tyrosine JJ O
phosphorylation NN O
. . O

Because IN O
RNase NNP B-Gene
III NNP I-Gene
host NN I-Gene
mutants NNS I-Gene
are VBP O
defective JJ O
in IN O
sib JJ B-Gene
regulation NN O
, , O
processing NN O
of IN O
the DT O
PL NNP B-Gene
mRNA NN I-Gene
at IN O
sib NN B-Gene
by IN O
this DT O
endoribonuclease NN O
may MD O
cause VB O
int NN B-Gene
mRNA NN I-Gene
decay NN O
and CC O
decrease NN O
int NN B-Gene
synthesis NN O
. . O

The DT O
tumorigenic JJ O
E1A NNP B-Gene
+ NNP O
cHa SYM B-Gene
- : I-Gene
ras NN I-Gene
cells NNS O
are VBP O
characterized VBN O
by IN O
high JJ O
and CC O
constitutive JJ O
DNA NNP O
binding NN O
activities NNS O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
in IN O
contrast NN O
to TO O
nontransformed VB O
cells NNS O
and CC O
the DT O
E1A NNP B-Gene
cells NNS O
. . O

RESULTS NN O
: : O
For IN O
E1 NNP O
, , O
itraconazole JJ O
plasma JJ O
drug NN O
concentration NN O
extrapolated VBN O
to TO O
time NN O
zero NN O
( ( O
IV NNP O
dose RB O
) ) O
was VBD O
5 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
micrograms NNS O
/ JJ O
ml NN O
, , O
and CC O
mean VB O
residence NN O
time NN O
( ( O
MRT NNP O
) ) O
was VBD O
37 CD O
+ JJ O
/ NNP O
- : O
16 CD O
hours NNS O
. . O

HLA NNP B-Gene
- : I-Gene
A DT I-Gene
and CC I-Gene
B NNP I-Gene
phenotypes NNS O
of IN O
105 CD O
patients NNS O
suffering VBG O
from IN O
malignant JJ O
melanomas NNS O
were VBD O
determined VBN O
, , O
with IN O
special JJ O
regard NN O
for IN O
metastatic JJ O
form NN O
or CC O
relapse NN O
. . O

Although IN O
there EX O
was VBD O
a DT O
high JJ O
correlation NN O
between IN O
sap JJ O
flux NN O
densities NNS O
registered VBN O
by IN O
the DT O
old JJ O
and CC O
new JJ O
sensors NNS O
, , O
significant JJ O
differences NNS O
in IN O
sap JJ O
flux NN O
densities NNS O
between IN O
the DT O
duplicated JJ O
sensors NNS O
were VBD O
detected VBN O
. . O

CONCLUSIONS NN O
: : O
Although IN O
the DT O
levels NNS O
of IN O
oxLDL NN B-Gene
antibodies NNS I-Gene
might MD O
be VB O
modified VBN O
in IN O
early JJ O
hypertension NN O
, , O
once RB O
advanced JJ O
coronary JJ O
artery NN O
disease NN O
has VBZ O
developed VBN O
the DT O
presence NN O
of IN O
hypertension NN O
does VBZ O
not RB O
affect VB O
anti SYM B-Gene
- : I-Gene
oxLDL NN I-Gene
levels NNS O
. . O

Comparison NNP O
of IN O
the DT O
sequences NNS O
of IN O
the DT O
xFxFG NNP O
repeat NN O
regions NNS O
of IN O
p62 NN B-Gene
and CC O
Nsplp NNP B-Gene
indicated VBD O
that IN O
NTF2 NNP B-Gene
was VBD O
probably RB O
interacting VBG O
with IN O
the DT O
phenylalanine NN O
- : O
containing VBG O
core NN O
of IN O
these DT O
repeats NNS O
and CC O
not RB O
the DT O
intervening VBG O
hydrophilic JJ O
linkers NNS O
. . O

In IN O
addition NN O
, , O
SLK NNP B-Gene
displays VBZ O
high JJ O
homology NN O
to TO O
microtubule NN B-Gene
and CC I-Gene
nuclear JJ I-Gene
associated VBN I-Gene
protein NN I-Gene
( ( O
M NNP B-Gene
- : I-Gene
NAP NN I-Gene
) ) O
and CC O
AT1 NNP B-Gene
- : I-Gene
46 CD I-Gene
, , O
both DT O
of IN O
unknown JJ O
function NN O
. . O

Synergistic JJ O
transactivation NN O
of IN O
the DT O
BMRF1 NNP B-Gene
promoter NN I-Gene
by IN O
the DT O
Z NNP B-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
combination NN O
appears VBZ O
to TO O
involve VB O
direct JJ O
binding NN O
by IN O
the DT O
Z NNP B-Gene
protein NN I-Gene
but CC O
not RB O
the DT O
c NN B-Gene
- : I-Gene
myb NN I-Gene
protein NN I-Gene
. . O

Wild NNP B-Gene
type NN I-Gene
and CC I-Gene
mutant JJ I-Gene
Epo NNP I-Gene
cDNAs NN I-Gene
were VBD O
transiently RB O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
COS1 NNP O
and CC O
COS7 NNP O
cells NNS O
. . O

Evaluation NN O
of IN O
human JJ O
and CC O
bovine NN O
modified VBN O
- : O
hemoglobin JJ B-Gene
solution NN O
as IN O
oxygen NN O
- : O
carrying NN O
fluid NN O
for IN O
blood NN O
volume NN O
replacement NN O
. . O

Rather RB O
, , O
usp JJ B-Gene
is VBZ O
required VBN O
in IN O
late JJ O
third JJ O
instar NN O
larvae NN O
for IN O
appropriate JJ O
developmental NN O
and CC O
transcriptional JJ O
responses NNS O
to TO O
the DT O
ecdysone NN O
pulse NN O
that IN O
triggers VBZ O
puparium JJ O
formation NN O
. . O

The DT O
influenza NN O
virus NN O
NS1 NNP B-Gene
protein NN O
is VBZ O
a DT O
unique JJ O
posttranscriptional JJ O
regulator NN O
that WDT O
has VBZ O
two CD O
activities NNS O
: : O
inhibition NN O
of IN O
the DT O
nuclear JJ O
export NN O
of IN O
poly NN O
A NNP O
- : O
containing NN O
mRNAs NN O
and CC O
inhibition NN O
of IN O
pre JJ O
- : O
mRNA NN O
splicing NN O
. . O

This DT O
last JJ O
region NN O
contains NNS O
two CD O
sites NNS O
that IN O
bind NN O
Ets NNP B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
present JJ O
in IN O
liver JJ O
nuclear JJ O
extracts NNS O
as RB O
well RB O
as IN O
recombinant JJ B-Gene
purified VBD I-Gene
Ets NNP I-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
cynomolgus NN O
monkeys NNS O
are VBP O
either RB O
less RBR O
sensitive JJ O
or CC O
respond NN O
differently RB O
than IN O
rhesus NN O
monkeys NNS O
to TO O
some DT O
of IN O
the DT O
pharmacological JJ O
effects NNS O
of IN O
norcocaine NN O
. . O

Thus RB O
, , O
in IN O
stress JJ O
- : O
induced JJ O
arrhythmic JJ O
disease NN O
as RB O
well RB O
as IN O
in IN O
ischemic JJ O
heart NN O
disease NN O
, , O
the DT O
main JJ O
pathogenetic JJ O
links NNS O
are VBP O
outside IN O
the DT O
heart NN O
, , O
but CC O
they PRP O
differ VBP O
from IN O
those DT O
observed VBN O
in IN O
ischemia NN O
. . O

Thus RB O
, , O
a DT O
negative JJ O
test NN O
is VBZ O
compatible JJ O
with IN O
low JJ O
disease NN O
activity NN O
and CC O
/ NN O
or CC O
efficacy NN O
of IN O
calcium JJ O
antagonist NN O
treatment NN O
. . O

Thus RB O
, , O
a DT O
negative JJ O
test NN O
is VBZ O
compatible JJ O
with IN O
low JJ O
disease NN O
activity NN O
and CC O
/ NN O
or CC O
efficacy NN O
of IN O
calcium JJ O
antagonist NN O
treatment NN O
. . O

Right RB O
LHR NNP O
( ( O
R NNP O
- : O
LHR NNP O
) ) O
provided VBD O
the DT O
best JJS O
interobserver NN O
and CC O
intraobserver NN O
reproducibility NN O
. . O

One CD O
member NN O
of IN O
this DT O
multigene JJ O
family NN O
, , O
GATA NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
is VBZ O
most JJS O
abundantly RB O
expressed VBN O
in IN O
T NNP O
lymphocytes NNS O
, , O
a DT O
cellular JJ O
target NN O
for IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
infection NN O
and CC O
replication NN O
. . O

We PRP O
also RB O
discovered VBD O
a DT O
V NNP B-Gene
lambda NN I-Gene
pseudogene NN I-Gene
, , O
called VBN O
psi NN B-Gene
V NNP I-Gene
lambda VBZ I-Gene
1 CD I-Gene
, , O
3 CD O
kb NN O
upstream NN O
of IN O
the DT O
U266 NNP B-Gene
lambda NN I-Gene
gene NN I-Gene
. . O

The DT O
influence NN O
of IN O
p53 NN B-Gene
on IN O
cytokine NN O
- : O
triggered VBN O
Janus NNP B-Gene
kinase NNP I-Gene
- : O
STAT NNP B-Gene
signaling NN O
was VBD O
investigated VBN O
in IN O
human JJ O
hepatoma NN O
Hep3B NNP O
cell NN O
lines NNS O
engineered VBD O
to TO O
constitutively RB O
express VB O
the DT O
temperature NN O
- : O
sensitive JJ O
Val135 NNP B-Gene
mutant NN I-Gene
of IN I-Gene
p53 NN I-Gene
. . O

We PRP O
have VBP O
visualized VBN O
DNA NNP O
- : O
protein NN O
complexes NNS O
by IN O
electron NN O
microscopy NN O
and CC O
a DT O
high JJ O
- : O
affinity NN O
binding VBG O
site NN O
of IN O
WDV NNP B-Gene
Rep NNP I-Gene
protein NN I-Gene
within IN O
the DT O
core NN O
element NN O
has VBZ O
been VBN O
mapped VBN O
to TO O
approximately RB O
144 CD O
+ NNS O
/ SYM O
- : O
18 CD O
bp NN O
upstream NN O
from IN O
the DT O
initiation NN O
site NN O
, , O
between IN O
the DT O
start NN O
site NN O
for IN O
complementary JJ O
- : O
sense NN O
transcription NN O
and CC O
the DT O
TATA NNP O
box NN O
. . O

Additional JJ O
studies NNS O
revealed VBD O
that IN O
bovine NN B-Gene
brain NN I-Gene
Galpha NNP I-Gene
( ( I-Gene
q JJ I-Gene
/ NNP I-Gene
11 CD I-Gene
) ) I-Gene
could MD O
also RB O
bind VB O
to TO O
an DT O
N NNP O
- : O
terminal JJ O
construct NN O
of IN O
GRK2 NNP B-Gene
, , O
while IN O
no DT O
binding NN O
of IN O
Galpha NNP B-Gene
( ( I-Gene
q JJ I-Gene
/ NNP I-Gene
11 CD I-Gene
) ) I-Gene
, , O
Galpha NNP B-Gene
( ( I-Gene
s NN I-Gene
) ) I-Gene
, , O
Galpha NNP B-Gene
( ( I-Gene
i NN I-Gene
) ) I-Gene
, , O
or CC O
Galpha NNP B-Gene
( ( I-Gene
12 CD I-Gene
/ RB I-Gene
13 CD I-Gene
) ) I-Gene
to TO O
comparable JJ O
constructs NNS O
of IN O
GRK5 NNP B-Gene
or CC O
GRK6 NNP B-Gene
was VBD O
observed VBN O
. . O

RESULTS NN O
: : O
The DT O
standardised JJ O
mortality NN O
ratio NN O
( ( O
SMR NNP O
) ) O
for IN O
all DT O
malignant JJ O
neoplasms NNS O
was VBD O
94 CD O
( ( O
95 CD O
% NN O
CI NNP O
74 CD O
to TO O
118 CD O
) ) O
. . O

We PRP O
find VBP O
that IN O
our PRP$ O
response NN O
function NN O
is VBZ O
well RB O
approximated VBN O
by IN O
the DT O
GSER NNP O
only RB O
within IN O
a DT O
particular JJ O
frequency NN O
range NN O
determined VBN O
by IN O
the DT O
material NN O
parameters NNS O
of IN O
both DT O
the DT O
bead NN O
and CC O
the DT O
network NN O
. . O

Multiple JJ O
copies NNS O
of IN O
rsmB NN B-Gene
+ NNP I-Gene
DNA NNP I-Gene
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
stimulate NN O
exoenzyme NN O
production NN O
by IN O
relieving VBG O
the DT O
negative JJ O
effects NNS O
of IN O
a DT O
chromosomal JJ O
copy NN O
of IN O
hexA NN B-Gene
+ NN I-Gene
. . O

Reverse JJ O
transcription NN O
( ( O
RT NNP O
) ) O
- : O
PCR NN O
products NNS O
were VBD O
synthesized VBN O
with IN O
two CD O
degenerate NN O
primers NNS O
derived VBN O
from IN O
the DT O
conserved JJ O
motifs NNS O
of IN O
various JJ O
tyrosine JJ B-Gene
kinases NNS I-Gene
. . O

A DT O
catalytic JJ O
domain NN O
of IN O
eukaryotic JJ B-Gene
DNA NNP I-Gene
topoisomerase NN I-Gene
I PRP I-Gene
. . O

Thus RB O
, , O
VDR NNP B-Gene
acts VBZ O
selectively RB O
on IN O
the DT O
two CD O
components NNS O
required VBN O
for IN O
activation NN O
of IN O
this DT O
promoter NN O
/ JJ O
enhancer NN O
: : O
it PRP O
competes VBZ O
with IN O
NFAT1 NNP B-Gene
for IN O
binding VBG O
to TO O
the DT O
composite JJ O
site NN O
, , O
positioning VBG O
itself PRP O
adjacent JJ O
to TO O
Jun NNP B-Gene
- : O
Fos NN B-Gene
on IN O
the DT O
DNA NN O
. . O

Our PRP$ O
studies NNS O
extend VBP O
these DT O
findings NNS O
and CC O
show NN O
that IN O
the DT O
E2 NNP B-Gene
transactivation NN I-Gene
gene NN I-Gene
is VBZ O
expressed VBN O
from IN O
multiple JJ O
promoters NNS O
. . O

Mobility NNP O
and CC O
supershift NN O
assays NNS O
demonstrated VBD O
that IN O
upstream JJ B-Gene
stimulatory NN I-Gene
factor NN I-Gene
( ( O
USF NNP B-Gene
) ) O
and CC O
Sp1 NNP B-Gene
bind NN O
to TO O
the DT O
former JJ O
elements NNS O
and CC O
competition NN O
experiments NNS O
confirmed VBD O
that IN O
CREB NNP B-Gene
/ NNP O
ATF NNP B-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
bind NN O
to TO O
the DT O
CRE NNP O
/ NNP O
TRE NNP O
element NN O
. . O

Using VBG O
a DT O
novel JJ O
method NN O
combining VBG O
chromatin JJ O
immunoprecipitation NN O
and CC O
genomic JJ O
array NN O
hybridization NN O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
460 CD B-Gene
- : I-Gene
kb NN I-Gene
CENP NNP I-Gene
- : I-Gene
A DT I-Gene
- : I-Gene
binding NN I-Gene
DNA NNP I-Gene
domain NN I-Gene
of IN O
a DT O
neocentromere JJ O
derived VBN O
from IN O
the DT O
20p12 CD O
region NN O
of IN O
an DT O
invdup NN O
( ( O
20p CD O
) ) O
human NN O
marker NN O
chromosome NN O
. . O

It PRP O
contains VBZ O
binding VBG O
sites NNS O
for IN O
several JJ O
transcription NN O
factors NNS O
, , O
for IN O
example NN O
: : O
( ( O
i NN O
) ) O
a DT O
well RB O
- : O
characterized VBN O
binding NN O
site NN O
for IN O
rel NN B-Gene
/ NNP O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
transcription NN O
factors NNS O
in IN O
its PRP$ O
3 CD O
' '' O
- : O
end NN O
( ( O
the DT O
H2TF1 NNP B-Gene
or CC O
kappaB1 VB B-Gene
element NN I-Gene
) ) O
, , O
( ( O
ii NN O
) ) O
a DT O
second JJ O
kappaB NN B-Gene
site NN I-Gene
( ( O
the DT O
kappaB2 NN B-Gene
element NN I-Gene
) ) O
, , O
which WDT O
is VBZ O
located VBN O
immediately RB O
adjacent JJ O
5 CD O
' '' O
to TO O
the DT O
H2TF1 NNP B-Gene
element NN I-Gene
and CC O
which WDT O
is VBZ O
recognized VBN O
by IN O
p65 NN B-Gene
/ NN O
relA NN B-Gene
in IN O
the DT O
human JJ B-Gene
HLA NNP I-Gene
system NN O
, , O
and CC O
( ( O
iii NN O
) ) O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ O
ATF NNP B-Gene
recognition NN O
sequence NN O
in IN O
the DT O
5 CD O
' POS O
end NN O
( ( O
EnA NNP B-Gene
- : I-Gene
TRE NN I-Gene
) ) O
. . O

A DT O
rare JJ O
case NN O
of IN O
primary JJ O
group NN O
A NNP O
streptococcal JJ O
peritonitis NN O
. . O

Reagent JJ O
strips NNS O
are VBP O
frequently RB O
used VBN O
in IN O
the DT O
practice NN O
of IN O
laboratory JJ O
medicine NN O
as RB O
well RB O
as IN O
outside IN O
the DT O
professional JJ O
laboratories NNS O
. . O

A DT O
complete JJ O
drug NN O
history NN O
was VBD O
compiled VBN O
, , O
specifying VBG O
the DT O
amount NN O
and CC O
duration NN O
of IN O
VGB NNP O
medication NN O
. . O

Protein NNP B-Gene
S NNP I-Gene
levels NNS O
were VBD O
virtually RB O
undetectable JJ O
at IN O
the DT O
time NN O
of IN O
admission NN O
and CC O
failed VBD O
to TO O
respond VB O
to TO O
infusions NNS O
of IN O
fresh JJ O
frozen JJ O
plasma NN O
, , O
despite IN O
correction NN O
of IN O
other JJ O
procoagulant NN O
and CC O
anticoagulant JJ O
factors NNS O
. . O

The DT O
newly RB O
defined VBN O
region NN O
contains VBZ O
an DT O
intron NN O
that WDT O
may MD O
be VB O
alternatively RB O
spliced VBN O
and CC O
seven CD O
polyadenylation NN O
signal JJ O
sequences NNS O
. . O

These DT O
combined VBN O
observations NNS O
define VBP O
a DT O
promoter NN O
and CC O
an DT O
enhancer NN O
for IN O
the DT O
chicken NN B-Gene
L NNP I-Gene
- : I-Gene
CAM NNP I-Gene
gene NN I-Gene
. . O

We PRP O
have VBP O
also RB O
isolated VBN O
and CC O
analyzed VBD O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
pea NN O
33RNP CD B-Gene
gene NN I-Gene
. . O

GLUT5 NNP B-Gene
mRNA NN I-Gene
is VBZ O
expressed VBN O
at IN O
highest JJS O
levels NNS O
in IN O
small JJ O
intestine NN O
and CC O
at IN O
much JJ O
lower JJR O
levels NNS O
in IN O
kidney NN O
, , O
skeletal JJ O
muscle NN O
, , O
and CC O
adipose JJ O
tissue NN O
. . O

A DT O
novel JJ O
potential JJ O
effector NN O
of IN O
M NNP B-Gene
- : I-Gene
Ras NN I-Gene
and CC O
p21 NN B-Gene
Ras NNP I-Gene
negatively RB O
regulates VBZ O
p21 JJ B-Gene
Ras NNP I-Gene
- : O
mediated VBD O
gene NN O
induction NN O
and CC O
cell NN O
growth NN O
. . O

NH2 NNP O
- : O
and CC O
COOH NNP O
- : O
terminal JJ O
deletion NN O
analysis NN O
revealed VBD O
that IN O
both DT O
the DT O
PH NNP B-Gene
and CC O
putative JJ O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factor NN I-Gene
domains NNS I-Gene
are VBP O
required VBN O
, , O
but CC O
the DT O
zinc NN O
butterfly NN O
is VBZ O
dispensable JJ O
, , O
for IN O
transformation NN O
. . O

The DT O
FMN NNP O
moiety NN O
but CC O
not RB O
the DT O
[ NN O
3Fe CD O
- : O
4S CD O
] JJ O
cluster NN O
of IN O
the DT O
subunit NN O
appears VBZ O
to TO O
participate VB O
in IN O
this DT O
reaction NN O
. . O

We PRP O
propose VBP O
that IN O
the DT O
ambiguous JJ O
discrimination NN O
required VBD O
a DT O
greater JJR O
time NN O
for IN O
simulus JJ O
evaluation NN O
and CC O
that IN O
this DT O
was VBD O
reflected VBN O
in IN O
the DT O
delayed JJ O
P3 NNP O
latencies NNS O
. . O

We PRP O
have VBP O
isolated VBN O
a DT O
novel JJ O
human JJ B-Gene
cyclin NN I-Gene
, , O
cyclin NN B-Gene
E2 NNP I-Gene
, , O
that WDT O
contains VBZ O
significant JJ O
homology NN O
to TO O
cyclin VB B-Gene
E NNP I-Gene
. . O

Identification NN O
of IN O
a DT O
novel JJ O
E2F3 NNP B-Gene
product NN I-Gene
suggests VBZ O
a DT O
mechanism NN O
for IN O
determining VBG O
specificity NN O
of IN O
repression NN O
by IN O
Rb NNP B-Gene
proteins NNS I-Gene
. . O

The DT O
alpha NN B-Gene
4 CD I-Gene
gene NN I-Gene
5 CD O
' '' O
flanking VBG O
region NN O
acted VBD O
as IN O
a DT O
promoter NN O
in IN O
transfection NN O
assays NNS O
. . O

Mae NNP O
West NNP O
and CC O
the DT O
doctor NN O
shortage NN O
. . O

Ion NNP O
injection NN O
. . O

195mPt CD O
- : O
labeled VBD O
cisplatin NN O
was VBD O
administered VBN O
iv NN O
and CC O
ip NN O
to TO O
control VB O
mice NN O
and CC O
to TO O
mice VB O
bearing VBG O
Sarcoma NNP O
180 CD O
. . O

Gamma NNP B-Gene
glutamyl NN I-Gene
transpeptidase NN I-Gene
( ( O
GGTP NNP B-Gene
) ) O
activity NN O
in IN O
the DT O
seminal JJ O
fluid NN O

A DT O
cDNA NN O
encoding VBG O
the DT O
NF NNP B-Gene
- : I-Gene
4FB CD I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
has VBZ O
been VBN O
cloned VBN O
by IN O
screening VBG O
a DT O
lambda JJ O
gt11 NN O
cDNA NN O
library NN O
with IN O
a DT O
rabiolabelled JJ O
oligonucleotide NN O
corresponding VBG O
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
4FB CD I-Gene
recognition NN I-Gene
sequence NN I-Gene
. . O

Over IN O
- : O
expression NN O
of IN O
the DT O
cofactor NN O
p300 NN B-Gene
, , O
which WDT O
functions VBZ O
as IN O
a DT O
coactivator NN O
of IN O
myoD JJ B-Gene
- : O
mediated VBN O
transcription NN O
, , O
alleviated VBN O
repression NN O
by IN O
COUP NNP B-Gene
- : I-Gene
TF NNP I-Gene
II NNP I-Gene
. . O

II NNP O
. . O

The DT O
prevalence NN O
of IN O
CPAF NNP O
was VBD O
similar JJ O
in IN O
type NN O
1 CD O
and CC O
type $ O
2 CD O
diabetes NNS O
, , O
was VBD O
greater JJR O
in IN O
women NNS O
than IN O
in IN O
men NNS O
, , O
and CC O
was VBD O
significantly RB O
greater JJR O
after IN O
repeated VBN O
administrations NNS O
than IN O
after IN O
one CD O
single JJ O
administration NN O
of IN O
chlorpropamide NN O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
III NNP I-Gene
( ( O
NFIII NNP B-Gene
) ) O
is VBZ O
a DT O
protein NN O
from IN O
HeLa NNP O
cells NNS O
that WDT O
stimulates VBZ O
the DT O
initiation NN O
of IN O
adenovirus NN O
type NN O
2 CD O
( ( O
Ad2 NNP O
) ) O
DNA NNP O
replication NN O
by IN O
binding VBG O
to TO O
a DT O
specific JJ O
nucleotide JJ O
sequence NN O
in IN O
the DT O
origin NN O
, , O
adjacent JJ O
to TO O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
I PRP I-Gene
recognition VBP I-Gene
site NN I-Gene
. . O

The DT O
RMR NNP O
was VBD O
measured VBN O
twice RB O
in IN O
each DT O
phase NN O
and CC O
found VBD O
to TO O
be VB O
similar JJ O
( ( O
F NNP O
( ( O
1 CD O
, , O
18 CD O
) ) O
= NN O
0 CD O
. . O
863 CD O
) ) O
across IN O
the DT O
follicular NN O
( ( O
5018 CD O
kJ NN O
/ VBD O
24 CD O
h NN O
) ) O
and CC O
the DT O
luteal NN O
( ( O
5098 CD O
kJ NN O
/ VBD O
24 CD O
h NN O
) ) O
phases VBZ O
. . O

Through IN O
a DT O
stretch NN O
of IN O
56 CD O
amino NN O
acids NNS O
, , O
constituting VBG O
the DT O
MADS NNP B-Gene
domain NN I-Gene
, , O
the DT O
two CD O
proteins NNS O
are VBP O
identical JJ O
except IN O
for IN O
two CD O
conservative JJ O
amino NN O
acid JJ O
substitutions NNS O
. . O

Using VBG O
the DT O
sequence NN O
data NNS O
obtained VBN O
from IN O
the DT O
human JJ O
TCRAC NNP B-Gene
/ NNP O
TCRDC NNP B-Gene
region NN O
, , O
we PRP O
have VBP O
extended VBN O
a DT O
polymerase NN O
chain NN O
reaction NN O
- : O
based VBN O
assay NN O
to TO O
test VB O
for IN O
the DT O
expression NN O
of IN O
the DT O
individual JJ O
TCRAJ NNP B-Gene
gene NN I-Gene
segments NNS I-Gene
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that DT O
high JJ O
level NN O
human JJ B-Gene
desmin NN I-Gene
expression NN O
depends VBZ O
on IN O
a DT O
280 CD O
- : O
base NN O
pair NN O
muscle NN O
- : O
specific JJ O
enhancer NN O
which WDT O
can MD O
function VB O
not RB O
only RB O
in IN O
myotubes NNS O
, , O
but CC O
can MD O
also RB O
activate VB O
gene NN O
expression NN O
in IN O
myoblasts NNS O
. . O

Exchange NNP O
of IN O
the DT O
LPL NNP B-Gene
and CC O
HL NNP B-Gene
lids NNS O
resulted VBD O
in IN O
a DT O
reversal NN O
of IN O
the DT O
phospholipase NN B-Gene
/ NNP O
neutral JJ O
lipase NN B-Gene
ratio NN O
, , O
establishing VBG O
the DT O
important JJ O
role NN O
of IN O
this DT O
region NN O
in IN O
mediating VBG O
substrate JJ O
specificity NN O
. . O

Far NNP O
Western NNP O
blot NN O
analysis NN O
suggested VBD O
that IN O
the DT O
tandem NN O
SH2 NNP B-Gene
domains NNS I-Gene
of IN O
SHP2 NNP B-Gene
bind NN O
to TO O
Gab1 NNP B-Gene
in IN O
a DT O
specific JJ O
orientation NN O
, , O
in IN O
which WDT O
the DT O
N NNP B-Gene
- : I-Gene
SH2 NNP I-Gene
domain VB I-Gene
binds NNS O
to TO O
phosphotyrosine VB O
( ( O
Tyr NNP O
( ( O
P NNP O
) ) O
) ) O
- : O
627 CD O
and CC O
the DT O
C NNP B-Gene
- : I-Gene
SH2 NNP I-Gene
domain VB I-Gene
binds NNS O
to TO O
Tyr NNP O
( ( O
P NNP O
) ) O
- : O
659 CD O
. . O

Lastly RB O
, , O
there EX O
are VBP O
multiple JJ O
instances NNS O
in IN O
which WDT O
short JJ O
oligonucleotide NN O
direct JJ O
repeats NNS O
flank VBD O
a DT O
region NN O
absent NN O
from IN O
either CC O
variola NN O
or CC O
vaccinia NN O
virus NN O
. . O

However RB O
, , O
during IN O
our PRP$ O
work NN O
with IN O
a DT O
replication NN O
- : O
deficient NN O
virus NN O
expressing VBG O
the DT O
ASF NNP B-Gene
/ NNP O
SF2 NNP B-Gene
splicing VBG O
factor NN O
from IN O
a DT O
progesterone NN O
antagonist NN O
- : O
inducible JJ O
gene NN O
cassette NN O
, , O
we PRP O
discovered VBD O
that IN O
ASF NNP B-Gene
/ NNP O
SF2 NNP B-Gene
was VBD O
expressed VBN O
at IN O
a DT O
significant JJ O
level NN O
in IN O
the DT O
293 CD O
producer NN O
cell NN O
line NN O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
inducer NN O
. . O

Five CD O
patients NNS O
with IN O
type JJ O
III NNP O
musculoskeletal JJ O
infection NN O
from IN O
nongonococcal JJ O
Neisseria NNP O
species NNS O
were VBD O
examined VBN O
during IN O
a DT O
13 CD O
- : O
month NN O
period NN O
. . O

On IN O
transition NN O
from IN O
high JJ O
to TO O
low JJ O
voltage NN O
there EX O
was VBD O
a DT O
significant JJ O
fall NN O
in IN O
arterial JJ O
pressure NN O
( ( O
7 CD O
% NN O
) ) O
and CC O
an DT O
increase NN O
in IN O
flow NN O
( ( O
19 CD O
- : O
38 CD O
% NN O
) ) O
to TO O
areas NNS O
of IN O
the DT O
brain NN O
corresponding NN O
to TO O
the DT O
arborization NN O
of IN O
the DT O
reticular JJ O
formation NN O
, , O
i NN O
. . O
e NN O
. . O
excluding VBG O
the DT O
cerebrum NN O
and CC O
cerebellum NN O
. . O

We PRP O
also RB O
report VBP O
here RB O
the DT O
complete JJ O
structural JJ O
organization NN O
of IN O
the DT O
goat NN B-Gene
alpha NN I-Gene
s1 SYM I-Gene
- : I-Gene
casein NN I-Gene
transcription NN I-Gene
unit NN I-Gene
, , O
deduced VBN O
from IN O
polymerase NN O
chain NN O
reaction NN O
experiments NNS O
. . O

Gonadotropin NNP B-Gene
levels NNS O
in IN O
mothers NNS O
who WP O
have VBP O
had VBN O
two CD O
sets NNS O
of IN O
DZ NNP O
twins NNS O
. . O

No DT O
TATA NNP O
box NN O
was VBD O
found VBN O
in IN O
the DT O
putative JJ O
promoter NN O
region NN O
, , O
but CC O
multiple JJ O
GC NNP O
boxes NNS O
were VBD O
found VBN O
around IN O
the DT O
cap NN O
sites VBZ O
, , O
supporting VBG O
the DT O
previously RB O
inferred VBN O
housekeeping JJ O
nature NN O
of IN O
CYP51 NNP B-Gene
gene NN I-Gene
and CC O
the DT O
existence NN O
of IN O
the DT O
multiple JJ O
transcription NN O
initiation NN O
sites NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
stereotypy NN O
can MD O
be VB O
evoked VBN O
also RB O
in IN O
the DT O
case NN O
when WRB O
the DT O
striatal JJ O
dopaminergic NN O
tone NN O
is VBZ O
normal JJ O
or CC O
even RB O
below IN O
normal JJ O
: : O
it PRP O
is VBZ O
the DT O
equilibrium NN O
of IN O
the DT O
striatal JJ O
cholinergic NN O
- : O
dopaminergic NN O
systems NNS O
which WDT O
must MD O
be VB O
shifted VBN O
towards NNS O
dopamine NN O
, , O
which WDT O
is VBZ O
necessary JJ O
for IN O
the DT O
development NN O
of IN O
this DT O
behavioral JJ O
manifestation NN O
. . O

The DT O
relationship NN O
of IN O
the DT O
factor NN B-Gene
V NNP I-Gene
Leiden NNP I-Gene
mutation NN I-Gene
or CC O
the DT O
deletion NN O
- : O
deletion NN O
polymorphism NN O
of IN O
the DT O
angiotensin NN B-Gene
converting VBG I-Gene
enzyme NN I-Gene
to TO O
postoperative VB O
thromboembolic JJ O
events NNS O
following VBG O
total JJ O
joint JJ O
arthroplasty NN O
. . O

Spontaneous JJ O
burst NN O
firing NN O
in IN O
cat NN O
primary JJ O
auditory JJ O
cortex NN O
: : O
age NN O
and CC O
depth NN O
dependence NN O
and CC O
its PRP$ O
effect NN O
on IN O
neural JJ O
interaction NN O
measures NNS O
. . O

Studies NNS O
on IN O
the DT O
hereditary JJ O
nature NN O
of IN O
sole JJ O
prints NNS O
- : O
- : O
with IN O
special JJ O
reference NN O
to TO O
interdigital JJ O
and CC O
triradii NN O

Thyroid JJ O
function NN O
tests NNS O
were VBD O
performed VBN O
on IN O
300 CD O
admissions NNS O
, , O
leaving VBG O
707 CD O
untested JJ O
. . O

Maize NNP B-Gene
rbcS JJ I-Gene
promoter NN I-Gene
activity NN O
depends VBZ O
on IN O
sequence NN O
elements NNS O
not RB O
found VBN O
in IN O
dicot JJ B-Gene
rbcS NN I-Gene
promoters NNS I-Gene
. . O

Cyclin NNP B-Gene
D1 NNP I-Gene
- : I-Gene
associated JJ I-Gene
kinase NN I-Gene
activity NN O
and CC O
protein NN O
levels NNS O
were VBD O
increased VBN O
in IN O
mammary JJ O
tumors NNS O
from IN O
murine JJ O
mammary JJ O
tumor NN O
virus NN O
- : O
pp60 NN B-Gene
( ( O
c SYM B-Gene
- : I-Gene
src527F NN I-Gene
) ) O
transgenic JJ O
mice NN O
. . O

CONCLUSIONS NN O
: : O
The DT O
myocardial JJ O
uptake NN O
of IN O
99mTc CD O
sestamibi NNS O
in IN O
normal JJ O
subjects NNS O
and CC O
patients NNS O
with IN O
coronary JJ O
artery NN O
disease NN O
is VBZ O
comparable JJ O
after IN O
exercise NN O
, , O
dipyridamole NN O
, , O
and CC O
adenosine JJ O
stress NN O
. . O

Our PRP$ O
mapping NN O
results NNS O
did VBD O
not RB O
suggest VB O
involvement NN O
of IN O
this DT O
gene NN O
in IN O
previously RB O
mapped VBN O
genetic JJ O
disorders NNS O
or CC O
in IN O
known VBN O
neoplasia JJ O
- : O
associated VBN O
translocation NN O
breakpoints NNS O
. . O

We PRP O
examined VBD O
the DT O
hypothesis NN O
that IN O
the DT O
coronary JJ O
vasomotor NN O
responses NNS O
to TO O
etomidate VB O
( ( O
ETO NNP O
) ) O
, , O
propofol FW O
( ( O
PRO NNP O
) ) O
, , O
and CC O
sodium NN O
thiopental NN O
( ( O
STP NNP O
) ) O
are VBP O
mediated VBN O
through IN O
contrasting VBG O
effects NNS O
on IN O
the DT O
resting VBG O
nitric JJ O
oxide NN O
( ( O
NO NNP O
) ) O
- : O
dependent JJ O
vasodilator NN O
tone NN O
that WDT O
opposes VBZ O
adrenergic JJ O
vasoconstrictor NN O
activity NN O
in IN O
the DT O
intact JJ O
dog NN O
. . O

In IN O
gel JJ O
mobility NN O
shift NN O
assays NNS O
, , O
low JJ O
binding NN O
activity NN O
of IN O
CBF NNP B-Gene
to TO O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
AtpC NNP I-Gene
promoter NN I-Gene
sequence NN I-Gene
was VBD O
observed VBN O
with IN O
nuclear JJ O
extracts NNS O
from IN O
tissue NN O
with IN O
low JJ O
AtpC NNP B-Gene
expression NN O
levels NNS O
, , O
i NN O
. . O
e NN O
. . O
extracts NNS O
from IN O
etiolated VBN O
and CC O
photobleached VBN O
seedlings NNS O
, , O
whereas RB O
high JJ O
binding NN O
activity NN O
was VBD O
detectable JJ O
with IN O
extracts NNS O
from IN O
tissues NNS O
with IN O
high JJ O
AtpC NNP B-Gene
expression NN O
levels NNS O
, , O
i NN O
. . O
e NN O
. . O
extracts NNS O
from IN O
light JJ O
- : O
grown JJ O
seedlings NNS O
and CC O
etiolated JJ O
seedlings NNS O
treated VBN O
with IN O
cytokinin NN B-Gene
. . O

Deletion NNP O
mapping NN O
experiments NNS O
determined VBD O
that IN O
the DT O
sequences NNS O
required VBN O
for IN O
full JJ O
activity NN O
in IN O
MSC NNP O
- : O
1 CD O
cells NNS O
were VBD O
included VBN O
within IN O
619 CD O
bp NN O
of IN O
the DT O
start NN O
site NN O
and CC O
identified VBD O
several JJ O
regions NNS O
that WDT O
demonstrated VBD O
increased JJ O
luciferase NN B-Gene
activity NN O
: : O
the DT O
- : O
583 CD O
bp NN O
to TO O
- : O
564 CD O
bp NN O
, , O
- : O
503 CD O
bp NN O
to TO O
- : O
484 CD O
bp NN O
, , O
and CC O
- : O
114 CD O
bp NN O
to TO O
- : O
65 CD O
regions NNS O
. . O

Before IN O
turnout NN O
, , O
a DT O
morantel NN O
sustained VBN O
release NN O
bolus NN O
( ( O
MSRB NNP O
) ) O
was VBD O
administered VBN O
to TO O
each DT O
animal NN O
in IN O
the DT O
"""" NN O
treated VBD O
"""" JJ O
category NN O
. . O

Ceftazidime NN O
shows NNS O
promise VBP O
as IN O
single JJ O
- : O
agent NN O
therapy NN O
for IN O
serious JJ O
gram NN O
- : O
negative JJ O
bacillary JJ O
infections NNS O
. . O

Liu NNP O
, , O
B NNP O
. . O

To TO O
clarify VB O
whether IN O
seizure NN O
- : O
offset NN O
patterns NNS O
are VBP O
reliable JJ O
in IN O
predicting VBG O
seizure NN O
outcome NN O
, , O
we PRP O
studied VBD O
SEEG NNP O
/ NNP O
ECoG NNP O
in IN O
a DT O
similar JJ O
group NN O
of IN O
patients NNS O
with IN O
temporal JJ O
lobe NN O
epilepsy NN O
( ( O
TLE NNP O
) ) O
. . O

Mutation NN O
of IN O
nucleotides NNS O
adjacent JJ O
to TO O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
cis SYM I-Gene
- : I-Gene
response NN I-Gene
elements NNS I-Gene
had VBD O
no DT O
effect NN O
on IN O
trans NNS O
- : O
activation NN O
. . O

All DT O
lambs VBZ O
with IN O
B NNP O
breeding NN O
had VBD O
significantly RB O
higher JJR O
Hb NNP B-Gene
levels NNS O
at IN O
the DT O
end NN O
of IN O
the DT O
experiment NN O
than IN O
did VBD O
NB NNP O
lambs NN O
. . O

b NN O
and CC O
S NNP O
x NNP O
B NNP O
lambs NN O
had VBD O
higher JJR O
( ( O
P NNP O
< NNP O
. . O
5 CD O
) ) O
Hb NN B-Gene
levels NNS O
than IN O
the DT O
D NNP O
x NNP O
B NNP O
lambs NN O
, , O
and CC O
B NNP O
lambs NN O
had VBD O
the DT O
highest JJS O
( ( O
P NNP O
< NNP O
. . O
5 CD O
) ) O
mean NN O
corpuscular JJ O
hemoglobin NN B-Gene
concentrations NNS O
. . O

Additionally RB O
, , O
observations NNS O
that IN O
patients NNS O
with IN O
mitral JJ O
versus NN O
aortic JJ O
regurgitation NN O
respond NN O
differently RB O
to TO O
valve VB O
replacement NN O
suggest JJS O
that IN O
differences NNS O
exist VBP O
preoperatively RB O
between IN O
these DT O
two CD O
types NNS O
of IN O
volume NN O
overload NN O
. . O

All DT O
injections NNS O
of IN O
CSF NNP B-Gene
were VBD O
given VBN O
after IN O
the DT O
initiation NN O
of IN O
neutropenia NN O
and CC O
continued VBN O
until IN O
the DT O
occurrence NN O
of IN O
an DT O
absolute NN O
neutrophil JJ O
recovery NN O
. . O

rHu NN B-Gene
GM NNP I-Gene
- : I-Gene
CSF NN I-Gene
and CC O
rHu NN B-Gene
G NNP I-Gene
- : I-Gene
CSF NNP I-Gene
, , O
administered VBD O
once RB O
daily JJ O
at IN O
the DT O
250 CD O
microg NN O
m NN O
( ( O
- : O
2 CD O
) ) O
day NN O
( ( O
- : O
1 CD O
) ) O
and CC O
5 CD O
microg NN O
kg NN O
( ( O
- : O
1 CD O
) ) O
day NN O
( ( O
- : O
1 CD O
) ) O
level NN O
, , O
were VBD O
effective JJ O
in IN O
increasing VBG O
the DT O
absolute NN O
neutrophil NN O
count NN O
and CC O
neutrophil JJ O
function NN O
, , O
as IN O
measured VBN O
by IN O
an DT O
automated VBN O
chemiluminescence NN O
system NN O
. . O

Gains NNS O
increased VBD O
3 CD O
. . O
5 CD O
% NN O
( ( O
P NNP O
less JJR O
than IN O
. . O
10 CD O
) ) O
and CC O
feed JJ O
conversion NN O
improved VBD O
5 CD O
. . O
9 CD O
% NN O
( ( O
P NNP O
less JJR O
than IN O
. . O
7 CD O
) ) O
in IN O
steers NNS O
fed VBP O
. . O
28 CD O
% NN O
AS IN O
- : O
VFA NN O
compared VBN O
with IN O
gain NN O
and CC O
feed JJ O
conversion NN O
of IN O
the DT O
control NN O
steers NNS O
. . O

By IN O
contrast NN O
, , O
mTRAP100 NN B-Gene
coprecipitates NNS O
in IN O
vivo NN O
with IN O
another DT O
component NN O
of IN O
the DT O
TRAP NNP B-Gene
complex NN I-Gene
( ( O
TRAP220 NNP B-Gene
) ) O
, , O
which WDT O
directly RB O
contacts VBZ O
TR NNP B-Gene
and CC O
the DT O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
in IN O
a DT O
ligand NN O
- : O
dependent JJ O
manner NN O
. . O

This DT O
test NN O
should MD O
provide VB O
another DT O
practical JJ O
means VBZ O
to TO O
study VB O
leprosy JJ O
. . O

In IN O
12 CD O
cases NNS O
( ( O
3 CD O
. . O
1 CD O
% NN O
) ) O
, , O
a DT O
change NN O
in IN O
stage NN O
resulted VBD O
. . O

In IN O
the DT O
context NN O
of IN O
the DT O
ADH2 NNP B-Gene
upstream JJ I-Gene
regulatory JJ I-Gene
region NN I-Gene
, , O
including VBG O
UAS1 NNP O
, , O
working VBG O
in IN O
concert NN O
with IN O
the DT O
ADH2 NNP B-Gene
basal NN I-Gene
promoter NN I-Gene
elements NNS I-Gene
, , O
UAS2 NNP O
- : O
dependent JJ O
gene NN O
activation NN O
was VBD O
dependent JJ O
on IN O
orientation NN O
, , O
copy NN O
number NN O
, , O
and CC O
helix NN O
phase NN O
. . O

The DT O
ability NN O
of IN O
chronic JJ O
UM NNP O
- : O
272 CD O
( ( O
dimethylpropranolol NN O
) ) O
treatment NN O
to TO O
prevent VB O
the DT O
induction NN O
of IN O
reentrant JJ O
ventricular JJ O
tachyarrhythmias NN O
was VBD O
assessed VBN O
in IN O
the DT O
conscious JJ O
dog NN O
subjected VBD O
to TO O
serial JJ O
programmed JJ O
electrical JJ O
stimulation NN O
on IN O
days NNS O
3 CD O
- : O
- : O
5 CD O
after IN O
myocardial JJ O
infarction NN O
. . O

Therefore RB O
, , O
in IN O
our PRP$ O
in IN O
vitro NN O
model NN O
, , O
the DT O
localization NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
K NNP B-Gene
- : I-Gene
ras NNS I-Gene
gene NN I-Gene
predisposes NNS O
to TO O
a DT O
different JJ O
level NN O
of IN O
aggressiveness NN O
in IN O
the DT O
transforming NN O
phenotype NN O
. . O

Patients NNS O
underwent JJ O
pretreatment JJ O
cystoscopy NN O
and CC O
detailed JJ O
tumor NN O
mapping NN O
, , O
and CC O
were VBD O
treated VBN O
with IN O
75 CD O
mg NNS O
. . O

/ JJ O
m NN O
. . O
2 CD O
cisplatin NN O
on IN O
day NN O
1 CD O
and CC O
1 CD O
gm NN O
. . O
/ JJ O
m NN O
. . O
2 CD O
daily JJ O
, , O
5 CD O
- : O
fluorouracil NN O
on IN O
days NNS O
1 CD O
to TO O
4 CD O
and CC O
definitive JJ O
radiotherapy NN O
. . O

The DT O
results NNS O
of IN O
these DT O
studies NNS O
support VBP O
a DT O
model NN O
in IN O
which WDT O
VirB4 NNP B-Gene
dimers NNS I-Gene
or CC O
homomultimers NNS O
contribute VBP O
structural JJ O
information NN O
for IN O
the DT O
assembly NN O
of IN O
a DT O
transenvelope NN O
channel NN O
competent NN O
for IN O
bidirectional JJ O
DNA NNP O
transfer NN O
, , O
whereas IN O
an DT O
ATP NNP O
- : O
dependent NN O
activity NN O
is VBZ O
required VBN O
for IN O
configuring VBG O
this DT O
channel NN O
as IN O
a DT O
dedicated JJ O
export NN O
machine NN O
. . O

Regulation NN O
of IN O
the DT O
Raf NNP B-Gene
kinase NN I-Gene
in IN O
T NNP O
cells NNS O
differs NNS O
from IN O
findings NNS O
with IN O
a DT O
variety NN O
of IN O
cell NN O
lines NNS O
that IN O
the DT O
catalytic JJ B-Gene
domain NN I-Gene
of IN I-Gene
Raf NNP I-Gene
( ( O
Raf NNP B-Gene
( ( O
delta26 SYM O
- : O
303 CD O
) ) O
) ) O
shows VBZ O
no DT O
activity NN O
. . O

These DT O
results NNS O
demonstrate VBP O
a DT O
specific JJ O
association NN O
of IN O
SIV NNP O
and CC O
HIV NNP B-Gene
- : I-Gene
2 CD I-Gene
nef NN I-Gene
, , O
but CC O
not RB O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
nef NNS I-Gene
, , O
with IN O
TCRzeta NNP B-Gene
. . O

Randomly RB O
selected VBN O
300 CD O
children NNS O
aged VBD O
3 CD O
months NNS O
- : O
3 CD O
yr NNS O
were VBD O
analysed VBN O
over IN O
a DT O
period NN O
of IN O
one CD O
year NN O
for IN O
estimating VBG O
prevalence NN O
of IN O
nutritional JJ O
anaemia NN O
. . O

Comparison NNP O
with IN O
alkaline JJ B-Gene
phosphatases NNS I-Gene
and CC O
5 CD B-Gene
- : I-Gene
nucleotidase NN I-Gene

Their PRP$ O
numbers NNS O
have VBP O
regularly RB O
increased VBN O
since IN O
the DT O
mid NN O
- : O
1970s CD O
. . O

We PRP O
show VBP O
here RB O
that IN O
RA NNP O
and CC O
E1A NNP B-Gene
induce VBP O
phosphorylation NN O
of IN O
the DT O
E1A NNP B-Gene
- : I-Gene
associated VBD I-Gene
300 CD I-Gene
kDa NN I-Gene
protein NN I-Gene
( ( O
p300 NN B-Gene
) ) O
during IN O
the DT O
differentiation NN O
of IN O
F9 NNP O
cells NNS O
. . O

Mammalian JJ B-Gene
ABPs NNP I-Gene
and CC O
SHBGs NNP B-Gene
bind VBP O
sex NN O
steroids NNS O
with IN O
high JJ O
affinity NN O
, , O
but CC O
some DT O
binding NN O
properties NNS O
differ VBP O
among IN O
species NNS O
. . O

Subunit NNP O
composition NN O
and CC O
domain NN O
structure NN O
of IN O
the DT O
Spo0A NNP B-Gene
sporulation NN I-Gene
transcription NN I-Gene
factor NN I-Gene
of IN I-Gene
Bacillus NN I-Gene
subtilis NNS I-Gene
. . O

A DT O
method NN O
of IN O
three CD O
- : O
station NN O
three CD O
- : O
dimensional JJ O
magnetic JJ O
resonance NN O
( ( O
MR NNP O
) ) O
angiography NN O
of IN O
the DT O
lower JJR O
extremities NNS O
with IN O
segmented JJ O
volume NN O
acquisition NN O
is VBZ O
presented VBN O
. . O

The DT O
value NN O
of IN O
different JJ O
sources NNS O
of IN O
nitrogen NN O
in IN O
diets NNS O
for IN O
the DT O
early JJ O
- : O
weaned VBN O
calf NN O
. . O

Vesicles NNS O
could MD O
be VB O
induced VBN O
only RB O
with IN O
multiple JJ O
exposures NNS O
to TO O
UVA NNP O
. . O

The DT O
pet56 NN B-Gene
and CC O
his3 NN B-Gene
genes NNS I-Gene
are VBP O
transcribed VBN O
divergently RB O
from IN O
initiation NN O
sites NNS O
that WDT O
are VBP O
separated VBN O
by IN O
only RB O
192 CD O
bp NN O
. . O

Neural NNP O
- : O
specific JJ O
expression NN O
, , O
genomic JJ O
structure NN O
, , O
and CC O
chromosomal JJ O
localization NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
zinc NN B-Gene
- : I-Gene
finger NN I-Gene
transcription NN I-Gene
factor NN I-Gene
NGFI NNP I-Gene
- : I-Gene
C NNP I-Gene
. . O

Modern JJ O
cancer NN O
therapy NN O
has VBZ O
included VBN O
surgery NN O
, , O
radiotherapy NN O
, , O
chemotherapy NN O
, , O
and CC O
most JJS O
recently RB O
, , O
immunotherapy NN O
and CC O
hyperthermia NN O
. . O

In IN O
several JJ O
cell NN O
lines NNS O
, , O
mTOR NN B-Gene
or CC O
its PRP$ O
downstream JJ O
targets NNS O
can MD O
be VB O
regulated VBN O
by IN O
phosphatidylinositol NN B-Gene
( ( I-Gene
PI NNP I-Gene
) ) I-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
; : O
protein CC B-Gene
kinases VBZ I-Gene
A NNP I-Gene
, , I-Gene
B NNP I-Gene
, , I-Gene
and CC I-Gene
C NNP I-Gene
; : O
heterotrimeric JJ B-Gene
G NNP I-Gene
- : I-Gene
proteins NNS I-Gene
; : O
a DT O
PD98059 NNP O
- : O
sensitive JJ O
kinase NN O
or CC O
calcium NN O
; : O
as RB O
well RB O
as IN O
by IN O
amino NN O
acids NNS O
. . O

Pharmacodynamic NNP O
studies NNS O
on IN O
the DT O
cardiovascular JJ O
system NN O
of IN O
spontaneously RB O
hypertensive JJ O
rats NNS O
. . O

As IN O
pleural JJ O
thickening NN O
is VBZ O
seen VBN O
commonly RB O
in IN O
asbestosis NN O
and CC O
may MD O
influence VB O
lung NN O
volumes NNS O
and CC O
the DT O
ratio NN O
of IN O
transfer NN B-Gene
factor NN I-Gene
to TO O
effective JJ O
alveolar JJ O
volume NN O
, , O
the DT O
results NNS O
of IN O
these DT O
measurements NNS O
were VBD O
compared VBN O
only RB O
in IN O
the DT O
cases NNS O
showing VBG O
absent NN O
or CC O
minimal JJ O
pleural JJ O
thickening NN O
. . O

To TO O
determine VB O
the DT O
relationship NN O
of IN O
these DT O
viruses NNS O
, , O
the DT O
complete JJ O
DNA NNP O
sequence NN O
of IN O
KV NNP O
consisting VBG O
of IN O
4754 CD O
bp NN O
was VBD O
determined VBN O
. . O

The DT O
data NN O
support NN O
the DT O
notion NN O
that IN O
suppression NN O
of IN O
images NNS O
during IN O
binocular JJ O
rivalry NN O
is VBZ O
independent JJ O
in IN O
both DT O
eyes NNS O
. . O

METHODS NN O
: : O
Total JJ O
muscle NN O
paralysis NN O
was VBD O
induced VBN O
under IN O
general JJ O
anesthesia NN O
in IN O
a DT O
group NN O
of IN O
obese JJ O
persons NNS O
( ( O
n JJ O
= VBZ O
9 CD O
; : O
body NN O
mass NN O
index NN O
, , O
32 CD O
+ NN O
/ NNP O
- : O
3 CD O
kg NN O
[ NNP O
- : O
2 CD O
] NN O
) ) O
and CC O
in IN O
a DT O
group NN O
of IN O
nonobese JJ O
persons NNS O
( ( O
n JJ O
= VBZ O
9 CD O
; : O
body NN O
mas FW O
index NN O
, , O
21 CD O
+ NN O
/ NNP O
- : O
2 CD O
kg NN O
[ NNP O
- : O
2 CD O
] NN O
) ) O
. . O

L NNP O
- : O
735 CD O
, , O
524 CD O
free JJ O
base NN O
or CC O
sulfate NN O
salt NN O
was VBD O
administered VBN O
orally RB O
as IN O
suspension NN O
, , O
solution NN O
or CC O
in IN O
solid JJ O
dosage NN O
forms NNS O
to TO O
fasted VB O
or CC O
fed VB O
Beagle NNP O
dogs NNS O
. . O

The DT O
concentration NN O
of IN O
PGI2 NNP O
on IN O
the DT O
newly RB O
- : O
formed VBN O
luminal JJ O
surface NN O
remained VBD O
low JJ O
. . O

This DT O
GAP NNP B-Gene
activity NN O
was VBD O
observed VBN O
in IN O
3T3 CD O
- : O
L1 NNP O
adipocyte NN O
lysates NNS O
, , O
and CC O
was VBD O
able JJ O
to TO O
accelerate VB O
the DT O
hydrolysis NN O
of IN O
the DT O
[ NNP O
alpha SYM O
- : O
32P CD O
] JJ O
GTP NNP O
bound NN O
to TO O
GST NNP B-Gene
- : O
Rab4 NNP B-Gene
into IN O
[ NNP O
alpha SYM O
- : O
32P CD O
] JJ O
GDP NNP O
. . O

The DT O
recommendation NN O
is VBZ O
made VBN O
that IN O
specific JJ O
sub SYM O
- : O
groups NNS O
of IN O
attempters NNS O
need VBP O
to TO O
be VB O
identified VBN O
and CC O
may MD O
warrant VB O
specialized JJ O
intervention NN O
strategies NNS O
. . O

Protamine NNP B-Gene
and CC O
heparin NN O
doses NNS O
, , O
their PRP$ O
sum NN O
( ( O
Sigma NNP O
- : O
dose NN O
) ) O
and CC O
differential JJ O
( ( O
Delta NNP O
- : O
dose NN O
) ) O
doses VBZ O
, , O
and CC O
activated VBD O
clotting VBG O
times NNS O
were VBD O
tabulated VBN O
. . O

The DT O
Oct NNP B-Gene
- : I-Gene
3 CD I-Gene
/ $ I-Gene
4 CD I-Gene
gene NN I-Gene
product NN I-Gene
, , O
which WDT O
belongs VBZ O
to TO O
the DT O
POU NNP B-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
is VBZ O
a DT O
good JJ O
candidate NN O
for IN O
regulating VBG O
initial JJ O
differentiation NN O
decisions NNS O
. . O

Mutation NN O
analyses NNS O
identified VBD O
the DT O
cobalt NN O
- : O
responsive JJ O
sequences NNS O
as IN O
the DT O
stress NN O
- : O
response NN O
elements NNS O
( ( O
StREs NNP O
) ) O
. . O

An DT O
extensive JJ O
inverted JJ O
repeat NN O
is VBZ O
present JJ O
3 CD O
' '' O
of IN O
rpeA NN B-Gene
; : O
inverted VBN O
repeats NNS O
are VBP O
found VBN O
downstream NN O
of IN O
all DT O
PE NNP B-Gene
operons NNS I-Gene
sequenced VBD O
to TO O
date NN O
, , O
although IN O
the DT O
sequence NN O
is VBZ O
not RB O
conserved VBN O
. . O

To TO O
define VB O
the DT O
mechanism NN O
responsible JJ O
for IN O
the DT O
loss NN O
of IN O
transcription NN O
elongation NN O
blockage NN O
and CC O
resulting VBG O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
deregulation NN O
in IN O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
, , O
we PRP O
analyzed VBD O
transcription NN O
patterns NNS O
after IN O
transfer NN O
of IN O
normal JJ O
and CC O
Burkitt NNP O
' POS O
s NN O
lymphoma NN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
alleles VBZ O
into IN O
murine NN O
cells NNS O
and CC O
Xenopus NNP O
oocyte VBP O
germinal JJ O
vesicles NNS O
. . O

Bilateral NNP O
Charnley NNP O
arthroplasty NN O
as IN O
a DT O
single JJ O
procedure NN O
. . O

The DT O
first JJ O
exon NN O
( ( O
exon JJ O
1A CD O
) ) O
that WDT O
corresponded VBD O
to TO O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
of IN O
the DT O
GHR NNP B-Gene
1A CD I-Gene
mRNA NN I-Gene
was VBD O
15 CD O
, , O
250 CD O
bp NN O
upstream NN O
from IN O
exon JJ O
2 CD O
in IN O
the DT O
GHR NNP B-Gene
gene NN I-Gene
. . O

A DT O
case NN O
of IN O
chronic JJ O
hepatitis NN O
C NNP O
with IN O
primary JJ O
hypothyroidism NN O
manifested VBD O
during IN O
interferon NN B-Gene
treatment NN O

The DT O
promoter NN O
activity NN O
of IN O
the DT O
gene NN B-Gene
encoding VBG I-Gene
Alzheimer NNP I-Gene
beta NN I-Gene
- : I-Gene
amyloid NN I-Gene
precursor NN I-Gene
protein NN I-Gene
( ( O
APP NNP B-Gene
) ) O
is VBZ O
regulated VBN O
by IN O
two CD O
blocks NNS O
of IN O
upstream JJ O
sequences NNS O
. . O

Frequency NN O
of IN O
seeing VBG O
curves NNS O
were VBD O
examined VBN O
for IN O
the DT O
method NN O
most RBS O
similar JJ O
to TO O
FDT NNP O
. . O

SPP NNP B-Gene
also RB O
induced VBD O
transient JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
focal JJ B-Gene
adhesion NN I-Gene
kinase NN I-Gene
( ( O
p125 NN B-Gene
( ( O
FAK NNP B-Gene
) ) O
) ) O
, , O
a DT O
cytosolic JJ B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
that WDT O
localizes VBZ O
in IN O
focal JJ O
adhesions NNS O
, , O
and CC O
of IN O
the DT O
cytoskeleton NN B-Gene
- : I-Gene
associated VBN I-Gene
protein JJ I-Gene
paxillin NN I-Gene
. . O

Therefore RB O
, , O
with IN O
a DT O
biopsy NN O
from IN O
the DT O
stoma NN O
site NN O
there EX O
is VBZ O
a DT O
risk NN O
of IN O
missing VBG O
early JJ O
rejection NN O
. . O

Variables NNS O
evaluated VBN O
were VBD O
number NN O
of IN O
weekly JJ O
anginal JJ O
events NNS O
, , O
data NNS O
from IN O
ergometric JJ O
exercise NN O
testing VBG O
with IN O
simultaneous JJ O
electrocardiographic JJ O
registration NN O
, , O
semiquantitative JJ O
evaluation NN O
of IN O
Tc NNP O
- : O
99m CD O
2 CD O
- : O
methoxy NN O
isobutyl NN O
isonitrile NN O
( ( O
MIBI NNP O
) ) O
scans NNS O
and CC O
rheologic JJ O
variables NNS O
. . O

L NNP O
/ NNP O
H NNP O
> NNP O
0 NNP O
. . O
61 CD O
( ( O
chi NN O
( ( O
2 CD O
) ) O
= NN O
10 CD O
. . O
8 CD O
; : O
P NNP O
: : O
< NN O
0 CD O
. . O
1 CD O
) ) O
and CC O
a DT O
restrictive JJ O
filling NN O
pattern NN O
( ( O
chi NN O
( ( O
2 CD O
) ) O
= NN O
3 CD O
. . O
6 CD O
; : O
P NNP O
: : O
< NN O
0 CD O
. . O
5 CD O
) ) O
were VBD O
independent JJ O
predictors NNS O
of IN O
events NNS O
. . O

This DT O
work NN O
, , O
therefore RB O
, , O
also RB O
emphasizes VBZ O
the DT O
importance NN O
of IN O
careful JJ O
choice NN O
of IN O
oligonucleotide NN O
and CC O
cDNA NN O
probes NNS O
to TO O
study VB O
PKC NNP B-Gene
zeta NNP I-Gene
mRNA NN I-Gene
. . O

Its PRP$ O
neuromuscular JJ O
effects NNS O
are VBP O
similar JJ O
to TO O
a DT O
single JJ O
ED90 NNP O
dose NN O
of IN O
vecuronium NN O
. . O

The DT O
95 CD O
% NN O
confidence NN O
values NNS O
( ( O
2SD CD O
) ) O
for IN O
the DT O
change NN O
in IN O
Ros NNP O
required VBD O
to TO O
exclude VB O
natural JJ O
variability NN O
were VBD O
0 CD O
. . O
39 CD O
, , O
0 CD O
. . O
50 CD O
and CC O
0 CD O
. . O
53 CD O
cmH2O NN O
l NN O
- : O
1 CD O
s NN O
, , O
respectively RB O
. . O

Thioredoxin NNP B-Gene
( ( O
TR NNP B-Gene
) ) O
is VBZ O
a DT O
small JJ O
ubiquitous JJ O
dithiol NN B-Gene
- : I-Gene
reductase NN I-Gene
enzyme NN I-Gene
first RB O
identified VBN O
in IN O
bacteria NNS O
and CC O
plants NNS O
. . O

We PRP O
determined VBD O
how WRB O
DNA NNP O
repair NN O
is VBZ O
affected VBN O
by IN O
TFA1 NNP B-Gene
conditional JJ O
mutations NNS O
. . O

To TO O
accomplish VB O
this DT O
, , O
actin NN B-Gene
cables NNS O
and CC O
patches NNS O
are VBP O
redistributed VBN O
during IN O
the DT O
cell NN O
cycle NN O
to TO O
direct VB O
secretory JJ O
components NNS O
to TO O
appropriate VB O
sites NNS O
for IN O
cell NN O
growth NN O
. . O

Because IN O
of IN O
its PRP$ O
wide JJ O
spectrum NN O
of IN O
activity NN O
particularly RB O
against IN O
ampicillin NN O
resistant JJ O
strains NNS O
of IN O
H NNP O
. . O
influenzae NN O
and CC O
because IN O
of IN O
its PRP$ O
good JJ O
tolerance NN O
Cefaclor NNP O
is VBZ O
very RB O
useful JJ O
in IN O
treatment NN O
of IN O
respiratory NN O
tract NN O
infections NNS O
in IN O
children NNS O
. . O

Six NNP O
healthy JJ O
male NN O
subjects NNS O
received VBD O
single JJ O
oral JJ O
doses NNS O
of IN O
regular JJ O
release NN O
( ( O
RR NNP O
) ) O
quinidine NN O
sulfate NN O
, , O
sustained VBN O
release NN O
( ( O
SR NNP O
) ) O
quinidine NN O
bisulfate NN O
and CC O
the DT O
same JJ O
dose NN O
of IN O
the DT O
SR NNP O
product NN O
with IN O
food NN O
( ( O
SR NNP O
- : O
F NN O
) ) O
. . O

Lysozyme NNP B-Gene
activity NN O
was VBD O
evidently RB O
increased VBN O
as RB O
well RB O
in IN O
undiluted JJ O
as IN O
in IN O
diluted JJ O
sera NN O
in IN O
all DT O
our PRP$ O
tested JJ O
patients NNS O
. . O

Klebsiella NNP O
oxytoca NN O
can MD O
assimilate VB O
nitrate NN O
and CC O
nitrite JJ O
by IN O
using VBG O
enzymes NNS O
encoded VBN O
by IN O
the DT O
nasFEDCBA JJ B-Gene
operon NN I-Gene
. . O

Interaction NN O
of IN O
the DT O
Fur NNP B-Gene
repressor NN I-Gene
with IN O
a DT O
150 CD O
- : O
bp NN O
fragment NN O
encompassing VBG O
the DT O
pvdS NN B-Gene
promoter NN I-Gene
was VBD O
demonstrated VBN O
in IN O
vivo NN O
by IN O
the DT O
Fur NNP B-Gene
titration NN O
assay NN O
and CC O
confirmed VBN O
in IN O
vitro NN O
by IN O
gel JJ O
retardation NN O
experiments NNS O
with IN O
a DT O
partially RB O
purified VBN O
Fur NNP B-Gene
preparation NN O
. . O

In IN O
the DT O
unclipped JJ O
group NN O
arterial JJ O
pressure NN O
decreased VBD O
50 CD O
mmHg NN O
to TO O
normal JJ O
by IN O
24 CD O
h NN O
and CC O
was VBD O
associated VBN O
with IN O
increased JJ O
diuresis NN O
and CC O
a DT O
small JJ O
decrease NN O
in IN O
blood NN O
volume NN O
( ( O
9 CD O
. . O
8 CD O
% NN O
) ) O
. . O

A DT O
13 CD O
base NN O
- : O
pair NN O
oligonucleotide IN O
spanning VBG O
nucleotides NNS O
+ $ O
80 CD O
to TO O
+ VB O
92 CD O
of IN O
the DT O
5 CD B-Gene
S NNP I-Gene
RNA NNP I-Gene
gene NN I-Gene
retained VBD O
specific JJ O
and CC O
high JJ O
- : O
affinity NN O
binding NN O
, , O
although IN O
the DT O
latter NN O
was VBD O
reduced VBN O
sixfold RB O
relative JJ O
to TO O
longer RBR O
DNA NNP O
fragments NNS O
. . O

Pulmonary NNP O
vein NN O
varix NN O
in IN O
association NN O
with IN O
bilateral JJ O
pulmonary JJ O
vein NN O
stenosis NN O
. . O

The DT O
cAMP NN O
- : O
dependent NN O
mitogenic JJ O
pathway NN O
is VBZ O
unique JJ O
as IN O
it PRP O
is VBZ O
independent JJ O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
activation NN O
and CC O
differs NNS O
from IN O
growth NN O
factor NN O
- : O
dependent NN O
pathways NNS O
at IN O
the DT O
level NN O
of IN O
the DT O
expression NN O
of IN O
several JJ O
protooncogenes NNS O
/ JJ O
transcription NN O
factors NNS O
. . O

Also RB O
, , O
the DT O
anti JJ O
- : O
inflammatory JJ O
activities NNS O
of IN O
an DT O
aqueous JJ O
extract NN O
of IN O
Buddleia NNP O
cordata NN O
and CC O
its PRP$ O
principal JJ O
glycoside JJ O
linarin NN O
were VBD O
evaluated VBN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
hypergastrinemia NN O
induced VBN O
by IN O
surgical JJ O
removal NN O
of IN O
acid JJ O
- : O
producing VBG O
mucosa NN O
in IN O
the DT O
rat NN O
has VBZ O
the DT O
same JJ O
effects NNS O
on IN O
oxyntical JJ O
mucosal NN B-Gene
HDC NNP I-Gene
activity NN O
, , O
histamine NN O
concentration NN O
and CC O
ECL NNP O
cell VBP O
density NN O
as IN O
hypergastrinemia NN O
induced VBN O
by IN O
continuous JJ O
gastrin JJ B-Gene
infusion NN O
or CC O
by IN O
long JJ O
- : O
term NN O
treatment NN O
with IN O
effective JJ O
antisecretagogues NNS O
. . O

Induction NN O
of IN O
the DT O
urokinase JJ B-Gene
promoter NN I-Gene
by IN O
HGF NNP B-Gene
/ NNP O
SF NNP B-Gene
via IN O
the DT O
Met NNP B-Gene
receptor NN I-Gene
was VBD O
blocked VBN O
by IN O
co NN O
- : O
expression NN O
of IN O
a DT O
dominant JJ O
- : O
negative JJ O
Grb2 NNP B-Gene
and CC O
Sos1 NNP B-Gene
expression NN O
construct NN O
. . O

Improvement NN O
of IN O
the DT O
CRT NNP O
display NN O
of IN O
an DT O
averager NN O
. . O

Several JJ O
authors NNS O
have VBP O
recently RB O
reported VBN O
interference NN O
in IN O
theophylline JJ O
analysis NN O
by IN O
paraxanthine NN O
( ( O
1 CD O
, , O
7 CD O
- : O
dimethylxanthine NN O
) ) O
, , O
an DT O
important JJ O
metabolite NN O
of IN O
caffeine NN O
. . O

Susceptibilities NNS O
of IN O
540 CD O
anaerobic JJ O
gram NN O
- : O
negative JJ O
bacilli NN O
to TO O
amoxicillin VB O
, , O
amoxicillin SYM O
- : O
BRL NNP O
42715 CD O
, , O
amoxicillin SYM O
- : O
clavulanate NN O
, , O
temafloxacin NN O
, , O
and CC O
clindamycin NN O
. . O

Of IN O
these DT O
179 CD O
samples NNS O
, , O
Mobiluncus NNP O
SP NNP O
was VBD O
observed VBN O
in IN O
35 CD O
( ( O
19 CD O
. . O
6 CD O
% NN O
) ) O
using VBG O
Gram NNP O
staining NN O
and CC O
in IN O
18 CD O
( ( O
10 CD O
. . O
1 CD O
% NN O
) ) O
this DT O
microorganism NN O
was VBD O
isolated VBN O
in IN O
agar JJ O
RLK NNP O
and CC O
anaerobic RB O
atmosphere RB O
. . O

Local JJ O
graft NN O
irradiation NN O
as IN O
an DT O
adjunct NN O
to TO O
pharmacologic VB O
immunosuppression NN O
. . O

Copyright JJ O
2000 CD O
Academic NNP O
Press NNP O
. . O

Supershift NNP O
assays NNS O
, , O
using VBG O
Jun NNP B-Gene
and CC I-Gene
Fos NNP I-Gene
family NN I-Gene
member NN I-Gene
- : I-Gene
specific JJ I-Gene
antibodies NNS I-Gene
, , O
showed VBD O
that IN O
protein NN O
complexes NNS O
formed VBN O
by IN O
AtT NNP O
- : O
20 CD O
cell NN O
nuclear JJ O
extracts VBZ O
bound NN O
to TO O
the DT O
c NN B-Gene
- : I-Gene
jun NN I-Gene
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
were VBD O
comprised VBN O
of IN O
Jun NNP B-Gene
family NN O
members NNS O
, , O
JunD NNP B-Gene
, , O
JunB NNP B-Gene
, , O
and CC O
cJun NN B-Gene
. . O

Thus RB O
, , O
our PRP$ O
studies NNS O
define VBP O
Rac NNP B-Gene
/ NNP O
Cdc42 NNP B-Gene
/ NNP O
Pak NNP B-Gene
as IN O
a DT O
module NN O
upstream NN O
of IN O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
during IN O
its PRP$ O
activation NN O
by IN O
microtubule NN O
disruption NN O
. . O

Blood NNP O
sampling NN O
procedures NNS O
were VBD O
videotaped VBN O
. . O

The DT O
priming NN O
activity NN O
of IN O
DNA NN O
incised VBN O
by IN O
either DT O
of IN O
the DT O
Drosophila NNP O
enzymes NNS O
can MD O
be VB O
enhanced VBN O
, , O
however RB O
, , O
by IN O
an DT O
additional JJ O
incubation NN O
with IN O
E NNP B-Gene
. . I-Gene
coli VB I-Gene
endonuclease JJ I-Gene
IV NNP I-Gene
, , O
which WDT O
is VBZ O
known VBN O
to TO O
cleave VB O
depurinated VBN O
DNA NNP O
on IN O
the DT O
5 CD O
' POS O
- : O
side NN O
of IN O
an DT O
apurinic JJ O
site NN O
. . O

Ki NNP B-Gene
- : I-Gene
ras4BVal NN I-Gene
- : I-Gene
12 CD I-Gene
transfectant JJ O
cells NNS O
expressed VBD O
2 CD O
- : O
fold NN O
elevated VBD O
protein JJ O
levels NNS O
of IN O
the DT O
lysosomal JJ B-Gene
cysteine NN I-Gene
protease NN I-Gene
cathepsin NN B-Gene
B NNP I-Gene
but CC O
did VBD O
not RB O
up IN O
- : O
regulate NN O
cathepsin NN B-Gene
B NNP I-Gene
mRNA NN I-Gene
expression NN O
. . O

Forty NNP O
- : O
five CD O
patients NNS O
with IN O
pleural JJ O
lesions NNS O
identified VBN O
on IN O
CT NNP O
scans NNS O
were VBD O
subsequently RB O
examined VBN O
by IN O
MR NNP O
imaging VBG O
at IN O
0 CD O
. . O
5 CD O
T NNP O
. . O

These DT O
elements NNS O
comprise VBP O
a DT O
binding NN O
site NN O
for IN O
Krox NNP B-Gene
proteins NNS I-Gene
, , O
one CD O
for IN O
nuclear JJ B-Gene
factor NN I-Gene
1 CD I-Gene
, , O
an DT O
octamer NN O
motif NN O
that WDT O
binds VBZ O
POU NNP B-Gene
- : I-Gene
homeodomain NN I-Gene
proteins NNS I-Gene
, , O
and CC O
a DT O
novel JJ O
TN NNP B-Gene
control NN I-Gene
element NN I-Gene
. . O

According VBG O
to TO O
the DT O
biochemical JJ O
tests NNS O
, , O
high JJ O
activity NN O
( ( O
over IN O
200 CD O
U NNP O
/ NNP O
l NN O
) ) O
of IN O
alkaline NN B-Gene
phosphatase NN I-Gene
was VBD O
recorded VBN O
exclusively RB O
in IN O
patients NNS O
with IN O
the DT O
lymphogranulomatosis NN O
- : O
induced VBN O
liver JJ O
damage NN O
. . O

Currently RB O
, , O
the DT O
clinical JJ O
use NN O
of IN O
5 CD O
- : O
aminolaevulinic JJ O
acid NN O
( ( O
ALA NNP O
) ) O
induced VBD O
protoporphyrin JJ B-Gene
IX NNP I-Gene
( ( O
PPIX NNP B-Gene
) ) O
for IN O
photodynamic JJ O
therapy NN O
( ( O
PDT NNP O
) ) O
is VBZ O
limited VBN O
by IN O
the DT O
maximum JJ O
tolerated JJ O
oral JJ O
ALA NNP O
dose NN O
( ( O
60 CD O
mg NN O
/ NNP O
kg NN O
) ) O
. . O

A DT O
second JJ O
domain NN O
, , O
located VBN O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
437 CD O
amino JJ O
acids NNS O
of IN O
IE1 NNP B-Gene
, , O
is VBZ O
required VBN O
for IN O
inhibitory NN O
and CC O
DNA NNP O
- : O
binding NN O
activities NNS O
. . O

The DT O
term NN O
endovascular JJ O
papillary JJ O
haemangioma NN O
is VBZ O
suggested VBN O
. . O

In IN O
HeLa NNP O
x NNP O
fibroblast NN O
cell NN O
hybrids VBZ O
its PRP$ O
expression NN O
correlates NNS O
with IN O
tumorigenicity NN O
. . O

Mutational JJ O
analysis NN O
of IN O
yeast NN B-Gene
CEG1 NNP I-Gene
demonstrated VBD O
that IN O
four CD O
of IN O
the DT O
five CD O
conserved VBN O
motifs NNS O
are VBP O
essential JJ O
for IN O
capping VBG B-Gene
enzyme JJ I-Gene
function NN O
in IN O
vivo NN O
. . O

More RBR O
importantly RB O
, , O
this DT O
fusion NN O
converted VBD O
a DT O
less RBR O
effective JJ O
vaccine NN O
into IN O
one NN O
with IN O
significant JJ O
potency NN O
against IN O
established VBN O
E7 NNP B-Gene
- : O
expressing VBG O
metastatic JJ O
tumors NNS O
. . O

Iron NNP O
and CC O
folate JJ O
deficiency NN O
in IN O
pregnancy NN O

The DT O
fission NN B-Gene
yeast NN I-Gene
dsk1 NN I-Gene
+ NNP I-Gene
gene NN I-Gene
, , O
a DT O
multicopy NN O
suppressor NN O
for IN O
cold JJ O
- : O
sensitive JJ O
dis1 NN B-Gene
mutants NNS I-Gene
, , O
encodes VBZ O
a DT O
novel JJ O
61 CD O
- : O
kd NN O
protein NN O
kinase NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
indicate VBP O
that IN O
multiple JJ O
survival NN O
pathways NNS O
are VBP O
triggered VBN O
via IN O
this DT O
receptor NN O
, , O
whereas WP O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
/ NN O
Rel NNP B-Gene
and CC O
PI NNP B-Gene
- : I-Gene
3K CD I-Gene
are VBP O
crucial JJ O
for IN O
CD40 NNP B-Gene
- : O
induced JJ O
proliferation NN O
. . O

Coimmunoprecipitation NN O
experiments NNS O
performed VBN O
in IN O
transfected JJ O
cells NNS O
showed VBD O
that IN O
BCMA NNP B-Gene
associates NNS O
with IN O
TNFR NNP B-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
( ( I-Gene
TRAF NNP I-Gene
) ) I-Gene
1 CD I-Gene
, , O
TRAF2 NNP B-Gene
, , O
and CC O
TRAF3 NNP B-Gene
adaptor NN I-Gene
proteins NNS I-Gene
. . O

Gastrin NNP B-Gene
secretion NN O
during IN O
food NN O
stimulation NN O
in IN O
digestive JJ O
system NN O
diseases NNS O

For IN O
E2 NNP O
, , O
each DT O
cat NN O
was VBD O
given VBN O
either RB O
5 CD O
( ( O
group NN O
[ NNP O
G NNP O
] NNP O
1 CD O
) ) O
or CC O
10 CD O
( ( O
G2 NNP O
) ) O
mg NN O
of IN O
itraconazole JJ O
/ NN O
kg NN O
( ( O
capsules NNS O
) ) O
twice RB O
daily RB O
for IN O
6 CD O
weeks NNS O
. . O

Phylogenetic JJ O
analysis NN O
gave VBD O
evidence NN O
for IN O
a DT O
close JJ O
evolutionary JJ O
relationship NN O
between IN O
PhHV NNP O
- : O
1 CD O
and CC O
members NNS O
of IN O
the DT O
Varicellovirus NNP O
genus NN O
of IN O
the DT O
alpha JJ O
- : O
Herpesvirinae NN O
and CC O
canid NN O
herpesvirus NN O
in IN O
particular JJ O
. . O

11 CD O
- : O
Aminoundecanoyl NNP O
- : O
SK NNP O
- : O
NH2 NNP O
and CC O
11 CD O
- : O
aminoundecanoyl NN O
- : O
SH NNP O
- : O
NH2 NNP O
establish VB O
that IN O
a DT O
simple JJ O
alkyl NN O
backbone NN O
can MD O
maintain VB O
an DT O
appropriate JJ O
distance NN O
between IN O
three CD O
elements NNS O
critical JJ O
for IN O
recognition NN O
by IN O
the DT O
fungal JJ O
enzyme NN O
' POS O
s NN O
peptide IN O
- : O
binding VBG O
site NN O
: : O
a DT O
simple JJ O
omega JJ O
- : O
terminal JJ O
amino NN O
group NN O
, , O
a DT O
beta NN O
- : O
hydroxyl NN O
, , O
and CC O
an DT O
epsilon NN O
- : O
amino NN O
group NN O
or CC O
an DT O
imidazole NN O
. . O

B NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
( ( O
BCR NNP B-Gene
) ) O
- : O
mediated VBN O
formation NN O
of IN O
a DT O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
pp120 NN B-Gene
complex JJ O
and CC O
its PRP$ O
inhibition NN O
by IN O
Fc NNP B-Gene
gamma NN I-Gene
RIIB1 NNP I-Gene
- : O
BCR NNP B-Gene
coligation NN O
. . O

Anti NNP B-Gene
- : I-Gene
HBc NNP I-Gene
production NN O
of IN O
PBMC NNP O
was VBD O
enhanced VBN O
remarkably RB O
in IN O
this DT O
case NN O
. . O

Separate JJ O
experiments NNS O
measured VBN O
AIB NNP O
and CC O
86RbCl CD O
uptake NN O
in IN O
36B CD O
- : O
10 CD O
cells NNS O
in IN O
vitro JJ O
1 CD O
and CC O
2 CD O
days NNS O
following VBG O
20 CD O
Gy NNP O
irradiation NN O
to TO O
assess VB O
whether IN O
this DT O
radiation NN O
dose NN O
reduced VBD O
the DT O
capacity NN O
of IN O
tumor NN O
cells NNS O
to TO O
trap VB O
AIB NNP O
or CC O
Rb NNP O
+ NNP O
. . O

An DT O
8 CD O
- : O
bp NN O
sequence NN O
( ( O
ATTTCAAA NNP O
) ) O
within IN O
the DT O
protected JJ O
region NN O
shares NNS O
significant JJ O
homology NN O
with IN O
promoter NN O
sequences NNS O
required VBN O
for IN O
ethylene JJ O
responsiveness NN O
from IN O
the DT O
tomato NN O
fruit NN O
- : O
ripening VBG O
E4 NNP B-Gene
gene NN I-Gene
. . O

The DT O
effect NN O
of IN O
independent JJ O
predictors NNS O
on IN O
survival NN O
was VBD O
examined VBN O
in IN O
a DT O
Cox NNP O
regression NN O
model NN O
with IN O
adjustment NN O
for IN O
existing VBG O
illnesses NNS O
. . O

Growth NNP O
factor NN O
stimulation NN O
of IN O
cells NNS O
causes VBZ O
the DT O
phosphorylation NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
Myc NNP I-Gene
transcriptional JJ I-Gene
activation NN I-Gene
domain NN I-Gene
at IN O
Ser62 NNP O
within IN O
a DT O
proline JJ O
- : O
rich JJ O
region NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
among IN O
members NNS O
of IN O
the DT O
Myc NNP B-Gene
family NN I-Gene
( ( O
Alvarez NNP O
, , O
E NNP O
. . O
, , O
Northwood NNP O
, , O
I PRP O
. . O
C NNP O
. . O
, , O
Gonzalez NNP O
, , O
F NNP O
. . O

The DT O
translation NN O
products NNS O
of IN O
both DT O
clones NNS O
are VBP O
highly RB O
homologous JJ O
to TO O
APS1 NNP B-Gene
( ( O
66 CD O
and CC O
86 CD O
% NN O
identity NN O
, , O
respectively RB O
) ) O
over IN O
their PRP$ O
entire JJ O
lengths NNS O
, , O
including VBG O
amino JJ O
terminal JJ O
sequences NNS O
resembling VBG O
transit NN O
peptides NNS O
for IN O
plastid JJ O
localization NN O
. . O

These DT O
results NNS O
continue VBP O
to TO O
support VB O
the DT O
hypothesis NN O
that WDT O
HS2 NNP O
, , O
HS3 NNP O
, , O
and CC O
HS4 NNP O
act NN O
as IN O
a DT O
single JJ O
, , O
integral JJ O
unit NN O
to TO O
regulate VB O
human JJ B-Gene
globin NN I-Gene
gene NN I-Gene
transcription NN O
as IN O
a DT O
holocomplex NN O
, , O
but CC O
they PRP O
can MD O
also RB O
be VB O
interpreted VBN O
to TO O
say VB O
that DT O
formation NN O
of IN O
a DT O
DNase NNP B-Gene
I PRP I-Gene
hypersensitive VBP O
holocomplex JJ O
alone RB O
is VBZ O
not RB O
sufficient JJ O
for IN O
mediating VBG O
high JJ O
- : O
level NN O
globin JJ B-Gene
gene NN I-Gene
transcription NN O
. . O

Interestingly RB O
, , O
the DT O
RXRalphaF318A NNP B-Gene
constitutive JJ O
activity NN O
generated VBD O
within IN O
heterodimers NNS O
in IN O
the DT O
presence NN O
of IN O
BMS614 NNP O
requires VBZ O
the DT O
integrity NN O
of IN O
both DT O
RXR NNP B-Gene
and CC O
RAR NNP B-Gene
AF NNP O
- : O
2 CD O
domains NNS O
. . O

Serum NNP O
antibodies NNS O
were VBD O
detected VBN O
in IN O
at IN O
least JJS O
95 CD O
% NN O
of IN O
the DT O
infected JJ O
guinea NN O
pigs NNS O
between IN O
4 CD O
- : O
30 CD O
WPI NNP O
and CC O
rats NNS O
between IN O
3 CD O
- : O
16 CD O
WPI NNP O
. . O

The DT O
addition NN O
of IN O
diatrizoate NN O
to TO O
the DT O
IPRK NNP O
led VBD O
to TO O
a DT O
dose JJ O
- : O
dependent JJ O
biphasic JJ O
change NN O
in IN O
RPF NNP O
and CC O
GFR NNP O
characterized VBN O
by IN O
an DT O
initial JJ O
transient NN O
increase NN O
followed VBN O
by IN O
a DT O
marked JJ O
and CC O
sustained JJ O
decrease NN O
. . O

The DT O
patient NN O
was VBD O
treated VBN O
with IN O
benzathine NN O
penicillin NN O
, , O
2 CD O
, , O
400 CD O
, , O
0 CD O
U NNP O
weekly NN O
for IN O
three CD O
weeks NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
xtRNA NNP B-Gene
( ( O
Sec NNP B-Gene
) ) O
gene NN O
needs VBZ O
the DT O
binding NN O
of IN O
the DT O
seven CD O
Staf NNP B-Gene
zinc NN I-Gene
fingers NNS I-Gene
, , O
but CC O
not RB O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
for IN O
optimal JJ O
transcriptional JJ O
capacity NN O
. . O

The DT O
levels NNS O
of IN O
fibrinogen NN B-Gene
as RB O
well RB O
as IN O
antithrombin NN B-Gene
III NNP I-Gene
( ( O
ATIII NNP B-Gene
) ) O
and CC O
heparin $ B-Gene
cofactor NN I-Gene
II NNP I-Gene
( ( O
HCII NNP B-Gene
) ) O
activities NNS O
were VBD O
steadily RB O
increased VBN O
in IN O
loop NN O
- : O
bearing NN O
animals NNS O
. . O

In IN O
contrast NN O
with IN O
the DT O
previously RB O
reported VBN O
HMGR1 NNP B-Gene
mRNA NN I-Gene
( ( O
HMGR1S NNP B-Gene
mRNA NN I-Gene
) ) O
, , O
which WDT O
is VBZ O
detected VBN O
at IN O
high JJ O
levels NNS O
in IN O
all DT O
tissues NNS O
of IN O
the DT O
plant NN O
, , O
HMGR1L NNP B-Gene
mRNA NN I-Gene
is VBZ O
present JJ O
at IN O
relatively RB O
low JJ O
levels NNS O
and CC O
its PRP$ O
expression NN O
is VBZ O
restricted VBN O
mostly RB O
to TO O
seedlings NNS O
, , O
roots NNS O
and CC O
inflorescences NNS O
. . O

Smoking VBG O
history NN O
and CC O
awake VB O
oxygen NN O
saturation NN O
( ( O
SaO2 NNP O
) ) O
was VBD O
recorded VBN O
in IN O
all DT O
of IN O
them PRP O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
pathway NN O
activation NN O
occurs VBZ O
during IN O
transformation NN O
induced VBN O
by IN O
a DT O
number NN O
of IN O
classical JJ O
oncogenes NNS O
, , O
including VBG O
Bcr NNP B-Gene
/ NNP O
Abl NNP B-Gene
, , O
Ras NNP B-Gene
and CC O
Rac NNP B-Gene
, , O
and CC O
is VBZ O
necessary JJ O
for IN O
full JJ O
transforming VBG O
potential JJ O
. . O

Imposed VBN O
angular JJ O
displacements NNS O
of IN O
monkey NN O
' '' O
s JJ O
wrist NN O
produce VBP O
three CD O
major JJ O
peaks NNS O
of IN O
activity NN O
( ( O
terms NNS O
M1 NNP O
, , O
M2 NNP O
, , O
and CC O
M3 NNP O
peaks NNS O
) ) O
in IN O
the DT O
averaged JJ O
gross JJ O
EMG NNP O
activity NN O
ot VBP O
the DT O
stretched JJ O
muscles NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
both DT O
N NNP O
- : O
and CC O
C NNP O
- : O
terminal JJ O
mutations NNS O
are VBP O
required VBN O
to TO O
inhibit VB O
transrepression NN O
by IN O
FBR NNP B-Gene
protein NN I-Gene
and CC O
that IN O
multiple JJ O
structural JJ O
mutations NNS O
accompanied VBN O
by IN O
posttranslational JJ O
protein NN O
modification NN O
alter NN O
gene NN O
regulation NN O
by IN O
FBR NNP B-Gene
protein NN I-Gene
. . O

The DT O
proportion NN O
of IN O
the DT O
biopsies NNS O
found VBD O
to TO O
be VB O
seropositive JJ O
for IN O
HBs NNP B-Gene
antigen NN I-Gene
was VBD O
27 CD O
. . O
9 CD O
% NN O
, , O
and CC O
these DT O
showed VBD O
either CC O
MGN NNP O
or CC O
MPGN NNP O
pattern NN O
. . O

Nephrotoxicity NN O
after IN O
orthotopic NN O
liver NN O
transplantation NN O
in IN O
cyclosporin NN O
A NNP O
and CC O
FK NNP O
506 CD O
- : O
treated JJ O
patients NNS O
. . O

LPO NNP O
and CC O
SOD NNP B-Gene
levels NNS O
were VBD O
measured VBN O
at IN O
five CD O
points NNS O
before IN O
and CC O
during IN O
the DT O
operation NN O
. . O

The DT O
participants NNS O
were VBD O
homosexual JJ O
men NNS O
in IN O
hepatitis NN O
B NNP O
vaccine NN O
trials NNS O
in IN O
Amsterdam NNP O
( ( O
n JJ O
= NNP O
74 CD O
) ) O
, , O
New NNP O
York NNP O
City NNP O
( ( O
n JJ O
= NNP O
120 CD O
) ) O
, , O
and CC O
San NNP O
Francisco NNP O
( ( O
n JJ O
= NNP O
168 CD O
) ) O
. . O

Whereas IN O
the DT O
mutant JJ O
enzymes NNS O
terminate VBP O
normally RB O
at IN O
the DT O
late JJ O
terminator NN O
in IN O
T7 NNP O
DNA NNP O
( ( O
T NNP O
( ( O
phi NN O
) ) O
) ) O
and CC O
rrnB JJ B-Gene
T2 NNP O
, , O
they PRP O
fail VBP O
to TO O
terminate VB O
at IN O
one CD O
of IN O
the DT O
termination NN O
sites VBZ O
of IN O
rrnB NN B-Gene
T1 NNP O
, , O
and CC O
also RB O
fail VBP O
to TO O
recognize VB O
the DT O
PTH NNP B-Gene
and CC O
CJ NNP O
signals NNS O
. . O

The DT O
asymmetric JJ O
methylation NN O
was VBD O
associated VBN O
with IN O
tissue NN O
- : O
specific JJ O
disruption NN O
of IN O
H19 NNP B-Gene
genomic JJ O
imprinting NN O
in IN O
fetal JJ O
brain NN O
. . O

The DT O
median JJ O
durations NNS O
for IN O
response NN O
and CC O
survival JJ O
time NN O
in IN O
the DT O
late JJ O
phase NN O
II NNP O
trial NN O
were VBD O
2 CD O
. . O
3 CD O
months NNS O
and CC O
5 CD O
. . O
8 CD O
months NNS O
, , O
respectively RB O
. . O

Recent JJ O
application NN O
of IN O
recombinant JJ O
canarypox NN O
ALVAC NNP O
/ NNP O
HIV NNP O
- : O
1 CD O
vectors NNS O
as IN O
vaccine NN O
immunogens NNS O
in IN O
HIV NNP O
- : O
1 CD O
, , O
- : O
noninfected VBN O
volunteers NNS O
has VBZ O
produced VBN O
CTL NNP O
responses NNS O
in IN O
a DT O
significant JJ O
number NN O
of IN O
vaccinees NNS O
. . O

Martin NNP O
Luther NNP O
and CC O
his PRP$ O
physicians NNS O
. . O

Structural JJ O
changes NNS O
in IN O
the DT O
kinetically RB O
more RBR O
damaged JJ O
E44D NNP O
mutant NN O
detected VBN O
in IN O
( ( O
1 CD O
) ) O
H NNP O
- : O
( ( O
15 CD O
) ) O
N NNP O
HSQC NNP O
spectra NN O
were VBD O
largely RB O
limited VBN O
to TO O
the DT O
loop NN O
I PRP O
- : O
helix NN O
I PRP O
motif VBP O
, , O
suggesting VBG O
that IN O
Glu NNP O
- : O
44 CD O
stabilizes VBZ O
the DT O
active JJ O
site NN O
region NN O
. . O

Point NN O
mutations NNS O
that WDT O
suppressed VBD O
the DT O
in IN O
vitro JJ O
binding NN O
of IN O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
to TO O
the DT O
internal JJ O
palindromic JJ O
arm NN O
reduced VBD O
the DT O
activity NN O
of IN O
the DT O
resident NN O
P4 NNP O
promoter NN O
, , O
while IN O
those DT O
preventing VBG O
complex JJ O
formation NN O
with IN O
USF NNP B-Gene
did VBD O
not RB O
, , O
as IN O
determined VBN O
by IN O
transient JJ O
expression NN O
assays NNS O
using VBG O
the DT O
luciferase NN B-Gene
reporter NN O
gene NN O
. . O

The DT O
effect NN O
of IN O
antilymphocyte NN O
sera NN O
on IN O
formation NN O
of IN O
transplantation NN O
and CC O
anti JJ O
- : O
infection NN O
immunity NN O
in IN O
mice NN O

Recombinant NNP O
, , O
bacterially RB O
expressed VBN O
PIP5KIalpha NNP B-Gene
possessed VBD O
PIP5K NNP B-Gene
activity NN O
and CC O
was VBD O
immunoreactive JJ O
with IN O
erythroid JJ B-Gene
PIP5KI NNP I-Gene
antibodies NNS I-Gene
. . O

To TO O
explore VB O
the DT O
function NN O
of IN O
human JJ O
SINA NNP B-Gene
- : I-Gene
homologous JJ I-Gene
( ( I-Gene
Siah NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
, , O
expression NN O
plasmids NNS O
encoding VBG O
Siah NNP B-Gene
- : I-Gene
1A CD I-Gene
were VBD O
transiently RB O
transfected VBN O
into IN O
293 CD O
epithelial JJ O
cells NNS O
and CC O
GM701 NNP O
fibroblast NN O
cells NNS O
, , O
resulting VBG O
in IN O
growth NN O
arrest NN O
without IN O
induction NN O
of IN O
apoptosis NN O
. . O

This DT O
experiment NN O
was VBD O
conducted VBN O
to TO O
determine VB O
if IN O
the DT O
sex NN O
or CC O
actual JJ O
egg NN O
production NN O
was VBD O
the DT O
important JJ O
factor NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Our PRP$ O
data NNS O
provide VB O
a DT O
biochemical JJ O
explanation NN O
for IN O
the DT O
similarity NN O
in IN O
phenotype NN O
between IN O
A NNP O
- : O
T NN O
and CC O
NBS NNP O
. . O

Velocity NNP O
sedimentation NN O
, , O
cross SYM O
- : O
linking NN O
, , O
and CC O
immunoprecipitation NN O
analyses NNS O
of IN O
detergent NN O
- : O
solubilized JJ O
rat NN O
brain NN O
revealed VBD O
that IN O
the DT O
32 CD O
and CC O
34 CD O
kDa NN O
polypeptides NNS O
reside VBP O
within IN O
heterotetramers NNS O
. . O

In IN O
the DT O
TLE NNP O
patients NNS O
the DT O
NAA NNP O
: : O
Cr JJ O
ratios NNS O
were VBD O
reduced VBN O
in IN O
the DT O
seizure NN O
focus NN O
, , O
while IN O
in IN O
the DT O
FLE NNP O
patients NNS O
they PRP O
were VBD O
not RB O
always RB O
reduced VBN O
in IN O
the DT O
seizure NN O
focus NN O
. . O

For IN O
Al NNP O
, , O
the DT O
exposure NN O
to TO O
1 CD O
. . O
36 CD O
mg JJ O
/ NNP O
m3 NN O
during IN O
the DT O
shift NN O
corresponded VBD O
to TO O
a DT O
urinary JJ O
concentration NN O
at IN O
the DT O
end NN O
of IN O
the DT O
shift NN O
of IN O
200 CD O
microgram NNS O
/ JJ O
g JJ O
creatinine NN O
. . O

Initial JJ O
experience NN O
with IN O
a DT O
serotonin JJ O
agonist NN O
. . O

PKC NNP B-Gene
- : I-Gene
gamma NN I-Gene
, , O
which WDT O
is VBZ O
not RB O
present JJ O
in IN O
keratinocytes NNS O
, , O
also RB O
induces VBZ O
involucrin JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
a DT O
TPA NNP O
- : O
independent JJ O
manner NN O
, , O
when WRB O
introduced VBN O
into IN O
SVHK NNP O
cells NNS O
. . O

Recombinant JJ B-Gene
human JJ I-Gene
erythropoietin NN I-Gene
( ( O
epoetin NN B-Gene
) ) O
is VBZ O
approved VBN O
to TO O
be VB O
administered VBN O
by IN O
the DT O
intravenous JJ O
( ( O
i JJ O
. . O
v NN O
. . O
) ) O
or CC O
subcutaneous JJ O
( ( O
SC NNP O
) ) O
route NN O
. . O

The DT O
sixth JJ O
nucleotide NN O
was VBD O
bulged VBN O
out RP O
to TO O
allow VB O
stacking NN O
of IN O
this DT O
U NNP O
. . O
G NNP O
pair NN O
on IN O
the DT O
adjacent JJ O
helical JJ O
region NN O
. . O

Decreased VBN O
levels NNS O
of IN O
alpha2 NN B-Gene
- : I-Gene
antiplasmin NN I-Gene
were VBD O
also RB O
observed VBN O
in IN O
the DT O
mediastinum NN O
( ( O
0 CD O
. . O
50 CD O
versus NN O
0 CD O
. . O
61 CD O
U NNP O
/ NNP O
mL NN O
; : O
p CC O
< $ O
0 CD O
. . O
5 CD O
) ) O
. . O

JPEG NNP O
53 CD O
, , O
resulting VBG O
in IN O
a DT O
compression NN O
ratio NN O
of IN O
1 CD O
: : O
21 CD O
, , O
does VBZ O
not RB O
compromise VB O
the DT O
diagnostic JJ O
performance NN O
in IN O
general JJ O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
distinct JJ O
cytoplasmic JJ O
domains NNS O
of IN O
these DT O
cytokine JJ O
receptors NNS O
elicit VBP O
convergent JJ O
signaling NN O
pathways NNS O
and CC O
provide VB O
evidence NN O
that IN O
beta NN B-Gene
c NNS I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
function NN O
as IN O
a DT O
complete JJ O
signal NN O
transducer NN O
. . O

A DT O
crucial JJ O
transcription NN O
factor NN O
in IN O
this DT O
process NN O
is VBZ O
STAT6 NNP B-Gene
, , O
which WDT O
binds VBZ O
to TO O
a DT O
specific JJ O
DNA NNP O
element NN O
upon IN O
cytokine JJ O
activation NN O
. . O

Linkage NN O
studies NNS O
have VBP O
shown VBN O
locus JJ O
heterogeneity NN O
with IN O
one CD O
TSC NNP B-Gene
gene NN I-Gene
mapped VBD O
to TO O
chromosome VB O
9q34 CD O
and CC O
a DT O
second JJ O
to TO O
16p13 CD O
. . O
3 CD O
. . O

Six CD O
of IN O
them PRP O
, , O
NUC1 NNP B-Gene
, , O
PRP21 NNP B-Gene
( ( O
also RB O
called VBN O
SPP91 NNP B-Gene
) ) O
, , O
CDC6 NNP B-Gene
, , O
CRY2 NNP B-Gene
, , O
the DT O
gene NN O
encoding VBG O
the DT O
ribosomal JJ B-Gene
protein NN I-Gene
S24 NNP I-Gene
and CC O
the DT O
gene NN O
coding VBG O
for IN O
a DT O
hypothetical JJ O
protein NN O
of IN O
599 CD O
amino NN O
acids NNS O
, , O
have VBP O
been VBN O
sequenced VBN O
previously RB O
. . O

Cortical JJ O
afferents NNS O
to TO O
the DT O
entorhinal JJ O
cortex NN O
of IN O
the DT O
Rhesus NNP O
monkey NN O
. . O

Intraoperatively RB O
the DT O
complement NN B-Gene
factor NN I-Gene
C3c NNP I-Gene
decreased VBN O
by IN O
20 CD O
% NN O
, , O
while IN O
alpha JJ B-Gene
1 CD I-Gene
- : I-Gene
antitrypsin NN I-Gene
showed VBD O
postoperatively RB O
an DT O
increase NN O
by IN O
30 CD O
% NN O
. . O

The DT O
response NN O
of IN O
serum NN B-Gene
GH NNP I-Gene
to TO O
arginine VB O
infusion NN O
was VBD O
normal JJ O
, , O
while IN O
that DT O
to TO O
insulin VB B-Gene
- : O
induced JJ O
hypoglycemia NN O
was VBD O
poor JJ O
. . O

As IN O
stands NNS O
shifted VBN O
in IN O
dominance NN O
from IN O
pine NN O
to TO O
fir VB O
with IN O
age NN O
, , O
subalpine JJ O
fir NN O
appeared VBD O
to TO O
maintain VB O
gradually RB O
increasing VBG O
rates NNS O
of IN O
whole JJ O
- : O
forest JJS O
productivity NN O
until IN O
stands NNS O
were VBD O
approximately RB O
400 CD O
years NNS O
old JJ O
. . O

A DT O
clinical JJ O
, , O
serological JJ O
and CC O
prognostic JJ O
study NN O

In IN O
epithelial JJ O
cells NNS O
, , O
the DT O
PH NNP B-Gene
domain NN I-Gene
of IN O
Akt NNP B-Gene
/ NNP O
PKB NNP B-Gene
localised VBD O
to TO O
sites NNS O
of IN O
cell NN O
- : O
cell NN O
and CC O
cell NN O
- : O
matrix NN O
contact NN O
, , O
distinct NN O
from IN O
focal JJ O
contacts NNS O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
serum NN O
. . O

Gemfibrozil NNP O
in IN O
hyperlipidaemic JJ O
patients NNS O
with IN O
peripheral JJ O
arterial JJ O
disease NN O
: : O
some DT O
undiscovered JJ O
actions NNS O
. . O

A DT O
- : O
tracts NNS O
functioned VBN O
best JJS O
when WRB O
positioned VBN O
close RB O
to TO O
the DT O
- : O
35 CD O
hexamer NN O
rather RB O
than IN O
one CD O
helical JJ O
turn NN O
farther RBR O
upstream RB O
, , O
similar JJ O
to TO O
the DT O
positioning NN O
optimal NN O
for IN O
UP NNP O
element NN O
function NN O
. . O

We PRP O
have VBP O
isolated VBN O
cDNA NN O
clones NNS O
from IN O
rat NN O
brain NN O
and CC O
human JJ O
liver NN O
encoding VBG O
a DT O
putative JJ O
isoform NN O
of IN O
the DT O
Na NNP B-Gene
, , I-Gene
K NNP I-Gene
- : I-Gene
ATPase NNP I-Gene
beta NN I-Gene
subunit NN I-Gene
. . O

The DT O
symptoms NNS O
and CC O
objective JJ O
findings NNS O
were VBD O
caused VBN O
by IN O
a DT O
malignant JJ O
lymphoma NN O
, , O
and CC O
the DT O
diagnosis NN O
was VBD O
established VBN O
from IN O
a DT O
drill NN O
biopsy NN O
. . O

SSG1 NNP B-Gene
, , O
a DT O
gene NN O
encoding VBG O
a DT O
sporulation NN B-Gene
- : I-Gene
specific JJ I-Gene
1 CD I-Gene
, , I-Gene
3 CD I-Gene
- : I-Gene
beta NN I-Gene
- : I-Gene
glucanase NN I-Gene
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

Thus RB O
, , O
cibenzoline NN O
is VBZ O
an DT O
effective JJ O
antiarrhythmic JJ O
agent NN O
with IN O
a DT O
favourable JJ O
pharmacokinetic JJ O
profile NN O
that WDT O
may MD O
be VB O
considered VBN O
with IN O
other JJ O
class NN O
I PRP O
drugs NNS O
in IN O
patients NNS O
requiring VBG O
therapy NN O
for IN O
high JJ O
risk NN O
arrhythmias NNS O
. . O

Optimal JJ O
activation NN O
of IN O
T NNP O
cells NNS O
requires VBZ O
at IN O
least JJS O
two CD O
signals NNS O
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
zebrafish JJ B-Gene
egr1 NN I-Gene
coding VBG I-Gene
region NN I-Gene
revealed VBD O
a DT O
high JJ O
level NN O
of IN O
homology NN O
to TO O
the DT O
mouse NN O
, , O
rat NN O
, , O
and CC O
human JJ B-Gene
Egr1 NNP I-Gene
genes NNS I-Gene
with IN O
the DT O
notable JJ O
exception NN O
of IN O
a DT O
polymorphic JJ O
, , O
triplet JJ O
nucleotide RB O
repeat NN O
sequence NN O
in IN O
the DT O
region NN O
coding VBG O
for IN O
the DT O
amino NN O
terminus NN O
of IN O
the DT O
Egr1 NNP B-Gene
protein NN I-Gene
. . O

A DT O
striking JJ O
finding NN O
in IN O
all DT O
of IN O
the DT O
studies NNS O
was VBD O
a DT O
positive JJ O
correlation NN O
between IN O
PI NNP O
ACTH NNP B-Gene
and CC O
MSH NNP B-Gene
contents NNS O
. . O

A DT O
randomised VBN O
, , O
controlled VBD O
trial NN O
was VBD O
undertaken VBN O
in IN O
40 CD O
patients NNS O
with IN O
active JJ O
Crohn NNP O
' POS O
s JJ O
disease NN O
to TO O
evaluate VB O
clinical JJ O
and CC O
nutritional JJ O
outcomes NNS O
after IN O
an DT O
amino NN O
acid NN O
based VBN O
diet JJ O
containing VBG O
3 CD O
% NN O
fat NN O
was VBD O
given VBN O
by IN O
a DT O
feeding NN O
tube NN O
compared VBN O
with IN O
a DT O
peptide NN O
based VBN O
diet JJ O
containing VBG O
33 CD O
% NN O
fat NN O
. . O

In IN O
the DT O
absence NN O
of IN O
Swi4 NNP B-Gene
and CC O
Swi6 NNP B-Gene
cell NN O
viability NN O
is VBZ O
lost VBN O
, , O
but CC O
can MD O
be VB O
regained VBN O
by IN O
ectopic JJ O
expression NN O
of IN O
the DT O
G1 NNP B-Gene
cyclin NN I-Gene
encoding VBG I-Gene
genes NNS I-Gene
, , O
CLN1 NNP B-Gene
or CC O
CLN2 NNP B-Gene
. . O

Cardiovascular JJ O
and CC O
adrenal JJ O
medullo NN O
- : O
sympathetic JJ O
reactions NNS O
to TO O
acute VB O
tobacco NN O
poisoning NN O

If IN O
no DT O
reply NN O
was VBD O
received VBN O
, , O
telephone NN O
contact NN O
or CC O
home NN O
visits NNS O
were VBD O
made VBN O
. . O

A DT O
mutation NN O
in IN O
the DT O
5 CD O
' POS O
C2U4 NNP O
repeat NN O
causes VBZ O
underaccumulation NN O
of IN O
snR13F NN B-Gene
, , O
whereas JJ O
mutations NNS O
in IN O
the DT O
3 CD O
' POS O
C2U4 NNP O
repeat NN O
cause NN O
the DT O
accumulation NN O
of IN O
two CD O
novel JJ O
RNAs NNP O
that WDT O
migrate NN O
in IN O
the DT O
500 CD O
- : O
nt NN O
range NN O
. . O

In IN O
conclusion NN O
, , O
the DT O
disposition NN O
of IN O
venlafaxine NN O
and CC O
O NNP O
- : O
desmethylvenlafaxine NN O
is VBZ O
markedly RB O
altered VBN O
in IN O
renal JJ O
disease NN O
; : O
therefore RB O
dosage NN O
adjustment NN O
is VBZ O
warranted VBN O
for IN O
patients NNS O
with IN O
creatinine JJ O
clearance NN O
values NNS O
below IN O
30 CD O
ml NNS O
/ JJ O
min NN O
. . O

A DT O
polymorphic JJ O
dinucleotide NN O
( ( O
GT NNP O
/ NNP O
CA NNP O
) ) O
n RB O
repeat NN O
contained VBN O
in IN O
the DT O
NHE5 NNP O
cosmid NN O
was VBD O
identified VBN O
and CC O
developed VBN O
into IN O
a DT O
microsatellite JJ O
PCR NNP O
marker NN O
. . O

Study NN O
on IN O
re NN O
- : O
establishment NN O
of IN O
ovulation NN O
after IN O
termination NN O
of IN O
sex NN O
- : O
steroidal NN O
treatment NN O
- : O
- : O
compared VBN O
with IN O
re JJ O
- : O
appearance NN O
of IN O
ovulation NN O
after IN O
abortion NN O
and CC O
premature NN O
delivery NN O
. . O

This DT O
Tbx6 NNP B-Gene
- : I-Gene
subfamily RB I-Gene
gene NN I-Gene
is VBZ O
likely JJ O
to TO O
participate VB O
in IN O
paraxial JJ O
mesoderm NN O
formation NN O
and CC O
somitogenesis NN O
in IN O
human JJ O
embryo NN O
. . O

Thus RB O
, , O
in IN O
T47D NNP O
breast NN O
carcinoma NN O
cells NNS O
, , O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
acts NNS O
in IN O
synergy NN O
with IN O
EGF NNP B-Gene
receptor NN I-Gene
autocrine NN O
activity NN O
to TO O
signal VB O
through IN O
the DT O
MAPK NNP B-Gene
/ NNP O
PI3K NNP B-Gene
pathways NNS O
. . O

Also RB O
, , O
small JJ O
, , O
sense NN O
and CC O
antisense NN O
approximately RB O
22 CD O
nt JJ O
RNAs NNP O
, , O
derived VBD O
from IN O
the DT O
satRNA NN O
, , O
were VBD O
associated VBN O
with IN O
the DT O
replicating VBG O
satellite NN O
. . O

The DT O
first JJ O
gene NN O
, , O
NSR1 NNP B-Gene
, , O
a DT O
previously RB O
identified VBN O
gene NN O
, , O
encodes VBZ O
a DT O
protein NN O
involved VBN O
in IN O
ribosomal JJ O
RNA NNP O
maturation NN O
and CC O
possibly RB O
in IN O
transport NN O
of IN O
proteins NNS O
into IN O
the DT O
nucleus NN O
. . O

Mechanism NN O
in IN O
the DT O
sequential JJ O
control NN O
of IN O
cell NN O
morphology NN O
and CC O
S NNP O
phase NN O
entry NN O
by IN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
involves VBZ O
distinct JJ O
MEK NNP B-Gene
/ NNP O
ERK NNP B-Gene
activations NNS O
. . O

Mycobacterium NNP O
avium NN O
- : O
intracellulare NN O
complex JJ O
infections NNS O
in IN O
the DT O
acquired JJ O
immunodeficiency NN O
syndrome NN O
. . O

EMSA NN O
showed VBD O
that IN O
nuclear JJ O
proteins NNS O
from IN O
PC12 NNP O
but CC O
not RB O
C6 NNP O
or CC O
Rat2 NNP O
cells NNS O
bind IN O
the DT O
CRE NNP O
as IN O
a DT O
complex JJ O
containing NN O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
( ( I-Gene
ATF NNP I-Gene
) ) I-Gene
- : I-Gene
4 CD I-Gene
and CC O
CCAAT NNP B-Gene
enhancer VBP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
beta NN I-Gene
, , O
while IN O
both DT O
PC12 NNP O
and CC O
C6 NNP O
cell VBP O
nuclear JJ O
extracts NNS O
were VBD O
recruited VBN O
by IN O
the DT O
CCAAT NNP O
- : O
box NN O
as IN O
a DT O
complex JJ O
containing NN O
nuclear JJ B-Gene
factor NN I-Gene
Y NNP I-Gene
. . O

Expression NN O
of IN O
Msp NNP B-Gene
was VBD O
toxic JJ O
to TO O
E NNP O
. . O
coli NN O
when WRB O
the DT O
entire JJ O
msp NN B-Gene
gene NN I-Gene
was VBD O
present JJ O
. . O

All DT O
nuclear JJ O
receptors NNS O
have VBP O
several JJ O
well RB O
- : O
characterized VBN O
structural JJ O
domains NNS O
, , O
including VBG O
a DT O
conserved JJ O
DNA NNP O
- : O
binding NN O
domain NN O
, , O
and CC O
a DT O
ligand NN O
binding VBG O
domain NN O
at IN O
the DT O
carboxyl JJ O
terminus NN O
of IN O
the DT O
receptor NN O
. . O

Substrates NNS O
include VBP O
the DT O
p21 NN B-Gene
( ( O
ras NNS B-Gene
) ) O
proteins NNS O
, , O
nuclear JJ B-Gene
lamins NNS I-Gene
, , O
and CC O
a DT O
series NN O
of IN O
retinal JJ O
proteins NNS O
. . O

1 CD O
- : O
( ( O
m SYM O
- : O
Chlorophenyl NN O
) ) O
piperazine NN O
( ( O
mCPP NN O
, , O
0 CD O
. . O
1 CD O
- : O
3 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
and CC O
1 CD O
- : O
( ( O
m SYM O
- : O
trifluoromethylphenyl NN O
) ) O
piperazine NN O
( ( O
TFMPP NNP O
, , O
0 CD O
. . O
1 CD O
- : O
3 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
, , O
both DT O
thought VBN O
to TO O
act VB O
primarily RB O
at IN O
5 CD B-Gene
- : I-Gene
HT1 NN I-Gene
sites NNS I-Gene
, , O
also RB O
decreased VBD O
responding VBG O
and CC O
this DT O
effect NN O
was VBD O
blocked VBN O
by IN O
methysergide NN O
and CC O
by IN O
1 CD O
- : O
NP NN O
, , O
but CC O
not RB O
by IN O
ketanserin NN O
. . O

Isolated VBN O
Systolic JJ O
Hypertension NNP O
: : O
An DT O
Update NNP O
. . O

The DT O
less JJR O
- : O
polar JJ O
mycolic JJ O
acid SYM O
- : O
containing VBG O
Rhodococcus NNP O
species NNS O
showed VBD O
chromatographic JJ O
patterns NNS O
that WDT O
partially RB O
overlapped VBD O
( ( O
in IN O
elution NN O
times NNS O
) ) O
the DT O
patterns NNS O
of IN O
Nocardia NNP O
asteroides NNS O
, , O
N NNP O
. . O
otitidiscaviarum NN O
, , O
and CC O
N NNP O
. . O
brasiliensis NN O
, , O
but CC O
the DT O
larger JJR O
number NN O
of IN O
peaks NNS O
in IN O
the DT O
last JJ O
species NNS O
made VBD O
separation NN O
between IN O
the DT O
genera NN O
possible JJ O
. . O

Transfection NN O
of IN O
HepG2 NNP O
and CC O
SK NNP O
- : O
N NNP O
- : O
MC NNP O
cells NNS O
with IN O
constructs NNS O
deleted VBN O
of IN O
additional JJ O
5 CD O
' POS O
- : O
flanking NN O
fragments NNS O
permitted VBD O
the DT O
definition NN O
of IN O
a DT O
minimal JJ O
200 CD O
bp NN O
promoter NN O
fragment NN O
containing VBG O
the DT O
pseudo NN O
- : O
TATA NNP O
box NN O
and CC O
two CD O
putative JJ O
SP1 NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

The DT O
control NN O
group NN O
revealed VBD O
significantly RB O
higher JJR O
levels NNS O
of IN O
coagulation NN B-Gene
factors NNS I-Gene
II NNP I-Gene
, , I-Gene
V NNP I-Gene
and CC I-Gene
VIII NNP I-Gene
, , O
compared VBN O
to TO O
the DT O
index NN O
group NN O
. . O

Gastritis NNP O
score NN O
was VBD O
significantly RB O
lower JJR O
in IN O
nod JJ O
- : O
/ NN O
CagA NNP B-Gene
- : O
children NNS O
than IN O
in IN O
nod JJ O
+ NNP O
/ NNP O
CagA NNP B-Gene
- : O
( ( O
p JJ O
= NNP O
. . O
4 CD O
) ) O
, , O
nod SYM O
- : O
/ NN O
CagA NNP B-Gene
+ NNP O
( ( O
p JJ O
= NNP O
. . O
2 CD O
) ) O
and CC O
nod JJ O
+ NNP O
/ NNP O
CagA NNP B-Gene
+ NNP O
( ( O
p JJ O
< NNP O
. . O
1 CD O
) ) O
, , O
both DT O
in IN O
the DT O
antrum NN O
and CC O
corpus NN O
. . O

Transcriptional NNP O
blockade NN O
was VBD O
reversed VBN O
by IN O
co NN O
- : O
transfections NNS O
of IN O
a DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
SRF NNP I-Gene
expression NN O
vector NN O
, , O
but CC O
was VBD O
not RB O
rescued VBN O
by IN O
the DT O
expression NN O
of IN O
other JJ O
myogenic JJ O
factors NNS O
, , O
such JJ O
as IN O
MyoD NNP B-Gene
and CC O
Mef NNP B-Gene
- : I-Gene
2C CD I-Gene
. . O

In IN O
conclusion NN O
, , O
changes NNS O
in IN O
carotid NN O
sinus NN O
stimulation NN O
alters NNS O
blood VBD O
flow NN O
to TO O
the DT O
hindlimb NN O
through IN O
changes NNS O
in IN O
both DT O
Pcrit NNP O
and CC O
Ra NNP O
. . O

Gel NNP O
- : O
shift NN O
assays NNS O
with IN O
nuclear JJ O
extracts NNS O
and CC O
oligonucleotide JJ O
sequences NNS O
spanning VBG O
the DT O
0 CD O
. . O
125 CD O
- : O
kb NN O
promoter NN O
region NN O
detected VBD O
an DT O
ETS NNP B-Gene
- : O
immunoreactive NN O
complex NN O
, , O
present JJ O
most RBS O
abundantly RB O
in IN O
cells NNS O
overexpressing VBG O
HER2 NNP B-Gene
, , O
whose WP$ O
high JJ O
- : O
affinity NN O
binding NN O
depended VBN O
on IN O
the DT O
GAGGAA NNP O
response NN O
element NN O
. . O

The DT O
genes NNS O
encoding VBG O
( ( B-Gene
2Fe CD I-Gene
- : I-Gene
2S CD I-Gene
) ) I-Gene
plant NN I-Gene
- : I-Gene
like IN I-Gene
ferredoxins NNS I-Gene
were VBD O
studied VBN O
in IN O
the DT O
widely RB O
used JJ O
cyanobacterium NN O
Synechocystis NNP O
PCC6803 NNP O
. . O

Of IN O
49 CD O
receptors NNS O
which WDT O
fired VBD O
in IN O
phase NN O
with IN O
ventilation NN O
, , O
13 CD O
behaved VBN O
like IN O
mammalian JJ O
rapidly RB O
adapting VBG O
pulmonary JJ O
stretch NN O
receptors NNS O
, , O
19 CD O
like IN O
mammalian JJ O
slowly RB O
adapting VBG O
pulmonary JJ O
stretch NN O
receptors NNS O
( ( O
PSR NNP O
) ) O
, , O
and CC O
17 CD O
like IN O
avian JJ O
intrapulmonary JJ O
CO2 NNP O
- : O
sensitive JJ O
chemoreceptors NNS O
( ( O
IPC NNP O
) ) O
. . O

Preheparin NNP O
LPL NNP B-Gene
mass NNP O
level NN O
did VBD O
not RB O
significantly RB O
differ VB O
in IN O
individuals NNS O
from IN O
19 CD O
to TO O
70 CD O
years NNS O
old JJ O
, , O
for IN O
both DT O
men NNS O
and CC O
women NNS O
. . O

In IN O
summary JJ O
, , O
p56 NN B-Gene
( ( O
lck JJ B-Gene
) ) O
activity NN O
stimulates VBZ O
G1 NNP O
/ NNP O
S NNP O
transition NN O
in IN O
immature NN O
thymoblasts NNS O
and CC O
maintains NNS O
cell VBP O
viability NN O
via IN O
transduction NN O
of IN O
constitutive JJ O
activation NN O
signals NNS O
downstream VBP O
to TO O
components NNS O
of IN O
the DT O
Ras NNP B-Gene
/ NNP O
Raf NNP B-Gene
/ NNP O
MAPK NNP B-Gene
pathway NN O
. . O

However RB O
, , O
its PRP$ O
participation NN O
in IN O
collagen NN B-Gene
binding NN O
has VBZ O
not RB O
been VBN O
shown VBN O
. . O

TOR2 NNP B-Gene
is VBZ O
part NN O
of IN O
two CD O
related JJ O
signaling VBG O
pathways NNS O
coordinating VBG O
cell NN O
growth NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

In IN O
mammals NNS O
, , O
the DT O
transcriptional JJ O
repressors NNS O
in IN O
the DT O
Wnt NNP B-Gene
pathway NN O
are VBP O
not RB O
well RB O
defined VBN O
. . O

Furthermore RB O
, , O
the DT O
validity NN O
of IN O
this DT O
new JJ O
subset NN O
of IN O
questions NNS O
was VBD O
shown VBN O
to TO O
be VB O
significant JJ O
( ( O
r VB O
= RB O
0 CD O
. . O
37 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
5 CD O
) ) O
for IN O
the DT O
correlation NN O
between IN O
a DT O
measure NN O
of IN O
the DT O
severity NN O
of IN O
binocular JJ O
visual JJ O
field NN O
loss NN O
and CC O
the DT O
mean JJ O
score NN O
of IN O
the DT O
variables NNS O
used VBN O
in IN O
the DT O
glaucoma NN O
specific JJ O
subgroup NN O
of IN O
questions NNS O
. . O

The DT O
same JJ O
- : O
sized VBN O
EBNA NNP B-Gene
protein NN I-Gene
( ( I-Gene
approximately RB I-Gene
78 CD I-Gene
, , I-Gene
0 CD I-Gene
) ) I-Gene
was VBD O
made VBN O
after IN O
transfection NN O
with IN O
BamHI NNP B-Gene
- : I-Gene
K NNP I-Gene
( ( I-Gene
5 CD I-Gene
. . I-Gene
2 CD I-Gene
kilobase NN I-Gene
pairs NNS I-Gene
[ VBP I-Gene
kbp VB I-Gene
] NNP I-Gene
) ) I-Gene
or CC O
the DT O
I1f NNP O
subfragment NN O
( ( O
2 CD O
. . O
9 CD O
kbp NN O
) ) O
. . O

The DT O
PCr NNP O
resynthesis NN O
rate NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
and CC O
the DT O
effective JJ O
maximal JJ O
rate NN O
of IN O
mitochondrial JJ O
ATP NNP O
synthesis NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
also RB O
improved VBN O
. . O

IdB NN O
1031 CD O
was VBD O
first RB O
extracted VBN O
by IN O
liquid JJ O
- : O
solid JJ O
partition NN O
and CC O
the DT O
extracts NNS O
were VBD O
evaporated VBN O
and CC O
analysed VBN O
on IN O
a DT O
reversed JJ O
- : O
phase NN O
column NN O
under IN O
isocratic JJ O
conditions NNS O
, , O
using VBG O
either CC O
an DT O
electrochemical JJ O
or CC O
a DT O
UV NNP O
detector NN O
. . O

Treatment NN O
of IN O
PCC4 NNP O
. . O
aza1R NN O
cells NNS O
with IN O
an DT O
RAR NNP B-Gene
- : O
selective JJ O
agonist NN O
also RB O
repressed VBD O
the DT O
expression NN O
of IN O
EC NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
while IN O
treatment NN O
with IN O
an DT O
RXR NNP B-Gene
- : O
selective JJ O
agonist NN O
reduced VBD O
EC NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
slightly RB O
. . O

Efficient JJ O
phosphorylation NN O
of IN O
BRDG1 NNP B-Gene
by IN O
Tec NNP B-Gene
required VBD O
the DT O
PH NNP B-Gene
and CC O
SH2 NNP B-Gene
domains VBZ I-Gene
as RB O
well RB O
as IN O
the DT O
kinase NN O
domain NN O
of IN O
the DT O
latter NN O
. . O

We PRP O
show VBP O
, , O
by IN O
injection NN O
of IN O
synthetic JJ O
mRNAs NN O
, , O
that IN O
the DT O
cis NN O
- : O
acting NN O
sequences NNS O
responsible JJ O
for IN O
repression NN O
of IN O
cyclin NN B-Gene
B1 NNP I-Gene
mRNA NN I-Gene
reside NN O
within IN O
its PRP$ O
3 CD O
' POS O
UTR NNP O
. . O

Since IN O
the DT O
stability NN O
of IN O
TF1 NNP B-Gene
resides NNS O
in IN O
its PRP$ O
primary JJ O
structure NN O
, , O
we PRP O
cloned VBD O
a DT O
gene NN O
coding VBG O
for IN O
TF1 NNP B-Gene
, , O
and CC O
the DT O
primary JJ O
structure NN O
of IN O
the DT O
beta NN O
subunit NN O
was VBD O
deduced VBN O
from IN O
the DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
gene NN O
to TO O
compare VB O
the DT O
sequence NN O
with IN O
those DT O
of IN O
beta NN O
' POS O
s NN O
of IN O
three CD O
major JJ O
categories NNS O
of IN O
F1 NNP B-Gene
' POS O
s NN O
; : O
prokaryotic JJ O
membranes NNS O
, , O
chloroplasts NNS O
, , O
and CC O
mitochondria NNS O
. . O

A DT O
short JJ O
open JJ O
reading NN O
frame NN O
( ( O
ORF2 NNP O
) ) O
, , O
of IN O
unknown JJ O
function NN O
, , O
is VBZ O
present JJ O
in IN O
all DT O
FIV NNP O
isolates NNS O
. . O

Valuing VBG O
families NNS O
: : O
social JJ O
work NN O
practice NN O
with IN O
families NNS O
from IN O
a DT O
strengths JJ O
perspective NN O
. . O

Prospects NNS O
for IN O
controlled VBN O
- : O
delivery NN O
systems NNS O
. . O

The DT O
role NN O
of IN O
neuroplasticity NN O
in IN O
the DT O
response NN O
to TO O
drugs NNS O
. . O

However RB O
, , O
in IN O
those DT O
studies NNS O
due VBP O
to TO O
the DT O
presence NN O
of IN O
thiol JJ O
agents NNS O
in IN O
the DT O
PKC NNP B-Gene
preparations NNS O
, , O
the DT O
sensitive JJ O
reaction NN O
of IN O
BPO NNP O
with IN O
redox JJ O
- : O
active JJ O
cysteine NN O
residues NNS O
in IN O
PKC NNP B-Gene
was VBD O
not RB O
observed VBN O
. . O

From IN O
these DT O
results NNS O
, , O
we PRP O
concluded VBD O
that IN O
this DT O
ORF NNP O
is VBZ O
the DT O
FRDS NNP B-Gene
gene NN I-Gene
. . O

Recessive JJ O
lethal JJ O
mutations NNS O
were VBD O
isolated VBN O
based VBN O
upon IN O
failure NN O
to TO O
complement VB O
the DT O
recessive JJ O
lethality NN O
of IN O
Df NNP O
( ( O
3L CD O
) ) O
RR2 NNP O
, , O
a DT O
deletion NN O
of IN O
the DT O
DRE NNP O
region NN O
that WDT O
removes VBZ O
16 CD O
- : O
18 CD O
polytene JJ O
chromosome NN O
bands NNS O
. . O

To TO O
identify VB O
the DT O
important JJ O
cis NN O
- : O
DNA NN O
regulatory JJ O
element NN O
( ( O
s PRP O
) ) O
involved VBN O
in IN O
the DT O
tissue NN O
- : O
, , O
region NN O
- : O
, , O
and CC O
cell NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
mE NN B-Gene
- : I-Gene
RABP NNP I-Gene
gene NN I-Gene
, , O
the DT O
5 CD O
- : O
kb NN O
DNA NNP O
fragment NN O
was VBD O
sequenced VBN O
. . O

Endosonography NNP O
accurately RB O
assessed VBD O
tumor NN O
extension NN O
in IN O
two CD O
T2 NNP O
tumors NNS O
, , O
14 CD O
T3 NNP O
tumors NNS O
, , O
and CC O
seven CD O
T4 NNP O
tumors NNS O
. . O

The DT O
sequence NN O
of IN O
the DT O
pMxL1 NN O
plasmid NN O
containing VBG O
the DT O
invertible JJ O
region NN O
contains VBZ O
a DT O
perfect JJ O
tandem NN O
repeat NN O
of IN O
19 CD O
bp NN O
in IN O
the DT O
orientation NN O
1 CD O
nonexpressed JJ O
pilin NN B-Gene
gene NN I-Gene
at IN O
the DT O
middle NN O
of IN O
the DT O
recombination NN O
junction NN O
site NN O
. . O

The DT O
nucleosomal JJ O
arrays NNS O
detected VBN O
by IN O
MPE NNP O
X NNP O
Fe NNP O
( ( O
II NNP O
) ) O
were VBD O
characterized VBN O
by IN O
a DT O
considerable JJ O
loss NN O
of IN O
detail NN O
and CC O
significantly RB O
enhanced JJ O
accessibility NN O
, , O
the DT O
extent NN O
of IN O
which WDT O
probably RB O
reflected VBD O
the DT O
relative JJ O
transcription NN O
rate NN O
of IN O
each DT O
gene NN O
. . O

Rat NNP B-Gene
liver NN I-Gene
catalase NN I-Gene
is VBZ O
sorted VBN O
to TO O
peroxisomes NNS O
by IN O
its PRP$ O
C NNP O
- : O
terminal JJ O
tripeptide NN O
Ala NNP O
- : O
Asn NNP O
- : O
Leu NNP O
, , O
not RB O
by IN O
the DT O
internal JJ O
Ser NNP O
- : O
Lys NNP O
- : O
Leu NNP O
motif NN O
. . O

N NNP O
- : O
terminal JJ O
sequence NN O
analysis NN O
and CC O
NMR NNP O
measurements NNS O
revealed VBD O
that IN O
this DT O
fragment JJ O
originates VBZ O
from IN O
the DT O
C NNP O
- : O
terminal JJ O
80 CD O
residues NNS O
of IN O
MBF1 NNP B-Gene
and CC O
form VB O
a DT O
well RB O
structured VBN O
C NNP O
- : O
terminal JJ O
domain NN O
of IN O
MBF1 NNP B-Gene
, , O
MBF1CTD NNP B-Gene
. . O

Twenty CD O
food NN O
products NNS O
were VBD O
contaminated VBN O
with IN O
V NNP O
. . O
cholerae NN O
O1 NNP O
, , O
Ogawa NNP O
, , O
toxigenic NN O
and CC O
not RB O
toxigenic JJ O
strains NNS O
: : O
yoghurt NN O
, , O
cream NN O
cheese NN O
, , O
apricot JJ O
marmelade NN O
, , O
hip NN O
rose VBD O
marmelade NN O
, , O
mayonnaise NN O
, , O
italian JJ O
pasta NN O
for IN O
"""" NNP O
empanadas FW O
"""" NNP O
, , O
"""" NNP O
dulce FW O
de FW O
leche FW O
"""" NNP O
, , O
meat NN O
sausage NN O
, , O
meat NN O
and CC O
spinach NN O
ravioli NN O
, , O
margarine NN O
, , O
milk NN O
dessert NN O
( ( O
made VBN O
with IN O
cocoa NN O
, , O
milk NN O
confiture NN O
, , O
starch NN O
and CC O
additives NNS O
) ) O
, , O
lettuce UH O
, , O
tuna JJ O
fish NN O
, , O
ricotta NN O
and CC O
sterilized VBN O
milk NN O
. . O

Bullous NNP O
keratopathy NN O
was VBD O
usually RB O
aphakic VBN O
in IN O
origin NN O
in IN O
1982 CD O
, , O
but CC O
after IN O
1983 CD O
pseudophakic NN O
bullous JJ O
keratopathy NN O
( ( O
PBK NNP O
) ) O
was VBD O
the DT O
most RBS O
common JJ O
cause NN O
of IN O
bullous JJ O
keratopathy NNS O
. . O

The DT O
por NN B-Gene
gene NN I-Gene
has VBZ O
been VBN O
expressed VBN O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
in IN O
anaerobically RB O
grown VBN O
Escherichia NNP O
coli NN O
behind IN O
the DT O
isopropyl JJ O
- : O
beta NN O
- : O
D NNP O
- : O
thiogalactopyranoside NN O
- : O
inducible JJ O
tac NN B-Gene
promoter NN I-Gene
, , O
resulting VBG O
in IN O
the DT O
production NN O
of IN O
POR NNP B-Gene
in IN O
its PRP$ O
active JJ O
form NN O
. . O

The DT O
interaction NN O
of IN O
caffeine NN O
, , O
theophylline NN O
and CC O
theobromine NN O
with IN O
monoamine JJ B-Gene
oxidase NN I-Gene
inhibitors NNS O
. . O

In IN O
the DT O
whole JJ O
group NN O
of IN O
infected JJ O
children NNS O
, , O
an DT O
age NN O
- : O
specific JJ O
z NN O
score NN O
< NNP O
- : O
2 CD O
for IN O
weight NN O
and CC O
for IN O
FFM NNP O
was VBD O
significantly RB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
death NN O
[ NNP O
relative NN O
risk NN O
( ( O
95 CD O
% NN O
CI NNP O
) ) O
= VBD O
11 CD O
. . O
4 CD O
( ( O
3 CD O
. . O
1 CD O
, , O
41 CD O
. . O
0 CD O
) ) O
and CC O
5 CD O
. . O
1 CD O
( ( O
1 CD O
. . O
5 CD O
, , O
18 CD O
. . O
2 CD O
) ) O
, , O
respectively RB O
] VBP O
; : O
when WRB O
only RB O
children NNS O
with IN O
more RBR O
severe JJ O
disease NN O
were VBD O
considered VBN O
, , O
only RB O
z VBZ O
score NN O
for IN O
weight NN O
was VBD O
significantly RB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
[ NN O
4 CD O
. . O
6 CD O
( ( O
1 CD O
. . O
4 CD O
, , O
14 CD O
. . O
9 CD O
) ) O
] NN O
. . O

1972 CD O
. . O

Two CD O
rare JJ O
novel JJ O
mutations NNS O
, , O
D811N NNP O
in IN O
exon CC O
20 CD O
and CC O
R835C NNP O
in IN O
exon JJ O
21 CD O
, , O
were VBD O
identified VBN O
in IN O
the DT O
first JJ O
nucleotide JJ O
- : O
binding NN O
fold NN O
( ( O
NBF NNP O
) ) O
, , O
a DT O
functionally RB O
important JJ O
region NN O
of IN O
SUR1 NNP B-Gene
, , O
in IN O
one CD O
patient NN O
each DT O
, , O
both DT O
heterozygotes NNS O
. . O

There EX O
were VBD O
15 CD O
deaths NNS O
, , O
seven CD O
of IN O
which WDT O
were VBD O
felt VBN O
to TO O
be VB O
avoidable JJ O
. . O

Since IN O
1948 CD O
, , O
the DT O
use NN O
of IN O
saline JJ O
- : O
washed VBN O
red JJ O
cells NNS O
( ( O
WRBCs NNP O
) ) O
has VBZ O
been VBN O
advocated VBN O
to TO O
minimize VB O
hemolysis NN O
after IN O
transfusion NN O
to TO O
patients NNS O
with IN O
PNH NNP O
. . O

The DT O
alternative JJ O
splice NN O
sites NNS O
for IN O
the DT O
smallest JJS O
adducin JJ B-Gene
isoform NN O
, , O
beta SYM B-Gene
- : I-Gene
3 CD I-Gene
, , O
are VBP O
alternative JJ O
donor NN O
and CC O
acceptor NN O
sites NNS O
within IN O
exons NNS O
7 CD O
and CC O
12 CD O
. . O

The DT O
ratio NN O
of IN O
the DT O
activity NN O
of IN O
arogenate JJ B-Gene
dehydrogenase NN I-Gene
to TO O
that DT O
of IN O
prephenate NN B-Gene
dehydrogenase NN I-Gene
( ( O
approximately RB O
3 CD O
: : O
1 CD O
) ) O
remained VBD O
constant JJ O
throughout IN O
purification NN O
, , O
and CC O
the DT O
two CD O
activities NNS O
were VBD O
therefore RB O
inseparable JJ O
. . O

Deletion NNP O
analysis NN O
of IN O
the DT O
ICL1 NNP B-Gene
promoter NN I-Gene
led VBD O
to TO O
the DT O
identification NN O
of IN O
an DT O
upstream JJ O
activating NN O
sequence NN O
element NN O
, , O
UASICL1 NNP O
( ( O
5 CD O
' '' O
CATTCATCCG NNP O
3 CD O
' '' O
) ) O
, , O
necessary JJ O
and CC O
sufficient JJ O
for IN O
conferring VBG O
carbon NN O
source NN O
- : O
dependent JJ O
regulation NN O
on IN O
a DT O
heterologous JJ O
reporter NN O
gene NN O
. . O

Pneumothorax NNP O
complicated VBN O
by IN O
chronic JJ O
steroid NN O
treatment NN O
. . O

Elements NNS O
that WDT O
are VBP O
fundamental JJ O
to TO O
the DT O
safety NN O
evaluation NN O
of IN O
flavor NN O
ingredients NNS O
include VBP O
exposure NN O
, , O
structural JJ O
analogy NN O
, , O
metabolism NN O
, , O
pharmacokinetics NNS O
and CC O
toxicology NN O
. . O

A DT O
7 CD O
- : O
day NN O
treatment NN O
of IN O
amphotericin NN O
B NNP O
( ( O
5 CD O
mg NN O
/ NNP O
kg NN O
/ NNP O
day NN O
i NN O
. . O
p NN O
. . O
) ) O
significantly RB O
reduced VBD O
the DT O
glomerular JJ O
filtration NN O
rate NN O
( ( O
GFR NNP O
) ) O
measured VBD O
as IN O
inuline JJ O
clearance NN O
and CC O
creatinine JJ O
clearance NN O
( ( O
0 CD O
. . O
74 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
29 CD O
and CC O
0 CD O
. . O
16 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
ml JJ O
/ NNP O
min NN O
, , O
respectively RB O
) ) O
in IN O
comparison NN O
to TO O
vehicle NN O
- : O
treated VBN O
rats NNS O
( ( O
2 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
23 CD O
and CC O
1 CD O
. . O
29 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
19 CD O
ml JJ O
/ NNP O
min NN O
, , O
respectively RB O
) ) O
. . O

Taken VBN O
together RB O
, , O
they PRP O
uphold VBP O
the DT O
emerging VBG O
concern NN O
that IN O
women NNS O
with IN O
ER NNP B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
cancers NNS O
may MD O
not RB O
benefit VB O
significantly RB O
from IN O
endocrine JJ O
treatment NN O
if IN O
the DT O
tumors NNS O
also RB O
overexpress VBP O
HER NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

The DT O
effect NN O
of IN O
Vpu NNP B-Gene
on IN O
class NN O
I PRP O
biogenesis NN O
was VBD O
analyzed VBN O
in IN O
more JJR O
detail NN O
using VBG O
a DT O
Vpu NNP B-Gene
- : O
expressing VBG O
recombinant JJ O
vaccinia NN O
virus NN O
( ( O
VV NNP O
) ) O
. . O

The DT O
extent NN O
of IN O
the DT O
fbpA NN B-Gene
operator NN I-Gene
sequence NN I-Gene
( ( I-Gene
42 CD I-Gene
bp NN I-Gene
) ) I-Gene
, , O
as IN O
defined VBN O
by IN O
our PRP$ O
footprinting NN O
analysis NN O
, , O
would MD O
suggest VB O
the DT O
binding NN O
of IN O
two CD O
Fur NNP B-Gene
repressor NN I-Gene
dimers NNS I-Gene
. . O

Liposomal NNP O
Amphotericin NNP O
- : O
B NNP O
failed VBD O
in IN O
6 CD O
/ JJ O
7 CD O
patients NNS O
with IN O
culture NN O
- : O
proven JJ O
mycosis NN O
who WP O
died VBD O
from IN O
infection NN O
with IN O
Aspergillus NNP O
( ( O
n JJ O
= NNP O
2 CD O
) ) O
and CC O
Candida NNP O
( ( O
n JJ O
= NNP O
4 CD O
) ) O
, , O
respectively RB O
. . O

Lack NNP O
of IN O
association NN O
between IN O
Kawasaki NNP O
syndrome NN O
and CC O
infection NN O
with IN O
Rickettsia NNP O
conorii NN O
, , O
Rickettsia NNP O
typhi NN O
, , O
Coxiella NNP O
burnetii NN O
or CC O
Ehrlichia NNP O
phagocytophila NN O
group NN O
. . O

Comparisons NNS O
with IN O
the DT O
available JJ O
amino NN O
acid NN O
residue NN O
( ( O
aa NN O
) ) O
sequence NN O
information NN O
from IN O
the DT O
complete JJ O
CPMV NNP B-Gene
RNA NNP I-Gene
1 CD I-Gene
sequence NN I-Gene
and CC O
the DT O
partial JJ O
sequence NN O
of IN O
red JJ B-Gene
clover NN I-Gene
mottle RB I-Gene
virus JJ I-Gene
RNA NNP I-Gene
1 CD I-Gene
suggest NN O
that IN O
CPSMV NNP B-Gene
RNA NNP I-Gene
1 CD I-Gene
specifies VBZ O
the DT O
expected JJ O
set NN O
of IN O
five CD O
mature JJ O
proteins NNS O
: : O
32K CD B-Gene
proteinase NN I-Gene
cofactor NN I-Gene
, , O
58K CD B-Gene
presumed JJ I-Gene
helicase NN I-Gene
, , O
VPg NNP B-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
linked VBN I-Gene
protein NN I-Gene
of IN O
the DT O
genomic JJ O
RNAs NNP O
, , O
24K CD B-Gene
proteinase NN I-Gene
, , O
and CC O
87K CD B-Gene
presumed JJ I-Gene
polymerase NN I-Gene
, , O
separated VBN O
by IN O
four CD O
cleavage NN O
sites NNS O
. . O

The DT O
structural JJ O
gene NN O
for IN O
hydrogenase NN B-Gene
encodes VBZ O
a DT O
protein JJ O
product NN O
of IN O
molecular JJ O
mass NN O
45820 CD O
Da NNP O
. . O

Probable JJ O
progressive JJ O
multifocal JJ O
leukoencephalopathy NN O
( ( O
PML NNP O
) ) O
was VBD O
diagnosed VBN O
on IN O
the DT O
basis NN O
of IN O
clinical JJ O
picture NN O
and CC O
magnetic JJ O
resonance NN O
imaging NN O
in IN O
a DT O
63 CD O
- : O
year NN O
- : O
old JJ O
man NN O
with IN O
a DT O
complete JJ O
remission NN O
of IN O
a DT O
non JJ O
- : O
Hodgkin NNP O
' POS O
s NN O
lymphoma NN O
. . O

Cotransfection NN O
of IN O
the DT O
helicase NN B-Gene
- : O
primase NN B-Gene
proteins NNS O
, , O
one CD O
of IN O
which WDT O
was VBD O
fused VBN O
to TO O
a DT O
heterologous JJ O
activation NN O
domain NN O
, , O
led VBN O
to TO O
Zta NNP B-Gene
- : O
dependent JJ O
superactivation NN O
of IN O
CAT NNP B-Gene
expression NN O
. . O

Recently RB O
, , O
an DT O
electrical JJ O
- : O
mechanical JJ O
analog NN O
model NN O
of IN O
heat NN O
flow NN O
within IN O
the DT O
brain NN O
has VBZ O
been VBN O
developed VBN O
from IN O
which WDT O
an DT O
expression NN O
for IN O
CBF NNP O
has VBZ O
been VBN O
derived VBN O
: : O
CBF NNP O
= NNP O
Cb NNP O
/ NNP O
( ( O
tau JJ O
rho NN O
c NN O
) ) O
where WRB O
tau NN O
is VBZ O
the DT O
thermal JJ O
decay NN O
constant NN O
, , O
rho NN O
is VBZ O
the DT O
density NN O
of IN O
blood NN O
, , O
and CC O
c NN O
is VBZ O
its PRP$ O
specific JJ O
heat NN O
. . O

Plasma NNP O
concentrations NNS O
of IN O
atracurium NN O
and CC O
laudanosine NN O
were VBD O
0 CD O
. . O
73 CD O
- : O
3 CD O
. . O
11 CD O
micrograms NNS O
ml VBD O
- : O
1 CD O
and CC O
0 CD O
. . O
48 CD O
- : O
8 CD O
. . O
65 CD O
micrograms NNS O
ml VBD O
- : O
1 CD O
, , O
respectively RB O
; : O
CSF NNP O
concentration NN O
of IN O
laudanosine NN O
was VBD O
70 CD O
- : O
440 CD O
ng JJ O
ml SYM O
- : O
1 CD O
. . O

Subcellular JJ O
localizations NNS O
of IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
CBFbeta NNP I-Gene
and CC O
the DT O
CBFbeta NNP B-Gene
- : O
SMMHC NNP B-Gene
fusion NN O
protein NN O
were VBD O
determined VBN O
by IN O
immunofluorescence NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
that IN O
overexpress NN O
wild SYM O
- : O
type NN O
or CC O
fusion NN O
protein NN O
. . O

Prognosis NN O
in IN O
Bowen NNP O
' POS O
s JJ O
disease NN O
localized VBN O
to TO O
the DT O
ano NN O
- : O
genital JJ O
region NN O
. . O

Chronic NNP O
dose JJ O
effects NNS O
of IN O
methyl JJ O
parathion NN O
on IN O
nuthatches NNS O
: : O
cholinesterase NN B-Gene
and CC O
ptilochronology NN O
. . O

The DT O
data NN O
indicate NN O
that IN O
the DT O
five CD O
different JJ O
( ( O
and CC O
partially RB O
overlapping VBG O
) ) O
sry NN B-Gene
messenger NN I-Gene
RNAs NNP I-Gene
detectable NN O
in IN O
early JJ O
embryos NN O
are VBP O
initiated VBN O
at IN O
three CD O
separate JJ O
sites NNS O
, , O
each DT O
directly RB O
upstream RB O
from IN O
one CD O
of IN O
the DT O
three CD O
protein SYM O
- : O
coding NN O
regions NNS O
, , O
designated VBN O
( ( O
in IN O
5 CD O
' '' O
to TO O
3 CD O
' '' O
order NN O
) ) O
beta NN O
, , O
alpha NN O
and CC O
delta NN O
. . O

Significance NN O
of IN O
thin JJ O
glomerular JJ O
basement NN O
membranes NNS O
in IN O
hematuric JJ O
children NNS O
. . O

Interestingly RB O
, , O
one CD O
IRF NNP B-Gene
binding VBG I-Gene
site NN I-Gene
was VBD O
found VBN O
within IN O
the DT O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
, , O
and CC O
expression NN O
of IN O
the DT O
IRF NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
was VBD O
affected VBN O
by IN O
both DT O
transient NN O
and CC O
stable JJ O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
. . O

Our PRP$ O
laboratory NN O
and CC O
others NNS O
have VBP O
shown VBN O
alternative JJ O
splicing NN O
of IN O
up IN O
to TO O
ten VB O
exons NNS O
at IN O
a DT O
discrete JJ O
extracellular JJ O
site NN O
to TO O
be VB O
primarily RB O
responsible JJ O
for IN O
the DT O
generation NN O
of IN O
CD44 NNP B-Gene
variant NN I-Gene
( ( O
CD44v NNP B-Gene
) ) O
isoforms NNS O
. . O

In IN O
visible JJ O
tumours NNS O
the DT O
best JJS O
results NNS O
were VBD O
obtained VBN O
with IN O
FB NNP O
( ( O
85 CD O
% NN O
) ) O
while IN O
TBN NNP O
was VBD O
positive JJ O
in IN O
65 CD O
% NN O
. . O

Use NNP O
of IN O
Medi NNP O
- : O
Jector NN O
EZ NNP O
dermojet NN O
for IN O
anesthesia NN O
in IN O
minor JJ O
surgery NN O

The DT O
second JJ O
part NN O
of IN O
this DT O
paper NN O
shows VBZ O
some DT O
medical JJ O
applications NNS O
of IN O
these DT O
two CD O
aspects NNS O
of IN O
NMR NNP O
, , O
with IN O
help NN O
of IN O
some DT O
examples NNS O
, , O
taken VBN O
from IN O
the DT O
literature NN O
, , O
according VBG O
to TO O
what WP O
is VBZ O
concerned VBN O
with IN O
endocrinology NN O
. . O

The DT O
mRNA JJ O
expression NN O
of IN O
RFX1 NNP B-Gene
, , O
RFX2 NNP B-Gene
, , O
and CC O
RFX3 NNP B-Gene
was VBD O
detected VBN O
ubiquitously RB O
, , O
but CC O
in IN O
transient JJ O
- : O
transfection NN O
assays NNS O
, , O
multimerized VBN B-Gene
RFX NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
front NN O
of IN O
a DT O
basal NN O
promoter NN O
efficiently RB O
functioned VBN O
in IN O
a DT O
tissue NN O
- : O
and CC O
lineage VB O
- : O
specific JJ O
manner NN O
. . O

A DT O
probe NN O
evoked VBN O
potentials NNS O
procedure NN O
was VBD O
used VBN O
to TO O
assess VB O
the DT O
relative JJ O
engagement NN O
of IN O
both DT O
cerebral JJ O
hemispheres NNS O
during IN O
a DT O
language NN O
task NN O
in IN O
the DT O
following JJ O
four CD O
groups NNS O
of IN O
dextral JJ O
adults NNS O
: : O
left NN O
hemisphere NN O
( ( O
LH NNP O
) ) O
- : O
damaged VBN O
aphasics NNS O
recovering VBG O
from IN O
stroke NN O
, , O
dysarthrics NNS O
, , O
right RB O
hemisphere RB O
( ( O
RH NNP O
) ) O
- : O
damaged VBN O
nonaphasic JJ O
patients NNS O
, , O
and CC O
normal JJ O
control NN O
subjects NNS O
. . O

Preceptorship NN O
of IN O
CNS JJ O
students NNS O
: : O
an DT O
exploratory NN O
study NN O
. . O

The DT O
patients NNS O
undergoing JJ O
VTLB NNP O
had VBD O
significantly RB O
shorter RBR O
operative JJ O
times NNS O
( ( O
VTLB NNP O
, , O
100 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
27 CD O
. . O
2 CD O
min NN O
. . O
vs NN O
OLB NNP O
, , O
119 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
42 CD O
. . O
6 CD O
min NN O
; : O
p CC O
< $ O
0 CD O
. . O
1 CD O
) ) O
and CC O
less JJR O
blood NN O
loss NN O
( ( O
VTLB NNP O
, , O
4 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
14 CD O
. . O
6 CD O
ml JJ O
vs NN O
OLB NNP O
, , O
65 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
77 CD O
. . O
0 CD O
ml NN O
; : O
p CC O
< $ O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
relation NN O
between IN O
VE NNP O
/ NNP O
VO2 NNP O
and CC O
Q NNP O
/ NNP O
VO2 NNP O
showed VBD O
a DT O
significant JJ O
negative JJ O
correlation NN O
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
93 CD O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Refined VBN O
Cox NNP O
models NNS O
using VBG O
a DT O
CD4 NNP B-Gene
count NN O
of IN O
150 CD O
/ NNS O
microL VBP O
rather RB O
than IN O
200 CD O
/ JJ O
microL NN O
to TO O
distinguish VB O
I0 NNP O
and CC O
I1 NNP O
yielded VBD O
a DT O
simplified JJ O
model NN O
with IN O
better JJR O
fit NN O
to TO O
the DT O
observed VBN O
data NNS O
. . O

The DT O
only JJ O
isolate NN O
of IN O
Aeromonas NNP O
hydrophila NN O
produced VBD O
cytotoxic JJ O
enterotoxin NN O
and CC O
was VBD O
invasive JJ O
. . O

The DT O
amount NN O
of IN O
drained JJ O
effusion NN O
was VBD O
measured VBN O
, , O
and CC O
fluid NN O
was VBD O
sent VBN O
for IN O
diagnostic JJ O
assessment NN O
. . O

Ischemia NNP O
- : O
induced JJ O
biphasic JJ O
arrhythmias NNS O
were VBD O
suppressed VBN O
in IN O
both DT O
zatebradine NN O
and CC O
propranolol NN O
groups NNS O
. . O

The DT O
sequence NN O
was VBD O
determined VBN O
of IN O
6493 CD O
nucleotides NNS O
encompassing VBG O
the DT O
bet NN B-Gene
genes NNS I-Gene
of IN I-Gene
Escherichia NNP I-Gene
coli NN I-Gene
which WDT O
encode VBZ O
the DT O
osmoregulatory JJ O
choline NN O
- : O
glycine NN O
betaine NN O
pathway NN O
. . O

Association NNP O
with IN O
HL NNP B-Gene
- : I-Gene
A DT I-Gene
W NNP I-Gene
- : I-Gene
27 CD I-Gene
. . O

Experimental JJ O
ischemic JJ O
heart NN O
disease NN O
induced VBN O
by IN O
thromboxane NN O
A2 NNP O
in IN O
rabbits NNS O
. . O

This DT O
study NN O
demonstrates VBZ O
that IN O
inducible JJ O
expression NN O
in IN O
response NN O
to TO O
either DT O
PMA NNP O
or CC O
TPO NNP B-Gene
is VBZ O
mediated VBN O
through IN O
the DT O
Ets NNP B-Gene
site NN I-Gene
in IN O
the DT O
proximal JJ O
promoter NN O
of IN O
GPIX NNP B-Gene
and CC O
is VBZ O
dependent JJ O
upon IN O
the DT O
upstream JJ O
activation NN O
of IN O
MAPK NNP B-Gene
/ NNP O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
. . O

Four CD O
p53 NN B-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
peptides NNS I-Gene
bind IN O
natural JJ O
p53 NN B-Gene
- : I-Gene
response NN I-Gene
elements NNS I-Gene
and CC O
bend VB O
the DT O
DNA NN O
. . O

In IN O
the DT O
B6 NNP O
- : O
derived VBD O
Db NNP B-Gene
mutant JJ I-Gene
B6 NNP I-Gene
. . I-Gene
CH NNP I-Gene
- : I-Gene
2bm13 CD I-Gene
( ( I-Gene
bm13 NN I-Gene
) ) I-Gene
strain NN O
, , O
part NN O
of IN O
the DT O
class NN B-Gene
I PRP I-Gene
Db NNP I-Gene
antigen SYM I-Gene
- : I-Gene
presenting NN I-Gene
groove NN I-Gene
is VBZ O
shaped VBN O
by IN O
a DT O
class NN B-Gene
I PRP I-Gene
Kb NNP I-Gene
- : I-Gene
encoded VBD I-Gene
sequence NN I-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
combined JJ O
treatment NN O
with IN O
a DT O
thromboxane NN B-Gene
synthetase NN I-Gene
inhibitor NN O
and CC O
a DT O
thromboxane NN B-Gene
receptor NN I-Gene
antagonist NN O
provides VBZ O
a DT O
better JJR O
protection NN O
against IN O
digoxin NN O
intoxication NN O
than IN O
with IN O
either DT O
agent NN O
alone RB O
. . O

The DT O
high JJ O
level NN O
of IN O
transformation NN O
- : O
associated VBN O
deletions NNS O
in IN O
the DT O
human JJ O
YACs NN O
was VBD O
reduced VBN O
over IN O
10 CD O
- : O
fold NN O
when WRB O
the DT O
host NN O
was VBD O
a DT O
recombination NN O
- : O
deficient NN O
strain NN O
deleted VBD O
for IN O
the DT O
RAD52 NNP B-Gene
gene NN I-Gene
. . O

ZEBRA NNP B-Gene
and CC O
cellular JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
bZip NN I-Gene
activators NNS I-Gene
, , O
such JJ O
as IN O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
, , O
have VBP O
homologous JJ O
DNA NNP O
- : O
binding NN O
domains NNS O
, , O
and CC O
their PRP$ O
DNA NN O
- : O
binding NN O
specificities NNS O
overlap VBP O
. . O

Comparison NNP O
of IN O
elastase NNP B-Gene
- : I-Gene
1 CD I-Gene
with IN O
amylase NN B-Gene
, , O
lipase NN B-Gene
, , O
and CC O
trypsin SYM B-Gene
- : O
like IN O
immunoreactivity NN O
in IN O
the DT O
diagnosis NN O
of IN O
acute JJ O
pancreatitis NN O
. . O

Analysis NN O
of IN O
several JJ O
Tat NNP B-Gene
mutants NNS I-Gene
indicated VBD O
that IN O
both DT O
the DT O
cysteine NN O
- : O
rich JJ O
and CC O
the DT O
core NN O
domains NNS O
of IN O
this DT O
transactivator NN O
are VBP O
necessary JJ O
and CC O
sufficient JJ O
to TO O
activate VB O
transcription NN O
when WRB O
TBP NNP B-Gene
is VBZ O
overexpressed VBN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
IIIa NNP O
pre VBD O
- : O
mRNA NN O
splicing NN O
is VBZ O
activated VBN O
more JJR O
than IN O
200 CD O
- : O
fold NN O
in IN O
nuclear JJ O
extracts NNS O
prepared VBN O
from IN O
late JJ O
adenovirus NN O
- : O
infected JJ O
cells NNS O
( ( O
Ad NNP O
- : O
NE NN O
) ) O
compared VBN O
to TO O
uninfected JJ O
HeLa NNP O
cell NN O
nuclear JJ O
extracts NNS O
( ( O
HeLa NNP O
- : O
NE NN O
) ) O
. . O

We PRP O
investigated VBD O
the DT O
production NN O
of IN O
hyaluronan NN O
( ( O
HA NNP O
) ) O
and CC O
its PRP$ O
effect NN O
on IN O
cell NN O
motility NN O
in IN O
cells NNS O
expressing VBG O
the DT O
v NN B-Gene
- : I-Gene
src NN I-Gene
mutants NNS I-Gene
. . O

Copyright JJ O
2002 CD O
American JJ O
Cancer NNP O
Society NNP O
. . O
DOI NNP O
10 CD O
. . O
1002 CD O
/ JJ O
cncr NN O
. . O
10318 CD O

Two CD O
homologues NNS O
of IN O
the DT O
rhombotin NN B-Gene
gene NN I-Gene
have VBP O
now RB O
been VBN O
isolated VBN O
. . O

Previously RB O
, , O
we PRP O
identified VBD O
a DT O
51 CD O
- : O
bp NN O
promoter NN O
fragment NN O
, , O
oligo31 JJ O
/ NN O
32 CD O
, , O
which WDT O
conferred VBD O
heat NN O
shock NN O
inducibility NN O
on IN O
the DT O
heterologous JJ O
CYC1 NNP B-Gene
- : O
lacZ NN B-Gene
reporter NN O
gene NN O
in IN O
S NNP O
. . O
cerevisiae NN O
( ( O
N NNP O
. . O

Its PRP$ O
interaction NN O
with IN O
RFX5 NNP B-Gene
and CC O
RFXAP NNP B-Gene
is VBZ O
essential JJ O
for IN O
binding NN O
of IN O
the DT O
RFX NNP B-Gene
complex NN I-Gene
to TO O
MHC NNP B-Gene
- : I-Gene
II NN I-Gene
promoters NNS I-Gene
. . O

No DT O
significant JJ O
differences NNS O
between IN O
the DT O
substituted VBN O
and CC O
wild JJ O
type NN O
peptides NNS O
were VBD O
observed VBN O
, , O
suggesting VBG O
that IN O
this DT O
substitution NN O
in IN O
the DT O
intact JJ O
protein NN O
may MD O
cause VB O
disruption NN O
of IN O
global JJ O
rather RB O
than IN O
local JJ O
structures NNS O
. . O

In IN O
6 CD O
of IN O
24 CD O
infants NNS O
studied VBN O
( ( O
27th CD O
- : O
40th JJ O
weeks NNS O
of IN O
gestation NN O
) ) O
, , O
acquired VBD O
and CC O
congenital JJ O
structural JJ O
anomalies NNS O
of IN O
the DT O
airways NNS O
were VBD O
detected VBN O
with IN O
an DT O
ultrathin JJ O
flexible JJ O
fiberscope NN O
( ( O
Olympus NNP O
PF18 NNP O
S NNP O
, , O
1 CD O
. . O
8 CD O
mm NN O
) ) O
. . O

Expression NN O
, , O
nucleotide JJ O
sequence NN O
and CC O
mutational JJ O
analysis NN O
of IN O
two CD O
open JJ O
reading VBG O
frames NNS O
in IN O
the DT O
nif JJ B-Gene
gene NN I-Gene
region NN I-Gene
of IN I-Gene
Anabaena NNP I-Gene
sp NN I-Gene
. . I-Gene
strain NN I-Gene
PCC7120 NNP I-Gene
. . O

In IN O
literature NN O
, , O
the DT O
HBE NNP O
has VBZ O
been VBN O
displayed VBN O
by IN O
application NN O
of IN O
the DT O
averaging VBG O
method NN O
. . O

The DT O
Asian JJ O
mouse NN O
Mus NNP O
castaneus NN O
is VBZ O
resistant JJ O
to TO O
infection NN O
by IN O
the DT O
polytropic NN O
mink NN O
cell NN O
focus SYM O
- : O
inducing NN O
( ( O
MCF NNP O
) ) O
subgroup NN O
of IN O
murine NN O
leukemia NN O
viruses NNS O
( ( O
MuLVs NNP O
) ) O
. . O

Ribonuclease NNP O
protection NN O
assays NNS O
revealed VBD O
that IN O
hmg1 NN B-Gene
and CC O
hmg2 NN B-Gene
are VBP O
differentially RB O
expressed VBN O
in IN O
a DT O
developmentally RB O
- : O
and CC O
spatially RB O
- : O
modulated JJ O
manner NN O
during IN O
morphogenesis NN O
of IN O
specialized JJ O
terpenoid NN O
- : O
containing VBG O
pigment JJ O
glands NNS O
in IN O
embryos NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
knowledge NN O
of IN O
the DT O
epidemiology NN O
of IN O
Parkinson NNP O
' POS O
s JJ O
disease NN O
is VBZ O
necessary JJ O
in IN O
creating VBG O
etiological JJ O
hypotheses NNS O
, , O
since IN O
only RB O
hypotheses VBZ O
consistent JJ O
with IN O
the DT O
epidemiological JJ O
profile NN O
deserve NN O
careful JJ O
testing NN O
. . O

We PRP O
purified VBD O
a DT O
Ca2 NNP B-Gene
+ NNP I-Gene
/ NNP I-Gene
calmodulin NN I-Gene
( ( I-Gene
CaM NNP I-Gene
) ) I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
CaM NNP B-Gene
kinase NN I-Gene
) ) O
from IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
with IN O
properties NNS O
similar JJ O
to TO O
mammalian JJ B-Gene
type NN I-Gene
II NNP I-Gene
CaM NNP I-Gene
kinases NNS I-Gene
. . O

Members NNS O
of IN O
the DT O
JAK NNP B-Gene
/ NNP O
Tyk NNP B-Gene
family NN O
of IN O
tyrosine NN B-Gene
kinases NNS I-Gene
mediate VBP O
phosphorylation NN O
of IN O
STAT3 NNP B-Gene
at IN O
Tyr705 NNP O
during IN O
CNTF NNP B-Gene
signaling VBG O
; : O
however RB O
, , O
the DT O
kinase NN O
responsible JJ O
for IN O
phosphorylation NN O
at IN O
STAT3 NNP B-Gene
Tyr727 NNP O
appears VBZ O
to TO O
depend VB O
on IN O
both DT O
the DT O
extracellular JJ O
stimulus NN O
and CC O
the DT O
cellular JJ O
context NN O
. . O

Baseline NNP O
data NNS O
were VBD O
obtained VBN O
from IN O
10 CD O
adults NNS O
. . O

Maternal NNP O
p NN O
, , O
p NN O
' POS O
DDE NNP O
and CC O
beta SYM O
- : O
HCH NN O
levels NNS O
were VBD O
also RB O
associated VBN O
with IN O
newborn JJ O
levels NNS O
, , O
but CC O
levels NNS O
of IN O
PCBs NNP O
were VBD O
not RB O
. . O

D NNP O
. . O
melanogaster NN O
HeT NNP B-Gene
- : I-Gene
A DT I-Gene
coding NN O
sequences NNS O
have VBP O
a DT O
polymorphic JJ O
region NN O
with IN O
insertions NNS O
/ VBP O
deletions NNS O
of IN O
1 CD O
- : O
31 CD O
codons NNS O
and CC O
many JJ O
nucleotide JJ O
changes NNS O
. . O

CD3 NNP B-Gene
cross SYM O
- : O
linking VBG O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
Sam68 NNP B-Gene
in IN O
uninfected JJ O
T NNP O
cells NNS O
. . O

Endoscopic NNP O
examinations NNS O
, , O
peripheral JJ O
white JJ O
blood NN O
cell NN O
( ( O
WBC NNP O
) ) O
counts VBZ O
, , O
and CC O
assays NNS O
of IN O
myeloperoxidase NN B-Gene
activity NN O
( ( O
MPO NNP B-Gene
) ) O
in IN O
homogenates NNS O
of IN O
colon NN O
mucosa NN O
were VBD O
performed VBN O
after IN O
one CD O
week NN O
( ( O
4 CD O
% NN O
DSS NNP O
model NN O
) ) O
and CC O
eight CD O
weeks NNS O
( ( O
1 CD O
% NN O
DSS NNP O
model NN O
) ) O
. . O

The DT O
protooncogene NN O
c SYM B-Gene
- : I-Gene
myb NN I-Gene
encodes VBZ O
a DT O
nuclear JJ O
transcription NN O
factor NN O
that WDT O
binds VBZ O
to TO O
DNA VB O
in IN O
a DT O
sequence NN O
- : O
specific JJ O
manner NN O
and CC O
transactivates VBZ O
transcription NN O
of IN O
several JJ O
viral JJ O
and CC O
cellular JJ O
genes NNS O
. . O

PKNbeta NNP B-Gene
had VBD O
high JJ O
sequence NN O
homology NN O
with IN O
PKNalpha NNP B-Gene
, , O
originally RB O
isolated VBN O
PKN NNP B-Gene
, , O
especially RB O
in IN O
the DT O
repeats NNS O
of IN O
charged VBN O
amino NN O
acid SYM O
- : O
rich JJ O
region NN O
with IN O
leucine JJ O
- : O
zipper NN O
like IN O
sequences NNS O
( ( O
CZ NNP O
region NN O
/ NNP O
HR1 NNP O
) ) O
, , O
in IN O
the DT O
carboxyl NN O
- : O
terminal JJ O
catalytic JJ O
domain NN O
, , O
and CC O
in IN O
approximately RB O
130 CD O
amino JJ O
acid NN O
stretch NN O
( ( O
D NNP O
region NN O
/ NNP O
HR2 NNP O
) ) O
, , O
located VBN O
between IN O
CZ NNP O
region NN O
/ NNP O
HR1 NNP O
and CC O
the DT O
catalytic JJ O
domain NN O
. . O

We PRP O
compare VBP O
the DT O
results NNS O
of IN O
this DT O
algorithm NN O
with IN O
the DT O
results NNS O
obtained VBN O
with IN O
two CD O
other JJ O
algorithms NNS O
, , O
the DT O
optimal JJ O
algorithm NN O
for IN O
monochannel NN O
nonoverlapping NN O
noise NN O
and CC O
the DT O
optimal JJ O
algorithm NN O
for IN O
multichannel NNS O
additive JJ O
noise NN O
, , O
and CC O
we PRP O
show VBP O
that IN O
in IN O
both DT O
cases NNS O
improvement NN O
can MD O
be VB O
obtained VBN O
. . O

1 CD O
. . O

Activation NN O
of IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
gene NN I-Gene
expression NN O
by IN O
a DT O
kinase NN O
- : O
deficient NN O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
. . O

Indoor JJ O
concentrations NNS O
were VBD O
only RB O
weakly RB O
correlated VBN O
with IN O
outdoor JJ O
concentrations NNS O
, , O
however RB O
, , O
and CC O
personal JJ O
exposures NNS O
were VBD O
even RB O
more JJR O
poorly RB O
correlated VBN O
with IN O
outdoor JJ O
concentrations NNS O
. . O

This DT O
may MD O
result VB O
in IN O
more JJR O
reabsorption NN O
and CC O
hence NN O
reduced VBD O
renal JJ O
clearance NN O
. . O

Structural JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
class NN B-Gene
I PRP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( O
MHC NNP B-Gene
) ) O
- : O
restricted VBN O
peptide IN O
- : O
specific JJ O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( I-Gene
TCR NNP I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
/ JJ I-Gene
betas NNS I-Gene
make VBP O
multiple JJ O
contacts NNS O
with IN O
the DT O
alpha1 NN O
and CC O
alpha2 JJ O
helices NNS O
of IN O
the DT O
MHC NNP B-Gene
, , O
but CC O
it PRP O
is VBZ O
unclear JJ O
which WDT O
or CC O
how WRB O
many JJ O
of IN O
these DT O
interactions NNS O
contribute VBP O
to TO O
functional JJ O
binding NN O
. . O

Greek JJ O
classicism NN O
in IN O
living NN O
structure NN O
? . O

Some DT O
deductive JJ O
pathways NNS O
in IN O
animal JJ O
morphology NN O
. . O

SM NNP B-Gene
is VBZ O
also RB O
shown VBN O
to TO O
be VB O
associated VBN O
in IN O
vivo NN O
with IN O
other JJ O
components NNS O
of IN O
the DT O
CRM NNP B-Gene
1 CD I-Gene
export NN O
pathway NN O
, , O
including VBG O
the DT O
small JJ B-Gene
GTPase NNP I-Gene
Ran NNP I-Gene
and CC O
the DT O
nucleoporin NN O
CAN NNP B-Gene
/ NNP O
Nup214 NNP B-Gene
. . O

The DT O
structure NN O
of IN O
digiprogenin NN O
. . O

The DT O
PC NNP O
- : O
based VBN O
RTPS NNP O
is VBZ O
designed VBN O
to TO O
run VB O
in IN O
the DT O
Microsoft NNP O
Windows NNP O
3 CD O
. . O
11 CD O
environment NN O
( ( O
and CC O
later RB O
versions NNS O
) ) O
, , O
for IN O
computers NNS O
equipped VBN O
with IN O
486 CD O
or CC O
Pentium NNP O
processors NNS O
. . O

The DT O
QT NNP O
interval NN O
was VBD O
related VBN O
to TO O
various JJ O
components NNS O
of IN O
the DT O
insulin NN B-Gene
resistance NN O
syndrome NN O
, , O
including VBG O
BP NNP O
and CC O
insulin JJ B-Gene
sensitivity NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
interaction NN O
between IN O
Jak2 NNP B-Gene
and CC O
PRLR NNP B-Gene
requires VBZ O
a DT O
proline JJ O
- : O
rich JJ O
sequence NN O
in IN O
the DT O
membrane NN O
proximal JJ O
region NN O
of IN O
the DT O
receptor NN O
, , O
which WDT O
is VBZ O
conserved VBN O
among IN O
the DT O
different JJ O
members NNS O
of IN O
the DT O
cytokine NN B-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

Necrosis NN O
appears VBZ O
6 CD O
h NN O
after IN O
TA NNP O
infusion NN O
, , O
being VBG O
5 CD O
. . O
77 CD O
% NN O
in IN O
extent NN O
after IN O
12 CD O
h NN O
, , O
14 CD O
. . O
9 CD O
% NN O
after IN O
24 CD O
h NN O
and CC O
animals NNS O
die VBP O
with IN O
an DT O
area NN O
of IN O
29 CD O
. . O
5 CD O
% NN O
necrosis NN O
. . O

For IN O
SMX NNP O
at IN O
pH NN O
7 CD O
. . O
0 CD O
, , O
a DT O
1 CD O
: : O
1 CD O
complex NN O
is VBZ O
formed VBN O
, , O
but CC O
at IN O
pH JJ O
7 CD O
. . O
5 CD O
HPCD NNP O
has VBZ O
little JJ O
effect NN O
on IN O
the DT O
solubility NN O
of IN O
the DT O
highly RB O
ionized JJ O
SMX NNP O
, , O
presumably RB O
since IN O
only RB O
un JJ O
- : O
ionized JJ O
molecules NNS O
can MD O
form VB O
inclusion NN O
complexes NNS O
with IN O
the DT O
HPCD NNP O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
AML1a NNP B-Gene
, , O
which WDT O
solely RB O
has VBZ O
no DT O
effects NNS O
as IN O
a DT O
transcriptional JJ O
regulator NN O
, , O
dominantly RB O
suppresses VBZ O
transcriptional JJ O
activation NN O
by IN O
AML1b NNP B-Gene
, , O
and CC O
that IN O
AML1a NNP B-Gene
exhibits VBZ O
the DT O
higher JJR O
affinity NN O
for IN O
DNA NNP O
- : O
binding NN O
than IN O
AML1b NNP B-Gene
. . O

Control NN O
experiments NNS O
showed VBD O
that IN O
each DT O
fusion NN O
protein NN O
had VBD O
a DT O
high JJ O
affinity NN O
binding VBG O
site NN O
for IN O
estradiol JJ O
- : O
17 CD O
beta NN O
and CC O
could MD O
transactivate VB O
an DT O
ERE NNP O
- : O
LacZ NNP B-Gene
reporter NN O
gene NN O
in IN O
yeast JJ O
similar JJ O
to TO O
the DT O
wild JJ B-Gene
type NN I-Gene
ER NNP I-Gene
. . O

Lactation NN O
of IN O
baboons NNS O
fed VBP O
a DT O
low JJ O
protein NN O
maintenance NN O
diet NN O
. . O

Management NN O
of IN O
hypertension NN O
in IN O
the DT O
elderly JJ O
. . O

The DT O
Laser NNP O
Scanning NNP O
Ophthalmoscope NNP O
enables VBZ O
a DT O
fundus NN O
- : O
based VBN O
examination NN O
and CC O
therefore RB O
allows NNS O
exact VBP O
comparison NN O
between IN O
morphologic JJ O
appearance NN O
and CC O
corresponding JJ O
function NN O
. . O

In IN O
addition NN O
to TO O
protein VB O
binding VBG O
at IN O
sequences NNS O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
transcription NN O
, , O
genomic JJ O
footprinting NN O
of IN O
the DT O
entire JJ O
promoter NN O
region NN O
also RB O
showed VBD O
that IN O
a DT O
protein NN O
factor NN O
is VBZ O
constitutively RB O
bound VBN O
to TO O
the DT O
first JJ O
intron NN O
of IN O
the DT O
rep3 JJ B-Gene
gene NN I-Gene
. . O

On IN O
the DT O
character NN O
of IN O
changes NNS O
in IN O
the DT O
enzyme NN O
activity NN O
in IN O
the DT O
brain NN O
tissue NN O
during IN O
reflex JJ O
epilepsy NN O

Depth NNP O
- : O
controlled VBD O
grazing VBG O
- : O
incidence NN O
diffraction NN O
of IN O
synchrotron NN O
x NN O
radiation NN O
. . O

RESULTS NN O
: : O
A DT O
novel JJ O
gene NN O
was VBD O
cloned VBN O
. . O

Total JJ O
cholesterol NN O
was VBD O
measured VBN O
in IN O
amniotic JJ O
fluids NNS O
collected VBN O
at IN O
different JJ O
stages NNS O
of IN O
gestation NN O
. . O

This DT O
laser NN O
provided VBD O
sufficient JJ O
power NN O
in IN O
an DT O
amniotic JJ O
fluid NN O
medium NN O
to TO O
occlude VB O
placental JJ O
vessels NNS O
as RB O
large JJ O
as IN O
7 CD O
mm NN O
in IN O
diameter NN O
within IN O
6 CD O
seconds NNS O
at IN O
a DT O
power NN O
density NN O
of IN O
2000 CD O
W NNP O
/ NNP O
cm2 NN O
. . O

They PRP O
generated VBD O
ca MD O
. . O

Voluntary JJ O
wheel NN O
running VBG O
did VBD O
not RB O
significantly RB O
increase VB O
estimated VBN O
alanine JJ O
or CC O
pyruvate JJ O
Gneo NNP O
or CC O
absolute VB O
glycerol NN O
Ra NNP O
. . O

Dialyzable JJ O
transfer NN B-Gene
factor NN I-Gene
. . O

From IN O
day NN O
30 CD O
after IN O
turnout NN O
, , O
the DT O
PFB NNP O
- : O
group NN O
had VBD O
significantly RB O
lower JJR O
serum NN B-Gene
pepsinogen NN I-Gene
levels NNS O
, , O
which WDT O
reflects VBZ O
the DT O
low JJ O
degree NN O
of IN O
abomasal JJ O
damage NN O
in IN O
these DT O
animals NNS O
. . O

A DT O
medical JJ O
- : O
geographical JJ O
review NN O

Telomerase NNP B-Gene
is VBZ O
a DT O
ribonucleoprotein NN O
complex NN O
that WDT O
synthesizes VBZ O
telomeric JJ O
DNA NNP O
onto IN O
chromosomes NNS O
using VBG O
its PRP$ O
RNA NNP O
component NN O
as IN O
template NN O
. . O

Fufang NNP O
wuzi NN O
yanzong RB O
pills NNS O
have VBP O
strong JJ O
leukogenic JJ O
effect NN O
on IN O
cyclophosphamide NN O
induced VBN O
leukopenia NN O
in IN O
mice NN O
. . O

Activity NN O
of IN O
acid JJ B-Gene
hydrolases NNS I-Gene
of IN O
peripheral JJ O
blood NN O
leukocytes NNS O
in IN O
focal JJ O
and CC O
segmental JJ O
pneumonia NN O
in IN O
children NNS O

Forty NNP O
- : O
five CD O
cases NNS O
were VBD O
surgically RB O
by IN O
direct JJ O
approach NN O
to TO O
the DT O
tumour NN O
, , O
while IN O
two CD O
cases NNS O
were VBD O
treated VBN O
only RB O
with IN O
a DT O
shunt NN O
. . O

The DT O
incidence NN O
of IN O
second JJ O
malignant JJ O
neoplasms NN O
was VBD O
lower JJR O
( ( O
1 CD O
. . O
3 CD O
% NN O
) ) O
in IN O
the DT O
group NN O
treated VBD O
with IN O
5 CD O
- : O
fluorouracil NN O
, , O
doxorubicin NN O
, , O
and CC O
cyclophosphamide NN O
than IN O
in IN O
the DT O
historical JJ O
control NN O
group NN O
( ( O
4 CD O
. . O
8 CD O
% NN O
) ) O
. . O

Because IN O
all DT O
PDGFbetaR NNP B-Gene
fusions NNS I-Gene
described VBD O
thus RB O
far RB O
result NN O
in IN O
splicing VBG O
to TO O
a DT O
common JJ O
exon NN O
of IN O
this DT O
gene NN O
, , O
we PRP O
performed VBD O
5 CD O
' '' O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
PCR NNP O
on IN O
patient JJ O
RNA NNP O
. . O

The DT O
characteristics NNS O
of IN O
the DT O
VirD1 NNP B-Gene
/ NNP O
VirD2 NNP B-Gene
- : O
mediated VBN O
cleavage NN O
reaction NN O
strongly RB O
resemble JJ O
those DT O
observed VBN O
with IN O
relaxosomes NNS O
of IN O
IncP NNP O
plasmids NNS O
involved VBN O
in IN O
initiation NN O
of IN O
transfer NN O
DNA NNP O
replication NN O
during IN O
bacterial JJ O
conjugation NN O
. . O

Sestamibi NNP O
scintigraphy NN O
, , O
performed VBN O
in IN O
70 CD O
patients NNS O
, , O
was VBD O
less RBR O
sensitive JJ O
than IN O
ultrasonography NN O
( ( O
80 CD O
% NN O
) ) O
. . O

A DT O
specific JJ O
distal JJ O
promoter NN O
controls NNS O
gamma VBP B-Gene
- : I-Gene
glutamyl NN I-Gene
transpeptidase NN I-Gene
gene NN I-Gene
expression NN O
in IN O
undifferentiated JJ O
rat NN O
transformed VBD O
liver JJ O
cells NNS O
. . O

The DT O
UBA NNP B-Gene
domains NNS I-Gene
of IN O
RAD23 NNP B-Gene
and CC O
DDI1 NNP B-Gene
are VBP O
required VBN O
for IN O
these DT O
interactions NNS O
. . O

This DT O
protein NN O
, , O
designated VBN O
p532 NN B-Gene
based VBN O
on IN O
its PRP$ O
predicted VBN O
molecular JJ O
weight NN O
( ( O
EMBO NNP O
J NNP O
15 CD O
: : O
5738 CD O
, , O
1996 CD O
) ) O
, , O
contains VBZ O
multiple JJ O
structural JJ O
domains NNS O
including VBG O
two CD O
regions NNS O
of IN O
seven CD O
internal JJ O
repeats NNS O
highly RB O
related VBN O
to TO O
the DT O
cell NN O
cycle NN O
regulator NN O
RCC1 NNP B-Gene
, , O
a DT O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factor NN I-Gene
for IN O
the DT O
small JJ B-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
Ran NNP B-Gene
, , O
seven CD O
beta SYM O
- : O
repeat NN O
domains VBZ O
characteristic JJ O
of IN O
the DT O
beta NN O
subunit NN O
of IN O
heterotrimeric JJ B-Gene
G NNP I-Gene
proteins NNS I-Gene
, , O
three CD O
putative JJ O
SH3 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
, , O
a DT O
putative JJ O
leucine NN O
- : O
zipper NN O
and CC O
a DT O
carboxy JJ B-Gene
- : I-Gene
terminal JJ I-Gene
HECT NNP I-Gene
domain NN I-Gene
characteristic NN O
of IN O
E3 NNP B-Gene
ubiquitin JJ I-Gene
- : I-Gene
protein NN I-Gene
ligases VBZ I-Gene
. . O

In IN O
the DT O
control NN O
group NN O
the DT O
histological JJ O
picture NN O
resembled VBD O
osteoarthritis NN O
. . O

Among IN O
953 CD O
infants NNS O
in IN O
22 CD O
neonatal JJ O
care NN O
units NNS O
studied VBN O
, , O
23 CD O
% NN O
( ( O
median JJ O
value NN O
, , O
range VBP O
0 CD O
- : O
78 CD O
) ) O
were VBD O
found VBN O
to TO O
be VB O
faecally RB O
colonized VBN O
with IN O
one CD O
of IN O
21 CD O
distinct JJ O
nosocomial JJ O
strains NNS O
of IN O
Escherichia NNP O
coli NN O
, , O
Klebsiella NNP O
or CC O
Enterobacter NNP O
spp NN O
. . O

Osteocalcin NNP B-Gene
( ( O
serum VB B-Gene
bone NN I-Gene
- : I-Gene
Gla NNP I-Gene
protein NN I-Gene
, , O
sBGP NN B-Gene
) ) O
, , O
serum JJ B-Gene
alkaline NN I-Gene
phosphatase NN I-Gene
( ( O
sAP NN B-Gene
) ) O
and CC O
urinary JJ O
hydroxyproline NN O
/ NNP O
creatinine NN O
ratio NN O
( ( O
uOH JJ O
- : O
Prol NN O
/ NNP O
creatinine NN O
) ) O
have VBP O
been VBN O
measured VBN O
in IN O
21 CD O
patients NNS O
with IN O
primary JJ O
hyperparathyroidism NN O
( ( O
PHPT NNP O
) ) O
and CC O
in IN O
nine CD O
patients NNS O
with IN O
hypercalcaemia NN O
of IN O
malignancy NN O
( ( O
HM NNP O
) ) O
. . O

The DT O
cDNAs NN O
cross NN O
- : O
hybridize NN O
with IN O
genomic JJ O
sequences NNS O
in IN O
rat NN O
, , O
human JJ O
, , O
and CC O
chicken NN O
DNA NN O
, , O
but CC O
not RB O
with IN O
DNA NN O
from IN O
frog NN O
, , O
Drosophila NNP O
, , O
or CC O
sea NN O
urchin JJ O
. . O

Nucleotide NNP O
sequence NN O
and CC O
transcriptional JJ O
analysis NN O
of IN O
the DT O
polyhedrin JJ B-Gene
gene NN I-Gene
of IN O
Spodoptera NNP O
exigua FW O
nuclear JJ O
polyhedrosis NN O
virus NN O
. . O

The DT O
iterative JJ O
method NN O
proposed VBN O
by IN O
Bengtsson NNP O
[ NNP O
Appl NNP O
. . O

Behcet NNP O
' POS O
s NN O
syndrome NN O

Changes NNS O
of IN O
the DT O
DB NNP O
sequence NN O
without IN O
affecting VBG O
the DT O
postulated JJ O
stem NN O
structure NN O
led VBD O
to TO O
drastic JJ O
losses NNS O
of IN O
translation NN O
efficiency NN O
. . O

The DT O
junctions NNS O
between IN O
viral JJ O
and CC O
cellular JJ O
sequences NNS O
were VBD O
determined VBN O
by IN O
DNA NNP O
sequence NN O
analysis NN O
to TO O
be VB O
517 CD O
nucleotides NNS O
into IN O
the DT O
p30 NN B-Gene
sequence NN I-Gene
and CC O
1 CD O
, , O
920 CD O
nucleotides NNS O
into IN O
the DT O
polymerase NN O
sequence NN O
. . O

The DT O
cause NN O
of IN O
death NN O
is VBZ O
often RB O
quite JJ O
apparent JJ O
from IN O
the DT O
pathological JJ O
and CC O
toxicological JJ O
findings NNS O
; : O
however RB O
, , O
the DT O
manner NN O
of IN O
death NN O
often RB O
gives VBZ O
the DT O
examining VBG O
official JJ O
some DT O
difficulty NN O
. . O

There EX O
was VBD O
a DT O
significant JJ O
effect NN O
of IN O
hematocrit NN O
on IN O
the DT O
General NNP O
Health NNP O
scale NN O
on IN O
the DT O
SF NNP O
- : O
36 CD O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
. . O

Multiple NNP O
single JJ O
- : O
stranded VBD O
cis JJ O
elements NNS O
are VBP O
associated VBN O
with IN O
activated JJ O
chromatin NN O
of IN O
the DT O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
myc NN I-Gene
gene NN I-Gene
in IN O
vivo NN O
. . O

Radiation NNP O
therapy NN O
was VBD O
effective JJ O
in IN O
controlling VBG O
symptomatic JJ O
metastasis NN O
in IN O
all DT O
three CD O
patients NNS O
. . O

Evidence NN O
for IN O
the DT O
promoting JJ O
role NN O
of IN O
the DT O
intra JJ B-Gene
- : I-Gene
uterine JJ I-Gene
kinin NN I-Gene
release NN O
in IN O
the DT O
development NN O
of IN O
late JJ O
hypertonic JJ O
saline NN O
- : O
induced JJ O
abortion NN O
. . O

The DT O
13 CD O
, , O
14 CD O
- : O
dihydro NN O
- : O
15 CD O
- : O
keto NN O
- : O
metabolites NNS O
of IN O
PGE2 NNP O
and CC O
PGF2 NNP O
alpha NN O
had VBD O
no DT O
statistically RB O
significant JJ O
antiarrhythmic JJ O
effect NN O
. . O

Twenty NNP O
- : O
one CD O
ELISA NNP O
- : O
positive JJ O
sera NN O
were VBD O
tested VBN O
and CC O
confirmed VBN O
positive JJ O
by IN O
plaque JJ O
reduction NN O
neutralization NN O
testing NN O
. . O

Coronary JJ O
arteries NNS O
- : O
- : O
old JJ O
and CC O
new JJ O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
tested VBD O
this DT O
notion NN O
by IN O
using VBG O
ligation NN O
- : O
mediated VBN O
PCR NNP O
to TO O
assess VB O
the DT O
formation NN O
of IN O
recombination NN B-Gene
- : I-Gene
activating VBG I-Gene
gene NN I-Gene
( ( O
RAG NNP B-Gene
) ) O
- : O
dependent NN O
double JJ O
- : O
strand NN O
breaks NNS O
( ( O
DSBs NNP O
) ) O
at IN O
RSSs NNP O
3 CD O
' '' O
of IN O
Ddelta3 NNP B-Gene
and CC O
5 CD O
' '' O
of IN O
Jdelta1 NNP B-Gene
. . O

Bone NNP O
marrow NN O
transplantation NN O
- : O
1979 CD O
. . O

A DT O
cAMP NN O
- : O
responsive JJ O
element NN O
- : O
like IN O
( ( O
CRE NNP O
- : O
like IN O
, , O
TGACGTGA NNP O
) ) O
promoter NN O
sequence NN O
and CC O
a DT O
protein NN B-Gene
kinase VBZ I-Gene
A NNP I-Gene
signaling VBG O
pathway NN O
are VBP O
involved VBN O
in IN O
this DT O
induction NN O
, , O
and CC O
activation NN O
of IN O
both DT O
CRE NNP B-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
and CC O
activating VBG B-Gene
transcription NN I-Gene
factor NN I-Gene
- : I-Gene
2 CD I-Gene
( ( O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
is VBZ O
required VBN O
in IN O
the DT O
above JJ O
process NN O
. . O

These DT O
results NNS O
confirmed VBD O
that IN O
cleavage NN O
of IN O
the DT O
leader NN O
peptide NN O
is VBZ O
the DT O
last JJ O
step NN O
in IN O
nisin JJ B-Gene
maturation NN O
and CC O
is VBZ O
necessary JJ O
to TO O
generate VB O
a DT O
biologically RB O
active JJ O
peptide NN O
. . O

After IN O
tilting VBG O
, , O
systolic JJ O
blood NN O
pressure NN O
fell VBD O
an DT O
average NN O
of IN O
17 CD O
% NN O
in IN O
patients NNS O
who WP O
cramped VBD O
infrequently RB O
( ( O
p JJ O
= NN O
0 CD O
. . O
31 CD O
) ) O
but CC O
only RB O
10 CD O
% NN O
in IN O
frequently RB O
cramping VBG O
patients NNS O
. . O

Primers NNS O
for IN O
subsequent JJ O
rounds NNS O
of IN O
RACE NNP O
were VBD O
designed VBN O
from IN O
the DT O
5 CD O
' POS O
- : O
ends NNS O
of IN O
amplified JJ O
RACE NNP O
products NNS O
. . O

The DT O
RET NNP B-Gene
/ NNP O
PTC3 NNP B-Gene
rearrangement NN O
is VBZ O
formed VBN O
by IN O
fusion NN O
of IN O
the DT O
ELE1 NNP B-Gene
and CC O
RET NNP B-Gene
genes NNS I-Gene
, , O
and CC O
is VBZ O
highly RB O
prevalent JJ O
in IN O
radiation NN O
- : O
induced JJ O
post NN O
- : O
Chernobyl NNP O
papillary JJ O
thyroid NN O
carcinomas NN O
. . O

The DT O
C5 NNP B-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
was VBD O
encoded VBN O
by IN O
49 CD O
kilobases NNS O
containing VBG O
26 CD O
exons NNS O
; : O
the DT O
beta NN O
- : O
chain NN O
was VBD O
encoded VBN O
by IN O
29 CD O
kilobases NNS O
containing VBG O
16 CD O
exons NNS O
. . O

Detection NN O
of IN O
hemophilia NN O
A DT O
carriers NNS O
. . O

The DT O
intranodal JJ O
mesothelial JJ O
cells NNS O
occupied VBD O
the DT O
sinusoids NNS O
of IN O
the DT O
lymph NN O
nodes NNS O
and CC O
were VBD O
initially RB O
suspected VBN O
of IN O
being VBG O
metastatic JJ O
from IN O
the DT O
ovarian JJ O
tumor NN O
in IN O
each DT O
case NN O
. . O

In IN O
comparison NN O
with IN O
the DT O
16 CD O
introns NNS O
reported VBN O
in IN O
AHA3 NNP B-Gene
, , O
AHA2 NNP B-Gene
is VBZ O
missing VBG O
one CD O
intron NN O
in IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
and CC O
a DT O
second JJ O
intron NN O
in IN O
the DT O
C NNP O
- : O
terminal JJ O
coding NN O
region NN O
. . O

Functional NNP O
studies NNS O
which WDT O
introduced VBD O
a DT O
mutation NN O
in IN O
the DT O
AP2 NNP B-Gene
core NN I-Gene
binding VBG I-Gene
region NN I-Gene
as RB O
well RB O
as IN O
cotransfection NN O
experiments NNS O
using VBG O
an DT O
AP2 NNP B-Gene
expression NN O
vector NN O
revealed VBD O
that IN O
AP2 NNP B-Gene
exerts VBZ O
a DT O
repressive JJ O
role NN O
on IN O
the DT O
HGF NNP B-Gene
gene NN I-Gene
promoter NN I-Gene
activity NN O
. . O

The DT O
mechanistic JJ O
implications NNS O
of IN O
aromatic JJ O
non FW O
- : O
responsiveness NN O
of IN O
autonomously RB O
expressed VBN O
A NNP O
- : O
domain NN O
, , O
despite IN O
its PRP$ O
demonstrated JJ O
ability NN O
to TO O
bind VB O
phenol NN O
, , O
are VBP O
discussed VBN O
. . O

Sprague NNP O
- : O
Dawley NNP O
newborn JJ O
rats NNS O
( ( O
n JJ O
= NNP O
85 CD O
) ) O
breathed VBD O
100 CD O
% NN O
oxygen NN O
( ( O
O2 NNP O
) ) O
or CC O
room NN O
air NN O
( ( O
RA NNP O
) ) O
during IN O
the DT O
first JJ O
8 CD O
days NNS O
of IN O
life NN O
, , O
and CC O
then RB O
RA NNP O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
ULK2 NNP B-Gene
is VBZ O
involved VBN O
in IN O
a DT O
previously RB O
uncharacterized JJ O
signaling VBG O
pathway NN O
in IN O
mammalian JJ O
cells NNS O
. . O

I PRP O
. . O

The DT O
LMW NNP B-Gene
FGF NNP I-Gene
- : I-Gene
2 CD I-Gene
up IN O
- : O
regulated VBD O
the DT O
PKC NNP B-Gene
epsilon NN I-Gene
levels NNS O
by IN O
1 CD O
. . O
6 CD O
- : O
fold NN O
; : O
by IN O
contrast NN O
the DT O
HMW NNP B-Gene
isoform VB I-Gene
down RP O
- : O
regulated VBD O
the DT O
level NN O
of IN O
this DT O
PKC NNP B-Gene
isotype NN I-Gene
by IN O
about IN O
3 CD O
- : O
fold NN O
and CC O
increased VBD O
the DT O
amount NN O
of IN O
PKC NNP B-Gene
delta NN I-Gene
by IN O
1 CD O
. . O
7 CD O
- : O
fold NN O
. . O

Mitomycin NNP O
- : O
C NN O
can MD O
cause VB O
severe JJ O
necrosis NN O
and CC O
ulceration NN O
when WRB O
extravasated VBN O
inadvertently RB O
into IN O
skin NN O
and CC O
soft JJ O
tissues NNS O
following VBG O
IV NNP O
drug NN O
administration NN O
. . O

HTLV NNP O
- : O
1 CD O
decreases NNS O
Th2 NNP O
type NN O
of IN O
immune JJ O
response NN O
in IN O
patients NNS O
with IN O
strongyloidiasis NN O
. . O

Spontaneous JJ O
recovery NN O
occurs VBZ O
within IN O
30 CD O
min NNS O
to TO O
2 CD O
hrs NN O
. . O

We PRP O
have VBP O
generated VBN O
a DT O
computer NN O
model NN O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
domain NN O
of IN O
the DT O
434 CD O
repressor NN O
based VBN O
on IN O
the DT O
crystal JJ O
structure NN O
of IN O
the DT O
homologous JJ B-Gene
UmuD NNP I-Gene
' POS I-Gene
protein NN I-Gene
. . O

This DT O
indicates VBZ O
that IN O
lipid JJ O
peroxidation NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
development NN O
of IN O
senile JJ O
cataract NN O
and CC O
, , O
as IN O
a DT O
direct JJ O
consequence NN O
of IN O
retinal JJ O
damage NN O
, , O
also RB O
in IN O
the DT O
pathogenesis NN O
of IN O
cataract NN O
in IN O
diabetes NNS O
and CC O
in IN O
severe JJ O
myopia NN O
. . O

We PRP O
performed VBD O
dipole JJ O
estimation NN O
of IN O
spikes NNS O
and CC O
SEP NNP O
components NNS O
in IN O
identical JJ O
patients NNS O
. . O

Senior JJ O
systems NNS O
- : O
- : O
45 CD O
; : O
Mental NNP O
health NN O
and CC O
illness NN O
in IN O
old JJ O
age NN O
- : O
- : O
3 CD O
. . O

e NN O
. . O

Thus RB O
RV NNP O
O2 NNP O
demand NN O
fell VBD O
when WRB O
RC NNP O
O2 NNP O
supply NN O
was VBD O
reduced VBN O
, , O
although IN O
a DT O
flow JJ O
reserve NN O
was VBD O
available JJ O
. . O

NDRF NNP B-Gene
/ NNP O
NeuroD2 NNP B-Gene
was VBD O
co JJ O
- : O
precipitated VBN O
with IN O
PKN NNP B-Gene
from IN O
the DT O
lysate NN O
of IN O
COS NNP O
- : O
7 CD O
cells NNS O
transfected VBN O
with IN O
both DT O
expression NN O
constructs NNS O
for IN O
NDRF NNP B-Gene
/ NNP O
NeuroD2 NNP B-Gene
and CC O
PKN NNP B-Gene
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
trans VBZ O
- : O
activation NN O
from IN O
the DT O
prothymosin NN B-Gene
intron NN I-Gene
enhancer NN I-Gene
is VBZ O
a DT O
faithful JJ O
reflection NN O
of IN O
the DT O
transforming VBG O
properties NNS O
of IN O
the DT O
Myc NNP B-Gene
protein NN I-Gene
. . O

Protein NNP B-Gene
tyrosine NN I-Gene
phosphatases NNS I-Gene
( ( O
PTPs NNP B-Gene
) ) O
, , O
together RB O
with IN O
protein JJ B-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
( ( O
PTKs NNP B-Gene
) ) O
, , O
are VBP O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
activation NN O
, , O
growth NN O
, , O
and CC O
differentiation NN O
. . O

This DT O
interaction NN O
inhibits VBZ O
the DT O
histone NN B-Gene
acetyltransferase NN I-Gene
activity NN O
of IN O
p300 NN B-Gene
, , O
resulting VBG O
in IN O
drastic JJ O
reduction NN O
of IN O
nucleosomal JJ O
histone NN B-Gene
acetylation NN O
and CC O
alteration NN O
of IN O
chromatin NN O
structure NN O
. . O

As IN O
a DT O
complement NN O
to TO O
genome VB O
- : O
wide JJ O
mapping NN O
and CC O
sequencing VBG O
efforts NNS O
, , O
it PRP O
is VBZ O
often RB O
important JJ O
to TO O
generate VB O
detailed JJ O
maps NNS O
and CC O
sequence NN O
data NNS O
for IN O
specific JJ O
regions NNS O
of IN O
interest NN O
. . O

Most JJS O
, , O
however RB O
, , O
would MD O
tell VB O
the DT O
spouse NN O
the DT O
full JJ O
truth NN O
about IN O
both DT O
diagnosis NN O
and CC O
prognosis NN O
. . O

Central NNP O
venous JJ O
catheter NN O
used VBN O
for IN O
recording VBG O
intracardiac JJ O
electrocardiogram NN O
. . O

Animals NNS O
received VBD O
a DT O
dose NN O
of IN O
dexamethasone NN O
( ( O
10 CD O
mg NN O
/ NNP O
kg NN O
i NN O
. . O
p NN O
. . O
) ) O
prior RB O
to TO O
the DT O
protein NN O
- : O
free JJ O
surfactant JJ O
preparation NN O
Exosurf NNP O
( ( O
pure JJ O
phospholipids NNS O
containing VBG O
surfactant NN O
, , O
Wellcome NNP O
GmbH NNP O
, , O
Burgwedel NNP O
, , O
Germany NNP O
) ) O
and CC O
a DT O
rSP JJ O
- : O
C NNP O
based VBN O
surfactant NN O
, , O
respectively RB O
. . O

Although IN O
a DT O
wide JJ O
range NN O
of IN O
cognitive JJ O
functions NNS O
had VBD O
been VBN O
tested VBN O
, , O
all DT O
but CC O
one CD O
seizure NN O
occurred VBD O
during IN O
assessment NN O
of IN O
memory NN O
performance NN O
. . O

In IN O
conclusion NN O
, , O
marmoset VB B-Gene
monkey NN I-Gene
LHR NNP I-Gene
seems VBZ O
to TO O
lack VB O
the DT O
sequence NN O
corresponding VBG O
to TO O
exon VB O
10 CD O
of IN O
the DT O
LHR NNP B-Gene
gene NN I-Gene
in IN O
other JJ O
mammalian JJ O
species NNS O
. . O

Methyllevamisole NNP O
was VBD O
used VBN O
as IN O
the DT O
internal JJ O
standard NN O
. . O

Raman NNP O
investigation NN O
of IN O
YBa2 NNP O
- : O
xLaxCu3O7 NN O
ceramics NNS O
. . O

Our PRP$ O
study NN O
was VBD O
designed VBN O
to TO O
investigate VB O
the DT O
effect NN O
of IN O
MMF NNP O
on IN O
in IN O
vivo NN O
bone NN O
mineral JJ O
metabolism NN O
. . O

PURPOSE NN O
: : O
To TO O
evaluate VB O
the DT O
kinetics NNS O
of IN O
erythropoietin NN B-Gene
( ( O
EPO NNP B-Gene
) ) O
production NN O
and CC O
address VB O
the DT O
pathogenesis NN O
of IN O
anemia NN O
of IN O
prematurity NN O
, , O
we PRP O
measured VBD O
EPO NNP B-Gene
levels NNS O
in IN O
infants NNS O
during IN O
the DT O
first JJ O
year NN O
of IN O
life NN O
. . O

Strains NNS O
bearing VBG O
the DT O
drs2 JJ B-Gene
mutation NN I-Gene
process NN O
the DT O
20S CD B-Gene
precursor NN I-Gene
of IN O
the DT O
mature NN B-Gene
18S CD I-Gene
rRNA NN I-Gene
slowly RB O
and CC O
are VBP O
deficient VBN O
in IN O
40S CD B-Gene
ribosomal JJ I-Gene
subunits NNS I-Gene
. . O

The DT O
TB NNP O
incidence NN O
in IN O
the DT O
"""" NNP O
AIRIN NNP O
"""" NNP O
area NN O
, , O
where WRB O
about RB O
20 CD O
% NN O
TB NN O
patients NNS O
are VBP O
homeless JJ O
, , O
shows VBZ O
highest JJS O
rate NN O
of IN O
above IN O
1 CD O
, , O
0 CD O
/ NN O
100 CD O
, , O
0 CD O
. . O

The DT O
influence NN O
of IN O
patient NN O
- : O
related JJ O
factors NNS O
on IN O
inter NN O
- : O
observer NN O
variability NN O
in IN O
the DT O
evaluation NN O
of IN O
neurological JJ O
signs NNS O
was VBD O
investigated VBN O
. . O

Anesthesia NN O
with IN O
M NNP O
/ NNP O
K NNP O
was VBD O
reversed VBN O
after IN O
41 CD O
. . O
6 CD O
min NN O
of IN O
immobilization NN O
with IN O
atipamezole NN O
. . O

Involvement NN O
of IN O
AP1 NNP B-Gene
and CC O
PEA3 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
regulation NN O
of IN O
murine JJ B-Gene
tissue NN I-Gene
inhibitor NN I-Gene
of IN I-Gene
metalloproteinases NNS I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TIMP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
transcription NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
surfaces NNS O
of IN O
tracheal JJ O
cartilage NN O
matrix NN O
are VBP O
collagen VBN B-Gene
- : O
rich JJ O
and CC O
surround VBD O
a DT O
proteoglycan JJ O
- : O
rich JJ O
core NN O
. . O

The DT O
hsp70 NN B-Gene
gene NN I-Gene
family NN I-Gene
of IN O
Neurospora NNP O
crassa NN O
: : O
cloning NN O
, , O
sequence NN O
analysis NN O
, , O
expression NN O
, , O
and CC O
genetic JJ O
mapping NN O
of IN O
the DT O
major JJ O
stress NN O
- : O
inducible JJ O
member NN O
. . O

The DT O
relations NNS O
among IN O
various JJ O
negative JJ O
emotional JJ O
and CC O
behavioral JJ O
characteristics NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
aggression NN O
, , O
anxiety NN O
, , O
undercompliance NN O
, , O
depressive JJ O
mood NN O
) ) O
and CC O
adjustment NN O
were VBD O
examined VBN O
through IN O
use NN O
of IN O
data NNS O
from IN O
the DT O
31 CD O
- : O
year NN O
- : O
old JJ O
New NNP O
York NNP O
Longitudinal NNP O
Study NNP O
. . O

There EX O
are VBP O
regions NNS O
with IN O
long JJ O
runs NNS O
of IN O
up IN O
to TO O
45 CD O
% NN O
C NNP O
or CC O
35 CD O
% NN O
G NNP O
residues NNS O
. . O

The DT O
amplification NN O
was VBD O
achieved VBN O
using VBG O
two CD O
primers NNS O
which WDT O
correspond VBP O
to TO O
TRH NNP B-Gene
progenitor NN I-Gene
sequence NN I-Gene
( ( O
Lys NNP O
/ NNP O
Arg NNP O
- : O
Arg NNP O
- : O
Gln NNP O
- : O
His PRP$ O
- : O
Pro NNP O
- : O
Gly NNP O
- : O
Lys NNP O
/ NNP O
Arg NNP O
- : O
Arg NN O
) ) O
. . O

In IN O
a DT O
prospective JJ O
, , O
multicentre JJ O
trial NN O
the DT O
efficacy NN O
of IN O
an DT O
Vitex NNP O
agnus NN O
castus NN O
L NNP O
extract NN O
Ze NNP O
440 CD O
was VBD O
investigated VBN O
in IN O
50 CD O
patients NNS O
with IN O
pre JJ O
- : O
menstrual JJ O
syndrome NN O
( ( O
PMS NNP O
) ) O
. . O

Evaluation NN O
of IN O
antiepileptic JJ O
drug NN O
effect NN O
on IN O
membrane NN O
fluidity NN O
. . O

METHODS NNP O
- : O
- : O
16 CD O
volunteered VBD O
for IN O
spirometry NN O
with IN O
methacholine JJ O
provocation NN O
test NN O
including VBG O
a DT O
test NN O
for IN O
small JJ O
airways NNS O
function NN O
by IN O
volume NN O
of IN O
trapped VBN O
gas NN O
( ( O
VTG NNP O
) ) O
. . O

In IN O
contrast NN O
, , O
when WRB O
the DT O
isoform NN O
containing VBG O
the DT O
C NNP O
epsilon4 NN O
domain NN O
joined VBD O
directly RB O
to TO O
the DT O
M2 NNP O
exon NN O
( ( O
IgE NNP B-Gene
grande NN I-Gene
) ) O
is VBZ O
expressed VBN O
in IN O
the DT O
J558L NNP O
cell NN O
line NN O
, , O
it PRP O
is VBZ O
degraded VBN O
intracellularly RB O
, , O
suggesting VBG O
a DT O
cell NN O
line NN O
- : O
dependent JJ O
regulation NN O
of IN O
secretion NN O
. . O

The DT O
authors NNS O
found VBD O
that IN O
except IN O
for IN O
fear NN O
and CC O
pugnacity NN O
all DT O
husband VBP O
- : O
wife NN O
trait NN O
correlations NNS O
were VBD O
positive JJ O
, , O
in IN O
contrast NN O
to TO O
Winch NNP O
' POS O
s JJ O
principle NN O
of IN O
type NN O
I PRP O
complementarity NN O
. . O

A DT O
positive JJ O
correlation NN O
between IN O
serum NN B-Gene
myoglobin NN I-Gene
and CC O
CA NNP B-Gene
III NNP I-Gene
concentrations NNS O
( ( O
rs VB O
= RB O
0 CD O
. . O
933 CD O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
was VBD O
observed VBN O
in IN O
hemodialyzed JJ O
patients NNS O
with IN O
chronic JJ O
renal JJ O
failure NN O
. . O

Behavioral NNP O
and CC O
electrographic JJ O
expression NN O
of IN O
natural JJ O
sleep NN O
and CC O
wakefulness NN O
in IN O
reptiles NNS O

The DT O
RAD6 NNP B-Gene
/ NNP O
UBC2 NNP B-Gene
gene NN O
from IN O
Saccharomyces NNP O
cerevisiae NN O
encodes VBZ O
a DT O
ubiquitin JJ B-Gene
- : I-Gene
conjugating VBG I-Gene
enzyme RB I-Gene
involved VBN O
in IN O
DNA NNP O
repair NN O
, , O
induced JJ O
mutagenesis NN O
, , O
and CC O
sporulation NN O
. . O

Two CD O
new JJ O
flavone NN O
glucosides NNS O
, , O
nevadensin RB O
5 CD O
- : O
O NNP O
- : O
beta NN O
- : O
D NNP O
- : O
glucoside NN O
and CC O
nevadensin $ O
5 CD O
- : O
O NNP O
- : O
beta NN O
- : O
D NNP O
- : O
glucosyl NN O
( ( O
1 CD O
- : O
- : O
> $ O
6 CD O
) ) O
beta NN O
- : O
D NNP O
- : O
glucoside NN O
, , O
have VBP O
been VBN O
isolated VBN O
from IN O
the DT O
aerial JJ O
parts NNS O
of IN O
Lysionotus NNP O
pauciflorus NN O
. . O

Role NNP O
of IN O
g2 NN O
in IN O
relating VBG O
the DT O
Schwinger NNP O
and CC O
Gerasimov NNP O
- : O
Drell NNP O
- : O
Hearn NNP O
sum NN O
rules NNS O
. . O

Increased VBN O
blood NN O
pressure NN O
during IN O
CyA NNP O
treatment NN O
was VBD O
independent JJ O
of IN O
circulating VBG O
ET NNP B-Gene
- : I-Gene
1 CD I-Gene
levels NNS O
. . O

There EX O
are VBP O
no DT O
introns NNS O
within IN O
the DT O
gene NN O
, , O
which WDT O
contains VBZ O
a DT O
9360 CD O
- : O
bp NN O
open JJ O
reading NN O
frame NN O
and CC O
encodes VBZ O
a DT O
377 CD O
- : O
kDa NN O
protein NN O
. . O

All DT O
four CD O
of IN O
the DT O
genes NNS O
have VBP O
a DT O
similar JJ O
structure NN O
, , O
with IN O
the DT O
receptor NN O
protein NN O
encoded VBD O
in IN O
a DT O
single JJ O
exon NN O
. . O

A DT O
decamer NN O
sequence NN O
, , O
5 CD O
' POS O
- : O
CGA NNP O
- : O
CCCCUCC NNP O
- : O
3 CD O
' '' O
, , O
complementary JJ O
to TO O
a DT O
conserved VBN O
sequence NN O
adjacent NN O
to TO O
the DT O
enzymatic JJ O
cleavage NN O
site NN O
on IN O
the DT O
mitochondrial JJ O
RNA NNP O
substrate NN O
, , O
is VBZ O
present JJ O
in IN O
the DT O
RNAase NNP B-Gene
MRP NNP I-Gene
RNA NNP I-Gene
. . O

Malaria NNP O
, , O
anaemia NN O
, , O
and CC O
HIV NNP O
- : O
1 CD O
transmission NN O
in IN O
central JJ O
Africa NNP O
. . O

A DT O
single JJ O
rectal NN O
dose NN O
of IN O
25 CD O
mg NNS O
/ JJ O
kg NNS O
will MD O
obtain VB O
this DT O
lower JJR O
concentration NN O
within IN O
1 CD O
h NN O
of IN O
administration NN O
and CC O
maintain VB O
it PRP O
for IN O
up IN O
to TO O
6 CD O
h NN O
. . O

No DT O
relevant JJ O
changes NNS O
in IN O
heart NN O
rate NN O
, , O
body NN O
weight NN O
, , O
and CC O
plasma NN O
levels NNS O
of IN O
renin NN B-Gene
activity NN O
and CC O
aldosterone NN O
concentration NN O
were VBD O
observed VBN O
. . O

Immediate NNP O
- : O
early JJ O
transcription NN O
from IN O
the DT O
channel NN O
catfish JJ O
virus NN O
genome NN O
: : O
characterization NN O
of IN O
two CD O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
transcripts NNS I-Gene
. . O

The DT O
maps NNS O
of IN O
Case NNP O
2 CD O
showed VBD O
that IN O
a DT O
maximum JJ O
first JJ O
appeared VBN O
on IN O
the DT O
upper JJ O
right NN O
back RB O
and CC O
then RB O
moved VBD O
down RB O
the DT O
right JJ O
side NN O
of IN O
the DT O
posterior JJ O
thorax NN O
. . O

The DT O
' '' O
Newcastle NNP O
' POS O
model NN O
, , O
which WDT O
is VBZ O
based VBN O
on IN O
Hotelling NNP O
' POS O
s NN O
T2 NNP O
statistic NN O
, , O
proved VBD O
to TO O
be VB O
more RBR O
sensitive JJ O
and CC O
diagnosed VBD O
a DT O
systematic JJ O
displacement NN O
for IN O
three CD O
prostate NN O
patients NNS O
. . O

Phase NNP O
II NNP O
study NN O
of IN O
paclitaxel NN O
and CC O
oral JJ O
etoposide NN O
in IN O
patients NNS O
with IN O
locally RB O
advanced JJ O
or CC O
metastatic JJ O
non NN O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

Assessment NN O
of IN O
nutrient JJ O
media NNS O
in IN O
the DT O
diagnosis NN O
of IN O
diptheria NN O

Compared VBN O
to TO O
its PRP$ O
counterpart NN O
in IN O
the DT O
GPB NNP B-Gene
gene NN I-Gene
, , O
exon VBZ O
3 CD O
of IN O
the DT O
GPE NNP B-Gene
gene NN I-Gene
contains VBZ O
several JJ O
point NN O
mutations NNS O
, , O
an DT O
insertion NN O
of IN O
24 CD O
bp NN O
, , O
and CC O
a DT O
stop NN O
codon NN O
which WDT O
shortens VBZ O
the DT O
reading NN O
frame NN O
. . O

With IN O
a DT O
cutoff NN O
level NN O
for IN O
TSST NNP B-Gene
- : I-Gene
1 CD I-Gene
of IN O
less JJR O
than IN O
100 CD O
pg JJ O
/ NNP O
ml NN O
, , O
28 CD O
samples NNS O
obtained VBN O
from IN O
12 CD O
patients NNS O
were VBD O
positive JJ O
for IN O
TSST NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Both DT O
groups NNS O
rejected VBD O
pops NNS O
with IN O
added JJ O
SOA NNP O
, , O
decreasing VBG O
mouthing VBG O
times NNS O
as IN O
SOA NNP O
concentration NN O
increased VBD O
. . O

A DT O
three CD O
- : O
phased VBD O
analysis NN O
of IN O
treatment NN O
plans NNS O
for IN O
45 CD O
patients NNS O
was VBD O
undertaken VBN O
. . O

( ( O
iii NN O
) ) O
In IN O
these DT O
cells NNS O
, , O
PKCbeta NNP B-Gene
plays VBZ O
a DT O
unique JJ O
Ras NNP B-Gene
- : O
independent JJ O
role NN O
in IN O
mediating VBG O
insulin NN B-Gene
but CC O
not RB O
EGF NNP B-Gene
or CC O
other JJ O
growth NN O
factor NN O
mitogenic JJ O
signals NNS O
. . O

Thyroid NNP O
lymphoma NN O
and CC O
its PRP$ O
management NN O
. . O

There EX O
were VBD O
no DT O
significant JJ O
changes NNS O
in IN O
either CC O
the DT O
fatty JJ O
acid JJ O
composition NN O
of IN O
biliary JJ O
lecithin NN O
or CC O
in IN O
the DT O
bile NN O
acid JJ O
composition NN O
of IN O
bile NN O
. . O

Uroflowmetry NN O
can MD O
detect VB O
dysuria NN O
, , O
which WDT O
may MD O
be VB O
poorly RB O
perceived VBN O
or CC O
even RB O
unknown JJ O
to TO O
the DT O
subjects NNS O
themselves PRP O
. . O

Antituberculosis NN O
agents NNS O
. . O

Enzyme NNP O
- : O
linked VBD O
immunosorbent JJ O
assay NN O
for IN O
screening VBG O
aflatoxin NN O
B1 NNP O
in IN O
cottonseed NN O
products NNS O
and CC O
mixed JJ O
feed NN O
: : O
collaborative JJ O
study NN O
. . O

It PRP O
is VBZ O
now RB O
well RB O
established VBN O
that IN O
progression NN O
through IN O
the DT O
eukaryotic JJ O
cell NN O
cycle NN O
is VBZ O
controlled VBN O
by IN O
oscillations NNS O
in IN O
the DT O
activity NN O
of IN O
cyclin NN B-Gene
- : I-Gene
dependent NN I-Gene
kinases NNS I-Gene
( ( O
CDKs NNP B-Gene
) ) O
. . O

The DT O
RanQ69L NNP B-Gene
preincubation NN O
leads VBZ O
to TO O
accumulation NN O
of IN O
CRM1 NNP B-Gene
at IN O
the DT O
cytoplasmic JJ O
periphery NN O
of IN O
the DT O
nuclear JJ O
pore NN O
complex NN O
( ( O
NPC NNP O
) ) O
in IN O
association NN O
with IN O
the DT O
p62 NN B-Gene
complex NN I-Gene
and CC O
Can NNP B-Gene
/ NNP O
Nup214 NNP B-Gene
. . O

MEK NNP B-Gene
itself PRP O
is VBZ O
activated VBN O
via IN O
serine JJ O
phosphorylation NN O
by IN O
upstream JJ B-Gene
activator NN I-Gene
kinases NNS I-Gene
, , O
including VBG O
c SYM B-Gene
- : I-Gene
raf NN I-Gene
, , O
mos NN B-Gene
and CC O
MEK NNP B-Gene
kinase NN I-Gene
. . O

In IN O
summary JJ O
, , O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
dependent JJ O
activation NN O
of IN O
NO NNP O
production NN O
mediates NNS O
apoptosis VBP O
after IN O
TG NNP B-Gene
exposure NN O
in IN O
JT NNP O
/ NNP O
Neo NNP O
cells NNS O
. . O

Sustained VBN O
ventricular JJ O
tachycardia NN O
and CC O
its PRP$ O
successful JJ O
prophylaxis NN O
during IN O
high JJ O
- : O
dose JJ O
bolus NN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
therapy NN O
for IN O
metastatic JJ O
renal NN O
cell NN O
carcinoma NN O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
relations NNS O
, , O
a DT O
risk NN O
factor NN O
- : O
selection NN O
scale NN O
( ( O
RFSS NNP O
) ) O
( ( O
range NN O
, , O
0 CD O
to TO O
10 CD O
) ) O
was VBD O
developed VBN O
by IN O
computing VBG O
appropriate JJ O
weights NNS O
for IN O
each DT O
risk NN O
factor NN O
. . O

Effects NNS O
of IN O
a DT O
new JJ O
antihypertensive JJ O
agent NN O
, , O
SGB NNP O
- : O
1534 CD O
, , O
on IN O
rat NN O
platelet NN O
aggregation NN O
. . O

Dopamine NNP B-Gene
receptor NN I-Gene
blockade NN O
and CC O
the DT O
neuroleptics NNS O
, , O
a DT O
crystallographic JJ O
study NN O
. . O

The DT O
expression NN O
of IN O
this DT O
clone NN O
in IN O
a DT O
wee1 NN B-Gene
/ NN O
mik1 SYM B-Gene
- : O
deficient NN O
mutant JJ O
causes VBZ O
an DT O
elongated JJ O
cell NN O
phenotype NN O
under IN O
non JJ O
- : O
permissive JJ O
growth NN O
conditions NNS O
. . O

The DT O
structural JJ O
gene NN O
encoding VBG O
the DT O
novel JJ O
lantibiotic JJ O
epilancin NN B-Gene
K7 NNP I-Gene
from IN O
Staphylococcus NNP O
epidermidis FW O
K7 NNP O
was VBD O
cloned VBN O
and CC O
its PRP$ O
nucleotide JJ O
sequence NN O
was VBD O
determined VBN O
. . O

Diet NNP O
and CC O
atopic JJ O
eczema NN O
. . O

Induced NNP O
expression NN O
of IN O
Rnd3 NNP B-Gene
is VBZ O
associated VBN O
with IN O
transformation NN O
of IN O
polarized JJ O
epithelial JJ O
cells NNS O
by IN O
the DT O
Raf NNP B-Gene
- : O
MEK NNP B-Gene
- : O
extracellular JJ O
signal JJ O
- : O
regulated JJ O
kinase NN O
pathway NN O
. . O

Mg2 NNP O
+ NNP O
and CC O
Mn2 NNP O
+ NNP O
compete NN O
for IN O
binding VBG O
sites NNS O
, , O
with IN O
the DT O
former JJ O
having VBG O
lower JJR O
affinity NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
mechanism NN O
of IN O
activation NN O
of IN O
HIF NNP B-Gene
- : I-Gene
1alpha CD I-Gene
is VBZ O
a DT O
multi JJ O
- : O
step NN O
process NN O
which WDT O
includes VBZ O
hypoxia NN O
- : O
dependent JJ O
nuclear JJ O
import NN O
and CC O
activation NN O
( ( O
derepression NN O
) ) O
of IN O
the DT O
transactivation NN O
domain NN O
, , O
resulting VBG O
in IN O
recruitment NN O
of IN O
the DT O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
CBP NNP B-Gene
) ) O
/ VBP O
p300 JJ B-Gene
coactivator NN I-Gene
. . O

The DT O
T NNP O
- : O
box NN O
motif NN O
is VBZ O
present JJ O
in IN O
a DT O
family NN O
of IN O
genes NNS O
whose WP$ O
structural JJ O
features NNS O
and CC O
expression NN O
patterns NNS O
support VBP O
their PRP$ O
involvement NN O
in IN O
developmental JJ O
gene NN O
regulation NN O
. . O

Cp NNP B-Gene
is VBZ O
normally RB O
the DT O
main JJ O
promoter NN O
for IN O
EBNA NNP B-Gene
mRNA NNP I-Gene
initiation NN O
, , O
so IN O
it PRP O
appears VBZ O
that IN O
EBNA3C NNP B-Gene
contributes VBZ O
to TO O
a DT O
negative JJ O
autoregulatory NN O
control NN O
loop NN O
. . O

Fibular JJ O
dimelia NN O
with IN O
deficiency NN O
of IN O
the DT O
tibia NN O
. . O

When WRB O
the DT O
promoter NN O
region NN O
was VBD O
linked VBN O
with IN O
a DT O
heterologous JJ O
reporter NN O
gene NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
promoter NN O
region NN O
is VBZ O
inducible JJ O
by IN O
both DT O
interferons NNS B-Gene
( ( O
interferon VB B-Gene
- : I-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
gamma NN I-Gene
) ) O
and CC O
interferon $ B-Gene
regulatory JJ I-Gene
factor NN I-Gene
1 CD I-Gene
. . O

Today NN O
there EX O
is VBZ O
no DT O
doubt NN O
that IN O
elevated VBD O
plasma NNS O
cholesterol NN O
levels NNS O
should MD O
be VB O
lowered VBN O
first JJ O
by IN O
dietary JJ O
modification NN O
even RB O
in IN O
early JJ O
childhood NN O
, , O
beginning VBG O
at IN O
the DT O
age NN O
of IN O
two CD O
years NNS O
. . O

Percent NNP O
identities NNS O
of IN O
the DT O
mouse NN B-Gene
PP2 NNP I-Gene
to TO O
mouse VB B-Gene
Y1 NNP I-Gene
, , O
mouse NN O
Y4 NNP B-Gene
/ NNP O
PP1 NNP B-Gene
and CC O
human JJ B-Gene
Y2 NNP I-Gene
receptors NNS I-Gene
are VBP O
53 CD O
, , O
42 CD O
, , O
and CC O
31 CD O
, , O
respectively RB O
. . O

To TO O
identify VB O
cis JJ O
- : O
acting VBG O
elements NNS O
that WDT O
target VBP O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
mRNA NN I-Gene
for IN O
downregulation NN O
during IN O
myogenesis NN O
, , O
we PRP O
stably RB O
transfected VBD O
C2C12 NNP O
cells NNS O
with IN O
mutant JJ B-Gene
myc NN I-Gene
genes NNS I-Gene
or CC O
chimeric JJ O
genes NNS O
in IN O
which WDT O
various JJ O
myc NNS B-Gene
sequences NNS I-Gene
were VBD O
fused VBN O
to TO O
the DT O
human JJ B-Gene
beta NN I-Gene
- : I-Gene
globin NN I-Gene
gene NN I-Gene
or CC O
to TO O
the DT O
bacterial JJ B-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
gene NN O
. . O

A DT O
new JJ O
hemagglutination NN O
test NN O
for IN O
the DT O
on IN O
- : O
slide NN O
assay NN O
of IN O
rheumatoid JJ B-Gene
factor NN I-Gene

Recent JJ O
work NN O
in IN O
this DT O
laboratory NN O
has VBZ O
shown VBN O
that IN O
the DT O
gene NN O
coding VBG O
for IN O
acetate JJ B-Gene
kinase NN I-Gene
( ( O
ackA NN B-Gene
) ) O
in IN O
Sinorhizobium NNP O
meliloti NN O
is VBZ O
up RP O
- : O
regulated VBN O
in IN O
response NN O
to TO O
phosphate VB O
limitation NN O
. . O

Quantitative JJ O
computed VBD O
tomography NN O
for IN O
measuring VBG O
vertebral JJ O
bone NN O
mineral NN O
content NN O
offers NNS O
high JJ O
sensitivity NN O
and CC O
reproducibility NN O
. . O

Biol NNP O
. . O

Mutations NNS O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
of IN O
the DT O
TIMP NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
that WDT O
prevented VBD O
formation NN O
of IN O
HMAP NNP B-Gene
- : I-Gene
1 CD I-Gene
caused VBD O
a DT O
70 CD O
% NN O
loss NN O
of IN O
activity NN O
in IN O
transfected VBN O
activated JJ O
HSCs NNP O
. . O

Mnt NN B-Gene
: : O
Max NNP B-Gene
complexes NNS O
also RB O
efficiently RB O
suppress JJ O
Myc NNP B-Gene
- : O
dependent JJ O
activation NN O
from IN O
the DT O
same JJ O
promoter NN O
. . O

Activation NN O
of IN O
the DT O
SH2 NNP B-Gene
- : I-Gene
containing VBG I-Gene
protein JJ I-Gene
tyrosine JJ I-Gene
phosphatase NN I-Gene
, , O
SH NNP B-Gene
- : I-Gene
PTP2 NN I-Gene
, , O
by IN O
phosphotyrosine JJ O
- : O
containing VBG O
peptides NNS O
derived VBN O
from IN O
insulin NN B-Gene
receptor NN I-Gene
substrate VBP I-Gene
- : I-Gene
1 CD I-Gene
. . O

Besides IN O
the DT O
characterization NN O
and CC O
discussion NN O
of IN O
the DT O
experimental JJ O
setup NN O
used VBN O
, , O
the DT O
rate NN O
constants NNS O
obtained VBN O
are VBP O
discussed VBN O
and CC O
compared VBN O
with IN O
estimated VBN O
values NNS O
. . O

For IN O
patients NNS O
with IN O
recurrent NN O
or CC O
metastatic JJ O
disease NN O
, , O
the DT O
data NN O
suggest NN O
that IN O
I PRP O
- : O
131 CD O
MIBG NNP O
scintigraphy NN O
is VBZ O
the DT O
examination NN O
of IN O
choice NN O
. . O

CONCLUSIONS NN O
: : O
We PRP O
obtained VBD O
normal JJ O
EPO NNP B-Gene
levels NNS O
for IN O
mothers NNS O
and CC O
newborns NNS O
for IN O
our PRP$ O
area NN O
, , O
similarly RB O
to TO O
the DT O
previously RB O
described VBN O
ones NNS O
. . O

Evoked JJ O
electromyographic JJ O
response NN O
to TO O
indirect VB O
supramaximal JJ O
stimulation NN O
at IN O
1 CD O
Hz NNP O
was VBD O
monitored VBN O
in IN O
ten JJ O
adult NN O
goats NNS O
under IN O
thiopentone NN O
- : O
halothane NN O
anaesthesia NN O
. . O

The DT O
yeast NN O
retrotransposon NN B-Gene
Ty5 NNP I-Gene
preferentially RB O
integrates VBZ O
into IN O
regions NNS O
of IN O
silent JJ O
chromatin NN O
. . O

During IN O
pentobarbital JJ O
anesthesia NN O
, , O
the DT O
basal NN O
VO2 NNP O
was VBD O
5 CD O
. . O
26 CD O
ml JJ O
/ NNP O
kg NN O
/ NNP O
min NN O
and CC O
was VBD O
increased VBN O
by IN O
epinephrine NN O
in IN O
a DT O
dose JJ O
dependent JJ O
manner NN O
at IN O
plasma JJ O
concentrations NNS O
between IN O
3 CD O
. . O
9 CD O
ng JJ O
/ NN O
ml NN O
( ( O
VO2 NNP O
= VBZ O
5 CD O
. . O
68 CD O
ml JJ O
/ NNP O
kg NN O
/ NNP O
min NN O
) ) O
and CC O
36 CD O
. . O
5 CD O
ng JJ O
/ NN O
ml NN O
( ( O
VO2 NNP O
= VBZ O
6 CD O
. . O
47 CD O
ml JJ O
/ NNP O
kg NN O
/ NNP O
min NN O
) ) O
. . O

In IN O
conclusion NN O
, , O
these DT O
observations NNS O
demonstrated VBD O
that IN O
stratification NN O
of IN O
acute JJ O
MI NNP O
patients NNS O
by IN O
plasma JJ O
ANF NNP B-Gene
level NN O
is VBZ O
a DT O
useful JJ O
non JJ O
- : O
invasive JJ O
method NN O
for IN O
predicting VBG O
prognosis NN O
and CC O
for IN O
identifying VBG O
individuals NNS O
at IN O
high JJ O
risk NN O
of IN O
cardiac JJ O
death NN O
. . O

The DT O
YccA NNP B-Gene
protein NN I-Gene
was VBD O
found VBN O
to TO O
be VB O
degraded VBN O
in IN O
an DT O
FtsH NNP B-Gene
- : O
dependent JJ O
manner NN O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
, , O
whereas IN O
the DT O
YccA11 NNP B-Gene
mutant NN I-Gene
protein NN I-Gene
, , O
lacking VBG O
eight CD O
amino NN O
acid NN O
residues NNS O
within IN O
the DT O
amino NN O
- : O
terminal JJ O
cytoplasmic JJ O
domain NN O
, , O
was VBD O
refractory NN O
to TO O
the DT O
degradation NN O
. . O

LCBF NNP O
in IN O
normal JJ O
and CC O
hypoxic JJ O
puppies NNS O
was VBD O
correlated VBN O
with IN O
local JJ O
cerebral JJ O
glucose NN O
utilization NN O
( ( O
LCGU NNP O
) ) O
obtained VBD O
under IN O
the DT O
same JJ O
experimental JJ O
conditions NNS O
( ( O
Duffy NNP O
et RB O
al RB O
, , O
1982 CD O
) ) O
. . O

To TO O
test VB O
the DT O
feasibility NN O
of IN O
using VBG O
liposomes NNS O
to TO O
deliver VB O
therapeutic JJ O
agents NNS O
to TO O
the DT O
lungs NNS O
, , O
the DT O
effect NN O
of IN O
liposome JJ O
- : O
encapsulated VBN O
superoxide JJ B-Gene
dismutase NN I-Gene
( ( O
SOD NNP B-Gene
) ) O
or CC O
catalase NN B-Gene
on IN O
pulmonary JJ O
oxygen NN O
toxicity NN O
was VBD O
studied VBN O
in IN O
rats NNS O
. . O

Foveating VBG O
saccades NNS O
, , O
therefore RB O
, , O
can MD O
be VB O
distinguished VBN O
from IN O
other JJ O
FEMs NNP O
on IN O
the DT O
basis NN O
of IN O
speed NN O
. . O

In IN O
eight CD O
groups NNS O
of IN O
subjects NNS O
operating VBG O
various JJ O
hand NN O
- : O
held NN O
vibrating NN O
tools NNS O
and CC O
aged VBN O
from IN O
30 CD O
to TO O
59 CD O
years NNS O
, , O
the DT O
prevalence NN O
rates NNS O
of IN O
vibration NN O
- : O
induced JJ O
white JJ O
finger NN O
( ( O
VWF NNP O
) ) O
and CC O
numbness JJ O
, , O
pain NN O
, , O
or CC O
stiffness NN O
in IN O
the DT O
upper JJ O
and CC O
lower JJR O
extremities NNS O
were VBD O
investigated VBN O
. . O

Colorimetric NNP O
method NN O
of IN O
determining VBG O
glycerin NN O
in IN O
the DT O
blood NN O

Convulsive JJ O
status NN O
epilepticus NN O
after IN O
infusion NN O
of IN O
cisplatin NN O

Functional JJ O
effects NNS O
following VBG O
subacute JJ O
administration NN O
. . O

ORF NNP O
M1 NNP O
has VBZ O
striking VBG O
homology NN O
to TO O
poxvirus VB O
serpins NNS B-Gene
, , O
while IN O
ORF NNP O
M11 NNP O
encodes VBZ O
a DT O
potential JJ O
homolog NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
like IN I-Gene
molecules NNS I-Gene
encoded VBN O
by IN O
other JJ O
gammaherpesviruses NNS O
( ( O
gene NN B-Gene
16 CD I-Gene
of IN O
HVS NNP O
and CC O
KSHV NNP O
and CC O
the DT O
BHRF1 NNP B-Gene
gene NN I-Gene
of IN O
EBV NNP O
) ) O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
gluconeogenic JJ O
genes NNS O
are VBP O
derepressed VBN O
upon IN O
binding NN O
of IN O
Cat8p NNP B-Gene
, , O
whose WP$ O
synthesis NN O
depends VBZ O
on IN O
the DT O
release NN O
of IN O
Cat4p NNP B-Gene
( ( O
Mig1p NNP B-Gene
) ) O
from IN O
the DT O
CAT8 NNP B-Gene
promoter NN I-Gene
. . O

Asthmatic JJ O
patients NNS O
showed VBD O
greater JJR O
responses NNS O
of IN O
both DT O
parameters NNS O
to TO O
adrenaline VB O
than IN O
controls NNS O
indicating VBG O
that IN O
long JJ O
- : O
term NN O
corticosteroid JJ O
treatment NN O
enhances VBZ O
the DT O
acute JJ O
responses NNS O
of IN O
plasminogen NN B-Gene
activator NN I-Gene
and CC O
clotting VBG B-Gene
factor NN I-Gene
VIII NNP I-Gene
to TO O
adrenaline VB O
infusion NN O
. . O

METHODS NN O
: : O
A DT O
structured JJ O
interview NN O
was VBD O
undertaken VBN O
at IN O
the DT O
time NN O
of IN O
initial JJ O
consultation NN O
and CC O
at IN O
subsequent JJ O
1 CD O
- : O
year NN O
intervals NNS O
regarding VBG O
type NN O
of IN O
BHS NNP O
, , O
frequency NN O
of IN O
spells NNS O
, , O
associated VBN O
phenomenon NN O
, , O
sequelae NN O
, , O
family NN O
history NN O
, , O
and CC O
age NN O
at IN O
termination NN O
of IN O
spells NNS O
. . O

Atherosclerosis NN O

Cholangiography NN O
was VBD O
performed VBN O
in IN O
all DT O
cases NNS O
and CC O
classified VBN O
by IN O
a DT O
scoring NN O
system NN O
specifically RB O
developed VBD O
for IN O
pediatric JJ O
patients NNS O
. . O

Patients NNS O
with IN O
lesions NNS O
affecting VBG O
the DT O
PRC NNP O
but CC O
sparing VBG O
the DT O
PHC NNP O
, , O
and CC O
patients NNS O
with IN O
lesions NNS O
affecting VBG O
both DT O
PRC NNP O
and CC O
PHC NNP O
, , O
performed VBD O
an DT O
oculomotor NN O
delayed VBN O
response NN O
task NN O
with IN O
unpredictably RB O
varied JJ O
memory NN O
delays NNS O
of IN O
up IN O
to TO O
30 CD O
s NNS O
. . O

The DT O
finding NN O
that IN O
the DT O
chimeric JJ B-Gene
TdT NN I-Gene
: : O
: : O
Pol NNP B-Gene
beta NN I-Gene
protein NN I-Gene
possessed VBD O
significant JJ O
template JJ O
- : O
dependent JJ O
polymerase NN O
activity NN O
suggests VBZ O
that IN O
aa NN O
1 CD O
- : O
60 CD O
of IN O
Pol NNP B-Gene
beta NN I-Gene
are VBP O
involved VBN O
in IN O
template JJ O
utilization NN O
during IN O
the DT O
polymerization NN O
reaction NN O
, , O
as IN O
suggested VBN O
by IN O
the DT O
previous JJ O
finding NN O
that IN O
the DT O
8 CD O
- : O
kDa NN O
N NNP O
- : O
terminal JJ O
domain NN O
of IN O
Pol NNP B-Gene
beta NN I-Gene
possesses NNS O
ssDNA VBP O
- : O
binding NN O
activity NN O
[ NNP O
Kumar NNP O
et FW O
al NN O
. . O
, , O
J NNP O
. . O

Cyclic NNP B-Gene
AMP NNP I-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinase VBD I-Gene
binding VBG O
to TO O
A NNP B-Gene
- : I-Gene
kinase NN I-Gene
anchoring VBG O
proteins NNS O
in IN O
living VBG O
cells NNS O
by IN O
fluorescence NN O
resonance NN O
energy NN O
transfer NN O
of IN O
green JJ B-Gene
fluorescent NN I-Gene
protein NN I-Gene
fusion NN O
proteins NNS O
. . O

The DT O
pharmacokinetics NNS O
of IN O
each DT O
tetracycline NN O
in IN O
serum NN O
and CC O
dermal NN O
, , O
suction NN O
blister NN O
fluid NN O
were VBD O
determined VBN O
after IN O
oral JJ O
doses NNS O
of IN O
300 CD O
mg JJ O
lymecycline NN O
or CC O
100 CD O
mg NNS O
doxycycline NN O
on IN O
the DT O
3rd CD O
day NN O
. . O

The DT O
following JJ O
aspects NNS O
were VBD O
assessed VBN O
: : O
( ( O
1 CD O
) ) O
The DT O
effect NN O
on IN O
the DT O
cardiovascular JJ O
system NN O
in IN O
terms NNS O
of IN O
brachial JJ O
arterial JJ O
pressure NN O
, , O
pulse JJ O
rate NN O
, , O
and CC O
oxygen NN O
consumption NN O
( ( O
VO2 NNP O
) ) O
during IN O
exercise NN O
in IN O
5 CD O
health NN O
volunteers NNS O
; : O
( ( O
2 CD O
) ) O
emg NN O
activity NN O
of IN O
the DT O
tibialis NN O
anterior NN O
and CC O
gastrocnemius NN O
muscles NNS O
during IN O
exercise NN O
in IN O
the DT O
same JJ O
5 CD O
volunteers NNS O
; : O
and CC O
( ( O
3 CD O
) ) O
postexercise NN O
ankle JJ O
pressure NN O
changes NNS O
in IN O
10 CD O
subjects NNS O
with IN O
angiographically RB O
proven JJ O
occlusive JJ O
arterial JJ O
diseases NNS O
of IN O
the DT O
lower JJR O
extremities NNS O
. . O

The DT O
52 CD O
- : O
protein NN O
subunit NN O
of IN O
T4 NNP B-Gene
DNA NNP I-Gene
topoisomerase NN I-Gene
is VBZ O
homologous JJ O
to TO O
the DT O
gyrA NN B-Gene
- : I-Gene
protein NN I-Gene
of IN O
gyrase NN B-Gene
. . O

The DT O
patients NNS O
are VBP O
two CD O
healthy JJ O
adult NN O
males NNS O
. . O

Pargyline NNP O
, , O
a DT O
monoamine JJ B-Gene
oxidase NN I-Gene
inhibitor NN O
, , O
reduces VBZ O
peak JJ O
3 CD O
transiently RB O
( ( O
max NN O
. . O

The DT O
timing NN O
of IN O
fla JJ B-Gene
gene NN I-Gene
expression NN O
in IN O
the DT O
cell NN O
cycle NN O
is VBZ O
determined VBN O
by IN O
specialized JJ O
forms NNS O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
and CC O
the DT O
appearance NN O
and CC O
/ NN O
or CC O
activation NN O
of IN O
regulatory JJ O
proteins NNS O
. . O

Potscoital JJ O
test NN O

Exposure NN O
of IN O
endothelium NN O
to TO O
pulsatile VB O
shear JJ O
stresses NNS O
that WDT O
followed VBD O
a DT O
tape NN O
recording NN O
of IN O
physiological JJ O
flow NN O
waveforms NNS O
( ( O
electromagnetic JJ O
flowmeter NN O
) ) O
did VBD O
not RB O
cause VB O
gross JJ O
injury NN O
or CC O
denudation NN O
even RB O
when WRB O
peak JJ O
shear NN O
exceeded VBD O
1500 CD O
dyne NN O
/ NNP O
cm2 NN O
. . O

Furthermore RB O
, , O
interactions NNS O
were VBD O
identified VBN O
between IN O
endogenous JJ B-Gene
E NNP I-Gene
- : I-Gene
cadherin NN I-Gene
and CC O
the DT O
chimera NN O
containing VBG O
the DT O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
extracellular JJ I-Gene
domain NN I-Gene
and CC O
the DT O
desmoglein NN B-Gene
1 CD I-Gene
intracellular JJ I-Gene
domain NN I-Gene
providing VBG O
in IN O
vivo JJ O
evidence NN O
for IN O
previously RB O
predicted VBN O
lateral JJ O
interactions NNS O
of IN O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
extracellular JJ I-Gene
domains NNS I-Gene
. . O

CONCLUSION NN O
: : O
The DT O
study NN O
demonstrates VBZ O
that IN O
transvaginal JJ O
ultrasonography NN O
has VBZ O
an DT O
efficiency NN O
of IN O
88 CD O
% NN O
in IN O
differentiating VBG O
endometriomas NN O
from IN O
other JJ O
ovarian JJ O
masses NNS O
with IN O
a DT O
specificity NN O
of IN O
90 CD O
% NN O
. . O

4 CD O
) ) O
PU NNP B-Gene
and CC O
PD NNP B-Gene
lacked VBD O
the DT O
canonical JJ O
TATA NNP O
or CC O
CAAT NNP O
motifs NNS O
, , O
and CC O
are VBP O
AT NNP O
- : O
rich NN O
. . O

A DT O
total NN O
of IN O
57 CD O
patients NNS O
with IN O
Hodgkin NNP O
' POS O
s NN O
disease NN O
limited VBD O
to TO O
above IN O
the DT O
diaphragm NN O
( ( O
Stages NNP O
I PRP O
and CC O
II NNP O
, , O
A NNP O
and CC O
B NNP O
) ) O
were VBD O
treated VBN O
with IN O
radiation NN O
therapy NN O
alone RB O
at IN O
the DT O
University NNP O
of IN O
Florida NNP O
between IN O
1964 CD O
and CC O
1974 CD O
. . O

Multistage NN O
models NNS O
and CC O
the DT O
A NNP O
- : O
bomb NN O
survivor NN O
data NNS O
: : O
implications NNS O
for IN O
carcinogenic JJ O
mechanisms NNS O
? . O

Here RB O
we PRP O
report VBP O
the DT O
cloning NN O
and CC O
characterization NN O
of IN O
Xenopus NNP B-Gene
Pax NNP I-Gene
- : I-Gene
5 CD I-Gene
and CC O
Pax NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
two CD O
orthologues NNS O
of IN O
the DT O
Pax NNP B-Gene
- : I-Gene
2 CD I-Gene
/ $ I-Gene
5 CD I-Gene
/ $ I-Gene
8 CD I-Gene
gene NN I-Gene
family NN I-Gene
. . O

Alternating VBG O
proline NN O
/ NNP O
alanine NN O
sequence NN O
of IN O
beta NN B-Gene
B1 NNP I-Gene
subunit NN I-Gene
originates VBZ O
from IN O
a DT O
repetitive JJ O
DNA NN O
sequence NN O
. . O

In IN O
gel JJ O
mobility NN O
shift NN O
assays NNS O
, , O
we PRP O
found VBD O
no DT O
evidence NN O
for IN O
VDR NNP B-Gene
- : O
TR NNP B-Gene
heterodimer VBZ O
interaction NN O
with IN O
any DT O
tested JJ O
element NN O
. . O

In IN O
vitro JJ O
precipitation NN O
with IN O
a DT O
glutathione NN B-Gene
- : I-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
- : I-Gene
fusion NN I-Gene
protein NN I-Gene
containing VBG O
the DT O
C NNP O
- : O
terminal JJ O
transactivation NN O
domain NN O
of IN O
STAT5a NNP B-Gene
showed VBD O
GH NNP B-Gene
- : O
regulated VBN O
association NN O
of IN O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
with IN O
the DT O
fusion NN O
protein NN O
, , O
while IN O
this DT O
was VBD O
not RB O
seen VBN O
when WRB O
serine JJ O
780 CD O
in IN O
STAT5a NNP B-Gene
was VBD O
changed VBN O
to TO O
alanine VB O
. . O

In IN O
ferrets NNS O
naturally RB O
infected VBN O
with IN O
H NNP O
. . O
mustelae NN O
, , O
a DT O
single JJ O
dose NN O
( ( O
50 CD O
mg NN O
/ NNP O
kg NN O
, , O
per IN O
os NN O
) ) O
of IN O
fluorofamide NN O
completely RB O
inhibited JJ O
bacterial JJ B-Gene
urease NN I-Gene
. . O

A DT O
reassessment NN O
of IN O
the DT O
prevalence NN O
data NN O
was VBD O
carried VBN O
out RP O
in IN O
the DT O
southern JJ O
province NN O
of IN O
Uusimaa NNP O
and CC O
in IN O
the DT O
western JJ O
province NN O
of IN O
Vaasa NNP O
, , O
the DT O
prevalence NN O
day NN O
being VBG O
January NNP O
1 CD O
, , O
1979 CD O
. . O

Elementary JJ O
visual JJ O
hallucinations NNS O
in IN O
migraine NN O
and CC O
epilepsy NN O
. . O

We PRP O
have VBP O
previously RB O
mapped VBN O
the DT O
defect NN O
in IN O
RIIIS NNP O
/ NNP O
J NNP O
to TO O
distal VB O
mouse NN O
Chr NNP O
11 CD O
, , O
distinct NN O
from IN O
the DT O
Vwf NNP B-Gene
locus NN I-Gene
on IN O
Chr NNP O
6 CD O
. . O

CONCLUSION NN O
: : O
We PRP O
were VBD O
unable JJ O
to TO O
identify VB O
features NNS O
of IN O
disease NN O
likely JJ O
to TO O
be VB O
associated VBN O
with IN O
a DT O
clinically RB O
useful JJ O
response NN O
to TO O
inhaled VB O
NO NNP O
therapy NN O
using VBG O
the DT O
parameters NNS O
studied VBD O
. . O

In IN O
group NN O
I PRP O
, , O
Paw NNP O
, , O
delta NN O
V NNP O
, , O
PaO2 NNP O
, , O
Vinj NNP O
and CC O
VT NNP O
significantly RB O
decreased VBD O
whereas NNS O
operating VBG O
pressure NN O
and CC O
E NNP O
significantly RB O
increased VBD O
when WRB O
the DT O
internal JJ O
diameter NN O
of IN O
the DT O
injector NN O
cannula NN O
was VBD O
reduced VBN O
. . O

Ig NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
Ig NNP B-Gene
- : I-Gene
beta NN I-Gene
contain NN O
extended VBD O
cytoplasmic JJ O
structure NN O
( ( O
61 CD O
and CC O
48 CD O
amino NN O
acids NNS O
, , O
respectively RB O
) ) O
and CC O
associate JJ O
with IN O
cytoplasmic JJ O
effectors NNS O
indicating VBG O
that IN O
they PRP O
are VBP O
directly RB O
involved VBN O
in IN O
signal JJ O
transduction NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
In IN O
807 CD O
consecutive JJ O
patients NNS O
from IN O
the DT O
Chilean NNP O
National NNP O
Registry NNP O
of IN O
Acute NNP O
Myocardial NNP O
Infarction NNP O
we PRP O
analyzed VBD O
the DT O
resolution NN O
of IN O
chest NN O
pain NN O
and CC O
ST NNP O
segment NN O
elevation NN O
over IN O
50 CD O
% NN O
within IN O
the DT O
first JJ O
90 CD O
min NN O
, , O
abrupt JJ O
CK NNP B-Gene
rise NN O
within IN O
8 CD O
h NN O
and CC O
T NNP O
wave VBP O
inversion NN O
in IN O
infarct NN O
related VBN O
EKG NNP O
leads VBZ O
within IN O
the DT O
first JJ O
24 CD O
h NN O
after IN O
thrombolysis NN O
. . O

Since IN O
one CD O
group NN O
of IN O
adolescents NNS O
more RBR O
difficult JJ O
to TO O
influence VB O
are VBP O
those DT O
whose WP$ O
parents NNS O
smoke VBD O
, , O
parental JJ O
involvement NN O
in IN O
smoking VBG O
prevention NN O
may MD O
be VB O
a DT O
powerful JJ O
enhancer NN O
. . O

All DT O
numbers NNS O
refer VBP O
to TO O
nucleotide VB O
positions NNS O
on IN O
the DT O
wild JJ O
- : O
type NN O
HIV NNP O
- : O
1 CD O
transcript NN O
. . O

Overproduction NN O
, , O
purification NN O
and CC O
characterization NN O
of IN O
M NNP B-Gene
. . I-Gene
HinfI NNP I-Gene
methyltransferase NN I-Gene
and CC O
its PRP$ O
deletion NN O
mutant NN O
. . O

Overexpression NN O
of IN O
Sed5p NNP B-Gene
allowed VBD O
growth NN O
in IN O
the DT O
absence NN O
of IN O
Vti1p NNP B-Gene
. . O

On IN O
physical JJ O
examination NN O
a DT O
mild JJ O
symmetrical JJ O
polyarthritis NN O
of IN O
small JJ O
and CC O
large JJ O
joints NNS O
was VBD O
seen VBN O
. . O

A DT O
neuropsychological JJ O
test NN O
battery NN O
was VBD O
used VBN O
that IN O
contained VBD O
the DT O
Wisconsin NNP O
card NN O
sorting VBG O
test NN O
, , O
Street NNP O
completion NN O
test NN O
, , O
Stroop NNP O
test NN O
, , O
a DT O
dichotic JJ O
memory NN O
listening VBG O
test NN O
, , O
and CC O
a DT O
facial JJ O
recognition NN O
test NN O
. . O

However RB O
, , O
the DT O
use NN O
of IN O
cyclosporin NN O
A NNP O
is VBZ O
associated VBN O
with IN O
an DT O
increased JJ O
prevalence NN O
of IN O
hypertension NN O
in IN O
kidney NN O
transplant NN O
recipients NNS O
. . O

Synthetic JJ O
enantiomers NNS O
of IN O
drugs NNS O

Successful JJ O
treatment NN O
with IN O
nasal JJ O
continuous JJ O
positive JJ O
airway NN O
pressure NN O
( ( O
8 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
5 CD O
cmH2O NN O
) ) O
for IN O
3 CD O
days NNS O
caused VBD O
a DT O
significant JJ O
decrease NN O
in IN O
mean JJ O
blood NN O
pressure NN O
in IN O
OSAS NNP O
. . O

This DT O
subfamily NN O
of IN O
genes NNS O
all DT O
have VBP O
a DT O
single JJ O
ATP NNP O
- : O
binding NN O
domain NN O
at IN O
the DT O
N NNP O
- : O
terminus NN O
and CC O
a DT O
single JJ O
C NNP O
- : O
terminal JJ O
set NN O
of IN O
transmembrane NN O
segments NNS O
. . O

Within IN O
this DT O
sequence NN O
the DT O
MSAS NNP B-Gene
gene NN I-Gene
was VBD O
identified VBN O
as IN O
a DT O
5322 CD O
- : O
bp SYM O
- : O
long JJ O
open JJ O
reading NN O
frame NN O
coding VBG O
for IN O
a DT O
protein NN O
of IN O
1774 CD O
amino NN O
acids NNS O
and CC O
190 CD O
, , O
731 CD O
Da NNP O
molecular JJ O
mass NN O
. . O

A DT O
site NN O
- : O
directed VBN O
R618K NNP O
mutation NN O
in IN O
the DT O
Stat5 NNP B-Gene
SH2 NNP B-Gene
domain NN I-Gene
abolished VBD O
the DT O
phosphorylation NN O
by IN O
Jak2 NNP B-Gene
, , O
while IN O
deletion NN O
of IN O
the DT O
C NNP O
terminus NN O
led VBD O
to TO O
Stat5 NNP B-Gene
hyperphosphorylation NN O
. . O

Circulating VBG O
oxytocin NN B-Gene
in IN O
male JJ O
guinea NN O
pigs NNS O
affected VBN O
by IN O
the DT O
female JJ O
cohabitation NN O
and CC O
reproductive JJ O
condition NN O
. . O

Methanesulfonyl NNP O
fluoride NN O
( ( O
MSF NNP O
) ) O
: : O
a DT O
double JJ O
- : O
blind NN O
, , O
placebo SYM O
- : O
controlled VBN O
study NN O
of IN O
safety NN O
and CC O
efficacy NN O
in IN O
the DT O
treatment NN O
of IN O
senile JJ O
dementia NN O
of IN O
the DT O
Alzheimer NNP O
type NN O
. . O

Using VBG O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
to TO O
screen VB O
for IN O
proteins NNS O
which WDT O
interact VBP O
with IN O
Tax1 NNP B-Gene
, , O
we PRP O
isolated VBD O
the DT O
B NNP O
subunit NN O
of IN O
the DT O
CCAAT NNP O
binding NN O
protein NN O
NF NNP B-Gene
- : I-Gene
Y NN I-Gene
from IN O
a DT O
HeLa NNP O
cDNA NN O
library NN O
. . O

Data NNS O
were VBD O
processed VBN O
with IN O
a DT O
semi JJ O
- : O
automatic JJ O
computer NN O
program NN O
which WDT O
develops VBZ O
an DT O
averaged JJ O
- : O
volume NN O
curve NN O
from IN O
an DT O
assigned VBN O
LV NNP O
region NN O
- : O
of IN O
- : O
interest NN O
. . O

In IN O
infected JJ O
mammalian JJ O
cells NNS O
, , O
the DT O
ARV NNP B-Gene
G NNP I-Gene
and CC O
GNS NNP B-Gene
genes NNS I-Gene
are VBP O
transcribed VBN O
primarily RB O
as IN O
a DT O
polycistronic NN O
mRNA NN O
which WDT O
appears VBZ O
to TO O
extend VB O
from IN O
the DT O
consensus NN O
sequence NN O
( ( O
AACAG NNP O
) ) O
at IN O
the DT O
start NN O
of IN O
the DT O
G NNP B-Gene
gene NN I-Gene
to TO O
the DT O
next JJ O
recognized VBN O
polyadenylation NN O
signal NN O
( ( O
CATG NNP O
[ VBZ O
A NNP O
] NNP O
7 CD O
) ) O
located VBD O
697 CD O
nucleotides NNS O
downstream NN O
of IN O
the DT O
GNS NNP B-Gene
protein NN I-Gene
termination NN O
codon NN O
. . O

Each DT O
group NN O
received VBD O
15 CD O
ml NNS O
/ JJ O
kg NN O
of IN O
either DT O
6 CD O
% NN O
pentafraction NN O
, , O
6 CD O
% NN O
pentastarch NN O
, , O
or CC O
plasma NN O
followed VBD O
two CD O
hours NNS O
later RB O
by IN O
1 CD O
. . O
5 CD O
micrograms NNS O
/ VBP O
kg VB O
/ JJ O
0 CD O
. . O
5 CD O
hr JJ O
E NN O
. . O

SRC NNP B-Gene
- : I-Gene
1 CD I-Gene
can MD O
relieve VB O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
mediated VBN O
repression NN O
of IN O
GR NNP B-Gene
activity NN O
. . O

It PRP O
is VBZ O
related VBN O
to TO O
a DT O
variety NN O
of IN O
mammalian JJ O
Golgi NNP O
- : O
associated JJ O
proteins NNS O
and CC O
to TO O
the DT O
yeast NN O
Uso1p NNP B-Gene
, , O
an DT O
essential JJ O
protein NN O
involved VBN O
in IN O
docking NN O
of IN O
endoplasmic JJ O
reticulum NN O
- : O
derived VBN O
vesicles NNS O
to TO O
the DT O
cis NN O
- : O
Golgi NNP O
. . O

Of IN O
270 CD O
patients NNS O
with IN O
well RB O
- : O
defined VBN O
drug NN O
reactions NNS O
, , O
190 CD O
( ( O
70 CD O
per IN O
cent NN O
) ) O
gave VBD O
a DT O
positive JJ O
response NN O
to TO O
the DT O
mast NN O
cell NN O
test NN O
. . O

OBJECTIVE NN O
: : O
The DT O
purpose NN O
of IN O
this DT O
article NN O
is VBZ O
to TO O
review VB O
balance NN O
instruments NNS O
developed VBD O
within IN O
the DT O
past JJ O
10 CD O
years NNS O
that WDT O
can MD O
be VB O
used VBN O
in IN O
the DT O
clinic NN O
or CC O
home NN O
environment NN O
. . O

In IN O
the DT O
icosahaedral JJ O
MVMi NNP O
capsid NN O
, , O
this DT O
sequence NN O
forms VBZ O
the DT O
carboxy JJ O
end NN O
of IN O
the DT O
amphipathic JJ O
beta NN O
- : O
strand NN O
I PRP O
( ( O
betaI NN O
) ) O
, , O
and CC O
all DT O
its PRP$ O
basic JJ O
residues NNS O
are VBP O
contiguously RB O
positioned VBN O
at IN O
the DT O
face NN O
that IN O
in IN O
the DT O
unassembled JJ O
subunit NN O
would MD O
be VB O
exposed VBN O
to TO O
solvent NN O
. . O

Instead RB O
, , O
affective JJ O
flattening NN O
was VBD O
associated VBN O
with IN O
both DT O
dopamine JJ B-Gene
receptor NN I-Gene
sensitivity NN O
and CC O
psychomotor NN O
slowing NN O
. . O

Since IN O
considerable JJ O
variations NNS O
in IN O
length NN O
and CC O
primary JJ O
sequence NN O
in IN O
the DT O
CDR3 NNP B-Gene
( ( O
complementarity NN B-Gene
determining VBG I-Gene
region NN I-Gene
) ) O
peptides NNS O
of IN O
all PDT O
the DT O
H NNP B-Gene
- : I-Gene
chains NNS I-Gene
are VBP O
evident JJ O
, , O
conservation NN O
of IN O
the DT O
D NNP B-Gene
- : I-Gene
region NN I-Gene
structure NN O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
necessary JJ O
for IN O
effective JJ O
hapten NN O
binding NN O
. . O

Asthma NNP O
was VBD O
significantly RB O
more RBR O
often RB O
associated VBN O
with IN O
ASA NNP O
group NN O
( ( O
91 CD O
% NN O
) ) O
vs VBZ O
46 CD O
% NN O
at IN O
AT NNP O
and CC O
in IN O
only RB O
16 CD O
% NN O
at IN O
INTR NNP O
group NN O
. . O

They PRP O
also RB O
reported VBD O
that IN O
E NNP B-Gene
mu VBD I-Gene
pim SYM I-Gene
- : I-Gene
1 CD I-Gene
transgenic JJ O
mice NN O
show NN O
greatly RB O
accelerated VBD O
lymphoma NN O
development NN O
when WRB O
infected VBN O
with IN O
wild JJ O
- : O
type NN O
M NNP O
- : O
MuLV NN O
at IN O
birth NN O
. . O

Adriamycin NNS O
: : O
comparison NN O
of IN O
a DT O
5 CD O
- : O
week NN O
schedule NN O
with IN O
a DT O
3 CD O
- : O
week NN O
schedule NN O
in IN O
the DT O
treatment NN O
of IN O
breast NN O
cancer NN O
. . O

Human NNP B-Gene
MN NNP I-Gene
/ NNP I-Gene
CA9 NNP I-Gene
gene NN I-Gene
, , O
a DT O
novel JJ O
member NN O
of IN O
the DT O
carbonic JJ B-Gene
anhydrase NN I-Gene
family NN I-Gene
: : O
structure NN O
and CC O
exon NN O
to TO O
protein VB O
domain JJ O
relationships NNS O
. . O

99Tcm CD O
- : O
DMP NNP O
- : O
HSA NN O
showed VBD O
an DT O
almost RB O
identical JJ O
behaviour NN O
to TO O
in IN O
vitro NN O
labelled VBN O
red JJ O
blood NN O
cells NNS O
( ( O
RBCs NNP O
) ) O
, , O
which WDT O
are VBP O
generally RB O
considered VBN O
the DT O
reference NN O
standard NN O
for IN O
blood NN O
pool NN O
agents NNS O
. . O

Halothane NNP O
is VBZ O
metabolized VBN O
by IN O
an DT O
oxidative JJ O
pathway NN O
to TO O
stable VB O
, , O
nonvolatile JJ O
end NN O
products NNS O
, , O
trifluoroacetic JJ O
acid NN O
( ( O
TFAA NNP O
) ) O
and CC O
bromide NN O
( ( O
Br NNP O
- : O
) ) O
, , O
and CC O
by IN O
reductive JJ O
pathways NNS O
to TO O
Br NNP O
- : O
and CC O
inorganic JJ O
fluoride NN O
( ( O
F NNP O
- : O
) ) O
. . O

In IN O
the DT O
case NN O
of IN O
the DT O
unspliceable JJ O
intron NN O
, , O
repression NN O
of IN O
luciferase NN B-Gene
expression NN O
likely RB O
involved JJ O
two CD O
AUF1 NNP B-Gene
- : I-Gene
binding NN I-Gene
sequences NNS I-Gene
, , O
since IN O
luciferase NN B-Gene
expression NN O
was VBD O
increased VBN O
by IN O
deletion NN O
of IN O
these DT O
sites NNS O
. . O

Surface NNP O
spin NN O
waves NNS O
in IN O
a DT O
Heisenberg NNP O
ferrimagnet NN O
with IN O
a DT O
single JJ O
- : O
ion NN O
anisotropy NN O
( ( O
uniaxial JJ O
and CC O
nonuniaxial JJ O
) ) O
. . O

Different JJ O
doses NNS O
of IN O
15 CD O
- : O
methyl NN O
- : O
PGF2 NNP O
alpha NN O
( ( O
0 CD O
. . O
125 CD O
- : O
10 CD O
mg NN O
) ) O
were VBD O
used VBN O
to TO O
induce VB O
luteolysis NN O
and CC O
oestrus NN O
in IN O
7 CD O
heifers NNS O
with IN O
28 CD O
treatments NNS O
on IN O
day NN O
8 CD O
- : O
12 CD O
of IN O
the DT O
oestrous JJ O
cycle NN O
. . O

The DT O
CDC7 NNP B-Gene
gene NN I-Gene
has VBZ O
two CD O
in IN O
- : O
frame NN O
AUG NNP O
codons NNS O
as IN O
possible JJ O
translation NN O
start NN O
sites NNS O
, , O
which WDT O
would MD O
produce VB O
58 CD O
- : O
and CC O
56 CD O
- : O
kDa NN O
proteins NNS O
, , O
respectively RB O
. . O

Six CD O
patients NNS O
with IN O
glomerulonephritis NN O
in IN O
association NN O
with IN O
a DT O
ventriculovascular JJ O
shunt NN O
were VBD O
treated VBN O
with IN O
three CD O
basic JJ O
modes NNS O
of IN O
therapy NN O
. . O

Radiotherapy NNP O
and CC O
early JJ O
orchiectomy NN O
in IN O
stage NN O
D1 NNP O
prostatic JJ O
carcinoma NN O

In IN O
vitro JJ O
assessment NN O
of IN O
the DT O
biocompatibility NN O
of IN O
dental JJ O
materials NNS O
- : O
- : O
the DT O
millipore NN O
filter NN O
method NN O
. . O

These DT O
findings NNS O
and CC O
the DT O
differential JJ O
tissue NN O
distribution NN O
of IN O
p54 NN B-Gene
suggest VBP O
that IN O
this DT O
novel JJ O
SR NNP B-Gene
protein NN I-Gene
may MD O
participate VB O
in IN O
regulation NN O
of IN O
alternative JJ O
splicing NN O
in IN O
a DT O
tissue NN O
- : O
and CC O
substrate VB O
- : O
dependent JJ O
manner NN O
. . O

Isolation NN O
and CC O
identification NN O
of IN O
genes NNS O
activating VBG O
UAS2 NNP B-Gene
- : I-Gene
dependent NN I-Gene
ADH2 NNP I-Gene
expression NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

When WRB O
data NNS O
were VBD O
expressed VBN O
in IN O
a DT O
cumulative JJ O
manner NN O
, , O
the DT O
response NN O
to TO O
intravenous JJ O
adenosine JJ O
3 CD O
mg NN O
, , O
6 CD O
mg NN O
, , O
9 CD O
mg NN O
and CC O
12 CD O
mg NN O
in IN O
the DT O
24 CD O
episodes NNS O
of IN O
PSVT NNP O
were VBD O
5 CD O
episodes NNS O
( ( O
21 CD O
% NN O
) ) O
, , O
16 CD O
episodes NNS O
( ( O
67 CD O
% NN O
) ) O
, , O
20 CD O
episodes NNS O
( ( O
83 CD O
% NN O
) ) O
and CC O
20 CD O
episodes NNS O
( ( O
83 CD O
% NN O
) ) O
respectively RB O
. . O

SPA NN O
from IN O
PAG NNP O
sites NNS O
was VBD O
associated VBN O
with IN O
aversion NN O
. . O

Molecular JJ O
cloning NN O
of IN O
rat NN B-Gene
SH2 NNP I-Gene
- : I-Gene
containing VBG I-Gene
inositol JJ I-Gene
phosphatase NN I-Gene
2 CD I-Gene
( ( O
SHIP2 NNP B-Gene
) ) O
and CC O
its PRP$ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
insulin NN B-Gene
signaling NN O
. . O

2 CD O
cases NNS O
of IN O
toxic JJ O
lymphomononucleosis NN O

Incorporation NN O
of IN O
0 CD O
. . O
1 CD O
or CC O
0 CD O
. . O
2 CD O
M NNP O
sodium NN O
dihydrogen NN O
phosphate NN O
in IN O
the DT O
sugar NN O
solutions NNS O
resulted VBD O
in IN O
a DT O
decrease NN O
in IN O
the DT O
shelf NN O
- : O
life NN O
of IN O
diltiazem NN O
. . O

This DT O
mechanism NN O
is VBZ O
not RB O
due JJ O
to TO O
the DT O
observed JJ O
grain NN O
boundary JJ O
precipitates NNS O
. . O

Thus RB O
, , O
Xlim NNP B-Gene
- : I-Gene
1 CD I-Gene
not RB O
only RB O
contains VBZ O
a DT O
unique JJ O
tyrosine NN O
- : O
rich JJ O
activation NN O
domain NN O
but CC O
also RB O
contains VBZ O
a DT O
negative JJ O
regulatory JJ O
domain NN O
in IN O
CT239 NNP O
- : O
403 CD O
, , O
suggesting VBG O
a DT O
complex JJ O
regulatory JJ O
mechanism NN O
underlying VBG O
the DT O
transcriptional JJ O
activity NN O
of IN O
Xlim NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
the DT O
organizer NN O
. . O

In IN O
this DT O
paper NN O
, , O
the DT O
current JJ O
status NN O
of IN O
the DT O
understanding NN O
of IN O
the DT O
interaction NN O
mechanisms NN O
of IN O
ultrasound NN O
with IN O
biological JJ O
media NNS O
and CC O
the DT O
factors NNS O
that WDT O
govern VBP O
different JJ O
biological JJ O
effects NNS O
are VBP O
surveyed VBN O
. . O

The DT O
recessive JJ O
hos1 NN B-Gene
mutation NN O
causes VBZ O
enhanced JJ O
induction NN O
of IN O
the DT O
CBF NNP B-Gene
transcription NN I-Gene
factors NNS I-Gene
by IN O
low JJ O
temperature NN O
as RB O
well RB O
as IN O
of IN O
their PRP$ O
downstream NN O
cold SYM O
- : O
responsive JJ O
genes NNS O
. . O

Differentiation NN O
was VBD O
not RB O
observed VBN O
after IN O
cellular JJ O
expression NN O
of IN O
GTPase NNP B-Gene
- : O
deficient NN O
forms NNS O
of IN O
alpha JJ B-Gene
i2 NN I-Gene
or CC O
alpha NN B-Gene
0 CD I-Gene
, , O
indicating VBG O
selectivity NN O
for IN O
the DT O
Gq NNP B-Gene
family NN I-Gene
of IN O
G NNP B-Gene
proteins NNS I-Gene
. . O

The DT O
test NN O
for IN O
alpha JJ B-Gene
- : I-Gene
naphthyl JJ I-Gene
esterase NN I-Gene
and CC O
quantitation NN O
of IN O
macrophages NNS O
( ( O
absolute JJ O
number NN O
) ) O
per IN O
infiltration NN O
area NN O
unit NN O
adjacent JJ O
to TO O
the DT O
abscess NN O
suggest VBP O
a DT O
direct JJ O
correlation NN O
between IN O
the DT O
absolute JJ O
number NN O
of IN O
macrophages NNS O
and CC O
the DT O
width NN O
of IN O
the DT O
capsule NN O
. . O

GAL4 NNP B-Gene
- : O
VP16 NNP B-Gene
- : O
mediated VBN O
antirepression NN O
required VBN O
an DT O
auxiliary JJ O
factor NN O
, , O
denoted VBN O
as IN O
a DT O
co NN O
- : O
antirepressor NN O
, , O
which WDT O
was VBD O
partially RB O
purified VBN O
from IN O
Drosophila NNP O
embryos NN O
. . O

Roizman NNP O
, , O
J NNP O
. . O

40 CD O
patients NNS O
with IN O
chronic JJ O
osteomyelitis NN O
were VBD O
treated VBN O
per IN O
os NN O
with IN O
the DT O
bactericidal NN O
beta SYM O
- : O
lactam NN O
- : O
antibiotic JJ O
cephalexin NN O
during IN O
3 CD O
to TO O
60 CD O
weeks NNS O
. . O

The DT O
CHARGE NNP O
association NN O
is VBZ O
a DT O
collection NN O
of IN O
multisystem NN O
congenital JJ O
anomalies NNS O
including VBG O
choanal JJ O
atresia NN O
. . O

A DT O
stratified JJ O
random JJ O
sample NN O
of IN O
20 CD O
active JJ O
employees NNS O
from IN O
a DT O
cohort NN O
of IN O
phenoxy JJ O
herbicide NN O
workers NNS O
was VBD O
selected VBN O
in IN O
1995 CD O
for IN O
determining VBG O
PCDD NNP O
and CC O
PCDF NNP O
congeners NNS O
in IN O
blood NN O
lipids NNS O
to TO O
assess VB O
the DT O
extent NN O
of IN O
past JJ O
PCDD NNP O
and CC O
PCDF NNP O
exposure NN O
in IN O
this DT O
cohort NN O
and CC O
whether IN O
that DT O
exposure NN O
might MD O
explain VB O
site NN O
- : O
specific JJ O
cancer NN O
findings NNS O
in IN O
the DT O
total JJ O
cohort NN O
. . O

Biological JJ O
action NN O
and CC O
kinetics NNS O
of IN O
the DT O
elimination NN O
of IN O
tritium NN O
oxide NN O
in IN O
dogs NNS O

The DT O
Ig NNP B-Gene
- : O
related VBN O
, , O
typical JJ O
metazoan NN O
, , O
module NN O
is VBZ O
classified VBN O
to TO O
the DT O
disulphide NN O
lacking VBG O
Ig NNP B-Gene
members NNS I-Gene
and CC O
represents VBZ O
the DT O
phylogenetic JJ O
earliest JJS O
member NN O
of IN O
this DT O
group NN O
. . O

We PRP O
demonstrate VBP O
that IN O
both DT O
R NNP B-Gene
and CC O
Z NNP B-Gene
activate VBP O
the DT O
cellular JJ O
stress NN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinases VBZ I-Gene
, , O
p38 NN B-Gene
and CC O
JNK NNP B-Gene
, , O
resulting VBG O
in IN O
phosphorylation NN O
( ( O
and CC O
activation NN O
) ) O
of IN O
the DT O
cellular JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
ATF2 NNP I-Gene
. . O

The DT O
data NN O
suggest NN O
that IN O
like IN O
in IN O
yeast NN O
, , O
in IN O
plants NNS O
a DT O
certain JJ O
subfamily NN O
of IN O
UBC NNP B-Gene
is VBZ O
specifically RB O
involved VBN O
in IN O
the DT O
proteolytic JJ O
degradation NN O
of IN O
abnormal JJ O
proteins NNS O
as IN O
result NN O
of IN O
stress NN O
. . O

The DT O
human JJ B-Gene
purH NN I-Gene
cDNA NN I-Gene
is VBZ O
1776 CD O
base NN O
pairs NNS O
in IN O
length NN O
encoding VBG O
for IN O
a DT O
591 CD O
- : O
amino NN O
acid JJ O
polypeptic JJ O
( ( O
Mr NNP O
= NNP O
64 CD O
, , O
425 CD O
) ) O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
fodrin JJ B-Gene
proteolysis NN O
in IN O
vivo NN O
may MD O
reflect VB O
the DT O
activity NN O
of IN O
multiple JJ O
ICE NNP B-Gene
/ NN O
Ced NNP B-Gene
- : I-Gene
3 CD I-Gene
proteases NNS O
whose WP$ O
partial JJ O
sensitivity NN O
to TO O
DEVD NNP O
- : O
CHO NNP O
reflects VBZ O
a DT O
limited JJ O
contribution NN O
from IN O
CPP32 NNP B-Gene
, , O
or CC O
an DT O
ICE NNP B-Gene
/ NN O
Ced NNP B-Gene
- : I-Gene
3 CD I-Gene
protease NN O
less RBR O
sensitive JJ O
than IN O
CPP32 NNP B-Gene
to TO O
DEVD NNP O
- : O
CHO NNP O
inhibition NN O
. . O

Since IN O
GAGs NNP O
are VBP O
the DT O
components NNS O
of IN O
cartilage NN O
matrix NN O
, , O
the DT O
depletion NN O
of IN O
which WDT O
is VBZ O
associated VBN O
with IN O
osteoarthrosis NN O
, , O
a DT O
method NN O
for IN O
measuring VBG O
sulphated VBN O
GAG NNP O
synthesis NN O
in IN O
culture NN O
has VBZ O
been VBN O
investigated VBN O
. . O

The DT O
clinical JJ O
picture NN O
and CC O
laboratory NN O
parameters NNS O
were VBD O
consistent JJ O
with IN O
a DT O
serum NN O
sickness NN O
reaction NN O
. . O

This DT O
DNA NN O
motif NN O
represents VBZ O
a DT O
novel JJ O
protein NN O
- : O
binding NN O
sequence NN O
. . O

Human NNP O
synovial JJ O
fluid NN O
: : O
detection NN O
of IN O
a DT O
new JJ O
component NN O
. . O

Here RB O
, , O
we PRP O
alter VBP O
the DT O
dimerization NN O
specificity NN O
of IN O
Fos NNP B-Gene
by IN O
precisely RB O
replacing VBG O
its PRP$ O
leucine NN O
zipper NN O
with IN O
that DT O
from IN O
GCN4 NNP B-Gene
. . O

Drosophila NNP B-Gene
UbcD1 NNP I-Gene
encodes VBZ O
a DT O
highly RB O
conserved VBN O
ubiquitin JJ B-Gene
- : O
conjugating VBG O
enzyme RB O
involved VBN O
in IN O
selective JJ O
protein NN O
degradation NN O
. . O

To TO O
investigate VB O
the DT O
effects NNS O
of IN O
isotretinoin NN O
on IN O
HDL NNP B-Gene
, , O
we PRP O
measured VBD O
HDL NNP B-Gene
- : I-Gene
C NNP I-Gene
, , O
HDL NNP B-Gene
phospholipids NNS O
( ( O
HDL NNP B-Gene
- : I-Gene
PL NN I-Gene
) ) O
, , O
apoprotein JJ B-Gene
A1 NNP I-Gene
( ( O
apo VB B-Gene
A NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
and CC O
HDL NNP B-Gene
- : I-Gene
C NNP I-Gene
subfractions NNS O
( ( O
HDL2 NNP B-Gene
- : I-Gene
C NNP I-Gene
and CC O
HDL3 NNP B-Gene
- : I-Gene
C NNP I-Gene
) ) O
in IN O
24 CD O
healthy JJ O
, , O
male JJ O
patients NNS O
receiving VBG O
a DT O
16 CD O
- : O
week NN O
course NN O
of IN O
isotretinoin NN O
( ( O
1 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
day NN O
) ) O
for IN O
treatment NN O
of IN O
severe JJ O
acne JJ O
vulgaris NN O
. . O

The DT O
wavenumbers NNS O
corresponding VBG O
to TO O
the DT O
normal JJ O
modes NNS O
of IN O
vibration NN O
were VBD O
calculated VBN O
using VBG O
the DT O
DFT NNP O
( ( O
B3LYP NNP O
/ VBZ O
6 CD O
- : O
31G CD O
* NNP O
* NNP O
) ) O
approximation NN O
and CC O
their PRP$ O
agreement NN O
with IN O
the DT O
measured JJ O
values NNS O
improved VBN O
after IN O
scaling NN O
of IN O
the DT O
associated JJ O
force NN O
field NN O
. . O

Subhuman NNP O
primates VBZ O
appear VBP O
to TO O
be VB O
more RBR O
sensitive JJ O
to TO O
reproductive VB O
and CC O
other JJ O
adverse JJ O
effects NNS O
of IN O
PCBs NNP O
than IN O
humans NNS O
. . O

In IN O
the DT O
absence NN O
of IN O
Mg2 NNP O
+ NNP O
, , O
a DT O
hydrophobic JJ O
exonuclease NN O
site NN O
dominates VBZ O
over IN O
the DT O
polymerase NN O
site NN O
for IN O
possession NN O
of IN O
the DT O
primer NN O
terminus NN O
. . O

It PRP O
is VBZ O
shown VBN O
that IN O
the DT O
displacement JJ O
distribution NN O
measured VBN O
by IN O
q SYM O
- : O
space NN O
MRI NNP O
in IN O
both CC O
the DT O
large JJ O
displacement NN O
( ( O
i JJ O
. . O
e NN O
. . O
, , O
large JJ O
r NN O
) ) O
and CC O
the DT O
long JJ O
- : O
wavelength NN O
( ( O
i JJ O
. . O
e NN O
. . O
, , O
small JJ O
q NN O
) ) O
limits VBZ O
is VBZ O
the DT O
same JJ O
3D CD O
Gaussian JJ O
displacement NN O
distribution NN O
assumed VBN O
in IN O
DT NNP O
- : O
MRI NN O
. . O

When WRB O
both DT O
lesions NNS O
were VBD O
complete JJ O
lateral JJ O
hemisections NNS O
in IN O
weanling VBG O
operates NNS O
, , O
little JJ O
behavioral JJ O
recovery NN O
was VBD O
observed VBN O
, , O
similar JJ O
to TO O
complete VB O
spinal JJ O
cord NN O
transection NN O
( ( O
N NNP O
= NNP O
3 CD O
) ) O
. . O

The DT O
significance NN O
of IN O
these DT O
palindromic JJ O
domains NNS O
in IN O
this DT O
ORF NNP O
is VBZ O
unclear JJ O
but CC O
the DT O
coincidence NN O
of IN O
the DT O
end NN O
of IN O
one CD O
larger JJR O
palindrome NN O
with IN O
the DT O
end NN O
of IN O
the DT O
translated JJ O
protein NN O
sequence NN O
that WDT O
has VBZ O
homology VBN O
with IN O
the DT O
B NNP O
chain NN O
of IN O
insulin NN B-Gene
suggests VBZ O
that IN O
the DT O
palindromes NNS O
may MD O
divide VB O
the DT O
T2 NNP B-Gene
protein NN I-Gene
into IN O
several JJ O
functional JJ O
units NNS O
. . O

Picture NN O
the DT O
smell NN O
. . O

Comparison NNP O
of IN O
the DT O
proportion NN O
of IN O
nonsynonymous JJ O
( ( O
pN NN O
) ) O
and CC O
synonymous JJ O
( ( O
pS NN O
) ) O
substitutions NNS O
occurring VBG O
per IN O
site NN O
within IN O
tamarin NN B-Gene
variable JJ I-Gene
region NN I-Gene
genes NNS I-Gene
demonstrated VBD O
a DT O
reduction NN O
in IN O
pN NN O
in IN O
the DT O
framework NN O
regions NNS O
compared VBN O
with IN O
pN NN O
in IN O
the DT O
presumed JJ O
MHC NNP B-Gene
contact NN I-Gene
regions NNS I-Gene
( ( O
CDR1 NNP B-Gene
and CC O
CDR2 NNP B-Gene
) ) O
. . O

Absorption NNP O
varied VBD O
between IN O
65 CD O
and CC O
95 CD O
per IN O
cent NN O
, , O
with IN O
a DT O
mean JJ O
absorption NN O
of IN O
80 CD O
per IN O
cent NN O
, , O
in IN O
both DT O
pregnant JJ O
and CC O
non JJ O
- : O
pregnant JJ O
subjects NNS O
. . O

We PRP O
have VBP O
carried VBN O
out RP O
a DT O
comprehensive JJ O
and CC O
systematic JJ O
mutagenesis NN O
of IN O
the DT O
Cse4p NNP B-Gene
N NNP I-Gene
terminus NN I-Gene
to TO O
analyze VB O
its PRP$ O
function NN O
. . O

In IN O
14 CD O
patients NNS O
whose WP$ O
PaCO2 NNP O
was VBD O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
39 CD O
torr NN O
( ( O
range VB O
39 CD O
to TO O
58 CD O
torr NN O
) ) O
and CC O
clinical JJ O
asthma NN O
score NN O
was VBD O
6 CD O
or CC O
greater JJR O
, , O
PaCO2 NNP O
decreased VBD O
a DT O
mean NN O
of IN O
11 CD O
. . O
7 CD O
torr NN O
during IN O
a DT O
mean NN O
of IN O
8 CD O
. . O
1 CD O
hours NNS O
. . O

Several JJ O
secondary JJ O
structure NN O
elements NNS O
were VBD O
identified VBN O
. . O

The DT O
effects NNS O
of IN O
loading VBG O
the DT O
respiratory NN O
pumps NNS O
on IN O
the DT O
oxygen NN O
consumption NN O
of IN O
Callionymus NNP O
lyra NN O
. . O

The DT O
mean JJ O
thickness NN O
of IN O
the DT O
visceral JJ O
peritoneum NN O
was VBD O
comparable JJ O
in IN O
both DT O
groups NNS O
of IN O
animals NNS O
, , O
but CC O
, , O
macroscopically RB O
, , O
more RBR O
severe JJ O
fibrosis NN O
was VBD O
found VBN O
in IN O
the DT O
peritoneum NN O
of IN O
rats NNS O
exposed VBN O
to TO O
CAPD NNP O
3 CD O
as IN O
compared VBN O
with IN O
animals NNS O
treated VBN O
with IN O
CAPD NNP O
3 CD O
Balance NNP O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
. . O

All DT O
33 CD O
subjects NNS O
were VBD O
given VBN O
psychometric JJ O
instruments NNS O
for IN O
measuring VBG O
various JJ O
components NNS O
of IN O
anger NN O
and CC O
anxiety NN O
: : O
Spielberger NNP O
' POS O
s NN O
State NNP O
- : O
Trait NN O
Personality NNP O
Inventory NNP O
, , O
the DT O
Anger NNP O
Expression NNP O
Scale NNP O
, , O
and CC O
the DT O
State NNP O
Anger NNP O
Reaction NNP O
Scale NNP O
. . O

However RB O
, , O
at IN O
lower JJR O
temperature NN O
the DT O
positive JJ O
staircase NN O
was VBD O
not RB O
clear JJ O
and CC O
rather RB O
negative JJ O
staircase NN O
appeared VBD O
( ( O
1 CD O
- : O
- : O
3 CD O
Hz NNP O
) ) O
. . O

Detailed VBN O
molecular JJ O
organization NN O
of IN O
the DT O
coding NN O
and CC O
upstream JJ O
regulatory JJ O
regions NNS O
of IN O
the DT O
murine NN O
homeodomain NN B-Gene
- : I-Gene
containing VBG I-Gene
gene NN I-Gene
, , O
Msx NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
is VBZ O
reported VBN O
. . O

Two CD O
overlapping VBG O
clones NNS O
contained VBD O
the DT O
complete JJ O
Adh NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
composed VBN O
of IN O
nine CD O
exons NNS O
in IN O
a DT O
12 CD O
- : O
kb NN O
region NN O
, , O
with IN O
the DT O
placement NN O
of IN O
introns NNS O
matching VBG O
that DT O
observed VBN O
in IN O
other JJ O
mammalian JJ B-Gene
ADH NNP I-Gene
genes NNS I-Gene
. . O

Mutation NN O
of IN O
the DT O
presumptive JJ O
phosphorylated JJ O
tyrosine NN O
and CC O
threonine NN O
residues NNS O
of IN O
Mpk1p NNP B-Gene
individually RB O
to TO O
phenylalanine VB O
and CC O
alanine VB O
, , O
respectively RB O
, , O
severely RB O
impaired JJ O
Mpk1p NNP B-Gene
function NN O
. . O

Isolation NN O
and CC O
genomic JJ O
structure NN O
of IN O
a DT O
human JJ O
homolog NN O
of IN O
the DT O
yeast NN B-Gene
periodic JJ I-Gene
tryptophan NN I-Gene
protein NN I-Gene
2 CD I-Gene
( ( O
PWP2 NNP B-Gene
) ) O
gene NN O
mapping VBG O
to TO O
21q22 CD O
. . O
3 CD O
. . O

Oncological NNP O
, , O
clinical JJ O
and CC O
psychological JJ O
aspects NNS O
are VBP O
evaluated VBN O
according VBG O
to TO O
experience NN O
accumulated VBN O
in IN O
recent JJ O
years NNS O
, , O
with IN O
immediate JJ O
and CC O
delayed JJ O
reconstruction NN O
, , O
carried VBD O
out RP O
in IN O
the DT O
most RBS O
diverse JJ O
specialized JJ O
centers NNS O
. . O

Treatment NN O
of IN O
Paget NNP O
' POS O
s JJ O
disease NN O
. . O

Plasma NNP O
membranes NNS O
of IN O
cultured JJ O
cells NNS O
contain VBP O
high JJ O
affinity NN O
receptors NNS O
for IN O
high JJ B-Gene
density NN I-Gene
lipoprotein NN I-Gene
( ( O
HDL NNP B-Gene
) ) O
that WDT O
appear VBP O
to TO O
mediate VB O
removal NN O
of IN O
excess JJ O
intracellular JJ O
cholesterol NN O
. . O

Hair NNP O
and CC O
blood NN O
samples NNS O
were VBD O
taken VBN O
before RB O
vitamin JJ O
C NNP O
or CC O
placebo JJ O
supplementation NN O
was VBD O
started VBN O
and CC O
at IN O
monthly JJ O
intervals NNS O
thereafter RB O
for IN O
three CD O
months NNS O
. . O

Nine NNP O
animals NNS O
served VBD O
as IN O
control NN O
animals NNS O
, , O
whereas NNS O
20 CD O
animals NNS O
received VBD O
a DT O
focal JJ O
arachnoid NN O
scar NN O
at IN O
C1 NNP O
- : O
C2 NNP O
, , O
which WDT O
was VBD O
produced VBN O
by IN O
placement NN O
of IN O
a DT O
kaolin NN O
- : O
soaked VBN O
fibrin JJ B-Gene
sponge NN O
on IN O
the DT O
posterior JJ O
surface NN O
of IN O
the DT O
spinal JJ O
cord NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
neonate JJ O
differs NNS O
from IN O
the DT O
adult NN O
in IN O
respect NN O
of IN O
both DT O
the DT O
nature NN O
of IN O
effects NNS O
of IN O
the DT O
drug NN O
and CC O
sensitivity NN O
to TO O
it PRP O
. . O

Of IN O
the DT O
53 CD O
units NNS O
tested VBN O
during IN O
sinusoidal JJ O
motion NN O
at IN O
0 CD O
. . O
5 CD O
Hz NNP O
( ( O
9 CD O
. . O
1 CD O
cm JJ O
/ NNP O
s NN O
) ) O
, , O
1 CD O
( ( O
1 CD O
. . O
9 CD O
% NN O
) ) O
was VBD O
responsive JJ O
to TO O
the DT O
otolith NN O
input NN O
only RB O
, , O
13 CD O
( ( O
24 CD O
. . O
5 CD O
% NN O
) ) O
were VBD O
influenced VBN O
by IN O
the DT O
visual JJ O
input NN O
only RB O
and CC O
23 CD O
( ( O
43 CD O
. . O
4 CD O
% NN O
) ) O
responded VBD O
to TO O
both DT O
modalities NNS O
. . O

The DT O
nucleotide NN O
( ( O
nt JJ O
) ) O
sequences NNS O
of IN O
the DT O
exons NNS O
, , O
exon VBP O
/ JJ O
intron NN O
boundaries NNS O
and CC O
5 CD O
' '' O
- : O
and CC O
3 CD O
' '' O
- : O
untranslated JJ O
regions NNS O
were VBD O
determined VBN O
. . O

Using VBG O
GST NNP B-Gene
- : O
PKR NNP B-Gene
fusion NN O
chromatography NN O
, , O
direct JJ O
physical JJ O
interaction NN O
between IN O
the DT O
mouse NN O
and CC O
human JJ B-Gene
PKR NNP I-Gene
homologs NN I-Gene
was VBD O
established VBN O
. . O

For IN O
an DT O
unsupervised JJ O
program NN O
, , O
the DT O
costs NNS O
were VBD O
estimated VBN O
at IN O
$ $ O
311 CD O
for IN O
the DT O
first JJ O
year NN O
and CC O
$ $ O
73 CD O
for IN O
all DT O
additional JJ O
years NNS O
. . O

A DT O
case NN O
of IN O
manifest JJS O
latent JJ O
nystagmus NN O
of IN O
late JJ O
onset NN O
in IN O
a DT O
13 CD O
- : O
year NN O
- : O
old JJ O
girl NN O
is VBZ O
reported VBN O
. . O

Normal JJ O
alpha1 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
collagen NN I-Gene
mRNA NN I-Gene
showed VBD O
no DT O
significant JJ O
reduction NN O
when WRB O
AR NNP O
or CC O
IR NNP O
was VBD O
expressed VBN O
from IN O
the DT O
pHbetaAPr NN O
- : O
1 CD O
- : O
neo NN O
vector NN O
and CC O
a DT O
small JJ O
( ( O
10 CD O
- : O
20 CD O
% NN O
) ) O
but CC O
significant JJ O
reduction NN O
when WRB O
either DT O
ribozyme NN O
was VBD O
expressed VBN O
from IN O
the DT O
pCI NN O
. . O
neo JJ O
vector NN O
. . O

Based VBN O
on IN O
mutational JJ O
data NNS O
and CC O
possible JJ O
mRNA NN O
structure NN O
, , O
we PRP O
hypothesized VBD O
about IN O
the DT O
effect NN O
of IN O
mRNA NN O
structure NN O
on IN O
translation NN O
of IN O
the DT O
two CD O
major JJ O
C NNP B-Gene
/ NNP I-Gene
EBPepsilon NNP I-Gene
isoforms NNS I-Gene
: : O
p32 NN B-Gene
and CC O
p30 NN B-Gene
. . O

Second NNP O
, , O
when WRB O
the DT O
NBF1 NNP B-Gene
+ NNP I-Gene
R NNP I-Gene
protein NN I-Gene
, , O
the DT O
NBF2 NNP B-Gene
protein NN I-Gene
, , O
and CC O
a DT O
mixture NN O
of IN O
the DT O
two CD O
proteins NNS O
were VBD O
folded VBN O
separately RB O
and CC O
analyzed VBN O
by IN O
molecular JJ O
sieve NN O
chomatography NN O
, , O
the DT O
mixture NN O
was VBD O
found VBN O
to TO O
elute VB O
prior RB O
to TO O
either DT O
NBF1 NNP B-Gene
+ NNP I-Gene
R NNP I-Gene
or CC O
NBF2 NNP B-Gene
. . O

Analysis NN O
of IN O
the DT O
sequence NN O
upstream NN O
of IN O
this DT O
initiation NN O
codon NN O
reveals VBZ O
the DT O
presence NN O
of IN O
a DT O
promotor NN O
sequence NN O
. . O

Hemolytic JJ O
jaundice NN O
due JJ O
to TO O
G6PD NNP B-Gene
deficiency NN O
causing VBG O
kernicterus NN O
in IN O
a DT O
female JJ O
newborn NN O
. . O

A DT O
new JJ O
bioencapsulation NN O
technology NN O
for IN O
microbial JJ O
inoculants NNS O
. . O

The DT O
human JJ O
cDNA NN O
clone NN O
NFBD1 NNP O
( ( O
previously RB O
designated VBN O
KIAA0170 NNP O
) ) O
encodes VBZ O
a DT O
novel JJ O
protein NN O
( ( O
2089 CD O
amino NN O
acids NNS O
in IN O
length NN O
; : O
calculated VBN O
molecular JJ O
mass NN O
226 CD O
, , O
440 CD O
D NNP O
) ) O
with IN O
possible JJ O
BRCT NNP B-Gene
domains VBZ I-Gene
at IN O
its PRP$ O
carboxy JJ O
terminus NN O
( ( O
amino JJ O
acid NN O
residues NNS O
1894 CD O
- : O
2089 CD O
) ) O
. . O

Moreover RB O
, , O
a DT O
severe JJ O
decrease NN O
of IN O
antithrombin JJ B-Gene
activity NN O
became VBD O
evident JJ O
during IN O
both DT O
experiments NNS O
( ( O
eg NN O
, , O
in IN O
experiment JJ O
2 CD O
from IN O
95 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
8 CD O
to TO O
59 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
6 CD O
% NN O
) ) O
. . O

RNA NNP O
in IN O
situ JJ O
hybridization NN O
on IN O
brain NN O
sections NNS O
of IN O
normal JJ O
human JJ O
embryos NN O
revealed VBD O
a DT O
strong JJ O
labeling NN O
in IN O
restricted JJ O
areas NNS O
of IN O
the DT O
cerebral JJ O
cortex NN O
. . O

Recently RB O
, , O
a DT O
distantly RB O
related VBN O
UmuC NNP B-Gene
- : I-Gene
homolog NN I-Gene
, , O
DinB NNP B-Gene
, , O
has VBZ O
also RB O
been VBN O
identified VBN O
in IN O
E NNP O
. . O
coli NN O
. . O

In IN O
this DT O
case NN O
the DT O
degree NN O
of IN O
promoter NN O
methylation NN O
, , O
which WDT O
could MD O
extend VB O
beyond IN O
the DT O
T NNP O
- : O
DNA NN O
borders NNS O
, , O
was VBD O
not RB O
correlated VBN O
with IN O
the DT O
reduction NN O
in IN O
steady JJ O
- : O
state NN O
poly NN O
( ( O
A DT O
) ) O
+ FW O
mRNA NN O
levels NNS O
, , O
the DT O
silenced JJ O
state NN O
was VBD O
transmitted VBN O
through IN O
meiosis NN O
and CC O
reactivation NN O
lasted VBD O
several JJ O
generations NNS O
. . O

Cystatin NNP B-Gene
A NNP I-Gene
, , O
a DT O
cysteine JJ B-Gene
proteinase NN I-Gene
inhibitor NN O
, , O
is VBZ O
one CD O
of IN O
the DT O
precursor NN O
proteins NNS O
of IN O
cornified VBN B-Gene
cell NN I-Gene
envelope NN I-Gene
of IN O
keratinocytes NNS O
and CC O
is VBZ O
expressed VBN O
during IN O
the DT O
late JJ O
stage NN O
of IN O
keratinocyte JJ O
differentiation NN O
. . O

The DT O
identification NN O
of IN O
viable JJ O
myocardium NN O
with IN O
both DT O
99mTc CD O
- : O
tetrofosmin NN O
and CC O
201Tl CD O
can MD O
be VB O
greatly RB O
enhanced VBN O
to TO O
a DT O
similar JJ O
degree NN O
if IN O
the DT O
severity NN O
of IN O
reduction NN O
in IN O
activity NN O
within IN O
nonreversible JJ O
defects NNS O
is VBZ O
considered VBN O
. . O

Structural JJ O
features NNS O
of IN O
the DT O
minimal JJ O
DNA NNP O
binding NN O
domain NN O
( ( O
M98 NNP O
- : O
F219 NNP O
) ) O
of IN O
human JJ B-Gene
nucleotide JJ I-Gene
excision NN I-Gene
repair NN I-Gene
protein JJ I-Gene
XPA NNP I-Gene
. . O

Cleavage NN O
and CC O
DNA NNP O
joining NN O
reactions NNS O
, , O
carried VBD O
out RP O
by IN O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
integrase NN I-Gene
, , O
are VBP O
necessary JJ O
to TO O
effect NN O
the DT O
covalent NN O
insertion NN O
of IN O
HIV NNP O
- : O
1 CD O
DNA NN O
into IN O
the DT O
host NN O
genome NN O
. . O

The DT O
murine NN O
Htf9 NNP B-Gene
- : I-Gene
a DT I-Gene
/ JJ O
RanBP1 NNP B-Gene
and CC O
Htf9 NNP B-Gene
- : I-Gene
c NN I-Gene
genes NNS I-Gene
are VBP O
divergently RB O
transcribed VBN O
from IN O
a DT O
shared VBN O
TATA NNP O
- : O
less JJR O
promoter NN O
. . O

Temporal JJ O
relationships NNS O
and CC O
the DT O
development NN O
phase NN O
affected VBD O
. . O

Selenium NN O
, , O
as IN O
a DT O
constituent NN O
of IN O
glutathione NN B-Gene
peroxidase NN I-Gene
, , O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
antioxidant JJ O
defense NN O
systems NNS O
of IN O
the DT O
body NN O
, , O
but CC O
other JJ O
metabolic JJ O
roles NNS O
for IN O
selenium NN O
may MD O
yet RB O
be VB O
discovered VBN O
. . O

Transfection NN O
of IN O
cDNAs NN O
for IN O
three CD O
mutant JJ O
enzymes NNS O
into IN O
FPGS NNP B-Gene
- : O
null NN O
Chinese JJ O
hamster NN O
ovary JJ O
cells NNS O
restored VBD O
a DT O
reduced JJ O
level NN O
of IN O
clonal JJ O
growth NN O
, , O
whereas IN O
a DT O
T339I NNP O
mutant NN O
supported VBD O
growth NN O
at IN O
a DT O
level NN O
comparable JJ O
to TO O
that DT O
of IN O
the DT O
wild JJ O
- : O
type NN O
enzyme NN O
. . O

Lack NN O
of IN O
controlled JJ O
prospective JJ O
studies NNS O
of IN O
sleep JJ O
electroencephalograms NNS O
( ( O
EEG NNP O
) ) O
, , O
and CC O
the DT O
use NN O
of IN O
medication NN O
, , O
in IN O
children NNS O
with IN O
developmental JJ O
dysphasia NN O
, , O
may MD O
deny VB O
appropriate JJ O
treatment NN O
strategies NNS O
to TO O
children NNS O
with IN O
severe JJ O
developmental JJ O
speech NN O
and CC O
language NN O
disorders NNS O
. . O

Type NN O
I PRP O
cysts NNS O
( ( O
with IN O
a DT O
high JJ O
K NNP O
+ NNP O
/ NNP O
Na NNP O
+ NNP O
ratio NN O
) ) O
tend VBP O
to TO O
have VB O
higher JJR O
total NN O
PSA NNP B-Gene
than IN O
Type NNP O
II NNP O
cysts NNS O
. . O

Just RB O
before RB O
inserting VBG O
on IN O
the DT O
anterior JJ O
margin NN O
and CC O
apex NN O
of IN O
the DT O
iliac JJ O
crest NN O
it PRP O
widens VBZ O
, , O
assuming VBG O
the DT O
aspect NN O
of IN O
a DT O
small JJ O
cone NN O
. . O

Histological JJ O
changes NNS O
, , O
including VBG O
cortical JJ O
cell NN O
involution NN O
and CC O
hemorrhage NN O
occurring VBG O
during IN O
the DT O
neonatal JJ O
period NN O
, , O
would MD O
seem VB O
to TO O
have VB O
crucial JJ O
relevance NN O
to TO O
the DT O
remodeling NN O
of IN O
the DT O
adrenal JJ O
vasculature NN O
. . O

Localization NN O
of IN O
the DT O
insertion NN O
locus NN O
in IN O
the DT O
yeast NN O
genome NN O
and CC O
complementation NN O
studies NNS O
with IN O
the DT O
temperature NN O
- : O
sensitive JJ O
mutant JJ O
indicate NN O
that IN O
the DT O
two CD O
mutations NNS O
are VBP O
allelic JJ O
. . O

Gal4 NNP B-Gene
- : O
Eed NNP B-Gene
fusion NN O
protein NN O
represses VBZ O
transcription NN O
of IN O
a DT O
reporter NN O
gene NN O
driven VBN O
by IN O
a DT O
promoter NN O
that WDT O
contains VBZ O
Gal4 NNP B-Gene
- : I-Gene
binding NN I-Gene
DNA NN I-Gene
elements NNS I-Gene
. . O

Subsequent JJ O
to TO O
their PRP$ O
secretion NN O
, , O
the DT O
IGF NNP B-Gene
- : I-Gene
II NN I-Gene
in IN O
xz97 NNP O
and CC O
G11 NNP O
cells NNS O
accumulated VBN O
in IN O
the DT O
conditioned JJ O
medium NN O
mostly RB O
as IN O
two CD O
partially RB O
processed JJ O
species NNS O
with IN O
appMr NN O
, , O
of IN O
17K CD O
and CC O
14K CD O
, , O
respectively RB O
. . O

Some DT O
of IN O
them PRP O
produce VBP O
gigantic JJ O
sperm NN O
several JJ O
times NNS O
the DT O
total JJ O
male NN O
body NN O
length NN O
. . O

A DT O
single JJ O
base NN O
change NN O
( ( O
A8G NNP O
) ) O
in IN O
either DT O
sequence NN O
reduces NNS O
hnRNP VBP B-Gene
A2 NNP I-Gene
binding NN O
and CC O
, , O
in IN O
the DT O
case NN O
of IN O
A2RE NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
inhibits NNS O
RNA NNP O
transport NN O
. . O

Fisher NNP O
' POS O
s NN O
exact JJ O
test NN O
or CC O
Pearson NNP O
' POS O
s NN O
chi2 NN O
test NN O
were VBD O
used VBN O
for IN O
statistical JJ O
analysis NN O
. . O

An DT O
intact JJ O
neurovascular JJ O
supply NN O
is VBZ O
essential JJ O
for IN O
the DT O
viability NN O
of IN O
a DT O
muscle NN O
flap NN O
. . O

Simian JJ O
immunodeficiency NN O
virus NN O
( ( O
SIV NNP O
) ) O
is VBZ O
a DT O
lentivirus NN O
with IN O
morphological JJ O
and CC O
antigenic JJ O
similarities NNS O
to TO O
human JJ O
immunodeficiency NN O
virus NN O
, , O
the DT O
causative JJ O
agent NN O
of IN O
acquired JJ O
immunodeficiency NN O
syndrome NN O
( ( O
AIDS NNP O
) ) O
of IN O
humans NNS O
. . O

Both DT O
fusion NN O
proteins VBZ O
form RBR O
stable JJ O
specific JJ O
complexes NNS O
with IN O
a DT O
short JJ O
DNA NN O
duplex JJ O
harboring VBG O
the DT O
CTGT NNP O
( ( O
at IN O
) ) O
4ACAG CD O
consensus NN O
sequence NN O
of IN O
the DT O
LexA NNP B-Gene
repressor NN I-Gene
. . O

The DT O
specificity NN O
of IN O
action NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
family NN I-Gene
members NNS I-Gene
may MD O
be VB O
derived VBN O
from IN O
the DT O
characteristics NNS O
of IN O
each DT O
factor NN O
, , O
including VBG O
the DT O
expression NN O
profiles NNS O
, , O
the DT O
DNA NNP O
binding NN O
affinities NNS O
, , O
the DT O
cofactors NNS O
, , O
and CC O
so RB O
on IN O
, , O
in IN O
addition NN O
to TO O
the DT O
DNA NNP O
binding NN O
specificities NNS O
. . O

As IN O
is VBZ O
deduced VBN O
from IN O
the DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
cDNA NN O
, , O
CBS NNP B-Gene
- : I-Gene
1 CD I-Gene
contains NNS O
an DT O
open JJ O
reading NN O
frame NN O
consisting VBG O
of IN O
182 CD O
amino NN O
acids NNS O
, , O
with IN O
a DT O
molecular JJ O
weight NN O
of IN O
19 CD O
. . O
5kDa CD O
. . O

These DT O
components NNS O
both DT O
had VBD O
a DT O
median JJ O
R2 NNP O
of IN O
0 CD O
. . O
84 CD O
, , O
compared VBN O
to TO O
median JJ O
R2s NNP O
ranging VBG O
from IN O
0 CD O
. . O
37 CD O
to TO O
0 CD O
. . O
83 CD O
for IN O
five CD O
commonly NNS O
used VBN O
ad NN O
hoc NN O
EEG NNP O
components NNS O
. . O

The DT O
human JJ B-Gene
SHBG NNP I-Gene
proximal NN I-Gene
promoter NN I-Gene
was VBD O
analyzed VBN O
by IN O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBP O
, , O
and CC O
the DT O
functional JJ O
significance NN O
of IN O
6 CD O
footprinted JJ O
regions NNS O
( ( O
FP1 NNP O
- : O
FP6 NN O
) ) O
within IN O
the DT O
proximal JJ O
promoter NN O
was VBD O
studied VBN O
in IN O
human JJ O
HepG2 NNP O
hepatoblastoma NN O
cells NNS O
. . O

To TO O
characterize VB O
the DT O
expression NN O
of IN O
this DT O
DNA NNP B-Gene
repair NN I-Gene
enzyme NN I-Gene
, , O
we PRP O
have VBP O
isolated VBN O
the DT O
corresponding JJ O
genomic JJ O
clone NN O
. . O

Biol NNP O
. . O

The DT O
high JJ O
sequence NN O
homology NN O
, , O
similar JJ O
genomic JJ O
structure NN O
, , O
and CC O
identical JJ O
chromosomal JJ O
loci NN O
of IN O
hKID NN B-Gene
, , O
MIP NNP B-Gene
, , O
and CC O
AQP NNP B-Gene
- : I-Gene
2 CD I-Gene
suggest VBP O
a DT O
MIP NNP B-Gene
family NN I-Gene
gene NN I-Gene
cluster NN I-Gene
at IN O
chromosome NN O
locus NN O
12q13 CD O
. . O

Phylogenetic JJ O
analysis NN O
showed VBD O
that IN O
the DT O
ToLCV NNP O
isolates NNS O
from IN O
Bangalore NNP O
constitute NN O
a DT O
group NN O
of IN O
viruses NNS O
separated VBN O
from IN O
those DT O
of IN O
Northern NNP O
India NNP O
. . O

A DT O
segmental JJ O
analysis NN O
of IN O
the DT O
key JJ O
regions NNS O
of IN O
HLA NNP B-Gene
- : I-Gene
DR1 VBZ I-Gene
that IN O
control NN O
T NNP O
cell NN O
allorecognition NN O
was VBD O
performed VBN O
by IN O
using VBG O
a DT O
series NN O
of IN O
transfected VBN O
cell NN O
lines NNS O
expressing VBG O
the DT O
products NNS O
of IN O
recombinant JJ O
DRB NNP B-Gene
/ NN O
H NNP B-Gene
- : I-Gene
2Eb CD I-Gene
genes NNS O
, , O
paired VBN O
with IN O
either DT O
DR NNP B-Gene
alpha NN I-Gene
or CC O
H NNP B-Gene
- : I-Gene
2E CD I-Gene
alpha NN I-Gene
. . O

Little NNP O
or CC O
no DT O
protection NN O
was VBD O
detected VBN O
using VBG O
adrenal JJ O
cortex NN O
, , O
adrenal JJ O
medulla NN O
, , O
liver RB O
, , O
kidney NN O
cortex NN O
, , O
spleen JJ O
, , O
or CC O
T NNP O
- : O
lymphocyte NN O
total JJ O
RNA NNP O
. . O

Despite IN O
this DT O
there EX O
was VBD O
no DT O
difference NN O
in IN O
the DT O
intubating JJ O
conditions NNS O
at IN O
one CD O
minute NN O
with IN O
25 CD O
excellent JJ O
/ RB O
5 CD O
good JJ O
in IN O
the DT O
suxamethonium NN O
group NN O
and CC O
27 CD O
excellent JJ O
/ RB O
3 CD O
good JJ O
in IN O
the DT O
rocuronium NN O
group NN O
. . O

A DT O
rapid JJ O
fluorimetric JJ O
procedure NN O
for IN O
the DT O
determination NN O
of IN O
the DT O
fungicide NN O
5 CD O
- : O
fluorocytosine NN O
in IN O
serum NN O
is VBZ O
described VBN O
. . O

The DT O
presence NN O
of IN O
an DT O
additional JJ O
sequence NN O
of IN O
nucleotides NNS O
145 CD O
- : O
165 CD O
from IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
RNA3 NNP B-Gene
enhanced VBD O
template JJ O
recognition NN O
by IN O
RdRp NNP B-Gene
in IN O
vitro NN O
and CC O
accumulation NN O
of IN O
RNA3 NNP B-Gene
in IN O
vivo NN O
to TO O
wild VB O
- : O
type NN O
levels NNS O
. . O

The DT O
drug NN O
packets NNS O
contained VBD O
acetyl JJ O
aspirin NN O
, , O
acetaminophen NN O
and CC O
chloramphenicol NN O
. . O

Surprisingly RB O
, , O
the DT O
full JJ O
- : O
deletion NN O
mutant NN O
showed VBD O
a DT O
strong JJ O
block NN O
in IN O
virus NN O
release NN O
, , O
suggesting VBG O
that IN O
NC NNP B-Gene
is VBZ O
involved VBN O
in IN O
virus NN O
assembly NN O
. . O

The DT O
authors NNS O
report VBP O
the DT O
results NNS O
of IN O
a DT O
series NN O
of IN O
toxicological JJ O
tests NNS O
conducted VBN O
on IN O
plastic NN O
materials NNS O
( ( O
polyethylene NN O
) ) O
activated VBD O
with IN O
tetraphenylbutadiene NN O
( ( O
TPB NNP O
) ) O
an DT O
additive JJ O
recently RB O
proposed VBN O
as IN O
a DT O
sensitizer NN O
capable JJ O
of IN O
photodegrading VBG O
plastic JJ O
materials NNS O
. . O

The DT O
interaction NN O
between IN O
U NNP O
( ( O
L NNP O
) ) O
3 CD O
. . O

Mutations NNS O
in IN O
seven CD O
other JJ O
lts NNS B-Gene
genes NNS I-Gene
do VBP O
not RB O
result VB O
in IN O
the DT O
mak NN B-Gene
- : I-Gene
phenotype NN I-Gene
. . O

Expression NN O
of IN O
this DT O
protein NN O
in IN O
E NNP O
. . O
coli NN O
demonstrated VBD O
that IN O
tyrosine NN O
was VBD O
incorporated VBN O
during IN O
suppression NN O
and CC O
that IN O
yeast JJ B-Gene
cytoplasmic JJ I-Gene
TyrRS NNP I-Gene
activity NN O
was VBD O
produced VBN O
. . O

Of IN O
major JJ O
concern NN O
to TO O
food NN O
processors NNS O
is VBZ O
the DT O
inadvertent JJ O
cross NN O
- : O
contact NN O
of IN O
food NN O
products NNS O
with IN O
allergenic JJ O
residues NNS O
, , O
which WDT O
could MD O
result VB O
in IN O
potentially RB O
life NN O
- : O
threatening JJ O
reactions NNS O
in IN O
those DT O
with IN O
a DT O
food NN O
allergy NN O
. . O

Mutations NNS O
that WDT O
alter VBP O
photoreceptor NN O
cell NN O
structure NN O
and CC O
development NN O
were VBD O
isolated VBN O
that IN O
fail NN O
to TO O
complement VB O
these DT O
deletions NNS O
. . O

Additional JJ O
information NN O
including VBG O
echocardiographic JJ O
sequences NNS O
, , O
perioperative JJ O
video NN O
sequences NNS O
, , O
x SYM O
- : O
ray NN O
analysis NN O
, , O
angiograms NNS O
, , O
etc FW O
. . O

is VBZ O
represented VBN O
in IN O
the DT O
program NN O
. . O

In IN O
ten CD O
other JJ O
experiments NNS O
( ( O
5 CD O
experimental NN O
and CC O
5 CD O
control NN O
rats NNS O
) ) O
99mTc CD O
- : O
sulfur NN O
colloid NN O
was VBD O
injected VBN O
intravenously RB O
. . O

The DT O
method NN O
described VBD O
may MD O
prove VB O
useful JJ O
in IN O
studying VBG O
the DT O
physiology NN O
of IN O
the DT O
nasal JJ O
cycle NN O
. . O

The DT O
yeast NN O
C NNP B-Gene
- : I-Gene
type NN I-Gene
cyclin NN I-Gene
Ume3p NNP B-Gene
/ NNP O
Srb11p NNP B-Gene
and CC O
its PRP$ O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
( ( O
Cdk NNP B-Gene
) ) O
Ume5p NNP B-Gene
are VBP O
required VBN O
for IN O
the DT O
full JJ O
repression NN O
of IN O
genes NNS O
involved VBN O
in IN O
the DT O
stress NN O
response NN O
or CC O
meiosis NN O
. . O

A DT O
DNase NNP B-Gene
I PRP I-Gene
- : I-Gene
hypersensitive NN I-Gene
site NN I-Gene
has VBZ O
also RB O
been VBN O
mapped VBN O
in IN O
the DT O
258 CD O
- : O
base NN O
pair NN O
enhancer JJ O
region NN O
. . O

The DT O
cloned JJ O
HindIII NNP B-Gene
fragment NN I-Gene
, , O
which WDT O
was VBD O
shown VBN O
by IN O
DNA NNP O
sequence NN O
analysis NN O
to TO O
encode VB O
the DT O
N NNP O
- : O
terminal JJ O
half NN O
of IN O
the DT O
B NNP B-Gene
. . I-Gene
subtilis NN I-Gene
IF2 NNP I-Gene
protein NN I-Gene
and CC O
0 CD O
. . O
2 CD O
kb NN O
of IN O
upstream JJ O
flanking NN O
sequence NN O
, , O
was VBD O
utilized VBN O
as IN O
a DT O
homologous JJ O
probe NN O
to TO O
clone VB O
an DT O
overlapping VBG O
2 CD B-Gene
. . I-Gene
76 CD I-Gene
- : I-Gene
kb NN I-Gene
ClaI NNP I-Gene
chromosomal JJ I-Gene
fragment NN I-Gene
containing VBG O
the DT O
entire JJ B-Gene
IF2 NNP I-Gene
structural JJ I-Gene
gene NN I-Gene
. . O

A DT O
73 CD O
bp NN O
fragment NN O
( ( O
X1 NNP O
region NN O
) ) O
of IN O
the DT O
PRB NNP B-Gene
- : I-Gene
1b CD I-Gene
promoter NN I-Gene
, , O
located VBN O
between IN O
positions NNS O
- : O
213 CD O
and CC O
- : O
141 CD O
, , O
was VBD O
sufficient JJ O
to TO O
confer VB O
ethylene JJ O
responsiveness NN O
to TO O
the DT O
reporter NN O
gene NN O
. . O

Thus RB O
, , O
hGRbeta PRP B-Gene
potentially RB O
functions NNS O
as IN O
a DT O
dominant JJ O
negative JJ O
inhibitor NN O
of IN O
hGRalpha NN B-Gene
activity NN O
. . O

The DT O
orf61 JJ B-Gene
gene NN I-Gene
product NN I-Gene
, , O
when WRB O
expressed VBN O
from IN O
an DT O
exogenous JJ O
promoter NN O
, , O
inhibited VBD O
int NN B-Gene
- : O
mediated VBN O
integration NN O
at IN O
the DT O
chromosomal JJ B-Gene
attB NN I-Gene
site NN I-Gene
. . O

Radiolabeled VBN O
recombinant JJ B-Gene
TARC NNP I-Gene
specifically RB O
bound VBD O
to TO O
T NNP O
cell NN O
lines NNS O
and CC O
peripheral JJ O
T NNP O
cells NNS O
but CC O
not RB O
to TO O
monocytes NNS O
or CC O
granulocytes NNS O
. . O

RESULTS NN O
: : O
Basal NNP O
plasma VBZ B-Gene
IGF NNP I-Gene
- : I-Gene
I PRP I-Gene
levels NNS O
as RB O
well RB O
as IN O
body NN O
mass NN O
index NN O
( ( O
BMI NNP O
) ) O
were VBD O
lower JJR O
in IN O
amenorrheic NN O
patients NNS O
than IN O
in IN O
healthy JJ O
controls NNS O
. . O

Postoperative JJ O
serum NN O
ACTH NNP B-Gene
levels NNS O
were VBD O
normal JJ O
. . O

Unilateral JJ O
naris JJ O
occlusion NN O
and CC O
the DT O
rat NN O
accessory JJ O
olfactory NN O
bulb NN O
. . O

Cyclosporine NNP O
treatment NN O
for IN O
intractable JJ O
polymyositis NN O
. . O

Kindling VBG O
of IN O
the DT O
primary JJ O
visual JJ O
cortex NN O
( ( O
VC NNP O
) ) O
was VBD O
compared VBN O
with IN O
that DT O
of IN O
the DT O
amygdala NN O
in IN O
cats NNS O
. . O

Immunelectrophoretic JJ O
pattern NN O
of IN O
Wassermann NNP O
reagin NN O
and CC O
comparison NN O
of IN O
the DT O
appearance NN O
time NN O
between IN O
RPCF NNP B-Gene
and CC O
FTA NNP B-Gene
antibodies NNS I-Gene

GH NNP B-Gene
deficiency NN O
may MD O
be VB O
absolute JJ O
, , O
but CC O
often RB O
is VBZ O
not RB O
and CC O
the DT O
diagnosis NN O
may MD O
be VB O
complicated VBN O
by IN O
a DT O
constellation NN O
of IN O
physical JJ O
and CC O
hormonal JJ O
findings NNS O
that WDT O
are VBP O
along IN O
a DT O
spectrum NN O
from IN O
low JJ O
normal JJ O
GH NNP B-Gene
sufficiency NN O
to TO O
absent VB O
GH NNP B-Gene
secretion NN O
. . O

Restoration NN O
of IN O
impaired JJ O
immune JJ O
functions NNS O
in IN O
aging VBG O
animals NNS O
. . O

This DT O
mode NN O
of IN O
ternary JJ O
complex JJ O
formation NN O
is VBZ O
in IN O
contrast NN O
to TO O
the DT O
one CD O
seen VBN O
in IN O
the DT O
promoter NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
fos NN I-Gene
protooncogene NN I-Gene
, , O
where WRB O
formation NN O
of IN O
the DT O
ternary JJ O
complex NN O
is VBZ O
dependent JJ O
on IN O
the DT O
prior JJ O
assembly NN O
of IN O
the DT O
serum NN B-Gene
response NN I-Gene
factor NN I-Gene
- : I-Gene
DNA NN I-Gene
binary JJ I-Gene
complex NN I-Gene
. . O

The DT O
logistic JJ O
regression NN O
analysis NN O
of IN O
the DT O
manual JJ O
method NN O
( ( O
percentage NN O
normal JJ O
morphology NN O
) ) O
and CC O
IVOS NNP O
indicated VBD O
that IN O
both DT O
were VBD O
predictors NNS O
of IN O
fertilization NN O
. . O

Encouraged VBN O
by IN O
a DT O
Dutch NN O
study NN O
using VBG O
etidronate JJ O
/ NNS O
fluoride RB O
in IN O
corticoid JJ O
- : O
induced JJ O
osteoporosis NN O
, , O
we PRP O
performed VBD O
a DT O
pilot NN O
study NN O
in IN O
33 CD O
men NNS O
with IN O
severe JJ O
established VBN O
primary JJ O
osteoporosis NN O
giving VBG O
cyclically RB O
etidronate VB O
for IN O
14 CD O
days NNS O
followed VBN O
by IN O
fluoride JJ O
plus CC O
calcium JJ O
/ NNP O
vitamin NN O
D NNP O
for IN O
76 CD O
days NNS O
. . O

The DT O
same JJ O
trend NN O
was VBD O
noted VBN O
between IN O
YG NNP O
4 CD O
. . O
5 CD O
heifers NNS O
and CC O
YG $ O
5 CD O
. . O
5 CD O
steers NNS O
, , O
indicating VBG O
a DT O
sex NN O
- : O
related JJ O
deposition NN O
of IN O
seam NN O
fat NN O
in IN O
fed JJ O
cattle NNS O
. . O

The DT O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
glutamine NN O
- : O
rich JJ O
and CC O
proline JJ O
- : O
rich JJ O
activation NN O
domains NNS O
can MD O
synergize VB O
with IN O
each DT O
other JJ O
or CC O
duplicates NNS O
of IN O
themselves PRP O
to TO O
activate VB O
transcription NN O
. . O

T NNP O
- : O
cell NN O
hybridomas NN O
, , O
thymocytes NNS O
, , O
and CC O
T NNP O
cells NNS O
can MD O
be VB O
induced VBN O
to TO O
undergo VB O
apoptotic JJ O
cell NN O
death NN O
by IN O
activation NN O
through IN O
the DT O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
receptor NN I-Gene
. . O

Effect NN O
of IN O
heat NN O
treatments NNS O
on IN O
the DT O
meltability NN O
of IN O
cheeses NNS O
. . O

Consciousness NNP O
is VBZ O
connected VBN O
with IN O
attention NN O
, , O
working VBG O
memory NN O
and CC O
perception NN O
. . O

To TO O
determine VB O
whether IN O
mononuclear JJ O
cell NN O
secretory NN O
products NNS O
contribute VBP O
to TO O
the DT O
changes NNS O
in IN O
bone NN O
turnover NN O
that WDT O
characterize VBZ O
the DT O
development NN O
of IN O
postmenopausal NN O
osteoporosis NN O
, , O
we PRP O
evaluated VBD O
the DT O
effects NNS O
of IN O
oophorectomy NN O
and CC O
subsequent JJ O
estrogen NN O
replacement NN O
on IN O
the DT O
spontaneous JJ O
secretion NN O
of IN O
interleukin JJ B-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
tumor JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
and CC O
on IN O
the DT O
phytohemagglutinin NN B-Gene
A NNP I-Gene
- : O
induced JJ O
secretion NN O
of IN O
granulocyte JJ B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
from IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

Alternative JJ O
processing NN O
of IN O
the DT O
tryptophanyl NN B-Gene
- : I-Gene
tRNA NN I-Gene
synthetase NN I-Gene
mRNA NN I-Gene
from IN O
interferon NN B-Gene
- : O
treated VBN O
human JJ O
cells NNS O
. . O

Another DT O
ORF NNP O
, , O
dda NN B-Gene
. . I-Gene
2 CD I-Gene
located VBN O
between IN O
modA NN B-Gene
and CC O
dda NN B-Gene
, , O
shares NNS O
sequence VBP O
similarity NN O
with IN O
sigma70 NN B-Gene
, , O
and CC O
we PRP O
call VBP O
it PRP O
srd NN B-Gene
. . O

Intriguingly RB O
, , O
three CD O
hypomorphic JJ O
Scm NNP B-Gene
mutations NNS O
, , O
which WDT O
map VBP O
within IN O
an DT O
mbt NN B-Gene
repeat NN I-Gene
, , O
interact NN O
with IN O
PcG NNP B-Gene
mutations NNS I-Gene
more RBR O
strongly RB O
than IN O
do VB O
Scm NNP B-Gene
null VB O
alleles NNS O
. . O

Clone NN O
4c CD O
( ( O
2681 CD O
bp NN O
) ) O
had VBD O
a DT O
coding JJ O
region NN O
identical JJ O
to TO O
that DT O
of IN O
clone NN O
22c CD O
but CC O
it PRP O
included VBD O
a DT O
putative JJ O
intron NN O
of IN O
959 CD O
bp NN O
. . O

However RB O
, , O
when WRB O
, , O
where WRB O
and CC O
how WRB O
the DT O
DSPP NNP B-Gene
is VBZ O
cleaved VBN O
into IN O
DSP NNP B-Gene
and CC O
DPP NNP B-Gene
is VBZ O
not RB O
clear JJ O
. . O

This DT O
is VBZ O
the DT O
first JJ O
example NN O
of IN O
a DT O
eukaryotic JJ O
transcription NN O
factor NN O
complex JJ O
containing VBG O
both DT O
a DT O
MADS NNP B-Gene
- : I-Gene
box NN I-Gene
and CC O
a DT O
forkhead JJ B-Gene
protein NN I-Gene
, , O
and CC O
it PRP O
has VBZ O
important JJ O
implications NNS O
for IN O
the DT O
regulation NN O
of IN O
mammalian JJ O
gene NN O
expression NN O
. . O

Ophthalmosonographic JJ O
evaluation NN O
of IN O
blood NN O
flow NN O
velocity NN O
in IN O
arteriocavernous JJ O
fistula NN O

We PRP O
show VBP O
here RB O
that IN O
, , O
despite IN O
their PRP$ O
structural JJ O
and CC O
functional JJ O
similarities NNS O
, , O
the DT O
pop1 NN B-Gene
and CC O
pop2 NN B-Gene
genes NNS I-Gene
fail VBP O
to TO O
complement VB O
each DT O
other JJ O
' POS O
s JJ O
deletion NN O
phenotypes NNS O
, , O
indicating VBG O
that IN O
they PRP O
perform VBP O
non JJ O
- : O
redundant NN O
, , O
but CC O
potentially RB O
interdependent JJ O
, , O
functions NNS O
in IN O
proteolysis NN O
. . O

Carbonic JJ B-Gene
anhydrase NN I-Gene
V NNP I-Gene
( ( O
CA NNP B-Gene
V NNP I-Gene
) ) O
is VBZ O
expressed VBN O
in IN O
mitochondrial JJ O
matrix NN O
in IN O
liver NN O
and CC O
several JJ O
other JJ O
tissues NNS O
. . O

Thus RB O
it PRP O
appears VBZ O
that IN O
the DT O
management NN O
of IN O
blood NN O
, , O
including VBG O
washing VBG O
is VBZ O
of IN O
great JJ O
importance NN O
. . O

Anastrozole NNP O
is VBZ O
the DT O
first JJ O
aromatase NN B-Gene
inhibitor NN O
to TO O
show VB O
a DT O
significant JJ O
survival JJ O
advantage NN O
over IN O
megestrol NN O
acetate NN O
in IN O
post NN O
- : O
menopausal NN O
women NNS O
with IN O
advanced JJ O
breast NN O
cancer NN O
. . O

Immunological JJ O
testing NN O
was VBD O
performed VBN O
on IN O
all DT O
brewery NN O
workers NNS O
and CC O
some DT O
control NN O
volunteers NNS O
using VBG O
skin JJ O
prick NN O
testing VBG O
with IN O
hops NNS O
, , O
barley NN O
, , O
and CC O
yeast RB O
antigens NNS O
as RB O
well RB O
as IN O
other JJ O
nonoccupational JJ O
allergens NNS O
, , O
and CC O
by IN O
determining VBG O
total JJ O
serum NN B-Gene
IgE NNP I-Gene
levels NNS O
. . O

A DT O
. . O
, , O
Slatkin NNP O
, , O
D NNP O
. . O

Prognostic JJ O
value NN O
of IN O
a DT O
treadmill NN O
exercise NN O
score NN O
in IN O
symptomatic JJ O
patients NNS O
with IN O
nonspecific JJ O
ST NNP O
- : O
T NNP O
abnormalities NNS O
on IN O
resting VBG O
ECG NNP O
. . O

Fluid NNP O
( ( O
AVLF NNP O
) ) O
31 CD O
. . O

Estrogen NNP O
replacement NN O
, , O
either CC O
as IN O
17 CD O
beta NN O
- : O
estradiol NN O
or CC O
beta NN O
- : O
estradiol NN O
- : O
3 CD O
- : O
benzoate NN O
via IN O
subcutaneous JJ O
Silastic NNP O
capsules NNS O
, , O
was VBD O
associated VBN O
with IN O
elevated JJ O
rates NNS O
of IN O
heat NN O
production NN O
and CC O
dry JJ O
heat NN O
loss NN O
relative NN O
to TO O
untreated JJ O
ovariectomized JJ O
controls NNS O
. . O

Bifunctionality NN O
of IN O
the DT O
AcMNPV NNP B-Gene
homologous JJ I-Gene
region NN I-Gene
sequence NN I-Gene
( ( O
hr1 NN B-Gene
) ) O
: : O
enhancer NN O
and CC O
ori JJ O
functions NNS O
have VBP O
different JJ O
sequence NN O
requirements NNS O
. . O

The DT O
values NNS O
were VBD O
consistently RB O
lower JJR O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
during IN O
summer NN O
( ( O
3 CD O
. . O
79 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
13 CD O
micrograms NNS O
/ VBP O
100 CD O
ml NN O
) ) O
, , O
as IN O
compared VBN O
to TO O
winter VB O
( ( O
5 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
27 CD O
) ) O
. . O

Using VBG O
mutated VBN B-Gene
IL2R NNP I-Gene
alpha JJ I-Gene
promoter NN I-Gene
constructs NNS I-Gene
in IN O
transient JJ O
transfection NN O
and CC O
DNA NNP O
binding NN O
assays NNS O
, , O
we PRP O
now RB O
demonstrate VBP O
that IN O
sequences NNS O
located VBN O
immediately RB O
upstream JJ O
and CC O
downstream NN O
of IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
enhancer NN I-Gene
also RB O
contribute VBZ O
to TO O
the DT O
regulation NN O
of IN O
IL2R NNP B-Gene
alpha JJ I-Gene
gene NN I-Gene
expression NN O
. . O

The DT O
importance NN O
of IN O
hepatitis NN O
C NNP O
virus NN O
( ( O
HCV NNP O
) ) O
infection NN O
as IN O
a DT O
cause NN O
of IN O
chronic JJ O
liver NN O
disease NN O
has VBZ O
become VBN O
clear JJ O
with IN O
the DT O
introduction NN O
of IN O
serologic JJ O
detection NN O
methods NNS O
. . O

Among IN O
unusual JJ O
features NNS O
, , O
we PRP O
report VBP O
numerous JJ O
large JJ O
G NNP O
+ NNP O
C NNP O
- : O
rich JJ O
conserved VBD O
sequences NNS O
located VBN O
in IN O
the DT O
first JJ O
intron NN O
. . O

Moreover RB O
, , O
it PRP O
also RB O
discusses VBZ O
the DT O
effects NNS O
of IN O
antihypertensive JJ O
drugs NNS O
currently RB O
regarded VBD O
as IN O
first JJ O
- : O
choice NN O
agents NNS O
, , O
i NN O
. . O
e NN O
. . O
calcium NN O
antagonists NNS O
and CC O
the DT O
angiotensin NN B-Gene
converting VBG I-Gene
enzyme JJ I-Gene
inhibitors NNS O
, , O
on IN O
intrarenal JJ O
hemodynamics NNS O
. . O

The DT O
progress NN O
of IN O
morphological JJ O
research NN O
on IN O
the DT O
parabrachial JJ O
nucleus NN O

Recombinant NNP B-Gene
Leishmania NNP I-Gene
surface NN I-Gene
glycoprotein NN I-Gene
GP63 NNP I-Gene
is VBZ O
secreted VBN O
in IN O
the DT O
baculovirus NN O
expression NN O
system NN O
as IN O
a DT O
latent JJ O
metalloproteinase NN B-Gene
. . O

Female NNP O
but CC O
not RB O
male JJ O
mortalities NNS O
were VBD O
significantly RB O
higher JJR O
for IN O
cake NN O
- : O
fed NN O
rats NNS O
than IN O
for IN O
those DT O
fed VBN O
diet JJ O
41B CD O
. . O

Examination NN O
of IN O
neurohumoral JJ O
factors NNS O
revealed VBD O
a DT O
hyperactive JJ O
sympathetic JJ O
nervous JJ O
system NN O
and CC O
an DT O
increase NN O
in IN O
plasma JJ O
renin NN B-Gene
activity NN O
. . O

In IN O
addition NN O
, , O
the DT O
hGCSFR NN B-Gene
gene NN I-Gene
was VBD O
chromosomally RB O
localized VBN O
by IN O
Southern NNP O
blot NN O
analysis NN O
of IN O
its PRP$ O
segregation NN O
pattern NN O
in IN O
a DT O
panel NN O
of IN O
rodent JJ O
- : O
human JJ O
hybrid JJ O
DNAs NNP O
using VBG O
the DT O
radiolabeled VBN O
cDNA NN O
probe NN O
. . O

The DT O
4 CD O
days NNS O
dexamethasone CD O
suppression NN O
test NN O
showed VBD O
more JJR O
than IN O
80 CD O
% NN O
suppression NN O
of IN O
dehydroepiandrosterone NN O
- : O
sulphate NN O
and CC O
a DT O
variable JJ O
( ( O
40 CD O
- : O
60 CD O
% NN O
) ) O
reduction NN O
of IN O
testosterone NN O
and CC O
androstenedione NN O
levels NNS O
. . O

Identification NN O
of IN O
the DT O
plakoglobin NN B-Gene
- : O
binding NN O
domain NN O
in IN O
desmoglein NN B-Gene
and CC O
its PRP$ O
role NN O
in IN O
plaque NN O
assembly NN O
and CC O
intermediate JJ O
filament NN O
anchorage NN O
. . O

E2F NNP B-Gene
is VBZ O
a DT O
heterodimeric JJ O
complex JJ O
consisting NN O
of IN O
E2F NNP B-Gene
family NN I-Gene
members NNS I-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
5 CD I-Gene
) ) I-Gene
and CC O
DP NNP B-Gene
proteins NNS I-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
3 CD I-Gene
) ) I-Gene
. . O

The DT O
side NN O
- : O
to TO O
- : O
side NN O
difference NN O
was VBD O
statistically RB O
significant JJ O
at IN O
EXT NNP O
30 CD O
degrees NNS O
/ JJ O
s NN O
and CC O
60 CD O
degrees NNS O
/ JJ O
s NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
. . O

To TO O
map VB O
this DT O
regulatory JJ O
serine NN O
phosphorylation NN O
site NN O
we PRP O
developed VBD O
a DT O
baculovirus NN O
- : O
mediated VBN O
expression NN O
system NN O
for IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
annexin NN I-Gene
II NNP I-Gene
and CC O
for IN O
a DT O
series NN O
of IN O
annexin JJ B-Gene
II NNP I-Gene
mutants NNS I-Gene
which WDT O
contained VBD O
substitutions NNS O
in IN O
one CD O
or CC O
more JJR O
serine JJ O
residues NNS O
present VBP O
in IN O
the DT O
N NNP O
- : O
terminal NN O
domain NN O
. . O

Five CD O
of IN O
10 CD O
scars NNS O
studied VBD O
decreased VBN O
at IN O
least JJS O
50 CD O
% NN O
in IN O
linear JJ O
dimensions NNS O
. . O

Expression NN O
of IN O
ME31B NNP B-Gene
cDNA NN I-Gene
in IN O
S NNP O
. . O
pombe NN O
suppresses VBZ O
the DT O
ste13 JJ B-Gene
mutation NN O
. . O

An DT O
endogenous JJ O
mammalian JJ O
regulator NN O
of IN O
this DT O
process NN O
, , O
named VBN O
Usurpin NNP B-Gene
, , O
has VBZ O
been VBN O
identified VBN O
( ( O
aliases NNS O
for IN O
Usurpin NNP B-Gene
include VBP O
CASH NNP B-Gene
, , O
Casper NNP B-Gene
, , O
CLARP NNP B-Gene
, , O
FLAME NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
FLIP NNP B-Gene
, , O
I PRP B-Gene
- : I-Gene
FLICE NN I-Gene
and CC O
MRIT NNP B-Gene
) ) O
. . O

A DT O
second JJ O
large JJ O
group NN O
of IN O
disorders NNS O
in IN O
pregnancy NN O
is VBZ O
caused VBN O
by IN O
effects NNS O
of IN O
infections NNS O
of IN O
the DT O
mother NN O
without IN O
pathogens NNS O
being VBG O
transmitted VBN O
to TO O
the DT O
embryo NN O
or CC O
the DT O
placenta NN O
. . O

Childhood NNP O
misbehavior NN O
and CC O
the DT O
risk NN O
of IN O
injecting VBG O
drug NN O
use NN O
. . O

In IN O
the DT O
DNAs NNP O
of IN O
all DT O
Ph1 NNP O
- : O
positive JJ O
chronic JJ O
myelocytic JJ O
leukemia NN O
patients NNS O
studied VBN O
to TO O
date NN O
, , O
a DT O
breakpoint NN O
on IN O
chromosome NN O
22 CD O
( ( O
the DT O
Ph1 NNP O
chromosome NN O
) ) O
can MD O
be VB O
demonstrated VBN O
with IN O
a DT O
probe NN O
from IN O
the DT O
bcr NN B-Gene
( ( O
breakpoint JJ B-Gene
cluster NN I-Gene
region NN I-Gene
) ) O
. . O

Eukaryotic JJ B-Gene
initiation NN I-Gene
factor NN I-Gene
3 CD I-Gene
( ( O
eIF3 NN B-Gene
) ) O
is VBZ O
a DT O
large JJ O
multisubunit NN O
complex NN O
that WDT O
stabilizes VBZ O
the DT O
ternary JJ O
complex NN O
, , O
eIF2 FW B-Gene
x FW O
GTP NNP O
x NNP O
tRNA NN B-Gene
( ( I-Gene
Met NNP I-Gene
) ) I-Gene
i NN I-Gene
and CC O
promotes NNS O
mRNA VBP O
binding VBG O
to TO O
the DT O
40 CD B-Gene
S NNP I-Gene
ribosomal JJ I-Gene
subunit NN I-Gene
. . O

eIF3 NN B-Gene
also RB O
functions VBZ O
as IN O
a DT O
ribosome JJ O
subunit NN O
anti SYM O
- : O
association NN O
factor NN O
. . O

Cells NNS O
lacking VBG O
p116 JJ B-Gene
exhibit NN O
a DT O
striking JJ O
defect NN O
in IN O
the DT O
formation NN O
of IN O
these DT O
macropinocytic JJ O
structures NNS O
, , O
a DT O
concomitant JJ O
reduction NN O
in IN O
the DT O
rate NN O
of IN O
fluid NN O
phase NN O
pinocytosis NN O
, , O
a DT O
significant JJ O
decrease NN O
in IN O
the DT O
efficiency NN O
of IN O
chemotactic JJ O
aggregation NN O
, , O
and CC O
a DT O
decrease NN O
in IN O
cellular JJ O
F NNP B-Gene
- : I-Gene
actin NN I-Gene
content NN O
. . O

Analysis NN O
of IN O
nucleotide JJ O
sequence NN O
of IN O
the DT O
rightmost NN O
43 CD O
kbp NN O
of IN O
herpesvirus NN O
saimiri NN O
( ( O
HVS NNP O
) ) O
L NNP O
- : O
DNA NN O
: : O
general JJ O
conservation NN O
of IN O
genetic JJ O
organization NN O
between IN O
HVS NNP O
and CC O
Epstein NNP O
- : O
Barr NNP O
virus NN O
. . O

Pigmentary JJ O
rhythms NN O
as IN O
indicators NNS O
of IN O
neurosecretion NN O
. . O

In IN O
vitro JJ O
expression NN O
levels NNS O
of IN O
the DT O
different JJ O
plasmids NNS O
differed VBN O
by IN O
as RB O
much JJ O
as IN O
tenfold NN O
. . O

When WRB O
mixed JJ O
with IN O
aqueous JJ O
solutions NNS O
of IN O
TMT NNP O
- : O
55 CD O
, , O
aqueous JJ O
solutions NNS O
of IN O
either DT O
reagent JJ O
- : O
grade NN O
zinc NN O
, , O
cadmium NN O
, , O
or CC O
lead JJ O
salts NNS O
precipitate VBP O
crystalline NN O
"""" NN O
Zn NNP O
- : O
TMT NNP O
"""" NNP O
, , O
amorphous JJ O
or CC O
crystalline JJ O
"""" JJ O
Cd NNP O
- : O
TMT NNP O
"""" NNP O
or CC O
amorphous JJ O
"""" NNS O
Pb NNP O
- : O
TMT NN O
"""" NN O
( ( O
M3 NNP O
[ NNP O
S3C3N3 NNP O
] VBD O
2 CD O
. . O
nH2O NN O
, , O
where WRB O
M NNP O
= NNP O
Cd2 NNP O
+ NNP O
, , O
Pb2 NNP O
+ NNP O
, , O
and CC O
Zn2 NNP O
+ NNP O
and CC O
n JJ O
> NN O
or CC O
= VB O
0 CD O
) ) O
that WDT O
may MD O
eventually RB O
crystallize VB O
if IN O
stored VBN O
in IN O
air NN O
. . O

In IN O
addition NN O
, , O
CaMig1 NNP B-Gene
formed VBD O
specific JJ O
complexes NNS O
with IN O
the DT O
URS1 NNP O
region NN O
of IN O
the DT O
S NNP B-Gene
. . I-Gene
cerevisiae NN I-Gene
FBP1 NNP I-Gene
gene NN I-Gene
. . O

These DT O
studies NNS O
support VBP O
the DT O
view NN O
that IN O
HMG NNP B-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
is VBZ O
an DT O
important JJ O
cofactor NN O
for IN O
HLA NNP B-Gene
- : I-Gene
DRA NNP I-Gene
gene NN I-Gene
activation NN O
by IN O
Oct NNP B-Gene
- : I-Gene
2A CD I-Gene
and CC O
provide VB O
insights NNS O
into IN O
its PRP$ O
mechanism NN O
of IN O
action NN O
. . O

Catch NNP O
- : O
up RB O
growth NN O
and CC O
craniofacial JJ O
dimensions NNS O
following VBG O
administration NN O
of IN O
the DT O
antineoplastic JJ O
agent NN O
vincristine NN O
to TO O
young JJ O
rats NNS O
. . O

When WRB O
the DT O
high JJ O
affinity NN O
hnRNP NN B-Gene
A1 NNP I-Gene
binding VBG I-Gene
site NN I-Gene
was VBD O
inserted VBN O
into IN O
the DT O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
reporter NN I-Gene
, , O
Rev NNP B-Gene
was VBD O
able JJ O
to TO O
increase VB O
the DT O
cytoplasmic JJ O
levels NNS O
of IN O
unspliced JJ O
mRNAs NN O
to TO O
14 CD O
% NN O
. . O

We PRP O
report VBP O
the DT O
results NNS O
of IN O
a DT O
detailed JJ O
policy NN O
analysis NN O
comparing VBG O
2 CD O
CJD NNP O
- : O
related JJ O
decisions NNS O
: : O
a DT O
1995 CD O
recall NN O
of IN O
blood NN O
from IN O
a DT O
donor NN O
with IN O
classic JJ O
CJD NNP O
and CC O
the DT O
1999 CD O
decision NN O
to TO O
defer VB O
donations NNS O
from IN O
individuals NNS O
with IN O
a DT O
6 CD O
- : O
month NN O
travel NN O
history NN O
to TO O
the DT O
UK NNP O
between IN O
1980 CD O
and CC O
1996 CD O
due JJ O
to TO O
concerns NNS O
related VBN O
to TO O
variant JJ O
CJD NNP O
. . O

GGS1 NNP B-Gene
is VBZ O
the DT O
same JJ O
gene NN O
as IN O
TPS1 NNP B-Gene
which WDT O
was VBD O
identified VBN O
as IN O
encoding VBG O
a DT O
subunit NN O
of IN O
the DT O
trehalose JJ B-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
phosphate NN I-Gene
synthase NN I-Gene
/ NNP I-Gene
phosphatase NN I-Gene
complex NN I-Gene
and CC O
it PRP O
is VBZ O
allelic JJ O
to TO O
the DT O
fdp1 NN B-Gene
, , O
byp1 NN B-Gene
, , O
glc6 NN B-Gene
and CC O
cif1 NN O
mutations NNS O
. . O

Interferon NNP B-Gene
type NN I-Gene
I PRP I-Gene
in IN O
protective JJ O
body NN O
reactions NNS O
in IN O
an DT O
experimental JJ O
Klebsiella NNP O
infection NN O

The DT O
following JJ O
markers NNS O
were VBD O
looked VBN O
for IN O
in IN O
the DT O
serum NN O
, , O
skin NN O
and CC O
liver NN O
of IN O
all DT O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
: : O
HBV NNP O
( ( O
HBs NNP B-Gene
Ag NNP I-Gene
and CC O
HBe NNP B-Gene
Ag NNP I-Gene
, , O
anti SYM B-Gene
- : I-Gene
HBs NNP I-Gene
, , O
anti SYM B-Gene
- : I-Gene
HBe NN I-Gene
and CC O
anti JJ B-Gene
- : I-Gene
HBc NN I-Gene
in IN O
the DT O
serum NN O
, , O
HBs NNP B-Gene
and CC I-Gene
HBc NNP I-Gene
Ag NNP I-Gene
in IN O
the DT O
liver NN O
) ) O
; : O
non CC B-Gene
- : I-Gene
A DT I-Gene
non JJ I-Gene
- : I-Gene
B NNP I-Gene
( ( O
non SYM B-Gene
- : I-Gene
A NN I-Gene
, , I-Gene
non SYM I-Gene
- : I-Gene
B NNP I-Gene
Ag NNP I-Gene
and CC I-Gene
antibody NN I-Gene
, , O
anti NN B-Gene
non SYM I-Gene
- : I-Gene
A DT I-Gene
non JJ I-Gene
- : I-Gene
Bc NN I-Gene
in IN O
the DT O
serum NN O
, , O
non SYM B-Gene
- : I-Gene
A NN I-Gene
, , I-Gene
non JJ I-Gene
- : I-Gene
Bc NNP I-Gene
Ag NNP I-Gene
in IN O
the DT O
liver NN O
) ) O
. . O

Cloning VBG O
and CC O
sequence NN O
analyses NNS O
revealed VBD O
a DT O
second JJ O
cDNA NN O
with IN O
a DT O
95 CD O
- : O
nt JJ O
deletion NN O
in IN O
the DT O
region NN O
coding VBG O
for IN O
the DT O
putative JJ O
second JJ O
intracellular JJ O
loop NN O
and CC O
the DT O
fourth JJ O
transmembrane NN O
domain NN O
of IN O
the DT O
5 CD B-Gene
- : I-Gene
HT2C NNP I-Gene
- : I-Gene
R NN I-Gene
. . O

METHODS NN O
: : O
T2 NNP O
* NNP O
- : O
weighted VBD O
, , O
three CD O
- : O
dimensional JJ O
gradient NN O
- : O
echo NN O
images NNS O
were VBD O
acquired VBN O
by IN O
exploiting VBG O
the DT O
magnetic JJ O
susceptibility NN O
difference NN O
between IN O
oxygenated VBN O
and CC O
deoxygenated VBN O
hemoglobin NN B-Gene
in IN O
the DT O
vasculature NN O
and CC O
microvasculature NN O
. . O

These DT O
fusion NN O
proteins NNS O
also RB O
allowed VBD O
the DT O
localization NN O
of IN O
the DT O
transcriptional JJ O
activation NN O
and CC O
DNA NNP O
binding VBG O
domains NNS O
of IN O
the DT O
ToxR NNP B-Gene
protein NN I-Gene
to TO O
its PRP$ O
cytoplasmically RB O
located VBN O
N NNP O
- : O
terminal JJ O
portion NN O
. . O

Second JJ O
, , O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
m8 NN I-Gene
3 CD I-Gene
' '' I-Gene
UTR NNP I-Gene
strongly RB O
reduces VBZ O
accumulation NN O
of IN O
heterologous JJ O
transcripts NNS O
in IN O
vivo NN O
, , O
an DT O
activity NN O
that WDT O
requires VBZ O
its PRP$ O
K NNP O
box NN O
sequences NNS O
. . O

Technetium NNP O
- : O
99m CD O
stannous JJ O
pyrophosphate NN O
myocardial JJ O
scintigrams NNS O
were VBD O
obtained VBN O
in IN O
138 CD O
clinically RB O
stable JJ O
patients NNS O
32 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
47 CD O
. . O
3 CD O
weeks NNS O
( ( O
range VB O
6 CD O
to TO O
260 CD O
) ) O
after IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

In IN O
view NN O
of IN O
these DT O
results NNS O
, , O
simultaneous JJ O
pancreas SYM O
- : O
kidney NN O
transplantation NN O
appears VBZ O
to TO O
be VB O
the DT O
treatment NN O
of IN O
choice NN O
for IN O
Type NNP O
I PRP O
diabetic JJ O
patients NNS O
. . O

Molecular JJ O
dissection NN O
of IN O
the DT O
multimeric JJ O
CD3 NNP B-Gene
- : O
TCR NN B-Gene
complex NN O
revealed VBD O
that IN O
at IN O
least JJS O
two CD O
associated JJ O
polypeptides NNS O
, , O
CD3 NNP B-Gene
zeta NN I-Gene
and CC O
CD3 NNP B-Gene
epsilon NN I-Gene
, , O
autonomously RB O
couple JJ O
antigenic JJ O
recognition NN O
event NN O
to TO O
early JJ O
and CC O
late JJ O
events NNS O
of IN O
the DT O
intracytoplasmic JJ O
activation NN O
cascade NN O
. . O

Single NNP O
tooth CC O
replacement NN O
with IN O
the DT O
aid NN O
of IN O
the DT O
ITI NNP O
( ( O
International NNP O
Team NNP O
fur RB O
Implantologie NNP O
) ) O
type NN O
F NNP O
hollow SYM O
- : O
cylinder NN O
implant NN O

Existence NN O
and CC O
uniqueness NN O
of IN O
solutions NNS O
of IN O
the DT O
appropriate JJ O
boundary JJ O
value NN O
problems NNS O
are VBP O
established VBN O
, , O
in IN O
the DT O
case NN O
of IN O
small JJ O
permeability NN O
coefficients NNS O
and CC O
transport NN O
rates NNS O
, , O
or CC O
large JJ O
diffusion NN O
coefficients NNS O
and CC O
small JJ O
resistance NN O
to TO O
flow VB O
constants NNS O
. . O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
hypothermia NN O
and CC O
chemical NN O
cardioplegia NN O
on IN O
the DT O
functional JJ O
recovery NN O
of IN O
hypertrophied JJ O
non JJ O
- : O
failing VBG O
rat NN O
hearts NNS O
subjected VBD O
to TO O
an DT O
extended JJ O
period NN O
of IN O
global JJ O
ischaemia NN O
. . O

Therefore RB O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
cis NN O
- : O
acting VBG O
element NN O
, , O
the DT O
E1 NNP O
E NNP O
- : O
box NN O
, , O
located VBN O
in IN O
the DT O
GAP NNP B-Gene
- : I-Gene
43 CD I-Gene
promoter NN O
region NN O
that WDT O
modulates VBZ O
either DT O
positively RB O
or CC O
negatively RB O
the DT O
expression NN O
of IN O
the DT O
GAP NNP B-Gene
- : I-Gene
43 CD I-Gene
gene NN I-Gene
depending VBG O
on IN O
which WDT O
E NNP B-Gene
- : I-Gene
box NN I-Gene
- : I-Gene
binding NN I-Gene
proteins VBZ I-Gene
occupy RP O
this DT O
site NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
ability NN O
of IN O
various JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
subunits VBZ I-Gene
to TO O
bind VB O
to TO O
, , O
and CC O
activate VBP O
transcription NN O
from IN O
, , O
the DT O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
promoter NN I-Gene
. . O

Resting VBG O
plasma NN O
norepinephrine NN O
( ( O
NE NNP O
) ) O
and CC O
epinephrine NN O
( ( O
E NNP O
) ) O
levels NNS O
were VBD O
lower JJR O
during IN O
active JJ O
therapy NN O
than IN O
2 CD O
wk NN O
after IN O
withdrawal NN O
( ( O
guanfacine JJ O
and CC O
control NN O
: : O
plasma NN O
NE NNP O
, , O
0 CD O
. . O
27 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
3 CD O
/ JJ O
0 CD O
. . O
64 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
13 CD O
ng JJ O
/ NNP O
ml NN O
; : O
plasma CC O
E NNP O
, , O
0 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
2 CD O
/ JJ O
0 CD O
. . O
17 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
ng JJ O
/ NNP O
ml NN O
) ) O
. . O

The DT O
clinical JJ O
relevance NN O
of IN O
these DT O
findings NNS O
is VBZ O
strengthened VBN O
by IN O
the DT O
observation NN O
that IN O
similar JJ O
results NNS O
were VBD O
obtained VBN O
when WRB O
P NNP O
. . O
HCl NNP O
was VBD O
given VBN O
by IN O
the DT O
intravenous JJ O
route NN O
. . O

Intraperitoneal NNP O
administration NN O
of IN O
L NNP O
- : O
5 CD O
- : O
hydroxytryptophan NN O
( ( O
L NNP O
- : O
5 CD O
- : O
HTP NN O
) ) O
at IN O
doses NNS O
of IN O
25 CD O
to TO O
100 CD O
mg NNS O
/ JJ O
kg VBP O
dramatically RB O
increase JJ O
defecation NN O
in IN O
mice NN O
. . O

Alignment NN O
of IN O
different JJ O
cDNAs NN O
of IN O
the DT O
NR5A2 NNP B-Gene
( ( O
hB1F NN B-Gene
) ) O
gene NN O
with IN O
the DT O
genomic JJ O
sequence NN O
facilitated VBD O
the DT O
delineation NN O
of IN O
its PRP$ O
structural JJ O
organization NN O
, , O
which WDT O
spans VBZ O
over IN O
150 CD O
kb NNS O
and CC O
consists NNS O
of IN O
eight CD O
exons NNS O
interrupted VBN O
by IN O
seven CD O
introns NNS O
. . O

Chicken NNP O
sterol NN B-Gene
carrier NN I-Gene
protein VBZ I-Gene
2 CD I-Gene
/ JJ O
sterol NN B-Gene
carrier NN I-Gene
protein NN I-Gene
x NN I-Gene
: : O
cDNA NN O
cloning VBG O
reveals NNS O
evolutionary JJ O
conservation NN O
of IN O
structure NN O
and CC O
regulated JJ O
expression NN O
. . O

Its PRP$ O
clearance NN O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
decreased VBN O
( ( O
typically RB O
by IN O
around IN O
25 CD O
% NN O
, , O
but CC O
often RB O
by IN O
far RB O
more JJR O
) ) O
by IN O
erythromycin NN O
, , O
troleandomycin NN O
( ( O
triacetyloleandomycin NN O
) ) O
, , O
roxithromycin NN O
, , O
enoxacin NN O
, , O
ciprofloxacin NN O
, , O
pefloxacin NN O
, , O
norfloxacin RB O
, , O
ofloxacin PRP O
, , O
fluoroquinolone RB O
T NNP O
- : O
3262 CD O
, , O
pipemidic JJ O
acid NN O
, , O
cimetidine NN O
, , O
etintidine NN O
, , O
propranolol NN O
, , O
verapamil NN O
, , O
diltiazem NN O
, , O
nifedipine NN O
, , O
furosemide NN O
( ( O
frusemide NN O
) ) O
, , O
at IN O
least JJS O
some DT O
anovulent JJ O
agents NNS O
, , O
viloxazine NN O
, , O
allopurinol NN O
, , O
ticlopidine NN O
, , O
idrocilamide NN O
, , O
thiabendazole NN O
, , O
disulfiram NN O
, , O
influenza JJ O
- : O
and CC O
BCG NNP O
- : O
vaccination NN O
, , O
interferon NN B-Gene
, , O
and CC O
caffeine NN O
( ( O
half PDT O
- : O
life NN O
increase NN O
) ) O
. . O

Breitbart NNP O
, , O
L NNP O
. . O

The DT O
mean JJ O
percentage NN O
of IN O
linoleic JJ O
acid NN O
in IN O
the DT O
triglycerides NNS O
of IN O
the DT O
subcutaneous JJ O
adipose JJ O
tissue NN O
( ( O
PLASAT NNP O
) ) O
of IN O
these DT O
subjects NNS O
was VBD O
substantially RB O
higher JJR O
than IN O
that DT O
in IN O
a DT O
similar JJ O
group NN O
examined VBD O
in IN O
1975 CD O
- : O
1976 CD O
. . O

The DT O
phi NN B-Gene
AP3 NNP I-Gene
factor NN I-Gene
is VBZ O
a DT O
nuclear JJ O
phosphoprotein NN O
; : O
the DT O
extent NN O
of IN O
its PRP$ O
phosphorylation NN O
is VBZ O
regulated VBN O
during IN O
the DT O
cell NN O
cycle NN O
. . O

Previously RB O
, , O
we PRP O
reported VBD O
the DT O
sequence NN O
of IN O
the DT O
gene NN B-Gene
encoding VBG I-Gene
human JJ I-Gene
K14 NNP I-Gene
( ( O
D NNP O
. . O

Distinguishing VBG O
roles NNS O
of IN O
the DT O
membrane NN O
- : O
cytoskeleton NN O
and CC O
cadherin NN B-Gene
mediated VBN O
cell NN O
- : O
cell NN O
adhesion NN O
in IN O
generating VBG O
different JJ O
Na NNP B-Gene
+ NNP I-Gene
, , I-Gene
K NNP I-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
- : I-Gene
ATPase NN I-Gene
distributions NNS O
in IN O
polarized JJ O
epithelia NN O
. . O

Consistent JJ O
with IN O
our PRP$ O
model NN O
, , O
CTCF NNP B-Gene
binding NN O
is VBZ O
abolished VBN O
by IN O
DNA NNP O
methylation NN O
. . O

The DT O
correcting VBG O
action NN O
of IN O
tropatepine NN O
hydrochloride NN O
upon IN O
the DT O
extrapyramidal JJ O
effects NNS O
induced VBN O
by IN O
neuroleptics NNS O
has VBZ O
been VBN O
studied VBN O
in IN O
32 CD O
acute JJ O
psychotic JJ O
states NNS O
. . O

The DT O
neural JJ O
mechanism NN O
of IN O
parkinsonian JJ O
motor NN O
symptoms NNS O
, , O
i NN O
. . O
e NN O
. . O
, , O
rigidity NN O
, , O
tremor NN O
and CC O
akinesia NN O
, , O
which WDT O
are VBP O
the DT O
result NN O
of IN O
nigrostriatal JJ O
dopamine NN O
deficiency NN O
, , O
is VBZ O
interpreted VBN O
from IN O
long JJ O
- : O
term NN O
observations NNS O
on IN O
the DT O
effect NN O
of IN O
surgical JJ O
and CC O
pharmacological JJ O
treatment NN O
of IN O
the DT O
disease NN O
in IN O
relation NN O
to TO O
the DT O
neuropathological JJ O
findings NNS O
within IN O
the DT O
substantia NN O
nigra NN O
zona NN O
compacta NN O
( ( O
SNc NNP O
) ) O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
differences NNS O
in IN O
the DT O
binding NN O
of IN O
nuclear JJ O
factors NNS O
from IN O
shoots NNS O
versus IN O
from IN O
roots NNS O
, , O
in IN O
agreement NN O
with IN O
the DT O
different JJ O
activities NNS O
of IN O
the DT O
promoter NN O
in IN O
these DT O
two CD O
organs NNS O
. . O

The DT O
ns2 JJ B-Gene
gene NN I-Gene
comprises VBZ O
an DT O
open JJ O
reading NN O
frame NN O
( ( O
ORF NNP O
) ) O
encoding VBG O
a DT O
putative JJ O
nonstructural JJ O
( ( O
ns JJ O
) ) O
protein NN O
of IN O
279 CD O
amino JJ O
acids NNS O
with IN O
a DT O
predicted JJ O
molecular JJ O
mass NN O
of IN O
32 CD O
- : O
kDa NN O
. . O

However RB O
, , O
a DT O
correlation NN O
was VBD O
observed VBN O
between IN O
SF NNP O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
with IN O
those DT O
of IN O
lactate NN O
, , O
LDH NNP B-Gene
, , O
beta VBD B-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
and CC O
glucose NN O
. . O

We PRP O
describe VBP O
a DT O
total NN O
of IN O
39 CD O
DEAH NNP B-Gene
helicases NNS I-Gene
in IN O
these DT O
four CD O
species NNS O
. . O

Our PRP$ O
analysis NN O
of IN O
nonsense JJ O
mutations NNS O
indicates VBZ O
that IN O
the DT O
C NNP O
terminus NN O
of IN O
eIF2Bepsilon NN B-Gene
( ( I-Gene
residues VBZ I-Gene
518 CD I-Gene
to TO I-Gene
712 CD I-Gene
) ) I-Gene
is VBZ O
required VBN O
for IN O
both DT O
catalytic JJ O
activity NN O
and CC O
interaction NN O
with IN O
eIF2 NN B-Gene
. . O

Experiments NNS O
on IN O
23 CD O
white JJ O
rats NNS O
and CC O
10 CD O
guinea NN O
pigs NNS O
have VBP O
shown VBN O
that IN O
preliminarily RB O
indomethacin VB O
- : O
induced JJ O
inhibition NN O
of IN O
prostaglandins NNS O
synthesis NN O
prevented VBD O
development NN O
of IN O
pulmonary JJ O
oedema NN O
, , O
evoked VBN O
by IN O
heterologous JJ O
serum NN O
in IN O
rats NNS O
and CC O
by IN O
vagotomy NN O
in IN O
guinea NN O
pigs NNS O
. . O

OBJECTIVE NN O
: : O
To TO O
evaluate VB O
the DT O
accuracy NN O
of IN O
working VBG O
casts NNS O
for IN O
crown NN O
and CC O
bridge NN O
restorations NNS O
made VBN O
from IN O
twin JJ O
mix NN O
putty NN O
/ NNP O
wash NN O
silicone NN O
elastomeric JJ O
impression NN O
materials NNS O
using VBG O
different JJ O
types NNS O
of IN O
stock NN O
tray NN O
. . O

Thus RB O
, , O
SPECT NNP O
was VBD O
not RB O
as RB O
sensitive JJ O
as IN O
PET NNP O
in IN O
this DT O
activation NN O
task NN O
. . O

A DT O
. . O

This DT O
mutant NN O
was VBD O
identified VBN O
by IN O
screening VBG O
with IN O
a DT O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
- : O
inducible JJ O
vector NN O
a DT O
series NN O
of IN O
mink NN O
lung NN O
epithelial JJ O
cell NN O
clones NNS O
that WDT O
have VBP O
normal JJ O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
binding NN O
activity NN O
but CC O
have VBP O
lost VBN O
antiproliferative JJ O
and CC O
transcriptional JJ O
responses NNS O
to TO O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
. . O

Regulation NN O
at IN O
37 CD O
degrees NNS O
C NNP O
, , O
therefore RB O
, , O
involves VBZ O
the DT O
action NN O
of IN O
three CD O
protein NNS O
kinase VBD O
cascades NNS O
that IN O
repress NN O
HSF1 NNP B-Gene
through IN O
phosphorylation NN O
of IN O
serine NN O
residues NNS O
303 CD O
, , O
307 CD O
, , O
and CC O
363 CD O
and CC O
may MD O
promote VB O
growth NN O
by IN O
suppressing VBG O
the DT O
heat NN O
shock NN O
response NN O
. . O

To TO O
characterize VB O
the DT O
gene NN O
products NNS O
, , O
the DT O
cvaA NN B-Gene
gene NN I-Gene
was VBD O
subcloned VBN O
and CC O
expressed VBN O
under IN O
the DT O
control NN O
of IN O
T7 NNP B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
promoter NN I-Gene
. . O

We PRP O
have VBP O
now RB O
located VBN O
the DT O
5 CD O
' POS O
ends NNS O
of IN O
the DT O
two CD O
remaining VBG O
late JJ O
mRNAs NN O
. . O

In IN O
about RB O
one CD O
third NN O
of IN O
the DT O
cases NNS O
this DT O
operation NN O
results NNS O
in IN O
tonal JJ O
and CC O
vocal JJ O
improvement NN O
for IN O
patients NNS O
suffering VBG O
from IN O
progressive JJ O
perceptive JJ O
deafness NN O
. . O

In IN O
the DT O
duodenum NN O
a DT O
small JJ O
part NN O
of IN O
the DT O
administered VBN O
dose NN O
was VBD O
transformed VBN O
to TO O
3H CD O
- : O
alpha NN O
- : O
acetyldigoxin NN O
. . O

Estimation NN O
of IN O
renin JJ B-Gene
secretion NN O
rate NN O
and CC O
renal JJ O
plasma NN O
flow NN O
from IN O
peripheral JJ O
and CC O
renal JJ B-Gene
vein NN I-Gene
renin NN I-Gene
levels NNS O
. . O

By IN O
stepwise NN O
linear JJ O
multiple JJ O
regression NN O
analysis NN O
, , O
ionized JJ O
magnesium NN O
was VBD O
significantly RB O
related VBN O
to TO O
cyclosporin VB O
trough JJ O
level NN O
and CC O
total JJ O
cholesterol NN O
but CC O
not RB O
to TO O
serum VB O
creatinine NN O
, , O
time NN O
after IN O
transplant NN O
or CC O
the DT O
dose NN O
of IN O
cyclosporin NN O
. . O

In IN O
an DT O
attempt NN O
to TO O
reduce VB O
the DT O
incidence NN O
of IN O
NSAID NNP O
- : O
induced VBD O
gastrointestinal JJ O
lesions NNS O
, , O
the DT O
following JJ O
approaches NNS O
have VBP O
been VBN O
proposed VBN O
: : O
( ( O
i NN O
) ) O
use NN O
of IN O
the DT O
prostaglandin NN O
analogue NN O
misoprostol NN O
, , O
which WDT O
is VBZ O
an DT O
antiulcer JJ O
drug NN O
which WDT O
has VBZ O
been VBN O
proven VBN O
to TO O
be VB O
as IN O
effective JJ O
in IN O
the DT O
prevention NN O
of IN O
NSAID NNP O
- : O
induced VBD O
gastric JJ O
and CC O
duodenal JJ O
ulcers NNS O
as IN O
in IN O
the DT O
reduction NN O
of IN O
serious JJ O
upper JJ O
gastrointestinal JJ O
complications NNS O
; : O
( ( O
ii NN O
) ) O
histamine NN B-Gene
H2 NNP I-Gene
receptor NN I-Gene
antagonists NNS O
( ( O
H2 NNP O
antagonists NNS O
) ) O
, , O
e RB O
. . O
g NN O
. . O
ranitidine NN O
, , O
cimetidine NN O
and CC O
famotidine NN O
, , O
which WDT O
are VBP O
useful JJ O
in IN O
the DT O
prevention NN O
of IN O
NSAID NNP O
- : O
induced VBD O
duodenal JJ O
ulcers NNS O
during IN O
long JJ O
term NN O
treatment NN O
, , O
but CC O
not RB O
in IN O
the DT O
prevention NN O
of IN O
NSAID NNP O
- : O
induced VBD O
gastric JJ O
ulcers NNS O
; : O
( ( O
iii NN O
) ) O
proton NN O
pump NN O
inhibitors NNS O
, , O
e NN O
. . O
g JJ O
omeprazole NN O
, , O
and CC O
pantoprazole NN O
, , O
whose WP$ O
efficacy NN O
in IN O
preventing VBG O
NSAID NNP O
- : O
associated VBN O
ulcers NNS O
has VBZ O
been VBN O
recently RB O
demonstrated VBN O
; : O
and CC O
( ( O
iv NN O
) ) O
barrier NN O
agents NNS O
, , O
e NN O
. . O
g NN O
. . O
sucralfate NN O
, , O
which WDT O
cannot VBP O
be VB O
recommended VBN O
as IN O
prophylactic JJ O
agents NNS O
to TO O
prevent VB O
NSAID NNP O
- : O
induced VBD O
gastropathy JJ O
. . O

UAS1 NNP O
is VBZ O
the DT O
binding NN O
site NN O
for IN O
the DT O
transcriptional JJ O
regulator NN O
Adr1p NNP B-Gene
. . O

Further JJ O
studies NNS O
on IN O
a DT O
"""" JJ O
new JJ O
"""" NNP O
human NN O
isoprecipitin NN B-Gene
system NN O
( ( O
Australia NNP O
antigen NN O
) ) O
. . O

Forced NNP O
expression NN O
of IN O
BZAP45 NNP B-Gene
strongly RB O
stimulates VBZ O
H4 NNP B-Gene
promoter NN I-Gene
( ( O
nt JJ O
- : O
215 CD O
to TO O
- : O
1 CD O
) ) O
/ FW O
CAT NNP B-Gene
reporter NN O
gene NN O
activity NN O
. . O

Focused JJ O
beams NNS O
of IN O
classical JJ O
light NN O
ablate JJ O
elements NNS O
of IN O
the DT O
cell NN O
division NN O
machinery NN O
and CC O
switch VB O
the DT O
beating NN O
of IN O
hearts NNS O
on IN O
a DT O
cellular JJ O
basis NN O
. . O

Comparison NNP O
of IN O
the DT O
sequences NNS O
of IN O
attP NN B-Gene
, , O
attB NN B-Gene
and CC O
bacteria SYM O
- : O
prophage NN O
junctions NNS O
attL VBP B-Gene
and CC O
attR VBP B-Gene
showed VBD O
a DT O
26 CD O
bp JJ O
common JJ O
core NN O
sequence NN O
, , O
where WRB O
recombination NN O
takes VBZ O
place NN O
, , O
near IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
integrase NN B-Gene
gene NN I-Gene
. . O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
HSF NNP B-Gene
in IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe NN O
. . O

This DT O
compares VBZ O
favorably RB O
to TO O
results NNS O
of IN O
similarly RB O
sized VBN O
melanomas NN O
treated VBN O
by IN O
enucleation NN O
. . O

Furthermore RB O
, , O
the DT O
amount NN O
of IN O
tRNA NN B-Gene
( ( I-Gene
3Lys CD I-Gene
) ) I-Gene
that WDT O
was VBD O
placed VBN O
onto IN O
viral JJ O
RNA NNP O
in IN O
mutated JJ O
viruses NNS O
was VBD O
significantly RB O
less JJR O
than IN O
that DT O
placed VBN O
in IN O
the DT O
wild JJ O
- : O
type NN O
virus NN O
. . O

Prazosin NNP O
alone RB O
was VBD O
effective JJ O
in IN O
volume NN O
responsive JJ O
patients NNS O
at IN O
a DT O
dose NN O
of IN O
5 CD O
+ NNS O
/ SYM O
- : O
1 CD O
. . O
0 CD O
mg JJ O
daily RB O
. . O

BRCA1 NNP B-Gene
, , O
a DT O
familial JJ O
breast NN O
and CC O
ovarian JJ O
cancer NN O
susceptibility NN O
gene NN O
encodes NNS O
nuclear JJ O
phosphoproteins NNS O
that WDT O
function VBP O
as IN O
tumor NN O
suppressors NNS O
in IN O
human JJ O
breast NN O
cancer NN O
cells NNS O
. . O

Anatomy NNP O
of IN O
the DT O
RNA NNP O
and CC O
gene NN O
products NNS O
of IN O
MC29 NNP O
and CC O
MH2 NNP O
, , O
two CD O
defective JJ O
avian JJ O
tumor NN O
viruses NNS O
causing VBG O
acute JJ O
leukemia NN O
and CC O
carcinoma NN O
: : O
evidence NN O
for IN O
a DT O
new JJ O
class NN O
of IN O
transforming VBG O
genes NNS O
. . O

Patients NNS O
receiving VBG O
VPA NNP O
showed VBD O
differences NNS O
in IN O
attention NN O
, , O
visuomotor NN O
performance NN O
, , O
verbal JJ O
span NN O
and CC O
sensory JJ O
discrimination NN O
tasks NNS O
at IN O
T1 NNP O
, , O
in IN O
visuomotor NN O
performance NN O
at IN O
T2 NNP O
and CC O
in IN O
spatial JJ O
span NN O
at IN O
T3 NNP O
, , O
whereas VBZ O
no DT O
differences NNS O
were VBD O
detected VBN O
at IN O
T4 NNP O
. . O

We PRP O
studied VBD O
GSH NNP O
- : O
Px NNP O
enzyme NN O
activity NN O
in IN O
serum NN O
after IN O
acute JJ O
myocardial JJ O
infarction NN O
( ( O
AMI NNP O
) ) O
and CC O
unstable JJ O
angina NN O
pectoris NN O
( ( O
UAP NNP O
) ) O
. . O

Finally RB O
, , O
a DT O
role NN O
for IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
in IN O
preventing VBG O
apoptosis NN O
induced VBN O
by IN O
ER NNP O
calcium NN O
release NN O
was VBD O
demonstrated VBN O
by IN O
data NNS O
showing VBG O
that IN O
sAPPalpha JJ B-Gene
prevents NNS O
thapsigargin VBP O
- : O
induced JJ O
apoptosis NN O
, , O
an DT O
effect NN O
blocked VBN O
by IN O
kappaB NN B-Gene
decoy NN O
DNA NNP O
. . O

All DT O
three CD O
genes NNS O
have VBP O
been VBN O
mapped VBN O
precisely RB O
to TO O
a DT O
small JJ O
region NN O
on IN O
human JJ O
chromosome NN O
16p12 CD O
. . O
1 CD O
- : O
p11 NN O
. . O
2 CD O
( ( O
homologous JJ O
to TO O
mouse VB O
chromosome NN O
7 CD O
) ) O
, , O
using VBG O
somatic JJ O
cell NN O
hybrids NNS O
and CC O
cosmid JJ O
clones NNS O
. . O

Significance NN O
of IN O
the DT O
biopsy NN O
site NN O
of IN O
the DT O
latissimus NN O
dorsi NN O
muscle NN O
for IN O
fiber NN O
typing NN O
. . O

As IN O
an DT O
application NN O
of IN O
reverse NN O
genetics NNS O
, , O
we PRP O
introduced VBD O
one CD O
nucleotide NN O
change NN O
( ( O
UCU NNP O
to TO O
ACU NNP O
) ) O
to TO O
immediate VB O
downstream NN O
of IN O
the DT O
RNA NNP O
- : O
editing VBG O
site NN O
of IN O
the DT O
V NNP B-Gene
gene NN I-Gene
in IN O
the DT O
full JJ O
- : O
length NN O
hPIV2 NN O
cDNA NN O
and CC O
were VBD O
able JJ O
to TO O
obtain VB O
infectious JJ O
viruses NNS O
[ VBP O
rPIV2V NN O
( ( O
- : O
) ) O
] NN O
from IN O
the DT O
cDNA NN O
. . O

Roles NNS O
of IN O
the DT O
Candida NNP B-Gene
albicans NNS I-Gene
mitogen VBP I-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
homolog NN I-Gene
, , O
Cek1p NNP B-Gene
, , O
in IN O
hyphal NN O
development NN O
and CC O
systemic JJ O
candidiasis NN O
. . O

Deletion NNP O
mapping NN O
of IN O
the DT O
human JJ B-Gene
presenilin NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
PS1 NNP B-Gene
) ) O
promoter NN O
delineated VBN O
the DT O
most RBS O
active JJ O
fragment NN O
from IN O
- : O
118 CD O
to TO O
+ VB O
178 CD O
in IN O
relation NN O
to TO O
the DT O
transcription NN O
start NN O
site NN O
mapped VBN O
in IN O
this DT O
study NN O
, , O
in IN O
both DT O
human JJ O
neuroblastoma NN O
SK NNP O
- : O
N NNP O
- : O
SH NN O
and CC O
hepatoma NN O
HepG2 NNP O
cells NNS O
. . O

In IN O
about RB O
770 CD O
bp NN O
upstream JJ O
region NN O
of IN O
Spam1 NNP B-Gene
that WDT O
has VBZ O
been VBN O
cloned VBN O
and CC O
sequenced VBN O
, , O
multiple JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
including VBG O
a DT O
CRE NNP O
( ( O
cAMP SYM O
- : O
responsive JJ O
element NN O
) ) O
were VBD O
found VBN O
. . O

Vaccinia NNP O
virus SYM O
- : O
expressed VBN O
, , O
purified VBN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
HPV NNP I-Gene
- : I-Gene
16 CD I-Gene
and CC I-Gene
BPV NNP I-Gene
- : I-Gene
1 CD I-Gene
E2 NNP I-Gene
proteins NNS I-Gene
bound VBD O
a DT O
consensus NN O
E2 NNP B-Gene
site NN I-Gene
with IN O
high JJ O
specific JJ O
affinities NNS O
( ( O
Kd NNP O
= NNP O
approximately RB O
10 CD O
( ( O
- : O
9 CD O
) ) O
M NNP O
) ) O
and CC O
stimulated VBN O
in IN O
vitro NN O
transcription NN O
up IN O
to TO O
six CD O
- : O
to TO O
eightfold VB O
. . O

5 CD O
) ) O
Before IN O
and CC O
ten VB O
days NNS O
after IN O
DOTC NNP O
infusion NN O
, , O
laboratory NN O
tests NNS O
for IN O
liver NN O
and CC O
renal JJ O
functions NNS O
and CC O
blood NN O
were VBD O
performed VBN O
. . O

Clinical JJ O
aspects NNS O
of IN O
early JJ O
increase NN O
in IN O
serum JJ O
gamma NN B-Gene
- : I-Gene
glutamyl NN I-Gene
transferase NN I-Gene
in IN O
cerebral JJ O
infarction NN O
. . O

The DT O
P NNP B-Gene
mRNA NN I-Gene
also RB O
contains VBZ O
a DT O
third JJ O
ORF NNP O
for IN O
the DT O
V NNP B-Gene
protein NN I-Gene
, , O
although IN O
it PRP O
is VBZ O
unclear JJ O
how WRB O
or CC O
whether IN O
this DT O
ORF NNP O
is VBZ O
accessed VBN O
. . O

Thereafter RB O
, , O
the DT O
aggregation NN O
rose VBD O
to TO O
the DT O
initial JJ O
100 CD O
% NN O
value NN O
4 CD O
h NN O
after IN O
drug NN O
application NN O
and CC O
remained VBD O
at IN O
this DT O
level NN O
during IN O
the DT O
observation NN O
period NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

RESULTS NN O
: : O
The DT O
bilinear JJ O
model NN O
provided VBD O
a DT O
significantly RB O
better JJR O
fit NN O
to TO O
the DT O
acuity NN O
outcome NN O
data NNS O
. . O

We PRP O
have VBP O
used VBN O
these DT O
modified VBN O
assay VBP O
conditions NNS O
to TO O
extend VB O
studies NNS O
on IN O
the DT O
transposition NN O
pathway NN O
. . O

The DT O
p36 NN B-Gene
gene NN I-Gene
is VBZ O
at IN O
least JJS O
22 CD O
kb NN O
in IN O
length NN O
and CC O
has VBZ O
a DT O
coding VBG O
sequence NN O
of IN O
approximately RB O
1 CD O
kb NNS O
, , O
representing VBG O
only RB O
4 CD O
. . O
5 CD O
% NN O
of IN O
the DT O
gene NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Sequence NNP O
analysis NN O
of IN O
these DT O
genes NNS O
and CC O
their PRP$ O
surrounding NN O
sequences NNS O
are VBP O
presented VBN O
and CC O
compared VBN O
with IN O
other JJ O
known VBN O
tRNA JJ O
genes NNS O
from IN O
plant NN O
mitochondria NN O
. . O

Analysis NN O
of IN O
the DT O
E2F1 NNP B-Gene
gene NN I-Gene
promoter NN I-Gene
showed VBD O
that IN O
the DT O
- : O
146 CD O
to TO O
- : O
54 CD O
region NN O
was VBD O
required VBN O
for IN O
E2 NNP B-Gene
- : O
responsiveness NN O
in IN O
transient JJ O
transfection NN O
assays NNS O
, , O
and CC O
subsequent JJ O
deletion NN O
/ NNP O
mutation NN O
analysis NN O
showed VBD O
that IN O
a DT O
single JJ O
upstream NN O
GC NNP O
- : O
rich JJ O
and CC O
two CD O
downstream NN O
CCAAT NNP O
- : O
binding NN O
sites NNS O
were VBD O
required VBN O
for IN O
transactivation NN O
by IN O
E2 NNP B-Gene
. . O

Five CD O
experiments NNS O
examined VBD O
the DT O
influence NN O
of IN O
opiate NN O
antagonists NNS O
on IN O
both DT O
the DT O
short JJ O
- : O
term NN O
analgesic JJ O
reaction NN O
resulting VBG O
30 CD O
min NN O
after IN O
exposure NN O
to TO O
inescapable VB O
shock NN O
and CC O
the DT O
long JJ O
- : O
term NN O
analgesic JJ O
reaction NN O
resulting VBG O
after IN O
reexposure NN O
to TO O
shock VB O
24 CD O
hr NN O
after IN O
inescapable JJ O
shock NN O
exposure NN O
. . O

The DT O
overexpressed JJ O
His6 NNP B-Gene
- : I-Gene
tagged VBD I-Gene
GrsA NNP I-Gene
derivatives NNS I-Gene
were VBD O
affinity JJ O
- : O
purified VBN O
, , O
and CC O
the DT O
catalytic JJ O
properties NNS O
of IN O
the DT O
deletion NN O
mutants NNS O
were VBD O
examined VBN O
by IN O
biochemical JJ O
studies NNS O
including VBG O
ATP NNP O
- : O
dependent NN O
amino NN O
acid JJ O
activation NN O
, , O
carboxyl VBP O
thioester NN O
formation NN O
, , O
and CC O
the DT O
ability NN O
to TO O
racemize VB O
the DT O
covalently RB O
bound VBN O
phenylalanine NN O
from IN O
L NNP O
- : O
to TO O
the DT O
D NNP O
- : O
isomer NN O
. . O

None NN O
of IN O
these DT O
organic JJ O
manifestations NNS O
was VBD O
discovered VBN O
by IN O
scintigraphic JJ O
means NNS O
. . O

This DT O
supports VBZ O
previous JJ O
arguments NNS O
for IN O
the DT O
improbability NN O
of IN O
biological JJ O
effects NNS O
at IN O
UHF NNP O
frequencies NNS O
unless IN O
a DT O
mechanism NN O
can MD O
be VB O
found VBN O
for IN O
accumulating VBG O
energy NN O
over IN O
time NN O
and CC O
space NN O
and CC O
focussing VBG O
it PRP O
. . O

The DT O
transcription NN O
initiation NN O
site NN O
was VBD O
determined VBN O
to TO O
occur VB O
66 CD O
bp JJ O
upstream NN O
of IN O
the DT O
initiating NN O
Met NNP O
. . O

Myosin NNP B-Gene
light NN I-Gene
chain NN I-Gene
kinase VBD I-Gene
functions NNS O
downstream NN O
of IN O
Ras NNP B-Gene
/ NNP O
ERK NNP B-Gene
to TO O
promote VB O
migration NN O
of IN O
urokinase JJ B-Gene
- : I-Gene
type NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
- : O
stimulated JJ O
cells NNS O
in IN O
an DT O
integrin JJ B-Gene
- : O
selective JJ O
manner NN O
. . O

Second JJ O
, , O
the DT O
membrane NN O
expression NN O
of IN O
alpha NN O
and CC O
beta NN O
subunits NNS O
was VBD O
mimicked VBN O
by IN O
cholesterol NN O
and CC O
17 CD O
- : O
ketocholesterol NN O
, , O
both DT O
of IN O
which WDT O
inhibit NN O
HMG NNP B-Gene
- : I-Gene
CoA NNP I-Gene
reductase NN I-Gene
. . O

Transcriptional NNP O
control NN O
signals NNS O
of IN O
a DT O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
type VBD I-Gene
1 CD I-Gene
late JJ I-Gene
( ( I-Gene
gamma JJ I-Gene
2 CD I-Gene
) ) I-Gene
gene NN I-Gene
lie NN O
within IN O
bases NNS O
- : O
34 CD O
to TO O
+ VB O
124 CD O
relative JJ O
to TO O
the DT O
5 CD O
' POS O
terminus NN O
of IN O
the DT O
mRNA NN O
. . O

Deletion NN O
analysis NN O
showed VBD O
that IN O
the DT O
- : O
321 CD O
/ JJ O
+ $ O
41 CD O
sequence NN O
was VBD O
sufficient JJ O
for IN O
both DT O
the DT O
constitutive JJ O
promoter NN O
activity NN O
and CC O
auto NN O
- : O
activation NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
identified VBD O
the DT O
interaction NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBPs NNP I-Gene
and CC O
Sp1 NNP B-Gene
to TO O
this DT O
region NN O
. . O

Regulation NN O
of IN O
ASN1 NNP B-Gene
and CC O
ASN2 NNP B-Gene
expression NN O
was VBD O
studied VBN O
using VBG O
lacZ JJ B-Gene
fusions NNS I-Gene
and CC O
both DT O
genes NNS O
were VBD O
found VBN O
to TO O
be VB O
several JJ O
times NNS O
less RBR O
expressed VBN O
in IN O
the DT O
absence NN O
of IN O
the DT O
transcription NN O
activator NN O
Gcn4p NNP B-Gene
. . O

Hand NNP O
- : O
held NN O
, , O
continuous JJ O
- : O
wave NN O
Doppler NNP O
probes NN O
, , O
coupled VBN O
with IN O
sound JJ O
spectral JJ O
analysis NN O
, , O
can MD O
successfully RB O
predict VB O
carotid NN O
artery NN O
stenosis NN O
. . O

The DT O
complete JJ O
gene NN O
organization NN O
was VBD O
obtained VBN O
by IN O
combining VBG O
the DT O
results NNS O
of IN O
the DT O
sequence NN O
of IN O
these DT O
clones NNS O
and CC O
those DT O
of IN O
the DT O
characterization NN O
of IN O
polymerase NN O
chain NN O
reaction NN O
- : O
amplified JJ O
genomic JJ O
segments NNS O
. . O

The DT O
position NN O
of IN O
the DT O
analyst NN O
as IN O
expert NN O
: : O
yesterday NN O
and CC O
today NN O
. . O

The DT O
encoded JJ O
amino NN O
acid NN O
sequences NNS O
in IN O
the DT O
full JJ O
- : O
length NN O
bovine NN O
and CC O
porcine NN O
cDNAs NN O
were VBD O
identical JJ O
, , O
consisting VBG O
of IN O
209 CD O
amino NN O
acid NN O
residues NNS O
, , O
and CC O
were VBD O
nearly RB O
the DT O
same JJ O
as IN O
the DT O
published VBN O
sequence NN O
determined VBN O
by IN O
Edman NNP O
degradation NN O
. . O

In IN O
3Y1 CD O
and CC O
3Y1 CD O
v NN B-Gene
- : I-Gene
crk NN I-Gene
- : O
transformed JJ O
fibroblasts NNS O
, , O
almost RB O
all DT O
of IN O
the DT O
total JJ O
PTP1B NNP B-Gene
and CC O
about RB O
40 CD O
% NN O
of IN O
total JJ O
p130 NN B-Gene
( ( O
Cas NNP B-Gene
) ) O
co VBP O
- : O
sediment NN O
with IN O
membranes NNS O
composed VBN O
primarily RB O
of IN O
endoplasmic JJ O
reticulum NN O
. . O

Green JJ O
fluorescent NN O
protein NN O
- : O
tagged VBN O
UNC NNP B-Gene
- : I-Gene
49B CD I-Gene
and CC O
UNC NNP B-Gene
- : I-Gene
49C CD I-Gene
subunits NNS I-Gene
are VBP O
coexpressed VBN O
in IN O
muscle NN O
cells NNS O
and CC O
are VBP O
colocalized VBN O
to TO O
synaptic JJ O
regions NNS O
. . O

Treatment NN O
of IN O
hypertension NN O
with IN O
a DT O
combination NN O
of IN O
the DT O
adrenergic JJ B-Gene
beta NN I-Gene
receptor NN I-Gene
blockader NN O
, , O
obsidan NN O
, , O
and CC O
the DT O
vasodilator NN O
, , O
apressin NN O

Lower JJR O
limits NNS O
( ( O
to TO O
10 CD O
micrograms NNS O
/ NNP O
kg NN O
) ) O
were VBD O
detectable JJ O
, , O
but CC O
with IN O
lower JJR O
reliability NN O
( ( O
60 CD O
% NN O
) ) O
. . O

How WRB O
do VB O
graduates NNS O
of IN O
different JJ O
types NNS O
of IN O
programs NNS O
perform VBP O
on IN O
state NN O
boards NNS O
? . O

In IN O
a DT O
third JJ O
experiment NN O
, , O
crossover NN O
AM NNP O
between IN O
dissimilar JJ O
textures NNS O
was VBD O
investigated VBN O
, , O
and CC O
it PRP O
was VBD O
found VBN O
that IN O
the DT O
more RBR O
salient JJ O
textures NNS O
carried VBD O
the DT O
AM NNP O
. . O

The DT O
hypBFCDE NN B-Gene
operon NN I-Gene
from IN O
Rhizobium NNP O
leguminosarum NN O
biovar NN O
viciae NN O
is VBZ O
expressed VBN O
from IN O
an DT O
Fnr NNP B-Gene
- : I-Gene
type NN I-Gene
promoter NN I-Gene
that WDT O
escapes VBZ O
mutagenesis NN O
of IN O
the DT O
fnrN JJ B-Gene
gene NN I-Gene
. . O

Experience NN O
with IN O
xylene NNP O
- : O
free JJ O
sections NNS O
since IN O
1995 CD O
at IN O
the DT O
Vrinnevi NNP O
Hospital NNP O
is VBZ O
favorable JJ O
. . O

The DT O
remaining VBG O
RAD NNP B-Gene
+ NNP I-Gene
cells NNS O
progressed VBD O
to TO O
form VB O
microcolonies NNS O
( ( O
< $ O
30 CD O
cells NNS O
) ) O
containing VBG O
aberrantly RB O
shaped VBN O
inviable JJ O
cells NNS O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
reduced JJ O
levels NNS O
of IN O
choline JJ B-Gene
acetyltransferase NN I-Gene
activity NN O
in IN O
the DT O
cerebral JJ O
cortex NN O
of IN O
patients NNS O
who WP O
died VBD O
after IN O
a DT O
head JJ O
injury NN O
, , O
demonstrating VBG O
that IN O
there EX O
is VBZ O
a DT O
loss NN O
of IN O
cortical JJ O
cholinergic JJ O
innervation NN O
. . O

CONCLUSION NN O
: : O
Rheumatic JJ O
fever NN O
in IN O
the DT O
Nazareth NNP O
area NN O
is VBZ O
still RB O
manifest JJS O
. . O

Interferon NNP B-Gene
stimulated VBD I-Gene
gene NN I-Gene
factor NN I-Gene
3 CD I-Gene
( ( O
ISGF3 NNP B-Gene
) ) O
is VBZ O
a DT O
trimeric JJ O
transcription NN O
factor NN O
activated VBD O
on IN O
treatment NN O
of IN O
cells NNS O
with IN O
interferon NN B-Gene
- : I-Gene
alpha NN I-Gene
and CC I-Gene
beta NN I-Gene
( ( O
type NN B-Gene
I PRP I-Gene
IFNs NNP I-Gene
) ) O
. . O

All DT O
were VBD O
tested VBN O
for IN O
serum NN O
ferritin NN B-Gene
( ( O
SF NNP B-Gene
) ) O
, , O
hemoglobin FW B-Gene
( ( O
Hb NNP B-Gene
) ) O
level NN O
and CC O
asked VBD O
for IN O
detailed JJ O
histories NNS O
of IN O
donations NNS O
and CC O
iron NN O
supplementation NN O
. . O

DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
analyses NNS O
revealed VBD O
two CD O
hepatocyte JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
HNF1 NNP B-Gene
) ) O
, , O
three CD O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) O
, , O
and CC O
one CD O
consensus NN O
palindromic JJ O
thyroid NN O
hormone NN O
response NN O
elements NNS O
within IN O
the DT O
first JJ O
215 CD O
base NN O
pairs NN O
( ( O
bp NN O
) ) O
of IN O
the DT O
promoter NN O
sequence NN O
of IN O
rat NN B-Gene
Std NNP I-Gene
. . O

Influence NN O
of IN O
cigarette NN O
smoking NN O
on IN O
some DT O
blood NN O
coagulation NN O
tests NNS O
. . O

Synthetic JJ O
oligonucleotides NNS O
representing VBG O
the DT O
19 CD O
bp NN O
repeat NN O
unit NN O
strongly RB O
reduced VBD O
the DT O
activity NN O
of IN O
the DT O
IE1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
enhancer NN I-Gene
/ NN I-Gene
promoter NN I-Gene
in IN O
cotransfection NN O
assays NNS O
after IN O
transient JJ O
expression NN O
. . O

The DT O
femoroarterial JJ O
coronary JJ O
sinus NN O
difference NN O
in IN O
lactate NN O
turned VBD O
negative JJ O
, , O
and CC O
pH NN O
, , O
PCO2 NNP O
and CC O
potassium NN O
differences NNS O
increased VBD O
in IN O
group NN O
2 CD O
during IN O
pacing NN O
. . O

The DT O
pathogenesis NN O
of IN O
Limited NNP O
Joint NNP O
Mobility NNP O
( ( O
LJM NNP O
) ) O
in IN O
diabetes NN O
is VBZ O
unknown JJ O
, , O
but CC O
the DT O
abnormality NN O
is VBZ O
said VBD O
to TO O
be VB O
associated VBN O
with IN O
an DT O
increased JJ O
incidence NN O
of IN O
microangiopathy NN O
. . O

Moreover RB O
, , O
when WRB O
added VBN O
to TO O
the DT O
osteoclast NN O
cultures NNS O
, , O
mrIhh SYM B-Gene
- : I-Gene
N NNP I-Gene
markedly RB O
stimulated VBD O
the DT O
formation NN O
of IN O
resorption NN O
pits NNS O
on IN O
dentine NN O
slices NNS O
. . O

Cytosolic JJ O
extracts NNS O
from IN O
a DT O
variety NN O
of IN O
mammalian JJ O
cell NN O
lines NNS O
( ( O
monkey JJ O
Cos7 NNP O
, , O
several JJ O
mouse NN O
fibrosarcomas NN O
and CC O
human JJ O
HeLa NNP O
S3 NNP O
) ) O
demonstrated VBD O
similar JJ O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
1 CD I-Gene
dependent NN O
RNA NNP O
- : O
protein NN O
band NN O
shifts NNS O
as IN O
cell NN O
extract NN O
from IN O
BALB NNP O
/ NNP O
c VBD O
3T3 CD O
mouse NN O
fibroblasts NNS O
. . O

The DT O
protein NN O
is VBZ O
composed VBN O
of IN O
two CD O
major JJ O
domains NNS O
separated VBN O
by IN O
a DT O
hydrophobic JJ O
linker NN O
region NN O
of IN O
20 CD O
amino NN O
acid NN O
residues NNS O
. . O

Finally RB O
, , O
nonphotosynthetic JJ O
mutants NNS O
, , O
including VBG O
the DT O
tscA NN B-Gene
- : I-Gene
lacking VBG I-Gene
photosystem NN I-Gene
I PRP I-Gene
mutant VBP I-Gene
, , O
H13 NNP O
, , O
did VBD O
not RB O
show VB O
evidence NN O
of IN O
light JJ O
- : O
stimulated VBN O
RNA NNP O
processing NN O
. . O

The DT O
gene NN B-Gene
encoding VBG I-Gene
human JJ I-Gene
tissue NN I-Gene
- : I-Gene
type NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
t JJ B-Gene
- : I-Gene
PA NN I-Gene
) ) O
is VBZ O
regulated VBN O
in IN O
a DT O
cell NN O
- : O
type NN O
- : O
specific JJ O
manner NN O
. . O

Blood NNP O
pressure NN O
also RB O
was VBD O
increased VBN O
by IN O
lidocaine NN O
( ( O
6 CD O
mg NN O
kg SYM O
- : O
1 CD O
) ) O
. . O

Thus RB O
, , O
the DT O
bovine NN B-Gene
PEDF NNP I-Gene
cDNA NN I-Gene
isolated VBD O
here RB O
codes NNS O
for IN O
a DT O
functional JJ O
soluble JJ O
secreted VBN B-Gene
PEDF NNP I-Gene
glycoprotein NN I-Gene
. . O

The DT O
mature NN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
mRNA NN I-Gene
is VBZ O
spliced VBN O
from IN O
7 CD O
exons NNS O
distributed VBN O
over IN O
a DT O
region NN O
of IN O
18 CD O
kb NNS O
genomic JJ O
DNA NNP O
. . O

These DT O
studies NNS O
show VBP O
that IN O
UCRBP NNP B-Gene
binds VBZ O
to TO O
various JJ O
target NN O
motifs NNS O
that WDT O
are VBP O
distinct JJ O
from IN O
the DT O
UCR NNP O
motif NN O
: : O
the DT O
adeno JJ B-Gene
- : I-Gene
associated VBN I-Gene
virus NN I-Gene
P5 NNP I-Gene
promoter NN I-Gene
and CC O
elements NNS O
in IN O
the DT O
immunoglobulin NN B-Gene
light JJ I-Gene
- : I-Gene
and CC I-Gene
heavy JJ I-Gene
- : I-Gene
chain NN I-Gene
genes NNS O
, , O
as RB O
well RB O
as IN O
elements NNS O
in IN O
ribosomal JJ B-Gene
protein NN I-Gene
genes NNS I-Gene
. . O

However RB O
, , O
little JJ O
was VBD O
understood VBN O
about IN O
the DT O
normal JJ O
function NN O
of IN O
CREB NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
mammalian JJ O
development NN O
or CC O
organ JJ O
physiology NN O
. . O

Thus RB O
, , O
depending VBG O
on IN O
their PRP$ O
location NN O
, , O
psoralen VBN O
cross SYM O
- : O
links NNS O
affected VBD O
different JJ O
steps NNS O
in IN O
the DT O
initiation NN O
process NN O
. . O

As IN O
it PRP O
had VBD O
been VBN O
previously RB O
reported VBN O
that IN O
the DT O
18 CD O
- : O
bp NN O
palindrome NN O
contains VBZ O
sufficient JJ O
nucleotide RB O
sequence NN O
information NN O
for IN O
E1 NNP B-Gene
binding NN O
, , O
we PRP O
speculate VBP O
that IN O
a DT O
minimal JJ O
E1 NNP B-Gene
recognition NN O
motif NN O
is VBZ O
presented VBN O
in IN O
each DT O
half NN O
site NN O
. . O

This DT O
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
315 CD O
- : O
residue JJ O
protein NN O
containing VBG O
seven CD O
hydrophobic JJ O
helical JJ O
regions NNS O
and CC O
a DT O
17 CD O
amino NN O
acid NN O
motif FW O
characteristic NN O
of IN O
the DT O
R7G NNP B-Gene
family NN I-Gene
of IN O
G NNP B-Gene
- : I-Gene
protein NN I-Gene
coupled VBD I-Gene
membrane SYM I-Gene
- : I-Gene
bound NN I-Gene
receptors NNS I-Gene
. . O

The DT O
second JJ O
primary JJ O
mutant NN O
contained VBD O
a DT O
proline NN O
- : O
to TO O
- : O
leucine NN O
change NN O
at IN O
position NN O
243 CD O
( ( O
P243L NNP O
) ) O
. . O

The DT O
genomic JJ O
fragments NNS O
were VBD O
fused VBN O
upstream NN O
of IN O
the DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
. . O

The DT O
mean JJ O
jitter NN O
and CC O
the DT O
fiber NN O
density NN O
did VBD O
not RB O
change VB O
significantly RB O
from IN O
day NN O
0 CD O
( ( O
30 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
6 CD O
microseconds NNS O
; : O
1 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
) ) O
to TO O
day NN O
30 CD O
( ( O
34 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
7 CD O
microseconds NNS O
; : O
1 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
13 CD O
) ) O
. . O

In IN O
this DT O
report NN O
we PRP O
describe VBP O
for IN O
the DT O
first JJ O
time NN O
the DT O
complete JJ O
primary JJ O
structure NN O
of IN O
type NN B-Gene
X NNP I-Gene
collagen NN I-Gene
, , O
based VBN O
on IN O
cloning NN O
and CC O
sequencing NN O
of IN O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
. . O

Patients NNS O
with IN O
antibody JJ O
peaks NNS O
, , O
defined VBD O
as IN O
fivefold NN O
or CC O
higher JJR O
increase NN O
in IN O
antibody NN O
titer NN O
compared VBN O
to TO O
the DT O
lowest JJS O
antibody NN O
titer NN O
over IN O
the DT O
course NN O
of IN O
GBS NNP O
, , O
had VBD O
higher JJR O
disability NN O
scores NNS O
during IN O
the DT O
first JJ O
two CD O
weeks NNS O
of IN O
GBS NNP O
and CC O
a DT O
worse JJR O
clinical JJ O
outcome NN O
( ( O
anti JJ B-Gene
- : I-Gene
GM1 NNP I-Gene
IgG NNP I-Gene
and CC O
anti SYM B-Gene
- : I-Gene
GD1a NNP I-Gene
IgM NNP I-Gene
antibody NN I-Gene
peaks NNS O
) ) O
and CC O
axonal JJ O
damage NN O
( ( O
anti JJ B-Gene
- : I-Gene
GD1a NNP I-Gene
IgM NNP I-Gene
antibody NN I-Gene
peaks NNS O
) ) O
, , O
compared VBN O
to TO O
patients NNS O
without IN O
peak JJ O
antibody NN O
titers NNS O
. . O

Airway NNP O
pressure NN O
and CC O
air NN O
flow NN O
were VBD O
measured VBN O
at IN O
the DT O
endotracheal NN O
tube NN O
in IN O
13 CD O
children NNS O
on IN O
a DT O
variety NN O
of IN O
ventilators NNS O
. . O

A DT O
potential JJ O
outcome NN O
of IN O
these DT O
biochemical JJ O
effects NNS O
may MD O
include VB O
the DT O
limited JJ O
responsiveness NN O
of IN O
infected JJ O
T NNP O
cells NNS O
to TO O
antigenic JJ O
stimulation NN O
observed VBD O
during IN O
HIV NNP O
- : O
1 CD O
infection NN O
. . O

Results NNS O
of IN O
two CD O
- : O
hybrid NN O
assays NNS O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
strongly RB O
suggest VBP O
that IN O
all DT O
HD NNP B-Gene
- : I-Gene
Zip NNP I-Gene
proteins NNS I-Gene
of IN O
families NNS O
I PRP O
and CC O
II NNP O
can MD O
form VB O
homodimers NNS O
and CC O
also RB O
heterodimers NNS O
with IN O
all DT O
HD NNP B-Gene
- : I-Gene
Zip NNP I-Gene
proteins NNS I-Gene
of IN O
the DT O
same JJ O
family NN O
. . O

When WRB O
the DT O
blood NN O
pressure NN O
increase NN O
in IN O
response NN O
to TO O
smoking NN O
was VBD O
blunted VBN O
by IN O
nitroprusside JJ O
infusion NN O
, , O
there EX O
was VBD O
a DT O
striking JJ O
increase NN O
in IN O
muscle NN O
SNA NNP O
. . O

Vascular JJ B-Gene
endothelial JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
VEGF NNP B-Gene
) ) O
, , O
a DT O
potent JJ O
agonist NN O
secreted VBN O
by IN O
virtually RB O
all DT O
cells NNS O
, , O
controls NNS O
migration NN O
and CC O
division NN O
of IN O
vascular JJ O
endothelial JJ O
cells NNS O
. . O

A DT O
second JJ O
peptide NN O
( ( O
amino JJ O
acids NNS O
58 CD O
- : O
77 CD O
) ) O
also RB O
antagonized VBN O
p21 JJ B-Gene
- : O
activity NN O
, , O
but CC O
this DT O
peptide NN O
did VBD O
not RB O
affect VB O
the DT O
ability NN O
of IN O
p21 NN B-Gene
to TO O
interact VB O
with IN O
cyclin NN B-Gene
E NNP I-Gene
/ NNP O
Cdk2 NNP B-Gene
. . O

RESULTS NN O
: : O
During IN O
the DT O
stabilization NN O
period NN O
, , O
PaCO2 NNP O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
was VBD O
33 CD O
+ JJ O
/ NNP O
- : O
5 CD O
mm NN O
Hg NNP O
, , O
and CC O
arrhythmias NNS O
were VBD O
not RB O
detected VBN O
. . O

Three CD O
cDNAs NN O
encoding VBG O
basic JJ B-Gene
leucine NN I-Gene
zipper NN I-Gene
( ( I-Gene
bZIP NN I-Gene
) ) I-Gene
- : I-Gene
type NN I-Gene
ABRE NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
were VBD O
isolated VBN O
by IN O
using VBG O
the DT O
yeast NN O
one CD O
- : O
hybrid NN O
system NN O
and CC O
were VBD O
designated VBN O
AREB1 NNP B-Gene
, , O
AREB2 NNP B-Gene
, , O
and CC O
AREB3 NNP B-Gene
( ( O
ABA NNP B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
) ) O
. . O

This DT O
study NN O
reports VBZ O
the DT O
effects NNS O
of IN O
a DT O
preparation NN O
with IN O
50 CD O
micrograms NNS O
ethinyl VBP O
estradiol NN O
and CC O
2 CD O
mg NN O
cyproterone NN O
acetate NN O
on IN O
gonadotropins NNS B-Gene
, , O
prolactin NN B-Gene
, , O
testosterone NN O
, , O
sex NN B-Gene
hormone NN I-Gene
binding VBG I-Gene
globulin NN I-Gene
( ( O
SHBG NNP B-Gene
) ) O
, , O
androstenedione NN O
, , O
and CC O
calculated VBD O
free JJ O
testosterone NN O
index NN O
before IN O
and CC O
after IN O
six CD O
months NNS O
of IN O
treatment NN O
. . O

Current JJ O
status NN O
of IN O
zinc NN O
deficiency NN O
in IN O
the DT O
pathogenesis NN O
of IN O
neurological JJ O
, , O
dermatological JJ O
and CC O
musculoskeletal JJ O
disorders NNS O
. . O

As IN O
predicted VBN O
by IN O
the DT O
Wing NNP O
and CC O
Kristofferson NNP O
model NN O
, , O
the DT O
durations NNS O
of IN O
successive JJ O
ISIs NNP O
tended VBD O
to TO O
be VB O
negatively RB O
correlated VBN O
. . O

Common JJ O
history NN O
and CC O
prospects NNS O
in IN O
surgical JJ O
gynecology NN O
of IN O
the DT O
Charite NNP O
and CC O
the DT O
Vienna NNP O
University NNP O
Clinic NNP O

Polypeptide NNP O
growth NN O
factors NNS O
and CC O
cytokines NNS O
mediate VBP O
their PRP$ O
biochemical JJ O
functions NNS O
through IN O
their PRP$ O
responsive JJ O
receptors NNS O
. . O

No DT O
systematic JJ O
L NNP O
- : O
R NN O
differences NNS O
were VBD O
observed VBN O
. . O

Ent NNP B-Gene
- : I-Gene
kaurene NN I-Gene
synthase NN I-Gene
from IN I-Gene
the DT I-Gene
fungus NN I-Gene
Phaeosphaeria NNP I-Gene
sp NN O
. . O

Dose NNP O
of IN O
20 CD O
ig NNS O
were VBD O
administered VBN O
within IN O
a DT O
scheme NN O
from IN O
0 CD O
. . O
1 CD O
to TO O
6 CD O
months NNS O
in IN O
order NN O
to TO O
study VB O
its PRP$ O
immunogenicity NN O
, , O
which WDT O
was VBD O
evaluated VBN O
at IN O
2 CD O
, , O
7 CD O
, , O
and CC O
12 CD O
months NNS O
after IN O
the DT O
first JJ O
dose NN O
. . O

Six CD O
out IN O
of IN O
ten JJ O
hearts NNS O
from IN O
macerated VBN O
stillborn NN O
infants NNS O
showed VBD O
varying VBG O
degrees NNS O
of IN O
positive JJ O
staining NN O
. . O

Transient NN O
transfections NNS O
showed VBD O
that IN O
a DT O
single JJ O
mutation NN O
( ( O
556M CD O
) ) O
decreased VBD O
TBLV NNP B-Gene
enhancer NN I-Gene
activity NN O
at IN O
least JJS O
20 CD O
- : O
fold NN O
in IN O
two CD O
different JJ O
T NNP O
- : O
cell NN O
lines NNS O
. . O

In IN O
EEG NNP O
only RB O
single JJ O
slow JJ O
waves NNS O
above IN O
left JJ O
temporal JJ O
region NN O
were VBD O
revealed VBN O
. . O

Changes NNS O
induced VBN O
in IN O
the DT O
gills NNS O
of IN O
milkfish NN O
( ( O
Chanos NNP O
chanos VBP O
Forsskal NNP O
) ) O
fingerlings NNS O
after IN O
acute JJ O
exposure NN O
to TO O
nifurpirinol VB O
( ( O
Furanace NNP O
; : O
P NNP O
- : O
7138 CD O
) ) O
. . O

Gag NNP B-Gene
protein NN O
sequence NN O
motifs NNS O
of IN O
the DT O
NC NNP B-Gene
domain NN I-Gene
of IN O
primate NN O
foamy NN O
viruses NNS O
assumed VBD O
to TO O
be VB O
involved VBN O
in IN O
genome JJ O
encapsidation NN O
are VBP O
not RB O
conserved VBN O
in IN O
FeFV NNP O
. . O

3 LS O
) ) O
and CC O
one CD O
distal NN O
( ( O
- : O
11 CD O
. . O
8 CD O
/ JJ O
- : O
10 CD O
. . O
9 CD O
) ) O
, , O
presented VBD O
an DT O
enhancer NN O
activity NN O
in IN O
pituitary JJ O
cells NNS O
when WRB O
placed VBN O
upstream NN O
of IN O
the DT O
SV40 NNP B-Gene
promoter NN I-Gene
. . O

REM NNP O
dream NN O
content NN O
was VBD O
scored VBN O
for IN O
categories NNS O
suggesting VBG O
the DT O
predominant JJ O
influence NN O
of IN O
the DT O
left NN O
hemisphere NN O
, , O
e NN O
. . O
g NN O
. . O
, , O
good JJ O
ego NN O
functioning NN O
, , O
verbalization NN O
, , O
or CC O
the DT O
right NN O
hemisphere NN O
, , O
e NN O
. . O
g NN O
. . O
, , O
music NN O
, , O
spatial JJ O
salience NN O
, , O
bizarreness NN O
. . O

The DT O
same JJ O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
inducible JJ O
reporter NN O
gene NN O
is VBZ O
also RB O
synergistically RB O
activated VBN O
by IN O
the DT O
endogenous JJ B-Gene
Stat6 NNP I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
proteins NNS I-Gene
in IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
stimulated VBN O
I PRP O
. . O
29mu CD O
B NNP O
lymphoma NN O
cells NNS O
. . O

The DT O
role NN O
of IN O
daunorubicin NN O
in IN O
induction NN O
therapy NN O
for IN O
adult NN O
acute NN O
myeloid NN O
leukemia NN O

Enantiomer NNP O
separation NN O
of IN O
venlafaxine NN O
and CC O
O NNP O
- : O
desmethylvenlafaxine NN O
in IN O
human JJ O
plasma NN O
. . O

Closeup NN O
: : O
a DT O
resource NN O
for IN O
nurses NNS O
who WP O
smoke VBP O
. . O

The DT O
results NNS O
of IN O
our PRP$ O
ten JJ O
- : O
fold NN O
cross NN O
- : O
validation NN O
experiments NNS O
show VBP O
that IN O
, , O
on IN O
the DT O
average NN O
, , O
the DT O
system NN O
increases VBZ O
the DT O
specificity NN O
from IN O
0 CD O
. . O
19 CD O
( ( O
0 CD O
. . O
35 CD O
) ) O
to TO O
0 CD O
. . O
69 CD O
( ( O
0 CD O
. . O
74 CD O
) ) O
at IN O
a DT O
sensitivity NN O
level NN O
of IN O
1 CD O
. . O
0 CD O
( ( O
0 CD O
. . O
95 CD O
) ) O
. . O

Selected VBN O
topics NNS O
in IN O
laboratory NN O
animal JJ O
medicine NN O
. . O

Study NNP O
of IN O
bacterial JJ O
motility NN O
and CC O
rate NN O
of IN O
movement NN O
using VBG O
a DT O
closed JJ O
circuit NN O
television NN O

The DT O
statistical JJ O
significance NN O
of IN O
the DT O
prognosis NN O
factors NNS O
was VBD O
studied VBN O
by IN O
uni JJ O
- : O
and CC O
multivariative JJ O
methods NNS O
, , O
according VBG O
to TO O
the DT O
model NN O
of IN O
Cox NNP O
, , O
with IN O
the DT O
help NN O
of IN O
an DT O
IMB NNP O
computer NN O
. . O

Spore RB O
inocula NN O
( ( O
approximately RB O
10 CD O
( ( O
6 CD O
) ) O
/ FW O
coupon NN O
) ) O
were VBD O
dried VBN O
onto IN O
0 CD O
. . O
5 CD O
- : O
in IN O
. . O

GlcNAc NNP O
- : O
and CC O
GlcNAc2 NNP O
- : O
PP NNP O
- : O
Dolichol NNP O
biosynthesis NN O
could MD O
be VB O
shown VBN O
with IN O
isolated JJ O
S NNP O
. . O
cerevisiae NN O
membranes NNS O
from IN O
cells NNS O
harboring VBG O
the DT O
recombinant NN O
plasmid NN O
and CC O
grown VBN O
on IN O
glucose JJ O
thus RB O
suppressing VBG O
transcription NN O
of IN O
the DT O
endogenous JJ O
gene NN O
. . O

These DT O
analyses NNS O
re VBP O
- : O
open VB O
the DT O
question NN O
whether IN O
all PDT O
the DT O
CesA NNP B-Gene
genes NNS I-Gene
encode VBP O
cellulose JJ B-Gene
synthases NNS I-Gene
or CC O
whether IN O
some DT O
of IN O
the DT O
sub JJ O
- : O
class NN O
members NNS O
may MD O
encode VB O
other JJ O
non JJ B-Gene
- : I-Gene
cellulosic NN I-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
- : I-Gene
> $ I-Gene
4 CD I-Gene
) ) I-Gene
beta NN I-Gene
- : I-Gene
glycan JJ I-Gene
synthases NNS I-Gene
in IN O
plants NNS O
. . O

In IN O
a DT O
second JJ O
patient NN O
the DT O
VT NNP O
became VBD O
nonsustained JJ O
. . O

A DT O
pharmacokinetic JJ O
study NN O
of IN O
apalcillin NN O
was VBD O
performed VBN O
in IN O
12 CD O
patients NNS O
in IN O
an DT O
intensive JJ O
- : O
care NN O
unit NN O
. . O

These DT O
articles NNS O
both DT O
report VBP O
the DT O
results NNS O
of IN O
multi JJ O
- : O
institutional JJ O
, , O
randomized VBN O
, , O
phase VB O
3 CD O
trials NNS O
for IN O
the DT O
treatment NN O
of IN O
patients NNS O
with IN O
localized JJ O
( ( O
T1 NNP O
- : O
3 CD O
N0 NNP O
- : O
1 CD O
M0 NNP O
) ) O
esophageal VBP O
squamous JJ O
cell NN O
carcinoma NN O
( ( O
SCC NNP O
) ) O
or CC O
esophageal JJ O
adenocarcinoma NN O
. . O

In IN O
contrast NN O
to TO O
previously RB O
characterized VBN O
proteophosphoglycans NNS O
, , O
the DT O
ppg1 JJ B-Gene
gene NN O
product NN O
is VBZ O
predominantly RB O
membrane JJ O
- : O
associated VBN O
and CC O
it PRP O
is VBZ O
expressed VBN O
on IN O
the DT O
promastigote NN O
cell NN O
surface NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
Rb NNP B-Gene
protein NN I-Gene
is VBZ O
interacting VBG O
with IN O
some DT O
component NN O
( ( O
s JJ O
) ) O
of IN O
the DT O
cell NN O
cycle NN O
- : O
regulatory JJ O
machinery NN O
during IN O
G2 NNP O
phase NN O
. . O

Effect NN O
of IN O
tracheal JJ O
insufflation NN O
of IN O
deferoxamine NN O
on IN O
acute JJ O
ozone NN O
toxicity NN O
in IN O
rats NNS O
. . O

Fundamental JJ O
and CC O
clinical JJ O
evaluation NN O
of IN O
equilibrium NN O
dialysis NN O
- : O
- : O
radioimmunoassay NN O
system NN O
for IN O
measurement NN O
of IN O
serum JJ O
free JJ O
thyroxine NN O

The DT O
cycle NN O
length NN O
of IN O
induced JJ O
VT NNP O
( ( O
n JJ O
= $ O
10 CD O
VTs NNP O
) ) O
was VBD O
380 CD O
+ JJ O
/ NNP O
- : O
41 CD O
msec NN O
. . O

Our PRP$ O
data NNS O
show NN O
also RB O
that IN O
phagocytic JJ O
killing NN O
of IN O
meningococci NN O
is VBZ O
probably RB O
a DT O
more RBR O
consistent JJ O
assay NN O
than IN O
antibody NN O
titer NN O
levels NNS O
for IN O
antimeningococcal JJ O
immunity NN O
, , O
especially RB O
in IN O
LCC NNP O
- : O
deficient NN O
patients NNS O
. . O

Female JJ O
patients NNS O
with IN O
breast JJ O
cancer NN O
diagnosed VBD O
between IN O
1982 CD O
and CC O
1991 CD O
at IN O
Roswell NNP O
Park NNP O
Cancer NNP O
Institute NNP O
( ( O
RPCI NNP O
) ) O
in IN O
Buffalo NNP O
, , O
New NNP O
York NNP O
, , O
who WP O
provided VBD O
information NN O
on IN O
their PRP$ O
cigarette NN O
smoking VBG O
history NN O
at IN O
the DT O
time NN O
of IN O
their PRP$ O
diagnosis NN O
were VBD O
included VBN O
. . O

An DT O
association NN O
was VBD O
demonstrated VBN O
between IN O
the DT O
expression NN O
of IN O
aberrantly RB O
and CC O
/ VB O
or CC O
alternatively RB O
spliced JJ O
mdm2 NN B-Gene
mRNAs NN I-Gene
and CC O
a DT O
lack NN O
of IN O
progesterone NN B-Gene
receptor NN I-Gene
. . O

A DT O
full JJ B-Gene
- : I-Gene
length NN I-Gene
PRL NNP I-Gene
receptor NN I-Gene
( ( O
PRLR NNP B-Gene
) ) O
complementary VBP O
DNA NN O
from IN O
pigeons NNS O
was VBD O
obtained VBN O
by IN O
screening VBG O
pigeon NN O
crop NN O
sac NN O
libraries NNS O
and CC O
by IN O
reverse JJ O
transcription NN O
coupled VBN O
with IN O
polymerase NN O
chain NN O
reaction NN O
. . O

Ficat NNP O
and CC O
Bizou NNP O
' POS O
s NN O
condylar NN O
depth NN O
index NN O
and CC O
the DT O
condylar JJ O
- : O
joint JJ O
surface NN O
angle NN O
of IN O
Brattstrom NNP O
are VBP O
recommended VBN O
as IN O
especially RB O
suitable JJ O
methods NNS O
of IN O
measurement NN O
. . O

We PRP O
suggest VBP O
that IN O
ventriculopleural JJ O
shunting NN O
should MD O
be VB O
considered VBN O
as IN O
the DT O
preferred JJ O
alternative NN O
to TO O
peritoneal VB O
drainage NN O
in IN O
children NNS O
with IN O
intra JJ O
- : O
abdominal JJ O
adhesions NNS O
or CC O
with IN O
a DT O
history NN O
of IN O
recent JJ O
peritoneal JJ O
infection NN O
. . O

Significance NN O
of IN O
the DT O
pulmonary JJ O
gas NN O
exchange NN O
reaction NN O
to TO O
physical JJ O
loading NN O
in IN O
evaluating VBG O
the DT O
effectiveness NN O
of IN O
mitral JJ O
commissurotomy NN O

Polymerization NN O
of IN O
neurofilament JJ B-Gene
L NNP I-Gene
protein NN I-Gene
in IN O
vitro NN O
was VBD O
inhibited VBN O
by IN O
phosphorylation NN O
of IN O
neurofilament JJ B-Gene
L NNP I-Gene
protein NN I-Gene
by IN O
PKN NNP B-Gene
. . O

Magnetotherapy NNP O
of IN O
hepatitis NN O
A NNP O
and CC O
B NNP O
in IN O
children NNS O

In IN O
Wnt NNP B-Gene
signaling NN O
, , O
beta SYM B-Gene
- : I-Gene
catenin NN I-Gene
and CC O
plakoglobin NN B-Gene
transduce NN O
signals NNS O
to TO O
the DT O
nucleus NN O
through IN O
interactions NNS O
with IN O
TCF NNP B-Gene
- : I-Gene
type NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

These DT O
rearrangements NNS O
result VBP O
in IN O
the DT O
formation NN O
of IN O
chimeric JJ O
genes NNS O
showing VBG O
the DT O
tyrosine JJ B-Gene
kinase NN I-Gene
domain NN I-Gene
of IN O
ret NNS B-Gene
fused VBN O
with IN O
the DT O
5 CD O
' POS O
end NN O
sequences NNS O
of IN O
different JJ O
genes NNS O
. . O

One CD O
extract NN O
with IN O
the DT O
lowest JJS O
PCA NNP O
content NN O
was VBD O
non JJ O
- : O
carcinogenic NN O
. . O

RPA190 NNP B-Gene
encodes VBZ O
a DT O
polypeptide NN O
chain NN O
of IN O
186 CD O
, , O
270 CD O
daltons NNS O
in IN O
a DT O
large JJ O
uninterrupted JJ O
reading NN O
frame NN O
. . O

In IN O
contrast NN O
, , O
no DT O
change NN O
was VBD O
detected VBN O
in IN O
the DT O
phenotype NN O
of IN O
' '' O
unstressed JJ O
' POS O
clones NNS O
, , O
with IN O
respect NN O
to TO O
any DT O
of IN O
the DT O
following JJ O
parameters NNS O
: : O
proliferation NN O
rate NN O
in IN O
monolayer NN O
, , O
serum SYM O
- : O
dependence NN O
for IN O
proliferation NN O
or CC O
survival NN O
, , O
tumorigenicity NN O
, , O
cellular JJ O
morphology NN O
, , O
or CC O
tissue NN O
- : O
specific JJ O
differentiation NN O
markers NNS O
. . O

Hydrallazine NNP O
also RB O
caused VBD O
a DT O
slight JJ O
increase NN O
in IN O
plasma JJ B-Gene
renin NN I-Gene
activity NN O
and CC O
urinary JJ O
excretion NN O
of IN O
noradrenaline NN O
. . O

CXC NNP O
chemokines NNS O
bind NN O
to TO O
unique JJ O
sets NNS O
of IN O
selectivity NN O
determinants NNS O
that WDT O
can MD O
function VB O
independently RB O
and CC O
are VBP O
broadly RB O
distributed VBN O
on IN O
multiple JJ O
domains NNS O
of IN O
human JJ O
interleukin JJ B-Gene
- : I-Gene
8 CD I-Gene
receptor NN I-Gene
B NNP I-Gene
. . O

Progression NN O
after IN O
first JJ O
- : O
line NN O
chemotherapy NN O
was VBD O
associated VBN O
with IN O
significantly RB O
worse JJR O
survival NN O
for IN O
patients NNS O
with IN O
metastasis NN O
. . O

To TO O
test VB O
the DT O
hypothesis NN O
that WDT O
progestin VBZ O
- : O
mediated VBN O
increases NNS O
in IN O
resting VBG O
core NN O
temperature NN O
and CC O
the DT O
core NN O
temperature NN O
threshold NN O
for IN O
sweating VBG O
onset NN O
are VBP O
counteracted VBN O
by IN O
estrogen NN O
, , O
we PRP O
studied VBD O
eight CD O
women NNS O
( ( O
24 CD O
+ NN O
/ NNP O
- : O
2 CD O
yr NN O
) ) O
at IN O
27 CD O
degrees NNS O
C NNP O
rest NN O
, , O
during IN O
20 CD O
min NNS O
of IN O
passive JJ O
heating NN O
( ( O
35 CD O
degrees NNS O
C NNP O
) ) O
, , O
and CC O
during IN O
40 CD O
min NNS O
of IN O
exercise NN O
at IN O
35 CD O
degrees NNS O
C NNP O
. . O

The DT O
other JJ O
hypoglycaemic JJ O
patient NN O
showed VBD O
an DT O
exaggerated JJ O
insulin NN B-Gene
release NN O
in IN O
response NN O
to TO O
tolbutamide VB O
. . O

For IN O
replication NN O
reporter NN O
constructs NNS O
where WRB O
E1 NNP B-Gene
and CC O
E2 NNP B-Gene
are VBP O
supplied VBN O
in IN O
trans NNS O
by IN O
the DT O
respective JJ O
expression NN O
vectors NNS O
, , O
distance NN O
between IN O
the DT O
half NN O
sites VBZ O
seems VBZ O
to TO O
play VB O
a DT O
major JJ O
role NN O
, , O
yet CC O
the DT O
phasing JJ O
relationships NNS O
are VBP O
measurable JJ O
. . O

Diclofenac NNP O
sodium NN O
- : O
chlormezanone NN O
poisoning NN O
. . O

Troubled JJ O
CareNetwork NNP O
gets VBZ O
pact NN O
from IN O
largest JJS O
teacher NN O
union NN O
in IN O
Wis NNP O
. . O

TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
exposure NN O
markedly RB O
increased VBD O
activity NN O
of IN O
several JJ O
RNA NNP O
- : O
binding NN O
proteins NNS O
, , O
especially RB O
a DT O
novel JJ O
Mr NNP O
50 CD O
, , O
0 CD O
- : O
55 CD O
, , O
0 CD O
RNA NNP O
- : O
binding NN O
protein NN O
. . O

A DT O
case NN O
observed VBN O
in IN O
Saigon NNP O

Cut NNP O
- : O
off NN O
levels NNS O
that WDT O
define VBP O
abnormality NN O
are VBP O
rather RB O
arbitrary JJ O
and CC O
this DT O
decreases VBZ O
the DT O
specificity NN O
of IN O
the DT O
test NN O
in IN O
apparently RB O
healthy JJ O
patients NNS O
. . O

Endocardial JJ O
fibro NN O
- : O
elastosis NN O
, , O
mitral JJ O
incompetence NN O
, , O
and CC O
coarctation NN O
of IN O
abdominal JJ O
aorta NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
less JJR O
antidopaminergic JJ O
activity NN O
of IN O
RHAL NNP O
in IN O
this DT O
neuroleptic JJ O
test NN O
might MD O
be VB O
explained VBN O
by IN O
the DT O
lesser JJR O
conversion NN O
of IN O
RHAL NNP O
to TO O
HAL NNP O
. . O

Ime1 NNP B-Gene
plays VBZ O
a DT O
pivotal JJ O
role NN O
in IN O
the DT O
initiation NN O
of IN O
meiosis NN O
in IN O
a DT O
/ JJ O
alpha NN O
diploid NN O
cells NNS O
of IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
COD NNP O
and CC O
color NN O
removals NNS O
were VBD O
both DT O
more JJR O
than IN O
90 CD O
% NN O
when WRB O
FeCl3 NNP O
was VBD O
used VBN O
as IN O
the DT O
coagulation NN O
( ( O
dosages NNS O
of IN O
two CD O
- : O
step NN O
coagulation NN O
were VBD O
0 CD O
. . O
31 CD O
and CC O
0 CD O
. . O
12 CD O
mol JJ O
/ NNP O
L NNP O
respectively RB O
) ) O
after IN O
a DT O
ferrous JJ O
hydrogen NN O
peroxide NN O
oxidation NN O
pretreatment NN O
at IN O
a DT O
H2O2 NNP O
dosage NN O
of IN O
0 CD O
. . O
6 CD O
mol JJ O
/ NNP O
L NNP O
. . O

EBER1 NNP B-Gene
mRNA NN I-Gene
, , O
a DT O
consistent JJ O
marker NN O
of IN O
viral JJ O
latency NN O
, , O
was VBD O
positive JJ O
in IN O
all DT O
PEL NNP O
cases NNS O
, , O
although IN O
at IN O
lower JJR O
levels NNS O
than IN O
in IN O
the DT O
non JJ O
- : O
PEL NN O
controls NNS O
due JJ O
to TO O
EBER1 NNP B-Gene
expression NN O
by IN O
only RB O
a DT O
variable JJ O
subset NN O
of IN O
lymphoma NN O
cells NNS O
. . O

Receptor NNP B-Gene
protein NN I-Gene
tyrosine NN I-Gene
phosphatases NNS I-Gene
( ( O
RPTPs NNP B-Gene
) ) O
comprise VBP O
a DT O
family NN O
of IN O
proteins NNS O
that WDT O
feature VBP O
intracellular JJ O
phosphatase NN O
domains NNS O
and CC O
an DT O
ectodomain NN O
with IN O
putative JJ O
ligand NN O
- : O
binding NN O
motifs NNS O
. . O

The DT O
rate NN O
of IN O
resectability NN O
is VBZ O
low JJ O
and CC O
5 CD O
- : O
year NN O
survival NN O
is VBZ O
very RB O
poor JJ O
. . O

Tyrosine NNP B-Gene
kinase NN I-Gene
oncogenes NNS O
abrogate VBP O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
dependence NN O
of IN O
murine NN O
myeloid NN O
cells NNS O
through IN O
signaling VBG O
pathways NNS O
involving VBG O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
: : O
conditional JJ O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
transcription NN O
by IN O
temperature NN O
- : O
sensitive JJ O
v NN B-Gene
- : I-Gene
abl NN I-Gene
. . O

Effect NN O
of IN O
indomethacin NN O
on IN O
coronary JJ O
circulation NN O
: : O
effect NN O
on IN O
ECG NNP O
tracing VBG O

In IN O
the DT O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
crystal NN O
, , O
the DT O
POU NNP B-Gene
- : I-Gene
specific JJ I-Gene
domain NN I-Gene
recognizes VBZ O
a DT O
GCAT NNP O
half NN O
- : O
site NN O
, , O
while IN O
the DT O
corresponding JJ O
sequence NN O
recognized VBN O
by IN O
the DT O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
POU NNP B-Gene
- : O
specific JJ O
domain NN O
, , O
GTAT NNP O
, , O
is VBZ O
on IN O
the DT O
opposing VBG O
strand NN O
. . O

We PRP O
analyzed VBD O
serial JJ O
biopsy NN O
specimens NNS O
from IN O
eight CD O
patients NNS O
with IN O
FL NNP O
for IN O
secondary JJ O
alterations NNS O
of IN O
the DT O
rearranged VBN B-Gene
bcl NN I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
the DT O
breakpoint NN O
and CC O
open JJ O
reading NN O
frame NN O
( ( O
ORF NNP O
) ) O
regions NNS O
. . O

Practical JJ O
use NN O
and CC O
interpretation NN O
of IN O
viral JJ O
hepatitis NN O
B NNP O
markers NNS O
and CC O
hepatic JJ O
biopsy NN O
in IN O
HBs NNP B-Gene
Ag NNP I-Gene
carriers NNS O
and CC O
at IN O
the DT O
chronic JJ O
hepatitis NN O
stage NN O

Distal NNP O
lower JJR O
motor NN O
neuron VBD O
syndrome NN O
with IN O
high JJ O
- : O
titer NN O
serum NN B-Gene
IgM NNP I-Gene
anti SYM I-Gene
- : I-Gene
GM1 JJ I-Gene
antibodies NNS I-Gene
: : O
improvement NN O
following VBG O
immunotherapy NN O
with IN O
monthly JJ O
plasma NNS O
exchange NN O
and CC O
intravenous JJ O
cyclophosphamide NN O
. . O

A DT O
cDNA NN O
clone NN O
was VBD O
identified VBN O
encoding VBG O
a DT O
second JJ O
GHS NNP B-Gene
- : I-Gene
R NNP I-Gene
- : I-Gene
related VBN I-Gene
gene NN I-Gene
( ( O
GPR39 NNP B-Gene
) ) O
. . O

Procion NNP O
yellow PRP O
dye NN O
was VBD O
injected VBN O
intracellularly RB O
into IN O
large JJ O
auditory JJ O
fibers NNS O
of IN O
goldfish JJ O
to TO O
investigate VB O
the DT O
relationship NN O
between IN O
the DT O
response NN O
type NN O
of IN O
these DT O
fibers NNS O
and CC O
their PRP$ O
site NN O
of IN O
termination NN O
in IN O
the DT O
saccular JJ O
macula NN O
. . O

The DT O
amino NN O
acid NN O
sequence NN O
was VBD O
determined VBN O
to TO O
be VB O
residues NNS O
716 CD O
- : O
724 CD O
and CC O
hence RB O
lysine JJ O
residue JJ O
721 CD O
is VBZ O
located VBN O
within IN O
the DT O
ATP NNP O
- : O
binding NN O
site NN O
. . O

Compound NN O
1 CD O
is VBZ O
either RB O
21 CD O
- : O
O NNP O
- : O
angeloyl NN O
, , O
22 CD O
- : O
O NNP O
- : O
tigloyl NN O
R1 NNP O
- : O
barrigenol NN O
, , O
or CC O
21 CD O
- : O
O NNP O
- : O
tigloyl NN O
, , O
22 CD O
- : O
O NNP O
- : O
angeloyl NN O
R1 NNP O
- : O
barrigenol NN O
. . O

The DT O
associations NNS O
between IN O
sex NN B-Gene
- : I-Gene
hormone NN I-Gene
- : I-Gene
binding NN I-Gene
globulin NN I-Gene
capacity NN O
( ( O
SHBG NNP B-Gene
) ) O
, , O
age NN O
, , O
body NN O
mass NN O
index NN O
( ( O
BMI NNP O
) ) O
, , O
and CC O
physical JJ O
fitness NN O
have VBP O
been VBN O
studied VBN O
in IN O
34 CD O
men NNS O
and CC O
36 CD O
women NNS O
. . O

The DT O
same JJ O
response NN O
occurs VBZ O
whether IN O
acrylamide NN O
is VBZ O
given VBN O
immediately RB O
after IN O
nerve JJ O
ligation NN O
or CC O
1 CD O
week NN O
later RB O
. . O

Tissue NNP O
- : O
specific JJ O
expression NN O
of IN O
the DT O
tmy NN B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
was VBD O
determined VBN O
by IN O
microinjection NN O
of IN O
a DT O
promoter NN B-Gene
/ NNP I-Gene
lacZ VBZ I-Gene
fusion NN I-Gene
gene NN I-Gene
and CC O
with IN O
immunohistochemistry NN O
by IN O
using VBG O
affinity NN O
- : O
purified JJ O
tissue NN B-Gene
- : I-Gene
specific JJ I-Gene
anti SYM I-Gene
- : I-Gene
tropomyosins NNS I-Gene
. . O

Mechanical JJ O
ventilation NN O
in IN O
control NN O
lungs NNS O
produced VBD O
a DT O
47 CD O
% NN O
decrease NN O
in IN O
chord NN O
compliance NN O
, , O
an DT O
increase NN O
in IN O
lung JJ O
lavage NN O
levels NNS O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( I-Gene
TNF NNP I-Gene
) ) I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
722 CD O
+ NN O
/ NNP O
- : O
306 CD O
pg NN O
/ NNP O
ml NN O
) ) O
, , O
interleukin FW B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
1beta CD I-Gene
( ( O
902 CD O
+ NN O
/ NNP O
- : O
322 CD O
pg NN O
/ NNP O
ml NN O
) ) O
, , O
and CC O
macrophage NN B-Gene
inflammatory NN I-Gene
protein SYM I-Gene
- : I-Gene
2 CD I-Gene
( ( O
MIP NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
( ( O
363 CD O
+ NN O
/ NNP O
- : O
104 CD O
pg NN O
/ NNP O
ml NN O
) ) O
as IN O
compared VBN O
with IN O
low JJ O
levels NNS O
of IN O
cytokines NNS O
detected VBN O
in IN O
preventilation NN O
data NNS O
, , O
and CC O
no DT O
change NN O
in IN O
percentage NN O
of IN O
surfactant JJ O
large JJ O
aggregates NNS O
( ( O
LA NNP O
) ) O
. . O

Envelope NNP O
- : O
function NN O
matching JJ O
conditions NNS O
for IN O
GaAs NNP O
/ NNP O
( ( O
Al NNP O
, , O
Ga NNP O
) ) O
As IN O
heterojunctions NNS O
. . O

Managing VBG O
HIV NNP O
. . O

Letter NN O
: : O
Lactose JJ O
tolerance NN O
tests NNS O
as IN O
a DT O
predictor NN O
of IN O
milk NN O
tolerance NN O
. . O

Herpes NNP O
virus NN O
infection NN O
was VBD O
characterized VBN O
by IN O
inversion NN O
of IN O
the DT O
T4 NNP O
/ NNP O
T8 NNP O
ratio NN O
below IN O
1 CD O
. . O
0 CD O
( ( O
sensitivity NN O
90 CD O
% NN O
, , O
specificity NN O
88 CD O
% NN O
) ) O
, , O
caused VBN O
by IN O
proliferation NN O
of IN O
the DT O
T8 NNP O
subpopulation NN O
, , O
which WDT O
- : O
- : O
compared VBN O
with IN O
the DT O
findings NNS O
in IN O
patients NNS O
with IN O
rejection NN O
crises NNS O
- : O
- : O
was VBD O
significantly RB O
raised VBN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

An DT O
essential JJ O
role NN O
of IN O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
Fos NN I-Gene
in IN O
basal NN O
and CC O
PMA NNP O
- : O
stimulated VBD O
transcription NN O
of IN O
the DT O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
is VBZ O
demonstrated VBN O
by IN O
our PRP$ O
finding NN O
that IN O
antisense NN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
oligodeoxynucleotides IN O
both DT O
strongly RB O
reduced VBN O
basal NN O
and CC O
PMA NNP O
- : O
stimulated VBD O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
synthesis NN O
. . O

Furthermore RB O
, , O
binding VBG O
of IN O
recombinant JJ B-Gene
Myb NNP I-Gene
and CC O
Ets NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
to TO O
these DT O
fragments NNS O
could MD O
be VB O
competed VBN O
with IN O
an DT O
excess NN O
of IN O
double JJ O
stranded JJ O
oligodeoxynucleotides NNS O
containing VBG O
canonical JJ O
, , O
but CC O
not RB O
mutated VBN O
, , O
Myb NNP B-Gene
- : O
or CC O
Ets NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

The DT O
alcoholic JJ O
patient NN O
, , O
his PRP$ O
work NN O
and CC O
the DT O
subjectivity NN O
of IN O
the DT O
period NN O

Protein NNP O
sequence NN O
analysis NN O
reveals NNS O
that IN O
MAN1 NNP B-Gene
shares NNS O
a DT O
conserved VBN O
globular JJ O
domain NN O
of IN O
approximately RB O
40 CD O
amino JJ O
acids NNS O
, , O
which WDT O
we PRP O
term NN O
the DT O
LEM NNP B-Gene
module NN I-Gene
, , O
with IN O
inner JJ O
nuclear JJ O
membrane NN O
proteins NNS O
lamina VBP B-Gene
- : I-Gene
associated VBN I-Gene
polypeptide IN I-Gene
2 CD I-Gene
and CC O
emerin NN B-Gene
. . O

No DT O
hypotension NN O
was VBD O
noted VBN O
in IN O
patients NNS O
with IN O
toxemia NN O
and CC O
only RB O
2 CD O
ran VBD O
a DT O
fever NN O
above IN O
37 CD O
. . O
5 CD O
degrees NNS O
C NNP O
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
Immediately RB O
before IN O
radical JJ O
prostatectomy NN O
, , O
bone NN O
marrow NN O
aspirates VBZ O
from IN O
both DT O
sides NNS O
of IN O
the DT O
iliac JJ O
crest NN O
were VBD O
taken VBN O
from IN O
287 CD O
patients NNS O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
: : O
Percentage NN O
change NN O
in IN O
the DT O
apnea NN O
- : O
hypopnea NN O
index NN O
( ( O
AHI NNP O
; : O
apnea JJ O
events NNS O
+ JJ O
hypopnea NN O
events NNS O
per IN O
hour NN O
of IN O
sleep NN O
) ) O
and CC O
odds NNS O
of IN O
developing VBG O
moderate JJ O
- : O
to TO O
- : O
severe JJ O
SDB NNP O
( ( O
defined VBN O
by IN O
an DT O
AHI NNP O
> NN O
or CC O
= $ O
15 CD O
events NNS O
per IN O
hour NN O
of IN O
sleep NN O
) ) O
, , O
with IN O
respect NN O
to TO O
change VB O
in IN O
weight NN O
. . O

Cocaine NNP O
- : O
treated VBD O
rats NNS O
acquired VBD O
a DT O
preference NN O
for IN O
cocaine NN O
- : O
associated VBN O
contextual JJ O
stimuli NN O
( ( O
CS NNP O
) ) O
relative VBP O
to TO O
saline VB O
- : O
injected VBN O
control NN O
rats NNS O
. . O

Strengthening VBG O
the DT O
biological JJ O
weapons NNS O
convention NN O
and CC O
implications NNS O
on IN O
the DT O
pharmaceutical JJ O
and CC O
biotechnology NN O
industry NN O
. . O

The DT O
simultaneous JJ O
recording NN O
of IN O
electrical JJ O
activity NN O
from IN O
the DT O
surface NN O
electrocardiogram NN O
, , O
right JJ O
ventricular NN O
apex NN O
, , O
His PRP$ O
bundle NN O
, , O
high JJ O
right NN O
atrium NN O
, , O
coronary JJ O
sinus NN O
, , O
with IN O
or CC O
without IN O
a DT O
roving VBG O
mapping NN O
catheter NN O
, , O
enables VBZ O
us PRP O
to TO O
precisely RB O
map VB O
the DT O
electrical JJ O
activation NN O
sequence NN O
in IN O
the DT O
heart NN O
. . O

Cells NNP O
differentiate NN O
in IN O
response NN O
to TO O
various JJ O
extracellular JJ O
stimuli NNS O
. . O

Influence NN O
of IN O
neural JJ O
regulation NN O
on IN O
anti JJ O
- : O
arrhythmic JJ O
effects NNS O
of IN O
GABA NNP O
in IN O
rats NNS O

They PRP O
were VBD O
randomly RB O
allocated VBN O
to TO O
receive VB O
either RB O
625 CD O
mg NN O
of IN O
calcium NN O
carbonate NN O
( ( O
250 CD O
mg NN O
of IN O
elemental JJ O
calcium NN O
) ) O
at IN O
the DT O
end NN O
of IN O
a DT O
meal NN O
three CD O
times NNS O
a DT O
day NN O
( ( O
group NN O
A NNP O
, , O
n JJ O
= NNP O
26 CD O
) ) O
or CC O
calcium NN O
carbonate NN O
in IN O
the DT O
same JJ O
manner NN O
plus CC O
0 CD O
. . O
625 CD O
mg JJ O
/ NNP O
day NN O
of IN O
conjugated JJ O
equine NN O
estrogen NN O
and CC O
5 CD O
mg NN O
medrogestone NN O
acetate NN O
from IN O
day NN O
1 CD O
- : O
12 CD O
each DT O
month NN O
( ( O
group NN O
B NNP O
, , O
n JJ O
= NNP O
30 CD O
) ) O
. . O

For IN O
oral JJ O
administration NN O
, , O
AUC0 NNP O
- : O
infinity NN O
was VBD O
58 CD O
. . O
47 CD O
+ JJ O
/ NNP O
- : O
16 CD O
. . O
37 CD O
microg JJ O
x NN O
h NN O
/ NNP O
ml NN O
, , O
t1 EX O
/ $ O
2beta CD O
was VBD O
18 CD O
. . O
39 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
hours NNS O
, , O
maximum JJ O
concentration NN O
( ( O
Cmax NNP O
) ) O
was VBD O
2 CD O
. . O
12 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
51 CD O
microg JJ O
/ NNP O
ml NN O
, , O
time NN O
to TO O
Cmax NNP O
was VBD O
2 CD O
. . O
20 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
17 CD O
hours NNS O
, , O
mean JJ O
absorption NN O
time NN O
was VBD O
2 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
51 CD O
hours NNS O
, , O
and CC O
bioavailability NN O
was VBD O
42 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
42 CD O
% NN O
. . O

The DT O
mei4 NN B-Gene
+ NNP I-Gene
gene NN I-Gene
of IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe NN O
was VBD O
cloned VBN O
by IN O
functional JJ O
complementation NN O
. . O

The DT O
approach NN O
derives VBZ O
from IN O
a DT O
recently RB O
described VBN O
strategy NN O
for IN O
making VBG O
recombinants NNS O
from IN O
five CD O
overlapping VBG O
EBV NNP O
cosmid SYM O
- : O
cloned VBN O
DNAs NNP O
( ( O
B NNP O
. . O

A DT O
TATA NNP O
- : O
less RBR O
promoter NN O
containing VBG O
binding VBG O
sites NNS O
for IN O
ubiquitous JJ O
transcription NN O
factors NNS O
mediates VBZ O
cell VBP O
type SYM O
- : O
specific JJ O
regulation NN O
of IN O
the DT O
gene NN O
for IN O
transcription NN B-Gene
enhancer NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TEF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Recent JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
regulates VBZ O
the DT O
function NN O
of IN O
Jak NNP B-Gene
family NN O
tyrosine NN B-Gene
kinases NNS I-Gene
, , O
as IN O
shown VBN O
by IN O
its PRP$ O
constitutive JJ O
association NN O
with IN O
the DT O
Tyk2 NNP B-Gene
kinase NN I-Gene
and CC O
the DT O
hyperphosphorylation NN O
of IN O
Jak NNP B-Gene
kinases NNS I-Gene
in IN O
the DT O
motheaten NN O
cells NNS O
that WDT O
lack VBP O
functional JJ O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Subsets NNS O
of IN O
patients NNS O
were VBD O
performed VBN O
according VBG O
to TO O
the DT O
severity NN O
of IN O
trauma NN O
( ( O
ISS NNP O
< NNP O
9 CD O
; : O
9 CD O
- : O
17 CD O
; : O
18 CD O
- : O
31 CD O
; : O
> CC O
32 CD O
) ) O
, , O
based VBN O
on IN O
the DT O
different JJ O
injury NN O
pattern NN O
, , O
and CC O
survivors NNS O
versus VBP O
nonsurvivors NNS O
as RB O
well RB O
. . O

Detailed JJ O
analysis NN O
of IN O
alpha1 NN B-Gene
, , I-Gene
3GT CD I-Gene
transcripts NNS I-Gene
revealed VBD O
two CD O
major JJ O
alternative JJ O
splicing VBG O
patterns NNS O
in IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
( ( O
5 CD O
' '' O
- : O
UTR NN O
) ) O
and CC O
evidence NN O
for IN O
minor JJ O
splicing NN O
activity NN O
that WDT O
occurs VBZ O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
manner NN O
. . O

Synaptic JJ O
targeting NN O
of IN O
the DT O
postsynaptic JJ B-Gene
density NN I-Gene
protein NN I-Gene
PSD NNP I-Gene
- : I-Gene
95 CD I-Gene
mediated VBN O
by IN O
a DT O
tyrosine NN O
- : O
based VBN O
trafficking JJ O
signal NN O
. . O

Primary JJ O
amenorrhoea NN O
in IN O
a DT O
phenotypically RB O
female JJ O
individual NN O
with IN O
a DT O
karyotype NN O
46 CD O
, , O
xy NN O
and CC O
bilateral JJ O
gonadoblastoma NN O

Dissociation NN O
and CC O
complexation NN O
of IN O
the DT O
fluoroquinolone NN O
antimicrobials VBZ O
- : O
- : O
an DT O
update NN O
. . O

Its PRP$ O
clinical JJ O
and CC O
histopathologic JJ O
characteristics NNS O
. . O

Cloning NNP O
, , O
sequencing VBG O
and CC O
expression NN O
of IN O
the DT O
3 CD B-Gene
- : I-Gene
phosphoglycerate NN I-Gene
kinase NN I-Gene
gene NN I-Gene
of IN O
Pyrococcus NNP O
woesei NN O
in IN O
Escherichia NNP O
coli NN O
and CC O
characterization NN O
of IN O
the DT O
protein NN O
. . O

J NNP O
. . O

The DT O
Harleco NNP O
apparatus NN O
is VBZ O
a DT O
simple JJ O
, , O
useful JJ O
, , O
cost NN O
- : O
effective JJ O
adjunct NN O
to TO O
the DT O
diagnosis NN O
and CC O
treatment NN O
of IN O
this DT O
life NN O
- : O
threatening JJ O
condition NN O
. . O

Schizosaccharomyces NNS O
pombe VBP O
cells NNS O
respond NN O
to TO O
nutrient JJ O
deprivation NN O
by IN O
altering VBG O
G2 NNP O
/ NNP O
M NNP O
cell NN O
size NN O
control NN O
. . O

Comparative JJ O
DNA NNP O
sequence NN O
analysis NN O
showed VBD O
the DT O
Genethon NNP O
microsatellite NN B-Gene
D19S596 NNP I-Gene
lies VBZ O
2 CD O
. . O
2 CD O
kb JJ O
downstream NN O
of IN O
the DT O
coding VBG O
region NN O
of IN O
FUT1 NNP B-Gene
, , O
indicating VBG O
that IN O
the DT O
cluster NN O
comprising VBG O
the DT O
closely RB O
linked VBN O
FUT1 NNP B-Gene
and CC O
FUT2 NNP B-Gene
genes NNS I-Gene
is VBZ O
located VBN O
4 CD O
cM JJ O
distal NN O
to TO O
D19S412 NNP B-Gene
( ( O
lod JJ O
score NN O
13 CD O
. . O
7 CD O
) ) O
and CC O
9 CD O
cM NN O
proximal NN O
to TO O
D19S571 NNP B-Gene
( ( O
lod JJ O
score NN O
11 CD O
. . O
7 CD O
) ) O
. . O

These DT O
results NNS O
are VBP O
the DT O
first JJ O
to TO O
demonstrate VB O
the DT O
structural JJ O
organization NN O
of IN O
a DT O
vertebrate JJ O
gene NN O
encoding VBG O
an DT O
integral JJ O
membrane NN O
protein NN O
of IN O
the DT O
nuclear JJ O
envelope NN O
that WDT O
may MD O
be VB O
a DT O
member NN O
of IN O
a DT O
family NN O
of IN O
polypeptides NNS O
conserved VBN O
in IN O
evolution NN O
. . O

Administration NN O
of IN O
dexamethasone NN O
was VBD O
associated VBN O
with IN O
progressive JJ O
rises NNS O
in IN O
plasma JJ O
17 CD O
alpha JJ O
OH NNP O
progesterone NN O
, , O
11 CD O
beta SYM O
- : O
desoxycortisol NN O
, , O
DHEA NNP O
sulphate NN O
, , O
androstenedione NN O
and CC O
testosterone NN O
, , O
together RB O
with IN O
increased JJ O
urinary JJ O
excretion NN O
of IN O
androsterone NN O
, , O
11 CD O
beta NN O
OH NNP O
androsterone NN O
, , O
etiocholanolone NN O
, , O
DHEA NNP O
, , O
and CC O
16 CD O
alpha NN O
OH NNP O
DHEA NNP O
. . O

The DT O
ultrastructure NN O
of IN O
retinal JJ O
vessels NNS O
was VBD O
examined VBN O
in IN O
three CD O
eyes NNS O
from IN O
diabetic JJ O
patients NNS O
and CC O
two CD O
eyes NNS O
from IN O
control NN O
subjects NNS O
. . O

Oxidative JJ O
degradation NN O
of IN O
adrenaline JJ O
solutions NNS O
: : O
study NN O
of IN O
the DT O
intermediate JJ O
stages NNS O
and CC O
their PRP$ O
analytic JJ O
value NN O
for IN O
the DT O
control NN O
of IN O
this DT O
solute NN O

A DT O
significant JJ O
direct JJ O
relationship NN O
was VBD O
observed VBN O
between IN O
the DT O
percent NN O
area NN O
density NN O
of IN O
smooth JJ O
muscle NN O
and CC O
the DT O
percent NN O
change NN O
in IN O
peak NN O
urinary JJ O
flow NN O
rate NN O
. . O

In IN O
Exp NNP O
. . O

To TO O
facilitate VB O
manipulation NN O
of IN O
large JJ O
genomic JJ O
sequences NNS O
, , O
we PRP O
developed VBD O
a DT O
method NN O
of IN O
converting VBG O
Escherichia NNP O
coli NNS O
P1 NNP O
artificial JJ O
chromosomes NNS O
( ( O
PACs NNPS O
) ) O
into IN O
yeast JJ O
artificial JJ O
chromosomes NNS O
( ( O
YACs NNP O
) ) O
. . O

In IN O
angiodysplasia NN O
, , O
ectatic JJ O
vessels NNS O
in IN O
the DT O
mucosa NN O
appeared VBD O
to TO O
contain VB O
less JJR O
collagen NN B-Gene
type NN I-Gene
IV NNP I-Gene
than IN O
similarly RB O
sized VBN O
vessels NNS O
in IN O
the DT O
submucosa NN O
, , O
and CC O
perforating VBG O
vessels NNS O
appeared VBD O
in IN O
many JJ O
cases NNS O
to TO O
lose VB O
staining NN O
at IN O
the DT O
level NN O
of IN O
the DT O
muscularis NN O
mucosae NN O
. . O

Marked VBN O
hemolysis NN O
significantly RB O
increased VBD O
plasma JJ O
values NNS O
of IN O
potassium NN O
, , O
phosphorus NN O
, , O
total JJ O
protein NN O
, , O
and CC O
aspartate JJ B-Gene
aminotransferase NN I-Gene
. . O

This DT O
coat NN B-Gene
protein NN I-Gene
consists VBZ O
of IN O
Sar1p NNP B-Gene
, , O
the DT O
Sec23p NNP B-Gene
protein NN I-Gene
complex NN I-Gene
containing VBG O
Sec23p NNP B-Gene
and CC O
Sec24p NNP B-Gene
, , O
and CC O
the DT O
Sec13p NNP B-Gene
protein NN I-Gene
complex NN I-Gene
containing VBG O
Sec13p NNP B-Gene
and CC O
a DT O
novel JJ O
150 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
, , I-Gene
p150 NN I-Gene
. . O

Examination NN O
of IN O
ANCA NNP B-Gene
is VBZ O
not RB O
only RB O
a DT O
significant JJ O
contribution NN O
towards IN O
a DT O
more RBR O
accurate JJ O
diagnosis NN O
of IN O
renal JJ O
vasculitis NN O
, , O
but CC O
also RB O
an DT O
indicator NN O
of IN O
the DT O
activity NN O
of IN O
the DT O
disease NN O
and CC O
thus RB O
of IN O
the DT O
effectiveness NN O
of IN O
immunosuppressive JJ O
treatment NN O
. . O

Linearized VBN O
overall JJ O
infection NN O
rates NNS O
( ( O
events NNS O
/ VBP O
100 CD O
patient JJ O
- : O
days NNS O
) ) O
were VBD O
2 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
33 CD O
( ( O
heart NN O
- : O
lung NN O
) ) O
and CC O
2 CD O
. . O
34 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
34 CD O
( ( O
double JJ O
- : O
lung NN O
; : O
P NNP O
= NNP O
NS NNP O
) ) O
at IN O
3 CD O
months NNS O
. . O

According VBG O
to TO O
symptoms NNS O
, , O
signs NNS O
, , O
imaging VBG O
features NNS O
, , O
operation NN O
findings NNS O
, , O
the DT O
original JJ O
places NNS O
and CC O
the DT O
expansive JJ O
directions NNS O
of IN O
the DT O
tumor NN O
, , O
they PRP O
were VBD O
divided VBN O
into IN O
four CD O
clinical JJ O
types NNS O
: : O
sellar NN O
, , O
clival NN O
, , O
occipito SYM O
- : O
temporal JJ O
and CC O
extent NN O
. . O

Schooling NN O
is VBZ O
found VBN O
to TO O
be VB O
related VBN O
to TO O
good JJ O
health NN O
even RB O
after IN O
controlling VBG O
for IN O
differences NNS O
in IN O
observable JJ O
health NN O
inputs NNS O
. . O

Statistical JJ O
analysis NN O
of IN O
the DT O
degrees NNS O
of IN O
secondary JJ O
spinal JJ O
cord NN O
compression NN O
was VBD O
performed VBN O
in IN O
group NN O
- : O
1 CD O
dogs NNS O
by IN O
measuring VBG O
and CC O
comparing VBG O
ratios NNS O
of IN O
the DT O
vertical JJ O
to TO O
the DT O
horizontal JJ O
diameters NNS O
of IN O
the DT O
transverse JJ O
spinal JJ O
cord NN O
sections NNS O
from IN O
locations NNS O
within IN O
( ( O
T12 NNP O
to TO O
L1 NNP O
) ) O
and CC O
out IN O
of IN O
( ( O
T11 NNP O
, , O
T11 NNP O
- : O
12 CD O
, , O
L1 NNP O
- : O
2 CD O
, , O
and CC O
L2 NNP O
) ) O
the DT O
region NN O
of IN O
surgical JJ O
intervention NN O
. . O

Inhibition NN O
of IN O
the DT O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
target NN I-Gene
ERK NNP B-Gene
kinase NN I-Gene
( ( O
MEK NNP B-Gene
) ) O
either RB O
attenuated VBD O
or CC O
abolished VBD O
Rp NNP O
- : O
cAMPS NN O
- : O
and CC O
PKI NNP B-Gene
- : O
induced VBD O
ERK NNP B-Gene
activation NN O
, , O
caldesmon JJ B-Gene
phosphorylation NN O
, , O
and CC O
stress JJ O
fiber NN O
formation NN O
. . O

Vitamin NNP O
D3 NNP O
plus CC O
nicotine JJ O
treatment NN O
produced VBD O
parallel JJ O
increases NNS O
in IN O
cardiac JJ O
mass NN O
and CC O
elastic JJ O
modulus NN O
, , O
with IN O
a DT O
significant JJ O
correlation NN O
between IN O
the DT O
two CD O
. . O

Genomic NNP O
organization NN O
of IN O
the DT O
human JJ O
phosphodiesterase NN B-Gene
PDE11A NNP I-Gene
gene NN I-Gene
. . O

This DT O
paper NN O
reports VBZ O
the DT O
results NNS O
of IN O
a DT O
laboratory NN O
study NN O
on IN O
aldicarb NN O
and CC O
its PRP$ O
main JJ O
metabolites NNS O
, , O
aldicarb VBP O
sulfone NN O
and CC O
aldicarb JJ O
sulfoxide NN O
. . O

Together RB O
, , O
these DT O
results NNS O
identify VBP O
HPK1 NNP B-Gene
as IN O
a DT O
new JJ O
component NN O
of IN O
TCR NNP B-Gene
signaling VBG O
. . O

Thus RB O
, , O
Hex NNP B-Gene
expression NN O
marks VBZ O
the DT O
earliest JJS O
unequivocal JJ O
molecular JJ O
anteroposterior JJ O
asymmetry NN O
in IN O
the DT O
mouse NN O
embryo NN O
and CC O
indicates VBZ O
that IN O
the DT O
anteroposterior JJ O
axis NN O
of IN O
the DT O
embryo NN O
develops VBZ O
from IN O
conversion NN O
of IN O
a DT O
proximodistal JJ O
asymmetry NN O
established VBN O
in IN O
the DT O
primitive JJ O
endoderm NN O
lineage NN O
. . O

The DT O
system NN O
consisted VBD O
of IN O
the DT O
intact JJ O
canine JJ O
heart NN O
connected VBN O
to TO O
a DT O
microcomputer NN O
that WDT O
operated VBD O
as IN O
the DT O
modulated JJ O
parasystolic JJ O
pacemaker NN O
. . O

Six NNP O
( ( O
four CD O
FAP NNP O
; : O
two CD O
primary JJ O
amyloidosis NN O
) ) O
also RB O
had VBD O
diffusely RB O
positive JJ O
myocardial JJ O
uptakes NNS O
, , O
but CC O
the DT O
intensity NN O
was VBD O
less JJR O
than IN O
that DT O
of IN O
the DT O
sternum NN O
. . O

In IN O
Experiments NNS O
1 CD O
and CC O
2 CD O
, , O
infants NNS O
, , O
like IN O
adults NNS O
, , O
initially RB O
categorized VBN O
novel JJ O
objects NNS O
on IN O
the DT O
basis NN O
of IN O
physical JJ O
appearance NN O
, , O
but CC O
only RB O
if IN O
trained VBN O
with IN O
multiple JJ O
exemplars NNS O
, , O
after IN O
delays NNS O
of IN O
1 CD O
and CC O
7 CD O
days NNS O
. . O

The DT O
patient NN O
with IN O
a DT O
prolonged JJ O
fever NN O
caused VBN O
by IN O
dissecting VBG O
aneurysm NN O
of IN O
the DT O
aorta NN O
in IN O
whom WP O
pleuropneumonia NN O
masked VBD O
the DT O
real JJ O
diseases NNS O
has VBZ O
been VBN O
presented VBN O
. . O

Within IN O
the DT O
compartment NN O
or CC O
dimension NN O
of IN O
severity NN O
of IN O
depression NN O
a DT O
subscale NN O
of IN O
the DT O
Hamilton NNP O
Depression NNP O
Scale NNP O
( ( O
or CC O
the DT O
Melancholia NNP O
Scale NNP O
) ) O
was VBD O
shown VBN O
to TO O
have VB O
reached VBN O
an DT O
instrumental JJ O
perfection NN O
, , O
e NN O
. . O
g NN O
. . O
as IN O
an DT O
outcome NN O
measure NN O
of IN O
antidepressant JJ O
treatment NN O
. . O

A DT O
low JJ O
aspirin JJ B-Gene
esterase NN I-Gene
activity NN O
may MD O
be VB O
a DT O
contributory JJ O
factor NN O
in IN O
precipitating VBG O
these DT O
aspirin JJ O
sensitive JJ O
reactions NNS O
. . O

STK NNP B-Gene
/ NNP O
RON NNP B-Gene
- : O
expressing VBG O
Ba NNP O
/ NNP O
F3 NNP O
pro FW O
- : O
B NN O
cells NNS O
( ( O
BaF NNP O
/ NNP O
STK NNP B-Gene
) ) O
exhibited VBD O
MSP NNP B-Gene
- : O
dependent JJ O
growth NN O
, , O
whereas WP O
STK NNP B-Gene
/ NNP O
RON NNP B-Gene
- : O
expressing NN O
mouse NN O
erythroleukaemia NN O
cells NNS O
( ( O
MEL NNP O
/ NNP O
STK NNP B-Gene
) ) O
displayed VBD O
MSP NNP B-Gene
- : O
induced JJ O
apoptosis NN O
. . O

Williams NNP O
, , O
2 CD O
August NNP O
1977 CD O
. . O

Effect NN O
of IN O
single JJ O
base NN O
substitutions NNS O
at IN O
glycine JJ O
- : O
870 CD O
codon NN O
of IN O
gramicidin NN B-Gene
S NNP I-Gene
synthetase NN I-Gene
2 CD I-Gene
gene NN I-Gene
on IN O
proline JJ O
activation NN O
. . O

METHODS NN O
: : O
Ten CD O
influenza VBZ O
A NNP O
( ( O
H3N2 NNP O
) ) O
viruses VBZ O
isolated JJ O
during IN O
the DT O
outbreaks NNS O
were VBD O
examined VBN O
for IN O
resistance NN O
to TO O
amantadine VB O
and CC O
rimantadine VB O
by IN O
means NNS O
of IN O
an DT O
enzyme JJ O
immunoassay NN O
and CC O
by IN O
sequencing VBG O
of IN O
the DT O
viral JJ O
nucleic NN O
acid NN O
that WDT O
encodes VBZ O
the DT O
transmembrane NN O
domain NN O
of IN O
the DT O
M2 NNP B-Gene
protein NN I-Gene
. . O

Identification NN O
of IN O
an DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
in IN O
the DT O
Marek NNP O
' POS O
s JJ O
disease NN O
virus NN O
long JJ O
internal JJ O
repeat NN O
region NN O
which WDT O
encodes VBZ O
a DT O
unique JJ O
14 CD O
- : O
kilodalton NN O
polypeptide NN O
. . O

Whereas IN O
both DT O
MAP NNP O
and CC O
MSNA NNP O
increase NN O
during IN O
SHG NNP O
, , O
the DT O
transition NN O
from IN O
SHG NNP O
to TO O
PHI NNP O
is VBZ O
characterized VBN O
by IN O
a DT O
transient JJ O
reduction NN O
in IN O
MAP NNP O
but CC O
sustained VBN O
elevation NN O
in IN O
MSNA NNP O
, , O
facilitating VBG O
separation NN O
of IN O
these DT O
factors NNS O
in IN O
vivo NN O
. . O

The DT O
sense NN O
of IN O
self NN O
. . O

Mutational JJ O
analysis NN O
of IN O
potential JJ O
activating VBG O
phosphorylation NN O
sites NNS O
found VBN O
in IN O
NIMA NNP B-Gene
, , O
NIM NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
related JJ O
protein NN O
kinases NNS O
was VBD O
performed VBN O
on IN O
NIMA NNP B-Gene
. . O

In IN O
rubella NN O
patients NNS O
with IN O
serologic JJ O
confirmation NN O
by IN O
HI NNP O
, , O
the DT O
IF NNP O
test NN O
detected VBD O
significant JJ O
rises NNS O
in IN O
219 CD O
( ( O
99 CD O
. . O
1 CD O
% NN O
) ) O
of IN O
221 CD O
patients NNS O
and CC O
the DT O
PHA NNP B-Gene
test NN O
detected VBD O
antibody NN O
conversion NN O
in IN O
68 CD O
( ( O
93 CD O
% NN O
) ) O
of IN O
73 CD O
patients NNS O
. . O

On IN O
admission NN O
to TO O
our PRP$ O
department NN O
in IN O
September NNP O
, , O
1987 CD O
, , O
the DT O
patient NN O
was VBD O
alert JJ O
and CC O
had VBD O
spastic JJ O
paraparesis NN O
, , O
the DT O
impairment NN O
of IN O
all DT O
sensory JJ O
modalities NNS O
below IN O
the DT O
level NN O
of IN O
Th NNP O
10 CD O
and CC O
urinary JJ O
disturbance NN O
. . O

The DT O
insulin NN B-Gene
therapy NN O
regimen NNS O
did VBD O
not RB O
affect VB O
the DT O
evolution NN O
of IN O
the DT O
patients NNS O
and CC O
no DT O
significant JJ O
relationship NN O
existed VBD O
between IN O
the DT O
age NN O
at IN O
diagnosis NN O
, , O
duration NN O
of IN O
diabetes NNS O
, , O
daily JJ O
insulin NN B-Gene
dosage NN O
or CC O
metabolic JJ O
control NN O
and CC O
height NN O
or CC O
BMI NNP O
. . O

Validation NN O
of IN O
automated JJ O
systems NNS O
- : O
- : O
system NN O
definition NN O
. . O

Deletion NN O
of IN O
fdsR NN B-Gene
revealed VBD O
a DT O
dual JJ O
regulatory JJ O
effect NN O
of IN O
FdsR NNP B-Gene
on IN O
the DT O
fds NN B-Gene
operon NN I-Gene
by IN O
acting VBG O
as IN O
transcriptional JJ O
activator NN O
in IN O
the DT O
presence NN O
of IN O
formate NN O
or CC O
as IN O
repressor NN O
in IN O
the DT O
absence NN O
of IN O
formate NN O
. . O

Regulation NN O
of IN O
RhoA NNP B-Gene
is VBZ O
required VBN O
to TO O
maintain VB O
adhesion NN O
in IN O
stationary JJ O
cells NNS O
, , O
but CC O
is VBZ O
also RB O
critical JJ O
for IN O
cell NN O
spreading NN O
and CC O
migration NN O
[ VBP O
3 CD O
] NN O
. . O

A DT O
newly RB O
synthesized VBN O
anti RP O
- : O
inflammatory NN O
agent NN O
, , O
Y NNP O
- : O
8004 CD O
demonstrated VBD O
a DT O
greater JJR O
inhibition NN O
than IN O
did VBD O
indomethacin VB O
( ( O
IM NNP O
) ) O
. . O
on IN O
inflammatory JJ O
response NN O
such JJ O
as IN O
ultraviolet JJ O
erythema NN O
in IN O
guinea NN O
pigs NNS O
, , O
carrageenin NN O
edema NN O
, , O
evans VBZ O
blue JJ O
and CC O
carrageenin JJ O
- : O
induced JJ O
pleuritis NN O
and CC O
acetic JJ O
acid NN O
- : O
induced JJ O
peritonitis NN O
in IN O
rats NNS O
. . O

When WRB O
10 CD O
fields NNS O
were VBD O
analysed VBN O
, , O
a DT O
strong JJ O
relationship NN O
was VBD O
found VBN O
between IN O
the DT O
presence NN O
of IN O
bacteria NNS O
on IN O
Gram NNP O
staining NN O
and CC O
the DT O
final JJ O
diagnosis NN O
of IN O
VAP NNP O
( ( O
for IN O
PSB NNP O
and CC O
PTC NNP O
respectively RB O
: : O
sensitivity NN O
74 CD O
and CC O
81 CD O
% NN O
, , O
specificity NN O
94 CD O
and CC O
100 CD O
% NN O
, , O
positive JJ O
predictive JJ O
value NN O
91 CD O
and CC O
100 CD O
% NN O
, , O
negative JJ O
predictive JJ O
value NN O
82 CD O
and CC O
88 CD O
% NN O
) ) O
. . O

This DT O
is VBZ O
concluded VBN O
from IN O
the DT O
isolation NN O
of IN O
cDNAs NN O
from IN O
spinach NN O
( ( O
Spinacia NNP O
oleracea NN O
) ) O
and CC O
barley NN O
( ( O
Hordeum NNP O
vulgare NN O
cv NN O
. . O

The DT O
following JJ O
data NNS O
were VBD O
recorded VBN O
at IN O
arrival NN O
in IN O
the DT O
intensive JJ O
care NN O
unit NN O
6 CD O
, , O
12 CD O
, , O
24 CD O
, , O
and CC O
48 CD O
hours NNS O
after IN O
termination NN O
of IN O
CPB NNP O
: : O
heart NN O
rate NN O
, , O
blood NN O
pressure NN O
, , O
left VBD O
atrial JJ O
pressure NN O
, , O
central JJ O
- : O
peripheral JJ O
temperature NN O
difference NN O
, , O
arterial JJ O
- : O
central JJ O
venous JJ O
oxygen NN O
saturation NN O
difference NN O
, , O
urine JJ O
output NN O
, , O
serum JJ O
creatinine NN O
, , O
lactate NN O
and CC O
neutrophil JJ B-Gene
elastase NN I-Gene
levels NNS O
, , O
the DT O
Doppler NNP O
echocardiographic JJ O
factors NNS O
shortening VBG O
fraction NN O
and CC O
preejection NN O
period NN O
/ NN O
left VBD O
- : O
ventricular JJ O
ejection NN O
time NN O
, , O
and CC O
cumulative JJ O
doses NNS O
of IN O
catecholamines NNS O
( ( O
epinephrine NN O
) ) O
, , O
enoximone NN O
, , O
and CC O
furosemide RB O
. . O

Using VBG O
varying VBG O
conditions NNS O
, , O
three CD O
distinct NN O
complexes NNS O
were VBD O
shown VBN O
to TO O
interact VB O
specifically RB O
with IN O
the DT O
NIP NNP B-Gene
region NN I-Gene
, , O
although IN O
only RB O
one CD O
correlates VBZ O
with IN O
repressor NN O
activity NN O
. . O

It PRP O
was VBD O
established VBN O
that IN O
intrathecal JJ O
or CC O
intraperitoneal JJ O
PTFL NNP O
, , O
elevated VBD O
the DT O
nociceptive JJ O
threshold NN O
for IN O
mechanical JJ O
stimuli NNS O
in IN O
the DT O
formalin JJ O
test NN O
in IN O
rats NNS O
. . O

These DT O
same JJ O
regions NNS O
showed VBD O
remarkable JJ O
homology NN O
to TO O
two CD O
invertebrate NN O
proteins NNS O
, , O
CNC NNP B-Gene
and CC O
skin VBD B-Gene
- : I-Gene
1 CD I-Gene
, , O
postulated VBN O
to TO O
regulate VB O
embryonic JJ O
development NN O
in IN O
Drosophila NNP O
melanogaster NN O
and CC O
Caenorhabditis NNP O
elegans NNS O
, , O
respectively RB O
. . O

The DT O
peptide NN O
sequence NN O
contains VBZ O
a DT O
region NN O
of IN O
80 CD O
amino NN O
acids NNS O
that WDT O
shows VBZ O
similarity NN O
to TO O
bcl VB B-Gene
- : I-Gene
2 CD I-Gene
and CC O
to TO O
the DT O
recently RB O
described VBN O
bcl SYM B-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
related VBN I-Gene
gene NN I-Gene
, , O
MCL1 NNP B-Gene
. . O

1 CD O
- : O
( ( O
1 CD O
- : O
Naphthyl NN O
) ) O
piperazine NN O
( ( O
1 CD O
- : O
NP NN O
) ) O
has VBZ O
been VBN O
reported VBN O
to TO O
have VB O
serotonin JJ O
antagonist NN O
properties NNS O
at IN O
the DT O
5 CD B-Gene
- : I-Gene
HT2 NNP I-Gene
subtype NN I-Gene
of IN O
receptor NN O
, , O
and CC O
it PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
it PRP O
may MD O
have VB O
agonist JJ O
actions NNS O
at IN O
the DT O
5 CD B-Gene
- : I-Gene
HT1 NNP I-Gene
site NN I-Gene
. . O

Piroxicam NNP O
produced VBD O
a DT O
lower JJR O
incidence NN O
of IN O
gastric JJ O
ulcers NNS O
than IN O
equivalent JJ O
doses NNS O
of IN O
indomethacin NN O
. . O

However RB O
, , O
Cbf5p NNP B-Gene
was VBD O
found VBN O
to TO O
be VB O
nucleolar JJ O
and CC O
is VBZ O
highly RB O
homologous JJ O
to TO O
the DT O
rat NN B-Gene
nucleolar JJ I-Gene
protein NN I-Gene
NAP57 NNP I-Gene
, , O
which WDT O
coimmunoprecipitates VBZ O
with IN O
Nopp140 NNP B-Gene
and CC O
which WDT O
is VBZ O
postulated VBN O
to TO O
be VB O
involved VBN O
in IN O
nucleolar JJ O
- : O
cytoplasmic JJ O
shuttling NN O
( ( O
U NNP O
. . O

In IN O
yeast NN O
, , O
the DT O
products NNS O
of IN O
the DT O
UPF1 NNP B-Gene
and CC O
UPF3 NNP B-Gene
genes NNS I-Gene
are VBP O
required VBN O
for IN O
this DT O
decay NN O
pathway NN O
, , O
and CC O
in IN O
this DT O
report NN O
we PRP O
focus VBP O
on IN O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
additional JJ O
factors NNS O
required VBN O
for IN O
rapid JJ O
decay NN O
of IN O
nonsense JJ O
- : O
containing VBG O
mRNAs NN O
. . O

Zn NNP O
( ( O
II NNP O
) ) O
coordination NN O
domain NN O
mutants NNS O
of IN O
T4 NNP O
gene NN B-Gene
32 CD I-Gene
protein NN O
. . O

Zn NNP O
( ( O
II NNP O
) ) O
coordination NN O
domain NN O
mutants NNS O
of IN O
T4 NNP B-Gene
gene NN I-Gene
32 CD I-Gene
protein NN I-Gene
. . O

The DT O
daily JJ O
administration NN O
of IN O
betamethasone NN O
for IN O
three CD O
weeks NNS O
markedly RB O
reduced VBD O
the DT O
absorption NN O
of IN O
calcium NN O
and CC O
phosphate NN O
as RB O
well RB O
as IN O
the DT O
growth NN O
rate NN O
. . O

A DT O
simple JJ O
registration NN O
as IN O
an DT O
incentive NN O
for IN O
improvement NN O

E2F NNP B-Gene
activity NN O
is VBZ O
regulated VBN O
in IN O
part NN O
by IN O
the DT O
retinoblastoma NN B-Gene
family NN I-Gene
of IN I-Gene
tumor NN I-Gene
suppressor NN I-Gene
proteins NNS I-Gene
. . O

Different JJ O
thermoluminescent NN O
detectors NNS O
( ( O
TLD NNP O
) ) O
have VBP O
been VBN O
used VBN O
to TO O
measure VB O
the DT O
contribution NN O
of IN O
the DT O
low JJ O
linear JJ O
energy NN O
transfer NN O
component NN O
( ( O
LET NNP O
< NNP O
10 CD O
keV NN O
/ NNP O
micrometer NN O
) ) O
and CC O
plastic JJ O
nuclear JJ O
track NN O
detectors NNS O
( ( O
PNTD NNP O
) ) O
for IN O
the DT O
high JJ O
linear JJ O
energy NN O
tranfer NN O
( ( O
LET NNP O
) ) O
component NN O
. . O

An DT O
industry NN O
- : O
wide JJ O
retrospective JJ O
cohort NN O
mortality NN O
study NN O
was VBD O
conducted VBN O
on IN O
6 CD O
, , O
152 CD O
chemical NN O
workers NNS O
( ( O
2 CD O
, , O
460 CD O
exposed VBD O
and CC O
3 CD O
, , O
692 CD O
nonexposed VBN O
) ) O
engaged VBN O
in IN O
chloromethyl NN O
ether NN O
manufacture NN O
at IN O
7 CD O
major JJ O
U NNP O
. . O
S NNP O
. . O
companies NNS O
between IN O
1948 CD O
and CC O
1980 CD O
. . O

A DT O
minimal JJ O
ER3 NNP O
sequence NN O
of IN O
DNA NNP O
was VBD O
further RB O
demonstrated VBN O
to TO O
function VB O
as IN O
a DT O
FXR NNP B-Gene
HRE NNP I-Gene
and CC O
was VBD O
bound VBN O
in IN O
vitro NN O
by IN O
FXR NNP B-Gene
- : O
expressing VBG O
yeast JJ O
extracts NNS O
. . O

The DT O
FBF NNP O
questionnaire NN O
did VBD O
not RB O
highlight VB O
a DT O
characteristic JJ O
basic NN O
symptoms NNS O
profile IN O
of IN O
schizoaffective JJ O
disorder NN O
, , O
when WRB O
compared VBN O
with IN O
bipolar JJ O
affective JJ O
disorder NN O
and CC O
schizophrenia NN O
. . O

In IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
entry NN O
into IN O
mitosis NN O
requires VBZ O
activation NN O
of IN O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
Cdc28 NNP B-Gene
in IN O
its PRP$ O
cyclin NN B-Gene
B NNP I-Gene
( ( O
Clb NNP B-Gene
) ) O
- : O
associated VBN O
form NN O
. . O

The DT O
carcinoma NN O
was VBD O
restricted VBN O
within IN O
the DT O
epithelium NN O
in IN O
one CD O
, , O
the DT O
mucosal NN O
layer NN O
in IN O
five CD O
, , O
and CC O
the DT O
submucosal NN O
layer NN O
in IN O
two CD O
. . O

Role NNP O
of IN O
histoclinical JJ O
studies NNS O
in IN O
the DT O
prophylaxis NN O
of IN O
spontaneous JJ O
abortions NNS O

The DT O
core NN O
of IN O
this DT O
enhancer NN O
contains VBZ O
two CD O
evolutionarily RB O
conserved VBD O
binding VBG O
sites NNS O
for IN O
the DT O
homeodomain NN B-Gene
protein NN I-Gene
Tinman NNP B-Gene
( ( O
Tin NNP B-Gene
) ) O
, , O
expressed VBN O
in IN O
developing VBG O
cardiac JJ O
, , O
somatic JJ O
, , O
and CC O
visceral JJ O
muscle NN O
lineages NNS O
. . O

Altogether RB O
, , O
we PRP O
confirm VBP O
that IN O
all DT O
genes NNS O
of IN O
the DT O
Rad52 NNP B-Gene
recombinational JJ O
repair NN O
pathway NNS O
are VBP O
required VBN O
for IN O
the DT O
survival NN O
of IN O
rad27 NN B-Gene
Delta NNP I-Gene
strains VBZ O
at IN O
both DT O
permissive JJ O
( ( O
23 CD O
degrees NNS O
C NNP O
) ) O
and CC O
semipermissive JJ O
( ( O
30 CD O
degrees NNS O
C NNP O
) ) O
temperatures VBZ O
for IN O
growth NN O
. . O

In IN O
gel JJ O
retardation NN O
assays NNS O
, , O
an DT O
RCS NNP O
cell NN O
- : O
specific JJ O
protein NN O
and CC O
another DT O
closely RB O
related VBN O
protein NN O
expressed VBN O
only RB O
in IN O
RCS NNP O
cells NNS O
and CC O
primary JJ O
chondrocytes NNS O
bound IN O
to TO O
a DT O
10 CD O
- : O
bp NN O
sequence NN O
within IN O
the DT O
18 CD O
- : O
mer NN O
. . O

We PRP O
investigate VBP O
the DT O
reaction NN O
kinetics NNS O
of IN O
small JJ O
spherical JJ O
particles NNS O
with IN O
inertia NN O
, , O
obeying VBG O
coalescence NN O
type NN O
of IN O
reaction NN O
, , O
B NNP O
+ NNP O
B NNP O
- : O
- : O
> NN O
B NNP O
, , O
and CC O
being VBG O
advected VBN O
by IN O
hydrodynamical JJ O
flows NNS O
with IN O
time NN O
- : O
periodic JJ O
forcing NN O
. . O

The DT O
examination NN O
was VBD O
focused VBN O
on IN O
assessment NN O
of IN O
different JJ O
types NNS O
of IN O
drusen NN O
, , O
on IN O
evaluation NN O
of IN O
the DT O
development NN O
and CC O
incidence NN O
of IN O
risk NN O
factors NNS O
leading VBG O
to TO O
complications NNS O
and CC O
loss NN O
of IN O
central JJ O
vision NN O
. . O

Depletion NN O
of IN O
dopamine NN O
in IN O
the DT O
nucleus NN O
accumbens VBZ O
led VBN O
to TO O
a DT O
dramatic JJ O
shift NN O
in IN O
behavior NN O
in IN O
which WDT O
there EX O
was VBD O
a DT O
significant JJ O
decrease NN O
in IN O
lever NN O
pressing NN O
but CC O
a DT O
significant JJ O
increase NN O
in IN O
consumption NN O
of IN O
lab NN O
chow NN O
. . O

Transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta1 NN I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
) ) O
can MD O
act VB O
as IN O
a DT O
tumor NN O
suppressor NN O
or CC O
a DT O
tumor NN O
promoter NN O
depending VBG O
on IN O
the DT O
characteristics NNS O
of IN O
the DT O
malignant JJ O
cell NN O
. . O

Drag NNP O
reduction NN O
in IN O
turbulent NN O
flows NNS O
by IN O
polymers NNS O
. . O

The DT O
major JJ B-Gene
49 CD I-Gene
- : I-Gene
kDa NN I-Gene
core NN I-Gene
protein NN I-Gene
in IN O
the DT O
liver NN O
HSPG NNP B-Gene
preparation NN O
was VBD O
found VBN O
to TO O
be VB O
reactive JJ O
to TO O
an DT O
antibody NN O
that WDT O
specifically RB O
recognizes VBZ O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
fibroglycan JJ B-Gene
. . O

The DT O
effects NNS O
of IN O
several JJ O
opioid JJ O
agonists NNS O
and CC O
the DT O
opioid JJ O
antagonist NN O
naloxone NN O
were VBD O
examined VBN O
in IN O
rats NNS O
responding VBG O
under IN O
a DT O
fixed JJ O
- : O
consecutive JJ O
- : O
number NN O
( ( O
FCN NNP O
) ) O
schedule NN O
. . O

Based VBN O
on IN O
the DT O
hypothesis NN O
that WDT O
evolutionarily RB O
conserved VBD O
regions NNS O
are VBP O
functionally RB O
important JJ O
and CC O
likely JJ O
to TO O
interact VB O
with IN O
coactivators NNS O
, , O
we PRP O
compared VBN O
the DT O
amino NN O
acid JJ O
sequence NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBPalpha NNP I-Gene
from IN O
different JJ O
species NNS O
( ( O
frog NN O
to TO O
human JJ O
) ) O
and CC O
identified VBN O
four CD O
highly RB O
conserved VBN O
regions NNS O
( ( O
CR1 NNP O
- : O
CR4 NN O
) ) O
within IN O
the DT O
transactivation NN O
domain NN O
. . O

With IN O
NEU NNP B-Gene
overexpression NN O
, , O
nodal JJ O
control NN O
decreased VBD O
from IN O
72 CD O
% NN O
to TO O
34 CD O
% NN O
( ( O
p JJ O
= NNP O
. . O
8 CD O
) ) O
. . O

Co NNP O
- : O
transfection NN O
of IN O
expression NN O
vectors NNS O
for IN O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( I-Gene
C NNP I-Gene
/ NNP I-Gene
EBP NNP I-Gene
) ) I-Gene
alpha NN I-Gene
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
trans NNS O
- : O
activated VBD O
the DT O
rat NN B-Gene
uncoupling VBG I-Gene
protein JJ I-Gene
gene NN I-Gene
promoter NN I-Gene
due JJ O
to TO O
sequences NNS O
in IN O
the DT O
5 CD O
' POS O
proximal JJ O
region NN O
. . O

Secondly RB O
, , O
an DT O
ethanol JJ O
repression NN O
autoregulation NN O
( ( O
ERA NNP O
) ) O
/ VBP O
twelve SYM O
- : O
fold JJ O
TA NNP O
repeat NN O
( ( O
TAB NNP O
) ) O
repressor NN O
element NN O
was VBD O
identified VBN O
within IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
GLK1 NNP B-Gene
gene NN I-Gene
. . O

Variety NN O
of IN O
cows NNS O
and CC O
sires NNS O
according VBG O
to TO O
types NNS O
of IN O
dermatoglyphics NNS O
( ( O
patterns NNS O
) ) O
of IN O
the DT O
nose JJ O
- : O
labial JJ O
mirror NN O
of IN O
cattle NNS O

Additionally RB O
, , O
although IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
and CC O
egr VB B-Gene
- : I-Gene
1 CD I-Gene
mRNAs NNS I-Gene
are VBP O
expressed VBN O
at IN O
elevated JJ O
levels NNS O
in IN O
stimulated VBN O
liver NN O
cells NNS O
, , O
fos SYM B-Gene
- : I-Gene
B NN I-Gene
, , O
fra SYM B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
egr SYM B-Gene
- : I-Gene
2 CD I-Gene
are VBP O
not RB O
, , O
which WDT O
suggests VBZ O
that IN O
factors NNS O
in IN O
addition NN O
to TO O
the DT O
serum NN B-Gene
response NN I-Gene
factor NN I-Gene
participate NN O
in IN O
the DT O
regulation NN O
of IN O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
induction NN O
. . O

( ( O
1994 CD O
, , O
Hum NNP O
. . O

All DT O
adults NNS O
attending VBG O
the DT O
outpatient JJ O
clinics NNS O
of IN O
a DT O
dermatological JJ O
hospital NN O
on IN O
predetermined JJ O
days NNS O
were VBD O
given VBN O
the DT O
12 CD O
- : O
item NN O
General NNP O
Health NNP O
Questionnaire NNP O
. . O

A DT O
high JJ O
degree NN O
of IN O
correlation NN O
in IN O
the DT O
sense NN O
of IN O
the DT O
classic JJ O
conception NN O
of IN O
brain NN O
localization NN O
of IN O
neuropsychological JJ O
syndromes NNS O
was VBD O
found VBN O
. . O

The DT O
characteristic JJ O
feature NN O
of IN O
liver NN O
and CC O
spleen JJ O
MP NNP O
function NN O
in IN O
patients NNS O
with IN O
VHA NNP O
associated VBN O
with IN O
HBsAg NNP B-Gene
carriership NN O
consisted VBD O
in IN O
the DT O
lack NN O
of IN O
the DT O
compensatory JJ O
reaction NN O
on IN O
the DT O
part NN O
of IN O
spleen JJ O
MP NNP O
, , O
which WDT O
was VBD O
likely JJ O
to TO O
be VB O
connected VBN O
with IN O
overstrain NN O
of IN O
long JJ O
standing NN O
and CC O
depletion NN O
of IN O
the DT O
MP NNP O
system NN O
due JJ O
to TO O
permanent JJ O
antigenic JJ O
stimulation NN O
of IN O
HBsAg NNP B-Gene
. . O

The DT O
wild JJ O
- : O
type NN O
and CC O
altered VBD O
forms NNS O
of IN O
the DT O
F NNP B-Gene
protein NN I-Gene
were VBD O
expressed VBN O
in IN O
BHK NNP O
- : O
21 CD O
and CC O
HeLa NNP O
T4 NNP O
cells NNS O
by IN O
use NN O
of IN O
the DT O
recombinant JJ B-Gene
vaccinia NN I-Gene
virus NN I-Gene
- : I-Gene
encoding VBG I-Gene
T7 NNP I-Gene
polymerase NN I-Gene
system NN O
. . O

Very RB O
small JJ O
deletions NNS O
within IN O
the DT O
conserved JJ O
region NN O
completely RB O
abolished VBD O
transforming VBG O
activity NN O
of IN O
dbl NN B-Gene
, , O
while IN O
extensive JJ O
deletion NN O
outside IN O
of IN O
this DT O
region NN O
had VBD O
no DT O
effect NN O
. . O

The DT O
abscess NN O
was VBD O
debrided VBN O
and CC O
the DT O
septum NN O
was VBD O
patched VBN O
with IN O
a DT O
single JJ O
layer NN O
of IN O
autologous JJ O
pericardium NN O
. . O

In IN O
experiment JJ O
2 CD O
, , O
no DT O
difference NN O
in IN O
gastric JJ O
emptying NN O
of IN O
40 CD O
% NN O
peptone NN O
or CC O
25 CD O
% NN O
glucose NN O
was VBD O
found VBN O
between IN O
rats NNS O
receiving VBG O
TPN NNP O
and CC O
those DT O
receiving VBG O
intragastric JJ O
nutrition NN O
for IN O
10 CD O
to TO O
12 CD O
days NNS O
. . O

The DT O
analysis NN O
of IN O
the DT O
prevalence NN O
values NNS O
shows VBZ O
clearly RB O
that IN O
the DT O
global JJ O
MS NNP O
- : O
frequency NN O
is VBZ O
closer RBR O
related VBN O
to TO O
the DT O
geomagnetic JJ O
than IN O
to TO O
the DT O
geographic JJ O
latitude NN O
. . O

The DT O
expression NN O
of IN O
the DT O
putative JJ O
operon NN O
bglPH NN B-Gene
of IN O
Bacillus NN O
subtilis NNS O
was VBD O
studied VBN O
by IN O
using VBG O
bglP NN B-Gene
' '' I-Gene
- : O
lacZ JJ B-Gene
transcriptional JJ O
fusions NNS O
. . O

Harmful JJ O
effects NNS O
in IN O
animals NNS O
and CC O
man NN O
may MD O
result VB O
from IN O
both DT O
deficient NN O
or CC O
excessive JJ O
amounts NNS O
of IN O
intake NN O
. . O

The DT O
differences NNS O
among IN O
subgenera NN O
of IN O
the DT O
genus NN O
Dermacentor NNP O
are VBP O
more RBR O
significant JJ O
. . O

Only RB O
fully RB O
processed VBN O
Pra NNP B-Gene
( ( O
N0 NNP O
and CC O
Nb NNP O
) ) O
and CC O
ICP35 NNP B-Gene
( ( O
ICP35 NNP B-Gene
e RB I-Gene
, , I-Gene
f NN I-Gene
) ) O
are VBP O
present JJ O
in IN O
B NNP O
capsids NNS O
, , O
which WDT O
are VBP O
believed VBN O
to TO O
be VB O
precursors NNS O
of IN O
mature NN O
virions NNS O
. . O

Similarly RB O
, , O
comparison NN O
of IN O
percentage NN O
reductions NNS O
of IN O
heart NN O
rate NN O
at IN O
supine NN O
, , O
sitting VBG O
and CC O
exercise NN O
by IN O
repeated JJ O
measure NN O
analysis NN O
showed VBD O
the DT O
Malays NNPS O
to TO O
have VB O
significantly RB O
higher JJR O
change NN O
compared VBN O
to TO O
the DT O
Chinese NNP O
( ( O
p JJ O
= NN O
0 CD O
. . O
40 CD O
) ) O
. . O

Regionalization NN O
of IN O
drug NN O
delivery NN O
is VBZ O
a DT O
potential JJ O
method NN O
to TO O
avoid VB O
this DT O
problem NN O
. . O

Among IN O
non JJ O
- : O
cirrhotics NNS O
, , O
lack NN O
of IN O
portal JJ O
vein NN O
visualisation NN O
had VBD O
a DT O
90 CD O
% NN O
sensitivity NN O
, , O
88 CD O
% NN O
specificity NN O
, , O
94 CD O
% NN O
negative JJ O
predictive JJ O
value NN O
, , O
and CC O
83 CD O
% NN O
positive JJ O
predictive JJ O
value NN O
in IN O
the DT O
diagnosis NN O
of IN O
pre JJ O
- : O
sinusoidal JJ O
portal JJ O
hypertension NN O
. . O

A511 NNP O
is VBZ O
a DT O
broad JJ O
- : O
host NN O
- : O
range NN O
, , O
virulent NN O
myovirus NN O
for IN O
Listeria NNP O
monocytogenes NNS O
. . O

The DT O
stability NN O
of IN O
isoniazid JJ O
solutions NNS O
increases VBZ O
markedly RB O
with IN O
increasing VBG O
NTA NNP O
or CC O
EDTA NNP O
concentration NN O
up RB O
to TO O
1 CD O
mmol NNS O
/ JJ O
l NN O
. . O

This DT O
effect NN O
was VBD O
observed VBN O
in IN O
the DT O
absence NN O
of IN O
de FW O
novo FW O
protein CC O
synthesis NN O
and CC O
was VBD O
independent JJ O
of IN O
histone JJ B-Gene
deacetylase NN I-Gene
activity NN O
. . O

Thus RB O
, , O
endemic JJ O
cumlations NNS O
of IN O
hepatitis NN O
A NNP O
diseases NNS O
are VBP O
possible JJ O
. . O

Similar JJ O
experiments NNS O
with IN O
TR NNP B-Gene
support NN O
the DT O
high JJ O
affinity NN O
of IN O
RIP140 NNP B-Gene
to TO O
the DT O
RXR NNP B-Gene
subunit NN I-Gene
and CC O
also RB O
suggest VBP O
that IN O
either DT O
partner NN O
in IN O
the DT O
TR NNP B-Gene
/ NNP O
RXR NNP B-Gene
heterodimer NN O
can MD O
independently RB O
respond VB O
to TO O
ligand VB O
. . O

Commun NNP O
. . O

Amino NNP O
acid NN O
residues VBZ O
147 CD O
- : O
167 CD O
of IN O
the DT O
previously RB O
reported VBN O
sequence NN O
are VBP O
replaced VBN O
by IN O
new JJ O
residues NNS O
147 CD O
to TO O
150 CD O
. . O

Raf NNP B-Gene
is VBZ O
a DT O
key JJ O
serine NN B-Gene
- : I-Gene
threonine NN I-Gene
protein NN I-Gene
kinase NN I-Gene
which WDT O
participates VBZ O
in IN O
the DT O
transmission NN O
of IN O
growth NN O
, , O
anti SYM O
- : O
apoptotic JJ O
and CC O
differentiation NN O
messages NNS O
. . O

These DT O
properties NNS O
indicate VBP O
that IN O
Gle1 NNP B-Gene
is VBZ O
an DT O
RNA NNP O
- : O
export NN O
factor NN O
and CC O
that IN O
Rev NNP B-Gene
may MD O
mediate VB O
viral JJ O
RNA NNP O
export NN O
by IN O
mimicking VBG O
the DT O
function NN O
of IN O
Gle1 NNP B-Gene
. . O

Many JJ O
cells NNS O
were VBD O
negative JJ O
for IN O
endothelial JJ O
- : O
cell NN O
markers NNS O
, , O
and CC O
they PRP O
reacted VBD O
with IN O
a DT O
monoclonal JJ O
antibody NN O
against IN O
muscle NN O
actin NN B-Gene
. . O

BACKGROUND NN O
: : O
There EX O
is VBZ O
increasing VBG O
interest NN O
on IN O
the DT O
part NN O
of IN O
investigators NNS O
and CC O
the DT O
public NN O
at IN O
large JJ O
in IN O
finding VBG O
ways NNS O
to TO O
study VB O
and CC O
improve VB O
treatments NNS O
for IN O
the DT O
seriously RB O
mentally RB O
ill VB O
without IN O
exposing VBG O
such JJ O
individuals NNS O
to TO O
unnecessary JJ O
risks NNS O
. . O

The DT O
DNA NNP O
sequence NN O
adjacent NN O
to TO O
the DT O
lacZ NN B-Gene
gene NN I-Gene
has VBZ O
been VBN O
determined VBN O
for IN O
91 CD O
vegetative JJ O
fusion NN O
genes NNS O
whose WP$ O
products NNS O
have VBP O
been VBN O
localized VBN O
and CC O
for IN O
43 CD O
meiotically RB O
induced JJ O
fusions NNS O
. . O

Furthermore RB O
, , O
the DT O
striking JJ O
ability NN O
of IN O
polyoma NN B-Gene
middle JJ I-Gene
T NNP I-Gene
antigens VBZ I-Gene
to TO O
promote VB O
retinoic NN O
acid SYM O
- : O
induced JJ O
differentiation NN O
appears VBZ O
to TO O
utilize VB O
ERK NNP B-Gene
, , O
but CC O
not RB O
JNK NNP B-Gene
/ NNP O
SPK NNP B-Gene
or CC O
p38 VB B-Gene
signaling NN O
. . O

Possibility NN O
of IN O
a DT O
TSH NNP B-Gene
- : O
Screening VBG O
method NN O
for IN O
detection NN O
of IN O
hypothyroidism NN O
in IN O
the DT O
newborn NN O

We PRP O
conclude VBP O
that IN O
TA NNP O
caused VBD O
a DT O
specific JJ O
decrease NN O
in IN O
AGD NNP O
on IN O
GD NNP O
20 CD O
that WDT O
was VBD O
largely RB O
reversed VBN O
by IN O
PCD NNP O
23 CD O
. . O

Analysis NN O
of IN O
a DT O
Mac1p NNP B-Gene
mutant NN I-Gene
, , O
refractile NN O
for IN O
copper NN O
- : O
dependent JJ O
repression NN O
of IN O
the DT O
Cu NNP B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
transport NN I-Gene
genes NNS I-Gene
, , O
showed VBD O
an DT O
aberrant JJ O
pattern NN O
of IN O
CUP1 NNP B-Gene
expression NN O
and CC O
copper NN O
sensitivity NN O
. . O

The DT O
presence NN O
of IN O
cutaneous JJ O
xanthomas NNS O
with IN O
normal JJ O
serum NNS O
lipid JJ O
levels NNS O
is VBZ O
due JJ O
to TO O
the DT O
antibetalipoproteic JJ O
activity NN O
of IN O
the DT O
monoclonal JJ B-Gene
immunoglobulin NN I-Gene
. . O

Binding NNP O
of IN O
SSP NNP B-Gene
to TO O
the DT O
stage NN B-Gene
selector NN I-Gene
element NN I-Gene
( ( O
SSE NNP B-Gene
) ) O
in IN O
the DT O
proximal JJ O
gamma NN B-Gene
- : I-Gene
globin NN I-Gene
promoter NN I-Gene
is VBZ O
integral JJ O
to TO O
the DT O
competitive JJ O
silencing NN O
of IN O
a DT O
linked VBN O
beta NN B-Gene
- : I-Gene
promoter NN I-Gene
in IN O
embryonic JJ O
/ NNP O
fetal JJ O
stage NN O
erythroleukemia NN O
( ( O
K562 NNP O
) ) O
cells NNS O
. . O

Because IN O
of IN O
serious JJ O
infections NNS O
( ( O
fever RB O
larger JJR O
than IN O
or CC O
equal JJ O
to TO O
101 CD O
degrees NNS O
F NNP O
. . O
granulocytes VBZ O
less JJR O
than IN O
1 CD O
, , O
0 CD O
/ NN O
mm NN O
, , O
3 CD O
and CC O
hospitalization NN O
) ) O
and CC O
1 CD O
drug NN O
death NN O
in IN O
the DT O
first JJ O
4 CD O
patients NNS O
, , O
oral JJ O
calcium NN O
leucovorin NN O
, , O
20 CD O
to TO O
30 CD O
mg NNS O
/ JJ O
m2 NN O
orally RB O
, , O
was VBD O
given VBN O
2 CD O
days NNS O
after IN O
methotrexate NN O
in IN O
subsequent JJ O
treatment NN O
cycles NNS O
. . O

The DT O
rat NN B-Gene
branched VBD I-Gene
- : I-Gene
chain NN I-Gene
- : I-Gene
2 CD I-Gene
- : I-Gene
oxo NN I-Gene
- : I-Gene
acid NN I-Gene
dehydrogenase NN I-Gene
( ( I-Gene
BCOD NNP I-Gene
) ) I-Gene
kinase NN I-Gene
mRNA NN I-Gene
is VBZ O
transcribed VBN O
from IN O
a DT O
TATA NNP O
- : O
less RBR O
promoter NN O
that WDT O
has VBZ O
GC NNP O
- : O
rich JJ O
sequences NNS O
and CC O
two CD O
putative JJ O
Sp1 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
near IN O
the DT O
transcription NN O
start NN O
site NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
5 CD O
KE NNP O
X NNP O
3 CD O
/ NNP O
W NNP O
may MD O
be VB O
the DT O
optimal JJ O
regimen NNS O
to TO O
augment VB O
the DT O
antitumor NN O
immunity NN O
of IN O
RNL NNP O
. . O

In IN O
vitro JJ O
antimalarial JJ O
activity NN O
of IN O
neem NN O
( ( O
Azadirachta NNP O
indica VBZ O
A NNP O
. . O

The DT O
existence NN O
of IN O
threshold JJ O
concentrations NNS O
, , O
above IN O
which WDT O
certain JJ O
phenomena NNS O
may MD O
occur VB O
, , O
strengthens VBZ O
the DT O
role NN O
of IN O
sentinels NNS O
. . O

To TO O
study VB O
the DT O
mechanisms NN O
as RB O
well RB O
as IN O
magnitude NN O
of IN O
the DT O
transmembrane NN O
transfer NN O
of IN O
bacterial JJ O
products NNS O
from IN O
the DT O
dialysate NN O
, , O
we PRP O
developed VBD O
a DT O
computerized VBN O
in IN O
vitro JJ O
dialysis NN O
model NN O
which WDT O
provides VBZ O
continuous JJ O
pressure NN O
recording VBG O
from IN O
the DT O
arterial JJ O
, , O
venous JJ O
, , O
dialysate JJ O
inflow NN O
and CC O
outflow JJ O
ports NNS O
. . O

At IN O
cross NN O
purposes NNS O
. . O

Histamine NNP O
metabolism NN O
in IN O
hemorrhagic JJ O
- : O
hypotensive NN O
shock NN O

These DT O
data NNS O
indicate VBP O
that IN O
although IN O
218leu CD O
retains NNS O
normal JJ O
transactivation NN O
activity NN O
on IN O
a DT O
p53 NN B-Gene
promoter NN I-Gene
in IN O
yeast NN O
at IN O
physiological JJ O
temperatures NNS O
, , O
it PRP O
is VBZ O
not RB O
capable JJ O
of IN O
normal JJ O
p53 NN B-Gene
function NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
248trp CD B-Gene
allele NN I-Gene
in IN O
SNU NNP O
- : O
C5 NNP O
cells NNS O
. . O

The DT O
close JJ O
proximity NN O
of IN O
the DT O
two CD O
neuropeptide JJ B-Gene
Y NNP I-Gene
receptor NN I-Gene
genes NNS I-Gene
suggests VBZ O
that IN O
they PRP O
have VBP O
evolved VBN O
from IN O
a DT O
gene NN O
duplication NN O
event NN O
with IN O
the DT O
small JJ O
intron NN O
interrupting VBG O
the DT O
coding VBG O
sequence NN O
of IN O
the DT O
y1 NN B-Gene
gene NN I-Gene
being VBG O
converted VBN O
into IN O
a DT O
functional JJ O
sequence NN O
within IN O
the DT O
y5 JJ B-Gene
gene NN I-Gene
, , O
while IN O
the DT O
reverse NN O
complementary JJ O
sequence NN O
was VBD O
utilized VBN O
as IN O
an DT O
alternatively RB O
spliced JJ O
5 CD O
' POS O
exon NN O
for IN O
the DT O
y1 JJ B-Gene
gene NN I-Gene
. . O

Overexpression NN O
of IN O
PTTG NNP B-Gene
in IN O
transfected JJ O
NIH NNP O
3T3 CD O
cells NNS O
also RB O
stimulated VBD O
expression NN O
and CC O
secretion NN O
of IN O
basic JJ B-Gene
fibroblast NN I-Gene
growth NN I-Gene
factor NN I-Gene
, , O
a DT O
human JJ B-Gene
pituitary JJ I-Gene
tumor NN I-Gene
growth NN I-Gene
- : I-Gene
regulating NN I-Gene
factor NN I-Gene
. . O

MDBP NN B-Gene
from IN O
HeLa NNP O
and CC O
Raji NNP O
cells NNS O
formed VBD O
DNA NNP O
- : O
protein NN O
complexes NNS O
with IN O
X NNP O
- : O
box NN O
oligonucleotides IN O
that DT O
coelectrophoresed VBD O
with IN O
those DT O
containing VBG O
standard JJ O
MDBP NNP B-Gene
sites NNS I-Gene
. . O

A DT O
careful JJ O
, , O
radiolabelled VBD O
tissue NN O
- : O
distribution NN O
study NN O
is VBZ O
warranted VBN O
to TO O
elucidate VB O
the DT O
complicated JJ O
metabolic JJ O
fate NN O
of IN O
perhexiline NN O
. . O

Merr NNP O
. . O
) ) O
embryo NN O
library NN O
. . O

The DT O
strategies NNS O
by IN O
which WDT O
hepatitis NN O
B NNP O
and CC O
hepatitis NN O
D NNP O
can MD O
be VB O
diminished VBN O
and CC O
eventually RB O
eliminated VBN O
are VBP O
: : O
immunization NN O
, , O
measures NNS O
to TO O
prevent VB O
exposure NN O
to TO O
infective VB O
blood NN O
or CC O
blood NN O
derivatives NNS O
and CC O
education NN O
( ( O
in IN O
particular JJ O
awareness NN O
that WDT O
hepatitis NN O
B NNP O
is VBZ O
a DT O
sexually RB O
transmitted JJ O
disease NN O
) ) O
. . O

Invited VBN O
editorial NN O
on IN O
"""" NNP O
Acute NNP O
and CC O
chronic JJ O
effects NNS O
of IN O
exercise NN O
on IN O
leptin NN B-Gene
levels NNS O
in IN O
humans NNS O
"""" VBP O
. . O

Chronic NNP O
hypophosphatemia NN O
is VBZ O
the DT O
most RBS O
common JJ O
type NN O
of IN O
"""" NNP O
resistant JJ O
"""" NNP O
rickets NNS O
. . O

This DT O
indicates VBZ O
that IN O
under IN O
certain JJ O
experimental JJ O
conditions NNS O
cdc2 VBP B-Gene
/ JJ O
p58 NN B-Gene
and CC O
cdc2 NN B-Gene
/ NNP O
p62 NN B-Gene
may MD O
express VB O
some DT O
differences NNS O
in IN O
their PRP$ O
catalytic JJ O
activity NN O
. . O

Interferon NNP B-Gene
- : I-Gene
alpha NN I-Gene
treatment NN O
of IN O
posttransplant JJ O
lymphoproliferative JJ O
disorder NN O
in IN O
recipients NNS O
of IN O
solid JJ O
organ JJ O
transplants NNS O
. . O

Stress NNP B-Gene
- : I-Gene
inducible JJ I-Gene
protein NN I-Gene
kinases VBZ I-Gene
capable JJ O
of IN O
activating VBG O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
expression NN O
include VBP O
stress JJ B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
SAPK NNP B-Gene
/ NNP O
JNK NNP B-Gene
) ) O
and CC O
p38 JJ B-Gene
members NNS O
of IN O
the DT O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
superfamily RB O
of IN O
signaling VBG O
molecules NNS O
. . O

False NNP O
positive JJ O
amniotic JJ B-Gene
fluid NN I-Gene
alpha NN I-Gene
fetoprotein NN I-Gene
levels NNS O
resulting VBG O
from IN O
contamination NN O
with IN O
fetal JJ O
blood NN O
: : O
results NNS O
of IN O
an DT O
experiment NN O
. . O

A DT O
new JJ O
variant NN O
of IN O
the DT O
EMG NNP O
- : O
BFB NNP O
method NN O
( ( O
multichannel NN O
) ) O
is VBZ O
offered VBN O
which WDT O
has VBZ O
made VBN O
it PRP O
possible JJ O
to TO O
use VB O
the DT O
method NN O
not RB O
only RB O
for IN O
training NN O
weakened VBN O
muscles NNS O
and CC O
reducing VBG O
spasticity NN O
in IN O
their PRP$ O
antagonists NNS O
but CC O
also RB O
for IN O
improving VBG O
motor NN O
coordination NN O
. . O

HIV NNP O
- : O
1 CD O
C NNP O
subtype NN O
in IN O
IDUs NNP O
accounted VBD O
for IN O
61 CD O
. . O
3 CD O
% NN O
. . O

Phagocytosis NN O
of IN O
tubercle NN O
bacilli NN O
by IN O
macrophages NNS O
. . O

Identification NN O
of IN O
pulmonary JJ O
vein NN O
stenosis NN O
after IN O
radiofrequency NN O
ablation NN O
for IN O
atrial JJ O
fibrillation NN O
using VBG O
MRI NNP O
. . O

In IN O
addition NN O
, , O
there EX O
was VBD O
a DT O
significant JJ O
increase NN O
in IN O
postdexamethasone JJ O
cortical JJ O
concentrations NNS O
with IN O
age NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
; : O
r NN O
= VBZ O
0 CD O
. . O
31 CD O
) ) O
. . O

Diagnosis NN O
and CC O
differential JJ O
diagnosis NN O

Effect NN O
of IN O
noise NN O
on IN O
CO NNP O
- : O
induced JJ O
increases NNS O
of IN O
LAP NNP B-Gene
and CC O
GPT NNP B-Gene
activity NN O
in IN O
the DT O
plasma NN O
of IN O
rats NNS O

Their PRP$ O
use NN O
resulted VBD O
in IN O
a DT O
sensitivity NN O
of IN O
73 CD O
% NN O
and CC O
a DT O
specificity NN O
of IN O
74 CD O
% NN O
with IN O
regard NN O
to TO O
predictability NN O
of IN O
ALT NNP B-Gene
levels NNS O
increasing VBG O
during IN O
the DT O
trial NN O
. . O

Structural JJ O
characteristics NNS O
of IN O
the DT O
erythrocyte NN O
membrane NN O
, , O
peroxidation NN O
processes NNS O
and CC O
antioxidant JJ O
function NN O
in IN O
children NNS O
with IN O
diffuse NN O
glomerulonephritis NN O

After IN O
selection NN O
and CC O
conversion NN O
to TO O
adipocytes NNS O
, , O
the DT O
level NN O
of IN O
EGFR NNP B-Gene
expression NN O
was VBD O
retained VBN O
in IN O
infectant JJ O
adipocytes NNS O
( ( O
150 CD O
, , O
0 CD O
and CC O
250 CD O
, , O
0 CD O
/ NN O
cell NN O
, , O
respectively RB O
) ) O
, , O
but CC O
not RB O
in IN O
the DT O
parental JJ O
3T3 CD O
- : O
L1 NN O
adipocytes NNS O
( ( O
< JJ O
5000 CD O
/ NNP O
cell NN O
) ) O
. . O

DESIGN NNP O
AND CC O
METHODS NNP O
: : O
Case NN O
study NN O
. . O

Evidence NNP O
- : O
based VBN O
care NN O
: : O
a DT O
new JJ O
formula NN O
for IN O
an DT O
old JJ O
problem NN O
? . O

Co NNP O
- : O
existence NN O
of IN O
these DT O
regulatory JJ O
elements NNS O
with IN O
other JJ O
elements NNS O
, , O
such JJ O
as IN O
the DT O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
element NN I-Gene
or CC O
CCAAT NNP O
box NN O
, , O
was VBD O
also RB O
found VBN O
. . O

We PRP O
have VBP O
shown VBN O
previously RB O
that IN O
GH3 NNP O
cells NNS O
transfected VBN O
with IN O
the DT O
rat NN B-Gene
GnRH NNP I-Gene
receptor NN I-Gene
cDNA NN I-Gene
( ( O
GGH3 NNP O
- : O
1 CD O
' '' O
cells NNS O
) ) O
support VBP O
the DT O
expression NN O
of IN O
a DT O
cotransfected JJ O
fusion NN O
gene NN O
composed VBD O
of IN O
797 CD O
base NN O
pairs NN O
of IN O
rat NN B-Gene
LHbeta NNP I-Gene
gene NN I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
flanking VBG I-Gene
sequence NN I-Gene
and CC O
the DT O
first JJ O
5 CD O
base NN O
pairs NN O
of IN O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
region NN O
fused VBN O
to TO O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
( ( I-Gene
- : I-Gene
797 CD I-Gene
/ JJ I-Gene
+ NNP I-Gene
5LHbetaLUC CD I-Gene
) ) I-Gene
and CC O
respond NN O
to TO O
a DT O
GnRH NNP B-Gene
agonist NN O
with IN O
a DT O
10 CD O
- : O
fold JJ O
stimulation NN O
of IN O
activity NN O
. . O

Identification NN O
, , O
purification NN O
, , O
and CC O
molecular JJ O
cloning NN O
of IN O
autonomously RB B-Gene
replicating VBG I-Gene
sequence NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
1 CD I-Gene
from IN I-Gene
fission NN I-Gene
yeast NN I-Gene
Schizosaccharomyces NNP I-Gene
pombe NN I-Gene
. . O

The DT O
femoral JJ O
artery NN O
/ NN O
vein NN O
and CC O
the DT O
soleus NN O
and CC O
gastrocnemius NN O
muscles NNS O
were VBD O
examined VBN O
in IN O
healthy JJ O
human JJ O
male NN O
volunteers NNS O
. . O

All DT O
groups NNS O
were VBD O
tested VBN O
in IN O
a DT O
Hebb NNP O
- : O
Williams NNP O
maze VBP O
at IN O
100 CD O
approximately RB O
10 CD O
days NNS O
of IN O
age NN O
. . O

The DT O
various JJ O
muscles NNS O
of IN O
the DT O
pelvic JJ O
floor NN O
region NN O
could MD O
be VB O
reflexly VBN O
activated JJ O
either CC O
individually RB O
or CC O
as IN O
a DT O
mass NN O
unit NN O
depending VBG O
on IN O
the DT O
intensity NN O
of IN O
stimulation NN O
. . O

Two CD O
copies NNS O
of IN O
the DT O
72 CD O
- : O
bp NN O
repeat NN O
provided VBD O
efficient JJ O
activation NN O
of IN O
gene NN O
expression NN O
. . O

The DT O
presence NN O
of IN O
such JJ O
a DT O
putative JJ O
RNA NNP O
- : O
binding NN O
domain NN O
suggests VBZ O
a DT O
mechanism NN O
for IN O
the DT O
observed JJ O
autoregulation NN O
of IN O
bacteriophage NN O
T4 NNP B-Gene
DNA NNP I-Gene
polymerase NN I-Gene
synthesis NN O
by IN O
binding VBG O
to TO O
its PRP$ O
own JJ O
mRNA NN O
. . O

The DT O
lack NN O
of IN O
the DT O
C2 NNP B-Gene
domain NN O
of IN O
the DT O
Ca NNP B-Gene
( ( I-Gene
2 CD I-Gene
+ NN I-Gene
) ) I-Gene
- : I-Gene
dependent JJ I-Gene
PKCs NNP I-Gene
and CC O
the DT O
presence NN O
of IN O
a DT O
unique JJ O
NH2 NNP O
- : O
terminal JJ O
sequence NN O
with IN O
a DT O
potential JJ O
signal NN O
peptide NN O
and CC O
a DT O
transmembrane NN O
domain NN O
suggest VBP O
that IN O
PKC NNP B-Gene
mu NN I-Gene
is VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
subgroup NN O
of IN O
atypical JJ O
PKCs NNP B-Gene
. . O

Clones NNS O
that WDT O
expressed VBD O
DBD NNP O
exhibited VBD O
a DT O
dominant JJ O
negative JJ O
phenotype NN O
and CC O
did VBD O
not RB O
elicit VB O
antiviral JJ O
activity NN O
against IN O
vesicular JJ O
stomatitis NN O
virus NN O
( ( O
VSV NNP O
) ) O
infection NN O
upon IN O
IFN NNP B-Gene
treatment NN O
. . O

Post NNP O
and CC O
core NN O
fabrication NN O
for IN O
divergent JJ O
canals NNS O
with IN O
a DT O
cast NN O
post NN O
and CC O
core NN O
and CC O
a DT O
prefabricated JJ O
dowel NN O
. . O

The DT O
six CD O
commonest JJS O
causes NNS O
of IN O
death NN O
varied VBN O
in IN O
the DT O
three CD O
ethnic JJ O
groups NNS O
. . O

Surveillance NN O
for IN O
preeclampsia NN O
was VBD O
conducted VBN O
by IN O
personnel NNS O
unaware NN O
of IN O
treatment NN O
- : O
group NN O
assignments NNS O
, , O
using VBG O
standardized JJ O
measurements NNS O
of IN O
blood NN O
pressure NN O
and CC O
urinary JJ O
protein NN O
excretion NN O
at IN O
uniformly RB O
scheduled VBN O
prenatal JJ O
visits NNS O
, , O
protocols NNS O
for IN O
monitoring VBG O
these DT O
measurements NNS O
during IN O
the DT O
hospitalization NN O
for IN O
delivery NN O
, , O
and CC O
reviews NNS O
of IN O
medical JJ O
records NNS O
of IN O
unscheduled JJ O
outpatient JJ O
visits NNS O
and CC O
all DT O
hospitalizations NNS O
. . O

The DT O
Bacillus NNP B-Gene
subtilis NNS I-Gene
phage NN I-Gene
phi VBP I-Gene
105 CD I-Gene
repressor NN I-Gene
, , O
a DT O
lambda NN B-Gene
repressor NN I-Gene
- : O
like IN O
transcriptional JJ O
regulatory JJ O
protein NN O
, , O
was VBD O
overproduced VBN O
in IN O
Escherichia NNP O
coli NN O
and CC O
purified VBD O
to TO O
near IN O
homogeneity NN O
in IN O
order NN O
to TO O
examine VB O
its PRP$ O
in IN O
vitro NN O
DNA NNP O
- : O
binding NN O
properties NNS O
. . O

All DT O
patients NNS O
with IN O
deterioriation NN O
in IN O
mental JJ O
status NN O
showed VBD O
a DT O
marked JJ O
increase NN O
in IN O
liver JJ O
enzymes NNS O
( ( O
aspartate NN B-Gene
and CC I-Gene
alanine JJ I-Gene
aminotransaminases NNS I-Gene
) ) O
and CC O
severe JJ O
coagulopathy NN O
. . O

RNA NNP O
transcripts NNS O
that WDT O
hybridize VBP O
to TO O
the DT O
introduced VBN O
foreign JJ O
gene NN O
have VBP O
been VBN O
identified VBN O
. . O

Deterministic JJ O
effects NNS O
. . O

They PRP O
are VBP O
subdivided VBN O
into IN O
two CD O
types NNS O
that IN O
activate VBP O
transduction NN O
pathways NNS O
via IN O
different JJ O
cell NN O
surface NN O
receptors NNS O
. . O

Bupropion NN O
to TO O
aid VB O
smoking NN O
cessation NN O
. . O

To TO O
prepare VB O
for IN O
analyses NNS O
with IN O
the DT O
family NN O
variables NNS O
, , O
we PRP O
next JJ O
present JJ O
descriptive NN O
data NNS O
based VBN O
on IN O
separate JJ O
principal JJ O
components NNS O
analysis NN O
( ( O
PCA NNP O
) ) O
and CC O
multidimensional JJ O
scaling NN O
analysis NN O
( ( O
MDS NNP O
) ) O
of IN O
14 CD O
self NN O
- : O
reported VBD O
health NN O
scores NNS O
for IN O
husbands NNS O
and CC O
for IN O
wives NNS O
. . O

Morphofunctional JJ O
status NN O
of IN O
the DT O
formed JJ O
elements NNS O
of IN O
the DT O
blood NN O
in IN O
rats NNS O
subjected VBN O
to TO O
different JJ O
variants NNS O
of IN O
combined JJ O
and CC O
isolated JJ O
exposure NN O
to TO O
BR NNP O
- : O
1 CD O
benzene NN O

This DT O
work NN O
unravels VBZ O
a DT O
new JJ O
model NN O
for IN O
the DT O
ets NNS B-Gene
- : I-Gene
1 CD I-Gene
/ JJ O
ets NNS B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
' '' O
s JJ O
evolution NN O
, , O
based VBN O
for IN O
the DT O
first JJ O
time NN O
on IN O
both DT O
structural JJ O
and CC O
functional JJ O
evidences NNS O
. . O

We PRP O
also RB O
demonstrate VBP O
that IN O
the DT O
spo20 NN B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
gene NN I-Gene
product NN I-Gene
is VBZ O
structurally RB O
homologous JJ O
to TO O
Saccharomyces NNPS B-Gene
cerevisiae NN I-Gene
Sec14 NNP I-Gene
, , O
the DT O
major JJ O
phosphatidylinositol NN O
transfer NN O
protein NN O
of IN O
budding VBG O
yeast NN O
. . O

Using VBG O
the DT O
presented JJ O
categorical JJ O
structure NN O
as IN O
domain NN O
model NN O
a DT O
prototype NN O
DSS NNP O
for IN O
dipslide JJ O
urine JJ O
cultures NNS O
has VBZ O
been VBN O
developed VBN O
. . O

CodY NN B-Gene
does VBZ O
not RB O
have VB O
any DT O
homologues NNS O
in IN O
the DT O
data NNS O
- : O
bases NNS O
. . O

The DT O
murine NN B-Gene
MHC NNP I-Gene
class NN I-Gene
I PRP I-Gene
genes NNS I-Gene
, , O
H NNP B-Gene
- : I-Gene
2Dq CD I-Gene
and CC O
H NNP B-Gene
- : I-Gene
2Lq CD I-Gene
, , O
are VBP O
strikingly RB O
homologous JJ O
to TO O
each DT O
other JJ O
, , O
H NNP B-Gene
- : I-Gene
2Ld CD I-Gene
, , O
and CC O
two CD O
genes NNS O
reported VBD O
to TO O
encode VB O
tumor NN O
- : O
specific JJ O
antigens NNS O
. . O

Rind NNP O
et CC O
al RB O
. . O
' '' O
s JJ O
study NN O
' POS O
s NN O
main JJ O
conclusions NNS O
were VBD O
not RB O
supported VBN O
by IN O
the DT O
original JJ O
data NNS O
. . O

The DT O
proteins NNS O
are VBP O
more JJR O
than IN O
90 CD O
% NN O
identical JJ O
to TO O
each DT O
other JJ O
within IN O
the DT O
protein NN O
kinase NN O
domain NN O
but CC O
only RB O
51 CD O
- : O
59 CD O
% NN O
identical JJ O
to TO O
other JJ O
casein JJ B-Gene
kinase NN I-Gene
I PRP I-Gene
isoforms VBP I-Gene
within IN O
this DT O
region NN O
. . O

CASE JJ O
REPORT NNP O
: : O
We PRP O
observed VBD O
a DT O
congenital JJ O
skin NN O
defect NN O
located VBN O
exclusively RB O
on IN O
the DT O
trunk NN O
. . O

MDS1 NNP B-Gene
/ NNP O
EVI1 NNP B-Gene
, , O
located VBN O
on IN O
chromosome NN O
3 CD O
band NN O
q26 NN O
, , O
encodes VBZ O
a DT O
zinc NN B-Gene
- : I-Gene
finger NN I-Gene
DNA NNP I-Gene
- : I-Gene
binding VBG I-Gene
transcription NN I-Gene
activator NN I-Gene
not RB O
detected VBN O
in IN O
normal JJ O
hematopoietic JJ O
cells NNS O
but CC O
expressed VBN O
in IN O
several JJ O
normal JJ O
tissues NNS O
. . O

Subretinal JJ O
fluid NN O
was VBD O
punctured VBN O
on IN O
the DT O
poorer JJR O
eye NN O
in IN O
19 CD O
eyes NNS O
( ( O
52 CD O
. . O
7 CD O
% NN O
) ) O
and CC O
on IN O
the DT O
better JJR O
eye NN O
in IN O
7 CD O
eyes NNS O
( ( O
19 CD O
. . O
4 CD O
% NN O
) ) O
. . O

According VBG O
to TO O
the DT O
literature NN O
, , O
second JJ O
malignant JJ O
epithelial JJ O
tumours NNS O
are VBP O
, , O
in IN O
contrast NN O
to TO O
mesenchymal VB O
tumours NNS O
such JJ O
as IN O
osteosarcoma NN O
, , O
very RB O
rare JJ O
in IN O
retinoblastoma NN O
survivors NNS O
. . O

CREST NNP O
syndrome NN O
; : O
a DT O
changing VBG O
clinical JJ O
significance NN O

Recently RB O
, , O
studies NNS O
of IN O
agents NNS O
that WDT O
disrupt VBP O
collagen NN B-Gene
synthesis NN O
and CC O
deposition NN O
have VBP O
yielded VBN O
several JJ O
new JJ O
angiogenesis NN O
inhibitors NNS O
. . O

A DT O
mutation NN O
which WDT O
abrogates VBZ O
the DT O
binding NN O
of IN O
these DT O
factors NNS O
reduces NNS O
Wp NNP B-Gene
reporter NN I-Gene
activity NN O
specifically RB O
in IN O
B NNP O
cell NN O
lines NNS O
, , O
whereas IN O
a DT O
mutation NN O
which WDT O
converts VBZ O
the DT O
site NN O
to TO O
a DT O
consensus NN O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
sequence NN I-Gene
maintains VBZ O
wild JJ O
- : O
type NN O
promoter NN O
function NN O
. . O

We PRP O
also RB O
identify VBP O
several JJ O
regulatory JJ O
domain NN O
mutants NNS O
in IN O
which WDT O
Cd NNP O
( ( O
2 CD O
+ NN O
) ) O
tolerance NN O
of IN O
the DT O
mutant JJ O
strain NN O
and CC O
transport NN O
activity NN O
of IN O
the DT O
protein NN O
are VBP O
dissociated VBN O
. . O

Aortic JJ O
diameters NNS O
in IN O
infants NNS O
and CC O
young JJ O
children NNS O
: : O
normative JJ O
angiographic JJ O
data NNS O
. . O

Results NNS O
demonstrated VBD O
that IN O
the DT O
presence NN O
of IN O
myofibroblasts NNS O
varied VBD O
considerably RB O
from IN O
case NN O
to TO O
case NN O
and CC O
was VBD O
always RB O
related VBN O
to TO O
smooth VB O
muscle NN O
cell NN O
dispersion NN O
, , O
which WDT O
occurred VBD O
around IN O
medium NN O
- : O
sized VBN O
damaged VBN O
portal JJ O
vein NN O
branches NNS O
. . O

The DT O
carboxy JJ O
terminus NN O
of IN O
Mbp1 NNP B-Gene
is VBZ O
sufficient JJ O
for IN O
interaction NN O
with IN O
Swi6 NNP B-Gene
, , O
and CC O
the DT O
carboxy JJ O
terminus NN O
of IN O
Swi6 NNP B-Gene
is VBZ O
required VBN O
for IN O
interaction NN O
with IN O
Mbp1 NNP B-Gene
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
crucial JJ O
role NN O
of IN O
the DT O
mutations NNS O
activating VBG O
v JJ B-Gene
- : I-Gene
erbA NN I-Gene
as IN O
an DT O
oncogene NN O
is VBZ O
to TO O
' '' O
freeze NN O
' '' O
c SYM B-Gene
- : I-Gene
ErbA NNP I-Gene
/ NNP O
TRalpha NNP B-Gene
in IN O
its PRP$ O
non JJ O
- : O
liganded VBN O
, , O
repressive JJ O
conformation NN O
and CC O
to TO O
facilitate VB O
its PRP$ O
overexpression NN O
. . O

Analysis NN O
of IN O
SRE NNP O
oligonucleotide IN O
gel JJ O
mobility NN O
shift NN O
assays VBZ O
with IN O
nuclear JJ O
extracts NNS O
from IN O
Sertoli NNP O
cells NNS O
demonstrated VBD O
the DT O
presence NN O
of IN O
both CC O
the DT O
SRF NNP B-Gene
and CC O
the DT O
ubiquitously RB O
expressed VBN O
bHLH NN O
protein NN O
E12 NNP B-Gene
/ NNP O
E47 NNP B-Gene
. . O

Drug NN O
and CC O
personnel NNS O
costs NNS O
were VBD O
reduced VBN O
when WRB O
batch NN O
manufacturing NN O
with IN O
40 CD O
- : O
mL NN O
multidose JJ O
vials NNS O
was VBD O
compared VBN O
with IN O
extemporaneous JJ O
compounding VBG O
with IN O
unit NN O
- : O
dose JJ O
vials NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
mammalian JJ O
erythroid NN O
alpha SYM B-Gene
- : I-Gene
spectrin NN I-Gene
evolved VBN O
by IN O
duplication NN O
and CC O
rapid JJ O
divergence NN O
from IN O
an DT O
ancestral JJ O
alpha NN B-Gene
- : I-Gene
fodrin JJ I-Gene
- : I-Gene
like IN I-Gene
gene NN I-Gene
. . O

Disruption NN O
of IN O
the DT O
HOG1 NNP B-Gene
and CC O
PBS2 NNP B-Gene
genes NNS I-Gene
leads VBZ O
to TO O
a DT O
dramatic JJ O
decrease NN O
of IN O
the DT O
HSP12 NNP B-Gene
inducibility NN O
in IN O
osmostressed JJ O
cells NNS O
, , O
whereas JJ O
overproduction NN O
of IN O
Hog1 NNP B-Gene
produces VBZ O
a DT O
fivefold JJ O
increase NN O
in IN O
wild JJ O
- : O
type NN O
induced JJ O
levels NNS O
upon IN O
a DT O
shift NN O
to TO O
a DT O
high JJ O
salt NN O
concentration NN O
. . O

Differential JJ O
expression NN O
of IN O
AP NNP B-Gene
- : I-Gene
2alpha CD I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
2beta CD I-Gene
in IN O
the DT O
developing VBG O
chick JJ O
retina NN O
: : O
repression NN O
of IN O
R NNP B-Gene
- : I-Gene
FABP NNP I-Gene
promoter NN I-Gene
activity NN O
by IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
with IN O
each DT O
of IN O
these DT O
sequences NNS O
demonstrated VBD O
complexes NNS O
with IN O
mobilities NNS O
identical JJ O
to TO O
those DT O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
site NN I-Gene
from IN O
the DT O
kappa NN B-Gene
light JJ I-Gene
- : I-Gene
chain NN I-Gene
gene NN I-Gene
. . O

At IN O
cuticular JJ O
positions NNS O
exhibiting VBG O
the DT O
Brd NNP B-Gene
bristle JJ I-Gene
loss NN I-Gene
phenotype NN I-Gene
, , O
we PRP O
have VBP O
found VBN O
that IN O
the DT O
progeny NN O
of IN O
the DT O
multiplied JJ O
SOPs NNP O
develop NN O
aberrantly RB O
, , O
in IN O
that DT O
neurons NNS O
and CC O
thecogen NN O
( ( O
sheath NN O
) ) O
cells NNS O
appear VBP O
but CC O
not RB O
trichogen NN O
( ( O
shaft NN O
) ) O
and CC O
tormogen NN O
( ( O
socket NN O
) ) O
cells NNS O
. . O

The DT O
pea NN B-Gene
rps10 NN I-Gene
intron NN I-Gene
is VBZ O
homologous JJ O
to TO O
introns NNS O
in IN O
rrn26 NN B-Gene
and CC O
cox3 NN B-Gene
in IN O
the DT O
Marchantia NNP O
mitochondrial JJ O
genome NN O
, , O
while IN O
the DT O
Marchantia NNP B-Gene
rps10 NN I-Gene
gene NN I-Gene
lacks VBZ O
an DT O
intron NN O
. . O

Mutational JJ O
analyses NNS O
showed VBD O
that IN O
in IN O
- : O
frame NN O
stop JJ O
codons NNS O
introduced VBD O
into IN O
five CD O
of IN O
seven CD O
RNA NNP B-Gene
2 CD I-Gene
ORFs NNP I-Gene
did VBD O
not RB O
affect JJ O
accumulation NN O
of IN O
progeny NN O
LIYV NNP B-Gene
RNA NNP I-Gene
1 CD I-Gene
or CC O
RNA NNP B-Gene
2 CD I-Gene
, , O
confirming VBG O
that IN O
RNA NNP B-Gene
2 CD I-Gene
does VBZ O
not RB O
encode VB O
proteins NNS O
necessary JJ O
for IN O
LIYV NNP O
RNA NNP O
replication NN O
. . O

Appl NNP O
. . O

However RB O
, , O
a DT O
zinc NN O
- : O
depleted VBD O
enzyme NN O
was VBD O
obtained VBN O
after IN O
prolonged JJ O
dialysis NN O
against IN O
the DT O
specific JJ O
chelating NN O
agent NN O
1 CD O
, , O
10 CD O
- : O
phenanthroline NN O
. . O

High JJ O
ADR1 NNP B-Gene
gene NN I-Gene
dosage NN O
increased VBD O
the DT O
transcription NN O
of IN O
genes NNS O
encoding VBG O
peroxisomal JJ O
proteins NNS O
as IN O
compared VBN O
to TO O
one CD O
copy NN O
of IN O
the DT O
ADR1 NNP B-Gene
gene NN I-Gene
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
these DT O
results NNS O
may MD O
raise VB O
the DT O
interesting JJ O
possibility NN O
of IN O
providing VBG O
a DT O
means NN O
of IN O
identifying VBG O
greater JJR O
or CC O
lesser JJR O
susceptibility NN O
to TO O
the DT O
coronary JJ O
effects NNS O
of IN O
Type NNP O
A NNP O
behavior NN O
. . O

We PRP O
have VBP O
initiated VBN O
studies NNS O
to TO O
identify VB O
candidate JJ O
signal NN O
transducers NNS O
that WDT O
associate VBP O
with IN O
the DT O
cytosolic NN O
domain NN O
( ( O
cd NN O
) ) O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
1R CD I-Gene
. . O

Low NNP O
- : O
grade NN O
glioma NN O
. . O

Factor NNP O
V NNP O
Leiden NNP O
is VBZ O
a DT O
genetic JJ O
disorder NN O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
venous JJ O
thrombosis NN O
. . O

Landsberg NNP O
( ( O
La NNP O
- : O
O NN O
) ) O
and CC O
cv NN O
. . O

Further RB O
, , O
the DT O
osteo JJ O
- : O
retentive JJ O
ability NN O
of IN O
the DT O
hydroxyapatite NN O
in IN O
the DT O
sockets NNS O
was VBD O
seen VBN O
to TO O
be VB O
close RB O
to TO O
significance NN O
( ( O
after IN O
six CD O
months NNS O
width JJ O
differences NNS O
, , O
in IN O
the DT O
canine JJ O
region NN O
: : O
P NNP O
= VBZ O
0 CD O
. . O
59 CD O
, , O
LHS NNP O
, , O
and CC O
P NNP O
= NNP O
0 CD O
. . O
65 CD O
, , O
RHS NNP O
) ) O
. . O

Using VBG O
a DT O
high JJ O
- : O
copy NN O
suppression NN O
strategy NN O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
yeast JJ O
gene NN O
( ( O
UBS1 NNP B-Gene
) ) O
whose WP$ O
elevated JJ O
expression NN O
suppresses VBZ O
the DT O
conditional JJ O
cell NN O
cycle NN O
defects NNS O
associated VBN O
with IN O
cdc34 JJ B-Gene
mutations NNS O
. . O

The DT O
17 CD O
- : O
kDa NN O
protein NN O
is VBZ O
required VBN O
for IN O
the DT O
systemic JJ O
infection NN O
of IN O
plants NNS O
. . O

Mutational JJ O
analysis NN O
of IN O
the DT O
major JJ O
homology NN O
region NN O
of IN O
Mason NNP O
- : O
Pfizer NNP O
monkey JJ O
virus NN O
by IN O
use NN O
of IN O
saturation NN O
mutagenesis NN O
. . O

When WRB O
expressed VBN O
in IN O
COS NNP O
- : O
7 CD O
cells NNS O
, , O
MKP NNP B-Gene
- : I-Gene
4 CD I-Gene
blocks NNS O
activation NN O
of IN O
MAP NNP B-Gene
kinases NNS I-Gene
with IN O
the DT O
selectivity NN O
ERK NNP B-Gene
> NNP O
p38 NN B-Gene
= NNP O
JNK NNP B-Gene
/ NNP O
SAPK NNP B-Gene
. . O

Out IN O
of IN O
40 CD O
patients NNS O
, , O
who WP O
initially RB O
did VBD O
not RB O
show VB O
eye NN O
complications NNS O
due JJ O
to TO O
leprosy VB O
, , O
37 CD O
patients NNS O
were VBD O
essentially RB O
the DT O
same JJ O
10 CD O
years NNS O
later RB O
. . O

In IN O
order NN O
to TO O
investigate VB O
the DT O
blood NN O
compatibility NN O
of IN O
autogenous JJ O
vein NN O
graft NN O
( ( O
AVG NNP O
) ) O
, , O
changes NNS O
in IN O
prostacyclin NN O
( ( O
PGI2 NNP O
) ) O
production NN O
following VBG O
harvesting NN O
and CC O
arterial JJ O
implantation NN O
were VBD O
studied VBN O
experimentally RB O
. . O

We PRP O
studied VBD O
the DT O
role NN O
of IN O
prostaglandins NNS O
in IN O
acid JJ O
- : O
induced JJ O
esophagitis NN O
and CC O
the DT O
associated JJ O
LES NNP O
hypotension NN O
by IN O
simultaneous JJ O
treatment NN O
of IN O
some DT O
animals NNS O
with IN O
indomethacin NN O
( ( O
150 CD O
micrograms NNS O
/ VBP O
kg RB O
intravenous JJ O
) ) O
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
prostaglandin JJ O
synthesis NN O
, , O
either CC O
during IN O
production NN O
of IN O
esophagitis NN O
or CC O
during IN O
recovery NN O
. . O

The DT O
hIGF NN B-Gene
- : I-Gene
I PRP I-Gene
gene NN I-Gene
has VBZ O
two CD O
promoters NNS O
, , O
P1 NNP O
and CC O
P2 NNP O
. . O

Five CD O
families NNS O
of IN O
Ashkenazi NNP O
Jewish NNP O
descent NN O
carried VBD O
the DT O
185delAG CD O
mutation NN O
and CC O
shared VBD O
the DT O
same JJ O
haplotype NN O
at IN O
eight CD O
polymorphic JJ O
markers NNS O
spanning VBG O
approximately RB O
850 CD O
kb NNS O
at IN O
BRCA1 NNP B-Gene
. . O

All DT O
patients NNS O
then RB O
received VBD O
suxamethonium JJ O
1 CD O
. . O
5 CD O
mg NN O
kg SYM O
- : O
1 CD O
i NN O
. . O
v NN O
. . O

Data NNS O
on IN O
the DT O
line NN O
spread NN O
function NN O
( ( O
LSF NNP O
) ) O
were VBD O
obtained VBN O
from IN O
the DT O
image NN O
of IN O
a DT O
0 CD O
. . O
2 CD O
mm JJ O
wide JJ O
slit NN O
between IN O
tungsten NN O
blocks NNS O
that WDT O
were VBD O
positioned VBN O
at IN O
the DT O
isocentre NN O
in IN O
front NN O
of IN O
a DT O
polystyrene NN O
phantom NN O
. . O

Point NNP O
mutations NNS O
of IN O
the DT O
site NN O
that WDT O
suppressed VBD O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
in IN O
vitro NN O
restored VBN O
full JJ O
tiGH NN B-Gene
promoter NN I-Gene
activity NN O
. . O

OBJECTIVE NN O
: : O
To TO O
perform VB O
a DT O
cost NN O
- : O
effectiveness NN O
analysis NN O
( ( O
CEA NNP O
) ) O
between IN O
a DT O
standard JJ O
antiemetic JJ O
regimen NNS O
- : O
chlorpromazine NN O
+ IN O
dexamethasone NN O
( ( O
CPM NNP O
- : O
DEX NN O
) ) O
- : O
and CC O
a DT O
5 CD B-Gene
- : I-Gene
HT3 NNP I-Gene
receptor NN I-Gene
antagonist NN O
- : O
tropisetron NN O
( ( O
TROP NNP O
) ) O
- : O
- : O
in IN O
the DT O
control NN O
of IN O
acute JJ O
emesis NN O
induced VBN O
by IN O
highly RB O
emetogenic JJ O
chemotherapy NN O
in IN O
children NNS O
, , O
considering VBG O
two CD O
analytic JJ O
perspectives NNS O
: : O
hospital NN O
and CC O
patients NNS O
. . O

This DT O
emphasizes VBZ O
the DT O
conclusion NN O
that IN O
CDF NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
not RB O
an DT O
E2F NNP B-Gene
family NN I-Gene
member NN I-Gene
and CC O
points NNS O
to TO O
profound VB O
differences NNS O
in IN O
the DT O
cell NN O
cycle NN O
regulation NN O
of IN O
CDF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
E2F NNP B-Gene
. . O

During IN O
most JJS O
of IN O
the DT O
cell NN O
cycle NN O
, , O
separase NN B-Gene
is VBZ O
kept VBN O
inactive JJ O
by IN O
binding VBG O
to TO O
an DT O
inhibitory NN O
protein NN O
called VBD O
securin NN B-Gene
. . O

In IN O
PB NNP O
mice NN O
, , O
there EX O
was VBD O
only RB O
a DT O
small JJ O
deficit NN O
in IN O
the DT O
number NN O
of IN O
the DT O
hippocampal JJ O
pyramidal NN O
neurons NNS O
compared VBN O
to TO O
controls NNS O
( ( O
15 CD O
% NN O
, , O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
, , O
and CC O
no DT O
deficit NN O
in IN O
the DT O
granule NN O
cells NNS O
. . O

Weaned VBN O
rats NNS O
were VBD O
fed VBN O
a DT O
normal JJ O
diet NN O
or CC O
a DT O
low JJ O
- : O
protein NN O
, , O
low JJ O
- : O
energy NN O
diet NN O
, , O
and CC O
injected VBD O
with IN O
saline NN O
or CC O
thyroxine NN O
( ( O
5 CD O
micrograms NNS O
/ VBP O
100 CD O
g JJ O
BW NNP O
) ) O
for IN O
22 CD O
days NNS O
. . O

Four CD O
possible JJ O
isoforms NNS O
( ( O
hGli2 JJ B-Gene
alpha NN I-Gene
, , I-Gene
beta NN I-Gene
, , I-Gene
gamma NN I-Gene
, , I-Gene
and CC I-Gene
delta NN I-Gene
) ) O
are VBP O
formed VBN O
by IN O
combinations NNS O
of IN O
two CD O
independent JJ O
alternative JJ O
splicings NNS O
, , O
and CC O
all PDT O
the DT O
isoforms NNS O
could MD O
bind VB O
to TO O
a DT O
DNA NN O
motif NN O
, , O
TRE2S NNP O
, , O
in IN O
the DT O
LTR NNP O
. . O

The DT O
psaD NN B-Gene
, , O
psaF NN B-Gene
, , O
psaH NN B-Gene
, , O
and CC O
psaL NN B-Gene
products NNS I-Gene
have VBP O
two CD O
isoforms NNS O
each DT O
that WDT O
are VBP O
distinguished VBN O
by IN O
different JJ O
mobilities NNS O
in IN O
polyacrylamide JJ O
gel NN O
electrophoresis NN O
, , O
and CC O
the DT O
psaE NN B-Gene
product NN I-Gene
has VBZ O
four CD O
isoforms NNS O
. . O

Calcimimetic JJ O
agents NNS O
directly RB O
inhibit VBP O
PTH NNP B-Gene
secretion NN O
by IN O
activating VBG O
the DT O
calcium NN O
- : O
sensing VBG O
receptor NN O
in IN O
the DT O
parathyroid NN O
glands VBZ O
, , O
but CC O
clinical JJ O
experience NN O
with IN O
them PRP O
is VBZ O
limited VBN O
. . O

For IN O
the DT O
2 CD O
. . O
5 CD O
to TO O
4 CD O
ng NNS O
/ JJ O
mL JJ O
model NN O
, , O
the DT O
AUC NNP O
of IN O
the DT O
ANN NNP O
ROC NNP O
curve NN O
was VBD O
significantly RB O
higher JJR O
than IN O
the DT O
AUCs NNP O
for IN O
percentage NN O
of IN O
free JJ O
PSA NNP B-Gene
( ( O
P NNP O
= NNP O
. . O
239 CD O
) ) O
, , O
PSA NNP O
- : O
TZ NNP O
( ( O
P NNP O
= NNP O
. . O
204 CD O
) ) O
, , O
and CC O
PSA NNP B-Gene
density NN O
and CC O
total JJ O
prostate NN O
volume NN O
( ( O
P NNP O
< NNP O
. . O
1 CD O
for IN O
both DT O
) ) O
. . O

Failures NNS O
of IN O
colorimetric JJ O
additivity NN O
under IN O
these DT O
experimental JJ O
conditions NNS O
are VBP O
discussed VBN O
. . O

Active JJ O
complexes NNS O
eluted VBN O
at IN O
a DT O
higher JJR O
molecular JJ O
weight NN O
than IN O
inactive JJ O
complexes NNS O
, , O
were VBD O
relatively RB O
deficient JJ O
in IN O
both DT O
p21 NN B-Gene
and CC O
p27 NN B-Gene
, , O
and CC O
contained VBD O
Cdk2 NNP B-Gene
with IN O
increased JJ O
threonine NN O
160 CD O
phosphorylation NN O
, , O
consistent JJ O
with IN O
a DT O
mechanism NN O
of IN O
activation NN O
of IN O
cyclin NN B-Gene
E NNP I-Gene
- : O
Cdk2 NN B-Gene
involving VBG O
both DT O
reduced VBN O
CDK NNP B-Gene
inhibitor NN O
association NN O
and CC O
CDK NNP B-Gene
- : I-Gene
activating VBG I-Gene
kinase VB I-Gene
- : O
mediated VBN O
phosphorylation NN O
of IN O
Cdk2 NNP B-Gene
. . O

Coronary JJ O
T1 NNP O
and CC O
T2 NNP O
weighted VBD O
images NNS O
were VBD O
obtained VBN O
. . O

Constitutive JJ O
phosphorylation NN O
of IN O
the DT O
CD30v NNP B-Gene
protein NN I-Gene
was VBD O
demonstrated VBN O
by IN O
in IN O
vitro NN O
labeling VBG O
with IN O
[ JJ O
32P CD O
] NN O
. . O

Preliminary JJ O
report NN O
. . O

We PRP O
have VBP O
isolated VBN O
and CC O
sequenced VBN O
the DT O
gene NN O
encoding VBG O
the DT O
human JJ B-Gene
U1 NNP I-Gene
- : I-Gene
70K CD I-Gene
snRNP NN I-Gene
protein NN I-Gene
. . O

We PRP O
studied VBD O
the DT O
functional JJ O
interaction NN O
between IN O
human JJ O
embryonic JJ O
zeta NN B-Gene
2 CD I-Gene
globin NN I-Gene
promoter NN O
and CC O
the DT O
alpha NN B-Gene
globin NN I-Gene
regulatory JJ I-Gene
element NN I-Gene
( ( O
HS NNP B-Gene
- : I-Gene
40 CD I-Gene
) ) O
located VBD O
40 CD O
kb JJ O
upstream NN O
of IN O
the DT O
zeta NN B-Gene
2 CD I-Gene
globin NN I-Gene
gene NN I-Gene
. . O

No DT O
patient NN O
in IN O
group NN O
2 CD O
developed VBD O
HAT NNP O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
6 CD O
versus NN O
group NN O
1 CD O
) ) O
. . O

The DT O
Scm NNP B-Gene
and CC O
ph NN B-Gene
proteins NNS O
share NN O
a DT O
homology NN O
domain NN O
with IN O
38 CD O
% NN O
identity NN O
over IN O
a DT O
length NN O
of IN O
65 CD O
amino NN O
acids NNS O
, , O
termed VBD O
the DT O
SPM NNP O
domain NN O
, , O
that WDT O
is VBZ O
located VBN O
at IN O
their PRP$ O
respective JJ O
C NNP O
termini NN O
. . O

The DT O
Novacor NNP O
Left NNP O
Ventricular NNP O
Assist NNP O
System NNP O
( ( O
LVAS NNP O
) ) O
( ( O
Novacor NNP O
Corp NNP O
, , O
Oakland NNP O
, , O
CA NNP O
) ) O
was VBD O
initially RB O
console JJ O
- : O
based VBN O
and CC O
has VBZ O
been VBN O
available JJ O
since IN O
1993 CD O
in IN O
a DT O
wearable JJ O
configuration NN O
. . O

Two CD O
members NNS O
of IN O
the DT O
Cbl NNP B-Gene
family NN I-Gene
have VBP O
since IN O
been VBN O
defined VBN O
in IN O
mammals NNS O
( ( O
c SYM B-Gene
- : I-Gene
Cbl NN I-Gene
and CC O
Cbl NNP B-Gene
- : I-Gene
b NN I-Gene
) ) O
, , O
one CD O
in IN O
C NNP O
. . O
elegans NNS O
( ( O
Sli NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
one CD O
in IN O
Drosophila NNP O
( ( O
D NNP B-Gene
- : I-Gene
Cbl NN I-Gene
) ) O
. . O

Replication NN O
of IN O
bovine NN O
papillomavirus NN O
- : O
1 CD O
( ( O
BPV NNP O
- : O
1 CD O
) ) O
DNA NN O
requires VBZ O
two CD O
viral JJ O
gene NN O
products NNS O
, , O
the DT O
E1 NNP B-Gene
protein NN I-Gene
and CC O
the DT O
full JJ B-Gene
- : I-Gene
length NN I-Gene
E2 NNP I-Gene
protein NN I-Gene
. . O

Low JJ O
MAO NNP B-Gene
subjects NNS O
showed VBD O
a DT O
pattern NN O
of IN O
higher JJR O
scores NNS O
in IN O
KSP NNP O
Impulsiveness NNP O
, , O
EPQ NNP O
Neuroticism NNP O
, , O
and CC O
KSP NNP O
Somatic NNP O
Anxiety NNP O
and CC O
Irritability NNP O
and CC O
lower JJR O
scores NNS O
in IN O
KSP NNP O
Socialization NNP O
, , O
in IN O
line NN O
with IN O
personality NN O
profiles NNS O
found VBN O
in IN O
alcoholics NNS O
, , O
psychopaths NNS O
, , O
and CC O
suicide JJ O
attempters NNS O
who WP O
also RB O
tend VBP O
to TO O
have VB O
low JJ O
platelet NN O
MAO NNP B-Gene
activity NN O
. . O

The DT O
protein NN B-Gene
ELT NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
encoded VBN O
by IN O
a DT O
single JJ O
- : O
copy NN O
gene NN O
homologous JJ O
to TO O
the DT O
GATA NNP B-Gene
family NN I-Gene
of IN I-Gene
vertebrate JJ I-Gene
transcription NN I-Gene
factors NNS I-Gene
, , O
is VBZ O
potentially RB O
capable JJ O
of IN O
interacting VBG O
with IN O
this DT O
element NN O
. . O

The DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
150 CD O
- : O
kDa NN O
protein NN O
contains VBZ O
an DT O
NTP NNP O
- : O
binding NN O
helicase NN B-Gene
motif NN I-Gene
and CC O
the DT O
readthrough JJ O
region NN O
, , O
an DT O
RNA NNP B-Gene
polymerase NN I-Gene
motif NN I-Gene
, , O
indicating VBG O
that IN O
these DT O
two CD O
overlapping VBG O
proteins NNS O
may MD O
form VB O
an DT O
RNA NNP O
replication NN O
complex NN O
similar JJ O
to TO O
those DT O
of IN O
tobamo JJ O
- : O
and CC O
tobraviruses NNS O
. . O

5 CD O
microU NN O
/ NNP O
l NN O
thyrotropin NN B-Gene
: : O
75 CD O
% NN O
( ( O
1974 CD O
) ) O
, , O
45 CD O
% NN O
( ( O
1977 CD O
) ) O
and CC O
20 CD O
% NN O
( ( O
1980 CD O
) ) O
. . O

Considerably RB O
high JJ O
levels NNS O
of IN O
IgE NNP B-Gene
antibodies NNS I-Gene
was VBD O
also RB O
established VBN O
while IN O
other JJ O
pollens NNS O
did VBD O
not RB O
show VB O
such JJ O
correspondence NN O
. . O

All DT O
runners NNS O
drank VBD O
a DT O
total NN O
of IN O
1 CD O
. . O
4 CD O
L NNP O
of IN O
water NN O
during IN O
the DT O
race NN O
. . O

Partial JJ O
N NNP O
- : O
terminal NN O
amino NN O
acid JJ O
sequence NN O
analysis NN O
showed VBD O
that IN O
the DT O
43K CD B-Gene
and CC I-Gene
42K CD I-Gene
T NNP I-Gene
antigens NNS I-Gene
contain VBP O
methionine NN O
at IN O
residues NNS O
1 CD O
and CC O
5 CD O
, , O
as IN O
predicted VBN O
from IN O
the DT O
DNA NNP O
sequence NN O
, , O
whereas IN O
no DT O
methionine NN O
was VBD O
released VBN O
from IN O
the DT O
39K CD B-Gene
T NNP I-Gene
antigen NN I-Gene
during IN O
the DT O
first JJ O
six CD O
cycles NNS O
of IN O
Edman NNP O
degradation NN O
. . O

This DT O
activation NN O
was VBD O
then RB O
blocked VBN O
by IN O
CGS NNP O
12066A CD O
. . O

IX NNP O
. . O

Hydrocoele NNP O
is VBZ O
common JJ O
in IN O
men NNS O
in IN O
Wuchereria NNP O
bancrofti SYM O
- : O
endemic JJ O
areas NNS O
, , O
the DT O
treatment NN O
for IN O
which WDT O
is VBZ O
currently RB O
surgical JJ O
intervention NN O
. . O

We PRP O
have VBP O
isolated VBN O
three CD O
mutant JJ O
alleles NNS O
of IN O
CDC4 NNP B-Gene
( ( O
cdc4 SYM B-Gene
- : I-Gene
10 CD I-Gene
, , O
cdc4 SYM B-Gene
- : I-Gene
11 CD I-Gene
, , O
and CC O
cdc4 SYM B-Gene
- : I-Gene
16 CD I-Gene
) ) O
which WDT O
suppress VBP O
the DT O
nuclear JJ O
division NN O
defect NN O
of IN O
cdc20 NN B-Gene
- : I-Gene
1 CD I-Gene
cells NNS O
. . O

All DT O
four CD O
doubly RB O
tyrosine NN O
phosphorylated VBN O
TAM NNP O
peptides NNS O
cross VBP O
- : O
compete NN O
with IN O
each DT O
other JJ O
for IN O
binding VBG O
to TO O
the DT O
tandem NN O
SH2 NNP B-Gene
domains NNS I-Gene
of IN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
. . O

Estrogen NNP O
replacement NN O
therapy NN O
and CC O
risk NN O
of IN O
breast NN O
cancer NN O
: : O
results NNS O
of IN O
two CD O
meta SYM O
- : O
analyses NNS O
. . O

Moreover RB O
, , O
the DT O
second JJ O
RCC1 NNP B-Gene
- : I-Gene
like IN I-Gene
motif NN I-Gene
located VBN O
at IN O
the DT O
amino NN O
- : O
terminus NN O
of IN O
p619 NN B-Gene
stimulates NNS O
guanine VBP O
nucleotide JJ O
exchange NN O
on IN O
ARF1 NNP B-Gene
and CC O
on IN O
members NNS O
of IN O
the DT O
related JJ O
Rab NNP B-Gene
proteins NNS I-Gene
, , O
but CC O
not RB O
on IN O
other JJ O
small JJ B-Gene
GTP NNP I-Gene
binding VBG I-Gene
proteins NNS I-Gene
such JJ O
as IN O
Ran NNP B-Gene
or CC O
R NNP B-Gene
- : I-Gene
Ras2 NNP I-Gene
/ NNP O
TC21 NNP B-Gene
. . O

Drug NNP O
inhibition NN O
of IN O
whole JJ O
blood NN O
aspirin NN B-Gene
esterase NN I-Gene
. . O

A DT O
needs JJ O
assessment NN O
of IN O
these DT O
families NNS O
was VBD O
also RB O
done VBN O
. . O

Following VBG O
intravenous JJ O
administration NN O
, , O
the DT O
myocardial JJ O
concentration NN O
of IN O
tracer NN O
thallium NN O
- : O
201 CD O
, , O
potassium NN O
- : O
43 CD O
, , O
and CC O
rubidium NN O
- : O
81 CD O
were VBD O
determined VBN O
in IN O
mice NN O
; : O
thallium NN O
was VBD O
present JJ O
in IN O
the DT O
greatest JJS O
concentration NN O
in IN O
the DT O
myocardium NN O
( ( O
2 CD O
. . O
8 CD O
% NN O
compared VBN O
1 CD O
. . O
25 CD O
% NN O
for IN O
potassium NN O
and CC O
1 CD O
. . O
15 CD O
% NN O
for IN O
rubidium NN O
at IN O
10 CD O
minutes NNS O
) ) O
. . O

Human NNP O
SRF NNP B-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
: : O
DNA NNP O
- : O
binding NN O
properties NNS O
and CC O
potential JJ O
regulatory JJ O
targets NNS O
. . O

These DT O
tumors NNS O
were VBD O
classified VBN O
into IN O
three CD O
broad JJ O
groups NNS O
: : O
I PRP O
, , O
cystadenoma NN O
; : O
II NNP O
, , O
cystadenocarcinoma NN O
; : O
and CC O
III NNP O
, , O
adenocarcinoma NN O
with IN O
mucin JJ B-Gene
production NN O
or CC O
an DT O
associated JJ O
cyst NN O
. . O

Stable JJ O
transfection NN O
of IN O
the DT O
truncated VBN O
reduced JJ B-Gene
folate NN I-Gene
carrier NN I-Gene
cDNA NN I-Gene
into IN O
mouse NN O
L1210 NNP O
leukemia NN O
cells NNS O
: : O
increased VBN O
folate NN O
accumulation NN O
, , O
decreased VBD O
their PRP$ O
leucovorin NN O
and CC O
folic JJ O
acid NN O
growth NN O
requirements NNS O
, , O
and CC O
increased VBD O
their PRP$ O
sensitivity NN O
to TO O
methotrexate VB O
. . O

The DT O
prophylactic JJ O
use NN O
of IN O
new JJ O
medication NN O
for IN O
patients NNS O
between IN O
the DT O
first JJ O
and CC O
second JJ O
cycle NN O
of IN O
chemotherapy NN O
, , O
in IN O
agreement NN O
with IN O
the DT O
estimates NNS O
calculated VBD O
, , O
does VBZ O
not RB O
save VB O
health NN O
care NN O
costs NNS O
but CC O
may MD O
improve VB O
the DT O
quality NN O
of IN O
life NN O
in IN O
these DT O
patients NNS O
and CC O
permit VBP O
the DT O
continuation NN O
of IN O
a DT O
therapeutic JJ O
schedule NN O
without IN O
interruption NN O
which WDT O
may MD O
improve VB O
the DT O
life NN O
expectancy NN O
of IN O
the DT O
patient NN O
. . O

Extraction NN O
procedure NN O
for IN O
the DT O
measurement NN O
of IN O
butyltin NN O
compounds NNS O
in IN O
biological JJ O
tissues NNS O
using VBG O
toluene NN O
, , O
HBr NNP O
, , O
and CC O
tropolone NN O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
DMVA NNP O
does VBZ O
not RB O
cause VB O
more RBR O
myocardial JJ O
trauma NN O
than IN O
CPB NNP O
when WRB O
used VBN O
to TO O
provide VB O
resuscitative JJ O
circulatory NN O
support NN O
. . O

Homologous JJ O
recombination NN O
between IN O
the DT O
Autographa NNP O
californica NN O
nuclear JJ O
polyhedrosis NN O
virus NN O
( ( O
AcNPV NNP O
) ) O
genome NN O
and CC O
a DT O
0 CD O
. . O
6 CD O
- : O
kbp NN O
- : O
long JJ O
DNA NNP O
fragment NN O
derived VBD O
from IN O
the DT O
putative JJ O
DNA NNP B-Gene
helicase NN I-Gene
gene NN I-Gene
of IN I-Gene
Bombyx NNP I-Gene
mori FW I-Gene
nuclear JJ I-Gene
polyhedrosis NN I-Gene
virus NN I-Gene
generates VBZ O
eh2 SYM O
- : O
AcNPV NNP O
, , O
an DT O
expanded VBN O
- : O
host NN O
- : O
range NN O
AcNPV NNP O
mutant NN O
( ( O
S NNP O
. . O

Regulation NN O
of IN O
laminin JJ B-Gene
beta2 NN I-Gene
chain NN I-Gene
gene NN I-Gene
expression NN O
in IN O
human JJ O
cancer NN O
cell NN O
lines NNS O
. . O

Blood NNP O
pressure NN O
in IN O
children NNS O
. . O

The DT O
consequences NNS O
of IN O
intensive JJ O
swine NN O
production NN O
on IN O
the DT O
environment NN O
and CC O
possible JJ O
solutions NNS O
by IN O
means NNS O
of IN O
nutrition NN O
are VBP O
outlined VBN O
. . O

Ovarian JJ O
tumors NNS O
in IN O
pregnancy NN O
. . O

Molecular JJ O
cloning NN O
, , O
genomic JJ O
mapping NN O
, , O
and CC O
expression NN O
of IN O
two CD O
secretor NN B-Gene
blood NN I-Gene
group NN I-Gene
alpha NN I-Gene
( ( I-Gene
1 CD I-Gene
, , I-Gene
2 CD I-Gene
) ) I-Gene
fucosyltransferase NN I-Gene
genes NNS I-Gene
differentially RB O
regulated VBN O
in IN O
mouse NN O
uterine JJ O
epithelium NN O
and CC O
gastrointestinal JJ O
tract NN O
. . O

Within IN O
each DT O
lobe NN O
, , O
the DT O
PA NNP O
dispersion NN O
was VBD O
up RB O
to TO O
10 CD O
cmH2O NN O
at IN O
CFV NNP O
of IN O
90 CD O
l NN O
/ NNP O
min NN O
; : O
when WRB O
flow NN O
decreased VBD O
, , O
PA NNP O
at IN O
all DT O
sites NNS O
decreased VBN O
, , O
as IN O
did VBD O
the DT O
intralobar NN O
dispersion NN O
. . O

Glutathione NNP B-Gene
peroxidase NN I-Gene
in IN O
human JJ O
red JJ O
cells NNS O
in IN O
health NN O
and CC O
disease NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
phosphatidyl NN O
inositol NN O
4 CD O
, , O
5 CD O
bisphosphate NN O
( ( O
PIP2 NNP O
) ) O
hydrolysis NN O
requires VBZ O
direct JJ O
phosphorylation NN O
at IN O
tyrosine JJ O
residue NN O
of IN O
the DT O
PLC NNP B-Gene
- : I-Gene
gamma1 NN I-Gene
isozyme NN I-Gene
. . O

The DT O
ability NN O
of IN O
U6 NNP B-Gene
- : O
U57 NN B-Gene
mutants NNS O
to TO O
influence VB O
the DT O
fidelity NN O
of IN O
both DT O
branch NN O
site NN O
and CC O
3 CD O
' '' O
splice NN O
site NN O
recognition NN O
suggests VBZ O
that IN O
this DT O
nucleotide NN O
may MD O
participate VB O
in IN O
the DT O
formation NN O
of IN O
the DT O
active JJ O
site NN O
( ( O
s JJ O
) ) O
of IN O
the DT O
spliceosome NN O
. . O

One CD O
antibody NN O
, , O
mAb1C2 NN B-Gene
, , O
and CC O
a DT O
synthetic JJ O
peptide NN O
comprising VBG O
its PRP$ O
epitope NN O
selectively RB O
inhibited VBN O
in IN O
vitro JJ O
transcription NN O
from IN O
TATA NNP O
- : O
containing NN O
, , O
but CC O
not RB O
from IN O
TATA NNP O
- : O
less JJR O
promoters NNS O
, , O
irrespective NN O
of IN O
whether IN O
they PRP O
were VBD O
transcribed VBN O
by IN O
Pol NNP B-Gene
II NNP I-Gene
or CC O
Pol NNP B-Gene
III NNP I-Gene
. . O

The DT O
nuclear JJ O
proteins NNS O
encoded VBN O
by IN O
the DT O
c NN B-Gene
- : I-Gene
fos NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
protooncogenes NNS I-Gene
are VBP O
expressed VBN O
during IN O
the DT O
proliferation NN O
period NN O
of IN O
osteoblast JJ O
phenotype NN O
development NN O
. . O

The DT O
cDNA NN O
of IN O
cpm7 NN B-Gene
encodes VBZ O
a DT O
closely RB O
related JJ O
protein NN O
of IN O
36 CD O
. . O
8 CD O
kDa NN O
. . O

Studies NNS O
carried VBD O
out RP O
with IN O
the DT O
Glossina NNP O
morsitans NNS O
colony NN O
of IN O
Lisbon NNP O
. . O

Thus RB O
, , O
CHOP NNP B-Gene
not RB O
only RB O
is VBZ O
a DT O
negative JJ O
or CC O
a DT O
positive JJ O
regulator NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
target NN O
genes NNS O
but CC O
also RB O
, , O
when WRB O
tethered VBN O
to TO O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
factors NNS I-Gene
, , O
can MD O
activate VB O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
target NN O
genes NNS O
. . O

Inducible JJ O
VT NNP O
was VBD O
suppressed VBN O
entirely RB O
in IN O
one CD O
patient NN O
. . O

In IN O
contrast NN O
to TO O
hemodynamic VB O
and CC O
histopathological JJ O
predictors NNS O
of IN O
survival NN O
, , O
vWF NN B-Gene
: : O
Ag NN O
does VBZ O
not RB O
require VB O
invasive JJ O
techniques NNS O
to TO O
be VB O
determined VBN O
. . O

To TO O
study VB O
the DT O
retinal JJ O
surface NN O
in IN O
the DT O
human JJ O
eye NN O
in IN O
normal JJ O
and CC O
diseased JJ O
states NNS O
we PRP O
used VBD O
laser RBR O
scanning VBG O
tomography NN O
. . O

Nature NN O
398 CD O
, , O
828 CD O
- : O
830 CD O
) ) O
that IN O
the DT O
amino NN O
acid JJ O
sequences NNS O
of IN O
peptide NN O
fragments NNS O
obtained VBN O
from IN O
a DT O
polypeptide NN O
found VBN O
in IN O
a DT O
complex NN O
of IN O
proteins NNS O
that WDT O
alters NNS O
chromatin VBP O
structure NN O
( ( O
ARC NNP B-Gene
) ) O
are VBP O
identical JJ O
to TO O
portions NNS O
of IN O
the DT O
deduced JJ O
open JJ O
reading NN O
frame NN O
of IN O
TIG NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
. . O

The DT O
routine JJ O
administration NN O
of IN O
fat JJ O
- : O
soluble JJ O
vitamins NNS O
appears VBZ O
unnecessary JJ O
but CC O
it PRP O
is VBZ O
prudent JJ O
to TO O
measure VB O
prothrombin JJ B-Gene
time NN O
and CC O
serum NN O
vitamins NNS O
A DT O
and CC O
E NNP O
at IN O
intervals NNS O
. . O

Also RB O
, , O
except IN O
in IN O
one CD O
patient NN O
who WP O
developed VBD O
gallstones NNS O
following VBG O
institution NN O
of IN O
colestipol NN O
, , O
saturation NN O
of IN O
gallbladder NN O
bile NN O
with IN O
cholesterol NN O
was VBD O
not RB O
markedly RB O
increased VBN O
by IN O
this DT O
drug NN O
alone RB O
. . O

Because IN O
of IN O
concerns NNS O
regarding VBG O
blood NN O
transfusion NN O
- : O
related VBN O
communicable JJ O
disease NN O
( ( O
eg JJ O
, , O
acquired VBD O
immune JJ O
deficiency NN O
syndrome NN O
and CC O
non JJ O
- : O
A NN O
, , O
non SYM O
- : O
B NNP O
hepatitis NN O
) ) O
, , O
there EX O
has VBZ O
been VBN O
increasing VBG O
research NN O
effort NN O
into IN O
postoperative JJ O
hemorrhage NN O
related VBN O
to TO O
cardiopulmonary JJ O
bypass NN O
with IN O
extracorporeal JJ O
circulation NN O
. . O

These DT O
defects VBZ O
no DT O
doubt NN O
impair VBZ O
the DT O
folding NN O
and CC O
configuration NN O
necessary JJ O
for IN O
normal JJ O
processing NN O
of IN O
the DT O
AVP NNP B-Gene
gene NN I-Gene
precursor NN I-Gene
. . O

4 CD O
Five CD O
patients NNS O
died VBD O
within IN O
one CD O
month NN O
of IN O
captopril NN O
and CC O
five CD O
between IN O
four CD O
and CC O
seven CD O
months NNS O
, , O
three CD O
of IN O
whom WP O
had VBD O
improved VBN O
to TO O
class NN O
IIM NNP O
and CC O
one CD O
to TO O
IIS NNP O
before IN O
death NN O
. . O

It PRP O
is VBZ O
likely JJ O
that IN O
other JJ O
pathways NNS O
involve VBP O
alternate JJ O
signal JJ O
transduction NN O
events NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
calcium JJ O
mobilization NN O
) ) O
and CC O
promoter NN O
response NN O
elements NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
SRE NNP O
) ) O
. . O

The DT O
patients NNS O
were VBD O
divided VBN O
into IN O
4 CD O
groups NNS O
receiving VBG O
NLA NNP O
II NNP O
with IN O
or CC O
without IN O
nalorphine JJ O
, , O
morphine NN O
or CC O
Micoren NNP O
. . O

A DT O
single JJ O
protease NN O
- : O
resistant JJ O
structure NN O
formed VBN O
by IN O
the DT O
entirety NN O
of IN O
both DT O
PDZ NNP B-Gene
repeats VBZ I-Gene
1 CD I-Gene
and CC I-Gene
2 CD I-Gene
( ( O
PDZ1 NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
contains VBZ O
the DT O
protein NN B-Gene
4 CD I-Gene
. . I-Gene
1 CD I-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
. . O

High JJ O
radial JJ O
r NN O
values NNS O
with IN O
small JJ O
standard JJ O
deviations NNS O
were VBD O
observed VBN O
in IN O
normal JJ O
LV NNP O
( ( O
0 CD O
. . O
972 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
16 CD O
) ) O
and CC O
in IN O
non JJ O
- : O
MI NN O
regions NNS O
( ( O
0 CD O
. . O
964 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
18 CD O
) ) O
, , O
indicating VBG O
temporally RB O
homogeneous JJ O
radial JJ O
shortening NN O
. . O

These DT O
include VBP O
NPF NNP O
repeats NNS O
, , O
a DT O
leucine NN O
heptad NN O
repeat NN O
enriched VBN O
in IN O
charged JJ O
residues NNS O
, , O
and CC O
a DT O
proline NN O
- : O
rich JJ O
SH3 NNP B-Gene
- : I-Gene
like IN I-Gene
and CC O
/ NNP O
or CC O
WW NNP O
domain VBP O
- : O
binding NN O
site NN O
in IN O
the DT O
N NNP O
- : O
terminal NN O
domain NN O
, , O
which WDT O
is VBZ O
followed VBN O
by IN O
a DT O
membrane NN O
core NN O
containing VBG O
four CD O
putative JJ O
transmembrane NN O
spans NNS O
and CC O
three CD O
amphiphilic JJ O
segments NNS O
that WDT O
are VBP O
the DT O
most RBS O
highly RB O
conserved JJ O
structural JJ O
elements NNS O
. . O

Hypoxic NNP O
ventilatory NN O
responses NNS O
were VBD O
- : O
1 CD O
. . O
99 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
37 CD O
L NNP O
/ NNP O
min NNP O
/ NNP O
% NN O
SaO2 NNP O
in IN O
the DT O
relatives NNS O
and CC O
- : O
1 CD O
. . O
54 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
25 CD O
L NNP O
/ NNP O
min NNP O
/ NNP O
% NN O
SaO2 NNP O
in IN O
the DT O
control NN O
subjects VBZ O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Molecular JJ O
cloning NN O
of IN O
Elk NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
a DT O
new JJ O
member NN O
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
expressed VBD O
during IN O
mouse NN O
embryogenesis NN O
and CC O
analysis NN O
of IN O
its PRP$ O
transcriptional JJ O
repression NN O
activity NN O
. . O

Adhesion NN O
, , O
phagocytosis NN O
, , O
chemotactic JJ O
and CC O
random JJ O
migration NN O
, , O
nitroblue JJ O
tetrazolium NN O
dye NN O
reduction NN O
of IN O
peritoneal JJ O
exudate NN O
neutrophils NNS O
and CC O
macrophages NNS O
, , O
fibrinogen NN B-Gene
level NN O
, , O
gelation NN O
of IN O
soluble JJ O
fibrin NN B-Gene
and CC O
serial JJ O
dilution NN O
protamine NN O
sulfate JJ O
test NN O
were VBD O
investigated VBN O
in IN O
115 CD O
New NNP O
Zealand NNP O
white JJ O
rabbits NNS O
with IN O
experimentally RB O
induced VBN O
Shwartzman NNP O
phenomenon NN O
in IN O
the DT O
colon NN O
, , O
and CC O
in IN O
control NN O
animals NNS O
. . O

We PRP O
have VBP O
previously RB O
identified VBN O
mouse NN B-Gene
and CC I-Gene
human JJ I-Gene
cDNAs NN I-Gene
encoding VBG I-Gene
UNC NNP I-Gene
- : I-Gene
51 CD I-Gene
- : I-Gene
like IN I-Gene
kinase NN I-Gene
( ( O
ULK1 NNP B-Gene
) ) O
. . O

In IN O
vitro JJ O
expression NN O
of IN O
four CD O
different JJ O
naturally RB O
occurring VBG O
nonsense NN O
and CC O
missense NN O
mutations NNS O
revealed VBD O
a DT O
dramatically RB O
altered JJ O
subcellular JJ O
location NN O
of IN O
the DT O
protein NN O
in IN O
cultured JJ O
cells NNS O
. . O

Splice NNP O
- : O
junction NN O
elements NNS O
and CC O
intronic JJ O
sequences NNS O
regulate VBP O
alternative JJ O
splicing NN O
of IN O
the DT O
Drosophila NNP O
myosin NNP B-Gene
heavy NN I-Gene
chain NN I-Gene
gene NN I-Gene
transcript NN O
. . O

20 CD O
% NN O
of IN O
total JJ O
HSL NNP B-Gene
transcripts NNS I-Gene
in IN O
human JJ O
subcutaneous JJ O
adipocytes NNS O
. . O

Northern NNP O
analysis NN O
revealed VBD O
no DT O
detectable JJ O
expression NN O
of IN O
the DT O
transcript NN O
in IN O
diapause NN O
- : O
or CC O
nondiapause IN O
- : O
programmed JJ O
wandering NN O
larvae NN O
, , O
and CC O
only RB O
trace JJ O
expression NN O
in IN O
nondiapausing VBG O
pupae NN O
. . O

Decreased VBN O
cardiac JJ O
glycogen NN O
following VBG O
phenformin JJ O
injection NN O
in IN O
hyperglycemic JJ O
, , O
hyperinsulinemic JJ O
anaesthetized JJ O
rats NNS O
. . O

Failure NN O
of IN O
stapedius JJ O
reflexometry NN O
in IN O
the DT O
diagnosis NN O
of IN O
myasthenia NN O
gravis NN O
. . O

Human NNP B-Gene
alpha VBZ I-Gene
- : I-Gene
galactosidase NN I-Gene
A DT I-Gene
: : O
nucleotide JJ O
sequence NN O
of IN O
a DT O
cDNA NN O
clone NN O
encoding VBG O
the DT O
mature NN O
enzyme NN O
. . O

Furthermore RB O
, , O
the DT O
3 CD O
' POS O
- : O
untranslated JJ O
regions NNS O
of IN O
pmGT10 NN B-Gene
display NN O
a DT O
marked JJ O
degree NN O
of IN O
homology NN O
to TO O
the DT O
3 CD O
' POS O
region NN O
of IN O
the DT O
rat NN B-Gene
Yb1 NNP I-Gene
gene NN I-Gene
, , O
while IN O
this DT O
region NN O
of IN O
pmGT2 NN B-Gene
displays NNS O
marked VBD O
homology NN O
to TO O
the DT O
corresponding JJ O
region NN O
of IN O
the DT O
rat NN B-Gene
Yb2 NNP I-Gene
gene NN I-Gene
. . O

Mutation NN O
analysis NN O
implicated VBN O
multiple JJ O
segments NNS O
of IN O
the DT O
5 CD O
' POS O
untranslated JJ O
region NN O
as IN O
contributing VBG O
to TO O
the DT O
inhibitory JJ O
effect NN O
. . O

Downstream NN O
of IN O
the DT O
G NNP O
- : O
A DT O
anastomosis NN O
, , O
the DT O
RD NNP O
, , O
CC NNP O
, , O
E NNP O
( ( O
p NN O
) ) O
and CC O
loop JJ O
areas NNS O
were VBD O
significantly RB O
different JJ O
from IN O
REF NNP O
, , O
but CC O
significantly RB O
different JJ O
from IN O
A NNP O
- : O
A NN O
. . O

Movement NNP O
programming VBG O
depends NNS O
on IN O
understanding NN O
of IN O
behavioral JJ O
requirements NNS O
. . O

The DT O
investigation NN O
was VBD O
apt VBN O
at IN O
studying VBG O
the DT O
relationship NN O
between IN O
urinary JJ O
metabolites NNS O
of IN O
serotonin NN O
and CC O
catecholamine NN O
( ( O
5 CD O
- : O
HIAA NN O
and CC O
VMA NNP O
) ) O
, , O
T NNP O
- : O
cells NNS O
( ( O
OKT3 NNP B-Gene
+ NNP I-Gene
) ) O
, , O
T NNP O
- : O
helper NN O
( ( O
OKT4 NNP B-Gene
+ NNP I-Gene
) ) O
, , O
T NNP O
- : O
suppressor NN O
( ( O
OKT8 NNP B-Gene
+ NNP I-Gene
) ) O
and CC O
B NNP O
- : O
cells NNS O
( ( O
EAC NNP O
- : O
rosette NN O
forming VBG O
cells NNS O
) ) O
in IN O
normal JJ O
( ( O
10 CD O
subjects NNS O
, , O
1 CD O
female NN O
, , O
9 CD O
male NN O
, , O
age NN O
21 CD O
+ NN O
/ NNP O
- : O
5 CD O
years NNS O
) ) O
and CC O
stress NN O
administered VBN O
subjects NNS O
( ( O
20 CD O
subjects NNS O
, , O
3 CD O
female NN O
, , O
17 CD O
male NN O
, , O
age NN O
20 CD O
+ NN O
/ NNP O
- : O
4 CD O
years NNS O
) ) O
. . O

Competition NN O
EMSA NNP O
established VBD O
that IN O
constitutively RB O
expressed VBN O
nuclear JJ O
proteins NNS O
bound IN O
the DT O
KCS NNP B-Gene
element NN I-Gene
selectively RB O
; : O
KCS NNP B-Gene
protein VBZ I-Gene
binding VBG O
activity NN O
correlated VBN O
with IN O
promoter NN O
activity NN O
in IN O
the DT O
transient JJ O
transfection NN O
reporter NN O
assay VBP O
. . O

Based VBN O
on IN O
this DT O
analysis NN O
, , O
we PRP O
propose VBP O
that IN O
the DT O
interactions NNS O
of IN O
Sos NNP B-Gene
with IN O
the DT O
switch NN O
1 CD O
and CC O
switch VB O
2 CD O
regions NNS O
of IN O
Ras NNP B-Gene
have VBP O
distinct JJ O
functional JJ O
consequences NNS O
: : O
the DT O
interaction NN O
with IN O
switch NN O
2 CD O
mediates VBZ O
the DT O
anchoring NN O
of IN O
Ras NNP B-Gene
to TO O
Sos NNP B-Gene
, , O
whereas IN O
the DT O
interaction NN O
with IN O
switch NN O
1 CD O
leads VBZ O
to TO O
disruption NN O
of IN O
the DT O
nucleotide JJ O
- : O
binding NN O
site NN O
and CC O
GDP NNP O
dissociation NN O
. . O

Effects NNS O
of IN O
chronic JJ O
descending VBG O
tractotomy NN O
on IN O
the DT O
response NN O
patterns NNS O
of IN O
neurons NNS O
in IN O
the DT O
trigeminal JJ O
nuclei NN O
principalis NN O
and CC O
oralis NN O
. . O

While IN O
blood NN O
pressure NN O
and CC O
noradrenergic JJ O
activity NN O
, , O
assessed VBN O
as IN O
changes NNS O
in IN O
the DT O
plasma NN O
levels NNS O
and CC O
urinary JJ O
excretion NN O
of IN O
norepinephrine NN O
, , O
remained VBD O
unaffected JJ O
in IN O
the DT O
Pl NNP O
group NN O
, , O
a DT O
significant JJ O
drop NN O
in IN O
the DT O
supine NN O
systolic NN O
and CC O
diastolic JJ O
blood NN O
pressures NNS O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
resting VBG O
venous JJ O
norepinephrine JJ O
level NN O
and CC O
in IN O
urinary JJ O
norepinephrine JJ O
excretion NN O
was VBD O
found VBN O
after IN O
the DT O
first JJ O
month NN O
of IN O
dF JJ O
administration NN O
. . O

Two CD O
XPG JJ B-Gene
regions NNS I-Gene
with IN O
putative JJ O
NLS NNP O
[ NNP O
amino NN O
acid NN O
( ( O
AA NNP O
) ) O
coordinates VBZ O
: : O
NLS NNP O
- : O
B NNP O
( ( O
AA NNP O
1057 CD O
- : O
1074 CD O
) ) O
and CC O
NLS NNP O
- : O
C NNP O
( ( O
AA NNP O
1171 CD O
- : O
1185 CD O
) ) O
] NN O
were VBD O
each DT O
shown VBN O
to TO O
independently RB O
localize VB O
the DT O
beta NN B-Gene
- : I-Gene
gal NN I-Gene
extensively RB O
( ( O
> JJ O
80 CD O
% NN O
) ) O
to TO O
the DT O
nucleus NN O
of IN O
HeLa NNP O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
Rho1p NNP B-Gene
regulates VBZ O
cytoskeletal JJ O
reorganization NN O
at IN O
least JJS O
through IN O
Bni1p NNP B-Gene
and CC O
Pkc1p NNP B-Gene
. . O

Esophageal NNP O
brush JJ O
cytological JJ O
screening NN O
was VBD O
undertaken JJ O
and CC O
blood NN O
concentrations NNS O
of IN O
micronutrients NNS O
( ( O
vitamin VB O
A NNP O
, , O
E NNP O
, , O
B12 NNP O
, , O
folic JJ O
acid NN O
and CC O
methionine NN O
) ) O
determined VBD O
from IN O
adults NNS O
at IN O
risk NN O
for IN O
esophageal JJ O
carcinoma NN O
( ( O
EC NNP O
) ) O
in IN O
Transkei NNP O
and CC O
Ciskei NNP O
, , O
Southern NNP O
Africa NNP O
. . O

In IN O
addition NN O
, , O
insulin NN B-Gene
induced VBD O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NNP O
binding NN O
activity NN O
, , O
this DT O
effect NN O
being VBG O
totally RB O
prevented VBN O
in IN O
the DT O
presence NN O
of IN O
MEK NNP B-Gene
- : I-Gene
1 CD I-Gene
inhibitor NN O
. . O

The DT O
latter NN O
was VBD O
determined VBN O
as IN O
follows VBZ O
: : O
Type NN O
I PRP O
- : O
solid JJ O
tumor NN O
tissue NN O
without IN O
significant JJ O
peripheral JJ O
isolated JJ O
tumor NN O
cells NNS O
; : O
Type NNP O
II NNP O
- : O
solid JJ O
tumor NN O
tissue NN O
associated VBN O
with IN O
peripheral JJ O
isolated JJ O
tumor NN O
cells NNS O
; : O
Type NNP O
III NNP O
- : O
isolated JJ O
tumor NN O
cells NNS O
only RB O
. . O

The DT O
relations NNS O
between IN O
type NN O
A NNP O
behavior NN O
, , O
clinically RB O
relevant JJ O
behavior NN O
, , O
academic JJ O
achievement NN O
, , O
and CC O
IQ NNP O
in IN O
children NNS O
. . O

Conclusion NN O
: : O
The DT O
Lp NNP B-Gene
( ( I-Gene
a DT I-Gene
) ) I-Gene
levels NNS O
in IN O
these DT O
children NNS O
were VBD O
the DT O
lower JJR O
ever RB O
reported VBN O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
xylitol NNP O
, , O
an DT O
activator NN O
of IN O
the DT O
pentose JJ O
phosphate NN O
pathway NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
neither CC O
phosphate NN O
buffered VBD O
saline JJ O
injection NN O
into IN O
the DT O
ES NNP O
nor CC O
primary JJ O
KLH NNP B-Gene
challenges NNS O
of IN O
the DT O
ES NNP O
were VBD O
capable JJ O
of IN O
elevating VBG O
the DT O
threshold JJ O
level NN O
and CC O
changing VBG O
the DT O
latency NN O
. . O

A DT O
5 CD O
' POS O
RNA NNP O
stem NN O
- : O
loop NN O
participates NNS O
in IN O
the DT O
transcription NN O
attenuation NN O
mechanism NN O
that WDT O
controls VBZ O
expression NN O
of IN O
the DT O
Bacillus NNP B-Gene
subtilis NNS I-Gene
trpEDCFBA VBP I-Gene
operon NN I-Gene
. . O

The DT O
nm23 JJ B-Gene
- : I-Gene
H1 NNP I-Gene
/ NNP O
nm23 SYM B-Gene
- : I-Gene
H2 NNP I-Gene
gene NN O
transcriptional JJ O
activity NN O
ratio NN O
varied VBD O
depending VBG O
on IN O
the DT O
cell NN O
line NN O
. . O

Structural JJ O
basis NN O
for IN O
activation NN O
of IN O
human JJ B-Gene
lymphocyte JJ I-Gene
kinase NN I-Gene
Lck NNP B-Gene
upon IN O
tyrosine JJ O
phosphorylation NN O
. . O

Regulatory NNP O
motifs NNS O
for IN O
gene NN O
expression NN O
such JJ O
as IN O
nuclear JJ B-Gene
- : I-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
- : I-Gene
binding VBG I-Gene
- : I-Gene
site NN I-Gene
- : I-Gene
like IN I-Gene
sequence NN I-Gene
( ( O
kappaB VB B-Gene
site NN I-Gene
) ) O
and CC O
nuclear JJ B-Gene
- : I-Gene
factor NN I-Gene
- : I-Gene
interleukin JJ I-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
binding NN I-Gene
- : I-Gene
site NN I-Gene
- : I-Gene
like IN I-Gene
sequence NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
site NN I-Gene
) ) O
were VBD O
found VBN O
in IN O
the DT O
5 CD O
' POS O
- : O
upstream NN O
regulatory JJ O
region NN O
. . O

Chimeric NNP O
phage NN O
- : O
plasmid JJ O
expression NN O
vectors NNS O
were VBD O
constructed VBN O
from IN O
pUC18 NN O
/ $ O
19 CD O
plasmids NNS O
by IN O
cloning VBG O
a DT O
single JJ O
- : O
stranded VBN O
DNA NNP O
( ( O
ssDNA NN O
) ) O
origin NN O
of IN O
replication NN O
from IN O
bacteriophage NN O
f1 NN O
and CC O
inserting VBG O
a DT O
bacteriophage NN O
T7 NNP O
promoter NN O
within IN O
the DT O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
gene NN I-Gene
. . O

Thus RB O
, , O
it PRP O
was VBD O
confirmed VBN O
that IN O
the DT O
sodium NN O
lauryl NN O
sulfate NN O
method NN O
of IN O
estimating VBG O
hemoglobin JJ B-Gene
concentration NN O
is VBZ O
an DT O
appropriate JJ O
alternative NN O
to TO O
the DT O
cyanmethemoglobin NN B-Gene
method NN O
and CC O
avoids VBZ O
the DT O
generation NN O
of IN O
toxic JJ O
wastes NNS O
. . O

Among IN O
a DT O
population NN O
of IN O
18 CD O
, , O
175 CD O
children NNS O
below IN O
7 CD O
years NNS O
of IN O
age NN O
in IN O
medium NN O
sized VBN O
towns NNS O
and CC O
rural JJ O
areas NNS O
in IN O
south JJ O
- : O
western JJ O
Germany NNP O
552 CD O
( ( O
3 CD O
. . O
3 CD O
% NN O
) ) O
cases NNS O
of IN O
croup NN O
were VBD O
registered VBN O
during IN O
a DT O
12 CD O
months NNS O
period NN O
in IN O
1984 CD O
- : O
85 CD O
by IN O
their PRP$ O
physicians NNS O
. . O

In IN O
vitro JJ O
evaluation NN O
of IN O
the DT O
mucolytic JJ O
action NN O
of IN O
urea NN O
. . O

Evidence NN O
that IN O
therapeutic JJ O
alterations NNS O
of IN O
a DT O
circadian JJ O
rhythm NN O
for IN O
gastric JJ O
emptying VBG O
response NN O
may MD O
be VB O
possible JJ O
. . O

i NN O
. . O

It PRP O
contained VBD O
seven CD O
extra JJ O
amino JJ O
acids NNS O
of IN O
FVVLNLQ NNP O
; : O
this DT O
short JJ O
stretch NN O
of IN O
extra JJ O
sequence NN O
was VBD O
found VBN O
between IN O
Gln NNP O
( ( O
421 CD O
) ) O
and CC O
Phe NNP O
( ( O
422 CD O
) ) O
within IN O
the DT O
SET NNP B-Gene
( ( O
Suvar3 NNP B-Gene
- : I-Gene
9 CD I-Gene
, , O
Enhancer NNP B-Gene
- : I-Gene
of IN I-Gene
- : I-Gene
zeste NN I-Gene
, , O
Trithorax NNP B-Gene
) ) O
interacting VBG O
domain NN O
( ( O
SID NNP O
) ) O
of IN O
rMTM NN B-Gene
. . O

A DT O
high JJ O
efficacy NN O
of IN O
the DT O
combined VBN O
use NN O
of IN O
nontoxic JJ O
doses NNS O
of IN O
two CD O
pharmaceuticals NNS O
: : O
cystamine NN O
( ( O
50 CD O
mg NN O
/ NNP O
kg NN O
) ) O
and CC O
mexamine NN O
( ( O
25 CD O
mg NN O
/ NNP O
kg NN O
) ) O
under IN O
the DT O
conditions NNS O
of IN O
short JJ O
- : O
term NN O
exogenous JJ O
hypoxia NN O
( ( O
7 CD O
. . O
5 CD O
% NN O
O2 NNP O
) ) O
was VBD O
found VBN O
in IN O
( ( O
CBA NNP O
X NNP O
C57Bl NNP O
) ) O
F1 NNP O
mice NN O
. . O

155 CD O
aa NN O
, , O
shares NNS O
78 CD O
% NN O
identity NN O
with IN O
the DT O
analogous JJ O
region NN O
of IN O
Xenopus NNP O
laevis FW O
FGF3 NNP B-Gene
and CC O
72 CD O
% NN O
identity NN O
with IN O
the DT O
product NN O
of IN O
the DT O
more RBR O
distantly RB O
related VBN O
human JJ O
gene NN O
. . O

In IN O
a DT O
retrospective JJ O
analysis NN O
of IN O
first JJ O
- : O
time NN O
total JJ O
colonoscopies NNS O
in IN O
685 CD O
patients NNS O
, , O
we PRP O
investigated VBD O
the DT O
relationship NN O
between IN O
hyperplastic JJ O
and CC O
adenomatous JJ O
polyps NNS O
. . O

METHODS NN O
: : O
Twenty CD O
- : O
two CD O
patients NNS O
were VBD O
grouped VBN O
according VBG O
to TO O
their PRP$ O
etiology NN O
based VBN O
on IN O
the DT O
study NN O
of IN O
antiadrenal JJ O
antibodies NNS O
at IN O
diagnosis NN O
of IN O
the DT O
disease NN O
: : O
7 CD O
were VBD O
positive JJ O
( ( O
autoimmune JJ O
etiology NN O
or CC O
EAA NNP O
) ) O
, , O
11 CD O
were VBD O
negative JJ O
( ( O
tuberculous JJ O
etiology NN O
or CC O
EAT NNP O
) ) O
and CC O
in IN O
four CD O
serologic NN O
study NN O
was VBD O
not RB O
available JJ O
( ( O
undetermined JJ O
etiology NN O
or CC O
EAI NNP O
) ) O
. . O

Taken VBN O
together RB O
, , O
we PRP O
provide VBP O
evidence NN O
for IN O
the DT O
existence NN O
of IN O
an DT O
activator NN O
, , O
NFE NNP B-Gene
, , O
which WDT O
in IN O
combination NN O
with IN O
the DT O
p50 NN B-Gene
and CC O
c SYM B-Gene
- : I-Gene
Rel JJ I-Gene
proteins NNS I-Gene
, , O
are VBP O
part NN O
of IN O
the DT O
transcription NN O
factor NN O
machinery NN O
that IN O
regulates VBZ O
3 CD O
' '' O
enhancer NN O
activity NN O
, , O
and CC O
thus RB O
the DT O
control NN O
of IN O
the DT O
IgH NNP B-Gene
locus NN I-Gene
in IN O
late JJ O
B NNP O
lymphocyte NN O
development NN O
. . O

As IN O
measured VBN O
by IN O
the DT O
PDQ NNP O
- : O
39 CD O
, , O
STN NNP O
- : O
DBS NNP O
significantly RB O
improves VBZ O
important JJ O
aspects NNS O
of IN O
QoL NNP O
in IN O
patients NNS O
with IN O
advanced JJ O
PD NNP O
. . O

Functional JJ O
analysis NN O
of IN O
DNase NNP B-Gene
- : I-Gene
I PRP I-Gene
hypersensitive VBP O
sites NNS O
at IN O
the DT O
mouse NN B-Gene
porphobilinogen NN I-Gene
deaminase NN I-Gene
gene NN I-Gene
locus NN I-Gene
. . O

Treatment NN O
of IN O
keratinocytes NNS O
expressing VBG O
a DT O
normal JJ O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
( ( O
EGFR NNP B-Gene
) ) O
with IN O
TGFalpha NNP B-Gene
or CC O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
for IN O
5 CD O
min NN O
induced VBD O
PKCdelta NNP B-Gene
tyrosine JJ O
phosphorylation NN O
. . O

Tranilast NN O
in IN O
the DT O
Therapy NNP O
of IN O
Coronary NNP O
Artery NNP O
Disease NNP O
. . O

Oral JJ O
supplementation NN O
of IN O
L NNP O
- : O
arginine NN O
significantly RB O
increased VBD O
plasma NN O
L NNP O
- : O
citrulline NN O
, , O
which WDT O
indicated VBD O
enhancement NN O
of IN O
NO DT O
production NN O
. . O

The DT O
administration NN O
of IN O
the DT O
GnRH NNP B-Gene
agonist NN O
reduced VBD O
the DT O
bone NN O
mineral JJ O
density NN O
in IN O
the DT O
whole JJ O
femur NN O
to TO O
91 CD O
. . O
0 CD O
% NN O
of IN O
that DT O
in IN O
the DT O
control NN O
group NN O
. . O

Transcripts NNS O
characterized VBN O
include VBP O
( ( O
i JJ O
) ) O
abundant VBP O
monocistronic JJ O
L11e NNP B-Gene
and CC O
tricistronic JJ O
L1e NNP B-Gene
- : O
L10e NNP B-Gene
- : O
L12e NNP B-Gene
transcripts NNS O
; : O
( ( O
ii NN O
) ) O
less RBR O
abundant JJ O
bicistronic JJ O
NAB NNP B-Gene
- : O
L11e NNP B-Gene
and CC O
monocistronic JJ O
NAB NNP B-Gene
transcripts NNS I-Gene
and CC O
( ( O
iii NN O
) ) O
a DT O
very RB O
rare JJ O
ORF NNP O
monocistronic NN O
transcript NN O
. . O

The DT O
nucleolin JJ B-Gene
gene NN I-Gene
extends VBZ O
over IN O
9000 CD O
base NN O
- : O
pairs NN O
and CC O
is VBZ O
split VBN O
into IN O
14 CD O
exons NNS O
that WDT O
encode VBP O
the DT O
706 CD O
amino NN O
acid NN O
residues NNS O
of IN O
the DT O
protein NN O
. . O

[ RB O
18F CD O
] NN O
( ( O
+ NNP O
) ) O
- : O
4 CD O
- : O
fluorobenzyltrozamicol NN O
( ( O
FBT NNP O
) ) O
, , O
which WDT O
selectively RB O
binds VBZ O
to TO O
the DT O
vesicular JJ O
acetylcholine NN B-Gene
transporter NN I-Gene
in IN O
the DT O
presynaptic JJ O
cholinergic NN O
neuron NN O
, , O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
useful JJ O
ligand NN O
for IN O
the DT O
study NN O
of IN O
cholinergic JJ O
terminal JJ O
density NN O
in IN O
the DT O
basal NN O
ganglia NN O
with IN O
PET NNP O
. . O

On IN O
the DT O
basis NN O
of IN O
a DT O
global JJ O
assessment NN O
patients NNS O
showed VBD O
a DT O
highly RB O
significant JJ O
preference NN O
for IN O
imipramine NN O
compared VBN O
with IN O
placebo NN O
as IN O
adjunctive JJ O
therapy NN O
. . O

Effects NNS O
of IN O
3 CD O
' POS O
terminus NN O
modifications NNS O
on IN O
mRNA JJ O
functional JJ O
decay NN O
during IN O
in IN O
vitro JJ O
protein NN O
synthesis NN O
. . O

We PRP O
have VBP O
explored VBN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
the DT O
fibronectin NN B-Gene
splicing VBG I-Gene
enhancer NN I-Gene
and CC O
found VBD O
that IN O
the DT O
SE NNP O
element NN O
is VBZ O
required VBN O
for IN O
efficient JJ O
assembly NN O
of IN O
early JJ O
splicing NN O
complexes NNS O
, , O
allowing VBG O
a DT O
more RBR O
efficient JJ O
interaction NN O
of IN O
the DT O
U2 NNP B-Gene
snRNP NN I-Gene
with IN O
branch NN O
site NN O
sequences NNS O
. . O

The DT O
subunit NN O
protein NN O
of IN O
curli NN B-Gene
was VBD O
highly RB O
homologous JJ O
at IN O
its PRP$ O
amino NN O
terminus NN O
to TO O
SEF NNP B-Gene
- : I-Gene
17 CD I-Gene
, , O
the DT O
subunit NN O
protein NN O
of IN O
thin JJ O
, , O
aggregative JJ O
fimbriae NN O
of IN O
Salmonella NNP O
enteritidis FW O
27655 CD O
strain NN O
3b CD O
, , O
suggesting VBG O
that IN O
these DT O
fibres NNS O
form VBP O
a DT O
novel JJ O
class NN O
of IN O
surface NN O
organelles NNS O
on IN O
enterobacteria NN O
. . O

Polyclonal NNP O
antiserum NN O
generated VBD O
to TO O
the DT O
fusion NN O
protein NN O
was VBD O
capable JJ O
of IN O
detecting VBG O
42 CD O
- : O
and CC O
46 CD O
- : O
kilodalton NN O
polypeptides NNS O
from IN O
virus NN O
particles NNS O
; : O
both DT O
polypeptides NNS O
were VBD O
also RB O
shown VBN O
to TO O
contain VB O
HBsAg NNP B-Gene
determinants NNS I-Gene
. . O

A DT O
novel JJ O
growth NN O
- : O
related VBN O
nuclear JJ O
protein NN O
binds NNS O
and CC O
inhibits NNS O
rat VBP O
aldolase NN B-Gene
B NNP I-Gene
gene NN I-Gene
promoter NN O
. . O

All DT O
mutant JJ B-Gene
JCV NNP I-Gene
T NNP I-Gene
antigens VBZ I-Gene
bound NN O
to TO O
JCV NNP O
and CC O
SV40 NNP O
origins NNS O
of IN O
DNA NNP O
replication NN O
. . O

Nine NNP O
cats NNS O
received VBD O
PMEA NNP O
at IN O
a DT O
dosage NN O
of IN O
10 CD O
mg NNS O
/ JJ O
kg FW O
body NN O
weight NN O
, , O
nine CD O
cats NNS O
received VBD O
FPMPA NNP O
at IN O
a DT O
dosage NN O
of IN O
25 CD O
mg NNS O
/ JJ O
kg FW O
body NN O
weight NN O
. . O

TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
induced VBD O
a DT O
dose JJ O
- : O
and CC O
time NN O
- : O
dependent JJ O
increase NN O
in IN O
cyclooxygenase JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
COX NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
expression NN O
and CC O
PGE2 NNP O
formation NN O
in IN O
human JJ O
NCI NNP O
- : O
H292 NNP O
epithelial JJ O
cells NNS O
. . O

Primer NNP O
extension NN O
experiments NNS O
revealed VBD O
a DT O
strong JJ O
transcription NN O
initiation NN O
site NN O
102 CD O
bp JJ O
upstream NN O
of IN O
the DT O
translational JJ O
start NN O
site NN O
. . O

Baseline NNP O
BMD NNP O
values NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
the DT O
oligo JJ O
- : O
amenorrheic NN O
group NN O
than IN O
in IN O
the DT O
two CD O
others NNS O
at IN O
the DT O
level NN O
of IN O
lumbar NN O
spine NN O
( ( O
anteroposterior JJ O
view NN O
: : O
0 CD O
. . O
941 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
39 CD O
in IN O
oligo JJ O
- : O
amenorrheic NN O
vs NN O
1 CD O
. . O
77 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
29 CD O
or CC O
1 CD O
. . O
51 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
17 CD O
g JJ O
x NN O
cm NN O
( ( O
- : O
2 CD O
) ) O
, , O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
, , O
in IN O
the DT O
eumenorrheic NN O
and CC O
contraceptive JJ O
user NN O
groups NNS O
, , O
respectively RB O
) ) O
but CC O
not RB O
in IN O
weight JJ O
- : O
bearing VBG O
bone NN O
such JJ O
as IN O
proximal JJ O
and CC O
midshaft JJ O
femur NN O
. . O

In IN O
none NN O
of IN O
the DT O
44 CD O
type NN O
I PRP O
attacks NNS O
and CC O
29 CD O
type NN O
II NNP O
attacks NNS O
which WDT O
were VBD O
recorded VBN O
did VBD O
circulatory JJ O
changes NNS O
; : O
the DT O
latter NN O
were VBD O
different JJ O
in IN O
the DT O
two CD O
groups NNS O
. . O

Interestingly RB O
, , O
this DT O
mutant JJ O
cell NN O
line NN O
lacks VBZ O
expression NN O
of IN O
the DT O
IKK NNP B-Gene
regulatory JJ I-Gene
protein NN I-Gene
, , O
IKKgamma NNP B-Gene
. . O

Drugs NNS O
suppressed VBD O
> NN O
or CC O
= VB O
75 CD O
% NN O
of IN O
the DT O
total JJ O
premature NN O
ventricular JJ O
contractions NNS O
in IN O
all DT O
patients NNS O
who WP O
had VBD O
both DT O
use IN O
- : O
dependent NN O
QRS NNP O
prolongation NN O
and CC O
reverse NN O
use NN O
- : O
dependent NN O
QT NNP O
prolongation NN O
, , O
in IN O
79 CD O
% NN O
of IN O
patients NNS O
with IN O
use NN O
- : O
dependent NN O
QRS NNP O
prolongation NN O
alone RB O
, , O
in IN O
70 CD O
% NN O
with IN O
reverse NN O
use NN O
- : O
dependent NN O
QT NNP O
prolongation NN O
alone RB O
, , O
and CC O
in IN O
11 CD O
% NN O
with IN O
neither DT O
use NN O
- : O
dependent NN O
QRS NNP O
prolongation NN O
nor CC O
reverse NN O
use NN O
- : O
dependent NN O
QT NNP O
prolongation NN O
. . O

The DT O
resulting VBG O
clone NN O
pKB11 NN B-Gene
, , O
which WDT O
has VBZ O
a DT O
1369 CD O
- : O
base NN O
pair NN O
( ( O
bp NN O
) ) O
cDNA NN O
insert NN O
, , O
overlapping VBG O
pCAD142 NN B-Gene
by IN O
781 CD O
bp NN O
, , O
was VBD O
identified VBN O
by IN O
hybridization NN O
methods NNS O
and CC O
sequence NN O
analysis NN O
and CC O
found VBD O
to TO O
contain VB O
the DT O
entire JJ O
cDNA NN O
sequence NN O
for IN O
the DT O
amino JJ O
end NN O
of IN O
the DT O
CAD NNP B-Gene
polypeptide NN I-Gene
. . O

Trinipatch NN O
is VBZ O
a DT O
small JJ O
, , O
transparent JJ O
, , O
matricial JJ O
, , O
monolayer JJ O
patch NN O
with IN O
an DT O
absorption NN O
promoter NN O
, , O
marketed VBN O
in IN O
two CD O
dose JJ O
- : O
strengths NNS O
( ( O
5 CD O
mg NN O
/ VBD O
24 CD O
h NN O
and CC O
10 CD O
mg NN O
/ VBD O
24 CD O
h NN O
) ) O
by IN O
Laboratoires NNP O
Synthelabo NNP O
. . O

The DT O
signalling NN O
molecules NNS O
Wnt1 NNP B-Gene
and CC O
Sonic NNP B-Gene
hedgehog NN I-Gene
, , O
implicated VBN O
in IN O
the DT O
activation NN O
of IN O
Myf5 NNP B-Gene
in IN O
myogenic JJ O
progenitor NN O
cells NNS O
in IN O
the DT O
somite NN O
, , O
are VBP O
also RB O
produced VBN O
in IN O
the DT O
viscinity NN O
of IN O
the DT O
Myf5 NNP B-Gene
expression NN I-Gene
domain NN I-Gene
in IN O
the DT O
mesencephalon NN O
. . O

SRF NNP B-Gene
- : O
deficient NN O
embryos NN O
( ( O
Srf NNP B-Gene
- : O
/ SYM O
- : O
) ) O
have VBP O
a DT O
severe JJ O
gastrulation NN O
defect NN O
and CC O
do VBP O
not RB O
develop VB O
to TO O
term NN O
. . O

The DT O
transcripts NNS O
were VBD O
equally RB O
active JJ O
with IN O
or CC O
without IN O
a DT O
5 CD O
' POS O
methylated JJ O
capstructure NN O
as IN O
expected VBN O
, , O
since IN O
EMCV NNP O
- : O
RNA NN O
is VBZ O
one CD O
of IN O
the DT O
mRNAs NN O
capable JJ O
of IN O
internal JJ O
initiation NN O
. . O

In IN O
contrast NN O
, , O
despite IN O
external JJ O
radiation NN O
therapy NN O
, , O
brain NN O
metastases NNS O
proved VBD O
fatal JJ O
. . O

From IN O
the DT O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
. . O

Interestingly RB O
, , O
internal JJ O
and CC O
5 CD O
' '' O
deletions NNS O
revealed VBD O
tha RP O
the DT O
distal JJ O
promoter NN O
was VBD O
not RB O
required VBN O
for IN O
full JJ O
transcriptional JJ O
activity NN O
and CC O
that IN O
the DT O
first JJ O
631 CD O
base NN O
pairs NN O
of IN O
WNT NNP B-Gene
- : I-Gene
5A CD I-Gene
harbored VBD O
the DT O
strongest JJS O
promoter NN O
activity NN O
. . O

RESULTS NNS O
: : O
We PRP O
isolated VBD O
a DT O
C NNP O
. . O
elegans NNS O
cDNA VBP O
that IN O
encoded VBD O
a DT O
protein NN O
which WDT O
was VBD O
similar JJ O
to TO O
, , O
but CC O
not RB O
exactly RB O
homologous JJ O
with IN O
mammalian JJ O
p120 NN B-Gene
Ras NNP B-Gene
- : O
GAP NN B-Gene
. . O

After IN O
gamma JJ O
- : O
irradiation NN O
, , O
the DT O
majority NN O
of IN O
F9 NNP O
cells NNS O
undergo JJ O
apoptosis NN O
implying VBG O
that IN O
wt SYM B-Gene
- : I-Gene
p53 NN I-Gene
likely JJ O
triggers NNS O
pro VBP O
- : O
apoptotic JJ O
gene NN O
expression NN O
in IN O
DNA NNP O
damaged VBD O
cells NNS O
. . O

Using VBG O
avidin SYM B-Gene
- : I-Gene
biotin NN I-Gene
complex JJ O
DNA NNP O
binding NN O
assays NNS O
, , O
a DT O
series NN O
of IN O
overlapping VBG O
alpha JJ B-Gene
promoter NN I-Gene
DNA NNP I-Gene
sequences NNS I-Gene
between IN O
- : O
170 CD O
to TO O
29 CD O
basepairs NNS O
were VBD O
tested VBN O
, , O
but CC O
each DT O
failed VBD O
to TO O
bind VB O
GR NNP B-Gene
, , O
whereas IN O
a DT O
control NN O
GRE NNP O
avidly RB O
bound VBD O
receptor NN O
. . O

The DT O
recovery NN O
index NN O
( ( O
T25 NNP O
- : O
T75 NN O
) ) O
after IN O
the DT O
infusion NN O
stopped VBD O
was VBD O
similar JJ O
in IN O
patients NNS O
who WP O
received VBD O
mivacurium NN O
and CC O
those DT O
who WP O
received VBD O
suxamethonium NN O
. . O

These DT O
clones NNS O
overlapped VBD O
and CC O
contained VBD O
the DT O
structural JJ O
gene NN O
encoding VBG O
the DT O
complete JJ O
C5 NNP B-Gene
alpha SYM I-Gene
- : I-Gene
chain NN I-Gene
and CC O
90 CD O
% NN O
of IN O
the DT O
beta NN O
- : O
chain NN O
. . O

The DT O
ability NN O
of IN O
sodium NN O
phenobarbital NN O
( ( O
60 CD O
mg NN O
/ NNP O
kg NN O
) ) O
and CC O
sodium JJ O
barbital NN O
( ( O
80 CD O
mg NN O
/ NNP O
kg NN O
) ) O
to TO O
produce VB O
a DT O
taste NN O
aversion NN O
in IN O
23 CD O
hr NN O
fluid NN O
deprived VBD O
rats NNS O
was VBD O
examined VBN O
using VBG O
a DT O
discrimination NN O
or CC O
two CD O
bottle JJ O
taste NN O
aversion NN O
task NN O
( ( O
0 CD O
. . O
125 CD O
% NN O
sodium NN O
saccharin JJ O
solution NN O
or CC O
water NN O
) ) O
. . O

Irmiere NNP O
, , O
and CC O
W NNP O
. . O

Management NN O
of IN O
postvitrectomy NN O
diabetic JJ O
vitreous JJ O
hemorrhage NN O
with IN O
tissue NN B-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
t JJ B-Gene
- : I-Gene
PA NN I-Gene
) ) O
and CC O
volume NN O
homeostatic JJ O
fluid NN O
- : O
fluid NN O
exchanger NN O
. . O

The DT O
mice NN O
are VBP O
phenotypically RB O
normal JJ O
and CC O
do VBP O
not RB O
develop VB O
spontaneous JJ O
tumors NNS O
at IN O
an DT O
early JJ O
age NN O
, , O
in IN O
contrast NN O
to TO O
knock VB O
- : O
out RP O
( ( O
p53 NN B-Gene
( ( I-Gene
- : I-Gene
/ SYM I-Gene
- : I-Gene
) ) I-Gene
) ) O
strains VBZ O
with IN O
a DT O
defective JJ O
p53 NN B-Gene
gene NN I-Gene
. . O

Collectively RB O
, , O
these DT O
results NNS O
show VBP O
that IN O
the DT O
differential JJ O
utilization NN O
of IN O
Staf NNP B-Gene
zinc NNP I-Gene
finger NN I-Gene
1 CD I-Gene
represents VBZ O
a DT O
new JJ O
, , O
critical JJ O
determinant NN O
of IN O
the DT O
transcriptional JJ O
activation NN O
mechanism NN O
for IN O
the DT O
Xenopus NNP B-Gene
tRNA NN I-Gene
( ( O
Sec NNP B-Gene
) ) O
and CC O
human JJ B-Gene
U6 NNP I-Gene
snRNA NN I-Gene
genes NNS I-Gene
. . O

The DT O
so RB O
- : O
called VBN O
"""" NN B-Gene
SH3 NNP I-Gene
"""" NNP I-Gene
segment NN I-Gene
of IN O
the DT O
linker NN O
domain NN O
, , O
in IN O
contrast NN O
, , O
shows VBZ O
species NNS O
- : O
specific JJ O
sequence NN O
identity NN O
in IN O
all DT O
but CC O
one CD O
amino NN O
acid NN O
residues NNS O
in IN O
both DT O
factors NNS O
, , O
in IN O
cattle NNS O
, , O
human JJ O
, , O
and CC O
mouse NN O
. . O

RESULTS NN O
: : O
A DT O
significant JJ O
correlation NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
was VBD O
observed VBN O
for IN O
mean NN O
wall NN O
thickness NN O
and CC O
vessel NN O
wall VBP O
area NN O
between IN O
MRI NNP O
and CC O
histopathology NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
87 CD O
and CC O
r VB O
= JJ O
0 CD O
. . O
85 CD O
, , O
respectively RB O
) ) O
. . O

This DT O
hypothesis NN O
is VBZ O
consistent JJ O
with IN O
the DT O
occurrence NN O
of IN O
PEA3 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
PEA3 NNP B-Gene
promoter NN I-Gene
and CC O
with IN O
the DT O
ability NN O
of IN O
PEA3 NNP B-Gene
to TO O
transactivate VB O
this DT O
promoter NN O
. . O

This DT O
study NN O
provides VBZ O
a DT O
direct JJ O
demonstration NN O
of IN O
a DT O
role NN O
for IN O
G NNP B-Gene
betagamma NN I-Gene
in IN O
mediating VBG O
the DT O
agonist NN O
- : O
stimulated JJ O
translocation NN O
of IN O
GRK2 NNP B-Gene
and CC O
GRK3 NNP B-Gene
in IN O
an DT O
intact JJ O
cellular JJ O
system NN O
and CC O
demonstrates VBZ O
isoform JJ O
specificity NN O
in IN O
the DT O
interaction NN O
of IN O
these DT O
components NNS O
. . O

IgG NNP B-Gene
levels NNS O
of IN O
1 CD O
/ NNS O
100 CD O
were VBD O
present JJ O
in IN O
only RB O
four CD O
out IN O
of IN O
ten JJ O
samples NNS O
obtained VBD O
150 CD O
days NNS O
after IN O
the DT O
clinical JJ O
onset NN O
. . O

In IN O
the DT O
control NN O
preparation NN O
before IN O
weight NN O
was VBD O
allowed VBN O
to TO O
increase VB O
, , O
isogravimetric JJ O
capillary JJ O
pressure NN O
( ( O
Pci NNP O
) ) O
averaged VBD O
8 CD O
mmHg NNS O
lower JJR O
than IN O
colloid JJ O
osmotic JJ O
pressure NN O
of IN O
the DT O
plasma NN O
( ( O
IIp NNP O
) ) O
. . O

Thirty NNP O
- : O
five CD O
patients NNS O
were VBD O
included VBN O
. . O

Treatment NN O
with IN O
heparin NN O
, , O
plasminogen NN B-Gene
activators NNS O
and CC O
fibrinogenolytic JJ O
agents NNS O
was VBD O
disappointing VBG O
although IN O
renal JJ O
function NN O
has VBZ O
stabilized VBN O
in IN O
one CD O
patient NN O
on IN O
long JJ O
term NN O
oral JJ O
anticoagulant JJ O
therapy NN O
. . O

The DT O
accumulation NN O
of IN O
both DT O
LHA4 NNP B-Gene
and CC O
LHA2 NNP B-Gene
mRNAs NN I-Gene
is VBZ O
induced VBN O
by IN O
the DT O
addition NN O
of IN O
exogenous JJ O
sugars NNS O
and CC O
this DT O
induction NN O
appears VBZ O
to TO O
be VB O
dependent JJ O
on IN O
sugar NN O
uptake NN O
and CC O
metabolism NN O
, , O
because IN O
mannitol NN O
and CC O
3 CD O
- : O
O NNP O
- : O
methylglucose NN O
do VBP O
not RB O
stimulate VB O
mRNA JJ O
accumulation NN O
. . O

This DT O
promoter NN O
segment NN O
could MD O
drive VB O
expression NN O
of IN O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
, , O
could MD O
confer VB O
correct JJ O
transcriptional JJ O
initiation NN O
to TO O
the DT O
reporter NN O
and CC O
could MD O
confer VB O
the DT O
EGF NNP B-Gene
- : O
responsiveness NN O
previously RB O
observed VBN O
in IN O
the DT O
native JJ O
gene NN O
. . O

Even RB O
when WRB O
the DT O
inoculum NN O
size NN O
was VBD O
reduced VBN O
sixfold JJ O
( ( O
i JJ O
. . O
e NN O
. . O
, , O
6 CD O
x NN O
10 CD O
( ( O
6 CD O
) ) O
CFU NNP O
/ NNP O
mouse NN O
) ) O
, , O
50 CD O
% NN O
of IN O
the DT O
RB6 NNP B-Gene
- : I-Gene
8C5 CD I-Gene
- : O
treated VBN O
animals NNS O
died VBD O
within IN O
6 CD O
days NNS O
. . O

The DT O
N NNP O
- : O
terminal JJ O
sequence NN O
of IN O
one CD O
hydrophilic JJ O
peptide NN O
of IN O
the DT O
FeS NNP B-Gene
protein NN I-Gene
has VBZ O
been VBN O
also RB O
obtained VBN O
confirming VBG O
the DT O
fbcF NN B-Gene
reading NN O
frame NN O
. . O

This DT O
slope NN O
tended VBD O
to TO O
be VB O
higher JJR O
( ( O
approximately RB O
1 CD O
. . O
6 CD O
dB JJ O
/ NNP O
dB NN O
) ) O
for IN O
L1 NNP O
= NNP O
L2 NNP O
greater JJR O
than IN O
80 CD O
dB NN O
. . O

These DT O
sequences NNS O
were VBD O
then RB O
used VBN O
to TO O
clone VB O
the DT O
full JJ O
- : O
length NN O
genes NNS O
from IN O
a DT O
yeast JJ O
genomic JJ O
library NN O
. . O

32Pi CD O
labeling NN O
or CC O
isoelectric JJ O
focusing VBG O
analysis NN O
of IN O
eIF JJ B-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
from IN O
conditional JJ O
casein NN B-Gene
kinase NN I-Gene
II NNP I-Gene
mutants NNS I-Gene
indicated VBD O
that IN O
phosphorylation NN O
of IN O
eIF JJ B-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
is VBZ O
abolished VBN O
or CC O
dephosphorylated VBN O
forms NNS O
of IN O
eIF JJ B-Gene
- : I-Gene
2 CD I-Gene
alpha NNS I-Gene
are VBP O
detected VBN O
when WRB O
these DT O
strains NNS O
are VBP O
grown VBN O
at IN O
the DT O
restrictive JJ O
growth NN O
conditions NNS O
. . O

We PRP O
have VBP O
been VBN O
able JJ O
to TO O
map VB O
specific JJ O
DNA NNP O
fragments NNS O
at IN O
the DT O
bases NNS O
of IN O
chromatin NN O
loops NNS O
with IN O
the DT O
help NN O
of IN O
a DT O
novel JJ O
extraction NN O
procedure NN O
by IN O
using VBG O
lithium JJ O
- : O
3 CD O
' '' O
, , O
5 CD O
' POS O
- : O
diiodosalicylate NN O
. . O

Cell NNP O
lines NNS O
derived VBN O
from IN O
the DT O
tumors NNS O
were VBD O
examined VBN O
by IN O
fluorescent NN O
in IN O
situ JJ O
hybridization NN O
for IN O
the DT O
status NN O
of IN O
the DT O
transferred JJ O
human JJ O
chromosome NN O
and CC O
by IN O
PCR NNP O
for IN O
marker NN O
loss NN O
. . O

To TO O
evaluate VB O
the DT O
comparative JJ O
safety NN O
of IN O
U NNP O
- : O
P NN O
and CC O
D NNP O
& CC O
E NNP O
, , O
we PRP O
analyzed VBD O
2 CD O
, , O
805 CD O
U NNP O
- : O
P NN O
and CC O
9 CD O
, , O
572 CD O
D NNP O
& CC O
E NNP O
abortions NNS O
at IN O
13 CD O
to TO O
24 CD O
menstrual JJ O
weeks NNS O
' POS O
gestation NN O
. . O

Biohydrogenation NN O
of IN O
linoleic JJ O
acid NN O
into IN O
octadecenoic JJ O
acid NN O
was VBD O
observed VBN O
. . O

The DT O
loss NN O
of IN O
SKO1 NNP B-Gene
completely RB O
restored VBD O
ENA1 NNP B-Gene
expression NN O
in IN O
a DT O
hog1 NN B-Gene
mutant NN I-Gene
and CC O
partially RB O
suppressed VBD O
the DT O
osmotic JJ O
stress NN O
sensitivity NN O
, , O
qualifying VBG O
Sko1p NNP B-Gene
as IN O
a DT O
downstream NN O
effector NN O
of IN O
the DT O
HOG NNP B-Gene
pathway NN O
. . O

Most JJS O
importantly RB O
, , O
the DT O
addition NN O
of IN O
purified JJ O
17S CD B-Gene
U2 NNP I-Gene
snRNPs NN I-Gene
, , O
but CC O
not RB O
of IN O
12S CD B-Gene
U2 NNP I-Gene
snRNPs NN I-Gene
, , O
to TO O
HeLa NNP O
splicing VBG O
extracts NNS O
in IN O
which WDT O
the DT O
endogeneous JJ B-Gene
U2 NNP I-Gene
snRNPs NN I-Gene
have VBP O
been VBN O
functionally RB O
neutralized VBN O
with IN O
anti JJ B-Gene
- : I-Gene
PRP9 NN I-Gene
antibodies NNS I-Gene
fully RB O
restores VBZ O
the DT O
mRNA NN O
- : O
splicing NN O
activity NN O
of IN O
the DT O
extracts NNS O
. . O

To TO O
investigate VB O
the DT O
regulation NN O
of IN O
expression NN O
of IN O
the DT O
human JJ B-Gene
mdr1 NN I-Gene
gene NN I-Gene
, , O
the DT O
response NN O
of IN O
the DT O
mdr1 NN B-Gene
promoter NN I-Gene
to TO O
signals NNS O
involved VBN O
in IN O
cell NN O
proliferation NN O
was VBD O
examined VBN O
. . O

By IN O
introducing VBG O
a DT O
series NN O
of IN O
deletions NNS O
in IN O
the DT O
vimentin NN B-Gene
promoter NN O
, , O
we PRP O
further VBP O
restrict VB O
these DT O
sequences NNS O
to TO O
30 CD O
base NN O
pairs NNS O
, , O
located VBN O
between IN O
241 CD O
and CC O
210 CD O
base NN O
pairs NNS O
upstream NN O
of IN O
the DT O
mRNA NN O
cap NN O
site NN O
. . O

We PRP O
show VBP O
that IN O
HRI NNP B-Gene
and CC O
dsRNA SYM B-Gene
- : I-Gene
PK NN I-Gene
phosphorylate NN O
yeast NN B-Gene
eIF SYM I-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
and CC O
functionally RB O
substitute VB O
for IN O
GCN2 NNP B-Gene
protein NN I-Gene
to TO O
stimulate VB O
GCN4 NNP B-Gene
translation NN O
in IN O
yeast NN O
. . O

A DT O
list NN O
of IN O
12 CD O
names NNS O
for IN O
the DT O
disease NN O
and CC O
37 CD O
diagnostic JJ O
criteria NNS O
were VBD O
proposed VBN O
to TO O
a DT O
Consensus NNP O
Panel NNP O
of IN O
12 CD O
Italian JJ O
experts NNS O
who WP O
ranked VBD O
them PRP O
in IN O
order NN O
so RB O
as IN O
to TO O
identify VB O
a DT O
core NN O
set NN O
of IN O
criteria NNS O
. . O

Nonreturn NNP O
rates NNS O
can MD O
be VB O
used VBN O
to TO O
derive VB O
more JJR O
elementary JJ O
biological JJ O
measures NNS O
for IN O
reproductive JJ O
efficiency NN O
, , O
such JJ O
as IN O
conception NN O
rate NN O
and CC O
calving VBG O
rate NN O
, , O
which WDT O
separately RB O
might MD O
be VB O
more RBR O
reliable JJ O
than IN O
nonreturn NN O
rate NN O
itself PRP O
to TO O
evaluate VB O
the DT O
fertility NN O
of IN O
a DT O
bull NN O
or CC O
the DT O
performance NN O
of IN O
an DT O
AI NNP O
technician NN O
. . O

Nuclear NNP O
hormone NN O
receptors NNS O
( ( O
NRs NNP O
) ) O
are VBP O
ligand JJ O
- : O
inducible JJ O
transcription NN O
factors NNS O
that WDT O
mediate VBP O
critical JJ O
functions NNS O
in IN O
many JJ O
species NNS O
. . O

We PRP O
measured VBD O
serum JJ B-Gene
hepatocyte NN I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
HGF NNP B-Gene
) ) O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
, , O
angina JJ O
pectoris NN O
, , O
and CC O
other JJ O
heart NN O
diseases NNS O
. . O

The DT O
B NNP O
- : O
oligomer NN O
of IN O
pertussis NN B-Gene
toxin NN I-Gene
deactivates VBZ O
CC NNP B-Gene
chemokine NN I-Gene
receptor NN I-Gene
5 CD I-Gene
and CC O
blocks NNS O
entry NN O
of IN O
M NNP O
- : O
tropic NN O
HIV NNP O
- : O
1 CD O
strains NNS O
. . O

This DT O
mutation NN O
also RB O
results NNS O
in IN O
markedly RB O
decreased JJ O
levels NNS O
of IN O
CAD NNP B-Gene
mRNA NN I-Gene
and CC O
protein NN O
in IN O
the DT O
mutant NN O
. . O

The DT O
effect NN O
of IN O
treatment NN O
may MD O
thus RB O
be VB O
divided VBN O
into IN O
two CD O
main JJ O
phases NNS O
- : O
- : O
an DT O
initial JJ O
phase NN O
with IN O
a DT O
reduction NN O
in IN O
LV NNP O
mass NN O
and CC O
a DT O
reduction NN O
in IN O
cardiac JJ O
output NN O
and CC O
no DT O
change NN O
in IN O
total JJ O
peripheral JJ O
resistance NN O
- : O
- : O
and CC O
a DT O
second JJ O
phase NN O
with IN O
a DT O
constant JJ O
LV NNP O
mass NN O
but CC O
an DT O
increase NN O
in IN O
cardiac JJ O
output NN O
to TO O
the DT O
pretreatment NN O
level NN O
again RB O
and CC O
a DT O
concomitant JJ O
decrease NN O
in IN O
total JJ O
peripheral JJ O
resistance NN O
. . O

Expression NN O
of IN O
SREBP NNP B-Gene
- : I-Gene
1a CD I-Gene
stimulated JJ O
StAR NNP B-Gene
promoter NN I-Gene
activity NN O
in IN O
the DT O
context NN O
of IN O
COS NNP O
- : O
1 CD O
cells NNS O
and CC O
human JJ O
granulosa NN O
- : O
lutein NN O
cells NNS O
. . O

A DT O
"""" JJ O
Level NNP O
A NNP O
"""" NN O
in IN O
vitro JJ O
/ NN O
in IN O
vivo JJ O
correlation NN O
was VBD O
established VBN O
for IN O
a DT O
sustained JJ O
release NN O
theophylline NN O
( ( O
CAS NNP O
58 CD O
- : O
55 CD O
- : O
9 CD O
) ) O
preparation NN O
( ( O
Bronchoretard NNP O
) ) O
under IN O
investigation NN O
. . O

Serum NNP O
prostatic JJ B-Gene
acid NN I-Gene
phosphatase NN I-Gene
levels NNS O
showed VBD O
a DT O
significantly RB O
weaker JJR O
correlation NN O
with IN O
cancer NN O
volume NN O
( ( O
r JJ O
equals NNS O
0 CD O
. . O
51 CD O
) ) O
and CC O
every DT O
other JJ O
pathological JJ O
parameter NN O
. . O

Gel NNP O
- : O
shift NN O
assays NNS O
identified VBD O
two CD O
Sp1 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
within IN O
this DT O
element NN O
. . O

Neither CC O
clone NN O
encoded VBD O
the DT O
cognate NN O
endonuclease NN O
. . O

Tumours NNS O
of IN O
the DT O
cavum NN O
oris NN O
and CC O
oropharynx NN O
of IN O
T1 NNP O
- : O
stage NN O
are VBP O
possible JJ O
only RB O
in IN O
1 CD O
of IN O
3 CD O
cases NNS O
. . O

Statement NN O
of IN O
the DT O
American NNP O
Academy NNP O
of IN O
Implant NNP O
Dentistry NNP O
. . O

First RB O
, , O
each DT O
lung NN O
was VBD O
cut VBN O
into IN O
slices NNS O
, , O
from IN O
which WDT O
primary JJ O
disectors NNS O
were VBD O
sampled VBN O
systematically RB O
with IN O
a DT O
known VBN O
sampling NN O
fraction NN O
. . O

Diuretics NNS O
: : O
basic JJ O
clinical JJ O
pharmacology NN O
and CC O
therapeutic JJ O
use NN O
. . O

In IN O
marked VBN O
contrast NN O
to TO O
AgfA NNP B-Gene
, , O
none NN O
of IN O
the DT O
chimeric JJ B-Gene
SefA NNP I-Gene
proteins NNS I-Gene
were VBD O
expressed VBN O
or CC O
assembled VBN O
into IN O
fimbriae NN O
. . O

This DT O
technique NN O
has VBZ O
a DT O
sensitivity NN O
and CC O
a DT O
specificity NN O
of IN O
almost RB O
100 CD O
% NN O
, , O
and CC O
is VBZ O
currently RB O
the DT O
best JJS O
way NN O
to TO O
diagnose VB O
nodal JJ O
involvement NN O
, , O
apart RB O
from IN O
laparotomy NN O
. . O

A DT O
large JJ O
increase NN O
of IN O
serum JJ O
ketones NNS O
occurred VBD O
under IN O
all DT O
conditions NNS O
, , O
and CC O
the DT O
exercise NN O
respiratory NN O
quotient NN O
suggested VBD O
some DT O
increase NN O
of IN O
fat JJ O
utilization NN O
, , O
WW NNP O
( ( O
0 CD O
. . O
85 CD O
) ) O
through IN O
CW NNP O
( ( O
0 CD O
. . O
84 CD O
) ) O
to TO O
CC NNP O
( ( O
0 CD O
. . O
83 CD O
) ) O
. . O

The DT O
survival NN O
rate NN O
at IN O
forty JJ O
months NNS O
in IN O
15 CD O
patients NNS O
with IN O
N2 NNP O
disease NN O
who WP O
underwent JJ O
R2b NNP O
operation NN O
was VBD O
51 CD O
% NN O
. . O

Lymphoproliferative JJ O
disorders NNS O
arising VBG O
under IN O
immunosuppression NN O
with IN O
FK NNP O
506 CD O
: : O
initial JJ O
observations NNS O
in IN O
a DT O
large JJ O
transplant NN O
population NN O
. . O

Among IN O
the DT O
transcription NN O
factors NNS O
known VBN O
to TO O
interact VB O
with IN O
Groucho NNP B-Gene
- : I-Gene
related JJ I-Gene
protein NN I-Gene
, , O
only RB O
RUNX1 NNP B-Gene
was VBD O
appreciably RB O
downregulated VBN O
by IN O
E2A NNP B-Gene
- : O
HLF NN B-Gene
. . O

A DT O
position NN O
- : O
independent JJ O
activation NN O
domain NN O
which WDT O
contained VBD O
conserved VBD O
regions NNS O
II NNP O
and CC O
III NNP O
was VBD O
identified VBN O
at IN O
the DT O
carboxyl JJ O
terminus NN O
of IN O
the DT O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
protein NN I-Gene
( ( O
amino JJ O
acids NNS O
361 CD O
to TO O
458 CD O
) ) O
. . O

Five CD O
of IN O
these DT O
eight CD O
patients NNS O
in IN O
group NN O
II NNP O
also RB O
received VBD O
8 CD O
- : O
in IN O
- : O
1 CD O
chemotherapy NN O
. . O

The DT O
triple JJ O
combination NN O
of IN O
nizatidine NN O
, , O
clarithromycin NN O
, , O
and CC O
bismuth NN O
subcitrate NN O
resulted VBD O
in IN O
an DT O
ulcer JJ O
healing VBG O
rate NN O
of IN O
98 CD O
% NN O
and CC O
an DT O
H NNP O
. . O
pylori CC O
eradication JJ O
rate NN O
of IN O
90 CD O
% NN O
. . O

We PRP O
characterized VBD O
the DT O
structure NN O
of IN O
this DT O
leader NN O
mRNA NN O
by IN O
using VBG O
the DT O
program NN O
Mfold NNP O
and CC O
a DT O
combination NN O
of IN O
nested JJ O
and CC O
internal JJ O
deletions NNS O
transcriptionally RB O
fused VBN O
to TO O
a DT O
promoterless NN O
lac NN B-Gene
operon NN I-Gene
. . O

No DT O
changes NNS O
were VBD O
evident JJ O
in IN O
the DT O
FR NNP O
- : O
task NN O
performance NN O
of IN O
controls NNS O
that WDT O
received VBD O
daily JJ O
saline JJ O
injections NNS O
. . O

The DT O
feed NN O
given VBN O
to TO O
young JJ O
broiler NN O
chickens NNS O
was VBD O
contaminated VBN O
artificially RB O
with IN O
Salmonella NNP O
kedougou NN O
, , O
a DT O
serotype NN O
associated VBN O
with IN O
both DT O
subclinical JJ O
infections NNS O
in IN O
commercially RB O
reared VBN O
chickens NNS O
and CC O
food NN O
poisoning NN O
in IN O
humans NNS O
. . O

The DT O
second JJ O
transcript NN O
, , O
rhis4l NN B-Gene
, , O
is VBZ O
bicistronic JJ O
. . O

The DT O
major JJ O
pathological JJ O
findings NNS O
of IN O
the DT O
placenta NN O
were VBD O
prematuration NN O
and CC O
hypoplasia NN O
. . O

The DT O
UCR NNP O
core NN O
sequence NN O
, , O
CGCCATTTT NNP O
, , O
binds VBZ O
a DT O
ubiquitous JJ O
nuclear JJ O
factor NN O
and CC O
mediates NNS O
negative JJ O
regulation NN O
of IN O
MuLV NNP O
promoter NN O
activity NN O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBD O
a DT O
region NN O
encoding VBG O
a DT O
lipase NN B-Gene
operon NN I-Gene
and CC O
a DT O
putative JJ O
, , O
previously RB O
uncharacterized JJ O
metalloprotease NN B-Gene
of IN I-Gene
Vibrio NNP I-Gene
cholerae NN I-Gene
O1 NNP I-Gene
. . O

Leukemia NNP O
in IN O
twins NNS O
: : O
world NN O
- : O
wide JJ O
review NN O
of IN O
clinical JJ O
cases NNS O
. . O

HANYS NNP O
criticizes VBZ O
laparoscopic FW O
gall JJ O
bladder NN O
guidelines NNS O
. . O

Three CD O
different JJ O
techniques NNS O
of IN O
EA NNP O
analysis NN O
were VBD O
used VBN O
in IN O
the DT O
study NN O
: : O
1 CD O
) ) O
fast RB O
Fourier NNP O
transformation NN O
( ( O
FFT NNP O
) ) O
of IN O
EA NNP O
in IN O
a DT O
broad JJ O
band NN O
, , O
2 CD O
) ) O
developed VBN O
by IN O
us PRP O
alternative JJ O
method NN O
of IN O
non JJ O
- : O
harmonic JJ O
expansion NN O
of IN O
the DT O
EEG NNP O
curves VBZ O
taking VBG O
into IN O
account PDT O
their PRP$ O
shape NN O
, , O
3 CD O
) ) O
factor NN O
analysis NN O
of IN O
the DT O
EA NNP O
spectral JJ O
densities NNS O
. . O

This DT O
up RP O
- : O
grading NN O
of IN O
the DT O
final JJ O
score NN O
by IN O
the DT O
CA NNP O
component NN O
is VBZ O
greater JJR O
( ( O
3 CD O
- : O
8 CD O
% NN O
) ) O
in IN O
the DT O
less RBR O
able JJ O
students NNS O
with IN O
scores NNS O
below IN O
the DT O
mean JJ O
level NN O
. . O

This DT O
study NN O
allows VBZ O
us PRP O
to TO O
draw VB O
conclusions NNS O
about IN O
the DT O
identity NN O
of IN O
proteins NNS O
required VBN O
for IN O
the DT O
development NN O
of IN O
the DT O
nervous JJ O
system NN O
in IN O
Drosophila NNP O
and CC O
provides VBZ O
an DT O
example NN O
of IN O
a DT O
molecular JJ O
approach NN O
to TO O
characterize VB O
en FW O
masse FW O
transposon NN O
- : O
tagged JJ O
mutations NNS O
identified VBN O
in IN O
genetic JJ O
screens NNS O
. . O

15 CD O
, , O
2500 CD O
- : O
2508 CD O
; : O
O NNP O
' POS O
Neill NNP O
, , O
T NNP O
. . O

A DT O
retrospective JJ O
study NN O
of IN O
banked VBN O
sera NN O
from IN O
19 CD O
cats NNS O
with IN O
the DT O
eosinophilic JJ O
granuloma NN O
complex NN O
revealed VBD O
that IN O
68 CD O
% NN O
of IN O
affected JJ O
cats NNS O
had VBD O
circulating VBG O
antibodies NNS O
to TO O
components NNS O
of IN O
normal JJ O
cat NN O
epithelium NN O
. . O

Local JJ O
control NN O
rates NNS O
were VBD O
91 CD O
% NN O
for IN O
metastatic JJ O
lung NN O
cancer NN O
, , O
89 CD O
% NN O
for IN O
primary JJ O
lung NN O
cancer NN O
and CC O
85 CD O
% NN O
for IN O
T1 NNP O
, , O
2N0M0 CD O
cases NNS O
. . O

In IN O
the DT O
premating NN O
period NN O
male JJ O
rate NN O
of IN O
aggression NN O
was VBD O
not RB O
significantly RB O
correlated VBN O
with IN O
testosterone NN O
level NN O
. . O

The DT O
synergistic JJ O
effect NN O
due JJ O
to TO O
the DT O
5 CD O
' POS O
- : O
3 CD O
' POS O
cooperation NN O
was VBD O
at IN O
least JJS O
fourfold RB O
greater JJR O
than IN O
the DT O
sum NN O
of IN O
the DT O
contributions NNS O
of IN O
the DT O
individual JJ O
UTRs NNP O
. . O

In IN O
mammalian JJ O
cells NNS O
, , O
phosphorylation NN O
of IN O
eIF JJ B-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
inhibits VBZ O
the DT O
activity NN O
of IN O
eIF NN B-Gene
- : I-Gene
2B CD I-Gene
, , O
the DT O
GDP NNP B-Gene
- : I-Gene
GTP NNP I-Gene
exchange NN I-Gene
factor NN I-Gene
for IN O
eIF JJ B-Gene
- : I-Gene
2 CD I-Gene
. . O

Deletional JJ O
analyses NNS O
of IN O
VDR NNP B-Gene
indicated VBD O
that IN O
GRIP1 NNP B-Gene
and CC O
RAC3 NNP B-Gene
required VBD O
an DT O
intact JJ O
VDR NNP B-Gene
activation NN O
function NN O
( ( O
AF NNP O
- : O
2 CD O
) ) O
domain NN O
for IN O
efficient JJ O
interaction NN O
as RB O
well RB O
as IN O
additional JJ O
but CC O
distinct JJ O
regions NNS O
of IN O
the DT O
VDR NNP B-Gene
. . O

DNA NN O
sequence NN O
and CC O
evolution NN O
of IN O
the DT O
CPS NNP B-Gene
domain NN I-Gene
of IN O
the DT O
Syrian JJ B-Gene
hamster NN I-Gene
multifunctional JJ I-Gene
protein NN I-Gene
CAD NNP I-Gene
. . O

Experiments NNS O
with IN O
recombinant JJ O
proteins NNS O
showed VBD O
that IN O
p50 NN B-Gene
/ NNP O
p65 NN B-Gene
and CC O
high JJ B-Gene
- : I-Gene
mobility NN I-Gene
- : I-Gene
group NN I-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
protein VBP I-Gene
cooperatively RB O
facilitated VBN O
the DT O
binding NN O
of IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
to TO O
the DT O
VCAM1 NNP B-Gene
IRF NNP B-Gene
binding VBG I-Gene
site NN I-Gene
and CC O
that IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
physically RB O
interacted VBN O
with IN O
p50 NN B-Gene
and CC O
with IN O
high JJ B-Gene
- : I-Gene
mobility NN I-Gene
- : I-Gene
group NN I-Gene
I PRP I-Gene
( ( I-Gene
Y NNP I-Gene
) ) I-Gene
protein NN I-Gene
. . O

Several JJ O
nuclear JJ O
factors NNS O
that IN O
interact NN O
with IN O
sequences NNS O
in IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
mouse NN B-Gene
tyrosinase NN I-Gene
gene NN I-Gene
were VBD O
identified VBN O
using VBG O
band NN O
shift NN O
and CC O
methylation NN O
interference NN O
assays NNS O
. . O

Synthesis NN O
of IN O
( ( O
+ NNP O
) ) O
- : O
lysergic JJ O
acid JJ O
diethylamide NN O
tartrate NN O

Key NNP O
areas NNS O
of IN O
the DT O
selection NN O
process NN O
including VBG O
medical JJ O
and CC O
surgical JJ O
alternatives NNS O
to TO O
transplantation NN O
, , O
the DT O
composition NN O
of IN O
the DT O
transplant NN O
work NN O
- : O
up RB O
, , O
specific JJ O
inclusion NN O
criteria NNS O
as RB O
well RB O
as IN O
specific JJ O
psychosocial JJ O
factors NNS O
and CC O
specific JJ O
disease NN O
etiologies NNS O
and CC O
co SYM O
- : O
morbidities NNS O
that WDT O
might MD O
represent VB O
contraindications NNS O
were VBD O
extensively RB O
reviewed VBN O
. . O

The DT O
majority NN O
of IN O
PI NNP B-Gene
kinase NN I-Gene
activity NN O
appeared VBD O
to TO O
be VB O
cbl JJ B-Gene
- : O
associated VBN O
after IN O
PRL NNP B-Gene
stimulation NN O
. . O

The DT O
results NNS O
of IN O
the DT O
lab NN O
and CC O
field NN O
tests NNS O
yielded VBD O
high JJ O
levels NNS O
of IN O
infestation NN O
in IN O
larvae NN O
with IN O
values NNS O
ranging VBG O
from IN O
90 CD O
to TO O
100 CD O
% NN O
and CC O
from IN O
85 CD O
to TO O
95 CD O
% NN O
, , O
respectively RB O
. . O

Cultivation NN O
technics NNS O
for IN O
Codonopsis NNP O
pilosula NN O

Following VBG O
iv JJ O
injection NN O
of IN O
0 CD O
. . O
5 CD O
g NN O
galactose NN O
per IN O
kg NN O
body NN O
weight NN O
, , O
together RB O
with IN O
2 CD O
mu NN O
Ci NNP O
generally RB O
14C CD O
- : O
labelled VBN O
galactose NN O
, , O
14CO2 CD O
is VBZ O
collected VBN O
in IN O
regular JJ O
intervals NNS O
during IN O
one CD O
hour NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
antagonistic JJ O
effects NNS O
of IN O
CRP NNP B-Gene
and CC O
KdgR NNP B-Gene
on IN O
the DT O
expression NN O
of IN O
the DT O
pectinolysis NN B-Gene
genes NNS I-Gene
occur VBP O
by IN O
different JJ O
mechanisms NNS O
, , O
including VBG O
direct JJ O
competition NN O
between IN O
the DT O
two CD O
regulators NNS O
or CC O
between IN O
the DT O
repressor NN O
and CC O
RNA NNP B-Gene
polymerase NN I-Gene
for IN O
the DT O
occupation NN O
of IN O
a DT O
common JJ O
DNA NNP O
region NN O
on IN O
the DT O
target NN O
genes NNS O
. . O

At IN O
pH JJ O
6 CD O
. . O
9 CD O
, , O
the DT O
same JJ O
lidocaine NN O
concentrations NNS O
significantly RB O
reduced VBD O
resting VBG O
potential NN O
( ( O
3 CD O
- : O
10 CD O
% NN O
) ) O
, , O
action NN O
potential JJ O
amplitude NN O
( ( O
3 CD O
- : O
8 CD O
% NN O
) ) O
and CC O
Vmax NNP O
( ( O
14 CD O
- : O
22 CD O
% NN O
) ) O
. . O

In IN O
addition NN O
, , O
26 CD O
amino NN O
acid NN O
residues NNS O
, , O
K69 NNP O
, , O
D88 NNP O
, , O
E94 NNP O
, , O
D134 NNP O
, , O
R154 NNP O
, , O
K169 NNP O
, , O
H197 NNP O
, , O
D233 NNP O
, , O
G235 NNP O
, , O
G236 NNP O
, , O
G237 NNP O
, , O
F238 NNP O
, , O
E274 NNP O
, , O
G276 NNP O
, , O
R277 NNP O
, , O
Y278 NNP O
, , O
K294 NNP O
, , O
Y323 NNP O
, , O
Y331 NNP O
, , O
D332 NNP O
, , O
C360 NNP O
, , O
D361 NNP O
, , O
D364 NNP O
, , O
G387 NNP O
, , O
Y389 NNP O
, , O
and CC O
F397 NNP O
( ( O
mouse VB O
ODC NNP B-Gene
numbering VBG O
) ) O
, , O
all DT O
of IN O
which WDT O
are VBP O
implicated VBN O
in IN O
the DT O
formation NN O
of IN O
the DT O
pyridoxal NN O
phosphate NN O
- : O
binding NN O
domain NN O
and CC O
the DT O
substrate NN O
- : O
binding NN O
domain NN O
and CC O
in IN O
dimer JJ O
stabilization NN O
with IN O
the DT O
eukaryotic JJ O
ODCs NNP B-Gene
, , O
were VBD O
also RB O
conserved VBN O
in IN O
S NNP O
. . O
ruminantium NN O
LDC NNP B-Gene
. . O

Chemical NNP O
constituents NNS O
of IN O
the DT O
gentianaceae NN O
V NNP O
: : O
tetraoxygenated JJ O
xanthones NNS O
of IN O
Swertia NNP O
chirata NN O
Buch NNP O
. . O
- : O
Ham NN O
. . O

Thus RB O
adaptation NN O
to TO O
continuous JJ O
mild JJ O
stress NN O
has VBZ O
a DT O
potent JJ O
antiarrhythmic JJ O
effect NN O
which WDT O
occurs VBZ O
due JJ O
to TO O
the DT O
increased VBN O
vagal NN O
tone NN O
. . O

Specific JJ O
and CC O
heritable JJ O
genetic JJ O
interference NN O
by IN O
double JJ O
- : O
stranded VBD O
RNA NNP O
in IN O
Arabidopsis NNP O
thaliana NN O
. . O

Slp1 NNP B-Gene
represses VBZ O
transcription NN O
via IN O
this DT O
binding VBG O
site NN O
in IN O
yeast NN O
cells NNS O
, , O
consistent JJ O
with IN O
its PRP$ O
role NN O
as IN O
a DT O
direct JJ O
repressor NN O
of IN O
ftz JJ B-Gene
stripes NNS O
in IN O
interstripe JJ O
regions NNS O
during IN O
late JJ O
stages NNS O
of IN O
embryogenesis NN O
. . O

Moreover RB O
, , O
the DT O
observation NN O
of IN O
enhanced JJ O
luteal NN B-Gene
HSP NNP I-Gene
- : I-Gene
27 CD I-Gene
phosphorylation NN O
in IN O
vivo NN O
, , O
in IN O
late JJ O
pregnancy NN O
, , O
when WRB O
PKC NNP B-Gene
- : I-Gene
delta NN I-Gene
is VBZ O
abundant JJ O
and CC O
active JJ O
, , O
suggests VBZ O
that IN O
select NN O
PKC NNP B-Gene
family NN I-Gene
members NNS I-Gene
contribute VBP O
to TO O
sHSP VB B-Gene
phosphorylation NN O
events NNS O
in IN O
vivo NN O
. . O

As IN O
PP2A NNP B-Gene
exerts VBZ O
a DT O
range NN O
of IN O
cellular JJ O
functions NNS O
including VBG O
cell NN O
cycle NN O
regulation NN O
and CC O
cell NN O
fate NN O
determination NN O
, , O
we PRP O
were VBD O
surprised VBN O
to TO O
find VB O
that IN O
these DT O
embryos NNS O
develop VBP O
normally RB O
until IN O
postimplantation NN O
, , O
around IN O
embryonic JJ O
day NN O
5 CD O
. . O
5 CD O
/ JJ O
6 CD O
. . O
0 CD O
. . O

The DT O
mammalian JJ B-Gene
homeodomain NN I-Gene
proteins NNS I-Gene
encoded VBN O
by IN O
Hox NNP B-Gene
genes NNS I-Gene
play VBP O
an DT O
important JJ O
role NN O
in IN O
embryonic JJ O
development NN O
by IN O
providing VBG O
positional JJ O
queues NNS O
which WDT O
define VBP O
developmental JJ O
identities NNS O
along IN O
the DT O
anteroposterior JJ O
axis NN O
of IN O
developing VBG O
organisms NNS O
. . O

Plasmid NNP O
pAL618 NN O
contains VBZ O
the DT O
genetic JJ O
determinants NNS O
for IN O
H2 NNP O
uptake NN O
( ( O
hup NN B-Gene
) ) O
from IN O
Rhizobium NNP O
leguminosarum NN O
bv NN O
. . O
viciae NN O
, , O
including VBG O
a DT O
cluster NN O
of IN O
17 CD O
genes NNS O
named VBN O
hupSLCDEFGHIJK SYM B-Gene
- : I-Gene
hypABFCDE NN I-Gene
. . O

Spatiotemporal JJ O
expression NN O
of IN O
the DT O
PAX3 NNP B-Gene
gene NN I-Gene
is VBZ O
tightly RB O
regulated VBN O
during IN O
development NN O
. . O

Previous JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
the DT O
616 CD O
amino NN O
acid NN O
, , O
70 CD B-Gene
- : I-Gene
kDa NN I-Gene
subunit NN I-Gene
of IN I-Gene
RPA NNP I-Gene
( ( O
RPA NNP B-Gene
70 CD I-Gene
) ) O
is VBZ O
composed VBN O
of IN O
multiple JJ O
structural JJ O
/ NNP O
functional JJ O
domains NNS O
. . O

After IN O
screening VBG O
the DT O
Berkeley NNP O
Drosophila NNP O
Genome NNP O
Project NNP O
database NN O
with IN O
sequences NNS O
from IN O
a DT O
recently RB O
characterized VBN O
Leu NNP B-Gene
- : I-Gene
rich JJ I-Gene
repeats NNS I-Gene
- : I-Gene
containing VBG I-Gene
G NNP I-Gene
protein NN I-Gene
- : I-Gene
coupled VBN I-Gene
receptor NN I-Gene
( ( O
LGR NNP B-Gene
) ) O
from IN O
Drosophila NNP O
( ( O
DLGR NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
we PRP O
identified VBD O
a DT O
second JJ O
gene NN O
for IN O
a DT O
different JJ O
LGR NNP B-Gene
( ( O
DLGR NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
and CC O
cloned VBD O
its PRP$ O
cDNA NN O
. . O

On IN O
parents NNS O

Losses NNS O
of IN O
dichlofluanid NN O
( ( O
54 CD O
% NN O
) ) O
, , O
chlozolinate NN O
( ( O
22 CD O
% NN O
) ) O
, , O
and CC O
etridiazole NN O
( ( O
40 CD O
% NN O
) ) O
, , O
previously RB O
reported VBN O
to TO O
occur VB O
during IN O
ambient JJ O
processing NN O
of IN O
apples NNS O
, , O
were VBD O
reduced VBN O
to TO O
barely RB O
significant JJ O
levels NNS O
( ( O
10 CD O
, , O
17 CD O
, , O
and CC O
14 CD O
% NN O
, , O
respectively RB O
) ) O
by IN O
cryogenic JJ O
processing NN O
. . O

Sequence NNP O
analysis NN O
of IN O
reverse NN O
transcribed NN O
, , O
amplified VBD O
cDNA NN O
generated VBN O
from IN O
total JJ O
RNA NNP O
isolated VBD O
from IN O
transfected JJ O
cells NNS O
demonstrated VBD O
the DT O
presence NN O
of IN O
abnormally RB O
spliced VBN O
products NNS O
containing VBG O
13 CD O
and CC O
78 CD O
additional JJ O
bases NNS O
as RB O
well RB O
as IN O
the DT O
accumulation NN O
of IN O
unspliced JJ O
mRNA NN O
. . O

Detection NN O
of IN O
congenital JJ O
hypothyroidism NN O
in IN O
26 CD O
, , O
282 CD O
newborn JJ O
infants NNS O

Serotonin NN O
levels NNS O
in IN O
infant JJ O
hypothyroidism NN O
. . O

This DT O
new JJ O
knowledge NN O
has VBZ O
contributed VBN O
to TO O
the DT O
development NN O
of IN O
a DT O
successful JJ O
immunoprophylactic JJ O
strategy NN O
for IN O
eliminating VBG O
Hib NNP O
disease NN O
. . O

T NNP O
. . O
, , O
Patel NNP O
, , O
S NNP O
. . O

Genetic NNP O
and CC O
phenotypic NN O
analysis NN O
indicates VBZ O
that IN O
NHP6A NNP B-Gene
and CC O
NHP6B NNP B-Gene
function NN O
downstream NN O
of IN O
SLT2 NNP B-Gene
. . O

Northern NNP O
blot NN O
and CC O
in IN O
situ JJ O
hybridization NN O
analyses NNS O
revealed VBD O
GPR34 NNP B-Gene
mRNA NN I-Gene
transcripts NNS I-Gene
in IN O
several JJ O
human JJ O
and CC O
rat NN O
brain NN O
regions NNS O
. . O

CM NNP B-Gene
- : I-Gene
ACO3 NNP I-Gene
is VBZ O
expressed VBN O
in IN O
flowers NNS O
and CC O
is VBZ O
not RB O
induced VBN O
by IN O
any DT O
of IN O
the DT O
stimuli NN O
tested VBD O
. . O

The DT O
coexpression NN O
of IN O
full JJ O
- : O
length NN O
expression NN O
constructs NNS O
for IN O
both DT O
DBP NNP B-Gene
and CC O
hepatic JJ B-Gene
leukemia NN I-Gene
factor NN I-Gene
resulted VBD O
in IN O
a DT O
dramatic JJ O
increase NN O
in IN O
activation NN O
mediated VBN O
by IN O
the DT O
GAL4 NNP B-Gene
- : O
DBP NNP B-Gene
fusion NN O
proteins NNS O
, , O
suggesting VBG O
the DT O
involvement NN O
of IN O
a DT O
regulated JJ O
coactivator NN O
in IN O
this DT O
process NN O
. . O

The DT O
amino NN O
acid JJ O
sequence NN O
of IN O
the DT O
S NNP O
. . O
aureus VB O
peptide IN O
carrying VBG O
the DT O
phosphoryl NN O
group NN O
was VBD O
found VBN O
to TO O
be VB O
Gln NNP O
- : O
Val NNP O
- : O
Val NNP O
- : O
Ser NNP O
- : O
Thr NNP O
- : O
Phe NNP O
- : O
Met NNP O
- : O
Gly NNP O
- : O
Asn NNP O
- : O
Gly NNP O
- : O
Leu NNP O
- : O
Ala NNP O
- : O
Ile NNP O
- : O
Pro NNP O
- : O
His PRP$ O
- : O
Gly NNP O
- : O
Thr NNP O
- : O
Asp NNP O
- : O
Asp NN O
. . O

The DT O
volume NN O
fraction NN O
( ( O
Vv NNP O
) ) O
and CC O
number NN O
/ NNP O
mm2 NN O
( ( O
Na NNP O
) ) O
of IN O
all DT O
capillaries NNS O
( ( O
perfused VBN O
and CC O
nonperfused VBN O
) ) O
in IN O
a DT O
given VBN O
area NN O
of IN O
brain NN O
were VBD O
determined VBN O
after IN O
staining VBG O
for IN O
alkaline JJ B-Gene
phosphatase NN I-Gene
. . O

We PRP O
investigated VBD O
the DT O
smoking NN O
habits NNS O
of IN O
relapsers NNS O
1 CD O
year NN O
after IN O
quitting VBG O
in IN O
a DT O
smoking NN O
cessation NN O
trial NN O
using VBG O
nicotine NN O
or CC O
placebo NN O
patches NNS O
. . O

Of IN O
the DT O
21 CD O
quadrants NNS O
positive JJ O
in IN O
the DT O
controls NNS O
, , O
17 CD O
were VBD O
correlated VBN O
with IN O
previously RB O
detected VBN O
jaw NN O
pathoses NNS O
. . O

As IN O
well RB O
, , O
further JJ O
deletion NN O
of IN O
the DT O
promoter NN O
region NN O
to TO O
nucleotide VB O
- : O
110 CD O
, , O
which WDT O
contains VBZ O
only RB O
one CD O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN I-Gene
site NN I-Gene
, , O
still RB O
retained VBD O
the DT O
ability NN O
to TO O
respond VB O
to TO O
exogenous JJ O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

We PRP O
show VBP O
here RB O
that IN O
these DT O
Jun NNP B-Gene
/ NNP O
eb1 NN B-Gene
chimeras NNS O
are VBP O
potent JJ O
transactivators NNS O
of IN O
AP1 NNP B-Gene
sites NNS I-Gene
and CC O
that IN O
they PRP O
can MD O
cooperate VB O
with IN O
c JJ B-Gene
- : I-Gene
Ha NNP I-Gene
- : I-Gene
Ras NN I-Gene
to TO O
induce VB O
foci NN O
. . O

Calcitriol NNP O
therapy NN O
was VBD O
associated VBN O
with IN O
a DT O
decrease NN O
in IN O
serum JJ O
iPTH NN B-Gene
levels NNS O
( ( O
701 CD O
+ NN O
/ NNP O
- : O
103 CD O
. . O
9 CD O
vs NN O
. . O

Workplace NNP O
violence NN O
- : O
- : O
nurses NNS O
at IN O
risk NN O
. . O

Mammalian JJ O
Ras NNP B-Gene
GTPase NNP B-Gene
- : I-Gene
activating VBG I-Gene
protein NN I-Gene
( ( O
GAP NNP B-Gene
) ) O
, , O
p120 JJ B-Gene
Ras NNP B-Gene
- : O
GAP NN B-Gene
, , O
has VBZ O
been VBN O
implicated VBN O
as IN O
both DT O
a DT O
downregulator NN O
and CC O
effector NN O
of IN O
Ras NNP B-Gene
proteins NNS I-Gene
, , O
but CC O
its PRP$ O
precise JJ O
role NN O
in IN O
Ras NNP B-Gene
- : O
mediated VBD O
signal JJ O
transduction NN O
pathways NNS O
is VBZ O
unclear JJ O
. . O

Mutation NN O
of IN O
the DT O
Sp1 NNP B-Gene
element NN I-Gene
, , O
which WDT O
abolishes VBZ O
Sp1 NNP B-Gene
binding NN O
, , O
results NNS O
in IN O
a DT O
6 CD O
- : O
10 CD O
- : O
fold NN O
reduction NN O
in IN O
reporter NN O
activity NN O
. . O

Posttranslational NNP O
regulation NN O
of IN O
Ty1 NNP B-Gene
retrotransposition NN O
by IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
Fus3 NNP I-Gene
. . O

Transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
) ) O
induced VBD O
growth NN O
arrest NN O
of IN O
cells NNS O
involves VBZ O
regulation NN O
of IN O
the DT O
activities NNS O
of IN O
both DT O
D NNP B-Gene
- : I-Gene
and CC I-Gene
E NNP I-Gene
- : I-Gene
type NN I-Gene
cyclin NN I-Gene
kinase NN I-Gene
complexes NNS I-Gene
thought VBD O
to TO O
be VB O
mediated VBN O
primarily RB O
by IN O
the DT O
regulation NN O
of IN O
p15 NN B-Gene
( ( O
Ink4b NNP B-Gene
) ) O
and CC O
p27 NN B-Gene
( ( O
Kip1 NNP B-Gene
) ) O
cyclin NN O
kinase NN O
inhibitors NNS O
. . O

Clinical JJ O
value NN O
of IN O
the DT O
estimation NN O
of IN O
growth NN O
kinetics NNS O
of IN O
primary JJ O
ovarian JJ O
cancer NN O
recurrences NNS O
by IN O
CA125 NNP B-Gene
doubling VBG O
time NN O

We PRP O
compared VBN O
the DT O
volume NN O
of IN O
the DT O
pulmonary JJ O
extravascular NN O
, , O
extracellular JJ O
water NN O
space NN O
using VBG O
sodium NN O
and CC O
sucrose JJ O
indicators NNS O
in IN O
8 CD O
normal JJ O
and CC O
11 CD O
edematous JJ O
rabbit NN O
lungs NNS O
by IN O
steady JJ O
- : O
state NN O
techniques NNS O
. . O

Regulators NNS O
responsible JJ O
for IN O
the DT O
pervasive NN O
, , O
nonsex SYM O
- : O
specific JJ O
alternative JJ O
pre NN O
- : O
mRNA NN O
splicing VBG O
characteristic NN O
of IN O
metazoans NNS O
are VBP O
almost RB O
entirely RB O
unknown JJ O
or CC O
uncertain JJ O
. . O

Cell NNP O
. . O

The DT O
amino NN O
acid JJ O
sequences NNS O
of IN O
the DT O
yeast NN O
and CC O
mammalian JJ O
mitochondrial NN O
targeting NN O
sequences NNS O
are VBP O
similar JJ O
but CC O
less RBR O
related JJ O
than IN O
the DT O
mature NN O
polypeptides NNS O
. . O

In IN O
particular JJ O
, , O
unc JJ B-Gene
- : I-Gene
86 CD I-Gene
encodes VBZ O
a DT O
POU NNP B-Gene
- : I-Gene
type NN I-Gene
homeodomain NN I-Gene
protein NN I-Gene
needed VBD O
for IN O
the DT O
production NN O
of IN O
the DT O
touch JJ O
cells NNS O
, , O
while IN O
mec SYM B-Gene
- : I-Gene
3 CD I-Gene
encodes VBZ O
a DT O
LIM NNP B-Gene
- : I-Gene
type NN I-Gene
homeodomain NN I-Gene
protein NN I-Gene
needed VBD O
for IN O
the DT O
differentiation NN O
of IN O
the DT O
touch JJ O
cells NNS O
. . O

Identification NN O
of IN O
an DT O
enhancer NN O
and CC O
an DT O
alternative JJ O
promoter NN O
in IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
alpha JJ B-Gene
- : I-Gene
fetoprotein NN I-Gene
gene NN I-Gene
. . O

The DT O
results NNS O
of IN O
induced JJ O
coexpression NN O
were VBD O
also RB O
supported VBN O
by IN O
rapid JJ O
generation NN O
of IN O
FeLV NNP O
recombinants NNS O
when WRB O
FeLV NNP O
- : O
C NNP O
was VBD O
used VBN O
to TO O
infect VB O
the DT O
feline NN O
3201B CD O
cell NN O
line NN O
that WDT O
constitutively RB O
expresses VBZ O
high JJ O
levels NNS O
of IN O
endogenous JJ O
FeLV NNP O
- : O
specific JJ O
mRNAs NN O
. . O

The DT O
homology NN O
to TO O
v VB B-Gene
- : I-Gene
mil NN I-Gene
starts VBZ O
within IN O
the DT O
coding VBG O
sequence NN O
of IN O
exon $ O
1 CD O
and CC O
ends NNS O
within IN O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
of IN O
exon NN O
11 CD O
, , O
12 CD O
nucleotides NNS O
downstream NN O
from IN O
the DT O
nonsense JJ O
codon NN O
terminating VBG O
the DT O
large JJ O
open JJ O
reading NN O
frame NN O
shared VBD O
between IN O
c SYM B-Gene
- : I-Gene
mil NN I-Gene
and CC O
v NN B-Gene
- : I-Gene
mil NN I-Gene
. . O

For IN O
instance NN O
, , O
a DT O
total JJ O
SIP NNP O
score NN O
of IN O
an DT O
individual JJ O
patient NN O
of IN O
28 CD O
. . O
3 CD O
% NN O
( ( O
which WDT O
is VBZ O
taken VBN O
as IN O
an DT O
example NN O
, , O
being VBG O
the DT O
mean NN O
score NN O
in IN O
the DT O
study NN O
population NN O
) ) O
should MD O
decrease VB O
by IN O
at IN O
least JJS O
9 CD O
. . O
26 CD O
% NN O
or CC O
approximately RB O
13 CD O
items NNS O
, , O
before IN O
any DT O
improvement NN O
beyond IN O
reproducibility NN O
noise NN O
can MD O
be VB O
detected VBN O
. . O

Characterization NN O
of IN O
the DT O
human JJ B-Gene
gene NN I-Gene
encoding VBG I-Gene
cytokeratin JJ I-Gene
17 CD I-Gene
and CC O
its PRP$ O
expression NN O
pattern NN O
. . O

Such JJ O
marked JJ O
differences NNS O
are VBP O
found VBN O
occasionally RB O
in IN O
the DT O
literature NN O
: : O
heterophile JJ O
antibodies NNS O
against IN O
bovine NN B-Gene
gammaglobulin NN I-Gene
are VBP O
regarded VBN O
as IN O
responsible JJ O
for IN O
the DT O
interference NN O
in IN O
the DT O
Sephadex NNP O
system NN O
of IN O
RIST NNP O
. . O

Large JJ O
differences NNS O
between IN O
the DT O
groups NNS O
were VBD O
not RB O
observed VBN O
in IN O
HA NNP B-Gene
- : I-Gene
synthesizing VBG I-Gene
enzyme JJ I-Gene
activity NN O
, , O
but CC O
degradative JJ O
enzyme NN O
activity NN O
was VBD O
much RB O
higher JJR O
in IN O
aspirin JJ O
- : O
induced JJ O
asthma IN O
- : O
related JJ O
polyps NNS O
than IN O
in IN O
other JJ O
types NNS O
of IN O
nasal JJ O
polyps NNS O
tested VBN O
. . O

However RB O
, , O
in IN O
a DT O
multivariate NN O
analysis NN O
considering VBG O
age NN O
, , O
gender NN O
, , O
and CC O
a DT O
previous JJ O
history NN O
of IN O
cardiovascular JJ O
diseases NNS O
, , O
female JJ O
gender NN O
was VBD O
not RB O
independently RB O
associated VBN O
with IN O
death NN O
. . O

In IN O
treated JJ O
herds NNS O
, , O
cows VBZ O
more JJR O
than IN O
40 CD O
d JJ O
postpartum NN O
with IN O
a DT O
corpus NN O
luteum NN O
received VBD O
prostaglandin JJ O
F2 NNP O
alpha NN O
. . O

The DT O
fusion NN O
proteins NNS O
were VBD O
tested VBN O
by IN O
ELISA NNP O
for IN O
reactivity NN O
with IN O
a DT O
panel NN O
of IN O
human JJ B-Gene
anti SYM I-Gene
- : I-Gene
La NNP I-Gene
sera NN I-Gene
in IN O
order NN O
to TO O
define VB O
the DT O
nature NN O
of IN O
the DT O
epitopes NNS O
. . O

A DT O
recently RB O
reported VBN O
new JJ O
member NN O
of IN O
the DT O
Vav NNP B-Gene
family NN I-Gene
proteins NNS I-Gene
, , O
Vav3 NNP B-Gene
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
Ros NNP B-Gene
receptor NN B-Gene
protein NN I-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
( ( O
RPTK NNP B-Gene
) ) O
interacting VBG O
protein NN O
by IN O
yeast NN O
two CD O
- : O
hybrid JJ O
screening NN O
. . O

Previous JJ O
investigators NNS O
have VBP O
suggested VBN O
that IN O
subretinal JJ O
blood NN O
damages NNS O
the DT O
retina NN O
in IN O
part NN O
because IN O
of IN O
its PRP$ O
solid JJ O
fibrin NN B-Gene
meshwork NN O
. . O

The DT O
relationship NN O
between IN O
estrogenic JJ O
properties NNS O
of IN O
Tamoxifen NNP O
and CC O
breast NN O
cancer NN O
management NN O
is VBZ O
discussed VBN O
. . O

It PRP O
was VBD O
argued VBN O
that IN O
this DT O
arose NN O
from IN O
the DT O
possibility NN O
that IN O
the DT O
nature NN O
of IN O
blue JJ O
collar NN O
jobs NNS O
was VBD O
physical JJ O
, , O
and CC O
that IN O
loss NN O
of IN O
myocardial JJ O
tissue NN O
might MD O
be VB O
expected VBN O
to TO O
more RBR O
markedly RB O
interfere RB O
with IN O
their PRP$ O
work NN O
efficiency NN O
( ( O
on IN O
returning VBG O
to TO O
work VB O
) ) O
than IN O
it PRP O
would MD O
the DT O
efficiency NN O
of IN O
the DT O
more JJR O
sedentary JJ O
jobs NNS O
of IN O
white JJ O
collar JJ O
workers NNS O
. . O

Like IN O
the DT O
elicitors NNS O
of IN O
the DT O
hypersensitive JJ O
reaction NN O
( ( O
HR NNP O
) ) O
produced VBN O
by IN O
E NNP O
. . O
chrysanthemi NN O
( ( O
HarpinEch NNP O
) ) O
and CC O
E NNP O
. . O
amylovora NN O
( ( O
HarpinEa NNP O
) ) O
, , O
the DT O
deduced JJ O
36 CD O
- : O
kDa NN O
protein NN O
does VBZ O
not RB O
possess VB O
a DT O
typical JJ O
signal NN O
sequence NN O
, , O
but CC O
it PRP O
contains VBZ O
a DT O
putative JJ O
membrane NN O
- : O
spanning NN O
domain NN O
. . O

It PRP O
was VBD O
suggested VBN O
that IN O
the DT O
absence NN O
of IN O
pronounced JJ O
differences NNS O
between IN O
conditions NNS O
may MD O
have VB O
been VBN O
due JJ O
to TO O
the DT O
complexity NN O
of IN O
the DT O
task NN O
or CC O
the DT O
type NN O
of IN O
prompts NNS O
employed VBN O
. . O

Integrated VBN O
mapping JJ O
analysis NN O
of IN O
the DT O
Werner NNP O
syndrome JJ O
region NN O
of IN O
chromosome NN O
8 CD O
. . O

The DT O
analysis NN O
of IN O
the DT O
structure NN O
of IN O
the DT O
sleep JJ O
period NN O
as IN O
a DT O
whole JJ O
reveals NNS O
that IN O
with IN O
increasing VBG O
of IN O
the DT O
age NN O
the DT O
delta NN O
- : O
wave NN O
stage NN O
( ( O
DS NNP O
) ) O
of IN O
the DT O
QS NNP O
( ( O
determined VBN O
by IN O
defined JJ O
polygraphic JJ O
parameters NNS O
) ) O
increases NNS O
, , O
while IN O
the DT O
paradoxical JJ O
phase NN O
of IN O
sleep NN O
( ( O
PS NNP O
) ) O
decreases VBZ O
, , O
this DT O
change NN O
being VBG O
more JJR O
pronounced JJ O
during IN O
the DT O
first JJ O
six CD O
months NNS O
than IN O
during IN O
the DT O
second JJ O
ones NNS O
of IN O
the DT O
first JJ O
year NN O
of IN O
the DT O
life NN O
. . O

Constructs NNS O
containing VBG O
the DT O
full JJ B-Gene
- : I-Gene
length NN I-Gene
PfCPK NNP I-Gene
cDNA NN I-Gene
have VBP O
been VBN O
expressed VBN O
in IN O
Escherichia NNP O
coli NN O
at IN O
a DT O
high JJ O
level NN O
to TO O
generate VB O
a DT O
60 CD O
- : O
kDa NN O
recombinant JJ O
protein NN O
. . O

CONCLUSION NN O
: : O
Sonographic JJ O
angiography NN O
has VBZ O
a DT O
possible JJ O
role NN O
in IN O
the DT O
detection NN O
of IN O
small JJ O
nodules NNS O
in IN O
patients NNS O
with IN O
CRF NNP O
. . O

Regulation NN O
of IN O
myosin JJ B-Gene
phosphatase NN I-Gene
activity NN O
involves VBZ O
changes NNS O
in IN O
subunit NN O
interactions NNS O
, , O
although IN O
molecular JJ O
mechanisms NNS O
are VBP O
not RB O
defined VBN O
. . O

Here RB O
we PRP O
show VBP O
in IN O
mouse NN O
fibroblasts NNS O
stably RB O
transformed VBN O
by IN O
v JJ B-Gene
- : I-Gene
Src NN I-Gene
that IN O
mRNA NN O
and CC O
protein NN O
levels NNS O
of IN O
p21 NN B-Gene
( ( O
WAF1 NNP B-Gene
/ NNP O
CIP1 NNP B-Gene
) ) O
, , O
cyclin JJ B-Gene
D1 NNP I-Gene
, , O
and CC O
cyclin NN B-Gene
E NNP I-Gene
are VBP O
elevated VBN O
. . O

Infarct NNP O
regional JJ O
ejection NN O
fraction NN O
improved VBN O
by IN O
10 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
1 CD O
% NN O
between IN O
early JJ O
and CC O
late JJ O
studies NNS O
when WRB O
the DT O
infarct NN O
- : O
related JJ O
artery NN O
was VBD O
patent NN O
and CC O
by IN O
4 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
% NN O
if IN O
it PRP O
was VBD O
occluded VBN O
( ( O
p JJ O
= NN O
0 CD O
. . O
48 CD O
) ) O
; : O
changes NNS O
in IN O
global JJ O
and CC O
noninfarct JJ O
regional JJ O
ejection NN O
fraction NN O
were VBD O
similar JJ O
irrespective NN O
of IN O
perfusion NN O
status NN O
. . O

Immobilized JJ O
dimers NNS O
of IN O
N NNP B-Gene
- : I-Gene
cadherin NN I-Gene
- : O
Fc NNP B-Gene
chimera NN O
mimic NN O
cadherin NN O
- : O
mediated VBN O
cell NN O
contact NN O
formation NN O
: : O
contribution NN O
of IN O
both DT O
outside JJ O
- : O
in IN O
and CC O
inside IN O
- : O
out IN O
signals NNS O
. . O

Routine NNP O
isotope NN O
cystography NN O
using VBG O
99M CD O
Tc NNP O
sulfur NN O
colloid NN O
for IN O
detection NN O
and CC O
follow VB O
- : O
up IN O
of IN O
vesico NN O
- : O
ureteral JJ O
reflux NN O

Prominent JJ O
protein NN O
kinase NN O
cascades NNS O
are VBP O
those DT O
that IN O
activate VBP O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinases VBZ I-Gene
. . O

Recent JJ O
investigations NNS O
have VBP O
detailed VBN O
a DT O
selective JJ O
dye NN O
release NN O
technique NN O
in IN O
which WDT O
a DT O
pulse NN O
of IN O
laser NN O
light NN O
induces VBZ O
the DT O
release NN O
of IN O
a DT O
fluorescent JJ O
dye NN O
from IN O
temperature NN O
- : O
sensitive JJ O
liposomes NNS O
circulating VBG O
in IN O
the DT O
retinal JJ O
vasculature NN O
. . O

PARTICIPANTS NNS O
: : O
Convenience NNP O
sample NN O
of IN O
ambulatory JJ O
outpatients NNS O
with IN O
hereditary JJ O
motor NN O
and CC O
sensory NN O
neuropathy NN O
, , O
type NN O
I PRP O
( ( O
n JJ O
= NNP O
9 CD O
) ) O
, , O
myotonic JJ O
muscular NN O
dystrophy NN O
( ( O
n JJ O
= NNP O
10 CD O
) ) O
, , O
and CC O
able JJ O
- : O
bodied VBN O
controls NNS O
( ( O
n JJ O
= NNP O
11 CD O
) ) O
. . O

Adenylosuccinate NNP B-Gene
synthetase NN I-Gene
( ( O
IMP NNP O
: : O
L NNP B-Gene
- : I-Gene
aspartate NN I-Gene
ligase NN I-Gene
( ( O
GDP NNP O
) ) O
, , O
EC NNP B-Gene
6 CD I-Gene
. . I-Gene
3 CD I-Gene
. . I-Gene
4 CD I-Gene
. . I-Gene
4 CD I-Gene
) ) O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
purine JJ O
biosynthesis NN O
catalyzing VBG O
the DT O
GTP NNP O
- : O
dependent JJ O
conversion NN O
of IN O
IMP NNP O
to TO O
AMP NNP O
. . O

This DT O
was VBD O
performed VBN O
in IN O
a DT O
double NN O
blinded VBN O
, , O
randomized VBN O
, , O
placebo SYM O
- : O
controlled VBN O
study NN O
. . O

An DT O
association NN O
between IN O
hSIE NN B-Gene
and CC O
Stat NNP B-Gene
- : I-Gene
3 CD I-Gene
after IN O
MHC NNP B-Gene
- : I-Gene
I PRP I-Gene
ligation NN O
was VBD O
directly RB O
demonstrated VBN O
by IN O
precipitating VBG O
Stat NNP B-Gene
- : I-Gene
3 CD I-Gene
from IN O
nuclear JJ O
extracts NNS O
with IN O
biotinylated JJ O
hSIE NN B-Gene
probe NN O
and CC O
avidin JJ B-Gene
- : O
coupled VBN O
agarose RB O
. . O

Reviewing VBG O
manuscripts NNS O
: : O
developing VBG O
an DT O
efficient NN O
system NN O
. . O

These DT O
clones NNS O
were VBD O
found VBN O
to TO O
share NN O
a DT O
common JJ O
domain NN O
encoded VBN O
by IN O
p NN O
( ( O
CA NNP O
) ) O
n NN O
repeats NNS O
; : O
a DT O
simple JJ O
sequence NN O
length NN O
polymorphism NN O
( ( O
SSLP NNP O
) ) O
. . O

Derivatives NNS O
of IN O
boswellic JJ O
acids NNS O
. . O

Cat NNP B-Gene
proteins NNS I-Gene
are VBP O
tyrosine JJ O
- : O
phosphorylated VBN O
when WRB O
co JJ O
- : O
expressed VBN O
in IN O
cells NNS O
with IN O
the DT O
focal JJ B-Gene
adhesion NN I-Gene
kinase NN I-Gene
Fak NNP B-Gene
and CC O
Src NNP B-Gene
. . O

The DT O
study NN O
made VBD O
to TO O
define VB O
the DT O
ability NN O
of IN O
lipid FW B-Gene
A NNP I-Gene
monoclonal JJ I-Gene
antibodies NNS I-Gene
to TO O
correct VB O
hemodynamic JJ O
disturbances NNS O
due JJ O
to TO O
endotoxemia VB O
in IN O
dog NN O
experiments NNS O
showed VBD O
the DT O
efficacy NN O
of IN O
the DT O
antibodies NNS O
administration NN O
. . O

Northern NNP O
( ( O
RNA NNP O
) ) O
blot NN O
analyses NNS O
indicated VBD O
that IN O
the DT O
cdh NN B-Gene
genes NNS I-Gene
encoding VBG O
the DT O
five CD O
subunits NNS O
and CC O
an DT O
open JJ O
reading NN O
frame NN O
( ( O
ORF1 NNP O
) ) O
with IN O
unknown JJ O
function NN O
are VBP O
cotranscribed VBN O
during IN O
growth NN O
on IN O
acetate NN O
. . O

A DT O
study NN O
was VBD O
conducted VBN O
of IN O
a DT O
human JJ O
male NN O
who WP O
had VBD O
inhaled VBN O
a DT O
mixture NN O
of IN O
241Am CD O
and CC O
Pu NNP O
. . O

In IN O
the DT O
present JJ O
report NN O
, , O
66 CD O
hemochromatosis NN O
families NNS O
yielding VBG O
151 CD O
hemochromatosis NN O
chromosomes NNS O
and CC O
182 CD O
normal JJ O
chromosomes NNS O
were VBD O
RFLP NNP O
- : O
typed VBD O
with IN O
a DT O
battery NN O
of IN O
probes NNS O
, , O
including VBG O
two CD O
newly RB O
derived VBN O
polymorphic JJ O
markers NNS O
from IN O
the DT O
6 CD O
. . O
7 CD O
and CC O
HLA NNP B-Gene
- : I-Gene
F NNP I-Gene
loci NN I-Gene
located VBD O
150 CD O
and CC O
250 CD O
kb NNS O
telomeric JJ O
to TO O
HLA NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
respectively RB O
. . O

Thus RB O
, , O
ZNF74 NNP B-Gene
sublocalization NN O
in IN O
nuclear JJ O
domains NNS O
enriched VBN O
in IN O
pre JJ O
- : O
mRNA NN O
maturating NN O
factors NNS O
, , O
its PRP$ O
RNA NNP O
binding NN O
activity NN O
, , O
and CC O
its PRP$ O
direct JJ O
phosphodependent NN O
interaction NN O
with IN O
the DT O
pol NN B-Gene
IIo NNP I-Gene
, , O
a DT O
form NN O
of IN O
the DT O
RNA NNP B-Gene
polymerase NN I-Gene
functionally RB O
associated VBN O
with IN O
pre JJ O
- : O
mRNA NN O
processing NN O
, , O
suggest VBP O
a DT O
role NN O
for IN O
this DT O
member NN O
of IN O
the DT O
KRAB NNP B-Gene
multifinger NN I-Gene
protein VBD I-Gene
family NN I-Gene
in IN O
RNA NNP O
processing NN O
. . O

The DT O
increase NN O
in IN O
number NN O
of IN O
terminal JJ O
hairs NNS O
, , O
which WDT O
are VBP O
defined VBN O
as IN O
hairs NNS O
more JJR O
than IN O
60 CD O
microm NN O
in IN O
diameter NN O
, , O
in IN O
the DT O
designated JJ O
area NN O
( ( O
0 CD O
. . O
5 CD O
cm NN O
square NN O
= VBZ O
0 CD O
. . O
25 CD O
cm2 JJ O
area NN O
) ) O
of IN O
the DT O
procyanidin NN O
B NNP O
- : O
2 CD O
group NN O
subjects NNS O
after IN O
the DT O
6 CD O
- : O
month NN O
trial NN O
was VBD O
significantly RB O
greater JJR O
than IN O
that DT O
of IN O
the DT O
placebo NN O
control NN O
group NN O
subjects NNS O
( ( O
procyanidin NN O
B NNP O
- : O
2 CD O
, , O
1 CD O
. . O
99 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
58 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
/ VBZ O
0 CD O
. . O
25 CD O
cm2 NN O
; : O
placebo NN O
, , O
- : O
0 CD O
. . O
82 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
40 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SD NN O
) ) O
/ VBZ O
0 CD O
. . O
25 CD O
cm2 NN O
; : O
P NNP O
< VBD O
0 CD O
. . O
2 CD O
, , O
two CD O
- : O
sample NN O
t JJ O
test NN O
) ) O
. . O

The DT O
occurrence NN O
, , O
maintenance NN O
and CC O
possible JJ O
involvement NN O
of IN O
these DT O
repeated VBN O
sequences NNS O
, , O
capable JJ O
of IN O
forming VBG O
stable JJ O
secondary JJ O
structures NNS O
, , O
are VBP O
discussed VBN O
in IN O
relation NN O
to TO O
their PRP$ O
location NN O
in IN O
the DT O
region NN O
of IN O
control NN O
signals NNS O
. . O

Far NNP O
- : O
infrared JJ O
hopping NN O
conductivity NN O
in IN O
the DT O
CuO NNP O
chains NNS O
of IN O
a DT O
single JJ O
- : O
domain NN O
YBa2Cu3O7 NNP O
- : O
delta NN O
crystal NN O
. . O

Acylation NN O
with IN O
the DT O
palmitate NN O
analog NN O
was VBD O
prevented VBN O
when WRB O
Gly NNP O
- : O
2 CD O
was VBD O
mutated VBN O
to TO O
alanine VB O
, , O
implying VBG O
that IN O
N NNP O
- : O
myristylation NN O
is VBZ O
required VBN O
for IN O
palmitylation NN O
, , O
and CC O
when WRB O
either DT O
Cys NNP O
- : O
3 CD O
or CC O
Cys NNP O
- : O
6 CD O
was VBD O
mutated VBN O
to TO O
serine VB O
. . O

Mothers NNS O
with IN O
severe JJ O
anatomical JJ O
abnormalities NNS O
, , O
who WP O
are VBP O
HIV NNP O
positive JJ O
, , O
have VBP O
active JJ O
TB NNP O
or CC O
whose WP$ O
children NNS O
have VBP O
inherited VBN O
mono SYM O
- : O
or CC O
disaccharide VB O
intolerances NNS O
should MD O
not RB O
breastfeed VB O
. . O

As IN O
in IN O
mammals NNS O
, , O
considerable JJ O
nucleotide JJ O
diversity NN O
was VBD O
observed VBN O
at IN O
the DT O
junctions NNS O
of IN O
the DT O
variable JJ O
, , O
diversity NN O
, , O
and CC O
joining VBG O
elements NNS O
in IN O
chicken NN B-Gene
TCR NNP I-Gene
beta NN I-Gene
cDNAs NN I-Gene
. . O

ARPIA NNP O
has VBZ O
been VBN O
implemented VBN O
by IN O
using VBG O
a DT O
relational JJ O
DBMS NNP O
, , O
very RB O
cheap JJ O
and CC O
highly RB O
diffused VBN O
on IN O
personal JJ O
computers NNS O
. . O

Copyright JJ O
2001 CD O
Academic NNP O
Press NNP O
. . O

Most RBS O
important JJ O
, , O
infection NN O
of IN O
the DT O
cells NNS O
with IN O
an DT O
adenoviral JJ O
construct NN O
expressing VBG O
this DT O
mutant NN O
inhibited VBD O
the DT O
induction NN O
of IN O
VEGF NNP B-Gene
mRNA FW I-Gene
under IN O
conditions NNS O
that WDT O
mimic VBP O
hypoxia NN O
. . O

A DT O
rise NN O
of IN O
hemoglobin JJ B-Gene
concentration NN O
accompanied VBN O
by IN O
an DT O
increase NN O
of IN O
the DT O
total JJ O
iron NN O
in IN O
the DT O
blood NN O
serum NN O
of IN O
white JJ O
mice NN O
was VBD O
found VBN O
under IN O
oxygen NN O
pressure NN O
of IN O
4 CD O
atm NN O
for IN O
an DT O
hour NN O
( ( O
preconvulsive JJ O
state NN O
) ) O
and CC O
6 CD O
atm NN O
( ( O
convulsive JJ O
state NN O
) ) O
. . O

A DT O
significant JJ O
association NN O
between IN O
a DT O
family NN O
history NN O
and CC O
a DT O
higher JJR O
urinary JJ O
pH NN O
was VBD O
observed VBN O
among IN O
the DT O
female JJ O
calcium NN O
stone NN O
patients NNS O
. . O

However RB O
, , O
most JJS O
produced JJ O
significant JJ O
alteration NN O
of IN O
small JJ O
intestinal JJ O
permeability NN O
. . O

Effects NNS O
of IN O
point NN O
defects NNS O
on IN O
lattice NN O
parameters NNS O
of IN O
semiconductors NNS O
. . O

The DT O
NF1 NNP B-Gene
locus NN I-Gene
encodes VBZ O
a DT O
protein NN O
functionally RB O
related VBN O
to TO O
mammalian JJ B-Gene
GAP NNP I-Gene
and CC O
yeast RB B-Gene
IRA NNP I-Gene
proteins NNS I-Gene
. . O

I PRP O
. . O

Repression NN O
is VBZ O
alleviated VBN O
when WRB O
the DT O
two CD O
( ( O
for IN O
E2 NNP B-Gene
) ) O
or CC O
three CD O
( ( O
for IN O
E2 NNP B-Gene
- : I-Gene
C NNP I-Gene
) ) O
promoter NN O
- : O
proximal JJ O
copies NNS O
of IN O
E2 NNP B-Gene
- : O
RS NN O
are VBP O
mutated VBN O
. . O

Prenatal JJ O
diagnosis NN O
of IN O
galactosaemia NN O
. . O

The DT O
genomic JJ O
structure NN O
and CC O
chromosomal JJ O
location NN O
of IN O
the DT O
human JJ B-Gene
TR2 NNP I-Gene
orphan NN I-Gene
receptor NN I-Gene
, , O
a DT O
member NN O
of IN O
the DT O
steroid JJ B-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

Other JJ O
adverse JJ O
events NNS O
with IN O
incidences NNS O
significantly RB O
higher JJR O
than IN O
with IN O
placebo NN O
were VBD O
dizziness JJ O
, , O
constipation NN O
, , O
sweating VBG O
, , O
nervousness NN O
, , O
and CC O
abnormal JJ O
ejaculation NN O
. . O

The DT O
Jem NNP B-Gene
peptide NN O
sequence NN O
shows VBZ O
a DT O
' '' O
leucine JJ O
- : O
zipper NN O
' POS O
dimerisation NN O
motif NN O
with IN O
limited JJ O
homology NN O
to TO O
Fos NNP B-Gene
/ NNP O
Jun NNP B-Gene
and CC O
ATF NNP B-Gene
/ NNP O
CREB NNP B-Gene
proteins NNS O
and CC O
several JJ O
putative JJ O
phosphorylation NN O
sites NNS O
. . O

Thirty SYM O
- : O
two CD O
rats NNS O
were VBD O
divided VBN O
into IN O
four CD O
groups NNS O
. . O

Skin NNP O
pH NN O
changes NNS O
associated VBN O
with IN O
iontophoresis NN O
. . O

An DT O
evolutionary JJ O
comparison NN O
of IN O
amino NN O
acid JJ O
sequences NNS O
of IN O
34 CD O
HSP70 NNP B-Gene
proteins NNS I-Gene
from IN O
17 CD O
species NNS O
suggests VBZ O
that IN O
BiP NNP B-Gene
genes NNS I-Gene
share NN O
a DT O
common JJ O
ancestor NN O
, , O
which WDT O
diverged VBD O
from IN O
other JJ O
HSP70 NNP B-Gene
genes NNS I-Gene
near IN O
the DT O
time NN O
when WRB O
eukaryotes NNS O
first RB O
appeared VBD O
. . O

In IN O
Salmo NNP O
gairdneri NN O
, , O
no DT O
specialized JJ O
system NN O
of IN O
portal JJ O
vessels NNS O
appears VBZ O
to TO O
exist VB O
between IN O
the DT O
pineal NN O
organ NN O
and CC O
other JJ O
portions NNS O
of IN O
the DT O
brain NN O
. . O

The DT O
lethal JJ O
toxicity NN O
of IN O
inorganic JJ O
( ( O
HgCl2 NNP O
) ) O
and CC O
organic JJ O
( ( O
CH3HgCl NNP O
) ) O
mercury NN O
chloride NN O
was VBD O
compared VBN O
for IN O
Coturnix NNP O
( ( O
Japanese JJ O
quail NN O
, , O
Coturnix NNP O
japonica NN O
) ) O
of IN O
different JJ O
ages NNS O
from IN O
hatch NN O
through IN O
adulthood NN O
by IN O
single JJ O
- : O
dose JJ O
acute JJ O
oral JJ O
and CC O
intramuscular JJ O
injections NNS O
and CC O
by IN O
a DT O
5 CD O
- : O
d NN O
dietary JJ O
trial NN O
. . O

Binding NNP O
of IN O
NusA NNP B-Gene
to TO O
RNA NNP O
in IN O
the DT O
presence NN O
of IN O
alpha NN O
or CC O
N NNP O
involves VBZ O
an DT O
amino NN B-Gene
- : I-Gene
terminal JJ I-Gene
S1 NNP I-Gene
homology NN I-Gene
region NN I-Gene
that WDT O
is VBZ O
otherwise RB O
inactive JJ O
in IN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
NusA NNP I-Gene
. . O

Insertion NN O
of IN O
4 CD O
bp NN O
reduced VBD O
SV40 NNP B-Gene
early JJ I-Gene
promoter NN I-Gene
- : O
dependent NN O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
expression NN O
by IN O
six CD O
- : O
to TO O
eightfold VB O
. . O

Since IN O
sildenafil NN O
came VBD O
on IN O
the DT O
market NN O
, , O
it PRP O
seems VBZ O
that IN O
the DT O
place NN O
of IN O
MUSE NNP O
is VBZ O
reduced VBN O
because IN O
comparative JJ O
studies NNS O
give VBP O
better JJR O
results NNS O
for IN O
sildenafil JJR O
than IN O
MUSE NNP O
( ( O
70 CD O
% NN O
vs JJ O
40 CD O
% NN O
) ) O
and CC O
of IN O
course NN O
with IN O
a DT O
better JJR O
acceptance NN O
. . O

Both DT O
examinations NNS O
are VBP O
sensitive JJ O
indicators NNS O
of IN O
CNS NNP O
abnormalities NNS O
associated VBN O
with IN O
bacterial JJ O
meningeal NN O
infections NNS O
and CC O
are VBP O
important JJ O
determinants NNS O
of IN O
the DT O
therapy NN O
and CC O
ultimate JJ O
prognosis NN O
of IN O
such JJ O
complications NNS O
. . O

Imaging NN O
of IN O
D2 NNP B-Gene
dopamine NN I-Gene
receptor NN I-Gene

Its PRP$ O
potential JJ O
as IN O
a DT O
diagnostic JJ O
tool NN O
for IN O
epidemiological JJ O
surveillance NN O
was VBD O
assessed VBN O
in IN O
comparison NN O
with IN O
three CD O
other JJ O
diagnostic JJ O
tests NNS O
: : O
stool NN O
examination NN O
, , O
ELISA NNP O
with IN O
soluble JJ B-Gene
egg NN I-Gene
antigen NN I-Gene
( ( O
SEA NNP B-Gene
) ) O
and CC O
the DT O
circumoval NN O
precipitin NN B-Gene
test NN O
( ( O
COPT NNP O
) ) O
. . O

Combining VBG O
multiple JJ O
laboratory JJ O
studies NNS O
may MD O
be VB O
of IN O
value NN O
in IN O
predetermining VBG O
the DT O
eventual JJ O
outcome NN O
in IN O
near JJ O
- : O
drowning NN O
. . O

Plane NNP O
wave VBP O
geometry NN O
is VBZ O
impractical JJ O
for IN O
clinical JJ O
use NN O
but CC O
the DT O
results NNS O
of IN O
this DT O
work NN O
encouraged VBD O
us PRP O
to TO O
further RBR O
develop VB O
the DT O
P3 NNP O
approximation NN O
for IN O
a DT O
spherical JJ O
geometry NN O
, , O
described VBN O
in IN O
this DT O
paper NN O
. . O

Hence NNP O
temperature NN O
and CC O
virF NN B-Gene
are VBP O
both DT O
required VBN O
for IN O
the DT O
induction NN O
of IN O
the DT O
yop NN B-Gene
regulon NN I-Gene
. . O

Human NNP B-Gene
thymine NN I-Gene
- : I-Gene
DNA NN I-Gene
glycosylase NN I-Gene
maps NNS O
at IN O
chromosome NN O
12q22 CD O
- : O
q24 NN O
. . O
1 CD O
: : O
a DT O
region NN O
of IN O
high JJ O
loss NN O
of IN O
heterozygosity NN O
in IN O
gastric JJ O
cancer NN O
. . O

The DT O
second JJ O
functional JJ O
pair NN O
of IN O
CreA NNP B-Gene
sites NNS I-Gene
is VBZ O
located VBN O
between IN O
the DT O
two CD O
transcription NN O
initiation NN O
sites NNS O
. . O

Members NNS O
of IN O
SVA NNP B-Gene
are VBP O
also RB O
present JJ O
in IN O
the DT O
complement NN B-Gene
C2 NNP I-Gene
gene NN I-Gene
located VBN O
about IN O
20 CD O
kilobases NNS O
upstream RB O
of IN O
RP1 NNP B-Gene
in IN O
the DT O
HLA NNP B-Gene
and CC O
in IN O
the DT O
cytochrome NN B-Gene
CYP1A1 NNP I-Gene
gene NN I-Gene
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
cloned VBN O
the DT O
human JJ B-Gene
DSG3 NNP I-Gene
gene NN I-Gene
and CC O
examined VBD O
the DT O
transcriptional JJ O
regulation NN O
of IN O
its PRP$ O
expression NN O
. . O

In IN O
untreated JJ O
mice NN O
, , O
bactericidal JJ O
activity NN O
of IN O
peritoneal NN O
macrophages NNS O
decreased VBN O
from IN O
one CD O
day NN O
to TO O
3 CD O
days NNS O
after IN O
ip JJ O
injection NN O
of IN O
killed VBN O
L NNP O
. . O
monocytogenes NNS O
. . O

Within IN O
the DT O
3 CD O
' POS O
terminal JJ O
50 CD O
nucleotides NNS O
, , O
the DT O
mouse NN B-Gene
mt VBD I-Gene
12S CD I-Gene
rRNA NN I-Gene
contains VBZ O
a DT O
potential JJ O
10 CD O
bp JJ O
hairpin NN O
structure NN O
and CC O
a DT O
sequence NN O
of IN O
15 CD O
consecutive JJ O
nucleotides NNS O
common JJ O
to TO O
the DT O
RNA NNP O
of IN O
the DT O
small JJ O
ribosomal JJ O
subunit NN O
in IN O
all DT O
systems NNS O
, , O
but CC O
does VBZ O
not RB O
contain VB O
the DT O
mRNA NN O
binding VBG O
site NN O
( ( O
ACCUCC NNP O
) ) O
found VBD O
in IN O
E NNP O
. . O
coli NN O
and CC O
corn NN O
chloroplast NN O
rRNAs NN O
. . O

Rapid JJ O
detection NN O
of IN O
radioisotopically RB O
contaminated VBN O
test NN O
serum NN O
before IN O
radioassay NN O
of IN O
vitamin NN O
B12 NNP O
. . O

Perfusion NN O
washout NN O
: : O
increasing VBG O
a DT O
microvascular JJ O
free JJ O
flap NN O
tolerance NN O
to TO O
ischemia VB O
. . O

Disruption NN O
of IN O
the DT O
IRA2 NNP B-Gene
gene NN I-Gene
resulted VBD O
in IN O
( ( O
i JJ O
) ) O
increased VBD O
sensitivity NN O
to TO O
heat VB O
shock NN O
and CC O
nitrogen NN O
starvation NN O
, , O
( ( O
ii NN O
) ) O
sporulation NN O
defects NNS O
, , O
and CC O
( ( O
iii NN O
) ) O
suppression NN O
of IN O
the DT O
lethality NN O
of IN O
the DT O
cdc25 NN B-Gene
mutant NN I-Gene
. . O

Campomelic NNP O
dysplasia NN O
translocation NN O
breakpoints NNS O
are VBP O
scattered VBN O
over IN O
1 CD O
Mb NNP O
proximal NN O
to TO O
SOX9 NNP B-Gene
: : O
evidence NN O
for IN O
an DT O
extended JJ O
control NN O
region NN O
. . O

All DT O
were VBD O
experienced VBN O
hearing VBG O
aid NN O
users NNS O
who WP O
wore VBP O
linear JJ O
Class NNP O
D NNP O
instruments NNS O
with IN O
input JJ O
compression NN O
limiting VBG O
at IN O
the DT O
time NN O
of IN O
their PRP$ O
enrollment NN O
in IN O
this DT O
study NN O
. . O

Computerized JJ O
detection NN O
of IN O
abnormal JJ O
asymmetry NN O
in IN O
digital JJ O
chest NN O
radiographs NN O
. . O

CONCLUSION NN O
: : O
This DT O
study NN O
documents NNS O
that IN O
regression NN O
of IN O
choroidal JJ O
neovascularization NN O
that WDT O
occurred VBD O
with IN O
alpha NN B-Gene
interferon NN I-Gene
treatment NN O
was VBD O
minimal JJ O
. . O

We PRP O
argue VBP O
that IN O
the DT O
primary JJ O
role NN O
of IN O
hh NN B-Gene
in IN O
controlling VBG O
polarity NN O
is VBZ O
to TO O
cause VB O
anterior JJ O
compartment NN O
cells NNS O
to TO O
reverse VB O
their PRP$ O
interpretation NN O
of IN O
an DT O
underlying VBG O
symmetric JJ O
polarization NN O
. . O

Reproducing VBG O
populations NNS O
of IN O
this DT O
aphid NN O
were VBD O
first RB O
detected VBN O
in IN O
Puerto NNP O
Rico NNP O
in IN O
April NNP O
1992 CD O
. . O

The DT O
effectiveness NN O
of IN O
alpha JJ O
- : O
mercapto NN O
- : O
beta NN O
- : O
( ( O
2 CD O
- : O
furyl NN O
) ) O
acrylic NN O
acid NN O
( ( O
MFA NNP O
) ) O
and CC O
N NNP O
- : O
benzyl NN O
- : O
N NNP O
- : O
dithiocarboxy NN O
- : O
D NNP O
- : O
glucamine NN O
( ( O
NaB NNP O
) ) O
, , O
used VBN O
in IN O
combination NN O
, , O
in IN O
the DT O
mobilization NN O
and CC O
excretion NN O
of IN O
lead NN O
was VBD O
investigated VBN O
in IN O
rats NNS O
. . O

Indeed RB O
the DT O
predicted JJ O
folding NN O
of IN O
the DT O
5 CD O
' POS O
and CC O
3 CD O
' '' O
- : O
untranslated JJ O
regions NNS O
revealed VBD O
patterns NNS O
of IN O
stem NN O
and CC O
loop NN O
structures NNS O
conserved VBN O
for IN O
all DT O
tick JJ O
- : O
borne NN O
flaviviruses VBZ O
suggesting VBG O
a DT O
purifying NN O
selection NN O
for IN O
preservation NN O
of IN O
essential JJ O
RNA NNP O
secondary JJ O
structures NNS O
which WDT O
could MD O
be VB O
involved VBN O
in IN O
translational JJ O
control NN O
and CC O
replication NN O
. . O

Since IN O
electrical JJ O
stimulation NN O
of IN O
neurones NNS O
may MD O
activate VB O
not RB O
only RB O
cell NN O
bodies NNS O
but CC O
also RB O
neuronal JJ O
fibres NNS O
, , O
this DT O
study NN O
aimed VBD O
to TO O
test VB O
a DT O
selectively RB O
cholinergic JJ O
neurochemical JJ O
stimulation NN O
of IN O
the DT O
rat NN O
substantia NN O
innominata NN O
( ( O
SI NNP O
) ) O
by IN O
the DT O
local JJ O
microinjection NN O
of IN O
carbachol NN O
; : O
the DT O
effects NNS O
of IN O
this DT O
acetylcholine JJ O
agonist NN O
were VBD O
compared VBN O
with IN O
glutamate NN O
. . O

The DT O
humanized VBN B-Gene
LL2 NNP I-Gene
( ( O
hLL2 NN B-Gene
) ) O
, , O
lacking VBG O
light NN B-Gene
chain NN I-Gene
variable JJ I-Gene
region NN I-Gene
glycosylation NN O
, , O
exhibited VBD O
immunoreactivities NNS O
that WDT O
were VBD O
comparable JJ O
to TO O
that DT O
of IN O
chimeric JJ B-Gene
LL2 NNP I-Gene
( ( O
cLL2 NN B-Gene
) ) O
, , O
which WDT O
was VBD O
shown VBN O
previously RB O
to TO O
have VB O
antigen VBN O
- : O
binding NN O
properties NNS O
similar JJ O
to TO O
its PRP$ O
murine JJ O
counterpart NN O
, , O
suggesting VBG O
that IN O
the DT O
VK NNP O
- : O
appended VBD O
oligosaccharides NNS O
found VBN O
in IN O
mLL2 NNS B-Gene
are VBP O
not RB O
necessary JJ O
for IN O
antigen NN O
binding NN O
. . O

These DT O
bacteria NNS O
produce VBP O
and CC O
export VBP O
proteins NNS O
capable JJ O
of IN O
specific JJ O
interactions NNS O
with IN O
key JJ O
mammalian JJ O
cell NN O
regulatory JJ O
molecules NNS O
in IN O
order NN O
to TO O
derail VB O
the DT O
normal JJ O
functions NNS O
of IN O
the DT O
cells NNS O
. . O

They PRP O
were VBD O
almost RB O
regularly RB O
excited VBN O
by IN O
pressure NN O
to TO O
the DT O
ipsilateral JJ O
cornea NN O
or CC O
to TO O
both DT O
corneas NNS O
at IN O
a DT O
strength NN O
well RB O
above IN O
the DT O
human JJ O
corneal NN O
pain NN O
threshold NN O
. . O

The DT O
MMPI NNP O
- : O
A DT O
( ( O
Butcher NNP O
et RB O
al RB O
. . O
, , O
1992 CD O
) ) O
, , O
like IN O
the DT O
older JJR O
MMPI NNP O
( ( O
Hathaway NNP O
& CC O
McKinley NNP O
, , O
1983 CD O
) ) O
, , O
distinguishes VBZ O
between IN O
anorexia NN O
and CC O
bulimia NN O
. . O

Glucose JJ O
disappearance NN O
rate NN O
and CC O
changes NNS O
in IN O
plasma NN O
nutrients NNS O
after IN O
intravenouly RB O
injected JJ O
glucose NN O
in IN O
normoglycaemic JJ O
and CC O
hypoglycaemic JJ O
underweight JJ O
newborns NNS O
. . O

Magnetic JJ O
trapping NN O
of IN O
spin NN O
- : O
polarized VBN O
atomic JJ O
hydrogen NN O
. . O

Therefore RB O
, , O
a DT O
prospective JJ O
Phase NNP O
II NNP O
trial NN O
was VBD O
conducted VBN O
to TO O
determine VB O
the DT O
safety NN O
and CC O
efficacy NN O
of IN O
cryosurgery NN O
following VBG O
radiation NN O
therapy NN O
in IN O
men NNS O
with IN O
local JJ O
recurrence NN O
. . O

RESULTS NN O
: : O
In IN O
this DT O
group NN O
of IN O
patients NNS O
, , O
male JJ O
gender NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O

Purified NNP B-Gene
Pra NNP I-Gene
was VBD O
also RB O
shown VBN O
to TO O
physically RB O
interact VB O
with IN O
pyruvate JJ B-Gene
kinase NN I-Gene
( ( O
Pk NNP B-Gene
) ) O
; : O
Pk NNP B-Gene
and CC O
Pra NNP B-Gene
can MD O
form VB O
a DT O
complex JJ O
, , O
but CC O
when WRB O
the DT O
12 CD B-Gene
- : I-Gene
kDa NN I-Gene
Ndk NNP I-Gene
, , O
Pk NNP B-Gene
, , O
and CC O
Pra NNP B-Gene
are VBP O
all DT O
present JJ O
, , O
Pk NNP B-Gene
has VBZ O
a DT O
higher JJR O
affinity NN O
than IN O
Pra NNP B-Gene
for IN O
forming VBG O
a DT O
complex JJ O
with IN O
the DT O
12 CD B-Gene
- : I-Gene
kDa NN I-Gene
Ndk NNP I-Gene
. . O

Plasma NNP O
lecithin VBZ B-Gene
/ NNP I-Gene
cholesterol NN I-Gene
acyltransferase NN I-Gene
( ( O
LCAT NNP B-Gene
) ) O
activity NN O
in IN O
multiple JJ O
- : O
organ JJ O
donors NNS O
: : O
a DT O
predictor NN O
of IN O
allograft NN O
viability NN O
in IN O
clinical JJ O
liver NN O
transplantation NN O
. . O

Motivational JJ O
factors NNS O
focusing VBG O
on IN O
attitudes NNS O
, , O
perceived VBD O
susceptibility NN O
to TO O
pregnancy NN O
, , O
and CC O
normative JJ O
factors NNS O
were VBD O
also RB O
relevant JJ O
. . O

Morphometrical JJ O
quantification NN O
of IN O
brain NN O
edema NN O
related VBN O
to TO O
experimental JJ O
multiple JJ O
micro NN O
- : O
infarcts NNS O
in IN O
mice NN O
: : O
assessment NN O
of IN O
neurotropin JJ B-Gene
effect NN O
. . O

Ectopic NNP O
expression NN O
of IN O
Apo NNP B-Gene
- : I-Gene
3 CD I-Gene
in IN O
HEK293 NNP O
or CC O
HeLa NNP O
cells NNS O
induced VBD O
marked JJ O
apoptosis NN O
. . O

Analysis NN O
of IN O
the DT O
upstream NN O
untranslated JJ O
region NN O
of IN O
CHL15 NNP B-Gene
revealed VBD O
the DT O
presence NN O
of IN O
the DT O
hexamer NN O
element NN O
, , O
ACGCGT NNP O
( ( O
an DT O
MluI NNP B-Gene
restriction NN I-Gene
site NN I-Gene
) ) O
controlling VBG O
both CC O
the DT O
periodic JJ O
expression NN O
and CC O
coordinate VB O
regulation NN O
of IN O
the DT O
DNA NNP O
synthesis NN O
genes NNS O
in IN O
budding VBG O
yeast NN O
. . O

Some DT O
of IN O
these DT O
targets NNS O
were VBD O
reported VBN O
to TO O
code VB O
for IN O
molecules NNS O
involved VBN O
in IN O
cell NN O
- : O
cell NN O
interactions NNS O
, , O
whereas IN O
no DT O
relationship NN O
has VBZ O
yet RB O
been VBN O
demonstrated VBN O
between IN O
Hox NNP B-Gene
genes NNS I-Gene
and CC O
other JJ O
transcription NN O
factors NNS O
involved VBN O
in IN O
determining VBG O
and CC O
/ NNP O
or CC O
maintaining VBG O
tissue NN O
specificity NN O
. . O

The DT O
relative JJ O
R NNP O
- : O
and CC O
L NNP O
- : O
brain NN O
weights NNS O
were VBD O
found VBN O
to TO O
be VB O
inversely RB O
related VBN O
to TO O
the DT O
relative JJ O
R NNP O
- : O
L NNP O
brain NN O
weight VBD O
only RB O
in IN O
the DT O
RH NNP O
female JJ O
cats NNS O
with IN O
R NNP O
- : O
L NNP O
brain NN O
weight VBD O
smaller JJR O
than IN O
zero CD O
( ( O
testosterone NN O
in IN O
males NNS O
, , O
estrogen NN O
in IN O
females NNS O
) ) O
. . O

However RB O
, , O
whether IN O
or CC O
not RB O
nonsense JJ O
codon NN O
recognition NN O
within IN O
TPI NNP B-Gene
transcripts NNS I-Gene
takes VBZ O
place NN O
prior RB O
to TO O
or CC O
after IN O
splicing VBG O
remained VBD O
unresolved JJ O
. . O

In IN O
the DT O
stable JJ O
transfectants NNS O
( ( O
BM3 NNP O
cells NNS O
) ) O
expressing VBG O
a DT O
mutant JJ B-Gene
bacterial JJ I-Gene
P450 NNP I-Gene
AA NNP I-Gene
epoxygenase NN I-Gene
, , O
F87V NNP O
BM3 NNP O
, , O
which WDT O
was VBD O
genetically RB O
engineered VBN O
to TO O
metabolize VB O
arachidonic JJ O
acid NN O
only RB O
to TO O
14 CD O
, , O
15 CD O
- : O
EET NN O
, , O
AA NNP O
did VBD O
not RB O
induce VB O
apoptosis NN O
and CC O
protected VBN O
against IN O
agonist JJ O
- : O
induced JJ O
apoptosis NN O
. . O

RESULTS NN O
: : O
In IN O
the DT O
pregnant JJ O
group NN O
, , O
serum NN O
PP14 NNP B-Gene
concentrations NNS O
were VBD O
markedly RB O
increased VBN O
after IN O
ET NNP O
, , O
and CC O
a DT O
significant JJ O
difference NN O
between IN O
the DT O
pregnant JJ O
group NN O
and CC O
the DT O
nonpregnant JJ O
group NN O
was VBD O
observed VBN O
8 CD O
days NNS O
following VBG O
ET NNP O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
. . O

Hepatitis NNP O
C NNP O
virus NN O
infection NN O
and CC O
lymphoproliferative JJ O
diseases NNS O
in IN O
France NNP O
: : O
a DT O
national JJ O
study NN O
. . O

Activation NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
subsequent JJ O
proinflammatory NN O
gene NN O
expression NN O
in IN O
human JJ O
airway NN O
epithelial JJ O
cells NNS O
can MD O
be VB O
evoked VBN O
by IN O
oxidative JJ O
stress NN O
. . O

Steroid NNP O
glucuronides NNS O
in IN O
amniotic JJ O
fluid NN O
at IN O
term NN O
. . O

Preimmune NNP B-Gene
IgG NNP I-Gene
, , O
anti SYM B-Gene
- : I-Gene
GalT NNP I-Gene
Fab NNP I-Gene
fragments NNS I-Gene
, , O
irrelevant JJ O
polymers NNS O
and CC O
monomeric JJ O
N NNP O
- : O
acetylglucosamine NN O
had VBD O
no DT O
effect NN O
. . O

Equine NNP O
amnion NN O
and CC O
live JJ O
yeast NN O
cell NN O
derivative JJ O
were VBD O
evaluated VBN O
as IN O
a DT O
biological JJ O
dressing NN O
and CC O
as IN O
a DT O
topical JJ O
wound NN O
medicament NN O
respectively RB O
, , O
in IN O
the DT O
treatment NN O
of IN O
granulating VBG O
wounds NNS O
of IN O
the DT O
distal JJ O
portion NN O
of IN O
the DT O
limbs NNS O
of IN O
horses NNS O
. . O

These DT O
TxRE NNP B-Gene
contain VBP O
cyclic JJ O
AMP NNP O
- : O
responsive JJ O
elements NNS O
( ( O
CRE NNP O
) ) O
, , O
but CC O
, , O
remarkably RB O
, , O
the DT O
"""" NNP O
TGACGTCA NNP O
"""" NNP O
consensus NN O
is VBZ O
never RB O
strictly RB O
conserved VBN O
in IN O
any DT O
viral JJ O
strain NN O
( ( O
e NN O
. . O
g NN O
. . O
, , O
AGACGTCA NNP O
, , O
TGACGGCA NNP O
, , O
TGACCTCA NNP O
) ) O
. . O

From IN O
the DT O
above JJ O
results NNS O
, , O
we PRP O
might MD O
infer VB O
that IN O
the DT O
seizure NN O
type NN O
of IN O
TLE NNP O
and CC O
a DT O
high JJ O
frequency NN O
of IN O
seizure NN O
are VBP O
two CD O
major JJ O
independent JJ O
precipitate NN O
factors NNS O
for IN O
abnormal JJ O
latencies NNS O
of IN O
P300 NNP O
in IN O
the DT O
epileptic JJ O
patients NNS O
. . O

We PRP O
show VBP O
that IN O
these DT O
three CD O
gain NN O
- : O
of IN O
- : O
function NN O
mutants NNS O
differ VBP O
considerably RB O
in IN O
their PRP$ O
ability NN O
to TO O
bypass VB O
the DT O
sex NN O
determination NN O
signal NN O
, , O
with IN O
SxlM4 NNP B-Gene
being VBG O
the DT O
strongest JJS O
and CC O
SxlM1 NNP B-Gene
the DT O
weakest JJS O
. . O

We PRP O
show VBP O
that IN O
these DT O
three CD O
gain NN O
- : O
of IN O
- : O
function NN O
mutants NNS O
differ VBP O
considerably RB O
in IN O
their PRP$ O
ability NN O
to TO O
bypass VB O
the DT O
sex NN O
determination NN O
signal NN O
, , O
with IN O
SxlM4 NNP B-Gene
being VBG O
the DT O
strongest JJS O
and CC O
SxlM1 NNP B-Gene
the DT O
weakest JJS O
. . O

Medicare NNP O
SNF NNP O
benefits NNS O
revised VBD O
- : O
- : O
again RB O
. . O

Comparative JJ O
analysis NN O
with IN O
an DT O
antiandrogen NN O
niftolid JJ O
and CC O
synthetic JJ B-Gene
GnRH NNP I-Gene
was VBD O
carried VBN O
out RP O
in IN O
22 CD O
normal JJ O
subjects NNS O
, , O
14 CD O
patients NNS O
with IN O
primary JJ O
and CC O
20 CD O
ones NNS O
with IN O
secondary JJ O
hypogonadism NN O
, , O
and CC O
in IN O
5 CD O
patients NNS O
with IN O
clinical JJ O
signs NNS O
of IN O
gonadal JJ O
insufficiency NN O
and CC O
obscure JJ O
diagnosis NN O
in IN O
order NN O
to TO O
elucidate VB O
the DT O
pituitary JJ B-Gene
gonadotropin NN I-Gene
reserves NNS O
. . O

Mutations NNS O
at IN O
two CD O
neighboring VBG O
sites NNS O
, , O
serine VBP O
242 CD O
and CC O
threonine VB O
255 CD O
, , O
exacerbated VBD O
the DT O
effect NN O
. . O

The DT O
relative JJ O
abundance NN O
of IN O
each DT O
alternatively RB O
spliced VBN O
mRNA NN O
was VBD O
determined VBN O
by IN O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
in IN O
various JJ O
human JJ O
tissues NNS O
and CC O
cell NN O
lines NNS O
. . O

Eastern NNP O
Cooperative NNP O
Oncology NNP O
Group NNP O
trial NN O
E3186 NNP O
was VBD O
initiated VBN O
to TO O
explore VB O
this DT O
question NN O
. . O

Cat NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
identical JJ O
to TO O
the DT O
recently RB O
identified VBN O
binding NN O
partner NN O
for IN O
the DT O
beta NN B-Gene
- : I-Gene
adrenergic JJ I-Gene
receptor NN I-Gene
kinase NN I-Gene
( ( O
betaARK NN B-Gene
or CC O
GRK NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
, , O
which WDT O
was VBD O
shown VBN O
to TO O
have VB O
Arf NNP B-Gene
- : O
GAP NN B-Gene
activity NN O
. . O

Examples NNS O
of IN O
its PRP$ O
use NN O
in IN O
the DT O
intensive JJ O
therapy NN O
unit NN O
are VBP O
described VBN O
. . O

Rat NNP B-Gene
kidney NN I-Gene
carboxylesterase NN I-Gene
. . O

The DT O
Klebsiella NNP B-Gene
aerogenes NNS I-Gene
gene NN I-Gene
maoA NN I-Gene
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
synthesis NN O
of IN O
monoamine NN B-Gene
oxidase NN I-Gene
, , O
was VBD O
induced VBN O
by IN O
tyramine NN O
and CC O
the DT O
related JJ O
compounds NNS O
, , O
subjected VBN O
to TO O
catabolite VB O
and CC O
ammonium VB O
ion NN O
repression NN O
, , O
and CC O
cloned VBD O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
is VBZ O
reported VBN O
to TO O
cause VB O
a DT O
shock NN O
syndrome NN O
similar JJ O
to TO O
that DT O
produced VBN O
by IN O
endotoxin NN O
( ( O
LPS NNP O
) ) O
. . O

The DT O
initial JJ O
translation NN O
protein NN O
encoded VBN O
by IN O
the DT O
cDNA NN O
is VBZ O
53 CD O
, , O
932 CD O
kDa NN O
and CC O
possesses VBZ O
a DT O
hydrophilic JJ O
amino NN O
acid JJ O
composition NN O
with IN O
glutamic JJ O
acid NN O
comprising VBG O
22 CD O
% NN O
of IN O
the DT O
total JJ O
amino NN O
acid NN O
residues NNS O
. . O

In IN O
addition NN O
, , O
a DT O
catalytically RB O
inactive JJ O
version NN O
of IN O
the DT O
Src NNP B-Gene
family NN I-Gene
member NN O
, , O
Lck NNP B-Gene
( ( O
lymphoid JJ B-Gene
cell NN I-Gene
kinase NN I-Gene
) ) O
, , O
was VBD O
expressed VBN O
, , O
purified VBN O
, , O
and CC O
evaluated VBD O
as IN O
a DT O
Csk NNP B-Gene
substrate NN O
. . O

Increased VBN O
dietary JJ O
energy NN O
decreased VBD O
PAB NNP O
and CC O
the DT O
use NN O
of IN O
added JJ O
dietary JJ O
CO NNP O
rather RB O
than IN O
PF NNP O
decreased VBD O
PSHL NNP O
in IN O
broiler NN O
breeders NNS O
between IN O
26 CD O
and CC O
47 CD O
wk NN O
of IN O
age NN O
. . O

UK NNP O
' POS O
s JJ O
biotechnology NN O
lacking VBG O
specialists NNS O
. . O

The DT O
greatest JJS O
difference NN O
between IN O
the DT O
Ad7 NNP B-Gene
and CC I-Gene
Ad5 NNP I-Gene
DBPs NNP I-Gene
is VBZ O
the DT O
absence NN O
, , O
in IN O
the DT O
Ad7 NNP O
protein NN O
, , O
of IN O
12 CD O
amino JJ O
acids NNS O
located VBN O
between IN O
the DT O
two CD O
functional JJ O
domains NNS O
in IN O
the DT O
Ad5 NNP O
protein NN O
( ( O
amino JJ O
acids NNS O
151 CD O
- : O
162 CD O
) ) O
. . O

Further RB O
outbreaks NNS O
of IN O
ocular JJ O
disease NN O
in IN O
farmed JJ O
red JJ O
deer NN O
calves NNS O
caused VBN O
by IN O
HVC NNP O
- : O
1 CD O
were VBD O
investigated VBN O
. . O

This DT O
intron NN O
occupies VBZ O
a DT O
conserved JJ O
position NN O
corresponding VBG O
to TO O
that DT O
of IN O
intron NN O
1 CD O
in IN O
the DT O
transit NN O
peptide JJ O
region NN O
of IN O
chloroplast NN B-Gene
GAPDH NNP I-Gene
genes NNS I-Gene
( ( O
GapA NNP B-Gene
and CC O
GapB NNP B-Gene
) ) O
of IN O
higher JJR O
plants NNS O
. . O

The DT O
subjects NNS O
were VBD O
shown VBN O
to TO O
be VB O
capable JJ O
of IN O
assessing VBG O
integrally RB O
the DT O
value NN O
of IN O
accelerations NNS O
and CC O
estimating VBG O
it PRP O
with IN O
an DT O
error NN O
of IN O
0 CD O
. . O
1 CD O
- : O
0 CD O
. . O
12 CD O
g NN O
. . O

The DT O
RAP74 NNP B-Gene
subunit NN I-Gene
of IN O
TFIIF NNP B-Gene
alone RB O
contained VBD O
the DT O
stimulatory NN O
activity NN O
and CC O
the DT O
minimal JJ O
region NN O
sufficient NN O
for IN O
stimulation NN O
corresponds NNS O
to TO O
COOH NNP O
- : O
terminal NN O
residues NNS O
358 CD O
- : O
517 CD O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
structure NN O
of IN O
the DT O
WNT NNP B-Gene
- : I-Gene
2B CD I-Gene
gene NN I-Gene
. . O

A DT O
comparison NN O
of IN O
the DT O
predicted JJ O
polypeptide NN O
sequence NN O
of IN O
the DT O
Drosophila NNP O
protein NN O
with IN O
the DT O
equivalent JJ O
subunits NNS O
from IN O
mouse NN O
and CC O
yeast NN O
suggests VBZ O
that IN O
they PRP O
are VBP O
closely RB O
related JJ O
and CC O
defines NNS O
three CD O
conserved VBD O
regions NNS O
which WDT O
are VBP O
likely JJ O
to TO O
be VB O
important JJ O
for IN O
enzyme JJ O
activity NN O
. . O

The DT O
influence NN O
of IN O
adrenergic JJ O
nerves NNS O
of IN O
the DT O
response NN O
of IN O
blood NN O
vessels NNS O
in IN O
the DT O
rabbit NN O
ear VBP O
to TO O
2 CD B-Gene
- : I-Gene
- : I-Gene
phenylalanine NN I-Gene
- : I-Gene
8 CD I-Gene
- : I-Gene
lysine NN I-Gene
vasopressin NN I-Gene
( ( O
Octapressin NNP B-Gene
) ) O
. . O

Peter NNP O
Elfer NNP O
explores VBZ O
the DT O
implications NNS O
of IN O
the DT O
ruling NN O
. . O

Pseudomonas NNP O
aeruginosa NN O
strains NNS O
infecting VBG O
patients NNS O
with IN O
cystic JJ O
fibrosis NN O
( ( O
CF NNP O
) ) O
acquire VB O
a DT O
mucoid NN O
phenotype NN O
due JJ O
to TO O
overproduction NN O
of IN O
alginate NN O
. . O

This DT O
resulted VBD O
in IN O
a DT O
complete JJ O
inhibition NN O
of IN O
Site NNP O
- : O
1 CD O
cleavage NN O
that WDT O
was VBD O
restored VBN O
by IN O
concomitant JJ O
overexpression NN O
of IN O
full JJ O
- : O
length NN O
SCAP NNP B-Gene
. . O

Genomic NNP O
Southern NNP O
blot NN O
analysis NN O
of IN O
rat NN B-Gene
EFIA NNP I-Gene
( ( O
gene NN O
encoding VBG O
enhancer JJ B-Gene
factor NN I-Gene
I PRP I-Gene
subunit VBP I-Gene
A DT I-Gene
) ) O
reveals VBZ O
a DT O
complex JJ O
band NN O
pattern NN O
when WRB O
cDNA NN O
subfragment NN O
probes NNS O
are VBP O
used VBN O
. . O

Myasthenia NNP O
gravis NN O
is VBZ O
an DT O
autoimmune JJ O
disease NN O
resulting VBG O
from IN O
the DT O
production NN O
of IN O
antibodies NNS O
against IN O
the DT O
ACh NNP B-Gene
receptors NNS I-Gene
of IN O
the DT O
neuromuscular JJ O
synapse NN O
. . O

Substitution NN O
of IN O
the DT O
Ser NNP O
- : O
Thr NN O
sites VBZ O
with IN O
the DT O
phosphomimetic JJ O
Asp NNP O
generated VBD O
a DT O
constitutively RB O
active JJ O
form NN O
of IN O
IRF NNP B-Gene
- : I-Gene
3 CD I-Gene
that WDT O
functioned VBD O
as IN O
a DT O
very RB O
strong JJ O
activator NN O
of IN O
promoters NNS O
containing VBG O
PRDI NNP B-Gene
- : O
PRDIII NN B-Gene
or CC O
ISRE NNP B-Gene
regulatory JJ I-Gene
elements NNS I-Gene
. . O

Five CD O
concensus NN O
poly NN O
A DT O
addition NN O
sites NNS O
are VBP O
located VBN O
in IN O
the DT O
350 CD O
base NN O
pairs NNS O
immediately RB O
following VBG O
the DT O
protein NN B-Gene
IX NNP I-Gene
coding VBG O
region NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
in IN O
cultured JJ O
Jurkat NNP O
T NNP O
cells NNS O
, , O
Cbl NNP B-Gene
is VBZ O
coprecipitated VBN O
with IN O
antibody NN O
against IN O
the DT O
adapter NN B-Gene
protein NN I-Gene
Grb2 NNP I-Gene
. . O

S6 NNP B-Gene
kinase NN I-Gene
activation NN O
requires VBZ O
displacement NN O
of IN O
this DT O
inhibitory NN O
segment NN O
, , O
which WDT O
is VBZ O
proposed VBN O
to TO O
occur VB O
consequent NN O
to TO O
its PRP$ O
multiple JJ O
phosphorylation NN O
. . O

Studied VBN O
groups NNS O
were VBD O
( ( O
1 CD O
) ) O
untreated VBD O
control NN O
, , O
n JJ O
= VBP O
12 CD O
; : O
( ( O
2 CD O
) ) O
FK NNP O
- : O
1 CD O
, , O
n RB O
= JJ O
8 CD O
; : O
( ( O
3 CD O
) ) O
FK NNP O
- : O
3 CD O
, , O
n RB O
= JJ O
8 CD O
. . O

IFN NNP B-Gene
alpha NN I-Gene
and CC O
IFN NNP B-Gene
gamma NN I-Gene
inducibility NN O
is VBZ O
mediated VBN O
by IN O
a DT O
single JJ O
element NN O
: : O
a DT O
high JJ O
affinity NN O
, , O
nearly RB O
palindromic JJ O
version NN O
of IN O
the DT O
IFN NNP B-Gene
gamma NN I-Gene
activation NN I-Gene
site NN I-Gene
( ( O
GAS NNP B-Gene
) ) O
. . O

ISIS NNP O
5 CD O
possibilities NNS O
. . O

We PRP O
found VBD O
the DT O
following NN O
: : O
Specific JJ O
mutations NNS O
affected VBD O
the DT O
precise JJ O
carbohydrate NN O
structure NN O
and CC O
folding NN O
of IN O
the DT O
HA NNP B-Gene
trimer NN I-Gene
. . O

Many JJ O
mammary JJ O
tumors NNS O
induced VBN O
by IN O
mouse NN O
mammary JJ O
tumor NN O
virus NN O
( ( O
MMTV NNP O
) ) O
contain VBP O
a DT O
provirus NN O
in IN O
the DT O
same JJ O
region NN O
of IN O
the DT O
host NN O
- : O
cell NN O
genome NN O
, , O
leading VBG O
to TO O
expression NN O
of IN O
a DT O
putative JJ O
cellular JJ O
oncogene NN O
called VBN O
int NN B-Gene
- : I-Gene
1 CD I-Gene
. . O

Epithelial JJ O
and CC O
corneal JJ O
thickness NN O
measurements NNS O
by IN O
in IN O
vivo JJ O
confocal JJ O
microscopy NN O
through IN O
focusing NN O
( ( O
CMTF NNP O
) ) O
. . O

Both DT O
proteins NNS O
were VBD O
shown VBN O
to TO O
be VB O
constitutively RB O
associated VBN O
with IN O
tubulin NN B-Gene
. . O

Data NNP O
supported VBD O
the DT O
brevity NN O
of IN O
the DT O
WISC NNP O
- : O
III NNP O
short JJ O
form NN O
and CC O
the DT O
criterion NN O
- : O
related JJ O
validity NN O
of IN O
both CC O
the DT O
K NNP O
- : O
FAST NN O
and CC O
and CC O
Kaufman NNP O
Short NNP O
Neuropsychological NNP O
Assessment NNP O
Procedure NNP O
( ( O
K NNP O
- : O
SNAP NN O
) ) O
. . O

Factors NNS O
associated VBN O
with IN O
afterdrop NN O
included VBD O
age NN O
, , O
end VBP O
- : O
of IN O
- : O
surgery NN O
temperature NN O
( ( O
both DT O
positively RB O
) ) O
and CC O
body NN O
mass NN O
( ( O
negatively RB O
) ) O
. . O

In IN O
general JJ O
, , O
two CD O
separate JJ O
high JJ O
- : O
performance NN O
liquid NN O
chromatographic JJ O
runs NNS O
were VBD O
performed VBN O
, , O
one CD O
for IN O
the DT O
gamma NN O
- : O
aminobutyric JJ O
acid JJ O
determination NN O
and CC O
one CD O
for IN O
the DT O
determination NN O
of IN O
the DT O
monoamines NNS O
. . O

Mycoplasma NNP O
pneumoniae NN O
was VBD O
isolated VBN O
from IN O
the DT O
pleural JJ O
fluid NN O
of IN O
this DT O
patient NN O
. . O

The DT O
DNA NN O
binding NN O
and CC O
multimerization NN O
activities NNS O
of IN O
c SYM B-Gene
- : I-Gene
Myb NN I-Gene
appear VBP O
to TO O
be VB O
unaffected VBN O
by IN O
the DT O
S528A NNP O
substitution NN O
, , O
suggesting VBG O
that IN O
phosphorylation NN O
of IN O
serine JJ O
528 CD O
may MD O
mediate VB O
its PRP$ O
effect NN O
on IN O
the DT O
transcription NN O
transactivating VBG O
activity NN O
of IN O
c SYM B-Gene
- : I-Gene
Myb NN I-Gene
by IN O
regulating VBG O
interactions NNS O
with IN O
other JJ O
proteins NNS O
. . O

At IN O
both DT O
water NN O
temperatures NNS O
, , O
VO2 NNP O
increased VBD O
linearly RB O
with IN O
increasing VBG O
swimming VBG O
velocity NN O
. . O

In IN O
patients NNS O
who WP O
had VBD O
received VBN O
no RB O
previous JJ O
drug NN O
treatment NN O
, , O
log FW O
baseline NN O
plasma NN B-Gene
renin NN I-Gene
activity NN O
and CC O
change NN O
in IN O
mean JJ O
blood NN O
pressure NN O
after IN O
SQ NNP O
20881 CD O
correlated VBN O
significantly RB O
( ( O
r VB O
= RB O
0 CD O
. . O
651 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

2 CD O
. . O

A DT O
novel NN O
, , O
testis NN B-Gene
- : I-Gene
specific JJ I-Gene
mRNA NN I-Gene
transcript NN I-Gene
encoding VBG O
an DT O
NH2 NNP B-Gene
- : I-Gene
terminal NN I-Gene
truncated VBD I-Gene
nitric JJ I-Gene
- : I-Gene
oxide JJ I-Gene
synthase NN I-Gene
. . O

mRNA JJ O
diversity NN O
represents VBZ O
a DT O
major JJ O
theme NN O
of IN O
neuronal JJ B-Gene
nitric JJ I-Gene
- : I-Gene
oxide JJ I-Gene
synthase NN I-Gene
( ( O
nNOS JJ B-Gene
) ) O
gene NN O
expression NN O
in IN O
somatic JJ O
cells NNS O
/ JJ O
tissues NNS O
. . O

Transcripts NNS O
of IN O
the DT O
immunoglobulin NN B-Gene
C NNP I-Gene
mu NN I-Gene
gene NN I-Gene
vary JJ O
in IN O
structure NN O
and CC O
splicing VBG O
during IN O
lymphoid JJ O
development NN O
. . O

The DT O
severity NN O
of IN O
pathologic JJ O
changes NNS O
increased VBD O
with IN O
the DT O
magnitude NN O
of IN O
percussion NN O
. . O

Using VBG O
5 CD O
ng JJ O
/ NNP O
mL NN O
as IN O
the DT O
cutoff NN O
, , O
the DT O
sensitivity NN O
of IN O
CEA NNP B-Gene
was VBD O
68 CD O
% NN O
. . O

The DT O
gene NN O
amplification NN O
model NN O
of IN O
Coquelle NNP O
et FW O
al NN O
. . O

Outcome NN O
of IN O
severe JJ O
congenital JJ O
hypothyroidism NN O
. . O

Pneumoscrotum NNP O
is VBZ O
a DT O
rare JJ O
condition NN O
that WDT O
receives VBZ O
little JJ O
discussion NN O
in IN O
standard JJ O
texts NN O
of IN O
urology NN O
. . O

To TO O
investigate VB O
the DT O
functions NNS O
of IN O
GE NNP O
, , O
IG NNP O
, , O
and CC O
GS NNP O
sequences NNS O
in IN O
transcription NN O
, , O
we PRP O
constructed VBD O
plasmids NNS O
containing VBG O
cDNAs NN O
of IN O
the DT O
full JJ O
- : O
length NN O
SV5 NNP O
genome NN O
in IN O
which WDT O
the DT O
gene NN O
junction NN O
sequences NNS O
( ( O
GE NNP O
, , O
IG NNP O
, , O
and CC O
GS NNP O
sequences NNS O
) ) O
located VBN O
between IN O
the DT O
hemagglutinin NN B-Gene
- : I-Gene
neuraminidase NN I-Gene
( ( O
HN NNP B-Gene
) ) O
and CC O
the DT O
polymerase NN B-Gene
( ( I-Gene
L NNP I-Gene
) ) I-Gene
genes NNS I-Gene
were VBD O
replaced VBN O
with IN O
the DT O
counterpart NN O
sequences NNS O
from IN O
other JJ O
gene NN O
junctions NNS O
. . O

When WRB O
cells NNS O
were VBD O
microinjected VBN O
with IN O
TFOs NNP O
designed VBD O
to TO O
bind VB O
to TO O
a DT O
30 CD O
- : O
bp NN O
polypurine NN O
site NN O
situated VBD O
between IN O
the DT O
two CD O
TK NNP B-Gene
genes NNS I-Gene
, , O
recombination NN O
was VBD O
observed VBN O
at IN O
frequencies NNS O
in IN O
the DT O
range NN O
of IN O
1 CD O
% NN O
, , O
2 CD O
, , O
500 CD O
- : O
fold NN O
above IN O
the DT O
background NN O
. . O

Here RB O
we PRP O
examine VBP O
the DT O
potential NN O
for IN O
VP16 NNP B-Gene
protein SYM O
- : O
protein NN O
interactions NNS O
specific VBP O
to TO O
virus VB O
- : O
infected JJ O
cells NNS O
and CC O
show VBP O
that IN O
VP16 NNP B-Gene
copurifies NNS O
in IN O
a DT O
highly RB O
enriched JJ O
fraction NN O
with IN O
a DT O
single JJ O
major JJ O
polypeptide NN O
which WDT O
we PRP O
identify VBP O
as IN O
the DT O
virus NN O
- : O
encoded JJ O
structural JJ O
protein NN O
VP22 NNP B-Gene
. . O

Studies NNS O
using VBG O
the DT O
yeast NN O
two CD O
- : O
hybrid NN O
system NN O
also RB O
did VBD O
not RB O
provide VB O
evidence NN O
for IN O
the DT O
formation NN O
of IN O
a DT O
VDR NNP B-Gene
- : O
TR NNP B-Gene
protein SYM O
- : O
protein NN O
interaction NN O
. . O

Cheung NNP O
and CC O
S NNP O
. . O

One CD O
class NN O
of IN O
plasmids NNS O
contained VBN O
tRNA NN B-Gene
( ( I-Gene
His PRP$ I-Gene
) ) I-Gene
genes NNS I-Gene
and CC O
conferred VBD O
efficient JJ O
suppression NN O
only RB O
when WRB O
cells NNS O
were VBD O
starved VBN O
for IN O
histidine NN O
; : O
these DT O
plasmids NNS O
suppressed VBD O
a DT O
gcn2 JJ B-Gene
deletion NN O
much RB O
less RBR O
efficiently RB O
than IN O
they PRP O
suppressed VBD O
gcn2 SYM B-Gene
- : I-Gene
507 CD I-Gene
. . O

RESULTS NN O
: : O
Circulating NNP O
leptin NN B-Gene
concentrations NNS O
in IN O
AN NNP O
were VBD O
3 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
versus NN O
7 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
2 CD O
ng JJ O
/ NNP O
ml NN O
in IN O
control NN O
subjects NNS O
. . O

The DT O
3 CD O
' POS O
fragment NN O
was VBD O
shown VBN O
to TO O
accumulate VB O
as IN O
full JJ O
- : O
length NN O
mRNA NN O
disappeared VBD O
in IN O
actinomycin NN O
D NNP O
- : O
treated VBD O
cells NNS O
, , O
indicating VBG O
a DT O
precursor NN O
- : O
product NN O
relationship NN O
. . O

Initially RB O
, , O
we PRP O
observed VBD O
that IN O
unmutated JJ O
p53 NN B-Gene
is VBZ O
strongly RB O
expressed VBN O
in IN O
premalignant JJ O
mammary JJ O
glands NNS O
and CC O
in IN O
mammary JJ O
tumors NNS O
derived VBN O
from IN O
the DT O
MMTV NNP O
- : O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
strain NN O
. . O

SRY NNP B-Gene
- : I-Gene
related JJ I-Gene
cDNA NN I-Gene
encoding VBG O
a DT O
protein NN O
with IN O
a DT O
high JJ B-Gene
- : I-Gene
mobility NN I-Gene
- : I-Gene
group NN I-Gene
( ( O
HMG NNP B-Gene
) ) O
box NN O
and CC O
a DT O
leucine JJ O
zipper NN O
motif NN O
, , O
which WDT O
was VBD O
designated VBN O
SOX NNP B-Gene
- : I-Gene
LZ NNP I-Gene
, , O
was VBD O
isolated VBN O
from IN O
a DT O
rainbow NN O
trout NN O
testis NN O
cDNA NN O
library NN O
. . O

Biol NNP O
. . O

In IN O
the DT O
chicken NN O
liver NN O
, , O
levels NNS O
of IN O
chicken NN B-Gene
MT NNP I-Gene
mRNA NN I-Gene
were VBD O
rapidly RB O
induced VBN O
by IN O
metals NNS O
( ( O
Cd2 NNP O
+ NNP O
, , O
Zn2 NNP O
+ NNP O
, , O
Cu2 NNP O
+ NNP O
) ) O
, , O
glucocorticoids NNS O
and CC O
lipopolysaccharide NN O
. . O

I PRP O
. . O

Increasing VBG O
the DT O
cut NN O
- : O
off RB O
point NN O
to TO O
3 CD O
positive JJ O
responses NNS O
decreased VBD O
the DT O
sensitivity NN O
to TO O
81 CD O
% NN O
and CC O
increased VBD O
the DT O
specificity NN O
to TO O
94 CD O
% NN O
. . O

Deletion NN O
and CC O
mutational JJ O
analyses NNS O
revealed VBD O
two CD O
positive JJ O
cis NN O
- : O
regulatory JJ O
elements NNS O
in IN O
this DT O
region NN O
that WDT O
are VBP O
essential JJ O
for IN O
CSX1 NNP B-Gene
expression NN O
in IN O
cardiomyocytes NNS O
. . O

The DT O
small JJ B-Gene
IGF NNP I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
is VBZ O
abundant JJ O
in IN O
human JJ O
amniotic JJ O
fluid NN O
. . O

Thus RB O
, , O
growth NN O
factor NN O
activation NN O
of IN O
ER NNP B-Gene
can MD O
mediate VB O
transactivation NN O
vs FW O
ER NNP B-Gene
/ NNP O
Sp1 NNP B-Gene
binding VBG O
to TO O
GC NNP O
- : O
rich JJ O
sites NNS O
and CC O
represents VBZ O
a DT O
novel JJ O
pathway NN O
for IN O
ligand NN O
- : O
independent JJ O
ER NNP B-Gene
action NN O
. . O

Furthermore RB O
, , O
the DT O
negative JJ O
transcriptional JJ O
effect NN O
of IN O
COUP NNP B-Gene
- : I-Gene
TFs NN I-Gene
is VBZ O
dominant JJ O
over IN O
the DT O
activating VBG O
effect NN O
of IN O
the DT O
Oct4 NNP B-Gene
embryonic JJ I-Gene
stem NN I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
. . O

Validation NN O
of IN O
the DT O
survey NN O
of IN O
work NN O
styles NNS O
: : O
a DT O
profile JJ O
measure NN O
of IN O
the DT O
type NN O
A DT O
behaviour NN O
pattern NN O
. . O

CKbeta4GT NNP B-Gene
- : I-Gene
II NNP I-Gene
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
type NN B-Gene
II NNP I-Gene
transmembrane NN I-Gene
glycoprotein NN I-Gene
of IN O
43 CD O
kDa NNS O
with IN O
five CD O
potential JJ O
N NNP O
- : O
linked VBN O
glycosylation NN O
sites NNS O
. . O

The DT O
pathogenesis NN O
of IN O
Dupuytren NNP O
' POS O
s NN O
contracture NN O

Comparison NNP O
of IN O
human JJ B-Gene
and CC I-Gene
murine JJ I-Gene
blk NN I-Gene
sequences NNS I-Gene
indicated VBD O
that IN O
they PRP O
share NN O
86 CD O
% NN O
amino NN O
acid NN O
identity NN O
, , O
the DT O
most RBS O
conserved JJ O
region NN O
being VBG O
the DT O
catalytic JJ O
domain NN O
( ( O
93 CD O
% NN O
identity NN O
) ) O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
forced VBN O
overexpression NN O
of IN O
the DT O
wild JJ O
type NN O
, , O
but CC O
not RB O
the DT O
kinase NN O
- : O
inactivated JJ O
mutant NN O
of IN O
nm23H1 NN B-Gene
, , O
converted VBD O
the DT O
GDP NNP O
- : O
bound NN O
forms NNS O
of IN O
Rac1 NNP B-Gene
, , O
Cdc42 NNP B-Gene
, , O
and CC O
RhoA NNP B-Gene
to TO O
their PRP$ O
GTP NNP O
- : O
bound NN O
forms NNS O
in IN O
vitro NN O
by IN O
its PRP$ O
nucleoside JJ B-Gene
diphosphate JJ I-Gene
kinase NN I-Gene
activity NN O
, , O
but CC O
nm23H1 RB B-Gene
alone RB O
apparently RB O
did VBD O
not RB O
produce VB O
the DT O
GTP NNP O
- : O
bound NN O
form NN O
of IN O
these DT O
GTPases NNS B-Gene
in IN O
vivo NN O
. . O

It PRP O
is VBZ O
impossible JJ O
to TO O
define VB O
only RB O
one CD O
clinical JJ O
outline NN O
because IN O
both DT O
symptomatic JJ O
and CC O
asymptomatic JJ O
infected VBN O
NB NNP O
may MD O
be VB O
found VBN O
with IN O
gestational JJ O
age NN O
at IN O
term NN O
and CC O
pre VB O
- : O
term NN O
and CC O
when WRB O
born VBN O
with IN O
a DT O
weight NN O
above IN O
or CC O
below IN O
2000 CD O
g NN O
. . O

CONCLUSIONS NN O
: : O
These DT O
routinely RB O
collected VBN O
data NN O
provided VBD O
quantitative JJ O
estimates NNS O
of IN O
changes NNS O
in IN O
CBZ NNP O
Cl NNP O
/ NNP O
F NNP O
due JJ O
to TO O
comedication NN O
and CC O
an DT O
age NN O
- : O
related JJ O
decrease NN O
in IN O
Cl NNP O
/ NNP O
F NNP O
The DT O
derived JJ O
regression NN O
equations NNS O
reasonably RB O
predicted VBD O
concentrations NNS O
in IN O
a DT O
separate JJ O
validation NN O
set VBN O
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
In IN O
25 CD O
open JJ O
- : O
chest NN O
, , O
anesthetized JJ O
dogs NNS O
, , O
progressive JJ O
circumflex NN O
artery NN O
stenosis NN O
led VBD O
to TO O
a DT O
concordant JJ O
decrease NN O
of IN O
circumflex JJ O
artery NN O
resting NN O
and CC O
hyperemic JJ O
flow NN O
, , O
coronary JJ O
flow NN O
reserve NN O
, , O
and CC O
inverse JJ O
angiographic JJ O
mean JJ O
transit NN O
time NN O
Tmicro NNP O
- : O
1 CD O
( ( O
P NNP O
< NNP O
. . O
1 CD O
) ) O
. . O

They PRP O
share NN O
many JJ O
downstream NN O
targets NNS O
, , O
including VBG O
remodeling NN O
of IN O
the DT O
actin JJ B-Gene
cytoskeleton NN O
, , O
activation NN O
of IN O
p70 NN B-Gene
( ( I-Gene
S6 NNP I-Gene
) ) I-Gene
kinase NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
, , O
and CC O
regulation NN O
of IN O
transcription NN O
and CC O
cell NN O
proliferation NN O
. . O

The DT O
study NN O
suggests VBZ O
the DT O
presence NN O
of IN O
an DT O
anatomical JJ O
sphincter NN O
at IN O
the DT O
RSJ NNP O
which WDT O
seems VBZ O
to TO O
regulate VB O
the DT O
passage NN O
of IN O
stools NNS O
from IN O
the DT O
sigmoid NN O
colon NN O
to TO O
the DT O
rectum NN O
. . O

Gtx NNP B-Gene
mRNA NN I-Gene
accumulates NNS O
in IN O
parallel NN O
with IN O
the DT O
RNAs NNP O
encoding VBG O
the DT O
major JJ O
structural JJ O
proteins NNS O
of IN O
myelin NN O
, , O
myelin NN B-Gene
basic JJ I-Gene
protein NN I-Gene
( ( O
MBP NNP B-Gene
) ) O
, , O
and CC O
proteolipid JJ B-Gene
protein NN I-Gene
( ( O
PLP NNP B-Gene
) ) O
during IN O
postnatal JJ O
brain NN O
development NN O
; : O
Gtx NNP B-Gene
mRNA NN I-Gene
decreases NNS O
in IN O
parallel NN O
with IN O
MBP NNP B-Gene
and CC O
PLP NNP B-Gene
mRNAs NN I-Gene
in IN O
the DT O
brains NNS O
of IN O
myelin NN O
- : O
deficient NN O
rats NNS O
, , O
which WDT O
have VBP O
a DT O
point NN O
mutation NN O
in IN O
the DT O
PLP NNP B-Gene
gene NN I-Gene
. . O

Interleukin NNP B-Gene
- : I-Gene
12 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
) ) O
is VBZ O
a DT O
cytokine NN O
produced VBN O
by IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( ( O
PBMC NNP O
) ) O
that WDT O
causes VBZ O
interferon SYM B-Gene
- : I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
) ) O
production NN O
and CC O
enhancement NN O
of IN O
cell NN O
- : O
mediated VBN O
cytotoxicity NN O
. . O

MK NNP O
- : O
801 CD O
administration NN O
resulted VBD O
in IN O
a DT O
biphasic JJ O
response NN O
in IN O
seizure NN O
latency NN O
. . O

Histological JJ O
examination NN O
showed VBD O
lichenoid JJ O
changes NNS O
, , O
acantholytic JJ O
blister NN O
formation NN O
and CC O
apoptotic JJ O
keratinocytes NNS O
. . O

Protein NNP O
kinases VBZ O
play VBP O
pivotal JJ O
roles NNS O
in IN O
the DT O
control NN O
of IN O
many JJ O
cellular JJ O
processes NNS O
. . O

Because IN O
Trp53 NNP B-Gene
( ( O
the DT O
mouse NN B-Gene
homolog NN I-Gene
of IN I-Gene
human JJ I-Gene
TP53 NNP I-Gene
) ) O
is VBZ O
located VBN O
with IN O
Tk1 NNP B-Gene
on IN O
chromosome NN O
11 CD O
and CC O
is VBZ O
critical JJ O
in IN O
regulating VBG O
cellular JJ O
responses NNS O
following VBG O
exposure NN O
to TO O
DNA NNP O
damaging VBG O
agents NNS O
, , O
we PRP O
wanted VBD O
to TO O
determine VB O
if IN O
these DT O
mouse FW O
lymphoma NN O
cells NNS O
harbor VBP O
mutations NNS O
in IN O
Trp53 NNP B-Gene
. . O

All DT O
9 CD O
untreated JJ O
patients NNS O
underwent JJ O
laparoscopy NN O
, , O
which WDT O
identified VBD O
3 CD O
intra JJ O
- : O
abdominal NN O
, , O
3 CD O
vanished VBD O
and CC O
2 CD O
peeping NN O
testes NNS O
, , O
and CC O
1 CD O
atrophic JJ O
testis NN O
in IN O
the DT O
inguinal JJ O
canal NN O
. . O

The DT O
well NN O
- : O
known VBN O
Rel NNP B-Gene
/ NNP O
NF NNP B-Gene
- : I-Gene
kappaB VBD I-Gene
family NN O
of IN O
vertebrate JJ O
transcription NN O
factors NNS O
comprises VBZ O
a DT O
number NN O
of IN O
structurally RB O
related VBN O
, , O
interacting VBG O
proteins NNS O
that WDT O
bind VBP O
DNA NNP O
as IN O
dimers NNS O
and CC O
whose WP$ O
activity NN O
is VBZ O
regulated VBN O
by IN O
subcellular JJ O
location NN O
. . O

PURPOSE NN O
: : O
A DT O
two CD O
- : O
generation NN O
consanguineous JJ O
Pakistani NNP O
family NN O
with IN O
autosomal JJ O
recessive JJ O
Leber NNP O
congenital JJ O
amaurosis NN O
( ( O
LCA NNP O
, , O
MIM NNP O
204 CD O
, , O
0 CD O
) ) O
and CC O
keratoconus NN O
was VBD O
identified VBN O
. . O

Oscillatory NNP O
exchange NN O
of IN O
atoms NNS O
between IN O
traps NNS O
containing VBG O
Bose NNP O
condensates NNS O
. . O

In IN O
that DT O
case NN O
, , O
the DT O
ratio NN O
of IN O
brush NN O
abrasion NN O
was VBD O
0 CD O
. . O
268 CD O
, , O
compressive NN O
and CC O
transverse JJ O
strength NN O
, , O
124 CD O
. . O
3 CD O
and CC O
86 CD O
. . O
3 CD O
MPa NNP O
respectively RB O
, , O
hardness NN O
, , O
43 CD O
. . O
2 CD O
Hk NNP O
, , O
water NN O
absorption NN O
14 CD O
. . O
2 CD O
micrograms NNS O
/ VBP O
mm3 NN O
and CC O
thermal JJ O
expansion NN O
coefficient NN O
, , O
47 CD O
. . O
4 CD O
x JJ O
10 CD O
( ( O
- : O
6 CD O
) ) O
/ NN O
degrees NNS O
C NNP O
. . O

Flap NNP O
survival NN O
depends VBZ O
on IN O
the DT O
development NN O
of IN O
a DT O
small JJ O
number NN O
of IN O
vascular JJ O
connections NNS O
between IN O
vessels NNS O
arising VBG O
from IN O
the DT O
pedicle NN O
and CC O
preexisting VBG O
dermal JJ O
vessels NNS O
. . O

Amino NNP O
acid NN O
residues NNS O
of IN O
beta NN O
1 CD O
' '' O
, , O
alpha IN O
A NNP O
' POS O
, , O
alpha NN O
B NNP O
' POS O
, , O
and CC O
the DT O
loop NN O
containing VBG O
His539 NNP O
of IN O
the DT O
RNase NNP B-Gene
H NNP I-Gene
domain NN I-Gene
interact NN O
with IN O
the DT O
primer NN O
strand NN O
of IN O
the DT O
dsDNA NN O
. . O

None NN O
of IN O
the DT O
measured JJ O
parameters NNS O
( ( O
heart NN O
contents NNS O
of IN O
neutral JJ O
lipids NNS O
, , O
total JJ O
phospholipids NNS O
, , O
phosphatidylcholine NN O
, , O
phosphatidylethanolamine NN O
, , O
diphosphatidylglycerol NN O
, , O
sphingomyelin NN O
and CC O
fatty JJ O
acid JJ O
composition NN O
of IN O
each DT O
phospholipid JJ O
class NN O
) ) O
appeared VBD O
to TO O
be VB O
related VBN O
with IN O
the DT O
grading NN O
of IN O
the DT O
lesions NNS O
. . O

JNK NNP B-Gene
and CC O
p38 NN B-Gene
are VBP O
constitutively RB O
present JJ O
in IN O
the DT O
nucleus NN O
, , O
and CC O
DNA NNP O
- : O
bound NN O
c SYM B-Gene
- : I-Gene
JUN NN I-Gene
and CC O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
are VBP O
stably RB O
contacted VBN O
by IN O
JNK NNP B-Gene
and CC O
p38 NN B-Gene
, , O
respectively RB O
. . O

These DT O
utilisation NN O
data NNS O
imply VBP O
annual JJ O
drug NN O
costs NNS O
in IN O
the DT O
range NN O
of IN O
$ $ O
US PRP O
480 CD O
, , O
0 CD O
to TO O
$ $ O
US PRP O
3 CD O
, , O
600 CD O
, , O
0 CD O
for IN O
TNF NNP B-Gene
antagonists NNS O
for IN O
RA NNP O
per IN O
1 CD O
million CD O
population NN O
. . O

The DT O
B NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
activates VBZ O
the DT O
Akt NNP B-Gene
( ( O
protein JJ B-Gene
kinase NN I-Gene
B NNP I-Gene
) ) O
/ VBP O
glycogen JJ B-Gene
synthase NN I-Gene
kinase VBD I-Gene
- : I-Gene
3 CD I-Gene
signaling VBG O
pathway NN O
via IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

Quantitative JJ O
PCR NNP O
studies NNS O
indicated VBD O
that IN O
synthesis NN O
and CC O
transport NN O
of IN O
vector NN O
DNA NNP O
into IN O
the DT O
nucleus NN O
were VBD O
similar JJ O
for IN O
macrophages NNS O
infected VBN O
with IN O
the DT O
clone NN O
239 CD O
and CC O
316 CD O
pseudotypes NNS O
, , O
suggesting VBG O
that IN O
the DT O
restriction NN O
for IN O
SIVmac239 NNP O
infection NN O
is VBZ O
after IN O
reverse JJ O
transcription NN O
and CC O
nuclear JJ O
import NN O
of IN O
viral JJ O
DNA NNP O
. . O

We PRP O
have VBP O
now RB O
shown VBN O
that IN O
in IN O
vivo JJ O
phosphorylation NN O
of IN O
14 CD B-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
3 CD I-Gene
zeta NN I-Gene
at IN O
the DT O
CKIalpha NNP B-Gene
site NN I-Gene
( ( I-Gene
Thr NNP I-Gene
- : I-Gene
233 CD I-Gene
) ) I-Gene
negatively RB O
regulates VBZ O
its PRP$ O
binding NN O
to TO O
c VB B-Gene
- : I-Gene
Raf NNP I-Gene
, , O
and CC O
may MD O
be VB O
important JJ O
in IN O
Raf NNP B-Gene
- : O
mediated VBD O
signal JJ O
transduction NN O
. . O

We PRP O
previously RB O
reported VBD O
that IN O
Tax NNP B-Gene
induced VBD O
cell NN O
cycle NN O
progression NN O
from IN O
G0 NNP O
/ NNP O
G1 NNP O
phase NN O
to TO O
S NNP O
and CC O
G2 NNP O
/ NNP O
M NNP O
phases VBZ O
in IN O
human JJ O
T NNP O
- : O
cell NN O
line NN O
Kit NNP O
225 CD O
cells NNS O
. . O

This DT O
specific JJ O
methylation NN O
pattern NN O
caused VBN O
inactivation NN O
of IN O
the DT O
HSV NNP B-Gene
tk NN I-Gene
gene NN I-Gene
, , O
while IN O
methylation NN O
of IN O
the DT O
cytosine NN O
residues NNS O
within IN O
the DT O
nucleotide JJ O
sequence NN O
from IN O
+ $ O
811 CD O
to TO O
+ VB O
1309 CD O
had VBD O
no DT O
effect NN O
on IN O
HSV NNP B-Gene
tk JJ I-Gene
gene NN I-Gene
activity NN O
. . O

Acad NNP O
. . O

The DT O
inhibition NN O
by IN O
cytosolic JJ O
Ca2 NNP O
+ NNP O
was VBD O
caused VBN O
by IN O
a DT O
decrease NN O
in IN O
cooperativity NN O
and CC O
by IN O
a DT O
shift NN O
in IN O
EC50 NNP O
toward IN O
higher JJR O
InsP3 NNP O
concentrations NNS O
. . O

The DT O
favourable JJ O
effect NN O
of IN O
thymic JJ O
shielding NN O
was VBD O
also RB O
reflected VBN O
in IN O
a DT O
significant JJ O
increase NN O
of IN O
LD50 NNP O
/ NNP O
30 CD O
, , O
and CC O
the DT O
dose JJ O
reduction NN O
factor NN O
was VBD O
equal JJ O
to TO O
2 CD O
. . O

To TO O
modulate VB O
transcription NN O
, , O
regulatory JJ O
factors NNS O
communicate VBP O
with IN O
basal JJ O
transcription NN O
factors NNS O
and CC O
/ NN O
or CC O
RNA NNP B-Gene
polymerases NNS I-Gene
in IN O
a DT O
variety NN O
of IN O
ways NNS O
. . O

Drug NN O
interactions NNS O
have VBP O
been VBN O
found VBN O
with IN O
drugs NNS O
that WDT O
compete VBP O
for IN O
the DT O
same JJ O
CYP450 NNP B-Gene
isoenzymes NNS I-Gene
as IN O
statins NNS O
. . O

An DT O
approach NN O
to TO O
a DT O
biomathematical JJ O
model NN O
of IN O
lymphocytopoiesis NN O
. . O

Nonetheless RB O
, , O
that IN O
ventricular JJ O
afferents NNS O
, , O
in IN O
certain JJ O
special JJ O
settings NNS O
, , O
are VBP O
able JJ O
to TO O
induce VB O
e NN O
. . O
g NN O
. . O
generalised VBN O
vasodilation NN O
and CC O
hypotension NN O
cannot NN O
be VB O
excluded VBN O
. . O

Topical JJ O
1 CD O
percent NN O
isoproterenol NN O
in IN O
the DT O
presence NN O
of IN O
the DT O
phosphodiesterase NN O
inhibitor NN O
theophylline NN O
was VBD O
tested VBN O
for IN O
its PRP$ O
ability NN O
to TO O
stimulate VB O
the DT O
rate NN O
of IN O
aqueous JJ O
humor NN O
flow NN O
through IN O
the DT O
anterior JJ O
chamber NN O
of IN O
the DT O
normal JJ O
and CC O
the DT O
partially RB O
adrenergically RB O
denervated VBN O
human JJ O
eye NN O
( ( O
Horner NNP O
' POS O
s JJ O
syndrome NN O
) ) O
. . O

The DT O
alpha NN O
T3 NNP O
- : O
1 CD O
cell NN O
line NN O
, , O
a DT O
GnRH NNP B-Gene
- : O
responsive JJ O
gonadotroph NN O
cell NN O
line NN O
developed VBN O
by IN O
targeted JJ O
oncogenesis NN O
in IN O
transgenic JJ O
mice NN O
, , O
was VBD O
used VBN O
to TO O
study VB O
regulation NN O
of IN O
the DT O
glycoprotein NN B-Gene
hormone NN I-Gene
alpha SYM I-Gene
- : I-Gene
subunit NN I-Gene
by IN O
activin NN B-Gene
. . O

The DT O
elevation NN O
of IN O
cyclic JJ O
AMP NNP O
( ( O
cAMP NN O
) ) O
levels NNS O
in IN O
the DT O
cell NN O
downregulates VBZ O
the DT O
activity NN O
of IN O
the DT O
Raf NNP B-Gene
- : I-Gene
1 CD I-Gene
kinase NN I-Gene
. . O

Infrared JJ O
measurements NNS O
of IN O
temperature NN O
changes NNS O
and CC O
estimates NNS O
of IN O
the DT O
heating NN O
produced VBN O
at IN O
the DT O
mical NN O
. . O

Genetics NNS O
Institute NNP O
has VBZ O
developed VBN O
and CC O
launched VBN O
oprelvekin FW B-Gene
( ( O
rhIL VB B-Gene
- : I-Gene
11 CD I-Gene
; : O
Neumega NNP O
) ) O
, , O
a DT O
recombinant JJ O
form NN O
of IN O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
11 CD I-Gene
. . O

Protein NNP O
films NNS O
are VBP O
distinctly RB O
different JJ O
in IN O
mechanical JJ O
profiles NNS O
from IN O
those DT O
films NNS O
made VBN O
of IN O
other JJ O
materials NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
greater JJR O
estrogenic JJ O
influence NN O
associated VBN O
with IN O
the DT O
ethinyl NN O
estradiol SYM O
- : O
containing VBG O
OC NNP O
resulted VBD O
in IN O
inhibition NN O
of IN O
coronary JJ O
artery NN O
atherosclerosis NN O
despite IN O
a DT O
pronounced JJ O
progestin NN O
- : O
induced JJ O
lowering NN O
of IN O
plasma NN O
HDL NNP B-Gene
cholesterol NN I-Gene
concentration NN O
and CC O
, , O
further RB O
, , O
that IN O
hormonal JJ O
balance NN O
may MD O
have VB O
a DT O
marked JJ O
influence NN O
on IN O
the DT O
relationship NN O
between IN O
plasma NN O
lipids NNS O
and CC O
atherogenesis NN O
. . O

Viral NNP O
and CC O
atypical JJ O
pathogens NNS O
as IN O
causes NNS O
of IN O
type NN O
1 CD O
acute JJ O
exacerbations NNS O
of IN O
chronic JJ O
bronchitis NN O
. . O

In IN O
metastasis NN O
- : O
free JJ O
patients NNS O
, , O
the DT O
best JJS O
results NNS O
were VBD O
obtained VBN O
with IN O
tumor NN O
diameters NNS O
under IN O
2 CD O
cm JJ O
regardless NN O
of IN O
their PRP$ O
localization NN O
in IN O
lung NN O
tissue NN O
and CC O
with IN O
2 CD O
- : O
- : O
4 CD O
. . O
9 CD O
cm JJ O
tumors NNS O
embedded VBD O
in IN O
lung NN O
parenchyma NN O
. . O

After IN O
a DT O
baseline NN O
study NN O
, , O
WPW NNP O
syndrome NN O
was VBD O
simulated VBN O
by IN O
stimulation NN O
at IN O
seven CD O
different JJ O
sites NNS O
around IN O
the DT O
base NN O
of IN O
the DT O
ventricles NNS O
, , O
and CC O
RNV NNP O
' POS O
s NN O
were VBD O
obtained VBN O
. . O

A DT O
comparative JJ O
study NN O
of IN O
the DT O
cortical JJ O
end NN O
of IN O
the DT O
auditory JJ O
analyzer NN O
during IN O
postnatal JJ O
ontogenesis NN O
in IN O
lower JJR O
monkeys NN O
and CC O
man NN O

We PRP O
performed VBD O
the DT O
present JJ O
study NN O
to TO O
clarify VB O
the DT O
relationship NN O
between IN O
the DT O
DOX NNP O
binding NN O
ability NN O
( ( O
% NN O
DB NNP O
) ) O
and CC O
the DT O
histologic JJ O
response NN O
, , O
rate NN O
of IN O
decrease NN O
in IN O
tumor NN O
volume NN O
of IN O
malignant JJ O
soft JJ O
tissue NN O
tumors NNS O
after IN O
preoperative JJ O
chemotherapy NN O
and CC O
prognosis NN O
. . O

It PRP O
is VBZ O
the DT O
oxidation NN O
peak NN O
of IN O
this DT O
product NN O
, , O
arising VBG O
in IN O
acidic JJ O
media NNS O
at IN O
0 CD O
. . O
42 CD O
V NNP O
, , O
which WDT O
was VBD O
analysed VBN O
using VBG O
DPV NNP O
, , O
again RB O
following VBG O
the DT O
accumulation NN O
of IN O
clenbuterol NN O
at IN O
the DT O
Nafion NNP O
- : O
modified VBD O
CPE NNP O
. . O

This DT O
DNA NN O
containing VBG O
promoter NN O
activity NN O
has VBZ O
been VBN O
sequenced VBN O
in IN O
its PRP$ O
entirety NN O
and CC O
found VBD O
to TO O
contain VB O
multiple JJ O
putative JJ O
regulatory JJ O
sites NNS O
. . O

In IN O
concert NN O
with IN O
the DT O
coactivator NN O
CREB NNP B-Gene
binding NN I-Gene
protein NN I-Gene
/ NNP O
p300 NN B-Gene
, , O
which WDT O
interacts VBZ O
with IN O
GABPalpha NNP B-Gene
, , O
the DT O
binding NN O
of IN O
GABPalpha NNP B-Gene
and CC I-Gene
- : I-Gene
beta NN I-Gene
to TO O
the DT O
dyad NN O
symmetry NN O
element NN O
controls VBZ O
the DT O
induction NN O
of IN O
IL NNP B-Gene
- : I-Gene
16 CD I-Gene
promoter NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

In IN O
the DT O
3 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
27 CD B-Gene
kDa NN I-Gene
zein NN I-Gene
gene NN I-Gene
, , O
several JJ O
AATAAA NNP O
- : O
like IN O
sequences NNS O
and CC O
a DT O
sequence NN O
resembling VBG O
the DT O
mammalian JJ O
GT NNP O
- : O
rich JJ O
sequence NN O
are VBP O
present JJ O
around IN O
the DT O
polyadenylation NN O
sites VBZ O
. . O

New NNP O
beta SYM O
- : O
blocking VBG O
drugs NNS O
have VBP O
been VBN O
introduced VBN O
which WDT O
may MD O
prove VB O
beneficial JJ O
in IN O
certain JJ O
clinical JJ O
situations NNS O
since IN O
they PRP O
exert VBP O
more RBR O
selective JJ O
blockade NN O
of IN O
the DT O
cardiac JJ B-Gene
receptors NNS I-Gene
( ( O
beta1 NN B-Gene
) ) O
as IN O
opposed VBN O
to TO O
smooth VB B-Gene
muscle NN I-Gene
receptors NNS I-Gene
( ( O
beta2 NN B-Gene
) ) O
. . O

However RB O
, , O
expression NN O
of IN O
sigma NN B-Gene
3 CD I-Gene
from IN O
S4 NNP B-Gene
( ( O
3 CD B-Gene
' '' I-Gene
UTR NNP I-Gene
/ NNP I-Gene
S1 NNP I-Gene
) ) O
, , O
which WDT O
included VBD O
the DT O
PKR NNP B-Gene
activator NN I-Gene
sequence NN I-Gene
from IN O
S1 NNP B-Gene
within IN O
the DT O
3 CD B-Gene
' POS I-Gene
- : I-Gene
UTR NN I-Gene
of IN I-Gene
S4 NNP I-Gene
, , O
was VBD O
comparable JJ O
to TO O
that DT O
from IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
S4 NNP I-Gene
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
Dbf8p NNP B-Gene
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
chromosome NN O
segregation NN O
. . O

Recombination NN O
, , O
replication NN O
, , O
repair NN O
: : O
from IN O
complexity NN O
to TO O
harmony NN O
. . O

Transcription NN O
initiation NN O
occurred VBD O
predominantly RB O
at IN O
the DT O
putative JJ O
sigmaA NN B-Gene
- : I-Gene
dependent JJ I-Gene
promoter NN I-Gene
in IN O
exponentially RB O
growing VBG O
cells NNS O
and CC O
was VBD O
induced VBN O
under IN O
stress NN O
conditions NNS O
. . O

The DT O
enzymic JJ O
hydrolysis NN O
of IN O
urea JJ O
produces NNS O
ammonia VBP O
which WDT O
causes VBZ O
a DT O
vivid JJ O
yellow NN O
to TO O
purple VB O
colour JJ O
change NN O
in IN O
the DT O
pH JJ O
indicator NN O
. . O

The DT O
virus NN O
- : O
associated VBN O
VAI NNP B-Gene
RNA NNP O
of IN O
adenovirus NN O
is VBZ O
a DT O
small JJ O
highly RB O
structured JJ O
RNA NNP O
that WDT O
is VBZ O
required VBN O
for IN O
the DT O
efficient JJ O
translation NN O
of IN O
cellular JJ O
and CC O
viral JJ O
mRNAs NN O
at IN O
late JJ O
times NNS O
after IN O
infection NN O
. . O

Lengthy NNP O
and CC O
repeated VBN O
hemodialyses NNS O
were VBD O
required VBN O
to TO O
lower VB O
lithemia NN O
to TO O
nontoxic JJ O
ranges NNS O
. . O

This DT O
analysis NN O
, , O
together RB O
with IN O
a DT O
consideration NN O
of IN O
the DT O
SCBs NNP O
found VBD O
upstream NN O
of IN O
known VBN O
SWI4 NNP B-Gene
, , I-Gene
6 CD I-Gene
- : O
dependent NN O
genes NNS O
, , O
leads VBZ O
to TO O
the DT O
proposal NN O
of IN O
a DT O
revised VBN O
consensus NN O
sequence NN O
for IN O
this DT O
important JJ O
regulatory JJ O
element NN O
. . O

However RB O
, , O
deletions NNS O
of IN O
the DT O
C NNP O
terminal JJ O
11 CD O
or CC O
14 CD O
amino JJ O
acids NNS O
had VBD O
more RBR O
substantial JJ O
effects NNS O
. . O

Neither DT O
CES1 NNP B-Gene
nor CC O
CES4 NNP B-Gene
is VBZ O
essential JJ O
for IN O
cell NN O
growth NN O
, , O
and CC O
a DT O
double JJ O
deletion NN O
mutant NN O
is VBZ O
viable JJ O
. . O

The DT O
growth NN B-Gene
factor NN I-Gene
receptor NN I-Gene
- : I-Gene
bound NN I-Gene
protein VBZ I-Gene
2 CD I-Gene
( ( O
Grb2 NNP B-Gene
) ) O
adaptor NN O
when WRB O
complexed NN O
with IN O
Sos NNP B-Gene
( ( O
Son NNP B-Gene
of IN I-Gene
sevenless NN I-Gene
) ) O
, , O
the DT O
exchange NN O
factor NN O
of IN O
Ras NNP B-Gene
, , O
conveys VBZ O
the DT O
signal NN O
induced VBN O
by IN O
tyrosine NN B-Gene
kinase NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
to TO O
Ras NNP B-Gene
by IN O
recruiting VBG O
Sos NNP B-Gene
to TO O
the DT O
membrane NN O
, , O
allowing VBG O
activation NN O
of IN O
Ras NNP B-Gene
. . O

Signaling VBG O
from IN O
the DT O
small JJ B-Gene
GTP NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
Rac1 NNP I-Gene
and CC O
Cdc42 NNP B-Gene
to TO O
the DT O
c NN B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
/ NNP O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathway NN O
. . O

The DT O
isolation NN O
of IN O
this DT O
gene NN O
was VBD O
based VBN O
on IN O
the DT O
identification NN O
of IN O
the DT O
Y NNP O
- : O
231 CD O
cosmid NN O
that WDT O
contains VBZ O
CpG NNP O
rich JJ O
sequences NNS O
( ( O
HTF NNP O
islands NNS O
) ) O
in IN O
its PRP$ O
human JJ O
insert NN O
. . O

In IN O
addition NN O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
production NN O
of IN O
active JJ B-Gene
recombinant JJ I-Gene
telomerase NN I-Gene
requires VBZ O
a DT O
factor NN O
in IN O
rabbit NN O
reticulocyte NN O
lysate NN O
that WDT O
promotes VBZ O
ribonucleoprotein NN O
assembly NN O
. . O

Compared VBN O
to TO O
controls NNS O
, , O
both DT O
UB NNP O
and CC O
OCS NNP O
rats NNS O
showed VBD O
a DT O
small JJ O
but CC O
significant JJ O
post NN O
- : O
operative JJ O
reduction NN O
in IN O
the DT O
nocturnality NN O
of IN O
drinking NN O
. . O

The DT O
use NN O
of IN O
antibodies NNS O
to TO O
the DT O
polypyrimidine NN B-Gene
tract NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
PTB NNP B-Gene
) ) O
to TO O
analyze VB O
the DT O
protein NN O
components NNS O
that WDT O
assemble VBP O
on IN O
alternatively RB O
spliced VBN O
pre NN O
- : O
mRNAs NN O
that WDT O
use NN O
distant JJ O
branch NN O
points NNS O
. . O

EB NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
tyrosine JJ B-Gene
kinase NN I-Gene
signal JJ I-Gene
transduction NN I-Gene
gene NN I-Gene
, , O
is VBZ O
transcriptionally RB O
activated VBN O
in IN O
the DT O
t NN O
( ( O
1 CD O
; : O
19 CD O
) ) O
subset NN O
of IN O
pre NN O
- : O
B NNP O
ALL NNP O
, , O
which WDT O
express VBP O
oncoprotein IN O
E2a NNP B-Gene
- : O
Pbx1 NN B-Gene
. . O

Despite IN O
supraphysiologic JJ O
E2 NNP O
concentrations NNS O
, , O
however RB O
, , O
cervical JJ O
mucus NN O
scores NNS O
were VBD O
significantly RB O
reduced VBN O
in IN O
the DT O
CC NNP O
- : O
treated VBN O
group NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Methods NNS O
included VBD O
24 CD O
- : O
hour NN O
dietary JJ O
recall NN O
, , O
menu JJ O
weights NNS O
, , O
and CC O
recipe JJ O
analysis NN O
. . O

Substrate NNP O
specificity NN O
of IN O
the DT O
RNase NNP B-Gene
activity NN O
of IN O
yeast NN B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
III NNP I-Gene
. . O

Three CD O
radiologists NNS O
without IN O
knowledge NN O
of IN O
patients NNS O
' POS O
data NNS O
and CC O
treatment NN O
analyzed VBD O
30 CD O
angiograms NNS O
with IN O
and CC O
30 CD O
examinations NNS O
without IN O
PGF NNP O
. . O

TCR NNP B-Gene
alpha NN I-Gene
( ( O
TCRA NNP B-Gene
) ) O
expression NN O
was VBD O
examined VBN O
in IN O
RNA NNP O
samples NNS O
from IN O
PBMC NNP O
and CC O
isolated JJ O
populations NNS O
of IN O
CD4 NNP B-Gene
+ NNP I-Gene
, , O
CD8 NNP B-Gene
+ NNP I-Gene
, , O
and CC O
DN NNP O
T NNP O
cells NNS O
from IN O
15 CD O
healthy JJ O
individuals NNS O
. . O

Levels NNS O
of IN O
serum NN O
IgE NNP B-Gene
were VBD O
measured VBN O
monthly RB O
, , O
and CC O
nasal RB O
IgE NNP B-Gene
was VBD O
measured VBN O
at IN O
the DT O
height NN O
and CC O
end NN O
of IN O
the DT O
season NN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
fog NN O
, , O
up RB O
to TO O
a DT O
level NN O
of IN O
base NN O
plus CC O
fog NN O
of IN O
0 CD O
. . O
6 CD O
optical JJ O
density NN O
units NNS O
, , O
had VBD O
no DT O
influence NN O
on IN O
the DT O
diagnostic JJ O
accuracy NN O
in IN O
the DT O
absence NN O
of IN O
any DT O
compensation NN O
. . O

Hippocampal NNP O
stimulation NN O
overlapping VBG O
conditioned VBN O
stimulus JJ O
preexposure NN O
produced VBN O
attenuation NN O
of IN O
latent JJ O
inhibition NN O
, , O
as IN O
did VBD O
stimulation NN O
presented VBN O
during IN O
conditioning NN O
after IN O
preexposure NN O
. . O

In IN O
the DT O
controls NNS O
, , O
it PRP O
was VBD O
found VBN O
that IN O
all DT O
right JJ O
- : O
handed VBN O
and CC O
10 CD O
out IN O
of IN O
14 CD O
left VBD O
- : O
handed VBN O
control NN O
subjects VBZ O
showed VBD O
a DT O
right JJ O
VHF NNP O
( ( O
i NN O
. . O
e NN O
. . O
, , O
left VBD O
hemisphere RB O
) ) O
advantage NN O
. . O

The DT O
purposes NNS O
of IN O
this DT O
study NN O
were VBD O
1 CD O
) ) O
to TO O
examine VB O
the DT O
effect NN O
of IN O
high JJ O
intensity NN O
, , O
low JJ O
frequency NN O
transcutaneous JJ O
electrical JJ O
nerve NN O
stimulation NN O
at IN O
auricular JJ O
acupuncture NN O
points NNS O
on IN O
experimental JJ O
pain NN O
threshold NN O
measured VBN O
at IN O
the DT O
wrist NN O
and CC O
2 CD O
) ) O
to TO O
determine VB O
the DT O
changes NNS O
in IN O
effect NN O
over IN O
time NN O
. . O

In IN O
contrast NN O
, , O
the DT O
distribution NN O
of IN O
endocytic JJ O
markers NNS O
is VBZ O
not RB O
affected VBN O
. . O

T4 NNP O
and CC O
FT4I NNP O
followed VBD O
parallel JJ O
courses NNS O
in IN O
both DT O
groups NNS O
; : O
during IN O
the DT O
first JJ O
45 CD O
days NNS O
, , O
however RB O
, , O
the DT O
values NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
premature JJ O
infants NNS O
under IN O
34 CD O
weeks NNS O
' POS O
EGA NNP O
than IN O
in IN O
term NN O
infants NNS O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Plasma NNP O
thromboxane NN O
B2 NNP O
levels NNS O
in IN O
the DT O
older JJR O
group NN O
were VBD O
about RB O
double JJ O
those DT O
in IN O
younger JJR O
piglets NNS O
. . O

NaeI NNP B-Gene
, , O
a DT O
novel JJ O
DNA NNP B-Gene
endonuclease NN I-Gene
, , O
shows VBZ O
topoisomerase NN B-Gene
and CC O
recombinase NN B-Gene
activities NNS O
when WRB O
a DT O
Lys NNP O
residue NN O
is VBZ O
substituted VBN O
for IN O
Leu NNP O
43 CD O
. . O

LHbeta NNP B-Gene
is VBZ O
expressed VBN O
in IN O
pituitary JJ O
gonadotrope NN O
cells NNS O
and CC O
CGbeta NNP B-Gene
is VBZ O
expressed VBN O
in IN O
placental JJ O
trophoblast NN O
cells NNS O
. . O

Neonatal NNP O
Chagas NNP O
disease NN O
: : O
laboratory JJ O
diagnosis NN O
during IN O
the DT O
first JJ O
year NN O
of IN O
life NN O

Chemotherapy NNP O
of IN O
metastasizing VBG O
breast NN O
cancer NN O

This DT O
article NN O
comparatively RB O
evaluates VBZ O
five CD O
Generic NNP O
Systems NNPS O
that WDT O
describe VBZ O
the DT O
basic JJ O
alternatives NNS O
to TO O
composting VBG O
facility NN O
design NN O
and CC O
control NN O
. . O

Several JJ O
studies NNS O
have VBP O
characterized VBN O
the DT O
upstream JJ O
regulatory JJ O
region NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
, , O
and CC O
identified VBD O
cis SYM O
- : O
acting VBG O
elements NNS O
termed VBD O
the DT O
cyclic JJ O
AMP NNP O
( ( O
cAMP NN O
) ) O
response NN O
elements NNS O
( ( O
CREs NNP O
) ) O
that WDT O
are VBP O
critical JJ O
for IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
transcription NN O
in IN O
response NN O
to TO O
a DT O
variety NN O
of IN O
extracellular JJ O
stimuli NNS O
. . O

The DT O
effects NNS O
initiated VBN O
from IN O
the DT O
nucleus NN O
accumbens VBZ O
septi VBN O
were VBD O
most RBS O
marked JJ O
. . O

Between JJ O
1967 CD O
and CC O
1994 CD O
, , O
495 CD O
patients NNS O
underwent JJ O
surgery NN O
for IN O
primary JJ O
PTC NNP O
at IN O
the DT O
Department NNP O
of IN O
Surgery NNP O
, , O
Helsinki NNP O
University NNP O
Central NNP O
Hospital NNP O
. . O

Following VBG O
retransfusion NN O
, , O
the DT O
affected JJ O
epithelial JJ O
lining NN O
appeared VBD O
greatly RB O
distended VBN O
over IN O
the DT O
oedematous JJ O
lamina NN O
propria NNS O
, , O
with IN O
almost RB O
complete JJ O
loss NN O
of IN O
structural JJ O
detail NN O
. . O

We PRP O
compared VBN O
the DT O
efficacy NN O
and CC O
costs NNS O
of IN O
valacyclovir NN O
in IN O
preventing VBG O
HSV NNP O
reactivation NN O
among IN O
HSV NNP O
seropositive VBP O
autologous JJ O
progenitor NN O
cell NN O
transplantation NN O
( ( O
APCT NNP O
) ) O
patients NNS O
with IN O
historical JJ O
controls NNS O
in IN O
whom WP O
intravenous JJ O
acyclovir NN O
or CC O
no DT O
HSV NNP O
prophylaxis NN O
were VBD O
used VBN O
. . O

No DT O
serious JJ O
side NN O
effects NNS O
were VBD O
observed VBN O
. . O

Overlapping VBG O
cDNA NN O
clones NNS O
were VBD O
isolated VBN O
and CC O
sequenced VBN O
. . O

Induction NN O
was VBD O
reversed VBN O
by IN O
coexpression NN O
of IN O
A NNP B-Gene
- : I-Gene
Fos NN I-Gene
, , O
a DT O
dominant JJ O
negative JJ O
to TO O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Restoration NN O
of IN O
opponens NNS O
function NN O
with IN O
transplantation NN O
of IN O
free JJ O
composites NNS O
dorsal VBP O
pedal JJ O
skin NN O
flap NN O
containing VBG O
m NN O
. . O
extensor NN O
hallucis NN O
brevis NN O

The DT O
Caenorhabditis NNP B-Gene
elegans VBZ I-Gene
vitellogenin JJ I-Gene
genes NNS I-Gene
are VBP O
subject JJ O
to TO O
sex NN O
- : O
, , O
stage NN O
- : O
, , O
and CC O
tissue NN O
- : O
specific JJ O
regulation NN O
: : O
they PRP O
are VBP O
expressed VBN O
solely RB O
in IN O
the DT O
adult NN O
hermaphrodite JJ O
intestine NN O
. . O

In IN O
such PDT O
a DT O
manner NN O
, , O
activated VBD O
PKR NNP B-Gene
inhibits NNS O
cell VBP O
growth NN O
and CC O
induces NNS O
apoptosis NN O
, , O
whereas JJ O
disruption NN O
of IN O
normal JJ O
PKR NNP B-Gene
signaling VBG O
results NNS O
in IN O
unregulated JJ O
cell NN O
growth NN O
. . O

SCFFWD1 NNP B-Gene
may MD O
be VB O
critical JJ O
for IN O
tumor NN O
development NN O
and CC O
suppression NN O
through IN O
regulation NN O
of IN O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
protein NN I-Gene
stability NN O
. . O

Signaling VBG O
by IN O
tyrosine JJ B-Gene
kinases NNS I-Gene
involves VBZ O
direct JJ O
associations NNS O
between IN O
proteins NNS O
with IN O
Src NNP B-Gene
homology NN I-Gene
2 CD I-Gene
( ( O
SH2 NNP B-Gene
) ) O
domains NNS O
and CC O
sites NNS O
of IN O
tyrosine JJ O
phosphorylation NN O
. . O

TBARS NN O
levels NNS O
, , O
oxygen SYM O
- : O
radical JJ O
absorbing NN O
capacity NN O
assay NN O
and CC O
AFR NNP O
release NN O
assessed VBN O
by IN O
electron NN O
paramagnetic JJ O
resonance NN O
( ( O
EPR NNP O
) ) O
were VBD O
used VBN O
to TO O
explore VB O
the DT O
existence NN O
of IN O
oxidative JJ O
stress NN O
in IN O
diabetes NNS O
. . O

Despite IN O
the DT O
favourable JJ O
natural JJ O
history NN O
of IN O
acute NN O
BI NNP O
, , O
mild NN O
, , O
moderate JJ O
, , O
and CC O
severe JJ O
posttraumatic JJ O
changes NNS O
were VBD O
shown VBN O
to TO O
appear VB O
as IN O
cicatricial JJ O
- : O
adhesive NN O
and CC O
atrophic JJ O
processes NNS O
, , O
intracerebral JJ O
cysts NNS O
, , O
porencephaly NN O
, , O
which WDT O
result VBP O
in IN O
posttraumatic JJ O
epilepsy NN O
, , O
hydrocephalus NN O
, , O
etc FW O
. . O

Therefore RB O
, , O
ICSBP NNP B-Gene
may MD O
be VB O
involved VBN O
in IN O
maintaining VBG O
submaximal JJ O
transcriptional JJ O
activity NN O
of IN O
IFN NNP B-Gene
- : O
inducible JJ O
genes NNS O
in IN O
hematopoietic JJ O
cells NNS O
. . O

Initial JJ O
estimates NNS O
indicate VBP O
that IN O
27 CD O
, , O
193 CD O
people NNS O
are VBP O
either RB O
in IN O
receipt NN O
of IN O
or CC O
in IN O
need NN O
of IN O
mental JJ O
handicap NN O
services NNS O
. . O

The DT O
gene NN B-Gene
ccpA NN I-Gene
encoding VBG O
the DT O
catabolite NN B-Gene
control NN I-Gene
protein VBP I-Gene
CcpA NNP I-Gene
of IN O
Staphylococcus NNP O
xylosus NNP O
has VBZ O
been VBN O
cloned VBN O
and CC O
characterized VBN O
. . O

Transcription NN O
of IN O
the DT O
first JJ O
operon NN O
coding VBG O
for IN O
m JJ O
- : O
xylene SYM O
- : O
degrading VBG O
enzymes NNS O
on IN O
the DT O
TOL NNP O
plasmid NN O
of IN O
Pseudomonas NNP O
putida NN O
is VBZ O
activated VBN O
by IN O
the DT O
xylR JJ B-Gene
gene NN I-Gene
product NN I-Gene
in IN O
the DT O
presence NN O
of IN O
m JJ O
- : O
xylene NN O
. . O

Strikingly RB O
, , O
these DT O
cells NNS O
contain VBP O
a DT O
missense JJ O
mutation NN O
of IN O
the DT O
p53 NN B-Gene
gene NN I-Gene
at IN O
codon $ O
242 CD O
( ( O
p53 NN B-Gene
( ( O
242 CD O
) ) O
) ) O
, , O
which WDT O
substitutes VBZ O
alanine NN O
for IN O
glycine NN O
. . O

USA NNP O
80 CD O
, , O
3618 CD O
- : O
3622 CD O
) ) O
The DT O
two CD O
proteins NNS O
show VBP O
36 CD O
% NN O
identities NNS O
in IN O
their PRP$ O
amino NN O
acid NN O
sequence NN O
, , O
in IN O
an DT O
alignment NN O
requiring VBG O
six CD O
gaps NNS O
. . O

Airflow NNP O
was VBD O
measured VBN O
with IN O
a DT O
custom NN O
- : O
designed VBN O
turbine NN O
and CC O
a DT O
45 CD O
- : O
ft NN O
. . O
- : O
long RB O
cable NN O
to TO O
reach VB O
the DT O
volume NN O
- : O
measuring NN O
module NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
contact NN O
allergy NN O
to TO O
K NNP O
- : O
CG NN O
is VBZ O
common JJ O
. . O

The DT O
promoter NN O
activity NN O
of IN O
the DT O
proximal JJ O
region NN O
was VBD O
found VBN O
to TO O
be VB O
restricted VBN O
to TO O
a DT O
subset NN O
of IN O
prestalk NN O
cells NNS O
. . O

To TO O
overcome VB O
this DT O
problem NN O
, , O
we PRP O
have VBP O
overexpressed VBN O
Kex2p NNP B-Gene
using VBG O
the DT O
baculovirus NN O
/ NNP O
insect NN O
cell NN O
expression NN O
system NN O
. . O

In IN O
contrast NN O
to TO O
the DT O
myoD NN B-Gene
promoter NN I-Gene
, , O
the DT O
myoD NN B-Gene
enhancer NN I-Gene
shows VBZ O
striking VBG O
conservation NN O
between IN O
humans NNS O
and CC O
mice VB O
both DT O
in IN O
its PRP$ O
sequence NN O
and CC O
its PRP$ O
distal JJ O
position NN O
. . O

The DT O
problem NN O
of IN O
disablement NN O
due JJ O
to TO O
pulmonary JJ O
tuberculosis NN O
, , O
on IN O
the DT O
basis NN O
of IN O
an DT O
analysis NN O
of IN O
the DT O
history NN O
of IN O
395 CD O
cases NNS O
as IN O
observed VBN O
in IN O
Gdansk NNP O
in IN O
the DT O
years NNS O
1946 CD O
- : O
1965 CD O

The DT O
viral JJ B-Gene
oncoprotein NN I-Gene
E1A NNP I-Gene
inhibits VBZ O
NFAT NNP B-Gene
- : O
dependent JJ O
transactivation NN O
in IN O
a DT O
p300 NN B-Gene
- : O
dependent JJ O
manner NN O
. . O

Monitoring NN O
of IN O
rheumatoid JJ O
arthritis NN O
. . O

Thus RB O
, , O
the DT O
system NN O
can MD O
be VB O
used VBN O
to TO O
detect VB O
and CC O
study VB O
dynamic JJ O
perfusion NN O
changes NNS O
from IN O
the DT O
brain NN O
surface NN O
with IN O
minimal JJ O
tissue NN O
damage NN O
. . O

The DT O
pulpal JJ O
tissues NNS O
of IN O
the DT O
permanent JJ O
mandibular JJ O
molars NNS O
were VBD O
amputated VBN O
and CC O
then RB O
dressed VBN O
with IN O
calcium NN O
hydrate NN O
. . O

We PRP O
purified VBD O
both DT O
proteins NNS O
from IN O
human JJ O
platelet NN O
membranes NNS O
using VBG O
DEAE NNP O
- : O
Sepharose NNP O
chromatography NN O
followed VBN O
by IN O
mAb NN B-Gene
F11 NNP I-Gene
affinity NN O
chromatography NN O
. . O

The DT O
present JJ O
treatment NN O
strategy NN O
in IN O
progressive JJ O
disorders NNS O
is VBZ O
mainly RB O
based VBN O
on IN O
the DT O
complementary JJ O
effect NN O
of IN O
intensive JJ O
radiochemotherapy NN O
, , O
autologous JJ O
stem NN O
- : O
cell NN O
transplantation NN O
and CC O
the DT O
rational JJ O
use NN O
of IN O
cytokines NNS O
, , O
mostly RB O
colony JJ B-Gene
- : I-Gene
stimulating NN I-Gene
factors NNS I-Gene
. . O

The DT O
proliferation NN O
- : O
specific JJ O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
/ NN O
fork NN B-Gene
head NN I-Gene
homolog VBD I-Gene
- : I-Gene
11B CD I-Gene
protein NN O
( ( O
HFH NNP B-Gene
- : I-Gene
11B CD I-Gene
; : O
also RB O
known VBN O
as IN O
Trident NN B-Gene
and CC O
Win NNP B-Gene
) ) O
is VBZ O
a DT O
family NN O
member NN O
of IN O
the DT O
winged JJ B-Gene
helix NN I-Gene
/ NNP O
fork NN B-Gene
head NN I-Gene
transcription NN O
factors NNS O
and CC O
in IN O
regenerating VBG O
liver CC O
its PRP$ O
expression NN O
is VBZ O
reactivated VBN O
prior RB O
to TO O
hepatocyte VB O
entry NN O
into IN O
DNA NNP O
replication NN O
( ( O
S NNP O
phase NN O
) ) O
. . O

In IN O
a DT O
gel JJ O
retardation NN O
assay VBP O
using VBG O
HepG2 NNP O
nuclear JJ O
extracts NNS O
, , O
the DT O
5 CD O
' POS O
flanking VBG O
sequence NN O
from IN O
- : O
74 CD O
to TO O
- : O
46 CD O
showed VBD O
a DT O
shifted JJ O
band NN O
. . O

Here RB O
we PRP O
report VBP O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
the DT O
forkhead JJ B-Gene
homologue NN I-Gene
in IN I-Gene
rhabdomyosarcoma NN I-Gene
( ( O
FKHR NNP B-Gene
) ) O
, , O
a DT O
recently RB O
described VBN O
member NN O
of IN O
the DT O
hepatocyte NN B-Gene
nuclear JJ I-Gene
factor NN I-Gene
3 CD I-Gene
/ JJ O
forkhead JJ B-Gene
homeotic JJ B-Gene
gene NN I-Gene
family NN I-Gene
, , O
as IN O
a DT O
nuclear JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
( ( O
NR NNP B-Gene
) ) O
intermediary JJ O
protein NN O
. . O

The DT O
relationship NN O
between IN O
the DT O
rare JJ O
complications NNS O
mentioned VBN O
above IN O
and CC O
the DT O
pathophysiology NN O
of IN O
Bartter NNP O
' POS O
s JJ O
syndrome NN O
is VBZ O
still RB O
obscure JJ O
. . O

The DT O
murine NN B-Gene
Mov NNP I-Gene
- : I-Gene
34 CD I-Gene
gene NN I-Gene
: : O
full JJ O
- : O
length NN O
cDNA NN O
and CC O
genomic JJ O
organization NN O
. . O

Retinoblastoma NN O
: : O
a DT O
study NN O
of IN O
natural JJ O
history NN O
and CC O
prognosis NN O
of IN O
268 CD O
cases NNS O
. . O

We PRP O
used VBD O
the DT O
Toshiba NNP O
IIDR NNP O
system NN O
, , O
which WDT O
is VBZ O
composed VBN O
of IN O
an DT O
X NNP O
- : O
ray NN O
TV NN O
system NN O
and CC O
a DT O
digital JJ O
image NN O
managing VBG O
circuit NN O
. . O

Sterols NNS O
in IN O
pollen NN O
. . O

Nrf2 NNP B-Gene
regulates VBZ O
expression NN O
of IN O
genes NNS O
encoding VBG O
enzymes NNS O
with IN O
antioxidant NN O
( ( O
e NN O
. . O
g NN O
. . O
heme NN B-Gene
oxygenase VBD I-Gene
- : I-Gene
1 CD I-Gene
( ( O
HO NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
) ) O
or CC O
xenobiotic JJ O
detoxification NN O
( ( O
e NN O
. . O
g NN O
. . O

Many JJ O
cytokine NN O
receptors NNS O
employ VBP O
Janus NNP B-Gene
protein NN I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
( ( O
Jaks NNP B-Gene
) ) O
and CC O
signal JJ B-Gene
transducers NNS I-Gene
and CC I-Gene
activators NNS I-Gene
of IN I-Gene
transcription NN I-Gene
( ( O
Stats NNP B-Gene
) ) O
for IN O
nuclear JJ O
signaling NN O
. . O

Normal JJ O
baseline NN O
( ( O
day NN O
- : O
8 CD O
) ) O
PC NN O
levels NNS O
( ( O
86 CD O
and CC O
89 CD O
% NN O
) ) O
were VBD O
markedly RB O
reduced VBN O
in IN O
both DT O
patients NNS O
at IN O
the DT O
time NN O
of IN O
VOD NNP O
manifestation NN O
on IN O
day NN O
20 CD O
and CC O
40 CD O
, , O
respectively RB O
( ( O
26 CD O
and CC O
31 CD O
% NN O
) ) O
. . O

Concomitantly RB O
, , O
the DT O
total JJ O
cellular JJ O
level NN O
of IN O
p21 NN B-Gene
increased VBN O
severalfold JJ O
via IN O
a DT O
posttranscriptional JJ O
mechanism NN O
. . O

Calves NNS O
fed VBP O
MCT NNP O
- : O
milk NN O
had VBD O
significantly RB O
lower JJR O
blood NN O
cholesterol NN O
than IN O
calves NNS O
fed VBN O
T NNP O
- : O
or CC O
SBO NNP O
- : O
milk NN O
. . O

Plasma NNP O
DHE NNP O
concentration NN O
rose VBD O
promptly RB O
above IN O
5 CD O
ng JJ O
/ NNP O
ml NN O
after IN O
the DT O
application NN O
of IN O
the DT O
PSA NNP O
tape NN O
onto IN O
the DT O
damaged VBN O
skin NN O
in IN O
hairless JJ O
rat NN O
. . O

The DT O
v NN B-Gene
- : I-Gene
ets NNS I-Gene
oncogene IN I-Gene
of IN O
the DT O
avian JJ O
retrovirus NN O
E26 NNP O
differs NNS O
from IN O
its PRP$ O
cellular JJ O
progenitor NN O
p68c SYM B-Gene
- : I-Gene
ets NNS I-Gene
- : I-Gene
1 CD I-Gene
by IN O
two CD O
amino NN O
acid NN O
substitutions NNS O
( ( O
alanine JJ O
285 CD O
and CC O
isoleucine VB O
445 CD O
in IN O
c JJ B-Gene
- : I-Gene
ets NNS I-Gene
- : I-Gene
1 CD I-Gene
both DT O
substituted VBN O
by IN O
valine NN O
in IN O
v JJ B-Gene
- : I-Gene
ets NNS I-Gene
, , O
mutations NNS O
A NNP O
and CC O
B NNP O
respectively RB O
) ) O
and CC O
its PRP$ O
carboxy JJ O
- : O
terminal JJ O
end NN O
( ( O
mutation NN O
C NNP O
) ) O
. . O

Escalation NN O
to TO O
180 CD O
mg NNS O
/ JJ O
m2 NN O
was VBD O
to TO O
be VB O
carried VBN O
out IN O
if IN O
white JJ O
blood NN O
cell NN O
nadir RB O
count NN O
was VBD O
> JJ O
2 CD O
. . O
0 CD O
x JJ O
10 CD O
( ( O
9 CD O
) ) O
/ NN O
l NN O
and CC O
platelet NN O
nadir NN O
count NN O
was VBD O
> JJ O
75 CD O
x JJ O
10 CD O
( ( O
9 CD O
) ) O
/ NN O
l NN O
. . O

Three CD O
patients NNS O
had VBD O
well RB O
- : O
, , O
6 CD O
patients NNS O
had VBD O
moderately RB O
- : O
, , O
and CC O
5 CD O
patients NNS O
had VBD O
poorly JJ O
- : O
differentiated JJ O
adenocarcinoma NN O
of IN O
the DT O
prostate NN O
. . O

Mice NNP O
homozygous JJ O
for IN O
the DT O
dlg JJ B-Gene
mutation NN O
exhibit NN O
growth NN O
retardation NN O
in IN O
utero NN O
, , O
have VBP O
hypoplasia NN O
of IN O
the DT O
premaxilla NN O
and CC O
mandible JJ O
, , O
have VBP O
a DT O
cleft NN O
secondary JJ O
palate NN O
, , O
and CC O
die VB O
perinatally RB O
. . O

An DT O
unexpected JJ O
finding NN O
was VBD O
the DT O
presence NN O
at IN O
position NN O
- : O
403 CD O
to TO O
- : O
385 CD O
of IN O
a DT O
putative JJ O
dioxin NN O
responsive JJ O
element NN O
, , O
a DT O
sequence NN O
found VBD O
to TO O
be VB O
responsible JJ O
for IN O
the DT O
induction NN O
of IN O
transcription NN O
of IN O
the DT O
cytochrome NN B-Gene
P450IA1 NNP I-Gene
gene NN I-Gene
( ( O
CYPIA1 NNP B-Gene
) ) O
and CC O
other JJ O
genes NNS O
involved VBN O
in IN O
detoxification NN O
/ NNP O
activation NN O
of IN O
polycyclic JJ O
aromatic JJ O
hydrocarbons NNS O
. . O

Full NNP B-Gene
- : I-Gene
length NN I-Gene
FLAP NNP I-Gene
clones NNS O
were VBD O
isolated VBN O
from IN O
a DT O
mouse NN O
skeletal JJ O
muscle NN O
cDNA NN O
library NN O
. . O

CONCLUSION NN O
: : O
Twice JJ O
daily JJ O
treatment NN O
with IN O
inhaled JJ O
fluticasone NN O
propionate NN O
50 CD O
micrograms NNS O
or CC O
100 CD O
micrograms NNS O
was VBD O
significantly RB O
more RBR O
effective JJ O
than IN O
theophylline NN O
in IN O
the DT O
treatment NN O
of IN O
mild JJ O
- : O
to TO O
- : O
moderate JJ O
asthma NN O
. . O

The DT O
defined JJ O
length NN O
of IN O
the DT O
mRNA NN O
, , O
1 CD O
, , O
838 CD O
nucleotides NNS O
, , O
was VBD O
in IN O
agreement NN O
with IN O
that DT O
of IN O
a DT O
1 CD O
. . O
9 CD O
- : O
kb NN O
RNA NNP O
expressed VBD O
throughout IN O
the DT O
replication NN O
cycle NN O
, , O
starting VBG O
at IN O
the DT O
early JJ O
stages NNS O
of IN O
infection NN O
. . O

This DT O
dominant JJ O
- : O
negative JJ O
effect NN O
of IN O
FRNK NNP B-Gene
was VBD O
reversed VBN O
by IN O
a DT O
point NN O
mutation NN O
( ( O
Leu NNP O
- : O
1034 CD O
to TO O
Ser NNP O
) ) O
which WDT O
prevented VBD O
FRNK NNP B-Gene
localization NN O
to TO O
focal JJ O
contact NN O
sites NNS O
. . O

Therefore RB O
, , O
homozygous JJ O
co SYM O
- : O
deletions NNS O
of IN O
CDKN2A NNP B-Gene
and CC O
CDKN2B NNP B-Gene
rather RB O
than IN O
mutations NNS O
targeting VBG O
individual JJ O
transcripts NNS O
are VBP O
frequently RB O
selected VBN O
for IN O
in IN O
these DT O
tumors NNS O
. . O

The DT O
ability NN O
of IN O
A20 NNP B-Gene
to TO O
block VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
was VBD O
mapped VBN O
to TO O
its PRP$ O
C NNP O
- : O
terminal JJ O
zinc NN O
finger NN O
domain NN O
. . O

Autorosette NNP O
- : O
forming NN O
cells NNS O
are VBP O
characterized VBN O
by IN O
a DT O
high JJ O
activity NN O
of IN O
alkaline NN B-Gene
and CC I-Gene
acid NN I-Gene
phosphatases NNS I-Gene
and CC O
low JJ O
NBT NNP O
- : O
test NN O
values NNS O
. . O

Complete JJ O
sequences NNS O
were VBD O
obtained VBN O
for IN O
the DT O
three CD O
large JJ O
thrombic JJ O
peptides NNS O
, , O
and CC O
these DT O
were VBD O
aligned VBN O
by IN O
using VBG O
peptides NNS O
from IN O
the DT O
V8 NNP B-Gene
protease NN I-Gene
digest NN O
. . O

Intraventricular JJ O
injection NN O
of IN O
( ( O
2S CD O
, , O
1 CD O
' '' O
R NNP O
, , O
2 CD O
' '' O
R NNP O
, , O
3 CD O
' POS O
R NNP O
) ) O
- : O
2 CD O
- : O
( ( O
2 CD O
, , O
3 CD O
- : O
dicarboxycyclopropyl NN O
) ) O
glycine NN O
( ( O
DCG NNP O
- : O
IV NN O
) ) O
, , O
a DT O
potent JJ O
agonist NN O
for IN O
metabotropic NN O
glutamate NN B-Gene
receptors NNS I-Gene
, , O
to TO O
rats VB O
retarded JJ O
dose JJ O
- : O
dependently RB O
the DT O
recovery NN O
from IN O
halothane NN O
anesthesia NN O
at IN O
a DT O
dose JJ O
range NN O
from IN O
30 CD O
to TO O
300 CD O
pmol NNS O
/ JJ O
rat NN O
. . O

The DT O
method NN O
was VBD O
adapted VBN O
for IN O
the DT O
determination NN O
of IN O
nadolol JJ O
racemate NN O
A NNP O
by IN O
a DT O
change NN O
in IN O
mobile JJ O
phase NN O
composition NN O
. . O

Transfection NN O
analyses NNS O
indicate VBP O
that IN O
mutation NN O
of IN O
any DT O
one CD O
of IN O
these DT O
TGACCT NNP O
motifs NNS O
or CC O
truncation NN O
of IN O
the DT O
entire JJ O
HD NNP B-Gene
PPRE NNP O
into IN O
a DT O
separate JJ O
DR1 NNP O
and CC O
DR2 NNP O
element NN O
significantly RB O
reduced VBD O
the DT O
transcriptional JJ O
response NN O
of IN O
HD NNP B-Gene
PPRE NNP O
to TO O
peroxisome VB O
proliferators NNS O
. . O

Role NNP O
of IN O
superoxide JJ B-Gene
dismutase NN I-Gene
in IN O
cellular JJ O
oxidative JJ O
processes NNS O
and CC O
method NN O
of IN O
its PRP$ O
determination NN O
in IN O
biological JJ O
materials NNS O

In IN O
contrast NN O
, , O
extracts NNS O
of IN O
the DT O
mutant JJ O
virions NNS O
catalyze VBP O
the DT O
wild JJ O
- : O
type NN O
level NN O
of IN O
transcription NN O
from IN O
an DT O
exogenous JJ O
template NN O
containing VBG O
an DT O
early JJ O
promoter NN O
. . O

However RB O
, , O
there EX O
were VBD O
some DT O
properties NNS O
of IN O
Rak NNP B-Gene
that WDT O
are VBP O
distinct JJ O
from IN O
Src NNP B-Gene
- : I-Gene
like JJ I-Gene
kinases NNS I-Gene
: : O
( ( O
a DT O
) ) O
expression NN O
of IN O
Rak NNP B-Gene
was VBD O
predominantly RB O
in IN O
epithelial JJ O
- : O
derived VBN O
cell NN O
lines NNS O
and CC O
tissues NNS O
, , O
especially RB O
normal JJ O
liver NN O
and CC O
kidney NN O
, , O
and CC O
cell NN O
lines NNS O
of IN O
breast NN O
and CC O
colon NN O
origin NN O
; : O
( ( O
b NN O
) ) O
Rak NN B-Gene
does VBZ O
not RB O
harbor VB O
the DT O
NH2 NNP O
- : O
terminal JJ O
glycine NN O
essential JJ O
for IN O
myristylation NN O
and CC O
membrane NN O
localization NN O
; : O
and CC O
( ( O
c NN O
) ) O
Rak NNP B-Gene
possesses VBZ O
a DT O
putative JJ O
bipartite NN O
nuclear JJ O
localization NN O
signal NN O
in IN O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
, , O
and CC O
subcellular JJ O
fractionation NN O
studies NNS O
revealed VBD O
that IN O
p54rak NN B-Gene
resides NNS O
predominantly RB O
in IN O
the DT O
nucleus NN O
. . O

Also RB O
, , O
the DT O
EWS NNP B-Gene
protein NN I-Gene
stimulates VBZ O
transcription NN O
mediated VBN O
by IN O
the DT O
COOH NNP O
- : O
terminal JJ O
transactivation NN O
domain NN O
of IN O
the DT O
cofactor NN O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
CBP NNP B-Gene
) ) O
. . O

6 CD O
. . O

The DT O
mouse NN O
extracellular JJ B-Gene
signal JJ I-Gene
- : I-Gene
regulated JJ I-Gene
kinase NN I-Gene
2 CD I-Gene
gene NN I-Gene
. . O

Overexpression NN O
of IN O
ICBP90 NNP B-Gene
in IN O
COS NNP O
- : O
1 CD O
- : O
transfected VBN O
cells NNS O
induced VBD O
an DT O
enhanced JJ O
expression NN O
of IN O
endogenous JJ B-Gene
topoisomerase NN I-Gene
IIalpha NNP I-Gene
. . O

Significantly RB O
higher JJR O
lung NN O
function NN O
parameters NNS O
were VBD O
obtained VBN O
in IN O
extubated JJ O
recipients NNS O
of IN O
LPD NNP O
preserved VBD O
grafts NNS O
2 CD O
weeks NNS O
after IN O
TX NNP O
. . O

We PRP O
did VBD O
not RB O
detect VB O
p50 NN B-Gene
in IN O
association NN O
with IN O
native JJ B-Gene
glucocorticoid NN I-Gene
receptor NN I-Gene
in IN O
L NNP O
cells NNS O
or CC O
with IN O
the DT O
overexpressed JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
in IN O
Chinese JJ O
hamster NN O
ovary JJ O
cells NNS O
. . O

The DT O
neglect NN O
of IN O
Richards NNP O
' POS O
s NN O
theory NN O
demonstrates VBZ O
the DT O
range NN O
of IN O
factors NNS O
, , O
other JJ O
than IN O
the DT O
strictly JJ O
scientific JJ O
, , O
which WDT O
can MD O
be VB O
important JJ O
in IN O
determining VBG O
the DT O
influence NN O
or CC O
otherwise NN O
of IN O
a DT O
psychological JJ O
theory NN O
. . O

Damage NN O
to TO O
the DT O
BBB NNP O
was VBD O
judged VBN O
by IN O
extravasation NN O
of IN O
Evans NNP O
Blue NNP O
( ( O
EB NNP O
) ) O
dye NN O
, , O
which WDT O
was VBD O
administered VBN O
either RB O
2 CD O
, , O
3 CD O
, , O
24 CD O
or CC O
48 CD O
h NN O
after IN O
onset NN O
of IN O
MCAo NNP O
. . O

In IN O
ciliates NNS O
, , O
both DT O
mechanisms NNS O
are VBP O
readily RB O
observed VBN O
. . O

Takayasu NNP O
' POS O
s JJ O
disease NN O
: : O
association NN O
with IN O
HLA NNP B-Gene
- : I-Gene
B5 NNP I-Gene
. . O

Regressing VBG O
microaneurysms NNS O
in IN O
5 CD O
cases NNS O
of IN O
hepatitis NN O
B NNP O
virus NN O
related VBN O
polyarteritis NN O
nodosa NN O
. . O

A DT O
picture NN O
is VBZ O
emerging VBG O
showing VBG O
a DT O
gradient NN O
of IN O
function NN O
among IN O
p53 NN B-Gene
, , O
p73 NN B-Gene
, , O
p63 VBP B-Gene
ranging VBG O
from IN O
tumor NN O
suppression NN O
to TO O
development NN O
. . O

Furthermore RB O
, , O
the DT O
NH2 NNP O
- : O
terminal JJ O
portion NN O
of IN O
the DT O
homologue NN O
was VBD O
not RB O
translocated VBN O
into IN O
the DT O
outer NN O
membrane NN O
without IN O
its PRP$ O
COOH NNP O
- : O
terminal JJ O
part NN O
. . O

Recombinant NNP B-Gene
BRI1 NNP I-Gene
- : I-Gene
KD NNP I-Gene
autophosphorylated VBD O
on IN O
serine NN O
( ( O
Ser NNP O
) ) O
and CC O
threonine NN O
( ( O
Thr NNP O
) ) O
residues VBZ O
with IN O
p JJ O
- : O
Ser NN O
predominating NN O
. . O

RXR NNP B-Gene
- : I-Gene
gamma NN I-Gene
expression NN O
produced VBD O
significant JJ O
reduction NN O
in IN O
levels NNS O
of IN O
RA NNP O
- : O
responsive JJ O
genes NNS O
including VBG O
the DT O
cyclin NN B-Gene
- : I-Gene
dependent JJ I-Gene
kinase NN I-Gene
inhibitors NNS O
p21Cip1 VBP B-Gene
/ JJ O
WAF1 NNP B-Gene
and CC O
p27Kip1 NN B-Gene
, , O
resulting VBG O
in IN O
increased VBN O
cdc2 NN B-Gene
and CC O
cdk2 JJ B-Gene
kinase NN I-Gene
activity NN O
and CC O
RB NNP B-Gene
phosphorylation NN O
. . O

In IN O
contrast NN O
, , O
overproduction NN O
of IN O
Der3p NNP B-Gene
is VBZ O
lethal VBN O
in IN O
a DT O
sec61 JJ B-Gene
- : I-Gene
2 CD I-Gene
strain NN O
at IN O
the DT O
permissive JJ O
temperature NN O
of IN O
25 CD O
degrees NNS O
C NNP O
. . O

Three CD O
large JJ O
field NN O
placement NN O
errors NNS O
( ( O
two CD O
patients NNS O
with IN O
11 CD O
. . O
5 CD O
and CC O
16 CD O
. . O
0 CD O
mm JJ O
distances NNS O
of IN O
the DT O
planned VBN O
versus NN O
simulated VBN O
isocenter NN O
, , O
respectively RB O
and CC O
one CD O
patient NN O
with IN O
a DT O
7 CD O
degree JJ O
rotational JJ O
error NN O
) ) O
were VBD O
detected VBN O
and CC O
, , O
as IN O
with IN O
the DT O
smaller JJR O
errors NNS O
, , O
were VBD O
immediately RB O
corrected VBN O
. . O

Methyl NNP O
formate NN O
was VBD O
used VBN O
as IN O
the DT O
solvent NN O
of IN O
biodegradable JJ O
oligoesters NNS O
for IN O
the DT O
fabrication NN O
of IN O
microspheres NNS O
with IN O
encapsulated JJ O
bovine NN B-Gene
serum NN I-Gene
albumin NN I-Gene
( ( O
BSA NNP B-Gene
) ) O
. . O

Effects NNS O
of IN O
dioxins NNS O
on IN O
thyroid JJ O
function NN O
in IN O
newborn JJ O
babies NNS O
. . O

This DT O
analysis NN O
revealed VBD O
an DT O
intact JJ O
gene NN O
( ( O
arg4 JJ B-Gene
) ) O
showing VBG O
a DT O
high JJ O
degree NN O
of IN O
homology NN O
with IN O
the DT O
Saccharomyces NNS B-Gene
cerevisiae VBP I-Gene
CPA2 NNP I-Gene
gene NN I-Gene
encoding VBG O
the DT O
large JJ O
subunit NN O
of IN O
carbamoyl NN B-Gene
- : I-Gene
phosphate NN I-Gene
synthetase NN I-Gene
( ( O
CPS NNP B-Gene
- : I-Gene
A DT I-Gene
) ) O
. . O

These DT O
animals NNS O
were VBD O
viable JJ O
and CC O
fertile JJ O
. . O

III NNP O
. . O

ORFK10 NNP B-Gene
. . I-Gene
5 CD I-Gene
encodes VBZ O
a DT O
protein NN O
, , O
latency NN B-Gene
- : I-Gene
associated VBN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
2 CD I-Gene
( ( O
LANA2 NNP B-Gene
) ) O
, , O
which WDT O
is VBZ O
expressed VBN O
in IN O
KSHV NNP O
- : O
infected VBN O
hematopoietic JJ O
tissues NNS O
, , O
including VBG O
PEL NNP O
and CC O
CD NNP O
but CC O
not RB O
KS NNP O
lesions NNS O
. . O

Gel NNP O
mobility NN O
shift NN O
and CC O
super JJ O
- : O
shift NN O
assays NNS O
using VBG O
liver JJ O
nuclear JJ O
extracts NNS O
from IN O
either DT O
rat NN O
liver NN O
or CC O
DDT1MF NNP O
- : O
2 CD O
cells NNS O
demonstrated VBD O
that IN O
the DT O
CRE NNP O
in IN O
the DT O
alpha NN B-Gene
1B CD I-Gene
- : I-Gene
AR NNP I-Gene
gene NN I-Gene
bound NN O
CRE NNP B-Gene
binding NN I-Gene
protein NN I-Gene
. . O

Hepatitis NN O
B NNP O
and CC O
C NNP O
seroprevalence NN O
rates NNS O
among IN O
high JJ O
- : O
risk NN O
adolescents NNS O
are VBP O
lower JJR O
in IN O
El NNP O
Paso NNP O
than IN O
in IN O
other JJ O
similar JJ O
US NNP O
populations NNS O
, , O
presenting VBG O
an DT O
ideal JJ O
climate NN O
for IN O
prevention NN O
programs NNS O
. . O

We PRP O
have VBP O
constructed VBN O
, , O
using VBG O
synthetic JJ O
DNA NNP O
oligonucleotides NNS O
, , O
a DT O
U14 NNP B-Gene
snRNA NN I-Gene
gene NN I-Gene
which WDT O
has VBZ O
been VBN O
positioned VBN O
behind IN O
a DT O
T7 NNP B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
promoter NN I-Gene
site NN I-Gene
and CC O
then RB O
inserted VBN O
into IN O
a DT O
plasmid NN O
. . O

Update NN O
on IN O
maternal JJ O
- : O
fetal JJ O
infections NNS O
by IN O
hepatitis NN O
C NNP O
, , O
HIV NNP O
and CC O
cytomegalovirus NN O

A DT O
comparative JJ O
study NN O
was VBD O
undertaken VBN O
between IN O
an DT O
enzymatic JJ O
immunohistochemical NN O
technique NN O
( ( O
EIT NNP O
) ) O
developed VBD O
for IN O
the DT O
diagnosis NN O
of IN O
human JJ O
trichinellosis NN O
and CC O
the DT O
indirect JJ O
immunofluorescence NN O
test NN O
( ( O
IIF NNP O
) ) O
, , O
analysing VBG O
sera NN O
from IN O
outbreaks NNS O
of IN O
human JJ O
trichinellosis NN O
in IN O
Argentina NNP O
. . O

Within IN O
- : O
subject JJ O
BP NNP O
differences NNS O
between IN O
fish JJ O
oil NN O
and CC O
corn NN O
oil NN O
treatment NN O
were VBD O
similar JJ O
for IN O
Dinamap NNP O
( ( O
3 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
8 CD O
/ JJ O
2 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
0 CD O
mm JJ O
Hg NNP O
) ) O
and CC O
for IN O
24 CD O
- : O
h NN O
ABP NNP O
( ( O
2 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
0 CD O
/ JJ O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
mm JJ O
Hg NNP O
) ) O
, , O
but CC O
were VBD O
more RBR O
significant JJ O
with IN O
the DT O
latter NN O
. . O

At IN O
1 CD O
, , O
5 CD O
, , O
and CC O
9 CD O
months NNS O
after IN O
initial JJ O
isolation NN O
of IN O
C NNP O
. . O
kutscheri NN O
from IN O
the DT O
oral JJ O
cavity NN O
, , O
hamsters NNS O
were VBD O
euthanatized VBN O
, , O
and CC O
attempts NNS O
were VBD O
made VBN O
to TO O
culture NN O
C NNP O
. . O
kutscheri NN O
from IN O
13 CD O
additional JJ O
sites NNS O
. . O

Single NNP O
- : O
alanine NN O
- : O
substitution NN O
mutations NNS O
had VBD O
minimal JJ O
, , O
if IN O
any DT O
, , O
effects NNS O
on IN O
S NNP O
- : O
induced VBD O
cell NN O
- : O
to TO O
- : O
cell NN O
fusion NN O
. . O

Progressive JJ O
100 CD O
- : O
mmHg NN O
stepwise NN O
decreases VBZ O
in IN O
superfusate NN O
oxygen NN O
partial JJ O
pressure NN O
( ( O
PO2 NNP O
) ) O
from IN O
control NN O
( ( O
95 CD O
% NN O
O2 NNP O
aeration NN O
, , O
PO2 NNP O
, , O
620 CD O
- : O
650 CD O
mmHg NN O
) ) O
were VBD O
produced VBN O
, , O
and CC O
subsequent JJ O
changes NNS O
in IN O
isometric JJ O
active JJ O
and CC O
resting VBG O
tension NN O
were VBD O
measured VBN O
. . O

In IN O
consequence NN O
, , O
the DT O
gpI NN B-Gene
derived VBD O
from IN O
cells NNS O
infected VBN O
with IN O
mO74 NN O
showed VBD O
antigenic JJ O
characteristics NNS O
similar JJ O
to TO O
those DT O
of IN O
gpI NN B-Gene
from IN O
VZV NNP O
- : O
infected JJ O
cells NNS O
as IN O
determined VBN O
from IN O
the DT O
immunoprecipitation NN O
pattern NN O
, , O
although IN O
the DT O
molecular JJ O
weight NN O
of IN O
each DT O
polypeptide NN O
was VBD O
different JJ O
, , O
and CC O
antibody NN O
produced VBN O
in IN O
rabbits NNS O
infected VBN O
with IN O
recombinant JJ O
virus NN O
had VBD O
a DT O
high JJ O
neutralizing NN O
activity NN O
, , O
when WRB O
the DT O
reaction NN O
was VBD O
performed VBN O
with IN O
complement NN O
. . O

Because IN O
ATF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
CREM NNP B-Gene
are VBP O
known VBN O
to TO O
bind VB O
to TO O
cAMP VB O
response NN O
elements NNS O
( ( O
CRE NNP O
) ) O
, , O
this DT O
functional JJ O
sequence NN O
was VBD O
named VBN O
the DT O
kappa NN B-Gene
E3 NNP I-Gene
' POS I-Gene
- : O
CRE NN O
. . O

We PRP O
have VBP O
measured VBN O
the DT O
release NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
by IN O
unstimulated JJ O
monocytes NNS O
and CC O
monocytes NNS O
stimulated VBN O
with IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
isolated VBD O
from IN O
the DT O
peripheral JJ O
blood NN O
of IN O
two CD O
patients NNS O
with IN O
acute JJ O
poststreptococcal JJ O
glomerulonephritis NN O
( ( O
AGN NNP O
) ) O
and CC O
16 CD O
healthy JJ O
controls NNS O
. . O

Here RB O
we PRP O
show VBP O
that IN O
messenger JJR O
RNAs NNP O
encoding VBG O
trans NNS O
- : O
sialidases NNS O
containing VBG O
the DT O
repeats NNS O
are VBP O
not RB O
present JJ O
in IN O
epimastigotes NNS O
but CC O
are VBP O
abundant JJ O
in IN O
trypomastigotes NNS O
. . O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
Cbl NNP B-Gene
, , O
the DT O
120 CD O
- : O
kDa NN O
protein JJ O
product NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
cbl NN I-Gene
proto NN I-Gene
- : I-Gene
oncogene NN I-Gene
, , O
serves VBZ O
as IN O
a DT O
substrate NN O
of IN O
a DT O
number NN O
of IN O
receptor NN B-Gene
- : I-Gene
coupled VBN I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
and CC O
forms NNS O
complexes NNS O
with IN O
SH3 NNP B-Gene
and CC O
SH2 NNP B-Gene
domain VBP O
- : O
containing NN O
proteins NNS O
, , O
pointing VBG O
to TO O
its PRP$ O
role NN O
in IN O
signal JJ O
transduction NN O
. . O

THE DT O
SCALING NN O
OF NNP O
SONG NNP O
FREQUENCY NNP O
IN NNP O
CICADAS NNP O

In IN O
both DT O
shoots NNS O
and CC O
roots NNS O
, , O
GT NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
is VBZ O
undetectable JJ O
in IN O
meristematic JJ O
tissue NN O
but CC O
becomes NNS O
expressed VBN O
at IN O
later JJ O
stages NNS O
of IN O
cellular JJ O
development NN O
, , O
consistent NN O
with IN O
a DT O
role NN O
in IN O
contributing VBG O
to TO O
the DT O
pattern NN O
of IN O
phytochrome NN B-Gene
A NNP I-Gene
gene NN I-Gene
expression NN O
. . O

Diagnostic JJ O
value NN O
of IN O
adenosine JJ B-Gene
deaminase NN I-Gene
activity NN O
in IN O
tuberculous JJ O
effusions NNS O
. . O

Early JJ O
infection NN O
was VBD O
detected VBN O
in IN O
one CD O
of IN O
50 CD O
control NN O
women NNS O
who WP O
gave VBD O
birth NN O
to TO O
a DT O
healthy JJ O
infant NN O
. . O

Two CD O
families NNS O
with IN O
concordant JJ O
inheritance NN O
of IN O
DNAH9 NNP B-Gene
alleles NNS I-Gene
in IN O
affected JJ O
individuals NNS O
were VBD O
observed VBN O
. . O

Fas NNP B-Gene
- : O
resistant NN O
DT NNP O
- : O
40 CD O
lymphoma NN O
B NNP O
- : O
cells NNS O
rendered VBN O
BTK NNP B-Gene
- : O
deficient NN O
through IN O
targeted VBN O
disruption NN O
of IN O
the DT O
btk NN B-Gene
gene NN I-Gene
by IN O
homologous JJ O
recombination NN O
knockout NN O
underwent JJ O
apoptosis NN O
after IN O
Fas NNP B-Gene
ligation NN O
, , O
but CC O
wild SYM O
- : O
type NN O
DT NNP O
- : O
40 CD O
cells NNS O
or CC O
BTK NNP B-Gene
- : O
deficient NN O
DT NNP O
- : O
40 CD O
cells NNS O
reconstituted VBN O
with IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
human JJ I-Gene
btk NN I-Gene
gene NN I-Gene
did VBD O
not RB O
. . O

Deletion NNP O
mutagenesis NN O
demonstrated VBD O
that IN O
these DT O
two CD O
elements NNS O
are VBP O
involved VBN O
in IN O
the DT O
positive JJ O
regulation NN O
of IN O
MLC NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
transcription NN O
. . O

ELISA NNP O
was VBD O
found VBN O
to TO O
make VB O
a DT O
contribution NN O
to TO O
the DT O
diagnosis NN O
of IN O
tuberculosis NN O
similar JJ O
to TO O
that DT O
of IN O
sputum NN O
smear NN O
. . O

NE NNP B-Gene
and CC O
PR3 NNP B-Gene
assist NN O
in IN O
the DT O
destruction NN O
of IN O
phagocytosed JJ O
microorganisms NNS O
, , O
cleave VBP O
the DT O
important JJ O
connective JJ B-Gene
- : I-Gene
tissue NN I-Gene
protein NN I-Gene
elastin NN I-Gene
, , O
and CC O
generate VB O
chemotactic JJ O
activities NNS O
by IN O
forming VBG O
alpha RB B-Gene
1 CD I-Gene
- : I-Gene
proteinase NN I-Gene
inhibitor NN I-Gene
complexes NNS I-Gene
and CC O
elastin NN B-Gene
peptides NNS I-Gene
. . O

Relations NNS O
between IN O
cellular JJ O
electrical JJ O
activity NN O
and CC O
cardiac JJ O
mechanical JJ O
activity NN O
in IN O
man NN O
, , O
the DT O
dog NN O
and CC O
the DT O
rabbit NN O

Thus RB O
, , O
the DT O
active JJ O
- : O
site NN O
mutation NN O
prevents VBZ O
the DT O
wild JJ O
- : O
type NN O
processing NN O
of IN O
the DT O
N NNP O
- : O
glycosylated VBD O
73 CD O
- : O
kDa NN O
precursor NN O
of IN O
PrB NNP B-Gene
to TO O
the DT O
41 CD B-Gene
. . I-Gene
5 CD I-Gene
kDa JJ I-Gene
pro FW I-Gene
- : I-Gene
PrB NN I-Gene
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
. . O

AIDS NNP O
- : O
related VBN O
disseminated JJ O
histoplasmosis NN O
in IN O
San NNP O
Francisco NNP O
, , O
California NNP O
. . O

The DT O
absence NN O
of IN O
other JJ O
regions NNS O
of IN O
hybridization NN O
suggests VBZ O
that IN O
there EX O
are VBP O
no DT O
closely RB O
related JJ O
sequences NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
reverse JJ O
transcribed VBD O
pseudogenes NNS O
) ) O
scattered VBD O
throughout IN O
the DT O
genome NN O
and CC O
that IN O
if IN O
there EX O
are VBP O
closely RB O
related JJ O
genes NNS O
, , O
they PRP O
must MD O
be VB O
clustered VBN O
near IN O
GSTT2 NNP B-Gene
. . O

A DT O
5 CD O
. . O
3 CD O
- : O
kb NN O
DNA NNP O
fragment NN O
, , O
which WDT O
included VBD O
the DT O
entire JJ O
structural JJ O
porin NN B-Gene
gene NN I-Gene
( ( O
named VBN O
porCa NN B-Gene
) ) O
and CC O
its PRP$ O
flanking NN O
regions NNS O
, , O
was VBD O
identified VBN O
. . O

( ( O
1997 CD O
) ) O
Science NN O
275 CD O
, , O
1927 CD O
- : O
1930 CD O
) ) O
. . O

These DT O
results NNS O
suggest VBP O
an DT O
increased VBN O
risk NN O
of IN O
developing VBG O
cancer NN O
among IN O
polyp JJ O
patients NNS O
and CC O
the DT O
possibility NN O
of IN O
prophylactic JJ O
effect NN O
of IN O
polypectomy NN O
against IN O
subsequent JJ O
cancer NN O
. . O

The DT O
effects NNS O
of IN O
contrast NN O
media NNS O
on IN O
coagulation NN B-Gene
factor NN I-Gene
XII NNP I-Gene
. . O

The DT O
TTG NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
has VBZ O
been VBN O
identified VBN O
at IN O
the DT O
site NN O
of IN O
chromosomal JJ O
translocations NNS O
in IN O
acute NN O
T NNP O
- : O
cell NN O
leukemia NN O
' '' O
s NN O
( ( O
T NNP O
- : O
ALL DT O
) ) O
. . O

Curiously RB O
, , O
testololactone NN O
was VBD O
earlier JJR O
and CC O
more RBR O
widely RB O
used VBN O
than IN O
aminoglutethimide RB O
in IN O
treating VBG O
advanced JJ O
breast NN O
carcinoma NN O
. . O

The DT O
TA NNP O
muscle NN O
was VBD O
fatigued VBN O
by IN O
four CD O
forms NNS O
of IN O
repeated JJ O
isometric JJ O
contractions NNS O
: : O
( ( O
1 CD O
) ) O
maximal NN O
voluntary JJ O
contractions NNS O
( ( O
MVC NNP O
) ) O
, , O
( ( O
2 CD O
) ) O
MVC NN O
with IN O
circulation NN O
occluded VBN O
, , O
( ( O
3 CD O
) ) O
electrically RB O
evoked VBD O
contractions NNS O
with IN O
20 CD O
Hz NNP O
supramaximal JJ O
voltage NN O
stimulation NN O
and CC O
( ( O
4 CD O
) ) O
electrically RB O
evoked VBD O
contractions NNS O
with IN O
circulation NN O
occluded VBN O
. . O

Delineating VBG O
the DT O
molecular JJ O
basis NN O
for IN O
agonist JJ O
- : O
induced JJ O
destabilization NN O
of IN O
mRNA NN O
of IN O
G NNP B-Gene
- : I-Gene
protein NN I-Gene
- : I-Gene
linked VBN I-Gene
receptors NNS I-Gene
that WDT O
contributes VBZ O
to TO O
receptor VB O
down RP O
- : O
regulation NN O
is VBZ O
fundamental JJ O
to TO O
our PRP$ O
understanding NN O
of IN O
long JJ O
- : O
term NN O
regulation NN O
of IN O
receptors NNS O
by IN O
agonist NN O
. . O

This DT O
technique NN O
was VBD O
employed VBN O
in IN O
12 CD O
patients NNS O
with IN O
a DT O
unicameral JJ O
bone NN O
cyst NN O
. . O

A DT O
set NN O
of IN O
peptides NNS O
corresponding VBG O
to TO O
the DT O
individual JJ O
elements NNS O
of IN O
secondary JJ O
structure NN O
derived VBN O
from IN O
the DT O
N NNP O
- : O
terminal JJ O
domain NN O
of IN O
the DT O
ribosomal JJ B-Gene
protein NN I-Gene
L9 NNP I-Gene
have VBP O
been VBN O
synthesized VBN O
. . O

The DT O
subjects NNS O
from IN O
the DT O
two CD O
regions NNS O
with IN O
a DT O
higher JJR O
pollution NN O
level NN O
had VBD O
lower JJR O
FVC NNP O
and CC O
FEV1 NNP O
values NNS O
than IN O
those DT O
from IN O
the DT O
Viskovo NNP O
region NN O
. . O

Together RB O
, , O
these DT O
data NNS O
identify VBP O
ERK2 NNP B-Gene
as IN O
a DT O
specific NN O
and CC O
direct JJ O
target NN O
of IN O
HePTP NNP B-Gene
and CC O
are VBP O
consistent JJ O
with IN O
a DT O
model NN O
in IN O
which WDT O
HePTP NNP B-Gene
negatively RB O
regulates VBZ O
ERK2 NNP B-Gene
activity NN O
as IN O
part NN O
of IN O
a DT O
feedback NN O
mechanism NN O
. . O

( ( O
ii NN O
) ) O
ICP27 NNP B-Gene
binds VBZ O
preferentially RB O
to TO O
less JJR O
modified JJ O
forms NNS O
of IN O
ICP4 NNP B-Gene
, , O
a DT O
protein NN O
that WDT O
is VBZ O
extensively RB O
modified VBN O
posttranslationally RB O
. . O

We PRP O
have VBP O
applied VBN O
the DT O
mRNA JJ O
differential JJ O
display NN O
method NN O
to TO O
compare VB O
and CC O
analyze VB O
mRNAs NN O
prepared VBN O
from IN O
five CD O
normal JJ O
nasopharyngeal JJ O
epithelial JJ O
cell NN O
cultures NNS O
and CC O
five CD O
nasopharyngeal JJ O
carcinoma NN O
cell NN O
lines NNS O
. . O

SELECTION NNP O
CRITERIA NNP O
: : O
Randomised VBN O
controlled JJ O
trials NNS O
of IN O
cabergoline NN O
versus NN O
placebo NN O
in IN O
patients NNS O
with IN O
a DT O
clinical JJ O
diagnosis NN O
of IN O
idiopathic JJ O
Parkinson NNP O
' POS O
s JJ O
disease NN O
and CC O
long JJ O
- : O
term NN O
complications NNS O
of IN O
levodopa JJ O
therapy NN O
. . O

All DT O
six CD O
genes NNS O
were VBD O
cloned VBN O
and CC O
characterised VBN O
. . O

The DT O
lack NN O
of IN O
change NN O
in IN O
the DT O
ratio NN O
of IN O
the DT O
two CD O
spliced VBD O
products NNS O
expressed VBN O
from IN O
either CC O
the DT O
normal JJ O
or CC O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
rearranged VBN I-Gene
myb NN I-Gene
further RBR O
indicates VBZ O
that IN O
the DT O
insertion NN O
of IN O
the DT O
unique JJ O
121 CD O
amino NN O
acids NNS O
in IN O
the DT O
larger JJR O
myb NN B-Gene
transcripts NNS I-Gene
is VBZ O
not RB O
a DT O
consequence NN O
of IN O
tumor NN O
- : O
specific JJ O
activation NN O
of IN O
the DT O
mouse NN B-Gene
myb NN I-Gene
oncogene NN I-Gene
. . O

Thus RB O
, , O
the DT O
absence NN O
of IN O
residual JJ O
infarct NN O
- : O
zone NN O
viability NN O
discriminates VBZ O
patients NNS O
who WP O
develop VBP O
progressive JJ O
left VBD O
ventricular JJ O
dilation NN O
after IN O
reperfused VBN O
AMI NNP O
from IN O
those DT O
who WP O
maintain VBP O
normal JJ O
left VBD O
ventricular JJ O
geometry NN O
. . O

Coexisting VBG O
vertical JJ O
and CC O
horizontal JJ O
one CD O
and CC O
a DT O
half JJ O
syndromes NNS O
. . O

Mutations NNS O
in IN O
UPF1 NNP B-Gene
lead NN O
to TO O
the DT O
selective JJ O
stabilization NN O
of IN O
mRNAs NN O
containing VBG O
early JJ O
nonsense NN O
mutations NNS O
without IN O
affecting VBG O
the DT O
decay NN O
rates NNS O
of IN O
most JJS O
other JJ O
mRNAs NN O
. . O

In IN O
both DT O
these DT O
respects NNS O
, , O
however RB O
, , O
the DT O
DBP NNP B-Gene
mRNA NN I-Gene
resembles VBZ O
the DT O
late JJ O
messengers NNS O
of IN O
SV40 NNP O
and CC O
polyoma NN O
viruses NNS O
. . O

It PRP O
applies VBZ O
Udry NNP O
' POS O
s JJ O
biosocial JJ O
perspective NN O
, , O
which WDT O
attempts VBZ O
to TO O
reconcile VB O
the DT O
biological JJ O
and CC O
sociological JJ O
models NNS O
of IN O
premarital JJ O
sexual JJ O
and CC O
reproductive JJ O
behaviour NN O
. . O

METHODS NN O
: : O
A DT O
population NN O
survey NN O
was VBD O
undertaken VBN O
in IN O
10 CD O
, , O
148 CD O
individuals NNS O
to TO O
measure VB O
the DT O
prevalence NN O
and CC O
identify VB O
the DT O
causes NNS O
of IN O
blindness NN O
in IN O
Lebanon NNP O
. . O

No DT O
preferential JJ O
VH NNP B-Gene
/ NNP O
VL NNP B-Gene
- : O
chains NNS O
correlated VBN O
with IN O
any DT O
of IN O
the DT O
12 CD O
different JJ O
antigen NN O
reactivities NNS O
, , O
even RB O
for IN O
mAbs NN O
with IN O
nearly RB O
identical JJ O
cross NN O
- : O
reactivities NNS O
. . O

Sequence NN O
and CC O
genetic JJ O
organization NN O
of IN O
a DT O
Zymomonas NNP O
mobilis NN O
gene NN O
cluster NN O
that WDT O
encodes VBZ O
several JJ O
enzymes NNS O
of IN O
glucose JJ O
metabolism NN O
. . O

The DT O
5 CD O
' POS O
and CC O
3 CD O
' '' O
untranslated JJ O
sequences NNS O
contain VBP O
characteristic JJ O
sequences NNS O
that WDT O
are VBP O
involved VBN O
in IN O
the DT O
initiation NN O
and CC O
termination NN O
of IN O
transcription NN O
, , O
including VBG O
two CD O
possible JJ O
promoters NNS O
, , O
one CD O
of IN O
which WDT O
may MD O
contain VB O
two CD O
overlapping VBG O
- : O
10 CD O
sequences NNS O
. . O

Consistent JJ O
with IN O
this DT O
prediction NN O
, , O
transfections NNS O
into IN O
the DT O
hematopoietic JJ O
cell NN O
line NN O
Jurkat NNP O
showed VBD O
a DT O
9 CD O
. . O
0 CD O
- : O
and CC O
2 CD O
. . O
5 CD O
- : O
fold JJ O
activation NN O
of IN O
the DT O
mim NN B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
by IN O
the DT O
p32 NN B-Gene
and CC O
p30 NN B-Gene
isoforms NNS I-Gene
, , O
respectively RB O
. . O

After IN O
a DT O
survey NN O
of IN O
the DT O
anatomical JJ O
and CC O
physiological JJ O
basis NN O
of IN O
operative JJ O
treatment NN O
of IN O
behaviour NN O
disorders NNS O
by IN O
stereotactic JJ O
lesions NNS O
in IN O
the DT O
amygdala NN O
and CC O
the DT O
posterior JJ O
medial JJ O
hypothalamus NN O
the DT O
author NN O
describes VBZ O
his PRP$ O
own JJ O
experiences NNS O
with IN O
603 CD O
operations NNS O
for IN O
control NN O
of IN O
conservatively RB O
untreatable JJ O
aggressiveness NN O
. . O

DESIGN NN O
: : O
A DT O
cross NN O
- : O
sectional JJ O
study NN O
. . O

Only RB O
one CD O
DC NNP O
cardioversion NN O
was VBD O
required VBN O
in IN O
the DT O
HBS NNP O
group NN O
, , O
whereas IN O
2 CD O
DC NNP O
in IN O
the DT O
CBC NNP O
group NN O
and CC O
total JJ O
7 CD O
DC NNP O
in IN O
the DT O
GIK NNP O
group NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
it PRP O
may MD O
be VB O
possible JJ O
to TO O
individualize VB O
hCG JJ B-Gene
administration NN O
at IN O
midcycle NN O
by IN O
determining VBG O
the DT O
number NN O
of IN O
follicles NNS O
greater JJR O
than IN O
1 CD O
cm NN O
by IN O
ultrasound NN O
on IN O
cycle NN O
day NN O
12 CD O
or CC O
13 CD O
and CC O
giving VBG O
hCG NN B-Gene
when WRB O
serum NN O
E2 NNP O
levels NNS O
reach VBP O
1100 CD O
to TO O
1200 CD O
pmol NN O
/ NNP O
l NN O
per IN O
follicle NN O
. . O

Inhibition NNP O
assays NNS O
performed VBD O
with IN O
over IN O
30 CD O
different JJ O
natural JJ O
and CC O
synthetic JJ O
sialylated VBN O
and CC O
/ CD O
or CC O
sulfated VBN O
compounds NNS O
are VBP O
utilized JJ O
to TO O
define VB O
in IN O
greater JJR O
detail NN O
specific JJ O
structural JJ O
features NNS O
involved VBN O
in IN O
oligosaccharide JJ O
- : O
protein NN O
binding NN O
. . O

Treatment NN O
of IN O
meat NN O
muscle NN O
800 CD O
V NNP O
for IN O
45 CD O
s NNS O
reduced VBD O
weeping VBG O
but CC O
increased VBD O
slightly RB O
the DT O
rate NN O
of IN O
autoxidation NN O
of IN O
lipids NNS O
. . O

Northern NNP O
blot NN O
hybridization NN O
demonstrated VBD O
that IN O
HEP NNP B-Gene
- : O
COP NNP B-Gene
was VBD O
expressed VBN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
human JJ O
adult NN O
and CC O
fetal JJ O
tissues NNS O
. . O

Molecule NNP O
( ( O
s PRP O
) ) O
secreted VBN O
by IN O
neuronal JJ O
cultures NNS O
contribute VBP O
to TO O
this DT O
induction NN O
of IN O
GLT NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
signaling NN O
pathways VBZ O
mediating VBG O
this DT O
regulation NN O
. . O

We PRP O
have VBP O
measured VBN O
the DT O
kinetics NNS O
of IN O
the DT O
recovery NN O
of IN O
mRNA JJ O
synthesis NN O
in IN O
the DT O
inducible JJ O
GAL10 NNP B-Gene
and CC O
RNR3 NNP B-Gene
genes NNS I-Gene
after IN O
exposure NN O
of IN O
yeast NN O
cells NNS O
to TO O
ultraviolet VB O
( ( O
UV NNP O
) ) O
radiation NN O
. . O

MED1 NNP B-Gene
has VBZ O
a DT O
weak JJ O
glycosylase NN B-Gene
activity NN O
on IN O
the DT O
mutagenic JJ O
adduct NN O
3 CD O
, , O
N NNP O
( ( O
4 CD O
) ) O
- : O
ethenocytosine NN O
, , O
a DT O
metabolite NN O
of IN O
vinyl JJ O
chloride NN O
and CC O
ethyl JJ O
carbamate NN O
. . O

Deletion NN O
of IN O
an DT O
intergenic JJ O
DNA NNP O
- : O
binding NN O
site NN O
for IN O
this DT O
complex NN O
from IN O
a DT O
human JJ B-Gene
beta NN I-Gene
- : I-Gene
globin NN I-Gene
locus JJ I-Gene
construct NN I-Gene
results NNS O
in IN O
delayed JJ O
human JJ B-Gene
gamma NN I-Gene
- : I-Gene
to TO I-Gene
beta VB I-Gene
- : I-Gene
globin NN I-Gene
switching VBG O
in IN O
transgenic JJ O
mice NN O
, , O
suggesting VBG O
that IN O
the DT O
PYR NNP B-Gene
complex JJ I-Gene
acts NNS O
to TO O
facilitate VB O
the DT O
switch NN O
. . O

The DT O
mRNA NN O
was VBD O
converted VBN O
to TO O
cDNA VB O
and CC O
amplified VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
technique NN O
. . O

Our PRP$ O
results NNS O
, , O
however RB O
, , O
were VBD O
obtained VBN O
for IN O
Z NNP O
itself PRP O
and CC O
not RB O
for IN O
[ NNP O
Z NNP O
] NNP O
. . O

The DT O
R2 NNP O
region NN O
within IN O
the DT O
class NN O
I PRP O
enhancer VBP O
acts NNS O
as IN O
a DT O
negative JJ O
element NN O
in IN O
Ad12 NNP O
- : O
transformed VBD O
cells NNS O
and CC O
exhibits VBZ O
a DT O
stronger JJR O
binding NN O
activity NN O
than IN O
is VBZ O
observed VBN O
in IN O
nontumorigenic JJ O
Ad5 NNP O
- : O
transformed VBD O
cells NNS O
, , O
which WDT O
are VBP O
not RB O
reduced VBN O
in IN O
class NN O
I PRP O
expression VBP O
. . O

Elimination NN O
of IN O
the DT O
inducible JJ O
response NN O
requires VBZ O
simultaneous JJ O
mutation NN O
of IN O
both DT O
sequences NNS O
, , O
however RB O
, , O
in IN O
the DT O
presence NN O
of IN O
an DT O
intact JJ O
EpRE NNP O
the DT O
upstream JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
is VBZ O
irrelevant JJ O
to TO O
induction NN O
. . O

RESULTS NN O
: : O
Abnormal JJ O
color NN O
perception NN O
was VBD O
found VBN O
in IN O
32 CD O
% NN O
of IN O
the DT O
epilepsy NN O
patients NNS O
treated VBN O
with IN O
vigabatrin JJ O
monotherapy NN O
and CC O
28 CD O
% NN O
of IN O
the DT O
epilepsy NN O
patients NNS O
treated VBN O
with IN O
carbamazepine JJ O
monotherapy NN O
. . O

The DT O
gene NN O
pairs NNS O
psbB VBP B-Gene
- : O
psbT NN B-Gene
and CC O
psbH NN B-Gene
- : O
psbN NN B-Gene
are VBP O
cotranscribed VBN O
from IN O
opposite JJ O
strands NNS O
. . O

Myocardial JJ O
perfusion NN O
was VBD O
evaluated VBN O
using VBG O
the DT O
enhanced JJ O
gray JJ O
level NN O
after IN O
contrast NN O
injection NN O
, , O
and CC O
the DT O
level NN O
was VBD O
compared VBN O
with IN O
the DT O
morphology NN O
and CC O
degree NN O
of IN O
collateral NN O
development NN O
. . O

These DT O
offspring NN O
of IN O
the DT O
alpha JJ B-Gene
- : I-Gene
MSH NNP I-Gene
treated VBD O
mothers NNS O
were VBD O
less RBR O
sensitive JJ O
to TO O
pain VB O
and CC O
as IN O
adults NNS O
showed VBD O
a DT O
reduced JJ O
analgesic JJ O
response NN O
to TO O
morphine VB O
. . O

Each DT O
sample NN O
was VBD O
analysed VBN O
as RB O
soon RB O
as IN O
possible JJ O
, , O
and CC O
repeated VBD O
15 CD O
, , O
30 CD O
, , O
60 CD O
and CC O
120 CD O
min NN O
after IN O
sampling VBG O
. . O

In IN O
the DT O
electrophoresis NN O
mobility NN O
shift NN O
assay VBP O
using VBG O
nuclear JJ O
extracts NNS O
of IN O
the DT O
myogenic JJ O
cells NNS O
, , O
MyoD NNP B-Gene
and CC O
myogenin NN B-Gene
bound NN O
to TO O
the DT O
right NN O
E NNP O
- : O
box NN O
in IN O
the DT O
enhancer JJ O
region NN O
of IN O
the DT O
MCK NNP B-Gene
gene NN I-Gene
even RB O
in IN O
the DT O
presence NN O
of IN O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Composites NNS O
as IN O
restoration NN O
materials NNS O

From IN O
an DT O
RNK NNP O
- : O
16 CD O
lambda SYM O
- : O
gt11 NN O
library NN O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
sequenced VBD O
a DT O
novel JJ O
cDNA NN O
rat NN B-Gene
NK NNP I-Gene
cell NN I-Gene
protease NN I-Gene
1 CD I-Gene
( ( O
RNKP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
that WDT O
has VBZ O
characteristics NNS O
unique JJ O
to TO O
serine VB B-Gene
proteases NNS I-Gene
. . O

These DT O
data NNS O
establish VB O
Smd1p NNP B-Gene
as IN O
a DT O
required JJ O
component NN O
of IN O
the DT O
cellular JJ O
splicing NN O
apparatus NN O
and CC O
a DT O
factor NN O
in IN O
snRNA JJ O
maturation NN O
and CC O
stability NN O
. . O

Patients NNS O
with IN O
CF NNP O
and CC O
meconium NN O
ileus NN O
presented VBD O
a DT O
poor JJ O
nutritional JJ O
status NN O
at IN O
diagnosis NN O
and CC O
a DT O
lower JJR O
survival NN O
rate NN O
compared VBN O
to TO O
the DT O
general JJ O
CF NNP O
population NN O
. . O

In IN O
contrast NN O
, , O
c SYM B-Gene
- : I-Gene
Src NNP I-Gene
activated VBN O
by IN O
isoproterenol NN O
led VBN O
to TO O
tyrosine VB O
phosphorylation NN O
of IN O
Shc NNP B-Gene
and CC O
subsequent JJ O
Erk NNP B-Gene
activation NN O
, , O
but CC O
not RB O
tyrosine JJ O
phosphorylation NN O
of IN O
cortactin NN B-Gene
or CC O
Stat3 NNP B-Gene
. . O

However RB O
, , O
using VBG O
ATL NNP O
- : O
16T CD O
nuclear JJ O
extract NN O
, , O
we PRP O
demonstrated VBD O
that IN O
GATA NNP B-Gene
- : I-Gene
4 CD I-Gene
is VBZ O
the DT O
only JJ O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
that IN O
forms VBZ O
specific JJ O
DNA NNP O
- : O
protein NN O
complex JJ O
with IN O
the DT O
- : O
70 CD O
GATA NNP O
site NN O
. . O

CONCLUSIONS NN O
: : O
The DT O
mechanism NN O
of IN O
MIRI NNP O
is VBZ O
Qi NNP O
deficiency NN O
and CC O
blood NN O
stasis NN O
in IN O
TCM NNP O
, , O
its PRP$ O
treating VBG O
principles NNS O
should MD O
be VB O
promoting VBG O
Qi NNP O
and CC O
removing VBG O
the DT O
blood NN O
stasis NN O
. . O

Transvenous JJ O
serial JJ O
xeroradiography NN O
. . O

The DT O
coding VBG O
region NN O
of IN O
mkh1 NN B-Gene
is VBZ O
contained VBN O
within IN O
a DT O
single JJ O
exon NN O
encoding VBG O
a DT O
1 CD O
, , O
116 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
. . O

Contrary JJ O
to TO O
1 CD O
, , O
8 CD O
- : O
dihydroxy NN O
- : O
9 CD O
- : O
anthrone NN O
, , O
1 CD O
, , O
8 CD O
, , O
9 CD O
- : O
triacetoxyanthracene NN O
and CC O
1 CD O
, , O
8 CD O
- : O
diacetoxy NN O
- : O
9 CD O
- : O
anthrone NN O
are VBP O
effective JJ O
against IN O
psoriatic JJ O
lesions NNS O
without IN O
accompanying VBG O
inflammations NNS O
of IN O
the DT O
skin NN O
. . O

Serological JJ O
studies NNS O
at IN O
the DT O
early JJ O
relapse NN O
stage NN O
of IN O
this DT O
disease NN O
showed VBD O
increased VBN O
serum NN B-Gene
ANA NNP I-Gene
, , O
IgA NNP B-Gene
and CC O
IgM NNP B-Gene
level NN O
with IN O
normal JJ O
IgG NNP B-Gene
and CC O
decrease NN O
of IN O
C3 NNP B-Gene
and CC O
C4 NNP B-Gene
. . O

Transfection NN O
with IN O
a DT O
CSF NNP B-Gene
- : I-Gene
1R CD I-Gene
expression NN O
plasmid NN O
permitted VBD O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
activation NN O
of IN O
the DT O
signalling VBG O
pathway NN O
targeting VBG O
an DT O
Ets NNP B-Gene
/ NNP O
AP1 NNP B-Gene
( ( O
activator NN B-Gene
protein RB I-Gene
1 CD I-Gene
) ) O
element NN O
in IN O
the DT O
uPA JJ B-Gene
promoter NN I-Gene
that WDT O
has VBZ O
been VBN O
shown VBN O
previously RB O
to TO O
be VB O
a DT O
target NN O
of IN O
oncogenic JJ B-Gene
ras NNS I-Gene
and CC O
protein JJ O
kinase NN O
C NNP O
pathways NNS O
. . O

Neither CC O
the DT O
p42 NN B-Gene
/ VBZ I-Gene
44 CD I-Gene
nor CC O
the DT O
JNK NNP B-Gene
pathway NN O
was VBD O
involved VBN O
in IN O
the DT O
action NN O
of IN O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
. . O

After IN O
hepatitis NN O
B NNP O
vaccine NN O
immunization NN O
, , O
serum VB O
antibody NN O
response NN O
was VBD O
of IN O
primary JJ O
type NN O
in IN O
33 CD O
cases NNS O
with IN O
anti JJ B-Gene
- : I-Gene
HBs NNP I-Gene
less JJR O
than IN O
2 CD O
. . O
1 CD O
S NNP O
/ NNP O
N NNP O
( ( O
S NNP O
/ NNP O
N NNP O
Ratio NNP O
Unit NNP O
) ) O
at IN O
T0 NNP O
, , O
the DT O
anti JJ B-Gene
- : I-Gene
HBs NNP I-Gene
positive JJ O
rate NN O
was VBD O
39 CD O
. . O
4 CD O
% NN O
, , O
84 CD O
. . O
8 CD O
% NN O
, , O
96 CD O
. . O
7 CD O
% NN O
and CC O
96 CD O
. . O
7 CD O
% NN O
in IN O
T1 NNP O
, , O
T2 NNP O
, , O
T0 NNP O
and CC O
T12 NNP O
respectively RB O
. . O

ULKs NNP B-Gene
and CC O
UNC NNP B-Gene
- : I-Gene
51 CD I-Gene
share NN O
a DT O
typical JJ O
domain NN O
structure NN O
of IN O
an DT O
amino NN O
- : O
terminal JJ O
kinase NN O
domain NN O
, , O
a DT O
central JJ O
proline NN O
/ NNP O
serine NN O
rich NN O
( ( O
PS NNP O
) ) O
domain NN O
, , O
and CC O
a DT O
carboxy JJ O
- : O
terminal NN O
( ( O
C NNP O
) ) O
domain NN O
. . O

Histogenetic JJ O
aspects NNS O
of IN O
mesoblastic JJ O
nephroma NN O
. . O

To TO O
dissect VB O
these DT O
mechanisms NNS O
, , O
wild JJ O
- : O
type NN O
and CC O
mutant JJ B-Gene
Raf NNP I-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
were VBD O
studied VBN O
in IN O
an DT O
in IN O
vitro NN O
system NN O
with IN O
purified JJ O
plasma NN O
membranes NNS O
from IN O
v JJ B-Gene
- : I-Gene
Ras NNP I-Gene
- : O
and CC O
v SYM B-Gene
- : I-Gene
Src NNP I-Gene
- : O
transformed VBD O
cells NNS O
( ( O
transformed VBN O
membranes NNS O
) ) O
. . O

Interestingly RB O
, , O
the DT O
IR5 NNP B-Gene
ORF NNP I-Gene
of IN O
EHV NNP O
- : O
1 CD O
possesses VBZ O
a DT O
sequence NN O
of IN O
13 CD O
amino JJ O
acids NNS O
( ( O
CAYWCCLGHAFAC NNP O
) ) O
that WDT O
is VBZ O
a DT O
perfect JJ O
match NN O
to TO O
the DT O
consensus NN O
zinc NN O
finger NN O
motif NN O
( ( O
C NNP O
- : O
X2 SYM O
- : O
4 CD O
- : O
C NNP O
- : O
X2 SYM O
- : O
15 CD O
- : O
C NNP O
/ NNP O
H NNP O
- : O
X2 SYM O
- : O
4 CD O
- : O
C NNP O
/ NNP O
H NNP O
) ) O
. . O

The DT O
introns NNS O
are VBP O
1 CD O
. . O
6 CD O
- : O
1 CD O
. . O
9 CD O
kbp NN O
long RB O
. . O

In IN O
3 CD O
treatments NNS O
the DT O
diet NN O
was VBD O
supplemented VBN O
with IN O
0 CD O
, , O
100 CD O
and CC O
150 CD O
mg NNS O
probiotic JJ O
/ NNP O
kg NN O
food NN O
. . O

Since IN O
general JJ B-Gene
regulatory JJ I-Gene
factor NN I-Gene
I PRP I-Gene
( ( O
GRFI NNP B-Gene
) ) O
/ NN O
repressor NN B-Gene
/ NNP I-Gene
activator NN I-Gene
site NN I-Gene
binding VBG I-Gene
protein JJ I-Gene
1 CD I-Gene
( ( O
RAP1 NNP B-Gene
) ) O
/ VBZ O
translation NN B-Gene
upstream JJ I-Gene
factor NN I-Gene
( ( O
TUF NNP B-Gene
) ) O
is VBZ O
believed VBN O
to TO O
be VB O
an DT O
activator NN O
of IN O
MAT NNP B-Gene
alpha JJ I-Gene
expression NN O
, , O
we PRP O
examined VBD O
whether IN O
PYK1 NNP B-Gene
, , O
which WDT O
is VBZ O
known VBN O
to TO O
be VB O
regulated VBN O
by IN O
GRFI NNP B-Gene
/ NNP O
RAP1 NNP B-Gene
/ NNP O
TUF NNP B-Gene
, , O
is VBZ O
also RB O
affected VBN O
by IN O
the DT O
gal11 JJ B-Gene
mutation NN I-Gene
. . O

Two CD O
independent JJ O
promoters NNS O
as RB O
well RB O
as IN O
5 CD O
' POS O
untranslated JJ O
regions NNS O
regulate VBP O
Dd NNP B-Gene
ras NNS I-Gene
expression NN O
in IN O
Dictyostelium NNP O
. . O

In IN O
this DT O
study NN O
26 CD O
patients NNS O
( ( O
20 CD O
females NNS O
and CC O
6 CD O
males NNS O
) ) O
were VBD O
evaluated VBN O
. . O

Mutational JJ O
analysis NN O
of IN O
the DT O
P2 NNP B-Gene
- : I-Gene
proximal JJ I-Gene
CTCF NNP I-Gene
binding NN I-Gene
site NN I-Gene
and CC O
transient JJ O
- : O
cotransfection NN O
experiments NNS O
demonstrate VBP O
that IN O
CTCF NNP B-Gene
is VBZ O
a DT O
transcriptional JJ O
repressor NN O
of IN O
the DT O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
myc JJ I-Gene
gene NN I-Gene
. . O

The DT O
location NN O
of IN O
multiple JJ O
GRK2 NNP B-Gene
and CC O
GRK5 NNP B-Gene
phosphoacceptor NN I-Gene
sites NNS I-Gene
at IN O
the DT O
extreme JJ O
carboxyl NN O
terminus NN O
of IN O
the DT O
beta2AR NN B-Gene
is VBZ O
highly RB O
reminiscent JJ O
of IN O
GRK1 NNP B-Gene
- : O
mediated VBD O
phosphorylation NN O
of IN O
rhodopsin NN B-Gene
. . O

Yusuf NNP O
Dawood NNP O
Docrat NNP O
L NNP O
. . O
R NNP O
. . O
C NNP O
. . O
P NNP O
. . O

In IN O
the DT O
further JJ O
development NN O
of IN O
bladder NN O
neck NN O
suspension NN O
according VBG O
to TO O
Stamey NNP O
- : O
Pereyra NN O
, , O
the DT O
use NN O
of IN O
miniature NN O
bone NN O
anchors NNS O
received VBD O
considerable JJ O
support NN O
. . O

The DT O
authors NNS O
describe VBP O
the DT O
technique NN O
of IN O
transverse JJ O
axial JJ O
tomography NN O
of IN O
the DT O
spine NN O
and CC O
give VB O
a DT O
detailed JJ O
description NN O
of IN O
the DT O
axial JJ O
anatomy NN O
of IN O
the DT O
normal JJ O
lumbar NN O
spine NN O
from IN O
L NNP O
- : O
4 CD O
to TO O
the DT O
sacrum NN O
. . O

Inactivation NN O
of IN O
p53 NN B-Gene
but CC O
not RB O
p73 JJ B-Gene
by IN O
adenovirus NN B-Gene
type NN I-Gene
5 CD I-Gene
E1B NNP I-Gene
55 CD I-Gene
- : I-Gene
kilodalton NN I-Gene
and CC I-Gene
E4 NNP I-Gene
34 CD I-Gene
- : I-Gene
kilodalton NN I-Gene
oncoproteins NNS I-Gene
. . O

The DT O
intracoronary JJ O
administration NN O
of IN O
both DT O
drugs NNS O
markedly RB O
reduced VBD O
the DT O
incidence NN O
of IN O
VF NNP O
induced VBN O
by IN O
the DT O
release NN O
of IN O
a DT O
40 CD O
- : O
min NN O
coronary JJ O
artery NN O
occlusion NN O
. . O

Mutagenesis NN O
of IN O
each DT O
NRF NNP B-Gene
- : I-Gene
1 CD I-Gene
motif NN I-Gene
in IN O
the DT O
ALAS NNP B-Gene
promoter NN I-Gene
gave VBD O
substantially RB O
lowered JJ O
levels NNS O
of IN O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
expression NN O
, , O
whereas JJ O
mutagenesis NN O
of IN O
both DT O
NRF NNP B-Gene
- : I-Gene
1 CD I-Gene
motifs NNS I-Gene
resulted VBD O
in IN O
the DT O
almost RB O
complete JJ O
loss NN O
of IN O
expression NN O
. . O

The DT O
assessment NN O
using VBG O
7 CD O
H NNP O
9 CD O
liquid NN O
medium NN O
by IN O
the DT O
former JJ O
author NN O
demonstrated VBD O
the DT O
potent JJ O
activities NNS O
of IN O
both DT O
CS NNP O
- : O
940 CD O
* NN O
and CC O
sparfloxacin NN O
( ( O
SPFX NNP O
) ) O
, , O
followed VBN O
by IN O
AM NNP O
- : O
1155 CD O
* NN O
, , O
ciprofloxacin NN O
( ( O
CPFX NNP O
) ) O
, , O
levofloxacin FW O
( ( O
LVFX NNP O
) ) O
, , O
OPC NNP O
- : O
17116 CD O
* NN O
, , O
NM NNP O
- : O
394 CD O
* NN O
in IN O
sequence NN O
. . O

Identification NN O
and CC O
structure NN O
of IN O
the DT O
Marek NNP B-Gene
' POS I-Gene
s JJ I-Gene
disease NN I-Gene
virus NN I-Gene
serotype VBD I-Gene
2 CD I-Gene
glycoprotein NNS I-Gene
M NNP I-Gene
gene NN I-Gene
: : O
comparison NN O
with IN O
glycoprotein JJ B-Gene
M NNP I-Gene
genes NNS I-Gene
of IN O
Herpesviridae NNP O
family NN O
. . O

Basal NNP O
plasma VBZ O
renin NN B-Gene
activity NN O
( ( O
PRA NNP O
) ) O
was VBD O
slightly RB O
raised VBN O
prior RB O
to TO O
training NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
7 CD O
) ) O
compared VBN O
to TO O
the DT O
controls NNS O
and CC O
post NN O
- : O
training NN O
. . O

Canadian JJ O
survey NN O
reveals NNS O
widespread JJ O
dissatisfaction NN O
among IN O
physicians NNS O
. . O

During IN O
exercise NN O
K NNP O
+ NNP O
is VBZ O
released VBN O
from IN O
contracting VBG O
muscle NN O
and CC O
plasma NN O
K NNP O
+ NNP O
concentration NN O
rises NNS O
. . O

From IN O
transient JJ O
expression NN O
studies NNS O
, , O
we PRP O
could MD O
demonstrate VB O
that IN O
the DT O
SH3 NNP B-Gene
domain NN I-Gene
of IN O
PLC NNP B-Gene
- : I-Gene
gamma1 NN I-Gene
is VBZ O
necessary JJ O
for IN O
the DT O
association NN O
with IN O
SOS1 NNP B-Gene
in IN O
vivo NN O
. . O

The DT O
Saccharomyces NNPS O
cerevisiae NN O
spindle JJ O
pole NN O
body NN O
duplication NN O
gene NN B-Gene
MPS1 NNP I-Gene
is VBZ O
part NN O
of IN O
a DT O
mitotic JJ O
checkpoint NN O
. . O

D NNP O
. . O

The DT O
predominant JJ O
sensitizing NN O
allergens NNS O
in IN O
Swedish NNP O
asthmatic JJ O
children NNS O
are VBP O
furred VBN O
pet JJ O
animals NNS O
. . O

As IN O
control NN O
, , O
the DT O
cells NNS O
were VBD O
transfected VBN O
with IN O
DNA NNP O
mixtures NNS O
containing VBG O
vector NN O
mU6 SYM O
- : O
C1 NN O
or CC O
mU6 VB O
- : O
C2 NNP O
. . O

To TO O
investigate VB O
the DT O
molecular JJ O
mechanisms NN O
of IN O
this DT O
Tax NNP B-Gene
- : O
mediated VBN O
inhibition NN O
, , O
we PRP O
analyzed VBD O
its PRP$ O
effect NN O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
myogenic JJ O
MyoD NNP B-Gene
protein NN I-Gene
, , O
which WDT O
was VBD O
used VBN O
as IN O
a DT O
paradigm NN O
of IN O
bHLH JJ B-Gene
factors NNS I-Gene
. . O

Furthermore RB O
, , O
cpxA JJ B-Gene
* JJ I-Gene
mutations NNS O
suppress VBP O
the DT O
toxicity NN O
conferred VBN O
by IN O
the DT O
LamB NNP B-Gene
- : O
LacZ NNP B-Gene
hybrid JJ O
protein NN O
, , O
which WDT O
exerts VBZ O
its PRP$ O
effects NNS O
in IN O
the DT O
cytoplasm NN O
, , O
sequestered VBN O
from IN O
DegP NNP B-Gene
. . O

This DT O
study NN O
was VBD O
performed VBN O
to TO O
clarify VB O
the DT O
location NN O
of IN O
a DT O
transesophageal JJ O
echocardiographic JJ O
( ( O
TEE NNP O
) ) O
transducer NN O
when WRB O
obtaining VBG O
the DT O
short JJ O
- : O
axis JJ O
view NN O
of IN O
the DT O
left JJ O
ventricle NN O
( ( O
S NNP O
- : O
LV NN O
) ) O
. . O

74 CD O
, , O
193 CD O
- : O
197 CD O
) ) O
. . O

After IN O
PTCA NNP O
, , O
ejection NN O
fraction NN O
increased VBD O
from IN O
54 CD O
+ NNS O
/ SYM O
- : O
8 CD O
% NN O
to TO O
59 CD O
+ NNS O
/ SYM O
- : O
8 CD O
% NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
and CC O
regional JJ O
function NN O
improved VBN O
significantly RB O
( ( O
maximal JJ O
standard NN O
deviation NN O
before IN O
PTCA NNP O
: : O
2 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
; : O
after IN O
PTCA NNP O
: : O
1 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
- : O
segments NNS O
below IN O
the DT O
first JJ O
standard JJ O
deviation NN O
before IN O
PTCA NNP O
: : O
31 CD O
+ NN O
/ NNP O
- : O
16 CD O
; : O
after IN O
PTCA NNP O
: : O
19 CD O
+ NN O
/ NNP O
- : O
17 CD O
) ) O
. . O

In IN O
vitro JJ O
studies NNS O
with IN O
blood NN O
cells NNS O
incubated VBN O
with IN O
acetate NN O
or CC O
bicarbonate NN O
ions NNS O
in IN O
concentrations NNS O
, , O
which WDT O
are VBP O
observed VBN O
in IN O
vivo NN O
during IN O
hemodialysis NN O
, , O
suggest VBP O
that IN O
probably RB O
these DT O
ions NNS O
do VBP O
not RB O
directly RB O
affect JJ O
superoxide NN O
anions NNS O
generation NN O
, , O
erythrocyte JJ O
SOD NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
catalase NN B-Gene
activities NNS O
and CC O
erythrocyte JJ O
membrane NN O
lipid JJ O
peroxidation NN O
. . O

Furthermore RB O
, , O
freezing VBG O
in IN O
the DT O
presence NN O
of IN O
bovine NN B-Gene
lactalbumin NN I-Gene
resulted VBD O
in IN O
a DT O
good JJ O
maintenance NN O
of IN O
the DT O
cellular JJ O
viability NN O
and CC O
of IN O
the DT O
CCCD NNP O
heterogeneity NN O
in IN O
respect NN O
to TO O
fresh JJ O
cells NNS O
. . O

Vacuum NNP O
Rabi NNP O
splitting NN O
as IN O
a DT O
feature NN O
of IN O
linear JJ O
- : O
dispersion NN O
theory NN O
: : O
Analysis NN O
and CC O
experimental JJ O
observations NNS O
. . O

This DT O
review NN O
summarizes VBZ O
the DT O
clinical JJ O
evidence NN O
to TO O
support VB O
current JJ O
therapies NNS O
in IN O
irritable JJ O
bowel NN O
syndrome NN O
( ( O
IBS NNP O
) ) O
. . O

Teratological NNP O
study NN O
of IN O
etoperidone NN O
in IN O
the DT O
rat NN O
and CC O
rabbit NN O
. . O

Therefore RB O
, , O
it PRP O
would MD O
be VB O
advantageous JJ O
to TO O
identify VB O
such JJ O
persons NNS O
and CC O
treat VB O
them PRP O
preferentially RB O
. . O

Third NNP O
- : O
and CC O
later RB O
- : O
parity NN O
cows NNS O
were VBD O
randomly RB O
assigned VBN O
after IN O
each DT O
parturition NN O
to TO O
Charolais NNP O
and CC O
Red NNP O
Poll NNP O
bulls VBZ O
in IN O
multiple JJ O
- : O
sire NN O
pastures NNS O
. . O

To TO O
investigate VB O
the DT O
mechanisms NNS O
involved VBN O
in IN O
the DT O
transcriptional JJ O
control NN O
of IN O
retinoid JJ B-Gene
X NNP I-Gene
receptor NN I-Gene
( ( O
RXR NNP B-Gene
) ) O
gene NN O
expression NN O
, , O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Gene
RXRgamma2 NNP I-Gene
isoform NN I-Gene
was VBD O
characterized VBN O
. . O

These DT O
include VBP O
the DT O
CACCC NNP O
and CC O
CAAT NNP O
motifs NNS O
. . O

The DT O
present JJ O
study NN O
was VBD O
designed VBN O
to TO O
evaluate VB O
the DT O
sensitivity NN O
and CC O
specificity NN O
of IN O
AMP NNP O
CT NNP O
( ( O
Gen NNP O
- : O
Probe NN O
Incorporated NNP O
, , O
San NNP O
Diego NNP O
, , O
CA NNP O
, , O
USA NNP O
) ) O
on IN O
urogenital JJ O
specimens NNS O
taken VBN O
from IN O
symptomatic JJ O
patients NNS O
and CC O
on IN O
first JJ O
void JJ O
urine NN O
( ( O
FVU NNP O
) ) O
specimens VBZ O
from IN O
asymptomatic JJ O
patients NNS O
. . O

Therefore RB O
, , O
we PRP O
propose VBP O
that IN O
p27 NN B-Gene
represents VBZ O
a DT O
crucial JJ O
molecule NN O
in IN O
HMBA NNP O
signaling VBG O
that IN O
cannot NN O
be VB O
replaced VBN O
by IN O
p21 NN B-Gene
. . O

The DT O
debate NN O
over IN O
electives NNS O
- : O
- : O
1899 CD O
. . O

Two CD O
differentially RB O
expressed VBN O
LNX NNP B-Gene
messages NNS I-Gene
encode VBP O
overlapping VBG O
proteins NNS O
with IN O
predicted JJ O
molecular JJ O
masses NNS O
of IN O
80 CD B-Gene
kDa NNS I-Gene
( ( I-Gene
LNX NNP I-Gene
) ) I-Gene
and CC O
70 CD B-Gene
kDa NN I-Gene
( ( I-Gene
LNX NNP I-Gene
- : I-Gene
b NN I-Gene
) ) I-Gene
. . O

The DT O
application NN O
of IN O
ISH NNP O
and CC O
IHC NNP O
did VBD O
not RB O
change VB O
significantly RB O
the DT O
routine JJ O
histologic NN O
classification NN O
of IN O
pneumonias NN O
into IN O
CMV NNP O
- : O
IP NN O
and CC O
IIP NNP O
. . O

A DT O
decrease NN O
of IN O
erythrocyte JJ O
Mn NNP O
with IN O
age NN O
, , O
expressed VBN O
in IN O
nmol JJ O
/ NNP O
L NNP O
, , O
was VBD O
noted VBN O
( ( O
p JJ O
< NN O
0 CD O
. . O
2 CD O
) ) O
. . O

No DT O
differences NNS O
in IN O
fixation NN O
quality NN O
were VBD O
observed VBN O
between IN O
cochleas NNS O
fixed VBN O
by IN O
intravascular JJ O
perfusion NN O
and CC O
cochleas NNS O
fixed VBN O
by IN O
intralabyrinthine JJ O
perfusion NN O
. . O

We PRP O
show VBP O
that IN O
p73 NN B-Gene
can MD O
transcriptionally RB O
inhibit VB O
a DT O
number NN O
of IN O
cellular JJ O
and CC O
viral JJ O
promoters NNS O
. . O

In IN O
transient JJ O
analysis NN O
using VBG O
particle JJ O
bombardment NN O
of IN O
tobacco NN O
leaf NN O
sections NNS O
, , O
a DT O
tetramer NN O
of IN O
the DT O
distB NN O
ABRE NNP O
( ( O
abscisic JJ O
acid NN O
- : O
responsive JJ O
element NN O
) ) O
mediated VBD O
transactivation NN O
by IN O
ABI3 NNP B-Gene
and CC O
ABI3 NNP B-Gene
- : O
dependent JJ O
response NN O
to TO O
ABA NNP O
, , O
whereas IN O
a DT O
tetramer NN O
of IN O
the DT O
composite JJ O
RY NNP O
/ NNP O
G NNP O
complex NN O
, , O
containing VBG O
RY NNP O
repeats NNS O
and CC O
a DT O
G NNP O
- : O
box NN O
, , O
mediated VBD O
only RB O
ABA NNP O
- : O
independent JJ O
transactivation NN O
by IN O
ABI3 NNP B-Gene
. . O

Underestimations NNS O
by IN O
as RB O
much JJ O
as IN O
35 CD O
% NN O
may MD O
occur VB O
due JJ O
to TO O
the DT O
problems NNS O
in IN O
the DT O
existing VBG O
methodologies NNS O
. . O

A DT O
total NN O
of IN O
25 CD O
patients NNS O
with IN O
malignant JJ O
brain NN O
tumours NNS O
were VBD O
investigated VBN O
. . O

Chem NNP O
. . O
, , O
270 CD O
: : O
7117 CD O
- : O
7124 CD O
, , O
1995 CD O
; : O
and CC O
MT NNP O
Hartsough NNP O
et FW O
al NN O
. . O
, , O
J NNP O
. . O

A DT O
rare JJ O
chronic JJ O
course NN O
of IN O
Budd NNP O
- : O
Chiari NNP O
syndrome NN O
associated VBN O
with IN O
thrombosis NN O
of IN O
the DT O
portal JJ O
vein NN O
was VBD O
observed VBN O
in IN O
a DT O
30 CD O
- : O
year NN O
- : O
old JJ O
male JJ O
patient NN O
suffering VBG O
from IN O
postmyocarditic JJ O
cardiosclerosis NN O
. . O

We PRP O
report VBP O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
myr NN B-Gene
4 CD I-Gene
( ( O
myosin NN B-Gene
from IN I-Gene
rat NN I-Gene
) ) O
, , O
the DT O
first JJ O
mammalian JJ B-Gene
myosin NN I-Gene
I PRP I-Gene
that WDT O
is VBZ O
not RB O
closely RB O
related VBN O
to TO O
brush VB O
border NN O
myosin NN B-Gene
I PRP I-Gene
. . O

A DT O
review NN O
of IN O
the DT O
literature NN O
identified VBD O
8 CD O
comprehensive JJ O
clinical JJ O
studies NNS O
, , O
all DT O
of IN O
which WDT O
failed VBD O
to TO O
document VB O
any DT O
relationship NN O
between IN O
NF1 NNP B-Gene
and CC O
intracranial JJ O
aneurysms NNS O
. . O

The DT O
deduced JJ O
amino NN O
acid NN O
sequence NN O
exhibited VBD O
98 CD O
% NN O
identity NN O
to TO O
the DT O
human JJ O
cellular JJ O
transglutaminase NN O
sequence NN O
. . O

J NNP O
. . O

A DT O
new JJ O
species NNS O
of IN O
Euspondylus NNP O
is VBZ O
described VBN O
based VBN O
on IN O
a DT O
female NN O
( ( O
taken VBN O
within IN O
a DT O
bromeliad NN O
) ) O
from IN O
Cerro NNP O
El NNP O
Humo NNP O
, , O
Sucre NNP O
, , O
northeastern JJ O
Venezuela NNP O
. . O

Expression NN O
of IN O
a DT O
novel JJ O
murine NN B-Gene
phospholipase NN I-Gene
D NNP I-Gene
homolog NN I-Gene
coincides NNS O
with IN O
late JJ O
neuronal JJ O
development NN O
in IN O
the DT O
forebrain NN O
. . O

( ( O
iii NN O
) ) O
The DT O
mRNA NN O
is VBZ O
not RB O
efficiently RB O
polyadenylated VBN O
at IN O
sequences NNS O
in IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
DHFR NNP B-Gene
cDNA NN I-Gene
but CC O
rather RB O
uses VBZ O
polyadenylation NN O
signals NNS O
downstream VBP O
from IN O
the DT O
DHFR NNP B-Gene
cDNA NN I-Gene
. . O

The DT O
glomerular JJ O
filtration NN O
rate NN O
and CC O
effective JJ O
renal JJ O
plasma NN O
flow NN O
were VBD O
determined VBN O
by IN O
a DT O
standard JJ O
clearance NN O
method NN O
, , O
employing VBG O
continuous JJ O
infusion NN O
of IN O
inulin NN O
and CC O
para NN O
- : O
aminohippuric JJ O
acid NN O
. . O

Moreover RB O
, , O
a DT O
recombinant JJ O
Ad NNP O
expressing NN O
Ad5 NNP B-Gene
E4orf6 NNP I-Gene
/ VBD I-Gene
7 CD I-Gene
induced JJ O
apoptosis NN O
in IN O
rat NN O
cells NNS O
when WRB O
coinfected VBN O
with IN O
wild JJ O
- : O
type NN O
p53 NN B-Gene
- : O
expressing NN O
Ad NN O
. . O

Dosimetric NNP O
estimates NNS O
for IN O
these DT O
organs NNS O
were VBD O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
1 CD O
and CC O
2 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
rad NN O
( ( O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
. . O
1 CD O
Gy NNP O
) ) O
, , O
respectively RB O
, , O
with IN O
a DT O
whole JJ O
- : O
body NN O
estimate NN O
of IN O
0 CD O
. . O
28 CD O
rad NN O
( ( O
. . O
3 CD O
Gy NNP O
) ) O
. . O

Only RB O
two CD O
of IN O
27 CD O
participants NNS O
( ( O
7 CD O
. . O
4 CD O
% NN O
) ) O
with IN O
definite JJ O
POAG NNP O
had VBD O
been VBN O
previously RB O
diagnosed VBN O
and CC O
treated VBN O
, , O
and CC O
66 CD O
. . O
7 CD O
% NN O
of IN O
the DT O
previously RB O
undiagnosed VBN O
had VBD O
IOP NNP O
less JJR O
than IN O
22 CD O
mmHg NN O
. . O

The DT O
PAI NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
is VBZ O
one CD O
of IN O
the DT O
most RBS O
TNF NNP B-Gene
- : I-Gene
responsive JJ I-Gene
genes NNS I-Gene
known VBN O
and CC O
is VBZ O
also RB O
highly RB O
induced VBN O
by IN O
the DT O
phorbol NN O
ester NN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
and CC O
the DT O
phosphatase NN O
inhibitor NN O
, , O
okadaic JJ O
acid NN O
, , O
in IN O
both DT O
HT NNP O
- : O
1080 CD O
fibrosarcoma NN O
and CC O
U NNP O
- : O
937 CD O
histiocytic JJ O
cells NNS O
. . O

Secretion NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
8 CD I-Gene
, , O
RANTES NNP B-Gene
, , O
macrophage NN B-Gene
inflammatory JJ I-Gene
protein NN I-Gene
1alpha CD I-Gene
, , O
and CC O
10 CD B-Gene
- : I-Gene
kappaDa NN I-Gene
IFN NNP I-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
inducible JJ I-Gene
protein NN I-Gene
were VBD O
increased VBN O
in IN O
differentiating VBG O
keratinocytes NNS O
by IN O
E6 NNP B-Gene
. . O

The DT O
preferences NNS O
were VBD O
for IN O
intact JJ O
vis FW O
- : O
a DT O
- : O
vis NN O
castrated VBD O
males NNS O
, , O
though IN O
injections NNS O
of IN O
TP NNP O
restored VBD O
the DT O
castrates NNS O
' POS O
attractiveness NN O
to TO O
the DT O
females NNS O
. . O

DESIGN NN O
: : O
Prospective JJ O
, , O
randomized VBN O
, , O
double JJ O
- : O
blind NN O
, , O
controlled VBN O
trial NN O
. . O

The DT O
physical JJ O
and CC O
chemical JJ O
stability NN O
of IN O
a DT O
combination NN O
of IN O
drugs NNS O
commonly RB O
administered VBD O
into IN O
the DT O
epidural JJ O
or CC O
intrathecal JJ O
space NN O
for IN O
the DT O
treatment NN O
of IN O
chronic JJ O
pain NN O
was VBD O
investigated VBN O
. . O

Together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
the DT O
carboxyl JJ O
terminus NN O
of IN O
CFTR NNP B-Gene
contains VBZ O
a DT O
tyrosine NN O
- : O
based VBN O
internalization NN O
signal NN O
that WDT O
interacts VBZ O
with IN O
the DT O
endocytic JJ O
adaptor NN O
complex JJ O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
to TO O
facilitate VB O
efficient JJ O
entry NN O
of IN O
CFTR NNP B-Gene
into IN O
clathrin JJ B-Gene
- : O
coated JJ O
vesicles NNS O
. . O

Role NNP O
of IN O
the DT O
infectious JJ O
- : O
disease NN O
specialist NN O
of IN O
a DT O
polyclinic NN O
in IN O
reducing VBG O
the DT O
incidence NN O
of IN O
communicable JJ O
diseases NNS O

From IN O
these DT O
results NNS O
, , O
it PRP O
is VBZ O
concluded VBN O
that IN O
EDLF NNP O
has VBZ O
clear JJ O
vasoconstrictor NN O
properties NNS O
which WDT O
are VBP O
not RB O
due JJ O
to TO O
adrenergic VB O
or CC O
calcium VB O
entry NN O
mechanisms NNS O
and CC O
that IN O
there EX O
are VBP O
differences NNS O
in IN O
the DT O
vasoconstrictor NN O
effects NNS O
of IN O
EDLFs NNP O
with IN O
respect NN O
to TO O
different JJ O
vascular JJ O
beds NNS O
. . O

A DT O
5 CD B-Gene
. . I-Gene
8S CD I-Gene
- : I-Gene
like IN I-Gene
structure NN I-Gene
is VBZ O
present JJ O
within IN O
the DT O
5 CD O
' POS O
- : O
terminal JJ O
region NN O
of IN O
all DT O
three CD O
fungal JJ B-Gene
mitochondrial JJ I-Gene
LSU NNP I-Gene
rRNAs NN I-Gene
; : O
in IN O
contrast NN O
, , O
no DT O
4 CD B-Gene
. . I-Gene
5S CD I-Gene
- : I-Gene
like IN I-Gene
structure NN I-Gene
is VBZ O
evident JJ O
at IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
these DT O
molecules NNS O
. . O

Scapulae NNP O
with IN O
a DT O
Type NN O
I PRP O
configuration VBP O
were VBD O
found VBN O
to TO O
have VB O
low JJ O
values NNS O
for IN O
the DT O
coraco NN O
- : O
glenoid NN O
angle NN O
and CC O
coracoid NN O
overlap NN O
, , O
which WDT O
are VBP O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
short JJ O
coraco NN O
- : O
humeral JJ O
distance NN O
. . O

Age NNP O
> NNP O
/ NNP O
= VBZ O
50 CD O
years NNS O
( ( O
odds NNS O
ratio VBP O
[ CD O
OR NNP O
] NNP O
, , O
14 CD O
. . O
1 CD O
) ) O
, , O
BMI NNP O
> NNP O
/ NNP O
= VBD O
28 CD O
kg NN O
/ NNP O
m NN O
( ( O
2 CD O
) ) O
( ( O
OR NNP O
, , O
5 CD O
. . O
7 CD O
) ) O
, , O
triglycerides VBZ O
> NNP O
/ NNP O
= VBD O
1 CD O
. . O
7 CD O
mmol JJ O
/ NN O
L NNP O
( ( O
OR NNP O
, , O
5 CD O
) ) O
, , O
and CC O
alanine JJ B-Gene
aminotransferase NN I-Gene
( ( O
ALT NNP B-Gene
) ) O
> VBP O
/ JJ O
= $ O
2N CD O
( ( O
OR NNP O
, , O
4 CD O
. . O
6 CD O
) ) O
were VBD O
independently RB O
associated VBN O
with IN O
septal JJ O
fibrosis NN O
. . O

Adding VBG O
10 CD O
mmol JJ O
SDS NNP O
/ NNP O
l NN O
led VBD O
to TO O
transient VB O
inhibition NN O
of IN O
acidification NN O
, , O
metal JJ O
solubilization NN O
and CC O
sulfur JJ O
oxidation NN O
. . O

Virol NNP O
. . O

A DT O
Chinese JJ O
( ( O
HK NNP O
) ) O
SF NNP O
- : O
36 CD O
survey NN O
form NN O
was VBD O
developed VBN O
by IN O
an DT O
iterative JJ O
translation NN O
process NN O
. . O

Studies NNS O
of IN O
MPO NNP B-Gene
gene NN I-Gene
regulation NN O
can MD O
help VB O
to TO O
elucidate VB O
the DT O
mechanism NN O
of IN O
normal JJ O
and CC O
abnormal JJ O
myeloid NN O
differentiation NN O
. . O

The DT O
predicted JJ O
receptor NN O
structure NN O
includes VBZ O
a DT O
cysteine NN O
- : O
rich JJ O
extracellular JJ O
domain NN O
, , O
a DT O
single JJ O
hydrophobic NN O
transmembrane NN O
domain NN O
, , O
and CC O
a DT O
predicted JJ O
cytoplasmic JJ B-Gene
serine NN I-Gene
/ NNP I-Gene
threonine NN I-Gene
kinase NN I-Gene
domain NN I-Gene
. . O

In IN O
particular JJ O
, , O
the DT O
potential NN O
for IN O
prostate NN O
cancer NN O
chemoprevention NN O
using VBG O
nonsteroidal JJ O
anti SYM O
- : O
inflammatory NN O
drugs NNS O
( ( O
cyclo SYM B-Gene
- : I-Gene
oxygenase NN I-Gene
inhibitors NNS O
; : O
NSAIDs NNP O
) ) O
has VBZ O
received VBN O
little JJ O
attention NN O
. . O

Rigid JJ O
point NN O
feature NN O
registration NN O
using VBG O
mutual JJ O
information NN O
. . O

Some DT O
studies NNS O
of IN O
exercise NN O
have VBP O
associated VBN O
beta SYM B-Gene
- : I-Gene
endorphin JJ I-Gene
release NN O
with IN O
increased JJ O
exertion NN O
levels NNS O
, , O
but CC O
other JJ O
evidence NN O
suggests VBZ O
that IN O
acidosis NN O
may MD O
stimulate VB O
the DT O
release NN O
of IN O
beta NN B-Gene
- : I-Gene
endorphin NN I-Gene
. . O

We PRP O
detected VBD O
mos NNS B-Gene
transcripts NNS I-Gene
by IN O
Northern NNP O
( ( O
RNA NNP O
) ) O
analyses VBZ O
in IN O
RNA NNP O
prepared VBD O
from IN O
chicken NN O
and CC O
quail NN O
ovaries NNS O
and CC O
testes NNS O
. . O

Fasting VBG O
gastrin NN B-Gene
levels NNS O
( ( O
normal JJ O
range NN O
: : O
25 CD O
- : O
110 CD O
mU NN O
/ NNP O
L NNP O
) ) O
varied VBD O
from IN O
48 CD O
. . O
78 CD O
mU JJ O
/ NNP O
L NNP O
- : O
168 CD O
. . O
20 CD O
( ( O
mean NN O
: : O
85 CD O
. . O
23 CD O
mU JJ O
/ NNP O
L NNP O
) ) O
. . O

The DT O
intron NN O
is VBZ O
capable JJ O
of IN O
splicing VBG O
despite IN O
the DT O
fact NN O
that IN O
both DT O
the DT O
EBS1 NNP B-Gene
/ NNP O
IBS1 NNP B-Gene
and CC O
the DT O
EBS2 NNP B-Gene
/ NNP O
IBS2 NNP B-Gene
sequence NN O
motifs NNS O
, , O
thought VBN O
to TO O
be VB O
necessary JJ O
for IN O
correct JJ O
splicing NN O
, , O
extend VBP O
over IN O
5 CD O
instead RB O
of IN O
6 CD O
bp NN O
. . O

Tih1 NNP B-Gene
maps NNS O
to TO O
distal VB O
mouse NN O
Chr NNP O
1 CD O
and CC O
human JJ O
Chr NNP O
1q31 CD O
, , O
chromosomal JJ O
regions NNS O
that WDT O
have VBP O
not RB O
shown VBN O
evidence NN O
for IN O
imprinting NN O
and CC O
, , O
in IN O
contrast NN O
to TO O
Ipl NNP B-Gene
, , O
Tih1 NNP B-Gene
is VBZ O
expressed VBN O
equally RB O
from IN O
both DT O
parental JJ O
alleles NNS O
. . O

The DT O
cloned VBN O
alcR NN B-Gene
gene NN I-Gene
provided VBN O
in IN O
trans NNS O
restored VBN O
these DT O
siderophore NN O
system NN O
activities NNS O
to TO O
the DT O
mutants NNS O
. . O

The DT O
cloned VBN O
alcR NN B-Gene
gene NN I-Gene
provided VBN O
in IN O
trans NNS O
restored VBN O
these DT O
siderophore NN O
system NN O
activities NNS O
to TO O
the DT O
mutants NNS O
. . O

Hyaluronan NNP O
treatment NN O
stimulated VBD O
collagen NN B-Gene
remodeling NN O
in IN O
the DT O
peripheral JJ O
region NN O
and CC O
inhibited VBD O
swelling NN O
of IN O
the DT O
meniscus NN O
repaired VBD O
in IN O
the DT O
inner JJ O
region NN O
. . O

Thalamotomy NN O
aiming VBG O
at IN O
the DT O
CM NNP O
- : O
Pf NN O
complex NN O
and CC O
using VBG O
stereotactic JJ O
gamma NN O
irradiation NN O
has VBZ O
been VBN O
performed VBN O
in IN O
a DT O
series NN O
of IN O
52 CD O
patients NNS O
with IN O
severe JJ O
pain NN O
due JJ O
to TO O
malignancy NN O
. . O

After IN O
the DT O
first JJ O
cycle NN O
, , O
18 CD O
cases NNS O
were VBD O
treated VBN O
at IN O
dose JJ O
level NN O
1 CD O
, , O
after IN O
a DT O
second JJ O
cycle NN O
, , O
13 CD O
cases NNS O
were VBD O
treated VBN O
at IN O
dose JJ O
level NN O
2 CD O
. . O

This DT O
protein NN O
encoded VBN O
by IN O
this DT O
cDNA NN O
, , O
which WDT O
we PRP O
have VBP O
termed VBN O
p150TSP NN B-Gene
( ( O
for IN O
TPR NNP O
- : O
containing NN O
, , O
SH2 NNP B-Gene
- : I-Gene
binding VBG I-Gene
phosphoprotein NN I-Gene
) ) O
, , O
is VBZ O
located VBN O
predominantly RB O
in IN O
the DT O
nucleus NN O
and CC O
is VBZ O
highly RB O
conserved VBN O
in IN O
evolution NN O
. . O

The DT O
cloning NN O
of IN O
PTR2 NNP B-Gene
represents VBZ O
the DT O
first JJ O
example NN O
of IN O
the DT O
molecular JJ O
genetic JJ O
characterization NN O
of IN O
a DT O
eucaryotic JJ O
peptide NN O
transport NN O
gene NN O
. . O

Activity NN O
of IN O
palgD NN B-Gene
in IN O
the DT O
cysB NN B-Gene
mutant NN I-Gene
, , O
in IN O
CHA NNP O
and CC O
in IN O
the DT O
non JJ O
- : O
mucoid NN O
strain NN O
PAO NNP O
was VBD O
assessed VBN O
by IN O
the DT O
use NN O
of IN O
a DT O
transcriptional JJ O
algD NN B-Gene
- : O
xylE JJ B-Gene
fusion NN O
. . O

OBJECTIVE NN O
: : O
This DT O
study NN O
was VBD O
conducted VBN O
to TO O
assess VB O
the DT O
relative JJ O
roles NNS O
of IN O
99mTc CD O
- : O
sestamibi NN O
scintimammography NN O
and CC O
sonography NN O
in IN O
the DT O
evaluation NN O
of IN O
breast NN O
lesions NNS O
that WDT O
are VBP O
indeterminate JJ O
or CC O
suspicious JJ O
on IN O
mammography NN O
or CC O
clinical JJ O
examination NN O
. . O

The DT O
9 CD O
; : O
22 CD O
chromosomal JJ O
translocation NN O
characteristic NN O
of IN O
CML NNP O
results NNS O
in IN O
a DT O
fused JJ O
bcr NN B-Gene
/ NNP O
abl VBZ B-Gene
gene NN O
and CC O
an DT O
abnormal JJ O
fusion NN O
protein NN O
, , O
p210bcr JJ B-Gene
/ NNP O
abl NN B-Gene
. . O

The DT O
neurohypophysial JJ O
vasopressin NN B-Gene
and CC O
oxytocin JJ B-Gene
content NN O
was VBD O
bioassayed VBN O
by IN O
pressor NN O
effect NN O
following VBG O
Dekanski NNP O
or CC O
milk NN O
- : O
ejection NN O
activity NN O
in IN O
vitro NN O
following VBG O
van NN O
Dongen NNP O
and CC O
Hays NNP O
, , O
respectively RB O
. . O

Coronary NNP O
flow NN O
was VBD O
reduced VBN O
by IN O
10 CD O
% NN O
in IN O
the DT O
phosphocreatine NN O
and CC O
by IN O
18 CD O
% NN O
in IN O
the DT O
control NN O
group NN O
. . O

Intraoperative JJ O
measurement NN O
of IN O
activated VBN O
partial JJ O
thromboplastin NN B-Gene
time NN O
and CC O
prothrombin JJ B-Gene
time NN O
with IN O
a DT O
new JJ O
compact JJ O
monitor NN O
. . O

We PRP O
suggest VBP O
that IN O
apart RB O
from IN O
the DT O
World NNP O
Summit NNP O
for IN O
Children NNP O
' POS O
s NN O
under IN O
- : O
five CD O
mortality NN O
target NN O
for IN O
the DT O
year NN O
2000 CD O
, , O
intraregional JJ O
targets NNS O
to TO O
reduce VB O
geographical JJ O
inequalities NNS O
in IN O
under IN O
- : O
five CD O
mortality NN O
should MD O
be VB O
specified VBN O
. . O

Sequence NNP O
comparison NN O
and CC O
binding VBG O
studies NNS O
of IN O
the DT O
18 CD B-Gene
- : I-Gene
bp NN I-Gene
MOK2 NNP I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
present VBP O
in IN O
intron NN O
2 CD O
of IN O
human NN O
, , O
bovine NN O
, , O
and CC O
mouse VB B-Gene
IRBP NNP I-Gene
genes NNS I-Gene
show VBP O
that IN O
the DT O
3 CD O
' POS O
- : O
half NN O
sequence NN O
is VBZ O
the DT O
essential JJ O
core NN O
element NN O
for IN O
MOK2 NNP B-Gene
binding NN O
. . O

Of IN O
the DT O
43 CD O
infants NNS O
with IN O
a DT O
( ( O
probable JJ O
) ) O
loss NN O
18 CD O
were VBD O
examined VBN O
again RB O
at IN O
3 CD O
months NNS O
corrected VBN O
age NN O
. . O

The DT O
polyubiquitin NN B-Gene
gene NN I-Gene
was VBD O
transcribed VBN O
throughout IN O
the DT O
Volvox NNP O
life NN O
cycle NN O
with IN O
peaks NNS O
in IN O
the DT O
1 CD O
. . O
6 CD O
- : O
kb NN O
mRNA NN O
levels NNS O
during IN O
pre NN O
- : O
cleavage NN O
, , O
cleavage NN O
, , O
and CC O
post SYM O
- : O
inversion NN O
. . O

The DT O
ICBF NNP O
in IN O
the DT O
ischaemic JJ O
cortex NN O
revealed VBD O
a DT O
graded JJ O
reduction NN O
from IN O
the DT O
ischaemic JJ O
centre NN O
to TO O
the DT O
surrounding VBG O
tissues NNS O
. . O

The DT O
effect NN O
of IN O
food NN O
on IN O
procainamide NN O
absorption NN O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
TATA NNP O
element NN O
is VBZ O
critical JJ O
for IN O
basal NN O
and CC O
Tat NNP B-Gene
- : O
induced VBD O
HIV NNP O
- : O
1 CD O
gene NN O
expression NN O
. . O

Role NNP O
of IN O
NH NNP O
( ( O
2 CD O
) ) O
- : O
and CC O
COOH NNP O
- : O
terminal JJ O
domains NNS O
of IN O
the DT O
P NNP B-Gene
protein NN I-Gene
of IN O
human JJ O
parainfluenza NN O
virus NN O
type NN O
3 CD O
in IN O
transcription NN O
and CC O
replication NN O
. . O

Pharmacokinetic NNP O
profile NN O
of IN O
clonazepam NN O
in IN O
rhesus NN O
monkeys NNS O
. . O

She PRP O
also RB O
had VBD O
slight JJ O
weakness NN O
of IN O
the DT O
upper JJ O
extremities NNS O
. . O

Furthermore RB O
the DT O
median JJ O
increase NN O
in IN O
cyclosporine JJ O
DR NNP O
/ NNP O
C NNP O
( ( O
SS NNP O
trough RB O
) ) O
was VBD O
18 CD O
l NN O
h NN O
- : O
1 CD O
( ( O
- : O
3 CD O
. . O
1 CD O
to TO O
42 CD O
. . O
1 CD O
l NN O
h NN O
- : O
1 CD O
, , O
interquartile JJ O
range NN O
) ) O
. . O

The DT O
structure NN O
of IN O
the DT O
calcineurin NN B-Gene
A NNP I-Gene
gene NN I-Gene
was VBD O
determined VBN O
by IN O
comparison NN O
of IN O
the DT O
genomic JJ O
and CC O
cDNA JJ O
sequences NNS O
. . O

The DT O
small JJ O
size NN O
and CC O
placement NN O
of IN O
the DT O
mutagenesis NN O
marker NN O
( ( O
the DT O
supF NN B-Gene
suppressor NN I-Gene
tRNA JJ I-Gene
gene NN I-Gene
from IN I-Gene
Escherichia NNP I-Gene
coli NN I-Gene
) ) O
within IN O
the DT O
vector NN O
substantially RB O
reduced VBD O
the DT O
frequency NN O
of IN O
spontaneous JJ O
mutations NNS O
normally RB O
observed VBD O
after IN O
transfection NN O
of IN O
mammalian JJ O
cells NNS O
with IN O
plasmid JJ O
DNA NNP O
; : O
hence NN O
, , O
UV NNP O
- : O
induced JJ O
mutations NNS O
were VBD O
easily RB O
identified VBN O
above IN O
the DT O
spontaneous JJ O
background NN O
. . O

Rams NNS O
were VBD O
weighed VBN O
and CC O
testis JJ O
size NN O
was VBD O
estimated VBN O
by IN O
orchimetry NN O
at IN O
each DT O
time NN O
period NN O
. . O

Thus RB O
, , O
the DT O
pol NN B-Gene
alpha SYM I-Gene
- : O
primase NN B-Gene
complex JJ O
appears VBZ O
to TO O
act VB O
processively RB O
for IN O
only RB O
a DT O
short JJ O
distance NN O
. . O

Of IN O
254 CD O
children NNS O
with IN O
neuroblastoma NN O
treated VBN O
at IN O
St NNP O
. . O

CONCLUSION NN O
: : O
Human JJ O
preterm NN O
birth NN O
is VBZ O
associated VBN O
with IN O
significantly RB O
lower JJR O
progesterone NN O
/ VBD O
17 CD O
beta NN O
- : O
estradiol NN O
ratios NNS O
than IN O
those DT O
of IN O
women NNS O
with IN O
preterm JJ O
labor NN O
delivered VBN O
at IN O
term NN O
. . O

That DT O
of IN O
the DT O
T2 NNP B-Gene
gene NN I-Gene
contains VBZ O
numerous JJ O
potential JJ O
sites NNS O
for IN O
binding VBG O
the DT O
mammalian JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
SP1 NNP I-Gene
, , O
but CC O
no DT O
TATA NNP O
or CC O
CCAAT NNP O
sequences NNS O
are VBP O
evident JJ O
near IN O
to TO O
its PRP$ O
5 CD O
' '' O
end NN O
, , O
although IN O
these DT O
latter JJ O
features NNS O
are VBP O
associated VBN O
with IN O
the DT O
human JJ B-Gene
T1 NNP I-Gene
gene NN I-Gene
. . O

ATF1 NNP B-Gene
transcription NN O
is VBZ O
negatively RB O
regulated VBN O
by IN O
unsaturated JJ O
fatty JJ O
acids NNS O
and CC O
oxygen NN O
. . O

Inverse JJ O
relation NN O
between IN O
serum NN O
IgG NNP B-Gene
concentration NN O
and CC O
glucose NN O
and CC O
xylose JJ O
absorption NN O
in IN O
Zambian JJ O
African NNP O
adults NNS O
. . O

In IN O
HeLa NNP O
cells NNS O
, , O
it PRP O
activated VBD O
transcription NN O
from IN O
the DT O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
thymidine NN I-Gene
kinase NN I-Gene
promoter NN I-Gene
linked VBN O
to TO O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
gene NN I-Gene
when WRB O
located VBN O
in IN O
inverted JJ O
orientation NN O
upstream NN O
of IN O
the DT O
thymidine JJ B-Gene
kinase NN I-Gene
promoter NN I-Gene
or CC O
downstream NN O
of IN O
the DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
gene NN I-Gene
coding VBG I-Gene
sequence NN I-Gene
. . O

Also RB O
, , O
component NN O
I PRP O
significantly RB O
correlated VBD O
with IN O
fasting JJ O
insulin NN B-Gene
and CC O
VO2 NNP O
max NN O
for IN O
both DT O
sexes NNS O
and CC O
with IN O
basal JJ O
metabolism NN O
and CC O
HDL NNP B-Gene
- : I-Gene
cholesterol NN I-Gene
for IN O
females NNS O
and CC O
males NNS O
, , O
respectively RB O
. . O

Various JJ O
mutant JJ B-Gene
HN NNP I-Gene
genes NNS I-Gene
were VBD O
constructed VBN O
to TO O
examine VB O
the DT O
role NN O
of IN O
residues NNS O
flanking VBG O
the DT O
signal JJ O
- : O
anchor NN O
domain NN O
, , O
including VBG O
the DT O
cytoplasmic JJ O
tail NN O
, , O
on IN O
assembly NN O
and CC O
intracellular JJ O
transport NN O
of IN O
the DT O
HN NNP B-Gene
glycoprotein NN I-Gene
. . O

In IN O
this DT O
article NN O
, , O
the DT O
clinical JJ O
actions NNS O
of IN O
the DT O
principal JJ O
dopamine NN B-Gene
receptor NN I-Gene
stimulating VBG O
agents NNS O
( ( O
apomorphine NN O
and CC O
its PRP$ O
derivatives NNS O
; : O
piribedil NN O
, , O
rye VB O
- : O
ergot NN O
derivatives NNS O
) ) O
are VBP O
discussed VBN O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
biochemical JJ O
and CC O
pharmacological JJ O
properties NNS O
. . O

To TO O
assess VB O
the DT O
health NN O
significance NN O
of IN O
the DT O
early JJ O
renal NN O
changes NNS O
after IN O
chronic JJ O
exposure NN O
to TO O
cadmium VB O
, , O
23 CD O
workers NNS O
removed VBN O
from IN O
exposure NN O
because IN O
of IN O
the DT O
discovery NN O
of IN O
an DT O
increased VBN O
urinary JJ O
excretion NN O
of IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
microglobulin NN I-Gene
or CC O
retinol VB B-Gene
binding VBG I-Gene
protein NN I-Gene
, , O
or CC O
both DT O
, , O
have VBP O
been VBN O
examined VBN O
once RB O
a DT O
year NN O
for IN O
five CD O
years NNS O
. . O

Interestingly RB O
, , O
disruption NN O
of IN O
the DT O
VPS34 NNP B-Gene
locus NN I-Gene
resulted VBD O
in IN O
a DT O
temperature NN O
- : O
sensitive JJ O
growth NN O
defect NN O
, , O
indicating VBG O
that IN O
the DT O
VPS34 NNP B-Gene
gene NN I-Gene
is VBZ O
essential JJ O
for IN O
vegetative JJ O
growth NN O
only RB O
at IN O
elevated VBN O
growth NN O
temperatures NNS O
. . O

In IN O
the DT O
predicted JJ O
transmembrane NN O
domain NN O
, , O
Casr NNP B-Gene
- : I-Gene
rs2 NN I-Gene
and CC O
Casr NNP B-Gene
- : I-Gene
rs3 NN I-Gene
are VBP O
95 CD O
% NN O
identical JJ O
to TO O
Casr NNP B-Gene
- : I-Gene
rs1 NN I-Gene
. . O

Antipyretic JJ O
therapy NN O
: : O
physiologic JJ O
rationale NN O
, , O
diagnostic JJ O
implications NNS O
, , O
and CC O
clinical JJ O
consequences NNS O
. . O

To TO O
test VB O
the DT O
role NN O
of IN O
ML NNP O
in IN O
human JJ O
reproductive JJ O
axis NN O
, , O
128 CD O
healthy JJ O
children NNS O
, , O
68 CD O
boys NNS O
and CC O
60 CD O
girls NNS O
, , O
were VBD O
studied VBN O
. . O

These DT O
alternative JJ O
splice NN O
variants NNS O
were VBD O
detected VBN O
in IN O
RNA NNP O
isolated VBD O
from IN O
several JJ O
sources NNS O
, , O
including VBG O
primary JJ O
leptomeningeal JJ O
tissue NN O
and CC O
an DT O
established VBN O
line NN O
of IN O
leptomeningeal NN O
cells NNS O
( ( O
LMC NNP O
) ) O
. . O

Using VBG O
a DT O
natural JJ O
dominant JJ O
negative JJ O
for IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcriptional JJ O
activity NN O
in IN O
ROS NNP O
17 CD O
/ NN O
2 CD O
. . O
8 CD O
cells NNS O
, , O
we PRP O
then RB O
showed VBD O
that IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factors NNS I-Gene
mediated VBD O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
- : O
and CC O
BMP NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
regulated VBN O
expression NN O
of IN O
the DT O
( ( B-Gene
alpha1 NN I-Gene
) ) I-Gene
collagen NN I-Gene
I PRP I-Gene
gene NN I-Gene
as RB O
well RB O
as IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
- : O
regulated JJ O
expression NN O
of IN O
the DT O
parathyroid NN B-Gene
hormone NN I-Gene
( ( O
PTH NNP B-Gene
) ) O
/ VBP O
PTH NNP B-Gene
- : I-Gene
related VBN I-Gene
peptide NN I-Gene
( ( I-Gene
PTHrP NNP I-Gene
) ) I-Gene
receptor NN I-Gene
. . O

Alanine NNP B-Gene
aminotransferase NN I-Gene
( ( O
ALT NNP B-Gene
) ) O
levels NNS O
had VBD O
been VBN O
elevated VBN O
for IN O
six CD O
months NNS O
in IN O
all DT O
patients NNS O
and CC O
hepatitis NN O
B NNP O
viral JJ O
infection NN O
was VBD O
replicative JJ O
. . O

Cestode NNP O
invasion NN O
in IN O
irradiated JJ O
host NN O
organism NN O
increases VBZ O
the DT O
negative JJ O
effect NN O
of IN O
ionizing VBG O
radiation NN O
on IN O
the DT O
hamster NN O
immune NN O
system NN O
. . O

All DT O
of IN O
the DT O
basal NN O
TPN NNP O
solutions NNS O
were VBD O
isonitrogenous JJ O
and CC O
identical JJ O
in IN O
nutrient JJ O
composition NN O
, , O
except IN O
for IN O
the DT O
difference NN O
in IN O
energy NN O
level NN O
, , O
which WDT O
was VBD O
adjusted VBN O
with IN O
glucose NN O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
aortic JJ O
explants NNS O
isolated VBN O
from IN O
PPARalpha NNP B-Gene
- : O
null JJ O
mice NN O
display VBD O
an DT O
exacerbated JJ O
response NN O
to TO O
inflammatory JJ O
stimuli NNS O
, , O
such JJ O
as IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
, , O
as IN O
demonstrated VBN O
by IN O
increased JJ O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
secretion NN O
. . O

Intrapocket NNP O
chemotherapy NN O
in IN O
adult NN O
periodontitis NN O
using VBG O
a DT O
new JJ O
controlled VBN O
- : O
release NN O
insert JJ O
containing VBG O
ofloxacin NN O
( ( O
PT NNP O
- : O
1 CD O
) ) O
. . O

Each DT O
trial NN O
consisted VBD O
of IN O
light NN O
and CC O
buzzer NN O
for IN O
five CD O
seconds NNS O
as IN O
conditioned VBN O
stimuli NN O
and CC O
electric JJ O
shock NN O
for IN O
five CD O
seconds NNS O
as IN O
an DT O
unconditioned JJ O
stimulus NN O
. . O

Two CD O
of IN O
the DT O
ORFs NNP O
are VBP O
completely RB O
internal JJ O
to TO O
longer JJR O
ones NNS O
and CC O
a DT O
third JJ O
is VBZ O
partially RB O
embedded VBN O
in IN O
G2850 NNP B-Gene
. . O

In IN O
contrast NN O
, , O
the DT O
ubiquitous JJ O
expression NN O
of IN O
p19 NN B-Gene
( ( O
INK4d NNP B-Gene
) ) O
has VBZ O
not RB O
been VBN O
previously RB O
described VBN O
in IN O
human JJ O
or CC O
murine NN O
B NNP O
- : O
lineage NN O
cells NNS O
. . O

X2 JJ O
test NN O
, , O
with IN O
Yates NNS O
correction VBP O
if IN O
need NN O
, , O
was VBD O
used VBN O
as IN O
statistical JJ O
. . O
method NN O
. . O

The DT O
clinical JJ O
picture NN O
of IN O
the DT O
disease NN O
was VBD O
significantly RB O
different JJ O
from IN O
anthropogenic JJ O
cutaneous JJ O
leishmaniasis NN O
caused VBN O
by IN O
L NNP O
. . O
tropica NN O
but CC O
similar JJ O
to TO O
cutaneous JJ O
patterns NNS O
caused VBN O
by IN O
L NNP O
. . O
infantum NN O
which WDT O
was VBD O
a DT O
prevalent JJ O
pattern NN O
in IN O
the DT O
southern JJ O
France NNP O
. . O

Expression NN O
plasmids NNS O
harboring VBG O
full JJ O
- : O
length NN O
or CC O
kinase VB O
domain NN O
of IN O
PKC NNP B-Gene
alpha NN I-Gene
and CC O
PKC NNP B-Gene
delta NN I-Gene
( ( O
PKC NNP B-Gene
alpha VBZ I-Gene
K NNP I-Gene
and CC O
PKC NNP B-Gene
delta NNP I-Gene
K NNP I-Gene
) ) O
were VBD O
constructed VBN O
. . O

Cross NNP O
- : O
talking VBG O
among IN O
Drosophila NNP O
nuclear JJ O
receptors NNS O
at IN O
the DT O
promiscuous JJ O
response NN O
element NN O
of IN O
the DT O
ng JJ B-Gene
- : I-Gene
1 CD I-Gene
and CC O
ng JJ B-Gene
- : I-Gene
2 CD I-Gene
intermolt NN I-Gene
genes NNS I-Gene
. . O

We PRP O
conclude VBP O
that IN O
( ( O
i NN O
) ) O
we PRP O
have VBP O
identified VBN O
several JJ O
candidate NN O
latency NN O
genes NNS O
of IN O
murine NN O
gammaHV68 NN O
, , O
( ( O
ii NN O
) ) O
expression NN O
of IN O
genes NNS O
during IN O
latency NN O
may MD O
be VB O
different JJ O
in IN O
different JJ O
organs NNS O
, , O
consistent NN O
with IN O
multiple JJ O
latency NN O
programs NNS O
and CC O
/ NNP O
or CC O
multiple JJ O
cellular JJ O
sites NNS O
of IN O
latency NN O
, , O
and CC O
( ( O
iii NN O
) ) O
regions NNS O
of IN O
the DT O
viral JJ O
genome NN O
( ( O
v JJ B-Gene
- : I-Gene
bcl NN I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
, , O
v FW B-Gene
- : I-Gene
GCR NNP I-Gene
gene NN I-Gene
, , O
and CC O
gene NN B-Gene
73 CD I-Gene
) ) O
are VBP O
transcribed VBN O
during IN O
latency NN O
with IN O
both DT O
gammaHV68 NNS O
and CC O
primate NN O
gammaherpesviruses NNS O
. . O

The DT O
drug NN O
- : O
resistant NN O
cell NN O
lines NNS O
P388 NNP O
/ NNP O
ADR NNP O
/ NNP O
3 CD O
and CC O
P388 NNP O
/ NNP O
ADR NNP O
/ VBD O
7 CD O
express NN O
a DT O
shortened VBN O
topo NN B-Gene
II NNP I-Gene
alpha NN I-Gene
mRNA NN I-Gene
transcript NN I-Gene
in IN O
addition NN O
to TO O
the DT O
native JJ O
transcript NN O
present NN O
in IN O
the DT O
drug NN O
- : O
sensitive JJ O
P388 NNP O
/ NNP O
4 CD O
cell NN O
line NN O
. . O

V NNP O
. . O

When WRB O
the DT O
blood NN O
clot NN O
is VBZ O
formed VBN O
in IN O
the DT O
vitreous JJ O
cavity NN O
, , O
intravitreal JJ O
injection NN O
of IN O
t JJ B-Gene
- : I-Gene
PA NN I-Gene
can MD O
convert VB O
plasminogen NN B-Gene
to TO O
plasmin VB B-Gene
and CC O
remove VB O
the DT O
clot NN O
. . O

The DT O
CAPLC1 NNP B-Gene
protein NN I-Gene
also RB O
exhibited VBD O
several JJ O
unique JJ O
features NNS O
, , O
including VBG O
a DT O
novel JJ O
stretch NN O
of IN O
18 CD O
- : O
19 CD O
amino NN O
acid NN O
residues NNS O
within IN O
the DT O
X NNP O
domain NN O
and CC O
an DT O
unusually RB O
long JJ O
N NNP O
- : O
terminus NN O
which WDT O
did VBD O
not RB O
contain VB O
a DT O
recognizable JJ O
EF NNP O
- : O
hand NN O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
binding VBG O
domain NN O
. . O

Diagnostic JJ O
value NN O
of IN O
serum JJ B-Gene
myoglobin NN I-Gene
in IN O
cases NNS O
of IN O
neuromuscular JJ O
disease NN O

The DT O
Mif1 NNP B-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
region NN I-Gene
contains VBZ O
a DT O
functional JJ O
ER NNP O
stress NN O
- : O
responsive NN O
element NN O
which WDT O
is VBZ O
sufficient JJ O
for IN O
induction NN O
by IN O
tunicamycin NN O
. . O

Thus RB O
, , O
the DT O
association NN O
of IN O
PS1 NNP B-Gene
fragments NNS I-Gene
may MD O
be VB O
maintained VBN O
during IN O
cycles NNS O
of IN O
phosphorylation NN O
/ NNP O
dephosphorylation NN O
of IN O
the DT O
PS1 NNP B-Gene
CTF NNP I-Gene
. . O

Northern NNP O
blotting VBG O
with IN O
a DT O
unique JJ O
17 CD O
- : O
mer NN O
oligonucleotide IN O
demonstrated VBD O
the DT O
absence NN O
of IN O
the DT O
mutant JJ O
sequence NN O
in IN O
the DT O
mRNA NN O
from IN O
which WDT O
the DT O
cDNA NN O
library NN O
giving VBG O
rise NN O
to TO O
the DT O
mutant JJ O
cDNA NN O
was VBD O
constructed VBN O
. . O

E2 NNP O
treatments NNS O
elevated VBD O
hen JJ O
plasma NN O
TG NNP O
7 CD O
. . O
2X CD O
, , O
PL NNP O
5 CD O
. . O
1X CD O
, , O
and CC O
C NNP O
7 CD O
. . O
2X CD O
; : O
and CC O
pullet VB O
plasma NN O
TG NNP O
6 CD O
. . O
8X CD O
, , O
PL NNP O
3 CD O
. . O
7X CD O
, , O
and CC O
C NNP O
2 CD O
. . O
5X CD O
. . O

Here RB O
we PRP O
describe VBP O
a DT O
mutant JJ O
alpha NN O
subunit NN O
designed VBN O
to TO O
inhibit VB O
receptor JJ O
- : O
mediated VBN O
hormonal JJ O
activation NN O
of IN O
Gs NNP B-Gene
, , O
the DT O
stimulatory JJ O
regulator NN O
of IN O
adenylyl JJ B-Gene
cyclase NN I-Gene
. . O

These DT O
results NNS O
lead VBP O
us PRP O
to TO O
hypothesize VB O
that IN O
a DT O
single JJ O
multisubunit NN B-Gene
TFIID NNP I-Gene
protein NN I-Gene
supports VBZ O
transcriptional JJ O
stimulation NN O
by IN O
diverse JJ O
activation NN O
domains NNS O
and CC O
from IN O
a DT O
TATA NNP O
- : O
less JJR O
promoter NN O
. . O

We PRP O
have VBP O
identified VBN O
two CD O
overlapping VBG O
expressed VBN O
sequence NN O
tag NN O
clones NNS O
, , O
which WDT O
contain VBP O
the DT O
missing VBG O
4 CD O
. . O
4 CD O
- : O
kb NN O
3 CD O
' '' O
- : O
UTR NN O
of IN O
the DT O
human JJ B-Gene
D2 NNP I-Gene
( ( O
hD2 NN B-Gene
) ) O
cDNA NN O
. . O

A DT O
human JJ O
nuclear JJ O
- : O
localized VBN O
chaperone NN O
that WDT O
regulates VBZ O
dimerization NN O
, , O
DNA NNP O
binding NN O
, , O
and CC O
transcriptional JJ O
activity NN O
of IN O
bZIP NN B-Gene
proteins NNS I-Gene
. . O

Glucose NNP B-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
phosphate NN I-Gene
dehydrogenase NN I-Gene
( ( O
G NNP B-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
PD NN I-Gene
) ) O
deficiency NN O
in IN O
the DT O
newborn NN O
. . O

A DT O
cAMP NN O
response NN O
element NN O
( ( O
CRE NNP O
) ) O
consensus NN O
signal NN O
was VBD O
identified VBN O
in IN O
the DT O
5 CD O
' POS O
- : O
noncoding JJ O
region NN O
. . O

cAMP NN O
regulates VBZ O
the DT O
expression NN O
of IN O
Kv1 NNP B-Gene
. . I-Gene
5 CD I-Gene
gene NN I-Gene
in IN O
a DT O
cell NN O
- : O
specific JJ O
manner NN O
. . O

The DT O
carboxyl NN O
- : O
terminal JJ O
proline NN O
- : O
rich JJ O
domain NN O
of IN O
SOS1 NNP B-Gene
is VBZ O
involved VBN O
in IN O
the DT O
interaction NN O
with IN O
the DT O
PLC NNP B-Gene
- : I-Gene
gamma1 NN I-Gene
SH3 NNP B-Gene
domain NN I-Gene
. . O

Scmh1 NNP B-Gene
maps NNS O
to TO O
4D1 CD O
- : O
D2 NN O
. . O
1 CD O
in IN O
mice NN O
. . O

In IN O
metabolic JJ O
acidosis NN O
there EX O
was VBD O
a DT O
marked JJ O
stimulation NN O
when WRB O
clamped NN O
at IN O
- : O
10 CD O
to TO O
- : O
100 CD O
mV NN O
. . O

Likewise RB O
, , O
rad6 SYM B-Gene
- : I-Gene
delta NN I-Gene
reduces NNS O
silencing NN O
of IN O
the DT O
telomere JJ B-Gene
- : I-Gene
located VBN I-Gene
RNAP NNP I-Gene
II NNP I-Gene
- : I-Gene
transcribed VBD I-Gene
genes NNS I-Gene
URA3 NNP I-Gene
and CC O
ADE2 NNP B-Gene
. . O

Interestingly RB O
, , O
the DT O
RNA NNP O
sequences NNS O
selected VBN O
by IN O
the DT O
mutated VBN O
zinc NN B-Gene
knuckle NN I-Gene
9G8 CD I-Gene
variant NN I-Gene
are VBP O
efficiently RB O
recognized VBN O
by IN O
SRp20 NNP B-Gene
, , O
in IN O
agreement NN O
with IN O
the DT O
fact NN O
that IN O
the DT O
RBD NNP O
of IN O
9G8 CD B-Gene
and CC O
SRp20 NNP B-Gene
are VBP O
similar JJ O
. . O

A DT O
critical JJ O
heart NN O
rate NN O
and CC O
/ NN O
or CC O
appropriate JJ O
sympathetic JJ O
state NN O
was VBD O
found VBN O
to TO O
provoke VB O
all DT O
instances NNS O
of IN O
reentrant NN O
or CC O
automatic JJ O
atrial JJ O
tachycardia NN O
and CC O
atypical JJ O
junctional JJ O
tachycardia NN O
. . O

A DT O
computed JJ O
tomographic JJ O
scan NN O
obtained VBN O
after IN O
EOE NNP O
- : O
13 CD O
infusion NN O
accurately RB O
showed VBD O
the DT O
perfusion NN O
pattern NN O
of IN O
the DT O
implanted JJ O
catheter NN O
. . O

The DT O
highest JJS O
prevalence NN O
of IN O
reported VBN O
pet NN O
allergy NN O
, , O
chronic JJ O
cough NN O
, , O
wheeze NN O
, , O
attacks NNS O
of IN O
shortness NN O
of IN O
breath NN O
with IN O
wheezing NN O
, , O
and CC O
doctor NN O
- : O
diagnosed VBD O
asthma NN O
was VBD O
found VBN O
in IN O
children NNS O
who WP O
had VBD O
pets NNS O
in IN O
the DT O
past NN O
but CC O
not RB O
anymore RB O
. . O

The DT O
reproductive JJ O
effects NNS O
of IN O
the DT O
administration NN O
of IN O
4 CD O
- : O
chloro NN O
- : O
2 CD O
- : O
methylphenoxyacetic JJ O
acid NN O
( ( O
MCPA NNP O
) ) O
to TO O
rats NNS O
were VBD O
evaluated VBN O
through IN O
two CD O
generations NNS O
, , O
from IN O
prior JJ O
to TO O
mating NN O
, , O
throughout IN O
mating NN O
, , O
to TO O
gestation NN O
and CC O
lactation NN O
. . O

In IN O
particular JJ O
, , O
Western JJ O
, , O
supershift NN O
, , O
and CC O
promoter NN O
deletion NN O
analyses NNS O
suggested VBD O
a DT O
role NN O
for IN O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
- : I-Gene
beta NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
beta NN I-Gene
) ) O
binding VBG O
site NN O
between IN O
- : O
2010 CD O
and CC O
- : O
1954 CD O
in IN O
regulating VBG O
transcription NN O
of IN O
collagenase NN B-Gene
- : I-Gene
1 CD I-Gene
in IN O
monocytic JJ O
cells NNS O
. . O

A DT O
cDNA NN O
for IN O
a DT O
newly RB O
discovered VBN O
pseudogene NN O
, , O
closely RB O
related VBN O
to TO O
the DT O
mouse NN B-Gene
mast NN I-Gene
cell NN I-Gene
chymases NNS I-Gene
was VBD O
isolated VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
from IN O
a DT O
mouse NN O
connective JJ O
tissue NN O
- : O
like IN O
mast NN O
cell NN O
line NN O
. . O

In IN O
PC NN O
, , O
rare JJ O
MNGCs NNP O
had VBD O
intranuclear JJ O
inclusions NNS O
and CC O
grooves NNS O
. . O

The DT O
patients NNS O
who WP O
presented VBD O
with IN O
mucocutaneous JJ O
disease NN O
also RB O
had VBD O
low JJ O
CD4 NNP B-Gene
+ NNP I-Gene
T NNP O
lymphocyte NN O
counts NNS O
, , O
and CC O
most JJS O
of IN O
them PRP O
had VBD O
AIDS NNP O
defining NN O
illnesses NNS O
. . O

Cloning VBG O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN O
encoding VBG O
a DT O
bacteriophage NN B-Gene
- : I-Gene
type NN I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
from IN O
the DT O
higher JJR O
plant NN O
Chenopodium NNP O
album NN O
. . O

Pacing VBG O
the DT O
Roux NNP O
limb NN O
abolished VBD O
the DT O
ectopic NN O
pacemakers NNS O
, , O
restored VBD O
the DT O
slow JJ O
emptying NN O
of IN O
liquids NNS O
to TO O
the DT O
more RBR O
rapid JJ O
rate NN O
found VBN O
in IN O
the DT O
Billroth NNP O
dogs NNS O
( ( O
t1 JJ O
/ VBZ O
2 CD O
: : O
paced VBN O
Roux NNP O
, , O
72 CD O
+ NN O
/ NNP O
- : O
15 CD O
minutes NNS O
; : O
Billroth NNP O
, , O
43 CD O
+ NN O
/ NNP O
- : O
9 CD O
minutes NNS O
; : O
p VBZ O
greater JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
and CC O
did VBD O
not RB O
change VB O
emptying VBG O
of IN O
solids NNS O
. . O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
show VBP O
that IN O
16K CD B-Gene
hPRL NN I-Gene
inhibits VBZ O
the DT O
VEGF NNP B-Gene
- : O
induced VBD O
Ras NNP B-Gene
activation NN O
; : O
this DT O
antagonism NN O
represents VBZ O
a DT O
novel NN O
and CC O
potentially RB O
important JJ O
mechanism NN O
for IN O
the DT O
control NN O
of IN O
angiogenesis NN O
. . O

In IN O
this DT O
model NN O
, , O
eltoprazine NN O
has VBZ O
a DT O
very RB O
specific JJ O
anti SYM O
- : O
aggressive JJ O
( ( O
serenic JJ O
) ) O
profile NN O
, , O
inhibiting VBG O
aggression NN O
while IN O
social JJ O
interaction NN O
and CC O
exploration NN O
are VBP O
not RB O
decreased VBN O
but CC O
even RB O
enhanced VBD O
; : O
inactivity NN O
, , O
a DT O
measure NN O
for IN O
sedation NN O
, , O
is VBZ O
not RB O
affected VBN O
. . O

The DT O
interrelation NN O
of IN O
the DT O
levels NNS O
of IN O
glucocorticoids NNS O
and CC O
insulin NN B-Gene
in IN O
the DT O
blood NN O
of IN O
irradiated JJ O
animals NNS O

Intracavitary JJ O
irradiation NN O
was VBD O
carried VBN O
out RP O
with IN O
a DT O
microSelectron NN O
HDR NNP O
afterloading VBG O
device NN O
and CC O
usually RB O
22 CD O
. . O
5 CD O
Gy NNP O
was VBD O
given VBN O
in IN O
three CD O
fractions NNS O
repeated VBD O
weekly RB O
. . O

A DT O
significant JJ O
correlation NN O
between IN O
a DT O
number NN O
of IN O
functional JJ O
parameters NNS O
of IN O
gastric JJ O
secretion NN O
, , O
incretion NN O
and CC O
histological JJ O
changes NNS O
of IN O
gastric JJ O
mucosa NN O
was VBD O
found VBN O
in IN O
patients NNS O
with IN O
chronic JJ O
gastritis NN O
. . O

The DT O
harpin NN B-Gene
- : O
encoding VBG O
hrpZ JJ B-Gene
gene NN I-Gene
is VBZ O
located VBN O
in IN O
an DT O
operon NN O
that WDT O
also RB O
encodes VBZ O
Hrp NNP B-Gene
secretion NN I-Gene
pathway NN I-Gene
components NNS I-Gene
and CC O
is VBZ O
part NN O
of IN O
the DT O
functional JJ O
cluster NN O
of IN O
hrp NN B-Gene
genes NNS I-Gene
carried VBD O
on IN O
cosmid NN O
pHIR11 NN O
that WDT O
enables VBZ O
saprophytic JJ O
bacteria NNS O
like IN O
Escherichia NNP O
coli NNS O
and CC O
Pseudomonas NNP O
fluorescens VBZ O
to TO O
elicit VB O
the DT O
HR NNP O
in IN O
tobacco NN O
leaves NNS O
. . O

The DT O
method NN O
requires VBZ O
a DT O
reversed JJ O
- : O
phase NN O
column NN O
and CC O
a DT O
paired JJ O
- : O
ion NN O
technique NN O
to TO O
separate VB O
docusate JJ O
sodium NN O
from IN O
other JJ O
components NNS O
. . O

In IN O
several JJ O
cases NNS O
of IN O
definite JJ O
SjS NNP O
, , O
labial JJ O
salivary JJ O
gland NN O
examinations NNS O
after IN O
more JJR O
than IN O
a DT O
one CD O
year NN O
interval NN O
were VBD O
performed VBN O
on IN O
two CD O
occasions NNS O
, , O
and CC O
the DT O
clinical JJ O
and CC O
histopathological JJ O
changes NNS O
were VBD O
investigated VBN O
. . O

Previous JJ O
experimental JJ O
evidence NN O
had VBD O
indicated VBN O
that IN O
Reg1 NNP B-Gene
might MD O
target VB O
Glc7 NNP B-Gene
to TO O
nuclear JJ O
substrates NNS O
such JJ O
as IN O
the DT O
Snf1 NNP B-Gene
kinase NN I-Gene
complex NN I-Gene
. . O

These DT O
factors NNS O
belong VBP O
to TO O
a DT O
set NN O
of IN O
genetically RB O
distinct JJ O
molecules NNS O
, , O
including VBG O
AP NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
MLTF NNP B-Gene
, , O
that WDT O
bind VBZ O
to TO O
the DT O
CACCTGTC NNP O
motif NN O
or CC O
related JJ O
sequences NNS O
. . O

SF NNP B-Gene
- : I-Gene
1 CD I-Gene
does VBZ O
not RB O
have VB O
an DT O
N NNP O
- : O
terminal JJ O
AF1 NNP O
domain NN O
. . O

Allergy NNP O
and CC O
Tourette NNP O
' POS O
s JJ O
syndrome NN O
. . O

Together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
EGF NNP B-Gene
/ NNP O
Ras NNP B-Gene
/ NNP O
Raf NNP B-Gene
induces VBZ O
transcription NN O
via IN O
combined JJ O
activation NN O
of IN O
ATF3 NNP B-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
and CC O
a DT O
52 CD O
- : O
kDa NN O
nuclear JJ O
factor NN O
, , O
whereas WP O
JunD NNP B-Gene
acts VBZ O
as IN O
a DT O
repressor NN O
of IN O
this DT O
response NN O
. . O

The DT O
histological JJ O
grading NN O
was VBD O
certified VBN O
in IN O
68 CD O
cases NNS O
: : O
12 CD O
G1 NNP O
, , O
39 CD O
G2 NNP O
, , O
17 CD O
G3 NNP O
; : O
extracapsular JJ O
spread NN O
was VBD O
found VBN O
in IN O
20 CD O
/ JJ O
54 CD O
cases NNS O
( ( O
37 CD O
% NN O
) ) O
. . O

These DT O
data NNS O
indicate VBP O
a DT O
functional JJ O
role NN O
for IN O
U1 NNP B-Gene
in IN O
NRS NNP B-Gene
- : O
mediated VBD O
splicing JJ O
inhibition NN O
. . O

There EX O
was VBD O
a DT O
slight JJ O
increase NN O
in IN O
total JJ O
transferrin NN B-Gene
2 CD O
hr NN O
after IN O
1 CD O
tablet NN O
and CC O
values NNS O
remained VBN O
high JJ O
throughout IN O
the DT O
experiment NN O
. . O

Two CD O
techniques NNS O
based VBN O
on IN O
assay JJ O
coefficients NNS O
of IN O
variation NN O
were VBD O
employed VBN O
to TO O
characterize VB O
a DT O
normal JJ O
circadian JJ O
pattern NN O
of IN O
cortisol NN O
. . O

The DT O
inhibition NN O
of IN O
focus NN O
formation NN O
observed VBN O
in IN O
the DT O
presence NN O
of IN O
C3G NNP B-Gene
was VBD O
not RB O
due JJ O
to TO O
toxic JJ O
effects NNS O
on IN O
cell NN O
viability NN O
, , O
since IN O
transfected VBN O
C3G NNP B-Gene
cells NNS O
exhibited VBD O
the DT O
same JJ O
survival NN O
and CC O
growth NN O
rates NNS O
as IN O
untransfected JJ O
NIH3T3 NNP O
cells NNS O
or CC O
cells NNS O
transfected VBN O
with IN O
plasmid JJ O
vector NN O
alone RB O
. . O

Nitrofurazone NN O
significantly RB O
reduced VBD O
the DT O
rise NN O
in IN O
LH NNP B-Gene
induced VBN O
by IN O
LHRH NNP B-Gene
. . O

Freezing VBG O
of IN O
plasma NN O
to TO O
obtain VB O
better JJR O
yield NN O
of IN O
factor NN B-Gene
VIII NNP I-Gene
: : O
C NNP O
. . O

Mutation NN O
of IN O
the DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
the DT O
Rous NNP B-Gene
sarcoma NN I-Gene
virus NN I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
and CC O
gag NN B-Gene
enhancers NNS I-Gene
. . O

In IN O
a DT O
second JJ O
experiment NN O
involving VBG O
an DT O
18 CD O
- : O
h NN O
lung JJ O
clearance NN O
assay NN O
, , O
we PRP O
used VBD O
the DT O
mAb NN B-Gene
3 CD I-Gene
. . I-Gene
2 CD I-Gene
. . I-Gene
3 CD I-Gene
to TO O
deplete VB O
rats NNS O
of IN O
LGL NNP O
/ NNP O
NK NNP O
cells NNS O
with IN O
the DT O
following JJ O
rationale NN O
: : O
if IN O
LGL NNP O
/ NNP O
NK NNP O
cells NNS O
are VBP O
necessary JJ O
to TO O
mediate VB O
an DT O
event NN O
, , O
then RB O
in IN O
their PRP$ O
absence NN O
, , O
that WDT O
event NN O
should MD O
not RB O
occur VB O
. . O

We PRP O
used VBD O
two CD O
approaches NNS O
to TO O
ascertain VB O
whether IN O
CDP NNP B-Gene
/ NNP O
cut VBD B-Gene
serves NNS O
as IN O
a DT O
repressor NN O
of IN O
gp91 JJ B-Gene
- : O
phox NN B-Gene
gene NN O
expression NN O
. . O

The DT O
STAT NNP B-Gene
protein NN I-Gene
accumulation NN O
resulting VBG O
from IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
expression NN O
was VBD O
tightly RB O
coupled VBN O
to TO O
the DT O
morphological JJ O
conversion NN O
of IN O
fibroblasts NNS O
to TO O
adipocytes NNS O
and CC O
represents VBZ O
an DT O
expression NN O
profile NN O
identical JJ O
to TO O
that DT O
reported VBN O
for IN O
mature NN O
adipocytes NNS O
in IN O
vivo NN O
. . O

Two CD O
domains NNS O
of IN O
EBNA2 NNP B-Gene
defined VBN O
by IN O
deletion NN O
of IN O
amino JJ O
acids NNS O
247 CD O
- : O
337 CD O
and CC O
437 CD O
- : O
476 CD O
were VBD O
found VBN O
to TO O
be VB O
important JJ O
for IN O
the DT O
activation NN O
of IN O
both DT O
promoters NNS O
, , O
while IN O
two CD O
different JJ O
domains NNS O
corresponding VBG O
to TO O
residues VB O
4 CD O
- : O
18 CD O
and CC O
118 CD O
- : O
198 CD O
were VBD O
required VBN O
solely RB O
for IN O
the DT O
LMP1 NNP B-Gene
promoter NN I-Gene
. . O

This DT O
activity NN O
is VBZ O
stimulated VBN O
by IN O
complex JJ O
formation NN O
with IN O
the DT O
other JJ O
eIF2B JJ B-Gene
subunits NNS I-Gene
. . O

The DT O
purpose NN O
of IN O
this DT O
investigation NN O
was VBD O
to TO O
study VB O
the DT O
morphological JJ O
characteristics NNS O
of IN O
the DT O
fibrous JJ O
tissue NN O
capsule NN O
resulting VBG O
from IN O
the DT O
implantation NN O
of IN O
aluminum NN O
calcium NN O
phosphate NN O
( ( O
ALCAP NNP O
) ) O
and CC O
hydroxyapetite $ O
( ( O
HA NNP O
) ) O
bioceramics NNS O
. . O

These DT O
introns NNS O
contain VBP O
only RB O
single JJ O
snoRNA NN B-Gene
genes NNS I-Gene
and CC O
their PRP$ O
processing NN O
involves VBZ O
exonucleolytic JJ O
release NN O
of IN O
the DT O
snoRNA NN O
from IN O
debranched VBN O
intron NN O
lariats NNS O
. . O

Angina NNP O
( ( O
Q NNP O
) ) O
persistence NN O
showed VBD O
marked JJ O
associations NNS O
with IN O
previous JJ O
myocardial JJ O
infarction NN O
, , O
diagnosed VBD O
angina NN O
, , O
electrocardiogram JJ O
ischemia NN O
, , O
and CC O
subsequent JJ O
major JJ O
ischemic JJ O
heart NN O
disease NN O
events NNS O
from IN O
Q5 NNP O
onward NN O
. . O

The DT O
yeast NN O
enzyme NN O
was VBD O
6 CD O
- : O
fold NN O
slower JJR O
than IN O
the DT O
mammalian JJ O
enzymes NNS O
, , O
which WDT O
made VBD O
it PRP O
amenable JJ O
to TO O
pre VB O
- : O
steady JJ O
- : O
state NN O
stopped VBD O
- : O
flow NN O
spectroscopic NN O
kinetic JJ O
analysis NN O
at IN O
30 CD O
degrees NNS O
C NNP O
and CC O
pH $ O
6 CD O
. . O
0 CD O
. . O

Phosphorylation NN O
of IN O
tyrosine NN O
residues NNS O
in IN O
the DT O
kinase NN O
domain NN O
and CC O
juxtamembrane NN O
region NN O
regulates VBZ O
the DT O
biological JJ O
and CC O
catalytic JJ O
activities NNS O
of IN O
Eph NNP B-Gene
receptors NNS I-Gene
. . O

Canine JJ O
reproduction NN O
: : O
effects NNS O
of IN O
a DT O
single JJ O
injection NN O
of IN O
medroxyprogesterone NN O
acetate NN O
on IN O
the DT O
reproductive JJ O
organs NNS O
of IN O
the DT O
bitch NN O
. . O

A DT O
case NN O
of IN O
anterior JJ O
cleavage NN O
syndrome NN O
in IN O
a DT O
27 CD O
- : O
year NN O
- : O
old JJ O
female JJ O
patient NN O
is VBZ O
described VBN O
. . O

However RB O
, , O
rapamycin RB O
inhibited JJ O
proliferation NN O
of IN O
Ba NNP O
/ NNP O
F3 NNP O
- : O
EpoRgp55 NN O
but CC O
not RB O
of IN O
MEL NNP O
cells NNS O
despite IN O
inhibition NN O
of IN O
p70 NN B-Gene
S6 NNP I-Gene
kinase NN I-Gene
activity NN O
in IN O
both DT O
cells NNS O
. . O

By IN O
contrast NN O
, , O
secretory JJ B-Gene
HI NNP I-Gene
antibodies NNS I-Gene
were VBD O
not RB O
demonstrated VBN O
at IN O
the DT O
onset NN O
of IN O
illness NN O
in IN O
any DT O
of IN O
the DT O
patients NNS O
, , O
but CC O
their PRP$ O
formation NN O
started VBD O
early RB O
and CC O
the DT O
antibodies NNS O
reached VBD O
maximal JJ O
levels NNS O
about IN O
10 CD O
days NNS O
after IN O
onset NN O
of IN O
illness NN O
. . O

Overexpression NN O
of IN O
either DT O
DAP NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
sentrin JJ B-Gene
causes NNS O
apoptosis NN O
of IN O
TNF NNP B-Gene
- : O
sensitive JJ O
L929 NNP O
fibroblast NN O
cell NN O
line NN O
, , O
as RB O
well RB O
as IN O
TNF NNP B-Gene
- : O
resistant JJ O
osteosarcoma NN O
cell NN O
line NN O
, , O
U2OS NNP O
. . O

Like IN O
the DT O
Tob NNP B-Gene
protein NN I-Gene
, , O
Tob2 NNP B-Gene
inhibited VBD O
cell NN O
cycle NN O
progression NN O
from IN O
the DT O
G0 NNP O
/ NNP O
G1 NNP O
to TO O
S NNP O
phases NNS O
. . O

The DT O
N NNP O
- : O
syndecan JJ O
- : O
dependent JJ O
neurite JJ O
outgrowth NN O
is VBZ O
inhibited VBN O
by IN O
the DT O
tyrosine NN B-Gene
kinase NN I-Gene
inhibitors NNS O
herbimycin VBP O
A DT O
and CC O
PP1 NNP B-Gene
. . O

Administration NN O
of IN O
the DT O
dopamine JJ O
agonist NN O
bromocriptine NN O
( ( O
2 CD O
. . O
5 CD O
mg NN O
three CD O
times NNS O
a DT O
day NN O
for IN O
4 CD O
days NNS O
) ) O
suppressed VBD O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
mean NN O
24 CD O
- : O
h NN O
plasma NN O
18 CD O
- : O
OHB NN O
levels NNS O
from IN O
21 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
0 CD O
to TO O
14 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
4 CD O
ng JJ O
/ NNP O
dl NN O
. . O

Two CD O
Pax2 NNP B-Gene
/ VBD I-Gene
5 CD I-Gene
/ NN I-Gene
8 CD I-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
in IN O
Engrailed2 NNP B-Gene
are VBP O
required VBN O
for IN O
proper JJ O
initiation NN O
of IN O
endogenous JJ O
mid FW O
- : O
hindbrain NN O
expression NN O
. . O

The DT O
use NN O
of IN O
specific JJ O
antibodies NNS O
allowed VBD O
the DT O
identification NN O
of IN O
at IN O
least JJS O
RAR NNP B-Gene
beta NN I-Gene
in IN O
some DT O
of IN O
the DT O
DNA NNP O
- : O
protein NN O
complexes NNS O
, , O
although IN O
the DT O
four CD O
sequences NNS O
bind VBP O
single JJ O
RARs NNP B-Gene
transfected VBD O
in IN O
COS NNP O
cells NNS O
much RB O
less RBR O
efficiently RB O
, , O
or CC O
not RB O
at IN O
all RB O
, , O
when WRB O
compared VBN O
to TO O
a DT O
canonical JJ O
RAR NNP B-Gene
responsive JJ I-Gene
element NN I-Gene
. . O

They PRP O
consisted VBD O
of IN O
behavioural JJ O
disorders NNS O
, , O
tetraparesis NN O
, , O
incontinence NN O
and CC O
oculomotor NN O
paralysis NN O
. . O

The DT O
gene NN O
( ( O
ApxII NNP B-Gene
) ) O
encoding VBG O
both DT O
chloroplastic JJ B-Gene
ascorbate NN I-Gene
peroxidase NN I-Gene
isoenzymes NNS I-Gene
was VBD O
isolated VBN O
and CC O
the DT O
organization NN O
of IN O
the DT O
gene NN O
was VBD O
determined VBN O
. . O

Genes NNS O
belonging VBG O
to TO O
the DT O
ras NNS B-Gene
superfamily RB I-Gene
encode RB O
low JJ B-Gene
- : I-Gene
molecular JJ I-Gene
- : I-Gene
weight NN I-Gene
GTP NNP I-Gene
/ NNP I-Gene
GDP NNP I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
that WDT O
are VBP O
highly RB O
conserved VBN O
in IN O
wide JJ O
variety NN O
of IN O
organisms NNS O
. . O

Comparison NNP O
of IN O
cDNA NN O
and CC O
genomic JJ O
sequences NNS O
shows VBZ O
that IN O
the DT O
ZNF189 NNP B-Gene
gene NN I-Gene
spans NNS O
approximately RB O
11 CD O
kb NNS O
and CC O
is VBZ O
organized VBN O
into IN O
at IN O
least JJS O
four CD O
exons NNS O
, , O
the DT O
large JJ O
3 CD O
' POS O
- : O
end NN O
exon NN O
coding VBG O
for IN O
the DT O
complete JJ O
zinc NN O
finger NN O
domain NN O
and CC O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
. . O

Her PRP$ O
serum NN O
FT3 NNP O
concentration NN O
was VBD O
, , O
however RB O
, , O
much RB O
higher JJR O
than IN O
the DT O
ranges NNS O
in IN O
normal JJ O
pregnancy NN O
or CC O
in IN O
GTD NNP O
patients NNS O
without IN O
clinical JJ O
hyperthyroidism NN O
. . O

In IN O
two CD O
further JJ O
cases NNS O
( ( O
one CD O
type NN O
I PRP O
and CC O
one CD O
type NN O
III NNP O
SMA NNP O
) ) O
, , O
de FW O
novo FW O
deletions NNS O
of IN O
only RB O
one CD O
copy NN O
of IN O
Ag1 NNP B-Gene
- : I-Gene
CA NN I-Gene
and CC O
C212 NNP B-Gene
were VBD O
found VBN O
. . O

Additional JJ O
factors NNS O
such JJ O
as IN O
advanced JJ O
age NN O
, , O
concomitant JJ O
use NN O
of IN O
corticosteroids NNS O
or CC O
anticoagulants NNS O
, , O
prior JJ O
ulcer JJ O
complications NNS O
and CC O
co SYM O
- : O
morbid NN O
diseases NNS O
may MD O
further RB O
increase VB O
the DT O
risk NN O
of IN O
bleeding NN O
. . O

Collagen NN B-Gene
was VBD O
extracted VBN O
from IN O
the DT O
skin NN O
, , O
and CC O
the DT O
lack NN O
of IN O
type NN B-Gene
III NNP I-Gene
collagen NN I-Gene
was VBD O
determined VBN O
by IN O
means NNS O
of IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
( ( O
SDS NNP O
- : O
PAGE NN O
) ) O
. . O

Scanning VBG O
electron NN O
microscopic NN O
investigations NNS O
on IN O
the DT O
formation NN O
of IN O
Reissner NNP O
' POS O
s NN O
fiber NN O
in IN O
Rattus NNP O
rattus NN O

The DT O
human JJ B-Gene
eps15 NN I-Gene
gene NN I-Gene
, , O
encoding VBG O
a DT O
tyrosine JJ B-Gene
kinase NN I-Gene
substrate NN O
, , O
is VBZ O
conserved VBN O
in IN O
evolution NN O
and CC O
maps NNS O
to TO O
1p31 CD O
- : O
p32 NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
Sm NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
and CC O
stem NN O
- : O
loop NN O
III NNP O
structures NNS O
are VBP O
necessary JJ O
for IN O
correct JJ O
3 CD O
' POS O
- : O
end NN O
formation NN O
. . O

Electron NNP O
microscopic NN O
and CC O
enzymatic JJ O
analyses NNS O
revealed VBD O
that IN O
the DT O
A118 NNP O
genome NN O
is VBZ O
a DT O
linear JJ O
, , O
circularly RB O
permuted VBN O
, , O
terminally RB O
redundant JJ O
collection NN O
of IN O
double JJ O
- : O
stranded VBD O
DNA NNP O
molecules NNS O
. . O

Down NNP O
- : O
regulation NN O
of IN O
IRS NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
linked VBN O
to TO O
its PRP$ O
serine JJ O
phosphorylation NN O
dependent NN O
on IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
activity NN O
and CC O
appears VBZ O
required VBN O
for IN O
differentiation NN O
to TO O
occur VB O
, , O
as IN O
IRS NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
not RB O
modified VBN O
and CC O
continues VBZ O
to TO O
accumulate VB O
in IN O
a DT O
nondifferentiating JJ O
myoblast NN O
cell NN O
line NN O
. . O

In IN O
contrast NN O
to TO O
other JJ O
known JJ O
retroviruses NNS O
, , O
the DT O
FV NNP B-Gene
pol NN I-Gene
genes NNS I-Gene
are VBP O
expressed VBN O
via IN O
spliced JJ O
transcripts NNS O
. . O

The DT O
difference NN O
between IN O
the DT O
patients NNS O
and CC O
the DT O
controls NNS O
was VBD O
statistically RB O
significant JJ O
( ( O
p JJ O
= NN O
0 CD O
. . O
3 CD O
) ) O
. . O

Gel NNP O
mobility NN O
shift NN O
assays NNS O
indicated VBD O
that IN O
at IN O
least JJS O
four CD O
nuclear JJ O
proteins NNS O
with IN O
distinct JJ O
biochemical JJ O
and CC O
binding VBG O
properties NNS O
possess IN O
the DT O
ability NN O
to TO O
bind VB O
the DT O
3 CD O
beta NN O
I PRP O
- : O
A DT O
element NN O
to TO O
produce VB O
four CD O
DNA NNP O
- : O
protein NN O
complexes NNS O
( ( O
R1 NNP O
to TO O
R4 NNP O
) ) O
. . O

However RB O
, , O
activation NN O
of IN O
the DT O
cAMP NN O
pathway NN O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
regulate VB O
inhibin JJ B-Gene
alpha JJ I-Gene
expression NN O
, , O
greatly RB O
enhanced VBD O
the DT O
actions NNS O
of IN O
SF NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

Both DT O
classes NNS O
of IN O
MHBst NNP B-Gene
proteins NNS I-Gene
were VBD O
found VBN O
to TO O
form VB O
dimers NNS O
; : O
an DT O
which WDT O
is VBZ O
involved VBN O
in IN O
mediating VBG O
the DT O
dimerization NN O
. . O

Anti NNP B-Gene
- : I-Gene
PTB NNP I-Gene
antibodies NNS I-Gene
did VBD O
not RB O
inhibit VB O
the DT O
binding NN O
of IN O
PTB NNP B-Gene
to TO O
RNA NNP O
because IN O
they PRP O
were VBD O
able JJ O
to TO O
supershift VB O
RNA NNP B-Gene
- : I-Gene
PTB NN I-Gene
complexes NNS I-Gene
. . O

Endo16 NNP B-Gene
transcripts NNS I-Gene
are VBP O
confined VBN O
to TO O
the DT O
definitive JJ O
vegetal NN O
plate NN O
in IN O
blastula NN O
stage NN O
embryos NN O
; : O
at IN O
gastrula NN O
stage NN O
this DT O
gene NN O
is VBZ O
expressed VBN O
throughout IN O
the DT O
archenteron NN O
, , O
but CC O
later RB O
only RB O
in IN O
the DT O
midgut NN O
. . O

The DT O
third JJ O
domain NN O
had VBD O
the DT O
motif NN O
of IN O
a DT O
cAMP NN O
response NN O
element NN O
( ( O
CRE NNP O
) ) O
. . O

Overexpression NN O
of IN O
c SYM B-Gene
- : I-Gene
Myc NN I-Gene
in IN O
serum JJ O
- : O
starved VBN O
human JJ O
or CC O
mouse NN O
embryonic JJ O
cells NNS O
leads VBZ O
to TO O
apoptosis VB O
which WDT O
is VBZ O
significantly RB O
reduced VBN O
in IN O
the DT O
presence NN O
of IN O
growth NN O
factor NN O
- : O
containing NN O
serum NN O
. . O

c SYM B-Gene
- : I-Gene
Myc NNP I-Gene
- : O
induced JJ O
apoptosis NN O
appears VBZ O
to TO O
be VB O
deficient JJ O
in IN O
bax JJ B-Gene
- : O
null NN O
as IN O
compared VBN O
with IN O
bax JJ B-Gene
- : O
wild JJ O
- : O
type NN O
mouse NN O
embryonic JJ O
fibroblasts NNS O
. . O

A DT O
coiled JJ O
- : O
coil NN O
domain NN O
, , O
conserved VBD O
within IN O
each DT O
encoded JJ O
protein NN O
, , O
serves VBZ O
as IN O
a DT O
potential JJ O
interaction NN O
motif NN O
for IN O
FLI NNP B-Gene
LRR NNP I-Gene
. . O

Mibefradil NNP O
( ( O
Ro NNP O
40 CD O
- : O
5967 CD O
) ) O
is VBZ O
a DT O
novel JJ O
calcium NN O
antagonist NN O
from IN O
a DT O
new JJ O
chemical JJ O
class NN O
and CC O
is VBZ O
the DT O
first JJ O
that WDT O
selectively RB O
blocks VBZ O
the DT O
T NNP O
- : O
type NN O
calcium NN O
channel NN O
. . O

In IN O
controls NNS O
, , O
most JJS O
of IN O
the DT O
output NN O
from IN O
the DT O
conduit NN O
occurred VBD O
during IN O
type NN O
I PRP O
activity NN O
( ( O
73 CD O
+ NN O
/ NNP O
- : O
14 CD O
% NN O
) ) O
. . O

On IN O
T2 NNP O
weighted VBD O
images NNS O
, , O
low JJ O
intensity NN O
areas NNS O
in IN O
the DT O
thalamus NN O
, , O
the DT O
striatum NN O
, , O
the DT O
anterior JJ O
limb NN O
of IN O
the DT O
internal JJ O
capsule NN O
, , O
the DT O
tegmentum NN O
of IN O
midbrain NN O
, , O
high JJ O
intensity NN O
areas NNS O
in IN O
middle JJ O
cerebellar JJ O
peduncle NN O
, , O
the DT O
posterior JJ O
limb NN O
of IN O
the DT O
internal JJ O
capsule NN O
, , O
the DT O
lateral JJ O
part NN O
of IN O
the DT O
cerebral JJ O
peduncle NN O
, , O
and CC O
the DT O
cerebral JJ O
white JJ O
matter NN O
were VBD O
noted VBN O
. . O

In IN O
addition NN O
to TO O
homologues NNS O
of IN O
the DT O
human JJ B-Gene
genes NNS I-Gene
PSMB5 NNP I-Gene
through IN O
PSMB9 NNP B-Gene
, , O
two CD O
new JJ O
genes NNS O
, , O
PSMB11 NNP B-Gene
and CC O
PSMB12 NNP B-Gene
, , O
have VBP O
been VBN O
found VBN O
for IN O
which WDT O
there EX O
are VBP O
no DT O
known JJ O
corresponding VBG O
genes NNS O
in IN O
humans NNS O
. . O

The DT O
obtained VBN O
results NNS O
were VBD O
compared VBN O
with IN O
control NN O
group NN O
( ( O
10 CD O
female NN O
volunteers NNS O
) ) O
. . O

Endogenous JJ O
release NN O
of IN O
neuronal JJ O
serotonin NN O
and CC O
5 CD O
- : O
hydroxyindoleacetic JJ O
acid NN O
in IN O
the DT O
caudate NN O
- : O
putamen NNS O
of IN O
the DT O
rat NN O
as IN O
revealed VBN O
by IN O
intracerebral JJ O
dialysis NN O
coupled VBN O
to TO O
high JJ O
- : O
performance NN O
liquid NN O
chromatography NN O
with IN O
fluorimetric JJ O
detection NN O
. . O

Chlamydial JJ O
agents NNS O
were VBD O
isolated VBN O
from IN O
the DT O
semen NNS O
near IN O
the DT O
end NN O
of IN O
the DT O
chlamydemic JJ O
phase NN O
. . O

The DT O
transactivation NN O
function NN O
of IN O
EBNA2 NNP B-Gene
was VBD O
also RB O
observed VBN O
in IN O
the DT O
HeLa NNP O
epithelial JJ O
cell NN O
line NN O
, , O
which WDT O
suggests VBZ O
that IN O
EBV NNP O
and CC O
HIV NNP O
- : O
1 CD O
infection NN O
of IN O
non JJ O
- : O
B NNP O
cells NNS O
may MD O
result VB O
in IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
activation NN O
. . O

Oligonucleotide NNP O
probes VBZ O
corresponding VBG O
to TO O
wild VB O
- : O
type NN O
and CC O
mutant JJ O
EpRE NNP O
sequences NNS O
were VBD O
used VBN O
in IN O
gel JJ O
- : O
shift NN O
and CC O
super JJ O
- : O
shift NN O
analyses VBZ O
to TO O
identify VB O
proteins NNS O
binding VBG O
. . O

Sequence NN O
analysis NN O
revealed VBD O
: : O
1 CD O
) ) O
a DT O
kinase NN O
catalytic JJ O
domain NN O
most JJS O
characteristic JJ O
of IN O
serine JJ B-Gene
/ NNP I-Gene
threonine NN I-Gene
kinases NNS I-Gene
but CC O
hybrid JJ O
between IN O
members NNS O
of IN O
the DT O
family NN O
of IN O
microtubule NN B-Gene
- : I-Gene
associated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
kinases NNS I-Gene
and CC O
the DT O
fibroblast JJ B-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
family NN I-Gene
; : O
2 CD O
) ) O
two CD O
putative JJ O
alpha NNS O
- : O
helical JJ O
leucine NN O
zipper NN O
motifs NNS O
separated VBN O
by IN O
a DT O
25 CD O
- : O
amino NN O
acid NN O
charged VBN O
intermediate JJ O
segment NN O
but CC O
lacking VBG O
an DT O
NH2 NNP O
- : O
terminal JJ O
basic JJ O
domain NN O
; : O
and CC O
3 CD O
) ) O
COOH NNP O
- : O
terminal NN O
and CC O
NH2 NNP O
- : O
terminal JJ O
proline NN O
- : O
rich JJ O
domains NNS O
suggestive JJ O
of IN O
src JJ B-Gene
homology NN I-Gene
3 CD I-Gene
( ( O
SH3 NNP B-Gene
) ) O
domain VBP O
binding VBG O
regions NNS O
. . O

OBJECTIVE NN O
: : O
The DT O
study NN O
was VBD O
designed VBN O
to TO O
investigate VB O
the DT O
frequency NN O
of IN O
alterations NNS O
in IN O
serum JJ O
creatinine NN O
in IN O
patients NNS O
with IN O
psoriasis NN O
receiving VBG O
5 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
day NN O
of IN O
cyclosporine NN O
. . O

T7 NNP O
transcription NN O
could MD O
be VB O
manipulated VBN O
to TO O
achieve VB O
different JJ O
levels NNS O
of IN O
constitutive JJ O
expression NN O
, , O
through IN O
the DT O
use NN O
of IN O
promoter NN O
mutations NNS O
. . O

More RBR O
specific JJ O
adverse JJ O
events NNS O
, , O
also RB O
frequently RB O
considered VBN O
as IN O
dose JJ O
- : O
limiting NN O
toxicities NNS O
, , O
include VBP O
hypotension NN O
with IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
severe JJ O
headache NN O
or CC O
skin VB O
rash NN O
with IN O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
and CC O
nasal JJ O
congestion NN O
and CC O
gastroduodenal JJ O
lesions NNS O
with IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

EEG NNP O
theta NN O
waves NNS O
and CC O
psychological JJ O
phenomena NN O
: : O
a DT O
review NN O
and CC O
analysis NN O
. . O

Other JJ O
than IN O
d JJ O
7 CD O
, , O
there EX O
was VBD O
no DT O
significant JJ O
effect NN O
on IN O
the DT O
number NN O
of IN O
implants NNS O
. . O

The DT O
naltrexone NN O
/ NNP O
lofexidine NN O
combination NN O
was VBD O
associated VBN O
with IN O
a DT O
more RBR O
rapid JJ O
resolution NN O
of IN O
the DT O
opiate NN O
withdrawal NN O
syndrome NN O
than IN O
a DT O
7 CD O
- : O
day NN O
lofexidine VB O
- : O
only RB O
treatment NN O
schedule NN O
, , O
without IN O
substantial JJ O
increases NNS O
in IN O
withdrawal NN O
symptoms NNS O
or CC O
hypotensive JJ O
side NN O
- : O
effects NNS O
. . O

Although IN O
pathological JJ O
thyroid NN O
function NN O
is VBZ O
related VBN O
to TO O
changes NNS O
in IN O
energy NN O
expenditure NN O
and CC O
body NN O
composition NN O
, , O
its PRP$ O
possible JJ O
influence NN O
on IN O
leptin NN B-Gene
levels NNS O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

A DT O
full JJ B-Gene
- : I-Gene
length NN I-Gene
human JJ I-Gene
pim NN I-Gene
- : I-Gene
1 CD I-Gene
cDNA NN I-Gene
was VBD O
subcloned VBN O
into IN O
the DT O
bacterial JJ O
vector NN O
pGEX VBD O
- : O
2T CD O
and CC O
the DT O
Pim NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
expressed VBD O
as IN O
a DT O
fusion NN O
product NN O
with IN O
bacterial JJ B-Gene
glutathione NN I-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
( ( O
GST NNP B-Gene
) ) O
. . O

The DT O
presence NN O
of IN O
the DT O
foreign JJ O
gene NN O
was VBD O
confirmed VBN O
by IN O
Southern JJ O
analysis NN O
. . O

Recently RB O
, , O
it PRP O
was VBD O
shown VBN O
that IN O
purified JJ O
RAG1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
proteins NNS I-Gene
can MD O
cleave VB O
DNA NNP O
hairpins NNS O
in IN O
vitro NN O
, , O
but CC O
the DT O
same JJ O
activity NN O
was VBD O
also RB O
described VBN O
for IN O
a DT O
protein NN O
complex NN O
of IN O
the DT O
DNA NNP O
repair NN O
proteins VBZ O
Nbs1 NNP B-Gene
/ NNP O
Mre11 NNP B-Gene
/ NNP O
Rad50 NNP B-Gene
. . O

The DT O
ParaSight NNP O
- : O
F NNP O
test NN O
alone NN O
was VBD O
used VBN O
to TO O
monitor VB O
serum JJ O
antigen NN O
levels NNS O
after IN O
treatment NN O
in IN O
24 CD O
patients NNS O
. . O

TMBr NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
identical JJ O
to TO O
striated JJ B-Gene
muscle NN I-Gene
alpha SYM I-Gene
- : I-Gene
tropomyosin NN I-Gene
from IN O
amino JJ O
acids NNS O
1 CD O
through IN O
258 CD O
but CC O
contains VBZ O
a DT O
novel JJ O
COOH NNP O
- : O
terminal JJ O
region NN O
from IN O
amino JJ O
acids NNS O
259 CD O
through IN O
281 CD O
. . O

Statistical JJ O
Analysis NNP O
included VBD O
ANOVA NNP O
, , O
the DT O
Pearson NNP O
Product NNP O
Moment NNP O
Correlation NNP O
Coefficient NNP O
, , O
Principal NNP O
Components NNP O
Analysis NNP O
and CC O
Discriminant NNP O
Function NNP O
Analysis NNP O
and CC O
the DT O
calculation NN O
of IN O
Cronbach NNP O
' POS O
s NN O
alpha NN O
( ( O
alpha NN O
) ) O
RESULTS NN O
: : O
Both DT O
Sensitivity NNP O
and CC O
specificity NN O
exceed VBP O
90 CD O
. . O
0 CD O
at IN O
23 CD O
/ JJ O
24 CD O
, , O
Chronbach NNP O
' POS O
s NN O
alpha NN O
for IN O
the DT O
total JJ O
scale NN O
was VBD O
equal JJ O
to TO O
0 CD O
. . O
95 CD O
. . O

DNA NNP O
strand VBP O
exchange NN O
catalyzed VBN O
by IN O
Rad51 NNP B-Gene
protein NN I-Gene
is VBZ O
also RB O
greatly RB O
stimulated VBN O
by IN O
RPA NNP B-Gene
. . O

We PRP O
conclude VBP O
that DT O
at IN O
steady JJ O
state NN O
the DT O
timing NN O
of IN O
a DT O
light JJ O
meal NN O
is VBZ O
unlikely JJ O
to TO O
alter VB O
in IN O
any DT O
clinically RB O
important JJ O
manner NN O
the DT O
pharmacokinetics NNS O
of IN O
nifedipine NN O
released VBN O
from IN O
' '' O
biphasic JJ O
' POS O
tablets NNS O
. . O

Interferon NNP B-Gene
beta NN I-Gene
therapy NN O
was VBD O
discontinued VBN O
for IN O
4 CD O
weeks NNS O
. . O

Promoter NN O
activities NNS O
were VBD O
estimated VBN O
using VBG O
beta NN B-Gene
- : I-Gene
glucuronidase NN I-Gene
and CC O
neomycin JJ B-Gene
phosphotransferase NN I-Gene
II NNP I-Gene
reporter NN I-Gene
gene NN I-Gene
systems NNS I-Gene
. . O

Our PRP$ O
findings NNS O
demonstrate VBP O
a DT O
dose JJ O
- : O
dependent JJ O
blockade NN O
of IN O
the DT O
mechanical JJ O
sensitivity NN O
caused VBN O
by IN O
a DT O
mild JJ O
thermal JJ O
injury NN O
by IN O
both DT O
GBP NNP O
and CC O
IBG NNP O
. . O

Altogether RB O
our PRP$ O
data NNS O
indicate VBP O
that IN O
PEDF NNP B-Gene
belongs VBZ O
to TO O
the DT O
subgroup NN O
of IN O
noninhibitory JJ O
serpins NNS B-Gene
and CC O
that IN O
its PRP$ O
N NNP O
- : O
terminal JJ O
region NN O
confers NNS O
a DT O
neurite JJ O
- : O
promoting NN O
activity NN O
to TO O
the DT O
protein NN O
. . O

We PRP O
have VBP O
isolated VBN O
and CC O
functionally RB O
characterized VBD O
the DT O
mouse NN O
gene NN O
for IN O
the DT O
C2 NNP O
subunit NN O
of IN O
the DT O
20S CD B-Gene
proteasome NN I-Gene
. . O

By IN O
electrophoresis NN O
mobility NN O
shift NN O
assays VBZ O
using VBG O
probes NNS O
corresponding VBG O
to TO O
different JJ O
segments NNS O
of IN O
the DT O
putative JJ O
human JJ B-Gene
c SYM I-Gene
- : I-Gene
myb NN I-Gene
intron NN I-Gene
1 CD I-Gene
transcription NN I-Gene
pause NN I-Gene
region NN I-Gene
and CC O
nuclear JJ O
extracts NNS O
from IN O
myeloid JJ O
leukemia NN O
HL NNP O
60 CD O
and CC O
fibroblast VBD O
WI NNP O
38 CD O
cells NNS O
, , O
we PRP O
detected VBD O
a DT O
HL NNP O
- : O
60 CD O
- : O
specific JJ O
DNA NNP O
- : O
protein NN O
complex JJ O
with IN O
a DT O
123 CD O
- : O
bp NN O
fragment NN O
containing VBG O
binding VBG O
sites NNS O
for IN O
the DT O
interferon NN B-Gene
regulatory JJ I-Gene
factors NNS I-Gene
( ( O
IRFs NNP B-Gene
) ) O
nuclear JJ O
proteins NNS O
. . O

Absorption NN O
was VBD O
rapid JJ O
, , O
with IN O
a DT O
mean JJ O
time NN O
to TO O
peak VB O
of IN O
39 CD O
min NN O
. . O

Two CD O
BASIC NNP O
computer NN O
programs NNS O
using VBG O
logit JJ O
transformation NN O
for IN O
the DT O
analysis NN O
of IN O
S NNP O
- : O
shaped VBD O
curves NNS O
are VBP O
presented VBN O
. . O

However RB O
, , O
butyrate NN O
was VBD O
at IN O
least JJS O
2 CD O
- : O
fold NN O
more RBR O
effective JJ O
in IN O
stimulating VBG O
CAT NNP B-Gene
activity NN O
of IN O
fusion NN O
genes NNS O
containing VBG O
upstream JJ O
sequences NNS O
( ( O
- : O
834 CD O
to TO O
- : O
576 CD O
) ) O
than IN O
those DT O
containing VBG O
proximal JJ O
sequences NNS O
( ( O
- : O
456 CD O
to TO O
- : O
172 CD O
) ) O
, , O
suggesting VBG O
two CD O
regions NNS O
in IN O
the DT O
PSG1 NNP B-Gene
- : I-Gene
I PRP I-Gene
gene NN I-Gene
that WDT O
mediate VBP O
the DT O
butyrate NN O
response NN O
. . O

The DT O
alpha NN B-Gene
2A CD I-Gene
- : I-Gene
adrenergic NN I-Gene
receptor NN I-Gene
( ( O
alpha JJ B-Gene
2AAR CD I-Gene
) ) O
is VBZ O
coupled VBN O
to TO O
a DT O
variety NN O
of IN O
effectors NNS O
via IN O
pertussis NN B-Gene
toxin NN I-Gene
- : O
sensitive JJ O
GTP NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

Members NNS O
of IN O
the DT O
titin NN B-Gene
/ JJ O
myosin NN B-Gene
light NN I-Gene
chain NN I-Gene
kinase VBD I-Gene
family NN O
play VB O
an DT O
essential JJ O
role NN O
in IN O
the DT O
organization NN O
of IN O
the DT O
actin NN B-Gene
/ NNP O
myosin NNP B-Gene
cytoskeleton NN O
, , O
especially RB O
in IN O
sarcomere JJ O
assembly NN O
and CC O
function NN O
. . O

The DT O
cytosolic JJ O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferases NNS I-Gene
( ( O
GSTs NNP B-Gene
, , O
EC NNP B-Gene
2 CD I-Gene
. . I-Gene
5 CD I-Gene
. . I-Gene
1 CD I-Gene
. . I-Gene
18 CD I-Gene
) ) O
are VBP O
a DT O
superfamily NN O
of IN O
dimeric NN O
isoenzymes NNS O
which WDT O
catalyze VBP O
the DT O
conjugation NN O
of IN O
electrophilic JJ O
substrates NNS O
with IN O
glutathione NN O
. . O

Human NNP B-Gene
Duo NNP I-Gene
contains VBZ O
a DT O
guanine NN B-Gene
nucleotide IN I-Gene
exchange NN I-Gene
factor NN I-Gene
( ( O
GEF NNP B-Gene
) ) O
domain NN O
that WDT O
is VBZ O
likely JJ O
to TO O
be VB O
rac1 JJ B-Gene
- : O
specific NN O
, , O
a DT O
pleckstrin NN B-Gene
homology NN I-Gene
( ( O
PH NNP B-Gene
) ) O
domain NN O
and CC O
spectrin JJ B-Gene
- : I-Gene
like IN I-Gene
repeat NN I-Gene
units NNS I-Gene
. . O

Conjugated VBN O
and CC O
unconjugated JJ O
phenylacetic JJ O
acid NN O
and CC O
m NN O
- : O
and CC O
p VB O
- : O
hydroxyphenylacetic JJ O
acid NNS O
have VBP O
been VBN O
determined VBN O
in IN O
the DT O
plasma NN O
of IN O
normal JJ O
, , O
healthy JJ O
subjects NNS O
after IN O
fasting VBG O
, , O
consumption NN O
of IN O
a DT O
meal NN O
and CC O
ingestion NN O
of IN O
deuterium NN O
labelled VBN O
amine JJ O
precursors NNS O
, , O
by IN O
high JJ O
- : O
resolution NN O
gas NN O
chromatography NN O
- : O
- : O
high JJ O
resolution NN O
mass NN O
spectrometry NN O
with IN O
selected VBN O
ion NN O
monitoring NN O
of IN O
their PRP$ O
trifluoroethyl NN O
- : O
pentafluoropropionyl NN O
derivatives NNS O
. . O

Experimental JJ O
studies NNS O
on IN O
virus NN O
excretion NN O
and CC O
non JJ O
- : O
arthropod NN O
transmission NN O
. . O

IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
was VBD O
elevated VBN O
during IN O
active JJ O
TB NNP O
when WRB O
compared VBN O
with IN O
healthy JJ O
controls NNS O
, , O
declining VBG O
during IN O
and CC O
after IN O
treatment NN O
. . O

We PRP O
compared VBN O
the DT O
parameters NNS O
pleural JJ B-Gene
adenosine JJ I-Gene
deaminase NN I-Gene
( ( O
PADA NNP B-Gene
, , O
determined VBD O
in IN O
405 CD O
patients NNS O
) ) O
, , O
the DT O
PADA NNP B-Gene
/ NNP O
serum VBD B-Gene
ADA NNP I-Gene
ratio NN O
( ( O
P NNP B-Gene
/ NNP O
SADA NNP B-Gene
; : O
276 CD O
cases NNS O
) ) O
, , O
pleural JJ B-Gene
lysozyme NN I-Gene
( ( O
PLYS NNP B-Gene
, , O
276 CD O
cases NNS O
) ) O
, , O
the DT O
PLYS NNP B-Gene
/ NNP O
serum NN B-Gene
LYS NNP I-Gene
ratio NN O
( ( O
P NNP B-Gene
/ NNP O
SLYS NNP B-Gene
; : O
276 CD O
cases NNS O
) ) O
, , O
and CC O
pleural JJ B-Gene
interferon NN I-Gene
gamma NN I-Gene
( ( O
IFN NNP B-Gene
, , O
145 CD O
cases NNS O
) ) O
regarding VBG O
their PRP$ O
ability NN O
to TO O
differentiate VB O
tuberculous JJ O
pleural JJ O
effusions NNS O
from IN O
others NNS O
. . O

LD50 NNP O
values NNS O
of IN O
terms NNS O
of IN O
KP NNP O
were VBD O
84 CD O
mg NNS O
/ JJ O
kg NN O
in IN O
male JJ O
rats NNS O
and CC O
122 CD O
mg NN O
/ NNP O
kg NN O
in IN O
female JJ O
rats NNS O
when WRB O
KP NNP O
- : O
CMC NN O
was VBD O
administered VBN O
intrarectally RB O
, , O
and CC O
117 CD O
mg NN O
/ NNP O
kg NN O
in IN O
male NN O
and CC O
92 CD O
mg NN O
/ NNP O
kg NN O
in IN O
female NN O
when WRB O
KP NNP O
- : O
T10 NN O
was VBD O
administered VBN O
intrarectally RB O
. . O
, , O
while IN O
peroral JJ O
administration NN O
of IN O
KP NNP O
- : O
CMC NN O
showed VBD O
LD50 NNP O
values NNS O
of IN O
68 CD O
mg NNS O
/ JJ O
kg NN O
in IN O
males NNS O
and CC O
78 CD O
mg NN O
/ NNP O
kg NN O
in IN O
females NNS O
in IN O
terms NNS O
of IN O
KP NNP O
. . O

GABA NNP B-Gene
( ( I-Gene
B NNP I-Gene
) ) I-Gene
R1g NNP I-Gene
was VBD O
expressed VBN O
in IN O
both DT O
brain NN O
and CC O
peripheral JJ O
tissues NNS O
. . O

We PRP O
now RB O
show VBP O
that IN O
RNU2 NNP B-Gene
fragility NN O
can MD O
be VB O
induced VBN O
by IN O
transfection NN O
with IN O
an DT O
expression NN O
vector NN O
encoding VBG O
Ad12 NNP B-Gene
E1B NNP I-Gene
55 CD O
kDa NN O
alone RB O
but CC O
not RB O
by IN O
an DT O
E1 NNP B-Gene
vector NN O
encoding VBG O
all DT O
E1 NNP B-Gene
products NNS I-Gene
( ( O
3 CD O
E1A NNP B-Gene
proteins NNS I-Gene
, , O
as RB O
well RB O
as IN O
the DT O
E1B NNP B-Gene
19 CD O
kDa NN O
and CC O
55 CD O
kDa NN O
proteins NNS O
) ) O
. . O

Although IN O
the DT O
consumption NN O
of IN O
myoglobin NN B-Gene
- : O
bound NN O
O2 NNP O
( ( O
MbO2 NNP O
) ) O
stores NNS O
in IN O
seal NN O
muscles NNS O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
seal JJ O
muscles NNS O
during IN O
laboratory JJ O
simulations NNS O
of IN O
diving NN O
, , O
this DT O
may MD O
not RB O
be VB O
a DT O
feature NN O
of IN O
normal JJ O
field NN O
diving NN O
in IN O
which WDT O
measurements NNS O
of IN O
heart NN O
rate NN O
and CC O
lactate NN O
production NN O
show NN O
marked VBD O
differences NNS O
from IN O
the DT O
profound NN O
diving VBG O
response NN O
induced VBN O
by IN O
forced JJ O
immersion NN O
. . O

The DT O
two CD O
main JJ O
experimental JJ O
variables NNS O
were VBD O
the DT O
attended JJ O
hemifield NN O
( ( O
left VBD O
or CC O
right JJ O
) ) O
and CC O
the DT O
proportion NN O
of IN O
trials NNS O
requiring VBG O
a DT O
shift NN O
within IN O
that DT O
hemifield NN O
( ( O
20 CD O
% NN O
or CC O
80 CD O
% NN O
) ) O
. . O

Of IN O
165 CD O
women NNS O
with IN O
non JJ O
- : O
malignant JJ O
diagnoses NNS O
26 CD O
( ( O
16 CD O
% NN O
) ) O
had VBD O
CA NNP B-Gene
125 CD I-Gene
levels NNS O
in IN O
excess NN O
of IN O
35 CD O
U NNP O
/ NNP O
ml NN O
and CC O
8 CD O
( ( O
5 CD O
% NN O
) ) O
greater JJR O
than IN O
65 CD O
U NNP O
/ NNP O
ml NN O
. . O

EMSA NNP O
competition NN O
experiments NNS O
showed VBD O
that IN O
mutations NNS O
within IN O
the DT O
direct JJ O
repeats NNS O
failed VBD O
to TO O
compete VB O
for IN O
binding NN O
of IN O
the DT O
nuclear JJ O
proteins NNS O
to TO O
labeled VB O
wild JJ O
type NN O
oligonucleotide NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Anu2p NNP B-Gene
is VBZ O
the DT O
yeast JJ B-Gene
homologue NN I-Gene
of IN I-Gene
mammalian JJ I-Gene
epsilon NN I-Gene
- : I-Gene
COP NN I-Gene
and CC O
the DT O
abrupt JJ O
accumulation NN O
of IN O
the DT O
ER NNP O
membrane NN O
caused VBN O
by IN O
a DT O
blockage NN O
of IN O
the DT O
early JJ O
protein NN O
transport NN O
pathway RB O
leads VBZ O
to TO O
alteration NN O
of IN O
nuclear JJ O
morphology NN O
of IN O
the DT O
budding NN O
yeast NN O
cells NNS O
. . O

When WRB O
RNA NNP O
encoding VBG O
the DT O
tail NN O
domain NN O
of IN O
desmoglein NN B-Gene
was VBD O
coinjected VBN O
with IN O
plakoglobin NN B-Gene
RNA NNP I-Gene
, , O
both PDT O
the DT O
dorsalizing NN O
effect NN O
and CC O
nuclear JJ O
accumulation NN O
of IN O
plakoglobin NN B-Gene
were VBD O
suppressed VBN O
. . O

Using VBG O
reference NN O
probes NNS O
as IN O
internal JJ O
standards NNS O
, , O
we PRP O
show VBP O
that IN O
the DT O
ost JJ B-Gene
transcription NN I-Gene
unit NN I-Gene
is VBZ O
located VBN O
within IN O
the DT O
cytogenetic JJ O
band NN O
interval NN O
89A1 CD O
, , O
2 CD O
on IN O
the DT O
right JJ O
arm NN O
of IN O
the DT O
third JJ O
chromosome NN O
, , O
and CC O
that IN O
it PRP O
exerts VBZ O
diagnostic JJ O
segmentation NN O
gene NN O
expression NN O
patterns NNS O
in IN O
the DT O
embryo NN O
. . O

The DT O
N NNP O
- : O
terminal JJ O
portion NN O
of IN O
Notch NNP B-Gene
( ( I-Gene
IC NNP I-Gene
) ) I-Gene
inhibited VBD O
p50 JJ B-Gene
DNA NNP O
binding NN O
and CC O
interacted VBN O
specifically RB O
with IN O
p50 JJ B-Gene
subunit NN I-Gene
, , O
not RB O
p65 NN B-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

CSR NNP O
is VBZ O
directed VBN O
to TO O
specific JJ O
heavy JJ O
chain NN O
isotypes NNS O
by IN O
cytokines NNS O
and CC O
B NNP O
cell NN O
activators NNS O
that WDT O
induce VBP O
transcription NN O
from IN O
the DT O
unrearranged JJ O
, , O
or CC O
germline NN O
( ( O
GL NNP O
) ) O
, , O
C NNP B-Gene
( ( I-Gene
H NNP I-Gene
) ) I-Gene
region NN I-Gene
genes NNS I-Gene
. . O

Hence NNP O
, , O
the DT O
uPA JJ B-Gene
promoter NN I-Gene
contains VBZ O
multiple JJ O
weak JJ O
cis NN O
- : O
acting JJ O
elements NNS O
distributed VBN O
over IN O
7 CD O
. . O
0 CD O
kb VBD O
5 CD O
' '' O
to TO O
the DT O
translation NN O
start NN O
site NN O
. . O

E3 NNP B-Gene
/ VBD I-Gene
19K CD I-Gene
resides NNS O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
where WRB O
it PRP O
binds VBZ O
to TO O
MHC NNP B-Gene
class NN I-Gene
I PRP I-Gene
molecules VBP I-Gene
, , O
thereby RB O
preventing VBG O
their PRP$ O
transport NN O
to TO O
the DT O
cell NN O
surface NN O
. . O

Moreover RB O
, , O
a DT O
complex JJ O
containing NN O
PTP NNP B-Gene
phi NN I-Gene
, , O
paxillin NN B-Gene
, , O
and CC O
a DT O
paxillin NN B-Gene
- : I-Gene
associated VBN I-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
, , O
Pyk2 NNP B-Gene
, , O
can MD O
be VB O
immunoprecipitated VBN O
from IN O
macrophage NN O
lysates NNS O
, , O
and CC O
the DT O
catalytic JJ O
domain NN O
of IN O
PTP NNP B-Gene
phi NN I-Gene
selectively RB O
binds VBZ O
paxillin NN B-Gene
and CC O
Pyk2 NNP B-Gene
in IN O
vitro NN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
ROSP NNP O
undergoes VBZ O
a DT O
number NN O
of IN O
fluctuations NNS O
in IN O
the DT O
negative JJ O
and CC O
positive JJ O
directions NNS O
with IN O
a DT O
gradually RB O
decreasing VBG O
amplitude NN O
in IN O
the DT O
course NN O
of IN O
5 CD O
- : O
25 CD O
days NNS O
following VBG O
the DT O
operation NN O
, , O
after IN O
which WDT O
relatively RB O
stable JJ O
negative JJ O
values NNS O
of IN O
the DT O
ROSP NNP O
are VBP O
established VBN O
on IN O
the DT O
average NN O
in IN O
electrodes NNS O
implanted VBN O
to TO O
the DT O
level NN O
of IN O
the DT O
dura NN O
mater NN O
, , O
and CC O
positive JJ O
values NNS O
in IN O
electrodes NNS O
implanted VBN O
to TO O
the DT O
level NN O
of IN O
the DT O
pia NN O
mater NN O
. . O

Among IN O
individuals NNS O
, , O
however RB O
, , O
changes NNS O
were VBD O
strongly RB O
correlated VBN O
with IN O
ACR NNP O
levels NNS O
at IN O
baseline NN O
. . O

Leukocyte NNP O
enzyme NN O
activity NN O
and CC O
blood NN O
lymphocyte NN O
blast NN O
transformation NN O
in IN O
chronic JJ O
bronchitis NN O

The DT O
goal NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
identify VB O
neuronal JJ O
cell NN O
cultures NNS O
that WDT O
express VBP O
RC3 NNP B-Gene
/ NNP O
neurogranin NN B-Gene
, , O
to TO O
check VB O
whether IN O
they PRP O
are VBP O
sensitive JJ O
to TO O
T3 NNP O
, , O
and CC O
to TO O
examine VB O
the DT O
mechanism NN O
of IN O
regulation NN O
. . O

Antibodies NNS O
against IN O
this DT O
purified JJ O
protein NN O
localize VB O
RIM1 NNP B-Gene
to TO O
mitochondria VB O
. . O

Acid NNP O
instilled VBD O
on IN O
the DT O
larynx NN O
of IN O
maturing VBG O
rabbits NNS O
resulted VBN O
in IN O
significant JJ O
obstructive JJ O
, , O
central JJ O
, , O
and CC O
mixed JJ O
apnea NN O
. . O

In IN O
2 CD O
subjects NNS O
the DT O
phytomitogen NN O
reactivity NN O
of IN O
the DT O
lymphocytes NNS O
was VBD O
improved VBN O
after IN O
treatment NN O
. . O

When WRB O
pollen NN O
allergen NN O
from IN O
three CD O
grass NN O
species NNS O
were VBD O
used VBN O
, , O
The DT O
RAST NNP O
- : O
test NN O
results NNS O
did VBD O
not RB O
differ VB O
from IN O
duplicate NN O
values NNS O
either DT O
. . O

The DT O
ESEG NNP O
' POS O
s NN O
are VBP O
a DT O
direct JJ O
result NN O
of IN O
the DT O
NEXT NNP O
study NN O
. . O

The DT O
child NN O
left VBD O
behind RP O
. . O

Autotransfusion NN O
was VBD O
performed VBN O
as IN O
follows VBZ O
: : O
Heparin NNP O
- : O
ACD NNP O
- : O
B NNP O
- : O
Heparin NNP O
- : O
DPD NNP O
- : O
Heparin NNP O
- : O
ACD NNP O
- : O
B NNP O
etc NN O
. . O

Concerted VBN O
transcriptional JJ O
activation NN O
of IN O
the DT O
low JJ B-Gene
density NN I-Gene
lipoprotein NN I-Gene
receptor NN I-Gene
gene NN I-Gene
by IN O
insulin NN B-Gene
and CC O
luteinizing VBG B-Gene
hormone NN I-Gene
in IN O
cultured JJ O
porcine NN O
granulosa NN O
- : O
luteal NN O
cells NNS O
: : O
possible JJ O
convergence NN O
of IN O
protein NN B-Gene
kinase NN I-Gene
a DT I-Gene
, , O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
, , O
and CC O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
signaling VBG O
pathways NNS O
. . O

The DT O
cost NN O
per IN O
test NN O
is VBZ O
less RBR O
than IN O
those DT O
for IN O
CC NNP O
, , O
kEIA NN O
and CC O
PACE2 NNP O
. . O

RT NNP O
- : O
PCR NNP O
using VBG O
1 CD O
. . O
D NNP O
- : O
specific JJ O
primers NNS O
showed VBD O
that IN O
kidney NN O
, , O
brain NN O
and CC O
prostate VB O
do VBP O
not RB O
express VB O
1 CD O
. . O
D NNP O
mRNA VBD O
even RB O
though IN O
kidney NN O
and CC O
brain NN O
are VBP O
the DT O
most RBS O
abundant JJ O
source NN O
for IN O
aFGF JJ B-Gene
protein NN I-Gene
. . O

Demispan NNP O
is VBZ O
a DT O
reliable JJ O
and CC O
reproducible JJ O
measure NN O
of IN O
stature NN O
in IN O
the DT O
elderly JJ O
. . O

The DT O
addition NN O
of IN O
culture NN O
to TO O
the DT O
CC NNP O
and CC O
CC NNP O
: : O
SW NN O
by IN O
- : O
products NNS O
resulted VBN O
in IN O
pH NN O
values NNS O
lower JJR O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
than IN O
those DT O
without IN O
culture NN O
on IN O
Day NNP O
21 CD O
, , O
and CC O
the DT O
15 CD O
% NN O
carbohydrate NN O
treatment NN O
significantly RB O
reduced VBN O
pH JJ O
beyond IN O
the DT O
5 CD O
% NN O
carbohydrate NN O
. . O

Gap NNP B-Gene
b3 NN I-Gene
consists VBZ O
of IN O
two CD O
polypeptide NN O
chains NNS O
( ( O
Mr NNP O
= NNP O
110 CD O
, , O
0 CD O
and CC O
30 CD O
, , O
0 CD O
) ) O
, , O
which WDT O
seem VBP O
to TO O
be VB O
proteolytic JJ O
cleavage NN O
products NNS O
connected VBN O
by IN O
disulfide JJ O
bonds NNS O
from IN O
a DT O
precursor NN O
protein NN O
. . O

Vancomycin NNP O
data NNS O
were VBD O
analyzed VBN O
according VBG O
to TO O
a DT O
one CD O
- : O
compartment NN O
open JJ O
model NN O
with IN O
use NN O
of IN O
NONMEM NNP O
population NN O
pharmacokinetic JJ O
software NN O
. . O

The DT O
second JJ O
mutation NN O
present NN O
in IN O
the DT O
original JJ O
mutant NN O
proved VBD O
to TO O
be VB O
an DT O
allele NN O
of IN O
a DT O
known VBN O
gene NN O
, , O
PBS2 NNP B-Gene
, , O
which WDT O
encodes VBZ O
a DT O
putative JJ O
protein NN O
kinase NN O
that WDT O
functions NNS O
in IN O
the DT O
high JJ O
osmolarity NN O
stress NN O
pathway NN O
. . O

There EX O
were VBD O
45 CD O
to TO O
56 CD O
nt NNS O
differences NNS O
between IN O
the DT O
virulent NN O
and CC O
avirulent NN O
groups NNS O
while IN O
there EX O
were VBD O
6 CD O
to TO O
14 CD O
nt NNS O
differences NNS O
among IN O
four CD O
avirulent NN O
strains NNS O
. . O

The DT O
genome NN O
of IN O
all DT O
retroviruses NNS O
consists NNS O
of IN O
two CD O
identical JJ O
RNAs NNP O
noncovalently RB O
linked VBD O
near IN O
their PRP$ O
5 CD O
' POS O
end NN O
. . O

As IN O
opposed VBN O
to TO O
in IN O
vitro NNP O
co SYM O
- : O
precipitation NN O
studies NNS O
, , O
the DT O
yeast NN O
two CD O
- : O
hybrid JJ O
screen NN O
reveals NNS O
in IN O
vivo NN O
protein NN O
- : O
protein NN O
interactions NNS O
. . O

In IN O
this DT O
manuscript NN O
we PRP O
demonstrate VBP O
that IN O
two CD O
tandem JJ B-Gene
Ets NNP I-Gene
sites VBZ I-Gene
in IN O
the DT O
mouse NN B-Gene
GL NNP I-Gene
alpha NN I-Gene
promoter NN I-Gene
bind IN O
the DT O
transcription NN B-Gene
factors NNS I-Gene
Elf NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
PU NNP B-Gene
. . I-Gene
1 CD I-Gene
, , O
and CC O
that IN O
the DT O
3 CD O
' POS O
site NN O
is VBZ O
essential JJ O
for IN O
expression NN O
of IN O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
driven VBN O
by IN O
the DT O
GL NNP B-Gene
alpha NN I-Gene
promoter NN I-Gene
. . O

Both DT O
neural JJ O
and CC O
hormonal JJ O
pathways NNS O
and CC O
both DT O
opiate NN O
and CC O
nonopiate NN O
substances NNS O
play VBP O
roles NNS O
in IN O
the DT O
complex JJ O
modulation NN O
of IN O
pain NN O
transmission NN O
. . O

Furthermore RB O
, , O
a DT O
mutant JJ O
receptor NN O
( ( O
Y977F NNP O
/ NNP O
Y989F NNP O
[ NNP O
PLC NNP B-Gene
gamma SYM I-Gene
- : O
binding NN O
sites NNS O
] VBP O
) ) O
could MD O
fully RB O
activate VB O
Ras NNP B-Gene
, , O
and CC O
the DT O
direct JJ O
activation NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
and CC O
calcium NN O
mobilization NN O
had VBD O
almost RB O
no DT O
effect NN O
on IN O
the DT O
GDP NNP O
/ NNP O
GTP NNP O
state NN O
of IN O
Ras NNP B-Gene
in IN O
this DT O
cell NN O
line NN O
. . O

Most JJS O
pituitary JJ O
hormone NN O
- : O
coding VBG O
gene NN O
promoters NNS O
are VBP O
activated VBN O
by IN O
Ptx1 NNP B-Gene
. . O

Krox NNP B-Gene
- : I-Gene
20 CD I-Gene
, , O
a DT O
zinc NN B-Gene
finger NN I-Gene
gene NN I-Gene
, , O
has VBZ O
a DT O
highly RB O
conserved JJ O
pattern NN O
of IN O
expression NN O
in IN O
r3 NN O
and CC O
r5 NN O
and CC O
is VBZ O
functionally RB O
required VBN O
for IN O
their PRP$ O
maintenance NN O
in IN O
mouse NN O
embryos NN O
. . O

Moreover RB O
, , O
exons NNS O
2a CD O
and CC O
2b CD O
share NN O
the DT O
same JJ O
5 CD O
' POS O
sequence NN O
but CC O
differ VBP O
from IN O
each DT O
other JJ O
by IN O
the DT O
use NN O
of IN O
two CD O
distinct JJ O
donor NN O
splice NN O
sites VBZ O
171 CD O
bp JJ O
apart RB O
in IN O
the DT O
gene NN O
. . O

A DT O
subsequent JJ O
screen NN O
for IN O
the DT O
loss NN O
of IN O
the DT O
positively RB O
selectable JJ O
target NN O
locus NN O
marker NN O
detects VBZ O
the DT O
desired JJ O
replacement NN O
at IN O
modest JJ O
frequency NN O
( ( O
> JJ O
2 CD O
% NN O
) ) O
. . O

Both DT O
BG NNP O
and CC O
IRI NNP B-Gene
concentrations NNS O
during IN O
the DT O
OGTT NNP O
were VBD O
the DT O
lowest JJS O
in IN O
body NN O
builders NNS O
, , O
medium NN O
in IN O
controls NNS O
, , O
and CC O
the DT O
highest JJS O
in IN O
obese JJ O
men NNS O
. . O

The DT O
TAF NNP O
factor NN O
appears VBZ O
to TO O
be VB O
particularly RB O
significant JJ O
in IN O
OCD NNP O
. . O

The DT O
resulting VBG O
mutants NNS O
were VBD O
coexpressed VBN O
with IN O
gE NN B-Gene
in IN O
the DT O
vaccinia NN O
virus NN O
- : O
based VBN O
vTF7 SYM O
- : O
3 CD O
system NN O
, , O
and CC O
the DT O
formation NN O
and CC O
endoplasmic JJ O
reticulum NN O
( ( O
ER NNP O
) ) O
- : O
to TO O
- : O
Golgi NNP O
transport NN O
of IN O
the DT O
hetero NN O
- : O
oligomeric JJ O
complex JJ O
were VBD O
monitored VBN O
. . O

Natl NNP O
. . O

Analysis NN O
of IN O
functional JJ O
domains NNS O
of IN O
Arix NNP B-Gene
reveals NNS O
an DT O
N NNP O
- : O
terminal JJ O
activation NN O
domain NN O
and CC O
a DT O
C NNP O
- : O
terminal JJ O
repression NN O
domain NN O
. . O

The DT O
location NN O
of IN O
the DT O
IBS NNP O
within IN O
the DT O
catB JJ B-Gene
structural JJ I-Gene
gene NN I-Gene
, , O
the DT O
cooperativity NN O
observed VBN O
in IN O
footprinting VBG O
studies NNS O
and CC O
phasing VBG O
studies NNS O
suggest VBP O
that IN O
the DT O
IBS NNP O
participates NNS O
in IN O
the DT O
interaction NN O
of IN O
CatR NNP B-Gene
with IN O
the DT O
upstream JJ O
binding NN O
sites NNS O
by IN O
looping VBG O
out RP O
the DT O
intervening VBG O
DNA NN O
. . O

In IN O
addition NN O
, , O
benzocaine NN O
and CC O
2 CD O
- : O
phenoxyethanol NN O
depressed JJ O
complement NN O
activity NN O
and CC O
phagocytosis NN O
, , O
while IN O
MS222 NNP O
and CC O
quinaldine JJ O
sulphate NN O
did VBD O
not RB O
. . O

Analyses NNS O
of IN O
additional JJ O
tumors NNS O
induced VBD O
in IN O
mice NN O
from IN O
two CD O
reciprocal JJ O
crosses NNS O
, , O
A NNP O
/ NNP O
J NNP O
x NNP O
C3H NNP O
/ NNP O
HeJ NNP O
F1 NNP O
( ( O
hereafter NN O
called VBN O
AC3F1 NNP O
) ) O
and CC O
C3H NNP O
/ NNP O
HeJ NNP O
x VBZ O
A NNP O
/ NNP O
J NNP O
F1 NNP O
( ( O
hereafter NN O
called VBN O
C3AF1 NNP O
) ) O
, , O
provided VBD O
evidence NN O
for IN O
the DT O
inactivation NN O
of IN O
one CD O
allele NN O
of IN O
the DT O
putative JJ O
chromosome NN O
4 CD O
tumor NN O
suppressor NN O
gene NN O
by IN O
parental JJ O
imprinting NN O
. . O

Identification NN O
of IN O
Ste4 NNP B-Gene
as IN O
a DT O
potential JJ O
regulator NN O
of IN O
Byr2 NNP B-Gene
in IN O
the DT O
sexual JJ O
response NN O
pathway NN O
of IN O
Schizosaccharomyces NNP O
pombe NN O
. . O

Radiolabelled VBN O
palmitate NN O
was VBD O
not RB O
incorporated VBN O
into IN O
the DT O
mutated JJ O
protein NN O
, , O
showing VBG O
that IN O
lipid JJ O
modification NN O
occurs VBZ O
at IN O
the DT O
Cys NNP O
- : O
22 CD O
residue NN O
. . O

PSI NNP B-Gene
- : I-Gene
G NNP I-Gene
and CC O
PSI NNP B-Gene
- : I-Gene
K NN I-Gene
probably RB O
have VBP O
evolved VBN O
from IN O
a DT O
gene NN O
duplication NN O
of IN O
an DT O
ancestral JJ O
gene NN O
. . O

Immunity NNP O
acquired VBN O
by IN O
mice NN O
during IN O
I PRP O
. . O
scapularis JJ O
nymphal JJ O
activity NN O
in IN O
early JJ O
summer NN O
may MD O
exclude VB O
a DT O
large JJ O
proportion NN O
of IN O
the DT O
mouse NN O
population NN O
from IN O
maintaining VBG O
E NNP O
. . O
phagocytophila NN O
during IN O
the DT O
period NN O
of IN O
larval NN O
activity NN O
later RB O
in IN O
the DT O
season NN O
. . O

The DT O
color NN O
- : O
word NN O
interference NN O
effect NN O
previously RB O
reported VBN O
with IN O
normal JJ O
populations NNS O
when WRB O
given VBN O
the DT O
Stroop NNP O
test NN O
was VBD O
demonstrated VBN O
for IN O
this DT O
retarded JJ O
sample NN O
using VBG O
a DT O
special JJ O
format NN O
. . O

TBPf NNP O
is VBZ O
defined VBN O
as IN O
a DT O
quotient NN O
of IN O
the DT O
difference NN O
of IN O
the DT O
first JJ O
and CC O
the DT O
second JJ O
measurement NN O
: : O
TBPf NNP O
= NNP O
( ( O
P1 NNP O
- : O
P2 NN O
) ) O
/ NN O
( ( O
A1 NNP O
- : O
A2 NN O
) ) O
. . O

The DT O
Saccharomyces NNPS B-Gene
cerevisiae VBP I-Gene
14DM CD I-Gene
gene NN I-Gene
, , O
encoding VBG O
cytochrome JJ B-Gene
P450 NNP I-Gene
lanosterol NN I-Gene
14 CD I-Gene
alpha NN I-Gene
- : I-Gene
demethylase NN I-Gene
( ( O
14DM CD B-Gene
) ) O
, , O
was VBD O
overexpressed VBN O
in IN O
various JJ O
S NNP O
. . O
cerevisiae NN O
strains NNS O
under IN O
the DT O
control NN O
of IN O
three CD O
strong JJ O
heterologous JJ O
yeast NN O
transcription NN O
promoters NNS O
( ( O
pADC1 NN B-Gene
, , O
pGPD NN B-Gene
, , O
pPHO5 NN B-Gene
) ) O
and CC O
under IN O
the DT O
control NN O
of IN O
its PRP$ O
own JJ O
promoter NN O
. . O

Toxicities NNS O
included VBD O
: : O
nausea NN O
/ IN O
vomiting VBG O
( ( O
69 CD O
% NN O
) ) O
, , O
headache NN O
( ( O
25 CD O
% NN O
) ) O
, , O
chills NNS O
( ( O
69 CD O
% NN O
) ) O
, , O
pain VBP O
at IN O
tumor NN O
sites NNS O
( ( O
63 CD O
% NN O
) ) O
, , O
hypotension NN O
( ( O
31 CD O
% NN O
) ) O
, , O
and CC O
hypertension NN O
( ( O
38 CD O
% NN O
) ) O
. . O

In IN O
nucleus JJ O
ventralis NN O
anterior RB O
thalami JJ O
- : O
nucleus NN O
ventralis NN O
lateralis NN O
thalami NN O
neurons NNS O
with IN O
an DT O
inhibitory NN O
input NN O
from IN O
nucleus JJ O
entopeduncularis NN O
, , O
a DT O
shortening NN O
of IN O
inhibition NN O
from IN O
17 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
6 CD O
to TO O
9 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
8 CD O
ms NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
under IN O
the DT O
haloperidol NN O
influence NN O
was VBD O
evident JJ O
. . O

In IN O
Trial NNP O
1 CD O
, , O
eight CD O
sows NNS O
were VBD O
allowed VBN O
to TO O
farrow VB O
naturally RB O
( ( O
d JJ O
114 CD O
, , O
NF NNP O
sows VBZ O
) ) O
and CC O
eight CD O
sows NNS O
were VBD O
induced VBN O
to TO O
farrow VB O
( ( O
IF NNP O
sows VBZ O
) ) O
prematurely RB O
by IN O
injection NN O
of IN O
prostaglandin NN O
F2 NNP O
alpha NN O
on IN O
d JJ O
112 CD O
of IN O
gestation NN O
. . O

The DT O
genomic JJ O
structure NN O
of IN O
brk NN B-Gene
consists NNS O
of IN O
8 CD O
exons NNS O
, , O
whose WP$ O
boundaries NNS O
are VBP O
distinct JJ O
from IN O
other JJ O
non JJ O
- : O
receptor NN O
PTK NNP B-Gene
family NN I-Gene
members NNS O
, , O
again RB O
indicating VBG O
a DT O
structural JJ O
and CC O
functional JJ O
divergence NN O
. . O

Dll3 NNP B-Gene
is VBZ O
mutated VBN O
in IN O
the DT O
X NNP O
- : O
ray NN O
- : O
induced VBN O
mouse NN B-Gene
mutant NN I-Gene
pudgy NN I-Gene
( ( O
pu NN B-Gene
) ) O
, , O
causing VBG O
a DT O
variety NN O
of IN O
vertebrocostal JJ O
defects NNS O
similar JJ O
to TO O
SD NNP O
phenotypes NNS O
. . O

Switching VBG O
FDC NNP O
- : O
P1 NNP O
/ NNP O
MAC NNP O
cells NNS O
from IN O
growth NN O
in IN O
M NNP B-Gene
- : I-Gene
CSF NN I-Gene
to TO O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
caused VBD O
the DT O
selective JJ O
degradation NN O
of IN O
c SYM B-Gene
- : I-Gene
fms NN I-Gene
mRNA NN I-Gene
within IN O
6 CD O
h NN O
after IN O
factor NN O
switching NN O
. . O

Human NNP O
ZFM1 NNP B-Gene
protein NN I-Gene
is VBZ O
a DT O
transcriptional JJ O
repressor NN O
that WDT O
interacts VBZ O
with IN O
the DT O
transcription NN B-Gene
activation NN I-Gene
domain NN I-Gene
of IN I-Gene
stage NN I-Gene
- : I-Gene
specific JJ I-Gene
activator NN I-Gene
protein NN I-Gene
. . O

Tissues NNS O
and CC O
exudates VBZ O
contain VBP O
sufficient JJ O
thymidine NN O
for IN O
growth NN O
of IN O
anaerobic JJ O
bacteria NNS O
in IN O
the DT O
presence NN O
of IN O
inhibitory JJ O
levels NNS O
of IN O
trimethoprim JJ O
- : O
sulfamethoxazole NN O
. . O

Lack NN O
of IN O
effect NN O
of IN O
the DT O
appetite NN O
stimulant NN O
pizotifen NN O
( ( O
BC NNP O
105 CD O
) ) O
on IN O
the DT O
absorption NN O
of IN O
isonicotinylhydrazine NN O
. . O

We PRP O
now RB O
describe VBZ O
a DT O
second JJ O
RIM NNP B-Gene
protein NN I-Gene
, , O
called VBN O
RIM2 NNP B-Gene
, , O
that WDT O
is VBZ O
highly RB O
homologous JJ O
to TO O
RIM1 NNP B-Gene
and CC O
also RB O
expressed VBD O
primarily RB O
in IN O
brain NN O
. . O

These DT O
results NNS O
strongly RB O
suggested VBD O
that IN O
similar JJ O
, , O
if IN O
not RB O
identical JJ O
, , O
the DT O
CArG NNP B-Gene
box NN I-Gene
binding VBG I-Gene
proteins NNS I-Gene
interact JJ O
with IN O
the DT O
functionally RB O
different JJ O
promoter NN O
element NN O
in IN O
the DT O
VLC1 NNP B-Gene
, , O
cardiac JJ B-Gene
alpha SYM I-Gene
- : I-Gene
actin NN I-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
genes NNS I-Gene
. . O

Exon NNP O
A NNP O
is VBZ O
located VBN O
approximately RB O
7 CD O
kb VBD O
5 CD O
' '' O
to TO O
the DT O
HSL NNP B-Gene
translation NN I-Gene
start NN I-Gene
site NN I-Gene
. . O

Oxygen NN O
delivery NN O
and CC O
base NN O
excess NN O
decreased VBN O
significantly RB O
and CC O
four CD O
pigs NNS O
died VBD O
. . O

Neither DT O
model NN O
, , O
as IN O
applied VBN O
, , O
provided VBD O
a DT O
satisfactory JJ O
account NN O
of IN O
the DT O
effects NNS O
of IN O
the DT O
main JJ O
variables NNS O
of IN O
number NN O
of IN O
tones NNS O
and CC O
amount NN O
of IN O
perturbation NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

The DT O
kallistatin NN B-Gene
gene NN I-Gene
was VBD O
localized VBN O
by IN O
in IN O
situ JJ O
hybridization NN O
to TO O
human JJ O
chromosome NN O
14q31 CD O
- : O
q32 NN O
. . O
1 CD O
, , O
close RB O
to TO O
the DT O
serpin NN B-Gene
genes NNS I-Gene
encoding VBG O
alpha RB B-Gene
1 CD I-Gene
- : I-Gene
antichymotrypsin NN I-Gene
, , O
protein VBP B-Gene
C NNP I-Gene
inhibitor NN I-Gene
, , O
alpha RB B-Gene
1 CD I-Gene
- : I-Gene
antitrypsin NN I-Gene
, , O
and CC O
corticosteroid SYM B-Gene
- : I-Gene
binding NN I-Gene
globulin NN I-Gene
. . O

Our PRP$ O
data NNS O
complement NN O
other JJ O
studies NNS O
of IN O
circumpolar JJ O
populations NNS O
and CC O
reinforce VB O
the DT O
reported VBN O
high JJ O
prevalences NNS O
of IN O
SPA NNP O
and CC O
HLA NNP B-Gene
- : I-Gene
B27 NNP I-Gene
among IN O
those DT O
populations NNS O
. . O

The DT O
liver NN O
in IN O
the DT O
severely RB O
ill JJ O

These DT O
results NNS O
demonstrate VBP O
that IN O
tip NN B-Gene
acts NNS O
at IN O
an DT O
early JJ O
stage NN O
of IN O
the DT O
T NNP O
- : O
cell NN O
signal JJ O
transduction NN O
cascade NN O
by IN O
associating VBG O
with IN O
Lck NNP B-Gene
and CC O
downregulating VBG O
Lck NNP O
- : O
mediated VBN O
activation NN O
. . O

At IN O
least JJS O
one CD O
clone NN O
, , O
lambda JJ O
HHG NNP O
41 CD O
, , O
contains NNS O
, , O
in IN O
addition NN O
to TO O
the DT O
histone NN B-Gene
genes NNS I-Gene
, , O
a DT O
region NN O
that WDT O
hybridizes VBZ O
with IN O
a DT O
cytoplasmic JJ O
RNA NNP O
approximately RB O
330 CD O
nucleotides NNS O
in IN O
length NN O
. . O

Phosphopeptide NNP O
mapping NN O
revealed VBD O
the DT O
same JJ O
autophosphorylation NN O
sites NNS O
utilized VBN O
by IN O
EGFR NNP B-Gene
- : I-Gene
IC NN I-Gene
as IN O
those DT O
identified VBN O
in IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
EGFR NNP I-Gene
. . O

Changes NNS O
in IN O
prognosis NN O
of IN O
twin JJ O
births NNS O
over IN O
20 CD O
years NNS O
. . O

During IN O
the DT O
past JJ O
4 CD O
years NNS O
, , O
a DT O
purposeful JJ O
search NN O
was VBD O
made VBN O
for IN O
electrocardiograms NNS O
with IN O
documented JJ O
reversible JJ O
QRS NNP O
changes NNS O
associated VBN O
with IN O
all DT O
acute JJ O
injury NN O
pattern NN O
. . O

The DT O
beta NN O
chain NN O
contains VBZ O
five CD O
potential JJ O
N NNP O
- : O
linked VBN O
glycosylation NN O
sites NNS O
, , O
and CC O
endoglycosidase VB B-Gene
digestion NN O
suggested VBD O
that IN O
the DT O
beta NN O
chain NN O
contained VBD O
multiple JJ O
complex JJ O
carbohydrate NN O
side NN O
chains NNS O
. . O

An DT O
immunologically RB O
related JJ O
protein NN O
was VBD O
detected VBN O
in IN O
ribosome NN O
and CC O
membrane NN O
fractions NNS O
of IN O
mitochondria NN O
from IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

The DT O
prevalence NN O
of IN O
hepatitis NN B-Gene
B NNP I-Gene
surface NN I-Gene
antigen NN I-Gene
( ( O
HBsAg NNP B-Gene
) ) O
and CC O
anti $ B-Gene
- : I-Gene
HBs NNP I-Gene
was VBD O
determined VBN O
by IN O
a DT O
sensitive JJ O
double JJ O
- : O
antibody NN O
radio NN O
- : O
immunoassay NN O
technique NN O
in IN O
a DT O
series NN O
of IN O
patients NNS O
with IN O
chronic JJ O
liver NN O
diseases NNS O
. . O

Patients NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
treatment NN O
with IN O
the DT O
ACE NNP B-Gene
inhibitor NN O
perindopril NN O
( ( O
and CC O
the DT O
diuretic JJ O
indapamide NN O
for IN O
those DT O
with IN O
no DT O
definite JJ O
indication NN O
for IN O
or CC O
contraindication NN O
to TO O
treatment NN O
with IN O
a DT O
diuretic JJ O
) ) O
or CC O
matching VBG O
placebo NN O
( ( O
s NN O
) ) O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
spontaneous JJ O
recovery NN O
of IN O
central JJ O
respiratory NN O
function NN O
after IN O
intoxication NN O
with IN O
Soman NNP O
or CC O
Sarin NNP O
may MD O
not RB O
be VB O
related VBN O
to TO O
the DT O
return NN O
of IN O
AChE NNP B-Gene
activity NN O
. . O

The DT O
nucleotide JJ O
sequences NNS O
at IN O
the DT O
5 CD O
' POS O
and CC O
3 CD O
' '' O
ends NNS O
of IN O
these DT O
introns NNS O
are VBP O
characteristic JJ O
of IN O
spliced JJ O
transcripts NNS O
from IN O
eukaryotic JJ O
protein NN O
- : O
encoding VBG O
genes NNS O
, , O
with IN O
one CD O
significant JJ O
difference NN O
; : O
i NN O
. . O
e NN O
. . O
, , O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
LAT NNP B-Gene
intron NN I-Gene
is VBZ O
GC NNP O
instead RB O
of IN O
the DT O
consensus NN O
sequence NN O
GT NNP O
. . O

We PRP O
suggest VBP O
that IN O
CT NNP O
scan JJ O
be VB O
preferable JJ O
in IN O
diagnosis NN O
of IN O
tumors NNS O
in IN O
that DT O
area NN O
. . O

The DT O
inserted JJ O
region NN O
, , O
which WDT O
represents VBZ O
an DT O
intron NN O
in IN O
brain NN O
and CC O
muscle NN O
, , O
is VBZ O
expressed VBN O
in IN O
the DT O
tumor NN O
cell NN O
lines NNS O
either CC O
as IN O
a DT O
"""" NNP O
readthrough NN O
"""" NNP O
form NN O
or CC O
with IN O
78 CD O
residues NNS O
deleted VBN O
from IN O
its PRP$ O
5 CD O
' POS O
end NN O
. . O

The DT O
magnitude NN O
of IN O
the DT O
early JJ O
response NN O
was VBD O
241 CD O
+ JJ O
/ NNP O
- : O
51 CD O
% NN O
in IN O
A NNP O
( ( O
% NN O
baseline NN O
RL NNP O
; : O
mean JJ O
+ NNP O
/ NNP O
- : O
SE NN O
) ) O
, , O
and CC O
significantly RB O
less RBR O
in IN O
B NNP O
( ( O
119 CD O
+ NN O
/ NNP O
- : O
7 CD O
% NN O
) ) O
and CC O
C NNP O
( ( O
131 CD O
+ NN O
/ NNP O
- : O
16 CD O
% NN O
) ) O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
outcome NN O
of IN O
the DT O
optimization NN O
of IN O
the DT O
seven CD O
- : O
field NN O
plan NN O
prompted VBD O
an DT O
investigation NN O
into IN O
the DT O
best JJS O
results NNS O
that WDT O
could MD O
be VB O
achieved VBN O
by IN O
an DT O
"""" JJ O
ideal NN O
"""" NNP O
conformal JJ O
radiotherapy NN O
technique NN O
. . O

For IN O
this DT O
reason NN O
, , O
the DT O
particle NN O
forming VBG O
capacity NN O
of IN O
derivatives NNS O
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
group NN I-Gene
specific JJ I-Gene
core NN I-Gene
antigen NN I-Gene
p55 NN I-Gene
gag NN I-Gene
was VBD O
assayed VBN O
and CC O
compared VBN O
dependent NN O
on IN O
various JJ O
expression NN O
systems NNS O
: : O
recombinant JJ O
bacteria NNS O
, , O
vaccinia SYM O
- : O
and CC O
baculoviruses NNS O
were VBD O
established VBN O
encoding VBG O
the DT O
entire JJ O
core NN B-Gene
protein NN I-Gene
p55 NN I-Gene
either RB O
in IN O
its PRP$ O
authentic JJ O
sequence NN O
or CC O
lacking VBG O
the DT O
myristylation NN O
consensus NN O
signal NN O
. . O

Chemical NNP O
histologic NN O
and CC O
immunologic JJ O
responses NNS O
in IN O
rats NNS O
to TO O
CC1 NNP O
- : O
4 CD O
by IN O
different JJ O
routes NNS O
of IN O
administration NN O
. . O

CONCLUSIONS NN O
: : O
These DT O
results NNS O
show VBP O
that DT O
once RB O
daily JJ O
oral JJ O
valganciclovir NN O
can MD O
produce VB O
exposures NNS O
of IN O
ganciclovir NN O
( ( O
AUC24 NNP O
) ) O
exceeding VBG O
those DT O
attained VBN O
using VBG O
intravenous JJ O
ganciclovir NNS O
10 CD O
mg NNS O
/ JJ O
kg NN O
. . O

Similarly RB O
, , O
curcumin NN O
( ( O
diferuloylmethane NN O
) ) O
, , O
an DT O
anti JJ O
- : O
inflammatory NN O
agent NN O
, , O
suppressed VBD O
OSM NNP B-Gene
- : O
stimulated VBD O
STAT1 NNP B-Gene
phosphorylation NN O
, , O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
STAT1 NNP B-Gene
, , O
and CC O
c SYM B-Gene
- : I-Gene
Jun NNP I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
activation NN O
without IN O
affecting VBG O
JAK1 NNP B-Gene
, , O
JAK2 NNP B-Gene
, , O
JAK3 NNP B-Gene
, , O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
, , O
and CC O
p38 JJ B-Gene
phosphorylation NN O
. . O

The DT O
results NNS O
corroborate VBP O
the DT O
idea NN O
that IN O
the DT O
structure NN O
of IN O
relaxation NN O
curves NNS O
contains VBZ O
information NN O
on IN O
the DT O
distance NN O
scale NN O
and CC O
on IN O
the DT O
architecture NN O
of IN O
the DT O
pore NN O
space NN O
, , O
even RB O
if IN O
it PRP O
is VBZ O
difficult JJ O
to TO O
extract VB O
it PRP O
without IN O
ambiguities NNS O
. . O

The DT O
study NN O
enrolled VBD O
994 CD O
people NNS O
co VBP O
- : O
infected VBN O
with IN O
CMV NNP O
and CC O
HIV NNP O
, , O
with IN O
at IN O
least JJS O
one CD O
CD4 NNP B-Gene
count NN O
recorded VBD O
< $ O
100 CD O
x $ O
10 CD O
( ( O
6 CD O
) ) O
cells NNS O
/ JJ O
l NN O
. . O

If IN O
NCR NNP O
- : O
sensitive JJ O
gene NN O
expression NN O
occurs VBZ O
exclusively RB O
by IN O
this DT O
pathway NN O
, , O
as IN O
has VBZ O
been VBN O
thought VBN O
to TO O
be VB O
the DT O
case NN O
, , O
then RB O
the DT O
NCR NNP O
sensitivity NN O
of IN O
a DT O
gene NN O
' POS O
s JJ O
expression NN O
should MD O
be VB O
abolished VBN O
by IN O
a DT O
ure2 JJ B-Gene
delta NN I-Gene
mutation NN I-Gene
. . O

Human NNP B-Gene
MGP NNP I-Gene
is VBZ O
a DT O
10 CD B-Gene
- : I-Gene
kD NN I-Gene
skeletal JJ I-Gene
extracellular JJ I-Gene
matrix NN I-Gene
( ( I-Gene
ECM NNP I-Gene
) ) I-Gene
protein VBP I-Gene
that IN O
consists VBZ O
of IN O
an DT O
84 CD O
- : O
aa NN O
mature NN O
protein NN O
and CC O
a DT O
19 CD O
- : O
aa NN O
transmembrane JJ O
signal JJ O
peptide NN O
. . O

We PRP O
examined VBD O
behavioral JJ O
alterations NNS O
in IN O
the DT O
brown JJ O
cockroach NN O
, , O
Periplaneta NNP O
brunnea NN O
, , O
infected VBN O
with IN O
the DT O
acanthocephalan NN O
, , O
Moniliformis NNP O
moniliformis NN O
. . O

Behavior NNP O
of IN O
aspartate JJ B-Gene
aminotransferase NN I-Gene
( ( O
EC NNP B-Gene
2 CD I-Gene
. . I-Gene
6 CD I-Gene
. . I-Gene
1 CD I-Gene
. . I-Gene
1 CD I-Gene
) ) O
and CC O
alanine JJ B-Gene
aminotransferase NN I-Gene
( ( O
EC NNP B-Gene
2 CD I-Gene
. . I-Gene
6 CD I-Gene
. . I-Gene
1 CD I-Gene
. . I-Gene
2 CD I-Gene
) ) O
in IN O
rat NN O
serum NN O
during IN O
the DT O
course NN O
of IN O
acute JJ O
radiation NN O
syndrome NN O
following VBG O
whole JJ O
body NN O
X NNP O
- : O
irradiation NN O

Neuron NNP B-Gene
- : I-Gene
specific JJ I-Gene
Bcl NNP I-Gene
- : I-Gene
2 CD I-Gene
homology NN I-Gene
3 CD I-Gene
domain NN I-Gene
- : I-Gene
only RB I-Gene
splice NN I-Gene
variant NN I-Gene
of IN O
Bak NNP B-Gene
is VBZ O
anti JJ O
- : O
apoptotic JJ O
in IN O
neurons NNS O
, , O
but CC O
pro JJ O
- : O
apoptotic NN O
in IN O
non JJ O
- : O
neuronal JJ O
cells NNS O
. . O

Therefore RB O
, , O
mechanisms NNS O
that IN O
control NN O
activation NN O
of IN O
the DT O
MAP NNP B-Gene
kinase NN I-Gene
cascade NN O
temporally RB O
and CC O
spatially RB O
may MD O
be VB O
important JJ O
for IN O
specification NN O
of IN O
cellular JJ O
responses NNS O
. . O

Several JJ O
particular JJ O
features NNS O
of IN O
this DT O
polypeptide JJ O
fragment NN O
from IN O
the DT O
hamster NN B-Gene
lysyl SYM I-Gene
- : I-Gene
tRNA NN I-Gene
synthetase NN I-Gene
suggest VBP O
that IN O
it PRP O
is VBZ O
implicated VBN O
in IN O
the DT O
assembly NN O
of IN O
that DT O
enzyme NN O
within IN O
the DT O
multisynthetase NN O
complex NN O
. . O

Goodpasture NNP O
' POS O
s JJ O
- : O
like IN O
syndrome NN O
and CC O
effect NN O
of IN O
extracorporeal JJ O
membrane NN O
oxygenator NN O
support NN O
. . O

Liver NNP O
microsomes NNS O
of IN O
the DT O
shag NN O
showed VBD O
smaller JJR O
than IN O
8 CD O
% NN O
of IN O
the DT O
epoxide JJ B-Gene
hydrase NN I-Gene
activity NN O
and CC O
smaller JJR O
than IN O
14 CD O
% NN O
of IN O
the DT O
hydroxylating VBG O
capacity NN O
of IN O
liver NN O
microsomes NNS O
from IN O
the DT O
rat NN O
. . O

It PRP O
is VBZ O
now RB O
recognized VBN O
that IN O
essentially RB O
all DT O
eukaryotic JJ O
and CC O
prokaryotic JJ O
genes NNS O
whose WP$ O
5 CD O
' '' O
- : O
flanking NN O
regions NNS O
are VBP O
known VBN O
and CC O
that IN O
encode NN O
barbiturate NN O
- : O
inducible JJ O
proteins NNS O
contain VBP O
the DT O
Barbie NNP O
box NN O
element NN O
. . O

Interestingly RB O
, , O
an DT O
increase NN O
of IN O
distance NN O
per IN O
se NN O
did VBD O
not RB O
have VB O
a DT O
deleterious JJ O
effect NN O
on IN O
translation NN O
efficiency NN O
. . O

Localized VBN O
fluorescence NN O
was VBD O
detectable JJ O
only RB O
in IN O
cells NNS O
containing VBG O
a DT O
visible JJ O
midcell NN O
constriction NN O
, , O
suggesting VBG O
that IN O
FtsK NNP B-Gene
targeting VBG O
normally RB O
occurs VBZ O
only RB O
at IN O
a DT O
late JJ O
stage NN O
of IN O
septation NN O
. . O

S NNP O
. . O
, , O
Kim NNP O
, , O
S NNP O
. . O

The DT O
unexpected JJ O
presence NN O
of IN O
the DT O
tRNA NN B-Gene
( ( I-Gene
trp NN I-Gene
) ) I-Gene
( ( I-Gene
CCA NNP I-Gene
) ) I-Gene
- : I-Gene
gene NN I-Gene
transcript NN I-Gene
in IN I-Gene
mitochondria NN I-Gene
is VBZ O
also RB O
reported VBN O
. . O

Amyloid NNP B-Gene
beta SYM I-Gene
- : I-Gene
protein NN I-Gene
( ( O
Abeta NNP B-Gene
) ) O
is VBZ O
the DT O
main JJ O
constituent NN O
of IN O
amyloid NN O
fibrils NNS O
found VBN O
in IN O
senile JJ O
plaques NNS O
and CC O
cerebral JJ O
vessels NNS O
in IN O
Alzheimer NNP O
' POS O
s NN O
disease NN O
( ( O
AD NNP O
) ) O
and CC O
is VBZ O
derived VBN O
by IN O
proteolysis NN O
from IN O
the DT O
beta NN B-Gene
- : I-Gene
amyloid NN I-Gene
precursor NN I-Gene
protein NN I-Gene
( ( O
APP NNP B-Gene
) ) O
. . O

A23187 NNP O
did VBD O
not RB O
induce VB O
any DT O
modifications NNS O
of IN O
the DT O
endolymphatic JJ O
potential NN O
, , O
the DT O
ampullar JJ O
direct JJ O
current JJ O
or CC O
the DT O
frequency NN O
of IN O
the DT O
evoked JJ O
afferent NN O
spikes NNS O
. . O

In IN O
the DT O
adult NN O
mouse NN O
, , O
ERR NNP B-Gene
alpha NN I-Gene
is VBZ O
most RBS O
highly RB O
expressed VBN O
in IN O
kidney NN O
, , O
heart NN O
, , O
and CC O
brown JJ O
adipocytes NNS O
, , O
tissues NNS O
which WDT O
preferentially RB O
metabolize VBP O
fatty JJ O
acids NNS O
. . O

Component NNP O
P100 NNP O
was VBD O
associated VBN O
with IN O
a DT O
frontal JJ O
negativity NN O
of IN O
similar JJ O
latency NN O
favoring VBG O
the DT O
hypothesis NN O
of IN O
a DT O
dipolar JJ O
occipital JJ O
generator NN O
. . O

G NNP O
- : O
box NN O
- : O
directed VBN O
expression NN O
in IN O
leaves NNS O
required VBD O
the DT O
presence NN O
of IN O
an DT O
enhancer JJ O
region NN O
from IN O
the DT O
cauliflower NN O
mosaic NN O
virus NN O
( ( O
CaMV NNP O
) ) O
35S CD B-Gene
promoter NN I-Gene
. . O

Vertebrate NNP B-Gene
synapsins NNS I-Gene
constitute VBP O
a DT O
family NN O
of IN O
synaptic JJ O
proteins NNS O
that WDT O
participate VBP O
in IN O
the DT O
regulation NN O
of IN O
neurotransmitter JJ O
release NN O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
describe VBP O
the DT O
characterization NN O
of IN O
two CD O
early JJ O
class NN B-Gene
II NNP I-Gene
flagellar JJ I-Gene
genes NNS I-Gene
contained VBN O
in IN O
the DT O
orfX JJ O
- : O
fliP NN B-Gene
locus NN O
. . O

Results NNS O
from IN O
our PRP$ O
and CC O
other JJ O
laboratories NNS O
have VBP O
suggested VBN O
that IN O
UCN NNP O
- : O
1 CD O
induces NNS O
preferential JJ O
G1 NNP O
- : O
phase NN O
accumulation NN O
in IN O
several JJ O
human JJ O
tumor NN O
cell NN O
lines NNS O
tested VBN O
. . O

Small JJ O
- : O
molecule NN O
control NN O
of IN O
insulin NN B-Gene
and CC O
PDGF NNP B-Gene
receptor NN I-Gene
signaling VBG O
and CC O
the DT O
role NN O
of IN O
membrane NN O
attachment NN O
. . O

The DT O
gene NN O
encoding VBG O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
was VBD O
previously RB O
found VBN O
to TO O
contain VB O
an DT O
intronic JJ O
enhancer NN O
element NN O
that WDT O
was VBD O
not RB O
tissue JJ O
- : O
specific NN O
in IN O
its PRP$ O
activity NN O
, , O
despite IN O
the DT O
restricted JJ O
expression NN O
of IN O
the DT O
intact JJ O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
encoding VBG I-Gene
gene NN I-Gene
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
bradycardic JJ O
agents NNS O
alinidine JJ O
and CC O
zatebradine NN O
do VBP O
not RB O
exert VB O
antiarrhythmic JJ O
efficacy NN O
against IN O
SVT NNP O
induced VBD O
during IN O
subacute JJ O
myocardial JJ O
infarction NN O
in IN O
conscious JJ O
dogs NNS O
. . O

To TO O
the DT O
problem NN O
of IN O
the DT O
stimulation NN O
of IN O
the DT O
growth NN O
of IN O
transplantable JJ O
tumors NNS O
of IN O
animals NNS O
previously RB O
treated VBN O
with IN O
antineoplastic JJ O
antibiotics NNS O

By IN O
using VBG O
lacZ JJ B-Gene
fusions NNS I-Gene
, , O
it PRP O
was VBD O
possible JJ O
to TO O
localize VB O
the DT O
DNA NNP O
sequences NNS O
required VBD O
to TO O
mediate VB O
nitrate JJ O
repression NN O
to TO O
the DT O
pfl NN B-Gene
promoter NN I-Gene
- : I-Gene
regulatory JJ I-Gene
region NN I-Gene
. . O

References NNS O
for IN O
occupational JJ O
fitness NN O
of IN O
adolescents NNS O
with IN O
diseases NNS O
of IN O
the DT O
respiratory NN O
tract NN O
and CC O
lungs NNS O

The DT O
reason NN O
that WDT O
nitrous JJ O
oxide NN O
does VBZ O
not RB O
produce VB O
hydroxyl JJ O
radicals NNS O
readily RB O
might MD O
be VB O
that IN O
the DT O
one CD O
- : O
electron NN O
reduction NN O
proceeds NNS O
through IN O
an DT O
N2O NNP O
- : O
intermediate NN O
which WDT O
is VBZ O
energetically RB O
very RB O
unfavourable JJ O
: : O
EO NNP O
( ( O
N2O NNP O
/ NNP O
N2O NNP O
- : O
) ) O
= SYM O
- : O
1 CD O
. . O
1 CD O
V NNP O
. . O

It PRP O
was VBD O
postulated VBN O
that IN O
persistent JJ O
challenge NN O
by IN O
M NNP O
. . O
leprae NN O
or CC O
its PRP$ O
antigens NNS O
to TO O
the DT O
IgA NNP B-Gene
immunocytes NNS O
of IN O
the DT O
intestinal JJ O
epithelium NN O
might MD O
have VB O
induced VBN O
tolerance NN O
leading VBG O
to TO O
IgA NNP B-Gene
deficiency NN O
and CC O
subsequent JJ O
subtotal JJ O
atrophy NN O
of IN O
the DT O
intestinal JJ O
villi NN O
in IN O
the DT O
patients NNS O
with IN O
lepromatous JJ O
leprosy NNS O
. . O

Directives NNS O
concerning VBG O
medical JJ O
care NN O

Alanine NNP B-Gene
aminotransferase NN I-Gene
in IN O
clinical JJ O
practice NN O
. . O

This DT O
scFv NN O
was VBD O
therefore RB O
used VBN O
as IN O
control NN O
in IN O
experiments NNS O
where WRB O
another DT O
anti NN B-Gene
- : I-Gene
Ras NNP I-Gene
scFv NN I-Gene
( ( O
Y259 NNP B-Gene
scFv NN I-Gene
, , O
derived VBN O
from IN O
the DT O
neutralizing VBG O
anti JJ B-Gene
- : I-Gene
Ras NNP I-Gene
mAb FW I-Gene
Y13 NNP I-Gene
- : I-Gene
259 CD I-Gene
) ) O
blocked VBD O
the DT O
Ras NNP B-Gene
pathway NN O
in IN O
vitro NN O
and CC O
led VBD O
to TO O
tumor VB O
regression NN O
in IN O
a DT O
nude JJ O
mouse NN O
model NN O
[ NNP O
Cochet NNP O
, , O
O NNP O
. . O
, , O
Kenigsberg NNP O
, , O
M NNP O
. . O
, , O
Delumeau NNP O
, , O
I PRP O
. . O
, , O
Virone NNP O
- : O
Oddos NNP O
, , O
A NNP O
. . O
, , O
Multon NNP O
, , O
M NNP O
. . O
C NNP O
. . O
, , O
Fridman NNP O
, , O
W NNP O
. . O
H NNP O
. . O
, , O
Schweighoffer NNP O
, , O
F NNP O
. . O
, , O
Teillaud NNP O
, , O
J NNP O
. . O
L NNP O
. . O
, , O
Tocque NNP O
, , O
B NNP O
. . O
, , O
1998 CD O
. . O

M NNP O
. . O

The DT O
hypothesis NN O
of IN O
Geisler NNP O
( ( O
Brain NNP O
Res NNP O
. . O

PURPOSE NN O
: : O
To TO O
introduce VB O
an DT O
image NN O
analysis NN O
of IN O
the DT O
cornea NN O
in IN O
photorefractive JJ O
keratectomy NN O
( ( O
PRK NNP O
) ) O
for IN O
preoperative NN O
and CC O
early JJ O
postoperative JJ O
determination NN O
of IN O
changes NNS O
in IN O
the DT O
condition NN O
of IN O
the DT O
cornea NN O
. . O

In IN O
general JJ O
lookback NN O
, , O
all DT O
patients NNS O
who WP O
received VBD O
blood NN O
before IN O
being VBG O
tested VBN O
for IN O
hepatitis NN O
C NNP O
are VBP O
advised VBN O
to TO O
undergo VB O
testing NN O
. . O

Two CD O
cases NNS O
with IN O
marked JJ O
chronic JJ O
arm NN O
lymphoedema NN O
reported VBD O
major JJ O
and CC O
persistent JJ O
improvements NNS O
in IN O
arm NN O
volume NN O
for IN O
at IN O
least JJS O
12 CD O
months NNS O
after IN O
treatment NN O
with IN O
HBO2 NNP O
. . O

Mutational JJ O
studies NNS O
provide VBP O
evidence NN O
to TO O
this DT O
end NN O
and CC O
indicate NN O
that IN O
the DT O
side NN O
chains NNS O
of IN O
subdomain NN O
4 CD O
. . O
2 CD O
make NN O
specific JJ O
contacts NNS O
with IN O
the DT O
nucleotides NNS O
at IN O
- : O
35 CD O
. . O

Band NNP O
- : O
shift NN O
assays NNS O
and CC O
DNase NNP B-Gene
I PRP I-Gene
footprinting VBG O
experiments NNS O
using VBG O
purified VBD O
42 CD O
kDa NN O
repressor NN O
isoform NN O
confirmed VBD O
that IN O
CIRs NNP B-Gene
5 CD I-Gene
and CC I-Gene
6 CD I-Gene
were VBD O
indeed RB O
the DT O
targets NNS O
for IN O
binding NN O
of IN O
this DT O
protein NN O
. . O

Following VBG O
the DT O
satisfactory JJ O
results NNS O
and CC O
taking VBG O
into IN O
account NN O
that IN O
the DT O
complications NNS O
had VBD O
reduced VBN O
to TO O
a DT O
very RB O
low JJ O
rate NN O
( ( O
in IN O
2 CD O
cases NNS O
lead JJ O
tip JJ O
displacement NN O
and CC O
pouch JJ O
haematoma NN O
occurred VBD O
respectively RB O
) ) O
, , O
the DT O
Authors NNS O
consider VBP O
the DT O
adopted VBN O
method NN O
an DT O
useful JJ O
approach NN O
for IN O
PMK NNP O
implantation NN O
particularly RB O
when WRB O
the DT O
use NN O
of IN O
the DT O
vena NN O
cephalica NN O
is VBZ O
deemed VBN O
impossible JJ O
. . O

Unlike IN O
the DT O
MAR NNP O
- : O
binding NN O
domain NN O
, , O
the DT O
homeodomain NN B-Gene
when WRB O
isolated JJ O
binds NNS O
poorly RB O
and CC O
with IN O
low JJ O
specificity NN O
to TO O
DNA NNP O
. . O

Full NNP O
thyroid NN O
function NN O
testing NN O
was VBD O
performed VBN O
on IN O
600 CD O
randomly RB O
selected VBN O
samples NNS O
with IN O
normal JJ O
TSH NNP B-Gene
values NNS O
and CC O
also RB O
on IN O
subjects NNS O
with IN O
abnormal JJ O
TSH NNP B-Gene
levels NNS O
. . O

These DT O
are VBP O
two CD O
regions NNS O
of IN O
known VBN O
conserved JJ O
synteny NN O
, , O
providing VBG O
further JJ O
evidence NN O
that IN O
the DT O
human JJ B-Gene
STEP NNP I-Gene
is VBZ O
a DT O
true JJ O
homolog NN O
of IN O
the DT O
murine JJ B-Gene
STEP NNP I-Gene
gene NN I-Gene
. . O

Jerseys NNS O
had VBD O
higher RBR O
hepatic JJ O
Cu NNP O
concentrations NNS O
than IN O
did VBD O
Holsteins NNP O
on IN O
d NN O
60 CD O
( ( O
346 CD O
vs NN O
. . O

In IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
, , O
copper NN O
levels NNS O
exert VBP O
some DT O
control NN O
over IN O
the DT O
level NN O
of IN O
SOD1 NNP B-Gene
expression NN O
. . O

RESULTS NN O
: : O
No DT O
significant JJ O
deformation NN O
in IN O
vertebral JJ O
artery NN O
flow NN O
was VBD O
noted VBN O
in IN O
the DT O
flexion NN O
- : O
distraction NN O
Stage NN O
I PRP O
injuries VBP O
within IN O
the DT O
physiologic JJ O
range NN O
of IN O
cervical JJ O
flexion NN O
. . O

No DT O
homology NN O
was VBD O
found VBN O
between IN O
RNA14 NNP B-Gene
and CC O
RNA15 NNP B-Gene
or CC O
between IN O
RNA14 NNP B-Gene
and CC O
other JJ O
proteins NNS O
contained VBN O
in IN O
data NNS O
banks NNS O
. . O

Ischemic NNP O
stroke VBD O
due JJ O
to TO O
protein VB B-Gene
C NNP I-Gene
deficiency NN O
. . O

Degenerate NNP O
primers NNS O
homologous JJ O
to TO O
highly RB O
conserved JJ O
regions NNS O
of IN O
known VBN O
CYP3A NNP B-Gene
sequences NNS I-Gene
were VBD O
used VBN O
for IN O
initial JJ O
RT NNP O
- : O
PCRs NN O
. . O

In IN O
the DT O
course NN O
of IN O
screening VBG O
for IN O
transcription NN O
factors NNS O
which WDT O
interact VBP O
with IN O
the DT O
human JJ B-Gene
myeloperoxidase NN I-Gene
( ( O
MPO NNP B-Gene
) ) O
promoter NN O
we PRP O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
identified VBN O
and CC O
cloned VBN O
the DT O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
for IN O
human JJ B-Gene
HBP1 NNP I-Gene
( ( O
HMG NNP B-Gene
- : I-Gene
Box NNP I-Gene
containing VBG I-Gene
protein RB I-Gene
1 CD I-Gene
) ) O
, , O
a DT O
member NN O
of IN O
the DT O
high JJ B-Gene
mobility NN I-Gene
group NN I-Gene
of IN I-Gene
non JJ I-Gene
- : I-Gene
histone NN I-Gene
chromosomal JJ I-Gene
proteins NNS I-Gene
. . O

A DT O
single JJ O
five CD O
minute JJ O
period NN O
of IN O
rapid JJ O
atrial JJ O
pacing NN O
fails NNS O
to TO O
limit VB O
infarct JJ O
size NN O
in IN O
the DT O
in IN O
situ JJ O
rabbit NN O
heart NN O
. . O

4 CD O
. . O

The DT O
GHR NNP B-Gene
mRNA NN I-Gene
: : O
GHBP NNP B-Gene
mRNA VBD I-Gene
ratio NN O
was VBD O
1 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
12 CD O
and CC O
remained VBD O
unchanged JJ O
during IN O
differentiation NN O
. . O

This DT O
organization NN O
suggests VBZ O
that IN O
duplication NN O
events NNS O
that WDT O
have VBP O
generated VBN O
the DT O
primate NN O
FUT3 NNP B-Gene
- : O
FUT5 NNP B-Gene
- : O
FUT6 NNP B-Gene
cluster NN O
might MD O
have VB O
occurred VBN O
through IN O
a DT O
long JJ O
- : O
interspersed VBN O
- : O
nuclear JJ O
- : O
element NN O
- : O
based VBN O
mechanism NN O
of IN O
unequal JJ O
crossing NN O
over RB O
, , O
as IN O
described VBN O
for IN O
the DT O
globin NN B-Gene
cluster NN I-Gene
. . O

However RB O
, , O
the DT O
beta5L NN O
splice NN O
variant NN O
was VBD O
found VBN O
only RB O
in IN O
the DT O
retina NN O
. . O

At IN O
physiological JJ O
doses NNS O
, , O
either CC O
insulin SYM B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
I PRP I-Gene
( ( O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
) ) O
or CC O
insulin NN B-Gene
turned VBD O
out RP O
to TO O
be VB O
as RB O
potent JJ O
as IN O
dibutyryl NN O
cAMP NN O
( ( O
dbcAMP NN O
) ) O
in IN O
increasing VBG O
UCP1 NNP B-Gene
gene NN I-Gene
transcription NN O
rate NN O
( ( O
1 CD O
h NN O
) ) O
and CC O
also RB O
UCP1 NNP B-Gene
mRNA NN I-Gene
accumulation NN O
( ( O
3 CD O
h NN O
) ) O
, , O
their PRP$ O
maximal JJ O
effect NN O
( ( O
15 CD O
- : O
fold JJ O
increase NN O
) ) O
reached VBD O
upon IN O
treatment NN O
for IN O
24 CD O
h NN O
. . O

The DT O
extended JJ O
rat NN B-Gene
SP NNP I-Gene
- : I-Gene
A DT I-Gene
isoforms NNS I-Gene
were VBD O
enriched VBN O
in IN O
the DT O
more RBR O
fully RB O
glycosylated VBN O
and CC O
multimeric JJ O
SP NNP B-Gene
- : I-Gene
A DT I-Gene
species NNS O
separated VBN O
on IN O
SDS NNP O
- : O
PAGE NN O
gels NNS O
. . O

Metabolic NNP O
labeling VBG O
studies NNS O
in IN O
S NNP O
. . O
cerevisiae NN O
and CC O
co NN O
- : O
expression NN O
of IN O
nmt72p NN B-Gene
with IN O
several JJ O
protein NNS O
substrates NNS O
of IN O
Nmt1p NNP B-Gene
in IN O
Escherichia NNP O
coli NN O
indicate NN O
that IN O
the DT O
Leu99 NNP O
- : O
- : O
> JJ O
Pro NNP O
substitution NN O
causes VBZ O
a DT O
reduction NN O
in IN O
the DT O
acylation NN O
of IN O
some DT O
but CC O
not RB O
all DT O
protein NN O
substrates VBZ O
. . O

The DT O
analysis NN O
of IN O
two CD O
distinct JJ O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
pathways NNS O
shows VBZ O
that IN O
stress NN B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
kinase NN I-Gene
- : O
Jun NNP B-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
activation NN O
, , O
resulting VBG O
in IN O
the DT O
phosphorylation NN O
of IN O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
c SYM B-Gene
- : I-Gene
Jun NN I-Gene
, , O
and CC O
JunD NNP B-Gene
, , O
is VBZ O
required VBN O
not RB O
only RB O
for IN O
the DT O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
but CC O
also RB O
for IN O
the DT O
TPA NNP O
- : O
dependent JJ O
induction NN O
, , O
while IN O
the DT O
extracellular JJ B-Gene
signal NN I-Gene
- : I-Gene
related JJ I-Gene
kinase NN I-Gene
1 CD I-Gene
( ( O
ERK NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
ERK NNP B-Gene
- : I-Gene
2 CD I-Gene
activation NN O
is VBZ O
involved VBN O
in IN O
the DT O
TPA NNP O
- : O
but CC O
not RB O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
stimulation NN O
of IN O
the DT O
uPA JJ B-Gene
enhancer NN I-Gene
. . O

Pharmacology NNP O
studies NNS O
with IN O
potassium NN O
chloride NN O
and CC O
acetylcholine NN O
suggest VBP O
that IN O
raveron NN O
acts NNS O
as IN O
a DT O
calcium NN O
antagonist NN O
by IN O
blocking VBG O
the DT O
influx NN O
of IN O
extracellular JJ O
calcium NN O
. . O

Future JJ O
analysis NN O
of IN O
long JJ O
- : O
term NN O
outcome JJ O
measures NNS O
of IN O
performance NN O
with IN O
the DT O
implant NN O
will MD O
confirm VB O
or CC O
dispute VB O
the DT O
benefit NN O
of IN O
ear JJ O
selection NN O
using VBG O
the DT O
Prom NNP O
- : O
EABR NN O
. . O

The DT O
maximum JJ O
deflections NNS O
of IN O
phase NN O
IV NNP O
for IN O
Ar NNP O
and CC O
N2 NNP O
from IN O
extrapolated VBN O
phase NN O
III NNP O
slopes NNS O
were VBD O
smaller JJR O
in IN O
the DT O
prone NN O
position NN O
, , O
suggesting VBG O
more RBR O
uniform JJ O
tracer NN O
gas NN O
concentrations NNS O
across IN O
the DT O
lungs NNS O
. . O

The DT O
single JJ O
strandedness NN O
is VBZ O
manifested VBN O
as IN O
a DT O
terminal JJ O
extension NN O
of IN O
the DT O
G NNP O
- : O
rich JJ O
strand NN O
( ( O
G NNP O
tails NNS O
) ) O
that WDT O
can MD O
occur VB O
independently RB O
of IN O
telomerase NN B-Gene
, , O
suggesting VBG O
that IN O
cdc17 NN B-Gene
/ NNP O
pol1 NN B-Gene
mutants NNS O
exhibit NN O
defects NNS O
in IN O
telomeric JJ O
lagging VBG O
- : O
strand NN O
synthesis NN O
. . O

Cloning NNP O
, , O
expression NN O
, , O
and CC O
nucleotide JJ O
sequence NN O
of IN O
rat NN B-Gene
liver FW I-Gene
sterol NN I-Gene
carrier NN I-Gene
protein VBZ I-Gene
2 CD I-Gene
cDNAs NN I-Gene
. . O

In IN O
summary JJ O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
adenoviral JJ O
oncoprotein NN O
E1A NNP B-Gene
activates VBZ O
transcription NN O
from IN O
the DT O
endogenous JJ O
AP NNP B-Gene
- : I-Gene
2alpha CD I-Gene
gene NN I-Gene
, , O
an DT O
effect NN O
that WDT O
involves VBZ O
transcriptional JJ O
derepression NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
2alpha CD I-Gene
promoter NN I-Gene
by IN O
interaction NN O
of IN O
E1A NNP B-Gene
with IN O
the DT O
AP NNP B-Gene
- : I-Gene
2rep CD I-Gene
corepressor NN O
CtBP1 NNP B-Gene
. . O

The DT O
frequency NN O
of IN O
lactase NN B-Gene
phenotypes NNS I-Gene
in IN O
Aymara NNP O
children NNS O
. . O

The DT O
protein NN O
first RB O
identified VBN O
by IN O
the DT O
monoclonal JJ B-Gene
antibody NN I-Gene
Q18 NNP I-Gene
is VBZ O
encoded VBN O
by IN O
a DT O
gene NN O
located VBN O
in IN O
57A CD O
on IN O
polytene NN O
chromosomes NNS O
and CC O
has VBZ O
been VBN O
consequently RB O
named VBN O
Hrb57A NNP B-Gene
. . O

These DT O
mutations NNS O
alter VBP O
two CD O
regions NNS O
of IN O
GAL4 NNP B-Gene
protein NN I-Gene
: : O
the DT O
DNA NN O
binding VBG O
domain NN O
, , O
and CC O
the DT O
transcription NN O
activation NN O
domain NN O
. . O

A DT O
similar JJ O
chimera NN O
was VBD O
assembled VBN O
from IN O
the DT O
two CD O
halves NNS O
of IN O
the DT O
molecule NN O
expressed VBD O
separately RB O
in IN O
different JJ O
bacteria NNS O
and CC O
refolded VBD O
together RB O
. . O

Both DT O
filters NNS O
equally RB O
contributed VBD O
to TO O
elevation NN O
of IN O
iliac JJ O
venous JJ O
pressure NN O
( ( O
median JJ O
, , O
9 CD O
. . O
3 CD O
and CC O
7 CD O
. . O
2 CD O
mm JJ O
Hg NNP O
[ NNP O
n VBD O
= $ O
9 CD O
] NN O
with IN O
the DT O
spring NN O
filter NN O
and CC O
RF02 NNP O
filter NN O
, , O
respectively RB O
) ) O
. . O

Carbohydrates NNS O
and CC O
glycoconjugates NNS O
biophysical JJ O
methods NNS O
. . O

The DT O
human JJ O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
snRNP NN O
contains VBZ O
60 CD O
and CC O
90kD CD O
proteins NNS O
that WDT O
are VBP O
structurally RB O
homologous JJ O
to TO O
the DT O
yeast NN O
splicing VBG O
factors NNS O
Prp4p NNP B-Gene
and CC O
Prp3p NNP B-Gene
. . O

Morphological NNP O
and CC O
functional JJ O
alterations NNS O
noted VBD O
after IN O
baboon JJ O
renal JJ O
allotransplantation NN O
. . O

Sequence NNP O
analysis NN O
of IN O
cloned VBN O
PCR NNP O
products NNS O
confirmed VBD O
the DT O
presence NN O
of IN O
two CD O
different JJ O
nifV SYM B-Gene
- : I-Gene
like IN I-Gene
DNA NNP I-Gene
fragments NNS I-Gene
, , O
which WDT O
were VBD O
subsequently RB O
used VBN O
as IN O
nifV JJ B-Gene
- : O
and CC O
leuA VB B-Gene
- : I-Gene
specific JJ I-Gene
probes NNS I-Gene
, , O
respectively RB O
, , O
to TO O
clone VB O
XbaI NNP B-Gene
fragments NNS I-Gene
of IN O
2 CD O
. . O
1 CD O
kbp NN O
( ( O
pOST4 NN O
) ) O
and CC O
2 CD O
. . O
6 CD O
kbp NN O
( ( O
pOST2 NN O
) ) O
. . O

Present JJ O
results NNS O
reveal VBP O
a DT O
frequency NN O
- : O
dependent JJ O
inhibition NN O
of IN O
ganglionic JJ O
transmission NN O
by IN O
diltiazem NN O
, , O
and CC O
suggest VBP O
that IN O
diltiazem NN O
may MD O
depress VB O
excessive JJ O
sympathetic JJ O
activity NN O
without IN O
affecting VBG O
normal JJ O
ganglionic JJ O
transmission NN O
. . O

The DT O
Sox NNP B-Gene
gene NN I-Gene
family NN I-Gene
( ( O
Sry NNP B-Gene
like IN I-Gene
HMG NNP I-Gene
box NNP I-Gene
gene NN I-Gene
) ) O
is VBZ O
characterised VBN O
by IN O
a DT O
conserved JJ O
DNA NNP O
sequence NN O
encoding VBG O
a DT O
domain NN O
of IN O
approximately RB O
80 CD O
amino NN O
acids NNS O
which WDT O
is VBZ O
responsible JJ O
for IN O
sequence NN O
specific JJ O
DNA NNP O
binding NN O
. . O

We PRP O
used VBD O
oligonucleotide PRP O
- : O
directed VBD O
mutagenesis NN O
to TO O
alter VB O
a DT O
site NN O
in IN O
MucA NNP B-Gene
homologous JJ O
to TO O
the DT O
Ala NNP O
- : O
Gly NNP O
cleavage VBP O
site NN O
of IN O
LexA NNP B-Gene
. . O

The DT O
calculated JJ O
pD2 NN O
values NNS O
were VBD O
8 CD O
. . O
8 CD O
for IN O
E NNP O
, , O
8 CD O
. . O
6 CD O
for IN O
DHE NNP O
and CC O
6 CD O
. . O
6 CD O
for IN O
M NNP O
. . O

The DT O
results NNS O
imply VBP O
that IN O
kindling VBG O
does VBZ O
not RB O
produce VB O
its PRP$ O
facilitating VBG O
effect NN O
on IN O
acquisition NN O
of IN O
HPC NNP O
SS NNP O
by IN O
removing VBG O
a DT O
disruptive JJ O
effect NN O
of IN O
the DT O
stimulation NN O
. . O

The DT O
serum JJ O
concentration NN O
of IN O
iP NN O
before IN O
dialysis NN O
( ( O
HD NNP O
) ) O
was VBD O
on IN O
average JJ O
3 CD O
. . O
6 CD O
( ( O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
81 CD O
) ) O
mmol NN O
/ NNP O
l NN O
and CC O
D NNP O
was VBD O
on IN O
average JJ O
55 CD O
. . O
6 CD O
( ( O
+ JJ O
/ NNP O
- : O
10 CD O
. . O
0 CD O
) ) O
mmol NN O
. . O

Furthermore RB O
, , O
in IN O
the DT O
ischemia NN O
/ NNP O
angiotension NN B-Gene
II NNP I-Gene
- : O
induced VBD O
AHF NNP O
model NN O
, , O
NIC NNP O
decreased VBD O
left VBD O
ventricular JJ O
end NN O
- : O
diastolic JJ O
pressure NN O
( ( O
LVEDP NNP O
) ) O
. . O

For IN O
functional JJ O
studies NNS O
, , O
two CD O
promoter NN O
regions NNS O
were VBD O
cloned VBN O
upstream NN O
of IN O
the DT O
reporter NN O
gene NN O
, , O
chloramphenicol JJ B-Gene
acetyl NN I-Gene
transferase NN I-Gene
( ( O
CAT NNP B-Gene
) ) O
: : O
( ( O
i NN O
) ) O
phbetaE NN O
- : O
B NNP O
- : O
the DT O
plasmid NN O
that WDT O
contains VBZ O
the DT O
human JJ O
( ( O
h NN O
) ) O
promoter NN O
region NN O
( ( O
- : O
2832 CD O
to TO O
+ VB O
101 CD O
) ) O
including VBG O
URE NNP O
, , O
and CC O
( ( O
ii NN O
) ) O
prhbetaE NN O
- : O
B NNP O
- : O
the DT O
plasmid NN O
that WDT O
contains VBZ O
the DT O
rhesus NN O
( ( O
rh NN O
) ) O
promoter NN O
region NN O
excluding VBG O
URE NNP O
as IN O
it PRP O
lacks VBZ O
a DT O
270 CD O
bp JJ O
region NN O
of IN O
the DT O
hbetaAPP NN B-Gene
promoter NN I-Gene
( ( O
- : O
2435 CD O
to TO O
- : O
2165 CD O
) ) O
. . O

Here RB O
, , O
a DT O
case NN O
of IN O
Sjogren NNP O
' POS O
s JJ O
syndrome NN O
is VBZ O
presented VBN O
that IN O
was VBD O
initially RB O
diagnosed VBN O
because IN O
of IN O
dental JJ O
complaints NNS O
, , O
and CC O
long RB O
- : O
term NN O
treatment NN O
of IN O
Sjogren NNP O
' POS O
s NN O
patients NNS O
is VBZ O
discussed VBN O
. . O

Magnetic JJ O
storm NN O
indicators NNS O
could MD O
be VB O
used VBN O
in IN O
medicine NN O
, , O
in IN O
geophysics NNS O
and CC O
for IN O
special JJ O
purposes NNS O
. . O

Short JJ O
therapy NN O
with IN O
omeprazole JJ O
20 CD O
mg NN O
/ NN O
b NN O
. . O
i NN O
. . O
d NN O
. . O
, , O
clarithromycin VBD O
500 CD O
mg NN O
/ NN O
b NN O
. . O
i NN O
. . O
d NN O
. . O
, , O
and CC O
CBS NNP O
120 CD O
mg NN O
/ NNP O
q NN O
. . O
i NN O
. . O
d NN O
. . O

is VBZ O
a DT O
safe JJ O
, , O
well RB O
tolerated VBN O
combination NN O
that WDT O
achieves VBZ O
a DT O
80 CD O
. . O
6 CD O
% NN O
eradication NN O
rate NN O
of IN O
H NNP O
. . O
pylori NN O
and CC O
duodenal JJ O
ulcer NN O
healing VBG O
rates NNS O
as RB O
good JJ O
as IN O
those DT O
achieved VBN O
by IN O
omeprazole JJ O
20 CD O
mg NN O
/ NNP O
d NN O
when WRB O
given VBN O
for IN O
4 CD O
wk NN O
. . O

Effects NNS O
of IN O
alcoholism NN O
on IN O
the DT O
family NN O

Samples NNS O
obtained VBN O
from IN O
normal JJ O
volunteers NNS O
and CC O
from IN O
the DT O
great JJ O
majority NN O
of IN O
the DT O
patients NNS O
, , O
excluding VBG O
those DT O
with IN O
asthma NN O
, , O
had VBD O
no DT O
effect NN O
on IN O
ciliary JJ O
beating NN O
. . O

Action NN O
of IN O
strontium NN O
- : O
90 CD O
and CC O
metaphos VB O
on IN O
Cyprinus NNP O
carpio NN O

Like IN O
the DT O
p190 NN B-Gene
- : I-Gene
B NNP I-Gene
exon NN O
, , O
the DT O
first JJ O
exon NN O
of IN O
p190 NN B-Gene
- : I-Gene
A DT I-Gene
is VBZ O
extremely RB O
large JJ O
( ( O
3 CD O
. . O
7 CD O
kb NN O
in IN O
length NN O
) ) O
, , O
encoding VBG O
both PDT O
the DT O
GTPase NNP B-Gene
and CC O
middle JJ O
domains NNS O
( ( O
residues NNS O
1 CD O
- : O
1228 CD O
) ) O
, , O
but CC O
not RB O
the DT O
remaining VBG O
GAP NNP B-Gene
domain NN I-Gene
, , O
suggesting VBG O
a DT O
high JJ O
conservation NN O
of IN O
genomic JJ O
structure NN O
between IN O
two CD O
p190 NN B-Gene
genes NNS I-Gene
. . O

These DT O
genes NNS O
encode VBP O
a DT O
tryptophanyl NN B-Gene
tRNA NN I-Gene
, , O
the DT O
protein NN B-Gene
translocase NN I-Gene
component NN O
SecE NNP B-Gene
, , O
the DT O
antiterminator NN B-Gene
protein NN I-Gene
NusG NNP I-Gene
, , O
and CC O
the DT O
ribosomal JJ O
proteins NNS O
L11 NNP B-Gene
and CC O
L1 NNP B-Gene
in IN O
addition NN O
to TO O
PkwR NNP B-Gene
, , O
a DT O
putative JJ O
regulatory JJ O
protein NN O
of IN O
the DT O
LacI NNP B-Gene
- : O
GalR NNP B-Gene
family NN O
. . O

I PRP O
. . O

Cardiovascular JJ O
risk NN O
factors NNS O
were VBD O
measured VBN O
by IN O
standardized JJ O
techniques NNS O
. . O

Electroglottography NN O
is VBZ O
a DT O
useful JJ O
, , O
non JJ O
- : O
invasive JJ O
technique NN O
that WDT O
can MD O
assist VB O
in IN O
the DT O
assessment NN O
of IN O
vocal JJ O
fold JJ O
dysfunction NN O
. . O

VEGF NNP B-Gene
promoter NN I-Gene
activity NN O
in IN O
transient JJ O
transfections NNS O
was VBD O
decreased VBN O
by IN O
either DT O
pharmacological JJ O
or CC O
genetic JJ O
inhibition NN O
of IN O
EGFR NNP B-Gene
, , O
Ras NNP B-Gene
, , O
or CC O
phosphatidylinositol RB B-Gene
3 CD I-Gene
' '' I-Gene
- : I-Gene
kinase NN I-Gene
[ JJ B-Gene
PI NNP I-Gene
( ( I-Gene
3 CD I-Gene
) ) I-Gene
kinase NN I-Gene
] NN I-Gene
. . O

We PRP O
have VBP O
also RB O
identified VBN O
a DT O
functional JJ O
domain NN O
in IN O
the DT O
ORF NNP O
50 CD O
protein NN O
, , O
an DT O
immediate JJ B-Gene
- : I-Gene
early JJ I-Gene
gene NN I-Gene
product NN I-Gene
that WDT O
is VBZ O
mainly RB O
encoded VBN O
by IN O
ORF NNP O
50 CD O
. . O

In IN O
vitro JJ O
protein NN O
retention NN O
experiments NNS O
in IN O
which WDT O
Hsp90 NNP B-Gene
heterocomplexes NNS I-Gene
were VBD O
precipitated VBN O
resulted VBN O
in IN O
coprecipitation NN O
of IN O
Cns1 NNP B-Gene
. . O

Only RB O
one CD O
gene NN O
, , O
fibronectin NN B-Gene
( ( O
FN NNP B-Gene
) ) O
, , O
was VBD O
highly RB O
overexpressed VBN O
( ( O
> $ O
60 CD O
- : O
fold NN O
) ) O
in IN O
LNCaP NNP O
- : O
r NN O
cells NNS O
, , O
consistent JJ O
with IN O
previously RB O
reported VBN O
overexpression NN O
of IN O
FN NNP B-Gene
in IN O
prostate NN O
cancer NN O
. . O

Immunologic NNP O
mechanisms NNS O
in IN O
chronic JJ O
brucellosis NN O
in IN O
humans NNS O
. . O

The DT O
measurement NN O
of IN O
NO NNP O
in IN O
biological JJ O
systems NNS O
using VBG O
chemiluminescence NN O
. . O

Laboratory NN O
exam NN O
: : O
IDR NN O
of IN O
the DT O
tuberculin NN B-Gene
was VBD O
high JJ O
positive JJ O
, , O
chest JJS O
radiography NN O
shows VBZ O
hilar JJ O
bilateral JJ O
calcifications NNS O
, , O
ORL NNP O
exam NN O
shows VBZ O
a DT O
tumor NN O
at IN O
the DT O
foot NN O
of IN O
the DT O
epiglottis NN O
and CC O
anatomopathological JJ O
exam NN O
shows NNS O
low JJ O
differentiated VBD O
epidermoid JJ O
carcinoma NN O
. . O

Recombination NN O
and CC O
transcription NN O
of IN O
the DT O
endogenous JJ B-Gene
Ig NNP I-Gene
heavy NN I-Gene
chain NN I-Gene
locus NN I-Gene
is VBZ O
effected VBN O
by IN O
the DT O
Ig NNP B-Gene
heavy NN I-Gene
chain NN I-Gene
intronic JJ I-Gene
enhancer NN I-Gene
core NN I-Gene
region NN I-Gene
in IN O
the DT O
absence NN O
of IN O
the DT O
matrix NN O
attachment NN O
regions NNS O
. . O

The DT O
present JJ O
study NN O
shows VBZ O
that IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
- : O
dependent JJ O
p38 NN B-Gene
kinase NN I-Gene
activation NN O
regulates VBZ O
Akt NNP B-Gene
phosphorylation NN O
and CC O
activity NN O
in IN O
human JJ O
neutrophils NNS O
. . O

Chromatin NNP O
repression NN O
of IN O
these DT O
replacement NN O
genes NNS O
would MD O
be VB O
avoided VBN O
, , O
consistent JJ O
with IN O
the DT O
high JJ O
, , O
constitutive JJ O
expression NN O
of IN O
replacement NN O
H3 NNP B-Gene
histone NN I-Gene
genes NNS I-Gene
in IN O
plants NNS O
. . O

Diethylene NNP O
benzene NN O

Recent JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
Y319 NNP O
also RB O
positively RB O
regulate VB O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
function NN O
. . O

Pathophysiology NN O
of IN O
bone NN O
loss NN O
in IN O
castrated JJ O
animals NNS O
. . O

Complexes NNS O
of IN O
qTBP42 NN B-Gene
with IN O
each DT O
complementary JJ O
strand NN O
of IN O
telomeric JJ O
DNA NNP O
and CC O
with IN O
quadruplex JJ O
forms NNS O
of IN O
the DT O
guanine NN O
- : O
rich JJ O
strand NN O
had VBD O
3 CD O
. . O
7 CD O
- : O
14 CD O
. . O
6 CD O
nM JJ O
dissociation NN O
constants NNS O
, , O
Kd NNP O
, , O
whereas IN O
complexes NNS O
with IN O
double JJ O
- : O
stranded VBD O
telomeric JJ O
DNA NN O
had VBD O
up RB O
to TO O
100 CD O
- : O
fold NN O
higher JJR O
Kd NNP O
values NNS O
. . O

Fifty NNP O
- : O
four CD O
patients NNS O
were VBD O
divided VBN O
into IN O
groups NNS O
according VBG O
to TO O
their PRP$ O
clinical JJ O
presentation NN O
; : O
seven CD O
asymptomatic JJ O
volunteers NNS O
, , O
20 CD O
patients NNS O
with IN O
duodenal JJ O
- : O
gastric JJ O
reflux NN O
gastropathy NN O
( ( O
DRG NNP O
) ) O
, , O
16 CD O
patients NNS O
with IN O
recurrent JJ O
ulcers NNS O
of IN O
the DT O
duodenal JJ O
bulb NN O
( ( O
RUD NNP O
) ) O
, , O
and CC O
11 CD O
patients NNS O
with IN O
Moynihan NNP O
' POS O
s JJ O
disease NN O
. . O

Proceedings NNS O
: : O
Barrels NNS O
and CC O
somatotopy NN O
in IN O
S NNP O
I PRP O
neocortex VBP O
of IN O
the DT O
brush NN O
- : O
tailed VBN O
possum NN O
. . O

Variability NN O
within IN O
Down NNP O
' POS O
s JJ O
syndrome NN O
( ( O
trisomy JJ O
- : O
21 CD O
) ) O
: : O
empirically RB O
observed VBD O
sex NN O
differences NNS O
in IN O
IQs NNP O
. . O

We PRP O
are VBP O
reporting VBG O
an DT O
autopsy JJ O
case NN O
of IN O
so RB O
- : O
called VBN O
"""" NNP O
acute NN O
multiple JJ O
sclerosis NN O
"""" NN O
that WDT O
was VBD O
difficult JJ O
to TO O
differentiate VB O
from IN O
a DT O
brain NN O
tumor NN O
on IN O
MRI NNP O
findings NNS O
. . O

The DT O
early JJ O
lethality NN O
of IN O
the DT O
left JJ O
- : O
sided VBD O
resectio NN O
was VBD O
0 CD O
% NN O
and CC O
the DT O
postoperative JJ O
survival NN O
- : O
- : O
5 CD O
- : O
10 CD O
months NNS O
. . O

ORF NNP B-Gene
E8 NNP I-Gene
colinear NN O
with IN O
ORF NNP B-Gene
E6 NNP I-Gene
, , O
which WDT O
could MD O
generate VB O
a DT O
50 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
with IN O
a DT O
hydrophobic JJ O
segment NN O
, , O
did VBD O
not RB O
transform VB O
cells NNS O
when WRB O
cloned VBN O
into IN O
the DT O
pZipNeo NN O
vector NN O
. . O

When WRB O
the DT O
cervical JJ O
Pap NNP O
smear NN O
is VBZ O
positive JJ O
. . O

However RB O
, , O
the DT O
inability NN O
to TO O
export VB O
RNA NNP O
from IN O
the DT O
nucleus NN O
to TO O
the DT O
cytoplasm NN O
was VBD O
not RB O
limited VBN O
to TO O
a DT O
particular JJ O
phase NN O
of IN O
the DT O
cell NN O
division NN O
cycle NN O
. . O

The DT O
mechanism NN O
of IN O
ligand NN O
- : O
activated VBN O
estrogen NN B-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( O
ERalpha NNP B-Gene
) ) O
- : O
dependent JJ O
activation NN O
of IN O
gene NN O
expression NN O
through IN O
the DT O
SRE NNP O
was VBD O
determined VBN O
by IN O
mutational JJ O
analysis NN O
of IN O
the DT O
promoter NN O
, , O
analysis NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
MAPK NNP B-Gene
) ) O
pathway NN O
activation NN O
by IN O
E2 NNP O
, , O
and CC O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TGF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
as IN O
a DT O
positive JJ O
control NN O
. . O

The DT O
results NNS O
were VBD O
as IN O
follows VBZ O
: : O
1 CD O
) ) O
Total NN O
integrated JJ O
EMG NNP O
activity NN O
of IN O
FB NNP O
group NN O
was VBD O
approximately RB O
equal JJ O
in IN O
any DT O
occluded JJ O
position NN O
, , O
whereas IN O
that DT O
of IN O
CG NNP O
and CC O
GF NNP O
group NN O
varied VBD O
from IN O
position NN O
to TO O
position NN O
. . O

For IN O
the DT O
first JJ O
group NN O
, , O
the DT O
maximal JJ O
decrease NN O
in IN O
plasma JJ O
potassium NN O
elicited VBN O
by IN O
salbutamol NN O
was VBD O
0 CD O
. . O
80 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
19 CD O
, , O
0 CD O
. . O
48 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
22 CD O
, , O
and CC O
0 CD O
. . O
78 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
46 CD O
mmol JJ O
/ NNP O
l NN O
, , O
and CC O
for IN O
the DT O
second JJ O
group NN O
, , O
maximal JJ O
decrement NN O
was VBD O
1 CD O
. . O
31 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
37 CD O
, , O
0 CD O
. . O
70 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
24 CD O
, , O
and CC O
0 CD O
. . O
84 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
17 CD O
mmol JJ O
/ NNP O
l NN O
for IN O
the DT O
iv NN O
, , O
po NN O
, , O
and CC O
it PRP O
routes VBZ O
, , O
respectively RB O
. . O

Plasma NNP B-Gene
lactoferrin NN I-Gene
and CC O
the DT O
blood NN O
count NN O
of IN O
polynuclear NN O
neutrophils NNS O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
sulfhydryl JJ O
group NN O
of IN O
certain JJ O
angiotensin NN B-Gene
converting VBG I-Gene
enzyme JJ I-Gene
inhibitors NNS O
can MD O
potentiate VB O
their PRP$ O
effect NN O
on IN O
the DT O
endogenous JJ O
nitrovasodilator NN O
EDRF NNP B-Gene
. . O

Disruption NN O
of IN O
the DT O
chromosomal JJ B-Gene
AAR1 NNP I-Gene
gene NN I-Gene
in IN O
alpha NN O
and CC O
a DT O
/ JJ O
alpha NN O
cells NNS O
conferred VBD O
the DT O
nonmating NN O
phenotype NN O
, , O
and CC O
the DT O
a DT O
/ JJ O
alpha NN O
diploids NNS O
could MD O
not RB O
sporulate VB O
. . O

Nevertheless RB O
, , O
they PRP O
are VBP O
functionally RB O
distinct JJ O
in IN O
that DT O
FcalphaRI NNP B-Gene
binds VBZ O
human JJ B-Gene
IgA NNP I-Gene
( ( O
hIgA NN B-Gene
) ) O
but CC O
not RB O
bovine VB B-Gene
IgG2 NNP I-Gene
( ( O
bIgG2 NN B-Gene
) ) O
, , O
whereas JJ O
bFcgamma2R NN B-Gene
binds NNS O
bIgG2 VBP B-Gene
but CC O
not RB O
hIgA VB B-Gene
. . O

Both DT O
mutations NNS O
completely RB O
abolished VBD O
binding NN O
of IN O
the DT O
Abl NNP B-Gene
SH3 NNP B-Gene
domain NN O
to TO O
proline VB O
- : O
rich JJ O
target NN O
proteins NNS O
in IN O
a DT O
filter NN O
- : O
binding NN O
assay NN O
. . O

BACKGROUND NN O
: : O
Left NNP O
ventricular JJ O
hypertrophy NN O
is VBZ O
a DT O
heterogeneous JJ O
disorder NN O
with IN O
distinct JJ O
morphologies NNS O
. . O

However RB O
, , O
study NN O
of IN O
the DT O
productive JJ O
gamma NN O
gene NN O
showed VBD O
that IN O
the DT O
skipped JJ O
variable JJ O
exon NN O
was VBD O
bounded VBN O
by IN O
normal JJ O
splicing NN O
signals NNS O
and CC O
that IN O
the DT O
adjacent JJ O
intron NN O
organization NN O
was VBD O
not RB O
altered VBN O
. . O

Intravenous JJ O
amine NN O
pressor NN O
tests NNS O
in IN O
healthy JJ O
volunteers NNS O
. . O

The DT O
colony NN B-Gene
- : I-Gene
stimulating NN I-Gene
factors NNS I-Gene
( ( O
CSFs NNP B-Gene
) ) O
principally RB O
involved VBN O
in IN O
the DT O
production NN O
of IN O
neutrophils NNS O
and CC O
monocytes NNS O
are VBP O
granulocyte JJ B-Gene
CSF NNP I-Gene
, , O
granulocyte SYM B-Gene
- : I-Gene
macrophage NN I-Gene
CSF NNP I-Gene
, , O
macrophage NN B-Gene
CSF NNP I-Gene
, , O
and CC O
interleukin JJ B-Gene
3 CD I-Gene
( ( O
sometimes RB O
called VBN O
multi NN B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
. . O

Expression NN O
of IN O
the DT O
phenylalanine NN B-Gene
hydroxylase NN I-Gene
gene NN I-Gene
in IN O
livers NNS O
and CC O
kidneys NNS O
of IN O
rodents NNS O
is VBZ O
activated VBN O
at IN O
birth NN O
and CC O
is VBZ O
induced VBN O
by IN O
glucocorticoids NNS O
and CC O
cyclic JJ O
AMP NNP O
in IN O
the DT O
liver NN O
. . O

The DT O
best JJS O
endometrial JJ O
ablation NN O
was VBD O
seen VBN O
when WRB O
SnET2 NNP O
was VBD O
given VBN O
by IN O
intrauterine JJ O
administration NN O
with IN O
light JJ O
treatment NN O
at IN O
150 CD O
J NNP O
/ NNP O
cm VBD O
24 CD O
hours NNS O
later RB O
. . O

Here RB O
we PRP O
report VBP O
the DT O
cloning NN O
, , O
expression NN O
, , O
and CC O
biochemical JJ O
characterization NN O
of IN O
the DT O
32 CD O
- : O
kDa NN O
subunit NN O
of IN O
human JJ O
( ( O
h NN O
) ) O
TFIID NNP B-Gene
, , O
termed VBD O
hTAFII32 NN B-Gene
. . O

Factors NNS O
associated VBN O
with IN O
intrafamilial JJ O
transmission NN O
of IN O
hepatitis NN O
B NNP O
virus NN O
infection NN O
in IN O
Korea NNP O
. . O

Purification NN O
and CC O
cloning NN O
of IN O
a DT O
novel JJ O
serine NN B-Gene
protease NN I-Gene
, , O
RNK NNP B-Gene
- : I-Gene
Met NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
from IN O
the DT O
granules NNS O
of IN O
a DT O
rat NN O
natural JJ O
killer NN O
cell NN O
leukemia NN O
. . O

Polysome NNP O
analyses NNS O
in IN O
a DT O
temperature NN O
- : O
sensitive JJ O
fal1 NN B-Gene
- : I-Gene
1 CD I-Gene
mutant NN I-Gene
and CC O
a DT O
Fal1p NNP B-Gene
- : O
depleted VBD O
strain JJ O
reveal NN O
a DT O
decrease NN O
in IN O
the DT O
number NN O
of IN O
40S CD B-Gene
ribosomal JJ I-Gene
subunits NNS I-Gene
. . O

S NNP O
. . O
, , O
and CC O
Walter NNP O
, , O
P NNP O
. . O

The DT O
multiple JJ O
functions NNS O
of IN O
Pmt3p NNP B-Gene
described VBD O
here RB O
suggest VBP O
that IN O
several JJ O
nuclear JJ O
proteins NNS O
are VBP O
regulated VBN O
by IN O
Pmt3p NNP B-Gene
conjugation NN O
. . O

Mutations NNS O
within IN O
the DT O
C NNP O
terminus NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
at IN O
serine NN O
residues NNS O
that WDT O
are VBP O
phosphorylation JJ O
targets NNS O
for IN O
growth NN O
factors NNS O
and CC O
MAP NNP B-Gene
kinase NNP I-Gene
completely RB O
abrogate JJ O
transactivation NN O
and CC O
block NN O
potentiation NN O
by IN O
MAP NNP B-Gene
kinase NN I-Gene
. . O

Transcriptional JJ O
regulators NNS O
utilizing VBG O
the DT O
POU NNP B-Gene
domain NN I-Gene
DNA NNP I-Gene
- : I-Gene
binding NN I-Gene
motif NNS I-Gene
have VBP O
been VBN O
shown VBN O
to TO O
form VB O
multi SYM O
- : O
protein NN O
complexes NNS O
dependent NN O
on IN O
the DT O
POU NNP B-Gene
domain NN I-Gene
itself PRP O
and CC O
its PRP$ O
flexible JJ O
recognition NN O
of IN O
various JJ O
octamer JJ O
sequence NN O
elements NNS O
. . O

Against NNP O
gram SYM O
- : O
positive JJ O
organisms NNS O
, , O
E NNP O
- : O
4767 CD O
and CC O
E NNP O
- : O
5065 CD O
were VBD O
, , O
in IN O
general JJ O
, , O
eight CD O
- : O
and CC O
fourfold VB O
more JJR O
active JJ O
than IN O
tosufloxacin NN O
, , O
which WDT O
is VBZ O
the DT O
most RBS O
potent NN O
of IN O
the DT O
reference NN O
compounds NNS O
. . O

The DT O
ORF NNP O
4 CD O
gene NN O
was VBD O
minimally RB O
active JJ O
, , O
whereas IN O
the DT O
ORF NNP O
62 CD O
gene NN O
gave VBD O
twofold JJ O
induction NN O
; : O
both DT O
genes NNS O
, , O
acting VBG O
together RB O
, , O
gave VBD O
fivefold VBN O
induction NN O
. . O

Thrombolysis NN O
was VBD O
followed VBN O
by IN O
a DT O
similar JJ O
increase NN O
of IN O
platelet NN O
activity NN O
with IN O
maximal JJ O
values NNS O
reached VBN O
at IN O
the DT O
3rd CD O
hour NN O
in IN O
both DT O
groups NNS O
( ( O
196 CD O
+ NN O
/ NNP O
- : O
43 CD O
IU NNP O
/ NNP O
ml NN O
in IN O
Group NNP O
1 CD O
and CC O
192 CD O
+ NN O
/ NNP O
- : O
39 CD O
in IN O
Group NNP O
2 CD O
: : O
p NN O
& CC O
lt NN O
; : O
001versus CD O
baseline NN O
and CC O
p NN O
NS NNP O
between IN O
the DT O
groups NNS O
) ) O
. . O

Rigorous JJ O
treatment NN O
protocols NNS O
for IN O
diet JJ O
delivery NN O
and CC O
EEN NNP O
- : O
related JJ O
GI NNP O
adverse JJ O
effects NNS O
were VBD O
applied VBN O
. . O

In IN O
addition NN O
, , O
an DT O
mck1 NN B-Gene
mds1 NN B-Gene
mrk1 NN B-Gene
triple NN O
disruptant NN O
was VBD O
viable JJ O
. . O

Employing VBG O
this DT O
sequence NN O
information NN O
from IN O
c11 NN O
/ NN O
1 CD O
, , O
the DT O
c11 NN O
/ VBZ O
1 CD O
- : O
specific JJ O
cDNA NN O
was VBD O
generated VBN O
from IN O
poly NN O
( ( O
A DT O
) ) O
+ FW O
RNA NNP O
of IN O
bovine NN O
PMNLs NNP O
by IN O
reverse JJ O
transcription NN O
and CC O
a DT O
combination NN O
of IN O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
methods NNS O
. . O

Relationship NN O
between IN O
mitochondrial JJ B-Gene
NADH NNP I-Gene
- : I-Gene
ubiquinone NN I-Gene
reductase NN I-Gene
and CC O
a DT O
bacterial JJ B-Gene
NAD NNP I-Gene
- : I-Gene
reducing VBG I-Gene
hydrogenase NN I-Gene
. . O

The DT O
effect NN O
of IN O
ibopamine NN O
and CC O
furosemide NN O
in IN O
130 CD O
patients NNS O
with IN O
NYHA NNP O
Class NNP O
I PRP O
and CC O
II NNP O
heart NN O
failure NN O
were VBD O
studied VBN O
in IN O
a DT O
parallel NN O
, , O
double JJ O
- : O
blind NN O
, , O
randomized VBN O
placebo NN O
- : O
controlled VBN O
multi SYM O
- : O
centre JJ O
trial NN O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
encoded VBN O
by IN O
a DT O
gene NN O
located VBN O
on IN O
chromosome NN O
6 CD O
near IN O
the DT O
HLA NNP B-Gene
locus NN I-Gene
. . O

After IN O
28 CD O
days NNS O
of IN O
haloperidol JJ O
treatment NN O
, , O
similar JJ O
changes NNS O
were VBD O
observed VBN O
for IN O
delta NN O
, , O
together RB O
with IN O
an DT O
increase NN O
of IN O
alpha JJ O
1 CD O
, , O
and CC O
a DT O
decrease NN O
of IN O
fast JJ O
beta NN O
. . O

Furthermore RB O
, , O
this DT O
study NN O
looks VBZ O
at IN O
the DT O
impact NN O
of IN O
synthesis NN O
conditions NNS O
on IN O
block NN O
length NN O
and CC O
crystallinity NN O
, , O
and CC O
the DT O
impact NN O
of IN O
the DT O
blocking NN O
on IN O
both DT O
, , O
crystallinity NN O
and CC O
solubility NN O
of IN O
the DT O
polymers NNS O
. . O

Scintigraphic JJ O
visualisation NN O
of IN O
Walker NNP O
carcinoma SYM O
- : O
256 CD O
in IN O
Sprague NNP O
- : O
Dawley NNP O
rats NNS O
by IN O
means NNS O
of IN O
99mTc CD O
- : O
labelled VBN O
monocytes NNS O
. . O

Laboratory NN O
pyrolyses NNS O
have VBP O
indeed RB O
shown VBN O
that IN O
PCBs NNP O
give VB O
significant JJ O
yields NNS O
of IN O
PCDFs NNP O
, , O
and CC O
chlorobenzenes NNS O
give VBP O
both DT O
PCDFs NNP O
and CC O
PCDDs NNP O
. . O

Concordantly RB O
, , O
it PRP O
was VBD O
shown VBN O
that IN O
the DT O
dnHLH NN B-Gene
protein NN I-Gene
Id1 NNP B-Gene
inhibits VBZ O
differentiation NN O
of IN O
muscle NN O
and CC O
myeloid NN O
cells NNS O
in IN O
vitro NN O
. . O

Protein NNP O
splicing NN O
: : O
evidence NN O
for IN O
an DT O
N NNP O
- : O
O NNP O
acyl JJ O
rearrangement NN O
as IN O
the DT O
initial JJ O
step NN O
in IN O
the DT O
splicing NN O
process NN O
. . O

Assays NNS O
of IN O
total JJ O
cholesterol NN O
as RB O
well RB O
as IN O
the DT O
HDL NNP B-Gene
, , O
HDL2 NNP B-Gene
, , O
LDL NNP B-Gene
, , O
triglycerides NNS O
, , O
endothelin SYM B-Gene
- : I-Gene
1 CD I-Gene
, , O
lipoprotein NN B-Gene
( ( I-Gene
a DT I-Gene
) ) I-Gene
, , O
estradiol FW O
and CC O
FSH NNP B-Gene
were VBD O
also RB O
obtained VBN O
at IN O
baseline NN O
before IN O
receiving VBG O
ERT NNP O
and CC O
after IN O
3 CD O
months NNS O
of IN O
ERT NNP O
. . O

A DT O
possible JJ O
decrease NN O
in IN O
theophylline NN O
' '' O
s JJ O
volume NN O
of IN O
distribution NN O
at IN O
4 CD O
days NNS O
, , O
but CC O
not RB O
immediately RB O
, , O
after IN O
administration NN O
of IN O
chloroquine NN O
was VBD O
suggested VBN O
, , O
although IN O
this DT O
just RB O
failed VBN O
to TO O
achieve VB O
statistical JJ O
significance NN O
( ( O
p JJ O
= NN O
0 CD O
. . O
55 CD O
) ) O
. . O

Effect NN O
of IN O
indomethacin NN O
and CC O
prostaglandin NN O
F2 NNP O
alpha NN O
on IN O
parturition NN O
in IN O
swine NN O
. . O

BACKGROUND NN O
: : O
Dermoscopy NNP O
is VBZ O
a DT O
noninvasive JJ O
technique NN O
that WDT O
increases VBZ O
the DT O
diagnostic JJ O
accuracy NN O
of IN O
pigmented JJ O
skin NN O
lesions NNS O
, , O
particularly RB O
improving VBG O
the DT O
diagnosis NN O
of IN O
patients NNS O
with IN O
cutaneous JJ O
melanoma NN O
in IN O
situ NN O
( ( O
CMIS NNP O
) ) O
and CC O
early JJ O
invasive JJ O
melanoma NN O
. . O

Lipid JJ O
concentration NN O
and CC O
lipase NN B-Gene
activity NN O
in IN O
the DT O
epiphysis NN O
of IN O
adrenalectomized JJ O
rats NNS O
consuming VBG O
food NN O
with IN O
different JJ O
sodium NN O
content NN O

Prostaglandin NNP O
synthesis NN O
inhibitors NNS O
have VBP O
been VBN O
shown VBN O
to TO O
delay VB O
healing NN O
of IN O
bone NN O
and CC O
this DT O
has VBZ O
led VBN O
to TO O
limitations NNS O
on IN O
their PRP$ O
use NN O
clinically RB O
in IN O
some DT O
situations NNS O
. . O

CONCLUSIONS NN O
: : O
Serum NNP O
levels NNS O
of IN O
S NNP B-Gene
- : I-Gene
100beta CD I-Gene
are VBP O
reliable JJ O
markers NNS O
for IN O
adverse JJ O
neurologic NN O
outcomes NNS O
after IN O
cardiac JJ O
surgery NN O
. . O

Using VBG O
lectin SYM B-Gene
- : O
affinity NN O
chromatography NN O
, , O
discordance NN O
between IN O
the DT O
pattern NN O
of IN O
O NNP O
- : O
glycosylation NN O
of IN O
SSBP NNP B-Gene
and CC O
DSBP NNP B-Gene
was VBD O
demonstrated VBN O
. . O

Pretreatment NN O
of IN O
cells NNS O
or CC O
mouse VB O
skin NN O
with IN O
antisense JJ O
oligonucleotides NNS O
of IN O
PKCzeta NNP B-Gene
impaired VBD O
UV NNP O
- : O
induced JJ O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
JB6 NNP O
cells NNS O
as RB O
well RB O
as IN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
luciferase NN B-Gene
transgenic JJ O
mice NN O
. . O

The DT O
expression NN O
of IN O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
was VBD O
detected VBN O
within IN O
1 CD O
h NN O
after IN O
infection NN O
of IN O
cells NNS O
with IN O
recombinant JJ O
virus NN O
, , O
reflecting VBG O
the DT O
early JJ O
nature NN O
of IN O
the DT O
promoters NNS O
used VBN O
. . O

Specifically RB O
, , O
the DT O
deduced JJ O
FR NNP B-Gene
- : I-Gene
19 CD I-Gene
amino NN I-Gene
acid NN I-Gene
sequence NN I-Gene
has VBZ O
approximately89 VBN O
, , O
77 CD O
, , O
and CC O
68 CD O
% NN O
overall JJ O
identity NN O
to TO O
chicken VB B-Gene
TEF NNP I-Gene
- : I-Gene
1A CD I-Gene
, , O
mouse NN B-Gene
TEF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
mouse RB B-Gene
embryonic JJ I-Gene
TEA NNP I-Gene
domain NN I-Gene
- : I-Gene
containing NN I-Gene
factor NN I-Gene
, , O
respectively RB O
. . O

Doppler NNP O
echo NN O
in IN O
evaluating VBG O
arteriovenous JJ O
fistulae NN O
for IN O
dialysis NN O

Cloning VBG O
by IN O
complementation NN O
and CC O
subsequent JJ O
physical NN O
and CC O
genetic JJ O
analysis NN O
revealed VBD O
that IN O
it PRP O
maps VBZ O
to TO O
RAF1 NNP B-Gene
. . O

Genetic NNP O
and CC O
biochemical JJ O
evidence NN O
suggests VBZ O
that IN O
v FW B-Gene
- : I-Gene
Crk NN I-Gene
can MD O
induce VB O
transformation NN O
of IN O
chicken NN O
embryo NN O
fibroblasts NNS O
by IN O
influencing VBG O
the DT O
activity NN O
of IN O
cellular JJ O
proteins NNS O
involved VBN O
in IN O
growth NN O
regulation NN O
. . O

The DT O
gene NN O
encoding VBG O
the DT O
105 CD B-Gene
- : I-Gene
kDa NN I-Gene
protein NN I-Gene
( ( I-Gene
p105 NN I-Gene
) ) I-Gene
precursor NN I-Gene
of IN O
the DT O
p50 JJ B-Gene
subunit NN I-Gene
of IN O
transcription NN O
factor NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
also RB O
encodes VBZ O
a DT O
p70 NN B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
protein NN I-Gene
, , O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
gamma NN I-Gene
, , O
which WDT O
is VBZ O
identical JJ O
to TO O
the DT O
C NNP O
- : O
terminal JJ O
607 CD O
amino JJ O
acids NNS O
of IN O
p105 NN B-Gene
. . O

STUDY NNP O
DESIGN NNP O
. . O

In IN O
vitro JJ O
translation NN O
of IN O
RNA NNP O
synthesized VBD O
from IN O
the DT O
cloned VBN O
cDNAs NN O
predicts VBZ O
that IN O
P0 NNP B-Gene
transcripts NNS I-Gene
are VBP O
translated VBN O
into IN O
a DT O
novel JJ O
12 CD O
. . O
5 CD O
- : O
kilodalton NN O
protein NN O
corresponding VBG O
to TO O
the DT O
first JJ O
open JJ O
reading NN O
frame NN O
. . O

Currents NNS O
aspects NNS O
of IN O
H2 NNP B-Gene
receptor NN I-Gene
antagonists NNS O
in IN O
the DT O
treatment NN O
of IN O
ulcers NNS O

On IN O
the DT O
basis NN O
of IN O
the DT O
mechanism NN O
of IN O
action NN O
, , O
two CD O
groups NNS O
of IN O
inodilators NNS O
are VBP O
distinguished VBN O
, , O
the DT O
phosphodiesterase NN O
inhibitors NNS O
and CC O
the DT O
dopaminergic JJ O
agents NNS O
. . O

There EX O
was VBD O
no DT O
clear JJ O
correlation NN O
between IN O
the DT O
MFA NNP O
and CC O
the DT O
severity NN O
of IN O
the DT O
UTS NNP O
phenotype NN O
. . O

The DT O
encoded JJ O
sequence NN O
revealed VBD O
a DT O
typical JJ O
signal NN O
peptide NN O
, , O
a DT O
predominantly RB O
hydrophilic JJ O
707 CD O
amino NN O
acid NN O
residue JJ O
domain NN O
with IN O
8 CD O
N NNP O
- : O
glycosylation NN O
sites NNS O
, , O
a DT O
transmembrane NN O
domain NN O
, , O
and CC O
a DT O
C NNP O
- : O
terminal JJ O
domain NN O
of IN O
52 CD O
amino JJ O
acids NNS O
. . O

Levels NNS O
of IN O
both DT O
PGF NNP O
and CC O
PGFM NNP O
were VBD O
significantly RB O
higher JJR O
during IN O
early RB O
spontaneous JJ O
labour NN O
, , O
at IN O
a DT O
cervical JJ O
dilatation NN O
of IN O
less JJR O
than IN O
4 CD O
cm NN O
, , O
than IN O
before IN O
the DT O
onset NN O
of IN O
labour NN O
. . O

The DT O
Stat5b NNP B-Gene
mRNA NN I-Gene
has VBZ O
a DT O
size NN O
of IN O
5 CD O
. . O
6 CD O
kb NN O
and CC O
encodes VBZ O
a DT O
protein NN O
of IN O
786 CD O
amino JJ O
acids NNS O
. . O

These DT O
regions NNS O
overlap VBP O
with IN O
the DT O
HIT NNP B-Gene
protein NN I-Gene
similarity NN I-Gene
regions NNS I-Gene
. . O

BACKGROUND NN O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
response NN O
rates NNS O
and CC O
toxicity NN O
of IN O
two CD O
regimens NNS O
containing VBG O
granulocyte NN B-Gene
- : I-Gene
macrophage NN I-Gene
- : I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
in IN O
combination NN O
with IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
in IN O
the DT O
treatment NN O
of IN O
patients NNS O
with IN O
metastatic JJ O
renal NN O
cell NN O
carcinoma NN O
. . O

All DT O
of IN O
the DT O
elements NNS O
exhibited VBD O
a DT O
uniform JJ O
structure NN O
. . O

Analysis NN O
of IN O
corticosteroids NNS O
. . O

NH3 NNP O
and CC O
NO NNP O
interaction NN O
with IN O
Si NNP O
( ( O
100 CD O
) ) O
- : O
( ( O
2 CD O
x RB O
1 CD O
) ) O
surfaces NNS O
. . O

Triumph NN O
of IN O
Leninist NNP O
national JJ O
policy NN O

At IN O
the DT O
time NN O
of IN O
the DT O
blind JJ O
therapeutic JJ O
doses NNS O
, , O
Tg NNP B-Gene
- : O
off RP O
values NNS O
ranged VBD O
from IN O
8 CD O
to TO O
608 CD O
microg NNS O
/ JJ O
l NN O
. . O

Sex NN O
of IN O
calf NN O
( ( O
variate JJ O
2 CD O
) ) O
was VBD O
associated VBN O
most JJS O
closely RB O
with IN O
width NN O
of IN O
muzzle NN O
and CC O
head NN O
. . O

A DT O
single JJ O
exon NN O
encodes VBZ O
the DT O
carboxyl NN O
- : O
terminal JJ O
26 CD O
amino JJ O
acids NNS O
of IN O
the DT O
ssd NN B-Gene
chain NN I-Gene
and CC O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
of IN O
its PRP$ O
mRNA NN O
, , O
ending VBG O
with IN O
a DT O
poly NN O
( ( O
A DT O
) ) O
- : O
addition NN O
site NN O
. . O

Furthermore RB O
, , O
loss NN O
of IN O
methylation NN O
also RB O
greatly RB O
reduced VBD O
the DT O
association NN O
of IN O
another DT O
yeast NN O
B NNP O
- : O
type NN O
subunit NN O
, , O
Rts1p NNP B-Gene
. . O

These DT O
results NNS O
suggested VBD O
that IN O
BACH1t NNP B-Gene
recruits VBZ O
BACH1 NNP B-Gene
to TO O
the DT O
nucleus NN O
through IN O
BTB NNP B-Gene
domain VBP O
- : O
mediated VBN O
interaction NN O
. . O

We PRP O
describe VBP O
a DT O
novel JJ O
method NN O
using VBG O
Saccharomyces NNS O
cerevisiae NN O
for IN O
detecting VBG O
protein JJ O
- : O
truncating VBG O
mutations NNS O
in IN O
any DT O
gene NN O
of IN O
interest NN O
. . O

Hydrogels NNS O
for IN O
tissue NN O
engineering NN O
. . O

The DT O
COL7A1 NNP B-Gene
gene NN I-Gene
, , O
which WDT O
encodes VBZ O
type NN B-Gene
VII NNP I-Gene
collagen NN I-Gene
, , O
has VBZ O
been VBN O
implicated VBN O
as IN O
a DT O
candidate NN O
gene NN O
for IN O
dominantly RB O
and CC O
recessively RB O
inherited JJ O
forms NNS O
of IN O
dystrophic JJ O
epidermolysis NN O
bullosa NN O
. . O

Thus RB O
, , O
in IN O
the DT O
presence NN O
of IN O
active JJ B-Gene
S NNP I-Gene
- : I-Gene
CDKs NN I-Gene
and CC O
Dbf4 NNP B-Gene
/ NNP O
Cdc7 NNP B-Gene
, , O
Mcms NNP B-Gene
may MD O
open VB O
origins NNS O
and CC O
thereby RB O
facilitate VB O
the DT O
loading NN O
of IN O
RPA NNP B-Gene
. . O

Antibodies NNS O
to TO O
the DT O
human JJ B-Gene
PTS1R NNP I-Gene
recognize NN O
this DT O
protein NN O
in IN O
human JJ O
, , O
monkey NN O
, , O
rat NN O
, , O
and CC O
hamster NN O
cells NNS O
. . O

Immunohistochemical JJ O
studies NNS O
revealed VBD O
positive JJ O
staining NN O
for IN O
S100 NNP B-Gene
protein NN I-Gene
in IN O
all PDT O
the DT O
granular JJ O
cell NN O
tumors NNS O
of IN O
the DT O
adult NN O
but CC O
in IN O
none NN O
of IN O
the DT O
congenital JJ O
granular NN O
cell NN O
epulides NNS O
. . O

In IN O
supine JJ O
position NN O
, , O
plasma JJ O
ANP NNP B-Gene
levels NNS O
ranged VBD O
from IN O
12 CD O
pg NN O
/ NN O
ml NN O
to TO O
51 CD O
. . O
5 CD O
pg JJ O
/ NNP O
ml NN O
, , O
with IN O
an DT O
average JJ O
level NN O
of IN O
35 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
11 CD O
. . O
5 CD O
pg JJ O
/ NNP O
ml NN O
. . O

DNA NN O
sequencing NN O
of IN O
a DT O
17 CD O
- : O
kb NN O
segment NN O
encompassing VBG O
a DT O
gammaherpesvirus NN O
divergent NN O
locus NN O
( ( O
DL NNP O
- : O
B NN O
) ) O
between IN O
ORF11 NNP O
and CC O
ORF17 NNP O
revealed VBD O
the DT O
presence NN O
of IN O
nine CD O
viral JJ O
ORFs NNP O
with IN O
predicted VBN O
gene NN O
products NNS O
related VBN O
to TO O
cellular JJ O
proteins NNS O
. . O

This DT O
is VBZ O
a DT O
challenging VBG O
task NN O
insofar NN O
as IN O
direct JJ O
measures NNS O
of IN O
ISF NNP O
glucose NN O
are VBP O
not RB O
readily RB O
available JJ O
. . O

The DT O
PEPCK NNP B-Gene
promoter NN O
fragment NN O
was VBD O
introduced VBN O
either RB O
in IN O
the DT O
proper JJ O
orientation NN O
for IN O
transcription NN O
of IN O
the DT O
TK NNP B-Gene
gene NN I-Gene
or CC O
in IN O
the DT O
opposite JJ O
orientation NN O
. . O

The DT O
mean JJ O
duration NN O
of IN O
pain NN O
relief NN O
was VBD O
4 CD O
- : O
6 CD O
weeks NNS O
. . O

The DT O
role NN O
of IN O
negative JJ O
regulators NNS O
such JJ O
as IN O
NCE3 NNP B-Gene
, , O
as RB O
well RB O
as IN O
the DT O
previously RB O
described VBN O
SIN5 NNP B-Gene
gene NN I-Gene
, , O
in IN O
determining VBG O
the DT O
promoter NN O
specificity NN O
of IN O
homologous JJ O
activators NNS O
is VBZ O
discussed VBN O
. . O

PURPOSE NN O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
bony NN O
anchorage NN O
of IN O
a DT O
new JJ O
implant NN O
( ( O
orderly RB O
wired VBN O
surface NN O
effect NN O
with IN O
alloy NN O
Ti NNP O
Al NNP O
Va NNP O
and CC O
ordered VBD O
pores NNS O
of IN O
488 CD O
mu NN O
) ) O
. . O

The DT O
distribution NN O
of IN O
patients NNS O
was VBD O
as IN O
follows VBZ O
: : O
group NN O
1 CD O
- : O
- : O
complex JJ O
gamma NN O
- : O
therapy NN O
( ( O
55 CD O
cases NNS O
) ) O
, , O
group NN O
2 CD O
- : O
- : O
complex JJ O
gamma NN O
- : O
therapy NN O
plus CC O
iliac JJ O
lymphadenectomy NN O
( ( O
50 CD O
cases NNS O
) ) O
and CC O
group NN O
3 CD O
- : O
- : O
complex JJ O
radiation NN O
treatment NN O
with IN O
megavolt NN O
bremsstrahlung NN O
beam NN O
from IN O
the DT O
luc NN O
type NN O
installation NN O
and CC O
iliac JJ O
lymphadenectomy NN O
( ( O
50 CD O
cases NNS O
) ) O
. . O

Chem NNP O
. . O

The DT O
Wnt NNP B-Gene
signaling VBG O
pathway JJ O
functions NNS O
reiteratively RB O
during IN O
animal NN O
development NN O
to TO O
control VB O
cell NN O
fate NN O
decisions NNS O
. . O

Similarly RB O
, , O
the DT O
sequence NN O
of IN O
the DT O
U2 NNP B-Gene
RNA NNP I-Gene
region NN I-Gene
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
pre JJ O
- : O
mRNA NN O
branchpoint NN O
recognition NN O
in IN O
yeast NN O
, , O
and CC O
exactly RB O
conserved VBN O
in IN O
metazoan NN B-Gene
U2 NNP I-Gene
RNAs NNP I-Gene
, , O
was VBD O
totally RB O
divergent JJ O
in IN O
trypanosomes NNS O
. . O

Value NNP O
of IN O
urine JJ O
glucose JJ O
tests NNS O
in IN O
the DT O
management NN O
of IN O
type NN O
II NNP O
diabetes VBZ O
mellitus NN O
. . O

The DT O
SH2 NNP B-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
inositol JJ I-Gene
5 CD I-Gene
' POS I-Gene
- : I-Gene
phosphatase NN I-Gene
( ( O
SHIP NNP B-Gene
) ) O
recruits VBZ O
the DT O
p85 JJ B-Gene
subunit NN I-Gene
of IN O
phosphoinositide NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
during IN O
FcgammaRIIb1 NNP B-Gene
- : O
mediated VBD O
inhibition NN O
of IN O
B NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
signaling VBG O
. . O

Thus RB O
, , O
IHHNV NNP O
is VBZ O
closely RB O
related VBN O
to TO O
densoviruses NNS O
of IN O
the DT O
genus NN O
Brevidensovirus NNP O
in IN O
the DT O
family NN O
Parvoviridae NNP O
, , O
and CC O
we PRP O
therefore VBP O
propose JJ O
to TO O
rename VB O
this DT O
virus NN O
Penaeus NNP O
stylirostris NN O
densovirus NN O
( ( O
PstDNV NNP O
) ) O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
HIV NNP O
- : O
1 CD O
Gag NNP B-Gene
sequences NNS I-Gene
can MD O
influence VB O
the DT O
viral JJ B-Gene
PR NNP I-Gene
- : O
mediated VBD O
processing NN O
of IN O
the DT O
MuLV NNP O
TM NNP B-Gene
Env NNP I-Gene
protein NN I-Gene
p15 NN B-Gene
( ( I-Gene
E NNP I-Gene
) ) I-Gene
. . O

Lipid NNP O
hydroperoxide NN O
levels NNS O
in IN O
plasma NN O
and CC O
LDL NNP B-Gene
remained VBD O
unchanged JJ O
throughout IN O
the DT O
study NN O
. . O

These DT O
consisted VBN O
of IN O
beading NN O
and CC O
strictures VBZ O
mainly RB O
of IN O
the DT O
intrahepatic JJ O
biliary JJ O
tree NN O
( ( O
IHB NNP O
) ) O
. . O

Removal NN O
of IN O
PDMP NNP O
from IN O
the DT O
cell NN O
medium NN O
resulted VBD O
in IN O
reversal NN O
of IN O
the DT O
cell NN O
cycle NN O
changes NNS O
, , O
with IN O
cells NNS O
re VBP O
- : O
entering VBG O
the DT O
S NNP O
phase NN O
. . O

Nucleotide NNP O
sequence NN O
and CC O
transcriptional JJ O
analysis NN O
of IN O
the DT O
DNA NNP B-Gene
polymerase NN I-Gene
gene NN I-Gene
of IN I-Gene
Bombyx NNP I-Gene
mori FW I-Gene
nuclear JJ I-Gene
polyhedrosis NN I-Gene
virus NN I-Gene
. . O

157 CD O
+ JJ O
/ NNP O
- : O
16 CD O
mg NN O
/ NNP O
dl NN O
; : O
NS NNP O
) ) O
, , O
glucose JJ O
levels NNS O
, , O
and CC O
basal NN O
( ( O
17 CD O
+ NN O
/ NNP O
- : O
4 CD O
vs NN O
. . O

Effects NNS O
of IN O
aging VBG O
and CC O
beta SYM O
- : O
adrenergic JJ O
- : O
blockade NN O
on IN O
standing VBG O
- : O
induced JJ O
QT NNP O
/ NNP O
QS2 NNP O
changes NNS O
. . O

Furthermore RB O
, , O
the DT O
potency NN O
of IN O
Dacarbacine NNP O
in IN O
the DT O
treatment NN O
of IN O
carcinoid NN O
tumors NNS O
seems VBZ O
to TO O
be VB O
underestimated VBN O
up RP O
to TO O
now RB O
. . O

Stat NNP B-Gene
activation NN O
in IN O
response NN O
to TO O
GH NNP B-Gene
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
was VBD O
determined VBN O
by IN O
reporter NN O
gene NN O
induction NN O
. . O

The DT O
hybridizing VBG O
clone NN O
of IN O
V NNP O
. . O
vulnificus NN O
chromosomal JJ O
DNA NNP O
complemented VBD O
a DT O
V NNP B-Gene
. . I-Gene
cholerae NN I-Gene
fur NN I-Gene
mutant NN I-Gene
. . O

Identification NN O
of IN O
this DT O
region NN O
as IN O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
tmk JJ I-Gene
gene NN I-Gene
was VBD O
confirmed VBN O
by IN O
functional JJ O
complementation NN O
of IN O
a DT O
yeast NN B-Gene
dTMP NN I-Gene
kinase NN I-Gene
temperature NN O
- : O
sensitive JJ O
mutant NN O
and CC O
by IN O
in IN O
vitro NN O
enzyme NNS O
assay VBP O
of IN O
the DT O
thymidylate JJ B-Gene
kinase NN I-Gene
activity NN O
in IN O
cell NN O
extracts NNS O
of IN O
E NNP O
. . O
coli NN O
by IN O
use NN O
of IN O
tmk NN B-Gene
- : O
overproducing NN O
plasmids NNS O
. . O

Sequence NNP O
comparison NN O
of IN O
the DT O
0 CD O
. . O
38 CD O
kb JJ O
promoter NN O
sequence NN O
with IN O
the DT O
promoters NNS O
of IN O
the DT O
Sm NNP B-Gene
- : I-Gene
E NN I-Gene
gene NN O
and CC O
U1 NNP B-Gene
snRNA VBP I-Gene
genes NNS I-Gene
revealed VBD O
several JJ O
homologous JJ O
motifs NNS O
, , O
suggesting VBG O
that IN O
genes NNS O
encoding VBG O
the DT O
snRNP JJ O
components NNS O
may MD O
be VB O
coordinately RB O
regulated VBN O
. . O

Foreign JJ O
profiles NNS O
in IN O
air NN O
pollution NN O
control NN O
activities NNS O
. . O

A DT O
new JJ O
method NN O
for IN O
the DT O
in IN O
vitro JJ O
transfer NN O
of IN O
delayed JJ O
hypersensitivity NN O
by IN O
dialysed JJ O
transfer NN B-Gene
factor NN I-Gene
. . O

Chronic JJ O
thyroiditis NN O
as IN O
a DT O
risk NN O
factor NN O
of IN O
B NNP O
- : O
cell NN O
lymphoma NN O
in IN O
the DT O
thyroid JJ O
gland NN O
. . O

Histamine NNP O
reactivity NN O
had VBD O
returned VBN O
to TO O
normal JJ O
in IN O
half PDT O
the DT O
workers NNS O
who WP O
had VBD O
left VBN O
their PRP$ O
original JJ O
factories NNS O
, , O
but CC O
in IN O
only RB O
one CD O
worker NN O
who WP O
had VBD O
moved VBN O
within IN O
her PRP O
original JJ O
factory NN O
. . O

Abdominal JJ O
tumors NNS O
in IN O
childhood NN O
. . O

The DT O
authors NNS O
present VBD O
the DT O
only JJ O
two CD O
studies NNS O
that WDT O
have VBP O
proved VBN O
successful JJ O
in IN O
treating VBG O
animal JJ O
models NNS O
of IN O
osteoarthritis NN O
using VBG O
gene NN O
therapy NN O
, , O
and CC O
propose VB O
an DT O
overview NN O
of IN O
several JJ O
strategies NNS O
for IN O
the DT O
development NN O
of IN O
gene NN O
therapy NN O
in IN O
osteoarthritis NN O
treatment NN O
in IN O
the DT O
future NN O
. . O

The DT O
87K CD O
protein NN O
, , O
together RB O
with IN O
proteins NNS O
of IN O
105 CD O
, , O
0 CD O
and CC O
75 CD O
, , O
0 CD O
daltons NNS O
, , O
are VBP O
translated VBN O
from IN O
leftward NN O
transcribed NN O
( ( O
1 CD O
- : O
strand NN O
) ) O
messenger NN O
RNAs NNP O
that WDT O
are VBP O
complementary JJ O
to TO O
the DT O
viral JJ O
genome NN O
between IN O
positions NNS O
11 CD O
. . O
2 CD O
and CC O
31 CD O
. . O
5 CD O
. . O

Monkeys NNS O
were VBD O
evaluated VBN O
before IN O
and CC O
after IN O
unilateral JJ O
and CC O
serial JJ O
bilateral JJ O
removal NN O
of IN O
superior JJ O
temporal JJ O
cortex NN O
. . O

The DT O
ORF1 NNP O
protein NN O
was VBD O
found VBN O
to TO O
be VB O
highly RB O
homologous JJ O
to TO O
the DT O
putative JJ O
potexvirus NN B-Gene
RNA NNP I-Gene
replicases VBZ I-Gene
; : O
ORF2 NNP O
, , O
- : O
3 CD O
, , O
- : O
5 CD O
and CC O
- : O
6 CD O
proteins NNS O
also RB O
have VBP O
analogues NNS O
among IN O
the DT O
potex NN O
- : O
and CC O
/ VB O
or CC O
carlavirus VB O
- : O
encoded JJ O
proteins NNS O
. . O

Eukaryotic JJ B-Gene
translation NN I-Gene
initiation NN I-Gene
factor NN I-Gene
4GI CD I-Gene
is VBZ O
a DT O
cellular JJ O
target NN O
for IN O
NS1 NNP B-Gene
protein NN I-Gene
, , O
a DT O
translational JJ O
activator NN O
of IN O
influenza JJ O
virus NN O
. . O

We PRP O
show VBP O
that IN O
Rlm1 NNP B-Gene
and CC O
Smp1 NNP B-Gene
have VBP O
MEF2 NNP B-Gene
- : O
related VBN O
DNA NNP O
- : O
binding NN O
specificities NNS O
: : O
Rlm1 NNP B-Gene
binds VBZ O
with IN O
the DT O
same JJ O
specificity NN O
as IN O
MEF2 NNP B-Gene
, , O
CTA NNP B-Gene
( ( I-Gene
T NNP I-Gene
/ NNP I-Gene
A NNP I-Gene
) ) I-Gene
4TAG CD I-Gene
, , O
while IN O
SMP1 NNP B-Gene
binds VBZ O
a DT O
more RBR O
extended JJ O
consensus NN O
sequence NN O
, , O
ACTACTA NNP O
( ( O
T NNP O
/ NNP O
A NNP O
) ) O
4TAG CD O
. . O

Repetitive JJ O
sequences NNS O
are VBP O
present JJ O
in IN O
at IN O
least JJS O
three CD O
introns NNS O
of IN O
the DT O
cytochrome NN B-Gene
P NNP I-Gene
- : I-Gene
450PBc2 CD I-Gene
gene NN I-Gene
, , O
but CC O
not RB O
in IN O
exons NNS O
or CC O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
. . O

The DT O
incidence NN O
of IN O
hepatitis NN B-Gene
B NNP I-Gene
antigen NN I-Gene
following VBG O
transfusion NN O
was VBD O
about IN O
2 CD O
. . O
8 CD O
per IN O
cent NN O
. . O

Plasma NNP O
vitamin NN O
E NNP O
, , O
total JJ O
lipids NNS O
and CC O
myeloperoxidase NN B-Gene
levels NNS O
during IN O
spinal JJ O
surgery NN O
. . O

Finally RB O
, , O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
ENBP1 NNP B-Gene
shows VBZ O
strong JJ O
homology NN O
to TO O
a DT O
protein NN O
from IN O
rat NN O
that WDT O
is VBZ O
specifically RB O
expressed VBN O
in IN O
testis NN O
tissue NN O
. . O

The DT O
action NN O
of IN O
nef NN B-Gene
was VBD O
specific JJ O
to TO O
the DT O
LTR NNP O
, , O
as IN O
expression NN O
of IN O
nef NN B-Gene
had VBD O
no DT O
effect NN O
on IN O
the DT O
activity NN O
of IN O
the DT O
simian JJ O
virus NN O
40 CD O
, , O
c SYM B-Gene
- : I-Gene
fms NN I-Gene
, , O
urokinase JJ B-Gene
plasminogen NN I-Gene
activator NN I-Gene
, , O
or CC O
type VB B-Gene
5 CD I-Gene
acid JJ I-Gene
phosphatase NN I-Gene
promoter NN I-Gene
. . O
trans VBZ O
- : O
activating NN O
activity NN O
was VBD O
also RB O
manifested VBN O
by IN O
a DT O
frameshift NN O
mutant NN O
expressing VBG O
only RB O
the DT O
first JJ O
35 CD O
amino JJ O
acids NNS O
of IN O
the DT O
protein NN O
. . O

Bertioga NNP O
( ( O
Guama NNP O
group NN O
) ) O
and CC O
Anhembi NNP O
( ( O
Bunyamwera NNP O
group NN O
) ) O
, , O
two CD O
new JJ O
arboviruses NNS O
isolated VBN O
in IN O
Sao NNP O
Paulo NNP O
, , O
Brazil NNP O
. . O

Comparison NNP O
of IN O
cDNA NN O
sequences NNS O
revealed VBD O
that IN O
the DT O
two CD O
mRNA NN O
species NNS O
arise VBP O
as IN O
a DT O
result NN O
of IN O
alternate NN O
use NN O
of IN O
poly NN O
( ( O
A DT O
) ) O
- : O
addition NN O
sites NNS O
. . O

Discordance NN O
on IN O
the DT O
cost NN O
dimension NN O
correlated VBD O
negatively RB O
with IN O
G NNP B-Gene
Hb NNP I-Gene
, , O
suggesting VBG O
better JJR O
glycemic JJ O
control NN O
with IN O
greater JJR O
disagreement NN O
. . O

The DT O
average JJ O
annual JJ O
cost NN O
per IN O
head NN O
of IN O
population NN O
was VBD O
US NNP O
+ $ O
0 CD O
X NNP O
46 CD O
. . O

Two CD O
- : O
way NN O
analysis NN O
of IN O
variance NN O
was VBD O
used VBN O
to TO O
determine VB O
whether IN O
composite JJ O
knowledge NN O
score RB O
differed VBD O
among IN O
patient JJ O
groups NNS O
. . O

In IN O
the DT O
presence NN O
of IN O
inositol NN O
and CC O
choline NN O
( ( O
repressing VBG O
) ) O
, , O
the DT O
product NN O
of IN O
the DT O
OPI1 NNP B-Gene
gene NN I-Gene
represses NNS O
transcription NN O
dictated VBN O
by IN O
the DT O
UASINO NNP O
element NN O
. . O

Armed VBN O
with IN O
a DT O
clear JJ O
understanding NN O
of IN O
the DT O
pathophysiologic NN O
pathways VBZ O
that WDT O
may MD O
cause VB O
and CC O
/ VB O
or CC O
contribute VB O
to TO O
the DT O
development NN O
of IN O
unconjugated JJ O
hyperbilirubinemia NN O
and CC O
the DT O
associated JJ O
jaundice NN O
, , O
the DT O
practitioner NN O
will MD O
be VB O
successful JJ O
in IN O
helping VBG O
the DT O
family NN O
understand VBP O
their PRP$ O
child NN O
' '' O
s JJ O
illness NN O
. . O

Potential JJ O
consensus NN O
sequences NNS O
for IN O
early RB O
and CC O
late JJ O
regulatory JJ O
elements NNS O
were VBD O
identified VBN O
. . O

Genomic NNP O
DNA NNP O
sequencing VBG O
in IN O
the DT O
vicinity NN O
of IN O
methylmalonyl JJ B-Gene
- : I-Gene
CoA NNP I-Gene
mutase NN I-Gene
gene NN I-Gene
( ( O
mutAB NNS B-Gene
) ) O
from IN O
a DT O
rifamycin NN O
SV NNP O
- : O
producing VBG O
Amycolatopsis NNP O
mediterranei NN O
U32 NNP O
allowed VBD O
us PRP O
to TO O
clone VB O
, , O
sequence NN O
, , O
and CC O
identify VB O
a DT O
gene NN O
encoding VBG O
a DT O
novel JJ O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
protein NN I-Gene
kinase NN I-Gene
( ( O
amk NN B-Gene
) ) O
. . O

Altogether RB O
these DT O
results NNS O
indicate VBP O
that IN O
the DT O
Syn NNP B-Gene
5 CD I-Gene
locus NN I-Gene
segregates NNS O
from IN O
the DT O
gene NN O
specifying VBG O
gH NNS B-Gene
, , O
to TO O
a DT O
region NN O
encompassing VBG O
portions NNS O
of IN O
the DT O
TK NNP B-Gene
and CC O
UL NNP B-Gene
24 CD I-Gene
genes NNS I-Gene
, , O
and CC O
that IN O
the DT O
syn JJ B-Gene
mutation NN I-Gene
does VBZ O
not RB O
affect VB O
the DT O
expression NN O
or CC O
activity NN O
of IN O
TK NNP B-Gene
. . O

TRAF2 NNP B-Gene
is VBZ O
a DT O
potent JJ O
activator NN O
of IN O
a DT O
95 CD B-Gene
- : I-Gene
kDa NN I-Gene
serine NN I-Gene
/ NNP I-Gene
threonine NN I-Gene
kinase NN I-Gene
termed VBD O
germinal JJ B-Gene
center NN I-Gene
kinase NN I-Gene
related VBN I-Gene
( ( O
GCKR NNP B-Gene
, , O
also RB O
referred VBD O
to TO O
as IN O
KHS1 NNP B-Gene
) ) O
, , O
which WDT O
signals VBZ O
activation NN O
of IN O
the DT O
SAPK NNP B-Gene
pathway NN O
. . O

Intravenous JJ O
antibiotic JJ O
therapy NN O
in IN O
cystic JJ O
fibrosis NN O
: : O
in IN O
hospital NN O
or CC O
at IN O
home NN O
? . O

Determination NN O
of IN O
potassium NN O
iodide NN O
in IN O
Polish NNP O
edible JJ O
salt NN O

Changes NNS O
in IN O
body NN O
weight NN O
and CC O
agonistic JJ O
behavior NN O
were VBD O
also RB O
recorded VBN O
. . O

The DT O
P165 NNP O
component NN O
, , O
however RB O
, , O
could MD O
be VB O
differentiated VBN O
from IN O
the DT O
two CD O
later JJ O
components NNS O
since IN O
it PRP O
increased VBD O
in IN O
amplitude NN O
with IN O
increased JJ O
task NN O
demands NNS O
while IN O
the DT O
N2 NNP O
and CC O
P3 NNP O
amplitudes NNS O
remained VBD O
constant JJ O
. . O

Symptoms NNS O
due JJ O
to TO O
the DT O
action NN O
of IN O
mastocyte NN O
mediators NNS O
were VBD O
observed VBN O
. . O

The DT O
genomic JJ O
structure NN O
of IN O
four CD O
members NNS O
of IN O
the DT O
SRC NNP B-Gene
- : I-Gene
family NN I-Gene
revealed VBD O
nearly RB O
identical JJ O
exon NN O
/ NNP O
intron NN O
boundaries NNS O
within IN O
the DT O
catalytic JJ O
domain NN O
of IN O
this DT O
family NN O
. . O

Therefore RB O
, , O
the DT O
results NNS O
indicate VBP O
that IN O
repeated VBD O
exposure NN O
to TO O
amphetamine VB O
or CC O
apomorphine VB O
overcomes VBZ O
the DT O
context NN O
- : O
dependent JJ O
component NN O
of IN O
sensitization NN O
of IN O
amphetamine JJ O
- : O
or CC O
apomorphine VB O
- : O
induced VBN O
stereotyped JJ O
behavior NN O
. . O

The DT O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
/ NN O
TGF NNP B-Gene
- : I-Gene
alpha NN I-Gene
HCCs NNP O
were VBD O
also RB O
characterized VBN O
by IN O
a DT O
particularly RB O
strong JJ O
expression NN O
of IN O
TGF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
very RB O
low JJ O
apoptotic JJ O
index NN O
in IN O
contrast NN O
to TO O
high JJ O
levels NNS O
of IN O
apoptosis NN O
in IN O
peritumorous JJ O
tissues NNS O
and CC O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
HCCs NNP O
. . O

SELECTION NNP O
CRITERIA NNP O
: : O
All DT O
randomised VBD O
controlled VBN O
trials NNS O
comparing VBG O
IUSs NNP O
with IN O
other JJ O
forms NNS O
of IN O
reversible JJ O
contraceptives NNS O
and CC O
reporting VBG O
on IN O
pre NN O
- : O
determined VBN O
outcomes NNS O
in IN O
women NNS O
of IN O
reproductive JJ O
years NNS O
. . O

In IN O
addition NN O
, , O
using VBG O
biochemical JJ O
activity NN O
assays NNS O
for IN O
Rho NNP B-Gene
- : O
like IN O
GTPases NNP B-Gene
, , O
we PRP O
show VBP O
that IN O
the DT O
expression NN O
of IN O
beta1A NN B-Gene
, , O
beta1D NN B-Gene
, , O
or CC O
IL2R NNP B-Gene
- : O
beta1A NN B-Gene
in IN O
GE11 NNP O
or CC O
GD25 NNP O
cells NNS O
triggers VBZ O
activation NN O
of IN O
both DT O
RhoA NNP B-Gene
and CC O
Rac1 NNP B-Gene
, , O
but CC O
not RB O
of IN O
Cdc42 NNP B-Gene
. . O

A DT O
subset NN O
of IN O
mutations NNS O
in IN O
the DT O
Psi NNP B-Gene
synthase NN I-Gene
domain NN I-Gene
impairs JJ O
association NN O
of IN O
the DT O
altered JJ O
Cbf5p NNP B-Gene
proteins NNS I-Gene
with IN O
selected VBN O
box NN O
H NNP B-Gene
/ NNP I-Gene
ACA NNP I-Gene
snoRNAs NN I-Gene
, , O
suggesting VBG O
that IN O
the DT O
functional JJ O
catalytic JJ O
domain NN O
is VBZ O
essential JJ O
for IN O
that DT O
interaction NN O
. . O

Here RB O
, , O
we PRP O
present VBP O
genetic JJ O
evidence NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
for IN O
a DT O
functional JJ O
interaction NN O
between IN O
the DT O
DEAH NNP B-Gene
protein NN I-Gene
Prp16 NNP B-Gene
, , O
and CC O
the DT O
U6 NNP B-Gene
and CC O
U2 NNP B-Gene
spliceosomal JJ I-Gene
snRNAs NN I-Gene
. . O

Thus RB O
, , O
transcriptional JJ O
regulation NN O
, , O
splicing VBG O
, , O
kinase VB O
interaction NN O
sites NNS O
, , O
and CC O
tyrosine JJ O
phosphorylation NN O
of IN O
the DT O
LMP2A NNP B-Gene
homologs NNS I-Gene
have VBP O
been VBN O
conserved VBN O
despite IN O
significant JJ O
sequences NNS O
heterogeneity NN O
in IN O
the DT O
preterminal JJ O
repeat NN O
regions NNS O
of IN O
these DT O
human JJ O
and CC O
nonhuman JJ O
primate NN O
EBVs NNP O
. . O

In IN O
addition NN O
, , O
two CD O
- : O
dimensional JJ O
nuclear JJ O
magnetic JJ O
resonance NN O
studies NNS O
with IN O
F17A NNP O
, , O
K13Q NNP O
, , O
F15Y NNP O
and CC O
F27Y NNP O
revealed VBD O
that IN O
the DT O
mutants NNS O
have VBP O
the DT O
same JJ O
overall JJ O
structure NN O
as IN O
the DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
CspB NNP I-Gene
protein NN I-Gene
. . O

The DT O
procedure NN O
has VBZ O
been VBN O
applied VBN O
to TO O
three CD O
materials NNS O
: : O
particle NN O
board NN O
with IN O
carpet NN O
; : O
gypsum CC O
board NN O
with IN O
wallpaper NN O
; : O
and CC O
plywood NN O
with IN O
polyurethane NN O
lacquer NN O
, , O
for IN O
which WDT O
the DT O
steady JJ O
- : O
state NN O
emission NN O
factors NNS O
( ( O
mg VB O
m SYM O
- : O
2 CD O
h NN O
- : O
1 CD O
) ) O
of IN O
several JJ O
compounds NNS O
are VBP O
given VBN O
. . O

Beta NNP B-Gene
- : I-Gene
endorphin NN I-Gene
, , O
ACTH NNP B-Gene
and CC O
cortisol JJ O
secretion NN O
were VBD O
measured VBN O
in IN O
twelve NN O
healthy JJ O
adult NN O
males NNS O
after IN O
nasal JJ O
spray JJ O
administration NN O
200 CD O
IU NNP O
salmon NN B-Gene
calcitonin NN I-Gene
. . O

In IN O
overdoses VBZ O
up RB O
to TO O
2 CD O
g NNS O
fluvoxamine JJ O
no DT O
lasting JJ O
toxic NN O
effects NNS O
were VBD O
observed VBN O
. . O

We PRP O
have VBP O
reviewed VBN O
the DT O
experience NN O
of IN O
a DT O
major JJ O
MMT NNP O
general JJ O
practice NN O
with IN O
hepatitis NN O
C NNP O
virus NN O
( ( O
HCV NNP O
) ) O
infection NN O
from IN O
1991 CD O
to TO O
1995 CD O
. . O

Weight NNP O
loss NN O
reduces VBZ O
arterial JJ O
pressure NN O
by IN O
a DT O
decrease NN O
in IN O
intravascular JJ O
volume NN O
and CC O
cardiac JJ O
output NN O
associated VBN O
with IN O
a DT O
fall NN O
in IN O
sympathetic JJ O
activity NN O
. . O

Factors NNS O
that WDT O
showed VBD O
significant JJ O
correlation NN O
to TO O
elevated VBN O
CIC NNP O
' POS O
s NN O
in IN O
the DT O
highly RB O
elevated JJ O
portion NN O
of IN O
our PRP$ O
CIC NNP O
population NN O
were VBD O
poor JJ O
NIH NNP O
score NN O
, , O
increased VBD O
patient JJ O
age NN O
, , O
low JJ O
peak NN O
expiratory NN O
flow NN O
rate NN O
, , O
and CC O
elevated VBD O
total JJ O
serum NN B-Gene
IgG NNP I-Gene
. . O

Follow NNP O
- : O
up RB O
study NN O
showed VBD O
85 CD O
% NN O
of IN O
these DT O
patients NNS O
with IN O
effectiveness NN O
. . O

The DT O
Fas NNP B-Gene
receptor NN I-Gene
mediates VBZ O
a DT O
signalling VBG O
cascade NN O
resulting VBG O
in IN O
programmed VBN O
cell NN O
death NN O
( ( O
apoptosis NN O
) ) O
within IN O
hours NNS O
of IN O
receptor NN O
cross NN O
- : O
linking NN O
. . O

Dystonic NNP O
movement NN O
of IN O
the DT O
left JJ O
upper JJ O
limb NN O
in IN O
a DT O
case NN O
of IN O
the DT O
right JJ O
pontine NN O
hemorrhage NN O

Potential JJ O
translational JJ O
start NN O
signals NNS O
are VBP O
upstream JJ O
of IN O
ORF1 NNP O
and CC O
ORF2 NNP O
. . O

The DT O
pharmacology NN O
of IN O
carnitine NN O
. . O

Primer NNP O
extension NN O
and CC O
S1 NNP B-Gene
nuclease NN I-Gene
mapping NN O
experiments NNS O
were VBD O
used VBN O
to TO O
locate VB O
the DT O
transcription NN O
initiation NN O
site NN O
of IN O
Nramp1 NNP B-Gene
and CC O
revealed VBD O
the DT O
presence NN O
of IN O
one CD O
major JJ O
and CC O
several JJ O
minor JJ O
initiation NN O
sites NNS O
. . O

Moreover RB O
, , O
in IN O
rats NNS O
allowed VBN O
to TO O
choose VB O
in IN O
a DT O
T NNP O
- : O
maze NN O
between IN O
immediate JJ O
- : O
but CC O
- : O
small JJ O
vs NN O
. . O
delayed VBN O
- : O
but CC O
- : O
large JJ O
reward NN O
, , O
BZP NNP O
significantly RB O
decreased VBD O
the DT O
frequency NN O
with IN O
which WDT O
the DT O
delayed FW O
reward NN O
was VBD O
chosen VBN O
, , O
with IN O
5 CD O
- : O
HT NNP O
uptake JJ O
blockers NNS O
producing VBG O
opposite JJ O
effects NNS O
. . O

The DT O
P131 NNP O
ORF NNP O
is VBZ O
followed VBN O
in IN O
- : O
frame NN O
by IN O
a DT O
second JJ O
ORF NNP O
which WDT O
is VBZ O
probably RB O
expressed VBN O
by IN O
partial JJ O
readthrough NN O
of IN O
the DT O
UGA NNP O
termination NN O
codon NN O
of IN O
the DT O
P131 NNP O
ORF NNP O
to TO O
produce VB O
a DT O
polypeptide NN O
of IN O
M NNP O
( ( O
r NN O
) ) O
191044 CD O
( ( O
P191 NNP O
) ) O
. . O

These DT O
mutants NNS O
grow VBP O
normally RB O
in IN O
3T6 CD O
mouse NN O
fibroblast NN O
cells NNS O
, , O
and CC O
they PRP O
do VBP O
not RB O
complement VB O
the DT O
wild JJ O
- : O
type NN O
virus NN O
in IN O
coinfection NN O
experiments NNS O
of IN O
C2 NNP O
myoblasts NNS O
. . O

Feeding VBG O
behavior NN O
, , O
circannual JJ O
body NN O
weight NN O
and CC O
hibernation NN O
rhythms NN O
in IN O
European JJ O
hamsters NNS O
lesioned VBD O
in IN O
the DT O
noradrenergic JJ O
ascending NN O
bundles NNS O

Patients NNS O
were VBD O
assessed VBN O
for IN O
cardiac JJ O
MIBG NNP O
uptake NN O
, , O
circulating VBG O
norepinephrine JJ O
concentration NN O
, , O
LVEF NNP O
, , O
peak NN O
Vo2 NNP O
, , O
x NNP O
- : O
ray NN O
cardiothoracic NN O
ratio NN O
, , O
M NNP O
- : O
mode NN O
echographic JJ O
end NN O
- : O
diastolic JJ O
diameter NN O
and CC O
right JJ O
- : O
sided JJ O
heart NN O
catheterization NN O
parameters NNS O
. . O

The DT O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptors NNS I-Gene
( ( O
PPARs NNP B-Gene
) ) O
are VBP O
members NNS O
of IN O
the DT O
nuclear JJ B-Gene
hormone NN I-Gene
receptor NN I-Gene
superfamily RB I-Gene
. . O

Another DT O
full JJ O
ORF NNP O
was VBD O
found VBN O
on IN O
the DT O
opposite JJ O
strand NN O
downstream NN O
from IN O
the DT O
nspC JJ B-Gene
gene NN I-Gene
. . O

The DT O
bile NN O
acid NN O
sequestrants NNS O
( ( O
cholestyramine NN O
and CC O
colestipol NN O
) ) O
, , O
nicotinic JJ O
acid NN O
, , O
fenofibrate NN O
and CC O
inhibitors NNS O
of IN O
hydroxymethylglutaryl NN B-Gene
coenzyme NN I-Gene
A NNP I-Gene
( ( I-Gene
HMG NNP I-Gene
CoA NNP I-Gene
) ) I-Gene
reductase NN I-Gene
( ( O
e NN O
. . O
g NN O
. . O
lovastatin NN O
or CC O
simvastatin NN O
) ) O
are VBP O
the DT O
most RBS O
effective JJ O
drugs NNS O
for IN O
use NN O
in IN O
patients NNS O
with IN O
primary JJ O
hypercholesterolaemia NN O
; : O
these DT O
agents NNS O
reduce VB O
plasma JJ O
concentrations NNS O
of IN O
total JJ O
and CC O
LDL NNP B-Gene
- : I-Gene
cholesterol NN I-Gene
by IN O
15 CD O
to TO O
45 CD O
% NN O
. . O

Mutants NNS O
with IN O
mild JJ O
lace NN B-Gene
alleles NNS I-Gene
grow VBP O
to TO O
become VB O
adults NNS O
with IN O
multiple JJ O
aberrant JJ O
morphologies NNS O
in IN O
the DT O
appendages NNS O
, , O
compound NN O
eye NN O
, , O
and CC O
bristles NNS O
. . O

Both DT O
GH NNP B-Gene
deficiency NN O
and CC O
impaired JJ O
spinal JJ O
growth NN O
may MD O
result VB O
in IN O
short JJ O
stature NN O
, , O
whereas IN O
the DT O
occurrence NN O
of IN O
early JJ O
puberty NN O
in IN O
association NN O
with IN O
GH NNP B-Gene
deficiency NN O
reduces VBZ O
the DT O
time NN O
available JJ O
for IN O
GH NNP B-Gene
therapy NN O
. . O

A DT O
rapid JJ O
staining NN O
technique NN O
for IN O
Leishmania NNP O
parasites NNS O
in IN O
splenic JJ O
aspirate NN O
smears NNS O
. . O

Endothelial NNP O
cell NN O
seeding NN O
. . O

Randomised VBN O
comparison NN O
of IN O
addition NN O
of IN O
autologous JJ O
bone NN O
- : O
marrow NN O
transplantation NN O
to TO O
intensive JJ O
chemotherapy NN O
for IN O
acute JJ O
myeloid NN O
leukaemia NN O
in IN O
first JJ O
remission NN O
: : O
results NNS O
of IN O
MRC NNP O
AML NNP O
10 CD O
trial NN O
. . O

The DT O
overall JJ O
prevalence NN O
of IN O
psoriasis NN O
was VBD O
4 CD O
. . O
79 CD O
% NN O
in IN O
men NNS O
and CC O
4 CD O
. . O
85 CD O
% NN O
in IN O
women NNS O
. . O

Human NNP B-Gene
papillomavirus NN I-Gene
type VBD I-Gene
31b CD I-Gene
late JJ I-Gene
gene NN I-Gene
expression NN O
is VBZ O
regulated VBN O
through IN O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
- : O
mediated VBN O
changes NNS O
in IN O
RNA NNP O
processing NN O
. . O

Clinical JJ O
nutrition NN O
of IN O
adult NN O
horses NNS O
. . O

Generally RB O
ILC NNP O
and CC O
ILVF NNP O
values NNS O
decreased VBN O
with IN O
increasing VBG O
exposure NN O
time NN O
with IN O
rate NN O
constants NNS O
ranging VBG O
from IN O
0 CD O
. . O
3 CD O
to TO O
0 CD O
. . O
33 CD O
day NN O
- : O
1 CD O
( ( O
wet NN O
and CC O
lipid JJ O
weight NN O
) ) O
for IN O
ILC NNP O
and CC O
0 CD O
. . O
3 CD O
to TO O
0 CD O
. . O
31 CD O
day NN O
- : O
1 CD O
for IN O
ILVF NNP O
. . O

Effects NNS O
of IN O
methylene NN O
chloride NN O
, , O
trichloroethane NN O
, , O
trichloroethylene NN O
, , O
tetrachloroethylene NN O
and CC O
toluene NN O
on IN O
the DT O
development NN O
of IN O
chick NN O
embryos NN O
. . O

The DT O
data NN O
suggest NN O
that IN O
ICP10 NNP B-Gene
constitutively RB O
increases VBZ O
ras JJ B-Gene
activity NN O
, , O
and CC O
its PRP$ O
TM NNP O
segment NN O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
transformation NN O
- : O
related JJ O
signaling NN O
pathways NNS O
. . O

Recombinant NNP O
plasmid NN O
pFV100 NN O
was VBD O
subsequently RB O
isolated VBN O
by IN O
its PRP$ O
ability NN O
to TO O
complement NN O
B NNP O
- : O
band NN O
expression NN O
in IN O
ge6 NN B-Gene
. . O

Before IN O
PO3 NNP O
administration NN O
, , O
more JJR O
than IN O
half NN O
( ( O
57 CD O
. . O
4 CD O
% NN O
) ) O
of IN O
the DT O
patients NNS O
received VBD O
only RB O
1 CD O
or CC O
2 CD O
antituberculous JJ O
drugs NNS O
( ( O
ethambutole NN O
and CC O
ethionamide NN O
or CC O
ethambutole NN O
and CC O
oprofloxacin NN O
) ) O
. . O

Removal NN O
of IN O
lipid JJ O
fractions NNS O
of IN O
plant NN O
extractions NNS O
with IN O
hexane NN O
is VBZ O
recommended VBN O
to TO O
avoid VB O
damage NN O
to TO O
the DT O
HPLC NNP O
column NN O
. . O

In IN O
NASCIS NNP O
III NNP O
, , O
a DT O
randomization NN O
imbalance NN O
occurred VBD O
that IN O
allocated VBD O
a DT O
disproportionate JJ O
number NN O
of IN O
patients NNS O
with IN O
no DT O
motor NN O
deficit NN O
( ( O
and CC O
therefore RB O
no DT O
chance NN O
for IN O
recovery NN O
) ) O
to TO O
the DT O
lower JJR O
dose JJ O
control NN O
group NN O
. . O

Neither CC O
class NN O
II NNP O
nor CC O
IV NNP O
infections NNS O
precluded VBD O
transplantation NN O
. . O

Combined VBN O
intravenous JJ O
and CC O
intra JJ O
- : O
arterial JJ O
recombinant JJ O
tissue NN B-Gene
plasminogen NN I-Gene
activator NN I-Gene
in IN O
acute JJ O
ischemic JJ O
stroke NN O
. . O

The DT O
heterogeneous JJ O
nuclear JJ B-Gene
ribonucleoprotein NN I-Gene
C NNP I-Gene
protein NN I-Gene
tetramer NN I-Gene
binds VBZ O
U1 NNP B-Gene
, , O
U2 NNP B-Gene
, , O
and CC O
U6 NNP B-Gene
snRNAs VBD I-Gene
through IN O
its PRP$ O
high JJ O
affinity NN O
RNA NNP O
binding NN O
domain NN O
( ( O
the DT O
bZIP NN O
- : O
like IN O
motif NN O
) ) O
. . O

This DT O
model NN O
is VBZ O
further RB O
supported VBN O
by IN O
binding NN O
of IN O
the DT O
Fos NNP B-Gene
- : O
Jun NN B-Gene
complex NN O
at IN O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
site NN I-Gene
in IN O
the DT O
type NN B-Gene
alpha NN I-Gene
I PRP I-Gene
collagen VBP I-Gene
promoter NN I-Gene
that WDT O
is VBZ O
contiguous JJ O
with IN O
, , O
but CC O
not RB O
overlapping JJ O
, , O
the DT O
VDRE NNP O
. . O

SCA NNP B-Gene
was VBD O
resistant JJ O
to TO O
inhibitors NNS O
of IN O
serine NN O
, , O
aspartyl NN O
, , O
and CC O
metalloproteases NNS B-Gene
, , O
but CC O
it PRP O
was VBD O
sensitive JJ O
to TO O
N NNP O
- : O
ethylmaleimide NN O
. . O

Mapping NN O
of IN O
the DT O
mouse NN B-Gene
ornithine NN I-Gene
decarboxylase NN I-Gene
- : I-Gene
related JJ I-Gene
sequence NN I-Gene
family NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
mitochondrial JJ O
presequences NNS O
interact NN O
with IN O
the DT O
mt NN B-Gene
- : I-Gene
hsp70 NN I-Gene
during IN O
or CC O
after IN O
mitochondrial JJ O
protein NN O
import NN O
. . O

40 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
10 CD O
. . O
1 CD O
mg JJ O
/ NN O
l NN O
( ( O
SD NNP O
) ) O
vs VBD O
31 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
8 CD O
. . O
0 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O
beta $ B-Gene
2m CD I-Gene
was VBD O
not RB O
significantly RB O
higher RBR O
in IN O
patients NNS O
with IN O
bone NN O
cysts NNS O
( ( O
37 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
11 CD O
. . O
4 CD O
mg JJ O
/ NNP O
l NN O
vs NN O
37 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
10 CD O
. . O
0 CD O
) ) O
, , O
but CC O
median JJ O
duration NN O
of IN O
dialysis NN O
was VBD O
significantly RB O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
longer RBR O
in IN O
patients NNS O
with IN O
bone NN O
cysts NNS O
( ( O
90 CD O
vs RB O
57 CD O
months NNS O
) ) O
. . O
beta $ B-Gene
2m CD I-Gene
was VBD O
lower JJR O
in IN O
patients NNS O
maintained VBN O
on IN O
dialysis NN O
for IN O
less JJR O
than IN O
1 CD O
year NN O
and CC O
whose WP$ O
residual JJ O
urine NN O
volume NN O
was VBD O
greater JJR O
than IN O
0 CD O
. . O
1 CD O
litre JJ O
per IN O
day NN O
. . O

As IN O
the DT O
rate NN O
of IN O
protein NN O
synthesis NN O
decreases VBZ O
during IN O
late JJ O
embryogenesis NN O
, , O
levels NNS O
of IN O
SEC NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
its PRP$ O
cognate NN O
mRNA NN O
decline NN O
precipitously RB O
. . O

The DT O
promoter NN O
of IN O
the DT O
first JJ O
gene NN O
, , O
epiF RB B-Gene
, , O
responded VBD O
to TO O
the DT O
activator NN B-Gene
protein NN I-Gene
EpiQ NNP I-Gene
and CC O
contained VBD O
a DT O
palindromic JJ O
sequence NN O
similar JJ O
to TO O
the DT O
EpiQ NNP B-Gene
binding VBG I-Gene
site NN I-Gene
of IN O
the DT O
epiA NN B-Gene
promoter NN I-Gene
, , O
which WDT O
is VBZ O
also RB O
activated VBN O
by IN O
EpiQ NNP B-Gene
. . O

The DT O
altered JJ O
amino NN O
acid NN O
residues NNS O
of IN O
the DT O
seven CD O
mutant JJ B-Gene
9ORF1 CD I-Gene
polypeptides NNS I-Gene
clustered VBD O
within IN O
three CD O
separate JJ O
regions NNS O
referred VBN O
to TO O
as IN O
region NN O
I PRP O
( ( O
residues VB O
34 CD O
to TO O
41 CD O
) ) O
, , O
region NN O
II NNP O
( ( O
residues VBZ O
89 CD O
to TO O
91 CD O
) ) O
, , O
and CC O
C NNP O
- : O
terminal JJ O
region NN O
III NNP O
( ( O
residues VBZ O
122 CD O
to TO O
125 CD O
) ) O
. . O

If IN O
no DT O
alloantibodies NNS O
are VBP O
detected VBN O
, , O
further JJ O
analysis NN O
to TO O
define VB O
a DT O
role NN O
of IN O
drug NN O
- : O
related VBN O
or CC O
autoantibodies NNS O
is VBZ O
required VBN O
. . O

Notably RB O
, , O
these DT O
residues NNS O
are VBP O
located VBN O
in IN O
different JJ O
domains NNS O
. . O

BACKGROUND NNS O
: : O
We PRP O
hypothesized VBD O
that IN O
the DT O
postoperative JJ O
serum NN O
level NN O
of IN O
TA90 NNP B-Gene
- : I-Gene
IC NNP I-Gene
, , O
an DT O
immune JJ O
complex NN O
of IN O
a DT O
90 CD O
- : O
kDa NN O
tumor NN O
- : O
associated VBN O
antigen NN O
and CC O
its PRP$ O
antibody NN O
, , O
might MD O
have VB O
a DT O
significant JJ O
correlation NN O
with IN O
recurrence NN O
and CC O
survival NN O
in IN O
patients NNS O
with IN O
thick JJ O
primary JJ O
melanomas NN O
. . O

A DT O
comparison NN O
of IN O
the DT O
Flavobacterium NNP O
glycosylasparaginase NN B-Gene
with IN O
a DT O
mammalian JJ O
glycosylasparaginase NN B-Gene
revealed VBD O
30 CD O
% NN O
structural JJ O
identity NN O
and CC O
60 CD O
% NN O
overall JJ O
similarity NN O
between IN O
the DT O
prokaryotic JJ O
and CC O
eukaryotic JJ O
forms NNS O
of IN O
the DT O
enzyme NN O
. . O

Although IN O
the DT O
DSK2 NNP B-Gene
- : I-Gene
1 CD I-Gene
mutation NN I-Gene
alters NNS O
a DT O
conserved JJ O
residue NN O
in IN O
the DT O
Dsk2p NNP B-Gene
ubiquitin JJ B-Gene
- : I-Gene
like IN I-Gene
domain NN I-Gene
, , O
we PRP O
detect VBP O
no DT O
differences NNS O
in IN O
Dsk2p NNP B-Gene
or CC O
Cdc31p NNP B-Gene
stability NN O
. . O

Dangers NNS O
in IN O
use NN O
of IN O
live JJ O
- : O
virus NN O
vaccines NNS O
. . O

The DT O
total JJ O
alkaloids NNS O
contained VBN O
in IN O
the DT O
peel NN O
of IN O
Atzimba NNP O
, , O
Lopez NNP O
, , O
Marciana NNP O
, , O
Montsama NNP O
, , O
Murca NNP O
, , O
and CC O
Puebla NNP O
was VBD O
lower JJR O
than IN O
the DT O
limits NNS O
recommended VBD O
for IN O
food NN O
safety NN O
. . O

Competition NN O
experiments NNS O
demonstrate VBP O
a DT O
negative JJ O
allosteric NN O
relationship NN O
between IN O
these DT O
RGD NNP O
recognition NN O
sites NNS O
. . O

A DT O
method NN O
for IN O
determining VBG O
cumulative JJ O
behavioral JJ O
toxicity NN O
after IN O
chronic JJ O
oral JJ O
administration NN O
of IN O
l JJ O
- : O
alpha NN O
- : O
acetylmethadol NN O
to TO O
female JJ O
rats NNS O
. . O

In IN O
patients NNS O
with IN O
limited JJ O
disease NN O
, , O
the DT O
survival NN O
in IN O
the DT O
alternating NN O
arm NN O
was VBD O
significantly RB O
superior JJ O
to TO O
the DT O
survival NN O
in IN O
the DT O
CAV NNP O
arm NN O
( ( O
P NNP O
= NNP O
. . O
14 CD O
) ) O
or CC O
the DT O
survival NN O
in IN O
the DT O
PE NNP O
arm NN O
( ( O
P NNP O
= NNP O
. . O
23 CD O
) ) O
. . O

RESULTS NN O
: : O
The DT O
parameters NNS O
SF2 NNP O
and CC O
plating VBG O
efficiency NN O
were VBD O
stable JJ O
throughout IN O
the DT O
4 CD O
- : O
year NN O
test NN O
period NN O
. . O

2 CD O
. . O
numerous JJ O
narrow JJ O
shunt NN O
vessels NNS O
departing VBG O
continuously RB O
from IN O
the DT O
primary JJ O
arteries NNS O
to TO O
feed VB O
a DT O
secondary JJ O
arterial NN O
system NN O
which WDT O
parallels VBZ O
the DT O
primary JJ O
one CD O
. . O

Two CD O
mutations NNS O
that IN O
affect VBP O
larval JJ B-Gene
cuticle NN I-Gene
protein NN I-Gene
gene NN I-Gene
expression NN O
in IN O
the DT O
2 CD O
/ $ O
3 CD O
variant JJ O
Drosophila NNP O
melanogaster NN O
strain NN O
were VBD O
investigated VBN O
. . O

In IN O
another DT O
study NN O
, , O
intravenous JJ O
administration NN O
of IN O
devazepide NN O
, , O
a DT O
specific JJ O
cholecystokinin NN B-Gene
- : I-Gene
A DT I-Gene
receptor NN I-Gene
antagonist NN O
, , O
at IN O
a DT O
dose NN O
of IN O
0 CD O
. . O
1 CD O
mg JJ O
/ NNP O
kg NN O
/ NNP O
hr NN O
was VBD O
begun VBN O
15 CD O
min NN O
before IN O
postprandial JJ O
saline NN O
intake NN O
and CC O
continued VBD O
for IN O
1 CD O
hr NN O
. . O

Caries NNS O
prevention NN O
in IN O
the DT O
dental JJ O
office NN O
. . O

The DT O
5 CD O
' POS O
regions NNS O
of IN O
these DT O
two CD O
soybean NN B-Gene
actin NN I-Gene
genes NNS I-Gene
contain VBP O
many JJ O
unusual JJ O
features NNS O
including VBG O
( ( O
CT NNP O
) ) O
repeats NNS O
and CC O
long JJ O
stretches NNS O
of IN O
pyrimidine NN O
- : O
rich JJ O
DNA NNP O
. . O

Nuclear JJ O
extracts NNS O
prepared VBN O
from IN O
both DT O
neural JJ O
and CC O
non JJ O
- : O
neural JJ O
cell NN O
lines NNS O
, , O
mouse NN O
brain NN O
, , O
and CC O
mouse RB O
liver RB O
contain VBP O
proteins NNS O
that WDT O
recognize VBP O
and CC O
bind VBP O
to TO O
the DT O
PROX NNP O
and CC O
PAL NNP O
sequences NNS O
indicating VBG O
that IN O
proteins NNS O
which WDT O
bind VBP O
to TO O
these DT O
target NN O
sequences NNS O
are VBP O
widespread JJ O
. . O

Guidelines NNS O
for IN O
performing VBG O
a DT O
routine JJ O
spiral NN O
assay NN O
are VBP O
presented VBN O
, , O
and CC O
alternative JJ O
test NN O
methods NNS O
intended VBN O
to TO O
overcome VB O
a DT O
variety NN O
of IN O
technical JJ O
difficulties NNS O
( ( O
such JJ O
as IN O
restricted JJ O
sample NN O
availability NN O
, , O
sample JJ O
viscosity NN O
or CC O
volatility NN O
, , O
etc FW O
. . O
) ) O
are VBP O
recommended VBN O
. . O

The DT O
levels NNS O
of IN O
NSE NNP B-Gene
and CC O
MBP NNP B-Gene
in IN O
the DT O
IJVB NNP O
were VBD O
compared VBN O
to TO O
those DT O
in IN O
the DT O
PVB NNP O
. . O

Another DT O
group NN O
of IN O
HIPP NNP O
- : O
and CC O
HCX NNP O
- : O
lesioned VBD O
animals NNS O
trained VBN O
on IN O
the DT O
tasks NNS O
after IN O
the DT O
lesion NN O
showed VBD O
reduced JJ O
impairments NNS O
of IN O
the DT O
type NN O
described VBN O
above IN O
, , O
suggesting VBG O
that IN O
extrahippocampal JJ O
structures NNS O
trained VBN O
after IN O
the DT O
lesion NN O
can MD O
assume VB O
the DT O
role NN O
of IN O
the DT O
hippocampus NN O
to TO O
some DT O
degree NN O
. . O

However RB O
, , O
a DT O
surprisingly RB O
high JJ O
degree NN O
of IN O
conservation NN O
of IN O
intron NN O
sequences NNS O
was VBD O
observed VBN O
between IN O
both DT O
species NNS O
. . O

Psychiatric JJ O
disorders NNS O
in IN O
children NNS O
and CC O
adolescents NNS O
carry VBP O
considerable JJ O
morbidity NN O
, , O
impede NN O
development NN O
, , O
and CC O
carry VBP O
a DT O
significant JJ O
mortality NN O
by IN O
suicide NN O
. . O

To TO O
test VB O
the DT O
hypothesis NN O
that IN O
these DT O
elements NNS O
are VBP O
required VBN O
for IN O
promoter NN O
activity NN O
, , O
we PRP O
compared VBN O
the DT O
reporter NN O
expression NN O
activity NN O
of IN O
segments NNS O
containing VBG O
mutations NNS O
of IN O
these DT O
elements NNS O
with IN O
activity NN O
of IN O
the DT O
parent NN B-Gene
Hlx NNP I-Gene
promoter NN I-Gene
sequence NN I-Gene
. . O

We PRP O
have VBP O
used VBN O
the DT O
hydrophobic JJ O
repeats NNS O
of IN O
the DT O
HSF1 NNP B-Gene
trimerization NN I-Gene
domain NN I-Gene
in IN O
the DT O
yeast NN O
two CD O
- : O
hybrid JJ O
protein NN O
interaction NN O
assay VBP O
to TO O
identify VB O
heat NN B-Gene
shock NN I-Gene
factor NN I-Gene
binding VBG I-Gene
protein NN I-Gene
1 CD I-Gene
( ( O
HSBP1 NNP B-Gene
) ) O
, , O
a DT O
novel NN O
, , O
conserved VBD O
, , O
76 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
that WDT O
contains VBZ O
two CD O
extended JJ O
arrays NNS O
of IN O
hydrophobic JJ O
repeats NNS O
that WDT O
interact VBP O
with IN O
the DT O
HSF1 NNP B-Gene
heptad NN I-Gene
repeats NNS I-Gene
. . O

Renin NNP B-Gene
studies NNS O
performed VBD O
in IN O
34 CD O
hypertensive JJ O
patients NNS O
and CC O
in IN O
a DT O
control NN O
group NN O
of IN O
11 CD O
recipients NNS O
showed VBD O
that IN O
elevation NN O
of IN O
plasma JJ B-Gene
renin NN I-Gene
activity NN O
and CC O
of IN O
plasma JJ O
aldosterone NN O
level NN O
is VBZ O
frequent JJ O
but CC O
difficult JJ O
to TO O
interpret VB O
, , O
particularly RB O
when WRB O
a DT O
renal JJ O
artery NN O
stenosis NN O
is VBZ O
observed VBN O
. . O

Skeletal JJ O
muscle NN O
metaboreceptor NN O
responses NNS O
are VBP O
impaired VBN O
in IN O
heart NN O
failure NN O
. . O

Forty NN O
patients NNS O
, , O
divided VBD O
according VBG O
to TO O
their PRP$ O
initial JJ O
total JJ O
gastrointestinal JJ O
transit NN O
times NNS O
and CC O
presenting VBG O
symptoms NNS O
, , O
were VBD O
treated VBN O
with IN O
cimetropium NN O
bromide NN O
50 CD O
mg NN O
t NN O
. . O
d NN O
. . O
s NN O
. . O
or CC O
placebo NN O
for IN O
1 CD O
month NN O
according VBG O
to TO O
a DT O
double JJ O
- : O
blind NN O
, , O
parallel JJ O
group NN O
design NN O
. . O

An DT O
end NN O
to TO O
the DT O
lottery NN O
. . O

In IN O
the DT O
course NN O
of IN O
a DT O
study NN O
of IN O
low JJ O
dose NN O
X NNP O
- : O
rays NNS O
effects NNS O
, , O
we PRP O
found VBD O
that IN O
male JJ O
ICR NNP O
white JJ O
Swiss JJ O
mice NN O
showed VBD O
remarkable JJ O
suppression NN O
of IN O
mounting VBG O
behavior NN O
after IN O
whole JJ O
body NN O
irradiation NN O
by IN O
5 CD O
to TO O
15 CD O
cGy NN O
X NNP O
- : O
rays NNS O
. . O

Human NNP O
recombinant NN O
DNA NNP O
- : O
derived VBD O
antihemophilic JJ B-Gene
factor NN I-Gene
( ( O
factor NN B-Gene
VIII NNP I-Gene
) ) O
in IN O
the DT O
treatment NN O
of IN O
hemophilia NN O
A NNP O
. . O
recombinant JJ O
Factor NNP B-Gene
VIII NNP I-Gene
Study NNP O
Group NNP O
. . O

The DT O
model NN O
captures VBZ O
the DT O
essence NN O
of IN O
predator NN O
- : O
prey NN O
dynamics NNS O
to TO O
provide VB O
reasonable JJ O
predictions NNS O
of IN O
population NN O
patterns NNS O
. . O

In IN O
an DT O
effort NN O
to TO O
contribute VB O
to TO O
the DT O
transcript NN O
map NN O
of IN O
human JJ O
chromosome NN O
21 CD O
and CC O
the DT O
understanding NN O
of IN O
the DT O
pathophysiology NN O
of IN O
trisomy NN O
21 CD O
, , O
we PRP O
have VBP O
used VBN O
exon RB O
trapping VBG O
to TO O
identify VB O
fragments NNS O
of IN O
chromosome NN O
21 CD O
genes NNS O
. . O

RT NNP O
- : O
PCR NN O
was VBD O
performed VBN O
using VBG O
previously RB O
reported VBN O
degenerate JJ O
oligonucleotide NN O
primers NNS O
to TO O
the DT O
ligand NN O
binding VBG O
domain NN O
( ( O
LBD NNP O
) ) O
of IN O
known VBN O
beta NN B-Gene
integrin NN I-Gene
subunits NNS I-Gene
and CC O
Bge NNP B-Gene
cDNA NN I-Gene
. . O

The DT O
p53 NN B-Gene
- : I-Gene
homolog NN I-Gene
p73beta NN B-Gene
also RB O
activated VBD O
the DT O
PIG3 NNP B-Gene
promoter NN I-Gene
, , O
but CC O
in IN O
contrast NN O
to TO O
p53 VB B-Gene
, , O
the DT O
proline NN O
- : O
rich JJ O
domain NN O
of IN O
p73beta NN B-Gene
( ( I-Gene
residues VBZ I-Gene
81 CD I-Gene
- : I-Gene
113 CD I-Gene
) ) I-Gene
was VBD O
dispensable JJ O
to TO O
induce VB O
the DT O
PIG3 NNP B-Gene
promoter NN I-Gene
. . O

Sparfloxacin NNP O
and CC O
clinafloxacin NN O
were VBD O
evaluated VBN O
against IN O
Enterococcus NNP O
faecium NN O
SF2149 NNP O
and CC O
Enterococcus NNP O
faecalis VBP O
WH245 NNP O
, , O
respectively RB O
. . O

Cotransfection NN O
of IN O
either DT O
construct NN O
with IN O
plasmids NNS O
encoding VBG O
PKI NNP B-Gene
( ( I-Gene
1 CD I-Gene
- : I-Gene
31 CD I-Gene
) ) I-Gene
inhibits NNS O
cAMP VBP O
- : O
stimulated VBN O
but CC O
not RB O
basal JJ O
- : O
or CC O
phorbol VB O
ester JJR O
- : O
stimulated VBN O
expression NN O
. . O

Fourteen NNP O
healthy JJ O
male NN O
volunteers NNS O
completed VBD O
the DT O
study NN O
. . O

We PRP O
have VBP O
synthesized VBN O
[ JJ O
7 CD O
, , O
7 CD O
- : O
2H2 CD O
] SYM O
- : O
19 CD O
- : O
OHA NN O
with IN O
high JJ O
deuterium NN O
content NN O
and CC O
, , O
together RB O
with IN O
[ JJ O
7 CD O
, , O
7 CD O
- : O
2H2 CD O
] IN O
A DT O
and CC O
[ $ O
9 CD O
, , O
11 CD O
- : O
2H2 CD O
] NN O
estrone NN O
( ( O
E1 NNP O
) ) O
, , O
have VBP O
developed VBN O
a DT O
quantitative JJ O
assay NN O
of IN O
serum JJ O
level NN O
19 CD O
- : O
OHA NN O
, , O
A NNP O
, , O
and CC O
E1 NNP O
using VBG O
the DT O
gas NN O
chromatography NN O
/ NNP O
mass NN O
spectrometry NN O
- : O
mass NN O
fragmentography NN O
method NN O
to TO O
monitor VB O
individual JJ O
subjects NNS O
throughout IN O
pregnancy NN O
. . O

Northern NNP O
blot NN O
analysis NN O
, , O
using VBG O
the DT O
Ltp4 NNP B-Gene
- : O
specific JJ O
probe NN O
, , O
indicated VBD O
that IN O
Xanthomonas NNP O
campestris VBD O
pv NN O
. . O
translucens NNS O
induced VBD O
an DT O
increase NN O
over IN O
basal JJ O
levels NNS O
of IN O
Ltp4 NNP B-Gene
mRNA NN I-Gene
, , O
while IN O
Pseudomonas NNP O
syringae VBD O
pv NN O
. . O
japonica NN O
caused VBD O
a DT O
decrease NN O
. . O

Immunochemical JJ O
studies NNS O
with IN O
filarial JJ O
antigens NNS O
. . O

Transfection NN O
of IN O
EGFP NNP B-Gene
- : O
tagged VBD O
DENTT NNP B-Gene
NLS NNP O
deletion NN O
constructs NNS O
lacking VBG O
the DT O
bipartite NN O
NLS NNP B-Gene
- : I-Gene
1 CD I-Gene
were VBD O
excluded VBN O
from IN O
the DT O
nucleolus NN O
. . O

The DT O
experimental JJ O
results NNS O
showed VBD O
that IN O
the DT O
coagulation NN O
- : O
electrooxidation NN O
process NN O
could MD O
efficiently RB O
remove VB O
the DT O
color NN O
and CC O
the DT O
COD NNP O
from IN O
the DT O
simulated JJ O
dye NN O
wastewater NN O
. . O

Comparison NNP O
of IN O
the DT O
plant NN O
nuclear JJ O
tRNA RB O
3 CD O
' '' O
processing NN O
enzyme NN O
with IN O
the DT O
plant NN O
mitochondrial JJ O
one CD O
suggests VBZ O
that IN O
both DT O
activities NNS O
are VBP O
different JJ O
enzymes NNS O
. . O

Sites NNS O
1 CD O
and CC O
4 CD O
in IN O
lumican JJ B-Gene
and CC O
keratocan JJ B-Gene
are VBP O
in IN O
a DT O
homologous JJ O
location NN O
. . O

Thus RB O
, , O
both DT O
the DT O
hyperplasia NN O
and CC O
thrombotic JJ O
complications NNS O
which WDT O
often RB O
follow VBP O
stenting VBG O
might MD O
be VB O
minimized VBN O
by IN O
employing VBG O
gold NN O
stents NNS O
, , O
which WDT O
have VBP O
a DT O
greater JJR O
capacity NN O
than IN O
steel NN O
in IN O
supporting VBG O
a DT O
functional JJ O
neo NN O
- : O
endothelium NN O
. . O

Ischemic NNP O
heart NN O
disease NN O
evaluated VBN O
by IN O
exercise NN O
stress NN O
thallium NN O
- : O
201 CD O
myocardial JJ O
scintigraphy NN O
: : O
a DT O
comparison NN O
of IN O
SPECT NNP O
and CC O
bull NN O
' '' O
s JJ O
eye NN O
display NN O

Baseline NNP O
MBF NNP O
in IN O
females NNS O
was VBD O
significantly RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
higher JJR O
than IN O
in IN O
males NNS O
. . O

The DT O
effects NNS O
of IN O
these DT O
mutations NNS O
on IN O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
activity NN O
were VBD O
assayed VBN O
by IN O
measuring VBG O
the DT O
ability NN O
of IN O
mutant JJ O
genes NNS O
to TO O
confer VB O
alpha JJ B-Gene
- : I-Gene
amanitin NN I-Gene
resistance NN O
after IN O
transfection NN O
of IN O
susceptible JJ O
rodent NN O
cells NNS O
. . O

Maximum JJ O
induction NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
reached VBN O
at IN O
a DT O
concentration NN O
of IN O
250 CD O
nmol JJ O
/ NNP O
L NNP O
of IN O
CalC NNP O
. . O

Risk NN O
factors NNS O
influencing VBG O
lymph NN O
nodes NNS O
metastasis NN O
in IN O
lung NN O
cancer NN O
with IN O
stage NN O
I PRP O
, , O
II NNP O
or CC O
IIIA NNP O

The DT O
Schistosoma NNP B-Gene
mansoni NNP I-Gene
homologue NN I-Gene
( ( O
SmSmad2 NNP B-Gene
) ) O
was VBD O
overexpressed VBN O
in IN O
bacteria NNS O
as IN O
a DT O
Sj26 NNP B-Gene
- : O
GST NNP B-Gene
fusion NN O
protein NN O
and CC O
used VBD O
to TO O
raise VB O
specific JJ O
antibodies NNS O
. . O

Histopathologic NNP O
response NN O
of IN O
gingival NN O
tissues NNS O
to TO O
hemodent VB O
and CC O
aluminum VB O
chloride JJ O
solutions NNS O
as IN O
tissue NN O
displacement NN O
materials NNS O
. . O

Sinusoidal NNP O
oscillations NNS O
of IN O
a DT O
gas NN O
dilution NN O
indicator NN O

In IN O
fus3 JJ B-Gene
mutants NNS I-Gene
, , O
the DT O
levels NNS O
of IN O
Ty1 NNP B-Gene
RNA NNP I-Gene
, , O
protein NN O
synthesis NN O
, , O
and CC O
proteolytic JJ O
processing NN O
were VBD O
not RB O
altered VBN O
relative JJ O
to TO O
those DT O
in IN O
FUS3 NNP B-Gene
strains NNS O
but CC O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
TyA NNP B-Gene
, , O
integrase NN B-Gene
, , O
and CC O
reverse VB B-Gene
transcriptase NN I-Gene
proteins NNS O
and CC O
Ty1 NNP B-Gene
cDNA NN I-Gene
were VBD O
all DT O
increased VBN O
. . O

Deletion NN O
of IN O
the DT O
last JJ O
two CD O
Ser NNP O
residues NNS O
, , O
including VBG O
one CD O
PKC NNP B-Gene
consensus NN O
site NN O
in IN O
the DT O
receptor NN O
tail NN O
, , O
prevented VBD O
only RB O
phorbol JJ O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
- : O
induced VBN O
desensitization NN O
by IN O
30 CD O
% NN O
. . O

Ig NNP B-Gene
D NNP I-Gene
- : O
JH NNP B-Gene
recombinations NNS O
may MD O
precede VB O
TcR NNP B-Gene
gene NN I-Gene
recombination NN O
in IN O
these DT O
early JJ O
T NNP O
cell NN O
lines NNS O
, , O
and CC O
some DT O
but CC O
not RB O
all DT O
express NN O
sterile JJ O
Cmu NNP B-Gene
transcripts NNS I-Gene
. . O

The DT O
data NNS O
provide NN O
evidence NN O
both DT O
for IN O
a DT O
signal JJ O
transduction NN O
pathway RB O
independent JJ O
of IN O
JNK NNP B-Gene
, , O
ERK NNP B-Gene
, , O
and CC O
p38 NN B-Gene
MAP NNP B-Gene
kinase NN I-Gene
to TO O
be VB O
involved VBN O
in IN O
the DT O
induction NN O
of IN O
rhoB NN B-Gene
by IN O
genotoxic JJ O
stress NN O
, , O
and CC O
furthermore RB O
, , O
indicate JJ O
autoregulation NN O
of IN O
rhoB NN B-Gene
. . O

In IN O
addition NN O
, , O
negatively RB O
regulatory JJ O
region NN O
may MD O
exist VB O
from IN O
- : O
1782 CD O
to TO O
- : O
1295 CD O
bp NN O
. . O

Post NNP O
- : O
operative JJ O
functional JJ O
outcome NN O
is VBZ O
related VBN O
to TO O
pre VB O
- : O
operative JJ O
functional JJ O
status NN O
. . O

Blood NN O
samples NNS O
were VBD O
obtained VBN O
daily RB O
during IN O
this DT O
supplementation NN O
period NN O
and CC O
5 CD O
d NN O
thereafter RB O
( ( O
d JJ O
11 CD O
to TO O
15 CD O
) ) O
. . O

The DT O
use NN O
of IN O
an DT O
appropriate JJ O
solution NN O
of IN O
methylene NN O
blue NN O
( ( O
0 CD O
. . O
2 CD O
% NN O
in IN O
0 CD O
. . O
9 CD O
M NNP O
NaCl NNP O
for IN O
15 CD O
min NN O
) ) O
permits VBZ O
the DT O
staining NN O
of IN O
premalignant JJ O
areas NNS O
and CC O
CIS NNP O
, , O
and CC O
their PRP$ O
early JJ O
diagnosis NN O
. . O

The DT O
assay NN O
herein NN O
described VBD O
allows VBZ O
the DT O
comparison NN O
of IN O
relative JJ O
FGFR NNP B-Gene
expression NN O
levels NNS O
, , O
both DT O
within IN O
a DT O
single JJ O
RNA NNP O
pool NN O
and CC O
among IN O
multiple JJ O
RNA NNP O
pool NN O
samples NNS O
. . O

The DT O
putative JJ O
immunity NN O
protein NN O
was VBD O
detected VBN O
among IN O
the DT O
[ NN O
35S CD O
] NN O
methionine NN O
- : O
labelled JJ O
proteins NNS O
produced VBN O
by IN O
minicells NNS O
carrying VBG O
cni NN B-Gene
cloned VBN O
under IN O
lac JJ B-Gene
promoter NN I-Gene
control NN O
, , O
and CC O
when WRB O
the DT O
gene NN O
was VBD O
subcloned VBN O
into IN O
expression NN O
vectors NNS O
under IN O
the DT O
control NN O
of IN O
a DT O
bacteriophage NN O
T7 NNP O
promoter NN O
. . O

The DT O
mutant JJ O
receptors NNS O
, , O
as RB O
well RB O
as IN O
sBMPR JJ B-Gene
- : I-Gene
IA NN I-Gene
, , O
were VBD O
expressed VBN O
as IN O
fusion NN O
proteins NNS O
with IN O
thioredoxin NN B-Gene
in IN O
Escherichia NNP O
coli NN O
, , O
and CC O
purified VBD O
using VBG O
reverse JJ O
phase NN O
high JJ O
performance NN O
liquid NN O
chromatography NN O
( ( O
RP NNP O
- : O
HPLC NNP O
) ) O
after IN O
digestion NN O
with IN O
enterokinase NN B-Gene
. . O

Interlimb NNP O
coordination NN O
during IN O
fictive JJ O
locomotion NN O
in IN O
the DT O
thalamic JJ O
cat NN O
. . O

The DT O
plasmin NN B-Gene
- : I-Gene
derived VBN I-Gene
D NNP I-Gene
( ( I-Gene
approximately RB I-Gene
105 CD I-Gene
- : I-Gene
kDa NN I-Gene
) ) I-Gene
product NN I-Gene
, , O
however RB O
, , O
could MD O
be VB O
cross JJ O
- : O
linked VBN O
into IN O
DD NNP O
dimers NNS O
. . O

We PRP O
also RB O
provide VBP O
evidence NN O
that IN O
neither CC O
the DT O
lambda JJ B-Gene
O NNP I-Gene
and CC O
P NNP B-Gene
initiators NNS I-Gene
nor CC O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
DnaJ NNP I-Gene
and CC O
DnaK NNP B-Gene
heat NN O
shock NN O
proteins NNS O
play VBP O
a DT O
direct JJ O
role NN O
in IN O
the DT O
propagation NN O
of IN O
lambda JJ O
replication NN O
forks NNS O
in IN O
vitro NN O
. . O

Using VBG O
Scheffe NNP O
' POS O
s JJ O
procedure NN O
as IN O
an DT O
illustration NN O
, , O
comparisons NNS O
are VBP O
made VBN O
to TO O
usual JJ O
sample NN O
size NN O
methods NNS O
that WDT O
incorrectly RB O
ignore VBP O
the DT O
stochastic JJ O
nature NN O
of IN O
S2p NNP O
. . O

[ JJ B-Gene
Ala85 NNP I-Gene
] NNP I-Gene
Dk NNP I-Gene
( ( I-Gene
69 CD I-Gene
- : I-Gene
85 CD I-Gene
) ) I-Gene
retains VBZ O
full JJ O
biological JJ O
activity NN O
. . O

To TO O
assess VB O
the DT O
ability NN O
of IN O
the DT O
atria NN O
to TO O
maintain VB O
elevated JJ O
plasma JJ O
concentrations NNS O
of IN O
atrial JJ B-Gene
natriuretic JJ I-Gene
peptide NN I-Gene
( ( O
ANP NNP B-Gene
) ) O
, , O
the DT O
temporal JJ O
changes NNS O
in IN O
plasma NN B-Gene
ANP NNP I-Gene
concentrations NNS O
were VBD O
studied VBN O
in IN O
seven CD O
chloralose JJ O
- : O
anaesthetized JJ O
dogs NNS O
during IN O
4 CD O
h NN O
of IN O
sustained JJ O
rapid JJ O
cardiac JJ O
pacing NN O
. . O

Furthermore RB O
, , O
beta VBD B-Gene
2 CD I-Gene
- : I-Gene
adrenoceptor NN I-Gene
sensitivity NN O
appears VBZ O
to TO O
be VB O
unaltered VBN O
in IN O
BHT NNP O
. . O

Ten CD O
out IN O
of IN O
10 CD O
patients NNS O
with IN O
progressive JJ O
disease NN O
had VBD O
mast VBN O
cells NNS O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
0 CD O
. . O
5 CD O
% NN O
, , O
hyaluronan NN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
50 CD O
micrograms NNS O
. . O
l SYM O
- : O
1 CD O
and CC O
fibronectin RB B-Gene
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
350 CD O
micrograms NNS O
. . O
l SYM O
- : O
1 CD O
compared VBN O
to TO O
eight CD O
out IN O
of IN O
41 CD O
patients NNS O
with IN O
stable JJ O
or CC O
regressive JJ O
disease NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

When WRB O
voltage NN O
- : O
operated VBN O
Ca2 NNP O
+ NNP O
channels NNS O
( ( O
VOC NNP O
) ) O
were VBD O
blocked VBN O
by IN O
nifedipine NN O
, , O
midazolam NN O
, , O
in IN O
concentrations NNS O
more JJR O
than IN O
1 CD O
microM NN O
, , O
attenuated VBD O
both DT O
phasic JJ O
and CC O
tonic JJ O
responses NNS O
. . O

Tonometry NN O
of IN O
blood NN O
samples NNS O
from IN O
patients NNS O
may MD O
also RB O
be VB O
used VBN O
in IN O
the DT O
determination NN O
of IN O
acid JJ O
- : O
base NN O
quantities NNS O
and CC O
hemoglobin SYM B-Gene
- : O
oxygen NN O
affinity NN O
e NN O
. . O
g NN O
. . O
p50 NN O
. . O

Evaluation NN O
of IN O
desmopressin NN O
for IN O
dental JJ O
extractions NNS O
in IN O
patients NNS O
with IN O
hemostatic JJ O
disorders NNS O
. . O

This DT O
is VBZ O
based VBN O
on IN O
partitioning VBG O
an DT O
underlying JJ O
multivariate NN O
normal JJ O
distribution NN O
. . O

We PRP O
discuss VBP O
the DT O
results NNS O
in IN O
relation NN O
to TO O
previous JJ O
systems NNS O
for IN O
parcellating VBG O
the DT O
posterior JJ O
ectosylvian JJ O
gyrus NN O
of IN O
the DT O
cat NN O
and CC O
consider VB O
the DT O
possibility NN O
that IN O
divisions NNS O
of IN O
the DT O
feline NN O
posterior JJ O
ectosylvian JJ O
gyrus NN O
correspond NN O
directly RB O
to TO O
areas NNS O
making VBG O
up RP O
the DT O
superior JJ O
temporal JJ O
gyrus NN O
in IN O
primates NNS O
. . O

At IN O
the DT O
MTD NNP O
( ( O
8 CD O
mg NN O
/ NNP O
m2 NN O
/ NNP O
day NN O
) ) O
, , O
the DT O
dose JJ O
- : O
limiting VBG O
toxicity NN O
of IN O
this DT O
agent NN O
is VBZ O
myelosuppression NN O
. . O

However RB O
, , O
the DT O
abi1 NN B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
product NN I-Gene
has VBZ O
no DT O
effect NN O
on IN O
the DT O
ABA NNP O
suppression NN O
of IN O
a DT O
GA NNP O
- : O
responsive NN O
alpha SYM B-Gene
- : I-Gene
amylase NN I-Gene
gene NN I-Gene
. . O

Mastocytosis NN O
. . O

Although IN O
differences NNS O
were VBD O
not RB O
significant JJ O
, , O
infants NNS O
in IN O
the DT O
experimental JJ O
group NN O
had VBD O
more JJR O
changes NNS O
in IN O
the DT O
intermittent JJ O
mandatory JJ O
ventilation NN O
( ( O
IMV NNP O
) ) O
settings NNS O
during IN O
transport NN O
, , O
and CC O
more RBR O
such JJ O
infants NNS O
arrived VBN O
at IN O
the DT O
receiving VBG O
hospital NN O
with IN O
acceptable JJ O
pH NN O
and CC O
PCO2 NNP O
values NNS O
. . O

Hu NNP B-Gene
- : I-Gene
Met NNP I-Gene
- : I-Gene
1 CD I-Gene
mRNA JJ I-Gene
expression NN O
in IN O
a DT O
small JJ O
number NN O
of IN O
human JJ O
T NNP O
cell NN O
tumor NN O
lines NNS O
did VBD O
not RB O
correlate VB O
with IN O
any DT O
particular JJ O
phenotype NN O
or CC O
stage NN O
of IN O
development NN O
. . O

Mucoepidermoid NNP O
and CC O
acinous JJ O
cell NN O
carcinomas NN O
of IN O
salivary JJ O
tissues NNS O
. . O

Interactions NNS O
between IN O
adrenergics NNS O
, , O
adrenolytics NNS O
and CC O
monoamine JJ B-Gene
oxidase NN I-Gene
inhibitors NNS O

176 CD O
: : O
787 CD O
- : O
792 CD O
, , O
1992 CD O
; : O
M NNP O
. . O

The DT O
pattern NN O
and CC O
timing NN O
of IN O
CARP NNP B-Gene
mRNA NNP I-Gene
expression NN O
, , O
including VBG O
transient JJ O
expression NN O
in IN O
the DT O
tongue NN O
at IN O
14 CD O
. . O
5 CD O
days NNS O
p RB O
. . O
c NN O
. . O
, , O
coincides VBZ O
with IN O
that DT O
of IN O
Nkx2 NNP B-Gene
. . I-Gene
5 CD I-Gene
/ JJ O
Csx NNP B-Gene
( ( O
a DT O
putative JJ O
homolog NN O
of IN O
tinman NN B-Gene
, , O
the DT O
Drosophila NNP O
melanogaster NN O
gene NN O
responsible JJ O
for IN O
cardiac JJ O
development NN O
) ) O
. . O

The DT O
experimental JJ O
design NN O
incorporated VBD O
a DT O
multiple JJ O
regression NN O
model NN O
, , O
sequential JJ O
treatments NNS O
and CC O
a DT O
proportional JJ O
end NN O
point NN O
( ( O
95 CD O
% NN O
) ) O
for IN O
protection NN O
time NN O
. . O

Because IN O
the DT O
CAP NNP O
measures NNS O
variables VBZ O
predictive NN O
of IN O
abusive JJ O
behavior NN O
, , O
a DT O
substantial JJ O
relationship NN O
was VBD O
expected VBN O
between IN O
the DT O
CAP NNP O
and CC O
the DT O
MHI NNP O
Loss NNP O
of IN O
Behavioral NNP O
/ NNP O
Emotional NNP O
Control NNP O
scale NN O
. . O

The DT O
feed NN O
consumed VBD O
which WDT O
was VBD O
lowered VBN O
by IN O
25 CD O
% NN O
initially RB O
, , O
did VBD O
not RB O
alter RB O
later RB O
. . O

Mechanism NN O
of IN O
interferon JJ B-Gene
action NN O
: : O
identification NN O
of IN O
essential JJ O
positions NNS O
within IN O
the DT O
novel JJ O
15 CD B-Gene
- : I-Gene
base NN I-Gene
- : I-Gene
pair NN I-Gene
KCS NNP I-Gene
element NN I-Gene
required VBN O
for IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
RNA NNP B-Gene
- : I-Gene
dependent NN I-Gene
protein NN I-Gene
kinase NN I-Gene
pkr JJ I-Gene
gene NN I-Gene
. . O

Although IN O
diagnostic JJ O
laparoscopy NN O
is VBZ O
still RB O
considered VBN O
the DT O
standard JJ O
reference NN O
in IN O
the DT O
diagnosis NN O
of IN O
ectopic JJ O
pregnancy NN O
( ( O
EP NNP O
) ) O
, , O
use NN O
of IN O
high JJ O
- : O
resolution NN O
endovaginal JJ O
sonography NN O
, , O
in IN O
conjunction NN O
with IN O
qualitative JJ O
serum NN O
assays NNS O
of IN O
the DT O
beta NN O
subunit NN O
of IN O
human JJ B-Gene
chorionic JJ I-Gene
gonadotropin NN I-Gene
( ( O
beta SYM B-Gene
- : I-Gene
hCG NN I-Gene
) ) O
, , O
allows VBZ O
detection NN O
of IN O
earlier JJR O
and CC O
smaller JJR O
EPs NNP O
. . O

The DT O
German JJ O
Society NNP O
of IN O
Pediatric NNP O
Oncology NNP O
in IN O
1981 CD O
initiated VBD O
the DT O
Cooperative NNP O
Ewing NNP O
' POS O
s NN O
Sarcoma NNP O
Study NNP O
( ( O
CESS NNP O
81 CD O
) ) O
using VBG O
a DT O
four CD O
- : O
drug NN O
combination NN O
of IN O
chemotherapy NN O
prior RB O
to TO O
definitive VB O
local JJ O
control NN O
with IN O
surgery NN O
and CC O
/ NN O
or CC O
radiation NN O
. . O

Lactate NNP O
accumulation NN O
peak NN O
was VBD O
unaffected VBN O
by IN O
supplementation NN O
( ( O
HMB NNP O
, , O
8 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
1 CD O
mM NN O
; : O
LEU NNP O
, , O
6 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
mM NN O
; : O
CON NNP O
, , O
7 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
3 CD O
mM NN O
) ) O
. . O

Arm NNP O
function NN O
tests NNS O
. . O

PURPOSE NN O
: : O
The DT O
role NN O
interleukin SYM B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
in IN O
the DT O
treatment NN O
of IN O
congenital JJ O
thrombocytopenias NN O
is VBZ O
unknown JJ O
. . O

Gng3lg NNP B-Gene
transcripts NNS I-Gene
are VBP O
expressed VBN O
in IN O
a DT O
variety NN O
of IN O
tissues NNS O
including VBG O
both DT O
brain NN O
and CC O
testes NNS O
. . O

The DT O
qualitative JJ O
concentrations NNS O
of IN O
HCG NNP B-Gene
had VBD O
a DT O
sensitivity NN O
of IN O
37 CD O
. . O
5 CD O
% NN O
and CC O
a DT O
specificity NN O
of IN O
100 CD O
% NN O
. . O

Four CD O
ruminally RB O
and CC O
duodenally RB O
cannulated VBN O
Hampshire NNP O
wethers NNS O
were VBD O
used VBN O
in IN O
a DT O
4 CD O
x NN O
4 CD O
Latin NNP O
square JJ O
experiment NN O
to TO O
determine VB O
whether IN O
linoleoyl JJ O
methionine NN O
and CC O
calcium NN O
linoleate NN O
would MD O
increase VB O
duodenal JJ O
flow NN O
of IN O
unsaturated JJ O
fatty JJ O
acids NNS O
( ( O
C18 NNP O
: : O
2 CD O
+ NN O
cis NN O
C18 NNP O
: : O
1 CD O
) ) O
. . O

Effect NN O
of IN O
time NN O
and CC O
dose VB O
on IN O
alterations NNS O
following VBG O
inhalation NN O
of IN O
plutonium NN O
- : O
239 CD O
dioxide NN O
aerosol NN O
in IN O
rat NN O
. . O

Cimetidine NNP O
800 CD O
mg NN O
given VBN O
at IN O
night NN O
is VBZ O
as RB O
effective JJ O
as IN O
400 CD O
mg JJ O
twice RB O
daily RB O
; : O
the DT O
single JJ O
dose JJ O
regimen NNS O
may MD O
improve VB O
patient NN O
compliance NN O
, , O
thus RB O
facilitating VBG O
treatment NN O
. . O

Plasma NNP O
, , O
LDL NNP B-Gene
and CC O
liver RB O
cholesterol NN O
concentrations NNS O
were VBD O
higher JJR O
in IN O
the DT O
hyperlipidemic NN O
control NN O
than IN O
the DT O
nonhyperlipidemic JJ O
control NN O
and CC O
lower JJR O
in IN O
the DT O
groups NNS O
fed VBP O
diets NNS O
containing VBG O
pectin NN B-Gene
or CC O
prune NN O
fiber NN O
than IN O
in IN O
the DT O
hyperlipidemic JJ O
control NN O
group NN O
. . O

Liver NNP O
TG NNP O
and CC O
serum VB O
NEFA NNP O
concentrations NNS O
were VBD O
positively RB O
correlated VBN O
. . O

Nine NNP O
DNA NNP O
fragments NNS O
that WDT O
were VBD O
specifically RB O
recognized VBN O
and CC O
bound VBN O
by IN O
histidine NN O
- : O
tagged VBN O
AdpA NNP B-Gene
were VBD O
isolated VBN O
by IN O
cycles NNS O
of IN O
a DT O
gel JJ O
mobility NN O
shift NN O
- : O
PCR NNP O
method NN O
. . O

( ( O
3 CD O
) ) O
. . O

To TO O
assess VB O
more RBR O
specific JJ O
PKA NNP B-Gene
- : O
dependent JJ O
mediation NN O
of IN O
LH NNP B-Gene
' POS I-Gene
s JJ I-Gene
contribution NN O
to TO O
combined VBN O
hormonal JJ O
drive NN O
, , O
the DT O
LDL NNP B-Gene
receptor NN I-Gene
( ( I-Gene
- : I-Gene
1076 CD I-Gene
to TO I-Gene
+ VB I-Gene
11 CD I-Gene
bp NN I-Gene
) ) I-Gene
reporter NN I-Gene
plasmid NN O
was VBD O
cotransfected VBN O
with IN O
a DT O
full JJ B-Gene
- : I-Gene
sequence NN I-Gene
rabbit NN I-Gene
muscle NN I-Gene
protein NN I-Gene
kinase NN I-Gene
inhibitor NN I-Gene
( ( O
PKI NNP B-Gene
) ) O
minigene VBD O
driven VBN O
constitutively RB O
by IN O
a DT O
Rous JJ B-Gene
sarcoma NN I-Gene
virus NN I-Gene
promoter NN I-Gene
. . O

Lys NNP O
( ( O
193 CD O
) ) O
and CC O
Arg NNP O
( ( O
194 CD O
) ) O
, , O
located VBN O
at IN O
the DT O
COOH NNP O
- : O
terminal JJ O
end NN O
of IN O
HD NNP B-Gene
, , O
are VBP O
essential JJ O
for IN O
dimerization NN O
. . O

Copyright JJ O
1998 CD O
Elsevier NNP O
Science NNP O
B NNP O
. . O
V NNP O
. . O

We PRP O
have VBP O
tested VBN O
this DT O
possibility NN O
by IN O
constructing VBG O
a DT O
consecutive JJ O
series NN O
of IN O
cysteine JJ O
substitutions NNS O
in IN O
the DT O
Neu NNP B-Gene
juxtamembrane NN I-Gene
domain NN I-Gene
in IN O
order NN O
to TO O
force VB O
dimerization NN O
along IN O
a DT O
series NN O
of IN O
interreceptor NN O
faces VBZ O
. . O

Although IN O
no DT O
differences NNS O
were VBD O
noted VBN O
in IN O
the DT O
decrease NN O
in IN O
platelet NN O
counts NNS O
between IN O
the DT O
two CD O
groups NNS O
, , O
fibrinogen NN B-Gene
levels NNS O
and CC O
alpha $ B-Gene
2 CD I-Gene
- : I-Gene
antiplasmin NN I-Gene
levels NNS O
declined VBD O
less RBR O
drastically RB O
in IN O
the DT O
antithrombin NN B-Gene
- : O
treated VBN O
group NN O
. . O

A DT O
decrease NN O
of IN O
the DT O
lysozyme NN B-Gene
activity NN O
coincided VBN O
with IN O
the DT O
clinical JJ O
improvement NN O
of IN O
the DT O
bacterial JJ O
meningitis NN O
. . O

HBx NNP B-Gene
strongly RB O
elevates VBZ O
levels NNS O
of IN O
GTP NNP O
- : O
bound NN O
Ras NNP B-Gene
, , O
activated VBD O
and CC O
phosphorylated VBD O
Raf NNP B-Gene
, , O
and CC O
tyrosine VB O
- : O
phosphorylated VBN O
and CC O
activated VBN O
MAP NNP B-Gene
kinase NN I-Gene
. . O

Hypothalamic NNP O
control NN O
of IN O
coronary JJ O
circulation NN O
in IN O
the DT O
dog NN O
. . O

Progressive NNP O
study NN O
and CC O
robustness JJ O
test NN O
of IN O
QSAR NNP O
model NN O
based VBN O
on IN O
quantum JJ O
chemical NN O
parameters NNS O
for IN O
predicting VBG O
BCF NNP O
of IN O
selected VBN O
polychlorinated JJ O
organic JJ O
compounds NNS O
( ( O
PCOCs NNP O
) ) O
. . O

Forty NNP O
- : O
eight CD O
pigs NNS O
were VBD O
removed VBN O
from IN O
sows NNS O
at IN O
1 CD O
d NN O
of IN O
age NN O
and CC O
randomly RB O
assigned VBN O
to TO O
one CD O
of IN O
three CD O
treatments NNS O
: : O
1 CD O
) ) O
control NN O
with IN O
lactose JJ O
as IN O
the DT O
carbohydrate NN O
source NN O
, , O
2 CD O
) ) O
lactose NN O
replaced VBN O
( ( O
gram NN O
for IN O
gram NN O
) ) O
with IN O
CSS NNP O
( ( O
dextrose JJ O
equivalent JJ O
[ NN O
DE NNP O
] NNP O
- : O
20 CD O
) ) O
, , O
and CC O
3 CD O
) ) O
lactose NN O
replaced VBD O
with IN O
DE NNP O
- : O
42 CD O
. . O

Double NNP O
- : O
blind NN O
randomised JJ O
trial NN O
of IN O
intravenous JJ O
tissue NN B-Gene
- : I-Gene
type NN I-Gene
plasminogen NN I-Gene
activator NN I-Gene
versus NN O
placebo NN O
in IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

Clb NNP B-Gene
/ NNP O
Cdc28 NNP B-Gene
kinases VBZ O
promote VBP O
nuclear JJ O
export NN O
of IN O
the DT O
replication NN B-Gene
initiator NN I-Gene
proteins VBZ I-Gene
Mcm2 NNP I-Gene
- : I-Gene
7 CD I-Gene
. . O

Specific JJ O
class NN B-Gene
I PRP I-Gene
and CC I-Gene
II NNP I-Gene
histone NN I-Gene
deacetylases NNS I-Gene
( ( O
HDACs NNP B-Gene
) ) O
interact NN O
in IN O
vivo NN O
with IN O
BCoR NNP B-Gene
, , O
suggesting VBG O
that IN O
BCoR NNP B-Gene
may MD O
functionally RB O
link VB O
these DT O
two CD O
classes NNS O
of IN O
HDACs NNP B-Gene
. . O

MRI NNP O
disclosed VBD O
one CD O
or CC O
more JJR O
of IN O
the DT O
following JJ O
abnormalities NNS O
in IN O
24 CD O
( ( O
63 CD O
% NN O
) ) O
of IN O
38 CD O
treated JJ O
kidneys NNS O
: : O
( ( O
1 CD O
) ) O
loss NN O
of IN O
corticomedullary JJ O
differentiation NN O
, , O
( ( O
2 CD O
) ) O
perirenal NN O
fluid NN O
, , O
( ( O
3 CD O
) ) O
subcapsular NN O
hematoma NN O
, , O
( ( O
4 CD O
) ) O
hemorrhage NN O
into IN O
a DT O
renal JJ O
cyst NN O
, , O
and CC O
( ( O
5 CD O
) ) O
unexplained JJ O
abnormalities NNS O
. . O

Stereotactic JJ O
radiofrequency NN O
lesioning NN O
of IN O
the DT O
hamartoma NN O
resulted VBD O
in IN O
seizure NN O
remission NN O
without IN O
complications NNS O
20 CD O
months NNS O
after IN O
surgery NN O
. . O

Hypersplenism NN O

This DT O
proposed VBN O
method NN O
is VBZ O
similar JJ O
in IN O
principle NN O
to TO O
the DT O
sets NNS O
technique NN O
but CC O
is VBZ O
shown VBN O
to TO O
have VB O
much RB O
better RBR O
expected JJ O
time NN O
to TO O
alarm VB O
properties NNS O
. . O

The DT O
grandfather NN O
and CC O
the DT O
granddaughter NN O
both DT O
had VBD O
microtia NN O
and CC O
meatal JJ O
atresia NN O
, , O
whereas IN O
the DT O
daughter NN O
had VBD O
a DT O
normal JJ O
outer NN O
ear VBP O
except IN O
for IN O
a DT O
narrow JJ O
meatus NN O
and CC O
auricular JJ O
appendages NNS O
. . O

The DT O
Ishasha NNP O
samples VBZ O
show VBP O
a DT O
range NN O
encompassing VBG O
three CD O
trophic JJ O
levels NNS O
. . O

Patients NNS O
at IN O
risk NN O
of IN O
hypothyroidism NN O
. . O

These DT O
natural JJ O
antisense NN O
S NNP B-Gene
transcripts NNS I-Gene
co VBP O
- : O
exist NN O
with IN O
several JJ O
less RBR O
abundant JJ O
sense NN O
S NNP B-Gene
transcripts NNS I-Gene
. . O

Mechanism NN O
of IN O
activation NN O
of IN O
the DT O
vav JJ B-Gene
protooncogene NN I-Gene
. . O
vav NN B-Gene
is VBZ O
a DT O
human JJ O
locus NN O
that WDT O
appears VBZ O
to TO O
be VB O
specifically RB O
expressed VBN O
in IN O
cells NNS O
of IN O
hematopoietic JJ O
origin NN O
regardless NN O
of IN O
their PRP$ O
differentiation NN O
lineage NN O
. . O

Two CD O
closely RB O
related JJ O
IgH NNP B-Gene
constant JJ O
region NN O
genes NNS O
, , O
CHA NNP B-Gene
and CC O
CHB NNP B-Gene
, , O
have VBP O
been VBN O
sequenced VBN O
completely RB O
. . O

Basal NNP O
midexpiratory NN O
lower JJR O
esophageal NN O
sphincter NN O
pressure NN O
was VBD O
similar JJ O
in IN O
the DT O
study NN O
group NN O
( ( O
mean JJ O
[ NNP O
SD NNP O
] VBD O
20 CD O
. . O
1 CD O
[ JJ O
9 CD O
. . O
1 CD O
] JJ O
mmHg NN O
) ) O
and CC O
controls NNS O
( ( O
17 CD O
. . O
6 CD O
[ JJ O
6 CD O
. . O
0 CD O
] JJ O
mmHg NN O
) ) O
; : O
the DT O
pressure NN O
did VBD O
not RB O
change VB O
following VBG O
EVS NNP O
or CC O
EVL NNP O
. . O

The DT O
hydrophobicity NN O
profile NN O
of IN O
the DT O
methyltransferase NN O
reveals VBZ O
the DT O
presence NN O
of IN O
at IN O
least JJS O
five CD O
potential JJ O
transmembrane NN O
domains NNS O
. . O

The DT O
sequence NN O
- : O
specific JJ O
interaction NN O
of IN O
nuclear JJ B-Gene
factor NN I-Gene
HiNF NNP I-Gene
- : I-Gene
D NN I-Gene
with IN O
this DT O
key JJ O
proximal JJ O
promoter NN O
element NN O
of IN O
the DT O
H4 NNP B-Gene
- : I-Gene
FO108 NNP I-Gene
gene NN I-Gene
is VBZ O
cell JJ O
cycle NN O
regulated VBN O
in IN O
normal JJ O
diploid JJ O
cells NNS O
( ( O
J NNP O
. . O

METHODS NN O
: : O
IgG NNP B-Gene
antibodies NNS I-Gene
vs VBP O
HHV NNP O
- : O
6 CD O
( ( O
anti JJ B-Gene
- : I-Gene
HHV NNP I-Gene
- : I-Gene
6 CD I-Gene
- : I-Gene
IgG NN I-Gene
) ) O
were VBD O
determined VBN O
by IN O
indirect JJ O
immunofluorescence NN O
in IN O
100 CD O
IVDA NNP O
( ( O
29 CD O
seronegative NN O
and CC O
71 CD O
seropositive NN O
for IN O
HIV NNP O
- : O
1 CD O
of IN O
which WDT O
45 CD O
were VBD O
in IN O
stage NN O
II NNP O
and CC O
26 CD O
in IN O
IV NNP O
- : O
C1 NN O
of IN O
CDC NNP O
) ) O
as RB O
well RB O
as IN O
in IN O
100 CD O
healthy JJ O
subjects NNS O
of IN O
a DT O
similar JJ O
age NN O
( ( O
control VB O
group NN O
) ) O
. . O

Diet NNP O
therapy NN O
with IN O
soy JJ O
proteins NNS O
for IN O
chronic JJ O
stomach NN O
ulcers NNS O

Despite IN O
i NN O
. . O
v NN O
. . O
steroid JJ O
therapy NN O
, , O
[ NNP O
NOexh NNP O
] NNP O
remained VBD O
elevated VBN O
throughout IN O
recovery NN O
( ( O
37 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
8 CD O
ppb NN O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
until IN O
discharge NN O
( ( O
40 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
3 CD O
ppb NN O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
. . O

Peripheral JJ O
metabolism NN O
of IN O
androgens NNS O
takes VBZ O
place NN O
in IN O
various JJ O
areas NNS O
within IN O
the DT O
pilosebaceous JJ O
unit NN O
, , O
as IN O
indicated VBN O
by IN O
local JJ O
differences NNS O
in IN O
the DT O
activities NNS O
of IN O
aromatase NN B-Gene
, , O
5alpha CD B-Gene
- : I-Gene
reductase NN I-Gene
as RB O
well RB O
as IN O
of IN O
the DT O
presence NN O
of IN O
the DT O
androgen NN B-Gene
receptors NNS I-Gene
. . O

Breast NNP O
- : O
fed NN O
newborn JJ O
infants NNS O
synthesize VB O
n JJ O
- : O
6 CD O
long JJ O
- : O
chain NN O
polyunsaturated VBD O
fatty JJ O
acids NNS O
already RB O
during IN O
the DT O
first JJ O
week NN O
of IN O
life NN O
, , O
but CC O
the DT O
contribution NN O
of IN O
endogenous JJ O
synthesis NN O
to TO O
the DT O
total JJ O
plasma NN O
long JJ O
- : O
chain NN O
polyunsaturated JJ O
pool NN O
is VBZ O
small JJ O
. . O

Marked VBN O
racial JJ O
variation NN O
in IN O
birthweight NN O
percentiles NNS O
by IN O
gestational JJ O
age NN O
was VBD O
evident JJ O
. . O

Deflunia NNP O
was VBD O
well RB O
tolerated VBN O
by IN O
25 CD O
patients NNS O
, , O
very RB O
well RB O
tolerated VBN O
by IN O
2 CD O
. . O

It PRP O
is VBZ O
striking VBG O
that IN O
the DT O
active JJ O
CHO NNP O
spacer NN O
promoter NN O
violated VBD O
the DT O
otherwise NN O
universal JJ O
rule NN O
that IN O
metazoan NN B-Gene
RNA NNP I-Gene
polymerase NN I-Gene
I PRP I-Gene
promoters VBP I-Gene
all DT O
have VBP O
a DT O
G NNP O
residue NN O
at IN O
position NN O
- : O
16 CD O
. . O

In IN O
situ JJ O
copper NN O
- : O
phenanthroline NN O
footprinting NN O
of IN O
individual JJ O
gel NN O
shift NN O
assembly RB O
intermediates VBZ O
shows NNS O
that IN O
on IN O
the DT O
302 CD O
- : O
nucleotide NN O
G4oric NNP O
, , O
the DT O
first JJ O
two CD O
SSB NNP B-Gene
tetramers NNS I-Gene
assemble JJ O
at IN O
random NN O
, , O
but CC O
the DT O
addition NN O
of IN O
more JJR O
SSB JJ B-Gene
tetramers NNS I-Gene
results NNS O
in IN O
formation NN O
of IN O
a DT O
unique JJ O
structure NN O
. . O

Here RB O
, , O
we PRP O
propose VBP O
that IN O
an DT O
antagonistic JJ O
, , O
BMP NNP B-Gene
/ NNP O
ALK2 NNP B-Gene
/ NNP O
Smad NNP B-Gene
- : O
mediated VBD O
signaling VBG O
pathway NN O
is VBZ O
active JJ O
on IN O
the DT O
right JJ O
side NN O
of IN O
the DT O
Xenopus NNP O
embryo NN O
. . O

In IN O
order NN O
to TO O
decipher VB O
the DT O
pathway NN O
that WDT O
leads VBZ O
to TO O
Hox NNP B-Gene
gene NN I-Gene
induction NN O
, , O
we PRP O
have VBP O
investigated VBN O
whether IN O
a DT O
Hox NNP B-Gene
gene NN I-Gene
regulator NN O
, , O
the DT O
leucine NN O
zipper NN O
transcription NN O
factor NN O
MafB NNP B-Gene
/ NNP O
Kr NNP B-Gene
, , O
is VBZ O
itself PRP O
transcriptionally RB O
regulated VBN O
by IN O
the DT O
environmental JJ O
signals NNS O
. . O

Thus RB O
, , O
the DT O
N NNP B-Gene
- : O
Nus NNP B-Gene
complex NN O
may MD O
be VB O
affected VBN O
through IN O
contacts NNS O
with IN O
the DT O
CTD NNP O
of IN O
the DT O
alpha JJ O
subunit NN O
of IN O
RNA NNP B-Gene
polymerase NN I-Gene
, , O
as IN O
is VBZ O
a DT O
group NN O
of IN O
regulatory JJ O
proteins NNS O
that WDT O
influences VBZ O
initiation NN O
of IN O
transcription NN O
. . O

We PRP O
report VBP O
a DT O
prevalence NN O
study NN O
of IN O
the DT O
best JJS O
visual JJ O
acuity NN O
in IN O
the DT O
affected JJ O
eye NN O
of IN O
100 CD O
selected JJ O
patients NNS O
with IN O
herpetic JJ O
keratitis NN O
seen VBN O
during IN O
a DT O
two CD O
- : O
year NN O
period NN O
. . O

Somatostatin NNP B-Gene
- : O
producing VBG O
endocrine JJ O
pancreatic JJ O
tumor NN O
in IN O
Recklinghausen NNP O
' POS O
s JJ O
neurofibromatosis NN O
. . O

The DT O
promoter NN O
and CC O
upstream JJ O
region NN O
of IN O
the DT O
Brassica NNP B-Gene
napus CC I-Gene
2S CD I-Gene
storage NN I-Gene
protein NN I-Gene
napA JJ I-Gene
gene NN I-Gene
were VBD O
studied VBN O
to TO O
identify VB O
cis JJ O
- : O
acting VBG O
sequences NNS O
involved VBN O
in IN O
developmental JJ O
seed NN O
- : O
specific JJ O
expression NN O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
degraded VBN O
via IN O
the DT O
ubiquitin JJ B-Gene
- : O
proteasome JJ O
pathway NN O
. . O

On IN O
the DT O
basis NN O
of IN O
serological JJ O
studies NNS O
, , O
the DT O
highly RB O
conserved VBN O
A NNP O
domain NN O
of IN O
HspA NNP B-Gene
was VBD O
found VBN O
to TO O
be VB O
the DT O
immunodominant JJ O
domain NN O
. . O

Fibrin NNP B-Gene
cloaking VBG O
along IN O
the DT O
catheter NN O
was VBD O
found VBN O
in IN O
20 CD O
patients NNS O
studied VBN O
by IN O
pull NN O
- : O
out IN O
arteriography NN O
and CC O
was VBD O
unassociated VBN O
with IN O
clinical JJ O
symptoms NNS O
. . O

In IN O
the DT O
remaining VBG O
case NN O
, , O
the DT O
aneurysm NN O
originated VBD O
from IN O
the DT O
proximal JJ O
end NN O
of IN O
the DT O
associated JJ O
A1 NNP O
fenestration NN O
. . O

TATA NNP O
and CC O
CCAAT NNP O
boxes NNS O
are VBP O
located VBN O
34 CD O
- : O
bp NN O
and CC O
68 CD O
- : O
bp NN O
, , O
respectively RB O
, , O
upstream NN O
of IN O
the DT O
transcription NN O
start NN O
site NN O
, , O
the DT O
5 CD O
' POS O
- : O
untranslated JJ O
leader NN O
is VBZ O
78 CD O
nucleotides NNS O
long RB O
, , O
and CC O
the DT O
intronless NN O
gene NN O
has VBZ O
at IN O
least JJS O
two CD O
different JJ O
polyadenylation NN O
sites NNS O
. . O

Sevelamer NNP O
hydrochloride NN O
( ( O
Renagel NNP O
) ) O
is VBZ O
a DT O
nonabsorbed JJ O
phosphate NN O
- : O
binding VBG O
polymer NN O
marketed VBN O
for IN O
the DT O
treatment NN O
of IN O
hyperphosphatemia NN O
in IN O
adult NN O
patients NNS O
receiving VBG O
hemodialysis NN O
. . O

The DT O
addition NN O
of IN O
a DT O
Paf NNP B-Gene
- : O
containing VBG O
extract NN O
does VBZ O
not RB O
lead VB O
to TO O
significant JJ O
protein NN O
binding VBG O
to TO O
these DT O
two CD O
hly RB B-Gene
target NN I-Gene
sequences NNS I-Gene
in IN O
the DT O
absence NN O
of IN O
PrfA NNP B-Gene
but CC O
converts VBZ O
the DT O
complex NN O
( ( O
CIII NNP O
) ) O
consisting VBG O
of IN O
PrfA NNP B-Gene
and CC O
the DT O
109 CD B-Gene
bp NN I-Gene
hly RB I-Gene
DNA NNP I-Gene
fragment NN I-Gene
to TO O
a DT O
slower JJR O
migrating NN O
PrfA NNP B-Gene
- : O
Paf NNP B-Gene
- : O
DNA NN O
complex NN O
( ( O
CI NNP O
) ) O
. . O

Construction NN O
of IN O
human NN O
cell NN O
lines NNS O
which WDT O
contain VBP O
and CC O
express VBP O
the DT O
adenovirus NN O
DNA NNP O
binding VBG O
protein JJ O
gene NN O
by IN O
cotransformation NN O
with IN O
the DT O
HSV NNP B-Gene
- : I-Gene
1 CD I-Gene
tk JJ I-Gene
gene NN I-Gene
. . O

We PRP O
conclude VBP O
that DT O
solidification NN O
could MD O
occur VB O
in IN O
all DT O
feeds NNS O
containing VBG O
casein NN B-Gene
and CC O
that IN O
alternative JJ O
feeds NNS O
should MD O
be VB O
considered VBN O
in IN O
patients NNS O
with IN O
increased JJ O
gastric JJ O
acidity NN O
. . O

356 CD O
, , O
93 CD O
- : O
98 CD O
] NN O
. . O

Promoter NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
sequence NN O
identical JJ O
to TO O
consensus VB O
cAMP JJ O
- : O
responsive JJ O
element NN O
( ( O
CRE NNP O
) ) O
located VBN O
at IN O
- : O
481 CD O
of IN O
the DT O
SMemb NNP B-Gene
promoter NN I-Gene
was VBD O
critical JJ O
for IN O
Hex NNP B-Gene
responsiveness NN O
. . O

The DT O
cDNA NN O
was VBD O
expressed VBN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
under IN O
the DT O
control NN O
of IN O
the DT O
yeast NN B-Gene
triose JJ I-Gene
phosphate JJ I-Gene
isomerase NN I-Gene
promoter NN I-Gene
. . O

The DT O
EC NNP O
( ( O
50 CD O
) ) O
for IN O
suppression NN O
of IN O
long JJ O
- : O
term NN O
memory NN O
( ( O
the DT O
concentration NN O
decreasing VBG O
memory NN O
by IN O
50 CD O
% NN O
) ) O
of IN O
fear NN O
conditioning NN O
to TO O
context VB O
was VBD O
2 CD O
. . O
0 CD O
% NN O
plus CC O
/ JJ O
minus NN O
0 CD O
. . O
1 CD O
% NN O
( ( O
mean JJ O
plus CC O
/ JJ O
minus CC O
SEM NNP O
) ) O
, , O
and CC O
for IN O
fear NN O
conditioning NN O
to TO O
tone NN O
was VBD O
3 CD O
. . O
45 CD O
% NN O
plus CC O
/ JJ O
minus NN O
0 CD O
. . O
26 CD O
% NN O
, , O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

Extensive JJ O
DNA NNP O
rearrangement NN O
occurs VBZ O
during IN O
the DT O
development NN O
of IN O
the DT O
somatic JJ O
macronucleus NN O
from IN O
the DT O
germ JJ O
line NN O
micronucleus NN O
in IN O
ciliated JJ O
protozoans NNS O
. . O

Twenty NNP O
- : O
eight CD O
were VBD O
excluded VBN O
as IN O
gallstones NNS O
were VBD O
not RB O
proved VBN O
: : O
of IN O
the DT O
remainder NN O
, , O
21 CD O
patients NNS O
received VBN O
glucagon NNS B-Gene
and CC O
22 CD O
placebo NN O
. . O

A DT O
recombinant JJ O
derivative JJ O
harboring VBG O
the DT O
pMJ101 NN O
replication NN O
region NN O
proved VBD O
to TO O
be VB O
compatible JJ O
with IN O
pJM1 NN O
, , O
a DT O
plasmid NN O
containing VBG O
the DT O
iron NN O
acquisition NN O
system NN O
required VBN O
for IN O
the DT O
virulence NN O
of IN O
V NNP O
. . O
anguillarum NN O
775 CD O
, , O
another DT O
important JJ O
pathogen NN O
that WDT O
causes VBZ O
vibriosis NN O
. . O

The DT O
mean JJ O
power NN O
( ( O
in IN O
mu NN O
W NNP O
) ) O
required VBD O
to TO O
produce VB O
the DT O
observed JJ O
flow NN O
rate NN O
was VBD O
estimated VBN O
at IN O
each DT O
outflow JJ O
pressure NN O
as IN O
the DT O
product NN O
of IN O
the DT O
flow NN O
rate NN O
and CC O
the DT O
pressure NN O
across IN O
the DT O
lymphatic JJ O
vessel NN O
. . O

By IN O
applying VBG O
the DT O
potentiometric JJ O
method NN O
, , O
in IN O
aqueous JJ O
medium NN O
of IN O
ionic JJ O
strength NN O
mu NN O
= VBD O
0 CD O
. . O
2 CD O
, , O
the DT O
stability NN O
constants NNS O
, , O
log NN O
beta NN O
1 CD O
= NN O
4 CD O
. . O
42 CD O
and CC O
log JJR O
beta NN O
2 CD O
= NN O
8 CD O
. . O
57 CD O
were VBD O
obtained VBN O
. . O

Aggregation NN O
of IN O
vHnf1 JJ B-Gene
- : O
deficient NN O
embryonic JJ O
stem NN O
cells NNS O
with IN O
wild JJ O
- : O
type NN O
tetraploid NN O
embryos NN O
, , O
which WDT O
contribute VBP O
exclusively RB O
to TO O
extraembryonic VB O
tissues NNS O
, , O
rescues NNS O
periimplantation VBP O
lethality NN O
and CC O
allows VBZ O
development NN O
to TO O
progress VB O
to TO O
early JJ O
organogenesis NN O
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
A DT O
64 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
confirmed JJ O
AV NNP O
nodal NN O
reentrant NN O
tachycardia NN O
underwent NN O
a DT O
successful JJ O
"""" NN O
slow VB O
pathway NN O
"""" NNP O
AV NNP O
modification NN O
with IN O
a DT O
single JJ O
radiofrequency NN O
application NN O
. . O

Adding VBG O
phytase NN B-Gene
and CC O
nP NN O
improved VBD O
the DT O
orderliness NN O
of IN O
development NN O
, , O
mineralization NN O
and CC O
arrangement NN O
of IN O
cartilage NN O
and CC O
bone NN O
cells NNS O
, , O
and CC O
alleviated VBD O
the DT O
effects NNS O
of IN O
P NNP O
deficiency NN O
on IN O
the DT O
histological JJ O
and CC O
gross JJ O
structure NN O
of IN O
the DT O
tibias NN O
. . O

We PRP O
have VBP O
elucidated VBN O
the DT O
exon NN O
- : O
intron NN O
organization NN O
of IN O
the DT O
entire JJ O
human JJ O
CD58 NNP B-Gene
gene NN I-Gene
, , O
including VBG O
approximately RB O
2 CD O
. . O
5 CD O
kilobases NNS O
( ( O
kb NN O
) ) O
of IN O
5 CD O
' POS O
- : O
flanking NN O
DNA NN O
. . O

The DT O
tumor NN O
suppressor NN O
and CC O
transcriptional JJ O
factor NN O
p53 NN B-Gene
is VBZ O
a DT O
phosphorylated JJ O
protein NN O
. . O

The DT O
cDNA NN O
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
1392 CD O
bp NN O
that WDT O
predicted VBD O
a DT O
protein NN O
of IN O
464 CD O
amino JJ O
acids NNS O
and CC O
a DT O
molecular JJ O
mass NN O
of IN O
52 CD O
kDa NN O
; : O
this DT O
protein NN O
has VBZ O
97 CD O
% NN O
identity NN O
to TO O
rat VB B-Gene
liver JJ I-Gene
glucokinase NN I-Gene
. . O

Nutritional JJ O
cataracts NNS O
in IN O
timber NN O
wolves NNS O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
analysis NN O
indicates VBZ O
that IN O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
, , O
as RB O
well RB O
as IN O
other JJ O
related JJ O
members NNS O
of IN O
this DT O
family NN O
, , O
bind RB O
specifically RB O
to TO O
the DT O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
6 CD I-Gene
site NN O
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
promoter NN I-Gene
. . O

Use NNP O
of IN O
Selenastrum NNP O
capricornutum NN O
and CC O
Microfeast NNP O
as IN O
food NN O
for IN O
Daphnia NNP O
pulex NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
RNK NNP B-Gene
- : I-Gene
Met NNP I-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
a DT O
serine JJ B-Gene
protease NN I-Gene
with IN O
unique JJ O
activity NN O
that WDT O
is VBZ O
expressed VBN O
in IN O
the DT O
granules NNS O
of IN O
large JJ O
granular JJ O
lymphocytes NNS O
. . O

After IN O
nadolol NN O
, , O
heart NN O
rate NN O
decreased VBN O
( ( O
- : O
22 CD O
+ NN O
/ NNP O
- : O
8 CD O
% NN O
) ) O
, , O
and CC O
so RB O
did VBD O
PBV NNP O
and CC O
PBF NNP O
( ( O
8 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
4 CD O
vs NN O
. . O

Phosphotyrosyl NNP O
peptides NNS O
block VBP O
Stat3 NNP B-Gene
- : O
mediated VBD O
DNA NNP O
binding NN O
activity NN O
, , O
gene NN O
regulation NN O
, , O
and CC O
cell NN O
transformation NN O
. . O

Inclusion NN O
of IN O
the DT O
extended JJ O
N NNP O
terminus NN O
into IN O
the DT O
originally RB O
reported VBN O
protein NN O
resulted VBD O
in IN O
a DT O
striking JJ O
similarity NN O
to TO O
the DT O
lymphoid JJ B-Gene
factor NN I-Gene
Lef NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

There EX O
was VBD O
a DT O
2 CD O
. . O
4 CD O
- : O
fold NN O
difference NN O
in IN O
CAT NNP B-Gene
produced VBD O
from IN O
these DT O
transcripts NNS O
in IN O
HeLa NNP O
cells NNS O
, , O
which WDT O
contain VBP O
a DT O
greater JJR O
natural JJ O
abundance NN O
of IN O
PTB NNP B-Gene
. . O

Closure NN O
of IN O
the DT O
patent NN O
ductus NN O
arteriosus NN O
with IN O
a DT O
Ligaclip NNP O
through IN O
a DT O
minithoracotomy NN O
. . O

In IN O
addition NN O
, , O
all DT O
three CD O
Opa NNP B-Gene
proteins NNS I-Gene
of IN O
C751 NNP O
bind NN O
equally RB O
well RB O
to TO O
HeLa NNP O
cells NNS O
transfected VBD O
with IN O
cDNA NN O
encoding VBG O
the DT O
carcinoembryonic JJ B-Gene
antigen NN I-Gene
[ NNP O
CEA NNP B-Gene
( ( O
CD66e NNP B-Gene
) ) O
] NNP O
subgroup NN O
of IN O
the DT O
CD66 NNP B-Gene
family NN I-Gene
, , O
but CC O
show VBP O
distinct JJ O
tropism NN O
for IN O
CGM1 NNP B-Gene
- : O
( ( O
CD66d NNP B-Gene
) ) O
and CC O
NCA NNP B-Gene
( ( O
CD66c NNP B-Gene
) ) O
- : O
expressing VBG O
cells NNS O
. . O

Surgical JJ O
treatment NN O
of IN O
pulmonary JJ O
metastases NNS O
. . O

Using VBG O
a DT O
series NN O
of IN O
mutant JJ B-Gene
T NNP I-Gene
antigens NNS I-Gene
expressed VBN O
by IN O
recombinant JJ O
baculoviruses NNS O
in IN O
Sf9 NNP O
cells NNS O
, , O
we PRP O
find VBP O
that IN O
the DT O
origin NN O
unwinding VBG O
activities NNS O
of IN O
both DT O
TS677 NNP O
- : O
- : O
> VB O
A DT O
and CC O
TS677 NNP O
, , O
679 CD O
- : O
- : O
> NN O
A DT O
are VBP O
inhibited VBN O
by IN O
the DT O
T NNP B-Gene
- : I-Gene
antigen NN I-Gene
kinase NN I-Gene
, , O
as IN O
is VBZ O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
T NNP I-Gene
antigen NN I-Gene
. . O

We PRP O
recently RB O
reported VBD O
the DT O
molecular JJ O
cloning NN O
of IN O
a DT O
PL NNP B-Gene
scramblase NN I-Gene
of IN O
human JJ O
( ( O
HuPLSCR1 NNP B-Gene
) ) O
and CC O
mouse $ O
origin NN O
, , O
respectively RB O
. . O

1 CD O
, , O
3 CD O
- : O
bis NN O
( ( O
2 CD O
- : O
chloroethyl NN O
) ) O
- : O
1 CD O
- : O
nitrosourea NN O
( ( O
bcnu NN O
) ) O
and CC O
other JJ O
nitrosoureas NNS O
in IN O
cancer NN O
treatment NN O
: : O
a DT O
review NN O
. . O

Acute NNP O
decrease NN O
in IN O
body NN O
temperature NN O
( ( O
TB NNP O
) ) O
lowered VBD O
PaCO2 NNP O
( ( O
32 CD O
. . O
5 CD O
to TO O
14 CD O
. . O
5 CD O
mmHg NN O
) ) O
and CC O
[ $ O
HCO3 NNP O
- : O
] NN O
a DT O
( ( O
24 CD O
. . O
20 CD O
mEq JJ O
/ NNP O
L NNP O
to TO O
17 CD O
. . O
56 CD O
mEq JJ O
/ NNP O
L NNP O
) ) O
, , O
increased VBN O
pHa NN O
( ( O
7 CD O
. . O
481 CD O
to TO O
7 CD O
. . O
608 CD O
) ) O
and CC O
diminished VBD O
the DT O
[ NNP O
OH NNP O
- : O
] NN O
/ JJ O
[ NNP O
H NNP O
+ NNP O
] NNP O
ratio NN O
, , O
but CC O
had VBD O
no DT O
significant JJ O
effect NN O
on IN O
[ NNP O
SID NNP O
] NNP O
or CC O
[ NNP O
Atot NNP O
] NNP O
, , O
although IN O
both DT O
total JJ O
phosphorus NN O
[ NNP O
PT NNP O
] NNP O
and CC O
inorganic JJ O
phosphate NN O
[ NNP O
Pi NNP O
] NNP O
increased VBD O
. . O

EEA1 NNP B-Gene
is VBZ O
a DT O
conserved JJ O
alpha NN O
- : O
helical JJ O
peripheral JJ O
membrane NN O
protein NN O
flanked VBN O
by IN O
cysteine NN O
"""" NN O
fingers NNS O
"""" VBP O
and CC O
contains VBZ O
a DT O
calmodulin NN B-Gene
- : I-Gene
binding NN I-Gene
IQ NNP I-Gene
motif NN I-Gene
. . O

The DT O
husband NN O
in IN O
one CD O
of IN O
the DT O
married JJ O
couples NNS O
was VBD O
treated VBN O
for IN O
hepatitis NN O
of IN O
unidentified JJ O
etiology NN O
in IN O
an DT O
Infectology NNP O
Department NNP O
four CD O
years NNS O
ago RB O
. . O

As IN O
authorized VBN O
by IN O
the DT O
World NNP O
Health NNP O
Organization NNP O
29th CD O
Expert NNP O
Committee NNP O
on IN O
Biological NNP O
Standardization NNP O
, , O
the DT O
preparation NN O
of IN O
human JJ B-Gene
prolactin NN I-Gene
in IN O
ampoules NNS O
coded VBD O
75 CD O
/ NN O
504 CD O
has VBZ O
been VBN O
established VBN O
as IN O
the DT O
International NNP O
Reference NNP O
Preparation NNP O
( ( O
IRP NNP O
) ) O
of IN O
human JJ B-Gene
prolactin NN I-Gene
for IN O
immunoassay NN O
. . O

We PRP O
investigated VBD O
the DT O
incidence NN O
of IN O
congenital JJ O
color NN O
deficiency NN O
among IN O
Koreans NNS O
by IN O
the DT O
use NN O
of IN O
H NNP O
- : O
R NNP O
- : O
R NNP O
pseudoisochromatic JJ O
plates NNS O
. . O

The DT O
C NNP O
terminus NN O
of IN O
TRBP NNP B-Gene
binds NNS O
to TO O
CBP NNP B-Gene
/ NNP O
p300 NN B-Gene
and CC O
DRIP130 NNP B-Gene
, , O
a DT O
component NN O
of IN O
the DT O
DRIP NNP B-Gene
/ NNP O
TRAP NNP B-Gene
/ NNP O
ARC NNP B-Gene
complex NN O
, , O
which WDT O
suggests VBZ O
that IN O
TRBP NNP B-Gene
may MD O
activate VB O
transcription NN O
by IN O
means NNS O
of IN O
such JJ O
interactions NNS O
. . O

Data NNP O
management NN O
in IN O
practice NN O
- : O
based VBN O
research NN O
. . O

The DT O
system NN O
, , O
designed VBN O
to TO O
exploit VB O
the DT O
relatively RB O
constant JJ O
small JJ O
intestine NN O
transit NN O
time NN O
, , O
consists VBZ O
of IN O
a DT O
drug NN O
- : O
containing VBG O
core NN O
coated VBN O
with IN O
a DT O
polymeric JJ O
matrix NN O
formed VBN O
by IN O
a DT O
channeling NN O
agent NN O
( ( O
NaCl NNP O
, , O
mannitol NN O
, , O
and CC O
Emdex NNP O
) ) O
and CC O
an DT O
inert JJ O
polymer NN O
( ( O
Eudragit NNP O
RS100 NNP O
) ) O
. . O

Conservative JJ O
treatment NN O
of IN O
central JJ O
nervous JJ O
system NN O
injuries NNS O

Most JJS O
recently RB O
, , O
the DT O
use NN O
of IN O
the DT O
product NN O
of IN O
brain NN O
weight NN O
and CC O
clearance NN O
has VBZ O
been VBN O
proposed VBN O
. . O

We PRP O
constructed VBD O
a DT O
yeast NN O
reporter NN O
strain NN O
containing VBG O
the DT O
lacZ JJ B-Gene
gene NN I-Gene
under IN O
the DT O
control NN O
of IN O
the DT O
CYC1 NNP B-Gene
promoter NN I-Gene
associated VBN O
with IN O
three CD O
copies NNS O
of IN O
TRE NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

An DT O
RNA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
gene NN I-Gene
( ( O
rbp1 NN B-Gene
) ) O
from IN O
Drosophila NNP O
melanogaster NN O
, , O
encoding VBG O
an DT O
RNA NNP O
recognition NN O
motif NN O
and CC O
an DT O
Arg NNP O
- : O
Ser NNP O
rich JJ O
( ( O
RS NNP O
) ) O
domain NN O
, , O
has VBZ O
been VBN O
characterized VBN O
. . O

In IN O
the DT O
Arithmetic NNP O
subtest JJS O
one CD O
of IN O
the DT O
items NNS O
would MD O
not RB O
meet VB O
the DT O
difficulty NN O
grading VBG O
shown VBN O
while IN O
the DT O
last JJ O
two CD O
items NNS O
offer VBP O
very RB O
little JJ O
possibility NN O
of IN O
success NN O
for IN O
all DT O
subjects NNS O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

2 CD O
Silastic JJ O
capsules NNS O
, , O
each DT O
containing VBG O
22 CD O
- : O
23 CD O
mg NN O
of IN O
ethinyl NN O
estradiol NN O
, , O
were VBD O
inserted VBN O
subcutaneously RB O
in IN O
5 CD O
men NNS O
with IN O
benign JJ O
prostatic JJ O
hypertrophy NN O
. . O

These DT O
viruses NNS O
depend VBP O
on IN O
the DT O
host NN O
cell NN O
machinery NN O
for IN O
their PRP$ O
existence NN O
, , O
and CC O
interference NN O
with IN O
these DT O
processes NNS O
typically RB O
interferes VBZ O
with IN O
other JJ O
important JJ O
host NN O
physiology NN O
. . O

It PRP O
is VBZ O
shown VBN O
that IN O
the DT O
( ( O
G NNP O
+ NNP O
C NNP O
) ) O
- : O
rich JJ O
element NN O
of IN O
the DT O
aldolase NN B-Gene
C NNP I-Gene
promoter NN I-Gene
directs VBZ O
transcription NN O
in IN O
neuronal JJ O
as RB O
well RB O
as IN O
in IN O
nonneuronal JJ O
cells NNS O
. . O

To TO O
identify VB O
structural JJ O
features NNS O
of IN O
residues NNS O
flanking VBG O
the DT O
c NN O
- : O
region NN O
that WDT O
influence NN O
the DT O
fidelity NN O
and CC O
efficiency NN O
of IN O
signal JJ O
peptidase NN O
cleavage NN O
as RB O
well RB O
as IN O
co NN O
- : O
translational JJ O
translocation NN O
, , O
we PRP O
introduced VBD O
six CD O
amino NN O
acid JJ O
substitutions NNS O
into IN O
the DT O
COOH NNP O
terminus NN O
of IN O
the DT O
hydrophobic NN O
core NN O
and CC O
seven CD O
substitutions NNS O
at IN O
the DT O
NH2 NNP O
terminus NN O
of IN O
the DT O
mature NN O
region NN O
( ( O
the DT O
+ NN O
1 CD O
position NN O
) ) O
of IN O
a DT O
model NN O
eukaryotic JJ B-Gene
preprotein NN I-Gene
- : I-Gene
human JJ I-Gene
pre NN I-Gene
( ( I-Gene
delta JJ I-Gene
pro NN I-Gene
) ) I-Gene
apoA VBZ I-Gene
- : I-Gene
II NN I-Gene
. . O

A DT O
new JJ O
semi NN O
- : O
automatic JJ O
method NN O
for IN O
quantifying VBG O
regional JJ O
cerebral JJ O
uptake NN O
of IN O
99m CD O
technetium NN O
- : O
hexamethylpropylene NN O
amine NN O
oxime NN O
( ( O
99mTc CD O
- : O
HMPAO NN O
) ) O
was VBD O
used VBN O
to TO O
assess VB O
single JJ O
photon NN O
emission NN O
tomograms NNS O
from IN O
5 CD O
normal JJ O
subjects NNS O
, , O
14 CD O
patients NNS O
with IN O
Alzheimer NNP O
' POS O
s NN O
disease NN O
, , O
14 CD O
patients NNS O
with IN O
dementia NN O
of IN O
frontal JJ O
lobe NN O
type NN O
and CC O
4 CD O
patients NNS O
with IN O
dementia NN O
with IN O
motor NN O
neurone NN O
disease NN O
. . O

Eight CD O
hr NN O
of IN O
acidosis NN O
caused VBD O
a DT O
significant JJ O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
decrease NN O
in IN O
P50 NNP O
in IN O
vitro NNP O
which WDT O
fell VBD O
from IN O
29 CD O
. . O
0 CD O
to TO O
24 CD O
. . O
4 CD O
torr NN O
. . O

Of IN O
the DT O
drugs NNS O
orally RB O
administered VBN O
, , O
WR NNP O
- : O
168643 CD O
was VBD O
the DT O
best JJS O
protector NN O
with IN O
a DT O
DMF NNP O
of IN O
1 CD O
. . O
51 CD O
. . O

Acute NNP O
pancreatitis NN O
is VBZ O
a DT O
rather RB O
common JJ O
abdominal JJ O
disorder NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
demonstrate VBP O
that IN O
BOX NNP O
DNA NNP O
enhances VBZ O
transcription NN O
from IN O
the DT O
thymidine NN B-Gene
kinase NN I-Gene
( ( O
TK NNP B-Gene
) ) O
promoter NN O
in IN O
various JJ O
EC NNP O
cells NNS O
. . O

Two CD O
activities NNS O
of IN O
the DT O
D NNP B-Gene
protein NN I-Gene
of IN O
the DT O
miniF NN O
plasmid NN O
have VBP O
been VBN O
found VBN O
. . O

Elevated JJ O
expression NN O
of IN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
UhpB NNP I-Gene
or CC O
of IN O
a DT O
soluble JJ O
hybrid JJ O
protein NN O
, , O
GST NNP B-Gene
- : O
Bc NNP B-Gene
, , O
which WDT O
is VBZ O
glutathione NN B-Gene
S NNP I-Gene
- : I-Gene
transferase NN I-Gene
( ( O
GST NNP B-Gene
) ) O
fused VBD O
to TO O
the DT O
cytoplasmic JJ O
C NNP O
- : O
terminal JJ O
portion NN O
of IN O
UhpB NNP B-Gene
, , O
results NNS O
in IN O
complete JJ O
blockage NN O
of IN O
uhpT JJ B-Gene
expression NN O
in IN O
a DT O
uhp NN B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
strain NN O
. . O

The DT O
sequence NN O
of IN O
four CD O
clones NNS O
was VBD O
sufficient JJ O
to TO O
construct VB O
a DT O
3018 CD B-Gene
- : I-Gene
bp NN I-Gene
BAL NNP I-Gene
cDNA NN I-Gene
structure NN O
. . O

New NNP O
techniques NNS O
for IN O
the DT O
mass NN O
spectrometry NN O
of IN O
natural JJ O
products NNS O
. . O

In IN O
the DT O
local JJ O
geomagnetic JJ O
field NN O
, , O
the DT O
animals NNS O
preferred VBD O
the DT O
SE NNP O
- : O
sector NN O
. . O

Sequence NN O
of IN O
10q24 CD B-Gene
locus NN I-Gene
surrounding VBG O
the DT O
HOX11 NNP B-Gene
oncogene NN I-Gene
reveals VBZ O
a DT O
new JJ O
gene NN O
HUG1 NNP B-Gene
expressed VBD O
in IN O
a DT O
T NNP O
- : O
ALL DT O
cell NN O
line NN O
. . O

We PRP O
have VBP O
determined VBN O
that IN O
these DT O
nicks NNS O
occur VBP O
in IN O
both CC O
the DT O
wild JJ O
- : O
type NN O
and CC O
the DT O
mutant JJ O
sites NNS O
. . O

Furthermore RB O
, , O
RING1 NNP B-Gene
overexpression NN O
results NNS O
in IN O
enhanced JJ O
expression NN O
of IN O
the DT O
proto NN O
- : O
oncogenes NNS O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
. . O

In IN O
B NNP O
cells NNS O
, , O
HEF1 NNP B-Gene
is VBZ O
phosphorylated VBN O
by IN O
a DT O
cytoskeleton NN O
- : O
dependent NN O
mechanism NN O
that WDT O
is VBZ O
triggered VBN O
by IN O
integrin JJ B-Gene
ligation NN O
. . O

Labile NNP O
LTR NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
appear VBP O
to TO O
be VB O
essential JJ O
for IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
hyperexpression NN O
, , O
since IN O
both DT O
LTR NNP O
- : O
enhanced JJ O
transcription NN O
and CC O
the DT O
activities NNS O
of IN O
LTR NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
are VBP O
specifically RB O
decreased VBN O
after IN O
inhibition NN O
of IN O
protein JJ O
synthesis NN O
( ( O
A DT O
. . O

In IN O
contrast NN O
, , O
cotransfection NN O
of IN O
TFIIB NNP B-Gene
and CC O
IRF NNP B-Gene
- : I-Gene
1 CD I-Gene
into IN O
NIH NNP O
3T3 CD O
cells NNS O
resulted VBN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
repression NN O
of IN O
promoter NN O
activation NN O
which WDT O
occurred VBD O
in IN O
a DT O
TATA NNP O
- : O
dependent JJ O
manner NN O
. . O

Variations NNS O
of IN O
the DT O
timing NN O
of IN O
deflections NNS O
in IN O
the DT O
His PRP$ O
bundle NN O
recordings NNS O
. . O

Alterations NNS O
in IN O
DNase NNP B-Gene
I PRP I-Gene
reactivity NN O
of IN O
the DT O
GC NNP O
- : O
response NN O
element JJ O
region NN O
suggest VBP O
that IN O
GC NNP B-Gene
receptor NN I-Gene
- : I-Gene
GC NNP I-Gene
complexes NNS I-Gene
may MD O
associate VB O
, , O
in IN O
a DT O
transient JJ O
manner NN O
, , O
with IN O
the DT O
promoter NN O
in IN O
the DT O
actively RB O
transcribing VBG O
control NN O
state NN O
. . O

Thus RB O
, , O
we PRP O
have VBP O
produced VBN O
lipoyl JJ O
domain NN O
constructs NNS O
that WDT O
can MD O
be VB O
employed VBN O
in IN O
sorting VBG O
the DT O
specific JJ O
roles NNS O
of IN O
E2L1 NNP B-Gene
and CC O
E2L2 NNP B-Gene
in IN O
facilitating VBG O
catalytic JJ O
and CC O
regulatory JJ O
processes NNS O
. . O

In IN O
this DT O
study NN O
we PRP O
examined VBD O
hepatic JJ O
stellate NN O
cell NN O
regulation NN O
of IN O
M6P NNP B-Gene
/ NNP O
IGFIIR NNP B-Gene
expression NN O
and CC O
found VBD O
that IN O
M6P NNP B-Gene
/ NNP O
IGFIIR NNP B-Gene
mRNA FW O
transcript NN O
levels NNS O
increased VBN O
in IN O
stellate NN O
cells NNS O
from IN O
rats NNS O
exposed VBN O
to TO O
carbon VB O
tetrachloride NN O
( ( O
CCl4 NNP O
) ) O
, , O
a DT O
potent NN O
fibrogenic JJ O
stimulant NN O
. . O

In IN O
a DT O
country NN O
where WRB O
general JJ O
HIV NNP O
prevalence NN O
is VBZ O
low JJ O
, , O
the DT O
strategy NN O
is VBZ O
cost VBN O
- : O
effective JJ O
for IN O
location NN O
and CC O
counselling NN O
of IN O
unknowingly RB O
seropositive JJ O
individuals NNS O
. . O

Analysis NN O
of IN O
various JJ O
deletion NN O
mutants NNS O
indicates VBZ O
that IN O
the DT O
sequence NN O
requirements NNS O
for IN O
binding VBG O
by IN O
QBP NNP B-Gene
in IN O
vitro NN O
are VBP O
indistinguishable JJ O
from IN O
those DT O
necessary JJ O
for IN O
Q NNP O
activity NN O
in IN O
vivo NN O
, , O
strongly RB O
suggesting VBG O
that IN O
QBP NNP B-Gene
is VBZ O
required VBN O
for IN O
the DT O
function NN O
of IN O
this DT O
TATA NNP O
- : O
independent JJ O
promoter NN O
. . O

Supplementing VBG O
a DT O
soybean NN O
protein NN O
and CC O
sucrose VB O
- : O
based VBN O
diet JJ O
with IN O
levels NNS O
of IN O
2 CD O
. . O
2 CD O
, , O
11 CD O
, , O
and CC O
55 CD O
ppm NN O
of IN O
the DT O
antibiotic JJ O
, , O
from IN O
the DT O
two CD O
sources NNS O
each DT O
with IN O
two CD O
different JJ O
purities NNS O
, , O
improved VBD O
weight JJ O
gain NN O
of IN O
chicks NNS O
an DT O
average NN O
of IN O
23 CD O
% NN O
and CC O
improved VBN O
feed NN O
efficiency NN O
an DT O
average NN O
of IN O
13 CD O
% NN O
at IN O
the DT O
higher JJR O
levels NNS O
( ( O
all DT O
P NNP O
less JJR O
than IN O
. . O
1 CD O
) ) O
. . O

Current JJ O
evidence NN O
for IN O
this DT O
type NN O
of IN O
DNA NNP O
supercoiling VBG O
- : O
dependent JJ O
transcriptional JJ O
coupling NN O
, , O
based VBN O
largely RB O
on IN O
the DT O
in IN O
vivo JJ O
activities NNS O
of IN O
promoters NNS O
contained VBN O
in IN O
engineered JJ O
DNA NNP O
constructs NNS O
, , O
suggests VBZ O
that IN O
the DT O
transcription NN O
complex NN O
must MD O
be VB O
physically RB O
hindered VBN O
to TO O
generate VB O
DNA NNP O
supercoils NNS O
and CC O
to TO O
prevent VB O
their PRP$ O
diffusion NN O
throughout IN O
the DT O
DNA NN O
duplex NN O
. . O

Semidominant JJ O
mutations NNS O
in IN O
the DT O
yeast NN B-Gene
Rad51 NNP I-Gene
protein NN I-Gene
and CC O
their PRP$ O
relationships NNS O
with IN O
the DT O
Srs2 NNP B-Gene
helicase NN I-Gene
. . O

Endothelial JJ O
cells NNS O
stored VBN O
with IN O
University NNP O
of IN O
Wisconsin NNP O
solution NN O
excluded VBD O
trypan NN O
blue NN O
better RBR O
( ( O
1 CD O
. . O
0 CD O
% NN O
+ NNP O
/ NNP O
- : O
0 CD O
. . O
5 CD O
% NN O
cells NNS O
stained VBN O
, , O
p VBZ O
less JJR O
than IN O
0 CD O
. . O
1 CD O
. . O

Three CD O
FGF NNP B-Gene
- : I-Gene
AS IN I-Gene
cDNAs NN I-Gene
were VBD O
isolated VBN O
; : O
the DT O
full JJ B-Gene
- : I-Gene
length NN I-Gene
FGF NNP I-Gene
- : I-Gene
AS IN I-Gene
mRNA NN I-Gene
and CC O
two CD O
alternative JJ O
splice NN O
variants NNS O
lacking VBG O
exon JJ O
2 CD O
or CC O
exons NNS O
2 CD O
and CC O
3 CD O
of IN O
the DT O
FGF NNP B-Gene
- : I-Gene
AS IN I-Gene
sequence NN I-Gene
. . O

A DT O
fluoroimmunoassay NN O
for IN O
the DT O
determination NN O
of IN O
serum NN O
of IN O
plasma NN O
levels NNS O
of IN O
propranolol NN O
was VBD O
developed VBN O
using VBG O
antibodies NNS O
to TO O
propranolol VB O
coupled VBN O
to TO O
magnetizable VB O
solid JJ O
- : O
phase NN O
particles NNS O
and CC O
fluorescein SYM O
- : O
labeled VBN O
propranolol NN O
as IN O
tracer NN O
. . O

The DT O
human JJ B-Gene
CD38 NNP I-Gene
gene NN I-Gene
consists VBZ O
of IN O
8 CD O
exons NNS O
that WDT O
extend VBP O
more JJR O
than IN O
77 CD O
kb NN O
on IN O
the DT O
human JJ O
genome NN O
. . O

Analysis NN O
of IN O
mRNA NN O
expression NN O
shows VBZ O
that IN O
AT NNP B-Gene
- : I-Gene
BP1 NN I-Gene
and CC O
AT NNP B-Gene
- : I-Gene
BP2 NNP I-Gene
are VBP O
expressed VBN O
in IN O
all PDT O
the DT O
tissues NNS O
examined VBN O
. . O

In IN O
order NN O
to TO O
infer VB O
shape NN O
from IN O
contour NN O
, , O
the DT O
human JJ O
visual JJ O
system NN O
must MD O
selectively RB O
integrate VB O
fragments NNS O
projecting VBG O
from IN O
a DT O
common JJ O
object NN O
while IN O
keeping VBG O
fragments NNS O
from IN O
different JJ O
objects NNS O
separate VBP O
. . O

CD NN O
was VBD O
determined VBN O
using VBG O
the DT O
Farnsworth NNP O
D NNP O
- : O
15 CD O
method NN O
. . O

However RB O
, , O
the DT O
a1 NN O
isoform NN O
is VBZ O
expressed VBN O
most JJS O
heavily RB O
in IN O
brain NN O
and CC O
heart NN O
, , O
a2 NN O
in IN O
liver NN O
and CC O
kidney NN O
, , O
and CC O
a3 NN O
in IN O
liver NN O
, , O
lung NN O
, , O
heart NN O
, , O
brain NN O
, , O
spleen JJ O
, , O
and CC O
kidney NN O
. . O

The DT O
Oct NNP B-Gene
and CC O
HMG2 NNP B-Gene
proteins NNS I-Gene
also RB O
interact VBP O
in IN O
vivo NN O
. . O

Gas6 NNP B-Gene
contains VBZ O
an DT O
NH2 NNP O
- : O
terminal JJ O
Gla NNP O
domain NN O
followed VBN O
by IN O
four CD O
epidermal JJ B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
like IN I-Gene
repeats NNS I-Gene
and CC O
tandem VB O
globular NN O
( ( O
G NNP O
) ) O
domains VBZ O
. . O

Men NNS O
were VBD O
more RBR O
positive JJ O
about IN O
their PRP$ O
physical JJ O
fitness NN O
than IN O
women NNS O
. . O

The DT O
human JJ B-Gene
MSH NNP I-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
product NN I-Gene
is VBZ O
a DT O
member NN O
of IN O
a DT O
highly RB O
conserved VBN O
family NN O
of IN O
proteins NNS O
which WDT O
are VBP O
involved VBN O
in IN O
post NN O
- : O
replication NN O
mismatch NN O
repair NN O
. . O

hMSH SYM B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
homologous JJ O
to TO O
Escherichia NNP O
coli NN O
( ( O
E NNP O
. . O
coli NN O
) ) O
MutS NNP B-Gene
and CC O
Sacchromyces NNP B-Gene
cerevisiae VBP I-Gene
MSH NNP I-Gene
- : I-Gene
1 CD I-Gene
and CC O
MSH NNP B-Gene
- : I-Gene
2 CD I-Gene
proteins NNS I-Gene
, , O
which WDT O
recognise VBP O
heteroduplex JJ O
DNA NN O
at IN O
the DT O
sites NNS O
of IN O
all DT O
single JJ O
base NN O
mismatches NNS O
and CC O
deletions NNS O
or CC O
insertions NNS O
up IN O
to TO O
4 CD O
base NN O
pairs NN O
. . O

hMSH SYM B-Gene
- : I-Gene
2 CD I-Gene
is VBZ O
one CD O
of IN O
the DT O
hereditary JJ B-Gene
non NN I-Gene
- : I-Gene
polyposis NN I-Gene
colorectal JJ I-Gene
cancer NN I-Gene
( ( I-Gene
HNPCC NNP I-Gene
) ) I-Gene
tumor NN I-Gene
suppressor NN I-Gene
genes NNS I-Gene
, , O
and CC O
maps NNS O
to TO O
human JJ O
chromosome NN O
2p16 CD O
. . O

A DT O
novel JJ O
myeloid NN O
- : O
restricted VBN O
zebrafish JJ O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
with IN O
a DT O
potent JJ O
transcriptional JJ O
activation NN O
domain NN O
. . O

The DT O
proteins NNS O
differ VBP O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
a DT O
21 CD O
- : O
amino NN O
- : O
acid NN O
sequence NN O
located VBD O
24 CD O
amino NN O
acids NNS O
C NNP O
terminal NN O
of IN O
the DT O
translational JJ O
initiation NN O
codon NN O
. . O

Sequencing VBG O
of IN O
the DT O
facB JJ B-Gene
gene NN I-Gene
revealed VBD O
that IN O
it PRP O
encodes VBZ O
a DT O
protein NN O
that WDT O
contains VBZ O
an DT O
N NNP O
- : O
terminal NN O
GAL4 NNP B-Gene
- : O
like IN O
Zn NNP O
( ( O
II NNP O
) ) O
2Cys6 CD O
( ( O
or CC O
C6 NNP O
zinc NN O
) ) O
binuclear VBP O
cluster NN O
for IN O
DNA NNP O
binding NN O
, , O
leucine JJ O
zipper SYM O
- : O
like IN O
heptad NN O
repeat NN O
motifs NNS O
and CC O
central JJ O
and CC O
C NNP O
- : O
terminal JJ O
acidic JJ O
alpha SYM O
- : O
helical JJ O
regions NNS O
, , O
consistent JJ O
with IN O
a DT O
function NN O
as IN O
a DT O
DNA NNP O
- : O
binding VBG O
transcriptional JJ O
activator NN O
. . O

Substitution NN O
of IN O
a DT O
threonine NN O
residue NN O
by IN O
an DT O
alanine NN O
residue NN O
at IN O
position NN O
- : O
2 CD O
( ( O
P2 NNP O
) ) O
of IN O
this DT O
cleavage NN O
site NN O
abolished VBD O
cleavage NN O
, , O
whereas JJ O
substitution NN O
of IN O
a DT O
tyrosine NN O
residue NN O
by IN O
a DT O
phenylalanine NN O
residue NN O
at IN O
amino NN O
acid NN O
position NN O
- : O
1 CD O
( ( O
P1 NNP O
) ) O
of IN O
the DT O
cleavage NN O
site NN O
did VBD O
not RB O
influence NN O
processing NN O
. . O

Cis NNP O
- : O
regulation NN O
downstream NN O
of IN O
cell NN O
type JJ O
specification NN O
: : O
a DT O
single JJ O
compact JJ O
element NN O
controls VBZ O
the DT O
complex JJ O
expression NN O
of IN O
the DT O
CyIIa NNP B-Gene
gene NN I-Gene
in IN O
sea NN O
urchin JJ O
embryos NN O
. . O

Groups NNP O
of IN O
ten JJ O
dependent JJ O
and CC O
ten JJ O
saline JJ O
mice NN O
were VBD O
singly RB O
tested VBN O
in IN O
both DT O
light JJ O
and CC O
dark JJ O
conditions NNS O
in IN O
each DT O
of IN O
five CD O
covered JJ O
cylinders NNS O
( ( O
2 CD O
- : O
23 CD O
in IN O
high JJ O
) ) O
. . O

Asymptomatic JJ O
bacteriospermia NN O
and CC O
fertility NN O

5 CD O
. . O

A DT O
high JJ O
- : O
frequency NN O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
was VBD O
evident JJ O
in IN O
the DT O
DNA NN O
from IN O
29 CD O
unrelated JJ O
individuals NNS O
using VBG O
the DT O
enzyme NN O
BglII NNP B-Gene
. . O

Our PRP$ O
data NNS O
show VBP O
that IN O
multiple JJ O
MLSN1 NNP B-Gene
transcripts NNS I-Gene
, , O
both DT O
constitutively RB O
expressed VBN O
and CC O
inducible JJ O
, , O
are VBP O
present JJ O
in IN O
cultured JJ O
pigmented JJ O
melanoma NN O
cells NNS O
, , O
and CC O
suggest VBP O
that IN O
MLSN1 NNP B-Gene
expression NN O
can MD O
be VB O
regulated VBN O
at IN O
the DT O
level NN O
of IN O
both DT O
transcription NN O
and CC O
mRNA NN O
processing NN O
. . O

We PRP O
show VBP O
also RB O
that IN O
RA NNP O
represses VBZ O
the DT O
transcriptional JJ O
activity NN O
of IN O
a DT O
reporter NN O
gene NN O
containing VBG O
a DT O
TPA NNP O
responding VBG O
AP1 NNP B-Gene
binding VBG I-Gene
site NN I-Gene
driving VBG O
the DT O
HSV NNP B-Gene
tk NN I-Gene
promoter NN I-Gene
. . O

The DT O
glucose JJ O
/ NNP O
insulin NN B-Gene
stimulation NN O
was VBD O
inhibited VBN O
by IN O
the DT O
addition NN O
of IN O
polyunsaturated JJ O
fatty JJ O
acids NNS O
. . O

MATERIALS NNP O
AND CC O
METHODS NNP O
: : O
Coronal JJ O
3D CD O
GRE NNP O
imaging NN O
was VBD O
used VBN O
to TO O
study VB O
the DT O
volar NN O
, , O
middle NN O
, , O
and CC O
dorsal JJ O
portions NNS O
of IN O
the DT O
SLL NNP O
in IN O
14 CD O
patients NNS O
with IN O
an DT O
arthroscopically RB O
normal JJ O
SLL NNP O
and CC O
in IN O
five CD O
cadaveric JJ O
wrists NNS O
that WDT O
had VBD O
a DT O
normal JJ O
SLL NNP O
proved VBD O
with IN O
dissection NN O
. . O

The DT O
current JJ O
study NN O
demonstrates VBZ O
that IN O
T3 NNP O
- : O
activated JJ O
transcription NN O
of IN O
the DT O
NADPH NNP B-Gene
: : I-Gene
cytochrome NN I-Gene
P450 NNP I-Gene
oxidoreductase NN I-Gene
( ( O
P450R NNP B-Gene
) ) O
gene NN O
is VBZ O
dependent JJ O
on IN O
the DT O
thyroid JJ O
hormonal JJ O
status NN O
of IN O
the DT O
animal NN O
, , O
with IN O
both DT O
transcriptional JJ O
and CC O
post NN O
- : O
transcriptional JJ O
pathways NNS O
being VBG O
important JJ O
in IN O
regulating VBG O
the DT O
cellular JJ O
P450R NNP B-Gene
mRNA NN O
level NN O
. . O

The DT O
second JJ O
goal NN O
was VBD O
to TO O
ascertain VB O
the DT O
somatotopic NN O
arrangement NN O
of IN O
the DT O
GPi NNP O
in IN O
PD NNP O
. . O

Moloney NNP O
murine NN O
leukemia NN O
virus NN O
( ( O
MMLV NNP O
) ) O
- : O
derived VBN O
pUCMoTiN SYM O
- : O
based VBN O
retroviral JJ O
vectors NNS O
were VBD O
engineered VBN O
to TO O
allow VB O
constitutive JJ O
and CC O
Tat NNP B-Gene
( ( O
trans SYM B-Gene
- : I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
) ) O
- : O
inducible JJ O
expression NN O
of IN O
five CD O
hammerhead JJ O
ribozymes NNS O
targeted VBN O
against IN O
highly RB O
conserved JJ O
sequences NNS O
within IN O
the DT O
group NN B-Gene
antigen NN I-Gene
( ( O
Gag NNP B-Gene
) ) O
, , O
protease NN B-Gene
( ( O
Pro NNP B-Gene
) ) O
, , O
reverse JJ B-Gene
transcriptase NN I-Gene
( ( O
RT NNP B-Gene
) ) O
, , O
tat NN B-Gene
, , O
and CC O
envelope NN B-Gene
( ( O
Env NNP B-Gene
) ) O
coding VBG O
regions NNS O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
- : O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
RNA NNP O
. . O

The DT O
intrapancreatic JJ O
spread NN O
of IN O
the DT O
carcinoma NN O
correlated VBD O
with IN O
portal JJ O
invasion NN O
of IN O
carcinoma NN O
, , O
hardness NN O
of IN O
the DT O
body NN O
and CC O
tail NN O
, , O
obstruction NN O
of IN O
main JJ O
pancreatic JJ O
duct NN O
and CC O
irregular JJ O
pancreaticogram NN O
. . O

Cryopreservation NNP O
straws VBZ O
filled VBN O
with IN O
media NNS O
plus CC O
additive JJ O
are VBP O
emersed VBN O
below IN O
the DT O
surface NN O
of IN O
an DT O
unprocessed JJ O
donor NN O
ejaculate NN O
. . O

Although IN O
the DT O
binding NN O
of IN O
IE2 NNP B-Gene
86 CD I-Gene
to TO O
nonphosphorylated VBN O
full JJ B-Gene
- : I-Gene
length NN I-Gene
CREB NNP I-Gene
or CC O
deltaCREB NN B-Gene
is VBZ O
minimal JJ O
, , O
IE2 NNP B-Gene
86 CD I-Gene
does VBZ O
form VB O
complexes NNS O
with IN O
p300 NN B-Gene
and CC O
the DT O
CREB NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
CBP NNP B-Gene
) ) O
, , O
which WDT O
in IN O
turn NN O
bind NN O
to TO O
CREB NNP B-Gene
and CC O
can MD O
serve VB O
as IN O
adaptor NN O
proteins NNS O
for IN O
CREB NNP B-Gene
function NN O
. . O

G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
( ( O
480 CD O
micrograms NNS O
subcutaneously RB O
( ( O
s UH O
. . O
c VB O
. . O
) ) O
) ) O
were VBD O
used VBN O
in IN O
55 CD O
and CC O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
( ( O
400 CD O
micrograms NNS O
s RB O
. . O
c VB O
. . O
) ) O
in IN O
28 CD O
chemotherapeutic JJ O
cycles NNS O
. . O

Some DT O
8 CD O
. . O
8 CD O
kb NN O
of IN O
the DT O
Lactobacillus NNP O
sake NN O
plasmid NN O
pCIM1 NN O
was VBD O
sequenced VBN O
, , O
revealing VBG O
eight CD O
tightly RB O
clustered VBN O
open JJ O
reading NN O
frames NNS O
( ( O
ORFs NNP O
) ) O
downstream NN O
from IN O
lasA NN B-Gene
, , O
which WDT O
encodes VBZ O
pre SYM B-Gene
- : I-Gene
lactocin NN I-Gene
S NNP I-Gene
. . O

Primer NNP O
extension NN O
experiments NNS O
indicated VBD O
that IN O
the DT O
transcription NN O
initiation NN O
site NN O
mapped VBD O
to TO O
a DT O
position NN O
on IN O
gene NN B-Gene
IV NNP I-Gene
that WDT O
was VBD O
analogous JJ O
to TO O
that DT O
reported VBN O
for IN O
the DT O
structurally RB O
similar JJ O
P NNP B-Gene
- : I-Gene
450e CD I-Gene
gene NN I-Gene
. . O

This DT O
shows VBZ O
that IN O
the DT O
characteristically RB O
diffuse VBP O
banding VBG O
pattern NN O
of IN O
plant NN O
nuclear JJ O
proteins VBZ O
interacting VBG O
with IN O
the DT O
G NNP O
- : O
box NN O
is VBZ O
also RB O
observed VBN O
in IN O
a DT O
binding NN O
assay NN O
using VBG O
only RB O
one CD O
recombinant NN B-Gene
GBF NNP I-Gene
. . O

In IN O
1993 CD O
and CC O
1994 CD O
and CC O
infection NN O
with IN O
body NN O
lice NN O
was VBD O
registered VBN O
41 CD O
times NNS O
in IN O
31 CD O
patients NNS O
at IN O
the DT O
clinic NN O
for IN O
homeless NN O
of IN O
the DT O
Community NNP O
Health NNP O
Service NNP O
of IN O
Utrecht NNP O
. . O

The DT O
distributed JJ O
current JJ O
density NN O
J NNP O
is VBZ O
calculated VBN O
within IN O
the DT O
volume NN O
defined VBN O
by IN O
the DT O
motor NN O
unit NN O
. . O

To TO O
analyze VB O
the DT O
VH NNP O
regions NNS O
of IN O
polyreactive JJ O
antibodies NNS O
, , O
with IN O
particular JJ O
attention NN O
at IN O
their PRP$ O
somatically RB O
mutated VBN O
status NN O
, , O
we PRP O
generated VBD O
five CD O
IgG NNP B-Gene
( ( O
three CD O
IgG1 NNP B-Gene
and CC O
two CD O
IgG3 NNP B-Gene
) ) O
mAb NN O
( ( O
using VBG O
B NNP O
cells NNS O
from IN O
a DT O
healthy JJ O
subject NN O
, , O
a DT O
patient NN O
with IN O
insulin JJ B-Gene
- : O
dependent NN O
diabetes VBZ O
mellitus NNS O
and CC O
a DT O
patient NN O
with IN O
SLE NNP O
) ) O
, , O
which WDT O
bound VBP O
with IN O
various JJ O
efficiencies NNS O
a DT O
number NN O
of IN O
different JJ O
self NN O
and CC O
foreign JJ O
Ag NNP O
. . O

We PRP O
provide VBP O
community NN O
metabolic JJ O
data NNS O
that WDT O
indicate VBP O
that IN O
large JJ O
changes NNS O
in IN O
CO2 NNP O
concentration NN O
can MD O
occur VB O
in IN O
coral JJ O
reef NN O
waters NNS O
via IN O
biogeochemical JJ O
processes NNS O
not RB O
directly RB O
associated VBN O
with IN O
photosynthesis NN O
, , O
respiration NN O
, , O
calcification NN O
, , O
and CC O
CaCO3 NNP O
dissolution NN O
. . O

These DT O
lesions NNS O
may MD O
be VB O
treated VBN O
by IN O
propranolol NN O
or CC O
phentolamine NN O
. . O

Additionally RB O
, , O
a DT O
variety NN O
of IN O
regulatory JJ O
schemes NNS O
contribute JJ O
temporal JJ O
and CC O
/ JJ O
or CC O
spatial JJ O
restriction NN O
to TO O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
responses NNS O
. . O

The DT O
recombinant JJ B-Gene
vaccinia NN I-Gene
virus NN I-Gene
- : I-Gene
expressed VBN I-Gene
mutant JJ I-Gene
P1 NNP I-Gene
polyproteins NNS I-Gene
were VBD O
analyzed VBN O
for IN O
proteolytic JJ O
processing NN O
defects NNS O
in IN O
cells NNS O
coinfected VBN O
with IN O
a DT O
recombinant JJ O
vaccinia NN O
virus NN O
( ( O
VVP3 NNP O
) ) O
that WDT O
expresses VBZ O
the DT O
poliovirus NN B-Gene
3CD CD I-Gene
protease NN I-Gene
and CC O
for IN O
processing NN O
and CC O
assembly NN O
defects NNS O
by IN O
using VBG O
a DT O
trans JJ O
complementation NN O
system NN O
in IN O
which WDT O
P1 NNP B-Gene
- : O
expressing VBG O
recombinant JJ O
vaccinia NN O
viruses NNS O
provide VBP O
capsid NN B-Gene
precursor NN I-Gene
to TO O
a DT O
defective JJ O
poliovirus NN O
genome NN O
that WDT O
does VBZ O
not RB O
express VB O
functional JJ O
capsid NN B-Gene
proteins NNS I-Gene
( ( O
D NNP O
. . O

However RB O
, , O
the DT O
lens NNS O
dose VBP O
( ( O
3 CD O
. . O
6 CD O
Gy NNP O
/ VBD O
25 CD O
fractions NNS O
) ) O
was VBD O
higher JJR O
compared VBN O
to TO O
the DT O
other JJ O
techniques NNS O
. . O

Proprotein NNP O
processing NN O
occurs VBZ O
intracellularly RB O
. . O

Actuarial JJ O
freedom NN O
from IN O
ventricular JJ O
arrhythmias NNS O
at IN O
4 CD O
- : O
year NN O
follow SYM O
- : O
up NN O
was VBD O
74 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
0 CD O
% NN O
in IN O
group NN O
A NNP O
vs NN O
. . O

Ileal NNP O
digestibilities NNS O
of IN O
DM NNP O
, , O
OM NNP O
, , O
CP NNP O
, , O
total JJ O
dietary JJ O
fiber NN O
( ( O
TDF NNP O
) ) O
, , O
fat JJ O
and CC O
gross JJ O
energy NN O
( ( O
GE NNP O
) ) O
were VBD O
lower JJR O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
for IN O
dogs NNS O
fed VBN O
diets NNS O
containing VBG O
supplemental JJ O
fiber NN O
compared VBN O
with IN O
dogs NNS O
fed VBP O
the DT O
control NN O
diet NN O
. . O

Histamine NNP O
reactivity NN O
was VBD O
significantly RB O
reduced VBN O
after IN O
the DT O
nifedipine JJ O
aerosol NN O
, , O
the DT O
geometric JJ O
mean NN O
provocative JJ O
concentration NN O
causing VBG O
a DT O
35 CD O
% NN O
fall NN O
in IN O
specific JJ O
airway NN O
conductance NN O
, , O
rising VBG O
from IN O
5 CD O
. . O
0 CD O
to TO O
10 CD O
. . O
9 CD O
mg JJ O
/ NNP O
ml NN O
of IN O
histamine NN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

Multilayer NNP O
- : O
relaxation NN O
geometry NN O
and CC O
electronic JJ O
structure NN O
of IN O
a DT O
W NNP O
( ( O
111 CD O
) ) O
surface NN O
. . O

Characterization NN O
of IN O
a DT O
human JJ B-Gene
alternatively RB I-Gene
spliced VBD I-Gene
truncated VBN I-Gene
reduced JJ I-Gene
folate NN I-Gene
carrier NN I-Gene
increasing VBG O
folate JJ O
accumulation NN O
in IN O
parental JJ O
leukemia NN O
cells NNS O
. . O

Recently RB O
, , O
a DT O
protein NN O
designated VBN O
GF14 NNP B-Gene
has VBZ O
been VBN O
isolated VBN O
that DT O
is VBZ O
associated VBN O
with IN O
the DT O
GBF NNP B-Gene
protein NN I-Gene
complex NN I-Gene
. . O

Coexpression NN O
of IN O
the DT O
p120 NN B-Gene
( ( O
ctn NN B-Gene
) ) O
protein NN O
with IN O
an DT O
N NNP O
- : O
terminal JJ O
deletion NN O
, , O
which WDT O
eliminates VBZ O
some DT O
potential JJ O
tyrosine NN O
phosphorylation NN O
sites NNS O
, , O
or CC O
the DT O
protein NN O
with IN O
a DT O
single JJ O
amino NN O
acid JJ O
substitution NN O
( ( O
tyrosine NN O
at IN O
217 CD O
to TO O
phenylalanine VB O
) ) O
resulted VBN O
in IN O
an DT O
increase NN O
in IN O
the DT O
aggregation NN O
of IN O
v JJ B-Gene
- : I-Gene
Src NNP I-Gene
- : O
transformed VBD O
EL NNP O
and CC O
EalphaCL NNP O
cells NNS O
. . O

Static JJ O
lung NN O
function NN O
in IN O
puppies NNS O
after IN O
pneumonectomy NN O
. . O

The DT O
emerging VBG O
view NN O
based VBN O
on IN O
studies NNS O
in IN O
yeast NN O
is VBZ O
that IN O
each DT O
class NN O
of IN O
snoRNPs NN O
is VBZ O
composed VBN O
of IN O
a DT O
unique JJ O
set NN O
of IN O
proteins NNS O
. . O

Htra2 NNP B-Gene
- : I-Gene
beta3 NN I-Gene
is VBZ O
developmentally RB O
regulated VBN O
and CC O
expressed VBN O
predominantly RB O
in IN O
brain NN O
, , O
liver RB O
testis NN O
, , O
and CC O
weakly RB O
in IN O
kidney NN O
. . O

We PRP O
analyzed VBD O
the DT O
P NNP O
- : O
SAECG NN O
in IN O
the DT O
time NN O
and CC O
frequency NN O
domain NN O
in IN O
23 CD O
patients NNS O
with IN O
Paf NNP O
and CC O
19 CD O
controls NNS O
. . O

He PRP O
was VBD O
administered VBN O
recombinant JJ B-Gene
IFN NNP I-Gene
alpha NN I-Gene
- : I-Gene
2b CD I-Gene
under IN O
the DT O
diagnosis NN O
of IN O
chronic JJ O
hepatitis NN O
C NNP O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
contribution NN O
of IN O
specific JJ O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
( ( O
TBP NNP B-Gene
) ) O
- : O
TATA NN O
interactions NNS O
to TO O
the DT O
promoter NN O
activity NN O
of IN O
a DT O
constitutively RB O
expressed VBN O
silkworm NN B-Gene
tRNA NN I-Gene
( ( I-Gene
C NNP I-Gene
) ) I-Gene
( ( I-Gene
Ala NNP I-Gene
) ) I-Gene
gene NN I-Gene
and CC O
have VBP O
also RB O
asked VBN O
whether IN O
the DT O
lack NN O
of IN O
similar JJ O
interactions NNS O
accounts NNS O
for IN O
the DT O
low JJ O
promoter NN O
activity NN O
of IN O
a DT O
silk NN B-Gene
gland NN I-Gene
- : I-Gene
specific JJ I-Gene
tRNA NN I-Gene
( ( I-Gene
SG NNP I-Gene
) ) I-Gene
( ( I-Gene
Ala NNP I-Gene
) ) I-Gene
gene NN I-Gene
. . O

Involvement NN O
of IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
regulation NN O
of IN O
the DT O
R NNP B-Gene
- : I-Gene
FABP NNP I-Gene
gene NN I-Gene
in IN O
the DT O
developing VBG O
chick JJ O
retina NN O
. . O

A DT O
phylogenetic JJ O
analysis NN O
with IN O
the DT O
TK NNP B-Gene
domains NNS I-Gene
from IN O
these DT O
sequences NNS O
and CC O
a DT O
fourth JJ O
, , O
from IN O
a DT O
novel JJ O
scavenger NN B-Gene
RTK NNP I-Gene
( ( O
all DT O
domains NNS O
comprise VBP O
the DT O
signature NN O
for IN O
the DT O
TK NNP B-Gene
class NN I-Gene
II NNP I-Gene
receptors NNS I-Gene
) ) O
, , O
showed VBD O
that IN O
they PRP O
are VBP O
distantly RB O
related VBN O
to TO O
the DT O
insulin NN B-Gene
and CC O
insulin NN B-Gene
- : I-Gene
like IN I-Gene
receptors NNS I-Gene
. . O

Presently RB O
four CD O
unique JJ O
variants NNS O
carrying VBG O
distinct JJ O
GAF NNP B-Gene
sequences NNS I-Gene
in IN O
the DT O
N NNP O
- : O
terminal JJ O
region NN O
have VBP O
been VBN O
identified VBN O
. . O

Gabapentin NNP O
for IN O
opiod SYM O
- : O
related JJ O
myoclonus NN O
in IN O
cancer NN O
patients NNS O
. . O

In IN O
the DT O
whole JJ O
group NN O
, , O
basal NN O
GH NNP B-Gene
and CC O
somatomedin SYM B-Gene
- : I-Gene
C NN I-Gene
levels NNS O
decreased VBN O
from IN O
a DT O
mean NN O
( ( O
+ JJ O
/ NNP O
- : O
standard JJ O
error NN O
of IN O
the DT O
mean NN O
) ) O
of IN O
52 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
12 CD O
. . O
7 CD O
to TO O
11 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
3 CD O
ng JJ O
/ NNP O
ml NN O
and CC O
from IN O
7 CD O
. . O
6 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
to TO O
2 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
5 CD O
U NNP O
/ NNP O
ml NN O
, , O
respectively RB O
. . O

IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
( ( O
10 CD O
ng RB O
/ NNP O
ml NN O
) ) O
drastically RB O
increased VBD O
both DT O
PDGFalphaR NNP B-Gene
and CC O
CCAAT NNP B-Gene
/ NNP I-Gene
enhancer SYM I-Gene
- : I-Gene
binding VBG I-Gene
protein NN I-Gene
delta NN I-Gene
( ( O
C NNP B-Gene
/ NNP I-Gene
EBPdelta NNP I-Gene
) ) O
mRNA NN O
levels NNS O
in IN O
a DT O
time NN O
dependent JJ O
manner NN O
. . O

If IN O
you PRP O
think VBP O
education NN O
is VBZ O
expensive JJ O
- : O
- : O
try NN O
ignorance NN O
- : O
- : O
Bok NNP O
' POS O
s NN O
Law NNP O
. . O

LH NNP B-Gene
/ NNP I-Gene
CG NNP I-Gene
receptor NN I-Gene
activation NN O
of IN O
ARNO NNP B-Gene
is VBZ O
not RB O
mediated VBN O
by IN O
activation NN O
of IN O
phosphatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
or CC O
by IN O
G NNP B-Gene
protein NN I-Gene
beta NN I-Gene
gamma NN I-Gene
subunits NNS I-Gene
. . O

Estimated VBN O
nucleic JJ O
acid NN O
N NNP O
absorption NN O
is VBZ O
7 CD O
- : O
8 CD O
% NN O
of IN O
N NNP O
intake NN O
. . O

Resistance NNP O
pattern NN O
of IN O
Mycobacterium NNP O
tuberculosis NN O
( ( O
H NNP O
37 CD O
Rv NNP O
) ) O
to TO O
a DT O
new JJ O
antibiotic JJ O
, , O
lividomycin JJ O

The DT O
skp1 NN B-Gene
+ NNP I-Gene
gene NN I-Gene
is VBZ O
not RB O
essential JJ O
. . O

Complementary NNP O
DNAs NNP O
encompassing VBG O
the DT O
coat NN B-Gene
protein NN I-Gene
coding NN O
and CC O
adjacent JJ O
regions NNS O
of IN O
Agropyron NNP O
mosaic FW O
virus NN O
( ( O
AgMV NNP O
) ) O
and CC O
Hordeum NNP O
mosaic VBP O
virus NN O
( ( O
HoMV NNP O
) ) O
were VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

Several JJ O
cytokines NNS O
exhibit VBP O
a DT O
high JJ O
degree NN O
of IN O
temporal JJ O
regulation NN O
as RB O
well RB O
as IN O
somnogenic JJ O
potency NN O
( ( O
e NN O
. . O
g NN O
. . O
, , O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
[ NN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
] NN O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
[ NN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
] NN O
) ) O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
protein JJ O
product NN O
of IN O
the DT O
ref NN B-Gene
- : I-Gene
1 CD I-Gene
gene NN I-Gene
stimulates VBZ O
the DT O
DNA NN O
binding VBG O
activity NN O
of IN O
Fos NNP B-Gene
- : O
Jun NN B-Gene
heterodimers NNS O
, , O
Jun NNP B-Gene
- : O
Jun NN B-Gene
homodimers NNS O
and CC O
Hela NNP O
cell NN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
as RB O
well RB O
as IN O
that DT O
of IN O
several JJ O
other JJ O
transcription NN O
factors NNS O
including VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
Myb NNP B-Gene
and CC O
members NNS O
of IN O
the DT O
ATF NNP B-Gene
/ NNP O
CREB NNP B-Gene
family NN O
. . O

The DT O
human JJ O
T NNP O
cell NN O
lymphotropic NN O
retrovirus NN O
type NN O
I PRP O
( ( O
HTLV NNP O
- : O
I PRP O
) ) O
trans VBZ O
- : O
activator NN O
, , O
Tax NNP B-Gene
, , O
interacts VBZ O
specifically RB O
with IN O
the DT O
basic JJ B-Gene
- : I-Gene
domain NN I-Gene
/ JJ I-Gene
leucine NN I-Gene
- : I-Gene
zipper NN I-Gene
( ( I-Gene
bZip NN I-Gene
) ) I-Gene
protein NN I-Gene
, , O
cAMP JJ B-Gene
response NN I-Gene
element NN I-Gene
binding VBG I-Gene
protein NN I-Gene
( ( O
CREB NNP B-Gene
) ) O
, , O
bound UH O
to TO O
the DT O
viral JJ B-Gene
Tax NNP I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
consisting NN O
of IN O
three CD O
imperfect JJ O
21 CD O
- : O
base NN O
pair NN O
repeats NNS O
, , O
each DT O
with IN O
a DT O
cAMP NN O
response NN O
element NN O
core NN O
flanked VBN O
by IN O
G NNP O
/ NNP O
C NNP O
- : O
rich JJ O
sequences NNS O
. . O

The DT O
tryptase NN B-Gene
locus NN I-Gene
also RB O
contains VBZ O
at IN O
least JJS O
four CD O
tryptase NN B-Gene
- : I-Gene
like IN I-Gene
pseudogenes NNS I-Gene
, , O
including VBG O
mastin NN B-Gene
, , O
a DT O
gene NN O
expressed VBN O
in IN O
dogs NNS O
but CC O
not RB O
in IN O
humans NNS O
. . O

The DT O
highly RB O
restrained JJ O
girls NNS O
had VBD O
a DT O
significantly RB O
higher JJR O
EAT NNP O
score RBR O
than IN O
the DT O
low JJ O
- : O
restrained VBN O
girls NNS O
, , O
and CC O
shared VBN O
with IN O
their PRP$ O
mothers NNS O
a DT O
susceptibility NN O
to TO O
the DT O
disinhibitory JJ O
effects NNS O
of IN O
negative JJ O
mood NN O
states NNS O
on IN O
their PRP$ O
eating JJ O
behaviour NN O
. . O

Despite IN O
these DT O
limitations NNS O
the DT O
CHIME NNP O
monitor NN O
provides VBZ O
an DT O
opportunity NN O
to TO O
record VB O
physiological JJ O
data NNS O
previously RB O
unavailable JJ O
in IN O
the DT O
home NN O
. . O

With IN O
regard NN O
to TO O
the DT O
optimal JJ O
threshold NN O
values NNS O
, , O
sensitivity NN O
and CC O
specificity NN O
were VBD O
100 CD O
% NN O
/ JJ O
97 CD O
% NN O
and CC O
95 CD O
% NN O
/ JJ O
95 CD O
% NN O
with IN O
FDG NNP O
PET NNP O
, , O
compared VBN O
to TO O
86 CD O
% NN O
/ JJ O
92 CD O
% NN O
and CC O
77 CD O
% NN O
/ JJ O
82 CD O
% NN O
with IN O
IS NNP O
, , O
respectively RB O
. . O

The DT O
effects NNS O
of IN O
mean JJ O
luminance NN O
were VBD O
also RB O
measured VBN O
and CC O
a DT O
general JJ O
expression NN O
that WDT O
would MD O
take VB O
them PRP O
into IN O
account NN O
was VBD O
derived VBN O
. . O

RESULTS NN O
: : O
Soluble JJ O
CD23 NN B-Gene
levels NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
women NNS O
with IN O
endometriosis NN O
before IN O
treatment NN O
than IN O
in IN O
ten JJ O
normal JJ O
controls NNS O
. . O

The DT O
second JJ O
class NN O
of IN O
cDNA NN O
hybridized VBN O
to TO O
a DT O
13 CD O
kb NN O
transcript NN O
, , O
which WDT O
was VBD O
approximately RB O
twice RB O
as RB O
large JJ O
as IN O
the DT O
mammalian JJ B-Gene
lactase NN I-Gene
mRNA NN I-Gene
. . O

In IN O
contrast NN O
, , O
c SYM B-Gene
- : I-Gene
Src NNP I-Gene
- : I-Gene
derived VBN I-Gene
construct NN I-Gene
( ( O
a DT B-Gene
- : I-Gene
Src NN I-Gene
) ) O
, , O
that WDT O
was VBD O
excluded VBN O
from IN O
detergent NN O
- : O
resistant JJ O
membranes NNS O
, , O
could MD O
not RB O
restore VB O
the DT O
series NN O
of IN O
phagocytosis NN O
signaling NN O
. . O

These DT O
sorting VBG B-Gene
nexins NNS I-Gene
also RB O
associated VBN O
with IN O
the DT O
long JJ O
isoform NN O
of IN O
the DT O
leptin JJ B-Gene
receptor NN I-Gene
but CC O
not RB O
with IN O
the DT O
short JJ O
and CC O
medium JJ O
isoforms NNS O
. . O

The DT O
repetitive JJ O
ETn NNP B-Gene
( ( O
early JJ B-Gene
transposon NN I-Gene
) ) O
family NN O
of IN O
sequences NNS O
represents VBZ O
an DT O
active JJ O
"""" NN O
mobile JJ O
mutagen NN O
"""" NN O
in IN O
the DT O
mouse NN O
genome NN O
. . O

Therefore RB O
, , O
we PRP O
studied VBD O
ninety JJ O
coagulopathic JJ O
patients NNS O
with IN O
the DT O
aim NN O
of IN O
determining VBG O
the DT O
prevalence NN O
of IN O
hepatitis NN B-Gene
C NNP I-Gene
virus NN I-Gene
( ( I-Gene
HCV NNP I-Gene
) ) I-Gene
antibodies VBZ I-Gene
using VBG O
the DT O
ELISA NNP O
and CC O
RIBA NNP O
methods NNS O
. . O

The DT O
possible JJ O
origin NN O
and CC O
role NN O
of IN O
CSF NNP B-Gene
prolactin NN I-Gene
are VBP O
discussed VBN O
. . O

Infectious JJ O
mutant JJ O
virus NN O
progeny NN O
was VBD O
obtained VBN O
only RB O
on IN O
complementing VBG O
gK JJ B-Gene
- : O
expressing VBG O
cells NNS O
, , O
suggesting VBG O
that IN O
gK NN B-Gene
has VBZ O
an DT O
important JJ O
function NN O
in IN O
the DT O
replication NN O
cycle NN O
. . O

However RB O
, , O
we PRP O
did VBD O
detect VB O
lot NN O
- : O
to TO O
- : O
lot NN O
variation NN O
and CC O
differences NNS O
in IN O
performance NN O
between IN O
narrow JJ O
bandpass NN O
and CC O
wide JJ O
bandpass NN O
spectrophotometers NNS O
. . O

BCR NNP B-Gene
cross SYM O
- : O
linking NN O
also RB O
led VBD O
to TO O
increased VBN O
MAPK NNP B-Gene
- : O
activated VBD O
protein JJ B-Gene
kinase NNP I-Gene
- : I-Gene
2 CD I-Gene
activity NN O
, , O
an DT O
enzyme NN O
that WDT O
lies VBZ O
immediately RB O
downstream NN O
from IN O
p38 JJ B-Gene
MAPK NNP I-Gene
; : O
MAPK NNP B-Gene
- : O
activated VBD O
protein JJ B-Gene
kinase NNP I-Gene
- : I-Gene
2 CD I-Gene
immune NN O
complexes NNS O
phosphorylated VBD O
a DT O
peptide JJ O
substrate NN O
containing VBG O
the DT O
CREB NNP B-Gene
serine NN I-Gene
133 CD I-Gene
phosphoacceptor NN I-Gene
motif NN I-Gene
. . O

These DT O
experiments NNS O
confirm VBP O
that IN O
the DT O
6 CD O
- : O
S NN O
liganded VBD O
form NN O
of IN O
the DT O
receptor NN O
identified VBN O
in IN O
nuclear JJ O
extracts NNS O
of IN O
cells NNS O
treated VBN O
with IN O
2 CD O
, , O
3 CD O
, , O
7 CD O
, , O
8 CD O
- : O
tetrachlorodibenzo NN O
- : O
p NN O
- : O
dioxin NN O
( ( O
TCDD NNP O
) ) O
contains VBZ O
the DT O
Ah NNP B-Gene
receptor NN I-Gene
protein NN I-Gene
and CC O
ARNT NNP B-Gene
but CC O
not RB O
the DT O
90 CD B-Gene
- : I-Gene
kDa NN I-Gene
heat NN I-Gene
shock NN I-Gene
protein NN I-Gene
. . O

Particularly RB O
striking NN O
was VBD O
the DT O
conservation NN O
of IN O
an DT O
AP NNP B-Gene
- : I-Gene
4 CD I-Gene
binding NN I-Gene
site NN I-Gene
within IN O
100 CD O
nucleotides NNS O
upstream NN O
of IN O
the DT O
transcription NN O
initiation NN O
site NN O
in IN O
both DT O
Aal NNP B-Gene
- : O
rpL34 NN B-Gene
and CC O
Aal NNP B-Gene
- : O
rpL8 NN B-Gene
genes NNS O
. . O

Despite IN O
considerable JJ O
research NN O
, , O
an DT O
explanation NN O
of IN O
this DT O
effect NN O
has VBZ O
been VBN O
elusive JJ O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
transiently RB O
expressed VBD O
in IN O
primary JJ O
cultures NNS O
of IN O
rat NN O
hepatocytes NNS O
plasmids VBP O
consisting VBG O
of IN O
CYP3A1 NNP B-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
flanking NN I-Gene
sequences NNS I-Gene
fused VBD O
to TO O
a DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
reporter NN I-Gene
plasmid NN O
. . O

Based VBN O
on IN O
these DT O
results NNS O
and CC O
because IN O
Cdc68 NNP B-Gene
has VBZ O
been VBN O
implicated VBN O
as IN O
a DT O
regulator NN O
of IN O
chromatin NN O
structure NN O
, , O
we PRP O
postulate VBP O
that IN O
polymerase NN B-Gene
alpha NN I-Gene
may MD O
interact VB O
with IN O
these DT O
proteins NNS O
to TO O
gain VB O
access NN O
to TO O
its PRP$ O
template NN O
or CC O
to TO O
origins NNS O
of IN O
replication NN O
in IN O
vivo NN O
. . O

Then RB O
, , O
pure NN O
pancreatic JJ O
juice NN O
was VBD O
infused VBN O
into IN O
the DT O
duodenum NN O
. . O

Encompassing VBG O
tamponade NN O
and CC O
pericardiocentesis NN O
data NNS O
, , O
left VBD O
ventricular JJ O
stroke NN O
work NN O
index NN O
showed VBD O
positive JJ O
correlation NN O
with IN O
TMFP1 NNP O
( ( O
r NN O
= NNP O
. . O
59 CD O
) ) O
and CC O
TMFP2 NNP O
( ( O
r NN O
= NNP O
. . O
52 CD O
) ) O
but CC O
not RB O
with IN O
TMFP3 NNP O
. . O

Truncations NNS O
composed VBD O
of IN O
78 CD O
and CC O
64 CD O
amino NN O
acids NNS O
were VBD O
translocated VBN O
across IN O
the DT O
endoplasmic JJ O
reticulum NN O
membrane NN O
, , O
and CC O
translocation NN O
was VBD O
found VBN O
to TO O
be VB O
strictly RB O
co JJ O
- : O
translational NN O
and CC O
SRP NNP B-Gene
- : O
dependent NN O
. . O

We PRP O
show VBP O
that IN O
cytR JJ B-Gene
expression NN O
is VBZ O
negatively RB O
controlled VBN O
by IN O
the DT O
CytR NNP B-Gene
protein NN I-Gene
and CC O
positively RB O
affected VBN O
by IN O
the DT O
cAMP NN B-Gene
/ JJ I-Gene
CAP NNP I-Gene
complex NN I-Gene
. . O

Plasmids NNS O
for IN O
the DT O
cloning NN O
and CC O
expression NN O
of IN O
full JJ O
- : O
length NN O
double JJ O
- : O
stranded VBD O
cDNAs JJ O
under IN O
control NN O
of IN O
the DT O
SV40 NNP B-Gene
early JJ I-Gene
or CC O
late JJ B-Gene
gene NN I-Gene
promoter NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
3 CD O
' POS O
- : O
end NN O
- : O
adjacent JJ O
sequence NN O
CA NNP O
( ( O
N NNP O
) ) O
3 CD O
- : O
10AGTNNAA CD O
, , O
conserved VBN O
in IN O
plant NN O
Pol NNP B-Gene
II NNP I-Gene
- : O
specific JJ O
U NNP B-Gene
snRNA NN I-Gene
genes NNS I-Gene
, , O
is VBZ O
essential JJ O
for IN O
the DT O
3 CD O
' POS O
- : O
end NN O
formation NN O
of IN O
U2 NNP B-Gene
transcripts NNS I-Gene
and CC O
, , O
similar JJ O
to TO O
the DT O
vertebrate NN O
3 CD O
' '' O
box NN O
, , O
is VBZ O
highly RB O
tolerant JJ O
to TO O
mutation NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
in IN O
experiments NNS O
in IN O
vitro NN O
that IN O
the DT O
hepatotrophic JJ O
organic JJ O
anions NNS O
, , O
the DT O
radiographic JJ O
contrast NN O
agent NN O
( ( O
RCA NNP O
) ) O
bilignost NN O
used VBN O
in IN O
cholecystography NN O
and CC O
Bengal NNP O
pink VBP O
, , O
have VBP O
an DT O
affinity NN O
, , O
unlike IN O
the DT O
urographic JJ O
RCA NNP O
triombrin NN O
and CC O
renotrophic JJ O
dye NN O
indigo SYM O
- : O
carmine NN O
, , O
for IN O
the DT O
plasmatic JJ O
membranes NNS O
( ( O
PM NNP O
) ) O
of IN O
liver NN O
cells NNS O
. . O

Factors NNS O
influencing VBG O
semen NNS O
characteristics NNS O
in IN O
young JJ O
boars NNS O
reared VBN O
in IN O
a DT O
subtropical JJ O
environment NN O
were VBD O
studied VBN O
. . O

Interestingly RB O
, , O
we PRP O
find VBP O
that IN O
the DT O
interaction NN O
between IN O
Tat NNP B-Gene
and CC O
hCycT1 NN B-Gene
requires VBZ O
zinc NN O
as RB O
well RB O
as IN O
essential JJ O
cysteine NN O
residues NNS O
in IN O
both DT O
proteins NNS O
. . O

Both DT O
mutations NNS O
confer VBP O
amino JJ O
acid JJ O
substitutions NNS O
in IN O
the DT O
viral JJ B-Gene
coat NN I-Gene
protein NN I-Gene
but CC O
differ VBP O
in IN O
their PRP$ O
relative JJ O
abilities NNS O
to TO O
utilize VB O
the DT O
foreign JJ O
scaffolding NN B-Gene
protein NN I-Gene
. . O

Although IN O
the DT O
spatial JJ O
and CC O
temporal JJ O
variability NN O
of IN O
LDF NNP O
signals NNS O
evoked VBN O
by IN O
cerebrocortical JJ O
microflow NN O
is VBZ O
in IN O
the DT O
same JJ O
range NN O
as IN O
with IN O
other JJ O
methods NNS O
and CC O
in IN O
other JJ O
organs NNS O
, , O
LDF NNP O
cerebrocortical JJ O
mapping NN O
is VBZ O
restricted VBN O
by IN O
the DT O
large JJ O
temporal JJ O
and CC O
spatial JJ O
heterogeneity NN O
of IN O
the DT O
cerebrocortical JJ O
vasculature NN O
. . O

Statistically RB O
significant JJ O
effects NNS O
were VBD O
noted VBN O
at IN O
doses NNS O
which WDT O
did VBD O
not RB O
appear VB O
to TO O
be VB O
maternally RB O
toxic JJ O
. . O

To TO O
address VB O
this DT O
issue NN O
, , O
the DT O
gene NN O
for IN O
factor NN B-Gene
Y NNP I-Gene
has VBZ O
been VBN O
cloned VBN O
molecularly RB O
and CC O
its PRP$ O
DNA NN O
sequence NN O
has VBZ O
been VBN O
determined VBN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
Hh NNP B-Gene
and CC O
Patched NNP B-Gene
( ( O
Ptc NNP B-Gene
) ) O
act NN O
through IN O
those DT O
Ci NNP B-Gene
binding VBG O
sites NNS O
to TO O
modulate VB O
the DT O
level NN O
of IN O
Ci NNP B-Gene
- : O
dependent JJ O
transcriptional JJ O
activation NN O
in IN O
S2 NNP O
cells NNS O
. . O

To TO O
investigate VB O
the DT O
convergent JJ O
role NN O
of IN O
the DT O
insulin NN B-Gene
/ NNP O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
effector VBP O
pathway RB O
mediating VBG O
bihormonal JJ O
stimulation NN O
of IN O
LDL NNP B-Gene
receptor NN I-Gene
promoter NN I-Gene
expression NN O
, , O
transfected VBD O
granulosa SYM O
- : O
luteal NN O
cells NNS O
were VBD O
pretreated VBN O
for IN O
30 CD O
min NNS O
with IN O
two CD O
specific JJ O
inhibitors NNS O
of IN O
phophatidylinositol NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
, , O
wortmannin NN O
( ( O
100 CD O
nM NN O
) ) O
and CC O
LY $ O
294002 CD O
( ( O
10 CD O
microM NN O
) ) O
, , O
or CC O
of IN O
mitogen JJ B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
, , O
PD NNP O
98059 CD O
( ( O
50 CD O
microM NN O
) ) O
, , O
U0126 NNP O
( ( O
10 CD O
microM NN O
) ) O
, , O
or CC O
the DT O
latter JJ O
' POS O
s NNS O
inactive VBP O
derivative JJ O
, , O
U0124 NNP O
( ( O
10 CD O
microM NN O
) ) O
. . O

We PRP O
suggest VBP O
that IN O
this DT O
gene NN O
cluster NN O
codes NNS O
for IN O
( ( O
parts NNS O
of IN O
) ) O
a DT O
multisubunit NN B-Gene
cytochrome JJ I-Gene
c NN I-Gene
haem NN I-Gene
lyase NN I-Gene
. . O

In IN O
sorted VBN O
bone NN O
marrow NN O
cells NNS O
expression NN O
of IN O
both DT O
VpreB NNP B-Gene
genes NNS I-Gene
was VBD O
detected VBN O
in IN O
pro JJ O
- : O
B NN O
/ NN O
pre NN O
- : O
BI NNP O
and CC O
large JJ O
pre NN O
- : O
BII NNP O
cells NNS O
, , O
while IN O
the DT O
RNA NNP O
steady JJ O
state NN O
levels NNS O
were VBD O
at IN O
least JJS O
100 CD O
- : O
fold NN O
lower RBR O
in IN O
small JJ O
pre NN O
- : O
BII NNP O
and CC O
immature NN O
/ NNP O
mature NN O
B NNP O
cells NNS O
. . O

High JJ O
expression NN O
of IN O
the DT O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( O
PPARalpha NNP B-Gene
) ) O
differentiates VBZ O
brown JJ O
fat NN O
from IN O
white JJ O
, , O
and CC O
is VBZ O
related VBN O
to TO O
its PRP$ O
high JJ O
capacity NN O
of IN O
lipid JJ O
oxidation NN O
. . O

We PRP O
further VBP O
found VBD O
that IN O
KmMig1p NNP B-Gene
is VBZ O
fully RB O
functional JJ O
when WRB O
expressed VBN O
in IN O
S NNP O
. . O
cerevisiae NN O
. . O

The DT O
authors NNS O
conclude VBP O
that IN O
nonspecificity NN O
of IN O
low JJ O
platelet NN B-Gene
MAO NNP I-Gene
as IN O
a DT O
possible JJ O
correlate NN O
of IN O
bipolar JJ O
affective JJ O
disorder NN O
, , O
as RB O
well RB O
as IN O
schizophrenia NN O
, , O
increases VBZ O
the DT O
burden NN O
of IN O
proof NN O
necessary JJ O
before IN O
findings NNS O
of IN O
low JJ O
platelet NN B-Gene
MAO NNP I-Gene
can MD O
be VB O
accepted VBN O
as IN O
primary JJ O
. . O

The DT O
diagnostic JJ O
significance NN O
of IN O
creatine JJ B-Gene
phosphokinase NN I-Gene
antibodies NNS O
in IN O
the DT O
cardiac JJ O
muscle NN O
in IN O
non JJ O
- : O
coronarogenic JJ O
myocardial NN O
diseases NNS O

The DT O
modification NN O
of IN O
P32 NNP O
uptake VBP O
into IN O
the DT O
Jensen NNP O
sarcoma NN O
in IN O
vitro NN O
by IN O
adding VBG O
of IN O
peroxide NN O
to TO O
the DT O
nutritive JJ O
medium NN O

This DT O
finding NN O
is VBZ O
consistent JJ O
with IN O
the DT O
notion NN O
that IN O
the DT O
dsRNA NN O
binding NN O
domains NNS O
may MD O
be VB O
composed VBN O
of IN O
two CD O
separate JJ O
functional JJ O
subdomains NNS O
. . O

We PRP O
have VBP O
previously RB O
identified VBN O
a DT O
liver NN O
- : O
enriched VBN O
transcription NN O
factor NN O
, , O
HNF NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
which WDT O
is VBZ O
required VBN O
for IN O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
promoter NN I-Gene
activity NN O
and CC O
also RB O
recognizes VBZ O
the DT O
regulatory JJ O
region NN O
of IN O
numerous JJ O
hepatocyte NN O
- : O
specific JJ O
genes NNS O
. . O

A DT O
- : O
69 CD O
- : O
year NN O
- : O
old JJ O
patient NN O
with IN O
postoperative JJ O
small JJ O
- : O
bowel NN O
obstruction NN O
underwent JJ O
laparotomy NN O
three CD O
times NNS O
. . O

This DT O
sensitivity NN O
analysis NN O
showed VBD O
that IN O
the DT O
practical JJ O
limits NNS O
of IN O
the DT O
accuracy NN O
of IN O
the DT O
used JJ O
screening NN O
test NN O
jeopardize NN O
the DT O
estimation NN O
of IN O
the DT O
true JJ O
herd NN O
prevalence NN O
within IN O
reasonable JJ O
confidence NN O
limits NNS O
, , O
because IN O
the DT O
within IN O
- : O
herd NN O
PTB NNP O
true JJ O
prevalence NN O
was VBD O
low JJ O
. . O
For IN O
this DT O
reason NN O
we PRP O
augmented VBD O
the DT O
herd NN O
specificity NN O
for IN O
herds NNS O
with IN O
larger JJR O
adult NN O
herd NN O
size NN O
( ( O
> $ O
5 CD O
) ) O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
Shh NNP B-Gene
can MD O
drive VB O
continued JJ O
cycling NN O
in IN O
immature NN O
, , O
proliferating VBG O
CGNPs NNP O
. . O

We PRP O
determined VBD O
whether IN O
regional JJ O
myocardial JJ O
work NN O
efficiency NN O
( ( O
segment NN O
work NN O
/ NNP O
regional JJ O
O2 NNP O
consumption NN O
) ) O
would MD O
be VB O
elevated VBN O
by IN O
surgically RB O
- : O
augmented VBN O
inflow NN O
. . O

Discrepant JJ O
results NNS O
with IN O
a DT O
latex JJ O
agglutination NN O
test NN O
in IN O
the DT O
assessment NN O
of IN O
cytomegalovirus NN O
antibody NN O
status NN O
of IN O
cardiac JJ O
transplant NN O
donors NNS O
. . O

We PRP O
also RB O
show VBP O
that IN O
zygotically RB O
activated VBN O
Xretpos NN O
transcripts NNS O
are VBP O
restricted VBN O
to TO O
ventro VB O
- : O
posterior NN O
specific JJ O
regions NNS O
and CC O
induced VBN O
by IN O
UV NNP O
- : O
irradiation NN O
and CC O
BMP NNP B-Gene
- : I-Gene
4 CD I-Gene
overexpression NN O
in IN O
cycloheximide JJ O
- : O
dependent JJ O
way NN O
. . O
genesis NN O
26 CD O
: : O
198 CD O
- : O
207 CD O
, , O
2000 CD O
. . O

The DT O
direct JJ O
effects NNS O
of IN O
transmitter NN O
release NN O
were VBD O
( ( O
a DT O
) ) O
an DT O
early JJ O
fall NN O
in IN O
MAP NNP O
followed VBN O
by IN O
a DT O
late JJ O
pressor NN O
effect NN O
; : O
and CC O
( ( O
b NN O
) ) O
an DT O
early JJ O
bradycardia NN O
followed VBN O
by IN O
a DT O
late JJ O
tachycardia NN O
. . O

Acad NNP O
. . O

Study NN O
of IN O
the DT O
alterations NNS O
of IN O
intestinal JJ O
absorption NN O
, , O
by IN O
means NNS O
of IN O
I PRP O
- : O
131 CD O
- : O
triolein NN O
, , O
in IN O
the DT O
whole JJ O
body NN O
irradiated VBD O
rat NN O

NB NNP O
- : O
506 CD O
completely RB O
inhibits VBZ O
the DT O
capacity NN O
of IN O
topoisomerase NN B-Gene
I PRP I-Gene
to TO O
phosphorylate VB O
, , O
in IN O
vitro NN O
, , O
the DT O
human JJ B-Gene
splicing VBG I-Gene
factor NN I-Gene
2 CD I-Gene
/ JJ O
alternative JJ B-Gene
splicing NN I-Gene
factor NN I-Gene
( ( O
SF2 NNP B-Gene
/ NNP O
ASF NNP B-Gene
) ) O
. . O

The DT O
dominant JJ O
negative JJ O
mutant NN O
of IN O
SHP NNP B-Gene
- : I-Gene
2 CD I-Gene
was VBD O
found VBN O
to TO O
inhibit VB O
the DT O
induction NN O
of IN O
tyrosine JJ O
phosphorylation NN O
and CC O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
m NN B-Gene
- : I-Gene
Stat5a NNP I-Gene
, , O
m SYM B-Gene
- : I-Gene
Stat5b NN I-Gene
, , O
and CC O
the DT O
carboxyl NN O
- : O
terminal JJ O
deletion NN O
variant NN O
m SYM B-Gene
- : I-Gene
Stat5adelta749 NN I-Gene
, , O
as RB O
well RB O
as IN O
the DT O
transactivation NN O
potential NN O
of IN O
m JJ B-Gene
- : I-Gene
Stat5a NN I-Gene
and CC O
m SYM B-Gene
- : I-Gene
Stat5b NN I-Gene
. . O

MSMS NNP O
Council NNP O
hears VBZ O
new JJ O
public JJ O
health NN O
director NN O
. . O

During IN O
the DT O
first JJ O
3 CD O
min NN O
of IN O
recovery NN O
, , O
plasma JJ O
potassium NN O
fell VBD O
rapidly RB O
in IN O
spite NN O
of IN O
nearly RB O
unchanged JJ O
blood NN O
acidosis NN O
and CC O
significantly RB O
decreasing VBG O
bicarbonate JJ O
concentration NN O
. . O

Alkoxymetgyl NNP O
- : O
3 CD O
, , O
4 CD O
- : O
dimethylpyridinium NN O
chlorides NNS O
were VBD O
synthetized VBN O
by IN O
reacting VBG O
3 CD O
, , O
4 CD O
- : O
dimethylpyridine NN O
with IN O
chloromethyl JJ O
alkyl NN O
ethers NNS O
, , O
while IN O
1 CD O
- : O
ethyloxymethyl NN O
- : O
3 CD O
- : O
alkylthiomethylimidazolium NN O
chlorides NNS O
were VBD O
obtained VBN O
in IN O
reactions NNS O
of IN O
1 CD O
- : O
ethyloxymethylimidazol NN O
with IN O
chloromethyl JJ O
alkyl NN O
sulfides NNS O
. . O

The DT O
properties NNS O
of IN O
the DT O
phi NN O
29 CD O
SSB NNP B-Gene
- : I-Gene
ssDNA NN I-Gene
complex NN O
are VBP O
described VBN O
. . O

There EX O
were VBD O
35 CD O
boys NNS O
and CC O
15 CD O
girls NNS O
, , O
with IN O
a DT O
mean JJ O
age NN O
of IN O
five CD O
and CC O
a DT O
half JJ O
years NNS O
. . O

Oligonucleotide IN O
mutagenesis NN O
of IN O
these DT O
binding VBG O
domains NNS O
indicated VBD O
their PRP$ O
importance NN O
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
E3 NNP B-Gene
promoter NN I-Gene
in IN O
yeast NN O
cells NNS O
. . O

Routine JJ O
blood NN O
examination NN O
showed VBD O
leukocytosis NN O
, , O
thrombocytopenia NN O
, , O
positive JJ O
CRP NNP B-Gene
, , O
and CC O
elevated VBD O
myocardial JJ O
enzymes NNS O
. . O

If IN O
E NNP O
. . O
coli NN O
is VBZ O
present JJ O
in IN O
any DT O
source NN O
water NN O
sample NN O
, , O
the DT O
borehole NN O
and CC O
any DT O
directly RB O
connected VBN O
borehole NN O
should MD O
be VB O
embargoed VBN O
. . O

A DT O
215 CD O
- : O
base NN O
- : O
pair NN O
( ( O
bp NN O
) ) O
region NN O
of IN O
the DT O
mouse NN B-Gene
MOPC NNP I-Gene
41 CD I-Gene
kappa NN I-Gene
light JJ I-Gene
- : I-Gene
chain NN I-Gene
immunoglobulin JJ I-Gene
gene NN I-Gene
enhancer NN I-Gene
has VBZ O
been VBN O
analyzed VBN O
for IN O
specific JJ O
binding NN O
of IN O
lymphoid NN O
and CC O
nonlymphoid JJ O
nuclear JJ O
factors NNS O
. . O

There EX O
are VBP O
two CD O
immunogenic JJ O
sites NNS O
on IN O
the DT O
type NN O
A NNP O
influenza NN O
A NNP O
/ NNP O
Japan NNP O
/ VBD O
57 CD O
( ( O
H2N2 NNP O
) ) O
hemagglutinin NN B-Gene
( ( O
HA NNP B-Gene
) ) O
that WDT O
can MD O
be VB O
recognized VBN O
by IN O
class NN B-Gene
I PRP I-Gene
major JJ I-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( O
MHC NNP B-Gene
) ) O
, , O
H NNP B-Gene
- : I-Gene
2Kd CD I-Gene
- : O
restricted VBN O
cytolytic JJ O
T NNP O
lymphocytes NNS O
( ( O
CTLs NNP O
) ) O
. . O

Therefore RB O
, , O
in IN O
conjunction NN O
with IN O
a DT O
positive JJ O
pregnancy NN O
test NN O
and CC O
the DT O
patient NN O
' POS O
s JJ O
clinical JJ O
history NN O
, , O
a DT O
severely RB O
depressed JJ O
or CC O
absent JJ O
serum NN O
PAPP NNP B-Gene
- : I-Gene
A DT I-Gene
level NN O
may MD O
aid VB O
in IN O
the DT O
diagnosis NN O
of IN O
extrauterine JJ O
pregnancy NN O
. . O

In IN O
line NN O
with IN O
the DT O
small JJ O
values NNS O
for IN O
QS NNP O
/ NNP O
QC NNP O
, , O
our PRP$ O
results NNS O
further RBR O
indicate VBP O
that IN O
even RB O
large JJ O
, , O
well RB O
- : O
perfused VBN O
, , O
occluded VBD O
air NN O
spaces NNS O
in IN O
the DT O
lung NN O
will MD O
hardly RB O
affect VB O
the DT O
recovered JJ O
ventilation NN O
/ NNP O
perfusion NN O
distribution NN O
obtained VBN O
from IN O
inert JJ O
gas NN O
data NNS O
when WRB O
CDCSF6 NNP O
exceeds VBZ O
0 CD O
. . O
1 CD O
ml NN O
. . O
min SYM O
- : O
1 CD O
. . O
mmHg VB O
- : O
1 CD O
. . O

The DT O
limits NNS O
of IN O
agreement NN O
between IN O
DBS NNP O
and CC O
TOF NNP O
responses NNS O
were VBD O
so RB O
wide JJ O
that IN O
they PRP O
cannot VBP O
be VB O
used VBN O
interchangeably RB O
. . O

The DT O
micromethod NN O
uses VBZ O
microcuvettes NNS O
and CC O
substitutes NNS O
ferrozine VBP O
for IN O
the DT O
bathophenanthroline NN O
chromogen NN O
of IN O
the DT O
ICSH NNP O
. . O

The DT O
BFA NNP O
System NNP O
reads VBZ O
a DT O
text NN O
file NN O
with IN O
flows NNS O
, , O
measured VBN O
with IN O
fluorescent NN O
microsphere NN O
technique NN O
, , O
and CC O
constructs VBZ O
the DT O
lung NN O
anatomy NN O
with IN O
volumetric JJ O
pixels NNS O
showing VBG O
the DT O
flows NNS O
with IN O
a DT O
color NN O
schema NN O
. . O

Clinico NNP O
- : O
physiological JJ O
experiment NN O

The DT O
N1 NNP O
and CC O
P2 NNP O
were VBD O
comparable JJ O
in IN O
amplitude NN O
and CC O
both DT O
had VBD O
prolonged VBN O
refractory NN O
periods NNS O
. . O

Calcinosis NNP O
cutis NN O
following VBG O
intravenous JJ O
infusion NN O
of IN O
calcium NN O
gluconate NN O
. . O

No DT O
dominant JJ O
clinical JJ O
factor NN O
of IN O
risk NN O
was VBD O
found VBN O
, , O
but CC O
multiple JJ O
regression NN O
analysis NN O
identified VBN O
age NN O
, , O
body NN O
surface JJ O
area NN O
, , O
valve FW O
size NN O
, , O
shop NN O
order NN O
fracture NN O
rate NN O
, , O
and CC O
manufacturing VBG O
period NN O
as IN O
risk NN O
factors NNS O
for IN O
OSF NNP O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
effect NN O
of IN O
the DT O
isomers NNS O
of IN O
pentobarbital NN O
and CC O
secobarbital NN O
on IN O
mult NN O
FR30 NNP O
FI600 NNP O
responding VBG O
and CC O
on IN O
suppressed JJ O
responding NN O
are VBP O
qualitatively RB O
similar JJ O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

MutY NNP B-Gene
is VBZ O
an DT O
adenine JJ B-Gene
- : I-Gene
DNA NN I-Gene
glycosylase NN I-Gene
with IN O
specificity NN O
for IN O
mismatches NNS O
involving VBG O
8 CD O
- : O
oxoguanine NN O
( ( O
oG UH O
. . O
A DT O
) ) O
or CC O
guanine NN O
( ( O
G NNP O
. . O
A DT O
) ) O
. . O

Kss1 NNP B-Gene
binds VBZ O
specifically RB O
to TO O
a DT O
GST NNP B-Gene
- : O
Dig1 NNP B-Gene
fusion NN O
in IN O
the DT O
absence NN O
of IN O
any DT O
other JJ O
yeast NN O
protein NN O
. . O

Also RB O
, , O
the DT O
deduced JJ O
amino NN O
acids NNS O
of IN O
the DT O
antigenic JJ B-Gene
regions NNS I-Gene
A NNP I-Gene
, , I-Gene
B NNP I-Gene
and CC I-Gene
C NNP I-Gene
of IN I-Gene
VP7 NNP I-Gene
were VBD O
nearly RB O
conserved VBN O
within IN O
the DT O
phylogenetic JJ O
lineages NNS O
. . O

Furthermore RB O
, , O
early JJ O
- : O
and CC O
late JJ O
- : O
firing NN O
origins NNS O
differ VBP O
not RB O
in IN O
the DT O
timing NN O
of IN O
their PRP$ O
recruitment NN O
of IN O
an DT O
Mcm NNP B-Gene
protein NN I-Gene
, , O
but CC O
in IN O
the DT O
timing NN O
of IN O
RPA NNP B-Gene
' POS I-Gene
s JJ I-Gene
recruitment NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
Ski NNP B-Gene
is VBZ O
a DT O
component NN O
of IN O
the DT O
HDAC NNP B-Gene
complex NN I-Gene
and CC O
that DT O
Ski NNP B-Gene
is VBZ O
required VBN O
for IN O
the DT O
transcriptional JJ O
repression NN O
mediated VBN O
by IN O
this DT O
complex NN O
. . O

We PRP O
have VBP O
generated VBN O
various JJ O
base NN O
substitutions NNS O
and CC O
internal JJ O
deletions NNS O
in IN O
and CC O
around IN O
DRE NNP O
( ( O
nucleotide JJ O
positions NNS O
- : O
93 CD O
to TO O
- : O
100 CD O
with IN O
respect NN O
to TO O
the DT O
transcription NN O
initiation NN O
site NN O
) ) O
of IN O
the DT O
PCNA NNP B-Gene
gene NN I-Gene
in IN O
vitro NN O
and CC O
subsequently RB O
examined VBD O
their PRP$ O
effects NNS O
on IN O
the DT O
binding NN O
to TO O
DREF NNP B-Gene
( ( O
DRE NNP B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
) ) O
and CC O
PCNA NNP B-Gene
gene NN I-Gene
promote NN O
activity NN O
in IN O
cultured JJ O
Drosophila NNP O
Kc NNP O
cells NNS O
as RB O
well RB O
as IN O
in IN O
living NN O
flies NNS O
. . O

We PRP O
report VBP O
here RB O
that IN O
out IN O
of IN O
the DT O
major JJ O
pro JJ O
- : O
inflammatory NN O
cytokines NNS O
examined VBD O
, , O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
, , O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
, , O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
, , O
only RB O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
was VBD O
generated VBN O
and CC O
secreted VBN O
in IN O
PKCeta NNP B-Gene
- : O
expressing VBG O
cells NNS O
without IN O
any DT O
additional JJ O
inducer NN O
in IN O
serum JJ O
- : O
supplemented VBN O
cultures NNS O
( ( O
10 CD O
% NN O
FCS NNP O
) ) O
. . O

CYC2 NNP B-Gene
encodes VBZ O
a DT O
24 CD O
- : O
kDa NN O
protein NN O
that WDT O
has VBZ O
sequence NN O
identity NN O
to TO O
the DT O
Neurospora NNP B-Gene
crassa NN I-Gene
PREG1 NNP I-Gene
and CC O
the DT O
S NNP B-Gene
. . I-Gene
cerevisiae NN I-Gene
PHO80 NNP I-Gene
cyclin NN I-Gene
. . O

DtxR NNP B-Gene
is VBZ O
an DT O
iron NN O
- : O
dependent JJ O
sequence NN O
- : O
specific JJ O
DNA NNP O
- : O
binding NN O
protein NN O
that WDT O
binds VBZ O
to TO O
the DT O
tox NN B-Gene
operator NN I-Gene
, , O
an DT O
inverted JJ O
- : O
repeat NN O
nucleotide JJ O
sequence NN O
located VBN O
upstream RB O
from IN O
the DT O
diphtheria NN B-Gene
toxin NN I-Gene
gene NN I-Gene
. . O

After IN O
MOPP NNP O
therapy NN O
, , O
complete JJ O
remission NN O
of IN O
Hodgkin NNP O
' POS O
s JJ O
disease NN O
was VBD O
accompanied VBN O
by IN O
normalization NN O
of IN O
the DT O
glucocerebrosidase NN B-Gene
level NN O
and CC O
disappearance NN O
of IN O
Gaucher NNP O
' POS O
s NN O
cells NNS O
. . O

Acute JJ O
appearance NN O
of IN O
hemiparesis NN O
or CC O
hemiplegia NN O
with IN O
initial JJ O
marked JJ O
spasticity NN O
was VBD O
observed VBN O
in IN O
8 CD O
stroke NN O
patients NNS O
. . O

Remarkably RB O
, , O
a DT O
construct NN O
corresponding VBG O
to TO O
residues VB O
631 CD O
to TO O
970 CD O
, , O
which WDT O
contains VBZ O
only RB O
the DT O
LXXLL NNP O
motifs NNS O
and CC O
the DT O
AD1 NNP O
region NN O
of IN O
SRC1 NNP B-Gene
, , O
retained VBD O
strong JJ O
coactivator NN O
activity NN O
in IN O
our PRP$ O
assays NNS O
. . O

Sputum NNP B-Gene
IL NNP I-Gene
- : I-Gene
8 CD I-Gene
and CC O
MPO NNP B-Gene
were VBD O
significantly RB O
increased VBN O
after IN O
BPT NNP O
in IN O
both DT O
TDI NNP O
- : O
and CC O
grain VB O
dust JJ O
- : O
asthma NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

In IN O
14 CD O
of IN O
21 CD O
infant NN O
hearts NNS O
( ( O
66 CD O
% NN O
) ) O
with IN O
aortic JJ O
arch NN O
interruption NN O
between IN O
the DT O
left JJ O
common JJ O
carotid NN O
and CC O
left VBD O
subclavian JJ O
arteries NNS O
( ( O
type NN O
B NNP O
of IN O
Celoria NNP O
and CC O
Patton NNP O
) ) O
, , O
the DT O
right JJ O
subclavian JJ O
artery NN O
( ( O
SA NNP O
) ) O
arose VBD O
anomalously RB O
. . O

The DT O
missing VBG O
5 CD O
' '' O
sequences NNS O
were VBD O
obtained VBN O
by IN O
5 CD O
' POS O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
and CC O
by IN O
analysis NN O
of IN O
an DT O
NHE5 NNP B-Gene
genomic JJ I-Gene
clone NN I-Gene
, , O
and CC O
the DT O
missing VBG O
3 CD O
' '' O
sequences NNS O
were VBD O
obtained VBN O
by IN O
3 CD O
' POS O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
. . O

Cdk2 NNP B-Gene
and CC O
MAPK NNP B-Gene
precipitates NNS O
from IN O
untreated JJ O
tumor NN O
lysates NNS O
phosphorylated VBD O
recombinant JJ B-Gene
wild JJ I-Gene
- : I-Gene
type NN I-Gene
p27 NN I-Gene
but CC O
not RB O
the DT O
T187A NNP O
mutant NN O
in IN O
vitro NN O
. . O

Furthermore RB O
, , O
the DT O
UvrA NNP B-Gene
protein NN I-Gene
interacts VBZ O
with IN O
the DT O
UvrB NNP B-Gene
protein NN I-Gene
to TO O
modulate VB O
its PRP$ O
activities NNS O
, , O
both DT O
in IN O
solution NN O
and CC O
in IN O
association NN O
with IN O
DNA NNP O
, , O
where WRB O
the DT O
UvrAB NNP B-Gene
complex JJ I-Gene
possesses VBZ O
a DT O
helicase NN B-Gene
activity NN O
. . O

SIT NNP B-Gene
( ( O
SHP2 NNP B-Gene
- : I-Gene
interacting VBG I-Gene
transmembrane NN I-Gene
adaptor NN I-Gene
protein NN I-Gene
) ) O
is VBZ O
a DT O
recently RB O
identified VBN O
transmembrane NN O
adaptor NN O
protein NN O
, , O
which WDT O
is VBZ O
expressed VBN O
in IN O
lymphocytes NNS O
. . O

In IN O
PC12 NNP O
cells NNS O
, , O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
induces VBZ O
neuronal JJ O
differentiation NN O
and CC O
repressed JJ O
expression NN O
of IN O
nrg JJ B-Gene
- : I-Gene
1 CD I-Gene
. . O

DNA NN O
sequence NN O
analysis NN O
revealed VBD O
that IN O
these DT O
clones NNS O
encode VBD O
two CD O
distinct JJ O
forms NNS O
of IN O
translocase NN B-Gene
. . O

The DT O
median JJ O
age NN O
was VBD O
33 CD O
years NNS O
( ( O
range NN O
17 CD O
- : O
56 CD O
years NNS O
) ) O
. . O

Five CD O
of IN O
the DT O
PDP1 NNP B-Gene
isoforms NNS I-Gene
differ VBP O
by IN O
the DT O
substitution NN O
or CC O
insertion NN O
of IN O
amino JJ O
acids NNS O
at IN O
or CC O
near IN O
the DT O
N NNP O
- : O
terminal NN O
of IN O
the DT O
protein NN O
. . O

These DT O
primers NNS O
yielded VBD O
a DT O
PCR NNP O
product NN O
of IN O
a DT O
characteristic JJ O
length NN O
within IN O
most JJS O
Xanthomonas JJ O
species NNS O
and CC O
pathovars NNS O
tested VBN O
. . O

Using VBG O
a DT O
3 CD O
' POS O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
strategy NN O
, , O
we PRP O
have VBP O
cloned VBN O
cDNAs NNS O
representing VBG O
the DT O
3 CD O
' POS O
- : O
termini NN O
of IN O
both CC O
the DT O
native NN O
and CC O
mutant JJ O
transcripts NNS O
from IN O
both DT O
P388 NNP O
/ NNP O
ADR NNP O
/ NNP O
3 CD O
and CC O
P388 NNP O
/ NNP O
ADR NNP O
/ VBD O
7 CD O
cells NNS O
. . O

BACKGROUND NN O
: : O
Chronic JJ O
alcohol NN O
consumption NN O
has VBZ O
been VBN O
demonstrated VBN O
to TO O
be VB O
deleterious JJ O
to TO O
bone VB O
health NN O
. . O

The DT O
subunit NN B-Gene
- : I-Gene
a DT I-Gene
gene NN I-Gene
is VBZ O
preceded VBN O
by IN O
a DT O
gene NN O
coding VBG O
for IN O
a DT O
small JJ O
hydrophobic NN O
protein NN O
, , O
as IN O
has VBZ O
been VBN O
observed VBN O
previously RB O
in IN O
the DT O
atp JJ B-Gene
operons NNS I-Gene
in IN O
E NNP O
. . O
coli NN O
, , O
bacterium NN O
PS3 NNP O
and CC O
cyanobacteria NN O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
sequences NNS O
in IN O
the DT O
SH2 NNP B-Gene
/ NNP O
SH3 NNP B-Gene
/ NNP O
SH2 NNP B-Gene
region NN O
of IN O
p120 NN B-Gene
GAP NNP B-Gene
are VBP O
required VBN O
for IN O
full JJ O
catalytic JJ O
activity NN O
toward IN O
Ras NNP B-Gene
. . O

The DT O
range NN O
of IN O
200 CD O
0 CD O
- : O
300 CD O
0 CD O
spermatozoa NN O
/ NNP O
microl NN O
appeared VBD O
to TO O
be VB O
a DT O
reasonable JJ O
compromise NN O
for IN O
both DT O
criteria NNS O
. . O

The DT O
effect NN O
of IN O
a DT O
tissue NN O
emulsion NN O
, , O
vitamin FW O
A DT O
and CC O
nonspecific JJ O
gamma NN B-Gene
- : I-Gene
globulin NN I-Gene
on IN O
the DT O
blood NN O
clearance NN O
in IN O
rabbits NNS O

After IN O
4 CD O
h NN O
, , O
lesions NNS O
in IN O
the DT O
secretory JJ O
part NN O
of IN O
the DT O
stomach NN O
were VBD O
scored VBN O
and CC O
mucosal JJ O
prostaglandin NN O
E2 NNP O
synthesis NN O
was VBD O
determined VBN O
by IN O
the DT O
ex NN O
vivo NN O
prostaglandin JJ O
generation NN O
technique NN O
. . O

Peripheral NNP O
and CC O
preemptive JJ O
opioid JJ O
antinociception NN O
in IN O
a DT O
mouse NN O
visceral JJ O
pain NN O
model NN O
. . O

Current JJ O
status NN O
and CC O
future NN O
perspectives NNS O

Therapeutic JJ O
use NN O
of IN O
cannabis NN O
. . O

Further JJ O
experiments NNS O
will MD O
be VB O
required VBN O
to TO O
highlight VB O
the DT O
in IN O
vivo JJ O
role NN O
of IN O
ELE1 NNP B-Gene
in IN O
nuclear JJ O
receptor NN O
functioning NN O
. . O

In IN O
early JJ O
Xenopus NN O
embryos NN O
, , O
the DT O
transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
beta NN I-Gene
member NN O
activin NN B-Gene
induces VBZ O
the DT O
gene NN B-Gene
Mix NNP I-Gene
. . I-Gene
2 CD I-Gene
by IN O
stimulating VBG O
the DT O
formation NN O
of IN O
a DT O
multiprotein NN O
complex NN O
, , O
activin SYM B-Gene
- : I-Gene
responsive JJ I-Gene
factor NN I-Gene
( ( O
ARF NNP B-Gene
) ) O
. . O

The DT O
first JJ O
146 CD O
consecutive JJ O
patients NNS O
treated VBN O
with IN O
EVL NNP O
during IN O
the DT O
period NN O
from IN O
August NNP O
, , O
1986 CD O
to TO O
July NNP O
, , O
1989 CD O
are VBP O
reported VBN O
. . O

DNA NN O
recognition NN O
by IN O
F NNP B-Gene
factor NN I-Gene
TraI36 NNP B-Gene
: : O
highly RB O
sequence NN O
- : O
specific JJ O
binding NN O
of IN O
single JJ O
- : O
stranded VBD O
DNA NN O
. . O

HEED NNP B-Gene
was VBD O
found VBN O
to TO O
bind VB O
to TO O
MA NNP B-Gene
protein NN I-Gene
in IN O
vitro NN O
, , O
as RB O
efficiently RB O
as IN O
in IN O
vivo NN O
in IN O
yeast NN O
cells NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
central JJ O
role NN O
of IN O
the DT O
Notch NNP B-Gene
- : O
CBF1 NNP B-Gene
/ NNP O
RBP NNP B-Gene
- : I-Gene
Jkappa NNP I-Gene
signaling VBG O
pathway RB O
in IN O
cell NN O
fate NN O
decisions NNS O
renders NNS O
it PRP O
susceptible JJ O
to TO O
pathways NNS O
of IN O
viral JJ O
replication NN O
and CC O
oncogenic JJ O
conversion NN O
. . O

The DT O
transforming VBG O
protein NN O
of IN O
Rous NNP O
sarcoma NN O
virus NN O
, , O
pp60v SYM B-Gene
- : I-Gene
src NN I-Gene
, , O
and CC O
its PRP$ O
normal JJ O
cellular JJ O
homolog NN O
, , O
pp60c SYM B-Gene
- : I-Gene
src NN I-Gene
, , O
differ NN O
not RB O
only RB O
in IN O
oncogenic JJ O
potential NN O
but CC O
also RB O
in IN O
their PRP$ O
subcellular JJ O
localization NN O
and CC O
cytoskeletal JJ O
binding NN O
ability NN O
. . O

pp60v SYM B-Gene
- : I-Gene
src NN I-Gene
has VBZ O
been VBN O
shown VBN O
to TO O
stably VB O
associate NN O
with IN O
a DT O
detergent NN O
- : O
insoluble JJ O
cytoskeletal JJ O
matrix NN O
, , O
whereas WP O
pp60c SYM B-Gene
- : I-Gene
src NN I-Gene
does VBZ O
not RB O
. . O

2 CD O
: : O
121 CD O
- : O
133 CD O
, , O
1988 CD O
) ) O
. . O

Fragments NNS O
containing VBG O
the DT O
21 CD O
- : O
base NN O
- : O
pair NN O
repeat NN O
region NN O
, , O
the DT O
enhancer NN B-Gene
of IN I-Gene
simian JJ I-Gene
virus NN I-Gene
40 CD I-Gene
or CC O
both DT O
strongly RB O
stimulated VBN O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
synthesis NN O
, , O
and CC O
three CD O
fragments NNS O
from IN O
the DT O
polyomavirus NN B-Gene
enhancer NN I-Gene
region NN I-Gene
stimulated VBD O
moderate JJ O
levels NNS O
. . O

DESIGN NNP O
- : O
- : O
A DT O
randomised JJ O
study NN O
was VBD O
conducted VBN O
in IN O
all DT O
women NNS O
aged VBD O
50 CD O
- : O
70 CD O
years NNS O
who WP O
were VBD O
eligible JJ O
for IN O
breast NN O
cancer NN O
screening NN O
and CC O
living NN O
in IN O
the DT O
city NN O
of IN O
Utrecht NNP O
. . O

This DT O
was VBD O
obtained VBN O
with IN O
the DT O
thermal JJ O
neutron NN O
fluency NN O
2 CD O
. . O
0 CD O
x JJ O
10 CD O
( ( O
10 CD O
) ) O
n NN O
/ JJ O
cm2 NN O
. . O

Clinical JJ O
studies NNS O
SY5555 NNP O
was VBD O
administered VBN O
to TO O
45 CD O
patients NNS O
with IN O
various JJ O
infectious JJ O
diseases NNS O
( ( O
2 CD O
with IN O
acute JJ O
pharyngitis NN O
, , O
8 CD O
with IN O
acute JJ O
tonsillitis NN O
, , O
4 CD O
with IN O
lacunar NN O
tonsillitis NN O
, , O
3 CD O
each DT O
with IN O
acute JJ O
bronchitis NN O
, , O
pneumonia NN O
and CC O
pertussis NN O
, , O
7 CD O
with IN O
scarlet NN O
fever NN O
, , O
3 CD O
with IN O
impetigo JJ O
contagiosa NN O
, , O
6 CD O
with IN O
acute JJ O
urinary JJ O
tract NN O
infections NNS O
, , O
2 CD O
with IN O
balanoposthitis NN O
and CC O
1 CD O
each DT O
with IN O
cervical JJ O
lymphadenitis NN O
, , O
S NNP O
. . O
S NNP O
. . O
S NNP O
. . O
S NNP O
. . O
, , O
vulvitis NN O
and CC O
acute JJ O
colitis NN O
) ) O
at IN O
daily JJ O
doses NNS O
between IN O
3 CD O
. . O
4 CD O
- : O
10 CD O
mg NN O
/ NNP O
kg NN O
, , O
t NN O
. . O
i NN O
. . O
d NN O
. . O
, , O
for IN O
3 CD O
- : O
14 CD O
days NNS O
. . O

Induction NN O
of IN O
Jurkat NNP O
leukemic JJ O
T NNP O
cells NNS O
with IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
and CC O
ionomycin NN O
did VBD O
not RB O
affect VB O
the DT O
level NN O
of IN O
FKBP NNP B-Gene
mRNA NN I-Gene
. . O

A DT O
patient NN O
matches VBZ O
a DT O
PIC NNP O
patient NN O
if IN O
both DT O
have VBP O
the DT O
same JJ O
mechanism NN O
of IN O
injury NN O
, , O
the DT O
same JJ O
coding NN O
of IN O
Revised VBN O
Trauma NNP O
Score NNP O
variables NNS O
( ( O
Glascow NNP O
Coma NNP O
Scale NNP O
score NN O
, , O
systolic JJ O
blood NN O
pressure NN O
, , O
respiratory JJ O
rate NN O
) ) O
, , O
the DT O
same JJ O
coded JJ O
age NN O
per IN O
A NNP O
Severity NNP O
Characterization NNP O
of IN O
Trauma NNP O
) ) O
( ( O
ASCOT NNP O
) ) O
, , O
and CC O
if IN O
they PRP O
differ VBP O
by IN O
no DT O
more JJR O
than IN O
0 CD O
. . O
5 CD O
for IN O
A NNP O
, , O
B NNP O
, , O
and CC O
C NNP O
( ( O
the DT O
ASCOT NNP O
components NNS O
for IN O
serious JJ O
injuries NNS O
) ) O
. . O

This DT O
constitutes VBZ O
evidence NN O
for IN O
an DT O
in IN O
vivo JJ O
role NN O
of IN O
SRC NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
dimerization NN O
- : O
induced VBN O
activation NN O
by IN O
OR1 NNP B-Gene
/ NNP O
RXRalpha NNP B-Gene
. . O

Demographic JJ O
characteristics NNS O
and CC O
risk NN O
factor NN O
data NNS O
for IN O
76 CD O
, , O
672 CD O
clients NNS O
were VBD O
studied VBN O
to TO O
characterize VB O
the DT O
distribution NN O
of IN O
infection NN O
with IN O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
and CC O
the DT O
use NN O
of IN O
counseling NN O
and CC O
testing VBG O
facilities NNS O
in IN O
Houston NNP O
, , O
Tex NNP O
. . O

To TO O
study VB O
the DT O
regulation NN O
of IN O
its PRP$ O
expression NN O
, , O
the DT O
human JJ B-Gene
aldehyde NN I-Gene
reductase NN I-Gene
gene NN I-Gene
and CC O
promoter NN O
were VBD O
cloned VBN O
and CC O
characterized VBN O
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
data NNS O
do VBP O
not RB O
support VB O
a DT O
role NN O
for IN O
IVIg NNP B-Gene
in IN O
the DT O
remyelination NN O
of IN O
stable JJ O
multiple JJ O
sclerosis NN O
lesions NNS O
as IN O
measured VBN O
by IN O
central JJ O
conduction NN O
time NN O
. . O

We PRP O
present JJ O
evidence NN O
that IN O
the DT O
upstream JJ O
open JJ O
reading NN O
frame NN O
( ( O
uORF JJ O
) ) O
represses VBZ O
the DT O
translation NN O
of IN O
the DT O
downstream NN O
major JJ O
open JJ O
reading NN O
frame NN O
( ( O
mORF NN O
) ) O
. . O

When WRB O
vascular JJ O
pressure NN O
( ( O
Pvas NNP O
) ) O
was VBD O
raised VBN O
abruptly RB O
from IN O
- : O
5 CD O
to TO O
+ VB O
25 CD O
cmH2O NN O
by IN O
air NN O
inflation NN O
for IN O
60 CD O
min NN O
, , O
Px NNP O
( ( O
f NN O
) ) O
became VBD O
abruptly RB O
less RBR O
negative JJ O
, , O
then RB O
remained VBD O
stable JJ O
. . O

Thirty NN O
of IN O
the DT O
clones NNS O
contained VBD O
a DT O
complete JJ O
340 CD O
base NN O
- : O
pair NN O
dimer JJ O
unit NN O
of IN O
the DT O
repeat NN O
. . O

In IN O
this DT O
animal NN O
, , O
infected VBN O
with IN O
what WP O
was VBD O
judged VBN O
previously RB O
to TO O
be VB O
the DT O
less RBR O
virulent NN O
of IN O
the DT O
two CD O
T NNP O
. . O
cruzi NN O
stocks NNS O
used VBN O
( ( O
' POS O
strain NN O
7 CD O
' '' O
) ) O
, , O
there EX O
was VBD O
severe JJ O
myocarditis NN O
, , O
with IN O
myofibre JJ O
degeneration NN O
, , O
and CC O
lesions NNS O
of IN O
the DT O
oesophagus NN O
. . O

The DT O
effect NN O
of IN O
smoking NN O
was VBD O
not RB O
examined VBN O
in IN O
this DT O
study NN O
, , O
as IN O
such JJ O
data NNS O
were VBD O
not RB O
available JJ O
. . O

The DT O
motility NN O
of IN O
sperm NN O
, , O
except IN O
for IN O
those DT O
adjacent JJ O
to TO O
both DT O
electrodes NNS O
, , O
did VBD O
not RB O
change NN O
after IN O
stimulation NN O
for IN O
60s CD O
, , O
despite IN O
a DT O
high JJ O
electrical JJ O
energy NN O
. . O

We PRP O
have VBP O
tested VBN O
the DT O
function NN O
of IN O
two CD O
potential JJ O
NF NNP B-Gene
- : I-Gene
kappaB SYM I-Gene
- : I-Gene
like IN I-Gene
sites NNS I-Gene
present JJ O
in IN O
the DT O
PAI NNP B-Gene
- : I-Gene
2 CD I-Gene
proximal JJ I-Gene
promoter NN I-Gene
for IN O
responsiveness NN O
to TO O
TNFalpha NNP B-Gene
using VBG O
chloramphenicol NN B-Gene
acetyl JJ I-Gene
transferase NN I-Gene
reporter NN I-Gene
gene NN I-Gene
deletion NN O
and CC O
mutation NN O
analyses NNS O
. . O

VII NNP O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
striatal JJ O
FDG NNP O
and CC O
particularly RB O
RACLO NNP O
are VBP O
sensitive JJ O
and CC O
effective JJ O
measures NNS O
of IN O
striatal JJ O
function NN O
and CC O
may MD O
help VB O
characterizing VBG O
patients NNS O
with IN O
multiple JJ O
system NN O
atrophy NN O
. . O

Our PRP$ O
previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
SHP NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
SH2 NNP B-Gene
domain NN I-Gene
- : I-Gene
containing VBG I-Gene
protein SYM I-Gene
- : I-Gene
tyrosine NN I-Gene
phosphatase NN I-Gene
, , O
is VBZ O
expressed VBN O
not RB O
only RB O
in IN O
cells NNS O
of IN O
hematopoietic JJ O
lineages NNS O
, , O
but CC O
also RB O
in IN O
many JJ O
non JJ O
- : O
hematopoietic JJ O
cells NNS O
under IN O
the DT O
control NN O
of IN O
an DT O
alternative JJ O
tissue NN O
- : O
specific JJ O
promoter NN O
, , O
P1 NNP O
. . O

Both DT O
genes NNS O
comprise VBP O
three CD O
exons NNS O
, , O
two CD O
introns NNS O
and CC O
an DT O
unusually RB O
long JJ O
3 CD O
' POS O
- : O
untranslated JJ O
region NN O
( ( O
3 CD O
. . O
2 CD O
kilobase NN O
pairs NN O
) ) O
, , O
specificying VBG O
a DT O
mRNA NN O
of IN O
approximately RB O
4 CD O
. . O
1 CD O
kilobases NNS O
. . O

Pediatric NNP O
medical JJ O
emergencies NNS O
in IN O
a DT O
regional JJ O
hospital NN O
: : O
appropriate JJ O
locale NN O
? . O

POU NNP B-Gene
- : I-Gene
domain NN I-Gene
proteins NNS I-Gene
, , O
such JJ O
as IN O
the DT O
pituitary JJ B-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
Pit NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
are VBP O
members NNS O
of IN O
the DT O
homeodomain JJ B-Gene
family NN I-Gene
of IN O
proteins NNS O
which WDT O
are VBP O
important JJ O
in IN O
development NN O
and CC O
homeostasis NN O
, , O
acting VBG O
constitutively RB O
or CC O
in IN O
response NN O
to TO O
signal VB O
- : O
transduction NN O
pathways VBZ O
to TO O
either DT O
repress NN O
or CC O
activate VB O
the DT O
expression NN O
of IN O
specific JJ O
genes NNS O
. . O

This DT O
two CD O
- : O
helix NN O
motif NN O
is VBZ O
thought VBN O
to TO O
be VB O
involved VBN O
in IN O
specific JJ O
DNA NNP O
sequence NN O
recognition NN O
by IN O
CAP NNP B-Gene
. . O

Furthermore RB O
, , O
upstream JJ O
insertion NN O
of IN O
the DT O
GSTP1 NNP B-Gene
silencer NN I-Gene
element NN I-Gene
failed VBD O
to TO O
inhibit VB O
activity NN O
of IN O
a DT O
heterologous JJ O
promoter NN O
in IN O
MCF7 NNP O
cells NNS O
. . O

Effects NNS O
of IN O
prostaglandin JJ O
inhibitors NNS O
on IN O
the DT O
onset NN O
of IN O
proteinuria NN O
and CC O
stroke NN O
in IN O
stroke NN O
- : O
prone NN O
spontaneously RB O
hypertensive JJ O
rats NNS O
. . O

Here RB O
, , O
we PRP O
describe VBP O
a DT O
tyrosine NN O
- : O
phosphorylated VBN O
nuclear JJ O
protein NN O
, , O
YT521 NNP B-Gene
- : I-Gene
B NN I-Gene
, , O
and CC O
show VBP O
that IN O
it PRP O
interacts VBZ O
with IN O
the DT O
nuclear JJ B-Gene
transcriptosomal JJ I-Gene
component NN I-Gene
scaffold VBD I-Gene
attachment JJ I-Gene
factor NN I-Gene
B NNP I-Gene
, , O
and CC O
the DT O
68 CD B-Gene
- : I-Gene
kDa NN I-Gene
Src NNP I-Gene
substrate NN O
associated VBN O
during IN O
mitosis NN O
, , O
Sam68 NNP B-Gene
. . O

Detection NN O
of IN O
airborne JJ O
Mycobacterium NNP O
tuberculosis NN O
by IN O
air NN O
filtration NN O
and CC O
polymerase NN O
chain NN O
reaction NN O
. . O

The DT O
loss NN O
of IN O
avirulence NN O
activity NN O
because IN O
of IN O
mutations NNS O
in IN O
the DT O
acidic JJ O
transcriptional JJ O
activation NN O
domain NN O
was VBD O
restored VBN O
by IN O
addition NN O
of IN O
the DT O
activation NN O
domain NN O
from IN O
the DT O
herpes NNS B-Gene
simplex JJ I-Gene
viral JJ I-Gene
protein NN I-Gene
VP16 NNP I-Gene
. . O

Reverse NNP B-Gene
transcriptase NN I-Gene
- : O
polymerase NN O
chain NN O
reaction NN O
assays VBZ O
showed VBD O
that IN O
PKRDeltaE7 NNP B-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
broad JJ O
range NN O
of IN O
human JJ O
tissues NNS O
at IN O
variable JJ O
levels NNS O
. . O

Interestingly RB O
, , O
a DT O
portion NN O
of IN O
the DT O
tail NN O
domain NN O
( ( O
aa UH O
, , O
1 CD O
, , O
94 CD O
- : O
1 CD O
, , O
830 CD O
) ) O
shares NNS O
58 CD O
% NN O
amino NN O
acid JJ O
sequence NN O
identity NN O
with IN O
a DT O
723 CD O
- : O
aa NN O
protein NN O
from IN O
mouse NN O
brain NN O
reported VBD O
to TO O
be VB O
a DT O
glutamic JJ B-Gene
acid NN I-Gene
decarboxylase NN I-Gene
. . O

Stimulation NN O
of IN O
macrophage NN O
function NN O
by IN O
killed VBN O
Bordetella NNP O
pertussis NN O
cells NNS O
did VBD O
not RB O
show VB O
any DT O
beneficial JJ O
effect NN O
as IN O
an DT O
increased JJ O
susceptibility NN O
became VBD O
apparent JJ O
. . O

In IN O
this DT O
report NN O
this DT O
technique NN O
was VBD O
applied VBN O
to TO O
human JJ O
breast NN O
carcinoma NN O
MDA NNP O
- : O
MB231 NNP O
cells NNS O
overexpressing VBG O
human JJ B-Gene
MPG NNP I-Gene
in IN O
order NN O
to TO O
assess VB O
whether IN O
up IN O
- : O
regulation NN O
of IN O
the DT O
initial JJ O
step NN O
in IN O
BER NNP O
alters NNS O
the DT O
activity NN O
of IN O
selected VBN O
other JJ O
BER NNP O
( ( O
hOGG1 NN B-Gene
and CC O
APE NNP B-Gene
/ NNP O
ref VBD B-Gene
- : I-Gene
1 CD I-Gene
) ) O
or CC O
direct JJ O
reversal NN O
( ( O
MGMT NNP B-Gene
) ) O
repair NN O
activities NNS O
. . O

The DT O
HOI NNP O
induced VBD O
a DT O
nearly RB O
fourfold JJ O
increase NN O
in IN O
ANF NNP B-Gene
in IN O
the DT O
elderly JJ O
, , O
whereas NNS O
that IN O
for IN O
the DT O
young JJ O
was VBD O
threefold JJ O
. . O

OBJECTIVE NN O
: : O
To TO O
compare VB O
pregnancy NN O
complications NNS O
in IN O
women NNS O
having VBG O
genetic JJ O
amniocentesis NN O
at IN O
11 CD O
- : O
14 CD O
weeks NNS O
versus VBP O
those DT O
undergoing JJ O
amniocentesis NN O
at IN O
16 CD O
- : O
19 CD O
weeks NNS O
' POS O
gestation NN O
. . O

Expression NN O
and CC O
regulation NN O
by IN O
interferon NN B-Gene
of IN O
a DT O
double JJ B-Gene
- : I-Gene
stranded VBN I-Gene
- : I-Gene
RNA NNP I-Gene
- : I-Gene
specific JJ I-Gene
adenosine JJ I-Gene
deaminase NN I-Gene
from IN O
human JJ O
cells NNS O
: : O
evidence NN O
for IN O
two CD O
forms NNS O
of IN O
the DT O
deaminase NN O
. . O

Both DT O
the DT O
presence NN O
of IN O
arginine NN O
and CC O
anaerobiosis NN O
are VBP O
needed VBN O
to TO O
trigger VB O
induction NN O
of IN O
the DT O
pathway NN O
. . O

Transfection NN O
experiments NNS O
demonstrated VBD O
that IN O
the DT O
5 CD O
' POS O
- : O
flanking NN O
region NN O
( ( O
- : O
1894 CD O
to TO O
+ VB O
37 CD O
) ) O
of IN O
the DT O
mStaf JJ B-Gene
gene NN I-Gene
drives NNS O
transcription NN O
in IN O
mouse NN O
NMuMG NNP O
cells NNS O
and CC O
that IN O
a DT O
construct NN O
containing VBG O
a DT O
fragment NN O
from IN O
- : O
387 CD O
to TO O
+ VB O
37 CD O
showed VBD O
the DT O
highest JJS O
transcriptional JJ O
activity NN O
. . O

Substitutions NNS O
in IN O
the DT O
YFV NNP B-Gene
Ag NNP B-Gene
- : I-Gene
binding NN I-Gene
region NN I-Gene
( ( O
ABR NNP B-Gene
) ) O
occur VBP O
at IN O
four CD O
of IN O
the DT O
eight CD O
highly RB O
conserved VBN O
residues NNS O
that WDT O
are VBP O
essential JJ O
for IN O
binding NN O
of IN O
peptide JJ O
- : O
Ag NN O
in IN O
the DT O
class NN O
Ia NNP O
molecules NNS O
. . O

METHODS NN O
: : O
93 CD O
female NN O
and CC O
43 CD O
male NN O
patients NNS O
undergoing VBG O
thyroid JJ O
surgery NN O
were VBD O
stratified VBN O
according VBG O
to TO O
gender NN O
and CC O
then RB O
randomised VBD O
to TO O
receive VB O
double JJ O
- : O
blind IN O
one CD O
of IN O
four CD O
antiemetic JJ O
regimes NNS O
: : O
50 CD O
mg NN O
dolasetron NN O
given VBN O
orally RB O
45 CD O
minutes NNS O
prior RB O
to TO O
induction NN O
of IN O
anaesthesia NN O
( ( O
group NN O
I PRP O
) ) O
, , O
12 CD O
. . O
5 CD O
mg JJ O
dolasetron NN O
given VBN O
intravenously RB O
during IN O
induction NN O
of IN O
anaesthesia NN O
( ( O
group NN O
II NNP O
) ) O
, , O
1 CD O
. . O
25 CD O
mg JJ O
DHB NNP B-Gene
given VBN O
intravenously RB O
during IN O
induction NN O
of IN O
anaesthesia NN O
( ( O
group NN O
III NNP O
) ) O
or CC O
placebo NN O
( ( O
group NN O
IV NNP O
) ) O
. . O

A DT O
genetic JJ O
system NN O
was VBD O
devised VBN O
to TO O
select VB O
for IN O
pi NN B-Gene
protein NN I-Gene
mutants NNS I-Gene
which WDT O
discriminate VBP O
between IN O
IR NNP O
and CC O
DR NNP O
( ( O
York NNP O
et RB O
al RB O
. . O
, , O
Gene NNP O
( ( O
Amst NNP O
. . O
) ) O
116 CD O
, , O
7 CD O
- : O
12 CD O
, , O
1992 CD O
; : O
York NNP O
and CC O
Filutowicz NNP O
, , O
J NNP O
. . O

Photopic NNP O
spectral JJ O
sensitivity NN O
determined VBD O
electroretinographically RB O
for IN O
the DT O
pigeon NN O
eye NN O
. . O

Overexpression NN O
of IN O
EFG1 NNP B-Gene
in IN O
C NNP O
. . O
albicans NNS O
leads VBZ O
to TO O
enhanced VB O
filamentous JJ O
growth NN O
in IN O
the DT O
form NN O
of IN O
extended JJ O
pseudohyphae NN O
in IN O
liquid NN O
and CC O
on IN O
solid JJ O
media NNS O
. . O

Our PRP$ O
analysis NN O
suggests VBZ O
that IN O
Upf1p NNP B-Gene
is VBZ O
a DT O
multifunctional JJ O
protein NN O
with IN O
separable JJ O
activities NNS O
that WDT O
can MD O
affect VB O
mRNA JJ O
turnover NN O
and CC O
nonsense JJ O
suppression NN O
. . O

All DT O
of IN O
the DT O
newly RB O
acquired VBN O
proviruses NNS O
identified VBN O
in IN O
mosaic JJ O
founder NN O
SWR NNP O
/ NNP O
J NNP O
- : O
RF NNP O
/ NNP O
J NNP O
mice NN O
that WDT O
could MD O
be VB O
transmitted VBN O
through IN O
the DT O
germ JJ O
line NN O
were VBD O
also RB O
present JJ O
in IN O
somatic JJ O
tissues NNS O
, , O
demonstrating VBG O
that IN O
viral JJ O
integration NN O
occurred VBD O
before IN O
the DT O
germ JJ O
line NN O
was VBD O
set VBN O
aside RB O
from IN O
the DT O
somatic JJ O
lineages NNS O
. . O

These DT O
studies NNS O
indicate VBP O
that IN O
the DT O
acidimetric JJ O
test NN O
was VBD O
less RBR O
sensitive JJ O
than IN O
the DT O
chromogenic JJ O
cephalosporin NN O
substrates NNS O
and CC O
that DT O
nitrocefin NN O
and CC O
S1 NNP O
could MD O
be VB O
used VBN O
to TO O
screen VB O
for IN O
beta NN B-Gene
- : I-Gene
lactamase NN I-Gene
production NN O
in IN O
these DT O
tested JJ O
species NNS O
. . O

Given VBN O
its PRP$ O
relative JJ O
longevity NN O
on IN O
the DT O
Web NNP O
, , O
TIE NNP O
researchers NNS O
have VBP O
been VBN O
in IN O
a DT O
unique JJ O
position NN O
to TO O
observe VB O
trends NNS O
in IN O
telemedicine NN O
. . O

A DT O
convenient JJ O
measure NN O
of IN O
this DT O
impairment NN O
may MD O
be VB O
obtained VBN O
using VBG O
the DT O
ratio NN O
of IN O
urine JJ O
volume NN O
( ( O
V NNP O
) ) O
divided VBN O
by IN O
lithium JJ O
clearance NN O
( ( O
CLi NNP O
) ) O
. . O

Radioimmunoassay NNP O
of IN O
serum JJ O
creatine NN B-Gene
kinase NN I-Gene
B NNP I-Gene
isoenzyme NN I-Gene
in IN O
the DT O
diagnosis NN O
of IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

Six NNP O
putative JJ O
MDV NNP O
genome NN O
products NNS O
, , O
including VBG O
one CD O
Rep NNP B-Gene
and CC O
five CD O
non NNS O
- : O
Rep NNP B-Gene
proteins VBZ O
, , O
show VBP O
high JJ O
( ( O
70 CD O
. . O
4 CD O
- : O
90 CD O
. . O
9 CD O
% NN O
) ) O
amino NN O
acid JJ O
identity NN O
to TO O
the DT O
corresponding JJ O
six CD O
FBNYV NNP B-Gene
proteins NNS I-Gene
, , O
whereas NNS O
two CD O
other JJ O
Rep NNP B-Gene
proteins NNS I-Gene
encoded VBN O
by IN O
MDV NNP B-Gene
- : I-Gene
C2 NN I-Gene
and CC O
C3 NNP B-Gene
are VBP O
82 CD O
. . O
3 CD O
% NN O
and CC O
73 CD O
. . O
0 CD O
% NN O
identical JJ O
to TO O
those DT O
encoded VBN O
by IN O
SCSV NNP B-Gene
- : I-Gene
C2 NN I-Gene
and CC O
C6 NNP B-Gene
, , O
respectively RB O
. . O

In IN O
our PRP$ O
opinion NN O
, , O
the DT O
SM NNP O
- : O
CMA NN O
system NN O
is VBZ O
, , O
despite IN O
some DT O
shortcomings NNS O
in IN O
its PRP$ O
user NN O
- : O
interface NN O
, , O
a DT O
useful JJ O
and CC O
versatile JJ O
instrument NN O
for IN O
examination NN O
of IN O
human JJ O
semen NNS O
samples NNS O
, , O
with IN O
desirable JJ O
features NNS O
. . O

Insertional JJ O
inactivation NN O
of IN O
sms NNS B-Gene
led VBN O
to TO O
increased VBN O
sensitivity NN O
to TO O
the DT O
alkylating VBG O
agent NN O
methylmethane NN O
sulfonate NN O
, , O
but CC O
not RB O
to TO O
a DT O
requirement NN O
for IN O
serine NN O
or CC O
other JJ O
metabolites NNS O
. . O

OBJECTIVE NN O
: : O
To TO O
demonstrate VB O
a DT O
lack NN O
of IN O
effect NN O
of IN O
steady JJ O
- : O
state NN O
concentrations NNS O
of IN O
cilomilast NN O
, , O
a DT O
new JJ O
oral JJ O
phosphodiesterase NN B-Gene
4 CD I-Gene
inhibitor NN O
for IN O
the DT O
treatment NN O
of IN O
chronic JJ O
obstructive JJ O
pulmonary JJ O
disease NN O
, , O
on IN O
warfarin SYM O
- : O
induced JJ O
anticoagulation NN O
. . O

These DT O
patients NNS O
appear VBP O
to TO O
have VB O
slightly RB O
better JJR O
pulmonary JJ O
function NN O
and CC O
nutritional JJ O
status NN O
; : O
yet RB O
, , O
they PRP O
seem VBP O
to TO O
have VB O
a DT O
higher JJR O
degree NN O
of IN O
health NN O
care NN O
utilization NN O
. . O

The DT O
extraction NN O
was VBD O
subsequently RB O
rated VBN O
as IN O
' '' O
easy JJ O
' '' O
or CC O
' POS O
difficult JJ O
' POS O
. . O
Taking VBG O
Pell NNP O
- : O
Gregory NNP O
class NN O
C NNP O
as IN O
a DT O
predictor NN O
of IN O
a DT O
' POS O
difficult JJ O
' POS O
extraction NN O
, , O
specificity NN O
was VBD O
88 CD O
% NN O
but CC O
sensitivity NN O
was VBD O
low JJ O
at IN O
15 CD O
% NN O
. . O

The DT O
genome NN O
of IN O
the DT O
human JJ O
herpesvirus NN O
8 CD O
( ( O
HHV NNP O
- : O
8 CD O
) ) O
contains VBZ O
a DT O
cluster NN O
of IN O
open JJ O
reading NN O
frames NNS O
( ( O
ORFs NNP O
) ) O
encoding VBG O
proteins NNS O
with IN O
homology NN O
to TO O
the DT O
cellular JJ O
transcription NN O
factors NNS O
of IN O
the DT O
interferon NN B-Gene
regulatory JJ I-Gene
factor NN I-Gene
( ( O
IRF NNP B-Gene
) ) O
family NN O
. . O

Sodium NNP O
dodecyl NN O
sulphate NN O
- : O
induced VBN O
cleavage NN O
by IN O
eukaryotic JJ B-Gene
topoisomerase NN I-Gene
I PRP I-Gene
is VBZ O
known VBN O
to TO O
yield VB O
enzyme RB O
covalently RB O
attached VBN O
to TO O
the DT O
3 CD O
' POS O
cut JJ O
end NN O
of IN O
the DT O
DNA NN O
. . O

Several JJ O
new JJ O
techniques NNS O
are VBP O
available JJ O
for IN O
monitoring VBG O
control NN O
of IN O
diabetes NNS O
. . O

Analysis NN O
of IN O
the DT O
genome JJ O
sequence NN O
revealed VBD O
26 CD O
, , O
588 CD O
protein SYM O
- : O
encoding VBG O
transcripts NNS O
for IN O
which WDT O
there EX O
was VBD O
strong JJ O
corroborating JJ O
evidence NN O
and CC O
an DT O
additional JJ O
approximately RB O
12 CD O
, , O
0 CD O
computationally RB O
derived VBN O
genes NNS O
with IN O
mouse NN O
matches NNS O
or CC O
other JJ O
weak JJ O
supporting VBG O
evidence NN O
. . O

These DT O
six CD O
districts NNS O
have VBP O
an DT O
area NN O
of IN O
34 CD O
, , O
0 CD O
km2 NN O
and CC O
hold VB O
a DT O
population NN O
of IN O
30 CD O
million CD O
. . O

While IN O
Pt NNP B-Gene
; : I-Gene
cycH NN I-Gene
; : I-Gene
1 CD I-Gene
and CC O
Os NNP B-Gene
; : I-Gene
cycH NN I-Gene
; : I-Gene
1 CD I-Gene
were VBD O
expressed VBN O
in IN O
all DT O
tissues NNS O
examined VBN O
, , O
the DT O
transcripts NNS O
accumulated VBN O
abundantly RB O
in IN O
dividing VBG O
cells NNS O
. . O

NOT4 NNP B-Gene
interacts VBZ O
with IN O
NOT1 NNP B-Gene
and CC O
NOT3 NNP B-Gene
in IN O
the DT O
two CD O
- : O
hybrid JJ O
assay NN O
, , O
and CC O
overexpression NN O
of IN O
NOT3 NNP B-Gene
or CC O
NOT4 NNP B-Gene
suppresses VBZ O
not1 JJ B-Gene
and CC O
not2 JJ B-Gene
mutations NNS O
. . O

We PRP O
compared VBN O
the DT O
inhibitory JJ O
effect NN O
of IN O
naturally RB O
occurring VBG O
mutant JJ B-Gene
hTR NN I-Gene
beta NN I-Gene
1 CD I-Gene
, , O
artificially RB O
created VBN O
hTR NN B-Gene
alpha VBZ I-Gene
1 CD I-Gene
mutants NNS I-Gene
, , O
c SYM B-Gene
- : I-Gene
erbA NN I-Gene
alpha VBZ I-Gene
2 CD I-Gene
and CC O
the DT O
human JJ B-Gene
peroxisome NN I-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
( ( O
hPPAR NN B-Gene
) ) O
on IN O
three CD O
prototypic NN O
T3 NNP O
- : O
response NN O
elements NNS O
( ( O
TREs NNP O
) ) O
, , O
TRE NNP O
- : O
PAL NN O
, , O
DR NNP O
+ NNP O
4 CD O
and CC O
TRE NNP O
- : O
LAP NN O
. . O

A DT O
note NN O
on IN O
the DT O
phase NN O
- : O
plane NN O
technique NN O
representation NN O
of IN O
cardiac JJ O
action NN O
potentials NNS O
. . O

Haemodilution NN O
in IN O
cardiopulmonary JJ O
bypass NN O
using VBG O
a DT O
gelatine NN O
derivative NN O
for IN O
priming NN O
. . O

Glomerular JJ O
lesions NNS O
in IN O
renal JJ O
allografts NNS O
. . O

Optical JJ O
- : O
absorption NN O
spectra NN O
, , O
crystal JJ O
- : O
field NN O
energy NN O
levels NNS O
, , O
and CC O
transition NN O
line NN O
strengths NNS O
of IN O
holmium NN O
in IN O
trigonal JJ O
Na3 NNP O

Biochemical JJ O
analysis NN O
reveals NNS O
that IN O
KS1 NNP B-Gene
is VBZ O
a DT O
nuclear JJ O
protein NN O
containing VBG O
two CD O
transcriptional JJ O
repressor NN O
domains NNS O
, , O
R1 NNP O
and CC O
R2 NNP O
. . O

Upstream NN O
of IN O
the DT O
dra NN B-Gene
gene NN I-Gene
an DT O
open JJ O
reading NN O
frame NN O
of IN O
313 CD O
amino JJ O
acids NNS O
was VBD O
identified VBN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
a DT O
major JJ O
part NN O
of IN O
the DT O
reduction NN O
in IN O
food NN O
intake NN O
in IN O
hyperphagic JJ O
rats NNS O
eating VBG O
a DT O
quinine JJ O
- : O
adulterated VBN O
diet NN O
is VBZ O
due JJ O
to TO O
postingestional JJ O
events NNS O
. . O

Erratum NN O
: : O
Absence NN O
of IN O
precursor NN O
effects NNS O
above IN O
the DT O
martensitic JJ O
transformation NN O
in IN O
a DT O
virgin JJ O
crystal NN O
of IN O
Li NNP O
metal NN O

Current JJ O
diagnostic JJ O
uses NNS O
of IN O
computerized JJ O
tomography NN O
in IN O
clinical JJ O
medicine NN O
. . O

METHOD NN O
: : O
The DT O
sample NN O
of IN O
subjects NNS O
was VBD O
drawn VBN O
from IN O
the DT O
Suffolk NNP O
County NNP O
Mental NNP O
Health NNP O
Project NNP O
, , O
a DT O
longitudinal JJ O
epidemiologic NN O
study NN O
of IN O
first JJ O
- : O
hospitalized VBN O
subjects NNS O
with IN O
psychotic JJ O
disorders NNS O
; : O
the DT O
present JJ O
study NN O
focused VBD O
on IN O
patients NNS O
with IN O
schizophrenic JJ O
disorders NNS O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
phorbol NN O
ester NN O
PMA NNP O
decreases VBZ O
both DT O
basal NN O
and CC O
dexamethasone NN O
/ NN O
cAMP SYM O
- : O
induced JJ O
expression NN O
of IN O
a DT O
luciferase JJ B-Gene
gene NN I-Gene
under IN O
the DT O
control NN O
of IN O
the DT O
G6Pase NNP B-Gene
promoter NN I-Gene
in IN O
transiently RB O
transfected VBN O
H4IIE NNP O
hepatoma NN O
cells NNS O
. . O

The DT O
human JJ B-Gene
immunodeficiency NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HIV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
Rev NNP I-Gene
protein NN I-Gene
is VBZ O
a DT O
positive JJ O
posttranscriptional JJ O
regulator NN O
of IN O
viral JJ O
structural JJ O
gene NN O
expression NN O
and CC O
essential JJ O
for IN O
virus JJ O
replication NN O
. . O

Commercially RB O
available JJ O
formulations NNS O
of IN O
2 CD O
. . O
5 CD O
% NN O
and CC O
5 CD O
% NN O
lambdacyhalothrin NN O
can MD O
be VB O
diluted VBN O
either DT O
with IN O
water NN O
for IN O
ULV NNP O
cold VBD O
aerosol JJ O
space NN O
- : O
spraying NN O
or CC O
with IN O
diesel JJ O
/ NNP O
kerosene NN O
for IN O
thermal JJ O
fogging NN O
at IN O
recommended JJ O
application NN O
rates NNS O
of IN O
0 CD O
. . O
5 CD O
- : O
1 CD O
g NN O
ai NN O
/ NNP O
ha NN O
for IN O
mosquito NN O
control NN O
and CC O
2 CD O
g NN O
ai NN O
/ NNP O
ha NN O
for IN O
housefly NN O
control NN O
. . O

XXI NN O
. . O

Study NN O
on IN O
distribution NN O
of IN O
metal NN O
in IN O
the DT O
teeth NNS O
treated VBN O
by IN O
iontophoresis NN O
with IN O
transparent NN O
specimens NNS O

Parkinsonian JJ O
patients NNS O
had VBD O
a DT O
significantly RB O
lower JJR O
prevalence NN O
of IN O
alcohol NN O
use NN O
. . O

Human NNP B-Gene
neuronal JJ I-Gene
Elav NNP I-Gene
- : I-Gene
like IN I-Gene
proteins NNS I-Gene
contain VBP O
three CD O
RNP NNP O
- : O
type NN O
RNA NNP O
recognition NN O
motifs NNS O
( ( O
RRMs NNP O
) ) O
. . O

Laboratory NN O
studies NNS O
showed VBD O
that IN O
the DT O
direct JJ O
fluorescent NN O
- : O
antibody NN O
kits NNS O
were VBD O
the DT O
least JJS O
sensitive JJ O
in IN O
this DT O
case NN O
and CC O
did VBD O
not RB O
detect VB O
fewer JJR O
than IN O
10 CD O
( ( O
4 CD O
) ) O
elementary JJ O
bodies NNS O
per IN O
ml NN O
, , O
while IN O
most JJS O
ELISA NNP O
kits NNS O
detected VBD O
between IN O
130 CD O
and CC O
600 CD O
elementary JJ O
bodies NNS O
per IN O
ml NN O
. . O

Large JJ O
ones NNS O
were VBD O
similar JJ O
in IN O
size NN O
to TO O
the DT O
main JJ O
lobe NN O
and CC O
small JJ O
ones NNS O
were VBD O
approximately RB O
1 CD O
/ JJ O
4 CD O
of IN O
the DT O
length NN O
of IN O
the DT O
main JJ O
lobe NN O
. . O

The DT O
interaction NN O
of IN O
radiation NN O
and CC O
hyperthermia NN O
was VBD O
systematically RB O
studied VBN O
in IN O
the DT O
Dunning NNP O
R3327G NNP O
prostatic JJ O
adenocarcinoma NN O
, , O
the DT O
preeminent NN O
animal NN O
model NN O
for IN O
human JJ O
prostatic JJ O
cancer NN O
. . O

Although IN O
increased VBN O
expression NN O
of IN O
the DT O
HMG NNP B-Gene
- : I-Gene
I PRP I-Gene
/ VBP I-Gene
Y JJ I-Gene
proteins NNS I-Gene
is VBZ O
associated VBN O
with IN O
cellular JJ O
proliferation NN O
, , O
neoplastic JJ O
transformation NN O
, , O
and CC O
several JJ O
human JJ O
cancers NNS O
, , O
the DT O
role NN O
of IN O
these DT O
proteins NNS O
in IN O
the DT O
pathogenesis NN O
of IN O
malignancy NN O
remains VBZ O
unclear JJ O
. . O

This DT O
computerized JJ O
list NN O
was VBD O
linked VBN O
to TO O
the DT O
central JJ O
files NNS O
of IN O
the DT O
Massachusetts NNP O
Cancer NNP O
Registry NNP O
and CC O
cases NNS O
diagnosed VBD O
between IN O
1982 CD O
and CC O
1988 CD O
were VBD O
identified VBN O
. . O

Adipocyte NNP O
differentiation NN O
of IN O
nontransformed JJ O
cells NNS O
also RB O
markedly RB O
represses VBZ O
the DT O
ability NN O
of IN O
SRF NNP B-Gene
to TO O
bind VB O
to TO O
the DT O
junB NN B-Gene
SRE NNP O
, , O
the DT O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
SRE NNP O
, , O
and CC O
other JJ O
SREs NNP O
, , O
as IN O
determined VBN O
by IN O
mobility NN O
shift NN O
and CC O
gel JJ O
supershift NN O
assays NNS O
, , O
without IN O
affecting VBG O
the DT O
DNA NN O
binding VBG O
characteristics NNS O
of IN O
the DT O
nuclear JJ O
protein NN O
SP NNP O
- : O
1 CD O
. . O

We PRP O
also RB O
identified VBD O
Sp1 NNP B-Gene
, , O
Sp3 NNP B-Gene
, , O
and CC O
NGFI NNP B-Gene
- : I-Gene
A DT I-Gene
/ JJ O
Egr NNP B-Gene
- : I-Gene
1 CD I-Gene
as IN O
the DT O
primary JJ O
nuclear JJ O
transcription NN O
factors NNS O
binding VBG O
to TO O
TRE1 NNP B-Gene
which WDT O
mediate VBP O
Tax NNP B-Gene
responsiveness NN O
. . O

Echosismography NN O
enables NNS O
to TO O
improve VB O
the DT O
diagnosis NN O
when WRB O
compared VBN O
with IN O
classical JJ O
sonography NN O
in IN O
about RB O
20 CD O
% NN O
of IN O
cases NNS O
. . O

The DT O
enteric JJ O
route NN O
is VBZ O
the DT O
principal JJ O
mode NN O
of IN O
transmission NN O
for IN O
hepatitis NN O
A NNP O
, , O
but CC O
maximal JJ O
levels NNS O
of IN O
hepatitis NN O
A NNP O
virus NN O
excretion NN O
occur NN O
before IN O
the DT O
onset NN O
of IN O
jaundice NN O
. . O

This DT O
paper NN O
reviews VBZ O
the DT O
middleware NN O
- : O
based VBN O
approach NN O
adopted VBN O
by IN O
CEN NNP O
ENV NNP O
12967 CD O
- : O
1 CD O
and CC O
the DT O
specialisation NN O
necessary JJ O
for IN O
the DT O
healthcare NN O
record NN O
based VBN O
on IN O
CEN NNP O
ENV NNP O
12265 CD O
' '' O
Electronic NNP O
Healthcare NNP O
Record NNP O
Architecture NNP O
' POS O
. . O

Plasma NNP B-Gene
renin NN I-Gene
activity NN O
rose VBD O
and CC O
the DT O
plasma NN O
aldosterone NN O
level NN O
fell VBD O
after IN O
taking VBG O
lisinopril NN O
. . O

Expression NN O
of IN O
neuronal JJ O
traits NNS O
in IN O
pancreatic JJ O
beta NN O
cells NNS O
. . O

Thus RB O
, , O
the DT O
anti JJ B-Gene
- : I-Gene
interferon NN I-Gene
functions NNS O
of IN O
vIRF NN B-Gene
- : I-Gene
2 CD I-Gene
may MD O
contribute VB O
to TO O
the DT O
establishment NN O
of IN O
a DT O
chronic NN O
or CC O
latent JJ O
infection NN O
. . O

In IN O
lean JJ O
mice NN O
, , O
the DT O
fat JJ O
/ JJ O
water NN O
intensity NN O
ratio NN O
was VBD O
about IN O
1 CD O
: : O
4 CD O
, , O
about RB O
half NN O
that IN O
in IN O
normal JJ O
mice NN O
. . O

ORF1 NNP O
( ( O
1029 CD O
bp NN O
; : O
EMBL NNP O
databank NN O
, , O
Accession NNP O
No NNP O
. . O

Epididymal JJ O
growth NN O
was VBD O
retarded VBN O
in IN O
animals NNS O
maintained VBD O
solely RB O
on IN O
chickpea NN O
haulm NN O
and CC O
improved VBN O
with IN O
supplementation NN O
. . O

The DT O
intron NN O
8 CD O
enhancer NN O
region NN O
was VBD O
not RB O
activated VBN O
by IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
together RB O
with IN O
Sp1 NNP B-Gene
in IN O
transactivation NN O
experiments NNS O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
indicating VBG O
the DT O
involvement NN O
of IN O
a DT O
related JJ O
Sp1 NNP B-Gene
protein NN I-Gene
or CC O
of IN O
another DT O
unidentified JJ O
erythroid NN O
factor NN O
. . O

Heparin NNP O
( ( O
100 CD O
U NNP O
. . O
kg NN O
( ( O
- : O
1 CD O
) ) O
. . O
day NN O
( ( O
- : O
1 CD O
) ) O
) ) O
was VBD O
injected VBN O
subcutaneously RB O
to TO O
the DT O
rats NNS O
in IN O
H NNP O
group NN O
while IN O
normal JJ O
saline NN O
to TO O
those DT O
in IN O
N NNP O
group NN O
once RB O
a DT O
day NN O
. . O

Mature NN O
and CC O
old JJ O
B6AF1 NNP O
and CC O
B6D2F1 NNP O
mice NN O
were VBD O
given VBN O
acidified JJ O
tap JJ O
water NN O
or CC O
promethazine NN O
HCl NNP O
( ( O
a DT O
phenothiazine NN O
with IN O
H1 NNP B-Gene
receptor NN I-Gene
blocking VBG O
activity NN O
) ) O
, , O
chlorpheniramine NN O
( ( O
an DT O
H1 NNP B-Gene
blocker NN O
) ) O
or CC O
trifluoperazine NN O
( ( O
a DT O
phenothiazine NN O
with IN O
no DT O
H1 NNP B-Gene
blocking VBG O
activity NN O
) ) O
in IN O
their PRP$ O
drinking NN O
water NN O
, , O
and CC O
the DT O
effects NNS O
of IN O
these DT O
agents NNS O
on IN O
bone JJ O
mineral JJ O
content NN O
were VBD O
assessed VBN O
by IN O
intermittently RB O
measuring VBG O
the DT O
24 CD O
- : O
h NN O
whole JJ O
body NN O
retention NN O
of IN O
Tc NNP O
99m CD O
methylene NN O
diphosphonate NN O
( ( O
Tc NNP O
99m CD O
MDP NNP O
, , O
an DT O
indicator NN O
of IN O
bone NN O
metabolism NN O
) ) O
and CC O
at IN O
the DT O
end NN O
of IN O
the DT O
studies NNS O
by IN O
determining VBG O
ash JJ O
weights NNS O
of IN O
femur NN O
, , O
ilium NN O
and CC O
sacrum NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNP O
: : O
One CD O
hundred VBD O
eighty SYM O
- : O
four CD O
chemotherapy NN O
- : O
naive JJ O
patients NNS O
receiving VBG O
high JJ O
- : O
dose NN O
cisplatin NN O
( ( O
81 CD O
to TO O
120 CD O
mg NNS O
/ NNP O
m2 NN O
) ) O
were VBD O
randomized VBN O
to TO O
receive VB O
one CD O
of IN O
four CD O
granisetron NN O
doses NNS O
( ( O
5 CD O
, , O
10 CD O
, , O
20 CD O
, , O
or CC O
40 CD O
micrograms NNS O
/ NNP O
kg NN O
) ) O
administered VBD O
before IN O
chemotherapy NN O
. . O

The DT O
dose NN O
was VBD O
50 CD O
Gy NNP O
/ VBD O
20 CD O
fractions NNS O
/ RB O
5 CD O
weeks NNS O
. . O

Prevention NN O
of IN O
maternal JJ O
Rh NNP O
sensitization NN O
: : O
anti JJ B-Gene
- : I-Gene
Rh NNP I-Gene
immune JJ I-Gene
globulin NN I-Gene
. . O

An DT O
unusual JJ O
feature NN O
of IN O
these DT O
replicative JJ O
genes NNS O
is VBZ O
that IN O
the DT O
smaller JJR O
mRNA NN O
begins VBZ O
within IN O
a DT O
long JJ O
open JJ O
reading NN O
frame NN O
of IN O
the DT O
larger JJR O
mRNA NN O
. . O

The DT O
serum NN O
levels NNS O
of IN O
IgE NNP B-Gene
, , O
and CC O
asIgE NN B-Gene
and CC O
IgG NNP B-Gene
- : I-Gene
4 CD I-Gene
against IN O
14 CD O
common JJ O
food NN O
allergens NNS O
were VBD O
determined VBN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
MIP NNP O
, , O
MMIF NNP O
, , O
FIC NNP O
, , O
Wimax NNP O
, , O
P0 NNP O
. . O
1 CD O
and CC O
minute JJ O
ventilation NN O
( ( O
Vr NNP O
) ) O
were VBD O
significantly RB O
increased VBN O
after IN O
administration NN O
of IN O
methylphenidatum NN O
and CC O
aminophylline NN O
. . O

In IN O
some DT O
instances NNS O
, , O
this DT O
is VBZ O
partly RB O
mediated VBN O
by IN O
the DT O
expression NN O
of IN O
virally RB O
encoded VBN O
proteases NNS O
which WDT O
lead VBP O
to TO O
the DT O
cleavage NN O
of IN O
initiation NN B-Gene
factor NN I-Gene
eIF4G NN I-Gene
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
: : O
Studies NNS O
were VBD O
undertaken VBN O
in IN O
9 CD O
isolated JJ O
guinea NN O
pig NN O
hearts NNS O
, , O
which WDT O
demonstrated VBD O
reverse NN O
use NN O
- : O
dependent JJ O
prolongation NN O
of IN O
cardiac JJ O
repolarization NN O
by IN O
100 CD O
nmol JJ O
/ NNP O
L NNP O
domperidone NN O
. . O

The DT O
large JJ O
fluxes NNS O
of IN O
239 CD O
+ NNS O
240Pu CD O
might MD O
be VB O
attributed VBN O
to TO O
episodic VB O
lateral JJ O
transport NN O
of IN O
particles NNS O
that WDT O
flow VBP O
down RP O
the DT O
continental JJ O
slope NN O
with IN O
the DT O
nepheloid NN O
layer NN O
which WDT O
was VBD O
considered VBN O
to TO O
be VB O
significant JJ O
for IN O
239 CD O
+ NNS O
240Pu CD O
transport NN O
on IN O
the DT O
continental JJ O
slope NN O
in IN O
the DT O
East NNP O
China NNP O
Sea NNP O
. . O

Relationship NN O
of IN O
mast NN O
cells NNS O
to TO O
sarcoidosis VB O
granuloma NN O
of IN O
the DT O
skin NN O

Additionally RB O
in IN O
seven CD O
subjects NNS O
adrenaline VBP O
( ( O
A DT O
) ) O
and CC O
noradrenaline JJ O
( ( O
null NNP O
) ) O
concentrations NNS O
were VBD O
determined VBN O
. . O

Therefore RB O
the DT O
binding NN O
sites NNS O
for IN O
liver NN O
- : O
enriched JJ O
factors NNS O
, , O
present NN O
in IN O
the DT O
hamster NN B-Gene
CYP7A1 NNP I-Gene
proximal JJ I-Gene
promoter NN I-Gene
in IN O
close JJ O
vicinity NN O
and CC O
conserved VBD O
between IN O
species NNS O
, , O
constitute VBP O
a DT O
regulatory JJ O
unit NN O
important JJ O
for IN O
basal JJ O
hepatic JJ O
expression NN O
and CC O
tissue NN O
restriction NN O
of IN O
the DT O
action NN O
of IN O
hormones NNS O
such JJ O
as IN O
insulin NN B-Gene
. . O

Differential JJ O
expression NN O
and CC O
regulation NN O
by IN O
20 CD O
- : O
hydroxyecdysone NN O
of IN O
mosquito JJ O
ultraspiracle NN O
isoforms NNS O
. . O

These DT O
changes NNS O
at IN O
the DT O
site NN O
of IN O
injection JJ O
consist NN O
of IN O
a DT O
focal JJ O
abnormality NN O
characterized VBN O
by IN O
a DT O
slight JJ O
increase NN O
in IN O
signal JJ O
intensity NN O
on IN O
T1 NNP O
weighted VBD O
images NNS O
and CC O
markedly RB O
increased VBD O
signal JJ O
intensity NN O
on IN O
T2 NNP O
weighted VBD O
images NNS O
. . O

We PRP O
now RB O
show VBP O
that IN O
the DT O
BAT1 NNP B-Gene
translation NN I-Gene
product NN I-Gene
is VBZ O
the DT O
homolog NN O
of IN O
the DT O
rat NN B-Gene
p47 NN I-Gene
nuclear JJ I-Gene
protein NN I-Gene
, , O
the DT O
WM6 NNP B-Gene
Drosophila NNP I-Gene
gene NN I-Gene
product NN I-Gene
, , O
and CC O
probably RB O
also RB O
Ce08102 NNP B-Gene
of IN O
Caenorhabditis NNP O
elegans NNS O
, , O
all DT O
members NNS O
of IN O
the DT O
DEAD NNP B-Gene
protein VBP I-Gene
family NN I-Gene
of IN O
ATP NNP B-Gene
- : I-Gene
dependent NN I-Gene
RNA NNP I-Gene
helicases VBZ I-Gene
. . O

Identification NN O
of IN O
a DT O
promoter NN O
- : O
specific JJ O
transactivation NN O
domain NN O
in IN O
the DT O
herpes NNS B-Gene
simplex JJ I-Gene
virus NN I-Gene
regulatory JJ I-Gene
protein NN I-Gene
ICP4 NNP I-Gene
. . O

The DT O
effects NNS O
of IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
were VBD O
further RB O
dissected VBN O
by IN O
showing VBG O
that IN O
c SYM B-Gene
- : I-Gene
myc NN I-Gene
can MD O
inhibit VB O
differentiation NN O
independently RB O
of IN O
Id NNP B-Gene
, , O
a DT O
negative JJ O
regulator NN O
of IN O
muscle NN O
differentiation NN O
. . O

In IN O
this DT O
method NN O
, , O
PLP NNP O
in IN O
plasma NN O
can MD O
be VB O
determined VBN O
with IN O
high JJ O
sensitivity NN O
using VBG O
derivatization NN O
with IN O
sodium NN O
bisulfite NN O
in IN O
the DT O
mobile JJ O
phase NN O
. . O

The DT O
role NN O
of IN O
' '' O
scientific JJ O
psychiatry NN O
' '' O
in IN O
understanding JJ O
patients NNS O
with IN O
chronic JJ O
schizophrenia NN O
or CC O
severe JJ O
personality NN O
disorder NN O
. . O

The DT O
psychologic JJ O
factors NNS O
associated VBD O
wth RB O
serious JJ O
illness NN O
, , O
terminal JJ O
prognoses NNS O
, , O
and CC O
dying VBG O
complicate VB O
the DT O
scenario NN O
even RB O
more RBR O
as IN O
compared VBN O
with IN O
that DT O
of IN O
nonmalignant JJ O
pain NN O
. . O

Theory NN O
and CC O
applications NNS O
of IN O
pulse JJ O
dosing NN O
: : O
a DT O
summary NN O
of IN O
the DT O
symposium NN O
. . O

Relationship NN O
between IN O
gross JJ O
lesions NNS O
and CC O
Escherichia NNP O
coli VBP O
serotypes NNS O
in IN O
chronic JJ O
respiratory NN O
disease NN O
( ( O
CRD NNP O
) ) O
of IN O
poultry NN O
. . O

Elimination NN O
of IN O
gamma JJ O
- : O
irradiation NN O
induced JJ O
oxidation NN O
in IN O
aqueous JJ O
drug NN O
preparations NNS O

Ste18p NNP B-Gene
was VBD O
targeted VBN O
to TO O
the DT O
plasma NN O
membrane NN O
even RB O
in IN O
the DT O
absence NN O
of IN O
prenylation NN O
or CC O
thioacylation NN O
. . O

Transforming VBG B-Gene
growth NN I-Gene
factor NN I-Gene
( ( I-Gene
TGF NNP I-Gene
) ) I-Gene
- : I-Gene
beta1 NN I-Gene
induces NNS O
extracellular JJ O
matrix JJ O
deposition NN O
and CC O
proliferation NN O
of IN O
mesenchymal JJ O
cells NNS O
. . O

However RB O
, , O
its PRP$ O
participation NN O
in IN O
gagging VBG O
induced VBN O
by IN O
oropharyngeal JJ O
irritation NN O
is VBZ O
unclear JJ O
. . O

The DT O
growth NN O
defect NN O
of IN O
a DT O
reg1 NN B-Gene
reg2 NN B-Gene
double JJ I-Gene
mutant NN I-Gene
is VBZ O
alleviated VBN O
by IN O
a DT O
loss NN O
- : O
of IN O
- : O
function NN O
mutation NN O
in IN O
the DT O
SNF1 NNP B-Gene
- : I-Gene
encoded VBD I-Gene
protein JJ I-Gene
kinase NN I-Gene
. . O

The DT O
B NNP B-Gene
. . I-Gene
germanica NN I-Gene
cyclophilin NN I-Gene
amino NN I-Gene
acid JJ I-Gene
sequence NN I-Gene
shares NNS O
83 CD O
% NN O
identity NN O
with IN O
the DT O
cytosolic JJ B-Gene
cyclophilin NN I-Gene
isoform NN I-Gene
from IN I-Gene
Drosophila NNP I-Gene
melanogaster NN I-Gene
( ( O
Cyp NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

Ventricular JJ O
volume NN O
stiffness NN O
vs NN O
. . O
the DT O
mean NN O
wall NN O
stress NN O
relationship NN O
of IN O
LVH NNP O
shifted VBD O
upward RB O
, , O
whereas IN O
the DT O
normalized JJ O
wall NN O
muscle NN O
stiffness NN O
vs NN O
. . O
the DT O
mean NN O
wall NN O
stress NN O
relationship NN O
of IN O
LVH NNP O
showed VBD O
a DT O
smaller JJR O
slope NN O
. . O

Strontium NNP O
chloride NN O
Sr NNP O
89 CD O
is VBZ O
costly JJ O
, , O
but CC O
preliminary JJ O
analysis NN O
indicates VBZ O
that IN O
it PRP O
may MD O
reduce VB O
management NN O
expenditures NNS O
overall JJ O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Nor CC O
is VBZ O
such JJ O
adjustment NN O
possible JJ O
unless IN O
one CD O
posits VBZ O
a DT O
model NN O
that WDT O
relates VBZ O
the DT O
missing VBG O
observations NNS O
to TO O
other JJ O
observed JJ O
information NN O
for IN O
each DT O
subject NN O
- : O
models NNS O
that WDT O
are VBP O
inherently RB O
untestable JJ O
. . O

Rare NNP O
neurogenic JJ O
tumor NN O
with IN O
metastasis NN O
to TO O
mouth VB O
, , O
jaw NN O
and CC O
face NN O
regions NNS O

We PRP O
suggest VBP O
that IN O
such JJ O
occlusions NNS O
occurred VBD O
at IN O
the DT O
time NN O
of IN O
the DT O
infarction NN O
. . O

The DT O
findings NNS O
are VBP O
compatible JJ O
with IN O
the DT O
idea NN O
that IN O
the DT O
genes NNS O
encoding VBG O
PDGF NNP B-Gene
receptors NNS I-Gene
in IN O
glioma NN O
cells NNS O
are VBP O
regulated VBN O
in IN O
concert NN O
with IN O
other JJ O
genes NNS O
, , O
the DT O
expression NN O
of IN O
which WDT O
may MD O
reflect VB O
the DT O
developmental JJ O
program NN O
of IN O
normal JJ O
glia NNS O
cell NN O
lineages NNS O
. . O

Identical JJ O
results NNS O
were VBD O
obtained VBN O
when WRB O
transfections NNS O
and CC O
mobility NN O
shift NN O
assays NNS O
were VBD O
performed VBN O
in IN O
primary JJ O
rat NN O
hepatocytes NNS O
in IN O
which WDT O
the DT O
endogenous JJ O
ALS NNP B-Gene
gene NN I-Gene
is VBZ O
expressed VBN O
. . O

MBP NNP B-Gene
- : O
Rep68 NNP B-Gene
delta SYM I-Gene
- : O
mediated VBN O
DNA NNP O
- : O
RNA JJ O
helicase NN O
activity NN O
required VBN O
ATP NNP O
hydrolysis NN O
and CC O
the DT O
presence NN O
of IN O
Mg2 NNP O
+ NNP O
ions NNS O
and CC O
was VBD O
inhibited VBN O
by IN O
high JJ O
ionic JJ O
strength NN O
. . O

Evidence NN O
for IN O
the DT O
involvement NN O
of IN O
the DT O
Glc7 NNP B-Gene
- : O
Reg1 NNP B-Gene
phosphatase NN O
and CC O
the DT O
Snf1 NNP B-Gene
- : O
Snf4 NNP B-Gene
kinase NN O
in IN O
the DT O
regulation NN O
of IN O
INO1 NNP B-Gene
transcription NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

However RB O
, , O
we PRP O
identified VBD O
a DT O
gene NN O
between IN O
the DT O
MDV2 NNP B-Gene
UL54 NNP I-Gene
and CC O
UL55 NNP B-Gene
genes NNS I-Gene
with IN O
homology NN O
to TO O
the DT O
first JJ B-Gene
ORF NNP I-Gene
( ( I-Gene
ORF NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
of IN I-Gene
equine NN I-Gene
herpesvirus NN I-Gene
type NN I-Gene
1 CD I-Gene
and CC O
corresponding VBG O
gene NN O
identified VBN O
in IN O
pseudorabies NNS O
virus NN O
. . O

Molecular JJ O
cloning NN O
of IN O
the DT O
polypeptide JJ O
component NN O
of IN O
the DT O
Rel NNP B-Gene
- : I-Gene
related JJ I-Gene
human JJ I-Gene
p75 NN I-Gene
nucleoprotein NN I-Gene
complex NN I-Gene
has VBZ O
revealed VBN O
its PRP$ O
identity NN O
with IN O
the DT O
65 CD O
- : O
kDa NN O
( ( O
p65 NN B-Gene
) ) O
subunit NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

Thus RB O
, , O
while IN O
the DT O
folds NNS O
of IN O
all DT O
Myb NNP B-Gene
domains NNS I-Gene
resemble JJ O
each DT O
other JJ O
closely RB O
, , O
the DT O
function NN O
of IN O
each DT O
Myb NNP B-Gene
domain NN I-Gene
depends VBZ O
on IN O
the DT O
amino NN O
acid NN O
residues NNS O
that WDT O
are VBP O
located VBN O
on IN O
the DT O
surface NN O
of IN O
each DT O
protein NN O
. . O

The DT O
solitary JJ O
kidney NN O
: : O
a DT O
model NN O
of IN O
chronic JJ O
hyperfiltration NN O
in IN O
humans NNS O
. . O

Brief JJ O
report NN O
. . O

Deletion NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
IL6 NNP I-Gene
beta NN I-Gene
leucine NN I-Gene
zipper NN I-Gene
domain NN I-Gene
also RB O
greatly RB O
diminished VBD O
the DT O
interaction NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

It PRP O
is VBZ O
surprising JJ O
that IN O
dnaE173 NN O
, , O
a DT O
potent JJ O
mutator NN O
mutation NN O
specific NN O
for IN O
sequence NN O
substitution NN O
as RB O
well RB O
as IN O
single JJ O
- : O
base NN O
frameshift NN O
, , O
did VBD O
not RB O
enhance VB O
the DT O
frequency NN O
of IN O
the DT O
hot JJ O
- : O
spot NN O
frameshift JJ O
mutation NN O
. . O

Separation NN O
of IN O
malaria NNS O
- : O
infected VBN O
erythrocytes NNS O
from IN O
whole JJ O
blood NN O
: : O
use NN O
of IN O
a DT O
selective JJ O
high JJ O
- : O
gradient NN O
magnetic JJ O
separation NN O
technique NN O
. . O

Further RB O
, , O
the DT O
PIP2 NNP O
content NN O
of IN O
the DT O
85 CD O
- : O
90 CD O
kDa NN O
protein NN O
appeared VBD O
to TO O
decrease VB O
with IN O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
treatment NN O
. . O

Prevention NN O
of IN O
acute JJ O
paraquat NN O
toxicity NN O
in IN O
rats NNS O
by IN O
superoxide JJ B-Gene
dismutase NN I-Gene
. . O

Further JJ O
analysis NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
DNA NN O
binding NN O
activities NNS O
in IN O
7 CD O
- : O
to TO O
14 CD O
- : O
day NN O
culture NN O
activated VBN O
HSCs NNP O
led VBD O
to TO O
the DT O
discovery NN O
of IN O
high JJ B-Gene
mobility NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
complexes NNS I-Gene
( ( O
HMAP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

The DT O
nmr JJ B-Gene
gene NN I-Gene
is VBZ O
the DT O
major JJ O
negative JJ O
regulatory JJ O
gene NN O
in IN O
the DT O
nitrogen NN O
control NN O
circuit NN O
of IN O
Neurospora NNP O
crassa NN O
, , O
which WDT O
, , O
together RB O
with IN O
positive JJ O
regulatory JJ O
genes NNS O
, , O
governs VBZ O
the DT O
expression NN O
of IN O
multiple JJ O
unlinked JJ O
structural JJ O
genes NNS O
of IN O
the DT O
circuit NN O
. . O

An DT O
intravenous JJ O
preparation NN O
of IN O
doxycycline NN O
( ( O
DOTC NNP O
, , O
Vibramycin NNP O
' POS O
Pfizer NNP O
' POS O
) ) O
, , O
a DT O
long JJ O
- : O
lasting NN O
tetracycline NN O
, , O
was VBD O
administered VBN O
mainly RB O
by IN O
drip JJ O
infusion NN O
for IN O
a DT O
series NN O
of IN O
study NN O
in IN O
the DT O
pediatrics NNS O
field NN O
, , O
and CC O
the DT O
results NNS O
were VBD O
as IN O
follows VBZ O
: : O
1 CD O
) ) O
DOTC NNP O
( ( O
100 CD O
mg NN O
) ) O
was VBD O
dissolved VBN O
in IN O
a DT O
100 CD O
ml NN O
of IN O
glucose JJ O
solution NN O
and CC O
2 CD O
- : O
- : O
3 CD O
mg NN O
/ NNP O
kg NN O
was VBD O
administered VBN O
intravenously RB O
. . O

The DT O
importance NN O
of IN O
these DT O
sites NNS O
for IN O
transcriptional JJ O
activation NN O
was VBD O
studied VBN O
by IN O
site NN O
- : O
directed VBN O
mutagenesis NN O
followed VBN O
by IN O
promoter NN O
function NN O
analysis NN O
of IN O
the DT O
mutants NNS O
with IN O
a DT O
chloramphenicol NN B-Gene
acetyltransferase NN I-Gene
reporter NN I-Gene
system NN O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
have VBP O
investigated VBN O
the DT O
regulatory JJ O
mechanism NN O
for IN O
CD95L NNP B-Gene
expression NN O
. . O

This DT O
lack NN O
of IN O
correlation NN O
may MD O
be VB O
due JJ O
to TO O
variations NNS O
in IN O
the DT O
metabolic JJ O
activity NN O
of IN O
the DT O
endometriotic JJ O
implants NNS O
present JJ O
at IN O
different JJ O
stages NNS O
of IN O
the DT O
disease NN O
. . O

Serum NNP O
antibody NN O
titre NN O
was VBD O
not RB O
significantly RB O
associated VBN O
with IN O
the DT O
recurrence NN O
rate NN O
or CC O
the DT O
duration NN O
of IN O
infection NN O
. . O

The DT O
intercistronic JJ O
gene NN O
junctions NNS O
of IN O
vesicular JJ O
stomatitis NN O
virus NN O
( ( O
VSV NNP O
) ) O
contain VBP O
conserved JJ O
sequence NN O
elements NNS O
that WDT O
are VBP O
important JJ O
for IN O
polyadenylation NN O
and CC O
transcription NN O
termination NN O
of IN O
upstream JJ O
transcript NN O
as RB O
well RB O
as IN O
reinitiation NN O
of IN O
transcription NN O
of IN O
downstream NN O
transcript NN O
. . O

The DT O
kappa JJ O
coefficient NN O
of IN O
agreement NN O
between IN O
the DT O
Patho NNP O
Dx NNP O
Kit NNP O
and CC O
the DT O
standard JJ O
method NN O
was VBD O
0 CD O
. . O
958 CD O
. . O

The DT O
bronchial JJ O
epithelia NN O
of IN O
all DT O
smoke FW O
- : O
exposed VBN O
animals NNS O
were VBD O
hyperplastic JJ O
, , O
and CC O
their PRP$ O
ultrastructure NN O
showed VBD O
invaginations NNS O
, , O
tilt NN O
of IN O
nuclear JJ O
axes NNS O
, , O
an DT O
increase NN O
in IN O
the DT O
number NN O
and CC O
size NN O
of IN O
lysosomes NNS O
and CC O
multivesiculated JJ O
bodies NNS O
, , O
and CC O
increased VBD O
numbers NNS O
of IN O
enlarged JJ O
intramitochondrial JJ O
granules NNS O
. . O

This DT O
study NN O
demonstrates VBZ O
that IN O
alteration NN O
of IN O
CDKN2 NNP B-Gene
is VBZ O
one CD O
of IN O
the DT O
most RBS O
frequent JJ O
genetic JJ O
abnormalities NNS O
in IN O
prostate NN O
cancer NN O
and CC O
may MD O
contribute VB O
to TO O
prostate VB O
carcinogenesis NN O
. . O

The DT O
ability NN O
of IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
to TO O
function NN O
as IN O
a DT O
transcriptional JJ O
repressor NN O
may MD O
contribute VB O
to TO O
its PRP$ O
ability NN O
to TO O
transform VB O
B NNP O
lymphocytes NNS O
in IN O
diffuse NN O
large JJ O
cell NN O
lymphoma NN O
. . O

We PRP O
were VBD O
interested JJ O
in IN O
studying VBG O
the DT O
relationship NN O
between IN O
the DT O
circadian JJ O
rhythm NN O
in IN O
body NN O
temperature NN O
and CC O
24 CD O
- : O
h NN O
variations NNS O
in IN O
plasma JJ O
concentrations NNS O
of IN O
iron NN O
, , O
zinc NN O
, , O
circulating VBG O
leukocyte NN O
counts NNS O
, , O
and CC O
plasma NN O
interleukin NN B-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
activity NN O
. . O

The DT O
mutants NNS O
were VBD O
obtained VBN O
by IN O
substitution NN O
into IN O
a DT O
molecular JJ O
clone NN O
of IN O
M NNP O
- : O
MuLV NNP O
DNA NNP O
by IN O
DNA NNP O
from IN O
two CD O
acutely RB O
transforming VBG O
viruses NNS O
, , O
Ableson NNP O
MuLV NNP O
( ( O
Ab NNP O
- : O
MuLV NN O
) ) O
and CC O
Moloney NNP O
murine NN O
sarcoma NN O
virus NN O
( ( O
M NNP O
- : O
MSV NN O
) ) O
. . O

Recovery NN O
of IN O
carbimazole JJ O
- : O
induced JJ O
agranulocytosis NN O
following VBG O
recombinant JJ B-Gene
granulocyte JJ I-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
stimulating VBG I-Gene
factor NN I-Gene
( ( O
rhGM JJ B-Gene
- : I-Gene
CSF NNP I-Gene
) ) O
administration NN O
. . O

A DT O
suspected JJ O
new JJ O
storage NN O
disease NN O
in IN O
cattle NNS O
. . O

A DT O
sterol NN O
- : O
regulated JJ O
protease NN O
initiates VBZ O
release NN O
of IN O
the DT O
NH2 NNP O
- : O
terminal JJ O
segments NNS O
of IN O
sterol NN B-Gene
regulatory JJ I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
( ( O
SREBPs NNP B-Gene
) ) O
from IN O
cell NN O
membranes NNS O
, , O
thereby RB O
allowing VBG O
them PRP O
to TO O
enter VB O
the DT O
nucleus NN O
and CC O
to TO O
stimulate VB O
transcription NN O
of IN O
genes NNS O
involved VBN O
in IN O
the DT O
uptake NN O
and CC O
synthesis NN O
of IN O
cholesterol NN O
and CC O
fatty JJ O
acids NNS O
. . O

To TO O
confirm VB O
the DT O
binding NN O
of IN O
protein NN O
to TO O
these DT O
sites NNS O
in IN O
cells NNS O
, , O
we PRP O
carried VBD O
out RP O
an DT O
in IN O
vivo NN O
genomic JJ O
footprinting NN O
analysis NN O
of IN O
this DT O
portion NN O
of IN O
the DT O
TGF NNP B-Gene
alpha NN I-Gene
promoter NN I-Gene
in IN O
normal JJ O
and CC O
transformed JJ O
rat NN O
liver RB O
epithelial JJ O
cell NN O
lines NNS O
that WDT O
express VBP O
the DT O
endogenous JJ O
gene NN O
at IN O
varying VBG O
levels NNS O
. . O

There EX O
is VBZ O
no DT O
TATA NNP O
box NN O
around IN O
the DT O
transcriptional JJ O
start NN O
points NNS O
( ( O
tsp NN O
) ) O
, , O
as IN O
determined VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
. . O

Control NNP O
subjects VBZ O
' POS O
evoked JJ O
potentials NNS O
( ( O
EPs NNP O
) ) O
were VBD O
characterized VBN O
by IN O
an DT O
initial JJ O
positivity NN O
in IN O
the DT O
90 CD O
- : O
140 CD O
ms NN O
range NN O
( ( O
P1 NNP O
) ) O
at IN O
the DT O
temporo NN O
- : O
occipital JJ O
site NN O
. . O

Since IN O
proteins NNS O
containing VBG O
TPR NNP O
elements NNS O
are VBP O
typically RB O
involved VBN O
in IN O
multiple JJ O
protein NN O
- : O
protein NN O
interactions NNS O
, , O
we PRP O
suggest VBP O
that IN O
the DT O
102kD CD O
protein NN O
interacts NNS O
within IN O
the DT O
tri JJ O
- : O
snRNP NN O
with IN O
both DT O
the DT O
U5 NNP B-Gene
and CC O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
snRNPs NN O
, , O
thus RB O
bridging VBG O
the DT O
two CD O
particles NNS O
. . O

Although IN O
some DT O
residues NNS O
are VBP O
found VBN O
reactive JJ O
toward IN O
dimethylsulphate NN O
and CC O
kethoxal NN O
in IN O
regions NNS O
predicted VBN O
to TO O
be VB O
unpaired VBN O
by IN O
the DT O
phylogenetic JJ O
secondary JJ O
structure NN O
model NN O
of IN O
4 CD B-Gene
. . I-Gene
5S CD I-Gene
RNA NNP I-Gene
, , O
generally RB O
the DT O
reactivity NN O
is VBZ O
low JJ O
, , O
and CC O
some DT O
residues NNS O
in IN O
internal JJ O
loops NNS O
are VBP O
not RB O
reactive JJ O
at IN O
all DT O
. . O

METHODS NN O
: : O
This DT O
retrospective JJ O
review NN O
comprised VBD O
2711 CD O
eyes NNS O
that WDT O
had VBD O
LASIK NNP O
between IN O
September NNP O
1996 CD O
and CC O
September NNP O
1999 CD O
. . O

Neither DT O
ethanol JJ O
regimen NNS O
impaired VBD O
spontaneous JJ O
alternation NN O
, , O
but CC O
the DT O
4 CD O
g NN O
ethanol NN O
. . O
kg VB O
- : O
1 CD O
x JJ O
day NN O
- : O
1 CD O
regimen NNS O
increased VBD O
the DT O
percent NN O
completed VBN O
trials NNS O
. . O

Northern NNP O
analysis NN O
of IN O
the DT O
3 CD B-Gene
. . I-Gene
1 CD I-Gene
- : I-Gene
kb NN I-Gene
PWP2H NNP I-Gene
cDNA NN I-Gene
revealed VBD O
that IN O
a DT O
3 CD O
. . O
3 CD O
- : O
kb NN O
major JJ O
transcript NN O
is VBZ O
ubiquitously RB O
expressed VBN O
in IN O
human JJ O
adult NN O
tissues NNS O
. . O

From IN O
August NNP O
1989 CD O
to TO O
October NNP O
1990 CD O
, , O
83 CD O
pregnant JJ O
Chinese JJ O
women NNS O
were VBD O
the DT O
subjects NNS O
for IN O
measuring VBG O
the DT O
levels NNS O
of IN O
plasma JJ O
functional JJ O
antithrombin NN B-Gene
III NNP I-Gene
( ( O
AT NNP B-Gene
III NNP I-Gene
) ) O
activity NN O
. . O

Absence NN O
of IN O
action NN O
potentials NNS O
in IN O
frog JJ O
slow JJ O
muscle NN O
fibres NNS O
paralysed VBN O
by IN O
botulinum NN B-Gene
toxin NN I-Gene
. . O

2 CD O
. . O
- : O
- : O
concepts NNS O
of IN O
higher JJR O
nervous JJ O
function NN O
in IN O
the DT O
USSR NNP O
. . O

The DT O
gene NN O
was VBD O
expressed VBN O
as IN O
an DT O
approximately RB O
1 CD O
. . O
5 CD O
- : O
kb NN O
mRNA NN O
in IN O
most JJS O
nonlymphoid JJ O
human JJ O
cells NNS O
/ VBP O
tissues NNS O
including VBG O
prostate NN O
, , O
lung NN O
, , O
liver NN O
, , O
and CC O
colon NN O
. . O

However RB O
, , O
we PRP O
did VBD O
not RB O
observe VB O
a DT O
correlation NN O
between IN O
serum NN O
and CC O
seminal JJ B-Gene
plasma NN I-Gene
PSA NNP I-Gene
levels NNS O
. . O

Ligand NNP O
binding VBG O
to TO O
the DT O
receptor NN O
complex JJ O
leads VBZ O
to TO O
tyrosine VB O
phosphorylation NN O
and CC O
activation NN O
of IN O
Janus NNP B-Gene
kinases NNS I-Gene
( ( O
Jak NNP B-Gene
) ) O
, , O
phosphorylation NN O
of IN O
the DT O
signal JJ B-Gene
transducing NN I-Gene
subunit NN I-Gene
gp130 NN I-Gene
, , O
followed VBN O
by IN O
recruitment NN O
and CC O
phosphorylation NN O
of IN O
the DT O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
STAT3 NNP B-Gene
and CC O
STAT1 NNP B-Gene
and CC O
the DT O
src NN B-Gene
homology NN I-Gene
domain NN I-Gene
( ( O
SH2 NNP B-Gene
) ) O
- : O
containing VBG O
protein JJ B-Gene
tyrosine JJ I-Gene
phosphatase NN I-Gene
( ( O
SHP2 NNP B-Gene
) ) O
. . O

Consistent JJ O
with IN O
this DT O
finding NN O
, , O
beta SYM B-Gene
- : I-Gene
catenin NN I-Gene
interacted VBN O
directly RB O
with IN O
the DT O
RA NNP B-Gene
receptor NN I-Gene
( ( O
RAR NNP B-Gene
) ) O
in IN O
a DT O
retinoid JJ O
- : O
dependent JJ O
manner NN O
, , O
but CC O
not RB O
with IN O
the DT O
retinoid NN B-Gene
X NNP I-Gene
receptor NN I-Gene
( ( O
RXR NNP B-Gene
) ) O
, , O
and CC O
RAR NNP B-Gene
competed VBD O
with IN O
TCF NNP B-Gene
for IN O
beta NN B-Gene
- : I-Gene
catenin NN I-Gene
binding NN O
. . O

In IN O
contrast NN O
to TO O
the DT O
situation NN O
in IN O
mammalian JJ O
cells NNS O
, , O
prolonged JJ O
exposure NN O
of IN O
the DT O
agonist NN O
( ( O
24 CD O
h NN O
) ) O
does VBZ O
not RB O
result VB O
in IN O
down JJ O
regulation NN O
of IN O
the DT O
remaining VBG O
70 CD O
% NN O
of IN O
the DT O
receptors NNS O
. . O

The DT O
author NN O
provides VBZ O
a DT O
rationale NN O
for IN O
an DT O
interactional JJ O
view NN O
and CC O
presents VBZ O
a DT O
case NN O
in IN O
which WDT O
post NN O
- : O
surgical JJ O
hiccups NNS O
were VBD O
successfully RB O
treated VBN O
, , O
using VBG O
principles NNS O
developed VBN O
by IN O
the DT O
Mental NNP O
Research NNP O
Institute NNP O
. . O

Grimelius NNP O
stain NN O
was VBD O
positive JJ O
, , O
Masson NNP O
Fontana NNP O
stain NN O
negative JJ O
. . O

Upon IN O
analysis NN O
of IN O
the DT O
tissue NN O
distribution NN O
of IN O
AAMP NNP B-Gene
, , O
it PRP O
was VBD O
found VBN O
to TO O
be VB O
expressed VBN O
strongly RB O
in IN O
endothelial JJ O
cells NNS O
, , O
cytotrophoblasts NNS O
, , O
and CC O
poorly RB O
differentiated VBN O
colon NN O
adenocarcinoma NN O
cells NNS O
found VBN O
in IN O
lymphatics NNS O
. . O

We PRP O
infer VBP O
that IN O
the DT O
dominant JJ O
negative JJ O
inhibition NN O
results NNS O
from IN O
both DT O
direct JJ O
proteolysis NN O
of IN O
the DT O
beta NN B-Gene
- : I-Gene
galactosidase NN I-Gene
tetramer NN I-Gene
by IN O
the DT O
fusion NN O
subunit NN O
and CC O
detour NN O
of IN O
the DT O
tetramer NN O
to TO O
the DT O
lysosome NN O
. . O

Furthermore RB O
, , O
formation NN O
of IN O
foci NN O
of IN O
transformed VBN O
RECs NNP O
by IN O
the DT O
c NN B-Gene
- : I-Gene
jun NN I-Gene
/ NN O
ras FW B-Gene
combination NN O
was VBD O
augmented VBN O
3 CD O
- : O
fold NN O
by IN O
the DT O
tumor NN O
promoter NN O
phorbol NN O
12 CD O
- : O
tetradecanoate NN O
13 CD O
- : O
acetate NN O
. . O

Functional JJ O
recognition NN O
of IN O
5 CD O
' POS O
splice NN O
site NN O
by IN O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
. . O
U5 NNP B-Gene
tri SYM O
- : O
snRNP NN O
defines VBZ O
a DT O
novel JJ O
ATP NNP O
- : O
dependent JJ O
step NN O
in IN O
early JJ O
spliceosome NN O
assembly NN O
. . O

Recombinant JJ O
expression NN O
of IN O
a DT O
chimeric JJ O
EGFR NNP B-Gene
/ NNP O
ErbB NNP B-Gene
- : I-Gene
3 CD I-Gene
receptor NN I-Gene
in IN O
NIH NNP O
3T3 CD O
fibroblasts NNS O
allowed VBD O
us PRP O
to TO O
investigate VB O
cytoplasmic JJ O
events NNS O
associated VBN O
with IN O
ErbB NNP B-Gene
- : I-Gene
3 CD I-Gene
signal JJ O
transduction NN O
upon IN O
ligand NN O
activation NN O
. . O

0 CD O
% NN O
) ) O
and CC O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
( ( O
42 CD O
. . O
6 CD O
% NN O
vs NN O
. . O

Unlike IN O
class NN O
II NNP O
- : O
and CC O
III NNP O
- : O
specific JJ O
TBP NNP B-Gene
- : O
TAF NN B-Gene
complexes NNS O
, , O
the DT O
corresponding JJ O
murine NN O
and CC O
human JJ O
class NN O
I PRP O
- : O
specific JJ O
transcription NN O
initiation NN O
factor NN O
TIF NNP B-Gene
- : I-Gene
IB NNP I-Gene
/ NNP O
SL1 NNP B-Gene
exhibits VBZ O
a DT O
pronounced JJ O
selectivity NN O
for IN O
its PRP$ O
homologous JJ O
promoter NN O
. . O

The DT O
results NNS O
also RB O
showed VBD O
that IN O
although IN O
oyster NN O
shell NN O
supplementation NN O
generally RB O
increased VBD O
alkaline JJ B-Gene
phosphatase NN I-Gene
activity NN O
, , O
bone NN O
mineralization NN O
was VBD O
relatively RB O
uninfluenced JJ O
as IN O
judged VBN O
by IN O
the DT O
low JJ O
coefficients NNS O
of IN O
variation NN O
( ( O
CV NNP O
) ) O
of IN O
3 CD O
. . O
14 CD O
- : O
3 CD O
. . O
51 CD O
% NN O
and CC O
3 CD O
. . O
39 CD O
- : O
4 CD O
. . O
82 CD O
% NN O
for IN O
calcium NN O
and CC O
phosphorus NN O
content NN O
in IN O
the DT O
femur NN O
and CC O
tibia NN O
respectively RB O
. . O

Mutational JJ O
analysis NN O
of IN O
chromosomal JJ O
segment NN O
64AB CD O
, , O
a DT O
region NN O
containing VBG O
the DT O
glutamic JJ B-Gene
acid NN I-Gene
decarboxylase NN I-Gene
gene NN I-Gene
. . O

Results NNS O
for IN O
men NNS O
who WP O
drank VBD O
up RB O
to TO O
two CD O
drinks NNS O
per IN O
day NN O
suggest VBP O
that IN O
if IN O
the DT O
dependence NN O
criteria NNS O
were VBD O
invalid JJ O
, , O
reductions NNS O
in IN O
the DT O
prevalence NN O
of IN O
specific JJ O
indicators NNS O
of IN O
alcohol NN O
dependence NN O
would MD O
range VB O
from IN O
0 CD O
. . O
3 CD O
% NN O
to TO O
5 CD O
. . O
2 CD O
% NN O
. . O

The DT O
two CD O
larger JJR O
peptides NNS O
, , O
one CD O
containing NN O
amino NN O
acids NNS O
1 CD O
- : O
228 CD O
and CC O
the DT O
other JJ O
containing VBG O
amino JJ O
acids NNS O
85 CD O
- : O
228 CD O
, , O
formed VBD O
dimers NNS O
in IN O
solution NN O
and CC O
bound NN O
DNA NNP O
specifically RB O
as IN O
a DT O
dimer NN O
. . O

This DT O
report NN O
expands VBZ O
on IN O
previous JJ O
work NN O
with IN O
interferon NN B-Gene
alfa NN I-Gene
- : I-Gene
2b CD I-Gene
( ( I-Gene
Intron NNP I-Gene
A NNP I-Gene
; : I-Gene
Schering VBG I-Gene
- : I-Gene
Plough NN I-Gene
) ) I-Gene
in IN O
the DT O
treatment NN O
of IN O
hairy NN O
cell NN O
leukemia NN O
( ( O
HCL NNP O
) ) O
. . O

In IN O
the DT O
diabetics NNS O
, , O
Ca2 NNP O
+ NNP O
infusions NNS O
induced VBD O
a DT O
rise NN O
of IN O
plasma NN O
Ca2 NNP O
+ VBZ O
up IN O
to TO O
3 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
1 CD O
mmol JJ O
/ NN O
1 CD O
and CC O
a DT O
fall NN O
of IN O
circulating VBG O
glucagon NN B-Gene
( ( O
- : O
26 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
5 CD O
. . O
7 CD O
% NN O
; : O
p CC O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
and CC O
glucose JJ O
( ( O
- : O
23 CD O
. . O
3 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
6 CD O
% NN O
; : O
p CC O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

A DT O
noncatalytic JJ O
domain NN O
conserved VBD O
among IN O
cytoplasmic JJ B-Gene
protein NN I-Gene
- : I-Gene
tyrosine NN I-Gene
kinases VBZ I-Gene
modifies VBZ O
the DT O
kinase NN O
function NN O
and CC O
transforming VBG O
activity NN O
of IN O
Fujinami NNP B-Gene
sarcoma NN I-Gene
virus NN I-Gene
P130gag NNP I-Gene
- : O
fps NN B-Gene
. . O

Here RB O
the DT O
conventional JJ O
tests NNS O
clearly RB O
pointed VBD O
to TO O
the DT O
presence NN O
of IN O
retrocochlear JJ O
disease NN O
. . O

Furthermore RB O
, , O
we PRP O
notice VBP O
two CD O
potential JJ O
consensus NN O
motifs NNS O
which WDT O
are VBP O
also RB O
found VBN O
in IN O
corresponding VBG O
positions NNS O
in IN O
the DT O
genes NNS O
for IN O
the DT O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
receptor NN I-Gene
and CC O
the DT O
68 CD B-Gene
- : I-Gene
kDa NN I-Gene
neurofilament JJ I-Gene
protein NN I-Gene
. . O

This DT O
slope NN O
was VBD O
further RBR O
significantly RB O
decreased VBN O
at IN O
5 CD O
min NN O
ischemia NN O
( ( O
- : O
26 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
8 CD O
. . O
8 CD O
microm NN O
/ NNP O
mmHg NN O
) ) O
but CC O
returned VBN O
toward IN O
control NN O
values NNS O
in IN O
short JJ O
- : O
term NN O
hibernating VBG O
myocardium NN O
at IN O
90 CD O
min NN O
ischemia NN O
( ( O
- : O
17 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
6 CD O
microm NN O
/ NNP O
mmHg NN O
) ) O
. . O

Transient JJ O
transfection NN O
assays NNS O
using VBG O
P19 NNP O
cells NNS O
revealed VBD O
that IN O
expression NN O
of IN O
NDRF NNP B-Gene
/ NNP O
NeuroD2 NNP B-Gene
increased VBD O
the DT O
transactivation NN O
of IN O
the DT O
rat NN B-Gene
insulin NN I-Gene
promoter NN I-Gene
element NN I-Gene
3 CD I-Gene
( ( O
RIPE3 NNP B-Gene
) ) O
enhancer VBZ O
up RP O
to TO O
approximately RB O
12 CD O
- : O
fold NN O
and CC O
that IN O
co SYM O
- : O
expression NN O
of IN O
catalytically RB O
active JJ O
form NN O
of IN O
PKN NNP B-Gene
, , O
but CC O
not RB O
kinase VB O
- : O
deficient NN O
derivative NN O
, , O
resulted VBD O
in IN O
a DT O
further JJ O
threefold JJ O
increase NN O
of IN O
NDRF NNP B-Gene
/ NNP O
NeuroD2 NNP B-Gene
- : O
mediated VBN O
transcription NN O
. . O

9 CD O
, , O
11 CD O
- : O
Seco NNP O
steroids NNS O
derived VBD O
from IN O
estradiol NN O
3 CD O
- : O
methyl NN O
ether NN O
. . O

During IN O
flexion NN O
whiplash NN O
, , O
the DT O
torque NN O
at IN O
the DT O
occipital JJ O
condyle NN O
reverses VBZ O
its PRP$ O
direction NN O
at IN O
about RB O
25 CD O
ms NNS O
after IN O
impact NN O
. . O

Six CD O
patients NNS O
with IN O
the DT O
diagnosis NN O
of IN O
acute JJ O
mania NN O
were VBD O
treated VBN O
with IN O
high JJ O
doses NNS O
of IN O
the DT O
beta NN O
- : O
adrenergic NN O
blocking VBG O
agent JJ O
propranolol NN O
. . O

Within IN O
their PRP$ O
polypeptide NN O
chain NN O
, , O
they PRP O
all DT O
contain VBP O
those DT O
conserved JJ O
features NNS O
that WDT O
define VBP O
a DT O
plant NN O
CDPK NNP B-Gene
; : O
kinase VB O
catalytic JJ O
sequences NNS O
are VBP O
linked VBN O
to TO O
a DT O
calmodulin JJ B-Gene
- : I-Gene
like IN I-Gene
regulatory JJ I-Gene
domain NN I-Gene
through IN O
a DT O
junction NN O
region NN O
. . O

The DT O
minus NN O
- : O
end NN O
- : O
directed VBN O
microtubule NN O
motors NNS O
, , O
the DT O
dyneins NNS B-Gene
, , O
may MD O
also RB O
constitute VB O
a DT O
superfamily NN O
of IN O
force NN O
- : O
generating VBG O
proteins NNS O
with IN O
distinct JJ O
attachment NN O
domains NNS O
. . O

The DT O
constraints NNS O
of IN O
primase NN B-Gene
recognition NN I-Gene
sequences NNS I-Gene
, , O
nucleotide RB O
substrate NN O
requirements NNS O
, , O
and CC O
the DT O
effects NNS O
of IN O
additional JJ O
proteins NNS O
on IN O
oligoribonucleotide IN O
synthesis NN O
by IN O
the DT O
63 CD B-Gene
- : I-Gene
kDa NN I-Gene
gene NN I-Gene
4 CD I-Gene
protein NNS I-Gene
have VBP O
been VBN O
examined VBN O
using VBG O
templates NNS O
of IN O
defined JJ O
sequence NN O
. . O

In IN O
the DT O
present JJ O
work NN O
, , O
the DT O
complete JJ O
genome NN O
sequences NNS O
of IN O
Pyrococcus NNP O
horikoshii NN O
and CC O
Pyrococcus NNP O
abyssi RB O
, , O
two CD O
species NNS O
in IN O
a DT O
genus NN O
of IN O
hyperthermophilic JJ O
archaeon NN O
( ( O
archaebacterium NN O
) ) O
, , O
were VBD O
compared VBN O
to TO O
detect VB O
large JJ O
genome JJ O
polymorphisms NNS O
linked VBN O
with IN O
restriction NN O
- : O
modification NN O
gene NN O
homologs NNS O
. . O

Gaucher NNP O
' POS O
s JJ O
disease NN O
is VBZ O
a DT O
rare JJ O
metabolic JJ O
disorder NN O
characterized VBN O
by IN O
the DT O
lack NN O
of IN O
beta NN B-Gene
- : I-Gene
glucocerebrosidase NN I-Gene
enzyme NN I-Gene
. . O

The DT O
results NNS O
suggested VBD O
that IN O
, , O
depending VBG O
upon IN O
the DT O
cell NN O
type NN O
, , O
gene NN O
cotransfer NN O
using VBG O
aminoglycoside JJ O
resistance NN O
as IN O
a DT O
selectable JJ O
marker NN O
may MD O
seriously RB O
perturb VB O
important JJ O
cellular JJ O
control NN O
mechanisms NNS O
such JJ O
as IN O
the DT O
PKC NNP B-Gene
pathway NN O
leading VBG O
to TO O
activation NN O
of IN O
gene NN O
expression NN O
. . O

Further JJ O
analysis NN O
of IN O
this DT O
domain NN O
by IN O
in IN O
vitro JJ O
mutagenesis NN O
pointed VBD O
to TO O
a DT O
core NN O
of IN O
hydrophobic NN O
and CC O
acidic JJ O
residues NNS O
as IN O
critical JJ O
for IN O
the DT O
activity NN O
. . O

The DT O
pharmacological JJ O
effects NNS O
of IN O
the DT O
novel JJ O
compound NN O
WEB NNP O
1881 CD O
FU NNP O
( ( O
4 CD O
- : O
amino NN O
- : O
methyl NN O
- : O
1 CD O
- : O
benzyl NN O
- : O
pyrrolidine NN O
- : O
2 CD O
- : O
one CD O
- : O
fumarate NN O
) ) O
were VBD O
investigated VBN O
. . O

Simultaneous JJ O
right NN O
and CC O
left VBD O
adrenal JJ O
and CC O
peripheral JJ O
blood NN O
samples NNS O
were VBD O
collected VBN O
for IN O
determination NN O
of IN O
oestrone NN O
( ( O
E1 NNP O
) ) O
and CC O
oestradiol $ O
( ( O
E2 NNP O
) ) O
. . O

Comparison NNP O
of IN O
the DT O
p50 NN B-Gene
sequence NN I-Gene
to TO O
other JJ O
cloned JJ O
proteins NNS O
revealed VBD O
89 CD O
% NN O
homology NN O
with IN O
a DT O
glycosaminoglycan JJ O
- : O
binding NN O
protein NN O
and CC O
54 CD O
% NN O
homology NN O
with IN O
Drosophila NNP B-Gene
cell NN I-Gene
cycle NN I-Gene
control NN I-Gene
protein NN I-Gene
( ( I-Gene
cdc NN I-Gene
) ) I-Gene
37 CD O
. . O

We PRP O
sought VBD O
to TO O
determine VB O
whether IN O
such JJ O
differences NNS O
in IN O
polyadenylation NN O
affect VBP O
the DT O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
DHFR NNP B-Gene
and CC O
mRNAs NNS O
expressed VBN O
from IN O
either CC O
allele JJ O
and CC O
, , O
in IN O
a DT O
more RBR O
general JJ O
sense NN O
, , O
to TO O
ask VB O
whether IN O
differences NNS O
in IN O
3 CD O
' POS O
end NN O
RNA NNP O
processing NN O
in IN O
a DT O
gene NN O
containing VBG O
multiple JJ O
poly NN O
( ( O
A DT O
) ) O
sites VBZ O
affects VBZ O
the DT O
final JJ O
level NN O
of IN O
gene NN O
expression NN O
. . O

CES4 NNP B-Gene
on IN O
a DT O
multicopy NN O
plasmid NN O
was VBD O
unable JJ O
to TO O
suppress VB O
tif1 JJ B-Gene
- : I-Gene
A79V NN I-Gene
. . O

Anatomy NNP O
of IN O
the DT O
uterine JJ O
artery NN O
. . O

Processing NN O
of IN O
the DT O
polycistronic NN O
precursor NN O
requires VBZ O
nucleases NNS O
also RB O
involved VBN O
in IN O
rRNA NN O
processing NN O
, , O
i NN O
. . O
e NN O
. . O
, , O
Rnt1p NNP B-Gene
and CC O
Rat1p NNP B-Gene
. . O

Sequence NNP O
comparison NN O
indicates VBZ O
that IN O
exons NNS O
5 CD O
' '' O
/ JJ O
L NNP O
and CC O
L NNP O
/ NNP O
N NNP O
in IN O
PSG12 NNP B-Gene
and CC O
PSG12 NNP B-Gene
psi NNS I-Gene
are VBP O
99 CD O
% NN O
identical JJ O
, , O
except IN O
that IN O
the DT O
L NNP O
/ NNP O
N NNP O
exon NN O
in IN O
the DT O
PSG12 NNP B-Gene
psi NN I-Gene
gene NN I-Gene
contains VBZ O
a DT O
stop JJ O
codon NN O
. . O

In IN O
addition NN O
, , O
a DT O
comparison NN O
of IN O
the DT O
hCHLR NN B-Gene
gene NN I-Gene
sequences NNS I-Gene
with IN O
available JJ O
databases NNS O
indicates VBZ O
that IN O
a DT O
large JJ O
portion NN O
of IN O
these DT O
genes NNS O
, , O
including VBG O
exons NNS O
encoding VBG O
two CD O
functional JJ O
domains NNS O
of IN O
the DT O
carboxyl NN O
- : O
terminal JJ O
region NN O
of IN O
these DT O
proteins NNS O
, , O
has VBZ O
been VBN O
duplicated VBN O
as IN O
part NN O
of IN O
a DT O
larger JJR O
human JJ O
telomeric JJ O
repeat NN O
sequence NN O
found VBD O
on IN O
many JJ O
human JJ O
chromosomes NNS O
. . O

Since IN O
the DT O
ETS NNP B-Gene
domain NN I-Gene
, , O
which WDT O
is VBZ O
localized VBN O
in IN O
the DT O
carboxy JJ O
terminal JJ O
region NN O
of IN O
the DT O
encoded JJ O
protein NN O
, , O
is VBZ O
95 CD O
% NN O
and CC O
96 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
PEA3 NNP B-Gene
and CC O
ER81 NNP B-Gene
, , O
respectively RB O
, , O
we PRP O
named VBD O
this DT O
new JJ O
member NN O
' POS B-Gene
Ets NNP I-Gene
Related NNP I-Gene
Molecule NNP I-Gene
PEA3 NNP I-Gene
- : I-Gene
like IN I-Gene
' '' I-Gene
( ( O
ERM NNP B-Gene
) ) O
. . O

This DT O
approximately RB O
125 CD O
- : O
nt NN O
RNA NNP O
proved VBD O
to TO O
arise VB O
via IN O
RNase NNP B-Gene
E NNP I-Gene
cleavage NN O
from IN O
the DT O
3 CD O
' POS O
- : O
terminal JJ O
region NN O
of IN O
the DT O
mRNAs NN O
bearing VBG O
the DT O
terminator NN O
. . O

CDNA NNP O
cloning NN O
of IN O
chick NN B-Gene
brain NN I-Gene
alpha IN I-Gene
- : I-Gene
amino NN I-Gene
- : I-Gene
3 CD I-Gene
- : I-Gene
hydroxy NN I-Gene
- : I-Gene
5 CD I-Gene
- : I-Gene
methyl NN I-Gene
- : I-Gene
4 CD I-Gene
- : I-Gene
isoxazolepropionic JJ I-Gene
acid NN I-Gene
receptors NNS I-Gene
reveals VBP O
conservation NN O
of IN O
structure NN O
, , O
function NN O
and CC O
post NN O
- : O
transcriptional JJ O
processes NNS O
with IN O
mammalian JJ O
receptors NNS O
. . O

Deletion NN O
analysis NN O
revealed VBD O
that IN O
the DT O
essential JJ O
domain NN O
of IN O
this DT O
promoter NN O
, , O
termed VBD O
the DT O
ORF5 NNP B-Gene
/ NNP I-Gene
deltaX NN I-Gene
transcript NN I-Gene
promoter NN I-Gene
, , O
mapped VBD O
to TO O
nucleotides VB O
1525 CD O
- : O
1625 CD O
. . O

The DT O
results NNS O
of IN O
these DT O
analyses NNS O
indicate VBP O
that IN O
the DT O
proteinase NN O
cleaves VBZ O
at IN O
amino NN O
acid NN O
residues NNS O
E960 NNP O
- : O
A961 NNP O
, , O
E1071 NNP O
- : O
S1072 NNP O
, , O
E1345 NNP O
- : O
T1346 NN O
, , O
and CC O
E1419 NNP O
- : O
G1420 NN O
; : O
however RB O
, , O
the DT O
cleavage NN O
efficiency NN O
is VBZ O
varied VBN O
. . O

We PRP O
have VBP O
demonstrated VBN O
previously RB O
that IN O
two CD O
binding VBG O
sites NNS O
in IN O
the DT O
- : B-Gene
184 CD I-Gene
HNF NNP I-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
promoter NN I-Gene
are VBP O
recognized VBN O
by IN O
widely RB O
distributed VBN O
factors NNS O
and CC O
that IN O
there EX O
is VBZ O
also RB O
a DT O
critical JJ O
autoregulatory NN O
site NN O
, , O
we PRP O
identified VBD O
a DT O
binding NN O
site NN O
for IN O
a DT O
cell NN O
- : O
specific JJ O
factor NN O
, , O
LF NNP B-Gene
- : I-Gene
H3 NNP I-Gene
beta NN I-Gene
, , O
that WDT O
may MD O
function VB O
in IN O
restricting VBG O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
gene NN I-Gene
expression NN O
to TO O
hepatocytes NNS O
. . O

Interestingly RB O
, , O
the DT O
activated JJ O
PDGF NNP B-Gene
beta NN I-Gene
- : I-Gene
receptor NN I-Gene
was VBD O
found VBN O
not RB O
to TO O
bind VB O
Crk NNP B-Gene
proteins NNS I-Gene
. . O

However RB O
, , O
the DT O
element NN O
proximal NN O
to TO O
the DT O
transcription NN O
start NN O
site NN O
is VBZ O
dependent JJ O
on IN O
the DT O
SRE NNP O
- : O
1 CD O
. . O

Measurements NNS O
included VBD O
bone JJ O
mineral JJ O
density NN O
of IN O
the DT O
lumbar NN O
spine NN O
and CC O
proximal JJ O
femur NN O
( ( O
by IN O
dual JJ O
- : O
energy NN O
X NNP O
- : O
ray NN O
absorptiometry NN O
) ) O
and CC O
biochemical JJ O
markers NNS O
of IN O
bone NN O
remodeling NN O
( ( O
serum VB O
bone NN O
- : O
specific JJ O
alkaline JJ B-Gene
phosphatase NN I-Gene
by IN O
immunoassay NN O
and CC O
urine JJ O
deoxypyridinoline NN O
by IN O
high JJ O
- : O
pressure NN O
liquid JJ O
chromatography NN O
) ) O
. . O

Recently RB O
, , O
our PRP$ O
laboratory NN O
developed VBD O
a DT O
screen NN O
that WDT O
identified VBD O
five CD O
multicopy NN O
suppressors NNS O
that WDT O
can MD O
rescue VB O
lethal JJ O
strains NNS O
of IN O
clathrin JJ B-Gene
heavy JJ O
chain NN O
- : O
deficient NN O
yeast NN O
( ( O
Chc NNP B-Gene
- : O
scd1 NN B-Gene
- : I-Gene
i NN I-Gene
) ) O
to TO O
viability NN O
. . O

MSSP NNP B-Gene
- : I-Gene
1 CD I-Gene
produced VBN O
in IN O
E NNP O
. . O
coli NN O
as IN O
a DT O
fusion NN O
protein NN O
with IN O
GST NNP B-Gene
specifically RB O
interacted VBD O
with IN O
single JJ O
- : O
stranded VBN O
TCTTAT NNP O
( ( O
plus CC O
myc NN B-Gene
( ( O
H NNP O
- : O
P NNP O
) ) O
21 CD O
) ) O
and CC O
ACT NNP O
- : O
ATT NNP O
( ( O
in IN O
minus NN O
myc NN B-Gene
( ( O
H NNP O
- : O
P NNP O
) ) O
21 CD O
) ) O
, , O
the DT O
consensus NN O
of IN O
which WDT O
can MD O
be VB O
referred VBN O
to TO O
as IN O
A NNP O
/ NNP O
TCTA NNP O
/ NNP O
TA NNP O
/ NNP O
TT NNP O
. . O

Use NNP O
of IN O
subcutaneous JJ O
deferoxamine NN O
in IN O
a DT O
child NN O
with IN O
hemochromatosis NN O
associated VBN O
with IN O
congenital JJ O
dyserythropoietic JJ O
anemia NN O
, , O
type NN O
I PRP O
. . O

However RB O
, , O
a DT O
strongly RB O
increased JJ O
frequency NN O
of IN O
CpG NNP O
dinucleotides NNS O
was VBD O
found VBN O
. . O

TDEYA NN O
at IN O
doses NNS O
of IN O
200 CD O
to TO O
500 CD O
mg NNS O
/ JJ O
kg VBP O
significantly RB O
suppressed VBN O
xanthine JJ B-Gene
oxidase NN I-Gene
( ( O
XO NNP B-Gene
) ) O
activity NN O
in IN O
the DT O
stomach NN O
tissue NN O
following VBG O
its PRP$ O
oral JJ O
administration NN O
. . O

Anti NNP B-Gene
- : I-Gene
hepatitis NN I-Gene
A DT I-Gene
virus NN O
( ( O
HAV NNP O
) ) O
titer NN O
after IN O
vaccination NN O
was VBD O
measured VBN O
in IN O
83 CD O
HIV NNP O
- : O
positive JJ O
and CC O
39 CD O
HIV NNP O
- : O
negative JJ O
men NNS O
. . O

Neuronal JJ O
mechanisms NNS O
underlying VBG O
stimulus JJ O
- : O
response NN O
( ( O
S NNP O
- : O
R NN O
) ) O
associations NNS O
in IN O
S NNP O
- : O
R NNP O
compatibility NN O
tasks NNS O
were VBD O
identified VBN O
in IN O
2 CD O
experiments NNS O
with IN O
monkeys NNS O
. . O

Autoimmune NNP O
neutropenia NN O
( ( O
AIN NNP O
) ) O
is VBZ O
a DT O
frequent JJ O
cause NN O
of IN O
chronic JJ O
neutropenia NN O
especially RB O
in IN O
youngest JJS O
children NNS O
. . O

Effects NNS O
of IN O
alterations NNS O
of IN O
primer NN O
- : O
binding NN O
site NN O
sequences NNS O
on IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
replication NN O
. . O

Following VBG O
baseline NN O
clinical JJ O
examination NN O
and CC O
initial JJ O
periodontal JJ O
therapy NN O
, , O
32 CD O
patients NNS O
received VBD O
mucogingival JJ O
surgery NN O
with IN O
free JJ O
gingival NN O
grafts NNS O
for IN O
treatment NN O
of IN O
insufficient NN O
attached VBN O
gingiva NN O
. . O

The DT O
orientations NNS O
of IN O
the DT O
contact NN O
surfaces NNS O
and CC O
their PRP$ O
locations NNS O
relative VBP O
to TO O
the DT O
object NN O
' POS O
s NN O
center NN O
of IN O
mass NN O
were VBD O
varied VBN O
. . O

These DT O
observations NNS O
establish VB O
that IN O
RsmC NNP B-Gene
negatively RB O
regulates VBZ O
rsmB JJ B-Gene
transcription NN O
but CC O
positively RB O
affects VBZ O
RsmA NNP B-Gene
production NN O
. . O

Sci NNP O
. . O

Involvement NN O
of IN O
early JJ B-Gene
growth NN I-Gene
response NN I-Gene
factor NN I-Gene
Egr NNP I-Gene
- : I-Gene
1 CD I-Gene
in IN O
apolipoprotein NN B-Gene
AI NNP I-Gene
gene NN I-Gene
transcription NN O
. . O

A DT O
pathway NN O
for IN O
regulation NN O
of IN O
B NNP B-Gene
lymphocyte NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
- : O
induced JJ O
calcium NN O
flux NN O
. . O

Summers NNS O
, , O
Virology NNP O
89 CD O
: : O
517 CD O
- : O
527 CD O
, , O
1978 CD O
) ) O
. . O

CONCLUSION NN O
: : O
During IN O
chronic JJ O
treatment NN O
, , O
the DT O
haemodynamic JJ O
response NN O
to TO O
oral JJ O
cilazapril NN O
was VBD O
attenuated VBN O
, , O
indicating VBG O
that IN O
continued JJ O
clinical JJ O
improvement NN O
in IN O
patients NNS O
with IN O
CHF NNP O
on IN O
CLZ NNP O
is VBZ O
independent JJ O
of IN O
to TO O
its PRP$ O
acute JJ O
haemodynamic JJ O
effects NNS O
. . O

SETTING NN O
: : O
University NNP O
hospital NN O
- : O
based VBN O
, , O
tertiary JJ O
care NN O
infertility NN O
center NN O
. . O

Unlike IN O
the DT O
introns NNS O
of IN O
other JJ O
duplicated VBN O
ribosomal JJ B-Gene
protein NN I-Gene
genes NNS I-Gene
which WDT O
are VBP O
highly RB O
diverged VBN O
, , O
the DT O
duplicated JJ O
S13 NNP B-Gene
genes NNS I-Gene
have VBP O
two CD O
nearly RB O
identical JJ O
DNA NNP O
sequences NNS O
of IN O
25 CD O
and CC O
31 CD O
bp NN O
in IN O
length NN O
within IN O
their PRP$ O
introns NNS O
. . O

GN101 NNP O
, , O
YC819 NNP O
- : O
9 CD O
, , O
and CC O
SB3 NNP O
. . O

Unlike IN O
the DT O
typical JJ O
enhancer NN O
element NN O
, , O
this DT O
region NN O
functions NNS O
in IN O
an DT O
orientation NN O
- : O
dependent JJ O
manner NN O
. . O

Psychological JJ O
disturbance NN O
was VBD O
greater JJR O
in IN O
the DT O
high JJ O
life NN O
stress NN O
group NN O
as IN O
indicated VBN O
by IN O
significant JJ O
elevations NNS O
on IN O
the DT O
global JJ O
severity NN O
index NN O
of IN O
the DT O
Symptom NNP O
Checklist NNP O
- : O
90 CD O
and CC O
elevations NNS O
on IN O
somatization NN O
, , O
obsessive JJ O
compulsive NN O
, , O
interpersonal JJ O
sensitivity NN O
, , O
depression NN O
, , O
anxiety NN O
and CC O
psychoticism NN O
subscales NNS O
. . O

Confirmatory JJ O
statistics NNS O
included VBD O
item NN O
2 CD O
of IN O
the DT O
Clinical NNP O
Global NNP O
Impression NNP O
( ( O
CGI NNP O
) ) O
, , O
the DT O
total JJ O
score NN O
of IN O
the DT O
Sandoz NNP O
Clinical NNP O
Assessment NNP O
Geriatric NNP O
( ( O
SCAG NNP O
) ) O
scale NN O
, , O
the DT O
subscale NN O
' POS O
need NN O
for IN O
help NN O
' CD O
of IN O
the DT O
nurse NN O
' POS O
s NN O
rating NN O
of IN O
geriatric JJ O
patients NNS O
( ( O
Beurteilungsskala NNP O
fur RB O
geriatrische VBZ O
Patienten NNP O
; : O
BGP NNP O
) ) O
and CC O
the DT O
total JJ O
score NN O
of IN O
the DT O
Short NNP O
Cognitive NNP O
Performance NNP O
Test NNP O
( ( O
Syndrom NNP O
- : O
Kurztest NNP O
; : O
SKT NNP O
) ) O
. . O

This DT O
observation NN O
cannot NN O
be VB O
explained VBN O
by IN O
the DT O
scanning NN O
model NN O
for IN O
ribosomal JJ O
initiation NN O
and CC O
suggests VBZ O
that IN O
ribosomes NNS O
may MD O
be VB O
binding VBG O
directly RB O
at IN O
an DT O
internal JJ O
mRNA NN O
site NN O
at IN O
or CC O
near IN O
the DT O
initiator NN O
AUG NNP O
codon NN O
for IN O
the DT O
C NNP B-Gene
protein NN I-Gene
. . O

Rather RB O
, , O
complete JJ O
skipping NN O
of IN O
exon JJ O
V NNP O
and CC O
subsequent JJ O
joining NN O
of IN O
exon JJ O
IV NNP O
to TO O
exon VB O
VI NNP O
caused VBD O
a DT O
shift NN O
in IN O
the DT O
open JJ O
reading NN O
frame NN O
, , O
which WDT O
remodeled VBD O
GPHe NNP B-Gene
( ( I-Gene
P2 NNP I-Gene
) ) I-Gene
with IN O
an DT O
elongated JJ O
new JJ O
hydrophobic JJ O
sequence NN O
for IN O
membrane NN O
anchoring NN O
. . O

The DT O
mode NN O
of IN O
resistance NN O
to TO O
quinupristin VB O
/ JJ O
dalfopristin NN O
was VBD O
not RB O
evident JJ O
( ( O
sat VB O
A NNP O
- : O
negative JJ O
by IN O
PCR NNP O
) ) O
; : O
and CC O
these DT O
cases NNS O
illustrate VBP O
the DT O
existence NN O
of IN O
streptogramin JJ O
- : O
resistant JJ O
isolates NNS O
before IN O
the DT O
introduction NN O
of IN O
this DT O
antimicrobial JJ O
class NN O
into IN O
human JJ O
clinical JJ O
practice NN O
. . O

METHODS NN O
: : O
DSF NNP O
was VBD O
instilled VBN O
in IN O
one CD O
eye NN O
chosen VBN O
at IN O
random NN O
and CC O
CF NNP O
in IN O
the DT O
fellow JJ O
eye NN O
of IN O
13 CD O
normal JJ O
subjects NNS O
and CC O
in IN O
13 CD O
patients NNS O
with IN O
KCS NNP O
. . O

Pathogens NNS O
( ( O
Staphylococcus NNP O
aureus VBZ O
or CC O
Gram NNP O
- : O
negative JJ O
bacilli NN O
) ) O
were VBD O
isolated VBN O
from IN O
only RB O
one CD O
member NN O
of IN O
staff NN O
in IN O
small JJ O
numbers NNS O
and CC O
irregularly RB O
and CC O
rarely RB O
in IN O
large JJ O
numbers NNS O
from IN O
patients NNS O
. . O

Neutron NNP O
scattering VBG O
measurements NNS O
of IN O
critical JJ O
exponents NNS O
in IN O
CsMnBr3 NNP O
: : O
A NNP O
Z2 NNP O
& CC O
gt NN O
; : O
= CC O
1 CD O
antiferromagnet NN O
. . O

Nevertheless RB O
, , O
in IN O
view NN O
of IN O
the DT O
potential JJ O
transmission NN O
rates NNS O
of IN O
HGV NNP O
and CC O
the DT O
lack NN O
of IN O
effective JJ O
immunization NN O
, , O
HGV NNP O
should MD O
be VB O
regarded VBN O
as IN O
a DT O
potential JJ O
occupational JJ O
hazard NN O
for IN O
medical JJ O
and CC O
dental JJ O
staff NN O
. . O

Effects NNS O
of IN O
cortisone NN O
, , O
starvation NN O
, , O
and CC O
rickets NNS O
on IN O
oxidative JJ O
enzyme NN O
activities NNS O
of IN O
epiphyseal JJ O
cartilage NN O
from IN O
rats NNS O
. . O

Removal NN O
of IN O
all DT O
core NN B-Gene
histone NN I-Gene
tail NN O
domains NNS O
by IN O
limited JJ O
trypsin NN B-Gene
proteolysis NN O
or CC O
acetylation NN O
of IN O
the DT O
core NN B-Gene
histone NN I-Gene
tails VBZ O
significantly RB O
relieves VBZ O
this DT O
inhibition NN O
and CC O
allows VBZ O
TFIIIA NNP B-Gene
to TO O
exhibit VB O
high JJ O
- : O
affinity NN O
binding NN O
to TO O
nucleosomal JJ O
DNA NNP O
. . O

Abbreviations NNS O
: : O
CAS NNP B-Gene
, , O
CRK NNP B-Gene
- : I-Gene
associated JJ I-Gene
substrate NN I-Gene
; : O
CH NNP B-Gene
, , O
calponin SYM B-Gene
- : I-Gene
homology NN I-Gene
domain NN I-Gene
; : O
CSK NNP B-Gene
, , O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
SRC NNP I-Gene
kinase NN I-Gene
; : O
E6 NNP B-Gene
, , O
Papillomavirus NNP B-Gene
E6 NNP I-Gene
protein NN I-Gene
; : O
FAK NNP B-Gene
, , O
focal JJ B-Gene
adhesion NN I-Gene
kinase NN I-Gene
; : O
GIT NNP B-Gene
, , O
GRK NNP B-Gene
interacter NN I-Gene
; : O
GPCR NNP B-Gene
, , O
heterotrimeric JJ B-Gene
- : I-Gene
G NNP I-Gene
- : I-Gene
protein NN I-Gene
- : I-Gene
coupled JJ I-Gene
receptor NN I-Gene
; : O
GRK NNP B-Gene
, , O
G NNP B-Gene
- : I-Gene
protein NN I-Gene
- : I-Gene
coupled VBN I-Gene
- : I-Gene
receptor NN I-Gene
kinase NN I-Gene
; : O
MAPK NNP B-Gene
, , O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
ERK NNP B-Gene
, , O
p38 NN B-Gene
, , O
JNK NNP B-Gene
) ) O
; : O
PAK NNP B-Gene
, , O
p21 SYM B-Gene
- : I-Gene
activated JJ I-Gene
kinase NN I-Gene
; : O
PBS NNP B-Gene
, , O
paxillin SYM B-Gene
- : I-Gene
binding NN I-Gene
subdomain NN I-Gene
; : O
PIX NNP B-Gene
, , O
PAK NNP B-Gene
- : I-Gene
interacting VBG I-Gene
exchange NN I-Gene
factor NN I-Gene
; : O
PKL NNP B-Gene
, , O
paxillin NN B-Gene
kinase NN I-Gene
linker NN I-Gene
; : O
POR1 NNP B-Gene
, , O
partner NN B-Gene
of IN I-Gene
Rac NNP I-Gene
; : O
PS NNP O
, , O
phosphoserine NN O
; : O
PT NNP O
, , O
phosphothreonine NN O
; : O
PY NNP O
, , O
phosphotyrosine NN O
; : O
RTK NNP B-Gene
, , O
growth NN B-Gene
factor NN I-Gene
receptor NN I-Gene
tyrosine JJ I-Gene
kinase NN I-Gene
; : O
SH NNP B-Gene
, , O
SRC NNP B-Gene
- : I-Gene
homology NN I-Gene
domain NN I-Gene
. . O

According VBG O
to TO O
their PRP$ O
staining NN O
affinity NN O
for IN O
anti JJ B-Gene
- : I-Gene
T NN I-Gene
antibodies NNS I-Gene
, , O
the DT O
glandular JJ O
tissue NN O
cells NNS O
were VBD O
classified VBN O
as IN O
T NNP B-Gene
- : O
, , O
T NNP B-Gene
+ NNP O
, , O
T NNP B-Gene
+ NNP O
+ NNP O
, , O
and CC O
T NNP B-Gene
and CC O
the DT O
annual JJ O
changes NNS O
in IN O
the DT O
numbers NNS O
of IN O
these DT O
cell NN O
populations NNS O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
volume NN O
occupied VBN O
by IN O
the DT O
glandular JJ O
tissue NN O
, , O
were VBD O
calculated VBN O
. . O

Marrow NNP O
dysplasia NN O
is VBZ O
a DT O
major JJ O
characteristic NN O
of IN O
patients NNS O
with IN O
myelodysplastic JJ O
syndrome NN O
( ( O
MDS NNP O
) ) O
, , O
along IN O
with IN O
marrow JJ O
blastosis NN O
, , O
cytopenia NN O
and CC O
cytogenetic JJ O
anomalies NNS O
. . O

Each DT O
repeat NN O
consists VBZ O
of IN O
12 CD O
nt NNS O
, , O
coding VBG O
for IN O
the DT O
reiterated JJ O
sequence NN O
, , O
K NNP O
/ NNP O
NPAG NNP O
. . O

Because IN O
the DT O
number NN O
of IN O
parameters NNS O
required VBN O
by IN O
a DT O
Volterra NNP O
series NN O
grows VBZ O
rapidly RB O
with IN O
both DT O
the DT O
length NN O
of IN O
its PRP$ O
memory NN O
and CC O
the DT O
order NN O
of IN O
its PRP$ O
nonlinearity NN O
, , O
methods NNS O
for IN O
identifying VBG O
these DT O
models NNS O
from IN O
measurements NNS O
of IN O
input NN O
/ NNP O
output NN O
data NNS O
are VBP O
limited VBN O
to TO O
low VB O
- : O
order NN O
systems NNS O
with IN O
relatively RB O
short JJ O
memories NNS O
. . O

The DT O
results NNS O
suggest VBP O
followings NNS O
- : O
- : O
1 CD O
) ) O
both DT O
eosinophils NNS O
and CC O
neutrophils NNS O
participate VBP O
in IN O
hypersecretion NN O
of IN O
type NN O
Ib NNP O
in IN O
atopic NN O
cases NNS O
, , O
and CC O
only RB O
eosinophils VBZ O
in IN O
non JJ O
- : O
atopic NN O
cases NNS O
. . O

To TO O
see VB O
if IN O
a DT O
pulse JJ O
oximeter NN O
can MD O
monitor VB O
the DT O
fetus NN O
during IN O
labour NN O
we PRP O
recruited VBD O
100 CD O
Caucasian JJ O
women NNS O
in IN O
normal JJ O
uncomplicated JJ O
labour NN O
. . O

P NNP O
. . O

Two CD O
remotely RB O
situated JJ O
exons NNS O
within IN O
the DT O
complement NN B-Gene
C3 NNP I-Gene
gene NN O
locus NN O
encode VBD O
an DT O
alternate NN O
5 CD O
' POS O
end NN O
and CC O
proximal JJ O
ORF NNP O
under IN O
the DT O
control NN O
of IN O
a DT O
bidirectional JJ O
promoter NN O
. . O

These DT O
mutants NNS O
all DT O
failed VBD O
to TO O
interact VB O
with IN O
the DT O
TraR NNP B-Gene
fusion NN I-Gene
in IN O
the DT O
two CD O
- : O
hybrid NN O
system NN O
. . O

In IN O
addition NN O
, , O
we PRP O
did VBD O
not RB O
detect VB O
significant JJ O
differences NNS O
in IN O
CDR3 NNP B-Gene
sequences NNS I-Gene
of IN O
endogenous JJ B-Gene
Ig NNP I-Gene
lambdaL NN I-Gene
and CC O
kappaL NN B-Gene
chain NN I-Gene
gene NN I-Gene
loci NN I-Gene
cloned VBN O
from IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
an DT O
NBS NNP O
patient NN O
and CC O
of IN O
healthy JJ O
individuals NNS O
. . O

The DT O
mutant JJ O
protein NN O
is VBZ O
present JJ O
at IN O
levels NNS O
slightly RB O
greater JJR O
than IN O
wild JJ O
- : O
type NN O
, , O
but CC O
exhibits VBZ O
the DT O
same JJ O
tissue NN O
distribution NN O
as IN O
wild JJ O
- : O
type NN O
protein NN O
, , O
and CC O
has VBZ O
approximately RB O
normal JJ O
affinity NN O
for IN O
known VBN O
target NN O
sequences NNS O
( ( O
though IN O
no DT O
DNA NNP O
targets NNS O
identified VBD O
to TO O
date NN O
require VB O
the DT O
first JJ O
cut NN O
repeat NN O
for IN O
binding VBG O
) ) O
. . O

Mean NNP O
total JJ O
lung NN O
capacity NN O
, , O
functional JJ O
residual JJ O
capacity NN O
, , O
and CC O
residual JJ O
volume NN O
increased VBD O
significantly RB O
, , O
and CC O
the DT O
mean JJ O
closing NN O
volume NN O
, , O
the DT O
lung NN O
volume NN O
above IN O
residual JJ O
volume NN O
at IN O
which WDT O
phase NN O
IV NNP O
begins VBZ O
, , O
decreased VBD O
significantly RB O
with IN O
11 CD O
cm NNS O
H20 NNP O
continuous JJ O
positive JJ O
airway NN O
pressure NN O
; : O
differences NNS O
at IN O
5 CD O
cm NNS O
H20 NNP O
were VBD O
not RB O
significant JJ O
. . O

A DT O
comparison NN O
of IN O
the DT O
nucleotide NN O
and CC O
deduced VBD O
amino NN O
acid NN O
sequences NNS O
of IN O
the DT O
core NN O
regions NNS O
of IN O
the DT O
RNA NNP B-Gene
- : I-Gene
dependent NN I-Gene
RNA NNP I-Gene
polymerase NN I-Gene
domains VBZ I-Gene
found VBN O
in IN O
these DT O
three CD O
dsRNAs NN O
suggested VBD O
that IN O
these DT O
dsRNAs NN O
probably RB O
evolved VBD O
independently RB O
within IN O
each DT O
host NN O
plant NN O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

CONCLUSIONS NN O
: : O
The DT O
largest JJS O
value NN O
of IN O
the DT O
joint JJ O
space NN O
may MD O
be VB O
used VBN O
when WRB O
evaluating VBG O
rheumatoid NN O
AC NNP O
joint JJ O
space NN O
. . O

Growth NNP O
, , O
4 CD O
- : O
PA NN O
and CC O
14C CD O
turnover NN O
data NNS O
indicated VBD O
that IN O
WB NNP O
contributed VBD O
to TO O
B NNP O
- : O
6 CD O
intake NN O
of IN O
these DT O
rats NNS O
. . O

Among IN O
9 CD O
group NN O
I PRP O
patients NNS O
with IN O
a DT O
positive JJ O
result NN O
on IN O
head NN O
- : O
up RB O
tilt SYM O
- : O
table JJ O
testing NN O
and CC O
no DT O
evidence NN O
of IN O
structural JJ O
heart NN O
disease NN O
( ( O
mean JJ O
follow VBP O
- : O
up RB O
4 CD O
. . O
3 CD O
years NNS O
) ) O
, , O
7 CD O
are VBP O
without IN O
further JJ O
episodes NNS O
of IN O
syncope NN O
; : O
3 CD O
have VBP O
discontinued VBN O
medication NN O
and CC O
5 CD O
have VBP O
resumed VBN O
at IN O
least JJS O
limited JJ O
exercise NN O
. . O

A DT O
favourable JJ O
response NN O
was VBD O
achieved VBN O
with IN O
a DT O
combination NN O
of IN O
amphotericin NN O
B NNP O
and CC O
cotrimoxazole NN O
. . O

The DT O
GRE NNP O
at IN O
nucleotide JJ O
7640 CD O
is VBZ O
a DT O
composite JJ O
GRE NNP O
( ( O
cGRE NN O
) ) O
containing VBG O
an DT O
overlapping VBG O
activator NN B-Gene
protein VBD I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
motif NN O
for IN O
the DT O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
homodimer NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
/ NNP O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
heterodimer NN O
. . O

Dopamine NNP O
SERS NNP O
spectra VBP O
from IN O
these DT O
electrodes NNS O
are VBP O
similar JJ O
to TO O
those DT O
obtained VBN O
at IN O
uncoated JJ O
electrodes NNS O
. . O

Yeast NNP B-Gene
U1 NNP I-Gene
snRNP VBD I-Gene
therefore RB O
contains VBZ O
16 CD O
different JJ O
proteins NNS O
, , O
including VBG O
seven CD O
snRNP JJ B-Gene
core NN I-Gene
proteins NNS I-Gene
, , O
three CD O
homologues NNS O
of IN O
the DT O
metazoan NN B-Gene
U1 NNP I-Gene
snRNP NN I-Gene
- : I-Gene
specific JJ I-Gene
proteins NNS I-Gene
, , O
and CC O
six CD O
yeast SYM B-Gene
- : I-Gene
specific JJ I-Gene
U1 NNP I-Gene
snRNP NN I-Gene
proteins NNS I-Gene
. . O

It PRP O
corresponds VBZ O
to TO O
the DT O
complete JJ O
mitochondrial JJ O
presequence NN O
and CC O
the DT O
lipoyl JJ O
- : O
bearing NN O
domain NN O
that WDT O
are VBP O
encoded VBN O
by IN O
exons NNS O
I PRP O
through IN O
IV NNP O
of IN O
the DT O
functional JJ O
E2 NNP B-Gene
gene NN I-Gene
. . O

The DT O
effects NNS O
of IN O
pharmacological JJ O
treatment NN O
and CC O
professional JJ O
care NN O
and CC O
support NN O
may MD O
improve VB O
when WRB O
dementia NN O
is VBZ O
detected VBN O
in IN O
an DT O
early JJ O
stage NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
genetically RB O
that IN O
plus CC O
- : O
strand NN O
DNA NNP O
synthesis NN O
of IN O
the DT O
yeast NN B-Gene
Ty1 NNP I-Gene
element NN I-Gene
is VBZ O
initiated VBN O
at IN O
two CD O
sites NNS O
located VBN O
at IN O
the DT O
5 CD O
' POS O
boundary NN O
of IN O
the DT O
3 CD O
' POS O
long JJ O
terminal JJ O
repeat NN O
( ( O
PPT1 NNP B-Gene
) ) O
and CC O
near IN O
the DT O
middle NN O
of IN O
the DT O
pol JJ B-Gene
gene NN I-Gene
in IN O
the DT O
integrase NN B-Gene
coding VBG I-Gene
sequence NN I-Gene
( ( O
PPT2 NNP B-Gene
) ) O
. . O

A DT O
13 CD O
- : O
bp NN O
cis NN O
- : O
regulatory JJ O
element NN O
in IN O
the DT O
LTR NNP O
promoter NN O
of IN O
the DT O
tobacco NN B-Gene
retrotransposon NN I-Gene
Tto1 NNP I-Gene
is VBZ O
involved VBN O
in IN O
responsiveness NN O
to TO O
tissue VB O
culture NN O
, , O
wounding NN O
, , O
methyl JJ O
jasmonate NN O
and CC O
fungal JJ O
elicitors NNS O
. . O

Ischaemia NNP O
was VBD O
induced VBN O
by IN O
a DT O
low JJ O
flow NN O
rate NN O
of IN O
0 CD O
. . O
8 CD O
mL NN O
min SYM O
- : O
1 CD O
for IN O
30 CD O
min NN O
, , O
and CC O
was VBD O
followed VBN O
by IN O
a DT O
40 CD O
- : O
minute NN O
reperfusion NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
in IN O
an DT O
animal JJ O
experiment NN O
that IN O
alterations NNS O
of IN O
the DT O
renal JJ O
vasculature NN O
and CC O
parenchyma NN O
after IN O
hemostasis NN O
performed VBN O
by IN O
Infrared NNP O
- : O
Contact NNP O
- : O
Coagulation NN O
are VBP O
best RB O
shown VBN O
by IN O
intravital JJ O
magnification NN O
angiography NN O
( ( O
magnification NN O
factor NN O
2 CD O
. . O
22 CD O
) ) O
. . O

Surprisingly RB O
, , O
calf NN B-Gene
thymus NN I-Gene
CstF NNP I-Gene
contained VBD O
an DT O
additional JJ O
, , O
novel JJ O
form NN O
of IN O
the DT O
64 CD O
- : O
kDa NN O
subunit NN O
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
70 CD O
kDa NNS O
. . O

Sequencing VBG O
of IN O
zebrafish NN O
( ( O
Danio NNP O
rerio NN O
) ) O
bacterial JJ O
artificial JJ O
chromosome NN O
and CC O
P1 NNP O
artificial JJ O
chromosome NN O
genomic JJ O
clone NN O
fragments NNS O
and CC O
of IN O
cDNA NN O
clones NNS O
has VBZ O
led VBN O
to TO O
the DT O
identification NN O
of IN O
five CD O
new JJ O
loci NN O
coding VBG O
for IN O
beta NN O
subunits NNS O
of IN O
proteasomes NNS O
( ( O
PSMB NNP B-Gene
) ) O
. . O

A DT O
reduction NN O
of IN O
the DT O
aspartate JJ B-Gene
aminotransferase NN I-Gene
activity NN O
was VBD O
observed VBN O
from IN O
800 CD O
mg NNS O
/ JJ O
kg NN O
b NN O
. . O
w NN O
. . O
/ CC O
d JJ O
onwards NNS O
. . O

During IN O
insulin JJ B-Gene
infusion NN O
, , O
a DT O
20 CD O
% NN O
dextrose JJ O
solution NN O
was VBD O
infused VBN O
by IN O
a DT O
Biostator NNP O
in IN O
order NN O
to TO O
maintain VB O
the DT O
patient NN O
' POS O
s JJ O
glycemia NN O
at IN O
90 CD O
mg NN O
/ NNP O
dl NN O
. . O

The DT O
immune JJ O
response NN O
of IN O
past JJ O
- : O
infection NN O
of IN O
cytomegalovirus NN O
in IN O
the DT O
patients NNS O
of IN O
RTID NNP O
is VBZ O
rather RB O
remarkable JJ O
. . O

STP1 NNP B-Gene
is VBZ O
an DT O
unessential JJ O
yeast NN O
gene NN O
involved VBN O
in IN O
the DT O
removal NN O
of IN O
intervening VBG O
sequences NNS O
from IN O
some DT O
, , O
but CC O
not RB O
all DT O
, , O
families NNS O
of IN O
intervening VBG O
sequence NN O
- : O
containing VBG O
pre JJ O
- : O
tRNAs NN O
. . O

METHODS NN O
: : O
Rats NNS O
received VBD O
continuous JJ O
intragastric JJ O
infusion NN O
of IN O
elemental JJ O
diet NN O
or CC O
with IN O
supplementation NN O
of IN O
oatbase NN O
, , O
Lactobacillus NNP O
reuteri NN O
R2LC NNP O
, , O
and CC O
Lactobacillus NNP O
plantarum VBP O
DSM NNP O
9843 CD O
, , O
with IN O
and CC O
without IN O
fermentation NN O
, , O
from IN O
the DT O
beginning NN O
of IN O
the DT O
study NN O
. . O

Comparison NNP O
of IN O
the DT O
deduced JJ O
amino NN B-Gene
acid JJ I-Gene
sequence NN I-Gene
of IN I-Gene
gamma JJ I-Gene
- : I-Gene
kafirin NN I-Gene
with IN O
the DT O
published JJ O
sequences NNS B-Gene
of IN I-Gene
gamma NN I-Gene
- : I-Gene
prolamins NNS I-Gene
of IN I-Gene
maize NN I-Gene
, , I-Gene
and CC I-Gene
Coix NNP I-Gene
revealed VBD O
highly RB O
conserved JJ O
domains NNS O
. . O

Creutzfeldt NNP O
- : O
Jakob NNP O
disease NN O
and CC O
lyophilised VBD O
dura NN O
mater NN O
grafts NNS O
: : O
report NN O
of IN O
two CD O
cases NNS O
. . O

Further RB O
, , O
the DT O
PIP2 NNP O
content NN O
of IN O
the DT O
85 CD O
- : O
90 CD O
kDa NN O
protein NN O
appeared VBD O
to TO O
decrease VB O
with IN O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
treatment NN O
. . O

In IN O
addition NN O
, , O
the DT O
R206S NNP B-Gene
HSF NNP I-Gene
substitution NN O
exhibits NNS O
constitutive VBP O
transcriptional JJ O
activation NN O
from IN O
a DT O
consensus NN O
HSE NNP O
( ( O
HSE2 NNP O
) ) O
. . O

1 CD O
The DT O
effects NNS O
in IN O
normal JJ O
subjects NNS O
of IN O
a DT O
single JJ O
oral JJ O
dose NN O
of IN O
Motival NNP O
( ( O
one CD O
tablet NN O
, , O
containing VBG O
fluphenazine JJ O
0 CD O
. . O
5 CD O
mg NN O
and CC O
nortriptyline JJ O
10 CD O
mg NN O
) ) O
on IN O
the DT O
contingent NN O
negative JJ O
variation NN O
( ( O
CNV NNP O
) ) O
, , O
reaction NN O
time NN O
, , O
heart NN O
rate NN O
, , O
blood NN O
pressure NN O
and CC O
self PRP O
- : O
rating NN O
scales NNS O
for IN O
alertness NN O
, , O
anxiety NN O
, , O
tension NN O
, , O
detachment NN O
and CC O
depression NN O
were VBD O
compared VBN O
with IN O
those DT O
of IN O
diazepam NN O
( ( O
5 CD O
mg NN O
and CC O
7 CD O
. . O
5 CD O
mg NN O
) ) O
and CC O
placebo NN O
or CC O
propranolol NN O
( ( O
60 CD O
mg NN O
) ) O
. . O

No DT O
somatic JJ O
mutations NNS O
were VBD O
found VBN O
in IN O
any DT O
of IN O
the DT O
samples NNS O
, , O
suggesting VBG O
that IN O
ING1 NNP B-Gene
is VBZ O
not RB O
a DT O
tumor NN O
suppressor NN O
gene NN O
target NN O
in IN O
head NN O
and CC O
neck NN O
cancer NN O
. . O

The DT O
clinical JJ O
tolerance NN O
and CC O
pharmacokinetics NNS O
of IN O
FCE NNP O
22101 CD O
( ( O
sodium NN O
( ( O
5R CD O
, , O
6S CD O
) ) O
- : O
6 CD O
- : O
[ NN O
( ( O
1R CD O
) ) O
- : O
hydroxyethyl NN O
] SYM O
- : O
2 CD O
- : O
carbamoyloxymethyl NN O
- : O
2 CD O
- : O
penem NN O
- : O
3 CD O
- : O
carboxylate NN O
) ) O
, , O
a DT O
new JJ O
penem NN O
antibiotic JJ O
, , O
have VBP O
been VBN O
studied VBN O
after IN O
giving VBG O
a DT O
single JJ O
i NN O
. . O
v NN O
. . O
dose NN O
of IN O
4 CD O
mg NN O
. . O
kg VB O
- : O
1 CD O
to TO O
ten VB O
healthy JJ O
male NN O
volunteers NNS O
. . O

Maternal JJ O
seizures NNS O
had VBD O
occurred VBN O
during IN O
pregnancy NN O
in IN O
52 CD O
per IN O
cent NN O
. . O

Sterol NNP O
- : O
mediated VBD O
suppression NN O
of IN O
cleavage NN O
of IN O
SREBP NNP B-Gene
- : I-Gene
1 CD I-Gene
was VBD O
found VBN O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
extreme JJ O
COOH NNP O
- : O
terminal JJ O
region NN O
( ( O
residue JJ O
1034 CD O
to TO O
the DT O
COOH NNP O
terminus NN O
) ) O
, , O
which WDT O
exists VBZ O
in IN O
two CD O
forms NNS O
as IN O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
. . O

Studies NNS O
on IN O
the DT O
method NN O
of IN O
size NN O
reduction NN O
of IN O
medicinal JJ O
compounds NNS O
. . O

A DT O
second JJ O
isotype NN O
of IN O
Raja NNP B-Gene
immunoglobulin NNP I-Gene
heavy JJ I-Gene
chain NN I-Gene
genes NNS I-Gene
has VBZ O
been VBN O
detected VBN O
by IN O
screening VBG O
a DT O
spleen JJ O
cDNA NN O
library NN O
with IN O
homologous JJ O
Raja NNP B-Gene
VH NNP I-Gene
- : O
and CC O
CH1 NNP B-Gene
- : O
specific JJ O
probes NNS O
complementing VBG O
the DT O
respective JJ O
regions NNS O
of IN O
the DT O
mu JJ B-Gene
- : I-Gene
like IN I-Gene
isotype NN I-Gene
. . O

Vam7p NNP B-Gene
, , O
a DT O
SNAP NNP B-Gene
- : I-Gene
25 CD I-Gene
- : I-Gene
like IN I-Gene
molecule NN I-Gene
, , O
and CC O
Vam3p NNP B-Gene
, , O
a DT O
syntaxin NN B-Gene
homolog NN I-Gene
, , O
function NN O
together RB O
in IN O
yeast NN O
vacuolar JJ O
protein NN O
trafficking NN O
. . O

Deletion NN O
from IN O
either CC O
the DT O
N NNP O
- : O
or CC O
C NNP O
- : O
terminal JJ O
ends NNS O
of IN O
repA NN B-Gene
( ( O
28 CD O
and CC O
69 CD O
codons NNS O
, , O
respectively RB O
, , O
out IN O
of IN O
the DT O
286 CD O
- : O
codon NN O
open JJ O
reading NN O
frame NN O
) ) O
affected VBD O
the DT O
initiator NN O
but CC O
not RB O
the DT O
inhibitory NN O
activity NN O
. . O

Pancreatic JJ O
and CC O
biliary JJ O
secretion NN O
and CC O
gastric JJ O
emptying VBG O
rates NNS O
of IN O
a DT O
liquid JJ O
test NN O
meal NN O
( ( O
LTM NNP O
) ) O
were VBD O
determined VBN O
in IN O
normal JJ O
persons NNS O
, , O
in IN O
patients NNS O
with IN O
subtotal JJ O
gastrectomy NN O
with IN O
gastroduodenostomy NN O
( ( O
STG NNP O
- : O
BI NNP O
) ) O
or CC O
with IN O
gastrojejunostomy NN O
( ( O
STG NNP O
- : O
BII NNP O
) ) O
, , O
and CC O
in IN O
patients NNS O
with IN O
truncal JJ O
vagotomy NN O
and CC O
pyloroplasty NN O
( ( O
V NNP O
& CC O
P NNP O
) ) O
. . O

The DT O
predicted JJ O
Pay4p NNP B-Gene
sequence NN I-Gene
contains VBZ O
two CD O
putative JJ O
ATP NNP O
- : O
binding NN O
domains NNS O
and CC O
shows VBZ O
structural JJ O
relationships NNS O
to TO O
other JJ O
potential JJ O
ATP NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
involved VBN O
in IN O
biological JJ O
processes NNS O
as RB O
diverse JJ O
as IN O
peroxisome JJ O
biogenesis NN O
, , O
vesicle NN O
- : O
mediated VBN O
protein NN O
transport NN O
, , O
cell NN O
cycle NN O
control NN O
, , O
and CC O
transcriptional JJ O
regulation NN O
. . O

Systematic JJ O
review NN O
of IN O
diagnostic JJ O
tests NNS O
for IN O
vaginal JJ O
trichomoniasis NN O
. . O

KEY JJ O
WORDS NNP O
: : O
Melaleuca NNP O
; : O
Lake NNP O
Okeechobee NNP O
; : O
Littoral NNP O
zone NN O
; : O
Water NNP O
level NN O
; : O
Regulation NNP O
schedule NN O

Diagnostic JJ O
importance NN O
of IN O
determining VBG O
the DT O
complement NN O
constituents NNS O
in IN O
children NNS O
with IN O
autoimmune NN O
thyroiditis NN O

Heterogeneous JJ B-Gene
nuclear JJ I-Gene
ribonucleoprotein NN I-Gene
A1 NNP I-Gene
binds VBZ O
to TO O
the DT O
transcription NN O
- : O
regulatory JJ O
region NN O
of IN O
mouse NN O
hepatitis NN O
virus NN O
RNA NNP O
. . O

An DT O
abnormally RB O
high JJ O
percentage NN O
of IN O
hypertensive JJ O
patients NNS O
( ( O
approximately RB O
30 CD O
% NN O
) ) O
undergoing NN O
cardiac JJ O
catheterization NN O
because IN O
of IN O
anginal JJ O
pain NN O
and CC O
/ NN O
or CC O
exercise NN O
- : O
induced JJ O
ST NNP O
- : O
segment NN O
depressions NNS O
has VBZ O
angiographically RB O
normal JJ O
coronary JJ O
arteries NNS O
. . O

A DT O
new JJ O
hypothesis NN O
on IN O
mechanisms NNS O
for IN O
inhibiting VBG O
catalytic JJ O
subunits NNS O
by IN O
gamma NN O
- : O
subunits NNS O
and CC O
activation NN O
of IN O
a DT O
holoenzyme NN O
by IN O
transducin NN B-Gene

A DT O
variety NN O
of IN O
nuclear JJ O
ribonucleoproteins NNS O
are VBP O
believed VBN O
to TO O
associate VB O
directly RB O
with IN O
nascent JJ O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
transcripts NNS I-Gene
and CC O
remain VBP O
associated JJ O
during IN O
subsequent JJ O
nuclear JJ O
RNA NNP O
processing NN O
reactions NNS O
, , O
including VBG O
pre SYM O
- : O
mRNA NN O
polyadenylation NN O
and CC O
splicing NN O
as RB O
well RB O
as IN O
nucleocytoplasmic JJ O
mRNA NN O
transport NN O
. . O

CONCLUSIONS NN O
: : O
In IN O
essential JJ O
hypertension NN O
an DT O
acute JJ O
protein NN O
load NN O
induces VBZ O
a DT O
decrease NN O
in IN O
GFR NNP O
that WDT O
may MD O
normalize VB O
under IN O
antihypertensive JJ O
treatment NN O
. . O

Frequent JJ O
loss NN O
of IN O
heterozygosity NN O
( ( O
LOH NNP O
) ) O
of IN O
> $ O
30 CD O
% NN O
of IN O
the DT O
informative JJ O
cases NNS O
was VBD O
observed VBN O
on IN O
chromosomes NNS O
3p CD O
( ( O
41 CD O
. . O
1 CD O
% NN O
) ) O
, , O
5q CD O
( ( O
52 CD O
. . O
6 CD O
% NN O
) ) O
, , O
6p CD O
( ( O
30 CD O
. . O
4 CD O
% NN O
) ) O
, , O
8p CD O
( ( O
33 CD O
. . O
3 CD O
% NN O
) ) O
, , O
9p CD O
( ( O
35 CD O
. . O
7 CD O
% NN O
) ) O
, , O
9q CD O
( ( O
30 CD O
. . O
8 CD O
% NN O
) ) O
, , O
11p CD O
( ( O
32 CD O
. . O
4 CD O
% NN O
) ) O
, , O
13q CD O
( ( O
52 CD O
. . O
7 CD O
% NN O
) ) O
, , O
17p CD O
( ( O
55 CD O
. . O
2 CD O
% NN O
) ) O
, , O
17q CD O
( ( O
33 CD O
. . O
3 CD O
% NN O
) ) O
, , O
18q CD O
( ( O
45 CD O
. . O
7 CD O
% NN O
) ) O
, , O
and CC O
19q CD O
( ( O
30 CD O
. . O
4 CD O
% NN O
) ) O
. . O

OBJECTIVE NN O
: : O
To TO O
evaluate VB O
the DT O
relationship NN O
between IN O
blood NN O
flow NN O
in IN O
the DT O
tumor NN O
assessed VBN O
by IN O
color NN O
Doppler NNP O
ultrasound NN O
, , O
microvessel NN O
density NN O
, , O
and CC O
vascular JJ B-Gene
endothelial JJ I-Gene
growth NN I-Gene
factor NN I-Gene
levels NNS O
in IN O
endometrial JJ O
carcinoma NN O
. . O

The DT O
30 CD O
- : O
day NN O
mortality NN O
in IN O
the DT O
CPB NNP O
group NN O
and CC O
the DT O
non JJ O
- : O
CPB NNP O
group NN O
were VBD O
20 CD O
% NN O
and CC O
4 CD O
. . O
6 CD O
% NN O
, , O
respectively RB O
which WDT O
was VBD O
not RB O
statistically RB O
significant JJ O
( ( O
p JJ O
= NN O
0 CD O
. . O
6 CD O
) ) O
. . O

Family RB O
visits NNS O
and CC O
involvement NN O
in IN O
treatment NN O
of IN O
patients NNS O
at IN O
a DT O
state NN O
hospital NN O
. . O

Similarity NNP O
is VBZ O
most JJS O
striking JJ O
in IN O
the DT O
zinc NN O
knuckle NN O
region NN O
, , O
a DT O
region NN O
characteristic NN O
of IN O
gag JJ B-Gene
genes NNS I-Gene
of IN O
most JJS O
replication NN O
- : O
competent NN O
retroelements NNS O
. . O

Here RB O
, , O
we PRP O
correlate VBP O
Dox NNP O
effects NNS O
on IN O
cell NN O
cycle NN O
with IN O
changes NNS O
of IN O
E2F NNP B-Gene
/ NNP O
DP NNP B-Gene
complexes NNS O
and CC O
activity NN O
in IN O
differentiating VBG O
C2C12 NNP O
myocytes NNS O
. . O

We PRP O
report VBP O
herein VBD O
the DT O
case NN O
of IN O
a DT O
30 CD O
- : O
year NN O
- : O
old JJ O
man NN O
in IN O
whom WP O
ectopic VBP O
mediastinal JJ O
parathyroid NN O
adenoma NN O
was VBD O
detected VBN O
by IN O
99mTc CD O
- : O
methoxyisobutylisonitrile NN O
scintigraphy NN O
( ( O
99mTc CD O
- : O
MIBI NN O
) ) O
. . O

CONCLUSIONS NN O
: : O
Serum NNP B-Gene
prolactin NN I-Gene
concentrations NNS O
show VBP O
age NN O
related JJ O
variations NNS O
in IN O
presumably RB O
fertile JJ O
men NNS O
. . O

Delayed NNP O
hypersensitivity NN O
in IN O
man NN O
: : O
effects NNS O
of IN O
systemic JJ O
anticoagulation NN O
. . O

The DT O
inflation NN O
hub NN O
of IN O
the DT O
probe NN O
is VBZ O
recreated VBN O
by IN O
modifying VBG O
a DT O
standard JJ O
USCI NNP O
Tuohy NNP O
- : O
Borst NNP O
Y NNP O
adaptor NN O
and CC O
attaching VBG O
this DT O
to TO O
the DT O
transected VBN O
probe NN O
hypotube NN O
. . O

A DT O
comparative JJ O
study NN O
of IN O
the DT O
total JJ O
protein NN O
profiles NNS O
of IN O
wild JJ O
- : O
type NN O
S NNP O
. . O
entomophila CC O
UC9 NNP O
and CC O
mutant JJ O
UC21 NNP O
revealed VBD O
that IN O
the DT O
mutant NN O
lacked VBD O
an DT O
approximately RB O
44 CD O
- : O
kDa NN O
protein NN O
and CC O
overexpressed VBD O
an DT O
approximately RB O
20 CD O
- : O
kDa NN O
protein NN O
. . O

Hypertonic NNP O
glucose NN O
administered VBD O
intrajejunally RB O
in IN O
Heidenhain NNP O
pouch JJ O
dogs NNS O
resulted VBD O
in IN O
an DT O
equal JJ O
inhibition NN O
of IN O
pentagastrin JJ O
- : O
induced JJ O
acid JJ O
secretion NN O
from IN O
the DT O
pouch JJ O
and CC O
the DT O
main JJ O
stomach NN O
, , O
whereas WP O
hypertonic JJ O
saline NN O
had VBD O
no DT O
effect NN O
. . O

We PRP O
established VBD O
that IN O
the DT O
2 CD O
. . O
6 CD O
kb JJ O
mRNA NN O
V NNP O
- : O
1 CD O
and CC O
the DT O
2 CD O
. . O
3 CD O
kb JJ O
GGT NNP B-Gene
mRNA NN O
V NNP O
- : O
2 CD O
derive NN O
, , O
by IN O
alternate NN O
splicing NN O
, , O
from IN O
a DT O
primary JJ O
transcript NN O
initiated VBN O
on IN O
a DT O
distal JJ O
promoter NN O
on IN O
the DT O
rat NN B-Gene
GGT NNP I-Gene
gene NN I-Gene
. . O

After IN O
termination NN O
of IN O
medication NN O
the DT O
animals NNS O
were VBD O
kindled VBN O
electrically RB O
in IN O
the DT O
nucleus JJ O
amygdala NN O
. . O

Therefore RB O
, , O
the DT O
rbcL NN B-Gene
- : O
rbcS NN B-Gene
locus NN O
seems VBZ O
to TO O
be VB O
barely RB O
expressed VBN O
under IN O
a DT O
standard JJ O
condition NN O
for IN O
photoautotrophic JJ O
growth NN O
. . O

Subsequently RB O
, , O
HD NNP O
inhibited VBD O
healing NN O
because IN O
it PRP O
significantly RB O
delayed VBD O
epithelialization NN O
and CC O
caused VBD O
protracted VBN O
inflammation NN O
. . O

Furthermore RB O
, , O
overexpression NN O
of IN O
AML3 NNP B-Gene
/ NNP O
CBFalpha1 NNP B-Gene
could MD O
rescue VB O
the DT O
AML1 NNP B-Gene
- : O
ETO NNP B-Gene
repression NN O
. . O

Gel NNP O
mobility NN O
shift NN O
assays VBZ O
using VBG O
a DT O
synthetic JJ O
E6 NNP B-Gene
motif NN I-Gene
detected VBD O
a DT O
B NNP O
- : O
cell NN O
- : O
specific JJ O
complex NN O
in IN O
addition NN O
to TO O
a DT O
ubiquitous JJ O
band NN O
found VBD O
also RB O
in IN O
T NNP O
cells NNS O
and CC O
HeLa NNP O
cells NNS O
. . O

MATERIAL NNP O
AND CC O
METHODS NNP O
: : O
The DT O
authors NNS O
analyzed VBD O
41 CD O
persons NNS O
formerly RB O
submitted VBN O
to TO O
surgery NN O
( ( O
after IN O
8 CD O
years NNS O
and CC O
4 CD O
months NNS O
, , O
as IN O
a DT O
mean NN O
) ) O
, , O
31 CD O
to TO O
highly RB O
selective JJ O
vagotomy NN O
, , O
and CC O
10 CD O
to TO O
truncal JJ O
or CC O
selective JJ O
vagotomy NN O
plus CC O
gastroduodenal JJ O
drainage NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
factor NN B-Gene
IX NNP I-Gene
activity NN O
is VBZ O
decreased VBN O
in IN O
coumarin NN O
treatment NN O
with IN O
factor NN B-Gene
IX NNP I-Gene
antigen NN O
remaining VBG O
normal JJ O
. . O

While IN O
no DT O
obvious JJ O
transmembrane NN O
regions NNS O
were VBD O
identified VBN O
, , O
several JJ O
short JJ O
hydrophobic NN O
amino NN O
acid JJ O
stretches NNS O
were VBD O
found VBN O
to TO O
be VB O
localized VBN O
in IN O
and CC O
around IN O
the DT O
Pro NNP O
II NNP O
region NN O
, , O
and CC O
these DT O
may MD O
be VB O
responsible JJ O
for IN O
attachment NN O
of IN O
precursors NNS O
to TO O
membranes NNS O
. . O

Instead RB O
, , O
the DT O
results NNS O
support VBP O
the DT O
idea NN O
that IN O
Pc NNP B-Gene
group NN I-Gene
products NNS I-Gene
provide VBP O
stable JJ O
memory NN O
or CC O
imprinting NN O
of IN O
boundaries NNS O
which WDT O
are VBP O
initially RB O
specified VBN O
by IN O
gap NN O
and CC O
pair NN O
- : O
rule NN O
regulators NNS O
. . O

No DT O
differences NNS O
in IN O
total JJ O
cholesterol NN O
levels NNS O
were VBD O
observed VBN O
between IN O
mapuches NNS O
and CC O
aymaras NNS O
. . O

Based VBN O
on IN O
AUC NNP O
infinity NN O
analyses NNS O
, , O
the DT O
pharmacokinetics NNS O
of IN O
buflomedil NN O
were VBD O
found VBN O
to TO O
be VB O
linear JJ O
within IN O
the DT O
dose JJ O
ranges NNS O
studied VBN O
( ( O
50 CD O
to TO O
200 CD O
mg NN O
for IN O
i NN O
. . O
v NN O
. . O
injection NN O
and CC O
150 CD O
to TO O
450 CD O
mg NN O
for IN O
oral JJ O
administration NN O
) ) O
. . O

Urinary JJ O
excretion NN O
of IN O
oestrone NN O
, , O
oestradiol SYM O
- : O
17 CD O
beta NN O
and CC O
oestriol NN O
in IN O
pregnancies NNS O
complicated VBN O
by IN O
steroid JJ B-Gene
sulphatase NN I-Gene
deficiency NN O
. . O

Validity NN O
of IN O
NIR NNP O
spectroscopy NN O
for IN O
quantitatively RB O
measuring VBG O
muscle NN O
oxidative JJ O
metabolic JJ O
rate NN O
in IN O
exercise NN O
. . O

The DT O
partial JJ O
categories NNS O
of IN O
the DT O
SIP NNP O
that WDT O
were VBD O
more RBR O
affected JJ O
were VBD O
work NN O
, , O
recreation NN O
and CC O
pastimes NNS O
, , O
home NN O
management NN O
, , O
and CC O
sleep NN O
and CC O
rest NN O
. . O

However RB O
, , O
regional JJ O
MVO2 NNP O
increased VBD O
to TO O
about IN O
the DT O
same JJ O
extent NN O
in IN O
the DT O
CFX NNP O
( ( O
from IN O
6 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
7 CD O
to TO O
12 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
9 CD O
ml JJ O
O2 NNP O
. . O
min SYM O
- : O
1 CD O
times NNS O
100 CD O
g JJ O
- : O
1 CD O
) ) O
and CC O
the DT O
LAD NNP O
region NN O
( ( O
from IN O
7 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
to TO O
14 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
3 CD O
ml JJ O
O2 NNP O
. . O
min SYM O
- : O
1 CD O
times NNS O
100 CD O
g JJ O
- : O
1 CD O
) ) O
. . O

The DT O
cleavage NN O
of IN O
Fak NNP B-Gene
by IN O
caspases NNS B-Gene
may MD O
thus RB O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
execution NN O
of IN O
the DT O
suicide JJ O
program NN O
by IN O
disabling VBG O
the DT O
anti JJ O
- : O
apoptotic JJ O
function NN O
of IN O
Fak NNP B-Gene
. . O

High JJ O
- : O
level NN O
expression NN O
in IN O
Escherichia NNP O
coli NN O
of IN O
selenocysteine JJ O
- : O
containing VBG O
rat NN B-Gene
thioredoxin NN I-Gene
reductase NN I-Gene
utilizing JJ O
gene NN O
fusions NNS O
with IN O
engineered VBN O
bacterial JJ O
- : O
type NN O
SECIS NNP O
elements NNS O
and CC O
co SYM O
- : O
expression NN O
with IN O
the DT O
selA NN B-Gene
, , O
selB NN B-Gene
and CC O
selC NN B-Gene
genes NNS I-Gene
. . O

Adverse JJ O
reaction NN O
of IN O
the DT O
apparently RB O
healthy JJ O
partner NN O
in IN O
response NN O
to TO O
improvement NN O
in IN O
the DT O
overtly JJ O
dysfunctional JJ O
partner NN O
. . O

Structure NN O
and CC O
localization NN O
of IN O
the DT O
human JJ O
gene NN O
encoding VBG O
SR NNP B-Gene
- : I-Gene
BI NNP I-Gene
/ NNP O
CLA NNP B-Gene
- : I-Gene
1 CD I-Gene
. . O

During IN O
the DT O
conditioning NN O
procedure NN O
, , O
the DT O
C NNP O
- : O
fiber NN O
reflex NN O
was VBD O
facilitated VBN O
( ( O
wind IN O
- : O
up RB O
) ) O
in IN O
a DT O
stimulus JJ O
- : O
dependent JJ O
fashion NN O
in IN O
intact JJ O
, , O
anesthetized JJ O
animals NNS O
during IN O
the DT O
application NN O
of IN O
the DT O
first JJ O
seven CD O
conditioning VBG O
stimuli NNS O
; : O
thereafter RB O
, , O
the DT O
magnitude NN O
of IN O
the DT O
responses NNS O
reached VBD O
a DT O
plateau NN O
and CC O
then RB O
decreased VBD O
. . O

Four CD O
casein NN B-Gene
kinase NN I-Gene
I PRP I-Gene
isoforms NNS I-Gene
are VBP O
differentially RB O
partitioned VBN O
between IN O
nucleus NNS O
and CC O
cytoplasm NN O
. . O

An DT O
apparent JJ O
ufo JJ B-Gene
mRNA NN I-Gene
overexpression NN O
was VBD O
not RB O
found VBN O
in IN O
any DT O
of IN O
the DT O
positive JJ O
leukemia NN O
cell NN O
lines NNS O
, , O
but CC O
was VBD O
identified VBN O
in IN O
the DT O
drug NN O
- : O
resistant JJ O
subclones NNS O
of IN O
the DT O
cervix NN O
carcinoma NN O
cell NN O
line NN O
HeLa NNP O
. . O

In IN O
Xenopus NNP O
laevis NN O
, , O
the DT O
gene NN O
encoding VBG O
the DT O
elongation NN B-Gene
factor NN I-Gene
1 CD I-Gene
- : I-Gene
alpha NN I-Gene
variant NN I-Gene
EF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
O NNP I-Gene
, , O
where WRB O
O NNP O
stands VBZ O
for IN O
oocyte NN O
, , O
is VBZ O
expressed VBN O
in IN O
oocytes NNS O
and CC O
early JJ O
embryos NN O
. . O

As IN O
the DT O
high JJ O
- : O
affinity NN O
Mg2 NNP O
+ NNP O
binding NN O
sites NNS O
are VBP O
filled VBN O
, , O
the DT O
primer NN O
terminus NN O
migrates NNS O
from IN O
the DT O
exonuclease NN O
site NN O
to TO O
a DT O
highly RB O
based VBN O
stacked JJ O
polymerase NN O
active JJ O
site NN O
. . O

Specifically RB O
, , O
by IN O
oligonucleotide IN O
- : O
directed VBN O
site NN O
- : O
specific JJ O
mutagenesis NN O
, , O
we PRP O
demonstrate VBP O
that IN O
of IN O
10 CD O
cysteine NN O
residues NNS O
in IN O
the DT O
ORF4 NNP O
polypeptide NN O
, , O
only RB O
C NNP O
- : O
421 CD O
and CC O
C NNP O
- : O
426 CD O
are VBP O
essential JJ O
for IN O
transactivator NN O
function NN O
and CC O
suggest VBP O
that IN O
these DT O
cysteine NN O
residues NNS O
may MD O
participate VB O
in IN O
critical JJ O
protein NN O
- : O
protein NN O
interactions NNS O
rather RB O
than IN O
protein VB O
- : O
nucleic JJ O
acid JJ O
interactions NNS O
to TO O
mediate VB O
ORF4 NNP O
inducibility NN O
. . O

Pro NNP O
- : O
inflammatory NN O
cytokine NN O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
, , O
produced VBN O
from IN O
adipose JJ O
tissues NNS O
in IN O
obese JJ O
subjects NNS O
, , O
is VBZ O
known VBN O
to TO O
play VB O
a DT O
predominant JJ O
role NN O
in IN O
inducing VBG O
insulin NN B-Gene
resistance NN O
. . O

Total JJ O
VO2 NNP O
was VBD O
decreased VBN O
in IN O
both DT O
groups NNS O
during IN O
severe JJ O
hypoxia NN O
but CC O
limb NN O
VO2 NNP O
was VBD O
maintained VBN O
in IN O
the DT O
beta NN O
- : O
block NN O
group NN O
. . O

beta SYM O
- : O
Block NNP O
prevented VBD O
the DT O
fall NN O
in IN O
total JJ O
and CC O
limb JJ O
peripheral JJ O
resistance NN O
seen VBN O
in IN O
severe JJ O
hypoxia NN O
but CC O
did VBD O
not RB O
alter VB O
the DT O
consistently RB O
more RBR O
efficient JJ O
utilization NN O
of IN O
total JJ O
O2 NNP O
delivery NN O
shown VBN O
by IN O
the DT O
limb NN O
in IN O
comparison NN O
to TO O
the DT O
whole JJ O
body NN O
by IN O
higher JJR O
O2 NNP O
extraction NN O
ratios NNS O
and CC O
lower JJR O
venous JJ O
O2 NNP O
pressure NN O
. . O

beta SYM B-Gene
- : I-Gene
Vasodilator NN I-Gene
receptors NNS I-Gene
evidently RB O
played VBD O
an DT O
active JJ O
part NN O
in IN O
the DT O
vasodilatation NN O
seen VBN O
during IN O
severe JJ O
hypoxia NN O
. . O

The DT O
results NNS O
show VBP O
that IN O
both DT O
the DT O
amino NN O
and CC O
carboxy JJ O
termini NN O
of IN O
the DT O
NS1 NNP B-Gene
protein NN I-Gene
molecule NN I-Gene
and CC O
the DT O
cysteines NNS O
at IN O
residues NNS O
337 CD O
and CC O
340 CD O
are VBP O
essential JJ O
for IN O
tubule NN O
formation NN O
. . O

To TO O
determine VB O
whether IN O
the DT O
NTP NNP O
- : O
binding NN O
motif NN O
is VBZ O
important JJ O
for IN O
Rad24 NNP B-Gene
function NN O
, , O
we PRP O
mutated VBD O
the DT O
conserved JJ O
lysine NN O
( ( O
115 CD O
) ) O
residue NN O
in IN O
this DT O
motif NN O
. . O

Aneurysmal NNP O
bone NN O
cyst NN O
of IN O
the DT O
jaws NN O
: : O
analysis NN O
of IN O
11 CD O
cases NNS O
. . O

( ( O
iv NN O
) ) O
The DT O
accumulation NN O
of IN O
cyclin NN B-Gene
D3 NNP I-Gene
protein NN I-Gene
in IN O
Vero NNP O
cells NNS O
infected VBN O
with IN O
an DT O
alpha0 JJ B-Gene
deletion NN I-Gene
mutant NN I-Gene
was VBD O
reduced VBN O
relative JJ O
to TO O
that DT O
of IN O
cells NNS O
infected VBN O
with IN O
wild JJ O
- : O
type NN O
virus NN O
or CC O
a DT O
recombinant JJ O
virus NN O
in IN O
which WDT O
the DT O
deleted VBN O
alpha0 NN B-Gene
sequences NNS I-Gene
were VBD O
restored VBN O
. . O

Neutrophil NN O
: : O
lymphocyte NN O
ratio NN O
, , O
plasma NN O
haptoglobin NN B-Gene
, , O
and CC O
CBG NNP B-Gene
levels NNS O
were VBD O
greater JJR O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
during IN O
the DT O
INITIAL NNP O
period NN O
than IN O
during IN O
the DT O
PRE NNP O
or CC O
POST NNP O
periods NNS O
but CC O
did VBD O
not RB O
differ VB O
between IN O
treatments NNS O
. . O

Homology NN O
with IN O
the DT O
human JJ O
protein NN O
is VBZ O
only RB O
34 CD O
% NN O
in IN O
the DT O
tandem NN O
repeat NN O
domain NN O
, , O
mainly RB O
showing VBG O
conservation NN O
of IN O
serines NNS O
and CC O
threonines NNS O
, , O
presumed VBN O
sites NNS O
of IN O
O NNP O
- : O
linked VBN O
carbohydrate JJ O
attachment NN O
. . O

Regulatory JJ O
regions NNS O
in IN O
the DT O
promoter NN O
and CC O
third JJ O
intron NN O
of IN O
the DT O
growth NN B-Gene
hormone NN I-Gene
gene NN I-Gene
in IN I-Gene
rainbow NN I-Gene
trout NN I-Gene
, , O
Oncorhynchus NNP O
mykiss NN O
walbaum NN O
. . O

A DT O
larger JJR O
region NN O
upstream NN O
of IN O
human JJ B-Gene
CMV NNP I-Gene
dbp NN I-Gene
also RB O
mediated VBD O
replication NN O
in IN O
transient NN O
assays NNS O
. . O

Enzyme NNP O
histochemical JJ O
findings NNS O
in IN O
the DT O
ultimobranchial JJ O
body NN O
of IN O
the DT O
horse NN O

Our PRP$ O
results NNS O
favor VBP O
the DT O
possibility NN O
that IN O
the DT O
Drosophila NNP B-Gene
EGF NNP I-Gene
receptor NN I-Gene
DER NNP B-Gene
/ NNP O
Egfr NNP B-Gene
expressed VBN O
by IN O
the DT O
EMA NNP O
cells NNS O
functions NNS O
as IN O
a DT O
receptor NN O
for IN O
Vein NNP B-Gene
. . O

A DT O
promising JJ O
new JJ O
cement NN O
, , O
4 CD O
- : O
META NNP O
/ NNP O
MMA NNP O
- : O
TBB NNP O
opaque MD O
resin VB O
, , O
has VBZ O
shown VBN O
remarkable JJ O
adhesive JJ O
properties NNS O
as IN O
a DT O
bone NN O
cement NN O
in IN O
vivo NN O
. . O

OsBBPI NNP B-Gene
was VBD O
found VBN O
to TO O
be VB O
rapidly RB O
induced VBN O
in IN O
rice NN O
seedling VBG O
leaf NN O
in IN O
response NN O
to TO O
cut VB B-Gene
, , O
exogenous JJ O
jasmonic JJ O
acid NN O
( ( O
JA NNP O
) ) O
, , O
and CC O
two CD O
potent NN O
protein NN B-Gene
phosphatase NN I-Gene
2A CD I-Gene
( ( O
PP2A NNP B-Gene
) ) O
inhibitors NNS O
, , O
cantharidin NN O
( ( O
CN NNP O
) ) O
and CC O
endothall $ O
( ( O
EN NNP O
) ) O
, , O
in IN O
a DT O
light JJ O
/ NN O
dark NN O
- : O
, , O
time NN O
- : O
and CC O
dose VB O
- : O
dependent JJ O
manner NN O
; : O
this DT O
induction NN O
was VBD O
completely RB O
inhibited VBN O
by IN O
cycloheximide NN O
( ( O
CHX NNP O
) ) O
, , O
indicating VBG O
a DT O
requirement NN O
for IN O
de FW O
novo FW O
protein FW O
synthesis NN O
in IN O
its PRP$ O
induction NN O
. . O

Surprisingly RB O
, , O
the DT O
results NNS O
of IN O
several JJ O
experiments NNS O
suggest VBP O
that IN O
the DT O
TSF NNP B-Gene
genes NNS I-Gene
encode VBP O
global JJ O
regulatory JJ O
factors NNS O
. . O

tsf1 NN B-Gene
to TO O
tsf6 VB B-Gene
mutations NNS O
derepressed VBN O
expression NN O
from IN O
yeast NN O
CYC NNP B-Gene
- : O
GAL NNP B-Gene
hybrid JJ O
promoters NNS O
( ( O
fused VBN O
to TO O
lacZ VB B-Gene
) ) O
that WDT O
harbor VBP O
a DT O
variety NN O
of IN O
operator NN O
sequences NNS O
, , O
and CC O
caused VBD O
pleiotropic NN O
defects NNS O
in IN O
cell NN O
growth NN O
, , O
mating NN O
, , O
and CC O
sporulation NN O
. . O

Variation NN O
in IN O
the DT O
temporal JJ O
- : O
spatial JJ O
distribution NN O
of IN O
228Ra CD O
and CC O
224Ra CD O
in IN O
the DT O
RES NNP O
and CC O
marrow VB O
- : O
free JJ O
skeleton NN O
after IN O
incorporation NN O
of IN O
colloidal NN O
ThO2 NNP O

Androgens NNS O
and CC O
growth NN O
. . O

The DT O
hTERT NN B-Gene
gene NN I-Gene
encompasses VBZ O
more JJR O
than IN O
37kb CD O
and CC O
consists NNS O
of IN O
16 CD O
exons NNS O
. . O

Immuno NNP O
- : O
cytochemistry NN O
, , O
using VBG O
antisera NN O
against IN O
Campylobacter NNP O
jejuni NN O
, , O
showed VBD O
that IN O
the DT O
positive JJ O
staining NN O
in IN O
altered JJ O
epithelial JJ O
cells NNS O
were VBD O
restricted VBN O
to TO O
intracellular VB O
organisms RP O
having VBG O
a DT O
structure NN O
resembling VBG O
Campylobacter NNP O
spp NN O
. . O

A DT O
conserved JJ O
role NN O
for IN O
L1 NNP B-Gene
as IN O
a DT O
transmembrane NN O
link NN O
between IN O
neuronal JJ O
adhesion NN O
and CC O
membrane NN O
cytoskeleton NN O
assembly NN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
stimulated VBD O
the DT O
rapid JJ O
accumulation NN O
of IN O
interferon NN B-Gene
regulated VBN I-Gene
factor NN I-Gene
( ( I-Gene
IRF NNP I-Gene
) ) I-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
, , O
followed VBN O
by IN O
a DT O
delayed NN O
and CC O
dose JJ O
- : O
dependent JJ O
inhibition NN O
of IN O
alpha1 NN B-Gene
( ( I-Gene
I PRP I-Gene
) ) I-Gene
procollagen NN I-Gene
mRNA JJ I-Gene
expression NN O
in IN O
skin JJ O
fibroblasts NNS O
from IN O
several JJ O
different JJ O
donors NNS O
. . O

Cytological NNP O
data NNS O
suggest VBP O
that IN O
the DT O
transgenes NNS O
associate VBP O
with IN O
a DT O
nucleolus NN O
. . O

447 CD O
microns NNS O
for IN O
A NNP O
. . O
microcephalum NN O
and CC O
350 CD O
microns NNS O
for IN O
A NNP O
. . O
wedli NN O
) ) O
, , O
and CC O
fewer JJR O
testes NNS O
per IN O
proglottis NN O
( ( O
44 CD O
- : O
73 CD O
vs NN O
. . O

An DT O
evolutionary JJ O
conserved JJ O
element NN O
is VBZ O
essential JJ O
for IN O
somite NN O
and CC O
adjacent JJ O
mesenchymal JJ O
expression NN O
of IN O
the DT O
Hoxa1 NNP B-Gene
gene NN I-Gene
. . O

The DT O
presence NN O
of IN O
regulatory JJ O
sequences NNS O
for IN O
the DT O
binding NN O
of IN O
transcription NN O
factors NNS O
such JJ O
as IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
whose WP$ O
activation NN O
is VBZ O
associated VBN O
with IN O
the DT O
immediate JJ O
response NN O
of IN O
the DT O
cell NN O
to TO O
an DT O
injury NN O
, , O
may MD O
be VB O
an DT O
indication NN O
of IN O
the DT O
important JJ O
role NN O
which WDT O
HO NNP B-Gene
- : I-Gene
1 CD I-Gene
may MD O
play VB O
in IN O
defense NN O
mechanisms NN O
against IN O
tissue NN O
injury NN O
. . O

Further JJ O
studies NNS O
of IN O
mandibular JJ O
movement NN O
at IN O
initial JJ O
tooth DT O
contact NN O
. . O

In IN O
an DT O
effort NN O
to TO O
isolate VB O
genes NNS O
with IN O
down RP O
- : O
regulated JJ O
expression NN O
at IN O
the DT O
mRNA JJ O
level NN O
during IN O
oncogenic JJ O
transformation NN O
of IN O
human JJ O
mammary JJ O
epithelial NN O
cells NNS O
( ( O
MECs NNP O
) ) O
, , O
we PRP O
performed VBD O
subtractive JJ O
hybridization NN O
between IN O
normal JJ O
MEC NNP O
strain NN O
76N CD O
and CC O
its PRP$ O
radiation NN O
- : O
transformed VBN O
tumorigenic JJ O
derivative JJ O
76R CD O
- : O
30 CD O
. . O

We PRP O
randomly VBP O
assigned VBN O
1 CD O
, , O
219 CD O
subjects NNS O
to TO O
receive VB O
either RB O
the DT O
standard NN O
three CD O
- : O
times NNS O
- : O
weekly NN O
( ( O
TIW NNP O
) ) O
interferon NN B-Gene
alfa SYM I-Gene
- : I-Gene
2b CD I-Gene
dose NN O
( ( O
3 CD O
MIU NNP O
) ) O
or CC O
the DT O
once RB O
- : O
weekly NN O
( ( O
QW NNP O
) ) O
peginterferon NN B-Gene
alfa SYM I-Gene
- : I-Gene
2b CD I-Gene
( ( O
0 CD O
. . O
5 CD O
, , O
1 CD O
. . O
0 CD O
, , O
or CC O
1 CD O
. . O
5 CD O
microg JJ O
/ NNP O
kg NN O
) ) O
. . O

Then RB O
we PRP O
correlated VBD O
HRCT NNP O
findings NNS O
with IN O
the DT O
clinical JJ O
features NNS O
, , O
pulmonary JJ O
functions NNS O
and CC O
methacholine NN O
PC20 NNP O
( ( O
PC20M NNP O
) ) O
and CC O
studied VBN O
their PRP$ O
clinical JJ O
significance NN O
. . O

The DT O
sites NNS O
targeted VBD O
for IN O
mutagenesis NN O
, , O
residues VBZ O
60 CD O
, , O
61 CD O
, , O
and CC O
66 CD O
, , O
are VBP O
located VBN O
within IN O
a DT O
putative JJ O
helical JJ O
loop NN O
structure NN O
which WDT O
may MD O
be VB O
involved VBN O
in IN O
substrate JJ O
recognition NN O
by IN O
the DT O
enzyme NN O
. . O

The DT O
sequencing NN O
of IN O
the DT O
conditional JJ O
lethal JJ O
mutation NN O
ts SYM O
- : O
A13 NNP O
, , O
localized VBN O
in IN O
the DT O
nrdE JJ B-Gene
cistron NN I-Gene
, , O
and CC O
the DT O
lethality NN O
of IN O
insertional JJ O
mutations NNS O
targeted VBN O
in IN O
the DT O
internal JJ O
region NN O
of IN O
nrdE NN B-Gene
and CC O
nrdF NN B-Gene
, , O
demonstrated VBD O
the DT O
essential JJ O
role NN O
of IN O
this DT O
locus NN O
. . O

In IN O
the DT O
first JJ O
part NN O
of IN O
our PRP$ O
study NN O
, , O
the DT O
highest JJS O
mutagenicity NN O
was VBD O
revealed VBN O
by IN O
TA98 NNP O
strain NN O
without IN O
enzymatic JJ O
activation NN O
, , O
suggesting VBG O
a DT O
direct JJ O
- : O
acting VBG O
mutagenicity NN O
prevalence NN O
in IN O
diesel NN O
particulate NN O
. . O

Coenzyme NNP O
Q10 NNP O
: : O
blood NN O
levels NNS O
and CC O
metabolic JJ O
demand NN O
. . O

Distant JJ O
spread NN O
was VBD O
found VBN O
in IN O
46 CD O
patients NNS O
( ( O
34 CD O
% NN O
) ) O
, , O
42 CD O
of IN O
whom WP O
had VBD O
serum VBN O
Tg NNP B-Gene
greater JJR O
than IN O
10 CD O
micrograms NNS O
/ JJ O
l NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
, , O
in IN O
this DT O
experimental JJ O
model NN O
, , O
ACE NNP B-Gene
inhibitors NNS O
limit VBP O
the DT O
arrhythmias NN O
following VBG O
ischemia NN O
- : O
reperfusion NN O
and CC O
free JJ O
radical JJ O
scavenging VBG O
action NN O
of IN O
these DT O
drugs NNS O
does VBZ O
not RB O
have VB O
a DT O
major JJ O
contributory NN O
role NN O
in IN O
their PRP$ O
protective JJ O
effect NN O
. . O

Nevertheless RB O
, , O
protein JJ B-Gene
kinase VBD I-Gene
A DT I-Gene
stimulation NN O
induces VBZ O
CREMalpha NNP B-Gene
to TO O
activate VB O
the DT O
complex JJ O
native JJ O
promoter NN O
in IN O
the DT O
phosphoenolpyruvate NN B-Gene
carboxykinase NN I-Gene
( ( O
PEPCK NNP B-Gene
) ) O
gene NN O
. . O

OBJECTIVE NN O
: : O
To TO O
investigate VB O
the DT O
incidence NN O
and CC O
presentation NN O
of IN O
acute JJ O
pernicious JJ O
or CC O
fulminating VBG O
beriberi NN O
in IN O
a DT O
general JJ O
district NN O
hospital NN O
. . O

METHODS NN O
: : O
Thyroid NN O
status NN O
was VBD O
measured VBN O
at IN O
baseline NN O
( ( O
1990 CD O
- : O
93 CD O
) ) O
, , O
through IN O
assessment NN O
of IN O
serum NN O
antibodies NNS O
to TO O
thyroid VB B-Gene
peroxidase NN I-Gene
( ( O
TPO NNP B-Gene
- : I-Gene
Abs NNP I-Gene
, , O
positive JJ O
: : O
> JJ O
10 CD O
IU NNP O
/ NNP O
ml NN O
) ) O
, , O
serum JJ B-Gene
TSH NNP I-Gene
levels NNS O
, , O
and CC O
when WRB O
TSH NNP B-Gene
was VBD O
abnormal JJ O
( ( O
< JJ O
0 CD O
. . O
4 CD O
or CC O
> $ O
4 CD O
. . O
0 CD O
mU JJ O
/ NNP O
l NN O
) ) O
, , O
serum JJ B-Gene
thyroxin NN I-Gene
levels NNS O
( ( O
T4 NNP O
) ) O
. . O

GHB NNP O
, , O
2 CD O
CB NNP O
, , O
HMB NNP O
, , O
are VBP O
some DT O
of IN O
these DT O
recent JJ O
substances NNS O
. . O

The DT O
construction NN O
of IN O
a DT O
small JJ O
library NN O
of IN O
mouse NN O
repetitive JJ O
DNA NNP O
has VBZ O
been VBN O
previously RB O
reported VBN O
( ( O
Pietras NNP O
et RB O
al RB O
. . O
, , O
Nucleic NNP O
Acids NNP O
Res NNP O
. . O

In IN O
H4IIE NNP O
rat NN O
hepatoma NN O
cells NNS O
, , O
glucocorticoids NNS O
, , O
retinoic NN O
acid NN O
and CC O
cyclic JJ O
AMP NNP O
( ( O
cAMP NN O
) ) O
increase NN O
PEPCK NNP B-Gene
gene NN I-Gene
transcription NN O
whereas IN O
insulin NN B-Gene
and CC O
phorbol NN O
esters NNS O
have VBP O
the DT O
opposite JJ O
effect NN O
. . O

As IN O
with IN O
VP16 NNP B-Gene
, , O
the DT O
transactivation NN O
function NN O
of IN O
Luman NNP B-Gene
is VBZ O
also RB O
regulated VBN O
by IN O
HCF NNP B-Gene
. . O

Thus RB O
, , O
the DT O
CCAAT NNP O
box NN O
also RB O
has VBZ O
tissue NN O
- : O
specific JJ O
characteristics NNS O
that WDT O
assist VBP O
in IN O
targeting VBG O
expression NN O
of IN O
the DT O
alpha JJ B-Gene
- : I-Gene
subunit NN I-Gene
gene NN I-Gene
to TO O
trophoblasts NNS O
. . O

Multivariate NNP O
logistic JJ O
regression NN O
analysis NN O
indicated VBD O
that IN O
seropositivity NN O
was VBD O
strongly RB O
associated VBN O
with IN O
the DT O
prevalence NN O
of IN O
hepatitis NN O
B NNP O
in IN O
an DT O
employee NN O
' POS O
s JJ O
country NN O
of IN O
birth NN O
and CC O
with IN O
age NN O
. . O

Analysis NN O
of IN O
chromosomal JJ O
DNA NNP O
sequence NN O
immediately RB O
downstream NN O
of IN O
the DT O
transposon NN O
insertion NN O
identified VBD O
two CD O
open JJ O
reading VBG O
frames NNS O
, , O
designated VBN O
csrR NN B-Gene
and CC O
csrS NN B-Gene
, , O
which WDT O
exhibited VBD O
sequence NN O
similarity NN O
to TO O
bacterial VB O
two CD O
- : O
component NN O
regulatory JJ O
systems NNS O
. . O

Expression NN O
of IN O
PTPRO NNP B-Gene
was VBD O
also RB O
observed VBN O
in IN O
human JJ B-Gene
CD34 NNP I-Gene
+ NNP I-Gene
bone NN O
marrow NN O
cells NNS O
and CC O
5 CD O
- : O
FU NNP O
- : O
treated VBD O
murine JJ O
primitive JJ O
stem NN O
cells NNS O
. . O

The DT O
extents NNS O
of IN O
phosphorylation NN O
of IN O
Ser44 NNP O
and CC O
Ser64 NNP O
were VBD O
1 CD O
: : O
1 CD O
, , O
whereas VBP O
those DT O
of IN O
the DT O
four CD O
minor NN O
sites VBZ O
all DT O
together RB O
were VBD O
< JJ O
30 CD O
% NN O
of IN O
the DT O
major JJ O
one NN O
. . O

Deletion NN O
analysis NN O
indicates VBZ O
that IN O
TBP NNP B-Gene
and CC O
hTAFII18 NN B-Gene
bind NN O
to TO O
distinct VB O
domains NNS O
of IN O
hTAFII28 NN B-Gene
. . O

hTAFII18 NN B-Gene
also RB O
interacts VBZ O
with IN O
TBP NNP B-Gene
, , O
but CC O
it PRP O
interacts VBZ O
more RBR O
strongly RB O
with IN O
hTAFII28 NN B-Gene
and CC O
hTAFII30 NN B-Gene
. . O

We PRP O
developed VBD O
a DT O
system NN O
for IN O
domain NN O
shuffling NN O
to TO O
establish VB O
the DT O
function NN O
of IN O
C1 NNP B-Gene
domains NNS O
from IN O
human JJ B-Gene
Raf NNP I-Gene
kinase NN I-Gene
and CC O
rat NN B-Gene
PKC NNP I-Gene
eta NN I-Gene
in IN O
yeast NN O
. . O

A DT O
- : O
- : O
A DT O
natural JJ O
hydrostatic JJ O
phenomenon NN O
, , O
at IN O
the DT O
level NN O
of IN O
the DT O
ends NNS O
of IN O
the DT O
plantar NN O
arcs NN O
, , O
diffuses VBZ O
body NN O
weight NN O
, , O
as IN O
PAIN NNP O
plays VBZ O
the DT O
role NN O
of IN O
outsentry NN O
( ( O
fig NN O
. . O
- : O
- : O
1 CD O
) ) O
( ( O
5 CD O
) ) O
; : O
B NNP O
- : O
- : O
Plantar NN O
perforating VBG O
ulceration NN O
( ( O
PPU NNP O
) ) O
is VBZ O
caused VBN O
by IN O
a DT O
combination NN O
of IN O
INSENSITIVITY NNP O
and CC O
TRAUMATIS NNP O
( ( O
1 CD O
) ) O
; : O
C NNP O
- : O
- : O
The DT O
patient NN O
reposing NN O
, , O
as IN O
body NN O
weight NN O
( ( O
traumatism NN O
) ) O
effects NNS O
disappear VBP O
, , O
cicatrization NN O
process NN O
can MD O
be VB O
easily RB O
observed VBN O
; : O
D NNP O
- : O
- : O
PNEUMATIC NN O
INSOLE NNP O
, , O
being VBG O
elastic JJ O
, , O
diffuses VBZ O
localized JJ O
compression NN O
at IN O
the DT O
ends NNS O
of IN O
the DT O
plantar NN O
arcs NN O
, , O
reduces VBZ O
attrition NN O
, , O
makes VBZ O
easier JJR O
blood NN O
circulation NN O
, , O
as RB O
well RB O
as IN O
cure NN O
and CC O
prophylaxis NN O
of IN O
PPU NNP O
( ( O
fig NN O
. . O
- : O
- : O
6 CD O
) ) O
( ( O
3 CD O
) ) O
. . O

Grossly RB O
, , O
the DT O
incidence NN O
of IN O
a DT O
type NN O
IIc NNP O
carcinoma NN O
was VBD O
46 CD O
. . O
5 CD O
% NN O
and CC O
that IN O
of IN O
a DT O
IIc NNP O
+ NNP O
III NNP O
type NN O
was VBD O
20 CD O
. . O
5 CD O
% NN O
, , O
respectively RB O
. . O

We PRP O
interpret VBP O
these DT O
data NNS O
as IN O
further JJ O
evidence NN O
that IN O
interaction NN O
with IN O
a DT O
small JJ B-Gene
GTPase NNP I-Gene
is VBZ O
the DT O
main JJ O
regulatory JJ O
function NN O
of IN O
the DT O
C1 NNP B-Gene
domain NN O
in IN O
yeast NN O
. . O

A DT O
safe JJ O
and CC O
simple JJ O
system NN O
for IN O
the DT O
detection NN O
of IN O
sudden JJ O
infant NN O
death NN O
syndrome NN O
( ( O
SIDS NNP O
) ) O
is VBZ O
proposed VBN O
. . O

During IN O
latency NN O
, , O
more JJR O
than IN O
1 CD O
% NN O
of IN O
neurons NNS O
in IN O
ganglia NN O
that WDT O
innervate VBP O
the DT O
footpad NN O
expressed VBD O
beta SYM B-Gene
- : I-Gene
galactosidase NN I-Gene
, , O
with IN O
the DT O
number NN O
of IN O
positive JJ O
cells NNS O
remaining VBG O
constant JJ O
for IN O
at IN O
least JJS O
5 CD O
months NNS O
. . O

Human NNP B-Gene
granulocyte VBZ I-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
hGM JJ B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
activates VBZ O
a DT O
set NN O
of IN O
genes NNS O
such JJ O
as IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
, , O
jun NN B-Gene
, , O
myc NN B-Gene
, , O
and CC O
early RB B-Gene
growth NN I-Gene
response NN I-Gene
gene NN I-Gene
1 CD I-Gene
( ( O
egr SYM B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

The DT O
biochemical JJ O
and CC O
molecular JJ O
spectrum NN O
of IN O
ornithine JJ B-Gene
transcarbamylase NN I-Gene
deficiency NN O
. . O

The DT O
present JJ O
investigation NN O
sought VBD O
to TO O
identify VB O
the DT O
principal JJ O
dimensions NNS O
of IN O
the DT O
Framingham NNP O
Type NNP O
A NNP O
scale NN O
( ( O
FTAS NNP O
) ) O
and CC O
then RB O
to TO O
examine VB O
their PRP$ O
physiological JJ O
and CC O
psychological JJ O
correlates NNS O
. . O

Tolerance NN O
to TO O
fenfluramine VB O
anorexia NN O
: : O
fact NN O
or CC O
fiction NN O
? . O

Recent JJ O
findings NNS O
in IN O
this DT O
laboratory NN O
with IN O
regard NN O
to TO O
tolerance VB O
to TO O
fenfluramine VB O
anorexia NN O
are VBP O
reviewed VBN O
with IN O
respect NN O
to TO O
generality NN O
of IN O
the DT O
behavioural JJ O
phenomenon NN O
. . O

Fetal JJ O
growth NN O
retardation NN O
as IN O
a DT O
cause NN O
of IN O
impaired JJ O
ovarian JJ O
development NN O
. . O

The DT O
effects NNS O
of IN O
dominant JJ O
interfering VBG O
forms NNS O
of IN O
the DT O
JNK NNP B-Gene
/ NNP O
p38 NN B-Gene
signaling VBG O
pathway NN O
demonstrate NN O
that IN O
activation NN O
of IN O
these DT O
kinases NNS O
is VBZ O
critical JJ O
for IN O
cytokine JJ O
- : O
induced JJ O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
gene NN I-Gene
expression NN O
. . O

Ras NNP B-Gene
- : O
GRF1 NNP B-Gene
transiently RB O
expressed VBD O
with IN O
v NN B-Gene
- : I-Gene
Src NN I-Gene
was VBD O
tyrosine JJ O
- : O
phosphorylated VBN O
and CC O
showed VBN O
significant JJ O
GEF NNP B-Gene
activity NN O
toward IN O
Rac NNP B-Gene
, , O
but CC O
not RB O
Rho NNP B-Gene
and CC O
Cdc42 NNP B-Gene
, , O
which WDT O
was VBD O
comparable JJ O
with IN O
that DT O
induced VBN O
by IN O
Gbetagamma NNP B-Gene
. . O

The DT O
use NN O
of IN O
CRF NNP B-Gene
- : I-Gene
41 CD I-Gene
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
Cushing VBG O
' '' O
s JJ O
syndrome NN O
and CC O
obesity NN O
. . O

Vitrectomy NNP O
and CC O
removal NN O
of IN O
retained JJ O
lens NNS O
fragments NNS O
restores NNS O
good JJ O
visual JJ O
acuity NN O
and CC O
reduces NNS O
secondary JJ O
glaucoma NN O
in IN O
the DT O
majority NN O
of IN O
patients NNS O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
the DT O
HA NNP B-Gene
gene NN I-Gene
in IN O
these DT O
two CD O
mutants NNS O
confirmed VBD O
the DT O
HA NNP B-Gene
- : I-Gene
phenotype NN O
. . O

The DT O
character NN O
of IN O
specific JJ O
immune JJ O
response NN O
in IN O
101 CD O
immunized JJ O
children NNS O
and CC O
in IN O
12 CD O
adults NNS O
belonging VBG O
to TO O
a DT O
high JJ O
risk NN O
group NN O
with IN O
respect NN O
to TO O
VHB NNP O
. . O

Analysis NN O
of IN O
mig NN B-Gene
/ NNP O
CAT NNP B-Gene
chimeric JJ O
constructs NNS O
transiently RB O
transfected VBN O
into IN O
the DT O
RAW NNP O
264 CD O
. . O
7 CD O
mouse NN O
monocytic JJ O
cell NN O
line NN O
revealed VBD O
a DT O
unique JJ O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
( ( O
gamma JJ B-Gene
RE NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

The DT O
MSY2 NNP B-Gene
associated JJ O
kinase NN O
is VBZ O
not RB O
casein JJ B-Gene
kinase NN I-Gene
2 CD I-Gene
, , O
the DT O
kinase NN O
believed VBD O
to TO O
phosphorylate VB O
mRNP3 NNS B-Gene
+ $ I-Gene
4 CD I-Gene
in IN O
oocytes NNS O
, , O
but CC O
a DT O
yet RB O
unidentified JJ O
kinase NN O
. . O

A DT O
key JJ O
event NN O
in IN O
this DT O
process NN O
is VBZ O
the DT O
selective JJ O
recognition NN O
of IN O
the DT O
target NN O
membrane NN O
by IN O
the DT O
vesicle NN O
and CC O
the DT O
current JJ O
view NN O
is VBZ O
that IN O
SNARE NNP B-Gene
protein NN I-Gene
interactions NNS O
likely JJ O
play VBP O
a DT O
central JJ O
role NN O
in IN O
vesicle NN O
- : O
target NN O
recognition NN O
and CC O
or CC O
membrane JJ O
fusion NN O
. . O

The DT O
average JJ O
values NNS O
were VBD O
199 CD O
and CC O
424 CD O
revertants NNS O
/ JJ O
g NN O
for IN O
the DT O
hamburgers NNS O
and CC O
hot JJ O
dogs NNS O
, , O
respectively RB O
. . O

Ca2 NNP B-Gene
+ NNP I-Gene
/ NNP I-Gene
calmodulin SYM I-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
II NNP I-Gene
( ( O
CaMK NNP B-Gene
II NNP I-Gene
) ) O
is VBZ O
a DT O
multifunctional JJ O
serine NN B-Gene
/ NNP I-Gene
threonine NN I-Gene
protein NN I-Gene
kinase VBD I-Gene
that IN O
regulates VBZ O
ion NN O
channels NNS O
, , O
metabolic JJ O
enzymes NNS O
, , O
cytoskeletal JJ O
proteins NNS O
, , O
and CC O
possibly RB O
transcription NN O
factors NNS O
. . O

Insulin NNP B-Gene
- : O
regulated VBD O
events NNS O
, , O
however RB O
, , O
occur VBP O
in IN O
all DT O
cells NNS O
. . O

In IN O
vitro JJ O
binding NN O
studies NNS O
using VBG O
GST NNP B-Gene
fusion NN O
proteins NNS O
and CC O
yeast JJ O
extracts NNS O
defined VBD O
distinct JJ O
binding NN O
sites NNS O
on IN O
yAP180A NN B-Gene
for IN O
Pan1p NNP B-Gene
and CC O
clathrin NN B-Gene
. . O

yAP180 NN B-Gene
proteins NNS I-Gene
and CC O
Pan1p NNP B-Gene
, , O
like IN O
actin NN B-Gene
, , O
localize VB O
to TO O
peripheral JJ O
patches NNS O
along IN O
the DT O
plasma NN O
membrane NN O
. . O

In IN O
summary JJ O
, , O
the DT O
efficacies NNS O
of IN O
adjuvant JJ O
carboplatin NN O
and CC O
of IN O
abdominal JJ O
radiotherapy NN O
seem VBP O
to TO O
be VB O
identical JJ O
. . O

Host NNP O
lipids NNS O
in IN O
tuberculous JJ O
infection NN O
. . O

Trichloroethylene NNP O
, , O
in IN O
turn NN O
, , O
increased VBD O
the DT O
AUC NNP O
5 CD O
. . O
0 CD O
( ( O
1 CD O
. . O
9 CD O
- : O
13 CD O
. . O
4 CD O
) ) O
, , O
25 CD O
. . O
8 CD O
( ( O
8 CD O
. . O
2 CD O
- : O
80 CD O
. . O
8 CD O
) ) O
and CC O
2 CD O
. . O
9 CD O
( ( O
1 CD O
. . O
6 CD O
- : O
5 CD O
. . O
4 CD O
) ) O
, , O
respectively RB O
, , O
whereas IN O
the DT O
corresponding JJ O
values NNS O
for IN O
n JJ O
- : O
hexane NN O
were VBD O
1 CD O
. . O
9 CD O
( ( O
0 CD O
. . O
7 CD O
- : O
5 CD O
. . O
1 CD O
) ) O
, , O
1 CD O
. . O
5 CD O
( ( O
0 CD O
. . O
5 CD O
- : O
4 CD O
. . O
6 CD O
) ) O
, , O
and CC O
3 CD O
. . O
2 CD O
( ( O
1 CD O
. . O
8 CD O
- : O
5 CD O
. . O
9 CD O
) ) O
. . O

Transient JJ O
expression NN O
of IN O
VSF NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
protoplasts NNS O
stimulated VBD O
vs JJ B-Gene
- : I-Gene
1 CD I-Gene
dependent JJ O
activation NN O
of IN O
the DT O
- : B-Gene
76 CD I-Gene
/ JJ I-Gene
grp1 NN I-Gene
. . I-Gene
8 CD I-Gene
minimal JJ I-Gene
promoter NN I-Gene
. . O

Experiences NNS O
with IN O
the DT O
clinical JJ O
and CC O
experimental JJ O
use NN O
of IN O
Urat NNP O
- : O
I PRP O
lithotriptor VBP O
. . O

Isolated VBN O
calcaneal NN O
tuberculous JJ O
osteomyelitis NN O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
although IN O
PI2 NNP O
and CC O
PI3 NNP O
viruses NNS O
belong RB O
to TO O
the DT O
same JJ O
parainfluenza NN O
virus NN O
genus NN O
, , O
these DT O
viruses NNS O
show VBP O
marked JJ O
differences NNS O
with IN O
respect NN O
to TO O
functional JJ O
requirements NNS O
for IN O
the DT O
cytoplasmic JJ O
tail NN O
of IN O
the DT O
F NNP B-Gene
glycoprotein NN I-Gene
. . O

Health NNP O
: : O
an DT O
integrative JJ O
reticulum NN O
. . O

Except IN O
for IN O
nonperfusion NN O
of IN O
neurosensory JJ O
retinal JJ O
vessels NNS O
at IN O
a DT O
light JJ O
dose NN O
of IN O
150 CD O
J NNP O
/ NNP O
cm2 NN O
, , O
no DT O
other JJ O
adverse JJ O
events NNS O
were VBD O
of IN O
concern NN O
. . O

GR63178A NNP O
is VBZ O
a DT O
water NN O
- : O
soluble JJ O
analogue NN O
of IN O
mitoquidone NN O
, , O
a DT O
pentacyclic JJ O
pyrroloquinone NN O
. . O

Pseudomonas NNP B-Gene
aeruginosa NN I-Gene
exotoxin NN I-Gene
A DT I-Gene
: : O
its PRP$ O
role NN O
in IN O
retardation NN O
of IN O
wound NN O
healing NN O
: : O
the DT O
1992 CD O
Lindberg NNP O
Award NNP O
. . O

Regression NN O
analyses NNS O
identified VBD O
7 CD O
risk NN O
and CC O
7 CD O
protective JJ O
factors NNS O
with IN O
minimal JJ O
overlap NN O
. . O

Gastrointestinal JJ O
manifestations NNS O
of IN O
systemic JJ O
sclerosis NN O

The DT O
Scales NNP O
of IN O
Cognitive NNP O
Impairment NNP O
Rated VBN O
From IN O
Institutional NNP O
Records NNP O
( ( O
SCIRFIR NNP O
) ) O
, , O
a DT O
battery NN O
based VBN O
on IN O
commonly RB O
used VBN O
dementia NN O
rating NN O
instruments NNS O
, , O
was VBD O
tested VBN O
on IN O
the DT O
records NNS O
of IN O
26 CD O
chronically RB O
institutionalized VBN O
, , O
elderly JJ O
schizophrenia NN O
patients NNS O
, , O
for IN O
the DT O
purpose NN O
of IN O
retrospectively RB O
evaluating VBG O
the DT O
long JJ O
- : O
term NN O
course NN O
of IN O
cognitive JJ O
change NN O
in IN O
schizophrenia NN O
and CC O
relating VBG O
it PRP O
to TO O
available JJ O
autopsy JJ O
materials NNS O
. . O

Analysis NN O
for IN O
DNA NNP O
- : O
protein NN O
interactions NNS O
by IN O
in IN O
vitro JJ O
DNase NNP B-Gene
- : I-Gene
I PRP I-Gene
footprinting VBG O
identified VBD O
a DT O
broad JJ O
region NN O
of IN O
protection NN O
extending VBG O
from IN O
nt JJ O
- : O
12 CD O
to TO O
+ VB O
38 CD O
. . O

Except IN O
for IN O
nonperfusion NN O
of IN O
neurosensory JJ O
retinal JJ O
vessels NNS O
at IN O
a DT O
light JJ O
dose NN O
of IN O
150 CD O
J NNP O
/ NNP O
cm2 NN O
, , O
no DT O
other JJ O
adverse JJ O
events NNS O
were VBD O
of IN O
concern NN O
. . O

The DT O
ability NN O
of IN O
rats NNS O
with IN O
control NN O
or CC O
hippocampal JJ O
lesions NNS O
to TO O
learn VB O
an DT O
object JJ O
- : O
place NN O
, , O
odor SYM O
- : O
place NN O
, , O
or CC O
object SYM O
- : O
odor NN O
paired VBD O
- : O
associate NN O
task NN O
was VBD O
assessed VBN O
in IN O
a DT O
cheeseboard NN O
maze NN O
apparatus NN O
. . O

Emergency NNP O
treatment NN O
of IN O
facial JJ O
and CC O
maxillary JJ O
/ NNP O
mandibular NN O
injuries NNS O

The DT O
men NNS O
self VBD O
- : O
selected VBN O
a DT O
prescribed JJ O
diet NN O
at IN O
home NN O
emphasizing NN O
saturated VBD O
fat JJ O
as IN O
the DT O
visible JJ O
fat NN O
for IN O
1 CD O
week NN O
. . O

We PRP O
propose VBP O
that IN O
TFOs NNP O
represent VBP O
a DT O
therapeutic JJ O
potential NN O
to TO O
specifically RB O
diminish VB O
the DT O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
sis NN I-Gene
/ NN O
PDGF NNP B-Gene
- : I-Gene
B NNP I-Gene
proto NN O
- : O
oncogene NN O
in IN O
various JJ O
pathologic JJ O
settings NNS O
where WRB O
constitutive JJ O
expression NN O
of IN O
this DT O
gene NN O
has VBZ O
been VBN O
observed VBN O
. . O

( ( O
1997 CD O
) ) O
Nature NN O
387 CD O
, , O
370 CD O
- : O
376 CD O
) ) O
] NN O
, , O
we PRP O
suggest VBP O
that IN O
the DT O
metal NN O
fluoride JJ O
ions NNS O
replaced VBD O
phosphate NN O
at IN O
the DT O
two CD O
ATP NNP O
- : O
binding VBG O
sites NNS O
of IN O
the DT O
iron NN O
protein NN O
, , O
Kp2 NNP B-Gene
. . O

These DT O
features NNS O
were VBD O
considered VBN O
consistent JJ O
with IN O
a DT O
diagnosis NN O
of IN O
Rothmund NNP O
- : O
Thomson NNP O
syndrome NN O
. . O

Visidex NN O
I PRP O
is VBZ O
unsuitable JJ O
for IN O
storage NN O
and CC O
re VB O
- : O
reading NN O
. . O

CONCLUSIONS NN O
: : O
Significant JJ O
elevations NNS O
of IN O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
1beta CD I-Gene
occur NN O
in IN O
patients NNS O
with IN O
bacterial JJ O
cystitis NN O
and CC O
microscopic NN O
hematuria NN O
. . O

Two CD O
promoters NNS O
were VBD O
identified VBN O
by IN O
S1 NNP B-Gene
nuclease NN I-Gene
mapping NN O
: : O
P1 NNP O
, , O
which WDT O
lies VBZ O
about IN O
72 CD O
bp NNS O
upstream RB O
from IN O
the DT O
structural JJ O
gene NN O
; : O
and CC O
P2 NNP O
, , O
which WDT O
lies VBZ O
about IN O
35 CD O
bp NN O
upstream NN O
. . O

The DT O
size NN O
of IN O
the DT O
group NN O
allocated VBD O
to TO O
the DT O
good JJ O
compliance NN O
category NN O
by IN O
the DT O
use NN O
of IN O
the DT O
digoxin NN O
marker NN O
was VBD O
equivalent JJ O
in IN O
size NN O
to TO O
a DT O
group NN O
of IN O
patients NNS O
who WP O
had VBD O
returned VBN O
less JJR O
than IN O
15 CD O
% NN O
of IN O
their PRP$ O
prescribed VBN O
dose NN O
or CC O
reported VBD O
a DT O
deviation NN O
of IN O
less JJR O
than IN O
6 CD O
% NN O
from IN O
their PRP$ O
prescription NN O
. . O

Plasma NNP O
NE NNP O
was VBD O
also RB O
low JJ O
in IN O
the DT O
anephric JJ O
group NN O
( ( O
289 CD O
mg NN O
/ NNP O
liter NN O
+ NNP O
/ NNP O
- : O
126 CD O
( ( O
1 CD O
SD NNP O
) ) O
vs VBD O
612 CD O
+ NNP O
/ NNP O
- : O
189 CD O
, , O
P NNP O
= VBZ O
0 CD O
. . O
33 CD O
, , O
resting VBG O
) ) O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

In IN O
the DT O
latter JJ O
category NN O
particular JJ O
emphasis NN O
is VBZ O
being VBG O
placed VBN O
on IN O
new JJ O
anthracycline JJ O
analogues NNS O
of IN O
doxorubicin NN O
and CC O
analogues NNS O
of IN O
cisplatinum NN O
diammine NN O
dichloride NN O
. . O

An DT O
experimental JJ O
long JJ O
- : O
term NN O
study NN O
. . O

Fermentation NNP O
process NN O
after IN O
supplementation NN O
of IN O
nitrate NN O
, , O
nitrite RB O
, , O
lactic JJ O
acid NN O
bacteria NNS O
and CC O
formic JJ O
acid NN O

The DT O
IgA NNP B-Gene
deficiency NN O
is VBZ O
combined VBN O
with IN O
the DT O
IgE NNP B-Gene
one NN O
. . O

Two CD O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
isoforms VBZ O
with IN O
different JJ O
estrogen NN O
dependencies NNS O
are VBP O
generated VBN O
from IN O
the DT O
trout NN B-Gene
ER NNP I-Gene
gene NN I-Gene
. . O

The DT O
N NNP O
- : O
terminus NN O
of IN O
another DT O
open JJ O
reading NN O
frame NN O
was VBD O
found VBN O
3 CD O
' '' O
from IN O
nifA NNS B-Gene
and CC O
tentatively RB O
identified VBN O
as IN O
nifB NN B-Gene
by IN O
amino NN O
acid JJ O
sequence NN O
comparison NN O
. . O

This DT O
regulation NN O
could MD O
not RB O
be VB O
appreciably RB O
modified VBN O
by IN O
enhanced JJ O
expression NN O
of IN O
STAT NNP B-Gene
proteins NNS I-Gene
. . O

Synthesis NN O
of IN O
antisense NN O
RNA NNP O
and CC O
S NNP O
phase NN O
- : O
dependent JJ O
binding NN O
of IN O
E2F NNP B-Gene
complexes NNS I-Gene
in IN O
intron NN O
1 CD O
. . O

Later RB O
in IN O
development NN O
, , O
Tbx6 NNP B-Gene
expression NN O
is VBZ O
restricted VBN O
to TO O
presomitic JJ O
, , O
paraxial JJ O
mesoderm NN O
and CC O
to TO O
the DT O
tail NN O
bud NN O
, , O
which WDT O
replaces VBZ O
the DT O
streak NN O
as IN O
the DT O
source NN O
of IN O
mesoderm NN O
. . O

We PRP O
found VBD O
that IN O
lung NN O
cancer NN O
tissues NNS O
of IN O
positive JJ O
67Ga CD O
scan JJ O
expressed VBN O
TFR NNP B-Gene
, , O
but CC O
those DT O
of IN O
a DT O
negative JJ O
scan NN O
did VBD O
not RB O
. . O

The DT O
apparatus NN O
consists VBZ O
of IN O
an DT O
Am NNP O
- : O
241 CD O
exciting VBG O
source NN O
( ( O
300 CD O
mCi NN O
) ) O
and CC O
pure JJ O
Ge NNP O
detector NN O
( ( O
50 CD O
mm2 NN O
X NNP O
5 CD O
mm NN O
) ) O
for IN O
measuring VBG O
K NNP O
alpha JJ O
fluorescent NN O
x NNP O
- : O
rays NNS O
( ( O
28 CD O
. . O
3 CD O
and CC O
28 CD O
. . O
6 CD O
KeV NNP O
) ) O
emitted VBD O
from IN O
exited VBN O
iodine NN O
. . O

However RB O
, , O
a DT O
clear JJ O
difference NN O
exists NNS O
between IN O
myoblasts NNS O
and CC O
10T1 CD O
/ JJ O
2 CD O
cells NNS O
( ( O
and CC O
other JJ O
non JJ O
- : O
muscle NN O
cell NN O
types NNS O
) ) O
in IN O
the DT O
chromatin NN O
structure NN O
of IN O
the DT O
chromosomal JJ O
myoD NN B-Gene
core NN I-Gene
enhancer NN I-Gene
, , O
suggesting VBG O
that IN O
the DT O
myoD NN B-Gene
enhancer NN I-Gene
is VBZ O
repressed VBN O
by IN O
epigenetic JJ O
mechanisms NNS O
in IN O
10T1 CD O
/ JJ O
2 CD O
cells NNS O
. . O

Patients NNS O
who WP O
have VBP O
undergone JJ O
thyroidectomy NN O
for IN O
thyroid JJ O
carcinoma NN O
are VBP O
frequently RB O
subjected VBN O
to TO O
periods NNS O
of IN O
induced VBN O
severe JJ O
hypothyroidism NN O
in IN O
preparation NN O
for IN O
131I CD O
whole JJ O
body NN O
scanning VBG O
and CC O
measurement NN O
of IN O
serum NN O
TG NNP B-Gene
. . O

Alison NNP O
Bell NNP O
Memorial NNP O
Award NNP O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
a DT O
class NN O
of IN O
proline NN O
- : O
rich JJ O
activator NN O
proteins NNS O
and CC O
RNA NNP B-Gene
polymerase NN I-Gene
II NNP I-Gene
possess NN O
a DT O
common JJ O
structural JJ O
and CC O
functional JJ O
component NN O
which WDT O
can MD O
interact VB O
with IN O
the DT O
same JJ O
target NN O
in IN O
the DT O
general JJ O
transcription NN O
machinery NN O
. . O

Malignant JJ O
lymphoma NN O
is VBZ O
very RB O
heterogeneous JJ O
in IN O
terms NNS O
of IN O
its PRP$ O
biological JJ O
behavior NN O
. . O

METHODS NN O
: : O
The DT O
responses NNS O
of IN O
a DT O
31 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
complex JJ O
regional JJ O
pain NN O
syndrome JJ O
type NN O
I PRP O
( ( O
reflex JJ O
sympathetic JJ O
dystrophy NN O
) ) O
to TO O
a DT O
thermal JJ O
grill NN O
were VBD O
evaluated VBN O
before IN O
and CC O
after IN O
stellate JJ O
ganglion NN O
block NN O
. . O

The DT O
2 CD O
kb NN O
of IN O
5 CD O
' POS O
- : O
flanking NN O
region NN O
and CC O
the DT O
1 CD O
. . O
1 CD O
kb NN O
of IN O
the DT O
entire JJ O
sGTH NN B-Gene
alpha NN I-Gene
subunit NN I-Gene
coding VBG O
region NN O
were VBD O
sequenced VBN O
from IN O
the DT O
genomic JJ O
clone NN O
, , O
sGTH NN B-Gene
alpha SYM I-Gene
- : I-Gene
G1 NN I-Gene
. . O

Northern NNP O
- : O
blot NN O
analysis NN O
of IN O
mRNA NN O
from IN O
Avicel NNP O
- : O
grown JJ O
N NNP O
. . O
patriciarum NN O
showed VBD O
that IN O
xynB NNP B-Gene
hybridized VBD O
to TO O
a DT O
3 CD O
. . O
4 CD O
kb JJ O
mRNA NN O
species NNS O
. . O

Individual JJ O
alcohol NN O
reaction NN O
profiles NNS O
. . O

Deaths NNP O
stopped VBD O
11 CD O
hours NNS O
after IN O
copper NN O
concentrations NNS O
decreased VBD O
below IN O
0 CD O
. . O
2 CD O
ppm NN O
and CC O
signs NNS O
of IN O
distress NN O
stopped VBN O
in IN O
surviving VBG O
pinfish JJ O
by IN O
approximately RB O
6 CD O
hours NNS O
after IN O
the DT O
last JJ O
death NN O
. . O

In IN O
these DT O
cases NNS O
, , O
asbestos NN O
or CC O
erionite JJ O
- : O
tissue NN O
burden NN O
followed VBN O
by IN O
fibrosis NN O
was VBD O
frequently RB O
observed VBN O
. . O

Conversely RB O
, , O
activation NN O
of IN O
Oct NNP B-Gene
- : I-Gene
3 CD I-Gene
/ $ I-Gene
4 CD I-Gene
promoter NN I-Gene
by IN O
RAR NNP B-Gene
: : O
RXR NNP B-Gene
heterodimers NNS I-Gene
was VBD O
completely RB O
abolished VBN O
by IN O
EAR NNP B-Gene
- : I-Gene
3 CD I-Gene
/ NN O
COUP NNP B-Gene
- : I-Gene
TFI NN I-Gene
and CC O
by IN O
ARP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ NN O
COUP NNP B-Gene
- : I-Gene
TFII NN I-Gene
. . O

Both DT O
increasing VBG O
basal NN O
FSH NNP B-Gene
and CC O
age NN O
were VBD O
associated VBN O
significantly RB O
with IN O
increased JJ O
total NN O
gonadotrophin NN B-Gene
dose NN O
, , O
and CC O
reduced JJ O
number NN O
of IN O
oocytes NNS O
collected VBN O
and CC O
pregnancy NN O
rate NN O
. . O

Transgenic NNP O
mice NN O
harboring VBG O
the DT O
rat NN O
TnI NNP B-Gene
- : O
CAT NNP B-Gene
fusion NN O
gene NN O
expressed VBD O
the DT O
reporter NN O
specifically RB O
in IN O
the DT O
skeletal JJ O
muscle NN O
. . O

The DT O
up RP O
- : O
regulation NN O
of IN O
E NNP B-Gene
- : I-Gene
selectin NN I-Gene
, , O
one CD O
of IN O
the DT O
adhesion NN O
molecules NNS O
on IN O
the DT O
endothelium NN O
, , O
is VBZ O
an DT O
important JJ O
event NN O
in IN O
the DT O
mediation NN O
of IN O
the DT O
inflammatory JJ O
response NN O
. . O

Mutational JJ O
analysis NN O
of IN O
a DT O
DNA NN O
sequence NN O
involved VBN O
in IN O
linking VBG O
gene NN O
expression NN O
to TO O
the DT O
cell NN O
cycle NN O
. . O

Experimentally RB O
in IN O
green JJ O
monkeys NNS O
, , O
Syrian JJ O
hamsters NNS O
and CC O
white JJ O
mice NN O
the DT O
authors NNS O
studied VBD O
the DT O
pathogenic JJ O
properties NNS O
of IN O
a DT O
new JJ O
virus NN O
Issyk NNP O
- : O
Kul NNP O
. . O

PACAP NNP B-Gene
mRNA NN I-Gene
was VBD O
widely RB O
expressed VBN O
in IN O
most JJS O
human JJ O
tissues NNS O
; : O
in IN O
transfected JJ O
cells NNS O
, , O
PACAP NNP B-Gene
was VBD O
diffusely RB O
expressed VBN O
in IN O
the DT O
cytoplasm NN O
. . O

Multiple JJ O
transcription NN O
start NN O
sites NNS O
were VBD O
revealed VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
of IN O
the DT O
mouse NN O
gene NN O
, , O
and CC O
transfection NN O
constructs NNS O
containing VBG O
the DT O
prospective JJ O
promoter NN O
generated VBD O
transcriptional JJ O
activity NN O
comparable JJ O
to TO O
that DT O
of IN O
the DT O
SV40 NNP B-Gene
promoter NN I-Gene
. . O

Functional JJ O
postnatal NN O
development NN O
of IN O
the DT O
rat NN O
primary JJ O
visual JJ O
cortex NN O
and CC O
the DT O
role NN O
of IN O
visual JJ O
experience NN O
: : O
dark NN O
rearing NN O
and CC O
monocular JJ O
deprivation NN O
. . O

The DT O
HPLC NNP O
method NN O
involves VBZ O
an DT O
octadecylsilane JJ O
column NN O
at IN O
55 CD O
degrees NNS O
C NNP O
, , O
a DT O
mixture NN O
of IN O
water NN O
- : O
acetonitrile NN O
- : O
orthophosphoric JJ O
acid NN O
( ( O
779 CD O
: : O
220 CD O
: : O
1 CD O
, , O
v FW O
/ NNP O
v NN O
) ) O
as IN O
mobile JJ O
phase NN O
and CC O
detection NN O
at IN O
226 CD O
nm NNS O
. . O

Three CD O
patients NNS O
with IN O
four CD O
renoureteral JJ O
units NNS O
have VBP O
undergone JJ O
single JJ O
- : O
stage NN O
reconstruction NN O
involving VBG O
ureteroureterostomy JJ O
and CC O
ipsilateral JJ O
ureteroneocystostomy NN O
following VBG O
temporary JJ O
loop RB O
cutaneous JJ O
ureterostomy NN O
. . O

Transplantation NN O
of IN O
kidneys NNS O
of IN O
juvenile NN O
donors NNS O
in IN O
adult NN O
recipients NNS O
. . O

The DT O
regional JJ O
blockade NN O
of IN O
H1R NNP B-Gene
was VBD O
observed VBN O
mainly RB O
in IN O
the DT O
frontal NN O
, , O
temporal JJ O
and CC O
anterior JJ O
cingulate NN O
cortices NNS O
, , O
and CC O
the DT O
intravenous JJ O
administration NN O
of IN O
d JJ O
- : O
chlorpheniramine NN O
as IN O
a DT O
therapeutic JJ O
dose NN O
( ( O
2 CD O
mg NN O
) ) O
blocked VBD O
over IN O
60 CD O
% NN O
of IN O
H1R NNP B-Gene
in IN O
the DT O
frontal JJ O
cortices NNS O
. . O

In IN O
the DT O
course NN O
of IN O
investigating VBG O
the DT O
mechanisms NN O
by IN O
which WDT O
OF5 NNP B-Gene
and CC O
OF3 NNP B-Gene
regulated VBD O
CYP11A1 NNP B-Gene
transcription NN O
, , O
we PRP O
found VBD O
that IN O
OF5 NNP B-Gene
and CC O
OF3 NNP B-Gene
bound NN O
Sp1 NNP B-Gene
and CC O
Sp3 NNP B-Gene
in IN O
JEG NNP O
- : O
3 CD O
cells NNS O
. . O

In IN O
PAV NNP O
- : O
3 CD O
, , O
the DT O
E1A NNP B-Gene
region NN I-Gene
is VBZ O
located VBN O
between IN O
1 CD O
. . O
5 CD O
and CC O
3 CD O
. . O
8 CD O
map JJ O
units NNS O
. . O

Arachnoid NNP O
cyst NN O
. . O

Moritta NNP O
) ) O
and CC O
contains VBZ O
Bis NNP O
- : O
GMA NNP O
. . O

Protein NNP B-Gene
phosphatase NN I-Gene
2A CD I-Gene
is VBZ O
a DT O
critical JJ O
regulator NN O
of IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
zeta NN I-Gene
signaling VBG O
targeted VBN O
by IN O
SV40 NNP B-Gene
small JJ I-Gene
t NN I-Gene
to TO O
promote VB O
cell NN O
growth NN O
and CC O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
. . O

The DT O
models NNS O
accurately RB O
localized VBD O
the DT O
common JJ O
boundaries NNS O
between IN O
the DT O
PBB NNP O
and CC O
CN NNP O
. . O

The DT O
possibility NN O
of IN O
selective JJ O
chemotherapy NN O
of IN O
progressive JJ O
recurring VBG O
ovarian JJ O
carcinoma NN O
with IN O
the DT O
aid NN O
of IN O
cytodiagnosis NN O
and CC O
incorporation NN O
of IN O
tagged JJ O
idoxuridine NN O

Snail NNP O
mortality NN O
did VBD O
not RB O
differ VB O
among IN O
the DT O
various JJ O
treatment NN O
conditions NNS O
. . O

A DT O
Bub2p NNP B-Gene
- : O
dependent NN O
spindle JJ O
checkpoint NN O
pathway NN O
regulates VBZ O
the DT O
Dbf2p NNP B-Gene
kinase NN I-Gene
in IN I-Gene
budding VBG I-Gene
yeast NN I-Gene
. . O

Its PRP$ O
vasodilatory NN O
, , O
anti SYM O
- : O
vasopressor NN O
, , O
and CC O
platelet NN O
stabilizing NN O
effects NNS O
could MD O
be VB O
expected VBN O
to TO O
counteract VB O
the DT O
placental JJ O
ischemia NN O
, , O
hypertension NN O
and CC O
excessive JJ O
coagulation NN O
that WDT O
are VBP O
seen VBN O
in IN O
pre JJ O
- : O
eclampsia NN O
. . O

The DT O
RF NNP O
values NNS O
correlated VBD O
well RB O
with IN O
the DT O
angiographic JJ O
semiquantitative JJ O
scale NN O
of IN O
severity NN O
of IN O
aortal JJ O
insufficiency NN O
( ( O
r JJ O
= NN O
0 CD O
. . O
805 CD O
; : O
p NN O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
, , O
although IN O
they PRP O
enabled VBD O
the DT O
authors NNS O
only RB O
to TO O
make VB O
a DT O
partial JJ O
differentiation NN O
of IN O
haemodynamically RB O
severe JJ O
regurgitations NNS O
and CC O
mild NN O
or CC O
insignificant JJ O
ones NNS O
. . O

In IN O
order NN O
to TO O
identify VB O
and CC O
classify VB O
the DT O
basic JJ O
CT NNP O
appearances NNS O
of IN O
interstitial JJ O
pneumonia NN O
, , O
radiologic JJ O
- : O
pathologic NN O
correlative NN O
study NN O
was VBD O
performed VBN O
using VBG O
inflated JJ O
and CC O
fixed JJ O
lungs NNS O
from IN O
autopsy NN O
and CC O
surgery NN O
. . O

The DT O
effect NN O
of IN O
zinc NN O
deficiency NN O
on IN O
trace NN O
metals NNS O
in IN O
the DT O
liver NN O
, , O
spleen NN O
, , O
kidney NN O
, , O
pancreas NNS O
and CC O
duodenum NN O
was VBD O
investigated VBN O
in IN O
the DT O
control NN O
and CC O
zinc NNP O
- : O
deficient NN O
rats NNS O
at IN O
17 CD O
days NNS O
and CC O
20 CD O
days NNS O
of IN O
pregnancy NN O
. . O

Selective JJ O
macrophage NN O
inhibition NN O
abolishes NNS O
warfarin VBP O
- : O
induced JJ O
reduction NN O
of IN O
metastasis NN O
. . O

Truncated VBN B-Gene
ICSBP NNP I-Gene
lacking VBG O
the DT O
first JJ O
33 CD O
amino NN O
- : O
terminal NN O
amino NN O
acids NNS O
fails VBZ O
to TO O
bind VB O
to TO O
the DT O
ICS NNP B-Gene
, , O
indicating VBG O
that IN O
at IN O
least JJS O
part NN O
of IN O
the DT O
DNA NNP O
binding NN O
domain NN O
is VBZ O
located VBN O
within IN O
the DT O
well NN O
conserved VBD O
amino JJ O
terminus NN O
. . O

We PRP O
found VBD O
that IN O
multiple JJ O
tumor NN O
suppressor NN O
genes NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
p53 NN B-Gene
, , O
DCC NNP B-Gene
, , O
APC NNP B-Gene
, , O
MCC NNP B-Gene
, , O
BRCA1 NNP B-Gene
, , O
and CC O
WAF1 NNP B-Gene
/ NNP O
CIP1 NNP B-Gene
) ) O
were VBD O
inactivated VBN O
at IN O
different JJ O
frequencies NNS O
via IN O
various JJ O
mechanisms NNS O
[ VBP O
e NN O
. . O
g NN O
. . O
, , O
loss NN O
of IN O
heterozygosity NN O
( ( O
LOH NNP O
) ) O
, , O
loss NN O
of IN O
expression NN O
( ( O
LOE NNP O
) ) O
, , O
mutation NN O
, , O
and CC O
inactivation NN O
by IN O
cellular JJ O
binding VBG O
protein NN O
] NN O
. . O

Anterior NNP O
body NN O
pattern NN O
in IN O
Drosophila NNP O
is VBZ O
specified VBN O
by IN O
the DT O
graded JJ O
distribution NN O
of IN O
the DT O
bicoid NN B-Gene
protein NN I-Gene
( ( O
bcd NN B-Gene
) ) O
, , O
which WDT O
activates VBZ O
subordinate JJ O
genes NNS O
in IN O
distinct JJ O
anterior JJ O
domains NNS O
. . O

Horvath NNP O
, , O
I PRP O
. . O

We PRP O
discuss VBP O
these DT O
results NNS O
in IN O
terms NNS O
of IN O
the DT O
influence NN O
that IN O
time NN O
and CC O
nutritional JJ O
constraints NNS O
have VBP O
on IN O
odonate NN O
development NN O
patterns NNS O
and CC O
fitness NN O
. . O

Clinical JJ O
applications NNS O
of IN O
inhibition NN O
of IN O
beta NN B-Gene
- : I-Gene
adrenergic JJ I-Gene
receptors NNS I-Gene
with IN O
propranolol NN O
. . O

Although IN O
MAP NNP B-Gene
( ( I-Gene
mitogen SYM I-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
) ) I-Gene
kinases NNS I-Gene
are VBP O
implicated VBN O
in IN O
cell NN O
proliferation NN O
and CC O
differentiation NN O
in IN O
many JJ O
cell NN O
types NNS O
, , O
the DT O
role NN O
of IN O
MAP NNP B-Gene
kinases NNS I-Gene
in IN O
cardiac JJ O
hypertrophy NN O
remains VBZ O
unclear JJ O
. . O

In IN O
concept NN O
II NNP O
62 CD O
patients NNS O
were VBD O
treated VBN O
with IN O
selective JJ O
vagotomy NN O
and CC O
pyloroplasty NN O
. . O

During IN O
presentation NN O
of IN O
happy JJ O
facial JJ O
expressions NNS O
, , O
we PRP O
detected VBD O
a DT O
signal JJ O
increase NN O
predominantly RB O
in IN O
the DT O
left NN O
anterior JJ O
cingulate NN O
gyrus NN O
, , O
bilateral JJ O
posterior JJ O
cingulate NN O
gyri NN O
, , O
medial JJ O
frontal JJ O
cortex NN O
and CC O
right JJ O
supramarginal JJ O
gyrus NN O
, , O
brain NN O
regions NNS O
previously RB O
implicated VBN O
in IN O
visuospatial JJ O
and CC O
emotion NN O
processing NN O
tasks NNS O
. . O

Hepatitis NNP O
- : O
B NNP O
vaccination NN O
in IN O
the DT O
elderly JJ O
. . O

This DT O
enhancer NN O
activates VBZ O
both DT O
the DT O
K19 NNP B-Gene
and CC O
TK NNP B-Gene
basal NN I-Gene
promoters NNS I-Gene
in IN O
HeLa NNP O
cells NNS O
. . O

A DT O
randomized JJ O
mix NN O
of IN O
180 CD O
sections NNS O
( ( O
10 CD O
samples NNS O
x RB O
3 CD O
tissues NNS O
x VBP O
3 CD O
stains NNS O
x JJ O
2 CD O
) ) O
gave VBD O
90 CD O
matched JJ O
pairs NNS O
. . O

During IN O
sub JJ O
- : O
maximal JJ O
exercise NN O
, , O
DCR NNP O
in IN O
the DT O
UT NNP O
dogs NNS O
decreased VBD O
from IN O
a DT O
resting VBG O
value NN O
of IN O
4 CD O
. . O
8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
18 CD O
mm JJ O
Hg NNP O
X NNP O
ml VBD O
- : O
1 CD O
X NNP O
min SYM O
- : O
1 CD O
to TO O
1 CD O
. . O
91 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
17 CD O
mm JJ O
Hg NNP O
X NNP O
ml VBD O
- : O
1 CD O
X NNP O
min SYM O
- : O
1 CD O
at IN O
a DT O
workload NN O
of IN O
6 CD O
. . O
4 CD O
kph NN O
( ( O
speed NN O
) ) O
/ VBZ O
16 CD O
% NN O
( ( O
grade NN O
) ) O
. . O

Hprp3p NNP B-Gene
is VBZ O
a DT O
77 CD O
kDa NN O
protein NN O
, , O
which WDT O
is VBZ O
homologous JJ O
to TO O
the DT O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
splicing VBG I-Gene
factor NN I-Gene
Prp3p NNP I-Gene
. . O

According VBG O
to TO O
the DT O
investigation NN O
, , O
the DT O
recent JJ O
burst NN O
of IN O
pseudoterranovosis NN O
in IN O
this DT O
area NN O
can MD O
be VB O
attributed VBN O
to TO O
the DT O
increased VBN O
presence NN O
of IN O
sea NN O
lions NNS O
, , O
which WDT O
proliferate VBP O
in IN O
the DT O
Arctic NNP O
region NN O
, , O
then RB O
migrate VB O
to TO O
the DT O
northern JJ O
Japan NNP O
Sea NNP O
and CC O
eat VB O
the DT O
intermediate JJ O
host NN O
fish NN O
. . O

60 CD O
patients NNS O
were VBD O
entered VBN O
into IN O
a DT O
randomised JJ O
study NN O
comparing VBG O
vindesine NN O
( ( O
3 CD O
mg NN O
/ NNP O
m2 NN O
/ NNP O
week NN O
) ) O
plus CC O
interferon JJ B-Gene
- : I-Gene
alpha NN I-Gene
2b CD I-Gene
( ( O
6 CD O
U NNP O
/ NNP O
m2 VBD O
3 CD O
times NNS O
per IN O
week NN O
) ) O
to TO O
vindesine VB O
alone RB O
or CC O
to TO O
interferon VB B-Gene
alone RB O
for IN O
the DT O
treatment NN O
of IN O
metastatic JJ O
malignant JJ O
melanoma NN O
. . O

In IN O
this DT O
regard NN O
, , O
we PRP O
have VBP O
recently RB O
observed VBN O
that IN O
a DT O
constitutively RB O
active JJ O
G NNP B-Gene
protein NN I-Gene
- : I-Gene
coupled VBN I-Gene
receptor NN I-Gene
( ( O
GPCR NNP B-Gene
) ) O
encoded VBN O
by IN O
the DT O
Kaposi NNP O
' POS O
s NN O
sarcoma NN O
- : O
associated VBN O
herpes NNS O
virus NN O
( ( O
KSHV NNP O
) ) O
/ VBP O
human JJ O
herpes NNS O
virus NN O
8 CD O
is VBZ O
oncogenic JJ O
and CC O
stimulates NNS O
angiogenesis NN O
by IN O
increasing VBG O
the DT O
secretion NN O
of IN O
vascular JJ B-Gene
endothelial JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
VEGF NNP B-Gene
) ) O
, , O
which WDT O
is VBZ O
a DT O
key JJ O
angiogenic JJ O
stimulator NN O
and CC O
a DT O
critical JJ O
mitogen NN O
for IN O
the DT O
development NN O
of IN O
Kaposi NNP O
' POS O
s NN O
sarcoma NN O
. . O

The DT O
drug NN O
was VBD O
given VBN O
in IN O
a DT O
daily JJ O
oral JJ O
dose NN O
of IN O
0 CD O
. . O
5 CD O
g JJ O
/ NNP O
m2 NN O
, , O
3 CD O
. . O
5 CD O
h JJ O
prior RB O
to TO O
each DT O
radiation NN O
treatment NN O
. . O

They PRP O
lack VBP O
a DT O
predicted JJ O
single JJ O
stranded VBN O
( ( O
ss NN O
) ) O
DNA NN O
binding VBG O
motif NN O
that WDT O
is VBZ O
unique JJ O
the DT O
large JJ O
terminase NN B-Gene
proteins NNS I-Gene
in IN O
T4 NNP B-Gene
gp17 NN I-Gene
, , O
and CC O
that DT O
has VBZ O
been VBN O
implicated VBN O
in IN O
recognizing VBG O
ssDNA NN O
regions NNS O
in IN O
replicating VBG O
and CC O
recombining VBG O
T4DNA NNP O
destined VBD O
to TO O
be VB O
packaged VBN O
. . O

The DT O
etiology NN O
, , O
pathology NN O
, , O
brain NN O
CT NNP O
scan JJ O
features NNS O
, , O
clinical JJ O
manifestations NNS O
and CC O
treatment NN O
of IN O
these DT O
accidents NNS O
were VBD O
discussed VBN O
. . O

Furthermore RB O
, , O
plasma JJ O
fibrinogen NN B-Gene
levels NNS O
increased VBN O
by IN O
a DT O
mean NN O
of IN O
17 CD O
. . O
6 CD O
% NN O
, , O
a DT O
potentially RB O
adverse JJ O
effect NN O
of IN O
gemfibrozil NN O
that WDT O
has VBZ O
not RB O
been VBN O
previously RB O
reported VBN O
. . O

Motile NNP O
nocardoid JJ O
Actinomycetales NNP O
. . O

The DT O
interaction NN O
of IN O
U1 NNP B-Gene
- : I-Gene
70K CD I-Gene
with IN O
the DT O
SRZ NNP B-Gene
proteins VBZ I-Gene
is VBZ O
confirmed VBN O
further RB O
in IN O
vitro NN O
using VBG O
a DT O
blot NN O
overlay NN O
assay NN O
. . O

Skin NNP O
cancers NNS O
, , O
followed VBN O
by IN O
gastrointestinal JJ O
tract NN O
and CC O
male NN O
genital JJ O
system NN O
affected VBD O
mostly RB O
older JJR O
age NN O
patients NNS O
. . O

Relief NN O
from IN O
autoinhibition NN O
and CC O
a DT O
subsequent JJ O
10 CD O
- : O
60 CD O
- : O
fold JJ O
increase NN O
in IN O
V NNP O
( ( O
max NN O
) ) O
have VBP O
been VBN O
observed VBN O
upon IN O
N NNP B-Gene
- : I-Gene
SH2 NNP I-Gene
domain NN I-Gene
engagement NN O
by IN O
a DT O
specific JJ O
phosphotyrosyl NN O
ligand NN O
or CC O
upon IN O
deletion NN O
of IN O
the DT O
SH2 NNP B-Gene
domains VBZ I-Gene
to TO O
yield VB O
the DT O
catalytic JJ O
PTPase NNP B-Gene
domain NN I-Gene
. . O

Acute NNP O
pancreatitis NN O
as IN O
a DT O
complication NN O
of IN O
polyarteritis NN O
nodosa NN O
. . O

Two CD O
of IN O
these DT O
resulted VBN O
in IN O
increased JJ O
levels NNS O
of IN O
the DT O
alpha NN O
subunit NN O
, , O
and CC O
one CD O
caused VBD O
a DT O
substitution NN O
of IN O
glycine NN O
for IN O
the DT O
aspartic JJ O
acid NN O
residue NN O
at IN O
position NN O
171 CD O
, , O
in IN O
the DT O
N NNP O
- : O
terminal NN O
domain NN O
. . O

Yeast NN O
mutants NNS O
assigned VBN O
to TO O
the DT O
pet JJ B-Gene
complementation NN O
group NN O
G104 NNP O
were VBD O
found VBN O
to TO O
lack VB O
alpha JJ B-Gene
- : I-Gene
ketoglutarate VB I-Gene
dehydrogenase NN I-Gene
activity NN O
as IN O
a DT O
result NN O
of IN O
mutations NNS O
in IN O
the DT O
dihydrolipoyl NN B-Gene
transsuccinylase NN I-Gene
( ( O
KE2 NNP B-Gene
) ) O
component NN O
of IN O
the DT O
complex NN O
. . O

They PRP O
contrast VBP O
trends NNS O
in IN O
fertility NN O
, , O
life NN O
expectancy NN O
ratios NNS O
, , O
and CC O
gender NN O
differences NNS O
in IN O
these DT O
countries NNS O
with IN O
the DT O
Hispanic JJ O
population NN O
of IN O
the DT O
United NNP O
States NNPS O
. . O

The DT O
secondary JJ O
, , O
but CC O
not RB O
the DT O
primary JJ O
, , O
antibody JJ O
responses NNS O
of IN O
male JJ O
C57Bl NNP O
/ NNP O
6 CD O
mice NN O
were VBD O
higher JJR O
among IN O
mice NNS O
housed VBD O
alone RB O
compared VBN O
to TO O
mice NNS O
housed VBN O
in IN O
groups NNS O
; : O
differences NNS O
were VBD O
observed VBN O
for IN O
both DT O
IgM NNP B-Gene
and CC O
IgG NNP B-Gene
anti VBP I-Gene
- : I-Gene
KLH NNP I-Gene
antibodies NNS I-Gene
. . O

CKII NNP B-Gene
as IN O
a DT O
CD44 NNP B-Gene
- : I-Gene
associated VBN I-Gene
serine JJ I-Gene
kinase NN I-Gene
therefore NN O
may MD O
serve VB O
as IN O
an DT O
important JJ O
molecule NN O
in IN O
a DT O
signaling NN O
cascade NN O
that WDT O
produces VBZ O
a DT O
variety NN O
of IN O
cellular JJ O
responses NNS O
in IN O
MDA231 NNP O
breast NN O
cancer NN O
cells NNS O
. . O

We PRP O
also RB O
localized VBD O
the DT O
Fra NNP B-Gene
- : I-Gene
2 CD I-Gene
phosphorylation NN I-Gene
sites NNS I-Gene
by IN O
MAPK NNP B-Gene
to TO O
three CD O
threonine NN O
and CC O
three CD O
serine NN O
residues NNS O
in IN O
the DT O
COOH NNP O
- : O
terminal JJ O
region NN O
by IN O
means NNS O
of IN O
site NN O
- : O
directed VBN O
mutagenesis NN O
and CC O
showed VBD O
that IN O
the DT O
threonine NN O
residues NNS O
were VBD O
more RBR O
susceptible JJ O
to TO O
MAPK NNP B-Gene
. . O

SSF JJ O
experiments NNS O
were VBD O
carried VBN O
out RP O
in IN O
bench JJ O
- : O
scale NN O
bioreactors NNS O
( ( O
equipped VBN O
with IN O
CO2 NNP O
and CC O
volatile JJ O
organic JJ O
traps NNS O
) ) O
containing VBG O
a DT O
mixture NN O
of IN O
lignocellulosic JJ O
materials NNS O
and CC O
a DT O
radiolabeled JJ O
pesticide NN O
. . O

Sequence NNP O
analysis NN O
of IN O
this DT O
100 CD O
- : O
bp NN O
Col2a1 NNP B-Gene
enhancer NN I-Gene
revealed VBD O
several JJ O
sequence NN O
motifs NNS O
similar JJ O
to TO O
motifs VB O
present JJ O
within IN O
the DT O
regulatory JJ O
region NN O
of IN O
the DT O
link NN B-Gene
protein NN I-Gene
gene NN I-Gene
, , O
another DT O
cartilage NN O
gene NN O
. . O

In IN O
addition NN O
, , O
the DT O
megabase NN O
region NN O
surrounding VBG O
the DT O
dagA NN B-Gene
locus NN I-Gene
was VBD O
mapped VBN O
. . O

STUDY NNP O
OBJECTIVE NNP O
: : O
This DT O
study NN O
assessed VBD O
several JJ O
methodological JJ O
aspects NNS O
related VBN O
to TO O
the DT O
quality NN O
of IN O
published VBN O
controlled JJ O
clinical JJ O
trials NNS O
( ( O
CCTs NNP O
) ) O
in IN O
relation NN O
to TO O
the DT O
participation NN O
of IN O
an DT O
epidemiologist NN O
/ NN O
biostatistician NN O
( ( O
E NNP O
/ NNP O
B NNP O
) ) O
. . O

BACKGROUND NN O
: : O
Ischemic JJ O
heart NN O
disease NN O
is VBZ O
the DT O
primary JJ O
cause NN O
of IN O
morbidity NN O
and CC O
mortality NN O
among IN O
diabetics NNS O
, , O
especially RB O
those DT O
who WP O
became VBD O
ill RB O
at IN O
a DT O
young JJ O
age NN O
. . O

CONCLUSION NN O
: : O
These DT O
findings NNS O
imply VBP O
that IN O
eotaxin NN O
either DT O
is VBZ O
mechanistically RB O
involved VBN O
in IN O
acute JJ O
asthma NN O
or CC O
serves NNS O
as IN O
a DT O
biomarker NN O
for IN O
activity NN O
of IN O
the DT O
CCR3 NNP B-Gene
receptor NN I-Gene
ligand NN I-Gene
system NN O
, , O
which WDT O
is VBZ O
functionally RB O
linked VBN O
to TO O
asthma VB O
. . O

Some DT O
artificial JJ O
promoter NN O
constructs NNS O
containing VBG O
multiple JJ O
Sp1 NNP B-Gene
sites NNS I-Gene
were VBD O
highly RB O
responsive JJ O
to TO O
ethanol VB O
, , O
but CC O
others NNS O
were VBD O
not RB O
, , O
suggesting VBG O
that IN O
the DT O
organization NN O
of IN O
the DT O
proximal JJ O
promoter NN O
region NN O
was VBD O
an DT O
additional JJ O
factor NN O
that WDT O
affected VBD O
the DT O
ethanol JJ O
response NN O
. . O

Moreover RB O
, , O
expression NN O
of IN O
antisense NN B-Gene
Ha NNP I-Gene
- : I-Gene
Ras NN I-Gene
or CC O
dominant JJ B-Gene
negative JJ I-Gene
Raf NNP I-Gene
- : I-Gene
1 CD I-Gene
abrogated VBD O
the DT O
mitogenic JJ O
effect NN O
of IN O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
in IN O
TSU NNP O
- : O
Pr1 NN O
, , O
and CC O
the DT O
TGF NNP B-Gene
- : I-Gene
beta1 NN I-Gene
inhibition NN O
of IN O
DU145 NNP O
was VBD O
switched VBN O
to TO O
stimulation NN O
by IN O
V12Ha NNP B-Gene
- : I-Gene
Ras NNP I-Gene
transfection NN O
. . O

Unlike IN O
most JJS O
other JJ O
members NNS O
of IN O
the DT O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
family NN I-Gene
, , O
BAD NNP B-Gene
( ( O
Bcl NNP B-Gene
- : I-Gene
xL NN I-Gene
/ NN I-Gene
Bcl NNP I-Gene
- : I-Gene
2 CD I-Gene
associated VBN I-Gene
death NN I-Gene
promoter NN I-Gene
) ) O
, , O
a DT O
death NN B-Gene
enhancer NN I-Gene
, , O
has VBZ O
no DT O
C NNP O
- : O
terminal JJ O
transmembrane NN O
domain NN O
for IN O
targeting VBG O
to TO O
the DT O
outer NN O
mitochondrial JJ O
membrane NN O
and CC O
nuclear JJ O
envelope NN O
. . O

Cicatricial JJ O
pemphigoid NN O
is VBZ O
an DT O
autoimmune JJ O
systemic JJ O
disease NN O
characterized VBN O
by IN O
chronic JJ O
conjunctival NN O
cicatrization NN O
. . O

The DT O
opioid JJ O
antagonist NN O
naltrexone NN O
( ( O
0 CD O
. . O
1 CD O
- : O
1 CD O
. . O
0 CD O
mg JJ O
/ NNP O
kg NN O
) ) O
antagonized VBD O
the DT O
discriminative JJ O
stimulus NN O
effects NNS O
of IN O
heroin NN O
, , O
but CC O
naltrexone RB O
at IN O
doses NNS O
up RB O
to TO O
10 CD O
mg NNS O
/ JJ O
kg NNS O
had VBD O
no DT O
effect NN O
on IN O
the DT O
discriminative JJ O
stimulus NN O
effects NNS O
of IN O
cocaine NN O
. . O

Similar JJ O
clinical JJ O
evaluation NN O
of IN O
an DT O
obligate NN O
carrier NN O
revealed VBD O
no DT O
ocular JJ O
abnormalities NNS O
. . O

Serum NNP O
levels NNS O
of IN O
albumin NN B-Gene
, , O
globulin NN B-Gene
, , O
and CC O
coagulation NN B-Gene
protein NN I-Gene
activity NN O
were VBD O
measured VBN O
preshock NN O
, , O
postshock NN O
, , O
and CC O
daily RB O
for IN O
3 CD O
days NNS O
; : O
skin JJ O
lymph NN O
levels NNS O
were VBD O
measured VBN O
on IN O
Day NNP O
3 CD O
. . O

Lead JJ O
fixation NN O
in IN O
dogs NNS O
achieved VBN O
with IN O
RF NNP O
energy NN O
. . O

Tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
alpha RB I-Gene
) ) O
, , O
a DT O
proinflammatory NN O
cytokine NN O
, , O
inhibits VBZ O
cAMP SYM O
- : O
stimulated VBN O
testosterone NN O
production NN O
in IN O
mouse NN O
Leydig NNP O
cells NNS O
. . O

The DT O
carcass NN O
of IN O
a DT O
great JJ O
horned VBN O
owl NN O
( ( O
Bubo NNP O
virginianus NN O
) ) O
, , O
which WDT O
had VBD O
been VBN O
found VBN O
moribund RBR O
in IN O
southern JJ O
Ontario NNP O
, , O
was VBD O
presented VBN O
for IN O
necropsy NN O
. . O

The DT O
spleen JJ O
rate NN O
of IN O
about IN O
600 CD O
villagers NNS O
of IN O
RK NNP O
I PRP O
examined VBD O
was VBD O
54 CD O
. . O
3 CD O
% NN O
and CC O
the DT O
parasite JJ O
rate NN O
13 CD O
. . O
2 CD O
% NN O
before IN O
the DT O
drug NN O
intervention NN O
. . O

We PRP O
established VBD O
the DT O
radiosensitive NN O
cell NN O
line NN O
SX9 NNP O
from IN O
mammary JJ O
carcinoma NN O
cell NN O
line NN O
FM3A NNP O
. . O

These DT O
thyroid VB O
hormone NN O
changes NNS O
may MD O
be VB O
mediated VBN O
in IN O
part NN O
by IN O
cytokines NNS O
or CC O
other JJ O
inflammatory JJ O
mediators NNS O
, , O
acting VBG O
at IN O
the DT O
level NN O
of IN O
the DT O
hypothalamus NN O
and CC O
pituitary JJ O
gland NN O
, , O
the DT O
thyroid NN O
gland NN O
, , O
and CC O
the DT O
hepatic JJ B-Gene
deiodinase NN I-Gene
system NN O
. . O

Although IN O
YopH NNP B-Gene
is VBZ O
a DT O
highly RB O
active JJ O
PTP NNP B-Gene
, , O
it PRP O
preferentially RB O
targets VBZ O
a DT O
subset NN O
of IN O
tyrosine JJ O
- : O
phosphorylated JJ O
proteins NNS O
in IN O
host NN O
cells NNS O
, , O
including VBG O
p130Cas NN B-Gene
. . O

Regulation NN O
of IN O
yeast NN B-Gene
LEU2 NNP I-Gene
. . O

In IN O
the DT O
long JJ O
term NN O
, , O
questions NNS O
still RB O
remain VBP O
about IN O
whether IN O
pre NN O
- : O
dialysis NN O
rHu NN B-Gene
EPO NNP I-Gene
either CC O
speeds VBZ O
up RP O
or CC O
delays VB O
the DT O
onset NN O
of IN O
dialysis NN O
. . O

Positive NNP O
genetic JJ O
selections NNS O
for IN O
inhibition NN O
of IN O
cyclin NN B-Gene
/ NNP O
CDK NNP B-Gene
function NN O
were VBD O
characterized VBN O
using VBG O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
neo NN I-Gene
and CC O
yeast NN B-Gene
LEU2 NNP I-Gene
genes NNS I-Gene
. . O

The DT O
core NN O
promoter NN O
of IN O
human JJ B-Gene
thioredoxin NN I-Gene
reductase NN I-Gene
1 CD I-Gene
: : O
cloning NN O
, , O
transcriptional JJ O
activity NN O
, , O
and CC O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
Sp1 NNP B-Gene
, , O
and CC O
Sp3 NNP B-Gene
binding VBG O
reveal VB O
a DT O
housekeeping NN O
- : O
type NN O
promoter NN O
for IN O
the DT O
AU NNP O
- : O
rich JJ O
element NN O
- : O
regulated VBN O
gene NN O
. . O

A DT O
novel JJ O
gene NN O
designated VBN O
cmr NN B-Gene
, , O
which WDT O
mapped VBD O
to TO O
18 CD O
. . O
8 CD O
min NN O
of IN O
the DT O
Escherichia NNP O
coli NN O
K NNP O
- : O
12 CD O
genome NN O
, , O
was VBD O
shown VBN O
to TO O
mediate VB O
resistance NN O
to TO O
chloramphenicol VB O
when WRB O
it PRP O
was VBD O
expressed VBN O
from IN O
a DT O
multicopy NN O
vector NN O
. . O

The DT O
results NNS O
obtained VBD O
tend JJ O
to TO O
prove VB O
that IN O
the DT O
reticuloendothelial JJ O
system NN O
mainly RB O
participated VBD O
in IN O
beryllium NN O
retention NN O
. . O

Strontium NN O
nitrate NN O
mixed JJ O
with IN O
glycolic JJ O
acid NN O
, , O
in IN O
comparison NN O
with IN O
glycolic JJ O
acid NN O
alone RB O
, , O
markedly RB O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
shortened VBD O
the DT O
duration NN O
of IN O
the DT O
irritation NN O
sensation NN O
from IN O
24 CD O
. . O
4 CD O
+ JJ O
/ NNP O
- : O
4 CD O
. . O
1 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SEM NN O
) ) O
min NN O
to TO O
8 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
7 CD O
( ( O
mean JJ O
+ NNP O
/ NNP O
- : O
SEM NN O
) ) O
min NN O
, , O
and CC O
significantly RB O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
reduced VBD O
the DT O
mean JJ O
magnitude NN O
of IN O
the DT O
irritation NN O
sensation NN O
at IN O
all DT O
time NN O
points NNS O
( ( O
overall JJ O
) ) O
. . O

After IN O
the DT O
application NN O
of IN O
RS NNP O
86 CD O
, , O
REM NNP O
latency NN O
was VBD O
shortened VBN O
in IN O
all DT O
groups NNS O
under IN O
investigation NN O
. . O

This DT O
study NN O
is VBZ O
a DT O
further JJ O
and CC O
more RBR O
extensive JJ O
validation NN O
of IN O
the DT O
clinician JJ O
rated VBN O
NIMH NNP O
- : O
LCM NNP O
- : O
p NN O
. . O

Contractile JJ O
responses NNS O
to TO O
norepinephrine VB O
, , O
serotonin NN O
and CC O
potassium NN O
( ( O
K NNP O
+ NNP O
) ) O
and CC O
relaxant JJ O
responses NNS O
to TO O
isoproterenol VB O
and CC O
papaverine VB O
were VBD O
studied VBN O
in IN O
vitro NN O
with IN O
spirally RB O
cut VBN O
thoracic JJ O
aortic JJ O
strips NNS O
from IN O
aortic JJ O
coarcted VBN O
hypertensive JJ O
rats NNS O
( ( O
AHR NNP O
) ) O
2 CD O
, , O
6 CD O
, , O
14 CD O
and CC O
28 CD O
days NNS O
postoperatively RB O
and CC O
compared VBN O
to TO O
time NN O
- : O
matched VBN O
, , O
sham SYM O
- : O
operated VBN O
normotensive JJ O
controls NNS O
. . O

Flow JJ O
cytomery NN O
was VBD O
used VBN O
for IN O
cell NN O
cycle NN O
analysis NN O
. . O

When WRB O
examined VBN O
as IN O
adults NNS O
( ( O
8 CD O
weeks NNS O
old JJ O
) ) O
, , O
the DT O
external JJ O
genitalia NN O
of IN O
TA NNP O
- : O
exposed VBD O
offspring VBG O
were VBD O
normal JJ O
. . O

The DT O
patient JJ O
underwent JJ O
two CD O
intracytoplasmic JJ O
sperm JJ O
injection NN O
cycles NNS O
with IN O
thawed VBN O
epididymal JJ O
spermatozoa NN O
, , O
in IN O
which WDT O
, , O
due JJ O
to TO O
a DT O
pharmacist NN O
' POS O
s NNS O
mistake VBP O
, , O
ovarian JJ O
stimulation NN O
was VBD O
carried VBN O
out RP O
by IN O
a DT O
combination NN O
of IN O
long JJ O
- : O
acting VBG O
gonadotrophin JJ B-Gene
- : I-Gene
releasing VBG I-Gene
hormone NN I-Gene
agonist NN O
( ( O
leuprolide IN O
depot NN O
) ) O
and CC O
gonadotrophins NNS B-Gene
. . O
